id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
155266088|NCT01486758|560409003|FG000|Overall Study|Lost to Follow-up|0|||
155266089|NCT01486758|560409004|FG001|Overall Study|Lost to Follow-up|1|||
155266090|NCT01062763|560409005|FG000|Overall Study|Adverse Event|3|||
155266091|NCT01062763|560409006|FG001|Overall Study|Adverse Event|4|||
155266092|NCT02392611|560409007|FG000|Overall Study|Adverse Event|0|||
155266093|NCT02392611|560409008|FG001|Overall Study|Adverse Event|0|||
155266094|NCT02392611|560409009|FG002|Overall Study|Adverse Event|0|||
155266095|NCT02392611|560409010|FG003|Overall Study|Adverse Event|1|||
155266096|NCT02392611|560409011|FG004|Overall Study|Adverse Event|0|||
155266097|NCT02392611|560409012|FG005|Overall Study|Adverse Event|0|||
155266098|NCT02392611|560409013|FG006|Overall Study|Adverse Event|0|||
155266099|NCT02392611|560409014|FG007|Overall Study|Adverse Event|0|||
155266100|NCT02392611|560409015|FG008|Overall Study|Adverse Event|0|||
155266101|NCT02392611|560409007|FG000|Overall Study|Progressive disease|0|||
155266102|NCT02392611|560409008|FG001|Overall Study|Progressive disease|0|||
155266103|NCT02392611|560409009|FG002|Overall Study|Progressive disease|0|||
155266104|NCT02392611|560409010|FG003|Overall Study|Progressive disease|2|||
155266105|NCT02392611|560409011|FG004|Overall Study|Progressive disease|1|||
155266106|NCT02392611|560409012|FG005|Overall Study|Progressive disease|0|||
155266107|NCT02392611|560409013|FG006|Overall Study|Progressive disease|0|||
155266108|NCT02392611|560409014|FG007|Overall Study|Progressive disease|0|||
155266109|NCT02392611|560409015|FG008|Overall Study|Progressive disease|0|||
155266110|NCT02392611|560409007|FG000|Overall Study|Death|1|||
155266111|NCT02392611|560409008|FG001|Overall Study|Death|0|||
155266112|NCT02392611|560409009|FG002|Overall Study|Death|0|||
155266113|NCT02392611|560409010|FG003|Overall Study|Death|0|||
155266114|NCT02392611|560409011|FG004|Overall Study|Death|0|||
155266115|NCT02392611|560409012|FG005|Overall Study|Death|1|||
155266116|NCT02392611|560409013|FG006|Overall Study|Death|0|||
155266117|NCT02392611|560409014|FG007|Overall Study|Death|0|||
155266118|NCT02392611|560409015|FG008|Overall Study|Death|0|||
155266119|NCT02392611|560409007|FG000|Overall Study|Withdrawal by Subject|0|||
155266120|NCT02392611|560409008|FG001|Overall Study|Withdrawal by Subject|0|||
155266121|NCT02392611|560409009|FG002|Overall Study|Withdrawal by Subject|0|||
155266122|NCT02392611|560409010|FG003|Overall Study|Withdrawal by Subject|1|||
155266123|NCT02392611|560409011|FG004|Overall Study|Withdrawal by Subject|0|||
155266124|NCT02392611|560409012|FG005|Overall Study|Withdrawal by Subject|0|||
155266125|NCT02392611|560409013|FG006|Overall Study|Withdrawal by Subject|0|||
155266126|NCT02392611|560409014|FG007|Overall Study|Withdrawal by Subject|0|||
155266127|NCT02392611|560409015|FG008|Overall Study|Withdrawal by Subject|0|||
155266128|NCT02392611|560409007|FG000|Overall Study|Lost to Follow-up|0|||
155266129|NCT02392611|560409008|FG001|Overall Study|Lost to Follow-up|0|||
155266130|NCT02392611|560409009|FG002|Overall Study|Lost to Follow-up|0|||
155266131|NCT02392611|560409010|FG003|Overall Study|Lost to Follow-up|0|||
155266132|NCT02392611|560409011|FG004|Overall Study|Lost to Follow-up|0|||
155266133|NCT02392611|560409012|FG005|Overall Study|Lost to Follow-up|0|||
155266134|NCT02392611|560409013|FG006|Overall Study|Lost to Follow-up|1|||
155266135|NCT02392611|560409014|FG007|Overall Study|Lost to Follow-up|0|||
155266136|NCT02392611|560409015|FG008|Overall Study|Lost to Follow-up|0|||
155266137|NCT02392611|560409007|FG000|Overall Study|Enrolled, not treated|0|||
155266138|NCT02392611|560409008|FG001|Overall Study|Enrolled, not treated|0|||
155266139|NCT02392611|560409009|FG002|Overall Study|Enrolled, not treated|0|||
155266140|NCT02392611|560409010|FG003|Overall Study|Enrolled, not treated|2|||
155266141|NCT02392611|560409011|FG004|Overall Study|Enrolled, not treated|0|||
155266142|NCT02392611|560409012|FG005|Overall Study|Enrolled, not treated|0|||
155266143|NCT02392611|560409013|FG006|Overall Study|Enrolled, not treated|0|||
155266144|NCT02392611|560409014|FG007|Overall Study|Enrolled, not treated|0|||
155266145|NCT02392611|560409015|FG008|Overall Study|Enrolled, not treated|0|||
155266146|NCT03239873|560409019|FG000|Overall Study|Lost to Follow-up|15|||
155266147|NCT03239873|560409020|FG001|Overall Study|Lost to Follow-up|16|||
155266148|NCT03239873|560409019|FG000|Overall Study|Physician Decision|1|||
155266149|NCT03239873|560409020|FG001|Overall Study|Physician Decision|0|||
155266150|NCT03239873|560409019|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
155266151|NCT03239873|560409020|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
155266152|NCT03239873|560409019|FG000|Overall Study|Withdrawal by Subject|2|||
155266153|NCT03239873|560409020|FG001|Overall Study|Withdrawal by Subject|0|||
155266154|NCT03239873|560409019|FG000|Overall Study|Contraindication to study medication|1|||
155266155|NCT03239873|560409020|FG001|Overall Study|Contraindication to study medication|0|||
155266156|NCT03239873|560409019|FG000|Overall Study|Protocol Violation|1|||
155266157|NCT03239873|560409020|FG001|Overall Study|Protocol Violation|0|||
155266158|NCT02291432|560409025|FG000|Overall Study|Withdrawal by Subject|2|||
155266159|NCT02145078|560409028|FG000|Overall Study|Death|1|||
155266160|NCT02145078|560409028|FG000|Overall Study|Reason not given|3|||
155266161|NCT00519896|560409029|FG000|Overall Study|Protocol Violation|1|||
155266162|NCT00519896|560409029|FG000|Overall Study|Adverse Event|1|||
155266163|NCT00810082|560409030|FG000|Overall Study|Lost to Follow-up|0|||
155266164|NCT00810082|560409031|FG001|Overall Study|Lost to Follow-up|4|||
155266165|NCT03327402|560409032|FG000|Overall Study|Withdrawal by Subject|1|||
155266166|NCT03327402|560409032|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
155266167|NCT01454830|560409035|FG000|Overall Study|Withdrawal by Subject|4|||
155266168|NCT01454830|560409036|FG001|Overall Study|Withdrawal by Subject|4|||
155266169|NCT01454830|560409035|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
155266170|NCT01454830|560409036|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
155266171|NCT01454830|560409035|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
155266172|NCT01454830|560409036|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
155266173|NCT01454830|560409035|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
155266174|NCT01454830|560409036|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
155266175|NCT01454830|560409035|FG000|Overall Study|Withdrawal - no polysomnography|3|||
155266176|NCT01454830|560409036|FG001|Overall Study|Withdrawal - no polysomnography|2|||
155266177|NCT00584805|560409037|FG000|Overall Study|No longer at risk of exposure|39|||
155266178|NCT00584805|560409037|FG000|Overall Study|Relocation|36|||
155266179|NCT00584805|560409037|FG000|Overall Study|Withdrawal by Subject|18|||
155266180|NCT00584805|560409037|FG000|Overall Study|Non-compliance|1|||
155266181|NCT00584805|560409037|FG000|Overall Study|Lost to follow up|3|||
155266182|NCT00584805|560409037|FG000|Overall Study|Screen failures|2|||
155266183|NCT01077362|560409038|FG000|Overall Study|Lack of Efficacy|13|||
155266184|NCT01077362|560409039|FG001|Overall Study|Lack of Efficacy|8|||
155266185|NCT01077362|560409040|FG002|Overall Study|Lack of Efficacy|10|||
155266186|NCT01077362|560409038|FG000|Overall Study|Lost to Follow-up|1|||
155266187|NCT01077362|560409039|FG001|Overall Study|Lost to Follow-up|0|||
155266188|NCT01077362|560409040|FG002|Overall Study|Lost to Follow-up|3|||
155266189|NCT01077362|560409038|FG000|Overall Study|Adverse Event|12|||
155266190|NCT01077362|560409039|FG001|Overall Study|Adverse Event|7|||
155266191|NCT01077362|560409040|FG002|Overall Study|Adverse Event|4|||
155266192|NCT01077362|560409038|FG000|Overall Study|Withdrawal by Subject|5|||
155266193|NCT01077362|560409039|FG001|Overall Study|Withdrawal by Subject|3|||
155266194|NCT01077362|560409040|FG002|Overall Study|Withdrawal by Subject|5|||
155266195|NCT01077362|560409038|FG000|Overall Study|Other|0|||
155266196|NCT01077362|560409039|FG001|Overall Study|Other|1|||
155266197|NCT01077362|560409040|FG002|Overall Study|Other|2|||
155266198|NCT00301080|560409041|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
155266199|NCT00301080|560409042|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266200|NCT00301080|560409043|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266201|NCT00301080|560409044|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266202|NCT00301080|560409045|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
155266203|NCT03097861|560409046|FG000|Overall Study|Adverse Event|3|||
155266204|NCT03097861|560409047|FG001|Overall Study|Adverse Event|8|||
155266205|NCT03097861|560409048|FG002|Overall Study|Adverse Event|4|||
155266206|NCT03097861|560409046|FG000|Overall Study|Investigator Decision|0|||
155266207|NCT03097861|560409047|FG001|Overall Study|Investigator Decision|1|||
155266208|NCT03097861|560409048|FG002|Overall Study|Investigator Decision|0|||
155266209|NCT03097861|560409046|FG000|Overall Study|Lost to Follow-up|0|||
155266210|NCT03097861|560409047|FG001|Overall Study|Lost to Follow-up|7|||
155152088|NCT01352117|559994045|FG000|Overall Study|Death|15|||
155152089|NCT01352117|559994046|FG001|Overall Study|Death|16|||
155152090|NCT01352117|559994045|FG000|Overall Study|Withdrawal by Subject|1|||
155152091|NCT01352117|559994046|FG001|Overall Study|Withdrawal by Subject|0|||
155152092|NCT01352117|559994045|FG000|Overall Study|Lost to Follow-up|2|||
155152093|NCT01352117|559994046|FG001|Overall Study|Lost to Follow-up|7|||
155152094|NCT01352117|559994045|FG000|Overall Study|Non-adherent to study requirements|1|||
155266211|NCT03097861|560409048|FG002|Overall Study|Lost to Follow-up|1|||
155266212|NCT03097861|560409046|FG000|Overall Study|Withdrawal by Subject|1|||
155266213|NCT03097861|560409047|FG001|Overall Study|Withdrawal by Subject|5|||
155266214|NCT03097861|560409048|FG002|Overall Study|Withdrawal by Subject|3|||
155266215|NCT03097861|560409046|FG000|Overall Study|Reason not provided|3|||
155266216|NCT03097861|560409047|FG001|Overall Study|Reason not provided|1|||
155266217|NCT03097861|560409048|FG002|Overall Study|Reason not provided|1|||
155266218|NCT03502616|560409049|FG000|Up to Week 16|Withdrawal by Subject|1|||
154924310|NCT00457249|559147989|FG000|Overall Study|Lost to Follow-up|3|||
154924311|NCT00457249|559147990|FG001|Overall Study|Lost to Follow-up|0|||
154924312|NCT00457249|559147989|FG000|Overall Study|Protocol Violation|4|||
154924313|NCT00457249|559147990|FG001|Overall Study|Protocol Violation|1|||
155266219|NCT03502616|560409050|FG001|Up to Week 16|Withdrawal by Subject|2|||
155266220|NCT03502616|560409049|FG000|Up to Week 16|Lost to Follow-up|0|||
155266221|NCT03502616|560409050|FG001|Up to Week 16|Lost to Follow-up|1|||
154924314|NCT00457249|559147989|FG000|Overall Study|Withdrawal by Subject|3|||
155152095|NCT01352117|559994046|FG001|Overall Study|Non-adherent to study requirements|1|||
155152096|NCT01352117|559994045|FG000|Overall Study|Did not initiate study treatment|1|||
155152097|NCT01352117|559994046|FG001|Overall Study|Did not initiate study treatment|0|||
155152098|NCT01352117|559994045|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
155152099|NCT01352117|559994046|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
155266222|NCT03502616|560409049|FG000|Up to Week 16|Randomized, but not treated|1|||
155266223|NCT03502616|560409050|FG001|Up to Week 16|Randomized, but not treated|0|||
155266224|NCT03502616|560409049|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
155266225|NCT03502616|560409050|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
155266226|NCT03502616|560409049|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
155266227|NCT03502616|560409050|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
155266228|NCT01785563|560409052|FG000|Overall Study|Physician Decision|10|||
155266229|NCT01785563|560409052|FG000|Overall Study|Withdrawal by Subject|1|||
155266230|NCT01785563|560409052|FG000|Overall Study|Protocol Violation|2|||
155266231|NCT01616771|560409055|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
155266232|NCT00744328|560409056|FG000|Overall Study|Lost to Follow-up|2|||
155266233|NCT00744328|560409057|FG001|Overall Study|Lost to Follow-up|5|||
155152100|NCT02994108|559994048|FG000|Intervention Messages|Withdrawal by Subject|2|||
155152101|NCT02994108|559994049|FG001|Intervention Messages|Withdrawal by Subject|0|||
155152102|NCT02994108|559994048|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
155152103|NCT02994108|559994049|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
155152104|NCT02994108|559994048|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
155152105|NCT02994108|559994049|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
155152106|NCT02994108|559994048|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
155152107|NCT02994108|559994049|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
155152108|NCT00089297|559994050|FG000|Overall Study|Adverse Event|9|||
155152109|NCT00089297|559994050|FG000|Overall Study|Death|1|||
155152110|NCT00089297|559994050|FG000|Overall Study|Withdrawal by Subject|12|||
155152111|NCT00089297|559994050|FG000|Overall Study|Disease progression|2|||
155152112|NCT00089297|559994050|FG000|Overall Study|Ineligible|11|||
155152113|NCT00089297|559994050|FG000|Overall Study|Secondary malignancy|1|||
155152114|NCT00089297|559994050|FG000|Overall Study|IRB approval not ready|1|||
155152115|NCT00089297|559994050|FG000|Overall Study|Non-compliance|1|||
155152116|NCT00904969|559994051|FG000|Overall Study|Lost to Follow-up|4|||
155152117|NCT00904969|559994051|FG000|Overall Study|Withdrawal by Subject|3|||
155152118|NCT00904969|559994051|FG000|Overall Study|Additional Treatments|11|||
155152119|NCT00904969|559994051|FG000|Overall Study|Case Aborted; Subject Exited|1|||
155152120|NCT01097668|559994052|FG000|Overall Study|Withdrawal by Subject|1|||
155152121|NCT01097668|559994053|FG001|Overall Study|Withdrawal by Subject|2|||
155152122|NCT01097668|559994052|FG000|Overall Study|Lost to Follow-up|1|||
155152123|NCT01097668|559994053|FG001|Overall Study|Lost to Follow-up|0|||
155152124|NCT04515771|559994061|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
155152125|NCT04515771|559994062|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
155152126|NCT04515771|559994061|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
155152127|NCT04515771|559994062|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
155152128|NCT04515771|559994061|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
155152129|NCT04515771|559994062|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
155152130|NCT00948246|559994065|FG000|Overall Study|Lost to Follow-up|11|||
155152131|NCT00948246|559994065|FG000|Overall Study|Adverse Event|11|||
155152132|NCT00948246|559994065|FG000|Overall Study|Death|1|||
155152133|NCT00948246|559994065|FG000|Overall Study|Withdrawal by Subject|1|||
155152134|NCT00148317|559994066|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
155152135|NCT00148317|559994066|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
155152136|NCT00148317|559994066|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
155152137|NCT04199351|559994069|FG000|Overall Study|Decision by sponsor|0|||
155152138|NCT04199351|559994070|FG001|Overall Study|Decision by sponsor|0|||
155152139|NCT04199351|559994071|FG002|Overall Study|Decision by sponsor|0|||
155152140|NCT04199351|559994072|FG003|Overall Study|Decision by sponsor|2|||
155152141|NCT04199351|559994073|FG004|Overall Study|Decision by sponsor|0|||
155152142|NCT04199351|559994074|FG005|Overall Study|Decision by sponsor|0|||
155152143|NCT04199351|559994075|FG006|Overall Study|Decision by sponsor|0|||
155152144|NCT04199351|559994076|FG007|Overall Study|Decision by sponsor|0|||
155152145|NCT04199351|559994077|FG008|Overall Study|Decision by sponsor|0|||
155152146|NCT04199351|559994078|FG009|Overall Study|Decision by sponsor|6|||
155152147|NCT04199351|559994069|FG000|Overall Study|Lost to Follow-up|0|||
155152148|NCT04199351|559994070|FG001|Overall Study|Lost to Follow-up|0|||
155152149|NCT04199351|559994071|FG002|Overall Study|Lost to Follow-up|1|||
155152150|NCT04199351|559994072|FG003|Overall Study|Lost to Follow-up|0|||
155152151|NCT04199351|559994073|FG004|Overall Study|Lost to Follow-up|0|||
155152152|NCT04199351|559994074|FG005|Overall Study|Lost to Follow-up|1|||
155152153|NCT04199351|559994075|FG006|Overall Study|Lost to Follow-up|0|||
155266234|NCT00744328|560409058|FG002|Overall Study|Lost to Follow-up|3|||
155266235|NCT00744328|560409056|FG000|Overall Study|Withdrawal by Subject|5|||
155266236|NCT00744328|560409057|FG001|Overall Study|Withdrawal by Subject|3|||
155152154|NCT04199351|559994076|FG007|Overall Study|Lost to Follow-up|0|||
155152155|NCT04199351|559994077|FG008|Overall Study|Lost to Follow-up|0|||
155152156|NCT04199351|559994078|FG009|Overall Study|Lost to Follow-up|0|||
155152157|NCT04199351|559994069|FG000|Overall Study|Withdrawal by Subject|0|||
155152158|NCT04199351|559994070|FG001|Overall Study|Withdrawal by Subject|1|||
155152159|NCT04199351|559994071|FG002|Overall Study|Withdrawal by Subject|0|||
155152160|NCT04199351|559994072|FG003|Overall Study|Withdrawal by Subject|0|||
155152161|NCT04199351|559994073|FG004|Overall Study|Withdrawal by Subject|1|||
155152162|NCT04199351|559994074|FG005|Overall Study|Withdrawal by Subject|4|||
155266237|NCT00744328|560409058|FG002|Overall Study|Withdrawal by Subject|4|||
155266238|NCT00744328|560409056|FG000|Overall Study|Found ineligible after randomization|0|||
155152163|NCT04199351|559994075|FG006|Overall Study|Withdrawal by Subject|2|||
155152164|NCT04199351|559994076|FG007|Overall Study|Withdrawal by Subject|0|||
155266239|NCT00744328|560409057|FG001|Overall Study|Found ineligible after randomization|0|||
155266240|NCT00744328|560409058|FG002|Overall Study|Found ineligible after randomization|1|||
155152165|NCT04199351|559994077|FG008|Overall Study|Withdrawal by Subject|3|||
155152166|NCT04199351|559994078|FG009|Overall Study|Withdrawal by Subject|0|||
155152167|NCT03623243|559994081|FG000|Overall Study|Adverse Event|15|||
155152168|NCT03623243|559994081|FG000|Overall Study|Guardian Decision|1|||
155152169|NCT03623243|559994081|FG000|Overall Study|New Therapy for Study Indication|1|||
155152170|NCT03623243|559994081|FG000|Overall Study|Protocol Deviation|3|||
155152171|NCT03623243|559994081|FG000|Overall Study|Physician Decision|4|||
155152172|NCT03623243|559994081|FG000|Overall Study|Patient Decision|15|||
155152173|NCT00979901|559994082|FG000|Overall Study|Adverse Event|1|||
155152174|NCT00979901|559994083|FG001|Overall Study|Adverse Event|3|||
155152175|NCT00979901|559994084|FG002|Overall Study|Adverse Event|9|||
155152176|NCT00979901|559994085|FG003|Overall Study|Adverse Event|2|||
155152177|NCT00979901|559994082|FG000|Overall Study|Lack of Efficacy|8|||
155152178|NCT00979901|559994083|FG001|Overall Study|Lack of Efficacy|4|||
155152179|NCT00979901|559994084|FG002|Overall Study|Lack of Efficacy|9|||
155152180|NCT00979901|559994085|FG003|Overall Study|Lack of Efficacy|0|||
155152181|NCT00979901|559994082|FG000|Overall Study|Lost to Follow-up|1|||
155152182|NCT00979901|559994083|FG001|Overall Study|Lost to Follow-up|1|||
155152183|NCT00979901|559994084|FG002|Overall Study|Lost to Follow-up|2|||
155152184|NCT00979901|559994085|FG003|Overall Study|Lost to Follow-up|0|||
155152185|NCT00979901|559994082|FG000|Overall Study|Protocol Violation|2|||
155152186|NCT00979901|559994083|FG001|Overall Study|Protocol Violation|2|||
155152187|NCT00979901|559994084|FG002|Overall Study|Protocol Violation|7|||
155152188|NCT00979901|559994085|FG003|Overall Study|Protocol Violation|1|||
155152189|NCT00979901|559994082|FG000|Overall Study|Withdrawal by Subject|2|||
155152190|NCT00979901|559994083|FG001|Overall Study|Withdrawal by Subject|1|||
155152191|NCT00979901|559994084|FG002|Overall Study|Withdrawal by Subject|1|||
155152192|NCT00979901|559994085|FG003|Overall Study|Withdrawal by Subject|1|||
155152193|NCT00979901|559994082|FG000|Overall Study|Noncompliance|1|||
155152194|NCT00979901|559994083|FG001|Overall Study|Noncompliance|0|||
155152195|NCT00979901|559994084|FG002|Overall Study|Noncompliance|0|||
155152196|NCT00979901|559994085|FG003|Overall Study|Noncompliance|0|||
155152197|NCT00979901|559994082|FG000|Overall Study|out-of-state|1|||
155152198|NCT00979901|559994083|FG001|Overall Study|out-of-state|0|||
155152199|NCT00979901|559994084|FG002|Overall Study|out-of-state|0|||
155152200|NCT00979901|559994085|FG003|Overall Study|out-of-state|0|||
155152201|NCT00979901|559994082|FG000|Overall Study|vacation|1|||
155152202|NCT00979901|559994083|FG001|Overall Study|vacation|0|||
155266241|NCT04399356|560409062|FG000|Overall Study|Lost to Follow-up|1|||
155266242|NCT04399356|560409063|FG001|Overall Study|Lost to Follow-up|1|||
155266243|NCT04399356|560409062|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
155266244|NCT04399356|560409063|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
155266245|NCT04399356|560409062|FG000|Overall Study|Withdrawal by Subject|1|||
155266246|NCT04399356|560409063|FG001|Overall Study|Withdrawal by Subject|0|||
155266247|NCT02091739|560409064|FG000|MP: 16 Weeks|Adverse Event|1|||
155266248|NCT02091739|560409065|FG001|MP: 16 Weeks|Adverse Event|1|||
155266249|NCT02091739|560409066|FG002|MP: 16 Weeks|Adverse Event|1|||
155266250|NCT02091739|560409067|FG003|MP: 16 Weeks|Adverse Event|0|||
155266251|NCT02091739|560409068|FG004|MP: 16 Weeks|Adverse Event|0|||
155266252|NCT02091739|560409064|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
155266253|NCT02091739|560409065|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
155266254|NCT02091739|560409066|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
155266255|NCT02091739|560409067|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
155266256|NCT02091739|560409068|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
155266257|NCT02091739|560409064|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
155038251|NCT02913105|559567812|FG000|Overall Study|Adverse Event|11|||
155038252|NCT02913105|559567813|FG001|Overall Study|Adverse Event|0|||
155038253|NCT02913105|559567814|FG002|Overall Study|Adverse Event|4|||
155038254|NCT02913105|559567812|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155038255|NCT02913105|559567813|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155038256|NCT02913105|559567814|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155038257|NCT02913105|559567812|FG000|Overall Study|Reason Not Specified|3|||
155038258|NCT02913105|559567813|FG001|Overall Study|Reason Not Specified|1|||
155152203|NCT00979901|559994084|FG002|Overall Study|vacation|0|||
155152204|NCT00979901|559994085|FG003|Overall Study|vacation|0|||
155152205|NCT00979901|559994082|FG000|Overall Study|elevated lab values pre-randomization|1|||
155152206|NCT00979901|559994083|FG001|Overall Study|elevated lab values pre-randomization|0|||
155152207|NCT00979901|559994084|FG002|Overall Study|elevated lab values pre-randomization|0|||
155152208|NCT00979901|559994085|FG003|Overall Study|elevated lab values pre-randomization|0|||
155152209|NCT00979901|559994082|FG000|Overall Study|Discontinued in Error|0|||
155152210|NCT00979901|559994083|FG001|Overall Study|Discontinued in Error|1|||
155152211|NCT00979901|559994084|FG002|Overall Study|Discontinued in Error|0|||
155266258|NCT02091739|560409065|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
155266259|NCT02091739|560409066|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
155152212|NCT00979901|559994085|FG003|Overall Study|Discontinued in Error|0|||
155152213|NCT00979901|559994082|FG000|Overall Study|Left Country|0|||
155152214|NCT00979901|559994083|FG001|Overall Study|Left Country|0|||
155152215|NCT00979901|559994084|FG002|Overall Study|Left Country|1|||
155152216|NCT00979901|559994085|FG003|Overall Study|Left Country|0|||
155152217|NCT00979901|559994082|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
155152218|NCT00979901|559994083|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
155152219|NCT00979901|559994084|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
155152220|NCT00979901|559994085|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
155152221|NCT03924622|559994086|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
155152222|NCT03924622|559994087|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155152223|NCT03924622|559994088|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155152224|NCT03924622|559994089|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
155152225|NCT03924622|559994090|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155152226|NCT03924622|559994091|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
155152227|NCT00248625|559994092|FG000|Overall Study|Withdrawal by Subject|0|||
155152228|NCT00248625|559994093|FG001|Overall Study|Withdrawal by Subject|2|||
155152229|NCT03284710|559994096|FG000|Overall Study|Withdrawal by Subject|1|||
155152230|NCT03284710|559994097|FG001|Overall Study|Withdrawal by Subject|0|||
155152231|NCT03284710|559994098|FG002|Overall Study|Withdrawal by Subject|1|||
155152232|NCT03284710|559994099|FG003|Overall Study|Withdrawal by Subject|6|||
155152233|NCT03284710|559994096|FG000|Overall Study|Lost to Follow-up|3|||
155152234|NCT03284710|559994097|FG001|Overall Study|Lost to Follow-up|3|||
155152235|NCT03284710|559994098|FG002|Overall Study|Lost to Follow-up|1|||
155152236|NCT03284710|559994099|FG003|Overall Study|Lost to Follow-up|0|||
155152237|NCT03284710|559994096|FG000|Overall Study|Physician Decision|1|||
155152238|NCT03284710|559994097|FG001|Overall Study|Physician Decision|0|||
155152239|NCT03284710|559994098|FG002|Overall Study|Physician Decision|0|||
155152240|NCT03284710|559994099|FG003|Overall Study|Physician Decision|0|||
155152241|NCT03284710|559994096|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
155152242|NCT03284710|559994097|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155152243|NCT03284710|559994098|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155152244|NCT03284710|559994099|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
155152245|NCT03284710|559994096|FG000|Overall Study|HIV Infection|0|||
155152246|NCT03284710|559994097|FG001|Overall Study|HIV Infection|2|||
155152247|NCT03284710|559994098|FG002|Overall Study|HIV Infection|2|||
155152248|NCT03284710|559994099|FG003|Overall Study|HIV Infection|1|||
155152249|NCT02814916|559994103|FG000|Overall Study|Withdrawal of consent|0|||
155152250|NCT02814916|559994104|FG001|Overall Study|Withdrawal of consent|2|||
155152251|NCT02814916|559994105|FG002|Overall Study|Withdrawal of consent|0|||
155152252|NCT02814916|559994103|FG000|Overall Study|Lost to Follow-up|0|||
155152253|NCT02814916|559994104|FG001|Overall Study|Lost to Follow-up|1|||
155152254|NCT02814916|559994105|FG002|Overall Study|Lost to Follow-up|0|||
155152255|NCT02814916|559994103|FG000|Overall Study|Other, not specified|0|||
155152256|NCT02814916|559994104|FG001|Overall Study|Other, not specified|1|||
155152257|NCT02814916|559994105|FG002|Overall Study|Other, not specified|0|||
155152258|NCT00286468|559994110|FG000|Overall Study|Hyperglycemic Rescue|28|||
155152259|NCT00286468|559994111|FG001|Overall Study|Hyperglycemic Rescue|30|||
155266260|NCT02091739|560409067|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
155038259|NCT02913105|559567814|FG002|Overall Study|Reason Not Specified|1|||
155266261|NCT02091739|560409068|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
155266262|NCT02091739|560409064|FG000|EP: 48 Weeks|Other|0|||
155266263|NCT02091739|560409065|FG001|EP: 48 Weeks|Other|0|||
155266264|NCT02091739|560409066|FG002|EP: 48 Weeks|Other|0|||
155266265|NCT02091739|560409067|FG003|EP: 48 Weeks|Other|1|||
155266266|NCT02091739|560409068|FG004|EP: 48 Weeks|Other|0|||
155266267|NCT02091739|560409064|FG000|EP: 48 Weeks|Death|0|||
155266268|NCT02091739|560409065|FG001|EP: 48 Weeks|Death|0|||
155266269|NCT02091739|560409066|FG002|EP: 48 Weeks|Death|0|||
155266270|NCT02091739|560409067|FG003|EP: 48 Weeks|Death|3|||
155266271|NCT02091739|560409068|FG004|EP: 48 Weeks|Death|2|||
155266272|NCT02091739|560409064|FG000|EP: 48 Weeks|Adverse Event|0|||
155266273|NCT02091739|560409065|FG001|EP: 48 Weeks|Adverse Event|0|||
155266274|NCT02091739|560409066|FG002|EP: 48 Weeks|Adverse Event|0|||
155266275|NCT02091739|560409067|FG003|EP: 48 Weeks|Adverse Event|2|||
155038260|NCT02913105|559567812|FG000|Overall Study|Physician Decision|1|||
155038261|NCT02913105|559567813|FG001|Overall Study|Physician Decision|1|||
155152260|NCT00286468|559994112|FG002|Overall Study|Hyperglycemic Rescue|31|||
155152261|NCT00286468|559994110|FG000|Overall Study|Adverse Event|2|||
155152262|NCT00286468|559994111|FG001|Overall Study|Adverse Event|6|||
155152263|NCT00286468|559994112|FG002|Overall Study|Adverse Event|4|||
155152264|NCT00286468|559994110|FG000|Overall Study|Protocol Violation|0|||
155266276|NCT02091739|560409068|FG004|EP: 48 Weeks|Adverse Event|6|||
155266277|NCT02091739|560409064|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
155266278|NCT02091739|560409065|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
155266279|NCT02091739|560409066|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
155152265|NCT00286468|559994111|FG001|Overall Study|Protocol Violation|3|||
155152266|NCT00286468|559994112|FG002|Overall Study|Protocol Violation|1|||
155152267|NCT00286468|559994110|FG000|Overall Study|Lost to Follow-up|1|||
155152268|NCT00286468|559994111|FG001|Overall Study|Lost to Follow-up|1|||
155152269|NCT00286468|559994112|FG002|Overall Study|Lost to Follow-up|2|||
155152270|NCT00286468|559994110|FG000|Overall Study|Withdrawal by Subject|3|||
155152271|NCT00286468|559994111|FG001|Overall Study|Withdrawal by Subject|8|||
155152272|NCT00286468|559994112|FG002|Overall Study|Withdrawal by Subject|11|||
155152273|NCT00286468|559994110|FG000|Overall Study|Physician Decision|3|||
155152274|NCT00286468|559994111|FG001|Overall Study|Physician Decision|2|||
155266280|NCT02091739|560409067|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
155266281|NCT02091739|560409068|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
155266282|NCT00130793|560409082|FG000|Overall Study|Lost to Follow-up|1|||
155266283|NCT00130793|560409083|FG001|Overall Study|Lost to Follow-up|4|||
155266284|NCT00130793|560409082|FG000|Overall Study|Withdrew consent|2|||
155266285|NCT00130793|560409083|FG001|Overall Study|Withdrew consent|0|||
155266286|NCT00211237|560409084|FG000|Baseline|Withdrew|1|||
155266287|NCT00211237|560409085|FG001|Baseline|Withdrew|3|||
155266288|NCT00211237|560409086|FG002|Baseline|Withdrew|0|||
155266289|NCT00211237|560409084|FG000|Baseline|Refused random assignment|1|||
155266290|NCT00211237|560409085|FG001|Baseline|Refused random assignment|0|||
155266291|NCT00211237|560409086|FG002|Baseline|Refused random assignment|0|||
155266292|NCT00211237|560409084|FG000|1 Month|Death|2|||
155266293|NCT00211237|560409085|FG001|1 Month|Death|1|||
155266294|NCT00211237|560409086|FG002|1 Month|Death|0|||
155266295|NCT00211237|560409084|FG000|1 Month|Lost to Follow-up|0|||
155266296|NCT00211237|560409085|FG001|1 Month|Lost to Follow-up|2|||
155152275|NCT00286468|559994112|FG002|Overall Study|Physician Decision|1|||
155152276|NCT02953652|559994113|FG000|Overall Study|Adverse Event|18|||
155152277|NCT02953652|559994113|FG000|Overall Study|Withdrawal by Subject|6|||
155152278|NCT02953652|559994113|FG000|Overall Study|Protocol Violation|1|||
155152279|NCT02953652|559994113|FG000|Overall Study|Disease Progression|27|||
155152280|NCT00671658|559994117|FG000|Overall Study|Physician Decision|5|||
155152281|NCT03617172|559994126|FG000|Overall Study|Lost to Follow-up|1|||
155152282|NCT03617172|559994127|FG001|Overall Study|Lost to Follow-up|0|||
155152283|NCT02587221|559994131|FG000|Overall Study|Adverse Event|3|||
155152284|NCT02587221|559994132|FG001|Overall Study|Adverse Event|3|||
155152285|NCT02587221|559994131|FG000|Overall Study|Death|33|||
155152286|NCT02587221|559994132|FG001|Overall Study|Death|34|||
155152287|NCT02587221|559994131|FG000|Overall Study|Withdrawal by Subject|66|||
155152288|NCT02587221|559994132|FG001|Overall Study|Withdrawal by Subject|61|||
155266297|NCT00211237|560409086|FG002|1 Month|Lost to Follow-up|0|||
155152289|NCT02587221|559994131|FG000|Overall Study|Lost to Follow-up|21|||
155152290|NCT02587221|559994132|FG001|Overall Study|Lost to Follow-up|19|||
155152291|NCT02587221|559994131|FG000|Overall Study|Protocol Violation|6|||
155152292|NCT02587221|559994132|FG001|Overall Study|Protocol Violation|5|||
155152293|NCT02587221|559994131|FG000|Overall Study|Other Reason or Unspecified|2|||
155152294|NCT02587221|559994132|FG001|Overall Study|Other Reason or Unspecified|1|||
155152295|NCT02546609|559994133|FG000|Overall Study|Withdrawal by Subject|0|||
155152296|NCT02546609|559994134|FG001|Overall Study|Withdrawal by Subject|1|||
155152297|NCT02546609|559994135|FG002|Overall Study|Withdrawal by Subject|2|||
155152298|NCT02546609|559994133|FG000|Overall Study|Adverse Event|0|||
155152299|NCT02546609|559994134|FG001|Overall Study|Adverse Event|6|||
155152300|NCT02546609|559994135|FG002|Overall Study|Adverse Event|1|||
155152301|NCT02546609|559994133|FG000|Overall Study|Protocol Violation|0|||
155152302|NCT02546609|559994134|FG001|Overall Study|Protocol Violation|1|||
155152303|NCT02546609|559994135|FG002|Overall Study|Protocol Violation|1|||
155152304|NCT02546609|559994133|FG000|Overall Study|Lost to Follow-up|2|||
155152305|NCT02546609|559994134|FG001|Overall Study|Lost to Follow-up|3|||
155152306|NCT02546609|559994135|FG002|Overall Study|Lost to Follow-up|1|||
155152307|NCT02546609|559994133|FG000|Overall Study|travel or work schedule restriction|0|||
155152308|NCT02546609|559994134|FG001|Overall Study|travel or work schedule restriction|0|||
155152309|NCT02546609|559994135|FG002|Overall Study|travel or work schedule restriction|2|||
155152310|NCT03988400|559994137|FG000|Overall Study|Adverse Event|1|||
155152311|NCT03988400|559994138|FG001|Overall Study|Adverse Event|0|||
155152312|NCT03988400|559994137|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
155152313|NCT03988400|559994138|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
155152314|NCT03988400|559994137|FG000|Overall Study|Lost to Follow-up|0|||
155266298|NCT00211237|560409084|FG000|1 Month|Withdrew|0|||
155266299|NCT00211237|560409085|FG001|1 Month|Withdrew|4|||
155266300|NCT00211237|560409086|FG002|1 Month|Withdrew|0|||
155152315|NCT03988400|559994138|FG001|Overall Study|Lost to Follow-up|1|||
155152316|NCT04913610|559994139|FG000|Randomized Participants|Did Not Receive Treatment|0|||
155152317|NCT04913610|559994140|FG001|Randomized Participants|Did Not Receive Treatment|0|||
155152318|NCT04913610|559994141|FG002|Randomized Participants|Did Not Receive Treatment|1|||
155152319|NCT04913610|559994142|FG003|Randomized Participants|Did Not Receive Treatment|1|||
155266301|NCT00211237|560409084|FG000|1 Month|Additional surgery needed|1|||
155266302|NCT00211237|560409085|FG001|1 Month|Additional surgery needed|0|||
155266303|NCT00211237|560409086|FG002|1 Month|Additional surgery needed|0|||
155152320|NCT04913610|559994143|FG004|Randomized Participants|Did Not Receive Treatment|0|||
155152321|NCT04913610|559994139|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
155152322|NCT04913610|559994140|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
155152323|NCT04913610|559994141|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
155152324|NCT04913610|559994142|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
155152325|NCT04913610|559994143|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
155152326|NCT03186209|559994144|FG000|Overall Study|Withdrawal by Subject|11|||
155152327|NCT03186209|559994145|FG001|Overall Study|Withdrawal by Subject|22|||
155152328|NCT03186209|559994144|FG000|Overall Study|Pregnancy|1|||
155152329|NCT03186209|559994145|FG001|Overall Study|Pregnancy|0|||
155152330|NCT03186209|559994144|FG000|Overall Study|Adverse Event|4|||
155152331|NCT03186209|559994145|FG001|Overall Study|Adverse Event|0|||
155152332|NCT03186209|559994144|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
155152333|NCT03186209|559994145|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
155152334|NCT03186209|559994144|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
155152335|NCT03186209|559994145|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
155152336|NCT03186209|559994144|FG000|Overall Study|Fail to meet randomization criteria|0|||
155152337|NCT03186209|559994145|FG001|Overall Study|Fail to meet randomization criteria|1|||
155152338|NCT03186209|559994144|FG000|Overall Study|Lost to Follow-up|0|||
155152339|NCT03186209|559994145|FG001|Overall Study|Lost to Follow-up|1|||
155152340|NCT03557970|559994163|FG000|Overall Study|Study closure|1|||
155152341|NCT03557970|559994164|FG001|Overall Study|Study closure|0|||
155152342|NCT03557970|559994163|FG000|Overall Study|Physician Decision|0|||
155152343|NCT03557970|559994164|FG001|Overall Study|Physician Decision|1|||
155152344|NCT03557970|559994163|FG000|Overall Study|Death|0|||
155152345|NCT03557970|559994164|FG001|Overall Study|Death|1|||
155152346|NCT02138890|559994167|FG000|Overall Study|Adverse Event|1|||
155152347|NCT02138890|559994168|FG001|Overall Study|Adverse Event|0|||
155152348|NCT00112736|559994169|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
155152349|NCT00112736|559994170|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
155152350|NCT05435339|559994171|FG000|Overall Study|Death|1|||
155152351|NCT05435339|559994172|FG001|Overall Study|Death|0|||
155152352|NCT05435339|559994173|FG002|Overall Study|Death|3|||
155152353|NCT05435339|559994174|FG003|Overall Study|Death|1|||
155152354|NCT05435339|559994175|FG004|Overall Study|Death|3|||
155152355|NCT05435339|559994176|FG005|Overall Study|Death|2|||
155152356|NCT05435339|559994177|FG006|Overall Study|Death|4|||
155152357|NCT05435339|559994178|FG007|Overall Study|Death|6|||
155152358|NCT05435339|559994171|FG000|Overall Study|Sponsor Decision|0|||
155152359|NCT05435339|559994172|FG001|Overall Study|Sponsor Decision|1|||
155152360|NCT05435339|559994173|FG002|Overall Study|Sponsor Decision|0|||
155152361|NCT05435339|559994174|FG003|Overall Study|Sponsor Decision|0|||
155152362|NCT05435339|559994175|FG004|Overall Study|Sponsor Decision|2|||
155152363|NCT05435339|559994176|FG005|Overall Study|Sponsor Decision|1|||
155152364|NCT05435339|559994177|FG006|Overall Study|Sponsor Decision|2|||
155152365|NCT05435339|559994178|FG007|Overall Study|Sponsor Decision|2|||
155152366|NCT05435339|559994171|FG000|Overall Study|Withdrawal by Subject|0|||
155152367|NCT05435339|559994172|FG001|Overall Study|Withdrawal by Subject|0|||
155152368|NCT05435339|559994173|FG002|Overall Study|Withdrawal by Subject|0|||
155152369|NCT05435339|559994174|FG003|Overall Study|Withdrawal by Subject|0|||
155152370|NCT05435339|559994175|FG004|Overall Study|Withdrawal by Subject|1|||
155152371|NCT05435339|559994176|FG005|Overall Study|Withdrawal by Subject|0|||
155152372|NCT05435339|559994177|FG006|Overall Study|Withdrawal by Subject|1|||
155152373|NCT05435339|559994178|FG007|Overall Study|Withdrawal by Subject|1|||
155152374|NCT03019406|559994179|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
155152375|NCT03019406|559994180|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
155152376|NCT03019406|559994181|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
155152377|NCT03019406|559994182|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
155152378|NCT01446159|559994183|FG000|Overall Study|Withdrawal by Subject|1|||
155152379|NCT01446159|559994184|FG001|Overall Study|Withdrawal by Subject|0|||
155152380|NCT01446159|559994185|FG002|Overall Study|Withdrawal by Subject|14|||
155152381|NCT01446159|559994186|FG003|Overall Study|Withdrawal by Subject|11|||
155152382|NCT01446159|559994183|FG000|Overall Study|Lost to Follow-up|0|||
155152383|NCT01446159|559994184|FG001|Overall Study|Lost to Follow-up|0|||
155152384|NCT01446159|559994185|FG002|Overall Study|Lost to Follow-up|1|||
155152385|NCT01446159|559994186|FG003|Overall Study|Lost to Follow-up|2|||
155152386|NCT01446159|559994183|FG000|Overall Study|Death|2|||
155152387|NCT01446159|559994184|FG001|Overall Study|Death|3|||
155152388|NCT01446159|559994185|FG002|Overall Study|Death|43|||
155152389|NCT01446159|559994186|FG003|Overall Study|Death|36|||
155152390|NCT01446159|559994183|FG000|Overall Study|Other|0|||
155152391|NCT01446159|559994184|FG001|Overall Study|Other|0|||
155152392|NCT01446159|559994185|FG002|Overall Study|Other|13|||
155152393|NCT01446159|559994186|FG003|Overall Study|Other|13|||
155152394|NCT01283139|559994187|FG000|Overall Study|Lost to Follow-up|5|||
155152395|NCT01283139|559994188|FG001|Overall Study|Lost to Follow-up|2|||
155152396|NCT01283139|559994189|FG002|Overall Study|Lost to Follow-up|3|||
155152397|NCT01283139|559994190|FG003|Overall Study|Lost to Follow-up|1|||
155152398|NCT01283139|559994187|FG000|Overall Study|Withdrawal by Subject|8|||
155152399|NCT01283139|559994188|FG001|Overall Study|Withdrawal by Subject|8|||
155152400|NCT01283139|559994189|FG002|Overall Study|Withdrawal by Subject|6|||
155152401|NCT01283139|559994190|FG003|Overall Study|Withdrawal by Subject|8|||
155152402|NCT01283139|559994187|FG000|Overall Study|Death|2|||
155152403|NCT01283139|559994188|FG001|Overall Study|Death|0|||
155152404|NCT01283139|559994189|FG002|Overall Study|Death|2|||
155152405|NCT01283139|559994190|FG003|Overall Study|Death|2|||
155152406|NCT01283139|559994187|FG000|Overall Study|Lack of Efficacy|1|||
155152407|NCT01283139|559994188|FG001|Overall Study|Lack of Efficacy|2|||
155266304|NCT00211237|560409084|FG000|1 Month|Non-medical problem|0|||
155266305|NCT00211237|560409085|FG001|1 Month|Non-medical problem|2|||
155266306|NCT00211237|560409086|FG002|1 Month|Non-medical problem|0|||
155266307|NCT00211237|560409084|FG000|3 Months|Death|7|||
155266308|NCT00211237|560409085|FG001|3 Months|Death|3|||
155266309|NCT00211237|560409086|FG002|3 Months|Death|0|||
155266310|NCT00211237|560409084|FG000|3 Months|Could not comply with protocol|1|||
155266311|NCT00211237|560409085|FG001|3 Months|Could not comply with protocol|0|||
155266312|NCT00211237|560409086|FG002|3 Months|Could not comply with protocol|0|||
155266313|NCT00211237|560409084|FG000|3 Months|Withdrew|0|||
155266314|NCT00211237|560409085|FG001|3 Months|Withdrew|1|||
155266315|NCT00211237|560409086|FG002|3 Months|Withdrew|0|||
155266316|NCT00211237|560409084|FG000|3 Months|Non-medical problem|0|||
155266317|NCT00211237|560409085|FG001|3 Months|Non-medical problem|0|||
155266318|NCT00211237|560409086|FG002|3 Months|Non-medical problem|1|||
155266319|NCT00211237|560409084|FG000|6 Months|Death|6|||
155266320|NCT00211237|560409085|FG001|6 Months|Death|0|||
155266321|NCT00211237|560409086|FG002|6 Months|Death|3|||
155266322|NCT00211237|560409084|FG000|6 Months|Lost to Follow-up|2|||
155266323|NCT00211237|560409085|FG001|6 Months|Lost to Follow-up|0|||
155266324|NCT00211237|560409086|FG002|6 Months|Lost to Follow-up|0|||
155266325|NCT00211237|560409084|FG000|6 Months|Could not comply with protocol|0|||
155266326|NCT00211237|560409085|FG001|6 Months|Could not comply with protocol|2|||
155266327|NCT00211237|560409086|FG002|6 Months|Could not comply with protocol|0|||
155266328|NCT00211237|560409084|FG000|12 Months|Death|8|||
155266329|NCT00211237|560409085|FG001|12 Months|Death|2|||
155266330|NCT00211237|560409086|FG002|12 Months|Death|3|||
155266331|NCT00211237|560409084|FG000|12 Months|Lost to Follow-up|1|||
155266332|NCT00211237|560409085|FG001|12 Months|Lost to Follow-up|0|||
155266333|NCT00211237|560409086|FG002|12 Months|Lost to Follow-up|1|||
155266334|NCT00211237|560409084|FG000|12 Months|Withdrew|0|||
155266335|NCT00211237|560409085|FG001|12 Months|Withdrew|0|||
155266336|NCT00211237|560409086|FG002|12 Months|Withdrew|1|||
155266337|NCT00211237|560409084|FG000|12 Months|unrelated medical problem|0|||
155266338|NCT00211237|560409085|FG001|12 Months|unrelated medical problem|0|||
155266339|NCT00211237|560409086|FG002|12 Months|unrelated medical problem|1|||
155266340|NCT01003639|560409089|FG000|Overall Study|Lost to Follow-up|6|||
155266341|NCT01003639|560409090|FG001|Overall Study|Lost to Follow-up|9|||
155266342|NCT01003639|560409089|FG000|Overall Study|Withdrawal by Subject|9|||
155266343|NCT01003639|560409090|FG001|Overall Study|Withdrawal by Subject|5|||
155266344|NCT01003639|560409089|FG000|Overall Study|Lack of Efficacy|1|||
155266345|NCT01003639|560409090|FG001|Overall Study|Lack of Efficacy|6|||
155266346|NCT01003639|560409089|FG000|Overall Study|Adverse Event|0|||
155379445|NCT02359877|560822334|FG000|Overall Study|Withdrawal by Subject|1|||
155379446|NCT02359877|560822335|FG001|Overall Study|Withdrawal by Subject|0|||
155379447|NCT02359877|560822336|FG002|Overall Study|Withdrawal by Subject|0|||
155379448|NCT02359877|560822337|FG003|Overall Study|Withdrawal by Subject|2|||
155379449|NCT02359877|560822334|FG000|Overall Study|Adverse Event|0|||
155379450|NCT02359877|560822335|FG001|Overall Study|Adverse Event|0|||
155379451|NCT02359877|560822336|FG002|Overall Study|Adverse Event|0|||
155379452|NCT02359877|560822337|FG003|Overall Study|Adverse Event|1|||
155379453|NCT00910689|560822351|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
155379454|NCT00910689|560822352|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
155379455|NCT00910689|560822353|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
155379456|NCT00910689|560822354|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
155379457|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
155379458|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
155379459|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
155379460|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
155379461|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
155379462|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
155379463|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
155266347|NCT01003639|560409090|FG001|Overall Study|Adverse Event|1|||
155266348|NCT01003639|560409089|FG000|Overall Study|Protocol Violation|0|||
155266349|NCT01003639|560409090|FG001|Overall Study|Protocol Violation|1|||
155266350|NCT01003639|560409089|FG000|Overall Study|Physician Decision|1|||
155266351|NCT01003639|560409090|FG001|Overall Study|Physician Decision|0|||
155266352|NCT02954458|560409091|FG000|Overall Study|Adverse Event|0|||
155266353|NCT02954458|560409092|FG001|Overall Study|Adverse Event|0|||
155266354|NCT02954458|560409093|FG002|Overall Study|Adverse Event|0|||
155379464|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
155379465|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
155379466|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
155379467|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
155379468|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
155379469|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
155379470|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
155379471|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
155379472|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
155379473|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
155379474|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
155379475|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
155379476|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
155379477|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
155379478|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
155379479|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
155379480|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
155379481|NCT00910689|560822351|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
155379482|NCT00910689|560822352|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
155379483|NCT00910689|560822353|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
155379484|NCT00910689|560822354|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
155379485|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
155379486|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
155379487|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
155379488|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
155379489|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
155379490|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
155379491|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
155379492|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
155266355|NCT02954458|560409094|FG003|Overall Study|Adverse Event|1|||
155266356|NCT02954458|560409091|FG000|Overall Study|Withdrawal by Subject|0|||
155266357|NCT02954458|560409092|FG001|Overall Study|Withdrawal by Subject|0|||
155266358|NCT02954458|560409093|FG002|Overall Study|Withdrawal by Subject|0|||
155266359|NCT02954458|560409094|FG003|Overall Study|Withdrawal by Subject|1|||
155266360|NCT02954458|560409091|FG000|Overall Study|Physician Decision|0|||
155266361|NCT02954458|560409092|FG001|Overall Study|Physician Decision|0|||
155266362|NCT02954458|560409093|FG002|Overall Study|Physician Decision|1|||
155266363|NCT02954458|560409094|FG003|Overall Study|Physician Decision|1|||
155266364|NCT02954458|560409091|FG000|Overall Study|Lost to Follow-up|1|||
155266365|NCT02954458|560409092|FG001|Overall Study|Lost to Follow-up|0|||
155266366|NCT02954458|560409093|FG002|Overall Study|Lost to Follow-up|0|||
155266367|NCT02954458|560409094|FG003|Overall Study|Lost to Follow-up|1|||
155266368|NCT02954458|560409091|FG000|Overall Study|Death|0|||
155266369|NCT02954458|560409092|FG001|Overall Study|Death|0|||
155266370|NCT02954458|560409093|FG002|Overall Study|Death|0|||
155266371|NCT02954458|560409094|FG003|Overall Study|Death|1|||
155266372|NCT02954458|560409091|FG000|Overall Study|Other|0|||
155266373|NCT02954458|560409092|FG001|Overall Study|Other|0|||
155266374|NCT02954458|560409093|FG002|Overall Study|Other|0|||
155266375|NCT02954458|560409094|FG003|Overall Study|Other|7|||
155266376|NCT04000594|560409095|FG000|Overall Study|Withdrawal by Subject|1|||
155266377|NCT04000594|560409096|FG001|Overall Study|Withdrawal by Subject|0|||
155266378|NCT04000594|560409097|FG002|Overall Study|Withdrawal by Subject|0|||
155266379|NCT01552954|560409098|FG000|Overall Study|Adverse Event|1|||
155266380|NCT01552954|560409099|FG001|Overall Study|Adverse Event|2|||
155266381|NCT01552954|560409098|FG000|Overall Study|Lost to Follow-up|1|||
155266382|NCT01552954|560409099|FG001|Overall Study|Lost to Follow-up|1|||
155266383|NCT01552954|560409098|FG000|Overall Study|Withdrawal by Subject|1|||
155266384|NCT01552954|560409099|FG001|Overall Study|Withdrawal by Subject|1|||
155266385|NCT01552954|560409098|FG000|Overall Study|Protocol Violation|1|||
155266386|NCT01552954|560409099|FG001|Overall Study|Protocol Violation|2|||
155266387|NCT01552954|560409098|FG000|Overall Study|diagnosed DM|1|||
155266388|NCT01552954|560409099|FG001|Overall Study|diagnosed DM|0|||
155266389|NCT00779779|560409100|FG000|Overall Study|Adverse Event|1|||
155266390|NCT00779779|560409100|FG000|Overall Study|Protocol Violation|14|||
155266391|NCT00779779|560409100|FG000|Overall Study|Withdrawal by Subject|4|||
155266392|NCT00779779|560409100|FG000|Overall Study|Lost to Follow-up|5|||
155266393|NCT01395823|560409101|FG000|Overall Study|Death|4|||
155266394|NCT01395823|560409102|FG001|Overall Study|Death|4|||
155266395|NCT01395823|560409101|FG000|Overall Study|Physician Decision|3|||
155266396|NCT01395823|560409102|FG001|Overall Study|Physician Decision|1|||
155266397|NCT01395823|560409101|FG000|Overall Study|Lost to Follow-up|1|||
155266398|NCT01395823|560409102|FG001|Overall Study|Lost to Follow-up|0|||
155266399|NCT01395823|560409101|FG000|Overall Study|Transplant|1|||
155266400|NCT01395823|560409102|FG001|Overall Study|Transplant|0|||
155266401|NCT01395823|560409101|FG000|Overall Study|GI symptoms|1|||
155266402|NCT01395823|560409102|FG001|Overall Study|GI symptoms|0|||
155266403|NCT01395823|560409101|FG000|Overall Study|Withdrawal by Subject|5|||
155266404|NCT01395823|560409102|FG001|Overall Study|Withdrawal by Subject|4|||
155266405|NCT01778556|560409103|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
155266406|NCT01778556|560409104|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
155266407|NCT01778556|560409103|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155266408|NCT01778556|560409104|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
155266409|NCT01778556|560409103|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
155266410|NCT01778556|560409104|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
155266411|NCT01778556|560409103|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
155266412|NCT01778556|560409104|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
155266413|NCT03300570|560409106|FG000|Overall Study|Adverse Event|0|||
155266414|NCT03300570|560409107|FG001|Overall Study|Adverse Event|1|||
155266415|NCT03300570|560409106|FG000|Overall Study|Withdrawal by Subject|1|||
155266416|NCT03300570|560409107|FG001|Overall Study|Withdrawal by Subject|0|||
155266417|NCT03300570|560409106|FG000|Overall Study|Inadequate bowel prep|1|||
155266418|NCT03300570|560409107|FG001|Overall Study|Inadequate bowel prep|0|||
155266419|NCT00116272|560409108|FG000|Overall Study|Lost to Follow-up|11|||
155266420|NCT00116272|560409109|FG001|Overall Study|Lost to Follow-up|6|||
155266421|NCT03188120|560409110|FG000|Overall Study|Adverse Event|4|||
155266422|NCT03188120|560409110|FG000|Overall Study|Insufficient Effectiveness|8|||
155266423|NCT03188120|560409110|FG000|Overall Study|Improved|12|||
155266424|NCT03188120|560409110|FG000|Overall Study|Lost to Follow-up|7|||
155266425|NCT03188120|560409110|FG000|Overall Study|Other than specified|3|||
155266426|NCT03188120|560409110|FG000|Overall Study|No visit after the first visit|13|||
155266427|NCT02178566|560409118|FG000|Overall Study|patient did not complete due to noncompliance|0|||
155266428|NCT02178566|560409119|FG001|Overall Study|patient did not complete due to noncompliance|1|||
155266429|NCT05778526|560409120|FG000|Overall Study|Lost to Follow-up|0|||
155266430|NCT05778526|560409121|FG001|Overall Study|Lost to Follow-up|1|||
155266431|NCT05778526|560409122|FG002|Overall Study|Lost to Follow-up|3|||
155266432|NCT05778526|560409120|FG000|Overall Study|Protocol Violation|0|||
155266433|NCT05778526|560409121|FG001|Overall Study|Protocol Violation|0|||
155266434|NCT05778526|560409122|FG002|Overall Study|Protocol Violation|8|||
155266435|NCT00085202|560409123|FG000|Overall Study|Still on therapy|2|||
155266436|NCT00085202|560409124|FG001|Overall Study|Still on therapy|0|||
155266437|NCT00085202|560409123|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
155266438|NCT00085202|560409124|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
155266439|NCT00085202|560409123|FG000|Overall Study|Excessive toxicity|6|||
155266440|NCT00085202|560409124|FG001|Overall Study|Excessive toxicity|5|||
155266441|NCT00085202|560409123|FG000|Overall Study|Non-specified|3|||
155266442|NCT00085202|560409124|FG001|Overall Study|Non-specified|5|||
155266443|NCT00085202|560409123|FG000|Overall Study|Withdrawal by Subject|2|||
155266444|NCT00085202|560409124|FG001|Overall Study|Withdrawal by Subject|1|||
155266445|NCT00085202|560409123|FG000|Overall Study|Physician Decision|4|||
155266446|NCT00085202|560409124|FG001|Overall Study|Physician Decision|1|||
155266447|NCT00085202|560409123|FG000|Overall Study|Progressive disease|1|||
155266448|NCT00085202|560409124|FG001|Overall Study|Progressive disease|11|||
155266449|NCT03238300|560409125|FG000|Baseline (Before Intervention)|Physician Decision|0|||
155266450|NCT03238300|560409126|FG001|Baseline (Before Intervention)|Physician Decision|1|||
155266451|NCT03238300|560409125|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
155266452|NCT03238300|560409126|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
155266453|NCT03238300|560409125|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
155266454|NCT03238300|560409126|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
155266455|NCT03238300|560409125|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
155266456|NCT03238300|560409126|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
155266457|NCT01436201|560409134|FG000|Overall Study|Adverse Event|2|||
155266458|NCT01436201|560409134|FG000|Overall Study|Withdrawal by Subject|1|||
155266459|NCT01436201|560409134|FG000|Overall Study|Protocol Violation|1|||
155266460|NCT00110890|560409135|FG000|Overall Study|Adverse Event|30|||
155266461|NCT00110890|560409136|FG001|Overall Study|Adverse Event|7|||
155266462|NCT00110890|560409135|FG000|Overall Study|Death|16|||
155266463|NCT00110890|560409136|FG001|Overall Study|Death|9|||
155266464|NCT00110890|560409135|FG000|Overall Study|Lost to Follow-up|3|||
155266465|NCT00110890|560409136|FG001|Overall Study|Lost to Follow-up|1|||
155266466|NCT00110890|560409135|FG000|Overall Study|Physician Decision|4|||
155266467|NCT00110890|560409136|FG001|Overall Study|Physician Decision|5|||
155266468|NCT00110890|560409135|FG000|Overall Study|Withdrawal by Subject|17|||
155266469|NCT00110890|560409136|FG001|Overall Study|Withdrawal by Subject|5|||
155266470|NCT00110890|560409135|FG000|Overall Study|Protocol Deviation|1|||
155266471|NCT00110890|560409136|FG001|Overall Study|Protocol Deviation|0|||
155266472|NCT00110890|560409135|FG000|Overall Study|Noncompliance|10|||
155266473|NCT00110890|560409136|FG001|Overall Study|Noncompliance|0|||
155266474|NCT00110890|560409135|FG000|Overall Study|Kidney Transplant|16|||
155266475|NCT00110890|560409136|FG001|Overall Study|Kidney Transplant|12|||
155266476|NCT00110890|560409135|FG000|Overall Study|Invest. Product Commercially Available|217|||
155266477|NCT00110890|560409136|FG001|Overall Study|Invest. Product Commercially Available|110|||
155266478|NCT00110890|560409135|FG000|Overall Study|Other|34|||
155266479|NCT00110890|560409136|FG001|Overall Study|Other|23|||
155266480|NCT00110890|560409135|FG000|Overall Study|Ineligibility determined|3|||
155266481|NCT00110890|560409136|FG001|Overall Study|Ineligibility determined|0|||
155266482|NCT00110890|560409135|FG000|Overall Study|Requirement for alternative therapy|0|||
155266483|NCT00110890|560409136|FG001|Overall Study|Requirement for alternative therapy|1|||
155266484|NCT00110890|560409135|FG000|Overall Study|Disease progression|0|||
155266485|NCT00110890|560409136|FG001|Overall Study|Disease progression|1|||
155266486|NCT00110890|560409135|FG000|Overall Study|Parathyroidectomy|0|||
155266487|NCT00110890|560409136|FG001|Overall Study|Parathyroidectomy|1|||
155266488|NCT00110890|560409135|FG000|Overall Study|Did not enter follow-up phase|10|||
155266489|NCT00110890|560409136|FG001|Overall Study|Did not enter follow-up phase|4|||
155266490|NCT01686581|560409137|FG000|Overall Study|Side-effects or Health Problems|15|||
155266491|NCT01686581|560409137|FG000|Overall Study|Lack of Efficacy|90|||
155266492|NCT01686581|560409137|FG000|Overall Study|Participant Concerned about Risks|6|||
155266493|NCT01686581|560409137|FG000|Overall Study|Thinks Injections Too Painful|8|||
155266494|NCT01686581|560409137|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
155266495|NCT01686581|560409137|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
155266496|NCT01686581|560409137|FG000|Overall Study|Thinks it is Inconvenient|17|||
155266497|NCT01686581|560409137|FG000|Overall Study|Other Miscellaneous Reasons|36|||
155266498|NCT01686581|560409137|FG000|Overall Study|Reason Missing|1|||
155266499|NCT01975220|560409138|FG000|Test Period 1|Not treated|0|||
155266500|NCT01975220|560409139|FG001|Test Period 1|Not treated|1|||
155266501|NCT01975220|560409140|FG002|Test Period 1|Not treated|0|||
155266502|NCT01975220|560409141|FG003|Test Period 1|Not treated|0|||
155266503|NCT01975220|560409142|FG004|Test Period 1|Not treated|0|||
155266504|NCT01975220|560409143|FG005|Test Period 1|Not treated|0|||
155266505|NCT02839343|560409144|FG000|Overall Study|Withdrawal by Subject|3|||
155266506|NCT02839343|560409145|FG001|Overall Study|Withdrawal by Subject|1|||
155266507|NCT02839343|560409144|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
155266508|NCT02839343|560409145|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
155266509|NCT02839343|560409144|FG000|Overall Study|Adverse Event|1|||
155266510|NCT02839343|560409145|FG001|Overall Study|Adverse Event|0|||
155266511|NCT01852058|560409148|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
155266512|NCT01852058|560409149|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266513|NCT01852058|560409150|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266514|NCT01852058|560409151|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266515|NCT01852058|560409152|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266516|NCT01852058|560409153|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266517|NCT01852058|560409154|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266518|NCT01852058|560409155|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266519|NCT01852058|560409156|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266520|NCT01852058|560409157|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266521|NCT01852058|560409158|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266522|NCT01852058|560409159|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
155266523|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266524|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266525|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266526|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266527|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
155266528|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266529|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266530|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266531|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266532|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266533|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266534|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
155266535|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266536|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266537|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266538|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266539|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
155266540|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
155266541|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266542|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266543|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266544|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266545|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266546|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
155266547|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266548|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266549|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266550|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266551|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
155266552|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266553|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266554|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266555|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266556|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266557|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266558|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
155266559|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266560|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266561|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266562|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266563|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
155266564|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
155266565|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266566|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266567|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266568|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266569|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266570|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
155266571|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266572|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266573|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266574|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
155266575|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266576|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266577|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266578|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266579|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266580|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266581|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266582|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
155266583|NCT01852058|560409148|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266584|NCT01852058|560409149|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266585|NCT01852058|560409150|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266586|NCT01852058|560409151|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266587|NCT01852058|560409152|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
155266588|NCT01852058|560409153|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
155266589|NCT01852058|560409154|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266590|NCT01852058|560409155|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266591|NCT01852058|560409156|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266592|NCT01852058|560409157|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266593|NCT01852058|560409158|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266594|NCT01852058|560409159|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
155266595|NCT01852058|560409148|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266596|NCT01852058|560409149|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266597|NCT01852058|560409150|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266598|NCT01852058|560409151|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266599|NCT01852058|560409152|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266600|NCT01852058|560409153|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266601|NCT01852058|560409154|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266602|NCT01852058|560409155|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
155266603|NCT01852058|560409156|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266604|NCT01852058|560409157|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266605|NCT01852058|560409158|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266606|NCT01852058|560409159|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
155266607|NCT01852058|560409148|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266608|NCT01852058|560409149|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266609|NCT01852058|560409150|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266610|NCT01852058|560409151|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266611|NCT01852058|560409152|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266612|NCT01852058|560409153|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266613|NCT01852058|560409154|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266614|NCT01852058|560409155|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266615|NCT01852058|560409156|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
155266616|NCT01852058|560409157|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266617|NCT01852058|560409158|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266618|NCT01852058|560409159|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
155266619|NCT01279343|560409161|FG000|Overall Study|Did not receive treatment|2|||
155266620|NCT01279343|560409162|FG001|Overall Study|Did not receive treatment|6|||
155266621|NCT03287414|560409163|FG000|Treatment Epoch|Adverse Event|0|||
155266622|NCT03287414|560409164|FG001|Treatment Epoch|Adverse Event|1|||
155266623|NCT03287414|560409163|FG000|Treatment Epoch|Study terminated by sponsor|2|||
155266624|NCT03287414|560409164|FG001|Treatment Epoch|Study terminated by sponsor|2|||
155266625|NCT03287414|560409163|FG000|Treatment Epoch|Subject/Guardian decision|4|||
155266626|NCT03287414|560409164|FG001|Treatment Epoch|Subject/Guardian decision|0|||
155266627|NCT03287414|560409163|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
155266628|NCT03287414|560409164|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
155266629|NCT03287414|560409163|FG000|Treatment Epoch|Withdrawal by Subject|1|||
155266630|NCT03287414|560409164|FG001|Treatment Epoch|Withdrawal by Subject|0|||
155266631|NCT03287414|560409163|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
155266632|NCT03287414|560409164|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
155266633|NCT03287414|560409163|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
155266634|NCT03287414|560409164|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
155266635|NCT01119898|560409167|FG000|Overall Study|Adverse Event|4|||
155266636|NCT01119898|560409168|FG001|Overall Study|Adverse Event|5|||
155266637|NCT01119898|560409167|FG000|Overall Study|Withdrawal by Subject|1|||
155266638|NCT01119898|560409168|FG001|Overall Study|Withdrawal by Subject|4|||
155266639|NCT01119898|560409167|FG000|Overall Study|Lack of Efficacy|0|||
155266640|NCT01119898|560409168|FG001|Overall Study|Lack of Efficacy|2|||
155266641|NCT01119898|560409167|FG000|Overall Study|Protocol Violation|1|||
155266642|NCT01119898|560409168|FG001|Overall Study|Protocol Violation|1|||
155266643|NCT01119898|560409167|FG000|Overall Study|Medical procedure|1|||
155266644|NCT01119898|560409168|FG001|Overall Study|Medical procedure|0|||
155266645|NCT01119898|560409167|FG000|Overall Study|Randomized in error did not participate|1|||
155266646|NCT01119898|560409168|FG001|Overall Study|Randomized in error did not participate|0|||
155266647|NCT02217280|560409169|FG000|Overall Study|Withdrawal by Subject|2|||
155266648|NCT02217280|560409169|FG000|Overall Study|Post-consent sceen fail|2|||
155266649|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
155266650|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
155266651|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
155266652|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
155266653|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
155266654|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
155266655|NCT00116844|560409172|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
155266656|NCT00116844|560409173|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
155266657|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
155266658|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
155266659|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
155266660|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
155266661|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
155266662|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
155266663|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
155266664|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
155266665|NCT00116844|560409172|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
155266666|NCT00116844|560409173|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
155266667|NCT01933880|560409174|FG000|Overall Study|Withdrawal by Subject|5|||
155266668|NCT01933880|560409175|FG001|Overall Study|Withdrawal by Subject|0|||
155266669|NCT01933880|560409174|FG000|Overall Study|Lack of Efficacy|1|||
155266670|NCT01933880|560409175|FG001|Overall Study|Lack of Efficacy|0|||
155266671|NCT01933880|560409174|FG000|Overall Study|Concomitant medication Interference|0|||
155266672|NCT01933880|560409175|FG001|Overall Study|Concomitant medication Interference|1|||
155266673|NCT01933880|560409174|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
155266674|NCT01933880|560409175|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
155266675|NCT01933880|560409174|FG000|Overall Study|Other|4|||
155266676|NCT01933880|560409175|FG001|Overall Study|Other|0|||
155266677|NCT01933880|560409174|FG000|Overall Study|Protocol Violation|1|||
155266678|NCT01933880|560409175|FG001|Overall Study|Protocol Violation|0|||
155266679|NCT01125722|560409178|FG000|Overall Study|Withdrawal by Subject|2|||
155266680|NCT01125722|560409179|FG001|Overall Study|Withdrawal by Subject|1|||
155266681|NCT01125722|560409178|FG000|Overall Study|Lost to Follow-up|1|||
155266682|NCT01125722|560409179|FG001|Overall Study|Lost to Follow-up|0|||
155266683|NCT00709059|560409182|FG000|Overall Study|Lost to Follow-up|34|||
155266684|NCT00709059|560409182|FG000|Overall Study|Withdrawal by Subject|19|||
155266685|NCT00709059|560409182|FG000|Overall Study|Physician Decision|7|||
155266686|NCT00709059|560409182|FG000|Overall Study|Disease complication|3|||
155266687|NCT00709059|560409182|FG000|Overall Study|Side effects|20|||
155266688|NCT00709059|560409182|FG000|Overall Study|Serious side effects|11|||
155266689|NCT02172625|560409183|FG000|Overall Study|Adverse Event|0|||
155266690|NCT02172625|560409184|FG001|Overall Study|Adverse Event|1|||
155266691|NCT02172625|560409183|FG000|Overall Study|Pregnancy|0|||
155266692|NCT02172625|560409184|FG001|Overall Study|Pregnancy|1|||
155266693|NCT02172625|560409183|FG000|Overall Study|car accident|0|||
155266694|NCT02172625|560409184|FG001|Overall Study|car accident|1|||
155266695|NCT02944656|560409185|FG000|Overall Study|No longer eligible|3|||
155266696|NCT02944656|560409186|FG001|Overall Study|No longer eligible|0|||
155266697|NCT02944656|560409185|FG000|Overall Study|Lost to Follow-up|7|||
155266698|NCT02944656|560409186|FG001|Overall Study|Lost to Follow-up|10|||
155266699|NCT03722264|560410854|FG000|Overall Study|Physician Decision|3|||
155266700|NCT02494921|560410855|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
155266701|NCT02494921|560410856|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
155266702|NCT02494921|560410857|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
155266703|NCT02494921|560410858|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
155266704|NCT02494921|560410859|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
155266705|NCT02494921|560410855|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
155266706|NCT02494921|560410856|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
155266707|NCT02494921|560410857|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
155266708|NCT02494921|560410858|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
155266709|NCT02494921|560410859|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
155266710|NCT02494921|560410855|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266711|NCT02494921|560410856|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266712|NCT02494921|560410857|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
155266713|NCT02494921|560410858|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266714|NCT02494921|560410859|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
155266715|NCT04105972|560410860|FG000|Overall Study|Adverse Event|2|||
155266716|NCT04105972|560410861|FG001|Overall Study|Adverse Event|1|||
155266717|NCT00768430|560410866|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
155266718|NCT00768430|560410867|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
155266719|NCT01478113|560410868|FG000|Overall Study|Withdrawal by Subject|0|||
155266720|NCT01478113|560410869|FG001|Overall Study|Withdrawal by Subject|1|||
155266721|NCT01478113|560410868|FG000|Overall Study|Physician Decision|1|||
155266722|NCT01478113|560410869|FG001|Overall Study|Physician Decision|0|||
155266723|NCT03585296|560410875|FG000|Overall Study|Adverse Event|1|||
155266724|NCT03585296|560410875|FG000|Overall Study|Lost to Follow-up|2|||
155266725|NCT03585296|560410875|FG000|Overall Study|Withdrawal by Subject|2|||
155266726|NCT00041756|560410876|FG000|Overall Study|Adverse Event|4|||
155266727|NCT00041756|560410877|FG001|Overall Study|Adverse Event|10|||
155266728|NCT00041756|560410878|FG002|Overall Study|Adverse Event|6|||
155266729|NCT00041756|560410879|FG003|Overall Study|Adverse Event|11|||
155266730|NCT00041756|560410880|FG004|Overall Study|Adverse Event|34|||
155266731|NCT00041756|560410876|FG000|Overall Study|Protocol Violation|1|||
155266732|NCT00041756|560410877|FG001|Overall Study|Protocol Violation|1|||
155266733|NCT00041756|560410878|FG002|Overall Study|Protocol Violation|2|||
155266734|NCT00041756|560410879|FG003|Overall Study|Protocol Violation|2|||
155266735|NCT00041756|560410880|FG004|Overall Study|Protocol Violation|1|||
155266736|NCT00041756|560410876|FG000|Overall Study|Withdrawal by Subject|3|||
155266737|NCT00041756|560410877|FG001|Overall Study|Withdrawal by Subject|3|||
155266738|NCT00041756|560410878|FG002|Overall Study|Withdrawal by Subject|4|||
155266739|NCT00041756|560410879|FG003|Overall Study|Withdrawal by Subject|2|||
155266740|NCT00041756|560410880|FG004|Overall Study|Withdrawal by Subject|3|||
155266741|NCT00041756|560410876|FG000|Overall Study|Lost to Follow-up|0|||
155266742|NCT00041756|560410877|FG001|Overall Study|Lost to Follow-up|1|||
155266743|NCT00041756|560410878|FG002|Overall Study|Lost to Follow-up|0|||
155266744|NCT00041756|560410879|FG003|Overall Study|Lost to Follow-up|1|||
155266745|NCT00041756|560410880|FG004|Overall Study|Lost to Follow-up|0|||
155266746|NCT00041756|560410876|FG000|Overall Study|Unable to meet protocol criteria|0|||
155266747|NCT00041756|560410877|FG001|Overall Study|Unable to meet protocol criteria|0|||
155266748|NCT00041756|560410878|FG002|Overall Study|Unable to meet protocol criteria|1|||
155266749|NCT00041756|560410879|FG003|Overall Study|Unable to meet protocol criteria|0|||
155266750|NCT00041756|560410880|FG004|Overall Study|Unable to meet protocol criteria|1|||
155038262|NCT02913105|559567814|FG002|Overall Study|Physician Decision|0|||
155038263|NCT02913105|559567812|FG000|Overall Study|Withdrawal by Subject|0|||
155266751|NCT00041756|560410876|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
155266752|NCT00041756|560410877|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
155266753|NCT00041756|560410878|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
155266754|NCT00041756|560410879|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
155266755|NCT00041756|560410880|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
155266756|NCT03980184|560410881|FG000|Overall Study|Dropped out before treatment|2|||
155266757|NCT03980184|560410882|FG001|Overall Study|Dropped out before treatment|2|||
155266758|NCT03980184|560410881|FG000|Overall Study|Lost to Follow-up|11|||
155266759|NCT03980184|560410882|FG001|Overall Study|Lost to Follow-up|13|||
155266760|NCT02002884|560410883|FG000|Main Period (MP)|Other|0|||
155266761|NCT02002884|560410884|FG001|Main Period (MP)|Other|3|||
155266762|NCT02002884|560410885|FG002|Main Period (MP)|Other|3|||
155266763|NCT02002884|560410886|FG003|Main Period (MP)|Other|0|||
155266764|NCT02002884|560410883|FG000|Main Period (MP)|Adverse Event|0|||
155266765|NCT02002884|560410884|FG001|Main Period (MP)|Adverse Event|1|||
155266766|NCT02002884|560410885|FG002|Main Period (MP)|Adverse Event|1|||
155266767|NCT02002884|560410886|FG003|Main Period (MP)|Adverse Event|0|||
155266768|NCT02002884|560410883|FG000|Main Period (MP)|Withdrawal by Subject|6|||
155266769|NCT02002884|560410884|FG001|Main Period (MP)|Withdrawal by Subject|2|||
155266770|NCT02002884|560410885|FG002|Main Period (MP)|Withdrawal by Subject|2|||
155266771|NCT02002884|560410886|FG003|Main Period (MP)|Withdrawal by Subject|0|||
155266772|NCT02002884|560410883|FG000|Main Period (MP)|Lost to Follow-up|0|||
155266773|NCT02002884|560410884|FG001|Main Period (MP)|Lost to Follow-up|0|||
155266774|NCT02002884|560410885|FG002|Main Period (MP)|Lost to Follow-up|2|||
155266775|NCT02002884|560410886|FG003|Main Period (MP)|Lost to Follow-up|0|||
155266776|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Other|0|||
155266777|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Other|0|||
155266778|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Other|0|||
155266779|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Other|24|||
155266780|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
155266781|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
155266782|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
155266783|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
155266784|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
154924315|NCT00457249|559147990|FG001|Overall Study|Withdrawal by Subject|1|||
154924316|NCT00457249|559147989|FG000|Overall Study|Serious Adverse Events|2|||
154924317|NCT00457249|559147990|FG001|Overall Study|Serious Adverse Events|0|||
154924318|NCT02411110|559147993|FG000|Treatment Period 1|Adverse Event|4|||
154924319|NCT02411110|559147994|FG001|Treatment Period 1|Adverse Event|2|||
154924320|NCT02411110|559147993|FG000|Treatment Period 1|Lost to Follow-up|1|||
154924321|NCT02411110|559147994|FG001|Treatment Period 1|Lost to Follow-up|0|||
154924322|NCT02411110|559147993|FG000|Treatment Period 1|Personal Reasons|2|||
154924323|NCT02411110|559147994|FG001|Treatment Period 1|Personal Reasons|5|||
154924324|NCT02411110|559147993|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
154924325|NCT02411110|559147994|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
154924326|NCT02411110|559147993|FG000|Treatment Period 2|Adverse Event|1|||
154924327|NCT02411110|559147994|FG001|Treatment Period 2|Adverse Event|0|||
154924328|NCT02411110|559147993|FG000|Treatment Period 2|Lost to Follow-up|0|||
154924329|NCT02411110|559147994|FG001|Treatment Period 2|Lost to Follow-up|2|||
154924330|NCT02411110|559147993|FG000|Treatment Period 2|Personal Reasons|0|||
154924331|NCT02411110|559147994|FG001|Treatment Period 2|Personal Reasons|2|||
154924332|NCT04888377|559147995|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
154924333|NCT04888377|559147996|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
154924334|NCT04888377|559147995|FG000|Overall Study|Physician Decision|6|||
154924335|NCT04888377|559147996|FG001|Overall Study|Physician Decision|6|||
154924336|NCT04888377|559147995|FG000|Overall Study|Withdrawal by Subject|7|||
154924337|NCT04888377|559147996|FG001|Overall Study|Withdrawal by Subject|3|||
154924338|NCT00526162|559147997|FG000|Overall Study|Device not implanted|3|||
154924339|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
154924340|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
154924341|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
154924342|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924343|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924344|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924345|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924346|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924347|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
154924348|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
154924349|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924350|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924351|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924352|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
155038264|NCT02913105|559567813|FG001|Overall Study|Withdrawal by Subject|3|||
155038265|NCT02913105|559567814|FG002|Overall Study|Withdrawal by Subject|1|||
155038266|NCT05243563|559567815|FG000|Overall Study|Withdrawal by Subject|1|||
155266785|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
154924353|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
154924354|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
155266786|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
155266787|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
155266788|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
155266789|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
155266790|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
155266791|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
155266792|NCT02002884|560410883|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
155266793|NCT02002884|560410884|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
154924355|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
154924356|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924357|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924358|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924359|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924360|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
154924361|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
154924362|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
154924363|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924364|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924365|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924366|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924367|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
154924368|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
154924369|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
154924370|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
154924371|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
154924372|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
154924373|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
154924374|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155266794|NCT02002884|560410885|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
155266795|NCT02002884|560410886|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
155266796|NCT02341456|560410888|FG000|Overall Study|Disease progression|2|||
155266797|NCT02341456|560410889|FG001|Overall Study|Disease progression|3|||
155266798|NCT02341456|560410890|FG002|Overall Study|Disease progression|1|||
155266799|NCT02341456|560410888|FG000|Overall Study|Death|1|||
155266800|NCT02341456|560410889|FG001|Overall Study|Death|1|||
155266801|NCT02341456|560410890|FG002|Overall Study|Death|1|||
155266802|NCT02341456|560410888|FG000|Overall Study|Withdrawal by Subject|0|||
155266803|NCT02341456|560410889|FG001|Overall Study|Withdrawal by Subject|1|||
155266804|NCT02341456|560410890|FG002|Overall Study|Withdrawal by Subject|1|||
155266805|NCT02341456|560410888|FG000|Overall Study|Moved to local access programme.|0|||
155266806|NCT02341456|560410889|FG001|Overall Study|Moved to local access programme.|1|||
155266807|NCT02341456|560410890|FG002|Overall Study|Moved to local access programme.|1|||
155266808|NCT02341456|560410888|FG000|Overall Study|Physician Decision|1|||
155266809|NCT02341456|560410889|FG001|Overall Study|Physician Decision|0|||
155266810|NCT02341456|560410890|FG002|Overall Study|Physician Decision|0|||
155266811|NCT01111838|560410894|FG000|Overall Study|Patient Ineligible|2|||
155266812|NCT01111838|560410894|FG000|Overall Study|Not Treated|3|||
155266813|NCT01111838|560410894|FG000|Overall Study|Clinical deterioration|1|||
155266814|NCT01111838|560410894|FG000|Overall Study|Other Complicating Disease|1|||
155266815|NCT02567825|560410899|FG000|Overall Study|No follow-up post-randomization|5|||
155266816|NCT02567825|560410900|FG001|Overall Study|No follow-up post-randomization|1|||
155266817|NCT02567825|560410899|FG000|Overall Study|Follow-up less than 23 months|16|||
155266818|NCT02567825|560410900|FG001|Overall Study|Follow-up less than 23 months|20|||
155266819|NCT05061537|560410905|FG000|Treatment Phase|Progressive disease|0|||
155266820|NCT05061537|560410906|FG001|Treatment Phase|Progressive disease|1|||
154924375|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
154924376|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
154924377|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
154924378|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
154966595|NCT02055547|559301093|FG004|Overall Study|Physician Decision|1|||
155266821|NCT05061537|560410907|FG002|Treatment Phase|Progressive disease|2|||
155266822|NCT05061537|560410908|FG003|Treatment Phase|Progressive disease|0|||
155266823|NCT05061537|560410909|FG004|Treatment Phase|Progressive disease|0|||
155266824|NCT05061537|560410905|FG000|Treatment Phase|Adverse Event|0|||
155266825|NCT05061537|560410906|FG001|Treatment Phase|Adverse Event|0|||
155266826|NCT05061537|560410907|FG002|Treatment Phase|Adverse Event|2|||
154924379|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
155266827|NCT05061537|560410908|FG003|Treatment Phase|Adverse Event|0|||
155266828|NCT05061537|560410909|FG004|Treatment Phase|Adverse Event|0|||
155266829|NCT05061537|560410905|FG000|Treatment Phase|Global deterioration of health status|0|||
154924380|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
154924381|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
154924382|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
154924383|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
154924384|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
154924385|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
155266830|NCT05061537|560410906|FG001|Treatment Phase|Global deterioration of health status|1|||
154924386|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
154924387|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
154924388|NCT04242446|559148002|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924389|NCT04242446|559148003|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
154924390|NCT04242446|559148004|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
154924391|NCT04242446|559148005|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924392|NCT04242446|559148006|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924393|NCT04242446|559148007|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924394|NCT04242446|559148008|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924395|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924396|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924397|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924398|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
154924399|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
154924400|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
154924401|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
154924402|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924403|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924404|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924405|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
154924406|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
154924407|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
154924408|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
154924409|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924410|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924411|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924412|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
154924413|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
154924414|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
154924415|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
154924416|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
154924417|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
154924418|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
154924419|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
154924420|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
154924421|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
154924422|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
154924423|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
154924424|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
154924425|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
154924426|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
154924427|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
154924428|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
155038267|NCT05243563|559567816|FG001|Overall Study|Withdrawal by Subject|0|||
155038268|NCT05243563|559567815|FG000|Overall Study|Physician Decision|1|||
155266831|NCT05061537|560410907|FG002|Treatment Phase|Global deterioration of health status|0|||
155266832|NCT05061537|560410908|FG003|Treatment Phase|Global deterioration of health status|0|||
155266833|NCT05061537|560410909|FG004|Treatment Phase|Global deterioration of health status|0|||
155266834|NCT05061537|560410905|FG000|Follow up|Other|2|||
155266835|NCT05061537|560410906|FG001|Follow up|Other|0|||
155266836|NCT05061537|560410907|FG002|Follow up|Other|2|||
155266837|NCT05061537|560410908|FG003|Follow up|Other|0|||
155038269|NCT05243563|559567816|FG001|Overall Study|Physician Decision|0|||
155038270|NCT00703326|559567817|FG000|Overall Study|Lost to Follow-up|47|||
155038271|NCT00703326|559567818|FG001|Overall Study|Lost to Follow-up|18|||
155038272|NCT00703326|559567817|FG000|Overall Study|Withdrawal by Subject|54|||
155038273|NCT00703326|559567818|FG001|Overall Study|Withdrawal by Subject|20|||
155038274|NCT00703326|559567817|FG000|Overall Study|Adverse Event|1|||
155038275|NCT00703326|559567818|FG001|Overall Study|Adverse Event|0|||
155038276|NCT02661061|559567820|FG000|Overall Study|Lack of Efficacy|1|||
155038277|NCT02661061|559567821|FG001|Overall Study|Lack of Efficacy|1|||
155038278|NCT02661061|559567820|FG000|Overall Study|Withdrawal by Subject|1|||
155038279|NCT02661061|559567821|FG001|Overall Study|Withdrawal by Subject|1|||
155038280|NCT02578940|559567822|FG000|Overall Study|Screening failure|5|||
155038281|NCT02578940|559567822|FG000|Overall Study|Lost to Follow-up|1|||
155038282|NCT03341936|559567830|FG000|Overall Study|Ineligible|1|||
155038283|NCT03341936|559567830|FG000|Overall Study|Disease Progression|2|||
155038284|NCT03341936|559567830|FG000|Overall Study|Withdrew Consent|4|||
155038285|NCT03341936|559567830|FG000|Overall Study|Non-Compliance|1|||
155038286|NCT03341936|559567830|FG000|Overall Study|Physician Decision|1|||
155038287|NCT03341936|559567830|FG000|Overall Study|Withdrawal by Subject|1|||
155038288|NCT03341936|559567830|FG000|Overall Study|Other|1|||
155038289|NCT02131636|559567836|FG000|Overall Study|Personal Reasons|4|||
155038290|NCT02131636|559567837|FG001|Overall Study|Personal Reasons|4|||
155038291|NCT02131636|559567836|FG000|Overall Study|Lost to Follow-up|4|||
155038292|NCT02131636|559567837|FG001|Overall Study|Lost to Follow-up|0|||
155038293|NCT02131636|559567836|FG000|Overall Study|Adverse Event|4|||
155038294|NCT02131636|559567837|FG001|Overall Study|Adverse Event|1|||
155038295|NCT02173379|559567838|FG000|Overall Study|Lost to Follow-up|89|||
155038296|NCT02173379|559567839|FG001|Overall Study|Lost to Follow-up|81|||
155038297|NCT02173379|559567838|FG000|Overall Study|Withdrawal by Subject|24|||
155038298|NCT02173379|559567839|FG001|Overall Study|Withdrawal by Subject|29|||
155038299|NCT02173379|559567838|FG000|Overall Study|Physician Decision|8|||
155038300|NCT02173379|559567839|FG001|Overall Study|Physician Decision|8|||
155038301|NCT02173379|559567838|FG000|Overall Study|Death|75|||
154924429|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
154924430|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
155038302|NCT02173379|559567839|FG001|Overall Study|Death|72|||
154924431|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
154924432|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
154924433|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
154924434|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
154924435|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
154924436|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
154924437|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
154924438|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
154924439|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
154924440|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
154924441|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
154924442|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
154924443|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
154924444|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
154924445|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
154924446|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
154924447|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
154924448|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
154924449|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
154924450|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
154924451|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
154924452|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
154924453|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
154924454|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
154924455|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
155038303|NCT02173379|559567838|FG000|Overall Study|Other Reason|1|||
155038304|NCT02173379|559567839|FG001|Overall Study|Other Reason|0|||
155038305|NCT06226649|559567841|FG000|Overall Study|Withdrawal by Subject|4|||
155038306|NCT06226649|559567842|FG001|Overall Study|Withdrawal by Subject|1|||
154924456|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
154924457|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
154924458|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
154924459|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
154924460|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
154924461|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
154924462|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
154924463|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
154924464|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
154924465|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
154924466|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
154924467|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
154924468|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
154924469|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
154924470|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
154924471|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
154924472|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
154924473|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
154924474|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
154924475|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
154924476|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
154924477|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
154924478|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
154924479|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
154924480|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
154924481|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
154924482|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
154924483|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
154924484|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
154924485|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
154924486|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
154924487|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
154924488|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
154924489|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
154924490|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
154924491|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
154924492|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
154924493|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
154924494|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
154924495|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
154924496|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
154924497|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
154924498|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
154924499|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
154924500|NCT04242446|559148002|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
154924501|NCT04242446|559148003|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
154924502|NCT04242446|559148004|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
154924503|NCT04242446|559148005|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
154924504|NCT04242446|559148006|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
155038307|NCT03956615|559567860|FG000|Overall Study|No multiple myeloma confirmed|2|||
155038308|NCT03956615|559567860|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
154924505|NCT04242446|559148007|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
154924506|NCT04242446|559148008|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
154924507|NCT03587116|559148009|FG000|Overall Study|Lost to Follow-up|0|||
154924508|NCT03587116|559148010|FG001|Overall Study|Lost to Follow-up|1|||
154924509|NCT03587116|559148009|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
155038309|NCT03956615|559567860|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
154924510|NCT03587116|559148010|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
154924511|NCT03587116|559148009|FG000|Overall Study|Withdrawal by Subject|4|||
154924512|NCT03587116|559148010|FG001|Overall Study|Withdrawal by Subject|0|||
154924513|NCT05993299|559148014|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
154924514|NCT05993299|559148014|FG000|Overall Study|Ongoing|4|||
154924515|NCT05644756|559148015|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
154924516|NCT05644756|559148015|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
154924517|NCT00478933|559148016|FG000|Overall Study|Protocol Violation|22|||
154924518|NCT00478933|559148016|FG000|Overall Study|Informed consent not verified|3|||
154924519|NCT00478933|559148016|FG000|Overall Study|Inadequate data available|53|||
154924520|NCT00643006|559148017|FG000|Overall Study|Lost to Follow-up|5|||
154924521|NCT00643006|559148018|FG001|Overall Study|Lost to Follow-up|4|||
154924522|NCT01283009|559148024|FG000|Overall Study|Death|83|||
154924523|NCT01283009|559148025|FG001|Overall Study|Death|78|||
154924524|NCT01283009|559148024|FG000|Overall Study|Study ended early|23|||
154924525|NCT01283009|559148025|FG001|Overall Study|Study ended early|26|||
154924526|NCT01283009|559148024|FG000|Overall Study|Withdrawal by Subject|10|||
154924527|NCT01283009|559148025|FG001|Overall Study|Withdrawal by Subject|8|||
154924528|NCT01283009|559148024|FG000|Overall Study|Physician Decision|1|||
154924529|NCT01283009|559148025|FG001|Overall Study|Physician Decision|1|||
154924530|NCT01283009|559148024|FG000|Overall Study|Lost to Follow-up|1|||
154924531|NCT01283009|559148025|FG001|Overall Study|Lost to Follow-up|0|||
154924532|NCT01283009|559148024|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
154924533|NCT01283009|559148025|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
154924534|NCT00183170|559148028|FG000|First Intervention|Did not complete study|1|||
154924535|NCT00183170|559148029|FG001|First Intervention|Did not complete study|0|||
154924536|NCT00183170|559148028|FG000|First Intervention|Did not meet targeted BrAC|1|||
154924537|NCT00183170|559148029|FG001|First Intervention|Did not meet targeted BrAC|0|||
154924538|NCT00183170|559148028|FG000|Washout 1 Week|Did not complete study|6|||
154924539|NCT00183170|559148029|FG001|Washout 1 Week|Did not complete study|8|||
154924540|NCT00183170|559148028|FG000|Second Intervention|Did not complete study|1|||
154924541|NCT00183170|559148029|FG001|Second Intervention|Did not complete study|0|||
154924542|NCT00183170|559148028|FG000|Second Intervention|Did not meet targeted BrAC|0|||
154924543|NCT00183170|559148029|FG001|Second Intervention|Did not meet targeted BrAC|2|||
154924544|NCT01215968|559148036|FG000|Overall Study|Adverse Event|0|||
154924545|NCT01215968|559148037|FG001|Overall Study|Adverse Event|2|||
154924546|NCT01215968|559148036|FG000|Overall Study|Protocol Violation|2|||
154924547|NCT01215968|559148037|FG001|Overall Study|Protocol Violation|4|||
154924548|NCT01215968|559148036|FG000|Overall Study|Not received study drug|0|||
154924549|NCT01215968|559148037|FG001|Overall Study|Not received study drug|1|||
154924550|NCT05643573|559148040|FG000|Overall Study|Adverse Event|117|||
154924551|NCT05643573|559148041|FG001|Overall Study|Adverse Event|90|||
154924552|NCT05643573|559148040|FG000|Overall Study|Death|53|||
154924553|NCT05643573|559148041|FG001|Overall Study|Death|57|||
154924554|NCT05643573|559148040|FG000|Overall Study|Lost to Follow-up|6|||
154924555|NCT05643573|559148041|FG001|Overall Study|Lost to Follow-up|3|||
154924556|NCT05643573|559148040|FG000|Overall Study|Other|18|||
154924557|NCT05643573|559148041|FG001|Overall Study|Other|15|||
154924558|NCT05643573|559148040|FG000|Overall Study|Outcome event|64|||
154924559|NCT05643573|559148041|FG001|Overall Study|Outcome event|36|||
154924560|NCT05643573|559148040|FG000|Overall Study|Physician Decision|33|||
154924561|NCT05643573|559148041|FG001|Overall Study|Physician Decision|19|||
154924562|NCT05643573|559148040|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
154924563|NCT05643573|559148041|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
154924564|NCT05643573|559148040|FG000|Overall Study|Site terminated by sponsor|10|||
154924565|NCT05643573|559148041|FG001|Overall Study|Site terminated by sponsor|10|||
154924566|NCT05643573|559148040|FG000|Overall Study|Study terminated by sponsor|1|||
154924567|NCT05643573|559148041|FG001|Overall Study|Study terminated by sponsor|0|||
154924568|NCT05643573|559148040|FG000|Overall Study|Withdrawal by Subject|178|||
154924569|NCT05643573|559148041|FG001|Overall Study|Withdrawal by Subject|130|||
154924570|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
154924571|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
154924572|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
154924573|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924574|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924575|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924576|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
154924577|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
154924578|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
154924579|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
154924580|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
154924581|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
155152408|NCT01283139|559994189|FG002|Overall Study|Lack of Efficacy|2|||
154924582|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
154924583|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
154924584|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
154924585|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924586|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
154924587|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924588|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924589|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924590|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
154924591|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
154924592|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924593|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
154924594|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924595|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924596|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924597|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
154924598|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
154924599|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
154924600|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
154924601|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924602|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924603|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924604|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
154924605|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
154924606|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
154924607|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
154924608|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
154924609|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
154924610|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
154924611|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
154924612|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
154924613|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
154924614|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
154924615|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
154924616|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
154924617|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
154924618|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
154924619|NCT04242498|559148046|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924620|NCT04242498|559148047|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
154924621|NCT04242498|559148048|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
154924622|NCT04242498|559148049|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924623|NCT04242498|559148050|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924624|NCT04242498|559148051|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924625|NCT04242498|559148052|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
154924626|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924627|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924628|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924629|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
154924630|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
154924631|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
154924632|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
154924633|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924634|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924635|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924636|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
154924637|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
154924638|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
154924639|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
154924640|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924641|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924642|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924643|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924644|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
154924645|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
154924646|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
154924647|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
154924648|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
154924649|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
154924650|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
154924651|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
154924652|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
154924653|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
154924654|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
154924655|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
154924656|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
154924657|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
154924658|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
154924659|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
154924660|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
154924661|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
154924662|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
155038310|NCT03956615|559567860|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
155038311|NCT03209518|559567867|FG000|Overall Study|Case Report Forms Uncollected|1|||
155038312|NCT03209518|559567867|FG000|Overall Study|Protocol Deviation|1|||
155038313|NCT00236899|559567868|FG000|Overall Study|Adverse Event (Study Related)|1|||
155038314|NCT00236899|559567869|FG001|Overall Study|Adverse Event (Study Related)|1|||
155038315|NCT00236899|559567870|FG002|Overall Study|Adverse Event (Study Related)|2|||
155038316|NCT00236899|559567871|FG003|Overall Study|Adverse Event (Study Related)|1|||
154924663|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
154924664|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
154924665|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
154924666|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
154924667|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
154924668|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
154924669|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
154924670|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
154924671|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
154924672|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
154924673|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
154924674|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
154924675|NCT04242498|559148046|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
154924676|NCT04242498|559148047|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
154924677|NCT04242498|559148048|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
154924678|NCT04242498|559148049|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
154924679|NCT04242498|559148050|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
154924680|NCT04242498|559148051|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
154924681|NCT04242498|559148052|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
154924682|NCT02500732|559148055|FG000|Overall Study|Physician Decision|0|||
154924683|NCT02500732|559148056|FG001|Overall Study|Physician Decision|1|||
154924684|NCT01958619|559148057|FG000|Overall Study|Protocol Violation|2|||
154924685|NCT01958619|559148058|FG001|Overall Study|Protocol Violation|0|||
155038317|NCT00236899|559567868|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
155038318|NCT00236899|559567869|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
155038319|NCT00236899|559567870|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
155038320|NCT00236899|559567871|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
155038321|NCT00236899|559567868|FG000|Overall Study|Death (Study Disease)|1|||
155038322|NCT00236899|559567869|FG001|Overall Study|Death (Study Disease)|4|||
155038323|NCT00236899|559567870|FG002|Overall Study|Death (Study Disease)|0|||
155038324|NCT00236899|559567871|FG003|Overall Study|Death (Study Disease)|0|||
154924686|NCT01958619|559148059|FG002|Overall Study|Protocol Violation|1|||
154924687|NCT01958619|559148060|FG003|Overall Study|Protocol Violation|0|||
155038325|NCT00236899|559567868|FG000|Overall Study|Death (Not Study Related)|2|||
155038326|NCT00236899|559567869|FG001|Overall Study|Death (Not Study Related)|0|||
155038327|NCT00236899|559567870|FG002|Overall Study|Death (Not Study Related)|0|||
154924688|NCT03205605|559148061|FG000|Overall Study|Withdrawal by Subject|1|||
154924689|NCT02396849|559148062|FG000|Overall Study|Lost to Follow-up|1|||
155038328|NCT00236899|559567871|FG003|Overall Study|Death (Not Study Related)|0|||
155038329|NCT00236899|559567868|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
155038330|NCT00236899|559567869|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
155038331|NCT00236899|559567870|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
155038332|NCT00236899|559567871|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
155038333|NCT00236899|559567868|FG000|Overall Study|Lost to Follow-up|0|||
155038334|NCT00236899|559567869|FG001|Overall Study|Lost to Follow-up|1|||
155038335|NCT00236899|559567870|FG002|Overall Study|Lost to Follow-up|0|||
155038336|NCT00236899|559567871|FG003|Overall Study|Lost to Follow-up|0|||
155038337|NCT00236899|559567868|FG000|Overall Study|Entry Criteria Exclusion|0|||
155038338|NCT00236899|559567869|FG001|Overall Study|Entry Criteria Exclusion|1|||
155038339|NCT00236899|559567870|FG002|Overall Study|Entry Criteria Exclusion|1|||
155038340|NCT00236899|559567871|FG003|Overall Study|Entry Criteria Exclusion|0|||
155038341|NCT00236899|559567868|FG000|Overall Study|Protocol Violation|1|||
155038342|NCT00236899|559567869|FG001|Overall Study|Protocol Violation|0|||
155038343|NCT00236899|559567870|FG002|Overall Study|Protocol Violation|0|||
155038344|NCT00236899|559567871|FG003|Overall Study|Protocol Violation|0|||
155038345|NCT00236899|559567868|FG000|Overall Study|Withdrawal by Subject|6|||
155038346|NCT00236899|559567869|FG001|Overall Study|Withdrawal by Subject|4|||
155038347|NCT00236899|559567870|FG002|Overall Study|Withdrawal by Subject|5|||
155038348|NCT00236899|559567871|FG003|Overall Study|Withdrawal by Subject|2|||
155038349|NCT00236899|559567868|FG000|Overall Study|Physician Decision|7|||
155038350|NCT00236899|559567869|FG001|Overall Study|Physician Decision|8|||
155038351|NCT00236899|559567870|FG002|Overall Study|Physician Decision|7|||
155038352|NCT00236899|559567871|FG003|Overall Study|Physician Decision|6|||
155038353|NCT00236899|559567868|FG000|Overall Study|Satisfactory Response|2|||
155038354|NCT00236899|559567869|FG001|Overall Study|Satisfactory Response|0|||
155038355|NCT00236899|559567870|FG002|Overall Study|Satisfactory Response|0|||
155038356|NCT00236899|559567871|FG003|Overall Study|Satisfactory Response|1|||
155038357|NCT00236899|559567868|FG000|Overall Study|Lack of Efficacy|18|||
155038358|NCT00236899|559567869|FG001|Overall Study|Lack of Efficacy|18|||
155038359|NCT00236899|559567870|FG002|Overall Study|Lack of Efficacy|25|||
155038360|NCT00236899|559567871|FG003|Overall Study|Lack of Efficacy|23|||
155038361|NCT00568334|559567874|FG000|Overall Study|Withdrawal by Subject|0|||
155038362|NCT00568334|559567875|FG001|Overall Study|Withdrawal by Subject|1|||
155038363|NCT00568334|559567874|FG000|Overall Study|Lost to Follow-up|1|||
155038364|NCT00568334|559567875|FG001|Overall Study|Lost to Follow-up|0|||
155038365|NCT03217968|559567876|FG000|Overall Study|Withdrawal by Subject|4|||
155038366|NCT03217968|559567876|FG000|Overall Study|Lost to Follow-up|1|||
155038367|NCT03217968|559567876|FG000|Overall Study|Protocol Violation|6|||
155038368|NCT05268016|559567879|FG000|Overall Study|Unacceptable toxicity or AE|2|||
155038369|NCT05268016|559567880|FG001|Overall Study|Unacceptable toxicity or AE|2|||
155038370|NCT05268016|559567881|FG002|Overall Study|Unacceptable toxicity or AE|4|||
155038371|NCT05268016|559567882|FG003|Overall Study|Unacceptable toxicity or AE|3|||
155038372|NCT05268016|559567883|FG004|Overall Study|Unacceptable toxicity or AE|1|||
155038373|NCT05268016|559567879|FG000|Overall Study|Withdrawal by Subject|1|||
155038374|NCT05268016|559567880|FG001|Overall Study|Withdrawal by Subject|3|||
155038375|NCT05268016|559567881|FG002|Overall Study|Withdrawal by Subject|2|||
155038376|NCT05268016|559567882|FG003|Overall Study|Withdrawal by Subject|2|||
155038377|NCT05268016|559567883|FG004|Overall Study|Withdrawal by Subject|1|||
155038378|NCT05268016|559567879|FG000|Overall Study|Lost to Follow-up|4|||
155038379|NCT05268016|559567880|FG001|Overall Study|Lost to Follow-up|7|||
155038380|NCT05268016|559567881|FG002|Overall Study|Lost to Follow-up|1|||
155038381|NCT05268016|559567882|FG003|Overall Study|Lost to Follow-up|3|||
155038382|NCT05268016|559567883|FG004|Overall Study|Lost to Follow-up|5|||
155038383|NCT05268016|559567879|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
155038384|NCT05268016|559567880|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
155038385|NCT05268016|559567881|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
155038386|NCT05268016|559567882|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
155038387|NCT05268016|559567883|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
155038388|NCT05268016|559567879|FG000|Overall Study|Lack of Efficacy|0|||
155038389|NCT05268016|559567880|FG001|Overall Study|Lack of Efficacy|0|||
154924690|NCT02396849|559148063|FG001|Overall Study|Lost to Follow-up|1|||
155038390|NCT05268016|559567881|FG002|Overall Study|Lack of Efficacy|0|||
155038391|NCT05268016|559567882|FG003|Overall Study|Lack of Efficacy|0|||
155038392|NCT05268016|559567883|FG004|Overall Study|Lack of Efficacy|4|||
155038393|NCT05268016|559567879|FG000|Overall Study|Physician Decision|0|||
155038394|NCT05268016|559567880|FG001|Overall Study|Physician Decision|0|||
155038395|NCT05268016|559567881|FG002|Overall Study|Physician Decision|0|||
155038396|NCT05268016|559567882|FG003|Overall Study|Physician Decision|1|||
155038397|NCT05268016|559567883|FG004|Overall Study|Physician Decision|0|||
155038398|NCT05268016|559567879|FG000|Overall Study|Other|1|||
155038399|NCT05268016|559567880|FG001|Overall Study|Other|0|||
155038400|NCT05268016|559567881|FG002|Overall Study|Other|1|||
155038401|NCT05268016|559567882|FG003|Overall Study|Other|2|||
155038402|NCT05268016|559567883|FG004|Overall Study|Other|0|||
155038403|NCT03013985|559567891|FG000|Overall Study|Protocol Violation|2|||
155038404|NCT03013985|559567892|FG001|Overall Study|Protocol Violation|2|||
155038405|NCT03013985|559567891|FG000|Overall Study|Withdrawal by Subject|14|||
155038406|NCT03013985|559567892|FG001|Overall Study|Withdrawal by Subject|17|||
155038407|NCT03411902|559567893|FG000|Overall Study|Lost to Follow-up|3|||
155038408|NCT03411902|559567894|FG001|Overall Study|Lost to Follow-up|0|||
155038409|NCT00076999|559567897|FG000|Overall Study|Adverse Event|2|||
155038410|NCT00076999|559567898|FG001|Overall Study|Adverse Event|8|||
155038411|NCT00076999|559567899|FG002|Overall Study|Adverse Event|6|||
155038412|NCT00076999|559567900|FG003|Overall Study|Adverse Event|0|||
155038413|NCT00076999|559567901|FG004|Overall Study|Adverse Event|2|||
155038414|NCT00076999|559567897|FG000|Overall Study|Protocol Violation|0|||
155038415|NCT00076999|559567898|FG001|Overall Study|Protocol Violation|3|||
155038416|NCT00076999|559567899|FG002|Overall Study|Protocol Violation|4|||
155038417|NCT00076999|559567900|FG003|Overall Study|Protocol Violation|0|||
155038418|NCT00076999|559567901|FG004|Overall Study|Protocol Violation|9|||
155038419|NCT00076999|559567897|FG000|Overall Study|Lost to Follow-up|2|||
155038420|NCT00076999|559567898|FG001|Overall Study|Lost to Follow-up|1|||
155038421|NCT00076999|559567899|FG002|Overall Study|Lost to Follow-up|0|||
155038422|NCT00076999|559567900|FG003|Overall Study|Lost to Follow-up|0|||
155038423|NCT00076999|559567901|FG004|Overall Study|Lost to Follow-up|0|||
155038424|NCT00076999|559567897|FG000|Overall Study|Withdrawal by Subject|0|||
155038425|NCT00076999|559567898|FG001|Overall Study|Withdrawal by Subject|4|||
155038426|NCT00076999|559567899|FG002|Overall Study|Withdrawal by Subject|3|||
155038427|NCT00076999|559567900|FG003|Overall Study|Withdrawal by Subject|0|||
155038428|NCT00076999|559567901|FG004|Overall Study|Withdrawal by Subject|1|||
155038429|NCT00076999|559567897|FG000|Overall Study|Other reason (not specified)|8|||
155038430|NCT00076999|559567898|FG001|Overall Study|Other reason (not specified)|8|||
155038431|NCT00076999|559567899|FG002|Overall Study|Other reason (not specified)|4|||
155038432|NCT00076999|559567900|FG003|Overall Study|Other reason (not specified)|1|||
155038433|NCT00076999|559567901|FG004|Overall Study|Other reason (not specified)|13|||
155038434|NCT01217385|559567903|FG000|Overall Study|Withdrawal by Subject|3|||
155038435|NCT01217385|559567903|FG000|Overall Study|DOSI not performed/not eval|12|||
155038436|NCT01217385|559567903|FG000|Overall Study|Central Path not Available|1|||
155038437|NCT01217385|559567903|FG000|Overall Study|Normal Breast TOI not available|10|||
155038438|NCT01534208|559567908|FG000|Overall Study|Lost to Follow-up|19|||
155038439|NCT01534208|559567909|FG001|Overall Study|Lost to Follow-up|14|||
155038440|NCT01534208|559567908|FG000|Overall Study|Withdrawal by Subject|6|||
155038441|NCT01534208|559567909|FG001|Overall Study|Withdrawal by Subject|20|||
155038442|NCT01534208|559567908|FG000|Overall Study|Adverse Event|15|||
155038443|NCT01534208|559567909|FG001|Overall Study|Adverse Event|8|||
155038444|NCT01534208|559567908|FG000|Overall Study|Physician Decision|2|||
155038445|NCT01534208|559567909|FG001|Overall Study|Physician Decision|0|||
155038446|NCT01534208|559567908|FG000|Overall Study|Lack of Efficacy|0|||
155038447|NCT01534208|559567909|FG001|Overall Study|Lack of Efficacy|3|||
155038448|NCT01534208|559567908|FG000|Overall Study|Protocol Violation|2|||
155038449|NCT01534208|559567909|FG001|Overall Study|Protocol Violation|2|||
155038450|NCT01534208|559567908|FG000|Overall Study|Sponsor decision|4|||
155038451|NCT01534208|559567909|FG001|Overall Study|Sponsor decision|1|||
155038452|NCT01534208|559567908|FG000|Overall Study|Subject relocation|2|||
155038453|NCT01534208|559567909|FG001|Overall Study|Subject relocation|0|||
155038454|NCT01534208|559567908|FG000|Overall Study|Lab assessment|2|||
155038455|NCT01534208|559567909|FG001|Overall Study|Lab assessment|1|||
155038456|NCT01534208|559567908|FG000|Overall Study|Eligibility error|3|||
155038457|NCT01534208|559567909|FG001|Overall Study|Eligibility error|0|||
155038458|NCT01534208|559567908|FG000|Overall Study|PCP decision|1|||
155038459|NCT01534208|559567909|FG001|Overall Study|PCP decision|0|||
155038460|NCT01534208|559567908|FG000|Overall Study|Needed prohibited meds|1|||
155038461|NCT01534208|559567909|FG001|Overall Study|Needed prohibited meds|0|||
155038462|NCT00672841|559567912|FG000|Overall Study|Comfort care|1|||
155038463|NCT00672841|559567913|FG001|Overall Study|Comfort care|4|||
155038464|NCT00672841|559567912|FG000|Overall Study|icteric specimens|0|||
155038465|NCT00672841|559567913|FG001|Overall Study|icteric specimens|3|||
155266838|NCT05061537|560410909|FG004|Follow up|Other|0|||
155038466|NCT00672841|559567912|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
155038467|NCT00672841|559567913|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
155038468|NCT00672841|559567912|FG000|Overall Study|Adverse Event|0|||
155038469|NCT00672841|559567913|FG001|Overall Study|Adverse Event|3|||
155038470|NCT00672841|559567912|FG000|Overall Study|Pregnancy|0|||
155038471|NCT00672841|559567913|FG001|Overall Study|Pregnancy|1|||
155038472|NCT02638259|559567914|FG000|Treatment Period 1|Adverse Event|1|||
155038473|NCT02638259|559567915|FG001|Treatment Period 1|Adverse Event|5|||
155038474|NCT02638259|559567914|FG000|Treatment Period 1|Death|0|||
155266839|NCT05061537|560410905|FG000|Follow up|Study terminated by sponsor|0|||
155038475|NCT02638259|559567915|FG001|Treatment Period 1|Death|1|||
155038476|NCT02638259|559567914|FG000|Treatment Period 1|Lack of Efficacy|0|||
155038477|NCT02638259|559567915|FG001|Treatment Period 1|Lack of Efficacy|1|||
155038478|NCT02638259|559567914|FG000|Treatment Period 1|Protocol Violation|0|||
155038479|NCT02638259|559567915|FG001|Treatment Period 1|Protocol Violation|3|||
155038480|NCT02638259|559567914|FG000|Treatment Period 1|Withdrawal by Subject|4|||
155038481|NCT02638259|559567915|FG001|Treatment Period 1|Withdrawal by Subject|6|||
154924691|NCT02396849|559148062|FG000|Overall Study|Did not tolerate intervention|1|||
154924692|NCT02396849|559148063|FG001|Overall Study|Did not tolerate intervention|1|||
154924693|NCT03759340|559148068|FG000|Overall Study|Adverse Event|2|||
155038482|NCT02638259|559567914|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
155038483|NCT02638259|559567915|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
155038484|NCT02638259|559567914|FG000|Treatment Period 2|Adverse Event|5|||
155038485|NCT02638259|559567915|FG001|Treatment Period 2|Adverse Event|4|||
155038486|NCT02638259|559567914|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155038487|NCT02638259|559567915|FG001|Treatment Period 2|Withdrawal by Subject|7|||
155038488|NCT04299048|559567917|FG000|Overall Study|Death|1|||
155038489|NCT04299048|559567917|FG000|Overall Study|Global deterioration of health status|2|||
155038490|NCT04299048|559567917|FG000|Overall Study|Enrolled and not treated|1|||
155038491|NCT00634049|559567918|FG000|Overall Study|Never received study drug|1|||
155038492|NCT00634049|559567918|FG000|Overall Study|Died prior to receiving study drug|1|||
155038493|NCT00634049|559567918|FG000|Overall Study|Screening failure|1|||
155038494|NCT01717391|559567919|FG000|Overall Study|Withdrawal by Subject|5|||
155038495|NCT01717391|559567919|FG000|Overall Study|Physician Decision|1|||
155038496|NCT01717391|559567919|FG000|Overall Study|FLT technical failure|3|||
155038497|NCT03677934|559567920|FG000|Overall Study|Adverse Event|1|||
155038498|NCT03677934|559567921|FG001|Overall Study|Adverse Event|1|||
155038499|NCT03677934|559567920|FG000|Overall Study|Death|8|||
155038500|NCT03677934|559567921|FG001|Overall Study|Death|4|||
155038501|NCT03677934|559567920|FG000|Overall Study|Lost to Follow-up|3|||
155038502|NCT03677934|559567921|FG001|Overall Study|Lost to Follow-up|0|||
155038503|NCT03677934|559567920|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155038504|NCT03677934|559567921|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155038505|NCT03677934|559567920|FG000|Overall Study|Physician Decision|0|||
155038506|NCT03677934|559567921|FG001|Overall Study|Physician Decision|1|||
155038507|NCT03677934|559567920|FG000|Overall Study|Withdrawal by Subject|1|||
155038508|NCT03677934|559567921|FG001|Overall Study|Withdrawal by Subject|7|||
155038509|NCT04769739|559567938|FG000|Overall Study|Colorectal cancer obstruction|2|||
155038510|NCT04769739|559567939|FG001|Overall Study|Colorectal cancer obstruction|0|||
155038511|NCT04769739|559567940|FG002|Overall Study|Colorectal cancer obstruction|0|||
155038512|NCT04769739|559567941|FG003|Overall Study|Colorectal cancer obstruction|0|||
155038513|NCT04769739|559567938|FG000|Overall Study|Failed cecal intubation|1|||
155038514|NCT04769739|559567939|FG001|Overall Study|Failed cecal intubation|0|||
155038515|NCT04769739|559567940|FG002|Overall Study|Failed cecal intubation|0|||
155038516|NCT04769739|559567941|FG003|Overall Study|Failed cecal intubation|1|||
155038517|NCT04769739|559567938|FG000|Overall Study|Poor bowel preparation|0|||
155038518|NCT04769739|559567939|FG001|Overall Study|Poor bowel preparation|0|||
155038519|NCT04769739|559567940|FG002|Overall Study|Poor bowel preparation|0|||
155038520|NCT04769739|559567941|FG003|Overall Study|Poor bowel preparation|1|||
155038521|NCT01260584|559567942|FG000|Period 1|Protocol Violation|0|||
155038522|NCT01260584|559567943|FG001|Period 1|Protocol Violation|0|||
155038523|NCT01260584|559567944|FG002|Period 1|Protocol Violation|1|||
155038524|NCT01260584|559567945|FG003|Period 1|Protocol Violation|1|||
155038525|NCT01260584|559567942|FG000|Period 1|Adverse Event|0|||
155038526|NCT01260584|559567943|FG001|Period 1|Adverse Event|0|||
155038527|NCT01260584|559567944|FG002|Period 1|Adverse Event|1|||
155038528|NCT01260584|559567945|FG003|Period 1|Adverse Event|0|||
155038529|NCT01260584|559567942|FG000|Period 2|Protocol Violation|0|||
155038530|NCT01260584|559567943|FG001|Period 2|Protocol Violation|2|||
155038531|NCT01260584|559567944|FG002|Period 2|Protocol Violation|3|||
155038532|NCT01260584|559567945|FG003|Period 2|Protocol Violation|1|||
155038533|NCT01260584|559567942|FG000|Period 2|Adverse Event|1|||
155038534|NCT01260584|559567943|FG001|Period 2|Adverse Event|0|||
155038535|NCT01260584|559567944|FG002|Period 2|Adverse Event|2|||
155038536|NCT01260584|559567945|FG003|Period 2|Adverse Event|0|||
155038537|NCT01260584|559567942|FG000|Period 2|Withdrawal by Subject|0|||
155038538|NCT01260584|559567943|FG001|Period 2|Withdrawal by Subject|1|||
155038539|NCT01260584|559567944|FG002|Period 2|Withdrawal by Subject|0|||
155038540|NCT01260584|559567945|FG003|Period 2|Withdrawal by Subject|0|||
155038541|NCT00045734|559567946|FG000|Overall Study|Protocol Violation|1|||
155038542|NCT02069093|559567947|FG000|Overall Study|Disease progression|14|||
155038543|NCT02069093|559567947|FG000|Overall Study|New cancer therapy|1|||
155038544|NCT02069093|559567947|FG000|Overall Study|Death|1|||
155038545|NCT02069093|559567947|FG000|Overall Study|Administrative problems|1|||
155038546|NCT02069093|559567947|FG000|Overall Study|Withdrawal by Subject|2|||
155038547|NCT02069093|559567947|FG000|Overall Study|Abnormal laboratory values|1|||
155038548|NCT02069093|559567947|FG000|Overall Study|Adverse Event|10|||
155038549|NCT01634659|559567952|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
155038550|NCT01634659|559567953|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
155038551|NCT01634659|559567952|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
155038552|NCT01634659|559567953|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
154924694|NCT03759340|559148068|FG000|Overall Study|Lost to Follow-up|1|||
155038553|NCT00586508|559567954|FG000|Overall Study|Progressive disease|52|||
155038554|NCT00586508|559567955|FG001|Overall Study|Progressive disease|8|||
155038555|NCT00586508|559567954|FG000|Overall Study|Death|0|||
155038556|NCT00586508|559567955|FG001|Overall Study|Death|1|||
155038557|NCT00586508|559567954|FG000|Overall Study|Adverse Event|12|||
155038558|NCT00586508|559567955|FG001|Overall Study|Adverse Event|4|||
155038559|NCT00586508|559567954|FG000|Overall Study|Withdrawal by Subject|4|||
155038560|NCT00586508|559567955|FG001|Overall Study|Withdrawal by Subject|0|||
155038561|NCT00561470|559567957|FG000|Overall Study|Adverse Event|74|||
155038562|NCT00561470|559567958|FG001|Overall Study|Adverse Event|163|||
155038563|NCT00561470|559567957|FG000|Overall Study|Disease progression|437|||
155038564|NCT00561470|559567958|FG001|Overall Study|Disease progression|305|||
155038565|NCT00561470|559567957|FG000|Overall Study|poor compliance to protocol|4|||
155038566|NCT00561470|559567958|FG001|Overall Study|poor compliance to protocol|4|||
155038567|NCT00561470|559567957|FG000|Overall Study|Lost to Follow-up|2|||
155038568|NCT00561470|559567958|FG001|Overall Study|Lost to Follow-up|0|||
155038569|NCT00561470|559567957|FG000|Overall Study|Physician Decision|21|||
155038570|NCT00561470|559567958|FG001|Overall Study|Physician Decision|20|||
155038571|NCT00561470|559567957|FG000|Overall Study|Consent Withdrawn|2|||
155038572|NCT00561470|559567958|FG001|Overall Study|Consent Withdrawn|6|||
155038573|NCT00561470|559567957|FG000|Overall Study|Subject request|43|||
155038574|NCT00561470|559567958|FG001|Overall Study|Subject request|77|||
155038575|NCT00561470|559567957|FG000|Overall Study|Metastatic surgery|10|||
155038576|NCT00561470|559567958|FG001|Overall Study|Metastatic surgery|12|||
155038577|NCT00561470|559567957|FG000|Overall Study|Unauthorized procedure|3|||
155038578|NCT00561470|559567958|FG001|Overall Study|Unauthorized procedure|1|||
155038579|NCT00561470|559567957|FG000|Overall Study|Randomized but not treated|5|||
155038580|NCT00561470|559567958|FG001|Overall Study|Randomized but not treated|5|||
155038581|NCT00561470|559567957|FG000|Overall Study|Missed visit window|1|||
155038582|NCT00561470|559567958|FG001|Overall Study|Missed visit window|4|||
155038583|NCT00561470|559567957|FG000|Overall Study|Planning surgery|1|||
155038584|NCT00561470|559567958|FG001|Overall Study|Planning surgery|1|||
155038585|NCT00561470|559567957|FG000|Overall Study|Ongoing Treatment|11|||
155038586|NCT00561470|559567958|FG001|Overall Study|Ongoing Treatment|14|||
155038587|NCT03434249|559567959|FG000|Overall Study|Adverse Event|1|||
155038588|NCT03434249|559567960|FG001|Overall Study|Adverse Event|0|||
155038589|NCT03434249|559567959|FG000|Overall Study|Lost to Follow-up|0|||
155038590|NCT03434249|559567960|FG001|Overall Study|Lost to Follow-up|1|||
155038591|NCT03434249|559567959|FG000|Overall Study|Non-compliance of family|2|||
155038592|NCT03434249|559567960|FG001|Overall Study|Non-compliance of family|1|||
155038593|NCT03434249|559567959|FG000|Overall Study|Difficulties in completing daily diary|2|||
155038594|NCT03434249|559567960|FG001|Overall Study|Difficulties in completing daily diary|1|||
155038595|NCT00232596|559567962|FG000|6-Week Titration Phase|Adverse Event|6|||
155038596|NCT00232596|559567963|FG001|6-Week Titration Phase|Adverse Event|19|||
155038597|NCT00232596|559567962|FG000|6-Week Titration Phase|Failed to Return|2|||
155038598|NCT00232596|559567963|FG001|6-Week Titration Phase|Failed to Return|1|||
155038599|NCT00232596|559567962|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
155038600|NCT00232596|559567963|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
155038601|NCT00232596|559567962|FG000|6-Week Titration Phase|Protocol Violation|1|||
155038602|NCT00232596|559567963|FG001|6-Week Titration Phase|Protocol Violation|3|||
155038603|NCT00232596|559567962|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
155038604|NCT00232596|559567963|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
155038605|NCT00232596|559567962|FG000|6-Week Titration Phase|Other|3|||
155038606|NCT00232596|559567963|FG001|6-Week Titration Phase|Other|3|||
155038607|NCT00232596|559567962|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
155038608|NCT00232596|559567963|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
155038609|NCT00232596|559567962|FG000|12-Week Maintenance Phase|Adverse Event|7|||
155038610|NCT00232596|559567963|FG001|12-Week Maintenance Phase|Adverse Event|22|||
155038611|NCT00232596|559567962|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
155038612|NCT00232596|559567963|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
155038613|NCT00232596|559567962|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
155038614|NCT00232596|559567963|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
155038615|NCT00232596|559567962|FG000|12-Week Maintenance Phase|Other|1|||
155038616|NCT00232596|559567963|FG001|12-Week Maintenance Phase|Other|3|||
155038617|NCT01253174|559567964|FG000|Period 1|Randomized but not treated|0|||
155038618|NCT01253174|559567965|FG001|Period 1|Randomized but not treated|1|||
155038619|NCT01253174|559567966|FG002|Period 1|Randomized but not treated|1|||
155038620|NCT01253174|559567967|FG003|Period 1|Randomized but not treated|0|||
155038621|NCT01253174|559567968|FG004|Period 1|Randomized but not treated|1|||
155038622|NCT01253174|559567969|FG005|Period 1|Randomized but not treated|0|||
155038623|NCT01253174|559567964|FG000|Period 2|Adverse Event|0|||
155038624|NCT01253174|559567965|FG001|Period 2|Adverse Event|0|||
155038625|NCT01253174|559567966|FG002|Period 2|Adverse Event|1|||
155038626|NCT01253174|559567967|FG003|Period 2|Adverse Event|0|||
155038627|NCT01253174|559567968|FG004|Period 2|Adverse Event|0|||
155038628|NCT01253174|559567969|FG005|Period 2|Adverse Event|0|||
155038629|NCT01253174|559567964|FG000|Period 3|Withdrawal by Subject|0|||
155038630|NCT01253174|559567965|FG001|Period 3|Withdrawal by Subject|1|||
155038631|NCT01253174|559567966|FG002|Period 3|Withdrawal by Subject|0|||
155038632|NCT01253174|559567967|FG003|Period 3|Withdrawal by Subject|0|||
155038633|NCT01253174|559567968|FG004|Period 3|Withdrawal by Subject|1|||
155038634|NCT01253174|559567969|FG005|Period 3|Withdrawal by Subject|0|||
155038635|NCT01253174|559567964|FG000|Period 3|Pregnancy|0|||
155038636|NCT01253174|559567965|FG001|Period 3|Pregnancy|0|||
155038637|NCT01253174|559567966|FG002|Period 3|Pregnancy|1|||
155038638|NCT01253174|559567967|FG003|Period 3|Pregnancy|0|||
155038639|NCT01253174|559567968|FG004|Period 3|Pregnancy|0|||
155038640|NCT01253174|559567969|FG005|Period 3|Pregnancy|0|||
155092489|NCT02777086|559773604|FG001|Overall Study|Lost to Follow-up|99|||
155092490|NCT01133665|559773605|FG000|Overall Study|Physician Decision|2|||
155092491|NCT01819272|559773606|FG000|Overall Study|Adverse Event|1|||
155092492|NCT01819272|559773607|FG001|Overall Study|Adverse Event|0|||
155092493|NCT01819272|559773608|FG002|Overall Study|Adverse Event|0|||
155092494|NCT01819272|559773609|FG003|Overall Study|Adverse Event|2|||
155092495|NCT01819272|559773610|FG004|Overall Study|Adverse Event|0|||
155092496|NCT01819272|559773611|FG005|Overall Study|Adverse Event|0|||
155092497|NCT01819272|559773606|FG000|Overall Study|Lost to Follow-up|3|||
155092498|NCT01819272|559773607|FG001|Overall Study|Lost to Follow-up|0|||
155092499|NCT01819272|559773608|FG002|Overall Study|Lost to Follow-up|1|||
155092500|NCT01819272|559773609|FG003|Overall Study|Lost to Follow-up|0|||
155092501|NCT01819272|559773610|FG004|Overall Study|Lost to Follow-up|0|||
155092502|NCT01819272|559773611|FG005|Overall Study|Lost to Follow-up|3|||
155092503|NCT01819272|559773606|FG000|Overall Study|Protocol Violation|0|||
155092504|NCT01819272|559773607|FG001|Overall Study|Protocol Violation|0|||
155092505|NCT01819272|559773608|FG002|Overall Study|Protocol Violation|0|||
155092506|NCT01819272|559773609|FG003|Overall Study|Protocol Violation|1|||
155092507|NCT01819272|559773610|FG004|Overall Study|Protocol Violation|2|||
155092508|NCT01819272|559773611|FG005|Overall Study|Protocol Violation|3|||
155092509|NCT01819272|559773606|FG000|Overall Study|Physician Decision|0|||
155092510|NCT01819272|559773607|FG001|Overall Study|Physician Decision|1|||
155092511|NCT01819272|559773608|FG002|Overall Study|Physician Decision|0|||
155092512|NCT01819272|559773609|FG003|Overall Study|Physician Decision|0|||
155092513|NCT01819272|559773610|FG004|Overall Study|Physician Decision|0|||
155092514|NCT01819272|559773611|FG005|Overall Study|Physician Decision|0|||
155092515|NCT01819272|559773606|FG000|Overall Study|Withdrawal of Consent|0|||
155092516|NCT01819272|559773607|FG001|Overall Study|Withdrawal of Consent|1|||
155092517|NCT01819272|559773608|FG002|Overall Study|Withdrawal of Consent|2|||
155092518|NCT01819272|559773609|FG003|Overall Study|Withdrawal of Consent|1|||
155266840|NCT05061537|560410906|FG001|Follow up|Study terminated by sponsor|0|||
155092519|NCT01819272|559773610|FG004|Overall Study|Withdrawal of Consent|0|||
155092520|NCT01819272|559773611|FG005|Overall Study|Withdrawal of Consent|1|||
155092521|NCT01819272|559773606|FG000|Overall Study|Loss of Glucose Control|2|||
155092522|NCT01819272|559773607|FG001|Overall Study|Loss of Glucose Control|1|||
155092523|NCT01819272|559773608|FG002|Overall Study|Loss of Glucose Control|0|||
155092524|NCT01819272|559773609|FG003|Overall Study|Loss of Glucose Control|1|||
155092525|NCT01819272|559773610|FG004|Overall Study|Loss of Glucose Control|2|||
155092526|NCT01819272|559773611|FG005|Overall Study|Loss of Glucose Control|0|||
155092527|NCT01732536|559773612|FG000|Overall Study|Withdrawal by Subject|1|||
155092528|NCT01732536|559773613|FG001|Overall Study|Withdrawal by Subject|1|||
155092529|NCT00805389|559773614|FG000|Overall Study|Adverse Event|0|||
155092530|NCT00805389|559773615|FG001|Overall Study|Adverse Event|0|||
155092531|NCT00805389|559773616|FG002|Overall Study|Adverse Event|1|||
155092532|NCT00805389|559773617|FG003|Overall Study|Adverse Event|2|||
155092533|NCT00805389|559773618|FG004|Overall Study|Adverse Event|0|||
155092534|NCT00805389|559773614|FG000|Overall Study|Lost to Follow-up|4|||
155092535|NCT00805389|559773615|FG001|Overall Study|Lost to Follow-up|3|||
155092536|NCT00805389|559773616|FG002|Overall Study|Lost to Follow-up|6|||
155092537|NCT00805389|559773617|FG003|Overall Study|Lost to Follow-up|10|||
155092538|NCT00805389|559773618|FG004|Overall Study|Lost to Follow-up|9|||
155092539|NCT00805389|559773614|FG000|Overall Study|Protocol Violation|0|||
155092540|NCT00805389|559773615|FG001|Overall Study|Protocol Violation|0|||
155092541|NCT00805389|559773616|FG002|Overall Study|Protocol Violation|1|||
155092542|NCT00805389|559773617|FG003|Overall Study|Protocol Violation|0|||
155092543|NCT00805389|559773618|FG004|Overall Study|Protocol Violation|0|||
155092544|NCT00805389|559773614|FG000|Overall Study|Withdrawal by Subject|3|||
155092545|NCT00805389|559773615|FG001|Overall Study|Withdrawal by Subject|2|||
155092546|NCT00805389|559773616|FG002|Overall Study|Withdrawal by Subject|4|||
155092547|NCT00805389|559773617|FG003|Overall Study|Withdrawal by Subject|5|||
155092548|NCT00805389|559773618|FG004|Overall Study|Withdrawal by Subject|4|||
155092549|NCT02336815|559773623|FG000|Overall Study|Disease Progression|45|||
155266841|NCT05061537|560410907|FG002|Follow up|Study terminated by sponsor|2|||
155092550|NCT02336815|559773624|FG001|Overall Study|Disease Progression|70|||
155092551|NCT02336815|559773623|FG000|Overall Study|Adverse Event|18|||
155092552|NCT02336815|559773624|FG001|Overall Study|Adverse Event|39|||
155092553|NCT02336815|559773623|FG000|Overall Study|Physician Decision|11|||
155092554|NCT02336815|559773624|FG001|Overall Study|Physician Decision|4|||
155092555|NCT02336815|559773623|FG000|Overall Study|Withdrawal by Subject|3|||
155038641|NCT03089853|559569794|FG000|Overall Study|Lost to Follow-up|2|||
155038642|NCT03089853|559569795|FG001|Overall Study|Lost to Follow-up|1|||
155038643|NCT01317004|559569796|FG000|Overall Study|Withdrawal by Subject|1|||
155038644|NCT01317004|559569797|FG001|Overall Study|Withdrawal by Subject|4|||
155038645|NCT01317004|559569796|FG000|Overall Study|Protocol Violation|0|||
155038646|NCT01317004|559569797|FG001|Overall Study|Protocol Violation|2|||
155038647|NCT01317004|559569796|FG000|Overall Study|Adverse Event|3|||
155038648|NCT01317004|559569797|FG001|Overall Study|Adverse Event|3|||
155038649|NCT01393106|559569798|FG000|Overall Study|Adverse Event|3|||
155038650|NCT01393106|559569798|FG000|Overall Study|Withdrawal by Subject|1|||
155038651|NCT01393106|559569798|FG000|Overall Study|Lack of Efficacy|1|||
155038652|NCT03052920|559569799|FG000|Overall Study|Withdrawal by Subject|1|||
155038653|NCT01698268|559569800|FG000|Overall Study|Physician Decision|2|||
155038654|NCT01698268|559569801|FG001|Overall Study|Physician Decision|1|||
155038655|NCT02263729|559569802|FG000|Overall Study|Lost to Follow-up|1|||
155038656|NCT02263729|559569803|FG001|Overall Study|Lost to Follow-up|1|||
155038657|NCT04591015|559569804|FG000|Overall Study|Death|6|||
155038658|NCT04591015|559569805|FG001|Overall Study|Death|4|||
155038659|NCT04591015|559569804|FG000|Overall Study|Withdrawal by Subject|6|||
155038660|NCT04591015|559569805|FG001|Overall Study|Withdrawal by Subject|3|||
155038661|NCT04591015|559569804|FG000|Overall Study|Lost to Follow-up|16|||
155038662|NCT04591015|559569805|FG001|Overall Study|Lost to Follow-up|11|||
155038663|NCT02509078|559569806|FG000|Overall Study|Protocol Violation|1|||
155038664|NCT02509078|559569807|FG001|Overall Study|Protocol Violation|1|||
155038665|NCT00631163|559569810|FG000|Number of Participants in Year 1|Adverse Event|12|||
155038666|NCT00631163|559569810|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
155038667|NCT00631163|559569810|FG000|Number of Participants in Year 1|Death|6|||
155038668|NCT00631163|559569810|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
155038669|NCT00631163|559569810|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
155038670|NCT00631163|559569810|FG000|Number of Participants in Year 1|Administrative problems|6|||
155038671|NCT00631163|559569810|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
155038672|NCT00631163|559569810|FG000|Number of Participants in Year 2|Adverse Event|1|||
155038673|NCT00631163|559569810|FG000|Number of Participants in Year 2|Protocol Violation|1|||
155038674|NCT00631163|559569810|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
155038675|NCT01636947|559569813|FG000|Overall Study|Not Treated|2|||
155038676|NCT01636947|559569814|FG001|Overall Study|Not Treated|2|||
155038677|NCT01636947|559569813|FG000|Overall Study|Lost to Follow-up|4|||
155038678|NCT01636947|559569814|FG001|Overall Study|Lost to Follow-up|0|||
155038679|NCT01636947|559569813|FG000|Overall Study|Protocol Violation|1|||
155038680|NCT01636947|559569814|FG001|Overall Study|Protocol Violation|1|||
155038681|NCT01636947|559569813|FG000|Overall Study|Withdrawal by Subject|3|||
155038682|NCT01636947|559569814|FG001|Overall Study|Withdrawal by Subject|3|||
155038683|NCT01636947|559569813|FG000|Overall Study|Adverse Event|1|||
155038684|NCT01636947|559569814|FG001|Overall Study|Adverse Event|1|||
155038685|NCT01636947|559569813|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155038686|NCT01636947|559569814|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
155038687|NCT02696434|559569815|FG000|Overall Study|Adverse Event|3|||
155038688|NCT02696434|559569816|FG001|Overall Study|Adverse Event|1|||
155038689|NCT02696434|559569815|FG000|Overall Study|Lost to Follow-up|5|||
155038690|NCT02696434|559569816|FG001|Overall Study|Lost to Follow-up|4|||
155038691|NCT02696434|559569815|FG000|Overall Study|Withdrawal by Subject|14|||
155038692|NCT02696434|559569816|FG001|Overall Study|Withdrawal by Subject|12|||
155038693|NCT02696434|559569815|FG000|Overall Study|Physician Decision|0|||
155038694|NCT02696434|559569816|FG001|Overall Study|Physician Decision|1|||
155038695|NCT00427999|559569843|FG000|Overall Study|Adverse Event|6|||
155038696|NCT00427999|559569843|FG000|Overall Study|Abnormal laboratory values|1|||
155038697|NCT00427999|559569843|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
155038698|NCT00427999|559569843|FG000|Overall Study|Protocol Violation|2|||
155038699|NCT00427999|559569843|FG000|Overall Study|Withdrawal by Subject|9|||
155038700|NCT00427999|559569843|FG000|Overall Study|Death|1|||
155038701|NCT02284568|559569844|FG000|Overall Study|Adverse Event|2|||
155038702|NCT02284568|559569845|FG001|Overall Study|Adverse Event|9|||
155038703|NCT02284568|559569846|FG002|Overall Study|Adverse Event|4|||
155038704|NCT02284568|559569844|FG000|Overall Study|Withdrawal by Subject|22|||
155038705|NCT02284568|559569845|FG001|Overall Study|Withdrawal by Subject|21|||
155038706|NCT02284568|559569846|FG002|Overall Study|Withdrawal by Subject|1|||
155038707|NCT02284568|559569844|FG000|Overall Study|Noncompliance with study drug admin|1|||
155038708|NCT02284568|559569845|FG001|Overall Study|Noncompliance with study drug admin|2|||
155038709|NCT02284568|559569846|FG002|Overall Study|Noncompliance with study drug admin|0|||
155038710|NCT02284568|559569844|FG000|Overall Study|Noncompliance|1|||
155038711|NCT02284568|559569845|FG001|Overall Study|Noncompliance|0|||
155038712|NCT02284568|559569846|FG002|Overall Study|Noncompliance|0|||
155038713|NCT02284568|559569844|FG000|Overall Study|Protocol Violation|0|||
155038714|NCT02284568|559569845|FG001|Overall Study|Protocol Violation|1|||
155038715|NCT02284568|559569846|FG002|Overall Study|Protocol Violation|0|||
155038716|NCT02284568|559569844|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
155152409|NCT01283139|559994190|FG003|Overall Study|Lack of Efficacy|1|||
155038717|NCT02284568|559569845|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
155038718|NCT02284568|559569846|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
155038719|NCT02284568|559569844|FG000|Overall Study|Lost to Follow-up|0|||
155038720|NCT02284568|559569845|FG001|Overall Study|Lost to Follow-up|3|||
155038721|NCT02284568|559569846|FG002|Overall Study|Lost to Follow-up|0|||
155038722|NCT02284568|559569844|FG000|Overall Study|Lack of Efficacy|4|||
155038723|NCT02284568|559569845|FG001|Overall Study|Lack of Efficacy|7|||
155038724|NCT02284568|559569846|FG002|Overall Study|Lack of Efficacy|0|||
155038725|NCT02284568|559569844|FG000|Overall Study|Other|1|||
155038726|NCT02284568|559569845|FG001|Overall Study|Other|2|||
155038727|NCT02284568|559569846|FG002|Overall Study|Other|0|||
155038728|NCT02284568|559569844|FG000|Overall Study|Withdrew before taking study drug|0|||
155038729|NCT02284568|559569845|FG001|Overall Study|Withdrew before taking study drug|1|||
155038730|NCT02284568|559569846|FG002|Overall Study|Withdrew before taking study drug|0|||
155038731|NCT00460265|559569847|FG000|Overall Study|Lost to Follow-up|14|||
155038732|NCT00460265|559569848|FG001|Overall Study|Lost to Follow-up|15|||
155038733|NCT00460265|559569847|FG000|Overall Study|Physician Decision|1|||
155038734|NCT00460265|559569848|FG001|Overall Study|Physician Decision|2|||
155038735|NCT00460265|559569847|FG000|Overall Study|Withdrawal by Subject|10|||
155038736|NCT00460265|559569848|FG001|Overall Study|Withdrawal by Subject|25|||
155038737|NCT00460265|559569847|FG000|Overall Study|Ongoing|60|||
155038738|NCT00460265|559569848|FG001|Overall Study|Ongoing|47|||
155038739|NCT01955109|559569859|FG000|Overall Study|Adverse Event|2|||
155038740|NCT01955109|559569860|FG001|Overall Study|Adverse Event|0|||
155038741|NCT01955109|559569859|FG000|Overall Study|Participant unwilling to continue|35|||
155038742|NCT01955109|559569860|FG001|Overall Study|Participant unwilling to continue|7|||
155038743|NCT01955109|559569859|FG000|Overall Study|Physician Decision|2|||
155038744|NCT01955109|559569860|FG001|Overall Study|Physician Decision|0|||
155038745|NCT01955109|559569859|FG000|Overall Study|Lost to Follow-up|3|||
155038746|NCT01955109|559569860|FG001|Overall Study|Lost to Follow-up|1|||
155038747|NCT01955109|559569859|FG000|Overall Study|Non-compliance|3|||
155038748|NCT01955109|559569860|FG001|Overall Study|Non-compliance|1|||
155038749|NCT00904839|559569861|FG000|Overall Study|Adverse Event|0|||
155038750|NCT00904839|559569862|FG001|Overall Study|Adverse Event|5|||
155038751|NCT00904839|559569863|FG002|Overall Study|Adverse Event|4|||
155038752|NCT00904839|559569861|FG000|Overall Study|Protocol Violation|0|||
155038753|NCT00904839|559569862|FG001|Overall Study|Protocol Violation|1|||
155038754|NCT00904839|559569863|FG002|Overall Study|Protocol Violation|1|||
155038755|NCT00904839|559569861|FG000|Overall Study|Lost to Follow-up|0|||
155038756|NCT00904839|559569862|FG001|Overall Study|Lost to Follow-up|1|||
155038757|NCT00904839|559569863|FG002|Overall Study|Lost to Follow-up|2|||
155038758|NCT00904839|559569861|FG000|Overall Study|Withdrawal by Subject|0|||
155038759|NCT00904839|559569862|FG001|Overall Study|Withdrawal by Subject|2|||
155038760|NCT00904839|559569863|FG002|Overall Study|Withdrawal by Subject|0|||
155038761|NCT00904839|559569861|FG000|Overall Study|Not treated|1|||
155038762|NCT00904839|559569862|FG001|Overall Study|Not treated|0|||
155038763|NCT00904839|559569863|FG002|Overall Study|Not treated|1|||
155038764|NCT00904839|559569861|FG000|Overall Study|Other than above|0|||
155038765|NCT00904839|559569862|FG001|Overall Study|Other than above|9|||
155038766|NCT00904839|559569863|FG002|Overall Study|Other than above|7|||
155038767|NCT01853696|559569870|FG000|Overall Study|Withdrawal by Subject|1|||
155038768|NCT01853696|559569871|FG001|Overall Study|Withdrawal by Subject|1|||
155038769|NCT01853696|559569870|FG000|Overall Study|Lost to Follow-up|5|||
155038770|NCT01853696|559569871|FG001|Overall Study|Lost to Follow-up|4|||
155038771|NCT01797094|559569872|FG000|Overall Study|Adverse Event|1|||
155038772|NCT01797094|559569873|FG001|Overall Study|Adverse Event|1|||
155038773|NCT01797094|559569872|FG000|Overall Study|Personal Reasons|4|||
155038774|NCT01797094|559569873|FG001|Overall Study|Personal Reasons|0|||
155038775|NCT01797094|559569872|FG000|Overall Study|Protocol Violation|0|||
155038776|NCT01797094|559569873|FG001|Overall Study|Protocol Violation|1|||
155038777|NCT01797094|559569872|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155038778|NCT01797094|559569873|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155038779|NCT00821015|559569874|FG000|Overall Study|Lost to Follow-up|12|||
155038780|NCT01887678|559569875|FG000|Overall Study|Adverse Event|4|||
155038781|NCT01887678|559569876|FG001|Overall Study|Adverse Event|6|||
155038782|NCT01887678|559569875|FG000|Overall Study|Exceeded rescue medication dosage|4|||
155038783|NCT01887678|559569876|FG001|Overall Study|Exceeded rescue medication dosage|5|||
155038784|NCT01887678|559569875|FG000|Overall Study|Withdrawal of consent|3|||
155038785|NCT01887678|559569876|FG001|Overall Study|Withdrawal of consent|4|||
155038786|NCT01887678|559569875|FG000|Overall Study|Lost to Follow-up|4|||
155038787|NCT01887678|559569876|FG001|Overall Study|Lost to Follow-up|2|||
155038788|NCT01887678|559569875|FG000|Overall Study|Deterioration of clinical condition|0|||
155038789|NCT01887678|559569876|FG001|Overall Study|Deterioration of clinical condition|4|||
155038790|NCT01887678|559569875|FG000|Overall Study|Lack of Efficacy|1|||
155038791|NCT01887678|559569876|FG001|Overall Study|Lack of Efficacy|2|||
155038792|NCT01887678|559569875|FG000|Overall Study|Non-compliance|0|||
155038793|NCT01887678|559569876|FG001|Overall Study|Non-compliance|3|||
155038794|NCT01887678|559569875|FG000|Overall Study|Specified|1|||
155038795|NCT01887678|559569876|FG001|Overall Study|Specified|2|||
155038796|NCT00791492|559569879|FG000|Overall Study|Withdrawal by Subject|1|||
155038797|NCT00791492|559569880|FG001|Overall Study|Withdrawal by Subject|2|||
155038798|NCT00791492|559569879|FG000|Overall Study|Liver transplantation|5|||
155038799|NCT00791492|559569880|FG001|Overall Study|Liver transplantation|1|||
155038800|NCT00090987|559569884|FG000|Overall Study|Adverse Event|5|||
155038801|NCT00090987|559569884|FG000|Overall Study|Lack of Efficacy|7|||
155038802|NCT00090987|559569884|FG000|Overall Study|Withdrawal by Subject|3|||
155038803|NCT00090987|559569884|FG000|Overall Study|alternative therapy|1|||
155038804|NCT00090987|559569884|FG000|Overall Study|Non-compliance|4|||
155038805|NCT00090987|559569884|FG000|Overall Study|Incarcerated|1|||
155038806|NCT00990665|559569889|FG000|Overall Study|Unsuccessful Implant|8|||
155038807|NCT00990665|559569889|FG000|Overall Study|Death|29|||
155038808|NCT00990665|559569889|FG000|Overall Study|Heart Transplant|1|||
155038809|NCT00990665|559569889|FG000|Overall Study|Withdrawal by Subject|6|||
155038810|NCT00990665|559569889|FG000|Overall Study|Lost to Follow-up|1|||
155038811|NCT00990665|559569889|FG000|Overall Study|System Explant|3|||
155038812|NCT00270231|559569890|FG000|First Intervention|Lost to Follow-up|1|||
155038813|NCT00270231|559569891|FG001|First Intervention|Lost to Follow-up|1|||
155038814|NCT00270231|559569890|FG000|Washout Period|Lost to Follow-up|1|||
155038815|NCT00270231|559569891|FG001|Washout Period|Lost to Follow-up|0|||
155038816|NCT00270231|559569890|FG000|Second Intervention|Lost to Follow-up|0|||
155038817|NCT00270231|559569891|FG001|Second Intervention|Lost to Follow-up|1|||
155038818|NCT02603562|559569892|FG000|Overall Study|Lost to Follow-up|1|||
155038819|NCT00574795|559569900|FG000|Infant Series|Withdrawal by Subject|2|||
155038820|NCT00574795|559569900|FG000|Infant Series|Protocol Violation|2|||
155038821|NCT00574795|559569900|FG000|Infant Series|Adverse Event|1|||
155038822|NCT00574795|559569900|FG000|After Infant Series|Withdrawal by Subject|1|||
155038823|NCT00574795|559569900|FG000|After Infant Series|Adverse Event|2|||
155038824|NCT00574795|559569900|FG000|Toddler Dose|Withdrawal by Subject|1|||
155038825|NCT01969084|559569905|FG000|Overall Study|Adverse Event|0|||
155038826|NCT01969084|559569906|FG001|Overall Study|Adverse Event|1|||
155038827|NCT05079230|559569907|FG000|Overall Study|Study Terminated by Sponsor|101|||
155038828|NCT05079230|559569908|FG001|Overall Study|Study Terminated by Sponsor|102|||
155038829|NCT05079230|559569907|FG000|Overall Study|Death|72|||
155038830|NCT05079230|559569908|FG001|Overall Study|Death|66|||
155038831|NCT05079230|559569907|FG000|Overall Study|Withdrew Consent|16|||
155038832|NCT05079230|559569908|FG001|Overall Study|Withdrew Consent|18|||
155038833|NCT05079230|559569907|FG000|Overall Study|Lost to Follow-up|0|||
155038834|NCT05079230|559569908|FG001|Overall Study|Lost to Follow-up|3|||
155038835|NCT01524783|559569909|FG000|Blinded Period|Adverse Event|64|||
155038836|NCT01524783|559569910|FG001|Blinded Period|Adverse Event|7|||
155038837|NCT01524783|559569911|FG002|Blinded Period|Adverse Event|0|||
155038838|NCT01524783|559569909|FG000|Blinded Period|Disease Progression|89|||
155038839|NCT01524783|559569910|FG001|Blinded Period|Disease Progression|75|||
155038840|NCT01524783|559569911|FG002|Blinded Period|Disease Progression|0|||
155038841|NCT01524783|559569909|FG000|Blinded Period|Withdrawal by Subject|19|||
155038842|NCT01524783|559569910|FG001|Blinded Period|Withdrawal by Subject|6|||
155038843|NCT01524783|559569911|FG002|Blinded Period|Withdrawal by Subject|0|||
155038844|NCT01524783|559569909|FG000|Blinded Period|Protocol deviation|2|||
155038845|NCT01524783|559569910|FG001|Blinded Period|Protocol deviation|1|||
155038846|NCT01524783|559569911|FG002|Blinded Period|Protocol deviation|0|||
155038847|NCT01524783|559569909|FG000|Blinded Period|Death|5|||
155038848|NCT01524783|559569910|FG001|Blinded Period|Death|2|||
155038849|NCT01524783|559569911|FG002|Blinded Period|Death|0|||
155038850|NCT01524783|559569909|FG000|Open-label Period|Disease progression|13|||
155038851|NCT01524783|559569910|FG001|Open-label Period|Disease progression|0|||
155038852|NCT01524783|559569911|FG002|Open-label Period|Disease progression|2|||
155038853|NCT01524783|559569909|FG000|Open-label Period|Administrative problems|5|||
155038854|NCT01524783|559569910|FG001|Open-label Period|Administrative problems|0|||
155038855|NCT01524783|559569911|FG002|Open-label Period|Administrative problems|2|||
155038856|NCT01524783|559569909|FG000|Open-label Period|Adverse Event|5|||
155038857|NCT01524783|559569910|FG001|Open-label Period|Adverse Event|0|||
155038858|NCT01524783|559569911|FG002|Open-label Period|Adverse Event|1|||
155038859|NCT01524783|559569909|FG000|Open-label Period|Withdrawal by Subject|2|||
155038860|NCT01524783|559569910|FG001|Open-label Period|Withdrawal by Subject|0|||
155038861|NCT01524783|559569911|FG002|Open-label Period|Withdrawal by Subject|1|||
155038862|NCT01524783|559569909|FG000|Open-label Period|Protocol deviation|1|||
155038863|NCT01524783|559569910|FG001|Open-label Period|Protocol deviation|0|||
155038864|NCT01524783|559569911|FG002|Open-label Period|Protocol deviation|0|||
155038865|NCT02920177|559569913|FG000|Overall Study|Withdrawal by Subject|1|||
155038866|NCT02920177|559569914|FG001|Overall Study|Withdrawal by Subject|1|||
155038867|NCT02920177|559569913|FG000|Overall Study|Physician Decision|1|||
155038868|NCT02920177|559569914|FG001|Overall Study|Physician Decision|0|||
155038869|NCT02920177|559569913|FG000|Overall Study|Lost to Follow-up|0|||
155038870|NCT02920177|559569914|FG001|Overall Study|Lost to Follow-up|1|||
155038871|NCT03164265|559569915|FG000|Overall Study|Physician Decision|3|||
155038872|NCT04907227|559569916|FG000|Overall Study|Death|12|||
155038873|NCT04907227|559569917|FG001|Overall Study|Death|8|||
155038874|NCT04907227|559569916|FG000|Overall Study|Withdrawal by Subject|2|||
155038875|NCT04907227|559569917|FG001|Overall Study|Withdrawal by Subject|2|||
155038876|NCT04907227|559569916|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
155038877|NCT04907227|559569917|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155038878|NCT04907227|559569916|FG000|Overall Study|Sponsor Decision|25|||
155038879|NCT04907227|559569917|FG001|Overall Study|Sponsor Decision|30|||
154966596|NCT02055547|559301094|FG005|Overall Study|Physician Decision|0|||
154966597|NCT02055547|559301095|FG006|Overall Study|Physician Decision|0|||
154966598|NCT02055547|559301096|FG007|Overall Study|Physician Decision|0|||
154966599|NCT02055547|559301097|FG008|Overall Study|Physician Decision|0|||
154966600|NCT02055547|559301098|FG009|Overall Study|Physician Decision|1|||
154966601|NCT02055547|559301099|FG010|Overall Study|Physician Decision|1|||
154966602|NCT02055547|559301100|FG011|Overall Study|Physician Decision|0|||
154966603|NCT02055547|559301101|FG012|Overall Study|Physician Decision|0|||
154966604|NCT02055547|559301102|FG013|Overall Study|Physician Decision|0|||
154966605|NCT02055547|559301103|FG014|Overall Study|Physician Decision|0|||
154966606|NCT02055547|559301104|FG015|Overall Study|Physician Decision|0|||
154966607|NCT02055547|559301105|FG016|Overall Study|Physician Decision|0|||
154966608|NCT02055547|559301106|FG017|Overall Study|Physician Decision|0|||
154966609|NCT02055547|559301107|FG018|Overall Study|Physician Decision|0|||
154966610|NCT02055547|559301089|FG000|Overall Study|Adverse Event|0|||
154966611|NCT02055547|559301090|FG001|Overall Study|Adverse Event|0|||
154966612|NCT02055547|559301091|FG002|Overall Study|Adverse Event|0|||
154966613|NCT02055547|559301092|FG003|Overall Study|Adverse Event|0|||
154966614|NCT02055547|559301093|FG004|Overall Study|Adverse Event|0|||
154966615|NCT02055547|559301094|FG005|Overall Study|Adverse Event|0|||
154966616|NCT02055547|559301095|FG006|Overall Study|Adverse Event|1|||
154966617|NCT02055547|559301096|FG007|Overall Study|Adverse Event|0|||
154966618|NCT02055547|559301097|FG008|Overall Study|Adverse Event|1|||
154966619|NCT02055547|559301098|FG009|Overall Study|Adverse Event|0|||
154966620|NCT02055547|559301099|FG010|Overall Study|Adverse Event|0|||
154966621|NCT02055547|559301100|FG011|Overall Study|Adverse Event|0|||
154966622|NCT02055547|559301101|FG012|Overall Study|Adverse Event|0|||
154966623|NCT02055547|559301102|FG013|Overall Study|Adverse Event|0|||
154966624|NCT02055547|559301103|FG014|Overall Study|Adverse Event|0|||
154966625|NCT02055547|559301104|FG015|Overall Study|Adverse Event|0|||
154966626|NCT02055547|559301105|FG016|Overall Study|Adverse Event|0|||
154966627|NCT02055547|559301106|FG017|Overall Study|Adverse Event|0|||
154966628|NCT02055547|559301107|FG018|Overall Study|Adverse Event|0|||
154966629|NCT02055547|559301089|FG000|Overall Study|Withdrawal by Subject|0|||
154966630|NCT02055547|559301090|FG001|Overall Study|Withdrawal by Subject|0|||
154966631|NCT02055547|559301091|FG002|Overall Study|Withdrawal by Subject|0|||
154966632|NCT02055547|559301092|FG003|Overall Study|Withdrawal by Subject|0|||
154966633|NCT02055547|559301093|FG004|Overall Study|Withdrawal by Subject|0|||
154966634|NCT02055547|559301094|FG005|Overall Study|Withdrawal by Subject|1|||
154966635|NCT02055547|559301095|FG006|Overall Study|Withdrawal by Subject|0|||
154966636|NCT02055547|559301096|FG007|Overall Study|Withdrawal by Subject|0|||
154966637|NCT02055547|559301097|FG008|Overall Study|Withdrawal by Subject|1|||
154966638|NCT02055547|559301098|FG009|Overall Study|Withdrawal by Subject|0|||
154966639|NCT02055547|559301099|FG010|Overall Study|Withdrawal by Subject|0|||
154966640|NCT02055547|559301100|FG011|Overall Study|Withdrawal by Subject|0|||
154966641|NCT02055547|559301101|FG012|Overall Study|Withdrawal by Subject|0|||
154966642|NCT02055547|559301102|FG013|Overall Study|Withdrawal by Subject|1|||
154966643|NCT02055547|559301103|FG014|Overall Study|Withdrawal by Subject|0|||
154966644|NCT02055547|559301104|FG015|Overall Study|Withdrawal by Subject|1|||
154966645|NCT02055547|559301105|FG016|Overall Study|Withdrawal by Subject|0|||
154966646|NCT02055547|559301106|FG017|Overall Study|Withdrawal by Subject|0|||
154966647|NCT02055547|559301107|FG018|Overall Study|Withdrawal by Subject|0|||
154966648|NCT02055547|559301089|FG000|Overall Study|Lost to Follow-up|0|||
154966649|NCT02055547|559301090|FG001|Overall Study|Lost to Follow-up|0|||
154966650|NCT02055547|559301091|FG002|Overall Study|Lost to Follow-up|1|||
154966651|NCT02055547|559301092|FG003|Overall Study|Lost to Follow-up|0|||
154966652|NCT02055547|559301093|FG004|Overall Study|Lost to Follow-up|0|||
154966653|NCT02055547|559301094|FG005|Overall Study|Lost to Follow-up|0|||
154966654|NCT02055547|559301095|FG006|Overall Study|Lost to Follow-up|0|||
154966655|NCT02055547|559301096|FG007|Overall Study|Lost to Follow-up|0|||
154966656|NCT02055547|559301097|FG008|Overall Study|Lost to Follow-up|0|||
154966657|NCT02055547|559301098|FG009|Overall Study|Lost to Follow-up|0|||
154966658|NCT02055547|559301099|FG010|Overall Study|Lost to Follow-up|0|||
154966659|NCT02055547|559301100|FG011|Overall Study|Lost to Follow-up|0|||
154966660|NCT02055547|559301101|FG012|Overall Study|Lost to Follow-up|0|||
154966661|NCT02055547|559301102|FG013|Overall Study|Lost to Follow-up|0|||
154966662|NCT02055547|559301103|FG014|Overall Study|Lost to Follow-up|0|||
154966663|NCT02055547|559301104|FG015|Overall Study|Lost to Follow-up|0|||
154966664|NCT02055547|559301105|FG016|Overall Study|Lost to Follow-up|0|||
154966665|NCT02055547|559301106|FG017|Overall Study|Lost to Follow-up|0|||
154966666|NCT02055547|559301107|FG018|Overall Study|Lost to Follow-up|0|||
155038880|NCT04907227|559569916|FG000|Overall Study|Physician Decision|1|||
155038881|NCT04907227|559569917|FG001|Overall Study|Physician Decision|0|||
155038882|NCT03723070|559569918|FG000|Overall Study|Lost to Follow-up|2|||
155038883|NCT03723070|559569918|FG000|Overall Study|Physician Decision|1|||
155038884|NCT03723070|559569918|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
155038885|NCT00721279|559569920|FG000|Overall Study|Lack of Efficacy|6|||
155038886|NCT00721279|559569921|FG001|Overall Study|Lack of Efficacy|3|||
155038887|NCT00721279|559569920|FG000|Overall Study|Tolerability insufficient|5|||
155038888|NCT00721279|559569921|FG001|Overall Study|Tolerability insufficient|2|||
155038889|NCT00721279|559569920|FG000|Overall Study|Withdrawal by Subject|13|||
155038890|NCT00721279|559569921|FG001|Overall Study|Withdrawal by Subject|3|||
155038891|NCT00721279|559569920|FG000|Overall Study|Other|12|||
155038892|NCT00721279|559569921|FG001|Overall Study|Other|16|||
155038893|NCT03673345|559569922|FG000|Overall Study|Lost to Follow-up|1|||
155038894|NCT03673345|559569923|FG001|Overall Study|Lost to Follow-up|0|||
155038895|NCT03673345|559569924|FG002|Overall Study|Lost to Follow-up|3|||
155038896|NCT03673345|559569925|FG003|Overall Study|Lost to Follow-up|3|||
155038897|NCT03673345|559569926|FG004|Overall Study|Lost to Follow-up|2|||
155038898|NCT03673345|559569927|FG005|Overall Study|Lost to Follow-up|1|||
155038899|NCT03673345|559569928|FG006|Overall Study|Lost to Follow-up|0|||
155038900|NCT03673345|559569929|FG007|Overall Study|Lost to Follow-up|0|||
155038901|NCT03673345|559569922|FG000|Overall Study|Withdrawal by Subject|1|||
155038902|NCT03673345|559569923|FG001|Overall Study|Withdrawal by Subject|0|||
155038903|NCT03673345|559569924|FG002|Overall Study|Withdrawal by Subject|4|||
155038904|NCT03673345|559569925|FG003|Overall Study|Withdrawal by Subject|2|||
155038905|NCT03673345|559569926|FG004|Overall Study|Withdrawal by Subject|0|||
155038906|NCT03673345|559569927|FG005|Overall Study|Withdrawal by Subject|0|||
155038907|NCT03673345|559569928|FG006|Overall Study|Withdrawal by Subject|0|||
155038908|NCT03673345|559569929|FG007|Overall Study|Withdrawal by Subject|0|||
155038909|NCT03673345|559569922|FG000|Overall Study|Physician Decision|0|||
155038910|NCT03673345|559569923|FG001|Overall Study|Physician Decision|0|||
155038911|NCT03673345|559569924|FG002|Overall Study|Physician Decision|2|||
155038912|NCT03673345|559569925|FG003|Overall Study|Physician Decision|0|||
155038913|NCT03673345|559569926|FG004|Overall Study|Physician Decision|0|||
155038914|NCT03673345|559569927|FG005|Overall Study|Physician Decision|0|||
155038915|NCT03673345|559569928|FG006|Overall Study|Physician Decision|0|||
155038916|NCT03673345|559569929|FG007|Overall Study|Physician Decision|0|||
155038917|NCT05153148|559569930|FG000|Overall Study|Adverse Event|1|||
155038918|NCT05153148|559569931|FG001|Overall Study|Adverse Event|0|||
155038919|NCT05153148|559569932|FG002|Overall Study|Adverse Event|3|||
155038920|NCT05153148|559569933|FG003|Overall Study|Adverse Event|5|||
155038921|NCT05153148|559569930|FG000|Overall Study|Lost to Follow-up|1|||
155038922|NCT05153148|559569931|FG001|Overall Study|Lost to Follow-up|1|||
155038923|NCT05153148|559569932|FG002|Overall Study|Lost to Follow-up|2|||
155038924|NCT05153148|559569933|FG003|Overall Study|Lost to Follow-up|0|||
155038925|NCT05153148|559569930|FG000|Overall Study|Withdrawal by Subject|6|||
155038926|NCT05153148|559569931|FG001|Overall Study|Withdrawal by Subject|8|||
155038927|NCT05153148|559569932|FG002|Overall Study|Withdrawal by Subject|6|||
155038928|NCT05153148|559569933|FG003|Overall Study|Withdrawal by Subject|8|||
155038929|NCT05153148|559569930|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155038930|NCT05153148|559569931|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155038931|NCT05153148|559569932|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
155038932|NCT05153148|559569933|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155038933|NCT05153148|559569930|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
155038934|NCT05153148|559569931|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
155038935|NCT05153148|559569932|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
155038936|NCT05153148|559569933|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
155038937|NCT05153148|559569930|FG000|Overall Study|Reason not Specified|1|||
155038938|NCT05153148|559569931|FG001|Overall Study|Reason not Specified|1|||
155038939|NCT05153148|559569932|FG002|Overall Study|Reason not Specified|1|||
155038940|NCT05153148|559569933|FG003|Overall Study|Reason not Specified|1|||
155038941|NCT02267135|559569934|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
155038942|NCT02267135|559569935|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
155038943|NCT02267135|559569934|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
155038944|NCT02267135|559569935|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
155038945|NCT02267135|559569934|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
155038946|NCT02267135|559569935|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
155038947|NCT02267135|559569934|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
155038948|NCT02267135|559569935|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
155038949|NCT02267135|559569934|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
155038950|NCT02267135|559569935|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
155038951|NCT00131365|559569936|FG000|Overall Study|Withdrawal by Subject|1|||
155038952|NCT00131365|559569936|FG000|Overall Study|Alternative treatment|3|||
155038953|NCT04608344|559569937|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
155038954|NCT04608344|559569938|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
155038955|NCT04608344|559569937|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
155038956|NCT04608344|559569938|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
155038957|NCT05249127|559569939|FG000|Overall Study|Protocol Violation|13|||
155038958|NCT05249127|559569939|FG000|Overall Study|Physician Decision|4|||
155038959|NCT05249127|559569939|FG000|Overall Study|Withdrawal by Subject|2|||
155038960|NCT05249127|559569939|FG000|Overall Study|Participant Non-compliance|1|||
155038961|NCT03053427|559569940|FG000|Overall Study|Adverse Event|4|||
155038962|NCT03053427|559569941|FG001|Overall Study|Adverse Event|4|||
155038963|NCT03053427|559569940|FG000|Overall Study|Lack of Efficacy|1|||
155038964|NCT03053427|559569941|FG001|Overall Study|Lack of Efficacy|3|||
155038965|NCT03053427|559569940|FG000|Overall Study|Lost to Follow-up|2|||
155038966|NCT03053427|559569941|FG001|Overall Study|Lost to Follow-up|2|||
155038967|NCT03053427|559569940|FG000|Overall Study|Worsening of the target disease|0|||
155038968|NCT03053427|559569941|FG001|Overall Study|Worsening of the target disease|1|||
155038969|NCT03053427|559569940|FG000|Overall Study|Protocol Deviation|3|||
155038970|NCT03053427|559569941|FG001|Overall Study|Protocol Deviation|3|||
155038971|NCT03053427|559569940|FG000|Overall Study|Withdrawal by Subject|3|||
155038972|NCT03053427|559569941|FG001|Overall Study|Withdrawal by Subject|2|||
155038973|NCT03053427|559569940|FG000|Overall Study|Miscellaneous|0|||
155038974|NCT03053427|559569941|FG001|Overall Study|Miscellaneous|1|||
155038975|NCT02607306|559569950|FG000|Overall Study|Adverse Event|8|||
155038976|NCT02607306|559569951|FG001|Overall Study|Adverse Event|6|||
155038977|NCT02607306|559569952|FG002|Overall Study|Adverse Event|6|||
155038978|NCT02607306|559569950|FG000|Overall Study|Unclassified|1|||
155038979|NCT02607306|559569951|FG001|Overall Study|Unclassified|4|||
155038980|NCT02607306|559569952|FG002|Overall Study|Unclassified|0|||
155038981|NCT02607306|559569950|FG000|Overall Study|Withdrawal by Subject|8|||
155038982|NCT02607306|559569951|FG001|Overall Study|Withdrawal by Subject|10|||
155038983|NCT02607306|559569952|FG002|Overall Study|Withdrawal by Subject|2|||
155038984|NCT02607306|559569950|FG000|Overall Study|Lack of Efficacy|0|||
155038985|NCT02607306|559569951|FG001|Overall Study|Lack of Efficacy|1|||
155038986|NCT02607306|559569952|FG002|Overall Study|Lack of Efficacy|1|||
155038987|NCT02607306|559569950|FG000|Overall Study|Protocol Violation|4|||
155038988|NCT02607306|559569951|FG001|Overall Study|Protocol Violation|2|||
155266842|NCT05061537|560410908|FG003|Follow up|Study terminated by sponsor|0|||
155038989|NCT02607306|559569952|FG002|Overall Study|Protocol Violation|1|||
155038990|NCT02360475|559569953|FG000|Overall Study|Lost to Follow-up|4|||
155038991|NCT02360475|559569954|FG001|Overall Study|Lost to Follow-up|12|||
155038992|NCT02360475|559569955|FG002|Overall Study|Lost to Follow-up|6|||
155038993|NCT02360475|559569956|FG003|Overall Study|Lost to Follow-up|4|||
155038994|NCT02360475|559569953|FG000|Overall Study|Withdrawal by Subject|0|||
155038995|NCT02360475|559569954|FG001|Overall Study|Withdrawal by Subject|1|||
155038996|NCT02360475|559569955|FG002|Overall Study|Withdrawal by Subject|2|||
155038997|NCT02360475|559569956|FG003|Overall Study|Withdrawal by Subject|0|||
155038998|NCT02360475|559569953|FG000|Overall Study|Migrated/moved from study area|0|||
155038999|NCT02360475|559569954|FG001|Overall Study|Migrated/moved from study area|0|||
155039000|NCT02360475|559569955|FG002|Overall Study|Migrated/moved from study area|0|||
155039001|NCT02360475|559569956|FG003|Overall Study|Migrated/moved from study area|1|||
155039002|NCT02510820|559571331|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155039003|NCT02510820|559571332|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155039004|NCT02510820|559571331|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155039005|NCT02510820|559571332|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155039006|NCT00642954|559571333|FG000|Overall Study|Progressive Disease|3|||
155039007|NCT00642954|559571334|FG001|Overall Study|Progressive Disease|3|||
155039008|NCT00642954|559571335|FG002|Overall Study|Progressive Disease|3|||
155039009|NCT00642954|559571336|FG003|Overall Study|Progressive Disease|3|||
155039010|NCT00642954|559571337|FG004|Overall Study|Progressive Disease|9|||
155039011|NCT00642954|559571333|FG000|Overall Study|Withdrawal by Subject|0|||
155039012|NCT00642954|559571334|FG001|Overall Study|Withdrawal by Subject|0|||
155039013|NCT00642954|559571335|FG002|Overall Study|Withdrawal by Subject|0|||
155039014|NCT00642954|559571336|FG003|Overall Study|Withdrawal by Subject|0|||
155039015|NCT00642954|559571337|FG004|Overall Study|Withdrawal by Subject|1|||
155039016|NCT00642954|559571333|FG000|Overall Study|Adverse Event|1|||
155039017|NCT00642954|559571334|FG001|Overall Study|Adverse Event|1|||
155039018|NCT00642954|559571335|FG002|Overall Study|Adverse Event|0|||
155039019|NCT00642954|559571336|FG003|Overall Study|Adverse Event|0|||
155039020|NCT00642954|559571337|FG004|Overall Study|Adverse Event|6|||
155039021|NCT01890759|559571340|FG000|Overall Study|Protocol Violation|0|||
155039022|NCT01890759|559571341|FG001|Overall Study|Protocol Violation|2|||
155039023|NCT01890759|559571340|FG000|Overall Study|Lost to Follow-up|0|||
155266843|NCT05061537|560410909|FG004|Follow up|Study terminated by sponsor|0|||
155039024|NCT01890759|559571341|FG001|Overall Study|Lost to Follow-up|2|||
155039025|NCT01890759|559571340|FG000|Overall Study|Withdrawal by Subject|2|||
155266844|NCT05061537|560410905|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
155039026|NCT01890759|559571341|FG001|Overall Study|Withdrawal by Subject|8|||
155039027|NCT01344759|559571342|FG000|Overall Study|Patients failed to reach sedation level|0|||
155039028|NCT01344759|559571343|FG001|Overall Study|Patients failed to reach sedation level|2|||
155039029|NCT04114656|559571346|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
155039030|NCT04114656|559571347|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
155039031|NCT04114656|559571346|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
155039032|NCT04114656|559571347|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
155039033|NCT04114656|559571346|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
155039034|NCT04114656|559571347|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
155039035|NCT04114656|559571346|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
155039036|NCT04114656|559571347|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
155039037|NCT04114656|559571346|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
155039038|NCT04114656|559571347|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
155039039|NCT02732015|559571348|FG000|Overall Study|Lost to Follow-up|0|||
155039040|NCT02732015|559571349|FG001|Overall Study|Lost to Follow-up|1|||
155039041|NCT01980628|559571350|FG000|Overall Study|Adverse Event|12|||
155039042|NCT01980628|559571350|FG000|Overall Study|Physician Decision|5|||
155039043|NCT01980628|559571350|FG000|Overall Study|Withdrawal by Subject|4|||
155039044|NCT01980628|559571350|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
155039045|NCT05437640|559571353|FG000|Washout (1 Week)|Adverse Event|1|||
155039046|NCT05437640|559571354|FG001|Washout (1 Week)|Adverse Event|0|||
155039047|NCT02474355|559571355|FG000|Overall Study|Other|43|||
155039048|NCT02474355|559571355|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
155039049|NCT02474355|559571355|FG000|Overall Study|Lost to Follow-up|98|||
155039050|NCT02474355|559571355|FG000|Overall Study|Withdrawal by Subject|124|||
155039051|NCT02474355|559571355|FG000|Overall Study|Death|1361|||
155039052|NCT01937715|559571357|FG000|Overall Study|Death|0|||
155039053|NCT01937715|559571358|FG001|Overall Study|Death|0|||
155039054|NCT01937715|559571359|FG002|Overall Study|Death|0|||
155039055|NCT01937715|559571360|FG003|Overall Study|Death|1|||
155039056|NCT01937715|559571361|FG004|Overall Study|Death|0|||
155039057|NCT01937715|559571357|FG000|Overall Study|Withdrawal by Subject|0|||
155039058|NCT01937715|559571358|FG001|Overall Study|Withdrawal by Subject|1|||
155039059|NCT01937715|559571359|FG002|Overall Study|Withdrawal by Subject|0|||
155039060|NCT01937715|559571360|FG003|Overall Study|Withdrawal by Subject|0|||
155039061|NCT01937715|559571361|FG004|Overall Study|Withdrawal by Subject|2|||
155039062|NCT01937715|559571357|FG000|Overall Study|Other|0|||
155039063|NCT01937715|559571358|FG001|Overall Study|Other|0|||
155039064|NCT01937715|559571359|FG002|Overall Study|Other|0|||
155039065|NCT01937715|559571360|FG003|Overall Study|Other|3|||
155039066|NCT01937715|559571361|FG004|Overall Study|Other|0|||
155039067|NCT01760447|559571362|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
155039068|NCT01760447|559571363|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
155039069|NCT01760447|559571364|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
155039070|NCT01760447|559571365|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
155039071|NCT01760447|559571362|FG000|Weeks 0-20|Withdrawal by Subject|2|||
155039072|NCT01760447|559571363|FG001|Weeks 0-20|Withdrawal by Subject|0|||
155039073|NCT01760447|559571364|FG002|Weeks 0-20|Withdrawal by Subject|1|||
155039074|NCT01760447|559571365|FG003|Weeks 0-20|Withdrawal by Subject|0|||
155039075|NCT01760447|559571362|FG000|Weeks 0-20|Lost to Follow-up|1|||
155039076|NCT01760447|559571363|FG001|Weeks 0-20|Lost to Follow-up|0|||
155039077|NCT01760447|559571364|FG002|Weeks 0-20|Lost to Follow-up|1|||
155039078|NCT01760447|559571365|FG003|Weeks 0-20|Lost to Follow-up|1|||
155039079|NCT01760447|559571362|FG000|Weeks 0-20|Randomized but not treated|0|||
155039080|NCT01760447|559571363|FG001|Weeks 0-20|Randomized but not treated|0|||
155039081|NCT01760447|559571364|FG002|Weeks 0-20|Randomized but not treated|2|||
155039082|NCT01760447|559571365|FG003|Weeks 0-20|Randomized but not treated|0|||
155039083|NCT01760447|559571362|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
155039084|NCT01760447|559571363|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
155039085|NCT01760447|559571364|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
155039086|NCT01760447|559571365|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
155039087|NCT01760447|559571362|FG000|Weeks 20-54|Withdrawal by Subject|2|||
155039088|NCT01760447|559571363|FG001|Weeks 20-54|Withdrawal by Subject|1|||
155039089|NCT01760447|559571364|FG002|Weeks 20-54|Withdrawal by Subject|1|||
155039090|NCT01760447|559571365|FG003|Weeks 20-54|Withdrawal by Subject|2|||
155039091|NCT01760447|559571362|FG000|Weeks 20-54|Lost to Follow-up|0|||
155039092|NCT01760447|559571363|FG001|Weeks 20-54|Lost to Follow-up|0|||
155039093|NCT01760447|559571364|FG002|Weeks 20-54|Lost to Follow-up|1|||
155039094|NCT01760447|559571365|FG003|Weeks 20-54|Lost to Follow-up|2|||
155039095|NCT03594955|559571368|FG000|Overall Study|Adverse Event|1|||
155039096|NCT03594955|559571368|FG000|Overall Study|Progressive disease|5|||
155039097|NCT03594955|559571368|FG000|Overall Study|Sponsor's decision|1|||
155039098|NCT03539484|559571370|FG000|Overall Study|Death|1|||
155039099|NCT03539484|559571371|FG001|Overall Study|Death|0|||
155039100|NCT03539484|559571372|FG002|Overall Study|Death|0|||
155039101|NCT03539484|559571373|FG003|Overall Study|Death|2|||
155039102|NCT03539484|559571374|FG004|Overall Study|Death|8|||
155039103|NCT03539484|559571375|FG005|Overall Study|Death|3|||
155039104|NCT03539484|559571376|FG006|Overall Study|Death|0|||
155039105|NCT03539484|559571370|FG000|Overall Study|Lost to Follow-up|0|||
155039106|NCT03539484|559571371|FG001|Overall Study|Lost to Follow-up|1|||
155039107|NCT03539484|559571372|FG002|Overall Study|Lost to Follow-up|0|||
155039108|NCT03539484|559571373|FG003|Overall Study|Lost to Follow-up|0|||
155039109|NCT03539484|559571374|FG004|Overall Study|Lost to Follow-up|1|||
155039110|NCT03539484|559571375|FG005|Overall Study|Lost to Follow-up|0|||
155039111|NCT03539484|559571376|FG006|Overall Study|Lost to Follow-up|0|||
155039112|NCT03539484|559571370|FG000|Overall Study|Withdrawal by Subject|0|||
155039113|NCT03539484|559571371|FG001|Overall Study|Withdrawal by Subject|0|||
155039114|NCT03539484|559571372|FG002|Overall Study|Withdrawal by Subject|0|||
155039115|NCT03539484|559571373|FG003|Overall Study|Withdrawal by Subject|0|||
155039116|NCT03539484|559571374|FG004|Overall Study|Withdrawal by Subject|2|||
155039117|NCT03539484|559571375|FG005|Overall Study|Withdrawal by Subject|0|||
155039118|NCT03539484|559571376|FG006|Overall Study|Withdrawal by Subject|1|||
155039119|NCT03539484|559571370|FG000|Overall Study|Study Terminated by Sponsor|0|||
155039120|NCT03539484|559571371|FG001|Overall Study|Study Terminated by Sponsor|0|||
155039121|NCT03539484|559571372|FG002|Overall Study|Study Terminated by Sponsor|1|||
155039122|NCT03539484|559571373|FG003|Overall Study|Study Terminated by Sponsor|1|||
155039123|NCT03539484|559571374|FG004|Overall Study|Study Terminated by Sponsor|2|||
155039124|NCT03539484|559571375|FG005|Overall Study|Study Terminated by Sponsor|2|||
155039125|NCT03539484|559571376|FG006|Overall Study|Study Terminated by Sponsor|1|||
155039126|NCT01937884|559571378|FG000|Overall Study|Withdrawal by Subject|1|||
155039127|NCT01937884|559571379|FG001|Overall Study|Withdrawal by Subject|0|||
155039128|NCT01167634|559571386|FG000|Overall Study|Lost to Follow-up|1|||
155039129|NCT01167634|559571387|FG001|Overall Study|Lost to Follow-up|3|||
155039130|NCT01167634|559571388|FG002|Overall Study|Lost to Follow-up|3|||
155039131|NCT01167634|559571389|FG003|Overall Study|Lost to Follow-up|4|||
155039132|NCT01167634|559571386|FG000|Overall Study|Withdrawal by Subject|1|||
155039133|NCT01167634|559571387|FG001|Overall Study|Withdrawal by Subject|1|||
155039134|NCT01167634|559571388|FG002|Overall Study|Withdrawal by Subject|0|||
155039135|NCT01167634|559571389|FG003|Overall Study|Withdrawal by Subject|0|||
155039136|NCT03003000|559571398|FG000|Overall Study|Adverse Event|1|||
155039137|NCT03003000|559571399|FG001|Overall Study|Adverse Event|2|||
155039138|NCT03003000|559571400|FG002|Overall Study|Adverse Event|3|||
155039139|NCT03003000|559571398|FG000|Overall Study|Lack of Efficacy|1|||
155039140|NCT03003000|559571399|FG001|Overall Study|Lack of Efficacy|0|||
155039141|NCT03003000|559571400|FG002|Overall Study|Lack of Efficacy|0|||
155039142|NCT03003000|559571398|FG000|Overall Study|Non-compliant with protocol|0|||
155039143|NCT03003000|559571399|FG001|Overall Study|Non-compliant with protocol|1|||
155039144|NCT03003000|559571400|FG002|Overall Study|Non-compliant with protocol|1|||
155039145|NCT03003000|559571398|FG000|Overall Study|Refused to continue medication|2|||
155039146|NCT03003000|559571399|FG001|Overall Study|Refused to continue medication|0|||
155039147|NCT03003000|559571400|FG002|Overall Study|Refused to continue medication|0|||
155039148|NCT03003000|559571398|FG000|Overall Study|Other than listed|1|||
155039149|NCT03003000|559571399|FG001|Overall Study|Other than listed|1|||
155039150|NCT03003000|559571400|FG002|Overall Study|Other than listed|1|||
155039151|NCT04933617|559571402|FG000|Dose Escalation|Early closure of study|0|||
155039152|NCT04933617|559571403|FG001|Dose Escalation|Early closure of study|3|||
155039153|NCT04933617|559571404|FG002|Dose Escalation|Early closure of study|0|||
155039154|NCT04933617|559571405|FG003|Dose Escalation|Early closure of study|0|||
155039155|NCT04933617|559571406|FG004|Dose Escalation|Early closure of study|0|||
155039156|NCT02191046|559571408|FG000|Overall Study|low compliance|5|||
155039157|NCT02191046|559571409|FG001|Overall Study|low compliance|1|||
155039158|NCT01964716|559571410|FG000|Overall Study|Withdrawal by Subject|2|||
155039159|NCT01964716|559571411|FG001|Overall Study|Withdrawal by Subject|3|||
155039160|NCT01964716|559571410|FG000|Overall Study|Lost to Follow-up|1|||
155039161|NCT01964716|559571411|FG001|Overall Study|Lost to Follow-up|2|||
155039162|NCT01964716|559571410|FG000|Overall Study|No longer met eligibility criteria|1|||
155039163|NCT01964716|559571411|FG001|Overall Study|No longer met eligibility criteria|1|||
155039164|NCT01964716|559571410|FG000|Overall Study|Death|1|||
155266845|NCT05061537|560410906|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
155039165|NCT01964716|559571411|FG001|Overall Study|Death|0|||
155039166|NCT02147067|559571412|FG000|Overall Study|Withdrawal by Subject|2|||
155039167|NCT02147067|559571413|FG001|Overall Study|Withdrawal by Subject|2|||
155039168|NCT00089635|559571414|FG000|Overall Study|Adverse Event|2|||
155039169|NCT00089635|559571414|FG000|Overall Study|Death|17|||
155039170|NCT00089635|559571414|FG000|Overall Study|Disease Progression|12|||
155039171|NCT00089635|559571414|FG000|Overall Study|Lost to Follow-up|3|||
155039172|NCT00089635|559571414|FG000|Overall Study|Withdrawal by Subject|6|||
155039173|NCT00089635|559571414|FG000|Overall Study|Ineligibility determined|1|||
155039174|NCT00089635|559571414|FG000|Overall Study|Other|2|||
155039175|NCT02603107|559571415|FG000|Randomized Phase|Withdrew consent|8|||
155039176|NCT02603107|559571416|FG001|Randomized Phase|Withdrew consent|15|||
155039177|NCT02603107|559571415|FG000|Randomized Phase|Lost to Follow-up|1|||
155039178|NCT02603107|559571416|FG001|Randomized Phase|Lost to Follow-up|3|||
155039179|NCT02603107|559571415|FG000|Randomized Phase|Adverse Event|2|||
155039180|NCT02603107|559571416|FG001|Randomized Phase|Adverse Event|0|||
155039181|NCT02603107|559571415|FG000|Randomized Phase|Death|1|||
155039182|NCT02603107|559571416|FG001|Randomized Phase|Death|1|||
155039183|NCT02603107|559571415|FG000|Randomized Phase|Non-compliance with study drug|1|||
155039184|NCT02603107|559571416|FG001|Randomized Phase|Non-compliance with study drug|1|||
155039185|NCT02603107|559571415|FG000|Randomized Phase|Investigator's discretion|0|||
155039186|NCT02603107|559571416|FG001|Randomized Phase|Investigator's discretion|1|||
155266846|NCT05061537|560410907|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
155266847|NCT05061537|560410908|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
155039187|NCT02603107|559571415|FG000|Randomized Phase|Lack of Efficacy|1|||
155039188|NCT02603107|559571416|FG001|Randomized Phase|Lack of Efficacy|0|||
155039189|NCT02603107|559571415|FG000|Randomized Phase|Protocol Violation|1|||
155039190|NCT02603107|559571416|FG001|Randomized Phase|Protocol Violation|0|||
155039191|NCT02603107|559571415|FG000|Optional Extension Phase|Lost to Follow-up|3|||
155039192|NCT02603107|559571416|FG001|Optional Extension Phase|Lost to Follow-up|3|||
155039193|NCT02603107|559571415|FG000|Optional Extension Phase|Withdrew consent|3|||
155039194|NCT02603107|559571416|FG001|Optional Extension Phase|Withdrew consent|2|||
155039195|NCT02603107|559571415|FG000|Optional Extension Phase|Investigator's discretion|2|||
155039196|NCT02603107|559571416|FG001|Optional Extension Phase|Investigator's discretion|2|||
155039197|NCT02603107|559571415|FG000|Optional Extension Phase|Pregnancy|0|||
155039198|NCT02603107|559571416|FG001|Optional Extension Phase|Pregnancy|3|||
155039199|NCT02603107|559571415|FG000|Optional Extension Phase|Adverse Event|0|||
155039200|NCT02603107|559571416|FG001|Optional Extension Phase|Adverse Event|2|||
155039201|NCT02603107|559571415|FG000|Optional Extension Phase|Not treated in extension phase|0|||
155039202|NCT02603107|559571416|FG001|Optional Extension Phase|Not treated in extension phase|1|||
155039203|NCT02603107|559571415|FG000|Optional Extension Phase|Protocol Violation|1|||
155039204|NCT02603107|559571416|FG001|Optional Extension Phase|Protocol Violation|0|||
155039205|NCT01693185|559571420|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
155039206|NCT01693185|559571421|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
155039207|NCT00419159|559571422|FG000|Overall Study|Adverse Event|7|||
155039208|NCT00419159|559571423|FG001|Overall Study|Adverse Event|15|||
155039209|NCT00419159|559571422|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155039210|NCT00419159|559571423|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155039211|NCT00419159|559571422|FG000|Overall Study|Subject's no longer requires study drug|0|||
155039212|NCT00419159|559571423|FG001|Overall Study|Subject's no longer requires study drug|1|||
155039213|NCT00419159|559571422|FG000|Overall Study|Protocol Violation|1|||
155039214|NCT00419159|559571423|FG001|Overall Study|Protocol Violation|0|||
155039215|NCT00419159|559571422|FG000|Overall Study|Withdrawal by Subject|10|||
155039216|NCT00419159|559571423|FG001|Overall Study|Withdrawal by Subject|3|||
155039217|NCT00419159|559571422|FG000|Overall Study|Lost to Follow-up|0|||
155039218|NCT00419159|559571423|FG001|Overall Study|Lost to Follow-up|1|||
155039219|NCT00419159|559571422|FG000|Overall Study|Death|2|||
155039220|NCT00419159|559571423|FG001|Overall Study|Death|2|||
155039221|NCT00419159|559571422|FG000|Overall Study|Disease progression|79|||
155039222|NCT00419159|559571423|FG001|Overall Study|Disease progression|76|||
155039223|NCT01017601|559571424|FG000|Overall Study|Disease Progression|12|||
155039224|NCT01017601|559571425|FG001|Overall Study|Disease Progression|12|||
155039225|NCT01017601|559571424|FG000|Overall Study|Withdrawal by Subject|0|||
155039226|NCT01017601|559571425|FG001|Overall Study|Withdrawal by Subject|1|||
155039227|NCT01857102|559571426|FG000|Period 1|No longer meets Eligibility Criteria|0|||
155039228|NCT01857102|559571427|FG001|Period 1|No longer meets Eligibility Criteria|2|||
155039229|NCT01857102|559571426|FG000|Period 1|Lost to Follow-up|0|||
155039230|NCT01857102|559571427|FG001|Period 1|Lost to Follow-up|3|||
155039231|NCT01857102|559571426|FG000|Period 1|Unsatisfactory Lens Fit|1|||
155039232|NCT01857102|559571427|FG001|Period 1|Unsatisfactory Lens Fit|0|||
155039233|NCT01857102|559571426|FG000|Period 1|Unsatisfactory Visual Response|1|||
155039234|NCT01857102|559571427|FG001|Period 1|Unsatisfactory Visual Response|0|||
155039235|NCT01857102|559571426|FG000|Period 1|Physician Decision|1|||
155039236|NCT01857102|559571427|FG001|Period 1|Physician Decision|0|||
155039237|NCT01857102|559571426|FG000|Period 2|Lens Discomfort|1|||
155039238|NCT01857102|559571427|FG001|Period 2|Lens Discomfort|0|||
155039239|NCT01857102|559571426|FG000|Period 2|Unsatisfactory Lens Fit|1|||
155039240|NCT01857102|559571427|FG001|Period 2|Unsatisfactory Lens Fit|0|||
155039241|NCT02117713|559571441|FG000|Week 48|Adverse Event|4|||
155039242|NCT02117713|559571441|FG000|Week 48|Withdrawal by caregiver|2|||
155039243|NCT02117713|559571441|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
155266848|NCT05061537|560410909|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
155266849|NCT05061537|560410905|FG000|Long-term Follow-up|Death|0|||
155039244|NCT02117713|559571441|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
155039245|NCT02117713|559571441|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
155039246|NCT02117713|559571441|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
155039247|NCT01094782|559571442|FG000|Overall Study|Withdrawal by Subject|5|||
155039248|NCT01094782|559571443|FG001|Overall Study|Withdrawal by Subject|5|||
155039249|NCT01094782|559571444|FG002|Overall Study|Withdrawal by Subject|1|||
155039250|NCT01094782|559571445|FG003|Overall Study|Withdrawal by Subject|5|||
155039251|NCT01094782|559571446|FG004|Overall Study|Withdrawal by Subject|5|||
155039252|NCT01094782|559571447|FG005|Overall Study|Withdrawal by Subject|0|||
155039253|NCT01094782|559571442|FG000|Overall Study|Lost to Follow-up|1|||
155039254|NCT01094782|559571443|FG001|Overall Study|Lost to Follow-up|0|||
155039255|NCT01094782|559571444|FG002|Overall Study|Lost to Follow-up|0|||
155039256|NCT01094782|559571445|FG003|Overall Study|Lost to Follow-up|2|||
155039257|NCT01094782|559571446|FG004|Overall Study|Lost to Follow-up|1|||
155039258|NCT01094782|559571447|FG005|Overall Study|Lost to Follow-up|4|||
155039259|NCT01094782|559571442|FG000|Overall Study|Positive Drug Screen|2|||
155039260|NCT01094782|559571443|FG001|Overall Study|Positive Drug Screen|2|||
155039261|NCT01094782|559571444|FG002|Overall Study|Positive Drug Screen|1|||
155039262|NCT01094782|559571445|FG003|Overall Study|Positive Drug Screen|1|||
155039263|NCT01094782|559571446|FG004|Overall Study|Positive Drug Screen|3|||
155039264|NCT01094782|559571447|FG005|Overall Study|Positive Drug Screen|2|||
155039265|NCT01094782|559571442|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
155039266|NCT01094782|559571443|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
155039267|NCT01094782|559571444|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
155039268|NCT01094782|559571445|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
155039269|NCT01094782|559571446|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
155039270|NCT01094782|559571447|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
155039271|NCT01094782|559571442|FG000|Overall Study|Unable to Complete Questionnaires|0|||
155039272|NCT01094782|559571443|FG001|Overall Study|Unable to Complete Questionnaires|1|||
155039273|NCT01094782|559571444|FG002|Overall Study|Unable to Complete Questionnaires|0|||
155039274|NCT01094782|559571445|FG003|Overall Study|Unable to Complete Questionnaires|0|||
155039275|NCT01094782|559571446|FG004|Overall Study|Unable to Complete Questionnaires|0|||
155039276|NCT01094782|559571447|FG005|Overall Study|Unable to Complete Questionnaires|0|||
155039277|NCT01094782|559571442|FG000|Overall Study|Healthy Subject Had Pain|0|||
155039278|NCT01094782|559571443|FG001|Overall Study|Healthy Subject Had Pain|1|||
155039279|NCT01094782|559571444|FG002|Overall Study|Healthy Subject Had Pain|0|||
155039280|NCT01094782|559571445|FG003|Overall Study|Healthy Subject Had Pain|0|||
155039281|NCT01094782|559571446|FG004|Overall Study|Healthy Subject Had Pain|0|||
155039282|NCT01094782|559571447|FG005|Overall Study|Healthy Subject Had Pain|0|||
155039283|NCT01094782|559571442|FG000|Overall Study|Hypertension|0|||
155039284|NCT01094782|559571443|FG001|Overall Study|Hypertension|0|||
155039285|NCT01094782|559571444|FG002|Overall Study|Hypertension|1|||
155039286|NCT01094782|559571445|FG003|Overall Study|Hypertension|0|||
155039287|NCT01094782|559571446|FG004|Overall Study|Hypertension|0|||
155152410|NCT01283139|559994187|FG000|Overall Study|Early termination due to AE/SAE|1|||
155152411|NCT01283139|559994188|FG001|Overall Study|Early termination due to AE/SAE|1|||
155152412|NCT01283139|559994189|FG002|Overall Study|Early termination due to AE/SAE|0|||
155152413|NCT01283139|559994190|FG003|Overall Study|Early termination due to AE/SAE|0|||
155152414|NCT01283139|559994187|FG000|Overall Study|Participant's refusal to continue|0|||
155152415|NCT01283139|559994188|FG001|Overall Study|Participant's refusal to continue|3|||
155152416|NCT01283139|559994189|FG002|Overall Study|Participant's refusal to continue|1|||
155152417|NCT01283139|559994190|FG003|Overall Study|Participant's refusal to continue|1|||
155152418|NCT01283139|559994187|FG000|Overall Study|Pregnancy|0|||
155152419|NCT01283139|559994188|FG001|Overall Study|Pregnancy|1|||
155152420|NCT01283139|559994189|FG002|Overall Study|Pregnancy|1|||
155039288|NCT01094782|559571447|FG005|Overall Study|Hypertension|0|||
155039289|NCT01094782|559571442|FG000|Overall Study|Wrong Pain Condition|0|||
155039290|NCT01094782|559571443|FG001|Overall Study|Wrong Pain Condition|0|||
155039291|NCT01094782|559571444|FG002|Overall Study|Wrong Pain Condition|0|||
155039292|NCT01094782|559571445|FG003|Overall Study|Wrong Pain Condition|2|||
155039293|NCT01094782|559571446|FG004|Overall Study|Wrong Pain Condition|1|||
155152421|NCT01283139|559994190|FG003|Overall Study|Pregnancy|0|||
155152422|NCT01283139|559994187|FG000|Overall Study|Missed follow-up visit|0|||
155152423|NCT01283139|559994188|FG001|Overall Study|Missed follow-up visit|1|||
155152424|NCT01283139|559994189|FG002|Overall Study|Missed follow-up visit|2|||
155152425|NCT01283139|559994190|FG003|Overall Study|Missed follow-up visit|2|||
155152426|NCT01283139|559994187|FG000|Overall Study|Participant randomized in error|0|||
155152427|NCT01283139|559994188|FG001|Overall Study|Participant randomized in error|0|||
155152428|NCT01283139|559994189|FG002|Overall Study|Participant randomized in error|1|||
155152429|NCT01283139|559994190|FG003|Overall Study|Participant randomized in error|0|||
155152430|NCT03668873|559994191|FG000|Overall Study|Lost to Follow-up|6|||
155152431|NCT03668873|559994192|FG001|Overall Study|Lost to Follow-up|3|||
155152432|NCT03155724|559994198|FG000|Overall Study|Death|3|||
155152433|NCT03155724|559994198|FG000|Overall Study|Physician Decision|1|||
155152434|NCT03155724|559994198|FG000|Overall Study|Study closure|7|||
155152435|NCT00849940|559994199|FG000|Overall Study|Physician Decision|4|||
155152436|NCT01295814|559996834|FG000|Overall Study|Lack of Efficacy|0|||
155152437|NCT01295814|559996835|FG001|Overall Study|Lack of Efficacy|2|||
155152438|NCT01295814|559996834|FG000|Overall Study|Withdrawal by Subject|2|||
155152439|NCT01295814|559996835|FG001|Overall Study|Withdrawal by Subject|0|||
155152440|NCT03414983|559996836|FG000|Pre-Treatment|Other reasons|1|||
155152441|NCT03414983|559996837|FG001|Pre-Treatment|Other reasons|0|||
155152442|NCT03414983|559996836|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
154966667|NCT03498560|559301109|FG000|Overall Study|Found Ineligible|2|||
154966668|NCT03498560|559301109|FG000|Overall Study|Withdrawal by Subject|14|||
154966669|NCT03498560|559301109|FG000|Overall Study|Lost to Follow-up|4|||
154966670|NCT03498560|559301109|FG000|Overall Study|Death|1|||
154966671|NCT02896296|559301110|FG000|Overall Study|Adverse Event|1|||
154966672|NCT02896296|559301110|FG000|Overall Study|Lost to Follow-up|19|||
154966673|NCT02896296|559301110|FG000|Overall Study|Pregnancy|1|||
154966674|NCT02896296|559301110|FG000|Overall Study|Physician Decision|2|||
154966675|NCT02896296|559301110|FG000|Overall Study|Withdrawal by Subject|10|||
154966676|NCT02896296|559301110|FG000|Overall Study|Site closing|7|||
154966677|NCT02896296|559301110|FG000|Overall Study|Incarceration|1|||
154966678|NCT02896296|559301110|FG000|Overall Study|Relocation|1|||
154966679|NCT02597049|559301111|FG000|Overall Study|Lost to Follow-up|0|||
154966680|NCT02597049|559301112|FG001|Overall Study|Lost to Follow-up|3|||
154966681|NCT02597049|559301113|FG002|Overall Study|Lost to Follow-up|2|||
154966682|NCT02597049|559301111|FG000|Overall Study|Withdrawal by Subject|2|||
154966683|NCT02597049|559301112|FG001|Overall Study|Withdrawal by Subject|2|||
154966684|NCT02597049|559301113|FG002|Overall Study|Withdrawal by Subject|1|||
154966685|NCT02597049|559301111|FG000|Overall Study|Adverse Event|2|||
154966686|NCT02597049|559301112|FG001|Overall Study|Adverse Event|0|||
154966687|NCT02597049|559301113|FG002|Overall Study|Adverse Event|0|||
154966688|NCT02597049|559301111|FG000|Overall Study|Death|2|||
154966689|NCT02597049|559301112|FG001|Overall Study|Death|0|||
154966690|NCT02597049|559301113|FG002|Overall Study|Death|0|||
154966691|NCT02597049|559301111|FG000|Overall Study|Noncompliant with Study Visits|1|||
154966692|NCT02597049|559301112|FG001|Overall Study|Noncompliant with Study Visits|0|||
154966693|NCT02597049|559301113|FG002|Overall Study|Noncompliant with Study Visits|0|||
154966694|NCT00227370|559301117|FG000|Overall Study|Withdrawal by Subject|1|||
154966695|NCT00227370|559301118|FG001|Overall Study|Withdrawal by Subject|2|||
154966696|NCT00227370|559301117|FG000|Overall Study|Death|3|||
154966697|NCT00227370|559301118|FG001|Overall Study|Death|4|||
154966698|NCT00227370|559301117|FG000|Overall Study|Adverse Event|6|||
154966699|NCT00227370|559301118|FG001|Overall Study|Adverse Event|11|||
154966700|NCT00227370|559301117|FG000|Overall Study|Physician Decision|9|||
154966701|NCT00227370|559301118|FG001|Overall Study|Physician Decision|6|||
154966702|NCT00227370|559301117|FG000|Overall Study|Other reasons|2|||
154966703|NCT00227370|559301118|FG001|Overall Study|Other reasons|1|||
154966704|NCT00147498|559301119|FG000|Overall Study|Adverse Event|1|||
154966705|NCT00147498|559301120|FG001|Overall Study|Adverse Event|6|||
154966706|NCT00147498|559301121|FG002|Overall Study|Adverse Event|7|||
154966707|NCT00147498|559301122|FG003|Overall Study|Adverse Event|3|||
154966708|NCT00147498|559301119|FG000|Overall Study|Lack of Efficacy|1|||
154966709|NCT00147498|559301120|FG001|Overall Study|Lack of Efficacy|1|||
154966710|NCT00147498|559301121|FG002|Overall Study|Lack of Efficacy|1|||
154966711|NCT00147498|559301122|FG003|Overall Study|Lack of Efficacy|8|||
154966712|NCT00147498|559301119|FG000|Overall Study|Laboratory abnormality|0|||
154966713|NCT00147498|559301120|FG001|Overall Study|Laboratory abnormality|0|||
154966714|NCT00147498|559301121|FG002|Overall Study|Laboratory abnormality|2|||
154966715|NCT00147498|559301122|FG003|Overall Study|Laboratory abnormality|0|||
154966716|NCT00147498|559301119|FG000|Overall Study|Participant defaulted|0|||
154966717|NCT00147498|559301120|FG001|Overall Study|Participant defaulted|1|||
154966718|NCT00147498|559301121|FG002|Overall Study|Participant defaulted|4|||
154966719|NCT00147498|559301122|FG003|Overall Study|Participant defaulted|3|||
154966720|NCT00147498|559301119|FG000|Overall Study|Other|1|||
154966721|NCT00147498|559301120|FG001|Overall Study|Other|1|||
154966722|NCT00147498|559301121|FG002|Overall Study|Other|3|||
154966723|NCT00147498|559301122|FG003|Overall Study|Other|3|||
154966724|NCT01473953|559301128|FG000|Overall Study|Other|1|||
154966725|NCT01473953|559301129|FG001|Overall Study|Other|0|||
154966726|NCT01473953|559301130|FG002|Overall Study|Other|0|||
154966727|NCT01473953|559301131|FG003|Overall Study|Other|0|||
154966728|NCT01473953|559301132|FG004|Overall Study|Other|0|||
154966729|NCT02011945|559301133|FG000|Overall Study|Participant requested to Discontinue|0|||
154966730|NCT02011945|559301134|FG001|Overall Study|Participant requested to Discontinue|1|||
154966731|NCT02011945|559301135|FG002|Overall Study|Participant requested to Discontinue|1|||
154966732|NCT02011945|559301133|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
154966733|NCT02011945|559301134|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
154966734|NCT02011945|559301135|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
154966735|NCT02011945|559301133|FG000|Overall Study|Study Drug Toxicity|0|||
154966736|NCT02011945|559301134|FG001|Overall Study|Study Drug Toxicity|0|||
154966737|NCT02011945|559301135|FG002|Overall Study|Study Drug Toxicity|1|||
154966738|NCT02011945|559301133|FG000|Overall Study|Treatment Failure|0|||
154966739|NCT02011945|559301134|FG001|Overall Study|Treatment Failure|7|||
154966740|NCT02011945|559301135|FG002|Overall Study|Treatment Failure|6|||
154966741|NCT02011945|559301133|FG000|Overall Study|No Longer Meets Study Criteria|1|||
154966742|NCT02011945|559301134|FG001|Overall Study|No Longer Meets Study Criteria|0|||
155039294|NCT01094782|559571447|FG005|Overall Study|Wrong Pain Condition|1|||
155039295|NCT01094782|559571442|FG000|Overall Study|Recent Interventional Injection|0|||
155039296|NCT01094782|559571443|FG001|Overall Study|Recent Interventional Injection|0|||
155039297|NCT01094782|559571444|FG002|Overall Study|Recent Interventional Injection|0|||
155039298|NCT01094782|559571445|FG003|Overall Study|Recent Interventional Injection|0|||
155039299|NCT01094782|559571446|FG004|Overall Study|Recent Interventional Injection|0|||
155039300|NCT01094782|559571447|FG005|Overall Study|Recent Interventional Injection|1|||
155039301|NCT01094782|559571442|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155152443|NCT03414983|559996837|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
155152444|NCT03414983|559996836|FG000|Pre-Treatment|Participant withdrew consent|1|||
155152445|NCT03414983|559996837|FG001|Pre-Treatment|Participant withdrew consent|3|||
155152446|NCT03414983|559996836|FG000|Treatment|Participant withdrew consent|4|||
155152447|NCT03414983|559996837|FG001|Treatment|Participant withdrew consent|3|||
155152448|NCT03414983|559996836|FG000|Treatment|Participant request to discontinue study treatment|8|||
155152449|NCT03414983|559996837|FG001|Treatment|Participant request to discontinue study treatment|10|||
155152450|NCT03414983|559996836|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
155152451|NCT03414983|559996837|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
155152452|NCT03414983|559996836|FG000|Treatment|Death|0|||
155152453|NCT03414983|559996837|FG001|Treatment|Death|1|||
155152454|NCT03414983|559996836|FG000|Treatment|Study Drug Toxicity|10|||
155152455|NCT03414983|559996837|FG001|Treatment|Study Drug Toxicity|5|||
155152456|NCT03414983|559996836|FG000|Treatment|Disease Progression|75|||
155152457|NCT03414983|559996837|FG001|Treatment|Disease Progression|29|||
155152458|NCT03414983|559996836|FG000|Treatment|Not reported|1|||
155152459|NCT03414983|559996837|FG001|Treatment|Not reported|0|||
155152460|NCT03414983|559996836|FG000|Treatment|Other reasons|3|||
155152461|NCT03414983|559996837|FG001|Treatment|Other reasons|2|||
155152462|NCT03414983|559996836|FG000|Treatment|Poor/non-compliance|2|||
155152463|NCT03414983|559996837|FG001|Treatment|Poor/non-compliance|0|||
155152464|NCT03414983|559996836|FG000|Treatment|Maximum clinical benefit|5|||
155152465|NCT03414983|559996837|FG001|Treatment|Maximum clinical benefit|9|||
155152466|NCT03414983|559996836|FG000|Treatment|Lost to Follow-up|0|||
155152467|NCT03414983|559996837|FG001|Treatment|Lost to Follow-up|1|||
155152468|NCT03414983|559996836|FG000|Treatment|Administrative reasons by sponsor|1|||
155152469|NCT03414983|559996837|FG001|Treatment|Administrative reasons by sponsor|0|||
155152470|NCT02608684|559996838|FG000|Overall Study|Physician Decision|2|||
155266850|NCT05061537|560410906|FG001|Long-term Follow-up|Death|1|||
155266851|NCT05061537|560410907|FG002|Long-term Follow-up|Death|0|||
155266852|NCT05061537|560410908|FG003|Long-term Follow-up|Death|0|||
155266853|NCT05061537|560410909|FG004|Long-term Follow-up|Death|0|||
155266854|NCT02247804|560410912|FG000|Treatment Period 1|Adverse Event|9|||
155266855|NCT02247804|560410913|FG001|Treatment Period 1|Adverse Event|2|||
155266856|NCT02247804|560410914|FG002|Treatment Period 1|Adverse Event|0|||
155266857|NCT02247804|560410912|FG000|Treatment Period 1|Lack of Efficacy|0|||
155266858|NCT02247804|560410913|FG001|Treatment Period 1|Lack of Efficacy|0|||
155266859|NCT02247804|560410914|FG002|Treatment Period 1|Lack of Efficacy|2|||
155266860|NCT02247804|560410912|FG000|Treatment Period 1|Lost to Follow-up|1|||
155266861|NCT02247804|560410913|FG001|Treatment Period 1|Lost to Follow-up|0|||
155266862|NCT02247804|560410914|FG002|Treatment Period 1|Lost to Follow-up|2|||
155266863|NCT02247804|560410912|FG000|Treatment Period 1|Personal Reasons|7|||
155266864|NCT02247804|560410913|FG001|Treatment Period 1|Personal Reasons|1|||
155266865|NCT02247804|560410914|FG002|Treatment Period 1|Personal Reasons|2|||
155266866|NCT02247804|560410912|FG000|Treatment Period 1|Protocol Deviation|0|||
155266867|NCT02247804|560410913|FG001|Treatment Period 1|Protocol Deviation|0|||
155266868|NCT02247804|560410914|FG002|Treatment Period 1|Protocol Deviation|1|||
155266869|NCT02247804|560410912|FG000|Treatment Period 1|Randomized but not Treated|5|||
155266870|NCT02247804|560410913|FG001|Treatment Period 1|Randomized but not Treated|1|||
155266871|NCT02247804|560410914|FG002|Treatment Period 1|Randomized but not Treated|1|||
155266872|NCT02247804|560410912|FG000|Treatment Period 2|Adverse Event|6|||
155266873|NCT02247804|560410913|FG001|Treatment Period 2|Adverse Event|3|||
155266874|NCT02247804|560410914|FG002|Treatment Period 2|Adverse Event|3|||
155266875|NCT02247804|560410912|FG000|Treatment Period 2|Lack of Efficacy|0|||
155266876|NCT02247804|560410913|FG001|Treatment Period 2|Lack of Efficacy|0|||
155266877|NCT02247804|560410914|FG002|Treatment Period 2|Lack of Efficacy|1|||
155266878|NCT02247804|560410912|FG000|Treatment Period 2|Lost to Follow-up|0|||
155266879|NCT02247804|560410913|FG001|Treatment Period 2|Lost to Follow-up|1|||
155266880|NCT02247804|560410914|FG002|Treatment Period 2|Lost to Follow-up|1|||
155266881|NCT02247804|560410912|FG000|Treatment Period 2|Personal Reasons|2|||
155266882|NCT02247804|560410913|FG001|Treatment Period 2|Personal Reasons|1|||
155152471|NCT02608684|559996838|FG000|Overall Study|Withdrawal by Subject|1|||
155152472|NCT01910298|559996839|FG000|Overall Study|Adverse Event|1|||
155152473|NCT01910298|559996840|FG001|Overall Study|Adverse Event|0|||
155266883|NCT02247804|560410914|FG002|Treatment Period 2|Personal Reasons|1|||
155266884|NCT02247804|560410912|FG000|Treatment Period 2|Reason not Specified|0|||
155266885|NCT02247804|560410913|FG001|Treatment Period 2|Reason not Specified|0|||
155266886|NCT02247804|560410914|FG002|Treatment Period 2|Reason not Specified|2|||
155266887|NCT02247804|560410912|FG000|Treatment Period 3|Adverse Event|4|||
155266888|NCT02247804|560410913|FG001|Treatment Period 3|Adverse Event|3|||
155266889|NCT02247804|560410914|FG002|Treatment Period 3|Adverse Event|3|||
155266890|NCT02247804|560410912|FG000|Treatment Period 3|Lack of Efficacy|0|||
155266891|NCT02247804|560410913|FG001|Treatment Period 3|Lack of Efficacy|1|||
155266892|NCT02247804|560410914|FG002|Treatment Period 3|Lack of Efficacy|0|||
155266893|NCT02247804|560410912|FG000|Treatment Period 3|Lost to Follow-up|1|||
155266894|NCT02247804|560410913|FG001|Treatment Period 3|Lost to Follow-up|2|||
155266895|NCT02247804|560410914|FG002|Treatment Period 3|Lost to Follow-up|2|||
155266896|NCT02247804|560410912|FG000|Treatment Period 3|Personal Reasons|4|||
155266897|NCT02247804|560410913|FG001|Treatment Period 3|Personal Reasons|3|||
155266898|NCT02247804|560410914|FG002|Treatment Period 3|Personal Reasons|2|||
155266899|NCT02247804|560410912|FG000|Treatment Period 3|Reason not Specified|2|||
155266900|NCT02247804|560410913|FG001|Treatment Period 3|Reason not Specified|1|||
155266901|NCT02247804|560410914|FG002|Treatment Period 3|Reason not Specified|3|||
155266902|NCT01834222|560410915|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
155266903|NCT01054573|560410916|FG000|Overall Study|Adverse Event|1|||
155266904|NCT01054573|560410917|FG001|Overall Study|Adverse Event|0|||
155266905|NCT01054573|560410918|FG002|Overall Study|Adverse Event|1|||
155266906|NCT01054573|560410919|FG003|Overall Study|Adverse Event|1|||
155266907|NCT01054573|560410916|FG000|Overall Study|Lost to Follow-up|0|||
155266908|NCT01054573|560410917|FG001|Overall Study|Lost to Follow-up|2|||
155266909|NCT01054573|560410918|FG002|Overall Study|Lost to Follow-up|0|||
155266910|NCT01054573|560410919|FG003|Overall Study|Lost to Follow-up|0|||
155266911|NCT01054573|560410916|FG000|Overall Study|Withdrawal by Subject|0|||
155266912|NCT01054573|560410917|FG001|Overall Study|Withdrawal by Subject|2|||
155266913|NCT01054573|560410918|FG002|Overall Study|Withdrawal by Subject|2|||
155266914|NCT01054573|560410919|FG003|Overall Study|Withdrawal by Subject|1|||
155266915|NCT03812536|560410920|FG000|Overall Study|Protocol Violation|2|||
155266916|NCT03812536|560410921|FG001|Overall Study|Protocol Violation|0|||
155266917|NCT03812536|560410920|FG000|Overall Study|Withdrawal by Subject|1|||
155266918|NCT03812536|560410921|FG001|Overall Study|Withdrawal by Subject|1|||
155266919|NCT00152009|560410922|FG000|Overall Study|Adverse Event|9|||
155266920|NCT00152009|560410923|FG001|Overall Study|Adverse Event|13|||
155266921|NCT00152009|560410924|FG002|Overall Study|Adverse Event|20|||
155266922|NCT00152009|560410925|FG003|Overall Study|Adverse Event|1|||
155266923|NCT00152009|560410922|FG000|Overall Study|Protocol Violation|3|||
155266924|NCT00152009|560410923|FG001|Overall Study|Protocol Violation|0|||
155266925|NCT00152009|560410924|FG002|Overall Study|Protocol Violation|0|||
155266926|NCT00152009|560410925|FG003|Overall Study|Protocol Violation|1|||
155266927|NCT00152009|560410922|FG000|Overall Study|Withdrawal by Subject|2|||
155379493|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
155379494|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
155379495|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
155379496|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
155379497|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
155379498|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
155379499|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
155379500|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
155379501|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
155379502|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
155379503|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
155379504|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
155379505|NCT00910689|560822351|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
155039302|NCT01094782|559571443|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155039303|NCT01094782|559571444|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155039304|NCT01094782|559571445|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155039305|NCT01094782|559571446|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
155039306|NCT01094782|559571447|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
155039307|NCT01094782|559571442|FG000|Overall Study|Noncompliance With Study Schedule|0|||
155039308|NCT01094782|559571443|FG001|Overall Study|Noncompliance With Study Schedule|0|||
155039309|NCT01094782|559571444|FG002|Overall Study|Noncompliance With Study Schedule|0|||
155039310|NCT01094782|559571445|FG003|Overall Study|Noncompliance With Study Schedule|1|||
155039311|NCT01094782|559571446|FG004|Overall Study|Noncompliance With Study Schedule|0|||
155039312|NCT01094782|559571447|FG005|Overall Study|Noncompliance With Study Schedule|0|||
155039313|NCT00957905|559571452|FG000|Part B|Not Treated|0|||
155039314|NCT00957905|559571453|FG001|Part B|Not Treated|1|||
155039315|NCT00957905|559571452|FG000|Part B|Physician Decision|0|||
155039316|NCT00957905|559571453|FG001|Part B|Physician Decision|1|||
155039317|NCT00957905|559571452|FG000|Part B|Death|0|||
155266928|NCT00152009|560410923|FG001|Overall Study|Withdrawal by Subject|3|||
155379506|NCT00910689|560822352|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
155379507|NCT00910689|560822353|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
155379508|NCT00910689|560822354|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
155379509|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
155039318|NCT00957905|559571453|FG001|Part B|Death|1|||
155039319|NCT00957905|559571452|FG000|Part B|Protocol Violation|0|||
155039320|NCT00957905|559571453|FG001|Part B|Protocol Violation|1|||
155039321|NCT02073656|559571454|FG000|Primary Study|Lost to Follow-up|6|||
155039322|NCT02073656|559571454|FG000|Primary Study|Death|1|||
155039323|NCT02073656|559571454|FG000|Primary Study|Withdrew Consent|1|||
155039324|NCT02450552|559571458|FG000|Overall Study|Withdrawal by Subject|4|||
155039325|NCT02450552|559571459|FG001|Overall Study|Withdrawal by Subject|0|||
155039326|NCT02450552|559571460|FG002|Overall Study|Withdrawal by Subject|4|||
155039327|NCT02450552|559571458|FG000|Overall Study|Physician Decision|1|||
155039328|NCT02450552|559571459|FG001|Overall Study|Physician Decision|0|||
155039329|NCT02450552|559571460|FG002|Overall Study|Physician Decision|1|||
155039330|NCT00900731|559571464|FG000|Overall Study|Adverse Event|31|||
155039331|NCT00900731|559571465|FG001|Overall Study|Adverse Event|27|||
155039332|NCT00900731|559571464|FG000|Overall Study|Withdrawal by Subject|8|||
155039333|NCT00900731|559571465|FG001|Overall Study|Withdrawal by Subject|7|||
155039334|NCT00900731|559571464|FG000|Overall Study|Protocol Deviation|8|||
155039335|NCT00900731|559571465|FG001|Overall Study|Protocol Deviation|11|||
155039336|NCT00900731|559571464|FG000|Overall Study|Administrative Problems|5|||
155039337|NCT00900731|559571465|FG001|Overall Study|Administrative Problems|4|||
155039338|NCT00900731|559571464|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
155039339|NCT00900731|559571465|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155039340|NCT00900731|559571464|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
155039341|NCT00900731|559571465|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
155039342|NCT00900731|559571464|FG000|Overall Study|Lost to Follow-up|2|||
155039343|NCT00900731|559571465|FG001|Overall Study|Lost to Follow-up|3|||
155039344|NCT00900731|559571464|FG000|Overall Study|Lack of Efficacy|1|||
155039345|NCT00900731|559571465|FG001|Overall Study|Lack of Efficacy|3|||
155039346|NCT00900731|559571464|FG000|Overall Study|Death|0|||
155039347|NCT00900731|559571465|FG001|Overall Study|Death|2|||
155039348|NCT01554176|559571466|FG000|Treatment Phase|Protocol Violation|1|||
155039349|NCT01554176|559571467|FG001|Treatment Phase|Protocol Violation|2|||
155039350|NCT01554176|559571468|FG002|Treatment Phase|Protocol Violation|0|||
155039351|NCT01554176|559571469|FG003|Treatment Phase|Protocol Violation|0|||
155039352|NCT01554176|559571470|FG004|Treatment Phase|Protocol Violation|0|||
155039353|NCT01554176|559571466|FG000|Treatment Phase|Physician Decision|1|||
155039354|NCT01554176|559571467|FG001|Treatment Phase|Physician Decision|1|||
155039355|NCT01554176|559571468|FG002|Treatment Phase|Physician Decision|0|||
155039356|NCT01554176|559571469|FG003|Treatment Phase|Physician Decision|0|||
155039357|NCT01554176|559571470|FG004|Treatment Phase|Physician Decision|0|||
155039358|NCT01554176|559571466|FG000|Treatment Phase|Lack of Efficacy|0|||
155039359|NCT01554176|559571467|FG001|Treatment Phase|Lack of Efficacy|1|||
155039360|NCT01554176|559571468|FG002|Treatment Phase|Lack of Efficacy|0|||
155039361|NCT01554176|559571469|FG003|Treatment Phase|Lack of Efficacy|0|||
155152474|NCT01910298|559996839|FG000|Overall Study|Withdrawal by Subject|2|||
155152475|NCT01910298|559996840|FG001|Overall Study|Withdrawal by Subject|7|||
155152476|NCT01910298|559996839|FG000|Overall Study|Protocol Deviation|0|||
155152477|NCT01910298|559996840|FG001|Overall Study|Protocol Deviation|5|||
155152478|NCT01910298|559996839|FG000|Overall Study|Lost to Follow-up|1|||
155152479|NCT01910298|559996840|FG001|Overall Study|Lost to Follow-up|1|||
155152480|NCT01910298|559996839|FG000|Overall Study|Study Terminated by Sponsor|1|||
155152481|NCT01910298|559996840|FG001|Overall Study|Study Terminated by Sponsor|17|||
155152482|NCT01910298|559996839|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155152483|NCT01910298|559996840|FG001|Overall Study|Other Miscellaneous Reasons|2|||
155152484|NCT01775501|559996841|FG000|Overall Study|Discontinued prior to treatment|1|||
155152485|NCT03037385|559996842|FG000|Overall Study|Adverse Event|0|||
155152486|NCT03037385|559996843|FG001|Overall Study|Adverse Event|0|||
155152487|NCT03037385|559996844|FG002|Overall Study|Adverse Event|1|||
155152488|NCT03037385|559996845|FG003|Overall Study|Adverse Event|0|||
155152489|NCT03037385|559996846|FG004|Overall Study|Adverse Event|0|||
155152490|NCT03037385|559996847|FG005|Overall Study|Adverse Event|0|||
155152491|NCT03037385|559996848|FG006|Overall Study|Adverse Event|0|||
155152492|NCT03037385|559996849|FG007|Overall Study|Adverse Event|0|||
155152493|NCT03037385|559996850|FG008|Overall Study|Adverse Event|0|||
155039362|NCT01554176|559571470|FG004|Treatment Phase|Lack of Efficacy|0|||
155039363|NCT01554176|559571466|FG000|Treatment Phase|Adverse event, non-fatal|1|||
155152494|NCT03037385|559996851|FG009|Overall Study|Adverse Event|6|||
155039364|NCT01554176|559571467|FG001|Treatment Phase|Adverse event, non-fatal|1|||
155039365|NCT01554176|559571468|FG002|Treatment Phase|Adverse event, non-fatal|0|||
155039366|NCT01554176|559571469|FG003|Treatment Phase|Adverse event, non-fatal|0|||
155039367|NCT01554176|559571470|FG004|Treatment Phase|Adverse event, non-fatal|0|||
155039368|NCT01554176|559571466|FG000|Treatment Phase|Non-compliance with study drug|1|||
155039369|NCT01554176|559571467|FG001|Treatment Phase|Non-compliance with study drug|0|||
155039370|NCT01554176|559571468|FG002|Treatment Phase|Non-compliance with study drug|0|||
155039371|NCT01554176|559571469|FG003|Treatment Phase|Non-compliance with study drug|0|||
155039372|NCT01554176|559571470|FG004|Treatment Phase|Non-compliance with study drug|0|||
155039373|NCT01554176|559571466|FG000|Treatment Phase|Withdrawal by Subject|1|||
155152495|NCT03037385|559996842|FG000|Overall Study|Death|1|||
155039374|NCT01554176|559571467|FG001|Treatment Phase|Withdrawal by Subject|0|||
155039375|NCT01554176|559571468|FG002|Treatment Phase|Withdrawal by Subject|0|||
155039376|NCT01554176|559571469|FG003|Treatment Phase|Withdrawal by Subject|0|||
155039377|NCT01554176|559571470|FG004|Treatment Phase|Withdrawal by Subject|0|||
155039378|NCT01554176|559571466|FG000|Treatment Phase|Lost to Follow-up|3|||
155039379|NCT01554176|559571467|FG001|Treatment Phase|Lost to Follow-up|0|||
155039380|NCT01554176|559571468|FG002|Treatment Phase|Lost to Follow-up|0|||
155379510|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
155039381|NCT01554176|559571469|FG003|Treatment Phase|Lost to Follow-up|0|||
155039382|NCT01554176|559571470|FG004|Treatment Phase|Lost to Follow-up|0|||
155039383|NCT01554176|559571466|FG000|Run-out Phase|Protocol Violation|0|||
155039384|NCT01554176|559571467|FG001|Run-out Phase|Protocol Violation|0|||
155039385|NCT01554176|559571468|FG002|Run-out Phase|Protocol Violation|0|||
155039386|NCT01554176|559571469|FG003|Run-out Phase|Protocol Violation|1|||
155039387|NCT01554176|559571470|FG004|Run-out Phase|Protocol Violation|0|||
155039388|NCT02678000|559571471|FG000|PART 2|Adverse Event|0|||
155039389|NCT02678000|559571472|FG001|PART 2|Adverse Event|0|||
155039390|NCT02678000|559571473|FG002|PART 2|Adverse Event|2|||
155039391|NCT02678000|559571474|FG003|PART 2|Adverse Event|1|||
155039392|NCT02678000|559571475|FG004|PART 2|Adverse Event|0|||
155039393|NCT02678000|559571471|FG000|PART 2|Withdrawal by Subject|0|||
155039394|NCT02678000|559571472|FG001|PART 2|Withdrawal by Subject|0|||
155039395|NCT02678000|559571473|FG002|PART 2|Withdrawal by Subject|1|||
155039396|NCT02678000|559571474|FG003|PART 2|Withdrawal by Subject|0|||
155039397|NCT02678000|559571475|FG004|PART 2|Withdrawal by Subject|0|||
155039398|NCT03759366|559571476|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
155039399|NCT03759366|559571476|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
155039400|NCT03759366|559571476|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
155039401|NCT03759366|559571476|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
155039402|NCT03759366|559571476|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
155039403|NCT03759366|559571476|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
155039404|NCT03759366|559571476|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
155039405|NCT00539032|559571477|FG000|Overall Study|Withdrawal by Subject|2|||
155039406|NCT00539032|559571478|FG001|Overall Study|Withdrawal by Subject|1|||
155039407|NCT01653327|559571479|FG000|Overall Study|Withdrawal by Subject|1|||
155039408|NCT01859949|559572924|FG000|Overall Study|Family Matters|0|||
155039409|NCT01859949|559572925|FG001|Overall Study|Family Matters|1|||
155039410|NCT01859949|559572924|FG000|Overall Study|Physician Decision|2|||
155039411|NCT01859949|559572925|FG001|Overall Study|Physician Decision|4|||
155039412|NCT01859949|559572924|FG000|Overall Study|Withdrawal by Subject|11|||
155039413|NCT01859949|559572925|FG001|Overall Study|Withdrawal by Subject|10|||
155039414|NCT01859949|559572924|FG000|Overall Study|Protocol Violation|1|||
155039415|NCT01859949|559572925|FG001|Overall Study|Protocol Violation|1|||
155039416|NCT01859949|559572924|FG000|Overall Study|Adverse Event|0|||
155039417|NCT01859949|559572925|FG001|Overall Study|Adverse Event|1|||
155039418|NCT03041467|559572926|FG000|Overall Study|Death|46|||
155039419|NCT03041467|559572927|FG001|Overall Study|Death|39|||
155039420|NCT03041467|559572926|FG000|Overall Study|Withdrawal by Subject|36|||
155039421|NCT03041467|559572927|FG001|Overall Study|Withdrawal by Subject|37|||
155039422|NCT03041467|559572926|FG000|Overall Study|Lost to Follow-up|6|||
155039423|NCT03041467|559572927|FG001|Overall Study|Lost to Follow-up|8|||
155039424|NCT03041467|559572926|FG000|Overall Study|Declined consent for study extension|21|||
155039425|NCT03041467|559572927|FG001|Overall Study|Declined consent for study extension|33|||
155039426|NCT03041467|559572926|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
155039427|NCT03041467|559572927|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
155039428|NCT04228965|559572931|FG000|Overall Study|Lost to Follow-up|26|||
155039429|NCT04228965|559572932|FG001|Overall Study|Lost to Follow-up|11|||
155039430|NCT04228965|559572931|FG000|Overall Study|Withdrawal by Subject|18|||
155039431|NCT04228965|559572932|FG001|Overall Study|Withdrawal by Subject|5|||
155039432|NCT00734656|559572935|FG000|Lab Session 1|Withdrawal by Subject|2|||
155039433|NCT00734656|559572936|FG001|Lab Session 1|Withdrawal by Subject|0|||
155039434|NCT00734656|559572937|FG002|Lab Session 1|Withdrawal by Subject|0|||
155039435|NCT00734656|559572938|FG003|Lab Session 1|Withdrawal by Subject|0|||
155039436|NCT00734656|559572935|FG000|Washout 1|Withdrawal by Subject|1|||
155039437|NCT00734656|559572936|FG001|Washout 1|Withdrawal by Subject|5|||
155039438|NCT00734656|559572937|FG002|Washout 1|Withdrawal by Subject|2|||
155039439|NCT00734656|559572938|FG003|Washout 1|Withdrawal by Subject|3|||
155039440|NCT00734656|559572935|FG000|Lab Session 2|Withdrawal by Subject|1|||
155039441|NCT00734656|559572936|FG001|Lab Session 2|Withdrawal by Subject|0|||
155039442|NCT00734656|559572937|FG002|Lab Session 2|Withdrawal by Subject|0|||
155039443|NCT00734656|559572938|FG003|Lab Session 2|Withdrawal by Subject|1|||
155039444|NCT00734656|559572935|FG000|Washout 2|Withdrawal by Subject|1|||
155039445|NCT00734656|559572936|FG001|Washout 2|Withdrawal by Subject|1|||
155039446|NCT00734656|559572937|FG002|Washout 2|Withdrawal by Subject|1|||
155039447|NCT00734656|559572938|FG003|Washout 2|Withdrawal by Subject|0|||
155039448|NCT00734656|559572935|FG000|Washout 3|Withdrawal by Subject|1|||
155039449|NCT00734656|559572936|FG001|Washout 3|Withdrawal by Subject|0|||
155039450|NCT00734656|559572937|FG002|Washout 3|Withdrawal by Subject|0|||
155152496|NCT03037385|559996843|FG001|Overall Study|Death|4|||
155152497|NCT03037385|559996844|FG002|Overall Study|Death|2|||
155152498|NCT03037385|559996845|FG003|Overall Study|Death|2|||
155152499|NCT03037385|559996846|FG004|Overall Study|Death|5|||
155152500|NCT03037385|559996847|FG005|Overall Study|Death|2|||
155152501|NCT03037385|559996848|FG006|Overall Study|Death|1|||
155152502|NCT03037385|559996849|FG007|Overall Study|Death|4|||
155152503|NCT03037385|559996850|FG008|Overall Study|Death|3|||
155152504|NCT03037385|559996851|FG009|Overall Study|Death|240|||
155152505|NCT03037385|559996842|FG000|Overall Study|Initiation of Another Therapy|1|||
155152506|NCT03037385|559996843|FG001|Overall Study|Initiation of Another Therapy|0|||
155152507|NCT03037385|559996844|FG002|Overall Study|Initiation of Another Therapy|0|||
155152508|NCT03037385|559996845|FG003|Overall Study|Initiation of Another Therapy|0|||
155152509|NCT03037385|559996846|FG004|Overall Study|Initiation of Another Therapy|0|||
155152510|NCT03037385|559996847|FG005|Overall Study|Initiation of Another Therapy|0|||
155152511|NCT03037385|559996848|FG006|Overall Study|Initiation of Another Therapy|0|||
155152512|NCT03037385|559996849|FG007|Overall Study|Initiation of Another Therapy|1|||
155152513|NCT03037385|559996850|FG008|Overall Study|Initiation of Another Therapy|0|||
155152514|NCT03037385|559996851|FG009|Overall Study|Initiation of Another Therapy|2|||
155152515|NCT03037385|559996842|FG000|Overall Study|Lost to Follow-up|0|||
155379511|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
155379512|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
155379513|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
155379514|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
155379515|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
155379516|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
155379517|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
155379518|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
155379519|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
155379520|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
155379521|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
155379522|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
155379523|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
155379524|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
155379525|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
155379526|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
155379527|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
155379528|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
155379529|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
155379530|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
155379531|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
155379532|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
155379533|NCT00910689|560822351|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
155379534|NCT00910689|560822352|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
155379535|NCT00910689|560822353|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
155379536|NCT00910689|560822354|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
155379537|NCT01290029|560822355|FG000|Overall Study|Other|2|||
155379538|NCT00189488|560822356|FG000|Overall Study|Ineligibility determined|1|||
155379539|NCT00189488|560822357|FG001|Overall Study|Ineligibility determined|0|||
155379540|NCT00189488|560822356|FG000|Overall Study|Protocol deviation|2|||
155379541|NCT00189488|560822357|FG001|Overall Study|Protocol deviation|1|||
155379542|NCT00189488|560822356|FG000|Overall Study|Adverse Event|2|||
155379543|NCT00189488|560822357|FG001|Overall Study|Adverse Event|1|||
155379544|NCT00189488|560822356|FG000|Overall Study|Withdrawal by Subject|2|||
155379545|NCT00189488|560822357|FG001|Overall Study|Withdrawal by Subject|6|||
155379546|NCT00189488|560822356|FG000|Overall Study|Disease progression|2|||
155379547|NCT00189488|560822357|FG001|Overall Study|Disease progression|4|||
155379548|NCT00189488|560822356|FG000|Overall Study|Administrative Decision|0|||
155379549|NCT00189488|560822357|FG001|Overall Study|Administrative Decision|2|||
155379550|NCT00189488|560822356|FG000|Overall Study|Death|5|||
155379551|NCT00189488|560822357|FG001|Overall Study|Death|8|||
155379552|NCT00189488|560822356|FG000|Overall Study|Other|1|||
155379553|NCT00189488|560822357|FG001|Overall Study|Other|0|||
155379554|NCT02349425|560822360|FG000|Period 1|Adverse Event|1|||
155379555|NCT02349425|560822361|FG001|Period 1|Adverse Event|1|||
155379556|NCT02349425|560822362|FG002|Period 1|Adverse Event|0|||
155379557|NCT02349425|560822363|FG003|Period 1|Adverse Event|0|||
155379558|NCT02349425|560822360|FG000|Period 2|Adverse Event|0|||
155379559|NCT02349425|560822361|FG001|Period 2|Adverse Event|1|||
155379560|NCT02349425|560822362|FG002|Period 2|Adverse Event|1|||
155379561|NCT02349425|560822363|FG003|Period 2|Adverse Event|0|||
155379562|NCT01143038|560822364|FG000|Overall Study|Withdrawal by Subject|4|||
155039451|NCT00734656|559572938|FG003|Washout 3|Withdrawal by Subject|1|||
155379563|NCT01143038|560822364|FG000|Overall Study|Requirement for alternative therapy|5|||
155379564|NCT01143038|560822364|FG000|Overall Study|Adverse Event|3|||
155379565|NCT01143038|560822364|FG000|Overall Study|Lost to Follow-up|2|||
155379566|NCT01143038|560822364|FG000|Overall Study|Protocol Deviation|1|||
155379567|NCT01143038|560822364|FG000|Overall Study|Death|1|||
155379568|NCT02336178|560822365|FG000|Overall Study|Lost to Follow-up|1|||
155379569|NCT02336178|560822365|FG000|Overall Study|Protocol Violation|1|||
155379570|NCT02336178|560822365|FG000|Overall Study|Withdrawal by Subject|1|||
155379571|NCT02336178|560822365|FG000|Overall Study|Other|1|||
155379572|NCT03310268|560822366|FG000|Overall Study|(Not specified)|1|||
155379573|NCT03310268|560822367|FG001|Overall Study|(Not specified)|5|||
155379574|NCT03310268|560822368|FG002|Overall Study|(Not specified)|0|||
155379575|NCT01236365|560822371|FG000|Overall Study|Lost to Follow-up|0|||
155379576|NCT01236365|560822372|FG001|Overall Study|Lost to Follow-up|2|||
155379577|NCT01236365|560822371|FG000|Overall Study|Moved Out of State|1|||
155379578|NCT01236365|560822372|FG001|Overall Study|Moved Out of State|0|||
155379579|NCT01236365|560822371|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
155379580|NCT01236365|560822372|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
155379581|NCT00558259|560822373|FG000|Overall Study|Adverse Event|50|||
155379582|NCT00558259|560822374|FG001|Overall Study|Adverse Event|81|||
155379583|NCT00558259|560822373|FG000|Overall Study|Protocol Violation|9|||
155379584|NCT00558259|560822374|FG001|Overall Study|Protocol Violation|5|||
155379585|NCT00558259|560822373|FG000|Overall Study|Withdrawal by Subject|12|||
155379586|NCT00558259|560822374|FG001|Overall Study|Withdrawal by Subject|13|||
155379587|NCT01183234|560822377|FG000|First Intervention|Adverse Event|1|||
155379588|NCT01183234|560822378|FG001|First Intervention|Adverse Event|0|||
155379589|NCT00822172|560822383|FG000|Overall Study|Adverse Event|10|||
155379590|NCT00822172|560822384|FG001|Overall Study|Adverse Event|12|||
155379591|NCT00822172|560822383|FG000|Overall Study|Death|1|||
155379592|NCT00822172|560822384|FG001|Overall Study|Death|0|||
155379593|NCT00822172|560822383|FG000|Overall Study|Lost to Follow-up|3|||
155379594|NCT00822172|560822384|FG001|Overall Study|Lost to Follow-up|1|||
155379595|NCT00822172|560822383|FG000|Overall Study|Withdrawal by Subject|1|||
155379596|NCT00822172|560822384|FG001|Overall Study|Withdrawal by Subject|4|||
155379597|NCT00822172|560822383|FG000|Overall Study|site closed|0|||
155379598|NCT00822172|560822384|FG001|Overall Study|site closed|1|||
155379599|NCT00822172|560822383|FG000|Overall Study|Other|0|||
155379600|NCT00822172|560822384|FG001|Overall Study|Other|1|||
155379601|NCT00700258|560822385|FG000|Overall Study|Premature discontinuation of documentation|136|||
155379602|NCT00700258|560822385|FG000|Overall Study|Type of study end not documented|1|||
155379603|NCT00700258|560822385|FG000|Overall Study|Lost to Follow-up|81|||
155379604|NCT00700258|560822385|FG000|Overall Study|Premature discontinuation of therapy|1013|||
155379605|NCT04772898|560822387|FG000|Overall Study|Withdrawal by Subject|0|||
155379606|NCT04772898|560822388|FG001|Overall Study|Withdrawal by Subject|1|||
155379607|NCT00473265|560822389|FG000|Overall Study|Unrelated adverse event|5|||
155379608|NCT00473265|560822389|FG000|Overall Study|Off treatment early|15|||
155379609|NCT00370331|560822391|FG000|Overall Study|Adverse Event|4|||
155379610|NCT00370331|560822392|FG001|Overall Study|Adverse Event|13|||
155379611|NCT00370331|560822391|FG000|Overall Study|Withdrawal by Subject|2|||
155379612|NCT00370331|560822392|FG001|Overall Study|Withdrawal by Subject|4|||
155379613|NCT00370331|560822391|FG000|Overall Study|Lost to Follow-up|0|||
155379614|NCT00370331|560822392|FG001|Overall Study|Lost to Follow-up|3|||
155379615|NCT00370331|560822391|FG000|Overall Study|Lack of Efficacy|0|||
155379616|NCT00370331|560822392|FG001|Overall Study|Lack of Efficacy|1|||
155379617|NCT00370331|560822391|FG000|Overall Study|Non-compliance|0|||
155379618|NCT00370331|560822392|FG001|Overall Study|Non-compliance|1|||
155379619|NCT00370331|560822391|FG000|Overall Study|Protocol Violation|1|||
155379620|NCT00370331|560822392|FG001|Overall Study|Protocol Violation|1|||
155379621|NCT02947087|560822393|FG000|Overall Study|Withdrawal by Subject|3|||
155379622|NCT02947087|560822394|FG001|Overall Study|Withdrawal by Subject|2|||
155379623|NCT00545051|560822395|FG000|Overall Study|Adverse Event|7|||
155379624|NCT00545051|560822396|FG001|Overall Study|Adverse Event|3|||
155379625|NCT00545051|560822395|FG000|Overall Study|Death|1|||
155379626|NCT00545051|560822396|FG001|Overall Study|Death|0|||
155379627|NCT00545051|560822395|FG000|Overall Study|Violation of inclusion/exclusion|0|||
155379628|NCT00545051|560822396|FG001|Overall Study|Violation of inclusion/exclusion|2|||
155379629|NCT00545051|560822395|FG000|Overall Study|Protocol Violation|1|||
155379630|NCT00545051|560822396|FG001|Overall Study|Protocol Violation|0|||
155379631|NCT00545051|560822395|FG000|Overall Study|Withdrawal by Subject|0|||
155379632|NCT00545051|560822396|FG001|Overall Study|Withdrawal by Subject|1|||
155379633|NCT00545051|560822395|FG000|Overall Study|Administrative reasons|0|||
155379634|NCT00545051|560822396|FG001|Overall Study|Administrative reasons|1|||
155379635|NCT01888900|560822399|FG000|Overall Study|failed treatment|0|||
155379636|NCT01888900|560822400|FG001|Overall Study|failed treatment|2|||
155379637|NCT03271021|560822401|FG000|Overall Study|Adverse Event|3|||
155379638|NCT03271021|560822402|FG001|Overall Study|Adverse Event|2|||
155379639|NCT03271021|560822401|FG000|Overall Study|Withdrawal by Subject|36|||
155379640|NCT03271021|560822402|FG001|Overall Study|Withdrawal by Subject|53|||
155379641|NCT03271021|560822401|FG000|Overall Study|Lost to Follow-up|34|||
155379642|NCT03271021|560822402|FG001|Overall Study|Lost to Follow-up|39|||
155379643|NCT03271021|560822401|FG000|Overall Study|Protocol Violation|6|||
155379644|NCT03271021|560822402|FG001|Overall Study|Protocol Violation|4|||
155379645|NCT03271021|560822401|FG000|Overall Study|Abnormal Lab Results|1|||
155379646|NCT03271021|560822402|FG001|Overall Study|Abnormal Lab Results|0|||
155379647|NCT03271021|560822401|FG000|Overall Study|Miscellaneous|9|||
155379648|NCT03271021|560822402|FG001|Overall Study|Miscellaneous|8|||
155379649|NCT03215810|560822403|FG000|Overall Study|Still responding to nivolumab|1|||
155379650|NCT03215810|560822403|FG000|Overall Study|Insufficient TIL growth|1|||
155379651|NCT03215810|560822403|FG000|Overall Study|Decline in performance status|1|||
155379652|NCT03215810|560822403|FG000|Overall Study|Withdrawal by Subject|1|||
155379653|NCT02313233|560822404|FG000|Overall Study|Withdrawal by Subject|1|||
155379654|NCT02313233|560822405|FG001|Overall Study|Withdrawal by Subject|2|||
155379655|NCT02313233|560822404|FG000|Overall Study|Administrative reason|1|||
155379656|NCT02313233|560822405|FG001|Overall Study|Administrative reason|1|||
155379657|NCT01859988|560822407|FG000|Overall Study|Withdrawal by Subject|6|||
155379658|NCT01859988|560822408|FG001|Overall Study|Withdrawal by Subject|3|||
155379659|NCT01859988|560822409|FG002|Overall Study|Withdrawal by Subject|4|||
155379660|NCT01859988|560822410|FG003|Overall Study|Withdrawal by Subject|3|||
155379661|NCT01859988|560822411|FG004|Overall Study|Withdrawal by Subject|2|||
155379662|NCT01859988|560822412|FG005|Overall Study|Withdrawal by Subject|2|||
155379663|NCT01859988|560822407|FG000|Overall Study|Lack of Efficacy|1|||
155379664|NCT01859988|560822408|FG001|Overall Study|Lack of Efficacy|1|||
155379665|NCT01859988|560822409|FG002|Overall Study|Lack of Efficacy|5|||
155379666|NCT01859988|560822410|FG003|Overall Study|Lack of Efficacy|0|||
155379667|NCT01859988|560822411|FG004|Overall Study|Lack of Efficacy|7|||
155379668|NCT01859988|560822412|FG005|Overall Study|Lack of Efficacy|9|||
155379669|NCT01859988|560822407|FG000|Overall Study|Physician Decision|1|||
155379670|NCT01859988|560822408|FG001|Overall Study|Physician Decision|3|||
155379671|NCT01859988|560822409|FG002|Overall Study|Physician Decision|1|||
155379672|NCT01859988|560822410|FG003|Overall Study|Physician Decision|3|||
155379673|NCT01859988|560822411|FG004|Overall Study|Physician Decision|4|||
155379674|NCT01859988|560822412|FG005|Overall Study|Physician Decision|1|||
155379675|NCT01859988|560822407|FG000|Overall Study|Adverse Event|2|||
155379676|NCT01859988|560822408|FG001|Overall Study|Adverse Event|1|||
155379677|NCT01859988|560822409|FG002|Overall Study|Adverse Event|3|||
155379678|NCT01859988|560822410|FG003|Overall Study|Adverse Event|1|||
155379679|NCT01859988|560822411|FG004|Overall Study|Adverse Event|2|||
155379680|NCT01859988|560822412|FG005|Overall Study|Adverse Event|2|||
155379681|NCT01859988|560822407|FG000|Overall Study|Lost to Follow-up|1|||
155379682|NCT01859988|560822408|FG001|Overall Study|Lost to Follow-up|2|||
155379683|NCT01859988|560822409|FG002|Overall Study|Lost to Follow-up|3|||
155379684|NCT01859988|560822410|FG003|Overall Study|Lost to Follow-up|0|||
155379685|NCT01859988|560822411|FG004|Overall Study|Lost to Follow-up|3|||
155379686|NCT01859988|560822412|FG005|Overall Study|Lost to Follow-up|2|||
155379687|NCT01859988|560822407|FG000|Overall Study|Protocol Violation|0|||
155379688|NCT01859988|560822408|FG001|Overall Study|Protocol Violation|0|||
155379689|NCT01859988|560822409|FG002|Overall Study|Protocol Violation|1|||
155379690|NCT01859988|560822410|FG003|Overall Study|Protocol Violation|0|||
155379691|NCT01859988|560822411|FG004|Overall Study|Protocol Violation|0|||
155379692|NCT01859988|560822412|FG005|Overall Study|Protocol Violation|0|||
155379693|NCT01859988|560822407|FG000|Overall Study|Other than specified above|0|||
155379694|NCT01859988|560822408|FG001|Overall Study|Other than specified above|2|||
155379695|NCT01859988|560822409|FG002|Overall Study|Other than specified above|11|||
155379696|NCT01859988|560822410|FG003|Overall Study|Other than specified above|3|||
155379697|NCT01859988|560822411|FG004|Overall Study|Other than specified above|5|||
155379698|NCT01859988|560822412|FG005|Overall Study|Other than specified above|3|||
155379699|NCT02930226|560822413|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379700|NCT02930226|560822414|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379701|NCT02930226|560822415|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379702|NCT02930226|560822416|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379703|NCT02930226|560822417|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
155379704|NCT02930226|560822418|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
155379705|NCT00635427|560822419|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379706|NCT00635427|560822420|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379707|NCT00635427|560822421|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
155379708|NCT00635427|560822422|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379709|NCT00635427|560822423|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
155379710|NCT00635427|560822419|FG000|Overall Study|Death|0|||
155379711|NCT00635427|560822420|FG001|Overall Study|Death|0|||
155379712|NCT00635427|560822421|FG002|Overall Study|Death|0|||
155379713|NCT00635427|560822422|FG003|Overall Study|Death|1|||
155379714|NCT00635427|560822423|FG004|Overall Study|Death|0|||
155379715|NCT00635427|560822419|FG000|Overall Study|Termination Of Study By Sponsor|12|||
155379716|NCT00635427|560822420|FG001|Overall Study|Termination Of Study By Sponsor|6|||
155379717|NCT00635427|560822421|FG002|Overall Study|Termination Of Study By Sponsor|10|||
155379718|NCT00635427|560822422|FG003|Overall Study|Termination Of Study By Sponsor|6|||
155379719|NCT00635427|560822423|FG004|Overall Study|Termination Of Study By Sponsor|6|||
155379720|NCT00635427|560822419|FG000|Overall Study|Withdrawal Of Consent|0|||
155379721|NCT00635427|560822420|FG001|Overall Study|Withdrawal Of Consent|0|||
155379722|NCT00635427|560822421|FG002|Overall Study|Withdrawal Of Consent|0|||
155379723|NCT00635427|560822422|FG003|Overall Study|Withdrawal Of Consent|2|||
155379724|NCT00635427|560822423|FG004|Overall Study|Withdrawal Of Consent|2|||
155379725|NCT01506609|560822426|FG000|Overall Study|Adverse Event Related to Progression|0|||
155379726|NCT01506609|560822427|FG001|Overall Study|Adverse Event Related to Progression|0|||
155379727|NCT01506609|560822428|FG002|Overall Study|Adverse Event Related to Progression|0|||
155379728|NCT01506609|560822429|FG003|Overall Study|Adverse Event Related to Progression|3|||
155379729|NCT01506609|560822430|FG004|Overall Study|Adverse Event Related to Progression|7|||
155379730|NCT01506609|560822431|FG005|Overall Study|Adverse Event Related to Progression|3|||
155379731|NCT01506609|560822426|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
155379732|NCT01506609|560822427|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
155379733|NCT01506609|560822428|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
155379734|NCT01506609|560822429|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
155379735|NCT01506609|560822430|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
155379736|NCT01506609|560822431|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
155379737|NCT01506609|560822426|FG000|Overall Study|Withdrawal by Subject|0|||
155379738|NCT01506609|560822427|FG001|Overall Study|Withdrawal by Subject|0|||
155379739|NCT01506609|560822428|FG002|Overall Study|Withdrawal by Subject|0|||
155379740|NCT01506609|560822429|FG003|Overall Study|Withdrawal by Subject|9|||
155379741|NCT01506609|560822430|FG004|Overall Study|Withdrawal by Subject|7|||
155379742|NCT01506609|560822431|FG005|Overall Study|Withdrawal by Subject|7|||
155379743|NCT01506609|560822426|FG000|Overall Study|Lost to Follow-up|0|||
155379744|NCT01506609|560822427|FG001|Overall Study|Lost to Follow-up|0|||
155379745|NCT01506609|560822428|FG002|Overall Study|Lost to Follow-up|0|||
155379746|NCT01506609|560822429|FG003|Overall Study|Lost to Follow-up|1|||
155379747|NCT01506609|560822430|FG004|Overall Study|Lost to Follow-up|2|||
155379748|NCT01506609|560822431|FG005|Overall Study|Lost to Follow-up|0|||
155379749|NCT01506609|560822426|FG000|Overall Study|Sponsor Discontinued Study|0|||
155379750|NCT01506609|560822427|FG001|Overall Study|Sponsor Discontinued Study|0|||
155379751|NCT01506609|560822428|FG002|Overall Study|Sponsor Discontinued Study|0|||
155379752|NCT01506609|560822429|FG003|Overall Study|Sponsor Discontinued Study|2|||
155379753|NCT01506609|560822430|FG004|Overall Study|Sponsor Discontinued Study|2|||
155379754|NCT01506609|560822431|FG005|Overall Study|Sponsor Discontinued Study|0|||
155379755|NCT01506609|560822426|FG000|Overall Study|Progressive Disease per Protocol|1|||
155379756|NCT01506609|560822427|FG001|Overall Study|Progressive Disease per Protocol|0|||
155379757|NCT01506609|560822428|FG002|Overall Study|Progressive Disease per Protocol|0|||
155379758|NCT01506609|560822429|FG003|Overall Study|Progressive Disease per Protocol|64|||
155379759|NCT01506609|560822430|FG004|Overall Study|Progressive Disease per Protocol|57|||
155379760|NCT01506609|560822431|FG005|Overall Study|Progressive Disease per Protocol|74|||
155379761|NCT01506609|560822426|FG000|Overall Study|Other, Not Specified|0|||
155379762|NCT01506609|560822427|FG001|Overall Study|Other, Not Specified|0|||
155379763|NCT01506609|560822428|FG002|Overall Study|Other, Not Specified|0|||
155379764|NCT01506609|560822429|FG003|Overall Study|Other, Not Specified|10|||
155379765|NCT01506609|560822430|FG004|Overall Study|Other, Not Specified|7|||
155379766|NCT01506609|560822431|FG005|Overall Study|Other, Not Specified|3|||
155379767|NCT01506609|560822426|FG000|Overall Study|Missing / Unknown Reason|1|||
155379768|NCT01506609|560822427|FG001|Overall Study|Missing / Unknown Reason|0|||
155379769|NCT01506609|560822428|FG002|Overall Study|Missing / Unknown Reason|1|||
155379770|NCT01506609|560822429|FG003|Overall Study|Missing / Unknown Reason|4|||
155379771|NCT01506609|560822430|FG004|Overall Study|Missing / Unknown Reason|4|||
155379772|NCT01506609|560822431|FG005|Overall Study|Missing / Unknown Reason|2|||
155379773|NCT00577473|560822436|FG000|Overall Study|Protocol Violation|1|||
155379774|NCT00577473|560822437|FG001|Overall Study|Protocol Violation|4|||
155379775|NCT00577473|560822436|FG000|Overall Study|Adverse Event|8|||
155379776|NCT00577473|560822437|FG001|Overall Study|Adverse Event|5|||
155379777|NCT00577473|560822436|FG000|Overall Study|Withdrawal by Subject|2|||
155379778|NCT00577473|560822437|FG001|Overall Study|Withdrawal by Subject|6|||
155379779|NCT00577473|560822436|FG000|Overall Study|Physician Decision|2|||
155379780|NCT00577473|560822437|FG001|Overall Study|Physician Decision|2|||
155379781|NCT00577473|560822436|FG000|Overall Study|Lack of Efficacy|8|||
155379782|NCT00577473|560822437|FG001|Overall Study|Lack of Efficacy|7|||
155379783|NCT01990560|560822438|FG000|Overall Study|Withdrawal by Subject|1|||
155379784|NCT02084056|560822444|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
155379785|NCT02084056|560822445|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155379786|NCT02084056|560822446|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155379787|NCT02084056|560822447|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155379788|NCT02084056|560822444|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
155379789|NCT02084056|560822445|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155379790|NCT02084056|560822446|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155379791|NCT02084056|560822447|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155379792|NCT00938860|560822448|FG000|Overall Study|Adverse Event|2|||
155379793|NCT00938860|560822449|FG001|Overall Study|Adverse Event|1|||
155379794|NCT00938860|560822448|FG000|Overall Study|Abnormal laboratory values|2|||
155379795|NCT00938860|560822449|FG001|Overall Study|Abnormal laboratory values|2|||
155379796|NCT00938860|560822448|FG000|Overall Study|Withdrawal by Subject|11|||
155379797|NCT00938860|560822449|FG001|Overall Study|Withdrawal by Subject|8|||
155379798|NCT00938860|560822448|FG000|Overall Study|Lost to Follow-up|4|||
155379799|NCT00938860|560822449|FG001|Overall Study|Lost to Follow-up|4|||
155379800|NCT00938860|560822448|FG000|Overall Study|Administration problems|2|||
155379801|NCT00938860|560822449|FG001|Overall Study|Administration problems|0|||
155379802|NCT00938860|560822448|FG000|Overall Study|Death|1|||
155379803|NCT00938860|560822449|FG001|Overall Study|Death|1|||
155379804|NCT00938860|560822448|FG000|Overall Study|Protocol Violation|3|||
155379805|NCT00938860|560822449|FG001|Overall Study|Protocol Violation|1|||
155379806|NCT01605019|560822450|FG000|Overall Study|pt did not meet transplant endpoint|3|||
155379807|NCT01605019|560822451|FG001|Overall Study|pt did not meet transplant endpoint|0|||
155379808|NCT00468559|560822455|FG000|Open-label Treatment Phase|Adverse Event|5|||
155379809|NCT00468559|560822456|FG001|Open-label Treatment Phase|Adverse Event|0|||
155379810|NCT00468559|560822457|FG002|Open-label Treatment Phase|Adverse Event|0|||
155379811|NCT00468559|560822455|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
155379812|NCT00468559|560822456|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
155379813|NCT00468559|560822457|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
155379814|NCT00468559|560822455|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
155379815|NCT00468559|560822456|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
155379816|NCT00468559|560822457|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
155379817|NCT00468559|560822455|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
155379818|NCT00468559|560822456|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
155379819|NCT00468559|560822457|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
155379820|NCT00468559|560822455|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
155379821|NCT00468559|560822456|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
155379822|NCT00468559|560822457|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
155379823|NCT00862719|560822458|FG000|Overall Study|Disease Progression|5|||
155379824|NCT00862719|560822459|FG001|Overall Study|Disease Progression|0|||
155379825|NCT00862719|560822460|FG002|Overall Study|Disease Progression|1|||
155379826|NCT00862719|560822461|FG003|Overall Study|Disease Progression|0|||
155379827|NCT00862719|560822458|FG000|Overall Study|Death|5|||
155379828|NCT00862719|560822459|FG001|Overall Study|Death|6|||
155379829|NCT00862719|560822460|FG002|Overall Study|Death|1|||
155379830|NCT00862719|560822461|FG003|Overall Study|Death|1|||
155379831|NCT00862719|560822458|FG000|Overall Study|Engraftment failure|0|||
155379832|NCT00862719|560822459|FG001|Overall Study|Engraftment failure|0|||
155379833|NCT00862719|560822460|FG002|Overall Study|Engraftment failure|1|||
155379834|NCT00862719|560822461|FG003|Overall Study|Engraftment failure|0|||
155379835|NCT00862719|560822458|FG000|Overall Study|Veno-Occlusive Disease|0|||
155379836|NCT00862719|560822459|FG001|Overall Study|Veno-Occlusive Disease|0|||
155379837|NCT00862719|560822460|FG002|Overall Study|Veno-Occlusive Disease|1|||
155379838|NCT00862719|560822461|FG003|Overall Study|Veno-Occlusive Disease|0|||
155379839|NCT00324116|560822462|FG000|Overall Study|Adverse Event|5|||
155379840|NCT00324116|560822462|FG000|Overall Study|Lack of Efficacy|17|||
155379841|NCT00324116|560822462|FG000|Overall Study|Withdrawal by Subject|5|||
155379842|NCT00324116|560822462|FG000|Overall Study|Other|5|||
155379843|NCT01153958|560822463|FG000|Overall Study|Study Terminated|36|||
155379844|NCT01153958|560822464|FG001|Overall Study|Study Terminated|32|||
155379845|NCT02624791|560822466|FG000|Overall Study|Withdrawal by Subject|2|||
155379846|NCT02624791|560822467|FG001|Overall Study|Withdrawal by Subject|0|||
155379847|NCT02624791|560822468|FG002|Overall Study|Withdrawal by Subject|0|||
155379848|NCT02624791|560822469|FG003|Overall Study|Withdrawal by Subject|0|||
155379849|NCT02624791|560822470|FG004|Overall Study|Withdrawal by Subject|0|||
155379850|NCT02624791|560822471|FG005|Overall Study|Withdrawal by Subject|0|||
155379851|NCT00998790|560822472|FG000|Overall Study|Withdrawal by Subject|21|||
155379852|NCT01605916|560822473|FG000|Overall Study|Adverse Event|1|||
155379853|NCT01605916|560822474|FG001|Overall Study|Adverse Event|0|||
155379854|NCT01605916|560822475|FG002|Overall Study|Adverse Event|0|||
155379855|NCT01605916|560822476|FG003|Overall Study|Adverse Event|1|||
155379856|NCT01605916|560822477|FG004|Overall Study|Adverse Event|0|||
155379857|NCT01605916|560822473|FG000|Overall Study|Lack of Efficacy|2|||
155379858|NCT01605916|560822474|FG001|Overall Study|Lack of Efficacy|3|||
155379859|NCT01605916|560822475|FG002|Overall Study|Lack of Efficacy|3|||
155379860|NCT01605916|560822476|FG003|Overall Study|Lack of Efficacy|5|||
155379861|NCT01605916|560822477|FG004|Overall Study|Lack of Efficacy|4|||
155379862|NCT01605916|560822473|FG000|Overall Study|Withdrawal by Subject|1|||
155379863|NCT01605916|560822474|FG001|Overall Study|Withdrawal by Subject|1|||
155379864|NCT01605916|560822475|FG002|Overall Study|Withdrawal by Subject|0|||
155379865|NCT01605916|560822476|FG003|Overall Study|Withdrawal by Subject|0|||
155379866|NCT01605916|560822477|FG004|Overall Study|Withdrawal by Subject|2|||
155379867|NCT01103362|560822484|FG000|Overall Study|study terminated|596|||
155379868|NCT00412061|560822486|FG000|Double Blind Phase|Disease Progression|101|||
155379869|NCT00412061|560822487|FG001|Double Blind Phase|Disease Progression|154|||
155379870|NCT00412061|560822486|FG000|Double Blind Phase|Adverse Event|61|||
155379871|NCT00412061|560822487|FG001|Double Blind Phase|Adverse Event|16|||
155379872|NCT00412061|560822486|FG000|Double Blind Phase|Final Primary Analysis|26|||
155379873|NCT00412061|560822487|FG001|Double Blind Phase|Final Primary Analysis|14|||
155379874|NCT00412061|560822486|FG000|Double Blind Phase|Withdrawal by Subject|18|||
155379875|NCT00412061|560822487|FG001|Double Blind Phase|Withdrawal by Subject|20|||
155379876|NCT00412061|560822486|FG000|Double Blind Phase|Death|6|||
155379877|NCT00412061|560822487|FG001|Double Blind Phase|Death|3|||
155379878|NCT00412061|560822486|FG000|Double Blind Phase|Protocol Violation|3|||
155379879|NCT00412061|560822487|FG001|Double Blind Phase|Protocol Violation|4|||
155379880|NCT00412061|560822486|FG000|Double Blind Phase|New Cander Therapy|1|||
155379881|NCT00412061|560822487|FG001|Double Blind Phase|New Cander Therapy|1|||
155379882|NCT00412061|560822486|FG000|Double Blind Phase|Lost to Follow-up|0|||
155379883|NCT00412061|560822487|FG001|Double Blind Phase|Lost to Follow-up|1|||
155379884|NCT00412061|560822486|FG000|Open Label Phase|Disease Progression|0|||
155379885|NCT00412061|560822487|FG001|Open Label Phase|Disease Progression|86|||
155379886|NCT00412061|560822486|FG000|Open Label Phase|Adverse Event|0|||
155379887|NCT00412061|560822487|FG001|Open Label Phase|Adverse Event|46|||
155379888|NCT00412061|560822486|FG000|Open Label Phase|Withdrawal by Subject|0|||
155379889|NCT00412061|560822487|FG001|Open Label Phase|Withdrawal by Subject|15|||
155379890|NCT00412061|560822486|FG000|Open Label Phase|Administrative Problems|0|||
155379891|NCT00412061|560822487|FG001|Open Label Phase|Administrative Problems|13|||
155379892|NCT00412061|560822486|FG000|Open Label Phase|Death|0|||
155379893|NCT00412061|560822487|FG001|Open Label Phase|Death|7|||
155379894|NCT00412061|560822486|FG000|Open Label Phase|Lost to Follow-up|0|||
155379895|NCT00412061|560822487|FG001|Open Label Phase|Lost to Follow-up|2|||
155379896|NCT00412061|560822486|FG000|Open Label Phase|New Cancer Therapy|0|||
155379897|NCT00412061|560822487|FG001|Open Label Phase|New Cancer Therapy|1|||
155379898|NCT03406078|560822489|FG000|Overall Study|Death|1|||
155379899|NCT03406078|560822490|FG001|Overall Study|Death|0|||
155379900|NCT03406078|560822489|FG000|Overall Study|Lost to Follow-up|0|||
155379901|NCT03406078|560822490|FG001|Overall Study|Lost to Follow-up|1|||
155379902|NCT03406078|560822489|FG000|Overall Study|Withdrawal by Subject|5|||
155379903|NCT03406078|560822490|FG001|Overall Study|Withdrawal by Subject|2|||
155379904|NCT03616977|560822492|FG000|Period 1|Physician Decision|0|||
155379905|NCT03616977|560822493|FG001|Period 1|Physician Decision|1|||
155379906|NCT03616977|560822492|FG000|Period 3|Adverse Event|1|||
155379907|NCT03616977|560822493|FG001|Period 3|Adverse Event|1|||
155379908|NCT02859324|560822494|FG000|Overall Study|Death|4|||
155379909|NCT02859324|560822495|FG001|Overall Study|Death|6|||
155379910|NCT02859324|560822496|FG002|Overall Study|Death|5|||
155379911|NCT02859324|560822494|FG000|Overall Study|Other reasons|3|||
155379912|NCT02859324|560822495|FG001|Overall Study|Other reasons|3|||
155379913|NCT02859324|560822496|FG002|Overall Study|Other reasons|0|||
155379914|NCT03798691|560822497|FG000|Overall Study|Lost to Follow-up|2|||
155379915|NCT03798691|560822498|FG001|Overall Study|Lost to Follow-up|2|||
155379916|NCT02186223|560823873|FG000|Overall Study|Not eligible for device placement|6|||
155379917|NCT02186223|560823873|FG000|Overall Study|Unable to obtain femoral access|3|||
155379918|NCT02186223|560823873|FG000|Overall Study|Death|3|||
155379919|NCT02186223|560823873|FG000|Overall Study|Device in place less than 48 hours|9|||
155379920|NCT00252733|560823874|FG000|Overall Study|Withdrawal by Subject|73|||
155379921|NCT00252733|560823875|FG001|Overall Study|Withdrawal by Subject|67|||
155379922|NCT00252733|560823874|FG000|Overall Study|Death|7|||
155379923|NCT00252733|560823875|FG001|Overall Study|Death|5|||
155379924|NCT00252733|560823874|FG000|Overall Study|Lost to Follow-up|12|||
155379925|NCT00252733|560823875|FG001|Overall Study|Lost to Follow-up|6|||
155379926|NCT00252733|560823874|FG000|Overall Study|Multiple Reasons|14|||
155379927|NCT00252733|560823875|FG001|Overall Study|Multiple Reasons|14|||
155379928|NCT00618982|560823876|FG000|Overall Study|Adverse Event|23|||
155379929|NCT00618982|560823876|FG000|Overall Study|Withdrawal by Subject|1|||
155379930|NCT00618982|560823876|FG000|Overall Study|Protocol Violation|1|||
155379931|NCT00618982|560823876|FG000|Overall Study|ongoing, still treated with study med.|25|||
155379932|NCT00706433|560823880|FG000|Overall Study|Lost to Follow-up|3|||
155379933|NCT00706433|560823881|FG001|Overall Study|Lost to Follow-up|1|||
155379934|NCT00706433|560823882|FG002|Overall Study|Lost to Follow-up|6|||
155379935|NCT00706433|560823883|FG003|Overall Study|Lost to Follow-up|0|||
155379936|NCT00706433|560823880|FG000|Overall Study|Withdrawal by Subject|1|||
155379937|NCT00706433|560823881|FG001|Overall Study|Withdrawal by Subject|2|||
155379938|NCT00706433|560823882|FG002|Overall Study|Withdrawal by Subject|3|||
155379939|NCT00706433|560823883|FG003|Overall Study|Withdrawal by Subject|1|||
155379940|NCT00706433|560823880|FG000|Overall Study|Adverse Event|0|||
155379941|NCT00706433|560823881|FG001|Overall Study|Adverse Event|0|||
155379942|NCT00706433|560823882|FG002|Overall Study|Adverse Event|1|||
155379943|NCT00706433|560823883|FG003|Overall Study|Adverse Event|0|||
155379944|NCT00706433|560823880|FG000|Overall Study|Protocol Violation|1|||
155379945|NCT00706433|560823881|FG001|Overall Study|Protocol Violation|0|||
155379946|NCT00706433|560823882|FG002|Overall Study|Protocol Violation|0|||
155379947|NCT00706433|560823883|FG003|Overall Study|Protocol Violation|0|||
155379948|NCT00706433|560823880|FG000|Overall Study|new job|0|||
155379949|NCT00706433|560823881|FG001|Overall Study|new job|0|||
155379950|NCT00706433|560823882|FG002|Overall Study|new job|0|||
155379951|NCT00706433|560823883|FG003|Overall Study|new job|1|||
155379952|NCT04101318|560823885|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
155379953|NCT04101318|560823886|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
155379954|NCT04101318|560823885|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
155379955|NCT04101318|560823886|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
155379956|NCT04101318|560823885|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
155379957|NCT04101318|560823886|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
155379958|NCT00993668|560823892|FG000|Single-Blind Period|Adverse Event|1|||
155379959|NCT00993668|560823893|FG001|Single-Blind Period|Adverse Event|1|||
155379960|NCT00993668|560823892|FG000|Single-Blind Period|Lack of Efficacy|0|||
155379961|NCT00993668|560823893|FG001|Single-Blind Period|Lack of Efficacy|1|||
155379962|NCT00993668|560823892|FG000|Single-Blind Period|Lost to Follow-up|3|||
155379963|NCT00993668|560823893|FG001|Single-Blind Period|Lost to Follow-up|1|||
155379964|NCT00993668|560823892|FG000|Open-Label Period|Adverse Event|9|||
155379965|NCT00993668|560823893|FG001|Open-Label Period|Adverse Event|8|||
155379966|NCT00993668|560823892|FG000|Open-Label Period|Lack of Efficacy|4|||
155379967|NCT00993668|560823893|FG001|Open-Label Period|Lack of Efficacy|3|||
155379968|NCT00993668|560823892|FG000|Open-Label Period|Withdrawal by Subject|4|||
155379969|NCT00993668|560823893|FG001|Open-Label Period|Withdrawal by Subject|3|||
155379970|NCT00993668|560823892|FG000|Open-Label Period|Lost to Follow-up|6|||
155379971|NCT00993668|560823893|FG001|Open-Label Period|Lost to Follow-up|1|||
155379972|NCT02207569|560823894|FG000|1-Month|Death|6|||
155379973|NCT02207569|560823894|FG000|1-Month|Withdrawal by Subject|2|||
155379974|NCT02207569|560823894|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
155379975|NCT02207569|560823894|FG000|6-Month|Death|8|||
155379976|NCT02207569|560823894|FG000|6-Month|Withdrawal by Subject|2|||
155379977|NCT02207569|560823894|FG000|12-Month|Death|14|||
155379978|NCT02207569|560823894|FG000|12-Month|Withdrawal by Subject|2|||
155379979|NCT02207569|560823894|FG000|24-Month|Death|23|||
155379980|NCT02207569|560823894|FG000|24-Month|Withdrawal by Subject|3|||
155379981|NCT02207569|560823894|FG000|36-Month|Death|23|||
155379982|NCT02207569|560823894|FG000|36-Month|Withdrawal by Subject|4|||
155379983|NCT02207569|560823894|FG000|48-Month|Death|25|||
155379984|NCT02207569|560823894|FG000|48-Month|Withdrawal by Subject|2|||
155379985|NCT02207569|560823894|FG000|48-Month|Lost to Follow-up|4|||
155379986|NCT02207569|560823894|FG000|60-Month|Death|1|||
155379987|NCT02207569|560823894|FG000|60-Month|Lost to Follow-up|1|||
155379988|NCT02207569|560823894|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
155379989|NCT02207569|560823894|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
155379990|NCT02585232|560823895|FG000|Overall Study|Lost to Follow-up|8|||
155379991|NCT02585232|560823896|FG001|Overall Study|Lost to Follow-up|8|||
155379992|NCT02585232|560823895|FG000|Overall Study|Withdrawal by Subject|4|||
155379993|NCT02585232|560823896|FG001|Overall Study|Withdrawal by Subject|8|||
155379994|NCT00297232|560823897|FG000|Overall Study|Lack of Efficacy|7|||
155379995|NCT00297232|560823897|FG000|Overall Study|Lost to Follow-up|10|||
155379996|NCT00297232|560823897|FG000|Overall Study|Adverse Event|63|||
155379997|NCT00297232|560823897|FG000|Overall Study|Voluntary Withdrawal|120|||
155379998|NCT00297232|560823897|FG000|Overall Study|Subject was Noncompliant|9|||
155379999|NCT00297232|560823897|FG000|Overall Study|Death|9|||
155380000|NCT00297232|560823897|FG000|Overall Study|Anti-natalizumab Positive|8|||
155380001|NCT00297232|560823897|FG000|Overall Study|Switched to Commercial Tysabri|22|||
155380002|NCT00297232|560823897|FG000|Overall Study|Disease Progression|8|||
155380003|NCT00297232|560823897|FG000|Overall Study|Fear of PML|10|||
155380004|NCT00297232|560823897|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
155380005|NCT00297232|560823897|FG000|Overall Study|Miscellaneous|5|||
155380006|NCT00297232|560823897|FG000|Overall Study|Sponsor Decision|34|||
155380007|NCT00297232|560823897|FG000|Overall Study|Subject Relocated|7|||
155380008|NCT00297232|560823897|FG000|Overall Study|Subject Withdrew Consent|37|||
155380009|NCT00297232|560823897|FG000|Overall Study|Persistently Positive Antibodies|11|||
155380010|NCT00297232|560823897|FG000|Overall Study|Investigator Withdrew From Program|19|||
155380011|NCT00297232|560823897|FG000|Overall Study|Did Not Enroll to Week 264|34|||
155380012|NCT00297232|560823897|FG000|Overall Study|Did Not Enroll to Week 480|17|||
155380013|NCT00297232|560823897|FG000|Overall Study|No data available after Week 264|161|||
155380014|NCT00297232|560823897|FG000|Overall Study|Other|1|||
155380015|NCT03038438|560823900|FG000|Overall Study|Death|3|||
155380016|NCT03038438|560823900|FG000|Overall Study|Lost to Follow-up|8|||
155380017|NCT03038438|560823900|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
155380018|NCT03038438|560823900|FG000|Overall Study|Withdrawal by Subject|5|||
155380019|NCT03038438|560823900|FG000|Overall Study|No 36-Month Follow-Up|18|||
155380020|NCT03406260|560823901|FG000|Period 1|Adverse Event|0|||
155380021|NCT03406260|560823902|FG001|Period 1|Adverse Event|0|||
155380022|NCT03406260|560823903|FG002|Period 1|Adverse Event|0|||
155380023|NCT03406260|560823904|FG003|Period 1|Adverse Event|0|||
155380024|NCT03406260|560823905|FG004|Period 1|Adverse Event|1|||
155380025|NCT03406260|560823906|FG005|Period 1|Adverse Event|0|||
155380026|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
155380027|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
155380028|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
155380029|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
155380030|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
155380031|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
155380032|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
155380033|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
155380034|NCT01029652|560823910|FG000|Core Study (0-12 Weeks)|Death|0|||
155380035|NCT01029652|560823911|FG001|Core Study (0-12 Weeks)|Death|1|||
155380036|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
155380037|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
155380038|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
155380039|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
155380040|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
155380041|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
155380042|NCT01029652|560823910|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
155380043|NCT01029652|560823911|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
155380044|NCT01029652|560823910|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
155380045|NCT01029652|560823911|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
155380046|NCT01029652|560823910|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
155380047|NCT01029652|560823911|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
155380048|NCT01029652|560823910|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
155380049|NCT01029652|560823911|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
155380050|NCT02095951|560823915|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
155380051|NCT02095951|560823916|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
155380052|NCT05383508|560823917|FG000|Overall Study|Withdrawal by Subject|1|||
155380053|NCT05383508|560823918|FG001|Overall Study|Withdrawal by Subject|0|||
155380054|NCT05383508|560823919|FG002|Overall Study|Withdrawal by Subject|1|||
155380055|NCT05383508|560823920|FG003|Overall Study|Withdrawal by Subject|1|||
155380056|NCT05383508|560823921|FG004|Overall Study|Withdrawal by Subject|2|||
155380057|NCT05383508|560823922|FG005|Overall Study|Withdrawal by Subject|0|||
155380058|NCT01621568|560823923|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
155380059|NCT01621568|560823924|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
155380060|NCT01621568|560823923|FG000|Week 5-6 No Treatment|Death|1|||
155380061|NCT01621568|560823924|FG001|Week 5-6 No Treatment|Death|0|||
155380062|NCT02399254|560823925|FG000|Overall Study|Physician Decision|2|||
155380063|NCT01642251|560823930|FG000|Overall Study|Progressive disease|0|||
155380064|NCT01642251|560823931|FG001|Overall Study|Progressive disease|0|||
155380065|NCT01642251|560823932|FG002|Overall Study|Progressive disease|3|||
155380066|NCT01642251|560823933|FG003|Overall Study|Progressive disease|3|||
155380067|NCT01642251|560823930|FG000|Overall Study|Adverse Event|0|||
155380068|NCT01642251|560823931|FG001|Overall Study|Adverse Event|0|||
155380069|NCT01642251|560823932|FG002|Overall Study|Adverse Event|5|||
155380070|NCT01642251|560823933|FG003|Overall Study|Adverse Event|4|||
155380071|NCT01642251|560823930|FG000|Overall Study|Death|0|||
155380072|NCT01642251|560823931|FG001|Overall Study|Death|0|||
155380073|NCT01642251|560823932|FG002|Overall Study|Death|1|||
155380074|NCT01642251|560823933|FG003|Overall Study|Death|3|||
155380075|NCT01642251|560823930|FG000|Overall Study|Withdrawal by Subject|0|||
155380076|NCT01642251|560823931|FG001|Overall Study|Withdrawal by Subject|0|||
155380077|NCT01642251|560823932|FG002|Overall Study|Withdrawal by Subject|1|||
155380078|NCT01642251|560823933|FG003|Overall Study|Withdrawal by Subject|3|||
155380079|NCT01642251|560823930|FG000|Overall Study|Alternative therapy|0|||
155380080|NCT01642251|560823931|FG001|Overall Study|Alternative therapy|0|||
155380081|NCT01642251|560823932|FG002|Overall Study|Alternative therapy|0|||
155380082|NCT01642251|560823933|FG003|Overall Study|Alternative therapy|2|||
155380083|NCT01642251|560823930|FG000|Overall Study|Other complicating disease|0|||
155380084|NCT01642251|560823931|FG001|Overall Study|Other complicating disease|0|||
155380085|NCT01642251|560823932|FG002|Overall Study|Other complicating disease|1|||
155380086|NCT01642251|560823933|FG003|Overall Study|Other complicating disease|0|||
155380087|NCT01642251|560823930|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
155380088|NCT01642251|560823931|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
155380089|NCT01642251|560823932|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
155380090|NCT01642251|560823933|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
155380091|NCT01993927|560823935|FG000|Overall Study|Case Report Forms Uncollected|18|||
155380092|NCT01993927|560823935|FG000|Overall Study|Protocol Violation|11|||
155380093|NCT00895154|560823936|FG000|Overall Study|Lost to Follow-up|1|||
155380094|NCT00895154|560823937|FG001|Overall Study|Lost to Follow-up|1|||
155380095|NCT00895154|560823936|FG000|Overall Study|Withdrawal by Subject|0|||
155380096|NCT00895154|560823937|FG001|Overall Study|Withdrawal by Subject|1|||
155380097|NCT00540046|560823940|FG000|Overall Study|Lost to Follow-up|33|||
155380098|NCT00540046|560823941|FG001|Overall Study|Lost to Follow-up|23|||
155380099|NCT02533531|560823945|FG000|Overall Study|Device did not turn on|1|||
155380100|NCT03814187|560823946|FG000|Overall Study|Sponsor's Administrative Decision|0|||
155380101|NCT03814187|560823947|FG001|Overall Study|Sponsor's Administrative Decision|0|||
155380102|NCT03814187|560823948|FG002|Overall Study|Sponsor's Administrative Decision|272|||
155380103|NCT03814187|560823946|FG000|Overall Study|Death|80|||
155380104|NCT03814187|560823947|FG001|Overall Study|Death|81|||
155380105|NCT03814187|560823948|FG002|Overall Study|Death|4|||
155380106|NCT03814187|560823946|FG000|Overall Study|Withdrew Consent|77|||
155380107|NCT03814187|560823947|FG001|Overall Study|Withdrew Consent|78|||
155380108|NCT03814187|560823948|FG002|Overall Study|Withdrew Consent|2|||
155380109|NCT03814187|560823946|FG000|Overall Study|Lost to Follow-up|47|||
155380110|NCT03814187|560823947|FG001|Overall Study|Lost to Follow-up|52|||
155380111|NCT03814187|560823948|FG002|Overall Study|Lost to Follow-up|1|||
155380112|NCT03814187|560823946|FG000|Overall Study|Adverse Event|22|||
155380113|NCT03814187|560823947|FG001|Overall Study|Adverse Event|23|||
155380114|NCT03814187|560823948|FG002|Overall Study|Adverse Event|0|||
155380115|NCT03814187|560823946|FG000|Overall Study|Physician Decision|7|||
155380116|NCT03814187|560823947|FG001|Overall Study|Physician Decision|4|||
155380117|NCT03814187|560823948|FG002|Overall Study|Physician Decision|2|||
155380118|NCT03814187|560823946|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
155380119|NCT03814187|560823947|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
155380120|NCT03814187|560823948|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
155380121|NCT03814187|560823946|FG000|Overall Study|Other reasons|34|||
155380122|NCT03814187|560823947|FG001|Overall Study|Other reasons|40|||
155380123|NCT03814187|560823948|FG002|Overall Study|Other reasons|2|||
155380124|NCT02047903|560823949|FG000|Overall Study|Adverse Event|14|||
155380125|NCT02047903|560823949|FG000|Overall Study|Serious adverse event|10|||
155380126|NCT02047903|560823949|FG000|Overall Study|Withdrawal by Subject|16|||
155380127|NCT02047903|560823949|FG000|Overall Study|Lost to Follow-up|4|||
155380128|NCT02047903|560823949|FG000|Overall Study|Reason not listed|6|||
155380129|NCT02047903|560823949|FG000|Overall Study|Not Treated|9|||
155380130|NCT01014533|560823950|FG000|Overall Study|Protocol Violation|3|||
155380131|NCT01014533|560823951|FG001|Overall Study|Protocol Violation|2|||
155380132|NCT01014533|560823950|FG000|Overall Study|Withdrawal by Subject|2|||
155380133|NCT01014533|560823951|FG001|Overall Study|Withdrawal by Subject|0|||
155380134|NCT01014533|560823950|FG000|Overall Study|unable to come to appointment|0|||
155380135|NCT01014533|560823951|FG001|Overall Study|unable to come to appointment|3|||
155380136|NCT02689518|560823952|FG000|Overall Study|Withdrawal by Subject|3|||
155380137|NCT01942590|560823953|FG000|Overall Study|Withdrawal by Subject|0|||
155380138|NCT01942590|560823954|FG001|Overall Study|Withdrawal by Subject|1|||
155380139|NCT01942590|560823953|FG000|Overall Study|Adverse Event|1|||
155380140|NCT01942590|560823954|FG001|Overall Study|Adverse Event|0|||
155380141|NCT01226095|560823957|FG000|Overall Study|Poor compliance|1|||
155380142|NCT00911768|560823963|FG000|Overall Study|Protocol Violation|5|||
155380143|NCT00911768|560823964|FG001|Overall Study|Protocol Violation|4|||
155380144|NCT00911768|560823963|FG000|Overall Study|Withdrawal by Subject|1|||
155380145|NCT00911768|560823964|FG001|Overall Study|Withdrawal by Subject|0|||
155380146|NCT00515853|560823968|FG000|Overall Study|Lost to Follow-up|9|||
155380147|NCT00515853|560823969|FG001|Overall Study|Lost to Follow-up|13|||
155380148|NCT00515853|560823968|FG000|Overall Study|Withdrawal by Subject|6|||
155380149|NCT00515853|560823969|FG001|Overall Study|Withdrawal by Subject|4|||
155380150|NCT03965351|560823970|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155380151|NCT03965351|560823971|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
155380152|NCT03965351|560823970|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
155380153|NCT03965351|560823971|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
155380154|NCT00943111|560823976|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
155380155|NCT00943111|560823977|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
155380156|NCT00943111|560823978|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
155380157|NCT00943111|560823976|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
155380158|NCT00943111|560823977|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
155380159|NCT00943111|560823978|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
155380160|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
155380161|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
155380162|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
155380163|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
155380164|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
155380165|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
155380166|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
155380167|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
155380168|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
155380169|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
155380170|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
155380171|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
155380172|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
155380173|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
155380174|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
155380175|NCT00943111|560823976|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
155380176|NCT00943111|560823977|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
155380177|NCT00943111|560823978|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
155380178|NCT02665338|560823980|FG000|Overall Study|Withdrawal by Subject|0|||
155380179|NCT02665338|560823981|FG001|Overall Study|Withdrawal by Subject|1|||
155380180|NCT00998335|560823982|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
155380181|NCT00998335|560823983|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
155380182|NCT05593445|560823998|FG000|12-Week DBVC Period|Adverse Event|1|||
155380183|NCT05593445|560823999|FG001|12-Week DBVC Period|Adverse Event|0|||
155380184|NCT05593445|560824000|FG002|12-Week DBVC Period|Adverse Event|0|||
155380185|NCT05593445|560824001|FG003|12-Week DBVC Period|Adverse Event|0|||
155380186|NCT05593445|560823998|FG000|12-Week DBVC Period|Physician Decision|0|||
155380187|NCT05593445|560823999|FG001|12-Week DBVC Period|Physician Decision|1|||
155380188|NCT05593445|560824000|FG002|12-Week DBVC Period|Physician Decision|0|||
155380189|NCT05593445|560824001|FG003|12-Week DBVC Period|Physician Decision|0|||
155380190|NCT05593445|560823998|FG000|12-Week DBVC Period|Protocol Violation|0|||
155380191|NCT05593445|560823999|FG001|12-Week DBVC Period|Protocol Violation|1|||
155380192|NCT05593445|560824000|FG002|12-Week DBVC Period|Protocol Violation|0|||
155380193|NCT05593445|560824001|FG003|12-Week DBVC Period|Protocol Violation|0|||
155380194|NCT05593445|560823998|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
155380195|NCT05593445|560823999|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
155380196|NCT05593445|560824000|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
155380197|NCT05593445|560824001|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
155380198|NCT05593445|560823998|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
155380199|NCT05593445|560823999|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
155380200|NCT05593445|560824000|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
155380201|NCT05593445|560824001|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
155380202|NCT05593445|560823998|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
155380203|NCT05593445|560823999|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
155380204|NCT05593445|560824000|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
155380205|NCT05593445|560824001|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
155380206|NCT05593445|560823998|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
155380207|NCT05593445|560823999|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
155380208|NCT05593445|560824000|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
155380209|NCT05593445|560824001|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
155380210|NCT05593445|560823998|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155380211|NCT05593445|560823999|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155380212|NCT05593445|560824000|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
155380213|NCT05593445|560824001|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155380214|NCT05559476|560824002|FG000|Overall Study|Adverse Event|2|||
155380215|NCT05559476|560824003|FG001|Overall Study|Adverse Event|0|||
155380216|NCT05559476|560824002|FG000|Overall Study|Lost to Follow-up|13|||
155380217|NCT05559476|560824003|FG001|Overall Study|Lost to Follow-up|12|||
155380218|NCT05559476|560824002|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
155380219|NCT05559476|560824003|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
155380220|NCT05559476|560824002|FG000|Overall Study|Other|0|||
155380221|NCT05559476|560824003|FG001|Overall Study|Other|2|||
155380222|NCT05110690|560824004|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
155380223|NCT05110690|560824004|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
155380224|NCT05110690|560824004|FG000|Completion of Intervention|Lost to Follow-up|1|||
155380225|NCT05110690|560824004|FG000|Completion of Intervention|Death|1|||
155380226|NCT05110690|560824004|FG000|Completion of Intervention|Withdrawal by Subject|2|||
155380227|NCT04289051|560826785|FG000|Overall Study|Lost to Follow-up|0|||
155380228|NCT04289051|560826786|FG001|Overall Study|Lost to Follow-up|0|||
155380229|NCT04289051|560826787|FG002|Overall Study|Lost to Follow-up|2|||
155380230|NCT00717067|560826788|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380231|NCT00717067|560826789|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380232|NCT00717067|560826790|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
155380233|NCT00717067|560826791|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380234|NCT00717067|560826792|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
155380235|NCT02090959|560826793|FG000|Overall Study|Withdrawal by Subject|10|||
155380236|NCT02090959|560826793|FG000|Overall Study|Adverse Event|1|||
155380237|NCT02090959|560826793|FG000|Overall Study|Investigator decision|2|||
155380238|NCT02090959|560826793|FG000|Overall Study|Study termination|6|||
155380239|NCT02090959|560826793|FG000|Overall Study|Enrolled but not treated|1|||
155380240|NCT02090959|560826793|FG000|Overall Study|Transfer for compassionate use medicine|4|||
155380241|NCT02090959|560826793|FG000|Overall Study|Move to medical need program|3|||
155380242|NCT02090959|560826793|FG000|Overall Study|Entered in to other study|34|||
155380243|NCT02090959|560826793|FG000|Overall Study|Switched to commercial supply|88|||
155380244|NCT02090959|560826793|FG000|Overall Study|Other than specified|2|||
155380245|NCT00522873|560826796|FG000|Overall Study|Adverse Event|41|||
155380246|NCT00522873|560826797|FG001|Overall Study|Adverse Event|26|||
155380247|NCT00522873|560826796|FG000|Overall Study|Withdrawal by Subject|20|||
155380248|NCT00522873|560826797|FG001|Overall Study|Withdrawal by Subject|9|||
155380249|NCT00522873|560826796|FG000|Overall Study|Protocol Violation|14|||
155380250|NCT00522873|560826797|FG001|Overall Study|Protocol Violation|4|||
155380251|NCT00522873|560826796|FG000|Overall Study|Lost to Follow-up|11|||
155380252|NCT00522873|560826797|FG001|Overall Study|Lost to Follow-up|3|||
155380253|NCT00522873|560826796|FG000|Overall Study|Personal Reasons|8|||
155380254|NCT00522873|560826797|FG001|Overall Study|Personal Reasons|1|||
155380255|NCT00522873|560826796|FG000|Overall Study|Medication Errors|1|||
155380256|NCT00522873|560826797|FG001|Overall Study|Medication Errors|1|||
155380257|NCT00522873|560826796|FG000|Overall Study|Never Received Medication|1|||
155380258|NCT00522873|560826797|FG001|Overall Study|Never Received Medication|0|||
155380259|NCT00657020|560826798|FG000|PERIOD 1|Adverse Event|0|||
155380260|NCT00657020|560826799|FG001|PERIOD 1|Adverse Event|1|||
155380261|NCT02029846|560826802|FG000|Overall Study|n=1 each arm|1|||
155380262|NCT02029846|560826803|FG001|Overall Study|n=1 each arm|1|||
155380263|NCT02966301|560826807|FG000|Overall Study|Death|2|||
155380264|NCT02966301|560826807|FG000|Overall Study|Withdrawal by Subject|1|||
155380265|NCT02937454|560826810|FG000|Overall Study|Adverse Event|0|||
155380266|NCT02937454|560826811|FG001|Overall Study|Adverse Event|1|||
155380267|NCT02937454|560826810|FG000|Overall Study|Death|98|||
155380268|NCT02937454|560826811|FG001|Overall Study|Death|95|||
155380269|NCT02937454|560826810|FG000|Overall Study|Lost to Follow-up|1|||
155380270|NCT02937454|560826811|FG001|Overall Study|Lost to Follow-up|1|||
155380271|NCT02937454|560826810|FG000|Overall Study|Physician Decision|0|||
155380272|NCT02937454|560826811|FG001|Overall Study|Physician Decision|1|||
155380273|NCT02937454|560826810|FG000|Overall Study|Protocol Violation|6|||
155380274|NCT02937454|560826811|FG001|Overall Study|Protocol Violation|10|||
155380275|NCT02937454|560826810|FG000|Overall Study|Withdrawal by Subject|27|||
155380276|NCT02937454|560826811|FG001|Overall Study|Withdrawal by Subject|15|||
155380277|NCT02937454|560826810|FG000|Overall Study|Other|8|||
155380278|NCT02937454|560826811|FG001|Overall Study|Other|5|||
155380279|NCT01375114|560826812|FG000|Overall Study|Lost to Follow-up|1|||
155380280|NCT01375114|560826813|FG001|Overall Study|Lost to Follow-up|0|||
155380281|NCT01375114|560826814|FG002|Overall Study|Lost to Follow-up|1|||
155380282|NCT01375114|560826812|FG000|Overall Study|Disease Progression|3|||
155380283|NCT01375114|560826813|FG001|Overall Study|Disease Progression|2|||
155380284|NCT01375114|560826814|FG002|Overall Study|Disease Progression|2|||
155380285|NCT01375114|560826812|FG000|Overall Study|Patient Changed Mind|0|||
155380286|NCT01375114|560826813|FG001|Overall Study|Patient Changed Mind|0|||
155380287|NCT01375114|560826814|FG002|Overall Study|Patient Changed Mind|2|||
155380288|NCT01375114|560826812|FG000|Overall Study|Pruritus|0|||
155380289|NCT01375114|560826813|FG001|Overall Study|Pruritus|0|||
155380290|NCT01375114|560826814|FG002|Overall Study|Pruritus|1|||
155380291|NCT01375114|560826812|FG000|Overall Study|Restlessness|0|||
155380292|NCT01375114|560826813|FG001|Overall Study|Restlessness|0|||
155380293|NCT01375114|560826814|FG002|Overall Study|Restlessness|1|||
155380294|NCT01375114|560826812|FG000|Overall Study|Diarrhea|0|||
155380295|NCT01375114|560826813|FG001|Overall Study|Diarrhea|0|||
155380296|NCT01375114|560826814|FG002|Overall Study|Diarrhea|1|||
155380297|NCT01375114|560826812|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
155380298|NCT01375114|560826813|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
155380299|NCT01375114|560826814|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
155380300|NCT01375114|560826812|FG000|Overall Study|Nausea|0|||
155380301|NCT01375114|560826813|FG001|Overall Study|Nausea|1|||
155380302|NCT01375114|560826814|FG002|Overall Study|Nausea|0|||
155380303|NCT01375114|560826812|FG000|Overall Study|Increased AST/ALT|0|||
155380304|NCT01375114|560826813|FG001|Overall Study|Increased AST/ALT|1|||
155380305|NCT01375114|560826814|FG002|Overall Study|Increased AST/ALT|0|||
155380306|NCT01375114|560826812|FG000|Overall Study|Vaginal Hemorrhage|0|||
155380307|NCT01375114|560826813|FG001|Overall Study|Vaginal Hemorrhage|1|||
155380308|NCT01375114|560826814|FG002|Overall Study|Vaginal Hemorrhage|0|||
155380309|NCT01375114|560826812|FG000|Overall Study|Family problem|0|||
155380310|NCT01375114|560826813|FG001|Overall Study|Family problem|1|||
155380311|NCT01375114|560826814|FG002|Overall Study|Family problem|0|||
155380312|NCT01375114|560826812|FG000|Overall Study|Protocol Violation|2|||
155380313|NCT01375114|560826813|FG001|Overall Study|Protocol Violation|0|||
155380314|NCT01375114|560826814|FG002|Overall Study|Protocol Violation|0|||
155380315|NCT01474434|560826815|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
155380316|NCT01474434|560826816|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
155380317|NCT01474434|560826817|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
155380318|NCT01474434|560826818|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
155380319|NCT01474434|560826815|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
155380320|NCT01474434|560826816|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
155380321|NCT01474434|560826817|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
155380322|NCT01474434|560826818|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
155380323|NCT01474434|560826815|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
155380324|NCT01474434|560826816|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
155380325|NCT01474434|560826817|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
155380326|NCT01474434|560826818|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
155380327|NCT03606668|560826823|FG000|Overall Study|Screen Failure|1|||
155380328|NCT03606668|560826823|FG000|Overall Study|Lost to Follow-up|1|||
155380329|NCT01014143|560826824|FG000|Second Intervention|Lost to Follow-up|2|||
155380330|NCT01014143|560826825|FG001|Second Intervention|Lost to Follow-up|0|||
155380331|NCT01014143|560826826|FG002|Second Intervention|Lost to Follow-up|0|||
155380332|NCT01878214|560826832|FG000|Overall Study|Withdrawal by Subject|18|||
155380333|NCT01878214|560826833|FG001|Overall Study|Withdrawal by Subject|7|||
155380334|NCT01878214|560826832|FG000|Overall Study|Death|0|||
155380335|NCT01878214|560826833|FG001|Overall Study|Death|1|||
155380336|NCT01878214|560826832|FG000|Overall Study|Lost to Follow-up|35|||
155380337|NCT01878214|560826833|FG001|Overall Study|Lost to Follow-up|36|||
155380338|NCT00495586|560826834|FG000|Overall Study|Withdrawal by Subject|4|||
155380339|NCT00495586|560826835|FG001|Overall Study|Withdrawal by Subject|4|||
155380340|NCT02038543|560826838|FG000|Overall Study|Screen Failure|0|||
155380341|NCT02038543|560826839|FG001|Overall Study|Screen Failure|0|||
155380342|NCT02038543|560826840|FG002|Overall Study|Screen Failure|0|||
155380343|NCT02038543|560826841|FG003|Overall Study|Screen Failure|1|||
155380344|NCT02038543|560826838|FG000|Overall Study|Withdrawal by Subject|0|||
155380345|NCT02038543|560826839|FG001|Overall Study|Withdrawal by Subject|0|||
155380346|NCT02038543|560826840|FG002|Overall Study|Withdrawal by Subject|0|||
155380347|NCT02038543|560826841|FG003|Overall Study|Withdrawal by Subject|1|||
155380348|NCT02647866|560826842|FG000|Overall Study|Adverse Event|0|||
155380349|NCT02647866|560826843|FG001|Overall Study|Adverse Event|0|||
155380350|NCT02647866|560826844|FG002|Overall Study|Adverse Event|2|||
155380351|NCT02647866|560826845|FG003|Overall Study|Adverse Event|2|||
155380352|NCT02647866|560826846|FG004|Overall Study|Adverse Event|1|||
155380353|NCT02647866|560826842|FG000|Overall Study|Disease Worsening|3|||
155380354|NCT02647866|560826843|FG001|Overall Study|Disease Worsening|1|||
155380355|NCT02647866|560826844|FG002|Overall Study|Disease Worsening|0|||
155380356|NCT02647866|560826845|FG003|Overall Study|Disease Worsening|0|||
155380357|NCT02647866|560826846|FG004|Overall Study|Disease Worsening|1|||
155380358|NCT02647866|560826842|FG000|Overall Study|Withdrawal by Subject|1|||
155380359|NCT02647866|560826843|FG001|Overall Study|Withdrawal by Subject|1|||
155380360|NCT02647866|560826844|FG002|Overall Study|Withdrawal by Subject|2|||
155380361|NCT02647866|560826845|FG003|Overall Study|Withdrawal by Subject|4|||
155380362|NCT02647866|560826846|FG004|Overall Study|Withdrawal by Subject|4|||
155380363|NCT02647866|560826842|FG000|Overall Study|Physician Decision|0|||
155380364|NCT02647866|560826843|FG001|Overall Study|Physician Decision|1|||
155380365|NCT02647866|560826844|FG002|Overall Study|Physician Decision|1|||
155380366|NCT02647866|560826845|FG003|Overall Study|Physician Decision|0|||
155380367|NCT02647866|560826846|FG004|Overall Study|Physician Decision|2|||
155380368|NCT02647866|560826842|FG000|Overall Study|Death|0|||
155380369|NCT02647866|560826843|FG001|Overall Study|Death|1|||
155380370|NCT02647866|560826844|FG002|Overall Study|Death|0|||
155380371|NCT02647866|560826845|FG003|Overall Study|Death|0|||
155380372|NCT02647866|560826846|FG004|Overall Study|Death|0|||
155380373|NCT02647866|560826842|FG000|Overall Study|Subject moved to different country|1|||
155380374|NCT02647866|560826843|FG001|Overall Study|Subject moved to different country|0|||
155380375|NCT02647866|560826844|FG002|Overall Study|Subject moved to different country|0|||
155380376|NCT02647866|560826845|FG003|Overall Study|Subject moved to different country|0|||
155380377|NCT02647866|560826846|FG004|Overall Study|Subject moved to different country|0|||
155380378|NCT03618823|560826847|FG000|Overall Study|Lost to Follow-up|63|||
155380379|NCT03618823|560826848|FG001|Overall Study|Lost to Follow-up|61|||
155380380|NCT02334423|560826851|FG000|Overall Study|Protocol Violation|10|||
155380381|NCT02334423|560826852|FG001|Overall Study|Protocol Violation|3|||
155380382|NCT02224690|560826856|FG000|Overall Study|Adverse Event|8|||
155380383|NCT02224690|560826857|FG001|Overall Study|Adverse Event|1|||
155380384|NCT02224690|560826856|FG000|Overall Study|Met Withdrawal Criteria|4|||
155380385|NCT02224690|560826857|FG001|Overall Study|Met Withdrawal Criteria|0|||
155380386|NCT02224690|560826856|FG000|Overall Study|Use of G-tube|1|||
155380387|NCT02224690|560826857|FG001|Overall Study|Use of G-tube|0|||
155380388|NCT02224690|560826856|FG000|Overall Study|Did not meet eligibility criteria|1|||
155380389|NCT02224690|560826857|FG001|Overall Study|Did not meet eligibility criteria|0|||
155380390|NCT02962960|560826858|FG000|Overall Study|Withdrawal by Subject|1|||
155380391|NCT02962960|560826859|FG001|Overall Study|Withdrawal by Subject|1|||
155380392|NCT02962960|560826860|FG002|Overall Study|Withdrawal by Subject|0|||
155380393|NCT02962960|560826858|FG000|Overall Study|Adverse Event|1|||
155380394|NCT02962960|560826859|FG001|Overall Study|Adverse Event|1|||
155380395|NCT02962960|560826860|FG002|Overall Study|Adverse Event|0|||
155380396|NCT02962960|560826858|FG000|Overall Study|Protocol Violation|1|||
155380397|NCT02962960|560826859|FG001|Overall Study|Protocol Violation|0|||
155380398|NCT02962960|560826860|FG002|Overall Study|Protocol Violation|0|||
155380399|NCT00528645|560826862|FG000|Overall Study|Adverse Event|3|||
155380400|NCT01154010|560826863|FG000|Overall Study|Lost to Follow-up|0|||
155380401|NCT01154010|560826864|FG001|Overall Study|Lost to Follow-up|1|||
154924695|NCT03759340|559148068|FG000|Overall Study|Withdrawal by Subject|15|||
154924696|NCT03759340|559148068|FG000|Overall Study|Study Terminated by Sponsor|38|||
154924697|NCT03795233|559148069|FG000|Overall Study|Withdrawal by Subject|2|||
154924698|NCT03795233|559148070|FG001|Overall Study|Withdrawal by Subject|1|||
154924699|NCT03795233|559148069|FG000|Overall Study|Lost to Follow-up|1|||
154924700|NCT03795233|559148070|FG001|Overall Study|Lost to Follow-up|0|||
154924701|NCT03795233|559148069|FG000|Overall Study|Death|1|||
154924702|NCT03795233|559148070|FG001|Overall Study|Death|0|||
155380402|NCT00439231|560826865|FG000|Overall Study|Lack of Efficacy|28|||
155380403|NCT02413333|560826871|FG000|Period 1|Adverse Event|1|||
155380404|NCT02413333|560826872|FG001|Period 1|Adverse Event|0|||
155380405|NCT02413333|560826871|FG000|Period 1|Reason Not Specified|0|||
155380406|NCT02413333|560826872|FG001|Period 1|Reason Not Specified|1|||
155380407|NCT02413333|560826871|FG000|Period 2|Protocol Deviation|1|||
155380408|NCT02413333|560826872|FG001|Period 2|Protocol Deviation|0|||
155380409|NCT01465347|560826873|FG000|Overall Study|Withdrawal by Subject|1|||
155380410|NCT01465347|560826874|FG001|Overall Study|Withdrawal by Subject|1|||
155380411|NCT01465347|560826873|FG000|Overall Study|Physician Decision|0|||
155380412|NCT01465347|560826874|FG001|Overall Study|Physician Decision|1|||
155380413|NCT01465347|560826873|FG000|Overall Study|Admitted to hospice|0|||
155380414|NCT01465347|560826874|FG001|Overall Study|Admitted to hospice|1|||
155380415|NCT02996474|560826875|FG000|Overall Study|Physician Decision|5|||
155380416|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
155380417|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
155380418|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
155380419|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
155380420|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
155380421|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
154924703|NCT02756182|559148071|FG000|Overall Study|StudyTechnical Difficulties|4|||
154924704|NCT01054443|559148072|FG000|Overall Study|Withdrawal by Subject|0|||
155380422|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
155380423|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
155380424|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
155380425|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
155380426|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
155380427|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
155380428|NCT04493502|560826876|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
155380429|NCT04493502|560826877|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
155380430|NCT04493502|560826876|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
155380431|NCT04493502|560826877|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
155380432|NCT04493502|560826876|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
155380433|NCT04493502|560826877|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
155380434|NCT04493502|560826876|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
155380435|NCT04493502|560826877|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
155380436|NCT04493502|560826876|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
155380437|NCT04493502|560826877|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
155380438|NCT04493502|560826876|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
155380439|NCT04493502|560826877|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
155380440|NCT04493502|560826876|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
155380441|NCT04493502|560826877|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
155380442|NCT02891837|560826878|FG000|Overall Study|Lost to Follow-up|2|||
155380443|NCT02891837|560826879|FG001|Overall Study|Lost to Follow-up|0|||
155380444|NCT02891837|560826878|FG000|Overall Study|Withdrawal by Subject|1|||
155380445|NCT02891837|560826879|FG001|Overall Study|Withdrawal by Subject|0|||
155380446|NCT00709852|560826880|FG000|Period 1|Adverse Event|2|||
155380447|NCT00709852|560826881|FG001|Period 1|Adverse Event|0|||
155380448|NCT00709852|560826880|FG000|Period 1|Withdrawal by Subject|4|||
155380449|NCT00709852|560826881|FG001|Period 1|Withdrawal by Subject|2|||
155380450|NCT00709852|560826880|FG000|Period 1|Protocol Violation|1|||
155380451|NCT00709852|560826881|FG001|Period 1|Protocol Violation|0|||
155380452|NCT00709852|560826880|FG000|Period 1|Defective scanner|0|||
155380453|NCT00709852|560826881|FG001|Period 1|Defective scanner|1|||
155380454|NCT00709852|560826880|FG000|Period 1|Lost to Follow-up|1|||
155380455|NCT00709852|560826881|FG001|Period 1|Lost to Follow-up|0|||
155380456|NCT00709852|560826880|FG000|Period 2|Protocol Violation|4|||
155380457|NCT00709852|560826881|FG001|Period 2|Protocol Violation|1|||
155380458|NCT00709852|560826880|FG000|Period 2|Adverse Event|1|||
155380459|NCT00709852|560826881|FG001|Period 2|Adverse Event|1|||
155380460|NCT00709852|560826880|FG000|Period 2|Lost to Follow-up|1|||
155380461|NCT00709852|560826881|FG001|Period 2|Lost to Follow-up|0|||
155380462|NCT00709852|560826880|FG000|Period 2|No 72-hour follow-up|3|||
155380463|NCT00709852|560826881|FG001|Period 2|No 72-hour follow-up|0|||
155380464|NCT00185965|560826882|FG000|Overall Study|Adverse Event|0|||
155380465|NCT00185965|560826883|FG001|Overall Study|Adverse Event|1|||
155380466|NCT01048671|560826884|FG000|Overall Study|Protocol Violation|0|||
155380467|NCT01048671|560826885|FG001|Overall Study|Protocol Violation|1|||
155380468|NCT01048671|560826886|FG002|Overall Study|Protocol Violation|1|||
155380469|NCT00296400|560826890|FG000|Overall Study|Adverse Event|7|||
155380470|NCT00296400|560826891|FG001|Overall Study|Adverse Event|7|||
155380471|NCT00296400|560826892|FG002|Overall Study|Adverse Event|7|||
155380472|NCT00296400|560826890|FG000|Overall Study|Withdrawal by Subject|5|||
155380473|NCT00296400|560826891|FG001|Overall Study|Withdrawal by Subject|6|||
155380474|NCT00296400|560826892|FG002|Overall Study|Withdrawal by Subject|2|||
155380475|NCT00296400|560826890|FG000|Overall Study|Incorrect enrollment|2|||
155380476|NCT00296400|560826891|FG001|Overall Study|Incorrect enrollment|0|||
155380477|NCT00296400|560826892|FG002|Overall Study|Incorrect enrollment|0|||
155380478|NCT00296400|560826890|FG000|Overall Study|Protocol Violation|1|||
155380479|NCT00296400|560826891|FG001|Overall Study|Protocol Violation|1|||
155380480|NCT00296400|560826892|FG002|Overall Study|Protocol Violation|1|||
155380481|NCT00296400|560826890|FG000|Overall Study|Lost to Follow-up|1|||
155380482|NCT00296400|560826891|FG001|Overall Study|Lost to Follow-up|1|||
155380483|NCT00296400|560826892|FG002|Overall Study|Lost to Follow-up|2|||
155380484|NCT00296400|560826890|FG000|Overall Study|Study specific discontinuation criteria|0|||
155380485|NCT00296400|560826891|FG001|Overall Study|Study specific discontinuation criteria|0|||
155380486|NCT00296400|560826892|FG002|Overall Study|Study specific discontinuation criteria|1|||
155380487|NCT00296400|560826890|FG000|Overall Study|Visit 10 was performed earlier|0|||
155380488|NCT00296400|560826891|FG001|Overall Study|Visit 10 was performed earlier|1|||
155380489|NCT00296400|560826892|FG002|Overall Study|Visit 10 was performed earlier|0|||
155380490|NCT00296400|560826890|FG000|Overall Study|Pregnancy|1|||
155380491|NCT00296400|560826891|FG001|Overall Study|Pregnancy|2|||
155380492|NCT00296400|560826892|FG002|Overall Study|Pregnancy|0|||
155380493|NCT00513604|560826893|FG000|Overall Study|Not treated|2|||
155380494|NCT00513604|560826894|FG001|Overall Study|Not treated|0|||
155380495|NCT00513604|560826895|FG002|Overall Study|Not treated|1|||
155380496|NCT00513604|560826896|FG003|Overall Study|Not treated|0|||
155380497|NCT00513604|560826897|FG004|Overall Study|Not treated|0|||
155380498|NCT00513604|560826893|FG000|Overall Study|Death during treatment|0|||
155380499|NCT00513604|560826894|FG001|Overall Study|Death during treatment|3|||
155380500|NCT00513604|560826895|FG002|Overall Study|Death during treatment|2|||
155380501|NCT00513604|560826896|FG003|Overall Study|Death during treatment|0|||
155380502|NCT00513604|560826897|FG004|Overall Study|Death during treatment|0|||
155380503|NCT02433340|560826902|FG000|Overall Study|Adverse Event|0|||
155380504|NCT02433340|560826903|FG001|Overall Study|Adverse Event|0|||
155380505|NCT02433340|560826904|FG002|Overall Study|Adverse Event|1|||
155380506|NCT02433340|560826905|FG003|Overall Study|Adverse Event|0|||
155380507|NCT02433340|560826902|FG000|Overall Study|Withdrawal by Subject|1|||
155152516|NCT03037385|559996843|FG001|Overall Study|Lost to Follow-up|0|||
155380508|NCT02433340|560826903|FG001|Overall Study|Withdrawal by Subject|0|||
155380509|NCT02433340|560826904|FG002|Overall Study|Withdrawal by Subject|1|||
155380510|NCT02433340|560826905|FG003|Overall Study|Withdrawal by Subject|2|||
155380511|NCT02433340|560826902|FG000|Overall Study|Lost to Follow-up|0|||
155380512|NCT02433340|560826903|FG001|Overall Study|Lost to Follow-up|1|||
155380513|NCT02433340|560826904|FG002|Overall Study|Lost to Follow-up|0|||
155380514|NCT02433340|560826905|FG003|Overall Study|Lost to Follow-up|0|||
155380515|NCT02433340|560826902|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
155380516|NCT02433340|560826903|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
155380517|NCT02433340|560826904|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
154924705|NCT01054443|559148073|FG001|Overall Study|Withdrawal by Subject|0|||
154924706|NCT01054443|559148074|FG002|Overall Study|Withdrawal by Subject|0|||
154924707|NCT01054443|559148075|FG003|Overall Study|Withdrawal by Subject|1|||
154924708|NCT00985114|559148077|FG000|Overall Study|Adverse Event|1|||
154924709|NCT00985114|559148078|FG001|Overall Study|Adverse Event|0|||
154924710|NCT00985114|559148077|FG000|Overall Study|Withdrawal by Subject|0|||
154924711|NCT00985114|559148078|FG001|Overall Study|Withdrawal by Subject|2|||
154924712|NCT02950831|559148079|FG000|Overall Study|Lost to Follow-up|1|||
154924713|NCT02950831|559148079|FG000|Overall Study|Withdrawal by Subject|3|||
154924714|NCT02950831|559148079|FG000|Overall Study|stimulation trail failure|5|||
154924715|NCT01003691|559148082|FG000|Overall Study|Adverse Event|0|||
154924716|NCT01003691|559148083|FG001|Overall Study|Adverse Event|0|||
154924717|NCT01003691|559148084|FG002|Overall Study|Adverse Event|0|||
154924718|NCT01003691|559148085|FG003|Overall Study|Adverse Event|1|||
154924719|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
154924720|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
154924721|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
154924722|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
154924723|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
154924724|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
154924725|NCT00828009|559148090|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
154924726|NCT00828009|559148090|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
154924727|NCT00828009|559148090|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
154924728|NCT00828009|559148090|FG000|Step 2 - Maintenance Therapy|Death|1|||
154924729|NCT00828009|559148090|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
154924730|NCT00828009|559148090|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
154924731|NCT00828009|559148090|FG000|Step 2 - Maintenance Therapy|Other|1|||
154924732|NCT01676818|559148094|FG000|Overall Study|Physician Decision|1|||
154924733|NCT01676818|559148094|FG000|Overall Study|Withdrawal by Subject|1|||
154966743|NCT02011945|559301135|FG002|Overall Study|No Longer Meets Study Criteria|0|||
154966744|NCT02011945|559301133|FG000|Overall Study|Proceeded to stem cell transplant|0|||
154966745|NCT02011945|559301134|FG001|Overall Study|Proceeded to stem cell transplant|0|||
154966746|NCT02011945|559301135|FG002|Overall Study|Proceeded to stem cell transplant|1|||
154966747|NCT02011945|559301133|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
154966748|NCT02011945|559301134|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
154966749|NCT02011945|559301135|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
154966750|NCT00902538|559301136|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
154966751|NCT00902538|559301137|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
154966752|NCT00902538|559301138|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
154966753|NCT00902538|559301139|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
154966754|NCT00902538|559301140|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
154966755|NCT00902538|559301141|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
155380518|NCT02433340|560826905|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
155380519|NCT02433340|560826902|FG000|Overall Study|Other|0|||
155380520|NCT02433340|560826903|FG001|Overall Study|Other|1|||
155380521|NCT02433340|560826904|FG002|Overall Study|Other|0|||
155380522|NCT02433340|560826905|FG003|Overall Study|Other|0|||
155380523|NCT01178385|560826906|FG000|Overall Study|Withdrawal by Subject|2|||
155380524|NCT01178385|560826907|FG001|Overall Study|Withdrawal by Subject|0|||
155380525|NCT00985946|560826912|FG000|Overall Study|Lost to Follow-up|6|||
155380526|NCT00985946|560826912|FG000|Overall Study|Withdrawal by Subject|1|||
155380527|NCT02679508|560826914|FG000|Healing Phase|Protocol Violation|1|||
155380528|NCT02679508|560826915|FG001|Healing Phase|Protocol Violation|1|||
155380529|NCT02679508|560826914|FG000|Healing Phase|Lost to Follow-up|1|||
155380530|NCT02679508|560826915|FG001|Healing Phase|Lost to Follow-up|0|||
154966756|NCT00902538|559301136|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
154966757|NCT00902538|559301137|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
154966758|NCT00902538|559301138|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
154966759|NCT00902538|559301139|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
154966760|NCT00902538|559301140|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
154966761|NCT00902538|559301141|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
155380531|NCT02679508|560826914|FG000|Maintenance Phase|Adverse Event|12|||
155380532|NCT02679508|560826915|FG001|Maintenance Phase|Adverse Event|2|||
155380533|NCT02679508|560826914|FG000|Maintenance Phase|Lost to Follow-up|0|||
155380534|NCT02679508|560826915|FG001|Maintenance Phase|Lost to Follow-up|1|||
155380535|NCT02679508|560826914|FG000|Maintenance Phase|Withdrawal by Subject|15|||
155380536|NCT02679508|560826915|FG001|Maintenance Phase|Withdrawal by Subject|8|||
155380537|NCT02679508|560826914|FG000|Maintenance Phase|Other|5|||
155380538|NCT02679508|560826915|FG001|Maintenance Phase|Other|4|||
155380539|NCT03538301|560826916|FG000|Overall Study|Adverse Event|1|||
155380540|NCT03538301|560826917|FG001|Overall Study|Adverse Event|4|||
155380541|NCT03538301|560826918|FG002|Overall Study|Adverse Event|4|||
155380542|NCT03538301|560826916|FG000|Overall Study|Death|1|||
155380543|NCT03538301|560826917|FG001|Overall Study|Death|1|||
155380544|NCT03538301|560826918|FG002|Overall Study|Death|0|||
155380545|NCT03538301|560826916|FG000|Overall Study|Physician Decision|0|||
155380546|NCT03538301|560826917|FG001|Overall Study|Physician Decision|1|||
155380547|NCT03538301|560826918|FG002|Overall Study|Physician Decision|0|||
155380548|NCT03538301|560826916|FG000|Overall Study|Protocol Violation|0|||
155380549|NCT03538301|560826917|FG001|Overall Study|Protocol Violation|0|||
155380550|NCT03538301|560826918|FG002|Overall Study|Protocol Violation|1|||
155380551|NCT03538301|560826916|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
155380552|NCT03538301|560826917|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
155380553|NCT03538301|560826918|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
155380554|NCT05326815|560826920|FG000|Overall Study|Withdrawal by Subject|3|||
155380555|NCT05326815|560826920|FG000|Overall Study|Did not complete required labs|6|||
155380556|NCT05326815|560826920|FG000|Overall Study|Screen fail- abnormal labs|5|||
155380557|NCT02631577|560826921|FG000|Overall Study|Death|1|||
155380558|NCT02631577|560826922|FG001|Overall Study|Death|7|||
155380559|NCT02631577|560826921|FG000|Overall Study|Withdrawal by Subject|0|||
155380560|NCT02631577|560826922|FG001|Overall Study|Withdrawal by Subject|3|||
155380561|NCT00979134|560826925|FG000|Overall Study|Disease progression|18|||
155380562|NCT00979134|560826926|FG001|Overall Study|Disease progression|2|||
155380563|NCT00979134|560826927|FG002|Overall Study|Disease progression|5|||
155380564|NCT00979134|560826925|FG000|Overall Study|Adverse Event|0|||
155380565|NCT00979134|560826926|FG001|Overall Study|Adverse Event|0|||
154924734|NCT01100073|559149356|FG000|Overall Study|Lack of Efficacy|4|||
154924735|NCT01100073|559149356|FG000|Overall Study|Insufficient Tolerability|21|||
155380566|NCT00979134|560826927|FG002|Overall Study|Adverse Event|2|||
155380567|NCT00979134|560826925|FG000|Overall Study|Withdrawal by Subject|1|||
155380568|NCT00979134|560826926|FG001|Overall Study|Withdrawal by Subject|1|||
155380569|NCT00979134|560826927|FG002|Overall Study|Withdrawal by Subject|2|||
155380570|NCT00979134|560826925|FG000|Overall Study|Lost to Follow-up|2|||
155380571|NCT00979134|560826926|FG001|Overall Study|Lost to Follow-up|2|||
155380572|NCT00979134|560826927|FG002|Overall Study|Lost to Follow-up|0|||
155380573|NCT00979134|560826925|FG000|Overall Study|Death|4|||
155380574|NCT00979134|560826926|FG001|Overall Study|Death|0|||
155380575|NCT00979134|560826927|FG002|Overall Study|Death|26|||
155380576|NCT00979134|560826925|FG000|Overall Study|Other|8|||
155380577|NCT00979134|560826926|FG001|Overall Study|Other|1|||
155380578|NCT00979134|560826927|FG002|Overall Study|Other|5|||
155380579|NCT05172050|560826928|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
155380580|NCT05172050|560826929|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
155380581|NCT05172050|560826930|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
155380582|NCT05172050|560826928|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
155380583|NCT05172050|560826929|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
155380584|NCT05172050|560826930|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
155380585|NCT05172050|560826928|FG000|Overall Study|Other|2|||
155380586|NCT05172050|560826929|FG001|Overall Study|Other|2|||
155380587|NCT05172050|560826930|FG002|Overall Study|Other|1|||
155380588|NCT05917470|560826931|FG000|Overall Study|Progressive Disease|1|||
155380589|NCT05917470|560826932|FG001|Overall Study|Progressive Disease|1|||
155380590|NCT05917470|560826933|FG002|Overall Study|Progressive Disease|2|||
155380591|NCT05917470|560826934|FG003|Overall Study|Progressive Disease|3|||
155380592|NCT05917470|560826935|FG004|Overall Study|Progressive Disease|1|||
155380593|NCT05917470|560826936|FG005|Overall Study|Progressive Disease|1|||
155380594|NCT05917470|560826937|FG006|Overall Study|Progressive Disease|0|||
155380595|NCT05917470|560826938|FG007|Overall Study|Progressive Disease|0|||
155380596|NCT05917470|560826931|FG000|Overall Study|Withdrawal by Subject|0|||
155380597|NCT05917470|560826932|FG001|Overall Study|Withdrawal by Subject|0|||
155380598|NCT05917470|560826933|FG002|Overall Study|Withdrawal by Subject|1|||
155380599|NCT05917470|560826934|FG003|Overall Study|Withdrawal by Subject|0|||
155380600|NCT05917470|560826935|FG004|Overall Study|Withdrawal by Subject|0|||
154924736|NCT01100073|559149356|FG000|Overall Study|Withdrawal by Subject|13|||
155380601|NCT05917470|560826936|FG005|Overall Study|Withdrawal by Subject|0|||
155380602|NCT05917470|560826937|FG006|Overall Study|Withdrawal by Subject|0|||
155380603|NCT05917470|560826938|FG007|Overall Study|Withdrawal by Subject|0|||
155380604|NCT05917470|560826931|FG000|Overall Study|Sponsor Decision|0|||
155380605|NCT05917470|560826932|FG001|Overall Study|Sponsor Decision|0|||
155380606|NCT05917470|560826933|FG002|Overall Study|Sponsor Decision|1|||
155380607|NCT05917470|560826934|FG003|Overall Study|Sponsor Decision|0|||
154924737|NCT01100073|559149356|FG000|Overall Study|Lost to Follow-up|39|||
154924738|NCT01100073|559149356|FG000|Overall Study|Lack of effect + patient's wish|2|||
154924739|NCT01100073|559149356|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
154924740|NCT01100073|559149356|FG000|Overall Study|Other|8|||
154924741|NCT01100073|559149356|FG000|Overall Study|Missing|5|||
154924742|NCT03099265|559149357|FG000|Overall Study|Adverse Event|1|||
154924743|NCT01656850|559149362|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
154924744|NCT01656850|559149363|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
155380608|NCT05917470|560826935|FG004|Overall Study|Sponsor Decision|2|||
155380609|NCT05917470|560826936|FG005|Overall Study|Sponsor Decision|1|||
155380610|NCT05917470|560826937|FG006|Overall Study|Sponsor Decision|3|||
155380611|NCT05917470|560826938|FG007|Overall Study|Sponsor Decision|3|||
155380612|NCT05917470|560826931|FG000|Overall Study|Adverse Event|0|||
155380613|NCT05917470|560826932|FG001|Overall Study|Adverse Event|0|||
155380614|NCT05917470|560826933|FG002|Overall Study|Adverse Event|0|||
155380615|NCT05917470|560826934|FG003|Overall Study|Adverse Event|0|||
155380616|NCT05917470|560826935|FG004|Overall Study|Adverse Event|0|||
155380617|NCT05917470|560826936|FG005|Overall Study|Adverse Event|1|||
155380618|NCT05917470|560826937|FG006|Overall Study|Adverse Event|0|||
155380619|NCT05917470|560826938|FG007|Overall Study|Adverse Event|0|||
155380620|NCT01586910|560828593|FG000|Overall Study|Death|4|||
155380621|NCT01586910|560828594|FG001|Overall Study|Death|4|||
155380622|NCT01586910|560828593|FG000|Overall Study|Withdrawal by Subject|6|||
155380623|NCT01586910|560828594|FG001|Overall Study|Withdrawal by Subject|43|||
155380624|NCT01586910|560828593|FG000|Overall Study|Physician withdrew Subject|5|||
155380625|NCT01586910|560828594|FG001|Overall Study|Physician withdrew Subject|24|||
154924745|NCT02074982|559149364|FG000|Overall Study|Adverse Event|15|||
154924746|NCT02074982|559149365|FG001|Overall Study|Adverse Event|7|||
154924747|NCT02074982|559149364|FG000|Overall Study|Lack of Efficacy|6|||
154924748|NCT02074982|559149365|FG001|Overall Study|Lack of Efficacy|1|||
154924749|NCT02074982|559149364|FG000|Overall Study|Lost to Follow-up|9|||
154924750|NCT02074982|559149365|FG001|Overall Study|Lost to Follow-up|10|||
154924751|NCT02074982|559149364|FG000|Overall Study|Non-compliance with study treatment|0|||
154924752|NCT02074982|559149365|FG001|Overall Study|Non-compliance with study treatment|2|||
154924753|NCT02074982|559149364|FG000|Overall Study|Physician Decision|1|||
154924754|NCT02074982|559149365|FG001|Overall Study|Physician Decision|1|||
154924755|NCT02074982|559149364|FG000|Overall Study|Pregnancy|1|||
154924756|NCT02074982|559149365|FG001|Overall Study|Pregnancy|2|||
154924757|NCT02074982|559149364|FG000|Overall Study|Protocol deviation|4|||
154924758|NCT02074982|559149365|FG001|Overall Study|Protocol deviation|3|||
154924759|NCT02074982|559149364|FG000|Overall Study|Technical problems|0|||
154924760|NCT02074982|559149365|FG001|Overall Study|Technical problems|2|||
154924761|NCT02074982|559149364|FG000|Overall Study|Subject/guardian decision|15|||
155380626|NCT00953407|560828595|FG000|Overall Study|Failed inclusion criteria|1|||
154924762|NCT02074982|559149365|FG001|Overall Study|Subject/guardian decision|24|||
154924763|NCT02074982|559149364|FG000|Overall Study|Death|0|||
154924764|NCT02074982|559149365|FG001|Overall Study|Death|2|||
154924765|NCT02094573|559149368|FG000|Overall Study|Adverse Event|4|||
154924766|NCT02094573|559149369|FG001|Overall Study|Adverse Event|14|||
154924767|NCT02094573|559149368|FG000|Overall Study|Clinical Progressive Disease|9|||
154924768|NCT02094573|559149369|FG001|Overall Study|Clinical Progressive Disease|13|||
154924769|NCT02094573|559149368|FG000|Overall Study|Death|11|||
154924770|NCT02094573|559149369|FG001|Overall Study|Death|3|||
154924771|NCT02094573|559149368|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
154924772|NCT02094573|559149369|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
154924773|NCT02094573|559149368|FG000|Overall Study|Non-compliance with Study Drug|1|||
154924774|NCT02094573|559149369|FG001|Overall Study|Non-compliance with Study Drug|1|||
155380627|NCT00953407|560828596|FG001|Overall Study|Failed inclusion criteria|1|||
155380628|NCT00953407|560828597|FG002|Overall Study|Failed inclusion criteria|1|||
155380629|NCT00953407|560828598|FG003|Overall Study|Failed inclusion criteria|1|||
155380630|NCT00953407|560828599|FG004|Overall Study|Failed inclusion criteria|1|||
155380631|NCT00953407|560828595|FG000|Overall Study|Lost to Follow-up|0|||
155380632|NCT00953407|560828596|FG001|Overall Study|Lost to Follow-up|0|||
155380633|NCT00953407|560828597|FG002|Overall Study|Lost to Follow-up|0|||
155380634|NCT00953407|560828598|FG003|Overall Study|Lost to Follow-up|1|||
155380635|NCT00953407|560828599|FG004|Overall Study|Lost to Follow-up|0|||
155380636|NCT02502097|560828600|FG000|Period 1|Adverse Event|0|||
155380637|NCT02502097|560828601|FG001|Period 1|Adverse Event|0|||
155380638|NCT02502097|560828602|FG002|Period 1|Adverse Event|1|||
155380639|NCT02502097|560828603|FG003|Period 1|Adverse Event|0|||
155380640|NCT02502097|560828600|FG000|Wash Out Period|Adverse Event|0|||
155380641|NCT02502097|560828601|FG001|Wash Out Period|Adverse Event|1|||
155380642|NCT02502097|560828602|FG002|Wash Out Period|Adverse Event|1|||
154924775|NCT02094573|559149368|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
154924776|NCT02094573|559149369|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
154924777|NCT02094573|559149368|FG000|Overall Study|Physician Decision|4|||
155380643|NCT02502097|560828603|FG003|Wash Out Period|Adverse Event|1|||
155380644|NCT02502097|560828600|FG000|Period 2|Adverse Event|0|||
155380645|NCT02502097|560828601|FG001|Period 2|Adverse Event|0|||
155380646|NCT02502097|560828602|FG002|Period 2|Adverse Event|1|||
155380647|NCT02502097|560828603|FG003|Period 2|Adverse Event|0|||
155380648|NCT01111474|560828604|FG000|Overall Study|Lost to Follow-up|12|||
155380649|NCT02518490|560828614|FG000|Overall Study|Withdrawal by Subject|1|||
155380650|NCT02518490|560828615|FG001|Overall Study|Withdrawal by Subject|1|||
155380651|NCT00346632|560828616|FG000|Overall Study|Progressive Disease|2|||
155380652|NCT00346632|560828617|FG001|Overall Study|Progressive Disease|2|||
155380653|NCT00346632|560828618|FG002|Overall Study|Progressive Disease|4|||
155380654|NCT00346632|560828619|FG003|Overall Study|Progressive Disease|3|||
155380655|NCT00346632|560828620|FG004|Overall Study|Progressive Disease|3|||
155380656|NCT00346632|560828621|FG005|Overall Study|Progressive Disease|1|||
155380657|NCT00346632|560828622|FG006|Overall Study|Progressive Disease|2|||
155380658|NCT00346632|560828623|FG007|Overall Study|Progressive Disease|2|||
155380659|NCT00346632|560828624|FG008|Overall Study|Progressive Disease|2|||
155380660|NCT00346632|560828625|FG009|Overall Study|Progressive Disease|2|||
155380661|NCT00346632|560828616|FG000|Overall Study|Adverse Event|0|||
155380662|NCT00346632|560828617|FG001|Overall Study|Adverse Event|0|||
155380663|NCT00346632|560828618|FG002|Overall Study|Adverse Event|0|||
155380664|NCT00346632|560828619|FG003|Overall Study|Adverse Event|0|||
155380665|NCT00346632|560828620|FG004|Overall Study|Adverse Event|1|||
155380666|NCT00346632|560828621|FG005|Overall Study|Adverse Event|1|||
155380667|NCT00346632|560828622|FG006|Overall Study|Adverse Event|1|||
155380668|NCT00346632|560828623|FG007|Overall Study|Adverse Event|0|||
155380669|NCT00346632|560828624|FG008|Overall Study|Adverse Event|0|||
155380670|NCT00346632|560828625|FG009|Overall Study|Adverse Event|0|||
155380671|NCT00346632|560828616|FG000|Overall Study|Death|0|||
155380672|NCT00346632|560828617|FG001|Overall Study|Death|0|||
155380673|NCT00346632|560828618|FG002|Overall Study|Death|1|||
155380674|NCT00346632|560828619|FG003|Overall Study|Death|0|||
155380675|NCT00346632|560828620|FG004|Overall Study|Death|0|||
155380676|NCT00346632|560828621|FG005|Overall Study|Death|0|||
155380677|NCT00346632|560828622|FG006|Overall Study|Death|0|||
155380678|NCT00346632|560828623|FG007|Overall Study|Death|0|||
155380679|NCT00346632|560828624|FG008|Overall Study|Death|0|||
155380680|NCT00346632|560828625|FG009|Overall Study|Death|0|||
155380681|NCT00346632|560828616|FG000|Overall Study|Protocol Violation|0|||
155380682|NCT00346632|560828617|FG001|Overall Study|Protocol Violation|0|||
155380683|NCT00346632|560828618|FG002|Overall Study|Protocol Violation|0|||
155380684|NCT00346632|560828619|FG003|Overall Study|Protocol Violation|0|||
155380685|NCT00346632|560828620|FG004|Overall Study|Protocol Violation|0|||
155380686|NCT00346632|560828621|FG005|Overall Study|Protocol Violation|0|||
155380687|NCT00346632|560828622|FG006|Overall Study|Protocol Violation|1|||
155380688|NCT00346632|560828623|FG007|Overall Study|Protocol Violation|0|||
155380689|NCT00346632|560828624|FG008|Overall Study|Protocol Violation|0|||
155380690|NCT00346632|560828625|FG009|Overall Study|Protocol Violation|0|||
155380691|NCT00346632|560828616|FG000|Overall Study|Withdrawal by Subject|0|||
155380692|NCT00346632|560828617|FG001|Overall Study|Withdrawal by Subject|0|||
155380693|NCT00346632|560828618|FG002|Overall Study|Withdrawal by Subject|0|||
155380694|NCT00346632|560828619|FG003|Overall Study|Withdrawal by Subject|0|||
155380695|NCT00346632|560828620|FG004|Overall Study|Withdrawal by Subject|0|||
155380696|NCT00346632|560828621|FG005|Overall Study|Withdrawal by Subject|0|||
155380697|NCT00346632|560828622|FG006|Overall Study|Withdrawal by Subject|1|||
155380698|NCT00346632|560828623|FG007|Overall Study|Withdrawal by Subject|0|||
155380699|NCT00346632|560828624|FG008|Overall Study|Withdrawal by Subject|0|||
155380700|NCT00346632|560828625|FG009|Overall Study|Withdrawal by Subject|0|||
155380701|NCT00346632|560828616|FG000|Overall Study|Switched to alternative treatment|0|||
155380702|NCT00346632|560828617|FG001|Overall Study|Switched to alternative treatment|0|||
155380703|NCT00346632|560828618|FG002|Overall Study|Switched to alternative treatment|1|||
155380704|NCT00346632|560828619|FG003|Overall Study|Switched to alternative treatment|0|||
155380705|NCT00346632|560828620|FG004|Overall Study|Switched to alternative treatment|0|||
155380706|NCT00346632|560828621|FG005|Overall Study|Switched to alternative treatment|0|||
154924778|NCT02094573|559149369|FG001|Overall Study|Physician Decision|4|||
155152517|NCT03037385|559996844|FG002|Overall Study|Lost to Follow-up|0|||
155380707|NCT00346632|560828622|FG006|Overall Study|Switched to alternative treatment|0|||
155380708|NCT00346632|560828623|FG007|Overall Study|Switched to alternative treatment|0|||
155380709|NCT00346632|560828624|FG008|Overall Study|Switched to alternative treatment|0|||
155380710|NCT00346632|560828625|FG009|Overall Study|Switched to alternative treatment|0|||
155380711|NCT00346632|560828616|FG000|Overall Study|Not Stated|1|||
155380712|NCT00346632|560828617|FG001|Overall Study|Not Stated|1|||
155380713|NCT00346632|560828618|FG002|Overall Study|Not Stated|0|||
155380714|NCT00346632|560828619|FG003|Overall Study|Not Stated|0|||
155380715|NCT00346632|560828620|FG004|Overall Study|Not Stated|0|||
155380716|NCT00346632|560828621|FG005|Overall Study|Not Stated|0|||
155380717|NCT00346632|560828622|FG006|Overall Study|Not Stated|0|||
155380718|NCT00346632|560828623|FG007|Overall Study|Not Stated|2|||
155380719|NCT00346632|560828624|FG008|Overall Study|Not Stated|2|||
155380720|NCT00346632|560828625|FG009|Overall Study|Not Stated|1|||
155380721|NCT02354508|560828628|FG000|Period 1: Core Phase|Adverse Event|1|||
155380722|NCT02354508|560828629|FG001|Period 1: Core Phase|Adverse Event|1|||
155380723|NCT02354508|560828630|FG002|Period 1: Core Phase|Adverse Event|2|||
155380724|NCT02354508|560828628|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
155380725|NCT02354508|560828629|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
155380726|NCT02354508|560828630|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
155380727|NCT02354508|560828628|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
155380728|NCT02354508|560828629|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
155380729|NCT02354508|560828630|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
155380730|NCT02354508|560828628|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
155380731|NCT02354508|560828629|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
155380732|NCT02354508|560828630|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
155380733|NCT02354508|560828628|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
155380734|NCT02354508|560828629|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
155380735|NCT02354508|560828630|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
155380736|NCT02354508|560828628|FG000|Period 2: Extension Phase|Physician Decision|5|||
155380737|NCT02354508|560828629|FG001|Period 2: Extension Phase|Physician Decision|0|||
155380738|NCT02354508|560828630|FG002|Period 2: Extension Phase|Physician Decision|1|||
155380739|NCT02354508|560828628|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
154924779|NCT02094573|559149368|FG000|Overall Study|Site Terminated by Sponsor|10|||
154924780|NCT02094573|559149369|FG001|Overall Study|Site Terminated by Sponsor|17|||
154924781|NCT02094573|559149368|FG000|Overall Study|Withdrawal by Subject|6|||
154924782|NCT02094573|559149369|FG001|Overall Study|Withdrawal by Subject|8|||
154924783|NCT02094573|559149368|FG000|Overall Study|Randomized but not Treated|3|||
154924784|NCT02094573|559149369|FG001|Overall Study|Randomized but not Treated|0|||
154924785|NCT02875340|559149370|FG000|Overall Study|Death|2|||
154924786|NCT02875340|559149370|FG000|Overall Study|Withdrawal by Subject|2|||
154924787|NCT02875340|559149370|FG000|Overall Study|Physician Decision|3|||
154924788|NCT02875340|559149370|FG000|Overall Study|Adverse Event|1|||
154924789|NCT01160770|559149373|FG000|Overall Study|Adverse Event|10|||
154924790|NCT01160770|559149373|FG000|Overall Study|Protocol Violation|2|||
154924791|NCT01160770|559149373|FG000|Overall Study|Subject/parent/caregiver request|33|||
154924792|NCT01160770|559149373|FG000|Overall Study|Physician Decision|1|||
154924793|NCT01160770|559149373|FG000|Overall Study|Lost to Follow-up|7|||
154924794|NCT01160770|559149373|FG000|Overall Study|Study termination or sponsor request|1|||
154924795|NCT01160770|559149373|FG000|Overall Study|Death|9|||
154924796|NCT01160770|559149373|FG000|Overall Study|Lack of Efficacy|15|||
154924797|NCT01160770|559149373|FG000|Overall Study|Other Reasons|1|||
154924798|NCT05279807|559149374|FG000|Overall Study|Withdrawal by Subject|1|||
154924799|NCT05279807|559149375|FG001|Overall Study|Withdrawal by Subject|0|||
154924800|NCT05279807|559149374|FG000|Overall Study|Adverse Event|0|||
154924801|NCT05279807|559149375|FG001|Overall Study|Adverse Event|1|||
154924802|NCT05279807|559149374|FG000|Overall Study|Laboratory Abnormal Results|1|||
154924803|NCT05279807|559149375|FG001|Overall Study|Laboratory Abnormal Results|0|||
154924804|NCT03985982|559149376|FG000|Double-Blind Phase|Lost to Follow-up|4|||
154924805|NCT03985982|559149377|FG001|Double-Blind Phase|Lost to Follow-up|3|||
154924806|NCT03985982|559149378|FG002|Double-Blind Phase|Lost to Follow-up|0|||
154924807|NCT03985982|559149376|FG000|Double-Blind Phase|Physician Decision|1|||
154924808|NCT03985982|559149377|FG001|Double-Blind Phase|Physician Decision|0|||
154924809|NCT03985982|559149378|FG002|Double-Blind Phase|Physician Decision|0|||
154924810|NCT03985982|559149376|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
154924811|NCT03985982|559149377|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
154924812|NCT03985982|559149378|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
154924813|NCT03985982|559149376|FG000|Double-Blind Phase|COVID-19|1|||
154924814|NCT03985982|559149377|FG001|Double-Blind Phase|COVID-19|0|||
154924815|NCT03985982|559149378|FG002|Double-Blind Phase|COVID-19|0|||
154924816|NCT03985982|559149376|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
154924817|NCT03985982|559149377|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
154924818|NCT03985982|559149378|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
154924819|NCT03985982|559149376|FG000|Open-Label Phase|Lost to Follow-up|0|||
154924820|NCT03985982|559149377|FG001|Open-Label Phase|Lost to Follow-up|0|||
154924821|NCT03985982|559149378|FG002|Open-Label Phase|Lost to Follow-up|13|||
154924822|NCT03985982|559149376|FG000|Open-Label Phase|Physician Decision|0|||
154924823|NCT03985982|559149377|FG001|Open-Label Phase|Physician Decision|0|||
154924824|NCT03985982|559149378|FG002|Open-Label Phase|Physician Decision|2|||
154924825|NCT03985982|559149376|FG000|Open-Label Phase|Withdrawal by Subject|0|||
154924826|NCT03985982|559149377|FG001|Open-Label Phase|Withdrawal by Subject|0|||
154924827|NCT03985982|559149378|FG002|Open-Label Phase|Withdrawal by Subject|11|||
154924828|NCT03526549|559149380|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
154924829|NCT03526549|559149381|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
154924830|NCT03526549|559149380|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
155152518|NCT03037385|559996845|FG003|Overall Study|Lost to Follow-up|0|||
155380740|NCT02354508|560828629|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
155380741|NCT02354508|560828630|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
154924831|NCT03526549|559149381|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
154924832|NCT03526549|559149380|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
154924833|NCT03526549|559149381|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
154924834|NCT03526549|559149380|FG000|Open-label Phase|Adverse Event|4|||
154924835|NCT03526549|559149381|FG001|Open-label Phase|Adverse Event|0|||
154924836|NCT03526549|559149380|FG000|Open-label Phase|Withdrawal by Subject|54|||
154924837|NCT03526549|559149381|FG001|Open-label Phase|Withdrawal by Subject|0|||
154924838|NCT03526549|559149380|FG000|Open-label Phase|Lost to Follow-up|35|||
154924839|NCT03526549|559149381|FG001|Open-label Phase|Lost to Follow-up|0|||
154924840|NCT03526549|559149380|FG000|Open-label Phase|Other than Specified|5|||
154924841|NCT03526549|559149381|FG001|Open-label Phase|Other than Specified|0|||
154924842|NCT05981365|559149382|FG000|Period 1|Adverse Event|1|||
154924843|NCT05981365|559149383|FG001|Period 1|Adverse Event|0|||
154924844|NCT05102162|559149388|FG000|Overall Study|Withdrawal by Subject|3|||
154924845|NCT05102162|559149389|FG001|Overall Study|Withdrawal by Subject|0|||
154924846|NCT05102162|559149388|FG000|Overall Study|Baseline cultures negative|4|||
154924847|NCT05102162|559149389|FG001|Overall Study|Baseline cultures negative|2|||
154924848|NCT05102162|559149388|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
154924849|NCT05102162|559149389|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
154924850|NCT05102162|559149388|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
154924851|NCT05102162|559149389|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
154924852|NCT01353586|559149390|FG000|Overall Study|Procedure terminated prior to ablation|3|||
154924853|NCT01353586|559149391|FG001|Overall Study|Procedure terminated prior to ablation|0|||
154924854|NCT01353586|559149390|FG000|Overall Study|Never had insertion of study catheter|4|||
154924855|NCT01353586|559149391|FG001|Overall Study|Never had insertion of study catheter|1|||
154924856|NCT01353586|559149390|FG000|Overall Study|Neurological exam not done|0|||
154924857|NCT01353586|559149391|FG001|Overall Study|Neurological exam not done|1|||
154924858|NCT05027958|559149392|FG000|Overall Study|Lost to Follow-up|1|||
154924859|NCT05027958|559149393|FG001|Overall Study|Lost to Follow-up|1|||
154924860|NCT05027958|559149392|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
154924861|NCT05027958|559149393|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
154924862|NCT05027958|559149392|FG000|Overall Study|Physician Decision|1|||
154924863|NCT05027958|559149393|FG001|Overall Study|Physician Decision|4|||
154924864|NCT05027958|559149392|FG000|Overall Study|Adverse Event|0|||
154924865|NCT05027958|559149393|FG001|Overall Study|Adverse Event|1|||
154924866|NCT02871921|559149394|FG000|Overall Study|Withdrawal by Subject|34|||
154924867|NCT02871921|559149395|FG001|Overall Study|Withdrawal by Subject|27|||
154924868|NCT02871921|559149396|FG002|Overall Study|Withdrawal by Subject|27|||
154924869|NCT02871921|559149397|FG003|Overall Study|Withdrawal by Subject|30|||
154924870|NCT00890409|559149403|FG000|Overall Study|Lost to Follow-up|20|||
154924871|NCT00890409|559149404|FG001|Overall Study|Lost to Follow-up|21|||
154924872|NCT02353572|559149405|FG000|Overall Study|Withdrawal by Subject|1|||
154924873|NCT02353572|559149405|FG000|Overall Study|Study terminated|2|||
154924874|NCT01870921|559149414|FG000|Overall Study|Subject decision|80|||
154924875|NCT01870921|559149414|FG000|Overall Study|Severe non-compliance to protocol|7|||
154924876|NCT01870921|559149414|FG000|Overall Study|Subject Lost to Follow up|2|||
154924877|NCT01870921|559149414|FG000|Overall Study|Other|1|||
154924878|NCT02060188|559149418|FG000|Overall Study|Disease Progression|36|||
154924879|NCT02060188|559149419|FG001|Overall Study|Disease Progression|42|||
154924880|NCT02060188|559149420|FG002|Overall Study|Disease Progression|8|||
154924881|NCT02060188|559149421|FG003|Overall Study|Disease Progression|5|||
154924882|NCT02060188|559149422|FG004|Overall Study|Disease Progression|6|||
154924883|NCT02060188|559149423|FG005|Overall Study|Disease Progression|3|||
154924884|NCT02060188|559149424|FG006|Overall Study|Disease Progression|23|||
154924885|NCT02060188|559149425|FG007|Overall Study|Disease Progression|20|||
154924886|NCT02060188|559149426|FG008|Overall Study|Disease Progression|43|||
154924887|NCT02060188|559149418|FG000|Overall Study|Study Drug Toxicity|10|||
154924888|NCT02060188|559149419|FG001|Overall Study|Study Drug Toxicity|18|||
154924889|NCT02060188|559149420|FG002|Overall Study|Study Drug Toxicity|7|||
154924890|NCT02060188|559149421|FG003|Overall Study|Study Drug Toxicity|4|||
154924891|NCT02060188|559149422|FG004|Overall Study|Study Drug Toxicity|3|||
154924892|NCT02060188|559149423|FG005|Overall Study|Study Drug Toxicity|0|||
154924893|NCT02060188|559149424|FG006|Overall Study|Study Drug Toxicity|2|||
154924894|NCT02060188|559149425|FG007|Overall Study|Study Drug Toxicity|5|||
154924895|NCT02060188|559149426|FG008|Overall Study|Study Drug Toxicity|0|||
154924896|NCT02060188|559149418|FG000|Overall Study|Adverse event unrelated to study drug|2|||
154924897|NCT02060188|559149419|FG001|Overall Study|Adverse event unrelated to study drug|5|||
154924898|NCT02060188|559149420|FG002|Overall Study|Adverse event unrelated to study drug|6|||
154924899|NCT02060188|559149421|FG003|Overall Study|Adverse event unrelated to study drug|0|||
154924900|NCT02060188|559149422|FG004|Overall Study|Adverse event unrelated to study drug|1|||
154924901|NCT02060188|559149423|FG005|Overall Study|Adverse event unrelated to study drug|0|||
154924902|NCT02060188|559149424|FG006|Overall Study|Adverse event unrelated to study drug|4|||
154924903|NCT02060188|559149425|FG007|Overall Study|Adverse event unrelated to study drug|4|||
154924904|NCT02060188|559149426|FG008|Overall Study|Adverse event unrelated to study drug|1|||
154924905|NCT02060188|559149418|FG000|Overall Study|Participant request to discontinue study treatment|7|||
154924906|NCT02060188|559149419|FG001|Overall Study|Participant request to discontinue study treatment|7|||
154924907|NCT02060188|559149420|FG002|Overall Study|Participant request to discontinue study treatment|4|||
154924908|NCT02060188|559149421|FG003|Overall Study|Participant request to discontinue study treatment|0|||
154924909|NCT02060188|559149422|FG004|Overall Study|Participant request to discontinue study treatment|0|||
154924910|NCT02060188|559149423|FG005|Overall Study|Participant request to discontinue study treatment|0|||
154924911|NCT02060188|559149424|FG006|Overall Study|Participant request to discontinue study treatment|1|||
154924912|NCT02060188|559149425|FG007|Overall Study|Participant request to discontinue study treatment|1|||
154924913|NCT02060188|559149426|FG008|Overall Study|Participant request to discontinue study treatment|0|||
154924914|NCT02060188|559149418|FG000|Overall Study|Participant withdrew consent|3|||
154924915|NCT02060188|559149419|FG001|Overall Study|Participant withdrew consent|0|||
154924916|NCT02060188|559149420|FG002|Overall Study|Participant withdrew consent|0|||
154924917|NCT02060188|559149421|FG003|Overall Study|Participant withdrew consent|0|||
154924918|NCT02060188|559149422|FG004|Overall Study|Participant withdrew consent|0|||
154924919|NCT02060188|559149423|FG005|Overall Study|Participant withdrew consent|0|||
154924920|NCT02060188|559149424|FG006|Overall Study|Participant withdrew consent|0|||
154924921|NCT02060188|559149425|FG007|Overall Study|Participant withdrew consent|0|||
154924922|NCT02060188|559149426|FG008|Overall Study|Participant withdrew consent|0|||
154924923|NCT02060188|559149418|FG000|Overall Study|Maximum clinical benefit|13|||
154924924|NCT02060188|559149419|FG001|Overall Study|Maximum clinical benefit|38|||
154924925|NCT02060188|559149420|FG002|Overall Study|Maximum clinical benefit|19|||
154924926|NCT02060188|559149421|FG003|Overall Study|Maximum clinical benefit|0|||
154924927|NCT02060188|559149422|FG004|Overall Study|Maximum clinical benefit|0|||
154924928|NCT02060188|559149423|FG005|Overall Study|Maximum clinical benefit|0|||
154924929|NCT02060188|559149424|FG006|Overall Study|Maximum clinical benefit|0|||
154924930|NCT02060188|559149425|FG007|Overall Study|Maximum clinical benefit|10|||
154924931|NCT02060188|559149426|FG008|Overall Study|Maximum clinical benefit|0|||
154924932|NCT02060188|559149418|FG000|Overall Study|Other reason|3|||
154924933|NCT02060188|559149419|FG001|Overall Study|Other reason|7|||
154924934|NCT02060188|559149420|FG002|Overall Study|Other reason|0|||
154924935|NCT02060188|559149421|FG003|Overall Study|Other reason|1|||
154924936|NCT02060188|559149422|FG004|Overall Study|Other reason|0|||
154924937|NCT02060188|559149423|FG005|Overall Study|Other reason|0|||
154924938|NCT02060188|559149424|FG006|Overall Study|Other reason|0|||
154924939|NCT02060188|559149425|FG007|Overall Study|Other reason|9|||
154924940|NCT02060188|559149426|FG008|Overall Study|Other reason|0|||
154924941|NCT02060188|559149418|FG000|Overall Study|Death|0|||
154924942|NCT02060188|559149419|FG001|Overall Study|Death|1|||
154924943|NCT02060188|559149420|FG002|Overall Study|Death|0|||
154924944|NCT02060188|559149421|FG003|Overall Study|Death|0|||
154924945|NCT02060188|559149422|FG004|Overall Study|Death|0|||
154924946|NCT02060188|559149423|FG005|Overall Study|Death|0|||
154924947|NCT02060188|559149424|FG006|Overall Study|Death|0|||
154924948|NCT02060188|559149425|FG007|Overall Study|Death|1|||
154924949|NCT02060188|559149426|FG008|Overall Study|Death|0|||
154924950|NCT02060188|559149418|FG000|Overall Study|Administrative reasons by sponsor|0|||
154924951|NCT02060188|559149419|FG001|Overall Study|Administrative reasons by sponsor|1|||
154924952|NCT02060188|559149420|FG002|Overall Study|Administrative reasons by sponsor|0|||
154924953|NCT02060188|559149421|FG003|Overall Study|Administrative reasons by sponsor|0|||
154924954|NCT02060188|559149422|FG004|Overall Study|Administrative reasons by sponsor|0|||
154924955|NCT02060188|559149423|FG005|Overall Study|Administrative reasons by sponsor|0|||
154924956|NCT02060188|559149424|FG006|Overall Study|Administrative reasons by sponsor|0|||
154924957|NCT02060188|559149425|FG007|Overall Study|Administrative reasons by sponsor|0|||
154924958|NCT02060188|559149426|FG008|Overall Study|Administrative reasons by sponsor|0|||
154924959|NCT02060188|559149418|FG000|Overall Study|Lost to Follow-up|0|||
154924960|NCT02060188|559149419|FG001|Overall Study|Lost to Follow-up|0|||
154924961|NCT02060188|559149420|FG002|Overall Study|Lost to Follow-up|1|||
154924962|NCT02060188|559149421|FG003|Overall Study|Lost to Follow-up|0|||
154924963|NCT02060188|559149422|FG004|Overall Study|Lost to Follow-up|0|||
154924964|NCT02060188|559149423|FG005|Overall Study|Lost to Follow-up|0|||
154924965|NCT02060188|559149424|FG006|Overall Study|Lost to Follow-up|0|||
154924966|NCT02060188|559149425|FG007|Overall Study|Lost to Follow-up|0|||
154924967|NCT02060188|559149426|FG008|Overall Study|Lost to Follow-up|0|||
155380742|NCT02354508|560828628|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
155380743|NCT02354508|560828629|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
154924968|NCT03707145|559149429|FG000|Overall Study|Lost to Follow-up|0|||
154924969|NCT03707145|559149430|FG001|Overall Study|Lost to Follow-up|1|||
154924970|NCT03707145|559149431|FG002|Overall Study|Lost to Follow-up|1|||
154924971|NCT03707145|559149432|FG003|Overall Study|Lost to Follow-up|0|||
154924972|NCT04221477|559149433|FG000|Overall Study|Adverse Event|1|||
154924973|NCT04221477|559149434|FG001|Overall Study|Adverse Event|1|||
154924974|NCT04221477|559149433|FG000|Overall Study|Death|5|||
154924975|NCT04221477|559149434|FG001|Overall Study|Death|4|||
154924976|NCT04221477|559149433|FG000|Overall Study|Lack of Efficacy|1|||
154924977|NCT04221477|559149434|FG001|Overall Study|Lack of Efficacy|2|||
155380744|NCT02354508|560828630|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
154924978|NCT04221477|559149433|FG000|Overall Study|Lost to Follow-up|1|||
154924979|NCT04221477|559149434|FG001|Overall Study|Lost to Follow-up|2|||
154924980|NCT04221477|559149433|FG000|Overall Study|Non-compliance with Study Drug|1|||
154924981|NCT04221477|559149434|FG001|Overall Study|Non-compliance with Study Drug|0|||
154924982|NCT04221477|559149433|FG000|Overall Study|Reason not Specified|0|||
154924983|NCT04221477|559149434|FG001|Overall Study|Reason not Specified|5|||
154924984|NCT04221477|559149433|FG000|Overall Study|Physician Decision|0|||
154924985|NCT04221477|559149434|FG001|Overall Study|Physician Decision|6|||
154924986|NCT04221477|559149433|FG000|Overall Study|Withdrawal by Subject|10|||
154924987|NCT04221477|559149434|FG001|Overall Study|Withdrawal by Subject|14|||
154924988|NCT04221477|559149433|FG000|Overall Study|Ongoing in the Study|116|||
154924989|NCT04221477|559149434|FG001|Overall Study|Ongoing in the Study|102|||
154924990|NCT02242942|559149435|FG000|Overall Study|Death|17|||
154924991|NCT02242942|559149436|FG001|Overall Study|Death|20|||
154924992|NCT02242942|559149437|FG002|Overall Study|Death|2|||
154924993|NCT02242942|559149435|FG000|Overall Study|Physician Decision|1|||
154924994|NCT02242942|559149436|FG001|Overall Study|Physician Decision|0|||
154924995|NCT02242942|559149437|FG002|Overall Study|Physician Decision|0|||
154924996|NCT02242942|559149435|FG000|Overall Study|Withdrawal by Subject|8|||
154924997|NCT02242942|559149436|FG001|Overall Study|Withdrawal by Subject|10|||
154924998|NCT02242942|559149437|FG002|Overall Study|Withdrawal by Subject|0|||
154924999|NCT02242942|559149435|FG000|Overall Study|On-going in Study|190|||
154925000|NCT02242942|559149436|FG001|Overall Study|On-going in Study|186|||
154925001|NCT02242942|559149437|FG002|Overall Study|On-going in Study|11|||
154925002|NCT04882085|559149438|FG000|Overall Study|Death|6|||
154925003|NCT04882085|559149439|FG001|Overall Study|Death|9|||
154925004|NCT04882085|559149438|FG000|Overall Study|Withdrawal by Subject|0|||
154925005|NCT04882085|559149439|FG001|Overall Study|Withdrawal by Subject|3|||
154925006|NCT04882085|559149438|FG000|Overall Study|Randomized not treated|1|||
154925007|NCT04882085|559149439|FG001|Overall Study|Randomized not treated|0|||
154925008|NCT04455620|559149443|FG000|Overall Study|Withdrawal by Subject|0|||
154925009|NCT04455620|559149444|FG001|Overall Study|Withdrawal by Subject|0|||
154925010|NCT04455620|559149445|FG002|Overall Study|Withdrawal by Subject|2|||
154925011|NCT04455620|559149446|FG003|Overall Study|Withdrawal by Subject|0|||
154925012|NCT04455620|559149447|FG004|Overall Study|Withdrawal by Subject|1|||
154925013|NCT04455620|559149443|FG000|Overall Study|Lost to Follow-up|0|||
154925014|NCT04455620|559149444|FG001|Overall Study|Lost to Follow-up|0|||
154925015|NCT04455620|559149445|FG002|Overall Study|Lost to Follow-up|1|||
154925016|NCT04455620|559149446|FG003|Overall Study|Lost to Follow-up|1|||
154925017|NCT04455620|559149447|FG004|Overall Study|Lost to Follow-up|0|||
154925018|NCT04455620|559149443|FG000|Overall Study|Death|1|||
154925019|NCT04455620|559149444|FG001|Overall Study|Death|6|||
154925020|NCT04455620|559149445|FG002|Overall Study|Death|20|||
154925021|NCT04455620|559149446|FG003|Overall Study|Death|1|||
154925022|NCT04455620|559149447|FG004|Overall Study|Death|7|||
154925023|NCT04455620|559149443|FG000|Overall Study|Study Termination|0|||
154925024|NCT04455620|559149444|FG001|Overall Study|Study Termination|2|||
154925025|NCT04455620|559149445|FG002|Overall Study|Study Termination|1|||
154925026|NCT04455620|559149446|FG003|Overall Study|Study Termination|0|||
154925027|NCT04455620|559149447|FG004|Overall Study|Study Termination|6|||
154925028|NCT03792633|559149448|FG000|Overall Study|Alternative Treatment|17|||
155380745|NCT02354508|560828628|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
155380746|NCT02354508|560828629|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
155380747|NCT02354508|560828630|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
155380748|NCT03587974|560828631|FG000|Overall Study|caregiver demented, care recipient died|3|||
155380749|NCT03587974|560828632|FG001|Overall Study|caregiver demented, care recipient died|3|||
155380750|NCT03587974|560828631|FG000|Overall Study|Withdrawal by Subject|2|||
155380751|NCT03587974|560828632|FG001|Overall Study|Withdrawal by Subject|1|||
155380752|NCT04447846|560828633|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
155380753|NCT00946101|560828634|FG000|Overall Study|Lost to Follow-up|2|||
155380754|NCT00946101|560828635|FG001|Overall Study|Lost to Follow-up|1|||
155380755|NCT00946101|560828634|FG000|Overall Study|Withdrawal of consent|2|||
155380756|NCT00946101|560828635|FG001|Overall Study|Withdrawal of consent|0|||
155380757|NCT00946101|560828634|FG000|Overall Study|Physician Decision|0|||
155380758|NCT00946101|560828635|FG001|Overall Study|Physician Decision|1|||
155380759|NCT00093808|560828636|FG000|Overall Study|Cancel participation before receiving tx|1|||
155380760|NCT00093808|560828636|FG000|Overall Study|Protocol Violation|1|||
154925029|NCT03792633|559149449|FG001|Overall Study|Alternative Treatment|19|||
154925030|NCT03792633|559149448|FG000|Overall Study|Death|2|||
154925031|NCT03792633|559149449|FG001|Overall Study|Death|0|||
154925032|NCT03792633|559149448|FG000|Overall Study|Disease progression|8|||
154925033|NCT03792633|559149449|FG001|Overall Study|Disease progression|9|||
154925034|NCT03792633|559149448|FG000|Overall Study|Lost to Follow-up|1|||
154925035|NCT03792633|559149449|FG001|Overall Study|Lost to Follow-up|1|||
154925036|NCT03792633|559149448|FG000|Overall Study|Screen fail|1|||
155380761|NCT00871780|560828637|FG000|Overall Study|Enrolled But Not Treated|6|||
155380762|NCT00871780|560828637|FG000|Overall Study|Withdrawal by Subject|9|||
155380763|NCT00871780|560828637|FG000|Overall Study|Adverse Event|6|||
155380764|NCT00871780|560828637|FG000|Overall Study|Voluntary Discontinuation|4|||
155380765|NCT00871780|560828637|FG000|Overall Study|Death|1|||
155380766|NCT00871780|560828637|FG000|Overall Study|Physician Decision|1|||
155380767|NCT00523640|560828640|FG000|Overall Study|Death|1|||
155380768|NCT06377488|560828641|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
155380769|NCT06377488|560828641|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
155380770|NCT06377488|560828641|FG000|Overall Study|Protocol Violation|1|||
155380771|NCT06377488|560828641|FG000|Overall Study|Lost to Follow-up|1|||
155380772|NCT06377488|560828641|FG000|Overall Study|Incorrect Lens Dispensed|2|||
155380773|NCT00652327|560828644|FG000|Overall Study|Adverse Event|0|||
155380774|NCT00652327|560828645|FG001|Overall Study|Adverse Event|2|||
155380775|NCT00652327|560828644|FG000|Overall Study|Lost to Follow-up|0|||
155380776|NCT00652327|560828645|FG001|Overall Study|Lost to Follow-up|3|||
154925037|NCT03792633|559149449|FG001|Overall Study|Screen fail|0|||
154925038|NCT03792633|559149448|FG000|Overall Study|Second malignancy|0|||
154925039|NCT03792633|559149449|FG001|Overall Study|Second malignancy|1|||
154925040|NCT00145119|559149450|FG000|Overall Study|Death|45|||
154925041|NCT05681715|559149451|FG000|Training Period (6-weeks)|Adverse Event|3|||
154925042|NCT05681715|559149452|FG001|Training Period (6-weeks)|Adverse Event|0|||
154925043|NCT05681715|559149453|FG002|Training Period (6-weeks)|Adverse Event|0|||
154925044|NCT05681715|559149451|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
154925045|NCT05681715|559149452|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
154925046|NCT05681715|559149453|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
154925047|NCT05681715|559149451|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
154925048|NCT05681715|559149452|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
154925049|NCT05681715|559149453|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
154925050|NCT05681715|559149451|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
154925051|NCT05681715|559149452|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
154925052|NCT05681715|559149453|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
154925053|NCT05681715|559149451|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
154925054|NCT05681715|559149452|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
154925055|NCT05681715|559149453|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
154925056|NCT05681715|559149451|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
154925057|NCT05681715|559149452|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
154925058|NCT05681715|559149453|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
154925059|NCT05681715|559149451|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
154925060|NCT05681715|559149452|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
154925061|NCT05681715|559149453|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
154925062|NCT05681715|559149451|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
154925063|NCT05681715|559149452|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
154925064|NCT05681715|559149453|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
154925065|NCT05455684|559149454|FG000|Overall Study|Withdrawal by Subject|7|||
154925066|NCT05455684|559149455|FG001|Overall Study|Withdrawal by Subject|4|||
154925067|NCT05455684|559149454|FG000|Overall Study|Lost to Follow-up|3|||
154925068|NCT05455684|559149455|FG001|Overall Study|Lost to Follow-up|3|||
154925069|NCT05455684|559149454|FG000|Overall Study|Adverse Event|2|||
154925070|NCT05455684|559149455|FG001|Overall Study|Adverse Event|3|||
154925071|NCT05455684|559149454|FG000|Overall Study|Protocol Violation|1|||
154925072|NCT05455684|559149455|FG001|Overall Study|Protocol Violation|1|||
154925073|NCT05455684|559149454|FG000|Overall Study|Non-Compliant with study drug|0|||
154925074|NCT05455684|559149455|FG001|Overall Study|Non-Compliant with study drug|1|||
154925075|NCT05455684|559149454|FG000|Overall Study|Other|1|||
154925076|NCT05455684|559149455|FG001|Overall Study|Other|2|||
154925077|NCT05455684|559149454|FG000|Overall Study|Randomized but not treated|1|||
154925078|NCT05455684|559149455|FG001|Overall Study|Randomized but not treated|0|||
154925079|NCT05204563|559149456|FG000|Overall Study|Other than Specified|2|||
154925080|NCT05204563|559149457|FG001|Overall Study|Other than Specified|1|||
154925081|NCT05204563|559149456|FG000|Overall Study|Death|18|||
154925082|NCT05204563|559149457|FG001|Overall Study|Death|4|||
154925083|NCT05204563|559149456|FG000|Overall Study|Lost to Follow-up|6|||
154925084|NCT05204563|559149457|FG001|Overall Study|Lost to Follow-up|3|||
154925085|NCT05204563|559149456|FG000|Overall Study|Withdrawal by Subject|12|||
154925086|NCT05204563|559149457|FG001|Overall Study|Withdrawal by Subject|3|||
155380777|NCT01076647|560828646|FG000|Overall Study|Adverse Event|4|||
155380778|NCT01076647|560828647|FG001|Overall Study|Adverse Event|1|||
155380779|NCT01076647|560828646|FG000|Overall Study|Lack of Efficacy|0|||
155380780|NCT01076647|560828647|FG001|Overall Study|Lack of Efficacy|1|||
155380781|NCT01076647|560828646|FG000|Overall Study|Protocol Violation|7|||
155380782|NCT01076647|560828647|FG001|Overall Study|Protocol Violation|9|||
155380783|NCT01076647|560828646|FG000|Overall Study|Withdrawal criteria|2|||
155380784|NCT01076647|560828647|FG001|Overall Study|Withdrawal criteria|2|||
155380785|NCT01076647|560828646|FG000|Overall Study|Unclassified|12|||
155380786|NCT01076647|560828647|FG001|Overall Study|Unclassified|12|||
155380787|NCT02292927|560828652|FG000|Overall Study|Protocol Violation|13|||
155380788|NCT02292927|560828653|FG001|Overall Study|Protocol Violation|7|||
155380789|NCT01656733|560828657|FG000|Overall Study|No permission to collect birth outcomes|0|||
155380790|NCT01656733|560828658|FG001|Overall Study|No permission to collect birth outcomes|1|||
155380791|NCT01656733|560828657|FG000|Overall Study|Delivery at another hospital|0|||
155380792|NCT01656733|560828658|FG001|Overall Study|Delivery at another hospital|2|||
155380793|NCT01656733|560828657|FG000|Overall Study|Spontaneous abortion|0|||
155380794|NCT01656733|560828658|FG001|Overall Study|Spontaneous abortion|1|||
155380795|NCT03625895|560828659|FG000|Overall Study|Protocol Violation|585|||
155380796|NCT02081417|560828660|FG000|Overall Study|Lost to Follow-up|26|||
155380797|NCT02081417|560828661|FG001|Overall Study|Lost to Follow-up|23|||
155380798|NCT02081417|560828660|FG000|Overall Study|Moved Away|1|||
155380799|NCT02081417|560828661|FG001|Overall Study|Moved Away|2|||
155380800|NCT02081417|560828660|FG000|Overall Study|Incarcerated|2|||
155380801|NCT02081417|560828661|FG001|Overall Study|Incarcerated|2|||
155380802|NCT02081417|560828660|FG000|Overall Study|Death|4|||
155380803|NCT02081417|560828661|FG001|Overall Study|Death|3|||
155380804|NCT02081417|560828660|FG000|Overall Study|Withdrawal by Subject|4|||
155380805|NCT02081417|560828661|FG001|Overall Study|Withdrawal by Subject|0|||
155380806|NCT02081417|560828660|FG000|Overall Study|Admitted to Residential Treatment|2|||
155380807|NCT02081417|560828661|FG001|Overall Study|Admitted to Residential Treatment|0|||
155380808|NCT02081417|560828660|FG000|Overall Study|Did not start treatment|17|||
155380809|NCT02081417|560828661|FG001|Overall Study|Did not start treatment|21|||
155380810|NCT01415531|560828664|FG000|Overall Study|Adverse Event|7|||
155380811|NCT01415531|560828665|FG001|Overall Study|Adverse Event|10|||
155380812|NCT01415531|560828664|FG000|Overall Study|Lack of Efficacy|3|||
155380813|NCT01415531|560828665|FG001|Overall Study|Lack of Efficacy|2|||
155380814|NCT01415531|560828664|FG000|Overall Study|Protocol Violation|0|||
155380815|NCT01415531|560828665|FG001|Overall Study|Protocol Violation|1|||
155380816|NCT01415531|560828664|FG000|Overall Study|Withdrawal by Subject|5|||
155380817|NCT01415531|560828665|FG001|Overall Study|Withdrawal by Subject|4|||
155380818|NCT01415531|560828664|FG000|Overall Study|Lost to Follow-up|6|||
155380819|NCT01415531|560828665|FG001|Overall Study|Lost to Follow-up|14|||
155380820|NCT01415531|560828664|FG000|Overall Study|Lack of Compliance|1|||
155380821|NCT01415531|560828665|FG001|Overall Study|Lack of Compliance|4|||
155380822|NCT01415531|560828664|FG000|Overall Study|Other Reasons|3|||
155380823|NCT01415531|560828665|FG001|Overall Study|Other Reasons|2|||
155380824|NCT05753670|560828666|FG000|Overall Study|Withdrawal by Subject|6|||
155380825|NCT05753670|560828667|FG001|Overall Study|Withdrawal by Subject|8|||
155380826|NCT05753670|560828666|FG000|Overall Study|Protocol Violation|3|||
155380827|NCT05753670|560828667|FG001|Overall Study|Protocol Violation|1|||
155380828|NCT00122460|560828668|FG000|Overall Study|investigational study phase ongoing|7|||
155380829|NCT00122460|560828669|FG001|Overall Study|investigational study phase ongoing|1|||
155380830|NCT01236339|560828670|FG000|Overall Study|Termination of study by sponsor|11|||
155380831|NCT01236339|560828671|FG001|Overall Study|Termination of study by sponsor|13|||
155380832|NCT02054741|560828672|FG000|Overall Study|Protocol Violation|13|||
155380833|NCT02054741|560828673|FG001|Overall Study|Protocol Violation|2|||
155380834|NCT02054741|560828672|FG000|Overall Study|Withdrawal by Subject|10|||
155380835|NCT02054741|560828673|FG001|Overall Study|Withdrawal by Subject|5|||
155380836|NCT02054741|560828672|FG000|Overall Study|Death|94|||
155380837|NCT02054741|560828673|FG001|Overall Study|Death|90|||
155380838|NCT02054741|560828672|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
155380839|NCT02054741|560828673|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
155380840|NCT02325557|560828674|FG000|Overall Study|Progressive disease|1|||
155380841|NCT02325557|560828675|FG001|Overall Study|Progressive disease|0|||
155380842|NCT02325557|560828676|FG002|Overall Study|Progressive disease|0|||
155380843|NCT02325557|560828677|FG003|Overall Study|Progressive disease|0|||
155380844|NCT02325557|560828674|FG000|Overall Study|Withdrawal by Subject|4|||
155380845|NCT02325557|560828675|FG001|Overall Study|Withdrawal by Subject|0|||
155380846|NCT02325557|560828676|FG002|Overall Study|Withdrawal by Subject|0|||
155380847|NCT02325557|560828677|FG003|Overall Study|Withdrawal by Subject|15|||
155380848|NCT02325557|560828674|FG000|Overall Study|Death|5|||
155380849|NCT02325557|560828675|FG001|Overall Study|Death|1|||
155380850|NCT02325557|560828676|FG002|Overall Study|Death|1|||
155380851|NCT02325557|560828677|FG003|Overall Study|Death|16|||
155380852|NCT02325557|560828674|FG000|Overall Study|Lost to Follow-up|0|||
155380853|NCT02325557|560828675|FG001|Overall Study|Lost to Follow-up|0|||
155380854|NCT02325557|560828676|FG002|Overall Study|Lost to Follow-up|1|||
155380855|NCT02325557|560828677|FG003|Overall Study|Lost to Follow-up|1|||
155380856|NCT02325557|560828674|FG000|Overall Study|Other|0|||
155380857|NCT02325557|560828675|FG001|Overall Study|Other|0|||
155380858|NCT02325557|560828676|FG002|Overall Study|Other|0|||
155380859|NCT02325557|560828677|FG003|Overall Study|Other|5|||
155380860|NCT01502631|560828678|FG000|Overall Study|Adverse Event|5|||
155380861|NCT01502631|560828679|FG001|Overall Study|Adverse Event|8|||
155380862|NCT01502631|560828678|FG000|Overall Study|Lost to Follow-up|2|||
155380863|NCT01502631|560828679|FG001|Overall Study|Lost to Follow-up|2|||
155380864|NCT01502631|560828678|FG000|Overall Study|Participant withdrew consent|2|||
155380865|NCT01502631|560828679|FG001|Overall Study|Participant withdrew consent|4|||
155380866|NCT01502631|560828678|FG000|Overall Study|Participant non-compliant|1|||
155380867|NCT01502631|560828679|FG001|Overall Study|Participant non-compliant|0|||
155380868|NCT01502631|560828678|FG000|Overall Study|Investigator's decision|0|||
155380869|NCT01502631|560828679|FG001|Overall Study|Investigator's decision|1|||
155380870|NCT01502631|560828678|FG000|Overall Study|Other|10|||
155380871|NCT01502631|560828679|FG001|Overall Study|Other|5|||
155380872|NCT01488487|560828680|FG000|Overall Study|Adverse Event|6|||
155380873|NCT01488487|560828680|FG000|Overall Study|Death|1|||
155380874|NCT01488487|560828680|FG000|Overall Study|Withdrawal by Subject|2|||
155380875|NCT00395460|560828683|FG000|Overall Study|Withdrawal by Subject|1|||
155380876|NCT00395460|560828684|FG001|Overall Study|Withdrawal by Subject|0|||
155380877|NCT02319525|560828690|FG000|Overall Study|Withdrawal by Subject|2|||
155380878|NCT02319525|560828691|FG001|Overall Study|Withdrawal by Subject|1|||
155380879|NCT04223830|560828695|FG000|Overall Study|Lost to Follow-up|9|||
155380880|NCT04223830|560828695|FG000|Overall Study|Adverse Event|1|||
155380881|NCT01806623|560828696|FG000|Overall Study|Withdrawal by Subject|1|||
155380882|NCT01806623|560828696|FG000|Overall Study|Adverse Event|1|||
155380883|NCT01806623|560828696|FG000|Overall Study|Did not meet the inclusion criteria|56|||
155380884|NCT01737827|560828697|FG000|Overall Study|Adverse Event|3|||
155380885|NCT01737827|560828698|FG001|Overall Study|Adverse Event|6|||
155380886|NCT01737827|560828699|FG002|Overall Study|Adverse Event|0|||
155380887|NCT01737827|560828697|FG000|Overall Study|Lost to Follow-up|0|||
155380888|NCT01737827|560828698|FG001|Overall Study|Lost to Follow-up|1|||
155380889|NCT01737827|560828699|FG002|Overall Study|Lost to Follow-up|0|||
155380890|NCT01737827|560828697|FG000|Overall Study|Physician Decision|0|||
155380891|NCT01737827|560828698|FG001|Overall Study|Physician Decision|2|||
155380892|NCT01737827|560828699|FG002|Overall Study|Physician Decision|0|||
155380893|NCT01737827|560828697|FG000|Overall Study|Progressive Disease|5|||
155380894|NCT01737827|560828698|FG001|Overall Study|Progressive Disease|16|||
155380895|NCT01737827|560828699|FG002|Overall Study|Progressive Disease|2|||
155380896|NCT01737827|560828697|FG000|Overall Study|Study Terminated by Sponsor|0|||
155380897|NCT01737827|560828698|FG001|Overall Study|Study Terminated by Sponsor|1|||
155380898|NCT01737827|560828699|FG002|Overall Study|Study Terminated by Sponsor|0|||
155380899|NCT01737827|560828697|FG000|Overall Study|Subject/Guardian Decision|0|||
155380900|NCT01737827|560828698|FG001|Overall Study|Subject/Guardian Decision|2|||
155380901|NCT01737827|560828699|FG002|Overall Study|Subject/Guardian Decision|0|||
155380902|NCT01451827|560828700|FG000|Overall Study|Adverse Event|2|||
155380903|NCT01451827|560828701|FG001|Overall Study|Adverse Event|0|||
155380904|NCT01451827|560828702|FG002|Overall Study|Adverse Event|1|||
155380905|NCT01451827|560828703|FG003|Overall Study|Adverse Event|1|||
155380906|NCT01451827|560828700|FG000|Overall Study|Protocol deviation|1|||
155380907|NCT01451827|560828701|FG001|Overall Study|Protocol deviation|0|||
155380908|NCT01451827|560828702|FG002|Overall Study|Protocol deviation|0|||
155380909|NCT01451827|560828703|FG003|Overall Study|Protocol deviation|0|||
155380910|NCT01451827|560828700|FG000|Overall Study|Lost to Follow-up|0|||
155380911|NCT01451827|560828701|FG001|Overall Study|Lost to Follow-up|3|||
155380912|NCT01451827|560828702|FG002|Overall Study|Lost to Follow-up|0|||
155380913|NCT01451827|560828703|FG003|Overall Study|Lost to Follow-up|2|||
155380914|NCT01451827|560828700|FG000|Overall Study|Participant met withdrawal criteria|0|||
155380915|NCT01451827|560828701|FG001|Overall Study|Participant met withdrawal criteria|2|||
155380916|NCT01451827|560828702|FG002|Overall Study|Participant met withdrawal criteria|0|||
155380917|NCT01451827|560828703|FG003|Overall Study|Participant met withdrawal criteria|0|||
155380918|NCT01451827|560828700|FG000|Overall Study|Withdrawal by Subject|0|||
155380919|NCT01451827|560828701|FG001|Overall Study|Withdrawal by Subject|0|||
155380920|NCT01451827|560828702|FG002|Overall Study|Withdrawal by Subject|1|||
155380921|NCT01451827|560828703|FG003|Overall Study|Withdrawal by Subject|1|||
155380922|NCT01964924|560828704|FG000|Trametinib Monotherapy|Progression|19|||
155380923|NCT01964924|560828705|FG001|Trametinib Monotherapy|Progression|0|||
155380924|NCT01528345|560828706|FG000|Overall Study|Adverse Event|10|||
155380925|NCT01528345|560828707|FG001|Overall Study|Adverse Event|1|||
155380926|NCT01528345|560828706|FG000|Overall Study|Death|1|||
155380927|NCT01528345|560828707|FG001|Overall Study|Death|1|||
155380928|NCT01528345|560828706|FG000|Overall Study|Non-compliance with study treatment|1|||
155380929|NCT01528345|560828707|FG001|Overall Study|Non-compliance with study treatment|0|||
155380930|NCT01528345|560828706|FG000|Overall Study|Progressive Disease|26|||
155380931|NCT01528345|560828707|FG001|Overall Study|Progressive Disease|40|||
155380932|NCT01528345|560828706|FG000|Overall Study|Study Terminated by Sponsor|4|||
155380933|NCT01528345|560828707|FG001|Overall Study|Study Terminated by Sponsor|8|||
155380934|NCT01528345|560828706|FG000|Overall Study|Subject/Guardian Decision|5|||
155380935|NCT01528345|560828707|FG001|Overall Study|Subject/Guardian Decision|0|||
155380936|NCT01034163|560828708|FG000|Overall Study|Treatment completed as per protocol|8|||
155380937|NCT01034163|560828709|FG001|Overall Study|Treatment completed as per protocol|7|||
155380938|NCT01034163|560828708|FG000|Overall Study|Withdrawal by Subject|8|||
155380939|NCT01034163|560828709|FG001|Overall Study|Withdrawal by Subject|2|||
155380940|NCT01034163|560828708|FG000|Overall Study|Protocol deviation|1|||
155380941|NCT01034163|560828709|FG001|Overall Study|Protocol deviation|0|||
155380942|NCT01034163|560828708|FG000|Overall Study|Disease progression|3|||
155380943|NCT01034163|560828709|FG001|Overall Study|Disease progression|4|||
155380944|NCT01034163|560828708|FG000|Overall Study|Adverse Event|6|||
155380945|NCT01034163|560828709|FG001|Overall Study|Adverse Event|0|||
155380946|NCT01034163|560828708|FG000|Overall Study|Administrative problems|0|||
155380947|NCT01034163|560828709|FG001|Overall Study|Administrative problems|1|||
155380948|NCT01034163|560828708|FG000|Overall Study|Abnormal laboratory value|1|||
155380949|NCT01034163|560828709|FG001|Overall Study|Abnormal laboratory value|0|||
155380950|NCT02424734|560828710|FG000|Overall Study|Treatment stopped to be discharged home|2|||
155380951|NCT02424734|560828711|FG001|Overall Study|Treatment stopped to be discharged home|2|||
155380952|NCT02424734|560828712|FG002|Overall Study|Treatment stopped to be discharged home|0|||
155380953|NCT01445301|560828713|FG000|Overall Study|Adverse Event|15|||
155380954|NCT01445301|560828714|FG001|Overall Study|Adverse Event|25|||
155380955|NCT01445301|560828715|FG002|Overall Study|Adverse Event|4|||
155380956|NCT01445301|560828713|FG000|Overall Study|Lack of Efficacy|0|||
155380957|NCT01445301|560828714|FG001|Overall Study|Lack of Efficacy|1|||
155380958|NCT01445301|560828715|FG002|Overall Study|Lack of Efficacy|0|||
155380959|NCT01445301|560828713|FG000|Overall Study|Protocol Violation|1|||
155380960|NCT01445301|560828714|FG001|Overall Study|Protocol Violation|0|||
155380961|NCT01445301|560828715|FG002|Overall Study|Protocol Violation|0|||
155380962|NCT01445301|560828713|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
155380963|NCT01445301|560828714|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
155380964|NCT01445301|560828715|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
155380965|NCT01445301|560828713|FG000|Overall Study|Physician Decision|0|||
155380966|NCT01445301|560828714|FG001|Overall Study|Physician Decision|2|||
155380967|NCT01445301|560828715|FG002|Overall Study|Physician Decision|0|||
155380968|NCT01445301|560828713|FG000|Overall Study|Withdrawal by Subject|5|||
155380969|NCT01445301|560828714|FG001|Overall Study|Withdrawal by Subject|6|||
155380970|NCT01445301|560828715|FG002|Overall Study|Withdrawal by Subject|4|||
155380971|NCT00752557|560828716|FG000|Overall Study|Withdrawal by Subject|4|||
155380972|NCT00752557|560828717|FG001|Overall Study|Withdrawal by Subject|3|||
155380973|NCT00752557|560828718|FG002|Overall Study|Withdrawal by Subject|3|||
155380974|NCT00752557|560828716|FG000|Overall Study|Unspecified resaons|0|||
155380975|NCT00752557|560828717|FG001|Overall Study|Unspecified resaons|2|||
155380976|NCT00752557|560828718|FG002|Overall Study|Unspecified resaons|2|||
155380977|NCT00752557|560828716|FG000|Overall Study|Lost to Follow-up|1|||
155380978|NCT00752557|560828717|FG001|Overall Study|Lost to Follow-up|0|||
155380979|NCT00752557|560828718|FG002|Overall Study|Lost to Follow-up|1|||
155380980|NCT02150343|560828723|FG000|Overall Study|Adverse Event|2|||
155380981|NCT02150343|560828724|FG001|Overall Study|Adverse Event|0|||
155380982|NCT02150343|560828725|FG002|Overall Study|Adverse Event|1|||
155380983|NCT02150343|560828726|FG003|Overall Study|Adverse Event|1|||
155380984|NCT02150343|560828723|FG000|Overall Study|Withdrawal by Subject|13|||
155380985|NCT02150343|560828724|FG001|Overall Study|Withdrawal by Subject|10|||
155380986|NCT02150343|560828725|FG002|Overall Study|Withdrawal by Subject|9|||
155380987|NCT02150343|560828726|FG003|Overall Study|Withdrawal by Subject|4|||
155380988|NCT02150343|560828723|FG000|Overall Study|Lost to Follow-up|4|||
155380989|NCT02150343|560828724|FG001|Overall Study|Lost to Follow-up|4|||
155380990|NCT02150343|560828725|FG002|Overall Study|Lost to Follow-up|2|||
155380991|NCT02150343|560828726|FG003|Overall Study|Lost to Follow-up|3|||
155380992|NCT02150343|560828723|FG000|Overall Study|Other|2|||
155380993|NCT02150343|560828724|FG001|Overall Study|Other|6|||
155380994|NCT02150343|560828725|FG002|Overall Study|Other|0|||
155380995|NCT02150343|560828726|FG003|Overall Study|Other|2|||
155380996|NCT00190749|560828727|FG000|Overall Study|Lost to Follow-up|8|||
155380997|NCT00190749|560828728|FG001|Overall Study|Lost to Follow-up|11|||
155380998|NCT00190749|560828727|FG000|Overall Study|Withdrawal by Subject|10|||
155380999|NCT00190749|560828728|FG001|Overall Study|Withdrawal by Subject|6|||
155381000|NCT00190749|560828727|FG000|Overall Study|Protocol Violation|5|||
155381001|NCT00190749|560828728|FG001|Overall Study|Protocol Violation|4|||
155381002|NCT00190749|560828727|FG000|Overall Study|Adverse Event|0|||
155381003|NCT00190749|560828728|FG001|Overall Study|Adverse Event|5|||
155381004|NCT00190749|560828727|FG000|Overall Study|Lack of Efficacy|2|||
155152519|NCT03037385|559996846|FG004|Overall Study|Lost to Follow-up|0|||
155381005|NCT00190749|560828728|FG001|Overall Study|Lack of Efficacy|3|||
155381006|NCT00190749|560828727|FG000|Overall Study|Reason Not Specified|0|||
155381007|NCT00190749|560828728|FG001|Overall Study|Reason Not Specified|2|||
155381008|NCT00190749|560828727|FG000|Overall Study|Sponsor Decision|1|||
155381009|NCT00190749|560828728|FG001|Overall Study|Sponsor Decision|0|||
155381010|NCT02729753|560828729|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
155381011|NCT02729753|560828730|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
155381012|NCT01090427|560828731|FG000|After Controlled Period|Death|0|||
155381013|NCT01090427|560828732|FG001|After Controlled Period|Death|0|||
154925087|NCT05204563|559149456|FG000|Overall Study|Enrolled, Not Treated|1|||
154925088|NCT05204563|559149457|FG001|Overall Study|Enrolled, Not Treated|0|||
154925089|NCT04411641|559149458|FG000|DB Period|Other|7|||
154925090|NCT04411641|559149459|FG001|DB Period|Other|27|||
154925091|NCT04411641|559149460|FG002|DB Period|Other|0|||
154925092|NCT04411641|559149461|FG003|DB Period|Other|0|||
154925093|NCT04411641|559149458|FG000|DB Period|Withdrawal by Subject|67|||
154925094|NCT04411641|559149459|FG001|DB Period|Withdrawal by Subject|122|||
154925095|NCT04411641|559149460|FG002|DB Period|Withdrawal by Subject|0|||
154925096|NCT04411641|559149461|FG003|DB Period|Withdrawal by Subject|0|||
154925097|NCT04411641|559149458|FG000|DB Period|Progressive disease|76|||
154925098|NCT04411641|559149459|FG001|DB Period|Progressive disease|116|||
154925099|NCT04411641|559149460|FG002|DB Period|Progressive disease|0|||
154925100|NCT04411641|559149461|FG003|DB Period|Progressive disease|0|||
154925101|NCT04411641|559149458|FG000|DB Period|Poor compliance to protocol|1|||
154925102|NCT04411641|559149459|FG001|DB Period|Poor compliance to protocol|5|||
154925103|NCT04411641|559149460|FG002|DB Period|Poor compliance to protocol|0|||
154925104|NCT04411641|559149461|FG003|DB Period|Poor compliance to protocol|0|||
154925105|NCT04411641|559149458|FG000|DB Period|Lack of Efficacy|19|||
154925106|NCT04411641|559149459|FG001|DB Period|Lack of Efficacy|19|||
154925107|NCT04411641|559149460|FG002|DB Period|Lack of Efficacy|0|||
154925108|NCT04411641|559149461|FG003|DB Period|Lack of Efficacy|0|||
154925109|NCT04411641|559149458|FG000|DB Period|Adverse Event|13|||
154925110|NCT04411641|559149459|FG001|DB Period|Adverse Event|29|||
154925111|NCT04411641|559149460|FG002|DB Period|Adverse Event|0|||
154925112|NCT04411641|559149461|FG003|DB Period|Adverse Event|0|||
154925113|NCT04411641|559149458|FG000|DB Period|Randomized and not treated|2|||
154925114|NCT04411641|559149459|FG001|DB Period|Randomized and not treated|2|||
154925115|NCT04411641|559149460|FG002|DB Period|Randomized and not treated|0|||
154925116|NCT04411641|559149461|FG003|DB Period|Randomized and not treated|0|||
154925117|NCT04411641|559149458|FG000|OL|Withdrawal by Subject|0|||
154925118|NCT04411641|559149459|FG001|OL|Withdrawal by Subject|0|||
154925119|NCT04411641|559149460|FG002|OL|Withdrawal by Subject|6|||
154925120|NCT04411641|559149461|FG003|OL|Withdrawal by Subject|17|||
154925121|NCT04411641|559149458|FG000|OL|Progressive disease|0|||
154925122|NCT04411641|559149459|FG001|OL|Progressive disease|0|||
154925123|NCT04411641|559149460|FG002|OL|Progressive disease|1|||
154925124|NCT04411641|559149461|FG003|OL|Progressive disease|2|||
154925125|NCT04411641|559149458|FG000|OL|Poor compliance to protocol|0|||
154925126|NCT04411641|559149459|FG001|OL|Poor compliance to protocol|0|||
154925127|NCT04411641|559149460|FG002|OL|Poor compliance to protocol|1|||
154925128|NCT04411641|559149461|FG003|OL|Poor compliance to protocol|0|||
154925129|NCT04411641|559149458|FG000|OL|Adverse Event|0|||
154925130|NCT04411641|559149459|FG001|OL|Adverse Event|0|||
154925131|NCT04411641|559149460|FG002|OL|Adverse Event|1|||
154925132|NCT04411641|559149461|FG003|OL|Adverse Event|0|||
154925133|NCT04411641|559149458|FG000|OL|Other|0|||
154925134|NCT04411641|559149459|FG001|OL|Other|0|||
154925135|NCT04411641|559149460|FG002|OL|Other|0|||
154925136|NCT04411641|559149461|FG003|OL|Other|6|||
154925137|NCT02268214|559149462|FG000|Overall Study|Subject no longer meets study criteria|0|||
154925138|NCT02268214|559149463|FG001|Overall Study|Subject no longer meets study criteria|2|||
154925139|NCT02268214|559149464|FG002|Overall Study|Subject no longer meets study criteria|0|||
154925140|NCT02268214|559149462|FG000|Overall Study|Pregnancy|2|||
154925141|NCT02268214|559149463|FG001|Overall Study|Pregnancy|2|||
154925142|NCT02268214|559149464|FG002|Overall Study|Pregnancy|1|||
154925143|NCT02268214|559149462|FG000|Overall Study|Lost to Follow-up|3|||
154925144|NCT02268214|559149463|FG001|Overall Study|Lost to Follow-up|3|||
154925145|NCT02268214|559149464|FG002|Overall Study|Lost to Follow-up|4|||
154925146|NCT02268214|559149462|FG000|Overall Study|Lack of Efficacy|1|||
154925147|NCT02268214|559149463|FG001|Overall Study|Lack of Efficacy|0|||
154925148|NCT02268214|559149464|FG002|Overall Study|Lack of Efficacy|2|||
154925149|NCT02268214|559149462|FG000|Overall Study|Adverse Event|11|||
154925150|NCT02268214|559149463|FG001|Overall Study|Adverse Event|14|||
154925151|NCT02268214|559149464|FG002|Overall Study|Adverse Event|9|||
154925152|NCT02268214|559149462|FG000|Overall Study|Withdrawal by Subject|4|||
154925153|NCT02268214|559149463|FG001|Overall Study|Withdrawal by Subject|5|||
154925154|NCT02268214|559149464|FG002|Overall Study|Withdrawal by Subject|10|||
154925155|NCT02268214|559149462|FG000|Overall Study|Subject request to discontinue treatment|10|||
154925156|NCT02268214|559149463|FG001|Overall Study|Subject request to discontinue treatment|8|||
154925157|NCT02268214|559149464|FG002|Overall Study|Subject request to discontinue treatment|6|||
154925158|NCT02268214|559149462|FG000|Overall Study|Poor/non-compliance|2|||
154925159|NCT02268214|559149463|FG001|Overall Study|Poor/non-compliance|1|||
154925160|NCT02268214|559149464|FG002|Overall Study|Poor/non-compliance|2|||
154925161|NCT02268214|559149462|FG000|Overall Study|Other reasons|7|||
154925162|NCT02268214|559149463|FG001|Overall Study|Other reasons|3|||
154925163|NCT02268214|559149464|FG002|Overall Study|Other reasons|3|||
154925164|NCT02268214|559149462|FG000|Overall Study|Not entering long-term period|2|||
154925165|NCT02268214|559149463|FG001|Overall Study|Not entering long-term period|3|||
154925166|NCT02268214|559149464|FG002|Overall Study|Not entering long-term period|5|||
154925167|NCT02951130|559149465|FG000|Overall Study|Protocol Violation|1|||
154925168|NCT02951130|559149466|FG001|Overall Study|Protocol Violation|1|||
154925169|NCT01119118|559149467|FG000|Overall Study|Adverse Event|1|||
154925170|NCT02711306|559149474|FG000|Overall Study|Withdrawal by Subject|2|||
154925171|NCT02711306|559149475|FG001|Overall Study|Withdrawal by Subject|2|||
154925172|NCT01519635|559150642|FG000|Overall Study|Withdrawal by Subject|0|||
154925173|NCT01519635|559150643|FG001|Overall Study|Withdrawal by Subject|1|||
154925174|NCT01519635|559150642|FG000|Overall Study|No possibility to put a catheter|1|||
154925175|NCT01519635|559150643|FG001|Overall Study|No possibility to put a catheter|2|||
154925176|NCT00347776|559150644|FG000|1.5 Month Follow-up|Death|2|||
154925177|NCT00347776|559150645|FG001|1.5 Month Follow-up|Death|0|||
154925178|NCT00347776|559150646|FG002|1.5 Month Follow-up|Death|0|||
154925179|NCT00347776|559150644|FG000|1.5 Month Follow-up|reached the endpoint|12|||
154925180|NCT00347776|559150645|FG001|1.5 Month Follow-up|reached the endpoint|8|||
154925181|NCT00347776|559150646|FG002|1.5 Month Follow-up|reached the endpoint|12|||
154925182|NCT00347776|559150644|FG000|6 Month Follow-up|Death|2|||
154925183|NCT00347776|559150645|FG001|6 Month Follow-up|Death|1|||
154925184|NCT00347776|559150646|FG002|6 Month Follow-up|Death|3|||
154925185|NCT00347776|559150644|FG000|6 Month Follow-up|reached endpont|20|||
154925186|NCT00347776|559150645|FG001|6 Month Follow-up|reached endpont|12|||
154925187|NCT00347776|559150646|FG002|6 Month Follow-up|reached endpont|15|||
154925188|NCT00347776|559150644|FG000|12 Month Follow-up|Lost to Follow-up|7|||
154925189|NCT00347776|559150645|FG001|12 Month Follow-up|Lost to Follow-up|6|||
154925190|NCT00347776|559150646|FG002|12 Month Follow-up|Lost to Follow-up|6|||
154925191|NCT00347776|559150644|FG000|12 Month Follow-up|Death|3|||
155381014|NCT01090427|560828733|FG002|After Controlled Period|Death|0|||
155381015|NCT01090427|560828734|FG003|After Controlled Period|Death|0|||
155381016|NCT01090427|560828735|FG004|After Controlled Period|Death|0|||
155381017|NCT01090427|560828736|FG005|After Controlled Period|Death|1|||
155381018|NCT01090427|560828737|FG006|After Controlled Period|Death|0|||
155381019|NCT01090427|560828731|FG000|After Controlled Period|Lack of Efficacy|0|||
155381020|NCT01090427|560828732|FG001|After Controlled Period|Lack of Efficacy|0|||
155381021|NCT01090427|560828733|FG002|After Controlled Period|Lack of Efficacy|0|||
155381022|NCT01090427|560828734|FG003|After Controlled Period|Lack of Efficacy|0|||
155381023|NCT01090427|560828735|FG004|After Controlled Period|Lack of Efficacy|0|||
155381024|NCT01090427|560828736|FG005|After Controlled Period|Lack of Efficacy|3|||
155381025|NCT01090427|560828737|FG006|After Controlled Period|Lack of Efficacy|2|||
155381026|NCT01090427|560828731|FG000|After Controlled Period|Adverse Event|0|||
155381027|NCT01090427|560828732|FG001|After Controlled Period|Adverse Event|0|||
155381028|NCT01090427|560828733|FG002|After Controlled Period|Adverse Event|0|||
155381029|NCT01090427|560828734|FG003|After Controlled Period|Adverse Event|2|||
155381030|NCT01090427|560828735|FG004|After Controlled Period|Adverse Event|0|||
155381031|NCT01090427|560828736|FG005|After Controlled Period|Adverse Event|1|||
155381032|NCT01090427|560828737|FG006|After Controlled Period|Adverse Event|0|||
155381033|NCT00928018|560828745|FG000|Overall Study|Withdrawal by Subject|1|||
155381034|NCT00928018|560828746|FG001|Overall Study|Withdrawal by Subject|0|||
155381035|NCT02008877|560828747|FG000|Overall Study|Inevaluable|0|||
155381036|NCT02008877|560828748|FG001|Overall Study|Inevaluable|1|||
155381037|NCT02008877|560828749|FG002|Overall Study|Inevaluable|0|||
155381038|NCT04227704|560828752|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
155381039|NCT04227704|560828753|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
155381040|NCT04227704|560828754|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
155381041|NCT04227704|560828752|FG000|Overall Study|due to C/S being cancelled|1|||
155381042|NCT04227704|560828753|FG001|Overall Study|due to C/S being cancelled|0|||
155381043|NCT04227704|560828754|FG002|Overall Study|due to C/S being cancelled|0|||
155381044|NCT02317432|560828755|FG000|Overall Study|Death|4|||
155381045|NCT02317432|560828756|FG001|Overall Study|Death|1|||
155381046|NCT02317432|560828755|FG000|Overall Study|Lost to Follow-up|0|||
155381047|NCT02317432|560828756|FG001|Overall Study|Lost to Follow-up|5|||
155381048|NCT02317432|560828755|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
154925192|NCT00347776|559150645|FG001|12 Month Follow-up|Death|4|||
154925193|NCT00347776|559150646|FG002|12 Month Follow-up|Death|4|||
154925194|NCT00347776|559150644|FG000|12 Month Follow-up|Reached endpoint|13|||
154925195|NCT00347776|559150645|FG001|12 Month Follow-up|Reached endpoint|6|||
154925196|NCT00347776|559150646|FG002|12 Month Follow-up|Reached endpoint|9|||
154925197|NCT00299546|559150647|FG000|Overall Study|Death|3|||
154925198|NCT00299546|559150648|FG001|Overall Study|Death|2|||
154925199|NCT00299546|559150649|FG002|Overall Study|Death|0|||
154925200|NCT00299546|559150647|FG000|Overall Study|Lost to Follow-up|2|||
154925201|NCT00299546|559150648|FG001|Overall Study|Lost to Follow-up|2|||
154925202|NCT00299546|559150649|FG002|Overall Study|Lost to Follow-up|5|||
154925203|NCT00299546|559150647|FG000|Overall Study|Adverse Event|37|||
154925204|NCT00299546|559150648|FG001|Overall Study|Adverse Event|22|||
155381049|NCT02317432|560828756|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
155381050|NCT00156819|560830794|FG000|Overall Study|Lost to Follow-up|1|||
155381051|NCT00156819|560830795|FG001|Overall Study|Lost to Follow-up|1|||
155381052|NCT00156819|560830796|FG002|Overall Study|Lost to Follow-up|3|||
155381053|NCT02808143|560830797|FG000|Maintenance Phase|Disease recurrence|1|||
154925205|NCT00299546|559150649|FG002|Overall Study|Adverse Event|27|||
154925206|NCT00299546|559150647|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
154925207|NCT00299546|559150648|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
154925208|NCT00299546|559150649|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
154925209|NCT00299546|559150647|FG000|Overall Study|Other|24|||
154925210|NCT00299546|559150648|FG001|Overall Study|Other|26|||
154925211|NCT00299546|559150649|FG002|Overall Study|Other|19|||
154925212|NCT00299546|559150647|FG000|Overall Study|Not treated|0|||
154925213|NCT00299546|559150648|FG001|Overall Study|Not treated|1|||
154925214|NCT00299546|559150649|FG002|Overall Study|Not treated|1|||
154925215|NCT00968539|559150653|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
154925216|NCT00968539|559150654|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
154925217|NCT00396318|559150655|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
154925218|NCT00326118|559150656|FG000|Active Phase|Withdrawal by Subject|4|||
154925219|NCT00326118|559150657|FG001|Active Phase|Withdrawal by Subject|1|||
154925220|NCT00602927|559150658|FG000|Period 1: 13 Days|Protocol Violation|2|||
154925221|NCT00602927|559150659|FG001|Period 1: 13 Days|Protocol Violation|4|||
154925222|NCT00602927|559150658|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
154925223|NCT00602927|559150659|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
154925224|NCT00602927|559150658|FG000|Period 1: 13 Days|Time|1|||
154925225|NCT00602927|559150659|FG001|Period 1: 13 Days|Time|0|||
154925226|NCT00602927|559150658|FG000|Period 1: 13 Days|Claustrophobia|0|||
154925227|NCT00602927|559150659|FG001|Period 1: 13 Days|Claustrophobia|1|||
154925228|NCT00602927|559150658|FG000|Period 2: 14 Days|Protocol Violation|0|||
154925229|NCT00602927|559150659|FG001|Period 2: 14 Days|Protocol Violation|2|||
154925230|NCT00602927|559150658|FG000|Period 3: 13 Days|Protocol Violation|0|||
154925231|NCT00602927|559150659|FG001|Period 3: 13 Days|Protocol Violation|1|||
154925232|NCT00602927|559150658|FG000|Period 3: 13 Days|MRI data quality|2|||
154925233|NCT00602927|559150659|FG001|Period 3: 13 Days|MRI data quality|2|||
154925234|NCT01741259|559150668|FG000|Overall Study|Protocol Violation|6|||
154925235|NCT01741259|559150669|FG001|Overall Study|Protocol Violation|4|||
154925236|NCT01741259|559150668|FG000|Overall Study|Withdrawal by Subject|0|||
154925237|NCT01741259|559150669|FG001|Overall Study|Withdrawal by Subject|2|||
154925238|NCT05604521|559150674|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
154925239|NCT05604521|559150675|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
154925240|NCT05604521|559150674|FG000|Overall Study|Adverse Event|1|||
154925241|NCT05604521|559150675|FG001|Overall Study|Adverse Event|0|||
154925242|NCT02525627|559150678|FG000|Overall Study|Revision|1|||
154925243|NCT02525627|559150679|FG001|Overall Study|Revision|1|||
154925244|NCT02525627|559150678|FG000|Overall Study|Withdrawal by Subject|1|||
154925245|NCT02525627|559150679|FG001|Overall Study|Withdrawal by Subject|2|||
154925246|NCT02525627|559150678|FG000|Overall Study|Death|1|||
154925247|NCT02525627|559150679|FG001|Overall Study|Death|0|||
154925248|NCT02525627|559150678|FG000|Overall Study|Site terminated|11|||
154925249|NCT02525627|559150679|FG001|Overall Study|Site terminated|10|||
154925250|NCT00242567|559150680|FG000|Overall Study|Adverse Event|70|||
154925251|NCT00242567|559150681|FG001|Overall Study|Adverse Event|43|||
154925252|NCT00242567|559150680|FG000|Overall Study|Disease Progression|17|||
154925253|NCT00242567|559150681|FG001|Overall Study|Disease Progression|22|||
154925254|NCT00242567|559150680|FG000|Overall Study|Symptomatic deterioration|9|||
154925255|NCT00242567|559150681|FG001|Overall Study|Symptomatic deterioration|3|||
154925256|NCT00242567|559150680|FG000|Overall Study|Lack of Efficacy|2|||
154925257|NCT00242567|559150681|FG001|Overall Study|Lack of Efficacy|2|||
154925258|NCT00242567|559150680|FG000|Overall Study|Lost to Follow-up|9|||
154925259|NCT00242567|559150681|FG001|Overall Study|Lost to Follow-up|19|||
154925260|NCT00242567|559150680|FG000|Overall Study|Withdrawal by Subject|33|||
154925261|NCT00242567|559150681|FG001|Overall Study|Withdrawal by Subject|28|||
154925262|NCT00242567|559150680|FG000|Overall Study|Protocol Violation|12|||
154925263|NCT00242567|559150681|FG001|Overall Study|Protocol Violation|12|||
154925264|NCT00242567|559150680|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
154925265|NCT00242567|559150681|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
154925266|NCT00242567|559150680|FG000|Overall Study|Other|14|||
154925267|NCT00242567|559150681|FG001|Overall Study|Other|9|||
154925268|NCT00630994|559150682|FG000|Overall Study|Adverse Event|1|||
154925269|NCT00630994|559150682|FG000|Overall Study|Disease Progression|1|||
154925270|NCT00630994|559150682|FG000|Overall Study|Lack of Efficacy|1|||
154925271|NCT00630994|559150682|FG000|Overall Study|Other|1|||
154925272|NCT05553600|559150683|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
154925273|NCT05553600|559150684|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
154925274|NCT05553600|559150685|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
154925275|NCT05553600|559150686|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
154925276|NCT05553600|559150683|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
154925277|NCT05553600|559150684|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
154925278|NCT05553600|559150685|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
154925279|NCT05553600|559150686|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
155152520|NCT03037385|559996847|FG005|Overall Study|Lost to Follow-up|1|||
154925280|NCT05553600|559150683|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
154925281|NCT05553600|559150684|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
154925282|NCT05553600|559150685|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
154925283|NCT05553600|559150686|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
154925284|NCT05553600|559150683|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
154925285|NCT05553600|559150684|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
154925286|NCT05553600|559150685|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
154925287|NCT05553600|559150686|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
154925288|NCT05553600|559150683|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
154925289|NCT05553600|559150684|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
154925290|NCT05553600|559150685|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
154925291|NCT05553600|559150686|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
154925292|NCT05553600|559150683|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
154925293|NCT05553600|559150684|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
154925294|NCT05553600|559150685|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
154925295|NCT05553600|559150686|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
154925296|NCT05553600|559150683|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
154925297|NCT05553600|559150684|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
154925298|NCT05553600|559150685|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
154925299|NCT05553600|559150686|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
154925300|NCT05553600|559150683|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
154925301|NCT05553600|559150684|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
154925302|NCT05553600|559150685|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
154925303|NCT05553600|559150686|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
154925304|NCT05553600|559150683|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
154925305|NCT05553600|559150684|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
154925306|NCT05553600|559150685|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
154925307|NCT05553600|559150686|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
154925308|NCT05553600|559150683|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
154925309|NCT05553600|559150684|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
154925310|NCT05553600|559150685|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
154925311|NCT05553600|559150686|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
154925312|NCT05553600|559150683|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
154925313|NCT05553600|559150684|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
154925314|NCT05553600|559150685|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
154925315|NCT05553600|559150686|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
154925316|NCT05553600|559150683|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
154925317|NCT05553600|559150684|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
154925318|NCT05553600|559150685|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
154925319|NCT05553600|559150686|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
154925320|NCT03710824|559150691|FG000|Overall Study|Withdrawal by Subject|1|||
154925321|NCT03710824|559150691|FG000|Overall Study|Lost to Follow-up|3|||
154925322|NCT03710824|559150691|FG000|Overall Study|Adverse Event|25|||
154925323|NCT03710824|559150691|FG000|Overall Study|Treatment discontinuation|2|||
154925324|NCT01605370|559150692|FG000|Overall Study|Adverse Event|1|||
154925325|NCT01605370|559150693|FG001|Overall Study|Adverse Event|0|||
154925326|NCT01317199|559150694|FG000|Dose-escalation Phase 1|Physician Decision|5|||
154925327|NCT01317199|559150695|FG001|Dose-escalation Phase 1|Physician Decision|0|||
154925328|NCT01317199|559150696|FG002|Dose-escalation Phase 1|Physician Decision|0|||
154925329|NCT01317199|559150697|FG003|Dose-escalation Phase 1|Physician Decision|0|||
154925330|NCT01317199|559150694|FG000|Dose-escalation Phase 1|Disease progression|1|||
154925331|NCT01317199|559150695|FG001|Dose-escalation Phase 1|Disease progression|0|||
154925332|NCT01317199|559150696|FG002|Dose-escalation Phase 1|Disease progression|0|||
154925333|NCT01317199|559150697|FG003|Dose-escalation Phase 1|Disease progression|0|||
154925334|NCT01317199|559150694|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
154925335|NCT01317199|559150695|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
154925336|NCT01317199|559150696|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
154925337|NCT01317199|559150697|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
154925338|NCT01317199|559150694|FG000|Randomized Phase 2|Disease progression|0|||
154925339|NCT01317199|559150695|FG001|Randomized Phase 2|Disease progression|3|||
154925340|NCT01317199|559150696|FG002|Randomized Phase 2|Disease progression|7|||
154925341|NCT01317199|559150697|FG003|Randomized Phase 2|Disease progression|5|||
154925342|NCT01317199|559150694|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
154925343|NCT01317199|559150695|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
154925344|NCT01317199|559150696|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
154925345|NCT01317199|559150697|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
154925346|NCT01317199|559150694|FG000|Randomized Phase 2|Adverse Event|0|||
154925347|NCT01317199|559150695|FG001|Randomized Phase 2|Adverse Event|0|||
154925348|NCT01317199|559150696|FG002|Randomized Phase 2|Adverse Event|0|||
154925349|NCT01317199|559150697|FG003|Randomized Phase 2|Adverse Event|1|||
154925350|NCT01317199|559150694|FG000|Randomized Phase 2|Comorbidities|0|||
154925351|NCT01317199|559150695|FG001|Randomized Phase 2|Comorbidities|2|||
154925352|NCT01317199|559150696|FG002|Randomized Phase 2|Comorbidities|2|||
154925353|NCT01317199|559150697|FG003|Randomized Phase 2|Comorbidities|2|||
154925354|NCT01317199|559150694|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
154925355|NCT01317199|559150695|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
154925356|NCT01317199|559150696|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
154925357|NCT01317199|559150697|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
154925358|NCT01317199|559150694|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
154925359|NCT01317199|559150695|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
154925360|NCT01317199|559150696|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
154925361|NCT01317199|559150697|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
154925362|NCT01317199|559150694|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
154925363|NCT01317199|559150695|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
154925364|NCT01317199|559150696|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
154925365|NCT01317199|559150697|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
154925366|NCT01317199|559150694|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
154925367|NCT01317199|559150695|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
155381054|NCT02808143|560830798|FG001|Maintenance Phase|Disease recurrence|3|||
155381055|NCT02808143|560830797|FG000|Maintenance Phase|Disease progression|1|||
155381056|NCT02808143|560830798|FG001|Maintenance Phase|Disease progression|2|||
155381057|NCT02808143|560830797|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
155381058|NCT02808143|560830798|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
155381059|NCT02808143|560830797|FG000|Survival Follow-Up|Disease recurrence|0|||
155381060|NCT02808143|560830798|FG001|Survival Follow-Up|Disease recurrence|2|||
155381061|NCT02808143|560830797|FG000|Survival Follow-Up|Adverse Event|0|||
155381062|NCT02808143|560830798|FG001|Survival Follow-Up|Adverse Event|1|||
155381063|NCT02808143|560830797|FG000|Survival Follow-Up|Death|1|||
155381064|NCT02808143|560830798|FG001|Survival Follow-Up|Death|0|||
155381065|NCT03718533|560830799|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
155381066|NCT03718533|560830799|FG000|Overall Study|Protocol deviation|1|||
155381067|NCT03718533|560830799|FG000|Overall Study|Disease progression|1|||
155381068|NCT03718533|560830799|FG000|Overall Study|Relapse|1|||
155381069|NCT03718533|560830799|FG000|Overall Study|Physician Decision|2|||
155381070|NCT03718533|560830799|FG000|Overall Study|Physician Decision and Adverse Event|1|||
155381071|NCT01248065|560830802|FG000|Overall Study|Lost to Follow-up|3|||
155381072|NCT01248065|560830803|FG001|Overall Study|Lost to Follow-up|5|||
155381073|NCT01248065|560830802|FG000|Overall Study|Withdrawal by Subject|14|||
155381074|NCT01248065|560830803|FG001|Overall Study|Withdrawal by Subject|11|||
155381075|NCT01248065|560830802|FG000|Overall Study|Adverse Event|3|||
155381076|NCT01248065|560830803|FG001|Overall Study|Adverse Event|0|||
155381077|NCT01248065|560830802|FG000|Overall Study|Third treatment failure event|3|||
155381078|NCT01248065|560830803|FG001|Overall Study|Third treatment failure event|1|||
155381079|NCT01248065|560830802|FG000|Overall Study|Other|3|||
155381080|NCT01248065|560830803|FG001|Overall Study|Other|5|||
155381081|NCT02781844|560830807|FG000|Treatment Period 1|Adverse Event|0|||
155381082|NCT02781844|560830808|FG001|Treatment Period 1|Adverse Event|0|||
155381083|NCT02781844|560830809|FG002|Treatment Period 1|Adverse Event|0|||
155381084|NCT02781844|560830810|FG003|Treatment Period 1|Adverse Event|0|||
155381085|NCT02781844|560830811|FG004|Treatment Period 1|Adverse Event|0|||
155381086|NCT02781844|560830812|FG005|Treatment Period 1|Adverse Event|1|||
155381087|NCT02781844|560830813|FG006|Treatment Period 1|Adverse Event|0|||
155381088|NCT02781844|560830814|FG007|Treatment Period 1|Adverse Event|0|||
155381089|NCT04256629|560830817|FG000|Overall Study|Adverse Event|0|||
155381090|NCT04256629|560830818|FG001|Overall Study|Adverse Event|0|||
155381091|NCT04256629|560830819|FG002|Overall Study|Adverse Event|0|||
155381092|NCT04256629|560830820|FG003|Overall Study|Adverse Event|0|||
155381093|NCT04256629|560830821|FG004|Overall Study|Adverse Event|0|||
155381094|NCT04256629|560830822|FG005|Overall Study|Adverse Event|1|||
154925368|NCT01317199|559150696|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
154925369|NCT01317199|559150697|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
154925370|NCT01353209|559150698|FG000|Overall Study|Adverse Event|1|||
154925371|NCT01353209|559150699|FG001|Overall Study|Adverse Event|1|||
154925372|NCT01301625|559150706|FG000|Overall Study|Death|5|||
154925373|NCT01301625|559150706|FG000|Overall Study|Not Due|21|||
154925374|NCT01301625|559150706|FG000|Overall Study|Expected|8|||
155381095|NCT04256629|560830817|FG000|Overall Study|Protocol Violation|0|||
155381096|NCT04256629|560830818|FG001|Overall Study|Protocol Violation|1|||
155381097|NCT04256629|560830819|FG002|Overall Study|Protocol Violation|0|||
155381098|NCT04256629|560830820|FG003|Overall Study|Protocol Violation|0|||
155381099|NCT04256629|560830821|FG004|Overall Study|Protocol Violation|0|||
155381100|NCT04256629|560830822|FG005|Overall Study|Protocol Violation|0|||
155381101|NCT00321373|560830823|FG000|Overall Study|Adverse Event|0|||
155381102|NCT00321373|560830824|FG001|Overall Study|Adverse Event|0|||
154925375|NCT01301625|559150706|FG000|Overall Study|Lost to Follow-up|1|||
154925376|NCT02684370|559150707|FG000|Part A|Adverse Event|2|||
154925377|NCT02684370|559150708|FG001|Part A|Adverse Event|0|||
154925378|NCT02684370|559150709|FG002|Part A|Adverse Event|1|||
154925379|NCT02684370|559150710|FG003|Part A|Adverse Event|0|||
154925380|NCT02684370|559150711|FG004|Part A|Adverse Event|0|||
154925381|NCT02684370|559150712|FG005|Part A|Adverse Event|0|||
154925382|NCT02684370|559150707|FG000|Part A|Lost to Follow-up|1|||
154925383|NCT02684370|559150708|FG001|Part A|Lost to Follow-up|1|||
154925384|NCT02684370|559150709|FG002|Part A|Lost to Follow-up|0|||
154925385|NCT02684370|559150710|FG003|Part A|Lost to Follow-up|0|||
154925386|NCT02684370|559150711|FG004|Part A|Lost to Follow-up|0|||
154925387|NCT02684370|559150712|FG005|Part A|Lost to Follow-up|0|||
154925388|NCT02684370|559150707|FG000|Part A|Subject Withdrawal|1|||
154925389|NCT02684370|559150708|FG001|Part A|Subject Withdrawal|0|||
154925390|NCT02684370|559150709|FG002|Part A|Subject Withdrawal|3|||
154925391|NCT02684370|559150710|FG003|Part A|Subject Withdrawal|0|||
154925392|NCT02684370|559150711|FG004|Part A|Subject Withdrawal|0|||
154925393|NCT02684370|559150712|FG005|Part A|Subject Withdrawal|0|||
154925394|NCT02684370|559150707|FG000|Part A|Other|0|||
154925395|NCT02684370|559150708|FG001|Part A|Other|0|||
154925396|NCT02684370|559150709|FG002|Part A|Other|1|||
155381103|NCT00321373|560830825|FG002|Overall Study|Adverse Event|1|||
155381104|NCT00321373|560830823|FG000|Overall Study|Lost to Follow-up|1|||
155381105|NCT00321373|560830824|FG001|Overall Study|Lost to Follow-up|0|||
155381106|NCT00321373|560830825|FG002|Overall Study|Lost to Follow-up|1|||
155381107|NCT00321373|560830823|FG000|Overall Study|Withdrawal by Subject|1|||
155381108|NCT00321373|560830824|FG001|Overall Study|Withdrawal by Subject|0|||
155381109|NCT00321373|560830825|FG002|Overall Study|Withdrawal by Subject|0|||
155381110|NCT00321373|560830823|FG000|Overall Study|Other|0|||
155381111|NCT00321373|560830824|FG001|Overall Study|Other|0|||
155381112|NCT00321373|560830825|FG002|Overall Study|Other|1|||
155381113|NCT01774487|560830826|FG000|Overall Study|Did not tolerate taste|4|||
155381114|NCT01774487|560830827|FG001|Overall Study|Did not tolerate taste|4|||
155381115|NCT01383499|560830828|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
155381116|NCT01383499|560830829|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155381117|NCT01383499|560830830|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155381118|NCT01383499|560830831|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
155381119|NCT00477334|560830832|FG000|Overall Study|Discontinued prior to taking study drug|106|||
155381120|NCT00477334|560830833|FG001|Overall Study|Discontinued prior to taking study drug|53|||
155381121|NCT00477334|560830832|FG000|Overall Study|Adverse Event|1|||
155381122|NCT00477334|560830833|FG001|Overall Study|Adverse Event|2|||
155381123|NCT00477334|560830832|FG000|Overall Study|Withdrawal by Subject|2|||
155381124|NCT00477334|560830833|FG001|Overall Study|Withdrawal by Subject|1|||
155381125|NCT00477334|560830832|FG000|Overall Study|Lost to Follow-up|15|||
155381126|NCT00477334|560830833|FG001|Overall Study|Lost to Follow-up|4|||
155381127|NCT00477334|560830832|FG000|Overall Study|Administrative Problems|39|||
155381128|NCT00477334|560830833|FG001|Overall Study|Administrative Problems|15|||
155381129|NCT00477334|560830832|FG000|Overall Study|Protocol Violation|7|||
155381130|NCT00477334|560830833|FG001|Overall Study|Protocol Violation|1|||
155381131|NCT02572882|560830834|FG000|Overall Study|Withdrawal by Subject|1|||
155381132|NCT02572882|560830834|FG000|Overall Study|Participant received kidney transplant|1|||
155381133|NCT04275089|560830835|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
155381134|NCT01079663|560830839|FG000|Overall Study|Adverse Event|0|||
155381135|NCT01079663|560830840|FG001|Overall Study|Adverse Event|2|||
155381136|NCT01079663|560830839|FG000|Overall Study|Protocol Violation|0|||
155381137|NCT01079663|560830840|FG001|Overall Study|Protocol Violation|2|||
155381138|NCT00461032|560830844|FG000|Overall Study|Adverse Event|5|||
155381139|NCT00461032|560830845|FG001|Overall Study|Adverse Event|6|||
155381140|NCT00461032|560830844|FG000|Overall Study|Lack of Efficacy|5|||
155381141|NCT00461032|560830845|FG001|Overall Study|Lack of Efficacy|1|||
155381142|NCT00461032|560830844|FG000|Overall Study|Lost to Follow-up|7|||
155381143|NCT00461032|560830845|FG001|Overall Study|Lost to Follow-up|12|||
155381144|NCT00461032|560830844|FG000|Overall Study|Protocol Violation|4|||
155381145|NCT00461032|560830845|FG001|Overall Study|Protocol Violation|4|||
155381146|NCT00461032|560830844|FG000|Overall Study|Withdrawal by Subject|7|||
155381147|NCT00461032|560830845|FG001|Overall Study|Withdrawal by Subject|15|||
155381148|NCT00461032|560830844|FG000|Overall Study|Patient Moved or Relocated|2|||
155381149|NCT00461032|560830845|FG001|Overall Study|Patient Moved or Relocated|1|||
154925397|NCT02684370|559150710|FG003|Part A|Other|0|||
154925398|NCT02684370|559150711|FG004|Part A|Other|0|||
154925399|NCT02684370|559150712|FG005|Part A|Other|0|||
154925400|NCT02684370|559150707|FG000|Part B|Adverse Event|0|||
154925401|NCT02684370|559150708|FG001|Part B|Adverse Event|0|||
154925402|NCT02684370|559150709|FG002|Part B|Adverse Event|0|||
155381150|NCT00461032|560830844|FG000|Overall Study|Other|7|||
155381151|NCT00461032|560830845|FG001|Overall Study|Other|5|||
154925403|NCT02684370|559150710|FG003|Part B|Adverse Event|0|||
154925404|NCT02684370|559150711|FG004|Part B|Adverse Event|2|||
154925405|NCT02684370|559150712|FG005|Part B|Adverse Event|1|||
154925406|NCT02684370|559150707|FG000|Part B|Lost to Follow-up|0|||
154925407|NCT02684370|559150708|FG001|Part B|Lost to Follow-up|0|||
155381152|NCT03486457|560830847|FG000|Up to Month 3|Adverse Event|2|||
155381153|NCT03486457|560830848|FG001|Up to Month 3|Adverse Event|5|||
155381154|NCT03486457|560830847|FG000|Up to Month 3|Lack of Efficacy|1|||
155381155|NCT03486457|560830848|FG001|Up to Month 3|Lack of Efficacy|0|||
155381156|NCT03486457|560830847|FG000|Up to Month 3|Withdrawal by Subject|1|||
155381157|NCT03486457|560830848|FG001|Up to Month 3|Withdrawal by Subject|0|||
155381158|NCT03486457|560830847|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
155381159|NCT03486457|560830848|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
155381160|NCT03486457|560830847|FG000|Up to Month 3|Other|1|||
155381161|NCT03486457|560830848|FG001|Up to Month 3|Other|0|||
154925408|NCT02684370|559150709|FG002|Part B|Lost to Follow-up|0|||
154925409|NCT02684370|559150710|FG003|Part B|Lost to Follow-up|1|||
154925410|NCT02684370|559150711|FG004|Part B|Lost to Follow-up|2|||
154925411|NCT02684370|559150712|FG005|Part B|Lost to Follow-up|5|||
154925412|NCT02684370|559150707|FG000|Part B|Subject Withdrawal|0|||
154925413|NCT02684370|559150708|FG001|Part B|Subject Withdrawal|0|||
154925414|NCT02684370|559150709|FG002|Part B|Subject Withdrawal|0|||
154925415|NCT02684370|559150710|FG003|Part B|Subject Withdrawal|1|||
154925416|NCT02684370|559150711|FG004|Part B|Subject Withdrawal|1|||
154925417|NCT02684370|559150712|FG005|Part B|Subject Withdrawal|2|||
154925418|NCT00326625|559150715|FG000|Overall Study|Adverse Event|20|||
154925419|NCT00326625|559150716|FG001|Overall Study|Adverse Event|9|||
154925420|NCT00326625|559150715|FG000|Overall Study|Withdrawal by Subject|15|||
154925421|NCT00326625|559150716|FG001|Overall Study|Withdrawal by Subject|12|||
154925422|NCT00326625|559150715|FG000|Overall Study|Death|18|||
154925423|NCT00326625|559150716|FG001|Overall Study|Death|16|||
154925424|NCT00326625|559150715|FG000|Overall Study|Lost to Follow-up|1|||
154925425|NCT00326625|559150716|FG001|Overall Study|Lost to Follow-up|0|||
155381162|NCT03486457|560830847|FG000|Month 3 to Month 6|Adverse Event|2|||
155381163|NCT03486457|560830848|FG001|Month 3 to Month 6|Adverse Event|0|||
155381164|NCT03486457|560830847|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
155381165|NCT03486457|560830848|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
155381166|NCT03486457|560830847|FG000|Month 3 to Month 6|Pregnancy|0|||
155381167|NCT03486457|560830848|FG001|Month 3 to Month 6|Pregnancy|1|||
155381168|NCT03486457|560830847|FG000|Month 3 to Month 6|Other|1|||
155381169|NCT03486457|560830848|FG001|Month 3 to Month 6|Other|0|||
155381170|NCT02257567|560830849|FG000|Overall Study|Adverse Event|0|||
155381171|NCT02257567|560830850|FG001|Overall Study|Adverse Event|0|||
155381172|NCT02257567|560830851|FG002|Overall Study|Adverse Event|0|||
155381173|NCT02257567|560830852|FG003|Overall Study|Adverse Event|1|||
154925426|NCT00326625|559150715|FG000|Overall Study|prescheduled medical intervention|0|||
154925427|NCT00326625|559150716|FG001|Overall Study|prescheduled medical intervention|1|||
154925428|NCT00625846|559150722|FG000|Overall Study|Withdrawal by Subject|2|||
154925429|NCT00625846|559150723|FG001|Overall Study|Withdrawal by Subject|0|||
154925430|NCT00625846|559150724|FG002|Overall Study|Withdrawal by Subject|1|||
155381174|NCT02257567|560830853|FG004|Overall Study|Adverse Event|1|||
155381175|NCT02257567|560830854|FG005|Overall Study|Adverse Event|0|||
155381176|NCT02257567|560830855|FG006|Overall Study|Adverse Event|0|||
155381177|NCT02257567|560830856|FG007|Overall Study|Adverse Event|0|||
155381178|NCT02257567|560830857|FG008|Overall Study|Adverse Event|1|||
155381179|NCT02257567|560830858|FG009|Overall Study|Adverse Event|0|||
155381180|NCT02257567|560830859|FG010|Overall Study|Adverse Event|0|||
155381181|NCT02257567|560830849|FG000|Overall Study|Death|2|||
155381182|NCT02257567|560830850|FG001|Overall Study|Death|2|||
155381183|NCT02257567|560830851|FG002|Overall Study|Death|2|||
155381184|NCT02257567|560830852|FG003|Overall Study|Death|4|||
155381185|NCT02257567|560830853|FG004|Overall Study|Death|15|||
155381186|NCT02257567|560830854|FG005|Overall Study|Death|11|||
155381187|NCT02257567|560830855|FG006|Overall Study|Death|26|||
155381188|NCT02257567|560830856|FG007|Overall Study|Death|30|||
155381189|NCT02257567|560830857|FG008|Overall Study|Death|2|||
155381190|NCT02257567|560830858|FG009|Overall Study|Death|18|||
155381191|NCT02257567|560830859|FG010|Overall Study|Death|65|||
155381192|NCT02257567|560830849|FG000|Overall Study|Lost to Follow-up|0|||
155381193|NCT02257567|560830850|FG001|Overall Study|Lost to Follow-up|0|||
155381194|NCT02257567|560830851|FG002|Overall Study|Lost to Follow-up|0|||
155381195|NCT02257567|560830852|FG003|Overall Study|Lost to Follow-up|0|||
155381196|NCT02257567|560830853|FG004|Overall Study|Lost to Follow-up|2|||
155381197|NCT02257567|560830854|FG005|Overall Study|Lost to Follow-up|2|||
155381198|NCT02257567|560830855|FG006|Overall Study|Lost to Follow-up|0|||
154925431|NCT00625846|559150725|FG003|Overall Study|Withdrawal by Subject|2|||
155381199|NCT02257567|560830856|FG007|Overall Study|Lost to Follow-up|0|||
154925432|NCT00807040|559150726|FG000|Overall Study|Death|24|||
154925433|NCT00807040|559150727|FG001|Overall Study|Death|29|||
154925434|NCT00807040|559150726|FG000|Overall Study|Withdrawal by Subject|8|||
154925435|NCT00807040|559150727|FG001|Overall Study|Withdrawal by Subject|6|||
154925436|NCT00807040|559150726|FG000|Overall Study|Lost to Follow-up|4|||
154925437|NCT00807040|559150727|FG001|Overall Study|Lost to Follow-up|6|||
154925438|NCT03075826|559150731|FG000|Overall Study|Withdrawal by Subject|1|||
154925439|NCT03075826|559150731|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
155381200|NCT02257567|560830857|FG008|Overall Study|Lost to Follow-up|0|||
155381201|NCT02257567|560830858|FG009|Overall Study|Lost to Follow-up|1|||
155381202|NCT02257567|560830859|FG010|Overall Study|Lost to Follow-up|1|||
155381203|NCT02257567|560830849|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381204|NCT02257567|560830850|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381205|NCT02257567|560830851|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381206|NCT02257567|560830852|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381207|NCT02257567|560830853|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
155381208|NCT02257567|560830854|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381209|NCT02257567|560830855|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
155381210|NCT02257567|560830856|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381211|NCT02257567|560830857|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381212|NCT02257567|560830858|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381213|NCT02257567|560830859|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
155381214|NCT02257567|560830849|FG000|Overall Study|Physician Decision|0|||
155381215|NCT02257567|560830850|FG001|Overall Study|Physician Decision|0|||
155381216|NCT02257567|560830851|FG002|Overall Study|Physician Decision|0|||
155381217|NCT02257567|560830852|FG003|Overall Study|Physician Decision|0|||
155381218|NCT02257567|560830853|FG004|Overall Study|Physician Decision|0|||
155381219|NCT02257567|560830854|FG005|Overall Study|Physician Decision|0|||
155381220|NCT02257567|560830855|FG006|Overall Study|Physician Decision|0|||
155381221|NCT02257567|560830856|FG007|Overall Study|Physician Decision|2|||
155381222|NCT02257567|560830857|FG008|Overall Study|Physician Decision|0|||
155381223|NCT02257567|560830858|FG009|Overall Study|Physician Decision|1|||
155381224|NCT02257567|560830859|FG010|Overall Study|Physician Decision|0|||
155381225|NCT02257567|560830849|FG000|Overall Study|Withdrawal by Subject|0|||
155381226|NCT02257567|560830850|FG001|Overall Study|Withdrawal by Subject|0|||
155381227|NCT02257567|560830851|FG002|Overall Study|Withdrawal by Subject|2|||
155381228|NCT02257567|560830852|FG003|Overall Study|Withdrawal by Subject|0|||
155381229|NCT02257567|560830853|FG004|Overall Study|Withdrawal by Subject|0|||
155381230|NCT02257567|560830854|FG005|Overall Study|Withdrawal by Subject|6|||
155381231|NCT02257567|560830855|FG006|Overall Study|Withdrawal by Subject|6|||
155381232|NCT02257567|560830856|FG007|Overall Study|Withdrawal by Subject|6|||
155381233|NCT02257567|560830857|FG008|Overall Study|Withdrawal by Subject|1|||
155381234|NCT02257567|560830858|FG009|Overall Study|Withdrawal by Subject|1|||
155381235|NCT02257567|560830859|FG010|Overall Study|Withdrawal by Subject|10|||
155381236|NCT03536143|560830860|FG000|Overall Study|Early termination, Sponsor decision|1|||
155381237|NCT01174160|560830861|FG000|Overall Study|Adverse Event|1|||
155381238|NCT01174160|560830862|FG001|Overall Study|Adverse Event|0|||
154925440|NCT04228107|559150732|FG000|Overall Study|Protocol Violation|1|||
154925441|NCT04228107|559150733|FG001|Overall Study|Protocol Violation|0|||
154925442|NCT04228107|559150732|FG000|Overall Study|Withdrawal by Subject|6|||
154925443|NCT04228107|559150733|FG001|Overall Study|Withdrawal by Subject|0|||
154925444|NCT04228107|559150732|FG000|Overall Study|Lost to Follow-up|18|||
154925445|NCT04228107|559150733|FG001|Overall Study|Lost to Follow-up|0|||
154925446|NCT04228107|559150732|FG000|Overall Study|No controller use data|1|||
154925447|NCT04228107|559150733|FG001|Overall Study|No controller use data|0|||
154925448|NCT04228107|559150732|FG000|Overall Study|No medication data collected|1|||
154925449|NCT04228107|559150733|FG001|Overall Study|No medication data collected|0|||
154925450|NCT00965562|559150734|FG000|Overall Study|Lost to Follow-up|1|||
154925451|NCT00965562|559150735|FG001|Overall Study|Lost to Follow-up|2|||
154925452|NCT00965562|559150736|FG002|Overall Study|Lost to Follow-up|3|||
154925453|NCT00965562|559150734|FG000|Overall Study|Withdrawal by Subject|2|||
154925454|NCT00965562|559150735|FG001|Overall Study|Withdrawal by Subject|2|||
154925455|NCT00965562|559150736|FG002|Overall Study|Withdrawal by Subject|0|||
154925456|NCT04755283|559150737|FG000|Overall Study|Withdrawal by Subject|14|||
154925457|NCT04755283|559150738|FG001|Overall Study|Withdrawal by Subject|3|||
154925458|NCT04755283|559150739|FG002|Overall Study|Withdrawal by Subject|6|||
154925459|NCT04755283|559150737|FG000|Overall Study|Lost to Follow-up|0|||
154925460|NCT04755283|559150738|FG001|Overall Study|Lost to Follow-up|0|||
154925461|NCT04755283|559150739|FG002|Overall Study|Lost to Follow-up|1|||
154925462|NCT04755283|559150737|FG000|Overall Study|Death|31|||
154925463|NCT04755283|559150738|FG001|Overall Study|Death|36|||
154925464|NCT04755283|559150739|FG002|Overall Study|Death|34|||
154925465|NCT04342390|559150743|FG000|Overall Study|Lost to Follow-up|3|||
154925466|NCT04342390|559150744|FG001|Overall Study|Lost to Follow-up|0|||
154925467|NCT04584294|559150745|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
154925468|NCT04584294|559150746|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
154966762|NCT00902538|559301136|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
155381239|NCT01174160|560830861|FG000|Overall Study|Lost to Follow-up|1|||
155381240|NCT01174160|560830862|FG001|Overall Study|Lost to Follow-up|0|||
155381241|NCT01174160|560830861|FG000|Overall Study|Physician Decision|1|||
155381242|NCT01174160|560830862|FG001|Overall Study|Physician Decision|0|||
155381243|NCT01174160|560830861|FG000|Overall Study|Protocol Violation|4|||
155381244|NCT01174160|560830862|FG001|Overall Study|Protocol Violation|6|||
155381245|NCT01174160|560830861|FG000|Overall Study|Withdrawal by Subject|1|||
155381246|NCT01174160|560830862|FG001|Overall Study|Withdrawal by Subject|0|||
155381247|NCT01590017|560830863|FG000|Overall Study|Adverse Event|1|||
155381248|NCT01590017|560830863|FG000|Overall Study|Withdrawal by Subject|1|||
155381249|NCT01590017|560830863|FG000|Overall Study|Lack of Efficacy|1|||
155381250|NCT01590017|560830863|FG000|Overall Study|Physician Decision|1|||
155381251|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
155381252|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381253|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381254|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381255|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381256|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
155381257|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
155381258|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381259|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381260|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381261|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381262|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
155381263|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381264|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
155381265|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381266|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381267|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381268|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
155381269|NCT02527343|560830864|FG000|RT Period: Weeks 1 to 52|Other|4|||
155381270|NCT02527343|560830865|FG001|RT Period: Weeks 1 to 52|Other|3|||
155381271|NCT02527343|560830866|FG002|RT Period: Weeks 1 to 52|Other|0|||
155381272|NCT02527343|560830867|FG003|RT Period: Weeks 1 to 52|Other|0|||
155381273|NCT02527343|560830868|FG004|RT Period: Weeks 1 to 52|Other|0|||
155381274|NCT02527343|560830869|FG005|RT Period: Weeks 1 to 52|Other|0|||
155381275|NCT02527343|560830864|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381276|NCT02527343|560830865|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381277|NCT02527343|560830866|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
155381278|NCT02527343|560830867|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381279|NCT02527343|560830868|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381280|NCT02527343|560830869|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
155381281|NCT02527343|560830864|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381282|NCT02527343|560830865|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381283|NCT02527343|560830866|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381284|NCT02527343|560830867|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
155381285|NCT02527343|560830868|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381286|NCT02527343|560830869|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
155381287|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381288|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381289|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381290|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381291|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
155381292|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
155381293|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381294|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381295|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381296|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
155381297|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
155381298|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
155381299|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381300|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381301|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381302|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
155381303|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
155381304|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
155381305|NCT02527343|560830864|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
155381306|NCT02527343|560830865|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
155381307|NCT02527343|560830866|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
155381308|NCT02527343|560830867|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
154925469|NCT04584294|559150745|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
154925470|NCT04584294|559150746|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
154925471|NCT04584294|559150745|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
154925472|NCT04584294|559150746|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
154925473|NCT04584294|559150745|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
154925474|NCT04584294|559150746|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
154925475|NCT04584294|559150745|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
154925476|NCT04584294|559150746|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
154925477|NCT04584294|559150745|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
154925478|NCT04584294|559150746|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
154925479|NCT05153629|559150757|FG000|Overall Study|Withdrawal by Subject|0|||
154925480|NCT05153629|559150758|FG001|Overall Study|Withdrawal by Subject|2|||
154925481|NCT00157820|559150766|FG000|Randomized|Physician Decision|4|||
154925482|NCT00157820|559150767|FG001|Randomized|Physician Decision|2|||
154925483|NCT00157820|559150768|FG002|Randomized|Physician Decision|3|||
154925484|NCT00157820|559150766|FG000|Randomized|Withdrawal by Subject|1|||
154925485|NCT00157820|559150767|FG001|Randomized|Withdrawal by Subject|2|||
154925486|NCT00157820|559150768|FG002|Randomized|Withdrawal by Subject|3|||
154925487|NCT00157820|559150766|FG000|Randomized|Protocol Violation|2|||
154925488|NCT00157820|559150767|FG001|Randomized|Protocol Violation|1|||
154925489|NCT00157820|559150768|FG002|Randomized|Protocol Violation|2|||
154925490|NCT00157820|559150766|FG000|1st 8 Month|Death|7|||
154925491|NCT00157820|559150767|FG001|1st 8 Month|Death|8|||
154925492|NCT00157820|559150768|FG002|1st 8 Month|Death|3|||
154925493|NCT00157820|559150766|FG000|1st 8 Month|Lost to Follow-up|1|||
154925494|NCT00157820|559150767|FG001|1st 8 Month|Lost to Follow-up|2|||
154925495|NCT00157820|559150768|FG002|1st 8 Month|Lost to Follow-up|1|||
154925496|NCT00157820|559150766|FG000|1st 8 Month|Premature cross-over|0|||
154925497|NCT00157820|559150767|FG001|1st 8 Month|Premature cross-over|2|||
154925498|NCT00157820|559150768|FG002|1st 8 Month|Premature cross-over|2|||
154925499|NCT00157820|559150766|FG000|2nd 8 Months|Death|3|||
154925500|NCT00157820|559150767|FG001|2nd 8 Months|Death|1|||
154925501|NCT00157820|559150768|FG002|2nd 8 Months|Death|3|||
154925502|NCT00157820|559150766|FG000|2nd 8 Months|Lost to Follow-up|1|||
154925503|NCT00157820|559150767|FG001|2nd 8 Months|Lost to Follow-up|5|||
154925504|NCT00157820|559150768|FG002|2nd 8 Months|Lost to Follow-up|2|||
154925505|NCT00157820|559150766|FG000|2nd 8 Months|Premature cross-over|1|||
154925506|NCT00157820|559150767|FG001|2nd 8 Months|Premature cross-over|7|||
154925507|NCT00157820|559150768|FG002|2nd 8 Months|Premature cross-over|9|||
154925508|NCT02207413|559150769|FG000|Overall Study|Withdrawal by Subject|1|||
154925509|NCT02207413|559150770|FG001|Overall Study|Withdrawal by Subject|0|||
154925510|NCT02207413|559150771|FG002|Overall Study|Withdrawal by Subject|0|||
154925511|NCT02207413|559150772|FG003|Overall Study|Withdrawal by Subject|0|||
154925512|NCT02207413|559150773|FG004|Overall Study|Withdrawal by Subject|3|||
154925513|NCT02207413|559150774|FG005|Overall Study|Withdrawal by Subject|7|||
154925514|NCT02207413|559150769|FG000|Overall Study|Lost to Follow-up|0|||
154925515|NCT02207413|559150770|FG001|Overall Study|Lost to Follow-up|0|||
154925516|NCT02207413|559150771|FG002|Overall Study|Lost to Follow-up|0|||
154925517|NCT02207413|559150772|FG003|Overall Study|Lost to Follow-up|1|||
154925518|NCT02207413|559150773|FG004|Overall Study|Lost to Follow-up|1|||
154925519|NCT02207413|559150774|FG005|Overall Study|Lost to Follow-up|5|||
154925520|NCT02207413|559150769|FG000|Overall Study|Adverse Event|0|||
154925521|NCT02207413|559150770|FG001|Overall Study|Adverse Event|0|||
154925522|NCT02207413|559150771|FG002|Overall Study|Adverse Event|0|||
154925523|NCT02207413|559150772|FG003|Overall Study|Adverse Event|0|||
154925524|NCT02207413|559150773|FG004|Overall Study|Adverse Event|2|||
154925525|NCT02207413|559150774|FG005|Overall Study|Adverse Event|1|||
154925526|NCT02207413|559150769|FG000|Overall Study|Migrated/moved from study area|0|||
154925527|NCT02207413|559150770|FG001|Overall Study|Migrated/moved from study area|0|||
154925528|NCT02207413|559150771|FG002|Overall Study|Migrated/moved from study area|0|||
154925529|NCT02207413|559150772|FG003|Overall Study|Migrated/moved from study area|0|||
154925530|NCT02207413|559150773|FG004|Overall Study|Migrated/moved from study area|1|||
154925531|NCT02207413|559150774|FG005|Overall Study|Migrated/moved from study area|0|||
154925532|NCT04075656|559150775|FG000|Overall Study|Withdrawal by Subject|5|||
154925533|NCT04075656|559150776|FG001|Overall Study|Withdrawal by Subject|5|||
154925534|NCT02181673|559152846|FG000|Up to Week 24|Adverse Event|2|||
154925535|NCT02181673|559152847|FG001|Up to Week 24|Adverse Event|0|||
154925536|NCT02181673|559152848|FG002|Up to Week 24|Adverse Event|3|||
154925537|NCT02181673|559152846|FG000|Up to Week 24|Death|1|||
154925538|NCT02181673|559152847|FG001|Up to Week 24|Death|0|||
154925539|NCT02181673|559152848|FG002|Up to Week 24|Death|0|||
154925540|NCT02181673|559152846|FG000|Up to Week 24|Lack of Efficacy|1|||
154925541|NCT02181673|559152847|FG001|Up to Week 24|Lack of Efficacy|0|||
154925542|NCT02181673|559152848|FG002|Up to Week 24|Lack of Efficacy|0|||
154925543|NCT02181673|559152846|FG000|Up to Week 24|Lost to Follow-up|1|||
154925544|NCT02181673|559152847|FG001|Up to Week 24|Lost to Follow-up|0|||
154925545|NCT02181673|559152848|FG002|Up to Week 24|Lost to Follow-up|0|||
154925546|NCT02181673|559152846|FG000|Up to Week 24|Physician Decision|0|||
154925547|NCT02181673|559152847|FG001|Up to Week 24|Physician Decision|0|||
154925548|NCT02181673|559152848|FG002|Up to Week 24|Physician Decision|3|||
154925549|NCT02181673|559152846|FG000|Up to Week 24|Withdrawal by Subject|10|||
154925550|NCT02181673|559152847|FG001|Up to Week 24|Withdrawal by Subject|0|||
154925551|NCT02181673|559152848|FG002|Up to Week 24|Withdrawal by Subject|1|||
154925552|NCT02181673|559152846|FG000|Up to Week 24|Other|2|||
154925553|NCT02181673|559152847|FG001|Up to Week 24|Other|0|||
154925554|NCT02181673|559152848|FG002|Up to Week 24|Other|3|||
154925555|NCT02181673|559152846|FG000|Up to Week 24|Randomized not Treated|0|||
154925556|NCT02181673|559152847|FG001|Up to Week 24|Randomized not Treated|0|||
154925557|NCT02181673|559152848|FG002|Up to Week 24|Randomized not Treated|1|||
154925558|NCT02181673|559152846|FG000|Week 24-Week 60|Adverse Event|0|||
154925559|NCT02181673|559152847|FG001|Week 24-Week 60|Adverse Event|4|||
154925560|NCT02181673|559152848|FG002|Week 24-Week 60|Adverse Event|10|||
154925561|NCT02181673|559152846|FG000|Week 24-Week 60|Other|0|||
154925562|NCT02181673|559152847|FG001|Week 24-Week 60|Other|2|||
154925563|NCT02181673|559152848|FG002|Week 24-Week 60|Other|1|||
154925564|NCT02181673|559152846|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
154925565|NCT02181673|559152847|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
154925566|NCT02181673|559152848|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
154925567|NCT02181673|559152846|FG000|Week 24-Week 60|Pregnancy|0|||
154925568|NCT02181673|559152847|FG001|Week 24-Week 60|Pregnancy|0|||
154925569|NCT02181673|559152848|FG002|Week 24-Week 60|Pregnancy|1|||
154925570|NCT02181673|559152846|FG000|Week 24-Week 60|Lack of Efficacy|0|||
154925571|NCT02181673|559152847|FG001|Week 24-Week 60|Lack of Efficacy|0|||
154925572|NCT02181673|559152848|FG002|Week 24-Week 60|Lack of Efficacy|1|||
154925573|NCT02181673|559152846|FG000|Week 24-Week 60|Lost to Follow-up|0|||
154925574|NCT02181673|559152847|FG001|Week 24-Week 60|Lost to Follow-up|0|||
154925575|NCT02181673|559152848|FG002|Week 24-Week 60|Lost to Follow-up|1|||
154925576|NCT02181673|559152846|FG000|Week 24-Week 60|Physician Decision|0|||
154925577|NCT02181673|559152847|FG001|Week 24-Week 60|Physician Decision|0|||
154925578|NCT02181673|559152848|FG002|Week 24-Week 60|Physician Decision|1|||
154925579|NCT00337727|559152851|FG000|Overall Study|Adverse Event|5|||
154925580|NCT00337727|559152852|FG001|Overall Study|Adverse Event|3|||
154925581|NCT00337727|559152851|FG000|Overall Study|Lost to Follow-up|5|||
154925582|NCT00337727|559152852|FG001|Overall Study|Lost to Follow-up|4|||
154925583|NCT00337727|559152851|FG000|Overall Study|Physician Decision|1|||
154925584|NCT00337727|559152852|FG001|Overall Study|Physician Decision|0|||
154925585|NCT00337727|559152851|FG000|Overall Study|Protocol Violation|4|||
154925586|NCT00337727|559152852|FG001|Overall Study|Protocol Violation|0|||
154925587|NCT00337727|559152851|FG000|Overall Study|Withdrawal by Subject|3|||
154925588|NCT00337727|559152852|FG001|Overall Study|Withdrawal by Subject|5|||
154925589|NCT00320801|559152853|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
154925590|NCT00320801|559152854|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
154925591|NCT00320801|559152855|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
154925592|NCT00320801|559152856|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
154925593|NCT00320801|559152853|FG000|Open-label Run-in Period|Adverse Event|33|||
154925594|NCT00320801|559152854|FG001|Open-label Run-in Period|Adverse Event|0|||
154925595|NCT00320801|559152855|FG002|Open-label Run-in Period|Adverse Event|0|||
154925596|NCT00320801|559152856|FG003|Open-label Run-in Period|Adverse Event|0|||
154925597|NCT00320801|559152853|FG000|Open-label Run-in Period|Administrative|10|||
154925598|NCT00320801|559152854|FG001|Open-label Run-in Period|Administrative|0|||
154925599|NCT00320801|559152855|FG002|Open-label Run-in Period|Administrative|0|||
154925600|NCT00320801|559152856|FG003|Open-label Run-in Period|Administrative|0|||
154925601|NCT00320801|559152853|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
154925602|NCT00320801|559152854|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
154925603|NCT00320801|559152855|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
154925604|NCT00320801|559152856|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
154925605|NCT00320801|559152853|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
154925606|NCT00320801|559152854|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
154925607|NCT00320801|559152855|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
154925608|NCT00320801|559152856|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
154925609|NCT00320801|559152853|FG000|Open-label Run-in Period|Did not qualify|1|||
154925610|NCT00320801|559152854|FG001|Open-label Run-in Period|Did not qualify|0|||
154925611|NCT00320801|559152855|FG002|Open-label Run-in Period|Did not qualify|0|||
154925612|NCT00320801|559152856|FG003|Open-label Run-in Period|Did not qualify|0|||
154925613|NCT00320801|559152853|FG000|Double-blind Phase|Withdrawal by Subject|0|||
154925614|NCT00320801|559152854|FG001|Double-blind Phase|Withdrawal by Subject|0|||
154925615|NCT00320801|559152855|FG002|Double-blind Phase|Withdrawal by Subject|1|||
154925616|NCT00320801|559152856|FG003|Double-blind Phase|Withdrawal by Subject|0|||
154925617|NCT00320801|559152853|FG000|Double-blind Phase|Adverse Event|0|||
154925618|NCT00320801|559152854|FG001|Double-blind Phase|Adverse Event|2|||
155381309|NCT02527343|560830868|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
154925619|NCT00320801|559152855|FG002|Double-blind Phase|Adverse Event|8|||
154925620|NCT00320801|559152856|FG003|Double-blind Phase|Adverse Event|0|||
154925621|NCT00320801|559152853|FG000|Double-blind Phase|Administrative|0|||
154925622|NCT00320801|559152854|FG001|Double-blind Phase|Administrative|0|||
155381310|NCT02527343|560830869|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
155381311|NCT02527343|560830864|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381312|NCT02527343|560830865|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381313|NCT02527343|560830866|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381314|NCT02527343|560830867|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
155381315|NCT02527343|560830868|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
155381316|NCT02527343|560830869|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
155381317|NCT02527343|560830864|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381318|NCT02527343|560830865|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381319|NCT02527343|560830866|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381320|NCT02527343|560830867|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381321|NCT02527343|560830868|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
155381322|NCT02527343|560830869|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
155381323|NCT02527343|560830864|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
155381324|NCT02527343|560830865|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
155381325|NCT02527343|560830866|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
155381326|NCT02527343|560830867|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
155381327|NCT02527343|560830868|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
155381328|NCT02527343|560830869|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
155381329|NCT05767021|560830870|FG000|Overall Study|Adverse Event|2|||
155381330|NCT05767021|560830870|FG000|Overall Study|Protocol Deviation|1|||
155381331|NCT05767021|560830870|FG000|Overall Study|Withdrawal by Subject|1|||
155381332|NCT05767021|560830870|FG000|Overall Study|Physician Decision|1|||
155381333|NCT05767021|560830870|FG000|Overall Study|Lack of Efficacy|11|||
155381334|NCT05767021|560830870|FG000|Overall Study|Assigned Treatment by Mistake|1|||
154925623|NCT00320801|559152855|FG002|Double-blind Phase|Administrative|4|||
154925624|NCT00320801|559152856|FG003|Double-blind Phase|Administrative|0|||
154925625|NCT00320801|559152853|FG000|Double-blind Phase|Lack of Efficacy|0|||
154925626|NCT00320801|559152854|FG001|Double-blind Phase|Lack of Efficacy|9|||
154925627|NCT00320801|559152855|FG002|Double-blind Phase|Lack of Efficacy|1|||
154925628|NCT00320801|559152856|FG003|Double-blind Phase|Lack of Efficacy|0|||
154925629|NCT00320801|559152853|FG000|Extension Phase|Withdrawal by Subject|0|||
154925630|NCT00320801|559152854|FG001|Extension Phase|Withdrawal by Subject|0|||
154925631|NCT00320801|559152855|FG002|Extension Phase|Withdrawal by Subject|0|||
154925632|NCT00320801|559152856|FG003|Extension Phase|Withdrawal by Subject|6|||
154925633|NCT00320801|559152853|FG000|Extension Phase|Adverse Event|0|||
154925634|NCT00320801|559152854|FG001|Extension Phase|Adverse Event|0|||
154925635|NCT00320801|559152855|FG002|Extension Phase|Adverse Event|0|||
154925636|NCT00320801|559152856|FG003|Extension Phase|Adverse Event|8|||
154925637|NCT00320801|559152853|FG000|Extension Phase|Administrative|0|||
154925638|NCT00320801|559152854|FG001|Extension Phase|Administrative|0|||
154925639|NCT00320801|559152855|FG002|Extension Phase|Administrative|0|||
154925640|NCT00320801|559152856|FG003|Extension Phase|Administrative|29|||
154925641|NCT00320801|559152853|FG000|Extension Phase|Lack of Efficacy|0|||
154925642|NCT00320801|559152854|FG001|Extension Phase|Lack of Efficacy|0|||
154925643|NCT00320801|559152855|FG002|Extension Phase|Lack of Efficacy|0|||
154925644|NCT00320801|559152856|FG003|Extension Phase|Lack of Efficacy|2|||
154925645|NCT00320801|559152853|FG000|Extension Phase|Lost to Follow-up|0|||
154925646|NCT00320801|559152854|FG001|Extension Phase|Lost to Follow-up|0|||
154925647|NCT00320801|559152855|FG002|Extension Phase|Lost to Follow-up|0|||
154925648|NCT00320801|559152856|FG003|Extension Phase|Lost to Follow-up|3|||
154925649|NCT00491322|559152858|FG000|Overall Study|Protocol Violation|1|||
154925650|NCT00491322|559152859|FG001|Overall Study|Protocol Violation|0|||
154925651|NCT00491322|559152858|FG000|Overall Study|Pregnancy|0|||
154925652|NCT00491322|559152859|FG001|Overall Study|Pregnancy|1|||
154925653|NCT06067191|559152860|FG000|Overall Study|Withdrawal by Subject|0|||
154925654|NCT06067191|559152861|FG001|Overall Study|Withdrawal by Subject|1|||
154925655|NCT03664024|559152863|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
154925656|NCT03664024|559152863|FG000|Overall Study|Lost to Follow-up|2|||
154925657|NCT03664024|559152863|FG000|Overall Study|Withdrawal by Subject|2|||
154925658|NCT03664024|559152863|FG000|Overall Study|Death|80|||
154925659|NCT01157065|559152864|FG000|Overall Study|Death|0|||
154925660|NCT01157065|559152865|FG001|Overall Study|Death|1|||
154925661|NCT05275673|559152868|FG000|Overall Study|Study Termination by Sponsor|2|||
154925662|NCT05275673|559152869|FG001|Overall Study|Study Termination by Sponsor|3|||
154925663|NCT05275673|559152868|FG000|Overall Study|Death|1|||
154925664|NCT05275673|559152869|FG001|Overall Study|Death|0|||
154925665|NCT05275673|559152868|FG000|Overall Study|Withdrawal by Subject|1|||
154925666|NCT05275673|559152869|FG001|Overall Study|Withdrawal by Subject|0|||
154925667|NCT02325739|559152870|FG000|Phase I Part|Adverse Event|1|||
154925668|NCT02325739|559152871|FG001|Phase I Part|Adverse Event|0|||
154925669|NCT02325739|559152872|FG002|Phase I Part|Adverse Event|1|||
154925670|NCT02325739|559152873|FG003|Phase I Part|Adverse Event|2|||
154925671|NCT02325739|559152874|FG004|Phase I Part|Adverse Event|3|||
154925672|NCT02325739|559152875|FG005|Phase I Part|Adverse Event|1|||
154925673|NCT02325739|559152876|FG006|Phase I Part|Adverse Event|0|||
154925674|NCT02325739|559152877|FG007|Phase I Part|Adverse Event|2|||
154925675|NCT02325739|559152878|FG008|Phase I Part|Adverse Event|0|||
154925676|NCT02325739|559152879|FG009|Phase I Part|Adverse Event|0|||
154925677|NCT02325739|559152880|FG010|Phase I Part|Adverse Event|0|||
154925678|NCT02325739|559152870|FG000|Phase I Part|Progressive disease|9|||
154925679|NCT02325739|559152871|FG001|Phase I Part|Progressive disease|6|||
154925680|NCT02325739|559152872|FG002|Phase I Part|Progressive disease|3|||
154925681|NCT02325739|559152873|FG003|Phase I Part|Progressive disease|23|||
154925682|NCT02325739|559152874|FG004|Phase I Part|Progressive disease|14|||
154925683|NCT02325739|559152875|FG005|Phase I Part|Progressive disease|6|||
154925684|NCT02325739|559152876|FG006|Phase I Part|Progressive disease|6|||
154925685|NCT02325739|559152877|FG007|Phase I Part|Progressive disease|3|||
154925686|NCT02325739|559152878|FG008|Phase I Part|Progressive disease|0|||
154925687|NCT02325739|559152879|FG009|Phase I Part|Progressive disease|0|||
154925688|NCT02325739|559152880|FG010|Phase I Part|Progressive disease|0|||
154925689|NCT02325739|559152870|FG000|Phase I Part|Subject/guardian decision|1|||
154925690|NCT02325739|559152871|FG001|Phase I Part|Subject/guardian decision|0|||
154925691|NCT02325739|559152872|FG002|Phase I Part|Subject/guardian decision|1|||
154925692|NCT02325739|559152873|FG003|Phase I Part|Subject/guardian decision|1|||
154925693|NCT02325739|559152874|FG004|Phase I Part|Subject/guardian decision|0|||
154925694|NCT02325739|559152875|FG005|Phase I Part|Subject/guardian decision|0|||
154925695|NCT02325739|559152876|FG006|Phase I Part|Subject/guardian decision|0|||
154925696|NCT02325739|559152877|FG007|Phase I Part|Subject/guardian decision|1|||
154925697|NCT02325739|559152878|FG008|Phase I Part|Subject/guardian decision|0|||
154925698|NCT02325739|559152879|FG009|Phase I Part|Subject/guardian decision|0|||
154925699|NCT02325739|559152880|FG010|Phase I Part|Subject/guardian decision|0|||
154925700|NCT02325739|559152870|FG000|Phase I Part|Death|0|||
154925701|NCT02325739|559152871|FG001|Phase I Part|Death|0|||
154925702|NCT02325739|559152872|FG002|Phase I Part|Death|0|||
154925703|NCT02325739|559152873|FG003|Phase I Part|Death|0|||
154925704|NCT02325739|559152874|FG004|Phase I Part|Death|2|||
154925705|NCT02325739|559152875|FG005|Phase I Part|Death|0|||
154925706|NCT02325739|559152876|FG006|Phase I Part|Death|0|||
154925707|NCT02325739|559152877|FG007|Phase I Part|Death|0|||
154925708|NCT02325739|559152878|FG008|Phase I Part|Death|0|||
154925709|NCT02325739|559152879|FG009|Phase I Part|Death|0|||
154925710|NCT02325739|559152880|FG010|Phase I Part|Death|0|||
154925711|NCT02325739|559152870|FG000|Phase II Part|Adverse Event|0|||
154925712|NCT02325739|559152871|FG001|Phase II Part|Adverse Event|0|||
154925713|NCT02325739|559152872|FG002|Phase II Part|Adverse Event|0|||
154925714|NCT02325739|559152873|FG003|Phase II Part|Adverse Event|0|||
154925715|NCT02325739|559152874|FG004|Phase II Part|Adverse Event|0|||
154925716|NCT02325739|559152875|FG005|Phase II Part|Adverse Event|0|||
154925717|NCT02325739|559152876|FG006|Phase II Part|Adverse Event|0|||
154925718|NCT02325739|559152877|FG007|Phase II Part|Adverse Event|0|||
154925719|NCT02325739|559152878|FG008|Phase II Part|Adverse Event|4|||
154925720|NCT02325739|559152879|FG009|Phase II Part|Adverse Event|5|||
154925721|NCT02325739|559152880|FG010|Phase II Part|Adverse Event|1|||
154925722|NCT02325739|559152870|FG000|Phase II Part|Physician Decision|0|||
154925723|NCT02325739|559152871|FG001|Phase II Part|Physician Decision|0|||
154925724|NCT02325739|559152872|FG002|Phase II Part|Physician Decision|0|||
154925725|NCT02325739|559152873|FG003|Phase II Part|Physician Decision|0|||
154925726|NCT02325739|559152874|FG004|Phase II Part|Physician Decision|0|||
154925727|NCT02325739|559152875|FG005|Phase II Part|Physician Decision|0|||
154925728|NCT02325739|559152876|FG006|Phase II Part|Physician Decision|0|||
154925729|NCT02325739|559152877|FG007|Phase II Part|Physician Decision|0|||
154925730|NCT02325739|559152878|FG008|Phase II Part|Physician Decision|0|||
154925731|NCT02325739|559152879|FG009|Phase II Part|Physician Decision|1|||
154925732|NCT02325739|559152880|FG010|Phase II Part|Physician Decision|0|||
154925733|NCT02325739|559152870|FG000|Phase II Part|Progressive disease|0|||
154925734|NCT02325739|559152871|FG001|Phase II Part|Progressive disease|0|||
154925735|NCT02325739|559152872|FG002|Phase II Part|Progressive disease|0|||
154925736|NCT02325739|559152873|FG003|Phase II Part|Progressive disease|0|||
154925737|NCT02325739|559152874|FG004|Phase II Part|Progressive disease|0|||
154925738|NCT02325739|559152875|FG005|Phase II Part|Progressive disease|0|||
154925739|NCT02325739|559152876|FG006|Phase II Part|Progressive disease|0|||
154925740|NCT02325739|559152877|FG007|Phase II Part|Progressive disease|0|||
154925741|NCT02325739|559152878|FG008|Phase II Part|Progressive disease|22|||
154925742|NCT02325739|559152879|FG009|Phase II Part|Progressive disease|29|||
154925743|NCT02325739|559152880|FG010|Phase II Part|Progressive disease|18|||
154925744|NCT02325739|559152870|FG000|Phase II Part|Subject/guardian decision|0|||
154925745|NCT02325739|559152871|FG001|Phase II Part|Subject/guardian decision|0|||
154925746|NCT02325739|559152872|FG002|Phase II Part|Subject/guardian decision|0|||
154925747|NCT02325739|559152873|FG003|Phase II Part|Subject/guardian decision|0|||
154925748|NCT02325739|559152874|FG004|Phase II Part|Subject/guardian decision|0|||
154925749|NCT02325739|559152875|FG005|Phase II Part|Subject/guardian decision|0|||
154925750|NCT02325739|559152876|FG006|Phase II Part|Subject/guardian decision|0|||
154925751|NCT02325739|559152877|FG007|Phase II Part|Subject/guardian decision|0|||
154925752|NCT02325739|559152878|FG008|Phase II Part|Subject/guardian decision|4|||
154925753|NCT02325739|559152879|FG009|Phase II Part|Subject/guardian decision|1|||
154925754|NCT02325739|559152880|FG010|Phase II Part|Subject/guardian decision|1|||
154925755|NCT03426995|559152881|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925756|NCT03426995|559152882|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925757|NCT03426995|559152883|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
154925758|NCT03426995|559152884|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925759|NCT03426995|559152885|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925760|NCT03426995|559152886|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925761|NCT03426995|559152887|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925762|NCT03426995|559152888|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925763|NCT03426995|559152889|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925764|NCT03426995|559152890|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925765|NCT03426995|559152891|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925766|NCT03426995|559152892|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925767|NCT03426995|559152893|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925768|NCT03426995|559152894|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925769|NCT03426995|559152895|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925770|NCT03426995|559152896|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925771|NCT03426995|559152897|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925772|NCT03426995|559152898|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925773|NCT03426995|559152899|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
154925774|NCT03426995|559152881|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925775|NCT03426995|559152882|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925776|NCT03426995|559152883|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925777|NCT03426995|559152884|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925778|NCT03426995|559152885|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925779|NCT03426995|559152886|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
154925780|NCT03426995|559152887|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925781|NCT03426995|559152888|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925782|NCT03426995|559152889|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925783|NCT03426995|559152890|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925784|NCT03426995|559152891|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925785|NCT03426995|559152892|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925786|NCT03426995|559152893|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925787|NCT03426995|559152894|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925788|NCT03426995|559152895|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925789|NCT03426995|559152896|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925790|NCT03426995|559152897|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925791|NCT03426995|559152898|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925792|NCT03426995|559152899|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
154925793|NCT03426995|559152881|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925794|NCT03426995|559152882|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925795|NCT03426995|559152883|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925796|NCT03426995|559152884|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925797|NCT03426995|559152885|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
154925798|NCT03426995|559152886|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
154925799|NCT03426995|559152887|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925800|NCT03426995|559152888|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925801|NCT03426995|559152889|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925802|NCT03426995|559152890|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925803|NCT03426995|559152891|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925804|NCT03426995|559152892|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925805|NCT03426995|559152893|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925806|NCT03426995|559152894|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925807|NCT03426995|559152895|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925808|NCT03426995|559152896|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925809|NCT03426995|559152897|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925810|NCT03426995|559152898|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925811|NCT03426995|559152899|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
154925812|NCT03426995|559152881|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925813|NCT03426995|559152882|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925814|NCT03426995|559152883|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925815|NCT03426995|559152884|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925816|NCT03426995|559152885|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925817|NCT03426995|559152886|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925818|NCT03426995|559152887|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925819|NCT03426995|559152888|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925820|NCT03426995|559152889|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925821|NCT03426995|559152890|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925822|NCT03426995|559152891|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
154925823|NCT03426995|559152892|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925824|NCT03426995|559152893|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925825|NCT03426995|559152894|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925826|NCT03426995|559152895|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925827|NCT03426995|559152896|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925828|NCT03426995|559152897|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925829|NCT03426995|559152898|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925830|NCT03426995|559152899|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
154925831|NCT03426995|559152881|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925832|NCT03426995|559152882|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925833|NCT03426995|559152883|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925834|NCT03426995|559152884|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925835|NCT03426995|559152885|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925836|NCT03426995|559152886|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925837|NCT03426995|559152887|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925838|NCT03426995|559152888|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
154925839|NCT03426995|559152889|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925840|NCT03426995|559152890|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925841|NCT03426995|559152891|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925842|NCT03426995|559152892|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925843|NCT03426995|559152893|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925844|NCT03426995|559152894|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925845|NCT03426995|559152895|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925846|NCT03426995|559152896|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925847|NCT03426995|559152897|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925848|NCT03426995|559152898|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925849|NCT03426995|559152899|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
154925850|NCT03426995|559152881|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925851|NCT03426995|559152882|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925852|NCT03426995|559152883|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925853|NCT03426995|559152884|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925854|NCT03426995|559152885|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925855|NCT03426995|559152886|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925856|NCT03426995|559152887|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925857|NCT03426995|559152888|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925858|NCT03426995|559152889|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925859|NCT03426995|559152890|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925860|NCT03426995|559152891|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925861|NCT03426995|559152892|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925862|NCT03426995|559152893|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925863|NCT03426995|559152894|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925864|NCT03426995|559152895|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
154925865|NCT03426995|559152896|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
154925866|NCT03426995|559152897|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925867|NCT03426995|559152898|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925868|NCT03426995|559152899|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
154925869|NCT03426995|559152881|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925870|NCT03426995|559152882|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925871|NCT03426995|559152883|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925872|NCT03426995|559152884|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925873|NCT03426995|559152885|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925874|NCT03426995|559152886|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925875|NCT03426995|559152887|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925876|NCT03426995|559152888|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925877|NCT03426995|559152889|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925878|NCT03426995|559152890|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925879|NCT03426995|559152891|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925880|NCT03426995|559152892|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925881|NCT03426995|559152893|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925882|NCT03426995|559152894|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925883|NCT03426995|559152895|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
155152521|NCT03037385|559996848|FG006|Overall Study|Lost to Follow-up|0|||
154925884|NCT03426995|559152896|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
154925885|NCT03426995|559152897|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925886|NCT03426995|559152898|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925887|NCT03426995|559152899|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
154925888|NCT00227591|559152900|FG000|Overall Study|Withdrawal by Subject|1|||
154925889|NCT02335411|559152901|FG000|Overall Study|Death|223|||
154925890|NCT02335411|559152902|FG001|Overall Study|Death|22|||
154925891|NCT02335411|559152903|FG002|Overall Study|Death|26|||
154925892|NCT02335411|559152901|FG000|Overall Study|Physician Decision|3|||
154925893|NCT02335411|559152902|FG001|Overall Study|Physician Decision|0|||
154925894|NCT02335411|559152903|FG002|Overall Study|Physician Decision|0|||
154925895|NCT02335411|559152901|FG000|Overall Study|Protocol Violation|1|||
154925896|NCT02335411|559152902|FG001|Overall Study|Protocol Violation|0|||
154925897|NCT02335411|559152903|FG002|Overall Study|Protocol Violation|0|||
154925898|NCT02335411|559152901|FG000|Overall Study|Withdrawal by Subject|11|||
154925899|NCT02335411|559152902|FG001|Overall Study|Withdrawal by Subject|0|||
154925900|NCT02335411|559152903|FG002|Overall Study|Withdrawal by Subject|3|||
154925901|NCT02335411|559152901|FG000|Overall Study|Sponsor Decision|12|||
154925902|NCT02335411|559152902|FG001|Overall Study|Sponsor Decision|3|||
154925903|NCT02335411|559152903|FG002|Overall Study|Sponsor Decision|2|||
154925904|NCT02335411|559152901|FG000|Overall Study|Adverse Event|9|||
154925905|NCT02335411|559152902|FG001|Overall Study|Adverse Event|0|||
154925906|NCT02335411|559152903|FG002|Overall Study|Adverse Event|0|||
154925907|NCT04456998|559152907|FG000|Overall Study|Adverse Event|0|||
154925908|NCT04456998|559152908|FG001|Overall Study|Adverse Event|4|||
154925909|NCT04456998|559152907|FG000|Overall Study|Protocol Deviation|0|||
154925910|NCT04456998|559152908|FG001|Overall Study|Protocol Deviation|1|||
154925911|NCT04456998|559152907|FG000|Overall Study|Withdrawal by Subject|0|||
154925912|NCT04456998|559152908|FG001|Overall Study|Withdrawal by Subject|1|||
154925913|NCT03917654|559152916|FG000|Year 1|Withdrawal by Subject|1|||
154925914|NCT03917654|559152917|FG001|Year 1|Withdrawal by Subject|0|||
154925915|NCT03917654|559152918|FG002|Year 1|Withdrawal by Subject|0|||
154925916|NCT03917654|559152919|FG003|Year 1|Withdrawal by Subject|0|||
154925917|NCT03917654|559152920|FG004|Year 1|Withdrawal by Subject|0|||
154925918|NCT03917654|559152921|FG005|Year 1|Withdrawal by Subject|1|||
154925919|NCT03917654|559152922|FG006|Year 1|Withdrawal by Subject|6|||
154925920|NCT03917654|559152923|FG007|Year 1|Withdrawal by Subject|2|||
154925921|NCT03917654|559152924|FG008|Year 1|Withdrawal by Subject|5|||
154925922|NCT03917654|559152925|FG009|Year 1|Withdrawal by Subject|3|||
154925923|NCT03917654|559152926|FG010|Year 1|Withdrawal by Subject|1|||
154925924|NCT03917654|559152927|FG011|Year 1|Withdrawal by Subject|0|||
154925925|NCT03917654|559152916|FG000|Year 1|Travel|0|||
154925926|NCT03917654|559152917|FG001|Year 1|Travel|1|||
154925927|NCT03917654|559152918|FG002|Year 1|Travel|1|||
154925928|NCT03917654|559152919|FG003|Year 1|Travel|0|||
154925929|NCT03917654|559152920|FG004|Year 1|Travel|4|||
154925930|NCT03917654|559152921|FG005|Year 1|Travel|4|||
154925931|NCT03917654|559152922|FG006|Year 1|Travel|10|||
154925932|NCT03917654|559152923|FG007|Year 1|Travel|8|||
154925933|NCT03917654|559152924|FG008|Year 1|Travel|2|||
154925934|NCT03917654|559152925|FG009|Year 1|Travel|5|||
154925935|NCT03917654|559152926|FG010|Year 1|Travel|3|||
154925936|NCT03917654|559152927|FG011|Year 1|Travel|3|||
154925937|NCT03917654|559152916|FG000|Year 1|Subject moved away from site|0|||
154925938|NCT03917654|559152917|FG001|Year 1|Subject moved away from site|1|||
154925939|NCT03917654|559152918|FG002|Year 1|Subject moved away from site|0|||
154925940|NCT03917654|559152919|FG003|Year 1|Subject moved away from site|0|||
154925941|NCT03917654|559152920|FG004|Year 1|Subject moved away from site|0|||
154925942|NCT03917654|559152921|FG005|Year 1|Subject moved away from site|0|||
154925943|NCT03917654|559152922|FG006|Year 1|Subject moved away from site|1|||
154925944|NCT03917654|559152923|FG007|Year 1|Subject moved away from site|2|||
154925945|NCT03917654|559152924|FG008|Year 1|Subject moved away from site|1|||
154925946|NCT03917654|559152925|FG009|Year 1|Subject moved away from site|0|||
154925947|NCT03917654|559152926|FG010|Year 1|Subject moved away from site|0|||
154925948|NCT03917654|559152927|FG011|Year 1|Subject moved away from site|3|||
154925949|NCT03917654|559152916|FG000|Year 1|Spouse/Family member request|0|||
154925950|NCT03917654|559152917|FG001|Year 1|Spouse/Family member request|0|||
154925951|NCT03917654|559152918|FG002|Year 1|Spouse/Family member request|1|||
154925952|NCT03917654|559152919|FG003|Year 1|Spouse/Family member request|0|||
154925953|NCT03917654|559152920|FG004|Year 1|Spouse/Family member request|1|||
154925954|NCT03917654|559152921|FG005|Year 1|Spouse/Family member request|0|||
154925955|NCT03917654|559152922|FG006|Year 1|Spouse/Family member request|0|||
154925956|NCT03917654|559152923|FG007|Year 1|Spouse/Family member request|2|||
154925957|NCT03917654|559152924|FG008|Year 1|Spouse/Family member request|0|||
154925958|NCT03917654|559152925|FG009|Year 1|Spouse/Family member request|0|||
154925959|NCT03917654|559152926|FG010|Year 1|Spouse/Family member request|0|||
154925960|NCT03917654|559152927|FG011|Year 1|Spouse/Family member request|1|||
154925961|NCT03917654|559152916|FG000|Year 1|Death|0|||
154925962|NCT03917654|559152917|FG001|Year 1|Death|0|||
154925963|NCT03917654|559152918|FG002|Year 1|Death|0|||
154925964|NCT03917654|559152919|FG003|Year 1|Death|0|||
154925965|NCT03917654|559152920|FG004|Year 1|Death|0|||
154925966|NCT03917654|559152921|FG005|Year 1|Death|0|||
154925967|NCT03917654|559152922|FG006|Year 1|Death|0|||
154925968|NCT03917654|559152923|FG007|Year 1|Death|0|||
154925969|NCT03917654|559152924|FG008|Year 1|Death|1|||
154925970|NCT03917654|559152925|FG009|Year 1|Death|1|||
154925971|NCT03917654|559152926|FG010|Year 1|Death|0|||
154925972|NCT03917654|559152927|FG011|Year 1|Death|0|||
154925973|NCT03917654|559152916|FG000|Year 1|Lost to Follow-up|0|||
154925974|NCT03917654|559152917|FG001|Year 1|Lost to Follow-up|0|||
154925975|NCT03917654|559152918|FG002|Year 1|Lost to Follow-up|0|||
154925976|NCT03917654|559152919|FG003|Year 1|Lost to Follow-up|0|||
154925977|NCT03917654|559152920|FG004|Year 1|Lost to Follow-up|0|||
154925978|NCT03917654|559152921|FG005|Year 1|Lost to Follow-up|0|||
154925979|NCT03917654|559152922|FG006|Year 1|Lost to Follow-up|2|||
154925980|NCT03917654|559152923|FG007|Year 1|Lost to Follow-up|0|||
154925981|NCT03917654|559152924|FG008|Year 1|Lost to Follow-up|0|||
154925982|NCT03917654|559152925|FG009|Year 1|Lost to Follow-up|0|||
154925983|NCT03917654|559152926|FG010|Year 1|Lost to Follow-up|0|||
154925984|NCT03917654|559152927|FG011|Year 1|Lost to Follow-up|0|||
154925985|NCT03917654|559152916|FG000|Year 1|Missed visits|0|||
154925986|NCT03917654|559152917|FG001|Year 1|Missed visits|0|||
154925987|NCT03917654|559152918|FG002|Year 1|Missed visits|0|||
154925988|NCT03917654|559152919|FG003|Year 1|Missed visits|0|||
154925989|NCT03917654|559152920|FG004|Year 1|Missed visits|0|||
154925990|NCT03917654|559152921|FG005|Year 1|Missed visits|0|||
154925991|NCT03917654|559152922|FG006|Year 1|Missed visits|0|||
154925992|NCT03917654|559152923|FG007|Year 1|Missed visits|0|||
154925993|NCT03917654|559152924|FG008|Year 1|Missed visits|0|||
154925994|NCT03917654|559152925|FG009|Year 1|Missed visits|0|||
154925995|NCT03917654|559152926|FG010|Year 1|Missed visits|1|||
154925996|NCT03917654|559152927|FG011|Year 1|Missed visits|1|||
154925997|NCT03917654|559152916|FG000|Year 1|Pregnancy|0|||
154925998|NCT03917654|559152917|FG001|Year 1|Pregnancy|0|||
154925999|NCT03917654|559152918|FG002|Year 1|Pregnancy|0|||
154926000|NCT03917654|559152919|FG003|Year 1|Pregnancy|0|||
154926001|NCT03917654|559152920|FG004|Year 1|Pregnancy|0|||
154926002|NCT03917654|559152921|FG005|Year 1|Pregnancy|0|||
154926003|NCT03917654|559152922|FG006|Year 1|Pregnancy|0|||
154926004|NCT03917654|559152923|FG007|Year 1|Pregnancy|1|||
154926005|NCT03917654|559152924|FG008|Year 1|Pregnancy|0|||
154926006|NCT03917654|559152925|FG009|Year 1|Pregnancy|1|||
154926007|NCT03917654|559152926|FG010|Year 1|Pregnancy|0|||
154926008|NCT03917654|559152927|FG011|Year 1|Pregnancy|0|||
154926009|NCT03917654|559152916|FG000|Year 2|Travel|1|||
154926010|NCT03917654|559152917|FG001|Year 2|Travel|0|||
154926011|NCT03917654|559152918|FG002|Year 2|Travel|0|||
154926012|NCT03917654|559152919|FG003|Year 2|Travel|0|||
154926013|NCT03917654|559152920|FG004|Year 2|Travel|1|||
154926014|NCT03917654|559152921|FG005|Year 2|Travel|1|||
154926015|NCT03917654|559152922|FG006|Year 2|Travel|2|||
154926016|NCT03917654|559152923|FG007|Year 2|Travel|1|||
154926017|NCT03917654|559152924|FG008|Year 2|Travel|0|||
154926018|NCT03917654|559152925|FG009|Year 2|Travel|1|||
154926019|NCT03917654|559152926|FG010|Year 2|Travel|0|||
154926020|NCT03917654|559152927|FG011|Year 2|Travel|1|||
154926021|NCT03917654|559152916|FG000|Year 2|Married|1|||
154926022|NCT03917654|559152917|FG001|Year 2|Married|0|||
154926023|NCT03917654|559152918|FG002|Year 2|Married|0|||
154926024|NCT03917654|559152919|FG003|Year 2|Married|0|||
154926025|NCT03917654|559152920|FG004|Year 2|Married|0|||
154926026|NCT03917654|559152921|FG005|Year 2|Married|0|||
154926027|NCT03917654|559152922|FG006|Year 2|Married|1|||
154926028|NCT03917654|559152923|FG007|Year 2|Married|1|||
154926029|NCT03917654|559152924|FG008|Year 2|Married|0|||
154926030|NCT03917654|559152925|FG009|Year 2|Married|0|||
154926031|NCT03917654|559152926|FG010|Year 2|Married|0|||
155381335|NCT04055090|560830871|FG000|Overall Study|screen failure|1|||
154926032|NCT03917654|559152927|FG011|Year 2|Married|0|||
154926033|NCT03917654|559152916|FG000|Year 2|Subject moved away from site|1|||
154926034|NCT03917654|559152917|FG001|Year 2|Subject moved away from site|0|||
154926035|NCT03917654|559152918|FG002|Year 2|Subject moved away from site|0|||
154926036|NCT03917654|559152919|FG003|Year 2|Subject moved away from site|0|||
154926037|NCT03917654|559152920|FG004|Year 2|Subject moved away from site|1|||
154926038|NCT03917654|559152921|FG005|Year 2|Subject moved away from site|0|||
154926039|NCT03917654|559152922|FG006|Year 2|Subject moved away from site|2|||
154926040|NCT03917654|559152923|FG007|Year 2|Subject moved away from site|3|||
154926041|NCT03917654|559152924|FG008|Year 2|Subject moved away from site|0|||
154926042|NCT03917654|559152925|FG009|Year 2|Subject moved away from site|2|||
154926043|NCT03917654|559152926|FG010|Year 2|Subject moved away from site|0|||
154926044|NCT03917654|559152927|FG011|Year 2|Subject moved away from site|1|||
154926045|NCT03917654|559152916|FG000|Year 2|Year 2 Screening failure|0|||
154926046|NCT03917654|559152917|FG001|Year 2|Year 2 Screening failure|1|||
154926047|NCT03917654|559152918|FG002|Year 2|Year 2 Screening failure|0|||
154926048|NCT03917654|559152919|FG003|Year 2|Year 2 Screening failure|0|||
154926049|NCT03917654|559152920|FG004|Year 2|Year 2 Screening failure|2|||
154926050|NCT03917654|559152921|FG005|Year 2|Year 2 Screening failure|0|||
154926051|NCT03917654|559152922|FG006|Year 2|Year 2 Screening failure|4|||
154926052|NCT03917654|559152923|FG007|Year 2|Year 2 Screening failure|3|||
154926053|NCT03917654|559152924|FG008|Year 2|Year 2 Screening failure|10|||
154926054|NCT03917654|559152925|FG009|Year 2|Year 2 Screening failure|2|||
154926055|NCT03917654|559152926|FG010|Year 2|Year 2 Screening failure|1|||
154926056|NCT03917654|559152927|FG011|Year 2|Year 2 Screening failure|1|||
154926057|NCT03917654|559152916|FG000|Year 2|Death|0|||
154926058|NCT03917654|559152917|FG001|Year 2|Death|0|||
154926059|NCT03917654|559152918|FG002|Year 2|Death|0|||
154926060|NCT03917654|559152919|FG003|Year 2|Death|0|||
154926061|NCT03917654|559152920|FG004|Year 2|Death|0|||
154926062|NCT03917654|559152921|FG005|Year 2|Death|1|||
154926063|NCT03917654|559152922|FG006|Year 2|Death|0|||
154926064|NCT03917654|559152923|FG007|Year 2|Death|0|||
154926065|NCT03917654|559152924|FG008|Year 2|Death|1|||
154926066|NCT03917654|559152925|FG009|Year 2|Death|1|||
154926067|NCT03917654|559152926|FG010|Year 2|Death|0|||
154926068|NCT03917654|559152927|FG011|Year 2|Death|0|||
154926069|NCT03917654|559152916|FG000|Year 2|Withdrawal by Subject|0|||
154926070|NCT03917654|559152917|FG001|Year 2|Withdrawal by Subject|0|||
154926071|NCT03917654|559152918|FG002|Year 2|Withdrawal by Subject|0|||
154926072|NCT03917654|559152919|FG003|Year 2|Withdrawal by Subject|0|||
154926073|NCT03917654|559152920|FG004|Year 2|Withdrawal by Subject|0|||
154926074|NCT03917654|559152921|FG005|Year 2|Withdrawal by Subject|0|||
154926075|NCT03917654|559152922|FG006|Year 2|Withdrawal by Subject|3|||
154926076|NCT03917654|559152923|FG007|Year 2|Withdrawal by Subject|0|||
154926077|NCT03917654|559152924|FG008|Year 2|Withdrawal by Subject|2|||
154926078|NCT03917654|559152925|FG009|Year 2|Withdrawal by Subject|5|||
154926079|NCT03917654|559152926|FG010|Year 2|Withdrawal by Subject|0|||
154926080|NCT03917654|559152927|FG011|Year 2|Withdrawal by Subject|0|||
154926081|NCT03917654|559152916|FG000|Year 2|Spouse/family member request|0|||
154926082|NCT03917654|559152917|FG001|Year 2|Spouse/family member request|0|||
154926083|NCT03917654|559152918|FG002|Year 2|Spouse/family member request|0|||
154926084|NCT03917654|559152919|FG003|Year 2|Spouse/family member request|0|||
154926085|NCT03917654|559152920|FG004|Year 2|Spouse/family member request|0|||
154926086|NCT03917654|559152921|FG005|Year 2|Spouse/family member request|0|||
154926087|NCT03917654|559152922|FG006|Year 2|Spouse/family member request|1|||
154926088|NCT03917654|559152923|FG007|Year 2|Spouse/family member request|0|||
154926089|NCT03917654|559152924|FG008|Year 2|Spouse/family member request|0|||
154926090|NCT03917654|559152925|FG009|Year 2|Spouse/family member request|0|||
154926091|NCT03917654|559152926|FG010|Year 2|Spouse/family member request|0|||
154926092|NCT03917654|559152927|FG011|Year 2|Spouse/family member request|0|||
154926093|NCT03917654|559152916|FG000|Year 2|Lost to Follow-up|0|||
154926094|NCT03917654|559152917|FG001|Year 2|Lost to Follow-up|0|||
154926095|NCT03917654|559152918|FG002|Year 2|Lost to Follow-up|0|||
154926096|NCT03917654|559152919|FG003|Year 2|Lost to Follow-up|0|||
154926097|NCT03917654|559152920|FG004|Year 2|Lost to Follow-up|0|||
154926098|NCT03917654|559152921|FG005|Year 2|Lost to Follow-up|0|||
154926099|NCT03917654|559152922|FG006|Year 2|Lost to Follow-up|1|||
154926100|NCT03917654|559152923|FG007|Year 2|Lost to Follow-up|0|||
154926101|NCT03917654|559152924|FG008|Year 2|Lost to Follow-up|1|||
154926102|NCT03917654|559152925|FG009|Year 2|Lost to Follow-up|0|||
154926103|NCT03917654|559152926|FG010|Year 2|Lost to Follow-up|0|||
154926104|NCT03917654|559152927|FG011|Year 2|Lost to Follow-up|1|||
154926105|NCT03917654|559152916|FG000|Year 2|Adverse Event|0|||
154926106|NCT03917654|559152917|FG001|Year 2|Adverse Event|0|||
154926107|NCT03917654|559152918|FG002|Year 2|Adverse Event|0|||
154926108|NCT03917654|559152919|FG003|Year 2|Adverse Event|0|||
154926109|NCT03917654|559152920|FG004|Year 2|Adverse Event|0|||
154926110|NCT03917654|559152921|FG005|Year 2|Adverse Event|0|||
154926111|NCT03917654|559152922|FG006|Year 2|Adverse Event|0|||
154926112|NCT03917654|559152923|FG007|Year 2|Adverse Event|0|||
154926113|NCT03917654|559152924|FG008|Year 2|Adverse Event|0|||
154926114|NCT03917654|559152925|FG009|Year 2|Adverse Event|1|||
154926115|NCT03917654|559152926|FG010|Year 2|Adverse Event|0|||
154926116|NCT03917654|559152927|FG011|Year 2|Adverse Event|0|||
154926117|NCT05012943|559152928|FG000|Overall Study|Adverse Event|2|||
154926118|NCT05012943|559152929|FG001|Overall Study|Adverse Event|1|||
154926119|NCT05012943|559152930|FG002|Overall Study|Adverse Event|0|||
154926120|NCT05012943|559152928|FG000|Overall Study|Withdrawal by Subject|1052|||
155381336|NCT04055090|560830872|FG001|Overall Study|screen failure|0|||
154926121|NCT05012943|559152929|FG001|Overall Study|Withdrawal by Subject|1006|||
154926122|NCT05012943|559152930|FG002|Overall Study|Withdrawal by Subject|20|||
154926123|NCT05012943|559152928|FG000|Overall Study|Death|25|||
154926124|NCT05012943|559152929|FG001|Overall Study|Death|17|||
154926125|NCT05012943|559152930|FG002|Overall Study|Death|4|||
154926126|NCT05012943|559152928|FG000|Overall Study|Lost to Follow-up|11|||
154926127|NCT05012943|559152929|FG001|Overall Study|Lost to Follow-up|24|||
154926128|NCT05012943|559152930|FG002|Overall Study|Lost to Follow-up|3|||
154926129|NCT05012943|559152928|FG000|Overall Study|Physician Decision|1|||
154926130|NCT05012943|559152929|FG001|Overall Study|Physician Decision|1|||
154926131|NCT05012943|559152930|FG002|Overall Study|Physician Decision|0|||
154926132|NCT05012943|559152928|FG000|Overall Study|Other than Specified|2|||
154926133|NCT05012943|559152929|FG001|Overall Study|Other than Specified|1|||
154926134|NCT05012943|559152930|FG002|Overall Study|Other than Specified|0|||
154926135|NCT00400985|559152932|FG000|Overall Study|Withdrawal by Subject|5|||
154926136|NCT00400985|559152932|FG000|Overall Study|system modification|8|||
154926137|NCT00400985|559152932|FG000|Overall Study|Death|30|||
154926138|NCT00400985|559152932|FG000|Overall Study|Lost to Follow-up|9|||
154926139|NCT05048875|559152934|FG000|Overall Study|Withdrawal by Subject|1|||
154926140|NCT05048875|559152935|FG001|Overall Study|Withdrawal by Subject|0|||
154926141|NCT05048875|559152936|FG002|Overall Study|Withdrawal by Subject|0|||
154926142|NCT05048875|559152937|FG003|Overall Study|Withdrawal by Subject|0|||
154926143|NCT05048875|559152938|FG004|Overall Study|Withdrawal by Subject|0|||
154926144|NCT05048875|559152939|FG005|Overall Study|Withdrawal by Subject|0|||
154926145|NCT05048875|559152940|FG006|Overall Study|Withdrawal by Subject|0|||
154926146|NCT05048875|559152941|FG007|Overall Study|Withdrawal by Subject|0|||
154926147|NCT05048875|559152934|FG000|Overall Study|Adverse Event|0|||
154926148|NCT05048875|559152935|FG001|Overall Study|Adverse Event|0|||
154926149|NCT05048875|559152936|FG002|Overall Study|Adverse Event|0|||
154926150|NCT05048875|559152937|FG003|Overall Study|Adverse Event|1|||
154926151|NCT05048875|559152938|FG004|Overall Study|Adverse Event|0|||
154926152|NCT05048875|559152939|FG005|Overall Study|Adverse Event|0|||
154926153|NCT05048875|559152940|FG006|Overall Study|Adverse Event|0|||
154926154|NCT05048875|559152941|FG007|Overall Study|Adverse Event|0|||
154926155|NCT04410978|559152954|FG000|Overall Study|Poor compliance to protocol|2|||
154926156|NCT04410978|559152955|FG001|Overall Study|Poor compliance to protocol|4|||
154926157|NCT04410978|559152954|FG000|Overall Study|Withdrawal by Subject|64|||
154926158|NCT04410978|559152955|FG001|Overall Study|Withdrawal by Subject|66|||
154926159|NCT04410978|559152954|FG000|Overall Study|Other|6|||
154926160|NCT04410978|559152955|FG001|Overall Study|Other|7|||
154926161|NCT04410978|559152954|FG000|Overall Study|Missing study status|1|||
154926162|NCT04410978|559152955|FG001|Overall Study|Missing study status|0|||
154926163|NCT02684162|559152956|FG000|Overall Study|Physician Decision|0|||
154926164|NCT02684162|559152957|FG001|Overall Study|Physician Decision|1|||
154926165|NCT02684162|559152958|FG002|Overall Study|Physician Decision|0|||
154926166|NCT04089566|559152963|FG000|Overall Study|Death|0|||
154926167|NCT04089566|559152964|FG001|Overall Study|Death|6|||
154926168|NCT04089566|559152965|FG002|Overall Study|Death|10|||
154926169|NCT04089566|559152966|FG003|Overall Study|Death|0|||
154926170|NCT04089566|559152967|FG004|Overall Study|Death|0|||
154926171|NCT04089566|559152968|FG005|Overall Study|Death|0|||
154926172|NCT04089566|559152963|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
154926173|NCT04089566|559152964|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
154926174|NCT04089566|559152965|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
154926175|NCT04089566|559152966|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
154926176|NCT04089566|559152967|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
154926177|NCT04089566|559152968|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
154926178|NCT04089566|559152963|FG000|Overall Study|Reason not Specified|0|||
154926179|NCT04089566|559152964|FG001|Overall Study|Reason not Specified|4|||
154926180|NCT04089566|559152965|FG002|Overall Study|Reason not Specified|4|||
154926181|NCT04089566|559152966|FG003|Overall Study|Reason not Specified|1|||
154926182|NCT04089566|559152967|FG004|Overall Study|Reason not Specified|0|||
154926183|NCT04089566|559152968|FG005|Overall Study|Reason not Specified|0|||
154926184|NCT01083121|559152969|FG000|Overall Study|Use of Humira outside the approved label|81|||
154926185|NCT03743571|559152975|FG000|Overall Study|Withdrawal by Subject|1|||
154926186|NCT03743571|559152976|FG001|Overall Study|Withdrawal by Subject|1|||
154926187|NCT03743571|559152975|FG000|Overall Study|Lost to Follow-up|1|||
154926188|NCT03743571|559152976|FG001|Overall Study|Lost to Follow-up|2|||
154926189|NCT04115488|559152977|FG000|Overall Study|Adverse Event|8|||
154926190|NCT04115488|559152978|FG001|Overall Study|Adverse Event|4|||
154926191|NCT04115488|559152977|FG000|Overall Study|Withdrawal by Subject|3|||
154926192|NCT04115488|559152978|FG001|Overall Study|Withdrawal by Subject|6|||
154926193|NCT04115488|559152977|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
154926194|NCT04115488|559152978|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
154926195|NCT04115488|559152977|FG000|Overall Study|Patient 's location change|1|||
154926196|NCT04115488|559152978|FG001|Overall Study|Patient 's location change|0|||
154926197|NCT04115488|559152977|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
154926198|NCT04115488|559152978|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
154926199|NCT00885677|559152979|FG000|Overall Study|Death|40|||
154926200|NCT00885677|559152980|FG001|Overall Study|Death|34|||
154926201|NCT00885677|559152979|FG000|Overall Study|Lost to Follow-up|15|||
154926202|NCT00885677|559152980|FG001|Overall Study|Lost to Follow-up|13|||
154926203|NCT00885677|559152979|FG000|Overall Study|Protocol Violation|54|||
154926204|NCT00885677|559152980|FG001|Overall Study|Protocol Violation|54|||
154926205|NCT00885677|559152979|FG000|Overall Study|premature study closure|41|||
154926206|NCT00885677|559152980|FG001|Overall Study|premature study closure|44|||
154926207|NCT00885677|559152979|FG000|Overall Study|device/lead revision or replacement|7|||
154926208|NCT00885677|559152980|FG001|Overall Study|device/lead revision or replacement|6|||
154926209|NCT00885677|559152979|FG000|Overall Study|Heart transplantation|1|||
154926210|NCT00885677|559152980|FG001|Overall Study|Heart transplantation|0|||
154926211|NCT00885677|559152979|FG000|Overall Study|Inclusion/exclusion not met|25|||
154926212|NCT00885677|559152980|FG001|Overall Study|Inclusion/exclusion not met|27|||
155381337|NCT04055090|560830871|FG000|Overall Study|Withdrawal by Subject|1|||
155381338|NCT04055090|560830872|FG001|Overall Study|Withdrawal by Subject|0|||
155381339|NCT04426851|560830873|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
155381340|NCT04426851|560830874|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
155381341|NCT04426851|560830873|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
155381342|NCT04426851|560830874|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
155381343|NCT03256851|560830878|FG000|Overall Study|Withdrawal by Subject|1|||
155381344|NCT03256851|560830879|FG001|Overall Study|Withdrawal by Subject|0|||
155381345|NCT01065844|560830880|FG000|Overall Study|Adverse Event|5|||
155381346|NCT00552240|560830881|FG000|Overall Study|Adverse Event|9|||
155381347|NCT00552240|560830882|FG001|Overall Study|Adverse Event|9|||
155381348|NCT00552240|560830881|FG000|Overall Study|Protocol Violation|1|||
155381349|NCT00552240|560830882|FG001|Overall Study|Protocol Violation|1|||
155381350|NCT00552240|560830881|FG000|Overall Study|Lost to Follow-up|5|||
155381351|NCT00552240|560830882|FG001|Overall Study|Lost to Follow-up|6|||
155381352|NCT00552240|560830881|FG000|Overall Study|Withdrawal by Subject|2|||
155381353|NCT00552240|560830882|FG001|Overall Study|Withdrawal by Subject|2|||
155381354|NCT00552240|560830881|FG000|Overall Study|Lack of Efficacy|6|||
155381355|NCT00552240|560830882|FG001|Overall Study|Lack of Efficacy|0|||
155381356|NCT00552240|560830881|FG000|Overall Study|Other|1|||
155381357|NCT00552240|560830882|FG001|Overall Study|Other|0|||
155381358|NCT02679573|560830884|FG000|Overall Study|Adverse Event|13|||
155381359|NCT02679573|560830885|FG001|Overall Study|Adverse Event|6|||
155381360|NCT02679573|560830884|FG000|Overall Study|Lack of Efficacy|12|||
155381361|NCT02679573|560830885|FG001|Overall Study|Lack of Efficacy|15|||
155381362|NCT02679573|560830884|FG000|Overall Study|Could not complete required study visits|6|||
155381363|NCT02679573|560830885|FG001|Overall Study|Could not complete required study visits|2|||
155381364|NCT02679573|560830884|FG000|Overall Study|Withdrawal by Subject|2|||
155381365|NCT02679573|560830885|FG001|Overall Study|Withdrawal by Subject|9|||
155381366|NCT02679573|560830884|FG000|Overall Study|Death|2|||
155381367|NCT02679573|560830885|FG001|Overall Study|Death|0|||
155381368|NCT02679573|560830884|FG000|Overall Study|Physician Decision|2|||
155381369|NCT02679573|560830885|FG001|Overall Study|Physician Decision|4|||
155381370|NCT02679573|560830884|FG000|Overall Study|Lost to Follow-up|0|||
155381371|NCT02679573|560830885|FG001|Overall Study|Lost to Follow-up|3|||
155381372|NCT03545503|560830887|FG000|Overall Study|Protocol Violation|14|||
155381373|NCT03545503|560830888|FG001|Overall Study|Protocol Violation|16|||
155381374|NCT02128542|560830889|FG000|Overall Study|Lost to Follow-up|3|||
155381375|NCT02128542|560830890|FG001|Overall Study|Lost to Follow-up|0|||
155381376|NCT02128542|560830889|FG000|Overall Study|Withdrew Consent|1|||
155381377|NCT02128542|560830890|FG001|Overall Study|Withdrew Consent|0|||
155381378|NCT02483585|560830891|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
155381379|NCT02483585|560830892|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
155381380|NCT02483585|560830891|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
155381381|NCT02483585|560830892|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
155381382|NCT02483585|560830891|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
155381383|NCT02483585|560830892|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
155381384|NCT02483585|560830891|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
155381385|NCT02483585|560830892|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
155381386|NCT02483585|560830891|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
155381387|NCT02483585|560830892|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
155381388|NCT02483585|560830891|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
155381389|NCT02483585|560830892|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
155381390|NCT02483585|560830891|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
155381391|NCT02483585|560830892|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
155381392|NCT00825916|560830896|FG000|Overall Study|Lost to Follow-up|4|||
155381393|NCT00825916|560830897|FG001|Overall Study|Lost to Follow-up|2|||
155381394|NCT00825916|560830898|FG002|Overall Study|Lost to Follow-up|1|||
155381395|NCT01098097|560830902|FG000|Overall Study|Adverse Event|17|||
155381396|NCT01098097|560830902|FG000|Overall Study|Lost to Follow-up|18|||
155381397|NCT01098097|560830902|FG000|Overall Study|Status unknown|16|||
155381398|NCT01098097|560830902|FG000|Overall Study|No reason reported|31|||
155381399|NCT00394082|560830905|FG000|Overall Study|Unacceptable toxicity|15|||
155381400|NCT00394082|560830905|FG000|Overall Study|Adverse Event|4|||
155381401|NCT00394082|560830905|FG000|Overall Study|Physician Decision|4|||
155381402|NCT00394082|560830905|FG000|Overall Study|Withdrawal by Subject|2|||
155381403|NCT00394082|560830905|FG000|Overall Study|Other|1|||
155381404|NCT01768117|560830909|FG000|Overall Study|Lost to Follow-up|1|||
155381405|NCT01768117|560830909|FG000|Overall Study|Withdrawal by Subject|2|||
155381406|NCT01768117|560830909|FG000|Overall Study|Protocol Violation|3|||
155381407|NCT01945060|560830910|FG000|Overall Study|Lost to follow up|1|||
155381408|NCT01945060|560830911|FG001|Overall Study|Lost to follow up|0|||
155381409|NCT01945060|560830910|FG000|Overall Study|Distress related to IV access|0|||
155381410|NCT01945060|560830911|FG001|Overall Study|Distress related to IV access|1|||
155381411|NCT01000636|560830914|FG000|Overall Study|Withdrawal by Subject|1|||
155381412|NCT01000636|560830914|FG000|Overall Study|Adverse Event|1|||
155381413|NCT00138671|560830915|FG000|Overall Study|Death|0|||
154926213|NCT01233284|559152995|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
154926214|NCT01233284|559152996|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
154926215|NCT01233284|559152997|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
154926216|NCT01233284|559152998|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
154926217|NCT01233284|559152999|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
154926218|NCT01233284|559152995|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
154926219|NCT01233284|559152996|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
154926220|NCT01233284|559152997|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
154926221|NCT01233284|559152998|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
154926222|NCT01233284|559152999|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
154926223|NCT01233284|559152995|FG000|Period 1 (4 Weeks)|Other|0|||
154926224|NCT01233284|559152996|FG001|Period 1 (4 Weeks)|Other|0|||
154926225|NCT01233284|559152997|FG002|Period 1 (4 Weeks)|Other|1|||
154926226|NCT01233284|559152998|FG003|Period 1 (4 Weeks)|Other|0|||
154926227|NCT01233284|559152999|FG004|Period 1 (4 Weeks)|Other|0|||
154926228|NCT01233284|559152995|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
154926229|NCT01233284|559152996|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
154926230|NCT01233284|559152997|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
154926231|NCT01233284|559152998|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
154926232|NCT01233284|559152999|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
154926233|NCT01233284|559152995|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
154926234|NCT01233284|559152996|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
154926235|NCT01233284|559152997|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
154926236|NCT01233284|559152998|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
154926237|NCT01233284|559152999|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
154926238|NCT01233284|559152995|FG000|Period 3 (4 Weeks)|Other|0|||
154926239|NCT01233284|559152996|FG001|Period 3 (4 Weeks)|Other|0|||
154926240|NCT01233284|559152997|FG002|Period 3 (4 Weeks)|Other|0|||
154926241|NCT01233284|559152998|FG003|Period 3 (4 Weeks)|Other|1|||
154926242|NCT01233284|559152999|FG004|Period 3 (4 Weeks)|Other|0|||
154926243|NCT01233284|559152995|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
154926244|NCT01233284|559152996|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
154926245|NCT01233284|559152997|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
154926246|NCT01233284|559152998|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
154926247|NCT01233284|559152999|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
154926248|NCT01233284|559152995|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
154926249|NCT01233284|559152996|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
154926250|NCT01233284|559152997|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
154926251|NCT01233284|559152998|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
154926252|NCT01233284|559152999|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
154926253|NCT05403502|559153001|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
154926254|NCT05403502|559153001|FG000|Humalog Lead-In Period|Physician Decision|2|||
154926255|NCT05403502|559153001|FG000|Humalog Lead-In Period|Protocol Violation|1|||
154926256|NCT05403502|559153001|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
154926257|NCT05403502|559153001|FG000|Lyumjev Treatment Period|Physician Decision|2|||
154926258|NCT01058707|559153002|FG000|Overall Study|Disease Progression|15|||
154926259|NCT01058707|559153003|FG001|Overall Study|Disease Progression|20|||
154926260|NCT01058707|559153004|FG002|Overall Study|Disease Progression|20|||
154926261|NCT01058707|559153005|FG003|Overall Study|Disease Progression|15|||
154926262|NCT01058707|559153006|FG004|Overall Study|Disease Progression|23|||
154926263|NCT01058707|559153007|FG005|Overall Study|Disease Progression|10|||
154926264|NCT01058707|559153008|FG006|Overall Study|Disease Progression|12|||
154926265|NCT01058707|559153002|FG000|Overall Study|Adverse Event|11|||
154926266|NCT01058707|559153003|FG001|Overall Study|Adverse Event|4|||
154926267|NCT01058707|559153004|FG002|Overall Study|Adverse Event|7|||
154926268|NCT01058707|559153005|FG003|Overall Study|Adverse Event|6|||
154926269|NCT01058707|559153006|FG004|Overall Study|Adverse Event|7|||
154926270|NCT01058707|559153007|FG005|Overall Study|Adverse Event|3|||
154926271|NCT01058707|559153008|FG006|Overall Study|Adverse Event|1|||
154926272|NCT01058707|559153002|FG000|Overall Study|Subject Decision|5|||
154926273|NCT01058707|559153003|FG001|Overall Study|Subject Decision|3|||
154926274|NCT01058707|559153004|FG002|Overall Study|Subject Decision|3|||
154926275|NCT01058707|559153005|FG003|Overall Study|Subject Decision|1|||
154926276|NCT01058707|559153006|FG004|Overall Study|Subject Decision|2|||
154926277|NCT01058707|559153007|FG005|Overall Study|Subject Decision|3|||
154926278|NCT01058707|559153008|FG006|Overall Study|Subject Decision|6|||
154926279|NCT01058707|559153002|FG000|Overall Study|Lost to Follow-up|0|||
154926280|NCT01058707|559153003|FG001|Overall Study|Lost to Follow-up|0|||
154926281|NCT01058707|559153004|FG002|Overall Study|Lost to Follow-up|1|||
154926282|NCT01058707|559153005|FG003|Overall Study|Lost to Follow-up|0|||
154926283|NCT01058707|559153006|FG004|Overall Study|Lost to Follow-up|0|||
154926284|NCT01058707|559153007|FG005|Overall Study|Lost to Follow-up|0|||
154926285|NCT01058707|559153008|FG006|Overall Study|Lost to Follow-up|0|||
154926286|NCT01058707|559153002|FG000|Overall Study|Reason Not Specified|0|||
154926287|NCT01058707|559153003|FG001|Overall Study|Reason Not Specified|3|||
154926288|NCT01058707|559153004|FG002|Overall Study|Reason Not Specified|2|||
154926289|NCT01058707|559153005|FG003|Overall Study|Reason Not Specified|0|||
154926290|NCT01058707|559153006|FG004|Overall Study|Reason Not Specified|7|||
154926291|NCT01058707|559153007|FG005|Overall Study|Reason Not Specified|1|||
154926292|NCT01058707|559153008|FG006|Overall Study|Reason Not Specified|7|||
154926293|NCT00167414|559153009|FG000|Overall Study|Death|10|||
154926294|NCT00795886|559153010|FG000|Overall Study|Death|10|||
154926295|NCT05554471|559153011|FG000|Overall Study|Physician Decision|2|||
154926296|NCT05554471|559153012|FG001|Overall Study|Physician Decision|1|||
154926297|NCT05554471|559153011|FG000|Overall Study|Lost to Follow-up|2|||
154926298|NCT05554471|559153012|FG001|Overall Study|Lost to Follow-up|1|||
154926299|NCT05554471|559153011|FG000|Overall Study|Death|0|||
154926300|NCT05554471|559153012|FG001|Overall Study|Death|1|||
154926301|NCT04814654|559153013|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
154926302|NCT04814654|559153014|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
154926303|NCT04814654|559153015|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
154926304|NCT03505606|559154398|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
154926305|NCT03505606|559154399|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
154926306|NCT03505606|559154400|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
154926307|NCT03505606|559154398|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
154926308|NCT03505606|559154399|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
154926309|NCT03505606|559154400|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
154926310|NCT03505606|559154398|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
154926311|NCT03505606|559154399|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
154926312|NCT03505606|559154400|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
154926313|NCT03505606|559154398|FG000|Overall Study|Poor compliance with refractive correction|0|||
154926314|NCT03505606|559154399|FG001|Overall Study|Poor compliance with refractive correction|0|||
154926315|NCT03505606|559154400|FG002|Overall Study|Poor compliance with refractive correction|1|||
154926316|NCT03505606|559154398|FG000|Overall Study|Insufficient anisometropia|0|||
154926317|NCT03505606|559154399|FG001|Overall Study|Insufficient anisometropia|0|||
154926318|NCT03505606|559154400|FG002|Overall Study|Insufficient anisometropia|2|||
154926319|NCT03505606|559154398|FG000|Overall Study|Ectopia Lentis|0|||
154926320|NCT03505606|559154399|FG001|Overall Study|Ectopia Lentis|0|||
154926321|NCT03505606|559154400|FG002|Overall Study|Ectopia Lentis|1|||
154926322|NCT03505606|559154398|FG000|Overall Study|alternation of amblyopic eye|0|||
154926323|NCT03505606|559154399|FG001|Overall Study|alternation of amblyopic eye|1|||
154926324|NCT03505606|559154400|FG002|Overall Study|alternation of amblyopic eye|0|||
154926325|NCT02087865|559154403|FG000|Overall Study|Withdrawal by Subject|6|||
154926326|NCT02087865|559154404|FG001|Overall Study|Withdrawal by Subject|0|||
154926327|NCT02087865|559154405|FG002|Overall Study|Withdrawal by Subject|1|||
154926328|NCT02087865|559154403|FG000|Overall Study|Lost to Follow-up|0|||
154926329|NCT02087865|559154404|FG001|Overall Study|Lost to Follow-up|0|||
154926330|NCT02087865|559154405|FG002|Overall Study|Lost to Follow-up|1|||
154926331|NCT02087865|559154403|FG000|Overall Study|Drug Non-compliance|0|||
154926332|NCT02087865|559154404|FG001|Overall Study|Drug Non-compliance|2|||
154926333|NCT02087865|559154405|FG002|Overall Study|Drug Non-compliance|0|||
154926334|NCT02087865|559154403|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
154926335|NCT02087865|559154404|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
154926336|NCT02087865|559154405|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
154926337|NCT01319994|559154406|FG000|Overall Study|Protocol Violation|7|||
154926338|NCT01319994|559154407|FG001|Overall Study|Protocol Violation|6|||
154926339|NCT01340794|559154408|FG000|Overall Study|Withdrawal by Subject|0|||
154926340|NCT01340794|559154409|FG001|Overall Study|Withdrawal by Subject|1|||
154926341|NCT02674568|559154418|FG000|Overall Study|Withdrawal by Subject|5|||
154926342|NCT02674568|559154418|FG000|Overall Study|Death|303|||
154926343|NCT02674568|559154418|FG000|Overall Study|Physician Decision|2|||
154926344|NCT02674568|559154418|FG000|Overall Study|Lost to Follow-up|9|||
154926345|NCT02674568|559154418|FG000|Overall Study|Other, Not Specified|20|||
154926346|NCT01808508|559154421|FG000|Overall Study|Lost to Follow-up|1|||
154926347|NCT01808508|559154422|FG001|Overall Study|Lost to Follow-up|0|||
154926348|NCT01808508|559154423|FG002|Overall Study|Lost to Follow-up|0|||
154926349|NCT01118949|559154424|FG000|Overall Study|Adverse Event|5|||
154926350|NCT01118949|559154424|FG000|Overall Study|Withdrawal by Subject|4|||
154926351|NCT01017731|559154425|FG000|Overall Study|Lost to Follow-up|2|||
154926352|NCT01017731|559154425|FG000|Overall Study|Withdrawal by Subject|3|||
154926353|NCT01017731|559154425|FG000|Overall Study|Physician Decision|2|||
154926354|NCT01017731|559154425|FG000|Overall Study|Adverse Event|1|||
154926355|NCT00685763|559154426|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
154926356|NCT00685763|559154426|FG000|Overall Study|Protocol Violation|1|||
154926357|NCT00929201|559154433|FG000|Period 1|Withdrawal by Subject|0|||
154926358|NCT00929201|559154434|FG001|Period 1|Withdrawal by Subject|1|||
154926359|NCT03606109|559154438|FG000|Overall Study|Lost to Follow-up|2|||
154926360|NCT03606109|559154439|FG001|Overall Study|Lost to Follow-up|1|||
154926361|NCT03286426|559154444|FG000|Overall Study|Physician Decision|3|||
154926362|NCT01817764|559154445|FG000|Overall Study|Adverse Event|7|||
154926363|NCT01817764|559154446|FG001|Overall Study|Adverse Event|10|||
154926364|NCT01817764|559154445|FG000|Overall Study|Lack of Efficacy|9|||
154926365|NCT01817764|559154446|FG001|Overall Study|Lack of Efficacy|7|||
154926366|NCT01817764|559154445|FG000|Overall Study|Protocol Violation|7|||
154926367|NCT01817764|559154446|FG001|Overall Study|Protocol Violation|5|||
154926368|NCT01817764|559154445|FG000|Overall Study|Lost to Follow-up|1|||
154926369|NCT01817764|559154446|FG001|Overall Study|Lost to Follow-up|4|||
154926370|NCT01817764|559154445|FG000|Overall Study|Withdrawal by Subject|10|||
154926371|NCT01817764|559154446|FG001|Overall Study|Withdrawal by Subject|12|||
154926372|NCT04292171|559154447|FG000|Overall Study|Pharmacy error|2|||
154926373|NCT04292171|559154448|FG001|Overall Study|Pharmacy error|0|||
154926374|NCT04292171|559154447|FG000|Overall Study|Delivered prior to procedure|0|||
154926375|NCT04292171|559154448|FG001|Overall Study|Delivered prior to procedure|1|||
154926376|NCT04633434|559154449|FG000|Overall Study|Lost to Follow-up|32|||
154926377|NCT04633434|559154450|FG001|Overall Study|Lost to Follow-up|32|||
154926378|NCT00471237|559154452|FG000|Overall Study|Adverse Event|6|||
154926379|NCT00471237|559154453|FG001|Overall Study|Adverse Event|5|||
154926380|NCT00471237|559154454|FG002|Overall Study|Adverse Event|4|||
154926381|NCT00471237|559154455|FG003|Overall Study|Adverse Event|8|||
154926382|NCT00471237|559154456|FG004|Overall Study|Adverse Event|7|||
154926383|NCT00471237|559154457|FG005|Overall Study|Adverse Event|5|||
154926384|NCT00471237|559154458|FG006|Overall Study|Adverse Event|0|||
154926385|NCT00471237|559154452|FG000|Overall Study|Lost to Follow-up|1|||
154926386|NCT00471237|559154453|FG001|Overall Study|Lost to Follow-up|1|||
154926387|NCT00471237|559154454|FG002|Overall Study|Lost to Follow-up|0|||
154926388|NCT00471237|559154455|FG003|Overall Study|Lost to Follow-up|2|||
154926389|NCT00471237|559154456|FG004|Overall Study|Lost to Follow-up|3|||
154926390|NCT00471237|559154457|FG005|Overall Study|Lost to Follow-up|0|||
154926391|NCT00471237|559154458|FG006|Overall Study|Lost to Follow-up|0|||
154926392|NCT00471237|559154452|FG000|Overall Study|Protocol Violation|3|||
154926393|NCT00471237|559154453|FG001|Overall Study|Protocol Violation|6|||
154926394|NCT00471237|559154454|FG002|Overall Study|Protocol Violation|3|||
154926395|NCT00471237|559154455|FG003|Overall Study|Protocol Violation|2|||
154926396|NCT00471237|559154456|FG004|Overall Study|Protocol Violation|2|||
154926397|NCT00471237|559154457|FG005|Overall Study|Protocol Violation|4|||
154926398|NCT00471237|559154458|FG006|Overall Study|Protocol Violation|1|||
154926399|NCT00471237|559154452|FG000|Overall Study|Withdrawal by Subject|8|||
154926400|NCT00471237|559154453|FG001|Overall Study|Withdrawal by Subject|6|||
154926401|NCT00471237|559154454|FG002|Overall Study|Withdrawal by Subject|5|||
154926402|NCT00471237|559154455|FG003|Overall Study|Withdrawal by Subject|8|||
154926403|NCT00471237|559154456|FG004|Overall Study|Withdrawal by Subject|7|||
154926404|NCT00471237|559154457|FG005|Overall Study|Withdrawal by Subject|4|||
154926405|NCT00471237|559154458|FG006|Overall Study|Withdrawal by Subject|2|||
154926406|NCT00471237|559154452|FG000|Overall Study|Sponsor terminated study|20|||
154926407|NCT00471237|559154453|FG001|Overall Study|Sponsor terminated study|23|||
154926408|NCT00471237|559154454|FG002|Overall Study|Sponsor terminated study|19|||
154926409|NCT00471237|559154455|FG003|Overall Study|Sponsor terminated study|22|||
154926410|NCT00471237|559154456|FG004|Overall Study|Sponsor terminated study|18|||
154926411|NCT00471237|559154457|FG005|Overall Study|Sponsor terminated study|24|||
154926412|NCT00471237|559154458|FG006|Overall Study|Sponsor terminated study|0|||
154926413|NCT00471237|559154452|FG000|Overall Study|Non-compliance|0|||
154926414|NCT00471237|559154453|FG001|Overall Study|Non-compliance|1|||
154926415|NCT00471237|559154454|FG002|Overall Study|Non-compliance|0|||
154926416|NCT00471237|559154455|FG003|Overall Study|Non-compliance|1|||
154926417|NCT00471237|559154456|FG004|Overall Study|Non-compliance|0|||
154926418|NCT00471237|559154457|FG005|Overall Study|Non-compliance|0|||
154926419|NCT00471237|559154458|FG006|Overall Study|Non-compliance|0|||
154926420|NCT00471237|559154452|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
154926421|NCT00471237|559154453|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
154926422|NCT00471237|559154454|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
154926423|NCT00471237|559154455|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
154926424|NCT00471237|559154456|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
154926425|NCT00471237|559154457|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
154926426|NCT00471237|559154458|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
154926427|NCT00471237|559154452|FG000|Overall Study|Early stopping due to non-efficacy|1|||
154926428|NCT00471237|559154453|FG001|Overall Study|Early stopping due to non-efficacy|0|||
154926429|NCT00471237|559154454|FG002|Overall Study|Early stopping due to non-efficacy|0|||
154926430|NCT00471237|559154455|FG003|Overall Study|Early stopping due to non-efficacy|0|||
154926431|NCT00471237|559154456|FG004|Overall Study|Early stopping due to non-efficacy|1|||
154926432|NCT00471237|559154457|FG005|Overall Study|Early stopping due to non-efficacy|0|||
154926433|NCT00471237|559154458|FG006|Overall Study|Early stopping due to non-efficacy|0|||
154926434|NCT00471237|559154452|FG000|Overall Study|Participant planned to travel to abraod|1|||
154926435|NCT00471237|559154453|FG001|Overall Study|Participant planned to travel to abraod|0|||
154926436|NCT00471237|559154454|FG002|Overall Study|Participant planned to travel to abraod|0|||
154926437|NCT00471237|559154455|FG003|Overall Study|Participant planned to travel to abraod|0|||
154926438|NCT00471237|559154456|FG004|Overall Study|Participant planned to travel to abraod|0|||
155152522|NCT03037385|559996849|FG007|Overall Study|Lost to Follow-up|0|||
154926439|NCT00471237|559154457|FG005|Overall Study|Participant planned to travel to abraod|1|||
154926440|NCT00471237|559154458|FG006|Overall Study|Participant planned to travel to abraod|0|||
154926441|NCT00471237|559154452|FG000|Overall Study|High parathyroid hormone|0|||
154926442|NCT00471237|559154453|FG001|Overall Study|High parathyroid hormone|0|||
154926443|NCT00471237|559154454|FG002|Overall Study|High parathyroid hormone|1|||
154926444|NCT00471237|559154455|FG003|Overall Study|High parathyroid hormone|0|||
154926445|NCT00471237|559154456|FG004|Overall Study|High parathyroid hormone|0|||
154926446|NCT00471237|559154457|FG005|Overall Study|High parathyroid hormone|0|||
154926447|NCT00471237|559154458|FG006|Overall Study|High parathyroid hormone|0|||
154926448|NCT00471237|559154452|FG000|Overall Study|Participant lost medication|0|||
154926449|NCT00471237|559154453|FG001|Overall Study|Participant lost medication|0|||
154926450|NCT00471237|559154454|FG002|Overall Study|Participant lost medication|0|||
154926451|NCT00471237|559154455|FG003|Overall Study|Participant lost medication|0|||
154926452|NCT00471237|559154456|FG004|Overall Study|Participant lost medication|1|||
154926453|NCT00471237|559154457|FG005|Overall Study|Participant lost medication|0|||
154926454|NCT00471237|559154458|FG006|Overall Study|Participant lost medication|0|||
154926455|NCT00471237|559154452|FG000|Overall Study|Administration of prohibited medicine|0|||
154926456|NCT00471237|559154453|FG001|Overall Study|Administration of prohibited medicine|0|||
154926457|NCT00471237|559154454|FG002|Overall Study|Administration of prohibited medicine|0|||
154926458|NCT00471237|559154455|FG003|Overall Study|Administration of prohibited medicine|0|||
154926459|NCT00471237|559154456|FG004|Overall Study|Administration of prohibited medicine|1|||
154926460|NCT00471237|559154457|FG005|Overall Study|Administration of prohibited medicine|0|||
154926461|NCT00471237|559154458|FG006|Overall Study|Administration of prohibited medicine|0|||
154926462|NCT00471237|559154452|FG000|Overall Study|Participant shifted residence|0|||
154926463|NCT00471237|559154453|FG001|Overall Study|Participant shifted residence|0|||
154926464|NCT00471237|559154454|FG002|Overall Study|Participant shifted residence|0|||
154926465|NCT00471237|559154455|FG003|Overall Study|Participant shifted residence|0|||
154926466|NCT00471237|559154456|FG004|Overall Study|Participant shifted residence|1|||
154926467|NCT00471237|559154457|FG005|Overall Study|Participant shifted residence|0|||
154926468|NCT00471237|559154458|FG006|Overall Study|Participant shifted residence|0|||
154926469|NCT00471237|559154452|FG000|Overall Study|Participant's decision|0|||
154926470|NCT00471237|559154453|FG001|Overall Study|Participant's decision|0|||
154926471|NCT00471237|559154454|FG002|Overall Study|Participant's decision|0|||
154926472|NCT00471237|559154455|FG003|Overall Study|Participant's decision|0|||
154926473|NCT00471237|559154456|FG004|Overall Study|Participant's decision|0|||
154926474|NCT00471237|559154457|FG005|Overall Study|Participant's decision|1|||
154926475|NCT00471237|559154458|FG006|Overall Study|Participant's decision|0|||
154926476|NCT00848965|559154459|FG000|Overall Study|Adverse Event|1|||
154926477|NCT00848965|559154459|FG000|Overall Study|Withdrawal by Subject|1|||
154926478|NCT02329834|559154460|FG000|Overall Study|Physician Decision|1|||
154926479|NCT02329834|559154461|FG001|Overall Study|Physician Decision|0|||
154926480|NCT00578448|559154462|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
154926481|NCT00578448|559154462|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
154926482|NCT00578448|559154462|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
154926483|NCT00578448|559154462|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
154926484|NCT01976104|559154463|FG000|Overall Study|Adverse Event|0|||
154926485|NCT01976104|559154464|FG001|Overall Study|Adverse Event|0|||
154926486|NCT01976104|559154465|FG002|Overall Study|Adverse Event|1|||
154926487|NCT01976104|559154466|FG003|Overall Study|Adverse Event|0|||
154926488|NCT01976104|559154463|FG000|Overall Study|Lost to Follow-up|3|||
154926489|NCT01976104|559154464|FG001|Overall Study|Lost to Follow-up|0|||
154926490|NCT01976104|559154465|FG002|Overall Study|Lost to Follow-up|1|||
154926491|NCT01976104|559154466|FG003|Overall Study|Lost to Follow-up|1|||
154926492|NCT01976104|559154463|FG000|Overall Study|Subject Choice|0|||
154926493|NCT01976104|559154464|FG001|Overall Study|Subject Choice|1|||
154926494|NCT01976104|559154465|FG002|Overall Study|Subject Choice|0|||
154926495|NCT01976104|559154466|FG003|Overall Study|Subject Choice|1|||
154926496|NCT01976104|559154463|FG000|Overall Study|Withdrawal by Subject|3|||
154926497|NCT01976104|559154464|FG001|Overall Study|Withdrawal by Subject|0|||
154926498|NCT01976104|559154465|FG002|Overall Study|Withdrawal by Subject|0|||
154926499|NCT01976104|559154466|FG003|Overall Study|Withdrawal by Subject|1|||
154926500|NCT01976104|559154463|FG000|Overall Study|Other|0|||
154926501|NCT01976104|559154464|FG001|Overall Study|Other|1|||
154926502|NCT01976104|559154465|FG002|Overall Study|Other|0|||
154926503|NCT01976104|559154466|FG003|Overall Study|Other|0|||
154926504|NCT03237325|559154474|FG000|Overall Study|Lost to Follow-up|3|||
154926505|NCT03237325|559154475|FG001|Overall Study|Lost to Follow-up|5|||
154926506|NCT03237325|559154474|FG000|Overall Study|Physician Decision|2|||
154926507|NCT03237325|559154475|FG001|Overall Study|Physician Decision|4|||
154926508|NCT03237325|559154474|FG000|Overall Study|Withdrawal by Subject|9|||
154926509|NCT03237325|559154475|FG001|Overall Study|Withdrawal by Subject|12|||
154926510|NCT03237325|559154474|FG000|Overall Study|Noncompliance with Study Procedures|1|||
154926511|NCT03237325|559154475|FG001|Overall Study|Noncompliance with Study Procedures|1|||
154926512|NCT03237325|559154474|FG000|Overall Study|Termination by Sponsor|0|||
155152523|NCT03037385|559996850|FG008|Overall Study|Lost to Follow-up|0|||
154926513|NCT03237325|559154475|FG001|Overall Study|Termination by Sponsor|1|||
154926514|NCT03237325|559154474|FG000|Overall Study|Reason other than described|0|||
154926515|NCT03237325|559154475|FG001|Overall Study|Reason other than described|2|||
154926516|NCT00627094|559154478|FG000|Overall Study|Adverse Event|8|||
154926517|NCT00627094|559154479|FG001|Overall Study|Adverse Event|7|||
154926518|NCT00627094|559154478|FG000|Overall Study|Lost to Follow-up|1|||
154926519|NCT00627094|559154479|FG001|Overall Study|Lost to Follow-up|0|||
154926520|NCT00627094|559154478|FG000|Overall Study|Withdrawal by Subject|1|||
154926521|NCT00627094|559154479|FG001|Overall Study|Withdrawal by Subject|1|||
154926522|NCT00627094|559154478|FG000|Overall Study|ulcer healed|1|||
154926523|NCT00627094|559154479|FG001|Overall Study|ulcer healed|7|||
154926524|NCT00627094|559154478|FG000|Overall Study|Other reason|1|||
154926525|NCT00627094|559154479|FG001|Overall Study|Other reason|0|||
154926526|NCT01833897|559154492|FG000|Overall Study|Lack of Efficacy|1|||
154926527|NCT00669110|559154493|FG000|Overall Study|Adverse Event|4|||
154926528|NCT00669110|559154494|FG001|Overall Study|Adverse Event|3|||
154926529|NCT00669110|559154493|FG000|Overall Study|Caregiver request|3|||
154926530|NCT00669110|559154494|FG001|Overall Study|Caregiver request|2|||
154926531|NCT00669110|559154493|FG000|Overall Study|Physician Decision|0|||
154926532|NCT00669110|559154494|FG001|Overall Study|Physician Decision|1|||
154926533|NCT00669110|559154493|FG000|Overall Study|Lost to Follow-up|1|||
154926534|NCT00669110|559154494|FG001|Overall Study|Lost to Follow-up|0|||
154926535|NCT00669110|559154493|FG000|Overall Study|Protocol Violation|0|||
154926536|NCT00669110|559154494|FG001|Overall Study|Protocol Violation|5|||
154926537|NCT00669110|559154493|FG000|Overall Study|Withdrawal by Subject|0|||
154926538|NCT00669110|559154494|FG001|Overall Study|Withdrawal by Subject|2|||
154926539|NCT00806416|559154497|FG000|Period 1 - Part I|Adverse Event|0|||
154926540|NCT00806416|559154498|FG001|Period 1 - Part I|Adverse Event|1|||
154926541|NCT00806416|559154499|FG002|Period 1 - Part I|Adverse Event|0|||
154926542|NCT00806416|559154500|FG003|Period 1 - Part I|Adverse Event|0|||
154926543|NCT00806416|559154497|FG000|Period 1 - Part I|Lost to Follow-up|0|||
154926544|NCT00806416|559154498|FG001|Period 1 - Part I|Lost to Follow-up|2|||
154926545|NCT00806416|559154499|FG002|Period 1 - Part I|Lost to Follow-up|0|||
154926546|NCT00806416|559154500|FG003|Period 1 - Part I|Lost to Follow-up|0|||
154926547|NCT00806416|559154497|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
154926548|NCT00806416|559154498|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
154926549|NCT00806416|559154499|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
154926550|NCT00806416|559154500|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
154926551|NCT00806416|559154497|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
154926552|NCT00806416|559154498|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
154926553|NCT00806416|559154499|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
154926554|NCT00806416|559154500|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
154926555|NCT01244516|559154504|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
154926556|NCT01244516|559154505|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
154926557|NCT01244516|559154506|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
154926558|NCT01244516|559154504|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
154926559|NCT01244516|559154505|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
154926560|NCT01244516|559154506|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
154926561|NCT01244516|559154504|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
154926562|NCT01244516|559154505|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
154926563|NCT01244516|559154506|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
154926564|NCT01244516|559154504|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
154926565|NCT01244516|559154505|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
154926566|NCT01244516|559154506|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
154926567|NCT01244516|559154504|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
154926568|NCT01244516|559154505|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
154926569|NCT01244516|559154506|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
154926570|NCT01244516|559154504|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
154926571|NCT01244516|559154505|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
154926572|NCT01244516|559154506|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
154926573|NCT01244516|559154504|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
154926574|NCT01244516|559154505|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
154926575|NCT01244516|559154506|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
154926576|NCT01102972|559154509|FG000|Overall Study|Adverse Event|8|||
154926577|NCT01102972|559154510|FG001|Overall Study|Adverse Event|2|||
154926578|NCT01102972|559154509|FG000|Overall Study|Lack of Efficacy|2|||
154926579|NCT01102972|559154510|FG001|Overall Study|Lack of Efficacy|1|||
154926580|NCT01102972|559154509|FG000|Overall Study|Protocol Violation|1|||
154926581|NCT01102972|559154510|FG001|Overall Study|Protocol Violation|0|||
154926582|NCT01102972|559154509|FG000|Overall Study|Lost to Follow-up|10|||
154926583|NCT01102972|559154510|FG001|Overall Study|Lost to Follow-up|5|||
154926584|NCT01102972|559154509|FG000|Overall Study|Investigator Discretion|2|||
154926585|NCT01102972|559154510|FG001|Overall Study|Investigator Discretion|0|||
154926586|NCT01102972|559154509|FG000|Overall Study|Withdrawal by Subject|6|||
154926587|NCT01102972|559154510|FG001|Overall Study|Withdrawal by Subject|6|||
154926588|NCT01886105|559154511|FG000|Overall Study|Lack of Efficacy|3|||
154926589|NCT01360021|559154512|FG000|Overall Study|Eligibility criteria + other|2|||
154926590|NCT01360021|559154513|FG001|Overall Study|Eligibility criteria + other|1|||
154926591|NCT01360021|559154514|FG002|Overall Study|Eligibility criteria + other|1|||
154926592|NCT01360021|559154512|FG000|Overall Study|Protocol Violation|0|||
154926593|NCT01360021|559154513|FG001|Overall Study|Protocol Violation|0|||
154926594|NCT01360021|559154514|FG002|Overall Study|Protocol Violation|1|||
154926595|NCT01360021|559154512|FG000|Overall Study|Withdrawal by Subject|4|||
154926596|NCT01360021|559154513|FG001|Overall Study|Withdrawal by Subject|0|||
154926597|NCT01360021|559154514|FG002|Overall Study|Withdrawal by Subject|2|||
154926598|NCT01360021|559154512|FG000|Overall Study|Adverse Event|2|||
154926599|NCT01360021|559154513|FG001|Overall Study|Adverse Event|3|||
154926600|NCT01360021|559154514|FG002|Overall Study|Adverse Event|3|||
155381414|NCT00138671|560830916|FG001|Overall Study|Death|3|||
155381415|NCT00138671|560830915|FG000|Overall Study|Adverse Event|6|||
155381416|NCT00138671|560830916|FG001|Overall Study|Adverse Event|3|||
155381417|NCT00138671|560830915|FG000|Overall Study|Lost to Follow-up|1|||
155381418|NCT00138671|560830916|FG001|Overall Study|Lost to Follow-up|2|||
155381419|NCT00138671|560830915|FG000|Overall Study|Withdrawal by Subject|3|||
155381420|NCT00138671|560830916|FG001|Overall Study|Withdrawal by Subject|5|||
155381421|NCT00138671|560830915|FG000|Overall Study|Other|3|||
155381422|NCT00138671|560830916|FG001|Overall Study|Other|3|||
155381423|NCT00906945|560830918|FG000|Overall Study|Found to be not eligible|0|||
155381424|NCT00906945|560830919|FG001|Overall Study|Found to be not eligible|0|||
155381425|NCT00906945|560830920|FG002|Overall Study|Found to be not eligible|0|||
155381426|NCT00906945|560830921|FG003|Overall Study|Found to be not eligible|1|||
155381427|NCT00906945|560830922|FG004|Overall Study|Found to be not eligible|1|||
155381428|NCT00906945|560830923|FG005|Overall Study|Found to be not eligible|1|||
155381429|NCT00906945|560830918|FG000|Overall Study|Physician Decision|0|||
155381430|NCT00906945|560830919|FG001|Overall Study|Physician Decision|0|||
155381431|NCT00906945|560830920|FG002|Overall Study|Physician Decision|0|||
155381432|NCT00906945|560830921|FG003|Overall Study|Physician Decision|0|||
155381433|NCT00906945|560830922|FG004|Overall Study|Physician Decision|0|||
155381434|NCT00906945|560830923|FG005|Overall Study|Physician Decision|1|||
155381435|NCT01853644|560830924|FG000|Registration and Treatment Start|Did not start treatment|1|||
155381436|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
155381437|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
155381438|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
155381439|NCT01853644|560830924|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
155381440|NCT01853644|560830924|FG000|Continued Treatment After First Response|Adverse Event|2|||
155381441|NCT01853644|560830924|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
155381442|NCT00705523|560830925|FG000|Overall Study|Lost to Follow-up|2|||
155381443|NCT00705523|560830926|FG001|Overall Study|Lost to Follow-up|3|||
155381444|NCT02673515|560830927|FG000|Overall Study|Lack of motivation|2|||
155381445|NCT02673515|560830928|FG001|Overall Study|Lack of motivation|1|||
155381446|NCT01323972|560830929|FG000|Overall Study|Withdrawal by Subject|1|||
155381447|NCT01323972|560830930|FG001|Overall Study|Withdrawal by Subject|0|||
155381448|NCT01323972|560830931|FG002|Overall Study|Withdrawal by Subject|1|||
155381449|NCT01323972|560830932|FG003|Overall Study|Withdrawal by Subject|0|||
155381450|NCT01323972|560830929|FG000|Overall Study|Migrated/moved from study area|1|||
154926601|NCT00530621|559154515|FG000|Overall Study|Adverse Event|11|||
154926602|NCT00530621|559154516|FG001|Overall Study|Adverse Event|8|||
154926603|NCT00530621|559154515|FG000|Overall Study|Physician Decision|2|||
154926604|NCT00530621|559154516|FG001|Overall Study|Physician Decision|4|||
154926605|NCT00530621|559154515|FG000|Overall Study|Progressive Disease (PD)|47|||
154926606|NCT00530621|559154516|FG001|Overall Study|Progressive Disease (PD)|40|||
154926607|NCT00530621|559154515|FG000|Overall Study|Sponsor Decision|12|||
154926608|NCT00530621|559154516|FG001|Overall Study|Sponsor Decision|15|||
155381451|NCT01323972|560830930|FG001|Overall Study|Migrated/moved from study area|2|||
155381452|NCT01323972|560830931|FG002|Overall Study|Migrated/moved from study area|0|||
155381453|NCT01323972|560830932|FG003|Overall Study|Migrated/moved from study area|0|||
155381454|NCT01323972|560830929|FG000|Overall Study|Lost to Follow-up|0|||
155381455|NCT01323972|560830930|FG001|Overall Study|Lost to Follow-up|1|||
155381456|NCT01323972|560830931|FG002|Overall Study|Lost to Follow-up|1|||
155381457|NCT01323972|560830932|FG003|Overall Study|Lost to Follow-up|1|||
155381458|NCT00994682|560830933|FG000|Double Bilnd|Withdrawal by Subject|5|||
155381459|NCT00994682|560830934|FG001|Double Bilnd|Withdrawal by Subject|6|||
155381460|NCT00994682|560830933|FG000|Double Bilnd|Lost to Follow-up|3|||
155381461|NCT00994682|560830934|FG001|Double Bilnd|Lost to Follow-up|3|||
155381462|NCT00994682|560830933|FG000|Double Bilnd|Adverse Event|1|||
155381463|NCT00994682|560830934|FG001|Double Bilnd|Adverse Event|0|||
155381464|NCT00994682|560830933|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
155381465|NCT00994682|560830934|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
154926609|NCT00530621|559154515|FG000|Overall Study|Subject Decision|4|||
155381466|NCT00994682|560830933|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
155381467|NCT00994682|560830934|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
154926610|NCT00530621|559154516|FG001|Overall Study|Subject Decision|7|||
154926611|NCT00530621|559154515|FG000|Overall Study|Death|3|||
154926612|NCT00530621|559154516|FG001|Overall Study|Death|6|||
154926613|NCT00530621|559154515|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
154926614|NCT00530621|559154516|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
154926615|NCT03179462|559154522|FG000|Overall Study|screening failure|1|||
154926616|NCT03179462|559154523|FG001|Overall Study|screening failure|2|||
154926617|NCT03179462|559154524|FG002|Overall Study|screening failure|0|||
154926618|NCT01593761|559154527|FG000|Overall Study|Lost to Follow-up|1|||
154926619|NCT01593761|559154527|FG000|Overall Study|culture negative for MRSA at baseline|5|||
154926620|NCT01593761|559154527|FG000|Overall Study|positive for hepatitis C virus|1|||
154926621|NCT01593761|559154527|FG000|Overall Study|secondary cellulitis|1|||
154926622|NCT01875731|559154528|FG000|Overall Study|Fail to obtain lab sample|1|||
154926623|NCT01875731|559154529|FG001|Overall Study|Fail to obtain lab sample|0|||
154926624|NCT02576951|559154530|FG000|Overall Study|Lost to Follow-up|0|||
154926625|NCT02576951|559154531|FG001|Overall Study|Lost to Follow-up|0|||
154926626|NCT02576951|559154532|FG002|Overall Study|Lost to Follow-up|2|||
154926627|NCT02576951|559154533|FG003|Overall Study|Lost to Follow-up|2|||
154926628|NCT02576951|559154530|FG000|Overall Study|Withdrawal by Subject|1|||
154926629|NCT02576951|559154531|FG001|Overall Study|Withdrawal by Subject|0|||
154926630|NCT02576951|559154532|FG002|Overall Study|Withdrawal by Subject|0|||
154926631|NCT02576951|559154533|FG003|Overall Study|Withdrawal by Subject|2|||
154926632|NCT02576951|559154530|FG000|Overall Study|Protocol Violation|0|||
154926633|NCT02576951|559154531|FG001|Overall Study|Protocol Violation|0|||
154926634|NCT02576951|559154532|FG002|Overall Study|Protocol Violation|0|||
154926635|NCT02576951|559154533|FG003|Overall Study|Protocol Violation|1|||
154926636|NCT03417102|559154534|FG000|Overall Study|Adverse Event|0|||
154926637|NCT03417102|559154535|FG001|Overall Study|Adverse Event|1|||
154926638|NCT03417102|559154534|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
154926639|NCT03417102|559154535|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
154926640|NCT03417102|559154534|FG000|Overall Study|Other|0|||
154926641|NCT03417102|559154535|FG001|Overall Study|Other|1|||
154926642|NCT02062385|559154539|FG000|Overall Study|Adverse Event|19|||
154926643|NCT02062385|559154540|FG001|Overall Study|Adverse Event|13|||
154926644|NCT02062385|559154541|FG002|Overall Study|Adverse Event|1|||
154926645|NCT02062385|559154542|FG003|Overall Study|Adverse Event|0|||
154926646|NCT02062385|559154539|FG000|Overall Study|Protocol Violation|1|||
154926647|NCT02062385|559154540|FG001|Overall Study|Protocol Violation|0|||
154926648|NCT02062385|559154541|FG002|Overall Study|Protocol Violation|0|||
154926649|NCT02062385|559154542|FG003|Overall Study|Protocol Violation|0|||
154926650|NCT02062385|559154539|FG000|Overall Study|Incomplete EPI by database lock|2|||
154926651|NCT02062385|559154540|FG001|Overall Study|Incomplete EPI by database lock|0|||
154926652|NCT02062385|559154541|FG002|Overall Study|Incomplete EPI by database lock|0|||
154926653|NCT02062385|559154542|FG003|Overall Study|Incomplete EPI by database lock|0|||
154926654|NCT02062385|559154539|FG000|Overall Study|Moved|10|||
154926655|NCT02062385|559154540|FG001|Overall Study|Moved|11|||
154926656|NCT02062385|559154541|FG002|Overall Study|Moved|1|||
154926657|NCT02062385|559154542|FG003|Overall Study|Moved|0|||
154926658|NCT02062385|559154539|FG000|Overall Study|Withdrawn by parent/guardian|46|||
154926659|NCT02062385|559154540|FG001|Overall Study|Withdrawn by parent/guardian|41|||
154926660|NCT02062385|559154541|FG002|Overall Study|Withdrawn by parent/guardian|9|||
154926661|NCT02062385|559154542|FG003|Overall Study|Withdrawn by parent/guardian|8|||
154926662|NCT02062385|559154539|FG000|Overall Study|Death|0|||
154926663|NCT02062385|559154540|FG001|Overall Study|Death|0|||
154926664|NCT02062385|559154541|FG002|Overall Study|Death|0|||
154926665|NCT02062385|559154542|FG003|Overall Study|Death|1|||
154926666|NCT02062385|559154539|FG000|Overall Study|Lost to Follow-up|0|||
154926667|NCT02062385|559154540|FG001|Overall Study|Lost to Follow-up|0|||
154926668|NCT02062385|559154541|FG002|Overall Study|Lost to Follow-up|1|||
154926669|NCT02062385|559154542|FG003|Overall Study|Lost to Follow-up|0|||
154926670|NCT03188991|559154543|FG000|Overall Study|Withdrawal by Subject|0|||
154926671|NCT03188991|559154544|FG001|Overall Study|Withdrawal by Subject|0|||
154926672|NCT03188991|559154545|FG002|Overall Study|Withdrawal by Subject|0|||
154926673|NCT03188991|559154546|FG003|Overall Study|Withdrawal by Subject|1|||
154926674|NCT00223990|559154547|FG000|Overall Study|Moved from area|2|||
154926675|NCT00223990|559154548|FG001|Overall Study|Moved from area|1|||
154926676|NCT00223990|559154547|FG000|Overall Study|Withdrawal by Subject|4|||
154926677|NCT00223990|559154548|FG001|Overall Study|Withdrawal by Subject|8|||
154926678|NCT00223990|559154547|FG000|Overall Study|Lost to Follow-up|1|||
154926679|NCT00223990|559154548|FG001|Overall Study|Lost to Follow-up|0|||
154926680|NCT01392469|559156811|FG000|Overall Study|Adverse Event|2|||
154926681|NCT01392469|559156811|FG000|Overall Study|Withdrawal by Subject|1|||
154926682|NCT01392469|559156811|FG000|Overall Study|Protocol Violation|1|||
154926683|NCT03255226|559156817|FG000|Overall Study|Adverse Event|2|||
154926684|NCT03255226|559156817|FG000|Overall Study|Physician Decision|3|||
154926685|NCT03255226|559156817|FG000|Overall Study|Withdrawal by Subject|1|||
154926686|NCT03255226|559156817|FG000|Overall Study|Serum or blood sodium increased|4|||
154926687|NCT03255226|559156817|FG000|Overall Study|Serum or blood potassium increased|4|||
154926688|NCT01035229|559156818|FG000|Overall Study|Adverse Event|61|||
154926689|NCT01035229|559156819|FG001|Overall Study|Adverse Event|14|||
154926690|NCT01035229|559156818|FG000|Overall Study|Withdrawal by Subject|20|||
154926691|NCT01035229|559156819|FG001|Overall Study|Withdrawal by Subject|7|||
154926692|NCT01035229|559156818|FG000|Overall Study|Lost to Follow-up|1|||
154926693|NCT01035229|559156819|FG001|Overall Study|Lost to Follow-up|0|||
154926694|NCT01035229|559156818|FG000|Overall Study|Administrative problems|1|||
154926695|NCT01035229|559156819|FG001|Overall Study|Administrative problems|1|||
154926696|NCT01035229|559156818|FG000|Overall Study|Death|13|||
154926697|NCT01035229|559156819|FG001|Overall Study|Death|5|||
154926698|NCT01035229|559156818|FG000|Overall Study|New cancer therapy|2|||
154926699|NCT01035229|559156819|FG001|Overall Study|New cancer therapy|0|||
154926700|NCT01035229|559156818|FG000|Overall Study|Protocol Violation|0|||
154926701|NCT01035229|559156819|FG001|Overall Study|Protocol Violation|2|||
154926702|NCT01035229|559156818|FG000|Overall Study|Sponsor's decision to end study|3|||
154926703|NCT01035229|559156819|FG001|Overall Study|Sponsor's decision to end study|3|||
154926704|NCT01035229|559156818|FG000|Overall Study|Disease Progression|261|||
154926705|NCT01035229|559156819|FG001|Overall Study|Disease Progression|152|||
154926706|NCT00648739|559156821|FG000|Overall Study|Adverse Event|1|||
154926707|NCT00648739|559156822|FG001|Overall Study|Adverse Event|0|||
154926708|NCT00648739|559156823|FG002|Overall Study|Adverse Event|1|||
154926709|NCT00648739|559156824|FG003|Overall Study|Adverse Event|2|||
154926710|NCT00648739|559156825|FG004|Overall Study|Adverse Event|1|||
154926711|NCT00648739|559156826|FG005|Overall Study|Adverse Event|0|||
154926712|NCT00648739|559156827|FG006|Overall Study|Adverse Event|0|||
154926713|NCT00648739|559156821|FG000|Overall Study|Withdrawal by Subject|1|||
154926714|NCT00648739|559156822|FG001|Overall Study|Withdrawal by Subject|0|||
154926715|NCT00648739|559156823|FG002|Overall Study|Withdrawal by Subject|1|||
154926716|NCT00648739|559156824|FG003|Overall Study|Withdrawal by Subject|0|||
154926717|NCT00648739|559156825|FG004|Overall Study|Withdrawal by Subject|0|||
154926718|NCT00648739|559156826|FG005|Overall Study|Withdrawal by Subject|2|||
154926719|NCT00648739|559156827|FG006|Overall Study|Withdrawal by Subject|0|||
154926720|NCT00648739|559156821|FG000|Overall Study|Lack of Efficacy|0|||
154926721|NCT00648739|559156822|FG001|Overall Study|Lack of Efficacy|0|||
154926722|NCT00648739|559156823|FG002|Overall Study|Lack of Efficacy|0|||
154926723|NCT00648739|559156824|FG003|Overall Study|Lack of Efficacy|0|||
154926724|NCT00648739|559156825|FG004|Overall Study|Lack of Efficacy|1|||
154926725|NCT00648739|559156826|FG005|Overall Study|Lack of Efficacy|2|||
154926726|NCT00648739|559156827|FG006|Overall Study|Lack of Efficacy|0|||
154926727|NCT00648739|559156821|FG000|Overall Study|Investigator Considered it Advisable|0|||
154926728|NCT00648739|559156822|FG001|Overall Study|Investigator Considered it Advisable|0|||
154926729|NCT00648739|559156823|FG002|Overall Study|Investigator Considered it Advisable|0|||
154926730|NCT00648739|559156824|FG003|Overall Study|Investigator Considered it Advisable|0|||
154926731|NCT00648739|559156825|FG004|Overall Study|Investigator Considered it Advisable|0|||
154926732|NCT00648739|559156826|FG005|Overall Study|Investigator Considered it Advisable|1|||
154926733|NCT00648739|559156827|FG006|Overall Study|Investigator Considered it Advisable|1|||
154926734|NCT00648739|559156821|FG000|Overall Study|Death|0|||
154926735|NCT00648739|559156822|FG001|Overall Study|Death|1|||
154926736|NCT00648739|559156823|FG002|Overall Study|Death|0|||
154926737|NCT00648739|559156824|FG003|Overall Study|Death|0|||
154926738|NCT00648739|559156825|FG004|Overall Study|Death|0|||
154926739|NCT00648739|559156826|FG005|Overall Study|Death|0|||
154926740|NCT00648739|559156827|FG006|Overall Study|Death|0|||
154926741|NCT00648739|559156821|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
154926742|NCT00648739|559156822|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
154926743|NCT00648739|559156823|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
154926744|NCT00648739|559156824|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
154926745|NCT00648739|559156825|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
154926746|NCT00648739|559156826|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
154926747|NCT00648739|559156827|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
154926748|NCT00648739|559156821|FG000|Overall Study|Follow-up Visits Not Completed|0|||
154926749|NCT00648739|559156822|FG001|Overall Study|Follow-up Visits Not Completed|1|||
154926750|NCT00648739|559156823|FG002|Overall Study|Follow-up Visits Not Completed|0|||
154926751|NCT00648739|559156824|FG003|Overall Study|Follow-up Visits Not Completed|0|||
154926752|NCT00648739|559156825|FG004|Overall Study|Follow-up Visits Not Completed|0|||
154926753|NCT00648739|559156826|FG005|Overall Study|Follow-up Visits Not Completed|0|||
154926754|NCT00648739|559156827|FG006|Overall Study|Follow-up Visits Not Completed|0|||
154926755|NCT00698009|559156830|FG000|Overall Study|Withdrawal by Subject|1|||
154926756|NCT00564486|559156834|FG000|Overall Study|Adverse Event|0|||
154926757|NCT00564486|559156835|FG001|Overall Study|Adverse Event|1|||
154926758|NCT00564486|559156836|FG002|Overall Study|Adverse Event|0|||
154926759|NCT00564486|559156837|FG003|Overall Study|Adverse Event|0|||
154926760|NCT00564486|559156834|FG000|Overall Study|Withdrawal by Subject|4|||
154926761|NCT00564486|559156835|FG001|Overall Study|Withdrawal by Subject|0|||
154926762|NCT00564486|559156836|FG002|Overall Study|Withdrawal by Subject|0|||
154926763|NCT00564486|559156837|FG003|Overall Study|Withdrawal by Subject|5|||
154926764|NCT00564486|559156834|FG000|Overall Study|Subject refused to have blood drawn|0|||
154926765|NCT00564486|559156835|FG001|Overall Study|Subject refused to have blood drawn|0|||
154926766|NCT00564486|559156836|FG002|Overall Study|Subject refused to have blood drawn|1|||
154926767|NCT00564486|559156837|FG003|Overall Study|Subject refused to have blood drawn|0|||
154926768|NCT00564486|559156834|FG000|Overall Study|Lost to Follow-up|3|||
154926769|NCT00564486|559156835|FG001|Overall Study|Lost to Follow-up|0|||
154926770|NCT00564486|559156836|FG002|Overall Study|Lost to Follow-up|2|||
154926771|NCT00564486|559156837|FG003|Overall Study|Lost to Follow-up|2|||
154926772|NCT03387423|559156838|FG000|Overall Study|Lost to Follow-up|16|||
154926773|NCT03387423|559156839|FG001|Overall Study|Lost to Follow-up|12|||
154926774|NCT03387423|559156840|FG002|Overall Study|Lost to Follow-up|1|||
154926775|NCT03387423|559156841|FG003|Overall Study|Lost to Follow-up|0|||
154926776|NCT03387423|559156838|FG000|Overall Study|Other|0|||
154926777|NCT03387423|559156839|FG001|Overall Study|Other|3|||
154926778|NCT03387423|559156840|FG002|Overall Study|Other|0|||
154926779|NCT03387423|559156841|FG003|Overall Study|Other|0|||
154926780|NCT03387423|559156838|FG000|Overall Study|Administrative Reason|166|||
154926781|NCT03387423|559156839|FG001|Overall Study|Administrative Reason|89|||
154926782|NCT03387423|559156840|FG002|Overall Study|Administrative Reason|17|||
154926783|NCT03387423|559156841|FG003|Overall Study|Administrative Reason|19|||
154926784|NCT03387423|559156838|FG000|Overall Study|Revocation Consent|76|||
154926785|NCT03387423|559156839|FG001|Overall Study|Revocation Consent|32|||
154926786|NCT03387423|559156840|FG002|Overall Study|Revocation Consent|3|||
154926787|NCT03387423|559156841|FG003|Overall Study|Revocation Consent|5|||
154926788|NCT04362761|559156848|FG000|Part A (48 Weeks)|Adverse Event|2|||
154926789|NCT04362761|559156848|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
154926790|NCT04362761|559156848|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
154926791|NCT04362761|559156848|FG000|Part A (48 Weeks)|Other|5|||
154926792|NCT04362761|559156848|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
154926793|NCT04362761|559156848|FG000|Part B (86 Weeks)|Other|4|||
154926794|NCT00798707|559156851|FG000|Overall Study|Adverse Event|6|||
154926795|NCT00798707|559156852|FG001|Overall Study|Adverse Event|8|||
154926796|NCT00798707|559156853|FG002|Overall Study|Adverse Event|8|||
154926797|NCT00798707|559156851|FG000|Overall Study|Failed to return|2|||
154926798|NCT00798707|559156852|FG001|Overall Study|Failed to return|2|||
154926799|NCT00798707|559156853|FG002|Overall Study|Failed to return|0|||
154926800|NCT00798707|559156851|FG000|Overall Study|Investigator|0|||
154926801|NCT00798707|559156852|FG001|Overall Study|Investigator|1|||
154926802|NCT00798707|559156853|FG002|Overall Study|Investigator|2|||
154926803|NCT00798707|559156851|FG000|Overall Study|Lack of Efficacy|2|||
154926804|NCT00798707|559156852|FG001|Overall Study|Lack of Efficacy|2|||
154926805|NCT00798707|559156853|FG002|Overall Study|Lack of Efficacy|1|||
154926806|NCT00798707|559156851|FG000|Overall Study|Lost to Follow-up|5|||
154926807|NCT00798707|559156852|FG001|Overall Study|Lost to Follow-up|6|||
154926808|NCT00798707|559156853|FG002|Overall Study|Lost to Follow-up|6|||
154926809|NCT00798707|559156851|FG000|Overall Study|Other|0|||
154926810|NCT00798707|559156852|FG001|Overall Study|Other|1|||
154926811|NCT00798707|559156853|FG002|Overall Study|Other|0|||
154926812|NCT00798707|559156851|FG000|Overall Study|Protocol Violation|4|||
154926813|NCT00798707|559156852|FG001|Overall Study|Protocol Violation|0|||
154926814|NCT00798707|559156853|FG002|Overall Study|Protocol Violation|2|||
154926815|NCT00798707|559156851|FG000|Overall Study|Withdrawal by Subject|3|||
154926816|NCT00798707|559156852|FG001|Overall Study|Withdrawal by Subject|8|||
154926817|NCT00798707|559156853|FG002|Overall Study|Withdrawal by Subject|2|||
154926818|NCT00798707|559156851|FG000|Overall Study|Randomized not treated|4|||
154926819|NCT00798707|559156852|FG001|Overall Study|Randomized not treated|5|||
154926820|NCT00798707|559156853|FG002|Overall Study|Randomized not treated|1|||
154926821|NCT01473589|559156854|FG000|Overall Study|Adverse Event|1|||
154926822|NCT01473589|559156855|FG001|Overall Study|Adverse Event|1|||
154926823|NCT01473589|559156854|FG000|Overall Study|Death|2|||
154926824|NCT01473589|559156855|FG001|Overall Study|Death|0|||
154926825|NCT01473589|559156854|FG000|Overall Study|Lost to Follow-up|2|||
154926826|NCT01473589|559156855|FG001|Overall Study|Lost to Follow-up|2|||
154926827|NCT01473589|559156854|FG000|Overall Study|Protocol Violation|1|||
154926828|NCT01473589|559156855|FG001|Overall Study|Protocol Violation|0|||
154926829|NCT01473589|559156854|FG000|Overall Study|Withdrawal by Subject|5|||
154926830|NCT01473589|559156855|FG001|Overall Study|Withdrawal by Subject|11|||
154926831|NCT01473589|559156854|FG000|Overall Study|Physician Decision|0|||
154926832|NCT01473589|559156855|FG001|Overall Study|Physician Decision|1|||
154926833|NCT01473589|559156854|FG000|Overall Study|Entry criteria not met|0|||
154926834|NCT01473589|559156855|FG001|Overall Study|Entry criteria not met|1|||
154926835|NCT03457727|559156859|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
154926836|NCT03457727|559156860|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
154926837|NCT03457727|559156861|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
154926838|NCT03457727|559156862|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
154926839|NCT01721200|559156865|FG000|Overall Study|Lost to Follow-up|3|||
154926840|NCT01721200|559156866|FG001|Overall Study|Lost to Follow-up|5|||
154926841|NCT03722849|559156869|FG000|Overall Study|Withdrawal by Subject|1|||
154926842|NCT03722849|559156870|FG001|Overall Study|Withdrawal by Subject|1|||
154926843|NCT03514121|559156871|FG000|Overall Study|Withdrawal by Subject|0|||
154926844|NCT03514121|559156872|FG001|Overall Study|Withdrawal by Subject|0|||
154926845|NCT03514121|559156873|FG002|Overall Study|Withdrawal by Subject|0|||
154926846|NCT03514121|559156874|FG003|Overall Study|Withdrawal by Subject|0|||
154926847|NCT03514121|559156875|FG004|Overall Study|Withdrawal by Subject|1|||
154926848|NCT03514121|559156876|FG005|Overall Study|Withdrawal by Subject|2|||
154926849|NCT03514121|559156877|FG006|Overall Study|Withdrawal by Subject|1|||
154926850|NCT03514121|559156878|FG007|Overall Study|Withdrawal by Subject|1|||
154926851|NCT03514121|559156879|FG008|Overall Study|Withdrawal by Subject|7|||
154926852|NCT03514121|559156880|FG009|Overall Study|Withdrawal by Subject|2|||
154926853|NCT03514121|559156871|FG000|Overall Study|Death|0|||
154926854|NCT03514121|559156872|FG001|Overall Study|Death|0|||
154926855|NCT03514121|559156873|FG002|Overall Study|Death|0|||
154926856|NCT03514121|559156874|FG003|Overall Study|Death|0|||
154926857|NCT03514121|559156875|FG004|Overall Study|Death|0|||
154926858|NCT03514121|559156876|FG005|Overall Study|Death|3|||
154926859|NCT03514121|559156877|FG006|Overall Study|Death|2|||
154926860|NCT03514121|559156878|FG007|Overall Study|Death|1|||
154926861|NCT03514121|559156879|FG008|Overall Study|Death|26|||
154926862|NCT03514121|559156880|FG009|Overall Study|Death|3|||
154926863|NCT03514121|559156871|FG000|Overall Study|Lost to Follow-up|0|||
154926864|NCT03514121|559156872|FG001|Overall Study|Lost to Follow-up|0|||
154926865|NCT03514121|559156873|FG002|Overall Study|Lost to Follow-up|1|||
154926866|NCT03514121|559156874|FG003|Overall Study|Lost to Follow-up|0|||
154926867|NCT03514121|559156875|FG004|Overall Study|Lost to Follow-up|0|||
154926868|NCT03514121|559156876|FG005|Overall Study|Lost to Follow-up|0|||
154926869|NCT03514121|559156877|FG006|Overall Study|Lost to Follow-up|0|||
154926870|NCT03514121|559156878|FG007|Overall Study|Lost to Follow-up|0|||
154926871|NCT03514121|559156879|FG008|Overall Study|Lost to Follow-up|1|||
154926872|NCT03514121|559156880|FG009|Overall Study|Lost to Follow-up|0|||
154926873|NCT03514121|559156871|FG000|Overall Study|Adverse Event|0|||
154926874|NCT03514121|559156872|FG001|Overall Study|Adverse Event|0|||
154926875|NCT03514121|559156873|FG002|Overall Study|Adverse Event|0|||
154926876|NCT03514121|559156874|FG003|Overall Study|Adverse Event|0|||
154926877|NCT03514121|559156875|FG004|Overall Study|Adverse Event|0|||
154926878|NCT03514121|559156876|FG005|Overall Study|Adverse Event|0|||
154926879|NCT03514121|559156877|FG006|Overall Study|Adverse Event|1|||
154926880|NCT03514121|559156878|FG007|Overall Study|Adverse Event|0|||
154926881|NCT03514121|559156879|FG008|Overall Study|Adverse Event|0|||
154926882|NCT03514121|559156880|FG009|Overall Study|Adverse Event|0|||
154926883|NCT03514121|559156871|FG000|Overall Study|Other|0|||
154926884|NCT03514121|559156872|FG001|Overall Study|Other|1|||
154926885|NCT03514121|559156873|FG002|Overall Study|Other|1|||
154926886|NCT03514121|559156874|FG003|Overall Study|Other|0|||
154926887|NCT03514121|559156875|FG004|Overall Study|Other|1|||
154926888|NCT03514121|559156876|FG005|Overall Study|Other|2|||
154926889|NCT03514121|559156877|FG006|Overall Study|Other|3|||
154926890|NCT03514121|559156878|FG007|Overall Study|Other|2|||
154926891|NCT03514121|559156879|FG008|Overall Study|Other|7|||
154926892|NCT03514121|559156880|FG009|Overall Study|Other|3|||
154926893|NCT03514121|559156871|FG000|Overall Study|Study termination by Sponsor|0|||
154926894|NCT03514121|559156872|FG001|Overall Study|Study termination by Sponsor|0|||
154926895|NCT03514121|559156873|FG002|Overall Study|Study termination by Sponsor|0|||
154926896|NCT03514121|559156874|FG003|Overall Study|Study termination by Sponsor|0|||
154926897|NCT03514121|559156875|FG004|Overall Study|Study termination by Sponsor|0|||
154926898|NCT03514121|559156876|FG005|Overall Study|Study termination by Sponsor|0|||
154926899|NCT03514121|559156877|FG006|Overall Study|Study termination by Sponsor|0|||
154926900|NCT03514121|559156878|FG007|Overall Study|Study termination by Sponsor|0|||
154926901|NCT03514121|559156879|FG008|Overall Study|Study termination by Sponsor|11|||
154926902|NCT03514121|559156880|FG009|Overall Study|Study termination by Sponsor|3|||
154926903|NCT03514121|559156871|FG000|Overall Study|Investigator decision|0|||
154926904|NCT03514121|559156872|FG001|Overall Study|Investigator decision|0|||
154926905|NCT03514121|559156873|FG002|Overall Study|Investigator decision|0|||
154926906|NCT03514121|559156874|FG003|Overall Study|Investigator decision|0|||
154926907|NCT03514121|559156875|FG004|Overall Study|Investigator decision|0|||
154926908|NCT03514121|559156876|FG005|Overall Study|Investigator decision|0|||
154926909|NCT03514121|559156877|FG006|Overall Study|Investigator decision|0|||
154926910|NCT03514121|559156878|FG007|Overall Study|Investigator decision|0|||
154926911|NCT03514121|559156879|FG008|Overall Study|Investigator decision|1|||
154926912|NCT03514121|559156880|FG009|Overall Study|Investigator decision|0|||
154926913|NCT04930536|559156881|FG000|Overall Study|Adverse Event|1|||
154926914|NCT04930536|559156882|FG001|Overall Study|Adverse Event|0|||
154926915|NCT04930536|559156881|FG000|Overall Study|Disease Progression|2|||
154926916|NCT04930536|559156882|FG001|Overall Study|Disease Progression|0|||
154926917|NCT04930536|559156881|FG000|Overall Study|Patient Decision|4|||
154926918|NCT04930536|559156882|FG001|Overall Study|Patient Decision|2|||
154926919|NCT04930536|559156881|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
154926920|NCT04930536|559156882|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
154926921|NCT01432600|559156883|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
154926922|NCT01432600|559156884|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
154926923|NCT01432600|559156885|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
154926924|NCT00740480|559156893|FG000|Overall Study|Adverse Event|1|||
154926925|NCT00740480|559156893|FG000|Overall Study|Physician Decision|1|||
154926926|NCT01005680|559156901|FG000|Overall Study|Lost to Follow-up|4|||
154926927|NCT01005680|559156902|FG001|Overall Study|Lost to Follow-up|6|||
154926928|NCT01005680|559156901|FG000|Overall Study|Withdrawal by Subject|1|||
154926929|NCT01005680|559156902|FG001|Overall Study|Withdrawal by Subject|4|||
154926930|NCT01005680|559156901|FG000|Overall Study|Physician Decision|1|||
154926931|NCT01005680|559156902|FG001|Overall Study|Physician Decision|1|||
154926932|NCT00297882|559156915|FG000|Day 14|Lack of Efficacy|12|||
155039452|NCT00734656|559572935|FG000|Lab Session 4|Withdrawal by Subject|0|||
155039453|NCT00734656|559572936|FG001|Lab Session 4|Withdrawal by Subject|0|||
155039454|NCT00734656|559572937|FG002|Lab Session 4|Withdrawal by Subject|0|||
155039455|NCT00734656|559572938|FG003|Lab Session 4|Withdrawal by Subject|1|||
155039456|NCT03214679|559572939|FG000|Overall Study|Lost to Follow-up|12|||
155039457|NCT03214679|559572940|FG001|Overall Study|Lost to Follow-up|14|||
155039458|NCT03214679|559572939|FG000|Overall Study|not eligible|2|||
155039459|NCT03214679|559572940|FG001|Overall Study|not eligible|0|||
155039460|NCT03015194|559572943|FG000|Overall Study|Death|10|||
155039461|NCT03015194|559572943|FG000|Overall Study|Withdrawal by Subject|2|||
155039462|NCT00298363|559572952|FG000|Overall Study|Lost to Follow-up|0|||
155039463|NCT00298363|559572953|FG001|Overall Study|Lost to Follow-up|0|||
155039464|NCT00298363|559572954|FG002|Overall Study|Lost to Follow-up|1|||
155039465|NCT00298363|559572952|FG000|Overall Study|Physician Decision|4|||
155039466|NCT00298363|559572953|FG001|Overall Study|Physician Decision|1|||
155039467|NCT00298363|559572954|FG002|Overall Study|Physician Decision|0|||
155039468|NCT00298363|559572952|FG000|Overall Study|Protocol Violation|1|||
155039469|NCT00298363|559572953|FG001|Overall Study|Protocol Violation|1|||
155039470|NCT00298363|559572954|FG002|Overall Study|Protocol Violation|0|||
155039471|NCT00298363|559572952|FG000|Overall Study|Withdrawal by Subject|5|||
155039472|NCT00298363|559572953|FG001|Overall Study|Withdrawal by Subject|1|||
155039473|NCT00298363|559572954|FG002|Overall Study|Withdrawal by Subject|3|||
154926933|NCT00297882|559156916|FG001|Day 14|Lack of Efficacy|49|||
154926934|NCT00297882|559156915|FG000|Day 28|Lost to Follow-up|13|||
154926935|NCT00297882|559156916|FG001|Day 28|Lost to Follow-up|23|||
154926936|NCT00297882|559156915|FG000|Day 28|Lack of Efficacy|3|||
154926937|NCT00297882|559156916|FG001|Day 28|Lack of Efficacy|0|||
154926938|NCT04242264|559156917|FG000|Overall Study|Lost to Follow-up|2|||
154926939|NCT04242264|559156918|FG001|Overall Study|Lost to Follow-up|2|||
154926940|NCT04242264|559156919|FG002|Overall Study|Lost to Follow-up|1|||
154926941|NCT04242264|559156920|FG003|Overall Study|Lost to Follow-up|1|||
154926942|NCT04242264|559156917|FG000|Overall Study|Withdrawal by Subject|1|||
154926943|NCT04242264|559156918|FG001|Overall Study|Withdrawal by Subject|0|||
154926944|NCT04242264|559156919|FG002|Overall Study|Withdrawal by Subject|0|||
154926945|NCT04242264|559156920|FG003|Overall Study|Withdrawal by Subject|0|||
154926946|NCT02116309|559156923|FG000|Overall Study|Lost to Follow-up|0|||
154926947|NCT02116309|559156924|FG001|Overall Study|Lost to Follow-up|1|||
154926948|NCT03292731|559156925|FG000|Overall Study|Protocol Violation|4|||
154926949|NCT03292731|559156926|FG001|Overall Study|Protocol Violation|11|||
154926950|NCT03292731|559156927|FG002|Overall Study|Protocol Violation|1|||
154926951|NCT00348348|559156928|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
154926952|NCT00348348|559156929|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
154926953|NCT00348348|559156928|FG000|Overall Study|Lack of Efficacy|1|||
154926954|NCT00348348|559156929|FG001|Overall Study|Lack of Efficacy|1|||
154926955|NCT00348348|559156928|FG000|Overall Study|Lost to Follow-up|8|||
154926956|NCT00348348|559156929|FG001|Overall Study|Lost to Follow-up|10|||
154926957|NCT00348348|559156928|FG000|Overall Study|Withdrawal by Subject|4|||
154926958|NCT00348348|559156929|FG001|Overall Study|Withdrawal by Subject|1|||
154926959|NCT00348348|559156928|FG000|Overall Study|Other|7|||
154926960|NCT00348348|559156929|FG001|Overall Study|Other|4|||
154926961|NCT00348348|559156928|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
154926962|NCT00348348|559156929|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
154926963|NCT00348348|559156928|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
154926964|NCT00348348|559156929|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
154926965|NCT00348348|559156928|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
154926966|NCT00348348|559156929|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
154926967|NCT00348348|559156928|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
154926968|NCT00348348|559156929|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
154926969|NCT00348348|559156928|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
154926970|NCT00348348|559156929|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
154926971|NCT00348348|559156928|FG000|Overall Study|Adverse event probably related to study|1|||
154926972|NCT00348348|559156929|FG001|Overall Study|Adverse event probably related to study|0|||
154926973|NCT04221373|559156933|FG000|Overall Study|Physician Decision|4|||
155039474|NCT00298363|559572952|FG000|Overall Study|Adverse Event|5|||
155039475|NCT00298363|559572953|FG001|Overall Study|Adverse Event|2|||
155039476|NCT00298363|559572954|FG002|Overall Study|Adverse Event|2|||
154926974|NCT04221373|559156934|FG001|Overall Study|Physician Decision|0|||
154926975|NCT01165424|559156942|FG000|Overall Study|Clinical adverse experiences|1|||
154926976|NCT01165424|559156942|FG000|Overall Study|Laboratory adverse experiences|1|||
154926977|NCT01165424|559156942|FG000|Overall Study|Did not meet entry criteria|1|||
154926978|NCT01165424|559156942|FG000|Overall Study|Participant moved (relocated)|1|||
154926979|NCT04139642|559156943|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
154926980|NCT04139642|559156944|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
154926981|NCT00433771|559156954|FG000|Overall Study|screen fail|14|||
154926982|NCT00433771|559156954|FG000|Overall Study|Treated and later found to be ineligible|2|||
154926983|NCT00433771|559156954|FG000|Overall Study|Death|2|||
154926984|NCT00433771|559156954|FG000|Overall Study|Failure to deploy stent|1|||
154926985|NCT00138658|559156955|FG000|Overall Study|Adverse Event|23|||
154926986|NCT00138658|559156955|FG000|Overall Study|Death|1|||
154926987|NCT00138658|559156955|FG000|Overall Study|Disease Progression|21|||
154926988|NCT00138658|559156955|FG000|Overall Study|Physician Decision|11|||
154926989|NCT00138658|559156955|FG000|Overall Study|Withdrawal by Subject|5|||
154926990|NCT01965431|559156961|FG000|Overall Study|Adverse Event|0|||
154926991|NCT01965431|559156962|FG001|Overall Study|Adverse Event|1|||
154926992|NCT01965431|559156963|FG002|Overall Study|Adverse Event|0|||
154926993|NCT01965431|559156964|FG003|Overall Study|Adverse Event|0|||
154926994|NCT01965431|559156965|FG004|Overall Study|Adverse Event|0|||
154926995|NCT01965431|559156966|FG005|Overall Study|Adverse Event|0|||
154926996|NCT01965431|559156961|FG000|Overall Study|Other than stated above|6|||
154926997|NCT01965431|559156962|FG001|Overall Study|Other than stated above|5|||
154926998|NCT01965431|559156963|FG002|Overall Study|Other than stated above|6|||
154926999|NCT01965431|559156964|FG003|Overall Study|Other than stated above|6|||
154927000|NCT01965431|559156965|FG004|Overall Study|Other than stated above|6|||
155381468|NCT00994682|560830933|FG000|Pioglitazone Open Label|Physician Decision|6|||
154927001|NCT01965431|559156966|FG005|Overall Study|Other than stated above|6|||
154927002|NCT00577031|559156967|FG000|Overall Study|Adverse Event|52|||
154927003|NCT00577031|559156967|FG000|Overall Study|Progression of disease|93|||
154927004|NCT00577031|559156967|FG000|Overall Study|Protocol Violation|5|||
154927005|NCT00577031|559156967|FG000|Overall Study|Participant withdrew consent|13|||
154927006|NCT00577031|559156967|FG000|Overall Study|Participant non-compliance|5|||
154927007|NCT00577031|559156967|FG000|Overall Study|Need for surgery|17|||
154927008|NCT00577031|559156967|FG000|Overall Study|Medical decision|14|||
154927009|NCT00577031|559156967|FG000|Overall Study|Death|6|||
154927010|NCT01067339|559156968|FG000|Overall Study|Withdrawal by Subject|6|||
154927011|NCT01067339|559156969|FG001|Overall Study|Withdrawal by Subject|5|||
154927012|NCT01179191|559156970|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
154927013|NCT01179191|559156970|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
154927014|NCT01179191|559156970|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
154927015|NCT01179191|559156970|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
154927016|NCT01179191|559156970|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
154927017|NCT01179191|559156970|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
154927018|NCT01179191|559156970|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
154927019|NCT01179191|559156970|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
154927020|NCT01179191|559156970|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
154927021|NCT01179191|559156970|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
154927022|NCT01179191|559156970|FG000|Maintenance Phase (8 Weeks)|Other|66|||
154927023|NCT01803464|559156973|FG000|Overall Study|Incomplete data|0|||
154927024|NCT01803464|559156974|FG001|Overall Study|Incomplete data|0|||
154927025|NCT01803464|559156975|FG002|Overall Study|Incomplete data|4|||
154927026|NCT01803464|559156976|FG003|Overall Study|Incomplete data|0|||
154927027|NCT01803464|559156973|FG000|Overall Study|Withdrawal by Subject|1|||
154927028|NCT01803464|559156974|FG001|Overall Study|Withdrawal by Subject|0|||
154927029|NCT01803464|559156975|FG002|Overall Study|Withdrawal by Subject|0|||
154927030|NCT01803464|559156976|FG003|Overall Study|Withdrawal by Subject|0|||
154927031|NCT03843775|559156982|FG000|Overall Study|Adverse Event|1|||
154927032|NCT03843775|559156983|FG001|Overall Study|Adverse Event|1|||
154927033|NCT03843775|559156982|FG000|Overall Study|Lack of Efficacy|2|||
154927034|NCT03843775|559156983|FG001|Overall Study|Lack of Efficacy|6|||
154927035|NCT03843775|559156982|FG000|Overall Study|Withdrawal by Subject|0|||
154927036|NCT03843775|559156983|FG001|Overall Study|Withdrawal by Subject|1|||
154927037|NCT00650806|559156985|FG000|Overall Study|Adverse Event|0|||
154927038|NCT00650806|559156986|FG001|Overall Study|Adverse Event|5|||
154927039|NCT00650806|559156987|FG002|Overall Study|Adverse Event|3|||
154927040|NCT00650806|559156988|FG003|Overall Study|Adverse Event|4|||
154927041|NCT00650806|559156985|FG000|Overall Study|Lost to Follow-up|7|||
154927042|NCT00650806|559156986|FG001|Overall Study|Lost to Follow-up|6|||
154927043|NCT00650806|559156987|FG002|Overall Study|Lost to Follow-up|11|||
154927044|NCT00650806|559156988|FG003|Overall Study|Lost to Follow-up|10|||
154927045|NCT00650806|559156985|FG000|Overall Study|Protocol Violation|0|||
154927046|NCT00650806|559156986|FG001|Overall Study|Protocol Violation|0|||
154927047|NCT00650806|559156987|FG002|Overall Study|Protocol Violation|0|||
154927048|NCT00650806|559156988|FG003|Overall Study|Protocol Violation|1|||
154927049|NCT00650806|559156985|FG000|Overall Study|Pregnancy|0|||
154927050|NCT00650806|559156986|FG001|Overall Study|Pregnancy|0|||
154927051|NCT00650806|559156987|FG002|Overall Study|Pregnancy|0|||
154927052|NCT00650806|559156988|FG003|Overall Study|Pregnancy|1|||
154927053|NCT00650806|559156985|FG000|Overall Study|Withdrawal by Subject|7|||
154927054|NCT00650806|559156986|FG001|Overall Study|Withdrawal by Subject|5|||
154927055|NCT00650806|559156987|FG002|Overall Study|Withdrawal by Subject|8|||
154927056|NCT00650806|559156988|FG003|Overall Study|Withdrawal by Subject|6|||
154927057|NCT00650806|559156985|FG000|Overall Study|Noncompliance with study drug regimen|1|||
154927058|NCT00650806|559156986|FG001|Overall Study|Noncompliance with study drug regimen|1|||
154927059|NCT00650806|559156987|FG002|Overall Study|Noncompliance with study drug regimen|0|||
154927060|NCT00650806|559156988|FG003|Overall Study|Noncompliance with study drug regimen|0|||
154927061|NCT00650806|559156985|FG000|Overall Study|Study terminated by sponsor|2|||
154927062|NCT00650806|559156986|FG001|Overall Study|Study terminated by sponsor|3|||
154927063|NCT00650806|559156987|FG002|Overall Study|Study terminated by sponsor|5|||
154927064|NCT00650806|559156988|FG003|Overall Study|Study terminated by sponsor|4|||
154927065|NCT00650806|559156985|FG000|Overall Study|Other|1|||
154927066|NCT00650806|559156986|FG001|Overall Study|Other|1|||
154927067|NCT00650806|559156987|FG002|Overall Study|Other|2|||
154927068|NCT00650806|559156988|FG003|Overall Study|Other|0|||
154927069|NCT02596009|559156993|FG000|Overall Study|Administrative problems|0|||
154927070|NCT02596009|559156994|FG001|Overall Study|Administrative problems|1|||
154927071|NCT02596009|559156995|FG002|Overall Study|Administrative problems|0|||
154927072|NCT02596009|559156996|FG003|Overall Study|Administrative problems|0|||
154927073|NCT02596009|559156997|FG004|Overall Study|Administrative problems|0|||
154927074|NCT02596009|559156998|FG005|Overall Study|Administrative problems|0|||
154927075|NCT04611152|559156999|FG000|Overall Study|Adverse Event|9|||
154927076|NCT04611152|559157000|FG001|Overall Study|Adverse Event|8|||
154927077|NCT04611152|559156999|FG000|Overall Study|Non-compliance with study schedule|1|||
154927078|NCT04611152|559157000|FG001|Overall Study|Non-compliance with study schedule|3|||
154927079|NCT04611152|559156999|FG000|Overall Study|Withdrawal by Subject|5|||
154927080|NCT04611152|559157000|FG001|Overall Study|Withdrawal by Subject|6|||
154927081|NCT04611152|559156999|FG000|Overall Study|Lost to Follow-up|11|||
154927082|NCT04611152|559157000|FG001|Overall Study|Lost to Follow-up|2|||
154927083|NCT00605839|559157003|FG000|Overall Study|Protocol Violation|1|||
154927084|NCT00605839|559157004|FG001|Overall Study|Protocol Violation|0|||
154927085|NCT00605839|559157005|FG002|Overall Study|Protocol Violation|0|||
154927086|NCT02255422|559157006|FG000|Overall Study|Withdrawal by Subject|0|||
154927087|NCT02255422|559157007|FG001|Overall Study|Withdrawal by Subject|0|||
154927088|NCT02255422|559157008|FG002|Overall Study|Withdrawal by Subject|0|||
154927089|NCT02255422|559157009|FG003|Overall Study|Withdrawal by Subject|0|||
154927090|NCT02255422|559157010|FG004|Overall Study|Withdrawal by Subject|0|||
154927091|NCT02255422|559157011|FG005|Overall Study|Withdrawal by Subject|0|||
154927092|NCT02255422|559157012|FG006|Overall Study|Withdrawal by Subject|2|||
154927093|NCT02255422|559157006|FG000|Overall Study|Lost to Follow-up|0|||
154927094|NCT02255422|559157007|FG001|Overall Study|Lost to Follow-up|0|||
154927095|NCT02255422|559157008|FG002|Overall Study|Lost to Follow-up|1|||
154927096|NCT02255422|559157009|FG003|Overall Study|Lost to Follow-up|0|||
154927097|NCT02255422|559157010|FG004|Overall Study|Lost to Follow-up|0|||
154927098|NCT02255422|559157011|FG005|Overall Study|Lost to Follow-up|0|||
154927099|NCT02255422|559157012|FG006|Overall Study|Lost to Follow-up|0|||
154927100|NCT00602667|559157013|FG000|Overall Study|Still on Therapy|0|||
154927101|NCT00602667|559157014|FG001|Overall Study|Still on Therapy|2|||
154927102|NCT00602667|559157015|FG002|Overall Study|Still on Therapy|2|||
154927103|NCT00602667|559157013|FG000|Overall Study|Death|0|||
154927104|NCT00602667|559157014|FG001|Overall Study|Death|1|||
154927105|NCT00602667|559157015|FG002|Overall Study|Death|1|||
154927106|NCT00602667|559157013|FG000|Overall Study|Family request|3|||
154927107|NCT00602667|559157014|FG001|Overall Study|Family request|25|||
154927108|NCT00602667|559157015|FG002|Overall Study|Family request|6|||
154927109|NCT00602667|559157013|FG000|Overall Study|Excessive toxicity|1|||
154927110|NCT00602667|559157014|FG001|Overall Study|Excessive toxicity|1|||
154927111|NCT00602667|559157015|FG002|Overall Study|Excessive toxicity|0|||
154927112|NCT00602667|559157013|FG000|Overall Study|Second malignancy|0|||
154927113|NCT00602667|559157014|FG001|Overall Study|Second malignancy|1|||
154927114|NCT00602667|559157015|FG002|Overall Study|Second malignancy|0|||
154927115|NCT00602667|559157013|FG000|Overall Study|Physician Decision|2|||
154927116|NCT00602667|559157014|FG001|Overall Study|Physician Decision|3|||
154927117|NCT00602667|559157015|FG002|Overall Study|Physician Decision|8|||
154927118|NCT00602667|559157013|FG000|Overall Study|Progressive disease|13|||
154927119|NCT00602667|559157014|FG001|Overall Study|Progressive disease|48|||
154927120|NCT00602667|559157015|FG002|Overall Study|Progressive disease|45|||
154927121|NCT00602667|559157013|FG000|Overall Study|Progressive disease prior to therapy|0|||
154927122|NCT00602667|559157014|FG001|Overall Study|Progressive disease prior to therapy|0|||
154927123|NCT00602667|559157015|FG002|Overall Study|Progressive disease prior to therapy|1|||
154927124|NCT01489865|559157023|FG000|Overall Study|Progression of Disease|4|||
154927125|NCT01489865|559157024|FG001|Overall Study|Progression of Disease|2|||
154927126|NCT01489865|559157025|FG002|Overall Study|Progression of Disease|2|||
154927127|NCT01489865|559157026|FG003|Overall Study|Progression of Disease|3|||
154927128|NCT01489865|559157027|FG004|Overall Study|Progression of Disease|1|||
154927129|NCT01489865|559157028|FG005|Overall Study|Progression of Disease|6|||
154927130|NCT01489865|559157029|FG006|Overall Study|Progression of Disease|3|||
154927131|NCT01489865|559157030|FG007|Overall Study|Progression of Disease|0|||
154927132|NCT01489865|559157031|FG008|Overall Study|Progression of Disease|23|||
154927133|NCT01489865|559157023|FG000|Overall Study|Adverse Event|2|||
154927134|NCT01489865|559157024|FG001|Overall Study|Adverse Event|0|||
154927135|NCT01489865|559157025|FG002|Overall Study|Adverse Event|0|||
154927136|NCT01489865|559157026|FG003|Overall Study|Adverse Event|0|||
154927137|NCT01489865|559157027|FG004|Overall Study|Adverse Event|1|||
154927138|NCT01489865|559157028|FG005|Overall Study|Adverse Event|0|||
154927139|NCT01489865|559157029|FG006|Overall Study|Adverse Event|2|||
154927140|NCT01489865|559157030|FG007|Overall Study|Adverse Event|0|||
154927141|NCT01489865|559157031|FG008|Overall Study|Adverse Event|5|||
154927142|NCT01489865|559157023|FG000|Overall Study|Death|0|||
154927143|NCT01489865|559157024|FG001|Overall Study|Death|1|||
154927144|NCT01489865|559157025|FG002|Overall Study|Death|0|||
154927145|NCT01489865|559157026|FG003|Overall Study|Death|0|||
154927146|NCT01489865|559157027|FG004|Overall Study|Death|1|||
154927147|NCT01489865|559157028|FG005|Overall Study|Death|0|||
154927148|NCT01489865|559157029|FG006|Overall Study|Death|0|||
154927149|NCT01489865|559157030|FG007|Overall Study|Death|0|||
154927150|NCT01489865|559157031|FG008|Overall Study|Death|2|||
154927151|NCT01489865|559157023|FG000|Overall Study|Withdrawal by Subject|0|||
154927152|NCT01489865|559157024|FG001|Overall Study|Withdrawal by Subject|0|||
154927153|NCT01489865|559157025|FG002|Overall Study|Withdrawal by Subject|0|||
154927154|NCT01489865|559157026|FG003|Overall Study|Withdrawal by Subject|0|||
154927155|NCT01489865|559157027|FG004|Overall Study|Withdrawal by Subject|0|||
154927156|NCT01489865|559157028|FG005|Overall Study|Withdrawal by Subject|1|||
154927157|NCT01489865|559157029|FG006|Overall Study|Withdrawal by Subject|1|||
154927158|NCT01489865|559157030|FG007|Overall Study|Withdrawal by Subject|0|||
154927159|NCT01489865|559157031|FG008|Overall Study|Withdrawal by Subject|2|||
154927160|NCT01489865|559157023|FG000|Overall Study|Shifted|0|||
154927161|NCT01489865|559157024|FG001|Overall Study|Shifted|0|||
154927162|NCT01489865|559157025|FG002|Overall Study|Shifted|1|||
154927163|NCT01489865|559157026|FG003|Overall Study|Shifted|0|||
154927164|NCT01489865|559157027|FG004|Overall Study|Shifted|0|||
154927165|NCT01489865|559157028|FG005|Overall Study|Shifted|0|||
154927166|NCT01489865|559157029|FG006|Overall Study|Shifted|0|||
154927167|NCT01489865|559157030|FG007|Overall Study|Shifted|0|||
154927168|NCT01489865|559157031|FG008|Overall Study|Shifted|0|||
154927169|NCT00972309|559157032|FG000|Overall Study|Switched to alternative treatment|0|||
154927170|NCT00972309|559157033|FG001|Overall Study|Switched to alternative treatment|2|||
154927171|NCT00972309|559157032|FG000|Overall Study|Refused further treatment|0|||
154927172|NCT00972309|559157033|FG001|Overall Study|Refused further treatment|1|||
154927173|NCT00972309|559157032|FG000|Overall Study|Late determination of ineligibility|0|||
154927174|NCT00972309|559157033|FG001|Overall Study|Late determination of ineligibility|1|||
154927175|NCT00972309|559157032|FG000|Overall Study|Second malignancy|1|||
154927176|NCT00972309|559157033|FG001|Overall Study|Second malignancy|1|||
154927177|NCT00972309|559157032|FG000|Overall Study|Visa issues|0|||
154927178|NCT00972309|559157033|FG001|Overall Study|Visa issues|1|||
154927179|NCT00972309|559157032|FG000|Overall Study|Secondary cancer (SCC)|0|||
154927180|NCT00972309|559157033|FG001|Overall Study|Secondary cancer (SCC)|1|||
154927181|NCT00972309|559157032|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
154927182|NCT00972309|559157033|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
154927183|NCT00972309|559157032|FG000|Overall Study|Lost to Follow-up|1|||
154927184|NCT00972309|559157033|FG001|Overall Study|Lost to Follow-up|1|||
154927185|NCT00972309|559157032|FG000|Overall Study|Disease progression on study|10|||
154927186|NCT00972309|559157033|FG001|Overall Study|Disease progression on study|4|||
154927187|NCT03862807|559158823|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
154927188|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
154927189|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
154927190|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
154927191|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
154927192|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
154927193|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
154927194|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
154927195|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
154927196|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
154927197|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
154927198|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
154927199|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
154927200|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
154927201|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
154927202|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
154927203|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
154927204|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
154927205|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
154927206|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
154927207|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
154927208|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
154927209|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
154927210|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
154927211|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
154927212|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
154927213|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
154927214|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
154927215|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
154927216|NCT01299272|559158829|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
154927217|NCT01299272|559158830|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
154927218|NCT01299272|559158831|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
154927219|NCT01299272|559158832|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
154927220|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
154927221|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
154927222|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
154927223|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
154927224|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
154927225|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
154927226|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
154927227|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
154927228|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
154927229|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
154927230|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
154927231|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
154927232|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
154927233|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
154927234|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
154927235|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
154927236|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
154927237|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
154927238|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
154927239|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
154927240|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
154927241|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
154927242|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
154927243|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
154927244|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
154927245|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
154927246|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
154927247|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
154927248|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
154927249|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
154927250|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
154927251|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
154927252|NCT01299272|559158829|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
154927253|NCT01299272|559158830|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
154927254|NCT01299272|559158831|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
154927255|NCT01299272|559158832|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
154927256|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
154927257|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
154927258|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
154927259|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
154927260|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
154927261|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
154927262|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
154927263|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
154927264|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
154927265|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
154927266|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
154927267|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
154927268|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
154927269|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
154927270|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
154927271|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
154927272|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
154927273|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
154927274|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
154927275|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
154927276|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
154927277|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
154927278|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
154927279|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
154927280|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
154927281|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
154927282|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
154927283|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
154927284|NCT01299272|559158829|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
154927285|NCT01299272|559158830|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
154927286|NCT01299272|559158831|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
154927287|NCT01299272|559158832|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
154927288|NCT00464308|559158833|FG000|Overall Study|Adverse Event|22|||
154927289|NCT00464308|559158834|FG001|Overall Study|Adverse Event|27|||
154927290|NCT00464308|559158835|FG002|Overall Study|Adverse Event|16|||
154927291|NCT00464308|559158833|FG000|Overall Study|Lost to Follow-up|29|||
154927292|NCT00464308|559158834|FG001|Overall Study|Lost to Follow-up|19|||
154927293|NCT00464308|559158835|FG002|Overall Study|Lost to Follow-up|20|||
154927294|NCT00464308|559158833|FG000|Overall Study|Patient discontinued and other reasons|17|||
154927295|NCT00464308|559158834|FG001|Overall Study|Patient discontinued and other reasons|17|||
154927296|NCT00464308|559158835|FG002|Overall Study|Patient discontinued and other reasons|23|||
154927297|NCT00464308|559158833|FG000|Overall Study|Physician Decision|1|||
154927298|NCT00464308|559158834|FG001|Overall Study|Physician Decision|0|||
154927299|NCT00464308|559158835|FG002|Overall Study|Physician Decision|0|||
154927300|NCT01513759|559158836|FG000|Overall Study|Protocol Violation|4|||
154927301|NCT01513759|559158836|FG000|Overall Study|Death during catheter placement|1|||
154927302|NCT03926728|559158837|FG000|Overall Study|Withdrawal by Subject|0|||
154927303|NCT03926728|559158838|FG001|Overall Study|Withdrawal by Subject|1|||
154927304|NCT03926728|559158839|FG002|Overall Study|Withdrawal by Subject|1|||
154927305|NCT03926728|559158840|FG003|Overall Study|Withdrawal by Subject|0|||
154927306|NCT03926728|559158841|FG004|Overall Study|Withdrawal by Subject|0|||
154927307|NCT03926728|559158842|FG005|Overall Study|Withdrawal by Subject|1|||
154927308|NCT03926728|559158843|FG006|Overall Study|Withdrawal by Subject|1|||
154927309|NCT03926728|559158844|FG007|Overall Study|Withdrawal by Subject|0|||
154927310|NCT03926728|559158845|FG008|Overall Study|Withdrawal by Subject|0|||
154927311|NCT03926728|559158846|FG009|Overall Study|Withdrawal by Subject|1|||
154927312|NCT03926728|559158847|FG010|Overall Study|Withdrawal by Subject|0|||
154927313|NCT03926728|559158848|FG011|Overall Study|Withdrawal by Subject|0|||
154927314|NCT03669640|559158849|FG000|Overall Study|Study Terminated by Sponsor|0|||
154927315|NCT03669640|559158850|FG001|Overall Study|Study Terminated by Sponsor|0|||
154927316|NCT03669640|559158851|FG002|Overall Study|Study Terminated by Sponsor|0|||
154927317|NCT03669640|559158852|FG003|Overall Study|Study Terminated by Sponsor|0|||
154927318|NCT03669640|559158853|FG004|Overall Study|Study Terminated by Sponsor|1|||
154927319|NCT03669640|559158854|FG005|Overall Study|Study Terminated by Sponsor|0|||
154927320|NCT03669640|559158849|FG000|Overall Study|Lost to Follow-up|0|||
154927321|NCT03669640|559158850|FG001|Overall Study|Lost to Follow-up|0|||
154927322|NCT03669640|559158851|FG002|Overall Study|Lost to Follow-up|2|||
154927323|NCT03669640|559158852|FG003|Overall Study|Lost to Follow-up|0|||
154927324|NCT03669640|559158853|FG004|Overall Study|Lost to Follow-up|0|||
154927325|NCT03669640|559158854|FG005|Overall Study|Lost to Follow-up|0|||
154927326|NCT03669640|559158849|FG000|Overall Study|Death|0|||
154927327|NCT03669640|559158850|FG001|Overall Study|Death|0|||
154927328|NCT03669640|559158851|FG002|Overall Study|Death|1|||
154927329|NCT03669640|559158852|FG003|Overall Study|Death|0|||
154927330|NCT03669640|559158853|FG004|Overall Study|Death|0|||
154927331|NCT03669640|559158854|FG005|Overall Study|Death|0|||
154927332|NCT03669640|559158849|FG000|Overall Study|Withdrawal by Subject|1|||
154927333|NCT03669640|559158850|FG001|Overall Study|Withdrawal by Subject|2|||
154927334|NCT03669640|559158851|FG002|Overall Study|Withdrawal by Subject|1|||
154927335|NCT03669640|559158852|FG003|Overall Study|Withdrawal by Subject|0|||
154927336|NCT03669640|559158853|FG004|Overall Study|Withdrawal by Subject|1|||
154927337|NCT03669640|559158854|FG005|Overall Study|Withdrawal by Subject|3|||
154927338|NCT03669640|559158849|FG000|Overall Study|Protocol Violation|1|||
154927339|NCT03669640|559158850|FG001|Overall Study|Protocol Violation|0|||
154927340|NCT03669640|559158851|FG002|Overall Study|Protocol Violation|0|||
154927341|NCT03669640|559158852|FG003|Overall Study|Protocol Violation|0|||
154927342|NCT03669640|559158853|FG004|Overall Study|Protocol Violation|0|||
154927343|NCT03669640|559158854|FG005|Overall Study|Protocol Violation|0|||
154927344|NCT03669640|559158849|FG000|Overall Study|Physician Decision|0|||
154927345|NCT03669640|559158850|FG001|Overall Study|Physician Decision|2|||
154927346|NCT03669640|559158851|FG002|Overall Study|Physician Decision|0|||
154927347|NCT03669640|559158852|FG003|Overall Study|Physician Decision|0|||
154927348|NCT03669640|559158853|FG004|Overall Study|Physician Decision|0|||
154927349|NCT03669640|559158854|FG005|Overall Study|Physician Decision|0|||
154927350|NCT03669640|559158849|FG000|Overall Study|Disease Relapse|1|||
154927351|NCT03669640|559158850|FG001|Overall Study|Disease Relapse|0|||
154927352|NCT03669640|559158851|FG002|Overall Study|Disease Relapse|0|||
154927353|NCT03669640|559158852|FG003|Overall Study|Disease Relapse|0|||
154927354|NCT03669640|559158853|FG004|Overall Study|Disease Relapse|0|||
154927355|NCT03669640|559158854|FG005|Overall Study|Disease Relapse|0|||
154927356|NCT03669640|559158849|FG000|Overall Study|Adverse Event|2|||
154927357|NCT03669640|559158850|FG001|Overall Study|Adverse Event|1|||
154927358|NCT03669640|559158851|FG002|Overall Study|Adverse Event|0|||
154927359|NCT03669640|559158852|FG003|Overall Study|Adverse Event|0|||
154927360|NCT03669640|559158853|FG004|Overall Study|Adverse Event|1|||
154927361|NCT03669640|559158854|FG005|Overall Study|Adverse Event|0|||
154927362|NCT03993288|559158855|FG000|Overall Study|Lost to Follow-up|2|||
154927363|NCT03993288|559158856|FG001|Overall Study|Lost to Follow-up|1|||
154927364|NCT03993288|559158855|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
154927365|NCT03993288|559158856|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
154927366|NCT03993288|559158855|FG000|Overall Study|wrong randomization|0|||
154927367|NCT03993288|559158856|FG001|Overall Study|wrong randomization|1|||
154927368|NCT03993288|559158855|FG000|Overall Study|improper enrollment|0|||
154927369|NCT03993288|559158856|FG001|Overall Study|improper enrollment|1|||
154927370|NCT03993288|559158855|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
154927371|NCT03993288|559158856|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
154927372|NCT03993288|559158855|FG000|Overall Study|developed SAE|2|||
154927373|NCT03993288|559158856|FG001|Overall Study|developed SAE|0|||
154927374|NCT03993288|559158855|FG000|Overall Study|consent withdrawal|1|||
154927375|NCT03993288|559158856|FG001|Overall Study|consent withdrawal|0|||
154927376|NCT03993288|559158855|FG000|Overall Study|did not follow the treatment schedule|1|||
154927377|NCT03993288|559158856|FG001|Overall Study|did not follow the treatment schedule|0|||
154927378|NCT03993288|559158855|FG000|Overall Study|did not follow the treatment regimen|1|||
154927379|NCT03993288|559158856|FG001|Overall Study|did not follow the treatment regimen|0|||
154927380|NCT03993288|559158855|FG000|Overall Study|Adverse Event|1|||
154927381|NCT03993288|559158856|FG001|Overall Study|Adverse Event|0|||
154927382|NCT03993288|559158855|FG000|Overall Study|Withdrawal by Subject|1|||
154927383|NCT03993288|559158856|FG001|Overall Study|Withdrawal by Subject|1|||
154927384|NCT02729545|559158857|FG000|Overall Study|Pregnancy|1|||
154927385|NCT02729545|559158858|FG001|Overall Study|Pregnancy|1|||
154927386|NCT02729545|559158857|FG000|Overall Study|Lost to Follow-up|0|||
154927387|NCT02729545|559158858|FG001|Overall Study|Lost to Follow-up|1|||
154927388|NCT02729545|559158857|FG000|Overall Study|Withdrawal by Subject|2|||
154927389|NCT02729545|559158858|FG001|Overall Study|Withdrawal by Subject|3|||
154927390|NCT03533608|559158859|FG000|Overall Study|Withdrawal by Subject|3|||
154927391|NCT03533608|559158859|FG000|Overall Study|Physician Decision|2|||
154927392|NCT00915473|559158860|FG000|Screening|Withdrawal by Subject|1|||
154927393|NCT00915473|559158861|FG001|Screening|Withdrawal by Subject|0|||
154927394|NCT00915473|559158860|FG000|4-week Follow Up|Lost to Follow-up|1|||
154927395|NCT00915473|559158861|FG001|4-week Follow Up|Lost to Follow-up|5|||
154927396|NCT01389024|559158862|FG000|Overall Study|Withdrawal by Subject|0|||
154927397|NCT01389024|559158863|FG001|Overall Study|Withdrawal by Subject|1|||
154927398|NCT01389024|559158862|FG000|Overall Study|Lost to Follow-up|1|||
154927399|NCT01389024|559158863|FG001|Overall Study|Lost to Follow-up|0|||
154927400|NCT03443973|559158867|FG000|Double-blind Treatment Period|Adverse Event|5|||
154927401|NCT03443973|559158868|FG001|Double-blind Treatment Period|Adverse Event|19|||
154927402|NCT03443973|559158869|FG002|Double-blind Treatment Period|Adverse Event|0|||
154927403|NCT03443973|559158870|FG003|Double-blind Treatment Period|Adverse Event|0|||
154927404|NCT03443973|559158867|FG000|Double-blind Treatment Period|Death|5|||
154927405|NCT03443973|559158868|FG001|Double-blind Treatment Period|Death|7|||
154927406|NCT03443973|559158869|FG002|Double-blind Treatment Period|Death|0|||
154927407|NCT03443973|559158870|FG003|Double-blind Treatment Period|Death|0|||
154927408|NCT03443973|559158867|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
154927409|NCT03443973|559158868|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
154927410|NCT03443973|559158869|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
154927411|NCT03443973|559158870|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
154927412|NCT03443973|559158867|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
154927413|NCT03443973|559158868|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
154927414|NCT03443973|559158869|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
154927415|NCT03443973|559158870|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
154927416|NCT03443973|559158867|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
154927417|NCT03443973|559158868|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
154927418|NCT03443973|559158869|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
154927419|NCT03443973|559158870|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
154927420|NCT03443973|559158867|FG000|Double-blind Treatment Period|Physician Decision|5|||
154927421|NCT03443973|559158868|FG001|Double-blind Treatment Period|Physician Decision|6|||
154927422|NCT03443973|559158869|FG002|Double-blind Treatment Period|Physician Decision|0|||
154927423|NCT03443973|559158870|FG003|Double-blind Treatment Period|Physician Decision|0|||
154927424|NCT03443973|559158867|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
154927425|NCT03443973|559158868|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
154927426|NCT03443973|559158869|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
154927427|NCT03443973|559158870|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
154927428|NCT03443973|559158867|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
154927429|NCT03443973|559158868|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
154927430|NCT03443973|559158869|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
154927431|NCT03443973|559158870|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
154927432|NCT03443973|559158867|FG000|Open-label Extension Period|Reason Not Specified|0|||
154927433|NCT03443973|559158868|FG001|Open-label Extension Period|Reason Not Specified|0|||
154927434|NCT03443973|559158869|FG002|Open-label Extension Period|Reason Not Specified|3|||
154927435|NCT03443973|559158870|FG003|Open-label Extension Period|Reason Not Specified|0|||
154927436|NCT03443973|559158867|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
154927437|NCT03443973|559158868|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
154927438|NCT03443973|559158869|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
154927439|NCT03443973|559158870|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
154927440|NCT00398632|559158871|FG000|Overall Study|Withdrawal by Subject|1|||
154927441|NCT00398632|559158871|FG000|Overall Study|Lack of Efficacy|1|||
154927442|NCT00529802|559158873|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
154927443|NCT00529802|559158873|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
154927444|NCT00529802|559158873|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
154927445|NCT00529802|559158873|FG000|Evaluable for Primary Endpoint|Death|1|||
154927446|NCT00529802|559158873|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
154927447|NCT00529802|559158873|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
154927448|NCT00529802|559158873|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
154927449|NCT02209454|559158875|FG000|Second Period|Adverse Event|1|||
154927450|NCT02209454|559158876|FG001|Second Period|Adverse Event|0|||
154927451|NCT00366678|559158879|FG000|Infant Series|Withdrawal by Subject|8|||
154927452|NCT00366678|559158880|FG001|Infant Series|Withdrawal by Subject|6|||
154927453|NCT00366678|559158881|FG002|Infant Series|Withdrawal by Subject|0|||
154927454|NCT00366678|559158879|FG000|Infant Series|Protocol Violation|4|||
154927455|NCT00366678|559158880|FG001|Infant Series|Protocol Violation|3|||
154927456|NCT00366678|559158881|FG002|Infant Series|Protocol Violation|0|||
154927457|NCT00366678|559158879|FG000|Infant Series|Failed to return|1|||
154927458|NCT00366678|559158880|FG001|Infant Series|Failed to return|1|||
154927459|NCT00366678|559158881|FG002|Infant Series|Failed to return|0|||
154927460|NCT00366678|559158879|FG000|Infant Series|Adverse Event|1|||
154927461|NCT00366678|559158880|FG001|Infant Series|Adverse Event|0|||
154927462|NCT00366678|559158881|FG002|Infant Series|Adverse Event|0|||
154927463|NCT00366678|559158879|FG000|After Infant|Withdrawal by Subject|8|||
154927464|NCT00366678|559158880|FG001|After Infant|Withdrawal by Subject|4|||
154927465|NCT00366678|559158881|FG002|After Infant|Withdrawal by Subject|0|||
154927466|NCT00366678|559158879|FG000|After Infant|Lost to Follow-up|2|||
154927467|NCT00366678|559158880|FG001|After Infant|Lost to Follow-up|1|||
154927468|NCT00366678|559158881|FG002|After Infant|Lost to Follow-up|0|||
154927469|NCT00366678|559158879|FG000|After Infant|Failed to return|5|||
154927470|NCT00366678|559158880|FG001|After Infant|Failed to return|5|||
154927471|NCT00366678|559158881|FG002|After Infant|Failed to return|0|||
154927472|NCT00366678|559158879|FG000|After Infant|Adverse Event|1|||
154927473|NCT00366678|559158880|FG001|After Infant|Adverse Event|0|||
154927474|NCT00366678|559158881|FG002|After Infant|Adverse Event|0|||
154927475|NCT00366678|559158879|FG000|After Infant|Protocol Violation|1|||
154927476|NCT00366678|559158880|FG001|After Infant|Protocol Violation|0|||
154927477|NCT00366678|559158881|FG002|After Infant|Protocol Violation|0|||
154927478|NCT00366678|559158879|FG000|Toddler Dose|Protocol Violation|2|||
154927479|NCT00366678|559158880|FG001|Toddler Dose|Protocol Violation|1|||
154927480|NCT00366678|559158881|FG002|Toddler Dose|Protocol Violation|0|||
154927481|NCT00366678|559158879|FG000|Toddler Dose|Failed to return|1|||
154927482|NCT00366678|559158880|FG001|Toddler Dose|Failed to return|0|||
154927483|NCT00366678|559158881|FG002|Toddler Dose|Failed to return|0|||
154927484|NCT00366678|559158879|FG000|Toddler Dose|Withdrawal by Subject|1|||
154927485|NCT00366678|559158880|FG001|Toddler Dose|Withdrawal by Subject|0|||
154927486|NCT00366678|559158881|FG002|Toddler Dose|Withdrawal by Subject|0|||
154927487|NCT00366678|559158879|FG000|Toddler Dose|protocol deviation|1|||
154927488|NCT00366678|559158880|FG001|Toddler Dose|protocol deviation|0|||
154927489|NCT00366678|559158881|FG002|Toddler Dose|protocol deviation|0|||
154927490|NCT04465916|559158888|FG000|Overall Study|Withdrawal by Subject|0|||
155039477|NCT00298363|559572952|FG000|Overall Study|Lack of Efficacy|2|||
154927491|NCT04465916|559158889|FG001|Overall Study|Withdrawal by Subject|1|||
154927492|NCT00826176|559158892|FG000|Overall Study|Lost to Follow-up|1|||
154927493|NCT00826176|559158893|FG001|Overall Study|Lost to Follow-up|0|||
154927494|NCT00826176|559158892|FG000|Overall Study|Subject Withdrew Consent|3|||
154927495|NCT00826176|559158893|FG001|Overall Study|Subject Withdrew Consent|0|||
154927496|NCT00826176|559158892|FG000|Overall Study|Administrative|9|||
154927497|NCT00826176|559158893|FG001|Overall Study|Administrative|0|||
154927498|NCT03079869|559158895|FG000|Overall Study|Adverse Event|6|||
154927499|NCT03079869|559158896|FG001|Overall Study|Adverse Event|8|||
154927500|NCT03079869|559158895|FG000|Overall Study|Withdrawal by Subject|4|||
154927501|NCT03079869|559158896|FG001|Overall Study|Withdrawal by Subject|1|||
154927502|NCT03079869|559158895|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
154927503|NCT03079869|559158896|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
154927504|NCT01325701|559158897|FG000|Overall Study|Adverse Event|12|||
154927505|NCT01325701|559158898|FG001|Overall Study|Adverse Event|0|||
154927506|NCT01325701|559158897|FG000|Overall Study|Protocol Violation|1|||
154927507|NCT01325701|559158898|FG001|Overall Study|Protocol Violation|0|||
155039478|NCT00298363|559572953|FG001|Overall Study|Lack of Efficacy|3|||
155039479|NCT00298363|559572954|FG002|Overall Study|Lack of Efficacy|0|||
155039480|NCT00433017|559572955|FG000|Overall Study|Adverse Event|5|||
155039481|NCT00433017|559572956|FG001|Overall Study|Adverse Event|3|||
155039482|NCT00433017|559572955|FG000|Overall Study|Withdrawal by Subject|4|||
155039483|NCT00433017|559572956|FG001|Overall Study|Withdrawal by Subject|5|||
155039484|NCT00433017|559572955|FG000|Overall Study|Lost to Follow-up|3|||
155039485|NCT00433017|559572956|FG001|Overall Study|Lost to Follow-up|4|||
155039486|NCT00433017|559572955|FG000|Overall Study|Administrative problems|80|||
155039487|NCT00433017|559572956|FG001|Overall Study|Administrative problems|86|||
155039488|NCT00433017|559572955|FG000|Overall Study|Protocol Violation|1|||
155039489|NCT00433017|559572956|FG001|Overall Study|Protocol Violation|0|||
155039490|NCT00433017|559572955|FG000|Overall Study|Death|2|||
155039491|NCT00433017|559572956|FG001|Overall Study|Death|2|||
155039492|NCT00433017|559572955|FG000|Overall Study|Subject no longer requires study drug|1|||
155039493|NCT00433017|559572956|FG001|Overall Study|Subject no longer requires study drug|1|||
155039494|NCT00135356|559572957|FG000|Overall Study|Adverse Event|6|||
155039495|NCT00135356|559572958|FG001|Overall Study|Adverse Event|2|||
155039496|NCT00135356|559572957|FG000|Overall Study|Lack of Efficacy|2|||
155039497|NCT00135356|559572958|FG001|Overall Study|Lack of Efficacy|0|||
155039498|NCT00135356|559572957|FG000|Overall Study|Lost to Follow-up|3|||
155039499|NCT00135356|559572958|FG001|Overall Study|Lost to Follow-up|1|||
155039500|NCT00135356|559572957|FG000|Overall Study|Surgery for abdominal fat|1|||
155039501|NCT00135356|559572958|FG001|Overall Study|Surgery for abdominal fat|0|||
155039502|NCT00135356|559572957|FG000|Overall Study|Change in antiviral regimen|0|||
155039503|NCT00135356|559572958|FG001|Overall Study|Change in antiviral regimen|1|||
155039504|NCT00135356|559572957|FG000|Overall Study|Poor/noncompliance|1|||
155039505|NCT00135356|559572958|FG001|Overall Study|Poor/noncompliance|1|||
155039506|NCT00135356|559572957|FG000|Overall Study|No longer meets study criteria|2|||
155039507|NCT00135356|559572958|FG001|Overall Study|No longer meets study criteria|0|||
155039508|NCT00135356|559572957|FG000|Overall Study|Withdrawal by Subject|2|||
155039509|NCT00135356|559572958|FG001|Overall Study|Withdrawal by Subject|4|||
155039510|NCT00153816|559572959|FG000|Overall Study|Death|6|||
155039511|NCT00153816|559572960|FG001|Overall Study|Death|5|||
155039512|NCT00153816|559572961|FG002|Overall Study|Death|4|||
155039513|NCT00153816|559572962|FG003|Overall Study|Death|6|||
155039514|NCT00153816|559572963|FG004|Overall Study|Death|0|||
155039515|NCT00153816|559572964|FG005|Overall Study|Death|2|||
155039516|NCT00153816|559572959|FG000|Overall Study|Lost to Follow-up|7|||
155039517|NCT00153816|559572960|FG001|Overall Study|Lost to Follow-up|8|||
155039518|NCT00153816|559572961|FG002|Overall Study|Lost to Follow-up|5|||
155039519|NCT00153816|559572962|FG003|Overall Study|Lost to Follow-up|8|||
155039520|NCT00153816|559572963|FG004|Overall Study|Lost to Follow-up|7|||
155039521|NCT00153816|559572964|FG005|Overall Study|Lost to Follow-up|9|||
155039522|NCT00153816|559572959|FG000|Overall Study|Withdrawal by Subject|9|||
155039523|NCT00153816|559572960|FG001|Overall Study|Withdrawal by Subject|9|||
155039524|NCT00153816|559572961|FG002|Overall Study|Withdrawal by Subject|9|||
155039525|NCT00153816|559572962|FG003|Overall Study|Withdrawal by Subject|4|||
155039526|NCT00153816|559572963|FG004|Overall Study|Withdrawal by Subject|1|||
155039527|NCT00153816|559572964|FG005|Overall Study|Withdrawal by Subject|5|||
155039528|NCT00153816|559572959|FG000|Overall Study|Follow-up exam not done|8|||
155039529|NCT00153816|559572960|FG001|Overall Study|Follow-up exam not done|7|||
155039530|NCT00153816|559572961|FG002|Overall Study|Follow-up exam not done|11|||
154927508|NCT01325701|559158897|FG000|Overall Study|Physician Decision|2|||
155039531|NCT00153816|559572962|FG003|Overall Study|Follow-up exam not done|10|||
155039532|NCT00153816|559572963|FG004|Overall Study|Follow-up exam not done|8|||
155039533|NCT00153816|559572964|FG005|Overall Study|Follow-up exam not done|9|||
155039534|NCT00153816|559572959|FG000|Overall Study|Follow-up exam done, histology missing|2|||
155039535|NCT00153816|559572960|FG001|Overall Study|Follow-up exam done, histology missing|3|||
155039536|NCT00153816|559572961|FG002|Overall Study|Follow-up exam done, histology missing|3|||
155152524|NCT03037385|559996851|FG009|Overall Study|Lost to Follow-up|16|||
155039537|NCT00153816|559572962|FG003|Overall Study|Follow-up exam done, histology missing|3|||
155039538|NCT00153816|559572963|FG004|Overall Study|Follow-up exam done, histology missing|1|||
155039539|NCT00153816|559572964|FG005|Overall Study|Follow-up exam done, histology missing|2|||
155039540|NCT01306214|559572965|FG000|Overall Study|Death|0|||
155039541|NCT01306214|559572966|FG001|Overall Study|Death|0|||
155039542|NCT01306214|559572967|FG002|Overall Study|Death|1|||
155039543|NCT01306214|559572965|FG000|Overall Study|Lost to Follow-up|3|||
155039544|NCT01306214|559572966|FG001|Overall Study|Lost to Follow-up|5|||
155039545|NCT01306214|559572967|FG002|Overall Study|Lost to Follow-up|4|||
155039546|NCT01306214|559572965|FG000|Overall Study|Withdrawal by Subject|24|||
155039547|NCT01306214|559572966|FG001|Overall Study|Withdrawal by Subject|22|||
155039548|NCT01306214|559572967|FG002|Overall Study|Withdrawal by Subject|16|||
155039549|NCT01306214|559572965|FG000|Overall Study|Not treated|1|||
155039550|NCT01306214|559572966|FG001|Overall Study|Not treated|1|||
155039551|NCT01306214|559572967|FG002|Overall Study|Not treated|1|||
155039552|NCT02686814|559572968|FG000|Overall Study|Physician Decision|14|||
155039553|NCT02686814|559572968|FG000|Overall Study|Withdrawal by Subject|4|||
155039554|NCT02686814|559572968|FG000|Overall Study|Death|1|||
155039555|NCT01026818|559572969|FG000|Screening Period|Entry Criteria Not Met|105|||
155039556|NCT01026818|559572970|FG001|Screening Period|Entry Criteria Not Met|0|||
155039557|NCT01026818|559572971|FG002|Screening Period|Entry Criteria Not Met|0|||
155039558|NCT01026818|559572972|FG003|Screening Period|Entry Criteria Not Met|0|||
155039559|NCT01026818|559572969|FG000|Screening Period|Withdrawal by Subject|49|||
155039560|NCT01026818|559572970|FG001|Screening Period|Withdrawal by Subject|0|||
155039561|NCT01026818|559572971|FG002|Screening Period|Withdrawal by Subject|0|||
155039562|NCT01026818|559572972|FG003|Screening Period|Withdrawal by Subject|0|||
155039563|NCT01026818|559572969|FG000|Screening Period|Protocol Deviation|3|||
155039564|NCT01026818|559572970|FG001|Screening Period|Protocol Deviation|0|||
155039565|NCT01026818|559572971|FG002|Screening Period|Protocol Deviation|0|||
155039566|NCT01026818|559572972|FG003|Screening Period|Protocol Deviation|0|||
155039567|NCT01026818|559572969|FG000|Screening Period|Adverse Event|2|||
155039568|NCT01026818|559572970|FG001|Screening Period|Adverse Event|0|||
155039569|NCT01026818|559572971|FG002|Screening Period|Adverse Event|0|||
155039570|NCT01026818|559572972|FG003|Screening Period|Adverse Event|0|||
155039571|NCT01026818|559572969|FG000|Screening Period|Physician Decision|1|||
155039572|NCT01026818|559572970|FG001|Screening Period|Physician Decision|0|||
155039573|NCT01026818|559572971|FG002|Screening Period|Physician Decision|0|||
155039574|NCT01026818|559572972|FG003|Screening Period|Physician Decision|0|||
155039575|NCT01026818|559572969|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
155039576|NCT01026818|559572970|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
155039577|NCT01026818|559572971|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
155039578|NCT01026818|559572972|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
155039579|NCT01026818|559572969|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
155039580|NCT01026818|559572970|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
155039581|NCT01026818|559572971|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
155039582|NCT01026818|559572972|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
155039583|NCT01026818|559572969|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
155039584|NCT01026818|559572970|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
155039585|NCT01026818|559572971|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
155039586|NCT01026818|559572972|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
155039587|NCT01026818|559572969|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
155039588|NCT01026818|559572970|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
155039589|NCT01026818|559572971|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
155039590|NCT01026818|559572972|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
155039591|NCT01026818|559572969|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
155039592|NCT01026818|559572970|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
155039593|NCT01026818|559572971|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
155039594|NCT01026818|559572972|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
155039595|NCT01026818|559572969|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
155039596|NCT01026818|559572970|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
155039597|NCT01026818|559572971|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
155039598|NCT01026818|559572972|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
155039599|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
155039600|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
155039601|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
155039602|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
155039603|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
155039604|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
155039605|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
155039606|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
155039607|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
155152525|NCT03037385|559996842|FG000|Overall Study|Physician Decision|0|||
155039608|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
155039609|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
154927509|NCT01325701|559158898|FG001|Overall Study|Physician Decision|2|||
154927510|NCT01325701|559158897|FG000|Overall Study|Withdrawal by Subject|2|||
154927511|NCT01325701|559158898|FG001|Overall Study|Withdrawal by Subject|1|||
154927512|NCT01325701|559158897|FG000|Overall Study|Rollerover Extension Study|4|||
154927513|NCT01325701|559158898|FG001|Overall Study|Rollerover Extension Study|0|||
154927514|NCT00568776|559158901|FG000|Overall Study|Adverse Event|8|||
154927515|NCT00568776|559158902|FG001|Overall Study|Adverse Event|8|||
154927516|NCT00568776|559158903|FG002|Overall Study|Adverse Event|10|||
154927517|NCT00568776|559158904|FG003|Overall Study|Adverse Event|8|||
154927518|NCT00568776|559158901|FG000|Overall Study|Death|0|||
154927519|NCT00568776|559158902|FG001|Overall Study|Death|1|||
154927520|NCT00568776|559158903|FG002|Overall Study|Death|4|||
154927521|NCT00568776|559158904|FG003|Overall Study|Death|3|||
154927522|NCT00568776|559158901|FG000|Overall Study|Physician Decision|0|||
154927523|NCT00568776|559158902|FG001|Overall Study|Physician Decision|2|||
154927524|NCT00568776|559158903|FG002|Overall Study|Physician Decision|0|||
154927525|NCT00568776|559158904|FG003|Overall Study|Physician Decision|0|||
154927526|NCT00568776|559158901|FG000|Overall Study|Lack of Efficacy|2|||
154927527|NCT00568776|559158902|FG001|Overall Study|Lack of Efficacy|2|||
154927528|NCT00568776|559158903|FG002|Overall Study|Lack of Efficacy|2|||
154927529|NCT00568776|559158904|FG003|Overall Study|Lack of Efficacy|4|||
154927530|NCT00568776|559158901|FG000|Overall Study|Lost to Follow-up|1|||
154927531|NCT00568776|559158902|FG001|Overall Study|Lost to Follow-up|1|||
154927532|NCT00568776|559158903|FG002|Overall Study|Lost to Follow-up|1|||
154927533|NCT00568776|559158904|FG003|Overall Study|Lost to Follow-up|1|||
154927534|NCT00568776|559158901|FG000|Overall Study|Protocol Violation|1|||
154927535|NCT00568776|559158902|FG001|Overall Study|Protocol Violation|0|||
154927536|NCT00568776|559158903|FG002|Overall Study|Protocol Violation|1|||
154927537|NCT00568776|559158904|FG003|Overall Study|Protocol Violation|1|||
154927538|NCT00568776|559158901|FG000|Overall Study|Withdrawal by Subject|13|||
154927539|NCT00568776|559158902|FG001|Overall Study|Withdrawal by Subject|15|||
154927540|NCT00568776|559158903|FG002|Overall Study|Withdrawal by Subject|13|||
154927541|NCT00568776|559158904|FG003|Overall Study|Withdrawal by Subject|7|||
154927542|NCT00568776|559158901|FG000|Overall Study|Loss of Caregiver|0|||
154927543|NCT00568776|559158902|FG001|Overall Study|Loss of Caregiver|2|||
154927544|NCT00568776|559158903|FG002|Overall Study|Loss of Caregiver|1|||
154927545|NCT00568776|559158904|FG003|Overall Study|Loss of Caregiver|2|||
154927546|NCT00568776|559158901|FG000|Overall Study|Sponsor Decision|2|||
154927547|NCT00568776|559158902|FG001|Overall Study|Sponsor Decision|2|||
154927548|NCT00568776|559158903|FG002|Overall Study|Sponsor Decision|41|||
154927549|NCT00568776|559158904|FG003|Overall Study|Sponsor Decision|42|||
154927550|NCT00568776|559158901|FG000|Overall Study|Miscellaeneous|3|||
154927551|NCT00568776|559158902|FG001|Overall Study|Miscellaeneous|3|||
154927552|NCT00568776|559158903|FG002|Overall Study|Miscellaeneous|1|||
154927553|NCT00568776|559158904|FG003|Overall Study|Miscellaeneous|4|||
154927554|NCT04484805|559158907|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
154927555|NCT04484805|559158908|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
154927556|NCT04484805|559158907|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
154927557|NCT04484805|559158908|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
154927558|NCT03733301|559158910|FG000|Overall Study|Screen Fail|1|||
154927559|NCT03733301|559158911|FG001|Overall Study|Screen Fail|0|||
154927560|NCT03733301|559158912|FG002|Overall Study|Screen Fail|0|||
154927561|NCT03733301|559158910|FG000|Overall Study|Non-compliance|1|||
154927562|NCT03733301|559158911|FG001|Overall Study|Non-compliance|0|||
154927563|NCT03733301|559158912|FG002|Overall Study|Non-compliance|0|||
154927564|NCT03733301|559158910|FG000|Overall Study|Lack of Efficacy|2|||
154927565|NCT03733301|559158911|FG001|Overall Study|Lack of Efficacy|3|||
154927566|NCT03733301|559158912|FG002|Overall Study|Lack of Efficacy|0|||
154927567|NCT03733301|559158910|FG000|Overall Study|Adverse Event|0|||
154927568|NCT03733301|559158911|FG001|Overall Study|Adverse Event|1|||
154927569|NCT03733301|559158912|FG002|Overall Study|Adverse Event|3|||
154927570|NCT03733301|559158910|FG000|Overall Study|Withdrawal by Subject|3|||
154927571|NCT03733301|559158911|FG001|Overall Study|Withdrawal by Subject|5|||
154927572|NCT03733301|559158912|FG002|Overall Study|Withdrawal by Subject|1|||
154927573|NCT04635631|559158915|FG000|Overall Study|Adverse Event|1|||
154927574|NCT04635631|559158915|FG000|Overall Study|Progressive disease|13|||
154927575|NCT04635631|559158915|FG000|Overall Study|Withdrawal by Subject|1|||
154927576|NCT00943826|559158916|FG000|Concurrent Phase|Adverse Event|50|||
154927577|NCT00943826|559158917|FG001|Concurrent Phase|Adverse Event|27|||
154927578|NCT00943826|559158916|FG000|Concurrent Phase|Withdrew consent|3|||
154927579|NCT00943826|559158917|FG001|Concurrent Phase|Withdrew consent|7|||
154927580|NCT00943826|559158916|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
154927581|NCT00943826|559158917|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
155152526|NCT03037385|559996843|FG001|Overall Study|Physician Decision|0|||
155039610|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
155039611|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
155039612|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
155039613|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
155039614|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
155039615|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
155039616|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
155039617|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
155039618|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
155039619|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
155039620|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
155039621|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
155039622|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
155039623|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
155039624|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
155039625|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
155039626|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
155039627|NCT01026818|559572969|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
155039628|NCT01026818|559572970|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
155039629|NCT01026818|559572971|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
155039630|NCT01026818|559572972|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
155039631|NCT01026818|559572969|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
155039632|NCT01026818|559572970|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
155039633|NCT01026818|559572971|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
155039634|NCT01026818|559572972|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
155039635|NCT01026818|559572969|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
155039636|NCT01026818|559572970|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
155039637|NCT01026818|559572971|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
155039638|NCT01026818|559572972|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
155039639|NCT01026818|559572969|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
155039640|NCT01026818|559572970|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
155039641|NCT01026818|559572971|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
155039642|NCT01026818|559572972|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
155039643|NCT01026818|559572969|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
155039644|NCT01026818|559572970|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
155039645|NCT01026818|559572971|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
155039646|NCT01026818|559572972|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
154927582|NCT00943826|559158916|FG000|Concurrent Phase|Administrative reasons|2|||
154927583|NCT00943826|559158917|FG001|Concurrent Phase|Administrative reasons|1|||
154927584|NCT00943826|559158916|FG000|Concurrent Phase|Protocol Violation|1|||
154927585|NCT00943826|559158917|FG001|Concurrent Phase|Protocol Violation|0|||
154927586|NCT00943826|559158916|FG000|Maintenance Phase|Adverse Event|31|||
154927587|NCT00943826|559158917|FG001|Maintenance Phase|Adverse Event|30|||
154927588|NCT00943826|559158916|FG000|Maintenance Phase|Withdrew consent|2|||
154927589|NCT00943826|559158917|FG001|Maintenance Phase|Withdrew consent|4|||
154927590|NCT00943826|559158916|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
154927591|NCT00943826|559158917|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
154927592|NCT00943826|559158916|FG000|Maintenance Phase|Administrative reasons|4|||
154927593|NCT00943826|559158917|FG001|Maintenance Phase|Administrative reasons|1|||
154927594|NCT00943826|559158916|FG000|Maintenance Phase|Failure to return|0|||
154927595|NCT00943826|559158917|FG001|Maintenance Phase|Failure to return|1|||
154927596|NCT00943826|559158916|FG000|Monotherapy Phase|Adverse Event|42|||
154927597|NCT00943826|559158917|FG001|Monotherapy Phase|Adverse Event|5|||
154927598|NCT00943826|559158916|FG000|Monotherapy Phase|Administrative reasons|11|||
154927599|NCT00943826|559158917|FG001|Monotherapy Phase|Administrative reasons|5|||
154927600|NCT00943826|559158916|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
154927601|NCT00943826|559158917|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
154927602|NCT00943826|559158916|FG000|Monotherapy Phase|Withdrew Consent|2|||
154927603|NCT00943826|559158917|FG001|Monotherapy Phase|Withdrew Consent|3|||
154927604|NCT00943826|559158916|FG000|Monotherapy Phase|Failure to return|2|||
154927605|NCT00943826|559158917|FG001|Monotherapy Phase|Failure to return|1|||
154927606|NCT00943826|559158916|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
154927607|NCT00943826|559158917|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
154927608|NCT00943826|559158916|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
154927609|NCT00943826|559158917|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
155039647|NCT01026818|559572969|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
155039648|NCT01026818|559572970|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
155039649|NCT01026818|559572971|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
155039650|NCT01026818|559572972|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
155039651|NCT01908582|559572973|FG000|Period 2|Physician Decision|1|||
155039652|NCT01908582|559572973|FG000|Period 2|Withdrawal by Subject|1|||
155039653|NCT01090050|559572975|FG000|Overall Study|Lost to Follow-up|0|||
155039654|NCT01090050|559572976|FG001|Overall Study|Lost to Follow-up|1|||
155039655|NCT01090050|559572975|FG000|Overall Study|Lack of Efficacy|1|||
155039656|NCT01090050|559572976|FG001|Overall Study|Lack of Efficacy|5|||
155039657|NCT01090050|559572975|FG000|Overall Study|Physician Decision|0|||
155039658|NCT01090050|559572976|FG001|Overall Study|Physician Decision|1|||
155039659|NCT02232061|559572977|FG000|Overall Study|Administrative problems|1|||
155039660|NCT02232061|559572977|FG000|Overall Study|Withdrawal by Subject|1|||
155039661|NCT04767529|559572978|FG000|Overall Study|Adverse Event|0|||
155039662|NCT04767529|559572979|FG001|Overall Study|Adverse Event|4|||
155039663|NCT04767529|559572980|FG002|Overall Study|Adverse Event|3|||
155039664|NCT04767529|559572978|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
155039665|NCT04767529|559572979|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
155039666|NCT04767529|559572980|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
155039667|NCT04767529|559572978|FG000|Overall Study|Required use of a prohibited medication|0|||
155039668|NCT04767529|559572979|FG001|Overall Study|Required use of a prohibited medication|1|||
155039669|NCT04767529|559572980|FG002|Overall Study|Required use of a prohibited medication|0|||
155039670|NCT04767529|559572978|FG000|Overall Study|Withdrawal by Subject|7|||
155039671|NCT04767529|559572979|FG001|Overall Study|Withdrawal by Subject|5|||
155039672|NCT04767529|559572980|FG002|Overall Study|Withdrawal by Subject|4|||
155039673|NCT04767529|559572978|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
155039674|NCT04767529|559572979|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
155039675|NCT04767529|559572980|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
155039676|NCT04767529|559572978|FG000|Overall Study|Lost to Follow-up|0|||
155039677|NCT04767529|559572979|FG001|Overall Study|Lost to Follow-up|2|||
155039678|NCT04767529|559572980|FG002|Overall Study|Lost to Follow-up|3|||
155039679|NCT00253370|559572981|FG000|Overall Study|Adverse Event|18|||
155039680|NCT00253370|559572981|FG000|Overall Study|Disease progression|13|||
155039681|NCT00253370|559572981|FG000|Overall Study|Death|2|||
155039682|NCT00253370|559572981|FG000|Overall Study|Withdrawal by Subject|6|||
155039683|NCT00253370|559572981|FG000|Overall Study|Non-protocol therapy|1|||
155039684|NCT00253370|559572981|FG000|Overall Study|Physician Decision|1|||
155039685|NCT00253370|559572981|FG000|Overall Study|Protocol Violation|1|||
155039686|NCT00253370|559572981|FG000|Overall Study|Abdominal pain due to disease|1|||
155039687|NCT00004088|559572983|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
155039688|NCT00004088|559572983|FG000|Overall Study|Withdrawal by Subject|1|||
155039689|NCT00004088|559572983|FG000|Overall Study|Protocol Violation|3|||
155039690|NCT00004088|559572983|FG000|Overall Study|Physician Decision|1|||
155039691|NCT00187278|559572992|FG000|Overall Study|Protocol Violation|10|||
155039692|NCT00187278|559572993|FG001|Overall Study|Protocol Violation|13|||
155039693|NCT02735096|559572994|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
155039694|NCT01080391|559572995|FG000|Overall Study|Randomized but not treated|7|||
155039695|NCT01080391|559572996|FG001|Overall Study|Randomized but not treated|4|||
155039696|NCT02083653|559572998|FG000|Overall Study|Randomized but not Treated|0|||
155039697|NCT02083653|559572999|FG001|Overall Study|Randomized but not Treated|2|||
155039698|NCT02083653|559573000|FG002|Overall Study|Randomized but not Treated|7|||
155039699|NCT02083653|559572998|FG000|Overall Study|Adverse Event|12|||
155039700|NCT02083653|559572999|FG001|Overall Study|Adverse Event|5|||
155039701|NCT02083653|559573000|FG002|Overall Study|Adverse Event|4|||
155039702|NCT02083653|559572998|FG000|Overall Study|Lost to Follow-up|1|||
155039703|NCT02083653|559572999|FG001|Overall Study|Lost to Follow-up|0|||
155039704|NCT02083653|559573000|FG002|Overall Study|Lost to Follow-up|0|||
155039705|NCT02083653|559572998|FG000|Overall Study|Death|2|||
155039706|NCT02083653|559572999|FG001|Overall Study|Death|2|||
155039707|NCT02083653|559573000|FG002|Overall Study|Death|2|||
155039708|NCT02083653|559572998|FG000|Overall Study|Progressive Disease|65|||
155039709|NCT02083653|559572999|FG001|Overall Study|Progressive Disease|73|||
155039710|NCT02083653|559573000|FG002|Overall Study|Progressive Disease|63|||
155039711|NCT02083653|559572998|FG000|Overall Study|Withdrawal by Subject|2|||
155039712|NCT02083653|559572999|FG001|Overall Study|Withdrawal by Subject|1|||
155039713|NCT02083653|559573000|FG002|Overall Study|Withdrawal by Subject|2|||
155039714|NCT02083653|559572998|FG000|Overall Study|Other Events|0|||
155039715|NCT02083653|559572999|FG001|Overall Study|Other Events|2|||
155039716|NCT02083653|559573000|FG002|Overall Study|Other Events|2|||
155039717|NCT02083653|559572998|FG000|Overall Study|Reason Missing|0|||
155039718|NCT02083653|559572999|FG001|Overall Study|Reason Missing|0|||
155039719|NCT02083653|559573000|FG002|Overall Study|Reason Missing|4|||
155039720|NCT00564395|559573005|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
155039721|NCT00564395|559573006|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
155039722|NCT00564395|559573005|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
155039723|NCT00564395|559573006|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
155039724|NCT02054910|559573007|FG000|Overall Study|Lost to Follow-up|4|||
155039725|NCT02054910|559573008|FG001|Overall Study|Lost to Follow-up|1|||
155039726|NCT01625689|559573009|FG000|Overall Study|Migration|2|||
155039727|NCT01625689|559573010|FG001|Overall Study|Migration|1|||
155039728|NCT02208050|559573015|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
155039729|NCT02208050|559573016|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
155039730|NCT03806231|559573019|FG000|Overall Study|Physician Decision|1|||
155039731|NCT03806231|559573020|FG001|Overall Study|Physician Decision|0|||
155039732|NCT03806231|559573019|FG000|Overall Study|Withdrawal by Subject|1|||
155039733|NCT03806231|559573020|FG001|Overall Study|Withdrawal by Subject|0|||
155039734|NCT00467961|559573021|FG000|Overall Study|Technical Failures|5|||
155039735|NCT00467961|559573021|FG000|Overall Study|Disease Progression|2|||
155039736|NCT02429310|559573023|FG000|Overall Study|Lost to Follow-up|1|||
155039737|NCT02429310|559573024|FG001|Overall Study|Lost to Follow-up|2|||
155039738|NCT02429310|559573023|FG000|Overall Study|Protocol Violation|1|||
155039739|NCT02429310|559573024|FG001|Overall Study|Protocol Violation|1|||
155039740|NCT00394433|559573025|FG000|Overall Study|Adverse Event|2|||
155039741|NCT00394433|559573025|FG000|Overall Study|Alternative Therapy|1|||
155039742|NCT03646305|559573026|FG000|Overall Study|Lost to Follow-up|4|||
155039743|NCT03646305|559573027|FG001|Overall Study|Lost to Follow-up|2|||
155039744|NCT03646305|559573028|FG002|Overall Study|Lost to Follow-up|2|||
155039745|NCT03646305|559573029|FG003|Overall Study|Lost to Follow-up|1|||
155039746|NCT03646305|559573026|FG000|Overall Study|Withdrawal by Subject|1|||
155039747|NCT03646305|559573027|FG001|Overall Study|Withdrawal by Subject|0|||
155039748|NCT03646305|559573028|FG002|Overall Study|Withdrawal by Subject|0|||
155039749|NCT03646305|559573029|FG003|Overall Study|Withdrawal by Subject|1|||
155039750|NCT01324570|559573030|FG000|Overall Study|Adverse Event|4|||
155039751|NCT01324570|559573031|FG001|Overall Study|Adverse Event|7|||
155039752|NCT01324570|559573030|FG000|Overall Study|Withdrawal by Subject|0|||
155039753|NCT01324570|559573031|FG001|Overall Study|Withdrawal by Subject|3|||
155039754|NCT01324570|559573030|FG000|Overall Study|Lack of Efficacy|0|||
155039755|NCT01324570|559573031|FG001|Overall Study|Lack of Efficacy|1|||
155039756|NCT01324570|559573030|FG000|Overall Study|Confirmed or suspected diversion|0|||
155039757|NCT01324570|559573031|FG001|Overall Study|Confirmed or suspected diversion|1|||
155039758|NCT01324570|559573030|FG000|Overall Study|Administrative|0|||
155039759|NCT01324570|559573031|FG001|Overall Study|Administrative|2|||
155039760|NCT00207727|559573032|FG000|Overall Study|Withdrawal by Subject|0|||
155039761|NCT00207727|559573033|FG001|Overall Study|Withdrawal by Subject|0|||
155039762|NCT00207727|559573034|FG002|Overall Study|Withdrawal by Subject|0|||
155039763|NCT00207727|559573035|FG003|Overall Study|Withdrawal by Subject|0|||
155039764|NCT00207727|559573036|FG004|Overall Study|Withdrawal by Subject|1|||
155039765|NCT00207727|559573032|FG000|Overall Study|Lost to Follow-up|0|||
155039766|NCT00207727|559573033|FG001|Overall Study|Lost to Follow-up|1|||
155039767|NCT00207727|559573034|FG002|Overall Study|Lost to Follow-up|0|||
155039768|NCT00207727|559573035|FG003|Overall Study|Lost to Follow-up|0|||
155039769|NCT00207727|559573036|FG004|Overall Study|Lost to Follow-up|0|||
155039770|NCT00207727|559573032|FG000|Overall Study|Other|38|||
155039771|NCT00207727|559573033|FG001|Overall Study|Other|41|||
155039772|NCT00207727|559573034|FG002|Overall Study|Other|41|||
155039773|NCT00207727|559573035|FG003|Overall Study|Other|37|||
155039774|NCT00207727|559573036|FG004|Overall Study|Other|33|||
155039775|NCT03611582|559573042|FG000|Overall Study|Adverse Event|26|||
155039776|NCT03611582|559573043|FG001|Overall Study|Adverse Event|6|||
155039777|NCT03611582|559573042|FG000|Overall Study|Protocol Violation|0|||
155039778|NCT03611582|559573043|FG001|Overall Study|Protocol Violation|1|||
155039779|NCT03611582|559573042|FG000|Overall Study|Pregnancy|1|||
155039780|NCT03611582|559573043|FG001|Overall Study|Pregnancy|2|||
155039781|NCT03611582|559573042|FG000|Overall Study|Lack of Efficacy|0|||
155039782|NCT03611582|559573043|FG001|Overall Study|Lack of Efficacy|1|||
155039783|NCT03611582|559573042|FG000|Overall Study|At the discretion of the investigator|1|||
155039784|NCT03611582|559573043|FG001|Overall Study|At the discretion of the investigator|0|||
155039785|NCT03611582|559573042|FG000|Overall Study|Safety concern as judged by the investigator|1|||
155039786|NCT03611582|559573043|FG001|Overall Study|Safety concern as judged by the investigator|2|||
155039787|NCT03611582|559573042|FG000|Overall Study|Withdrawal by Subject|4|||
155039788|NCT03611582|559573043|FG001|Overall Study|Withdrawal by Subject|3|||
155039789|NCT03611582|559573042|FG000|Overall Study|Lost to Follow-up|18|||
155039790|NCT03611582|559573043|FG001|Overall Study|Lost to Follow-up|7|||
155039791|NCT03611582|559573042|FG000|Overall Study|other|17|||
155039792|NCT03611582|559573043|FG001|Overall Study|other|16|||
155039793|NCT01783821|559573044|FG000|Overall Study|Screen Failure|1|||
155039794|NCT01783821|559573045|FG001|Overall Study|Screen Failure|1|||
155039795|NCT02333383|559573046|FG000|Overall Study|Adalimumab discontinuation|21|||
155039796|NCT02333383|559573046|FG000|Overall Study|Lost to Follow-up|15|||
155039797|NCT02333383|559573046|FG000|Overall Study|Withdrawal by Subject|3|||
155039798|NCT02333383|559573046|FG000|Overall Study|Transfer to another hospital|2|||
155152527|NCT03037385|559996844|FG002|Overall Study|Physician Decision|0|||
155039799|NCT00463840|559573048|FG000|Overall Study|Disease progression|7|||
155039800|NCT00463840|559573048|FG000|Overall Study|Withdrawal by Subject|2|||
155039801|NCT00463840|559573048|FG000|Overall Study|Adverse Event|3|||
155039802|NCT00866333|559573054|FG000|Overall Study|Withdrawal of consent|0|||
155039803|NCT00866333|559573055|FG001|Overall Study|Withdrawal of consent|1|||
155039804|NCT00866333|559573056|FG002|Overall Study|Withdrawal of consent|2|||
155039805|NCT00866333|559573054|FG000|Overall Study|Reason not Specified|3|||
155039806|NCT00866333|559573055|FG001|Overall Study|Reason not Specified|1|||
155039807|NCT00866333|559573056|FG002|Overall Study|Reason not Specified|1|||
155039808|NCT00866333|559573054|FG000|Overall Study|Study Terminated by Sponsor|2|||
155039809|NCT00866333|559573055|FG001|Overall Study|Study Terminated by Sponsor|5|||
155039810|NCT00866333|559573056|FG002|Overall Study|Study Terminated by Sponsor|9|||
155039811|NCT02669082|559573057|FG000|Overall Study|Adverse Event|1|||
155039812|NCT04918355|559573061|FG000|Overall Study|no qualifying health encounter|497|||
155039813|NCT04918355|559573062|FG001|Overall Study|no qualifying health encounter|192|||
155039814|NCT04918355|559573063|FG002|Overall Study|no qualifying health encounter|438|||
155039815|NCT04918355|559573064|FG003|Overall Study|no qualifying health encounter|424|||
155039816|NCT04683939|559573065|FG000|Overall Study|Study termination by the sponsor|0|||
155039817|NCT04683939|559573066|FG001|Overall Study|Study termination by the sponsor|1|||
155039818|NCT04683939|559573067|FG002|Overall Study|Study termination by the sponsor|2|||
155039819|NCT04683939|559573068|FG003|Overall Study|Study termination by the sponsor|2|||
155039820|NCT04683939|559573065|FG000|Overall Study|Death|1|||
155039821|NCT04683939|559573066|FG001|Overall Study|Death|1|||
155039822|NCT04683939|559573067|FG002|Overall Study|Death|2|||
155039823|NCT04683939|559573068|FG003|Overall Study|Death|1|||
155039824|NCT04683939|559573065|FG000|Overall Study|Withdrawal by Subject|1|||
155039825|NCT04683939|559573066|FG001|Overall Study|Withdrawal by Subject|0|||
155039826|NCT04683939|559573067|FG002|Overall Study|Withdrawal by Subject|0|||
155039827|NCT04683939|559573068|FG003|Overall Study|Withdrawal by Subject|0|||
155039828|NCT04683939|559573065|FG000|Overall Study|Physician Decision|1|||
155039829|NCT04683939|559573066|FG001|Overall Study|Physician Decision|0|||
155039830|NCT04683939|559573067|FG002|Overall Study|Physician Decision|0|||
155039831|NCT04683939|559573068|FG003|Overall Study|Physician Decision|0|||
155039832|NCT04683939|559573065|FG000|Overall Study|Lost to Follow-up|0|||
155039833|NCT04683939|559573066|FG001|Overall Study|Lost to Follow-up|1|||
155039834|NCT04683939|559573067|FG002|Overall Study|Lost to Follow-up|0|||
155039835|NCT04683939|559573068|FG003|Overall Study|Lost to Follow-up|0|||
155039836|NCT04852276|559573069|FG000|Overall Study|Death|2|||
155039837|NCT04852276|559573070|FG001|Overall Study|Death|0|||
155039838|NCT04852276|559573069|FG000|Overall Study|Lost to Follow-up|15|||
155039839|NCT04852276|559573070|FG001|Overall Study|Lost to Follow-up|9|||
155039840|NCT04852276|559573069|FG000|Overall Study|Withdrawal by Subject|26|||
155039841|NCT04852276|559573070|FG001|Overall Study|Withdrawal by Subject|6|||
155039842|NCT01744483|559575407|FG000|Overall Study|Death|9|||
155039843|NCT01744483|559575408|FG001|Overall Study|Death|4|||
155039844|NCT01744483|559575409|FG002|Overall Study|Death|11|||
155039845|NCT01744483|559575407|FG000|Overall Study|Lost to Follow-up|8|||
155039846|NCT01744483|559575408|FG001|Overall Study|Lost to Follow-up|9|||
155039847|NCT01744483|559575409|FG002|Overall Study|Lost to Follow-up|11|||
155039848|NCT01744483|559575407|FG000|Overall Study|Protocol Violation|1|||
155039849|NCT01744483|559575408|FG001|Overall Study|Protocol Violation|2|||
155039850|NCT01744483|559575409|FG002|Overall Study|Protocol Violation|1|||
155039851|NCT01744483|559575407|FG000|Overall Study|Withdrawal by Subject|4|||
155039852|NCT01744483|559575408|FG001|Overall Study|Withdrawal by Subject|6|||
155039853|NCT01744483|559575409|FG002|Overall Study|Withdrawal by Subject|2|||
155039854|NCT01744483|559575407|FG000|Overall Study|No ICU Admit|5|||
155039855|NCT01744483|559575408|FG001|Overall Study|No ICU Admit|1|||
155039856|NCT01744483|559575409|FG002|Overall Study|No ICU Admit|2|||
155039857|NCT01744483|559575407|FG000|Overall Study|Routed to OSH|2|||
155039858|NCT01744483|559575408|FG001|Overall Study|Routed to OSH|0|||
155039859|NCT01744483|559575409|FG002|Overall Study|Routed to OSH|1|||
155039860|NCT03915626|559575410|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
155039861|NCT01754766|559575413|FG000|Overall Study|Personal reasons|1|||
155039862|NCT01754766|559575414|FG001|Overall Study|Personal reasons|1|||
155039863|NCT01754766|559575415|FG002|Overall Study|Personal reasons|0|||
155039864|NCT02469168|559575417|FG000|Overall Study|Trial closed|1|||
155039865|NCT02469168|559575418|FG001|Overall Study|Trial closed|0|||
155039866|NCT01533688|559575419|FG000|Overall Study|Withdrawal by Subject|5|||
155039867|NCT01533688|559575420|FG001|Overall Study|Withdrawal by Subject|4|||
155039868|NCT01533688|559575421|FG002|Overall Study|Withdrawal by Subject|3|||
155039869|NCT01533688|559575419|FG000|Overall Study|Medically unstable|1|||
155039870|NCT01533688|559575420|FG001|Overall Study|Medically unstable|3|||
155039871|NCT01533688|559575421|FG002|Overall Study|Medically unstable|3|||
155039872|NCT01533688|559575419|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
155039873|NCT01533688|559575420|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
155039874|NCT01533688|559575421|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
155039875|NCT02335346|559575426|FG000|Overall Study|Adverse Event|11|||
155039876|NCT02335346|559575426|FG000|Overall Study|Withdrawal by Subject|1|||
155039877|NCT03300050|559575427|FG000|Overall Study|Lost to Follow-up|2|||
155039878|NCT03300050|559575428|FG001|Overall Study|Lost to Follow-up|1|||
155152528|NCT03037385|559996845|FG003|Overall Study|Physician Decision|0|||
155039879|NCT03300050|559575429|FG002|Overall Study|Lost to Follow-up|0|||
155039880|NCT03300050|559575430|FG003|Overall Study|Lost to Follow-up|0|||
155039881|NCT03300050|559575431|FG004|Overall Study|Lost to Follow-up|1|||
155039882|NCT03300050|559575427|FG000|Overall Study|Withdrawal by Subject|1|||
155039883|NCT03300050|559575428|FG001|Overall Study|Withdrawal by Subject|1|||
155039884|NCT03300050|559575429|FG002|Overall Study|Withdrawal by Subject|1|||
155039885|NCT03300050|559575430|FG003|Overall Study|Withdrawal by Subject|0|||
155039886|NCT03300050|559575431|FG004|Overall Study|Withdrawal by Subject|0|||
155039887|NCT03300050|559575427|FG000|Overall Study|Death|0|||
155039888|NCT03300050|559575428|FG001|Overall Study|Death|0|||
155039889|NCT03300050|559575429|FG002|Overall Study|Death|1|||
155039890|NCT03300050|559575430|FG003|Overall Study|Death|0|||
155039891|NCT03300050|559575431|FG004|Overall Study|Death|0|||
155039892|NCT03300050|559575427|FG000|Overall Study|Not Eligible at Randomization|0|||
155039893|NCT03300050|559575428|FG001|Overall Study|Not Eligible at Randomization|0|||
155039894|NCT03300050|559575429|FG002|Overall Study|Not Eligible at Randomization|1|||
155039895|NCT03300050|559575430|FG003|Overall Study|Not Eligible at Randomization|1|||
155039896|NCT03300050|559575431|FG004|Overall Study|Not Eligible at Randomization|0|||
155039897|NCT01214668|559575432|FG000|Overall Study|Adverse Event|0|||
155039898|NCT01214668|559575433|FG001|Overall Study|Adverse Event|1|||
155039899|NCT01214668|559575434|FG002|Overall Study|Adverse Event|0|||
155039900|NCT01214668|559575435|FG003|Overall Study|Adverse Event|2|||
155039901|NCT01214668|559575436|FG004|Overall Study|Adverse Event|1|||
155039902|NCT01214668|559575437|FG005|Overall Study|Adverse Event|1|||
155039903|NCT01214668|559575432|FG000|Overall Study|Death|0|||
155039904|NCT01214668|559575433|FG001|Overall Study|Death|0|||
155039905|NCT01214668|559575434|FG002|Overall Study|Death|1|||
155039906|NCT01214668|559575435|FG003|Overall Study|Death|0|||
155039907|NCT01214668|559575436|FG004|Overall Study|Death|0|||
155039908|NCT01214668|559575437|FG005|Overall Study|Death|0|||
155039909|NCT01214668|559575432|FG000|Overall Study|Progressive Disease|4|||
155039910|NCT01214668|559575433|FG001|Overall Study|Progressive Disease|2|||
155039911|NCT01214668|559575434|FG002|Overall Study|Progressive Disease|5|||
155039912|NCT01214668|559575435|FG003|Overall Study|Progressive Disease|4|||
155039913|NCT01214668|559575436|FG004|Overall Study|Progressive Disease|4|||
155039914|NCT01214668|559575437|FG005|Overall Study|Progressive Disease|5|||
155039915|NCT01214668|559575432|FG000|Overall Study|Withdrawal by Subject|0|||
155039916|NCT01214668|559575433|FG001|Overall Study|Withdrawal by Subject|0|||
155039917|NCT01214668|559575434|FG002|Overall Study|Withdrawal by Subject|0|||
155039918|NCT01214668|559575435|FG003|Overall Study|Withdrawal by Subject|0|||
155039919|NCT01214668|559575436|FG004|Overall Study|Withdrawal by Subject|1|||
155039920|NCT01214668|559575437|FG005|Overall Study|Withdrawal by Subject|0|||
155039921|NCT02907619|559575438|FG000|Overall Study|Study terminated by sponsor|18|||
155039922|NCT02907619|559575439|FG001|Overall Study|Study terminated by sponsor|18|||
155039923|NCT02907619|559575440|FG002|Overall Study|Study terminated by sponsor|19|||
155039924|NCT02907619|559575438|FG000|Overall Study|Death|0|||
155039925|NCT02907619|559575439|FG001|Overall Study|Death|0|||
155039926|NCT02907619|559575440|FG002|Overall Study|Death|1|||
155039927|NCT02907619|559575438|FG000|Overall Study|Withdrawal by Subject|1|||
155039928|NCT02907619|559575439|FG001|Overall Study|Withdrawal by Subject|1|||
155039929|NCT02907619|559575440|FG002|Overall Study|Withdrawal by Subject|0|||
155039930|NCT02907619|559575438|FG000|Overall Study|Other|0|||
155039931|NCT02907619|559575439|FG001|Overall Study|Other|1|||
155039932|NCT02907619|559575440|FG002|Overall Study|Other|0|||
155039933|NCT03326518|559575441|FG000|Overall Study|Protocol Violation|1|||
155039934|NCT03326518|559575442|FG001|Overall Study|Protocol Violation|0|||
155039935|NCT03326518|559575443|FG002|Overall Study|Protocol Violation|0|||
155039936|NCT03326518|559575441|FG000|Overall Study|Withdrawal by Subject|1|||
155039937|NCT03326518|559575442|FG001|Overall Study|Withdrawal by Subject|0|||
155039938|NCT03326518|559575443|FG002|Overall Study|Withdrawal by Subject|0|||
155039939|NCT03326518|559575441|FG000|Overall Study|Lost to Follow-up|1|||
155039940|NCT03326518|559575442|FG001|Overall Study|Lost to Follow-up|0|||
155039941|NCT03326518|559575443|FG002|Overall Study|Lost to Follow-up|1|||
155039942|NCT01375374|559575444|FG000|Overall Study|Adverse Event|1|||
155039943|NCT02065518|559575445|FG000|Overall Study|Lost to Follow-up|3|||
155039944|NCT02065518|559575446|FG001|Overall Study|Lost to Follow-up|4|||
155039945|NCT02065518|559575447|FG002|Overall Study|Lost to Follow-up|0|||
155039946|NCT02065518|559575448|FG003|Overall Study|Lost to Follow-up|3|||
155039947|NCT02065518|559575445|FG000|Overall Study|Withdrawal by Subject|3|||
155039948|NCT02065518|559575446|FG001|Overall Study|Withdrawal by Subject|4|||
155039949|NCT02065518|559575447|FG002|Overall Study|Withdrawal by Subject|9|||
155039950|NCT02065518|559575448|FG003|Overall Study|Withdrawal by Subject|2|||
155039951|NCT01066663|559575449|FG000|Overall Study|Adverse Event|0|||
155039952|NCT01066663|559575450|FG001|Overall Study|Adverse Event|0|||
155039953|NCT01066663|559575451|FG002|Overall Study|Adverse Event|1|||
155039954|NCT00571103|559575452|FG000|Overall Study|Withdrawal by Subject|1|||
155039955|NCT00571103|559575452|FG000|Overall Study|Lost to Follow-up|1|||
155039956|NCT00564278|559575455|FG000|Overall Study|Lost to Follow-up|35|||
155039957|NCT00564278|559575456|FG001|Overall Study|Lost to Follow-up|33|||
155039958|NCT00564278|559575455|FG000|Overall Study|Physician Decision|1|||
155039959|NCT00564278|559575456|FG001|Overall Study|Physician Decision|2|||
155039960|NCT00564278|559575455|FG000|Overall Study|Withdrawal by Subject|11|||
155039961|NCT00564278|559575456|FG001|Overall Study|Withdrawal by Subject|7|||
155039962|NCT00560703|559575457|FG000|Overall Study|Adverse Event|0|||
155039963|NCT00560703|559575458|FG001|Overall Study|Adverse Event|2|||
155039964|NCT00560703|559575457|FG000|Overall Study|Protocol Violation|0|||
155039965|NCT00560703|559575458|FG001|Overall Study|Protocol Violation|2|||
155039966|NCT00560703|559575457|FG000|Overall Study|Withdrawal by Subject|0|||
155039967|NCT00560703|559575458|FG001|Overall Study|Withdrawal by Subject|1|||
155039968|NCT00560703|559575457|FG000|Overall Study|non-compliance|0|||
155039969|NCT00560703|559575458|FG001|Overall Study|non-compliance|1|||
155039970|NCT06439095|559575459|FG000|Overall Study|Lost to Follow-up|2|||
155039971|NCT02368886|559575460|FG000|Overall Study|Cancel|1|||
155039972|NCT02368886|559575461|FG001|Overall Study|Cancel|1|||
155039973|NCT02368886|559575462|FG002|Overall Study|Cancel|1|||
155039974|NCT02368886|559575463|FG003|Overall Study|Cancel|3|||
155039975|NCT02368886|559575460|FG000|Overall Study|Ineligible|0|||
155039976|NCT02368886|559575461|FG001|Overall Study|Ineligible|0|||
155039977|NCT02368886|559575462|FG002|Overall Study|Ineligible|0|||
155039978|NCT02368886|559575463|FG003|Overall Study|Ineligible|1|||
155039979|NCT03484403|559575465|FG000|Overall Study|Withdrawal by Subject|6|||
155039980|NCT03484403|559575466|FG001|Overall Study|Withdrawal by Subject|4|||
155039981|NCT04278924|559575467|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
155039982|NCT04278924|559575468|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
155039983|NCT04278924|559575469|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155039984|NCT04278924|559575470|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
155039985|NCT04278924|559575471|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155039986|NCT04278924|559575472|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155039987|NCT04278924|559575473|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
155039988|NCT04278924|559575467|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
155039989|NCT04278924|559575468|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
155039990|NCT04278924|559575469|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
155039991|NCT04278924|559575470|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
155039992|NCT04278924|559575471|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
155039993|NCT04278924|559575472|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
155039994|NCT04278924|559575473|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
155039995|NCT04847232|559575474|FG000|Overall Study|Death|123|||
155039996|NCT04847232|559575475|FG001|Overall Study|Death|115|||
155039997|NCT04847232|559575474|FG000|Overall Study|Lost to Follow-up|3|||
155039998|NCT04847232|559575475|FG001|Overall Study|Lost to Follow-up|10|||
155039999|NCT04847232|559575474|FG000|Overall Study|Withdrawal by Subject|73|||
155040000|NCT04847232|559575475|FG001|Overall Study|Withdrawal by Subject|101|||
155040001|NCT04847232|559575474|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
155040002|NCT04847232|559575475|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
155040003|NCT02476916|559575480|FG000|Core Period|Adverse Event|2|||
155040004|NCT02476916|559575481|FG001|Core Period|Adverse Event|2|||
155040005|NCT02476916|559575480|FG000|Core Period|Investigator decision|1|||
155040006|NCT02476916|559575481|FG001|Core Period|Investigator decision|1|||
155040007|NCT02476916|559575480|FG000|Core Period|Withdrawal by Subject|3|||
155040008|NCT02476916|559575481|FG001|Core Period|Withdrawal by Subject|0|||
155040009|NCT02476916|559575480|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
155040010|NCT02476916|559575481|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
155040011|NCT02476916|559575480|FG000|Extension Period|On Treatment|12|||
155040012|NCT02476916|559575481|FG001|Extension Period|On Treatment|17|||
155040013|NCT06010732|559575483|FG000|Crossover Period 1|Protocol Violation|0|||
155040014|NCT06010732|559575484|FG001|Crossover Period 1|Protocol Violation|0|||
155040015|NCT06010732|559575485|FG002|Crossover Period 1|Protocol Violation|1|||
155040016|NCT06010732|559575486|FG003|Crossover Period 1|Protocol Violation|0|||
155040017|NCT06010732|559575487|FG004|Crossover Period 1|Protocol Violation|1|||
155040018|NCT06010732|559575488|FG005|Crossover Period 1|Protocol Violation|0|||
155040019|NCT06010732|559575483|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155040020|NCT06010732|559575484|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
155040021|NCT06010732|559575485|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155040022|NCT06010732|559575486|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155040023|NCT06010732|559575487|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155040024|NCT06010732|559575488|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
155040025|NCT06010732|559575483|FG000|Crossover Period 2|Adverse Event|0|||
155040026|NCT06010732|559575484|FG001|Crossover Period 2|Adverse Event|1|||
155040027|NCT06010732|559575485|FG002|Crossover Period 2|Adverse Event|0|||
155040028|NCT06010732|559575486|FG003|Crossover Period 2|Adverse Event|0|||
155040029|NCT06010732|559575487|FG004|Crossover Period 2|Adverse Event|0|||
155040030|NCT06010732|559575488|FG005|Crossover Period 2|Adverse Event|0|||
155040031|NCT06010732|559575483|FG000|Crossover Period 2|broken denture|0|||
155040032|NCT06010732|559575484|FG001|Crossover Period 2|broken denture|0|||
155040033|NCT06010732|559575485|FG002|Crossover Period 2|broken denture|1|||
155040034|NCT06010732|559575486|FG003|Crossover Period 2|broken denture|0|||
155040035|NCT06010732|559575487|FG004|Crossover Period 2|broken denture|0|||
155040036|NCT06010732|559575488|FG005|Crossover Period 2|broken denture|0|||
155040037|NCT00715520|559575490|FG000|Overall Study|Screen failure|8|||
155040038|NCT00715520|559575491|FG001|Overall Study|Screen failure|1|||
155040039|NCT00715520|559575492|FG002|Overall Study|Screen failure|1|||
155040040|NCT00715520|559575490|FG000|Overall Study|Withdrawal by Subject|2|||
155040041|NCT00715520|559575491|FG001|Overall Study|Withdrawal by Subject|0|||
155040042|NCT00715520|559575492|FG002|Overall Study|Withdrawal by Subject|1|||
155040043|NCT04942210|559575496|FG000|Overall Study|Adverse Event|0|||
155040044|NCT04942210|559575497|FG001|Overall Study|Adverse Event|1|||
155040045|NCT04942210|559575496|FG000|Overall Study|Protocol Deviation|4|||
155040046|NCT04942210|559575497|FG001|Overall Study|Protocol Deviation|1|||
155040047|NCT04942210|559575496|FG000|Overall Study|Withdrawal by Subject|5|||
155040048|NCT04942210|559575497|FG001|Overall Study|Withdrawal by Subject|2|||
155040049|NCT04942210|559575496|FG000|Overall Study|Lost to Follow-up|16|||
155040050|NCT04942210|559575497|FG001|Overall Study|Lost to Follow-up|7|||
155040051|NCT04942210|559575496|FG000|Overall Study|Ongoing at the time of DBL date|60|||
155040052|NCT04942210|559575497|FG001|Overall Study|Ongoing at the time of DBL date|25|||
155040053|NCT04942210|559575496|FG000|Overall Study|Randomized but did not receive vaccination|3|||
155040054|NCT04942210|559575497|FG001|Overall Study|Randomized but did not receive vaccination|0|||
155040055|NCT04122625|559575500|FG000|Part A (up to 2.92 Years)|Death|2|||
155040056|NCT04122625|559575501|FG001|Part A (up to 2.92 Years)|Death|4|||
155040057|NCT04122625|559575502|FG002|Part A (up to 2.92 Years)|Death|0|||
155040058|NCT04122625|559575503|FG003|Part A (up to 2.92 Years)|Death|0|||
155040059|NCT04122625|559575504|FG004|Part A (up to 2.92 Years)|Death|0|||
155040060|NCT04122625|559575505|FG005|Part A (up to 2.92 Years)|Death|0|||
155040061|NCT04122625|559575500|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
155040062|NCT04122625|559575501|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
155040063|NCT04122625|559575502|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
155040064|NCT04122625|559575503|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
155040065|NCT04122625|559575504|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
155040066|NCT04122625|559575505|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
155040067|NCT04122625|559575500|FG000|Part B (up to 2.33 Years)|Death|0|||
155040068|NCT04122625|559575501|FG001|Part B (up to 2.33 Years)|Death|0|||
155040069|NCT04122625|559575502|FG002|Part B (up to 2.33 Years)|Death|5|||
155040070|NCT04122625|559575503|FG003|Part B (up to 2.33 Years)|Death|7|||
155040071|NCT04122625|559575504|FG004|Part B (up to 2.33 Years)|Death|6|||
155040072|NCT04122625|559575505|FG005|Part B (up to 2.33 Years)|Death|7|||
155040073|NCT04348500|559575506|FG000|Overall Study|Death|2|||
155040074|NCT04348500|559575507|FG001|Overall Study|Death|2|||
155040075|NCT04348500|559575506|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
155040076|NCT04348500|559575507|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
155040077|NCT02776670|559575508|FG000|Overall Study|Adverse Event|0|||
155040078|NCT02776670|559575509|FG001|Overall Study|Adverse Event|2|||
155040079|NCT02776670|559575508|FG000|Overall Study|Protocol Violation|0|||
155040080|NCT02776670|559575509|FG001|Overall Study|Protocol Violation|2|||
155040081|NCT02776670|559575508|FG000|Overall Study|Withdrawal by Subject|0|||
155040082|NCT02776670|559575509|FG001|Overall Study|Withdrawal by Subject|1|||
155040083|NCT02776670|559575508|FG000|Overall Study|Other - Reason not given|0|||
155040084|NCT02776670|559575509|FG001|Overall Study|Other - Reason not given|1|||
155040085|NCT03699540|559575510|FG000|Overall Study|Lost to Follow-up|1|||
155040086|NCT02697591|559575515|FG000|Overall Study|Lost to Follow-up|0|||
155040087|NCT02697591|559575516|FG001|Overall Study|Lost to Follow-up|0|||
155040088|NCT02697591|559575517|FG002|Overall Study|Lost to Follow-up|0|||
155040089|NCT02697591|559575518|FG003|Overall Study|Lost to Follow-up|0|||
155040090|NCT02697591|559575519|FG004|Overall Study|Lost to Follow-up|0|||
155040091|NCT02697591|559575520|FG005|Overall Study|Lost to Follow-up|1|||
155040092|NCT02697591|559575521|FG006|Overall Study|Lost to Follow-up|1|||
155040093|NCT02697591|559575522|FG007|Overall Study|Lost to Follow-up|0|||
155040094|NCT02697591|559575523|FG008|Overall Study|Lost to Follow-up|0|||
155040095|NCT02697591|559575524|FG009|Overall Study|Lost to Follow-up|1|||
155040096|NCT02697591|559575515|FG000|Overall Study|Withdrawal by Subject|1|||
155040097|NCT02697591|559575516|FG001|Overall Study|Withdrawal by Subject|1|||
155040098|NCT02697591|559575517|FG002|Overall Study|Withdrawal by Subject|2|||
155040099|NCT02697591|559575518|FG003|Overall Study|Withdrawal by Subject|1|||
155040100|NCT02697591|559575519|FG004|Overall Study|Withdrawal by Subject|7|||
155040101|NCT02697591|559575520|FG005|Overall Study|Withdrawal by Subject|6|||
155040102|NCT02697591|559575521|FG006|Overall Study|Withdrawal by Subject|9|||
155040103|NCT02697591|559575522|FG007|Overall Study|Withdrawal by Subject|1|||
155040104|NCT02697591|559575523|FG008|Overall Study|Withdrawal by Subject|6|||
155040105|NCT02697591|559575524|FG009|Overall Study|Withdrawal by Subject|10|||
155040106|NCT02697591|559575515|FG000|Overall Study|Physician Decision|1|||
155040107|NCT02697591|559575516|FG001|Overall Study|Physician Decision|0|||
155040108|NCT02697591|559575517|FG002|Overall Study|Physician Decision|0|||
155040109|NCT02697591|559575518|FG003|Overall Study|Physician Decision|0|||
155040110|NCT02697591|559575519|FG004|Overall Study|Physician Decision|1|||
155040111|NCT02697591|559575520|FG005|Overall Study|Physician Decision|2|||
155040112|NCT02697591|559575521|FG006|Overall Study|Physician Decision|0|||
155040113|NCT02697591|559575522|FG007|Overall Study|Physician Decision|0|||
155040114|NCT02697591|559575523|FG008|Overall Study|Physician Decision|1|||
155040115|NCT02697591|559575524|FG009|Overall Study|Physician Decision|1|||
155040116|NCT02697591|559575515|FG000|Overall Study|Death|2|||
155040117|NCT02697591|559575516|FG001|Overall Study|Death|3|||
155040118|NCT02697591|559575517|FG002|Overall Study|Death|1|||
155040119|NCT02697591|559575518|FG003|Overall Study|Death|1|||
155040120|NCT02697591|559575519|FG004|Overall Study|Death|4|||
155040121|NCT02697591|559575520|FG005|Overall Study|Death|5|||
155040122|NCT02697591|559575521|FG006|Overall Study|Death|3|||
155040123|NCT02697591|559575522|FG007|Overall Study|Death|1|||
155040124|NCT02697591|559575523|FG008|Overall Study|Death|1|||
155040125|NCT02697591|559575524|FG009|Overall Study|Death|5|||
155040126|NCT02697591|559575515|FG000|Overall Study|Reason not Specified|0|||
155040127|NCT02697591|559575516|FG001|Overall Study|Reason not Specified|0|||
155040128|NCT02697591|559575517|FG002|Overall Study|Reason not Specified|0|||
155040129|NCT02697591|559575518|FG003|Overall Study|Reason not Specified|1|||
155040130|NCT02697591|559575519|FG004|Overall Study|Reason not Specified|1|||
155040131|NCT02697591|559575520|FG005|Overall Study|Reason not Specified|2|||
155040132|NCT02697591|559575521|FG006|Overall Study|Reason not Specified|3|||
155040133|NCT02697591|559575522|FG007|Overall Study|Reason not Specified|1|||
155040134|NCT02697591|559575523|FG008|Overall Study|Reason not Specified|1|||
155040135|NCT02697591|559575524|FG009|Overall Study|Reason not Specified|3|||
155040136|NCT02722746|559575525|FG000|Overall Study|Withdrawal by Subject|0|||
155040137|NCT02722746|559575526|FG001|Overall Study|Withdrawal by Subject|1|||
155040138|NCT02722746|559575527|FG002|Overall Study|Withdrawal by Subject|0|||
155040139|NCT02722746|559575525|FG000|Overall Study|Protocol Violation|8|||
155040140|NCT02722746|559575526|FG001|Overall Study|Protocol Violation|4|||
155040141|NCT02722746|559575527|FG002|Overall Study|Protocol Violation|6|||
155040142|NCT02636699|559575528|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
155040143|NCT02636699|559575529|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
155040144|NCT02636699|559575530|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
155040145|NCT02636699|559575528|FG000|Screening Period|Withdrawal by Subject|0|||
155040146|NCT02636699|559575529|FG001|Screening Period|Withdrawal by Subject|0|||
155040147|NCT02636699|559575530|FG002|Screening Period|Withdrawal by Subject|23|||
155040148|NCT02636699|559575528|FG000|Screening Period|Adverse Event|0|||
155040149|NCT02636699|559575529|FG001|Screening Period|Adverse Event|0|||
155040150|NCT02636699|559575530|FG002|Screening Period|Adverse Event|1|||
155040151|NCT02636699|559575528|FG000|Screening Period|Other not specified|0|||
155040152|NCT02636699|559575529|FG001|Screening Period|Other not specified|0|||
155040153|NCT02636699|559575530|FG002|Screening Period|Other not specified|3|||
155040154|NCT02636699|559575528|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
155040155|NCT02636699|559575529|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
155040156|NCT02636699|559575530|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
155040157|NCT02636699|559575528|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
155040158|NCT02636699|559575529|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
155040159|NCT02636699|559575530|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
155040160|NCT02636699|559575528|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
155040161|NCT02636699|559575529|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
155040162|NCT02636699|559575530|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
155040163|NCT02636699|559575528|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
155040164|NCT02636699|559575529|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
155040165|NCT02636699|559575530|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
155040166|NCT02636699|559575528|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
155040167|NCT02636699|559575529|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
155040168|NCT02636699|559575530|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
155040169|NCT02636699|559575528|FG000|Treatment and Follow-up Periods|Other|3|||
155040170|NCT02636699|559575529|FG001|Treatment and Follow-up Periods|Other|1|||
155040171|NCT02636699|559575530|FG002|Treatment and Follow-up Periods|Other|0|||
155040172|NCT00624832|559575531|FG000|Overall Study|Adverse Event|0|||
155040173|NCT00624832|559575532|FG001|Overall Study|Adverse Event|1|||
155040174|NCT00624832|559575533|FG002|Overall Study|Adverse Event|0|||
155040175|NCT00624832|559575534|FG003|Overall Study|Adverse Event|1|||
155040176|NCT00624832|559575531|FG000|Overall Study|Abnormal Laboratory Value|2|||
155040177|NCT00624832|559575532|FG001|Overall Study|Abnormal Laboratory Value|0|||
155040178|NCT00624832|559575533|FG002|Overall Study|Abnormal Laboratory Value|0|||
155040179|NCT00624832|559575534|FG003|Overall Study|Abnormal Laboratory Value|0|||
155040180|NCT01939223|559575535|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
155040181|NCT01939223|559575536|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
155040182|NCT01939223|559575535|FG000|Overall Study|Disease recurrence (radiological)|1|||
155040183|NCT01939223|559575536|FG001|Overall Study|Disease recurrence (radiological)|3|||
155040184|NCT01939223|559575535|FG000|Overall Study|Study stopped by Sponsor|5|||
155152529|NCT03037385|559996846|FG004|Overall Study|Physician Decision|0|||
155040185|NCT01939223|559575536|FG001|Overall Study|Study stopped by Sponsor|7|||
155040186|NCT01939223|559575535|FG000|Overall Study|Withdrawal by Subject|6|||
155040187|NCT01939223|559575536|FG001|Overall Study|Withdrawal by Subject|0|||
155040188|NCT04379700|559575537|FG000|Overall Study|Withdrawal by Subject|10|||
155040189|NCT04379700|559575537|FG000|Overall Study|Screen Fail|4|||
155040190|NCT04379700|559575537|FG000|Overall Study|Lost to Follow-up|3|||
155040191|NCT03624569|559575539|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155040192|NCT03624569|559575540|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
155040193|NCT03624569|559575539|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
155040194|NCT03624569|559575540|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
155040195|NCT01618916|559575543|FG000|Overall Study|Adverse Event|1|||
155040196|NCT01618916|559575544|FG001|Overall Study|Adverse Event|0|||
155040197|NCT01618916|559575545|FG002|Overall Study|Adverse Event|0|||
155040198|NCT01618916|559575546|FG003|Overall Study|Adverse Event|0|||
155040199|NCT01618916|559575547|FG004|Overall Study|Adverse Event|0|||
155040200|NCT01618916|559575548|FG005|Overall Study|Adverse Event|0|||
155040201|NCT01618916|559575543|FG000|Overall Study|Withdrawal by Subject|0|||
155040202|NCT01618916|559575544|FG001|Overall Study|Withdrawal by Subject|1|||
155040203|NCT01618916|559575545|FG002|Overall Study|Withdrawal by Subject|1|||
155040204|NCT01618916|559575546|FG003|Overall Study|Withdrawal by Subject|0|||
155040205|NCT01618916|559575547|FG004|Overall Study|Withdrawal by Subject|1|||
155040206|NCT01618916|559575548|FG005|Overall Study|Withdrawal by Subject|0|||
155040207|NCT01618916|559575543|FG000|Overall Study|Lost to Follow-up|1|||
155040208|NCT01618916|559575544|FG001|Overall Study|Lost to Follow-up|0|||
155040209|NCT01618916|559575545|FG002|Overall Study|Lost to Follow-up|0|||
155040210|NCT01618916|559575546|FG003|Overall Study|Lost to Follow-up|2|||
155040211|NCT01618916|559575547|FG004|Overall Study|Lost to Follow-up|0|||
155040212|NCT01618916|559575548|FG005|Overall Study|Lost to Follow-up|0|||
155040213|NCT03004924|559575549|FG000|Overall Study|Adverse Event|6|||
155040214|NCT03004924|559575550|FG001|Overall Study|Adverse Event|5|||
155040215|NCT03004924|559575551|FG002|Overall Study|Adverse Event|10|||
155040216|NCT03004924|559575549|FG000|Overall Study|Protocol Violation|4|||
155040217|NCT03004924|559575550|FG001|Overall Study|Protocol Violation|0|||
155040218|NCT03004924|559575551|FG002|Overall Study|Protocol Violation|1|||
155040219|NCT03004924|559575549|FG000|Overall Study|Withdrawal by Subject|5|||
155040220|NCT03004924|559575550|FG001|Overall Study|Withdrawal by Subject|3|||
155040221|NCT03004924|559575551|FG002|Overall Study|Withdrawal by Subject|5|||
155040222|NCT03004924|559575549|FG000|Overall Study|Lost to Follow-up|6|||
155040223|NCT03004924|559575550|FG001|Overall Study|Lost to Follow-up|1|||
155040224|NCT03004924|559575551|FG002|Overall Study|Lost to Follow-up|4|||
155040225|NCT03004924|559575549|FG000|Overall Study|Lack of Efficacy|2|||
155040226|NCT03004924|559575550|FG001|Overall Study|Lack of Efficacy|4|||
155040227|NCT03004924|559575551|FG002|Overall Study|Lack of Efficacy|2|||
155040228|NCT03004924|559575549|FG000|Overall Study|Physician Decision|1|||
155040229|NCT03004924|559575550|FG001|Overall Study|Physician Decision|0|||
155040230|NCT03004924|559575551|FG002|Overall Study|Physician Decision|1|||
155040231|NCT03004924|559575549|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155040232|NCT03004924|559575550|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155040233|NCT03004924|559575551|FG002|Overall Study|Withdrawal by parent/guardian|2|||
155040234|NCT03004924|559575549|FG000|Overall Study|Screen Failure|1|||
155040235|NCT03004924|559575550|FG001|Overall Study|Screen Failure|0|||
155040236|NCT03004924|559575551|FG002|Overall Study|Screen Failure|0|||
155040237|NCT03004924|559575549|FG000|Overall Study|Pregnancy|0|||
155040238|NCT03004924|559575550|FG001|Overall Study|Pregnancy|1|||
155040239|NCT03004924|559575551|FG002|Overall Study|Pregnancy|0|||
155040240|NCT03004924|559575549|FG000|Overall Study|Terminated by Sponsor|0|||
155040241|NCT03004924|559575550|FG001|Overall Study|Terminated by Sponsor|0|||
155040242|NCT03004924|559575551|FG002|Overall Study|Terminated by Sponsor|1|||
155040243|NCT03004924|559575549|FG000|Overall Study|Missed Study Visit|0|||
155040244|NCT03004924|559575550|FG001|Overall Study|Missed Study Visit|0|||
155040245|NCT03004924|559575551|FG002|Overall Study|Missed Study Visit|2|||
155040246|NCT03004924|559575549|FG000|Overall Study|HSV1 Positive|1|||
155040247|NCT03004924|559575550|FG001|Overall Study|HSV1 Positive|0|||
155040248|NCT03004924|559575551|FG002|Overall Study|HSV1 Positive|0|||
155040249|NCT01370616|559575557|FG000|Overall Study|Adverse Event|11|||
155040250|NCT01370616|559575558|FG001|Overall Study|Adverse Event|16|||
155040251|NCT01370616|559575557|FG000|Overall Study|Death|1|||
155040252|NCT01370616|559575558|FG001|Overall Study|Death|0|||
155040253|NCT01370616|559575557|FG000|Overall Study|Lack of Efficacy|6|||
155040254|NCT01370616|559575558|FG001|Overall Study|Lack of Efficacy|2|||
155040255|NCT01370616|559575557|FG000|Overall Study|Lost to Follow-up|0|||
155040256|NCT01370616|559575558|FG001|Overall Study|Lost to Follow-up|3|||
155040257|NCT01370616|559575557|FG000|Overall Study|Physician Decision|6|||
155040258|NCT01370616|559575558|FG001|Overall Study|Physician Decision|6|||
155040259|NCT01370616|559575557|FG000|Overall Study|Progressive Disease|0|||
155040260|NCT01370616|559575558|FG001|Overall Study|Progressive Disease|1|||
155040261|NCT01370616|559575557|FG000|Overall Study|Recovery|1|||
155040262|NCT01370616|559575558|FG001|Overall Study|Recovery|0|||
155040263|NCT01370616|559575557|FG000|Overall Study|Technical Problems|3|||
155040264|NCT01370616|559575558|FG001|Overall Study|Technical Problems|5|||
155040265|NCT01370616|559575557|FG000|Overall Study|Withdrawal by Subject|34|||
155040266|NCT01370616|559575558|FG001|Overall Study|Withdrawal by Subject|34|||
155040267|NCT00090584|559575562|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
155040268|NCT00090584|559575563|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
155040269|NCT00090584|559575562|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
155040270|NCT00090584|559575563|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
155040271|NCT02536781|559575565|FG000|Overall Study|Lost to Follow-up|2|||
155040272|NCT02536781|559575566|FG001|Overall Study|Lost to Follow-up|0|||
155040273|NCT03423147|559575567|FG000|Overall Study|Lost to Follow-up|5|||
155040274|NCT03423147|559575568|FG001|Overall Study|Lost to Follow-up|8|||
155040275|NCT03423147|559575567|FG000|Overall Study|Withdrawal by Subject|1|||
155040276|NCT03423147|559575568|FG001|Overall Study|Withdrawal by Subject|0|||
155040277|NCT03423147|559575567|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
155040278|NCT03423147|559575568|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
155040279|NCT03423147|559575567|FG000|Overall Study|Age < 18|1|||
155040280|NCT03423147|559575568|FG001|Overall Study|Age < 18|0|||
155040281|NCT03423147|559575567|FG000|Overall Study|No Trial of Labor|0|||
155040282|NCT03423147|559575568|FG001|Overall Study|No Trial of Labor|1|||
155040283|NCT01048099|559575569|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
155040284|NCT01048099|559575569|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
155040285|NCT00508157|559575570|FG000|Overall Study|Adverse Event|0|||
155040286|NCT00508157|559575571|FG001|Overall Study|Adverse Event|1|||
155040287|NCT00508157|559575570|FG000|Overall Study|Subject Withdrew Consent|1|||
155040288|NCT00508157|559575571|FG001|Overall Study|Subject Withdrew Consent|0|||
155040289|NCT00508157|559575570|FG000|Overall Study|Lost to Follow-up|1|||
155040290|NCT00508157|559575571|FG001|Overall Study|Lost to Follow-up|0|||
155040291|NCT00508157|559575570|FG000|Overall Study|Subject no longer met study criteria|0|||
155040292|NCT00508157|559575571|FG001|Overall Study|Subject no longer met study criteria|1|||
155040293|NCT00508157|559575570|FG000|Overall Study|Other known cause|0|||
155040294|NCT00508157|559575571|FG001|Overall Study|Other known cause|1|||
155040295|NCT01987232|559575572|FG000|Overall Study|Ongoing in Study|0|||
155040296|NCT01987232|559575573|FG001|Overall Study|Ongoing in Study|0|||
155040297|NCT01987232|559575574|FG002|Overall Study|Ongoing in Study|0|||
155040298|NCT01987232|559575575|FG003|Overall Study|Ongoing in Study|1|||
155040299|NCT01987232|559575576|FG004|Overall Study|Ongoing in Study|0|||
155040300|NCT01731470|559575577|FG000|Overall Study|Withdrawal by Subject|1|||
155040301|NCT01731470|559575577|FG000|Overall Study|Did not meet study criteria|1|||
155040302|NCT02258334|559575580|FG000|Overall Study|Adverse Event|1|||
155040303|NCT02258334|559575581|FG001|Overall Study|Adverse Event|0|||
155040304|NCT02258334|559575582|FG002|Overall Study|Adverse Event|0|||
155040305|NCT02258334|559575583|FG003|Overall Study|Adverse Event|0|||
155040306|NCT00432276|559575590|FG000|Overall Study|Hyperglycemic Rescue|44|||
155040307|NCT00432276|559575591|FG001|Overall Study|Hyperglycemic Rescue|87|||
155040308|NCT00432276|559575590|FG000|Overall Study|Adverse Event|13|||
155040309|NCT00432276|559575591|FG001|Overall Study|Adverse Event|16|||
155040310|NCT00432276|559575590|FG000|Overall Study|Protocol Violation|25|||
155040311|NCT00432276|559575591|FG001|Overall Study|Protocol Violation|20|||
155040312|NCT00432276|559575590|FG000|Overall Study|Lost to Follow-up|6|||
155040313|NCT00432276|559575591|FG001|Overall Study|Lost to Follow-up|2|||
155040314|NCT00432276|559575590|FG000|Overall Study|Withdrawal by Subject|25|||
155040315|NCT00432276|559575591|FG001|Overall Study|Withdrawal by Subject|20|||
155040316|NCT00432276|559575590|FG000|Overall Study|Physician Decision|6|||
155040317|NCT00432276|559575591|FG001|Overall Study|Physician Decision|8|||
155040318|NCT00432276|559575590|FG000|Overall Study|Other|2|||
155040319|NCT00432276|559575591|FG001|Overall Study|Other|3|||
155040320|NCT00594386|559575592|FG000|Overall Study|Major protocol violation|2|||
155040321|NCT00594386|559575592|FG000|Overall Study|Lack of Efficacy|12|||
155040322|NCT00594386|559575592|FG000|Overall Study|Adverse Event|68|||
155040323|NCT00594386|559575592|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
155040324|NCT00594386|559575592|FG000|Overall Study|Subject withdrew consent|35|||
155040325|NCT00594386|559575592|FG000|Overall Study|Study ended per sponsor|115|||
155040326|NCT00594386|559575592|FG000|Overall Study|Lost to Follow-up|6|||
155040327|NCT00594386|559575592|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
155040328|NCT00594386|559575592|FG000|Overall Study|Other: Subject moved to Seattle|1|||
155040329|NCT00594386|559575592|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
155040330|NCT00594386|559575592|FG000|Overall Study|Other: Study terminated per investigator|2|||
155040331|NCT00594386|559575592|FG000|Overall Study|Other: Sponsor closure of study|1|||
155040332|NCT00594386|559575592|FG000|Overall Study|Other: Site terminated participation|1|||
155040333|NCT00594386|559575592|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
155040334|NCT00594386|559575592|FG000|Overall Study|Other: Loss of drivers license|1|||
155040335|NCT04459598|559575597|FG000|Overall Study|Adverse Event|1|||
155040336|NCT04459598|559575598|FG001|Overall Study|Adverse Event|1|||
155040337|NCT01687283|559577394|FG000|Overall Study|Adverse Event|11|||
155040338|NCT01687283|559577395|FG001|Overall Study|Adverse Event|4|||
155040339|NCT01687283|559577394|FG000|Overall Study|Lack of Efficacy|3|||
155040340|NCT01687283|559577395|FG001|Overall Study|Lack of Efficacy|1|||
155040341|NCT01687283|559577394|FG000|Overall Study|Protocol Violation|1|||
155040342|NCT01687283|559577395|FG001|Overall Study|Protocol Violation|3|||
155040343|NCT01687283|559577394|FG000|Overall Study|protocol defined stopping criteria|8|||
155040344|NCT01687283|559577395|FG001|Overall Study|protocol defined stopping criteria|10|||
155040345|NCT01687283|559577394|FG000|Overall Study|Lost to Follow-up|1|||
155040346|NCT01687283|559577395|FG001|Overall Study|Lost to Follow-up|1|||
155040347|NCT01687283|559577394|FG000|Overall Study|Investigator discretion|2|||
155040348|NCT01687283|559577395|FG001|Overall Study|Investigator discretion|0|||
155040349|NCT01687283|559577394|FG000|Overall Study|Withdrawal by Subject|9|||
155040350|NCT01687283|559577395|FG001|Overall Study|Withdrawal by Subject|8|||
155040351|NCT01153009|559577399|FG000|Overall Study|Adverse Event|4|||
155040352|NCT01153009|559577400|FG001|Overall Study|Adverse Event|14|||
155040353|NCT01153009|559577401|FG002|Overall Study|Adverse Event|14|||
155040354|NCT01153009|559577402|FG003|Overall Study|Adverse Event|10|||
155040355|NCT01153009|559577399|FG000|Overall Study|Lack of Efficacy|9|||
155040356|NCT01153009|559577400|FG001|Overall Study|Lack of Efficacy|0|||
155040357|NCT01153009|559577401|FG002|Overall Study|Lack of Efficacy|2|||
155040358|NCT01153009|559577402|FG003|Overall Study|Lack of Efficacy|1|||
155040359|NCT01153009|559577399|FG000|Overall Study|Noncompliance with Study Medication|1|||
155040360|NCT01153009|559577400|FG001|Overall Study|Noncompliance with Study Medication|3|||
155040361|NCT01153009|559577401|FG002|Overall Study|Noncompliance with Study Medication|4|||
155040362|NCT01153009|559577402|FG003|Overall Study|Noncompliance with Study Medication|1|||
155040363|NCT01153009|559577399|FG000|Overall Study|Protocol Deviations|4|||
155040364|NCT01153009|559577400|FG001|Overall Study|Protocol Deviations|3|||
155040365|NCT01153009|559577401|FG002|Overall Study|Protocol Deviations|3|||
155040366|NCT01153009|559577402|FG003|Overall Study|Protocol Deviations|2|||
155040367|NCT01153009|559577399|FG000|Overall Study|Withdrawal of Consent|5|||
155040368|NCT01153009|559577400|FG001|Overall Study|Withdrawal of Consent|5|||
155040369|NCT01153009|559577401|FG002|Overall Study|Withdrawal of Consent|4|||
155040370|NCT01153009|559577402|FG003|Overall Study|Withdrawal of Consent|6|||
155040371|NCT01153009|559577399|FG000|Overall Study|Lost to Follow-up|8|||
155040372|NCT01153009|559577400|FG001|Overall Study|Lost to Follow-up|8|||
155040373|NCT01153009|559577401|FG002|Overall Study|Lost to Follow-up|11|||
155040374|NCT01153009|559577402|FG003|Overall Study|Lost to Follow-up|15|||
155040375|NCT01153009|559577399|FG000|Overall Study|Other|1|||
155040376|NCT01153009|559577400|FG001|Overall Study|Other|1|||
155040377|NCT01153009|559577401|FG002|Overall Study|Other|3|||
155040378|NCT01153009|559577402|FG003|Overall Study|Other|2|||
155040379|NCT00410072|559577403|FG000|Day 1 to Week 48|Adverse Event|1|||
155040380|NCT00410072|559577404|FG001|Day 1 to Week 48|Adverse Event|2|||
155040381|NCT00410072|559577403|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
155040382|NCT00410072|559577404|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
155040383|NCT00410072|559577403|FG000|Day 1 to Week 48|Other|0|||
155040384|NCT00410072|559577404|FG001|Day 1 to Week 48|Other|1|||
155040385|NCT00410072|559577403|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
155040386|NCT00410072|559577404|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
155040387|NCT00410072|559577403|FG000|Day 1 to Week 48|Pregnancy|0|||
155040388|NCT00410072|559577404|FG001|Day 1 to Week 48|Pregnancy|2|||
155040389|NCT00410072|559577403|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
155040390|NCT00410072|559577404|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
155040391|NCT00410072|559577403|FG000|After Week 48 to Week 96|Adverse Event|1|||
155040392|NCT00410072|559577404|FG001|After Week 48 to Week 96|Adverse Event|2|||
155040393|NCT00410072|559577403|FG000|After Week 48 to Week 96|Death|0|||
155040394|NCT00410072|559577404|FG001|After Week 48 to Week 96|Death|1|||
155040395|NCT00410072|559577403|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
155040396|NCT00410072|559577404|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
155040397|NCT00410072|559577403|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
155040398|NCT00410072|559577404|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
155040399|NCT00410072|559577403|FG000|After Week 48 to Week 96|Other|2|||
155040400|NCT00410072|559577404|FG001|After Week 48 to Week 96|Other|0|||
155040401|NCT00410072|559577403|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
155040402|NCT00410072|559577404|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
155040403|NCT00410072|559577403|FG000|After Week 48 to Week 96|Pregnancy|0|||
155040404|NCT00410072|559577404|FG001|After Week 48 to Week 96|Pregnancy|2|||
155040405|NCT00410072|559577403|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
155040406|NCT00410072|559577404|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
155040407|NCT04494425|559577407|FG000|Overall Study|Death|160|||
155381469|NCT00994682|560830934|FG001|Pioglitazone Open Label|Physician Decision|1|||
155040408|NCT04494425|559577408|FG001|Overall Study|Death|166|||
155040409|NCT04494425|559577407|FG000|Overall Study|Withdrawal by Subject|10|||
155040410|NCT04494425|559577408|FG001|Overall Study|Withdrawal by Subject|40|||
155040411|NCT04494425|559577407|FG000|Overall Study|Other|1|||
155040412|NCT04494425|559577408|FG001|Overall Study|Other|1|||
155040413|NCT04494425|559577407|FG000|Overall Study|Ongoing at the time of PCD|265|||
155381470|NCT01049217|560830935|FG000|Overall Study|Adverse Event|2|||
155040414|NCT04494425|559577408|FG001|Overall Study|Ongoing at the time of PCD|223|||
155040415|NCT01270321|559577410|FG000|Overall Study|Death|3|||
154927610|NCT00943826|559158916|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
154927611|NCT00943826|559158917|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
154927612|NCT00943826|559158916|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
154927613|NCT00943826|559158917|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
154927614|NCT02050373|559158918|FG000|Overall Study|Adverse Event|4|||
154927615|NCT02050373|559158919|FG001|Overall Study|Adverse Event|7|||
154927616|NCT02050373|559158918|FG000|Overall Study|Death|3|||
154927617|NCT02050373|559158919|FG001|Overall Study|Death|3|||
154927618|NCT04764669|559158921|FG000|Overall Study|Adverse Event|1|||
154927619|NCT04764669|559158922|FG001|Overall Study|Adverse Event|0|||
154927620|NCT04764669|559158923|FG002|Overall Study|Adverse Event|1|||
154927621|NCT04764669|559158924|FG003|Overall Study|Adverse Event|0|||
154927622|NCT04764669|559158921|FG000|Overall Study|Subject Choice|0|||
154927623|NCT04764669|559158922|FG001|Overall Study|Subject Choice|0|||
154927624|NCT04764669|559158923|FG002|Overall Study|Subject Choice|1|||
154927625|NCT04764669|559158924|FG003|Overall Study|Subject Choice|0|||
154927626|NCT04764669|559158921|FG000|Overall Study|Withdrawal by Subject|2|||
154927627|NCT04764669|559158922|FG001|Overall Study|Withdrawal by Subject|0|||
154927628|NCT04764669|559158923|FG002|Overall Study|Withdrawal by Subject|0|||
154927629|NCT04764669|559158924|FG003|Overall Study|Withdrawal by Subject|0|||
154927630|NCT00557830|559158926|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
154927631|NCT00557830|559158927|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
154927632|NCT00557830|559158928|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
154927633|NCT00557830|559158926|FG000|Screening Treatment Phase|Adverse Event|2|||
154927634|NCT00557830|559158927|FG001|Screening Treatment Phase|Adverse Event|0|||
154927635|NCT00557830|559158928|FG002|Screening Treatment Phase|Adverse Event|0|||
154927636|NCT00557830|559158926|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
154927637|NCT00557830|559158927|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
154927638|NCT00557830|559158928|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
154927639|NCT02860039|559158929|FG000|Overall Study|Death|4|||
154927640|NCT02860039|559158930|FG001|Overall Study|Death|0|||
154927641|NCT02860039|559158929|FG000|Overall Study|Lost to Follow-up|2|||
154927642|NCT02860039|559158930|FG001|Overall Study|Lost to Follow-up|2|||
154927643|NCT02860039|559158929|FG000|Overall Study|Protocol Violation|3|||
154927644|NCT02860039|559158930|FG001|Overall Study|Protocol Violation|1|||
154927645|NCT02860039|559158929|FG000|Overall Study|Withdrawal by Subject|1|||
154927646|NCT02860039|559158930|FG001|Overall Study|Withdrawal by Subject|0|||
154927647|NCT02860039|559158929|FG000|Overall Study|Not otherwise eligible|1|||
154927648|NCT02860039|559158930|FG001|Overall Study|Not otherwise eligible|1|||
154927649|NCT03170271|559158931|FG000|Overall Study|Adverse Event|7|||
154927650|NCT03170271|559158932|FG001|Overall Study|Adverse Event|2|||
154927651|NCT03170271|559158931|FG000|Overall Study|Lost to Follow-up|0|||
154927652|NCT03170271|559158932|FG001|Overall Study|Lost to Follow-up|1|||
154927653|NCT03170271|559158931|FG000|Overall Study|Physician Decision|1|||
154927654|NCT03170271|559158932|FG001|Overall Study|Physician Decision|0|||
154927655|NCT03170271|559158931|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
154927656|NCT03170271|559158932|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
154927657|NCT03170271|559158931|FG000|Overall Study|Withdrawal by Subject|17|||
154927658|NCT03170271|559158932|FG001|Overall Study|Withdrawal by Subject|5|||
154927659|NCT03170271|559158931|FG000|Overall Study|Other|2|||
154927660|NCT03170271|559158932|FG001|Overall Study|Other|2|||
154927661|NCT03170271|559158931|FG000|Overall Study|Randomized in error|4|||
154927662|NCT03170271|559158932|FG001|Overall Study|Randomized in error|0|||
154927663|NCT03466060|559158933|FG000|Period 1|Test Lens Damage|0|||
154927664|NCT03466060|559158934|FG001|Period 1|Test Lens Damage|2|||
154927665|NCT03466060|559158935|FG002|Period 1|Test Lens Damage|0|||
154927666|NCT03466060|559158936|FG003|Period 1|Test Lens Damage|0|||
154927667|NCT03466060|559158937|FG004|Period 1|Test Lens Damage|0|||
154927668|NCT03466060|559158938|FG005|Period 1|Test Lens Damage|0|||
154927669|NCT03466060|559158933|FG000|Period 1|Withdrawal by Subject|0|||
154927670|NCT03466060|559158934|FG001|Period 1|Withdrawal by Subject|0|||
154927671|NCT03466060|559158935|FG002|Period 1|Withdrawal by Subject|2|||
154927672|NCT03466060|559158936|FG003|Period 1|Withdrawal by Subject|0|||
154927673|NCT03466060|559158937|FG004|Period 1|Withdrawal by Subject|0|||
154927674|NCT03466060|559158938|FG005|Period 1|Withdrawal by Subject|0|||
154927675|NCT03466060|559158933|FG000|Period 1|Lost to Follow-up|0|||
154927676|NCT03466060|559158934|FG001|Period 1|Lost to Follow-up|0|||
154927677|NCT03466060|559158935|FG002|Period 1|Lost to Follow-up|0|||
154927678|NCT03466060|559158936|FG003|Period 1|Lost to Follow-up|1|||
154927679|NCT03466060|559158937|FG004|Period 1|Lost to Follow-up|0|||
154927680|NCT03466060|559158938|FG005|Period 1|Lost to Follow-up|0|||
154927681|NCT03466060|559158933|FG000|Period 1|Grade 2 Conjunctivitis|0|||
154927682|NCT03466060|559158934|FG001|Period 1|Grade 2 Conjunctivitis|0|||
154927683|NCT03466060|559158935|FG002|Period 1|Grade 2 Conjunctivitis|1|||
154927684|NCT03466060|559158936|FG003|Period 1|Grade 2 Conjunctivitis|0|||
154927685|NCT03466060|559158937|FG004|Period 1|Grade 2 Conjunctivitis|0|||
154927686|NCT03466060|559158938|FG005|Period 1|Grade 2 Conjunctivitis|0|||
154927687|NCT03466060|559158933|FG000|Period 2|Lens Handling Difficulties|0|||
155040416|NCT01270321|559577411|FG001|Overall Study|Death|1|||
155040417|NCT01270321|559577412|FG002|Overall Study|Death|4|||
155040418|NCT01270321|559577410|FG000|Overall Study|Adverse Event|7|||
155040419|NCT01270321|559577411|FG001|Overall Study|Adverse Event|9|||
155040420|NCT01270321|559577412|FG002|Overall Study|Adverse Event|5|||
155040421|NCT04003623|559577416|FG000|Overall Study|Withdrawal by Subject|1|||
155040422|NCT04003623|559577417|FG001|Overall Study|Withdrawal by Subject|0|||
155040423|NCT03307837|559577423|FG000|Overall Study|Withdrawal by Subject|0|||
155040424|NCT03307837|559577424|FG001|Overall Study|Withdrawal by Subject|0|||
155040425|NCT03307837|559577425|FG002|Overall Study|Withdrawal by Subject|1|||
155040426|NCT03307837|559577426|FG003|Overall Study|Withdrawal by Subject|0|||
155040427|NCT03307837|559577427|FG004|Overall Study|Withdrawal by Subject|0|||
155040428|NCT03307837|559577428|FG005|Overall Study|Withdrawal by Subject|1|||
155040429|NCT03307837|559577423|FG000|Overall Study|Lost to Follow-up|1|||
155040430|NCT03307837|559577424|FG001|Overall Study|Lost to Follow-up|1|||
155040431|NCT03307837|559577425|FG002|Overall Study|Lost to Follow-up|0|||
155040432|NCT03307837|559577426|FG003|Overall Study|Lost to Follow-up|0|||
155040433|NCT03307837|559577427|FG004|Overall Study|Lost to Follow-up|0|||
155040434|NCT03307837|559577428|FG005|Overall Study|Lost to Follow-up|1|||
155040435|NCT01190189|559577429|FG000|Overall Study|Lost to Follow-up|4|||
155040436|NCT01190189|559577429|FG000|Overall Study|Withdrawal by Subject|1|||
155040437|NCT01190189|559577429|FG000|Overall Study|Migrated/moved from study area|1|||
155040438|NCT02634801|559577437|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
155040439|NCT02634801|559577438|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
155040440|NCT02634801|559577439|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
155040441|NCT02634801|559577437|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
155040442|NCT02634801|559577438|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
155040443|NCT02634801|559577439|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
155040444|NCT02634801|559577437|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
155040445|NCT02634801|559577438|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
155040446|NCT02634801|559577439|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
155040447|NCT02634801|559577437|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
155040448|NCT02634801|559577438|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
155040449|NCT02634801|559577439|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
155040450|NCT02634801|559577437|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
155040451|NCT02634801|559577438|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
155040452|NCT02634801|559577439|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
155040453|NCT02634801|559577437|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
155040454|NCT02634801|559577438|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
155040455|NCT02634801|559577439|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
155040456|NCT02634801|559577437|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
155040457|NCT02634801|559577438|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
155040458|NCT02634801|559577439|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
155040459|NCT02634801|559577437|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
155040460|NCT02634801|559577438|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
155040461|NCT02634801|559577439|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
155040462|NCT02634801|559577437|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
155040463|NCT02634801|559577438|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
155040464|NCT02634801|559577439|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
155040465|NCT02634801|559577437|FG000|Follow-up Period|Lost to Follow-up|3|||
155040466|NCT02634801|559577438|FG001|Follow-up Period|Lost to Follow-up|1|||
155040467|NCT02634801|559577439|FG002|Follow-up Period|Lost to Follow-up|2|||
155040468|NCT02634801|559577437|FG000|Follow-up Period|Physician Decision|0|||
155040469|NCT02634801|559577438|FG001|Follow-up Period|Physician Decision|0|||
155040470|NCT02634801|559577439|FG002|Follow-up Period|Physician Decision|1|||
155040471|NCT02634801|559577437|FG000|Follow-up Period|Withdrawal by Subject|1|||
155040472|NCT02634801|559577438|FG001|Follow-up Period|Withdrawal by Subject|2|||
155040473|NCT02634801|559577439|FG002|Follow-up Period|Withdrawal by Subject|5|||
155040474|NCT02634801|559577437|FG000|Follow-up Period|Adverse Event|1|||
155040475|NCT02634801|559577438|FG001|Follow-up Period|Adverse Event|5|||
155040476|NCT02634801|559577439|FG002|Follow-up Period|Adverse Event|0|||
155040477|NCT01548768|559577460|FG000|Overall Study|Withdrawal by Subject|0|||
155040478|NCT01548768|559577461|FG001|Overall Study|Withdrawal by Subject|2|||
155040479|NCT01548768|559577462|FG002|Overall Study|Withdrawal by Subject|1|||
155040480|NCT01548768|559577463|FG003|Overall Study|Withdrawal by Subject|0|||
155040481|NCT01548768|559577460|FG000|Overall Study|Physician Decision|1|||
155040482|NCT01548768|559577461|FG001|Overall Study|Physician Decision|0|||
155040483|NCT01548768|559577462|FG002|Overall Study|Physician Decision|0|||
155040484|NCT01548768|559577463|FG003|Overall Study|Physician Decision|0|||
155040485|NCT01548768|559577460|FG000|Overall Study|Adverse Event|0|||
155040486|NCT01548768|559577461|FG001|Overall Study|Adverse Event|0|||
155040487|NCT01548768|559577462|FG002|Overall Study|Adverse Event|0|||
155040488|NCT01548768|559577463|FG003|Overall Study|Adverse Event|1|||
155040489|NCT01548768|559577460|FG000|Overall Study|Non-Compliance|0|||
155040490|NCT01548768|559577461|FG001|Overall Study|Non-Compliance|0|||
155040491|NCT01548768|559577462|FG002|Overall Study|Non-Compliance|0|||
155040492|NCT01548768|559577463|FG003|Overall Study|Non-Compliance|3|||
155040493|NCT02784288|559577464|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
155040494|NCT02757625|559577465|FG000|Overall Study|Investigator's discretion|0|||
155040495|NCT02757625|559577466|FG001|Overall Study|Investigator's discretion|0|||
155040496|NCT02757625|559577467|FG002|Overall Study|Investigator's discretion|1|||
155040497|NCT02757625|559577468|FG003|Overall Study|Investigator's discretion|0|||
155040498|NCT02757625|559577465|FG000|Overall Study|Adverse Event|0|||
155040499|NCT02757625|559577466|FG001|Overall Study|Adverse Event|0|||
155040500|NCT02757625|559577467|FG002|Overall Study|Adverse Event|1|||
155040501|NCT02757625|559577468|FG003|Overall Study|Adverse Event|0|||
155040502|NCT00645671|559577469|FG000|Overall Study|Protocol Violation|1|||
155040503|NCT00645671|559577470|FG001|Overall Study|Protocol Violation|0|||
155040504|NCT00645671|559577469|FG000|Overall Study|Withdrawal by Subject|0|||
155040505|NCT00645671|559577470|FG001|Overall Study|Withdrawal by Subject|4|||
155040506|NCT00645671|559577469|FG000|Overall Study|Adverse Event|0|||
155040507|NCT00645671|559577470|FG001|Overall Study|Adverse Event|1|||
155040508|NCT00645671|559577469|FG000|Overall Study|Physician Decision|0|||
155040509|NCT00645671|559577470|FG001|Overall Study|Physician Decision|1|||
155040510|NCT05600036|559577471|FG000|Overall Study|Adverse Event|0|||
155040511|NCT05600036|559577472|FG001|Overall Study|Adverse Event|2|||
155040512|NCT05600036|559577473|FG002|Overall Study|Adverse Event|1|||
155040513|NCT05600036|559577474|FG003|Overall Study|Adverse Event|0|||
155040514|NCT05600036|559577475|FG004|Overall Study|Adverse Event|1|||
155040515|NCT05600036|559577476|FG005|Overall Study|Adverse Event|0|||
155040516|NCT05600036|559577471|FG000|Overall Study|Lost to Follow-up|0|||
155040517|NCT05600036|559577472|FG001|Overall Study|Lost to Follow-up|2|||
155040518|NCT05600036|559577473|FG002|Overall Study|Lost to Follow-up|1|||
155040519|NCT05600036|559577474|FG003|Overall Study|Lost to Follow-up|1|||
155040520|NCT05600036|559577475|FG004|Overall Study|Lost to Follow-up|0|||
155040521|NCT05600036|559577476|FG005|Overall Study|Lost to Follow-up|0|||
155040522|NCT05600036|559577471|FG000|Overall Study|Protocol Violation|0|||
155040523|NCT05600036|559577472|FG001|Overall Study|Protocol Violation|0|||
155040524|NCT05600036|559577473|FG002|Overall Study|Protocol Violation|2|||
155040525|NCT05600036|559577474|FG003|Overall Study|Protocol Violation|0|||
155040526|NCT05600036|559577475|FG004|Overall Study|Protocol Violation|0|||
155040527|NCT05600036|559577476|FG005|Overall Study|Protocol Violation|0|||
155040528|NCT05600036|559577471|FG000|Overall Study|Withdrawal by Subject|0|||
155040529|NCT05600036|559577472|FG001|Overall Study|Withdrawal by Subject|1|||
155040530|NCT05600036|559577473|FG002|Overall Study|Withdrawal by Subject|2|||
155040531|NCT05600036|559577474|FG003|Overall Study|Withdrawal by Subject|0|||
155040532|NCT05600036|559577475|FG004|Overall Study|Withdrawal by Subject|3|||
155040533|NCT05600036|559577476|FG005|Overall Study|Withdrawal by Subject|5|||
155040534|NCT05600036|559577471|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155040535|NCT05600036|559577472|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155040536|NCT05600036|559577473|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155040537|NCT05600036|559577474|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
155040538|NCT05600036|559577475|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155040539|NCT05600036|559577476|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
155040540|NCT05600036|559577471|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155040541|NCT05600036|559577472|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
155040542|NCT05600036|559577473|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155040543|NCT05600036|559577474|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155040544|NCT05600036|559577475|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155040545|NCT05600036|559577476|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
155040546|NCT05600036|559577471|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155040547|NCT05600036|559577472|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155040548|NCT05600036|559577473|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155040549|NCT05600036|559577474|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
155040550|NCT05600036|559577475|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155040551|NCT05600036|559577476|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
155040552|NCT04401202|559577477|FG000|Overall Study|Lost to Follow-up|2|||
155381471|NCT01049217|560830936|FG001|Overall Study|Adverse Event|1|||
155381472|NCT01049217|560830935|FG000|Overall Study|Lack of Efficacy|1|||
155381473|NCT01049217|560830936|FG001|Overall Study|Lack of Efficacy|1|||
155381474|NCT01049217|560830935|FG000|Overall Study|Lost to Follow-up|3|||
155040553|NCT04401202|559577478|FG001|Overall Study|Lost to Follow-up|2|||
155040554|NCT04401202|559577477|FG000|Overall Study|Adverse Event|0|||
155040555|NCT04401202|559577478|FG001|Overall Study|Adverse Event|1|||
155040556|NCT04401202|559577477|FG000|Overall Study|Hospitalized|4|||
155040557|NCT04401202|559577478|FG001|Overall Study|Hospitalized|1|||
155040558|NCT02714036|559577480|FG000|Overall Study|Adverse Event|9|||
155040559|NCT02714036|559577481|FG001|Overall Study|Adverse Event|2|||
155040560|NCT02714036|559577480|FG000|Overall Study|Withdrawal by Subject|3|||
155040561|NCT02714036|559577481|FG001|Overall Study|Withdrawal by Subject|2|||
155040562|NCT01006590|559577482|FG000|Overall Study|Adverse Event|2|||
155040563|NCT01006590|559577483|FG001|Overall Study|Adverse Event|3|||
155040564|NCT01006590|559577482|FG000|Overall Study|Death|1|||
155040565|NCT01006590|559577483|FG001|Overall Study|Death|1|||
155040566|NCT01006590|559577482|FG000|Overall Study|Lost to Follow-up|1|||
155040567|NCT01006590|559577483|FG001|Overall Study|Lost to Follow-up|1|||
155040568|NCT01006590|559577482|FG000|Overall Study|Protocol Violation|1|||
155040569|NCT01006590|559577483|FG001|Overall Study|Protocol Violation|0|||
155040570|NCT01006590|559577482|FG000|Overall Study|Withdrawal by Subject|4|||
155040571|NCT01006590|559577483|FG001|Overall Study|Withdrawal by Subject|2|||
155040572|NCT01006590|559577482|FG000|Overall Study|Study specific discontinuation criteria|16|||
155040573|NCT01006590|559577483|FG001|Overall Study|Study specific discontinuation criteria|23|||
155040574|NCT01006590|559577482|FG000|Overall Study|Other|3|||
155040575|NCT01006590|559577483|FG001|Overall Study|Other|2|||
155040576|NCT03332095|559577484|FG000|Overall Study|Lost to Follow-up|1|||
155040577|NCT03332095|559577485|FG001|Overall Study|Lost to Follow-up|0|||
155040578|NCT03332095|559577484|FG000|Overall Study|Pregnancy|0|||
155040579|NCT03332095|559577485|FG001|Overall Study|Pregnancy|1|||
155040580|NCT05697627|559577486|FG000|Overall Study|Adverse Event|1|||
155040581|NCT02700698|559577493|FG000|Overall Study|Withdrawal by Subject|1|||
155040582|NCT02700698|559577494|FG001|Overall Study|Withdrawal by Subject|0|||
155040583|NCT00703118|559577495|FG000|Overall Study|Adverse Event|1|||
155040584|NCT00703118|559577496|FG001|Overall Study|Adverse Event|2|||
155040585|NCT00703118|559577497|FG002|Overall Study|Adverse Event|2|||
155040586|NCT00703118|559577495|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
155040587|NCT00703118|559577496|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
155040588|NCT00703118|559577497|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
155040589|NCT00703118|559577495|FG000|Overall Study|Lost to Follow-up|6|||
155040590|NCT00703118|559577496|FG001|Overall Study|Lost to Follow-up|4|||
155040591|NCT00703118|559577497|FG002|Overall Study|Lost to Follow-up|4|||
155040592|NCT00703118|559577495|FG000|Overall Study|Withdrawal by Subject|8|||
155040593|NCT00703118|559577496|FG001|Overall Study|Withdrawal by Subject|7|||
155040594|NCT00703118|559577497|FG002|Overall Study|Withdrawal by Subject|13|||
155040595|NCT00703118|559577495|FG000|Overall Study|Other|0|||
155040596|NCT00703118|559577496|FG001|Overall Study|Other|0|||
155040597|NCT00703118|559577497|FG002|Overall Study|Other|1|||
155040598|NCT00055497|559577506|FG000|Overall Study|Adverse Event|1|||
155040599|NCT00055497|559577507|FG001|Overall Study|Adverse Event|1|||
155040600|NCT00055497|559577508|FG002|Overall Study|Adverse Event|1|||
155040601|NCT00055497|559577509|FG003|Overall Study|Adverse Event|28|||
155040602|NCT00055497|559577506|FG000|Overall Study|Withdrawal by Subject|3|||
155040603|NCT00055497|559577507|FG001|Overall Study|Withdrawal by Subject|1|||
155040604|NCT00055497|559577508|FG002|Overall Study|Withdrawal by Subject|1|||
155040605|NCT00055497|559577509|FG003|Overall Study|Withdrawal by Subject|15|||
155040606|NCT00055497|559577506|FG000|Overall Study|Lost to Follow-up|0|||
155040607|NCT00055497|559577507|FG001|Overall Study|Lost to Follow-up|1|||
155040608|NCT00055497|559577508|FG002|Overall Study|Lost to Follow-up|0|||
155040609|NCT00055497|559577509|FG003|Overall Study|Lost to Follow-up|5|||
155040610|NCT00055497|559577506|FG000|Overall Study|Protocol Violation|0|||
155040611|NCT00055497|559577507|FG001|Overall Study|Protocol Violation|0|||
155040612|NCT00055497|559577508|FG002|Overall Study|Protocol Violation|0|||
155040613|NCT00055497|559577509|FG003|Overall Study|Protocol Violation|3|||
155040614|NCT00055497|559577506|FG000|Overall Study|Lack of Efficacy|1|||
155040615|NCT00055497|559577507|FG001|Overall Study|Lack of Efficacy|0|||
155040616|NCT00055497|559577508|FG002|Overall Study|Lack of Efficacy|0|||
155040617|NCT00055497|559577509|FG003|Overall Study|Lack of Efficacy|27|||
155040618|NCT00055497|559577506|FG000|Overall Study|Administrative Reasons|0|||
155040619|NCT00055497|559577507|FG001|Overall Study|Administrative Reasons|0|||
155040620|NCT00055497|559577508|FG002|Overall Study|Administrative Reasons|0|||
155040621|NCT00055497|559577509|FG003|Overall Study|Administrative Reasons|1|||
155040622|NCT00055497|559577506|FG000|Overall Study|Other|0|||
155040623|NCT00055497|559577507|FG001|Overall Study|Other|0|||
155040624|NCT00055497|559577508|FG002|Overall Study|Other|0|||
155040625|NCT00055497|559577509|FG003|Overall Study|Other|11|||
155040626|NCT01084538|559577510|FG000|Overall Study|Drug not available|30|||
155040627|NCT01084538|559577510|FG000|Overall Study|Adverse Event|9|||
155040628|NCT01084538|559577510|FG000|Overall Study|Kidney transplant|6|||
155040629|NCT01084538|559577510|FG000|Overall Study|Serious Adverse Event|3|||
155040630|NCT01084538|559577510|FG000|Overall Study|Lack of effectiveness|2|||
155040631|NCT01084538|559577510|FG000|Overall Study|Patient noncompliance|2|||
155040632|NCT01084538|559577510|FG000|Overall Study|Hyperphosphatemia|2|||
155040633|NCT01084538|559577510|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
155040634|NCT01084538|559577510|FG000|Overall Study|Change of residence|2|||
155040635|NCT01084538|559577510|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
155040636|NCT01084538|559577510|FG000|Overall Study|Reason unknown|8|||
155040637|NCT00803205|559577515|FG000|Overall Study|Adverse Event|7|||
155040638|NCT00803205|559577516|FG001|Overall Study|Adverse Event|2|||
155040639|NCT00803205|559577515|FG000|Overall Study|Lost to Follow-up|1|||
155040640|NCT00803205|559577516|FG001|Overall Study|Lost to Follow-up|0|||
155040641|NCT00803205|559577515|FG000|Overall Study|Withdrawal by Subject|9|||
155040642|NCT00803205|559577516|FG001|Overall Study|Withdrawal by Subject|9|||
155040643|NCT00803205|559577515|FG000|Overall Study|Physician Decision|1|||
155040644|NCT00803205|559577516|FG001|Overall Study|Physician Decision|0|||
155040645|NCT00803205|559577515|FG000|Overall Study|Protocol Violation|1|||
155040646|NCT00803205|559577516|FG001|Overall Study|Protocol Violation|1|||
155040647|NCT00803205|559577515|FG000|Overall Study|Medical Monitor Decision|1|||
155040648|NCT00803205|559577516|FG001|Overall Study|Medical Monitor Decision|0|||
155040649|NCT00803205|559577515|FG000|Overall Study|Acquired a Lung Infection|0|||
155040650|NCT00803205|559577516|FG001|Overall Study|Acquired a Lung Infection|1|||
155040651|NCT00803205|559577515|FG000|Overall Study|Sponsor Decision|0|||
155040652|NCT00803205|559577516|FG001|Overall Study|Sponsor Decision|1|||
155040653|NCT01490697|559577519|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
155040654|NCT01490697|559577520|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
155040655|NCT00379808|559577521|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
155040656|NCT00379808|559577522|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
155040657|NCT03742258|559577527|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
155040658|NCT03742258|559577528|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
155040659|NCT03742258|559577529|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
155040660|NCT03742258|559577527|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
155040661|NCT03742258|559577528|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
155040662|NCT03742258|559577529|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
155040663|NCT03742258|559577527|FG000|Survival Follow-Up|Still in Follow-up|0|||
155040664|NCT03742258|559577528|FG001|Survival Follow-Up|Still in Follow-up|0|||
155040665|NCT03742258|559577529|FG002|Survival Follow-Up|Still in Follow-up|2|||
155040666|NCT01380691|559577530|FG000|Washout (7 Days)|Protocol Violation|0|||
155040667|NCT01380691|559577531|FG001|Washout (7 Days)|Protocol Violation|0|||
155040668|NCT01380691|559577532|FG002|Washout (7 Days)|Protocol Violation|0|||
155040669|NCT01380691|559577533|FG003|Washout (7 Days)|Protocol Violation|1|||
155040670|NCT01380691|559577530|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
155040671|NCT01380691|559577531|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
155040672|NCT01380691|559577532|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
155040673|NCT01380691|559577533|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
155040674|NCT01952080|559577534|FG000|Overall Study|Withdrawal by Subject|0|||
155040675|NCT01952080|559577535|FG001|Overall Study|Withdrawal by Subject|0|||
155040676|NCT01952080|559577536|FG002|Overall Study|Withdrawal by Subject|0|||
155040677|NCT01952080|559577537|FG003|Overall Study|Withdrawal by Subject|1|||
155040678|NCT01952080|559577534|FG000|Overall Study|Protocol Non-compliance|0|||
155040679|NCT01952080|559577535|FG001|Overall Study|Protocol Non-compliance|1|||
155040680|NCT01952080|559577536|FG002|Overall Study|Protocol Non-compliance|0|||
155040681|NCT01952080|559577537|FG003|Overall Study|Protocol Non-compliance|0|||
155040682|NCT03564795|559577538|FG000|Overall Study|Withdrawal by Subject|3|||
155040683|NCT03564795|559577538|FG000|Overall Study|Lost to Follow-up|6|||
155040684|NCT03564795|559577538|FG000|Overall Study|Physician Decision|2|||
155040685|NCT01333956|559577543|FG000|Overall Study|Lost to Follow-up|1|||
155040686|NCT01333956|559577544|FG001|Overall Study|Lost to Follow-up|2|||
155040687|NCT01333956|559577545|FG002|Overall Study|Lost to Follow-up|0|||
155040688|NCT01333956|559577546|FG003|Overall Study|Lost to Follow-up|1|||
155040689|NCT01333956|559577543|FG000|Overall Study|Unable to complete study procedure|1|||
155040690|NCT01333956|559577544|FG001|Overall Study|Unable to complete study procedure|0|||
155040691|NCT01333956|559577545|FG002|Overall Study|Unable to complete study procedure|0|||
155040692|NCT01333956|559577546|FG003|Overall Study|Unable to complete study procedure|1|||
155040693|NCT01333956|559577543|FG000|Overall Study|Withdrawal by Subject|0|||
155040694|NCT01333956|559577544|FG001|Overall Study|Withdrawal by Subject|2|||
155040695|NCT01333956|559577545|FG002|Overall Study|Withdrawal by Subject|1|||
155040696|NCT01333956|559577546|FG003|Overall Study|Withdrawal by Subject|0|||
155040697|NCT02134353|559577547|FG000|Overall Study|Adverse Event|10|||
155040698|NCT02134353|559577548|FG001|Overall Study|Adverse Event|6|||
155040699|NCT02134353|559577547|FG000|Overall Study|Lost to Follow-up|1|||
155040700|NCT02134353|559577548|FG001|Overall Study|Lost to Follow-up|1|||
155040701|NCT02134353|559577547|FG000|Overall Study|Lack of Efficacy|2|||
155040702|NCT02134353|559577548|FG001|Overall Study|Lack of Efficacy|1|||
155040703|NCT02134353|559577547|FG000|Overall Study|Withdrawal by Subject|12|||
155040704|NCT02134353|559577548|FG001|Overall Study|Withdrawal by Subject|13|||
155040705|NCT02134353|559577547|FG000|Overall Study|Death|0|||
155040706|NCT02134353|559577548|FG001|Overall Study|Death|1|||
155040707|NCT02134353|559577547|FG000|Overall Study|Pregnancy|0|||
155040708|NCT02134353|559577548|FG001|Overall Study|Pregnancy|1|||
155040709|NCT02134353|559577547|FG000|Overall Study|Relocation|1|||
155040710|NCT02134353|559577548|FG001|Overall Study|Relocation|0|||
155040711|NCT02134353|559577547|FG000|Overall Study|Other - Patient's Choice|0|||
155040712|NCT02134353|559577548|FG001|Overall Study|Other - Patient's Choice|1|||
155040713|NCT00477607|559577549|FG000|Overall Study|Lost to Follow-up|7|||
155040714|NCT00477607|559577550|FG001|Overall Study|Lost to Follow-up|7|||
155040715|NCT01732471|559577551|FG000|Overall Study|Withdrawal by Subject|1|||
155040716|NCT00474786|559577554|FG000|Overall Study|Not Meeting Study Criteria|0|||
155040717|NCT00474786|559577555|FG001|Overall Study|Not Meeting Study Criteria|1|||
155040718|NCT00474786|559577554|FG000|Overall Study|Investigator Request|2|||
155040719|NCT00474786|559577555|FG001|Overall Study|Investigator Request|1|||
155040720|NCT00474786|559577554|FG000|Overall Study|Death|189|||
155040721|NCT00474786|559577555|FG001|Overall Study|Death|170|||
155040722|NCT00474786|559577554|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
155040723|NCT00474786|559577555|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
155040724|NCT00474786|559577554|FG000|Overall Study|Lost to Follow-up|4|||
155040725|NCT00474786|559577555|FG001|Overall Study|Lost to Follow-up|7|||
155040726|NCT00474786|559577554|FG000|Overall Study|Protocol Violation|2|||
155040727|NCT00474786|559577555|FG001|Overall Study|Protocol Violation|0|||
155040728|NCT00474786|559577554|FG000|Overall Study|Withdrawal by Subject|15|||
155040729|NCT00474786|559577555|FG001|Overall Study|Withdrawal by Subject|15|||
155040730|NCT00474786|559577554|FG000|Overall Study|Other|5|||
155040731|NCT00474786|559577555|FG001|Overall Study|Other|0|||
155040732|NCT02892513|559577556|FG000|Overall Study|Withdrawal by Subject|0|||
155040733|NCT02892513|559577557|FG001|Overall Study|Withdrawal by Subject|1|||
155040734|NCT03426436|559577558|FG000|Overall Study|Incorrect lead placement|12|||
155040735|NCT03426436|559577558|FG000|Overall Study|Withdrawal by Subject|2|||
155040736|NCT03426436|559577558|FG000|Overall Study|Consent issue|1|||
155040737|NCT03426436|559577558|FG000|Overall Study|ECGs not saved|4|||
155040738|NCT04776018|559577559|FG000|Overall Study|Death|0|||
155040739|NCT04776018|559577560|FG001|Overall Study|Death|1|||
155040740|NCT04776018|559577561|FG002|Overall Study|Death|4|||
155040741|NCT04776018|559577562|FG003|Overall Study|Death|1|||
155040742|NCT04776018|559577563|FG004|Overall Study|Death|4|||
155040743|NCT04776018|559577564|FG005|Overall Study|Death|0|||
155040744|NCT04776018|559577565|FG006|Overall Study|Death|0|||
155040745|NCT04776018|559577559|FG000|Overall Study|Study terminated by sponsor|2|||
155040746|NCT04776018|559577560|FG001|Overall Study|Study terminated by sponsor|1|||
155040747|NCT04776018|559577561|FG002|Overall Study|Study terminated by sponsor|4|||
155040748|NCT04776018|559577562|FG003|Overall Study|Study terminated by sponsor|0|||
155040749|NCT04776018|559577563|FG004|Overall Study|Study terminated by sponsor|3|||
155040750|NCT04776018|559577564|FG005|Overall Study|Study terminated by sponsor|0|||
155040751|NCT04776018|559577565|FG006|Overall Study|Study terminated by sponsor|0|||
155040752|NCT04776018|559577559|FG000|Overall Study|Withdrawal by Subject|1|||
155040753|NCT04776018|559577560|FG001|Overall Study|Withdrawal by Subject|0|||
155040754|NCT04776018|559577561|FG002|Overall Study|Withdrawal by Subject|0|||
155040755|NCT04776018|559577562|FG003|Overall Study|Withdrawal by Subject|2|||
155040756|NCT04776018|559577563|FG004|Overall Study|Withdrawal by Subject|1|||
155040757|NCT04776018|559577564|FG005|Overall Study|Withdrawal by Subject|0|||
155040758|NCT04776018|559577565|FG006|Overall Study|Withdrawal by Subject|0|||
155040759|NCT04776018|559577559|FG000|Overall Study|Other|0|||
155040760|NCT04776018|559577560|FG001|Overall Study|Other|1|||
155040761|NCT04776018|559577561|FG002|Overall Study|Other|1|||
155040762|NCT04776018|559577562|FG003|Overall Study|Other|0|||
155040763|NCT04776018|559577563|FG004|Overall Study|Other|0|||
155040764|NCT04776018|559577564|FG005|Overall Study|Other|0|||
155040765|NCT04776018|559577565|FG006|Overall Study|Other|0|||
155040766|NCT04776018|559577559|FG000|Overall Study|Lost to Follow-up|0|||
155040767|NCT04776018|559577560|FG001|Overall Study|Lost to Follow-up|0|||
155040768|NCT04776018|559577561|FG002|Overall Study|Lost to Follow-up|1|||
155040769|NCT04776018|559577562|FG003|Overall Study|Lost to Follow-up|0|||
155040770|NCT04776018|559577563|FG004|Overall Study|Lost to Follow-up|0|||
155040771|NCT04776018|559577564|FG005|Overall Study|Lost to Follow-up|0|||
155040772|NCT04776018|559577565|FG006|Overall Study|Lost to Follow-up|0|||
155040773|NCT00386425|559577568|FG000|Overall Study|Physician Decision|3|||
155040774|NCT00386425|559577569|FG001|Overall Study|Physician Decision|0|||
155040775|NCT00386425|559577570|FG002|Overall Study|Physician Decision|0|||
155040776|NCT00386425|559577568|FG000|Overall Study|Withdrawal by Subject|0|||
155040777|NCT00386425|559577569|FG001|Overall Study|Withdrawal by Subject|1|||
155040778|NCT00386425|559577570|FG002|Overall Study|Withdrawal by Subject|0|||
155040779|NCT00422292|559577571|FG000|Overall Study|Serious adverse events|1|||
155040780|NCT00422292|559577572|FG001|Overall Study|Serious adverse events|4|||
155040781|NCT00422292|559577573|FG002|Overall Study|Serious adverse events|0|||
155040782|NCT00422292|559577574|FG003|Overall Study|Serious adverse events|0|||
155040783|NCT00422292|559577571|FG000|Overall Study|Adverse Event|1|||
155040784|NCT00422292|559577572|FG001|Overall Study|Adverse Event|0|||
155040785|NCT00422292|559577573|FG002|Overall Study|Adverse Event|1|||
155040786|NCT00422292|559577574|FG003|Overall Study|Adverse Event|0|||
155040787|NCT00422292|559577571|FG000|Overall Study|Protocol Violation|4|||
155040788|NCT00422292|559577572|FG001|Overall Study|Protocol Violation|25|||
155040789|NCT00422292|559577573|FG002|Overall Study|Protocol Violation|8|||
155040790|NCT00422292|559577574|FG003|Overall Study|Protocol Violation|5|||
155040791|NCT00422292|559577571|FG000|Overall Study|Lost to Follow-up|6|||
155040792|NCT00422292|559577572|FG001|Overall Study|Lost to Follow-up|12|||
155040793|NCT00422292|559577573|FG002|Overall Study|Lost to Follow-up|6|||
155040794|NCT00422292|559577574|FG003|Overall Study|Lost to Follow-up|6|||
155040795|NCT00422292|559577571|FG000|Overall Study|Withdrawal by Subject|6|||
155040796|NCT00422292|559577572|FG001|Overall Study|Withdrawal by Subject|25|||
155040797|NCT00422292|559577573|FG002|Overall Study|Withdrawal by Subject|7|||
155040798|NCT00422292|559577574|FG003|Overall Study|Withdrawal by Subject|13|||
155040799|NCT02440854|559577575|FG000|Overall Study|Relocation of patient|1|||
155040800|NCT02440854|559577575|FG000|Overall Study|Death|6|||
155040801|NCT02440854|559577575|FG000|Overall Study|Lost to Follow-up|10|||
155040802|NCT02440854|559577575|FG000|Overall Study|Afatinib discontinuation|46|||
155040803|NCT02440854|559577575|FG000|Overall Study|stopped study at earlier timepoint|14|||
155040804|NCT02440854|559577575|FG000|Overall Study|Study medication not received|1|||
155040805|NCT02440854|559577575|FG000|Overall Study|Violation of inclusion criteria|2|||
155040806|NCT02243046|559577576|FG000|Overall Study|Lost to Follow-up|1|||
155040807|NCT02243046|559577577|FG001|Overall Study|Lost to Follow-up|1|||
155040808|NCT02243046|559577578|FG002|Overall Study|Lost to Follow-up|4|||
155040809|NCT00904917|559579292|FG000|Overall Study|Lost to Follow-up|2|||
155040810|NCT00904917|559579293|FG001|Overall Study|Lost to Follow-up|2|||
155040811|NCT00904917|559579294|FG002|Overall Study|Lost to Follow-up|2|||
155040812|NCT00904917|559579295|FG003|Overall Study|Lost to Follow-up|2|||
155040813|NCT02442206|559579296|FG000|Period 1|Adverse Event|1|||
155040814|NCT02442206|559579297|FG001|Period 1|Adverse Event|1|||
155040815|NCT02442206|559579296|FG000|Period 1|withdrew consent|0|||
155040816|NCT02442206|559579297|FG001|Period 1|withdrew consent|1|||
155040817|NCT02442206|559579296|FG000|Period 1|COPD exacerbation|0|||
155040818|NCT02442206|559579297|FG001|Period 1|COPD exacerbation|1|||
155040819|NCT02442206|559579296|FG000|Period 2|Adverse Event|1|||
155040820|NCT02442206|559579297|FG001|Period 2|Adverse Event|0|||
155040821|NCT01471444|559579298|FG000|Overall Study|Physician Decision|3|||
155040822|NCT01471444|559579299|FG001|Overall Study|Physician Decision|2|||
155040823|NCT01471444|559579298|FG000|Overall Study|Withdrawal by Subject|0|||
155040824|NCT01471444|559579299|FG001|Overall Study|Withdrawal by Subject|1|||
155040825|NCT01709409|559579304|FG000|Overall Study|Protocol Violation|1|||
155040826|NCT01709409|559579305|FG001|Overall Study|Protocol Violation|0|||
155040827|NCT02412878|559579306|FG000|Overall Study|Withdrawal by Subject|19|||
155040828|NCT02412878|559579307|FG001|Overall Study|Withdrawal by Subject|10|||
155040829|NCT02412878|559579306|FG000|Overall Study|Lost to Follow-up|2|||
155040830|NCT02412878|559579307|FG001|Overall Study|Lost to Follow-up|3|||
155040831|NCT02190721|559579308|FG000|Overall Study|Patient was out of the city|0|||
155040832|NCT02190721|559579309|FG001|Overall Study|Patient was out of the city|1|||
155040833|NCT02190721|559579310|FG002|Overall Study|Patient was out of the city|0|||
155040834|NCT05025332|559579311|FG000|Screening|Screen failure|12|||
155040835|NCT05025332|559579311|FG000|Treatment & Follow Up|Protocol Violation|1|||
155040836|NCT05025332|559579311|FG000|Treatment & Follow Up|Adverse Event|4|||
155040837|NCT04676152|559579312|FG000|Overall Study|screen fail|9|||
155040838|NCT01928199|559579313|FG000|Overall Study|Lost to Follow-up|2|||
155040839|NCT01928199|559579314|FG001|Overall Study|Lost to Follow-up|1|||
155040840|NCT01928199|559579313|FG000|Overall Study|Withdrawal by Subject|3|||
155040841|NCT01928199|559579314|FG001|Overall Study|Withdrawal by Subject|5|||
155040842|NCT02107313|559579316|FG000|Overall Study|One participant did not do the FED cohor|0|||
155040843|NCT02107313|559579317|FG001|Overall Study|One participant did not do the FED cohor|1|||
155040844|NCT01031004|559579320|FG000|Overall Study|Protocol Violation|0|||
155040845|NCT01031004|559579321|FG001|Overall Study|Protocol Violation|1|||
155040846|NCT01031004|559579320|FG000|Overall Study|Lost to Follow-up|1|||
155040847|NCT01031004|559579321|FG001|Overall Study|Lost to Follow-up|0|||
155040848|NCT01641471|559579322|FG000|Overall Study|Withdrawal by Subject|19|||
155040849|NCT01641471|559579323|FG001|Overall Study|Withdrawal by Subject|19|||
155040850|NCT01641471|559579322|FG000|Overall Study|Lost to Follow-up|2|||
155040851|NCT01641471|559579323|FG001|Overall Study|Lost to Follow-up|4|||
155040852|NCT01641471|559579322|FG000|Overall Study|Protocol Violation|2|||
155040853|NCT01641471|559579323|FG001|Overall Study|Protocol Violation|4|||
155040854|NCT04575584|559579324|FG000|Overall Study|Death|6|||
155040855|NCT04575584|559579325|FG001|Overall Study|Death|4|||
155040856|NCT04575584|559579326|FG002|Overall Study|Death|6|||
155040857|NCT04575584|559579327|FG003|Overall Study|Death|2|||
155040858|NCT04575584|559579328|FG004|Overall Study|Death|0|||
155040859|NCT04575584|559579329|FG005|Overall Study|Death|0|||
155040860|NCT04575584|559579324|FG000|Overall Study|Lost to Follow-up|1|||
155040861|NCT04575584|559579325|FG001|Overall Study|Lost to Follow-up|1|||
155040862|NCT04575584|559579326|FG002|Overall Study|Lost to Follow-up|1|||
155040863|NCT04575584|559579327|FG003|Overall Study|Lost to Follow-up|1|||
155040864|NCT04575584|559579328|FG004|Overall Study|Lost to Follow-up|0|||
155040865|NCT04575584|559579329|FG005|Overall Study|Lost to Follow-up|0|||
155040866|NCT04575584|559579324|FG000|Overall Study|Physician Decision|0|||
155040867|NCT04575584|559579325|FG001|Overall Study|Physician Decision|1|||
155040868|NCT04575584|559579326|FG002|Overall Study|Physician Decision|1|||
155040869|NCT04575584|559579327|FG003|Overall Study|Physician Decision|1|||
155040870|NCT04575584|559579328|FG004|Overall Study|Physician Decision|0|||
155040871|NCT04575584|559579329|FG005|Overall Study|Physician Decision|0|||
155040872|NCT04575584|559579324|FG000|Overall Study|Withdrawal by Subject|7|||
155040873|NCT04575584|559579325|FG001|Overall Study|Withdrawal by Subject|9|||
155040874|NCT04575584|559579326|FG002|Overall Study|Withdrawal by Subject|5|||
155040875|NCT04575584|559579327|FG003|Overall Study|Withdrawal by Subject|3|||
155040876|NCT04575584|559579328|FG004|Overall Study|Withdrawal by Subject|0|||
155040877|NCT04575584|559579329|FG005|Overall Study|Withdrawal by Subject|0|||
155040878|NCT04575584|559579324|FG000|Overall Study|Not recorded|0|||
155040879|NCT04575584|559579325|FG001|Overall Study|Not recorded|0|||
155040880|NCT04575584|559579326|FG002|Overall Study|Not recorded|0|||
155040881|NCT04575584|559579327|FG003|Overall Study|Not recorded|1|||
155040882|NCT04575584|559579328|FG004|Overall Study|Not recorded|0|||
155040883|NCT04575584|559579329|FG005|Overall Study|Not recorded|0|||
155040884|NCT01108237|559579330|FG000|Overall Study|No alignment data|2|||
155040885|NCT01108237|559579331|FG001|Overall Study|No alignment data|15|||
155040886|NCT01108237|559579330|FG000|Overall Study|Did not meet criteria for analysis|7|||
155040887|NCT01108237|559579331|FG001|Overall Study|Did not meet criteria for analysis|0|||
155040888|NCT02178358|559579334|FG000|Overall Study|Withdrawal by Subject|0|||
155040889|NCT02178358|559579335|FG001|Overall Study|Withdrawal by Subject|2|||
155040890|NCT02178358|559579336|FG002|Overall Study|Withdrawal by Subject|2|||
155040891|NCT02178358|559579334|FG000|Overall Study|Lost to Follow-up|1|||
155040892|NCT02178358|559579335|FG001|Overall Study|Lost to Follow-up|0|||
155040893|NCT02178358|559579336|FG002|Overall Study|Lost to Follow-up|0|||
155040894|NCT03297021|559579337|FG000|Overall Study|Incomplete/illegible data sheet|4|||
155040895|NCT03297021|559579338|FG001|Overall Study|Incomplete/illegible data sheet|2|||
155040896|NCT03297021|559579339|FG002|Overall Study|Incomplete/illegible data sheet|3|||
155040897|NCT03297021|559579337|FG000|Overall Study|Missing Post-Op Data|1|||
155040898|NCT03297021|559579338|FG001|Overall Study|Missing Post-Op Data|2|||
155040899|NCT03297021|559579339|FG002|Overall Study|Missing Post-Op Data|1|||
155040900|NCT02734862|559579340|FG000|Part A|Death|3|||
155040901|NCT02734862|559579341|FG001|Part A|Death|4|||
155040902|NCT02734862|559579342|FG002|Part A|Death|6|||
155040903|NCT02734862|559579340|FG000|Part A|Lost to Follow-up|2|||
155040904|NCT02734862|559579341|FG001|Part A|Lost to Follow-up|1|||
155040905|NCT02734862|559579342|FG002|Part A|Lost to Follow-up|1|||
155040906|NCT02734862|559579340|FG000|Part A|Withdrawal by Subject|1|||
155040907|NCT02734862|559579341|FG001|Part A|Withdrawal by Subject|1|||
155040908|NCT02734862|559579342|FG002|Part A|Withdrawal by Subject|2|||
155040909|NCT02734862|559579340|FG000|Part A|Physician Decision|2|||
155040910|NCT02734862|559579341|FG001|Part A|Physician Decision|0|||
155040911|NCT02734862|559579342|FG002|Part A|Physician Decision|1|||
155040912|NCT02734862|559579340|FG000|Part A|Adverse Event|2|||
155040913|NCT02734862|559579341|FG001|Part A|Adverse Event|0|||
155040914|NCT02734862|559579342|FG002|Part A|Adverse Event|1|||
155040915|NCT02734862|559579340|FG000|Part A|Noncompliance|1|||
155040916|NCT02734862|559579341|FG001|Part A|Noncompliance|1|||
155040917|NCT02734862|559579342|FG002|Part A|Noncompliance|0|||
155040918|NCT02734862|559579340|FG000|Part A|Other|1|||
155040919|NCT02734862|559579341|FG001|Part A|Other|1|||
155040920|NCT02734862|559579342|FG002|Part A|Other|3|||
155040921|NCT02734862|559579340|FG000|Part B|Death|8|||
155040922|NCT02734862|559579341|FG001|Part B|Death|3|||
155040923|NCT02734862|559579342|FG002|Part B|Death|5|||
155040924|NCT02734862|559579340|FG000|Part B|Lost to Follow-up|2|||
155040925|NCT02734862|559579341|FG001|Part B|Lost to Follow-up|2|||
155040926|NCT02734862|559579342|FG002|Part B|Lost to Follow-up|0|||
155040927|NCT02734862|559579340|FG000|Part B|Withdrawal by Subject|3|||
155040928|NCT02734862|559579341|FG001|Part B|Withdrawal by Subject|1|||
155040929|NCT02734862|559579342|FG002|Part B|Withdrawal by Subject|0|||
155040930|NCT02734862|559579340|FG000|Part B|Other|0|||
155040931|NCT02734862|559579341|FG001|Part B|Other|1|||
155040932|NCT02734862|559579342|FG002|Part B|Other|0|||
155040933|NCT02095197|559579343|FG000|Overall Study|Lost to Follow-up|0|||
155040934|NCT02095197|559579344|FG001|Overall Study|Lost to Follow-up|3|||
155040935|NCT00493311|559579345|FG000|Overall Study|Need for rescue medication|2|||
155040936|NCT00493311|559579346|FG001|Overall Study|Need for rescue medication|2|||
155040937|NCT02779075|559579347|FG000|Overall Study|Withdrawal by Subject|1|||
155040938|NCT02779075|559579348|FG001|Overall Study|Withdrawal by Subject|3|||
155040939|NCT02779075|559579347|FG000|Overall Study|IV lost during 2nd study|1|||
155040940|NCT02779075|559579348|FG001|Overall Study|IV lost during 2nd study|0|||
155040941|NCT00790556|559579349|FG000|Treatment Period 1|Physician Decision|1|||
155040942|NCT00790556|559579350|FG001|Treatment Period 1|Physician Decision|0|||
155040943|NCT00790556|559579349|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155040944|NCT00790556|559579350|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155040945|NCT01005901|559579353|FG000|Overall Study|Withdrawal by Subject|38|||
155040946|NCT01005901|559579354|FG001|Overall Study|Withdrawal by Subject|14|||
155040947|NCT01005901|559579353|FG000|Overall Study|Adverse Event|30|||
155040948|NCT01005901|559579354|FG001|Overall Study|Adverse Event|16|||
155040949|NCT01005901|559579353|FG000|Overall Study|Administrative problems|21|||
155040950|NCT01005901|559579354|FG001|Overall Study|Administrative problems|13|||
155040951|NCT01005901|559579353|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155040952|NCT01005901|559579354|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
155040953|NCT01005901|559579353|FG000|Overall Study|Protocol Violation|4|||
155381475|NCT01049217|560830936|FG001|Overall Study|Lost to Follow-up|8|||
155381476|NCT01049217|560830935|FG000|Overall Study|Withdrawal by Subject|4|||
155381477|NCT01049217|560830936|FG001|Overall Study|Withdrawal by Subject|3|||
155381478|NCT01049217|560830935|FG000|Overall Study|Protocol Violation|1|||
155381479|NCT01049217|560830936|FG001|Overall Study|Protocol Violation|3|||
155381480|NCT01049217|560830935|FG000|Overall Study|Pregnancy|1|||
155381481|NCT01049217|560830936|FG001|Overall Study|Pregnancy|0|||
155381482|NCT01049217|560830935|FG000|Overall Study|Study Terminated by Sponsor|43|||
155040954|NCT01005901|559579354|FG001|Overall Study|Protocol Violation|3|||
155040955|NCT01005901|559579353|FG000|Overall Study|Death|2|||
155040956|NCT01005901|559579354|FG001|Overall Study|Death|3|||
155040957|NCT01005901|559579353|FG000|Overall Study|Lost to Follow-up|1|||
155040958|NCT01005901|559579354|FG001|Overall Study|Lost to Follow-up|2|||
155040959|NCT01005901|559579353|FG000|Overall Study|Patient's inability to use the device|1|||
155040960|NCT01005901|559579354|FG001|Overall Study|Patient's inability to use the device|1|||
155040961|NCT01005901|559579353|FG000|Overall Study|No longer requires study drug|0|||
155040962|NCT01005901|559579354|FG001|Overall Study|No longer requires study drug|1|||
155040963|NCT00957424|559579355|FG000|Overall Study|Lost to Follow-up|19|||
155040964|NCT00957424|559579355|FG000|Overall Study|Protocol Violation|3|||
155040965|NCT00957424|559579355|FG000|Overall Study|Withdrawal by Subject|1|||
155040966|NCT01038752|559579356|FG000|Overall Study|Tumor Progression|2|||
155040967|NCT01038752|559579357|FG001|Overall Study|Tumor Progression|2|||
155040968|NCT01038752|559579356|FG000|Overall Study|Lost to Follow-up|3|||
155040969|NCT01038752|559579357|FG001|Overall Study|Lost to Follow-up|3|||
155040970|NCT04165135|559579364|FG000|Overall Study|Protocol Violation|10|||
155040971|NCT04165135|559579364|FG000|Overall Study|Participants withdrawal of consent|5|||
155040972|NCT05053035|559579371|FG000|Overall Study|Withdrawal by Subject|1|||
155040973|NCT05053035|559579372|FG001|Overall Study|Withdrawal by Subject|0|||
155040974|NCT00438256|559579373|FG000|Overall Study|Ineligible for Resection|2|||
155040975|NCT00438256|559579374|FG001|Overall Study|Ineligible for Resection|1|||
155040976|NCT00438256|559579375|FG002|Overall Study|Ineligible for Resection|1|||
155040977|NCT00438256|559579376|FG003|Overall Study|Ineligible for Resection|7|||
155040978|NCT00438256|559579373|FG000|Overall Study|Excluded final Diagnosis|0|||
155040979|NCT00438256|559579374|FG001|Overall Study|Excluded final Diagnosis|0|||
155040980|NCT00438256|559579375|FG002|Overall Study|Excluded final Diagnosis|0|||
155040981|NCT00438256|559579376|FG003|Overall Study|Excluded final Diagnosis|2|||
155040982|NCT02005627|559579377|FG000|Overall Study|Lost to Follow-up|1|||
155040983|NCT02005627|559579378|FG001|Overall Study|Lost to Follow-up|2|||
155040984|NCT02005627|559579377|FG000|Overall Study|Withdrawal by Subject|1|||
155040985|NCT02005627|559579378|FG001|Overall Study|Withdrawal by Subject|2|||
155040986|NCT00849290|559579384|FG000|Overall Study|Adverse Event|3|||
155040987|NCT00849290|559579384|FG000|Overall Study|Death|14|||
155040988|NCT00849290|559579384|FG000|Overall Study|Withdrawal by Subject|11|||
155040989|NCT00849290|559579384|FG000|Overall Study|Lost to Follow-up|2|||
155040990|NCT00849290|559579384|FG000|Overall Study|Protocol Violation|5|||
155040991|NCT00849290|559579384|FG000|Overall Study|Disease Progression|20|||
155040992|NCT03913104|559579391|FG000|Overall Study|Lost to Follow-up|20|||
155040993|NCT03913104|559579391|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
155040994|NCT03913104|559579391|FG000|Overall Study|Withdrawal by Subject|2|||
155040995|NCT04527978|559579393|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
155040996|NCT04527978|559579394|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
155040997|NCT00048165|559579396|FG000|Completed 6 Months Study|Administration/Other|8|||
155040998|NCT00048165|559579397|FG001|Completed 6 Months Study|Administration/Other|8|||
155040999|NCT00048165|559579396|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
155041000|NCT00048165|559579397|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
155041001|NCT00048165|559579396|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
155041002|NCT00048165|559579397|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
155041003|NCT00048165|559579396|FG000|Completed 6 Months Study|Death|12|||
155041004|NCT00048165|559579397|FG001|Completed 6 Months Study|Death|6|||
155041005|NCT00048165|559579396|FG000|Completed 6 Months Study|Insufficient therapy|1|||
155041006|NCT00048165|559579397|FG001|Completed 6 Months Study|Insufficient therapy|4|||
155041007|NCT00048165|559579396|FG000|Completed 6 Months Study|Other violation|4|||
155041008|NCT00048165|559579397|FG001|Completed 6 Months Study|Other violation|6|||
155041009|NCT00048165|559579396|FG000|Completed 6 Months Study|Refused treatment|5|||
155041010|NCT00048165|559579397|FG001|Completed 6 Months Study|Refused treatment|5|||
155041011|NCT00048165|559579396|FG000|Completed 6 Months Study|Violation criteria|0|||
155041012|NCT00048165|559579397|FG001|Completed 6 Months Study|Violation criteria|2|||
155041013|NCT00048165|559579396|FG000|Completed 6 Months Study|Did not receive study drug|6|||
155041014|NCT00048165|559579397|FG001|Completed 6 Months Study|Did not receive study drug|6|||
155041015|NCT00048165|559579396|FG000|Completed 12 Months Study|Administration/Other|0|||
155041016|NCT00048165|559579397|FG001|Completed 12 Months Study|Administration/Other|2|||
155041017|NCT00048165|559579396|FG000|Completed 12 Months Study|Death|2|||
155041018|NCT00048165|559579397|FG001|Completed 12 Months Study|Death|1|||
155041019|NCT00048165|559579396|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
155381483|NCT01049217|560830936|FG001|Overall Study|Study Terminated by Sponsor|43|||
154927688|NCT03466060|559158934|FG001|Period 2|Lens Handling Difficulties|0|||
154927689|NCT03466060|559158935|FG002|Period 2|Lens Handling Difficulties|1|||
154927690|NCT03466060|559158936|FG003|Period 2|Lens Handling Difficulties|0|||
154927691|NCT03466060|559158937|FG004|Period 2|Lens Handling Difficulties|0|||
154927692|NCT03466060|559158938|FG005|Period 2|Lens Handling Difficulties|0|||
154927693|NCT01610284|559158939|FG000|Randomization Phase|Adverse Event|1|||
154927694|NCT01610284|559158940|FG001|Randomization Phase|Adverse Event|0|||
154927695|NCT01610284|559158939|FG000|Randomization Phase|Physician Decision|1|||
154927696|NCT01610284|559158940|FG001|Randomization Phase|Physician Decision|1|||
154927697|NCT01610284|559158939|FG000|Randomization Phase|Death|0|||
154927698|NCT01610284|559158940|FG001|Randomization Phase|Death|1|||
154927699|NCT01610284|559158939|FG000|Treatment Phase|Adverse Event|80|||
154927700|NCT01610284|559158940|FG001|Treatment Phase|Adverse Event|12|||
154927701|NCT01610284|559158939|FG000|Treatment Phase|Lost to Follow-up|1|||
154927702|NCT01610284|559158940|FG001|Treatment Phase|Lost to Follow-up|0|||
155041020|NCT00048165|559579397|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
155041021|NCT00731731|559579398|FG000|Overall Study|Protocol Violation|0|||
155041022|NCT00731731|559579399|FG001|Overall Study|Protocol Violation|0|||
155041023|NCT00731731|559579400|FG002|Overall Study|Protocol Violation|1|||
155041024|NCT00731731|559579398|FG000|Overall Study|Cancel prior to treatment|0|||
155041025|NCT00731731|559579399|FG001|Overall Study|Cancel prior to treatment|0|||
155041026|NCT00731731|559579400|FG002|Overall Study|Cancel prior to treatment|2|||
155041027|NCT02112877|559579401|FG000|Overall Study|Withdrawal by Subject|1|||
155041028|NCT02112877|559579402|FG001|Overall Study|Withdrawal by Subject|7|||
155041029|NCT02112877|559579401|FG000|Overall Study|Visit Missed|1|||
155041030|NCT02112877|559579402|FG001|Overall Study|Visit Missed|6|||
155041031|NCT01578499|559579415|FG000|Overall Study|Reason not Specified|0|||
155041032|NCT01578499|559579416|FG001|Overall Study|Reason not Specified|1|||
155041033|NCT01578499|559579415|FG000|Overall Study|Lost to Follow-up|2|||
155041034|NCT01578499|559579416|FG001|Overall Study|Lost to Follow-up|1|||
155041035|NCT01578499|559579415|FG000|Overall Study|Withdrawal by Subject|10|||
155041036|NCT01578499|559579416|FG001|Overall Study|Withdrawal by Subject|16|||
155041037|NCT01578499|559579415|FG000|Overall Study|Death|20|||
155041038|NCT01578499|559579416|FG001|Overall Study|Death|25|||
155041039|NCT01578499|559579415|FG000|Overall Study|Died and End of Study Page not Completed|2|||
155041040|NCT01578499|559579416|FG001|Overall Study|Died and End of Study Page not Completed|0|||
155041041|NCT00862459|559579419|FG000|Overall Study|Lost to Follow-up|1|||
155041042|NCT00862459|559579420|FG001|Overall Study|Lost to Follow-up|2|||
155041043|NCT00862459|559579421|FG002|Overall Study|Lost to Follow-up|2|||
155041044|NCT00862459|559579419|FG000|Overall Study|Protocol Violation|1|||
155041045|NCT00862459|559579420|FG001|Overall Study|Protocol Violation|0|||
155041046|NCT00862459|559579421|FG002|Overall Study|Protocol Violation|0|||
155041047|NCT00862459|559579419|FG000|Overall Study|Withdrawal by Subject|1|||
155041048|NCT00862459|559579420|FG001|Overall Study|Withdrawal by Subject|1|||
155041049|NCT00862459|559579421|FG002|Overall Study|Withdrawal by Subject|3|||
155041050|NCT00862459|559579419|FG000|Overall Study|Adverse Event|0|||
155041051|NCT00862459|559579420|FG001|Overall Study|Adverse Event|1|||
155041052|NCT00862459|559579421|FG002|Overall Study|Adverse Event|0|||
155041053|NCT00862459|559579419|FG000|Overall Study|Personal reasons|1|||
155041054|NCT00862459|559579420|FG001|Overall Study|Personal reasons|0|||
155041055|NCT00862459|559579421|FG002|Overall Study|Personal reasons|0|||
155041056|NCT00862459|559579419|FG000|Overall Study|Operation|1|||
155041057|NCT00862459|559579420|FG001|Overall Study|Operation|1|||
155041058|NCT00862459|559579421|FG002|Overall Study|Operation|0|||
155041059|NCT00862459|559579419|FG000|Overall Study|Intravenous (IV) site problems|1|||
155041060|NCT00862459|559579420|FG001|Overall Study|Intravenous (IV) site problems|0|||
155041061|NCT00862459|559579421|FG002|Overall Study|Intravenous (IV) site problems|1|||
155041062|NCT00862459|559579419|FG000|Overall Study|Unable to hold still for imaging|0|||
155041063|NCT00862459|559579420|FG001|Overall Study|Unable to hold still for imaging|1|||
155041064|NCT00862459|559579421|FG002|Overall Study|Unable to hold still for imaging|0|||
155041065|NCT00862459|559579419|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
155041066|NCT00862459|559579420|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
155041067|NCT00862459|559579421|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
155041068|NCT00862459|559579419|FG000|Overall Study|Administrative problems|0|||
155041069|NCT00862459|559579420|FG001|Overall Study|Administrative problems|1|||
155041070|NCT00862459|559579421|FG002|Overall Study|Administrative problems|0|||
155041071|NCT00358956|559579422|FG000|Overall Study|Adverse Event|3|||
155041072|NCT00358956|559579422|FG000|Overall Study|condition under investigation worsened|4|||
155041073|NCT00358956|559579422|FG000|Overall Study|Withdrawal by Subject|1|||
155041074|NCT00655681|559579423|FG000|Overall Study|Lost to Follow-up|1|||
155041075|NCT00655681|559579424|FG001|Overall Study|Lost to Follow-up|1|||
154927703|NCT01610284|559158939|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
155041076|NCT03417024|559579428|FG000|Overall Study|Study Termination prior to follow-up|11|||
155041077|NCT03417024|559579428|FG000|Overall Study|Physician Decision|2|||
154927704|NCT01610284|559158940|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
154927705|NCT01610284|559158939|FG000|Treatment Phase|Physician Decision|27|||
154927706|NCT01610284|559158940|FG001|Treatment Phase|Physician Decision|24|||
154927707|NCT01610284|559158939|FG000|Treatment Phase|Progressive Disease|377|||
154927708|NCT01610284|559158940|FG001|Treatment Phase|Progressive Disease|486|||
154927709|NCT01610284|559158939|FG000|Treatment Phase|Protocol Deviation|2|||
154927710|NCT01610284|559158940|FG001|Treatment Phase|Protocol Deviation|3|||
154927711|NCT01610284|559158939|FG000|Treatment Phase|Study terminated by Sponsor|18|||
154927712|NCT01610284|559158940|FG001|Treatment Phase|Study terminated by Sponsor|15|||
154927713|NCT01610284|559158939|FG000|Treatment Phase|Subject/Guardian Decision|55|||
154927714|NCT01610284|559158940|FG001|Treatment Phase|Subject/Guardian Decision|23|||
154927715|NCT01610284|559158939|FG000|Treatment Phase|Death|6|||
154927716|NCT01610284|559158940|FG001|Treatment Phase|Death|5|||
154927717|NCT01610284|559158939|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
154927718|NCT01610284|559158940|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
154927719|NCT01610284|559158939|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
154927720|NCT01610284|559158940|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
154927721|NCT01610284|559158939|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
154927722|NCT01610284|559158940|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
154927723|NCT01610284|559158939|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
154927724|NCT01610284|559158940|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
154927725|NCT01610284|559158939|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
154927726|NCT01610284|559158940|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
154927727|NCT01610284|559158939|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
154927728|NCT01610284|559158940|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
154927729|NCT01856257|559158941|FG000|Overall Study|Death|2|||
154927730|NCT01856257|559158942|FG001|Overall Study|Death|0|||
154927731|NCT01856257|559158943|FG002|Overall Study|Death|0|||
154927732|NCT01856257|559158944|FG003|Overall Study|Death|0|||
154927733|NCT01856257|559158941|FG000|Overall Study|Physician Decision|0|||
154927734|NCT01856257|559158942|FG001|Overall Study|Physician Decision|0|||
154927735|NCT01856257|559158943|FG002|Overall Study|Physician Decision|0|||
154927736|NCT01856257|559158944|FG003|Overall Study|Physician Decision|1|||
154927737|NCT01856257|559158941|FG000|Overall Study|Withdrawal by Subject|1|||
154927738|NCT01856257|559158942|FG001|Overall Study|Withdrawal by Subject|1|||
154927739|NCT01856257|559158943|FG002|Overall Study|Withdrawal by Subject|0|||
154927740|NCT01856257|559158944|FG003|Overall Study|Withdrawal by Subject|0|||
154927741|NCT01856257|559158941|FG000|Overall Study|Donor complication|0|||
154927742|NCT01856257|559158942|FG001|Overall Study|Donor complication|0|||
154927743|NCT01856257|559158943|FG002|Overall Study|Donor complication|0|||
154927744|NCT01856257|559158944|FG003|Overall Study|Donor complication|1|||
154927745|NCT04935931|559158945|FG000|Overall Study|Withdrawal by Subject|1|||
154927746|NCT05168657|559158946|FG000|Overall Study|Adverse Event|0|||
154927747|NCT05168657|559158947|FG001|Overall Study|Adverse Event|0|||
154927748|NCT05168657|559158948|FG002|Overall Study|Adverse Event|1|||
154927749|NCT05168657|559158949|FG003|Overall Study|Adverse Event|0|||
154927750|NCT05168657|559158950|FG004|Overall Study|Adverse Event|0|||
154927751|NCT05168657|559158951|FG005|Overall Study|Adverse Event|0|||
154927752|NCT05168657|559158952|FG006|Overall Study|Adverse Event|0|||
154927753|NCT05168657|559158953|FG007|Overall Study|Adverse Event|0|||
154927754|NCT00077766|559158956|FG000|Overall Study|Adverse Event|1|||
154927755|NCT00077766|559158957|FG001|Overall Study|Adverse Event|1|||
154927756|NCT00077766|559158956|FG000|Overall Study|Withdrawal by Subject|4|||
154927757|NCT00077766|559158957|FG001|Overall Study|Withdrawal by Subject|3|||
154927758|NCT00077766|559158956|FG000|Overall Study|Death|12|||
154927759|NCT00077766|559158957|FG001|Overall Study|Death|10|||
154927760|NCT00077766|559158956|FG000|Overall Study|Lost to Follow-up|2|||
154927761|NCT00077766|559158957|FG001|Overall Study|Lost to Follow-up|0|||
154927762|NCT00077766|559158956|FG000|Overall Study|Protocol Violation|1|||
154927763|NCT00077766|559158957|FG001|Overall Study|Protocol Violation|0|||
154927764|NCT00077766|559158956|FG000|Overall Study|Kidney Transplantation|9|||
154927765|NCT00077766|559158957|FG001|Overall Study|Kidney Transplantation|5|||
154927766|NCT00077766|559158956|FG000|Overall Study|Transplantation|5|||
154927767|NCT00077766|559158957|FG001|Overall Study|Transplantation|1|||
154927768|NCT00077766|559158956|FG000|Overall Study|Investigators Discretion|1|||
154927769|NCT00077766|559158957|FG001|Overall Study|Investigators Discretion|0|||
154927770|NCT00077766|559158956|FG000|Overall Study|Participant's decision|1|||
154927771|NCT00077766|559158957|FG001|Overall Study|Participant's decision|0|||
154927772|NCT00077766|559158956|FG000|Overall Study|Dialysis Discontinued|1|||
154927773|NCT00077766|559158957|FG001|Overall Study|Dialysis Discontinued|0|||
154927774|NCT00077766|559158956|FG000|Overall Study|Dialysis|0|||
154927775|NCT00077766|559158957|FG001|Overall Study|Dialysis|1|||
154927776|NCT00077766|559158956|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
154927777|NCT00077766|559158957|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
154927778|NCT00077766|559158956|FG000|Overall Study|Started Nocturnal Dialysis|0|||
154927779|NCT00077766|559158957|FG001|Overall Study|Started Nocturnal Dialysis|1|||
154927780|NCT00077766|559158956|FG000|Overall Study|Stop Dialysis|0|||
154927781|NCT00077766|559158957|FG001|Overall Study|Stop Dialysis|1|||
155041078|NCT03168919|559579429|FG000|Overall Study|Withdrawal by Subject|2|||
155041079|NCT01085136|559579430|FG000|Part A|Other Adverse event|223|||
155041080|NCT01085136|559579431|FG001|Part A|Other Adverse event|0|||
155041081|NCT01085136|559579432|FG002|Part A|Other Adverse event|0|||
155041082|NCT01085136|559579430|FG000|Part A|Protocol Violation|3|||
155041083|NCT01085136|559579431|FG001|Part A|Protocol Violation|0|||
155041084|NCT01085136|559579432|FG002|Part A|Protocol Violation|0|||
155041085|NCT01085136|559579430|FG000|Part A|Lost to Follow-up|3|||
155041086|NCT01085136|559579431|FG001|Part A|Lost to Follow-up|0|||
155041087|NCT01085136|559579432|FG002|Part A|Lost to Follow-up|0|||
155041088|NCT01085136|559579430|FG000|Part A|Refusal to continue trial medication|64|||
155041089|NCT01085136|559579431|FG001|Part A|Refusal to continue trial medication|0|||
155041090|NCT01085136|559579432|FG002|Part A|Refusal to continue trial medication|0|||
155041091|NCT01085136|559579430|FG000|Part A|Other reason not defined above|30|||
155041092|NCT01085136|559579431|FG001|Part A|Other reason not defined above|0|||
155041093|NCT01085136|559579432|FG002|Part A|Other reason not defined above|0|||
155041094|NCT01085136|559579430|FG000|Part B|Other AE|0|||
155041095|NCT01085136|559579431|FG001|Part B|Other AE|29|||
155041096|NCT01085136|559579432|FG002|Part B|Other AE|8|||
155041097|NCT01085136|559579430|FG000|Part B|Refusal to continue trial medication|0|||
155041098|NCT01085136|559579431|FG001|Part B|Refusal to continue trial medication|12|||
155041099|NCT01085136|559579432|FG002|Part B|Refusal to continue trial medication|7|||
155041100|NCT01085136|559579430|FG000|Part B|Not treated|0|||
155381484|NCT01049217|560830935|FG000|Overall Study|Other|1|||
155381485|NCT01049217|560830936|FG001|Overall Study|Other|2|||
155381486|NCT01049217|560830935|FG000|Overall Study|Randomized but not Treated|0|||
155381487|NCT01049217|560830936|FG001|Overall Study|Randomized but not Treated|2|||
155381488|NCT00589121|560830937|FG000|Overall Study|Protocol Violation|2|||
155381489|NCT00589121|560830938|FG001|Overall Study|Protocol Violation|6|||
155381490|NCT00589121|560830937|FG000|Overall Study|No protocol treatment received|0|||
155381491|NCT00589121|560830938|FG001|Overall Study|No protocol treatment received|1|||
155381492|NCT02412371|560830939|FG000|Overall Study|Withdrawal by Subject|0|||
155381493|NCT02412371|560830940|FG001|Overall Study|Withdrawal by Subject|2|||
155381494|NCT02412371|560830941|FG002|Overall Study|Withdrawal by Subject|0|||
155381495|NCT02412371|560830942|FG003|Overall Study|Withdrawal by Subject|1|||
155381496|NCT02412371|560830943|FG004|Overall Study|Withdrawal by Subject|1|||
155381497|NCT02412371|560830944|FG005|Overall Study|Withdrawal by Subject|0|||
155381498|NCT02412371|560830939|FG000|Overall Study|Sponsor Discontinued Study|1|||
155381499|NCT02412371|560830940|FG001|Overall Study|Sponsor Discontinued Study|4|||
155381500|NCT02412371|560830941|FG002|Overall Study|Sponsor Discontinued Study|6|||
155381501|NCT02412371|560830942|FG003|Overall Study|Sponsor Discontinued Study|4|||
155381502|NCT02412371|560830943|FG004|Overall Study|Sponsor Discontinued Study|5|||
155381503|NCT02412371|560830944|FG005|Overall Study|Sponsor Discontinued Study|0|||
155381504|NCT02412371|560830939|FG000|Overall Study|Death|4|||
155381505|NCT02412371|560830940|FG001|Overall Study|Death|2|||
155381506|NCT02412371|560830941|FG002|Overall Study|Death|1|||
155381507|NCT02412371|560830942|FG003|Overall Study|Death|3|||
155381508|NCT02412371|560830943|FG004|Overall Study|Death|5|||
155381509|NCT02412371|560830944|FG005|Overall Study|Death|2|||
155381510|NCT02412371|560830939|FG000|Overall Study|Other|2|||
155381511|NCT02412371|560830940|FG001|Overall Study|Other|1|||
155381512|NCT02412371|560830941|FG002|Overall Study|Other|0|||
155381513|NCT02412371|560830942|FG003|Overall Study|Other|0|||
155381514|NCT02412371|560830943|FG004|Overall Study|Other|1|||
155381515|NCT02412371|560830944|FG005|Overall Study|Other|3|||
155381516|NCT00847808|560830945|FG000|Overall Study|Adverse Event|7|||
155381517|NCT00847808|560830945|FG000|Overall Study|Protocol Violation|1|||
155381518|NCT00847808|560830945|FG000|Overall Study|Lost to Follow-up|1|||
155381519|NCT00847808|560830945|FG000|Overall Study|Withdrawal by Subject|4|||
155381520|NCT00847808|560830945|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
155381521|NCT00847808|560830945|FG000|Overall Study|Participant Took Excluded Medication|1|||
155381522|NCT05000931|560830954|FG000|Overall Study|Lost to Follow-up|1|||
155041101|NCT01085136|559579431|FG001|Part B|Not treated|4|||
155041102|NCT01085136|559579432|FG002|Part B|Not treated|8|||
155041103|NCT01085136|559579430|FG000|Part B|Other reason not defined above|0|||
155041104|NCT01085136|559579431|FG001|Part B|Other reason not defined above|6|||
155381523|NCT00925132|560830955|FG000|Overall Study|Withdrawal by Subject|2|||
155381524|NCT00925132|560830956|FG001|Overall Study|Withdrawal by Subject|0|||
155381525|NCT00925132|560830957|FG002|Overall Study|Withdrawal by Subject|0|||
155381526|NCT00925132|560830958|FG003|Overall Study|Withdrawal by Subject|0|||
155381527|NCT00925132|560830959|FG004|Overall Study|Withdrawal by Subject|1|||
155381528|NCT00925132|560830955|FG000|Overall Study|Removed due to disease progression|0|||
155041105|NCT01085136|559579432|FG002|Part B|Other reason not defined above|3|||
155041106|NCT02195427|559579433|FG000|Overall Study|Did not consent to study extension|13|||
155381529|NCT00925132|560830956|FG001|Overall Study|Removed due to disease progression|0|||
155041107|NCT02195427|559579434|FG001|Overall Study|Did not consent to study extension|9|||
155041108|NCT02195427|559579433|FG000|Overall Study|Withdrawal by Subject|4|||
155041109|NCT02195427|559579434|FG001|Overall Study|Withdrawal by Subject|2|||
155381530|NCT00925132|560830957|FG002|Overall Study|Removed due to disease progression|0|||
154927782|NCT00077766|559158956|FG000|Overall Study|Participants Vacation|2|||
154927783|NCT00077766|559158957|FG001|Overall Study|Participants Vacation|1|||
154927784|NCT02057549|559158959|FG000|Overall Study|Lost to Follow-up|1|||
154927785|NCT02057549|559158960|FG001|Overall Study|Lost to Follow-up|0|||
154927786|NCT02057549|559158959|FG000|Overall Study|Physician Decision|1|||
154927787|NCT02057549|559158960|FG001|Overall Study|Physician Decision|0|||
154927788|NCT02057549|559158959|FG000|Overall Study|Withdrawal by Subject|1|||
154927789|NCT02057549|559158960|FG001|Overall Study|Withdrawal by Subject|0|||
154927790|NCT04636437|559158963|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
154927791|NCT04636437|559158964|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
154927792|NCT04636437|559158965|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
154927793|NCT04636437|559158963|FG000|Overall Study|Started weight loss drug/program|2|||
154927794|NCT04636437|559158964|FG001|Overall Study|Started weight loss drug/program|1|||
154927795|NCT04636437|559158965|FG002|Overall Study|Started weight loss drug/program|1|||
154927796|NCT04636437|559158963|FG000|Overall Study|Lost to Follow-up|3|||
154927797|NCT04636437|559158964|FG001|Overall Study|Lost to Follow-up|1|||
154927798|NCT04636437|559158965|FG002|Overall Study|Lost to Follow-up|4|||
154927799|NCT04636437|559158963|FG000|Overall Study|Participant or physician decision|3|||
154927800|NCT04636437|559158964|FG001|Overall Study|Participant or physician decision|1|||
154927801|NCT04636437|559158965|FG002|Overall Study|Participant or physician decision|1|||
154927802|NCT00816166|559158966|FG000|Overall Study|Lost to Follow-up|6|||
154927803|NCT00816166|559158967|FG001|Overall Study|Lost to Follow-up|10|||
154927804|NCT00816166|559158966|FG000|Overall Study|Death|4|||
154927805|NCT00816166|559158967|FG001|Overall Study|Death|2|||
154927806|NCT01071278|559158968|FG000|Overall Study|Premature Discontinuation|254|||
154927807|NCT01071278|559158968|FG000|Overall Study|Completion Status Unknown|459|||
154927808|NCT02851069|559158969|FG000|Overall Study|Failure to Return|3|||
154927809|NCT02851069|559158969|FG000|Overall Study|Other|3|||
154927810|NCT00352664|559158970|FG000|Overall Study|Withdrawal by Subject|7|||
154927811|NCT00352664|559158971|FG001|Overall Study|Withdrawal by Subject|0|||
154927812|NCT03539952|559158972|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
154927813|NCT03539952|559158973|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
154927814|NCT03539952|559158972|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
154927815|NCT03539952|559158973|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
154927816|NCT03539952|559158972|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
154927817|NCT03539952|559158973|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
154927818|NCT03539952|559158972|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
154927819|NCT03539952|559158973|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
154927820|NCT03539952|559158972|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
154927821|NCT03539952|559158973|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
154927822|NCT03539952|559158972|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
154927823|NCT03539952|559158973|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
154927824|NCT03539952|559158972|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
154927825|NCT03539952|559158973|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
154927826|NCT02184988|559158974|FG000|Overall Study|Pregnancy|2|||
154927827|NCT02184988|559158974|FG000|Overall Study|Adverse Event|2|||
154927828|NCT02184988|559158974|FG000|Overall Study|moving away/travelling/unable to complet|6|||
154927829|NCT02184988|559158974|FG000|Overall Study|work scheduling issues|4|||
154927830|NCT02184988|559158974|FG000|Overall Study|various other reasons|9|||
154927831|NCT02184988|559158974|FG000|Overall Study|Lost to Follow-up|32|||
154927832|NCT03075215|559158975|FG000|12-Month Primary Endpoint|Death|152|||
154927833|NCT03075215|559158975|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
154927834|NCT03075215|559158975|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
154927835|NCT03075215|559158975|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
154927836|NCT01821391|559158976|FG000|Overall Study|Adverse Event|1|||
154927837|NCT01821391|559158977|FG001|Overall Study|Adverse Event|0|||
154927838|NCT02146365|559158978|FG000|Overall Study|Lost to Follow-up|2|||
154927839|NCT02146365|559158979|FG001|Overall Study|Lost to Follow-up|1|||
154927840|NCT02146365|559158980|FG002|Overall Study|Lost to Follow-up|3|||
154927841|NCT02146365|559158981|FG003|Overall Study|Lost to Follow-up|3|||
154927842|NCT02146365|559158982|FG004|Overall Study|Lost to Follow-up|1|||
154927843|NCT02146365|559158983|FG005|Overall Study|Lost to Follow-up|1|||
154927844|NCT02146365|559158984|FG006|Overall Study|Lost to Follow-up|0|||
154927845|NCT02146365|559158985|FG007|Overall Study|Lost to Follow-up|1|||
154927846|NCT02146365|559158978|FG000|Overall Study|Withdrawal by Subject|1|||
154927847|NCT02146365|559158979|FG001|Overall Study|Withdrawal by Subject|2|||
154927848|NCT02146365|559158980|FG002|Overall Study|Withdrawal by Subject|1|||
154927849|NCT02146365|559158981|FG003|Overall Study|Withdrawal by Subject|5|||
154927850|NCT02146365|559158982|FG004|Overall Study|Withdrawal by Subject|1|||
154927851|NCT02146365|559158983|FG005|Overall Study|Withdrawal by Subject|0|||
154927852|NCT02146365|559158984|FG006|Overall Study|Withdrawal by Subject|0|||
154927853|NCT02146365|559158985|FG007|Overall Study|Withdrawal by Subject|0|||
154927854|NCT02146365|559158978|FG000|Overall Study|Unable to Comply with Protocol|0|||
155041110|NCT02195427|559579433|FG000|Overall Study|Lost to Follow-up|0|||
155041111|NCT02195427|559579434|FG001|Overall Study|Lost to Follow-up|1|||
155041112|NCT02195427|559579433|FG000|Overall Study|Protocol Violation|7|||
155041113|NCT02195427|559579434|FG001|Overall Study|Protocol Violation|14|||
155041114|NCT02195427|559579433|FG000|Overall Study|Conditional re-treatment at W52|2|||
155041115|NCT02195427|559579434|FG001|Overall Study|Conditional re-treatment at W52|1|||
155041116|NCT01210144|559579435|FG000|Overall Study|Lack of ovarian response|1|||
155041117|NCT01210144|559579436|FG001|Overall Study|Lack of ovarian response|0|||
155041118|NCT01210144|559579435|FG000|Overall Study|No fertilization|1|||
155041119|NCT01210144|559579436|FG001|Overall Study|No fertilization|0|||
155041120|NCT01210144|559579435|FG000|Overall Study|No transfer|1|||
155041121|NCT01210144|559579436|FG001|Overall Study|No transfer|0|||
155041122|NCT02655419|559579438|FG000|Overall Study|Enrolled but not treated|1|||
155041123|NCT02655419|559579439|FG001|Overall Study|Enrolled but not treated|5|||
155041124|NCT02655419|559579438|FG000|Overall Study|Withdrawal by Subject|4|||
155041125|NCT02655419|559579439|FG001|Overall Study|Withdrawal by Subject|1|||
155041126|NCT02655419|559579438|FG000|Overall Study|Other|0|||
155041127|NCT02655419|559579439|FG001|Overall Study|Other|1|||
155041128|NCT04226495|559579443|FG000|Overall Study|Withdrawal by Subject|3|||
155041129|NCT04226495|559579444|FG001|Overall Study|Withdrawal by Subject|3|||
155041130|NCT04226495|559579443|FG000|Overall Study|PI discretion|3|||
155041131|NCT04226495|559579444|FG001|Overall Study|PI discretion|4|||
155041132|NCT02496039|559580919|FG000|Overall Study|Adverse Event|3|||
155041133|NCT02496039|559580919|FG000|Overall Study|Protocol Violation|1|||
155041134|NCT00530790|559580920|FG000|Overall Study|Adverse Event|2|||
155041135|NCT00530790|559580920|FG000|Overall Study|Withdrawal by Subject|2|||
155041136|NCT00530790|559580920|FG000|Overall Study|Physician Decision|1|||
155041137|NCT00938587|559580921|FG000|Overall Study|Adverse Event|2|||
155041138|NCT00938587|559580922|FG001|Overall Study|Adverse Event|0|||
155041139|NCT00938587|559580923|FG002|Overall Study|Adverse Event|0|||
155041140|NCT00938587|559580924|FG003|Overall Study|Adverse Event|2|||
155041141|NCT00938587|559580921|FG000|Overall Study|Did not meet entrance criteria|0|||
155041142|NCT00938587|559580922|FG001|Overall Study|Did not meet entrance criteria|0|||
155041143|NCT00938587|559580923|FG002|Overall Study|Did not meet entrance criteria|1|||
155041144|NCT00938587|559580924|FG003|Overall Study|Did not meet entrance criteria|0|||
155041145|NCT00938587|559580921|FG000|Overall Study|Withdrawal by Subject|1|||
155041146|NCT00938587|559580922|FG001|Overall Study|Withdrawal by Subject|1|||
155041147|NCT00938587|559580923|FG002|Overall Study|Withdrawal by Subject|0|||
155041148|NCT00938587|559580924|FG003|Overall Study|Withdrawal by Subject|0|||
155041149|NCT01464619|559580925|FG000|Overall Study|Lost to Follow-up|3|||
155041150|NCT01464619|559580926|FG001|Overall Study|Lost to Follow-up|4|||
155041151|NCT00080483|559580931|FG000|Overall Study|Lost to Follow-up|1|||
155041152|NCT00080483|559580932|FG001|Overall Study|Lost to Follow-up|1|||
155041153|NCT00080483|559580931|FG000|Overall Study|Physician Decision|1|||
155041154|NCT00080483|559580932|FG001|Overall Study|Physician Decision|1|||
155041155|NCT01119846|559580935|FG000|Overall Study|Adverse Event|1|||
155041156|NCT01119846|559580936|FG001|Overall Study|Adverse Event|0|||
155041157|NCT01119846|559580937|FG002|Overall Study|Adverse Event|6|||
155041158|NCT01119846|559580935|FG000|Overall Study|Physician Decision|1|||
155041159|NCT01119846|559580936|FG001|Overall Study|Physician Decision|0|||
155041160|NCT01119846|559580937|FG002|Overall Study|Physician Decision|0|||
155041161|NCT01119846|559580935|FG000|Overall Study|Protocol Violation|0|||
155041162|NCT01119846|559580936|FG001|Overall Study|Protocol Violation|0|||
155041163|NCT01119846|559580937|FG002|Overall Study|Protocol Violation|1|||
155041164|NCT01119846|559580935|FG000|Overall Study|Withdrawal by Subject|0|||
155041165|NCT01119846|559580936|FG001|Overall Study|Withdrawal by Subject|0|||
155041166|NCT01119846|559580937|FG002|Overall Study|Withdrawal by Subject|4|||
155041167|NCT00048997|559580940|FG000|Overall Study|Protocol Violation|7|||
155041168|NCT00048997|559580941|FG001|Overall Study|Protocol Violation|2|||
155041169|NCT00048997|559580940|FG000|Overall Study|Withdrawal by Subject|6|||
155041170|NCT00048997|559580941|FG001|Overall Study|Withdrawal by Subject|1|||
155041171|NCT02819440|559580942|FG000|Overall Study|Adverse Event|3|||
155041172|NCT02819440|559580943|FG001|Overall Study|Adverse Event|1|||
155041173|NCT02819440|559580942|FG000|Overall Study|Lost to Follow-up|1|||
155041174|NCT02819440|559580943|FG001|Overall Study|Lost to Follow-up|3|||
155041175|NCT02819440|559580942|FG000|Overall Study|Withdrawal by Subject|9|||
155041176|NCT02819440|559580943|FG001|Overall Study|Withdrawal by Subject|8|||
155041177|NCT01404949|559580948|FG000|Overall Study|Not Treated|1|||
155041178|NCT00002525|559580950|FG000|Overall Study|Adverse Event|36|||
155041179|NCT00002525|559580951|FG001|Overall Study|Adverse Event|0|||
155041180|NCT00002525|559580950|FG000|Overall Study|Death|5|||
155041181|NCT00002525|559580951|FG001|Overall Study|Death|0|||
155041182|NCT00002525|559580950|FG000|Overall Study|Withdrawal by Subject|11|||
155041183|NCT00002525|559580951|FG001|Overall Study|Withdrawal by Subject|0|||
155041184|NCT00002525|559580950|FG000|Overall Study|Start non-protocol therapy|1|||
155041185|NCT00002525|559580951|FG001|Overall Study|Start non-protocol therapy|0|||
155041186|NCT00002525|559580950|FG000|Overall Study|Other complicating disease|1|||
155041187|NCT00002525|559580951|FG001|Overall Study|Other complicating disease|0|||
155041188|NCT00002525|559580950|FG000|Overall Study|Duke's A, B1, D disease|92|||
155041189|NCT00002525|559580951|FG001|Overall Study|Duke's A, B1, D disease|0|||
155041190|NCT00002525|559580950|FG000|Overall Study|Error|6|||
155041191|NCT00002525|559580951|FG001|Overall Study|Error|0|||
155041192|NCT00002525|559580950|FG000|Overall Study|Other|26|||
155041193|NCT00002525|559580951|FG001|Overall Study|Other|0|||
155041194|NCT00002525|559580950|FG000|Overall Study|Never start protocol therapy|8|||
155041195|NCT00002525|559580951|FG001|Overall Study|Never start protocol therapy|0|||
155041196|NCT03304184|559580952|FG000|Overall Study|Withdrawal by Subject|1|||
155041197|NCT03304184|559580953|FG001|Overall Study|Withdrawal by Subject|2|||
155041198|NCT03420222|559580956|FG000|Overall Study|Withdrawal by Subject|5|||
155041199|NCT03420222|559580957|FG001|Overall Study|Withdrawal by Subject|0|||
155041200|NCT03420222|559580956|FG000|Overall Study|Physician Decision|0|||
155041201|NCT03420222|559580957|FG001|Overall Study|Physician Decision|1|||
155041202|NCT02334384|559580960|FG000|Overall Study|Lost to Follow-up|1|||
155041203|NCT02334384|559580961|FG001|Overall Study|Lost to Follow-up|1|||
154927855|NCT02146365|559158979|FG001|Overall Study|Unable to Comply with Protocol|1|||
154927856|NCT02146365|559158980|FG002|Overall Study|Unable to Comply with Protocol|1|||
154927857|NCT02146365|559158981|FG003|Overall Study|Unable to Comply with Protocol|0|||
154927858|NCT02146365|559158982|FG004|Overall Study|Unable to Comply with Protocol|0|||
154927859|NCT02146365|559158983|FG005|Overall Study|Unable to Comply with Protocol|0|||
154927860|NCT02146365|559158984|FG006|Overall Study|Unable to Comply with Protocol|0|||
154927861|NCT02146365|559158985|FG007|Overall Study|Unable to Comply with Protocol|0|||
154927862|NCT02146365|559158978|FG000|Overall Study|Other|1|||
154927863|NCT02146365|559158979|FG001|Overall Study|Other|0|||
154927864|NCT02146365|559158980|FG002|Overall Study|Other|2|||
154927865|NCT02146365|559158981|FG003|Overall Study|Other|1|||
154927866|NCT02146365|559158982|FG004|Overall Study|Other|0|||
154927867|NCT02146365|559158983|FG005|Overall Study|Other|0|||
154927868|NCT02146365|559158984|FG006|Overall Study|Other|0|||
154927869|NCT02146365|559158985|FG007|Overall Study|Other|0|||
154927870|NCT01608321|559158986|FG000|Overall Study|Withdrawal by Subject|1|||
154927871|NCT01608321|559158987|FG001|Overall Study|Withdrawal by Subject|0|||
154927872|NCT03222856|559158990|FG000|Overall Study|Adverse Event|6|||
154927873|NCT03222856|559158990|FG000|Overall Study|Death|1|||
154927874|NCT01956123|559160664|FG000|COS Cycle 2|Protocol Violation|8|||
154927875|NCT01956123|559160665|FG001|COS Cycle 2|Protocol Violation|3|||
154927876|NCT01956123|559160666|FG002|COS Cycle 2|Protocol Violation|0|||
154927877|NCT01956123|559160667|FG003|COS Cycle 2|Protocol Violation|0|||
154927878|NCT01956123|559160664|FG000|COS Cycle 2|Adverse Event|3|||
154927879|NCT01956123|559160665|FG001|COS Cycle 2|Adverse Event|4|||
154927880|NCT01956123|559160666|FG002|COS Cycle 2|Adverse Event|0|||
154927881|NCT01956123|559160667|FG003|COS Cycle 2|Adverse Event|0|||
154927882|NCT01956123|559160664|FG000|COS Cycle 2|Personal Reasons|2|||
154927883|NCT01956123|559160665|FG001|COS Cycle 2|Personal Reasons|0|||
154927884|NCT01956123|559160666|FG002|COS Cycle 2|Personal Reasons|0|||
154927885|NCT01956123|559160667|FG003|COS Cycle 2|Personal Reasons|0|||
154927886|NCT01956123|559160664|FG000|COS Cycle 2|Withdrawal by Subject|1|||
154927887|NCT01956123|559160665|FG001|COS Cycle 2|Withdrawal by Subject|0|||
154927888|NCT01956123|559160666|FG002|COS Cycle 2|Withdrawal by Subject|0|||
155041204|NCT02651688|559580962|FG000|Overall Study|Non-compliance|0|||
155041205|NCT02651688|559580963|FG001|Overall Study|Non-compliance|0|||
155041206|NCT02651688|559580964|FG002|Overall Study|Non-compliance|1|||
155041207|NCT02651688|559580962|FG000|Overall Study|Principal Investigator (PI) decision|0|||
155041208|NCT02651688|559580963|FG001|Overall Study|Principal Investigator (PI) decision|2|||
155041209|NCT02651688|559580964|FG002|Overall Study|Principal Investigator (PI) decision|0|||
154927889|NCT01956123|559160667|FG003|COS Cycle 2|Withdrawal by Subject|0|||
154927890|NCT01956123|559160664|FG000|COS Cycle 3|Protocol Violation|0|||
154927891|NCT01956123|559160665|FG001|COS Cycle 3|Protocol Violation|0|||
155041210|NCT02651688|559580962|FG000|Overall Study|Lost to Follow-up|1|||
155041211|NCT02651688|559580963|FG001|Overall Study|Lost to Follow-up|3|||
154927892|NCT01956123|559160666|FG002|COS Cycle 3|Protocol Violation|2|||
154927893|NCT01956123|559160667|FG003|COS Cycle 3|Protocol Violation|1|||
154927894|NCT01956123|559160664|FG000|COS Cycle 3|Adverse Event|0|||
154927895|NCT01956123|559160665|FG001|COS Cycle 3|Adverse Event|0|||
154927896|NCT01956123|559160666|FG002|COS Cycle 3|Adverse Event|3|||
154927897|NCT01956123|559160667|FG003|COS Cycle 3|Adverse Event|0|||
154927898|NCT01956123|559160664|FG000|COS Cycle 3|Personal Reasons|0|||
154927899|NCT01956123|559160665|FG001|COS Cycle 3|Personal Reasons|0|||
154927900|NCT01956123|559160666|FG002|COS Cycle 3|Personal Reasons|1|||
155041212|NCT02651688|559580964|FG002|Overall Study|Lost to Follow-up|0|||
155041213|NCT02651688|559580962|FG000|Overall Study|Withdrawal by Subject|1|||
155041214|NCT02651688|559580963|FG001|Overall Study|Withdrawal by Subject|0|||
155041215|NCT02651688|559580964|FG002|Overall Study|Withdrawal by Subject|2|||
155041216|NCT00625183|559580965|FG000|Overall Study|Disease Progression|1|||
155041217|NCT01606748|559580966|FG000|Overall Study|Adverse Event|1|||
154927901|NCT01956123|559160667|FG003|COS Cycle 3|Personal Reasons|0|||
154927902|NCT01956123|559160664|FG000|COS Cycle 3|Withdrawal by Subject|0|||
154927903|NCT01956123|559160665|FG001|COS Cycle 3|Withdrawal by Subject|0|||
155041218|NCT01606748|559580967|FG001|Overall Study|Adverse Event|0|||
155041219|NCT01606748|559580966|FG000|Overall Study|Progressive Disease|1|||
155041220|NCT01606748|559580967|FG001|Overall Study|Progressive Disease|0|||
155041221|NCT01606748|559580966|FG000|Overall Study|Withdrawal by Subject|1|||
155041222|NCT01606748|559580967|FG001|Overall Study|Withdrawal by Subject|0|||
155041223|NCT03084315|559580968|FG000|Overall Study|Lost to Follow-up|8|||
155041224|NCT03084315|559580969|FG001|Overall Study|Lost to Follow-up|7|||
155041225|NCT03084315|559580968|FG000|Overall Study|Withdrawal by Subject|2|||
155041226|NCT03084315|559580969|FG001|Overall Study|Withdrawal by Subject|2|||
155041227|NCT02906033|559580972|FG000|Baseline|Protocol Violation|37|||
155041228|NCT02906033|559580973|FG001|Baseline|Protocol Violation|33|||
155041229|NCT02906033|559580972|FG000|Follow-up|Lost to Follow-up|46|||
155041230|NCT02906033|559580973|FG001|Follow-up|Lost to Follow-up|62|||
155041231|NCT03782974|559580988|FG000|Overall Study|Withdrawal by Subject|7|||
155041232|NCT03782974|559580989|FG001|Overall Study|Withdrawal by Subject|7|||
155041233|NCT03782974|559580988|FG000|Overall Study|Pregnancy|1|||
155041234|NCT03782974|559580989|FG001|Overall Study|Pregnancy|0|||
155041235|NCT00505661|559580992|FG000|Overall Study|Not Eligible|4|||
155041236|NCT01907217|559580994|FG000|Overall Study|Withdrawal by Subject|0|||
155041237|NCT01907217|559580995|FG001|Overall Study|Withdrawal by Subject|2|||
155041238|NCT01764659|559581000|FG000|Overall Study|Death|1|||
155041239|NCT01764659|559581000|FG000|Overall Study|Physician Decision|1|||
155041240|NCT01210352|559581002|FG000|Overall Study|Adverse Event|0|||
155041241|NCT01210352|559581003|FG001|Overall Study|Adverse Event|0|||
155041242|NCT01210352|559581004|FG002|Overall Study|Adverse Event|0|||
155041243|NCT01210352|559581005|FG003|Overall Study|Adverse Event|0|||
155041244|NCT01210352|559581006|FG004|Overall Study|Adverse Event|0|||
155041245|NCT01210352|559581007|FG005|Overall Study|Adverse Event|0|||
155041246|NCT01210352|559581008|FG006|Overall Study|Adverse Event|0|||
155041247|NCT01210352|559581009|FG007|Overall Study|Adverse Event|2|||
155041248|NCT01210352|559581010|FG008|Overall Study|Adverse Event|1|||
155041249|NCT01210352|559581002|FG000|Overall Study|Lack of Efficacy|0|||
155041250|NCT01210352|559581003|FG001|Overall Study|Lack of Efficacy|0|||
155041251|NCT01210352|559581004|FG002|Overall Study|Lack of Efficacy|0|||
155041252|NCT01210352|559581005|FG003|Overall Study|Lack of Efficacy|0|||
155041253|NCT01210352|559581006|FG004|Overall Study|Lack of Efficacy|0|||
155041254|NCT01210352|559581007|FG005|Overall Study|Lack of Efficacy|0|||
155041255|NCT01210352|559581008|FG006|Overall Study|Lack of Efficacy|1|||
155041256|NCT01210352|559581009|FG007|Overall Study|Lack of Efficacy|0|||
155041257|NCT01210352|559581010|FG008|Overall Study|Lack of Efficacy|0|||
155041258|NCT01210352|559581002|FG000|Overall Study|Physician Decision|0|||
155041259|NCT01210352|559581003|FG001|Overall Study|Physician Decision|0|||
155041260|NCT01210352|559581004|FG002|Overall Study|Physician Decision|0|||
155041261|NCT01210352|559581005|FG003|Overall Study|Physician Decision|0|||
155041262|NCT01210352|559581006|FG004|Overall Study|Physician Decision|0|||
155041263|NCT01210352|559581007|FG005|Overall Study|Physician Decision|0|||
155041264|NCT01210352|559581008|FG006|Overall Study|Physician Decision|0|||
155041265|NCT01210352|559581009|FG007|Overall Study|Physician Decision|1|||
155041266|NCT01210352|559581010|FG008|Overall Study|Physician Decision|2|||
155041267|NCT01210352|559581002|FG000|Overall Study|Withdrawal by Subject|0|||
155041268|NCT01210352|559581003|FG001|Overall Study|Withdrawal by Subject|0|||
155041269|NCT01210352|559581004|FG002|Overall Study|Withdrawal by Subject|1|||
155041270|NCT01210352|559581005|FG003|Overall Study|Withdrawal by Subject|0|||
155041271|NCT01210352|559581006|FG004|Overall Study|Withdrawal by Subject|0|||
155041272|NCT01210352|559581007|FG005|Overall Study|Withdrawal by Subject|0|||
155041273|NCT01210352|559581008|FG006|Overall Study|Withdrawal by Subject|1|||
155041274|NCT01210352|559581009|FG007|Overall Study|Withdrawal by Subject|0|||
155041275|NCT01210352|559581010|FG008|Overall Study|Withdrawal by Subject|1|||
155041276|NCT01210352|559581002|FG000|Overall Study|Patient Discharged Early|0|||
155041277|NCT01210352|559581003|FG001|Overall Study|Patient Discharged Early|0|||
155041278|NCT01210352|559581004|FG002|Overall Study|Patient Discharged Early|1|||
155041279|NCT01210352|559581005|FG003|Overall Study|Patient Discharged Early|0|||
155041280|NCT01210352|559581006|FG004|Overall Study|Patient Discharged Early|0|||
155041281|NCT01210352|559581007|FG005|Overall Study|Patient Discharged Early|0|||
155041282|NCT01210352|559581008|FG006|Overall Study|Patient Discharged Early|0|||
155041283|NCT01210352|559581009|FG007|Overall Study|Patient Discharged Early|0|||
155041284|NCT01210352|559581010|FG008|Overall Study|Patient Discharged Early|0|||
155041285|NCT03338569|559581011|FG000|Overall Study|Physician Decision|8|||
155041286|NCT03338569|559581012|FG001|Overall Study|Physician Decision|3|||
155041287|NCT03338569|559581011|FG000|Overall Study|Withdrawal by Subject|0|||
155041288|NCT03338569|559581012|FG001|Overall Study|Withdrawal by Subject|1|||
155041289|NCT03338569|559581011|FG000|Overall Study|Lost to Follow-up|0|||
155041290|NCT03338569|559581012|FG001|Overall Study|Lost to Follow-up|1|||
155041291|NCT04607980|559581013|FG000|Overall Study|Adverse Event|3|||
155041292|NCT04607980|559581014|FG001|Overall Study|Adverse Event|4|||
155041293|NCT04607980|559581013|FG000|Overall Study|Death|0|||
155041294|NCT04607980|559581014|FG001|Overall Study|Death|1|||
155041295|NCT04607980|559581013|FG000|Overall Study|Withdrawal by Subject|2|||
155041296|NCT04607980|559581014|FG001|Overall Study|Withdrawal by Subject|5|||
155041297|NCT04607980|559581013|FG000|Overall Study|Lost to Follow-up|4|||
155041298|NCT04607980|559581014|FG001|Overall Study|Lost to Follow-up|8|||
155041299|NCT04607980|559581013|FG000|Overall Study|Protocol Violation|0|||
155041300|NCT04607980|559581014|FG001|Overall Study|Protocol Violation|3|||
155041301|NCT04607980|559581013|FG000|Overall Study|Other|3|||
155041302|NCT04607980|559581014|FG001|Overall Study|Other|0|||
155041303|NCT00448812|559581016|FG000|Year 2|Missed visit but remained in study|4|||
155041304|NCT00448812|559581017|FG001|Year 2|Missed visit but remained in study|1|||
155041305|NCT00448812|559581016|FG000|Year 3|Withdrawal by Subject|1|||
155041306|NCT00448812|559581017|FG001|Year 3|Withdrawal by Subject|3|||
155041307|NCT00448812|559581016|FG000|Year 3|Lost to Follow-up|1|||
155041308|NCT00448812|559581017|FG001|Year 3|Lost to Follow-up|0|||
155041309|NCT00448812|559581016|FG000|Year 3|Missed visit but remained in study|2|||
155041310|NCT00448812|559581017|FG001|Year 3|Missed visit but remained in study|0|||
155041311|NCT00448812|559581016|FG000|Year 5|Missed visit but remained in study|1|||
155041312|NCT00448812|559581017|FG001|Year 5|Missed visit but remained in study|0|||
155041313|NCT01854879|559581020|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
155041314|NCT01854879|559581020|FG000|Overall Study|screen fail|3|||
155041315|NCT01854879|559581020|FG000|Overall Study|incomplete data set|1|||
155041316|NCT02012959|559581021|FG000|Treatment Phase A|Adverse Event|2|||
155041317|NCT02012959|559581022|FG001|Treatment Phase A|Adverse Event|0|||
155041318|NCT02012959|559581023|FG002|Treatment Phase A|Adverse Event|0|||
155041319|NCT02012959|559581024|FG003|Treatment Phase A|Adverse Event|0|||
155041320|NCT02012959|559581025|FG004|Treatment Phase A|Adverse Event|0|||
155381531|NCT00925132|560830958|FG003|Overall Study|Removed due to disease progression|0|||
155381532|NCT00925132|560830959|FG004|Overall Study|Removed due to disease progression|4|||
155381533|NCT02545933|560830960|FG000|Overall Study|Adverse Event|3|||
155381534|NCT02545933|560830961|FG001|Overall Study|Adverse Event|0|||
155381535|NCT02545933|560830962|FG002|Overall Study|Adverse Event|0|||
155381536|NCT02545933|560830960|FG000|Overall Study|Withdrawal by Subject|2|||
155381537|NCT02545933|560830961|FG001|Overall Study|Withdrawal by Subject|3|||
155381538|NCT02545933|560830962|FG002|Overall Study|Withdrawal by Subject|3|||
155381539|NCT02545933|560830960|FG000|Overall Study|Protocol Violation|1|||
155381540|NCT02545933|560830961|FG001|Overall Study|Protocol Violation|0|||
155381541|NCT02545933|560830962|FG002|Overall Study|Protocol Violation|1|||
155381542|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Death|0|||
155381543|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Death|0|||
155381544|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Death|0|||
155381545|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Death|1|||
155381546|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Death|2|||
155381547|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Death|1|||
155381548|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Death|1|||
155381549|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Death|2|||
155381550|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Death|4|||
155381551|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Death|1|||
155381552|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Death|0|||
155381553|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Death|0|||
155381554|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Death|1|||
155381555|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381556|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381557|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381558|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381559|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381560|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381561|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381562|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
155381563|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381564|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381565|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381566|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
155381567|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
155381568|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381569|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381570|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381571|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
155381572|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
155381573|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
155381574|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
155041321|NCT00762034|559582543|FG000|Induction Period|Protocol Violation|1|||
155041322|NCT00762034|559582544|FG001|Induction Period|Protocol Violation|2|||
155041323|NCT00762034|559582543|FG000|Induction Period|Entry Criterion Not Met|12|||
155041324|NCT00762034|559582544|FG001|Induction Period|Entry Criterion Not Met|11|||
155041325|NCT00762034|559582543|FG000|Induction Period|Adverse Event|27|||
155041326|NCT00762034|559582544|FG001|Induction Period|Adverse Event|38|||
155041327|NCT00762034|559582543|FG000|Induction Period|Lost to Follow-up|1|||
155041328|NCT00762034|559582544|FG001|Induction Period|Lost to Follow-up|1|||
155041329|NCT00762034|559582543|FG000|Induction Period|Progressive Disease|73|||
155041330|NCT00762034|559582544|FG001|Induction Period|Progressive Disease|55|||
155041331|NCT00762034|559582543|FG000|Induction Period|Physician Decision|21|||
155041332|NCT00762034|559582544|FG001|Induction Period|Physician Decision|20|||
155041333|NCT00762034|559582543|FG000|Induction Period|Withdrawal by Subject|15|||
155041334|NCT00762034|559582544|FG001|Induction Period|Withdrawal by Subject|19|||
154927904|NCT01956123|559160666|FG002|COS Cycle 3|Withdrawal by Subject|0|||
154927905|NCT01956123|559160667|FG003|COS Cycle 3|Withdrawal by Subject|1|||
154927906|NCT00267020|559160670|FG000|Overall Study|Adverse Event|22|||
154927907|NCT00267020|559160671|FG001|Overall Study|Adverse Event|5|||
154927908|NCT00267020|559160670|FG000|Overall Study|Death|2|||
154927909|NCT00267020|559160671|FG001|Overall Study|Death|1|||
154927910|NCT00267020|559160670|FG000|Overall Study|Withdrawal by Subject|17|||
155041335|NCT00762034|559582543|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
155041336|NCT00762034|559582544|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
155041337|NCT00762034|559582543|FG000|Induction Period|Deaths Due to Study Disease|9|||
155041338|NCT00762034|559582544|FG001|Induction Period|Deaths Due to Study Disease|9|||
155041339|NCT00762034|559582543|FG000|Maintenance Period|Protocol Violation|1|||
155041340|NCT00762034|559582544|FG001|Maintenance Period|Protocol Violation|3|||
155041341|NCT00762034|559582543|FG000|Maintenance Period|Entry Criterion Not Met|0|||
155041342|NCT00762034|559582544|FG001|Maintenance Period|Entry Criterion Not Met|2|||
155041343|NCT00762034|559582543|FG000|Maintenance Period|Adverse Event|42|||
155041344|NCT00762034|559582544|FG001|Maintenance Period|Adverse Event|26|||
155041345|NCT00762034|559582543|FG000|Maintenance Period|Progressive Disease|186|||
155041346|NCT00762034|559582544|FG001|Maintenance Period|Progressive Disease|224|||
155041347|NCT00762034|559582543|FG000|Maintenance Period|Physician Decision|25|||
155041348|NCT00762034|559582544|FG001|Maintenance Period|Physician Decision|20|||
155041349|NCT00762034|559582543|FG000|Maintenance Period|Withdrawal by Subject|34|||
155041350|NCT00762034|559582544|FG001|Maintenance Period|Withdrawal by Subject|14|||
155041351|NCT00762034|559582543|FG000|Maintenance Period|Death not due to study disease|2|||
155041352|NCT00762034|559582544|FG001|Maintenance Period|Death not due to study disease|5|||
155041353|NCT00762034|559582543|FG000|Maintenance Period|Death due to study disease|3|||
155041354|NCT00762034|559582544|FG001|Maintenance Period|Death due to study disease|3|||
155041355|NCT00762034|559582543|FG000|Maintenance Period|Other|1|||
155041356|NCT00762034|559582544|FG001|Maintenance Period|Other|1|||
155041357|NCT00497146|559582545|FG000|Treatment Period|Adverse Event|6|||
155041358|NCT00497146|559582546|FG001|Treatment Period|Adverse Event|2|||
155041359|NCT00497146|559582545|FG000|Treatment Period|Withdrawal by Subject|5|||
155041360|NCT00497146|559582546|FG001|Treatment Period|Withdrawal by Subject|9|||
155041361|NCT00497146|559582545|FG000|Treatment Period|Lost to Follow-up|1|||
155041362|NCT00497146|559582546|FG001|Treatment Period|Lost to Follow-up|3|||
155041363|NCT00497146|559582545|FG000|Treatment Period|Required dialysis|4|||
155041364|NCT00497146|559582546|FG001|Treatment Period|Required dialysis|1|||
155041365|NCT00497146|559582545|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
155041366|NCT00497146|559582546|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
155041367|NCT00497146|559582545|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
155041368|NCT00497146|559582546|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
155041369|NCT00497146|559582545|FG000|Treatment Period|Other Reason|2|||
155041370|NCT00497146|559582546|FG001|Treatment Period|Other Reason|3|||
155041371|NCT00497146|559582545|FG000|Long-term Follow-up Period|Adverse Event|2|||
155041372|NCT00497146|559582546|FG001|Long-term Follow-up Period|Adverse Event|2|||
155041373|NCT00497146|559582545|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
155041374|NCT00497146|559582546|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
155041375|NCT00497146|559582545|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
155041376|NCT00497146|559582546|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
155041377|NCT00497146|559582545|FG000|Long-term Follow-up Period|Other|0|||
155041378|NCT00497146|559582546|FG001|Long-term Follow-up Period|Other|1|||
155041379|NCT04571385|559582549|FG000|Overall Study|Participant non-compliance|1|||
155041380|NCT04571385|559582550|FG001|Overall Study|Participant non-compliance|0|||
155041381|NCT04571385|559582551|FG002|Overall Study|Participant non-compliance|0|||
155041382|NCT04571385|559582549|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
155041383|NCT04571385|559582550|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
155041384|NCT04571385|559582551|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
155041385|NCT04571385|559582549|FG000|Overall Study|Screen failure|0|||
155041386|NCT04571385|559582550|FG001|Overall Study|Screen failure|0|||
155041387|NCT04571385|559582551|FG002|Overall Study|Screen failure|1|||
155041388|NCT01212159|559582552|FG000|Overall Study|Withdrawal by Subject|12|||
154927911|NCT00267020|559160671|FG001|Overall Study|Withdrawal by Subject|7|||
155041389|NCT01212159|559582553|FG001|Overall Study|Withdrawal by Subject|12|||
155041390|NCT00582426|559582564|FG000|Overall Study|Lost to Follow-up|0|||
155041391|NCT00582426|559582565|FG001|Overall Study|Lost to Follow-up|2|||
154927912|NCT00267020|559160670|FG000|Overall Study|Physician Decision|3|||
155041392|NCT00582426|559582564|FG000|Overall Study|Adverse Event|4|||
155041393|NCT00582426|559582565|FG001|Overall Study|Adverse Event|2|||
155041394|NCT00582426|559582564|FG000|Overall Study|Protocol Violation|6|||
155041395|NCT00582426|559582565|FG001|Overall Study|Protocol Violation|2|||
155041396|NCT00582426|559582564|FG000|Overall Study|Death|4|||
155041397|NCT00582426|559582565|FG001|Overall Study|Death|3|||
155041398|NCT00582426|559582564|FG000|Overall Study|Withdrawal by Subject|3|||
155041399|NCT00582426|559582565|FG001|Overall Study|Withdrawal by Subject|2|||
155041400|NCT00582426|559582564|FG000|Overall Study|Disease Progression|2|||
155041401|NCT00582426|559582565|FG001|Overall Study|Disease Progression|2|||
155041402|NCT00582426|559582564|FG000|Overall Study|Use of illicit drugs|1|||
155041403|NCT00582426|559582565|FG001|Overall Study|Use of illicit drugs|0|||
155041404|NCT00662311|559582566|FG000|Overall Study|Respiratory Infection|1|||
155041405|NCT00662311|559582567|FG001|Overall Study|Respiratory Infection|0|||
155041406|NCT00662311|559582568|FG002|Overall Study|Respiratory Infection|0|||
155041407|NCT02164318|559582569|FG000|Overall Study|Withdrawal by Subject|0|||
155041408|NCT02164318|559582570|FG001|Overall Study|Withdrawal by Subject|1|||
155041409|NCT02164318|559582571|FG002|Overall Study|Withdrawal by Subject|0|||
155041410|NCT02164318|559582572|FG003|Overall Study|Withdrawal by Subject|1|||
155041411|NCT02499263|559582576|FG000|Overall Study|Lost to Follow-up|9|||
155041412|NCT02499263|559582576|FG000|Overall Study|Participant's withdrawal of consent|4|||
155041413|NCT02499263|559582576|FG000|Overall Study|Lack of Efficacy|22|||
155041414|NCT02499263|559582576|FG000|Overall Study|investigator's judgment|12|||
155041415|NCT02499263|559582576|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
155041416|NCT02499263|559582576|FG000|Overall Study|Participant's decision|3|||
155041417|NCT02499263|559582576|FG000|Overall Study|Pregnancy|1|||
155041418|NCT02815267|559582577|FG000|Double-Blind Phase|Adverse Event|0|||
155041419|NCT02815267|559582578|FG001|Double-Blind Phase|Adverse Event|3|||
155041420|NCT02815267|559582577|FG000|Double-Blind Phase|Lost to Follow-up|17|||
155041421|NCT02815267|559582578|FG001|Double-Blind Phase|Lost to Follow-up|9|||
155041422|NCT02815267|559582577|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
155041423|NCT02815267|559582578|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
155041424|NCT02815267|559582577|FG000|Double-Blind Phase|Protocol Violation|3|||
155041425|NCT02815267|559582578|FG001|Double-Blind Phase|Protocol Violation|2|||
155041426|NCT02815267|559582577|FG000|Double-Blind Phase|Site withdrawal|1|||
155041427|NCT02815267|559582578|FG001|Double-Blind Phase|Site withdrawal|6|||
155041428|NCT02815267|559582577|FG000|Double-Blind Phase|Received a disallowed medication|1|||
155041429|NCT02815267|559582578|FG001|Double-Blind Phase|Received a disallowed medication|1|||
155041430|NCT02815267|559582577|FG000|Open-Label Phase|Adverse Event|1|||
155041431|NCT02815267|559582578|FG001|Open-Label Phase|Adverse Event|1|||
155041432|NCT02815267|559582577|FG000|Open-Label Phase|Lost to Follow-up|23|||
154927913|NCT00267020|559160671|FG001|Overall Study|Physician Decision|2|||
154927914|NCT00267020|559160670|FG000|Overall Study|Disease Progression|39|||
154927915|NCT00267020|559160671|FG001|Overall Study|Disease Progression|25|||
154927916|NCT00267020|559160670|FG000|Overall Study|Unrelated Complication|1|||
154927917|NCT00267020|559160671|FG001|Overall Study|Unrelated Complication|1|||
154927918|NCT00267020|559160670|FG000|Overall Study|Sponsor Request|1|||
154927919|NCT00267020|559160671|FG001|Overall Study|Sponsor Request|0|||
154927920|NCT00267020|559160670|FG000|Overall Study|Other|1|||
154927921|NCT00267020|559160671|FG001|Overall Study|Other|2|||
154927922|NCT00640614|559160674|FG000|Overall Study|Lost to Follow-up|1|||
154927923|NCT00640614|559160675|FG001|Overall Study|Lost to Follow-up|0|||
154927924|NCT02545868|559160678|FG000|Overall Study|Lack of Efficacy|1|||
154927925|NCT02545868|559160679|FG001|Overall Study|Lack of Efficacy|1|||
154927926|NCT02545868|559160680|FG002|Overall Study|Lack of Efficacy|0|||
154927927|NCT02545868|559160678|FG000|Overall Study|Lost to Follow-up|1|||
154927928|NCT02545868|559160679|FG001|Overall Study|Lost to Follow-up|5|||
154927929|NCT02545868|559160680|FG002|Overall Study|Lost to Follow-up|1|||
154927930|NCT02545868|559160678|FG000|Overall Study|Non-compliance|1|||
154927931|NCT02545868|559160679|FG001|Overall Study|Non-compliance|1|||
154927932|NCT02545868|559160680|FG002|Overall Study|Non-compliance|1|||
154927933|NCT02545868|559160678|FG000|Overall Study|Treatment change|21|||
155041433|NCT02815267|559582578|FG001|Open-Label Phase|Lost to Follow-up|9|||
155381575|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
154927934|NCT02545868|559160679|FG001|Overall Study|Treatment change|19|||
154927935|NCT02545868|559160680|FG002|Overall Study|Treatment change|22|||
154927936|NCT02545868|559160678|FG000|Overall Study|Physician Decision|1|||
154927937|NCT02545868|559160679|FG001|Overall Study|Physician Decision|1|||
155381576|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
155041434|NCT02815267|559582577|FG000|Open-Label Phase|Withdrawal by Subject|24|||
155041435|NCT02815267|559582578|FG001|Open-Label Phase|Withdrawal by Subject|13|||
155041436|NCT02815267|559582577|FG000|Open-Label Phase|Protocol Violation|0|||
155041437|NCT02815267|559582578|FG001|Open-Label Phase|Protocol Violation|1|||
155041438|NCT02815267|559582577|FG000|Open-Label Phase|Administrative|21|||
155041439|NCT02815267|559582578|FG001|Open-Label Phase|Administrative|12|||
155041440|NCT02815267|559582577|FG000|Open-Label Phase|Other|2|||
154927938|NCT02545868|559160680|FG002|Overall Study|Physician Decision|1|||
154927939|NCT02545868|559160678|FG000|Overall Study|Withdrawal by Subject|6|||
154927940|NCT02545868|559160679|FG001|Overall Study|Withdrawal by Subject|7|||
154927941|NCT02545868|559160680|FG002|Overall Study|Withdrawal by Subject|9|||
154927942|NCT01777191|559160681|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
154927943|NCT01777191|559160682|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
154927944|NCT01777191|559160681|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
154927945|NCT01777191|559160682|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
154927946|NCT01777191|559160681|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
154927947|NCT01777191|559160682|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
154927948|NCT01777191|559160681|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
154927949|NCT01777191|559160682|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
154927950|NCT01777191|559160681|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
154927951|NCT01777191|559160682|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
154927952|NCT01777191|559160681|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
154927953|NCT01777191|559160682|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
154927954|NCT01777191|559160681|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
154927955|NCT01777191|559160682|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
154927956|NCT01777191|559160681|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
154927957|NCT01777191|559160682|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
154927958|NCT01777191|559160681|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
154927959|NCT01777191|559160682|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
154927960|NCT01777191|559160681|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
154927961|NCT01777191|559160682|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
154927962|NCT01777191|559160681|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
154927963|NCT01777191|559160682|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
154927964|NCT03286400|559160687|FG000|Overall Study|Death|10|||
154927965|NCT03286400|559160687|FG000|Overall Study|Lost to Follow-up|10|||
154927966|NCT03286400|559160687|FG000|Overall Study|Physician Decision|1|||
154927967|NCT03286400|559160687|FG000|Overall Study|Scheduling difficulty|4|||
154927968|NCT01856686|559160688|FG000|Overall Study|Lost to Follow-up|5|||
154927969|NCT01856686|559160689|FG001|Overall Study|Lost to Follow-up|11|||
154927970|NCT01461369|559160690|FG000|Overall Study|Lack of Efficacy|2|||
154927971|NCT01461369|559160691|FG001|Overall Study|Lack of Efficacy|0|||
154927972|NCT01461369|559160692|FG002|Overall Study|Lack of Efficacy|6|||
154927973|NCT01461369|559160690|FG000|Overall Study|Lost to Follow-up|0|||
154927974|NCT01461369|559160691|FG001|Overall Study|Lost to Follow-up|0|||
154927975|NCT01461369|559160692|FG002|Overall Study|Lost to Follow-up|3|||
154927976|NCT01461369|559160690|FG000|Overall Study|Adverse Event|9|||
154927977|NCT01461369|559160691|FG001|Overall Study|Adverse Event|12|||
154927978|NCT01461369|559160692|FG002|Overall Study|Adverse Event|4|||
154927979|NCT01461369|559160690|FG000|Overall Study|Protocol Violation|1|||
154927980|NCT01461369|559160691|FG001|Overall Study|Protocol Violation|2|||
154927981|NCT01461369|559160692|FG002|Overall Study|Protocol Violation|2|||
154927982|NCT01461369|559160690|FG000|Overall Study|Withdrawal by Subject|1|||
154927983|NCT01461369|559160691|FG001|Overall Study|Withdrawal by Subject|3|||
154927984|NCT01461369|559160692|FG002|Overall Study|Withdrawal by Subject|2|||
154927985|NCT03576131|559160695|FG000|Overall Study|Investigator decision|0|||
154927986|NCT03576131|559160696|FG001|Overall Study|Investigator decision|0|||
154927987|NCT03576131|559160697|FG002|Overall Study|Investigator decision|0|||
154927988|NCT03576131|559160698|FG003|Overall Study|Investigator decision|1|||
154927989|NCT03576131|559160699|FG004|Overall Study|Investigator decision|0|||
154927990|NCT03576131|559160700|FG005|Overall Study|Investigator decision|1|||
154927991|NCT03576131|559160701|FG006|Overall Study|Investigator decision|0|||
154927992|NCT03576131|559160702|FG007|Overall Study|Investigator decision|0|||
154927993|NCT03576131|559160695|FG000|Overall Study|Withdrawal by Subject|1|||
154927994|NCT03576131|559160696|FG001|Overall Study|Withdrawal by Subject|1|||
154927995|NCT03576131|559160697|FG002|Overall Study|Withdrawal by Subject|0|||
154927996|NCT03576131|559160698|FG003|Overall Study|Withdrawal by Subject|1|||
154927997|NCT03576131|559160699|FG004|Overall Study|Withdrawal by Subject|2|||
154927998|NCT03576131|559160700|FG005|Overall Study|Withdrawal by Subject|3|||
154927999|NCT03576131|559160701|FG006|Overall Study|Withdrawal by Subject|1|||
154928000|NCT03576131|559160702|FG007|Overall Study|Withdrawal by Subject|0|||
154928001|NCT03576131|559160695|FG000|Overall Study|Death|3|||
154928002|NCT03576131|559160696|FG001|Overall Study|Death|3|||
154928003|NCT03576131|559160697|FG002|Overall Study|Death|1|||
155041441|NCT02815267|559582578|FG001|Open-Label Phase|Other|5|||
154928004|NCT03576131|559160698|FG003|Overall Study|Death|5|||
154928005|NCT03576131|559160699|FG004|Overall Study|Death|4|||
154928006|NCT03576131|559160700|FG005|Overall Study|Death|1|||
154928007|NCT03576131|559160701|FG006|Overall Study|Death|0|||
154928008|NCT03576131|559160702|FG007|Overall Study|Death|1|||
154928009|NCT03576131|559160695|FG000|Overall Study|New anti-cancer treatment|5|||
154928010|NCT03576131|559160696|FG001|Overall Study|New anti-cancer treatment|1|||
155041442|NCT04126317|559582579|FG000|Overall Study|Adverse Event|0|||
155041443|NCT04126317|559582580|FG001|Overall Study|Adverse Event|1|||
155041444|NCT04126317|559582579|FG000|Overall Study|Withdrawal by Subject|4|||
154928011|NCT03576131|559160697|FG002|Overall Study|New anti-cancer treatment|2|||
154928012|NCT03576131|559160698|FG003|Overall Study|New anti-cancer treatment|3|||
154928013|NCT03576131|559160699|FG004|Overall Study|New anti-cancer treatment|0|||
154928014|NCT03576131|559160700|FG005|Overall Study|New anti-cancer treatment|0|||
155041445|NCT04126317|559582580|FG001|Overall Study|Withdrawal by Subject|1|||
155041446|NCT00424593|559582581|FG000|Acute Double-Blind Period|Adverse Event|16|||
155041447|NCT00424593|559582582|FG001|Acute Double-Blind Period|Adverse Event|7|||
154928015|NCT03576131|559160701|FG006|Overall Study|New anti-cancer treatment|0|||
154928016|NCT03576131|559160702|FG007|Overall Study|New anti-cancer treatment|0|||
154928017|NCT03576131|559160695|FG000|Overall Study|Unspecified reason|0|||
154928018|NCT03576131|559160696|FG001|Overall Study|Unspecified reason|0|||
154928019|NCT03576131|559160697|FG002|Overall Study|Unspecified reason|1|||
154928020|NCT03576131|559160698|FG003|Overall Study|Unspecified reason|1|||
154928021|NCT03576131|559160699|FG004|Overall Study|Unspecified reason|1|||
154928022|NCT03576131|559160700|FG005|Overall Study|Unspecified reason|1|||
154928023|NCT03576131|559160701|FG006|Overall Study|Unspecified reason|0|||
154928024|NCT03576131|559160702|FG007|Overall Study|Unspecified reason|0|||
154928025|NCT03576131|559160695|FG000|Overall Study|Subject non-compliance|0|||
154928026|NCT03576131|559160696|FG001|Overall Study|Subject non-compliance|0|||
154928027|NCT03576131|559160697|FG002|Overall Study|Subject non-compliance|0|||
154928028|NCT03576131|559160698|FG003|Overall Study|Subject non-compliance|0|||
154928029|NCT03576131|559160699|FG004|Overall Study|Subject non-compliance|0|||
154928030|NCT03576131|559160700|FG005|Overall Study|Subject non-compliance|1|||
154928031|NCT03576131|559160701|FG006|Overall Study|Subject non-compliance|0|||
154928032|NCT03576131|559160702|FG007|Overall Study|Subject non-compliance|0|||
154928033|NCT02118896|559160707|FG000|Overall Study|Death|4|||
154928034|NCT02118896|559160708|FG001|Overall Study|Death|0|||
154928035|NCT02118896|559160709|FG002|Overall Study|Death|4|||
154928036|NCT02118896|559160710|FG003|Overall Study|Death|6|||
154928037|NCT02118896|559160711|FG004|Overall Study|Death|3|||
154928038|NCT02118896|559160712|FG005|Overall Study|Death|1|||
154928039|NCT02118896|559160713|FG006|Overall Study|Death|0|||
154928040|NCT02118896|559160714|FG007|Overall Study|Death|0|||
154928041|NCT02118896|559160715|FG008|Overall Study|Death|0|||
154928042|NCT02118896|559160716|FG009|Overall Study|Death|0|||
154928043|NCT02118896|559160707|FG000|Overall Study|Adverse Event|5|||
154928044|NCT02118896|559160708|FG001|Overall Study|Adverse Event|4|||
154928045|NCT02118896|559160709|FG002|Overall Study|Adverse Event|4|||
154928046|NCT02118896|559160710|FG003|Overall Study|Adverse Event|5|||
154928047|NCT02118896|559160711|FG004|Overall Study|Adverse Event|5|||
154928048|NCT02118896|559160712|FG005|Overall Study|Adverse Event|9|||
154928049|NCT02118896|559160713|FG006|Overall Study|Adverse Event|1|||
154928050|NCT02118896|559160714|FG007|Overall Study|Adverse Event|1|||
155041448|NCT00424593|559582581|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
155041449|NCT00424593|559582582|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
155041450|NCT00424593|559582581|FG000|Acute Double-Blind Period|Protocol Violation|2|||
155041451|NCT00424593|559582582|FG001|Acute Double-Blind Period|Protocol Violation|2|||
155041452|NCT00424593|559582581|FG000|Acute Double-Blind Period|Physician Decision|1|||
155041453|NCT00424593|559582582|FG001|Acute Double-Blind Period|Physician Decision|2|||
155041454|NCT00424593|559582581|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
155041455|NCT00424593|559582582|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
155041456|NCT00424593|559582581|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
155041457|NCT00424593|559582582|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
155041458|NCT00424593|559582581|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
155041459|NCT00424593|559582582|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
155041460|NCT00424593|559582581|FG000|Dose-Blind Extension Period|Adverse Event|18|||
155041461|NCT00424593|559582582|FG001|Dose-Blind Extension Period|Adverse Event|0|||
155041462|NCT00424593|559582581|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
155041463|NCT00424593|559582582|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
155041464|NCT00424593|559582581|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
155041465|NCT00424593|559582582|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
155041466|NCT00424593|559582581|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
155041467|NCT00424593|559582582|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
155041468|NCT00424593|559582581|FG000|Dose-Blind Extension Period|Physician Decision|3|||
155041469|NCT00424593|559582582|FG001|Dose-Blind Extension Period|Physician Decision|0|||
155041470|NCT00948922|559582583|FG000|Overall Study|Did not start study treatment|2|||
154928051|NCT02118896|559160715|FG008|Overall Study|Adverse Event|4|||
154928052|NCT02118896|559160716|FG009|Overall Study|Adverse Event|0|||
154928053|NCT02118896|559160707|FG000|Overall Study|Consent withdrawn|2|||
154928054|NCT02118896|559160708|FG001|Overall Study|Consent withdrawn|0|||
154928055|NCT02118896|559160709|FG002|Overall Study|Consent withdrawn|3|||
154928056|NCT02118896|559160710|FG003|Overall Study|Consent withdrawn|4|||
154928057|NCT02118896|559160711|FG004|Overall Study|Consent withdrawn|1|||
154928058|NCT02118896|559160712|FG005|Overall Study|Consent withdrawn|4|||
154928059|NCT02118896|559160713|FG006|Overall Study|Consent withdrawn|0|||
154928060|NCT02118896|559160714|FG007|Overall Study|Consent withdrawn|0|||
155041471|NCT00948922|559582584|FG001|Overall Study|Did not start study treatment|5|||
155041472|NCT00948922|559582585|FG002|Overall Study|Did not start study treatment|0|||
155041473|NCT00948922|559582583|FG000|Overall Study|Withdrawal by Subject|0|||
155041474|NCT00948922|559582584|FG001|Overall Study|Withdrawal by Subject|2|||
155041475|NCT00948922|559582585|FG002|Overall Study|Withdrawal by Subject|1|||
155041476|NCT00948922|559582583|FG000|Overall Study|Death|3|||
155041477|NCT00948922|559582584|FG001|Overall Study|Death|0|||
155041478|NCT00948922|559582585|FG002|Overall Study|Death|0|||
155041479|NCT00948922|559582583|FG000|Overall Study|Disease progression|0|||
155041480|NCT00948922|559582584|FG001|Overall Study|Disease progression|1|||
155041481|NCT00948922|559582585|FG002|Overall Study|Disease progression|0|||
155041482|NCT00948922|559582583|FG000|Overall Study|Insurance issues|1|||
155041483|NCT00948922|559582584|FG001|Overall Study|Insurance issues|0|||
155041484|NCT00948922|559582585|FG002|Overall Study|Insurance issues|0|||
155041485|NCT00948922|559582583|FG000|Overall Study|Transplant eligibility issues|2|||
155041486|NCT00948922|559582584|FG001|Overall Study|Transplant eligibility issues|3|||
155041487|NCT00948922|559582585|FG002|Overall Study|Transplant eligibility issues|0|||
155041488|NCT00948922|559582583|FG000|Overall Study|Not evaluable at time of analysis|0|||
155041489|NCT00948922|559582584|FG001|Overall Study|Not evaluable at time of analysis|3|||
155041490|NCT00948922|559582585|FG002|Overall Study|Not evaluable at time of analysis|0|||
155041491|NCT02131233|559582586|FG000|Overall Study|Not Treated|2|||
155041492|NCT02131233|559582587|FG001|Overall Study|Not Treated|3|||
155041493|NCT02131233|559582586|FG000|Overall Study|Adverse Event|7|||
155041494|NCT02131233|559582587|FG001|Overall Study|Adverse Event|6|||
155041495|NCT02131233|559582586|FG000|Overall Study|Death|0|||
155041496|NCT02131233|559582587|FG001|Overall Study|Death|1|||
155041497|NCT02131233|559582586|FG000|Overall Study|Lack of Efficacy|6|||
154928061|NCT02118896|559160715|FG008|Overall Study|Consent withdrawn|0|||
154928062|NCT02118896|559160716|FG009|Overall Study|Consent withdrawn|0|||
154928063|NCT02118896|559160707|FG000|Overall Study|Non-compliance|2|||
154928064|NCT02118896|559160708|FG001|Overall Study|Non-compliance|1|||
154928065|NCT02118896|559160709|FG002|Overall Study|Non-compliance|1|||
154928066|NCT02118896|559160710|FG003|Overall Study|Non-compliance|5|||
154928067|NCT02118896|559160711|FG004|Overall Study|Non-compliance|0|||
154928068|NCT02118896|559160712|FG005|Overall Study|Non-compliance|1|||
154928069|NCT02118896|559160713|FG006|Overall Study|Non-compliance|0|||
154928070|NCT02118896|559160714|FG007|Overall Study|Non-compliance|1|||
154928071|NCT02118896|559160715|FG008|Overall Study|Non-compliance|0|||
154928072|NCT02118896|559160716|FG009|Overall Study|Non-compliance|0|||
154928073|NCT02118896|559160707|FG000|Overall Study|Pregnancy|1|||
154928074|NCT02118896|559160708|FG001|Overall Study|Pregnancy|1|||
154928075|NCT02118896|559160709|FG002|Overall Study|Pregnancy|0|||
154928076|NCT02118896|559160710|FG003|Overall Study|Pregnancy|0|||
154928077|NCT02118896|559160711|FG004|Overall Study|Pregnancy|1|||
154928078|NCT02118896|559160712|FG005|Overall Study|Pregnancy|3|||
154928079|NCT02118896|559160713|FG006|Overall Study|Pregnancy|1|||
154928080|NCT02118896|559160714|FG007|Overall Study|Pregnancy|0|||
154928081|NCT02118896|559160715|FG008|Overall Study|Pregnancy|0|||
154928082|NCT02118896|559160716|FG009|Overall Study|Pregnancy|0|||
154928083|NCT02118896|559160707|FG000|Overall Study|Lost to Follow-up|1|||
154928084|NCT02118896|559160708|FG001|Overall Study|Lost to Follow-up|2|||
154928085|NCT02118896|559160709|FG002|Overall Study|Lost to Follow-up|1|||
154928086|NCT02118896|559160710|FG003|Overall Study|Lost to Follow-up|0|||
154928087|NCT02118896|559160711|FG004|Overall Study|Lost to Follow-up|2|||
154928088|NCT02118896|559160712|FG005|Overall Study|Lost to Follow-up|1|||
154928089|NCT02118896|559160713|FG006|Overall Study|Lost to Follow-up|0|||
154928090|NCT02118896|559160714|FG007|Overall Study|Lost to Follow-up|0|||
154928091|NCT02118896|559160715|FG008|Overall Study|Lost to Follow-up|0|||
155041498|NCT02131233|559582587|FG001|Overall Study|Lack of Efficacy|3|||
155041499|NCT02131233|559582586|FG000|Overall Study|Lost to Follow-up|14|||
155041500|NCT02131233|559582587|FG001|Overall Study|Lost to Follow-up|13|||
155041501|NCT02131233|559582586|FG000|Overall Study|Non-Compliance With Study Drug|8|||
155041502|NCT02131233|559582587|FG001|Overall Study|Non-Compliance With Study Drug|5|||
155152530|NCT03037385|559996847|FG005|Overall Study|Physician Decision|0|||
154928092|NCT02118896|559160716|FG009|Overall Study|Lost to Follow-up|0|||
154928093|NCT02118896|559160707|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
154928094|NCT02118896|559160708|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
154928095|NCT02118896|559160709|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
154928096|NCT02118896|559160710|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
155041503|NCT02131233|559582586|FG000|Overall Study|Physician Decision|7|||
155041504|NCT02131233|559582587|FG001|Overall Study|Physician Decision|0|||
155041505|NCT02131233|559582586|FG000|Overall Study|Pregnancy|4|||
155041506|NCT02131233|559582587|FG001|Overall Study|Pregnancy|0|||
155041507|NCT02131233|559582586|FG000|Overall Study|Withdrawal by Subject|18|||
154928097|NCT02118896|559160711|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
154928098|NCT02118896|559160712|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
154928099|NCT02118896|559160713|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
154928100|NCT02118896|559160714|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
154928101|NCT02118896|559160715|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
155041508|NCT02131233|559582587|FG001|Overall Study|Withdrawal by Subject|11|||
155041509|NCT05114564|559582588|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
155041510|NCT05114564|559582589|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
155041511|NCT05114564|559582588|FG000|First Intervention|Adverse Event|0|||
155041512|NCT05114564|559582589|FG001|First Intervention|Adverse Event|1|||
155041513|NCT00255840|559582590|FG000|Overall Study|Lost to Follow-up|10|||
155041514|NCT00255840|559582591|FG001|Overall Study|Lost to Follow-up|14|||
155041515|NCT00255840|559582590|FG000|Overall Study|Discontinued intervention|53|||
155041516|NCT00255840|559582591|FG001|Overall Study|Discontinued intervention|56|||
155041517|NCT00339833|559582594|FG000|Overall Study|Withdrawal by Subject|1|||
155041518|NCT00339833|559582595|FG001|Overall Study|Withdrawal by Subject|2|||
155041519|NCT00339833|559582594|FG000|Overall Study|toothache|0|||
155041520|NCT00339833|559582595|FG001|Overall Study|toothache|1|||
155041521|NCT00339833|559582594|FG000|Overall Study|indigestion|0|||
155041522|NCT00339833|559582595|FG001|Overall Study|indigestion|1|||
155041523|NCT00339833|559582594|FG000|Overall Study|Chest pain|0|||
155041524|NCT00339833|559582595|FG001|Overall Study|Chest pain|1|||
155041525|NCT00339833|559582594|FG000|Overall Study|minor infection|0|||
155041526|NCT00339833|559582595|FG001|Overall Study|minor infection|1|||
155041527|NCT00339833|559582594|FG000|Overall Study|Poor venous access|2|||
155041528|NCT00339833|559582595|FG001|Overall Study|Poor venous access|2|||
155041529|NCT00339833|559582594|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
155041530|NCT00339833|559582595|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
155041531|NCT00339833|559582594|FG000|Overall Study|Error in data records|1|||
155041532|NCT00339833|559582595|FG001|Overall Study|Error in data records|0|||
155041533|NCT00217581|559582596|FG000|Overall Study|Withdrawal by Subject|1|||
155041534|NCT02829047|559582597|FG000|Overall Study|Withdrawal by Subject|1|||
155041535|NCT01597492|559582599|FG000|Overall Study|Withdrawal by Subject|1|||
155041536|NCT01597492|559582600|FG001|Overall Study|Withdrawal by Subject|2|||
155041537|NCT01597492|559582599|FG000|Overall Study|Adverse Event|3|||
155041538|NCT01597492|559582600|FG001|Overall Study|Adverse Event|0|||
155041539|NCT01597492|559582599|FG000|Overall Study|Lost to Follow-up|0|||
155041540|NCT01597492|559582600|FG001|Overall Study|Lost to Follow-up|2|||
155041541|NCT01597492|559582599|FG000|Overall Study|Other Reason|2|||
155041542|NCT01597492|559582600|FG001|Overall Study|Other Reason|0|||
155041543|NCT02570750|559582601|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
155041544|NCT02570750|559582602|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
155041545|NCT02570750|559582601|FG000|Overall Study|Protocol deviation|4|||
155041546|NCT02570750|559582602|FG001|Overall Study|Protocol deviation|2|||
155041547|NCT02570750|559582601|FG000|Overall Study|Withdrawal by Subject|5|||
155041548|NCT02570750|559582602|FG001|Overall Study|Withdrawal by Subject|0|||
155041549|NCT02570750|559582601|FG000|Overall Study|Lost to Follow-up|2|||
155041550|NCT02570750|559582602|FG001|Overall Study|Lost to Follow-up|2|||
155041551|NCT02570750|559582601|FG000|Overall Study|Adverse Event|2|||
155041552|NCT02570750|559582602|FG001|Overall Study|Adverse Event|1|||
155041553|NCT01410240|559582603|FG000|Overall Study|Physician Decision|0|||
155041554|NCT01410240|559582604|FG001|Overall Study|Physician Decision|0|||
155041555|NCT01410240|559582605|FG002|Overall Study|Physician Decision|1|||
155041556|NCT01410240|559582603|FG000|Overall Study|Missed week 6 assessments|1|||
155041557|NCT01410240|559582604|FG001|Overall Study|Missed week 6 assessments|1|||
155041558|NCT01410240|559582605|FG002|Overall Study|Missed week 6 assessments|1|||
155041559|NCT00496587|559582606|FG000|Overall Study|Adverse Event|2|||
155041560|NCT00496587|559582606|FG000|Overall Study|Progressive Disease|24|||
155041561|NCT00496587|559582606|FG000|Overall Study|Withdrawal by Subject|2|||
155041562|NCT00496587|559582606|FG000|Overall Study|Death|1|||
155041563|NCT00496587|559582606|FG000|Overall Study|Complications unrelated|2|||
155041564|NCT00162097|559582607|FG000|Overall Study|Participant no longer met study criteria|0|||
155041565|NCT00162097|559582608|FG001|Overall Study|Participant no longer met study criteria|0|||
155041566|NCT00162097|559582609|FG002|Overall Study|Participant no longer met study criteria|0|||
155041567|NCT00162097|559582610|FG003|Overall Study|Participant no longer met study criteria|1|||
155041568|NCT01204918|559582611|FG000|Overall Study|Withdrawal by Subject|4|||
155041569|NCT01204918|559582612|FG001|Overall Study|Withdrawal by Subject|10|||
155041570|NCT01204918|559582613|FG002|Overall Study|Withdrawal by Subject|5|||
155041571|NCT03517449|559582618|FG000|Overall Study|Death|184|||
155041572|NCT03517449|559582619|FG001|Overall Study|Death|236|||
155041573|NCT03517449|559582618|FG000|Overall Study|Lost to Follow-up|0|||
155041574|NCT03517449|559582619|FG001|Overall Study|Lost to Follow-up|2|||
155041575|NCT03517449|559582618|FG000|Overall Study|Withdrawal by Subject|7|||
155041576|NCT03517449|559582619|FG001|Overall Study|Withdrawal by Subject|26|||
155041577|NCT03517449|559582618|FG000|Overall Study|Participants Ongoing|220|||
155041578|NCT03517449|559582619|FG001|Overall Study|Participants Ongoing|152|||
155041579|NCT00269477|559582629|FG000|Overall Study|Protocol Violation|5|||
155041580|NCT00269477|559582630|FG001|Overall Study|Protocol Violation|5|||
155041581|NCT00269477|559582631|FG002|Overall Study|Protocol Violation|1|||
155041582|NCT00269477|559582632|FG003|Overall Study|Protocol Violation|0|||
155041583|NCT00269477|559582629|FG000|Overall Study|Missed post-vaccination blood draw|0|||
155041584|NCT00269477|559582630|FG001|Overall Study|Missed post-vaccination blood draw|1|||
155041585|NCT00269477|559582631|FG002|Overall Study|Missed post-vaccination blood draw|0|||
155041586|NCT00269477|559582632|FG003|Overall Study|Missed post-vaccination blood draw|0|||
155041587|NCT00431067|559582633|FG000|Overall Study|Other Adverse Event|9|||
155041588|NCT00431067|559582633|FG000|Overall Study|Progressive disease|30|||
155041589|NCT00431067|559582633|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
155041590|NCT03760458|559582635|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
155041591|NCT03760458|559582636|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
155041592|NCT03760458|559582637|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
155041593|NCT03760458|559582638|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
155041594|NCT03760458|559582639|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
155041595|NCT00750919|559582640|FG000|Overall Study|Adverse Event|9|||
155041596|NCT00750919|559582640|FG000|Overall Study|Withdrawal by Subject|1|||
155041597|NCT00750919|559582640|FG000|Overall Study|Lack of Efficacy|8|||
155041598|NCT00750919|559582640|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
155041599|NCT00750919|559582640|FG000|Overall Study|Other|36|||
155041600|NCT02670382|559582652|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
155041601|NCT02670382|559582653|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
155041602|NCT03244618|559582654|FG000|Overall Study|Lost to Follow-up|3|||
155041603|NCT03244618|559582655|FG001|Overall Study|Lost to Follow-up|4|||
155041604|NCT03244618|559582654|FG000|Overall Study|Protocol Violation|4|||
155041605|NCT03244618|559582655|FG001|Overall Study|Protocol Violation|3|||
155041606|NCT03244618|559582654|FG000|Overall Study|Withdrawal by Subject|0|||
155041607|NCT03244618|559582655|FG001|Overall Study|Withdrawal by Subject|2|||
155041608|NCT03469999|559582658|FG000|Overall Study|Lost to Follow-up|2|||
155041609|NCT01863732|559582659|FG000|Overall Study|Adverse Event|2|||
155041610|NCT01863732|559582660|FG001|Overall Study|Adverse Event|0|||
155041611|NCT01863732|559582661|FG002|Overall Study|Adverse Event|3|||
155041612|NCT01863732|559582662|FG003|Overall Study|Adverse Event|3|||
155041613|NCT01863732|559582659|FG000|Overall Study|Lack of Efficacy|1|||
155041614|NCT01863732|559582660|FG001|Overall Study|Lack of Efficacy|0|||
155041615|NCT01863732|559582661|FG002|Overall Study|Lack of Efficacy|2|||
155041616|NCT01863732|559582662|FG003|Overall Study|Lack of Efficacy|1|||
155041617|NCT01863732|559582659|FG000|Overall Study|Lost to Follow-up|2|||
155041618|NCT01863732|559582660|FG001|Overall Study|Lost to Follow-up|2|||
155041619|NCT01863732|559582661|FG002|Overall Study|Lost to Follow-up|1|||
155041620|NCT01863732|559582662|FG003|Overall Study|Lost to Follow-up|1|||
155041621|NCT01863732|559582659|FG000|Overall Study|Physician Decision|1|||
155041622|NCT01863732|559582660|FG001|Overall Study|Physician Decision|0|||
155041623|NCT01863732|559582661|FG002|Overall Study|Physician Decision|1|||
155041624|NCT01863732|559582662|FG003|Overall Study|Physician Decision|0|||
155041625|NCT01863732|559582659|FG000|Overall Study|Pregnancy|0|||
155041626|NCT01863732|559582660|FG001|Overall Study|Pregnancy|0|||
155041627|NCT01863732|559582661|FG002|Overall Study|Pregnancy|0|||
155041628|NCT01863732|559582662|FG003|Overall Study|Pregnancy|1|||
155041629|NCT01863732|559582659|FG000|Overall Study|Technical problems|0|||
155041630|NCT01863732|559582660|FG001|Overall Study|Technical problems|1|||
155041631|NCT01863732|559582661|FG002|Overall Study|Technical problems|1|||
155041632|NCT01863732|559582662|FG003|Overall Study|Technical problems|0|||
155041633|NCT01863732|559582659|FG000|Overall Study|Subject/guardian decision|6|||
155041634|NCT01863732|559582660|FG001|Overall Study|Subject/guardian decision|9|||
155041635|NCT01863732|559582661|FG002|Overall Study|Subject/guardian decision|3|||
155041636|NCT01863732|559582662|FG003|Overall Study|Subject/guardian decision|1|||
155041637|NCT01863732|559582659|FG000|Overall Study|Death|1|||
155041638|NCT01863732|559582660|FG001|Overall Study|Death|0|||
155041639|NCT01863732|559582661|FG002|Overall Study|Death|0|||
155041640|NCT01863732|559582662|FG003|Overall Study|Death|1|||
155041641|NCT04424914|559582663|FG000|Overall Study|Other|0|||
155041642|NCT04424914|559582664|FG001|Overall Study|Other|0|||
155041643|NCT04424914|559582665|FG002|Overall Study|Other|28|||
155041644|NCT04424914|559582663|FG000|Overall Study|Withdrawal by Subject|3|||
155041645|NCT04424914|559582664|FG001|Overall Study|Withdrawal by Subject|0|||
155041646|NCT04424914|559582665|FG002|Overall Study|Withdrawal by Subject|0|||
155041647|NCT04424914|559582663|FG000|Overall Study|Study terminated by sponsor|23|||
155381577|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155041648|NCT04424914|559582664|FG001|Overall Study|Study terminated by sponsor|7|||
155041649|NCT04424914|559582665|FG002|Overall Study|Study terminated by sponsor|0|||
155041650|NCT04424914|559582663|FG000|Overall Study|Lost to Follow-up|0|||
155041651|NCT04424914|559582664|FG001|Overall Study|Lost to Follow-up|0|||
155041652|NCT04424914|559582665|FG002|Overall Study|Lost to Follow-up|1|||
155041653|NCT04424914|559582663|FG000|Overall Study|Death|3|||
155041654|NCT04424914|559582664|FG001|Overall Study|Death|1|||
155041655|NCT04424914|559582665|FG002|Overall Study|Death|0|||
155041656|NCT00460746|559582666|FG000|Overall Study|Adverse Event|1|||
155041657|NCT00460746|559582666|FG000|Overall Study|Lost to Follow-up|1|||
155041658|NCT02791438|559582668|FG000|Treatment Period|Adverse Event|1|||
155041659|NCT02791438|559582669|FG001|Treatment Period|Adverse Event|0|||
155041660|NCT02791438|559582668|FG000|Treatment Period|Withdrawal by Subject|0|||
155041661|NCT02791438|559582669|FG001|Treatment Period|Withdrawal by Subject|1|||
155041662|NCT02791438|559582668|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
155041663|NCT02791438|559582669|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
155041664|NCT01603394|559582670|FG000|Overall Study|Adverse Event|1|||
155041665|NCT00394771|559582673|FG000|Overall Study|Did not meet protocol requirements|1|||
155041666|NCT00394771|559582674|FG001|Overall Study|Did not meet protocol requirements|0|||
155041667|NCT00394771|559582675|FG002|Overall Study|Did not meet protocol requirements|2|||
155041668|NCT00394771|559582676|FG003|Overall Study|Did not meet protocol requirements|0|||
155041669|NCT00394771|559582673|FG000|Overall Study|Protocol Violation|2|||
155041670|NCT00394771|559582674|FG001|Overall Study|Protocol Violation|4|||
155041671|NCT00394771|559582675|FG002|Overall Study|Protocol Violation|9|||
155041672|NCT00394771|559582676|FG003|Overall Study|Protocol Violation|7|||
155041673|NCT00394771|559582673|FG000|Overall Study|Withdrawal by Subject|10|||
155041674|NCT00394771|559582674|FG001|Overall Study|Withdrawal by Subject|6|||
155041675|NCT00394771|559582675|FG002|Overall Study|Withdrawal by Subject|8|||
155041676|NCT00394771|559582676|FG003|Overall Study|Withdrawal by Subject|12|||
155041677|NCT00394771|559582673|FG000|Overall Study|Adverse Event|10|||
155041678|NCT00394771|559582674|FG001|Overall Study|Adverse Event|5|||
155041679|NCT00394771|559582675|FG002|Overall Study|Adverse Event|12|||
155041680|NCT00394771|559582676|FG003|Overall Study|Adverse Event|8|||
155041681|NCT00394771|559582673|FG000|Overall Study|Participant pregnant|0|||
155041682|NCT00394771|559582674|FG001|Overall Study|Participant pregnant|1|||
155041683|NCT00394771|559582675|FG002|Overall Study|Participant pregnant|2|||
155041684|NCT00394771|559582676|FG003|Overall Study|Participant pregnant|2|||
155041685|NCT00394771|559582673|FG000|Overall Study|Lost to Follow-up|15|||
155041686|NCT00394771|559582674|FG001|Overall Study|Lost to Follow-up|15|||
155041687|NCT00394771|559582675|FG002|Overall Study|Lost to Follow-up|13|||
155041688|NCT00394771|559582676|FG003|Overall Study|Lost to Follow-up|10|||
155041689|NCT00394771|559582673|FG000|Overall Study|Other|3|||
155041690|NCT00394771|559582674|FG001|Overall Study|Other|3|||
155041691|NCT00394771|559582675|FG002|Overall Study|Other|1|||
155041692|NCT00394771|559582676|FG003|Overall Study|Other|0|||
155041693|NCT00094536|559582679|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
155041694|NCT00094536|559582679|FG000|Treatment and Follow-up|Adverse Event|4|||
155041695|NCT00094536|559582679|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
155041696|NCT00094536|559582679|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
155041697|NCT00094536|559582679|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
155041698|NCT00094536|559582679|FG000|Treatment and Follow-up|Subject non-compliance|9|||
155041699|NCT00094536|559582679|FG000|Treatment and Follow-up|Unable to attend visits|1|||
155041700|NCT01900431|559582680|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
155041701|NCT01900431|559582681|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
155041702|NCT01900431|559582682|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
155041703|NCT01900431|559582680|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
155041704|NCT01900431|559582681|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
155041705|NCT01900431|559582682|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
155041706|NCT01900431|559582680|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
155041707|NCT01900431|559582681|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
155041708|NCT01900431|559582682|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
155041709|NCT01900431|559582680|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
155041710|NCT01900431|559582681|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
155041711|NCT01900431|559582682|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
155041712|NCT01900431|559582680|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
155041713|NCT01900431|559582681|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
155041714|NCT01900431|559582682|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
155041715|NCT01900431|559582680|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
155041716|NCT01900431|559582681|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
155041717|NCT01900431|559582682|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
155041718|NCT01900431|559582680|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
155041719|NCT01900431|559582681|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
155041720|NCT01900431|559582682|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
155381578|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381579|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381580|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
155381581|NCT03149549|560830963|FG000|Study Discontinuation--Treatment Period|Other|0|||
155041721|NCT01900431|559582680|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
155041722|NCT01900431|559582681|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
155041723|NCT01900431|559582682|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
155041724|NCT01900431|559582680|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
155041725|NCT01900431|559582681|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
155041726|NCT01900431|559582682|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
155041727|NCT00435019|559582683|FG000|Overall Study|Adverse Event|1|||
155152531|NCT03037385|559996848|FG006|Overall Study|Physician Decision|0|||
155041728|NCT00435019|559582684|FG001|Overall Study|Adverse Event|0|||
155041729|NCT00435019|559582683|FG000|Overall Study|Lack of Efficacy|1|||
155041730|NCT00435019|559582684|FG001|Overall Study|Lack of Efficacy|2|||
155041731|NCT00435019|559582683|FG000|Overall Study|Protocol Violation|3|||
155041732|NCT00435019|559582684|FG001|Overall Study|Protocol Violation|1|||
155041733|NCT00435019|559582683|FG000|Overall Study|Personal reasons for withdrawal|8|||
155041734|NCT00435019|559582684|FG001|Overall Study|Personal reasons for withdrawal|7|||
155041735|NCT00385827|559584566|FG000|Part 1|Adverse Event|1|||
155041736|NCT00385827|559584567|FG001|Part 1|Adverse Event|0|||
155041737|NCT00385827|559584568|FG002|Part 1|Adverse Event|0|||
155041738|NCT00385827|559584566|FG000|Part 1|Death|2|||
155041739|NCT00385827|559584567|FG001|Part 1|Death|0|||
155041740|NCT00385827|559584568|FG002|Part 1|Death|0|||
155041741|NCT00385827|559584566|FG000|Part 1|Lack of Efficacy|5|||
155041742|NCT00385827|559584567|FG001|Part 1|Lack of Efficacy|0|||
155041743|NCT00385827|559584568|FG002|Part 1|Lack of Efficacy|0|||
155041744|NCT00385827|559584566|FG000|Part 1|Other|1|||
155041745|NCT00385827|559584567|FG001|Part 1|Other|0|||
155041746|NCT00385827|559584568|FG002|Part 1|Other|0|||
155041747|NCT00385827|559584566|FG000|Part 2|Adverse Event|0|||
155041748|NCT00385827|559584567|FG001|Part 2|Adverse Event|6|||
155041749|NCT00385827|559584568|FG002|Part 2|Adverse Event|10|||
155041750|NCT00385827|559584566|FG000|Part 2|Death|0|||
155041751|NCT00385827|559584567|FG001|Part 2|Death|0|||
155041752|NCT00385827|559584568|FG002|Part 2|Death|2|||
155041753|NCT00385827|559584566|FG000|Part 2|Lack of Efficacy|0|||
155041754|NCT00385827|559584567|FG001|Part 2|Lack of Efficacy|14|||
155381582|NCT03149549|560830964|FG001|Study Discontinuation--Treatment Period|Other|0|||
155381583|NCT03149549|560830965|FG002|Study Discontinuation--Treatment Period|Other|0|||
155381584|NCT03149549|560830966|FG003|Study Discontinuation--Treatment Period|Other|0|||
155381585|NCT03149549|560830967|FG004|Study Discontinuation--Treatment Period|Other|0|||
155381586|NCT03149549|560830968|FG005|Study Discontinuation--Treatment Period|Other|0|||
155381587|NCT03149549|560830969|FG006|Study Discontinuation--Treatment Period|Other|0|||
155381588|NCT03149549|560830970|FG007|Study Discontinuation--Treatment Period|Other|1|||
155381589|NCT03149549|560830971|FG008|Study Discontinuation--Treatment Period|Other|0|||
155381590|NCT03149549|560830972|FG009|Study Discontinuation--Treatment Period|Other|1|||
155381591|NCT03149549|560830973|FG010|Study Discontinuation--Treatment Period|Other|0|||
155381592|NCT03149549|560830974|FG011|Study Discontinuation--Treatment Period|Other|0|||
155381593|NCT03149549|560830975|FG012|Study Discontinuation--Treatment Period|Other|0|||
155381594|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381595|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381596|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381597|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381598|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381599|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
155381600|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
155381601|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381602|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
155381603|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381604|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381605|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381606|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
155381607|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381608|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381609|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381610|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381611|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
155381612|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381613|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381614|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
155381615|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
155381616|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381617|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
155381618|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
155041755|NCT00385827|559584568|FG002|Part 2|Lack of Efficacy|13|||
155041756|NCT00385827|559584566|FG000|Part 2|Randomized but not treated|0|||
155041757|NCT00385827|559584567|FG001|Part 2|Randomized but not treated|2|||
155041758|NCT00385827|559584568|FG002|Part 2|Randomized but not treated|2|||
155381619|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
155381620|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155041759|NCT00385827|559584566|FG000|Part 2|Other|0|||
155041760|NCT00385827|559584567|FG001|Part 2|Other|11|||
155041761|NCT00385827|559584568|FG002|Part 2|Other|21|||
155041762|NCT01421147|559584569|FG000|Treatment Period|Adverse Event|2|||
155041763|NCT01421147|559584570|FG001|Treatment Period|Adverse Event|3|||
155041764|NCT01421147|559584569|FG000|Treatment Period|Lost to Follow-up|2|||
155041765|NCT01421147|559584570|FG001|Treatment Period|Lost to Follow-up|1|||
155041766|NCT01421147|559584569|FG000|Treatment Period|Physician Decision|2|||
155041767|NCT01421147|559584570|FG001|Treatment Period|Physician Decision|2|||
155041768|NCT01421147|559584569|FG000|Treatment Period|Withdrawal by Subject|10|||
155041769|NCT01421147|559584570|FG001|Treatment Period|Withdrawal by Subject|5|||
155041770|NCT01421147|559584569|FG000|Extension Period|Adverse Event|0|||
155041771|NCT01421147|559584570|FG001|Extension Period|Adverse Event|2|||
155041772|NCT01421147|559584569|FG000|Extension Period|Death|0|||
155041773|NCT01421147|559584570|FG001|Extension Period|Death|1|||
155041774|NCT01421147|559584569|FG000|Extension Period|Lost to Follow-up|2|||
155041775|NCT01421147|559584570|FG001|Extension Period|Lost to Follow-up|5|||
155041776|NCT01421147|559584569|FG000|Extension Period|Physician Decision|1|||
155041777|NCT01421147|559584570|FG001|Extension Period|Physician Decision|0|||
155041778|NCT01421147|559584569|FG000|Extension Period|Withdrawal by Subject|5|||
155041779|NCT01421147|559584570|FG001|Extension Period|Withdrawal by Subject|3|||
155041780|NCT00171158|559584573|FG000|Core Study|Death|27|||
155041781|NCT00171158|559584573|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
155041782|NCT00171158|559584573|FG000|Core Study|Protocol Violation|4|||
155041783|NCT00171158|559584573|FG000|Core Study|Administrative problems|1|||
155041784|NCT00171158|559584573|FG000|Core Study|Adverse event, non-fatal|21|||
155041785|NCT00171158|559584573|FG000|Core Study|Consent withdrawn by subject|6|||
155041786|NCT00171158|559584573|FG000|Core Study|No longer required drug (BMT)|14|||
155041787|NCT00171158|559584573|FG000|Core Study|Abnormal Laboratory Values|2|||
155041788|NCT00171158|559584573|FG000|Core Study|Lost to Follow-up|1|||
155041789|NCT00171158|559584573|FG000|E2 Extension|Other|7|||
155041790|NCT02757352|559584574|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
155041791|NCT02757352|559584575|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041792|NCT02757352|559584576|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
155041793|NCT02757352|559584577|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041794|NCT02757352|559584578|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041795|NCT02757352|559584579|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041796|NCT02757352|559584580|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041797|NCT02757352|559584581|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041798|NCT02757352|559584582|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041799|NCT02757352|559584583|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
155041800|NCT02757352|559584574|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041801|NCT02757352|559584575|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041802|NCT02757352|559584576|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
155041803|NCT02757352|559584577|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041804|NCT02757352|559584578|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041805|NCT02757352|559584579|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041806|NCT02757352|559584580|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041807|NCT02757352|559584581|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041808|NCT02757352|559584582|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041809|NCT02757352|559584583|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
155041810|NCT02757352|559584574|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
155041811|NCT02757352|559584575|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
155041812|NCT02757352|559584576|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
155041813|NCT02757352|559584577|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041814|NCT02757352|559584578|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041815|NCT02757352|559584579|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041816|NCT02757352|559584580|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041817|NCT02757352|559584581|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041818|NCT02757352|559584582|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041819|NCT02757352|559584583|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
155041820|NCT02757352|559584574|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041821|NCT02757352|559584575|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
155041822|NCT02757352|559584576|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041823|NCT02757352|559584577|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041824|NCT02757352|559584578|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041825|NCT02757352|559584579|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041826|NCT02757352|559584580|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041827|NCT02757352|559584581|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041828|NCT02757352|559584582|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041829|NCT02757352|559584583|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
155041830|NCT02757352|559584574|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155381621|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
154928102|NCT02118896|559160716|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
154928103|NCT02118896|559160707|FG000|Overall Study|Prohibited medication|0|||
154928104|NCT02118896|559160708|FG001|Overall Study|Prohibited medication|0|||
154928105|NCT02118896|559160709|FG002|Overall Study|Prohibited medication|0|||
155041831|NCT02757352|559584575|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155041832|NCT02757352|559584576|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041833|NCT02757352|559584577|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
154928106|NCT02118896|559160710|FG003|Overall Study|Prohibited medication|0|||
154928107|NCT02118896|559160711|FG004|Overall Study|Prohibited medication|1|||
154928108|NCT02118896|559160712|FG005|Overall Study|Prohibited medication|3|||
154928109|NCT02118896|559160713|FG006|Overall Study|Prohibited medication|0|||
154928110|NCT02118896|559160714|FG007|Overall Study|Prohibited medication|0|||
154928111|NCT02118896|559160715|FG008|Overall Study|Prohibited medication|0|||
154928112|NCT02118896|559160716|FG009|Overall Study|Prohibited medication|0|||
154928113|NCT02118896|559160707|FG000|Overall Study|Miscellaneous|1|||
154928114|NCT02118896|559160708|FG001|Overall Study|Miscellaneous|2|||
154928115|NCT02118896|559160709|FG002|Overall Study|Miscellaneous|0|||
154928116|NCT02118896|559160710|FG003|Overall Study|Miscellaneous|2|||
154928117|NCT02118896|559160711|FG004|Overall Study|Miscellaneous|0|||
154928118|NCT02118896|559160712|FG005|Overall Study|Miscellaneous|4|||
154928119|NCT02118896|559160713|FG006|Overall Study|Miscellaneous|0|||
154928120|NCT02118896|559160714|FG007|Overall Study|Miscellaneous|0|||
154928121|NCT02118896|559160715|FG008|Overall Study|Miscellaneous|0|||
154928122|NCT02118896|559160716|FG009|Overall Study|Miscellaneous|0|||
154928123|NCT00539006|559160717|FG000|Pre-treatment|Other|0|||
154928124|NCT00539006|559160718|FG001|Pre-treatment|Other|1|||
154928125|NCT00539006|559160719|FG002|Pre-treatment|Other|0|||
154928126|NCT00539006|559160720|FG003|Pre-treatment|Other|0|||
154928127|NCT00539006|559160717|FG000|Treatment Period 1|Lost to Follow-up|0|||
154928128|NCT00539006|559160718|FG001|Treatment Period 1|Lost to Follow-up|0|||
154928129|NCT00539006|559160719|FG002|Treatment Period 1|Lost to Follow-up|1|||
154928130|NCT00539006|559160720|FG003|Treatment Period 1|Lost to Follow-up|0|||
154928131|NCT00539006|559160717|FG000|Treatment Period 1|Protocol Violation|0|||
154928132|NCT00539006|559160718|FG001|Treatment Period 1|Protocol Violation|0|||
154928133|NCT00539006|559160719|FG002|Treatment Period 1|Protocol Violation|1|||
154928134|NCT00539006|559160720|FG003|Treatment Period 1|Protocol Violation|0|||
154928135|NCT00539006|559160717|FG000|Treatment Period 1|Lack of Efficacy|0|||
154928136|NCT00539006|559160718|FG001|Treatment Period 1|Lack of Efficacy|0|||
154928137|NCT00539006|559160719|FG002|Treatment Period 1|Lack of Efficacy|0|||
154928138|NCT00539006|559160720|FG003|Treatment Period 1|Lack of Efficacy|1|||
154928139|NCT00539006|559160717|FG000|Washout|Adverse Event|2|||
154928140|NCT00539006|559160718|FG001|Washout|Adverse Event|1|||
154928141|NCT00539006|559160719|FG002|Washout|Adverse Event|0|||
154928142|NCT00539006|559160720|FG003|Washout|Adverse Event|0|||
154928143|NCT00539006|559160717|FG000|Washout|Protocol Violation|1|||
154928144|NCT00539006|559160718|FG001|Washout|Protocol Violation|1|||
155041834|NCT02757352|559584578|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041835|NCT02757352|559584579|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041836|NCT02757352|559584580|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041837|NCT02757352|559584581|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041838|NCT02757352|559584582|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041839|NCT02757352|559584583|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041840|NCT02757352|559584574|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155041841|NCT02757352|559584575|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155041842|NCT02757352|559584576|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
155041843|NCT02757352|559584577|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041844|NCT02757352|559584578|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041845|NCT02757352|559584579|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041846|NCT02757352|559584580|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041847|NCT02757352|559584581|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041848|NCT02757352|559584582|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
154928145|NCT00539006|559160719|FG002|Washout|Protocol Violation|0|||
154928146|NCT00539006|559160720|FG003|Washout|Protocol Violation|0|||
154928147|NCT00539006|559160717|FG000|Washout|Withdrawal by Subject|0|||
154928148|NCT00539006|559160718|FG001|Washout|Withdrawal by Subject|2|||
154928149|NCT00539006|559160719|FG002|Washout|Withdrawal by Subject|0|||
154928150|NCT00539006|559160720|FG003|Washout|Withdrawal by Subject|0|||
154928151|NCT00539006|559160717|FG000|Washout|Failed to meet continuation criteria|16|||
154928152|NCT00539006|559160718|FG001|Washout|Failed to meet continuation criteria|5|||
154928153|NCT00539006|559160719|FG002|Washout|Failed to meet continuation criteria|14|||
154928154|NCT00539006|559160720|FG003|Washout|Failed to meet continuation criteria|6|||
154928155|NCT00539006|559160717|FG000|Washout|Other|1|||
154928156|NCT00539006|559160718|FG001|Washout|Other|1|||
154928157|NCT00539006|559160719|FG002|Washout|Other|2|||
154928158|NCT00539006|559160720|FG003|Washout|Other|3|||
155041849|NCT02757352|559584583|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041850|NCT02757352|559584574|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
155041851|NCT02757352|559584575|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
155041852|NCT02757352|559584576|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
155041853|NCT02757352|559584577|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041854|NCT02757352|559584578|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041855|NCT02757352|559584579|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041856|NCT02757352|559584580|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041857|NCT02757352|559584581|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041858|NCT02757352|559584582|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041859|NCT02757352|559584583|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
155041860|NCT02757352|559584574|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041861|NCT02757352|559584575|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041862|NCT02757352|559584576|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041863|NCT02757352|559584577|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
155041864|NCT02757352|559584578|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041865|NCT02757352|559584579|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
155041866|NCT02757352|559584580|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041867|NCT02757352|559584581|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041868|NCT02757352|559584582|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041869|NCT02757352|559584583|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
155041870|NCT02757352|559584574|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041871|NCT02757352|559584575|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041872|NCT02757352|559584576|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041873|NCT02757352|559584577|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
155041874|NCT02757352|559584578|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155041875|NCT02757352|559584579|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
155041876|NCT02757352|559584580|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041877|NCT02757352|559584581|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041878|NCT02757352|559584582|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041879|NCT02757352|559584583|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155041880|NCT02757352|559584574|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041881|NCT02757352|559584575|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041882|NCT02757352|559584576|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041883|NCT02757352|559584577|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041884|NCT02757352|559584578|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
155041885|NCT02757352|559584579|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041886|NCT02757352|559584580|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041887|NCT02757352|559584581|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041888|NCT02757352|559584582|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041889|NCT02757352|559584583|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
155041890|NCT02757352|559584574|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041891|NCT02757352|559584575|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041892|NCT02757352|559584576|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041893|NCT02757352|559584577|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041894|NCT02757352|559584578|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041895|NCT02757352|559584579|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
155041896|NCT02757352|559584580|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041897|NCT02757352|559584581|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041898|NCT02757352|559584582|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041899|NCT02757352|559584583|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
155041900|NCT02757352|559584574|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041901|NCT02757352|559584575|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041902|NCT02757352|559584576|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041903|NCT02757352|559584577|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
155041904|NCT02757352|559584578|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155041905|NCT02757352|559584579|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
155041906|NCT02757352|559584580|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041907|NCT02757352|559584581|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041908|NCT02757352|559584582|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041909|NCT02757352|559584583|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155041910|NCT02757352|559584574|FG000|Follow-Up Period|Adverse Event|0|||
155041911|NCT02757352|559584575|FG001|Follow-Up Period|Adverse Event|0|||
155041912|NCT02757352|559584576|FG002|Follow-Up Period|Adverse Event|0|||
155041913|NCT02757352|559584577|FG003|Follow-Up Period|Adverse Event|0|||
155041914|NCT02757352|559584578|FG004|Follow-Up Period|Adverse Event|0|||
155041915|NCT02757352|559584579|FG005|Follow-Up Period|Adverse Event|0|||
155041916|NCT02757352|559584580|FG006|Follow-Up Period|Adverse Event|1|||
155041917|NCT02757352|559584581|FG007|Follow-Up Period|Adverse Event|0|||
155041918|NCT02757352|559584582|FG008|Follow-Up Period|Adverse Event|2|||
155041919|NCT02757352|559584583|FG009|Follow-Up Period|Adverse Event|0|||
155041920|NCT02757352|559584574|FG000|Follow-Up Period|Lost to Follow-up|0|||
155041921|NCT02757352|559584575|FG001|Follow-Up Period|Lost to Follow-up|0|||
155041922|NCT02757352|559584576|FG002|Follow-Up Period|Lost to Follow-up|0|||
155041923|NCT02757352|559584577|FG003|Follow-Up Period|Lost to Follow-up|0|||
155041924|NCT02757352|559584578|FG004|Follow-Up Period|Lost to Follow-up|0|||
155041925|NCT02757352|559584579|FG005|Follow-Up Period|Lost to Follow-up|0|||
155041926|NCT02757352|559584580|FG006|Follow-Up Period|Lost to Follow-up|0|||
155041927|NCT02757352|559584581|FG007|Follow-Up Period|Lost to Follow-up|0|||
155041928|NCT02757352|559584582|FG008|Follow-Up Period|Lost to Follow-up|1|||
155041929|NCT02757352|559584583|FG009|Follow-Up Period|Lost to Follow-up|0|||
155041930|NCT02757352|559584574|FG000|Follow-Up Period|Lack of Efficacy|0|||
155041931|NCT02757352|559584575|FG001|Follow-Up Period|Lack of Efficacy|0|||
155041932|NCT02757352|559584576|FG002|Follow-Up Period|Lack of Efficacy|0|||
155041933|NCT02757352|559584577|FG003|Follow-Up Period|Lack of Efficacy|0|||
155041934|NCT02757352|559584578|FG004|Follow-Up Period|Lack of Efficacy|0|||
155041935|NCT02757352|559584579|FG005|Follow-Up Period|Lack of Efficacy|0|||
155041936|NCT02757352|559584580|FG006|Follow-Up Period|Lack of Efficacy|0|||
155041937|NCT02757352|559584581|FG007|Follow-Up Period|Lack of Efficacy|0|||
155041938|NCT02757352|559584582|FG008|Follow-Up Period|Lack of Efficacy|1|||
155041939|NCT02757352|559584583|FG009|Follow-Up Period|Lack of Efficacy|1|||
155041940|NCT02757352|559584574|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155041941|NCT02757352|559584575|FG001|Follow-Up Period|Withdrawal by Subject|0|||
155041942|NCT02757352|559584576|FG002|Follow-Up Period|Withdrawal by Subject|0|||
155041943|NCT02757352|559584577|FG003|Follow-Up Period|Withdrawal by Subject|0|||
155041944|NCT02757352|559584578|FG004|Follow-Up Period|Withdrawal by Subject|0|||
155041945|NCT02757352|559584579|FG005|Follow-Up Period|Withdrawal by Subject|0|||
155041946|NCT02757352|559584580|FG006|Follow-Up Period|Withdrawal by Subject|0|||
155041947|NCT02757352|559584581|FG007|Follow-Up Period|Withdrawal by Subject|1|||
155041948|NCT02757352|559584582|FG008|Follow-Up Period|Withdrawal by Subject|6|||
155041949|NCT02757352|559584583|FG009|Follow-Up Period|Withdrawal by Subject|2|||
155041950|NCT03536663|559584584|FG000|Endexo|Protocol Violation|1|||
155041951|NCT04750278|559584585|FG000|Overall Study|Death|9|||
155041952|NCT04750278|559584586|FG001|Overall Study|Death|10|||
155041953|NCT04750278|559584587|FG002|Overall Study|Death|10|||
155041954|NCT04750278|559584585|FG000|Overall Study|Withdrawal by Subject|4|||
155041955|NCT04750278|559584586|FG001|Overall Study|Withdrawal by Subject|1|||
155041956|NCT04750278|559584587|FG002|Overall Study|Withdrawal by Subject|2|||
155041957|NCT04750278|559584585|FG000|Overall Study|Lost to Follow-up|1|||
155041958|NCT04750278|559584586|FG001|Overall Study|Lost to Follow-up|1|||
155041959|NCT04750278|559584587|FG002|Overall Study|Lost to Follow-up|1|||
155041960|NCT04750278|559584585|FG000|Overall Study|Pregnancy|1|||
155041961|NCT04750278|559584586|FG001|Overall Study|Pregnancy|0|||
155041962|NCT04750278|559584587|FG002|Overall Study|Pregnancy|0|||
155041963|NCT04750278|559584585|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
155041964|NCT04750278|559584586|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
155041965|NCT04750278|559584587|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
155041966|NCT04750278|559584585|FG000|Overall Study|Non-compliance|0|||
155041967|NCT04750278|559584586|FG001|Overall Study|Non-compliance|0|||
155041968|NCT04750278|559584587|FG002|Overall Study|Non-compliance|1|||
155041969|NCT04750278|559584585|FG000|Overall Study|Transfer to Outside Facility|0|||
155041970|NCT04750278|559584586|FG001|Overall Study|Transfer to Outside Facility|2|||
155041971|NCT04750278|559584587|FG002|Overall Study|Transfer to Outside Facility|1|||
155041972|NCT04750278|559584585|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
155041973|NCT04750278|559584586|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
155041974|NCT04750278|559584587|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
155041975|NCT04750278|559584585|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
155041976|NCT04750278|559584586|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
155041977|NCT04750278|559584587|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
155041978|NCT01616758|559584591|FG000|Overall Study|Adverse Event|1|||
155041979|NCT01616758|559584591|FG000|Overall Study|Withdrawal by Subject|2|||
155041980|NCT01616758|559584591|FG000|Overall Study|Disease progression|18|||
155041981|NCT01616758|559584591|FG000|Overall Study|Study termination by Sponsor|1|||
155041982|NCT03504189|559584596|FG000|Overall Study|Withdrawal by Subject|1|||
155041983|NCT03504189|559584596|FG000|Overall Study|Screening Failure|1|||
155041984|NCT03504189|559584596|FG000|Overall Study|Device Failure|2|||
155041985|NCT00199849|559584604|FG000|Overall Study|Unrelated illness or complication|0|||
154928159|NCT00539006|559160717|FG000|Treatment Period 2|Protocol Violation|1|||
154928160|NCT00539006|559160718|FG001|Treatment Period 2|Protocol Violation|0|||
154928161|NCT00539006|559160719|FG002|Treatment Period 2|Protocol Violation|0|||
154928162|NCT00539006|559160720|FG003|Treatment Period 2|Protocol Violation|0|||
154928163|NCT00539006|559160717|FG000|Treatment Period 2|Other|0|||
154928164|NCT00539006|559160718|FG001|Treatment Period 2|Other|1|||
154928165|NCT00539006|559160719|FG002|Treatment Period 2|Other|0|||
154928166|NCT00539006|559160720|FG003|Treatment Period 2|Other|0|||
154928167|NCT00572910|559160721|FG000|Overall Study|Adverse Event|1|||
155041986|NCT00199849|559584605|FG001|Overall Study|Unrelated illness or complication|1|||
154928168|NCT00572910|559160722|FG001|Overall Study|Adverse Event|2|||
154928169|NCT00572910|559160723|FG002|Overall Study|Adverse Event|0|||
154928170|NCT00572910|559160724|FG003|Overall Study|Adverse Event|2|||
154928171|NCT00572910|559160725|FG004|Overall Study|Adverse Event|0|||
154928172|NCT00572910|559160726|FG005|Overall Study|Adverse Event|0|||
154928173|NCT00572910|559160727|FG006|Overall Study|Adverse Event|4|||
154928174|NCT00572910|559160728|FG007|Overall Study|Adverse Event|2|||
154928175|NCT00572910|559160729|FG008|Overall Study|Adverse Event|1|||
154928176|NCT00572910|559160730|FG009|Overall Study|Adverse Event|3|||
154928177|NCT00572910|559160731|FG010|Overall Study|Adverse Event|2|||
154928178|NCT00572910|559160721|FG000|Overall Study|Lost to Follow-up|0|||
154928179|NCT00572910|559160722|FG001|Overall Study|Lost to Follow-up|1|||
154928180|NCT00572910|559160723|FG002|Overall Study|Lost to Follow-up|1|||
154928181|NCT00572910|559160724|FG003|Overall Study|Lost to Follow-up|2|||
154928182|NCT00572910|559160725|FG004|Overall Study|Lost to Follow-up|1|||
155041987|NCT00199849|559584606|FG002|Overall Study|Unrelated illness or complication|0|||
155041988|NCT00199849|559584604|FG000|Overall Study|Progressive disease requiring intervention|0|||
155041989|NCT00199849|559584605|FG001|Overall Study|Progressive disease requiring intervention|0|||
155041990|NCT00199849|559584606|FG002|Overall Study|Progressive disease requiring intervention|1|||
155041991|NCT00199849|559584604|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
155041992|NCT00199849|559584605|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
155041993|NCT00199849|559584606|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
155041994|NCT04727528|559584607|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
155041995|NCT04727528|559584608|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
155041996|NCT04727528|559584607|FG000|Open-label Period|Randomized who did not receive treatment|1|||
155041997|NCT04727528|559584608|FG001|Open-label Period|Randomized who did not receive treatment|0|||
155041998|NCT04727528|559584607|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155041999|NCT04727528|559584608|FG001|Double-blind Treatment Phase|Adverse Event|1|||
154928183|NCT00572910|559160726|FG005|Overall Study|Lost to Follow-up|0|||
154928184|NCT00572910|559160727|FG006|Overall Study|Lost to Follow-up|0|||
154928185|NCT00572910|559160728|FG007|Overall Study|Lost to Follow-up|0|||
155042000|NCT04727528|559584607|FG000|Double-blind Treatment Phase|Death|0|||
155042001|NCT04727528|559584608|FG001|Double-blind Treatment Phase|Death|1|||
155042002|NCT04727528|559584607|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
155042003|NCT04727528|559584608|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
155042004|NCT04727528|559584607|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
155042005|NCT04727528|559584608|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
155042006|NCT04727528|559584607|FG000|Double-blind Treatment Phase|Physician Decision|0|||
155042007|NCT04727528|559584608|FG001|Double-blind Treatment Phase|Physician Decision|1|||
155042008|NCT04727528|559584607|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
155042009|NCT04727528|559584608|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155042010|NCT01467271|559584610|FG000|Overall Study|Death|84|||
155042011|NCT01467271|559584610|FG000|Overall Study|Lost to Follow-up|83|||
155042012|NCT01467271|559584610|FG000|Overall Study|Retraction of patient's consent|21|||
155042013|NCT01467271|559584610|FG000|Overall Study|Other reason|14|||
155042014|NCT01964989|559584611|FG000|Overall Study|Protocol Violation|3|||
155042015|NCT01964989|559584612|FG001|Overall Study|Protocol Violation|4|||
155042016|NCT01964989|559584611|FG000|Overall Study|Administrative Reason|103|||
155042017|NCT01964989|559584612|FG001|Overall Study|Administrative Reason|95|||
155042018|NCT01964989|559584611|FG000|Overall Study|Adverse Event|0|||
155042019|NCT01964989|559584612|FG001|Overall Study|Adverse Event|1|||
155042020|NCT01964989|559584611|FG000|Overall Study|Death|1|||
155042021|NCT01964989|559584612|FG001|Overall Study|Death|3|||
155042022|NCT01964989|559584611|FG000|Overall Study|Withdrawal by Subject|156|||
154928186|NCT00572910|559160729|FG008|Overall Study|Lost to Follow-up|0|||
154928187|NCT00572910|559160730|FG009|Overall Study|Lost to Follow-up|1|||
154928188|NCT00572910|559160731|FG010|Overall Study|Lost to Follow-up|0|||
154928189|NCT00572910|559160721|FG000|Overall Study|Withdrawal by Subject|3|||
154928190|NCT00572910|559160722|FG001|Overall Study|Withdrawal by Subject|0|||
154928191|NCT00572910|559160723|FG002|Overall Study|Withdrawal by Subject|1|||
154928192|NCT00572910|559160724|FG003|Overall Study|Withdrawal by Subject|0|||
154928193|NCT00572910|559160725|FG004|Overall Study|Withdrawal by Subject|1|||
154928194|NCT00572910|559160726|FG005|Overall Study|Withdrawal by Subject|3|||
155042023|NCT01964989|559584612|FG001|Overall Study|Withdrawal by Subject|160|||
155042024|NCT01964989|559584611|FG000|Overall Study|Lost to Follow-up|254|||
155042025|NCT01964989|559584612|FG001|Overall Study|Lost to Follow-up|232|||
155042026|NCT01964989|559584611|FG000|Overall Study|Other|267|||
155042027|NCT01964989|559584612|FG001|Overall Study|Other|252|||
155042028|NCT02769312|559584613|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
155042029|NCT02769312|559584614|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
155042030|NCT02769312|559584613|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
155042031|NCT02769312|559584614|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
155042032|NCT02769312|559584613|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
155042033|NCT02769312|559584614|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
155042034|NCT02769312|559584613|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
155042035|NCT02769312|559584614|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
155042036|NCT02769312|559584613|FG000|Follow-up|Lost to Follow-up|1|||
155042037|NCT02769312|559584614|FG001|Follow-up|Lost to Follow-up|1|||
155042038|NCT00660595|559584617|FG000|Overall Study|Lost to Follow-up|0|||
155042039|NCT00660595|559584618|FG001|Overall Study|Lost to Follow-up|1|||
155042040|NCT00660595|559584617|FG000|Overall Study|Did not consent to participate in study|12|||
155042041|NCT00660595|559584618|FG001|Overall Study|Did not consent to participate in study|8|||
155042042|NCT00660595|559584617|FG000|Overall Study|Participant left hospital|1|||
155042043|NCT00660595|559584618|FG001|Overall Study|Participant left hospital|0|||
155042044|NCT00660595|559584617|FG000|Overall Study|Non Specified reasons|5|||
155042045|NCT00660595|559584618|FG001|Overall Study|Non Specified reasons|0|||
155042046|NCT01148459|559584621|FG000|Overall Study|Serious Adverse Event|5|||
155042047|NCT01148459|559584622|FG001|Overall Study|Serious Adverse Event|4|||
155042048|NCT01148459|559584621|FG000|Overall Study|Withdrawal by Subject|1|||
155042049|NCT01148459|559584622|FG001|Overall Study|Withdrawal by Subject|0|||
155042050|NCT01148459|559584621|FG000|Overall Study|Migrated/moved from study area|3|||
155042051|NCT01148459|559584622|FG001|Overall Study|Migrated/moved from study area|6|||
155042052|NCT01148459|559584621|FG000|Overall Study|Lost to Follow-up|2|||
155042053|NCT01148459|559584622|FG001|Overall Study|Lost to Follow-up|0|||
155042054|NCT01148459|559584621|FG000|Overall Study|Refusal|1|||
155042055|NCT01148459|559584622|FG001|Overall Study|Refusal|0|||
155042056|NCT01148459|559584621|FG000|Overall Study|Failure to comply with study procedures|0|||
155042057|NCT01148459|559584622|FG001|Overall Study|Failure to comply with study procedures|1|||
155042058|NCT04854057|559584623|FG000|Overall Study|Adverse Event|0|||
155042059|NCT04854057|559584624|FG001|Overall Study|Adverse Event|1|||
155042060|NCT03077607|559584632|FG000|Period 1 (15 Days)|Adverse Event|1|||
155042061|NCT03077607|559584633|FG001|Period 1 (15 Days)|Adverse Event|0|||
155042062|NCT03077607|559584632|FG000|Period 1 (15 Days)|Death|1|||
155042063|NCT03077607|559584633|FG001|Period 1 (15 Days)|Death|0|||
155042064|NCT03077607|559584632|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
155042065|NCT03077607|559584633|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
155042066|NCT03077607|559584632|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
155042067|NCT03077607|559584633|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
155042068|NCT00482170|559584652|FG000|Overall Study|Adverse Event|5|||
155042069|NCT00482170|559584653|FG001|Overall Study|Adverse Event|14|||
155042070|NCT00482170|559584652|FG000|Overall Study|Withdrawal by Subject|6|||
155042071|NCT00482170|559584653|FG001|Overall Study|Withdrawal by Subject|1|||
155042072|NCT00482170|559584652|FG000|Overall Study|Protocol Violation|2|||
155042073|NCT00482170|559584653|FG001|Overall Study|Protocol Violation|3|||
155042074|NCT00482170|559584652|FG000|Overall Study|Lost to Follow-up|2|||
155042075|NCT00482170|559584653|FG001|Overall Study|Lost to Follow-up|0|||
155042076|NCT00482170|559584652|FG000|Overall Study|Unspecified reason|0|||
155042077|NCT00482170|559584653|FG001|Overall Study|Unspecified reason|2|||
155042078|NCT01557517|559584654|FG000|Overall Study|Death|1|||
155042079|NCT01557517|559584655|FG001|Overall Study|Death|0|||
155042080|NCT01557517|559584654|FG000|Overall Study|Refused further treatment|0|||
155042081|NCT01557517|559584655|FG001|Overall Study|Refused further treatment|2|||
155042082|NCT01557517|559584654|FG000|Overall Study|Adverse Event|0|||
155042083|NCT01557517|559584655|FG001|Overall Study|Adverse Event|2|||
155042084|NCT01557517|559584654|FG000|Overall Study|Pt declined before treatment started|1|||
155042085|NCT01557517|559584655|FG001|Overall Study|Pt declined before treatment started|0|||
155042086|NCT03585712|559584656|FG000|Treatment Period 1|Protocol Violation|1|||
155042087|NCT03585712|559584657|FG001|Treatment Period 1|Protocol Violation|0|||
155381622|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155042088|NCT03585712|559584658|FG002|Treatment Period 1|Protocol Violation|0|||
155042089|NCT03585712|559584656|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
155042090|NCT03585712|559584657|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
155042091|NCT03585712|559584658|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
155042092|NCT03585712|559584656|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
155042093|NCT03585712|559584657|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
155042094|NCT03585712|559584658|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
155042095|NCT03585712|559584656|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
155042096|NCT03585712|559584657|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
154928195|NCT00572910|559160727|FG006|Overall Study|Withdrawal by Subject|0|||
154928196|NCT00572910|559160728|FG007|Overall Study|Withdrawal by Subject|2|||
154928197|NCT00572910|559160729|FG008|Overall Study|Withdrawal by Subject|2|||
154928198|NCT00572910|559160730|FG009|Overall Study|Withdrawal by Subject|2|||
154928199|NCT00572910|559160731|FG010|Overall Study|Withdrawal by Subject|1|||
154928200|NCT02230332|559160732|FG000|Overall Study|Adverse Event|2|||
154928201|NCT02230332|559160733|FG001|Overall Study|Adverse Event|1|||
154928202|NCT02230332|559160732|FG000|Overall Study|Lost to Follow-up|1|||
154928203|NCT02230332|559160733|FG001|Overall Study|Lost to Follow-up|0|||
154928204|NCT02230332|559160732|FG000|Overall Study|Protocol Violation|1|||
154928205|NCT02230332|559160733|FG001|Overall Study|Protocol Violation|0|||
154928206|NCT01260194|559160735|FG000|Overall Study|Withdrawal of Consent|1|||
154928207|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
154928208|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
154928209|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
154928210|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
154928211|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
154928212|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
154928213|NCT00566631|559160737|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
154928214|NCT00566631|559160737|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
154928215|NCT00566631|559160737|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
154928216|NCT00566631|559160737|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
154928217|NCT00566631|559160737|FG000|Part 2: Extension Phase|Adverse Event|11|||
154928218|NCT00566631|559160737|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
154928219|NCT00566631|559160737|FG000|Part 2: Extension Phase|Death|1|||
154928220|NCT00566631|559160737|FG000|Part 2: Extension Phase|Other|5|||
154928221|NCT00877799|559160738|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
154928222|NCT00877799|559160739|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
154928223|NCT00877799|559160740|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
154928224|NCT00877799|559160741|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
154928225|NCT00877799|559160742|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
154928226|NCT00877799|559160738|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
154928227|NCT00877799|559160739|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
154928228|NCT00877799|559160740|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
154928229|NCT00877799|559160741|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
154928230|NCT00877799|559160742|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
154928231|NCT00877799|559160738|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
154928232|NCT00877799|559160739|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
154928233|NCT00877799|559160740|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
154928234|NCT00877799|559160741|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
154928235|NCT00877799|559160742|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
154928236|NCT00877799|559160738|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
154928237|NCT00877799|559160739|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
154928238|NCT00877799|559160740|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
154928239|NCT00877799|559160741|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
154928240|NCT00877799|559160742|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
154928241|NCT00877799|559160738|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
154928242|NCT00877799|559160739|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
154928243|NCT00877799|559160740|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
154928244|NCT00877799|559160741|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
154928245|NCT00877799|559160742|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
154928246|NCT00592007|559160743|FG000|Overall Study|Withdrawal by Subject|1|||
154928247|NCT00592007|559160743|FG000|Overall Study|patient ineligible (out of lab range)|1|||
155042097|NCT03585712|559584658|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
155042098|NCT01280682|559584663|FG000|Overall Study|Lost to Follow-up|0|||
155042099|NCT01280682|559584664|FG001|Overall Study|Lost to Follow-up|6|||
155042100|NCT01280682|559584663|FG000|Overall Study|Withdrawal by Subject|0|||
155042101|NCT01280682|559584664|FG001|Overall Study|Withdrawal by Subject|7|||
155042102|NCT00548249|559584665|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
155042103|NCT00548249|559584666|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
155042104|NCT00548249|559584667|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
155042105|NCT00548249|559584668|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
155042106|NCT00548249|559584669|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
155042107|NCT00548249|559584665|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
155042108|NCT00548249|559584666|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
154928248|NCT04054011|559160744|FG000|Overall Study|COVID|3|||
154928249|NCT00595127|559160745|FG000|Overall Study|Death|6|||
154928250|NCT00595127|559160745|FG000|Overall Study|Relapsed|3|||
154928251|NCT00595127|559160745|FG000|Overall Study|joined another trial|1|||
154928252|NCT00538473|559160747|FG000|Overall Study|Adverse Event|1|||
155042109|NCT00548249|559584667|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
155042110|NCT00548249|559584668|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
155042111|NCT00548249|559584669|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
155042112|NCT00548249|559584665|FG000|Overall Study|Protocol Violation|1|||
155042113|NCT00548249|559584666|FG001|Overall Study|Protocol Violation|1|||
155042114|NCT00548249|559584667|FG002|Overall Study|Protocol Violation|4|||
155042115|NCT00548249|559584668|FG003|Overall Study|Protocol Violation|0|||
155042116|NCT00548249|559584669|FG004|Overall Study|Protocol Violation|3|||
155042117|NCT00548249|559584665|FG000|Overall Study|Miscellaneous|2|||
155042118|NCT00548249|559584666|FG001|Overall Study|Miscellaneous|3|||
155042119|NCT00548249|559584667|FG002|Overall Study|Miscellaneous|2|||
155042120|NCT00548249|559584668|FG003|Overall Study|Miscellaneous|0|||
155042121|NCT00548249|559584669|FG004|Overall Study|Miscellaneous|2|||
155042122|NCT00548249|559584665|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
155042123|NCT00548249|559584666|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
155042124|NCT00548249|559584667|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
155042125|NCT00548249|559584668|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
155042126|NCT00548249|559584669|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
155042127|NCT00548249|559584665|FG000|Overall Study|Adverse Event|2|||
155042128|NCT00548249|559584666|FG001|Overall Study|Adverse Event|2|||
155042129|NCT00548249|559584667|FG002|Overall Study|Adverse Event|0|||
155042130|NCT00548249|559584668|FG003|Overall Study|Adverse Event|1|||
155042131|NCT00548249|559584669|FG004|Overall Study|Adverse Event|1|||
155042132|NCT00548249|559584665|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
155042133|NCT00548249|559584666|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
155042134|NCT00548249|559584667|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
155042135|NCT00548249|559584668|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
155042136|NCT00548249|559584669|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
155042137|NCT00548249|559584665|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
155042138|NCT00548249|559584666|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
155042139|NCT00548249|559584667|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
155042140|NCT00548249|559584668|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
155042141|NCT00548249|559584669|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
155042142|NCT00548249|559584665|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155042143|NCT00548249|559584666|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155042144|NCT00548249|559584667|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155042145|NCT00548249|559584668|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
155042146|NCT00548249|559584669|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
155042147|NCT00548249|559584665|FG000|Overall Study|Prolonged hospitalization|0|||
155042148|NCT00548249|559584666|FG001|Overall Study|Prolonged hospitalization|0|||
155042149|NCT00548249|559584667|FG002|Overall Study|Prolonged hospitalization|2|||
155042150|NCT00548249|559584668|FG003|Overall Study|Prolonged hospitalization|1|||
155042151|NCT00548249|559584669|FG004|Overall Study|Prolonged hospitalization|0|||
155042152|NCT00548249|559584665|FG000|Overall Study|Withdrawal by Subject|2|||
155042153|NCT00548249|559584666|FG001|Overall Study|Withdrawal by Subject|0|||
155042154|NCT00548249|559584667|FG002|Overall Study|Withdrawal by Subject|0|||
155042155|NCT00548249|559584668|FG003|Overall Study|Withdrawal by Subject|0|||
155042156|NCT00548249|559584669|FG004|Overall Study|Withdrawal by Subject|0|||
155042157|NCT00548249|559584665|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
155042158|NCT00548249|559584666|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
155042159|NCT00548249|559584667|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
155042160|NCT00548249|559584668|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
155042161|NCT00548249|559584669|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
155042162|NCT00548249|559584665|FG000|Overall Study|Sponsor's request|0|||
155042163|NCT00548249|559584666|FG001|Overall Study|Sponsor's request|0|||
155042164|NCT00548249|559584667|FG002|Overall Study|Sponsor's request|0|||
155042165|NCT00548249|559584668|FG003|Overall Study|Sponsor's request|1|||
155042166|NCT00548249|559584669|FG004|Overall Study|Sponsor's request|0|||
155042167|NCT02007278|559584670|FG000|Overall Study|Failure to comply with an eligibility|0|||
155042168|NCT02007278|559584671|FG001|Overall Study|Failure to comply with an eligibility|1|||
155042169|NCT02007278|559584670|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
155042170|NCT02007278|559584671|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
155042171|NCT02007278|559584670|FG000|Overall Study|Incorrect medication administration|1|||
155042172|NCT02007278|559584671|FG001|Overall Study|Incorrect medication administration|0|||
155042173|NCT02007278|559584670|FG000|Overall Study|Mis-randomization|1|||
155042174|NCT02007278|559584671|FG001|Overall Study|Mis-randomization|1|||
155042175|NCT01429441|559584674|FG000|Overall Study|Adverse Event|5|||
155042176|NCT01429441|559584675|FG001|Overall Study|Adverse Event|1|||
155042177|NCT01429441|559584674|FG000|Overall Study|Death|0|||
155042178|NCT01429441|559584675|FG001|Overall Study|Death|2|||
155042179|NCT01429441|559584674|FG000|Overall Study|Lost to Follow-up|5|||
155042180|NCT01429441|559584675|FG001|Overall Study|Lost to Follow-up|2|||
155042181|NCT01429441|559584674|FG000|Overall Study|Physician Decision|1|||
155042182|NCT01429441|559584675|FG001|Overall Study|Physician Decision|0|||
154928253|NCT00538473|559160748|FG001|Overall Study|Adverse Event|0|||
154928254|NCT01569074|559160749|FG000|Overall Study|Study stopped|6|||
155042183|NCT01429441|559584674|FG000|Overall Study|Withdrawal by Subject|27|||
155042184|NCT01429441|559584675|FG001|Overall Study|Withdrawal by Subject|18|||
155042185|NCT02279745|559584676|FG000|Overall Study|Adverse Event|7|||
155042186|NCT02279745|559584676|FG000|Overall Study|Death|6|||
155042187|NCT02279745|559584676|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
155042188|NCT02279745|559584676|FG000|Overall Study|Withdrawal by Subject|2|||
155042189|NCT02279745|559584676|FG000|Overall Study|Pregnancy|1|||
155042190|NCT02279745|559584676|FG000|Overall Study|Study Non-compliance|1|||
155042191|NCT02279745|559584676|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
155042192|NCT03383692|559584681|FG000|Overall Study|Progressive disease as per RECIST|3|||
155042193|NCT03383692|559584682|FG001|Overall Study|Progressive disease as per RECIST|3|||
155042194|NCT03383692|559584681|FG000|Overall Study|Clinical progression|0|||
155042195|NCT03383692|559584682|FG001|Overall Study|Clinical progression|1|||
155042196|NCT03383692|559584681|FG000|Overall Study|Adverse Event|3|||
155042197|NCT03383692|559584682|FG001|Overall Study|Adverse Event|0|||
155042198|NCT03816007|559584683|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
155042199|NCT03816007|559584684|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
155042200|NCT03816007|559584683|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
155042201|NCT03816007|559584684|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
155042202|NCT03816007|559584683|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
154928255|NCT01569074|559160750|FG001|Overall Study|Study stopped|6|||
154928256|NCT01569074|559160751|FG002|Overall Study|Study stopped|8|||
154928257|NCT01569074|559160752|FG003|Overall Study|Study stopped|7|||
154928258|NCT01569074|559160753|FG004|Overall Study|Study stopped|7|||
154928259|NCT01569074|559160749|FG000|Overall Study|Study-specific discontinuation criteria|0|||
154928260|NCT01569074|559160750|FG001|Overall Study|Study-specific discontinuation criteria|1|||
154928261|NCT01569074|559160751|FG002|Overall Study|Study-specific discontinuation criteria|0|||
154928262|NCT01569074|559160752|FG003|Overall Study|Study-specific discontinuation criteria|0|||
154928263|NCT01569074|559160753|FG004|Overall Study|Study-specific discontinuation criteria|0|||
154928264|NCT01569074|559160749|FG000|Overall Study|Severe non-compliance to protocol|0|||
154928265|NCT01569074|559160750|FG001|Overall Study|Severe non-compliance to protocol|0|||
154928266|NCT01569074|559160751|FG002|Overall Study|Severe non-compliance to protocol|1|||
154928267|NCT01569074|559160752|FG003|Overall Study|Severe non-compliance to protocol|0|||
154928268|NCT01569074|559160753|FG004|Overall Study|Severe non-compliance to protocol|0|||
154928269|NCT01569074|559160749|FG000|Overall Study|eg change in circumstances|0|||
154928270|NCT01569074|559160750|FG001|Overall Study|eg change in circumstances|2|||
154928271|NCT01569074|559160751|FG002|Overall Study|eg change in circumstances|0|||
154928272|NCT01569074|559160752|FG003|Overall Study|eg change in circumstances|1|||
154928273|NCT01569074|559160753|FG004|Overall Study|eg change in circumstances|1|||
154928274|NCT01569074|559160749|FG000|Overall Study|Adverse Event|1|||
154928275|NCT01569074|559160750|FG001|Overall Study|Adverse Event|0|||
154928276|NCT01569074|559160751|FG002|Overall Study|Adverse Event|3|||
154928277|NCT01569074|559160752|FG003|Overall Study|Adverse Event|0|||
154928278|NCT01569074|559160753|FG004|Overall Study|Adverse Event|0|||
154928279|NCT02723786|559160761|FG000|Overall Study|Lost to Follow-up|1|||
154928280|NCT00127192|559160765|FG000|Overall Study|Adverse Event|0|||
154928281|NCT00127192|559160766|FG001|Overall Study|Adverse Event|1|||
154928282|NCT00127192|559160767|FG002|Overall Study|Adverse Event|1|||
154928283|NCT00127192|559160768|FG003|Overall Study|Adverse Event|1|||
154928284|NCT00127192|559160769|FG004|Overall Study|Adverse Event|0|||
154928285|NCT00127192|559160765|FG000|Overall Study|Lack of Efficacy|2|||
154928286|NCT00127192|559160766|FG001|Overall Study|Lack of Efficacy|0|||
155042203|NCT03816007|559584684|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
155042204|NCT01428115|559584685|FG000|Overall Study|Lack of Efficacy|3|||
155042205|NCT01428115|559584685|FG000|Overall Study|Lost to Follow-up|10|||
155042206|NCT01428115|559584685|FG000|Overall Study|Pregnancy|1|||
155042207|NCT01428115|559584685|FG000|Overall Study|Protocol Violation|3|||
155042208|NCT01428115|559584685|FG000|Overall Study|Withdrawal by Subject|4|||
155042209|NCT02179749|559584687|FG000|Overall Study|Adverse Event|0|||
155042210|NCT02179749|559584688|FG001|Overall Study|Adverse Event|0|||
155042211|NCT02179749|559584689|FG002|Overall Study|Adverse Event|1|||
154928287|NCT00127192|559160767|FG002|Overall Study|Lack of Efficacy|0|||
154928288|NCT00127192|559160768|FG003|Overall Study|Lack of Efficacy|0|||
154928289|NCT00127192|559160769|FG004|Overall Study|Lack of Efficacy|2|||
155042212|NCT02179749|559584687|FG000|Overall Study|Withdrawal by Subject|0|||
154928290|NCT00127192|559160765|FG000|Overall Study|Withdrawal by Subject|0|||
154928291|NCT00127192|559160766|FG001|Overall Study|Withdrawal by Subject|0|||
154928292|NCT00127192|559160767|FG002|Overall Study|Withdrawal by Subject|1|||
154928293|NCT00127192|559160768|FG003|Overall Study|Withdrawal by Subject|0|||
154928294|NCT00127192|559160769|FG004|Overall Study|Withdrawal by Subject|3|||
154928295|NCT00127192|559160765|FG000|Overall Study|Adverse event in pre-treatment period|1|||
154928296|NCT00127192|559160766|FG001|Overall Study|Adverse event in pre-treatment period|0|||
155042213|NCT02179749|559584688|FG001|Overall Study|Withdrawal by Subject|0|||
155042214|NCT02179749|559584689|FG002|Overall Study|Withdrawal by Subject|1|||
155042215|NCT02620384|559584690|FG000|Overall Study|Adverse Event|2|||
155042216|NCT02620384|559584691|FG001|Overall Study|Adverse Event|1|||
155042217|NCT02620384|559584690|FG000|Overall Study|Discharged prior to 2nd dose|2|||
155042218|NCT02620384|559584691|FG001|Overall Study|Discharged prior to 2nd dose|5|||
155042219|NCT02620384|559584690|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
155042220|NCT02620384|559584691|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
155042221|NCT02071082|559584692|FG000|Overall Study|Enrolled and Never Treated|1|||
155042222|NCT02071082|559584693|FG001|Overall Study|Enrolled and Never Treated|1|||
155042223|NCT02071082|559584692|FG000|Overall Study|Adverse Event|0|||
155042224|NCT02071082|559584693|FG001|Overall Study|Adverse Event|1|||
155042225|NCT02071082|559584692|FG000|Overall Study|Withdrew Consent|0|||
155042226|NCT02071082|559584693|FG001|Overall Study|Withdrew Consent|4|||
155042227|NCT02071082|559584692|FG000|Overall Study|Lost to Follow-up|1|||
155042228|NCT02071082|559584693|FG001|Overall Study|Lost to Follow-up|1|||
155042229|NCT02101359|559584694|FG000|Overall Study|Not included|23|||
155042230|NCT02101359|559584695|FG001|Overall Study|Not included|13|||
155042231|NCT02101359|559584694|FG000|Overall Study|Withdrawal by Subject|5|||
155042232|NCT02101359|559584695|FG001|Overall Study|Withdrawal by Subject|4|||
155042233|NCT02101359|559584694|FG000|Overall Study|Lost to Follow-up|1|||
155042234|NCT02101359|559584695|FG001|Overall Study|Lost to Follow-up|0|||
155042235|NCT02101359|559584694|FG000|Overall Study|Protocol Violation|0|||
155042236|NCT02101359|559584695|FG001|Overall Study|Protocol Violation|2|||
155042237|NCT01841567|559584700|FG000|Overall Study|Adverse Event|3|||
155042238|NCT00630747|559584701|FG000|Overall Study|Death|1|||
155042239|NCT00630747|559584701|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
155042240|NCT00630747|559584701|FG000|Overall Study|Returned to country of origin|1|||
155042241|NCT04503668|559584704|FG000|Overall Study|Incomplete data|4|||
155042242|NCT04503668|559584705|FG001|Overall Study|Incomplete data|3|||
155042243|NCT04503668|559584704|FG000|Overall Study|Withdrawal by Subject|1|||
155042244|NCT04503668|559584705|FG001|Overall Study|Withdrawal by Subject|1|||
154928297|NCT00127192|559160767|FG002|Overall Study|Adverse event in pre-treatment period|0|||
154928298|NCT00127192|559160768|FG003|Overall Study|Adverse event in pre-treatment period|0|||
155042245|NCT04503668|559584704|FG000|Overall Study|Adverse Event|2|||
155042246|NCT04503668|559584705|FG001|Overall Study|Adverse Event|0|||
155042247|NCT00603382|559584706|FG000|Overall Study|Adverse Event|0|||
155042248|NCT00603382|559584707|FG001|Overall Study|Adverse Event|1|||
155042249|NCT00603382|559584708|FG002|Overall Study|Adverse Event|1|||
155042250|NCT00603382|559584709|FG003|Overall Study|Adverse Event|2|||
155042251|NCT00603382|559584710|FG004|Overall Study|Adverse Event|1|||
155042252|NCT00603382|559584711|FG005|Overall Study|Adverse Event|2|||
154928299|NCT00127192|559160769|FG004|Overall Study|Adverse event in pre-treatment period|0|||
154928300|NCT01036594|559160778|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
154928301|NCT01036594|559160779|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
154928302|NCT01036594|559160778|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
154928303|NCT01036594|559160779|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
154928304|NCT01036594|559160778|FG000|Week 12 Evaluation|Adverse Event|5|||
154928305|NCT01036594|559160779|FG001|Week 12 Evaluation|Adverse Event|0|||
154928306|NCT01036594|559160778|FG000|Week 12 Evaluation|Physician Decision|1|||
154928307|NCT01036594|559160779|FG001|Week 12 Evaluation|Physician Decision|0|||
154928308|NCT01036594|559160778|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
154928309|NCT01036594|559160779|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
154928310|NCT01036594|559160778|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
154928311|NCT01036594|559160779|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
154928312|NCT01036594|559160778|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
154928313|NCT01036594|559160779|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
154928314|NCT01036594|559160778|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
154928315|NCT01036594|559160779|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
154928316|NCT01036594|559160778|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
154928317|NCT01036594|559160779|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
154928318|NCT03345485|559160780|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
154928319|NCT03345485|559160781|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
154928320|NCT03345485|559160782|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
154928321|NCT03345485|559160783|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
154928322|NCT03345485|559160784|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
154928323|NCT03345485|559160785|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
154928324|NCT03345485|559160786|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
154928325|NCT03345485|559160787|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
154928326|NCT03345485|559160788|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
154928327|NCT03345485|559160789|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
154928328|NCT03345485|559160790|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
155042253|NCT00603382|559584706|FG000|Overall Study|Lack of Efficacy|14|||
155042254|NCT00603382|559584707|FG001|Overall Study|Lack of Efficacy|9|||
155042255|NCT00603382|559584708|FG002|Overall Study|Lack of Efficacy|3|||
154928329|NCT03345485|559160791|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
154928330|NCT03345485|559160792|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
154928331|NCT01125358|559160796|FG000|Overall Study|Adverse Event|3|||
154928332|NCT01125358|559160797|FG001|Overall Study|Adverse Event|0|||
154928333|NCT01125358|559160798|FG002|Overall Study|Adverse Event|0|||
154928334|NCT01125358|559160799|FG003|Overall Study|Adverse Event|2|||
154928335|NCT01125358|559160796|FG000|Overall Study|Perceived Lack of Efficacy|6|||
154928336|NCT01125358|559160797|FG001|Overall Study|Perceived Lack of Efficacy|3|||
154928337|NCT01125358|559160798|FG002|Overall Study|Perceived Lack of Efficacy|7|||
154928338|NCT01125358|559160799|FG003|Overall Study|Perceived Lack of Efficacy|4|||
154928339|NCT01125358|559160796|FG000|Overall Study|Protocol Violation|1|||
154928340|NCT01125358|559160797|FG001|Overall Study|Protocol Violation|0|||
154928341|NCT01125358|559160798|FG002|Overall Study|Protocol Violation|0|||
154928342|NCT01125358|559160799|FG003|Overall Study|Protocol Violation|0|||
154928343|NCT01125358|559160796|FG000|Overall Study|Sponsor Decision|0|||
154928344|NCT01125358|559160797|FG001|Overall Study|Sponsor Decision|0|||
154928345|NCT01125358|559160798|FG002|Overall Study|Sponsor Decision|1|||
154928346|NCT01125358|559160799|FG003|Overall Study|Sponsor Decision|1|||
154928347|NCT01125358|559160796|FG000|Overall Study|Withdrawal by Subject|2|||
154928348|NCT01125358|559160797|FG001|Overall Study|Withdrawal by Subject|1|||
154928349|NCT01125358|559160798|FG002|Overall Study|Withdrawal by Subject|1|||
154928350|NCT01125358|559160799|FG003|Overall Study|Withdrawal by Subject|1|||
154928351|NCT00962013|559160805|FG000|Overall Study|Did not have surgery|1|||
154928352|NCT00962013|559160805|FG000|Overall Study|Death|8|||
154928353|NCT00962013|559160805|FG000|Overall Study|Lost to Follow-up|12|||
154928354|NCT00962013|559160805|FG000|Overall Study|Unable/Unwilling to return|6|||
154928355|NCT00962013|559160805|FG000|Overall Study|Withdrawal by Subject|8|||
154928356|NCT00962013|559160805|FG000|Overall Study|Removal of study device|3|||
154928357|NCT00962013|559160805|FG000|Overall Study|Site Termination|24|||
154928358|NCT00962013|559160805|FG000|Overall Study|No 5 year evaluation|6|||
154928359|NCT00424632|559160808|FG000|Overall Study|Death|0|||
154928360|NCT00424632|559160809|FG001|Overall Study|Death|0|||
154928361|NCT00424632|559160810|FG002|Overall Study|Death|0|||
154928362|NCT00424632|559160811|FG003|Overall Study|Death|0|||
154928363|NCT00424632|559160812|FG004|Overall Study|Death|0|||
154928364|NCT00424632|559160813|FG005|Overall Study|Death|2|||
154928365|NCT00424632|559160814|FG006|Overall Study|Death|0|||
154928366|NCT00424632|559160815|FG007|Overall Study|Death|0|||
154928367|NCT00424632|559160816|FG008|Overall Study|Death|0|||
154928368|NCT00424632|559160817|FG009|Overall Study|Death|0|||
154928369|NCT00424632|559160808|FG000|Overall Study|Adverse Event|0|||
154928370|NCT00424632|559160809|FG001|Overall Study|Adverse Event|0|||
154928371|NCT00424632|559160810|FG002|Overall Study|Adverse Event|0|||
155042256|NCT00603382|559584709|FG003|Overall Study|Lack of Efficacy|6|||
155042257|NCT00603382|559584710|FG004|Overall Study|Lack of Efficacy|6|||
155042258|NCT00603382|559584711|FG005|Overall Study|Lack of Efficacy|11|||
155042259|NCT00603382|559584706|FG000|Overall Study|Protocol Violation|1|||
155042260|NCT00603382|559584707|FG001|Overall Study|Protocol Violation|0|||
155042261|NCT00603382|559584708|FG002|Overall Study|Protocol Violation|1|||
155042262|NCT00603382|559584709|FG003|Overall Study|Protocol Violation|2|||
155042263|NCT00603382|559584710|FG004|Overall Study|Protocol Violation|1|||
155042264|NCT00603382|559584711|FG005|Overall Study|Protocol Violation|0|||
155042265|NCT00603382|559584706|FG000|Overall Study|Lost to Follow-up|0|||
155042266|NCT00603382|559584707|FG001|Overall Study|Lost to Follow-up|1|||
155042267|NCT00603382|559584708|FG002|Overall Study|Lost to Follow-up|1|||
155042268|NCT00603382|559584709|FG003|Overall Study|Lost to Follow-up|1|||
155042269|NCT00603382|559584710|FG004|Overall Study|Lost to Follow-up|0|||
155042270|NCT00603382|559584711|FG005|Overall Study|Lost to Follow-up|1|||
155042271|NCT00603382|559584706|FG000|Overall Study|Physician Decision|0|||
155042272|NCT00603382|559584707|FG001|Overall Study|Physician Decision|0|||
155042273|NCT00603382|559584708|FG002|Overall Study|Physician Decision|2|||
155042274|NCT00603382|559584709|FG003|Overall Study|Physician Decision|0|||
155042275|NCT00603382|559584710|FG004|Overall Study|Physician Decision|1|||
155042276|NCT00603382|559584711|FG005|Overall Study|Physician Decision|3|||
155042277|NCT00603382|559584706|FG000|Overall Study|Withdrawal by Subject|3|||
154928372|NCT00424632|559160811|FG003|Overall Study|Adverse Event|0|||
154928373|NCT00424632|559160812|FG004|Overall Study|Adverse Event|0|||
155042278|NCT00603382|559584707|FG001|Overall Study|Withdrawal by Subject|3|||
155042279|NCT00603382|559584708|FG002|Overall Study|Withdrawal by Subject|1|||
155042280|NCT00603382|559584709|FG003|Overall Study|Withdrawal by Subject|1|||
155042281|NCT00603382|559584710|FG004|Overall Study|Withdrawal by Subject|0|||
154928374|NCT00424632|559160813|FG005|Overall Study|Adverse Event|0|||
154928375|NCT00424632|559160814|FG006|Overall Study|Adverse Event|0|||
154928376|NCT00424632|559160815|FG007|Overall Study|Adverse Event|0|||
154928377|NCT00424632|559160816|FG008|Overall Study|Adverse Event|3|||
154928378|NCT00424632|559160817|FG009|Overall Study|Adverse Event|2|||
154928379|NCT00424632|559160808|FG000|Overall Study|Global deterioration of health status|0|||
155042282|NCT00603382|559584711|FG005|Overall Study|Withdrawal by Subject|1|||
155042283|NCT00395642|559584712|FG000|Overall Study|Death|4|||
155042284|NCT00395642|559584712|FG000|Overall Study|Lost to Follow-up|1|||
155042285|NCT00395642|559584712|FG000|Overall Study|Physician Decision|7|||
155042286|NCT00395642|559584712|FG000|Overall Study|Withdrawal by Subject|1|||
155042287|NCT01078298|559584713|FG000|Overall Study|Lost to Follow-up|12|||
155042288|NCT01078298|559584714|FG001|Overall Study|Lost to Follow-up|13|||
155042289|NCT01078298|559584713|FG000|Overall Study|Withdrawal by Subject|31|||
155042290|NCT01078298|559584714|FG001|Overall Study|Withdrawal by Subject|33|||
155042291|NCT01078298|559584713|FG000|Overall Study|Protocol Violation|6|||
155042292|NCT01078298|559584714|FG001|Overall Study|Protocol Violation|6|||
155042293|NCT01078298|559584713|FG000|Overall Study|Adverse Event|6|||
155042294|NCT01078298|559584714|FG001|Overall Study|Adverse Event|5|||
155042295|NCT01078298|559584713|FG000|Overall Study|Death|2|||
155042296|NCT01078298|559584714|FG001|Overall Study|Death|0|||
155042297|NCT01078298|559584713|FG000|Overall Study|Did not meet entrance criteria|0|||
155042298|NCT01078298|559584714|FG001|Overall Study|Did not meet entrance criteria|1|||
155042299|NCT01078298|559584713|FG000|Overall Study|Other|24|||
155042300|NCT01078298|559584714|FG001|Overall Study|Other|32|||
155042301|NCT00659776|559584718|FG000|Overall Study|Withdrawal by Subject|12|||
155042302|NCT00659776|559584719|FG001|Overall Study|Withdrawal by Subject|2|||
155042303|NCT00659776|559584720|FG002|Overall Study|Withdrawal by Subject|0|||
155042304|NCT00742027|559584721|FG000|Overall Study|Disease Progression|76|||
155042305|NCT00742027|559584721|FG000|Overall Study|New Cancer Therapy|19|||
155042306|NCT00742027|559584721|FG000|Overall Study|Withdrawal by Subject|18|||
155042307|NCT00742027|559584721|FG000|Overall Study|Death|7|||
155042308|NCT00742027|559584721|FG000|Overall Study|Lost to Follow-up|4|||
155042309|NCT00742027|559584721|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
155042310|NCT00742027|559584721|FG000|Overall Study|Missing|2|||
155042311|NCT00742027|559584721|FG000|Overall Study|Administrative Problems|1|||
155042312|NCT01180049|559584722|FG000|Overall Study|Other|9|||
155042313|NCT01180049|559584723|FG001|Overall Study|Other|7|||
155042314|NCT01180049|559584722|FG000|Overall Study|Lost to Follow-up|8|||
155042315|NCT01180049|559584723|FG001|Overall Study|Lost to Follow-up|6|||
155042316|NCT01180049|559584722|FG000|Overall Study|Death|36|||
155042317|NCT01180049|559584723|FG001|Overall Study|Death|35|||
155042318|NCT00628927|559584724|FG000|Overall Study|Problems performing blood draw|6|||
155042319|NCT00628927|559584725|FG001|Overall Study|Problems performing blood draw|0|||
155042320|NCT00628927|559584724|FG000|Overall Study|Lost to Follow-up|1|||
155042321|NCT00628927|559584725|FG001|Overall Study|Lost to Follow-up|0|||
155042322|NCT00628927|559584724|FG000|Overall Study|Equipment failure|1|||
155042323|NCT00628927|559584725|FG001|Overall Study|Equipment failure|0|||
155042324|NCT01298141|559584729|FG000|Overall Study|Adverse Event|3|||
155042325|NCT01298141|559584729|FG000|Overall Study|Refusal of Required Study Procedures|1|||
155042326|NCT01298141|559584729|FG000|Overall Study|Withdrawal by Subject|6|||
155042327|NCT01298141|559584729|FG000|Overall Study|Termination of Study by the Investigator|5|||
155042328|NCT01298141|559584729|FG000|Overall Study|Other|5|||
155042329|NCT01298141|559584729|FG000|Overall Study|Lost to Follow-up|1|||
155042330|NCT01298141|559584729|FG000|Overall Study|Death|6|||
155042331|NCT01298141|559584729|FG000|Overall Study|Not treated|4|||
155042332|NCT02109445|559584730|FG000|Overall Study|Symptomatic deterioration|2|||
154928380|NCT00424632|559160809|FG001|Overall Study|Global deterioration of health status|0|||
154928381|NCT00424632|559160810|FG002|Overall Study|Global deterioration of health status|0|||
154928382|NCT00424632|559160811|FG003|Overall Study|Global deterioration of health status|1|||
154928383|NCT00424632|559160812|FG004|Overall Study|Global deterioration of health status|1|||
154928384|NCT00424632|559160813|FG005|Overall Study|Global deterioration of health status|0|||
154928385|NCT00424632|559160814|FG006|Overall Study|Global deterioration of health status|0|||
154928386|NCT00424632|559160815|FG007|Overall Study|Global deterioration of health status|0|||
154928387|NCT00424632|559160816|FG008|Overall Study|Global deterioration of health status|0|||
154928388|NCT00424632|559160817|FG009|Overall Study|Global deterioration of health status|0|||
154928389|NCT00424632|559160808|FG000|Overall Study|Objective progression or relapse|1|||
154928390|NCT00424632|559160809|FG001|Overall Study|Objective progression or relapse|1|||
154928391|NCT00424632|559160810|FG002|Overall Study|Objective progression or relapse|1|||
154928392|NCT00424632|559160811|FG003|Overall Study|Objective progression or relapse|2|||
154928393|NCT00424632|559160812|FG004|Overall Study|Objective progression or relapse|2|||
154928394|NCT00424632|559160813|FG005|Overall Study|Objective progression or relapse|13|||
154928395|NCT00424632|559160814|FG006|Overall Study|Objective progression or relapse|7|||
154928396|NCT00424632|559160815|FG007|Overall Study|Objective progression or relapse|3|||
154928397|NCT00424632|559160816|FG008|Overall Study|Objective progression or relapse|12|||
154928398|NCT00424632|559160817|FG009|Overall Study|Objective progression or relapse|4|||
154928399|NCT00424632|559160808|FG000|Overall Study|Other|0|||
155042333|NCT02109445|559584730|FG000|Overall Study|Adverse Event|1|||
155042334|NCT04227405|559586629|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
155042335|NCT04227405|559586630|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
155042336|NCT04227405|559586629|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
155042337|NCT04227405|559586630|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
155042338|NCT04227405|559586629|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
154928400|NCT00424632|559160809|FG001|Overall Study|Other|0|||
154928401|NCT00424632|559160810|FG002|Overall Study|Other|0|||
154928402|NCT00424632|559160811|FG003|Overall Study|Other|1|||
154928403|NCT00424632|559160812|FG004|Overall Study|Other|0|||
154928404|NCT00424632|559160813|FG005|Overall Study|Other|0|||
154928405|NCT00424632|559160814|FG006|Overall Study|Other|0|||
154928406|NCT00424632|559160815|FG007|Overall Study|Other|0|||
154928407|NCT00424632|559160816|FG008|Overall Study|Other|1|||
154928408|NCT00424632|559160817|FG009|Overall Study|Other|0|||
154928409|NCT02628418|559160818|FG000|Overall Study|Lost to Follow-up|1|||
154928410|NCT02628418|559160819|FG001|Overall Study|Lost to Follow-up|2|||
154928411|NCT01984229|559160822|FG000|Safety Follow-up Period|Adverse Event|1|||
154928412|NCT01984229|559160823|FG001|Safety Follow-up Period|Adverse Event|1|||
154928413|NCT01984229|559160822|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
154928414|NCT01984229|559160823|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
155042339|NCT04227405|559586630|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
155042340|NCT04985942|559586631|FG000|Overall Study|Adverse Event|14|||
155042341|NCT04985942|559586632|FG001|Overall Study|Adverse Event|2|||
155042342|NCT04985942|559586631|FG000|Overall Study|Lack of Efficacy|0|||
155042343|NCT04985942|559586632|FG001|Overall Study|Lack of Efficacy|3|||
155042344|NCT04985942|559586631|FG000|Overall Study|Lost to Follow-up|1|||
155042345|NCT04985942|559586632|FG001|Overall Study|Lost to Follow-up|1|||
155042346|NCT04985942|559586631|FG000|Overall Study|Protocol Violation|1|||
155042347|NCT04985942|559586632|FG001|Overall Study|Protocol Violation|1|||
155042348|NCT04985942|559586631|FG000|Overall Study|Withdrawal by Subject|5|||
155042349|NCT04985942|559586632|FG001|Overall Study|Withdrawal by Subject|4|||
155042350|NCT03630705|559586633|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
155042351|NCT03630705|559586634|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
155042352|NCT03630705|559586635|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155042353|NCT03630705|559586636|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155042354|NCT03630705|559586633|FG000|Overall Study|Lost to Follow-up|1|||
155042355|NCT03630705|559586634|FG001|Overall Study|Lost to Follow-up|2|||
155042356|NCT03630705|559586635|FG002|Overall Study|Lost to Follow-up|0|||
155042357|NCT03630705|559586636|FG003|Overall Study|Lost to Follow-up|0|||
155042358|NCT01054222|559586637|FG000|Overall Study|Lack of Efficacy|1|||
155042359|NCT01054222|559586637|FG000|Overall Study|Lost to Follow-up|4|||
155042360|NCT01054222|559586637|FG000|Overall Study|Withdrawal by Subject|6|||
155042361|NCT03782571|559586638|FG000|Period 1|Withdrawal by Subject|1|||
155042362|NCT03782571|559586639|FG001|Period 1|Withdrawal by Subject|0|||
155042363|NCT03782571|559586640|FG002|Period 1|Withdrawal by Subject|0|||
155042364|NCT03782571|559586641|FG003|Period 1|Withdrawal by Subject|0|||
155042365|NCT03782571|559586638|FG000|Period 3|Subject Unable to Attend V5|1|||
155042366|NCT03782571|559586639|FG001|Period 3|Subject Unable to Attend V5|0|||
155042367|NCT03782571|559586640|FG002|Period 3|Subject Unable to Attend V5|0|||
155042368|NCT03782571|559586641|FG003|Period 3|Subject Unable to Attend V5|0|||
155042369|NCT03782571|559586638|FG000|Period 3|Adverse Event|1|||
155042370|NCT03782571|559586639|FG001|Period 3|Adverse Event|0|||
155042371|NCT03782571|559586640|FG002|Period 3|Adverse Event|0|||
155042372|NCT03782571|559586641|FG003|Period 3|Adverse Event|0|||
155042373|NCT03488563|559586642|FG000|Overall Study|Lost to Follow-up|7|||
155381623|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381624|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381625|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381626|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381627|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
155381628|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381629|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381630|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
155381631|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
155381632|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
155381633|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
155381634|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
155381635|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
155381636|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
154928415|NCT01418365|559160830|FG000|First Intervention|Withdrawal by Subject|0|||
154928416|NCT01418365|559160831|FG001|First Intervention|Withdrawal by Subject|1|||
154928417|NCT01418365|559160830|FG000|First Intervention|Non-compliance|1|||
154928418|NCT01418365|559160831|FG001|First Intervention|Non-compliance|0|||
155042374|NCT03488563|559586643|FG001|Overall Study|Lost to Follow-up|6|||
155042375|NCT03488563|559586644|FG002|Overall Study|Lost to Follow-up|7|||
155042376|NCT03488563|559586642|FG000|Overall Study|Withdrawal by Subject|8|||
155042377|NCT03488563|559586643|FG001|Overall Study|Withdrawal by Subject|7|||
155042378|NCT03488563|559586644|FG002|Overall Study|Withdrawal by Subject|7|||
155042379|NCT03488563|559586642|FG000|Overall Study|Physician Decision|0|||
155042380|NCT03488563|559586643|FG001|Overall Study|Physician Decision|0|||
154928419|NCT01418365|559160830|FG000|Second Intervention|Withdrawal by Subject|0|||
155042381|NCT03488563|559586644|FG002|Overall Study|Physician Decision|1|||
155042382|NCT03488563|559586642|FG000|Overall Study|Protocol Violation|3|||
155042383|NCT03488563|559586643|FG001|Overall Study|Protocol Violation|2|||
155042384|NCT03488563|559586644|FG002|Overall Study|Protocol Violation|6|||
155042385|NCT03488563|559586642|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
155042386|NCT03488563|559586643|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
155042387|NCT03488563|559586644|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
155042388|NCT03488563|559586642|FG000|Overall Study|Use of prohibited medication|2|||
155042389|NCT03488563|559586643|FG001|Overall Study|Use of prohibited medication|0|||
155042390|NCT03488563|559586644|FG002|Overall Study|Use of prohibited medication|0|||
155042391|NCT03488563|559586642|FG000|Overall Study|Adverse Event|1|||
155042392|NCT03488563|559586643|FG001|Overall Study|Adverse Event|0|||
155042393|NCT03488563|559586644|FG002|Overall Study|Adverse Event|1|||
155042394|NCT03488563|559586642|FG000|Overall Study|Subject returned for ET visit|0|||
155042395|NCT03488563|559586643|FG001|Overall Study|Subject returned for ET visit|1|||
155042396|NCT03488563|559586644|FG002|Overall Study|Subject returned for ET visit|0|||
155042397|NCT03488563|559586642|FG000|Overall Study|Sponsor's decision|0|||
155042398|NCT03488563|559586643|FG001|Overall Study|Sponsor's decision|0|||
155042399|NCT03488563|559586644|FG002|Overall Study|Sponsor's decision|1|||
155042400|NCT01411319|559586656|FG000|Overall Study|Lost to Follow-up|1|||
155042401|NCT00460239|559586676|FG000|Overall Study|Physician Decision|0|||
155042402|NCT00460239|559586677|FG001|Overall Study|Physician Decision|1|||
155042403|NCT00460239|559586678|FG002|Overall Study|Physician Decision|0|||
155042404|NCT00460239|559586679|FG003|Overall Study|Physician Decision|0|||
155042405|NCT00460239|559586680|FG004|Overall Study|Physician Decision|0|||
155042406|NCT00460239|559586681|FG005|Overall Study|Physician Decision|2|||
155042407|NCT00460239|559586682|FG006|Overall Study|Physician Decision|0|||
155042408|NCT00460239|559586683|FG007|Overall Study|Physician Decision|0|||
155042409|NCT00460239|559586684|FG008|Overall Study|Physician Decision|0|||
155042410|NCT00460239|559586676|FG000|Overall Study|Withdrawal by Subject|0|||
155042411|NCT00460239|559586677|FG001|Overall Study|Withdrawal by Subject|0|||
155042412|NCT00460239|559586678|FG002|Overall Study|Withdrawal by Subject|0|||
155042413|NCT00460239|559586679|FG003|Overall Study|Withdrawal by Subject|0|||
155042414|NCT00460239|559586680|FG004|Overall Study|Withdrawal by Subject|0|||
155042415|NCT00460239|559586681|FG005|Overall Study|Withdrawal by Subject|1|||
155042416|NCT00460239|559586682|FG006|Overall Study|Withdrawal by Subject|0|||
155042417|NCT00460239|559586683|FG007|Overall Study|Withdrawal by Subject|0|||
155042418|NCT00460239|559586684|FG008|Overall Study|Withdrawal by Subject|0|||
155042419|NCT00760487|559586686|FG000|Overall Study|Unilateral implantation|3|||
155042420|NCT05259917|559586695|FG000|Overall Study|Protocol Violation|0|||
155042421|NCT05259917|559586696|FG001|Overall Study|Protocol Violation|0|||
155042422|NCT05259917|559586697|FG002|Overall Study|Protocol Violation|1|||
155042423|NCT05259917|559586698|FG003|Overall Study|Protocol Violation|0|||
155042424|NCT05259917|559586699|FG004|Overall Study|Protocol Violation|0|||
155042425|NCT05259917|559586700|FG005|Overall Study|Protocol Violation|0|||
155042426|NCT05259917|559586695|FG000|Overall Study|Lost to Follow-up|0|||
155042427|NCT05259917|559586696|FG001|Overall Study|Lost to Follow-up|0|||
155042428|NCT05259917|559586697|FG002|Overall Study|Lost to Follow-up|1|||
155042429|NCT05259917|559586698|FG003|Overall Study|Lost to Follow-up|0|||
155042430|NCT05259917|559586699|FG004|Overall Study|Lost to Follow-up|0|||
155042431|NCT05259917|559586700|FG005|Overall Study|Lost to Follow-up|1|||
155042432|NCT05259917|559586695|FG000|Overall Study|Physician Decision|0|||
155042433|NCT05259917|559586696|FG001|Overall Study|Physician Decision|1|||
155042434|NCT05259917|559586697|FG002|Overall Study|Physician Decision|0|||
155042435|NCT05259917|559586698|FG003|Overall Study|Physician Decision|0|||
155042436|NCT05259917|559586699|FG004|Overall Study|Physician Decision|0|||
155042437|NCT05259917|559586700|FG005|Overall Study|Physician Decision|0|||
155042438|NCT05259917|559586695|FG000|Overall Study|Withdrawal by Subject|0|||
155042439|NCT05259917|559586696|FG001|Overall Study|Withdrawal by Subject|1|||
155042440|NCT05259917|559586697|FG002|Overall Study|Withdrawal by Subject|0|||
155042441|NCT05259917|559586698|FG003|Overall Study|Withdrawal by Subject|0|||
155042442|NCT05259917|559586699|FG004|Overall Study|Withdrawal by Subject|1|||
155042443|NCT05259917|559586700|FG005|Overall Study|Withdrawal by Subject|1|||
155042444|NCT05259917|559586695|FG000|Overall Study|Trial Termination by Sponsor|7|||
155042445|NCT05259917|559586696|FG001|Overall Study|Trial Termination by Sponsor|2|||
155042446|NCT05259917|559586697|FG002|Overall Study|Trial Termination by Sponsor|3|||
155042447|NCT05259917|559586698|FG003|Overall Study|Trial Termination by Sponsor|5|||
155042448|NCT05259917|559586699|FG004|Overall Study|Trial Termination by Sponsor|11|||
155042449|NCT05259917|559586700|FG005|Overall Study|Trial Termination by Sponsor|4|||
155042450|NCT05259917|559586695|FG000|Overall Study|Other|1|||
155042451|NCT05259917|559586696|FG001|Overall Study|Other|0|||
155042452|NCT05259917|559586697|FG002|Overall Study|Other|2|||
155042453|NCT05259917|559586698|FG003|Overall Study|Other|0|||
155042454|NCT05259917|559586699|FG004|Overall Study|Other|0|||
155042455|NCT05259917|559586700|FG005|Overall Study|Other|0|||
155042456|NCT00592592|559586701|FG000|Overall Study|Patient found ineligible upon chart review|1|||
155042457|NCT01134263|559586702|FG000|Overall Study|Serious adverse event|2|||
154928420|NCT01418365|559160831|FG001|Second Intervention|Withdrawal by Subject|1|||
154928421|NCT03319368|559160836|FG000|Overall Study|Discharge swabs not collected from resident|57|||
154928422|NCT03319368|559160837|FG001|Overall Study|Discharge swabs not collected from resident|46|||
154928423|NCT04150107|559160842|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
154928424|NCT04150107|559160843|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
154928425|NCT04150107|559160842|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
154928426|NCT04150107|559160843|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
154928427|NCT00824993|559160844|FG000|Overall Study|Withdrawal by Subject|1|||
154928428|NCT00824993|559160845|FG001|Overall Study|Withdrawal by Subject|1|||
154928429|NCT00824993|559160844|FG000|Overall Study|Malignancy Relapse|9|||
154928430|NCT00824993|559160845|FG001|Overall Study|Malignancy Relapse|10|||
154928431|NCT00824993|559160844|FG000|Overall Study|Rapid Bone Loss|0|||
154928432|NCT00824993|559160845|FG001|Overall Study|Rapid Bone Loss|1|||
154928433|NCT00824993|559160844|FG000|Overall Study|Non-Compliant|2|||
154928434|NCT00824993|559160845|FG001|Overall Study|Non-Compliant|1|||
154928435|NCT00824993|559160844|FG000|Overall Study|Insurance Issue|2|||
154928436|NCT00824993|559160845|FG001|Overall Study|Insurance Issue|1|||
154928437|NCT00824993|559160844|FG000|Overall Study|Death|0|||
154928438|NCT00824993|559160845|FG001|Overall Study|Death|3|||
154928439|NCT00388674|559162091|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
154928440|NCT00388674|559162092|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
154928441|NCT00388674|559162091|FG000|Initial Treatment|Adverse Event|22|||
154928442|NCT00388674|559162092|FG001|Initial Treatment|Adverse Event|87|||
154928443|NCT00388674|559162091|FG000|Initial Treatment|Death|215|||
154928444|NCT00388674|559162092|FG001|Initial Treatment|Death|216|||
154928445|NCT00388674|559162091|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
154928446|NCT00388674|559162092|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
154928447|NCT00388674|559162091|FG000|Initial Treatment|HCC|12|||
154928448|NCT00388674|559162092|FG001|Initial Treatment|HCC|20|||
154928449|NCT00388674|559162091|FG000|Initial Treatment|Lost to Follow-up|526|||
154928450|NCT00388674|559162092|FG001|Initial Treatment|Lost to Follow-up|624|||
154928451|NCT00388674|559162091|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
154928452|NCT00388674|559162092|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
154928453|NCT00388674|559162091|FG000|Initial Treatment|Never Treated with Study Medication|1|||
155042458|NCT01134263|559586703|FG001|Overall Study|Serious adverse event|1|||
155042459|NCT01134263|559586704|FG002|Overall Study|Serious adverse event|1|||
155042460|NCT01134263|559586705|FG003|Overall Study|Serious adverse event|1|||
155042461|NCT01134263|559586706|FG004|Overall Study|Serious adverse event|1|||
155042462|NCT01134263|559586702|FG000|Overall Study|Other adverse event|1|||
155042463|NCT01134263|559586703|FG001|Overall Study|Other adverse event|2|||
155042464|NCT01134263|559586704|FG002|Overall Study|Other adverse event|5|||
155042465|NCT01134263|559586705|FG003|Overall Study|Other adverse event|3|||
155042466|NCT01134263|559586706|FG004|Overall Study|Other adverse event|0|||
155042467|NCT01134263|559586702|FG000|Overall Study|Protocol Violation|8|||
155042468|NCT01134263|559586703|FG001|Overall Study|Protocol Violation|7|||
155042469|NCT01134263|559586704|FG002|Overall Study|Protocol Violation|2|||
155042470|NCT01134263|559586705|FG003|Overall Study|Protocol Violation|4|||
155042471|NCT01134263|559586706|FG004|Overall Study|Protocol Violation|2|||
155042472|NCT01134263|559586702|FG000|Overall Study|Lost to Follow-up|4|||
155042473|NCT01134263|559586703|FG001|Overall Study|Lost to Follow-up|3|||
155042474|NCT01134263|559586704|FG002|Overall Study|Lost to Follow-up|5|||
155042475|NCT01134263|559586705|FG003|Overall Study|Lost to Follow-up|3|||
155042476|NCT01134263|559586706|FG004|Overall Study|Lost to Follow-up|1|||
155042477|NCT01134263|559586702|FG000|Overall Study|Withdrawal by Subject|8|||
155042478|NCT01134263|559586703|FG001|Overall Study|Withdrawal by Subject|6|||
155042479|NCT01134263|559586704|FG002|Overall Study|Withdrawal by Subject|16|||
155042480|NCT01134263|559586705|FG003|Overall Study|Withdrawal by Subject|7|||
155042481|NCT01134263|559586706|FG004|Overall Study|Withdrawal by Subject|5|||
155042482|NCT01134263|559586702|FG000|Overall Study|Enrolled, but not treated|1|||
155042483|NCT01134263|559586703|FG001|Overall Study|Enrolled, but not treated|1|||
155042484|NCT01134263|559586704|FG002|Overall Study|Enrolled, but not treated|0|||
155042485|NCT01134263|559586705|FG003|Overall Study|Enrolled, but not treated|1|||
155042486|NCT01134263|559586706|FG004|Overall Study|Enrolled, but not treated|0|||
155042487|NCT02886884|559586711|FG000|Follow-up|Withdrawal by Subject|0|||
155042488|NCT02886884|559586712|FG001|Follow-up|Withdrawal by Subject|0|||
155042489|NCT02886884|559586713|FG002|Follow-up|Withdrawal by Subject|0|||
155042490|NCT02886884|559586714|FG003|Follow-up|Withdrawal by Subject|1|||
155042491|NCT00435188|559586715|FG000|Overall Study|Death|1|||
155042492|NCT00435188|559586716|FG001|Overall Study|Death|6|||
154928454|NCT00388674|559162092|FG001|Initial Treatment|Never Treated with Study Medication|7|||
154928455|NCT00388674|559162091|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
154928456|NCT00388674|559162092|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
154928457|NCT00388674|559162091|FG000|Initial Treatment|Not Defined|125|||
154928458|NCT00388674|559162092|FG001|Initial Treatment|Not Defined|172|||
154928459|NCT00388674|559162091|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
154928460|NCT00388674|559162092|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
155042493|NCT00435188|559586715|FG000|Overall Study|Withdrawal by Subject|16|||
154928461|NCT00388674|559162091|FG000|Initial Treatment|Pregnancy|26|||
154928462|NCT00388674|559162092|FG001|Initial Treatment|Pregnancy|16|||
154928463|NCT00388674|559162091|FG000|Initial Treatment|Study Drug Toxicity|5|||
154928464|NCT00388674|559162092|FG001|Initial Treatment|Study Drug Toxicity|92|||
154928465|NCT00388674|559162091|FG000|Initial Treatment|Participant Request|501|||
154928466|NCT00388674|559162092|FG001|Initial Treatment|Participant Request|673|||
154928467|NCT00388674|559162091|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
154928468|NCT00388674|559162092|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
154928469|NCT00388674|559162091|FG000|Initial Treatment|Not Reported|10|||
154928470|NCT00388674|559162092|FG001|Initial Treatment|Not Reported|12|||
154928471|NCT00388674|559162091|FG000|End of Study|Administrative Reason By Sponsor|299|||
154928472|NCT00388674|559162092|FG001|End of Study|Administrative Reason By Sponsor|253|||
154928473|NCT00388674|559162091|FG000|End of Study|Death|239|||
154928474|NCT00388674|559162092|FG001|End of Study|Death|262|||
154928475|NCT00388674|559162091|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
154928476|NCT00388674|559162092|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
154928477|NCT00388674|559162091|FG000|End of Study|HCC|8|||
154928478|NCT00388674|559162092|FG001|End of Study|HCC|7|||
154928479|NCT00388674|559162091|FG000|End of Study|Lost to Follow-up|587|||
154928480|NCT00388674|559162092|FG001|End of Study|Lost to Follow-up|715|||
154928481|NCT00388674|559162091|FG000|End of Study|Malignancy (Non-HCC)|1|||
154928482|NCT00388674|559162092|FG001|End of Study|Malignancy (Non-HCC)|1|||
154928483|NCT00388674|559162091|FG000|End of Study|Non-Study Related Comorbidities|3|||
154928484|NCT00388674|559162092|FG001|End of Study|Non-Study Related Comorbidities|4|||
154928485|NCT00388674|559162091|FG000|End of Study|Not Defined|135|||
154928486|NCT00388674|559162092|FG001|End of Study|Not Defined|214|||
154928487|NCT00388674|559162091|FG000|End of Study|Participant Withdrew Consent|437|||
154928488|NCT00388674|559162092|FG001|End of Study|Participant Withdrew Consent|673|||
154928489|NCT00388674|559162091|FG000|End of Study|No Off-Treatment Status Data|22|||
154928490|NCT00388674|559162092|FG001|End of Study|No Off-Treatment Status Data|30|||
154928491|NCT00388674|559162091|FG000|End of Study|Not Reported|0|||
154928492|NCT00388674|559162092|FG001|End of Study|Not Reported|1|||
154928493|NCT00996632|559162095|FG000|Overall Study|Physician Decision|0|||
154928494|NCT00996632|559162096|FG001|Overall Study|Physician Decision|0|||
154928495|NCT01569594|559162099|FG000|Overall Study|Physician Decision|4|||
154928496|NCT01569594|559162099|FG000|Overall Study|Death|13|||
154928497|NCT01569594|559162099|FG000|Overall Study|Lost to Follow-up|22|||
154928498|NCT01569594|559162099|FG000|Overall Study|Adverse Event|2|||
154928499|NCT01569594|559162099|FG000|Overall Study|Withdrawal by Subject|13|||
154928500|NCT01569594|559162099|FG000|Overall Study|Other|4|||
154928501|NCT01569594|559162099|FG000|Overall Study|No ECM used|9|||
154928502|NCT03069365|559162100|FG000|Overall Study|Adverse Event|1|||
154928503|NCT02886494|559162101|FG000|Overall Study|Adverse Event|1|||
154928504|NCT02886494|559162102|FG001|Overall Study|Adverse Event|0|||
154928505|NCT02886494|559162101|FG000|Overall Study|Withdrawal by Subject|12|||
154928506|NCT02886494|559162102|FG001|Overall Study|Withdrawal by Subject|3|||
154928507|NCT02886494|559162101|FG000|Overall Study|Protocol Violation|4|||
154928508|NCT02886494|559162102|FG001|Overall Study|Protocol Violation|1|||
154928509|NCT00537056|559162106|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
154928510|NCT00203892|559162108|FG000|Overall Study|Physician Decision|1|||
154928511|NCT00203892|559162109|FG001|Overall Study|Physician Decision|2|||
154928512|NCT00203892|559162110|FG002|Overall Study|Physician Decision|0|||
154928513|NCT00203892|559162108|FG000|Overall Study|Death|1|||
154928514|NCT00203892|559162109|FG001|Overall Study|Death|0|||
154928515|NCT00203892|559162110|FG002|Overall Study|Death|0|||
154928516|NCT01612780|559162121|FG000|Overall Study|Treatment not completed|1|||
154928517|NCT01612780|559162121|FG000|Overall Study|Withdrawal by Subject|5|||
154928518|NCT00556166|559162122|FG000|Overall Study|Withdrawal by Subject|1|||
154928519|NCT00244881|559162125|FG000|Overall Study|Withdrawal by Subject|3|||
154928520|NCT02985515|559162126|FG000|Olfaction Testing|Lost to Follow-up|0|||
154928521|NCT02985515|559162127|FG001|Olfaction Testing|Lost to Follow-up|5|||
154928522|NCT02985515|559162126|FG000|Olfaction Testing|Protocol Violation|0|||
154928523|NCT02985515|559162127|FG001|Olfaction Testing|Protocol Violation|3|||
154928524|NCT03020966|559162128|FG000|Overall Study|Withdrawal by Subject|2|||
154928525|NCT03020966|559162129|FG001|Overall Study|Withdrawal by Subject|0|||
154928526|NCT01060007|559162132|FG000|Overall Study|Withdrawal by Subject|1|||
154928527|NCT01060007|559162132|FG000|Overall Study|Inevaluable for response at surgery|3|||
154928528|NCT03159611|559162136|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
154928529|NCT03159611|559162137|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
154928530|NCT03159611|559162136|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
154928531|NCT03159611|559162137|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
154928532|NCT03159611|559162136|FG000|Overall Study|Protocol Violation|7|||
154928533|NCT03159611|559162137|FG001|Overall Study|Protocol Violation|4|||
154928534|NCT03159611|559162136|FG000|Overall Study|Adverse Event|1|||
154928535|NCT03159611|559162137|FG001|Overall Study|Adverse Event|0|||
154928536|NCT03159611|559162136|FG000|Overall Study|Withdrawal by Subject|1|||
154928537|NCT03159611|559162137|FG001|Overall Study|Withdrawal by Subject|1|||
154928538|NCT03159611|559162136|FG000|Overall Study|Non-compliance with protocol requirement|3|||
155042494|NCT00435188|559586716|FG001|Overall Study|Withdrawal by Subject|11|||
155042495|NCT00435188|559586715|FG000|Overall Study|Lost to Follow-up|5|||
155042496|NCT00435188|559586716|FG001|Overall Study|Lost to Follow-up|6|||
155042497|NCT01915771|559586717|FG000|Day 1|Withdrawal by Subject|1|||
155042498|NCT01915771|559586717|FG000|Day 15|Withdrawal by Subject|1|||
155042499|NCT00575510|559586720|FG000|Overall Study|Lost to Follow-up|4|||
155042500|NCT00575510|559586721|FG001|Overall Study|Lost to Follow-up|6|||
155042501|NCT00575510|559586722|FG002|Overall Study|Lost to Follow-up|9|||
155042502|NCT00575510|559586720|FG000|Overall Study|Withdrawal by Subject|1|||
155042503|NCT00575510|559586721|FG001|Overall Study|Withdrawal by Subject|0|||
155042504|NCT00575510|559586722|FG002|Overall Study|Withdrawal by Subject|0|||
155042505|NCT00575510|559586720|FG000|Overall Study|Clinic Called Patient|7|||
155042506|NCT00575510|559586721|FG001|Overall Study|Clinic Called Patient|7|||
155042507|NCT00575510|559586722|FG002|Overall Study|Clinic Called Patient|7|||
155042508|NCT00575510|559586720|FG000|Overall Study|Pregnancy|0|||
155042509|NCT00575510|559586721|FG001|Overall Study|Pregnancy|0|||
155042510|NCT00575510|559586722|FG002|Overall Study|Pregnancy|1|||
155042511|NCT02697734|559586723|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
155042512|NCT02697734|559586724|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
155042513|NCT02697734|559586723|FG000|Core Phase - up to Week 48|Adverse Event|1|||
155042514|NCT02697734|559586724|FG001|Core Phase - up to Week 48|Adverse Event|2|||
155042515|NCT02697734|559586723|FG000|Core Phase - up to Week 48|Physician Decision|1|||
155042516|NCT02697734|559586724|FG001|Core Phase - up to Week 48|Physician Decision|0|||
155042517|NCT02697734|559586723|FG000|Optional Extension Phase|Adverse Event|5|||
155042518|NCT02697734|559586724|FG001|Optional Extension Phase|Adverse Event|1|||
155042519|NCT02697734|559586723|FG000|Optional Extension Phase|Physician Decision|0|||
155042520|NCT02697734|559586724|FG001|Optional Extension Phase|Physician Decision|1|||
155042521|NCT02324699|559586725|FG000|Overall Study|study terminated|1|||
155042522|NCT03970200|559586726|FG000|Overall Study|Death|2|||
155042523|NCT03970200|559586727|FG001|Overall Study|Death|2|||
155042524|NCT03970200|559586728|FG002|Overall Study|Death|1|||
155042525|NCT03970200|559586726|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
155042526|NCT03970200|559586727|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
155042527|NCT03970200|559586728|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
155042528|NCT01098162|559586729|FG000|Overall Study|Adverse Event|37|||
155042529|NCT01098162|559586729|FG000|Overall Study|Lack of Efficacy|4|||
155042530|NCT01098162|559586729|FG000|Overall Study|Wish of Patient|7|||
155042531|NCT01098162|559586729|FG000|Overall Study|Lost to Follow-up|9|||
155042532|NCT01098162|559586729|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
155042533|NCT01098162|559586729|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
155042534|NCT01098162|559586729|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
155042535|NCT01098162|559586729|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
155042536|NCT01098162|559586729|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
155042537|NCT01098162|559586729|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
155042538|NCT01098162|559586729|FG000|Overall Study|Other Reason|1|||
155042539|NCT01098162|559586729|FG000|Overall Study|Reason Unknown|26|||
155042540|NCT01605825|559586730|FG000|Overall Study|Adverse Event|4|||
155042541|NCT01605825|559586731|FG001|Overall Study|Adverse Event|2|||
155042542|NCT01605825|559586730|FG000|Overall Study|Withdrawal by Subject|0|||
155042543|NCT01605825|559586731|FG001|Overall Study|Withdrawal by Subject|1|||
155042544|NCT01605825|559586730|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
155042545|NCT01605825|559586731|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
155042546|NCT01605825|559586730|FG000|Overall Study|Non-Compliance with Protocol|3|||
155042547|NCT01605825|559586731|FG001|Overall Study|Non-Compliance with Protocol|0|||
155042548|NCT00380718|559586734|FG000|Overall Study|Adverse Event|1|||
155042549|NCT00380718|559586734|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
155042550|NCT01706575|559586736|FG000|Overall Study|Participant Withdrew Consent|4|||
155042551|NCT01706575|559586736|FG000|Overall Study|Lost to Follow-up|2|||
155042552|NCT01706575|559586736|FG000|Overall Study|Started but not Treated|6|||
155042553|NCT00621517|559586741|FG000|Overall Study|Lost to Follow-up|3|||
155042554|NCT00621517|559586742|FG001|Overall Study|Lost to Follow-up|3|||
155042555|NCT00621517|559586741|FG000|Overall Study|Withdrawal by Subject|3|||
155042556|NCT00621517|559586742|FG001|Overall Study|Withdrawal by Subject|4|||
155042557|NCT00621517|559586741|FG000|Overall Study|Adverse Event|1|||
155152532|NCT03037385|559996849|FG007|Overall Study|Physician Decision|0|||
155152533|NCT03037385|559996850|FG008|Overall Study|Physician Decision|0|||
155042558|NCT00621517|559586742|FG001|Overall Study|Adverse Event|0|||
155042559|NCT02155322|559586747|FG000|Overall Study|Adverse Event|1|||
155042560|NCT02155322|559586747|FG000|Overall Study|Physician Decision|1|||
155042561|NCT02155322|559586747|FG000|Overall Study|Relapse/Recurrence|8|||
155042562|NCT02155322|559586747|FG000|Overall Study|Withdrawal by Subject|4|||
155042563|NCT00840034|559586755|FG000|Acute Treatment Phase|Adverse Event|6|||
155042564|NCT00840034|559586756|FG001|Acute Treatment Phase|Adverse Event|8|||
155152534|NCT03037385|559996851|FG009|Overall Study|Physician Decision|1|||
154928539|NCT03159611|559162137|FG001|Overall Study|Non-compliance with protocol requirement|2|||
154928540|NCT03159611|559162136|FG000|Overall Study|Inability to perform procedures|1|||
154928541|NCT03159611|559162137|FG001|Overall Study|Inability to perform procedures|0|||
154928542|NCT02072174|559162138|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
154928543|NCT02072174|559162139|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
154928544|NCT02072174|559162138|FG000|Overall Study|Protocol Violation|16|||
154928545|NCT02072174|559162139|FG001|Overall Study|Protocol Violation|23|||
154928546|NCT02072174|559162138|FG000|Overall Study|Physician Decision|0|||
154928547|NCT02072174|559162139|FG001|Overall Study|Physician Decision|1|||
154928548|NCT02072174|559162138|FG000|Overall Study|Non-compliance with protocol requirement|2|||
154928549|NCT02072174|559162139|FG001|Overall Study|Non-compliance with protocol requirement|0|||
154928550|NCT05674721|559162140|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
154928551|NCT05674721|559162141|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
154928552|NCT05674721|559162140|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
154928553|NCT05674721|559162141|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
154928554|NCT03506425|559162151|FG000|Overall Study|Adverse Event|1|||
154928555|NCT03506425|559162152|FG001|Overall Study|Adverse Event|3|||
154928556|NCT03506425|559162153|FG002|Overall Study|Adverse Event|0|||
154928557|NCT03506425|559162151|FG000|Overall Study|Death|1|||
154928558|NCT03506425|559162152|FG001|Overall Study|Death|0|||
154928559|NCT03506425|559162153|FG002|Overall Study|Death|0|||
154928560|NCT03506425|559162151|FG000|Overall Study|Withdrawal by Subject|0|||
154928561|NCT03506425|559162152|FG001|Overall Study|Withdrawal by Subject|0|||
154928562|NCT03506425|559162153|FG002|Overall Study|Withdrawal by Subject|1|||
154928563|NCT03409328|559162154|FG000|Overall Study|Lost to Follow-up|6|||
154928564|NCT03409328|559162155|FG001|Overall Study|Lost to Follow-up|3|||
154928565|NCT02998645|559162156|FG000|Treatment Period 1|Adverse Event|6|||
154928566|NCT02998645|559162156|FG000|Treatment Period 1|Death|5|||
154928567|NCT02998645|559162156|FG000|Treatment Period 1|Technical Problems|4|||
154928568|NCT02998645|559162156|FG000|Treatment Period 1|Lack of Efficacy|2|||
154928569|NCT02998645|559162156|FG000|Treatment Period 1|Progressive disease|1|||
154928570|NCT02998645|559162156|FG000|Treatment Period 1|Subject/guardian decision|1|||
154928571|NCT02998645|559162156|FG000|Treatment Period 2|Lack of Efficacy|5|||
154928572|NCT02998645|559162156|FG000|Treatment Period 2|Adverse Event|2|||
154928573|NCT02998645|559162156|FG000|Treatment Period 2|Progressive disease|2|||
154928574|NCT02998645|559162156|FG000|Treatment Period 2|Physician Decision|1|||
154928575|NCT00478673|559162157|FG000|30-Days Post-Procedure|Death|2|||
154928576|NCT00478673|559162157|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
154928577|NCT00478673|559162157|FG000|30-Days Post-Procedure|Missed Visit|7|||
154928578|NCT00478673|559162157|FG000|12-Months Post-Procedure|Death|23|||
154928579|NCT00478673|559162157|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
154928580|NCT00478673|559162157|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
154928581|NCT00478673|559162157|FG000|12-Months Post-Procedure|Missed Visit|25|||
154928582|NCT00478673|559162157|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
154928583|NCT03701516|559162158|FG000|Period 1|Lost to Follow-up|0|||
154928584|NCT03701516|559162159|FG001|Period 1|Lost to Follow-up|1|||
154928585|NCT03701516|559162158|FG000|Period 1|Adverse Event|0|||
154928586|NCT03701516|559162159|FG001|Period 1|Adverse Event|2|||
154928587|NCT03701516|559162158|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
154928588|NCT03701516|559162159|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
154928589|NCT03701516|559162158|FG000|Period 1|Non Compliance to Protocol|2|||
154928590|NCT03701516|559162159|FG001|Period 1|Non Compliance to Protocol|1|||
154928591|NCT03701516|559162158|FG000|Period 1|Withdrawal by Subject|0|||
154928592|NCT03701516|559162159|FG001|Period 1|Withdrawal by Subject|1|||
154928593|NCT03701516|559162158|FG000|Period 2|failed to meet all eligibility creiteria|1|||
154928594|NCT03701516|559162159|FG001|Period 2|failed to meet all eligibility creiteria|0|||
154928595|NCT03701516|559162158|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
154928596|NCT03701516|559162159|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
154928597|NCT03930615|559162162|FG000|Overall Study|Death|9|||
154928598|NCT03930615|559162163|FG001|Overall Study|Death|3|||
154928599|NCT03930615|559162162|FG000|Overall Study|Lost to Follow-up|1|||
154928600|NCT03930615|559162163|FG001|Overall Study|Lost to Follow-up|2|||
154928601|NCT03930615|559162162|FG000|Overall Study|Physician Decision|3|||
154928602|NCT03930615|559162163|FG001|Overall Study|Physician Decision|4|||
154928603|NCT03930615|559162162|FG000|Overall Study|Withdrawal by Subject|13|||
154928604|NCT03930615|559162163|FG001|Overall Study|Withdrawal by Subject|2|||
154928605|NCT03930615|559162162|FG000|Overall Study|Not treated|1|||
154928606|NCT03930615|559162163|FG001|Overall Study|Not treated|1|||
154928607|NCT03644927|559162166|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
154928608|NCT03644927|559162167|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
154928609|NCT00956813|559162168|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
154928610|NCT00956813|559162169|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
154928611|NCT00956813|559162168|FG000|Flaxseed and Placebo|Ineligible|3|||
154928612|NCT00956813|559162169|FG001|Flaxseed and Placebo|Ineligible|1|||
154928613|NCT02380248|559162170|FG000|Overall Study|Lost to Follow-up|11|||
154928614|NCT02380248|559162170|FG000|Overall Study|Withdrawal by Subject|3|||
154928615|NCT01275170|559162173|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
155042565|NCT00840034|559586755|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
155042566|NCT00840034|559586756|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
155042567|NCT00840034|559586755|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
155042568|NCT00840034|559586756|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
155042569|NCT00840034|559586755|FG000|Acute Treatment Phase|Physician Decision|0|||
155042570|NCT00840034|559586756|FG001|Acute Treatment Phase|Physician Decision|1|||
154928616|NCT01275170|559162174|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928617|NCT01275170|559162175|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928618|NCT01275170|559162176|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928619|NCT01275170|559162177|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928620|NCT01275170|559162178|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928621|NCT01275170|559162179|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928622|NCT01275170|559162180|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
154928623|NCT02864953|559162181|FG000|Overall Study|Adverse Event|22|||
154928624|NCT02864953|559162182|FG001|Overall Study|Adverse Event|19|||
154928625|NCT02864953|559162181|FG000|Overall Study|Withdrawal by Subject|1|||
154928626|NCT02864953|559162182|FG001|Overall Study|Withdrawal by Subject|0|||
154928627|NCT02864953|559162181|FG000|Overall Study|Physician Decision|4|||
154928628|NCT02864953|559162182|FG001|Overall Study|Physician Decision|2|||
154928629|NCT02864953|559162181|FG000|Overall Study|Death|3|||
154928630|NCT02864953|559162182|FG001|Overall Study|Death|13|||
154928631|NCT02864953|559162181|FG000|Overall Study|Reason not specified|14|||
154928632|NCT02864953|559162182|FG001|Overall Study|Reason not specified|12|||
154928633|NCT02864953|559162181|FG000|Overall Study|Withdrew Prior to Dosing|9|||
154928634|NCT02864953|559162182|FG001|Overall Study|Withdrew Prior to Dosing|8|||
154928635|NCT00981019|559162183|FG000|Overall Study|Did not respond|65|||
154928636|NCT00981019|559162183|FG000|Overall Study|Did not match target population|94|||
154928637|NCT00981019|559162183|FG000|Overall Study|Inadvertent exclusion|239|||
154928638|NCT00981019|559162183|FG000|Overall Study|Hit the survey after closure|79|||
154928639|NCT00358670|559162184|FG000|Overall Study|Adverse Event|26|||
154928640|NCT00358670|559162185|FG001|Overall Study|Adverse Event|29|||
154928641|NCT00358670|559162184|FG000|Overall Study|Lack of Efficacy|20|||
154928642|NCT00358670|559162185|FG001|Overall Study|Lack of Efficacy|23|||
154928643|NCT00358670|559162184|FG000|Overall Study|Protocol Violation|6|||
154928644|NCT00358670|559162185|FG001|Overall Study|Protocol Violation|9|||
154928645|NCT00358670|559162184|FG000|Overall Study|Lost to Follow-up|4|||
154928646|NCT00358670|559162185|FG001|Overall Study|Lost to Follow-up|5|||
154928647|NCT00358670|559162184|FG000|Overall Study|Withdrawal by Subject|13|||
155042571|NCT00840034|559586755|FG000|Acute Treatment Phase|Protocol Violation|2|||
155042572|NCT00840034|559586756|FG001|Acute Treatment Phase|Protocol Violation|4|||
155042573|NCT00840034|559586755|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
155042574|NCT00840034|559586756|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
155042575|NCT00840034|559586755|FG000|Taper Phase|Adverse Event|1|||
155042576|NCT00840034|559586756|FG001|Taper Phase|Adverse Event|0|||
155042577|NCT00840034|559586755|FG000|Taper Phase|Lost to Follow-up|1|||
155042578|NCT00840034|559586756|FG001|Taper Phase|Lost to Follow-up|1|||
155042579|NCT00840034|559586755|FG000|Taper Phase|Withdrawal by Subject|1|||
155042580|NCT00840034|559586756|FG001|Taper Phase|Withdrawal by Subject|1|||
155042581|NCT01215435|559586757|FG000|Overall Study|Adverse Event|1|||
155042582|NCT01215435|559586758|FG001|Overall Study|Adverse Event|0|||
155042583|NCT01215435|559586757|FG000|Overall Study|Protocol Violation|2|||
155042584|NCT01215435|559586758|FG001|Overall Study|Protocol Violation|0|||
155042585|NCT01215435|559586757|FG000|Overall Study|Withdrawal Criteria|8|||
155042586|NCT01215435|559586758|FG001|Overall Study|Withdrawal Criteria|11|||
155042587|NCT01215435|559586757|FG000|Overall Study|Lost to Follow-up|3|||
155042588|NCT01215435|559586758|FG001|Overall Study|Lost to Follow-up|0|||
155042589|NCT01215435|559586757|FG000|Overall Study|Unclassified|5|||
155042590|NCT01215435|559586758|FG001|Overall Study|Unclassified|5|||
155042591|NCT02839876|559586763|FG000|Overall Study|Protocol Violation|10|||
155042592|NCT02839876|559586764|FG001|Overall Study|Protocol Violation|11|||
155042593|NCT00636961|559586769|FG000|Period 1|Administrative problems|1|||
155042594|NCT00636961|559586770|FG001|Period 1|Administrative problems|1|||
155042595|NCT00636961|559586769|FG000|Period 2|Adverse Event|1|||
155042596|NCT00636961|559586770|FG001|Period 2|Adverse Event|0|||
155042597|NCT01156051|559586773|FG000|Overall Study|Lost to Follow-up|1|||
155152535|NCT03037385|559996842|FG000|Overall Study|Progressive Disease|0|||
155152536|NCT03037385|559996843|FG001|Overall Study|Progressive Disease|1|||
155152537|NCT03037385|559996844|FG002|Overall Study|Progressive Disease|1|||
155152538|NCT03037385|559996845|FG003|Overall Study|Progressive Disease|5|||
154928648|NCT00358670|559162185|FG001|Overall Study|Withdrawal by Subject|24|||
154928649|NCT00358670|559162184|FG000|Overall Study|Protocol Defined Clinical Event|0|||
154928650|NCT00358670|559162185|FG001|Overall Study|Protocol Defined Clinical Event|1|||
154928651|NCT00358670|559162184|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
154928652|NCT00358670|559162185|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
155152539|NCT03037385|559996846|FG004|Overall Study|Progressive Disease|2|||
155152540|NCT03037385|559996847|FG005|Overall Study|Progressive Disease|0|||
155042598|NCT01156051|559586774|FG001|Overall Study|Lost to Follow-up|0|||
155152541|NCT03037385|559996848|FG006|Overall Study|Progressive Disease|1|||
155152542|NCT03037385|559996849|FG007|Overall Study|Progressive Disease|0|||
155152543|NCT03037385|559996850|FG008|Overall Study|Progressive Disease|0|||
155152544|NCT03037385|559996851|FG009|Overall Study|Progressive Disease|30|||
155152545|NCT03037385|559996842|FG000|Overall Study|Withdrawal by Subject|0|||
155152546|NCT03037385|559996843|FG001|Overall Study|Withdrawal by Subject|0|||
155152547|NCT03037385|559996844|FG002|Overall Study|Withdrawal by Subject|1|||
155152548|NCT03037385|559996845|FG003|Overall Study|Withdrawal by Subject|2|||
155152549|NCT03037385|559996846|FG004|Overall Study|Withdrawal by Subject|1|||
155152550|NCT03037385|559996847|FG005|Overall Study|Withdrawal by Subject|3|||
155152551|NCT03037385|559996848|FG006|Overall Study|Withdrawal by Subject|0|||
155152552|NCT03037385|559996849|FG007|Overall Study|Withdrawal by Subject|0|||
154928653|NCT00358670|559162184|FG000|Overall Study|Administrative|153|||
154928654|NCT00358670|559162185|FG001|Overall Study|Administrative|125|||
154928655|NCT05083559|559162187|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
154928656|NCT05083559|559162188|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
154928657|NCT05083559|559162187|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
154928658|NCT05083559|559162188|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
154928659|NCT05083559|559162187|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
154928660|NCT05083559|559162188|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
154928661|NCT02704130|559162189|FG000|Overall Study|Physician Decision|5|||
154928662|NCT02704130|559162190|FG001|Overall Study|Physician Decision|3|||
154928663|NCT02666768|559162193|FG000|Overall Study|Withdrawal by Subject|4|||
154928664|NCT00905437|559162197|FG000|Overall Study|Adverse Event|3|||
154928665|NCT00905437|559162198|FG001|Overall Study|Adverse Event|2|||
154928666|NCT00905437|559162197|FG000|Overall Study|Lost to Follow-up|0|||
154928667|NCT00905437|559162198|FG001|Overall Study|Lost to Follow-up|1|||
154928668|NCT00905437|559162197|FG000|Overall Study|Withdrawal by Subject|0|||
154928669|NCT00905437|559162198|FG001|Overall Study|Withdrawal by Subject|1|||
154928670|NCT00905437|559162197|FG000|Overall Study|Other|5|||
154928671|NCT00905437|559162198|FG001|Overall Study|Other|6|||
154928672|NCT01306968|559162199|FG000|Overall Study|Lost to Follow-up|1|||
154928673|NCT01306968|559162200|FG001|Overall Study|Lost to Follow-up|1|||
154928674|NCT01306968|559162201|FG002|Overall Study|Lost to Follow-up|0|||
154928675|NCT01306968|559162202|FG003|Overall Study|Lost to Follow-up|0|||
154928676|NCT01306968|559162199|FG000|Overall Study|Physician Decision|0|||
154928677|NCT01306968|559162200|FG001|Overall Study|Physician Decision|1|||
154928678|NCT01306968|559162201|FG002|Overall Study|Physician Decision|0|||
154928679|NCT01306968|559162202|FG003|Overall Study|Physician Decision|0|||
154928680|NCT01306968|559162199|FG000|Overall Study|Relocated and left active duty|0|||
154928681|NCT01306968|559162200|FG001|Overall Study|Relocated and left active duty|1|||
154928682|NCT01306968|559162201|FG002|Overall Study|Relocated and left active duty|1|||
154928683|NCT01306968|559162202|FG003|Overall Study|Relocated and left active duty|1|||
154928684|NCT01306968|559162199|FG000|Overall Study|Withdrew - time commitment|0|||
154928685|NCT01306968|559162200|FG001|Overall Study|Withdrew - time commitment|0|||
154928686|NCT01306968|559162201|FG002|Overall Study|Withdrew - time commitment|0|||
154928687|NCT01306968|559162202|FG003|Overall Study|Withdrew - time commitment|2|||
154928688|NCT01306968|559162199|FG000|Overall Study|Withdrew over privacy concerns|0|||
154928689|NCT01306968|559162200|FG001|Overall Study|Withdrew over privacy concerns|0|||
154928690|NCT01306968|559162201|FG002|Overall Study|Withdrew over privacy concerns|0|||
154928691|NCT01306968|559162202|FG003|Overall Study|Withdrew over privacy concerns|1|||
154928692|NCT03252015|559162205|FG000|Overall Study|Withdrawal by Subject|0|||
154928693|NCT03252015|559162206|FG001|Overall Study|Withdrawal by Subject|1|||
154928694|NCT03252015|559162207|FG002|Overall Study|Withdrawal by Subject|1|||
154928695|NCT03252015|559162208|FG003|Overall Study|Withdrawal by Subject|0|||
154928696|NCT03252015|559162205|FG000|Overall Study|Adverse Event|1|||
154928697|NCT03252015|559162206|FG001|Overall Study|Adverse Event|0|||
154928698|NCT03252015|559162207|FG002|Overall Study|Adverse Event|0|||
154928699|NCT03252015|559162208|FG003|Overall Study|Adverse Event|1|||
154928700|NCT03128931|559162209|FG000|Overall Study|Physician Decision|1|||
154928701|NCT03128931|559162209|FG000|Overall Study|Equipment Issues|3|||
154928702|NCT04993339|559162210|FG000|Overall Study|Lost to Follow-up|0|||
154928703|NCT04993339|559162211|FG001|Overall Study|Lost to Follow-up|1|||
154928704|NCT04993339|559162210|FG000|Overall Study|no MRI scan|3|||
154928705|NCT04993339|559162211|FG001|Overall Study|no MRI scan|1|||
154928706|NCT00903409|559162212|FG000|Overall Study|Adverse Event|11|||
154928707|NCT00903409|559162213|FG001|Overall Study|Adverse Event|9|||
154928708|NCT00903409|559162212|FG000|Overall Study|Non-compliance with Protocol|1|||
154928709|NCT00903409|559162213|FG001|Overall Study|Non-compliance with Protocol|1|||
154928710|NCT00903409|559162212|FG000|Overall Study|Laboratory Abnormality|2|||
154928711|NCT00903409|559162213|FG001|Overall Study|Laboratory Abnormality|0|||
154928712|NCT00903409|559162212|FG000|Overall Study|Withdrawal by Subject|8|||
154928713|NCT00903409|559162213|FG001|Overall Study|Withdrawal by Subject|8|||
155152553|NCT03037385|559996850|FG008|Overall Study|Withdrawal by Subject|0|||
155152554|NCT03037385|559996851|FG009|Overall Study|Withdrawal by Subject|52|||
154928714|NCT00903409|559162212|FG000|Overall Study|Other|2|||
155152555|NCT03037385|559996842|FG000|Overall Study|Reason Not Specified|0|||
155152556|NCT03037385|559996843|FG001|Overall Study|Reason Not Specified|1|||
155152557|NCT03037385|559996844|FG002|Overall Study|Reason Not Specified|0|||
155152558|NCT03037385|559996845|FG003|Overall Study|Reason Not Specified|4|||
155152559|NCT03037385|559996846|FG004|Overall Study|Reason Not Specified|3|||
155152560|NCT03037385|559996847|FG005|Overall Study|Reason Not Specified|6|||
155152561|NCT03037385|559996848|FG006|Overall Study|Reason Not Specified|2|||
155152562|NCT03037385|559996849|FG007|Overall Study|Reason Not Specified|0|||
154928715|NCT00903409|559162213|FG001|Overall Study|Other|3|||
154928716|NCT00903409|559162212|FG000|Overall Study|Lost to Follow-up|2|||
154928717|NCT00903409|559162213|FG001|Overall Study|Lost to Follow-up|6|||
154928718|NCT00797316|559162214|FG000|Overall Study|Administrative problems|1|||
155152563|NCT03037385|559996850|FG008|Overall Study|Reason Not Specified|1|||
155152564|NCT03037385|559996851|FG009|Overall Study|Reason Not Specified|181|||
155152565|NCT03007966|559996855|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
155152566|NCT03007966|559996856|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
155152567|NCT00474487|559996860|FG000|Overall Study|Withdrawal by Subject|6|||
155152568|NCT00474487|559996861|FG001|Overall Study|Withdrawal by Subject|0|||
155152569|NCT00474487|559996862|FG002|Overall Study|Withdrawal by Subject|0|||
155152570|NCT00474487|559996863|FG003|Overall Study|Withdrawal by Subject|0|||
155152571|NCT00474487|559996860|FG000|Overall Study|Lost to Follow-up|20|||
155152572|NCT00474487|559996861|FG001|Overall Study|Lost to Follow-up|1|||
155152573|NCT00474487|559996862|FG002|Overall Study|Lost to Follow-up|7|||
155152574|NCT00474487|559996863|FG003|Overall Study|Lost to Follow-up|0|||
155152575|NCT00474487|559996860|FG000|Overall Study|Inappropriate enrollment|4|||
155152576|NCT00474487|559996861|FG001|Overall Study|Inappropriate enrollment|0|||
155152577|NCT00474487|559996862|FG002|Overall Study|Inappropriate enrollment|7|||
155152578|NCT00474487|559996863|FG003|Overall Study|Inappropriate enrollment|0|||
155152579|NCT00474487|559996860|FG000|Overall Study|Death|0|||
155152580|NCT00474487|559996861|FG001|Overall Study|Death|1|||
155152581|NCT00474487|559996862|FG002|Overall Study|Death|0|||
155152582|NCT00474487|559996863|FG003|Overall Study|Death|0|||
155152583|NCT02220920|559996864|FG000|Overall Study|Adverse Event|1|||
154928719|NCT00797316|559162215|FG001|Overall Study|Administrative problems|0|||
154928720|NCT00797316|559162214|FG000|Overall Study|Adverse Event|5|||
155152584|NCT02220920|559996865|FG001|Overall Study|Adverse Event|0|||
155152585|NCT02220920|559996864|FG000|Overall Study|Lack of Efficacy|0|||
155152586|NCT02220920|559996865|FG001|Overall Study|Lack of Efficacy|1|||
155152587|NCT02220920|559996864|FG000|Overall Study|Withdrawal by Subject|1|||
155152588|NCT02220920|559996865|FG001|Overall Study|Withdrawal by Subject|0|||
155152589|NCT02220920|559996864|FG000|Overall Study|Conflict with the stopping criteria|1|||
155152590|NCT02220920|559996865|FG001|Overall Study|Conflict with the stopping criteria|2|||
155152591|NCT05176314|559996868|FG000|Overall Study|Lost to Follow-up|2|||
155152592|NCT05176314|559996868|FG000|Overall Study|Physician Decision|1|||
155152593|NCT05176314|559996868|FG000|Overall Study|Adverse Event|1|||
155152594|NCT05543265|559996871|FG000|Overall Study|Lost to Follow-up|3|||
155152595|NCT05543265|559996872|FG001|Overall Study|Lost to Follow-up|3|||
155152596|NCT05543265|559996871|FG000|Overall Study|Withdrawal by Subject|0|||
155152597|NCT05543265|559996872|FG001|Overall Study|Withdrawal by Subject|1|||
155152598|NCT05316597|559996873|FG000|First Session|Withdrawal by Subject|0|||
155152599|NCT05316597|559996874|FG001|First Session|Withdrawal by Subject|1|||
155152600|NCT05316597|559996873|FG000|Washout Period|Lost to Follow-up|1|||
155152601|NCT05316597|559996874|FG001|Washout Period|Lost to Follow-up|2|||
155152602|NCT05316597|559996873|FG000|Washout Period|Physician Decision|1|||
155152603|NCT05316597|559996874|FG001|Washout Period|Physician Decision|1|||
155152604|NCT05316597|559996873|FG000|Washout Period|Excluded before second session|1|||
155152605|NCT05316597|559996874|FG001|Washout Period|Excluded before second session|1|||
155152606|NCT05316597|559996873|FG000|Washout Period|Withdrawal by Subject|0|||
155152607|NCT05316597|559996874|FG001|Washout Period|Withdrawal by Subject|4|||
155152608|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
155152609|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
155152610|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
155152611|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Death|9|||
155152612|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Death|0|||
155152613|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Death|0|||
155152614|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
155381637|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
154928721|NCT00797316|559162215|FG001|Overall Study|Adverse Event|3|||
154928722|NCT00797316|559162214|FG000|Overall Study|Lost to Follow-up|4|||
155152615|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155152616|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155152617|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
155152618|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
155152619|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
155152620|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Other|135|||
154928723|NCT00797316|559162215|FG001|Overall Study|Lost to Follow-up|8|||
154928724|NCT00797316|559162214|FG000|Overall Study|Protocol Deviation|1|||
154928725|NCT00797316|559162215|FG001|Overall Study|Protocol Deviation|2|||
154928726|NCT00797316|559162214|FG000|Overall Study|Patient withdrew consent|12|||
154928727|NCT00797316|559162215|FG001|Overall Study|Patient withdrew consent|6|||
154928728|NCT00797316|559162214|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
154928729|NCT00797316|559162215|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
154928730|NCT01721369|559162216|FG000|Overall Study|Not initial etiological diagnosis|12|||
154928731|NCT01819467|559163696|FG000|Overall Study|Physician Decision|20|||
154928732|NCT01819467|559163697|FG001|Overall Study|Physician Decision|9|||
154928733|NCT00734617|559163702|FG000|Overall Study|Adverse Event|4|||
154928734|NCT00734617|559163703|FG001|Overall Study|Adverse Event|7|||
154928735|NCT00734617|559163702|FG000|Overall Study|Withdrawal by Subject|103|||
154928736|NCT00734617|559163703|FG001|Overall Study|Withdrawal by Subject|95|||
154928737|NCT03692078|559163706|FG000|Overall Study|Adverse Event|0|||
154928738|NCT03692078|559163707|FG001|Overall Study|Adverse Event|0|||
154928739|NCT03692078|559163708|FG002|Overall Study|Adverse Event|0|||
154928740|NCT03692078|559163709|FG003|Overall Study|Adverse Event|0|||
154928741|NCT03692078|559163710|FG004|Overall Study|Adverse Event|0|||
154928742|NCT03692078|559163711|FG005|Overall Study|Adverse Event|1|||
154928743|NCT03692078|559163712|FG006|Overall Study|Adverse Event|0|||
154928744|NCT03692078|559163706|FG000|Overall Study|Enrollment Closed|5|||
154928745|NCT03692078|559163707|FG001|Overall Study|Enrollment Closed|0|||
154928746|NCT03692078|559163708|FG002|Overall Study|Enrollment Closed|0|||
154928747|NCT03692078|559163709|FG003|Overall Study|Enrollment Closed|0|||
154928748|NCT03692078|559163710|FG004|Overall Study|Enrollment Closed|0|||
154928749|NCT03692078|559163711|FG005|Overall Study|Enrollment Closed|0|||
154928750|NCT03692078|559163712|FG006|Overall Study|Enrollment Closed|0|||
154928751|NCT03692078|559163706|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
154928752|NCT03692078|559163707|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
154928753|NCT03692078|559163708|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
154928754|NCT03692078|559163709|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
154928755|NCT03692078|559163710|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
154928756|NCT03692078|559163711|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
154928757|NCT03692078|559163712|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
154928758|NCT03692078|559163706|FG000|Overall Study|Withdrawal by Subject|0|||
154928759|NCT03692078|559163707|FG001|Overall Study|Withdrawal by Subject|2|||
154928760|NCT03692078|559163708|FG002|Overall Study|Withdrawal by Subject|0|||
154928761|NCT03692078|559163709|FG003|Overall Study|Withdrawal by Subject|1|||
154928762|NCT03692078|559163710|FG004|Overall Study|Withdrawal by Subject|5|||
154928763|NCT03692078|559163711|FG005|Overall Study|Withdrawal by Subject|3|||
154928764|NCT03692078|559163712|FG006|Overall Study|Withdrawal by Subject|3|||
154928765|NCT01563029|559163713|FG000|Overall Study|Adverse Event|1|||
154928766|NCT01563029|559163714|FG001|Overall Study|Adverse Event|0|||
154928767|NCT01563029|559163715|FG002|Overall Study|Adverse Event|1|||
154928768|NCT01563029|559163716|FG003|Overall Study|Adverse Event|2|||
154928769|NCT01563029|559163717|FG004|Overall Study|Adverse Event|1|||
154928770|NCT01563029|559163713|FG000|Overall Study|Lack of Efficacy|42|||
154928771|NCT01563029|559163714|FG001|Overall Study|Lack of Efficacy|16|||
154928772|NCT01563029|559163715|FG002|Overall Study|Lack of Efficacy|23|||
155152621|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Other|0|||
155152622|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Other|0|||
155152623|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
155152624|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
155152625|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
155152626|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
155152627|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
155152628|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
155152629|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
154928773|NCT01563029|559163716|FG003|Overall Study|Lack of Efficacy|21|||
154928774|NCT01563029|559163717|FG004|Overall Study|Lack of Efficacy|19|||
154928775|NCT01563029|559163713|FG000|Overall Study|Protocol Violation|1|||
154928776|NCT01563029|559163714|FG001|Overall Study|Protocol Violation|2|||
154928777|NCT01563029|559163715|FG002|Overall Study|Protocol Violation|3|||
154928778|NCT01563029|559163716|FG003|Overall Study|Protocol Violation|1|||
154928779|NCT01563029|559163717|FG004|Overall Study|Protocol Violation|3|||
155152630|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
155152631|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
154928780|NCT01563029|559163713|FG000|Overall Study|Protocol defined stopping criteria|1|||
154928781|NCT01563029|559163714|FG001|Overall Study|Protocol defined stopping criteria|0|||
154928782|NCT01563029|559163715|FG002|Overall Study|Protocol defined stopping criteria|0|||
154928783|NCT01563029|559163716|FG003|Overall Study|Protocol defined stopping criteria|0|||
154928784|NCT01563029|559163717|FG004|Overall Study|Protocol defined stopping criteria|0|||
154928785|NCT01563029|559163713|FG000|Overall Study|Lost to Follow-up|1|||
154928786|NCT01563029|559163714|FG001|Overall Study|Lost to Follow-up|0|||
154928787|NCT01563029|559163715|FG002|Overall Study|Lost to Follow-up|1|||
155152632|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Other|3|||
155152633|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Other|0|||
155152634|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Other|0|||
155152635|NCT02118584|559996875|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
155152636|NCT02118584|559996876|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155152637|NCT02118584|559996877|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155152638|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155152639|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
155152640|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155152641|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
155152642|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
155152643|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
155152644|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
155152645|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
155152646|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
155152647|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155152648|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155152649|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
155152650|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
155152651|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
155152652|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
155152653|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
155152654|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
155152655|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
155152656|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155152657|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
155152658|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155152659|NCT02118584|559996875|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
155152660|NCT02118584|559996876|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
155152661|NCT02118584|559996877|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
155152662|NCT02927301|559996880|FG000|Overall Study|Death|39|||
155152663|NCT02927301|559996880|FG000|Overall Study|Lost to Follow-up|8|||
155152664|NCT02927301|559996880|FG000|Overall Study|Physician Decision|2|||
155152665|NCT02927301|559996880|FG000|Overall Study|Withdrawal by Subject|12|||
155152666|NCT02927301|559996880|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
155152667|NCT02218372|559996881|FG000|Overall Study|Adverse Event|1|||
155152668|NCT02218372|559996882|FG001|Overall Study|Adverse Event|1|||
155152669|NCT02218372|559996881|FG000|Overall Study|Miscellaneous|2|||
155152670|NCT02218372|559996882|FG001|Overall Study|Miscellaneous|1|||
155152671|NCT02218372|559996881|FG000|Overall Study|Randomized but did not receive treatment|2|||
155152672|NCT02218372|559996882|FG001|Overall Study|Randomized but did not receive treatment|3|||
155152673|NCT02218372|559996881|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155152674|NCT02218372|559996882|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155152675|NCT03406780|559996887|FG000|Overall Study|Withdrawal by Subject|1|||
155152676|NCT03406780|559996888|FG001|Overall Study|Withdrawal by Subject|1|||
155152677|NCT03406780|559996887|FG000|Overall Study|Other|0|||
155152678|NCT03406780|559996888|FG001|Overall Study|Other|2|||
155152679|NCT01488045|559996890|FG000|Overall Study|Withdrawal by Subject|6|||
155152680|NCT01488045|559996891|FG001|Overall Study|Withdrawal by Subject|11|||
155152681|NCT01488045|559996890|FG000|Overall Study|Failure to present for colonoscopy|3|||
155152682|NCT01488045|559996891|FG001|Overall Study|Failure to present for colonoscopy|6|||
155152683|NCT01488045|559996890|FG000|Overall Study|Failure to report exclusion criteria|0|||
155152684|NCT01488045|559996891|FG001|Overall Study|Failure to report exclusion criteria|1|||
155152685|NCT00953667|559996893|FG000|Overall Study|Lost to Follow-up|11|||
155152686|NCT00953667|559996893|FG000|Overall Study|Physician Decision|35|||
155152687|NCT00953667|559996893|FG000|Overall Study|Withdrawal by Subject|63|||
155152688|NCT00953667|559996893|FG000|Overall Study|Adverse Event|10|||
155152689|NCT00953667|559996893|FG000|Overall Study|poor venous access,unable to draw blood|4|||
155152690|NCT05135871|559996907|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
155152691|NCT05135871|559996908|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
155381638|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
154928788|NCT01563029|559163716|FG003|Overall Study|Lost to Follow-up|1|||
154928789|NCT01563029|559163717|FG004|Overall Study|Lost to Follow-up|1|||
154928790|NCT01563029|559163713|FG000|Overall Study|Physician Decision|3|||
154928791|NCT01563029|559163714|FG001|Overall Study|Physician Decision|5|||
155152692|NCT05135871|559996909|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
154928792|NCT01563029|559163715|FG002|Overall Study|Physician Decision|2|||
155152693|NCT05135871|559996910|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
155152694|NCT00525512|559996911|FG000|Double-Blind Phase|Adverse Event|48|||
155152695|NCT00525512|559996912|FG001|Double-Blind Phase|Adverse Event|28|||
155152696|NCT00525512|559996913|FG002|Double-Blind Phase|Adverse Event|0|||
155152697|NCT00525512|559996914|FG003|Double-Blind Phase|Adverse Event|0|||
155152698|NCT00525512|559996911|FG000|Double-Blind Phase|Protocol Violation|3|||
155152699|NCT00525512|559996912|FG001|Double-Blind Phase|Protocol Violation|1|||
155152700|NCT00525512|559996913|FG002|Double-Blind Phase|Protocol Violation|0|||
155152701|NCT00525512|559996914|FG003|Double-Blind Phase|Protocol Violation|0|||
155152702|NCT00525512|559996911|FG000|Double-Blind Phase|Lost to Follow-up|3|||
155152703|NCT00525512|559996912|FG001|Double-Blind Phase|Lost to Follow-up|7|||
155152704|NCT00525512|559996913|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155152705|NCT00525512|559996914|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155152706|NCT00525512|559996911|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
155152707|NCT00525512|559996912|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
155152708|NCT00525512|559996913|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155152709|NCT00525512|559996914|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155152710|NCT00525512|559996911|FG000|Double-Blind Phase|Lack of Efficacy|13|||
155152711|NCT00525512|559996912|FG001|Double-Blind Phase|Lack of Efficacy|5|||
155152712|NCT00525512|559996913|FG002|Double-Blind Phase|Lack of Efficacy|0|||
155152713|NCT00525512|559996914|FG003|Double-Blind Phase|Lack of Efficacy|0|||
155152714|NCT00525512|559996911|FG000|Double-Blind Phase|Other reason (not specified)|12|||
155152715|NCT00525512|559996912|FG001|Double-Blind Phase|Other reason (not specified)|13|||
155152716|NCT00525512|559996913|FG002|Double-Blind Phase|Other reason (not specified)|0|||
155152717|NCT00525512|559996914|FG003|Double-Blind Phase|Other reason (not specified)|0|||
155152718|NCT00525512|559996911|FG000|Open-Label Phase|Adverse Event|0|||
155152719|NCT00525512|559996912|FG001|Open-Label Phase|Adverse Event|0|||
155152720|NCT00525512|559996913|FG002|Open-Label Phase|Adverse Event|1|||
155152721|NCT00525512|559996914|FG003|Open-Label Phase|Adverse Event|0|||
155152722|NCT00525512|559996911|FG000|Open-Label Phase|Lost to Follow-up|0|||
155152723|NCT00525512|559996912|FG001|Open-Label Phase|Lost to Follow-up|0|||
155152724|NCT00525512|559996913|FG002|Open-Label Phase|Lost to Follow-up|1|||
155152725|NCT00525512|559996914|FG003|Open-Label Phase|Lost to Follow-up|0|||
155152726|NCT00525512|559996911|FG000|Open-Label Phase|Other reason (not specified)|0|||
155152727|NCT00525512|559996912|FG001|Open-Label Phase|Other reason (not specified)|0|||
155152728|NCT00525512|559996913|FG002|Open-Label Phase|Other reason (not specified)|4|||
155152729|NCT00525512|559996914|FG003|Open-Label Phase|Other reason (not specified)|5|||
155152730|NCT01601535|559996915|FG000|Phase 1|Adverse Event|1|||
155152731|NCT01601535|559996916|FG001|Phase 1|Adverse Event|0|||
155152732|NCT01601535|559996917|FG002|Phase 1|Adverse Event|2|||
155152733|NCT01601535|559996918|FG003|Phase 1|Adverse Event|1|||
155152734|NCT01601535|559996919|FG004|Phase 1|Adverse Event|0|||
155152735|NCT01601535|559996920|FG005|Phase 1|Adverse Event|0|||
155152736|NCT01601535|559996915|FG000|Phase 1|Withdrawal by Subject|2|||
155152737|NCT01601535|559996916|FG001|Phase 1|Withdrawal by Subject|1|||
155152738|NCT01601535|559996917|FG002|Phase 1|Withdrawal by Subject|1|||
155152739|NCT01601535|559996918|FG003|Phase 1|Withdrawal by Subject|2|||
155152740|NCT01601535|559996919|FG004|Phase 1|Withdrawal by Subject|0|||
155152741|NCT01601535|559996920|FG005|Phase 1|Withdrawal by Subject|0|||
155152742|NCT01601535|559996915|FG000|Phase 1|Progressive Disease|2|||
155152743|NCT01601535|559996916|FG001|Phase 1|Progressive Disease|3|||
155152744|NCT01601535|559996917|FG002|Phase 1|Progressive Disease|2|||
155152745|NCT01601535|559996918|FG003|Phase 1|Progressive Disease|1|||
155152746|NCT01601535|559996919|FG004|Phase 1|Progressive Disease|0|||
155152747|NCT01601535|559996920|FG005|Phase 1|Progressive Disease|0|||
155152748|NCT01601535|559996915|FG000|Phase 1|Started Another Treatment|1|||
155152749|NCT01601535|559996916|FG001|Phase 1|Started Another Treatment|2|||
155152750|NCT01601535|559996917|FG002|Phase 1|Started Another Treatment|0|||
155152751|NCT01601535|559996918|FG003|Phase 1|Started Another Treatment|0|||
154928793|NCT01563029|559163716|FG003|Overall Study|Physician Decision|4|||
154928794|NCT01563029|559163717|FG004|Overall Study|Physician Decision|2|||
155152752|NCT01601535|559996919|FG004|Phase 1|Started Another Treatment|0|||
155152753|NCT01601535|559996920|FG005|Phase 1|Started Another Treatment|0|||
155152754|NCT01601535|559996915|FG000|Phase 2|Adverse Event|0|||
155152755|NCT01601535|559996916|FG001|Phase 2|Adverse Event|0|||
155152756|NCT01601535|559996917|FG002|Phase 2|Adverse Event|0|||
155152757|NCT01601535|559996918|FG003|Phase 2|Adverse Event|0|||
155152758|NCT01601535|559996919|FG004|Phase 2|Adverse Event|5|||
155152759|NCT01601535|559996920|FG005|Phase 2|Adverse Event|1|||
155152760|NCT01601535|559996915|FG000|Phase 2|Withdrawal by Subject|0|||
155042599|NCT01156051|559586773|FG000|Overall Study|patient not compliant with protocol|0|||
155152761|NCT01601535|559996916|FG001|Phase 2|Withdrawal by Subject|0|||
155152762|NCT01601535|559996917|FG002|Phase 2|Withdrawal by Subject|0|||
155152763|NCT01601535|559996918|FG003|Phase 2|Withdrawal by Subject|0|||
155152764|NCT01601535|559996919|FG004|Phase 2|Withdrawal by Subject|8|||
155152765|NCT01601535|559996920|FG005|Phase 2|Withdrawal by Subject|2|||
155152766|NCT01601535|559996915|FG000|Phase 2|Progressive Disease|0|||
155152767|NCT01601535|559996916|FG001|Phase 2|Progressive Disease|0|||
155152768|NCT01601535|559996917|FG002|Phase 2|Progressive Disease|0|||
155152769|NCT01601535|559996918|FG003|Phase 2|Progressive Disease|0|||
155152770|NCT01601535|559996919|FG004|Phase 2|Progressive Disease|5|||
155152771|NCT01601535|559996920|FG005|Phase 2|Progressive Disease|7|||
155152772|NCT01601535|559996915|FG000|Phase 2|Started Another Treatment|0|||
155152773|NCT01601535|559996916|FG001|Phase 2|Started Another Treatment|0|||
155152774|NCT01601535|559996917|FG002|Phase 2|Started Another Treatment|0|||
155152775|NCT01601535|559996918|FG003|Phase 2|Started Another Treatment|0|||
155152776|NCT01601535|559996919|FG004|Phase 2|Started Another Treatment|1|||
155152777|NCT01601535|559996920|FG005|Phase 2|Started Another Treatment|2|||
155152778|NCT04576988|559996923|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
155152779|NCT04576988|559996924|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
155152780|NCT04576988|559996923|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
155152781|NCT04576988|559996924|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
155152782|NCT04576988|559996923|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
155152783|NCT04576988|559996924|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
155152784|NCT04576988|559996923|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
155152785|NCT04576988|559996924|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
155152786|NCT04576988|559996923|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
155152787|NCT04576988|559996924|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
155152788|NCT04576988|559996923|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
155152789|NCT04576988|559996924|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
155152790|NCT04576988|559996923|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
155152791|NCT04576988|559996924|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
155152792|NCT04576988|559996923|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
155152793|NCT04576988|559996924|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
155152794|NCT04576988|559996923|FG000|Long Term Double Blind (LTDB)|Death|2|||
155152795|NCT04576988|559996924|FG001|Long Term Double Blind (LTDB)|Death|1|||
155152796|NCT04576988|559996923|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
155152797|NCT04576988|559996924|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
155152798|NCT02362724|559996935|FG000|Overall Study|Withdrawal by Subject|3|||
155152799|NCT02362724|559996936|FG001|Overall Study|Withdrawal by Subject|1|||
155152800|NCT02362724|559996935|FG000|Overall Study|Adverse Event|3|||
155152801|NCT02362724|559996936|FG001|Overall Study|Adverse Event|0|||
155152802|NCT02025179|559996937|FG000|Overall Study|Lost to Follow-up|0|||
155152803|NCT02025179|559996938|FG001|Overall Study|Lost to Follow-up|0|||
155152804|NCT02025179|559996939|FG002|Overall Study|Lost to Follow-up|1|||
155152805|NCT01927497|559996942|FG000|Overall Study|Death|0|||
155152806|NCT01927497|559996943|FG001|Overall Study|Death|1|||
155152807|NCT01927497|559996942|FG000|Overall Study|Protocol Violation|2|||
155152808|NCT01927497|559996943|FG001|Overall Study|Protocol Violation|0|||
155152809|NCT00395746|559996944|FG000|Overall Study|Adverse Event|5|||
155152810|NCT00395746|559996945|FG001|Overall Study|Adverse Event|2|||
155152811|NCT00395746|559996946|FG002|Overall Study|Adverse Event|2|||
155152812|NCT00395746|559996944|FG000|Overall Study|Protocol Violation|0|||
155152813|NCT00395746|559996945|FG001|Overall Study|Protocol Violation|1|||
155152814|NCT00395746|559996946|FG002|Overall Study|Protocol Violation|0|||
155152815|NCT00395746|559996944|FG000|Overall Study|Lack of Efficacy|2|||
155152816|NCT00395746|559996945|FG001|Overall Study|Lack of Efficacy|0|||
155152817|NCT00395746|559996946|FG002|Overall Study|Lack of Efficacy|17|||
155152818|NCT00395746|559996944|FG000|Overall Study|Hypoglycaemia|2|||
155152819|NCT00395746|559996945|FG001|Overall Study|Hypoglycaemia|1|||
155152820|NCT00395746|559996946|FG002|Overall Study|Hypoglycaemia|0|||
155152821|NCT00395746|559996944|FG000|Overall Study|Subject decision|0|||
155152822|NCT00395746|559996945|FG001|Overall Study|Subject decision|0|||
155152823|NCT00395746|559996946|FG002|Overall Study|Subject decision|1|||
155152824|NCT00395746|559996944|FG000|Overall Study|Withdrawal of consent|0|||
155152825|NCT00395746|559996945|FG001|Overall Study|Withdrawal of consent|0|||
155152826|NCT00395746|559996946|FG002|Overall Study|Withdrawal of consent|1|||
155152827|NCT00395746|559996944|FG000|Overall Study|Difficultulty in use of device|0|||
155152828|NCT00395746|559996945|FG001|Overall Study|Difficultulty in use of device|0|||
155152829|NCT00395746|559996946|FG002|Overall Study|Difficultulty in use of device|1|||
155152830|NCT00395746|559996944|FG000|Overall Study|Unable to visit site on schedule|1|||
155152831|NCT00395746|559996945|FG001|Overall Study|Unable to visit site on schedule|0|||
155152832|NCT00395746|559996946|FG002|Overall Study|Unable to visit site on schedule|0|||
155152833|NCT04528641|559996947|FG000|Overall Study|Withdrawal by Subject|0|||
155152834|NCT04528641|559996948|FG001|Overall Study|Withdrawal by Subject|0|||
155152835|NCT04528641|559996949|FG002|Overall Study|Withdrawal by Subject|0|||
155152836|NCT04528641|559996950|FG003|Overall Study|Withdrawal by Subject|1|||
155152837|NCT04528641|559996951|FG004|Overall Study|Withdrawal by Subject|0|||
155152838|NCT04528641|559996952|FG005|Overall Study|Withdrawal by Subject|1|||
155152839|NCT00517296|559996953|FG000|Overall Study|Withdrawal by Subject|1|||
155152840|NCT00517296|559996954|FG001|Overall Study|Withdrawal by Subject|0|||
155152841|NCT04764162|559996955|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
155381639|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
155042600|NCT01156051|559586774|FG001|Overall Study|patient not compliant with protocol|1|||
154928795|NCT01563029|559163713|FG000|Overall Study|Withdrawal by Subject|4|||
154928796|NCT01563029|559163714|FG001|Overall Study|Withdrawal by Subject|1|||
154928797|NCT01563029|559163715|FG002|Overall Study|Withdrawal by Subject|3|||
154928798|NCT01563029|559163716|FG003|Overall Study|Withdrawal by Subject|4|||
154928799|NCT01563029|559163717|FG004|Overall Study|Withdrawal by Subject|3|||
154928800|NCT02861534|559163718|FG000|Overall Study|Death|541|||
154928801|NCT02861534|559163719|FG001|Overall Study|Death|552|||
154928802|NCT02861534|559163718|FG000|Overall Study|Lost to Follow-up|14|||
154928803|NCT02861534|559163719|FG001|Overall Study|Lost to Follow-up|14|||
154928804|NCT02861534|559163718|FG000|Overall Study|Site Terminated by Sponsor|4|||
154928805|NCT02861534|559163719|FG001|Overall Study|Site Terminated by Sponsor|3|||
154928806|NCT02861534|559163718|FG000|Overall Study|Withdrawal by Subject|15|||
154928807|NCT02861534|559163719|FG001|Overall Study|Withdrawal by Subject|18|||
154928808|NCT02780115|559163720|FG000|Overall Study|Withdrawal by Subject|0|||
154928809|NCT02780115|559163721|FG001|Overall Study|Withdrawal by Subject|1|||
154928810|NCT02780115|559163722|FG002|Overall Study|Withdrawal by Subject|1|||
154928811|NCT02780115|559163723|FG003|Overall Study|Withdrawal by Subject|0|||
154928812|NCT02780115|559163724|FG004|Overall Study|Withdrawal by Subject|0|||
154928813|NCT02780115|559163720|FG000|Overall Study|Adverse Event|0|||
154928814|NCT02780115|559163721|FG001|Overall Study|Adverse Event|0|||
154928815|NCT02780115|559163722|FG002|Overall Study|Adverse Event|0|||
154928816|NCT02780115|559163723|FG003|Overall Study|Adverse Event|1|||
154928817|NCT02780115|559163724|FG004|Overall Study|Adverse Event|1|||
154928818|NCT00916617|559163725|FG000|Overall Study|Adverse Event|3|||
154928819|NCT00916617|559163726|FG001|Overall Study|Adverse Event|2|||
154928820|NCT00916617|559163727|FG002|Overall Study|Adverse Event|6|||
154928821|NCT00916617|559163728|FG003|Overall Study|Adverse Event|3|||
154928822|NCT00916617|559163725|FG000|Overall Study|Withdrawal by Subject|3|||
154928823|NCT00916617|559163726|FG001|Overall Study|Withdrawal by Subject|2|||
154928824|NCT00916617|559163727|FG002|Overall Study|Withdrawal by Subject|0|||
154928825|NCT00916617|559163728|FG003|Overall Study|Withdrawal by Subject|1|||
154928826|NCT00916617|559163725|FG000|Overall Study|Caregiver Request|3|||
154928827|NCT00916617|559163726|FG001|Overall Study|Caregiver Request|2|||
154928828|NCT00916617|559163727|FG002|Overall Study|Caregiver Request|1|||
154928829|NCT00916617|559163728|FG003|Overall Study|Caregiver Request|0|||
154928830|NCT00916617|559163725|FG000|Overall Study|Physician Decision|1|||
154928831|NCT00916617|559163726|FG001|Overall Study|Physician Decision|1|||
154928832|NCT00916617|559163727|FG002|Overall Study|Physician Decision|0|||
154928833|NCT00916617|559163728|FG003|Overall Study|Physician Decision|0|||
154928834|NCT00916617|559163725|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
154928835|NCT00916617|559163726|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
154928836|NCT00916617|559163727|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
154928837|NCT00916617|559163728|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
154928838|NCT00916617|559163725|FG000|Overall Study|Lost to Follow-up|2|||
154928839|NCT00916617|559163726|FG001|Overall Study|Lost to Follow-up|1|||
154928840|NCT00916617|559163727|FG002|Overall Study|Lost to Follow-up|0|||
154928841|NCT00916617|559163728|FG003|Overall Study|Lost to Follow-up|0|||
154928842|NCT00916617|559163725|FG000|Overall Study|Lack of Efficacy|1|||
154928843|NCT00916617|559163726|FG001|Overall Study|Lack of Efficacy|0|||
154928844|NCT00916617|559163727|FG002|Overall Study|Lack of Efficacy|0|||
154928845|NCT00916617|559163728|FG003|Overall Study|Lack of Efficacy|0|||
154928846|NCT00916617|559163725|FG000|Overall Study|Other|2|||
154928847|NCT00916617|559163726|FG001|Overall Study|Other|0|||
154928848|NCT00916617|559163727|FG002|Overall Study|Other|0|||
154928849|NCT00916617|559163728|FG003|Overall Study|Other|2|||
154928850|NCT00769132|559163733|FG000|Period 1|Adverse Event|1|||
154928851|NCT00769132|559163734|FG001|Period 1|Adverse Event|0|||
154928852|NCT00769132|559163735|FG002|Period 1|Adverse Event|0|||
154928853|NCT00769132|559163736|FG003|Period 1|Adverse Event|1|||
154928854|NCT00769132|559163733|FG000|Period 2|Withdrawal by Subject|0|||
154928855|NCT00769132|559163734|FG001|Period 2|Withdrawal by Subject|0|||
154928856|NCT00769132|559163735|FG002|Period 2|Withdrawal by Subject|0|||
154928857|NCT00769132|559163736|FG003|Period 2|Withdrawal by Subject|1|||
154928858|NCT00769132|559163733|FG000|Period 3|Withdrawal by Subject|1|||
154928859|NCT00769132|559163734|FG001|Period 3|Withdrawal by Subject|0|||
154928860|NCT00769132|559163735|FG002|Period 3|Withdrawal by Subject|0|||
154928861|NCT00769132|559163736|FG003|Period 3|Withdrawal by Subject|0|||
154928862|NCT00769132|559163733|FG000|Period 4|Withdrawal by Subject|0|||
154928863|NCT00769132|559163734|FG001|Period 4|Withdrawal by Subject|1|||
154928864|NCT00769132|559163735|FG002|Period 4|Withdrawal by Subject|0|||
154928865|NCT00769132|559163736|FG003|Period 4|Withdrawal by Subject|0|||
154928866|NCT00499252|559163737|FG000|Overall Study|Adverse Event|3|||
154928867|NCT00499252|559163737|FG000|Overall Study|Refused further treatment|2|||
154928868|NCT00499252|559163737|FG000|Overall Study|Ineligible|4|||
154928869|NCT00499252|559163737|FG000|Overall Study|<no further label>|3|||
154928870|NCT01257737|559163739|FG000|Overall Study|Lost to Follow-up|1|||
154928871|NCT01257737|559163740|FG001|Overall Study|Lost to Follow-up|2|||
154928872|NCT01257737|559163739|FG000|Overall Study|Liver transplant|1|||
154928873|NCT01257737|559163740|FG001|Overall Study|Liver transplant|0|||
154928874|NCT01257737|559163739|FG000|Overall Study|Relocation out of the country|0|||
154928875|NCT01257737|559163740|FG001|Overall Study|Relocation out of the country|1|||
154928876|NCT01257737|559163739|FG000|Overall Study|Withdrew from study|0|||
154928877|NCT01257737|559163740|FG001|Overall Study|Withdrew from study|1|||
154928878|NCT00938015|559163751|FG000|Overall Study|Death|2|||
154928879|NCT00938015|559163751|FG000|Overall Study|Lost to Follow-up|32|||
154928880|NCT00938015|559163751|FG000|Overall Study|Adverse Event|32|||
154928881|NCT00938015|559163751|FG000|Overall Study|Non-responder|52|||
154928882|NCT00938015|559163751|FG000|Overall Study|Reason not related to Etanercept|29|||
154928883|NCT00664066|559163753|FG000|Overall Study|Study terminated|3|||
154928884|NCT02575807|559163755|FG000|Overall Study|Death|8|||
154928885|NCT02575807|559163756|FG001|Overall Study|Death|3|||
154928886|NCT02575807|559163757|FG002|Overall Study|Death|7|||
154928887|NCT02575807|559163758|FG003|Overall Study|Death|0|||
154928888|NCT02575807|559163759|FG004|Overall Study|Death|1|||
154928889|NCT02575807|559163755|FG000|Overall Study|Study terminated by Sponsor|0|||
154928890|NCT02575807|559163756|FG001|Overall Study|Study terminated by Sponsor|1|||
154928891|NCT02575807|559163757|FG002|Overall Study|Study terminated by Sponsor|7|||
154928892|NCT02575807|559163758|FG003|Overall Study|Study terminated by Sponsor|0|||
154928893|NCT02575807|559163759|FG004|Overall Study|Study terminated by Sponsor|1|||
154928894|NCT02575807|559163755|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
154928895|NCT02575807|559163756|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
154928896|NCT02575807|559163757|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
154928897|NCT02575807|559163758|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
154928898|NCT02575807|559163759|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
154928899|NCT02575807|559163755|FG000|Overall Study|Terminated due to physician decision|0|||
154928900|NCT02575807|559163756|FG001|Overall Study|Terminated due to physician decision|0|||
154928901|NCT02575807|559163757|FG002|Overall Study|Terminated due to physician decision|1|||
154928902|NCT02575807|559163758|FG003|Overall Study|Terminated due to physician decision|0|||
154928903|NCT02575807|559163759|FG004|Overall Study|Terminated due to physician decision|0|||
154928904|NCT02575807|559163755|FG000|Overall Study|Subject ineligible - medical implant|0|||
154928905|NCT02575807|559163756|FG001|Overall Study|Subject ineligible - medical implant|0|||
154928906|NCT02575807|559163757|FG002|Overall Study|Subject ineligible - medical implant|0|||
154928907|NCT02575807|559163758|FG003|Overall Study|Subject ineligible - medical implant|1|||
154928908|NCT02575807|559163759|FG004|Overall Study|Subject ineligible - medical implant|0|||
154928909|NCT02575807|559163755|FG000|Overall Study|Withdrawal by Subject|0|||
154928910|NCT02575807|559163756|FG001|Overall Study|Withdrawal by Subject|0|||
154928911|NCT02575807|559163757|FG002|Overall Study|Withdrawal by Subject|1|||
154928912|NCT02575807|559163758|FG003|Overall Study|Withdrawal by Subject|1|||
154928913|NCT02575807|559163759|FG004|Overall Study|Withdrawal by Subject|2|||
154928914|NCT02180659|559163760|FG000|Overall Study|Adverse Event|1|||
154928915|NCT02180659|559163761|FG001|Overall Study|Adverse Event|0|||
154928916|NCT02180659|559163760|FG000|Overall Study|Lost to Follow-up|4|||
154928917|NCT02180659|559163761|FG001|Overall Study|Lost to Follow-up|2|||
154928918|NCT02180659|559163760|FG000|Overall Study|Subject incarcerated during conduct|1|||
154928919|NCT02180659|559163761|FG001|Overall Study|Subject incarcerated during conduct|0|||
154928920|NCT02180659|559163760|FG000|Overall Study|Withdrawal by Subject|0|||
154928921|NCT02180659|559163761|FG001|Overall Study|Withdrawal by Subject|2|||
154928922|NCT02180659|559163760|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
154928923|NCT02180659|559163761|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
154928924|NCT03000075|559163762|FG000|Part A|Adverse Event|4|||
154928925|NCT03000075|559163763|FG001|Part A|Adverse Event|0|||
154928926|NCT03000075|559163764|FG002|Part A|Adverse Event|0|||
154928927|NCT03000075|559163765|FG003|Part A|Adverse Event|0|||
154928928|NCT03000075|559163766|FG004|Part A|Adverse Event|0|||
154928929|NCT03000075|559163767|FG005|Part A|Adverse Event|0|||
154928930|NCT03000075|559163768|FG006|Part A|Adverse Event|0|||
154928931|NCT03000075|559163762|FG000|Part B|Not dosed due to AE|0|||
154928932|NCT03000075|559163763|FG001|Part B|Not dosed due to AE|0|||
154928933|NCT03000075|559163764|FG002|Part B|Not dosed due to AE|0|||
154928934|NCT03000075|559163765|FG003|Part B|Not dosed due to AE|0|||
154928935|NCT03000075|559163766|FG004|Part B|Not dosed due to AE|0|||
154928936|NCT03000075|559163767|FG005|Part B|Not dosed due to AE|2|||
154928937|NCT03000075|559163768|FG006|Part B|Not dosed due to AE|1|||
154928938|NCT03000075|559163762|FG000|Part B|Adverse Event|0|||
154928939|NCT03000075|559163763|FG001|Part B|Adverse Event|0|||
154928940|NCT03000075|559163764|FG002|Part B|Adverse Event|0|||
154928941|NCT03000075|559163765|FG003|Part B|Adverse Event|0|||
154928942|NCT03000075|559163766|FG004|Part B|Adverse Event|1|||
154928943|NCT03000075|559163767|FG005|Part B|Adverse Event|0|||
154928944|NCT03000075|559163768|FG006|Part B|Adverse Event|0|||
154928945|NCT00440193|559163769|FG000|Treatment Period|Adverse Event|74|||
154928946|NCT00440193|559163770|FG001|Treatment Period|Adverse Event|67|||
154928947|NCT00440193|559163769|FG000|Treatment Period|Death|19|||
154928948|NCT00440193|559163770|FG001|Treatment Period|Death|22|||
154928949|NCT00440193|559163769|FG000|Treatment Period|Lack of Efficacy|0|||
155042601|NCT01810783|559586777|FG000|Overall Study|Adverse Event|32|||
154928950|NCT00440193|559163770|FG001|Treatment Period|Lack of Efficacy|1|||
154928951|NCT00440193|559163769|FG000|Treatment Period|Lost to Follow-up|12|||
154928952|NCT00440193|559163770|FG001|Treatment Period|Lost to Follow-up|18|||
154928953|NCT00440193|559163769|FG000|Treatment Period|Physician Decision|3|||
155042602|NCT01810783|559586777|FG000|Overall Study|Withdrawal by Subject|22|||
155042603|NCT01810783|559586777|FG000|Overall Study|Lack of Efficacy|12|||
155042604|NCT01810783|559586777|FG000|Overall Study|Lost to Follow-up|10|||
155042605|NCT01810783|559586777|FG000|Overall Study|Protocol Violation|5|||
155042606|NCT01810783|559586777|FG000|Overall Study|Non-compliance with IMP|4|||
155042607|NCT01810783|559586777|FG000|Overall Study|Adminstrative or other reason(s)|23|||
155042608|NCT01810783|559586777|FG000|Overall Study|Enrolled, not treated|1|||
155042609|NCT00793546|559586778|FG000|Overall Study|Death|3|||
155042610|NCT00793546|559586779|FG001|Overall Study|Death|0|||
155042611|NCT00793546|559586778|FG000|Overall Study|Lost to Follow-up|1|||
155042612|NCT00793546|559586779|FG001|Overall Study|Lost to Follow-up|0|||
155042613|NCT00793546|559586778|FG000|Overall Study|Withdrawal by Subject|1|||
155042614|NCT00793546|559586779|FG001|Overall Study|Withdrawal by Subject|1|||
155042615|NCT00793546|559586778|FG000|Overall Study|Study Terminated by Sponsor|8|||
155042616|NCT00793546|559586779|FG001|Overall Study|Study Terminated by Sponsor|27|||
155042617|NCT00793546|559586778|FG000|Overall Study|Other|1|||
155042618|NCT00793546|559586779|FG001|Overall Study|Other|0|||
155042619|NCT00494221|559586780|FG000|Overall Study|Death|15|||
155042620|NCT00494221|559586781|FG001|Overall Study|Death|9|||
155042621|NCT00494221|559586782|FG002|Overall Study|Death|14|||
155042622|NCT00494221|559586780|FG000|Overall Study|Withdrawal by Subject|1|||
155042623|NCT00494221|559586781|FG001|Overall Study|Withdrawal by Subject|2|||
155042624|NCT00494221|559586782|FG002|Overall Study|Withdrawal by Subject|0|||
155042625|NCT02732327|559586783|FG000|Overall Study|Protocol Violation|0|||
155042626|NCT02732327|559586784|FG001|Overall Study|Protocol Violation|1|||
155042627|NCT02306694|559586785|FG000|Overall Study|Withdrawal by Subject|3|||
155042628|NCT02306694|559586785|FG000|Overall Study|Lost to Follow-up|1|||
155042629|NCT01573754|559586793|FG000|Overall Study|Noncompliance or remission not achieved|3|||
155042630|NCT01573754|559586794|FG001|Overall Study|Noncompliance or remission not achieved|15|||
155042631|NCT01738191|559586795|FG000|Overall Study|Withdrawal by Subject|4|||
155042632|NCT01738191|559586796|FG001|Overall Study|Withdrawal by Subject|1|||
155042633|NCT02483572|559586797|FG000|Overall Study|Withdrawal by Subject|1|||
155042634|NCT02483572|559586798|FG001|Overall Study|Withdrawal by Subject|0|||
155042635|NCT02483572|559586797|FG000|Overall Study|Lost to Follow-up|1|||
155152842|NCT04764162|559996956|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
155381640|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
155381641|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
155381642|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
155381643|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
155381644|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
155381645|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
155381646|NCT03149549|560830963|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
155381647|NCT03149549|560830964|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
155381648|NCT03149549|560830965|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
155381649|NCT03149549|560830966|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
155381650|NCT03149549|560830967|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
155381651|NCT03149549|560830968|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
155381652|NCT03149549|560830969|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
154928954|NCT00440193|559163770|FG001|Treatment Period|Physician Decision|6|||
154928955|NCT00440193|559163769|FG000|Treatment Period|Protocol Violation|16|||
154928956|NCT00440193|559163770|FG001|Treatment Period|Protocol Violation|19|||
155152843|NCT03361137|559996957|FG000|Overall Study|Reason not specified|1|||
155152844|NCT03361137|559996958|FG001|Overall Study|Reason not specified|0|||
155152845|NCT03361137|559996959|FG002|Overall Study|Reason not specified|0|||
155152846|NCT03361137|559996960|FG003|Overall Study|Reason not specified|0|||
155152847|NCT03361137|559996961|FG004|Overall Study|Reason not specified|0|||
155152848|NCT03009058|559996964|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
155152849|NCT05556265|559996965|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155152850|NCT05556265|559996966|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
155152851|NCT05556265|559996967|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155152852|NCT05556265|559996968|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
154928957|NCT00440193|559163769|FG000|Treatment Period|Withdrawal by Subject|36|||
155042636|NCT02483572|559586798|FG001|Overall Study|Lost to Follow-up|0|||
155152853|NCT05556265|559996969|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
155152854|NCT05556265|559996965|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155152855|NCT05556265|559996966|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
155381653|NCT03149549|560830970|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
155381654|NCT03149549|560830971|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
155042637|NCT02483572|559586797|FG000|Overall Study|Physician Decision|0|||
155381655|NCT03149549|560830972|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
154928958|NCT00440193|559163770|FG001|Treatment Period|Withdrawal by Subject|77|||
154928959|NCT00440193|559163769|FG000|Treatment Period|Clinical endpoint reached|28|||
154928960|NCT00440193|559163770|FG001|Treatment Period|Clinical endpoint reached|25|||
154928961|NCT00440193|559163769|FG000|Treatment Period|Study terminated by sponsor|102|||
154928962|NCT00440193|559163770|FG001|Treatment Period|Study terminated by sponsor|94|||
154928963|NCT00440193|559163769|FG000|Treatment Period|Protocol driven decision point|2|||
154928964|NCT00440193|559163770|FG001|Treatment Period|Protocol driven decision point|2|||
154928965|NCT00440193|559163769|FG000|Treatment Period|Switch to commercial drug|0|||
154928966|NCT00440193|559163770|FG001|Treatment Period|Switch to commercial drug|2|||
154928967|NCT00440193|559163769|FG000|Treatment Period|Technical problems|1|||
154928968|NCT00440193|559163770|FG001|Treatment Period|Technical problems|1|||
154928969|NCT00440193|559163769|FG000|Treatment Period|Participant convenience|5|||
154928970|NCT00440193|559163770|FG001|Treatment Period|Participant convenience|2|||
154928971|NCT00440193|559163769|FG000|Treatment Period|Participant did not receive treatment|7|||
154928972|NCT00440193|559163770|FG001|Treatment Period|Participant did not receive treatment|13|||
154928973|NCT00440193|559163769|FG000|Treatment Period|Site closed by investigator|0|||
154928974|NCT00440193|559163770|FG001|Treatment Period|Site closed by investigator|2|||
154928975|NCT00440193|559163769|FG000|Observational Period|Adverse Event|2|||
154928976|NCT00440193|559163770|FG001|Observational Period|Adverse Event|2|||
154928977|NCT00440193|559163769|FG000|Observational Period|Death|15|||
154928978|NCT00440193|559163770|FG001|Observational Period|Death|20|||
154928979|NCT00440193|559163769|FG000|Observational Period|Lost to Follow-up|12|||
154928980|NCT00440193|559163770|FG001|Observational Period|Lost to Follow-up|8|||
154928981|NCT00440193|559163769|FG000|Observational Period|Protocol Violation|1|||
154928982|NCT00440193|559163770|FG001|Observational Period|Protocol Violation|0|||
154928983|NCT00440193|559163769|FG000|Observational Period|Withdrawal by Subject|11|||
154928984|NCT00440193|559163770|FG001|Observational Period|Withdrawal by Subject|8|||
154928985|NCT00440193|559163769|FG000|Observational Period|Physician Decision|1|||
154928986|NCT00440193|559163770|FG001|Observational Period|Physician Decision|0|||
154928987|NCT00440193|559163769|FG000|Observational Period|Clinical endpoint reached|1|||
154928988|NCT00440193|559163770|FG001|Observational Period|Clinical endpoint reached|0|||
154928989|NCT00440193|559163769|FG000|Observational Period|Participant convenience|2|||
154928990|NCT00440193|559163770|FG001|Observational Period|Participant convenience|0|||
154928991|NCT00834366|559163771|FG000|Treatment Period 1|Adverse Event|1|||
154928992|NCT00834366|559163772|FG001|Treatment Period 1|Adverse Event|1|||
154928993|NCT03014570|559163773|FG000|Overall Study|COVID-19 Restrictions|38|||
154928994|NCT03014570|559163774|FG001|Overall Study|COVID-19 Restrictions|24|||
154928995|NCT03014570|559163773|FG000|Overall Study|Death|70|||
154928996|NCT03014570|559163774|FG001|Overall Study|Death|79|||
154928997|NCT03014570|559163773|FG000|Overall Study|Transfer from facility|11|||
154928998|NCT03014570|559163774|FG001|Overall Study|Transfer from facility|14|||
154928999|NCT03014570|559163773|FG000|Overall Study|Hospitalized|5|||
154929000|NCT03014570|559163774|FG001|Overall Study|Hospitalized|3|||
154929001|NCT03014570|559163773|FG000|Overall Study|Transfer within facility|1|||
154929002|NCT03014570|559163774|FG001|Overall Study|Transfer within facility|0|||
154929003|NCT03014570|559163773|FG000|Overall Study|Site refusal|0|||
154929004|NCT03014570|559163774|FG001|Overall Study|Site refusal|11|||
154929005|NCT01154673|559163780|FG000|Overall Study|Lost to Follow-up|1|||
154929006|NCT01154673|559163781|FG001|Overall Study|Lost to Follow-up|0|||
154929007|NCT01154673|559163780|FG000|Overall Study|moved out of province|1|||
154929008|NCT01154673|559163781|FG001|Overall Study|moved out of province|0|||
154929009|NCT00518011|559163782|FG000|Overall Study|Death|1|||
154929010|NCT00518011|559163783|FG001|Overall Study|Death|1|||
154929011|NCT00518011|559163782|FG000|Overall Study|Adverse Event|2|||
154929012|NCT00518011|559163783|FG001|Overall Study|Adverse Event|3|||
154929013|NCT00518011|559163782|FG000|Overall Study|Disease Progression|2|||
154929014|NCT00518011|559163783|FG001|Overall Study|Disease Progression|2|||
154929015|NCT00518011|559163782|FG000|Overall Study|Other Reasons|3|||
154929016|NCT00518011|559163783|FG001|Overall Study|Other Reasons|2|||
154929017|NCT00518011|559163782|FG000|Overall Study|Withdrawal by Subject|1|||
154929018|NCT00518011|559163783|FG001|Overall Study|Withdrawal by Subject|0|||
154929019|NCT00090259|559163784|FG000|Overall Study|Lost to Follow-up|30|||
154929020|NCT00090259|559163785|FG001|Overall Study|Lost to Follow-up|26|||
154929021|NCT00090259|559163784|FG000|Overall Study|Withdrawal by Subject|21|||
154929022|NCT00090259|559163785|FG001|Overall Study|Withdrawal by Subject|15|||
154929023|NCT00090259|559163784|FG000|Overall Study|Investigator site closed|11|||
154929024|NCT00090259|559163785|FG001|Overall Study|Investigator site closed|7|||
154929025|NCT04797637|559163787|FG000|Overall Study|Lost to Follow-up|23|||
154929026|NCT04797637|559163788|FG001|Overall Study|Lost to Follow-up|32|||
154929027|NCT04797637|559163787|FG000|Overall Study|Withdrawal by Subject|0|||
154929028|NCT04797637|559163788|FG001|Overall Study|Withdrawal by Subject|1|||
154929029|NCT03083639|559163789|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
154929030|NCT03083639|559163790|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
154929031|NCT03083639|559163789|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
154929032|NCT03083639|559163790|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
154929033|NCT00960687|559163794|FG000|Washout Period of 7 Days|Adverse Event|3|||
154929034|NCT00960687|559163795|FG001|Washout Period of 7 Days|Adverse Event|2|||
154929035|NCT00960687|559163794|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
154929036|NCT00960687|559163795|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
154929037|NCT00865306|559163796|FG000|Controlled Trial|Lost to Follow-up|1|||
154929038|NCT00865306|559163797|FG001|Controlled Trial|Lost to Follow-up|1|||
154929039|NCT00865306|559163796|FG000|Controlled Trial|Difficulty commuting|2|||
154929040|NCT00865306|559163797|FG001|Controlled Trial|Difficulty commuting|0|||
154929041|NCT00865306|559163796|FG000|Controlled Trial|Improved btw baseline and first session|1|||
154929042|NCT00865306|559163797|FG001|Controlled Trial|Improved btw baseline and first session|0|||
154929043|NCT00865306|559163796|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
154929044|NCT00865306|559163797|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
154929045|NCT00865306|559163796|FG000|Controlled Trial|Withdrawal by Subject|0|||
154929046|NCT00865306|559163797|FG001|Controlled Trial|Withdrawal by Subject|1|||
154929047|NCT01216319|559163798|FG000|Overall Study|Lost to Follow-up|2|||
154929048|NCT01216319|559163798|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
154929049|NCT01023022|559163802|FG000|Overall Study|Death|5|||
154929050|NCT01023022|559163802|FG000|Overall Study|Lost to Follow-up|7|||
154929051|NCT01023022|559163802|FG000|Overall Study|due to technical issues|2|||
154929052|NCT03728257|559163803|FG000|Overall Study|Death|3|||
154929053|NCT03728257|559163804|FG001|Overall Study|Death|0|||
154929054|NCT03239340|559163805|FG000|Overall Study|Other|26|||
154929055|NCT03239340|559163805|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
154929056|NCT03239340|559163805|FG000|Overall Study|Death|40|||
154929057|NCT03239340|559163805|FG000|Overall Study|Lost to Follow-up|2|||
154929058|NCT03239340|559163805|FG000|Overall Study|Physician Decision|16|||
154929059|NCT03239340|559163805|FG000|Overall Study|Withdrawal by Subject|27|||
154929060|NCT02332655|559163816|FG000|Overall Study|Lack of Efficacy|1|||
154929061|NCT01843660|559163817|FG000|Overall Study|Other|30|||
154929062|NCT01977482|559163818|FG000|Overall Study|Adverse Event|0|||
154929063|NCT01977482|559163819|FG001|Overall Study|Adverse Event|1|||
154929064|NCT01977482|559163820|FG002|Overall Study|Adverse Event|1|||
154929065|NCT01977482|559163821|FG003|Overall Study|Adverse Event|0|||
154929066|NCT01977482|559163822|FG004|Overall Study|Adverse Event|2|||
154929067|NCT01977482|559163823|FG005|Overall Study|Adverse Event|0|||
154929068|NCT01977482|559163818|FG000|Overall Study|Lost to Follow-up|1|||
154929069|NCT01977482|559163819|FG001|Overall Study|Lost to Follow-up|0|||
154929070|NCT01977482|559163820|FG002|Overall Study|Lost to Follow-up|0|||
154929071|NCT01977482|559163821|FG003|Overall Study|Lost to Follow-up|0|||
154929072|NCT01977482|559163822|FG004|Overall Study|Lost to Follow-up|0|||
154929073|NCT01977482|559163823|FG005|Overall Study|Lost to Follow-up|0|||
154929074|NCT01977482|559163818|FG000|Overall Study|Physician Decision|0|||
154929075|NCT01977482|559163819|FG001|Overall Study|Physician Decision|1|||
154929076|NCT01977482|559163820|FG002|Overall Study|Physician Decision|0|||
154929077|NCT01977482|559163821|FG003|Overall Study|Physician Decision|0|||
154929078|NCT01977482|559163822|FG004|Overall Study|Physician Decision|0|||
154929079|NCT01977482|559163823|FG005|Overall Study|Physician Decision|0|||
154929080|NCT01977482|559163818|FG000|Overall Study|Protocol Violation|0|||
154929081|NCT01977482|559163819|FG001|Overall Study|Protocol Violation|0|||
154929082|NCT01977482|559163820|FG002|Overall Study|Protocol Violation|1|||
154929083|NCT01977482|559163821|FG003|Overall Study|Protocol Violation|0|||
154929084|NCT01977482|559163822|FG004|Overall Study|Protocol Violation|0|||
154929085|NCT01977482|559163823|FG005|Overall Study|Protocol Violation|0|||
154929086|NCT01977482|559163818|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
154929087|NCT01977482|559163819|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
154929088|NCT01977482|559163820|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
154929089|NCT01977482|559163821|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
154929090|NCT01977482|559163822|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
154929091|NCT01977482|559163823|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
154929092|NCT01977482|559163818|FG000|Overall Study|Withdrawal by Subject|2|||
154929093|NCT01977482|559163819|FG001|Overall Study|Withdrawal by Subject|4|||
154929094|NCT01977482|559163820|FG002|Overall Study|Withdrawal by Subject|1|||
154929095|NCT01977482|559163821|FG003|Overall Study|Withdrawal by Subject|3|||
154929096|NCT01977482|559163822|FG004|Overall Study|Withdrawal by Subject|1|||
154929097|NCT01977482|559163823|FG005|Overall Study|Withdrawal by Subject|5|||
154929098|NCT00209560|559163824|FG000|Overall Study|Lack of Efficacy|1|||
154929099|NCT00209560|559163825|FG001|Overall Study|Lack of Efficacy|0|||
154929100|NCT01525407|559163832|FG000|Overall Study|Change in recipient treatment plan|2|||
154929101|NCT01525407|559163833|FG001|Overall Study|Change in recipient treatment plan|2|||
154929102|NCT01525407|559163832|FG000|Overall Study|Withdrawal by Subject|0|||
154929103|NCT01525407|559163833|FG001|Overall Study|Withdrawal by Subject|1|||
154929104|NCT01525407|559163832|FG000|Overall Study|Transplant was delayed|0|||
154929105|NCT01525407|559163833|FG001|Overall Study|Transplant was delayed|1|||
154929106|NCT01525407|559163832|FG000|Overall Study|Delay in Transplant|1|||
154929107|NCT01525407|559163833|FG001|Overall Study|Delay in Transplant|0|||
155152856|NCT05556265|559996967|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
154929108|NCT03256526|559165030|FG000|Overall Study|Adverse Event|1|||
154929109|NCT03256526|559165031|FG001|Overall Study|Adverse Event|0|||
154929110|NCT03256526|559165032|FG002|Overall Study|Adverse Event|1|||
154929111|NCT03256526|559165030|FG000|Overall Study|Lost to Follow-up|1|||
154929112|NCT03256526|559165031|FG001|Overall Study|Lost to Follow-up|0|||
154929113|NCT03256526|559165032|FG002|Overall Study|Lost to Follow-up|2|||
154929114|NCT01607398|559165033|FG000|Overall Study|Adverse Event|0|||
154929115|NCT01607398|559165034|FG001|Overall Study|Adverse Event|2|||
154929116|NCT01607398|559165033|FG000|Overall Study|Severe COPD|2|||
154929117|NCT01607398|559165034|FG001|Overall Study|Severe COPD|0|||
154929118|NCT02325401|559165038|FG000|Overall Study|Withdrawal by Subject|0|||
154929119|NCT02325401|559165039|FG001|Overall Study|Withdrawal by Subject|1|||
154929120|NCT02325401|559165040|FG002|Overall Study|Withdrawal by Subject|1|||
154929121|NCT02428231|559165043|FG000|Overall Study|Other|10|||
154929122|NCT02428231|559165044|FG001|Overall Study|Other|16|||
154929123|NCT02428231|559165043|FG000|Overall Study|Required Symptomatic Therapy|0|||
154929124|NCT02428231|559165044|FG001|Overall Study|Required Symptomatic Therapy|1|||
154929125|NCT02428231|559165043|FG000|Overall Study|Adverse Event|3|||
154929126|NCT02428231|559165044|FG001|Overall Study|Adverse Event|0|||
154929127|NCT00602979|559165047|FG000|Overall Study|Lost to Follow-up|3|||
154929128|NCT00602979|559165048|FG001|Overall Study|Lost to Follow-up|2|||
154929129|NCT00602979|559165049|FG002|Overall Study|Lost to Follow-up|3|||
154929130|NCT00602979|559165050|FG003|Overall Study|Lost to Follow-up|2|||
154929131|NCT00602979|559165051|FG004|Overall Study|Lost to Follow-up|3|||
154929132|NCT00602979|559165047|FG000|Overall Study|Failed Intubation|0|||
154929133|NCT00602979|559165048|FG001|Overall Study|Failed Intubation|1|||
154929134|NCT00602979|559165049|FG002|Overall Study|Failed Intubation|0|||
154929135|NCT00602979|559165050|FG003|Overall Study|Failed Intubation|1|||
154929136|NCT00602979|559165051|FG004|Overall Study|Failed Intubation|0|||
154929137|NCT03976076|559165052|FG000|Overall Study|Withdrawal by Subject|2|||
154929138|NCT02406742|559165053|FG000|Overall Study|Progression of Disease|5|||
154929139|NCT02406742|559165054|FG001|Overall Study|Progression of Disease|1|||
154929140|NCT02406742|559165055|FG002|Overall Study|Progression of Disease|6|||
154929141|NCT02406742|559165053|FG000|Overall Study|Adverse Event|3|||
154929142|NCT02406742|559165054|FG001|Overall Study|Adverse Event|0|||
154929143|NCT02406742|559165055|FG002|Overall Study|Adverse Event|2|||
154929144|NCT02406742|559165053|FG000|Overall Study|Death|1|||
154929145|NCT02406742|559165054|FG001|Overall Study|Death|0|||
154929146|NCT02406742|559165055|FG002|Overall Study|Death|0|||
154929147|NCT02406742|559165053|FG000|Overall Study|Lack of Efficacy|0|||
154929148|NCT02406742|559165054|FG001|Overall Study|Lack of Efficacy|0|||
154929149|NCT02406742|559165055|FG002|Overall Study|Lack of Efficacy|1|||
154929150|NCT02406742|559165053|FG000|Overall Study|Withdrawal by Participant|1|||
154929151|NCT02406742|559165054|FG001|Overall Study|Withdrawal by Participant|2|||
154929152|NCT02406742|559165055|FG002|Overall Study|Withdrawal by Participant|0|||
154929153|NCT02406742|559165053|FG000|Overall Study|Physician Decision|1|||
154929154|NCT02406742|559165054|FG001|Overall Study|Physician Decision|2|||
154929155|NCT02406742|559165055|FG002|Overall Study|Physician Decision|1|||
154929156|NCT02406742|559165053|FG000|Overall Study|Transition to other treatment|2|||
154929157|NCT02406742|559165054|FG001|Overall Study|Transition to other treatment|0|||
154929158|NCT02406742|559165055|FG002|Overall Study|Transition to other treatment|1|||
154929159|NCT02406742|559165053|FG000|Overall Study|Other Reasons|1|||
154929160|NCT02406742|559165054|FG001|Overall Study|Other Reasons|11|||
154929161|NCT02406742|559165055|FG002|Overall Study|Other Reasons|5|||
154929162|NCT02367729|559165060|FG000|Overall Study|Organic disorder diagnosed|2|||
154929163|NCT02367729|559165061|FG001|Overall Study|Organic disorder diagnosed|1|||
154929164|NCT02367729|559165060|FG000|Overall Study|Adverse Event|1|||
154929165|NCT02367729|559165061|FG001|Overall Study|Adverse Event|2|||
154929166|NCT02367729|559165060|FG000|Overall Study|Withdrawal by Subject|0|||
154929167|NCT02367729|559165061|FG001|Overall Study|Withdrawal by Subject|5|||
154929168|NCT00457418|559165071|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
155152857|NCT05556265|559996968|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155152858|NCT05556265|559996969|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
155152859|NCT05556265|559996965|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155152860|NCT05556265|559996966|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
155152861|NCT05556265|559996967|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155152862|NCT05556265|559996968|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155152863|NCT05556265|559996969|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
155152864|NCT05556265|559996965|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
155152865|NCT05556265|559996966|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
155152866|NCT05556265|559996967|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
155152867|NCT05556265|559996968|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
155152868|NCT05556265|559996969|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
155152869|NCT05556265|559996965|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
155152870|NCT05556265|559996966|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
154929169|NCT00457418|559165071|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
154929170|NCT00457418|559165071|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
154929171|NCT00457418|559165071|FG000|Post PK Maintenance|Adverse Event|10|||
154929172|NCT00457418|559165071|FG000|Post PK Maintenance|Progression of Disease|6|||
154929173|NCT00457418|559165071|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
155042638|NCT02483572|559586798|FG001|Overall Study|Physician Decision|1|||
155042639|NCT00350779|559586799|FG000|Overall Study|Adverse Event|4|||
155042640|NCT00350779|559586800|FG001|Overall Study|Adverse Event|2|||
155042641|NCT00350779|559586799|FG000|Overall Study|Lack of Efficacy|0|||
155042642|NCT00350779|559586800|FG001|Overall Study|Lack of Efficacy|4|||
155042643|NCT00350779|559586799|FG000|Overall Study|Lost to Follow-up|2|||
155042644|NCT00350779|559586800|FG001|Overall Study|Lost to Follow-up|0|||
155042645|NCT00350779|559586799|FG000|Overall Study|Physician Decision|2|||
155042646|NCT00350779|559586800|FG001|Overall Study|Physician Decision|4|||
155042647|NCT00350779|559586799|FG000|Overall Study|Protocol Violation|3|||
155042648|NCT00350779|559586800|FG001|Overall Study|Protocol Violation|1|||
155042649|NCT00350779|559586799|FG000|Overall Study|Withdrawal by Subject|9|||
155042650|NCT00350779|559586800|FG001|Overall Study|Withdrawal by Subject|8|||
155042651|NCT00350779|559586799|FG000|Overall Study|Patient Moved|2|||
155042652|NCT00350779|559586800|FG001|Overall Study|Patient Moved|1|||
155042653|NCT00350779|559586799|FG000|Overall Study|Non-compliance with study procedures|0|||
155042654|NCT00350779|559586800|FG001|Overall Study|Non-compliance with study procedures|1|||
155042655|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
155042656|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042657|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042658|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042659|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042660|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042661|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042662|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042663|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
155042664|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155042665|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
155042666|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
154929174|NCT00457418|559165071|FG000|Post PK Maintenance|Lost to Follow-up|1|||
154929175|NCT01785472|559165072|FG000|Overall Study|Adverse Event|5|||
154929176|NCT01785472|559165073|FG001|Overall Study|Adverse Event|4|||
154929177|NCT01785472|559165074|FG002|Overall Study|Adverse Event|6|||
154929178|NCT01785472|559165072|FG000|Overall Study|Lack of Efficacy|2|||
154929179|NCT01785472|559165073|FG001|Overall Study|Lack of Efficacy|0|||
154929180|NCT01785472|559165074|FG002|Overall Study|Lack of Efficacy|1|||
154929181|NCT01785472|559165072|FG000|Overall Study|Lost to Follow-up|1|||
154929182|NCT01785472|559165073|FG001|Overall Study|Lost to Follow-up|2|||
154929183|NCT01785472|559165074|FG002|Overall Study|Lost to Follow-up|0|||
154929184|NCT01785472|559165072|FG000|Overall Study|Physician Decision|1|||
154929185|NCT01785472|559165073|FG001|Overall Study|Physician Decision|1|||
154929186|NCT01785472|559165074|FG002|Overall Study|Physician Decision|1|||
154929187|NCT01785472|559165072|FG000|Overall Study|Protocol deviation|0|||
154929188|NCT01785472|559165073|FG001|Overall Study|Protocol deviation|2|||
154929189|NCT01785472|559165074|FG002|Overall Study|Protocol deviation|2|||
154929190|NCT01785472|559165072|FG000|Overall Study|Subject/guardian decision|15|||
154929191|NCT01785472|559165073|FG001|Overall Study|Subject/guardian decision|10|||
154929192|NCT01785472|559165074|FG002|Overall Study|Subject/guardian decision|11|||
154929193|NCT01785472|559165072|FG000|Overall Study|Technical problems|0|||
154929194|NCT01785472|559165073|FG001|Overall Study|Technical problems|0|||
154929195|NCT01785472|559165074|FG002|Overall Study|Technical problems|1|||
154929196|NCT02086968|559165075|FG000|Overall Study|Adverse Event|1|||
154929197|NCT02086968|559165076|FG001|Overall Study|Adverse Event|5|||
154929198|NCT02086968|559165075|FG000|Overall Study|Lost to Follow-up|2|||
154929199|NCT02086968|559165076|FG001|Overall Study|Lost to Follow-up|3|||
154929200|NCT02086968|559165075|FG000|Overall Study|Study drug received outside protocol|0|||
154929201|NCT02086968|559165076|FG001|Overall Study|Study drug received outside protocol|1|||
154929202|NCT02086968|559165075|FG000|Overall Study|Physician Decision|4|||
154929203|NCT02086968|559165076|FG001|Overall Study|Physician Decision|0|||
154929204|NCT02086968|559165075|FG000|Overall Study|Withdrawal by Subject|1|||
154929205|NCT02086968|559165076|FG001|Overall Study|Withdrawal by Subject|4|||
154929206|NCT03359473|559165080|FG000|Overall Study|Adverse Event|0|||
154929207|NCT03359473|559165081|FG001|Overall Study|Adverse Event|2|||
154929208|NCT03359473|559165082|FG002|Overall Study|Adverse Event|5|||
154929209|NCT03359473|559165083|FG003|Overall Study|Adverse Event|3|||
154929210|NCT03359473|559165080|FG000|Overall Study|Lost to Follow-up|0|||
155042667|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
155042668|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155042669|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
155042670|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
155152871|NCT05556265|559996967|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
155152872|NCT05556265|559996968|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
155152873|NCT05556265|559996969|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
155381656|NCT03149549|560830973|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
155381657|NCT03149549|560830974|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
155381658|NCT03149549|560830975|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
155381659|NCT01892540|560830976|FG000|Overall Study|Did not complete PET/MRI|0|||
155381660|NCT01892540|560830977|FG001|Overall Study|Did not complete PET/MRI|0|||
155381661|NCT01892540|560830978|FG002|Overall Study|Did not complete PET/MRI|2|||
155381662|NCT01892540|560830976|FG000|Overall Study|Did not fit in scanner|0|||
155381663|NCT01892540|560830977|FG001|Overall Study|Did not fit in scanner|0|||
155381664|NCT01892540|560830978|FG002|Overall Study|Did not fit in scanner|1|||
155381665|NCT01370590|560830979|FG000|Period 1|Adverse Event|8|||
155381666|NCT01370590|560830980|FG001|Period 1|Adverse Event|4|||
155381667|NCT01370590|560830979|FG000|Period 1|Lost to Follow-up|2|||
155381668|NCT01370590|560830980|FG001|Period 1|Lost to Follow-up|2|||
155381669|NCT01370590|560830979|FG000|Period 1|Protocol Violation|2|||
155381670|NCT01370590|560830980|FG001|Period 1|Protocol Violation|2|||
155381671|NCT01370590|560830979|FG000|Period 1|Withdrawal by Subject|4|||
155381672|NCT01370590|560830980|FG001|Period 1|Withdrawal by Subject|2|||
155381673|NCT01370590|560830979|FG000|Period 1|Could not access randomization system|0|||
155381674|NCT01370590|560830980|FG001|Period 1|Could not access randomization system|1|||
155381675|NCT01370590|560830979|FG000|Crossover Washout Period|Adverse Event|1|||
155381676|NCT01370590|560830980|FG001|Crossover Washout Period|Adverse Event|4|||
155381677|NCT01370590|560830979|FG000|Crossover Washout Period|Lost to Follow-up|2|||
155381678|NCT01370590|560830980|FG001|Crossover Washout Period|Lost to Follow-up|0|||
155381679|NCT01370590|560830979|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
155381680|NCT01370590|560830980|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
155381681|NCT01370590|560830979|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
155381682|NCT01370590|560830980|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
155381683|NCT01370590|560830979|FG000|Period 2|Adverse Event|0|||
155381684|NCT01370590|560830980|FG001|Period 2|Adverse Event|1|||
155381685|NCT01370590|560830979|FG000|Period 2|Withdrawal by Subject|1|||
154929211|NCT03359473|559165081|FG001|Overall Study|Lost to Follow-up|1|||
155042671|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155042672|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
155042673|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
155042674|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
155042675|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
155042676|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
155042677|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
155042678|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
155042679|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
155042680|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
155042681|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
155042682|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
155042683|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
155042684|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
155042685|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
155042686|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
155042687|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
155042688|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
155042689|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
155152874|NCT05556265|559996965|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
155152875|NCT05556265|559996966|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
155152876|NCT05556265|559996967|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
155152877|NCT05556265|559996968|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
155152878|NCT05556265|559996969|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
155152879|NCT05556265|559996965|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
155152880|NCT05556265|559996966|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
155381686|NCT01370590|560830980|FG001|Period 2|Withdrawal by Subject|1|||
155381687|NCT04617275|560830984|FG000|Treatment Period|Adverse Event|1|||
155381688|NCT04617275|560830985|FG001|Treatment Period|Adverse Event|6|||
155381689|NCT04617275|560830986|FG002|Treatment Period|Adverse Event|4|||
155381690|NCT04617275|560830987|FG003|Treatment Period|Adverse Event|6|||
155381691|NCT04617275|560830988|FG004|Treatment Period|Adverse Event|7|||
155381692|NCT04617275|560830989|FG005|Treatment Period|Adverse Event|8|||
155381693|NCT04617275|560830990|FG006|Treatment Period|Adverse Event|0|||
155381694|NCT04617275|560830991|FG007|Treatment Period|Adverse Event|12|||
155381695|NCT04617275|560830984|FG000|Treatment Period|Lost to Follow-up|0|||
154929212|NCT03359473|559165082|FG002|Overall Study|Lost to Follow-up|0|||
154929213|NCT03359473|559165083|FG003|Overall Study|Lost to Follow-up|0|||
154929214|NCT03359473|559165080|FG000|Overall Study|Physician Decision|0|||
154929215|NCT03359473|559165081|FG001|Overall Study|Physician Decision|1|||
154929216|NCT03359473|559165082|FG002|Overall Study|Physician Decision|0|||
154929217|NCT03359473|559165083|FG003|Overall Study|Physician Decision|1|||
154929218|NCT03359473|559165080|FG000|Overall Study|Withdrawal by Subject|1|||
154929219|NCT03359473|559165081|FG001|Overall Study|Withdrawal by Subject|2|||
154929220|NCT03359473|559165082|FG002|Overall Study|Withdrawal by Subject|1|||
154929221|NCT03359473|559165083|FG003|Overall Study|Withdrawal by Subject|0|||
154929222|NCT03359473|559165080|FG000|Overall Study|Protocol-defined stopping criteria|1|||
154929223|NCT03359473|559165081|FG001|Overall Study|Protocol-defined stopping criteria|0|||
154929224|NCT03359473|559165082|FG002|Overall Study|Protocol-defined stopping criteria|0|||
154929225|NCT03359473|559165083|FG003|Overall Study|Protocol-defined stopping criteria|1|||
154929226|NCT04101721|559165085|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
154929227|NCT04101721|559165086|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
154929228|NCT04101721|559165085|FG000|Overall Study|Death|0|||
154929229|NCT04101721|559165086|FG001|Overall Study|Death|1|||
154929230|NCT04101721|559165085|FG000|Overall Study|Lost to Follow-up|0|||
154929231|NCT04101721|559165086|FG001|Overall Study|Lost to Follow-up|3|||
154929232|NCT01215955|559165087|FG000|Overall Study|Adverse Event|1|||
154929233|NCT01215955|559165088|FG001|Overall Study|Adverse Event|4|||
154929234|NCT01215955|559165089|FG002|Overall Study|Adverse Event|2|||
154929235|NCT01215955|559165090|FG003|Overall Study|Adverse Event|3|||
154929236|NCT01215955|559165087|FG000|Overall Study|Death|2|||
154929237|NCT01215955|559165088|FG001|Overall Study|Death|0|||
154929238|NCT01215955|559165089|FG002|Overall Study|Death|1|||
154929239|NCT01215955|559165090|FG003|Overall Study|Death|3|||
154929240|NCT01215955|559165087|FG000|Overall Study|Entry Criteria Not Met|1|||
154929241|NCT01215955|559165088|FG001|Overall Study|Entry Criteria Not Met|3|||
154929242|NCT01215955|559165089|FG002|Overall Study|Entry Criteria Not Met|4|||
154929243|NCT01215955|559165090|FG003|Overall Study|Entry Criteria Not Met|7|||
154929244|NCT01215955|559165087|FG000|Overall Study|Lack of Efficacy|1|||
154929245|NCT01215955|559165088|FG001|Overall Study|Lack of Efficacy|2|||
154929246|NCT01215955|559165089|FG002|Overall Study|Lack of Efficacy|1|||
154929247|NCT01215955|559165090|FG003|Overall Study|Lack of Efficacy|0|||
154929248|NCT01215955|559165087|FG000|Overall Study|Lost to Follow-up|4|||
154929249|NCT01215955|559165088|FG001|Overall Study|Lost to Follow-up|4|||
154929250|NCT01215955|559165089|FG002|Overall Study|Lost to Follow-up|8|||
154929251|NCT01215955|559165090|FG003|Overall Study|Lost to Follow-up|9|||
154929252|NCT01215955|559165087|FG000|Overall Study|Physician Decision|4|||
154929253|NCT01215955|559165088|FG001|Overall Study|Physician Decision|10|||
154929254|NCT01215955|559165089|FG002|Overall Study|Physician Decision|8|||
154929255|NCT01215955|559165090|FG003|Overall Study|Physician Decision|11|||
154929256|NCT01215955|559165087|FG000|Overall Study|Protocol Violation|17|||
154929257|NCT01215955|559165088|FG001|Overall Study|Protocol Violation|13|||
154929258|NCT01215955|559165089|FG002|Overall Study|Protocol Violation|8|||
154929259|NCT01215955|559165090|FG003|Overall Study|Protocol Violation|8|||
154929260|NCT01215955|559165087|FG000|Overall Study|Sponsor Decision|1|||
154929261|NCT01215955|559165088|FG001|Overall Study|Sponsor Decision|2|||
154929262|NCT01215955|559165089|FG002|Overall Study|Sponsor Decision|0|||
154929263|NCT01215955|559165090|FG003|Overall Study|Sponsor Decision|1|||
154929264|NCT01215955|559165087|FG000|Overall Study|Withdrawal by Subject|14|||
154929265|NCT01215955|559165088|FG001|Overall Study|Withdrawal by Subject|15|||
154929266|NCT01215955|559165089|FG002|Overall Study|Withdrawal by Subject|13|||
154929267|NCT01215955|559165090|FG003|Overall Study|Withdrawal by Subject|9|||
154929268|NCT01215955|559165087|FG000|Overall Study|Quality Issues|0|||
154929269|NCT01215955|559165088|FG001|Overall Study|Quality Issues|0|||
154929270|NCT01215955|559165089|FG002|Overall Study|Quality Issues|3|||
154929271|NCT01215955|559165090|FG003|Overall Study|Quality Issues|2|||
154929272|NCT00445458|559165091|FG000|Overall Study|Disease Progression|3|||
154929273|NCT00445458|559165092|FG001|Overall Study|Disease Progression|4|||
154929274|NCT00445458|559165093|FG002|Overall Study|Disease Progression|54|||
154929275|NCT00445458|559165094|FG003|Overall Study|Disease Progression|27|||
154929276|NCT00445458|559165091|FG000|Overall Study|Withdrawal by Subject|0|||
154929277|NCT00445458|559165092|FG001|Overall Study|Withdrawal by Subject|0|||
154929278|NCT00445458|559165093|FG002|Overall Study|Withdrawal by Subject|7|||
154929279|NCT00445458|559165094|FG003|Overall Study|Withdrawal by Subject|0|||
154929280|NCT00445458|559165091|FG000|Overall Study|Adverse Event|0|||
154929281|NCT00445458|559165092|FG001|Overall Study|Adverse Event|0|||
154929282|NCT00445458|559165093|FG002|Overall Study|Adverse Event|3|||
154929283|NCT00445458|559165094|FG003|Overall Study|Adverse Event|0|||
154929284|NCT00445458|559165091|FG000|Overall Study|Death|0|||
154929285|NCT00445458|559165092|FG001|Overall Study|Death|1|||
154929286|NCT00445458|559165093|FG002|Overall Study|Death|2|||
154929287|NCT00445458|559165094|FG003|Overall Study|Death|0|||
154929288|NCT00445458|559165091|FG000|Overall Study|Physician Decision|0|||
154929289|NCT00445458|559165092|FG001|Overall Study|Physician Decision|0|||
154929290|NCT00445458|559165093|FG002|Overall Study|Physician Decision|1|||
154929291|NCT00445458|559165094|FG003|Overall Study|Physician Decision|1|||
154929292|NCT00445458|559165091|FG000|Overall Study|Surgery|0|||
155042690|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
155042691|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042692|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042693|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042694|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
155042695|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042696|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
155042697|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042698|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042699|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
155042700|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
155042701|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155042702|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
155042703|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155042704|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155042705|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
155042706|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155042707|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155042708|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
155042709|NCT00528372|559586801|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
155042710|NCT00528372|559586802|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155042711|NCT00528372|559586803|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155042712|NCT00528372|559586804|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
155042713|NCT00528372|559586805|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155042714|NCT00528372|559586806|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155042715|NCT00528372|559586807|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155042716|NCT00528372|559586808|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
155042717|NCT00528372|559586809|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
155042718|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
155042719|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
155042720|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
155042721|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
155042722|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
155042723|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
155042724|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
155042725|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
155042726|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
155042727|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
155042728|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
155042729|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
155042730|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
155042731|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
155042732|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
155042733|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
155042734|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
155042735|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
155042736|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
155042737|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
155042738|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
155042739|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
155042740|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
155042741|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
155042742|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
155042743|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
155042744|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
155042745|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
155042746|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
155042747|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
155042748|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
155042749|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
155042750|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
155381696|NCT04617275|560830985|FG001|Treatment Period|Lost to Follow-up|0|||
154929293|NCT00445458|559165092|FG001|Overall Study|Surgery|0|||
154929294|NCT00445458|559165093|FG002|Overall Study|Surgery|1|||
154929295|NCT00445458|559165094|FG003|Overall Study|Surgery|0|||
154929296|NCT03186794|559165095|FG000|Overall Study|Physician Decision|2|||
154929297|NCT03186794|559165095|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
154929298|NCT01329562|559165098|FG000|Overall Study|Protocol Violation|5|||
154929299|NCT01329562|559165099|FG001|Overall Study|Protocol Violation|3|||
154929300|NCT01329562|559165098|FG000|Overall Study|Lost to Follow-up|1|||
154929301|NCT01329562|559165099|FG001|Overall Study|Lost to Follow-up|1|||
154929302|NCT01329562|559165098|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
154929303|NCT01329562|559165099|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
154929304|NCT01329562|559165098|FG000|Overall Study|Physician Decision|0|||
154929305|NCT01329562|559165099|FG001|Overall Study|Physician Decision|1|||
154929306|NCT03151226|559165100|FG000|Overall Study|Withdrawal by Subject|2|||
154929307|NCT03151226|559165100|FG000|Overall Study|not wear device correctly|1|||
154929308|NCT00061568|559165101|FG000|Overall Study|Lost to Follow-up|12|||
154929309|NCT00061568|559165102|FG001|Overall Study|Lost to Follow-up|0|||
154929310|NCT00061568|559165101|FG000|Overall Study|Death|6|||
154929311|NCT00061568|559165102|FG001|Overall Study|Death|0|||
154929312|NCT00061568|559165101|FG000|Overall Study|Withdrawal by Subject|1|||
154929313|NCT00061568|559165102|FG001|Overall Study|Withdrawal by Subject|0|||
154929314|NCT01381068|559165103|FG000|Overall Study|Death|1|||
154929315|NCT01381068|559165104|FG001|Overall Study|Death|0|||
154929316|NCT00402779|559165107|FG000|Overall Study|Screen Failure|77|||
154929317|NCT00402779|559165108|FG001|Overall Study|Screen Failure|76|||
154929318|NCT00690573|559165115|FG000|Overall Study|Lack of Efficacy|8|||
154929319|NCT00690573|559165115|FG000|Overall Study|Withdrawal by Subject|1|||
154929320|NCT00777920|559165116|FG000|Overall Study|Adverse Event|39|||
154929321|NCT00777920|559165116|FG000|Overall Study|Withdrawal of Consent|4|||
154929322|NCT00777920|559165116|FG000|Overall Study|Lost to Follow-up|1|||
155042751|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
155042752|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
155042753|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
155042754|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155042755|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155042756|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155042757|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155042758|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155042759|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155042760|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
155042761|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155042762|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
155042763|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042764|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042765|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042766|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042767|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
155042768|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
155042769|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042770|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042771|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
155042772|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155042773|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
155042774|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155042775|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155042776|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155042777|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155042778|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
155042779|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
155042780|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
155042781|NCT00528372|559586801|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
155042782|NCT00528372|559586802|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
154929323|NCT00777920|559165116|FG000|Overall Study|Investigator's discretion|1|||
154929324|NCT00777920|559165116|FG000|Overall Study|Clinical status did not improve|1|||
154929325|NCT00777920|559165116|FG000|Overall Study|Other, not specified|4|||
154929326|NCT02392377|559165117|FG000|Overall Study|Withdrawal by Subject|0|||
154929327|NCT02392377|559165118|FG001|Overall Study|Withdrawal by Subject|1|||
154929328|NCT01126359|559165121|FG000|First Intervention (20-minutes)|Physician Decision|0|||
154929329|NCT01126359|559165122|FG001|First Intervention (20-minutes)|Physician Decision|1|||
154929330|NCT00902486|559165123|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
154929331|NCT00902486|559165124|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
154929332|NCT00902486|559165125|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
154929333|NCT00902486|559165126|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
154929334|NCT00902486|559165127|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
154929335|NCT00902486|559165128|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
154929336|NCT00902486|559165123|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
154929337|NCT00902486|559165124|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
154929338|NCT00902486|559165125|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
154929339|NCT00902486|559165126|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
154929340|NCT00902486|559165127|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
154929341|NCT00902486|559165128|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
154929342|NCT00902486|559165123|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
154929343|NCT00902486|559165124|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
154929344|NCT00902486|559165125|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
154929345|NCT00902486|559165126|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
154929346|NCT00902486|559165127|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
154929347|NCT00902486|559165128|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
154929348|NCT00902486|559165123|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
154929349|NCT00902486|559165124|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
154929350|NCT00902486|559165125|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
154929351|NCT00902486|559165126|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
154929352|NCT00902486|559165127|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
154929353|NCT00902486|559165128|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
154929354|NCT00902486|559165123|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
154929355|NCT00902486|559165124|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
154929356|NCT00902486|559165125|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
154929357|NCT00902486|559165126|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
154929358|NCT00902486|559165127|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
154929359|NCT00902486|559165128|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
154929360|NCT00902486|559165123|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
154929361|NCT00902486|559165124|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
154929362|NCT00902486|559165125|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
154929363|NCT00902486|559165126|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
154929364|NCT00902486|559165127|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
154929365|NCT00902486|559165128|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
154929366|NCT00902486|559165123|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
154929367|NCT00902486|559165124|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
154929368|NCT00902486|559165125|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
154929369|NCT00902486|559165126|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
154929370|NCT00902486|559165127|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
154929371|NCT00902486|559165128|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
154929372|NCT00902486|559165123|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
154929373|NCT00902486|559165124|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
154929374|NCT00902486|559165125|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
154929375|NCT00902486|559165126|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
154929376|NCT00902486|559165127|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
154929377|NCT00902486|559165128|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
154929378|NCT00902486|559165123|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
154929379|NCT00902486|559165124|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
154929380|NCT00902486|559165125|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
154929381|NCT00902486|559165126|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
154929382|NCT00902486|559165127|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
154929383|NCT00902486|559165128|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
154929384|NCT00902486|559165123|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
154929385|NCT00902486|559165124|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
154929386|NCT00902486|559165125|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
154929387|NCT00902486|559165126|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
154929388|NCT00902486|559165127|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
154929389|NCT00902486|559165128|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
154929390|NCT00902486|559165123|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
154929391|NCT00902486|559165124|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
155042783|NCT00528372|559586803|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
155042784|NCT00528372|559586804|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
154929392|NCT00902486|559165125|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
154929393|NCT00902486|559165126|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
154929394|NCT00902486|559165127|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
154929395|NCT00902486|559165128|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
154929396|NCT05378269|559167240|FG000|Overall Study|Protocol Violation|1|||
154929397|NCT05378269|559167241|FG001|Overall Study|Protocol Violation|0|||
154929398|NCT05378269|559167242|FG002|Overall Study|Protocol Violation|2|||
154929399|NCT05378269|559167243|FG003|Overall Study|Protocol Violation|0|||
154929400|NCT05378269|559167244|FG004|Overall Study|Protocol Violation|0|||
154929401|NCT00359073|559167245|FG000|Overall Study|Withdrawal by Subject|1|||
154929402|NCT00359073|559167246|FG001|Overall Study|Withdrawal by Subject|1|||
154929403|NCT00359073|559167245|FG000|Overall Study|Eligibility criteria no longer met|3|||
154929404|NCT00359073|559167246|FG001|Overall Study|Eligibility criteria no longer met|0|||
154929405|NCT00359073|559167245|FG000|Overall Study|developed RV16 antibody|0|||
154929406|NCT00359073|559167246|FG001|Overall Study|developed RV16 antibody|1|||
154929407|NCT01371006|559167247|FG000|Overall Study|Adverse Event|1|||
154929408|NCT01371006|559167248|FG001|Overall Study|Adverse Event|0|||
154929409|NCT00684645|559167249|FG000|Overall Study|Death|2|||
154929410|NCT00684645|559167249|FG000|Overall Study|Progressive disease|67|||
154929411|NCT00684645|559167249|FG000|Overall Study|Adverse Event|27|||
154929412|NCT00684645|559167249|FG000|Overall Study|Lost to Follow-up|3|||
154929413|NCT00684645|559167249|FG000|Overall Study|Other|15|||
154929414|NCT00891527|559167250|FG000|Overall Study|Withdrawal by Subject|2|||
154929415|NCT01186744|559167251|FG000|Overall Study|Lack of Efficacy|156|||
154929416|NCT01186744|559167252|FG001|Overall Study|Lack of Efficacy|99|||
154929417|NCT01186744|559167253|FG002|Overall Study|Lack of Efficacy|0|||
154929418|NCT01186744|559167254|FG003|Overall Study|Lack of Efficacy|2|||
154929419|NCT01186744|559167255|FG004|Overall Study|Lack of Efficacy|2|||
154929420|NCT01186744|559167256|FG005|Overall Study|Lack of Efficacy|5|||
154929421|NCT01186744|559167251|FG000|Overall Study|Protocol Violation|1|||
154929422|NCT01186744|559167252|FG001|Overall Study|Protocol Violation|2|||
154929423|NCT01186744|559167253|FG002|Overall Study|Protocol Violation|0|||
155042785|NCT00528372|559586805|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
155042786|NCT00528372|559586806|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
155042787|NCT00528372|559586807|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
155042788|NCT00528372|559586808|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
155042789|NCT00528372|559586809|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
155042790|NCT02432144|559586812|FG000|Overall Study|Participant Non-Compliance|1|||
155042791|NCT00262002|559586813|FG000|Overall Study|Adverse Event|2|||
155042792|NCT00262002|559586814|FG001|Overall Study|Adverse Event|1|||
155042793|NCT00262002|559586815|FG002|Overall Study|Adverse Event|0|||
155042794|NCT00262002|559586816|FG003|Overall Study|Adverse Event|0|||
155042795|NCT00262002|559586817|FG004|Overall Study|Adverse Event|0|||
155042796|NCT00262002|559586818|FG005|Overall Study|Adverse Event|1|||
155042797|NCT00262002|559586819|FG006|Overall Study|Adverse Event|0|||
155042798|NCT00262002|559586813|FG000|Overall Study|Withdrawal by Subject|4|||
155042799|NCT00262002|559586814|FG001|Overall Study|Withdrawal by Subject|2|||
155042800|NCT00262002|559586815|FG002|Overall Study|Withdrawal by Subject|0|||
155042801|NCT00262002|559586816|FG003|Overall Study|Withdrawal by Subject|1|||
155042802|NCT00262002|559586817|FG004|Overall Study|Withdrawal by Subject|2|||
155042803|NCT00262002|559586818|FG005|Overall Study|Withdrawal by Subject|2|||
155042804|NCT00262002|559586819|FG006|Overall Study|Withdrawal by Subject|2|||
155042805|NCT00262002|559586813|FG000|Overall Study|Lost to Follow-up|2|||
155042806|NCT00262002|559586814|FG001|Overall Study|Lost to Follow-up|0|||
155042807|NCT00262002|559586815|FG002|Overall Study|Lost to Follow-up|0|||
155042808|NCT00262002|559586816|FG003|Overall Study|Lost to Follow-up|2|||
155042809|NCT00262002|559586817|FG004|Overall Study|Lost to Follow-up|0|||
155042810|NCT00262002|559586818|FG005|Overall Study|Lost to Follow-up|1|||
155042811|NCT00262002|559586819|FG006|Overall Study|Lost to Follow-up|0|||
155042812|NCT00262002|559586813|FG000|Overall Study|Inapropriate enrollment|0|||
155042813|NCT00262002|559586814|FG001|Overall Study|Inapropriate enrollment|1|||
155042814|NCT00262002|559586815|FG002|Overall Study|Inapropriate enrollment|0|||
155042815|NCT00262002|559586816|FG003|Overall Study|Inapropriate enrollment|0|||
154929424|NCT01186744|559167254|FG003|Overall Study|Protocol Violation|1|||
154929425|NCT01186744|559167255|FG004|Overall Study|Protocol Violation|1|||
154929426|NCT01186744|559167256|FG005|Overall Study|Protocol Violation|2|||
154929427|NCT01186744|559167251|FG000|Overall Study|Lost to Follow-up|15|||
154929428|NCT01186744|559167252|FG001|Overall Study|Lost to Follow-up|16|||
154929429|NCT01186744|559167253|FG002|Overall Study|Lost to Follow-up|2|||
154929430|NCT01186744|559167254|FG003|Overall Study|Lost to Follow-up|1|||
154929431|NCT01186744|559167255|FG004|Overall Study|Lost to Follow-up|1|||
155042816|NCT00262002|559586817|FG004|Overall Study|Inapropriate enrollment|0|||
155042817|NCT00262002|559586818|FG005|Overall Study|Inapropriate enrollment|0|||
155042818|NCT00262002|559586819|FG006|Overall Study|Inapropriate enrollment|0|||
155042819|NCT00262002|559586813|FG000|Overall Study|Protocol Violation|3|||
155042820|NCT00262002|559586814|FG001|Overall Study|Protocol Violation|2|||
154929432|NCT01186744|559167256|FG005|Overall Study|Lost to Follow-up|4|||
155042821|NCT00262002|559586815|FG002|Overall Study|Protocol Violation|0|||
154929433|NCT01186744|559167251|FG000|Overall Study|Screen failure|1|||
154929434|NCT01186744|559167252|FG001|Overall Study|Screen failure|1|||
154929435|NCT01186744|559167253|FG002|Overall Study|Screen failure|0|||
154929436|NCT01186744|559167254|FG003|Overall Study|Screen failure|1|||
154929437|NCT01186744|559167255|FG004|Overall Study|Screen failure|0|||
154929438|NCT01186744|559167256|FG005|Overall Study|Screen failure|0|||
154929439|NCT01186744|559167251|FG000|Overall Study|Withdrawal by Subject|14|||
154929440|NCT01186744|559167252|FG001|Overall Study|Withdrawal by Subject|10|||
154929441|NCT01186744|559167253|FG002|Overall Study|Withdrawal by Subject|2|||
154929442|NCT01186744|559167254|FG003|Overall Study|Withdrawal by Subject|5|||
154929443|NCT01186744|559167255|FG004|Overall Study|Withdrawal by Subject|0|||
154929444|NCT01186744|559167256|FG005|Overall Study|Withdrawal by Subject|6|||
154929445|NCT01186744|559167251|FG000|Overall Study|Study terminated by Sponsor|1|||
154929446|NCT01186744|559167252|FG001|Overall Study|Study terminated by Sponsor|0|||
154929447|NCT01186744|559167253|FG002|Overall Study|Study terminated by Sponsor|0|||
154929448|NCT01186744|559167254|FG003|Overall Study|Study terminated by Sponsor|0|||
154929449|NCT01186744|559167255|FG004|Overall Study|Study terminated by Sponsor|0|||
154929450|NCT01186744|559167256|FG005|Overall Study|Study terminated by Sponsor|0|||
154929451|NCT01186744|559167251|FG000|Overall Study|Other|9|||
154929452|NCT01186744|559167252|FG001|Overall Study|Other|10|||
154929453|NCT01186744|559167253|FG002|Overall Study|Other|1|||
154929454|NCT01186744|559167254|FG003|Overall Study|Other|2|||
154929455|NCT01186744|559167255|FG004|Overall Study|Other|1|||
154929456|NCT01186744|559167256|FG005|Overall Study|Other|5|||
154929457|NCT01186744|559167251|FG000|Overall Study|Adverse Event|10|||
154929458|NCT01186744|559167252|FG001|Overall Study|Adverse Event|14|||
154929459|NCT01186744|559167253|FG002|Overall Study|Adverse Event|1|||
154929460|NCT01186744|559167254|FG003|Overall Study|Adverse Event|0|||
154929461|NCT01186744|559167255|FG004|Overall Study|Adverse Event|1|||
154929462|NCT01186744|559167256|FG005|Overall Study|Adverse Event|4|||
154929463|NCT01186744|559167251|FG000|Overall Study|Death|1|||
154929464|NCT01186744|559167252|FG001|Overall Study|Death|0|||
154929465|NCT01186744|559167253|FG002|Overall Study|Death|0|||
154929466|NCT01186744|559167254|FG003|Overall Study|Death|0|||
154929467|NCT01186744|559167255|FG004|Overall Study|Death|0|||
154929468|NCT01186744|559167256|FG005|Overall Study|Death|0|||
154929469|NCT03515837|559167259|FG000|Overall Study|Death|219|||
154929470|NCT03515837|559167260|FG001|Overall Study|Death|227|||
154929471|NCT03515837|559167259|FG000|Overall Study|Lost to Follow-up|0|||
154929472|NCT03515837|559167260|FG001|Overall Study|Lost to Follow-up|1|||
154929473|NCT03515837|559167259|FG000|Overall Study|Withdrawal by Subject|0|||
154929474|NCT03515837|559167260|FG001|Overall Study|Withdrawal by Subject|4|||
154929475|NCT03515837|559167259|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
154929476|NCT03515837|559167260|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
154929477|NCT01964898|559167261|FG000|Overall Study|ineligible post-randomization|1|||
154929478|NCT01964898|559167262|FG001|Overall Study|ineligible post-randomization|1|||
154929479|NCT01964898|559167261|FG000|Overall Study|did not receive the allocated interventi|2|||
154929480|NCT01964898|559167262|FG001|Overall Study|did not receive the allocated interventi|1|||
154929481|NCT01964898|559167261|FG000|Overall Study|Lost to Follow-up|3|||
154929482|NCT01964898|559167262|FG001|Overall Study|Lost to Follow-up|5|||
154929483|NCT01964898|559167261|FG000|Overall Study|Withdrawal by Subject|1|||
154929484|NCT01964898|559167262|FG001|Overall Study|Withdrawal by Subject|0|||
154929485|NCT00391092|559167263|FG000|Overall Study|Death|78|||
154929486|NCT00391092|559167264|FG001|Overall Study|Death|81|||
154929487|NCT00391092|559167263|FG000|Overall Study|Lost to Follow-up|13|||
154929488|NCT00391092|559167264|FG001|Overall Study|Lost to Follow-up|18|||
154929489|NCT00391092|559167263|FG000|Overall Study|Alive on treatment|29|||
154929490|NCT00391092|559167264|FG001|Overall Study|Alive on treatment|33|||
154929491|NCT00391092|559167263|FG000|Overall Study|Alive in follow-up|88|||
154929492|NCT00391092|559167264|FG001|Overall Study|Alive in follow-up|84|||
154929493|NCT00858234|559167265|FG000|Overall Study|Adverse Event|6|||
154929494|NCT00858234|559167265|FG000|Overall Study|Progressive disease|2|||
154929495|NCT00858234|559167265|FG000|Overall Study|Status unknown|1|||
154929496|NCT02957682|559167268|FG000|Overall Study|Adverse Event|64|||
154929497|NCT02957682|559167269|FG001|Overall Study|Adverse Event|67|||
154929498|NCT02957682|559167268|FG000|Overall Study|Poor Compliance to Protocol|30|||
154929499|NCT02957682|559167269|FG001|Overall Study|Poor Compliance to Protocol|26|||
154929500|NCT02957682|559167268|FG000|Overall Study|Physician Decision|4|||
154929501|NCT02957682|559167269|FG001|Overall Study|Physician Decision|4|||
154929502|NCT02957682|559167268|FG000|Overall Study|Study Terminated by Sponsor|4|||
154929503|NCT02957682|559167269|FG001|Overall Study|Study Terminated by Sponsor|3|||
154929504|NCT02957682|559167268|FG000|Overall Study|Subject Moved|10|||
154929505|NCT02957682|559167269|FG001|Overall Study|Subject Moved|16|||
154929506|NCT02957682|559167268|FG000|Overall Study|Withdrawal by Subject|64|||
154929507|NCT02957682|559167269|FG001|Overall Study|Withdrawal by Subject|33|||
154929508|NCT02957682|559167268|FG000|Overall Study|Related to IMP Administration|3|||
154929509|NCT02957682|559167269|FG001|Overall Study|Related to IMP Administration|6|||
154929510|NCT02957682|559167268|FG000|Overall Study|Non-disclosed|16|||
154929511|NCT02957682|559167269|FG001|Overall Study|Non-disclosed|12|||
155042822|NCT00262002|559586816|FG003|Overall Study|Protocol Violation|2|||
155042823|NCT00262002|559586817|FG004|Overall Study|Protocol Violation|5|||
155042824|NCT00262002|559586818|FG005|Overall Study|Protocol Violation|3|||
155042825|NCT00262002|559586819|FG006|Overall Study|Protocol Violation|2|||
155042826|NCT00262002|559586813|FG000|Overall Study|Unable to classify|0|||
155042827|NCT00262002|559586814|FG001|Overall Study|Unable to classify|0|||
155042828|NCT00262002|559586815|FG002|Overall Study|Unable to classify|0|||
155042829|NCT00262002|559586816|FG003|Overall Study|Unable to classify|0|||
155042830|NCT00262002|559586817|FG004|Overall Study|Unable to classify|0|||
155042831|NCT00262002|559586818|FG005|Overall Study|Unable to classify|0|||
155042832|NCT00262002|559586819|FG006|Overall Study|Unable to classify|2|||
155042833|NCT03951753|559586820|FG000|Overall Study|Adverse Event|1|||
155042834|NCT03951753|559586821|FG001|Overall Study|Adverse Event|0|||
155042835|NCT03951753|559586822|FG002|Overall Study|Adverse Event|3|||
155042836|NCT03951753|559586820|FG000|Overall Study|Withdrawal by Subject|3|||
155042837|NCT03951753|559586821|FG001|Overall Study|Withdrawal by Subject|1|||
155042838|NCT03951753|559586822|FG002|Overall Study|Withdrawal by Subject|0|||
155042839|NCT03951753|559586820|FG000|Overall Study|Lost to Follow-up|0|||
155042840|NCT03951753|559586821|FG001|Overall Study|Lost to Follow-up|0|||
155042841|NCT03951753|559586822|FG002|Overall Study|Lost to Follow-up|1|||
155042842|NCT00966355|559586829|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
155042843|NCT00966355|559586830|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
155042844|NCT00966355|559586831|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
155042845|NCT00966355|559586829|FG000|Overall Study|newly diagnosed advanced HCC|11|||
155042846|NCT00966355|559586830|FG001|Overall Study|newly diagnosed advanced HCC|12|||
155042847|NCT00966355|559586831|FG002|Overall Study|newly diagnosed advanced HCC|10|||
155042848|NCT00966355|559586829|FG000|Overall Study|Lost to Follow-up|5|||
155042849|NCT00966355|559586830|FG001|Overall Study|Lost to Follow-up|4|||
155042850|NCT00966355|559586831|FG002|Overall Study|Lost to Follow-up|3|||
155042851|NCT00958412|559586832|FG000|Overall Study|Study prematurely terminated|18|||
155042852|NCT02552888|559586833|FG000|Overall Study|Lost to Follow-up|1|||
155042853|NCT02552888|559586834|FG001|Overall Study|Lost to Follow-up|1|||
155042854|NCT03396822|559587958|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
155042855|NCT03396822|559587958|FG000|Overall Study|Physician Decision|1|||
155042856|NCT01128400|559587963|FG000|Overall Study|Lost to Follow-up|1|||
155042857|NCT01128400|559587964|FG001|Overall Study|Lost to Follow-up|0|||
155042858|NCT01128400|559587965|FG002|Overall Study|Lost to Follow-up|1|||
155042859|NCT01128400|559587963|FG000|Overall Study|Screening failure|1|||
155042860|NCT01128400|559587964|FG001|Overall Study|Screening failure|0|||
155042861|NCT01128400|559587965|FG002|Overall Study|Screening failure|0|||
155042862|NCT01128400|559587963|FG000|Overall Study|were not invited to participate on taste|0|||
155042863|NCT01128400|559587964|FG001|Overall Study|were not invited to participate on taste|0|||
155042864|NCT01128400|559587965|FG002|Overall Study|were not invited to participate on taste|15|||
155042865|NCT01128400|559587963|FG000|Overall Study|Excluded due to sinus problems|0|||
155042866|NCT01128400|559587964|FG001|Overall Study|Excluded due to sinus problems|1|||
155042867|NCT01128400|559587965|FG002|Overall Study|Excluded due to sinus problems|0|||
155042868|NCT04076319|559587966|FG000|Overall Study|Withdrawal by Subject|2|||
155042869|NCT04076319|559587967|FG001|Overall Study|Withdrawal by Subject|0|||
155042870|NCT04076319|559587966|FG000|Overall Study|Death|1|||
155042871|NCT04076319|559587967|FG001|Overall Study|Death|0|||
155042872|NCT02626000|559587970|FG000|Overall Study|Decision by Sponsor|1|||
155042873|NCT02626000|559587970|FG000|Overall Study|Death|29|||
155042874|NCT03746405|559587979|FG000|Overall Study|Withdrawal by Subject|3|||
155042875|NCT03746405|559587980|FG001|Overall Study|Withdrawal by Subject|0|||
155042876|NCT03746405|559587979|FG000|Overall Study|technical difficulties|0|||
155042877|NCT03746405|559587980|FG001|Overall Study|technical difficulties|2|||
155042878|NCT03479008|559587981|FG000|Overall Study|Withdrawal by Subject|3|||
155042879|NCT00412932|559587982|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
155042880|NCT00412932|559587982|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
155042881|NCT00412932|559587982|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
155042882|NCT00412932|559587982|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
155042883|NCT00412932|559587982|FG000|Olmesartan (Olm) 20 mg|Other|1|||
155042884|NCT00412932|559587982|FG000|Olmesartan 40 mg|Adverse Event|4|||
155042885|NCT00412932|559587982|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
155042886|NCT00412932|559587982|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
155042887|NCT00412932|559587982|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
155042888|NCT00412932|559587982|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
155042889|NCT00412932|559587982|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
155152881|NCT05556265|559996967|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
155152882|NCT05556265|559996968|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
155042890|NCT00412932|559587982|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
155042891|NCT01796301|559587987|FG000|Overall Study|Withdrawal by Subject|15|||
155042892|NCT01796301|559587988|FG001|Overall Study|Withdrawal by Subject|15|||
155042893|NCT01796301|559587987|FG000|Overall Study|Lost to Follow-up|3|||
155042894|NCT01796301|559587988|FG001|Overall Study|Lost to Follow-up|3|||
155042895|NCT01796301|559587987|FG000|Overall Study|Death|0|||
154929512|NCT02957682|559167268|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
154929513|NCT02957682|559167269|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
154929514|NCT02953262|559167277|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
154929515|NCT02953262|559167278|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
154929516|NCT02953262|559167279|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
154929517|NCT02953262|559167280|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
154929518|NCT00934622|559167281|FG000|Overall Study|Lost to Follow-up|7|||
154929519|NCT00934622|559167281|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
154929520|NCT00468312|559167282|FG000|Overall Study|Adverse Event|2|||
154929521|NCT00468312|559167283|FG001|Overall Study|Adverse Event|1|||
154929522|NCT00468312|559167282|FG000|Overall Study|Lack of Efficacy|0|||
154929523|NCT00468312|559167283|FG001|Overall Study|Lack of Efficacy|1|||
154929524|NCT00468312|559167282|FG000|Overall Study|Withdrawal by Subject|0|||
154929525|NCT00468312|559167283|FG001|Overall Study|Withdrawal by Subject|1|||
154929526|NCT00468312|559167282|FG000|Overall Study|Protocol Violation|2|||
154929527|NCT00468312|559167283|FG001|Overall Study|Protocol Violation|1|||
154929528|NCT00468312|559167282|FG000|Overall Study|Did not meet protocol eligibility|0|||
154929529|NCT00468312|559167283|FG001|Overall Study|Did not meet protocol eligibility|1|||
154929530|NCT03387735|559167285|FG000|Overall Study|Lost to Follow-up|4|||
154929531|NCT03387735|559167286|FG001|Overall Study|Lost to Follow-up|8|||
154929532|NCT03387735|559167285|FG000|Overall Study|Death|4|||
154929533|NCT03387735|559167286|FG001|Overall Study|Death|8|||
154929534|NCT01346501|559167293|FG000|Overall Study|Initiated Other Biological Agents|3|||
154929535|NCT01346501|559167294|FG001|Overall Study|Initiated Other Biological Agents|1|||
154929536|NCT01346501|559167293|FG000|Overall Study|Other|8|||
154929537|NCT01346501|559167294|FG001|Overall Study|Other|12|||
154929538|NCT02564952|559167295|FG000|Overall Study|Adverse Event|6|||
154929539|NCT02564952|559167295|FG000|Overall Study|Lost to Follow-up|1|||
154929540|NCT02564952|559167295|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
154929541|NCT02564952|559167295|FG000|Overall Study|Withdrawal by Subject|1|||
154929542|NCT02564952|559167295|FG000|Overall Study|Low Efficacy|1|||
154929543|NCT02564952|559167295|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
154929544|NCT00756652|559167296|FG000|Original Phase|Withdrawal by Subject|864|||
154929545|NCT00756652|559167297|FG001|Original Phase|Withdrawal by Subject|23|||
154929546|NCT00756652|559167296|FG000|Original Phase|Lost to Follow-up|601|||
154929547|NCT00756652|559167297|FG001|Original Phase|Lost to Follow-up|0|||
154929548|NCT00756652|559167296|FG000|Original Phase|Other Discontinuation|797|||
154929549|NCT00756652|559167297|FG001|Original Phase|Other Discontinuation|5|||
154929550|NCT00756652|559167296|FG000|Original Phase|Participant Noncompliance|18622|||
154929551|NCT00756652|559167297|FG001|Original Phase|Participant Noncompliance|424|||
154929552|NCT00756652|559167296|FG000|Original Phase|Unknown Discontinuation Reason|2|||
154929553|NCT00756652|559167297|FG001|Original Phase|Unknown Discontinuation Reason|0|||
154929554|NCT00756652|559167296|FG000|Original Phase|Participants without data|3259|||
154929555|NCT00756652|559167297|FG001|Original Phase|Participants without data|466|||
154929556|NCT00756652|559167296|FG000|Original Phase|Death|168|||
154929557|NCT00756652|559167297|FG001|Original Phase|Death|1|||
154929558|NCT00756652|559167296|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
154929559|NCT00756652|559167297|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
154929560|NCT00756652|559167296|FG000|Re-Op Phase|Withdrawal by Subject|62|||
154929561|NCT00756652|559167297|FG001|Re-Op Phase|Withdrawal by Subject|0|||
154929562|NCT00756652|559167296|FG000|Re-Op Phase|Death|6|||
154929563|NCT00756652|559167297|FG001|Re-Op Phase|Death|0|||
154929564|NCT00756652|559167296|FG000|Re-Op Phase|Lost to Follow-up|340|||
154929565|NCT00756652|559167297|FG001|Re-Op Phase|Lost to Follow-up|0|||
154929566|NCT00756652|559167296|FG000|Re-Op Phase|Site Closed|2454|||
154929567|NCT00756652|559167297|FG001|Re-Op Phase|Site Closed|0|||
154929568|NCT00756652|559167296|FG000|Re-Op Phase|Withdrawn after explant|14|||
154929569|NCT00756652|559167297|FG001|Re-Op Phase|Withdrawn after explant|0|||
154929570|NCT03972709|559167308|FG000|Overall Study|Withdrawal by Subject|18|||
154929571|NCT03972709|559167309|FG001|Overall Study|Withdrawal by Subject|7|||
154929572|NCT03972709|559167310|FG002|Overall Study|Withdrawal by Subject|14|||
154929573|NCT03972709|559167308|FG000|Overall Study|Study Terminated by Sponsor|48|||
154929574|NCT03972709|559167309|FG001|Overall Study|Study Terminated by Sponsor|25|||
154929575|NCT03972709|559167310|FG002|Overall Study|Study Terminated by Sponsor|50|||
154929576|NCT03972709|559167308|FG000|Overall Study|Physician Decision|1|||
154929577|NCT03972709|559167309|FG001|Overall Study|Physician Decision|0|||
154929578|NCT03972709|559167310|FG002|Overall Study|Physician Decision|0|||
154929579|NCT03972709|559167308|FG000|Overall Study|COVID-19|0|||
154929580|NCT03972709|559167309|FG001|Overall Study|COVID-19|1|||
154929581|NCT03972709|559167310|FG002|Overall Study|COVID-19|1|||
154929582|NCT03972709|559167308|FG000|Overall Study|Lost to Follow-up|6|||
154929583|NCT03972709|559167309|FG001|Overall Study|Lost to Follow-up|1|||
154929584|NCT03972709|559167310|FG002|Overall Study|Lost to Follow-up|2|||
154929585|NCT03972709|559167308|FG000|Overall Study|Death|5|||
154929586|NCT03972709|559167309|FG001|Overall Study|Death|1|||
154929587|NCT03972709|559167310|FG002|Overall Study|Death|4|||
154929588|NCT03972709|559167308|FG000|Overall Study|Adverse Event|3|||
154929589|NCT03972709|559167309|FG001|Overall Study|Adverse Event|1|||
154929590|NCT03972709|559167310|FG002|Overall Study|Adverse Event|4|||
154929591|NCT03972709|559167308|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
154929592|NCT03972709|559167309|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
154929593|NCT03972709|559167310|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
154929594|NCT03972709|559167308|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
154929595|NCT03972709|559167309|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
154929596|NCT03972709|559167310|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
154929597|NCT03972709|559167308|FG000|Overall Study|Subject Unable to be Contacted|0|||
154929598|NCT03972709|559167309|FG001|Overall Study|Subject Unable to be Contacted|1|||
154929599|NCT03972709|559167310|FG002|Overall Study|Subject Unable to be Contacted|0|||
154929600|NCT03972709|559167308|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
154929601|NCT03972709|559167309|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
154929602|NCT03972709|559167310|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
154929603|NCT03972709|559167308|FG000|Overall Study|Subject Moved|0|||
154929604|NCT03972709|559167309|FG001|Overall Study|Subject Moved|1|||
154929605|NCT03972709|559167310|FG002|Overall Study|Subject Moved|0|||
154929606|NCT03972709|559167308|FG000|Overall Study|Missed Study Visits|1|||
154929607|NCT03972709|559167309|FG001|Overall Study|Missed Study Visits|0|||
154929608|NCT03972709|559167310|FG002|Overall Study|Missed Study Visits|0|||
154929609|NCT01523301|559167311|FG000|Overall Study|Adverse Event|25|||
154929610|NCT01523301|559167312|FG001|Overall Study|Adverse Event|16|||
154929611|NCT01523301|559167311|FG000|Overall Study|Lack of Efficacy|0|||
154929612|NCT01523301|559167312|FG001|Overall Study|Lack of Efficacy|2|||
154929613|NCT01523301|559167311|FG000|Overall Study|Protocol Violation|3|||
154929614|NCT01523301|559167312|FG001|Overall Study|Protocol Violation|4|||
154929615|NCT01523301|559167311|FG000|Overall Study|Lost to Follow-up|1|||
155152883|NCT05556265|559996969|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
155152884|NCT05556265|559996965|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
155152885|NCT05556265|559996966|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
155152886|NCT05556265|559996967|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
155152887|NCT05556265|559996968|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
155152888|NCT05556265|559996969|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
155152889|NCT05556265|559996965|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
155152890|NCT05556265|559996966|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
155152891|NCT05556265|559996967|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
155152892|NCT05556265|559996968|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
155152893|NCT05556265|559996969|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
155152894|NCT03077542|559996972|FG000|Overall Study|Death|4|||
155152895|NCT03077542|559996973|FG001|Overall Study|Death|0|||
155152896|NCT03077542|559996972|FG000|Overall Study|Physician Decision|6|||
155152897|NCT03077542|559996973|FG001|Overall Study|Physician Decision|1|||
155152898|NCT03077542|559996972|FG000|Overall Study|Withdrawal by Subject|0|||
155152899|NCT03077542|559996973|FG001|Overall Study|Withdrawal by Subject|1|||
155152900|NCT00795704|559996974|FG000|Overall Study|Withdrawal by Subject|3|||
155152901|NCT00795704|559996975|FG001|Overall Study|Withdrawal by Subject|2|||
155152902|NCT00795704|559996974|FG000|Overall Study|Adverse Event|1|||
155152903|NCT00795704|559996975|FG001|Overall Study|Adverse Event|1|||
155152904|NCT03980730|559996976|FG000|Overall Study|Study Terminated by Sponsor|0|||
155152905|NCT03980730|559996977|FG001|Overall Study|Study Terminated by Sponsor|3|||
155152906|NCT03980730|559996976|FG000|Overall Study|Adverse Event|2|||
155152907|NCT03980730|559996977|FG001|Overall Study|Adverse Event|0|||
155152908|NCT03980730|559996976|FG000|Overall Study|Sponsor Request|0|||
155152909|NCT03980730|559996977|FG001|Overall Study|Sponsor Request|1|||
155152910|NCT01300728|559996978|FG000|Overall Study|Withdrawal by Subject|1|||
155152911|NCT01300728|559996979|FG001|Overall Study|Withdrawal by Subject|1|||
155152912|NCT01300728|559996978|FG000|Overall Study|Physician Decision|1|||
155152913|NCT01300728|559996979|FG001|Overall Study|Physician Decision|0|||
155152914|NCT03474588|559996987|FG000|Overall Study|Withdrawal by Subject|4|||
155152915|NCT03474588|559996988|FG001|Overall Study|Withdrawal by Subject|3|||
155152916|NCT03474588|559996987|FG000|Overall Study|Death|0|||
155152917|NCT03474588|559996988|FG001|Overall Study|Death|1|||
155381697|NCT04617275|560830986|FG002|Treatment Period|Lost to Follow-up|2|||
154929616|NCT01523301|559167312|FG001|Overall Study|Lost to Follow-up|0|||
155152918|NCT00945009|559996992|FG000|Overall Study|Lack of Efficacy|10|||
155152919|NCT00945009|559996993|FG001|Overall Study|Lack of Efficacy|0|||
155152920|NCT00945009|559996994|FG002|Overall Study|Lack of Efficacy|0|||
155152921|NCT00945009|559996992|FG000|Overall Study|Physician Decision|21|||
155152922|NCT00945009|559996993|FG001|Overall Study|Physician Decision|4|||
155152923|NCT00945009|559996994|FG002|Overall Study|Physician Decision|3|||
154929617|NCT01523301|559167311|FG000|Overall Study|Withdrawal by Subject|6|||
155042896|NCT01796301|559587988|FG001|Overall Study|Death|1|||
155152924|NCT00945009|559996992|FG000|Overall Study|Protocol Violation|6|||
155152925|NCT00945009|559996993|FG001|Overall Study|Protocol Violation|1|||
155152926|NCT00945009|559996994|FG002|Overall Study|Protocol Violation|0|||
155152927|NCT00945009|559996992|FG000|Overall Study|Withdrawal by Subject|1|||
155152928|NCT00945009|559996993|FG001|Overall Study|Withdrawal by Subject|0|||
155152929|NCT00945009|559996994|FG002|Overall Study|Withdrawal by Subject|0|||
155152930|NCT00945009|559996992|FG000|Overall Study|Ineligible|6|||
155152931|NCT00945009|559996993|FG001|Overall Study|Ineligible|1|||
155152932|NCT00945009|559996994|FG002|Overall Study|Ineligible|0|||
155152933|NCT00945009|559996992|FG000|Overall Study|Inevaluable|0|||
155152934|NCT00945009|559996993|FG001|Overall Study|Inevaluable|1|||
155152935|NCT00945009|559996994|FG002|Overall Study|Inevaluable|0|||
155152936|NCT00945009|559996992|FG000|Overall Study|Refusal of further protocol|1|||
155152937|NCT00945009|559996993|FG001|Overall Study|Refusal of further protocol|0|||
155152938|NCT00945009|559996994|FG002|Overall Study|Refusal of further protocol|0|||
155152939|NCT04886154|559996995|FG000|Overall Study|Adverse Event|0|||
155152940|NCT04886154|559996996|FG001|Overall Study|Adverse Event|0|||
155152941|NCT04886154|559996997|FG002|Overall Study|Adverse Event|0|||
155152942|NCT04886154|559996998|FG003|Overall Study|Adverse Event|0|||
155152943|NCT04886154|559996999|FG004|Overall Study|Adverse Event|1|||
155152944|NCT04886154|559997000|FG005|Overall Study|Adverse Event|0|||
155152945|NCT04886154|559997001|FG006|Overall Study|Adverse Event|0|||
155042897|NCT01796301|559587987|FG000|Overall Study|Decision by Sponsor|0|||
155042898|NCT01796301|559587988|FG001|Overall Study|Decision by Sponsor|1|||
155042899|NCT00667563|559587989|FG000|Overall Study|Protocol Violation|24|||
155042900|NCT02985021|559587992|FG000|Overall Study|Inability to comply with study procedures|1|||
155042901|NCT01491841|559587993|FG000|Overall Study|Screen Failure|10|||
155042902|NCT01491841|559587993|FG000|Overall Study|Withdrawal by Subject|1|||
155042903|NCT00741598|559587994|FG000|Overall Study|Lost to Follow-up|3|||
155042904|NCT00741598|559587995|FG001|Overall Study|Lost to Follow-up|4|||
155042905|NCT00741598|559587994|FG000|Overall Study|Lack of Efficacy|1|||
155042906|NCT00741598|559587995|FG001|Overall Study|Lack of Efficacy|2|||
155042907|NCT00741598|559587994|FG000|Overall Study|Physician Decision|1|||
155042908|NCT00741598|559587995|FG001|Overall Study|Physician Decision|1|||
155042909|NCT00741598|559587994|FG000|Overall Study|Pregnancy|1|||
155042910|NCT00741598|559587995|FG001|Overall Study|Pregnancy|0|||
155042911|NCT00741598|559587994|FG000|Overall Study|Withdrawal by Subject|3|||
155042912|NCT00741598|559587995|FG001|Overall Study|Withdrawal by Subject|2|||
155042913|NCT04105842|559587996|FG000|Overall Study|Withdrawal by Subject|2|||
155042914|NCT01951573|559587997|FG000|Washout Period|Adverse Event|0|||
155042915|NCT01951573|559587998|FG001|Washout Period|Adverse Event|1|||
155042916|NCT04399889|559587999|FG000|Overall Study|Death|5|||
155042917|NCT04399889|559588000|FG001|Overall Study|Death|1|||
155042918|NCT04399889|559588001|FG002|Overall Study|Death|1|||
155042919|NCT00707980|559588002|FG000|Overall Study|Adverse Event|49|||
155042920|NCT00707980|559588002|FG000|Overall Study|Lack of Efficacy|35|||
155042921|NCT00707980|559588002|FG000|Overall Study|Non-Compliance with Study Drug|28|||
155042922|NCT00707980|559588002|FG000|Overall Study|Protocol Deviations|19|||
155042923|NCT00707980|559588002|FG000|Overall Study|Withdrawal of Consent|81|||
155042924|NCT00707980|559588002|FG000|Overall Study|Lost to Follow-up|59|||
155042925|NCT00707980|559588002|FG000|Overall Study|Other|39|||
155042926|NCT01152996|559588006|FG000|Overall Study|Withdrawal by Subject|142|||
155042927|NCT01152996|559588006|FG000|Overall Study|Adverse Event|115|||
155042928|NCT01152996|559588006|FG000|Overall Study|Lost to Follow-up|112|||
155042929|NCT01152996|559588006|FG000|Overall Study|Lack of Efficacy|68|||
155042930|NCT01152996|559588006|FG000|Overall Study|Noncompliance|41|||
155042931|NCT01152996|559588006|FG000|Overall Study|Other|36|||
155042932|NCT01152996|559588006|FG000|Overall Study|Protocol Violation|22|||
155042933|NCT01152996|559588006|FG000|Overall Study|Elevated liver enzymes|1|||
155042934|NCT01535443|559588009|FG000|Overall Study|Physician Decision|3|||
155042935|NCT02260817|559588014|FG000|Overall Study|Lost to Follow-up|0|||
155042936|NCT02260817|559588015|FG001|Overall Study|Lost to Follow-up|14|||
155042937|NCT02260817|559588014|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
155042938|NCT02260817|559588015|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
155042939|NCT02260817|559588014|FG000|Overall Study|Observation, no biopsy|0|||
155042940|NCT02260817|559588015|FG001|Overall Study|Observation, no biopsy|1|||
155042941|NCT02260817|559588014|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
155042942|NCT02260817|559588015|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
155042943|NCT02260817|559588014|FG000|Overall Study|Protocol Violation|0|||
155042944|NCT02260817|559588015|FG001|Overall Study|Protocol Violation|14|||
155042945|NCT03299101|559588016|FG000|Overall Study|Lost to Follow-up|1|||
155042946|NCT03299101|559588016|FG000|Overall Study|Withdrawal by Subject|5|||
155042947|NCT03299101|559588016|FG000|Overall Study|Surgery was changed|3|||
155042948|NCT03299101|559588016|FG000|Overall Study|Not enough time to complete prehab|1|||
155042949|NCT03230838|559588018|FG000|Overall Study|Withdrawal by Subject|3|||
155042950|NCT03230838|559588019|FG001|Overall Study|Withdrawal by Subject|0|||
155042951|NCT03230838|559588018|FG000|Overall Study|Temperature excursion|1|||
155042952|NCT03230838|559588019|FG001|Overall Study|Temperature excursion|0|||
155042953|NCT01607346|559588022|FG000|Overall Study|Adverse Event|3|||
155042954|NCT02912455|559588023|FG000|Overall Study|Withdrawal by Subject|0|||
154929618|NCT01523301|559167312|FG001|Overall Study|Withdrawal by Subject|8|||
154929619|NCT01523301|559167311|FG000|Overall Study|Other Reason|0|||
154929620|NCT01523301|559167312|FG001|Overall Study|Other Reason|2|||
154929621|NCT00728988|559167313|FG000|Overall Study|Not Treated|2|||
154929622|NCT00728988|559167314|FG001|Overall Study|Not Treated|2|||
154929623|NCT00728988|559167313|FG000|Overall Study|Death|1|||
154929624|NCT00728988|559167314|FG001|Overall Study|Death|1|||
154929625|NCT00728988|559167313|FG000|Overall Study|Adverse Event|3|||
154929626|NCT00728988|559167314|FG001|Overall Study|Adverse Event|2|||
154929627|NCT00728988|559167313|FG000|Overall Study|Other|85|||
154929628|NCT00728988|559167314|FG001|Overall Study|Other|77|||
154929629|NCT00728988|559167313|FG000|Overall Study|Withdrawal by Subject|2|||
154929630|NCT00728988|559167314|FG001|Overall Study|Withdrawal by Subject|6|||
154929631|NCT05013749|559167320|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
154929632|NCT05013749|559167321|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
154929633|NCT05013749|559167320|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
154929634|NCT05013749|559167321|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
154929635|NCT01393626|559167322|FG000|Overall Study|Adverse Event|2|||
154929636|NCT01393626|559167323|FG001|Overall Study|Adverse Event|1|||
154929637|NCT01393626|559167324|FG002|Overall Study|Adverse Event|5|||
154929638|NCT01393626|559167325|FG003|Overall Study|Adverse Event|0|||
154929639|NCT01393626|559167322|FG000|Overall Study|Did not meet entrance criteria|1|||
154929640|NCT01393626|559167323|FG001|Overall Study|Did not meet entrance criteria|0|||
154929641|NCT01393626|559167324|FG002|Overall Study|Did not meet entrance criteria|0|||
154929642|NCT01393626|559167325|FG003|Overall Study|Did not meet entrance criteria|0|||
154929643|NCT01393626|559167322|FG000|Overall Study|Lack of Efficacy|6|||
154929644|NCT01393626|559167323|FG001|Overall Study|Lack of Efficacy|6|||
154929645|NCT01393626|559167324|FG002|Overall Study|Lack of Efficacy|4|||
154929646|NCT01393626|559167325|FG003|Overall Study|Lack of Efficacy|1|||
154929647|NCT01393626|559167322|FG000|Overall Study|Lost to Follow-up|1|||
154929648|NCT01393626|559167323|FG001|Overall Study|Lost to Follow-up|1|||
154929649|NCT01393626|559167324|FG002|Overall Study|Lost to Follow-up|1|||
154929650|NCT01393626|559167325|FG003|Overall Study|Lost to Follow-up|0|||
154929651|NCT01393626|559167322|FG000|Overall Study|Withdrawal by Subject|6|||
154929652|NCT01393626|559167323|FG001|Overall Study|Withdrawal by Subject|4|||
154929653|NCT01393626|559167324|FG002|Overall Study|Withdrawal by Subject|0|||
154929654|NCT01393626|559167325|FG003|Overall Study|Withdrawal by Subject|0|||
154929655|NCT01393626|559167322|FG000|Overall Study|Other|1|||
154929656|NCT01393626|559167323|FG001|Overall Study|Other|0|||
154929657|NCT01393626|559167324|FG002|Overall Study|Other|0|||
154929658|NCT01393626|559167325|FG003|Overall Study|Other|0|||
154929659|NCT01393626|559167322|FG000|Overall Study|Protocol Violation|1|||
154929660|NCT01393626|559167323|FG001|Overall Study|Protocol Violation|0|||
154929661|NCT01393626|559167324|FG002|Overall Study|Protocol Violation|2|||
154929662|NCT01393626|559167325|FG003|Overall Study|Protocol Violation|0|||
154929663|NCT02426125|559167326|FG000|Overall Study|Lost to Follow-up|14|||
154929664|NCT02426125|559167327|FG001|Overall Study|Lost to Follow-up|12|||
154929665|NCT02426125|559167326|FG000|Overall Study|Withdrawal by Subject|13|||
154929666|NCT02426125|559167327|FG001|Overall Study|Withdrawal by Subject|14|||
154929667|NCT02426125|559167326|FG000|Overall Study|Death|185|||
154929668|NCT02426125|559167327|FG001|Overall Study|Death|200|||
154929669|NCT02426125|559167326|FG000|Overall Study|Randomized, But Never Treated|5|||
154929670|NCT02426125|559167327|FG001|Overall Study|Randomized, But Never Treated|2|||
154929671|NCT02858076|559167328|FG000|Overall Study|Death|6|||
154929672|NCT02858076|559167329|FG001|Overall Study|Death|3|||
154929673|NCT02858076|559167328|FG000|Overall Study|Withdrawal by Subject|1|||
154929674|NCT02858076|559167329|FG001|Overall Study|Withdrawal by Subject|5|||
154929675|NCT02858076|559167328|FG000|Overall Study|Lost to Follow-up|2|||
154929676|NCT02858076|559167329|FG001|Overall Study|Lost to Follow-up|7|||
154929677|NCT02858076|559167328|FG000|Overall Study|Completed Out of Window|1|||
154929678|NCT02858076|559167329|FG001|Overall Study|Completed Out of Window|3|||
154929679|NCT02643394|559167330|FG000|Overall Study|Protocol Violation|4|||
154929680|NCT02643394|559167331|FG001|Overall Study|Protocol Violation|5|||
154929681|NCT00943384|559167332|FG000|Overall Study|Dispositioned prior to treatment|23|||
154929682|NCT00943384|559167332|FG000|Overall Study|Treated off protocol-protocol violation|5|||
154929683|NCT00943384|559167332|FG000|Overall Study|Lost to Follow-up|16|||
154929684|NCT00943384|559167332|FG000|Overall Study|Withdrawal by Subject|5|||
154929685|NCT00096200|559167333|FG000|Overall Study|Adverse Event|0|||
154929686|NCT00096200|559167334|FG001|Overall Study|Adverse Event|4|||
154929687|NCT00096200|559167335|FG002|Overall Study|Adverse Event|0|||
154929688|NCT00096200|559167333|FG000|Overall Study|Withdrawal by Subject|1|||
154929689|NCT00096200|559167334|FG001|Overall Study|Withdrawal by Subject|2|||
154929690|NCT00096200|559167335|FG002|Overall Study|Withdrawal by Subject|0|||
154929691|NCT00096200|559167333|FG000|Overall Study|Ineligible pathology|0|||
154929692|NCT00096200|559167334|FG001|Overall Study|Ineligible pathology|1|||
154929693|NCT00096200|559167335|FG002|Overall Study|Ineligible pathology|0|||
154929694|NCT02341482|559167339|FG000|Overall Study|Adverse Event|1|||
154929695|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
154929696|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
154929697|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Death|5|||
154929698|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Death|2|||
154929699|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
154929700|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
154929701|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
154929702|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
154929703|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
155152946|NCT04886154|559997002|FG007|Overall Study|Adverse Event|1|||
155152947|NCT04886154|559997003|FG008|Overall Study|Adverse Event|1|||
155152948|NCT04886154|559997004|FG009|Overall Study|Adverse Event|0|||
155152949|NCT04886154|559997005|FG010|Overall Study|Adverse Event|0|||
155152950|NCT04886154|559997006|FG011|Overall Study|Adverse Event|1|||
155152951|NCT04886154|559997007|FG012|Overall Study|Adverse Event|0|||
155152952|NCT04886154|559997008|FG013|Overall Study|Adverse Event|0|||
155152953|NCT04886154|559997009|FG014|Overall Study|Adverse Event|3|||
155152954|NCT04886154|559996995|FG000|Overall Study|Lost to Follow-up|1|||
155152955|NCT04886154|559996996|FG001|Overall Study|Lost to Follow-up|0|||
155152956|NCT04886154|559996997|FG002|Overall Study|Lost to Follow-up|2|||
155152957|NCT04886154|559996998|FG003|Overall Study|Lost to Follow-up|0|||
155152958|NCT04886154|559996999|FG004|Overall Study|Lost to Follow-up|17|||
155152959|NCT04886154|559997000|FG005|Overall Study|Lost to Follow-up|7|||
155152960|NCT04886154|559997001|FG006|Overall Study|Lost to Follow-up|8|||
155152961|NCT04886154|559997002|FG007|Overall Study|Lost to Follow-up|7|||
155152962|NCT04886154|559997003|FG008|Overall Study|Lost to Follow-up|8|||
155152963|NCT04886154|559997004|FG009|Overall Study|Lost to Follow-up|0|||
155152964|NCT04886154|559997005|FG010|Overall Study|Lost to Follow-up|2|||
155152965|NCT04886154|559997006|FG011|Overall Study|Lost to Follow-up|0|||
155152966|NCT04886154|559997007|FG012|Overall Study|Lost to Follow-up|0|||
155152967|NCT04886154|559997008|FG013|Overall Study|Lost to Follow-up|0|||
155152968|NCT04886154|559997009|FG014|Overall Study|Lost to Follow-up|0|||
155152969|NCT04886154|559996995|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152970|NCT04886154|559996996|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152971|NCT04886154|559996997|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152972|NCT04886154|559996998|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152973|NCT04886154|559996999|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152974|NCT04886154|559997000|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152975|NCT04886154|559997001|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
155152976|NCT04886154|559997002|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152977|NCT04886154|559997003|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152978|NCT04886154|559997004|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152979|NCT04886154|559997005|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152980|NCT04886154|559997006|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152981|NCT04886154|559997007|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152982|NCT04886154|559997008|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152983|NCT04886154|559997009|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
155152984|NCT04886154|559996995|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152985|NCT04886154|559996996|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152986|NCT04886154|559996997|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152987|NCT04886154|559996998|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152988|NCT04886154|559996999|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155152989|NCT04886154|559997000|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152990|NCT04886154|559997001|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155152991|NCT04886154|559997002|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155152992|NCT04886154|559997003|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152993|NCT04886154|559997004|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152994|NCT04886154|559997005|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154929704|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
154929705|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Relapse|1|||
155152995|NCT04886154|559997006|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152996|NCT04886154|559997007|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152997|NCT04886154|559997008|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155152998|NCT04886154|559997009|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155152999|NCT04886154|559996995|FG000|Overall Study|Other, Not Specified|0|||
155153000|NCT04886154|559996996|FG001|Overall Study|Other, Not Specified|0|||
155153001|NCT04886154|559996997|FG002|Overall Study|Other, Not Specified|0|||
155153002|NCT04886154|559996998|FG003|Overall Study|Other, Not Specified|0|||
155153003|NCT04886154|559996999|FG004|Overall Study|Other, Not Specified|11|||
155153004|NCT04886154|559997000|FG005|Overall Study|Other, Not Specified|8|||
155153005|NCT04886154|559997001|FG006|Overall Study|Other, Not Specified|9|||
155153006|NCT04886154|559997002|FG007|Overall Study|Other, Not Specified|10|||
155153007|NCT04886154|559997003|FG008|Overall Study|Other, Not Specified|6|||
155153008|NCT04886154|559997004|FG009|Overall Study|Other, Not Specified|1|||
155153009|NCT04886154|559997005|FG010|Overall Study|Other, Not Specified|1|||
155153010|NCT04886154|559997006|FG011|Overall Study|Other, Not Specified|2|||
155153011|NCT04886154|559997007|FG012|Overall Study|Other, Not Specified|1|||
155153012|NCT04886154|559997008|FG013|Overall Study|Other, Not Specified|2|||
155153013|NCT04886154|559997009|FG014|Overall Study|Other, Not Specified|3|||
155153014|NCT03919773|559997018|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
155153015|NCT03919773|559997019|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
155153016|NCT03919773|559997018|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
155153017|NCT03919773|559997019|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
155153018|NCT04659044|559997022|FG000|Induction|Physician Decision|1|||
155153019|NCT04659044|559997022|FG000|Induction|Adverse Event|2|||
155153020|NCT04966013|559997024|FG000|Overall Study|Withdrawal by Subject|0|||
155153021|NCT04966013|559997025|FG001|Overall Study|Withdrawal by Subject|2|||
155153022|NCT04966013|559997026|FG002|Overall Study|Withdrawal by Subject|1|||
155153023|NCT04966013|559997024|FG000|Overall Study|Adverse Event|2|||
155153024|NCT04966013|559997025|FG001|Overall Study|Adverse Event|1|||
155153025|NCT04966013|559997026|FG002|Overall Study|Adverse Event|1|||
155153026|NCT03724942|559997027|FG000|Overall Study|Adverse Event|20|||
155153027|NCT03724942|559997028|FG001|Overall Study|Adverse Event|14|||
155153028|NCT03724942|559997027|FG000|Overall Study|Lack of Efficacy|0|||
155153029|NCT03724942|559997028|FG001|Overall Study|Lack of Efficacy|1|||
155153030|NCT03724942|559997027|FG000|Overall Study|Physician Decision|5|||
155153031|NCT03724942|559997028|FG001|Overall Study|Physician Decision|2|||
155153032|NCT03724942|559997027|FG000|Overall Study|Protocol Violation|1|||
155153033|NCT03724942|559997028|FG001|Overall Study|Protocol Violation|0|||
155153034|NCT03724942|559997027|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
155153035|NCT03724942|559997028|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
155153036|NCT03724942|559997027|FG000|Overall Study|Withdrawal by Legal Representative|3|||
155153037|NCT03724942|559997028|FG001|Overall Study|Withdrawal by Legal Representative|0|||
155153038|NCT04875975|559997029|FG000|Overall Study|Adverse Event|1|||
155153039|NCT04875975|559997030|FG001|Overall Study|Adverse Event|2|||
155153040|NCT04875975|559997029|FG000|Overall Study|Lack of Efficacy|2|||
155153041|NCT04875975|559997030|FG001|Overall Study|Lack of Efficacy|2|||
155153042|NCT04875975|559997029|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
155153043|NCT04875975|559997030|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
155153044|NCT04875975|559997029|FG000|Overall Study|Relapse With Insults|0|||
155153045|NCT04875975|559997030|FG001|Overall Study|Relapse With Insults|1|||
155153046|NCT04875975|559997029|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
155153047|NCT04875975|559997030|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
155153048|NCT02429830|559997031|FG000|Overall Study|Lost to Follow-up|1|||
155153049|NCT02429830|559997031|FG000|Overall Study|Device Explant|2|||
155170008|NCT00830869|560062411|FG006|Period 2: Part 2|Protocol Violation|0|||
155170009|NCT00830869|560062412|FG007|Period 2: Part 2|Protocol Violation|1|||
155170010|NCT00830869|560062413|FG008|Period 2: Part 2|Protocol Violation|0|||
155170011|NCT00830869|560062414|FG009|Period 2: Part 2|Protocol Violation|1|||
155170012|NCT00830869|560062415|FG010|Period 2: Part 2|Protocol Violation|0|||
155170013|NCT00830869|560062416|FG011|Period 2: Part 2|Protocol Violation|0|||
155170014|NCT00830869|560062405|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
155170015|NCT00830869|560062406|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
155170016|NCT00830869|560062407|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
155170017|NCT00830869|560062408|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
155170018|NCT00830869|560062409|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
155170019|NCT00830869|560062410|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
155170020|NCT00830869|560062411|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
155170021|NCT00830869|560062412|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
155170022|NCT00830869|560062413|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
155266929|NCT00152009|560410924|FG002|Overall Study|Withdrawal by Subject|4|||
155266930|NCT00152009|560410925|FG003|Overall Study|Withdrawal by Subject|9|||
155266931|NCT00152009|560410922|FG000|Overall Study|Lost to Follow-up|2|||
155266932|NCT00152009|560410923|FG001|Overall Study|Lost to Follow-up|4|||
155266933|NCT00152009|560410924|FG002|Overall Study|Lost to Follow-up|3|||
155266934|NCT00152009|560410925|FG003|Overall Study|Lost to Follow-up|3|||
155266935|NCT00152009|560410922|FG000|Overall Study|Lack of Efficacy|8|||
155266936|NCT00152009|560410923|FG001|Overall Study|Lack of Efficacy|6|||
155266937|NCT00152009|560410924|FG002|Overall Study|Lack of Efficacy|7|||
155266938|NCT00152009|560410925|FG003|Overall Study|Lack of Efficacy|15|||
155266939|NCT00152009|560410922|FG000|Overall Study|ECG abnormalities|2|||
155266940|NCT00152009|560410923|FG001|Overall Study|ECG abnormalities|2|||
155266941|NCT00152009|560410924|FG002|Overall Study|ECG abnormalities|2|||
155266942|NCT00152009|560410925|FG003|Overall Study|ECG abnormalities|1|||
155266943|NCT00152009|560410922|FG000|Overall Study|Sponsor's decision|3|||
155266944|NCT00152009|560410923|FG001|Overall Study|Sponsor's decision|3|||
155266945|NCT00152009|560410924|FG002|Overall Study|Sponsor's decision|1|||
154929706|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Relapse|0|||
154929707|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
154929708|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
154929709|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
154929710|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
154929711|NCT00111007|559167340|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
154929712|NCT00111007|559167341|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
154929713|NCT00111007|559167340|FG000|Active Follow-up|Adverse Event|1|||
154929714|NCT00111007|559167341|FG001|Active Follow-up|Adverse Event|0|||
154929715|NCT00111007|559167340|FG000|Active Follow-up|Death|2|||
154929716|NCT00111007|559167341|FG001|Active Follow-up|Death|0|||
154929717|NCT00111007|559167340|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
154929718|NCT00111007|559167341|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
154929719|NCT00111007|559167340|FG000|Long Term Follow-up|Death|34|||
154929720|NCT00111007|559167341|FG001|Long Term Follow-up|Death|39|||
154929721|NCT00111007|559167340|FG000|Long Term Follow-up|Lost to Follow-up|1|||
154929722|NCT00111007|559167341|FG001|Long Term Follow-up|Lost to Follow-up|1|||
154929723|NCT00111007|559167340|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
154929724|NCT00111007|559167341|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
154929725|NCT00111007|559167340|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
154929726|NCT00111007|559167341|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
154929727|NCT00111007|559167340|FG000|Long Term Follow-up|Missing|10|||
154929728|NCT00111007|559167341|FG001|Long Term Follow-up|Missing|3|||
154929729|NCT01495793|559167342|FG000|Overall Study|Lost to Follow-up|1|||
154929730|NCT01495793|559167342|FG000|Overall Study|Violation of inclusion criteria|1|||
154929731|NCT02362646|559167346|FG000|Overall Study|Death|15|||
154929732|NCT02362646|559167347|FG001|Overall Study|Death|8|||
154929733|NCT02362646|559167346|FG000|Overall Study|Withdrawal by Subject|2|||
154929734|NCT02362646|559167347|FG001|Overall Study|Withdrawal by Subject|2|||
154929735|NCT02362646|559167346|FG000|Overall Study|received transplant|21|||
154929736|NCT02362646|559167347|FG001|Overall Study|received transplant|14|||
154929737|NCT03611751|559167351|FG000|Pre-treatment|Randomized but not treated|1|||
154929738|NCT03611751|559167352|FG001|Pre-treatment|Randomized but not treated|1|||
154929739|NCT03611751|559167353|FG002|Pre-treatment|Randomized but not treated|0|||
154929740|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
154929741|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
154929742|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
154929743|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
154929744|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
154929745|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
154929746|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
154929747|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
154929748|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
154929749|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
154929750|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
154929751|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
154929752|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
154929753|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
154929754|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
154929755|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
154929756|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
154929757|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
154929758|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
154929759|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
154929760|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
154929761|NCT03611751|559167351|FG000|Treatment Week 0 - Week 16|Death|0|||
154929762|NCT03611751|559167352|FG001|Treatment Week 0 - Week 16|Death|0|||
154929763|NCT03611751|559167353|FG002|Treatment Week 0 - Week 16|Death|1|||
154929764|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
154929765|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
154929766|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
154929767|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
154929768|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
154929769|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
154929770|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
154929771|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
154929772|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
154929773|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
154929774|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
154929775|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
154929776|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
154929777|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
154929778|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
154929779|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
154929780|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
154929781|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
154929782|NCT03611751|559167351|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
154929783|NCT03611751|559167352|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
154929784|NCT03611751|559167353|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
154929785|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
154929786|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
154929787|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
154929788|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
154929789|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
154929790|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
154929791|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
154929792|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
154929793|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
154929794|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
154929795|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
154929796|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
154929797|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
154929798|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
154929799|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
154929800|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
154929801|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
154929802|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
154929803|NCT03611751|559167351|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
154929804|NCT03611751|559167352|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
154929805|NCT03611751|559167353|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
154929806|NCT00929864|559167354|FG000|Overall Study|Death|1|||
154929807|NCT00929864|559167355|FG001|Overall Study|Death|1|||
154929808|NCT00929864|559167354|FG000|Overall Study|Adverse Event|11|||
154929809|NCT00929864|559167355|FG001|Overall Study|Adverse Event|30|||
154929810|NCT00929864|559167354|FG000|Overall Study|Lack of Efficacy|19|||
154929811|NCT00929864|559167355|FG001|Overall Study|Lack of Efficacy|16|||
154929812|NCT00929864|559167354|FG000|Overall Study|Lost to Follow-up|7|||
154929813|NCT00929864|559167355|FG001|Overall Study|Lost to Follow-up|12|||
154929814|NCT00929864|559167354|FG000|Overall Study|Withdrawal by Subject|20|||
154929815|NCT00929864|559167355|FG001|Overall Study|Withdrawal by Subject|9|||
154929816|NCT00929864|559167354|FG000|Overall Study|No longer met criteria|2|||
154929817|NCT00929864|559167355|FG001|Overall Study|No longer met criteria|1|||
154929818|NCT00929864|559167354|FG000|Overall Study|Poor or non-compliance|3|||
154929819|NCT00929864|559167355|FG001|Overall Study|Poor or non-compliance|3|||
154929820|NCT00929864|559167354|FG000|Overall Study|Pregnancy|0|||
154929821|NCT00929864|559167355|FG001|Overall Study|Pregnancy|3|||
154929822|NCT00929864|559167354|FG000|Overall Study|Administrative reason by Sponsor|1|||
154929823|NCT00929864|559167355|FG001|Overall Study|Administrative reason by Sponsor|1|||
154929824|NCT00929864|559167354|FG000|Overall Study|Non-specified|2|||
154929825|NCT00929864|559167355|FG001|Overall Study|Non-specified|7|||
154929826|NCT03940742|559167358|FG000|Overall Study|Lost to Follow-up|0|||
154929827|NCT03940742|559167359|FG001|Overall Study|Lost to Follow-up|0|||
154929828|NCT03940742|559167360|FG002|Overall Study|Lost to Follow-up|0|||
154929829|NCT03940742|559167361|FG003|Overall Study|Lost to Follow-up|1|||
154929830|NCT03428217|559167363|FG000|Overall Study|Death|89|||
154929831|NCT03428217|559167364|FG001|Overall Study|Death|93|||
154929832|NCT03428217|559167363|FG000|Overall Study|Withdrawal by Subject|8|||
154929833|NCT03428217|559167364|FG001|Overall Study|Withdrawal by Subject|7|||
154929834|NCT03428217|559167363|FG000|Overall Study|Lost to Follow-up|1|||
154929835|NCT03428217|559167364|FG001|Overall Study|Lost to Follow-up|3|||
154929836|NCT03428217|559167363|FG000|Overall Study|Study terminated by sponsor|124|||
154929837|NCT03428217|559167364|FG001|Overall Study|Study terminated by sponsor|118|||
154929838|NCT03428217|559167363|FG000|Overall Study|Other, Not Specified|1|||
154929839|NCT03428217|559167364|FG001|Overall Study|Other, Not Specified|0|||
154929840|NCT03889197|559167365|FG000|Overall Study|Withdrawal by Subject|1|||
154929841|NCT03889197|559167366|FG001|Overall Study|Withdrawal by Subject|0|||
154929842|NCT03889197|559167365|FG000|Overall Study|Physician Decision|0|||
155042955|NCT02912455|559588024|FG001|Overall Study|Withdrawal by Subject|1|||
155042956|NCT02912455|559588023|FG000|Overall Study|Lack of Efficacy|0|||
155042957|NCT02912455|559588024|FG001|Overall Study|Lack of Efficacy|1|||
155042958|NCT02912455|559588023|FG000|Overall Study|Lost to Follow-up|2|||
155042959|NCT02912455|559588024|FG001|Overall Study|Lost to Follow-up|1|||
155042960|NCT00073008|559588026|FG000|Overall Study|Missing|6|||
155042961|NCT00073008|559588027|FG001|Overall Study|Missing|6|||
155042962|NCT00073008|559588026|FG000|Overall Study|Withdrawal by Subject|2|||
155042963|NCT00073008|559588027|FG001|Overall Study|Withdrawal by Subject|2|||
155042964|NCT00073008|559588026|FG000|Overall Study|Lost to Follow-up|1|||
154929843|NCT03889197|559167366|FG001|Overall Study|Physician Decision|1|||
155042965|NCT00073008|559588027|FG001|Overall Study|Lost to Follow-up|3|||
154929844|NCT03889197|559167365|FG000|Overall Study|met exclusion criteria|0|||
154929845|NCT03889197|559167366|FG001|Overall Study|met exclusion criteria|1|||
154929846|NCT03889197|559167365|FG000|Overall Study|Protocol Violation|1|||
154929847|NCT03889197|559167366|FG001|Overall Study|Protocol Violation|0|||
154929848|NCT00621309|559167367|FG000|Overall Study|Withdrawal by Subject|2|||
154929849|NCT00621309|559167368|FG001|Overall Study|Withdrawal by Subject|0|||
154929850|NCT00621309|559167369|FG002|Overall Study|Withdrawal by Subject|1|||
154929851|NCT00621309|559167370|FG003|Overall Study|Withdrawal by Subject|1|||
154929852|NCT00621309|559167371|FG004|Overall Study|Withdrawal by Subject|1|||
154929853|NCT00621309|559167372|FG005|Overall Study|Withdrawal by Subject|1|||
154929854|NCT05246111|559167373|FG000|Period 01|NOT ELIGIBLE IC5|1|||
154929855|NCT05246111|559167374|FG001|Period 01|NOT ELIGIBLE IC5|0|||
154929856|NCT05004181|559167377|FG000|Overall Study|Withdrawal of consent|0|||
154929857|NCT05004181|559167378|FG001|Overall Study|Withdrawal of consent|0|||
154929858|NCT05004181|559167379|FG002|Overall Study|Withdrawal of consent|1|||
154929859|NCT05004181|559167380|FG003|Overall Study|Withdrawal of consent|3|||
154929860|NCT05004181|559167381|FG004|Overall Study|Withdrawal of consent|3|||
154929861|NCT05004181|559167382|FG005|Overall Study|Withdrawal of consent|0|||
154929862|NCT05004181|559167383|FG006|Overall Study|Withdrawal of consent|30|||
154929863|NCT05004181|559167384|FG007|Overall Study|Withdrawal of consent|9|||
154929864|NCT05004181|559167385|FG008|Overall Study|Withdrawal of consent|3|||
154929865|NCT05004181|559167386|FG009|Overall Study|Withdrawal of consent|2|||
154929866|NCT05004181|559167387|FG010|Overall Study|Withdrawal of consent|5|||
154929867|NCT05004181|559167388|FG011|Overall Study|Withdrawal of consent|1|||
154929868|NCT05004181|559167377|FG000|Overall Study|Lost to Follow-up|2|||
154929869|NCT05004181|559167378|FG001|Overall Study|Lost to Follow-up|4|||
154929870|NCT05004181|559167379|FG002|Overall Study|Lost to Follow-up|2|||
154929871|NCT05004181|559167380|FG003|Overall Study|Lost to Follow-up|3|||
154929872|NCT05004181|559167381|FG004|Overall Study|Lost to Follow-up|5|||
154929873|NCT05004181|559167382|FG005|Overall Study|Lost to Follow-up|2|||
154929874|NCT05004181|559167383|FG006|Overall Study|Lost to Follow-up|15|||
154929875|NCT05004181|559167384|FG007|Overall Study|Lost to Follow-up|12|||
154929876|NCT05004181|559167385|FG008|Overall Study|Lost to Follow-up|38|||
154929877|NCT05004181|559167386|FG009|Overall Study|Lost to Follow-up|6|||
154929878|NCT05004181|559167387|FG010|Overall Study|Lost to Follow-up|6|||
154929879|NCT05004181|559167388|FG011|Overall Study|Lost to Follow-up|0|||
154929880|NCT05004181|559167377|FG000|Overall Study|Death|0|||
154929881|NCT05004181|559167378|FG001|Overall Study|Death|0|||
154929882|NCT05004181|559167379|FG002|Overall Study|Death|0|||
154929883|NCT05004181|559167380|FG003|Overall Study|Death|0|||
154929884|NCT05004181|559167381|FG004|Overall Study|Death|0|||
154929885|NCT05004181|559167382|FG005|Overall Study|Death|0|||
154929886|NCT05004181|559167383|FG006|Overall Study|Death|1|||
154929887|NCT05004181|559167384|FG007|Overall Study|Death|0|||
154929888|NCT05004181|559167385|FG008|Overall Study|Death|2|||
154929889|NCT05004181|559167386|FG009|Overall Study|Death|0|||
154929890|NCT05004181|559167387|FG010|Overall Study|Death|0|||
154929891|NCT05004181|559167388|FG011|Overall Study|Death|0|||
154929892|NCT05004181|559167377|FG000|Overall Study|Physician Decision|0|||
154929893|NCT05004181|559167378|FG001|Overall Study|Physician Decision|0|||
154929894|NCT05004181|559167379|FG002|Overall Study|Physician Decision|0|||
154929895|NCT05004181|559167380|FG003|Overall Study|Physician Decision|0|||
154929896|NCT05004181|559167381|FG004|Overall Study|Physician Decision|0|||
154929897|NCT05004181|559167382|FG005|Overall Study|Physician Decision|0|||
154929898|NCT05004181|559167383|FG006|Overall Study|Physician Decision|2|||
154929899|NCT05004181|559167384|FG007|Overall Study|Physician Decision|0|||
154929900|NCT05004181|559167385|FG008|Overall Study|Physician Decision|7|||
154929901|NCT05004181|559167386|FG009|Overall Study|Physician Decision|0|||
154929902|NCT05004181|559167387|FG010|Overall Study|Physician Decision|0|||
154929903|NCT05004181|559167388|FG011|Overall Study|Physician Decision|0|||
154929904|NCT05004181|559167377|FG000|Overall Study|Withdrawal by Subject|2|||
155266946|NCT00152009|560410925|FG003|Overall Study|Sponsor's decision|3|||
155266947|NCT01306201|560410926|FG000|Overall Study|Arrhythmia|4|||
154929905|NCT05004181|559167378|FG001|Overall Study|Withdrawal by Subject|3|||
154929906|NCT05004181|559167379|FG002|Overall Study|Withdrawal by Subject|2|||
154929907|NCT05004181|559167380|FG003|Overall Study|Withdrawal by Subject|2|||
154929908|NCT05004181|559167381|FG004|Overall Study|Withdrawal by Subject|4|||
154929909|NCT05004181|559167382|FG005|Overall Study|Withdrawal by Subject|2|||
154929910|NCT05004181|559167383|FG006|Overall Study|Withdrawal by Subject|4|||
154929911|NCT05004181|559167384|FG007|Overall Study|Withdrawal by Subject|22|||
154929912|NCT05004181|559167385|FG008|Overall Study|Withdrawal by Subject|8|||
154929913|NCT05004181|559167386|FG009|Overall Study|Withdrawal by Subject|1|||
154929914|NCT05004181|559167387|FG010|Overall Study|Withdrawal by Subject|3|||
154929915|NCT05004181|559167388|FG011|Overall Study|Withdrawal by Subject|2|||
154929916|NCT05004181|559167377|FG000|Overall Study|Protocol Violation|2|||
154929917|NCT05004181|559167378|FG001|Overall Study|Protocol Violation|3|||
155266948|NCT01306201|560410926|FG000|Overall Study|Files could not be processed|3|||
154929918|NCT05004181|559167379|FG002|Overall Study|Protocol Violation|0|||
154929919|NCT05004181|559167380|FG003|Overall Study|Protocol Violation|0|||
155266949|NCT01306201|560410926|FG000|Overall Study|Files unreadable|3|||
154929920|NCT05004181|559167381|FG004|Overall Study|Protocol Violation|1|||
154929921|NCT05004181|559167382|FG005|Overall Study|Protocol Violation|0|||
154929922|NCT05004181|559167383|FG006|Overall Study|Protocol Violation|16|||
154929923|NCT05004181|559167384|FG007|Overall Study|Protocol Violation|18|||
154929924|NCT05004181|559167385|FG008|Overall Study|Protocol Violation|2|||
154929925|NCT05004181|559167386|FG009|Overall Study|Protocol Violation|2|||
154929926|NCT05004181|559167387|FG010|Overall Study|Protocol Violation|2|||
154929927|NCT05004181|559167388|FG011|Overall Study|Protocol Violation|1|||
154929928|NCT05004181|559167377|FG000|Overall Study|Not further specified|1|||
154929929|NCT05004181|559167378|FG001|Overall Study|Not further specified|0|||
154929930|NCT05004181|559167379|FG002|Overall Study|Not further specified|0|||
154929931|NCT05004181|559167380|FG003|Overall Study|Not further specified|0|||
154929932|NCT05004181|559167381|FG004|Overall Study|Not further specified|0|||
154929933|NCT05004181|559167382|FG005|Overall Study|Not further specified|0|||
154929934|NCT05004181|559167383|FG006|Overall Study|Not further specified|1|||
154929935|NCT05004181|559167384|FG007|Overall Study|Not further specified|0|||
154929936|NCT05004181|559167385|FG008|Overall Study|Not further specified|2|||
154929937|NCT05004181|559167386|FG009|Overall Study|Not further specified|1|||
154929938|NCT05004181|559167387|FG010|Overall Study|Not further specified|0|||
154929939|NCT05004181|559167388|FG011|Overall Study|Not further specified|1|||
154929940|NCT01298661|559167393|FG000|Overall Study|Withdrawal by Subject|2|||
154929941|NCT01298661|559167394|FG001|Overall Study|Withdrawal by Subject|0|||
154929942|NCT01298661|559167395|FG002|Overall Study|Withdrawal by Subject|2|||
154929943|NCT00526227|559167396|FG000|Overall Study|Device not implanted|1|||
154929944|NCT00526227|559167396|FG000|Overall Study|Death|1|||
154929945|NCT01652573|559169208|FG000|Overall Study|Adverse Event|0|||
154929946|NCT01652573|559169209|FG001|Overall Study|Adverse Event|1|||
154929947|NCT03284424|559169210|FG000|Overall Study|Death|70|||
154929948|NCT03284424|559169211|FG001|Overall Study|Death|24|||
154929949|NCT03284424|559169210|FG000|Overall Study|Lost to Follow-up|3|||
154929950|NCT03284424|559169211|FG001|Overall Study|Lost to Follow-up|1|||
154929951|NCT03284424|559169210|FG000|Overall Study|Physician Decision|1|||
154929952|NCT03284424|559169211|FG001|Overall Study|Physician Decision|2|||
154929953|NCT03284424|559169210|FG000|Overall Study|Withdrawal by Subject|4|||
154929954|NCT03284424|559169211|FG001|Overall Study|Withdrawal by Subject|5|||
154929955|NCT03284424|559169210|FG000|Overall Study|Sponsor's decision|27|||
154929956|NCT03284424|559169211|FG001|Overall Study|Sponsor's decision|22|||
154929957|NCT01052038|559169212|FG000|Overall Study|Lost to Follow-up|2|||
154929958|NCT01052038|559169213|FG001|Overall Study|Lost to Follow-up|3|||
154929959|NCT01052038|559169214|FG002|Overall Study|Lost to Follow-up|1|||
154929960|NCT01052038|559169212|FG000|Overall Study|Protocol Violation|2|||
154929961|NCT01052038|559169213|FG001|Overall Study|Protocol Violation|3|||
154929962|NCT01052038|559169214|FG002|Overall Study|Protocol Violation|3|||
154929963|NCT03349437|559169215|FG000|Screening|Screen Fail|4|||
154929964|NCT03349437|559169216|FG001|Screening|Screen Fail|0|||
154929965|NCT03349437|559169217|FG002|Screening|Screen Fail|0|||
154929966|NCT03349437|559169215|FG000|Screening|Withdrawn|1|||
154929967|NCT03349437|559169216|FG001|Screening|Withdrawn|0|||
154929968|NCT03349437|559169217|FG002|Screening|Withdrawn|0|||
154929969|NCT00765999|559169218|FG000|Overall Study|Adverse Event|203|||
154929970|NCT00765999|559169218|FG000|Overall Study|Insufficient Therapeutic Response|100|||
154929971|NCT00765999|559169218|FG000|Overall Study|Protocol Violation|95|||
154929972|NCT00765999|559169218|FG000|Overall Study|Consent Withdrawn|202|||
154929973|NCT00765999|559169218|FG000|Overall Study|Lost to Follow-up|131|||
154929974|NCT00765999|559169218|FG000|Overall Study|Study Terminated by Sponsor|2|||
154929975|NCT00765999|559169218|FG000|Overall Study|Other Miscellaneous Reasons|51|||
154929976|NCT00759174|559169221|FG000|Overall Study|Other|0|||
154929977|NCT00759174|559169222|FG001|Overall Study|Other|2|||
154929978|NCT01890109|559169223|FG000|Overall Study|Withdrawal by Subject|0|||
154929979|NCT01890109|559169224|FG001|Overall Study|Withdrawal by Subject|3|||
154929980|NCT01890109|559169223|FG000|Overall Study|Lost to Follow-up|1|||
154929981|NCT01890109|559169224|FG001|Overall Study|Lost to Follow-up|2|||
154929982|NCT01643928|559169225|FG000|Overall Study|Lost to Follow-up|1|||
154929983|NCT01643928|559169226|FG001|Overall Study|Lost to Follow-up|0|||
154929984|NCT01643928|559169227|FG002|Overall Study|Lost to Follow-up|2|||
154929985|NCT01643928|559169228|FG003|Overall Study|Lost to Follow-up|0|||
154929986|NCT01643928|559169229|FG004|Overall Study|Lost to Follow-up|0|||
154929987|NCT01643928|559169225|FG000|Overall Study|Withdrawal by Subject|2|||
154929988|NCT01643928|559169226|FG001|Overall Study|Withdrawal by Subject|0|||
154929989|NCT01643928|559169227|FG002|Overall Study|Withdrawal by Subject|0|||
154929990|NCT01643928|559169228|FG003|Overall Study|Withdrawal by Subject|1|||
154929991|NCT01643928|559169229|FG004|Overall Study|Withdrawal by Subject|0|||
154929992|NCT01643928|559169225|FG000|Overall Study|Pregnancy|0|||
154929993|NCT01643928|559169226|FG001|Overall Study|Pregnancy|0|||
154929994|NCT01643928|559169227|FG002|Overall Study|Pregnancy|0|||
154929995|NCT01643928|559169228|FG003|Overall Study|Pregnancy|1|||
154929996|NCT01643928|559169229|FG004|Overall Study|Pregnancy|0|||
154929997|NCT01643928|559169225|FG000|Overall Study|Other|5|||
154929998|NCT01643928|559169226|FG001|Overall Study|Other|1|||
154929999|NCT01643928|559169227|FG002|Overall Study|Other|1|||
154930000|NCT01643928|559169228|FG003|Overall Study|Other|0|||
154930001|NCT01643928|559169229|FG004|Overall Study|Other|0|||
154930002|NCT01643928|559169225|FG000|Overall Study|Adverse Event|2|||
154930003|NCT01643928|559169226|FG001|Overall Study|Adverse Event|1|||
154930004|NCT01643928|559169227|FG002|Overall Study|Adverse Event|0|||
154930005|NCT01643928|559169228|FG003|Overall Study|Adverse Event|1|||
154930006|NCT01643928|559169229|FG004|Overall Study|Adverse Event|2|||
154930007|NCT05723835|559169235|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
154930008|NCT05723835|559169236|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
154930009|NCT05723835|559169237|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
154930010|NCT05723835|559169238|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
154930011|NCT05723835|559169239|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
154930012|NCT05723835|559169240|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
154930013|NCT05723835|559169241|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
154930014|NCT05723835|559169242|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
154930015|NCT05226286|559169243|FG000|Overall Study|Screen failures prior to implant|62|||
154930016|NCT05226286|559169243|FG000|Overall Study|Withdrawal by Subject|13|||
154930017|NCT05226286|559169243|FG000|Overall Study|Lost to Follow-up|3|||
154930018|NCT05226286|559169243|FG000|Overall Study|Physician Decision|1|||
154930019|NCT05226286|559169243|FG000|Overall Study|Adverse Event|1|||
154930020|NCT05226286|559169243|FG000|Overall Study|Death|1|||
154930021|NCT05226286|559169243|FG000|Overall Study|Device explant with no planned replacement|1|||
154930022|NCT05226286|559169243|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
154930023|NCT05226286|559169243|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
154930024|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
154930025|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
154930026|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
154930027|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
154930028|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
154930029|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
154930030|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
154930031|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
154930032|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
154930033|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
154930034|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
154930035|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
154930036|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
154930037|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
154930038|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
154930039|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
154930040|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
154930041|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
154930042|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
154930043|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
154930044|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
154930045|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
154930046|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
154930047|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
154930048|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
154930049|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
154930050|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
154930051|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
154930052|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
154930053|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
154930054|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
154930055|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
154930056|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
154930057|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
154930058|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
154930059|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
154930060|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
154930061|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
154930062|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
154930063|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
154930064|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
154930065|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
154930066|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
154930067|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
154930068|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
154930069|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
154930070|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
154930071|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
154930072|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
154930073|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
154930074|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
154930075|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
154930076|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
154930077|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
154930078|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
154930079|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
154930080|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
154930081|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
154930082|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
154930083|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
154930084|NCT03395197|559169244|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
154930085|NCT03395197|559169245|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
154930086|NCT03395197|559169246|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
154930087|NCT03395197|559169247|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
154930088|NCT03395197|559169248|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
154930089|NCT03395197|559169249|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
154930090|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Death|0|||
154930091|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Death|0|||
154930092|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Death|0|||
154930093|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Death|0|||
154930094|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Death|1|||
154930095|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Death|4|||
154930096|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
154930097|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
154930098|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
154930099|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
154930100|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
154930101|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
154930102|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
154930103|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
154930104|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
154930105|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
154930106|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
154930107|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
154930108|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
154930109|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
154930110|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
154930111|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
154930112|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
154930113|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
154930114|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
154930115|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
154930116|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
154930117|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
154930118|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
154930119|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
154930120|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
154930121|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
154930122|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
154930123|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
155042966|NCT00073008|559588026|FG000|Overall Study|Death|46|||
154930124|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
154930125|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
154930126|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
154930127|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
154930128|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
154930129|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
154930130|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
154930131|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
154930132|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Other|0|||
154930133|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Other|0|||
154930134|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Other|0|||
154930135|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Other|0|||
154930136|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Other|3|||
154930137|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Other|3|||
154930138|NCT03395197|559169244|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
154930139|NCT03395197|559169245|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
154930140|NCT03395197|559169246|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
154930141|NCT03395197|559169247|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
154930142|NCT03395197|559169248|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
154930143|NCT03395197|559169249|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
154930144|NCT00602641|559169250|FG000|Overall Study|Never started protocol therapy|6|||
154930145|NCT00602641|559169251|FG001|Overall Study|Never started protocol therapy|2|||
154930146|NCT00602641|559169250|FG000|Overall Study|Still on treatment at time of analysis|8|||
154930147|NCT00602641|559169251|FG001|Overall Study|Still on treatment at time of analysis|15|||
154930148|NCT00602641|559169250|FG000|Overall Study|Adverse Event|62|||
154930149|NCT00602641|559169251|FG001|Overall Study|Adverse Event|53|||
154930150|NCT00602641|559169250|FG000|Overall Study|Disease progression|38|||
154930151|NCT00602641|559169251|FG001|Overall Study|Disease progression|55|||
154930152|NCT00602641|559169250|FG000|Overall Study|Death|6|||
154930153|NCT00602641|559169251|FG001|Overall Study|Death|5|||
154930154|NCT00602641|559169250|FG000|Overall Study|Withdrawal by Subject|15|||
154930155|NCT00602641|559169251|FG001|Overall Study|Withdrawal by Subject|12|||
154930156|NCT00602641|559169250|FG000|Overall Study|Alternative therapy|5|||
154930157|NCT00602641|559169251|FG001|Overall Study|Alternative therapy|2|||
154930158|NCT00602641|559169250|FG000|Overall Study|Other Complicating Disease|5|||
154930159|NCT00602641|559169251|FG001|Overall Study|Other Complicating Disease|2|||
154930160|NCT00602641|559169250|FG000|Overall Study|Physician Decision|5|||
154930161|NCT00602641|559169251|FG001|Overall Study|Physician Decision|4|||
154930162|NCT00602641|559169250|FG000|Overall Study|Administrative Closure|1|||
154930163|NCT00602641|559169251|FG001|Overall Study|Administrative Closure|1|||
154930164|NCT00602641|559169250|FG000|Overall Study|Other|3|||
154930165|NCT00602641|559169251|FG001|Overall Study|Other|1|||
154930166|NCT01826201|559169254|FG000|Overall Study|Non compliance with protocol|4|||
154930167|NCT01615822|559169255|FG000|Period 1|Withdrawal by Subject|0|||
154930168|NCT01615822|559169256|FG001|Period 1|Withdrawal by Subject|1|||
154930169|NCT01615822|559169257|FG002|Period 1|Withdrawal by Subject|0|||
154930170|NCT01615822|559169255|FG000|Period 1|Adverse Event|1|||
154930171|NCT01615822|559169256|FG001|Period 1|Adverse Event|1|||
154930172|NCT01615822|559169257|FG002|Period 1|Adverse Event|0|||
154930173|NCT01615822|559169255|FG000|Period 2|Lost to Follow-up|0|||
154930174|NCT01615822|559169256|FG001|Period 2|Lost to Follow-up|1|||
154930175|NCT01615822|559169257|FG002|Period 2|Lost to Follow-up|2|||
154930176|NCT01988337|559169260|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
154930177|NCT02742818|559169261|FG000|Overall Study|Adverse Event|0|||
154930178|NCT02742818|559169262|FG001|Overall Study|Adverse Event|1|||
154930179|NCT02742818|559169261|FG000|Overall Study|Protocol Violation|0|||
154930180|NCT02742818|559169262|FG001|Overall Study|Protocol Violation|1|||
154930181|NCT04701658|559169263|FG000|Overall Study|Lost to Follow-up|6|||
154930182|NCT03099161|559169266|FG000|Overall Study|Adverse Event|0|||
154930183|NCT03099161|559169267|FG001|Overall Study|Adverse Event|0|||
154930184|NCT03099161|559169268|FG002|Overall Study|Adverse Event|2|||
154930185|NCT03099161|559169266|FG000|Overall Study|Physician Decision|2|||
154930186|NCT03099161|559169267|FG001|Overall Study|Physician Decision|0|||
155042967|NCT00073008|559588027|FG001|Overall Study|Death|47|||
154930187|NCT03099161|559169268|FG002|Overall Study|Physician Decision|0|||
154930188|NCT03099161|559169266|FG000|Overall Study|Progressive Disease|1|||
154930189|NCT03099161|559169267|FG001|Overall Study|Progressive Disease|4|||
154930190|NCT03099161|559169268|FG002|Overall Study|Progressive Disease|1|||
154930191|NCT00110084|559169269|FG000|Overall Study|Adverse Event|9|||
154930192|NCT00110084|559169269|FG000|Overall Study|Death|1|||
154930193|NCT00110084|559169269|FG000|Overall Study|Patient Refusal|10|||
154930194|NCT00110084|559169269|FG000|Overall Study|Alternate Therapy|5|||
154930195|NCT00110084|559169269|FG000|Overall Study|Intercurrent Illness|1|||
154930196|NCT00110084|559169269|FG000|Overall Study|Other|2|||
154930197|NCT04854707|559169270|FG000|Overall Study|Lack of Efficacy|78|||
154930198|NCT04854707|559169271|FG001|Overall Study|Lack of Efficacy|59|||
154930199|NCT04854707|559169272|FG002|Overall Study|Lack of Efficacy|30|||
154930200|NCT05302414|559169274|FG000|Pretest to Posttest|Lost to Follow-up|12|||
154930201|NCT05302414|559169275|FG001|Pretest to Posttest|Lost to Follow-up|8|||
154930202|NCT05302414|559169276|FG002|Pretest to Posttest|Lost to Follow-up|8|||
154930203|NCT05302414|559169274|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
154930204|NCT05302414|559169275|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
154930205|NCT05302414|559169276|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
154930206|NCT00742859|559169277|FG000|Overall Study|Adverse Event|5|||
154930207|NCT00742859|559169278|FG001|Overall Study|Adverse Event|6|||
154930208|NCT00742859|559169279|FG002|Overall Study|Adverse Event|3|||
154930209|NCT00742859|559169280|FG003|Overall Study|Adverse Event|1|||
154930210|NCT00742859|559169277|FG000|Overall Study|Death|1|||
154930211|NCT00742859|559169278|FG001|Overall Study|Death|0|||
154930212|NCT00742859|559169279|FG002|Overall Study|Death|0|||
154930213|NCT00742859|559169280|FG003|Overall Study|Death|1|||
154930214|NCT00742859|559169277|FG000|Overall Study|Physician Decision|1|||
154930215|NCT00742859|559169278|FG001|Overall Study|Physician Decision|2|||
154930216|NCT00742859|559169279|FG002|Overall Study|Physician Decision|0|||
154930217|NCT00742859|559169280|FG003|Overall Study|Physician Decision|0|||
154930218|NCT00742859|559169277|FG000|Overall Study|Withdrawal by Subject|4|||
154930219|NCT00742859|559169278|FG001|Overall Study|Withdrawal by Subject|2|||
154930220|NCT00742859|559169279|FG002|Overall Study|Withdrawal by Subject|4|||
154930221|NCT00742859|559169280|FG003|Overall Study|Withdrawal by Subject|1|||
154930222|NCT00742859|559169277|FG000|Overall Study|Endpoint|0|||
154930223|NCT00742859|559169278|FG001|Overall Study|Endpoint|1|||
154930224|NCT00742859|559169279|FG002|Overall Study|Endpoint|1|||
154930225|NCT00742859|559169280|FG003|Overall Study|Endpoint|2|||
154930226|NCT00742859|559169277|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
154930227|NCT00742859|559169278|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
154930228|NCT00742859|559169279|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
154930229|NCT00742859|559169280|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
154930230|NCT00742859|559169277|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
154930231|NCT00742859|559169278|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
154930232|NCT00742859|559169279|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
154930233|NCT00742859|559169280|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
154930234|NCT00742859|559169277|FG000|Overall Study|Sponsor request patient out of town|0|||
154930235|NCT00742859|559169278|FG001|Overall Study|Sponsor request patient out of town|0|||
154930236|NCT00742859|559169279|FG002|Overall Study|Sponsor request patient out of town|1|||
154930237|NCT00742859|559169280|FG003|Overall Study|Sponsor request patient out of town|1|||
154930238|NCT00742859|559169277|FG000|Overall Study|Site error|0|||
154930239|NCT00742859|559169278|FG001|Overall Study|Site error|0|||
154930240|NCT00742859|559169279|FG002|Overall Study|Site error|1|||
154930241|NCT00742859|559169280|FG003|Overall Study|Site error|1|||
154930242|NCT02017535|559169283|FG000|Overall Study|Withdrawal by Subject|1|||
154930243|NCT02017535|559169284|FG001|Overall Study|Withdrawal by Subject|0|||
154930244|NCT02017535|559169285|FG002|Overall Study|Withdrawal by Subject|0|||
154930245|NCT02017535|559169286|FG003|Overall Study|Withdrawal by Subject|0|||
154930246|NCT05824273|559169289|FG000|Overall Study|Lost to Follow-up|16|||
154930247|NCT05824273|559169290|FG001|Overall Study|Lost to Follow-up|13|||
154930248|NCT02736695|559169291|FG000|Overall Study|Ineligible|6|||
154930249|NCT02736695|559169292|FG001|Overall Study|Ineligible|0|||
154930250|NCT03193190|559169295|FG000|Stage 1|Arm Terminated by Sponsor|0|||
154930251|NCT03193190|559169296|FG001|Stage 1|Arm Terminated by Sponsor|0|||
154930252|NCT03193190|559169297|FG002|Stage 1|Arm Terminated by Sponsor|0|||
154930253|NCT03193190|559169298|FG003|Stage 1|Arm Terminated by Sponsor|1|||
154930254|NCT03193190|559169299|FG004|Stage 1|Arm Terminated by Sponsor|0|||
154930255|NCT03193190|559169300|FG005|Stage 1|Arm Terminated by Sponsor|2|||
154930256|NCT03193190|559169301|FG006|Stage 1|Arm Terminated by Sponsor|0|||
154930257|NCT03193190|559169302|FG007|Stage 1|Arm Terminated by Sponsor|0|||
154930258|NCT03193190|559169303|FG008|Stage 1|Arm Terminated by Sponsor|0|||
154930259|NCT03193190|559169304|FG009|Stage 1|Arm Terminated by Sponsor|0|||
154930260|NCT03193190|559169305|FG010|Stage 1|Arm Terminated by Sponsor|0|||
154930261|NCT03193190|559169306|FG011|Stage 1|Arm Terminated by Sponsor|0|||
154930262|NCT03193190|559169307|FG012|Stage 1|Arm Terminated by Sponsor|0|||
154930263|NCT03193190|559169308|FG013|Stage 1|Arm Terminated by Sponsor|0|||
154930264|NCT03193190|559169309|FG014|Stage 1|Arm Terminated by Sponsor|0|||
154930265|NCT03193190|559169310|FG015|Stage 1|Arm Terminated by Sponsor|0|||
154930266|NCT03193190|559169295|FG000|Stage 1|Death|22|||
154930267|NCT03193190|559169296|FG001|Stage 1|Death|8|||
154930268|NCT03193190|559169297|FG002|Stage 1|Death|23|||
154930269|NCT03193190|559169298|FG003|Stage 1|Death|14|||
154930270|NCT03193190|559169299|FG004|Stage 1|Death|34|||
154930271|NCT03193190|559169300|FG005|Stage 1|Death|28|||
154930272|NCT03193190|559169301|FG006|Stage 1|Death|19|||
154930273|NCT03193190|559169302|FG007|Stage 1|Death|21|||
154930274|NCT03193190|559169303|FG008|Stage 1|Death|14|||
154930275|NCT03193190|559169304|FG009|Stage 1|Death|10|||
154930276|NCT03193190|559169305|FG010|Stage 1|Death|59|||
154930277|NCT03193190|559169306|FG011|Stage 1|Death|14|||
154930278|NCT03193190|559169307|FG012|Stage 1|Death|14|||
154930279|NCT03193190|559169308|FG013|Stage 1|Death|0|||
154930280|NCT03193190|559169309|FG014|Stage 1|Death|0|||
154930281|NCT03193190|559169310|FG015|Stage 1|Death|0|||
154930282|NCT03193190|559169295|FG000|Stage 1|Lost to Follow-up|2|||
154930283|NCT03193190|559169296|FG001|Stage 1|Lost to Follow-up|1|||
154930284|NCT03193190|559169297|FG002|Stage 1|Lost to Follow-up|1|||
154930285|NCT03193190|559169298|FG003|Stage 1|Lost to Follow-up|0|||
154930286|NCT03193190|559169299|FG004|Stage 1|Lost to Follow-up|0|||
154930287|NCT03193190|559169300|FG005|Stage 1|Lost to Follow-up|0|||
154930288|NCT03193190|559169301|FG006|Stage 1|Lost to Follow-up|1|||
154930289|NCT03193190|559169302|FG007|Stage 1|Lost to Follow-up|0|||
154930290|NCT03193190|559169303|FG008|Stage 1|Lost to Follow-up|0|||
154930291|NCT03193190|559169304|FG009|Stage 1|Lost to Follow-up|0|||
154930292|NCT03193190|559169305|FG010|Stage 1|Lost to Follow-up|0|||
154930293|NCT03193190|559169306|FG011|Stage 1|Lost to Follow-up|0|||
154930294|NCT03193190|559169307|FG012|Stage 1|Lost to Follow-up|0|||
154930295|NCT03193190|559169308|FG013|Stage 1|Lost to Follow-up|0|||
154930296|NCT03193190|559169309|FG014|Stage 1|Lost to Follow-up|0|||
154930297|NCT03193190|559169310|FG015|Stage 1|Lost to Follow-up|0|||
154930298|NCT03193190|559169295|FG000|Stage 1|Reason not Specified|1|||
154930299|NCT03193190|559169296|FG001|Stage 1|Reason not Specified|0|||
154930300|NCT03193190|559169297|FG002|Stage 1|Reason not Specified|0|||
154930301|NCT03193190|559169298|FG003|Stage 1|Reason not Specified|1|||
154930302|NCT03193190|559169299|FG004|Stage 1|Reason not Specified|0|||
154930303|NCT03193190|559169300|FG005|Stage 1|Reason not Specified|1|||
154930304|NCT03193190|559169301|FG006|Stage 1|Reason not Specified|2|||
154930305|NCT03193190|559169302|FG007|Stage 1|Reason not Specified|2|||
154930306|NCT03193190|559169303|FG008|Stage 1|Reason not Specified|0|||
154930307|NCT03193190|559169304|FG009|Stage 1|Reason not Specified|1|||
154930308|NCT03193190|559169305|FG010|Stage 1|Reason not Specified|3|||
154930309|NCT03193190|559169306|FG011|Stage 1|Reason not Specified|0|||
154930310|NCT03193190|559169307|FG012|Stage 1|Reason not Specified|1|||
154930311|NCT03193190|559169308|FG013|Stage 1|Reason not Specified|0|||
154930312|NCT03193190|559169309|FG014|Stage 1|Reason not Specified|0|||
154930313|NCT03193190|559169310|FG015|Stage 1|Reason not Specified|0|||
154930314|NCT03193190|559169295|FG000|Stage 1|Physician Decision|0|||
154930315|NCT03193190|559169296|FG001|Stage 1|Physician Decision|0|||
154930316|NCT03193190|559169297|FG002|Stage 1|Physician Decision|0|||
154930317|NCT03193190|559169298|FG003|Stage 1|Physician Decision|0|||
154930318|NCT03193190|559169299|FG004|Stage 1|Physician Decision|0|||
154930319|NCT03193190|559169300|FG005|Stage 1|Physician Decision|0|||
154930320|NCT03193190|559169301|FG006|Stage 1|Physician Decision|0|||
154930321|NCT03193190|559169302|FG007|Stage 1|Physician Decision|0|||
154930322|NCT03193190|559169303|FG008|Stage 1|Physician Decision|0|||
154930323|NCT03193190|559169304|FG009|Stage 1|Physician Decision|0|||
154930324|NCT03193190|559169305|FG010|Stage 1|Physician Decision|0|||
154930325|NCT03193190|559169306|FG011|Stage 1|Physician Decision|1|||
154930326|NCT03193190|559169307|FG012|Stage 1|Physician Decision|0|||
154930327|NCT03193190|559169308|FG013|Stage 1|Physician Decision|0|||
154930328|NCT03193190|559169309|FG014|Stage 1|Physician Decision|0|||
154930329|NCT03193190|559169310|FG015|Stage 1|Physician Decision|0|||
154930330|NCT03193190|559169295|FG000|Stage 1|Progressive Disease|1|||
154930331|NCT03193190|559169296|FG001|Stage 1|Progressive Disease|0|||
154930332|NCT03193190|559169297|FG002|Stage 1|Progressive Disease|0|||
154930333|NCT03193190|559169298|FG003|Stage 1|Progressive Disease|0|||
154930334|NCT03193190|559169299|FG004|Stage 1|Progressive Disease|0|||
154930335|NCT03193190|559169300|FG005|Stage 1|Progressive Disease|0|||
154930336|NCT03193190|559169301|FG006|Stage 1|Progressive Disease|0|||
154930337|NCT03193190|559169302|FG007|Stage 1|Progressive Disease|0|||
154930338|NCT03193190|559169303|FG008|Stage 1|Progressive Disease|0|||
154930339|NCT03193190|559169304|FG009|Stage 1|Progressive Disease|0|||
154930340|NCT03193190|559169305|FG010|Stage 1|Progressive Disease|0|||
154930341|NCT03193190|559169306|FG011|Stage 1|Progressive Disease|0|||
154930342|NCT03193190|559169307|FG012|Stage 1|Progressive Disease|0|||
154930343|NCT03193190|559169308|FG013|Stage 1|Progressive Disease|0|||
154930344|NCT03193190|559169309|FG014|Stage 1|Progressive Disease|0|||
154930345|NCT03193190|559169310|FG015|Stage 1|Progressive Disease|0|||
154930346|NCT03193190|559169295|FG000|Stage 1|Study Terminated By Sponsor|3|||
155042968|NCT00073008|559588026|FG000|Overall Study|"Other selected on Case Report Form"|7|||
155042969|NCT00073008|559588027|FG001|Overall Study|"Other selected on Case Report Form"|5|||
155042970|NCT01778751|559588035|FG000|Overall Study|Lost to Follow-up|1|||
154930347|NCT03193190|559169296|FG001|Stage 1|Study Terminated By Sponsor|0|||
154930348|NCT03193190|559169297|FG002|Stage 1|Study Terminated By Sponsor|0|||
154930349|NCT03193190|559169298|FG003|Stage 1|Study Terminated By Sponsor|0|||
154930350|NCT03193190|559169299|FG004|Stage 1|Study Terminated By Sponsor|6|||
154930351|NCT03193190|559169300|FG005|Stage 1|Study Terminated By Sponsor|0|||
154930352|NCT03193190|559169301|FG006|Stage 1|Study Terminated By Sponsor|0|||
154930353|NCT03193190|559169302|FG007|Stage 1|Study Terminated By Sponsor|0|||
154930354|NCT03193190|559169303|FG008|Stage 1|Study Terminated By Sponsor|0|||
154930355|NCT03193190|559169304|FG009|Stage 1|Study Terminated By Sponsor|0|||
155381698|NCT04617275|560830987|FG003|Treatment Period|Lost to Follow-up|0|||
154930356|NCT03193190|559169305|FG010|Stage 1|Study Terminated By Sponsor|0|||
154930357|NCT03193190|559169306|FG011|Stage 1|Study Terminated By Sponsor|0|||
154930358|NCT03193190|559169307|FG012|Stage 1|Study Terminated By Sponsor|0|||
154930359|NCT03193190|559169308|FG013|Stage 1|Study Terminated By Sponsor|0|||
154930360|NCT03193190|559169309|FG014|Stage 1|Study Terminated By Sponsor|0|||
154930361|NCT03193190|559169310|FG015|Stage 1|Study Terminated By Sponsor|0|||
154930362|NCT03193190|559169295|FG000|Stage 1|Withdrawal by Subject|6|||
154930363|NCT03193190|559169296|FG001|Stage 1|Withdrawal by Subject|0|||
154930364|NCT03193190|559169297|FG002|Stage 1|Withdrawal by Subject|1|||
154930365|NCT03193190|559169298|FG003|Stage 1|Withdrawal by Subject|0|||
154930366|NCT03193190|559169299|FG004|Stage 1|Withdrawal by Subject|2|||
154930367|NCT03193190|559169300|FG005|Stage 1|Withdrawal by Subject|0|||
154930368|NCT03193190|559169301|FG006|Stage 1|Withdrawal by Subject|3|||
154930369|NCT03193190|559169302|FG007|Stage 1|Withdrawal by Subject|2|||
154930370|NCT03193190|559169303|FG008|Stage 1|Withdrawal by Subject|2|||
154930371|NCT03193190|559169304|FG009|Stage 1|Withdrawal by Subject|4|||
154930372|NCT03193190|559169305|FG010|Stage 1|Withdrawal by Subject|9|||
154930373|NCT03193190|559169306|FG011|Stage 1|Withdrawal by Subject|1|||
154930374|NCT03193190|559169307|FG012|Stage 1|Withdrawal by Subject|0|||
154930375|NCT03193190|559169308|FG013|Stage 1|Withdrawal by Subject|0|||
154930376|NCT03193190|559169309|FG014|Stage 1|Withdrawal by Subject|0|||
154930377|NCT03193190|559169310|FG015|Stage 1|Withdrawal by Subject|0|||
154930378|NCT03193190|559169295|FG000|Stage 2|Death|0|||
154930379|NCT03193190|559169296|FG001|Stage 2|Death|0|||
154930380|NCT03193190|559169297|FG002|Stage 2|Death|0|||
154930381|NCT03193190|559169298|FG003|Stage 2|Death|0|||
154930382|NCT03193190|559169299|FG004|Stage 2|Death|0|||
154930383|NCT03193190|559169300|FG005|Stage 2|Death|0|||
154930384|NCT03193190|559169301|FG006|Stage 2|Death|0|||
154930385|NCT03193190|559169302|FG007|Stage 2|Death|0|||
154930386|NCT03193190|559169303|FG008|Stage 2|Death|0|||
154930387|NCT03193190|559169304|FG009|Stage 2|Death|0|||
154930388|NCT03193190|559169305|FG010|Stage 2|Death|0|||
154930389|NCT03193190|559169306|FG011|Stage 2|Death|0|||
154930390|NCT03193190|559169307|FG012|Stage 2|Death|0|||
154930391|NCT03193190|559169308|FG013|Stage 2|Death|14|||
154930392|NCT03193190|559169309|FG014|Stage 2|Death|4|||
154930393|NCT03193190|559169310|FG015|Stage 2|Death|1|||
154930394|NCT03193190|559169295|FG000|Stage 2|Lost to Follow-up|0|||
154930395|NCT03193190|559169296|FG001|Stage 2|Lost to Follow-up|0|||
154930396|NCT03193190|559169297|FG002|Stage 2|Lost to Follow-up|0|||
154930397|NCT03193190|559169298|FG003|Stage 2|Lost to Follow-up|0|||
154930398|NCT03193190|559169299|FG004|Stage 2|Lost to Follow-up|0|||
154930399|NCT03193190|559169300|FG005|Stage 2|Lost to Follow-up|0|||
154930400|NCT03193190|559169301|FG006|Stage 2|Lost to Follow-up|0|||
154930401|NCT03193190|559169302|FG007|Stage 2|Lost to Follow-up|0|||
154930402|NCT03193190|559169303|FG008|Stage 2|Lost to Follow-up|0|||
154930403|NCT03193190|559169304|FG009|Stage 2|Lost to Follow-up|0|||
154930404|NCT03193190|559169305|FG010|Stage 2|Lost to Follow-up|0|||
154930405|NCT03193190|559169306|FG011|Stage 2|Lost to Follow-up|0|||
154930406|NCT03193190|559169307|FG012|Stage 2|Lost to Follow-up|0|||
154930407|NCT03193190|559169308|FG013|Stage 2|Lost to Follow-up|0|||
154930408|NCT03193190|559169309|FG014|Stage 2|Lost to Follow-up|1|||
154930409|NCT03193190|559169310|FG015|Stage 2|Lost to Follow-up|0|||
154930410|NCT03193190|559169295|FG000|Stage 2|Withdrawal by Subject|0|||
154930411|NCT03193190|559169296|FG001|Stage 2|Withdrawal by Subject|0|||
154930412|NCT03193190|559169297|FG002|Stage 2|Withdrawal by Subject|0|||
154930413|NCT03193190|559169298|FG003|Stage 2|Withdrawal by Subject|0|||
154930414|NCT03193190|559169299|FG004|Stage 2|Withdrawal by Subject|0|||
154930415|NCT03193190|559169300|FG005|Stage 2|Withdrawal by Subject|0|||
154930416|NCT03193190|559169301|FG006|Stage 2|Withdrawal by Subject|0|||
154930417|NCT03193190|559169302|FG007|Stage 2|Withdrawal by Subject|0|||
154930418|NCT03193190|559169303|FG008|Stage 2|Withdrawal by Subject|0|||
154930419|NCT03193190|559169304|FG009|Stage 2|Withdrawal by Subject|0|||
154930420|NCT03193190|559169305|FG010|Stage 2|Withdrawal by Subject|0|||
154930421|NCT03193190|559169306|FG011|Stage 2|Withdrawal by Subject|0|||
154930422|NCT03193190|559169307|FG012|Stage 2|Withdrawal by Subject|0|||
154930423|NCT03193190|559169308|FG013|Stage 2|Withdrawal by Subject|1|||
154930424|NCT03193190|559169309|FG014|Stage 2|Withdrawal by Subject|1|||
154930425|NCT03193190|559169310|FG015|Stage 2|Withdrawal by Subject|0|||
154930426|NCT03868059|559169311|FG000|Overall Study|Adverse Event|3|||
154930427|NCT03868059|559169311|FG000|Overall Study|Lost to Follow-up|3|||
154930428|NCT03868059|559169311|FG000|Overall Study|Withdrawal by Subject|6|||
154930429|NCT04278872|559169318|FG000|Overall Study|Adverse Event|1|||
154930430|NCT04278872|559169319|FG001|Overall Study|Adverse Event|0|||
154930431|NCT04278872|559169318|FG000|Overall Study|Protocol Violation|0|||
154930432|NCT04278872|559169319|FG001|Overall Study|Protocol Violation|1|||
154930433|NCT04278872|559169318|FG000|Overall Study|Study Termination|2|||
154930434|NCT04278872|559169319|FG001|Overall Study|Study Termination|0|||
154930435|NCT05838755|559169325|FG000|Overall Study|Adverse Event|1|||
154930436|NCT05838755|559169326|FG001|Overall Study|Adverse Event|0|||
154930437|NCT05838755|559169327|FG002|Overall Study|Adverse Event|0|||
154930438|NCT05838755|559169325|FG000|Overall Study|Lack of Efficacy|1|||
154930439|NCT05838755|559169326|FG001|Overall Study|Lack of Efficacy|0|||
154930440|NCT05838755|559169327|FG002|Overall Study|Lack of Efficacy|1|||
154930441|NCT05838755|559169325|FG000|Overall Study|Lost to Follow-up|0|||
154930442|NCT05838755|559169326|FG001|Overall Study|Lost to Follow-up|1|||
154930443|NCT05838755|559169327|FG002|Overall Study|Lost to Follow-up|4|||
154930444|NCT05838755|559169325|FG000|Overall Study|Withdrawal by Subject|0|||
154930445|NCT05838755|559169326|FG001|Overall Study|Withdrawal by Subject|2|||
154930446|NCT05838755|559169327|FG002|Overall Study|Withdrawal by Subject|0|||
154930447|NCT05838755|559169325|FG000|Overall Study|Study terminated by sponsor|26|||
154930448|NCT05838755|559169326|FG001|Overall Study|Study terminated by sponsor|27|||
154930449|NCT05838755|559169327|FG002|Overall Study|Study terminated by sponsor|26|||
154930450|NCT05838755|559169325|FG000|Overall Study|Randomized, not treated|2|||
154930451|NCT05838755|559169326|FG001|Overall Study|Randomized, not treated|0|||
154930452|NCT05838755|559169327|FG002|Overall Study|Randomized, not treated|1|||
154930453|NCT05838755|559169325|FG000|Overall Study|Pregnancy|0|||
154930454|NCT05838755|559169326|FG001|Overall Study|Pregnancy|1|||
154930455|NCT05838755|559169327|FG002|Overall Study|Pregnancy|0|||
154930456|NCT00096031|559169328|FG000|Overall Study|Adverse Event|3|||
154930457|NCT00096031|559169328|FG000|Overall Study|Lack of Efficacy|42|||
154930458|NCT00096031|559169328|FG000|Overall Study|Death|4|||
154930459|NCT00096031|559169328|FG000|Overall Study|Withdrawal by Subject|1|||
154930460|NCT00096031|559169328|FG000|Overall Study|Ineligible|8|||
154930461|NCT00096031|559169328|FG000|Overall Study|Not protocol specified|5|||
154930462|NCT01283282|559169329|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
154930463|NCT01283282|559169330|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
154930464|NCT01283282|559169329|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
154930465|NCT01283282|559169330|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
154930466|NCT01283282|559169329|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
154930467|NCT01283282|559169330|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
154930468|NCT00483717|559169331|FG000|Overall Study|Protocol Violation|5|||
154930469|NCT00483717|559169332|FG001|Overall Study|Protocol Violation|7|||
154930470|NCT00483717|559169331|FG000|Overall Study|Time of dosing missing|1|||
154930471|NCT00483717|559169332|FG001|Overall Study|Time of dosing missing|1|||
154930472|NCT00483717|559169331|FG000|Overall Study|No treatment for migraine|16|||
154930473|NCT00483717|559169332|FG001|Overall Study|No treatment for migraine|13|||
154930474|NCT00483717|559169331|FG000|Overall Study|Lost to Follow-up|1|||
154930475|NCT00483717|559169332|FG001|Overall Study|Lost to Follow-up|0|||
154930476|NCT00483717|559169331|FG000|Overall Study|Withdrawal by Subject|1|||
154930477|NCT00483717|559169332|FG001|Overall Study|Withdrawal by Subject|0|||
154930478|NCT00083226|559169333|FG000|Overall Study|Lack of Efficacy|19|||
154930479|NCT00083226|559169333|FG000|Overall Study|Adverse Event|9|||
154930480|NCT00083226|559169333|FG000|Overall Study|Death|4|||
154930481|NCT00083226|559169333|FG000|Overall Study|Withdrawal by Subject|4|||
154930482|NCT00083226|559169333|FG000|Overall Study|Other|2|||
154930483|NCT00083226|559169333|FG000|Overall Study|ineligible or not receiving treatment|4|||
154930484|NCT00909857|559169334|FG000|Overall Study|Withdrawal by Subject|6|||
154930485|NCT00909857|559169335|FG001|Overall Study|Withdrawal by Subject|10|||
154930486|NCT00909857|559169334|FG000|Overall Study|Adverse Event|5|||
154930487|NCT00909857|559169335|FG001|Overall Study|Adverse Event|5|||
154930488|NCT00909857|559169334|FG000|Overall Study|Lost to Follow-up|2|||
154930489|NCT00909857|559169335|FG001|Overall Study|Lost to Follow-up|5|||
154930490|NCT00909857|559169334|FG000|Overall Study|Protocol Violation|2|||
154930491|NCT00909857|559169335|FG001|Overall Study|Protocol Violation|1|||
154930492|NCT00909857|559169334|FG000|Overall Study|Pregnancy|1|||
154930493|NCT00909857|559169335|FG001|Overall Study|Pregnancy|0|||
154930494|NCT00909857|559169334|FG000|Overall Study|Other|1|||
154930495|NCT00909857|559169335|FG001|Overall Study|Other|0|||
154930496|NCT00909857|559169334|FG000|Overall Study|Did not receive study medication|19|||
154930497|NCT00909857|559169335|FG001|Overall Study|Did not receive study medication|24|||
154930498|NCT03878108|559169336|FG000|Overall Study|Adverse Event|1|||
154930499|NCT03878108|559169337|FG001|Overall Study|Adverse Event|0|||
154930500|NCT00604175|559169344|FG000|Entry Through Week 28|Death|2|||
154930501|NCT00604175|559169345|FG001|Entry Through Week 28|Death|0|||
154930502|NCT00604175|559169346|FG002|Entry Through Week 28|Death|0|||
154930503|NCT00604175|559169344|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
154930504|NCT00604175|559169345|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
154930505|NCT00604175|559169346|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
154930506|NCT00604175|559169344|FG000|Entry Through Week 28|Lost to Follow-up|4|||
154930507|NCT00604175|559169345|FG001|Entry Through Week 28|Lost to Follow-up|3|||
154930508|NCT00604175|559169346|FG002|Entry Through Week 28|Lost to Follow-up|0|||
154930509|NCT00604175|559169344|FG000|Entry Through Week 28|Ineligible|1|||
154930510|NCT00604175|559169345|FG001|Entry Through Week 28|Ineligible|0|||
154930511|NCT00604175|559169346|FG002|Entry Through Week 28|Ineligible|0|||
154930512|NCT00604175|559169344|FG000|Entry Through Week 28|Did not start intervention|2|||
154930513|NCT00604175|559169345|FG001|Entry Through Week 28|Did not start intervention|0|||
154930514|NCT00604175|559169346|FG002|Entry Through Week 28|Did not start intervention|1|||
154930515|NCT00604175|559169344|FG000|Week 29 Through Week 72|Death|0|||
154930516|NCT00604175|559169345|FG001|Week 29 Through Week 72|Death|0|||
154930517|NCT00604175|559169346|FG002|Week 29 Through Week 72|Death|1|||
154930518|NCT00604175|559169344|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
154930519|NCT00604175|559169345|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
154930520|NCT00604175|559169346|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
154930521|NCT00604175|559169344|FG000|Week 29 Through Week 72|Site closure|0|||
154930522|NCT00604175|559169345|FG001|Week 29 Through Week 72|Site closure|1|||
154930523|NCT00604175|559169346|FG002|Week 29 Through Week 72|Site closure|0|||
154930524|NCT00604175|559169344|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
154930525|NCT00604175|559169345|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
154930526|NCT00604175|559169346|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
154930527|NCT01682681|559169347|FG000|Overall Study|Lack of Efficacy|62|||
154930528|NCT01682681|559169347|FG000|Overall Study|Withdrawal by Subject|1|||
154930529|NCT01682681|559169347|FG000|Overall Study|Moved to other hospital|10|||
154930530|NCT01682681|559169347|FG000|Overall Study|Lost to Follow-up|174|||
154930531|NCT01682681|559169347|FG000|Overall Study|Adverse Event|46|||
154930532|NCT01682681|559169347|FG000|Overall Study|tapering of topiramate|5|||
154930533|NCT01682681|559169347|FG000|Overall Study|Other|21|||
154930534|NCT01682681|559169347|FG000|Overall Study|Low compliance|13|||
154930535|NCT02044094|559169348|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
154930536|NCT02044094|559169348|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
154930537|NCT02044094|559169348|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
154930538|NCT02044094|559169348|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
154930539|NCT02044094|559169348|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
154930540|NCT02044094|559169348|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
154930541|NCT02044094|559169348|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
154930542|NCT02044094|559169348|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
154930543|NCT03353415|559169351|FG000|Masked CGM Wear|Lost to Follow-up|2|||
154930544|NCT03353415|559169351|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
154930545|NCT00975000|559169352|FG000|Overall Study|Other|1|||
154930546|NCT00975000|559169353|FG001|Overall Study|Other|0|||
154930547|NCT00975000|559169352|FG000|Overall Study|Adverse Event|1|||
154930548|NCT00975000|559169353|FG001|Overall Study|Adverse Event|1|||
154930549|NCT00975000|559169352|FG000|Overall Study|Withdrawal by Subject|2|||
154930550|NCT00975000|559169353|FG001|Overall Study|Withdrawal by Subject|2|||
154930551|NCT00975000|559169352|FG000|Overall Study|Lost to Follow-up|0|||
154930552|NCT00975000|559169353|FG001|Overall Study|Lost to Follow-up|1|||
154930553|NCT00975000|559169352|FG000|Overall Study|Protocol-specified Criteria|1|||
154930554|NCT00975000|559169353|FG001|Overall Study|Protocol-specified Criteria|0|||
154930555|NCT00975000|559169352|FG000|Overall Study|Non-compliance|0|||
154930556|NCT00975000|559169353|FG001|Overall Study|Non-compliance|1|||
154930557|NCT03205163|559169354|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
154930558|NCT03205163|559169355|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
154930559|NCT00005879|559169356|FG000|Overall Study|Withdrawal by Subject|8|||
154930560|NCT00005879|559169357|FG001|Overall Study|Withdrawal by Subject|10|||
154930561|NCT01238172|559169358|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
154930562|NCT01238172|559169359|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
154930563|NCT01238172|559169358|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
154930564|NCT01238172|559169359|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
154930565|NCT05257109|559169360|FG000|Overall Study|Withdrawal by Subject|1|||
154930566|NCT05257109|559169361|FG001|Overall Study|Withdrawal by Subject|0|||
154930567|NCT05257109|559169362|FG002|Overall Study|Withdrawal by Subject|0|||
154930568|NCT05257109|559169363|FG003|Overall Study|Withdrawal by Subject|0|||
154930569|NCT00981409|559170658|FG000|Overall Study|Adverse Event|4|||
154930570|NCT00981409|559170659|FG001|Overall Study|Adverse Event|0|||
154930571|NCT00981409|559170658|FG000|Overall Study|Protocol Violation|0|||
154930572|NCT00981409|559170659|FG001|Overall Study|Protocol Violation|1|||
154930573|NCT00981409|559170658|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
154930574|NCT00981409|559170659|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
154930575|NCT03869684|559170662|FG000|Overall Study|Adverse Event|0|||
154930576|NCT03869684|559170663|FG001|Overall Study|Adverse Event|3|||
154930577|NCT03869684|559170664|FG002|Overall Study|Adverse Event|1|||
154930578|NCT03869684|559170662|FG000|Overall Study|Withdrawal by Subject|1|||
154930579|NCT03869684|559170663|FG001|Overall Study|Withdrawal by Subject|0|||
154930580|NCT03869684|559170664|FG002|Overall Study|Withdrawal by Subject|0|||
154930581|NCT03869684|559170662|FG000|Overall Study|Lost to Follow-up|1|||
154930582|NCT03869684|559170663|FG001|Overall Study|Lost to Follow-up|0|||
154930583|NCT03869684|559170664|FG002|Overall Study|Lost to Follow-up|0|||
154930584|NCT03869684|559170662|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
154930585|NCT03869684|559170663|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
154930586|NCT03869684|559170664|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
154930587|NCT04056299|559170665|FG000|Overall Study|Sponsor discontinued study|3|||
154930588|NCT04056299|559170666|FG001|Overall Study|Sponsor discontinued study|3|||
154930589|NCT01227954|559170671|FG000|Overall Study|Protocol Violation|6|||
154930590|NCT01227954|559170671|FG000|Overall Study|No protocol treatment|7|||
154930591|NCT00078312|559170672|FG000|Overall Study|Adverse Event|43|||
154930592|NCT00078312|559170672|FG000|Overall Study|Lack of Efficacy|15|||
154930593|NCT00078312|559170672|FG000|Overall Study|Lost to Follow-up|41|||
154930594|NCT00078312|559170672|FG000|Overall Study|Physician Decision|9|||
154930595|NCT00078312|559170672|FG000|Overall Study|Protocol Violation|3|||
154930596|NCT00078312|559170672|FG000|Overall Study|Withdrawal by Subject|33|||
154930597|NCT00078312|559170672|FG000|Overall Study|Miscellaneous|33|||
154930598|NCT01296152|559170675|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
154930599|NCT03901352|559170676|FG000|Double-blind Phase|Adverse Event|6|||
154930600|NCT03901352|559170677|FG001|Double-blind Phase|Adverse Event|4|||
154930601|NCT03901352|559170676|FG000|Double-blind Phase|Death|1|||
154930602|NCT03901352|559170677|FG001|Double-blind Phase|Death|0|||
154930603|NCT03901352|559170676|FG000|Double-blind Phase|Lack of Efficacy|0|||
154930604|NCT03901352|559170677|FG001|Double-blind Phase|Lack of Efficacy|1|||
154930605|NCT03901352|559170676|FG000|Double-blind Phase|Protocol Violation|0|||
154930606|NCT03901352|559170677|FG001|Double-blind Phase|Protocol Violation|1|||
154930607|NCT03901352|559170676|FG000|Double-blind Phase|Withdrawal by Subject|10|||
154930608|NCT03901352|559170677|FG001|Double-blind Phase|Withdrawal by Subject|8|||
154930609|NCT03901352|559170676|FG000|Open-label Extension Phase|Adverse Event|24|||
154930610|NCT03901352|559170677|FG001|Open-label Extension Phase|Adverse Event|0|||
154930611|NCT03901352|559170676|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
154930612|NCT03901352|559170677|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
154930613|NCT03901352|559170676|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
154930614|NCT03901352|559170677|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
154930615|NCT03901352|559170676|FG000|Open-label Extension Phase|Other|1|||
154930616|NCT03901352|559170677|FG001|Open-label Extension Phase|Other|0|||
154930617|NCT03901339|559170678|FG000|Overall Study|Death|220|||
154930618|NCT03901339|559170679|FG001|Overall Study|Death|192|||
154930619|NCT03901339|559170678|FG000|Overall Study|Informed consent withdrawn|13|||
154930620|NCT03901339|559170679|FG001|Overall Study|Informed consent withdrawn|40|||
154930621|NCT03901339|559170678|FG000|Overall Study|Sponsor request|30|||
154930622|NCT03901339|559170679|FG001|Overall Study|Sponsor request|23|||
154930623|NCT03901339|559170678|FG000|Overall Study|Reason not specified|5|||
154930624|NCT03901339|559170679|FG001|Overall Study|Reason not specified|7|||
154930625|NCT03901339|559170678|FG000|Overall Study|Lost to Follow-up|4|||
154930626|NCT03901339|559170679|FG001|Overall Study|Lost to Follow-up|7|||
154930627|NCT03901339|559170678|FG000|Overall Study|Covid19|0|||
154930628|NCT03901339|559170679|FG001|Overall Study|Covid19|2|||
154930629|NCT03981614|559170680|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
154930630|NCT03981614|559170681|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
154930631|NCT03981614|559170682|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
154930632|NCT01071083|559170687|FG000|Overall Study|Adverse Event|1|||
154930633|NCT01071083|559170688|FG001|Overall Study|Adverse Event|0|||
154930634|NCT01071083|559170689|FG002|Overall Study|Adverse Event|1|||
154930635|NCT01071083|559170690|FG003|Overall Study|Adverse Event|0|||
154930636|NCT01071083|559170691|FG004|Overall Study|Adverse Event|1|||
154930637|NCT01071083|559170687|FG000|Overall Study|Withdrawal by Subject|3|||
154930638|NCT01071083|559170688|FG001|Overall Study|Withdrawal by Subject|0|||
154930639|NCT01071083|559170689|FG002|Overall Study|Withdrawal by Subject|2|||
154930640|NCT01071083|559170690|FG003|Overall Study|Withdrawal by Subject|0|||
154930641|NCT01071083|559170691|FG004|Overall Study|Withdrawal by Subject|3|||
154930642|NCT01071083|559170687|FG000|Overall Study|Physician Decision|1|||
154930643|NCT01071083|559170688|FG001|Overall Study|Physician Decision|0|||
154930644|NCT01071083|559170689|FG002|Overall Study|Physician Decision|0|||
154930645|NCT01071083|559170690|FG003|Overall Study|Physician Decision|1|||
154930646|NCT01071083|559170691|FG004|Overall Study|Physician Decision|1|||
154930647|NCT01071083|559170687|FG000|Overall Study|Early Rescue|1|||
154930648|NCT01071083|559170688|FG001|Overall Study|Early Rescue|0|||
154930649|NCT01071083|559170689|FG002|Overall Study|Early Rescue|0|||
154930650|NCT01071083|559170690|FG003|Overall Study|Early Rescue|0|||
154930651|NCT01071083|559170691|FG004|Overall Study|Early Rescue|1|||
154930652|NCT01071083|559170687|FG000|Overall Study|Subject Moved|0|||
154930653|NCT01071083|559170688|FG001|Overall Study|Subject Moved|1|||
154930654|NCT01071083|559170689|FG002|Overall Study|Subject Moved|0|||
154930655|NCT01071083|559170690|FG003|Overall Study|Subject Moved|0|||
154930656|NCT01071083|559170691|FG004|Overall Study|Subject Moved|0|||
154930657|NCT01071083|559170687|FG000|Overall Study|Images Not Usable (Motion)|0|||
154930658|NCT01071083|559170688|FG001|Overall Study|Images Not Usable (Motion)|1|||
154930659|NCT01071083|559170689|FG002|Overall Study|Images Not Usable (Motion)|0|||
154930660|NCT01071083|559170690|FG003|Overall Study|Images Not Usable (Motion)|0|||
154930661|NCT01071083|559170691|FG004|Overall Study|Images Not Usable (Motion)|0|||
154930662|NCT01071083|559170687|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
154930663|NCT01071083|559170688|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
154930664|NCT01071083|559170689|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
154930665|NCT01071083|559170690|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
154930666|NCT01071083|559170691|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
154930667|NCT01071083|559170687|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
154930668|NCT01071083|559170688|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
154930669|NCT01071083|559170689|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
154930670|NCT01071083|559170690|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
154930671|NCT01071083|559170691|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
154930672|NCT01071083|559170687|FG000|Overall Study|Subject Refused to Continue|1|||
154930673|NCT01071083|559170688|FG001|Overall Study|Subject Refused to Continue|0|||
154930674|NCT01071083|559170689|FG002|Overall Study|Subject Refused to Continue|0|||
154930675|NCT01071083|559170690|FG003|Overall Study|Subject Refused to Continue|0|||
154930676|NCT01071083|559170691|FG004|Overall Study|Subject Refused to Continue|0|||
154930677|NCT00038467|559170692|FG000|Overall Study|Adverse Event|170|||
154930678|NCT00038467|559170693|FG001|Overall Study|Adverse Event|145|||
154930679|NCT00038467|559170692|FG000|Overall Study|Withdrawal by Subject|150|||
154930680|NCT00038467|559170693|FG001|Overall Study|Withdrawal by Subject|107|||
154930681|NCT00038467|559170692|FG000|Overall Study|Protocol Violation|19|||
154930682|NCT00038467|559170693|FG001|Overall Study|Protocol Violation|22|||
154930683|NCT00038467|559170692|FG000|Overall Study|Death|22|||
154930684|NCT00038467|559170693|FG001|Overall Study|Death|16|||
154930685|NCT00038467|559170692|FG000|Overall Study|Lost to Follow-up|15|||
154930686|NCT00038467|559170693|FG001|Overall Study|Lost to Follow-up|10|||
154930687|NCT00038467|559170692|FG000|Overall Study|Recurrence|109|||
154930688|NCT00038467|559170693|FG001|Overall Study|Recurrence|179|||
154930689|NCT00038467|559170692|FG000|Overall Study|Randomized, but not treated|31|||
154930690|NCT00038467|559170693|FG001|Overall Study|Randomized, but not treated|35|||
154930691|NCT00038467|559170692|FG000|Overall Study|Other|26|||
154930692|NCT00038467|559170693|FG001|Overall Study|Other|28|||
154930693|NCT04732728|559170694|FG000|Overall Study|Death|12|||
154930694|NCT04732728|559170694|FG000|Overall Study|Withdrawn|136|||
154930695|NCT01339000|559170695|FG000|Overall Study|study closed due to lack of drug supply|1|||
154930696|NCT01339000|559170696|FG001|Overall Study|study closed due to lack of drug supply|0|||
154930697|NCT05349188|559170697|FG000|Overall Study|Withdrawal by Subject|1|||
154930698|NCT05349188|559170698|FG001|Overall Study|Withdrawal by Subject|0|||
154930699|NCT05511428|559170699|FG000|Overall Study|Withdrawal by Subject|1|||
154930700|NCT05511428|559170699|FG000|Overall Study|Adverse Event|1|||
154930701|NCT04088734|559170700|FG000|Overall Study|Other, Not Specified|5|||
154930702|NCT03829462|559170701|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
154930703|NCT03829462|559170702|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
154930704|NCT03829462|559170701|FG000|Overall Study|No treatment due to progression disease|0|||
154930705|NCT03829462|559170702|FG001|Overall Study|No treatment due to progression disease|1|||
154930706|NCT04971226|559170705|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
154930707|NCT04971226|559170706|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
154930708|NCT04971226|559170707|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
154930709|NCT04971226|559170708|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
154930710|NCT04971226|559170705|FG000|Overall Study|Adverse Event|6|||
154930711|NCT04971226|559170706|FG001|Overall Study|Adverse Event|5|||
154930712|NCT04971226|559170707|FG002|Overall Study|Adverse Event|11|||
154930713|NCT04971226|559170708|FG003|Overall Study|Adverse Event|10|||
154930714|NCT04971226|559170705|FG000|Overall Study|Progressive disease|2|||
154930715|NCT04971226|559170706|FG001|Overall Study|Progressive disease|0|||
154930716|NCT04971226|559170707|FG002|Overall Study|Progressive disease|3|||
154930717|NCT04971226|559170708|FG003|Overall Study|Progressive disease|1|||
154930718|NCT04971226|559170705|FG000|Overall Study|Protocol Deviation|1|||
154930719|NCT04971226|559170706|FG001|Overall Study|Protocol Deviation|0|||
154930720|NCT04971226|559170707|FG002|Overall Study|Protocol Deviation|1|||
154930721|NCT04971226|559170708|FG003|Overall Study|Protocol Deviation|1|||
154930722|NCT04971226|559170705|FG000|Overall Study|Subject Decision|0|||
154930723|NCT04971226|559170706|FG001|Overall Study|Subject Decision|1|||
154930724|NCT04971226|559170707|FG002|Overall Study|Subject Decision|1|||
154930725|NCT04971226|559170708|FG003|Overall Study|Subject Decision|1|||
154930726|NCT04971226|559170705|FG000|Overall Study|Pregnancy|0|||
154930727|NCT04971226|559170706|FG001|Overall Study|Pregnancy|0|||
154930728|NCT04971226|559170707|FG002|Overall Study|Pregnancy|0|||
154930729|NCT04971226|559170708|FG003|Overall Study|Pregnancy|1|||
154930730|NCT04971226|559170705|FG000|Overall Study|Participants not treated|1|||
154930731|NCT04971226|559170706|FG001|Overall Study|Participants not treated|0|||
154930732|NCT04971226|559170707|FG002|Overall Study|Participants not treated|2|||
154930733|NCT04971226|559170708|FG003|Overall Study|Participants not treated|1|||
154930734|NCT00481871|559170709|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
154930735|NCT00481871|559170710|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
154930736|NCT00481871|559170711|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
154930737|NCT00481871|559170712|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
154930738|NCT00481871|559170713|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
154930739|NCT03332212|559170714|FG000|Overall Study|Not treated|0|||
154930740|NCT03332212|559170715|FG001|Overall Study|Not treated|1|||
154930741|NCT03332212|559170716|FG002|Overall Study|Not treated|0|||
154930742|NCT03332212|559170717|FG003|Overall Study|Not treated|0|||
154930743|NCT03332212|559170714|FG000|Overall Study|Adverse Event|0|||
154930744|NCT03332212|559170715|FG001|Overall Study|Adverse Event|0|||
154930745|NCT03332212|559170716|FG002|Overall Study|Adverse Event|0|||
154930746|NCT03332212|559170717|FG003|Overall Study|Adverse Event|1|||
154930747|NCT03332212|559170714|FG000|Overall Study|worsening of disease under study|1|||
154930748|NCT03332212|559170715|FG001|Overall Study|worsening of disease under study|1|||
154930749|NCT03332212|559170716|FG002|Overall Study|worsening of disease under study|0|||
154930750|NCT03332212|559170717|FG003|Overall Study|worsening of disease under study|0|||
154930751|NCT04439149|559170721|FG000|Overall Study|Ineligible|1|||
154930752|NCT04439149|559170721|FG000|Overall Study|Never start protocol therapy|1|||
154930753|NCT04439149|559170721|FG000|Overall Study|Adverse Event|4|||
154930754|NCT04439149|559170721|FG000|Overall Study|Disease Progression|14|||
154930755|NCT04439149|559170721|FG000|Overall Study|Complicating disease|1|||
154930756|NCT04439149|559170721|FG000|Overall Study|Withdrawal by Subject|3|||
154930757|NCT05264506|559170724|FG000|Overall Study|Adverse Event|59|||
154930758|NCT05264506|559170724|FG000|Overall Study|Lost to Follow-up|204|||
154930759|NCT05264506|559170724|FG000|Overall Study|Protocol Violation|185|||
154930760|NCT05264506|559170724|FG000|Overall Study|Pregnancy|60|||
154930761|NCT05264506|559170724|FG000|Overall Study|Physician Decision|6|||
154930762|NCT05264506|559170724|FG000|Overall Study|Non-compliance with Study Drug|29|||
154930763|NCT05264506|559170724|FG000|Overall Study|Study termination|677|||
154930764|NCT05264506|559170724|FG000|Overall Study|Withdrawal by Subject|208|||
154930765|NCT05264506|559170724|FG000|Overall Study|Discontinued prior treatment|89|||
154930766|NCT02032823|559170732|FG000|Overall Study|Death|75|||
154930767|NCT02032823|559170733|FG001|Overall Study|Death|109|||
154930768|NCT02032823|559170732|FG000|Overall Study|Lost to Follow-up|18|||
154930769|NCT02032823|559170733|FG001|Overall Study|Lost to Follow-up|17|||
154930770|NCT02032823|559170732|FG000|Overall Study|Withdrawal by Subject|70|||
154930771|NCT02032823|559170733|FG001|Overall Study|Withdrawal by Subject|53|||
154930772|NCT02032823|559170732|FG000|Overall Study|Ongoing study at data cut-off|755|||
154930773|NCT02032823|559170733|FG001|Overall Study|Ongoing study at data cut-off|731|||
154930774|NCT02032823|559170732|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
154930775|NCT02032823|559170733|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
154930776|NCT04521608|559170734|FG000|Overall Study|Death|8|||
154930777|NCT04521608|559170735|FG001|Overall Study|Death|9|||
154930778|NCT04521608|559170734|FG000|Overall Study|Withdrawal by Subject|25|||
154930779|NCT04521608|559170735|FG001|Overall Study|Withdrawal by Subject|18|||
154930780|NCT04521608|559170734|FG000|Overall Study|Disease Progression|3|||
154930781|NCT04521608|559170735|FG001|Overall Study|Disease Progression|10|||
154930782|NCT04521608|559170734|FG000|Overall Study|Complicating Disease|6|||
154930783|NCT04521608|559170735|FG001|Overall Study|Complicating Disease|3|||
154930784|NCT04521608|559170734|FG000|Overall Study|Lost Contact|25|||
154930785|NCT04521608|559170735|FG001|Overall Study|Lost Contact|27|||
154930786|NCT04521608|559170734|FG000|Overall Study|Ineligible|1|||
154930787|NCT04521608|559170735|FG001|Overall Study|Ineligible|0|||
154930788|NCT04521608|559170734|FG000|Overall Study|Refused Further Study Participation|13|||
154930789|NCT04521608|559170735|FG001|Overall Study|Refused Further Study Participation|7|||
154930790|NCT04083378|559170736|FG000|Overall Study|Death|18|||
154930791|NCT04083378|559170737|FG001|Overall Study|Death|4|||
154930792|NCT04083378|559170736|FG000|Overall Study|Lost to Follow-up|4|||
154930793|NCT04083378|559170737|FG001|Overall Study|Lost to Follow-up|0|||
154930794|NCT00644228|559170738|FG000|Randomization & Eligibility|Ineligible|31|||
154930795|NCT00644228|559170739|FG001|Randomization & Eligibility|Ineligible|21|||
154930796|NCT00644228|559170738|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
154930797|NCT00644228|559170739|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
154930798|NCT00644228|559170738|FG000|Randomization & Eligibility|Invalid Consent|0|||
154930799|NCT00644228|559170739|FG001|Randomization & Eligibility|Invalid Consent|1|||
154930800|NCT00644228|559170738|FG000|Induction Therapy|Adverse Event|22|||
154930801|NCT00644228|559170739|FG001|Induction Therapy|Adverse Event|55|||
154930802|NCT00644228|559170738|FG000|Induction Therapy|Withdrawal by Subject|10|||
154930803|NCT00644228|559170739|FG001|Induction Therapy|Withdrawal by Subject|3|||
154930804|NCT00644228|559170738|FG000|Induction Therapy|Progression/Relapse|24|||
154930805|NCT00644228|559170739|FG001|Induction Therapy|Progression/Relapse|12|||
154930806|NCT00644228|559170738|FG000|Induction Therapy|Death|3|||
154930807|NCT00644228|559170739|FG001|Induction Therapy|Death|7|||
154930808|NCT00644228|559170738|FG000|Induction Therapy|Not Protocol-Specified|24|||
154930809|NCT00644228|559170739|FG001|Induction Therapy|Not Protocol-Specified|28|||
154930810|NCT00644228|559170738|FG000|Maintenance|Adverse Event|27|||
154930811|NCT00644228|559170739|FG001|Maintenance|Adverse Event|31|||
155266950|NCT00393523|560410927|FG000|Overall Study|Lost to Follow-up|0|||
155266951|NCT00393523|560410928|FG001|Overall Study|Lost to Follow-up|0|||
154930812|NCT00644228|559170738|FG000|Maintenance|Withdrawal by Subject|6|||
154930813|NCT00644228|559170739|FG001|Maintenance|Withdrawal by Subject|4|||
154930814|NCT00644228|559170738|FG000|Maintenance|Progression/Relapse|67|||
154930815|NCT00644228|559170739|FG001|Maintenance|Progression/Relapse|42|||
154930816|NCT00644228|559170738|FG000|Maintenance|Death|3|||
154930817|NCT00644228|559170739|FG001|Maintenance|Death|3|||
154930818|NCT00644228|559170738|FG000|Maintenance|Not Protocol-Specified|14|||
154930819|NCT00644228|559170739|FG001|Maintenance|Not Protocol-Specified|15|||
154930820|NCT00644228|559170738|FG000|Maintenance|On Treatment|26|||
154930821|NCT00644228|559170739|FG001|Maintenance|On Treatment|40|||
154930822|NCT06078124|559170740|FG000|Overall Study|Lost to Follow-up|14|||
154930823|NCT06078124|559170741|FG001|Overall Study|Lost to Follow-up|14|||
154930824|NCT00285012|559170742|FG000|Assigned to Study Treatment (Tx)|Other|2|||
154930825|NCT00285012|559170743|FG001|Assigned to Study Treatment (Tx)|Other|3|||
154930826|NCT00285012|559170742|FG000|Received Study Tx|Death|2|||
154930827|NCT00285012|559170743|FG001|Received Study Tx|Death|1|||
154930828|NCT00285012|559170742|FG000|Received Study Tx|Adverse Event|5|||
154930829|NCT00285012|559170743|FG001|Received Study Tx|Adverse Event|11|||
154930830|NCT00285012|559170742|FG000|Received Study Tx|Lack of Efficacy|0|||
154930831|NCT00285012|559170743|FG001|Received Study Tx|Lack of Efficacy|3|||
154930832|NCT00285012|559170742|FG000|Received Study Tx|Lost to Follow-up|29|||
154930833|NCT00285012|559170743|FG001|Received Study Tx|Lost to Follow-up|31|||
154930834|NCT00285012|559170742|FG000|Received Study Tx|Withdrawal by Subject|31|||
154930835|NCT00285012|559170743|FG001|Received Study Tx|Withdrawal by Subject|43|||
154930836|NCT00285012|559170742|FG000|Received Study Tx|Other|5|||
154930837|NCT00285012|559170743|FG001|Received Study Tx|Other|5|||
154930838|NCT04050293|559170744|FG000|Overall Study|Lost to Follow-up|1|||
154930839|NCT04050293|559170745|FG001|Overall Study|Lost to Follow-up|2|||
154930840|NCT04050293|559170744|FG000|Overall Study|Withdrawal by Subject|2|||
154930841|NCT04050293|559170745|FG001|Overall Study|Withdrawal by Subject|0|||
154930842|NCT04223193|559170750|FG000|Overall Study|Adverse Event|6|||
154930843|NCT04223193|559170751|FG001|Overall Study|Adverse Event|36|||
154930844|NCT04223193|559170750|FG000|Overall Study|Lack of Efficacy|2|||
154930845|NCT04223193|559170751|FG001|Overall Study|Lack of Efficacy|2|||
154930846|NCT04223193|559170750|FG000|Overall Study|Lost to Follow-up|1|||
154930847|NCT04223193|559170751|FG001|Overall Study|Lost to Follow-up|1|||
154930848|NCT04223193|559170750|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
154930849|NCT04223193|559170751|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
154930850|NCT04223193|559170750|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
154930851|NCT04223193|559170751|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
154930852|NCT04223193|559170750|FG000|Overall Study|Non-Compliance with Study Drug|0|||
154930853|NCT04223193|559170751|FG001|Overall Study|Non-Compliance with Study Drug|1|||
154930854|NCT04223193|559170750|FG000|Overall Study|Physician Decision|0|||
154930855|NCT04223193|559170751|FG001|Overall Study|Physician Decision|1|||
154930856|NCT04223193|559170750|FG000|Overall Study|Protocol Violation|1|||
154930857|NCT04223193|559170751|FG001|Overall Study|Protocol Violation|1|||
154930858|NCT04223193|559170750|FG000|Overall Study|Site Terminated by Sponsor|1|||
154930859|NCT04223193|559170751|FG001|Overall Study|Site Terminated by Sponsor|3|||
154930860|NCT04223193|559170750|FG000|Overall Study|Withdrawal by Subject|5|||
154930861|NCT04223193|559170751|FG001|Overall Study|Withdrawal by Subject|6|||
154930862|NCT04223193|559170750|FG000|Overall Study|Other|3|||
154930863|NCT04223193|559170751|FG001|Overall Study|Other|6|||
154930864|NCT03532295|559170757|FG000|Overall Study|Did not start treatment|0|||
154930865|NCT03532295|559170758|FG001|Overall Study|Did not start treatment|2|||
154930866|NCT01907516|559170759|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
154930867|NCT01907516|559170760|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
154930868|NCT01907516|559170759|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
154930869|NCT01907516|559170760|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
154930870|NCT01907516|559170759|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
154930871|NCT01907516|559170760|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
154930872|NCT01907516|559170759|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
154930873|NCT01907516|559170760|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
154930874|NCT04644237|559170764|FG000|Overall Study|Death|4|||
154930875|NCT04644237|559170765|FG001|Overall Study|Death|2|||
154930876|NCT04644237|559170764|FG000|Overall Study|Adverse Event|18|||
154930877|NCT04644237|559170765|FG001|Overall Study|Adverse Event|19|||
154930878|NCT04644237|559170764|FG000|Overall Study|Progressive Disease|61|||
154930879|NCT04644237|559170765|FG001|Overall Study|Progressive Disease|23|||
154930880|NCT04644237|559170764|FG000|Overall Study|Clinical Progression|4|||
154930881|NCT04644237|559170765|FG001|Overall Study|Clinical Progression|1|||
154930882|NCT04644237|559170764|FG000|Overall Study|Withdrawal by Subject|4|||
154930883|NCT04644237|559170765|FG001|Overall Study|Withdrawal by Subject|2|||
154930884|NCT04644237|559170764|FG000|Overall Study|Physician Decision|4|||
154930885|NCT04644237|559170765|FG001|Overall Study|Physician Decision|0|||
154930886|NCT04644237|559170764|FG000|Overall Study|Other|6|||
154930887|NCT04644237|559170765|FG001|Overall Study|Other|3|||
154930888|NCT04644237|559170764|FG000|Overall Study|Randomized but not Treated|1|||
154930889|NCT04644237|559170765|FG001|Overall Study|Randomized but not Treated|0|||
154930890|NCT03131817|559170766|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
154930891|NCT02061293|559170768|FG000|Overall Study|Elevated Blood Pressure|1|||
155042971|NCT01778751|559588036|FG001|Overall Study|Lost to Follow-up|0|||
154930892|NCT02061293|559170769|FG001|Overall Study|Elevated Blood Pressure|1|||
154930893|NCT04066894|559170771|FG000|Overall Study|Lack of Efficacy|1|||
154930894|NCT04066894|559170771|FG000|Overall Study|Screen Failure|1|||
154930895|NCT02949219|559170772|FG000|Overall Study|Withdrawal by Subject|1|||
154930896|NCT05022121|559170777|FG000|Overall Study|Lack of Efficacy|1|||
154930897|NCT05022121|559170778|FG001|Overall Study|Lack of Efficacy|0|||
154930898|NCT05022121|559170777|FG000|Overall Study|Lost to Follow-up|0|||
154930899|NCT05022121|559170778|FG001|Overall Study|Lost to Follow-up|2|||
154930900|NCT04439110|559170779|FG000|Overall Study|Ineligible|2|||
154930901|NCT04439110|559170779|FG000|Overall Study|Adverse Event|4|||
154930902|NCT04439110|559170779|FG000|Overall Study|Death|2|||
154930903|NCT04439110|559170779|FG000|Overall Study|Disease proression|25|||
154930904|NCT04439110|559170779|FG000|Overall Study|Withdrawal by Subject|1|||
154930905|NCT04439110|559170779|FG000|Overall Study|Alternative therapy|1|||
154930906|NCT04439110|559170779|FG000|Overall Study|Other complicating disease|1|||
154930907|NCT04439110|559170779|FG000|Overall Study|Personal reasons|1|||
154930908|NCT04439110|559170779|FG000|Overall Study|Still on treatment|1|||
154930909|NCT00131937|559170780|FG000|Overall Study|Adverse Event|3|||
154930910|NCT00131937|559170780|FG000|Overall Study|Withdrawal by Subject|2|||
154930911|NCT00131937|559170780|FG000|Overall Study|Physician Decision|1|||
154930912|NCT00131937|559170780|FG000|Overall Study|Disease Progression|7|||
154930913|NCT00131937|559170780|FG000|Overall Study|Alternative therapy|1|||
154930914|NCT04647253|559170787|FG000|Overall Study|Death ≤ 365 Days|16|||
154930915|NCT04647253|559170788|FG001|Overall Study|Death ≤ 365 Days|7|||
154930916|NCT04647253|559170787|FG000|Overall Study|Physician Decision|0|||
154930917|NCT04647253|559170788|FG001|Overall Study|Physician Decision|1|||
154930918|NCT04647253|559170787|FG000|Overall Study|Withdrawal by Subject|7|||
154930919|NCT04647253|559170788|FG001|Overall Study|Withdrawal by Subject|2|||
154930920|NCT04647253|559170787|FG000|Overall Study|Missed 12-Month Visit|9|||
154930921|NCT04647253|559170788|FG001|Overall Study|Missed 12-Month Visit|7|||
154930922|NCT04647253|559170787|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
154930923|NCT04647253|559170788|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
154930924|NCT01211613|559172212|FG000|Overall Study|Lost to Follow-up|2|||
154930925|NCT01211613|559172213|FG001|Overall Study|Lost to Follow-up|2|||
154930926|NCT01211613|559172214|FG002|Overall Study|Lost to Follow-up|2|||
154930927|NCT01211613|559172212|FG000|Overall Study|Withdrawal by Subject|1|||
154930928|NCT01211613|559172213|FG001|Overall Study|Withdrawal by Subject|0|||
154930929|NCT01211613|559172214|FG002|Overall Study|Withdrawal by Subject|0|||
154930930|NCT01020773|559172215|FG000|Overall Study|Withdrawal by Subject|4|||
154930931|NCT01020773|559172216|FG001|Overall Study|Withdrawal by Subject|3|||
154930932|NCT03853213|559172217|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
154930933|NCT03853213|559172218|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
154930934|NCT03853213|559172217|FG000|Overall Study|Other (e.g., too busy)|0|||
154930935|NCT03853213|559172218|FG001|Overall Study|Other (e.g., too busy)|2|||
154930936|NCT03302299|559172219|FG000|Overall Study|Protocol Violation|1|||
155266952|NCT00393523|560410929|FG002|Overall Study|Lost to Follow-up|0|||
155266953|NCT00393523|560410930|FG003|Overall Study|Lost to Follow-up|2|||
154930937|NCT01458132|559172220|FG000|Overall Study|Other|15|||
154930938|NCT01458132|559172221|FG001|Overall Study|Other|3|||
154930939|NCT02038959|559172226|FG000|Overall Study|Withdrawal by Subject|6|||
154930940|NCT02038959|559172227|FG001|Overall Study|Withdrawal by Subject|8|||
154930941|NCT00819091|559172233|FG000|Overall Study|Adverse Event|3|||
154930942|NCT00819091|559172234|FG001|Overall Study|Adverse Event|5|||
154930943|NCT00819091|559172233|FG000|Overall Study|Protocol Violation|0|||
154930944|NCT00819091|559172234|FG001|Overall Study|Protocol Violation|1|||
154930945|NCT00819091|559172233|FG000|Overall Study|Lost to Follow-up|2|||
154930946|NCT00819091|559172234|FG001|Overall Study|Lost to Follow-up|0|||
154930947|NCT00819091|559172233|FG000|Overall Study|Withdrawal by Subject|1|||
154930948|NCT00819091|559172234|FG001|Overall Study|Withdrawal by Subject|2|||
154930949|NCT00819091|559172233|FG000|Overall Study|Other|1|||
154930950|NCT00819091|559172234|FG001|Overall Study|Other|2|||
154930951|NCT01788163|559172236|FG000|Overall Study|Other|53|||
154930952|NCT01788163|559172237|FG001|Overall Study|Other|0|||
154930953|NCT01788163|559172238|FG002|Overall Study|Other|0|||
154930954|NCT01788163|559172239|FG003|Overall Study|Other|0|||
154930955|NCT01788163|559172240|FG004|Overall Study|Other|0|||
154930956|NCT01788163|559172241|FG005|Overall Study|Other|7|||
154930957|NCT01788163|559172242|FG006|Overall Study|Other|1|||
154930958|NCT01788163|559172243|FG007|Overall Study|Other|48|||
154930959|NCT01788163|559172244|FG008|Overall Study|Other|15|||
154930960|NCT01788163|559172236|FG000|Overall Study|Withdrawal by Subject|2|||
154930961|NCT01788163|559172237|FG001|Overall Study|Withdrawal by Subject|0|||
154930962|NCT01788163|559172238|FG002|Overall Study|Withdrawal by Subject|0|||
154930963|NCT01788163|559172239|FG003|Overall Study|Withdrawal by Subject|0|||
154930964|NCT01788163|559172240|FG004|Overall Study|Withdrawal by Subject|0|||
155381699|NCT04617275|560830988|FG004|Treatment Period|Lost to Follow-up|0|||
154930965|NCT01788163|559172241|FG005|Overall Study|Withdrawal by Subject|0|||
154930966|NCT01788163|559172242|FG006|Overall Study|Withdrawal by Subject|0|||
154930967|NCT01788163|559172243|FG007|Overall Study|Withdrawal by Subject|0|||
154930968|NCT01788163|559172244|FG008|Overall Study|Withdrawal by Subject|1|||
154930969|NCT00545441|559172245|FG000|Overall Study|Fistula draining at 6 months|2|||
154930970|NCT00545441|559172246|FG001|Overall Study|Fistula draining at 6 months|4|||
154930971|NCT00545441|559172245|FG000|Overall Study|Lost to Follow-up|9|||
154930972|NCT00545441|559172246|FG001|Overall Study|Lost to Follow-up|5|||
154930973|NCT00545441|559172245|FG000|Overall Study|Technical failure|0|||
154930974|NCT00545441|559172246|FG001|Overall Study|Technical failure|1|||
154930975|NCT00545441|559172245|FG000|Overall Study|Withdrawal by Subject|1|||
154930976|NCT00545441|559172246|FG001|Overall Study|Withdrawal by Subject|1|||
154930977|NCT00545441|559172245|FG000|Overall Study|Persistence or recurrence of fistula|5|||
155266954|NCT00393523|560410931|FG004|Overall Study|Lost to Follow-up|1|||
155266955|NCT00393523|560410927|FG000|Overall Study|Protocol Violation|6|||
155266956|NCT00393523|560410928|FG001|Overall Study|Protocol Violation|2|||
155266957|NCT00393523|560410929|FG002|Overall Study|Protocol Violation|0|||
155266958|NCT00393523|560410930|FG003|Overall Study|Protocol Violation|1|||
155266959|NCT00393523|560410931|FG004|Overall Study|Protocol Violation|0|||
155266960|NCT00393523|560410927|FG000|Overall Study|Withdrawal by Subject|6|||
155266961|NCT00393523|560410928|FG001|Overall Study|Withdrawal by Subject|7|||
155266962|NCT00393523|560410929|FG002|Overall Study|Withdrawal by Subject|2|||
155266963|NCT00393523|560410930|FG003|Overall Study|Withdrawal by Subject|3|||
155266964|NCT00393523|560410931|FG004|Overall Study|Withdrawal by Subject|0|||
155266965|NCT00393523|560410927|FG000|Overall Study|Difficulties in specimen collection|0|||
155266966|NCT00393523|560410928|FG001|Overall Study|Difficulties in specimen collection|0|||
155266967|NCT00393523|560410929|FG002|Overall Study|Difficulties in specimen collection|1|||
155266968|NCT00393523|560410930|FG003|Overall Study|Difficulties in specimen collection|0|||
155266969|NCT00393523|560410931|FG004|Overall Study|Difficulties in specimen collection|0|||
155266970|NCT00393523|560410927|FG000|Overall Study|Vaccine supply issue|0|||
155266971|NCT00393523|560410928|FG001|Overall Study|Vaccine supply issue|0|||
155266972|NCT00393523|560410929|FG002|Overall Study|Vaccine supply issue|1|||
155266973|NCT00393523|560410930|FG003|Overall Study|Vaccine supply issue|0|||
155266974|NCT00393523|560410931|FG004|Overall Study|Vaccine supply issue|0|||
155266975|NCT04145037|560410937|FG000|Overall Study|Study terminated|2|||
155266976|NCT04145037|560410938|FG001|Overall Study|Study terminated|0|||
155266977|NCT04145037|560410937|FG000|Overall Study|Withdrawal by Subject|1|||
155266978|NCT04145037|560410938|FG001|Overall Study|Withdrawal by Subject|0|||
155266979|NCT04145037|560410937|FG000|Overall Study|Lost to Follow-up|1|||
155266980|NCT04145037|560410938|FG001|Overall Study|Lost to Follow-up|0|||
155266981|NCT00525265|560410943|FG000|Overall Study|Protocol Violation|1|||
155266982|NCT00525265|560410944|FG001|Overall Study|Protocol Violation|0|||
155266983|NCT00098254|560410947|FG000|Overall Study|Adverse Event|2|||
155266984|NCT00098254|560410947|FG000|Overall Study|Death|1|||
155266985|NCT00744263|560410948|FG000|Overall Study|Death|3006|||
155266986|NCT00744263|560410949|FG001|Overall Study|Death|3005|||
155266987|NCT00744263|560410948|FG000|Overall Study|Lost to Follow-up|2038|||
155266988|NCT00744263|560410949|FG001|Overall Study|Lost to Follow-up|2135|||
155266989|NCT00744263|560410948|FG000|Overall Study|Withdrawal by Subject|166|||
155266990|NCT00744263|560410949|FG001|Overall Study|Withdrawal by Subject|150|||
155266991|NCT00744263|560410948|FG000|Overall Study|Physician Decision|20|||
155266992|NCT00744263|560410949|FG001|Overall Study|Physician Decision|23|||
155266993|NCT00744263|560410948|FG000|Overall Study|Protocol Violation|3|||
155266994|NCT00744263|560410949|FG001|Overall Study|Protocol Violation|5|||
155266995|NCT00744263|560410948|FG000|Overall Study|Adverse Event|1|||
155266996|NCT00744263|560410949|FG001|Overall Study|Adverse Event|0|||
155266997|NCT00744263|560410948|FG000|Overall Study|Other|2|||
155266998|NCT00744263|560410949|FG001|Overall Study|Other|2|||
155266999|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
155267000|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
155267001|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
155267002|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
155267003|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
155267004|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
155267005|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
155267006|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
155267007|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
155267008|NCT03500640|560410950|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
155267009|NCT03500640|560410951|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
155267010|NCT03500640|560410952|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
155267011|NCT03500640|560410950|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
155381700|NCT04617275|560830989|FG005|Treatment Period|Lost to Follow-up|3|||
155381701|NCT04617275|560830990|FG006|Treatment Period|Lost to Follow-up|0|||
155267012|NCT03500640|560410951|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
155267013|NCT03500640|560410952|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
155267014|NCT03500640|560410950|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
155267015|NCT03500640|560410951|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
155267016|NCT03500640|560410952|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
155267017|NCT03500640|560410950|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
155267018|NCT03500640|560410951|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
155267019|NCT03500640|560410952|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
155267020|NCT03500640|560410950|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
155267021|NCT03500640|560410951|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
155267022|NCT03500640|560410952|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
155267023|NCT03500640|560410950|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
154930978|NCT00545441|559172246|FG001|Overall Study|Persistence or recurrence of fistula|2|||
154930979|NCT00545441|559172245|FG000|Overall Study|Patients were not treated|1|||
154930980|NCT00545441|559172246|FG001|Overall Study|Patients were not treated|3|||
154930981|NCT03911960|559172247|FG000|Overall Study|Lost to Follow-up|5|||
154930982|NCT03911960|559172248|FG001|Overall Study|Lost to Follow-up|3|||
154930983|NCT00424515|559172251|FG000|Overall Study|Progressive Disease|10|||
154930984|NCT00424515|559172252|FG001|Overall Study|Progressive Disease|11|||
154930985|NCT00424515|559172251|FG000|Overall Study|Adverse Event|0|||
154930986|NCT00424515|559172252|FG001|Overall Study|Adverse Event|1|||
154930987|NCT00424515|559172251|FG000|Overall Study|Intercurrent Illness|0|||
154930988|NCT00424515|559172252|FG001|Overall Study|Intercurrent Illness|1|||
154930989|NCT00424515|559172251|FG000|Overall Study|Withdrawal by Subject|1|||
154930990|NCT00424515|559172252|FG001|Overall Study|Withdrawal by Subject|0|||
154930991|NCT04071366|559172253|FG000|Part 1: Open-label (29 Days)|Death|4|||
154930992|NCT04071366|559172254|FG001|Part 1: Open-label (29 Days)|Death|2|||
154930993|NCT04071366|559172255|FG002|Part 1: Open-label (29 Days)|Death|8|||
154930994|NCT04071366|559172256|FG003|Part 1: Open-label (29 Days)|Death|0|||
154930995|NCT04071366|559172257|FG004|Part 1: Open-label (29 Days)|Death|0|||
154930996|NCT04071366|559172253|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
154930997|NCT04071366|559172254|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
154930998|NCT04071366|559172255|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
154930999|NCT04071366|559172256|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
154931000|NCT04071366|559172257|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
154931001|NCT04071366|559172253|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
154931002|NCT04071366|559172254|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
154931003|NCT04071366|559172255|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
154931004|NCT04071366|559172256|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
154931005|NCT04071366|559172257|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
154931006|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Death|0|||
154931007|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Death|0|||
154931008|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Death|0|||
154931009|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Death|2|||
154931010|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Death|2|||
154931011|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
154931012|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
154931013|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
154931014|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
154931015|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
154931016|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
154931017|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
154931018|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
154931019|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
154931020|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
154931021|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
154931022|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
154931023|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
154931024|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
154931025|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
154931026|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
154931027|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
154931028|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
154931029|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
154931030|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
154931031|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
154931032|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
154931033|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
154931034|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
154931035|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
154931036|NCT04071366|559172253|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
154931037|NCT04071366|559172254|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
154931038|NCT04071366|559172255|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
154931039|NCT04071366|559172256|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
154931040|NCT04071366|559172257|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
154931041|NCT02239692|559172258|FG000|Overall Study|Incomplete colonoscopy|1|||
154931042|NCT02239692|559172259|FG001|Overall Study|Incomplete colonoscopy|2|||
154931043|NCT02239692|559172258|FG000|Overall Study|Adverse Event|0|||
154931044|NCT02239692|559172259|FG001|Overall Study|Adverse Event|1|||
154931045|NCT02239692|559172258|FG000|Overall Study|Physician Decision|0|||
154931046|NCT02239692|559172259|FG001|Overall Study|Physician Decision|1|||
154931047|NCT02239692|559172258|FG000|Overall Study|Lost to Follow-up|1|||
154931048|NCT02239692|559172259|FG001|Overall Study|Lost to Follow-up|4|||
154931049|NCT02239692|559172258|FG000|Overall Study|Withdrawal by Subject|3|||
154931050|NCT02239692|559172259|FG001|Overall Study|Withdrawal by Subject|5|||
154931051|NCT02239692|559172258|FG000|Overall Study|Other reason|1|||
154931052|NCT02239692|559172259|FG001|Overall Study|Other reason|0|||
154931053|NCT04318535|559172260|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
154931054|NCT04318535|559172261|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
154931055|NCT04318535|559172262|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
154931056|NCT01678924|559172264|FG000|Overall Study|Adverse Event|1|||
154931057|NCT01678924|559172265|FG001|Overall Study|Adverse Event|1|||
154931058|NCT01678924|559172266|FG002|Overall Study|Adverse Event|0|||
154931059|NCT01678924|559172267|FG003|Overall Study|Adverse Event|1|||
154931060|NCT01678924|559172264|FG000|Overall Study|Lack of Efficacy|7|||
154931061|NCT01678924|559172265|FG001|Overall Study|Lack of Efficacy|2|||
154931062|NCT01678924|559172266|FG002|Overall Study|Lack of Efficacy|0|||
154931063|NCT01678924|559172267|FG003|Overall Study|Lack of Efficacy|5|||
154931064|NCT01678924|559172264|FG000|Overall Study|Lost to Follow-up|0|||
154931065|NCT01678924|559172265|FG001|Overall Study|Lost to Follow-up|4|||
154931066|NCT01678924|559172266|FG002|Overall Study|Lost to Follow-up|0|||
154931067|NCT01678924|559172267|FG003|Overall Study|Lost to Follow-up|2|||
154931068|NCT01678924|559172264|FG000|Overall Study|Personal Reasons|2|||
154931069|NCT01678924|559172265|FG001|Overall Study|Personal Reasons|2|||
154931070|NCT01678924|559172266|FG002|Overall Study|Personal Reasons|2|||
154931071|NCT01678924|559172267|FG003|Overall Study|Personal Reasons|7|||
154931072|NCT01678924|559172264|FG000|Overall Study|Withdrawal by Subject|0|||
154931073|NCT01678924|559172265|FG001|Overall Study|Withdrawal by Subject|3|||
154931074|NCT01678924|559172266|FG002|Overall Study|Withdrawal by Subject|0|||
154931075|NCT01678924|559172267|FG003|Overall Study|Withdrawal by Subject|2|||
154931076|NCT01678924|559172264|FG000|Overall Study|Unable to attend scheduled visits|0|||
154931077|NCT01678924|559172265|FG001|Overall Study|Unable to attend scheduled visits|0|||
154931078|NCT01678924|559172266|FG002|Overall Study|Unable to attend scheduled visits|0|||
154931079|NCT01678924|559172267|FG003|Overall Study|Unable to attend scheduled visits|1|||
154931080|NCT02156466|559172271|FG000|Overall Study|Adverse Event|0|||
154931081|NCT02156466|559172272|FG001|Overall Study|Adverse Event|0|||
154931082|NCT02156466|559172273|FG002|Overall Study|Adverse Event|1|||
154931083|NCT02156466|559172274|FG003|Overall Study|Adverse Event|1|||
154931084|NCT02156466|559172275|FG004|Overall Study|Adverse Event|0|||
154931085|NCT02156466|559172271|FG000|Overall Study|Quantiferon Positivity|0|||
154931086|NCT02156466|559172272|FG001|Overall Study|Quantiferon Positivity|0|||
154931087|NCT02156466|559172273|FG002|Overall Study|Quantiferon Positivity|0|||
154931088|NCT02156466|559172274|FG003|Overall Study|Quantiferon Positivity|1|||
154931089|NCT02156466|559172275|FG004|Overall Study|Quantiferon Positivity|0|||
154931090|NCT01784419|559172276|FG000|Overall Study|Adverse Event|3|||
154931091|NCT00080288|559172277|FG000|Overall Study|Adverse Event|7|||
154931092|NCT00080288|559172278|FG001|Overall Study|Adverse Event|4|||
154931093|NCT00080288|559172277|FG000|Overall Study|Lost to Follow-up|3|||
154931094|NCT00080288|559172278|FG001|Overall Study|Lost to Follow-up|5|||
154931095|NCT00080288|559172277|FG000|Overall Study|Physician Decision|6|||
154931096|NCT00080288|559172278|FG001|Overall Study|Physician Decision|2|||
154931097|NCT00080288|559172277|FG000|Overall Study|Withdrawal by Subject|3|||
154931098|NCT00080288|559172278|FG001|Overall Study|Withdrawal by Subject|16|||
154931099|NCT00080288|559172277|FG000|Overall Study|Miscellaneous|11|||
154931100|NCT00080288|559172278|FG001|Overall Study|Miscellaneous|11|||
154931101|NCT02253654|559172279|FG000|Overall Study|Withdrawal by Subject|12|||
155267024|NCT03500640|560410951|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
155267025|NCT03500640|560410952|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
155267026|NCT03500640|560410950|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
155267027|NCT03500640|560410951|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
154931102|NCT02253654|559172280|FG001|Overall Study|Withdrawal by Subject|4|||
154931103|NCT02253654|559172279|FG000|Overall Study|Decision by Sponsor|1|||
154931104|NCT02253654|559172280|FG001|Overall Study|Decision by Sponsor|1|||
154931105|NCT02253654|559172279|FG000|Overall Study|Lost to Follow-up|2|||
154931106|NCT02253654|559172280|FG001|Overall Study|Lost to Follow-up|5|||
154931107|NCT02253654|559172279|FG000|Overall Study|Death|4|||
155267028|NCT03500640|560410952|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
155267029|NCT00661661|560410958|FG000|Overall Study|Adverse Event|99|||
154931108|NCT02253654|559172280|FG001|Overall Study|Death|7|||
154931109|NCT02253654|559172279|FG000|Overall Study|Did Not Receive Study Treatment|4|||
154931110|NCT02253654|559172280|FG001|Overall Study|Did Not Receive Study Treatment|1|||
154931111|NCT03044431|559172283|FG000|Overall Study|Lost to Follow-up|59|||
154931112|NCT03456726|559172284|FG000|Overall Study|Disease Progression|6|||
154931113|NCT03456726|559172285|FG001|Overall Study|Disease Progression|1|||
154931114|NCT03456726|559172284|FG000|Overall Study|Adverse Event|4|||
154931115|NCT03456726|559172285|FG001|Overall Study|Adverse Event|2|||
154931116|NCT03456726|559172284|FG000|Overall Study|Withdrawal by Subject|1|||
154931117|NCT03456726|559172285|FG001|Overall Study|Withdrawal by Subject|0|||
154931118|NCT03456726|559172284|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
154931119|NCT03456726|559172285|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
154931120|NCT01614925|559172286|FG000|Overall Study|Withdrawal by Subject|1|||
154931121|NCT01614925|559172287|FG001|Overall Study|Withdrawal by Subject|0|||
154931122|NCT01614925|559172286|FG000|Overall Study|Protocol Violation|3|||
154931123|NCT01614925|559172287|FG001|Overall Study|Protocol Violation|2|||
154931124|NCT04470622|559172288|FG000|Overall Study|Withdrawal by Subject|0|||
154931125|NCT04470622|559172289|FG001|Overall Study|Withdrawal by Subject|1|||
154931126|NCT04470622|559172288|FG000|Overall Study|Screen Failure|0|||
154931127|NCT04470622|559172289|FG001|Overall Study|Screen Failure|1|||
154931128|NCT04470622|559172288|FG000|Overall Study|Death|0|||
154931129|NCT04470622|559172289|FG001|Overall Study|Death|1|||
154931130|NCT02576054|559172290|FG000|Overall Study|Withdrawal by Subject|1|||
154931131|NCT00791154|559172291|FG000|Overall Study|Noncompliance|0|||
154931132|NCT00791154|559172292|FG001|Overall Study|Noncompliance|1|||
154931133|NCT00791154|559172293|FG002|Overall Study|Noncompliance|0|||
154931134|NCT00791154|559172294|FG003|Overall Study|Noncompliance|0|||
154931135|NCT00791154|559172295|FG004|Overall Study|Noncompliance|1|||
154931136|NCT00791154|559172296|FG005|Overall Study|Noncompliance|1|||
154931137|NCT00791154|559172297|FG006|Overall Study|Noncompliance|1|||
154931138|NCT00791154|559172291|FG000|Overall Study|Adverse Event|0|||
154931139|NCT00791154|559172292|FG001|Overall Study|Adverse Event|0|||
154931140|NCT00791154|559172293|FG002|Overall Study|Adverse Event|0|||
154931141|NCT00791154|559172294|FG003|Overall Study|Adverse Event|0|||
154931142|NCT00791154|559172295|FG004|Overall Study|Adverse Event|2|||
154931143|NCT00791154|559172296|FG005|Overall Study|Adverse Event|0|||
154931144|NCT00791154|559172297|FG006|Overall Study|Adverse Event|1|||
154931145|NCT00791154|559172291|FG000|Overall Study|Full Consent withdrawn|1|||
154931146|NCT00791154|559172292|FG001|Overall Study|Full Consent withdrawn|3|||
154931147|NCT00791154|559172293|FG002|Overall Study|Full Consent withdrawn|0|||
154931148|NCT00791154|559172294|FG003|Overall Study|Full Consent withdrawn|0|||
154931149|NCT00791154|559172295|FG004|Overall Study|Full Consent withdrawn|1|||
154931150|NCT00791154|559172296|FG005|Overall Study|Full Consent withdrawn|3|||
154931151|NCT00791154|559172297|FG006|Overall Study|Full Consent withdrawn|1|||
154931152|NCT00791154|559172291|FG000|Overall Study|Lost to Follow-up|0|||
154931153|NCT00791154|559172292|FG001|Overall Study|Lost to Follow-up|0|||
154931154|NCT00791154|559172293|FG002|Overall Study|Lost to Follow-up|0|||
154931155|NCT00791154|559172294|FG003|Overall Study|Lost to Follow-up|1|||
154931156|NCT00791154|559172295|FG004|Overall Study|Lost to Follow-up|2|||
154931157|NCT00791154|559172296|FG005|Overall Study|Lost to Follow-up|0|||
154931158|NCT00791154|559172297|FG006|Overall Study|Lost to Follow-up|4|||
154931159|NCT00791154|559172291|FG000|Overall Study|Death|5|||
154931160|NCT00791154|559172292|FG001|Overall Study|Death|4|||
154931161|NCT00791154|559172293|FG002|Overall Study|Death|4|||
154931162|NCT00791154|559172294|FG003|Overall Study|Death|7|||
154931163|NCT00791154|559172295|FG004|Overall Study|Death|54|||
154931164|NCT00791154|559172296|FG005|Overall Study|Death|54|||
155267030|NCT00661661|560410959|FG001|Overall Study|Adverse Event|24|||
154931165|NCT00791154|559172297|FG006|Overall Study|Death|52|||
154931166|NCT00791154|559172291|FG000|Overall Study|Other event|0|||
155267031|NCT00661661|560410958|FG000|Overall Study|Lack of Efficacy|3|||
155267032|NCT00661661|560410959|FG001|Overall Study|Lack of Efficacy|2|||
155267033|NCT00661661|560410958|FG000|Overall Study|Lost to Follow-up|0|||
155267034|NCT00661661|560410959|FG001|Overall Study|Lost to Follow-up|1|||
155267035|NCT00661661|560410958|FG000|Overall Study|Withdrawal by Subject|15|||
155267036|NCT00661661|560410959|FG001|Overall Study|Withdrawal by Subject|5|||
155267037|NCT00661661|560410958|FG000|Overall Study|Other|22|||
155267038|NCT00661661|560410959|FG001|Overall Study|Other|7|||
155267039|NCT00661661|560410958|FG000|Overall Study|Not assigned treatment|1|||
154931167|NCT00791154|559172292|FG001|Overall Study|Other event|0|||
154931168|NCT00791154|559172293|FG002|Overall Study|Other event|2|||
154931169|NCT00791154|559172294|FG003|Overall Study|Other event|0|||
154931170|NCT00791154|559172295|FG004|Overall Study|Other event|2|||
154931171|NCT00791154|559172296|FG005|Overall Study|Other event|4|||
154931172|NCT00791154|559172297|FG006|Overall Study|Other event|2|||
155267040|NCT00661661|560410959|FG001|Overall Study|Not assigned treatment|0|||
155267041|NCT04512066|560410960|FG000|Double-blind Treatment Period|Adverse Event|6|||
154931173|NCT00450177|559172298|FG000|Overall Study|Adverse Event|7|||
154931174|NCT00450177|559172299|FG001|Overall Study|Adverse Event|4|||
154931175|NCT00450177|559172298|FG000|Overall Study|Withdrawal by Subject|1|||
154931176|NCT00450177|559172299|FG001|Overall Study|Withdrawal by Subject|6|||
154931177|NCT00450177|559172298|FG000|Overall Study|Withdrawal by Primary Team|1|||
154931178|NCT00450177|559172299|FG001|Overall Study|Withdrawal by Primary Team|1|||
154931179|NCT00835068|559172300|FG000|Overall Study|Death|1|||
155267042|NCT04512066|560410961|FG001|Double-blind Treatment Period|Adverse Event|4|||
155267043|NCT04512066|560410962|FG002|Double-blind Treatment Period|Adverse Event|5|||
155267044|NCT04512066|560410963|FG003|Double-blind Treatment Period|Adverse Event|1|||
155267045|NCT04512066|560410964|FG004|Double-blind Treatment Period|Adverse Event|0|||
155267046|NCT04512066|560410965|FG005|Double-blind Treatment Period|Adverse Event|0|||
155267047|NCT04512066|560410960|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
154931180|NCT00835068|559172301|FG001|Overall Study|Death|0|||
154931181|NCT00835068|559172300|FG000|Overall Study|Adverse Event|0|||
154931182|NCT00835068|559172301|FG001|Overall Study|Adverse Event|1|||
154931183|NCT00835068|559172300|FG000|Overall Study|Other|8|||
154931184|NCT00835068|559172301|FG001|Overall Study|Other|0|||
154931185|NCT00835068|559172300|FG000|Overall Study|Withdrawal by Subject|1|||
154931186|NCT00835068|559172301|FG001|Overall Study|Withdrawal by Subject|0|||
154931187|NCT04803214|559172304|FG000|Overall Study|Adverse Event|1|||
154931188|NCT04803214|559172305|FG001|Overall Study|Adverse Event|0|||
154931189|NCT04803214|559172304|FG000|Overall Study|Withdrawal by Subject|1|||
154931190|NCT04803214|559172305|FG001|Overall Study|Withdrawal by Subject|2|||
154931191|NCT04803214|559172304|FG000|Overall Study|Lost to Follow-up|2|||
154931192|NCT04803214|559172305|FG001|Overall Study|Lost to Follow-up|4|||
154931193|NCT04803214|559172304|FG000|Overall Study|Physician Decision|1|||
154931194|NCT04803214|559172305|FG001|Overall Study|Physician Decision|1|||
154931195|NCT04803214|559172304|FG000|Overall Study|Missed 12 month visit|0|||
154931196|NCT04803214|559172305|FG001|Overall Study|Missed 12 month visit|3|||
154931197|NCT05631093|559172311|FG000|Overall Study|Death|0|||
154931198|NCT05631093|559172312|FG001|Overall Study|Death|1|||
154931199|NCT05631093|559172311|FG000|Overall Study|Lost to Follow-up|1|||
154931200|NCT05631093|559172312|FG001|Overall Study|Lost to Follow-up|2|||
154931201|NCT05631093|559172311|FG000|Overall Study|Physician Decision|1|||
154931202|NCT05631093|559172312|FG001|Overall Study|Physician Decision|0|||
154931203|NCT05631093|559172311|FG000|Overall Study|Withdrawal by Subject|4|||
154931204|NCT05631093|559172312|FG001|Overall Study|Withdrawal by Subject|1|||
154931205|NCT05631093|559172311|FG000|Overall Study|Ongoing|353|||
154931206|NCT05631093|559172312|FG001|Overall Study|Ongoing|177|||
154931207|NCT05631093|559172311|FG000|Overall Study|Adverse Event|0|||
154931208|NCT05631093|559172312|FG001|Overall Study|Adverse Event|1|||
154931209|NCT03732677|559172313|FG000|Overall Study|Terminated the study|154|||
154931210|NCT03732677|559172314|FG001|Overall Study|Terminated the study|197|||
154931211|NCT03732677|559172313|FG000|Overall Study|Continuing study off treatment|379|||
154931212|NCT03732677|559172314|FG001|Overall Study|Continuing study off treatment|333|||
154931213|NCT03494816|559172316|FG000|Overall Study|Protocol Violation|2|||
154931214|NCT03494816|559172316|FG000|Overall Study|Physician Decision|2|||
154931215|NCT03494816|559172316|FG000|Overall Study|Did not start trial treatment|1|||
154931216|NCT03494816|559172316|FG000|Overall Study|Adverse Event|1|||
154931217|NCT04502862|559172321|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
154931218|NCT04502862|559172322|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
154931219|NCT04502862|559172321|FG000|Overall Study|Withdrawal by Subject|1|||
154931220|NCT04502862|559172322|FG001|Overall Study|Withdrawal by Subject|0|||
154931221|NCT04502862|559172321|FG000|Overall Study|Adverse Event|1|||
154931222|NCT04502862|559172322|FG001|Overall Study|Adverse Event|1|||
154931223|NCT00265239|559173369|FG000|Overall Study|Adverse Event|2|||
154931224|NCT00265239|559173370|FG001|Overall Study|Adverse Event|1|||
154931225|NCT02803138|559173371|FG000|Overall Study|Failure to return|38|||
154931226|NCT02803138|559173371|FG000|Overall Study|Insufficient virological response|2|||
154931227|NCT02803138|559173371|FG000|Overall Study|Withdrawn consent|1|||
154931228|NCT02803138|559173371|FG000|Overall Study|Death|1|||
154931229|NCT02803138|559173371|FG000|Overall Study|Other, not specified|28|||
154931230|NCT02237118|559173374|FG000|Overall Study|Protocol Violation|0|||
154931231|NCT02237118|559173375|FG001|Overall Study|Protocol Violation|1|||
154931232|NCT02237118|559173374|FG000|Overall Study|consent withdrawn|1|||
154931233|NCT02237118|559173375|FG001|Overall Study|consent withdrawn|0|||
154931234|NCT00569231|559173376|FG000|Overall Study|Study unrelated surgery|1|||
154931235|NCT00569231|559173376|FG000|Overall Study|Airfare expense|2|||
154931236|NCT00569231|559173376|FG000|Overall Study|Withdrawal by Subject|1|||
154931237|NCT00569231|559173376|FG000|Overall Study|Car accident injury|1|||
154931238|NCT00569231|559173376|FG000|Overall Study|Non-compliance|2|||
154931239|NCT00399490|559173379|FG000|Overall Study|Adverse Event|19|||
155267048|NCT04512066|560410961|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
155267049|NCT04512066|560410962|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
154931240|NCT00399490|559173379|FG000|Overall Study|Lack of Efficacy|31|||
154931241|NCT00399490|559173379|FG000|Overall Study|Lost to Follow-up|5|||
154931242|NCT00399490|559173379|FG000|Overall Study|Withdrawal by Subject|18|||
154931243|NCT00399490|559173379|FG000|Overall Study|Other|25|||
154931244|NCT04723173|559173384|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
154931245|NCT00953927|559173385|FG000|Overall Study|Lost to Follow-up|61|||
154931246|NCT00953927|559173386|FG001|Overall Study|Lost to Follow-up|65|||
154931247|NCT00953927|559173385|FG000|Overall Study|Withdrawal by Subject|36|||
154931248|NCT00953927|559173386|FG001|Overall Study|Withdrawal by Subject|25|||
154931249|NCT00953927|559173385|FG000|Overall Study|Death|7|||
154931250|NCT00953927|559173386|FG001|Overall Study|Death|4|||
154931251|NCT00953927|559173385|FG000|Overall Study|Other study discontinuation|1|||
154931252|NCT00953927|559173386|FG001|Overall Study|Other study discontinuation|1|||
154931253|NCT01396161|559173388|FG000|Overall Study|Withdrawal by Subject|0|||
154931254|NCT01396161|559173389|FG001|Overall Study|Withdrawal by Subject|0|||
154931255|NCT01396161|559173390|FG002|Overall Study|Withdrawal by Subject|0|||
154931256|NCT01396161|559173391|FG003|Overall Study|Withdrawal by Subject|0|||
154931257|NCT01396161|559173392|FG004|Overall Study|Withdrawal by Subject|1|||
154931258|NCT01396161|559173393|FG005|Overall Study|Withdrawal by Subject|0|||
154931259|NCT01396161|559173394|FG006|Overall Study|Withdrawal by Subject|0|||
154931260|NCT01396161|559173388|FG000|Overall Study|Other|0|||
154931261|NCT01396161|559173389|FG001|Overall Study|Other|0|||
154931262|NCT01396161|559173390|FG002|Overall Study|Other|0|||
154931263|NCT01396161|559173391|FG003|Overall Study|Other|0|||
154931264|NCT01396161|559173392|FG004|Overall Study|Other|0|||
154931265|NCT01396161|559173393|FG005|Overall Study|Other|0|||
154931266|NCT01396161|559173394|FG006|Overall Study|Other|1|||
154931267|NCT02962739|559173399|FG000|Overall Study|Withdrawal by Subject|0|||
154931268|NCT02962739|559173400|FG001|Overall Study|Withdrawal by Subject|1|||
154931269|NCT02962739|559173401|FG002|Overall Study|Withdrawal by Subject|0|||
154931270|NCT02962739|559173402|FG003|Overall Study|Withdrawal by Subject|0|||
154931271|NCT02962739|559173403|FG004|Overall Study|Withdrawal by Subject|0|||
154931272|NCT02962739|559173404|FG005|Overall Study|Withdrawal by Subject|0|||
154931273|NCT02962739|559173399|FG000|Overall Study|Protocol Violation|0|||
154931274|NCT02962739|559173400|FG001|Overall Study|Protocol Violation|0|||
154931275|NCT02962739|559173401|FG002|Overall Study|Protocol Violation|1|||
154931276|NCT02962739|559173402|FG003|Overall Study|Protocol Violation|0|||
154931277|NCT02962739|559173403|FG004|Overall Study|Protocol Violation|1|||
154931278|NCT02962739|559173404|FG005|Overall Study|Protocol Violation|0|||
154931279|NCT00414011|559173405|FG000|Overall Study|Physician Decision|3|||
154931280|NCT00414011|559173405|FG000|Overall Study|Withdrawal by Subject|2|||
154931281|NCT00306852|559173406|FG000|Overall Study|Death|14|||
154931282|NCT00306852|559173407|FG001|Overall Study|Death|14|||
154931283|NCT00306852|559173406|FG000|Overall Study|Lost to Follow-up|15|||
154931284|NCT00306852|559173407|FG001|Overall Study|Lost to Follow-up|24|||
154931285|NCT00817778|559173409|FG000|Overall Study|Adverse Event|1|||
154931286|NCT00817778|559173410|FG001|Overall Study|Adverse Event|0|||
154931287|NCT00817778|559173409|FG000|Overall Study|Withdrawal by Subject|1|||
155267050|NCT04512066|560410963|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
155267051|NCT04512066|560410964|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
155267052|NCT04512066|560410965|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
155267053|NCT04512066|560410960|FG000|Double-blind Treatment Period|Physician Decision|1|||
155267054|NCT04512066|560410961|FG001|Double-blind Treatment Period|Physician Decision|0|||
155267055|NCT04512066|560410962|FG002|Double-blind Treatment Period|Physician Decision|1|||
154931288|NCT00817778|559173410|FG001|Overall Study|Withdrawal by Subject|1|||
154931289|NCT00817778|559173409|FG000|Overall Study|Protocol Violation|0|||
154931290|NCT00817778|559173410|FG001|Overall Study|Protocol Violation|1|||
154931291|NCT00817778|559173409|FG000|Overall Study|Study-specific discontinuation criteria|0|||
154931292|NCT00817778|559173410|FG001|Overall Study|Study-specific discontinuation criteria|1|||
154931293|NCT00817778|559173409|FG000|Overall Study|Poor venous access|1|||
154931294|NCT00817778|559173410|FG001|Overall Study|Poor venous access|0|||
154931295|NCT03343054|559173411|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
154931296|NCT03343054|559173412|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
154931297|NCT03343054|559173413|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
154931298|NCT03343054|559173411|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
154931299|NCT03343054|559173412|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
154931300|NCT03343054|559173413|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
154931301|NCT03343054|559173411|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
154931302|NCT03343054|559173412|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
154931303|NCT03343054|559173413|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
154931304|NCT03343054|559173411|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
154931305|NCT03343054|559173412|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
154931306|NCT03343054|559173413|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
154931307|NCT01537549|559173414|FG000|Overall Study|Lost to Follow-up|1|||
154931308|NCT01537549|559173414|FG000|Overall Study|Withdrawal by Subject|2|||
154931309|NCT00883740|559173415|FG000|First Intervention|Lost to Follow-up|1|||
154931310|NCT00883740|559173416|FG001|First Intervention|Lost to Follow-up|0|||
154931311|NCT00883740|559173415|FG000|First Intervention|No longer willing to participate|2|||
154931312|NCT00883740|559173416|FG001|First Intervention|No longer willing to participate|0|||
154931313|NCT00883740|559173415|FG000|First Intervention|Protocol Violation|3|||
154931314|NCT00883740|559173416|FG001|First Intervention|Protocol Violation|6|||
154931315|NCT00883740|559173415|FG000|First Intervention|Adverse Event|1|||
154931316|NCT00883740|559173416|FG001|First Intervention|Adverse Event|2|||
155267056|NCT04512066|560410963|FG003|Double-blind Treatment Period|Physician Decision|0|||
154931317|NCT00883740|559173415|FG000|Second Intervention|Protocol Violation|1|||
154931318|NCT00883740|559173416|FG001|Second Intervention|Protocol Violation|0|||
154931319|NCT00883740|559173415|FG000|Second Intervention|No longer willing to participate|0|||
154931320|NCT00883740|559173416|FG001|Second Intervention|No longer willing to participate|1|||
154931321|NCT01286207|559173417|FG000|Overall Study|Adverse Event|27|||
154931322|NCT01286207|559173418|FG001|Overall Study|Adverse Event|41|||
154931323|NCT01286207|559173419|FG002|Overall Study|Adverse Event|8|||
154931324|NCT01286207|559173417|FG000|Overall Study|Lost to Follow-up|49|||
154931325|NCT01286207|559173418|FG001|Overall Study|Lost to Follow-up|43|||
154931326|NCT01286207|559173419|FG002|Overall Study|Lost to Follow-up|20|||
154931327|NCT01286207|559173417|FG000|Overall Study|Withdrawal by Subject|93|||
154931328|NCT01286207|559173418|FG001|Overall Study|Withdrawal by Subject|79|||
154931329|NCT01286207|559173419|FG002|Overall Study|Withdrawal by Subject|41|||
154931330|NCT01286207|559173417|FG000|Overall Study|Lack of Response|92|||
154931331|NCT01286207|559173418|FG001|Overall Study|Lack of Response|38|||
154931332|NCT01286207|559173419|FG002|Overall Study|Lack of Response|8|||
154931333|NCT01286207|559173417|FG000|Overall Study|Other|37|||
154931334|NCT01286207|559173418|FG001|Overall Study|Other|47|||
154931335|NCT01286207|559173419|FG002|Overall Study|Other|13|||
154931336|NCT02923115|559173420|FG000|Overall Study|Lost to Follow-up|0|||
154931337|NCT02923115|559173421|FG001|Overall Study|Lost to Follow-up|0|||
154931338|NCT02923115|559173422|FG002|Overall Study|Lost to Follow-up|0|||
154931339|NCT02923115|559173423|FG003|Overall Study|Lost to Follow-up|1|||
154931340|NCT02923115|559173424|FG004|Overall Study|Lost to Follow-up|0|||
154931341|NCT02923115|559173425|FG005|Overall Study|Lost to Follow-up|0|||
154931342|NCT02923115|559173420|FG000|Overall Study|Withdrawal by Subject|0|||
154931343|NCT02923115|559173421|FG001|Overall Study|Withdrawal by Subject|1|||
154931344|NCT02923115|559173422|FG002|Overall Study|Withdrawal by Subject|0|||
154931345|NCT02923115|559173423|FG003|Overall Study|Withdrawal by Subject|0|||
154931346|NCT02923115|559173424|FG004|Overall Study|Withdrawal by Subject|0|||
154931347|NCT02923115|559173425|FG005|Overall Study|Withdrawal by Subject|0|||
154931348|NCT02923115|559173420|FG000|Overall Study|Randomized, but not dosed|0|||
154931349|NCT02923115|559173421|FG001|Overall Study|Randomized, but not dosed|0|||
154931350|NCT02923115|559173422|FG002|Overall Study|Randomized, but not dosed|3|||
154931351|NCT02923115|559173423|FG003|Overall Study|Randomized, but not dosed|1|||
154931352|NCT02923115|559173424|FG004|Overall Study|Randomized, but not dosed|5|||
154931353|NCT02923115|559173425|FG005|Overall Study|Randomized, but not dosed|0|||
154931354|NCT01875991|559173432|FG000|Overall Study|Withdrawal by Subject|6|||
154931355|NCT01875991|559173433|FG001|Overall Study|Withdrawal by Subject|6|||
154931356|NCT01875991|559173432|FG000|Overall Study|Sponsor Decision|1|||
154931357|NCT01875991|559173433|FG001|Overall Study|Sponsor Decision|0|||
154931358|NCT04840901|559173434|FG000|Overall Study|Lost to Follow-up|3|||
154931359|NCT04840901|559173435|FG001|Overall Study|Lost to Follow-up|1|||
154931360|NCT04840901|559173434|FG000|Overall Study|Moved|1|||
154931361|NCT04840901|559173435|FG001|Overall Study|Moved|0|||
154931362|NCT04840901|559173434|FG000|Overall Study|Unable to comply with study schedule|0|||
154931363|NCT04840901|559173435|FG001|Overall Study|Unable to comply with study schedule|1|||
154931364|NCT04840901|559173434|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
154931365|NCT04840901|559173435|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
154931366|NCT01268683|559173436|FG000|Overall Study|Lost to Follow-up|1|||
154931367|NCT01268683|559173436|FG000|Overall Study|Death|1|||
154931368|NCT00103259|559173442|FG000|Overall Study|Death|3|||
154931369|NCT00103259|559173443|FG001|Overall Study|Death|2|||
154931370|NCT00103259|559173442|FG000|Overall Study|Withdrawal by Subject|2|||
154931371|NCT00103259|559173443|FG001|Overall Study|Withdrawal by Subject|3|||
154931372|NCT00103259|559173442|FG000|Overall Study|alternative therapy|1|||
155267057|NCT04512066|560410964|FG004|Double-blind Treatment Period|Physician Decision|0|||
155267058|NCT04512066|560410965|FG005|Double-blind Treatment Period|Physician Decision|0|||
154931373|NCT00103259|559173443|FG001|Overall Study|alternative therapy|0|||
155267059|NCT04512066|560410960|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
154931374|NCT00103259|559173442|FG000|Overall Study|other (reasons were not specified)|2|||
154931375|NCT00103259|559173443|FG001|Overall Study|other (reasons were not specified)|1|||
154931376|NCT00103259|559173442|FG000|Overall Study|ineligible/no protocol therapy|4|||
154931377|NCT00103259|559173443|FG001|Overall Study|ineligible/no protocol therapy|6|||
154931378|NCT03224234|559173444|FG000|Main Study|Lost to Follow-up|5|||
154931379|NCT03224234|559173445|FG001|Main Study|Lost to Follow-up|5|||
154931380|NCT02610842|559173446|FG000|Overall Study|Lost to Follow-up|5|||
155267060|NCT04512066|560410961|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
154931381|NCT02125734|559173453|FG000|Period 2|Adverse Event|0|||
154931382|NCT02125734|559173454|FG001|Period 2|Adverse Event|1|||
154931383|NCT01308762|559173455|FG000|Overall Study|Protocol Violation|0|||
154931384|NCT01308762|559173456|FG001|Overall Study|Protocol Violation|1|||
154931385|NCT01308762|559173457|FG002|Overall Study|Protocol Violation|0|||
154931386|NCT02617446|559173458|FG000|Overall Study|Withdrawal by Subject|0|||
154931387|NCT02617446|559173459|FG001|Overall Study|Withdrawal by Subject|2|||
154931388|NCT02617446|559173460|FG002|Overall Study|Withdrawal by Subject|0|||
154931389|NCT02617446|559173458|FG000|Overall Study|Adverse Event|1|||
154931390|NCT02617446|559173459|FG001|Overall Study|Adverse Event|0|||
154931391|NCT02617446|559173460|FG002|Overall Study|Adverse Event|5|||
154931392|NCT02617446|559173458|FG000|Overall Study|Lost to Follow-up|3|||
154931393|NCT02617446|559173459|FG001|Overall Study|Lost to Follow-up|0|||
154931394|NCT02617446|559173460|FG002|Overall Study|Lost to Follow-up|0|||
154931395|NCT02617446|559173458|FG000|Overall Study|Death|0|||
154931396|NCT02617446|559173459|FG001|Overall Study|Death|0|||
154931397|NCT02617446|559173460|FG002|Overall Study|Death|2|||
154931398|NCT01556490|559173469|FG000|Randomized Patients Summary|Protocol Violation|22|||
154931399|NCT01556490|559173470|FG001|Randomized Patients Summary|Protocol Violation|23|||
154931400|NCT01556490|559173469|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
154931401|NCT01556490|559173470|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
154931402|NCT06065176|559173471|FG000|Overall Study|Lost to Follow-up|11|||
154931403|NCT06065176|559173472|FG001|Overall Study|Lost to Follow-up|11|||
154931404|NCT06065176|559173473|FG002|Overall Study|Lost to Follow-up|10|||
154931405|NCT06065176|559173471|FG000|Overall Study|Withdrawal by Subject|1|||
154931406|NCT06065176|559173472|FG001|Overall Study|Withdrawal by Subject|1|||
154931407|NCT06065176|559173473|FG002|Overall Study|Withdrawal by Subject|2|||
154931408|NCT06065176|559173471|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
154931409|NCT06065176|559173472|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
154931410|NCT06065176|559173473|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
155267061|NCT04512066|560410962|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
155267062|NCT04512066|560410963|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
155267063|NCT04512066|560410964|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
155267064|NCT04512066|560410965|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
155267065|NCT04512066|560410960|FG000|Extension Period|Adverse Event|0|||
155267066|NCT04512066|560410961|FG001|Extension Period|Adverse Event|1|||
155267067|NCT04512066|560410962|FG002|Extension Period|Adverse Event|4|||
155267068|NCT04512066|560410963|FG003|Extension Period|Adverse Event|3|||
155267069|NCT04512066|560410964|FG004|Extension Period|Adverse Event|1|||
155267070|NCT04512066|560410965|FG005|Extension Period|Adverse Event|3|||
155267071|NCT04512066|560410960|FG000|Extension Period|Death|0|||
155267072|NCT04512066|560410961|FG001|Extension Period|Death|0|||
155267073|NCT04512066|560410962|FG002|Extension Period|Death|0|||
155267074|NCT04512066|560410963|FG003|Extension Period|Death|0|||
155267075|NCT04512066|560410964|FG004|Extension Period|Death|0|||
155267076|NCT04512066|560410965|FG005|Extension Period|Death|1|||
155267077|NCT04512066|560410960|FG000|Extension Period|Lack of Efficacy|0|||
155267078|NCT04512066|560410961|FG001|Extension Period|Lack of Efficacy|4|||
155267079|NCT04512066|560410962|FG002|Extension Period|Lack of Efficacy|4|||
155267080|NCT04512066|560410963|FG003|Extension Period|Lack of Efficacy|1|||
155267081|NCT04512066|560410964|FG004|Extension Period|Lack of Efficacy|3|||
155267082|NCT04512066|560410965|FG005|Extension Period|Lack of Efficacy|3|||
155267083|NCT04512066|560410960|FG000|Extension Period|Lost to Follow-up|0|||
155267084|NCT04512066|560410961|FG001|Extension Period|Lost to Follow-up|1|||
155267085|NCT04512066|560410962|FG002|Extension Period|Lost to Follow-up|5|||
155267086|NCT04512066|560410963|FG003|Extension Period|Lost to Follow-up|2|||
155267087|NCT04512066|560410964|FG004|Extension Period|Lost to Follow-up|3|||
155267088|NCT04512066|560410965|FG005|Extension Period|Lost to Follow-up|2|||
155267089|NCT04512066|560410960|FG000|Extension Period|Non-compliance with study drug|0|||
155267090|NCT04512066|560410961|FG001|Extension Period|Non-compliance with study drug|1|||
155267091|NCT04512066|560410962|FG002|Extension Period|Non-compliance with study drug|0|||
155267092|NCT04512066|560410963|FG003|Extension Period|Non-compliance with study drug|0|||
155267093|NCT04512066|560410964|FG004|Extension Period|Non-compliance with study drug|0|||
155267094|NCT04512066|560410965|FG005|Extension Period|Non-compliance with study drug|1|||
155267095|NCT04512066|560410960|FG000|Extension Period|Other|0|||
155267096|NCT04512066|560410961|FG001|Extension Period|Other|2|||
155267097|NCT04512066|560410962|FG002|Extension Period|Other|0|||
155267098|NCT04512066|560410963|FG003|Extension Period|Other|0|||
154931411|NCT02588651|559173474|FG000|Overall Study|Adverse Event|1|||
154931412|NCT02588651|559173474|FG000|Overall Study|Withdrawal by Subject|2|||
154931413|NCT02588651|559173474|FG000|Overall Study|Death|1|||
154931414|NCT02588651|559173474|FG000|Overall Study|Lack of Efficacy|13|||
154931415|NCT02588651|559173474|FG000|Overall Study|Lost to Follow-up|1|||
154931416|NCT02588651|559173474|FG000|Overall Study|Physician Decision|1|||
155267099|NCT04512066|560410964|FG004|Extension Period|Other|0|||
155267100|NCT04512066|560410965|FG005|Extension Period|Other|0|||
155267101|NCT04512066|560410960|FG000|Extension Period|Physician Decision|0|||
155267102|NCT04512066|560410961|FG001|Extension Period|Physician Decision|2|||
155267103|NCT04512066|560410962|FG002|Extension Period|Physician Decision|0|||
155267104|NCT04512066|560410963|FG003|Extension Period|Physician Decision|1|||
155267105|NCT04512066|560410964|FG004|Extension Period|Physician Decision|1|||
155267106|NCT04512066|560410965|FG005|Extension Period|Physician Decision|0|||
155267107|NCT04512066|560410960|FG000|Extension Period|Withdrawal by Subject|0|||
155267108|NCT04512066|560410961|FG001|Extension Period|Withdrawal by Subject|3|||
155267109|NCT04512066|560410962|FG002|Extension Period|Withdrawal by Subject|7|||
155267110|NCT04512066|560410963|FG003|Extension Period|Withdrawal by Subject|11|||
155267111|NCT04512066|560410964|FG004|Extension Period|Withdrawal by Subject|8|||
155267112|NCT04512066|560410965|FG005|Extension Period|Withdrawal by Subject|4|||
155267113|NCT01657266|560410967|FG000|Overall Study|Lost to Follow-up|2|||
155267114|NCT01657266|560410968|FG001|Overall Study|Lost to Follow-up|2|||
155267115|NCT01657266|560410967|FG000|Overall Study|Adverse Event|2|||
155267116|NCT01657266|560410968|FG001|Overall Study|Adverse Event|3|||
155267117|NCT01353222|560410971|FG000|Overall Study|Death|30|||
155267118|NCT01353222|560410972|FG001|Overall Study|Death|30|||
155267119|NCT01353222|560410971|FG000|Overall Study|Withdrawal by Subject|8|||
155267120|NCT01353222|560410972|FG001|Overall Study|Withdrawal by Subject|5|||
155267121|NCT01353222|560410971|FG000|Overall Study|Study Terminated|31|||
155267122|NCT01353222|560410972|FG001|Overall Study|Study Terminated|37|||
155267123|NCT01353222|560410971|FG000|Overall Study|Site closed research department|1|||
155267124|NCT01353222|560410972|FG001|Overall Study|Site closed research department|0|||
155267125|NCT03474549|560410975|FG000|Overall Study|Death|31|||
155267126|NCT03474549|560410975|FG000|Overall Study|Lost to Follow-up|4|||
155267127|NCT03474549|560410975|FG000|Overall Study|Withdrawal by Subject|2|||
155267128|NCT01861522|560410976|FG000|Overall Study|Adverse Event|1|||
155267129|NCT01861522|560410977|FG001|Overall Study|Adverse Event|0|||
155267130|NCT01861522|560410976|FG000|Overall Study|Withdrawal by Subject|2|||
155267131|NCT01861522|560410977|FG001|Overall Study|Withdrawal by Subject|0|||
155267132|NCT03573908|560410981|FG000|Treatment Period|Adverse Event|4|||
155267133|NCT03573908|560410982|FG001|Treatment Period|Adverse Event|9|||
155267134|NCT03573908|560410983|FG002|Treatment Period|Adverse Event|0|||
155267135|NCT03573908|560410984|FG003|Treatment Period|Adverse Event|0|||
155267136|NCT03573908|560410985|FG004|Treatment Period|Adverse Event|0|||
155267137|NCT03573908|560410981|FG000|Treatment Period|Protocol Violation|1|||
155267138|NCT03573908|560410982|FG001|Treatment Period|Protocol Violation|0|||
155267139|NCT03573908|560410983|FG002|Treatment Period|Protocol Violation|0|||
155267140|NCT03573908|560410984|FG003|Treatment Period|Protocol Violation|0|||
155267141|NCT03573908|560410985|FG004|Treatment Period|Protocol Violation|0|||
155267142|NCT03573908|560410981|FG000|Treatment Period|Withdrawal by Subject|7|||
155267143|NCT03573908|560410982|FG001|Treatment Period|Withdrawal by Subject|5|||
155267144|NCT03573908|560410983|FG002|Treatment Period|Withdrawal by Subject|0|||
155267145|NCT03573908|560410984|FG003|Treatment Period|Withdrawal by Subject|0|||
155267146|NCT03573908|560410985|FG004|Treatment Period|Withdrawal by Subject|0|||
155267147|NCT03573908|560410981|FG000|Treatment Period|Lost to Follow-up|7|||
155267148|NCT03573908|560410982|FG001|Treatment Period|Lost to Follow-up|6|||
155267149|NCT03573908|560410983|FG002|Treatment Period|Lost to Follow-up|0|||
155267150|NCT03573908|560410984|FG003|Treatment Period|Lost to Follow-up|0|||
155267151|NCT03573908|560410985|FG004|Treatment Period|Lost to Follow-up|0|||
155267152|NCT03573908|560410981|FG000|Treatment Period|Pregnancy|1|||
155267153|NCT03573908|560410982|FG001|Treatment Period|Pregnancy|0|||
155267154|NCT03573908|560410983|FG002|Treatment Period|Pregnancy|0|||
155267155|NCT03573908|560410984|FG003|Treatment Period|Pregnancy|0|||
155267156|NCT03573908|560410985|FG004|Treatment Period|Pregnancy|0|||
155267157|NCT03573908|560410981|FG000|Treatment Period|Other, Not Specified|4|||
155267158|NCT03573908|560410982|FG001|Treatment Period|Other, Not Specified|6|||
155267159|NCT03573908|560410983|FG002|Treatment Period|Other, Not Specified|0|||
155267160|NCT03573908|560410984|FG003|Treatment Period|Other, Not Specified|0|||
155267161|NCT03573908|560410985|FG004|Treatment Period|Other, Not Specified|0|||
155267162|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Adverse Event|0|||
155267163|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Adverse Event|0|||
155267164|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Adverse Event|3|||
155267165|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Adverse Event|0|||
155381702|NCT04617275|560830991|FG007|Treatment Period|Lost to Follow-up|2|||
155381703|NCT04617275|560830984|FG000|Treatment Period|No longer meets eligibility criteria|0|||
155381704|NCT04617275|560830985|FG001|Treatment Period|No longer meets eligibility criteria|0|||
155381705|NCT04617275|560830986|FG002|Treatment Period|No longer meets eligibility criteria|0|||
155267166|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Adverse Event|0|||
155267167|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267168|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267169|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267170|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
155267171|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
155267172|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267173|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267174|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
155267175|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267176|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
155267177|NCT03573908|560410981|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
155267178|NCT03573908|560410982|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
155267179|NCT03573908|560410983|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
155267180|NCT03573908|560410984|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
155267181|NCT03573908|560410985|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
155267182|NCT04006925|560410986|FG000|Overall Study|Side effects|2|||
155267183|NCT04006925|560410987|FG001|Overall Study|Side effects|0|||
155267184|NCT00738101|560410993|FG000|Overall Study|Physician Decision|5|||
155267185|NCT00738101|560410993|FG000|Overall Study|Death|1|||
155267186|NCT00738101|560410993|FG000|Overall Study|Repeat enrollment|1|||
155267187|NCT00926003|560410994|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
155267188|NCT00926003|560410995|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
155267189|NCT00926003|560410996|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
155267190|NCT00926003|560410994|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
155267191|NCT00926003|560410995|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
155267192|NCT00926003|560410996|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
155267193|NCT01396317|560410997|FG000|Overall Study|Adverse Event|1|||
155267194|NCT01396317|560410998|FG001|Overall Study|Adverse Event|0|||
155267195|NCT00524030|560411001|FG000|Overall Study|Lack of Efficacy|10|||
155267196|NCT00524030|560411002|FG001|Overall Study|Lack of Efficacy|24|||
155267197|NCT00524030|560411001|FG000|Overall Study|Lost to Follow-up|0|||
155267198|NCT00524030|560411002|FG001|Overall Study|Lost to Follow-up|2|||
155267199|NCT00524030|560411001|FG000|Overall Study|Withdrawal by Subject|3|||
155267200|NCT00524030|560411002|FG001|Overall Study|Withdrawal by Subject|8|||
155267201|NCT00524030|560411001|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
155267202|NCT00524030|560411002|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
155267203|NCT00524030|560411001|FG000|Overall Study|Protocol Violation|0|||
155267204|NCT00524030|560411002|FG001|Overall Study|Protocol Violation|1|||
155267205|NCT00524030|560411001|FG000|Overall Study|Pregnancy|1|||
155267206|NCT00524030|560411002|FG001|Overall Study|Pregnancy|0|||
155267207|NCT00524030|560411001|FG000|Overall Study|Adverse Event|3|||
155267208|NCT00524030|560411002|FG001|Overall Study|Adverse Event|21|||
155267209|NCT00524030|560411001|FG000|Overall Study|Death|0|||
155267210|NCT00524030|560411002|FG001|Overall Study|Death|1|||
155267211|NCT03315130|560411003|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
155267212|NCT03315130|560411004|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
155267213|NCT03315130|560411005|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
155267214|NCT03315130|560411006|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
155267215|NCT03315130|560411003|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
155267216|NCT03315130|560411004|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
155267217|NCT03315130|560411005|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
155267218|NCT03315130|560411006|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
155267219|NCT03315130|560411003|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
155267220|NCT03315130|560411004|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
155267221|NCT03315130|560411005|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
155267222|NCT03315130|560411006|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
155267223|NCT03315130|560411003|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
155267224|NCT03315130|560411004|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
155267225|NCT03315130|560411005|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
155267226|NCT03315130|560411006|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
155267227|NCT03315130|560411003|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
155267228|NCT03315130|560411004|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
155267229|NCT03315130|560411005|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
155267230|NCT03315130|560411006|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
155267231|NCT03315130|560411003|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
155267232|NCT03315130|560411004|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
155267233|NCT03315130|560411005|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
155267234|NCT03315130|560411006|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
155267235|NCT04398537|560411007|FG000|Overall Study|Physician Decision|10|||
155267236|NCT04398537|560411008|FG001|Overall Study|Physician Decision|15|||
155267237|NCT03535337|560411009|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
155267238|NCT03535337|560411010|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
155267239|NCT03535337|560411011|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
155267240|NCT03535337|560411012|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
155267241|NCT03535337|560411013|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
155267242|NCT03535337|560411014|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
155267243|NCT03535337|560411015|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
155267244|NCT03535337|560411016|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
155267245|NCT03535337|560411017|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
155267246|NCT03535337|560411018|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
155381706|NCT04617275|560830987|FG003|Treatment Period|No longer meets eligibility criteria|1|||
155267247|NCT00386308|560412457|FG000|Overall Study|Adverse Event|3|||
155267248|NCT00386308|560412458|FG001|Overall Study|Adverse Event|3|||
155267249|NCT00386308|560412457|FG000|Overall Study|Protocol Violation|2|||
155267250|NCT00386308|560412458|FG001|Overall Study|Protocol Violation|5|||
155267251|NCT00386308|560412457|FG000|Overall Study|Lack of Efficacy|0|||
155267252|NCT00386308|560412458|FG001|Overall Study|Lack of Efficacy|2|||
155267253|NCT00386308|560412457|FG000|Overall Study|Lost to Follow-up|10|||
155267254|NCT00386308|560412458|FG001|Overall Study|Lost to Follow-up|6|||
155267255|NCT00386308|560412457|FG000|Overall Study|Withdrawal by Subject|6|||
155267256|NCT00386308|560412458|FG001|Overall Study|Withdrawal by Subject|2|||
155267257|NCT00386308|560412457|FG000|Overall Study|Other Event|8|||
155267258|NCT00386308|560412458|FG001|Overall Study|Other Event|1|||
155267259|NCT03518658|560412459|FG000|Overall Study|Other|51|||
155267260|NCT03518658|560412460|FG001|Overall Study|Other|0|||
155267261|NCT00649389|560412461|FG000|Overall Study|Adverse Event|22|||
155267262|NCT00649389|560412462|FG001|Overall Study|Adverse Event|46|||
155267263|NCT00649389|560412463|FG002|Overall Study|Adverse Event|38|||
155267264|NCT00649389|560412464|FG003|Overall Study|Adverse Event|48|||
155267265|NCT00649389|560412461|FG000|Overall Study|Lost to Follow-up|15|||
155267266|NCT00649389|560412462|FG001|Overall Study|Lost to Follow-up|17|||
155267267|NCT00649389|560412463|FG002|Overall Study|Lost to Follow-up|21|||
155267268|NCT00649389|560412464|FG003|Overall Study|Lost to Follow-up|26|||
155267269|NCT00649389|560412461|FG000|Overall Study|Protocol Violation|11|||
155267270|NCT00649389|560412462|FG001|Overall Study|Protocol Violation|13|||
155267271|NCT00649389|560412463|FG002|Overall Study|Protocol Violation|9|||
155267272|NCT00649389|560412464|FG003|Overall Study|Protocol Violation|8|||
155267273|NCT00649389|560412461|FG000|Overall Study|Withdrawal by Subject|20|||
155267274|NCT00649389|560412462|FG001|Overall Study|Withdrawal by Subject|21|||
155267275|NCT00649389|560412463|FG002|Overall Study|Withdrawal by Subject|19|||
155267276|NCT00649389|560412464|FG003|Overall Study|Withdrawal by Subject|23|||
155267277|NCT00649389|560412461|FG000|Overall Study|Other|3|||
155267278|NCT00649389|560412462|FG001|Overall Study|Other|9|||
155267279|NCT00649389|560412463|FG002|Overall Study|Other|1|||
155267280|NCT00649389|560412464|FG003|Overall Study|Other|6|||
155267281|NCT02746575|560412467|FG000|Overall Study|Surgery cancelled or time chaned|13|||
155381707|NCT04617275|560830988|FG004|Treatment Period|No longer meets eligibility criteria|0|||
155381708|NCT04617275|560830989|FG005|Treatment Period|No longer meets eligibility criteria|0|||
155042972|NCT01778751|559588035|FG000|Overall Study|Withdrawal by Subject|0|||
155042973|NCT01778751|559588036|FG001|Overall Study|Withdrawal by Subject|2|||
155042974|NCT01778751|559588035|FG000|Overall Study|Transfered care|1|||
155042975|NCT01778751|559588036|FG001|Overall Study|Transfered care|0|||
155042976|NCT02669667|559588037|FG000|Overall Study|Lost to Follow-up|0|||
155042977|NCT02669667|559588038|FG001|Overall Study|Lost to Follow-up|0|||
155042978|NCT02669667|559588039|FG002|Overall Study|Lost to Follow-up|0|||
155042979|NCT02669667|559588040|FG003|Overall Study|Lost to Follow-up|0|||
155042980|NCT02669667|559588041|FG004|Overall Study|Lost to Follow-up|0|||
155042981|NCT02669667|559588042|FG005|Overall Study|Lost to Follow-up|1|||
155042982|NCT02669667|559588043|FG006|Overall Study|Lost to Follow-up|0|||
155042983|NCT03628716|559588048|FG000|Overall Study|Adverse Event|1|||
155042984|NCT03628716|559588049|FG001|Overall Study|Adverse Event|1|||
155042985|NCT03628716|559588048|FG000|Overall Study|Death|1|||
155042986|NCT03628716|559588049|FG001|Overall Study|Death|0|||
155042987|NCT03628716|559588048|FG000|Overall Study|Lack of Efficacy|15|||
155042988|NCT03628716|559588049|FG001|Overall Study|Lack of Efficacy|20|||
155042989|NCT03628716|559588048|FG000|Overall Study|Withdrawal by Subject|1|||
155042990|NCT03628716|559588049|FG001|Overall Study|Withdrawal by Subject|2|||
155042991|NCT03628716|559588048|FG000|Overall Study|Study Terminated by Sponsor|1|||
155042992|NCT03628716|559588049|FG001|Overall Study|Study Terminated by Sponsor|0|||
155042993|NCT00856843|559588050|FG000|Overall Study|Withdrawal by Subject|1|||
155042994|NCT00856843|559588051|FG001|Overall Study|Withdrawal by Subject|5|||
155042995|NCT00856843|559588050|FG000|Overall Study|Lack of Efficacy|1|||
155042996|NCT00856843|559588051|FG001|Overall Study|Lack of Efficacy|0|||
155042997|NCT03755518|559588052|FG000|Overall Study|Lack of Efficacy|10|||
155042998|NCT03755518|559588052|FG000|Overall Study|Adverse Event|7|||
155042999|NCT03755518|559588052|FG000|Overall Study|Study Terminated by Sponsor|5|||
155043000|NCT03755518|559588052|FG000|Overall Study|Death|1|||
155043001|NCT03755518|559588052|FG000|Overall Study|Withdrawal by Subject|3|||
155043002|NCT03755518|559588052|FG000|Overall Study|Progressive Disease|4|||
155043003|NCT03755518|559588052|FG000|Overall Study|Bone Marrow Transplant|4|||
155043004|NCT03755518|559588052|FG000|Overall Study|Physicians Decision|1|||
155043005|NCT03755518|559588052|FG000|Overall Study|Relapse|1|||
155043006|NCT03755518|559588052|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
155043007|NCT03755518|559588052|FG000|Overall Study|Withdrawal by PI|1|||
155043008|NCT03172364|559588053|FG000|Overall Study|Adverse Event|1|||
155043009|NCT03172364|559588054|FG001|Overall Study|Adverse Event|1|||
155043010|NCT03172364|559588053|FG000|Overall Study|Protocol Violation|1|||
155267282|NCT02746575|560412467|FG000|Overall Study|Received epidural|10|||
155267283|NCT02746575|560412467|FG000|Overall Study|Withdrawal by Subject|3|||
155267284|NCT02746575|560412467|FG000|Overall Study|Bradycardia/hypotension|9|||
155267285|NCT02746575|560412467|FG000|Overall Study|Study paused|8|||
155267286|NCT02746575|560412467|FG000|Overall Study|put on beta-blocker|3|||
155267287|NCT02746575|560412467|FG000|Overall Study|type of surgery|1|||
155267288|NCT02746575|560412467|FG000|Overall Study|typ of surgery|1|||
155267289|NCT02746575|560412467|FG000|Overall Study|PI unavailable|1|||
155267290|NCT02746575|560412467|FG000|Overall Study|Unknown history of CVA|1|||
155267291|NCT00976482|560412468|FG000|Overall Study|Death|208|||
155267292|NCT00976482|560412468|FG000|Overall Study|Withdrawal by Subject|45|||
155267293|NCT00976482|560412468|FG000|Overall Study|Center terminated|1|||
155267294|NCT00976482|560412468|FG000|Overall Study|Protocol Violation|5|||
155267295|NCT02959671|560412469|FG000|Overall Study|Adverse Event|2|||
155267296|NCT02959671|560412469|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
155267297|NCT02254408|560412480|FG000|Overall Study|Randomized But Not Treated|1|||
155267298|NCT02254408|560412481|FG001|Overall Study|Randomized But Not Treated|3|||
155267299|NCT02254408|560412480|FG000|Overall Study|Adverse Event|1|||
155267300|NCT02254408|560412481|FG001|Overall Study|Adverse Event|0|||
155267301|NCT02254408|560412480|FG000|Overall Study|Death|2|||
155267302|NCT02254408|560412481|FG001|Overall Study|Death|3|||
155267303|NCT02254408|560412480|FG000|Overall Study|Investigator's Discretion|0|||
155267304|NCT02254408|560412481|FG001|Overall Study|Investigator's Discretion|1|||
155267305|NCT02254408|560412480|FG000|Overall Study|Withdrawal by Subject|3|||
155267306|NCT02254408|560412481|FG001|Overall Study|Withdrawal by Subject|3|||
155267307|NCT02254408|560412480|FG000|Overall Study|Lost to Follow-up|1|||
155267308|NCT02254408|560412481|FG001|Overall Study|Lost to Follow-up|0|||
155267309|NCT00917267|560412482|FG000|Overall Study|Adverse Event|15|||
155267310|NCT00917267|560412483|FG001|Overall Study|Adverse Event|36|||
155267311|NCT00917267|560412482|FG000|Overall Study|Physician Decision|2|||
155267312|NCT00917267|560412483|FG001|Overall Study|Physician Decision|4|||
155267313|NCT00917267|560412482|FG000|Overall Study|Protocol Violation|9|||
155267314|NCT00917267|560412483|FG001|Overall Study|Protocol Violation|18|||
155267315|NCT00917267|560412482|FG000|Overall Study|Withdrawal by Subject|5|||
155267316|NCT00917267|560412483|FG001|Overall Study|Withdrawal by Subject|12|||
155267317|NCT00917267|560412482|FG000|Overall Study|Lost to follow up|0|||
155267318|NCT00917267|560412483|FG001|Overall Study|Lost to follow up|2|||
155267319|NCT00917267|560412482|FG000|Overall Study|Entry Criteria Not Met|1|||
155267320|NCT00917267|560412483|FG001|Overall Study|Entry Criteria Not Met|0|||
155267321|NCT00917267|560412482|FG000|Overall Study|Sponsor Decision|5|||
155267322|NCT00917267|560412483|FG001|Overall Study|Sponsor Decision|5|||
155267323|NCT00917267|560412482|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
155267324|NCT00917267|560412483|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
155267325|NCT00802659|560412488|FG000|Overall Study|Physician Decision|0|||
155267326|NCT00802659|560412489|FG001|Overall Study|Physician Decision|1|||
155267327|NCT00802659|560412490|FG002|Overall Study|Physician Decision|0|||
155267328|NCT00802659|560412491|FG003|Overall Study|Physician Decision|0|||
155267329|NCT00289770|560412492|FG000|Year 15|Withdrawal by Subject|1|||
155267330|NCT00423293|560412493|FG000|Overall Study|Ineligible / No protocol treatment|11|||
155267331|NCT00067990|560412499|FG000|Overall Study|Death|5|||
155267332|NCT00067990|560412500|FG001|Overall Study|Death|7|||
155267333|NCT00067990|560412499|FG000|Overall Study|ESRD, Non IF/TA|1|||
155267334|NCT00067990|560412500|FG001|Overall Study|ESRD, Non IF/TA|3|||
155267335|NCT00067990|560412499|FG000|Overall Study|Withdrawal by Subject|4|||
155267336|NCT00067990|560412500|FG001|Overall Study|Withdrawal by Subject|12|||
155267337|NCT03810313|560412507|FG000|Overall Study|Study terminated by sponsor|164|||
155267338|NCT03810313|560412508|FG001|Overall Study|Study terminated by sponsor|159|||
155267339|NCT03810313|560412507|FG000|Overall Study|Subject decision|10|||
155267340|NCT03810313|560412508|FG001|Overall Study|Subject decision|11|||
155267341|NCT03810313|560412507|FG000|Overall Study|Lost to Follow-up|3|||
155267342|NCT03810313|560412508|FG001|Overall Study|Lost to Follow-up|3|||
155267343|NCT03810313|560412507|FG000|Overall Study|Adverse Event|2|||
155267344|NCT03810313|560412508|FG001|Overall Study|Adverse Event|1|||
155267345|NCT03810313|560412507|FG000|Overall Study|Death|2|||
155267346|NCT03810313|560412508|FG001|Overall Study|Death|1|||
155267347|NCT03810313|560412507|FG000|Overall Study|Physician Decision|0|||
155267348|NCT03810313|560412508|FG001|Overall Study|Physician Decision|1|||
155267349|NCT01872910|560412515|FG000|Overall Study|Lost to Follow-up|2|||
155267350|NCT01872910|560412516|FG001|Overall Study|Lost to Follow-up|0|||
155267351|NCT01872910|560412517|FG002|Overall Study|Lost to Follow-up|2|||
155267352|NCT01872910|560412518|FG003|Overall Study|Lost to Follow-up|0|||
155267353|NCT01872910|560412519|FG004|Overall Study|Lost to Follow-up|0|||
155267354|NCT01872910|560412520|FG005|Overall Study|Lost to Follow-up|0|||
155267355|NCT01540565|560412521|FG000|Overall Study|Ineligible|2|||
155267356|NCT00154310|560412522|FG000|Overall Study|Adverse Event|19|||
155267357|NCT00154310|560412523|FG001|Overall Study|Adverse Event|9|||
155267358|NCT00154310|560412522|FG000|Overall Study|Lack of Efficacy|5|||
155267359|NCT00154310|560412523|FG001|Overall Study|Lack of Efficacy|4|||
155267360|NCT00154310|560412522|FG000|Overall Study|Protocol Violation|4|||
155267361|NCT00154310|560412523|FG001|Overall Study|Protocol Violation|2|||
155267362|NCT00154310|560412522|FG000|Overall Study|Withdrawal by Subject|9|||
155267363|NCT00154310|560412523|FG001|Overall Study|Withdrawal by Subject|3|||
155267364|NCT00154310|560412522|FG000|Overall Study|Lost to Follow-up|0|||
155267365|NCT00154310|560412523|FG001|Overall Study|Lost to Follow-up|8|||
155267366|NCT00154310|560412522|FG000|Overall Study|Administrative problems|0|||
155267367|NCT00154310|560412523|FG001|Overall Study|Administrative problems|1|||
155267368|NCT00154310|560412522|FG000|Overall Study|Death|0|||
155267369|NCT00154310|560412523|FG001|Overall Study|Death|1|||
155267370|NCT03469349|560412524|FG000|Overall Study|Withdrawal by Subject|1|||
155267371|NCT03469349|560412525|FG001|Overall Study|Withdrawal by Subject|3|||
155267372|NCT03469349|560412524|FG000|Overall Study|Progressive Disease|0|||
155267373|NCT03469349|560412525|FG001|Overall Study|Progressive Disease|1|||
155267374|NCT03469349|560412524|FG000|Overall Study|Lost to Follow-up|2|||
155267375|NCT03469349|560412525|FG001|Overall Study|Lost to Follow-up|2|||
155267376|NCT03469349|560412524|FG000|Overall Study|Adverse Event|2|||
155267377|NCT03469349|560412525|FG001|Overall Study|Adverse Event|4|||
155267378|NCT02086162|560412527|FG000|Overall Study|Withdrawal by Subject|4|||
155267379|NCT02086162|560412528|FG001|Overall Study|Withdrawal by Subject|4|||
155267380|NCT02086162|560412527|FG000|Overall Study|moved|1|||
155267381|NCT02086162|560412528|FG001|Overall Study|moved|1|||
155267382|NCT02086162|560412527|FG000|Overall Study|Lost to Follow-up|4|||
155267383|NCT02086162|560412528|FG001|Overall Study|Lost to Follow-up|2|||
155267384|NCT02086162|560412527|FG000|Overall Study|Death|1|||
155267385|NCT02086162|560412528|FG001|Overall Study|Death|0|||
155267386|NCT03447730|560412529|FG000|Overall Study|Adverse Event|0|||
155267387|NCT03447730|560412530|FG001|Overall Study|Adverse Event|2|||
155267388|NCT03447730|560412531|FG002|Overall Study|Adverse Event|0|||
155267389|NCT01350505|560412535|FG000|Overall Study|Lost to Follow-up|4|||
155267390|NCT04702568|560412539|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
155267391|NCT04702568|560412540|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
155267392|NCT04702568|560412539|FG000|Overall Study|Pregnancy|1|||
155267393|NCT04702568|560412540|FG001|Overall Study|Pregnancy|0|||
155267394|NCT04702568|560412539|FG000|Overall Study|Bone marrow transplant|1|||
155267395|NCT04702568|560412540|FG001|Overall Study|Bone marrow transplant|0|||
155267396|NCT04702568|560412539|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
155267397|NCT04702568|560412540|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
155267398|NCT04702568|560412539|FG000|Overall Study|Withdrawal by Subject|0|||
155267399|NCT04702568|560412540|FG001|Overall Study|Withdrawal by Subject|2|||
155267400|NCT01735396|560412541|FG000|Overall Study|not evaluable|1|||
155267401|NCT00423852|560412544|FG000|Overall Study|Removed pior to the high-dose portion|3|||
155267402|NCT00980005|560412545|FG000|Overall Study|Withdrawal by Subject|6|||
155267403|NCT00980005|560412546|FG001|Overall Study|Withdrawal by Subject|17|||
155267404|NCT00980005|560412545|FG000|Overall Study|Lost to Follow-up|37|||
155267405|NCT00980005|560412546|FG001|Overall Study|Lost to Follow-up|43|||
155267406|NCT00980005|560412545|FG000|Overall Study|Other|4|||
155267407|NCT00980005|560412546|FG001|Overall Study|Other|3|||
155267408|NCT00572624|560412547|FG000|Overall Study|Lost to Follow-up|10|||
155267409|NCT00572624|560412548|FG001|Overall Study|Lost to Follow-up|4|||
155267410|NCT00572624|560412547|FG000|Overall Study|Wanted to do a different diet program|1|||
155267411|NCT00572624|560412548|FG001|Overall Study|Wanted to do a different diet program|0|||
155267412|NCT00572624|560412547|FG000|Overall Study|Medication change|1|||
155267413|NCT00572624|560412548|FG001|Overall Study|Medication change|0|||
155267414|NCT00572624|560412547|FG000|Overall Study|Started a new job-- no time for study|1|||
155267415|NCT00572624|560412548|FG001|Overall Study|Started a new job-- no time for study|0|||
155267416|NCT00572624|560412547|FG000|Overall Study|Admitted to being a smoker|1|||
155267417|NCT00572624|560412548|FG001|Overall Study|Admitted to being a smoker|0|||
155267418|NCT00572624|560412547|FG000|Overall Study|Refused to do the stress test|1|||
155267419|NCT00572624|560412548|FG001|Overall Study|Refused to do the stress test|0|||
155267420|NCT00572624|560412547|FG000|Overall Study|Problem with vascular access|1|||
155267421|NCT00572624|560412548|FG001|Overall Study|Problem with vascular access|0|||
155267422|NCT00572624|560412547|FG000|Overall Study|Health issues unrelated to the study|1|||
155267423|NCT00572624|560412548|FG001|Overall Study|Health issues unrelated to the study|0|||
155267424|NCT04078035|560412553|FG000|Session 2|Lost to Follow-up|3|||
155267425|NCT04078035|560412554|FG001|Session 2|Lost to Follow-up|1|||
155267426|NCT04078035|560412553|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
155267427|NCT04078035|560412554|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
155267428|NCT01905046|560412559|FG000|Months 13-24|Withdrawal by Subject|10|||
155267429|NCT01905046|560412560|FG001|Months 13-24|Withdrawal by Subject|10|||
155267430|NCT01905046|560412559|FG000|Months 13-24|Adverse Event|3|||
155267431|NCT01905046|560412560|FG001|Months 13-24|Adverse Event|2|||
155267432|NCT01905046|560412559|FG000|Months 13-24|Protocol Violation|3|||
155267433|NCT01905046|560412560|FG001|Months 13-24|Protocol Violation|3|||
155267434|NCT01905046|560412559|FG000|Months 13-24|Physician Decision|1|||
155267435|NCT01905046|560412560|FG001|Months 13-24|Physician Decision|0|||
155267436|NCT00612534|560412564|FG000|Overall Study|Adverse Event|0|||
155267437|NCT00612534|560412565|FG001|Overall Study|Adverse Event|4|||
155267438|NCT00612534|560412566|FG002|Overall Study|Adverse Event|2|||
155267439|NCT00612534|560412567|FG003|Overall Study|Adverse Event|1|||
155267440|NCT00612534|560412564|FG000|Overall Study|Lack of Efficacy|13|||
155267441|NCT00612534|560412565|FG001|Overall Study|Lack of Efficacy|12|||
155267442|NCT00612534|560412566|FG002|Overall Study|Lack of Efficacy|5|||
155267443|NCT00612534|560412567|FG003|Overall Study|Lack of Efficacy|16|||
155267444|NCT00612534|560412564|FG000|Overall Study|Other Reason|0|||
155267445|NCT00612534|560412565|FG001|Overall Study|Other Reason|1|||
155267446|NCT00612534|560412566|FG002|Overall Study|Other Reason|0|||
155267447|NCT00612534|560412567|FG003|Overall Study|Other Reason|0|||
155267448|NCT01435655|560412573|FG000|Overall Study|Death|2|||
155267449|NCT01435655|560412573|FG000|Overall Study|Other|1|||
155267450|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
155267451|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
155267452|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
155267453|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
155267454|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
155267455|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
155267456|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
155267457|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
155267458|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
155267459|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
155267460|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
155267461|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
155267462|NCT04534114|560412574|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
155267463|NCT04534114|560412575|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
155267464|NCT04534114|560412576|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
155267465|NCT04534114|560412577|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
155267466|NCT04534114|560412574|FG000|Main Treatment Period|Physician Decision|0|||
155267467|NCT04534114|560412575|FG001|Main Treatment Period|Physician Decision|0|||
155267468|NCT04534114|560412576|FG002|Main Treatment Period|Physician Decision|0|||
155267469|NCT04534114|560412577|FG003|Main Treatment Period|Physician Decision|1|||
155267470|NCT04534114|560412574|FG000|Main Treatment Period|Death|1|||
155267471|NCT04534114|560412575|FG001|Main Treatment Period|Death|0|||
155267472|NCT04534114|560412576|FG002|Main Treatment Period|Death|0|||
155267473|NCT04534114|560412577|FG003|Main Treatment Period|Death|1|||
155267474|NCT04534114|560412574|FG000|Main Treatment Period|Other reason|1|||
155267475|NCT04534114|560412575|FG001|Main Treatment Period|Other reason|1|||
155267476|NCT04534114|560412576|FG002|Main Treatment Period|Other reason|0|||
155267477|NCT04534114|560412577|FG003|Main Treatment Period|Other reason|0|||
155267478|NCT04534114|560412574|FG000|Main Treatment Period|Participant decision|1|||
155267479|NCT04534114|560412575|FG001|Main Treatment Period|Participant decision|3|||
155267480|NCT04534114|560412576|FG002|Main Treatment Period|Participant decision|3|||
155267481|NCT04534114|560412577|FG003|Main Treatment Period|Participant decision|1|||
155267482|NCT04534114|560412574|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
155267483|NCT04534114|560412575|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
155267484|NCT04534114|560412576|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
155267485|NCT04534114|560412577|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
155267486|NCT04534114|560412574|FG000|Main Treatment Period|Adverse Event|4|||
155267487|NCT04534114|560412575|FG001|Main Treatment Period|Adverse Event|2|||
155267488|NCT04534114|560412576|FG002|Main Treatment Period|Adverse Event|1|||
155267489|NCT04534114|560412577|FG003|Main Treatment Period|Adverse Event|2|||
155267490|NCT04534114|560412574|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
155267491|NCT04534114|560412575|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
155267492|NCT04534114|560412576|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
155267493|NCT04534114|560412577|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
155267494|NCT04534114|560412574|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
155267495|NCT04534114|560412575|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
155267496|NCT04534114|560412576|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
155267497|NCT04534114|560412577|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
155267498|NCT04534114|560412574|FG000|Extension Treatment Period|Other reason|0|||
155267499|NCT04534114|560412575|FG001|Extension Treatment Period|Other reason|1|||
155267500|NCT04534114|560412576|FG002|Extension Treatment Period|Other reason|0|||
155267501|NCT04534114|560412577|FG003|Extension Treatment Period|Other reason|0|||
155267502|NCT04534114|560412574|FG000|Extension Treatment Period|Death|0|||
155267503|NCT04534114|560412575|FG001|Extension Treatment Period|Death|0|||
155267504|NCT04534114|560412576|FG002|Extension Treatment Period|Death|1|||
155267505|NCT04534114|560412577|FG003|Extension Treatment Period|Death|2|||
155267506|NCT04534114|560412574|FG000|Extension Treatment Period|Adverse Event|0|||
155267507|NCT04534114|560412575|FG001|Extension Treatment Period|Adverse Event|1|||
155267508|NCT04534114|560412576|FG002|Extension Treatment Period|Adverse Event|0|||
155267509|NCT04534114|560412577|FG003|Extension Treatment Period|Adverse Event|1|||
155267510|NCT04534114|560412574|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
155267511|NCT04534114|560412575|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
155267512|NCT04534114|560412576|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
155267513|NCT04534114|560412577|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
155267514|NCT02223754|560412578|FG000|Period 1|Adverse Event|1|||
155267515|NCT02223754|560412579|FG001|Period 1|Adverse Event|0|||
155267516|NCT02223754|560412578|FG000|Period 1|Lost to Follow-up|0|||
155267517|NCT02223754|560412579|FG001|Period 1|Lost to Follow-up|1|||
155267518|NCT02223754|560412578|FG000|Period 1|Protocol Violation|2|||
155267519|NCT02223754|560412579|FG001|Period 1|Protocol Violation|4|||
155267520|NCT02223754|560412578|FG000|Period 1|Withdrawal by Subject|0|||
155267521|NCT02223754|560412579|FG001|Period 1|Withdrawal by Subject|4|||
155267522|NCT02223754|560412578|FG000|Period 1|Test Article No Longer Available|1|||
155267523|NCT02223754|560412579|FG001|Period 1|Test Article No Longer Available|5|||
155267524|NCT02223754|560412578|FG000|Period 1|Unsatisfactory Visual Response|0|||
155267525|NCT02223754|560412579|FG001|Period 1|Unsatisfactory Visual Response|1|||
155267526|NCT02223754|560412578|FG000|Period 2|Adverse Event|0|||
155267527|NCT02223754|560412579|FG001|Period 2|Adverse Event|1|||
155267528|NCT02223754|560412578|FG000|Period 2|Protocol Violation|1|||
155267529|NCT02223754|560412579|FG001|Period 2|Protocol Violation|0|||
155267530|NCT02223754|560412578|FG000|Period 2|Lens Discomfort|1|||
155267531|NCT02223754|560412579|FG001|Period 2|Lens Discomfort|1|||
155267532|NCT02223754|560412578|FG000|Period 2|Lost to Follow-up|1|||
155267533|NCT02223754|560412579|FG001|Period 2|Lost to Follow-up|0|||
155267534|NCT02223754|560412578|FG000|Period 2|Test Article No Longer Available|0|||
155267535|NCT02223754|560412579|FG001|Period 2|Test Article No Longer Available|1|||
155267536|NCT01008475|560412581|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
155267537|NCT01008475|560412582|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
155267538|NCT01008475|560412583|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
155267539|NCT01008475|560412584|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
155267540|NCT01008475|560412585|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
155267541|NCT01008475|560412586|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
155267542|NCT01008475|560412587|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
155267543|NCT02668016|560412588|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
155267544|NCT02668016|560412588|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
155267545|NCT02668016|560412588|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
155267546|NCT02668016|560412588|FG000|Month 4|Withdrawal due to severe symptoms|1|||
155267547|NCT02668016|560412588|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
155267548|NCT02668016|560412588|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
155267549|NCT02668016|560412588|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
155267550|NCT02668016|560412588|FG000|Month 6|Withdrawal due to severe symptoms|2|||
155267551|NCT02668016|560412588|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
155267552|NCT02668016|560412588|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
155267553|NCT02668016|560412588|FG000|Month 8|Withdrawal due to severe symptoms|1|||
155267554|NCT02668016|560412588|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
155267555|NCT02668016|560412588|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
155267556|NCT02668016|560412588|FG000|Month 10|Withdrawal due to severe symptoms|1|||
155267557|NCT02668016|560412588|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
155267558|NCT01122381|560412590|FG000|Overall Study|study terminated early|0|||
155267559|NCT01122381|560412591|FG001|Overall Study|study terminated early|1|||
155267560|NCT02395133|560412592|FG000|Overall Study|Adverse Event|4|||
155267561|NCT02395133|560412593|FG001|Overall Study|Adverse Event|1|||
155267562|NCT02395133|560412594|FG002|Overall Study|Adverse Event|3|||
155267563|NCT02395133|560412595|FG003|Overall Study|Adverse Event|0|||
155267564|NCT02395133|560412592|FG000|Overall Study|Lack of Efficacy|1|||
155267565|NCT02395133|560412593|FG001|Overall Study|Lack of Efficacy|0|||
155267566|NCT02395133|560412594|FG002|Overall Study|Lack of Efficacy|1|||
155267567|NCT02395133|560412595|FG003|Overall Study|Lack of Efficacy|1|||
155267568|NCT02395133|560412592|FG000|Overall Study|Protocol Violation|1|||
155267569|NCT02395133|560412593|FG001|Overall Study|Protocol Violation|1|||
155267570|NCT02395133|560412594|FG002|Overall Study|Protocol Violation|0|||
155267571|NCT02395133|560412595|FG003|Overall Study|Protocol Violation|3|||
155267572|NCT02395133|560412592|FG000|Overall Study|Lost to Follow-up|0|||
155267573|NCT02395133|560412593|FG001|Overall Study|Lost to Follow-up|1|||
155267574|NCT02395133|560412594|FG002|Overall Study|Lost to Follow-up|1|||
155267575|NCT02395133|560412595|FG003|Overall Study|Lost to Follow-up|0|||
155267576|NCT02395133|560412592|FG000|Overall Study|Pregnancy|0|||
155267577|NCT02395133|560412593|FG001|Overall Study|Pregnancy|0|||
155267578|NCT02395133|560412594|FG002|Overall Study|Pregnancy|3|||
155267579|NCT02395133|560412595|FG003|Overall Study|Pregnancy|0|||
155267580|NCT02395133|560412592|FG000|Overall Study|Consent withdrawn with no reason given|1|||
155267581|NCT02395133|560412593|FG001|Overall Study|Consent withdrawn with no reason given|3|||
155267582|NCT02395133|560412594|FG002|Overall Study|Consent withdrawn with no reason given|0|||
155267583|NCT02395133|560412595|FG003|Overall Study|Consent withdrawn with no reason given|2|||
155267584|NCT02395133|560412592|FG000|Overall Study|Consent withdrawn with personal reason|0|||
155267585|NCT02395133|560412593|FG001|Overall Study|Consent withdrawn with personal reason|1|||
155267586|NCT02395133|560412594|FG002|Overall Study|Consent withdrawn with personal reason|0|||
155267587|NCT02395133|560412595|FG003|Overall Study|Consent withdrawn with personal reason|3|||
155267588|NCT02395133|560412592|FG000|Overall Study|Sponsor decision|2|||
155267589|NCT02395133|560412593|FG001|Overall Study|Sponsor decision|0|||
155267590|NCT02395133|560412594|FG002|Overall Study|Sponsor decision|0|||
155267591|NCT02395133|560412595|FG003|Overall Study|Sponsor decision|1|||
155267592|NCT02395133|560412592|FG000|Overall Study|Other than specified above|5|||
155267593|NCT02395133|560412593|FG001|Overall Study|Other than specified above|2|||
155267594|NCT02395133|560412594|FG002|Overall Study|Other than specified above|2|||
155267595|NCT02395133|560412595|FG003|Overall Study|Other than specified above|4|||
155267596|NCT00510458|560412596|FG000|Overall Study|5 year not evaluable/missed|21|||
155267597|NCT00510458|560412596|FG000|Overall Study|Death|1|||
155267598|NCT00510458|560412596|FG000|Overall Study|Terminated|14|||
155267599|NCT00510458|560412596|FG000|Overall Study|Lost to Follow-up|6|||
155267600|NCT00510458|560412596|FG000|Overall Study|Withdrawal by Subject|3|||
155267601|NCT00510458|560412596|FG000|Overall Study|Revision|2|||
155267602|NCT02569710|560412597|FG000|Overall Study|Adverse Event|1|||
155267603|NCT02569710|560412598|FG001|Overall Study|Adverse Event|0|||
155267604|NCT02569710|560412599|FG002|Overall Study|Adverse Event|0|||
155267605|NCT02569710|560412600|FG003|Overall Study|Adverse Event|0|||
155267606|NCT02569710|560412601|FG004|Overall Study|Adverse Event|0|||
155267607|NCT02569710|560412602|FG005|Overall Study|Adverse Event|0|||
155267608|NCT02569710|560412603|FG006|Overall Study|Adverse Event|0|||
155267609|NCT02569710|560412604|FG007|Overall Study|Adverse Event|0|||
155267610|NCT02569710|560412605|FG008|Overall Study|Adverse Event|0|||
155267611|NCT02569710|560412606|FG009|Overall Study|Adverse Event|0|||
155267612|NCT02569710|560412597|FG000|Overall Study|Lost to Follow-up|0|||
155267613|NCT02569710|560412598|FG001|Overall Study|Lost to Follow-up|0|||
155267614|NCT02569710|560412599|FG002|Overall Study|Lost to Follow-up|0|||
155267615|NCT02569710|560412600|FG003|Overall Study|Lost to Follow-up|0|||
155267616|NCT02569710|560412601|FG004|Overall Study|Lost to Follow-up|0|||
155267617|NCT02569710|560412602|FG005|Overall Study|Lost to Follow-up|0|||
155267618|NCT02569710|560412603|FG006|Overall Study|Lost to Follow-up|1|||
155267619|NCT02569710|560412604|FG007|Overall Study|Lost to Follow-up|0|||
155267620|NCT02569710|560412605|FG008|Overall Study|Lost to Follow-up|1|||
155267621|NCT02569710|560412606|FG009|Overall Study|Lost to Follow-up|0|||
155267622|NCT02569710|560412597|FG000|Overall Study|Virologic failure|0|||
155267623|NCT02569710|560412598|FG001|Overall Study|Virologic failure|0|||
155267624|NCT02569710|560412599|FG002|Overall Study|Virologic failure|0|||
155267625|NCT02569710|560412600|FG003|Overall Study|Virologic failure|0|||
155267626|NCT02569710|560412601|FG004|Overall Study|Virologic failure|1|||
155267627|NCT02569710|560412602|FG005|Overall Study|Virologic failure|0|||
155267628|NCT02569710|560412603|FG006|Overall Study|Virologic failure|1|||
155267629|NCT02569710|560412604|FG007|Overall Study|Virologic failure|0|||
155267630|NCT02569710|560412605|FG008|Overall Study|Virologic failure|0|||
155267631|NCT02569710|560412606|FG009|Overall Study|Virologic failure|0|||
155267632|NCT02569710|560412597|FG000|Overall Study|Withdrawal by Subject|0|||
155267633|NCT02569710|560412598|FG001|Overall Study|Withdrawal by Subject|0|||
155267634|NCT02569710|560412599|FG002|Overall Study|Withdrawal by Subject|0|||
155267635|NCT02569710|560412600|FG003|Overall Study|Withdrawal by Subject|0|||
155267636|NCT02569710|560412601|FG004|Overall Study|Withdrawal by Subject|0|||
155267637|NCT02569710|560412602|FG005|Overall Study|Withdrawal by Subject|1|||
155267638|NCT02569710|560412603|FG006|Overall Study|Withdrawal by Subject|0|||
155267639|NCT02569710|560412604|FG007|Overall Study|Withdrawal by Subject|0|||
154931417|NCT02588651|559173474|FG000|Overall Study|Disease progression|2|||
155267640|NCT02569710|560412605|FG008|Overall Study|Withdrawal by Subject|0|||
155267641|NCT02569710|560412606|FG009|Overall Study|Withdrawal by Subject|0|||
155381709|NCT04617275|560830990|FG006|Treatment Period|No longer meets eligibility criteria|0|||
155381710|NCT04617275|560830991|FG007|Treatment Period|No longer meets eligibility criteria|0|||
155381711|NCT04617275|560830984|FG000|Treatment Period|Other|0|||
155381712|NCT04617275|560830985|FG001|Treatment Period|Other|1|||
155381713|NCT04617275|560830986|FG002|Treatment Period|Other|0|||
155381714|NCT04617275|560830987|FG003|Treatment Period|Other|0|||
155381715|NCT04617275|560830988|FG004|Treatment Period|Other|0|||
155381716|NCT04617275|560830989|FG005|Treatment Period|Other|0|||
155381717|NCT04617275|560830990|FG006|Treatment Period|Other|0|||
155381718|NCT04617275|560830991|FG007|Treatment Period|Other|0|||
155381719|NCT04617275|560830984|FG000|Treatment Period|Withdrawal by Subject|2|||
155381720|NCT04617275|560830985|FG001|Treatment Period|Withdrawal by Subject|0|||
155381721|NCT04617275|560830986|FG002|Treatment Period|Withdrawal by Subject|0|||
155381722|NCT04617275|560830987|FG003|Treatment Period|Withdrawal by Subject|2|||
155381723|NCT04617275|560830988|FG004|Treatment Period|Withdrawal by Subject|2|||
154931418|NCT02706353|559173479|FG000|Dose Level 1|Disease Progression|1|||
155381724|NCT04617275|560830989|FG005|Treatment Period|Withdrawal by Subject|0|||
155381725|NCT04617275|560830990|FG006|Treatment Period|Withdrawal by Subject|1|||
155381726|NCT04617275|560830991|FG007|Treatment Period|Withdrawal by Subject|2|||
155381727|NCT04617275|560830984|FG000|Follow-up Period|Adverse Event|1|||
154931419|NCT02706353|559173480|FG001|Dose Level 1|Disease Progression|0|||
154931420|NCT02706353|559173481|FG002|Dose Level 1|Disease Progression|0|||
155267642|NCT00432835|560414360|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
155267643|NCT00432835|560414361|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
155267644|NCT01827254|560414364|FG000|Overall Study|Death|10|||
155267645|NCT01827254|560414364|FG000|Overall Study|Case report form not completed|4|||
155267646|NCT01827254|560414364|FG000|Overall Study|Invalidated centre|3|||
155267647|NCT01827254|560414364|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
155267648|NCT01827254|560414364|FG000|Overall Study|Did not complete re-challenge|1|||
155267649|NCT01827254|560414364|FG000|Overall Study|Disease progression|36|||
155267650|NCT01827254|560414364|FG000|Overall Study|Intolerance to treatment|4|||
155267651|NCT00308737|560414368|FG000|Overall Study|Adverse Event|104|||
155267652|NCT00308737|560414369|FG001|Overall Study|Adverse Event|9|||
155267653|NCT00308737|560414370|FG002|Overall Study|Adverse Event|0|||
155267654|NCT00308737|560414368|FG000|Overall Study|Death|4|||
155267655|NCT00308737|560414369|FG001|Overall Study|Death|3|||
155267656|NCT00308737|560414370|FG002|Overall Study|Death|0|||
155267657|NCT00308737|560414368|FG000|Overall Study|Lost to Follow-up|56|||
155267658|NCT00308737|560414369|FG001|Overall Study|Lost to Follow-up|80|||
155267659|NCT00308737|560414370|FG002|Overall Study|Lost to Follow-up|5|||
155267660|NCT00308737|560414368|FG000|Overall Study|Physician Decision|15|||
155267661|NCT00308737|560414369|FG001|Overall Study|Physician Decision|2|||
155267662|NCT00308737|560414370|FG002|Overall Study|Physician Decision|1|||
155267663|NCT00308737|560414368|FG000|Overall Study|Protocol Violation|34|||
155267664|NCT00308737|560414369|FG001|Overall Study|Protocol Violation|9|||
155267665|NCT00308737|560414370|FG002|Overall Study|Protocol Violation|5|||
155267666|NCT00308737|560414368|FG000|Overall Study|Withdrawal by Subject|218|||
155267667|NCT00308737|560414369|FG001|Overall Study|Withdrawal by Subject|166|||
155267668|NCT00308737|560414370|FG002|Overall Study|Withdrawal by Subject|18|||
155267669|NCT00308737|560414368|FG000|Overall Study|Various|32|||
155267670|NCT00308737|560414369|FG001|Overall Study|Various|20|||
155267671|NCT00308737|560414370|FG002|Overall Study|Various|8|||
155267672|NCT01225822|560414371|FG000|Overall Study|Adverse Event|13|||
155267673|NCT01225822|560414372|FG001|Overall Study|Adverse Event|31|||
155267674|NCT01225822|560414373|FG002|Overall Study|Adverse Event|18|||
155267675|NCT01225822|560414374|FG003|Overall Study|Adverse Event|23|||
155267676|NCT01225822|560414375|FG004|Overall Study|Adverse Event|14|||
155267677|NCT01225822|560414371|FG000|Overall Study|Protocol Violation|6|||
155267678|NCT01225822|560414372|FG001|Overall Study|Protocol Violation|8|||
155267679|NCT01225822|560414373|FG002|Overall Study|Protocol Violation|6|||
155267680|NCT01225822|560414374|FG003|Overall Study|Protocol Violation|7|||
155267681|NCT01225822|560414375|FG004|Overall Study|Protocol Violation|4|||
155267682|NCT01225822|560414371|FG000|Overall Study|Lost to Follow-up|0|||
155267683|NCT01225822|560414372|FG001|Overall Study|Lost to Follow-up|0|||
155267684|NCT01225822|560414373|FG002|Overall Study|Lost to Follow-up|0|||
155267685|NCT01225822|560414374|FG003|Overall Study|Lost to Follow-up|1|||
155267686|NCT01225822|560414375|FG004|Overall Study|Lost to Follow-up|0|||
155267687|NCT01225822|560414371|FG000|Overall Study|Withdrawal by Subject|6|||
155267688|NCT01225822|560414372|FG001|Overall Study|Withdrawal by Subject|7|||
155267689|NCT01225822|560414373|FG002|Overall Study|Withdrawal by Subject|7|||
155267690|NCT01225822|560414374|FG003|Overall Study|Withdrawal by Subject|11|||
155267691|NCT01225822|560414375|FG004|Overall Study|Withdrawal by Subject|6|||
155267692|NCT01225822|560414371|FG000|Overall Study|Other|13|||
155267693|NCT01225822|560414372|FG001|Overall Study|Other|10|||
155267694|NCT01225822|560414373|FG002|Overall Study|Other|7|||
155267695|NCT01225822|560414374|FG003|Overall Study|Other|10|||
155267696|NCT01225822|560414375|FG004|Overall Study|Other|7|||
155267697|NCT01290822|560414376|FG000|Overall Study|Withdrawal by Subject|1|||
155267698|NCT01290822|560414376|FG000|Overall Study|Physician Decision|10|||
155267699|NCT01515189|560414377|FG000|Induction|Disease Progression|109|||
155267700|NCT01515189|560414378|FG001|Induction|Disease Progression|155|||
155267701|NCT01515189|560414377|FG000|Induction|Study drug toxicity|86|||
155267702|NCT01515189|560414378|FG001|Induction|Study drug toxicity|36|||
155267703|NCT01515189|560414377|FG000|Induction|Death|24|||
155267704|NCT01515189|560414378|FG001|Induction|Death|17|||
155267705|NCT01515189|560414377|FG000|Induction|Adverse Event|14|||
155267706|NCT01515189|560414378|FG001|Induction|Adverse Event|9|||
155267707|NCT01515189|560414377|FG000|Induction|Withdrawal by Subject|3|||
155267708|NCT01515189|560414378|FG001|Induction|Withdrawal by Subject|9|||
155267709|NCT01515189|560414377|FG000|Induction|No longer meets study criteria|0|||
155267710|NCT01515189|560414378|FG001|Induction|No longer meets study criteria|2|||
155267711|NCT01515189|560414377|FG000|Induction|Lost to Follow-up|1|||
155267712|NCT01515189|560414378|FG001|Induction|Lost to Follow-up|0|||
155267713|NCT01515189|560414377|FG000|Induction|Other|0|||
155267714|NCT01515189|560414378|FG001|Induction|Other|4|||
155267715|NCT01515189|560414377|FG000|First Re-Induction Phase|Disease progression|6|||
155267716|NCT01515189|560414378|FG001|First Re-Induction Phase|Disease progression|14|||
155267717|NCT01515189|560414377|FG000|First Re-Induction Phase|Study drug toxicity|5|||
155267718|NCT01515189|560414378|FG001|First Re-Induction Phase|Study drug toxicity|0|||
155267719|NCT01515189|560414377|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
155267720|NCT01515189|560414378|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
155267721|NCT01515189|560414377|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
155267722|NCT01515189|560414378|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
155267723|NCT01515189|560414377|FG000|First Re-Induction Phase|Other|1|||
155267724|NCT01515189|560414378|FG001|First Re-Induction Phase|Other|0|||
155267725|NCT02100722|560414379|FG000|Overall Study|Withdrawal pre-procedure|4|||
155267726|NCT02100722|560414380|FG001|Overall Study|Withdrawal pre-procedure|9|||
155267727|NCT02100722|560414379|FG000|Overall Study|Withdrawal post-procedure|0|||
155267728|NCT02100722|560414380|FG001|Overall Study|Withdrawal post-procedure|3|||
155267729|NCT02100722|560414379|FG000|Overall Study|Lost to Follow-up|2|||
155267730|NCT02100722|560414380|FG001|Overall Study|Lost to Follow-up|2|||
155267731|NCT02100722|560414379|FG000|Overall Study|Continuing on study|751|||
155267732|NCT02100722|560414380|FG001|Overall Study|Continuing on study|729|||
155267733|NCT02541383|560414381|FG000|Overall Study|Death|50|||
155267734|NCT02541383|560414382|FG001|Overall Study|Death|37|||
155267735|NCT02541383|560414383|FG002|Overall Study|Death|48|||
155267736|NCT02541383|560414384|FG003|Overall Study|Death|41|||
155267737|NCT02541383|560414385|FG004|Overall Study|Death|21|||
155267738|NCT02541383|560414386|FG005|Overall Study|Death|25|||
155267739|NCT02541383|560414381|FG000|Overall Study|Lost to Follow-up|5|||
155267740|NCT02541383|560414382|FG001|Overall Study|Lost to Follow-up|3|||
155267741|NCT02541383|560414383|FG002|Overall Study|Lost to Follow-up|1|||
155267742|NCT02541383|560414384|FG003|Overall Study|Lost to Follow-up|1|||
155267743|NCT02541383|560414385|FG004|Overall Study|Lost to Follow-up|3|||
155267744|NCT02541383|560414386|FG005|Overall Study|Lost to Follow-up|0|||
155267745|NCT02541383|560414381|FG000|Overall Study|Consent withdrawn|5|||
155267746|NCT02541383|560414382|FG001|Overall Study|Consent withdrawn|6|||
155267747|NCT02541383|560414383|FG002|Overall Study|Consent withdrawn|1|||
155267748|NCT02541383|560414384|FG003|Overall Study|Consent withdrawn|1|||
155267749|NCT02541383|560414385|FG004|Overall Study|Consent withdrawn|0|||
155267750|NCT02541383|560414386|FG005|Overall Study|Consent withdrawn|0|||
155267751|NCT02541383|560414381|FG000|Overall Study|Sponsor's decision|1|||
155267752|NCT02541383|560414382|FG001|Overall Study|Sponsor's decision|1|||
155267753|NCT02541383|560414383|FG002|Overall Study|Sponsor's decision|0|||
155267754|NCT02541383|560414384|FG003|Overall Study|Sponsor's decision|0|||
155267755|NCT02541383|560414385|FG004|Overall Study|Sponsor's decision|0|||
155267756|NCT02541383|560414386|FG005|Overall Study|Sponsor's decision|0|||
155267757|NCT05644353|560414387|FG000|Overall Study|Physician Decision|1|||
155267758|NCT05644353|560414388|FG001|Overall Study|Physician Decision|0|||
155267759|NCT05644353|560414389|FG002|Overall Study|Physician Decision|0|||
155267760|NCT05644353|560414390|FG003|Overall Study|Physician Decision|0|||
155267761|NCT05644353|560414391|FG004|Overall Study|Physician Decision|0|||
155267762|NCT05644353|560414392|FG005|Overall Study|Physician Decision|0|||
155267763|NCT05644353|560414387|FG000|Overall Study|Protocol Violation|1|||
155267764|NCT05644353|560414388|FG001|Overall Study|Protocol Violation|0|||
155267765|NCT05644353|560414389|FG002|Overall Study|Protocol Violation|0|||
155267766|NCT05644353|560414390|FG003|Overall Study|Protocol Violation|0|||
155267767|NCT05644353|560414391|FG004|Overall Study|Protocol Violation|0|||
155267768|NCT05644353|560414392|FG005|Overall Study|Protocol Violation|0|||
155267769|NCT05644353|560414387|FG000|Overall Study|Withdrawal by Subject|0|||
155267770|NCT05644353|560414388|FG001|Overall Study|Withdrawal by Subject|2|||
155267771|NCT05644353|560414389|FG002|Overall Study|Withdrawal by Subject|0|||
155267772|NCT05644353|560414390|FG003|Overall Study|Withdrawal by Subject|0|||
155267773|NCT05644353|560414391|FG004|Overall Study|Withdrawal by Subject|1|||
155267774|NCT05644353|560414392|FG005|Overall Study|Withdrawal by Subject|0|||
155267775|NCT05644353|560414387|FG000|Overall Study|Lost to Follow-up|0|||
155267776|NCT05644353|560414388|FG001|Overall Study|Lost to Follow-up|0|||
155267777|NCT05644353|560414389|FG002|Overall Study|Lost to Follow-up|1|||
155267778|NCT05644353|560414390|FG003|Overall Study|Lost to Follow-up|0|||
155267779|NCT05644353|560414391|FG004|Overall Study|Lost to Follow-up|0|||
155267780|NCT05644353|560414392|FG005|Overall Study|Lost to Follow-up|0|||
155267781|NCT04986982|560414393|FG000|Overall Study|Withdrawal by Subject|3|||
155267782|NCT04986982|560414394|FG001|Overall Study|Withdrawal by Subject|1|||
155267783|NCT04986982|560414393|FG000|Overall Study|Lack of Efficacy|0|||
155267784|NCT04986982|560414394|FG001|Overall Study|Lack of Efficacy|2|||
155267785|NCT04986982|560414393|FG000|Overall Study|Ineligibility|3|||
155267786|NCT04986982|560414394|FG001|Overall Study|Ineligibility|0|||
155267787|NCT04986982|560414393|FG000|Overall Study|Adverse Event|4|||
155267788|NCT04986982|560414394|FG001|Overall Study|Adverse Event|4|||
155043011|NCT03172364|559588054|FG001|Overall Study|Protocol Violation|0|||
155267789|NCT04986982|560414393|FG000|Overall Study|Lost to Follow-up|0|||
155267790|NCT04986982|560414394|FG001|Overall Study|Lost to Follow-up|1|||
155267791|NCT04986982|560414393|FG000|Overall Study|Sponsor's discretion|1|||
155267792|NCT04986982|560414394|FG001|Overall Study|Sponsor's discretion|0|||
155267793|NCT05796518|560414395|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
155267794|NCT01535274|560414396|FG000|Overall Study|Determined to be ineligible|0|||
155267795|NCT01535274|560414397|FG001|Overall Study|Determined to be ineligible|1|||
155267796|NCT01535274|560414396|FG000|Overall Study|Misallocated to propofol intervention|0|||
155267797|NCT01535274|560414397|FG001|Overall Study|Misallocated to propofol intervention|1|||
155267798|NCT02690077|560414400|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
155381728|NCT04617275|560830985|FG001|Follow-up Period|Adverse Event|1|||
155267799|NCT02690077|560414401|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
155267800|NCT02690077|560414400|FG000|Overall Study|Withdrawal by Subject|0|||
155267801|NCT02690077|560414401|FG001|Overall Study|Withdrawal by Subject|5|||
155267802|NCT02690077|560414400|FG000|Overall Study|Excluded by IRB|0|||
155267803|NCT02690077|560414401|FG001|Overall Study|Excluded by IRB|2|||
155267804|NCT01845974|560414402|FG000|Overall Study|screen failure|1|||
155267805|NCT01845974|560414403|FG001|Overall Study|screen failure|0|||
155267806|NCT02667886|560414404|FG000|Dose Escalation (Part A)|Adverse Event|1|||
155267807|NCT02667886|560414405|FG001|Dose Escalation (Part A)|Adverse Event|3|||
155267808|NCT02667886|560414406|FG002|Dose Escalation (Part A)|Adverse Event|1|||
155267809|NCT02667886|560414407|FG003|Dose Escalation (Part A)|Adverse Event|0|||
155267810|NCT02667886|560414408|FG004|Dose Escalation (Part A)|Adverse Event|0|||
155267811|NCT02667886|560414404|FG000|Dose Escalation (Part A)|Disease Progression|1|||
155267812|NCT02667886|560414405|FG001|Dose Escalation (Part A)|Disease Progression|4|||
155267813|NCT02667886|560414406|FG002|Dose Escalation (Part A)|Disease Progression|3|||
155267814|NCT02667886|560414407|FG003|Dose Escalation (Part A)|Disease Progression|0|||
155267815|NCT02667886|560414408|FG004|Dose Escalation (Part A)|Disease Progression|0|||
155267816|NCT02667886|560414404|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267817|NCT02667886|560414405|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267818|NCT02667886|560414406|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
155267819|NCT02667886|560414407|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267820|NCT02667886|560414408|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
155267821|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Adverse Event|0|||
155267822|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Adverse Event|0|||
155267823|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Adverse Event|0|||
155267824|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Adverse Event|9|||
155267825|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Adverse Event|0|||
155267826|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267827|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267828|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267829|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
155267830|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
155267831|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Disease Progression|0|||
155267832|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Disease Progression|0|||
155267833|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Disease Progression|0|||
155267834|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Disease Progression|38|||
155267835|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Disease Progression|0|||
155267836|NCT02667886|560414404|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267837|NCT02667886|560414405|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267838|NCT02667886|560414406|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267839|NCT02667886|560414407|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
155267840|NCT02667886|560414408|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
155267841|NCT02667886|560414404|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267842|NCT02667886|560414405|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267843|NCT02667886|560414406|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267844|NCT02667886|560414407|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
155267845|NCT02667886|560414408|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
155267846|NCT02667886|560414404|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
155267847|NCT02667886|560414405|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
155267848|NCT02667886|560414406|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
155267849|NCT02667886|560414407|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
155267850|NCT02667886|560414408|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
155267851|NCT00594217|560414409|FG000|Overall Study|Withdrawal by Subject|1|||
155267852|NCT00594217|560414410|FG001|Overall Study|Withdrawal by Subject|3|||
155267853|NCT05672680|560414411|FG000|Overall Study|Patient Did Not Complete the Form|5|||
155267854|NCT05672680|560414412|FG001|Overall Study|Patient Did Not Complete the Form|4|||
155267855|NCT05672680|560414411|FG000|Overall Study|Procedure Aborted|1|||
155267856|NCT05672680|560414412|FG001|Overall Study|Procedure Aborted|0|||
155267857|NCT04186403|560414413|FG000|Overall Study|Adverse Event|1|||
155267858|NCT04186403|560414414|FG001|Overall Study|Adverse Event|8|||
155267859|NCT04186403|560414413|FG000|Overall Study|Lost to Follow-up|7|||
155267860|NCT04186403|560414414|FG001|Overall Study|Lost to Follow-up|3|||
155267861|NCT04186403|560414413|FG000|Overall Study|Physician Decision|1|||
155267862|NCT04186403|560414414|FG001|Overall Study|Physician Decision|0|||
155267863|NCT04186403|560414413|FG000|Overall Study|Withdrawal by Subject|7|||
155267864|NCT04186403|560414414|FG001|Overall Study|Withdrawal by Subject|8|||
155267865|NCT04186403|560414413|FG000|Overall Study|Other: Not Related to Covid-19|3|||
155267866|NCT04186403|560414414|FG001|Overall Study|Other: Not Related to Covid-19|0|||
155267867|NCT03929562|560414419|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
155267868|NCT03929562|560414420|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
155267869|NCT03929562|560414419|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
155381729|NCT04617275|560830986|FG002|Follow-up Period|Adverse Event|2|||
155267870|NCT03929562|560414420|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
155267871|NCT03929562|560414419|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
155267872|NCT03929562|560414420|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
155267873|NCT01407354|560414428|FG000|First Intervention|Withdrawal by Subject|0|||
155267874|NCT01407354|560414429|FG001|First Intervention|Withdrawal by Subject|2|||
155267875|NCT01407354|560414428|FG000|First Intervention|Adverse Event|1|||
155267876|NCT01407354|560414429|FG001|First Intervention|Adverse Event|0|||
155267877|NCT01407354|560414428|FG000|First Intervention|Physician Decision|1|||
155267878|NCT01407354|560414429|FG001|First Intervention|Physician Decision|0|||
155267879|NCT01036022|560414430|FG000|Overall Study|Adverse Event|1|||
155267880|NCT01036022|560414431|FG001|Overall Study|Adverse Event|3|||
155267881|NCT01036022|560414432|FG002|Overall Study|Adverse Event|2|||
155267882|NCT01036022|560414433|FG003|Overall Study|Adverse Event|1|||
155267883|NCT01036022|560414434|FG004|Overall Study|Adverse Event|0|||
155267884|NCT01036022|560414435|FG005|Overall Study|Adverse Event|2|||
155267885|NCT01036022|560414430|FG000|Overall Study|Lack of Efficacy|1|||
155267886|NCT01036022|560414431|FG001|Overall Study|Lack of Efficacy|1|||
155267887|NCT01036022|560414432|FG002|Overall Study|Lack of Efficacy|1|||
155267888|NCT01036022|560414433|FG003|Overall Study|Lack of Efficacy|0|||
155267889|NCT01036022|560414434|FG004|Overall Study|Lack of Efficacy|1|||
155267890|NCT01036022|560414435|FG005|Overall Study|Lack of Efficacy|1|||
155267891|NCT01036022|560414430|FG000|Overall Study|Physician Decision|0|||
155267892|NCT01036022|560414431|FG001|Overall Study|Physician Decision|0|||
155267893|NCT01036022|560414432|FG002|Overall Study|Physician Decision|1|||
155267894|NCT01036022|560414433|FG003|Overall Study|Physician Decision|0|||
155267895|NCT01036022|560414434|FG004|Overall Study|Physician Decision|0|||
155267896|NCT01036022|560414435|FG005|Overall Study|Physician Decision|0|||
155267897|NCT01036022|560414430|FG000|Overall Study|Withdrawal by Subject|0|||
155267898|NCT01036022|560414431|FG001|Overall Study|Withdrawal by Subject|0|||
155267899|NCT01036022|560414432|FG002|Overall Study|Withdrawal by Subject|0|||
155267900|NCT01036022|560414433|FG003|Overall Study|Withdrawal by Subject|1|||
155267901|NCT01036022|560414434|FG004|Overall Study|Withdrawal by Subject|2|||
155267902|NCT01036022|560414435|FG005|Overall Study|Withdrawal by Subject|0|||
155267903|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
155267904|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
155267905|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
155267906|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
155267907|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
155267908|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
155267909|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
155267910|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
155267911|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
155267912|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
155267913|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
155267914|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
155267915|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267916|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267917|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267918|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267919|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
155267920|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
155267921|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
155267922|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267923|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267924|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267925|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
155267926|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
155267927|NCT02778399|560414436|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267928|NCT02778399|560414437|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267929|NCT02778399|560414438|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267930|NCT02778399|560414439|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
155267931|NCT02778399|560414440|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
155267932|NCT02778399|560414441|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
155267933|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
155267934|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
155267935|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
155267936|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
155267937|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
155267938|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
155267939|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
155267940|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
155267941|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
155267942|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
155267943|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
155267944|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
155267945|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267946|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
155267947|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267948|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267949|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267950|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
155267951|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
155267952|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
155267953|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
155267954|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
155267955|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
155267956|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
155267957|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
155267958|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267959|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
155267960|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267961|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267962|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
155267963|NCT02778399|560414436|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
155267964|NCT02778399|560414437|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
155267965|NCT02778399|560414438|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
155267966|NCT02778399|560414439|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
155267967|NCT02778399|560414440|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
155267968|NCT02778399|560414441|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
155267969|NCT00405639|560414443|FG000|Overall Study|Withdrawal by Subject|1|||
155267970|NCT00405639|560414444|FG001|Overall Study|Withdrawal by Subject|0|||
155267971|NCT00405639|560414443|FG000|Overall Study|Adverse Event|1|||
155267972|NCT00405639|560414444|FG001|Overall Study|Adverse Event|0|||
155267973|NCT00405639|560414443|FG000|Overall Study|Seizure prior to receiving BNP|1|||
155267974|NCT00405639|560414444|FG001|Overall Study|Seizure prior to receiving BNP|0|||
155267975|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
155267976|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
155267977|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
155267978|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
155267979|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
155267980|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
155267981|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
155267982|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
155267983|NCT01336621|560414450|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
155267984|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
155267985|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
155267986|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
155267987|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
155267988|NCT01336621|560414450|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
155267989|NCT02487095|560414451|FG000|Dose Expansion|Unable to scan/restage participant|0|||
155267990|NCT02487095|560414452|FG001|Dose Expansion|Unable to scan/restage participant|0|||
155267991|NCT02487095|560414453|FG002|Dose Expansion|Unable to scan/restage participant|0|||
155267992|NCT02487095|560414454|FG003|Dose Expansion|Unable to scan/restage participant|0|||
155267993|NCT02487095|560414455|FG004|Dose Expansion|Unable to scan/restage participant|1|||
155267994|NCT02130284|560414463|FG000|Overall Study|Withdrawal by Subject|3|||
155267995|NCT02130284|560414463|FG000|Overall Study|Subject Withdrew Consent|1|||
155267996|NCT02130284|560414463|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
155267997|NCT02130284|560414463|FG000|Overall Study|Subject was screened as backup for study|3|||
155267998|NCT02130284|560414463|FG000|Overall Study|Screen Failure|1|||
155267999|NCT03108157|560414464|FG000|Overall Study|Protocol Violation|15|||
155268000|NCT03108157|560414465|FG001|Overall Study|Protocol Violation|4|||
155268001|NCT04395183|560414466|FG000|Overall Study|Withdrawal by Subject|1|||
155268002|NCT04395183|560414467|FG001|Overall Study|Withdrawal by Subject|0|||
155268003|NCT04395183|560414468|FG002|Overall Study|Withdrawal by Subject|2|||
155268004|NCT04395183|560414469|FG003|Overall Study|Withdrawal by Subject|2|||
155268005|NCT01807650|560414476|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
155268006|NCT01807650|560414476|FG000|Overall Study|Adverse Event|5|||
155268007|NCT01807650|560414476|FG000|Overall Study|Other|2|||
155268008|NCT00736489|560414477|FG000|Period 1|Lost to Follow-up|1|||
155268009|NCT00736489|560414478|FG001|Period 1|Lost to Follow-up|0|||
155268010|NCT00736489|560414479|FG002|Period 1|Lost to Follow-up|0|||
155268011|NCT00736489|560414480|FG003|Period 1|Lost to Follow-up|0|||
155268012|NCT00736489|560414481|FG004|Period 1|Lost to Follow-up|0|||
155268013|NCT00736489|560414482|FG005|Period 1|Lost to Follow-up|0|||
155268014|NCT00736489|560414477|FG000|Period 1|Withdrawal by Subject|0|||
155268015|NCT00736489|560414478|FG001|Period 1|Withdrawal by Subject|0|||
155268016|NCT00736489|560414479|FG002|Period 1|Withdrawal by Subject|0|||
155268017|NCT00736489|560414480|FG003|Period 1|Withdrawal by Subject|0|||
155268018|NCT00736489|560414481|FG004|Period 1|Withdrawal by Subject|0|||
155268019|NCT00736489|560414482|FG005|Period 1|Withdrawal by Subject|1|||
155268020|NCT02946918|560414487|FG000|Overall Study|Patient unblinded himself|1|||
155268021|NCT02946918|560414488|FG001|Overall Study|Patient unblinded himself|0|||
155268022|NCT02946918|560414487|FG000|Overall Study|Physician Decision|0|||
155268023|NCT02946918|560414488|FG001|Overall Study|Physician Decision|2|||
155268024|NCT02946918|560414487|FG000|Overall Study|Ran out of study medication|0|||
155268025|NCT02946918|560414488|FG001|Overall Study|Ran out of study medication|1|||
155268026|NCT00069784|560414489|FG000|Overall Study|Adverse Event|105|||
155268027|NCT00069784|560414490|FG001|Overall Study|Adverse Event|0|||
155268028|NCT00069784|560414489|FG000|Overall Study|Withdrawal by Subject|1090|||
155268029|NCT00069784|560414490|FG001|Overall Study|Withdrawal by Subject|0|||
155268030|NCT00069784|560414489|FG000|Overall Study|Other|17|||
155268031|NCT00069784|560414490|FG001|Overall Study|Other|0|||
155268032|NCT02669095|560414494|FG000|Overall Study|Adverse Event|1|||
155268033|NCT02669095|560414495|FG001|Overall Study|Adverse Event|0|||
155268034|NCT02669095|560414494|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155268035|NCT02669095|560414495|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155268036|NCT02669095|560414494|FG000|Overall Study|Torn Lens|0|||
155268037|NCT02669095|560414495|FG001|Overall Study|Torn Lens|1|||
155268038|NCT02669095|560414494|FG000|Overall Study|Visit 5 assessments not completed|0|||
155268039|NCT02669095|560414495|FG001|Overall Study|Visit 5 assessments not completed|1|||
155268040|NCT01555164|560414500|FG000|Overall Study|Adverse Event|5|||
155268041|NCT01555164|560414501|FG001|Overall Study|Adverse Event|7|||
155268042|NCT01555164|560414500|FG000|Overall Study|Hyperglycemia|0|||
155268043|NCT01555164|560414501|FG001|Overall Study|Hyperglycemia|1|||
155268044|NCT01555164|560414500|FG000|Overall Study|Investigator's Discretion|2|||
155268045|NCT01555164|560414501|FG001|Overall Study|Investigator's Discretion|2|||
155268046|NCT01555164|560414500|FG000|Overall Study|Lost to Follow-up|4|||
155268047|NCT01555164|560414501|FG001|Overall Study|Lost to Follow-up|3|||
155268048|NCT01555164|560414500|FG000|Overall Study|Protocol Violation|9|||
155268049|NCT01555164|560414501|FG001|Overall Study|Protocol Violation|5|||
155268050|NCT01555164|560414500|FG000|Overall Study|Subject Non-compliance|14|||
155268051|NCT01555164|560414501|FG001|Overall Study|Subject Non-compliance|6|||
155268052|NCT01555164|560414500|FG000|Overall Study|Subject Withdrew Consent|6|||
155268053|NCT01555164|560414501|FG001|Overall Study|Subject Withdrew Consent|11|||
155268054|NCT03203694|560414502|FG000|Overall Study|Withdrawal by Subject|2|||
155268055|NCT03203694|560414503|FG001|Overall Study|Withdrawal by Subject|0|||
155268056|NCT03203694|560414504|FG002|Overall Study|Withdrawal by Subject|0|||
155268057|NCT03203694|560414505|FG003|Overall Study|Withdrawal by Subject|0|||
155268058|NCT03203694|560414506|FG004|Overall Study|Withdrawal by Subject|0|||
155268059|NCT03203694|560414507|FG005|Overall Study|Withdrawal by Subject|0|||
155268060|NCT03443713|560414508|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
155268061|NCT03443713|560414509|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
155268062|NCT03443713|560414510|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
155268063|NCT01672853|560414515|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
155268064|NCT01672853|560414516|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
155268065|NCT01672853|560414517|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
155268066|NCT01672853|560414515|FG000|Overall Study|Pregnancy|0|||
155268067|NCT01672853|560414516|FG001|Overall Study|Pregnancy|1|||
155268068|NCT01672853|560414517|FG002|Overall Study|Pregnancy|0|||
155268069|NCT01672853|560414515|FG000|Overall Study|Investigator's Discretion|1|||
155268070|NCT01672853|560414516|FG001|Overall Study|Investigator's Discretion|0|||
154931421|NCT02706353|559173482|FG003|Dose Level 1|Disease Progression|0|||
155268071|NCT01672853|560414517|FG002|Overall Study|Investigator's Discretion|0|||
155268072|NCT01672853|560414515|FG000|Overall Study|Withdrew Consent|5|||
155268073|NCT01672853|560414516|FG001|Overall Study|Withdrew Consent|5|||
155268074|NCT01672853|560414517|FG002|Overall Study|Withdrew Consent|5|||
155268075|NCT01672853|560414515|FG000|Overall Study|Adverse Event|4|||
155381730|NCT04617275|560830987|FG003|Follow-up Period|Adverse Event|3|||
155381731|NCT04617275|560830988|FG004|Follow-up Period|Adverse Event|4|||
154931422|NCT02706353|559173483|FG004|Dose Level 1|Disease Progression|0|||
155268076|NCT01672853|560414516|FG001|Overall Study|Adverse Event|6|||
155268077|NCT01672853|560414517|FG002|Overall Study|Adverse Event|8|||
155268078|NCT01672853|560414515|FG000|Overall Study|Lost to Follow-up|0|||
155268079|NCT01672853|560414516|FG001|Overall Study|Lost to Follow-up|1|||
155268080|NCT01672853|560414517|FG002|Overall Study|Lost to Follow-up|0|||
155268081|NCT01672853|560414515|FG000|Overall Study|Randomized but Never Treated|0|||
154931423|NCT02706353|559173484|FG005|Dose Level 1|Disease Progression|0|||
155268082|NCT01672853|560414516|FG001|Overall Study|Randomized but Never Treated|0|||
155381732|NCT04617275|560830989|FG005|Follow-up Period|Adverse Event|3|||
155268083|NCT01672853|560414517|FG002|Overall Study|Randomized but Never Treated|1|||
155268084|NCT02969525|560414518|FG000|Double-Blind Period|Adverse Event|0|||
155268085|NCT02969525|560414519|FG001|Double-Blind Period|Adverse Event|0|||
155268086|NCT02969525|560414520|FG002|Double-Blind Period|Adverse Event|1|||
155268087|NCT02969525|560414521|FG003|Double-Blind Period|Adverse Event|1|||
155268088|NCT02969525|560414522|FG004|Double-Blind Period|Adverse Event|0|||
155268089|NCT02969525|560414523|FG005|Double-Blind Period|Adverse Event|0|||
155268090|NCT02969525|560414524|FG006|Double-Blind Period|Adverse Event|0|||
155268091|NCT02969525|560414525|FG007|Double-Blind Period|Adverse Event|0|||
155268092|NCT02969525|560414526|FG008|Double-Blind Period|Adverse Event|0|||
155268093|NCT02969525|560414527|FG009|Double-Blind Period|Adverse Event|0|||
155268094|NCT02969525|560414528|FG010|Double-Blind Period|Adverse Event|0|||
155268095|NCT02969525|560414529|FG011|Double-Blind Period|Adverse Event|0|||
155268096|NCT02969525|560414518|FG000|Double-Blind Period|LOW EGFR|0|||
155268097|NCT02969525|560414519|FG001|Double-Blind Period|LOW EGFR|0|||
155268098|NCT02969525|560414520|FG002|Double-Blind Period|LOW EGFR|0|||
155268099|NCT02969525|560414521|FG003|Double-Blind Period|LOW EGFR|1|||
155268100|NCT02969525|560414522|FG004|Double-Blind Period|LOW EGFR|0|||
155268101|NCT02969525|560414523|FG005|Double-Blind Period|LOW EGFR|0|||
155268102|NCT02969525|560414524|FG006|Double-Blind Period|LOW EGFR|0|||
155268103|NCT02969525|560414525|FG007|Double-Blind Period|LOW EGFR|0|||
155268104|NCT02969525|560414526|FG008|Double-Blind Period|LOW EGFR|0|||
155268105|NCT02969525|560414527|FG009|Double-Blind Period|LOW EGFR|0|||
155268106|NCT02969525|560414528|FG010|Double-Blind Period|LOW EGFR|0|||
155268107|NCT02969525|560414529|FG011|Double-Blind Period|LOW EGFR|0|||
155268108|NCT02969525|560414518|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
155268109|NCT02969525|560414519|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268110|NCT02969525|560414520|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268111|NCT02969525|560414521|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
155268112|NCT02969525|560414522|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268113|NCT02969525|560414523|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268114|NCT02969525|560414524|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268115|NCT02969525|560414525|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268116|NCT02969525|560414526|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268117|NCT02969525|560414527|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268118|NCT02969525|560414528|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268119|NCT02969525|560414529|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
155268120|NCT02969525|560414518|FG000|Dose-Blind Period|Adverse Event|0|||
155268121|NCT02969525|560414519|FG001|Dose-Blind Period|Adverse Event|0|||
155268122|NCT02969525|560414520|FG002|Dose-Blind Period|Adverse Event|0|||
155268123|NCT02969525|560414521|FG003|Dose-Blind Period|Adverse Event|0|||
155268124|NCT02969525|560414522|FG004|Dose-Blind Period|Adverse Event|0|||
155268125|NCT02969525|560414523|FG005|Dose-Blind Period|Adverse Event|0|||
155268126|NCT02969525|560414524|FG006|Dose-Blind Period|Adverse Event|0|||
155268127|NCT02969525|560414525|FG007|Dose-Blind Period|Adverse Event|0|||
155268128|NCT02969525|560414526|FG008|Dose-Blind Period|Adverse Event|0|||
155268129|NCT02969525|560414527|FG009|Dose-Blind Period|Adverse Event|1|||
155268130|NCT02969525|560414528|FG010|Dose-Blind Period|Adverse Event|1|||
155268131|NCT02969525|560414529|FG011|Dose-Blind Period|Adverse Event|1|||
155268132|NCT02969525|560414518|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
155268133|NCT02969525|560414519|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
155268134|NCT02969525|560414520|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
155268135|NCT02969525|560414521|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
155268136|NCT02969525|560414522|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
155268137|NCT02969525|560414523|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
155268138|NCT02969525|560414524|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
155268139|NCT02969525|560414525|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
155268140|NCT02969525|560414526|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
155268141|NCT02969525|560414527|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
155268142|NCT02969525|560414528|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
155268143|NCT02969525|560414529|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
155268144|NCT02969525|560414518|FG000|Dose-Blind Period|Non-cooperating patient|0|||
155268145|NCT02969525|560414519|FG001|Dose-Blind Period|Non-cooperating patient|0|||
155268146|NCT02969525|560414520|FG002|Dose-Blind Period|Non-cooperating patient|0|||
155268147|NCT02969525|560414521|FG003|Dose-Blind Period|Non-cooperating patient|0|||
155268148|NCT02969525|560414522|FG004|Dose-Blind Period|Non-cooperating patient|0|||
155268149|NCT02969525|560414523|FG005|Dose-Blind Period|Non-cooperating patient|0|||
155268150|NCT02969525|560414524|FG006|Dose-Blind Period|Non-cooperating patient|0|||
155268151|NCT02969525|560414525|FG007|Dose-Blind Period|Non-cooperating patient|0|||
155268152|NCT02969525|560414526|FG008|Dose-Blind Period|Non-cooperating patient|0|||
155268153|NCT02969525|560414527|FG009|Dose-Blind Period|Non-cooperating patient|0|||
155268154|NCT02969525|560414528|FG010|Dose-Blind Period|Non-cooperating patient|0|||
155268155|NCT02969525|560414529|FG011|Dose-Blind Period|Non-cooperating patient|1|||
155268156|NCT02969525|560414518|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
154931424|NCT02706353|559173479|FG000|Dose Level 3|Disease Progression|0|||
154931425|NCT02706353|559173480|FG001|Dose Level 3|Disease Progression|0|||
154931426|NCT02706353|559173481|FG002|Dose Level 3|Disease Progression|2|||
154931427|NCT02706353|559173482|FG003|Dose Level 3|Disease Progression|0|||
154931428|NCT02706353|559173483|FG004|Dose Level 3|Disease Progression|0|||
154931429|NCT02706353|559173484|FG005|Dose Level 3|Disease Progression|0|||
154931430|NCT02706353|559173479|FG000|Dose Level 4|Disease Progression|0|||
154931431|NCT02706353|559173480|FG001|Dose Level 4|Disease Progression|0|||
154931432|NCT02706353|559173481|FG002|Dose Level 4|Disease Progression|0|||
154931433|NCT02706353|559173482|FG003|Dose Level 4|Disease Progression|1|||
154931434|NCT02706353|559173483|FG004|Dose Level 4|Disease Progression|0|||
154931435|NCT02706353|559173484|FG005|Dose Level 4|Disease Progression|0|||
154931436|NCT02706353|559173479|FG000|Dose Level 4|Toxicity|0|||
154931437|NCT02706353|559173480|FG001|Dose Level 4|Toxicity|0|||
154931438|NCT02706353|559173481|FG002|Dose Level 4|Toxicity|0|||
154931439|NCT02706353|559173482|FG003|Dose Level 4|Toxicity|1|||
154931440|NCT02706353|559173483|FG004|Dose Level 4|Toxicity|0|||
154931441|NCT02706353|559173484|FG005|Dose Level 4|Toxicity|0|||
154931442|NCT02706353|559173479|FG000|Dose Level 4|Death|0|||
154931443|NCT02706353|559173480|FG001|Dose Level 4|Death|0|||
154931444|NCT02706353|559173481|FG002|Dose Level 4|Death|0|||
154931445|NCT02706353|559173482|FG003|Dose Level 4|Death|1|||
154931446|NCT02706353|559173483|FG004|Dose Level 4|Death|0|||
154931447|NCT02706353|559173484|FG005|Dose Level 4|Death|0|||
154931448|NCT02706353|559173479|FG000|Dose Level 5|Toxicity|0|||
154931449|NCT02706353|559173480|FG001|Dose Level 5|Toxicity|0|||
154931450|NCT02706353|559173481|FG002|Dose Level 5|Toxicity|0|||
154931451|NCT02706353|559173482|FG003|Dose Level 5|Toxicity|0|||
154931452|NCT02706353|559173483|FG004|Dose Level 5|Toxicity|1|||
154931453|NCT02706353|559173484|FG005|Dose Level 5|Toxicity|0|||
154931454|NCT02706353|559173479|FG000|Dose Level 5|Disease Progression|0|||
154931455|NCT02706353|559173480|FG001|Dose Level 5|Disease Progression|0|||
154931456|NCT02706353|559173481|FG002|Dose Level 5|Disease Progression|0|||
154931457|NCT02706353|559173482|FG003|Dose Level 5|Disease Progression|0|||
154931458|NCT02706353|559173483|FG004|Dose Level 5|Disease Progression|3|||
154931459|NCT02706353|559173484|FG005|Dose Level 5|Disease Progression|2|||
154931460|NCT02706353|559173479|FG000|Dose Level 5|Death|0|||
154931461|NCT02706353|559173480|FG001|Dose Level 5|Death|0|||
154931462|NCT02706353|559173481|FG002|Dose Level 5|Death|0|||
154931463|NCT02706353|559173482|FG003|Dose Level 5|Death|0|||
154931464|NCT02706353|559173483|FG004|Dose Level 5|Death|1|||
154931465|NCT02706353|559173484|FG005|Dose Level 5|Death|6|||
154931466|NCT02706353|559173479|FG000|Dose Level 5|Withdrawal by Subject|0|||
154931467|NCT02706353|559173480|FG001|Dose Level 5|Withdrawal by Subject|0|||
154931468|NCT02706353|559173481|FG002|Dose Level 5|Withdrawal by Subject|0|||
154931469|NCT02706353|559173482|FG003|Dose Level 5|Withdrawal by Subject|0|||
154931470|NCT02706353|559173483|FG004|Dose Level 5|Withdrawal by Subject|0|||
154931471|NCT02706353|559173484|FG005|Dose Level 5|Withdrawal by Subject|2|||
154931472|NCT00021229|559175097|FG000|Overall Study|Adverse Event|10|||
154931473|NCT00021229|559175098|FG001|Overall Study|Adverse Event|5|||
154931474|NCT00021229|559175099|FG002|Overall Study|Adverse Event|2|||
154931475|NCT00021229|559175097|FG000|Overall Study|Death|0|||
154931476|NCT00021229|559175098|FG001|Overall Study|Death|1|||
154931477|NCT00021229|559175099|FG002|Overall Study|Death|0|||
154931478|NCT00021229|559175097|FG000|Overall Study|Withdrawal by Subject|7|||
154931479|NCT00021229|559175098|FG001|Overall Study|Withdrawal by Subject|7|||
154931480|NCT00021229|559175099|FG002|Overall Study|Withdrawal by Subject|1|||
154931481|NCT00021229|559175097|FG000|Overall Study|Progressive Disease|15|||
154931482|NCT00021229|559175098|FG001|Overall Study|Progressive Disease|19|||
154931483|NCT00021229|559175099|FG002|Overall Study|Progressive Disease|12|||
154931484|NCT00021229|559175097|FG000|Overall Study|Protocol Violation|1|||
154931485|NCT00021229|559175098|FG001|Overall Study|Protocol Violation|1|||
154931486|NCT00021229|559175099|FG002|Overall Study|Protocol Violation|0|||
154931487|NCT00021229|559175097|FG000|Overall Study|Physician Decision|0|||
154931488|NCT00021229|559175098|FG001|Overall Study|Physician Decision|0|||
154931489|NCT00021229|559175099|FG002|Overall Study|Physician Decision|1|||
154931490|NCT00021229|559175097|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
154931491|NCT00021229|559175098|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
154931492|NCT00021229|559175099|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
154931493|NCT01901146|559175103|FG000|Neoadjuvant Phase|Death|1|||
154931494|NCT01901146|559175104|FG001|Neoadjuvant Phase|Death|2|||
154931495|NCT01901146|559175105|FG002|Neoadjuvant Phase|Death|0|||
154931496|NCT01901146|559175106|FG003|Neoadjuvant Phase|Death|0|||
154931497|NCT01901146|559175107|FG004|Neoadjuvant Phase|Death|0|||
154931498|NCT01901146|559175103|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
154931499|NCT01901146|559175104|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
154931500|NCT01901146|559175105|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
154931501|NCT01901146|559175106|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
154931502|NCT01901146|559175107|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
154931503|NCT01901146|559175103|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
154931504|NCT01901146|559175104|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
154931505|NCT01901146|559175105|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
155268157|NCT02969525|560414519|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268158|NCT02969525|560414520|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268159|NCT02969525|560414521|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268160|NCT02969525|560414522|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268161|NCT02969525|560414523|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268162|NCT02969525|560414524|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268163|NCT02969525|560414525|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268164|NCT02969525|560414526|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268165|NCT02969525|560414527|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268166|NCT02969525|560414528|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
155268167|NCT02969525|560414529|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
155268168|NCT03445065|560414530|FG000|Overall Study|Withdrawal by Subject|3|||
155268169|NCT03445065|560414531|FG001|Overall Study|Withdrawal by Subject|6|||
155268170|NCT03445065|560414532|FG002|Overall Study|Withdrawal by Subject|2|||
155268171|NCT03445065|560414533|FG003|Overall Study|Withdrawal by Subject|2|||
155268172|NCT03445065|560414530|FG000|Overall Study|Other|4|||
155268173|NCT03445065|560414531|FG001|Overall Study|Other|3|||
155268174|NCT03445065|560414532|FG002|Overall Study|Other|3|||
155268175|NCT03445065|560414533|FG003|Overall Study|Other|1|||
155268176|NCT01158378|560416372|FG000|Overall Study|Death|4|||
155268177|NCT01158378|560416373|FG001|Overall Study|Death|5|||
155268178|NCT01158378|560416372|FG000|Overall Study|Lost to Follow-up|2|||
155268179|NCT01158378|560416373|FG001|Overall Study|Lost to Follow-up|4|||
155268180|NCT01158378|560416372|FG000|Overall Study|Withdrawal by Subject|4|||
155268181|NCT01158378|560416373|FG001|Overall Study|Withdrawal by Subject|0|||
155268182|NCT03017235|560416374|FG000|Overall Study|Withdrawal by Subject|4|||
155268183|NCT03017235|560416375|FG001|Overall Study|Withdrawal by Subject|3|||
155268184|NCT03017235|560416374|FG000|Overall Study|Lost to Follow-up|2|||
155268185|NCT03017235|560416375|FG001|Overall Study|Lost to Follow-up|7|||
155268186|NCT03017235|560416374|FG000|Overall Study|Adverse Event|0|||
155268187|NCT03017235|560416375|FG001|Overall Study|Adverse Event|1|||
155268188|NCT03017235|560416374|FG000|Overall Study|Protocol Violation|2|||
155268189|NCT03017235|560416375|FG001|Overall Study|Protocol Violation|1|||
155268190|NCT03017235|560416374|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
155268191|NCT03017235|560416375|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
155268192|NCT00453310|560416380|FG000|Overall Study|Progression of Disease|10|||
155268193|NCT01806740|560416381|FG000|Overall Study|Withdrawal by Subject|4|||
155268194|NCT01806740|560416381|FG000|Overall Study|Physician Decision|1|||
155268195|NCT01806740|560416381|FG000|Overall Study|Patient's refusal of treatment|1|||
155268196|NCT04666922|560416382|FG000|Overall Study|Withdrawal by Subject|1|||
155268197|NCT04666922|560416383|FG001|Overall Study|Withdrawal by Subject|0|||
155268198|NCT04666922|560416384|FG002|Overall Study|Withdrawal by Subject|0|||
155268199|NCT04666922|560416385|FG003|Overall Study|Withdrawal by Subject|0|||
155268200|NCT04666922|560416386|FG004|Overall Study|Withdrawal by Subject|0|||
155268201|NCT04666922|560416387|FG005|Overall Study|Withdrawal by Subject|0|||
155268202|NCT04666922|560416388|FG006|Overall Study|Withdrawal by Subject|0|||
155268203|NCT01382940|560416391|FG000|Overall Study|Adverse Event|19|||
155268204|NCT01382940|560416391|FG000|Overall Study|Lost to Follow-up|4|||
155268205|NCT01382940|560416391|FG000|Overall Study|Physician Decision|7|||
155268206|NCT01382940|560416391|FG000|Overall Study|Withdrawal by Subject|23|||
155268207|NCT01382940|560416391|FG000|Overall Study|Protocol Violation|20|||
155268208|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
155268209|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268210|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268211|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268212|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
155268213|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
155268214|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268215|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268216|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268217|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
155268218|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
155268219|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155268220|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
154931506|NCT01901146|559175106|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
155043012|NCT01714609|559588055|FG000|Overall Study|Protocol Violation|1|||
155268221|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155268222|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
155268223|NCT00244374|560416394|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
155381733|NCT04617275|560830990|FG006|Follow-up Period|Adverse Event|0|||
155268224|NCT00244374|560416395|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268225|NCT00244374|560416396|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268226|NCT00244374|560416397|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268227|NCT00244374|560416398|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
155268228|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
155268229|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268230|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268231|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268232|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
155268233|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
155268234|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268235|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268236|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268237|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
155268238|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
155268239|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268240|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268241|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268242|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
155268243|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
155268244|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268245|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268246|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268247|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
155268248|NCT00244374|560416394|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
155268249|NCT00244374|560416395|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268250|NCT00244374|560416396|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268251|NCT00244374|560416397|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268252|NCT00244374|560416398|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
155268253|NCT02105636|560416400|FG000|Pre-Treatment|Disease Progression|1|||
155268254|NCT02105636|560416401|FG001|Pre-Treatment|Disease Progression|0|||
155268255|NCT02105636|560416400|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
155268256|NCT02105636|560416401|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
155268257|NCT02105636|560416400|FG000|Pre-Treatment|Participant withdrew consent|0|||
155268258|NCT02105636|560416401|FG001|Pre-Treatment|Participant withdrew consent|6|||
155268259|NCT02105636|560416400|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155268260|NCT02105636|560416401|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
155268261|NCT02105636|560416400|FG000|Treatment|Study Drug Toxicity|14|||
155268262|NCT02105636|560416401|FG001|Treatment|Study Drug Toxicity|10|||
155268263|NCT02105636|560416400|FG000|Treatment|Adverse event unrelated to study drug|19|||
155268264|NCT02105636|560416401|FG001|Treatment|Adverse event unrelated to study drug|3|||
155268265|NCT02105636|560416400|FG000|Treatment|Participant request to discontinue study treatment|8|||
155268266|NCT02105636|560416401|FG001|Treatment|Participant request to discontinue study treatment|6|||
155268267|NCT02105636|560416400|FG000|Treatment|Participant withdrew consent|5|||
155268268|NCT02105636|560416401|FG001|Treatment|Participant withdrew consent|1|||
155268269|NCT02105636|560416400|FG000|Treatment|Lost to Follow-up|1|||
155268270|NCT02105636|560416401|FG001|Treatment|Lost to Follow-up|0|||
155268271|NCT02105636|560416400|FG000|Treatment|Maximum Clinical Benefit|1|||
155268272|NCT02105636|560416401|FG001|Treatment|Maximum Clinical Benefit|3|||
155268273|NCT02105636|560416400|FG000|Treatment|Poor/Non-compliance|0|||
155268274|NCT02105636|560416401|FG001|Treatment|Poor/Non-compliance|1|||
155268275|NCT02105636|560416400|FG000|Treatment|Participant no longer meets study criteria|1|||
155268276|NCT02105636|560416401|FG001|Treatment|Participant no longer meets study criteria|0|||
155268277|NCT02105636|560416400|FG000|Treatment|Other reasons|1|||
155268278|NCT02105636|560416401|FG001|Treatment|Other reasons|0|||
155268279|NCT02105636|560416400|FG000|Treatment|Disease Progression|185|||
155268280|NCT02105636|560416401|FG001|Treatment|Disease Progression|87|||
155268281|NCT00720902|560416402|FG000|Overall Study|Withdrawal by Subject|1|||
155268282|NCT00720902|560416403|FG001|Overall Study|Withdrawal by Subject|0|||
155268283|NCT00720902|560416402|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
155268284|NCT00720902|560416403|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
155381734|NCT04617275|560830991|FG007|Follow-up Period|Adverse Event|3|||
155381735|NCT04617275|560830984|FG000|Follow-up Period|Lost to Follow-up|0|||
155268285|NCT03462706|560416405|FG000|Overall Study|Polyp was pedunculated|1|||
155268286|NCT03462706|560416406|FG001|Overall Study|Polyp was pedunculated|0|||
155268287|NCT03462706|560416407|FG002|Overall Study|Polyp was pedunculated|1|||
155268288|NCT03462706|560416408|FG003|Overall Study|Polyp was pedunculated|0|||
155268289|NCT03462706|560416405|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
155268290|NCT03462706|560416406|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
155268291|NCT03462706|560416407|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
155268292|NCT03462706|560416408|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
155268293|NCT00474929|560416418|FG000|Overall Study|Withdrawal by Subject|0|||
155268294|NCT00474929|560416419|FG001|Overall Study|Withdrawal by Subject|1|||
155268295|NCT00474929|560416420|FG002|Overall Study|Withdrawal by Subject|0|||
155268296|NCT00474929|560416421|FG003|Overall Study|Withdrawal by Subject|0|||
155268297|NCT00474929|560416422|FG004|Overall Study|Withdrawal by Subject|0|||
155268298|NCT00474929|560416418|FG000|Overall Study|Unrelated medical condition|0|||
155268299|NCT00474929|560416419|FG001|Overall Study|Unrelated medical condition|0|||
155268300|NCT00474929|560416420|FG002|Overall Study|Unrelated medical condition|1|||
155268301|NCT00474929|560416421|FG003|Overall Study|Unrelated medical condition|0|||
155268302|NCT00474929|560416422|FG004|Overall Study|Unrelated medical condition|0|||
155268303|NCT00474929|560416418|FG000|Overall Study|Physician Decision|0|||
155268304|NCT00474929|560416419|FG001|Overall Study|Physician Decision|0|||
155268305|NCT00474929|560416420|FG002|Overall Study|Physician Decision|1|||
155268306|NCT00474929|560416421|FG003|Overall Study|Physician Decision|2|||
155268307|NCT00474929|560416422|FG004|Overall Study|Physician Decision|0|||
155268308|NCT03661996|560416425|FG000|Overall Study|Adverse Event|0|||
155268309|NCT03661996|560416426|FG001|Overall Study|Adverse Event|0|||
155268310|NCT03661996|560416427|FG002|Overall Study|Adverse Event|1|||
155268311|NCT03661996|560416428|FG003|Overall Study|Adverse Event|1|||
155268312|NCT03661996|560416429|FG004|Overall Study|Adverse Event|0|||
155268313|NCT03661996|560416425|FG000|Overall Study|Lost to Follow-up|5|||
155268314|NCT03661996|560416426|FG001|Overall Study|Lost to Follow-up|1|||
155268315|NCT03661996|560416427|FG002|Overall Study|Lost to Follow-up|2|||
155268316|NCT03661996|560416428|FG003|Overall Study|Lost to Follow-up|2|||
155268317|NCT03661996|560416429|FG004|Overall Study|Lost to Follow-up|6|||
155268318|NCT03661996|560416425|FG000|Overall Study|Physician Decision|1|||
155268319|NCT03661996|560416426|FG001|Overall Study|Physician Decision|1|||
155268320|NCT03661996|560416427|FG002|Overall Study|Physician Decision|1|||
155268321|NCT03661996|560416428|FG003|Overall Study|Physician Decision|2|||
155268322|NCT03661996|560416429|FG004|Overall Study|Physician Decision|0|||
155268323|NCT03661996|560416425|FG000|Overall Study|Protocol Violation|0|||
155268324|NCT03661996|560416426|FG001|Overall Study|Protocol Violation|0|||
155268325|NCT03661996|560416427|FG002|Overall Study|Protocol Violation|0|||
155268326|NCT03661996|560416428|FG003|Overall Study|Protocol Violation|0|||
155268327|NCT03661996|560416429|FG004|Overall Study|Protocol Violation|1|||
155268328|NCT03661996|560416425|FG000|Overall Study|Withdrawal by Subject|3|||
155268329|NCT03661996|560416426|FG001|Overall Study|Withdrawal by Subject|5|||
155268330|NCT03661996|560416427|FG002|Overall Study|Withdrawal by Subject|1|||
155268331|NCT03661996|560416428|FG003|Overall Study|Withdrawal by Subject|7|||
155268332|NCT03661996|560416429|FG004|Overall Study|Withdrawal by Subject|7|||
155268333|NCT03661996|560416425|FG000|Overall Study|Sponsors Decision|2|||
155268334|NCT03661996|560416426|FG001|Overall Study|Sponsors Decision|0|||
155268335|NCT03661996|560416427|FG002|Overall Study|Sponsors Decision|0|||
155268336|NCT03661996|560416428|FG003|Overall Study|Sponsors Decision|0|||
155268337|NCT03661996|560416429|FG004|Overall Study|Sponsors Decision|0|||
155268338|NCT03661996|560416425|FG000|Overall Study|Other|1|||
155268339|NCT03661996|560416426|FG001|Overall Study|Other|1|||
155268340|NCT03661996|560416427|FG002|Overall Study|Other|1|||
155268341|NCT03661996|560416428|FG003|Overall Study|Other|1|||
155268342|NCT03661996|560416429|FG004|Overall Study|Other|0|||
155268343|NCT03321513|560416430|FG000|Overall Study|Death|11|||
155268344|NCT03321513|560416431|FG001|Overall Study|Death|5|||
155268345|NCT03321513|560416430|FG000|Overall Study|Withdrawal by Subject|5|||
155268346|NCT03321513|560416431|FG001|Overall Study|Withdrawal by Subject|10|||
155268347|NCT03321513|560416430|FG000|Overall Study|Lost to Follow-up|10|||
155268348|NCT03321513|560416431|FG001|Overall Study|Lost to Follow-up|11|||
155268349|NCT01976364|560416432|FG000|Main Study (36 Months)|Adverse Event|63|||
155268350|NCT01976364|560416433|FG001|Main Study (36 Months)|Adverse Event|0|||
155268351|NCT01976364|560416434|FG002|Main Study (36 Months)|Adverse Event|0|||
155268352|NCT01976364|560416432|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
155268353|NCT01976364|560416433|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
155268354|NCT01976364|560416434|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
155043013|NCT01714609|559588056|FG001|Overall Study|Protocol Violation|0|||
155043014|NCT03403621|559588057|FG000|Overall Study|Withdrawal by Subject|2|||
155268355|NCT01976364|560416432|FG000|Main Study (36 Months)|Other|13|||
155268356|NCT01976364|560416433|FG001|Main Study (36 Months)|Other|0|||
155268357|NCT01976364|560416434|FG002|Main Study (36 Months)|Other|0|||
155268358|NCT01976364|560416432|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
155268359|NCT01976364|560416433|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
155268360|NCT01976364|560416434|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
155268361|NCT01976364|560416432|FG000|Main Study (36 Months)|Medication error|1|||
155268362|NCT01976364|560416433|FG001|Main Study (36 Months)|Medication error|0|||
155268363|NCT01976364|560416434|FG002|Main Study (36 Months)|Medication error|0|||
155268364|NCT01976364|560416432|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
155268365|NCT01976364|560416433|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
155268366|NCT01976364|560416434|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
155268367|NCT01976364|560416432|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
155268368|NCT01976364|560416433|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
155268369|NCT01976364|560416434|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
155268370|NCT01976364|560416432|FG000|Main Study (36 Months)|Protocol Violation|13|||
155268371|NCT01976364|560416433|FG001|Main Study (36 Months)|Protocol Violation|0|||
155268372|NCT01976364|560416434|FG002|Main Study (36 Months)|Protocol Violation|0|||
155268373|NCT01976364|560416432|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
155268374|NCT01976364|560416433|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
155268375|NCT01976364|560416434|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
155268376|NCT01976364|560416432|FG000|Main Study (36 Months)|Death|5|||
155268377|NCT01976364|560416433|FG001|Main Study (36 Months)|Death|0|||
155268378|NCT01976364|560416434|FG002|Main Study (36 Months)|Death|0|||
155268379|NCT01976364|560416432|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
155268380|NCT01976364|560416433|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
155268381|NCT01976364|560416434|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
155268382|NCT01976364|560416432|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
155268383|NCT01976364|560416433|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
155268384|NCT01976364|560416434|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
155268385|NCT01976364|560416432|FG000|Sub-study (12 Months)|Protocol Violation|0|||
155268386|NCT01976364|560416433|FG001|Sub-study (12 Months)|Protocol Violation|1|||
155268387|NCT01976364|560416434|FG002|Sub-study (12 Months)|Protocol Violation|1|||
155268388|NCT01976364|560416432|FG000|Sub-study (12 Months)|Adverse Event|0|||
155268389|NCT01976364|560416433|FG001|Sub-study (12 Months)|Adverse Event|4|||
155268390|NCT01976364|560416434|FG002|Sub-study (12 Months)|Adverse Event|3|||
155268391|NCT02757521|560416435|FG000|Overall Study|Adverse Event|1|||
155268392|NCT02757521|560416436|FG001|Overall Study|Adverse Event|0|||
155268393|NCT01161472|560416437|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
155268394|NCT01161472|560416438|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
155268395|NCT01161472|560416439|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
155268396|NCT01161472|560416440|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
155268397|NCT00003511|560416441|FG000|Overall Study|Not evaluable|4|||
155268398|NCT02914184|560416442|FG000|Overall Study|Lost to Follow-up|7|||
155268399|NCT02914184|560416443|FG001|Overall Study|Lost to Follow-up|10|||
155268400|NCT02914184|560416444|FG002|Overall Study|Lost to Follow-up|8|||
155268401|NCT02914184|560416445|FG003|Overall Study|Lost to Follow-up|7|||
155268402|NCT02914184|560416442|FG000|Overall Study|Withdrawal by Subject|4|||
155268403|NCT02914184|560416443|FG001|Overall Study|Withdrawal by Subject|2|||
155268404|NCT02914184|560416444|FG002|Overall Study|Withdrawal by Subject|7|||
155268405|NCT02914184|560416445|FG003|Overall Study|Withdrawal by Subject|3|||
155268406|NCT02914184|560416442|FG000|Overall Study|Other|1|||
155268407|NCT02914184|560416443|FG001|Overall Study|Other|0|||
155268408|NCT02914184|560416444|FG002|Overall Study|Other|0|||
155268409|NCT02914184|560416445|FG003|Overall Study|Other|0|||
155268410|NCT02914184|560416442|FG000|Overall Study|Migrated/moved from the study area|2|||
155268411|NCT02914184|560416443|FG001|Overall Study|Migrated/moved from the study area|1|||
155268412|NCT02914184|560416444|FG002|Overall Study|Migrated/moved from the study area|2|||
155268413|NCT02914184|560416445|FG003|Overall Study|Migrated/moved from the study area|1|||
155268414|NCT00798174|560416449|FG000|Overall Study|inability to implant azygos coil|3|||
155268415|NCT00798174|560416450|FG001|Overall Study|inability to implant azygos coil|3|||
155268416|NCT00798174|560416449|FG000|Overall Study|Inability to sedate for DFT testing|1|||
155268417|NCT00798174|560416450|FG001|Overall Study|Inability to sedate for DFT testing|0|||
155268418|NCT01683994|560416469|FG000|Overall Study|Withdrawal by Subject|1|||
155268419|NCT01683994|560416470|FG001|Overall Study|Withdrawal by Subject|0|||
155268420|NCT01683994|560416471|FG002|Overall Study|Withdrawal by Subject|0|||
155268421|NCT01683994|560416472|FG003|Overall Study|Withdrawal by Subject|1|||
155268422|NCT01683994|560416473|FG004|Overall Study|Withdrawal by Subject|0|||
155268423|NCT01683994|560416469|FG000|Overall Study|Intercurrent illness|0|||
155268424|NCT01683994|560416470|FG001|Overall Study|Intercurrent illness|0|||
155268425|NCT01683994|560416471|FG002|Overall Study|Intercurrent illness|0|||
155268426|NCT01683994|560416472|FG003|Overall Study|Intercurrent illness|2|||
155268427|NCT01683994|560416473|FG004|Overall Study|Intercurrent illness|1|||
155268428|NCT00999661|560416474|FG000|Overall Study|Lost to Follow-up|59|||
155268429|NCT00999661|560416474|FG000|Overall Study|Adverse Event|1|||
155268430|NCT00999661|560416474|FG000|Overall Study|Withdrawal by Subject|1|||
155268431|NCT00999661|560416474|FG000|Overall Study|Not meeting eligibility criteria|9|||
155268432|NCT00312858|560416475|FG000|Overall Study|Adverse Event|0|||
155268433|NCT00312858|560416476|FG001|Overall Study|Adverse Event|1|||
155268434|NCT00312858|560416475|FG000|Overall Study|Lost to Follow-up|25|||
155268435|NCT00312858|560416476|FG001|Overall Study|Lost to Follow-up|42|||
155268436|NCT00312858|560416475|FG000|Overall Study|Protocol Violation|3|||
155268437|NCT00312858|560416476|FG001|Overall Study|Protocol Violation|8|||
155268438|NCT00312858|560416475|FG000|Overall Study|Withdraw by Participant|20|||
155268439|NCT00312858|560416476|FG001|Overall Study|Withdraw by Participant|20|||
155268440|NCT00312858|560416475|FG000|Overall Study|Participant Moved|11|||
155268441|NCT00312858|560416476|FG001|Overall Study|Participant Moved|10|||
155268442|NCT00312858|560416475|FG000|Overall Study|Other|9|||
155268443|NCT00312858|560416476|FG001|Overall Study|Other|12|||
155268444|NCT03638635|560416477|FG000|Initial Hospitalization|Study terminated prematurely|0|||
155268445|NCT03638635|560416478|FG001|Initial Hospitalization|Study terminated prematurely|1|||
155268446|NCT03638635|560416477|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
155268447|NCT03638635|560416478|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
155268448|NCT03638635|560416477|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
155268449|NCT03638635|560416478|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
155268450|NCT02318719|560416481|FG000|Double-blind Phase|Adverse Event|7|||
155268451|NCT02318719|560416482|FG001|Double-blind Phase|Adverse Event|6|||
155268452|NCT02318719|560416483|FG002|Double-blind Phase|Adverse Event|12|||
155268453|NCT02318719|560416484|FG003|Double-blind Phase|Adverse Event|4|||
155268454|NCT02318719|560416485|FG004|Double-blind Phase|Adverse Event|0|||
155268455|NCT02318719|560416481|FG000|Double-blind Phase|Lack of Efficacy|5|||
155268456|NCT02318719|560416482|FG001|Double-blind Phase|Lack of Efficacy|0|||
155268457|NCT02318719|560416483|FG002|Double-blind Phase|Lack of Efficacy|1|||
155268458|NCT02318719|560416484|FG003|Double-blind Phase|Lack of Efficacy|1|||
155268459|NCT02318719|560416485|FG004|Double-blind Phase|Lack of Efficacy|0|||
155268460|NCT02318719|560416481|FG000|Double-blind Phase|Protocol Violation|0|||
155268461|NCT02318719|560416482|FG001|Double-blind Phase|Protocol Violation|1|||
155268462|NCT02318719|560416483|FG002|Double-blind Phase|Protocol Violation|3|||
155268463|NCT02318719|560416484|FG003|Double-blind Phase|Protocol Violation|0|||
155268464|NCT02318719|560416485|FG004|Double-blind Phase|Protocol Violation|0|||
155268465|NCT02318719|560416481|FG000|Double-blind Phase|Withdrawal by Subject|25|||
155268466|NCT02318719|560416482|FG001|Double-blind Phase|Withdrawal by Subject|7|||
155268467|NCT02318719|560416483|FG002|Double-blind Phase|Withdrawal by Subject|9|||
155268468|NCT02318719|560416484|FG003|Double-blind Phase|Withdrawal by Subject|10|||
154931507|NCT01901146|559175107|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
154931508|NCT01901146|559175103|FG000|Neoadjuvant Phase|Physician Decision|1|||
154931509|NCT01901146|559175104|FG001|Neoadjuvant Phase|Physician Decision|2|||
154931510|NCT01901146|559175105|FG002|Neoadjuvant Phase|Physician Decision|0|||
154931511|NCT01901146|559175106|FG003|Neoadjuvant Phase|Physician Decision|0|||
154931512|NCT01901146|559175107|FG004|Neoadjuvant Phase|Physician Decision|0|||
154931513|NCT01901146|559175103|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
154931514|NCT01901146|559175104|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
154931515|NCT01901146|559175105|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
154931516|NCT01901146|559175106|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
154931517|NCT01901146|559175107|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
154931518|NCT01901146|559175103|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
154931519|NCT01901146|559175104|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
154931520|NCT01901146|559175105|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
154931521|NCT01901146|559175106|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
154931522|NCT01901146|559175107|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
154931523|NCT01901146|559175103|FG000|Adjuvant Phase|Other|0|||
154931524|NCT01901146|559175104|FG001|Adjuvant Phase|Other|0|||
154931525|NCT01901146|559175105|FG002|Adjuvant Phase|Other|1|||
154931526|NCT01901146|559175106|FG003|Adjuvant Phase|Other|0|||
154931527|NCT01901146|559175107|FG004|Adjuvant Phase|Other|0|||
154931528|NCT01901146|559175103|FG000|Adjuvant Phase|Death|0|||
154931529|NCT01901146|559175104|FG001|Adjuvant Phase|Death|0|||
154931530|NCT01901146|559175105|FG002|Adjuvant Phase|Death|0|||
154931531|NCT01901146|559175106|FG003|Adjuvant Phase|Death|0|||
154931532|NCT01901146|559175107|FG004|Adjuvant Phase|Death|3|||
154931533|NCT01901146|559175103|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
154931534|NCT01901146|559175104|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
154931535|NCT01901146|559175105|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
154931536|NCT01901146|559175106|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
154931537|NCT01901146|559175107|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
154931538|NCT01901146|559175103|FG000|Adjuvant Phase|Physician Decision|0|||
154931539|NCT01901146|559175104|FG001|Adjuvant Phase|Physician Decision|0|||
155268469|NCT02318719|560416485|FG004|Double-blind Phase|Withdrawal by Subject|0|||
155268470|NCT02318719|560416481|FG000|Double-blind Phase|Other|1|||
155268471|NCT02318719|560416482|FG001|Double-blind Phase|Other|2|||
155268472|NCT02318719|560416483|FG002|Double-blind Phase|Other|0|||
154931540|NCT01901146|559175105|FG002|Adjuvant Phase|Physician Decision|9|||
154931541|NCT01901146|559175106|FG003|Adjuvant Phase|Physician Decision|2|||
154931542|NCT01901146|559175107|FG004|Adjuvant Phase|Physician Decision|4|||
154931543|NCT01901146|559175103|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
154931544|NCT01901146|559175104|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
155268473|NCT02318719|560416484|FG003|Double-blind Phase|Other|0|||
155268474|NCT02318719|560416485|FG004|Double-blind Phase|Other|0|||
155268475|NCT02318719|560416481|FG000|Open-label Extension Phase|Adverse Event|0|||
155268476|NCT02318719|560416482|FG001|Open-label Extension Phase|Adverse Event|0|||
155268477|NCT02318719|560416483|FG002|Open-label Extension Phase|Adverse Event|0|||
155268478|NCT02318719|560416484|FG003|Open-label Extension Phase|Adverse Event|0|||
155268479|NCT02318719|560416485|FG004|Open-label Extension Phase|Adverse Event|15|||
155268480|NCT02318719|560416481|FG000|Open-label Extension Phase|Death|0|||
155268481|NCT02318719|560416482|FG001|Open-label Extension Phase|Death|0|||
155268482|NCT02318719|560416483|FG002|Open-label Extension Phase|Death|0|||
155268483|NCT02318719|560416484|FG003|Open-label Extension Phase|Death|0|||
155268484|NCT02318719|560416485|FG004|Open-label Extension Phase|Death|1|||
155268485|NCT02318719|560416481|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
155268486|NCT02318719|560416482|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
155268487|NCT02318719|560416483|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
155268488|NCT02318719|560416484|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
155268489|NCT02318719|560416485|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
155268490|NCT02318719|560416481|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
155268491|NCT02318719|560416482|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
155268492|NCT02318719|560416483|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
155268493|NCT02318719|560416484|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
155268494|NCT02318719|560416485|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
155268495|NCT02318719|560416481|FG000|Open-label Extension Phase|Other|0|||
155268496|NCT02318719|560416482|FG001|Open-label Extension Phase|Other|0|||
155268497|NCT02318719|560416483|FG002|Open-label Extension Phase|Other|0|||
155268498|NCT02318719|560416484|FG003|Open-label Extension Phase|Other|0|||
155268499|NCT02318719|560416485|FG004|Open-label Extension Phase|Other|7|||
155268500|NCT03093428|560416486|FG000|Overall Study|Not eligible for treatment|2|||
155268501|NCT03093428|560416487|FG001|Overall Study|Not eligible for treatment|1|||
155268502|NCT03093428|560416486|FG000|Overall Study|Progression|14|||
155268503|NCT03093428|560416487|FG001|Overall Study|Progression|4|||
155268504|NCT03093428|560416486|FG000|Overall Study|Death|1|||
155268505|NCT03093428|560416487|FG001|Overall Study|Death|0|||
155268506|NCT03093428|560416486|FG000|Overall Study|Adverse Event|1|||
155268507|NCT03093428|560416487|FG001|Overall Study|Adverse Event|0|||
155268508|NCT03093428|560416486|FG000|Overall Study|Withdrawal by Subject|1|||
155268509|NCT03093428|560416487|FG001|Overall Study|Withdrawal by Subject|1|||
155268510|NCT01014975|560416488|FG000|Overall Study|Withdrawal by Subject|1|||
155268511|NCT01014975|560416489|FG001|Overall Study|Withdrawal by Subject|0|||
155268512|NCT01014975|560416490|FG002|Overall Study|Withdrawal by Subject|1|||
155268513|NCT01014975|560416488|FG000|Overall Study|Death|3|||
155268514|NCT01014975|560416489|FG001|Overall Study|Death|3|||
155268515|NCT01014975|560416490|FG002|Overall Study|Death|4|||
155268516|NCT01014975|560416488|FG000|Overall Study|Lost to Follow-up|0|||
155268517|NCT01014975|560416489|FG001|Overall Study|Lost to Follow-up|0|||
155268518|NCT01014975|560416490|FG002|Overall Study|Lost to Follow-up|1|||
155268519|NCT01336634|560416491|FG000|Overall Study|Study closed/terminated|5|||
155268520|NCT01336634|560416492|FG001|Overall Study|Study closed/terminated|6|||
155268521|NCT01336634|560416493|FG002|Overall Study|Study closed/terminated|6|||
155268522|NCT01336634|560416491|FG000|Overall Study|Lost to Follow-up|2|||
155268523|NCT01336634|560416492|FG001|Overall Study|Lost to Follow-up|1|||
155268524|NCT01336634|560416493|FG002|Overall Study|Lost to Follow-up|1|||
155268525|NCT01336634|560416491|FG000|Overall Study|Physician Decision|1|||
155268526|NCT01336634|560416492|FG001|Overall Study|Physician Decision|1|||
155268527|NCT01336634|560416493|FG002|Overall Study|Physician Decision|0|||
155268528|NCT01336634|560416491|FG000|Overall Study|Withdrawal by Subject|6|||
155268529|NCT01336634|560416492|FG001|Overall Study|Withdrawal by Subject|0|||
155268530|NCT01336634|560416493|FG002|Overall Study|Withdrawal by Subject|2|||
155268531|NCT02176421|560416494|FG000|Overall Study|Lost to Follow-up|4|||
155268532|NCT02176421|560416494|FG000|Overall Study|Adverse Event|1|||
155268533|NCT02632786|560416499|FG000|Overall Study|Adverse Event|2|||
155268534|NCT02632786|560416500|FG001|Overall Study|Adverse Event|1|||
155268535|NCT02632786|560416499|FG000|Overall Study|Death|3|||
155268536|NCT02632786|560416500|FG001|Overall Study|Death|2|||
155268537|NCT02632786|560416499|FG000|Overall Study|Physician Decision|5|||
155268538|NCT02632786|560416500|FG001|Overall Study|Physician Decision|4|||
155268539|NCT02632786|560416499|FG000|Overall Study|Withdrawal by Subject|1|||
155268540|NCT02632786|560416500|FG001|Overall Study|Withdrawal by Subject|0|||
155268541|NCT05266963|560416504|FG000|Drug Period A|Withdrawal by Subject|0|||
155268542|NCT05266963|560416505|FG001|Drug Period A|Withdrawal by Subject|1|||
155268543|NCT02912468|560416506|FG000|Overall Study|Adverse Event|3|||
155268544|NCT02912468|560416507|FG001|Overall Study|Adverse Event|2|||
155268545|NCT02912468|560416506|FG000|Overall Study|Withdrawal by Subject|6|||
155268546|NCT02912468|560416507|FG001|Overall Study|Withdrawal by Subject|2|||
155268547|NCT02912468|560416506|FG000|Overall Study|Randomized and not treated|0|||
155268548|NCT02912468|560416507|FG001|Overall Study|Randomized and not treated|1|||
155268549|NCT04091360|560416508|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268550|NCT04091360|560416509|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268551|NCT04091360|560416510|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268552|NCT04091360|560416511|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268553|NCT04091360|560416512|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268554|NCT04091360|560416513|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268555|NCT04091360|560416514|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268556|NCT04091360|560416515|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
155268557|NCT04091360|560416516|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
155268558|NCT04091360|560416517|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
155268559|NCT04091360|560416508|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268560|NCT04091360|560416509|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268561|NCT04091360|560416510|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268562|NCT04091360|560416511|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268563|NCT04091360|560416512|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268564|NCT04091360|560416513|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268565|NCT04091360|560416514|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
155268566|NCT04091360|560416515|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
155268567|NCT04091360|560416516|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268568|NCT04091360|560416517|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
155268569|NCT04091360|560416508|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268570|NCT04091360|560416509|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268571|NCT04091360|560416510|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268572|NCT04091360|560416511|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268573|NCT04091360|560416512|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268574|NCT04091360|560416513|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268575|NCT04091360|560416514|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
155268576|NCT04091360|560416515|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268577|NCT04091360|560416516|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
155268578|NCT04091360|560416517|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
155268579|NCT01107743|560416518|FG000|Overall Study|Protocol Violation|46|||
155268580|NCT01913639|560416521|FG000|Overall Study|Not Eligible|3|||
155268581|NCT00962247|560416526|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
155268582|NCT00962247|560416526|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
155268583|NCT00886639|560416536|FG000|Overall Study|acute exacerbation|14|||
155268584|NCT00886639|560416536|FG000|Overall Study|non-compliance|2|||
155268585|NCT01871558|560416537|FG000|Overall Study|Other reason|0|||
155268586|NCT01871558|560416538|FG001|Overall Study|Other reason|1|||
155268587|NCT01871558|560416537|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
155268588|NCT01871558|560416538|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
155268589|NCT01871558|560416537|FG000|Overall Study|Withdrawal by Subject|2|||
155268590|NCT01871558|560416538|FG001|Overall Study|Withdrawal by Subject|0|||
155268591|NCT01709305|560416539|FG000|Phase 1|Clinical Adverse Event|80|||
155268592|NCT01709305|560416540|FG001|Phase 1|Clinical Adverse Event|0|||
155268593|NCT01709305|560416541|FG002|Phase 1|Clinical Adverse Event|0|||
155268594|NCT01709305|560416542|FG003|Phase 1|Clinical Adverse Event|0|||
155268595|NCT01709305|560416543|FG004|Phase 1|Clinical Adverse Event|0|||
155268596|NCT01709305|560416539|FG000|Phase 1|Death|2|||
155268597|NCT01709305|560416540|FG001|Phase 1|Death|0|||
155268598|NCT01709305|560416541|FG002|Phase 1|Death|0|||
155268599|NCT01709305|560416542|FG003|Phase 1|Death|0|||
155268600|NCT01709305|560416543|FG004|Phase 1|Death|0|||
155268601|NCT01709305|560416539|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
155268602|NCT01709305|560416540|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268603|NCT01709305|560416541|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268604|NCT01709305|560416542|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268605|NCT01709305|560416543|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
155268606|NCT01709305|560416539|FG000|Phase 1|Laboratory Adverse Event|16|||
155268607|NCT01709305|560416540|FG001|Phase 1|Laboratory Adverse Event|0|||
155268608|NCT01709305|560416541|FG002|Phase 1|Laboratory Adverse Event|0|||
155268609|NCT01709305|560416542|FG003|Phase 1|Laboratory Adverse Event|0|||
155268610|NCT01709305|560416543|FG004|Phase 1|Laboratory Adverse Event|0|||
155268611|NCT01709305|560416539|FG000|Phase 1|Lost to Follow-up|147|||
155268612|NCT01709305|560416540|FG001|Phase 1|Lost to Follow-up|0|||
155268613|NCT01709305|560416541|FG002|Phase 1|Lost to Follow-up|0|||
155268614|NCT01709305|560416542|FG003|Phase 1|Lost to Follow-up|0|||
155268615|NCT01709305|560416543|FG004|Phase 1|Lost to Follow-up|0|||
155268616|NCT01709305|560416539|FG000|Phase 1|Travel, moving, etc.|30|||
155268617|NCT01709305|560416540|FG001|Phase 1|Travel, moving, etc.|0|||
155268618|NCT01709305|560416541|FG002|Phase 1|Travel, moving, etc.|0|||
154931545|NCT01901146|559175105|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
154931546|NCT01901146|559175106|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
155268619|NCT01709305|560416542|FG003|Phase 1|Travel, moving, etc.|0|||
155268620|NCT01709305|560416543|FG004|Phase 1|Travel, moving, etc.|0|||
155268621|NCT01709305|560416539|FG000|Phase 1|Physician Decision|13|||
155268622|NCT01709305|560416540|FG001|Phase 1|Physician Decision|0|||
155268623|NCT01709305|560416541|FG002|Phase 1|Physician Decision|0|||
155268624|NCT01709305|560416542|FG003|Phase 1|Physician Decision|0|||
155268625|NCT01709305|560416543|FG004|Phase 1|Physician Decision|0|||
155268626|NCT01709305|560416539|FG000|Phase 1|Protocol Violation|118|||
155268627|NCT01709305|560416540|FG001|Phase 1|Protocol Violation|0|||
155268628|NCT01709305|560416541|FG002|Phase 1|Protocol Violation|0|||
155268629|NCT01709305|560416542|FG003|Phase 1|Protocol Violation|0|||
155268630|NCT01709305|560416543|FG004|Phase 1|Protocol Violation|0|||
155268631|NCT01709305|560416539|FG000|Phase 1|Withdrawal by Subject|218|||
155268632|NCT01709305|560416540|FG001|Phase 1|Withdrawal by Subject|0|||
155268633|NCT01709305|560416541|FG002|Phase 1|Withdrawal by Subject|0|||
155268634|NCT01709305|560416542|FG003|Phase 1|Withdrawal by Subject|0|||
155268635|NCT01709305|560416543|FG004|Phase 1|Withdrawal by Subject|0|||
155268636|NCT01709305|560416539|FG000|Phase 2|Clinical Adverse Event|0|||
155268637|NCT01709305|560416540|FG001|Phase 2|Clinical Adverse Event|10|||
155268638|NCT01709305|560416541|FG002|Phase 2|Clinical Adverse Event|10|||
155268639|NCT01709305|560416542|FG003|Phase 2|Clinical Adverse Event|6|||
155268640|NCT01709305|560416543|FG004|Phase 2|Clinical Adverse Event|11|||
155268641|NCT01709305|560416539|FG000|Phase 2|Death|0|||
155268642|NCT01709305|560416540|FG001|Phase 2|Death|0|||
155268643|NCT01709305|560416541|FG002|Phase 2|Death|1|||
155268644|NCT01709305|560416542|FG003|Phase 2|Death|0|||
155268645|NCT01709305|560416543|FG004|Phase 2|Death|0|||
155268646|NCT01709305|560416539|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268647|NCT01709305|560416540|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268648|NCT01709305|560416541|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268649|NCT01709305|560416542|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
155268650|NCT01709305|560416543|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
155268651|NCT01709305|560416539|FG000|Phase 2|Laboratory Adverse Event|0|||
155268652|NCT01709305|560416540|FG001|Phase 2|Laboratory Adverse Event|1|||
155268653|NCT01709305|560416541|FG002|Phase 2|Laboratory Adverse Event|0|||
155268654|NCT01709305|560416542|FG003|Phase 2|Laboratory Adverse Event|1|||
155268655|NCT01709305|560416543|FG004|Phase 2|Laboratory Adverse Event|1|||
155268656|NCT01709305|560416539|FG000|Phase 2|Lost to Follow-up|0|||
155268657|NCT01709305|560416540|FG001|Phase 2|Lost to Follow-up|10|||
155268658|NCT01709305|560416541|FG002|Phase 2|Lost to Follow-up|6|||
155268659|NCT01709305|560416542|FG003|Phase 2|Lost to Follow-up|9|||
155268660|NCT01709305|560416543|FG004|Phase 2|Lost to Follow-up|5|||
155268661|NCT01709305|560416539|FG000|Phase 2|Travel, moving, etc.|0|||
155268662|NCT01709305|560416540|FG001|Phase 2|Travel, moving, etc.|2|||
155268663|NCT01709305|560416541|FG002|Phase 2|Travel, moving, etc.|3|||
155268664|NCT01709305|560416542|FG003|Phase 2|Travel, moving, etc.|3|||
155268665|NCT01709305|560416543|FG004|Phase 2|Travel, moving, etc.|5|||
155268666|NCT01709305|560416539|FG000|Phase 2|Physician Decision|0|||
155268667|NCT01709305|560416540|FG001|Phase 2|Physician Decision|2|||
155268668|NCT01709305|560416541|FG002|Phase 2|Physician Decision|0|||
155268669|NCT01709305|560416542|FG003|Phase 2|Physician Decision|1|||
155268670|NCT01709305|560416543|FG004|Phase 2|Physician Decision|2|||
155268671|NCT01709305|560416539|FG000|Phase 2|Protocol Violation|0|||
155268672|NCT01709305|560416540|FG001|Phase 2|Protocol Violation|19|||
155268673|NCT01709305|560416541|FG002|Phase 2|Protocol Violation|19|||
155268674|NCT01709305|560416542|FG003|Phase 2|Protocol Violation|13|||
155268675|NCT01709305|560416543|FG004|Phase 2|Protocol Violation|9|||
155268676|NCT01709305|560416539|FG000|Phase 2|Withdrawal by Subject|0|||
155268677|NCT01709305|560416540|FG001|Phase 2|Withdrawal by Subject|8|||
155268678|NCT01709305|560416541|FG002|Phase 2|Withdrawal by Subject|6|||
155268679|NCT01709305|560416542|FG003|Phase 2|Withdrawal by Subject|15|||
155268680|NCT01709305|560416543|FG004|Phase 2|Withdrawal by Subject|12|||
155268681|NCT00118898|560416546|FG000|Overall Study|Death|6|||
155268682|NCT00118898|560416547|FG001|Overall Study|Death|11|||
155268683|NCT00118898|560416548|FG002|Overall Study|Death|6|||
155268684|NCT00118898|560416549|FG003|Overall Study|Death|8|||
155268685|NCT00118898|560416546|FG000|Overall Study|Lost to Follow-up|26|||
155268686|NCT00118898|560416547|FG001|Overall Study|Lost to Follow-up|34|||
155268687|NCT00118898|560416548|FG002|Overall Study|Lost to Follow-up|33|||
155268688|NCT00118898|560416549|FG003|Overall Study|Lost to Follow-up|33|||
155268689|NCT00118898|560416546|FG000|Overall Study|Withdrawal by Subject|10|||
155268690|NCT00118898|560416547|FG001|Overall Study|Withdrawal by Subject|5|||
155268691|NCT00118898|560416548|FG002|Overall Study|Withdrawal by Subject|8|||
155268692|NCT00118898|560416549|FG003|Overall Study|Withdrawal by Subject|8|||
155268693|NCT00118898|560416546|FG000|Overall Study|Site Closure|33|||
155268694|NCT00118898|560416547|FG001|Overall Study|Site Closure|31|||
155268695|NCT00118898|560416548|FG002|Overall Study|Site Closure|28|||
155268696|NCT00118898|560416549|FG003|Overall Study|Site Closure|37|||
155043015|NCT03403621|559588058|FG001|Overall Study|Withdrawal by Subject|2|||
155268697|NCT00118898|560416546|FG000|Overall Study|Severe debilitation|1|||
155268698|NCT00118898|560416547|FG001|Overall Study|Severe debilitation|4|||
155268699|NCT00118898|560416548|FG002|Overall Study|Severe debilitation|6|||
155268700|NCT00118898|560416549|FG003|Overall Study|Severe debilitation|4|||
155268701|NCT00118898|560416546|FG000|Overall Study|Not compliant with requirements|11|||
155268702|NCT00118898|560416547|FG001|Overall Study|Not compliant with requirements|13|||
155268703|NCT00118898|560416548|FG002|Overall Study|Not compliant with requirements|11|||
155268704|NCT00118898|560416549|FG003|Overall Study|Not compliant with requirements|11|||
155268705|NCT00118898|560416546|FG000|Overall Study|Not able to get to clinic|34|||
155268706|NCT00118898|560416547|FG001|Overall Study|Not able to get to clinic|43|||
155268707|NCT00118898|560416548|FG002|Overall Study|Not able to get to clinic|31|||
155268708|NCT00118898|560416549|FG003|Overall Study|Not able to get to clinic|40|||
155268709|NCT01338012|560416552|FG000|Overall Study|Death|4|||
155268710|NCT01338012|560416552|FG000|Overall Study|Study terminated|4|||
155268711|NCT02714205|560416553|FG000|Overall Study|Cannot tolerate medication|1|||
155268712|NCT02714205|560416554|FG001|Overall Study|Cannot tolerate medication|0|||
155268713|NCT02714205|560416553|FG000|Overall Study|Adverse Event|2|||
155268714|NCT02714205|560416554|FG001|Overall Study|Adverse Event|0|||
155268715|NCT02714205|560416553|FG000|Overall Study|Too busy|1|||
155268716|NCT02714205|560416554|FG001|Overall Study|Too busy|0|||
155268717|NCT02714205|560416553|FG000|Overall Study|Incomplete outcome data|0|||
155268718|NCT02714205|560416554|FG001|Overall Study|Incomplete outcome data|1|||
155268719|NCT05879198|560416555|FG000|Overall Study|Lost to Follow-up|1|||
155268720|NCT02089230|560416556|FG000|Overall Study|Death|0|||
155268721|NCT02089230|560416557|FG001|Overall Study|Death|0|||
155268722|NCT02089230|560416558|FG002|Overall Study|Death|2|||
155268723|NCT02089230|560416556|FG000|Overall Study|Seeking Alternative Therapy|0|||
155268724|NCT02089230|560416557|FG001|Overall Study|Seeking Alternative Therapy|0|||
155268725|NCT02089230|560416558|FG002|Overall Study|Seeking Alternative Therapy|4|||
155268726|NCT01598298|560416559|FG000|Overall Study|Not eligible|5|||
155268727|NCT01598298|560416560|FG001|Overall Study|Not eligible|5|||
155268728|NCT01598298|560416559|FG000|Overall Study|Adverse Event|21|||
155268729|NCT01598298|560416560|FG001|Overall Study|Adverse Event|19|||
155268730|NCT01598298|560416559|FG000|Overall Study|Progression/relapse|0|||
155268731|NCT01598298|560416560|FG001|Overall Study|Progression/relapse|2|||
155268732|NCT01598298|560416559|FG000|Overall Study|Withdrawal by Subject|10|||
155268733|NCT01598298|560416560|FG001|Overall Study|Withdrawal by Subject|15|||
155268734|NCT01598298|560416559|FG000|Overall Study|Other reason (not protocol specified)|4|||
155268735|NCT01598298|560416560|FG001|Overall Study|Other reason (not protocol specified)|0|||
155268736|NCT02073097|560416561|FG000|Overall Study|Adverse Event|0|||
155268737|NCT02073097|560416562|FG001|Overall Study|Adverse Event|0|||
155268738|NCT02073097|560416563|FG002|Overall Study|Adverse Event|0|||
155268739|NCT02073097|560416564|FG003|Overall Study|Adverse Event|0|||
155268740|NCT02073097|560416565|FG004|Overall Study|Adverse Event|0|||
155268741|NCT02073097|560416566|FG005|Overall Study|Adverse Event|0|||
155268742|NCT02073097|560416567|FG006|Overall Study|Adverse Event|0|||
155268743|NCT02073097|560416568|FG007|Overall Study|Adverse Event|2|||
155268744|NCT02073097|560416561|FG000|Overall Study|Withdrawal by Subject|0|||
155268745|NCT02073097|560416562|FG001|Overall Study|Withdrawal by Subject|0|||
155268746|NCT02073097|560416563|FG002|Overall Study|Withdrawal by Subject|0|||
155268747|NCT02073097|560416564|FG003|Overall Study|Withdrawal by Subject|0|||
155268748|NCT02073097|560416565|FG004|Overall Study|Withdrawal by Subject|0|||
155268749|NCT02073097|560416566|FG005|Overall Study|Withdrawal by Subject|0|||
155268750|NCT02073097|560416567|FG006|Overall Study|Withdrawal by Subject|0|||
155268751|NCT02073097|560416568|FG007|Overall Study|Withdrawal by Subject|2|||
155268752|NCT02073097|560416561|FG000|Overall Study|Death|0|||
155268753|NCT02073097|560416562|FG001|Overall Study|Death|0|||
155268754|NCT02073097|560416563|FG002|Overall Study|Death|0|||
155268755|NCT02073097|560416564|FG003|Overall Study|Death|0|||
155268756|NCT02073097|560416565|FG004|Overall Study|Death|0|||
155268757|NCT02073097|560416566|FG005|Overall Study|Death|0|||
155268758|NCT02073097|560416567|FG006|Overall Study|Death|0|||
155268759|NCT02073097|560416568|FG007|Overall Study|Death|1|||
155268760|NCT02073097|560416561|FG000|Overall Study|Physician Decision|0|||
155268761|NCT02073097|560416562|FG001|Overall Study|Physician Decision|0|||
155268762|NCT02073097|560416563|FG002|Overall Study|Physician Decision|0|||
155268763|NCT02073097|560416564|FG003|Overall Study|Physician Decision|0|||
155268764|NCT02073097|560416565|FG004|Overall Study|Physician Decision|0|||
155268765|NCT02073097|560416566|FG005|Overall Study|Physician Decision|0|||
155268766|NCT02073097|560416567|FG006|Overall Study|Physician Decision|0|||
155268767|NCT02073097|560416568|FG007|Overall Study|Physician Decision|1|||
155268768|NCT03813147|560416569|FG000|Overall Study|Lack of Efficacy|4|||
155268769|NCT03813147|560416570|FG001|Overall Study|Lack of Efficacy|4|||
155268770|NCT03813147|560416569|FG000|Overall Study|Physician Decision|2|||
155268771|NCT03813147|560416570|FG001|Overall Study|Physician Decision|1|||
155268772|NCT01693692|560416571|FG000|Overall Study|Withdrawal by Subject|12|||
155268773|NCT01693692|560416572|FG001|Overall Study|Withdrawal by Subject|10|||
155268774|NCT01693692|560416573|FG002|Overall Study|Withdrawal by Subject|11|||
155268775|NCT01693692|560416571|FG000|Overall Study|Adverse Event|7|||
155268776|NCT01693692|560416572|FG001|Overall Study|Adverse Event|14|||
155268777|NCT01693692|560416573|FG002|Overall Study|Adverse Event|9|||
155268778|NCT01693692|560416571|FG000|Overall Study|Physician Decision|0|||
155268779|NCT01693692|560416572|FG001|Overall Study|Physician Decision|0|||
155268780|NCT01693692|560416573|FG002|Overall Study|Physician Decision|1|||
155268781|NCT01693692|560416571|FG000|Overall Study|Protocol Violation|5|||
155268782|NCT01693692|560416572|FG001|Overall Study|Protocol Violation|4|||
155268783|NCT01693692|560416573|FG002|Overall Study|Protocol Violation|6|||
155268784|NCT01693692|560416571|FG000|Overall Study|Lost to Follow-up|2|||
155268785|NCT01693692|560416572|FG001|Overall Study|Lost to Follow-up|2|||
155268786|NCT01693692|560416573|FG002|Overall Study|Lost to Follow-up|3|||
155268787|NCT01693692|560416571|FG000|Overall Study|Other|4|||
155268788|NCT01693692|560416572|FG001|Overall Study|Other|4|||
155268789|NCT01693692|560416573|FG002|Overall Study|Other|6|||
155268790|NCT02906683|560418913|FG000|Overall Study|Adverse Event|0|||
155268791|NCT02906683|560418914|FG001|Overall Study|Adverse Event|1|||
155268792|NCT02906683|560418915|FG002|Overall Study|Adverse Event|0|||
155268793|NCT02906683|560418913|FG000|Overall Study|Physician Decision|0|||
155268794|NCT02906683|560418914|FG001|Overall Study|Physician Decision|1|||
155268795|NCT02906683|560418915|FG002|Overall Study|Physician Decision|1|||
155268796|NCT02906683|560418913|FG000|Overall Study|Withdrawal by Subject|0|||
155268797|NCT02906683|560418914|FG001|Overall Study|Withdrawal by Subject|2|||
155268798|NCT02906683|560418915|FG002|Overall Study|Withdrawal by Subject|1|||
155268799|NCT02906683|560418913|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
155268800|NCT02906683|560418914|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
155268801|NCT02906683|560418915|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
155268802|NCT02906683|560418913|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
155268803|NCT02906683|560418914|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
155268804|NCT02906683|560418915|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
155268805|NCT01167179|560418918|FG000|Overall Study|disease recurrence|4|||
155268806|NCT01167179|560418919|FG001|Overall Study|disease recurrence|4|||
155268807|NCT01167179|560418918|FG000|Overall Study|Death|4|||
155268808|NCT01167179|560418919|FG001|Overall Study|Death|10|||
155268809|NCT01167179|560418918|FG000|Overall Study|Withdrawal by Subject|1|||
155268810|NCT01167179|560418919|FG001|Overall Study|Withdrawal by Subject|2|||
155268811|NCT01167179|560418918|FG000|Overall Study|diverse|6|||
155268812|NCT01167179|560418919|FG001|Overall Study|diverse|5|||
155268813|NCT00663117|560418920|FG000|Overall Study|Lack of Efficacy|1|||
155268814|NCT00663117|560418921|FG001|Overall Study|Lack of Efficacy|0|||
155268815|NCT02769065|560418922|FG000|Overall Study|Voluntary Withdrawal|1|||
155268816|NCT02769065|560418923|FG001|Overall Study|Voluntary Withdrawal|0|||
155268817|NCT02769065|560418924|FG002|Overall Study|Voluntary Withdrawal|0|||
155268818|NCT02769065|560418925|FG003|Overall Study|Voluntary Withdrawal|0|||
155268819|NCT02769065|560418926|FG004|Overall Study|Voluntary Withdrawal|0|||
155268820|NCT02769065|560418927|FG005|Overall Study|Voluntary Withdrawal|0|||
155268821|NCT02769065|560418928|FG006|Overall Study|Voluntary Withdrawal|0|||
155268822|NCT02769065|560418929|FG007|Overall Study|Voluntary Withdrawal|0|||
155268823|NCT02769065|560418930|FG008|Overall Study|Voluntary Withdrawal|0|||
155268824|NCT02769065|560418931|FG009|Overall Study|Voluntary Withdrawal|0|||
155268825|NCT02769065|560418932|FG010|Overall Study|Voluntary Withdrawal|0|||
155268826|NCT02769065|560418933|FG011|Overall Study|Voluntary Withdrawal|0|||
155268827|NCT02769065|560418934|FG012|Overall Study|Voluntary Withdrawal|0|||
155268828|NCT02769065|560418935|FG013|Overall Study|Voluntary Withdrawal|0|||
155268829|NCT02769065|560418936|FG014|Overall Study|Voluntary Withdrawal|0|||
155268830|NCT02769065|560418937|FG015|Overall Study|Voluntary Withdrawal|0|||
155268831|NCT02769065|560418938|FG016|Overall Study|Voluntary Withdrawal|0|||
155268832|NCT02769065|560418939|FG017|Overall Study|Voluntary Withdrawal|0|||
155268833|NCT02769065|560418940|FG018|Overall Study|Voluntary Withdrawal|0|||
155268834|NCT02769065|560418941|FG019|Overall Study|Voluntary Withdrawal|0|||
155268835|NCT02769065|560418942|FG020|Overall Study|Voluntary Withdrawal|0|||
155268836|NCT02769065|560418943|FG021|Overall Study|Voluntary Withdrawal|0|||
155268837|NCT02769065|560418944|FG022|Overall Study|Voluntary Withdrawal|0|||
155268838|NCT02769065|560418945|FG023|Overall Study|Voluntary Withdrawal|0|||
155268839|NCT02769065|560418946|FG024|Overall Study|Voluntary Withdrawal|0|||
155268840|NCT02769065|560418947|FG025|Overall Study|Voluntary Withdrawal|0|||
155268841|NCT02769065|560418948|FG026|Overall Study|Voluntary Withdrawal|0|||
155268842|NCT02769065|560418949|FG027|Overall Study|Voluntary Withdrawal|0|||
155268843|NCT02769065|560418950|FG028|Overall Study|Voluntary Withdrawal|0|||
155268844|NCT02769065|560418951|FG029|Overall Study|Voluntary Withdrawal|0|||
155268845|NCT02769065|560418922|FG000|Overall Study|Reason Not Specified|0|||
155268846|NCT02769065|560418923|FG001|Overall Study|Reason Not Specified|0|||
155268847|NCT02769065|560418924|FG002|Overall Study|Reason Not Specified|0|||
155268848|NCT02769065|560418925|FG003|Overall Study|Reason Not Specified|0|||
155268849|NCT02769065|560418926|FG004|Overall Study|Reason Not Specified|0|||
155268850|NCT02769065|560418927|FG005|Overall Study|Reason Not Specified|0|||
155268851|NCT02769065|560418928|FG006|Overall Study|Reason Not Specified|1|||
155268852|NCT02769065|560418929|FG007|Overall Study|Reason Not Specified|0|||
155268853|NCT02769065|560418930|FG008|Overall Study|Reason Not Specified|0|||
155268854|NCT02769065|560418931|FG009|Overall Study|Reason Not Specified|0|||
155268855|NCT02769065|560418932|FG010|Overall Study|Reason Not Specified|0|||
155268856|NCT02769065|560418933|FG011|Overall Study|Reason Not Specified|0|||
155268857|NCT02769065|560418934|FG012|Overall Study|Reason Not Specified|0|||
155268858|NCT02769065|560418935|FG013|Overall Study|Reason Not Specified|0|||
155268859|NCT02769065|560418936|FG014|Overall Study|Reason Not Specified|0|||
155268860|NCT02769065|560418937|FG015|Overall Study|Reason Not Specified|0|||
155268861|NCT02769065|560418938|FG016|Overall Study|Reason Not Specified|0|||
155268862|NCT02769065|560418939|FG017|Overall Study|Reason Not Specified|0|||
155268863|NCT02769065|560418940|FG018|Overall Study|Reason Not Specified|0|||
155268864|NCT02769065|560418941|FG019|Overall Study|Reason Not Specified|0|||
155268865|NCT02769065|560418942|FG020|Overall Study|Reason Not Specified|0|||
155268866|NCT02769065|560418943|FG021|Overall Study|Reason Not Specified|0|||
155268867|NCT02769065|560418944|FG022|Overall Study|Reason Not Specified|0|||
155268868|NCT02769065|560418945|FG023|Overall Study|Reason Not Specified|0|||
155268869|NCT02769065|560418946|FG024|Overall Study|Reason Not Specified|0|||
155268870|NCT02769065|560418947|FG025|Overall Study|Reason Not Specified|0|||
155268871|NCT02769065|560418948|FG026|Overall Study|Reason Not Specified|0|||
155268872|NCT02769065|560418949|FG027|Overall Study|Reason Not Specified|0|||
155268873|NCT02769065|560418950|FG028|Overall Study|Reason Not Specified|0|||
155268874|NCT02769065|560418951|FG029|Overall Study|Reason Not Specified|0|||
155268875|NCT02769065|560418922|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268876|NCT02769065|560418923|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268877|NCT02769065|560418924|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268878|NCT02769065|560418925|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268879|NCT02769065|560418926|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268880|NCT02769065|560418927|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268881|NCT02769065|560418928|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268882|NCT02769065|560418929|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268883|NCT02769065|560418930|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268884|NCT02769065|560418931|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268885|NCT02769065|560418932|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
155268886|NCT02769065|560418933|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268887|NCT02769065|560418934|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268888|NCT02769065|560418935|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268889|NCT02769065|560418936|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268890|NCT02769065|560418937|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268891|NCT02769065|560418938|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268892|NCT02769065|560418939|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268893|NCT02769065|560418940|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268894|NCT02769065|560418941|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268895|NCT02769065|560418942|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268896|NCT02769065|560418943|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268897|NCT02769065|560418944|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268898|NCT02769065|560418945|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268899|NCT02769065|560418946|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268900|NCT02769065|560418947|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268901|NCT02769065|560418948|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268902|NCT02769065|560418949|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268903|NCT02769065|560418950|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268904|NCT02769065|560418951|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
155268905|NCT02531295|560418952|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268906|NCT02531295|560418953|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268907|NCT02531295|560418954|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268908|NCT02531295|560418955|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268909|NCT02531295|560418956|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
155268910|NCT02531295|560418957|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
155268911|NCT01923896|560418959|FG000|Overall Study|Adverse Event|1|||
155268912|NCT01923896|560418960|FG001|Overall Study|Adverse Event|0|||
155268913|NCT03545113|560418961|FG000|Overall Study|Surgery Cancelled|1|||
155268914|NCT03545113|560418962|FG001|Overall Study|Surgery Cancelled|0|||
155268915|NCT03545113|560418961|FG000|Overall Study|Death|1|||
155268916|NCT03545113|560418962|FG001|Overall Study|Death|0|||
155268917|NCT03545113|560418961|FG000|Overall Study|Adverse Event|2|||
155268918|NCT03545113|560418962|FG001|Overall Study|Adverse Event|0|||
155268919|NCT03545113|560418961|FG000|Overall Study|Received different surgery|1|||
155268920|NCT03545113|560418962|FG001|Overall Study|Received different surgery|0|||
155268921|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
155268922|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
155268923|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
155268924|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
155268925|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
155268926|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
155268927|NCT03029247|560418963|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
155268928|NCT03029247|560418964|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
155268929|NCT02593305|560418965|FG000|Post 1|Comparison only group. No intervention.|0|||
155268930|NCT02593305|560418966|FG001|Post 1|Comparison only group. No intervention.|0|||
155268931|NCT02593305|560418967|FG002|Post 1|Comparison only group. No intervention.|10|||
155268932|NCT01993017|560418968|FG000|Overall Study|Death|23|||
155268933|NCT01993017|560418969|FG001|Overall Study|Death|26|||
155268934|NCT01993017|560418970|FG002|Overall Study|Death|18|||
155268935|NCT01993017|560418968|FG000|Overall Study|Could not be contacted|43|||
155268936|NCT01993017|560418969|FG001|Overall Study|Could not be contacted|42|||
155268937|NCT01993017|560418970|FG002|Overall Study|Could not be contacted|38|||
155268938|NCT01993017|560418968|FG000|Overall Study|Dropped out|19|||
155268939|NCT01993017|560418969|FG001|Overall Study|Dropped out|6|||
155268940|NCT01993017|560418970|FG002|Overall Study|Dropped out|11|||
155268941|NCT01993017|560418968|FG000|Overall Study|Other reasons|17|||
155268942|NCT01993017|560418969|FG001|Overall Study|Other reasons|11|||
155268943|NCT01993017|560418970|FG002|Overall Study|Other reasons|7|||
155268944|NCT01993017|560418968|FG000|Overall Study|Ineligible after randomization|4|||
155268945|NCT01993017|560418969|FG001|Overall Study|Ineligible after randomization|5|||
155268946|NCT01993017|560418970|FG002|Overall Study|Ineligible after randomization|5|||
155268947|NCT00068380|560418971|FG000|Overall Study|Withdrawal by Subject|3|||
155268948|NCT00068380|560418971|FG000|Overall Study|Adverse Event|2|||
155268949|NCT01190215|560418972|FG000|Up to Month 6|Lost to Follow-up|2|||
155268950|NCT01190215|560418973|FG001|Up to Month 6|Lost to Follow-up|0|||
155268951|NCT02960763|560418976|FG000|Step 1|Withdrawal by Subject|10|||
155268952|NCT02960763|560418977|FG001|Step 1|Withdrawal by Subject|8|||
155268953|NCT02960763|560418978|FG002|Step 1|Withdrawal by Subject|13|||
155268954|NCT02960763|560418979|FG003|Step 1|Withdrawal by Subject|0|||
155268955|NCT02960763|560418980|FG004|Step 1|Withdrawal by Subject|0|||
155268956|NCT02960763|560418976|FG000|Step 1|Lost to Follow-up|7|||
155268957|NCT02960763|560418977|FG001|Step 1|Lost to Follow-up|9|||
155268958|NCT02960763|560418978|FG002|Step 1|Lost to Follow-up|12|||
155268959|NCT02960763|560418979|FG003|Step 1|Lost to Follow-up|0|||
155268960|NCT02960763|560418980|FG004|Step 1|Lost to Follow-up|0|||
155268961|NCT02960763|560418976|FG000|Step 1|Death|1|||
155268962|NCT02960763|560418977|FG001|Step 1|Death|1|||
155268963|NCT02960763|560418978|FG002|Step 1|Death|1|||
155268964|NCT02960763|560418979|FG003|Step 1|Death|0|||
155268965|NCT02960763|560418980|FG004|Step 1|Death|0|||
155268966|NCT02960763|560418976|FG000|Step 1|Investigator discretion|1|||
155268967|NCT02960763|560418977|FG001|Step 1|Investigator discretion|0|||
155268968|NCT02960763|560418978|FG002|Step 1|Investigator discretion|1|||
155268969|NCT02960763|560418979|FG003|Step 1|Investigator discretion|0|||
155268970|NCT02960763|560418980|FG004|Step 1|Investigator discretion|0|||
155268971|NCT02960763|560418976|FG000|Step 1|Other|0|||
155268972|NCT02960763|560418977|FG001|Step 1|Other|0|||
155268973|NCT02960763|560418978|FG002|Step 1|Other|1|||
155268974|NCT02960763|560418979|FG003|Step 1|Other|0|||
155268975|NCT02960763|560418980|FG004|Step 1|Other|0|||
155268976|NCT02960763|560418976|FG000|Step 2|Withdrawal by Subject|0|||
155268977|NCT02960763|560418977|FG001|Step 2|Withdrawal by Subject|0|||
155268978|NCT02960763|560418978|FG002|Step 2|Withdrawal by Subject|0|||
155268979|NCT02960763|560418979|FG003|Step 2|Withdrawal by Subject|7|||
155268980|NCT02960763|560418980|FG004|Step 2|Withdrawal by Subject|3|||
155268981|NCT02960763|560418976|FG000|Step 2|Lost to Follow-up|0|||
155268982|NCT02960763|560418977|FG001|Step 2|Lost to Follow-up|0|||
155268983|NCT02960763|560418978|FG002|Step 2|Lost to Follow-up|0|||
155268984|NCT02960763|560418979|FG003|Step 2|Lost to Follow-up|4|||
155268985|NCT02960763|560418980|FG004|Step 2|Lost to Follow-up|1|||
155268986|NCT02960763|560418976|FG000|Step 2|Investigator discretion|0|||
155268987|NCT02960763|560418977|FG001|Step 2|Investigator discretion|0|||
155268988|NCT02960763|560418978|FG002|Step 2|Investigator discretion|0|||
155268989|NCT02960763|560418979|FG003|Step 2|Investigator discretion|0|||
155268990|NCT02960763|560418980|FG004|Step 2|Investigator discretion|1|||
155268991|NCT05340751|560418985|FG000|Overall Study|Physician Decision|3|||
155268992|NCT01973491|560419000|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
155268993|NCT01973491|560419000|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
155268994|NCT01973491|560419000|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
155268995|NCT01863043|560419001|FG000|Overall Study|Death|6|||
155268996|NCT01863043|560419002|FG001|Overall Study|Death|1|||
155268997|NCT01863043|560419001|FG000|Overall Study|Withdrawal by Subject|0|||
155268998|NCT01863043|560419002|FG001|Overall Study|Withdrawal by Subject|2|||
155268999|NCT01863043|560419001|FG000|Overall Study|Adverse Event|7|||
155269000|NCT01863043|560419002|FG001|Overall Study|Adverse Event|8|||
155269001|NCT01863043|560419001|FG000|Overall Study|exclusion criteria found after enrollment|0|||
155269002|NCT01863043|560419002|FG001|Overall Study|exclusion criteria found after enrollment|1|||
155269003|NCT01987596|560419003|FG000|Overall Study|Physician Decision|1|||
155269004|NCT01987596|560419004|FG001|Overall Study|Physician Decision|0|||
155269005|NCT01987596|560419003|FG000|Overall Study|Progressive Disease; missing all period|0|||
155269006|NCT01987596|560419004|FG001|Overall Study|Progressive Disease; missing all period|1|||
155269007|NCT00854295|560419005|FG000|Overall Study|Death|7|||
155269008|NCT00854295|560419006|FG001|Overall Study|Death|0|||
155269009|NCT00854295|560419007|FG002|Overall Study|Death|1|||
155269010|NCT00854295|560419008|FG003|Overall Study|Death|1|||
155269011|NCT00854295|560419005|FG000|Overall Study|Adverse Event|6|||
155269012|NCT00854295|560419006|FG001|Overall Study|Adverse Event|1|||
155269013|NCT00854295|560419007|FG002|Overall Study|Adverse Event|1|||
155269014|NCT00854295|560419008|FG003|Overall Study|Adverse Event|3|||
155269015|NCT00854295|560419005|FG000|Overall Study|Lost to Follow-up|18|||
155269016|NCT00854295|560419006|FG001|Overall Study|Lost to Follow-up|5|||
155269017|NCT00854295|560419007|FG002|Overall Study|Lost to Follow-up|21|||
155269018|NCT00854295|560419008|FG003|Overall Study|Lost to Follow-up|21|||
155269019|NCT00854295|560419005|FG000|Overall Study|Physician Decision|10|||
155269020|NCT00854295|560419006|FG001|Overall Study|Physician Decision|0|||
155269021|NCT00854295|560419007|FG002|Overall Study|Physician Decision|0|||
155269022|NCT00854295|560419008|FG003|Overall Study|Physician Decision|0|||
155269023|NCT00709592|560419009|FG000|Overall Study|Unable to proceed to transplant|0|||
155269024|NCT00709592|560419010|FG001|Overall Study|Unable to proceed to transplant|1|||
155269025|NCT02440594|560419014|FG000|Overall Study|Lost to Follow-up|34|||
155269026|NCT02440594|560419015|FG001|Overall Study|Lost to Follow-up|33|||
155269027|NCT02440594|560419016|FG002|Overall Study|Lost to Follow-up|54|||
155269028|NCT02440594|560419017|FG003|Overall Study|Lost to Follow-up|47|||
155269029|NCT02440594|560419018|FG004|Overall Study|Lost to Follow-up|5|||
155269030|NCT02440594|560419019|FG005|Overall Study|Lost to Follow-up|4|||
155269031|NCT02440594|560419020|FG006|Overall Study|Lost to Follow-up|28|||
155269032|NCT02440594|560419021|FG007|Overall Study|Lost to Follow-up|48|||
155269033|NCT02440594|560419014|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
155269034|NCT02440594|560419015|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
155269035|NCT02440594|560419016|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
155269036|NCT02440594|560419017|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
155269037|NCT02440594|560419018|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
155269038|NCT02440594|560419019|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
155269039|NCT02440594|560419020|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
155269040|NCT02440594|560419021|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
155269041|NCT02440594|560419014|FG000|Overall Study|Withdrawal by Subject|81|||
155269042|NCT02440594|560419015|FG001|Overall Study|Withdrawal by Subject|67|||
155269043|NCT02440594|560419016|FG002|Overall Study|Withdrawal by Subject|59|||
155269044|NCT02440594|560419017|FG003|Overall Study|Withdrawal by Subject|38|||
155269045|NCT02440594|560419018|FG004|Overall Study|Withdrawal by Subject|2|||
155269046|NCT02440594|560419019|FG005|Overall Study|Withdrawal by Subject|2|||
155269047|NCT02440594|560419020|FG006|Overall Study|Withdrawal by Subject|7|||
155269048|NCT02440594|560419021|FG007|Overall Study|Withdrawal by Subject|7|||
155269049|NCT02440594|560419014|FG000|Overall Study|Administratively w/drawn|3|||
155269050|NCT02440594|560419015|FG001|Overall Study|Administratively w/drawn|2|||
155269051|NCT02440594|560419016|FG002|Overall Study|Administratively w/drawn|0|||
155269052|NCT02440594|560419017|FG003|Overall Study|Administratively w/drawn|0|||
155269053|NCT02440594|560419018|FG004|Overall Study|Administratively w/drawn|0|||
155269054|NCT02440594|560419019|FG005|Overall Study|Administratively w/drawn|0|||
155269055|NCT02440594|560419020|FG006|Overall Study|Administratively w/drawn|2|||
155269056|NCT02440594|560419021|FG007|Overall Study|Administratively w/drawn|1|||
155269057|NCT04250337|560419022|FG000|Overall Study|Adverse Event|0|||
155269058|NCT04250337|560419023|FG001|Overall Study|Adverse Event|3|||
155269059|NCT04250337|560419022|FG000|Overall Study|Lack of Efficacy|1|||
155269060|NCT04250337|560419023|FG001|Overall Study|Lack of Efficacy|3|||
155269061|NCT04250337|560419022|FG000|Overall Study|Physician Decision|1|||
155269062|NCT04250337|560419023|FG001|Overall Study|Physician Decision|0|||
155269063|NCT04250337|560419022|FG000|Overall Study|Protocol Deviation|2|||
155269064|NCT04250337|560419023|FG001|Overall Study|Protocol Deviation|2|||
155269065|NCT04250337|560419022|FG000|Overall Study|Withdrawal by Subject|4|||
155269066|NCT04250337|560419023|FG001|Overall Study|Withdrawal by Subject|3|||
155269067|NCT01129336|560419024|FG000|Overall Study|Protocol Violation|1|||
155269068|NCT01129336|560419025|FG001|Overall Study|Protocol Violation|0|||
155269069|NCT01129336|560419024|FG000|Overall Study|Disease Progression|1|||
155269070|NCT01129336|560419025|FG001|Overall Study|Disease Progression|4|||
155269071|NCT01129336|560419024|FG000|Overall Study|Lost to Follow-up|1|||
155269072|NCT01129336|560419025|FG001|Overall Study|Lost to Follow-up|0|||
155269073|NCT01129336|560419024|FG000|Overall Study|Withdrawal by Subject|7|||
155269074|NCT01129336|560419025|FG001|Overall Study|Withdrawal by Subject|4|||
155269075|NCT01129336|560419024|FG000|Overall Study|Adverse Event|0|||
155269076|NCT01129336|560419025|FG001|Overall Study|Adverse Event|1|||
155269077|NCT01129336|560419024|FG000|Overall Study|Missing Study Completion Status|2|||
155269078|NCT01129336|560419025|FG001|Overall Study|Missing Study Completion Status|3|||
155269079|NCT01129336|560419024|FG000|Overall Study|Death|0|||
155269080|NCT01129336|560419025|FG001|Overall Study|Death|4|||
155269081|NCT00152763|560419026|FG000|Overall Study|Death|4|||
155269082|NCT00152763|560419027|FG001|Overall Study|Death|1|||
155381736|NCT04617275|560830985|FG001|Follow-up Period|Lost to Follow-up|1|||
155269083|NCT00152763|560419028|FG002|Overall Study|Death|2|||
155269084|NCT00152763|560419029|FG003|Overall Study|Death|1|||
155269085|NCT00152763|560419026|FG000|Overall Study|Lost to Follow-up|6|||
155269086|NCT00152763|560419027|FG001|Overall Study|Lost to Follow-up|4|||
155269087|NCT00152763|560419028|FG002|Overall Study|Lost to Follow-up|2|||
155269088|NCT00152763|560419029|FG003|Overall Study|Lost to Follow-up|13|||
155269089|NCT00569803|560419030|FG000|Overall Study|Lost to Follow-up|1|||
155269090|NCT00569803|560419031|FG001|Overall Study|Lost to Follow-up|0|||
155269091|NCT00569803|560419032|FG002|Overall Study|Lost to Follow-up|0|||
155269092|NCT00569803|560419033|FG003|Overall Study|Lost to Follow-up|0|||
155269093|NCT00569803|560419034|FG004|Overall Study|Lost to Follow-up|0|||
155269094|NCT00569803|560419035|FG005|Overall Study|Lost to Follow-up|0|||
155269095|NCT00569803|560419036|FG006|Overall Study|Lost to Follow-up|0|||
155269096|NCT00569803|560419037|FG007|Overall Study|Lost to Follow-up|0|||
155269097|NCT00569803|560419030|FG000|Overall Study|injection syringe leaked during dosing|0|||
155269098|NCT00569803|560419031|FG001|Overall Study|injection syringe leaked during dosing|0|||
155269099|NCT00569803|560419032|FG002|Overall Study|injection syringe leaked during dosing|0|||
155269100|NCT00569803|560419033|FG003|Overall Study|injection syringe leaked during dosing|1|||
155269101|NCT00569803|560419034|FG004|Overall Study|injection syringe leaked during dosing|0|||
155269102|NCT00569803|560419035|FG005|Overall Study|injection syringe leaked during dosing|0|||
155269103|NCT00569803|560419036|FG006|Overall Study|injection syringe leaked during dosing|0|||
155269104|NCT00569803|560419037|FG007|Overall Study|injection syringe leaked during dosing|0|||
155269105|NCT00569803|560419030|FG000|Overall Study|Withdrawal by Subject|0|||
155269106|NCT00569803|560419031|FG001|Overall Study|Withdrawal by Subject|0|||
155269107|NCT00569803|560419032|FG002|Overall Study|Withdrawal by Subject|0|||
155269108|NCT00569803|560419033|FG003|Overall Study|Withdrawal by Subject|0|||
155269109|NCT00569803|560419034|FG004|Overall Study|Withdrawal by Subject|0|||
155269110|NCT00569803|560419035|FG005|Overall Study|Withdrawal by Subject|0|||
155269111|NCT00569803|560419036|FG006|Overall Study|Withdrawal by Subject|0|||
155269112|NCT00569803|560419037|FG007|Overall Study|Withdrawal by Subject|1|||
155269113|NCT04668989|560419038|FG000|First Intervention|Covid-19 related self-isolation|0|||
155269114|NCT04668989|560419039|FG001|First Intervention|Covid-19 related self-isolation|1|||
155269115|NCT04668989|560419038|FG000|Second Intervention|Adverse Event|0|||
155269116|NCT04668989|560419039|FG001|Second Intervention|Adverse Event|1|||
155269117|NCT01993823|560419040|FG000|Overall Study|Requested by the patient|6|||
155269118|NCT01993823|560419041|FG001|Overall Study|Requested by the patient|11|||
155269119|NCT01993823|560419040|FG000|Overall Study|Protocol Violation|0|||
155269120|NCT01993823|560419041|FG001|Overall Study|Protocol Violation|1|||
155269121|NCT01993823|560419040|FG000|Overall Study|Lost to Follow-up|1|||
155269122|NCT01993823|560419041|FG001|Overall Study|Lost to Follow-up|4|||
155269123|NCT01622348|560419044|FG000|Overall Study|Withdrawal by Subject|1|||
155269124|NCT01622348|560419045|FG001|Overall Study|Withdrawal by Subject|0|||
155269125|NCT01622348|560419046|FG002|Overall Study|Withdrawal by Subject|1|||
155269126|NCT00791921|560419049|FG000|Overall Study|Protocol planed|24|||
155269127|NCT00791921|560419050|FG001|Overall Study|Protocol planed|88|||
155269128|NCT00791921|560419049|FG000|Overall Study|Withdrawal by Subject|1|||
155269129|NCT00791921|560419050|FG001|Overall Study|Withdrawal by Subject|2|||
155269130|NCT00791921|560419049|FG000|Overall Study|Adverse Event|8|||
155269131|NCT00791921|560419050|FG001|Overall Study|Adverse Event|2|||
155269132|NCT00791921|560419049|FG000|Overall Study|Lack of Efficacy|0|||
155269133|NCT00791921|560419050|FG001|Overall Study|Lack of Efficacy|2|||
155269134|NCT00791921|560419049|FG000|Overall Study|Lack of study drug administration|1|||
155269135|NCT00791921|560419050|FG001|Overall Study|Lack of study drug administration|1|||
155269136|NCT00791921|560419049|FG000|Overall Study|Reason other than those above|0|||
155269137|NCT00791921|560419050|FG001|Overall Study|Reason other than those above|1|||
155269138|NCT00422799|560419054|FG000|Overall Study|Withdrawal by Subject|6|||
155269139|NCT00422799|560419054|FG000|Overall Study|Adverse Event|7|||
155269140|NCT01965158|560419055|FG000|Overall Study|Adverse Event|14|||
155269141|NCT01965158|560419056|FG001|Overall Study|Adverse Event|5|||
155269142|NCT01965158|560419055|FG000|Overall Study|Withdrawal by Subject|16|||
155269143|NCT01965158|560419056|FG001|Overall Study|Withdrawal by Subject|24|||
155269144|NCT01965158|560419055|FG000|Overall Study|Lost to Follow-up|7|||
155269145|NCT01965158|560419056|FG001|Overall Study|Lost to Follow-up|5|||
155269146|NCT01965158|560419055|FG000|Overall Study|Protocol Violation|1|||
155269147|NCT01965158|560419056|FG001|Overall Study|Protocol Violation|1|||
155269148|NCT01965158|560419055|FG000|Overall Study|Other - Miscellaneous|3|||
155381737|NCT04617275|560830986|FG002|Follow-up Period|Lost to Follow-up|2|||
155381738|NCT04617275|560830987|FG003|Follow-up Period|Lost to Follow-up|0|||
155269149|NCT01965158|560419056|FG001|Overall Study|Other - Miscellaneous|0|||
155269150|NCT00474175|560419057|FG000|Overall Study|Lack of Efficacy|0|||
155269151|NCT00474175|560419058|FG001|Overall Study|Lack of Efficacy|0|||
155269152|NCT00474175|560419059|FG002|Overall Study|Lack of Efficacy|1|||
155269153|NCT00474175|560419057|FG000|Overall Study|Withdrawal by Subject|0|||
155269154|NCT00474175|560419058|FG001|Overall Study|Withdrawal by Subject|1|||
155269155|NCT00474175|560419059|FG002|Overall Study|Withdrawal by Subject|1|||
155269156|NCT00474175|560419057|FG000|Overall Study|Ineligible|1|||
155269157|NCT00474175|560419058|FG001|Overall Study|Ineligible|3|||
155269158|NCT00474175|560419059|FG002|Overall Study|Ineligible|1|||
155269159|NCT00474175|560419057|FG000|Overall Study|Protocol Violation|0|||
155269160|NCT00474175|560419058|FG001|Overall Study|Protocol Violation|2|||
155269161|NCT00474175|560419059|FG002|Overall Study|Protocol Violation|1|||
155269162|NCT00474175|560419057|FG000|Overall Study|Administrative|0|||
155269163|NCT00474175|560419058|FG001|Overall Study|Administrative|1|||
155269164|NCT00474175|560419059|FG002|Overall Study|Administrative|0|||
155269165|NCT00467142|560419060|FG000|Overall Study|Withdrawal by Subject|1|||
155269166|NCT00467142|560419060|FG000|Overall Study|Adverse Event|1|||
155269167|NCT00467142|560419060|FG000|Overall Study|Protocol Violation|1|||
155269168|NCT01619787|560419061|FG000|Overall Study|Lost to Follow-up|5|||
155269169|NCT04537897|560419062|FG000|Overall Study|Other than listed|0|||
155269170|NCT04537897|560419063|FG001|Overall Study|Other than listed|0|||
155269171|NCT04537897|560419064|FG002|Overall Study|Other than listed|0|||
155269172|NCT04537897|560419065|FG003|Overall Study|Other than listed|0|||
155269173|NCT04537897|560419066|FG004|Overall Study|Other than listed|0|||
155269174|NCT04537897|560419067|FG005|Overall Study|Other than listed|0|||
155269175|NCT04537897|560419068|FG006|Overall Study|Other than listed|1|||
155269176|NCT04537897|560419069|FG007|Overall Study|Other than listed|0|||
155269177|NCT04537897|560419070|FG008|Overall Study|Other than listed|0|||
155269178|NCT04537897|560419062|FG000|Overall Study|Adverse Event|0|||
155269179|NCT04537897|560419063|FG001|Overall Study|Adverse Event|0|||
155269180|NCT04537897|560419064|FG002|Overall Study|Adverse Event|0|||
155269181|NCT04537897|560419065|FG003|Overall Study|Adverse Event|1|||
155269182|NCT04537897|560419066|FG004|Overall Study|Adverse Event|0|||
155269183|NCT04537897|560419067|FG005|Overall Study|Adverse Event|0|||
155269184|NCT04537897|560419068|FG006|Overall Study|Adverse Event|0|||
155269185|NCT04537897|560419069|FG007|Overall Study|Adverse Event|0|||
155269186|NCT04537897|560419070|FG008|Overall Study|Adverse Event|0|||
155269187|NCT04537897|560419062|FG000|Overall Study|Withdrawal by Subject|0|||
155269188|NCT04537897|560419063|FG001|Overall Study|Withdrawal by Subject|1|||
155269189|NCT04537897|560419064|FG002|Overall Study|Withdrawal by Subject|0|||
155269190|NCT04537897|560419065|FG003|Overall Study|Withdrawal by Subject|0|||
155269191|NCT04537897|560419066|FG004|Overall Study|Withdrawal by Subject|0|||
155269192|NCT04537897|560419067|FG005|Overall Study|Withdrawal by Subject|0|||
155269193|NCT04537897|560419068|FG006|Overall Study|Withdrawal by Subject|0|||
155269194|NCT04537897|560419069|FG007|Overall Study|Withdrawal by Subject|0|||
155269195|NCT04537897|560419070|FG008|Overall Study|Withdrawal by Subject|0|||
155269196|NCT03029780|560419077|FG000|Overall Study|Disease Progression|20|||
155269197|NCT03029780|560419078|FG001|Overall Study|Disease Progression|22|||
155269198|NCT03029780|560419077|FG000|Overall Study|Study Drug Toxicity|15|||
155269199|NCT03029780|560419078|FG001|Overall Study|Study Drug Toxicity|11|||
155269200|NCT03029780|560419077|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155269201|NCT03029780|560419078|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155269202|NCT03029780|560419077|FG000|Overall Study|Participant request to discontinue study treatment|4|||
155269203|NCT03029780|560419078|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155269204|NCT03029780|560419077|FG000|Overall Study|Maximum clinical benefit|1|||
155269205|NCT03029780|560419078|FG001|Overall Study|Maximum clinical benefit|0|||
155269206|NCT03029780|560419077|FG000|Overall Study|Participant no longer meets study criteria|0|||
155269207|NCT03029780|560419078|FG001|Overall Study|Participant no longer meets study criteria|1|||
155269208|NCT03029780|560419077|FG000|Overall Study|Other reasons|6|||
155269209|NCT03029780|560419078|FG001|Overall Study|Other reasons|6|||
155269210|NCT03029780|560419077|FG000|Overall Study|Not reported|1|||
155269211|NCT03029780|560419078|FG001|Overall Study|Not reported|1|||
155269212|NCT03029780|560419077|FG000|Overall Study|Death|2|||
155269213|NCT03029780|560419078|FG001|Overall Study|Death|6|||
155269214|NCT00197028|560419079|FG000|Overall Study|Adverse Event|2|||
155269215|NCT00197028|560419080|FG001|Overall Study|Adverse Event|2|||
155269216|NCT00197028|560419079|FG000|Overall Study|Protocol Violation|2|||
155269217|NCT00197028|560419080|FG001|Overall Study|Protocol Violation|1|||
155269218|NCT00197028|560419079|FG000|Overall Study|Withdrawal by Subject|8|||
155269219|NCT00197028|560419080|FG001|Overall Study|Withdrawal by Subject|12|||
155269220|NCT00197028|560419079|FG000|Overall Study|Lost to Follow-up|1|||
155269221|NCT00197028|560419080|FG001|Overall Study|Lost to Follow-up|0|||
155269222|NCT00197028|560419079|FG000|Overall Study|Other|3|||
155269223|NCT00197028|560419080|FG001|Overall Study|Other|6|||
155043016|NCT00583102|559588059|FG000|Overall Study|Adverse Event|3|||
155269224|NCT00178256|560419081|FG000|Overall Study|Adverse Event|2|||
155269225|NCT00178256|560419082|FG001|Overall Study|Adverse Event|0|||
155269226|NCT00178256|560419083|FG002|Overall Study|Adverse Event|0|||
155269227|NCT00178256|560419084|FG003|Overall Study|Adverse Event|0|||
155269228|NCT00178256|560419081|FG000|Overall Study|Death|0|||
155269229|NCT00178256|560419082|FG001|Overall Study|Death|1|||
155269230|NCT00178256|560419083|FG002|Overall Study|Death|0|||
155269231|NCT00178256|560419084|FG003|Overall Study|Death|1|||
155269232|NCT00178256|560419081|FG000|Overall Study|Cancer progression|2|||
155269233|NCT00178256|560419082|FG001|Overall Study|Cancer progression|0|||
155269234|NCT00178256|560419083|FG002|Overall Study|Cancer progression|0|||
155269235|NCT00178256|560419084|FG003|Overall Study|Cancer progression|1|||
155269236|NCT03066622|560419085|FG000|Overall Study|Lost to Follow-up|24|||
155269237|NCT03066622|560419086|FG001|Overall Study|Lost to Follow-up|25|||
155269238|NCT03066622|560419085|FG000|Overall Study|Withdrawal by Subject|2|||
155269239|NCT03066622|560419086|FG001|Overall Study|Withdrawal by Subject|1|||
155269240|NCT04741802|560419087|FG000|Overall Study|Death|1|||
155269241|NCT04741802|560419087|FG000|Overall Study|Lost to Follow-up|11|||
155269242|NCT03101241|560419088|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
155269243|NCT03101241|560419089|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
155269244|NCT03101241|560419088|FG000|Overall Study|Participant withdrew consent|3|||
155269245|NCT03101241|560419089|FG001|Overall Study|Participant withdrew consent|1|||
155269246|NCT03101241|560419088|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
155269247|NCT03101241|560419089|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
155269248|NCT03101241|560419088|FG000|Overall Study|Lost to Follow-up|2|||
155269249|NCT03101241|560419089|FG001|Overall Study|Lost to Follow-up|0|||
155269250|NCT03101241|560419088|FG000|Overall Study|Lack of Efficacy|0|||
155269251|NCT03101241|560419089|FG001|Overall Study|Lack of Efficacy|1|||
155269252|NCT03101241|560419088|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
155269253|NCT03101241|560419089|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
155269254|NCT00692406|560419090|FG000|Overall Study|PI dropped, bad data|57|||
155269255|NCT02597933|560419091|FG000|Overall Study|Withdrawal by Subject|7|||
155269256|NCT02597933|560419092|FG001|Overall Study|Withdrawal by Subject|5|||
155269257|NCT02597933|560419091|FG000|Overall Study|Protocol Violation|2|||
155269258|NCT02597933|560419092|FG001|Overall Study|Protocol Violation|2|||
155269259|NCT02597933|560419091|FG000|Overall Study|Adverse Event|20|||
155269260|NCT02597933|560419092|FG001|Overall Study|Adverse Event|28|||
155269261|NCT02597933|560419091|FG000|Overall Study|Not treated|2|||
155269262|NCT02597933|560419092|FG001|Overall Study|Not treated|2|||
155269263|NCT02597933|560419091|FG000|Overall Study|Other than stated above|7|||
155269264|NCT02597933|560419092|FG001|Overall Study|Other than stated above|14|||
155269265|NCT01617005|560419095|FG000|Overall Study|Pregnancy|1|||
155269266|NCT01617005|560419095|FG000|Overall Study|Lack of motivation for treatment|1|||
155269267|NCT01320735|560419099|FG000|Overall Study|Adverse Event|3|||
155269268|NCT01320735|560419099|FG000|Overall Study|Withdrawal by Subject|3|||
155269269|NCT01320735|560419099|FG000|Overall Study|Lost to Follow-up|13|||
155269270|NCT01320735|560419099|FG000|Overall Study|Administrative Reason|6|||
155269271|NCT01320735|560419099|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
155269272|NCT01320735|560419099|FG000|Overall Study|Protocol Violation|1|||
155269273|NCT01320735|560419099|FG000|Overall Study|Other|1|||
155269274|NCT01320735|560419099|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
155269275|NCT01320735|560419099|FG000|Overall Study|Investigator Unable to be Contacted|17|||
155269276|NCT04599101|560419100|FG000|Overall Study|Lost to Follow-up|5|||
155269277|NCT04599101|560419101|FG001|Overall Study|Lost to Follow-up|5|||
155269278|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
155269279|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
155269280|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
155269281|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
155269282|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
155269283|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
155269284|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
155269285|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
155269286|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
155269287|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
155269288|NCT02307513|560419102|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
155269289|NCT02307513|560419103|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
155269290|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
155269291|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
155269292|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
155269293|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
155269294|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
155269295|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
155269296|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
155269297|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
155269298|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
155269299|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
155269300|NCT02307513|560419102|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
155269301|NCT02307513|560419103|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
155269302|NCT02307513|560419102|FG000|Long-term Extension|Physician Decision|1|||
155269303|NCT02307513|560419103|FG001|Long-term Extension|Physician Decision|0|||
155269304|NCT05952297|560419104|FG000|Overall Study|Withdrawal by Subject|1|||
155269305|NCT05952297|560419105|FG001|Overall Study|Withdrawal by Subject|0|||
155269306|NCT00284089|560419108|FG000|Multiple Dose Phase|Adverse Event|1|||
155269307|NCT00284089|560419109|FG001|Multiple Dose Phase|Adverse Event|0|||
155269308|NCT00284089|560419110|FG002|Multiple Dose Phase|Adverse Event|1|||
154931547|NCT01901146|559175107|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
154931548|NCT00297492|559175108|FG000|Set Quit Date|Lost to Follow-up|7|||
154931549|NCT00297492|559175109|FG001|Set Quit Date|Lost to Follow-up|13|||
154931550|NCT00297492|559175110|FG002|Set Quit Date|Lost to Follow-up|5|||
154931551|NCT00297492|559175108|FG000|6 Month Follow-up|Lost to Follow-up|63|||
154931552|NCT00297492|559175109|FG001|6 Month Follow-up|Lost to Follow-up|49|||
154931553|NCT00297492|559175110|FG002|6 Month Follow-up|Lost to Follow-up|27|||
154931554|NCT02675426|559175111|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
154931555|NCT02675426|559175112|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
154931556|NCT02675426|559175113|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
154931557|NCT02675426|559175114|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
154931558|NCT02675426|559175111|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
154931559|NCT02675426|559175112|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
154931560|NCT02675426|559175113|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
154931561|NCT02675426|559175114|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
154931562|NCT02675426|559175111|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
154931563|NCT02675426|559175112|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
154931564|NCT02675426|559175113|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
154931565|NCT02675426|559175114|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
154931566|NCT02675426|559175111|FG000|Period 1: Week 1 to Week 12|Other|2|||
154931567|NCT02675426|559175112|FG001|Period 1: Week 1 to Week 12|Other|1|||
154931568|NCT02675426|559175113|FG002|Period 1: Week 1 to Week 12|Other|0|||
154931569|NCT02675426|559175114|FG003|Period 1: Week 1 to Week 12|Other|2|||
154931570|NCT02675426|559175111|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
154931571|NCT02675426|559175112|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
154931572|NCT02675426|559175113|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
154931573|NCT02675426|559175114|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
154931574|NCT02675426|559175111|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
154931575|NCT02675426|559175112|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
154931576|NCT02675426|559175113|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
154931577|NCT02675426|559175114|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
154931578|NCT02675426|559175111|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
154931579|NCT02675426|559175112|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
154931580|NCT02675426|559175113|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
154931581|NCT02675426|559175114|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
154931582|NCT02675426|559175111|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
154931583|NCT02675426|559175112|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
154931584|NCT02675426|559175113|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
154931585|NCT02675426|559175114|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
154931586|NCT02675426|559175111|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
154931587|NCT02675426|559175112|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
154931588|NCT02675426|559175113|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
154931589|NCT02675426|559175114|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
154931590|NCT02675426|559175111|FG000|Period 2: Week 12 to Week 260|Other|8|||
154931591|NCT02675426|559175112|FG001|Period 2: Week 12 to Week 260|Other|12|||
154931592|NCT02675426|559175113|FG002|Period 2: Week 12 to Week 260|Other|23|||
154931593|NCT02675426|559175114|FG003|Period 2: Week 12 to Week 260|Other|15|||
154931594|NCT03724968|559175115|FG000|Overall Study|Insurance issues|0|||
154931595|NCT03724968|559175116|FG001|Overall Study|Insurance issues|1|||
154931596|NCT03724968|559175115|FG000|Overall Study|Study closed|0|||
154931597|NCT03724968|559175116|FG001|Overall Study|Study closed|1|||
154931598|NCT01858558|559175117|FG000|Overall Study|Death|1|||
154931599|NCT01858558|559175118|FG001|Overall Study|Death|1|||
154931600|NCT01858558|559175117|FG000|Overall Study|Lost to Follow-up|1|||
154931601|NCT01858558|559175118|FG001|Overall Study|Lost to Follow-up|0|||
154931602|NCT01858558|559175117|FG000|Overall Study|Disease progression|3|||
154931603|NCT01858558|559175118|FG001|Overall Study|Disease progression|1|||
154931604|NCT01858558|559175117|FG000|Overall Study|Product contamination|2|||
154931605|NCT01858558|559175118|FG001|Overall Study|Product contamination|0|||
154931606|NCT01858558|559175117|FG000|Overall Study|Failed expansion of cell product|2|||
154931607|NCT01858558|559175118|FG001|Overall Study|Failed expansion of cell product|0|||
154931608|NCT01336608|559175119|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
154931609|NCT01336608|559175120|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
154931610|NCT01336608|559175121|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
154931611|NCT01336608|559175122|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
154931612|NCT01336608|559175119|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
154931613|NCT01336608|559175120|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
154931614|NCT01336608|559175121|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
154931615|NCT01336608|559175122|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
154931616|NCT01336608|559175119|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
155269309|NCT00284089|560419111|FG003|Multiple Dose Phase|Adverse Event|1|||
155269310|NCT00284089|560419108|FG000|Multiple Dose Phase|Protocol Violation|0|||
155269311|NCT00284089|560419109|FG001|Multiple Dose Phase|Protocol Violation|0|||
155269312|NCT00284089|560419110|FG002|Multiple Dose Phase|Protocol Violation|1|||
155269313|NCT00284089|560419111|FG003|Multiple Dose Phase|Protocol Violation|0|||
155269314|NCT00284089|560419108|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
155269315|NCT00284089|560419109|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
155269316|NCT00284089|560419110|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
155269317|NCT00284089|560419111|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
155269318|NCT00284089|560419108|FG000|Multiple Dose Phase|Death|0|||
155269319|NCT00284089|560419109|FG001|Multiple Dose Phase|Death|0|||
155269320|NCT00284089|560419110|FG002|Multiple Dose Phase|Death|1|||
155269321|NCT00284089|560419111|FG003|Multiple Dose Phase|Death|1|||
155269322|NCT00284089|560419108|FG000|Extension Phase|Adverse Event|0|||
155269323|NCT00284089|560419109|FG001|Extension Phase|Adverse Event|0|||
155269324|NCT00284089|560419110|FG002|Extension Phase|Adverse Event|2|||
155269325|NCT00284089|560419111|FG003|Extension Phase|Adverse Event|2|||
155269326|NCT00284089|560419108|FG000|Extension Phase|condition no longer requires study drug|2|||
155269327|NCT00284089|560419109|FG001|Extension Phase|condition no longer requires study drug|0|||
155269328|NCT00284089|560419110|FG002|Extension Phase|condition no longer requires study drug|2|||
155269329|NCT00284089|560419111|FG003|Extension Phase|condition no longer requires study drug|7|||
155269330|NCT00284089|560419108|FG000|Extension Phase|Protocol Violation|0|||
155269331|NCT00284089|560419109|FG001|Extension Phase|Protocol Violation|0|||
155269332|NCT00284089|560419110|FG002|Extension Phase|Protocol Violation|1|||
155269333|NCT00284089|560419111|FG003|Extension Phase|Protocol Violation|0|||
155269334|NCT00284089|560419108|FG000|Extension Phase|Withdrawal by Subject|0|||
155269335|NCT00284089|560419109|FG001|Extension Phase|Withdrawal by Subject|0|||
155269336|NCT00284089|560419110|FG002|Extension Phase|Withdrawal by Subject|1|||
155269337|NCT00284089|560419111|FG003|Extension Phase|Withdrawal by Subject|3|||
155269338|NCT02759185|560419113|FG000|Stage 1|Adverse Event|0|||
155269339|NCT02759185|560419114|FG001|Stage 1|Adverse Event|1|||
155269340|NCT02759185|560419115|FG002|Stage 1|Adverse Event|3|||
155269341|NCT02759185|560419116|FG003|Stage 1|Adverse Event|0|||
155269342|NCT02759185|560419117|FG004|Stage 1|Adverse Event|0|||
155269343|NCT02759185|560419118|FG005|Stage 1|Adverse Event|0|||
155269344|NCT02759185|560419119|FG006|Stage 1|Adverse Event|0|||
155269345|NCT02759185|560419113|FG000|Stage 1|Withdrawal by Subject|1|||
155269346|NCT02759185|560419114|FG001|Stage 1|Withdrawal by Subject|0|||
155269347|NCT02759185|560419115|FG002|Stage 1|Withdrawal by Subject|0|||
155269348|NCT02759185|560419116|FG003|Stage 1|Withdrawal by Subject|0|||
155269349|NCT02759185|560419117|FG004|Stage 1|Withdrawal by Subject|0|||
155269350|NCT02759185|560419118|FG005|Stage 1|Withdrawal by Subject|0|||
155269351|NCT02759185|560419119|FG006|Stage 1|Withdrawal by Subject|0|||
155269352|NCT02759185|560419113|FG000|Stage 2|Adverse Event|0|||
155269353|NCT02759185|560419114|FG001|Stage 2|Adverse Event|0|||
155269354|NCT02759185|560419115|FG002|Stage 2|Adverse Event|0|||
155269355|NCT02759185|560419116|FG003|Stage 2|Adverse Event|0|||
155269356|NCT02759185|560419117|FG004|Stage 2|Adverse Event|1|||
155269357|NCT02759185|560419118|FG005|Stage 2|Adverse Event|2|||
155269358|NCT02759185|560419119|FG006|Stage 2|Adverse Event|0|||
155269359|NCT02759185|560419113|FG000|Stage 2|Withdrawal by Subject|0|||
155269360|NCT02759185|560419114|FG001|Stage 2|Withdrawal by Subject|0|||
155269361|NCT02759185|560419115|FG002|Stage 2|Withdrawal by Subject|0|||
155269362|NCT02759185|560419116|FG003|Stage 2|Withdrawal by Subject|0|||
155269363|NCT02759185|560419117|FG004|Stage 2|Withdrawal by Subject|1|||
155269364|NCT02759185|560419118|FG005|Stage 2|Withdrawal by Subject|1|||
155269365|NCT02759185|560419119|FG006|Stage 2|Withdrawal by Subject|1|||
154931617|NCT01336608|559175120|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
154931618|NCT01336608|559175121|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
154931619|NCT01336608|559175122|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
154931620|NCT01336608|559175119|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
154931621|NCT01336608|559175120|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
154931622|NCT01336608|559175121|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
154931623|NCT01336608|559175122|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
154931624|NCT01336608|559175119|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
154931625|NCT01336608|559175120|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
154931626|NCT01336608|559175121|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155269366|NCT02234063|560419120|FG000|Overall Study|Lost to Follow-up|235|||
155269367|NCT02234063|560419121|FG001|Overall Study|Lost to Follow-up|42|||
154931627|NCT01336608|559175122|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155043017|NCT00401193|559590037|FG000|Overall Study|Adverse Event|1|||
155269368|NCT02234063|560419120|FG000|Overall Study|Withdrawal by Subject|20|||
155269369|NCT02234063|560419121|FG001|Overall Study|Withdrawal by Subject|1|||
155269370|NCT02781506|560420685|FG000|Overall Study|Adverse Event|5|||
154931628|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155269371|NCT00437125|560420686|FG000|Overall Study|Adverse Event|12|||
155269372|NCT00437125|560420686|FG000|Overall Study|Death|1|||
155269373|NCT00437125|560420686|FG000|Overall Study|Clinical Relapse|1|||
155269374|NCT00437125|560420686|FG000|Overall Study|Lack of Efficacy|1|||
155269375|NCT00437125|560420686|FG000|Overall Study|Lost to Follow-up|1|||
155269376|NCT00437125|560420686|FG000|Overall Study|Withdrawal by Subject|13|||
155269377|NCT00437125|560420686|FG000|Overall Study|Withdrawal by Caregiver|2|||
155269378|NCT00437125|560420686|FG000|Overall Study|Physician Decision|1|||
155269379|NCT02248961|560420687|FG000|Overall Study|Adverse Event|1|||
155269380|NCT02248961|560420688|FG001|Overall Study|Adverse Event|0|||
155269381|NCT02248961|560420687|FG000|Overall Study|Withdrawal by Subject|1|||
155269382|NCT02248961|560420688|FG001|Overall Study|Withdrawal by Subject|2|||
155269383|NCT02248961|560420687|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
155269384|NCT02248961|560420688|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
155269385|NCT02802319|560420694|FG000|Overall Study|Physician Decision|2|||
155269386|NCT02802319|560420695|FG001|Overall Study|Physician Decision|1|||
155269387|NCT02802319|560420694|FG000|Overall Study|Lost to Follow-up|0|||
155269388|NCT02802319|560420695|FG001|Overall Study|Lost to Follow-up|4|||
155269389|NCT04651114|560420696|FG000|Overall Study|Withdrawal by Subject|8|||
155269390|NCT00235443|560420701|FG000|Overall Study|Adverse Event|4|||
155269391|NCT00235443|560420702|FG001|Overall Study|Adverse Event|12|||
155269392|NCT00235443|560420703|FG002|Overall Study|Adverse Event|17|||
155269393|NCT00235443|560420704|FG003|Overall Study|Adverse Event|44|||
155269394|NCT00235443|560420705|FG004|Overall Study|Adverse Event|10|||
155269395|NCT00235443|560420706|FG005|Overall Study|Adverse Event|15|||
155269396|NCT00235443|560420701|FG000|Overall Study|Lack of Efficacy|0|||
155269397|NCT00235443|560420702|FG001|Overall Study|Lack of Efficacy|1|||
155269398|NCT00235443|560420703|FG002|Overall Study|Lack of Efficacy|5|||
155269399|NCT00235443|560420704|FG003|Overall Study|Lack of Efficacy|12|||
155269400|NCT00235443|560420705|FG004|Overall Study|Lack of Efficacy|2|||
155269401|NCT00235443|560420706|FG005|Overall Study|Lack of Efficacy|9|||
155269402|NCT00235443|560420701|FG000|Overall Study|Withdrawal by Subject|3|||
155269403|NCT00235443|560420702|FG001|Overall Study|Withdrawal by Subject|9|||
155269404|NCT00235443|560420703|FG002|Overall Study|Withdrawal by Subject|25|||
155269405|NCT00235443|560420704|FG003|Overall Study|Withdrawal by Subject|24|||
155269406|NCT00235443|560420705|FG004|Overall Study|Withdrawal by Subject|10|||
155269407|NCT00235443|560420706|FG005|Overall Study|Withdrawal by Subject|12|||
155269408|NCT00235443|560420701|FG000|Overall Study|Lost to Follow-up|0|||
155269409|NCT00235443|560420702|FG001|Overall Study|Lost to Follow-up|8|||
155269410|NCT00235443|560420703|FG002|Overall Study|Lost to Follow-up|6|||
155269411|NCT00235443|560420704|FG003|Overall Study|Lost to Follow-up|6|||
155269412|NCT00235443|560420705|FG004|Overall Study|Lost to Follow-up|4|||
155269413|NCT00235443|560420706|FG005|Overall Study|Lost to Follow-up|3|||
155269414|NCT00235443|560420701|FG000|Overall Study|Unsatisfactory compliance|0|||
155269415|NCT00235443|560420702|FG001|Overall Study|Unsatisfactory compliance|2|||
155269416|NCT00235443|560420703|FG002|Overall Study|Unsatisfactory compliance|3|||
155269417|NCT00235443|560420704|FG003|Overall Study|Unsatisfactory compliance|4|||
155269418|NCT00235443|560420705|FG004|Overall Study|Unsatisfactory compliance|1|||
155269419|NCT00235443|560420706|FG005|Overall Study|Unsatisfactory compliance|0|||
155269420|NCT00235443|560420701|FG000|Overall Study|Other reasons for premature termination|1|||
155269421|NCT00235443|560420702|FG001|Overall Study|Other reasons for premature termination|6|||
155269422|NCT00235443|560420703|FG002|Overall Study|Other reasons for premature termination|6|||
155269423|NCT00235443|560420704|FG003|Overall Study|Other reasons for premature termination|7|||
155269424|NCT00235443|560420705|FG004|Overall Study|Other reasons for premature termination|3|||
155269425|NCT00235443|560420706|FG005|Overall Study|Other reasons for premature termination|6|||
155269426|NCT01763788|560420711|FG000|Overall Study|Lost to Follow-up|0|||
155269427|NCT01763788|560420712|FG001|Overall Study|Lost to Follow-up|0|||
155269428|NCT01763788|560420713|FG002|Overall Study|Lost to Follow-up|1|||
155269429|NCT01763788|560420714|FG003|Overall Study|Lost to Follow-up|0|||
155269430|NCT03321006|560420715|FG000|Overall Study|Death|1|||
155269431|NCT03321006|560420716|FG001|Overall Study|Death|0|||
155269432|NCT03321006|560420715|FG000|Overall Study|Lack of Efficacy|1|||
155269433|NCT03321006|560420716|FG001|Overall Study|Lack of Efficacy|0|||
155269434|NCT03303469|560420717|FG000|Overall Study|Lost to Follow-up|2|||
155269435|NCT03560258|560420720|FG000|Overall Study|Lost to Follow-up|3|||
155269436|NCT03560258|560420721|FG001|Overall Study|Lost to Follow-up|0|||
155269437|NCT03560258|560420722|FG002|Overall Study|Lost to Follow-up|0|||
155269438|NCT03560258|560420720|FG000|Overall Study|Protocol Violation|0|||
155269439|NCT03560258|560420721|FG001|Overall Study|Protocol Violation|1|||
155269440|NCT03560258|560420722|FG002|Overall Study|Protocol Violation|0|||
155269441|NCT03560258|560420720|FG000|Overall Study|Withdrawal by Subject|0|||
155269442|NCT03560258|560420721|FG001|Overall Study|Withdrawal by Subject|0|||
155269443|NCT03560258|560420722|FG002|Overall Study|Withdrawal by Subject|1|||
155269444|NCT01460160|560420723|FG000|Treatment Phase|Lack of Efficacy|3|||
155269445|NCT01460160|560420723|FG000|Treatment Phase|Study Drug Toxicity|2|||
155269446|NCT01460160|560420723|FG000|Treatment Phase|Adverse Event|8|||
155269447|NCT01460160|560420723|FG000|Treatment Phase|Withdrawal by Subject|4|||
155269448|NCT01460160|560420723|FG000|Treatment Phase|Death|2|||
155269449|NCT01460160|560420723|FG000|Treatment Phase|Other reasons|9|||
155269450|NCT01460160|560420723|FG000|Follow-up Phase|Withdrawal by Subject|4|||
155269451|NCT01460160|560420723|FG000|Follow-up Phase|Death|14|||
155269452|NCT01460160|560420723|FG000|Follow-up Phase|Lost to Follow-up|7|||
155269453|NCT01460160|560420723|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
155269454|NCT01460160|560420723|FG000|Follow-up Phase|Other and not reported reasons|5|||
155269455|NCT03893825|560420724|FG000|Overall Study|Death|2|||
155269456|NCT03893825|560420725|FG001|Overall Study|Death|1|||
155269457|NCT03893825|560420724|FG000|Overall Study|Adverse Event|0|||
155269458|NCT03893825|560420725|FG001|Overall Study|Adverse Event|2|||
155269459|NCT03893825|560420724|FG000|Overall Study|Withdrawal by Subject|19|||
155269460|NCT03893825|560420725|FG001|Overall Study|Withdrawal by Subject|21|||
155269461|NCT03893825|560420724|FG000|Overall Study|Protocol deviation|1|||
155269462|NCT03893825|560420725|FG001|Overall Study|Protocol deviation|0|||
155269463|NCT03893825|560420724|FG000|Overall Study|Lost to Follow-up|10|||
155269464|NCT03893825|560420725|FG001|Overall Study|Lost to Follow-up|10|||
155269465|NCT03893825|560420724|FG000|Overall Study|Other than specified|7|||
155269466|NCT03893825|560420725|FG001|Overall Study|Other than specified|6|||
155269467|NCT02006121|560420729|FG000|Double Blind Phase|Adverse Event|6|||
155269468|NCT02006121|560420730|FG001|Double Blind Phase|Adverse Event|0|||
155269469|NCT02006121|560420729|FG000|Double Blind Phase|Lack of Efficacy|1|||
155269470|NCT02006121|560420730|FG001|Double Blind Phase|Lack of Efficacy|16|||
155269471|NCT02006121|560420729|FG000|Double Blind Phase|Withdrawal by Subject|3|||
155269472|NCT02006121|560420730|FG001|Double Blind Phase|Withdrawal by Subject|4|||
155269473|NCT02006121|560420729|FG000|Double Blind Phase|Non-compliance with study drug|1|||
155269474|NCT02006121|560420730|FG001|Double Blind Phase|Non-compliance with study drug|3|||
155269475|NCT02006121|560420729|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
155269476|NCT02006121|560420730|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
155269477|NCT02006121|560420729|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
155269478|NCT02006121|560420730|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
155269479|NCT02006121|560420729|FG000|Open Label Phase|Adverse Event|15|||
155269480|NCT02006121|560420730|FG001|Open Label Phase|Adverse Event|0|||
155269481|NCT02006121|560420729|FG000|Open Label Phase|Lack of Efficacy|2|||
155269482|NCT02006121|560420730|FG001|Open Label Phase|Lack of Efficacy|0|||
155269483|NCT02006121|560420729|FG000|Open Label Phase|Protocol Violation|2|||
155269484|NCT02006121|560420730|FG001|Open Label Phase|Protocol Violation|0|||
155269485|NCT02006121|560420729|FG000|Open Label Phase|Withdrawal by Subject|3|||
155269486|NCT02006121|560420730|FG001|Open Label Phase|Withdrawal by Subject|0|||
155269487|NCT02006121|560420729|FG000|Open Label Phase|Non-compliance with study drug|3|||
155269488|NCT02006121|560420730|FG001|Open Label Phase|Non-compliance with study drug|0|||
155269489|NCT04498247|560420734|FG000|Overall Study|Lost to Follow-up|0|||
155269490|NCT04498247|560420735|FG001|Overall Study|Lost to Follow-up|0|||
155269491|NCT04498247|560420736|FG002|Overall Study|Lost to Follow-up|0|||
155269492|NCT04498247|560420737|FG003|Overall Study|Lost to Follow-up|1|||
155269493|NCT04498247|560420738|FG004|Overall Study|Lost to Follow-up|0|||
155269494|NCT04498247|560420739|FG005|Overall Study|Lost to Follow-up|0|||
155269495|NCT04498247|560420740|FG006|Overall Study|Lost to Follow-up|0|||
155269496|NCT04498247|560420741|FG007|Overall Study|Lost to Follow-up|0|||
155269497|NCT04498247|560420734|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
155269498|NCT04498247|560420735|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269499|NCT04498247|560420736|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269500|NCT04498247|560420737|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269501|NCT04498247|560420738|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269502|NCT04498247|560420739|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269503|NCT04498247|560420740|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269504|NCT04498247|560420741|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
155269505|NCT04498247|560420734|FG000|Overall Study|Withdrawal by Subject|0|||
155269506|NCT04498247|560420735|FG001|Overall Study|Withdrawal by Subject|8|||
155269507|NCT04498247|560420736|FG002|Overall Study|Withdrawal by Subject|0|||
155269508|NCT04498247|560420737|FG003|Overall Study|Withdrawal by Subject|7|||
155269509|NCT04498247|560420738|FG004|Overall Study|Withdrawal by Subject|0|||
155269510|NCT04498247|560420739|FG005|Overall Study|Withdrawal by Subject|0|||
155269511|NCT04498247|560420740|FG006|Overall Study|Withdrawal by Subject|1|||
155269512|NCT04498247|560420741|FG007|Overall Study|Withdrawal by Subject|0|||
154931629|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
154931630|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
155269513|NCT04498247|560420734|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269514|NCT04498247|560420735|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
155269515|NCT04498247|560420736|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269516|NCT04498247|560420737|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
155269517|NCT04498247|560420738|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269518|NCT04498247|560420739|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269519|NCT04498247|560420740|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
154931631|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
155269520|NCT04498247|560420741|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
155269521|NCT00669903|560420742|FG000|Overall Study|Adverse Event|0|||
155269522|NCT00669903|560420743|FG001|Overall Study|Adverse Event|1|||
155269523|NCT00669903|560420744|FG002|Overall Study|Adverse Event|3|||
155269524|NCT00669903|560420745|FG003|Overall Study|Adverse Event|1|||
155269525|NCT00669903|560420742|FG000|Overall Study|Withdrawal by Subject|0|||
155269526|NCT00669903|560420743|FG001|Overall Study|Withdrawal by Subject|2|||
155269527|NCT00669903|560420744|FG002|Overall Study|Withdrawal by Subject|2|||
155269528|NCT00669903|560420745|FG003|Overall Study|Withdrawal by Subject|2|||
155269529|NCT00669903|560420742|FG000|Overall Study|Lost to Follow-up|1|||
155269530|NCT00669903|560420743|FG001|Overall Study|Lost to Follow-up|1|||
155269531|NCT00669903|560420744|FG002|Overall Study|Lost to Follow-up|0|||
155269532|NCT00669903|560420745|FG003|Overall Study|Lost to Follow-up|1|||
155269533|NCT00669903|560420742|FG000|Overall Study|Protocol Violation|0|||
155269534|NCT00669903|560420743|FG001|Overall Study|Protocol Violation|1|||
155269535|NCT00669903|560420744|FG002|Overall Study|Protocol Violation|0|||
155269536|NCT00669903|560420745|FG003|Overall Study|Protocol Violation|0|||
155269537|NCT04488003|560420751|FG000|Assessed for Eligibility|Screen Failure|24|||
155269538|NCT04488003|560420752|FG001|Assessed for Eligibility|Screen Failure|0|||
155269539|NCT04488003|560420753|FG002|Assessed for Eligibility|Screen Failure|0|||
155269540|NCT04488003|560420751|FG000|Assessed for Eligibility|Adverse Event|1|||
155269541|NCT04488003|560420752|FG001|Assessed for Eligibility|Adverse Event|0|||
155269542|NCT04488003|560420753|FG002|Assessed for Eligibility|Adverse Event|0|||
155269543|NCT04488003|560420751|FG000|Assessed for Eligibility|Death|1|||
155269544|NCT04488003|560420752|FG001|Assessed for Eligibility|Death|0|||
155269545|NCT04488003|560420753|FG002|Assessed for Eligibility|Death|0|||
155269546|NCT04488003|560420751|FG000|Assessed for Eligibility|Physician Decision|1|||
155269547|NCT04488003|560420752|FG001|Assessed for Eligibility|Physician Decision|0|||
155269548|NCT04488003|560420753|FG002|Assessed for Eligibility|Physician Decision|0|||
155269549|NCT04488003|560420751|FG000|Allocated to Treatment|Progressive Disease|51|||
155269550|NCT04488003|560420752|FG001|Allocated to Treatment|Progressive Disease|0|||
155269551|NCT04488003|560420753|FG002|Allocated to Treatment|Progressive Disease|0|||
155269552|NCT04488003|560420751|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
155269553|NCT04488003|560420752|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
155269554|NCT04488003|560420753|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
155269555|NCT04488003|560420751|FG000|Allocated to Treatment|Adverse Event|6|||
155269556|NCT04488003|560420752|FG001|Allocated to Treatment|Adverse Event|0|||
155269557|NCT04488003|560420753|FG002|Allocated to Treatment|Adverse Event|0|||
155269558|NCT04488003|560420751|FG000|Allocated to Treatment|Other|5|||
155269559|NCT04488003|560420752|FG001|Allocated to Treatment|Other|0|||
155269560|NCT04488003|560420753|FG002|Allocated to Treatment|Other|0|||
155269561|NCT04488003|560420751|FG000|Allocated to Treatment|Physician Decision|4|||
155269562|NCT04488003|560420752|FG001|Allocated to Treatment|Physician Decision|0|||
155269563|NCT04488003|560420753|FG002|Allocated to Treatment|Physician Decision|0|||
155269564|NCT04488003|560420751|FG000|Allocated to Treatment|Death|4|||
155269565|NCT04488003|560420752|FG001|Allocated to Treatment|Death|0|||
155269566|NCT04488003|560420753|FG002|Allocated to Treatment|Death|0|||
155269567|NCT01737996|560420754|FG000|Overall Study|Adverse Event|0|||
155269568|NCT01737996|560420755|FG001|Overall Study|Adverse Event|1|||
155269569|NCT01737996|560420756|FG002|Overall Study|Adverse Event|1|||
155269570|NCT01737996|560420754|FG000|Overall Study|Withdrawal by Subject|0|||
155269571|NCT01737996|560420755|FG001|Overall Study|Withdrawal by Subject|0|||
155269572|NCT01737996|560420756|FG002|Overall Study|Withdrawal by Subject|1|||
155269573|NCT01248962|560420759|FG000|Overall Study|Withdrawal by Subject|1|||
155269574|NCT01248962|560420760|FG001|Overall Study|Withdrawal by Subject|1|||
155269575|NCT01248962|560420759|FG000|Overall Study|Adverse Event|2|||
155269576|NCT01248962|560420760|FG001|Overall Study|Adverse Event|1|||
155269577|NCT01248962|560420759|FG000|Overall Study|Complete Response after 4 Cycles|1|||
155269578|NCT01248962|560420760|FG001|Overall Study|Complete Response after 4 Cycles|0|||
155269579|NCT01248962|560420759|FG000|Overall Study|Complete Response after 3 Cycles|0|||
155269580|NCT01248962|560420760|FG001|Overall Study|Complete Response after 3 Cycles|1|||
155269581|NCT01248962|560420759|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
155269582|NCT01248962|560420760|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
155269583|NCT00245856|560420762|FG000|Period Two|Withdrawal by Subject|0|||
155269584|NCT00245856|560420763|FG001|Period Two|Withdrawal by Subject|1|||
155269585|NCT01003184|560420764|FG000|Overall Study|Adverse Event|12|||
155381739|NCT04617275|560830988|FG004|Follow-up Period|Lost to Follow-up|0|||
155269586|NCT01003184|560420765|FG001|Overall Study|Adverse Event|5|||
155269587|NCT01003184|560420764|FG000|Overall Study|Lost to Follow-up|1|||
155269588|NCT01003184|560420765|FG001|Overall Study|Lost to Follow-up|0|||
155269589|NCT01003184|560420764|FG000|Overall Study|Loss of glucose control|1|||
155269590|NCT01003184|560420765|FG001|Overall Study|Loss of glucose control|1|||
155269591|NCT01003184|560420764|FG000|Overall Study|Protocol Violation|3|||
155269592|NCT01003184|560420765|FG001|Overall Study|Protocol Violation|0|||
155269593|NCT01003184|560420764|FG000|Overall Study|Withdrawal by Subject|1|||
155269594|NCT01003184|560420765|FG001|Overall Study|Withdrawal by Subject|6|||
155269595|NCT01003184|560420764|FG000|Overall Study|Physician Decision|1|||
155043018|NCT00401193|559590038|FG001|Overall Study|Adverse Event|3|||
155269596|NCT01003184|560420765|FG001|Overall Study|Physician Decision|0|||
155269597|NCT00557622|560420766|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
155269598|NCT00557622|560420767|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
155269599|NCT00557622|560420766|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
155269600|NCT00557622|560420767|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
155269601|NCT00557622|560420766|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
155269602|NCT00557622|560420767|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
155269603|NCT01468922|560420768|FG000|Overall Study|Screening failure|0|||
155269604|NCT01468922|560420769|FG001|Overall Study|Screening failure|0|||
155269605|NCT01468922|560420770|FG002|Overall Study|Screening failure|0|||
155269606|NCT01468922|560420771|FG003|Overall Study|Screening failure|0|||
155269607|NCT01468922|560420772|FG004|Overall Study|Screening failure|0|||
154931632|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155269608|NCT01468922|560420773|FG005|Overall Study|Screening failure|0|||
155269609|NCT01468922|560420774|FG006|Overall Study|Screening failure|0|||
155269610|NCT01468922|560420775|FG007|Overall Study|Screening failure|0|||
155269611|NCT01468922|560420776|FG008|Overall Study|Screening failure|1|||
155269612|NCT01468922|560420768|FG000|Overall Study|Per patient choice|1|||
155269613|NCT01468922|560420769|FG001|Overall Study|Per patient choice|0|||
155269614|NCT01468922|560420770|FG002|Overall Study|Per patient choice|0|||
155269615|NCT01468922|560420771|FG003|Overall Study|Per patient choice|0|||
155269616|NCT01468922|560420772|FG004|Overall Study|Per patient choice|0|||
155269617|NCT01468922|560420773|FG005|Overall Study|Per patient choice|0|||
155269618|NCT01468922|560420774|FG006|Overall Study|Per patient choice|0|||
155269619|NCT01468922|560420775|FG007|Overall Study|Per patient choice|0|||
155269620|NCT01468922|560420776|FG008|Overall Study|Per patient choice|0|||
155269621|NCT01468922|560420768|FG000|Overall Study|Switched to alternative treatment|1|||
155269622|NCT01468922|560420769|FG001|Overall Study|Switched to alternative treatment|0|||
155269623|NCT01468922|560420770|FG002|Overall Study|Switched to alternative treatment|0|||
155269624|NCT01468922|560420771|FG003|Overall Study|Switched to alternative treatment|0|||
155269625|NCT01468922|560420772|FG004|Overall Study|Switched to alternative treatment|1|||
155269626|NCT01468922|560420773|FG005|Overall Study|Switched to alternative treatment|0|||
155269627|NCT01468922|560420774|FG006|Overall Study|Switched to alternative treatment|0|||
155269628|NCT01468922|560420775|FG007|Overall Study|Switched to alternative treatment|0|||
155269629|NCT01468922|560420776|FG008|Overall Study|Switched to alternative treatment|0|||
155269630|NCT01468922|560420768|FG000|Overall Study|Enrolled on new protocol|0|||
155269631|NCT01468922|560420769|FG001|Overall Study|Enrolled on new protocol|0|||
155269632|NCT01468922|560420770|FG002|Overall Study|Enrolled on new protocol|0|||
155269633|NCT01468922|560420771|FG003|Overall Study|Enrolled on new protocol|0|||
155269634|NCT01468922|560420772|FG004|Overall Study|Enrolled on new protocol|1|||
155269635|NCT01468922|560420773|FG005|Overall Study|Enrolled on new protocol|0|||
155269636|NCT01468922|560420774|FG006|Overall Study|Enrolled on new protocol|0|||
155269637|NCT01468922|560420775|FG007|Overall Study|Enrolled on new protocol|0|||
155269638|NCT01468922|560420776|FG008|Overall Study|Enrolled on new protocol|0|||
155269639|NCT01468922|560420768|FG000|Overall Study|Adverse Event|0|||
155269640|NCT01468922|560420769|FG001|Overall Study|Adverse Event|0|||
155269641|NCT01468922|560420770|FG002|Overall Study|Adverse Event|0|||
155269642|NCT01468922|560420771|FG003|Overall Study|Adverse Event|0|||
155269643|NCT01468922|560420772|FG004|Overall Study|Adverse Event|0|||
155269644|NCT01468922|560420773|FG005|Overall Study|Adverse Event|0|||
155269645|NCT01468922|560420774|FG006|Overall Study|Adverse Event|0|||
155269646|NCT01468922|560420775|FG007|Overall Study|Adverse Event|1|||
155269647|NCT01468922|560420776|FG008|Overall Study|Adverse Event|0|||
155269648|NCT01468922|560420768|FG000|Overall Study|Infection of blood|0|||
155269649|NCT01468922|560420769|FG001|Overall Study|Infection of blood|0|||
155269650|NCT01468922|560420770|FG002|Overall Study|Infection of blood|0|||
155269651|NCT01468922|560420771|FG003|Overall Study|Infection of blood|0|||
155269652|NCT01468922|560420772|FG004|Overall Study|Infection of blood|0|||
154931633|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
154931634|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
154931635|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
154931636|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
155269653|NCT01468922|560420773|FG005|Overall Study|Infection of blood|0|||
155269654|NCT01468922|560420774|FG006|Overall Study|Infection of blood|0|||
155269655|NCT01468922|560420775|FG007|Overall Study|Infection of blood|1|||
155269656|NCT01468922|560420776|FG008|Overall Study|Infection of blood|0|||
155269657|NCT01468922|560420768|FG000|Overall Study|Patient choice - surgery|0|||
155269658|NCT01468922|560420769|FG001|Overall Study|Patient choice - surgery|0|||
155269659|NCT01468922|560420770|FG002|Overall Study|Patient choice - surgery|0|||
155269660|NCT01468922|560420771|FG003|Overall Study|Patient choice - surgery|0|||
155269661|NCT01468922|560420772|FG004|Overall Study|Patient choice - surgery|0|||
155269662|NCT01468922|560420773|FG005|Overall Study|Patient choice - surgery|0|||
155269663|NCT01468922|560420774|FG006|Overall Study|Patient choice - surgery|0|||
155269664|NCT01468922|560420775|FG007|Overall Study|Patient choice - surgery|1|||
155269665|NCT01468922|560420776|FG008|Overall Study|Patient choice - surgery|0|||
155269666|NCT01468922|560420768|FG000|Overall Study|Refused further treatment|0|||
155269667|NCT01468922|560420769|FG001|Overall Study|Refused further treatment|0|||
155269668|NCT01468922|560420770|FG002|Overall Study|Refused further treatment|0|||
155269669|NCT01468922|560420771|FG003|Overall Study|Refused further treatment|0|||
155269670|NCT01468922|560420772|FG004|Overall Study|Refused further treatment|0|||
155269671|NCT01468922|560420773|FG005|Overall Study|Refused further treatment|0|||
155269672|NCT01468922|560420774|FG006|Overall Study|Refused further treatment|0|||
155269673|NCT01468922|560420775|FG007|Overall Study|Refused further treatment|1|||
155269674|NCT01468922|560420776|FG008|Overall Study|Refused further treatment|0|||
155269675|NCT01923389|560420777|FG000|Overall Study|Protocol Violation|1|||
155269676|NCT01923389|560420778|FG001|Overall Study|Protocol Violation|0|||
155269677|NCT04848662|560420779|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
155269678|NCT04848662|560420780|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
155269679|NCT03237013|560420788|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
155269680|NCT03237013|560420789|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
155269681|NCT03237013|560420790|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
155269682|NCT00007475|560420793|FG000|Overall Study|Withdrawal by Subject|1|||
155269683|NCT00007475|560420794|FG001|Overall Study|Withdrawal by Subject|0|||
155269684|NCT00007475|560420795|FG002|Overall Study|Withdrawal by Subject|0|||
155269685|NCT00007475|560420796|FG003|Overall Study|Withdrawal by Subject|0|||
155269686|NCT00007475|560420793|FG000|Overall Study|Adverse Event|3|||
155269687|NCT00007475|560420794|FG001|Overall Study|Adverse Event|0|||
155269688|NCT00007475|560420795|FG002|Overall Study|Adverse Event|0|||
155269689|NCT00007475|560420796|FG003|Overall Study|Adverse Event|0|||
155269690|NCT01719224|560420797|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
155269691|NCT01719224|560420798|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
155269692|NCT00258440|560420799|FG000|Overall Study|Withdrawal by Subject|0|||
155269693|NCT00258440|560420800|FG001|Overall Study|Withdrawal by Subject|0|||
155269694|NCT00258440|560420801|FG002|Overall Study|Withdrawal by Subject|1|||
155269695|NCT00737061|560420802|FG000|Waiting Period|Lost to Follow-up|6|||
155269696|NCT00737061|560420802|FG000|Waiting Period|Withdrawal by Subject|1|||
155269697|NCT00737061|560420802|FG000|Waiting Period|Bilateral placement failure|34|||
155269698|NCT00737061|560420802|FG000|Waiting Period|Deemed patent following HSG|26|||
155269699|NCT00737061|560420802|FG000|Waiting Period|Alternative contraception failure|3|||
155269700|NCT00737061|560420802|FG000|Waiting Period|Elected surgical tubal ligation|5|||
155269701|NCT00737061|560420802|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
155269702|NCT00737061|560420802|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
155269703|NCT00737061|560420802|FG000|1 Year Wearing Period|Discontinued reilance|3|||
155269704|NCT00737061|560420802|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
155269705|NCT03000673|560420803|FG000|Overall Study|Withdrawal by Subject|1|||
155269706|NCT03000673|560420804|FG001|Overall Study|Withdrawal by Subject|0|||
155269707|NCT03000673|560420805|FG002|Overall Study|Withdrawal by Subject|0|||
155269708|NCT03000673|560420806|FG003|Overall Study|Withdrawal by Subject|0|||
155269709|NCT01512745|560420808|FG000|Overall Study|Adverse Event|22|||
155269710|NCT01512745|560420809|FG001|Overall Study|Adverse Event|3|||
155269711|NCT01512745|560420808|FG000|Overall Study|Death|9|||
155269712|NCT01512745|560420809|FG001|Overall Study|Death|13|||
155269713|NCT01512745|560420808|FG000|Overall Study|Withdrawal by Subject|2|||
155269714|NCT01512745|560420809|FG001|Overall Study|Withdrawal by Subject|2|||
155269715|NCT01512745|560420808|FG000|Overall Study|Lost to Follow-up|4|||
155269716|NCT01512745|560420809|FG001|Overall Study|Lost to Follow-up|0|||
155269717|NCT01512745|560420808|FG000|Overall Study|Lack of Efficacy|2|||
155269718|NCT01512745|560420809|FG001|Overall Study|Lack of Efficacy|2|||
155269719|NCT01512745|560420808|FG000|Overall Study|Protocol Violation|1|||
155269720|NCT01512745|560420809|FG001|Overall Study|Protocol Violation|0|||
155269721|NCT02357810|560420810|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
155269722|NCT02357810|560420810|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
155269723|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Adverse Event|5|||
155269724|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
155269725|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
155269726|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
155269727|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Death|1|||
155269728|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Physician Decision|1|||
155269729|NCT02357810|560420810|FG000|Reached 12 Weeks Response|Other|1|||
155269730|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
155269731|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
155269732|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
155269733|NCT02357810|560420810|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
155269734|NCT02357810|560420810|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
155269735|NCT02357810|560420810|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
155269736|NCT00562978|560420811|FG000|Overall Study|Patient had imaging dose only|1|||
155269737|NCT00562978|560420812|FG001|Overall Study|Patient had imaging dose only|11|||
155269738|NCT00152971|560420814|FG000|Overall Study|Adverse Event|12|||
155043019|NCT00401193|559590039|FG002|Overall Study|Adverse Event|1|||
155269739|NCT00152971|560420815|FG001|Overall Study|Adverse Event|10|||
155269740|NCT00152971|560420816|FG002|Overall Study|Adverse Event|9|||
155269741|NCT00152971|560420814|FG000|Overall Study|Protocol Violation|10|||
155269742|NCT00152971|560420815|FG001|Overall Study|Protocol Violation|11|||
155269743|NCT00152971|560420816|FG002|Overall Study|Protocol Violation|8|||
155269744|NCT00152971|560420814|FG000|Overall Study|Lost to Follow-up|17|||
155269745|NCT00152971|560420815|FG001|Overall Study|Lost to Follow-up|14|||
155269746|NCT00152971|560420816|FG002|Overall Study|Lost to Follow-up|13|||
155269747|NCT00152971|560420814|FG000|Overall Study|Withdrawal by Subject|9|||
155269748|NCT00152971|560420815|FG001|Overall Study|Withdrawal by Subject|8|||
155269749|NCT00152971|560420816|FG002|Overall Study|Withdrawal by Subject|14|||
155269750|NCT00152971|560420814|FG000|Overall Study|Other|3|||
155269751|NCT00152971|560420815|FG001|Overall Study|Other|5|||
155269752|NCT00152971|560420816|FG002|Overall Study|Other|5|||
155269753|NCT00152971|560420814|FG000|Treatment|Adverse Event|49|||
155269754|NCT00152971|560420815|FG001|Treatment|Adverse Event|40|||
155269755|NCT00152971|560420816|FG002|Treatment|Adverse Event|54|||
155269756|NCT00152971|560420814|FG000|Treatment|Protocol Violation|8|||
155269757|NCT00152971|560420815|FG001|Treatment|Protocol Violation|6|||
155269758|NCT00152971|560420816|FG002|Treatment|Protocol Violation|10|||
155269759|NCT00152971|560420814|FG000|Treatment|Lost to Follow-up|1|||
155269760|NCT00152971|560420815|FG001|Treatment|Lost to Follow-up|2|||
155269761|NCT00152971|560420816|FG002|Treatment|Lost to Follow-up|1|||
155269762|NCT00152971|560420814|FG000|Treatment|Withdrawal by Subject|4|||
155269763|NCT00152971|560420815|FG001|Treatment|Withdrawal by Subject|4|||
155269764|NCT00152971|560420816|FG002|Treatment|Withdrawal by Subject|5|||
155269765|NCT00152971|560420814|FG000|Treatment|Other|9|||
155269766|NCT00152971|560420815|FG001|Treatment|Other|11|||
155269767|NCT00152971|560420816|FG002|Treatment|Other|10|||
155269768|NCT00675506|560420817|FG000|Overall Study|Lost to Follow-up|1|||
155269769|NCT00675506|560420818|FG001|Overall Study|Lost to Follow-up|5|||
155269770|NCT00675506|560420817|FG000|Overall Study|Lost interest|3|||
155269771|NCT00675506|560420818|FG001|Overall Study|Lost interest|5|||
155269772|NCT00675506|560420817|FG000|Overall Study|Elevated fasting glucose|2|||
155269773|NCT00675506|560420818|FG001|Overall Study|Elevated fasting glucose|1|||
155269774|NCT00675506|560420817|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
155269775|NCT00675506|560420818|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
155269776|NCT00675506|560420817|FG000|Overall Study|Elevated IGF-1|2|||
155269777|NCT00675506|560420818|FG001|Overall Study|Elevated IGF-1|0|||
155269778|NCT00675506|560420817|FG000|Overall Study|Hypersensitivity Reaction|1|||
155269779|NCT00675506|560420818|FG001|Overall Study|Hypersensitivity Reaction|0|||
155269780|NCT00675506|560420817|FG000|Overall Study|Disclosed history of cancer|1|||
155269781|NCT00675506|560420818|FG001|Overall Study|Disclosed history of cancer|0|||
155269782|NCT00675506|560420817|FG000|Overall Study|Declined participation|1|||
155269783|NCT00675506|560420818|FG001|Overall Study|Declined participation|0|||
155269784|NCT00675506|560420817|FG000|Overall Study|Schedule conflict|0|||
155269785|NCT00675506|560420818|FG001|Overall Study|Schedule conflict|1|||
155269786|NCT00936221|560420819|FG000|Overall Study|Withdrawal by Subject|1|||
155269787|NCT00936221|560420820|FG001|Overall Study|Withdrawal by Subject|1|||
155269788|NCT06173570|560420821|FG000|Overall Study|Adverse Event|1|||
155269789|NCT06173570|560420822|FG001|Overall Study|Adverse Event|0|||
155269790|NCT06173570|560420823|FG002|Overall Study|Adverse Event|0|||
155269791|NCT06173570|560420824|FG003|Overall Study|Adverse Event|2|||
155269792|NCT06173570|560420825|FG004|Overall Study|Adverse Event|0|||
155269793|NCT06173570|560420821|FG000|Overall Study|Lost to Follow-up|1|||
155269794|NCT06173570|560420822|FG001|Overall Study|Lost to Follow-up|0|||
155269795|NCT06173570|560420823|FG002|Overall Study|Lost to Follow-up|0|||
155269796|NCT06173570|560420824|FG003|Overall Study|Lost to Follow-up|0|||
155269797|NCT06173570|560420825|FG004|Overall Study|Lost to Follow-up|2|||
155269798|NCT06173570|560420821|FG000|Overall Study|Protocol Violation|0|||
155269799|NCT06173570|560420822|FG001|Overall Study|Protocol Violation|2|||
155269800|NCT06173570|560420823|FG002|Overall Study|Protocol Violation|0|||
155269801|NCT06173570|560420824|FG003|Overall Study|Protocol Violation|0|||
155381740|NCT04617275|560830989|FG005|Follow-up Period|Lost to Follow-up|4|||
155381741|NCT04617275|560830990|FG006|Follow-up Period|Lost to Follow-up|0|||
155269802|NCT06173570|560420825|FG004|Overall Study|Protocol Violation|1|||
155269803|NCT06173570|560420821|FG000|Overall Study|Withdrawal by Subject|0|||
155269804|NCT06173570|560420822|FG001|Overall Study|Withdrawal by Subject|1|||
155269805|NCT06173570|560420823|FG002|Overall Study|Withdrawal by Subject|1|||
155269806|NCT06173570|560420824|FG003|Overall Study|Withdrawal by Subject|1|||
155269807|NCT06173570|560420825|FG004|Overall Study|Withdrawal by Subject|1|||
155269808|NCT06173570|560420821|FG000|Overall Study|Non-compliance with Study Drug|1|||
155269809|NCT06173570|560420822|FG001|Overall Study|Non-compliance with Study Drug|0|||
155269810|NCT06173570|560420823|FG002|Overall Study|Non-compliance with Study Drug|0|||
155269811|NCT06173570|560420824|FG003|Overall Study|Non-compliance with Study Drug|0|||
155269812|NCT06173570|560420825|FG004|Overall Study|Non-compliance with Study Drug|0|||
155269813|NCT06173570|560420821|FG000|Overall Study|Screen Failure|0|||
155269814|NCT06173570|560420822|FG001|Overall Study|Screen Failure|0|||
155381742|NCT04617275|560830991|FG007|Follow-up Period|Lost to Follow-up|3|||
155269815|NCT06173570|560420823|FG002|Overall Study|Screen Failure|0|||
155269816|NCT06173570|560420824|FG003|Overall Study|Screen Failure|0|||
154931637|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
154931638|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
154931639|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
154931640|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
154931641|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
154931642|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
154931643|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
154931644|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
154931645|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
154931646|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
154931647|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
154931648|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154931649|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
154931650|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154931651|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154931652|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
154931653|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
154931654|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
154931655|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
154931656|NCT01336608|559175119|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
154931657|NCT01336608|559175120|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
154931658|NCT01336608|559175121|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
154931659|NCT01336608|559175122|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
154931660|NCT02437890|559175129|FG000|Overall Study|Non-compliance to study drug|0|||
154931661|NCT02437890|559175130|FG001|Overall Study|Non-compliance to study drug|1|||
154931662|NCT02437890|559175131|FG002|Overall Study|Non-compliance to study drug|0|||
154931663|NCT02437890|559175132|FG003|Overall Study|Non-compliance to study drug|0|||
154931664|NCT02437890|559175133|FG004|Overall Study|Non-compliance to study drug|1|||
154931665|NCT02437890|559175129|FG000|Overall Study|Sponsor's decision|1|||
154931666|NCT02437890|559175130|FG001|Overall Study|Sponsor's decision|1|||
154931667|NCT02437890|559175131|FG002|Overall Study|Sponsor's decision|4|||
154931668|NCT02437890|559175132|FG003|Overall Study|Sponsor's decision|0|||
154931669|NCT02437890|559175133|FG004|Overall Study|Sponsor's decision|2|||
154931670|NCT02437890|559175129|FG000|Overall Study|Physician Decision|0|||
154931671|NCT02437890|559175130|FG001|Overall Study|Physician Decision|0|||
154931672|NCT02437890|559175131|FG002|Overall Study|Physician Decision|0|||
154931673|NCT02437890|559175132|FG003|Overall Study|Physician Decision|1|||
154931674|NCT02437890|559175133|FG004|Overall Study|Physician Decision|0|||
154931675|NCT02437890|559175129|FG000|Overall Study|Unable to attend visit(s)|1|||
154931676|NCT02437890|559175130|FG001|Overall Study|Unable to attend visit(s)|0|||
154931677|NCT02437890|559175131|FG002|Overall Study|Unable to attend visit(s)|0|||
154931678|NCT02437890|559175132|FG003|Overall Study|Unable to attend visit(s)|0|||
154931679|NCT02437890|559175133|FG004|Overall Study|Unable to attend visit(s)|0|||
154931680|NCT02437890|559175129|FG000|Overall Study|Lack of Efficacy|1|||
154931681|NCT02437890|559175130|FG001|Overall Study|Lack of Efficacy|3|||
154931682|NCT02437890|559175131|FG002|Overall Study|Lack of Efficacy|0|||
154931683|NCT02437890|559175132|FG003|Overall Study|Lack of Efficacy|3|||
154931684|NCT02437890|559175133|FG004|Overall Study|Lack of Efficacy|1|||
154931685|NCT02437890|559175129|FG000|Overall Study|Adverse Event|4|||
154931686|NCT02437890|559175130|FG001|Overall Study|Adverse Event|9|||
154931687|NCT02437890|559175131|FG002|Overall Study|Adverse Event|5|||
154931688|NCT02437890|559175132|FG003|Overall Study|Adverse Event|11|||
154931689|NCT02437890|559175133|FG004|Overall Study|Adverse Event|7|||
154931690|NCT02437890|559175129|FG000|Overall Study|Withdrawal by Subject|1|||
154931691|NCT02437890|559175130|FG001|Overall Study|Withdrawal by Subject|2|||
154931692|NCT02437890|559175131|FG002|Overall Study|Withdrawal by Subject|6|||
154931693|NCT02437890|559175132|FG003|Overall Study|Withdrawal by Subject|5|||
154931694|NCT02437890|559175133|FG004|Overall Study|Withdrawal by Subject|5|||
154931695|NCT02437890|559175129|FG000|Overall Study|Death|0|||
154931696|NCT02437890|559175130|FG001|Overall Study|Death|0|||
154931697|NCT02437890|559175131|FG002|Overall Study|Death|0|||
155269817|NCT06173570|560420825|FG004|Overall Study|Screen Failure|1|||
155269818|NCT06173570|560420821|FG000|Overall Study|Other|2|||
154931698|NCT02437890|559175132|FG003|Overall Study|Death|2|||
154931699|NCT02437890|559175133|FG004|Overall Study|Death|0|||
154931700|NCT02328547|559175134|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
154931701|NCT02328547|559175135|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
154931702|NCT02328547|559175134|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
154931703|NCT02328547|559175135|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
155269819|NCT06173570|560420822|FG001|Overall Study|Other|1|||
155269820|NCT06173570|560420823|FG002|Overall Study|Other|0|||
155269821|NCT06173570|560420824|FG003|Overall Study|Other|2|||
155269822|NCT06173570|560420825|FG004|Overall Study|Other|0|||
155269823|NCT03820323|560420826|FG000|Overall Study|Lost to Follow-up|2|||
155269824|NCT03820323|560420827|FG001|Overall Study|Lost to Follow-up|1|||
155269825|NCT03820323|560420826|FG000|Overall Study|Missed 12-month visit|22|||
155269826|NCT03820323|560420827|FG001|Overall Study|Missed 12-month visit|14|||
155269827|NCT03820323|560420826|FG000|Overall Study|Death|2|||
155269828|NCT03820323|560420827|FG001|Overall Study|Death|1|||
155269829|NCT03820323|560420826|FG000|Overall Study|Transferred out|13|||
155269830|NCT03820323|560420827|FG001|Overall Study|Transferred out|11|||
155269831|NCT03820323|560420826|FG000|Overall Study|Terminated|0|||
155269832|NCT03820323|560420827|FG001|Overall Study|Terminated|3|||
155269833|NCT03820323|560420826|FG000|Overall Study|Withdrawal by Subject|1|||
155269834|NCT03820323|560420827|FG001|Overall Study|Withdrawal by Subject|6|||
155269835|NCT03151395|560420828|FG000|Overall Study|Adverse Event|2|||
155269836|NCT03151395|560420828|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
155269837|NCT03151395|560420828|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
155269838|NCT03151395|560420828|FG000|Overall Study|Unspecified reason|4|||
155269839|NCT00366301|560420829|FG000|Overall Study|Lost to Follow-up|4|||
155269840|NCT00366301|560420830|FG001|Overall Study|Lost to Follow-up|4|||
155269841|NCT00366301|560420831|FG002|Overall Study|Lost to Follow-up|3|||
155269842|NCT00366301|560420832|FG003|Overall Study|Lost to Follow-up|7|||
155269843|NCT00366301|560420829|FG000|Overall Study|Withdrawal by Subject|4|||
155269844|NCT00366301|560420830|FG001|Overall Study|Withdrawal by Subject|2|||
155269845|NCT00366301|560420831|FG002|Overall Study|Withdrawal by Subject|1|||
155269846|NCT00366301|560420832|FG003|Overall Study|Withdrawal by Subject|1|||
155269847|NCT01348776|560420833|FG000|Overall Study|Lost to Follow-up|3|||
155269848|NCT01372605|560420837|FG000|Overall Study|Death|1|||
155269849|NCT01372605|560420838|FG001|Overall Study|Death|2|||
155269850|NCT01372605|560420837|FG000|Overall Study|Lost to Follow-up|2|||
155269851|NCT01372605|560420838|FG001|Overall Study|Lost to Follow-up|1|||
155269852|NCT01372605|560420837|FG000|Overall Study|Withdrawal by Subject|4|||
155269853|NCT01372605|560420838|FG001|Overall Study|Withdrawal by Subject|7|||
155269854|NCT01372605|560420837|FG000|Overall Study|Moved|3|||
155269855|NCT01372605|560420838|FG001|Overall Study|Moved|0|||
155269856|NCT01372605|560420837|FG000|Overall Study|Changed medical home|2|||
155269857|NCT01372605|560420838|FG001|Overall Study|Changed medical home|0|||
155269858|NCT01108510|560420839|FG000|Overall Study|Randomized but Not Treated|5|||
155269859|NCT01108510|560420840|FG001|Overall Study|Randomized but Not Treated|1|||
155269860|NCT01108510|560420839|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
155269861|NCT01108510|560420840|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
155269862|NCT01108510|560420839|FG000|Overall Study|Adverse Event|26|||
155269863|NCT01108510|560420840|FG001|Overall Study|Adverse Event|19|||
155269864|NCT01108510|560420839|FG000|Overall Study|Lost to Follow-up|20|||
155269865|NCT01108510|560420840|FG001|Overall Study|Lost to Follow-up|17|||
155269866|NCT01108510|560420839|FG000|Overall Study|Withdrew Consent|21|||
155269867|NCT01108510|560420840|FG001|Overall Study|Withdrew Consent|15|||
155269868|NCT01108510|560420839|FG000|Overall Study|Investigator's Discretion|12|||
155269869|NCT01108510|560420840|FG001|Overall Study|Investigator's Discretion|10|||
155269870|NCT01108510|560420839|FG000|Overall Study|Participant Noncompliance|5|||
155269871|NCT01108510|560420840|FG001|Overall Study|Participant Noncompliance|7|||
155269872|NCT01108510|560420839|FG000|Overall Study|Lack of Efficacy|3|||
155269873|NCT01108510|560420840|FG001|Overall Study|Lack of Efficacy|0|||
155269874|NCT01108510|560420839|FG000|Overall Study|Pregnancy|0|||
155269875|NCT01108510|560420840|FG001|Overall Study|Pregnancy|3|||
155269876|NCT01108510|560420839|FG000|Overall Study|Death|1|||
155269877|NCT01108510|560420840|FG001|Overall Study|Death|1|||
155269878|NCT00210119|560420841|FG000|Overall Study|Protocol Violation|1|||
155269879|NCT00210119|560420841|FG000|Overall Study|Withdrawal by Subject|1|||
155269880|NCT00951509|560420842|FG000|Overall Study|Withdrawal by Subject|2|||
155269881|NCT03125941|560420844|FG000|Overall Study|did not receive intervention|1|||
155269882|NCT03125941|560420845|FG001|Overall Study|did not receive intervention|2|||
155269883|NCT00089895|560420846|FG000|Overall Study|Consent Withdrawn|11|||
155269884|NCT00089895|560420847|FG001|Overall Study|Consent Withdrawn|14|||
155269885|NCT00089895|560420846|FG000|Overall Study|Technical reason|7|||
155269886|NCT00089895|560420847|FG001|Overall Study|Technical reason|2|||
155043020|NCT00401193|559590037|FG000|Overall Study|Protocol Violation|3|||
155269887|NCT00089895|560420846|FG000|Overall Study|Surgery|0|||
155269888|NCT00089895|560420847|FG001|Overall Study|Surgery|1|||
155269889|NCT00089895|560420846|FG000|Overall Study|Bleeding|0|||
155269890|NCT00089895|560420847|FG001|Overall Study|Bleeding|2|||
155269891|NCT00089895|560420846|FG000|Overall Study|Physician Decision|3|||
155269892|NCT00089895|560420847|FG001|Overall Study|Physician Decision|7|||
155269893|NCT00089895|560420846|FG000|Overall Study|Exclusion criteria met|6|||
155269894|NCT00089895|560420847|FG001|Overall Study|Exclusion criteria met|6|||
155269895|NCT00089895|560420846|FG000|Overall Study|Not otherwise specified|4|||
155269896|NCT00089895|560420847|FG001|Overall Study|Not otherwise specified|8|||
155269897|NCT00089895|560420846|FG000|Overall Study|Missing|4|||
155269898|NCT00089895|560420847|FG001|Overall Study|Missing|2|||
155269899|NCT01103960|560420850|FG000|Overall Study|Adverse Event|2|||
155269900|NCT01103960|560420851|FG001|Overall Study|Adverse Event|1|||
155269901|NCT01103960|560420850|FG000|Overall Study|Withdrawal by Subject|2|||
155269902|NCT01103960|560420851|FG001|Overall Study|Withdrawal by Subject|1|||
155269903|NCT01103960|560420850|FG000|Overall Study|Other|1|||
155269904|NCT01103960|560420851|FG001|Overall Study|Other|0|||
155269905|NCT01017120|560422496|FG000|Overall Study|Adverse Event|9|||
155269906|NCT01017120|560422497|FG001|Overall Study|Adverse Event|0|||
155269907|NCT01017120|560422496|FG000|Overall Study|Lost to Follow-up|13|||
155269908|NCT01017120|560422497|FG001|Overall Study|Lost to Follow-up|11|||
155269909|NCT01017120|560422496|FG000|Overall Study|Lack of Efficacy|1|||
155269910|NCT01017120|560422497|FG001|Overall Study|Lack of Efficacy|0|||
155269911|NCT01017120|560422496|FG000|Overall Study|Withdrawal by Subject|39|||
155269912|NCT01017120|560422497|FG001|Overall Study|Withdrawal by Subject|21|||
155269913|NCT01017120|560422496|FG000|Overall Study|Pregnancy|1|||
155269914|NCT01017120|560422497|FG001|Overall Study|Pregnancy|1|||
155269915|NCT01017120|560422496|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155269916|NCT01017120|560422497|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155269917|NCT01017120|560422496|FG000|Overall Study|Relocated Out of Town|0|||
155269918|NCT01017120|560422497|FG001|Overall Study|Relocated Out of Town|2|||
155269919|NCT01017120|560422496|FG000|Overall Study|Protocol Violation|1|||
155269920|NCT01017120|560422497|FG001|Overall Study|Protocol Violation|0|||
155269921|NCT01017120|560422496|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
155269922|NCT01017120|560422497|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
155269923|NCT01087723|560422498|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
155269924|NCT01087723|560422499|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
155269925|NCT01087723|560422498|FG000|Overall Study|Withdrawal by Subject|10|||
155269926|NCT01087723|560422499|FG001|Overall Study|Withdrawal by Subject|13|||
155269927|NCT01087723|560422498|FG000|Overall Study|Physician Decision|2|||
155269928|NCT01087723|560422499|FG001|Overall Study|Physician Decision|0|||
155269929|NCT01087723|560422498|FG000|Overall Study|Lost to Follow-up|1|||
155269930|NCT01087723|560422499|FG001|Overall Study|Lost to Follow-up|4|||
155269931|NCT01087723|560422498|FG000|Overall Study|Reason Not Specified|1|||
155269932|NCT01087723|560422499|FG001|Overall Study|Reason Not Specified|2|||
155269933|NCT00806624|560422500|FG000|Overall Study|Adverse Event|2|||
155269934|NCT00806624|560422501|FG001|Overall Study|Adverse Event|8|||
155269935|NCT00806624|560422502|FG002|Overall Study|Adverse Event|0|||
155269936|NCT00806624|560422500|FG000|Overall Study|Death|0|||
155269937|NCT00806624|560422501|FG001|Overall Study|Death|1|||
155269938|NCT00806624|560422502|FG002|Overall Study|Death|1|||
155269939|NCT00806624|560422500|FG000|Overall Study|Lost to Follow-up|1|||
155269940|NCT00806624|560422501|FG001|Overall Study|Lost to Follow-up|0|||
155269941|NCT00806624|560422502|FG002|Overall Study|Lost to Follow-up|1|||
155269942|NCT00806624|560422500|FG000|Overall Study|Withdrawal by Subject|6|||
155269943|NCT00806624|560422501|FG001|Overall Study|Withdrawal by Subject|3|||
155269944|NCT00806624|560422502|FG002|Overall Study|Withdrawal by Subject|3|||
155269945|NCT00806624|560422500|FG000|Overall Study|discontinued before start of treatment|0|||
155269946|NCT00806624|560422501|FG001|Overall Study|discontinued before start of treatment|0|||
155269947|NCT00806624|560422502|FG002|Overall Study|discontinued before start of treatment|1|||
155269948|NCT01912222|560422503|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
155269949|NCT01912222|560422504|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
155269950|NCT01912222|560422505|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
155269951|NCT01912222|560422503|FG000|Part B: Treatment Period|Progressive disease|10|||
155269952|NCT01912222|560422504|FG001|Part B: Treatment Period|Progressive disease|12|||
155269953|NCT01912222|560422505|FG002|Part B: Treatment Period|Progressive disease|15|||
155269954|NCT01912222|560422503|FG000|Part B: Treatment Period|Adverse Event|1|||
155269955|NCT01912222|560422504|FG001|Part B: Treatment Period|Adverse Event|2|||
155269956|NCT01912222|560422505|FG002|Part B: Treatment Period|Adverse Event|3|||
155269957|NCT01912222|560422503|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
155269958|NCT01912222|560422504|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
155269959|NCT01912222|560422505|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
155269960|NCT00603265|560422506|FG000|Overall Study|Adverse Event|2|||
155269961|NCT00603265|560422507|FG001|Overall Study|Adverse Event|11|||
155269962|NCT00603265|560422508|FG002|Overall Study|Adverse Event|1|||
155269963|NCT00603265|560422506|FG000|Overall Study|Withdrawal by Subject|1|||
155269964|NCT00603265|560422507|FG001|Overall Study|Withdrawal by Subject|2|||
155269965|NCT00603265|560422508|FG002|Overall Study|Withdrawal by Subject|1|||
155269966|NCT00603265|560422506|FG000|Overall Study|Lack of Efficacy|3|||
155269967|NCT00603265|560422507|FG001|Overall Study|Lack of Efficacy|0|||
155269968|NCT00603265|560422508|FG002|Overall Study|Lack of Efficacy|3|||
155269969|NCT00603265|560422506|FG000|Overall Study|Lost to Follow-up|0|||
155269970|NCT00603265|560422507|FG001|Overall Study|Lost to Follow-up|1|||
155269971|NCT00603265|560422508|FG002|Overall Study|Lost to Follow-up|0|||
155269972|NCT00603265|560422506|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
155269973|NCT00603265|560422507|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
155269974|NCT00603265|560422508|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
155269975|NCT00603265|560422506|FG000|Overall Study|Participant Left Country, No Responses|0|||
155269976|NCT00603265|560422507|FG001|Overall Study|Participant Left Country, No Responses|1|||
155269977|NCT00603265|560422508|FG002|Overall Study|Participant Left Country, No Responses|0|||
155269978|NCT00603265|560422506|FG000|Overall Study|Protocol Violation|1|||
155269979|NCT00603265|560422507|FG001|Overall Study|Protocol Violation|0|||
155269980|NCT00603265|560422508|FG002|Overall Study|Protocol Violation|0|||
155269981|NCT04399551|560422509|FG000|Overall Study|Adverse Event|15|||
155269982|NCT04399551|560422509|FG000|Overall Study|Withdrawal by Subject|6|||
155269983|NCT04399551|560422509|FG000|Overall Study|Physician Decision|3|||
155269984|NCT04399551|560422509|FG000|Overall Study|Lost to Follow-up|2|||
155269985|NCT04399551|560422509|FG000|Overall Study|Protocol Deviation|2|||
155269986|NCT01118455|560422513|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
155269987|NCT01118455|560422514|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
155269988|NCT00636792|560422515|FG000|Overall Study|Adverse Event|16|||
155269989|NCT00636792|560422515|FG000|Overall Study|Physician Decision|7|||
155269990|NCT00636792|560422515|FG000|Overall Study|Progressive Disease|4|||
155269991|NCT00636792|560422515|FG000|Overall Study|Withdrawal by Subject|3|||
155269992|NCT00636792|560422515|FG000|Overall Study|Other|3|||
155269993|NCT01928225|560422518|FG000|Overall Study|Pregnancy|1|||
155269994|NCT01928225|560422519|FG001|Overall Study|Pregnancy|0|||
155269995|NCT01928225|560422518|FG000|Overall Study|basaloid cervical cancer|1|||
155269996|NCT01928225|560422519|FG001|Overall Study|basaloid cervical cancer|0|||
155269997|NCT01928225|560422518|FG000|Overall Study|Lost to Follow-up|1|||
155043021|NCT00401193|559590038|FG001|Overall Study|Protocol Violation|1|||
155043022|NCT00401193|559590039|FG002|Overall Study|Protocol Violation|1|||
155269998|NCT01928225|560422519|FG001|Overall Study|Lost to Follow-up|3|||
155269999|NCT00451217|560422521|FG000|Overall Study|Lost to Follow-up|0|||
155270000|NCT00451217|560422522|FG001|Overall Study|Lost to Follow-up|1|||
155270001|NCT00451217|560422523|FG002|Overall Study|Lost to Follow-up|1|||
155270002|NCT00451217|560422524|FG003|Overall Study|Lost to Follow-up|1|||
155270003|NCT00451217|560422521|FG000|Overall Study|Withdrawal by Subject|1|||
155270004|NCT00451217|560422522|FG001|Overall Study|Withdrawal by Subject|0|||
155270005|NCT00451217|560422523|FG002|Overall Study|Withdrawal by Subject|0|||
155270006|NCT00451217|560422524|FG003|Overall Study|Withdrawal by Subject|0|||
155270007|NCT00451217|560422521|FG000|Overall Study|Not Treated|1|||
155270008|NCT00451217|560422522|FG001|Overall Study|Not Treated|1|||
155270009|NCT00451217|560422523|FG002|Overall Study|Not Treated|3|||
155270010|NCT00451217|560422524|FG003|Overall Study|Not Treated|4|||
155270011|NCT03154359|560422525|FG000|Overall Study|Adverse Event|1|||
155270012|NCT03154359|560422525|FG000|Overall Study|Lack of Efficacy|2|||
155270013|NCT03154359|560422525|FG000|Overall Study|Lost to Follow-up|3|||
155270014|NCT03154359|560422525|FG000|Overall Study|Physician Decision|3|||
154931704|NCT00344305|559175136|FG000|Overall Study|Lost to Follow-up|2|||
154931705|NCT00344305|559175137|FG001|Overall Study|Lost to Follow-up|0|||
154931706|NCT00344305|559175136|FG000|Overall Study|Participant was not contacted in window|0|||
154931707|NCT00344305|559175137|FG001|Overall Study|Participant was not contacted in window|1|||
154931708|NCT01190098|559175138|FG000|Overall Study|Adverse Event|2|||
154931709|NCT01190098|559175139|FG001|Overall Study|Adverse Event|0|||
154931710|NCT01190098|559175138|FG000|Overall Study|Patient coomorbidity|0|||
154931711|NCT01190098|559175139|FG001|Overall Study|Patient coomorbidity|1|||
154931712|NCT01190098|559175138|FG000|Overall Study|Lack of transportation|1|||
154931713|NCT01190098|559175139|FG001|Overall Study|Lack of transportation|0|||
154931714|NCT01190098|559175138|FG000|Overall Study|Other|0|||
154931715|NCT01190098|559175139|FG001|Overall Study|Other|1|||
154931716|NCT03978117|559175140|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
154931717|NCT03978117|559175141|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
154931718|NCT03978117|559175140|FG000|Overall Study|Lost to Follow-up|4|||
154931719|NCT03978117|559175141|FG001|Overall Study|Lost to Follow-up|4|||
154931720|NCT01586624|559175146|FG000|Overall Study|Adverse Event|3|||
154931721|NCT01586624|559175147|FG001|Overall Study|Adverse Event|0|||
154931722|NCT01586624|559175148|FG002|Overall Study|Adverse Event|2|||
154931723|NCT01586624|559175149|FG003|Overall Study|Adverse Event|1|||
154931724|NCT01586624|559175150|FG004|Overall Study|Adverse Event|3|||
154931725|NCT01586624|559175151|FG005|Overall Study|Adverse Event|3|||
154931726|NCT01586624|559175152|FG006|Overall Study|Adverse Event|2|||
155270015|NCT03154359|560422525|FG000|Overall Study|Protocol Violation|4|||
155270016|NCT03154359|560422525|FG000|Overall Study|Withdrawal by Subject|5|||
154931727|NCT01586624|559175153|FG007|Overall Study|Adverse Event|3|||
154931728|NCT01586624|559175146|FG000|Overall Study|Physician Decision|0|||
154931729|NCT01586624|559175147|FG001|Overall Study|Physician Decision|1|||
154931730|NCT01586624|559175148|FG002|Overall Study|Physician Decision|1|||
154931731|NCT01586624|559175149|FG003|Overall Study|Physician Decision|0|||
154931732|NCT01586624|559175150|FG004|Overall Study|Physician Decision|2|||
155270017|NCT03154359|560422525|FG000|Overall Study|Disruption of study due to COVID-19|4|||
155270018|NCT05033743|560422532|FG000|Overall Study|Lost to Follow-up|1|||
155270019|NCT05033743|560422532|FG000|Overall Study|Protocol Violation|2|||
155270020|NCT05033743|560422532|FG000|Overall Study|Withdrawal by Subject|1|||
155270021|NCT01592695|560422533|FG000|Overall Study|Lost to Follow-up|8|||
155270022|NCT01592695|560422534|FG001|Overall Study|Lost to Follow-up|4|||
155270023|NCT00641719|560422536|FG000|Overall Study|Lack of Efficacy|1|||
155270024|NCT00641719|560422537|FG001|Overall Study|Lack of Efficacy|2|||
155270025|NCT00641719|560422536|FG000|Overall Study|Adverse Event|24|||
155270026|NCT00641719|560422537|FG001|Overall Study|Adverse Event|29|||
155270027|NCT00641719|560422536|FG000|Overall Study|Withdrawal by Subject|4|||
155270028|NCT00641719|560422537|FG001|Overall Study|Withdrawal by Subject|4|||
155270029|NCT00641719|560422536|FG000|Overall Study|Reason Not Specified|1|||
155270030|NCT00641719|560422537|FG001|Overall Study|Reason Not Specified|2|||
155270031|NCT00885352|560422538|FG000|Overall Study|Adverse Event|2|||
155270032|NCT00885352|560422539|FG001|Overall Study|Adverse Event|3|||
155270033|NCT00885352|560422538|FG000|Overall Study|Lost to Follow-up|2|||
155270034|NCT00885352|560422539|FG001|Overall Study|Lost to Follow-up|2|||
155270035|NCT00885352|560422538|FG000|Overall Study|Physician Decision|0|||
155270036|NCT00885352|560422539|FG001|Overall Study|Physician Decision|3|||
155270037|NCT00885352|560422538|FG000|Overall Study|Protocol Violation|0|||
155270038|NCT00885352|560422539|FG001|Overall Study|Protocol Violation|2|||
155270039|NCT00885352|560422538|FG000|Overall Study|Withdrawal by Subject|1|||
155270040|NCT00885352|560422539|FG001|Overall Study|Withdrawal by Subject|5|||
155270041|NCT00885352|560422538|FG000|Overall Study|Contradiction to study medication|0|||
155270042|NCT00885352|560422539|FG001|Overall Study|Contradiction to study medication|2|||
155270043|NCT00885352|560422538|FG000|Overall Study|Excluded medication|2|||
155270044|NCT00885352|560422539|FG001|Overall Study|Excluded medication|2|||
155270045|NCT00885352|560422538|FG000|Overall Study|Lab abnormalities|1|||
155270046|NCT00885352|560422539|FG001|Overall Study|Lab abnormalities|1|||
155270047|NCT01381874|560422540|FG000|Overall Study|Lost to Follow-up|1|||
155270048|NCT01381874|560422541|FG001|Overall Study|Lost to Follow-up|1|||
155270049|NCT01381874|560422542|FG002|Overall Study|Lost to Follow-up|0|||
155270050|NCT01381874|560422540|FG000|Overall Study|Withdrawal by Subject|9|||
155270051|NCT01381874|560422541|FG001|Overall Study|Withdrawal by Subject|10|||
155270052|NCT01381874|560422542|FG002|Overall Study|Withdrawal by Subject|9|||
155270053|NCT01381874|560422540|FG000|Overall Study|Other|67|||
155270054|NCT01381874|560422541|FG001|Overall Study|Other|52|||
155270055|NCT01381874|560422542|FG002|Overall Study|Other|67|||
155270056|NCT02765490|560422543|FG000|Overall Study|Lost to Follow-up|1|||
155270057|NCT02765490|560422544|FG001|Overall Study|Lost to Follow-up|1|||
155270058|NCT02765490|560422543|FG000|Overall Study|Other|0|||
155270059|NCT02765490|560422544|FG001|Overall Study|Other|1|||
155270060|NCT02765490|560422543|FG000|Overall Study|Death|0|||
155270061|NCT02765490|560422544|FG001|Overall Study|Death|1|||
155270062|NCT03662997|560422545|FG000|Overall Study|Adverse Event|0|||
155270063|NCT03662997|560422546|FG001|Overall Study|Adverse Event|2|||
155270064|NCT03662997|560422547|FG002|Overall Study|Adverse Event|0|||
155270065|NCT03662997|560422548|FG003|Overall Study|Adverse Event|0|||
155270066|NCT01830881|560422552|FG000|Overall Study|Changed decision to have an abortion|0|||
155270067|NCT01830881|560422553|FG001|Overall Study|Changed decision to have an abortion|1|||
155270068|NCT00734214|560422554|FG000|Overall Study|Withdrawal by Subject|3|||
155270069|NCT00734214|560422555|FG001|Overall Study|Withdrawal by Subject|4|||
155270070|NCT00734214|560422554|FG000|Overall Study|MD withdrawal|1|||
155270071|NCT00734214|560422555|FG001|Overall Study|MD withdrawal|0|||
155270072|NCT04362137|560422558|FG000|Overall Study|Death|9|||
155270073|NCT04362137|560422559|FG001|Overall Study|Death|3|||
155270074|NCT04362137|560422558|FG000|Overall Study|Patient decision|6|||
155270075|NCT04362137|560422559|FG001|Overall Study|Patient decision|3|||
155270076|NCT04362137|560422558|FG000|Overall Study|Adverse Event|1|||
155270077|NCT04362137|560422559|FG001|Overall Study|Adverse Event|0|||
155270078|NCT04362137|560422558|FG000|Overall Study|Lost to Follow-up|1|||
155270079|NCT04362137|560422559|FG001|Overall Study|Lost to Follow-up|0|||
155270080|NCT04362137|560422558|FG000|Overall Study|Protocol deviation|1|||
155270081|NCT04362137|560422559|FG001|Overall Study|Protocol deviation|0|||
155270082|NCT02494206|560422576|FG000|Overall Study|Adverse Event|1|||
155270083|NCT02494206|560422576|FG000|Overall Study|Disease Progression|1|||
155270084|NCT01013792|560422577|FG000|Overall Study|Study suspended|2|||
155270085|NCT01013792|560422578|FG001|Overall Study|Study suspended|1|||
155270086|NCT01013792|560422577|FG000|Overall Study|Adverse Event|0|||
155270087|NCT01013792|560422578|FG001|Overall Study|Adverse Event|3|||
154931733|NCT01586624|559175151|FG005|Overall Study|Physician Decision|0|||
155270088|NCT01013792|560422577|FG000|Overall Study|Lost to Follow-up|0|||
155270089|NCT01013792|560422578|FG001|Overall Study|Lost to Follow-up|1|||
155270090|NCT01121484|560422580|FG000|Overall Study|Adverse Event|12|||
155270091|NCT01121484|560422581|FG001|Overall Study|Adverse Event|5|||
155270092|NCT01121484|560422580|FG000|Overall Study|Lack of Efficacy|3|||
155270093|NCT01121484|560422581|FG001|Overall Study|Lack of Efficacy|11|||
155270094|NCT01121484|560422580|FG000|Overall Study|Lost to Follow-up|5|||
155270095|NCT01121484|560422581|FG001|Overall Study|Lost to Follow-up|9|||
155270096|NCT01121484|560422580|FG000|Overall Study|Physician Decision|0|||
155270097|NCT01121484|560422581|FG001|Overall Study|Physician Decision|3|||
155270098|NCT01121484|560422580|FG000|Overall Study|Protocol Violation|1|||
155270099|NCT01121484|560422581|FG001|Overall Study|Protocol Violation|0|||
155270100|NCT01121484|560422580|FG000|Overall Study|Withdrawal by Subject|8|||
155270101|NCT01121484|560422581|FG001|Overall Study|Withdrawal by Subject|7|||
155270102|NCT01121484|560422580|FG000|Overall Study|Discontinuation of study by sponsor|0|||
155270103|NCT01121484|560422581|FG001|Overall Study|Discontinuation of study by sponsor|1|||
155270104|NCT01121484|560422580|FG000|Overall Study|Other|3|||
155270105|NCT01121484|560422581|FG001|Overall Study|Other|3|||
155270106|NCT01121484|560422580|FG000|Overall Study|Randomized, not treated|1|||
155270107|NCT01121484|560422581|FG001|Overall Study|Randomized, not treated|4|||
155270108|NCT03679767|560422582|FG000|Overall Study|Death|16|||
155270109|NCT03679767|560422583|FG001|Overall Study|Death|11|||
155270110|NCT03679767|560422584|FG002|Overall Study|Death|17|||
155270111|NCT03679767|560422585|FG003|Overall Study|Death|10|||
155270112|NCT03679767|560422582|FG000|Overall Study|Lost to Follow-up|1|||
155270113|NCT03679767|560422583|FG001|Overall Study|Lost to Follow-up|1|||
155270114|NCT03679767|560422584|FG002|Overall Study|Lost to Follow-up|1|||
155270115|NCT03679767|560422585|FG003|Overall Study|Lost to Follow-up|1|||
155270116|NCT03679767|560422582|FG000|Overall Study|Withdrawal by Subject|0|||
155270117|NCT03679767|560422583|FG001|Overall Study|Withdrawal by Subject|0|||
155270118|NCT03679767|560422584|FG002|Overall Study|Withdrawal by Subject|0|||
155270119|NCT03679767|560422585|FG003|Overall Study|Withdrawal by Subject|1|||
155270120|NCT03679767|560422582|FG000|Overall Study|Follow-up Completed|18|||
155270121|NCT03679767|560422583|FG001|Overall Study|Follow-up Completed|11|||
155270122|NCT03679767|560422584|FG002|Overall Study|Follow-up Completed|11|||
155270123|NCT03679767|560422585|FG003|Overall Study|Follow-up Completed|20|||
155270124|NCT03679767|560422582|FG000|Overall Study|Entered Hospice Care|0|||
155270125|NCT03679767|560422583|FG001|Overall Study|Entered Hospice Care|0|||
155270126|NCT03679767|560422584|FG002|Overall Study|Entered Hospice Care|0|||
155270127|NCT03679767|560422585|FG003|Overall Study|Entered Hospice Care|1|||
155270128|NCT03679767|560422582|FG000|Overall Study|Progressive Disease|0|||
155270129|NCT03679767|560422583|FG001|Overall Study|Progressive Disease|0|||
155270130|NCT03679767|560422584|FG002|Overall Study|Progressive Disease|0|||
155270131|NCT03679767|560422585|FG003|Overall Study|Progressive Disease|1|||
155270132|NCT03915951|560422586|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
155270133|NCT03915951|560422587|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
155270134|NCT03915951|560422586|FG000|Overall Study|Adverse Event|12|||
155270135|NCT03915951|560422587|FG001|Overall Study|Adverse Event|6|||
155270136|NCT03915951|560422586|FG000|Overall Study|Disease progression (radiological)|17|||
155270137|NCT03915951|560422587|FG001|Overall Study|Disease progression (radiological)|15|||
155270138|NCT03915951|560422586|FG000|Overall Study|Disease progression (clinical)|4|||
155270139|NCT03915951|560422587|FG001|Overall Study|Disease progression (clinical)|1|||
155270140|NCT03915951|560422586|FG000|Overall Study|Patient decision|0|||
155270141|NCT03915951|560422587|FG001|Overall Study|Patient decision|4|||
155270142|NCT03915951|560422586|FG000|Overall Study|Investigator decision|0|||
155270143|NCT03915951|560422587|FG001|Overall Study|Investigator decision|1|||
155270144|NCT03915951|560422586|FG000|Overall Study|Consent withdrawn|1|||
155270145|NCT03915951|560422587|FG001|Overall Study|Consent withdrawn|1|||
155270146|NCT03915951|560422586|FG000|Overall Study|Death|0|||
155270147|NCT03915951|560422587|FG001|Overall Study|Death|3|||
155270148|NCT05408468|560422588|FG000|Overall Study|Lost to Follow-up|3|||
155270149|NCT05408468|560422589|FG001|Overall Study|Lost to Follow-up|1|||
155270150|NCT05408468|560422588|FG000|Overall Study|Physician Decision|1|||
155270151|NCT05408468|560422589|FG001|Overall Study|Physician Decision|0|||
155270152|NCT05408468|560422588|FG000|Overall Study|Overwhelmed by clinical situation|3|||
155270153|NCT05408468|560422589|FG001|Overall Study|Overwhelmed by clinical situation|0|||
155270154|NCT05408468|560422588|FG000|Overall Study|Personal illness precluding participation|1|||
155270155|NCT05408468|560422589|FG001|Overall Study|Personal illness precluding participation|0|||
155270156|NCT05408468|560422588|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
155270157|NCT05408468|560422589|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
155270158|NCT02204579|560422594|FG000|Overall Study|Screen failures|2|||
155270159|NCT01396395|560422595|FG000|Overall Study|Withdrawal by Subject|10|||
155270160|NCT01396395|560422596|FG001|Overall Study|Withdrawal by Subject|12|||
155270161|NCT01396395|560422595|FG000|Overall Study|Protocol Violation|3|||
155270162|NCT01396395|560422596|FG001|Overall Study|Protocol Violation|1|||
155270163|NCT01396395|560422595|FG000|Overall Study|Adverse Event|10|||
155270164|NCT01396395|560422596|FG001|Overall Study|Adverse Event|2|||
155270165|NCT01396395|560422595|FG000|Overall Study|Lost to Follow-up|17|||
155270166|NCT01396395|560422596|FG001|Overall Study|Lost to Follow-up|11|||
155270167|NCT01396395|560422595|FG000|Overall Study|Other|0|||
155270168|NCT01396395|560422596|FG001|Overall Study|Other|1|||
155270169|NCT01370005|560422597|FG000|Overall Study|Not treated|1|||
155270170|NCT01370005|560422598|FG001|Overall Study|Not treated|0|||
155270171|NCT01370005|560422599|FG002|Overall Study|Not treated|0|||
155270172|NCT01370005|560422597|FG000|Overall Study|Adverse Event|5|||
155270173|NCT01370005|560422598|FG001|Overall Study|Adverse Event|5|||
155270174|NCT01370005|560422599|FG002|Overall Study|Adverse Event|6|||
155270175|NCT01370005|560422597|FG000|Overall Study|Lack of Efficacy|1|||
155270176|NCT01370005|560422598|FG001|Overall Study|Lack of Efficacy|0|||
155270177|NCT01370005|560422599|FG002|Overall Study|Lack of Efficacy|0|||
155270178|NCT01370005|560422597|FG000|Overall Study|Non compliant with protocol|0|||
155270179|NCT01370005|560422598|FG001|Overall Study|Non compliant with protocol|1|||
155270180|NCT01370005|560422599|FG002|Overall Study|Non compliant with protocol|2|||
155270181|NCT01370005|560422597|FG000|Overall Study|Lost to Follow-up|1|||
155270182|NCT01370005|560422598|FG001|Overall Study|Lost to Follow-up|1|||
155270183|NCT01370005|560422599|FG002|Overall Study|Lost to Follow-up|1|||
155270184|NCT01370005|560422597|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
155270185|NCT01370005|560422598|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
155270186|NCT01370005|560422599|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
155270187|NCT01370005|560422597|FG000|Overall Study|Other reason not defined above|3|||
155270188|NCT01370005|560422598|FG001|Overall Study|Other reason not defined above|0|||
155270189|NCT01370005|560422599|FG002|Overall Study|Other reason not defined above|2|||
155270190|NCT03691948|560422600|FG000|Overall Study|Lost to Follow-up|1|||
155270191|NCT03691948|560422601|FG001|Overall Study|Lost to Follow-up|3|||
155270192|NCT03916744|560422603|FG000|Overall Study|Withdrawal by Subject|0|||
155270193|NCT03916744|560422604|FG001|Overall Study|Withdrawal by Subject|1|||
155270194|NCT03916744|560422605|FG002|Overall Study|Withdrawal by Subject|2|||
155270195|NCT03556358|560422610|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
155270196|NCT03556358|560422611|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
155270197|NCT03556358|560422610|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
155270198|NCT03556358|560422611|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
155270199|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
155270200|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
155270201|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
155270202|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
155270203|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
155270204|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
155270205|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
155270206|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
155270207|NCT03556358|560422610|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
155270208|NCT03556358|560422611|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
155270209|NCT00180713|560422620|FG000|Overall Study|Withdrawal by Subject|2|||
155270210|NCT00180713|560422621|FG001|Overall Study|Withdrawal by Subject|0|||
155270211|NCT00180713|560422620|FG000|Overall Study|Adverse Event|3|||
155270212|NCT00180713|560422621|FG001|Overall Study|Adverse Event|3|||
155270213|NCT05067933|560422623|FG000|Overall Study|Withdrawal by Subject|2|||
155270214|NCT05067933|560422624|FG001|Overall Study|Withdrawal by Subject|0|||
155270215|NCT05067933|560422625|FG002|Overall Study|Withdrawal by Subject|0|||
155270216|NCT05067933|560422626|FG003|Overall Study|Withdrawal by Subject|0|||
155270217|NCT05067933|560422627|FG004|Overall Study|Withdrawal by Subject|0|||
155270218|NCT05067933|560422628|FG005|Overall Study|Withdrawal by Subject|0|||
155270219|NCT05067933|560422623|FG000|Overall Study|Lost to Follow-up|1|||
155270220|NCT05067933|560422624|FG001|Overall Study|Lost to Follow-up|1|||
155270221|NCT05067933|560422625|FG002|Overall Study|Lost to Follow-up|1|||
155270222|NCT05067933|560422626|FG003|Overall Study|Lost to Follow-up|2|||
155270223|NCT05067933|560422627|FG004|Overall Study|Lost to Follow-up|1|||
155270224|NCT05067933|560422628|FG005|Overall Study|Lost to Follow-up|0|||
155270225|NCT05067933|560422623|FG000|Overall Study|Miscellaneous|1|||
155270226|NCT05067933|560422624|FG001|Overall Study|Miscellaneous|0|||
155270227|NCT05067933|560422625|FG002|Overall Study|Miscellaneous|0|||
155270228|NCT05067933|560422626|FG003|Overall Study|Miscellaneous|0|||
155270229|NCT05067933|560422627|FG004|Overall Study|Miscellaneous|0|||
155270230|NCT05067933|560422628|FG005|Overall Study|Miscellaneous|0|||
155270231|NCT05067933|560422623|FG000|Overall Study|Death|0|||
155270232|NCT05067933|560422624|FG001|Overall Study|Death|0|||
155270233|NCT05067933|560422625|FG002|Overall Study|Death|0|||
155270234|NCT05067933|560422626|FG003|Overall Study|Death|1|||
155270235|NCT05067933|560422627|FG004|Overall Study|Death|0|||
155270236|NCT05067933|560422628|FG005|Overall Study|Death|0|||
155270237|NCT01065350|560422629|FG000|Overall Study|Received incorrect drug allocation|0|||
155270238|NCT01065350|560422630|FG001|Overall Study|Received incorrect drug allocation|1|||
155270239|NCT02716038|560422637|FG000|Overall Study|Not evaluable|1|||
155270240|NCT02716038|560422637|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
155270241|NCT02716038|560422637|FG000|Overall Study|Unresectable|3|||
155270242|NCT02875834|560422640|FG000|Open-label Phase|Withdrawal by Subject|3|||
155270243|NCT02875834|560422641|FG001|Open-label Phase|Withdrawal by Subject|0|||
155270244|NCT02875834|560422642|FG002|Open-label Phase|Withdrawal by Subject|0|||
155270245|NCT02875834|560422643|FG003|Open-label Phase|Withdrawal by Subject|0|||
155270246|NCT02875834|560422640|FG000|Open-label Phase|(Not collected)|4|||
155270247|NCT02875834|560422641|FG001|Open-label Phase|(Not collected)|0|||
155270248|NCT02875834|560422642|FG002|Open-label Phase|(Not collected)|0|||
155270249|NCT02875834|560422643|FG003|Open-label Phase|(Not collected)|0|||
155270250|NCT02875834|560422640|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
155270251|NCT02875834|560422641|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
155270252|NCT02875834|560422642|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
155270253|NCT02875834|560422643|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
155270254|NCT02875834|560422640|FG000|Randomized Treatment Phase|Protocol Violation|0|||
155270255|NCT02875834|560422641|FG001|Randomized Treatment Phase|Protocol Violation|2|||
155270256|NCT02875834|560422642|FG002|Randomized Treatment Phase|Protocol Violation|0|||
155270257|NCT02875834|560422643|FG003|Randomized Treatment Phase|Protocol Violation|0|||
155270258|NCT02875834|560422640|FG000|Randomized Treatment Phase|(Not collected)|0|||
155270259|NCT02875834|560422641|FG001|Randomized Treatment Phase|(Not collected)|9|||
155270260|NCT02875834|560422642|FG002|Randomized Treatment Phase|(Not collected)|10|||
155270261|NCT02875834|560422643|FG003|Randomized Treatment Phase|(Not collected)|9|||
155270262|NCT05200936|560422646|FG000|Overall Study|Withdrawal by Subject|2|||
155270263|NCT05200936|560422647|FG001|Overall Study|Withdrawal by Subject|2|||
155270264|NCT05200936|560422646|FG000|Overall Study|Lost to Follow-up|2|||
155270265|NCT05200936|560422647|FG001|Overall Study|Lost to Follow-up|0|||
155270266|NCT05200936|560422646|FG000|Overall Study|Pregnancy|0|||
155270267|NCT05200936|560422647|FG001|Overall Study|Pregnancy|1|||
155270268|NCT00539279|560422648|FG000|Treatment|Withdrawal by Subject|10|||
155270269|NCT00539279|560422649|FG001|Treatment|Withdrawal by Subject|8|||
155270270|NCT00539279|560422648|FG000|Treatment|Death|1|||
155270271|NCT00539279|560422649|FG001|Treatment|Death|0|||
155270272|NCT00539279|560422648|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
155270273|NCT00539279|560422649|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
155270274|NCT00539279|560422648|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
155270275|NCT00539279|560422649|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
155270276|NCT01340482|560424097|FG000|Overall Study|Adverse Event|2|||
155270277|NCT01340482|560424098|FG001|Overall Study|Adverse Event|0|||
155270278|NCT01340482|560424099|FG002|Overall Study|Adverse Event|0|||
155270279|NCT02593539|560424100|FG000|Overall Study|Adverse Event|1|||
155270280|NCT01282476|560424101|FG000|Overall Study|Death|11|||
155270281|NCT01811563|560424108|FG000|Overall Study|Lost to Follow-up|5|||
155270282|NCT01811563|560424109|FG001|Overall Study|Lost to Follow-up|2|||
155270283|NCT01811563|560424108|FG000|Overall Study|Incorrect Randomization procedure|0|||
155270284|NCT01811563|560424109|FG001|Overall Study|Incorrect Randomization procedure|1|||
155270285|NCT04424290|560424111|FG000|Overall Study|Not treated|0|||
155270286|NCT04424290|560424112|FG001|Overall Study|Not treated|0|||
155270287|NCT04424290|560424113|FG002|Overall Study|Not treated|1|||
155270288|NCT04424290|560424114|FG003|Overall Study|Not treated|0|||
155270289|NCT04424290|560424115|FG004|Overall Study|Not treated|1|||
155270290|NCT04424290|560424111|FG000|Overall Study|Adverse Event|0|||
155270291|NCT04424290|560424112|FG001|Overall Study|Adverse Event|0|||
155270292|NCT04424290|560424113|FG002|Overall Study|Adverse Event|0|||
155270293|NCT04424290|560424114|FG003|Overall Study|Adverse Event|2|||
155270294|NCT04424290|560424115|FG004|Overall Study|Adverse Event|0|||
155270295|NCT04424290|560424111|FG000|Overall Study|Withdrawal by Subject|0|||
155270296|NCT04424290|560424112|FG001|Overall Study|Withdrawal by Subject|0|||
155270297|NCT04424290|560424113|FG002|Overall Study|Withdrawal by Subject|0|||
155270298|NCT04424290|560424114|FG003|Overall Study|Withdrawal by Subject|0|||
155270299|NCT04424290|560424115|FG004|Overall Study|Withdrawal by Subject|1|||
155270300|NCT04424290|560424111|FG000|Overall Study|Other than listed|0|||
155270301|NCT04424290|560424112|FG001|Overall Study|Other than listed|0|||
155270302|NCT04424290|560424113|FG002|Overall Study|Other than listed|0|||
155270303|NCT04424290|560424114|FG003|Overall Study|Other than listed|1|||
155270304|NCT04424290|560424115|FG004|Overall Study|Other than listed|0|||
155270305|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
155270306|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
155270307|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
155270308|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
155270309|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
155270310|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
155270311|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Death|0|||
155270312|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Death|1|||
155270313|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Adverse Event|11|||
155270314|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Adverse Event|11|||
155270315|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
155270316|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
155270317|NCT02936037|560424117|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155270318|NCT02936037|560424118|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155270319|NCT02936037|560424117|FG000|Open Label Extension|Adverse Event|0|||
155270320|NCT02936037|560424118|FG001|Open Label Extension|Adverse Event|3|||
155270321|NCT02936037|560424117|FG000|Open Label Extension|Other|0|||
155270322|NCT02936037|560424118|FG001|Open Label Extension|Other|3|||
155270323|NCT02936037|560424117|FG000|Open Label Extension|Withdrawal by Subject|0|||
155270324|NCT02936037|560424118|FG001|Open Label Extension|Withdrawal by Subject|4|||
155270325|NCT01267825|560424119|FG000|Overall Study|study terminated. no data collected.|1|||
155270326|NCT01267825|560424120|FG001|Overall Study|study terminated. no data collected.|0|||
155270327|NCT04249336|560424121|FG000|Overall Study|Lost to Follow-up|3|||
155270328|NCT04249336|560424122|FG001|Overall Study|Lost to Follow-up|3|||
155270329|NCT04249336|560424123|FG002|Overall Study|Lost to Follow-up|3|||
155270330|NCT04249336|560424124|FG003|Overall Study|Lost to Follow-up|3|||
155270331|NCT01242176|560424125|FG000|Washout Period of 7 Days|Adverse Event|0|||
155270332|NCT01242176|560424126|FG001|Washout Period of 7 Days|Adverse Event|2|||
155270333|NCT01242176|560424125|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
155270334|NCT01242176|560424126|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
155270335|NCT00871351|560424127|FG000|Overall Study|Withdrawal by Subject|1|||
155270336|NCT00871351|560424128|FG001|Overall Study|Withdrawal by Subject|0|||
155270337|NCT00871351|560424129|FG002|Overall Study|Withdrawal by Subject|0|||
155270338|NCT00871351|560424127|FG000|Overall Study|Adverse Event|3|||
155270339|NCT00871351|560424128|FG001|Overall Study|Adverse Event|1|||
155270340|NCT00871351|560424129|FG002|Overall Study|Adverse Event|0|||
155270341|NCT02791490|560424130|FG000|Overall Study|Lost to Follow-up|1|||
155270342|NCT02791490|560424131|FG001|Overall Study|Lost to Follow-up|2|||
155270343|NCT02791490|560424130|FG000|Overall Study|Withdrawal by Subject|2|||
155270344|NCT02791490|560424131|FG001|Overall Study|Withdrawal by Subject|6|||
155270345|NCT01189890|560424132|FG000|Overall Study|Adverse Event|3|||
155270346|NCT01189890|560424133|FG001|Overall Study|Adverse Event|4|||
155270347|NCT01189890|560424132|FG000|Overall Study|Lack of Efficacy|7|||
155270348|NCT01189890|560424133|FG001|Overall Study|Lack of Efficacy|2|||
155270349|NCT01189890|560424132|FG000|Overall Study|Lost to Follow-up|1|||
155270350|NCT01189890|560424133|FG001|Overall Study|Lost to Follow-up|7|||
155270351|NCT01189890|560424132|FG000|Overall Study|Protocol Violation|1|||
155270352|NCT01189890|560424133|FG001|Overall Study|Protocol Violation|5|||
155270353|NCT01189890|560424132|FG000|Overall Study|Withdrawal by Subject|15|||
155270354|NCT01189890|560424133|FG001|Overall Study|Withdrawal by Subject|11|||
155270355|NCT01189890|560424132|FG000|Overall Study|Non Compliance|0|||
155270356|NCT01189890|560424133|FG001|Overall Study|Non Compliance|1|||
155270357|NCT01189890|560424132|FG000|Overall Study|Physician Decision|5|||
155270358|NCT01189890|560424133|FG001|Overall Study|Physician Decision|4|||
155270359|NCT01189890|560424132|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
155270360|NCT01189890|560424133|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
155270361|NCT00077636|560424134|FG000|Overall Study|Refused Treatment|9|||
155270362|NCT00077636|560424135|FG001|Overall Study|Refused Treatment|31|||
155270363|NCT00077636|560424134|FG000|Overall Study|Admin|3|||
155270364|NCT00077636|560424135|FG001|Overall Study|Admin|3|||
155270365|NCT00077636|560424134|FG000|Overall Study|Withdrawal by Subject|2|||
155270366|NCT00077636|560424135|FG001|Overall Study|Withdrawal by Subject|2|||
155270367|NCT00077636|560424134|FG000|Overall Study|Adverse Event|17|||
155270368|NCT00077636|560424135|FG001|Overall Study|Adverse Event|34|||
155270369|NCT00077636|560424134|FG000|Overall Study|Protocol Violation|0|||
155270370|NCT00077636|560424135|FG001|Overall Study|Protocol Violation|2|||
155270371|NCT00077636|560424134|FG000|Overall Study|Lost to Follow-up|10|||
155270372|NCT00077636|560424135|FG001|Overall Study|Lost to Follow-up|18|||
155270373|NCT00077636|560424134|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
155270374|NCT00077636|560424135|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
155270375|NCT00592319|560424136|FG000|Overall Study|Lost to Follow-up|0|||
155270376|NCT00592319|560424137|FG001|Overall Study|Lost to Follow-up|3|||
155270377|NCT02032173|560424140|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
155270378|NCT01642602|560424143|FG000|Overall Study|Adverse Event|2|||
155270379|NCT01112514|560424144|FG000|Overall Study|Lost to Follow-up|1|||
155270380|NCT02961881|560424145|FG000|Overall Study|Adverse Event|1|||
155270381|NCT02961881|560424146|FG001|Overall Study|Adverse Event|2|||
155270382|NCT02961881|560424147|FG002|Overall Study|Adverse Event|2|||
155270383|NCT02961881|560424148|FG003|Overall Study|Adverse Event|0|||
155270384|NCT02961881|560424149|FG004|Overall Study|Adverse Event|1|||
155270385|NCT02961881|560424145|FG000|Overall Study|Participant request|0|||
155270386|NCT02961881|560424146|FG001|Overall Study|Participant request|2|||
155270387|NCT02961881|560424147|FG002|Overall Study|Participant request|0|||
155270388|NCT02961881|560424148|FG003|Overall Study|Participant request|0|||
155270389|NCT02961881|560424149|FG004|Overall Study|Participant request|0|||
154931734|NCT01586624|559175152|FG006|Overall Study|Physician Decision|1|||
155270390|NCT02961881|560424145|FG000|Overall Study|Disease progression|1|||
155270391|NCT02961881|560424146|FG001|Overall Study|Disease progression|0|||
155270392|NCT02961881|560424147|FG002|Overall Study|Disease progression|1|||
155270393|NCT02961881|560424148|FG003|Overall Study|Disease progression|0|||
155270394|NCT02961881|560424149|FG004|Overall Study|Disease progression|0|||
155270395|NCT01235975|560424155|FG000|Overall Study|Serious Adverse Event|0|||
155270396|NCT01235975|560424156|FG001|Overall Study|Serious Adverse Event|1|||
155270397|NCT01235975|560424155|FG000|Overall Study|Withdrawal by Subject|8|||
155270398|NCT01235975|560424156|FG001|Overall Study|Withdrawal by Subject|2|||
155270399|NCT01235975|560424155|FG000|Overall Study|Migrated/moved from study area|2|||
155270400|NCT01235975|560424156|FG001|Overall Study|Migrated/moved from study area|1|||
155270401|NCT01235975|560424155|FG000|Overall Study|Lost to Follow-up|7|||
155270402|NCT01235975|560424156|FG001|Overall Study|Lost to Follow-up|3|||
155270403|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
155270404|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
155270405|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
155270406|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
155270407|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
155270408|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
155270409|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
155270410|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
155270411|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
155270412|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
155270413|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
155270414|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
155270415|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
155270416|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
155270417|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
155270418|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
155270419|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
155270420|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
155270421|NCT00365378|560424168|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
155270422|NCT00365378|560424169|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
155270423|NCT00365378|560424170|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
155270424|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
155270425|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
155270426|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
155270427|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
155270428|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
155270429|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
155270430|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
155270431|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
155270432|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
155270433|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
155270434|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
155270435|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
155270436|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
155270437|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
155270438|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
155270439|NCT00365378|560424168|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
155270440|NCT00365378|560424169|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
155270441|NCT00365378|560424170|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
155270442|NCT00365378|560424168|FG000|Extension|Adverse Event|0|||
155270443|NCT00365378|560424169|FG001|Extension|Adverse Event|0|||
155270444|NCT00365378|560424170|FG002|Extension|Adverse Event|1|||
155270445|NCT00365378|560424168|FG000|Extension|Moved|0|||
155270446|NCT00365378|560424169|FG001|Extension|Moved|0|||
155270447|NCT00365378|560424170|FG002|Extension|Moved|8|||
155270448|NCT00365378|560424168|FG000|Extension|Lost to Follow-up|0|||
155270449|NCT00365378|560424169|FG001|Extension|Lost to Follow-up|0|||
155270450|NCT00365378|560424170|FG002|Extension|Lost to Follow-up|57|||
155270451|NCT00365378|560424168|FG000|Extension|Protocol Violation|0|||
155270452|NCT00365378|560424169|FG001|Extension|Protocol Violation|0|||
155270453|NCT00365378|560424170|FG002|Extension|Protocol Violation|2|||
155270454|NCT00365378|560424168|FG000|Extension|Withdrawal by Subject|0|||
155270455|NCT00365378|560424169|FG001|Extension|Withdrawal by Subject|0|||
155270456|NCT00365378|560424170|FG002|Extension|Withdrawal by Subject|98|||
155270457|NCT00365378|560424168|FG000|Extension|Other|0|||
155270458|NCT00365378|560424169|FG001|Extension|Other|0|||
155270459|NCT00365378|560424170|FG002|Extension|Other|31|||
155270460|NCT00251927|560424176|FG000|Overall Study|Adverse Event|3|||
155270461|NCT00251927|560424177|FG001|Overall Study|Adverse Event|15|||
155270462|NCT00251927|560424176|FG000|Overall Study|Lack of Efficacy|22|||
155270463|NCT00251927|560424177|FG001|Overall Study|Lack of Efficacy|16|||
155270464|NCT00251927|560424176|FG000|Overall Study|Lost to Follow-up|22|||
155270465|NCT00251927|560424177|FG001|Overall Study|Lost to Follow-up|8|||
155270466|NCT00251927|560424176|FG000|Overall Study|Protocol Violation|1|||
155270467|NCT00251927|560424177|FG001|Overall Study|Protocol Violation|2|||
155270468|NCT00251927|560424176|FG000|Overall Study|Pregnancy|2|||
155270469|NCT00251927|560424177|FG001|Overall Study|Pregnancy|0|||
155270470|NCT00251927|560424176|FG000|Overall Study|Withdrawal by Subject|40|||
155270471|NCT00251927|560424177|FG001|Overall Study|Withdrawal by Subject|25|||
155381743|NCT04617275|560830984|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
155270472|NCT00251927|560424176|FG000|Overall Study|Study-specific discont. achieved|13|||
155270473|NCT00251927|560424177|FG001|Overall Study|Study-specific discont. achieved|2|||
155270474|NCT00251927|560424176|FG000|Overall Study|Study procedure non-compliance|5|||
155270475|NCT00251927|560424177|FG001|Overall Study|Study procedure non-compliance|6|||
155270476|NCT01678820|560424178|FG000|Overall Study|Study Terminated by Sponsor|45|||
155270477|NCT01678820|560424179|FG001|Overall Study|Study Terminated by Sponsor|43|||
155270478|NCT01678820|560424180|FG002|Overall Study|Study Terminated by Sponsor|43|||
155270479|NCT01678820|560424178|FG000|Overall Study|Withdrawal by Subject|2|||
155270480|NCT01678820|560424179|FG001|Overall Study|Withdrawal by Subject|5|||
155270481|NCT01678820|560424180|FG002|Overall Study|Withdrawal by Subject|2|||
155270482|NCT01678820|560424178|FG000|Overall Study|Protocol Specified Criteria|2|||
155270483|NCT01678820|560424179|FG001|Overall Study|Protocol Specified Criteria|3|||
155270484|NCT01678820|560424180|FG002|Overall Study|Protocol Specified Criteria|1|||
155270485|NCT01678820|560424178|FG000|Overall Study|Adverse Event|2|||
155270486|NCT01678820|560424179|FG001|Overall Study|Adverse Event|2|||
155270487|NCT01678820|560424180|FG002|Overall Study|Adverse Event|2|||
155270488|NCT01678820|560424178|FG000|Overall Study|Lost to Follow-up|7|||
155270489|NCT01678820|560424179|FG001|Overall Study|Lost to Follow-up|2|||
155270490|NCT01678820|560424180|FG002|Overall Study|Lost to Follow-up|2|||
155270491|NCT01678820|560424178|FG000|Overall Study|Non-compliance with study drug|0|||
155270492|NCT01678820|560424179|FG001|Overall Study|Non-compliance with study drug|1|||
155270493|NCT01678820|560424180|FG002|Overall Study|Non-compliance with study drug|0|||
155270494|NCT01678820|560424178|FG000|Overall Study|Physician Decision|0|||
155270495|NCT01678820|560424179|FG001|Overall Study|Physician Decision|0|||
155270496|NCT01678820|560424180|FG002|Overall Study|Physician Decision|1|||
155270497|NCT01678820|560424178|FG000|Overall Study|Protocol Violation|4|||
155270498|NCT01678820|560424179|FG001|Overall Study|Protocol Violation|5|||
155270499|NCT01678820|560424180|FG002|Overall Study|Protocol Violation|4|||
155270500|NCT01678820|560424178|FG000|Overall Study|Not treated with double-blind study drug|0|||
155270501|NCT01678820|560424179|FG001|Overall Study|Not treated with double-blind study drug|2|||
155270502|NCT01678820|560424180|FG002|Overall Study|Not treated with double-blind study drug|2|||
155270503|NCT00452413|560424184|FG000|Overall Study|Progressive Disease|4|||
155270504|NCT00452413|560424185|FG001|Overall Study|Progressive Disease|11|||
155270505|NCT00452413|560424186|FG002|Overall Study|Progressive Disease|30|||
155270506|NCT00452413|560424184|FG000|Overall Study|Withdrawal by Subject|0|||
155270507|NCT00452413|560424185|FG001|Overall Study|Withdrawal by Subject|1|||
155270508|NCT00452413|560424186|FG002|Overall Study|Withdrawal by Subject|4|||
155270509|NCT00452413|560424184|FG000|Overall Study|Adverse Event|0|||
155270510|NCT00452413|560424185|FG001|Overall Study|Adverse Event|0|||
155270511|NCT00452413|560424186|FG002|Overall Study|Adverse Event|5|||
155270512|NCT00452413|560424184|FG000|Overall Study|Physician Decision|0|||
155270513|NCT00452413|560424185|FG001|Overall Study|Physician Decision|0|||
155270514|NCT00452413|560424186|FG002|Overall Study|Physician Decision|4|||
155270515|NCT00452413|560424184|FG000|Overall Study|Death due to study disease|0|||
155270516|NCT00452413|560424185|FG001|Overall Study|Death due to study disease|0|||
155270517|NCT00452413|560424186|FG002|Overall Study|Death due to study disease|2|||
155270518|NCT00452413|560424184|FG000|Overall Study|Death due to adverse event (AE)|0|||
155270519|NCT00452413|560424185|FG001|Overall Study|Death due to adverse event (AE)|0|||
155270520|NCT00452413|560424186|FG002|Overall Study|Death due to adverse event (AE)|1|||
155270521|NCT00452413|560424184|FG000|Overall Study|On treatment|0|||
155270522|NCT00452413|560424185|FG001|Overall Study|On treatment|0|||
155270523|NCT00452413|560424186|FG002|Overall Study|On treatment|3|||
155270524|NCT03119610|560424188|FG000|Overall Study|Adverse Event|1|||
155270525|NCT03119610|560424189|FG001|Overall Study|Adverse Event|0|||
155270526|NCT03119610|560424188|FG000|Overall Study|Lost to Follow-up|0|||
155270527|NCT03119610|560424189|FG001|Overall Study|Lost to Follow-up|1|||
155270528|NCT00114634|560424214|FG000|Overall Study|failure to return forms|3|||
155270529|NCT00684762|560424215|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
155270530|NCT00684762|560424216|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
155270531|NCT01539863|560424223|FG000|Overall Study|Lost to Follow-up|5|||
155270532|NCT01539863|560424224|FG001|Overall Study|Lost to Follow-up|4|||
155270533|NCT02693834|560424225|FG000|Baseline Measurement|Withdrawal by Subject|1|||
155270534|NCT02693834|560424226|FG001|Baseline Measurement|Withdrawal by Subject|0|||
155270535|NCT02693834|560424225|FG000|Baseline Measurement|Adverse Event|1|||
155270536|NCT02693834|560424226|FG001|Baseline Measurement|Adverse Event|0|||
155270537|NCT02693834|560424225|FG000|Week 2 Practice|Adverse Event|0|||
155270538|NCT02693834|560424226|FG001|Week 2 Practice|Adverse Event|1|||
155270539|NCT03306043|560424233|FG000|Overall Study|Adverse Event|1|||
155270540|NCT03306043|560424233|FG000|Overall Study|Lost to Follow-up|1|||
155381744|NCT04617275|560830985|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
155043023|NCT00401193|559590037|FG000|Overall Study|Lost to Follow-up|6|||
155270541|NCT03306043|560424233|FG000|Overall Study|Withdrawal by Subject|2|||
155270542|NCT01544491|560424234|FG000|Overall Study|Withdrawal by Subject|3|||
155270543|NCT01544491|560424235|FG001|Overall Study|Withdrawal by Subject|2|||
155270544|NCT01544491|560424234|FG000|Overall Study|Lost to Follow-up|0|||
155270545|NCT01544491|560424235|FG001|Overall Study|Lost to Follow-up|1|||
155270546|NCT01544491|560424234|FG000|Overall Study|administrative problems|2|||
155270547|NCT01544491|560424235|FG001|Overall Study|administrative problems|0|||
155270548|NCT05229653|560424237|FG000|Overall Study|Lost to Follow-up|1|||
155043024|NCT00401193|559590038|FG001|Overall Study|Lost to Follow-up|5|||
155270549|NCT05229653|560424238|FG001|Overall Study|Lost to Follow-up|0|||
155270550|NCT05295732|560424239|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
155270551|NCT05295732|560424240|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
155270552|NCT05295732|560424241|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
155270553|NCT05295732|560424242|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
155270554|NCT05295732|560424243|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
155270555|NCT05295732|560424239|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
155270556|NCT05295732|560424240|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
155270557|NCT05295732|560424241|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
155270558|NCT05295732|560424242|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
155270559|NCT05295732|560424243|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
155270560|NCT00550550|560424244|FG000|Overall Study|Adverse Event|13|||
155270561|NCT00550550|560424245|FG001|Overall Study|Adverse Event|5|||
155270562|NCT00550550|560424244|FG000|Overall Study|Treatment Failure|0|||
155270563|NCT00550550|560424245|FG001|Overall Study|Treatment Failure|1|||
155270564|NCT00550550|560424244|FG000|Overall Study|Lost to Follow-up|4|||
155270565|NCT00550550|560424245|FG001|Overall Study|Lost to Follow-up|0|||
155270566|NCT00550550|560424244|FG000|Overall Study|Withdrawal by Subject|10|||
155270567|NCT00550550|560424245|FG001|Overall Study|Withdrawal by Subject|8|||
155270568|NCT00550550|560424244|FG000|Overall Study|Protocol Violation|5|||
155270569|NCT00550550|560424245|FG001|Overall Study|Protocol Violation|14|||
155270570|NCT00550550|560424244|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
155270571|NCT00550550|560424245|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
155270572|NCT00550550|560424244|FG000|Overall Study|Randomized But Not Treated|1|||
155270573|NCT00550550|560424245|FG001|Overall Study|Randomized But Not Treated|0|||
155270574|NCT02459093|560424246|FG000|Overall Study|Protocol Violation|6|||
155270575|NCT02459093|560424247|FG001|Overall Study|Protocol Violation|11|||
155270576|NCT02459093|560424246|FG000|Overall Study|Lost to Follow-up|6|||
155270577|NCT02459093|560424247|FG001|Overall Study|Lost to Follow-up|7|||
155270578|NCT00591864|560424248|FG000|Overall Study|Incomplete Imaging|5|||
155270579|NCT00118092|560424253|FG000|Overall Study|Withdrawal by Subject|1|||
155270580|NCT00118092|560424253|FG000|Overall Study|Protocol Violation|1|||
155270581|NCT03311230|560424258|FG000|Overall Study|Withdrawal by Subject|1|||
155270582|NCT03311230|560424259|FG001|Overall Study|Withdrawal by Subject|4|||
155270583|NCT03311230|560424260|FG002|Overall Study|Withdrawal by Subject|2|||
155270584|NCT03311230|560424261|FG003|Overall Study|Withdrawal by Subject|7|||
155270585|NCT03311230|560424258|FG000|Overall Study|Unrelated injury|0|||
155270586|NCT03311230|560424259|FG001|Overall Study|Unrelated injury|1|||
155270587|NCT03311230|560424260|FG002|Overall Study|Unrelated injury|0|||
155270588|NCT03311230|560424261|FG003|Overall Study|Unrelated injury|0|||
155270589|NCT01302938|560424262|FG000|Overall Study|Withdrawal by Subject|1|||
155270590|NCT01302938|560424263|FG001|Overall Study|Withdrawal by Subject|0|||
155270591|NCT01302938|560424262|FG000|Overall Study|Adverse Event|1|||
155270592|NCT01302938|560424263|FG001|Overall Study|Adverse Event|0|||
155270593|NCT03342053|560424264|FG000|Overall Study|Adverse Event|2|||
155270594|NCT03342053|560424265|FG001|Overall Study|Adverse Event|0|||
155270595|NCT03342053|560424264|FG000|Overall Study|Withdrawal by Subject|0|||
155270596|NCT03342053|560424265|FG001|Overall Study|Withdrawal by Subject|1|||
155270597|NCT02294474|560424266|FG000|Overall Study|Adverse Event|7|||
155270598|NCT02294474|560424267|FG001|Overall Study|Adverse Event|7|||
155270599|NCT02294474|560424266|FG000|Overall Study|Lack of Efficacy|2|||
155270600|NCT02294474|560424267|FG001|Overall Study|Lack of Efficacy|1|||
155270601|NCT02294474|560424266|FG000|Overall Study|Protocol Violation|4|||
155270602|NCT02294474|560424267|FG001|Overall Study|Protocol Violation|2|||
155270603|NCT02294474|560424266|FG000|Overall Study|Other than specified above|12|||
155270604|NCT02294474|560424267|FG001|Overall Study|Other than specified above|12|||
155270605|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270606|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
155381745|NCT04617275|560830986|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
155270607|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
155270608|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270609|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270610|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270611|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
155270612|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
155270613|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270614|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270615|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270616|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270617|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270618|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155270619|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
155270620|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
155270621|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
155270622|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270623|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270624|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270625|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155270626|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270627|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
155270628|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
155270629|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270630|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270631|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270632|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
155270633|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270634|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270635|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
155270636|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270637|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270638|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270639|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
155270640|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
155270641|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
155270642|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
155270643|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270644|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270645|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270646|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155270647|NCT04921969|560424275|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
155270648|NCT04921969|560424276|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
155270649|NCT04921969|560424277|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270650|NCT04921969|560424278|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270651|NCT04921969|560424279|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270652|NCT04921969|560424280|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270653|NCT04921969|560424281|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
155270654|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270655|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270656|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270657|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270658|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270659|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
155270660|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
155270661|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270662|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270663|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270664|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
155270665|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155270666|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
155270667|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
155270668|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155270669|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155270670|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155270671|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
155270672|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
155270673|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
155270674|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
155270675|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270676|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270677|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270678|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
155270679|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
155270680|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
155270681|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
155270682|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155270683|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155270684|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155270685|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
155270686|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
155270687|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
155270688|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
155270689|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270690|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270691|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270692|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
155270693|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
155270694|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
155270695|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
155270696|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270697|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270698|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270699|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
155270700|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270701|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
155270702|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
155270703|NCT04921969|560424275|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270704|NCT04921969|560424276|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270705|NCT04921969|560424277|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270706|NCT04921969|560424278|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270707|NCT04921969|560424279|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
155270708|NCT04921969|560424280|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
155270709|NCT04921969|560424281|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
155270710|NCT04287868|560424282|FG000|Overall Study|Screening fail|1|||
155270711|NCT04287868|560424283|FG001|Overall Study|Screening fail|0|||
155270712|NCT02291289|560425739|FG000|Induction Treatment|Withdrawal by Subject|0|||
155270713|NCT02291289|560425740|FG001|Induction Treatment|Withdrawal by Subject|0|||
155270714|NCT02291289|560425741|FG002|Induction Treatment|Withdrawal by Subject|0|||
155270715|NCT02291289|560425742|FG003|Induction Treatment|Withdrawal by Subject|24|||
155270716|NCT02291289|560425743|FG004|Induction Treatment|Withdrawal by Subject|0|||
155270717|NCT02291289|560425744|FG005|Induction Treatment|Withdrawal by Subject|0|||
155270718|NCT02291289|560425745|FG006|Induction Treatment|Withdrawal by Subject|0|||
155270719|NCT02291289|560425746|FG007|Induction Treatment|Withdrawal by Subject|0|||
155270720|NCT02291289|560425747|FG008|Induction Treatment|Withdrawal by Subject|0|||
155270721|NCT02291289|560425748|FG009|Induction Treatment|Withdrawal by Subject|18|||
155270722|NCT02291289|560425749|FG010|Induction Treatment|Withdrawal by Subject|0|||
155270723|NCT02291289|560425750|FG011|Induction Treatment|Withdrawal by Subject|0|||
155270724|NCT02291289|560425751|FG012|Induction Treatment|Withdrawal by Subject|0|||
155270725|NCT02291289|560425739|FG000|Induction Treatment|Adverse Event|0|||
155270726|NCT02291289|560425740|FG001|Induction Treatment|Adverse Event|0|||
155270727|NCT02291289|560425741|FG002|Induction Treatment|Adverse Event|0|||
155270728|NCT02291289|560425742|FG003|Induction Treatment|Adverse Event|3|||
155270729|NCT02291289|560425743|FG004|Induction Treatment|Adverse Event|0|||
155270730|NCT02291289|560425744|FG005|Induction Treatment|Adverse Event|0|||
155270731|NCT02291289|560425745|FG006|Induction Treatment|Adverse Event|0|||
155270732|NCT02291289|560425746|FG007|Induction Treatment|Adverse Event|0|||
155270733|NCT02291289|560425747|FG008|Induction Treatment|Adverse Event|0|||
155270734|NCT02291289|560425748|FG009|Induction Treatment|Adverse Event|1|||
155270735|NCT02291289|560425749|FG010|Induction Treatment|Adverse Event|0|||
155270736|NCT02291289|560425750|FG011|Induction Treatment|Adverse Event|0|||
155381746|NCT04617275|560830987|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
154931735|NCT01586624|559175153|FG007|Overall Study|Physician Decision|1|||
154931736|NCT01586624|559175146|FG000|Overall Study|Withdrawal by Subject|0|||
154931737|NCT01586624|559175147|FG001|Overall Study|Withdrawal by Subject|0|||
154931738|NCT01586624|559175148|FG002|Overall Study|Withdrawal by Subject|0|||
154931739|NCT01586624|559175149|FG003|Overall Study|Withdrawal by Subject|1|||
154931740|NCT01586624|559175150|FG004|Overall Study|Withdrawal by Subject|0|||
154931741|NCT01586624|559175151|FG005|Overall Study|Withdrawal by Subject|0|||
154931742|NCT01586624|559175152|FG006|Overall Study|Withdrawal by Subject|0|||
154931743|NCT01586624|559175153|FG007|Overall Study|Withdrawal by Subject|0|||
154931744|NCT01586624|559175146|FG000|Overall Study|Evidence of disease progression|1|||
154931745|NCT01586624|559175147|FG001|Overall Study|Evidence of disease progression|3|||
154931746|NCT01586624|559175148|FG002|Overall Study|Evidence of disease progression|2|||
154931747|NCT01586624|559175149|FG003|Overall Study|Evidence of disease progression|5|||
154931748|NCT01586624|559175150|FG004|Overall Study|Evidence of disease progression|3|||
154931749|NCT01586624|559175151|FG005|Overall Study|Evidence of disease progression|5|||
154931750|NCT01586624|559175152|FG006|Overall Study|Evidence of disease progression|4|||
154931751|NCT01586624|559175153|FG007|Overall Study|Evidence of disease progression|6|||
154931752|NCT01586624|559175146|FG000|Overall Study|Screen failure (no treatment received)|0|||
155043025|NCT00401193|559590039|FG002|Overall Study|Lost to Follow-up|1|||
154931753|NCT01586624|559175147|FG001|Overall Study|Screen failure (no treatment received)|0|||
155270737|NCT02291289|560425751|FG012|Induction Treatment|Adverse Event|0|||
155270738|NCT02291289|560425739|FG000|Induction Treatment|Death|25|||
155270739|NCT02291289|560425740|FG001|Induction Treatment|Death|0|||
155270740|NCT02291289|560425741|FG002|Induction Treatment|Death|0|||
155270741|NCT02291289|560425742|FG003|Induction Treatment|Death|111|||
155270742|NCT02291289|560425743|FG004|Induction Treatment|Death|0|||
155270743|NCT02291289|560425744|FG005|Induction Treatment|Death|0|||
155270744|NCT02291289|560425745|FG006|Induction Treatment|Death|1|||
155381747|NCT04617275|560830988|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
155381748|NCT04617275|560830989|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
155381749|NCT04617275|560830990|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
155381750|NCT04617275|560830991|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
155381751|NCT04617275|560830984|FG000|Follow-up Period|Other|0|||
155381752|NCT04617275|560830985|FG001|Follow-up Period|Other|1|||
155381753|NCT04617275|560830986|FG002|Follow-up Period|Other|0|||
155381754|NCT04617275|560830987|FG003|Follow-up Period|Other|0|||
155381755|NCT04617275|560830988|FG004|Follow-up Period|Other|0|||
155381756|NCT04617275|560830989|FG005|Follow-up Period|Other|0|||
155381757|NCT04617275|560830990|FG006|Follow-up Period|Other|0|||
155381758|NCT04617275|560830991|FG007|Follow-up Period|Other|0|||
155381759|NCT04617275|560830984|FG000|Follow-up Period|Withdrawal by Subject|2|||
155381760|NCT04617275|560830985|FG001|Follow-up Period|Withdrawal by Subject|0|||
155381761|NCT04617275|560830986|FG002|Follow-up Period|Withdrawal by Subject|0|||
155381762|NCT04617275|560830987|FG003|Follow-up Period|Withdrawal by Subject|2|||
155381763|NCT04617275|560830988|FG004|Follow-up Period|Withdrawal by Subject|2|||
155381764|NCT04617275|560830989|FG005|Follow-up Period|Withdrawal by Subject|0|||
155381765|NCT04617275|560830990|FG006|Follow-up Period|Withdrawal by Subject|1|||
155381766|NCT04617275|560830991|FG007|Follow-up Period|Withdrawal by Subject|2|||
155381767|NCT00729378|560833192|FG000|Baseline|Did not complete study measurements|72|||
155381768|NCT00729378|560833193|FG001|Baseline|Did not complete study measurements|33|||
155381769|NCT00729378|560833192|FG000|Baseline|Withdrawal by Subject|66|||
155381770|NCT00729378|560833193|FG001|Baseline|Withdrawal by Subject|59|||
155270745|NCT02291289|560425746|FG007|Induction Treatment|Death|0|||
155270746|NCT02291289|560425747|FG008|Induction Treatment|Death|0|||
155270747|NCT02291289|560425748|FG009|Induction Treatment|Death|82|||
155270748|NCT02291289|560425749|FG010|Induction Treatment|Death|0|||
155270749|NCT02291289|560425750|FG011|Induction Treatment|Death|0|||
155270750|NCT02291289|560425751|FG012|Induction Treatment|Death|0|||
155270751|NCT02291289|560425739|FG000|Induction Treatment|Lost to Follow-up|1|||
155270752|NCT02291289|560425740|FG001|Induction Treatment|Lost to Follow-up|0|||
155270753|NCT02291289|560425741|FG002|Induction Treatment|Lost to Follow-up|0|||
155270754|NCT02291289|560425742|FG003|Induction Treatment|Lost to Follow-up|12|||
155270755|NCT02291289|560425743|FG004|Induction Treatment|Lost to Follow-up|0|||
155270756|NCT02291289|560425744|FG005|Induction Treatment|Lost to Follow-up|0|||
155270757|NCT02291289|560425745|FG006|Induction Treatment|Lost to Follow-up|0|||
155270758|NCT02291289|560425746|FG007|Induction Treatment|Lost to Follow-up|0|||
155270759|NCT02291289|560425747|FG008|Induction Treatment|Lost to Follow-up|0|||
155270760|NCT02291289|560425748|FG009|Induction Treatment|Lost to Follow-up|9|||
155270761|NCT02291289|560425749|FG010|Induction Treatment|Lost to Follow-up|0|||
155270762|NCT02291289|560425750|FG011|Induction Treatment|Lost to Follow-up|0|||
155270763|NCT02291289|560425751|FG012|Induction Treatment|Lost to Follow-up|0|||
155270764|NCT02291289|560425739|FG000|Induction Treatment|Non-Compliance|0|||
155270765|NCT02291289|560425740|FG001|Induction Treatment|Non-Compliance|0|||
155270766|NCT02291289|560425741|FG002|Induction Treatment|Non-Compliance|0|||
155270767|NCT02291289|560425742|FG003|Induction Treatment|Non-Compliance|1|||
155270768|NCT02291289|560425743|FG004|Induction Treatment|Non-Compliance|0|||
155270769|NCT02291289|560425744|FG005|Induction Treatment|Non-Compliance|0|||
155270770|NCT02291289|560425745|FG006|Induction Treatment|Non-Compliance|0|||
155270771|NCT02291289|560425746|FG007|Induction Treatment|Non-Compliance|0|||
155270772|NCT02291289|560425747|FG008|Induction Treatment|Non-Compliance|0|||
155270773|NCT02291289|560425748|FG009|Induction Treatment|Non-Compliance|1|||
155270774|NCT02291289|560425749|FG010|Induction Treatment|Non-Compliance|0|||
155270775|NCT02291289|560425750|FG011|Induction Treatment|Non-Compliance|0|||
155270776|NCT02291289|560425751|FG012|Induction Treatment|Non-Compliance|0|||
155270777|NCT02291289|560425739|FG000|Induction Treatment|Reason Not Specified|0|||
155270778|NCT02291289|560425740|FG001|Induction Treatment|Reason Not Specified|0|||
155270779|NCT02291289|560425741|FG002|Induction Treatment|Reason Not Specified|0|||
155270780|NCT02291289|560425742|FG003|Induction Treatment|Reason Not Specified|4|||
155270781|NCT02291289|560425743|FG004|Induction Treatment|Reason Not Specified|0|||
155270782|NCT02291289|560425744|FG005|Induction Treatment|Reason Not Specified|0|||
155270783|NCT02291289|560425745|FG006|Induction Treatment|Reason Not Specified|0|||
155270784|NCT02291289|560425746|FG007|Induction Treatment|Reason Not Specified|0|||
155270785|NCT02291289|560425747|FG008|Induction Treatment|Reason Not Specified|0|||
155270786|NCT02291289|560425748|FG009|Induction Treatment|Reason Not Specified|7|||
155270787|NCT02291289|560425749|FG010|Induction Treatment|Reason Not Specified|0|||
155270788|NCT02291289|560425750|FG011|Induction Treatment|Reason Not Specified|0|||
155381771|NCT00729378|560833192|FG000|12-months|Lost to Follow-up|100|||
155381772|NCT00729378|560833193|FG001|12-months|Lost to Follow-up|65|||
155381773|NCT00729378|560833192|FG000|24-months|Lost to Follow-up|72|||
155270789|NCT02291289|560425751|FG012|Induction Treatment|Reason Not Specified|0|||
155270790|NCT02291289|560425739|FG000|Induction Treatment|Physician Decision|0|||
155381774|NCT00729378|560833193|FG001|24-months|Lost to Follow-up|51|||
155270791|NCT02291289|560425740|FG001|Induction Treatment|Physician Decision|0|||
155270792|NCT02291289|560425741|FG002|Induction Treatment|Physician Decision|0|||
155270793|NCT02291289|560425742|FG003|Induction Treatment|Physician Decision|3|||
154931754|NCT01586624|559175148|FG002|Overall Study|Screen failure (no treatment received)|0|||
154931755|NCT01586624|559175149|FG003|Overall Study|Screen failure (no treatment received)|0|||
154931756|NCT01586624|559175150|FG004|Overall Study|Screen failure (no treatment received)|0|||
154931757|NCT01586624|559175151|FG005|Overall Study|Screen failure (no treatment received)|0|||
154931758|NCT01586624|559175152|FG006|Overall Study|Screen failure (no treatment received)|1|||
154931759|NCT01586624|559175153|FG007|Overall Study|Screen failure (no treatment received)|0|||
154931760|NCT03578276|559175156|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
154931761|NCT03578276|559175157|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
154931762|NCT02360397|559175160|FG000|Overall Study|Incomplete screening|3|||
154931763|NCT02360397|559175160|FG000|Overall Study|Adverse Event|1|||
154931764|NCT04256759|559175161|FG000|Overall Study|Physician Decision|1|||
154931765|NCT04256759|559175161|FG000|Overall Study|Lack of Efficacy|1|||
154931766|NCT04075292|559175162|FG000|Overall Study|Withdrawal by Subject|1|||
154931767|NCT04075292|559175163|FG001|Overall Study|Withdrawal by Subject|9|||
154931768|NCT04075292|559175162|FG000|Overall Study|Death|2|||
154931769|NCT04075292|559175163|FG001|Overall Study|Death|5|||
154931770|NCT04075292|559175162|FG000|Overall Study|Remained on study at time of DCO|74|||
154931771|NCT04075292|559175163|FG001|Overall Study|Remained on study at time of DCO|64|||
154931772|NCT00185731|559175164|FG000|Overall Study|Withdrawal by Subject|1|||
154931773|NCT00185731|559175164|FG000|Overall Study|Not Eligible|1|||
154931774|NCT02494583|559175165|FG000|Overall Study|Death|224|||
154931775|NCT02494583|559175166|FG001|Overall Study|Death|214|||
154931776|NCT02494583|559175167|FG002|Overall Study|Death|225|||
154931777|NCT02494583|559175165|FG000|Overall Study|Lost to Follow-up|1|||
154931778|NCT02494583|559175166|FG001|Overall Study|Lost to Follow-up|0|||
154931779|NCT02494583|559175167|FG002|Overall Study|Lost to Follow-up|0|||
154931780|NCT02494583|559175165|FG000|Overall Study|Protocol Violation|1|||
154931781|NCT02494583|559175166|FG001|Overall Study|Protocol Violation|2|||
154931782|NCT02494583|559175167|FG002|Overall Study|Protocol Violation|0|||
154931783|NCT02494583|559175165|FG000|Overall Study|Screen Failure|0|||
154931784|NCT02494583|559175166|FG001|Overall Study|Screen Failure|1|||
154931785|NCT02494583|559175167|FG002|Overall Study|Screen Failure|0|||
154931786|NCT02494583|559175165|FG000|Overall Study|Transferred to Extension Study|15|||
154931787|NCT02494583|559175166|FG001|Overall Study|Transferred to Extension Study|15|||
154931788|NCT02494583|559175167|FG002|Overall Study|Transferred to Extension Study|6|||
154931789|NCT02494583|559175165|FG000|Overall Study|Did Not Continue on Extension Study|8|||
154931790|NCT02494583|559175166|FG001|Overall Study|Did Not Continue on Extension Study|10|||
154931791|NCT02494583|559175167|FG002|Overall Study|Did Not Continue on Extension Study|4|||
154931792|NCT02494583|559175165|FG000|Overall Study|Withdrawal by Subject|7|||
154931793|NCT02494583|559175166|FG001|Overall Study|Withdrawal by Subject|15|||
154931794|NCT02494583|559175167|FG002|Overall Study|Withdrawal by Subject|15|||
154931795|NCT00627458|559175168|FG000|Overall Study|Migrated from study area|1|||
154931796|NCT00627458|559175169|FG001|Overall Study|Migrated from study area|0|||
154931797|NCT00627458|559175170|FG002|Overall Study|Migrated from study area|1|||
154931798|NCT00627458|559175168|FG000|Overall Study|Withdrawal by Subject|2|||
154931799|NCT00627458|559175169|FG001|Overall Study|Withdrawal by Subject|6|||
154931800|NCT00627458|559175170|FG002|Overall Study|Withdrawal by Subject|5|||
154931801|NCT00627458|559175168|FG000|Overall Study|Lost to Follow-up|1|||
154931802|NCT00627458|559175169|FG001|Overall Study|Lost to Follow-up|1|||
154931803|NCT00627458|559175170|FG002|Overall Study|Lost to Follow-up|0|||
154931804|NCT03891875|559175171|FG000|Overall Study|Withdrawal by Subject|20|||
154931805|NCT03891875|559175172|FG001|Overall Study|Withdrawal by Subject|3|||
154931806|NCT03891875|559175171|FG000|Overall Study|Adverse Event|10|||
154931807|NCT03891875|559175172|FG001|Overall Study|Adverse Event|4|||
154931808|NCT03891875|559175171|FG000|Overall Study|Physician Decision|1|||
154931809|NCT03891875|559175172|FG001|Overall Study|Physician Decision|1|||
154931810|NCT03891875|559175171|FG000|Overall Study|Protocol Violation|1|||
154931811|NCT03891875|559175172|FG001|Overall Study|Protocol Violation|0|||
154931812|NCT03891875|559175171|FG000|Overall Study|Lost to Follow-up|1|||
154931813|NCT03891875|559175172|FG001|Overall Study|Lost to Follow-up|0|||
154931814|NCT03891875|559175171|FG000|Overall Study|COVID-19 infection|1|||
154931815|NCT03891875|559175172|FG001|Overall Study|COVID-19 infection|0|||
154931816|NCT01787188|559175173|FG000|Overall Study|Adverse Event|2|||
154931817|NCT01787188|559175174|FG001|Overall Study|Adverse Event|4|||
155043026|NCT00401193|559590037|FG000|Overall Study|Withdrawal by Subject|2|||
155043027|NCT00401193|559590038|FG001|Overall Study|Withdrawal by Subject|0|||
155043028|NCT00401193|559590039|FG002|Overall Study|Withdrawal by Subject|1|||
155381775|NCT00729378|560833192|FG000|36-months|Lost to Follow-up|15|||
154931818|NCT01787188|559175175|FG002|Overall Study|Adverse Event|6|||
154931819|NCT01787188|559175173|FG000|Overall Study|Lack of Efficacy|7|||
154931820|NCT01787188|559175174|FG001|Overall Study|Lack of Efficacy|3|||
154931821|NCT01787188|559175175|FG002|Overall Study|Lack of Efficacy|5|||
154931822|NCT01787188|559175173|FG000|Overall Study|Non-compliance with Study Drug|0|||
154931823|NCT01787188|559175174|FG001|Overall Study|Non-compliance with Study Drug|1|||
154931824|NCT01787188|559175175|FG002|Overall Study|Non-compliance with Study Drug|0|||
154931825|NCT01787188|559175173|FG000|Overall Study|Withdrawal by Subject|4|||
154931826|NCT01787188|559175174|FG001|Overall Study|Withdrawal by Subject|3|||
154931827|NCT01787188|559175175|FG002|Overall Study|Withdrawal by Subject|2|||
154931828|NCT01787188|559175173|FG000|Overall Study|Protocol Violation|3|||
154931829|NCT01787188|559175174|FG001|Overall Study|Protocol Violation|2|||
154931830|NCT01787188|559175175|FG002|Overall Study|Protocol Violation|3|||
154931831|NCT01787188|559175173|FG000|Overall Study|Lost to Follow-up|1|||
154931832|NCT01787188|559175174|FG001|Overall Study|Lost to Follow-up|2|||
154931833|NCT01787188|559175175|FG002|Overall Study|Lost to Follow-up|2|||
154931834|NCT01787188|559175173|FG000|Overall Study|Other, including patient moved|0|||
154931835|NCT01787188|559175174|FG001|Overall Study|Other, including patient moved|3|||
154931836|NCT01787188|559175175|FG002|Overall Study|Other, including patient moved|0|||
154931837|NCT00854607|559175176|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
154931838|NCT02268045|559175184|FG000|Overall Study|Death|4|||
154931839|NCT02268045|559175185|FG001|Overall Study|Death|4|||
154931840|NCT02268045|559175184|FG000|Overall Study|Disease Progression|2|||
154931841|NCT02268045|559175185|FG001|Overall Study|Disease Progression|1|||
154931842|NCT02268045|559175184|FG000|Overall Study|Adverse Event|7|||
154931843|NCT02268045|559175185|FG001|Overall Study|Adverse Event|7|||
154931844|NCT02268045|559175184|FG000|Overall Study|Withdrawal by Subject|2|||
154931845|NCT02268045|559175185|FG001|Overall Study|Withdrawal by Subject|6|||
154931846|NCT02268045|559175184|FG000|Overall Study|Physician Decision|0|||
154931847|NCT02268045|559175185|FG001|Overall Study|Physician Decision|1|||
154931848|NCT02268045|559175184|FG000|Overall Study|Protocol Violation|1|||
154931849|NCT02268045|559175185|FG001|Overall Study|Protocol Violation|1|||
154931850|NCT03151707|559175186|FG000|Overall Study|Lost to Follow-up|6|||
154931851|NCT00646282|559175188|FG000|Overall Study|Protocol terminated|4|||
154931852|NCT00646282|559175189|FG001|Overall Study|Protocol terminated|4|||
154931853|NCT02181842|559175193|FG000|Overall Study|Case Report Forms Uncollected|2|||
154931854|NCT01652872|559175194|FG000|Overall Study|Death|36|||
154931855|NCT01652872|559175195|FG001|Overall Study|Death|39|||
154931856|NCT01652872|559175194|FG000|Overall Study|Lost to Follow-up|28|||
154931857|NCT01652872|559175195|FG001|Overall Study|Lost to Follow-up|23|||
154931858|NCT01652872|559175194|FG000|Overall Study|Decision by sponsor|5|||
154931859|NCT01652872|559175195|FG001|Overall Study|Decision by sponsor|7|||
154931860|NCT01652872|559175194|FG000|Overall Study|Withdrawal by Subject|76|||
154931861|NCT01652872|559175195|FG001|Overall Study|Withdrawal by Subject|84|||
154931862|NCT00758706|559175196|FG000|Overall Study|Adverse Event|4|||
154931863|NCT00758706|559175197|FG001|Overall Study|Adverse Event|4|||
154931864|NCT03985293|559175212|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
154931865|NCT03985293|559175213|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
154931866|NCT03985293|559175214|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
154931867|NCT03985293|559175215|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
154931868|NCT03985293|559175216|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
154931869|NCT03985293|559175217|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
154931870|NCT03985293|559175212|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
154931871|NCT03985293|559175213|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
154931872|NCT03985293|559175214|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
154931873|NCT03985293|559175215|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
154931874|NCT03985293|559175216|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
154931875|NCT03985293|559175217|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
154931876|NCT03985293|559175212|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
154931877|NCT03985293|559175213|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
154931878|NCT03985293|559175214|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
154931879|NCT03985293|559175215|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
154931880|NCT03985293|559175216|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
154931881|NCT03985293|559175217|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
154931882|NCT03985293|559175212|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
154931883|NCT03985293|559175213|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
154931884|NCT03985293|559175214|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
154931885|NCT03985293|559175215|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
154931886|NCT03985293|559175216|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
154931887|NCT03985293|559175217|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
154931888|NCT03985293|559175212|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
154931889|NCT03985293|559175213|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
154931890|NCT03985293|559175214|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
154931891|NCT03985293|559175215|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
155043029|NCT00401193|559590037|FG000|Overall Study|Other Event|3|||
155381776|NCT00729378|560833193|FG001|36-months|Lost to Follow-up|6|||
154931892|NCT03985293|559175216|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
154931893|NCT03985293|559175217|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
154931894|NCT03985293|559175212|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
154931895|NCT03985293|559175213|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
154931896|NCT03985293|559175214|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
154931897|NCT03985293|559175215|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
154931898|NCT03985293|559175216|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
154931899|NCT03985293|559175217|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
154931900|NCT03985293|559175212|FG000|FOLLOW-UP|Lost to Follow-up|0|||
154931901|NCT03985293|559175213|FG001|FOLLOW-UP|Lost to Follow-up|0|||
154931902|NCT03985293|559175214|FG002|FOLLOW-UP|Lost to Follow-up|1|||
154931903|NCT03985293|559175215|FG003|FOLLOW-UP|Lost to Follow-up|0|||
154931904|NCT03985293|559175216|FG004|FOLLOW-UP|Lost to Follow-up|0|||
154931905|NCT03985293|559175217|FG005|FOLLOW-UP|Lost to Follow-up|0|||
154931906|NCT03107715|559175218|FG000|Overall Study|did not deliver at the home hospital|4|||
154931907|NCT03107715|559175219|FG001|Overall Study|did not deliver at the home hospital|6|||
154931908|NCT03107715|559175218|FG000|Overall Study|infant stillborn|0|||
154931909|NCT03107715|559175219|FG001|Overall Study|infant stillborn|1|||
154931910|NCT03252756|559175222|FG000|Overall Study|Protocol Violation|2|||
154931911|NCT03252756|559175223|FG001|Overall Study|Protocol Violation|4|||
154931912|NCT03252756|559175222|FG000|Overall Study|COVID-19 Pandemic|1|||
154931913|NCT03252756|559175223|FG001|Overall Study|COVID-19 Pandemic|1|||
154931914|NCT03252756|559175222|FG000|Overall Study|Study Drug Expiration|0|||
154931915|NCT03252756|559175223|FG001|Overall Study|Study Drug Expiration|1|||
154931916|NCT03594175|559175224|FG000|Overall Study|Not treated|8|||
154931917|NCT03594175|559175225|FG001|Overall Study|Not treated|1|||
154931918|NCT03594175|559175226|FG002|Overall Study|Not treated|5|||
154931919|NCT03594175|559175224|FG000|Overall Study|Adverse Event|3|||
154931920|NCT03594175|559175225|FG001|Overall Study|Adverse Event|0|||
154931921|NCT03594175|559175226|FG002|Overall Study|Adverse Event|0|||
154931922|NCT03594175|559175224|FG000|Overall Study|Withdrawal by Subject|3|||
154931923|NCT03594175|559175225|FG001|Overall Study|Withdrawal by Subject|0|||
154931924|NCT03594175|559175226|FG002|Overall Study|Withdrawal by Subject|0|||
154931925|NCT03594175|559175224|FG000|Overall Study|Protocol Violation|2|||
154931926|NCT03594175|559175225|FG001|Overall Study|Protocol Violation|2|||
154931927|NCT03594175|559175226|FG002|Overall Study|Protocol Violation|2|||
154931928|NCT00633217|559175227|FG000|Overall Study|Adverse Event|5|||
154931929|NCT00633217|559175228|FG001|Overall Study|Adverse Event|9|||
154931930|NCT00633217|559175227|FG000|Overall Study|Lack of Efficacy|0|||
154931931|NCT00633217|559175228|FG001|Overall Study|Lack of Efficacy|2|||
154931932|NCT00633217|559175227|FG000|Overall Study|Protocol Violation|3|||
154931933|NCT00633217|559175228|FG001|Overall Study|Protocol Violation|7|||
154931934|NCT00633217|559175227|FG000|Overall Study|Lost to Follow-up|2|||
154931935|NCT00633217|559175228|FG001|Overall Study|Lost to Follow-up|2|||
154931936|NCT00633217|559175227|FG000|Overall Study|Investigator Discretion|2|||
154931937|NCT00633217|559175228|FG001|Overall Study|Investigator Discretion|0|||
154931938|NCT00633217|559175227|FG000|Overall Study|Withdrew Consent|3|||
154931939|NCT00633217|559175228|FG001|Overall Study|Withdrew Consent|3|||
154931940|NCT04822701|559175229|FG000|Overall Study|Not treated|2|||
154931941|NCT04822701|559175230|FG001|Overall Study|Not treated|0|||
154931942|NCT04822701|559175229|FG000|Overall Study|Lost to Follow-up|1|||
154931943|NCT04822701|559175230|FG001|Overall Study|Lost to Follow-up|0|||
154931944|NCT04822701|559175229|FG000|Overall Study|Withdrawal by Subject|1|||
154931945|NCT04822701|559175230|FG001|Overall Study|Withdrawal by Subject|0|||
154931946|NCT03560466|559175231|FG000|Overall Study|Adverse Event|1|||
154931947|NCT03560466|559175232|FG001|Overall Study|Adverse Event|2|||
154931948|NCT03560466|559175233|FG002|Overall Study|Adverse Event|0|||
154931949|NCT03560466|559175231|FG000|Overall Study|Poor Compliance to Protocol|0|||
154931950|NCT03560466|559175232|FG001|Overall Study|Poor Compliance to Protocol|2|||
154931951|NCT03560466|559175233|FG002|Overall Study|Poor Compliance to Protocol|0|||
154931952|NCT03560466|559175231|FG000|Overall Study|Other|6|||
154931953|NCT03560466|559175232|FG001|Overall Study|Other|8|||
154931954|NCT03560466|559175233|FG002|Overall Study|Other|1|||
154931955|NCT02996448|559177120|FG000|Overall Study|Study terminated due to adverse effects|3|||
154931956|NCT01160198|559177129|FG000|Overall Study|Withdrawal by Subject|2|||
154931957|NCT01160198|559177130|FG001|Overall Study|Withdrawal by Subject|1|||
154931958|NCT01160198|559177131|FG002|Overall Study|Withdrawal by Subject|0|||
154931959|NCT01160198|559177129|FG000|Overall Study|Adverse Event|0|||
154931960|NCT01160198|559177130|FG001|Overall Study|Adverse Event|1|||
154931961|NCT01160198|559177131|FG002|Overall Study|Adverse Event|0|||
155270794|NCT02291289|560425743|FG004|Induction Treatment|Physician Decision|0|||
154931962|NCT01160198|559177129|FG000|Overall Study|Lost to Follow-up|0|||
154931963|NCT01160198|559177130|FG001|Overall Study|Lost to Follow-up|1|||
154931964|NCT01160198|559177131|FG002|Overall Study|Lost to Follow-up|0|||
154931965|NCT01160198|559177129|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
154931966|NCT01160198|559177130|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
155270795|NCT02291289|560425744|FG005|Induction Treatment|Physician Decision|0|||
155270796|NCT02291289|560425745|FG006|Induction Treatment|Physician Decision|0|||
154931967|NCT01160198|559177131|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
154931968|NCT01796860|559177133|FG000|Overall Study|Withdrawal by Subject|3|||
154931969|NCT01408576|559177134|FG000|Overall Study|Lack of Efficacy|17|||
154931970|NCT01408576|559177135|FG001|Overall Study|Lack of Efficacy|30|||
154931971|NCT01408576|559177136|FG002|Overall Study|Lack of Efficacy|48|||
154931972|NCT01408576|559177134|FG000|Overall Study|Protocol Violation|1|||
154931973|NCT01408576|559177135|FG001|Overall Study|Protocol Violation|2|||
155270797|NCT02291289|560425746|FG007|Induction Treatment|Physician Decision|0|||
154931974|NCT01408576|559177136|FG002|Overall Study|Protocol Violation|2|||
154931975|NCT01408576|559177134|FG000|Overall Study|Lost to Follow-up|10|||
154931976|NCT01408576|559177135|FG001|Overall Study|Lost to Follow-up|9|||
154931977|NCT01408576|559177136|FG002|Overall Study|Lost to Follow-up|17|||
154931978|NCT01408576|559177134|FG000|Overall Study|Withdrawal by Subject|34|||
154931979|NCT01408576|559177135|FG001|Overall Study|Withdrawal by Subject|60|||
154931980|NCT01408576|559177136|FG002|Overall Study|Withdrawal by Subject|66|||
154931981|NCT01408576|559177134|FG000|Overall Study|Sponsor terminated study|89|||
154931982|NCT01408576|559177135|FG001|Overall Study|Sponsor terminated study|333|||
154931983|NCT01408576|559177136|FG002|Overall Study|Sponsor terminated study|330|||
154931984|NCT01408576|559177134|FG000|Overall Study|AE, serious fatal|4|||
154931985|NCT01408576|559177135|FG001|Overall Study|AE, serious fatal|4|||
154931986|NCT01408576|559177136|FG002|Overall Study|AE, serious fatal|1|||
154931987|NCT01408576|559177134|FG000|Overall Study|SAE, non-fatal|11|||
154931988|NCT01408576|559177135|FG001|Overall Study|SAE, non-fatal|23|||
154931989|NCT01408576|559177136|FG002|Overall Study|SAE, non-fatal|14|||
154931990|NCT01408576|559177134|FG000|Overall Study|AE, non-serious non-fatal|12|||
154931991|NCT01408576|559177135|FG001|Overall Study|AE, non-serious non-fatal|19|||
154931992|NCT01408576|559177136|FG002|Overall Study|AE, non-serious non-fatal|11|||
154931993|NCT01408576|559177134|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
154931994|NCT01408576|559177135|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
154931995|NCT01408576|559177136|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
154931996|NCT01408576|559177134|FG000|Overall Study|AE, unknown type|0|||
154931997|NCT01408576|559177135|FG001|Overall Study|AE, unknown type|1|||
154931998|NCT01408576|559177136|FG002|Overall Study|AE, unknown type|0|||
154931999|NCT01408576|559177134|FG000|Overall Study|Other|10|||
154932000|NCT01408576|559177135|FG001|Overall Study|Other|16|||
154932001|NCT01408576|559177136|FG002|Overall Study|Other|18|||
154932002|NCT00802529|559177137|FG000|Overall Study|Lost to Follow-up|0|||
154932003|NCT00802529|559177138|FG001|Overall Study|Lost to Follow-up|1|||
154932004|NCT02476851|559177139|FG000|Overall Study|Protocol Violation|1|||
154932005|NCT02476851|559177140|FG001|Overall Study|Protocol Violation|1|||
154932006|NCT00337129|559177141|FG000|Overall Study|Adverse Event|4|||
154932007|NCT00337129|559177141|FG000|Overall Study|Withdrawal by Subject|1|||
154932008|NCT00337129|559177141|FG000|Overall Study|Lack of Efficacy|32|||
154932009|NCT00337129|559177141|FG000|Overall Study|Death|2|||
154932010|NCT00337129|559177141|FG000|Overall Study|not protocol specified|1|||
154932011|NCT00647426|559177142|FG000|Overall Study|Withdrawal by Subject|2|||
154932012|NCT01508325|559177146|FG000|Overall Study|Withdrawal by Subject|8|||
154932013|NCT01508325|559177147|FG001|Overall Study|Withdrawal by Subject|9|||
154932014|NCT01508325|559177146|FG000|Overall Study|Protocol Violation|0|||
154932015|NCT01508325|559177147|FG001|Overall Study|Protocol Violation|3|||
154932016|NCT01508325|559177146|FG000|Overall Study|Physician Decision|2|||
154932017|NCT01508325|559177147|FG001|Overall Study|Physician Decision|1|||
154932018|NCT01508325|559177146|FG000|Overall Study|Adverse Event|1|||
154932019|NCT01508325|559177147|FG001|Overall Study|Adverse Event|0|||
154932020|NCT01508325|559177146|FG000|Overall Study|Lost to Follow-up|5|||
154932021|NCT01508325|559177147|FG001|Overall Study|Lost to Follow-up|6|||
154932022|NCT01508325|559177146|FG000|Overall Study|Other|2|||
154932023|NCT01508325|559177147|FG001|Overall Study|Other|2|||
155270798|NCT02291289|560425747|FG008|Induction Treatment|Physician Decision|0|||
155270799|NCT02291289|560425748|FG009|Induction Treatment|Physician Decision|1|||
155270800|NCT02291289|560425749|FG010|Induction Treatment|Physician Decision|0|||
155270801|NCT02291289|560425750|FG011|Induction Treatment|Physician Decision|0|||
155270802|NCT02291289|560425751|FG012|Induction Treatment|Physician Decision|0|||
155270803|NCT02291289|560425739|FG000|Induction Treatment|Protocol Violation|0|||
155270804|NCT02291289|560425740|FG001|Induction Treatment|Protocol Violation|0|||
155270805|NCT02291289|560425741|FG002|Induction Treatment|Protocol Violation|0|||
154932024|NCT03543046|559177151|FG000|Overall Study|Adverse Event|1|||
154932025|NCT03543046|559177152|FG001|Overall Study|Adverse Event|1|||
154932026|NCT03543046|559177151|FG000|Overall Study|Physician Decision|1|||
154932027|NCT03543046|559177152|FG001|Overall Study|Physician Decision|1|||
154932028|NCT03543046|559177151|FG000|Overall Study|Protocol Violation|1|||
154932029|NCT03543046|559177152|FG001|Overall Study|Protocol Violation|0|||
154932030|NCT00520494|559177153|FG000|Overall Study|Withdrawal by Subject|1|||
154932031|NCT02748616|559177156|FG000|Overall Study|Lost to Follow-up|1|||
154932032|NCT02748616|559177156|FG000|Overall Study|Withdrawal by Subject|2|||
154932033|NCT02748616|559177156|FG000|Overall Study|Physician Decision|2|||
154932034|NCT02748616|559177156|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
154932035|NCT00589693|559177157|FG000|Overall Study|randomized in error|12|||
154932036|NCT00589693|559177158|FG001|Overall Study|randomized in error|6|||
154932037|NCT00589693|559177157|FG000|Overall Study|Adverse Event|4|||
155270806|NCT02291289|560425742|FG003|Induction Treatment|Protocol Violation|3|||
154932038|NCT00589693|559177158|FG001|Overall Study|Adverse Event|4|||
154932039|NCT00589693|559177157|FG000|Overall Study|Death|26|||
154932040|NCT00589693|559177158|FG001|Overall Study|Death|16|||
154932041|NCT00589693|559177157|FG000|Overall Study|Lack of Efficacy|0|||
154932042|NCT00589693|559177158|FG001|Overall Study|Lack of Efficacy|1|||
154932043|NCT00589693|559177157|FG000|Overall Study|Lost to Follow-up|1|||
154932044|NCT00589693|559177158|FG001|Overall Study|Lost to Follow-up|0|||
154932045|NCT00589693|559177157|FG000|Overall Study|Physician Decision|0|||
154932046|NCT00589693|559177158|FG001|Overall Study|Physician Decision|1|||
154932047|NCT00589693|559177157|FG000|Overall Study|Protocol Violation|1|||
154932048|NCT00589693|559177158|FG001|Overall Study|Protocol Violation|1|||
154932049|NCT01447628|559177161|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
154932050|NCT01447628|559177162|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
154932051|NCT01447628|559177163|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
154932052|NCT01447628|559177164|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
154932053|NCT05144477|559177167|FG000|Overall Study|Withdrawal by Subject|1|||
154932054|NCT05144477|559177168|FG001|Overall Study|Withdrawal by Subject|1|||
154932055|NCT00965263|559177171|FG000|Overall Study|Physician Decision|2|||
154932056|NCT00965263|559177172|FG001|Overall Study|Physician Decision|0|||
154932057|NCT00965263|559177171|FG000|Overall Study|Family emergency|0|||
154932058|NCT00965263|559177172|FG001|Overall Study|Family emergency|1|||
154932059|NCT00965263|559177171|FG000|Overall Study|Protocol Violation|0|||
154932060|NCT00965263|559177172|FG001|Overall Study|Protocol Violation|2|||
154932061|NCT02756078|559177173|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
154932062|NCT02756078|559177174|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
154932063|NCT02756078|559177173|FG000|Period 1|Lost to Follow-up|0|||
154932064|NCT02756078|559177174|FG001|Period 1|Lost to Follow-up|2|||
154932065|NCT02756078|559177173|FG000|Period 1|Protocol Violation|0|||
154932066|NCT02756078|559177174|FG001|Period 1|Protocol Violation|1|||
154932067|NCT02756078|559177173|FG000|Period 1|Adverse Event|1|||
154932068|NCT02756078|559177174|FG001|Period 1|Adverse Event|10|||
154932069|NCT02756078|559177173|FG000|Period 1|Withdrawal by Subject|6|||
154932070|NCT02756078|559177174|FG001|Period 1|Withdrawal by Subject|6|||
154932071|NCT02756078|559177173|FG000|Period 1|Lens Discomfort|2|||
154932072|NCT02756078|559177174|FG001|Period 1|Lens Discomfort|2|||
154932073|NCT02756078|559177173|FG000|Period 2|Adverse Event|3|||
154932074|NCT02756078|559177174|FG001|Period 2|Adverse Event|5|||
154932075|NCT02756078|559177173|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
154932076|NCT02756078|559177174|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
154932077|NCT02756078|559177173|FG000|Period 2|Withdrawal by Subject|3|||
154932078|NCT02756078|559177174|FG001|Period 2|Withdrawal by Subject|1|||
154932079|NCT02587325|559177178|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
154932080|NCT02587325|559177179|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
154932081|NCT02587325|559177180|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
154932082|NCT02587325|559177181|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
154932083|NCT02587325|559177182|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
154932084|NCT02587325|559177178|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
154932085|NCT02587325|559177179|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
154932086|NCT02587325|559177180|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
154932087|NCT02587325|559177181|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
154932088|NCT02587325|559177182|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
154932089|NCT02587325|559177178|FG000|32-Week Optional Extension Part|Adverse Event|0|||
154932090|NCT02587325|559177179|FG001|32-Week Optional Extension Part|Adverse Event|0|||
154932091|NCT02587325|559177180|FG002|32-Week Optional Extension Part|Adverse Event|1|||
154932092|NCT02587325|559177181|FG003|32-Week Optional Extension Part|Adverse Event|0|||
154932093|NCT02587325|559177182|FG004|32-Week Optional Extension Part|Adverse Event|0|||
154932094|NCT02587325|559177178|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
154932095|NCT02587325|559177179|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
154932096|NCT02587325|559177180|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
154932097|NCT02587325|559177181|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
154932098|NCT02587325|559177182|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
154932099|NCT00390572|559177183|FG000|Overall Study|Lost to Follow-up|8|||
154932100|NCT00390572|559177184|FG001|Overall Study|Lost to Follow-up|4|||
154932101|NCT00390572|559177183|FG000|Overall Study|health condition|0|||
154932102|NCT00390572|559177184|FG001|Overall Study|health condition|1|||
154932103|NCT02913261|559177191|FG000|Overall Study|Technical problems|0|||
154932104|NCT02913261|559177192|FG001|Overall Study|Technical problems|1|||
154932105|NCT02913261|559177191|FG000|Overall Study|Lack of Efficacy|32|||
154932106|NCT02913261|559177192|FG001|Overall Study|Lack of Efficacy|69|||
154932107|NCT02913261|559177191|FG000|Overall Study|Adverse Event|27|||
154932108|NCT02913261|559177192|FG001|Overall Study|Adverse Event|5|||
154932109|NCT02913261|559177191|FG000|Overall Study|Death|25|||
154932110|NCT02913261|559177192|FG001|Overall Study|Death|22|||
154932111|NCT02913261|559177191|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
154932112|NCT02913261|559177192|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
154932113|NCT02913261|559177191|FG000|Overall Study|Disease relapse|8|||
154932114|NCT02913261|559177192|FG001|Overall Study|Disease relapse|13|||
154932115|NCT02913261|559177191|FG000|Overall Study|Physician Decision|8|||
154932116|NCT02913261|559177192|FG001|Overall Study|Physician Decision|9|||
154932117|NCT02913261|559177191|FG000|Overall Study|Subject/guardian decision|4|||
154932118|NCT02913261|559177192|FG001|Overall Study|Subject/guardian decision|6|||
154932119|NCT02913261|559177191|FG000|Overall Study|Graft loss|2|||
154932120|NCT02913261|559177192|FG001|Overall Study|Graft loss|0|||
154932121|NCT02304302|559177193|FG000|Overall Study|Adverse Event|2|||
155270807|NCT02291289|560425743|FG004|Induction Treatment|Protocol Violation|0|||
155270808|NCT02291289|560425744|FG005|Induction Treatment|Protocol Violation|0|||
155270809|NCT02291289|560425745|FG006|Induction Treatment|Protocol Violation|0|||
155270810|NCT02291289|560425746|FG007|Induction Treatment|Protocol Violation|0|||
155270811|NCT02291289|560425747|FG008|Induction Treatment|Protocol Violation|0|||
155270812|NCT02291289|560425748|FG009|Induction Treatment|Protocol Violation|2|||
155270813|NCT02291289|560425749|FG010|Induction Treatment|Protocol Violation|0|||
155270814|NCT02291289|560425750|FG011|Induction Treatment|Protocol Violation|0|||
155270815|NCT02291289|560425751|FG012|Induction Treatment|Protocol Violation|0|||
155270816|NCT02291289|560425739|FG000|Induction Treatment|Missing|4|||
155270817|NCT02291289|560425740|FG001|Induction Treatment|Missing|0|||
155270818|NCT02291289|560425741|FG002|Induction Treatment|Missing|0|||
155270819|NCT02291289|560425742|FG003|Induction Treatment|Missing|14|||
155270820|NCT02291289|560425743|FG004|Induction Treatment|Missing|0|||
155270821|NCT02291289|560425744|FG005|Induction Treatment|Missing|0|||
155270822|NCT02291289|560425745|FG006|Induction Treatment|Missing|0|||
155270823|NCT02291289|560425746|FG007|Induction Treatment|Missing|0|||
155270824|NCT02291289|560425747|FG008|Induction Treatment|Missing|0|||
155270825|NCT02291289|560425748|FG009|Induction Treatment|Missing|54|||
155270826|NCT02291289|560425749|FG010|Induction Treatment|Missing|0|||
155270827|NCT02291289|560425750|FG011|Induction Treatment|Missing|0|||
155270828|NCT02291289|560425751|FG012|Induction Treatment|Missing|0|||
155270829|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270830|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270831|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270832|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270833|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
155270834|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
155270835|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270836|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270837|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270838|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270839|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
155270840|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
155270841|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155270842|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Death|0|||
155270843|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Death|29|||
155270844|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Death|16|||
155270845|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Death|0|||
155270846|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Death|188|||
155270847|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Death|107|||
155270848|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Death|0|||
155270849|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Death|1|||
155270850|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Death|1|||
155270851|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Death|0|||
155270852|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Death|46|||
155270853|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Death|19|||
155270854|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Death|0|||
155270855|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Adverse Event|0|||
155270856|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Adverse Event|0|||
155270857|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Adverse Event|0|||
155270858|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Adverse Event|0|||
155270859|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Adverse Event|1|||
155270860|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Adverse Event|1|||
155270861|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Adverse Event|0|||
155270862|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Adverse Event|0|||
155270863|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Adverse Event|0|||
155381777|NCT00690443|560833194|FG000|Overall Study|Adverse Event|1|||
154932122|NCT02304302|559177194|FG001|Overall Study|Adverse Event|3|||
154932123|NCT02304302|559177193|FG000|Overall Study|Lost to Follow-up|1|||
154932124|NCT02304302|559177194|FG001|Overall Study|Lost to Follow-up|4|||
154932125|NCT02304302|559177193|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
154932126|NCT02304302|559177194|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
154932127|NCT00391118|559177195|FG000|Overall Study|Adverse Event|3|||
155270864|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Adverse Event|0|||
155270865|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Adverse Event|0|||
155270866|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Adverse Event|0|||
155270867|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Adverse Event|0|||
155270868|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270869|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
154932128|NCT00391118|559177196|FG001|Overall Study|Adverse Event|10|||
155270870|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270871|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270872|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
155270873|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
155381778|NCT00690443|560833195|FG001|Overall Study|Adverse Event|2|||
155270874|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270875|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
155270876|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270877|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270878|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
155270879|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
155270880|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
155270881|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
155270882|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
155270883|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
155270884|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
155270885|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
155270886|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
155270887|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
155270888|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
155270889|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
155270890|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
155270891|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
155270892|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
155270893|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
155270894|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Physician Decision|0|||
155270895|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Physician Decision|2|||
155270896|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Physician Decision|0|||
155270897|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Physician Decision|0|||
155270898|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Physician Decision|3|||
155270899|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Physician Decision|0|||
155270900|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Physician Decision|0|||
155270901|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Physician Decision|0|||
155270902|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Physician Decision|0|||
155270903|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Physician Decision|0|||
155270904|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Physician Decision|1|||
155270905|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Physician Decision|3|||
155270906|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Physician Decision|0|||
155270907|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Not Treated|0|||
155270908|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Not Treated|0|||
155270909|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Not Treated|2|||
155270910|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Not Treated|0|||
155270911|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Not Treated|0|||
155270912|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Not Treated|0|||
155270913|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Not Treated|0|||
155270914|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Not Treated|0|||
155270915|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Not Treated|0|||
155270916|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Not Treated|0|||
155270917|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Not Treated|0|||
155270918|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Not Treated|0|||
155270919|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Not Treated|0|||
155270920|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270921|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
155270922|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270923|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270924|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270925|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270926|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270927|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270928|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270929|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270930|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270931|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270932|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
155270933|NCT02291289|560425739|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
155270934|NCT02291289|560425740|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
155270935|NCT02291289|560425741|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
155270936|NCT02291289|560425742|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
155270937|NCT02291289|560425743|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
155270938|NCT02291289|560425744|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
155270939|NCT02291289|560425745|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
155270940|NCT02291289|560425746|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
155270941|NCT02291289|560425747|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
155270942|NCT02291289|560425748|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
155270943|NCT02291289|560425749|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
155270944|NCT02291289|560425750|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
155270945|NCT02291289|560425751|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
155270946|NCT02291289|560425739|FG000|Early Disease Progression|Death|0|||
155270947|NCT02291289|560425740|FG001|Early Disease Progression|Death|0|||
155270948|NCT02291289|560425741|FG002|Early Disease Progression|Death|0|||
155270949|NCT02291289|560425742|FG003|Early Disease Progression|Death|0|||
155270950|NCT02291289|560425743|FG004|Early Disease Progression|Death|0|||
155270951|NCT02291289|560425744|FG005|Early Disease Progression|Death|0|||
155270952|NCT02291289|560425745|FG006|Early Disease Progression|Death|0|||
155270953|NCT02291289|560425746|FG007|Early Disease Progression|Death|0|||
155270954|NCT02291289|560425747|FG008|Early Disease Progression|Death|0|||
155270955|NCT02291289|560425748|FG009|Early Disease Progression|Death|0|||
155270956|NCT02291289|560425749|FG010|Early Disease Progression|Death|0|||
155270957|NCT02291289|560425750|FG011|Early Disease Progression|Death|0|||
155270958|NCT02291289|560425751|FG012|Early Disease Progression|Death|10|||
155270959|NCT02291289|560425739|FG000|Early Disease Progression|Lost to Follow-up|0|||
155270960|NCT02291289|560425740|FG001|Early Disease Progression|Lost to Follow-up|0|||
155270961|NCT02291289|560425741|FG002|Early Disease Progression|Lost to Follow-up|0|||
155270962|NCT02291289|560425742|FG003|Early Disease Progression|Lost to Follow-up|0|||
155270963|NCT02291289|560425743|FG004|Early Disease Progression|Lost to Follow-up|0|||
155270964|NCT02291289|560425744|FG005|Early Disease Progression|Lost to Follow-up|0|||
155270965|NCT02291289|560425745|FG006|Early Disease Progression|Lost to Follow-up|0|||
155270966|NCT02291289|560425746|FG007|Early Disease Progression|Lost to Follow-up|0|||
155270967|NCT02291289|560425747|FG008|Early Disease Progression|Lost to Follow-up|0|||
155270968|NCT02291289|560425748|FG009|Early Disease Progression|Lost to Follow-up|0|||
155270969|NCT02291289|560425749|FG010|Early Disease Progression|Lost to Follow-up|0|||
155270970|NCT02291289|560425750|FG011|Early Disease Progression|Lost to Follow-up|0|||
155270971|NCT02291289|560425751|FG012|Early Disease Progression|Lost to Follow-up|1|||
155270972|NCT01868035|560425755|FG000|Overall Study|Lost to Follow-up|3|||
155270973|NCT01868035|560425755|FG000|Overall Study|Withdrawal by Subject|1|||
155270974|NCT01868035|560425755|FG000|Overall Study|Progressive Disease|2|||
155270975|NCT01868035|560425755|FG000|Overall Study|Non-compliance|1|||
155270976|NCT00154063|560425762|FG000|Overall Study|Adverse Event|4|||
155270977|NCT00154063|560425763|FG001|Overall Study|Adverse Event|8|||
155270978|NCT00154063|560425762|FG000|Overall Study|Protocol Violation|1|||
155270979|NCT00154063|560425763|FG001|Overall Study|Protocol Violation|1|||
155270980|NCT00154063|560425762|FG000|Overall Study|Investigator or Sponsor Request|0|||
155270981|NCT00154063|560425763|FG001|Overall Study|Investigator or Sponsor Request|1|||
155270982|NCT00154063|560425762|FG000|Overall Study|Withdrawal by Subject|4|||
155270983|NCT00154063|560425763|FG001|Overall Study|Withdrawal by Subject|9|||
155270984|NCT00154063|560425762|FG000|Overall Study|Other|3|||
155270985|NCT00154063|560425763|FG001|Overall Study|Other|3|||
155270986|NCT01912781|560425767|FG000|Overall Study|Withdrawal by Subject|2|||
155270987|NCT01912781|560425768|FG001|Overall Study|Withdrawal by Subject|0|||
155270988|NCT03377790|560425769|FG000|Overall Study|Withdrawal by Subject|1|||
155270989|NCT03377790|560425770|FG001|Overall Study|Withdrawal by Subject|0|||
155270990|NCT03377790|560425769|FG000|Overall Study|Adverse Event|1|||
155270991|NCT03377790|560425770|FG001|Overall Study|Adverse Event|0|||
155270992|NCT03377790|560425769|FG000|Overall Study|Lost to Follow-up|0|||
155270993|NCT03377790|560425770|FG001|Overall Study|Lost to Follow-up|2|||
155270994|NCT03377790|560425769|FG000|Overall Study|Randomized but not treated|1|||
155270995|NCT03377790|560425770|FG001|Overall Study|Randomized but not treated|0|||
155270996|NCT03377790|560425769|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
155270997|NCT03377790|560425770|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
155270998|NCT00919893|560425771|FG000|Overall Study|Protocol Violation|19|||
155270999|NCT00919893|560425772|FG001|Overall Study|Protocol Violation|9|||
155271000|NCT00708305|560425777|FG000|Period 1|Protocol Violation|1|||
154932129|NCT00391118|559177197|FG002|Overall Study|Adverse Event|7|||
154932130|NCT00391118|559177195|FG000|Overall Study|Lost to Follow-up|0|||
154932131|NCT00391118|559177196|FG001|Overall Study|Lost to Follow-up|2|||
154932132|NCT00391118|559177197|FG002|Overall Study|Lost to Follow-up|3|||
154932133|NCT00391118|559177195|FG000|Overall Study|Withdrawal by Subject|0|||
154932134|NCT00391118|559177196|FG001|Overall Study|Withdrawal by Subject|9|||
155271001|NCT00708305|560425778|FG001|Period 1|Protocol Violation|0|||
155271002|NCT00708305|560425779|FG002|Period 1|Protocol Violation|1|||
155271003|NCT00708305|560425780|FG003|Period 1|Protocol Violation|0|||
155271004|NCT00708305|560425777|FG000|Period 1|Other Reason|0|||
155271005|NCT00708305|560425778|FG001|Period 1|Other Reason|0|||
155271006|NCT00708305|560425779|FG002|Period 1|Other Reason|0|||
155271007|NCT00708305|560425780|FG003|Period 1|Other Reason|2|||
155271008|NCT00708305|560425777|FG000|Period 2|Lost to Follow-up|0|||
155271009|NCT00708305|560425778|FG001|Period 2|Lost to Follow-up|1|||
155271010|NCT00708305|560425779|FG002|Period 2|Lost to Follow-up|0|||
155271011|NCT00708305|560425780|FG003|Period 2|Lost to Follow-up|0|||
155271012|NCT00708305|560425777|FG000|Period 2|Protocol Violation|0|||
155271013|NCT00708305|560425778|FG001|Period 2|Protocol Violation|1|||
155271014|NCT00708305|560425779|FG002|Period 2|Protocol Violation|0|||
155271015|NCT00708305|560425780|FG003|Period 2|Protocol Violation|0|||
155271016|NCT00708305|560425777|FG000|Period 2|Other Reason|1|||
155271017|NCT00708305|560425778|FG001|Period 2|Other Reason|0|||
155271018|NCT00708305|560425779|FG002|Period 2|Other Reason|0|||
155271019|NCT00708305|560425780|FG003|Period 2|Other Reason|1|||
155271020|NCT00708305|560425777|FG000|Period 3|Protocol Violation|0|||
155271021|NCT00708305|560425778|FG001|Period 3|Protocol Violation|2|||
155271022|NCT00708305|560425779|FG002|Period 3|Protocol Violation|0|||
155271023|NCT00708305|560425780|FG003|Period 3|Protocol Violation|0|||
155271024|NCT00708305|560425777|FG000|Period 3|Other Reason|1|||
155271025|NCT00708305|560425778|FG001|Period 3|Other Reason|0|||
155271026|NCT00708305|560425779|FG002|Period 3|Other Reason|0|||
155271027|NCT00708305|560425780|FG003|Period 3|Other Reason|0|||
155271028|NCT03283696|560425785|FG000|Overall Study|Physician Decision|5|||
155271029|NCT03283696|560425786|FG001|Overall Study|Physician Decision|6|||
155271030|NCT03283696|560425785|FG000|Overall Study|Withdrawal by Subject|2|||
155271031|NCT03283696|560425786|FG001|Overall Study|Withdrawal by Subject|0|||
155271032|NCT02572817|560425792|FG000|Overall Study|Death|6|||
155271033|NCT02572817|560425793|FG001|Overall Study|Death|3|||
155271034|NCT02572817|560425792|FG000|Overall Study|Lost to Follow-up|3|||
155271035|NCT02572817|560425793|FG001|Overall Study|Lost to Follow-up|3|||
155271036|NCT02310126|560425799|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
155271037|NCT02310126|560425800|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
155271038|NCT02310126|560425799|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
155271039|NCT02310126|560425800|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
155271040|NCT02111213|560425803|FG000|Overall Study|Withdrawal by Subject|3|||
155271041|NCT02111213|560425804|FG001|Overall Study|Withdrawal by Subject|2|||
155271042|NCT02111213|560425803|FG000|Overall Study|Lost to Follow-up|3|||
155271043|NCT02111213|560425804|FG001|Overall Study|Lost to Follow-up|4|||
155271044|NCT00439179|560425807|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
155271045|NCT00439179|560425808|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
155271046|NCT00439179|560425809|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
155271047|NCT00439179|560425810|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
155271048|NCT02761629|560425811|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
155271049|NCT02761629|560425812|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
155271050|NCT02761629|560425811|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155271051|NCT02761629|560425812|FG001|Overall Study|Insufficient Therapeutic Response|7|||
155271052|NCT02761629|560425811|FG000|Overall Study|Failure to Return|2|||
155271053|NCT02761629|560425812|FG001|Overall Study|Failure to Return|4|||
155271054|NCT02761629|560425811|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
155271055|NCT02761629|560425812|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
155271056|NCT02761629|560425811|FG000|Overall Study|Protocol Violation|2|||
155271057|NCT02761629|560425812|FG001|Overall Study|Protocol Violation|2|||
155271058|NCT02761629|560425811|FG000|Overall Study|Withdrawal by Subject|0|||
155271059|NCT02761629|560425812|FG001|Overall Study|Withdrawal by Subject|3|||
155271060|NCT02761629|560425811|FG000|Overall Study|Other|0|||
155271061|NCT02761629|560425812|FG001|Overall Study|Other|2|||
155271062|NCT02761629|560425811|FG000|Overall Study|Lost to Follow-up|4|||
155271063|NCT02761629|560425812|FG001|Overall Study|Lost to Follow-up|1|||
155271064|NCT02761629|560425811|FG000|Overall Study|Randomized But Not Treated|8|||
155271065|NCT02761629|560425812|FG001|Overall Study|Randomized But Not Treated|4|||
155271066|NCT01844115|560425822|FG000|Overall Study|Adverse Event|4|||
155271067|NCT01844115|560425823|FG001|Overall Study|Adverse Event|22|||
155271068|NCT01844115|560425822|FG000|Overall Study|Lack of Efficacy|1|||
155271069|NCT01844115|560425823|FG001|Overall Study|Lack of Efficacy|4|||
155271070|NCT01844115|560425822|FG000|Overall Study|Protocol Violation|12|||
155271071|NCT01844115|560425823|FG001|Overall Study|Protocol Violation|10|||
155271072|NCT01844115|560425822|FG000|Overall Study|Withdrawal by Subject|11|||
155271073|NCT01844115|560425823|FG001|Overall Study|Withdrawal by Subject|11|||
155271074|NCT01844115|560425822|FG000|Overall Study|Lost to Follow-up|11|||
155271075|NCT01844115|560425823|FG001|Overall Study|Lost to Follow-up|10|||
155271076|NCT01844115|560425822|FG000|Overall Study|Pregnancy|0|||
155271077|NCT01844115|560425823|FG001|Overall Study|Pregnancy|1|||
154932135|NCT00391118|559177197|FG002|Overall Study|Withdrawal by Subject|1|||
155271078|NCT00545363|560425824|FG000|Overall Study|Adverse Event|6|||
155271079|NCT00545363|560425825|FG001|Overall Study|Adverse Event|7|||
155271080|NCT00545363|560425824|FG000|Overall Study|Withdrawal by Subject|6|||
155271081|NCT00545363|560425825|FG001|Overall Study|Withdrawal by Subject|5|||
155271082|NCT00545363|560425824|FG000|Overall Study|Non-compliance|3|||
155271083|NCT00545363|560425825|FG001|Overall Study|Non-compliance|1|||
155271084|NCT00545363|560425824|FG000|Overall Study|Did not meet entry criteria|1|||
155271085|NCT00545363|560425825|FG001|Overall Study|Did not meet entry criteria|1|||
155271086|NCT00545363|560425824|FG000|Overall Study|Lost to Follow-up|2|||
155271087|NCT00545363|560425825|FG001|Overall Study|Lost to Follow-up|0|||
155271088|NCT00545363|560425824|FG000|Overall Study|Other|1|||
155271089|NCT00545363|560425825|FG001|Overall Study|Other|1|||
155271090|NCT01258660|560425826|FG000|Overall Study|Adverse Event|2|||
155271091|NCT01258660|560425827|FG001|Overall Study|Adverse Event|4|||
155271092|NCT01258660|560425826|FG000|Overall Study|Withdrawal by Subject|3|||
155271093|NCT01258660|560425827|FG001|Overall Study|Withdrawal by Subject|0|||
155271094|NCT01258660|560425826|FG000|Overall Study|due to relocation|2|||
155271095|NCT01258660|560425827|FG001|Overall Study|due to relocation|0|||
155271096|NCT01258660|560425826|FG000|Overall Study|Protocol Violation|0|||
155271097|NCT01258660|560425827|FG001|Overall Study|Protocol Violation|1|||
155271098|NCT01258660|560425826|FG000|Overall Study|Invalid for primary analysis data set|4|||
155271099|NCT01258660|560425827|FG001|Overall Study|Invalid for primary analysis data set|6|||
155271100|NCT00582491|560425828|FG000|Overall Study|Withdrawal by Subject|1|||
155271101|NCT00582491|560425829|FG001|Overall Study|Withdrawal by Subject|0|||
155271102|NCT04192630|560425832|FG000|Overall Study|Discontinued before surgery|2|||
155271103|NCT04192630|560425833|FG001|Overall Study|Discontinued before surgery|0|||
155271104|NCT04192630|560425832|FG000|Overall Study|Discontinued after surgery|5|||
155271105|NCT04192630|560425833|FG001|Overall Study|Discontinued after surgery|3|||
155271106|NCT01193582|560425834|FG000|Vaccination Series|Withdrawal by Subject|11|||
155271107|NCT01193582|560425835|FG001|Vaccination Series|Withdrawal by Subject|13|||
155271108|NCT01193582|560425836|FG002|Vaccination Series|Withdrawal by Subject|8|||
155271109|NCT01193582|560425837|FG003|Vaccination Series|Withdrawal by Subject|3|||
155271110|NCT01193582|560425834|FG000|12 Month Follow-up|Death|0|||
155271111|NCT01193582|560425835|FG001|12 Month Follow-up|Death|0|||
155271112|NCT01193582|560425836|FG002|12 Month Follow-up|Death|1|||
155271113|NCT01193582|560425837|FG003|12 Month Follow-up|Death|0|||
155271114|NCT01193582|560425834|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
155271115|NCT01193582|560425835|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
155271116|NCT01193582|560425836|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
155271117|NCT01193582|560425837|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
155271118|NCT01425632|560425838|FG000|Overall Study|Adverse Event|0|||
155271119|NCT01425632|560425839|FG001|Overall Study|Adverse Event|1|||
155271120|NCT01425632|560425840|FG002|Overall Study|Adverse Event|1|||
155271121|NCT01425632|560425838|FG000|Overall Study|Physician Decision|1|||
155271122|NCT01425632|560425839|FG001|Overall Study|Physician Decision|0|||
155271123|NCT01425632|560425840|FG002|Overall Study|Physician Decision|0|||
155271124|NCT01425632|560425838|FG000|Overall Study|Protocol Violation|0|||
155271125|NCT01425632|560425839|FG001|Overall Study|Protocol Violation|0|||
155271126|NCT01425632|560425840|FG002|Overall Study|Protocol Violation|2|||
155271127|NCT01425632|560425838|FG000|Overall Study|Withdrawal by Subject|0|||
155271128|NCT01425632|560425839|FG001|Overall Study|Withdrawal by Subject|0|||
155271129|NCT01425632|560425840|FG002|Overall Study|Withdrawal by Subject|1|||
155271130|NCT00406419|560425848|FG000|Overall Study|Death|3|||
155271131|NCT00406419|560425849|FG001|Overall Study|Death|1|||
155271132|NCT00406419|560425850|FG002|Overall Study|Death|4|||
155271133|NCT00406419|560425848|FG000|Overall Study|Protocol Violation|6|||
155271134|NCT00406419|560425849|FG001|Overall Study|Protocol Violation|2|||
155271135|NCT00406419|560425850|FG002|Overall Study|Protocol Violation|5|||
155271136|NCT00406419|560425848|FG000|Overall Study|Study Terminated by Sponsor|260|||
155271137|NCT00406419|560425849|FG001|Overall Study|Study Terminated by Sponsor|288|||
155271138|NCT00406419|560425850|FG002|Overall Study|Study Terminated by Sponsor|282|||
155271139|NCT00406419|560425848|FG000|Overall Study|Withdrawal by Subject|17|||
155271140|NCT00406419|560425849|FG001|Overall Study|Withdrawal by Subject|24|||
155271141|NCT00406419|560425850|FG002|Overall Study|Withdrawal by Subject|26|||
155271142|NCT00406419|560425848|FG000|Overall Study|Lack of Efficacy|12|||
155271143|NCT00406419|560425849|FG001|Overall Study|Lack of Efficacy|1|||
155271144|NCT00406419|560425850|FG002|Overall Study|Lack of Efficacy|6|||
155271145|NCT00406419|560425848|FG000|Overall Study|Non-Compliance with Study Drug|5|||
155271146|NCT00406419|560425849|FG001|Overall Study|Non-Compliance with Study Drug|6|||
155271147|NCT00406419|560425850|FG002|Overall Study|Non-Compliance with Study Drug|3|||
155271148|NCT00406419|560425848|FG000|Overall Study|Adverse Event|10|||
155271149|NCT00406419|560425849|FG001|Overall Study|Adverse Event|12|||
155271150|NCT00406419|560425850|FG002|Overall Study|Adverse Event|16|||
155271151|NCT00406419|560425848|FG000|Overall Study|Lost to Follow-up|11|||
155271152|NCT00406419|560425849|FG001|Overall Study|Lost to Follow-up|10|||
155271153|NCT00406419|560425850|FG002|Overall Study|Lost to Follow-up|5|||
155271154|NCT01775930|560425851|FG000|Overall Study|Futility stopping boundary met|1|||
155271155|NCT01208415|560425852|FG000|Overall Study|Death|1|||
155271156|NCT01208415|560425852|FG000|Overall Study|Lost to Follow-up|2|||
155271157|NCT01208415|560425852|FG000|Overall Study|Withdrawal by Subject|3|||
154932136|NCT00391118|559177195|FG000|Overall Study|Death|0|||
155271158|NCT01208415|560425852|FG000|Overall Study|Device not placed|1|||
155271159|NCT01208415|560425852|FG000|Overall Study|Still be eligible for follow-up|33|||
155271160|NCT01115491|560425853|FG000|Overall Study|Death|22|||
155271161|NCT01115491|560425853|FG000|Overall Study|Adverse Event|3|||
155271162|NCT01115491|560425853|FG000|Overall Study|Lost to Follow-up|3|||
155271163|NCT01115491|560425853|FG000|Overall Study|Withdrawal by Subject|1|||
155271164|NCT01115491|560425853|FG000|Overall Study|Physician Decision|1|||
155271165|NCT03856996|560425854|FG000|Overall Study|Withdrawal by Subject|1|||
155271166|NCT03856996|560425855|FG001|Overall Study|Withdrawal by Subject|0|||
155271167|NCT03856996|560425854|FG000|Overall Study|Lost to Follow-up|0|||
155271168|NCT03856996|560425855|FG001|Overall Study|Lost to Follow-up|1|||
155271169|NCT03856996|560425854|FG000|Overall Study|Adverse Event|1|||
155271170|NCT03856996|560425855|FG001|Overall Study|Adverse Event|1|||
155271171|NCT03856996|560425854|FG000|Overall Study|Other|1|||
155271172|NCT03856996|560425855|FG001|Overall Study|Other|0|||
155271173|NCT02340520|560425858|FG000|Overall Study|Lost to Follow-up|1|||
155271174|NCT02340520|560425858|FG000|Overall Study|Patient did not take drug as specified|1|||
155271175|NCT02340520|560425858|FG000|Overall Study|Withdrawal by Subject|1|||
155271176|NCT01586338|560425860|FG000|Overall Study|Adverse Event|3|||
155271177|NCT01586338|560425860|FG000|Overall Study|Lost to Follow-up|1|||
155271178|NCT01586338|560425860|FG000|Overall Study|Withdrawal by participant|3|||
155271179|NCT01586338|560425860|FG000|Overall Study|Other|1|||
155271180|NCT01868074|560425861|FG000|Overall Study|Lost to Follow-up|3|||
155271181|NCT01868074|560425862|FG001|Overall Study|Lost to Follow-up|2|||
155271182|NCT01868074|560425861|FG000|Overall Study|Withdrawal by Subject|4|||
155271183|NCT01868074|560425862|FG001|Overall Study|Withdrawal by Subject|2|||
155271184|NCT00896454|560425863|FG000|Overall Study|Death|10|||
155271185|NCT00896454|560425863|FG000|Overall Study|Adverse Event|8|||
155271186|NCT00896454|560425863|FG000|Overall Study|Disease Progression|5|||
155271187|NCT00896454|560425863|FG000|Overall Study|Other|4|||
155271188|NCT00896454|560425863|FG000|Overall Study|Requirement for alternative therapy|3|||
155271189|NCT00896454|560425863|FG000|Overall Study|Ongoing in study|2|||
155271190|NCT00896454|560425863|FG000|Overall Study|Withdrawal by Subject|1|||
155271191|NCT01461993|560425864|FG000|Overall Study|Withdrawal by Subject|60|||
155271192|NCT01461993|560425865|FG001|Overall Study|Withdrawal by Subject|53|||
155271193|NCT01461993|560425866|FG002|Overall Study|Withdrawal by Subject|16|||
155271194|NCT01461993|560425864|FG000|Overall Study|Lost to Follow-up|44|||
155271195|NCT01461993|560425865|FG001|Overall Study|Lost to Follow-up|48|||
155271196|NCT01461993|560425866|FG002|Overall Study|Lost to Follow-up|22|||
155271197|NCT01461993|560425864|FG000|Overall Study|Protocol Violation|10|||
155271198|NCT01461993|560425865|FG001|Overall Study|Protocol Violation|9|||
155271199|NCT01461993|560425866|FG002|Overall Study|Protocol Violation|7|||
155271200|NCT01461993|560425864|FG000|Overall Study|Adverse Event|9|||
155271201|NCT01461993|560425865|FG001|Overall Study|Adverse Event|11|||
155271202|NCT01461993|560425866|FG002|Overall Study|Adverse Event|3|||
155271203|NCT01461993|560425864|FG000|Overall Study|No longer met eligibility criteria|13|||
155271204|NCT01461993|560425865|FG001|Overall Study|No longer met eligibility criteria|18|||
155271205|NCT01461993|560425866|FG002|Overall Study|No longer met eligibility criteria|10|||
155271206|NCT01461993|560425864|FG000|Overall Study|Did not meet entrance criteria|2|||
155271207|NCT01461993|560425865|FG001|Overall Study|Did not meet entrance criteria|3|||
155271208|NCT01461993|560425866|FG002|Overall Study|Did not meet entrance criteria|0|||
155271209|NCT01461993|560425864|FG000|Overall Study|Other|13|||
155271210|NCT01461993|560425865|FG001|Overall Study|Other|15|||
155271211|NCT01461993|560425866|FG002|Overall Study|Other|6|||
155271212|NCT00680056|560425867|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
155271213|NCT00680056|560425868|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
155271214|NCT00680056|560425867|FG000|Second Intervention|Protocol Violation|3|||
155271215|NCT00680056|560425868|FG001|Second Intervention|Protocol Violation|1|||
155271216|NCT01821898|560425869|FG000|Overall Study|Withdrawal by Subject|2|||
155271217|NCT01821898|560425870|FG001|Overall Study|Withdrawal by Subject|1|||
155271218|NCT05064735|560425871|FG000|Overall Study|Withdrawal by Subject|7|||
155271219|NCT05064735|560425872|FG001|Overall Study|Withdrawal by Subject|8|||
155271220|NCT05064735|560425871|FG000|Overall Study|Lost to Follow-up|7|||
155271221|NCT05064735|560425872|FG001|Overall Study|Lost to Follow-up|2|||
155271222|NCT05064735|560425871|FG000|Overall Study|Physician Decision|2|||
155271223|NCT05064735|560425872|FG001|Overall Study|Physician Decision|1|||
155271224|NCT05064735|560425871|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
155271225|NCT05064735|560425872|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
155271226|NCT05064735|560425871|FG000|Overall Study|Site Closure|7|||
155271227|NCT05064735|560425872|FG001|Overall Study|Site Closure|2|||
155381779|NCT02874924|560833196|FG000|Overall Study|Adverse Event|2|||
155381780|NCT02874924|560833197|FG001|Overall Study|Adverse Event|0|||
155381781|NCT02874924|560833198|FG002|Overall Study|Adverse Event|0|||
155381782|NCT02874924|560833196|FG000|Overall Study|Withdrawal by Subject|1|||
155381783|NCT02874924|560833197|FG001|Overall Study|Withdrawal by Subject|0|||
155381784|NCT02874924|560833198|FG002|Overall Study|Withdrawal by Subject|0|||
155381785|NCT01689337|560833199|FG000|Overall Study|Study Discontinuation|1|||
155381786|NCT01874431|560833200|FG000|Overall Study|Physician Decision|0|||
155381787|NCT01874431|560833201|FG001|Overall Study|Physician Decision|0|||
155381788|NCT01874431|560833202|FG002|Overall Study|Physician Decision|1|||
155381789|NCT01874431|560833203|FG003|Overall Study|Physician Decision|0|||
155381790|NCT01874431|560833204|FG004|Overall Study|Physician Decision|0|||
155381791|NCT01874431|560833205|FG005|Overall Study|Physician Decision|0|||
155381792|NCT01874431|560833206|FG006|Overall Study|Physician Decision|0|||
155271228|NCT01018563|560425874|FG000|Overall Study|Termination of the study by Sponsor|2|||
155271229|NCT01018563|560425875|FG001|Overall Study|Termination of the study by Sponsor|1|||
155271230|NCT04844970|560425878|FG000|Overall Study|Adverse Event|0|||
155381793|NCT01874431|560833207|FG007|Overall Study|Physician Decision|0|||
155271231|NCT04844970|560425879|FG001|Overall Study|Adverse Event|1|||
155271232|NCT04844970|560425878|FG000|Overall Study|Withdrawal by Subject|2|||
155271233|NCT04844970|560425879|FG001|Overall Study|Withdrawal by Subject|0|||
155271234|NCT00447954|560425880|FG000|Overall Study|Adverse Event|0|||
154932137|NCT00391118|559177196|FG001|Overall Study|Death|1|||
154932138|NCT00391118|559177197|FG002|Overall Study|Death|0|||
154932139|NCT00391118|559177195|FG000|Overall Study|Physician Decision|0|||
154932140|NCT00391118|559177196|FG001|Overall Study|Physician Decision|3|||
154932141|NCT00391118|559177197|FG002|Overall Study|Physician Decision|0|||
154932142|NCT00391118|559177195|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
154932143|NCT00391118|559177196|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
154932144|NCT00391118|559177197|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
155271235|NCT00447954|560425881|FG001|Overall Study|Adverse Event|2|||
155271236|NCT00447954|560425882|FG002|Overall Study|Adverse Event|0|||
155271237|NCT00447954|560425880|FG000|Overall Study|Withdrawal by Subject|0|||
155271238|NCT00447954|560425881|FG001|Overall Study|Withdrawal by Subject|1|||
155271239|NCT00447954|560425882|FG002|Overall Study|Withdrawal by Subject|1|||
155271240|NCT00447954|560425880|FG000|Overall Study|Lost to Follow-up|0|||
155271241|NCT00447954|560425881|FG001|Overall Study|Lost to Follow-up|1|||
155271242|NCT00447954|560425882|FG002|Overall Study|Lost to Follow-up|0|||
155271243|NCT00447954|560425880|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
154932145|NCT00391118|559177195|FG000|Overall Study|Progressive Disease|7|||
154932146|NCT00391118|559177196|FG001|Overall Study|Progressive Disease|26|||
154932147|NCT00391118|559177197|FG002|Overall Study|Progressive Disease|43|||
154932148|NCT00391118|559177195|FG000|Overall Study|Sponsor Decision|0|||
155271244|NCT00447954|560425881|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
155271245|NCT00447954|560425882|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
155271246|NCT00856661|560425883|FG000|Overall Study|Death|15|||
155271247|NCT00856661|560425884|FG001|Overall Study|Death|18|||
155271248|NCT00856661|560425883|FG000|Overall Study|Protocol Violation|2|||
155271249|NCT00856661|560425884|FG001|Overall Study|Protocol Violation|1|||
155271250|NCT00856661|560425883|FG000|Overall Study|Withdrawal by Subject|1|||
155271251|NCT00856661|560425884|FG001|Overall Study|Withdrawal by Subject|2|||
155271252|NCT00856661|560425883|FG000|Overall Study|Lost to Follow-up|1|||
155271253|NCT00856661|560425884|FG001|Overall Study|Lost to Follow-up|3|||
155271254|NCT00856661|560425883|FG000|Overall Study|Physician Judgement|8|||
155271255|NCT00856661|560425884|FG001|Overall Study|Physician Judgement|5|||
155271256|NCT02120664|560425885|FG000|Overall Study|Withdrawal by Subject|0|||
155271257|NCT02120664|560425886|FG001|Overall Study|Withdrawal by Subject|0|||
155271258|NCT02120664|560425887|FG002|Overall Study|Withdrawal by Subject|0|||
155271259|NCT02120664|560425888|FG003|Overall Study|Withdrawal by Subject|1|||
155271260|NCT02120664|560425889|FG004|Overall Study|Withdrawal by Subject|0|||
155271261|NCT03176238|560425890|FG000|Overall Study|Unacceptable AEs|15|||
155271262|NCT03176238|560425891|FG001|Overall Study|Unacceptable AEs|8|||
155271263|NCT03176238|560425890|FG000|Overall Study|Abnormal lab value(s)|2|||
155271264|NCT03176238|560425891|FG001|Overall Study|Abnormal lab value(s)|0|||
155271265|NCT03176238|560425890|FG000|Overall Study|Inter-current illness|0|||
155271266|NCT03176238|560425891|FG001|Overall Study|Inter-current illness|1|||
155271267|NCT03176238|560425890|FG000|Overall Study|Consent withdrawal|14|||
155271268|NCT03176238|560425891|FG001|Overall Study|Consent withdrawal|2|||
155271269|NCT03176238|560425890|FG000|Overall Study|Lost to Follow-up|3|||
155271270|NCT03176238|560425891|FG001|Overall Study|Lost to Follow-up|0|||
155271271|NCT03176238|560425890|FG000|Overall Study|Administrative problems|1|||
155271272|NCT03176238|560425891|FG001|Overall Study|Administrative problems|0|||
155271273|NCT03176238|560425890|FG000|Overall Study|Death|3|||
154932149|NCT00391118|559177196|FG001|Overall Study|Sponsor Decision|1|||
154932150|NCT00391118|559177197|FG002|Overall Study|Sponsor Decision|3|||
154932151|NCT00391118|559177195|FG000|Overall Study|Protocol Violation|1|||
154932152|NCT00391118|559177196|FG001|Overall Study|Protocol Violation|0|||
154932153|NCT00391118|559177197|FG002|Overall Study|Protocol Violation|0|||
154932154|NCT01892020|559177198|FG000|Period 1|Adverse Event|1|||
155271274|NCT03176238|560425891|FG001|Overall Study|Death|0|||
155271275|NCT03176238|560425890|FG000|Overall Study|Disease Progression|133|||
155271276|NCT03176238|560425891|FG001|Overall Study|Disease Progression|22|||
155271277|NCT03176238|560425890|FG000|Overall Study|Tx duration completed per EAP|0|||
155271278|NCT03176238|560425891|FG001|Overall Study|Tx duration completed per EAP|1|||
155271279|NCT03176238|560425890|FG000|Overall Study|Patient is switched to commercial drug|16|||
155271280|NCT03176238|560425891|FG001|Overall Study|Patient is switched to commercial drug|1|||
155271281|NCT03176238|560425890|FG000|Overall Study|Protocol Violation|1|||
155271282|NCT03176238|560425891|FG001|Overall Study|Protocol Violation|0|||
155271283|NCT03176238|560425890|FG000|Overall Study|Changes in the patient's condition|2|||
155271284|NCT03176238|560425891|FG001|Overall Study|Changes in the patient's condition|1|||
155271285|NCT03176238|560425890|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
155271286|NCT03176238|560425891|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
155271287|NCT04524598|560425892|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
155271288|NCT04524598|560425893|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
155271289|NCT04524598|560425894|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
155271290|NCT04524598|560425895|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
154932155|NCT01892020|559177199|FG001|Period 1|Adverse Event|1|||
154932156|NCT01892020|559177198|FG000|Period 1|Protocol Violation|2|||
154932157|NCT01892020|559177199|FG001|Period 1|Protocol Violation|4|||
155271291|NCT04524598|560425896|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
155271292|NCT04524598|560425892|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
155271293|NCT04524598|560425893|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
155271294|NCT04524598|560425894|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271295|NCT04524598|560425895|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271296|NCT04524598|560425896|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271297|NCT04524598|560425892|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
155271298|NCT04524598|560425893|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
155271299|NCT04524598|560425894|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
155271300|NCT04524598|560425895|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
155271301|NCT04524598|560425896|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
155271302|NCT04524598|560425892|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
155271303|NCT04524598|560425893|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
155271304|NCT04524598|560425894|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
155271305|NCT04524598|560425895|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
155271306|NCT04524598|560425896|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
155271307|NCT04524598|560425892|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271308|NCT04524598|560425893|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271309|NCT04524598|560425894|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
155271310|NCT04524598|560425895|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
155271311|NCT04524598|560425896|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271312|NCT04524598|560425892|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
155271313|NCT04524598|560425893|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
155271314|NCT04524598|560425894|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
155271315|NCT04524598|560425895|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
155271316|NCT04524598|560425896|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
155271317|NCT04524598|560425892|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271318|NCT04524598|560425893|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271319|NCT04524598|560425894|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271320|NCT04524598|560425895|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
155271321|NCT04524598|560425896|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
155271322|NCT02736968|560425900|FG000|Overall Study|Lost to Follow-up|0|||
155271323|NCT02736968|560425901|FG001|Overall Study|Lost to Follow-up|0|||
155271324|NCT02736968|560425902|FG002|Overall Study|Lost to Follow-up|0|||
155271325|NCT02736968|560425903|FG003|Overall Study|Lost to Follow-up|0|||
155271326|NCT02736968|560425904|FG004|Overall Study|Lost to Follow-up|0|||
155271327|NCT02736968|560425905|FG005|Overall Study|Lost to Follow-up|0|||
155271328|NCT02736968|560425906|FG006|Overall Study|Lost to Follow-up|5|||
155271329|NCT02736968|560425907|FG007|Overall Study|Lost to Follow-up|2|||
155271330|NCT02736968|560425900|FG000|Overall Study|COVID-19 Pandemic|0|||
155271331|NCT02736968|560425901|FG001|Overall Study|COVID-19 Pandemic|0|||
155271332|NCT02736968|560425902|FG002|Overall Study|COVID-19 Pandemic|0|||
155271333|NCT02736968|560425903|FG003|Overall Study|COVID-19 Pandemic|0|||
155271334|NCT02736968|560425904|FG004|Overall Study|COVID-19 Pandemic|0|||
155271335|NCT02736968|560425905|FG005|Overall Study|COVID-19 Pandemic|0|||
155271336|NCT02736968|560425906|FG006|Overall Study|COVID-19 Pandemic|2|||
155271337|NCT02736968|560425907|FG007|Overall Study|COVID-19 Pandemic|0|||
155271338|NCT02736968|560425900|FG000|Overall Study|Withdrawal by Subject|0|||
155271339|NCT02736968|560425901|FG001|Overall Study|Withdrawal by Subject|0|||
155271340|NCT02736968|560425902|FG002|Overall Study|Withdrawal by Subject|0|||
155271341|NCT02736968|560425903|FG003|Overall Study|Withdrawal by Subject|0|||
155271342|NCT02736968|560425904|FG004|Overall Study|Withdrawal by Subject|0|||
155271343|NCT02736968|560425905|FG005|Overall Study|Withdrawal by Subject|0|||
155271344|NCT02736968|560425906|FG006|Overall Study|Withdrawal by Subject|1|||
155271345|NCT02736968|560425907|FG007|Overall Study|Withdrawal by Subject|0|||
155271346|NCT01804673|560427257|FG000|Overall Study|Adverse Event|4|||
155271347|NCT01804673|560427257|FG000|Overall Study|Withdrawal by Subject|1|||
154932158|NCT01892020|559177198|FG000|Period 1|Unclassified|0|||
154932159|NCT01892020|559177199|FG001|Period 1|Unclassified|1|||
155271348|NCT01804673|560427257|FG000|Overall Study|Lack of Efficacy|9|||
155271349|NCT01804673|560427257|FG000|Overall Study|Change to Oral Therapy|37|||
155271350|NCT01804673|560427257|FG000|Overall Study|No Further Therapy Required|84|||
155271351|NCT01804673|560427257|FG000|Overall Study|Use of Prohibited Medication|1|||
155271352|NCT01804673|560427257|FG000|Overall Study|Other|4|||
155271353|NCT01857934|560427265|FG000|Overall Study|Relapse or progression|2|||
155271354|NCT01857934|560427265|FG000|Overall Study|Unacceptable toxicity|3|||
155271355|NCT01857934|560427265|FG000|Overall Study|Unwillingness or inability to comply|2|||
155271356|NCT01857934|560427265|FG000|Overall Study|Physician Decision|3|||
155271357|NCT01024959|560427266|FG000|Overall Study|ineligible|12|||
154932160|NCT01892020|559177198|FG000|Period 2|Protocol Violation|1|||
155271358|NCT01024959|560427266|FG000|Overall Study|results not evaluable|12|||
155271359|NCT01024959|560427266|FG000|Overall Study|missing results required for analysis|17|||
155271360|NCT00313911|560427267|FG000|Overall Study|Serious adverse event|6|||
155271361|NCT00313911|560427268|FG001|Overall Study|Serious adverse event|1|||
155271362|NCT00313911|560427267|FG000|Overall Study|Adverse Event|2|||
155271363|NCT00313911|560427268|FG001|Overall Study|Adverse Event|3|||
155271364|NCT00313911|560427267|FG000|Overall Study|Protocol Violation|19|||
155271365|NCT00313911|560427268|FG001|Overall Study|Protocol Violation|10|||
155271366|NCT00313911|560427267|FG000|Overall Study|Lost to Follow-up|27|||
155271367|NCT00313911|560427268|FG001|Overall Study|Lost to Follow-up|14|||
155271368|NCT00313911|560427267|FG000|Overall Study|Withdrawal by Subject|39|||
155271369|NCT00313911|560427268|FG001|Overall Study|Withdrawal by Subject|12|||
155271370|NCT00313911|560427267|FG000|Overall Study|Did not meet age criteria|1|||
155271371|NCT00313911|560427268|FG001|Overall Study|Did not meet age criteria|1|||
155271372|NCT04161807|560427271|FG000|Overall Study|Withdrawal by Subject|2|||
155271373|NCT04161807|560427271|FG000|Overall Study|Performed only 1 treatment|2|||
155271374|NCT00192023|560427278|FG000|Period III - Double-Blind|Adverse Event|3|||
155271375|NCT00192023|560427279|FG001|Period III - Double-Blind|Adverse Event|0|||
155271376|NCT00192023|560427278|FG000|Period III - Double-Blind|Physician Decision|2|||
155271377|NCT00192023|560427279|FG001|Period III - Double-Blind|Physician Decision|0|||
155271378|NCT00192023|560427278|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
155271379|NCT00192023|560427279|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
155271380|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
155271381|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
155271382|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
155271383|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
155271384|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
155271385|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
155271386|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
155271387|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
155271388|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
155271389|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
155271390|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
155271391|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
155271392|NCT00192023|560427278|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
155271393|NCT00192023|560427279|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
155271394|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
155271395|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
155271396|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
155271397|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
155271398|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
155271399|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
155271400|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155271401|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
155271402|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155271403|NCT02441946|560427283|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
155271404|NCT02441946|560427284|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
155271405|NCT02441946|560427285|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
155271406|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
155271407|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
155271408|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
155271409|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
155271410|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
155271411|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
155271412|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
155271413|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
155271414|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
155271415|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
155271416|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
155381794|NCT01874431|560833200|FG000|Overall Study|Adverse Event|5|||
155381795|NCT01874431|560833201|FG001|Overall Study|Adverse Event|4|||
154932161|NCT01892020|559177199|FG001|Period 2|Protocol Violation|0|||
155381796|NCT01874431|560833202|FG002|Overall Study|Adverse Event|6|||
155381797|NCT01874431|560833203|FG003|Overall Study|Adverse Event|5|||
155381798|NCT01874431|560833204|FG004|Overall Study|Adverse Event|2|||
155381799|NCT01874431|560833205|FG005|Overall Study|Adverse Event|8|||
154932162|NCT03078192|559177204|FG000|Overall Study|Withdrawal by Subject|2|||
155381800|NCT01874431|560833206|FG006|Overall Study|Adverse Event|2|||
154932163|NCT03078192|559177205|FG001|Overall Study|Withdrawal by Subject|1|||
154932164|NCT03078192|559177204|FG000|Overall Study|screen failure|0|||
154932165|NCT03078192|559177205|FG001|Overall Study|screen failure|3|||
155271417|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
155381801|NCT01874431|560833207|FG007|Overall Study|Adverse Event|3|||
155381802|NCT01874431|560833200|FG000|Overall Study|Protocol Violation|1|||
155381803|NCT01874431|560833201|FG001|Overall Study|Protocol Violation|1|||
155381804|NCT01874431|560833202|FG002|Overall Study|Protocol Violation|1|||
155381805|NCT01874431|560833203|FG003|Overall Study|Protocol Violation|0|||
155381806|NCT01874431|560833204|FG004|Overall Study|Protocol Violation|3|||
155381807|NCT01874431|560833205|FG005|Overall Study|Protocol Violation|2|||
155381808|NCT01874431|560833206|FG006|Overall Study|Protocol Violation|1|||
155381809|NCT01874431|560833207|FG007|Overall Study|Protocol Violation|1|||
155381810|NCT01874431|560833200|FG000|Overall Study|Non-compliance|0|||
155381811|NCT01874431|560833201|FG001|Overall Study|Non-compliance|0|||
155381812|NCT01874431|560833202|FG002|Overall Study|Non-compliance|0|||
155381813|NCT01874431|560833203|FG003|Overall Study|Non-compliance|0|||
155381814|NCT01874431|560833204|FG004|Overall Study|Non-compliance|1|||
155381815|NCT01874431|560833205|FG005|Overall Study|Non-compliance|0|||
155381816|NCT01874431|560833206|FG006|Overall Study|Non-compliance|1|||
155381817|NCT01874431|560833207|FG007|Overall Study|Non-compliance|0|||
155381818|NCT01874431|560833200|FG000|Overall Study|Logistical difficulties|0|||
155381819|NCT01874431|560833201|FG001|Overall Study|Logistical difficulties|0|||
155381820|NCT01874431|560833202|FG002|Overall Study|Logistical difficulties|0|||
155381821|NCT01874431|560833203|FG003|Overall Study|Logistical difficulties|0|||
155381822|NCT01874431|560833204|FG004|Overall Study|Logistical difficulties|0|||
155381823|NCT01874431|560833205|FG005|Overall Study|Logistical difficulties|0|||
155381824|NCT01874431|560833206|FG006|Overall Study|Logistical difficulties|1|||
155381825|NCT01874431|560833207|FG007|Overall Study|Logistical difficulties|0|||
155381826|NCT01874431|560833200|FG000|Overall Study|Withdrawal by Subject|0|||
155381827|NCT01874431|560833201|FG001|Overall Study|Withdrawal by Subject|0|||
155381828|NCT01874431|560833202|FG002|Overall Study|Withdrawal by Subject|1|||
155381829|NCT01874431|560833203|FG003|Overall Study|Withdrawal by Subject|2|||
155381830|NCT01874431|560833204|FG004|Overall Study|Withdrawal by Subject|1|||
155381831|NCT01874431|560833205|FG005|Overall Study|Withdrawal by Subject|1|||
155381832|NCT01874431|560833206|FG006|Overall Study|Withdrawal by Subject|3|||
155381833|NCT01874431|560833207|FG007|Overall Study|Withdrawal by Subject|0|||
155381834|NCT01874431|560833200|FG000|Overall Study|Sponsor decision|0|||
155381835|NCT01874431|560833201|FG001|Overall Study|Sponsor decision|0|||
155381836|NCT01874431|560833202|FG002|Overall Study|Sponsor decision|0|||
155381837|NCT01874431|560833203|FG003|Overall Study|Sponsor decision|0|||
155381838|NCT01874431|560833204|FG004|Overall Study|Sponsor decision|1|||
155381839|NCT01874431|560833205|FG005|Overall Study|Sponsor decision|0|||
155381840|NCT01874431|560833206|FG006|Overall Study|Sponsor decision|0|||
155381841|NCT01874431|560833207|FG007|Overall Study|Sponsor decision|0|||
155381842|NCT01874431|560833200|FG000|Overall Study|Lost to Follow-up|0|||
155381843|NCT01874431|560833201|FG001|Overall Study|Lost to Follow-up|0|||
155381844|NCT01874431|560833202|FG002|Overall Study|Lost to Follow-up|1|||
155381845|NCT01874431|560833203|FG003|Overall Study|Lost to Follow-up|0|||
155381846|NCT01874431|560833204|FG004|Overall Study|Lost to Follow-up|0|||
155381847|NCT01874431|560833205|FG005|Overall Study|Lost to Follow-up|0|||
155381848|NCT01874431|560833206|FG006|Overall Study|Lost to Follow-up|0|||
155381849|NCT01874431|560833207|FG007|Overall Study|Lost to Follow-up|0|||
155381850|NCT00642772|560833209|FG000|Overall Study|Lost to Follow-up|3|||
155381851|NCT00642772|560833209|FG000|Overall Study|Withdrawal by Subject|7|||
155381852|NCT05398237|560833218|FG000|Overall Study|Withdrawal by Subject|1|||
155381853|NCT01312857|560833220|FG000|Overall Study|Adverse Event|1|||
155381854|NCT01312857|560833221|FG001|Overall Study|Adverse Event|1|||
155381855|NCT01312857|560833220|FG000|Overall Study|Lost to Follow-up|2|||
155381856|NCT01312857|560833221|FG001|Overall Study|Lost to Follow-up|0|||
155381857|NCT01312857|560833220|FG000|Overall Study|Physician Decision|3|||
155381858|NCT01312857|560833221|FG001|Overall Study|Physician Decision|0|||
155381859|NCT01312857|560833220|FG000|Overall Study|Withdrawal by Subject|2|||
155381860|NCT01312857|560833221|FG001|Overall Study|Withdrawal by Subject|0|||
155381861|NCT01382706|560833224|FG000|Overall Study|Adverse Event|1|||
154932166|NCT02873195|559177206|FG000|Overall Study|Ineligible|5|||
154932167|NCT02873195|559177207|FG001|Overall Study|Ineligible|0|||
154932168|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155381862|NCT01382706|560833224|FG000|Overall Study|Withdrawal by Subject|1|||
155381863|NCT04745026|560833225|FG000|Overall Study|Physician Decision|1|||
155381864|NCT04745026|560833226|FG001|Overall Study|Physician Decision|0|||
155381865|NCT04745026|560833225|FG000|Overall Study|Adverse Event|2|||
155381866|NCT04745026|560833226|FG001|Overall Study|Adverse Event|2|||
155381867|NCT04745026|560833225|FG000|Overall Study|Protocol Violation|1|||
155381868|NCT04745026|560833226|FG001|Overall Study|Protocol Violation|3|||
155381869|NCT04745026|560833225|FG000|Overall Study|Lost to Follow-up|4|||
155381870|NCT04745026|560833226|FG001|Overall Study|Lost to Follow-up|3|||
154932169|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155381871|NCT04745026|560833225|FG000|Overall Study|Withdrawal by Subject|5|||
154932170|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155381872|NCT04745026|560833226|FG001|Overall Study|Withdrawal by Subject|5|||
155381873|NCT02344004|560833229|FG000|Overall Study|Adverse Event|11|||
155381874|NCT02344004|560833230|FG001|Overall Study|Adverse Event|1|||
154932171|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
155271418|NCT02441946|560427283|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
155271419|NCT02441946|560427284|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
155271420|NCT02441946|560427285|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
155271421|NCT02441946|560427283|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
155271422|NCT02441946|560427284|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
155271423|NCT02441946|560427285|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
155271424|NCT02441946|560427283|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
155271425|NCT02441946|560427284|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155271426|NCT02441946|560427285|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
155271427|NCT00758160|560427288|FG000|Overall Study|No Longer Requires Study Medication|4|||
155271428|NCT00758160|560427288|FG000|Overall Study|Administration Problems|3|||
155271429|NCT00758160|560427288|FG000|Overall Study|Adverse Event|15|||
155271430|NCT00758160|560427288|FG000|Overall Study|Lack of Efficacy|10|||
155271431|NCT00758160|560427288|FG000|Overall Study|Lost to Follow-up|14|||
155271432|NCT00758160|560427288|FG000|Overall Study|Protocol Violation|12|||
155271433|NCT00758160|560427288|FG000|Overall Study|Withdrawal by Subject|8|||
155271434|NCT02153359|560427289|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
155271435|NCT02153359|560427290|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
155271436|NCT01234649|560427295|FG000|Overall Study|Withdrawal by Subject|32|||
155271437|NCT01234649|560427296|FG001|Overall Study|Withdrawal by Subject|26|||
155271438|NCT01234649|560427295|FG000|Overall Study|Pregnancy|6|||
155271439|NCT01234649|560427296|FG001|Overall Study|Pregnancy|6|||
155271440|NCT01234649|560427295|FG000|Overall Study|intolerant to side effects|4|||
155271441|NCT01234649|560427296|FG001|Overall Study|intolerant to side effects|3|||
155271442|NCT01234649|560427295|FG000|Overall Study|Allergic reaction|1|||
155271443|NCT01234649|560427296|FG001|Overall Study|Allergic reaction|0|||
155271444|NCT01234649|560427295|FG000|Overall Study|Lack of Efficacy|0|||
155271445|NCT01234649|560427296|FG001|Overall Study|Lack of Efficacy|3|||
155271446|NCT02733042|560427305|FG000|Overall Study|Adverse Event|1|||
155271447|NCT02733042|560427306|FG001|Overall Study|Adverse Event|0|||
155271448|NCT02733042|560427307|FG002|Overall Study|Adverse Event|1|||
155271449|NCT02733042|560427308|FG003|Overall Study|Adverse Event|1|||
155271450|NCT02733042|560427309|FG004|Overall Study|Adverse Event|0|||
155271451|NCT02733042|560427310|FG005|Overall Study|Adverse Event|0|||
155271452|NCT02733042|560427311|FG006|Overall Study|Adverse Event|0|||
155271453|NCT02733042|560427312|FG007|Overall Study|Adverse Event|0|||
155271454|NCT02733042|560427313|FG008|Overall Study|Adverse Event|0|||
155271455|NCT02733042|560427314|FG009|Overall Study|Adverse Event|0|||
155271456|NCT02733042|560427315|FG010|Overall Study|Adverse Event|2|||
155271457|NCT02733042|560427316|FG011|Overall Study|Adverse Event|2|||
155271458|NCT02733042|560427317|FG012|Overall Study|Adverse Event|0|||
155271459|NCT02733042|560427318|FG013|Overall Study|Adverse Event|2|||
155271460|NCT02733042|560427319|FG014|Overall Study|Adverse Event|0|||
155271461|NCT02733042|560427320|FG015|Overall Study|Adverse Event|0|||
155271462|NCT02733042|560427321|FG016|Overall Study|Adverse Event|0|||
155271463|NCT02733042|560427322|FG017|Overall Study|Adverse Event|1|||
155271464|NCT02733042|560427323|FG018|Overall Study|Adverse Event|0|||
155271465|NCT02733042|560427305|FG000|Overall Study|Progressive Disease|2|||
155271466|NCT02733042|560427306|FG001|Overall Study|Progressive Disease|1|||
155271467|NCT02733042|560427307|FG002|Overall Study|Progressive Disease|3|||
155271468|NCT02733042|560427308|FG003|Overall Study|Progressive Disease|1|||
155271469|NCT02733042|560427309|FG004|Overall Study|Progressive Disease|2|||
155271470|NCT02733042|560427310|FG005|Overall Study|Progressive Disease|3|||
155271471|NCT02733042|560427311|FG006|Overall Study|Progressive Disease|0|||
155271472|NCT02733042|560427312|FG007|Overall Study|Progressive Disease|3|||
155271473|NCT02733042|560427313|FG008|Overall Study|Progressive Disease|3|||
155271474|NCT02733042|560427314|FG009|Overall Study|Progressive Disease|2|||
155271475|NCT02733042|560427315|FG010|Overall Study|Progressive Disease|2|||
154932172|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
154932173|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155271476|NCT02733042|560427316|FG011|Overall Study|Progressive Disease|2|||
155271477|NCT02733042|560427317|FG012|Overall Study|Progressive Disease|8|||
155271478|NCT02733042|560427318|FG013|Overall Study|Progressive Disease|1|||
155271479|NCT02733042|560427319|FG014|Overall Study|Progressive Disease|4|||
155271480|NCT02733042|560427320|FG015|Overall Study|Progressive Disease|7|||
155271481|NCT02733042|560427321|FG016|Overall Study|Progressive Disease|2|||
155271482|NCT02733042|560427322|FG017|Overall Study|Progressive Disease|3|||
155271483|NCT02733042|560427323|FG018|Overall Study|Progressive Disease|4|||
155271484|NCT02733042|560427305|FG000|Overall Study|Withdrawal by Subject|0|||
155271485|NCT02733042|560427306|FG001|Overall Study|Withdrawal by Subject|1|||
155381875|NCT02344004|560833229|FG000|Overall Study|Death|9|||
155381876|NCT02344004|560833230|FG001|Overall Study|Death|7|||
155271486|NCT02733042|560427307|FG002|Overall Study|Withdrawal by Subject|2|||
155271487|NCT02733042|560427308|FG003|Overall Study|Withdrawal by Subject|1|||
155271488|NCT02733042|560427309|FG004|Overall Study|Withdrawal by Subject|1|||
155271489|NCT02733042|560427310|FG005|Overall Study|Withdrawal by Subject|0|||
155381877|NCT02344004|560833229|FG000|Overall Study|Physician Decision|4|||
155271490|NCT02733042|560427311|FG006|Overall Study|Withdrawal by Subject|0|||
155271491|NCT02733042|560427312|FG007|Overall Study|Withdrawal by Subject|0|||
155271492|NCT02733042|560427313|FG008|Overall Study|Withdrawal by Subject|1|||
155271493|NCT02733042|560427314|FG009|Overall Study|Withdrawal by Subject|1|||
155271494|NCT02733042|560427315|FG010|Overall Study|Withdrawal by Subject|0|||
155271495|NCT02733042|560427316|FG011|Overall Study|Withdrawal by Subject|2|||
155271496|NCT02733042|560427317|FG012|Overall Study|Withdrawal by Subject|1|||
155271497|NCT02733042|560427318|FG013|Overall Study|Withdrawal by Subject|1|||
155271498|NCT02733042|560427319|FG014|Overall Study|Withdrawal by Subject|0|||
155271499|NCT02733042|560427320|FG015|Overall Study|Withdrawal by Subject|0|||
155271500|NCT02733042|560427321|FG016|Overall Study|Withdrawal by Subject|0|||
155271501|NCT02733042|560427322|FG017|Overall Study|Withdrawal by Subject|0|||
155271502|NCT02733042|560427323|FG018|Overall Study|Withdrawal by Subject|0|||
155271503|NCT02733042|560427305|FG000|Overall Study|Other Reasons|0|||
155271504|NCT02733042|560427306|FG001|Overall Study|Other Reasons|0|||
155271505|NCT02733042|560427307|FG002|Overall Study|Other Reasons|1|||
155271506|NCT02733042|560427308|FG003|Overall Study|Other Reasons|0|||
155271507|NCT02733042|560427309|FG004|Overall Study|Other Reasons|0|||
155271508|NCT02733042|560427310|FG005|Overall Study|Other Reasons|0|||
155271509|NCT02733042|560427311|FG006|Overall Study|Other Reasons|0|||
155271510|NCT02733042|560427312|FG007|Overall Study|Other Reasons|0|||
155271511|NCT02733042|560427313|FG008|Overall Study|Other Reasons|0|||
155271512|NCT02733042|560427314|FG009|Overall Study|Other Reasons|1|||
155271513|NCT02733042|560427315|FG010|Overall Study|Other Reasons|1|||
155271514|NCT02733042|560427316|FG011|Overall Study|Other Reasons|0|||
155271515|NCT02733042|560427317|FG012|Overall Study|Other Reasons|0|||
155271516|NCT02733042|560427318|FG013|Overall Study|Other Reasons|0|||
155271517|NCT02733042|560427319|FG014|Overall Study|Other Reasons|0|||
155271518|NCT02733042|560427320|FG015|Overall Study|Other Reasons|1|||
155271519|NCT02733042|560427321|FG016|Overall Study|Other Reasons|0|||
155271520|NCT02733042|560427322|FG017|Overall Study|Other Reasons|1|||
155271521|NCT02733042|560427323|FG018|Overall Study|Other Reasons|0|||
155271522|NCT02733042|560427305|FG000|Overall Study|Death|0|||
155271523|NCT02733042|560427306|FG001|Overall Study|Death|0|||
155271524|NCT02733042|560427307|FG002|Overall Study|Death|0|||
155271525|NCT02733042|560427308|FG003|Overall Study|Death|0|||
155271526|NCT02733042|560427309|FG004|Overall Study|Death|0|||
155271527|NCT02733042|560427310|FG005|Overall Study|Death|0|||
155271528|NCT02733042|560427311|FG006|Overall Study|Death|1|||
155271529|NCT02733042|560427312|FG007|Overall Study|Death|0|||
155271530|NCT02733042|560427313|FG008|Overall Study|Death|1|||
155271531|NCT02733042|560427314|FG009|Overall Study|Death|0|||
155271532|NCT02733042|560427315|FG010|Overall Study|Death|1|||
155271533|NCT02733042|560427316|FG011|Overall Study|Death|0|||
155271534|NCT02733042|560427317|FG012|Overall Study|Death|0|||
155271535|NCT02733042|560427318|FG013|Overall Study|Death|0|||
155271536|NCT02733042|560427319|FG014|Overall Study|Death|1|||
155271537|NCT02733042|560427320|FG015|Overall Study|Death|2|||
155271538|NCT02733042|560427321|FG016|Overall Study|Death|0|||
155271539|NCT02733042|560427322|FG017|Overall Study|Death|0|||
155271540|NCT02733042|560427323|FG018|Overall Study|Death|0|||
155271541|NCT02838628|560427324|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
155271542|NCT02838628|560427325|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
155271543|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Adverse Event|1|||
155271544|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Adverse Event|0|||
155271545|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Non-compliance|0|||
155271546|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Non-compliance|1|||
155271547|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
155271548|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
155271549|NCT02838628|560427324|FG000|Recurrence Follow-up Period|Other un-specified|1|||
155271550|NCT02838628|560427325|FG001|Recurrence Follow-up Period|Other un-specified|1|||
155271551|NCT04175912|560427330|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
154932174|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155271552|NCT04175912|560427331|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
155271553|NCT04175912|560427330|FG000|Overall Study|Adverse Event|0|||
155271554|NCT04175912|560427331|FG001|Overall Study|Adverse Event|3|||
155271555|NCT04175912|560427330|FG000|Overall Study|Never started treatment|3|||
155271556|NCT04175912|560427331|FG001|Overall Study|Never started treatment|3|||
155271557|NCT04175912|560427330|FG000|Overall Study|Death|0|||
155271558|NCT04175912|560427331|FG001|Overall Study|Death|1|||
155271559|NCT04654468|560427332|FG000|Overall Study|Death|1|||
155271560|NCT04654468|560427332|FG000|Overall Study|Ongoing in the Study|50|||
155271561|NCT06390826|560427333|FG000|Overall Study|Never Start Protocol Therapy|1|||
155271562|NCT06390826|560427333|FG000|Overall Study|Adverse Event|1|||
155271563|NCT06390826|560427333|FG000|Overall Study|Disease Progression|8|||
155271564|NCT02009696|560427334|FG000|Overall Study|Withdrawal by Subject|2|||
155271565|NCT02344537|560427335|FG000|Overall Study|Protocol Violation|1|||
155271566|NCT02344537|560427336|FG001|Overall Study|Protocol Violation|1|||
155271567|NCT02344537|560427335|FG000|Overall Study|Subject started another treatment after wk 6|1|||
155271568|NCT02344537|560427336|FG001|Overall Study|Subject started another treatment after wk 6|0|||
155271569|NCT02344537|560427335|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
155271570|NCT02344537|560427336|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
155271571|NCT05490329|560427337|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
155271572|NCT05490329|560427338|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
155271573|NCT05490329|560427337|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
155271574|NCT05490329|560427338|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
155271575|NCT05490329|560427337|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
155271576|NCT05490329|560427338|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
155271577|NCT02460263|560427339|FG000|Transition Period|Withdrawal by Subject|1|||
155271578|NCT02460263|560427339|FG000|Transition Period|Death|1|||
155271579|NCT02306122|560427340|FG000|Initial Physician Randomization|Physician Decision|0|||
155271580|NCT02306122|560427341|FG001|Initial Physician Randomization|Physician Decision|0|||
155271581|NCT02306122|560427342|FG002|Initial Physician Randomization|Physician Decision|0|||
155271582|NCT02306122|560427343|FG003|Initial Physician Randomization|Physician Decision|0|||
155271583|NCT02306122|560427344|FG004|Initial Physician Randomization|Physician Decision|0|||
155271584|NCT02306122|560427345|FG005|Initial Physician Randomization|Physician Decision|0|||
155271585|NCT02306122|560427346|FG006|Initial Physician Randomization|Physician Decision|0|||
155271586|NCT02306122|560427347|FG007|Initial Physician Randomization|Physician Decision|0|||
155271587|NCT02306122|560427348|FG008|Initial Physician Randomization|Physician Decision|1|||
155271588|NCT02306122|560427349|FG009|Initial Physician Randomization|Physician Decision|0|||
155271589|NCT02306122|560427350|FG010|Initial Physician Randomization|Physician Decision|0|||
155271590|NCT01351025|560427352|FG000|Week 0 - 20|Lost to Follow-up|2|||
155271591|NCT01351025|560427353|FG001|Week 0 - 20|Lost to Follow-up|1|||
155271592|NCT01351025|560427352|FG000|Week 0 - 20|Withdrawal by Subject|1|||
155271593|NCT01351025|560427353|FG001|Week 0 - 20|Withdrawal by Subject|0|||
155271594|NCT01351025|560427352|FG000|Week 24 - 44|Lost to Follow-up|0|||
155271595|NCT01351025|560427353|FG001|Week 24 - 44|Lost to Follow-up|2|||
155271596|NCT01351025|560427352|FG000|Week 24 - 44|Site closed|0|||
155271597|NCT01351025|560427353|FG001|Week 24 - 44|Site closed|1|||
155271598|NCT01351025|560427352|FG000|Week 24 - 44|unable to get to clinic|1|||
155271599|NCT01351025|560427353|FG001|Week 24 - 44|unable to get to clinic|1|||
155271600|NCT04152343|560427356|FG000|Overall Study|Transplanted|5|||
155271601|NCT04152343|560427356|FG000|Overall Study|Death|20|||
155271602|NCT04152343|560427356|FG000|Overall Study|Lost to Follow-up|3|||
155271603|NCT02090634|560427357|FG000|Overall Study|Lost to Follow-up|0|||
155271604|NCT02090634|560427358|FG001|Overall Study|Lost to Follow-up|1|||
155271605|NCT02090634|560427357|FG000|Overall Study|Death|0|||
155271606|NCT02090634|560427358|FG001|Overall Study|Death|1|||
155271607|NCT02090634|560427357|FG000|Overall Study|Protocol Violation|3|||
155271608|NCT02090634|560427358|FG001|Overall Study|Protocol Violation|1|||
155271609|NCT02090634|560427357|FG000|Overall Study|Adverse Event|2|||
155271610|NCT02090634|560427358|FG001|Overall Study|Adverse Event|0|||
155271611|NCT01965938|560427359|FG000|Overall Study|Withdrawal by Subject|1|||
155271612|NCT01965938|560427360|FG001|Overall Study|Withdrawal by Subject|0|||
155271613|NCT03757234|560427361|FG000|Overall Study|Adverse Event|0|||
155271614|NCT03757234|560427362|FG001|Overall Study|Adverse Event|0|||
155271615|NCT03757234|560427363|FG002|Overall Study|Adverse Event|0|||
155271616|NCT03757234|560427364|FG003|Overall Study|Adverse Event|0|||
155271617|NCT03757234|560427365|FG004|Overall Study|Adverse Event|1|||
155271618|NCT03757234|560427361|FG000|Overall Study|Lost to Follow-up|1|||
155271619|NCT03757234|560427362|FG001|Overall Study|Lost to Follow-up|0|||
155271620|NCT03757234|560427363|FG002|Overall Study|Lost to Follow-up|0|||
155271621|NCT03757234|560427364|FG003|Overall Study|Lost to Follow-up|0|||
155271622|NCT03757234|560427365|FG004|Overall Study|Lost to Follow-up|1|||
155271623|NCT03757234|560427361|FG000|Overall Study|Withdrawal by Subject|1|||
155271624|NCT03757234|560427362|FG001|Overall Study|Withdrawal by Subject|1|||
155271625|NCT03757234|560427363|FG002|Overall Study|Withdrawal by Subject|0|||
155271626|NCT03757234|560427364|FG003|Overall Study|Withdrawal by Subject|1|||
155271627|NCT03757234|560427365|FG004|Overall Study|Withdrawal by Subject|2|||
155271628|NCT03757234|560427361|FG000|Overall Study|Other|1|||
155271629|NCT03757234|560427362|FG001|Overall Study|Other|1|||
155271630|NCT03757234|560427363|FG002|Overall Study|Other|0|||
155271631|NCT03757234|560427364|FG003|Overall Study|Other|0|||
155271632|NCT03757234|560427365|FG004|Overall Study|Other|0|||
155271633|NCT00171873|560427370|FG000|Overall Study|Withdrawal by Subject|4|||
155271634|NCT00171873|560427371|FG001|Overall Study|Withdrawal by Subject|2|||
155271635|NCT00171873|560427370|FG000|Overall Study|Adverse Event|5|||
155271636|NCT00171873|560427371|FG001|Overall Study|Adverse Event|0|||
155271637|NCT00171873|560427370|FG000|Overall Study|Switched to Octreotide|0|||
155271638|NCT00171873|560427371|FG001|Overall Study|Switched to Octreotide|1|||
155271639|NCT02041923|560427372|FG000|Overall Study|Lost to Follow-up|26|||
155271640|NCT02041923|560427373|FG001|Overall Study|Lost to Follow-up|30|||
155271641|NCT00309608|560427378|FG000|Overall Study|Adverse Event|1|||
155271642|NCT00309608|560427379|FG001|Overall Study|Adverse Event|5|||
155271643|NCT00309608|560427380|FG002|Overall Study|Adverse Event|3|||
155271644|NCT00309608|560427381|FG003|Overall Study|Adverse Event|2|||
155271645|NCT00309608|560427382|FG004|Overall Study|Adverse Event|3|||
155271646|NCT00309608|560427378|FG000|Overall Study|Protocol Violation|2|||
155271647|NCT00309608|560427379|FG001|Overall Study|Protocol Violation|0|||
155271648|NCT00309608|560427380|FG002|Overall Study|Protocol Violation|0|||
155271649|NCT00309608|560427381|FG003|Overall Study|Protocol Violation|0|||
155271650|NCT00309608|560427382|FG004|Overall Study|Protocol Violation|0|||
155271651|NCT00309608|560427378|FG000|Overall Study|Lost to Follow-up|0|||
155271652|NCT00309608|560427379|FG001|Overall Study|Lost to Follow-up|0|||
155271653|NCT00309608|560427380|FG002|Overall Study|Lost to Follow-up|2|||
155271654|NCT00309608|560427381|FG003|Overall Study|Lost to Follow-up|0|||
155271655|NCT00309608|560427382|FG004|Overall Study|Lost to Follow-up|1|||
155271656|NCT00309608|560427378|FG000|Overall Study|Withdrawal by Subject|1|||
155271657|NCT00309608|560427379|FG001|Overall Study|Withdrawal by Subject|4|||
155271658|NCT00309608|560427380|FG002|Overall Study|Withdrawal by Subject|2|||
155271659|NCT00309608|560427381|FG003|Overall Study|Withdrawal by Subject|0|||
155271660|NCT00309608|560427382|FG004|Overall Study|Withdrawal by Subject|0|||
155271661|NCT00309608|560427378|FG000|Overall Study|Other incl. Lack of efficacy|10|||
155271662|NCT00309608|560427379|FG001|Overall Study|Other incl. Lack of efficacy|4|||
155271663|NCT00309608|560427380|FG002|Overall Study|Other incl. Lack of efficacy|3|||
155271664|NCT00309608|560427381|FG003|Overall Study|Other incl. Lack of efficacy|4|||
155271665|NCT00309608|560427382|FG004|Overall Study|Other incl. Lack of efficacy|0|||
155271666|NCT00621296|560427389|FG000|Overall Study|Adverse Event|2|||
155271667|NCT00621296|560427389|FG000|Overall Study|Lack of Efficacy|1|||
155271668|NCT00621296|560427389|FG000|Overall Study|Physician Decision|7|||
155271669|NCT00621296|560427389|FG000|Overall Study|Unmatch Criteria|1|||
155271670|NCT00621296|560427389|FG000|Overall Study|Stopping Criteria|3|||
155271671|NCT00127413|560427390|FG000|Overall Study|Lost to Follow-up|6|||
155271672|NCT00127413|560427391|FG001|Overall Study|Lost to Follow-up|4|||
155271673|NCT00127413|560427392|FG002|Overall Study|Lost to Follow-up|8|||
155271674|NCT00127413|560427393|FG003|Overall Study|Lost to Follow-up|2|||
155271675|NCT01051063|560427398|FG000|Overall Study|Death|2|||
155271676|NCT01051063|560427399|FG001|Overall Study|Death|2|||
155271677|NCT01051063|560427398|FG000|Overall Study|Withdrawal by Subject|1|||
155271678|NCT01051063|560427399|FG001|Overall Study|Withdrawal by Subject|1|||
155271679|NCT01051063|560427398|FG000|Overall Study|Termination of the study|5|||
155271680|NCT01051063|560427399|FG001|Overall Study|Termination of the study|0|||
155271681|NCT01051063|560427398|FG000|Overall Study|Moved from the study site area|1|||
155271682|NCT01051063|560427399|FG001|Overall Study|Moved from the study site area|0|||
155271683|NCT01051063|560427398|FG000|Overall Study|Other|1|||
155271684|NCT01051063|560427399|FG001|Overall Study|Other|0|||
155271685|NCT01051063|560427398|FG000|Overall Study|Lost to Follow-up|0|||
155271686|NCT01051063|560427399|FG001|Overall Study|Lost to Follow-up|1|||
155271687|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
155271688|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
155271689|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
155271690|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
155271691|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
155271692|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
155271693|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
155271694|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
155271695|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
155271696|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
155271697|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
155271698|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
155271699|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
155271700|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
155271701|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
155271702|NCT02023879|560427401|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
155271703|NCT02023879|560427402|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
155271704|NCT02023879|560427403|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
155271705|NCT02023879|560427401|FG000|Extension Open Label Treatment|Adverse Event|1|||
154932175|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
154932176|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155271706|NCT02023879|560427402|FG001|Extension Open Label Treatment|Adverse Event|7|||
155381878|NCT02344004|560833230|FG001|Overall Study|Physician Decision|1|||
154932177|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
154932178|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
155271707|NCT02023879|560427403|FG002|Extension Open Label Treatment|Adverse Event|3|||
155271708|NCT02023879|560427401|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
155381879|NCT02344004|560833229|FG000|Overall Study|Withdrawal by Subject|22|||
155271709|NCT02023879|560427402|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
155271710|NCT02023879|560427403|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
155271711|NCT02023879|560427401|FG000|Extension Open Label Treatment|Participant moved|1|||
155271712|NCT02023879|560427402|FG001|Extension Open Label Treatment|Participant moved|2|||
155271713|NCT02023879|560427403|FG002|Extension Open Label Treatment|Participant moved|0|||
155271714|NCT02023879|560427401|FG000|Extension Open Label Treatment|Other than specified above|2|||
155271715|NCT02023879|560427402|FG001|Extension Open Label Treatment|Other than specified above|7|||
155271716|NCT02023879|560427403|FG002|Extension Open Label Treatment|Other than specified above|2|||
155271717|NCT03713021|560427404|FG000|Overall Study|Did not have CT sim scan available|6|||
155271718|NCT03713021|560427404|FG000|Overall Study|Not eligible|4|||
155271719|NCT03713021|560427404|FG000|Overall Study|Issues with TraceIT markers|5|||
155271720|NCT00874432|560427405|FG000|Overall Study|Withdrawal by Subject|1|||
155271721|NCT00874432|560427406|FG001|Overall Study|Withdrawal by Subject|0|||
155271722|NCT00874432|560427407|FG002|Overall Study|Withdrawal by Subject|0|||
155271723|NCT00874432|560427408|FG003|Overall Study|Withdrawal by Subject|0|||
155271724|NCT00874432|560427405|FG000|Overall Study|Physician Decision|1|||
155271725|NCT00874432|560427406|FG001|Overall Study|Physician Decision|0|||
155271726|NCT00874432|560427407|FG002|Overall Study|Physician Decision|0|||
155271727|NCT00874432|560427408|FG003|Overall Study|Physician Decision|0|||
155271728|NCT00874432|560427405|FG000|Overall Study|Other|1|||
155271729|NCT00874432|560427406|FG001|Overall Study|Other|2|||
155271730|NCT00874432|560427407|FG002|Overall Study|Other|8|||
155271731|NCT00874432|560427408|FG003|Overall Study|Other|3|||
155271732|NCT00384059|560427413|FG000|Infant Series|Not consented|2|||
155271733|NCT00384059|560427414|FG001|Infant Series|Not consented|6|||
155271734|NCT00384059|560427413|FG000|Infant Series|Withdrawal by Subject|2|||
154932179|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
154932180|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
154932181|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
154932182|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
154932183|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
154932184|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
154932185|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
154932186|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
154932187|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932188|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932189|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932190|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932191|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932192|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
154932193|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932194|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932195|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932196|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
154932197|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932198|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932199|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932200|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
154932201|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
154932202|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
154932203|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
154932204|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
154932205|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
154932206|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
154932207|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932208|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932209|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932210|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932211|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
154932212|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932213|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932214|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155271735|NCT00384059|560427414|FG001|Infant Series|Withdrawal by Subject|2|||
154932215|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932216|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155271736|NCT00384059|560427413|FG000|Infant Series|Adverse Event|1|||
155271737|NCT00384059|560427414|FG001|Infant Series|Adverse Event|2|||
155271738|NCT00384059|560427413|FG000|Infant Series|Protocol Violation|1|||
155271739|NCT00384059|560427414|FG001|Infant Series|Protocol Violation|2|||
155271740|NCT00384059|560427413|FG000|Infant Series|Lost to Follow-up|0|||
155271741|NCT00384059|560427414|FG001|Infant Series|Lost to Follow-up|1|||
155271742|NCT00384059|560427413|FG000|After Infant Series|Protocol Violation|2|||
155271743|NCT00384059|560427414|FG001|After Infant Series|Protocol Violation|3|||
155271744|NCT00384059|560427413|FG000|After Infant Series|Withdrawal by Subject|2|||
155271745|NCT00384059|560427414|FG001|After Infant Series|Withdrawal by Subject|2|||
155271746|NCT00384059|560427413|FG000|After Infant Series|Failed to Return|0|||
155271747|NCT00384059|560427414|FG001|After Infant Series|Failed to Return|2|||
155271748|NCT00384059|560427413|FG000|After Infant Series|Adverse Event|0|||
155271749|NCT00384059|560427414|FG001|After Infant Series|Adverse Event|1|||
155271750|NCT00384059|560427413|FG000|After Infant Series|Physician Decision|0|||
155271751|NCT00384059|560427414|FG001|After Infant Series|Physician Decision|1|||
155271752|NCT00384059|560427413|FG000|After Infant Series|Lost to Follow-up|0|||
155271753|NCT00384059|560427414|FG001|After Infant Series|Lost to Follow-up|1|||
155271754|NCT00384059|560427413|FG000|Toddler Dose|Lost to Follow-up|1|||
155271755|NCT00384059|560427414|FG001|Toddler Dose|Lost to Follow-up|1|||
155271756|NCT00384059|560427413|FG000|Toddler Dose|Failed to return|0|||
155271757|NCT00384059|560427414|FG001|Toddler Dose|Failed to return|1|||
155271758|NCT00381641|560427417|FG000|Overall Study|Withdrawal by Subject|0|||
155271759|NCT00381641|560427418|FG001|Overall Study|Withdrawal by Subject|2|||
155271760|NCT03864926|560429642|FG000|Overall Study|Death|0|||
155271761|NCT03864926|560429643|FG001|Overall Study|Death|2|||
155271762|NCT00445601|560429644|FG000|Overall Study|Withdrawal by Subject|11|||
155271763|NCT00445601|560429645|FG001|Overall Study|Withdrawal by Subject|11|||
155271764|NCT00445601|560429644|FG000|Overall Study|TURBT Complication|12|||
155271765|NCT00445601|560429645|FG001|Overall Study|TURBT Complication|8|||
155271766|NCT00445601|560429644|FG000|Overall Study|Incorrect Disease Status|6|||
155271767|NCT00445601|560429645|FG001|Overall Study|Incorrect Disease Status|6|||
155271768|NCT00445601|560429644|FG000|Overall Study|Drug Delivery Issue|2|||
155271769|NCT00445601|560429645|FG001|Overall Study|Drug Delivery Issue|2|||
155271770|NCT00445601|560429644|FG000|Overall Study|Adverse Event|2|||
155271771|NCT00445601|560429645|FG001|Overall Study|Adverse Event|0|||
155271772|NCT00445601|560429644|FG000|Overall Study|Death prior to TURBT|0|||
155271773|NCT00445601|560429645|FG001|Overall Study|Death prior to TURBT|1|||
155271774|NCT01091428|560429646|FG000|Phase 1|Progressive Disease|24|||
155271775|NCT01091428|560429647|FG001|Phase 1|Progressive Disease|8|||
155271776|NCT01091428|560429648|FG002|Phase 1|Progressive Disease|0|||
155271777|NCT01091428|560429649|FG003|Phase 1|Progressive Disease|0|||
155271778|NCT01091428|560429646|FG000|Phase 1|Symptomatic Deterioration|3|||
155271779|NCT01091428|560429647|FG001|Phase 1|Symptomatic Deterioration|2|||
155271780|NCT01091428|560429648|FG002|Phase 1|Symptomatic Deterioration|0|||
155271781|NCT01091428|560429649|FG003|Phase 1|Symptomatic Deterioration|0|||
155271782|NCT01091428|560429646|FG000|Phase 1|Adverse Event|2|||
155271783|NCT01091428|560429647|FG001|Phase 1|Adverse Event|0|||
155271784|NCT01091428|560429648|FG002|Phase 1|Adverse Event|0|||
155271785|NCT01091428|560429649|FG003|Phase 1|Adverse Event|0|||
155271786|NCT01091428|560429646|FG000|Phase 1|Withdrawal by Subject|7|||
155271787|NCT01091428|560429647|FG001|Phase 1|Withdrawal by Subject|0|||
155271788|NCT01091428|560429648|FG002|Phase 1|Withdrawal by Subject|0|||
155271789|NCT01091428|560429649|FG003|Phase 1|Withdrawal by Subject|0|||
155271790|NCT01091428|560429646|FG000|Phase 1|Reason not specified|0|||
155271791|NCT01091428|560429647|FG001|Phase 1|Reason not specified|1|||
155271792|NCT01091428|560429648|FG002|Phase 1|Reason not specified|0|||
155271793|NCT01091428|560429649|FG003|Phase 1|Reason not specified|0|||
155271794|NCT01091428|560429646|FG000|Phase 1|Single-Patient IND|2|||
155271795|NCT01091428|560429647|FG001|Phase 1|Single-Patient IND|0|||
155271796|NCT01091428|560429648|FG002|Phase 1|Single-Patient IND|0|||
155271797|NCT01091428|560429649|FG003|Phase 1|Single-Patient IND|0|||
154932217|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932218|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932219|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932220|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
154932221|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
155271798|NCT01091428|560429646|FG000|Phase 2|Progressive Disease|0|||
155271799|NCT01091428|560429647|FG001|Phase 2|Progressive Disease|0|||
155381880|NCT02344004|560833230|FG001|Overall Study|Withdrawal by Subject|5|||
154932222|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932223|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
155271800|NCT01091428|560429648|FG002|Phase 2|Progressive Disease|44|||
155271801|NCT01091428|560429649|FG003|Phase 2|Progressive Disease|46|||
155271802|NCT01091428|560429646|FG000|Phase 2|Symptomatic Deterioration|0|||
155271803|NCT01091428|560429647|FG001|Phase 2|Symptomatic Deterioration|0|||
155271804|NCT01091428|560429648|FG002|Phase 2|Symptomatic Deterioration|1|||
155271805|NCT01091428|560429649|FG003|Phase 2|Symptomatic Deterioration|6|||
155271806|NCT01091428|560429646|FG000|Phase 2|Adverse Event|0|||
155271807|NCT01091428|560429647|FG001|Phase 2|Adverse Event|0|||
155271808|NCT01091428|560429648|FG002|Phase 2|Adverse Event|12|||
155271809|NCT01091428|560429649|FG003|Phase 2|Adverse Event|5|||
155271810|NCT01091428|560429646|FG000|Phase 2|Withdrawal by Subject|0|||
155271811|NCT01091428|560429647|FG001|Phase 2|Withdrawal by Subject|0|||
155271812|NCT01091428|560429648|FG002|Phase 2|Withdrawal by Subject|9|||
155271813|NCT01091428|560429649|FG003|Phase 2|Withdrawal by Subject|8|||
155271814|NCT01091428|560429646|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
155271815|NCT01091428|560429647|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
155271816|NCT01091428|560429648|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
155271817|NCT01091428|560429649|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
155271818|NCT01091428|560429646|FG000|Phase 2|Reason not specified|0|||
155271819|NCT01091428|560429647|FG001|Phase 2|Reason not specified|0|||
155271820|NCT01091428|560429648|FG002|Phase 2|Reason not specified|4|||
155271821|NCT01091428|560429649|FG003|Phase 2|Reason not specified|3|||
155271822|NCT01091428|560429646|FG000|Phase 2|Physician Decision|0|||
155271823|NCT01091428|560429647|FG001|Phase 2|Physician Decision|0|||
155271824|NCT01091428|560429648|FG002|Phase 2|Physician Decision|2|||
155271825|NCT01091428|560429649|FG003|Phase 2|Physician Decision|0|||
155271826|NCT04213989|560429656|FG000|Overall Study|Withdrawal by Subject|3|||
155271827|NCT04213989|560429657|FG001|Overall Study|Withdrawal by Subject|2|||
155043030|NCT00401193|559590038|FG001|Overall Study|Other Event|2|||
155271828|NCT04213989|560429656|FG000|Overall Study|Physician Decision|1|||
155271829|NCT04213989|560429657|FG001|Overall Study|Physician Decision|0|||
155271830|NCT04213989|560429656|FG000|Overall Study|Lost to Follow-up|0|||
155271831|NCT04213989|560429657|FG001|Overall Study|Lost to Follow-up|4|||
155271832|NCT03918239|560429660|FG000|Overall Study|Lost to Follow-up|3|||
155271833|NCT03918239|560429661|FG001|Overall Study|Lost to Follow-up|1|||
155271834|NCT03918239|560429660|FG000|Overall Study|Pregnancy|0|||
155271835|NCT03918239|560429661|FG001|Overall Study|Pregnancy|2|||
155271836|NCT03918239|560429660|FG000|Overall Study|Withdrawal by Subject|3|||
155271837|NCT03918239|560429661|FG001|Overall Study|Withdrawal by Subject|3|||
155271838|NCT03918239|560429660|FG000|Overall Study|positive urine drug screening results|4|||
155271839|NCT03918239|560429661|FG001|Overall Study|positive urine drug screening results|1|||
155271840|NCT00358215|560429663|FG000|Overall Study|Ineligibility determined|4|||
155271841|NCT00358215|560429664|FG001|Overall Study|Ineligibility determined|3|||
155271842|NCT00358215|560429663|FG000|Overall Study|Adverse Event|83|||
155271843|NCT00358215|560429664|FG001|Overall Study|Adverse Event|65|||
155271844|NCT00358215|560429663|FG000|Overall Study|Withdrawal by Subject|111|||
155271845|NCT00358215|560429664|FG001|Overall Study|Withdrawal by Subject|102|||
155271846|NCT00358215|560429663|FG000|Overall Study|Participant request|65|||
155271847|NCT00358215|560429664|FG001|Overall Study|Participant request|64|||
155271848|NCT00358215|560429663|FG000|Overall Study|Physician Decision|47|||
155271849|NCT00358215|560429664|FG001|Overall Study|Physician Decision|39|||
155271850|NCT00358215|560429663|FG000|Overall Study|Lost to Follow-up|16|||
155271851|NCT00358215|560429664|FG001|Overall Study|Lost to Follow-up|22|||
155271852|NCT00358215|560429663|FG000|Overall Study|Death|265|||
155271853|NCT00358215|560429664|FG001|Overall Study|Death|281|||
155271854|NCT00358215|560429663|FG000|Overall Study|Protocol Violation|64|||
155271855|NCT00358215|560429664|FG001|Overall Study|Protocol Violation|59|||
155271856|NCT00358215|560429663|FG000|Overall Study|Pregnancy|1|||
155271857|NCT00358215|560429664|FG001|Overall Study|Pregnancy|0|||
155271858|NCT00358215|560429663|FG000|Overall Study|Other|21|||
155271859|NCT00358215|560429664|FG001|Overall Study|Other|14|||
155271860|NCT00358215|560429663|FG000|Overall Study|Did not receive investigational product|2|||
155271861|NCT00358215|560429664|FG001|Overall Study|Did not receive investigational product|3|||
155271862|NCT00744237|560429665|FG000|Overall Study|Lack of Efficacy|1|||
155271863|NCT00744237|560429666|FG001|Overall Study|Lack of Efficacy|1|||
155271864|NCT00744237|560429667|FG002|Overall Study|Lack of Efficacy|0|||
155271865|NCT00744237|560429665|FG000|Overall Study|Withdrawal by Subject|9|||
155271866|NCT00744237|560429666|FG001|Overall Study|Withdrawal by Subject|5|||
155271867|NCT00744237|560429667|FG002|Overall Study|Withdrawal by Subject|3|||
155271868|NCT00744237|560429665|FG000|Overall Study|Lost to Follow-up|1|||
155271869|NCT00744237|560429666|FG001|Overall Study|Lost to Follow-up|1|||
155271870|NCT00744237|560429667|FG002|Overall Study|Lost to Follow-up|1|||
155271871|NCT00744237|560429665|FG000|Overall Study|Protocol Violation|3|||
155271872|NCT00744237|560429666|FG001|Overall Study|Protocol Violation|4|||
155271873|NCT00744237|560429667|FG002|Overall Study|Protocol Violation|3|||
155271874|NCT00744237|560429665|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
155271875|NCT00744237|560429666|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
155043031|NCT00401193|559590039|FG002|Overall Study|Other Event|2|||
155043032|NCT02526160|559590040|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
155043033|NCT02526160|559590041|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
155271876|NCT00744237|560429667|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
155271877|NCT00744237|560429665|FG000|Overall Study|Dosing Error|1|||
155271878|NCT00744237|560429666|FG001|Overall Study|Dosing Error|0|||
155271879|NCT00744237|560429667|FG002|Overall Study|Dosing Error|1|||
155271880|NCT00744237|560429665|FG000|Overall Study|Study Drug Error|1|||
155271881|NCT00744237|560429666|FG001|Overall Study|Study Drug Error|0|||
155271882|NCT00744237|560429667|FG002|Overall Study|Study Drug Error|0|||
155271883|NCT00744237|560429665|FG000|Overall Study|Prohibited Concomitant Medication|0|||
155271884|NCT00744237|560429666|FG001|Overall Study|Prohibited Concomitant Medication|0|||
155271885|NCT00744237|560429667|FG002|Overall Study|Prohibited Concomitant Medication|1|||
154932224|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
154932225|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932226|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932227|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932228|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932229|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932230|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932231|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932232|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932233|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932234|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932235|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
154932236|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932237|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932238|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
154932239|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932240|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932241|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
154932242|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
154932243|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
154932244|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
154932245|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
154932246|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
154932247|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
154932248|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155271886|NCT00744237|560429665|FG000|Overall Study|Poor Compliance|0|||
155271887|NCT00744237|560429666|FG001|Overall Study|Poor Compliance|2|||
155271888|NCT00744237|560429667|FG002|Overall Study|Poor Compliance|0|||
155271889|NCT00744237|560429665|FG000|Overall Study|Administrative. Site Closed|1|||
155271890|NCT00744237|560429666|FG001|Overall Study|Administrative. Site Closed|1|||
155271891|NCT00744237|560429667|FG002|Overall Study|Administrative. Site Closed|1|||
155271892|NCT00744237|560429665|FG000|Overall Study|Adverse Event|9|||
155271893|NCT00744237|560429666|FG001|Overall Study|Adverse Event|13|||
155271894|NCT00744237|560429667|FG002|Overall Study|Adverse Event|5|||
155271895|NCT06017999|560429668|FG000|Overall Study|Withdrawal by Subject|0|||
155271896|NCT06017999|560429669|FG001|Overall Study|Withdrawal by Subject|4|||
155271897|NCT06017999|560429670|FG002|Overall Study|Withdrawal by Subject|3|||
155271898|NCT06017999|560429668|FG000|Overall Study|Adverse Event|2|||
155271899|NCT06017999|560429669|FG001|Overall Study|Adverse Event|1|||
155271900|NCT06017999|560429670|FG002|Overall Study|Adverse Event|1|||
155271901|NCT06017999|560429668|FG000|Overall Study|Lost to Follow-up|0|||
155271902|NCT06017999|560429669|FG001|Overall Study|Lost to Follow-up|0|||
155271903|NCT06017999|560429670|FG002|Overall Study|Lost to Follow-up|1|||
155271904|NCT06017999|560429668|FG000|Overall Study|Physician Decision|1|||
155271905|NCT06017999|560429669|FG001|Overall Study|Physician Decision|1|||
155271906|NCT06017999|560429670|FG002|Overall Study|Physician Decision|0|||
155271907|NCT06017999|560429668|FG000|Overall Study|Non-Compliance|0|||
155271908|NCT06017999|560429669|FG001|Overall Study|Non-Compliance|0|||
155271909|NCT06017999|560429670|FG002|Overall Study|Non-Compliance|1|||
155271910|NCT06017999|560429668|FG000|Overall Study|Lack of Efficacy|1|||
155271911|NCT06017999|560429669|FG001|Overall Study|Lack of Efficacy|0|||
155271912|NCT06017999|560429670|FG002|Overall Study|Lack of Efficacy|7|||
155271913|NCT06017999|560429668|FG000|Overall Study|COVID Positive|0|||
155271914|NCT06017999|560429669|FG001|Overall Study|COVID Positive|1|||
155271915|NCT06017999|560429670|FG002|Overall Study|COVID Positive|0|||
155271916|NCT06017999|560429668|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
155271917|NCT06017999|560429669|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
155271918|NCT06017999|560429670|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
155271919|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
155271920|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
155271921|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271922|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271923|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271924|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
155271925|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
155271926|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
155381881|NCT02344004|560833229|FG000|Overall Study|Rescue Medication|2|||
154932249|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
154932250|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
154932251|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
154932252|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
154932253|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
154932254|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
154932255|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
155043034|NCT02526160|559590040|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
155043035|NCT02526160|559590041|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
155043036|NCT02526160|559590040|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
155043037|NCT02526160|559590041|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
155043038|NCT02526160|559590040|FG000|Open-Label Treatment Extension Period I|Death|0|||
155043039|NCT02526160|559590041|FG001|Open-Label Treatment Extension Period I|Death|1|||
155043040|NCT02526160|559590040|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
155043041|NCT02526160|559590041|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
155043042|NCT02526160|559590040|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
155043043|NCT02526160|559590041|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
155043044|NCT02526160|559590040|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
155043045|NCT02526160|559590041|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
155043046|NCT02526160|559590040|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
155043047|NCT02526160|559590041|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
155043048|NCT00398216|559590042|FG000|Overall Study|Adverse Event|4|||
155043049|NCT00398216|559590043|FG001|Overall Study|Adverse Event|2|||
155043050|NCT00398216|559590044|FG002|Overall Study|Adverse Event|5|||
155043051|NCT00398216|559590045|FG003|Overall Study|Adverse Event|7|||
155043052|NCT00398216|559590046|FG004|Overall Study|Adverse Event|2|||
155043053|NCT00398216|559590042|FG000|Overall Study|Protocol Violation|2|||
155043054|NCT00398216|559590043|FG001|Overall Study|Protocol Violation|4|||
155043055|NCT00398216|559590044|FG002|Overall Study|Protocol Violation|5|||
155043056|NCT00398216|559590045|FG003|Overall Study|Protocol Violation|7|||
155043057|NCT00398216|559590046|FG004|Overall Study|Protocol Violation|5|||
155043058|NCT00398216|559590042|FG000|Overall Study|Lost to Follow-up|1|||
155043059|NCT00398216|559590043|FG001|Overall Study|Lost to Follow-up|6|||
155043060|NCT00398216|559590044|FG002|Overall Study|Lost to Follow-up|4|||
155043061|NCT00398216|559590045|FG003|Overall Study|Lost to Follow-up|4|||
155043062|NCT00398216|559590046|FG004|Overall Study|Lost to Follow-up|1|||
155043063|NCT00398216|559590042|FG000|Overall Study|Death|0|||
155043064|NCT00398216|559590043|FG001|Overall Study|Death|3|||
155043065|NCT00398216|559590044|FG002|Overall Study|Death|0|||
155043066|NCT00398216|559590045|FG003|Overall Study|Death|0|||
155043067|NCT00398216|559590046|FG004|Overall Study|Death|0|||
155043068|NCT00398216|559590042|FG000|Overall Study|Withdrawal by Subject|1|||
155043069|NCT00398216|559590043|FG001|Overall Study|Withdrawal by Subject|0|||
155043070|NCT00398216|559590044|FG002|Overall Study|Withdrawal by Subject|3|||
155043071|NCT00398216|559590045|FG003|Overall Study|Withdrawal by Subject|1|||
155043072|NCT00398216|559590046|FG004|Overall Study|Withdrawal by Subject|2|||
155043073|NCT00398216|559590042|FG000|Overall Study|administrative reasons|3|||
155043074|NCT00398216|559590043|FG001|Overall Study|administrative reasons|4|||
155043075|NCT00398216|559590044|FG002|Overall Study|administrative reasons|4|||
155043076|NCT00398216|559590045|FG003|Overall Study|administrative reasons|3|||
155043077|NCT00398216|559590046|FG004|Overall Study|administrative reasons|3|||
155043078|NCT00398216|559590042|FG000|Overall Study|entrance criteria|0|||
155043079|NCT00398216|559590043|FG001|Overall Study|entrance criteria|0|||
155043080|NCT00398216|559590044|FG002|Overall Study|entrance criteria|0|||
155043081|NCT00398216|559590045|FG003|Overall Study|entrance criteria|0|||
155043082|NCT00398216|559590046|FG004|Overall Study|entrance criteria|2|||
155043083|NCT04378569|559590050|FG000|Overall Study|Adverse Event|0|||
155043084|NCT04378569|559590051|FG001|Overall Study|Adverse Event|0|||
155043085|NCT04378569|559590052|FG002|Overall Study|Adverse Event|2|||
155043086|NCT04378569|559590053|FG003|Overall Study|Adverse Event|0|||
155043087|NCT04378569|559590054|FG004|Overall Study|Adverse Event|3|||
155043088|NCT04378569|559590055|FG005|Overall Study|Adverse Event|3|||
155043089|NCT04378569|559590050|FG000|Overall Study|Lost to Follow-up|0|||
155043090|NCT04378569|559590051|FG001|Overall Study|Lost to Follow-up|3|||
155043091|NCT04378569|559590052|FG002|Overall Study|Lost to Follow-up|1|||
155043092|NCT04378569|559590053|FG003|Overall Study|Lost to Follow-up|0|||
155043093|NCT04378569|559590054|FG004|Overall Study|Lost to Follow-up|1|||
155043094|NCT04378569|559590055|FG005|Overall Study|Lost to Follow-up|1|||
155043095|NCT04378569|559590050|FG000|Overall Study|Protocol Violation|0|||
155043096|NCT04378569|559590051|FG001|Overall Study|Protocol Violation|0|||
155043097|NCT04378569|559590052|FG002|Overall Study|Protocol Violation|0|||
155043098|NCT04378569|559590053|FG003|Overall Study|Protocol Violation|0|||
155043099|NCT04378569|559590054|FG004|Overall Study|Protocol Violation|0|||
155043100|NCT04378569|559590055|FG005|Overall Study|Protocol Violation|1|||
155271927|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271928|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271929|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271930|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
155271931|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
155271932|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
155271933|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271934|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271935|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271936|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
155271937|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271938|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
155271939|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271940|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271941|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271942|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
155271943|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
155271944|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271945|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271946|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271947|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271948|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
155271949|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
155271950|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
155271951|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271952|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271953|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271954|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
155271955|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
155271956|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
155271957|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271958|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271959|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271960|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
155271961|NCT01089556|560429678|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
155271962|NCT01089556|560429679|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
155271963|NCT01089556|560429680|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271964|NCT01089556|560429681|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271965|NCT01089556|560429682|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271966|NCT01089556|560429683|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
155271967|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
155271968|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
155271969|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
155271970|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
154932256|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
154932257|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
154932258|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
154932259|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
154932260|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
154932261|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
154932262|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
154932263|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932264|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
154932265|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
154932266|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932267|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932268|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932269|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
155271971|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
155271972|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
155271973|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
154932270|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
155043101|NCT04378569|559590050|FG000|Overall Study|Withdrawal by Subject|0|||
155271974|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
155271975|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271976|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271977|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271978|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
155271979|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271980|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271981|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271982|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
155271983|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
155271984|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
155271985|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271986|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271987|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
155271988|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271989|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271990|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
155271991|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
155271992|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
155271993|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
155271994|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
155271995|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
155271996|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
155271997|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
155271998|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
155271999|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
155272000|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
155272001|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
155272002|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
155272003|NCT01089556|560429678|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
155272004|NCT01089556|560429679|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
155272005|NCT01089556|560429680|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
155272006|NCT01089556|560429681|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
155272007|NCT01089556|560429682|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
155272008|NCT01089556|560429683|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
155272009|NCT01757665|560429684|FG000|Overall Study|Still on Study - Visit Completed|240|||
155272010|NCT01757665|560429685|FG001|Overall Study|Still on Study - Visit Completed|30|||
155272011|NCT01757665|560429684|FG000|Overall Study|Still on Study - Visit Pending|398|||
155272012|NCT01757665|560429685|FG001|Overall Study|Still on Study - Visit Pending|40|||
155272013|NCT01757665|560429684|FG000|Overall Study|Still on Study - Missed Visit|14|||
155272014|NCT01757665|560429685|FG001|Overall Study|Still on Study - Missed Visit|1|||
155272015|NCT01757665|560429684|FG000|Overall Study|Death|25|||
155272016|NCT01757665|560429685|FG001|Overall Study|Death|8|||
155272017|NCT01757665|560429684|FG000|Overall Study|Explant|1|||
155272018|NCT01757665|560429685|FG001|Overall Study|Explant|2|||
155272019|NCT01757665|560429684|FG000|Overall Study|Withdrawal by Subject|10|||
155272020|NCT01757665|560429685|FG001|Overall Study|Withdrawal by Subject|0|||
155272021|NCT01757665|560429684|FG000|Overall Study|Lost to Follow-up|1|||
155272022|NCT01757665|560429685|FG001|Overall Study|Lost to Follow-up|1|||
155272023|NCT01757665|560429684|FG000|Overall Study|Not Implanted with Device|5|||
155272024|NCT01757665|560429685|FG001|Overall Study|Not Implanted with Device|1|||
155272025|NCT01702428|560429686|FG000|Overall Study|Adverse Event|2|||
155272026|NCT01702428|560429687|FG001|Overall Study|Adverse Event|0|||
155272027|NCT01702428|560429688|FG002|Overall Study|Adverse Event|0|||
155272028|NCT01702428|560429689|FG003|Overall Study|Adverse Event|0|||
155272029|NCT01702428|560429686|FG000|Overall Study|Lost to Follow-up|33|||
155272030|NCT01702428|560429687|FG001|Overall Study|Lost to Follow-up|41|||
155272031|NCT01702428|560429688|FG002|Overall Study|Lost to Follow-up|37|||
155272032|NCT01702428|560429689|FG003|Overall Study|Lost to Follow-up|44|||
155272033|NCT01702428|560429686|FG000|Overall Study|Parents cannot assist to site|1|||
155272034|NCT01702428|560429687|FG001|Overall Study|Parents cannot assist to site|0|||
155272035|NCT01702428|560429688|FG002|Overall Study|Parents cannot assist to site|1|||
155272036|NCT01702428|560429689|FG003|Overall Study|Parents cannot assist to site|0|||
155272037|NCT01702428|560429686|FG000|Overall Study|Lost Coverage|0|||
155272038|NCT01702428|560429687|FG001|Overall Study|Lost Coverage|0|||
155272039|NCT01702428|560429688|FG002|Overall Study|Lost Coverage|0|||
155272040|NCT01702428|560429689|FG003|Overall Study|Lost Coverage|1|||
155272041|NCT01702428|560429686|FG000|Overall Study|Lost Health Plan|3|||
155272042|NCT01702428|560429687|FG001|Overall Study|Lost Health Plan|5|||
155272043|NCT01702428|560429688|FG002|Overall Study|Lost Health Plan|0|||
155272044|NCT01702428|560429689|FG003|Overall Study|Lost Health Plan|2|||
155272045|NCT01702428|560429686|FG000|Overall Study|Mother transferred care|0|||
155272046|NCT01702428|560429687|FG001|Overall Study|Mother transferred care|1|||
155272047|NCT01702428|560429688|FG002|Overall Study|Mother transferred care|0|||
155272048|NCT01702428|560429689|FG003|Overall Study|Mother transferred care|0|||
155272049|NCT01702428|560429686|FG000|Overall Study|Parents too busy|1|||
155153050|NCT00419393|559998524|FG000|Overall Study|Adverse Event|5|||
154932271|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
154932272|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
154932273|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932274|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
154932275|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932276|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
154932277|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932278|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
154932279|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
154932280|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
154932281|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
154932282|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155272050|NCT01702428|560429687|FG001|Overall Study|Parents too busy|0|||
155272051|NCT01702428|560429688|FG002|Overall Study|Parents too busy|0|||
155272052|NCT01702428|560429689|FG003|Overall Study|Parents too busy|0|||
155272053|NCT01702428|560429686|FG000|Overall Study|Protocol Violation|3|||
155272054|NCT01702428|560429687|FG001|Overall Study|Protocol Violation|0|||
155272055|NCT01702428|560429688|FG002|Overall Study|Protocol Violation|1|||
155272056|NCT01702428|560429689|FG003|Overall Study|Protocol Violation|0|||
155272057|NCT01702428|560429686|FG000|Overall Study|Withdrawal by Subject|21|||
155272058|NCT01702428|560429687|FG001|Overall Study|Withdrawal by Subject|23|||
154932283|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932284|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155272059|NCT01702428|560429688|FG002|Overall Study|Withdrawal by Subject|14|||
154932285|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932286|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
155272060|NCT01702428|560429689|FG003|Overall Study|Withdrawal by Subject|10|||
155272061|NCT02091869|560429690|FG000|Overall Study|Withdrawal by Subject|0|||
155272062|NCT02091869|560429691|FG001|Overall Study|Withdrawal by Subject|3|||
155272063|NCT01533714|560429693|FG000|Overall Study|Adverse Event|0|||
155272064|NCT01533714|560429694|FG001|Overall Study|Adverse Event|1|||
155272065|NCT01533714|560429695|FG002|Overall Study|Adverse Event|2|||
155272066|NCT01533714|560429696|FG003|Overall Study|Adverse Event|2|||
155272067|NCT01533714|560429697|FG004|Overall Study|Adverse Event|2|||
155272068|NCT01533714|560429698|FG005|Overall Study|Adverse Event|1|||
155272069|NCT01533714|560429693|FG000|Overall Study|Lack of Efficacy|0|||
155272070|NCT01533714|560429694|FG001|Overall Study|Lack of Efficacy|0|||
155272071|NCT01533714|560429695|FG002|Overall Study|Lack of Efficacy|0|||
155272072|NCT01533714|560429696|FG003|Overall Study|Lack of Efficacy|0|||
155272073|NCT01533714|560429697|FG004|Overall Study|Lack of Efficacy|0|||
155272074|NCT01533714|560429698|FG005|Overall Study|Lack of Efficacy|1|||
155272075|NCT01533714|560429693|FG000|Overall Study|Withdrawal by Subject|0|||
154932287|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932288|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932289|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932290|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155272076|NCT01533714|560429694|FG001|Overall Study|Withdrawal by Subject|1|||
155272077|NCT01533714|560429695|FG002|Overall Study|Withdrawal by Subject|0|||
155272078|NCT01533714|560429696|FG003|Overall Study|Withdrawal by Subject|1|||
155272079|NCT01533714|560429697|FG004|Overall Study|Withdrawal by Subject|1|||
155272080|NCT01533714|560429698|FG005|Overall Study|Withdrawal by Subject|0|||
155272081|NCT01533714|560429693|FG000|Overall Study|Exclusion criteria|0|||
154932291|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
154932292|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932293|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932294|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932295|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932296|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932297|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155272082|NCT01533714|560429694|FG001|Overall Study|Exclusion criteria|1|||
155272083|NCT01533714|560429695|FG002|Overall Study|Exclusion criteria|0|||
155272084|NCT01533714|560429696|FG003|Overall Study|Exclusion criteria|0|||
155272085|NCT01533714|560429697|FG004|Overall Study|Exclusion criteria|0|||
155272086|NCT01533714|560429698|FG005|Overall Study|Exclusion criteria|0|||
155272087|NCT01533714|560429693|FG000|Overall Study|Positive for purified protein derivative|0|||
155272088|NCT01533714|560429694|FG001|Overall Study|Positive for purified protein derivative|0|||
155272089|NCT01533714|560429695|FG002|Overall Study|Positive for purified protein derivative|1|||
155272090|NCT01533714|560429696|FG003|Overall Study|Positive for purified protein derivative|0|||
155272091|NCT01533714|560429697|FG004|Overall Study|Positive for purified protein derivative|1|||
155272092|NCT01533714|560429698|FG005|Overall Study|Positive for purified protein derivative|0|||
155272093|NCT01533714|560429693|FG000|Overall Study|Withdrawal criteria|0|||
155272094|NCT01533714|560429694|FG001|Overall Study|Withdrawal criteria|0|||
155272095|NCT01533714|560429695|FG002|Overall Study|Withdrawal criteria|1|||
155272096|NCT01533714|560429696|FG003|Overall Study|Withdrawal criteria|0|||
155272097|NCT01533714|560429697|FG004|Overall Study|Withdrawal criteria|3|||
155272098|NCT01533714|560429698|FG005|Overall Study|Withdrawal criteria|1|||
155272099|NCT01533714|560429693|FG000|Overall Study|Ineligibility reason|0|||
155272100|NCT01533714|560429694|FG001|Overall Study|Ineligibility reason|0|||
155272101|NCT01533714|560429695|FG002|Overall Study|Ineligibility reason|0|||
155272102|NCT01533714|560429696|FG003|Overall Study|Ineligibility reason|1|||
155272103|NCT01533714|560429697|FG004|Overall Study|Ineligibility reason|0|||
155272104|NCT01533714|560429698|FG005|Overall Study|Ineligibility reason|0|||
155272105|NCT02564055|560429703|FG000|Overall Study|Adverse Event|1|||
155272106|NCT02564055|560429704|FG001|Overall Study|Adverse Event|0|||
155272107|NCT02564055|560429705|FG002|Overall Study|Adverse Event|4|||
155272108|NCT02564055|560429706|FG003|Overall Study|Adverse Event|1|||
155272109|NCT02564055|560429707|FG004|Overall Study|Adverse Event|4|||
155272110|NCT02564055|560429708|FG005|Overall Study|Adverse Event|1|||
155272111|NCT02564055|560429703|FG000|Overall Study|Protocol Violation|1|||
155272112|NCT02564055|560429704|FG001|Overall Study|Protocol Violation|0|||
155272113|NCT02564055|560429705|FG002|Overall Study|Protocol Violation|0|||
155272114|NCT02564055|560429706|FG003|Overall Study|Protocol Violation|0|||
155272115|NCT02564055|560429707|FG004|Overall Study|Protocol Violation|0|||
155272116|NCT02564055|560429708|FG005|Overall Study|Protocol Violation|0|||
155272117|NCT02564055|560429703|FG000|Overall Study|Reached stopping criteria|0|||
155272118|NCT02564055|560429704|FG001|Overall Study|Reached stopping criteria|0|||
155272119|NCT02564055|560429705|FG002|Overall Study|Reached stopping criteria|0|||
155272120|NCT02564055|560429706|FG003|Overall Study|Reached stopping criteria|0|||
155272121|NCT02564055|560429707|FG004|Overall Study|Reached stopping criteria|0|||
155272122|NCT02564055|560429708|FG005|Overall Study|Reached stopping criteria|1|||
155272123|NCT02564055|560429703|FG000|Overall Study|Lost to Follow-up|0|||
155272124|NCT02564055|560429704|FG001|Overall Study|Lost to Follow-up|1|||
155272125|NCT02564055|560429705|FG002|Overall Study|Lost to Follow-up|4|||
155272126|NCT02564055|560429706|FG003|Overall Study|Lost to Follow-up|2|||
155272127|NCT02564055|560429707|FG004|Overall Study|Lost to Follow-up|1|||
155272128|NCT02564055|560429708|FG005|Overall Study|Lost to Follow-up|0|||
155272129|NCT02564055|560429703|FG000|Overall Study|Physician Decision|0|||
155272130|NCT02564055|560429704|FG001|Overall Study|Physician Decision|0|||
155272131|NCT02564055|560429705|FG002|Overall Study|Physician Decision|1|||
155381882|NCT02344004|560833230|FG001|Overall Study|Rescue Medication|0|||
155381883|NCT02344004|560833229|FG000|Overall Study|Other Not Specified|12|||
155381884|NCT02344004|560833230|FG001|Overall Study|Other Not Specified|0|||
155381885|NCT02344004|560833229|FG000|Overall Study|Protocol Violation|1|||
155381886|NCT02344004|560833230|FG001|Overall Study|Protocol Violation|0|||
155381887|NCT00577577|560833232|FG000|Overall Study|Adverse Event|3|||
155381888|NCT00577577|560833233|FG001|Overall Study|Adverse Event|2|||
155381889|NCT00577577|560833232|FG000|Overall Study|Lost to Follow-up|1|||
155381890|NCT00577577|560833233|FG001|Overall Study|Lost to Follow-up|0|||
155381891|NCT00577577|560833232|FG000|Overall Study|Protocol Violation|0|||
155381892|NCT00577577|560833233|FG001|Overall Study|Protocol Violation|3|||
155381893|NCT00577577|560833232|FG000|Overall Study|Transportation|1|||
155381894|NCT00577577|560833233|FG001|Overall Study|Transportation|0|||
155381895|NCT00232544|560833234|FG000|Overall Study|Lost to Follow-up|20|||
155381896|NCT00232544|560833235|FG001|Overall Study|Lost to Follow-up|15|||
155381897|NCT00116753|560833236|FG000|Overall Study|Adverse Event|16|||
155381898|NCT00116753|560833237|FG001|Overall Study|Adverse Event|10|||
155381899|NCT00116753|560833238|FG002|Overall Study|Adverse Event|7|||
155381900|NCT00116753|560833236|FG000|Overall Study|Withdrawal by Subject|11|||
155381901|NCT00116753|560833237|FG001|Overall Study|Withdrawal by Subject|12|||
155381902|NCT00116753|560833238|FG002|Overall Study|Withdrawal by Subject|8|||
155381903|NCT00116753|560833236|FG000|Overall Study|Lost to Follow-up|0|||
155381904|NCT00116753|560833237|FG001|Overall Study|Lost to Follow-up|2|||
155381905|NCT00116753|560833238|FG002|Overall Study|Lost to Follow-up|1|||
155381906|NCT00116753|560833236|FG000|Overall Study|Protocol Violation|0|||
155381907|NCT00116753|560833237|FG001|Overall Study|Protocol Violation|0|||
155381908|NCT00116753|560833238|FG002|Overall Study|Protocol Violation|1|||
155381909|NCT00116753|560833236|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
155381910|NCT00116753|560833237|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
155381911|NCT00116753|560833238|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
155381912|NCT00116753|560833236|FG000|Overall Study|Disease Progression|3|||
155381913|NCT00116753|560833237|FG001|Overall Study|Disease Progression|4|||
155381914|NCT00116753|560833238|FG002|Overall Study|Disease Progression|3|||
155381915|NCT00116753|560833236|FG000|Overall Study|Abnormal Echocardiogram|0|||
155381916|NCT00116753|560833237|FG001|Overall Study|Abnormal Echocardiogram|0|||
155381917|NCT00116753|560833238|FG002|Overall Study|Abnormal Echocardiogram|1|||
155381918|NCT00116753|560833236|FG000|Overall Study|Progressive Parkinson's Disease|1|||
155381919|NCT00116753|560833237|FG001|Overall Study|Progressive Parkinson's Disease|0|||
155272132|NCT02564055|560429706|FG003|Overall Study|Physician Decision|0|||
155272133|NCT02564055|560429707|FG004|Overall Study|Physician Decision|0|||
155272134|NCT02564055|560429708|FG005|Overall Study|Physician Decision|0|||
155381920|NCT00116753|560833238|FG002|Overall Study|Progressive Parkinson's Disease|0|||
155272135|NCT02564055|560429703|FG000|Overall Study|Withdrawal by Subject|4|||
155272136|NCT02564055|560429704|FG001|Overall Study|Withdrawal by Subject|4|||
155272137|NCT02564055|560429705|FG002|Overall Study|Withdrawal by Subject|3|||
155272138|NCT02564055|560429706|FG003|Overall Study|Withdrawal by Subject|3|||
155272139|NCT02564055|560429707|FG004|Overall Study|Withdrawal by Subject|10|||
155272140|NCT02564055|560429708|FG005|Overall Study|Withdrawal by Subject|10|||
155272141|NCT01375959|560429709|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
155272142|NCT01375959|560429710|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
155272143|NCT01375959|560429709|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
155272144|NCT01375959|560429710|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
155272145|NCT01375959|560429709|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155272146|NCT01375959|560429710|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
155272147|NCT02771210|560429711|FG000|Period 1|Adverse Event|5|||
155272148|NCT02771210|560429712|FG001|Period 1|Adverse Event|3|||
155272149|NCT02771210|560429711|FG000|Period 1|Lack of Efficacy|3|||
155272150|NCT02771210|560429712|FG001|Period 1|Lack of Efficacy|6|||
155272151|NCT02771210|560429711|FG000|Period 1|Lost to Follow-up|2|||
155272152|NCT02771210|560429712|FG001|Period 1|Lost to Follow-up|0|||
155272153|NCT02771210|560429711|FG000|Period 1|Physician Decision|0|||
155272154|NCT02771210|560429712|FG001|Period 1|Physician Decision|1|||
155272155|NCT02771210|560429711|FG000|Period 1|Withdrawal by Subject|0|||
155272156|NCT02771210|560429712|FG001|Period 1|Withdrawal by Subject|3|||
155272157|NCT02771210|560429711|FG000|Period 1|Withdrawal of informed consent|1|||
155272158|NCT02771210|560429712|FG001|Period 1|Withdrawal of informed consent|5|||
155272159|NCT02771210|560429711|FG000|Period 2|Adverse Event|1|||
155272160|NCT02771210|560429712|FG001|Period 2|Adverse Event|0|||
155272161|NCT02771210|560429711|FG000|Period 2|Lack of Efficacy|0|||
155272162|NCT02771210|560429712|FG001|Period 2|Lack of Efficacy|1|||
155272163|NCT02771210|560429711|FG000|Period 2|Withdrawal by Subject|1|||
155272164|NCT02771210|560429712|FG001|Period 2|Withdrawal by Subject|0|||
155272165|NCT02771210|560429711|FG000|Period 2|Withdrawal of informed consent|0|||
155272166|NCT02771210|560429712|FG001|Period 2|Withdrawal of informed consent|2|||
155272167|NCT04012814|560429717|FG000|Overall Study|Lost to Follow-up|4|||
155272168|NCT04012814|560429717|FG000|Overall Study|Withdrawal by Subject|2|||
155272169|NCT04012814|560429717|FG000|Overall Study|Protocol Violation|1|||
155272170|NCT04012814|560429717|FG000|Overall Study|Adverse Event|1|||
155272171|NCT04397523|560429718|FG000|Overall Study|Lost to Follow-up|3|||
155272172|NCT04397523|560429718|FG000|Overall Study|Transfer from/to other hospital|8|||
155272173|NCT04789577|560429719|FG000|Overall Study|Withdrawal by Subject|1|||
155272174|NCT04789577|560429720|FG001|Overall Study|Withdrawal by Subject|1|||
155272175|NCT04789577|560429721|FG002|Overall Study|Withdrawal by Subject|1|||
155272176|NCT04789577|560429722|FG003|Overall Study|Withdrawal by Subject|3|||
155272177|NCT04789577|560429723|FG004|Overall Study|Withdrawal by Subject|1|||
155272178|NCT04789577|560429724|FG005|Overall Study|Withdrawal by Subject|7|||
155272179|NCT04789577|560429725|FG006|Overall Study|Withdrawal by Subject|1|||
155272180|NCT04789577|560429719|FG000|Overall Study|Lost to Follow-up|7|||
155272181|NCT04789577|560429720|FG001|Overall Study|Lost to Follow-up|12|||
155272182|NCT04789577|560429721|FG002|Overall Study|Lost to Follow-up|7|||
155272183|NCT04789577|560429722|FG003|Overall Study|Lost to Follow-up|10|||
155272184|NCT04789577|560429723|FG004|Overall Study|Lost to Follow-up|8|||
155272185|NCT04789577|560429724|FG005|Overall Study|Lost to Follow-up|6|||
155272186|NCT04789577|560429725|FG006|Overall Study|Lost to Follow-up|10|||
155272187|NCT04789577|560429719|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
155272188|NCT04789577|560429720|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
155272189|NCT04789577|560429721|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
155272190|NCT04789577|560429722|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
155272191|NCT04789577|560429723|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
155272192|NCT04789577|560429724|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
155272193|NCT04789577|560429725|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
155272194|NCT04789577|560429719|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
155272195|NCT04789577|560429720|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
155272196|NCT04789577|560429721|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
155272197|NCT04789577|560429722|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
155272198|NCT04789577|560429723|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
155272199|NCT04789577|560429724|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
155272200|NCT04789577|560429725|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
155272201|NCT01275196|560429726|FG000|Overall Study|Adverse Event|3|||
155272202|NCT01275196|560429727|FG001|Overall Study|Adverse Event|5|||
155272203|NCT01275196|560429726|FG000|Overall Study|Withdrawal by Subject|4|||
155272204|NCT01275196|560429727|FG001|Overall Study|Withdrawal by Subject|5|||
155272205|NCT01275196|560429726|FG000|Overall Study|Lost to Follow-up|1|||
155272206|NCT01275196|560429727|FG001|Overall Study|Lost to Follow-up|0|||
155272207|NCT01275196|560429726|FG000|Overall Study|Disease Progression|6|||
155272208|NCT01275196|560429727|FG001|Overall Study|Disease Progression|5|||
155272209|NCT01275196|560429726|FG000|Overall Study|Protocol Violation|1|||
155272210|NCT01275196|560429727|FG001|Overall Study|Protocol Violation|0|||
155272211|NCT01275196|560429726|FG000|Overall Study|Suboptimal response/treatment failure|5|||
155272212|NCT01275196|560429727|FG001|Overall Study|Suboptimal response/treatment failure|6|||
155272213|NCT01027364|560429728|FG000|Overall Study|Adverse Event|1|||
155272214|NCT01027364|560429729|FG001|Overall Study|Adverse Event|0|||
155272215|NCT01027364|560429730|FG002|Overall Study|Adverse Event|1|||
155272216|NCT01027364|560429731|FG003|Overall Study|Adverse Event|0|||
155272217|NCT01027364|560429728|FG000|Overall Study|Lost to Follow-up|1|||
155272218|NCT01027364|560429729|FG001|Overall Study|Lost to Follow-up|0|||
155272219|NCT01027364|560429730|FG002|Overall Study|Lost to Follow-up|0|||
155272220|NCT01027364|560429731|FG003|Overall Study|Lost to Follow-up|0|||
155272221|NCT01027364|560429728|FG000|Overall Study|Protocol Violation|1|||
155272222|NCT01027364|560429729|FG001|Overall Study|Protocol Violation|0|||
155272223|NCT01027364|560429730|FG002|Overall Study|Protocol Violation|0|||
155272224|NCT01027364|560429731|FG003|Overall Study|Protocol Violation|1|||
155272225|NCT01027364|560429728|FG000|Overall Study|Withdrawal by Subject|1|||
155272226|NCT01027364|560429729|FG001|Overall Study|Withdrawal by Subject|2|||
155272227|NCT01027364|560429730|FG002|Overall Study|Withdrawal by Subject|0|||
155272228|NCT01027364|560429731|FG003|Overall Study|Withdrawal by Subject|0|||
155272229|NCT01394250|560429732|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
155272230|NCT01394250|560429733|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
155272231|NCT01394250|560429732|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
155272232|NCT01394250|560429733|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
155272233|NCT02226172|560429734|FG000|Overall Study|Participant refused further follow-up|4|||
155272234|NCT02226172|560429734|FG000|Overall Study|Other|5|||
155272235|NCT02226172|560429734|FG000|Overall Study|Death|1|||
155272236|NCT02226172|560429734|FG000|Overall Study|Study terminated by sponsor|1|||
155272237|NCT02226172|560429734|FG000|Overall Study|Adverse Event|6|||
155272238|NCT00779584|560429737|FG000|Overall Study|Protocol Violation|0|||
155272239|NCT00779584|560429738|FG001|Overall Study|Protocol Violation|0|||
155272240|NCT00779584|560429739|FG002|Overall Study|Protocol Violation|0|||
155272241|NCT00779584|560429740|FG003|Overall Study|Protocol Violation|0|||
155272242|NCT00779584|560429741|FG004|Overall Study|Protocol Violation|0|||
155272243|NCT00779584|560429742|FG005|Overall Study|Protocol Violation|1|||
155272244|NCT00779584|560429743|FG006|Overall Study|Protocol Violation|0|||
155272245|NCT00779584|560429744|FG007|Overall Study|Protocol Violation|0|||
155272246|NCT00779584|560429745|FG008|Overall Study|Protocol Violation|0|||
155272247|NCT00779584|560429737|FG000|Overall Study|Withdrawal by Subject|1|||
155272248|NCT00779584|560429738|FG001|Overall Study|Withdrawal by Subject|1|||
155272249|NCT00779584|560429739|FG002|Overall Study|Withdrawal by Subject|2|||
155272250|NCT00779584|560429740|FG003|Overall Study|Withdrawal by Subject|0|||
155272251|NCT00779584|560429741|FG004|Overall Study|Withdrawal by Subject|0|||
155272252|NCT00779584|560429742|FG005|Overall Study|Withdrawal by Subject|2|||
155272253|NCT00779584|560429743|FG006|Overall Study|Withdrawal by Subject|1|||
155272254|NCT00779584|560429744|FG007|Overall Study|Withdrawal by Subject|0|||
155272255|NCT00779584|560429745|FG008|Overall Study|Withdrawal by Subject|0|||
155272256|NCT00779584|560429737|FG000|Overall Study|Lost to Follow-up|0|||
155272257|NCT00779584|560429738|FG001|Overall Study|Lost to Follow-up|0|||
155272258|NCT00779584|560429739|FG002|Overall Study|Lost to Follow-up|0|||
155272259|NCT00779584|560429740|FG003|Overall Study|Lost to Follow-up|0|||
155272260|NCT00779584|560429741|FG004|Overall Study|Lost to Follow-up|1|||
155272261|NCT00779584|560429742|FG005|Overall Study|Lost to Follow-up|0|||
155272262|NCT00779584|560429743|FG006|Overall Study|Lost to Follow-up|0|||
155272263|NCT00779584|560429744|FG007|Overall Study|Lost to Follow-up|0|||
155272264|NCT00779584|560429745|FG008|Overall Study|Lost to Follow-up|0|||
155272265|NCT00779584|560429737|FG000|Overall Study|Progression of Disease|0|||
155272266|NCT00779584|560429738|FG001|Overall Study|Progression of Disease|1|||
155272267|NCT00779584|560429739|FG002|Overall Study|Progression of Disease|2|||
155272268|NCT00779584|560429740|FG003|Overall Study|Progression of Disease|6|||
155272269|NCT00779584|560429741|FG004|Overall Study|Progression of Disease|5|||
155272270|NCT00779584|560429742|FG005|Overall Study|Progression of Disease|1|||
155272271|NCT00779584|560429743|FG006|Overall Study|Progression of Disease|4|||
155272272|NCT00779584|560429744|FG007|Overall Study|Progression of Disease|2|||
155272273|NCT00779584|560429745|FG008|Overall Study|Progression of Disease|1|||
154932298|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
155272274|NCT00779584|560429737|FG000|Overall Study|Adverse Event|1|||
155272275|NCT00779584|560429738|FG001|Overall Study|Adverse Event|0|||
155272276|NCT00779584|560429739|FG002|Overall Study|Adverse Event|2|||
155272277|NCT00779584|560429740|FG003|Overall Study|Adverse Event|0|||
155272278|NCT00779584|560429741|FG004|Overall Study|Adverse Event|0|||
155272279|NCT00779584|560429742|FG005|Overall Study|Adverse Event|0|||
155272280|NCT00779584|560429743|FG006|Overall Study|Adverse Event|2|||
155272281|NCT00779584|560429744|FG007|Overall Study|Adverse Event|1|||
155272282|NCT00779584|560429745|FG008|Overall Study|Adverse Event|1|||
155272283|NCT00779584|560429737|FG000|Overall Study|Symptomatic Deterioration|1|||
155272284|NCT00779584|560429738|FG001|Overall Study|Symptomatic Deterioration|1|||
155272285|NCT00779584|560429739|FG002|Overall Study|Symptomatic Deterioration|1|||
155272286|NCT00779584|560429740|FG003|Overall Study|Symptomatic Deterioration|0|||
155272287|NCT00779584|560429741|FG004|Overall Study|Symptomatic Deterioration|0|||
155272288|NCT00779584|560429742|FG005|Overall Study|Symptomatic Deterioration|1|||
155272289|NCT00779584|560429743|FG006|Overall Study|Symptomatic Deterioration|1|||
155272290|NCT00779584|560429744|FG007|Overall Study|Symptomatic Deterioration|0|||
155272291|NCT00779584|560429745|FG008|Overall Study|Symptomatic Deterioration|0|||
155272292|NCT00779584|560429737|FG000|Overall Study|Ongoing in Study|0|||
155272293|NCT00779584|560429738|FG001|Overall Study|Ongoing in Study|0|||
155272294|NCT00779584|560429739|FG002|Overall Study|Ongoing in Study|0|||
155272295|NCT00779584|560429740|FG003|Overall Study|Ongoing in Study|0|||
155272296|NCT00779584|560429741|FG004|Overall Study|Ongoing in Study|1|||
155272297|NCT00779584|560429742|FG005|Overall Study|Ongoing in Study|1|||
155272298|NCT00779584|560429743|FG006|Overall Study|Ongoing in Study|0|||
155272299|NCT00779584|560429744|FG007|Overall Study|Ongoing in Study|0|||
155272300|NCT00779584|560429745|FG008|Overall Study|Ongoing in Study|0|||
155272301|NCT03632434|560429746|FG000|Overall Study|Withdrawal by Subject|2|||
155272302|NCT04297241|560429750|FG000|Overall Study|Withdrawal by Subject|1|||
155272303|NCT04297241|560429750|FG000|Overall Study|Adverse Event|1|||
155272304|NCT04297241|560429750|FG000|Overall Study|Physician Decision|3|||
155272305|NCT00786474|560429759|FG000|Overall Study|Death|5|||
155272306|NCT00786474|560429760|FG001|Overall Study|Death|4|||
155272307|NCT00786474|560429759|FG000|Overall Study|Withdrawal by Subject|23|||
155272308|NCT00786474|560429760|FG001|Overall Study|Withdrawal by Subject|31|||
155272309|NCT00786474|560429759|FG000|Overall Study|Lost to Follow-up|3|||
155272310|NCT00786474|560429760|FG001|Overall Study|Lost to Follow-up|3|||
155272311|NCT00786474|560429759|FG000|Overall Study|Physician Decision|2|||
155272312|NCT00786474|560429760|FG001|Overall Study|Physician Decision|1|||
155272313|NCT00786474|560429759|FG000|Overall Study|Other|4|||
155272314|NCT00786474|560429760|FG001|Overall Study|Other|4|||
155272315|NCT01799720|560429761|FG000|Overall Study|Withdrawal by Subject|3|||
155272316|NCT01799720|560429762|FG001|Overall Study|Withdrawal by Subject|0|||
155272317|NCT01799720|560429763|FG002|Overall Study|Withdrawal by Subject|0|||
155272318|NCT01799720|560429761|FG000|Overall Study|Protocol Violation|0|||
155272319|NCT01799720|560429762|FG001|Overall Study|Protocol Violation|1|||
155272320|NCT01799720|560429763|FG002|Overall Study|Protocol Violation|0|||
155272321|NCT01799720|560429761|FG000|Overall Study|Pregnancy|0|||
155272322|NCT01799720|560429762|FG001|Overall Study|Pregnancy|0|||
155272323|NCT01799720|560429763|FG002|Overall Study|Pregnancy|1|||
155272324|NCT03688711|560429767|FG000|Overall Study|Withdrawal by Subject|0|||
155272325|NCT03688711|560429768|FG001|Overall Study|Withdrawal by Subject|1|||
155272326|NCT01088529|560429769|FG000|Overall Study|Did not receive study treatment|0|||
155272327|NCT01088529|560429770|FG001|Overall Study|Did not receive study treatment|1|||
155272328|NCT01155661|560429773|FG000|Overall Study|Adverse Event|101|||
155272329|NCT01155661|560429773|FG000|Overall Study|Death|1|||
155272330|NCT01155661|560429773|FG000|Overall Study|Lack of Efficacy|32|||
155272331|NCT01155661|560429773|FG000|Overall Study|Lost to Follow-up|22|||
155272332|NCT01155661|560429773|FG000|Overall Study|Physician Decision|3|||
155272333|NCT01155661|560429773|FG000|Overall Study|Protocol Violation|35|||
155272334|NCT01155661|560429773|FG000|Overall Study|Withdrawal by Subject|73|||
155272335|NCT01155661|560429773|FG000|Overall Study|Sponsor Decision|13|||
155272336|NCT01263106|560429774|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
155272337|NCT01263106|560429775|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
155272338|NCT03169881|560429785|FG000|Overall Study|Incomplete Follow-up|10|||
155272339|NCT03169881|560429786|FG001|Overall Study|Incomplete Follow-up|15|||
155272340|NCT03169881|560429785|FG000|Overall Study|Lost to Follow-up|18|||
155272341|NCT03169881|560429786|FG001|Overall Study|Lost to Follow-up|20|||
155272342|NCT03169881|560429785|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
155272343|NCT03169881|560429786|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
155272344|NCT03936777|560429787|FG000|Overall Study|Adverse Event|3|||
155272345|NCT03936777|560429787|FG000|Overall Study|Death|3|||
155272346|NCT03936777|560429787|FG000|Overall Study|Lack of Efficacy|24|||
155272347|NCT03936777|560429787|FG000|Overall Study|Lost to Follow-up|3|||
155043102|NCT04378569|559590051|FG001|Overall Study|Withdrawal by Subject|6|||
155043103|NCT04378569|559590052|FG002|Overall Study|Withdrawal by Subject|7|||
155272348|NCT03936777|560429787|FG000|Overall Study|Physician Decision|1|||
155272349|NCT03936777|560429787|FG000|Overall Study|Withdrawal by Subject|11|||
155272350|NCT03936777|560429787|FG000|Overall Study|Subjected Weaned of ZX008|1|||
155272351|NCT03936777|560429787|FG000|Overall Study|Missing|6|||
155272352|NCT02301156|560429788|FG000|Overall Study|Adverse Event|13|||
155272353|NCT02301156|560429789|FG001|Overall Study|Adverse Event|14|||
155272354|NCT02301156|560429788|FG000|Overall Study|Death|1|||
155272355|NCT02301156|560429789|FG001|Overall Study|Death|5|||
155272356|NCT02301156|560429788|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
155272357|NCT02301156|560429789|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
155272358|NCT02301156|560429788|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
155272359|NCT02301156|560429789|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
155272360|NCT02301156|560429788|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
155272361|NCT02301156|560429789|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
155272362|NCT02301156|560429788|FG000|Overall Study|Reason not Specified|6|||
155272363|NCT02301156|560429789|FG001|Overall Study|Reason not Specified|3|||
154932299|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932300|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
154932301|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
154932302|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
154932303|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
154932304|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
154932305|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
154932306|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
154932307|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
154932308|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
154932309|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
154932310|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
154932311|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
154932312|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
155272364|NCT02638623|560429790|FG000|Overall Study|Surgery timing|5|||
155272365|NCT02638623|560429791|FG001|Overall Study|Surgery timing|6|||
155272366|NCT02638623|560429790|FG000|Overall Study|Not given intervention|2|||
155272367|NCT02638623|560429791|FG001|Overall Study|Not given intervention|0|||
155272368|NCT03797326|560429795|FG000|Overall Study|Lost to Follow-up|1|||
155272369|NCT03797326|560429796|FG001|Overall Study|Lost to Follow-up|0|||
155272370|NCT03797326|560429797|FG002|Overall Study|Lost to Follow-up|0|||
155272371|NCT03797326|560429798|FG003|Overall Study|Lost to Follow-up|1|||
155272372|NCT03797326|560429799|FG004|Overall Study|Lost to Follow-up|0|||
155272373|NCT03797326|560429800|FG005|Overall Study|Lost to Follow-up|0|||
155272374|NCT03797326|560429801|FG006|Overall Study|Lost to Follow-up|0|||
155272375|NCT03797326|560429802|FG007|Overall Study|Lost to Follow-up|0|||
155272376|NCT03797326|560429795|FG000|Overall Study|Withdrawal by Subject|0|||
155272377|NCT03797326|560429796|FG001|Overall Study|Withdrawal by Subject|0|||
155272378|NCT03797326|560429797|FG002|Overall Study|Withdrawal by Subject|1|||
155272379|NCT03797326|560429798|FG003|Overall Study|Withdrawal by Subject|3|||
155272380|NCT03797326|560429799|FG004|Overall Study|Withdrawal by Subject|0|||
155272381|NCT03797326|560429800|FG005|Overall Study|Withdrawal by Subject|2|||
155272382|NCT03797326|560429801|FG006|Overall Study|Withdrawal by Subject|2|||
155272383|NCT03797326|560429802|FG007|Overall Study|Withdrawal by Subject|3|||
155272384|NCT03797326|560429795|FG000|Overall Study|Sponsor Decision|3|||
155272385|NCT03797326|560429796|FG001|Overall Study|Sponsor Decision|3|||
155272386|NCT03797326|560429797|FG002|Overall Study|Sponsor Decision|3|||
155272387|NCT03797326|560429798|FG003|Overall Study|Sponsor Decision|6|||
155272388|NCT03797326|560429799|FG004|Overall Study|Sponsor Decision|0|||
155272389|NCT03797326|560429800|FG005|Overall Study|Sponsor Decision|3|||
155272390|NCT03797326|560429801|FG006|Overall Study|Sponsor Decision|3|||
155272391|NCT03797326|560429802|FG007|Overall Study|Sponsor Decision|2|||
155272392|NCT03797326|560429795|FG000|Overall Study|Death|27|||
155272393|NCT03797326|560429796|FG001|Overall Study|Death|28|||
155272394|NCT03797326|560429797|FG002|Overall Study|Death|95|||
155272395|NCT03797326|560429798|FG003|Overall Study|Death|95|||
154932313|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
154932314|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
154932315|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
154932316|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
154932317|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
154932318|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
154932319|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
154932320|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932321|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932322|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932323|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932324|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932325|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155272396|NCT03797326|560429799|FG004|Overall Study|Death|30|||
155272397|NCT03797326|560429800|FG005|Overall Study|Death|96|||
155272398|NCT03797326|560429801|FG006|Overall Study|Death|97|||
155272399|NCT03797326|560429802|FG007|Overall Study|Death|98|||
155272400|NCT03797326|560429795|FG000|Overall Study|Enrolled in error|0|||
154932326|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932327|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932328|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155272401|NCT03797326|560429796|FG001|Overall Study|Enrolled in error|0|||
155272402|NCT03797326|560429797|FG002|Overall Study|Enrolled in error|3|||
155272403|NCT03797326|560429798|FG003|Overall Study|Enrolled in error|2|||
155272404|NCT03797326|560429799|FG004|Overall Study|Enrolled in error|2|||
155272405|NCT03797326|560429800|FG005|Overall Study|Enrolled in error|1|||
155272406|NCT03797326|560429801|FG006|Overall Study|Enrolled in error|1|||
155272407|NCT03797326|560429802|FG007|Overall Study|Enrolled in error|0|||
155272408|NCT03012061|560429803|FG000|Overall Study|Withdrawal by Subject|1|||
155272409|NCT03012061|560429804|FG001|Overall Study|Withdrawal by Subject|5|||
155272410|NCT03012061|560429805|FG002|Overall Study|Withdrawal by Subject|4|||
155272411|NCT03012061|560429803|FG000|Overall Study|Investigator Site Closed|1|||
155272412|NCT03012061|560429804|FG001|Overall Study|Investigator Site Closed|2|||
155272413|NCT03012061|560429805|FG002|Overall Study|Investigator Site Closed|0|||
155272414|NCT03012061|560429803|FG000|Overall Study|Lost to Follow-up|2|||
155272415|NCT03012061|560429804|FG001|Overall Study|Lost to Follow-up|1|||
155272416|NCT03012061|560429805|FG002|Overall Study|Lost to Follow-up|0|||
155272417|NCT03012061|560429803|FG000|Overall Study|Study closed/ Terminated|0|||
155272418|NCT03012061|560429804|FG001|Overall Study|Study closed/ Terminated|0|||
155272419|NCT03012061|560429805|FG002|Overall Study|Study closed/ Terminated|1|||
155272420|NCT03012061|560429803|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
155272421|NCT03012061|560429804|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
155272422|NCT03012061|560429805|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
155272423|NCT03012061|560429803|FG000|Overall Study|Protocol Violation|0|||
155272424|NCT03012061|560429804|FG001|Overall Study|Protocol Violation|0|||
155272425|NCT03012061|560429805|FG002|Overall Study|Protocol Violation|2|||
155272426|NCT03012061|560429803|FG000|Overall Study|Lack of Efficacy|0|||
155272427|NCT03012061|560429804|FG001|Overall Study|Lack of Efficacy|1|||
155272428|NCT03012061|560429805|FG002|Overall Study|Lack of Efficacy|0|||
155272429|NCT03012061|560429803|FG000|Overall Study|Adverse Event|2|||
155272430|NCT03012061|560429804|FG001|Overall Study|Adverse Event|0|||
155272431|NCT03012061|560429805|FG002|Overall Study|Adverse Event|0|||
155272432|NCT02401308|560429812|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
155272433|NCT02401308|560429813|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
155272434|NCT00147225|560429816|FG000|Overall Study|Withdrawal by Subject|1|||
155272435|NCT00147225|560429817|FG001|Overall Study|Withdrawal by Subject|0|||
155272436|NCT00147225|560429818|FG002|Overall Study|Withdrawal by Subject|1|||
155272437|NCT00147225|560429819|FG003|Overall Study|Withdrawal by Subject|0|||
155272438|NCT00147225|560429820|FG004|Overall Study|Withdrawal by Subject|0|||
155272439|NCT00147225|560429821|FG005|Overall Study|Withdrawal by Subject|1|||
155272440|NCT00147225|560429816|FG000|Overall Study|Adverse Event|0|||
155272441|NCT00147225|560429817|FG001|Overall Study|Adverse Event|0|||
155272442|NCT00147225|560429818|FG002|Overall Study|Adverse Event|1|||
155272443|NCT00147225|560429819|FG003|Overall Study|Adverse Event|1|||
155272444|NCT00147225|560429820|FG004|Overall Study|Adverse Event|0|||
155272445|NCT00147225|560429821|FG005|Overall Study|Adverse Event|0|||
155272446|NCT00147225|560429816|FG000|Overall Study|Screen Failure|0|||
155272447|NCT00147225|560429817|FG001|Overall Study|Screen Failure|0|||
155272448|NCT00147225|560429818|FG002|Overall Study|Screen Failure|0|||
155272449|NCT00147225|560429819|FG003|Overall Study|Screen Failure|0|||
155272450|NCT00147225|560429820|FG004|Overall Study|Screen Failure|1|||
155272451|NCT00147225|560429821|FG005|Overall Study|Screen Failure|0|||
155272452|NCT00147225|560429816|FG000|Overall Study|Chemotherapy Changed|0|||
155272453|NCT00147225|560429817|FG001|Overall Study|Chemotherapy Changed|0|||
155272454|NCT00147225|560429818|FG002|Overall Study|Chemotherapy Changed|0|||
155272455|NCT00147225|560429819|FG003|Overall Study|Chemotherapy Changed|0|||
155272456|NCT00147225|560429820|FG004|Overall Study|Chemotherapy Changed|0|||
155272457|NCT00147225|560429821|FG005|Overall Study|Chemotherapy Changed|1|||
155272458|NCT01032044|560429822|FG000|Overall Study|Protocol Violation|14|||
155272459|NCT01032044|560429823|FG001|Overall Study|Protocol Violation|8|||
155272460|NCT01032044|560429822|FG000|Overall Study|Adverse Event|0|||
155272461|NCT01032044|560429823|FG001|Overall Study|Adverse Event|1|||
155272462|NCT01032044|560429822|FG000|Overall Study|Lost to Follow-up|11|||
155272463|NCT01032044|560429823|FG001|Overall Study|Lost to Follow-up|11|||
155272464|NCT02998021|560429824|FG000|Overall Study|Withdrawal by Subject|3|||
155272465|NCT02998021|560429825|FG001|Overall Study|Withdrawal by Subject|1|||
155272466|NCT02998021|560429824|FG000|Overall Study|unsafe home|0|||
154932329|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932330|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
154932331|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932332|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155272467|NCT02998021|560429825|FG001|Overall Study|unsafe home|1|||
155272468|NCT02961374|560429826|FG000|Overall Study|Adverse Event|4|||
154932333|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
155272469|NCT03390036|560431303|FG000|Overall Study|Lost to Follow-up|1|||
155272470|NCT03390036|560431304|FG001|Overall Study|Lost to Follow-up|0|||
155272471|NCT03390036|560431305|FG002|Overall Study|Lost to Follow-up|0|||
155272472|NCT03390036|560431303|FG000|Overall Study|Lack of Efficacy|1|||
155272473|NCT03390036|560431304|FG001|Overall Study|Lack of Efficacy|0|||
155272474|NCT03390036|560431305|FG002|Overall Study|Lack of Efficacy|0|||
155272475|NCT01984424|560431306|FG000|Overall Study|Withdrawal by Subject|3|||
155272476|NCT01984424|560431307|FG001|Overall Study|Withdrawal by Subject|5|||
155381921|NCT00116753|560833236|FG000|Overall Study|Dosing Error|0|||
155272477|NCT01984424|560431306|FG000|Overall Study|Sponsor Decision|0|||
155043104|NCT04378569|559590053|FG003|Overall Study|Withdrawal by Subject|4|||
155043105|NCT04378569|559590054|FG004|Overall Study|Withdrawal by Subject|5|||
155043106|NCT04378569|559590055|FG005|Overall Study|Withdrawal by Subject|4|||
155043107|NCT04378569|559590050|FG000|Overall Study|Lack of response|0|||
155043108|NCT04378569|559590051|FG001|Overall Study|Lack of response|0|||
155043109|NCT04378569|559590052|FG002|Overall Study|Lack of response|1|||
155043110|NCT04378569|559590053|FG003|Overall Study|Lack of response|0|||
155043111|NCT04378569|559590054|FG004|Overall Study|Lack of response|1|||
155043112|NCT04378569|559590055|FG005|Overall Study|Lack of response|1|||
155043113|NCT01048944|559590056|FG000|Overall Study|Protocol Violation|8|||
155043114|NCT01048944|559590057|FG001|Overall Study|Protocol Violation|10|||
155043115|NCT01048944|559590058|FG002|Overall Study|Protocol Violation|10|||
155043116|NCT01048944|559590059|FG003|Overall Study|Protocol Violation|2|||
155043117|NCT01844817|559590060|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
155043118|NCT01844817|559590061|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
155043119|NCT01844817|559590060|FG000|Treatment|Progressive Disease|27|||
155043120|NCT01844817|559590061|FG001|Treatment|Progressive Disease|36|||
155043121|NCT01844817|559590060|FG000|Treatment|Adverse Event|17|||
155043122|NCT01844817|559590061|FG001|Treatment|Adverse Event|9|||
155043123|NCT01844817|559590060|FG000|Treatment|Withdrawal by Subject|10|||
155043124|NCT01844817|559590061|FG001|Treatment|Withdrawal by Subject|6|||
155043125|NCT01844817|559590060|FG000|Treatment|Death|10|||
155043126|NCT01844817|559590061|FG001|Treatment|Death|8|||
155043127|NCT01844817|559590060|FG000|Treatment|Lost to Follow-up|0|||
155043128|NCT01844817|559590061|FG001|Treatment|Lost to Follow-up|1|||
155043129|NCT01844817|559590060|FG000|Treatment|Other|0|||
155043130|NCT01844817|559590061|FG001|Treatment|Other|3|||
155043131|NCT01133704|559590062|FG000|Overall Study|Death|44|||
155043132|NCT01133704|559590063|FG001|Overall Study|Death|26|||
155043133|NCT01133704|559590062|FG000|Overall Study|Patient refused to continue|4|||
155043134|NCT01133704|559590063|FG001|Overall Study|Patient refused to continue|0|||
155043135|NCT01133704|559590062|FG000|Overall Study|Study Closure|1|||
155043136|NCT01133704|559590063|FG001|Overall Study|Study Closure|0|||
155043137|NCT02207400|559590064|FG000|Overall Study|Adverse Event|1|||
155043138|NCT02207400|559590065|FG001|Overall Study|Adverse Event|1|||
155043139|NCT02207400|559590064|FG000|Overall Study|Lost to Follow-up|6|||
155043140|NCT02207400|559590065|FG001|Overall Study|Lost to Follow-up|7|||
155043141|NCT02207400|559590064|FG000|Overall Study|Protocol Violation|1|||
155043142|NCT02207400|559590065|FG001|Overall Study|Protocol Violation|1|||
155043143|NCT02207400|559590064|FG000|Overall Study|Withdrawal by Subject|8|||
155043144|NCT02207400|559590065|FG001|Overall Study|Withdrawal by Subject|4|||
155043145|NCT02207400|559590064|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
155043146|NCT02207400|559590065|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
155043147|NCT02362425|559590066|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
155043148|NCT02362425|559590067|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
155043149|NCT02362425|559590068|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
155043150|NCT02362425|559590069|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
155043151|NCT02362425|559590066|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
155043152|NCT02362425|559590067|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
155043153|NCT02362425|559590068|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
155043154|NCT02362425|559590069|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
155043155|NCT02362425|559590066|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
155043156|NCT02362425|559590067|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
155043157|NCT02362425|559590068|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
155043158|NCT02362425|559590069|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
155043159|NCT02362425|559590066|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
155043160|NCT02362425|559590067|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
155043161|NCT02362425|559590068|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
155043162|NCT02362425|559590069|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
155043163|NCT02362425|559590066|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
155043164|NCT02362425|559590067|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
155043165|NCT02362425|559590068|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
155043166|NCT02362425|559590069|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
155043167|NCT02362425|559590066|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
155043168|NCT02362425|559590067|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
155043169|NCT02362425|559590068|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
155043170|NCT02362425|559590069|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
155043171|NCT02362425|559590066|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
155043172|NCT02362425|559590067|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
155043173|NCT02362425|559590068|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
155043174|NCT02362425|559590069|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
155043175|NCT02362425|559590066|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
155043176|NCT02362425|559590067|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
155092556|NCT02336815|559773624|FG001|Overall Study|Withdrawal by Subject|2|||
155272478|NCT01984424|560431307|FG001|Overall Study|Sponsor Decision|1|||
155272479|NCT01984424|560431306|FG000|Overall Study|Lost to Follow-up|0|||
155272480|NCT01984424|560431307|FG001|Overall Study|Lost to Follow-up|1|||
155272481|NCT01807221|560431308|FG000|Overall Study|Progressive disease|1|||
154932334|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932335|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932336|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932337|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932338|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
154932339|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
154932340|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
154932341|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
154932342|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
154932343|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
154932344|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
154932345|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155272482|NCT01807221|560431309|FG001|Overall Study|Progressive disease|0|||
155272483|NCT01807221|560431310|FG002|Overall Study|Progressive disease|1|||
155272484|NCT01807221|560431311|FG003|Overall Study|Progressive disease|0|||
155272485|NCT01807221|560431312|FG004|Overall Study|Progressive disease|0|||
155272486|NCT01807221|560431313|FG005|Overall Study|Progressive disease|0|||
155272487|NCT01807221|560431308|FG000|Overall Study|Death|7|||
155272488|NCT01807221|560431309|FG001|Overall Study|Death|9|||
155272489|NCT01807221|560431310|FG002|Overall Study|Death|4|||
155272490|NCT01807221|560431311|FG003|Overall Study|Death|2|||
155272491|NCT01807221|560431312|FG004|Overall Study|Death|1|||
155272492|NCT01807221|560431313|FG005|Overall Study|Death|6|||
155272493|NCT01807221|560431308|FG000|Overall Study|Physician Decision|2|||
155272494|NCT01807221|560431309|FG001|Overall Study|Physician Decision|1|||
155272495|NCT01807221|560431310|FG002|Overall Study|Physician Decision|0|||
155272496|NCT01807221|560431311|FG003|Overall Study|Physician Decision|0|||
155272497|NCT01807221|560431312|FG004|Overall Study|Physician Decision|0|||
155272498|NCT01807221|560431313|FG005|Overall Study|Physician Decision|0|||
155272499|NCT01807221|560431308|FG000|Overall Study|Adverse Event|33|||
155272500|NCT01807221|560431309|FG001|Overall Study|Adverse Event|22|||
155272501|NCT01807221|560431310|FG002|Overall Study|Adverse Event|26|||
155272502|NCT01807221|560431311|FG003|Overall Study|Adverse Event|25|||
155272503|NCT01807221|560431312|FG004|Overall Study|Adverse Event|18|||
155272504|NCT01807221|560431313|FG005|Overall Study|Adverse Event|21|||
155272505|NCT01807221|560431308|FG000|Overall Study|Protocol Violation|0|||
155272506|NCT01807221|560431309|FG001|Overall Study|Protocol Violation|2|||
155272507|NCT01807221|560431310|FG002|Overall Study|Protocol Violation|1|||
155272508|NCT01807221|560431311|FG003|Overall Study|Protocol Violation|2|||
155272509|NCT01807221|560431312|FG004|Overall Study|Protocol Violation|0|||
155272510|NCT01807221|560431313|FG005|Overall Study|Protocol Violation|1|||
155272511|NCT01807221|560431308|FG000|Overall Study|Non-compliance|1|||
155272512|NCT01807221|560431309|FG001|Overall Study|Non-compliance|2|||
155272513|NCT01807221|560431310|FG002|Overall Study|Non-compliance|0|||
155272514|NCT01807221|560431311|FG003|Overall Study|Non-compliance|1|||
155272515|NCT01807221|560431312|FG004|Overall Study|Non-compliance|0|||
155272516|NCT01807221|560431313|FG005|Overall Study|Non-compliance|0|||
155272517|NCT01807221|560431308|FG000|Overall Study|Logistical difficulties|0|||
155272518|NCT01807221|560431309|FG001|Overall Study|Logistical difficulties|1|||
155272519|NCT01807221|560431310|FG002|Overall Study|Logistical difficulties|0|||
155272520|NCT01807221|560431311|FG003|Overall Study|Logistical difficulties|0|||
155272521|NCT01807221|560431312|FG004|Overall Study|Logistical difficulties|1|||
155272522|NCT01807221|560431313|FG005|Overall Study|Logistical difficulties|0|||
155272523|NCT01807221|560431308|FG000|Overall Study|Withdrawal by Subject|33|||
155272524|NCT01807221|560431309|FG001|Overall Study|Withdrawal by Subject|15|||
154932346|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
154932347|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
154932348|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
155272525|NCT01807221|560431310|FG002|Overall Study|Withdrawal by Subject|8|||
155272526|NCT01807221|560431311|FG003|Overall Study|Withdrawal by Subject|14|||
155272527|NCT01807221|560431312|FG004|Overall Study|Withdrawal by Subject|16|||
155272528|NCT01807221|560431313|FG005|Overall Study|Withdrawal by Subject|13|||
155272529|NCT01807221|560431308|FG000|Overall Study|Sponsor decision|2|||
155272530|NCT01807221|560431309|FG001|Overall Study|Sponsor decision|0|||
155272531|NCT01807221|560431310|FG002|Overall Study|Sponsor decision|1|||
155272532|NCT01807221|560431311|FG003|Overall Study|Sponsor decision|1|||
155272533|NCT01807221|560431312|FG004|Overall Study|Sponsor decision|0|||
155272534|NCT01807221|560431313|FG005|Overall Study|Sponsor decision|0|||
154932349|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
155092557|NCT02336815|559773623|FG000|Overall Study|Lost to Follow-up|1|||
155272535|NCT01807221|560431308|FG000|Overall Study|Lost to Follow-up|1|||
155272536|NCT01807221|560431309|FG001|Overall Study|Lost to Follow-up|0|||
155272537|NCT01807221|560431310|FG002|Overall Study|Lost to Follow-up|2|||
155043177|NCT02362425|559590068|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
155043178|NCT02362425|559590069|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
155043179|NCT04304508|559590077|FG000|Overall Study|Subject Decision|29|||
155043180|NCT04304508|559590078|FG001|Overall Study|Subject Decision|39|||
155043181|NCT04304508|559590079|FG002|Overall Study|Subject Decision|37|||
155043182|NCT04304508|559590080|FG003|Overall Study|Subject Decision|48|||
155043183|NCT04304508|559590077|FG000|Overall Study|Death|6|||
155043184|NCT04304508|559590078|FG001|Overall Study|Death|1|||
155043185|NCT04304508|559590079|FG002|Overall Study|Death|8|||
155043186|NCT04304508|559590080|FG003|Overall Study|Death|5|||
155043187|NCT04304508|559590077|FG000|Overall Study|Non-compliance With Study Drug|3|||
155043188|NCT04304508|559590078|FG001|Overall Study|Non-compliance With Study Drug|1|||
155043189|NCT04304508|559590079|FG002|Overall Study|Non-compliance With Study Drug|2|||
155043190|NCT04304508|559590080|FG003|Overall Study|Non-compliance With Study Drug|0|||
155043191|NCT04304508|559590077|FG000|Overall Study|Switching To Other Therapy|1|||
155043192|NCT04304508|559590078|FG001|Overall Study|Switching To Other Therapy|1|||
155043193|NCT04304508|559590079|FG002|Overall Study|Switching To Other Therapy|1|||
155043194|NCT04304508|559590080|FG003|Overall Study|Switching To Other Therapy|2|||
155043195|NCT04304508|559590077|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
155043196|NCT04304508|559590078|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
155043197|NCT04304508|559590079|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
155043198|NCT04304508|559590080|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
155043199|NCT04304508|559590077|FG000|Overall Study|Withdrawal by Subject|7|||
155043200|NCT04304508|559590078|FG001|Overall Study|Withdrawal by Subject|5|||
155043201|NCT04304508|559590079|FG002|Overall Study|Withdrawal by Subject|11|||
155043202|NCT04304508|559590080|FG003|Overall Study|Withdrawal by Subject|6|||
155043203|NCT04304508|559590077|FG000|Overall Study|Logistical Difficulties|2|||
155043204|NCT04304508|559590078|FG001|Overall Study|Logistical Difficulties|2|||
155043205|NCT04304508|559590079|FG002|Overall Study|Logistical Difficulties|3|||
155043206|NCT04304508|559590080|FG003|Overall Study|Logistical Difficulties|2|||
155043207|NCT04304508|559590077|FG000|Overall Study|Missing Information|1|||
155043208|NCT04304508|559590078|FG001|Overall Study|Missing Information|2|||
155043209|NCT04304508|559590079|FG002|Overall Study|Missing Information|1|||
155043210|NCT04304508|559590080|FG003|Overall Study|Missing Information|3|||
155043211|NCT04304508|559590077|FG000|Overall Study|Other|7|||
155043212|NCT04304508|559590078|FG001|Overall Study|Other|6|||
155043213|NCT04304508|559590079|FG002|Overall Study|Other|5|||
155043214|NCT04304508|559590080|FG003|Overall Study|Other|4|||
155043215|NCT04304508|559590077|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
155043216|NCT04304508|559590078|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
155043217|NCT04304508|559590079|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
155043218|NCT04304508|559590080|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
155043219|NCT04304508|559590077|FG000|Overall Study|Physician Decision|3|||
155043220|NCT04304508|559590078|FG001|Overall Study|Physician Decision|4|||
155043221|NCT04304508|559590079|FG002|Overall Study|Physician Decision|9|||
155043222|NCT04304508|559590080|FG003|Overall Study|Physician Decision|7|||
155043223|NCT04304508|559590077|FG000|Overall Study|Study drug never administered|10|||
155043224|NCT04304508|559590078|FG001|Overall Study|Study drug never administered|4|||
155043225|NCT04304508|559590079|FG002|Overall Study|Study drug never administered|4|||
155043226|NCT04304508|559590080|FG003|Overall Study|Study drug never administered|4|||
155043227|NCT04304508|559590077|FG000|Overall Study|Adverse Event|49|||
155043228|NCT04304508|559590078|FG001|Overall Study|Adverse Event|50|||
155043229|NCT04304508|559590079|FG002|Overall Study|Adverse Event|51|||
155043230|NCT04304508|559590080|FG003|Overall Study|Adverse Event|56|||
155043231|NCT04304508|559590077|FG000|Overall Study|Lost to Follow-up|1|||
155043232|NCT04304508|559590078|FG001|Overall Study|Lost to Follow-up|5|||
155043233|NCT04304508|559590079|FG002|Overall Study|Lost to Follow-up|2|||
155043234|NCT04304508|559590080|FG003|Overall Study|Lost to Follow-up|3|||
155043235|NCT02688764|559590087|FG000|Overall Study|Adverse Event|3|||
155043236|NCT02688764|559590088|FG001|Overall Study|Adverse Event|3|||
155043237|NCT02688764|559590087|FG000|Overall Study|AE/Kidney transplant|1|||
155043238|NCT02688764|559590088|FG001|Overall Study|AE/Kidney transplant|0|||
155043239|NCT02688764|559590087|FG000|Overall Study|AE/Lack of efficacy|1|||
155043240|NCT02688764|559590088|FG001|Overall Study|AE/Lack of efficacy|0|||
155043241|NCT02688764|559590087|FG000|Overall Study|AE/Non-compl.|1|||
155043242|NCT02688764|559590088|FG001|Overall Study|AE/Non-compl.|0|||
155043243|NCT02688764|559590087|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
155043244|NCT02688764|559590088|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
155043245|NCT02688764|559590087|FG000|Overall Study|AE/Other|0|||
155043246|NCT02688764|559590088|FG001|Overall Study|AE/Other|1|||
155043247|NCT02688764|559590087|FG000|Overall Study|AE/Physician decision|1|||
155043248|NCT02688764|559590088|FG001|Overall Study|AE/Physician decision|0|||
155043249|NCT02688764|559590087|FG000|Overall Study|AE/Withd. parent|3|||
155043250|NCT02688764|559590088|FG001|Overall Study|AE/Withd. parent|0|||
155043251|NCT02688764|559590087|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
155043252|NCT02688764|559590088|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
155272538|NCT01807221|560431311|FG003|Overall Study|Lost to Follow-up|1|||
155272539|NCT01807221|560431312|FG004|Overall Study|Lost to Follow-up|0|||
155272540|NCT01807221|560431313|FG005|Overall Study|Lost to Follow-up|0|||
155272541|NCT00373295|560431314|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272542|NCT00373295|560431315|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
155272543|NCT00373295|560431316|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272544|NCT00373295|560431317|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272545|NCT00373295|560431318|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
155272546|NCT00373295|560431319|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
155272547|NCT04267614|560431320|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
155272548|NCT04267614|560431320|FG000|Overall Study|Lost to Follow-up|115|||
155272549|NCT00988351|560431324|FG000|Overall Study|Withdrawal by Subject|8|||
155272550|NCT00988351|560431325|FG001|Overall Study|Withdrawal by Subject|0|||
155272551|NCT00988351|560431324|FG000|Overall Study|Lost to Follow-up|6|||
155272552|NCT00988351|560431325|FG001|Overall Study|Lost to Follow-up|9|||
155272553|NCT00988351|560431324|FG000|Overall Study|not using CPAP|5|||
155272554|NCT00988351|560431325|FG001|Overall Study|not using CPAP|3|||
155272555|NCT02303626|560431337|FG000|Overall Study|Lack of Efficacy|1|||
155272556|NCT02303626|560431338|FG001|Overall Study|Lack of Efficacy|0|||
155272557|NCT02303626|560431339|FG002|Overall Study|Lack of Efficacy|1|||
155272558|NCT02303626|560431337|FG000|Overall Study|Adverse Event|0|||
155272559|NCT02303626|560431338|FG001|Overall Study|Adverse Event|2|||
155272560|NCT02303626|560431339|FG002|Overall Study|Adverse Event|0|||
155272561|NCT02303626|560431337|FG000|Overall Study|Protocol Violation|0|||
155272562|NCT02303626|560431338|FG001|Overall Study|Protocol Violation|1|||
155272563|NCT02303626|560431339|FG002|Overall Study|Protocol Violation|0|||
155272564|NCT02303626|560431337|FG000|Overall Study|Pregnancy|0|||
155272565|NCT02303626|560431338|FG001|Overall Study|Pregnancy|0|||
155272566|NCT02303626|560431339|FG002|Overall Study|Pregnancy|1|||
155272567|NCT02303626|560431337|FG000|Overall Study|Subject Non-Compliance|0|||
155272568|NCT02303626|560431338|FG001|Overall Study|Subject Non-Compliance|0|||
155272569|NCT02303626|560431339|FG002|Overall Study|Subject Non-Compliance|1|||
154932350|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
154932351|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
154932352|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
154932353|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
154932354|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
154932355|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
154932356|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
154932357|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
154932358|NCT01915498|559177209|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
154932359|NCT01915498|559177210|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
154932360|NCT01915498|559177211|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
154932361|NCT01915498|559177212|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
154932362|NCT01915498|559177213|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
154932363|NCT01915498|559177214|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
154932364|NCT01915498|559177215|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
154932365|NCT01915498|559177216|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
154932366|NCT01915498|559177217|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
154932367|NCT01915498|559177218|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
154932368|NCT01915498|559177219|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
154932369|NCT01915498|559177220|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
154932370|NCT01915498|559177221|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
154932371|NCT01915498|559177222|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
154932372|NCT01915498|559177223|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
154932373|NCT01915498|559177224|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
154932374|NCT01915498|559177225|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
154932375|NCT01915498|559177226|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
154932376|NCT01915498|559177227|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
154932377|NCT01915498|559177209|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
155272570|NCT05832437|560431340|FG000|Overall Study|time off work|1|||
155272571|NCT05832437|560431341|FG001|Overall Study|time off work|0|||
155272572|NCT05832437|560431342|FG002|Overall Study|time off work|0|||
155272573|NCT05832437|560431343|FG003|Overall Study|time off work|0|||
155272574|NCT05376371|560431344|FG000|Overall Study|change in release date|10|||
155272575|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272576|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272577|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272578|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272579|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
154932378|NCT01915498|559177210|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932379|NCT01915498|559177211|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932380|NCT01915498|559177212|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932381|NCT01915498|559177213|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932382|NCT01915498|559177214|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932383|NCT01915498|559177215|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932384|NCT01915498|559177216|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932385|NCT01915498|559177217|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932386|NCT01915498|559177218|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932387|NCT01915498|559177219|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932388|NCT01915498|559177220|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932389|NCT01915498|559177221|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932390|NCT01915498|559177222|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932391|NCT01915498|559177223|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932392|NCT01915498|559177224|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932393|NCT01915498|559177225|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932394|NCT01915498|559177226|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
154932395|NCT01915498|559177227|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
154932396|NCT01915498|559177209|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932397|NCT01915498|559177210|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932398|NCT01915498|559177211|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932399|NCT01915498|559177212|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932400|NCT01915498|559177213|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932401|NCT01915498|559177214|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932402|NCT01915498|559177215|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932403|NCT01915498|559177216|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932404|NCT01915498|559177217|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932405|NCT01915498|559177218|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932406|NCT01915498|559177219|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932407|NCT01915498|559177220|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
155043253|NCT02688764|559590087|FG000|Overall Study|AE/Withd. subject|1|||
155272580|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272581|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
155272582|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
155272583|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272584|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
155272585|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272586|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272587|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272588|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272589|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272590|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272591|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272592|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
155272593|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272594|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
155272595|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272596|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272597|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272598|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272599|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272600|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272601|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272602|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
155272603|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155381922|NCT00116753|560833237|FG001|Overall Study|Dosing Error|1|||
155381923|NCT00116753|560833238|FG002|Overall Study|Dosing Error|0|||
155381924|NCT01200589|560833239|FG000|Overall Study|Withdrawal by Subject|13|||
155272604|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
155272605|NCT04159415|560431345|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272606|NCT04159415|560431346|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272607|NCT04159415|560431347|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272608|NCT04159415|560431348|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272609|NCT04159415|560431349|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272610|NCT04159415|560431350|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272611|NCT04159415|560431351|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272612|NCT04159415|560431352|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272613|NCT04159415|560431353|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
155272614|NCT04159415|560431354|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
155272615|NCT05407311|560431355|FG000|Overall Study|Withdrawal by Subject|5|||
155272616|NCT05407311|560431355|FG000|Overall Study|Protocol Violation|3|||
155272617|NCT05407311|560431355|FG000|Overall Study|Physician Decision|1|||
155272618|NCT05407311|560431355|FG000|Overall Study|Non-compliance|1|||
155272619|NCT00337662|560431357|FG000|Study Period II|Lost to Follow-up|0|||
155272620|NCT00337662|560431358|FG001|Study Period II|Lost to Follow-up|0|||
155272621|NCT00337662|560431359|FG002|Study Period II|Lost to Follow-up|0|||
155272622|NCT00337662|560431360|FG003|Study Period II|Lost to Follow-up|35|||
155272623|NCT00337662|560431357|FG000|Study Period II|Withdrawal by Subject|0|||
155272624|NCT00337662|560431358|FG001|Study Period II|Withdrawal by Subject|0|||
155272625|NCT00337662|560431359|FG002|Study Period II|Withdrawal by Subject|0|||
155272626|NCT00337662|560431360|FG003|Study Period II|Withdrawal by Subject|20|||
155272627|NCT00337662|560431357|FG000|Study Period II|Adverse Event|0|||
155272628|NCT00337662|560431358|FG001|Study Period II|Adverse Event|0|||
155272629|NCT00337662|560431359|FG002|Study Period II|Adverse Event|0|||
155272630|NCT00337662|560431360|FG003|Study Period II|Adverse Event|16|||
155272631|NCT00337662|560431357|FG000|Study Period II|Physician Decision|0|||
155272632|NCT00337662|560431358|FG001|Study Period II|Physician Decision|0|||
155272633|NCT00337662|560431359|FG002|Study Period II|Physician Decision|0|||
155272634|NCT00337662|560431360|FG003|Study Period II|Physician Decision|13|||
155272635|NCT00337662|560431357|FG000|Study Period II|Entry Criteria Not Met|0|||
155272636|NCT00337662|560431358|FG001|Study Period II|Entry Criteria Not Met|0|||
155272637|NCT00337662|560431359|FG002|Study Period II|Entry Criteria Not Met|0|||
155272638|NCT00337662|560431360|FG003|Study Period II|Entry Criteria Not Met|6|||
155272639|NCT00337662|560431357|FG000|Study Period II|Protocol Violation|0|||
155272640|NCT00337662|560431358|FG001|Study Period II|Protocol Violation|0|||
155272641|NCT00337662|560431359|FG002|Study Period II|Protocol Violation|0|||
155272642|NCT00337662|560431360|FG003|Study Period II|Protocol Violation|6|||
155272643|NCT00337662|560431357|FG000|Study Period II|Lack of Efficacy|0|||
155272644|NCT00337662|560431358|FG001|Study Period II|Lack of Efficacy|0|||
155272645|NCT00337662|560431359|FG002|Study Period II|Lack of Efficacy|0|||
155272646|NCT00337662|560431360|FG003|Study Period II|Lack of Efficacy|7|||
155272647|NCT00337662|560431357|FG000|Study Period II|Sponsor Decision|0|||
155272648|NCT00337662|560431358|FG001|Study Period II|Sponsor Decision|0|||
155272649|NCT00337662|560431359|FG002|Study Period II|Sponsor Decision|0|||
155272650|NCT00337662|560431360|FG003|Study Period II|Sponsor Decision|2|||
155272651|NCT00337662|560431357|FG000|Study Period II|Parent/Caregiver Decision|0|||
155272652|NCT00337662|560431358|FG001|Study Period II|Parent/Caregiver Decision|0|||
155272653|NCT00337662|560431359|FG002|Study Period II|Parent/Caregiver Decision|0|||
155272654|NCT00337662|560431360|FG003|Study Period II|Parent/Caregiver Decision|1|||
155272655|NCT00337662|560431357|FG000|Study Period III|Lost to Follow-up|14|||
155272656|NCT00337662|560431358|FG001|Study Period III|Lost to Follow-up|16|||
155272657|NCT00337662|560431359|FG002|Study Period III|Lost to Follow-up|14|||
155272658|NCT00337662|560431360|FG003|Study Period III|Lost to Follow-up|0|||
155272659|NCT00337662|560431357|FG000|Study Period III|Withdrawal by Subject|18|||
155272660|NCT00337662|560431358|FG001|Study Period III|Withdrawal by Subject|14|||
155272661|NCT00337662|560431359|FG002|Study Period III|Withdrawal by Subject|12|||
155272662|NCT00337662|560431360|FG003|Study Period III|Withdrawal by Subject|0|||
155272663|NCT00337662|560431357|FG000|Study Period III|Adverse Event|9|||
155272664|NCT00337662|560431358|FG001|Study Period III|Adverse Event|10|||
155272665|NCT00337662|560431359|FG002|Study Period III|Adverse Event|8|||
155272666|NCT00337662|560431360|FG003|Study Period III|Adverse Event|0|||
155272667|NCT00337662|560431357|FG000|Study Period III|Protocol Violation|3|||
155272668|NCT00337662|560431358|FG001|Study Period III|Protocol Violation|8|||
155272669|NCT00337662|560431359|FG002|Study Period III|Protocol Violation|2|||
155272670|NCT00337662|560431360|FG003|Study Period III|Protocol Violation|0|||
155272671|NCT00337662|560431357|FG000|Study Period III|Physician Decision|6|||
155272672|NCT00337662|560431358|FG001|Study Period III|Physician Decision|5|||
155272673|NCT00337662|560431359|FG002|Study Period III|Physician Decision|0|||
155272674|NCT00337662|560431360|FG003|Study Period III|Physician Decision|0|||
155272675|NCT00337662|560431357|FG000|Study Period III|Entry Criteria Not Met|4|||
155272676|NCT00337662|560431358|FG001|Study Period III|Entry Criteria Not Met|1|||
155272677|NCT00337662|560431359|FG002|Study Period III|Entry Criteria Not Met|3|||
155272678|NCT00337662|560431360|FG003|Study Period III|Entry Criteria Not Met|0|||
155272679|NCT00337662|560431357|FG000|Study Period III|Lack of Efficacy|4|||
155272680|NCT00337662|560431358|FG001|Study Period III|Lack of Efficacy|4|||
155272681|NCT00337662|560431359|FG002|Study Period III|Lack of Efficacy|2|||
155272682|NCT00337662|560431360|FG003|Study Period III|Lack of Efficacy|0|||
155272683|NCT00337662|560431357|FG000|Study Period III|Parent/Caregiver Decision|0|||
155272684|NCT00337662|560431358|FG001|Study Period III|Parent/Caregiver Decision|0|||
155272685|NCT00337662|560431359|FG002|Study Period III|Parent/Caregiver Decision|2|||
155272686|NCT00337662|560431360|FG003|Study Period III|Parent/Caregiver Decision|0|||
155272687|NCT00337662|560431357|FG000|Study Period III|Sponsor Decision|1|||
155272688|NCT00337662|560431358|FG001|Study Period III|Sponsor Decision|0|||
155272689|NCT00337662|560431359|FG002|Study Period III|Sponsor Decision|1|||
155043254|NCT02688764|559590088|FG001|Overall Study|AE/Withd. subject|0|||
155043255|NCT02688764|559590087|FG000|Overall Study|Kidney transplant|10|||
155043256|NCT02688764|559590088|FG001|Overall Study|Kidney transplant|4|||
155043257|NCT02688764|559590087|FG000|Overall Study|Lack of Efficacy|3|||
155043258|NCT02688764|559590088|FG001|Overall Study|Lack of Efficacy|2|||
155043259|NCT02688764|559590087|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
155043260|NCT02688764|559590088|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
155043261|NCT02688764|559590087|FG000|Overall Study|Non-compliance with study drug|4|||
155043262|NCT02688764|559590088|FG001|Overall Study|Non-compliance with study drug|0|||
155043263|NCT02688764|559590087|FG000|Overall Study|Non-compl./Physician decision|2|||
155043264|NCT02688764|559590088|FG001|Overall Study|Non-compl./Physician decision|0|||
155043265|NCT02688764|559590087|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
155043266|NCT02688764|559590088|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
155043267|NCT02688764|559590087|FG000|Overall Study|Non-compl./Withd. subject|0|||
155043268|NCT02688764|559590088|FG001|Overall Study|Non-compl./Withd. subject|2|||
155043269|NCT02688764|559590087|FG000|Overall Study|Phosphorus level outside safe range|0|||
155043270|NCT02688764|559590088|FG001|Overall Study|Phosphorus level outside safe range|1|||
155043271|NCT02688764|559590087|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
155043272|NCT02688764|559590088|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
155043273|NCT02688764|559590087|FG000|Overall Study|Study drug taste/Withd. parent|1|||
155043274|NCT02688764|559590088|FG001|Overall Study|Study drug taste/Withd. parent|0|||
155043275|NCT02688764|559590087|FG000|Overall Study|Subject moving out|2|||
155043276|NCT02688764|559590088|FG001|Overall Study|Subject moving out|0|||
155043277|NCT02688764|559590087|FG000|Overall Study|Subject taken off dialysis|1|||
155043278|NCT02688764|559590088|FG001|Overall Study|Subject taken off dialysis|0|||
155043279|NCT02688764|559590087|FG000|Overall Study|Withdrawal by parent|3|||
155043280|NCT02688764|559590088|FG001|Overall Study|Withdrawal by parent|0|||
155043281|NCT02113007|559590089|FG000|Overall Study|Progressive disease|2|||
155043282|NCT00885378|559590090|FG000|Overall Study|Lack of Efficacy|2|||
155043283|NCT00885378|559590091|FG001|Overall Study|Lack of Efficacy|2|||
155043284|NCT00885378|559590090|FG000|Overall Study|Withdrawal by Subject|1|||
155043285|NCT00885378|559590091|FG001|Overall Study|Withdrawal by Subject|2|||
155043286|NCT00885378|559590090|FG000|Overall Study|Lost to Follow-up|1|||
155043287|NCT00885378|559590091|FG001|Overall Study|Lost to Follow-up|2|||
155043288|NCT00885378|559590090|FG000|Overall Study|Poor/Noncompliance|2|||
155043289|NCT00885378|559590091|FG001|Overall Study|Poor/Noncompliance|2|||
155043290|NCT00885378|559590090|FG000|Overall Study|Protocol Violation|2|||
155043291|NCT00885378|559590091|FG001|Overall Study|Protocol Violation|0|||
155043292|NCT01775787|559590092|FG000|First 7-10 Days|Adverse Event|0|||
155043293|NCT01775787|559590093|FG001|First 7-10 Days|Adverse Event|1|||
155043294|NCT01775787|559590092|FG000|First 7-10 Days|family emergency|0|||
155043295|NCT01775787|559590093|FG001|First 7-10 Days|family emergency|1|||
155043296|NCT01775787|559590092|FG000|First 7-10 Days|time commitment|0|||
155043297|NCT01775787|559590093|FG001|First 7-10 Days|time commitment|2|||
155043298|NCT01775787|559590092|FG000|First 7-10 Days|concerns with using IV|1|||
155043299|NCT01775787|559590093|FG001|First 7-10 Days|concerns with using IV|2|||
155043300|NCT01775787|559590092|FG000|Second 7-10 Days|time commitment|0|||
155043301|NCT01775787|559590093|FG001|Second 7-10 Days|time commitment|1|||
155043302|NCT01775787|559590092|FG000|Second 7-10 Days|concerns with using IV|0|||
155043303|NCT01775787|559590093|FG001|Second 7-10 Days|concerns with using IV|1|||
155043304|NCT01299896|559590094|FG000|Overall Study|Withdrawal by Subject|1|||
155043305|NCT01299896|559590095|FG001|Overall Study|Withdrawal by Subject|7|||
155043306|NCT01299896|559590094|FG000|Overall Study|Lost to Follow-up|0|||
155043307|NCT01299896|559590095|FG001|Overall Study|Lost to Follow-up|11|||
155272690|NCT00337662|560431360|FG003|Study Period III|Sponsor Decision|0|||
155272691|NCT00337662|560431357|FG000|Study Period III|Clinical Relapse|1|||
155043308|NCT01502956|559590098|FG000|Overall Study|Death|0|||
155043309|NCT01502956|559590099|FG001|Overall Study|Death|2|||
155043310|NCT01502956|559590098|FG000|Overall Study|Lost to Follow-up|14|||
155043311|NCT01502956|559590099|FG001|Overall Study|Lost to Follow-up|11|||
155043312|NCT01502956|559590098|FG000|Overall Study|Physician Decision|2|||
155272692|NCT00337662|560431358|FG001|Study Period III|Clinical Relapse|0|||
155272693|NCT00337662|560431359|FG002|Study Period III|Clinical Relapse|0|||
155272694|NCT00337662|560431360|FG003|Study Period III|Clinical Relapse|0|||
155043313|NCT01502956|559590099|FG001|Overall Study|Physician Decision|3|||
155272695|NCT01265823|560431363|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
155272696|NCT01265823|560431363|FG000|Overall Study|Failure to Return|4|||
155272697|NCT01265823|560431363|FG000|Overall Study|Protocol Violation|1|||
155272698|NCT01265823|560431363|FG000|Overall Study|Participant Request|1|||
155272699|NCT00960752|560431372|FG000|Overall Study|Adverse Event|0|||
155272700|NCT00960752|560431373|FG001|Overall Study|Adverse Event|0|||
155272701|NCT00960752|560431374|FG002|Overall Study|Adverse Event|1|||
155272702|NCT00960752|560431372|FG000|Overall Study|Progression|0|||
155272703|NCT00960752|560431373|FG001|Overall Study|Progression|0|||
155272704|NCT00960752|560431374|FG002|Overall Study|Progression|1|||
155272705|NCT05027074|560431377|FG000|Overall Study|Death|47|||
155272706|NCT05027074|560431378|FG001|Overall Study|Death|42|||
155272707|NCT05027074|560431379|FG002|Overall Study|Death|39|||
155272708|NCT05027074|560431377|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155272709|NCT05027074|560431378|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155272710|NCT05027074|560431379|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155272711|NCT05027074|560431377|FG000|Overall Study|Site Terminated By Sponsor|3|||
155272712|NCT05027074|560431378|FG001|Overall Study|Site Terminated By Sponsor|0|||
155272713|NCT05027074|560431379|FG002|Overall Study|Site Terminated By Sponsor|2|||
155272714|NCT05027074|560431377|FG000|Overall Study|Withdrawal by Subject|13|||
155272715|NCT05027074|560431378|FG001|Overall Study|Withdrawal by Subject|8|||
155272716|NCT05027074|560431379|FG002|Overall Study|Withdrawal by Subject|10|||
155272717|NCT05027074|560431377|FG000|Overall Study|Lost to Follow-up|2|||
155272718|NCT05027074|560431378|FG001|Overall Study|Lost to Follow-up|4|||
155272719|NCT05027074|560431379|FG002|Overall Study|Lost to Follow-up|3|||
155272720|NCT05027074|560431377|FG000|Overall Study|Status Not Recorded|0|||
155272721|NCT05027074|560431378|FG001|Overall Study|Status Not Recorded|0|||
155272722|NCT05027074|560431379|FG002|Overall Study|Status Not Recorded|1|||
155272723|NCT03734991|560431384|FG000|Overall Study|Adverse Event|4|||
155272724|NCT03734991|560431385|FG001|Overall Study|Adverse Event|0|||
155272725|NCT03734991|560431384|FG000|Overall Study|Lost to Follow-up|4|||
155272726|NCT03734991|560431385|FG001|Overall Study|Lost to Follow-up|0|||
155272727|NCT03734991|560431384|FG000|Overall Study|Physician Decision|0|||
155272728|NCT03734991|560431385|FG001|Overall Study|Physician Decision|1|||
155272729|NCT03734991|560431384|FG000|Overall Study|Pregnancy|1|||
155272730|NCT03734991|560431385|FG001|Overall Study|Pregnancy|0|||
155272731|NCT03734991|560431384|FG000|Overall Study|Withdrawal by Subject|6|||
155272732|NCT03734991|560431385|FG001|Overall Study|Withdrawal by Subject|3|||
155272733|NCT03734991|560431384|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
155272734|NCT03734991|560431385|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
155272735|NCT03734991|560431384|FG000|Overall Study|Other|2|||
155272736|NCT03734991|560431385|FG001|Overall Study|Other|2|||
155272737|NCT02322814|560431388|FG000|Overall Study|Death|7|||
155272738|NCT02322814|560431389|FG001|Overall Study|Death|29|||
155272739|NCT02322814|560431390|FG002|Overall Study|Death|32|||
155272740|NCT02322814|560431391|FG003|Overall Study|Death|23|||
155272741|NCT02322814|560431392|FG004|Overall Study|Death|14|||
155272742|NCT02322814|560431388|FG000|Overall Study|Lost to Follow-up|1|||
155272743|NCT02322814|560431389|FG001|Overall Study|Lost to Follow-up|3|||
155272744|NCT02322814|560431390|FG002|Overall Study|Lost to Follow-up|3|||
155272745|NCT02322814|560431391|FG003|Overall Study|Lost to Follow-up|1|||
155272746|NCT02322814|560431392|FG004|Overall Study|Lost to Follow-up|0|||
155272747|NCT02322814|560431388|FG000|Overall Study|Various Reasons|2|||
155272748|NCT02322814|560431389|FG001|Overall Study|Various Reasons|0|||
155272749|NCT02322814|560431390|FG002|Overall Study|Various Reasons|1|||
155272750|NCT02322814|560431391|FG003|Overall Study|Various Reasons|1|||
155272751|NCT02322814|560431392|FG004|Overall Study|Various Reasons|0|||
155272752|NCT02322814|560431388|FG000|Overall Study|Progressive Disease|0|||
155272753|NCT02322814|560431389|FG001|Overall Study|Progressive Disease|0|||
155272754|NCT02322814|560431390|FG002|Overall Study|Progressive Disease|0|||
155272755|NCT02322814|560431391|FG003|Overall Study|Progressive Disease|1|||
155272756|NCT02322814|560431392|FG004|Overall Study|Progressive Disease|1|||
155272757|NCT02322814|560431388|FG000|Overall Study|Protocol Violation|1|||
155272758|NCT02322814|560431389|FG001|Overall Study|Protocol Violation|0|||
155272759|NCT02322814|560431390|FG002|Overall Study|Protocol Violation|0|||
155272760|NCT02322814|560431391|FG003|Overall Study|Protocol Violation|0|||
155272761|NCT02322814|560431392|FG004|Overall Study|Protocol Violation|0|||
155272762|NCT02322814|560431388|FG000|Overall Study|Study Terminated by Sponsor|0|||
155272763|NCT02322814|560431389|FG001|Overall Study|Study Terminated by Sponsor|7|||
155272764|NCT02322814|560431390|FG002|Overall Study|Study Terminated by Sponsor|9|||
155272765|NCT02322814|560431391|FG003|Overall Study|Study Terminated by Sponsor|5|||
155272766|NCT02322814|560431392|FG004|Overall Study|Study Terminated by Sponsor|13|||
155272767|NCT02322814|560431388|FG000|Overall Study|Withdrawal by Subject|5|||
155272768|NCT02322814|560431389|FG001|Overall Study|Withdrawal by Subject|4|||
155272769|NCT02322814|560431390|FG002|Overall Study|Withdrawal by Subject|2|||
155272770|NCT02322814|560431391|FG003|Overall Study|Withdrawal by Subject|1|||
155272771|NCT02322814|560431392|FG004|Overall Study|Withdrawal by Subject|3|||
155272772|NCT01164228|560431393|FG000|Overall Study|Progression|24|||
155272773|NCT01164228|560431394|FG001|Overall Study|Progression|25|||
155272774|NCT01164228|560431393|FG000|Overall Study|Adverse Event|13|||
154932408|NCT01915498|559177221|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932409|NCT01915498|559177222|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932410|NCT01915498|559177223|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932411|NCT01915498|559177224|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932412|NCT01915498|559177225|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932413|NCT01915498|559177226|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
154932414|NCT01915498|559177227|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
154932415|NCT01915498|559177209|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932416|NCT01915498|559177210|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932417|NCT01915498|559177211|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932418|NCT01915498|559177212|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932419|NCT01915498|559177213|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932420|NCT01915498|559177214|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932421|NCT01915498|559177215|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932422|NCT01915498|559177216|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932423|NCT01915498|559177217|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932424|NCT01915498|559177218|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932425|NCT01915498|559177219|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932426|NCT01915498|559177220|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932427|NCT01915498|559177221|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932428|NCT01915498|559177222|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932429|NCT01915498|559177223|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932430|NCT01915498|559177224|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932431|NCT01915498|559177225|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932432|NCT01915498|559177226|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
154932433|NCT01915498|559177227|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
154932434|NCT01500434|559177228|FG000|Overall Study|Death|1|||
154932435|NCT01500434|559177228|FG000|Overall Study|Withdrawal by Subject|1|||
154932436|NCT01500434|559177228|FG000|Overall Study|Missed 12-month follow-up|5|||
154932437|NCT00314262|559177235|FG000|Overall Study|Adverse Event|2|||
154932438|NCT00314262|559177235|FG000|Overall Study|Withdrawal by Subject|2|||
154932439|NCT00314262|559177235|FG000|Overall Study|Physician Decision|1|||
154932440|NCT00883129|559177236|FG000|Overall Study|Adverse Event|7|||
154932441|NCT00883129|559177237|FG001|Overall Study|Adverse Event|15|||
154932442|NCT00883129|559177236|FG000|Overall Study|Withdrawal by Subject|8|||
154932443|NCT00883129|559177237|FG001|Overall Study|Withdrawal by Subject|9|||
154932444|NCT00883129|559177236|FG000|Overall Study|Non-compliance|3|||
154932445|NCT00883129|559177237|FG001|Overall Study|Non-compliance|6|||
154932446|NCT00883129|559177236|FG000|Overall Study|Lost to Follow-up|1|||
154932447|NCT00883129|559177237|FG001|Overall Study|Lost to Follow-up|2|||
154932448|NCT00883129|559177236|FG000|Overall Study|Death|1|||
154932449|NCT00883129|559177237|FG001|Overall Study|Death|2|||
154932450|NCT00883129|559177236|FG000|Overall Study|Defined Treatment Failure|0|||
154932451|NCT00883129|559177237|FG001|Overall Study|Defined Treatment Failure|2|||
154932452|NCT01185639|559177239|FG000|Overall Study|Progressed and didn't receive therapy|2|||
154932453|NCT01966107|559177240|FG000|Overall Study|excluded from FAS|21|||
154932454|NCT01966107|559177241|FG001|Overall Study|excluded from FAS|20|||
154932455|NCT01966107|559177240|FG000|Overall Study|discontinued treatment|345|||
154932456|NCT01966107|559177241|FG001|Overall Study|discontinued treatment|372|||
154932457|NCT01966107|559177240|FG000|Overall Study|due to study closure|164|||
154932458|NCT01966107|559177241|FG001|Overall Study|due to study closure|186|||
154932459|NCT01966107|559177240|FG000|Overall Study|withdrew from the study|272|||
154932460|NCT01966107|559177241|FG001|Overall Study|withdrew from the study|303|||
154932461|NCT02200614|559177242|FG000|Double Blind Treatment|Adverse Event|86|||
154932462|NCT02200614|559177243|FG001|Double Blind Treatment|Adverse Event|48|||
154932463|NCT02200614|559177242|FG000|Double Blind Treatment|Confirmed metastasis|120|||
154932464|NCT02200614|559177243|FG001|Double Blind Treatment|Confirmed metastasis|140|||
154932465|NCT02200614|559177242|FG000|Double Blind Treatment|Judgment of the investigator|59|||
154932466|NCT02200614|559177243|FG001|Double Blind Treatment|Judgment of the investigator|99|||
154932467|NCT02200614|559177242|FG000|Double Blind Treatment|Metastasis by local reading|1|||
154932468|NCT02200614|559177243|FG001|Double Blind Treatment|Metastasis by local reading|3|||
154932469|NCT02200614|559177242|FG000|Double Blind Treatment|Other reason|6|||
154932470|NCT02200614|559177243|FG001|Double Blind Treatment|Other reason|2|||
154932471|NCT02200614|559177242|FG000|Double Blind Treatment|Personal reason|77|||
154932472|NCT02200614|559177243|FG001|Double Blind Treatment|Personal reason|85|||
155043314|NCT01502956|559590098|FG000|Overall Study|Withdrawal by Subject|8|||
155043315|NCT01502956|559590099|FG001|Overall Study|Withdrawal by Subject|10|||
155043316|NCT03026283|559590100|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
155043317|NCT03026283|559590101|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
155043318|NCT03026283|559590102|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
154932473|NCT02200614|559177242|FG000|Double Blind Treatment|Protocol deviation|14|||
154932474|NCT02200614|559177243|FG001|Double Blind Treatment|Protocol deviation|7|||
154932475|NCT02200614|559177242|FG000|Double Blind Treatment|Not treated|1|||
154932476|NCT02200614|559177243|FG001|Double Blind Treatment|Not treated|0|||
154932477|NCT02200614|559177242|FG000|Open Label|Adverse Event|41|||
154932478|NCT02200614|559177243|FG001|Open Label|Adverse Event|11|||
154932479|NCT02200614|559177242|FG000|Open Label|Confirmed metastasis|1|||
154932480|NCT02200614|559177243|FG001|Open Label|Confirmed metastasis|0|||
154932481|NCT02200614|559177242|FG000|Open Label|Judgment of the investigator|29|||
154932482|NCT02200614|559177243|FG001|Open Label|Judgment of the investigator|2|||
154932483|NCT02200614|559177242|FG000|Open Label|Metastasis by local reading|138|||
154932484|NCT02200614|559177243|FG001|Open Label|Metastasis by local reading|27|||
154932485|NCT02200614|559177242|FG000|Open Label|Other reason|22|||
154932486|NCT02200614|559177243|FG001|Open Label|Other reason|4|||
154932487|NCT02200614|559177242|FG000|Open Label|Personal reason|60|||
154932488|NCT02200614|559177243|FG001|Open Label|Personal reason|8|||
154932489|NCT02200614|559177242|FG000|Open Label|Protocol deviation|3|||
154932490|NCT02200614|559177243|FG001|Open Label|Protocol deviation|2|||
154932491|NCT02200614|559177242|FG000|Open Label|Missing|2|||
154932492|NCT02200614|559177243|FG001|Open Label|Missing|2|||
154932493|NCT00532779|559177244|FG000|Overall Study|Adverse Event|122|||
154932494|NCT00532779|559177245|FG001|Overall Study|Adverse Event|112|||
154932495|NCT00532779|559177246|FG002|Overall Study|Adverse Event|56|||
154932496|NCT00532779|559177244|FG000|Overall Study|Lost to Follow-up|76|||
154932497|NCT00532779|559177245|FG001|Overall Study|Lost to Follow-up|65|||
154932498|NCT00532779|559177246|FG002|Overall Study|Lost to Follow-up|66|||
154932499|NCT00532779|559177244|FG000|Overall Study|Withdrawal by Subject|63|||
154932500|NCT00532779|559177245|FG001|Overall Study|Withdrawal by Subject|60|||
154932501|NCT00532779|559177246|FG002|Overall Study|Withdrawal by Subject|90|||
154932502|NCT00532779|559177244|FG000|Overall Study|Lack of Efficacy|12|||
154932503|NCT00532779|559177245|FG001|Overall Study|Lack of Efficacy|12|||
154932504|NCT00532779|559177246|FG002|Overall Study|Lack of Efficacy|40|||
154932505|NCT00532779|559177244|FG000|Overall Study|Protocol Violation|5|||
154932506|NCT00532779|559177245|FG001|Overall Study|Protocol Violation|9|||
154932507|NCT00532779|559177246|FG002|Overall Study|Protocol Violation|7|||
154932508|NCT00532779|559177244|FG000|Overall Study|Pregnancy|2|||
154932509|NCT00532779|559177245|FG001|Overall Study|Pregnancy|5|||
154932510|NCT00532779|559177246|FG002|Overall Study|Pregnancy|3|||
154932511|NCT00532779|559177244|FG000|Overall Study|Death|0|||
154932512|NCT00532779|559177245|FG001|Overall Study|Death|1|||
154932513|NCT00532779|559177246|FG002|Overall Study|Death|0|||
154932514|NCT00532779|559177244|FG000|Overall Study|Drug noncompliance, moved, other|14|||
154932515|NCT00532779|559177245|FG001|Overall Study|Drug noncompliance, moved, other|23|||
154932516|NCT00532779|559177246|FG002|Overall Study|Drug noncompliance, moved, other|29|||
154932517|NCT02662556|559177247|FG000|Overall Study|Adverse Event|4|||
154932518|NCT02662556|559177247|FG000|Overall Study|Lack of Efficacy|4|||
154932519|NCT00828516|559177256|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
154932520|NCT00689273|559177257|FG000|Overall Study|Adverse Event|3|||
154932521|NCT00689273|559177258|FG001|Overall Study|Adverse Event|1|||
154932522|NCT00689273|559177257|FG000|Overall Study|Lack of Efficacy|3|||
154932523|NCT00689273|559177258|FG001|Overall Study|Lack of Efficacy|0|||
154932524|NCT00689273|559177257|FG000|Overall Study|Lost to Follow-up|0|||
154932525|NCT00689273|559177258|FG001|Overall Study|Lost to Follow-up|2|||
154932526|NCT00689273|559177257|FG000|Overall Study|Other|6|||
154932527|NCT00689273|559177258|FG001|Overall Study|Other|2|||
154932528|NCT00689273|559177257|FG000|Overall Study|Randomized but not Treated|1|||
154932529|NCT00689273|559177258|FG001|Overall Study|Randomized but not Treated|0|||
154932530|NCT02787746|559177263|FG000|Overall Study|Adverse Event|42|||
155272775|NCT01164228|560431394|FG001|Overall Study|Adverse Event|7|||
155272776|NCT01164228|560431393|FG000|Overall Study|Death|1|||
155272777|NCT01164228|560431394|FG001|Overall Study|Death|1|||
155272778|NCT01164228|560431393|FG000|Overall Study|Withdrawal by Subject|2|||
154932531|NCT02787746|559177263|FG000|Overall Study|Withdrawal by Subject|65|||
154932532|NCT02787746|559177263|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
154932533|NCT03703297|559177268|FG000|Overall Study|Death|115|||
154932534|NCT03703297|559177269|FG001|Overall Study|Death|0|||
155272779|NCT01164228|560431394|FG001|Overall Study|Withdrawal by Subject|0|||
154932535|NCT03703297|559177270|FG002|Overall Study|Death|144|||
154932536|NCT03703297|559177268|FG000|Overall Study|Withdrawal by Subject|9|||
154932537|NCT03703297|559177269|FG001|Overall Study|Withdrawal by Subject|0|||
154932538|NCT03703297|559177270|FG002|Overall Study|Withdrawal by Subject|11|||
154932539|NCT03703297|559177268|FG000|Overall Study|Ongoing at the time of DCO|140|||
154932540|NCT03703297|559177269|FG001|Overall Study|Ongoing at the time of DCO|200|||
155272780|NCT01164228|560431393|FG000|Overall Study|Physician Decision|1|||
155272781|NCT01164228|560431394|FG001|Overall Study|Physician Decision|2|||
154932541|NCT03703297|559177270|FG002|Overall Study|Ongoing at the time of DCO|111|||
154932542|NCT01726335|559179691|FG000|Overall Study|Lost to Follow-up|2|||
154932543|NCT01726335|559179691|FG000|Overall Study|Withdrawal by Subject|15|||
154932544|NCT01726335|559179691|FG000|Overall Study|Adverse Event|4|||
155272782|NCT01164228|560431393|FG000|Overall Study|Symptomatic deterioration|1|||
154932545|NCT01726335|559179691|FG000|Overall Study|Lost to Follow-up|2|||
154932546|NCT01726335|559179691|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
154932547|NCT02162511|559179698|FG000|Overall Study|Lack of Efficacy|0|||
155272783|NCT01164228|560431394|FG001|Overall Study|Symptomatic deterioration|0|||
155272784|NCT01164228|560431393|FG000|Overall Study|Never started treatment|1|||
155272785|NCT01164228|560431394|FG001|Overall Study|Never started treatment|3|||
155272786|NCT01164228|560431393|FG000|Overall Study|Ineligible|1|||
155272787|NCT01164228|560431394|FG001|Overall Study|Ineligible|0|||
155272788|NCT04908449|560431395|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
155272789|NCT04908449|560431396|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
155272790|NCT04908449|560431395|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
155272791|NCT04908449|560431396|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
155272792|NCT01567865|560431399|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
155272793|NCT01567865|560431400|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
155272794|NCT01567865|560431401|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
155272795|NCT01567865|560431402|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
155272796|NCT01567865|560431399|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
155272797|NCT01567865|560431400|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
155272798|NCT01567865|560431401|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
155272799|NCT01567865|560431402|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
155272800|NCT05256381|560431403|FG000|Overall Study|Withdrawal by Subject|4|||
155272801|NCT05256381|560431404|FG001|Overall Study|Withdrawal by Subject|0|||
155272802|NCT05256381|560431405|FG002|Overall Study|Withdrawal by Subject|2|||
155272803|NCT05256381|560431406|FG003|Overall Study|Withdrawal by Subject|2|||
155272804|NCT05256381|560431407|FG004|Overall Study|Withdrawal by Subject|8|||
155272805|NCT05256381|560431408|FG005|Overall Study|Withdrawal by Subject|6|||
155272806|NCT05256381|560431403|FG000|Overall Study|Physician Decision|0|||
155272807|NCT05256381|560431404|FG001|Overall Study|Physician Decision|0|||
155272808|NCT05256381|560431405|FG002|Overall Study|Physician Decision|1|||
155272809|NCT05256381|560431406|FG003|Overall Study|Physician Decision|0|||
155272810|NCT05256381|560431407|FG004|Overall Study|Physician Decision|2|||
155272811|NCT05256381|560431408|FG005|Overall Study|Physician Decision|0|||
155272812|NCT05256381|560431403|FG000|Overall Study|Death|17|||
155272813|NCT05256381|560431404|FG001|Overall Study|Death|3|||
155272814|NCT05256381|560431405|FG002|Overall Study|Death|4|||
155272815|NCT05256381|560431406|FG003|Overall Study|Death|5|||
155272816|NCT05256381|560431407|FG004|Overall Study|Death|24|||
155272817|NCT05256381|560431408|FG005|Overall Study|Death|21|||
155272818|NCT05256381|560431403|FG000|Overall Study|Other, not specified|0|||
155272819|NCT05256381|560431404|FG001|Overall Study|Other, not specified|0|||
155272820|NCT05256381|560431405|FG002|Overall Study|Other, not specified|0|||
155272821|NCT05256381|560431406|FG003|Overall Study|Other, not specified|0|||
155272822|NCT05256381|560431407|FG004|Overall Study|Other, not specified|2|||
155272823|NCT05256381|560431408|FG005|Overall Study|Other, not specified|1|||
155272824|NCT05256381|560431403|FG000|Overall Study|Study terminated by sponsor|18|||
155272825|NCT05256381|560431404|FG001|Overall Study|Study terminated by sponsor|5|||
155272826|NCT05256381|560431405|FG002|Overall Study|Study terminated by sponsor|5|||
155272827|NCT05256381|560431406|FG003|Overall Study|Study terminated by sponsor|5|||
155272828|NCT05256381|560431407|FG004|Overall Study|Study terminated by sponsor|18|||
155272829|NCT05256381|560431408|FG005|Overall Study|Study terminated by sponsor|11|||
155272830|NCT05256381|560431403|FG000|Overall Study|Lost to Follow-up|1|||
155272831|NCT05256381|560431404|FG001|Overall Study|Lost to Follow-up|0|||
155272832|NCT05256381|560431405|FG002|Overall Study|Lost to Follow-up|0|||
155272833|NCT05256381|560431406|FG003|Overall Study|Lost to Follow-up|0|||
155272834|NCT05256381|560431407|FG004|Overall Study|Lost to Follow-up|1|||
155272835|NCT05256381|560431408|FG005|Overall Study|Lost to Follow-up|0|||
155272836|NCT05569954|560431409|FG000|Overall Study|Lost to Follow-up|3|||
155272837|NCT05569954|560431410|FG001|Overall Study|Lost to Follow-up|4|||
155272838|NCT05569954|560431409|FG000|Overall Study|Protocol Violation|1|||
155272839|NCT05569954|560431410|FG001|Overall Study|Protocol Violation|2|||
155272840|NCT05569954|560431409|FG000|Overall Study|Withdrawal by Subject|4|||
155272841|NCT05569954|560431410|FG001|Overall Study|Withdrawal by Subject|2|||
155272842|NCT01518946|560431418|FG000|Open-label Phase|Other|4|||
154932548|NCT02162511|559179699|FG001|Overall Study|Lack of Efficacy|0|||
154932549|NCT02162511|559179700|FG002|Overall Study|Lack of Efficacy|2|||
155272843|NCT01518946|560431419|FG001|Open-label Phase|Other|0|||
155272844|NCT01518946|560431420|FG002|Open-label Phase|Other|0|||
155272845|NCT01518946|560431418|FG000|Randomized Phase (First Intervention)|Other|0|||
155272846|NCT01518946|560431419|FG001|Randomized Phase (First Intervention)|Other|1|||
155272847|NCT01518946|560431420|FG002|Randomized Phase (First Intervention)|Other|0|||
155272848|NCT03857841|560431421|FG000|Overall Study|Death|1|||
155272849|NCT03857841|560431422|FG001|Overall Study|Death|0|||
155272850|NCT03857841|560431423|FG002|Overall Study|Death|0|||
155272851|NCT03857841|560431424|FG003|Overall Study|Death|0|||
155272852|NCT03857841|560431421|FG000|Overall Study|Study Terminated by Sponsor|1|||
155272853|NCT03857841|560431422|FG001|Overall Study|Study Terminated by Sponsor|0|||
154932550|NCT02016755|559179704|FG000|Overall Study|Major amputation of index limb|2|||
154932551|NCT02016755|559179704|FG000|Overall Study|Adverse Event|2|||
154932552|NCT02016755|559179704|FG000|Overall Study|Physician Decision|1|||
154932553|NCT02016755|559179704|FG000|Overall Study|Death|2|||
154932554|NCT01084603|559179714|FG000|Baseline|Withdrawal by Subject|2|||
154932555|NCT01084603|559179714|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
154932556|NCT01084603|559179714|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
154932557|NCT01084603|559179714|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
154932558|NCT01084603|559179714|FG000|Washout Period 4|Adverse Event|1|||
154932559|NCT01392170|559179716|FG000|Overall Study|Withdrawal by Subject|1|||
154932560|NCT01392170|559179716|FG000|Overall Study|Ineligible|1|||
154932561|NCT02018042|559179728|FG000|Overall Study|Withdrawal by Subject|1|||
154932562|NCT02419469|559179729|FG000|Overall Study|Withdrawal by Subject|1|||
154932563|NCT01414062|559179730|FG000|Overall Study|Lost to Follow-up|3|||
154932564|NCT01414062|559179731|FG001|Overall Study|Lost to Follow-up|2|||
154932565|NCT01414062|559179730|FG000|Overall Study|Left Country|1|||
154932566|NCT01414062|559179731|FG001|Overall Study|Left Country|1|||
154932567|NCT01414062|559179730|FG000|Overall Study|Family Disapproval|1|||
154932568|NCT01414062|559179731|FG001|Overall Study|Family Disapproval|0|||
154932569|NCT01414062|559179730|FG000|Overall Study|Withdrawal by Subject|0|||
154932570|NCT01414062|559179731|FG001|Overall Study|Withdrawal by Subject|1|||
154932571|NCT04285983|559179732|FG000|Overall Study|Protocol Violation|6|||
154932572|NCT00902265|559179735|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
154932573|NCT00902265|559179735|FG000|Overall Study|Adverse Event|2|||
154932574|NCT00902265|559179735|FG000|Overall Study|Lack of Efficacy|2|||
154932575|NCT00902265|559179735|FG000|Overall Study|Protocol Violation|1|||
154932576|NCT02866695|559179736|FG000|Overall Study|Adverse Event|1|||
154932577|NCT02866695|559179736|FG000|Overall Study|Lost to Follow-up|1|||
154932578|NCT05016765|559179737|FG000|Overall Study|Lost to Follow-up|4|||
154932579|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
154932580|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
154932581|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
154932582|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
154932583|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
154932584|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
154932585|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
154932586|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
154932587|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
154932588|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
154932589|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
154932590|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
154932591|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
154932592|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
154932593|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
154932594|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
154932595|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
154932596|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
154932597|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
154932598|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
154932599|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
154932600|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
154932601|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
154932602|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
154932603|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
154932604|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
155043319|NCT03026283|559590103|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
154932605|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
154932606|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
154932607|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
155043320|NCT03026283|559590104|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
155043321|NCT03026283|559590105|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
155043322|NCT03026283|559590106|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
155043323|NCT03026283|559590107|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
155043324|NCT03026283|559590100|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
155043325|NCT03026283|559590101|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
155043326|NCT03026283|559590102|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
155043327|NCT03026283|559590103|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
154932608|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
154932609|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
154932610|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
155043328|NCT03026283|559590104|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
154932611|NCT03747939|559179738|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
154932612|NCT03747939|559179739|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
154932613|NCT03747939|559179740|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
154932614|NCT03747939|559179741|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
154932615|NCT03747939|559179738|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
154932616|NCT03747939|559179739|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
154932617|NCT03747939|559179740|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
154932618|NCT03747939|559179741|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
154932619|NCT03747939|559179738|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
154932620|NCT03747939|559179739|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
154932621|NCT03747939|559179740|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
154932622|NCT03747939|559179741|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
154932623|NCT03747939|559179738|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
154932624|NCT03747939|559179739|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
154932625|NCT03747939|559179740|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
154932626|NCT03747939|559179741|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
154932627|NCT03747939|559179738|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
154932628|NCT03747939|559179739|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
154932629|NCT03747939|559179740|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
154932630|NCT03747939|559179741|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
154932631|NCT03747939|559179738|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
154932632|NCT03747939|559179739|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
154932633|NCT03747939|559179740|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
154932634|NCT03747939|559179741|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
154932635|NCT01988493|559179742|FG000|Overall Study|Randomized but not treated|0|||
154932636|NCT01988493|559179743|FG001|Overall Study|Randomized but not treated|0|||
154932637|NCT01988493|559179744|FG002|Overall Study|Randomized but not treated|0|||
154932638|NCT01988493|559179745|FG003|Overall Study|Randomized but not treated|0|||
154932639|NCT01988493|559179746|FG004|Overall Study|Randomized but not treated|1|||
154932640|NCT03087773|559179747|FG000|Overall Study|Withdrawal by Subject|8|||
154932641|NCT03087773|559179748|FG001|Overall Study|Withdrawal by Subject|4|||
154932642|NCT03087773|559179747|FG000|Overall Study|Lost to Follow-up|12|||
154932643|NCT03087773|559179748|FG001|Overall Study|Lost to Follow-up|8|||
154932644|NCT03496207|559179751|FG000|Base Study|Adverse Event|0|||
154932645|NCT03496207|559179752|FG001|Base Study|Adverse Event|0|||
154932646|NCT03496207|559179753|FG002|Base Study|Adverse Event|1|||
154932647|NCT03496207|559179754|FG003|Base Study|Adverse Event|1|||
154932648|NCT03496207|559179755|FG004|Base Study|Adverse Event|4|||
154932649|NCT03496207|559179751|FG000|Base Study|Death|0|||
154932650|NCT03496207|559179752|FG001|Base Study|Death|0|||
154932651|NCT03496207|559179753|FG002|Base Study|Death|0|||
154932652|NCT03496207|559179754|FG003|Base Study|Death|0|||
154932653|NCT03496207|559179755|FG004|Base Study|Death|1|||
154932654|NCT03496207|559179751|FG000|Base Study|Withdrawal by Subject|0|||
154932655|NCT03496207|559179752|FG001|Base Study|Withdrawal by Subject|0|||
154932656|NCT03496207|559179753|FG002|Base Study|Withdrawal by Subject|1|||
154932657|NCT03496207|559179754|FG003|Base Study|Withdrawal by Subject|0|||
154932658|NCT03496207|559179755|FG004|Base Study|Withdrawal by Subject|1|||
154932659|NCT03496207|559179751|FG000|Extension Period|Adverse Event|0|||
154932660|NCT03496207|559179752|FG001|Extension Period|Adverse Event|0|||
154932661|NCT03496207|559179753|FG002|Extension Period|Adverse Event|0|||
154932662|NCT03496207|559179754|FG003|Extension Period|Adverse Event|1|||
154932663|NCT03496207|559179755|FG004|Extension Period|Adverse Event|1|||
154932664|NCT03496207|559179751|FG000|Extension Period|Death|1|||
154932665|NCT03496207|559179752|FG001|Extension Period|Death|0|||
154932666|NCT03496207|559179753|FG002|Extension Period|Death|0|||
154932667|NCT03496207|559179754|FG003|Extension Period|Death|1|||
154932668|NCT03496207|559179755|FG004|Extension Period|Death|2|||
154932669|NCT03496207|559179751|FG000|Extension Period|Withdrawal by Subject|1|||
154932670|NCT03496207|559179752|FG001|Extension Period|Withdrawal by Subject|0|||
154932671|NCT03496207|559179753|FG002|Extension Period|Withdrawal by Subject|0|||
154932672|NCT03496207|559179754|FG003|Extension Period|Withdrawal by Subject|1|||
154932673|NCT03496207|559179755|FG004|Extension Period|Withdrawal by Subject|1|||
154932674|NCT03496207|559179751|FG000|Extension Period|Elevated hemoglobin levels|0|||
154932675|NCT03496207|559179752|FG001|Extension Period|Elevated hemoglobin levels|0|||
154932676|NCT03496207|559179753|FG002|Extension Period|Elevated hemoglobin levels|0|||
154932677|NCT03496207|559179754|FG003|Extension Period|Elevated hemoglobin levels|0|||
154932678|NCT03496207|559179755|FG004|Extension Period|Elevated hemoglobin levels|1|||
155043329|NCT03026283|559590105|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
155272854|NCT03857841|560431423|FG002|Overall Study|Study Terminated by Sponsor|0|||
154932679|NCT01783483|559179757|FG000|Overall Study|Death|3|||
154932680|NCT01783483|559179758|FG001|Overall Study|Death|3|||
154932681|NCT01783483|559179757|FG000|Overall Study|Lost to Follow-up|14|||
154932682|NCT01783483|559179758|FG001|Overall Study|Lost to Follow-up|10|||
154932683|NCT01783483|559179757|FG000|Overall Study|Withdrawal by Subject|2|||
154932684|NCT01783483|559179758|FG001|Overall Study|Withdrawal by Subject|1|||
154932685|NCT01783483|559179757|FG000|Overall Study|Physician Decision|1|||
154932686|NCT01783483|559179758|FG001|Overall Study|Physician Decision|1|||
154932687|NCT01591499|559179759|FG000|Baseline Visit|Withdrawal by Subject|0|||
154932688|NCT01591499|559179760|FG001|Baseline Visit|Withdrawal by Subject|2|||
154932689|NCT01591499|559179761|FG002|Baseline Visit|Withdrawal by Subject|0|||
154932690|NCT01591499|559179762|FG003|Baseline Visit|Withdrawal by Subject|2|||
154932691|NCT01591499|559179759|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
154932692|NCT01591499|559179760|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
154932693|NCT01591499|559179761|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
154932694|NCT01591499|559179762|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
154932695|NCT01591499|559179759|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
154932696|NCT01591499|559179760|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
154932697|NCT01591499|559179761|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
154932698|NCT01591499|559179762|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
154932699|NCT00530088|559179763|FG000|Overall Study|Disease Progression|4|||
154932700|NCT00530088|559179763|FG000|Overall Study|Physician Decision|4|||
154932701|NCT00530088|559179763|FG000|Overall Study|Other Not Specified|2|||
154932702|NCT00902278|559179764|FG000|Overall Study|Physician Decision|1|||
154932703|NCT00902278|559179765|FG001|Overall Study|Physician Decision|0|||
154932704|NCT00902278|559179766|FG002|Overall Study|Physician Decision|2|||
154932705|NCT00902278|559179767|FG003|Overall Study|Physician Decision|0|||
154932706|NCT00902278|559179768|FG004|Overall Study|Physician Decision|1|||
154932707|NCT00902278|559179764|FG000|Overall Study|Lost to Follow-up|3|||
154932708|NCT00902278|559179765|FG001|Overall Study|Lost to Follow-up|2|||
154932709|NCT00902278|559179766|FG002|Overall Study|Lost to Follow-up|3|||
154932710|NCT00902278|559179767|FG003|Overall Study|Lost to Follow-up|0|||
154932711|NCT00902278|559179768|FG004|Overall Study|Lost to Follow-up|1|||
154932712|NCT02058368|559179771|FG000|Overall Study|Adverse Event|15|||
154932713|NCT02058368|559179772|FG001|Overall Study|Adverse Event|20|||
154932714|NCT02058368|559179771|FG000|Overall Study|Lack of Efficacy|0|||
154932715|NCT02058368|559179772|FG001|Overall Study|Lack of Efficacy|1|||
154932716|NCT02058368|559179771|FG000|Overall Study|Protocol Violation|0|||
154932717|NCT02058368|559179772|FG001|Overall Study|Protocol Violation|4|||
154932718|NCT02058368|559179771|FG000|Overall Study|Lost to Follow-up|2|||
154932719|NCT02058368|559179772|FG001|Overall Study|Lost to Follow-up|0|||
154932720|NCT02058368|559179771|FG000|Overall Study|Physician Decision|2|||
154932721|NCT02058368|559179772|FG001|Overall Study|Physician Decision|3|||
154932722|NCT02058368|559179771|FG000|Overall Study|Withdrawal by Subject|22|||
154932723|NCT02058368|559179772|FG001|Overall Study|Withdrawal by Subject|26|||
154932724|NCT01289990|559179773|FG000|Overall Study|Death|0|||
154932725|NCT01289990|559179774|FG001|Overall Study|Death|0|||
154932726|NCT01289990|559179775|FG002|Overall Study|Death|0|||
154932727|NCT01289990|559179776|FG003|Overall Study|Death|1|||
154932728|NCT01289990|559179777|FG004|Overall Study|Death|2|||
154932729|NCT01289990|559179778|FG005|Overall Study|Death|1|||
154932730|NCT01289990|559179779|FG006|Overall Study|Death|0|||
154932731|NCT01289990|559179780|FG007|Overall Study|Death|0|||
154932732|NCT01289990|559179781|FG008|Overall Study|Death|0|||
154932733|NCT01289990|559179782|FG009|Overall Study|Death|0|||
154932734|NCT01289990|559179783|FG010|Overall Study|Death|0|||
154932735|NCT01289990|559179784|FG011|Overall Study|Death|1|||
154932736|NCT01289990|559179785|FG012|Overall Study|Death|0|||
154932737|NCT01289990|559179773|FG000|Overall Study|Lost to Follow-up|3|||
154932738|NCT01289990|559179774|FG001|Overall Study|Lost to Follow-up|2|||
154932739|NCT01289990|559179775|FG002|Overall Study|Lost to Follow-up|5|||
154932740|NCT01289990|559179776|FG003|Overall Study|Lost to Follow-up|5|||
154932741|NCT01289990|559179777|FG004|Overall Study|Lost to Follow-up|3|||
154932742|NCT01289990|559179778|FG005|Overall Study|Lost to Follow-up|4|||
154932743|NCT01289990|559179779|FG006|Overall Study|Lost to Follow-up|2|||
154932744|NCT01289990|559179780|FG007|Overall Study|Lost to Follow-up|2|||
154932745|NCT01289990|559179781|FG008|Overall Study|Lost to Follow-up|1|||
154932746|NCT01289990|559179782|FG009|Overall Study|Lost to Follow-up|4|||
155272855|NCT03857841|560431424|FG003|Overall Study|Study Terminated by Sponsor|0|||
154932747|NCT01289990|559179783|FG010|Overall Study|Lost to Follow-up|2|||
154932748|NCT01289990|559179784|FG011|Overall Study|Lost to Follow-up|1|||
155272856|NCT01625910|560432827|FG000|Overall Study|Lost to Follow-up|3|||
154932749|NCT01289990|559179785|FG012|Overall Study|Lost to Follow-up|2|||
155272857|NCT01625910|560432828|FG001|Overall Study|Lost to Follow-up|4|||
155272858|NCT02391038|560432829|FG000|Overall Study|Progressive disease|3|||
154932750|NCT01289990|559179773|FG000|Overall Study|Withdrawal by Subject|15|||
154932751|NCT01289990|559179774|FG001|Overall Study|Withdrawal by Subject|14|||
154932752|NCT01289990|559179775|FG002|Overall Study|Withdrawal by Subject|12|||
154932753|NCT01289990|559179776|FG003|Overall Study|Withdrawal by Subject|13|||
154932754|NCT01289990|559179777|FG004|Overall Study|Withdrawal by Subject|8|||
154932755|NCT01289990|559179778|FG005|Overall Study|Withdrawal by Subject|7|||
154932756|NCT01289990|559179779|FG006|Overall Study|Withdrawal by Subject|13|||
154932757|NCT01289990|559179780|FG007|Overall Study|Withdrawal by Subject|9|||
154932758|NCT01289990|559179781|FG008|Overall Study|Withdrawal by Subject|12|||
154932759|NCT01289990|559179782|FG009|Overall Study|Withdrawal by Subject|13|||
154932760|NCT01289990|559179783|FG010|Overall Study|Withdrawal by Subject|11|||
154932761|NCT01289990|559179784|FG011|Overall Study|Withdrawal by Subject|13|||
154932762|NCT01289990|559179785|FG012|Overall Study|Withdrawal by Subject|16|||
154932763|NCT01289990|559179773|FG000|Overall Study|discontinued in preceding trial|18|||
154932764|NCT01289990|559179774|FG001|Overall Study|discontinued in preceding trial|20|||
154932765|NCT01289990|559179775|FG002|Overall Study|discontinued in preceding trial|41|||
154932766|NCT01289990|559179776|FG003|Overall Study|discontinued in preceding trial|17|||
154932767|NCT01289990|559179777|FG004|Overall Study|discontinued in preceding trial|11|||
154932768|NCT01289990|559179778|FG005|Overall Study|discontinued in preceding trial|12|||
154932769|NCT01289990|559179779|FG006|Overall Study|discontinued in preceding trial|18|||
154932770|NCT01289990|559179780|FG007|Overall Study|discontinued in preceding trial|8|||
154932771|NCT01289990|559179781|FG008|Overall Study|discontinued in preceding trial|17|||
154932772|NCT01289990|559179782|FG009|Overall Study|discontinued in preceding trial|21|||
154932773|NCT01289990|559179783|FG010|Overall Study|discontinued in preceding trial|17|||
154932774|NCT01289990|559179784|FG011|Overall Study|discontinued in preceding trial|17|||
154932775|NCT01289990|559179785|FG012|Overall Study|discontinued in preceding trial|24|||
154932776|NCT01289990|559179773|FG000|Overall Study|did not continue in extension|41|||
154932777|NCT01289990|559179774|FG001|Overall Study|did not continue in extension|45|||
154932778|NCT01289990|559179775|FG002|Overall Study|did not continue in extension|51|||
154932779|NCT01289990|559179776|FG003|Overall Study|did not continue in extension|51|||
154932780|NCT01289990|559179777|FG004|Overall Study|did not continue in extension|48|||
154932781|NCT01289990|559179778|FG005|Overall Study|did not continue in extension|50|||
154932782|NCT01289990|559179779|FG006|Overall Study|did not continue in extension|54|||
154932783|NCT01289990|559179780|FG007|Overall Study|did not continue in extension|36|||
154932784|NCT01289990|559179781|FG008|Overall Study|did not continue in extension|44|||
154932785|NCT01289990|559179782|FG009|Overall Study|did not continue in extension|48|||
154932786|NCT01289990|559179783|FG010|Overall Study|did not continue in extension|45|||
154932787|NCT01289990|559179784|FG011|Overall Study|did not continue in extension|34|||
154932788|NCT01289990|559179785|FG012|Overall Study|did not continue in extension|56|||
154932789|NCT01289990|559179773|FG000|Overall Study|Not treated|0|||
154932790|NCT01289990|559179774|FG001|Overall Study|Not treated|0|||
154932791|NCT01289990|559179775|FG002|Overall Study|Not treated|0|||
154932792|NCT01289990|559179776|FG003|Overall Study|Not treated|0|||
154932793|NCT01289990|559179777|FG004|Overall Study|Not treated|0|||
154932794|NCT01289990|559179778|FG005|Overall Study|Not treated|0|||
154932795|NCT01289990|559179779|FG006|Overall Study|Not treated|1|||
154932796|NCT01289990|559179780|FG007|Overall Study|Not treated|0|||
154932797|NCT01289990|559179781|FG008|Overall Study|Not treated|1|||
154932798|NCT01289990|559179782|FG009|Overall Study|Not treated|0|||
154932799|NCT01289990|559179783|FG010|Overall Study|Not treated|1|||
154932800|NCT01289990|559179784|FG011|Overall Study|Not treated|2|||
154932801|NCT01289990|559179785|FG012|Overall Study|Not treated|0|||
154932802|NCT02441179|559179786|FG000|Overall Study|Withdrawal by Subject|1|||
154932803|NCT02441179|559179787|FG001|Overall Study|Withdrawal by Subject|1|||
154932804|NCT03454672|559179789|FG000|Overall Study|Adverse Event|1|||
154932805|NCT03454672|559179790|FG001|Overall Study|Adverse Event|1|||
154932806|NCT03454672|559179789|FG000|Overall Study|Lost to Follow-up|1|||
154932807|NCT03454672|559179790|FG001|Overall Study|Lost to Follow-up|3|||
154932808|NCT03454672|559179789|FG000|Overall Study|painful|1|||
154932809|NCT03454672|559179790|FG001|Overall Study|painful|2|||
154932810|NCT03454672|559179789|FG000|Overall Study|Non-compliance|2|||
154932811|NCT03454672|559179790|FG001|Overall Study|Non-compliance|4|||
154932812|NCT03454672|559179789|FG000|Overall Study|personal reasons|3|||
154932813|NCT03454672|559179790|FG001|Overall Study|personal reasons|2|||
154932814|NCT03454672|559179789|FG000|Overall Study|Withdrawal by Subject|1|||
154932815|NCT03454672|559179790|FG001|Overall Study|Withdrawal by Subject|0|||
154932816|NCT01488071|559179791|FG000|Overall Study|Adverse Event|15|||
154932817|NCT01488071|559179792|FG001|Overall Study|Adverse Event|23|||
154932818|NCT01488071|559179791|FG000|Overall Study|Lack of Efficacy|11|||
154932819|NCT01488071|559179792|FG001|Overall Study|Lack of Efficacy|17|||
154932820|NCT01488071|559179791|FG000|Overall Study|Non-compliance with study drug|2|||
154932821|NCT01488071|559179792|FG001|Overall Study|Non-compliance with study drug|0|||
154932822|NCT01488071|559179791|FG000|Overall Study|Protocol Violation|5|||
154932823|NCT01488071|559179792|FG001|Overall Study|Protocol Violation|7|||
154932824|NCT01488071|559179791|FG000|Overall Study|Withdrawal of Consent|14|||
154932825|NCT01488071|559179792|FG001|Overall Study|Withdrawal of Consent|12|||
154932826|NCT01488071|559179791|FG000|Overall Study|Lost to Follow-up|1|||
154932827|NCT01488071|559179792|FG001|Overall Study|Lost to Follow-up|0|||
154932828|NCT01488071|559179791|FG000|Overall Study|Administrative or Other Reason(s)|5|||
154932829|NCT01488071|559179792|FG001|Overall Study|Administrative or Other Reason(s)|4|||
154932830|NCT02139306|559179793|FG000|Overall Study|Withdrawal by Subject|4|||
154932831|NCT02139306|559179794|FG001|Overall Study|Withdrawal by Subject|6|||
154932832|NCT02139306|559179793|FG000|Overall Study|Adverse Event|3|||
154932833|NCT02139306|559179794|FG001|Overall Study|Adverse Event|4|||
154932834|NCT02139306|559179793|FG000|Overall Study|Physician Decision|0|||
154932835|NCT02139306|559179794|FG001|Overall Study|Physician Decision|1|||
154932836|NCT02139306|559179793|FG000|Overall Study|Other Unspecified|2|||
154932837|NCT02139306|559179794|FG001|Overall Study|Other Unspecified|3|||
154932838|NCT02139306|559179793|FG000|Overall Study|Protocol Violation|4|||
154932839|NCT02139306|559179794|FG001|Overall Study|Protocol Violation|0|||
154932840|NCT04449354|559179795|FG000|Overall Study|Withdrawal by Subject|1|||
154932841|NCT05899218|559179796|FG000|Overall Study|Lost to Follow-up|2|||
154932842|NCT05899218|559179797|FG001|Overall Study|Lost to Follow-up|2|||
154932843|NCT05899218|559179796|FG000|Overall Study|deemed ineligible out of country|1|||
154932844|NCT05899218|559179797|FG001|Overall Study|deemed ineligible out of country|0|||
154932845|NCT01220128|559179798|FG000|Overall Study|Progressive disease|0|||
154932846|NCT01220128|559179799|FG001|Overall Study|Progressive disease|0|||
154932847|NCT01220128|559179800|FG002|Overall Study|Progressive disease|2|||
154932848|NCT01220128|559179801|FG003|Overall Study|Progressive disease|0|||
154932849|NCT01220128|559179802|FG004|Overall Study|Progressive disease|0|||
154932850|NCT01220128|559179803|FG005|Overall Study|Progressive disease|0|||
154932851|NCT01220128|559179804|FG006|Overall Study|Progressive disease|0|||
154932852|NCT01220128|559179798|FG000|Overall Study|Sponsor study termination|0|||
154932853|NCT01220128|559179799|FG001|Overall Study|Sponsor study termination|1|||
154932854|NCT01220128|559179800|FG002|Overall Study|Sponsor study termination|0|||
154932855|NCT01220128|559179801|FG003|Overall Study|Sponsor study termination|0|||
154932856|NCT01220128|559179802|FG004|Overall Study|Sponsor study termination|0|||
154932857|NCT01220128|559179803|FG005|Overall Study|Sponsor study termination|0|||
154932858|NCT01220128|559179804|FG006|Overall Study|Sponsor study termination|1|||
154932859|NCT01220128|559179798|FG000|Overall Study|Adverse event, serious fatal|2|||
154932860|NCT01220128|559179799|FG001|Overall Study|Adverse event, serious fatal|0|||
154932861|NCT01220128|559179800|FG002|Overall Study|Adverse event, serious fatal|0|||
154932862|NCT01220128|559179801|FG003|Overall Study|Adverse event, serious fatal|0|||
154932863|NCT01220128|559179802|FG004|Overall Study|Adverse event, serious fatal|0|||
154932864|NCT01220128|559179803|FG005|Overall Study|Adverse event, serious fatal|0|||
154932865|NCT01220128|559179804|FG006|Overall Study|Adverse event, serious fatal|1|||
154932866|NCT01220128|559179798|FG000|Overall Study|Adverse event, non-fatal|1|||
154932867|NCT01220128|559179799|FG001|Overall Study|Adverse event, non-fatal|0|||
154932868|NCT01220128|559179800|FG002|Overall Study|Adverse event, non-fatal|0|||
154932869|NCT01220128|559179801|FG003|Overall Study|Adverse event, non-fatal|0|||
154932870|NCT01220128|559179802|FG004|Overall Study|Adverse event, non-fatal|0|||
154932871|NCT01220128|559179803|FG005|Overall Study|Adverse event, non-fatal|0|||
154932872|NCT01220128|559179804|FG006|Overall Study|Adverse event, non-fatal|3|||
154932873|NCT01220128|559179798|FG000|Overall Study|Other|0|||
154932874|NCT01220128|559179799|FG001|Overall Study|Other|0|||
154932875|NCT01220128|559179800|FG002|Overall Study|Other|1|||
154932876|NCT01220128|559179801|FG003|Overall Study|Other|0|||
154932877|NCT01220128|559179802|FG004|Overall Study|Other|0|||
154932878|NCT01220128|559179803|FG005|Overall Study|Other|0|||
154932879|NCT01220128|559179804|FG006|Overall Study|Other|0|||
154932880|NCT01220128|559179798|FG000|Overall Study|Consent withdrawn by subject|1|||
154932881|NCT01220128|559179799|FG001|Overall Study|Consent withdrawn by subject|0|||
154932882|NCT01220128|559179800|FG002|Overall Study|Consent withdrawn by subject|0|||
154932883|NCT01220128|559179801|FG003|Overall Study|Consent withdrawn by subject|0|||
154932884|NCT01220128|559179802|FG004|Overall Study|Consent withdrawn by subject|0|||
154932885|NCT01220128|559179803|FG005|Overall Study|Consent withdrawn by subject|0|||
154932886|NCT01220128|559179804|FG006|Overall Study|Consent withdrawn by subject|0|||
154932887|NCT02508649|559179830|FG000|Overall Study|Withdrawal by Subject|4|||
154932888|NCT02508649|559179831|FG001|Overall Study|Withdrawal by Subject|6|||
154932889|NCT02508649|559179832|FG002|Overall Study|Withdrawal by Subject|5|||
154932890|NCT02508649|559179833|FG003|Overall Study|Withdrawal by Subject|6|||
154932891|NCT02508649|559179830|FG000|Overall Study|Investigator withdrew the subject|1|||
154932892|NCT02508649|559179831|FG001|Overall Study|Investigator withdrew the subject|2|||
154932893|NCT02508649|559179832|FG002|Overall Study|Investigator withdrew the subject|1|||
154932894|NCT02508649|559179833|FG003|Overall Study|Investigator withdrew the subject|0|||
154932895|NCT02508649|559179830|FG000|Overall Study|Post randomization screening failure|12|||
154932896|NCT02508649|559179831|FG001|Overall Study|Post randomization screening failure|4|||
154932897|NCT02508649|559179832|FG002|Overall Study|Post randomization screening failure|9|||
154932898|NCT02508649|559179833|FG003|Overall Study|Post randomization screening failure|3|||
154932899|NCT02508649|559179830|FG000|Overall Study|Lost to Follow-up|1|||
154932900|NCT02508649|559179831|FG001|Overall Study|Lost to Follow-up|1|||
154932901|NCT02508649|559179832|FG002|Overall Study|Lost to Follow-up|0|||
154932902|NCT02508649|559179833|FG003|Overall Study|Lost to Follow-up|1|||
154932903|NCT01311505|559179834|FG000|First Intervention Period|Protocol Violation|0|||
154932904|NCT01311505|559179835|FG001|First Intervention Period|Protocol Violation|1|||
154932905|NCT00567996|559179842|FG000|Overall Study|Adverse Event|18|||
154932906|NCT00567996|559179843|FG001|Overall Study|Adverse Event|16|||
154932907|NCT00567996|559179844|FG002|Overall Study|Adverse Event|13|||
154932908|NCT00567996|559179842|FG000|Overall Study|Protocol Deviation|9|||
154932909|NCT00567996|559179843|FG001|Overall Study|Protocol Deviation|11|||
154932910|NCT00567996|559179844|FG002|Overall Study|Protocol Deviation|13|||
154932911|NCT00567996|559179842|FG000|Overall Study|Withdrawal by Subject|8|||
154932912|NCT00567996|559179843|FG001|Overall Study|Withdrawal by Subject|12|||
154932913|NCT00567996|559179844|FG002|Overall Study|Withdrawal by Subject|22|||
154932914|NCT00567996|559179842|FG000|Overall Study|Abnormal Lab value(s)|2|||
154932915|NCT00567996|559179843|FG001|Overall Study|Abnormal Lab value(s)|1|||
154932916|NCT00567996|559179844|FG002|Overall Study|Abnormal Lab value(s)|2|||
154932917|NCT00567996|559179842|FG000|Overall Study|Abnormal test procedure result(s)|2|||
154932918|NCT00567996|559179843|FG001|Overall Study|Abnormal test procedure result(s)|1|||
154932919|NCT00567996|559179844|FG002|Overall Study|Abnormal test procedure result(s)|1|||
154932920|NCT00567996|559179842|FG000|Overall Study|Lost to Follow-up|2|||
154932921|NCT00567996|559179843|FG001|Overall Study|Lost to Follow-up|5|||
154932922|NCT00567996|559179844|FG002|Overall Study|Lost to Follow-up|2|||
154932923|NCT00567996|559179842|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154932924|NCT00567996|559179843|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
154932925|NCT00567996|559179844|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
154932926|NCT00567996|559179842|FG000|Overall Study|Administrative problems|1|||
154932927|NCT00567996|559179843|FG001|Overall Study|Administrative problems|1|||
154932928|NCT00567996|559179844|FG002|Overall Study|Administrative problems|0|||
154932929|NCT00567996|559179842|FG000|Overall Study|Death|1|||
154932930|NCT00567996|559179843|FG001|Overall Study|Death|0|||
154932931|NCT00567996|559179844|FG002|Overall Study|Death|2|||
154932932|NCT00567996|559179842|FG000|Overall Study|Patient's inability to use the device|0|||
154932933|NCT00567996|559179843|FG001|Overall Study|Patient's inability to use the device|1|||
154932934|NCT00567996|559179844|FG002|Overall Study|Patient's inability to use the device|0|||
154932935|NCT02149199|559179845|FG000|Overall Study|Study specific withdrawal criteria|4|||
154932936|NCT02149199|559179846|FG001|Overall Study|Study specific withdrawal criteria|21|||
154932937|NCT02149199|559179847|FG002|Overall Study|Study specific withdrawal criteria|6|||
154932938|NCT02149199|559179845|FG000|Overall Study|Other|20|||
154932939|NCT02149199|559179846|FG001|Overall Study|Other|25|||
154932940|NCT02149199|559179847|FG002|Overall Study|Other|20|||
154932941|NCT02149199|559179845|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
154932942|NCT02149199|559179846|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
154932943|NCT02149199|559179847|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
154932944|NCT02149199|559179845|FG000|Overall Study|Withdrawal by Subject|75|||
154932945|NCT02149199|559179846|FG001|Overall Study|Withdrawal by Subject|93|||
154932946|NCT02149199|559179847|FG002|Overall Study|Withdrawal by Subject|77|||
154932947|NCT02149199|559179845|FG000|Overall Study|Protocol Violation|16|||
154932948|NCT02149199|559179846|FG001|Overall Study|Protocol Violation|13|||
154932949|NCT02149199|559179847|FG002|Overall Study|Protocol Violation|15|||
154932950|NCT02149199|559179845|FG000|Overall Study|Lost to Follow-up|3|||
154932951|NCT02149199|559179846|FG001|Overall Study|Lost to Follow-up|12|||
154932952|NCT02149199|559179847|FG002|Overall Study|Lost to Follow-up|11|||
154932953|NCT02149199|559179845|FG000|Overall Study|Death|0|||
154932954|NCT02149199|559179846|FG001|Overall Study|Death|0|||
154932955|NCT02149199|559179847|FG002|Overall Study|Death|1|||
154932956|NCT02149199|559179845|FG000|Overall Study|Adverse Event|6|||
154932957|NCT02149199|559179846|FG001|Overall Study|Adverse Event|15|||
154932958|NCT02149199|559179847|FG002|Overall Study|Adverse Event|9|||
154932959|NCT02956005|559179848|FG000|Overall Study|Not eligible|1|||
154932960|NCT02956005|559179848|FG000|Overall Study|Withdrawal by Subject|3|||
154932961|NCT02956005|559179848|FG000|Overall Study|Physician Decision|12|||
154932962|NCT02524665|559179853|FG000|Overall Study|Lost to Follow-up|1|||
154932963|NCT01066039|559179856|FG000|Overall Study|Adverse Event|6|||
154932964|NCT01066039|559179856|FG000|Overall Study|Withdrawal by Subject|17|||
154932965|NCT01066039|559179856|FG000|Overall Study|Protocol Violation|2|||
154932966|NCT01066039|559179856|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
154932967|NCT01066039|559179856|FG000|Overall Study|Investigator's Request|1|||
154932968|NCT01066039|559179856|FG000|Overall Study|Dropout due to Insulin Administration|1|||
154932969|NCT01066039|559179856|FG000|Overall Study|Additional Antihypertensive Required|4|||
154932970|NCT01066039|559179856|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
154932971|NCT01066039|559179856|FG000|Overall Study|Failure to Control Blood Pressure|1|||
154932972|NCT01066039|559179856|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
154932973|NCT03022799|559179857|FG000|Overall Study|Adverse Event|0|||
154932974|NCT03022799|559179858|FG001|Overall Study|Adverse Event|0|||
154932975|NCT03022799|559179859|FG002|Overall Study|Adverse Event|0|||
154932976|NCT03022799|559179860|FG003|Overall Study|Adverse Event|0|||
154932977|NCT03022799|559179861|FG004|Overall Study|Adverse Event|0|||
154932978|NCT03022799|559179862|FG005|Overall Study|Adverse Event|0|||
154932979|NCT03022799|559179863|FG006|Overall Study|Adverse Event|0|||
154932980|NCT03022799|559179864|FG007|Overall Study|Adverse Event|0|||
155272859|NCT02391038|560432830|FG001|Overall Study|Progressive disease|3|||
154932981|NCT03022799|559179865|FG008|Overall Study|Adverse Event|0|||
154932982|NCT03022799|559179866|FG009|Overall Study|Adverse Event|1|||
154932983|NCT03022799|559179867|FG010|Overall Study|Adverse Event|1|||
154932984|NCT03022799|559179868|FG011|Overall Study|Adverse Event|0|||
154932985|NCT03022799|559179869|FG012|Overall Study|Adverse Event|0|||
154932986|NCT04881448|559179872|FG000|Overall Study|Study cancelled by sponsor|220|||
154932987|NCT04881448|559179872|FG000|Overall Study|Withdrawal by Subject|2|||
154932988|NCT04881448|559179872|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
154932989|NCT01898884|559179874|FG000|Multiple Dose Period|Adverse Event|0|||
154932990|NCT01898884|559179875|FG001|Multiple Dose Period|Adverse Event|0|||
154932991|NCT01898884|559179876|FG002|Multiple Dose Period|Adverse Event|0|||
154932992|NCT01898884|559179877|FG003|Multiple Dose Period|Adverse Event|0|||
154932993|NCT01898884|559179878|FG004|Multiple Dose Period|Adverse Event|0|||
154932994|NCT01898884|559179879|FG005|Multiple Dose Period|Adverse Event|0|||
154932995|NCT01898884|559179880|FG006|Multiple Dose Period|Adverse Event|1|||
154932996|NCT01898884|559179881|FG007|Multiple Dose Period|Adverse Event|0|||
154932997|NCT01898884|559179882|FG008|Multiple Dose Period|Adverse Event|0|||
154932998|NCT01898884|559179874|FG000|Multiple Dose Period|Randomized Not Treated|0|||
154932999|NCT01898884|559179875|FG001|Multiple Dose Period|Randomized Not Treated|0|||
154933000|NCT01898884|559179876|FG002|Multiple Dose Period|Randomized Not Treated|0|||
154933001|NCT01898884|559179877|FG003|Multiple Dose Period|Randomized Not Treated|0|||
154933002|NCT01898884|559179878|FG004|Multiple Dose Period|Randomized Not Treated|0|||
154933003|NCT01898884|559179879|FG005|Multiple Dose Period|Randomized Not Treated|0|||
154933004|NCT01898884|559179880|FG006|Multiple Dose Period|Randomized Not Treated|0|||
154933005|NCT01898884|559179881|FG007|Multiple Dose Period|Randomized Not Treated|0|||
154933006|NCT01898884|559179882|FG008|Multiple Dose Period|Randomized Not Treated|1|||
154933007|NCT01142466|559181849|FG000|Overall Study|Adverse Event|2|||
154933008|NCT01142466|559181850|FG001|Overall Study|Adverse Event|1|||
154933009|NCT01142466|559181849|FG000|Overall Study|Withdrawal by Subject|1|||
154933010|NCT01142466|559181850|FG001|Overall Study|Withdrawal by Subject|1|||
154933011|NCT00700310|559181855|FG000|Overall Study|Adverse Event|6|||
154933012|NCT00700310|559181856|FG001|Overall Study|Adverse Event|10|||
154933013|NCT00700310|559181857|FG002|Overall Study|Adverse Event|5|||
154933014|NCT00700310|559181858|FG003|Overall Study|Adverse Event|11|||
154933015|NCT00700310|559181855|FG000|Overall Study|Lost to Follow-up|4|||
154933016|NCT00700310|559181856|FG001|Overall Study|Lost to Follow-up|1|||
154933017|NCT00700310|559181857|FG002|Overall Study|Lost to Follow-up|0|||
154933018|NCT00700310|559181858|FG003|Overall Study|Lost to Follow-up|1|||
154933019|NCT00700310|559181855|FG000|Overall Study|Withdrawal by Subject|8|||
154933020|NCT00700310|559181856|FG001|Overall Study|Withdrawal by Subject|9|||
154933021|NCT00700310|559181857|FG002|Overall Study|Withdrawal by Subject|8|||
154933022|NCT00700310|559181858|FG003|Overall Study|Withdrawal by Subject|8|||
154933023|NCT00700310|559181855|FG000|Overall Study|Lack of Efficacy|0|||
154933024|NCT00700310|559181856|FG001|Overall Study|Lack of Efficacy|3|||
154933025|NCT00700310|559181857|FG002|Overall Study|Lack of Efficacy|0|||
154933026|NCT00700310|559181858|FG003|Overall Study|Lack of Efficacy|1|||
154933027|NCT00700310|559181855|FG000|Overall Study|Administrative/Other|1|||
154933028|NCT00700310|559181856|FG001|Overall Study|Administrative/Other|3|||
154933029|NCT00700310|559181857|FG002|Overall Study|Administrative/Other|1|||
154933030|NCT00700310|559181858|FG003|Overall Study|Administrative/Other|3|||
154933031|NCT00700310|559181855|FG000|Overall Study|Randomized, Not Treated|2|||
154933032|NCT00700310|559181856|FG001|Overall Study|Randomized, Not Treated|0|||
154933033|NCT00700310|559181857|FG002|Overall Study|Randomized, Not Treated|2|||
154933034|NCT00700310|559181858|FG003|Overall Study|Randomized, Not Treated|2|||
154933035|NCT02414854|559181859|FG000|Overall Study|Adverse Event|9|||
154933036|NCT02414854|559181860|FG001|Overall Study|Adverse Event|7|||
154933037|NCT02414854|559181861|FG002|Overall Study|Adverse Event|1|||
154933038|NCT02414854|559181862|FG003|Overall Study|Adverse Event|12|||
155272860|NCT02391038|560432831|FG002|Overall Study|Progressive disease|6|||
155272861|NCT02959138|560432832|FG000|Overall Study|Enrolled but Never Treated|0|||
155272862|NCT02959138|560432833|FG001|Overall Study|Enrolled but Never Treated|1|||
155272863|NCT02959138|560432834|FG002|Overall Study|Enrolled but Never Treated|0|||
155272864|NCT01327547|560432840|FG000|Overall Study|Adverse Event|4|||
155272865|NCT01327547|560432841|FG001|Overall Study|Adverse Event|1|||
155272866|NCT01327547|560432840|FG000|Overall Study|Death|1|||
155272867|NCT01327547|560432841|FG001|Overall Study|Death|2|||
155272868|NCT01327547|560432840|FG000|Overall Study|Lost to Follow-up|6|||
155272869|NCT01327547|560432841|FG001|Overall Study|Lost to Follow-up|6|||
155272870|NCT01327547|560432840|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
155272871|NCT01327547|560432841|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
154933039|NCT02414854|559181859|FG000|Overall Study|Poor compliance to protocol|1|||
155272872|NCT01327547|560432840|FG000|Overall Study|Withdrawal by Subject|3|||
155272873|NCT01327547|560432841|FG001|Overall Study|Withdrawal by Subject|7|||
155381925|NCT01200589|560833240|FG001|Overall Study|Withdrawal by Subject|11|||
154933040|NCT02414854|559181860|FG001|Overall Study|Poor compliance to protocol|1|||
154933041|NCT02414854|559181861|FG002|Overall Study|Poor compliance to protocol|2|||
154933042|NCT02414854|559181862|FG003|Overall Study|Poor compliance to protocol|2|||
154933043|NCT02414854|559181859|FG000|Overall Study|Other than specified above|12|||
154933044|NCT02414854|559181860|FG001|Overall Study|Other than specified above|37|||
155381926|NCT01200589|560833239|FG000|Overall Study|Physician Decision|2|||
154933045|NCT02414854|559181861|FG002|Overall Study|Other than specified above|17|||
155272874|NCT01327547|560432840|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
155272875|NCT01327547|560432841|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
154933046|NCT02414854|559181862|FG003|Overall Study|Other than specified above|37|||
154933047|NCT01355523|559181863|FG000|Overall Study|Withdrawal by Subject|1|||
154933048|NCT01355523|559181864|FG001|Overall Study|Withdrawal by Subject|4|||
154933049|NCT01355523|559181863|FG000|Overall Study|Lost to Follow-up|0|||
154933050|NCT01355523|559181864|FG001|Overall Study|Lost to Follow-up|2|||
154933051|NCT01355523|559181863|FG000|Overall Study|Protocol Violation|0|||
154933052|NCT01355523|559181864|FG001|Overall Study|Protocol Violation|2|||
154933053|NCT01355523|559181863|FG000|Overall Study|Adverse Event|0|||
154933054|NCT01355523|559181864|FG001|Overall Study|Adverse Event|2|||
154933055|NCT01422720|559181865|FG000|Overall Study|Adverse Event|16|||
154933056|NCT01422720|559181865|FG000|Overall Study|Lack of Efficacy|1|||
154933057|NCT01422720|559181865|FG000|Overall Study|Withdrawal by Subject|4|||
154933058|NCT01422720|559181865|FG000|Overall Study|Ineligibility|1|||
154933059|NCT00606801|559181866|FG000|Intervention|Protocol Violation|3|||
154933060|NCT00606801|559181867|FG001|Intervention|Protocol Violation|3|||
154933061|NCT02082262|559181868|FG000|Overall Study|Withdrawal by Subject|3|||
154933062|NCT02082262|559181868|FG000|Overall Study|Adverse Event|48|||
154933063|NCT00303316|559181869|FG000|Overall Study|Protocol Violation|1|||
154933064|NCT00303316|559181870|FG001|Overall Study|Protocol Violation|0|||
154933065|NCT00303316|559181869|FG000|Overall Study|Lost to Follow-up|0|||
154933066|NCT00303316|559181870|FG001|Overall Study|Lost to Follow-up|1|||
154933067|NCT00303316|559181869|FG000|Overall Study|Withdrawal by Subject|1|||
154933068|NCT00303316|559181870|FG001|Overall Study|Withdrawal by Subject|2|||
154933069|NCT01074307|559181872|FG000|Overall Study|No primary endpoint evaluation|14|||
154933070|NCT01074307|559181873|FG001|Overall Study|No primary endpoint evaluation|6|||
154933071|NCT01074307|559181872|FG000|Overall Study|Exclusion criterion|0|||
155043330|NCT03026283|559590106|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
155043331|NCT03026283|559590107|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
155043332|NCT03026283|559590100|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043333|NCT03026283|559590101|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
155043334|NCT03026283|559590102|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043335|NCT03026283|559590103|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043336|NCT03026283|559590104|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043337|NCT03026283|559590105|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043338|NCT03026283|559590106|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043339|NCT03026283|559590107|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
155043340|NCT03026283|559590100|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155043341|NCT03026283|559590101|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
154933072|NCT01074307|559181873|FG001|Overall Study|Exclusion criterion|1|||
154933073|NCT01074307|559181872|FG000|Overall Study|Protocol Violation|8|||
154933074|NCT01074307|559181873|FG001|Overall Study|Protocol Violation|5|||
154933075|NCT02703454|559181875|FG000|Overall Study|Not treated|1|||
154933076|NCT02703454|559181876|FG001|Overall Study|Not treated|3|||
154933077|NCT02703454|559181875|FG000|Overall Study|Withdrawal by Subject|4|||
154933078|NCT02703454|559181876|FG001|Overall Study|Withdrawal by Subject|3|||
154933079|NCT02703454|559181875|FG000|Overall Study|Lost to Follow-up|1|||
154933080|NCT02703454|559181876|FG001|Overall Study|Lost to Follow-up|2|||
154933081|NCT02703454|559181875|FG000|Overall Study|Study discontinuation|5|||
154933082|NCT02703454|559181876|FG001|Overall Study|Study discontinuation|8|||
154933083|NCT02284373|559181877|FG000|Overall Study|Withdrawal by Subject|0|||
154933084|NCT02284373|559181878|FG001|Overall Study|Withdrawal by Subject|1|||
154933085|NCT02284373|559181879|FG002|Overall Study|Withdrawal by Subject|0|||
154933086|NCT02284373|559181877|FG000|Overall Study|Other|0|||
154933087|NCT02284373|559181878|FG001|Overall Study|Other|1|||
154933088|NCT02284373|559181879|FG002|Overall Study|Other|0|||
154933089|NCT02284373|559181877|FG000|Overall Study|Lost to Follow-up|0|||
154933090|NCT02284373|559181878|FG001|Overall Study|Lost to Follow-up|1|||
154933091|NCT02284373|559181879|FG002|Overall Study|Lost to Follow-up|0|||
154933092|NCT00552617|559181881|FG000|Overall Study|Not Treated|0|||
154933093|NCT00552617|559181882|FG001|Overall Study|Not Treated|0|||
154933094|NCT00552617|559181883|FG002|Overall Study|Not Treated|1|||
154933095|NCT00552617|559181884|FG003|Overall Study|Not Treated|0|||
154933096|NCT00552617|559181885|FG004|Overall Study|Not Treated|0|||
154933097|NCT00552617|559181886|FG005|Overall Study|Not Treated|0|||
154933098|NCT00552617|559181887|FG006|Overall Study|Not Treated|0|||
154933099|NCT00552617|559181888|FG007|Overall Study|Not Treated|0|||
154933100|NCT00552617|559181889|FG008|Overall Study|Not Treated|0|||
154933101|NCT00552617|559181890|FG009|Overall Study|Not Treated|1|||
154933102|NCT00552617|559181881|FG000|Overall Study|Lost to Follow-up|0|||
154933103|NCT00552617|559181882|FG001|Overall Study|Lost to Follow-up|0|||
154933104|NCT00552617|559181883|FG002|Overall Study|Lost to Follow-up|0|||
154933105|NCT00552617|559181884|FG003|Overall Study|Lost to Follow-up|1|||
154933106|NCT00552617|559181885|FG004|Overall Study|Lost to Follow-up|0|||
154933107|NCT00552617|559181886|FG005|Overall Study|Lost to Follow-up|2|||
154933108|NCT00552617|559181887|FG006|Overall Study|Lost to Follow-up|0|||
154933109|NCT00552617|559181888|FG007|Overall Study|Lost to Follow-up|0|||
155043342|NCT03026283|559590102|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
154933110|NCT00552617|559181889|FG008|Overall Study|Lost to Follow-up|2|||
154933111|NCT00552617|559181890|FG009|Overall Study|Lost to Follow-up|0|||
154933112|NCT04651218|559181891|FG000|Overall Study|Withdrawal by Subject|0|||
154933113|NCT04651218|559181892|FG001|Overall Study|Withdrawal by Subject|2|||
154933114|NCT01399125|559181897|FG000|Overall Study|Adverse Event|32|||
154933115|NCT01399125|559181898|FG001|Overall Study|Adverse Event|30|||
154933116|NCT01399125|559181897|FG000|Overall Study|Abnormal Lab values|0|||
154933117|NCT01399125|559181898|FG001|Overall Study|Abnormal Lab values|1|||
154933118|NCT01399125|559181897|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
154933119|NCT01399125|559181898|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
154933120|NCT01399125|559181897|FG000|Overall Study|Withdrawal by Subject|5|||
154933121|NCT01399125|559181898|FG001|Overall Study|Withdrawal by Subject|8|||
154933122|NCT01399125|559181897|FG000|Overall Study|Lost to Follow-up|2|||
154933123|NCT01399125|559181898|FG001|Overall Study|Lost to Follow-up|3|||
154933124|NCT01399125|559181897|FG000|Overall Study|Administrative Problems|7|||
154933125|NCT01399125|559181898|FG001|Overall Study|Administrative Problems|11|||
154933126|NCT01399125|559181897|FG000|Overall Study|Death|0|||
154933127|NCT01399125|559181898|FG001|Overall Study|Death|1|||
154933128|NCT01399125|559181897|FG000|Overall Study|Protocol Deviation|5|||
154933129|NCT01399125|559181898|FG001|Overall Study|Protocol Deviation|2|||
154933130|NCT00563524|559181899|FG000|Overall Study|Adverse Event|0|||
154933131|NCT00563524|559181900|FG001|Overall Study|Adverse Event|1|||
154933132|NCT00563524|559181901|FG002|Overall Study|Adverse Event|0|||
154933133|NCT00563524|559181902|FG003|Overall Study|Adverse Event|0|||
154933134|NCT00563524|559181903|FG004|Overall Study|Adverse Event|2|||
154933135|NCT00563524|559181904|FG005|Overall Study|Adverse Event|0|||
154933136|NCT00563524|559181899|FG000|Overall Study|Lost to Follow-up|1|||
154933137|NCT00563524|559181900|FG001|Overall Study|Lost to Follow-up|0|||
154933138|NCT00563524|559181901|FG002|Overall Study|Lost to Follow-up|0|||
154933139|NCT00563524|559181902|FG003|Overall Study|Lost to Follow-up|0|||
154933140|NCT00563524|559181903|FG004|Overall Study|Lost to Follow-up|0|||
154933141|NCT00563524|559181904|FG005|Overall Study|Lost to Follow-up|0|||
154933142|NCT00563524|559181899|FG000|Overall Study|Protocol Violation|0|||
154933143|NCT00563524|559181900|FG001|Overall Study|Protocol Violation|1|||
154933144|NCT00563524|559181901|FG002|Overall Study|Protocol Violation|0|||
154933145|NCT00563524|559181902|FG003|Overall Study|Protocol Violation|0|||
154933146|NCT00563524|559181903|FG004|Overall Study|Protocol Violation|0|||
154933147|NCT00563524|559181904|FG005|Overall Study|Protocol Violation|0|||
154933148|NCT00563524|559181899|FG000|Overall Study|Withdrawal by Subject|1|||
154933149|NCT00563524|559181900|FG001|Overall Study|Withdrawal by Subject|1|||
154933150|NCT00563524|559181901|FG002|Overall Study|Withdrawal by Subject|3|||
154933151|NCT00563524|559181902|FG003|Overall Study|Withdrawal by Subject|0|||
154933152|NCT00563524|559181903|FG004|Overall Study|Withdrawal by Subject|0|||
154933153|NCT00563524|559181904|FG005|Overall Study|Withdrawal by Subject|1|||
154933154|NCT01467570|559181906|FG000|Overall Study|Lost to Follow-up|8|||
154933155|NCT01467570|559181907|FG001|Overall Study|Lost to Follow-up|9|||
154933156|NCT02626182|559181910|FG000|Overall Study|Adverse Event|2|||
154933157|NCT02626182|559181911|FG001|Overall Study|Adverse Event|0|||
155272876|NCT01327547|560432840|FG000|Overall Study|Protocol Violation|1|||
155272877|NCT01327547|560432841|FG001|Overall Study|Protocol Violation|0|||
155272878|NCT01327547|560432840|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
155272879|NCT01327547|560432841|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
155272880|NCT01327547|560432840|FG000|Overall Study|Required prohibited medication|2|||
155272881|NCT01327547|560432841|FG001|Overall Study|Required prohibited medication|0|||
155272882|NCT01327547|560432840|FG000|Overall Study|Non-compliance with study procedures|1|||
155272883|NCT01327547|560432841|FG001|Overall Study|Non-compliance with study procedures|0|||
155272884|NCT01327547|560432840|FG000|Overall Study|By investigator in subject's interest|0|||
155272885|NCT01327547|560432841|FG001|Overall Study|By investigator in subject's interest|1|||
155272886|NCT00329719|560432842|FG000|Overall Study|Lost to Follow-up|0|||
155272887|NCT00329719|560432843|FG001|Overall Study|Lost to Follow-up|0|||
155272888|NCT00329719|560432844|FG002|Overall Study|Lost to Follow-up|0|||
155272889|NCT00329719|560432845|FG003|Overall Study|Lost to Follow-up|1|||
155272890|NCT01681368|560432850|FG000|Overall Study|Refused further treatment|1|||
155272891|NCT01681368|560432850|FG000|Overall Study|Refused further follow up|1|||
155381927|NCT01200589|560833240|FG001|Overall Study|Physician Decision|2|||
154933158|NCT02766088|559181923|FG000|Overall Study|Sponsor study termination|498|||
154933159|NCT02766088|559181923|FG000|Overall Study|Migrated/moved from the study area|1|||
154933160|NCT02766088|559181923|FG000|Overall Study|Lost to Follow-up|5|||
154933161|NCT02766088|559181923|FG000|Overall Study|Other|1|||
154933162|NCT02766088|559181923|FG000|Overall Study|Death|1|||
154933163|NCT01222715|559181924|FG000|Overall Study|Adverse Event|0|||
154933164|NCT01222715|559181925|FG001|Overall Study|Adverse Event|4|||
154933165|NCT01222715|559181924|FG000|Overall Study|Death|0|||
154933166|NCT01222715|559181925|FG001|Overall Study|Death|1|||
154933167|NCT01222715|559181924|FG000|Overall Study|Lack of Efficacy|22|||
155272892|NCT00900627|560432855|FG000|Overall Study|Condition under investigation worsened|4|||
155272893|NCT00900627|560432856|FG001|Overall Study|Condition under investigation worsened|0|||
155381928|NCT01200589|560833239|FG000|Overall Study|Lost to Follow-up|5|||
154933168|NCT01222715|559181925|FG001|Overall Study|Lack of Efficacy|14|||
154933169|NCT01222715|559181924|FG000|Overall Study|Physician Decision|12|||
154933170|NCT01222715|559181925|FG001|Overall Study|Physician Decision|2|||
154933171|NCT01222715|559181924|FG000|Overall Study|Refusal of further protocol therapy|0|||
154933172|NCT01222715|559181925|FG001|Overall Study|Refusal of further protocol therapy|4|||
154933173|NCT01222715|559181924|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
154933174|NCT01222715|559181925|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
154933175|NCT01222715|559181924|FG000|Overall Study|Ineligible|0|||
154933176|NCT01222715|559181925|FG001|Overall Study|Ineligible|1|||
154933177|NCT01222715|559181924|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
154933178|NCT01222715|559181925|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
154933179|NCT03836729|559181926|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
155272894|NCT00900627|560432857|FG002|Overall Study|Condition under investigation worsened|5|||
154933180|NCT00948025|559181927|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
154933181|NCT00948025|559181928|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
154933182|NCT00948025|559181927|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
154933183|NCT00948025|559181928|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
154933184|NCT00948025|559181927|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
154933185|NCT00948025|559181928|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
154933186|NCT03174925|559181931|FG000|Overall Study|Elastographic images not retrievable|2|||
154933187|NCT03174925|559181931|FG000|Overall Study|Elastography image not interpretable|1|||
154933188|NCT04247594|559181936|FG000|Overall Study|Withdrawal by Subject|4|||
154933189|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
154933190|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
154933191|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
154933192|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
154933193|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
154933194|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
154933195|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
154933196|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
154933197|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
154933198|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
154933199|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
154933200|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
154933201|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
154933202|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
154933203|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
154933204|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
154933205|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
154933206|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
154933207|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
154933208|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
154933209|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
154933210|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
154933211|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
154933212|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
154933213|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
154933214|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
154933215|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
154933216|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
154933217|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
154933218|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
154933219|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
154933220|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
154933221|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
154933222|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
154933223|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
154933224|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
154933225|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
154933226|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
154933227|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
154933228|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
154933229|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
154933230|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
155272895|NCT00900627|560432858|FG003|Overall Study|Condition under investigation worsened|3|||
154933231|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
154933232|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
154933233|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
154933234|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
154933235|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
154933236|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
154933237|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
154933238|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
154933239|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
154933240|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
154933241|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
154933242|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
154933243|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
154933244|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
154933245|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
154933246|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
154933247|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
154933248|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
154933249|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
154933250|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
154933251|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
154933252|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
154933253|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
154933254|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
154933255|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
154933256|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
154933257|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
154933258|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
154933259|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
154933260|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
154933261|NCT04440163|559181938|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
154933262|NCT04440163|559181939|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
154933263|NCT04440163|559181940|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
154933264|NCT04440163|559181941|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
154933265|NCT04440163|559181942|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
154933266|NCT04440163|559181943|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
154933267|NCT04440163|559181944|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
154933268|NCT04440163|559181945|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
154933269|NCT04440163|559181938|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
154933270|NCT04440163|559181939|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
154933271|NCT04440163|559181940|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
154933272|NCT04440163|559181941|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
154933273|NCT04440163|559181942|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
154933274|NCT04440163|559181943|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
154933275|NCT04440163|559181944|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
154933276|NCT04440163|559181945|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
154933277|NCT04440163|559181938|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933278|NCT04440163|559181939|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933279|NCT04440163|559181940|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933280|NCT04440163|559181941|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
154933281|NCT04440163|559181942|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933282|NCT04440163|559181943|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933283|NCT04440163|559181944|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933284|NCT04440163|559181945|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
154933285|NCT00068406|559181949|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
154933286|NCT00068406|559181949|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
154933287|NCT03231709|559181953|FG000|Treatment Period 1|Reason not Specified|0|||
154933288|NCT03231709|559181954|FG001|Treatment Period 1|Reason not Specified|1|||
154933289|NCT03231709|559181953|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
154933290|NCT03231709|559181954|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
154933291|NCT02609178|559181955|FG000|First Crown|Withdrawal by Subject|0|||
154933292|NCT02609178|559181956|FG001|First Crown|Withdrawal by Subject|0|||
154933293|NCT02609178|559181957|FG002|First Crown|Withdrawal by Subject|1|||
154933294|NCT02609178|559181958|FG003|First Crown|Withdrawal by Subject|1|||
154933295|NCT02609178|559181959|FG004|First Crown|Withdrawal by Subject|0|||
155272896|NCT00900627|560432859|FG004|Overall Study|Condition under investigation worsened|0|||
155272897|NCT00900627|560432860|FG005|Overall Study|Condition under investigation worsened|0|||
155272898|NCT00900627|560432855|FG000|Overall Study|Withdrawal by Subject|1|||
155272899|NCT00900627|560432856|FG001|Overall Study|Withdrawal by Subject|0|||
155272900|NCT00900627|560432857|FG002|Overall Study|Withdrawal by Subject|1|||
155272901|NCT00900627|560432858|FG003|Overall Study|Withdrawal by Subject|0|||
155272902|NCT00900627|560432859|FG004|Overall Study|Withdrawal by Subject|1|||
155272903|NCT00900627|560432860|FG005|Overall Study|Withdrawal by Subject|2|||
155272904|NCT00900627|560432855|FG000|Overall Study|Adverse Event|1|||
155272905|NCT00900627|560432856|FG001|Overall Study|Adverse Event|2|||
155272906|NCT00900627|560432857|FG002|Overall Study|Adverse Event|0|||
155272907|NCT00900627|560432858|FG003|Overall Study|Adverse Event|3|||
155272908|NCT00900627|560432859|FG004|Overall Study|Adverse Event|0|||
155272909|NCT00900627|560432860|FG005|Overall Study|Adverse Event|0|||
155272910|NCT00900627|560432855|FG000|Overall Study|Death|0|||
155272911|NCT00900627|560432856|FG001|Overall Study|Death|0|||
155272912|NCT00900627|560432857|FG002|Overall Study|Death|0|||
155272913|NCT00900627|560432858|FG003|Overall Study|Death|0|||
155272914|NCT00900627|560432859|FG004|Overall Study|Death|28|||
155272915|NCT00900627|560432860|FG005|Overall Study|Death|24|||
155272916|NCT00594906|560432866|FG000|Overall Study|Physician Decision|1|||
155272917|NCT00594906|560432867|FG001|Overall Study|Physician Decision|0|||
155272918|NCT00594906|560432866|FG000|Overall Study|Physician Decision|0|||
155272919|NCT00594906|560432867|FG001|Overall Study|Physician Decision|1|||
155272920|NCT00594906|560432866|FG000|Overall Study|Death|0|||
155272921|NCT00594906|560432867|FG001|Overall Study|Death|1|||
155272922|NCT03685708|560432868|FG000|Overall Study|Withdrawal by Subject|0|||
155272923|NCT03685708|560432869|FG001|Overall Study|Withdrawal by Subject|0|||
155272924|NCT03685708|560432870|FG002|Overall Study|Withdrawal by Subject|1|||
155272925|NCT03685708|560432868|FG000|Overall Study|Screen Fail|0|||
155272926|NCT03685708|560432869|FG001|Overall Study|Screen Fail|1|||
155272927|NCT03685708|560432870|FG002|Overall Study|Screen Fail|1|||
155272928|NCT03685708|560432868|FG000|Overall Study|COVID 19 Pandemic|1|||
155272929|NCT03685708|560432869|FG001|Overall Study|COVID 19 Pandemic|1|||
155272930|NCT03685708|560432870|FG002|Overall Study|COVID 19 Pandemic|6|||
155272931|NCT03685708|560432868|FG000|Overall Study|Disease Progression|0|||
155272932|NCT03685708|560432869|FG001|Overall Study|Disease Progression|0|||
155272933|NCT03685708|560432870|FG002|Overall Study|Disease Progression|1|||
155272934|NCT02222896|560432878|FG000|Abdomen|Did not qualify|34|||
155272935|NCT02222896|560432879|FG001|Abdomen|Did not qualify|10|||
155272936|NCT02222896|560432880|FG002|Abdomen|Did not qualify|32|||
155272937|NCT02222896|560432878|FG000|Groin|Did not qualify|43|||
155272938|NCT02222896|560432879|FG001|Groin|Did not qualify|9|||
155272939|NCT02222896|560432880|FG002|Groin|Did not qualify|40|||
155272940|NCT01744496|560432881|FG000|Titration Period|Adverse Event|2|||
155272941|NCT01744496|560432882|FG001|Titration Period|Adverse Event|1|||
155272942|NCT01744496|560432881|FG000|Titration Period|Personal reasons|0|||
155272943|NCT01744496|560432882|FG001|Titration Period|Personal reasons|1|||
155272944|NCT01744496|560432881|FG000|Maintenance Period|Adverse Event|1|||
155272945|NCT01744496|560432882|FG001|Maintenance Period|Adverse Event|3|||
155272946|NCT01744496|560432881|FG000|Maintenance Period|Protocol Violation|1|||
155272947|NCT01744496|560432882|FG001|Maintenance Period|Protocol Violation|0|||
155272948|NCT01744496|560432881|FG000|Maintenance Period|Withdrawal by Subject|1|||
155272949|NCT01744496|560432882|FG001|Maintenance Period|Withdrawal by Subject|1|||
155272950|NCT01744496|560432881|FG000|Maintenance Period|Subject left town|1|||
155272951|NCT01744496|560432882|FG001|Maintenance Period|Subject left town|0|||
155272952|NCT01865617|560432886|FG000|Overall Study|Death|27|||
155272953|NCT01865617|560432887|FG001|Overall Study|Death|3|||
155272954|NCT01865617|560432888|FG002|Overall Study|Death|1|||
155272955|NCT01865617|560432889|FG003|Overall Study|Death|1|||
155272956|NCT01865617|560432890|FG004|Overall Study|Death|5|||
155272957|NCT01865617|560432891|FG005|Overall Study|Death|1|||
155272958|NCT01865617|560432892|FG006|Overall Study|Death|11|||
155272959|NCT01865617|560432893|FG007|Overall Study|Death|1|||
155272960|NCT01865617|560432894|FG008|Overall Study|Death|11|||
155272961|NCT01865617|560432895|FG009|Overall Study|Death|3|||
155272962|NCT01865617|560432896|FG010|Overall Study|Death|32|||
155272963|NCT01865617|560432897|FG011|Overall Study|Death|6|||
155272964|NCT01865617|560432898|FG012|Overall Study|Death|13|||
155272965|NCT01865617|560432886|FG000|Overall Study|Lost to Follow-up|2|||
155272966|NCT01865617|560432887|FG001|Overall Study|Lost to Follow-up|0|||
155272967|NCT01865617|560432888|FG002|Overall Study|Lost to Follow-up|0|||
155272968|NCT01865617|560432889|FG003|Overall Study|Lost to Follow-up|0|||
155272969|NCT01865617|560432890|FG004|Overall Study|Lost to Follow-up|0|||
155272970|NCT01865617|560432891|FG005|Overall Study|Lost to Follow-up|0|||
155272971|NCT01865617|560432892|FG006|Overall Study|Lost to Follow-up|0|||
155272972|NCT01865617|560432893|FG007|Overall Study|Lost to Follow-up|0|||
155272973|NCT01865617|560432894|FG008|Overall Study|Lost to Follow-up|0|||
155272974|NCT01865617|560432895|FG009|Overall Study|Lost to Follow-up|0|||
155272975|NCT01865617|560432896|FG010|Overall Study|Lost to Follow-up|0|||
155272976|NCT01865617|560432897|FG011|Overall Study|Lost to Follow-up|0|||
155272977|NCT01865617|560432898|FG012|Overall Study|Lost to Follow-up|0|||
154933296|NCT02609178|559181960|FG005|First Crown|Withdrawal by Subject|0|||
154933297|NCT01128153|559181961|FG000|Overall Study|Adverse Event|1|||
154933298|NCT01128153|559181962|FG001|Overall Study|Adverse Event|3|||
154933299|NCT01128153|559181961|FG000|Overall Study|Condition under investigation worsened|8|||
154933300|NCT01128153|559181962|FG001|Overall Study|Condition under investigation worsened|7|||
154933301|NCT01128153|559181961|FG000|Overall Study|Withdrawal by Subject|2|||
154933302|NCT01128153|559181962|FG001|Overall Study|Withdrawal by Subject|3|||
154933303|NCT01128153|559181961|FG000|Overall Study|Incorrect enrolment to study|2|||
154933304|NCT01128153|559181962|FG001|Overall Study|Incorrect enrolment to study|1|||
154933305|NCT01128153|559181961|FG000|Overall Study|Protocol Violation|2|||
154933306|NCT01128153|559181962|FG001|Overall Study|Protocol Violation|0|||
154933307|NCT01128153|559181961|FG000|Overall Study|Developed discontinuation criteria|1|||
154933308|NCT01128153|559181962|FG001|Overall Study|Developed discontinuation criteria|1|||
154933309|NCT01954082|559181963|FG000|Overall Study|Study Suspension|42|||
154933310|NCT01954082|559181964|FG001|Overall Study|Study Suspension|36|||
154933311|NCT01954082|559181963|FG000|Overall Study|Adverse Event|10|||
154933312|NCT01954082|559181964|FG001|Overall Study|Adverse Event|4|||
154933313|NCT01954082|559181963|FG000|Overall Study|Intolerance|0|||
154933314|NCT01954082|559181964|FG001|Overall Study|Intolerance|1|||
154933315|NCT01954082|559181963|FG000|Overall Study|Non-compliance|6|||
154933316|NCT01954082|559181964|FG001|Overall Study|Non-compliance|4|||
154933317|NCT01954082|559181963|FG000|Overall Study|Physician Decision|2|||
154933318|NCT01954082|559181964|FG001|Overall Study|Physician Decision|0|||
154933319|NCT01954082|559181963|FG000|Overall Study|Parent Decision|1|||
154933320|NCT01954082|559181964|FG001|Overall Study|Parent Decision|0|||
154933321|NCT01954082|559181963|FG000|Overall Study|Withdrawal by Subject|0|||
154933322|NCT01954082|559181964|FG001|Overall Study|Withdrawal by Subject|1|||
154933323|NCT01954082|559181963|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
154933324|NCT01954082|559181964|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
154933325|NCT01954082|559181963|FG000|Overall Study|Redirection of Care|0|||
154933326|NCT01954082|559181964|FG001|Overall Study|Redirection of Care|2|||
154933327|NCT01954082|559181963|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
154933328|NCT01954082|559181964|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
154933329|NCT01954082|559181963|FG000|Overall Study|Comfort Care|0|||
154933330|NCT01954082|559181964|FG001|Overall Study|Comfort Care|1|||
154933331|NCT01954082|559181963|FG000|Overall Study|Infant Moved|0|||
154933332|NCT01954082|559181964|FG001|Overall Study|Infant Moved|1|||
154933333|NCT01954082|559181963|FG000|Overall Study|Randomized not Treated|4|||
154933334|NCT01954082|559181964|FG001|Overall Study|Randomized not Treated|2|||
154933335|NCT01682512|559181965|FG000|Overall Study|Adverse Event|6|||
154933336|NCT01682512|559181966|FG001|Overall Study|Adverse Event|5|||
154933337|NCT01682512|559181967|FG002|Overall Study|Adverse Event|2|||
154933338|NCT01682512|559181965|FG000|Overall Study|Withdrawal by Subject|2|||
154933339|NCT01682512|559181966|FG001|Overall Study|Withdrawal by Subject|6|||
154933340|NCT01682512|559181967|FG002|Overall Study|Withdrawal by Subject|3|||
154933341|NCT01682512|559181965|FG000|Overall Study|Physician Decision|0|||
154933342|NCT01682512|559181966|FG001|Overall Study|Physician Decision|2|||
154933343|NCT01682512|559181967|FG002|Overall Study|Physician Decision|0|||
154933344|NCT01682512|559181965|FG000|Overall Study|Study terminated by sponsor|46|||
154933345|NCT01682512|559181966|FG001|Overall Study|Study terminated by sponsor|43|||
154933346|NCT01682512|559181967|FG002|Overall Study|Study terminated by sponsor|0|||
154933347|NCT01682512|559181965|FG000|Overall Study|Lost to Follow-up|3|||
154933348|NCT01682512|559181966|FG001|Overall Study|Lost to Follow-up|0|||
154933349|NCT01682512|559181967|FG002|Overall Study|Lost to Follow-up|2|||
154933350|NCT01682512|559181965|FG000|Overall Study|Protocol Violation|2|||
154933351|NCT01682512|559181966|FG001|Overall Study|Protocol Violation|3|||
154933352|NCT01682512|559181967|FG002|Overall Study|Protocol Violation|2|||
154933353|NCT01682512|559181965|FG000|Overall Study|Primary lack of efficacy|10|||
154933354|NCT01682512|559181966|FG001|Overall Study|Primary lack of efficacy|7|||
154933355|NCT01682512|559181967|FG002|Overall Study|Primary lack of efficacy|7|||
154933356|NCT01682512|559181965|FG000|Overall Study|Secondary lack of efficacy|1|||
154933357|NCT01682512|559181966|FG001|Overall Study|Secondary lack of efficacy|1|||
154933358|NCT01682512|559181967|FG002|Overall Study|Secondary lack of efficacy|0|||
154933359|NCT01682512|559181965|FG000|Overall Study|Other than stated above|2|||
154933360|NCT01682512|559181966|FG001|Overall Study|Other than stated above|4|||
154933361|NCT01682512|559181967|FG002|Overall Study|Other than stated above|2|||
154933362|NCT01377233|559181968|FG000|Open-label|Adverse Event|1|||
154933363|NCT01377233|559181969|FG001|Open-label|Adverse Event|0|||
154933364|NCT01377233|559181970|FG002|Open-label|Adverse Event|0|||
154933365|NCT01377233|559181971|FG003|Open-label|Adverse Event|0|||
154933366|NCT01377233|559181972|FG004|Open-label|Adverse Event|0|||
154933367|NCT01377233|559181968|FG000|Open-label|Withdrawal by Subject|3|||
154933368|NCT01377233|559181969|FG001|Open-label|Withdrawal by Subject|0|||
154933369|NCT01377233|559181970|FG002|Open-label|Withdrawal by Subject|0|||
154933370|NCT01377233|559181971|FG003|Open-label|Withdrawal by Subject|0|||
154933371|NCT01377233|559181972|FG004|Open-label|Withdrawal by Subject|0|||
154933372|NCT01377233|559181968|FG000|Double-blind|Adverse Event|0|||
154933373|NCT01377233|559181969|FG001|Double-blind|Adverse Event|1|||
154933374|NCT01377233|559181970|FG002|Double-blind|Adverse Event|2|||
154933375|NCT01377233|559181971|FG003|Double-blind|Adverse Event|2|||
154933376|NCT01377233|559181972|FG004|Double-blind|Adverse Event|0|||
154933377|NCT01377233|559181968|FG000|Double-blind|Protocol Violation|0|||
154933378|NCT01377233|559181969|FG001|Double-blind|Protocol Violation|0|||
154933379|NCT01377233|559181970|FG002|Double-blind|Protocol Violation|0|||
154933380|NCT01377233|559181971|FG003|Double-blind|Protocol Violation|0|||
154933381|NCT01377233|559181972|FG004|Double-blind|Protocol Violation|1|||
154933382|NCT01377233|559181968|FG000|Double-blind|Withdrawal by Subject|0|||
154933383|NCT01377233|559181969|FG001|Double-blind|Withdrawal by Subject|0|||
154933384|NCT01377233|559181970|FG002|Double-blind|Withdrawal by Subject|0|||
154933385|NCT01377233|559181971|FG003|Double-blind|Withdrawal by Subject|1|||
154933386|NCT01377233|559181972|FG004|Double-blind|Withdrawal by Subject|0|||
154933387|NCT01377233|559181968|FG000|Double-blind|Administrative or other|0|||
154933388|NCT01377233|559181969|FG001|Double-blind|Administrative or other|0|||
154933389|NCT01377233|559181970|FG002|Double-blind|Administrative or other|0|||
154933390|NCT01377233|559181971|FG003|Double-blind|Administrative or other|1|||
154933391|NCT01377233|559181972|FG004|Double-blind|Administrative or other|1|||
154933392|NCT01785875|559181973|FG000|Overall Study|Withdrawal by Subject|41|||
154933393|NCT01785875|559181974|FG001|Overall Study|Withdrawal by Subject|34|||
154933394|NCT01785875|559181975|FG002|Overall Study|Withdrawal by Subject|36|||
154933395|NCT01785875|559181973|FG000|Overall Study|Lost to Follow-up|19|||
154933396|NCT01785875|559181974|FG001|Overall Study|Lost to Follow-up|22|||
154933397|NCT01785875|559181975|FG002|Overall Study|Lost to Follow-up|6|||
154933398|NCT01785875|559181973|FG000|Overall Study|Death|27|||
154933399|NCT01785875|559181974|FG001|Overall Study|Death|16|||
154933400|NCT01785875|559181975|FG002|Overall Study|Death|7|||
154933401|NCT01785875|559181973|FG000|Overall Study|Sponsor Decision|0|||
154933402|NCT01785875|559181974|FG001|Overall Study|Sponsor Decision|2|||
154933403|NCT01785875|559181975|FG002|Overall Study|Sponsor Decision|0|||
154933404|NCT01785875|559181973|FG000|Overall Study|Protocol Specified Criteria|207|||
154933405|NCT01785875|559181974|FG001|Overall Study|Protocol Specified Criteria|214|||
154933406|NCT01785875|559181975|FG002|Overall Study|Protocol Specified Criteria|55|||
154933407|NCT01785875|559181973|FG000|Overall Study|Missing|0|||
154933408|NCT01785875|559181974|FG001|Overall Study|Missing|1|||
154933409|NCT01785875|559181975|FG002|Overall Study|Missing|3|||
154933410|NCT00417027|559181978|FG000|Overall Study|Protocol Violation|0|||
154933411|NCT00417027|559181979|FG001|Overall Study|Protocol Violation|5|||
154933412|NCT00417027|559181980|FG002|Overall Study|Protocol Violation|5|||
154933413|NCT02216214|559181981|FG000|Overall Study|Randomized Never Received Study Drug|1|||
154933414|NCT02216214|559181982|FG001|Overall Study|Randomized Never Received Study Drug|0|||
154933415|NCT02216214|559181981|FG000|Overall Study|Adverse Event|10|||
154933416|NCT02216214|559181982|FG001|Overall Study|Adverse Event|8|||
154933417|NCT02216214|559181981|FG000|Overall Study|Lack of Efficacy|2|||
154933418|NCT02216214|559181982|FG001|Overall Study|Lack of Efficacy|2|||
154933419|NCT02216214|559181981|FG000|Overall Study|Lost to Follow-up|3|||
154933420|NCT02216214|559181982|FG001|Overall Study|Lost to Follow-up|2|||
154933421|NCT02216214|559181981|FG000|Overall Study|Protocol Violation|4|||
154933422|NCT02216214|559181982|FG001|Overall Study|Protocol Violation|2|||
154933423|NCT02216214|559181981|FG000|Overall Study|Withdrawal by Subject|22|||
154933424|NCT02216214|559181982|FG001|Overall Study|Withdrawal by Subject|20|||
154933425|NCT02216214|559181981|FG000|Overall Study|Study Terminated By Sponsor|0|||
154933426|NCT02216214|559181982|FG001|Overall Study|Study Terminated By Sponsor|1|||
154933427|NCT02216214|559181981|FG000|Overall Study|Miscellaneous|1|||
154933428|NCT02216214|559181982|FG001|Overall Study|Miscellaneous|1|||
154933429|NCT05354206|559181983|FG000|Overall Study|Withdrawal by Subject|1|||
154933430|NCT05354206|559181984|FG001|Overall Study|Withdrawal by Subject|0|||
154933431|NCT00422058|559181985|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
154933432|NCT00422058|559181986|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
154933433|NCT00422058|559181987|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
154933434|NCT00422058|559181988|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
154933435|NCT00422058|559181989|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
154933436|NCT00422058|559181990|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
154933437|NCT00422058|559181985|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
154933438|NCT00422058|559181986|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
154933439|NCT00422058|559181987|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
154933440|NCT00422058|559181988|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
154933441|NCT00422058|559181989|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
154933442|NCT00422058|559181990|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
154933443|NCT00422058|559181985|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
154933444|NCT00422058|559181986|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
154933445|NCT00422058|559181987|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
154933446|NCT00422058|559181988|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
154933447|NCT00422058|559181989|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
154933448|NCT00422058|559181990|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
154933449|NCT00422058|559181985|FG000|Double-Blind, Week 0-20|Other|11|||
154933450|NCT00422058|559181986|FG001|Double-Blind, Week 0-20|Other|3|||
154933451|NCT00422058|559181987|FG002|Double-Blind, Week 0-20|Other|8|||
154933452|NCT00422058|559181988|FG003|Double-Blind, Week 0-20|Other|8|||
154933453|NCT00422058|559181989|FG004|Double-Blind, Week 0-20|Other|4|||
154933454|NCT00422058|559181990|FG005|Double-Blind, Week 0-20|Other|10|||
154933455|NCT00422058|559181985|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
154933456|NCT00422058|559181986|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
154933457|NCT00422058|559181987|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
154933458|NCT00422058|559181988|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
154933459|NCT00422058|559181989|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
154933460|NCT00422058|559181990|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
154933461|NCT00422058|559181985|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
154933462|NCT00422058|559181986|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
154933463|NCT00422058|559181987|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
154933464|NCT00422058|559181988|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
154933465|NCT00422058|559181989|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
154933466|NCT00422058|559181990|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
154933467|NCT00422058|559181985|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
154933468|NCT00422058|559181986|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
154933469|NCT00422058|559181987|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
154933470|NCT00422058|559181988|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
154933471|NCT00422058|559181989|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
154933472|NCT00422058|559181990|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
154933473|NCT00422058|559181985|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
154933474|NCT00422058|559181986|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
154933475|NCT00422058|559181987|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
154933476|NCT00422058|559181988|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
154933477|NCT00422058|559181989|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
154933478|NCT00422058|559181990|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
154933479|NCT00422058|559181985|FG000|Open-Label Extension, Week 20-104|Other|13|||
154933480|NCT00422058|559181986|FG001|Open-Label Extension, Week 20-104|Other|14|||
154933481|NCT00422058|559181987|FG002|Open-Label Extension, Week 20-104|Other|6|||
154933482|NCT00422058|559181988|FG003|Open-Label Extension, Week 20-104|Other|13|||
154933483|NCT00422058|559181989|FG004|Open-Label Extension, Week 20-104|Other|16|||
154933484|NCT00422058|559181990|FG005|Open-Label Extension, Week 20-104|Other|18|||
154933485|NCT03959137|559181991|FG000|Overall Study|Protocol Violation|6|||
154933486|NCT00190684|559181992|FG000|Overall Study|Adverse Event|86|||
154933487|NCT00190684|559181992|FG000|Overall Study|Satisfactory response|80|||
154933488|NCT00190684|559181992|FG000|Overall Study|Lack of efficacy|204|||
154933489|NCT00190684|559181992|FG000|Overall Study|Lost to Follow-up|232|||
154933490|NCT00190684|559181992|FG000|Overall Study|Patient moved|60|||
154933491|NCT00190684|559181992|FG000|Overall Study|Patient Decision|432|||
154933492|NCT00190684|559181992|FG000|Overall Study|Clinical relapse|67|||
154933493|NCT00190684|559181992|FG000|Overall Study|Sponsor's decision|17|||
154933494|NCT00190684|559181992|FG000|Overall Study|Physician Decision|84|||
154933495|NCT00190684|559181992|FG000|Overall Study|Protocol Violation|123|||
154933496|NCT00190684|559181992|FG000|Overall Study|Study Period III Completed|103|||
154933497|NCT00190684|559181992|FG000|Overall Study|Study Period V Completed|1|||
154933498|NCT00810615|559181998|FG000|Overall Study|Withdrawal by Subject|1|||
154933499|NCT00810615|559181999|FG001|Overall Study|Withdrawal by Subject|1|||
154933500|NCT02567266|559182000|FG000|Overall Study|Withdrawal by Subject|10|||
154933501|NCT02567266|559182001|FG001|Overall Study|Withdrawal by Subject|7|||
154933502|NCT02567266|559182002|FG002|Overall Study|Withdrawal by Subject|6|||
154933503|NCT02567266|559182000|FG000|Overall Study|Lost to Follow-up|13|||
154933504|NCT02567266|559182001|FG001|Overall Study|Lost to Follow-up|8|||
154933505|NCT02567266|559182002|FG002|Overall Study|Lost to Follow-up|10|||
154933506|NCT01542736|559182003|FG000|Overall Study|Death|1|||
155272978|NCT01865617|560432886|FG000|Overall Study|Withdrawal by Subject|1|||
155272979|NCT01865617|560432887|FG001|Overall Study|Withdrawal by Subject|0|||
155272980|NCT01865617|560432888|FG002|Overall Study|Withdrawal by Subject|0|||
155272981|NCT01865617|560432889|FG003|Overall Study|Withdrawal by Subject|0|||
155272982|NCT01865617|560432890|FG004|Overall Study|Withdrawal by Subject|0|||
155272983|NCT01865617|560432891|FG005|Overall Study|Withdrawal by Subject|0|||
155272984|NCT01865617|560432892|FG006|Overall Study|Withdrawal by Subject|0|||
155272985|NCT01865617|560432893|FG007|Overall Study|Withdrawal by Subject|0|||
155381929|NCT01200589|560833240|FG001|Overall Study|Lost to Follow-up|4|||
154933507|NCT01766310|559182004|FG000|Overall Study|Lost to Follow-up|1|||
154933508|NCT01766310|559182005|FG001|Overall Study|Lost to Follow-up|3|||
154933509|NCT02602080|559182006|FG000|Overall Study|Protocol Violation|6|||
154933510|NCT02602080|559182007|FG001|Overall Study|Protocol Violation|1|||
154933511|NCT02602080|559182008|FG002|Overall Study|Protocol Violation|3|||
154933512|NCT02574260|559182014|FG000|Overall Study|Disease Progression|1|||
154933513|NCT00752895|559182015|FG000|Overall Study|Withdrawal by Subject|8|||
154933514|NCT00752895|559182016|FG001|Overall Study|Withdrawal by Subject|3|||
155272986|NCT01865617|560432894|FG008|Overall Study|Withdrawal by Subject|0|||
154933515|NCT03273257|559182017|FG000|Overall Study|Death|0|||
154933516|NCT03273257|559182018|FG001|Overall Study|Death|1|||
154933517|NCT03273257|559182017|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
154933518|NCT03273257|559182018|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
154933519|NCT03273257|559182017|FG000|Overall Study|Study terminated|3|||
154933520|NCT03273257|559182018|FG001|Overall Study|Study terminated|2|||
154933521|NCT00434148|559182019|FG000|Overall Study|Adverse Event|18|||
154933522|NCT00434148|559182020|FG001|Overall Study|Adverse Event|18|||
154933523|NCT00434148|559182019|FG000|Overall Study|Lack of Efficacy|25|||
154933524|NCT00434148|559182020|FG001|Overall Study|Lack of Efficacy|28|||
154933525|NCT00434148|559182019|FG000|Overall Study|Withdrawal by Subject|15|||
154933526|NCT00434148|559182020|FG001|Overall Study|Withdrawal by Subject|15|||
154933527|NCT00434148|559182019|FG000|Overall Study|Protocol Violation|4|||
154933528|NCT00434148|559182020|FG001|Overall Study|Protocol Violation|0|||
154933529|NCT00434148|559182019|FG000|Overall Study|Administrative problems|6|||
154933530|NCT00434148|559182020|FG001|Overall Study|Administrative problems|10|||
154933531|NCT00434148|559182019|FG000|Overall Study|Lost to Follow-up|0|||
154933532|NCT00434148|559182020|FG001|Overall Study|Lost to Follow-up|1|||
154933533|NCT00434148|559182019|FG000|Overall Study|Condition no longer requires study drug|1|||
154933534|NCT00434148|559182020|FG001|Overall Study|Condition no longer requires study drug|0|||
154933535|NCT00434148|559182019|FG000|Overall Study|Abnormal test procedure result|0|||
154933536|NCT00434148|559182020|FG001|Overall Study|Abnormal test procedure result|1|||
154933537|NCT01640964|559182026|FG000|Overall Study|Lost to Follow-up|0|||
154933538|NCT01640964|559182027|FG001|Overall Study|Lost to Follow-up|0|||
154933539|NCT01640964|559182028|FG002|Overall Study|Lost to Follow-up|1|||
154933540|NCT01640964|559182026|FG000|Overall Study|Protocol Deviation|1|||
154933541|NCT01640964|559182027|FG001|Overall Study|Protocol Deviation|1|||
154933542|NCT01640964|559182028|FG002|Overall Study|Protocol Deviation|2|||
154933543|NCT02464059|559183860|FG000|Overall Study|Lost to Follow-up|6|||
154933544|NCT02499406|559183863|FG000|Overall Study|missed 3 treatment sessions|4|||
154933545|NCT03591107|559183867|FG000|Overall Study|Same patient in both arms|1|||
154933546|NCT03591107|559183868|FG001|Overall Study|Same patient in both arms|1|||
154933547|NCT03591107|559183867|FG000|Overall Study|Sought care at other clinics|0|||
154933548|NCT03591107|559183868|FG001|Overall Study|Sought care at other clinics|2|||
154933549|NCT03591107|559183867|FG000|Overall Study|Discharged from clinic|0|||
154933550|NCT03591107|559183868|FG001|Overall Study|Discharged from clinic|1|||
154933551|NCT03591107|559183867|FG000|Overall Study|Withdrawal by Subject|0|||
154933552|NCT03591107|559183868|FG001|Overall Study|Withdrawal by Subject|1|||
154933553|NCT01902134|559183869|FG000|Overall Study|Adverse Event|3|||
154933554|NCT01902134|559183870|FG001|Overall Study|Adverse Event|1|||
154933555|NCT01902134|559183871|FG002|Overall Study|Adverse Event|2|||
154933556|NCT01902134|559183872|FG003|Overall Study|Adverse Event|1|||
154933557|NCT01902134|559183873|FG004|Overall Study|Adverse Event|1|||
154933558|NCT01902134|559183874|FG005|Overall Study|Adverse Event|3|||
154933559|NCT01902134|559183869|FG000|Overall Study|Lack of Efficacy|0|||
154933560|NCT01902134|559183870|FG001|Overall Study|Lack of Efficacy|0|||
154933561|NCT01902134|559183871|FG002|Overall Study|Lack of Efficacy|2|||
154933562|NCT01902134|559183872|FG003|Overall Study|Lack of Efficacy|0|||
154933563|NCT01902134|559183873|FG004|Overall Study|Lack of Efficacy|0|||
154933564|NCT01902134|559183874|FG005|Overall Study|Lack of Efficacy|1|||
154933565|NCT01902134|559183869|FG000|Overall Study|Physician Decision|0|||
154933566|NCT01902134|559183870|FG001|Overall Study|Physician Decision|1|||
154933567|NCT01902134|559183871|FG002|Overall Study|Physician Decision|0|||
154933568|NCT01902134|559183872|FG003|Overall Study|Physician Decision|0|||
154933569|NCT01902134|559183873|FG004|Overall Study|Physician Decision|0|||
154933570|NCT01902134|559183874|FG005|Overall Study|Physician Decision|0|||
154933571|NCT01902134|559183869|FG000|Overall Study|Protocol Violation|0|||
154933572|NCT01902134|559183870|FG001|Overall Study|Protocol Violation|0|||
154933573|NCT01902134|559183871|FG002|Overall Study|Protocol Violation|0|||
154933574|NCT01902134|559183872|FG003|Overall Study|Protocol Violation|0|||
154933575|NCT01902134|559183873|FG004|Overall Study|Protocol Violation|0|||
154933576|NCT01902134|559183874|FG005|Overall Study|Protocol Violation|1|||
154933577|NCT01902134|559183869|FG000|Overall Study|Withdrawal by Subject|4|||
154933578|NCT01902134|559183870|FG001|Overall Study|Withdrawal by Subject|8|||
154933579|NCT01902134|559183871|FG002|Overall Study|Withdrawal by Subject|9|||
154933580|NCT01902134|559183872|FG003|Overall Study|Withdrawal by Subject|1|||
154933581|NCT01902134|559183873|FG004|Overall Study|Withdrawal by Subject|5|||
154933582|NCT01902134|559183874|FG005|Overall Study|Withdrawal by Subject|4|||
154933583|NCT01902134|559183869|FG000|Overall Study|no compliance|1|||
154933584|NCT01902134|559183870|FG001|Overall Study|no compliance|0|||
154933585|NCT01902134|559183871|FG002|Overall Study|no compliance|0|||
154933586|NCT01902134|559183872|FG003|Overall Study|no compliance|0|||
154933587|NCT01902134|559183873|FG004|Overall Study|no compliance|0|||
154933588|NCT01902134|559183874|FG005|Overall Study|no compliance|0|||
154933589|NCT01902134|559183869|FG000|Overall Study|Other|0|||
154933590|NCT01902134|559183870|FG001|Overall Study|Other|1|||
154933591|NCT01902134|559183871|FG002|Overall Study|Other|2|||
154933592|NCT01902134|559183872|FG003|Overall Study|Other|0|||
154933593|NCT01902134|559183873|FG004|Overall Study|Other|1|||
154933594|NCT01902134|559183874|FG005|Overall Study|Other|0|||
154933595|NCT00305110|559183875|FG000|Overall Study|Missing data|29|||
154933596|NCT01272193|559183878|FG000|Overall Study|Adverse Event|1|||
154933597|NCT01272193|559183879|FG001|Overall Study|Adverse Event|1|||
154933598|NCT01272193|559183878|FG000|Overall Study|Lack of Efficacy|0|||
154933599|NCT01272193|559183879|FG001|Overall Study|Lack of Efficacy|3|||
154933600|NCT01272193|559183878|FG000|Overall Study|Withdrawal Criteria|1|||
154933601|NCT01272193|559183879|FG001|Overall Study|Withdrawal Criteria|1|||
154933602|NCT01272193|559183878|FG000|Overall Study|Unclassified|8|||
154933603|NCT01272193|559183879|FG001|Overall Study|Unclassified|7|||
154933604|NCT00350519|559183888|FG000|Overall Study|Death|0|||
154933605|NCT00350519|559183889|FG001|Overall Study|Death|1|||
154933606|NCT00350519|559183888|FG000|Overall Study|Physician Decision|0|||
154933607|NCT00350519|559183889|FG001|Overall Study|Physician Decision|1|||
154933608|NCT00350519|559183888|FG000|Overall Study|Protocol Violation|1|||
154933609|NCT00350519|559183889|FG001|Overall Study|Protocol Violation|2|||
154933610|NCT00350519|559183888|FG000|Overall Study|Withdrawal by Subject|3|||
154933611|NCT00350519|559183889|FG001|Overall Study|Withdrawal by Subject|2|||
154933612|NCT00736099|559183891|FG000|Overall Study|Adverse Event|61|||
154933613|NCT00736099|559183892|FG001|Overall Study|Adverse Event|18|||
154933614|NCT00736099|559183891|FG000|Overall Study|Protocol Violation|10|||
154933615|NCT00736099|559183892|FG001|Overall Study|Protocol Violation|4|||
154933616|NCT00736099|559183891|FG000|Overall Study|Lost to Follow-up|12|||
154933617|NCT00736099|559183892|FG001|Overall Study|Lost to Follow-up|5|||
154933618|NCT00736099|559183891|FG000|Overall Study|Withdrawal by Subject|42|||
154933619|NCT00736099|559183892|FG001|Overall Study|Withdrawal by Subject|13|||
154933620|NCT00736099|559183891|FG000|Overall Study|Lack of Efficacy|15|||
154933621|NCT00736099|559183892|FG001|Overall Study|Lack of Efficacy|8|||
154933622|NCT00736099|559183891|FG000|Overall Study|Other reason|43|||
154933623|NCT00736099|559183892|FG001|Overall Study|Other reason|10|||
154933624|NCT02239601|559183897|FG000|Overall Study|Withdrawal by Subject|3|||
154933625|NCT02239601|559183898|FG001|Overall Study|Withdrawal by Subject|4|||
154933626|NCT02239601|559183897|FG000|Overall Study|Protocol Violation|4|||
154933627|NCT02239601|559183898|FG001|Overall Study|Protocol Violation|2|||
154933628|NCT01791127|559183902|FG000|Overall Study|Death|356|||
154933629|NCT01791127|559183902|FG000|Overall Study|Patient has withdrawn from study|293|||
154933630|NCT01791127|559183902|FG000|Overall Study|Lost to Follow-up|42|||
154933631|NCT01791127|559183902|FG000|Overall Study|All Siello leads are explanted|31|||
154933632|NCT01791127|559183902|FG000|Overall Study|Completion of 30 day safety registry|1|||
154933633|NCT01791127|559183902|FG000|Overall Study|Study terminated for EP Passion|749|||
154933634|NCT03137082|559183907|FG000|Overall Study|Withdrawal by Subject|1|||
154933635|NCT03137082|559183908|FG001|Overall Study|Withdrawal by Subject|1|||
154933636|NCT03137082|559183907|FG000|Overall Study|Lost to Follow-up|1|||
154933637|NCT03137082|559183908|FG001|Overall Study|Lost to Follow-up|0|||
154933638|NCT00707174|559183909|FG000|Overall Study|Adverse Event|1|||
154933639|NCT00707174|559183910|FG001|Overall Study|Adverse Event|6|||
154933640|NCT00707174|559183909|FG000|Overall Study|Withdrawal by Subject|4|||
154933641|NCT00707174|559183910|FG001|Overall Study|Withdrawal by Subject|1|||
154933642|NCT00544557|559183911|FG000|Overall Study|Adverse Event|140|||
154933643|NCT00544557|559183911|FG000|Overall Study|Lack of Efficacy|196|||
154933644|NCT00544557|559183911|FG000|Overall Study|Other|98|||
154933645|NCT01020305|559183914|FG000|Overall Study|Adverse Event|2|||
154933646|NCT00467818|559183915|FG000|Overall Study|Adverse Event|1|||
154933647|NCT00467818|559183916|FG001|Overall Study|Adverse Event|0|||
154933648|NCT00467818|559183915|FG000|Overall Study|Lost to Follow-up|2|||
154933649|NCT00467818|559183916|FG001|Overall Study|Lost to Follow-up|2|||
154933650|NCT01017029|559183917|FG000|Overall Study|Lost to Follow-up|1|||
154933651|NCT01017029|559183918|FG001|Overall Study|Lost to Follow-up|0|||
154933652|NCT01017029|559183917|FG000|Overall Study|Administrative problem|0|||
154933653|NCT01017029|559183918|FG001|Overall Study|Administrative problem|1|||
155272987|NCT01865617|560432895|FG009|Overall Study|Withdrawal by Subject|0|||
155272988|NCT01865617|560432896|FG010|Overall Study|Withdrawal by Subject|0|||
155272989|NCT01865617|560432897|FG011|Overall Study|Withdrawal by Subject|0|||
154933654|NCT01017029|559183917|FG000|Overall Study|Death|3|||
154933655|NCT01017029|559183918|FG001|Overall Study|Death|1|||
154933656|NCT04936334|559183919|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
154933657|NCT00713830|559183920|FG000|Overall Study|Adverse Event|23|||
154933658|NCT00713830|559183921|FG001|Overall Study|Adverse Event|71|||
154933659|NCT00713830|559183920|FG000|Overall Study|Lack of Efficacy|24|||
154933660|NCT00713830|559183921|FG001|Overall Study|Lack of Efficacy|16|||
154933661|NCT00713830|559183920|FG000|Overall Study|Lost to Follow-up|2|||
154933662|NCT00713830|559183921|FG001|Overall Study|Lost to Follow-up|9|||
154933663|NCT00713830|559183920|FG000|Overall Study|Withdrawal by Subject|13|||
154933664|NCT00713830|559183921|FG001|Overall Study|Withdrawal by Subject|23|||
154933665|NCT00713830|559183920|FG000|Overall Study|Poor Compliance to Protocol|7|||
154933666|NCT00713830|559183921|FG001|Overall Study|Poor Compliance to Protocol|14|||
154933667|NCT00713830|559183920|FG000|Overall Study|Familial and Personal Reasons|9|||
154933668|NCT00713830|559183921|FG001|Overall Study|Familial and Personal Reasons|34|||
154933669|NCT00713830|559183920|FG000|Overall Study|Sponsor Decision|4|||
154933670|NCT00713830|559183921|FG001|Overall Study|Sponsor Decision|10|||
154933671|NCT04057118|559183924|FG000|Overall Study|Adverse Event|1|||
154933672|NCT04057118|559183925|FG001|Overall Study|Adverse Event|0|||
154933673|NCT04057118|559183926|FG002|Overall Study|Adverse Event|1|||
154933674|NCT04057118|559183927|FG003|Overall Study|Adverse Event|1|||
154933675|NCT04057118|559183924|FG000|Overall Study|Physician Decision|0|||
154933676|NCT04057118|559183925|FG001|Overall Study|Physician Decision|0|||
154933677|NCT04057118|559183926|FG002|Overall Study|Physician Decision|1|||
154933678|NCT04057118|559183927|FG003|Overall Study|Physician Decision|1|||
154933679|NCT04057118|559183924|FG000|Overall Study|Withdrawal by Subject|2|||
154933680|NCT04057118|559183925|FG001|Overall Study|Withdrawal by Subject|2|||
154933681|NCT04057118|559183926|FG002|Overall Study|Withdrawal by Subject|0|||
154933682|NCT04057118|559183927|FG003|Overall Study|Withdrawal by Subject|2|||
154933683|NCT04057118|559183924|FG000|Overall Study|Not Specific|0|||
154933684|NCT04057118|559183925|FG001|Overall Study|Not Specific|0|||
154933685|NCT04057118|559183926|FG002|Overall Study|Not Specific|1|||
154933686|NCT04057118|559183927|FG003|Overall Study|Not Specific|1|||
154933687|NCT02787785|559183928|FG000|Overall Study|Death|3|||
154933688|NCT02787785|559183929|FG001|Overall Study|Death|4|||
154933689|NCT02787785|559183928|FG000|Overall Study|Lost to Follow-up|1|||
154933690|NCT02787785|559183929|FG001|Overall Study|Lost to Follow-up|1|||
154933691|NCT02787785|559183928|FG000|Overall Study|Withdrawal by Subject|0|||
154933692|NCT02787785|559183929|FG001|Overall Study|Withdrawal by Subject|5|||
154933693|NCT02030834|559183935|FG000|Overall Study|Death|4|||
154933694|NCT02030834|559183936|FG001|Overall Study|Death|0|||
154933695|NCT02030834|559183937|FG002|Overall Study|Death|0|||
154933696|NCT02030834|559183935|FG000|Overall Study|Manufacturing failure|2|||
154933697|NCT02030834|559183936|FG001|Overall Study|Manufacturing failure|0|||
154933698|NCT02030834|559183937|FG002|Overall Study|Manufacturing failure|1|||
154933699|NCT02030834|559183935|FG000|Overall Study|Disease progression|2|||
154933700|NCT02030834|559183936|FG001|Overall Study|Disease progression|0|||
154933701|NCT02030834|559183937|FG002|Overall Study|Disease progression|2|||
154933702|NCT02030834|559183935|FG000|Overall Study|Lost to Follow-up|1|||
154933703|NCT02030834|559183936|FG001|Overall Study|Lost to Follow-up|0|||
154933704|NCT02030834|559183937|FG002|Overall Study|Lost to Follow-up|0|||
154933705|NCT02030834|559183935|FG000|Overall Study|Withdrawal by Subject|1|||
154933706|NCT02030834|559183936|FG001|Overall Study|Withdrawal by Subject|0|||
154933707|NCT02030834|559183937|FG002|Overall Study|Withdrawal by Subject|0|||
154933708|NCT02030834|559183935|FG000|Overall Study|Lack of funding|1|||
154933709|NCT02030834|559183936|FG001|Overall Study|Lack of funding|0|||
154933710|NCT02030834|559183937|FG002|Overall Study|Lack of funding|0|||
154933711|NCT01347879|559183938|FG000|Overall Study|Adverse Event|0|||
154933712|NCT01347879|559183939|FG001|Overall Study|Adverse Event|12|||
154933713|NCT01347879|559183938|FG000|Overall Study|Lost to Follow-up|2|||
154933714|NCT01347879|559183939|FG001|Overall Study|Lost to Follow-up|0|||
154933715|NCT01347879|559183938|FG000|Overall Study|Withdrawal by Subject|3|||
154933716|NCT01347879|559183939|FG001|Overall Study|Withdrawal by Subject|2|||
154933717|NCT01347879|559183938|FG000|Overall Study|Other|2|||
154933718|NCT01347879|559183939|FG001|Overall Study|Other|3|||
154933719|NCT01850108|559183944|FG000|Overall Study|Lost to Follow-up|4|||
154933720|NCT01850108|559183944|FG000|Overall Study|Not eligible|1|||
154933721|NCT01850108|559183944|FG000|Overall Study|Failed engraftment|2|||
154933722|NCT01850108|559183944|FG000|Overall Study|Physician Decision|1|||
154933723|NCT03273712|559183955|FG000|Overall Study|Death|5|||
154933724|NCT03273712|559183955|FG000|Overall Study|Adverse Event|1|||
154933725|NCT03273712|559183955|FG000|Overall Study|Disease Progression|1|||
154933726|NCT04333199|559183956|FG000|Evaluated Patients|Lost to Follow-up|0|||
154933727|NCT04333199|559183957|FG001|Evaluated Patients|Lost to Follow-up|1|||
154933728|NCT04333199|559183958|FG002|Evaluated Patients|Lost to Follow-up|2|||
154933729|NCT00666718|559183963|FG000|Overall Study|Adverse Event|0|||
155043343|NCT03026283|559590103|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
154933730|NCT00666718|559183964|FG001|Overall Study|Adverse Event|1|||
154933731|NCT00666718|559183963|FG000|Overall Study|Death|1|||
154933732|NCT00666718|559183964|FG001|Overall Study|Death|0|||
154933733|NCT00666718|559183963|FG000|Overall Study|Lost to Follow-up|1|||
154933734|NCT00666718|559183964|FG001|Overall Study|Lost to Follow-up|0|||
154933735|NCT00666718|559183963|FG000|Overall Study|Entry Criteria Not Met|2|||
154933736|NCT00666718|559183964|FG001|Overall Study|Entry Criteria Not Met|0|||
154933737|NCT00666718|559183963|FG000|Overall Study|Protocol Violation|1|||
154933738|NCT00666718|559183964|FG001|Overall Study|Protocol Violation|3|||
154933739|NCT00666718|559183963|FG000|Overall Study|Withdrawal by Subject|7|||
154933740|NCT00666718|559183964|FG001|Overall Study|Withdrawal by Subject|12|||
154933741|NCT00666718|559183963|FG000|Overall Study|Physician Decision|0|||
154933742|NCT00666718|559183964|FG001|Overall Study|Physician Decision|2|||
154933743|NCT04529096|559183972|FG000|Overall Study|Adverse Event|6|||
154933744|NCT04529096|559183973|FG001|Overall Study|Adverse Event|1|||
154933745|NCT04529096|559183972|FG000|Overall Study|Lack of Efficacy|1|||
154933746|NCT04529096|559183973|FG001|Overall Study|Lack of Efficacy|0|||
154933747|NCT04529096|559183972|FG000|Overall Study|Lost to Follow-up|1|||
154933748|NCT04529096|559183973|FG001|Overall Study|Lost to Follow-up|1|||
154933749|NCT04529096|559183972|FG000|Overall Study|Non-Compliance With Study Drug|0|||
154933750|NCT04529096|559183973|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154933751|NCT04529096|559183972|FG000|Overall Study|Physician Decision|1|||
154933752|NCT04529096|559183973|FG001|Overall Study|Physician Decision|3|||
154933753|NCT04529096|559183972|FG000|Overall Study|Withdrawal by Subject|5|||
154933754|NCT04529096|559183973|FG001|Overall Study|Withdrawal by Subject|0|||
154933755|NCT04529499|559183974|FG000|Overall Study|Withdrawal by Subject|9|||
154933756|NCT04529499|559183975|FG001|Overall Study|Withdrawal by Subject|11|||
154933757|NCT04529499|559183974|FG000|Overall Study|Physician Decision|1|||
154933758|NCT04529499|559183975|FG001|Overall Study|Physician Decision|2|||
154933759|NCT04529499|559183974|FG000|Overall Study|Adverse Event|4|||
154933760|NCT04529499|559183975|FG001|Overall Study|Adverse Event|4|||
154933761|NCT04529499|559183974|FG000|Overall Study|Death|14|||
154933762|NCT04529499|559183975|FG001|Overall Study|Death|11|||
154933763|NCT04529499|559183974|FG000|Overall Study|Lost to Follow-up|1|||
154933764|NCT04529499|559183975|FG001|Overall Study|Lost to Follow-up|1|||
154933765|NCT04529499|559183974|FG000|Overall Study|Others|7|||
155272990|NCT01865617|560432898|FG012|Overall Study|Withdrawal by Subject|0|||
155272991|NCT01865617|560432886|FG000|Overall Study|Patient proceeded to new therapy|0|||
155272992|NCT01865617|560432887|FG001|Overall Study|Patient proceeded to new therapy|0|||
154933766|NCT04529499|559183975|FG001|Overall Study|Others|11|||
154933767|NCT00683904|559183976|FG000|Dose Level 1|Disease progression|2|||
154933768|NCT00683904|559183977|FG001|Dose Level 1|Disease progression|0|||
154933769|NCT00683904|559183976|FG000|Dose Level 1|Adverse Event|1|||
154933770|NCT00683904|559183977|FG001|Dose Level 1|Adverse Event|0|||
154933771|NCT00683904|559183976|FG000|Dose Level 2|Adverse Event|0|||
154933772|NCT00683904|559183977|FG001|Dose Level 2|Adverse Event|2|||
154933773|NCT03091400|559183978|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
154933774|NCT03091400|559183979|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
154933775|NCT00975884|559183980|FG000|Overall Study|Adverse Event|1|||
154933776|NCT00975884|559183981|FG001|Overall Study|Adverse Event|0|||
154933777|NCT00975884|559183980|FG000|Overall Study|Lost to Follow-up|5|||
154933778|NCT00975884|559183981|FG001|Overall Study|Lost to Follow-up|3|||
154933779|NCT00975884|559183980|FG000|Overall Study|Withdrawal by Subject|9|||
154933780|NCT00975884|559183981|FG001|Overall Study|Withdrawal by Subject|9|||
154933781|NCT00975884|559183980|FG000|Overall Study|Other|1|||
154933782|NCT00975884|559183981|FG001|Overall Study|Other|3|||
154933783|NCT00363129|559183982|FG000|Overall Study|Withdrawal by Subject|11|||
154933784|NCT00363129|559183983|FG001|Overall Study|Withdrawal by Subject|18|||
154933785|NCT00363129|559183982|FG000|Overall Study|Adverse Event|8|||
154933786|NCT00363129|559183983|FG001|Overall Study|Adverse Event|3|||
154933787|NCT00363129|559183982|FG000|Overall Study|Alternate Treatment|2|||
154933788|NCT00363129|559183983|FG001|Overall Study|Alternate Treatment|4|||
154933789|NCT00363129|559183982|FG000|Overall Study|Other Medical Problems|2|||
154933790|NCT00363129|559183983|FG001|Overall Study|Other Medical Problems|4|||
154933791|NCT00363129|559183982|FG000|Overall Study|Death|0|||
154933792|NCT00363129|559183983|FG001|Overall Study|Death|1|||
154933793|NCT00363129|559183982|FG000|Overall Study|Other Reasons|6|||
154933794|NCT00363129|559183983|FG001|Overall Study|Other Reasons|3|||
154933795|NCT05166512|559183984|FG000|Randomized|Lost to Follow-up|2|||
154933796|NCT05166512|559183985|FG001|Randomized|Lost to Follow-up|0|||
154933797|NCT05166512|559183984|FG000|Randomized|Withdrawal by Subject|1|||
154933798|NCT05166512|559183985|FG001|Randomized|Withdrawal by Subject|0|||
155043344|NCT03026283|559590104|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155272993|NCT01865617|560432888|FG002|Overall Study|Patient proceeded to new therapy|0|||
155272994|NCT01865617|560432889|FG003|Overall Study|Patient proceeded to new therapy|0|||
155272995|NCT01865617|560432890|FG004|Overall Study|Patient proceeded to new therapy|2|||
155272996|NCT01865617|560432891|FG005|Overall Study|Patient proceeded to new therapy|0|||
155272997|NCT01865617|560432892|FG006|Overall Study|Patient proceeded to new therapy|0|||
155272998|NCT01865617|560432893|FG007|Overall Study|Patient proceeded to new therapy|0|||
155272999|NCT01865617|560432894|FG008|Overall Study|Patient proceeded to new therapy|0|||
155273000|NCT01865617|560432895|FG009|Overall Study|Patient proceeded to new therapy|0|||
155273001|NCT01865617|560432896|FG010|Overall Study|Patient proceeded to new therapy|0|||
155381930|NCT01200589|560833239|FG000|Overall Study|Study terminated|170|||
154933799|NCT05166512|559183984|FG000|Baseline Data Collection|Lost to Follow-up|0|||
154933800|NCT05166512|559183985|FG001|Baseline Data Collection|Lost to Follow-up|3|||
154933801|NCT05166512|559183984|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
154933802|NCT05166512|559183985|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
154933803|NCT05166512|559183984|FG000|Baseline Data Collection|Protocol Violation|2|||
154933804|NCT05166512|559183985|FG001|Baseline Data Collection|Protocol Violation|0|||
154933805|NCT05166512|559183984|FG000|4 Month Data Collection|Lost to Follow-up|1|||
154933806|NCT05166512|559183985|FG001|4 Month Data Collection|Lost to Follow-up|0|||
154933807|NCT05166512|559183984|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
154933808|NCT05166512|559183985|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
154933809|NCT05166512|559183984|FG000|12 Month Data Collection|Lost to Follow-up|3|||
154933810|NCT05166512|559183985|FG001|12 Month Data Collection|Lost to Follow-up|1|||
154933811|NCT05166512|559183984|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
154933812|NCT05166512|559183985|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
154933813|NCT00420849|559183986|FG000|Overall Study|Lack of Efficacy|154|||
154933814|NCT00420849|559183986|FG000|Overall Study|Adverse Event|107|||
154933815|NCT00420849|559183986|FG000|Overall Study|Withdrawal by Subject|28|||
154933816|NCT00420849|559183986|FG000|Overall Study|Death|18|||
154933817|NCT00420849|559183986|FG000|Overall Study|Other|14|||
154933818|NCT00420849|559183986|FG000|Overall Study|Transplant|8|||
154933819|NCT00420849|559183986|FG000|Overall Study|Protocol Violation|1|||
154933820|NCT00420849|559183986|FG000|Overall Study|Lost to Follow-up|1|||
154933821|NCT05789420|559183987|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
154933822|NCT05789420|559183987|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
154933823|NCT02278952|559183988|FG000|Overall Study|Insufficient Sample|6|||
154933824|NCT00659581|559183989|FG000|Overall Study|Adverse Event|1006|||
154933825|NCT00659581|559183989|FG000|Overall Study|Lack of Efficacy|1183|||
154933826|NCT00659581|559183989|FG000|Overall Study|Other|6393|||
154933827|NCT05473247|559183990|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
154933828|NCT01831596|559183991|FG000|Overall Study|Other|8|||
154933829|NCT00446134|559183992|FG000|Overall Study|Adverse Event|7|||
154933830|NCT00446134|559183993|FG001|Overall Study|Adverse Event|17|||
154933831|NCT00446134|559183994|FG002|Overall Study|Adverse Event|13|||
154933832|NCT00446134|559183995|FG003|Overall Study|Adverse Event|18|||
154933833|NCT00446134|559183992|FG000|Overall Study|Lack of Efficacy|19|||
154933834|NCT00446134|559183993|FG001|Overall Study|Lack of Efficacy|19|||
154933835|NCT00446134|559183994|FG002|Overall Study|Lack of Efficacy|24|||
154933836|NCT00446134|559183995|FG003|Overall Study|Lack of Efficacy|19|||
154933837|NCT00446134|559183992|FG000|Overall Study|Protocol Violation|0|||
154933838|NCT00446134|559183993|FG001|Overall Study|Protocol Violation|2|||
154933839|NCT00446134|559183994|FG002|Overall Study|Protocol Violation|1|||
154933840|NCT00446134|559183995|FG003|Overall Study|Protocol Violation|0|||
154933841|NCT00446134|559183992|FG000|Overall Study|Lost to Follow-up|1|||
154933842|NCT00446134|559183993|FG001|Overall Study|Lost to Follow-up|3|||
154933843|NCT00446134|559183994|FG002|Overall Study|Lost to Follow-up|1|||
154933844|NCT00446134|559183995|FG003|Overall Study|Lost to Follow-up|1|||
154933845|NCT00446134|559183992|FG000|Overall Study|Withdrawal by Subject|3|||
154933846|NCT00446134|559183993|FG001|Overall Study|Withdrawal by Subject|3|||
154933847|NCT00446134|559183994|FG002|Overall Study|Withdrawal by Subject|1|||
155273002|NCT01865617|560432897|FG011|Overall Study|Patient proceeded to new therapy|0|||
155273003|NCT01865617|560432898|FG012|Overall Study|Patient proceeded to new therapy|0|||
155273004|NCT01865617|560432886|FG000|Overall Study|Other|0|||
155273005|NCT01865617|560432887|FG001|Overall Study|Other|0|||
155273006|NCT01865617|560432888|FG002|Overall Study|Other|0|||
155273007|NCT01865617|560432889|FG003|Overall Study|Other|0|||
155273008|NCT01865617|560432890|FG004|Overall Study|Other|0|||
154933848|NCT00446134|559183995|FG003|Overall Study|Withdrawal by Subject|3|||
154933849|NCT00446134|559183992|FG000|Overall Study|Physician Decision|0|||
154933850|NCT00446134|559183993|FG001|Overall Study|Physician Decision|0|||
154933851|NCT00446134|559183994|FG002|Overall Study|Physician Decision|0|||
154933852|NCT00446134|559183995|FG003|Overall Study|Physician Decision|2|||
154933853|NCT00446134|559183992|FG000|Overall Study|Adverse Event-Diarrhea|1|||
154933854|NCT00446134|559183993|FG001|Overall Study|Adverse Event-Diarrhea|1|||
154933855|NCT00446134|559183994|FG002|Overall Study|Adverse Event-Diarrhea|2|||
154933856|NCT00446134|559183995|FG003|Overall Study|Adverse Event-Diarrhea|0|||
155273009|NCT01865617|560432891|FG005|Overall Study|Other|0|||
155273010|NCT01865617|560432892|FG006|Overall Study|Other|1|||
155273011|NCT01865617|560432893|FG007|Overall Study|Other|0|||
155273012|NCT01865617|560432894|FG008|Overall Study|Other|0|||
155273013|NCT01865617|560432895|FG009|Overall Study|Other|0|||
155273014|NCT01865617|560432896|FG010|Overall Study|Other|0|||
155273015|NCT01865617|560432897|FG011|Overall Study|Other|0|||
155273016|NCT01865617|560432898|FG012|Overall Study|Other|0|||
155273017|NCT02500979|560432903|FG000|Period 1|Hyperglycemia|1|||
155273018|NCT02500979|560432904|FG001|Period 1|Hyperglycemia|0|||
155273019|NCT02500979|560432903|FG000|Period 1|Severe non-compliance to protocol|0|||
155273020|NCT02500979|560432904|FG001|Period 1|Severe non-compliance to protocol|1|||
155273021|NCT02500979|560432903|FG000|Period 1|Adverse Event|1|||
155273022|NCT02500979|560432904|FG001|Period 1|Adverse Event|0|||
155273023|NCT02500979|560432903|FG000|Period 1|Subject decision|2|||
155273024|NCT02500979|560432904|FG001|Period 1|Subject decision|0|||
155273025|NCT02500979|560432903|FG000|Period 2|Change in risk|1|||
155273026|NCT02500979|560432904|FG001|Period 2|Change in risk|0|||
154933857|NCT00446134|559183992|FG000|Overall Study|Reason Not Completed|3|||
154933858|NCT00446134|559183993|FG001|Overall Study|Reason Not Completed|0|||
154933859|NCT00446134|559183994|FG002|Overall Study|Reason Not Completed|1|||
154933860|NCT00446134|559183995|FG003|Overall Study|Reason Not Completed|2|||
154933861|NCT03125629|559183996|FG000|Overall Study|Withdrawal by Subject|2|||
155273027|NCT03772314|560432905|FG000|Overall Study|Adverse Event|7|||
155273028|NCT03772314|560432906|FG001|Overall Study|Adverse Event|2|||
155273029|NCT01613027|560432907|FG000|Overall Study|Lost to Follow-up|5|||
155273030|NCT01613027|560432907|FG000|Overall Study|Switched Physician|1|||
154933862|NCT03125629|559183996|FG000|Overall Study|Equipment malfunction|1|||
154933863|NCT04508621|559183997|FG000|Overall Study|Adverse Event|39|||
154933864|NCT04508621|559183998|FG001|Overall Study|Adverse Event|16|||
154933865|NCT04508621|559183997|FG000|Overall Study|Lack of Efficacy|2|||
154933866|NCT04508621|559183998|FG001|Overall Study|Lack of Efficacy|8|||
154933867|NCT04508621|559183997|FG000|Overall Study|Physician Decision|0|||
154933868|NCT04508621|559183998|FG001|Overall Study|Physician Decision|1|||
154933869|NCT04508621|559183997|FG000|Overall Study|Withdrawal by Subject|10|||
154933870|NCT04508621|559183998|FG001|Overall Study|Withdrawal by Subject|14|||
154933871|NCT04508621|559183997|FG000|Overall Study|Lost to Follow-up|12|||
154933872|NCT04508621|559183998|FG001|Overall Study|Lost to Follow-up|9|||
154933873|NCT04508621|559183997|FG000|Overall Study|COVID-19 related crisis|3|||
154933874|NCT04508621|559183998|FG001|Overall Study|COVID-19 related crisis|0|||
154933875|NCT04508621|559183997|FG000|Overall Study|Subject non-compliance|1|||
154933876|NCT04508621|559183998|FG001|Overall Study|Subject non-compliance|0|||
154933877|NCT00759759|559183999|FG000|Overall Study|didn't return for period 2|1|||
154933878|NCT00759759|559184000|FG001|Overall Study|didn't return for period 2|0|||
154933879|NCT00759759|559183999|FG000|Overall Study|Didn't receive drug in period 2|1|||
154933880|NCT00759759|559184000|FG001|Overall Study|Didn't receive drug in period 2|0|||
154933881|NCT00759759|559183999|FG000|Overall Study|Withdrawal by Subject|2|||
154933882|NCT00759759|559184000|FG001|Overall Study|Withdrawal by Subject|1|||
154933883|NCT01556165|559184001|FG000|Overall Study|Adverse Event|5|||
154933884|NCT01556165|559184002|FG001|Overall Study|Adverse Event|3|||
154933885|NCT01556165|559184001|FG000|Overall Study|Protocol Violation|0|||
154933886|NCT01556165|559184002|FG001|Overall Study|Protocol Violation|3|||
154933887|NCT01556165|559184001|FG000|Overall Study|Withdrawal of Consent|7|||
154933888|NCT01556165|559184002|FG001|Overall Study|Withdrawal of Consent|1|||
154933889|NCT02531698|559184005|FG000|Overall Study|Adverse Event|2|||
154933890|NCT02531698|559184006|FG001|Overall Study|Adverse Event|1|||
154933891|NCT02531698|559184005|FG000|Overall Study|Withdrawal by Subject|6|||
154933892|NCT02531698|559184006|FG001|Overall Study|Withdrawal by Subject|1|||
154933893|NCT02531698|559184005|FG000|Overall Study|Protocol Violation|2|||
154933894|NCT02531698|559184006|FG001|Overall Study|Protocol Violation|0|||
154933895|NCT02531698|559184005|FG000|Overall Study|Lost to Follow-up|1|||
154933896|NCT02531698|559184006|FG001|Overall Study|Lost to Follow-up|0|||
154933897|NCT02395536|559184007|FG000|Overall Study|Lost to Follow-up|4|||
154933898|NCT02395536|559184008|FG001|Overall Study|Lost to Follow-up|4|||
154933899|NCT02395536|559184007|FG000|Overall Study|Death|2|||
154933900|NCT02395536|559184008|FG001|Overall Study|Death|0|||
154933901|NCT02395536|559184007|FG000|Overall Study|Physician Decision|4|||
154933902|NCT02395536|559184008|FG001|Overall Study|Physician Decision|6|||
154933903|NCT02395536|559184007|FG000|Overall Study|Withdrawal by Subject|9|||
154933904|NCT02395536|559184008|FG001|Overall Study|Withdrawal by Subject|17|||
154933905|NCT02395536|559184007|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
154933906|NCT02395536|559184008|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
154933907|NCT02395536|559184007|FG000|Overall Study|Insurance issue|0|||
154933908|NCT02395536|559184008|FG001|Overall Study|Insurance issue|1|||
154933909|NCT00701558|559184009|FG000|Overall Study|Death|7|||
154933910|NCT00701558|559184009|FG000|Overall Study|Lost to Follow-up|8|||
154933911|NCT01637961|559185942|FG000|Overall Study|Ineligible: wrong primary|1|||
154933912|NCT01637961|559185942|FG000|Overall Study|Ineligible: inadequate pathology|1|||
154933913|NCT04006847|559185943|FG000|Overall Study|Product issue|1|||
154933914|NCT03555890|559185951|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154933915|NCT03555890|559185952|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154933916|NCT03555890|559185953|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154933917|NCT03555890|559185954|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
154933918|NCT03372369|559185955|FG000|Qualification Period|Withdrawal by Subject|16|||
154933919|NCT03372369|559185956|FG001|Qualification Period|Withdrawal by Subject|13|||
154933920|NCT03372369|559185955|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
154933921|NCT03372369|559185956|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
154933922|NCT03372369|559185955|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
154933923|NCT03372369|559185956|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
154933924|NCT01383954|559185957|FG000|Overall Study|Lack of Efficacy|2|||
154933925|NCT01383954|559185957|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
154933926|NCT01383954|559185957|FG000|Overall Study|Adverse Event|1|||
154933927|NCT01383954|559185957|FG000|Overall Study|Reason Not Specified|9|||
154933928|NCT04388527|559185959|FG000|Overall Study|Death|14|||
154933929|NCT04388527|559185959|FG000|Overall Study|Withdrawal by Subject|2|||
154933930|NCT04388527|559185959|FG000|Overall Study|Lost to Follow-up|1|||
154933931|NCT02773446|559185965|FG000|First Admission|Withdrawal by Subject|0|||
154933932|NCT02773446|559185966|FG001|First Admission|Withdrawal by Subject|0|||
154933933|NCT02773446|559185967|FG002|First Admission|Withdrawal by Subject|0|||
154933934|NCT02773446|559185968|FG003|First Admission|Withdrawal by Subject|1|||
154933935|NCT02773446|559185969|FG004|First Admission|Withdrawal by Subject|0|||
154933936|NCT02773446|559185970|FG005|First Admission|Withdrawal by Subject|0|||
154933937|NCT02773446|559185965|FG000|First Admission|Lost to Follow-up|1|||
154933938|NCT02773446|559185966|FG001|First Admission|Lost to Follow-up|0|||
154933939|NCT02773446|559185967|FG002|First Admission|Lost to Follow-up|0|||
154933940|NCT02773446|559185968|FG003|First Admission|Lost to Follow-up|0|||
154933941|NCT02773446|559185969|FG004|First Admission|Lost to Follow-up|0|||
154933942|NCT02773446|559185970|FG005|First Admission|Lost to Follow-up|0|||
154933943|NCT00289731|559185971|FG000|Overall Study|Adverse Event|1|||
154933944|NCT00289731|559185972|FG001|Overall Study|Adverse Event|2|||
154933945|NCT00289731|559185973|FG002|Overall Study|Adverse Event|2|||
154933946|NCT00289731|559185971|FG000|Overall Study|Other|1|||
154933947|NCT00289731|559185972|FG001|Overall Study|Other|0|||
154933948|NCT00289731|559185973|FG002|Overall Study|Other|0|||
154933949|NCT04023994|559185974|FG000|Overall Study|Lost to Follow-up|0|||
154933950|NCT04023994|559185975|FG001|Overall Study|Lost to Follow-up|1|||
154933951|NCT04023994|559185976|FG002|Overall Study|Lost to Follow-up|2|||
154933952|NCT04023994|559185977|FG003|Overall Study|Lost to Follow-up|0|||
154933953|NCT04023994|559185978|FG004|Overall Study|Lost to Follow-up|0|||
154933954|NCT04023994|559185979|FG005|Overall Study|Lost to Follow-up|0|||
154933955|NCT04023994|559185974|FG000|Overall Study|Withdrawal by Subject|0|||
154933956|NCT04023994|559185975|FG001|Overall Study|Withdrawal by Subject|0|||
154933957|NCT04023994|559185976|FG002|Overall Study|Withdrawal by Subject|0|||
154933958|NCT04023994|559185977|FG003|Overall Study|Withdrawal by Subject|1|||
154933959|NCT04023994|559185978|FG004|Overall Study|Withdrawal by Subject|0|||
154933960|NCT04023994|559185979|FG005|Overall Study|Withdrawal by Subject|0|||
154933961|NCT01613131|559185980|FG000|Overall Study|Withdrawal by Subject|3|||
154933962|NCT01613131|559185981|FG001|Overall Study|Withdrawal by Subject|5|||
154933963|NCT02454972|559185982|FG000|Overall Study|Progressive disease|17|||
154933964|NCT02454972|559185983|FG001|Overall Study|Progressive disease|16|||
154933965|NCT02454972|559185984|FG002|Overall Study|Progressive disease|59|||
154933966|NCT02454972|559185985|FG003|Overall Study|Progressive disease|23|||
154933967|NCT02454972|559185986|FG004|Overall Study|Progressive disease|16|||
154933968|NCT02454972|559185987|FG005|Overall Study|Progressive disease|12|||
154933969|NCT02454972|559185988|FG006|Overall Study|Progressive disease|19|||
154933970|NCT02454972|559185989|FG007|Overall Study|Progressive disease|27|||
154933971|NCT02454972|559185990|FG008|Overall Study|Progressive disease|0|||
154933972|NCT02454972|559185982|FG000|Overall Study|Death|0|||
154933973|NCT02454972|559185983|FG001|Overall Study|Death|0|||
154933974|NCT02454972|559185984|FG002|Overall Study|Death|5|||
154933975|NCT02454972|559185985|FG003|Overall Study|Death|1|||
154933976|NCT02454972|559185986|FG004|Overall Study|Death|0|||
154933977|NCT02454972|559185987|FG005|Overall Study|Death|0|||
154933978|NCT02454972|559185988|FG006|Overall Study|Death|0|||
154933979|NCT02454972|559185989|FG007|Overall Study|Death|0|||
154933980|NCT02454972|559185990|FG008|Overall Study|Death|95|||
154933981|NCT02454972|559185982|FG000|Overall Study|Physician Decision|0|||
154933982|NCT02454972|559185983|FG001|Overall Study|Physician Decision|1|||
154933983|NCT02454972|559185984|FG002|Overall Study|Physician Decision|2|||
154933984|NCT02454972|559185985|FG003|Overall Study|Physician Decision|1|||
154933985|NCT02454972|559185986|FG004|Overall Study|Physician Decision|2|||
154933986|NCT02454972|559185987|FG005|Overall Study|Physician Decision|0|||
154933987|NCT02454972|559185988|FG006|Overall Study|Physician Decision|0|||
154933988|NCT02454972|559185989|FG007|Overall Study|Physician Decision|1|||
154933989|NCT02454972|559185990|FG008|Overall Study|Physician Decision|0|||
154933990|NCT02454972|559185982|FG000|Overall Study|Non treatment-related adverse event|2|||
154933991|NCT02454972|559185983|FG001|Overall Study|Non treatment-related adverse event|0|||
154933992|NCT02454972|559185984|FG002|Overall Study|Non treatment-related adverse event|1|||
154933993|NCT02454972|559185985|FG003|Overall Study|Non treatment-related adverse event|0|||
154933994|NCT02454972|559185986|FG004|Overall Study|Non treatment-related adverse event|0|||
154933995|NCT02454972|559185987|FG005|Overall Study|Non treatment-related adverse event|1|||
154933996|NCT02454972|559185988|FG006|Overall Study|Non treatment-related adverse event|0|||
154933997|NCT02454972|559185989|FG007|Overall Study|Non treatment-related adverse event|1|||
154933998|NCT02454972|559185990|FG008|Overall Study|Non treatment-related adverse event|0|||
154933999|NCT02454972|559185982|FG000|Overall Study|Treatment-related adverse events|0|||
154934000|NCT02454972|559185983|FG001|Overall Study|Treatment-related adverse events|1|||
154934001|NCT02454972|559185984|FG002|Overall Study|Treatment-related adverse events|1|||
154934002|NCT02454972|559185985|FG003|Overall Study|Treatment-related adverse events|0|||
154934003|NCT02454972|559185986|FG004|Overall Study|Treatment-related adverse events|2|||
154934004|NCT02454972|559185987|FG005|Overall Study|Treatment-related adverse events|0|||
154934005|NCT02454972|559185988|FG006|Overall Study|Treatment-related adverse events|0|||
154934006|NCT02454972|559185989|FG007|Overall Study|Treatment-related adverse events|2|||
154934007|NCT02454972|559185990|FG008|Overall Study|Treatment-related adverse events|0|||
154934008|NCT02454972|559185982|FG000|Overall Study|Patient moves to compassionate use|0|||
154934009|NCT02454972|559185983|FG001|Overall Study|Patient moves to compassionate use|0|||
154934010|NCT02454972|559185984|FG002|Overall Study|Patient moves to compassionate use|0|||
154934011|NCT02454972|559185985|FG003|Overall Study|Patient moves to compassionate use|0|||
154934012|NCT02454972|559185986|FG004|Overall Study|Patient moves to compassionate use|0|||
154934013|NCT02454972|559185987|FG005|Overall Study|Patient moves to compassionate use|0|||
154934014|NCT02454972|559185988|FG006|Overall Study|Patient moves to compassionate use|2|||
154934015|NCT02454972|559185989|FG007|Overall Study|Patient moves to compassionate use|0|||
154934016|NCT02454972|559185990|FG008|Overall Study|Patient moves to compassionate use|0|||
154934017|NCT02454972|559185982|FG000|Overall Study|Withdrawal by Subject|0|||
154934018|NCT02454972|559185983|FG001|Overall Study|Withdrawal by Subject|1|||
154934019|NCT02454972|559185984|FG002|Overall Study|Withdrawal by Subject|5|||
154934020|NCT02454972|559185985|FG003|Overall Study|Withdrawal by Subject|2|||
154934021|NCT02454972|559185986|FG004|Overall Study|Withdrawal by Subject|3|||
154934022|NCT02454972|559185987|FG005|Overall Study|Withdrawal by Subject|2|||
154934023|NCT02454972|559185988|FG006|Overall Study|Withdrawal by Subject|0|||
154934024|NCT02454972|559185989|FG007|Overall Study|Withdrawal by Subject|1|||
154934025|NCT02454972|559185990|FG008|Overall Study|Withdrawal by Subject|2|||
154934026|NCT02454972|559185982|FG000|Overall Study|Multiple delay/holds on treatment|0|||
154934027|NCT02454972|559185983|FG001|Overall Study|Multiple delay/holds on treatment|0|||
154934028|NCT02454972|559185984|FG002|Overall Study|Multiple delay/holds on treatment|0|||
154934029|NCT02454972|559185985|FG003|Overall Study|Multiple delay/holds on treatment|1|||
154934030|NCT02454972|559185986|FG004|Overall Study|Multiple delay/holds on treatment|0|||
154934031|NCT02454972|559185987|FG005|Overall Study|Multiple delay/holds on treatment|0|||
154934032|NCT02454972|559185988|FG006|Overall Study|Multiple delay/holds on treatment|0|||
154934033|NCT02454972|559185989|FG007|Overall Study|Multiple delay/holds on treatment|0|||
154934034|NCT02454972|559185990|FG008|Overall Study|Multiple delay/holds on treatment|0|||
154934035|NCT02454972|559185982|FG000|Overall Study|Never treated|0|||
154934036|NCT02454972|559185983|FG001|Overall Study|Never treated|0|||
154934037|NCT02454972|559185984|FG002|Overall Study|Never treated|3|||
154934038|NCT02454972|559185985|FG003|Overall Study|Never treated|1|||
154934039|NCT02454972|559185986|FG004|Overall Study|Never treated|1|||
154934040|NCT02454972|559185987|FG005|Overall Study|Never treated|0|||
154934041|NCT02454972|559185988|FG006|Overall Study|Never treated|0|||
154934042|NCT02454972|559185989|FG007|Overall Study|Never treated|0|||
154934043|NCT02454972|559185990|FG008|Overall Study|Never treated|5|||
154934044|NCT02454972|559185982|FG000|Overall Study|Lost to Follow-up|0|||
154934045|NCT02454972|559185983|FG001|Overall Study|Lost to Follow-up|0|||
154934046|NCT02454972|559185984|FG002|Overall Study|Lost to Follow-up|0|||
154934047|NCT02454972|559185985|FG003|Overall Study|Lost to Follow-up|0|||
154934048|NCT02454972|559185986|FG004|Overall Study|Lost to Follow-up|0|||
154934049|NCT02454972|559185987|FG005|Overall Study|Lost to Follow-up|0|||
154934050|NCT02454972|559185988|FG006|Overall Study|Lost to Follow-up|0|||
154934051|NCT02454972|559185989|FG007|Overall Study|Lost to Follow-up|0|||
154934052|NCT02454972|559185990|FG008|Overall Study|Lost to Follow-up|2|||
154934053|NCT02454972|559185982|FG000|Overall Study|Study termination|0|||
154934054|NCT02454972|559185983|FG001|Overall Study|Study termination|0|||
154934055|NCT02454972|559185984|FG002|Overall Study|Study termination|0|||
154934056|NCT02454972|559185985|FG003|Overall Study|Study termination|0|||
154934057|NCT02454972|559185986|FG004|Overall Study|Study termination|0|||
154934058|NCT02454972|559185987|FG005|Overall Study|Study termination|0|||
154934059|NCT02454972|559185988|FG006|Overall Study|Study termination|0|||
154934060|NCT02454972|559185989|FG007|Overall Study|Study termination|0|||
154934061|NCT02454972|559185990|FG008|Overall Study|Study termination|6|||
154934062|NCT01070966|559185995|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
154934063|NCT01070966|559185995|FG000|Participants for Safety Evaluation|Off-label use|9|||
154934064|NCT01070966|559185995|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
154934065|NCT01070966|559185995|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
154934066|NCT01070966|559185995|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
154934067|NCT01070966|559185995|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
154934068|NCT01070966|559185995|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
154934069|NCT01070966|559185995|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
154934070|NCT02770716|559185996|FG000|Overall Study|Death|101|||
154934071|NCT02770716|559185997|FG001|Overall Study|Death|45|||
154934072|NCT02770716|559185996|FG000|Overall Study|Withdrawal by Subject|4|||
154934073|NCT02770716|559185997|FG001|Overall Study|Withdrawal by Subject|2|||
154934074|NCT02770716|559185996|FG000|Overall Study|Lost to Follow-up|1|||
154934075|NCT02770716|559185997|FG001|Overall Study|Lost to Follow-up|0|||
154934076|NCT02770716|559185996|FG000|Overall Study|Various reasons|6|||
154934077|NCT02770716|559185997|FG001|Overall Study|Various reasons|2|||
154934078|NCT01725113|559185998|FG000|Overall Study|Kidney Transplant|1|||
154934079|NCT01725113|559185999|FG001|Overall Study|Kidney Transplant|1|||
155381931|NCT01200589|560833240|FG001|Overall Study|Study terminated|172|||
154934080|NCT01725113|559185998|FG000|Overall Study|Withdrawal by Subject|0|||
154934081|NCT01725113|559185999|FG001|Overall Study|Withdrawal by Subject|1|||
154934082|NCT01415921|559186002|FG000|Overall Study|Adverse Event|0|||
154934083|NCT01415921|559186003|FG001|Overall Study|Adverse Event|1|||
154934084|NCT01415921|559186002|FG000|Overall Study|Physician Decision|1|||
154934085|NCT01415921|559186003|FG001|Overall Study|Physician Decision|1|||
154934086|NCT01415921|559186002|FG000|Overall Study|Withdrawal by Subject|0|||
154934087|NCT01415921|559186003|FG001|Overall Study|Withdrawal by Subject|1|||
154934088|NCT01415921|559186002|FG000|Overall Study|Other|2|||
154934089|NCT01415921|559186003|FG001|Overall Study|Other|0|||
154934090|NCT00572156|559186014|FG000|Overall Study|Adverse Event|3|||
154934091|NCT00572156|559186015|FG001|Overall Study|Adverse Event|1|||
154934092|NCT00572156|559186016|FG002|Overall Study|Adverse Event|5|||
154934093|NCT00572156|559186017|FG003|Overall Study|Adverse Event|1|||
154934094|NCT00572156|559186014|FG000|Overall Study|Lost to Follow-up|1|||
154934095|NCT00572156|559186015|FG001|Overall Study|Lost to Follow-up|1|||
154934096|NCT00572156|559186016|FG002|Overall Study|Lost to Follow-up|1|||
154934097|NCT00572156|559186017|FG003|Overall Study|Lost to Follow-up|0|||
154934098|NCT00572156|559186014|FG000|Overall Study|Protocol Violation|1|||
154934099|NCT00572156|559186015|FG001|Overall Study|Protocol Violation|2|||
154934100|NCT00572156|559186016|FG002|Overall Study|Protocol Violation|0|||
154934101|NCT00572156|559186017|FG003|Overall Study|Protocol Violation|2|||
154934102|NCT00572156|559186014|FG000|Overall Study|Patient/Parent Decision|1|||
154934103|NCT00572156|559186015|FG001|Overall Study|Patient/Parent Decision|6|||
154934104|NCT00572156|559186016|FG002|Overall Study|Patient/Parent Decision|4|||
154934105|NCT00572156|559186017|FG003|Overall Study|Patient/Parent Decision|3|||
154934106|NCT00572156|559186014|FG000|Overall Study|Sponsor Decision|20|||
154934107|NCT00572156|559186015|FG001|Overall Study|Sponsor Decision|16|||
154934108|NCT00572156|559186016|FG002|Overall Study|Sponsor Decision|17|||
154934109|NCT00572156|559186017|FG003|Overall Study|Sponsor Decision|19|||
154934110|NCT01440595|559186018|FG000|Overall Study|Lost to Follow-up|0|||
154934111|NCT01440595|559186019|FG001|Overall Study|Lost to Follow-up|1|||
154934112|NCT01440595|559186020|FG002|Overall Study|Lost to Follow-up|0|||
154934113|NCT01440595|559186018|FG000|Overall Study|Study terminated by sponsor.|1|||
154934114|NCT01440595|559186019|FG001|Overall Study|Study terminated by sponsor.|2|||
154934115|NCT01440595|559186020|FG002|Overall Study|Study terminated by sponsor.|1|||
154934116|NCT03216954|559186021|FG000|Overall Study|Adverse Event|0|||
154934117|NCT03216954|559186022|FG001|Overall Study|Adverse Event|0|||
154934118|NCT03216954|559186023|FG002|Overall Study|Adverse Event|1|||
154934119|NCT03216954|559186024|FG003|Overall Study|Adverse Event|0|||
154934120|NCT03216954|559186025|FG004|Overall Study|Adverse Event|1|||
154934121|NCT03216954|559186021|FG000|Overall Study|Withdrawal by Subject|2|||
154934122|NCT03216954|559186022|FG001|Overall Study|Withdrawal by Subject|0|||
154934123|NCT03216954|559186023|FG002|Overall Study|Withdrawal by Subject|0|||
154934124|NCT03216954|559186024|FG003|Overall Study|Withdrawal by Subject|0|||
154934125|NCT03216954|559186025|FG004|Overall Study|Withdrawal by Subject|0|||
154934126|NCT03216954|559186021|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
154934127|NCT03216954|559186022|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
154934128|NCT03216954|559186023|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
154934129|NCT03216954|559186024|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
154934130|NCT03216954|559186025|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
154934131|NCT02981602|559186028|FG000|Overall Study|Adverse Event|0|||
154934132|NCT02981602|559186029|FG001|Overall Study|Adverse Event|0|||
154934133|NCT02981602|559186030|FG002|Overall Study|Adverse Event|0|||
154934134|NCT02981602|559186031|FG003|Overall Study|Adverse Event|1|||
154934135|NCT02981602|559186032|FG004|Overall Study|Adverse Event|0|||
154934136|NCT00963599|559186033|FG000|Overall Study|Adverse Event|2|||
154934137|NCT00963599|559186034|FG001|Overall Study|Adverse Event|0|||
154934138|NCT00963599|559186035|FG002|Overall Study|Adverse Event|1|||
154934139|NCT00963599|559186036|FG003|Overall Study|Adverse Event|2|||
154934140|NCT00963599|559186033|FG000|Overall Study|Lack of Efficacy|0|||
154934141|NCT00963599|559186034|FG001|Overall Study|Lack of Efficacy|2|||
154934142|NCT00963599|559186035|FG002|Overall Study|Lack of Efficacy|1|||
154934143|NCT00963599|559186036|FG003|Overall Study|Lack of Efficacy|4|||
154934144|NCT00963599|559186033|FG000|Overall Study|Lost to Follow-up|0|||
154934145|NCT00963599|559186034|FG001|Overall Study|Lost to Follow-up|1|||
154934146|NCT00963599|559186035|FG002|Overall Study|Lost to Follow-up|1|||
154934147|NCT00963599|559186036|FG003|Overall Study|Lost to Follow-up|1|||
154934148|NCT00963599|559186033|FG000|Overall Study|Protocol Violation|2|||
154934149|NCT00963599|559186034|FG001|Overall Study|Protocol Violation|2|||
154934150|NCT00963599|559186035|FG002|Overall Study|Protocol Violation|3|||
154934151|NCT00963599|559186036|FG003|Overall Study|Protocol Violation|4|||
154934152|NCT00963599|559186033|FG000|Overall Study|Withdrawal by Subject|2|||
154934153|NCT00963599|559186034|FG001|Overall Study|Withdrawal by Subject|1|||
154934154|NCT00963599|559186035|FG002|Overall Study|Withdrawal by Subject|3|||
154934155|NCT00963599|559186036|FG003|Overall Study|Withdrawal by Subject|3|||
154934156|NCT02983227|559186038|FG000|Overall Study|Adverse Event|21|||
154934157|NCT02983227|559186039|FG001|Overall Study|Adverse Event|3|||
154934158|NCT02983227|559186038|FG000|Overall Study|Death|3|||
154934159|NCT02983227|559186039|FG001|Overall Study|Death|0|||
154934160|NCT02983227|559186038|FG000|Overall Study|Lack of Efficacy|8|||
154934161|NCT02983227|559186039|FG001|Overall Study|Lack of Efficacy|1|||
154934162|NCT02983227|559186038|FG000|Overall Study|Lost to Follow-up|3|||
154934163|NCT02983227|559186039|FG001|Overall Study|Lost to Follow-up|0|||
154934164|NCT02983227|559186038|FG000|Overall Study|Multiple Reasons|2|||
154934165|NCT02983227|559186039|FG001|Overall Study|Multiple Reasons|1|||
154934166|NCT02983227|559186038|FG000|Overall Study|Physician Decision|3|||
154934167|NCT02983227|559186039|FG001|Overall Study|Physician Decision|1|||
154934168|NCT02983227|559186038|FG000|Overall Study|Withdrawal by Subject|19|||
154934169|NCT02983227|559186039|FG001|Overall Study|Withdrawal by Subject|8|||
154934170|NCT01706770|559186040|FG000|Overall Study|Lost to Follow-up|1|||
154934171|NCT01706770|559186041|FG001|Overall Study|Lost to Follow-up|0|||
154934172|NCT01706770|559186040|FG000|Overall Study|Physician Decision|1|||
154934173|NCT01706770|559186041|FG001|Overall Study|Physician Decision|0|||
154934174|NCT00068445|559186044|FG000|Randomization|Cancel|1|||
154934175|NCT00068445|559186045|FG001|Randomization|Cancel|3|||
154934176|NCT00068445|559186044|FG000|Randomization|Ineligible|1|||
154934177|NCT00068445|559186045|FG001|Randomization|Ineligible|1|||
154934178|NCT00068445|559186044|FG000|Treatment|Refused Further Treatment|13|||
154934179|NCT00068445|559186045|FG001|Treatment|Refused Further Treatment|10|||
154934180|NCT00068445|559186044|FG000|Treatment|Adverse Event|7|||
154934181|NCT00068445|559186045|FG001|Treatment|Adverse Event|1|||
154934182|NCT00068445|559186044|FG000|Treatment|Other (Specifics not available)|9|||
154934183|NCT00068445|559186045|FG001|Treatment|Other (Specifics not available)|5|||
154934184|NCT01896700|559186046|FG000|Overall Study|Adverse Event|4|||
154934185|NCT01896700|559186047|FG001|Overall Study|Adverse Event|5|||
154934186|NCT01896700|559186046|FG000|Overall Study|Withdrawal by Subject|0|||
154934187|NCT01896700|559186047|FG001|Overall Study|Withdrawal by Subject|1|||
154934188|NCT00423488|559186048|FG000|Overall Study|No evidence of study drug intake|2|||
154934189|NCT00423488|559186049|FG001|Overall Study|No evidence of study drug intake|1|||
154934190|NCT00423488|559186048|FG000|Overall Study|No post baseline data|3|||
154934191|NCT00423488|559186049|FG001|Overall Study|No post baseline data|0|||
154934192|NCT03835975|559186050|FG000|Overall Study|Lost to Follow-up|1|||
154934193|NCT03835975|559186051|FG001|Overall Study|Lost to Follow-up|1|||
154934194|NCT03835975|559186052|FG002|Overall Study|Lost to Follow-up|0|||
154934195|NCT03835975|559186053|FG003|Overall Study|Lost to Follow-up|0|||
154934196|NCT03835975|559186054|FG004|Overall Study|Lost to Follow-up|0|||
154934197|NCT03835975|559186050|FG000|Overall Study|No longer met eligibility criteria|0|||
154934198|NCT03835975|559186051|FG001|Overall Study|No longer met eligibility criteria|1|||
154934199|NCT03835975|559186052|FG002|Overall Study|No longer met eligibility criteria|0|||
154934200|NCT03835975|559186053|FG003|Overall Study|No longer met eligibility criteria|0|||
154934201|NCT03835975|559186054|FG004|Overall Study|No longer met eligibility criteria|0|||
154934202|NCT03835975|559186050|FG000|Overall Study|Protocol Violation|1|||
154934203|NCT03835975|559186051|FG001|Overall Study|Protocol Violation|1|||
154934204|NCT03835975|559186052|FG002|Overall Study|Protocol Violation|2|||
154934205|NCT03835975|559186053|FG003|Overall Study|Protocol Violation|0|||
154934206|NCT03835975|559186054|FG004|Overall Study|Protocol Violation|0|||
154934207|NCT03835975|559186050|FG000|Overall Study|Withdrawal by Subject|1|||
154934208|NCT03835975|559186051|FG001|Overall Study|Withdrawal by Subject|0|||
154934209|NCT03835975|559186052|FG002|Overall Study|Withdrawal by Subject|1|||
154934210|NCT03835975|559186053|FG003|Overall Study|Withdrawal by Subject|1|||
154934211|NCT03835975|559186054|FG004|Overall Study|Withdrawal by Subject|0|||
154934212|NCT01612702|559186057|FG000|Overall Study|Protocol Violation|11|||
154934213|NCT01612702|559186058|FG001|Overall Study|Protocol Violation|11|||
154934214|NCT03070431|559186059|FG000|Overall Study|Withdrawal by Subject|2|||
154934215|NCT03070431|559186059|FG000|Overall Study|Lost to Follow-up|2|||
154934216|NCT03674827|559186062|FG000|Treatment Phase|Adverse Event|0|||
154934217|NCT03674827|559186063|FG001|Treatment Phase|Adverse Event|0|||
154934218|NCT03674827|559186064|FG002|Treatment Phase|Adverse Event|0|||
154934219|NCT03674827|559186065|FG003|Treatment Phase|Adverse Event|0|||
154934220|NCT03674827|559186066|FG004|Treatment Phase|Adverse Event|0|||
154934221|NCT03674827|559186067|FG005|Treatment Phase|Adverse Event|2|||
154934222|NCT03674827|559186062|FG000|Treatment Phase|Death|2|||
154934223|NCT03674827|559186063|FG001|Treatment Phase|Death|0|||
154934224|NCT03674827|559186064|FG002|Treatment Phase|Death|0|||
154934225|NCT03674827|559186065|FG003|Treatment Phase|Death|0|||
154934226|NCT03674827|559186066|FG004|Treatment Phase|Death|1|||
154934227|NCT03674827|559186067|FG005|Treatment Phase|Death|0|||
154934228|NCT03674827|559186062|FG000|Treatment Phase|Progressive Disease|0|||
154934229|NCT03674827|559186063|FG001|Treatment Phase|Progressive Disease|4|||
154934230|NCT03674827|559186064|FG002|Treatment Phase|Progressive Disease|3|||
154934231|NCT03674827|559186065|FG003|Treatment Phase|Progressive Disease|4|||
154934232|NCT03674827|559186066|FG004|Treatment Phase|Progressive Disease|4|||
154934233|NCT03674827|559186067|FG005|Treatment Phase|Progressive Disease|9|||
154934234|NCT03674827|559186062|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
154934235|NCT03674827|559186063|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
154934236|NCT03674827|559186064|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
154934237|NCT03674827|559186065|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
154934238|NCT03674827|559186066|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
154934239|NCT03674827|559186067|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
154934240|NCT03674827|559186062|FG000|Treatment Phase|Withdrawal by Subject|0|||
154934241|NCT03674827|559186063|FG001|Treatment Phase|Withdrawal by Subject|0|||
154934242|NCT03674827|559186064|FG002|Treatment Phase|Withdrawal by Subject|0|||
154934243|NCT03674827|559186065|FG003|Treatment Phase|Withdrawal by Subject|0|||
154934244|NCT03674827|559186066|FG004|Treatment Phase|Withdrawal by Subject|0|||
154934245|NCT03674827|559186067|FG005|Treatment Phase|Withdrawal by Subject|1|||
154934246|NCT03674827|559186062|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
154934247|NCT03674827|559186063|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
154934248|NCT03674827|559186064|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
154934249|NCT03674827|559186065|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
154934250|NCT03674827|559186066|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
154934251|NCT03674827|559186067|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
154934252|NCT03674827|559186062|FG000|Treatment Phase|Other|0|||
154934253|NCT03674827|559186063|FG001|Treatment Phase|Other|1|||
154934254|NCT03674827|559186064|FG002|Treatment Phase|Other|0|||
154934255|NCT03674827|559186065|FG003|Treatment Phase|Other|0|||
154934256|NCT03674827|559186066|FG004|Treatment Phase|Other|0|||
154934257|NCT03674827|559186067|FG005|Treatment Phase|Other|1|||
154934258|NCT03674827|559186062|FG000|Long-Term Follow-up Phase|Death|2|||
154934259|NCT03674827|559186063|FG001|Long-Term Follow-up Phase|Death|4|||
154934260|NCT03674827|559186064|FG002|Long-Term Follow-up Phase|Death|2|||
154934261|NCT03674827|559186065|FG003|Long-Term Follow-up Phase|Death|3|||
154934262|NCT03674827|559186066|FG004|Long-Term Follow-up Phase|Death|2|||
154934263|NCT03674827|559186067|FG005|Long-Term Follow-up Phase|Death|6|||
154934264|NCT03674827|559186062|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
154934265|NCT03674827|559186063|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
154934266|NCT03674827|559186064|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
154934267|NCT03674827|559186065|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
154934268|NCT03674827|559186066|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
154934269|NCT03674827|559186067|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
154934270|NCT03674827|559186062|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
154934271|NCT03674827|559186063|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
154934272|NCT03674827|559186064|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
154934273|NCT03674827|559186065|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
154934274|NCT03674827|559186066|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
154934275|NCT03674827|559186067|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
154934276|NCT00527397|559186068|FG000|Overall Study|Adverse Event|3|||
154934277|NCT00527397|559186068|FG000|Overall Study|Lack of Efficacy|1|||
154934278|NCT00527397|559186068|FG000|Overall Study|Protocol Violation|1|||
154934279|NCT00527397|559186068|FG000|Overall Study|Withdrawal by Subject|6|||
154934280|NCT00527397|559186068|FG000|Overall Study|Study terminated by sponsor|13|||
154934281|NCT00370396|559186076|FG000|Overall Study|Withdrawal by Subject|0|||
154934282|NCT00370396|559186077|FG001|Overall Study|Withdrawal by Subject|0|||
154934283|NCT00370396|559186078|FG002|Overall Study|Withdrawal by Subject|1|||
154934284|NCT00370396|559186076|FG000|Overall Study|Lost to Follow-up|11|||
154934285|NCT00370396|559186077|FG001|Overall Study|Lost to Follow-up|1|||
154934286|NCT00370396|559186078|FG002|Overall Study|Lost to Follow-up|0|||
154934287|NCT02065791|559186079|FG000|Overall Study|Closed Site|1|||
154934288|NCT02065791|559186080|FG001|Overall Study|Closed Site|1|||
154934289|NCT02065791|559186079|FG000|Overall Study|Withdrawal by Subject|11|||
154934290|NCT02065791|559186080|FG001|Overall Study|Withdrawal by Subject|5|||
154934291|NCT02065791|559186079|FG000|Overall Study|Lost to Follow-up|13|||
154934292|NCT02065791|559186080|FG001|Overall Study|Lost to Follow-up|9|||
154934293|NCT02702271|559186083|FG000|Overall Study|Death|36|||
154934294|NCT02702271|559186084|FG001|Overall Study|Death|7|||
154934295|NCT02702271|559186083|FG000|Overall Study|Lost to Follow-up|12|||
154934296|NCT02702271|559186084|FG001|Overall Study|Lost to Follow-up|0|||
154934297|NCT02702271|559186083|FG000|Overall Study|Withdrawal by Subject|8|||
154934298|NCT02702271|559186084|FG001|Overall Study|Withdrawal by Subject|1|||
154934299|NCT02702271|559186083|FG000|Overall Study|Physician Decision|2|||
154934300|NCT02702271|559186084|FG001|Overall Study|Physician Decision|0|||
154934301|NCT02702271|559186083|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
154934302|NCT02702271|559186084|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
154934303|NCT01494649|559186085|FG000|Overall Study|Lost to Follow-up|0|||
154934304|NCT01494649|559186086|FG001|Overall Study|Lost to Follow-up|1|||
154934305|NCT03467971|559186087|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154934306|NCT03467971|559186088|FG001|Treatment Period 2|Withdrawal by Subject|1|||
154934307|NCT03707522|559186091|FG000|Overall Study|Lost to Follow-up|24|||
154934308|NCT03707522|559186092|FG001|Overall Study|Lost to Follow-up|27|||
154934309|NCT03707522|559186093|FG002|Overall Study|Lost to Follow-up|41|||
154934310|NCT03707522|559186094|FG003|Overall Study|Lost to Follow-up|36|||
154934311|NCT00383019|559186095|FG000|Overall Study|Adverse Event|5|||
154934312|NCT00383019|559186096|FG001|Overall Study|Adverse Event|1|||
154934313|NCT00383019|559186095|FG000|Overall Study|Withdrawal by Subject|0|||
154934314|NCT00383019|559186096|FG001|Overall Study|Withdrawal by Subject|1|||
154934315|NCT01619085|559186100|FG000|Overall Study|Adverse Event|231|||
154934316|NCT01619085|559186100|FG000|Overall Study|Protocol Violation|4|||
154934317|NCT01619085|559186100|FG000|Overall Study|Lost to Follow-up|3|||
154934318|NCT01619085|559186100|FG000|Overall Study|Withdrawal by Subject|45|||
154934319|NCT01619085|559186100|FG000|Overall Study|Other than specified|96|||
154934320|NCT01619085|559186100|FG000|Overall Study|Not treated|1|||
154934321|NCT01619085|559186100|FG000|Overall Study|Death|145|||
154934322|NCT01345058|559186101|FG000|Overall Study|Withdrawal by Subject|1|||
154934323|NCT01345058|559186102|FG001|Overall Study|Withdrawal by Subject|0|||
154934324|NCT01345058|559186101|FG000|Overall Study|Participant Reported Increase in Events|1|||
154934325|NCT01345058|559186102|FG001|Overall Study|Participant Reported Increase in Events|0|||
154934326|NCT01345058|559186101|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
154934327|NCT01345058|559186102|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
154934328|NCT01345058|559186101|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
154934329|NCT01345058|559186102|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
154934330|NCT01345058|559186101|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
154934331|NCT01345058|559186102|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
154934332|NCT00000135|559186103|FG000|Overall Study|Death|27|||
154934333|NCT00000135|559186104|FG001|Overall Study|Death|14|||
154934334|NCT00743119|559186107|FG000|Overall Study|unreliable|3|||
154934335|NCT00743119|559186107|FG000|Overall Study|Withdrawal by Subject|1|||
154934336|NCT02989610|559186108|FG000|Overall Study|Withdrawal by Subject|20|||
154934337|NCT02989610|559186108|FG000|Overall Study|Departure of PI from Site|8|||
154934338|NCT02989610|559186108|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
154934339|NCT02989610|559186108|FG000|Overall Study|Lost to Follow-up|3|||
154934340|NCT02989610|559186108|FG000|Overall Study|Death|3|||
154934341|NCT02989610|559186108|FG000|Overall Study|System Explant|3|||
154934342|NCT02989610|559186108|FG000|Overall Study|Subject Non-Compliance|2|||
154934343|NCT02989610|559186108|FG000|Overall Study|System Revision|2|||
154934344|NCT02989610|559186108|FG000|Overall Study|PI Left, Study Closing|1|||
154934345|NCT02989610|559186108|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
154934346|NCT02989610|559186108|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
154934347|NCT01861717|559186112|FG000|Overall Study|Lost to Follow-up|1|||
154934348|NCT01861717|559186112|FG000|Overall Study|Withdrawal by Subject|1|||
154934349|NCT03101293|559187367|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
154934350|NCT03101293|559187368|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
154934351|NCT04682639|559187371|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
154934352|NCT04682639|559187372|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
154934353|NCT04682639|559187373|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
154934354|NCT04682639|559187374|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
155043345|NCT03026283|559590105|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155043346|NCT03026283|559590106|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155043347|NCT03026283|559590107|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
155043348|NCT03026283|559590100|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
154934355|NCT04682639|559187375|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
154934356|NCT04682639|559187371|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
154934357|NCT04682639|559187372|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
154934358|NCT04682639|559187373|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
154934359|NCT04682639|559187374|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154934360|NCT04682639|559187375|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154934361|NCT04682639|559187371|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
154934362|NCT04682639|559187372|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154934363|NCT04682639|559187373|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154934364|NCT04682639|559187374|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154934365|NCT04682639|559187375|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154934366|NCT04682639|559187371|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
154934367|NCT04682639|559187372|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
154934368|NCT04682639|559187373|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
154934369|NCT04682639|559187374|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
154934370|NCT04682639|559187375|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
154934371|NCT04682639|559187371|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
154934372|NCT04682639|559187372|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
154934373|NCT04682639|559187373|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
154934374|NCT04682639|559187374|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
154934375|NCT04682639|559187375|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
154934376|NCT04682639|559187371|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
154934377|NCT04682639|559187372|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
154934378|NCT04682639|559187373|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
154934379|NCT04682639|559187374|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
154934380|NCT04682639|559187375|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
154934381|NCT04682639|559187371|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
154934382|NCT04682639|559187372|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
154934383|NCT04682639|559187373|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
154934384|NCT04682639|559187374|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
155043349|NCT03026283|559590101|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
154934385|NCT04682639|559187375|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
154934386|NCT04682639|559187371|FG000|OLE Period (28 Weeks)|Other|1|||
154934387|NCT04682639|559187372|FG001|OLE Period (28 Weeks)|Other|2|||
154934388|NCT04682639|559187373|FG002|OLE Period (28 Weeks)|Other|0|||
154934389|NCT04682639|559187374|FG003|OLE Period (28 Weeks)|Other|0|||
154934390|NCT04682639|559187375|FG004|OLE Period (28 Weeks)|Other|1|||
154934391|NCT04682639|559187371|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
154934392|NCT04682639|559187372|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
154934393|NCT04682639|559187373|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
154934394|NCT04682639|559187374|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
154934395|NCT04682639|559187375|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
154934396|NCT04682639|559187371|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
154934397|NCT04682639|559187372|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
154934398|NCT04682639|559187373|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154934399|NCT04682639|559187374|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154934400|NCT04682639|559187375|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154934401|NCT04682639|559187371|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
154934402|NCT04682639|559187372|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
154934403|NCT04682639|559187373|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154934404|NCT04682639|559187374|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154934405|NCT04682639|559187375|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154934406|NCT04682639|559187371|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
154934407|NCT04682639|559187372|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
154934408|NCT04682639|559187373|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
154934409|NCT04682639|559187374|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
154934410|NCT04682639|559187375|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
154934411|NCT00763269|559187376|FG000|Overall Study|Lost to Follow-up|12|||
154934412|NCT00763269|559187377|FG001|Overall Study|Lost to Follow-up|13|||
154934413|NCT03333382|559187378|FG000|Overall Study|Lost to Follow-up|1|||
154934414|NCT03333382|559187379|FG001|Overall Study|Lost to Follow-up|0|||
154934415|NCT03471182|559187380|FG000|Overall Study|Withdrawal by Subject|1|||
154934416|NCT03471182|559187381|FG001|Overall Study|Withdrawal by Subject|1|||
154934417|NCT03471182|559187382|FG002|Overall Study|Withdrawal by Subject|0|||
154934418|NCT03471182|559187380|FG000|Overall Study|Technical failure|2|||
154934419|NCT03471182|559187381|FG001|Overall Study|Technical failure|0|||
154934420|NCT03471182|559187382|FG002|Overall Study|Technical failure|0|||
154934421|NCT03451331|559187386|FG000|Overall Study|Withdrawal by Subject|1|||
154934422|NCT03451331|559187387|FG001|Overall Study|Withdrawal by Subject|0|||
154934423|NCT03451331|559187386|FG000|Overall Study|Unable to start treatment.|1|||
154934424|NCT03451331|559187387|FG001|Overall Study|Unable to start treatment.|1|||
154934425|NCT01830920|559187390|FG000|Overall Study|Adverse Event|1|||
154934426|NCT01830920|559187391|FG001|Overall Study|Adverse Event|0|||
154934427|NCT01830920|559187392|FG002|Overall Study|Adverse Event|1|||
154934428|NCT01830920|559187393|FG003|Overall Study|Adverse Event|0|||
154934429|NCT01830920|559187394|FG004|Overall Study|Adverse Event|0|||
154934430|NCT01830920|559187390|FG000|Overall Study|Withdrawal by Subject|2|||
154934431|NCT01830920|559187391|FG001|Overall Study|Withdrawal by Subject|2|||
154934432|NCT01830920|559187392|FG002|Overall Study|Withdrawal by Subject|1|||
154934433|NCT01830920|559187393|FG003|Overall Study|Withdrawal by Subject|7|||
154934434|NCT01830920|559187394|FG004|Overall Study|Withdrawal by Subject|1|||
154934435|NCT01830920|559187390|FG000|Overall Study|Death|3|||
154934436|NCT01830920|559187391|FG001|Overall Study|Death|3|||
154934437|NCT01830920|559187392|FG002|Overall Study|Death|5|||
154934438|NCT01830920|559187393|FG003|Overall Study|Death|4|||
154934439|NCT01830920|559187394|FG004|Overall Study|Death|4|||
154934440|NCT01830920|559187390|FG000|Overall Study|Other|15|||
154934441|NCT01830920|559187391|FG001|Overall Study|Other|1|||
154934442|NCT01830920|559187392|FG002|Overall Study|Other|1|||
154934443|NCT01830920|559187393|FG003|Overall Study|Other|5|||
154934444|NCT01830920|559187394|FG004|Overall Study|Other|3|||
154934445|NCT01313728|559187395|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
154934446|NCT04736576|559187398|FG000|Overall Study|Progressive disease|3|||
154934447|NCT04736576|559187399|FG001|Overall Study|Progressive disease|1|||
154934448|NCT04736576|559187398|FG000|Overall Study|Death|1|||
154934449|NCT04736576|559187399|FG001|Overall Study|Death|0|||
155273031|NCT01613027|560432907|FG000|Overall Study|Lack of Efficacy|1|||
155273032|NCT01613027|560432907|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
155273033|NCT00119262|560432911|FG000|Overall Study|Lack of Efficacy|0|||
154934450|NCT00720304|559187403|FG000|Overall Study|Withdrawal by Subject|14|||
154934451|NCT00720304|559187404|FG001|Overall Study|Withdrawal by Subject|1|||
154934452|NCT00720304|559187403|FG000|Overall Study|Death|1|||
154934453|NCT00720304|559187404|FG001|Overall Study|Death|0|||
154934454|NCT00720304|559187403|FG000|Overall Study|Physician Decision|5|||
154934455|NCT00720304|559187404|FG001|Overall Study|Physician Decision|2|||
154934456|NCT00720304|559187403|FG000|Overall Study|Adverse Event|3|||
154934457|NCT00720304|559187404|FG001|Overall Study|Adverse Event|1|||
154934458|NCT00720304|559187403|FG000|Overall Study|Disease progression|6|||
154934459|NCT00720304|559187404|FG001|Overall Study|Disease progression|1|||
155273034|NCT00119262|560432912|FG001|Overall Study|Lack of Efficacy|3|||
154934460|NCT04330482|559187407|FG000|Overall Study|Lost to Follow-up|2|||
154934461|NCT04330482|559187408|FG001|Overall Study|Lost to Follow-up|1|||
154934462|NCT04330482|559187407|FG000|Overall Study|Withdrawal by Subject|0|||
154934463|NCT04330482|559187408|FG001|Overall Study|Withdrawal by Subject|3|||
154934464|NCT05180630|559187409|FG000|First Intervention|Physician Decision|0|||
154934465|NCT05180630|559187410|FG001|First Intervention|Physician Decision|0|||
154934466|NCT05180630|559187411|FG002|First Intervention|Physician Decision|3|||
154934467|NCT00996918|559187412|FG000|Overall Study|Lack of Efficacy|1|||
154934468|NCT00996918|559187413|FG001|Overall Study|Lack of Efficacy|1|||
154934469|NCT00996918|559187414|FG002|Overall Study|Lack of Efficacy|2|||
154934470|NCT00996918|559187415|FG003|Overall Study|Lack of Efficacy|2|||
154934471|NCT00996918|559187416|FG004|Overall Study|Lack of Efficacy|0|||
154934472|NCT00996918|559187412|FG000|Overall Study|Adverse Event|2|||
154934473|NCT00996918|559187413|FG001|Overall Study|Adverse Event|5|||
154934474|NCT00996918|559187414|FG002|Overall Study|Adverse Event|2|||
154934475|NCT00996918|559187415|FG003|Overall Study|Adverse Event|6|||
154934476|NCT00996918|559187416|FG004|Overall Study|Adverse Event|0|||
154934477|NCT00996918|559187412|FG000|Overall Study|Withdrawal by Subject|1|||
154934478|NCT00996918|559187413|FG001|Overall Study|Withdrawal by Subject|4|||
154934479|NCT00996918|559187414|FG002|Overall Study|Withdrawal by Subject|3|||
154934480|NCT00996918|559187415|FG003|Overall Study|Withdrawal by Subject|3|||
154934481|NCT00996918|559187416|FG004|Overall Study|Withdrawal by Subject|2|||
154934482|NCT00996918|559187412|FG000|Overall Study|Physician Decision|1|||
154934483|NCT00996918|559187413|FG001|Overall Study|Physician Decision|0|||
154934484|NCT00996918|559187414|FG002|Overall Study|Physician Decision|0|||
154934485|NCT00996918|559187415|FG003|Overall Study|Physician Decision|0|||
154934486|NCT00996918|559187416|FG004|Overall Study|Physician Decision|0|||
154934487|NCT00996918|559187412|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
154934488|NCT00996918|559187413|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
154934489|NCT00996918|559187414|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
154934490|NCT00996918|559187415|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
154934491|NCT00996918|559187416|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
154934492|NCT00996918|559187412|FG000|Overall Study|Loss of Caregiver|0|||
154934493|NCT00996918|559187413|FG001|Overall Study|Loss of Caregiver|1|||
154934494|NCT00996918|559187414|FG002|Overall Study|Loss of Caregiver|0|||
154934495|NCT00996918|559187415|FG003|Overall Study|Loss of Caregiver|0|||
154934496|NCT00996918|559187416|FG004|Overall Study|Loss of Caregiver|0|||
154934497|NCT00996918|559187412|FG000|Overall Study|Other|3|||
154934498|NCT00996918|559187413|FG001|Overall Study|Other|1|||
154934499|NCT00996918|559187414|FG002|Overall Study|Other|0|||
154934500|NCT00996918|559187415|FG003|Overall Study|Other|0|||
154934501|NCT00996918|559187416|FG004|Overall Study|Other|0|||
154934502|NCT01333475|559187419|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
154934503|NCT01333475|559187420|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
154934504|NCT01333475|559187419|FG000|Overall Study|Toxicity|1|||
154934505|NCT01333475|559187420|FG001|Overall Study|Toxicity|3|||
154934506|NCT04440007|559187421|FG000|Overall Study|Adverse Event|0|||
154934507|NCT04440007|559187422|FG001|Overall Study|Adverse Event|1|||
154934508|NCT04440007|559187421|FG000|Overall Study|Lost to Follow-up|1|||
154934509|NCT04440007|559187422|FG001|Overall Study|Lost to Follow-up|3|||
154934510|NCT04440007|559187421|FG000|Overall Study|Death|7|||
154934511|NCT04440007|559187422|FG001|Overall Study|Death|2|||
154934512|NCT04440007|559187421|FG000|Overall Study|Physician Decision|1|||
154934513|NCT04440007|559187422|FG001|Overall Study|Physician Decision|1|||
154934514|NCT04440007|559187421|FG000|Overall Study|Withdrawal by Subject|2|||
154934515|NCT04440007|559187422|FG001|Overall Study|Withdrawal by Subject|1|||
154934516|NCT04440007|559187421|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
154934517|NCT04440007|559187422|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
154934518|NCT04440007|559187421|FG000|Overall Study|Discontinued prior to dosing|0|||
154934519|NCT04440007|559187422|FG001|Overall Study|Discontinued prior to dosing|2|||
154934520|NCT01466673|559187423|FG000|Overall Study|Non-compliance with study treatment|2|||
154934521|NCT01466673|559187424|FG001|Overall Study|Non-compliance with study treatment|0|||
154934522|NCT01466673|559187423|FG000|Overall Study|Lost to Follow-up|3|||
154934523|NCT01466673|559187424|FG001|Overall Study|Lost to Follow-up|5|||
154934524|NCT01466673|559187423|FG000|Overall Study|Adverse Event|2|||
154934525|NCT01466673|559187424|FG001|Overall Study|Adverse Event|1|||
154934526|NCT02725671|559187425|FG000|Overall Study|Lost to Follow-up|1|||
154934527|NCT02354976|559187432|FG000|Overall Study|Other - reason not specified|1|||
154934528|NCT02354976|559187433|FG001|Overall Study|Other - reason not specified|0|||
154934529|NCT02354976|559187434|FG002|Overall Study|Other - reason not specified|1|||
154934530|NCT02354976|559187432|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
154934531|NCT02354976|559187433|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
154934532|NCT02354976|559187434|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
154934533|NCT02354976|559187432|FG000|Overall Study|Adverse Event|1|||
154934534|NCT02354976|559187433|FG001|Overall Study|Adverse Event|0|||
154934535|NCT02354976|559187434|FG002|Overall Study|Adverse Event|2|||
154934536|NCT01155284|559187435|FG000|Overall Study|Withdrawal by Subject|4|||
154934537|NCT01155284|559187436|FG001|Overall Study|Withdrawal by Subject|3|||
154934538|NCT01155284|559187435|FG000|Overall Study|Lost to Follow-up|1|||
154934539|NCT01155284|559187436|FG001|Overall Study|Lost to Follow-up|2|||
154934540|NCT01155284|559187435|FG000|Overall Study|Physician Decision|1|||
154934541|NCT01155284|559187436|FG001|Overall Study|Physician Decision|0|||
154934542|NCT01155284|559187435|FG000|Overall Study|Adverse Event|1|||
154934543|NCT01155284|559187436|FG001|Overall Study|Adverse Event|0|||
154934544|NCT00123487|559187437|FG000|Randomized|Death prior to starting treatment|0|||
154934545|NCT00123487|559187438|FG001|Randomized|Death prior to starting treatment|1|||
154934546|NCT00123487|559187437|FG000|Randomized|SAE prior to starting treatment|1|||
154934547|NCT00123487|559187438|FG001|Randomized|SAE prior to starting treatment|0|||
154934548|NCT00123487|559187437|FG000|Treated With Study Drug|Adverse Event|23|||
154934549|NCT00123487|559187438|FG001|Treated With Study Drug|Adverse Event|22|||
154934550|NCT00123487|559187437|FG000|Treated With Study Drug|Disease Progression|141|||
154934551|NCT00123487|559187438|FG001|Treated With Study Drug|Disease Progression|122|||
154934552|NCT00123487|559187437|FG000|Treated With Study Drug|Physician Decision|8|||
154934553|NCT00123487|559187438|FG001|Treated With Study Drug|Physician Decision|9|||
154934554|NCT00123487|559187437|FG000|Treated With Study Drug|Other|59|||
154934555|NCT00123487|559187438|FG001|Treated With Study Drug|Other|58|||
154934556|NCT00123487|559187437|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
154934557|NCT00123487|559187438|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
154934558|NCT00123487|559187437|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
154934559|NCT00123487|559187438|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
154934560|NCT00123487|559187437|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
154934561|NCT00123487|559187438|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
154934562|NCT03118765|559187439|FG000|Overall Study|Withdrawal by Subject|0|||
154934563|NCT03118765|559187440|FG001|Overall Study|Withdrawal by Subject|0|||
154934564|NCT03118765|559187441|FG002|Overall Study|Withdrawal by Subject|1|||
154934565|NCT03118765|559187442|FG003|Overall Study|Withdrawal by Subject|0|||
154934566|NCT03118765|559187443|FG004|Overall Study|Withdrawal by Subject|0|||
154934567|NCT03118765|559187439|FG000|Overall Study|Adverse Event|1|||
154934568|NCT03118765|559187440|FG001|Overall Study|Adverse Event|1|||
154934569|NCT03118765|559187441|FG002|Overall Study|Adverse Event|1|||
154934570|NCT03118765|559187442|FG003|Overall Study|Adverse Event|1|||
154934571|NCT03118765|559187443|FG004|Overall Study|Adverse Event|1|||
154934572|NCT03118765|559187439|FG000|Overall Study|Non compliance with Study Procedures|0|||
154934573|NCT03118765|559187440|FG001|Overall Study|Non compliance with Study Procedures|0|||
154934574|NCT03118765|559187441|FG002|Overall Study|Non compliance with Study Procedures|0|||
154934575|NCT03118765|559187442|FG003|Overall Study|Non compliance with Study Procedures|1|||
154934576|NCT03118765|559187443|FG004|Overall Study|Non compliance with Study Procedures|0|||
154934577|NCT03118765|559187439|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
154934578|NCT03118765|559187440|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
154934579|NCT03118765|559187441|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
154934580|NCT03118765|559187442|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
154934581|NCT03118765|559187443|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
154934582|NCT03118765|559187439|FG000|Overall Study|COPD Exacerbation|1|||
154934583|NCT03118765|559187440|FG001|Overall Study|COPD Exacerbation|0|||
154934584|NCT03118765|559187441|FG002|Overall Study|COPD Exacerbation|0|||
154934585|NCT03118765|559187442|FG003|Overall Study|COPD Exacerbation|1|||
154934586|NCT03118765|559187443|FG004|Overall Study|COPD Exacerbation|0|||
154934587|NCT03118765|559187439|FG000|Overall Study|Lost to Follow-up|1|||
154934588|NCT03118765|559187440|FG001|Overall Study|Lost to Follow-up|0|||
154934589|NCT03118765|559187441|FG002|Overall Study|Lost to Follow-up|1|||
154934590|NCT03118765|559187442|FG003|Overall Study|Lost to Follow-up|0|||
154934591|NCT03118765|559187443|FG004|Overall Study|Lost to Follow-up|0|||
154934592|NCT03118765|559187439|FG000|Overall Study|Sponsor Decision|1|||
154934593|NCT03118765|559187440|FG001|Overall Study|Sponsor Decision|0|||
154934594|NCT03118765|559187441|FG002|Overall Study|Sponsor Decision|1|||
155273035|NCT00119262|560432911|FG000|Overall Study|Withdrawal by Subject|12|||
155273036|NCT00119262|560432912|FG001|Overall Study|Withdrawal by Subject|11|||
155273037|NCT00119262|560432911|FG000|Overall Study|Adverse Event|33|||
155273038|NCT00119262|560432912|FG001|Overall Study|Adverse Event|35|||
155273039|NCT00119262|560432911|FG000|Overall Study|other disease|0|||
155273040|NCT00119262|560432912|FG001|Overall Study|other disease|2|||
154934595|NCT03118765|559187442|FG003|Overall Study|Sponsor Decision|0|||
154934596|NCT03118765|559187443|FG004|Overall Study|Sponsor Decision|1|||
154934597|NCT02164539|559187446|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
154934598|NCT02164539|559187447|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
155273041|NCT00119262|560432911|FG000|Overall Study|ineligble|1|||
154934599|NCT02164539|559187448|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
154934600|NCT02164539|559187449|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
154934601|NCT02164539|559187450|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
155273042|NCT00119262|560432912|FG001|Overall Study|ineligble|2|||
155273043|NCT00119262|560432911|FG000|Overall Study|others|0|||
154934602|NCT02164539|559187451|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
154934603|NCT02164539|559187452|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
154934604|NCT02164539|559187446|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
154934605|NCT02164539|559187447|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
154934606|NCT02164539|559187448|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
154934607|NCT02164539|559187449|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
154934608|NCT02164539|559187450|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
154934609|NCT02164539|559187451|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
154934610|NCT02164539|559187452|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
154934611|NCT02164539|559187446|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
154934612|NCT02164539|559187447|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
154934613|NCT02164539|559187448|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
154934614|NCT02164539|559187449|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
154934615|NCT02164539|559187450|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
154934616|NCT02164539|559187451|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
154934617|NCT02164539|559187452|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
154934618|NCT02164539|559187446|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
154934619|NCT02164539|559187447|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
154934620|NCT02164539|559187448|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
154934621|NCT02164539|559187449|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
154934622|NCT02164539|559187450|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
154934623|NCT02164539|559187451|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
154934624|NCT02164539|559187452|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
154934625|NCT02164539|559187446|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
154934626|NCT02164539|559187447|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
154934627|NCT02164539|559187448|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
154934628|NCT02164539|559187449|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
154934629|NCT02164539|559187450|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
154934630|NCT02164539|559187451|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
154934631|NCT02164539|559187452|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
154934632|NCT02164539|559187446|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
154934633|NCT02164539|559187447|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
154934634|NCT02164539|559187448|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
154934635|NCT02164539|559187449|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
154934636|NCT02164539|559187450|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
154934637|NCT02164539|559187451|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
154934638|NCT02164539|559187452|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
154934639|NCT01255722|559187453|FG000|Overall Study|Adverse Event|0|||
154934640|NCT01255722|559187454|FG001|Overall Study|Adverse Event|1|||
154934641|NCT01255722|559187455|FG002|Overall Study|Adverse Event|1|||
154934642|NCT01255722|559187453|FG000|Overall Study|asymptomatic patient|1|||
154934643|NCT01255722|559187454|FG001|Overall Study|asymptomatic patient|0|||
154934644|NCT01255722|559187455|FG002|Overall Study|asymptomatic patient|0|||
154934645|NCT01255722|559187453|FG000|Overall Study|beta-blocker contraindicated|2|||
154934646|NCT01255722|559187454|FG001|Overall Study|beta-blocker contraindicated|0|||
154934647|NCT01255722|559187455|FG002|Overall Study|beta-blocker contraindicated|0|||
154934648|NCT02643966|559187456|FG000|First Screening Round|ineligible|1|||
154934649|NCT02643966|559187456|FG000|First Screening Round|excluded from analysis|2|||
154934650|NCT02643966|559187456|FG000|First Screening Round|Lost to Follow-up|56|||
154934651|NCT02643966|559187456|FG000|First Screening Round|Withdrawal by Subject|28|||
154934652|NCT02643966|559187456|FG000|First Screening Round|Death|1|||
154934653|NCT02643966|559187456|FG000|Between First and Second Screening|Lost to Follow-up|65|||
154934654|NCT02643966|559187456|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
154934655|NCT02643966|559187456|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
154934656|NCT02643966|559187456|FG000|Second Screening Round|Withdrawal by Subject|20|||
154934657|NCT02643966|559187456|FG000|Second Screening Round|Lost to Follow-up|57|||
154934658|NCT02643966|559187456|FG000|Second Screening Round|Physician Decision|2|||
154934659|NCT02643966|559187456|FG000|Second Screening Round|Death|4|||
154934660|NCT02643966|559187456|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
154934661|NCT02643966|559187456|FG000|Between Second and Third Screening|Death|1|||
154934662|NCT02643966|559187456|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
154934663|NCT02643966|559187456|FG000|Third Screening Round|PI excluded|2|||
154934664|NCT02643966|559187456|FG000|Third Screening Round|Lost to Follow-up|241|||
154934665|NCT01493531|559187457|FG000|Overall Study|Adverse Event|4|||
154934666|NCT01493531|559187458|FG001|Overall Study|Adverse Event|12|||
154934667|NCT01493531|559187459|FG002|Overall Study|Adverse Event|9|||
154934668|NCT01493531|559187457|FG000|Overall Study|Gout flare|3|||
154934669|NCT01493531|559187458|FG001|Overall Study|Gout flare|0|||
154934670|NCT01493531|559187459|FG002|Overall Study|Gout flare|2|||
154934671|NCT01493531|559187457|FG000|Overall Study|Protocol Violation|8|||
154934672|NCT01493531|559187458|FG001|Overall Study|Protocol Violation|15|||
154934673|NCT01493531|559187459|FG002|Overall Study|Protocol Violation|12|||
154934674|NCT01493531|559187457|FG000|Overall Study|Sponsor terminated study|5|||
154934675|NCT01493531|559187458|FG001|Overall Study|Sponsor terminated study|2|||
154934676|NCT01493531|559187459|FG002|Overall Study|Sponsor terminated study|3|||
154934677|NCT01493531|559187457|FG000|Overall Study|Lost to Follow-up|5|||
154934678|NCT01493531|559187458|FG001|Overall Study|Lost to Follow-up|7|||
154934679|NCT01493531|559187459|FG002|Overall Study|Lost to Follow-up|11|||
154934680|NCT01493531|559187457|FG000|Overall Study|Withdrawal by Subject|16|||
154934681|NCT01493531|559187458|FG001|Overall Study|Withdrawal by Subject|13|||
154934682|NCT01493531|559187459|FG002|Overall Study|Withdrawal by Subject|11|||
154934683|NCT01493531|559187457|FG000|Overall Study|Death|0|||
154934684|NCT01493531|559187458|FG001|Overall Study|Death|1|||
154934685|NCT01493531|559187459|FG002|Overall Study|Death|0|||
154934686|NCT01946282|559187460|FG000|Year 1|Did not return FIT kit|4186|||
154934687|NCT01946282|559187461|FG001|Year 1|Did not return FIT kit|608|||
154934688|NCT01946282|559187462|FG002|Year 1|Did not return FIT kit|654|||
154934689|NCT01946282|559187460|FG000|Year 2|Did not return FIT kit|803|||
154934690|NCT01946282|559187461|FG001|Year 2|Did not return FIT kit|131|||
154934691|NCT01946282|559187462|FG002|Year 2|Did not return FIT kit|115|||
154934692|NCT01946282|559187460|FG000|Year 3|Did not return FIT kit|288|||
154934693|NCT01946282|559187461|FG001|Year 3|Did not return FIT kit|43|||
154934694|NCT01946282|559187462|FG002|Year 3|Did not return FIT kit|30|||
154934695|NCT03031431|559187465|FG000|Overall Study|Infant removed by maternal request|1|||
154934696|NCT01462695|559187466|FG000|Overall Study|Adverse Event|1|||
154934697|NCT01462695|559187467|FG001|Overall Study|Adverse Event|1|||
154934698|NCT01462695|559187466|FG000|Overall Study|Death|2|||
154934699|NCT01462695|559187467|FG001|Overall Study|Death|0|||
154934700|NCT01462695|559187466|FG000|Overall Study|Lack of Efficacy|6|||
154934701|NCT01462695|559187467|FG001|Overall Study|Lack of Efficacy|12|||
154934702|NCT01462695|559187466|FG000|Overall Study|Physician Decision|5|||
154934703|NCT01462695|559187467|FG001|Overall Study|Physician Decision|0|||
154934704|NCT01462695|559187466|FG000|Overall Study|Withdrawal by Subject|2|||
154934705|NCT01462695|559187467|FG001|Overall Study|Withdrawal by Subject|0|||
154934706|NCT01462695|559187466|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
154934707|NCT01462695|559187467|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
154934708|NCT00995488|559187468|FG000|Overall Study|Withdrawal by Subject|1|||
154934709|NCT01656967|559187469|FG000|Overall Study|faulty monitor|1|||
154934710|NCT01656967|559187470|FG001|Overall Study|faulty monitor|0|||
154934711|NCT01656967|559187469|FG000|Overall Study|unsuccessful ETT insertion|3|||
154934712|NCT01656967|559187470|FG001|Overall Study|unsuccessful ETT insertion|2|||
154934713|NCT00051636|559187471|FG000|Period 1 - Core|Adverse Event|2|||
154934714|NCT00051636|559187472|FG001|Period 1 - Core|Adverse Event|2|||
154934715|NCT00051636|559187471|FG000|Period 1 - Core|Protocol Violation|1|||
154934716|NCT00051636|559187472|FG001|Period 1 - Core|Protocol Violation|0|||
154934717|NCT00051636|559187471|FG000|Period 1 - Core|Withdrawal by Subject|1|||
154934718|NCT00051636|559187472|FG001|Period 1 - Core|Withdrawal by Subject|2|||
154934719|NCT00051636|559187471|FG000|Period 1 - Core|Lost to Follow-up|0|||
154934720|NCT00051636|559187472|FG001|Period 1 - Core|Lost to Follow-up|2|||
154934721|NCT00051636|559187471|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
154934722|NCT00051636|559187472|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
154934723|NCT00051636|559187471|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
154934724|NCT00051636|559187472|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
154934725|NCT00051636|559187471|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
154934726|NCT00051636|559187472|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
154934727|NCT00051636|559187471|FG000|Period 2- Extended Observation Period|Death|4|||
154934728|NCT00051636|559187472|FG001|Period 2- Extended Observation Period|Death|5|||
154934729|NCT00051636|559187471|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
154934730|NCT00051636|559187472|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
154934731|NCT01174368|559187473|FG000|Overall Study|Withdrawal by Subject|1|||
154934732|NCT00479765|559187474|FG000|Overall Study|study terminated|4|||
154934733|NCT00725725|559187477|FG000|Overall Study|Adverse Event|1|||
154934734|NCT00725725|559187478|FG001|Overall Study|Adverse Event|3|||
154934735|NCT00725725|559187479|FG002|Overall Study|Adverse Event|2|||
154934736|NCT00725725|559187477|FG000|Overall Study|Lost to Follow-up|2|||
155043350|NCT03026283|559590102|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
154934737|NCT00725725|559187478|FG001|Overall Study|Lost to Follow-up|0|||
154934738|NCT00725725|559187479|FG002|Overall Study|Lost to Follow-up|2|||
154934739|NCT00725725|559187477|FG000|Overall Study|Withdrawal by Subject|1|||
154934740|NCT00725725|559187478|FG001|Overall Study|Withdrawal by Subject|0|||
154934741|NCT00725725|559187479|FG002|Overall Study|Withdrawal by Subject|1|||
154934742|NCT00725725|559187477|FG000|Overall Study|Protocol Violation|0|||
154934743|NCT00725725|559187478|FG001|Overall Study|Protocol Violation|1|||
154934744|NCT00725725|559187479|FG002|Overall Study|Protocol Violation|0|||
154934745|NCT02392559|559187480|FG000|Overall Study|Withdrawal by Subject|0|||
154934746|NCT02392559|559187481|FG001|Overall Study|Withdrawal by Subject|1|||
154934747|NCT02340078|559187487|FG000|Overall Study|Protocol Violation|1|||
154934748|NCT00944125|559187488|FG000|3 to 6 Months|Withdrawal by Subject|0|||
154934749|NCT00944125|559187489|FG001|3 to 6 Months|Withdrawal by Subject|2|||
155092558|NCT02336815|559773624|FG001|Overall Study|Lost to Follow-up|3|||
154934750|NCT00944125|559187488|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
154934751|NCT00944125|559187489|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
154934752|NCT04816877|559187490|FG000|Overall Study|Withdrawal by Subject|1|||
154934753|NCT04816877|559187491|FG001|Overall Study|Withdrawal by Subject|0|||
154934754|NCT00995930|559187492|FG000|Overall Study|Protocol deviation|2|||
154934755|NCT00995930|559187493|FG001|Overall Study|Protocol deviation|5|||
154934756|NCT00995930|559187492|FG000|Overall Study|Death|0|||
154934757|NCT00995930|559187493|FG001|Overall Study|Death|1|||
154934758|NCT00995930|559187492|FG000|Overall Study|Administrative problems|4|||
154934759|NCT00995930|559187493|FG001|Overall Study|Administrative problems|2|||
154934760|NCT00995930|559187492|FG000|Overall Study|Lost to Follow-up|1|||
154934761|NCT00995930|559187493|FG001|Overall Study|Lost to Follow-up|2|||
154934762|NCT00995930|559187492|FG000|Overall Study|Withdrawal by Subject|3|||
154934763|NCT00995930|559187493|FG001|Overall Study|Withdrawal by Subject|4|||
154934764|NCT00995930|559187492|FG000|Overall Study|Adverse Event|11|||
154934765|NCT00995930|559187493|FG001|Overall Study|Adverse Event|14|||
154934766|NCT00833976|559188653|FG000|Overall Study|Withdrawal by Subject|5|||
154934767|NCT00833976|559188653|FG000|Overall Study|Lost to Follow-up|4|||
154934768|NCT00833976|559188653|FG000|Overall Study|Did not meet eligibility criteria|41|||
154934769|NCT00833976|559188653|FG000|Overall Study|Physician Decision|1|||
154934770|NCT01246973|559188658|FG000|Overall Study|Other|38|||
154934771|NCT01246973|559188659|FG001|Overall Study|Other|25|||
154934772|NCT01246973|559188658|FG000|Overall Study|Adverse Event|16|||
154934773|NCT01246973|559188659|FG001|Overall Study|Adverse Event|9|||
154934774|NCT01246973|559188658|FG000|Overall Study|Withdrawal by Subject|7|||
154934775|NCT01246973|559188659|FG001|Overall Study|Withdrawal by Subject|13|||
154934776|NCT02598622|559188660|FG000|Overall Study|Withdrawal by Subject|3|||
154934777|NCT02598622|559188661|FG001|Overall Study|Withdrawal by Subject|0|||
154934778|NCT02598622|559188660|FG000|Overall Study|Physician Decision|3|||
154934779|NCT02598622|559188661|FG001|Overall Study|Physician Decision|0|||
154934780|NCT00681824|559188665|FG000|Overall Study|withdrawn by investigator|0|||
154934781|NCT00681824|559188666|FG001|Overall Study|withdrawn by investigator|0|||
154934782|NCT00681824|559188667|FG002|Overall Study|withdrawn by investigator|1|||
154934783|NCT00681824|559188665|FG000|Overall Study|scheduling conflict|1|||
154934784|NCT00681824|559188666|FG001|Overall Study|scheduling conflict|0|||
154934785|NCT00681824|559188667|FG002|Overall Study|scheduling conflict|0|||
154934786|NCT00681824|559188665|FG000|Overall Study|Death|0|||
154934787|NCT00681824|559188666|FG001|Overall Study|Death|1|||
154934788|NCT00681824|559188667|FG002|Overall Study|Death|0|||
154934789|NCT03724916|559188668|FG000|Overall Study|Withdrawal by Subject|0|||
154934790|NCT03724916|559188669|FG001|Overall Study|Withdrawal by Subject|1|||
154934791|NCT03724916|559188670|FG002|Overall Study|Withdrawal by Subject|1|||
154934792|NCT03724916|559188671|FG003|Overall Study|Withdrawal by Subject|2|||
154934793|NCT03724916|559188668|FG000|Overall Study|Randomized but not Treated|1|||
154934794|NCT03724916|559188669|FG001|Overall Study|Randomized but not Treated|0|||
154934795|NCT03724916|559188670|FG002|Overall Study|Randomized but not Treated|0|||
154934796|NCT03724916|559188671|FG003|Overall Study|Randomized but not Treated|0|||
154934797|NCT04575038|559188672|FG000|Overall Study|Withdrawal by Subject|1|||
154934798|NCT04575038|559188673|FG001|Overall Study|Withdrawal by Subject|1|||
154934799|NCT01416142|559188678|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
154934800|NCT01416142|559188679|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
154934801|NCT01416142|559188680|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
154934802|NCT04335110|559188681|FG000|Overall Study|Withdrawal by Subject|1|||
154934803|NCT04335110|559188682|FG001|Overall Study|Withdrawal by Subject|1|||
154934804|NCT04335110|559188681|FG000|Overall Study|Death|0|||
154934805|NCT04335110|559188682|FG001|Overall Study|Death|1|||
154934806|NCT02513459|559188684|FG000|Overall Study|Adverse Event|7|||
154934807|NCT02513459|559188684|FG000|Overall Study|Withdrew consent|5|||
154934808|NCT02513459|559188684|FG000|Overall Study|Loss of efficacy|2|||
154934809|NCT02513459|559188684|FG000|Overall Study|Pregnancy|2|||
154934810|NCT02513459|559188684|FG000|Overall Study|Subject decision|2|||
154934811|NCT02513459|559188684|FG000|Overall Study|Lack of response|1|||
154934812|NCT02513459|559188684|FG000|Overall Study|Reproductive plans|1|||
154934813|NCT02513459|559188684|FG000|Overall Study|Surgery planned-- not done|1|||
154934814|NCT00787566|559188687|FG000|Overall Study|AE related to chemotherapy|0|||
154934815|NCT00787566|559188688|FG001|Overall Study|AE related to chemotherapy|1|||
154934816|NCT00787566|559188689|FG002|Overall Study|AE related to chemotherapy|0|||
154934817|NCT00660790|559188698|FG000|Baseline to 3 Months|Death|1|||
154934818|NCT00660790|559188698|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
154934819|NCT00660790|559188698|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
154934820|NCT00686374|559188704|FG000|Overall Study|Lack of Efficacy|10|||
154934821|NCT00686374|559188704|FG000|Overall Study|Adverse Event|8|||
154934822|NCT00686374|559188704|FG000|Overall Study|Withdrew consent|5|||
154934823|NCT00686374|559188704|FG000|Overall Study|Lost to Follow-up|1|||
154934824|NCT00686374|559188704|FG000|Overall Study|Missing reason|33|||
154934825|NCT00686374|559188704|FG000|Overall Study|Other, not specified|4|||
154934826|NCT00618774|559188705|FG000|Overall Study|Adverse Event|5|||
154934827|NCT00618774|559188706|FG001|Overall Study|Adverse Event|3|||
154934828|NCT00618774|559188705|FG000|Overall Study|Withdrawal by Subject|1|||
154934829|NCT00618774|559188706|FG001|Overall Study|Withdrawal by Subject|0|||
154934830|NCT02753400|559188708|FG000|Overall Study|Adverse Event|3|||
154934831|NCT02753400|559188709|FG001|Overall Study|Adverse Event|0|||
154934832|NCT02753400|559188708|FG000|Overall Study|Withdrawal by Subject|2|||
154934833|NCT02753400|559188709|FG001|Overall Study|Withdrawal by Subject|1|||
154934834|NCT03989115|559188710|FG000|Overall Study|Withdrawal by Subject|2|||
154934835|NCT03989115|559188711|FG001|Overall Study|Withdrawal by Subject|1|||
154934836|NCT03989115|559188712|FG002|Overall Study|Withdrawal by Subject|3|||
154934837|NCT03989115|559188713|FG003|Overall Study|Withdrawal by Subject|0|||
154934838|NCT03989115|559188714|FG004|Overall Study|Withdrawal by Subject|17|||
154934839|NCT03989115|559188715|FG005|Overall Study|Withdrawal by Subject|1|||
154934840|NCT03989115|559188716|FG006|Overall Study|Withdrawal by Subject|0|||
154934841|NCT03989115|559188717|FG007|Overall Study|Withdrawal by Subject|0|||
154934842|NCT03989115|559188710|FG000|Overall Study|Sponsor decision to terminate the study|1|||
154934843|NCT03989115|559188711|FG001|Overall Study|Sponsor decision to terminate the study|1|||
154934844|NCT03989115|559188712|FG002|Overall Study|Sponsor decision to terminate the study|0|||
154934845|NCT03989115|559188713|FG003|Overall Study|Sponsor decision to terminate the study|1|||
154934846|NCT03989115|559188714|FG004|Overall Study|Sponsor decision to terminate the study|11|||
154934847|NCT03989115|559188715|FG005|Overall Study|Sponsor decision to terminate the study|0|||
154934848|NCT03989115|559188716|FG006|Overall Study|Sponsor decision to terminate the study|2|||
154934849|NCT03989115|559188717|FG007|Overall Study|Sponsor decision to terminate the study|1|||
154934850|NCT03989115|559188710|FG000|Overall Study|Lost to Follow-up|2|||
154934851|NCT03989115|559188711|FG001|Overall Study|Lost to Follow-up|0|||
154934852|NCT03989115|559188712|FG002|Overall Study|Lost to Follow-up|0|||
154934853|NCT03989115|559188713|FG003|Overall Study|Lost to Follow-up|0|||
154934854|NCT03989115|559188714|FG004|Overall Study|Lost to Follow-up|1|||
154934855|NCT03989115|559188715|FG005|Overall Study|Lost to Follow-up|0|||
154934856|NCT03989115|559188716|FG006|Overall Study|Lost to Follow-up|0|||
154934857|NCT03989115|559188717|FG007|Overall Study|Lost to Follow-up|0|||
154934858|NCT03989115|559188710|FG000|Overall Study|Death|2|||
154934859|NCT03989115|559188711|FG001|Overall Study|Death|2|||
154934860|NCT03989115|559188712|FG002|Overall Study|Death|9|||
154934861|NCT03989115|559188713|FG003|Overall Study|Death|6|||
154934862|NCT03989115|559188714|FG004|Overall Study|Death|31|||
154934863|NCT03989115|559188715|FG005|Overall Study|Death|6|||
154934864|NCT03989115|559188716|FG006|Overall Study|Death|2|||
154934865|NCT03989115|559188717|FG007|Overall Study|Death|3|||
154934866|NCT03989115|559188710|FG000|Overall Study|Other|1|||
154934867|NCT03989115|559188711|FG001|Overall Study|Other|2|||
154934868|NCT03989115|559188712|FG002|Overall Study|Other|0|||
154934869|NCT03989115|559188713|FG003|Overall Study|Other|0|||
154934870|NCT03989115|559188714|FG004|Overall Study|Other|5|||
154934871|NCT03989115|559188715|FG005|Overall Study|Other|0|||
154934872|NCT03989115|559188716|FG006|Overall Study|Other|0|||
154934873|NCT03989115|559188717|FG007|Overall Study|Other|0|||
154934874|NCT02143947|559188718|FG000|Overall Study|Lost to Follow-up|4|||
154934875|NCT02143947|559188719|FG001|Overall Study|Lost to Follow-up|2|||
154934876|NCT01244815|559188722|FG000|Overall Study|Not Treated|0|||
154934877|NCT01244815|559188723|FG001|Overall Study|Not Treated|1|||
154934878|NCT01244815|559188724|FG002|Overall Study|Not Treated|0|||
154934879|NCT01244815|559188725|FG003|Overall Study|Not Treated|0|||
154934880|NCT01244815|559188722|FG000|Overall Study|Adverse Event|4|||
154934881|NCT01244815|559188723|FG001|Overall Study|Adverse Event|7|||
154934882|NCT01244815|559188724|FG002|Overall Study|Adverse Event|5|||
154934883|NCT01244815|559188725|FG003|Overall Study|Adverse Event|5|||
154934884|NCT01244815|559188722|FG000|Overall Study|Treatment Failure|0|||
154934885|NCT01244815|559188723|FG001|Overall Study|Treatment Failure|0|||
154934886|NCT01244815|559188724|FG002|Overall Study|Treatment Failure|0|||
154934887|NCT01244815|559188725|FG003|Overall Study|Treatment Failure|1|||
154934888|NCT01244815|559188722|FG000|Overall Study|Lost to Follow-up|3|||
154934889|NCT01244815|559188723|FG001|Overall Study|Lost to Follow-up|2|||
154934890|NCT01244815|559188724|FG002|Overall Study|Lost to Follow-up|3|||
154934891|NCT01244815|559188725|FG003|Overall Study|Lost to Follow-up|2|||
154934892|NCT01244815|559188722|FG000|Overall Study|Withdrawal by Subject|0|||
155273044|NCT00119262|560432912|FG001|Overall Study|others|5|||
155273045|NCT00882921|560432918|FG000|Overall Study|Death|2|||
154934893|NCT01244815|559188723|FG001|Overall Study|Withdrawal by Subject|2|||
154934894|NCT01244815|559188724|FG002|Overall Study|Withdrawal by Subject|0|||
154934895|NCT01244815|559188725|FG003|Overall Study|Withdrawal by Subject|3|||
154934896|NCT01244815|559188722|FG000|Overall Study|Protocol Violation|7|||
154934897|NCT01244815|559188723|FG001|Overall Study|Protocol Violation|4|||
154934898|NCT01244815|559188724|FG002|Overall Study|Protocol Violation|3|||
154934899|NCT01244815|559188725|FG003|Overall Study|Protocol Violation|1|||
154934900|NCT01244815|559188722|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
154934901|NCT01244815|559188723|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
154934902|NCT01244815|559188724|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
154934903|NCT01244815|559188725|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
155273046|NCT00882921|560432918|FG000|Overall Study|Other|3|||
154934904|NCT00697112|559188726|FG000|Overall Study|Adverse Event|8|||
154934905|NCT00697112|559188726|FG000|Overall Study|Lost to Follow-up|1|||
154934906|NCT00697112|559188726|FG000|Overall Study|Did not meet inclusion criteria|1|||
154934907|NCT03402126|559188731|FG000|Overall Study|Lost to Follow-up|6|||
154934908|NCT03402126|559188731|FG000|Overall Study|Protocol Violation|10|||
154934909|NCT03402126|559188731|FG000|Overall Study|Sponsor request/Study termination|29|||
154934910|NCT03402126|559188731|FG000|Overall Study|Study product no longer in use|1|||
154934911|NCT03402126|559188731|FG000|Overall Study|Technical problems|1|||
154934912|NCT03402126|559188731|FG000|Overall Study|Withdrawal by Subject|6|||
154934913|NCT03402126|559188731|FG000|Overall Study|Physician Decision|2|||
154934914|NCT03402126|559188731|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
154934915|NCT03402126|559188731|FG000|Overall Study|Death|4|||
154934916|NCT02261974|559188732|FG000|Overall Study|Withdrawal by Subject|3|||
154934917|NCT02261974|559188733|FG001|Overall Study|Withdrawal by Subject|2|||
154934918|NCT02261974|559188732|FG000|Overall Study|Pregnancy|0|||
154934919|NCT02261974|559188733|FG001|Overall Study|Pregnancy|1|||
154934920|NCT02261974|559188732|FG000|Overall Study|Missed treatment cut-off date|6|||
154934921|NCT02261974|559188733|FG001|Overall Study|Missed treatment cut-off date|3|||
154934922|NCT02261974|559188732|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
154934923|NCT02261974|559188733|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
154934924|NCT02261974|559188732|FG000|Overall Study|Lost to Follow-up|2|||
154934925|NCT02261974|559188733|FG001|Overall Study|Lost to Follow-up|0|||
154934926|NCT02261974|559188732|FG000|Overall Study|Adverse Event|1|||
154934927|NCT02261974|559188733|FG001|Overall Study|Adverse Event|0|||
154934928|NCT00709735|559188736|FG000|Overall Study|Lost to Follow-up|1|||
154934929|NCT00709735|559188737|FG001|Overall Study|Lost to Follow-up|1|||
154934930|NCT00709735|559188736|FG000|Overall Study|Relapse into Opioid Abuse|0|||
154934931|NCT00709735|559188737|FG001|Overall Study|Relapse into Opioid Abuse|1|||
154934932|NCT00709735|559188736|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
154934933|NCT00709735|559188737|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
154934934|NCT02555618|559188740|FG000|Overall Study|Sponsor's Circumstances|1|||
154934935|NCT02555618|559188741|FG001|Overall Study|Sponsor's Circumstances|0|||
154934936|NCT01021137|559188749|FG000|Overall Study|Lost to Follow-up|9|||
154934937|NCT01021137|559188750|FG001|Overall Study|Lost to Follow-up|4|||
154934938|NCT01021137|559188751|FG002|Overall Study|Lost to Follow-up|2|||
154934939|NCT01021137|559188752|FG003|Overall Study|Lost to Follow-up|6|||
154934940|NCT01021137|559188749|FG000|Overall Study|Withdrawal by Subject|1|||
154934941|NCT01021137|559188750|FG001|Overall Study|Withdrawal by Subject|0|||
154934942|NCT01021137|559188751|FG002|Overall Study|Withdrawal by Subject|0|||
154934943|NCT01021137|559188752|FG003|Overall Study|Withdrawal by Subject|3|||
154934944|NCT02176642|559188762|FG000|Overall Study|Withdrawal by Subject|0|||
154934945|NCT02176642|559188763|FG001|Overall Study|Withdrawal by Subject|1|||
154934946|NCT03338673|559188765|FG000|Overall Study|Lost to Follow-up|1|||
154934947|NCT03338673|559188766|FG001|Overall Study|Lost to Follow-up|1|||
154934948|NCT04523831|559188776|FG000|Overall Study|Lost to Follow-up|15|||
154934949|NCT04523831|559188777|FG001|Overall Study|Lost to Follow-up|17|||
154934950|NCT04523831|559188776|FG000|Overall Study|Death|0|||
154934951|NCT04523831|559188777|FG001|Overall Study|Death|3|||
154934952|NCT04523831|559188776|FG000|Overall Study|Adverse Event|2|||
154934953|NCT04523831|559188777|FG001|Overall Study|Adverse Event|0|||
154934954|NCT04556838|559188778|FG000|Overall Study|Withdrawal by Subject|3|||
154934955|NCT04556838|559188779|FG001|Overall Study|Withdrawal by Subject|1|||
154934956|NCT04556838|559188780|FG002|Overall Study|Withdrawal by Subject|2|||
154934957|NCT04556838|559188778|FG000|Overall Study|Adverse Event|0|||
154934958|NCT04556838|559188779|FG001|Overall Study|Adverse Event|1|||
154934959|NCT04556838|559188780|FG002|Overall Study|Adverse Event|1|||
154934960|NCT04556838|559188778|FG000|Overall Study|Lost to Follow-up|0|||
154934961|NCT04556838|559188779|FG001|Overall Study|Lost to Follow-up|0|||
154934962|NCT04556838|559188780|FG002|Overall Study|Lost to Follow-up|2|||
154934963|NCT04556838|559188778|FG000|Overall Study|Subject travel|0|||
154934964|NCT04556838|559188779|FG001|Overall Study|Subject travel|1|||
154934965|NCT04556838|559188780|FG002|Overall Study|Subject travel|0|||
154934966|NCT04556838|559188778|FG000|Overall Study|Physician Decision|1|||
154934967|NCT04556838|559188779|FG001|Overall Study|Physician Decision|0|||
154934968|NCT04556838|559188780|FG002|Overall Study|Physician Decision|0|||
154934969|NCT05788237|559188785|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
154934970|NCT05788237|559188786|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
154934971|NCT05788237|559188787|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
154934972|NCT05788237|559188788|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
154934973|NCT05788237|559188785|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
154934974|NCT05788237|559188786|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
154934975|NCT05788237|559188787|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
154934976|NCT05788237|559188788|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
154934977|NCT05788237|559188785|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
155043351|NCT03026283|559590103|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
155092559|NCT02336815|559773623|FG000|Overall Study|Other|1|||
154934978|NCT05788237|559188786|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
154934979|NCT05788237|559188787|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
154934980|NCT05788237|559188788|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
154934981|NCT05788237|559188785|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
154934982|NCT05788237|559188786|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
154934983|NCT05788237|559188787|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
154934984|NCT05788237|559188788|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
154934985|NCT05788237|559188785|FG000|SSA (Approximately 2 Months)|Death|0|||
154934986|NCT05788237|559188786|FG001|SSA (Approximately 2 Months)|Death|1|||
154934987|NCT05788237|559188787|FG002|SSA (Approximately 2 Months)|Death|0|||
154934988|NCT05788237|559188788|FG003|SSA (Approximately 2 Months)|Death|0|||
154934989|NCT05788237|559188785|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
154934990|NCT05788237|559188786|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
154934991|NCT05788237|559188787|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
154934992|NCT05788237|559188788|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
154934993|NCT05788237|559188785|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
154934994|NCT05788237|559188786|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
154934995|NCT05788237|559188787|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
154934996|NCT05788237|559188788|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
154934997|NCT05788237|559188785|FG000|SSB (Approximately 1 Month)|Other|0|||
154934998|NCT05788237|559188786|FG001|SSB (Approximately 1 Month)|Other|0|||
154934999|NCT05788237|559188787|FG002|SSB (Approximately 1 Month)|Other|0|||
154935000|NCT05788237|559188788|FG003|SSB (Approximately 1 Month)|Other|1|||
154935001|NCT00678379|559190564|FG000|Overall Study|Injection performed after tonsillectomy|2|||
154935002|NCT00678379|559190565|FG001|Overall Study|Injection performed after tonsillectomy|0|||
154935003|NCT00678379|559190566|FG002|Overall Study|Injection performed after tonsillectomy|1|||
154935004|NCT00678379|559190564|FG000|Overall Study|Incomplete Data|4|||
154935005|NCT00678379|559190565|FG001|Overall Study|Incomplete Data|3|||
154935006|NCT00678379|559190566|FG002|Overall Study|Incomplete Data|3|||
154935007|NCT00923195|559190569|FG000|Overall Study|Death|0|||
154935008|NCT00923195|559190570|FG001|Overall Study|Death|1|||
154935009|NCT00525031|559190571|FG000|Overall Study|Disease Progression|1|||
154935010|NCT00525031|559190572|FG001|Overall Study|Disease Progression|1|||
154935011|NCT02140164|559190575|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
154935012|NCT00775983|559190576|FG000|Overall Study|Protocol Violation|1|||
154935013|NCT00775983|559190577|FG001|Overall Study|Protocol Violation|2|||
154935014|NCT02424565|559190578|FG000|Period 1 (D0)|Protocol Violation|0|||
154935015|NCT02424565|559190579|FG001|Period 1 (D0)|Protocol Violation|1|||
154935016|NCT01427920|559190587|FG000|Overall Study|Adverse Event|1|||
154935017|NCT01427920|559190588|FG001|Overall Study|Adverse Event|2|||
154935018|NCT01427920|559190587|FG000|Overall Study|Lack of Efficacy|1|||
154935019|NCT01427920|559190588|FG001|Overall Study|Lack of Efficacy|0|||
154935020|NCT01427920|559190587|FG000|Overall Study|Protocol Violation|1|||
154935021|NCT01427920|559190588|FG001|Overall Study|Protocol Violation|3|||
154935022|NCT01427920|559190587|FG000|Overall Study|Withdrawal Criteria|4|||
154935023|NCT01427920|559190588|FG001|Overall Study|Withdrawal Criteria|4|||
154935024|NCT01427920|559190587|FG000|Overall Study|Unclassified|2|||
154935025|NCT01427920|559190588|FG001|Overall Study|Unclassified|8|||
154935026|NCT04228302|559190589|FG000|Overall Study|Adverse Event|0|||
154935027|NCT04228302|559190590|FG001|Overall Study|Adverse Event|0|||
154935028|NCT04228302|559190591|FG002|Overall Study|Adverse Event|0|||
154935029|NCT04228302|559190592|FG003|Overall Study|Adverse Event|0|||
154935030|NCT04228302|559190593|FG004|Overall Study|Adverse Event|1|||
154935031|NCT04228302|559190594|FG005|Overall Study|Adverse Event|0|||
154935032|NCT03066440|559190597|FG000|Overall Study|Physician Decision|1|||
154935033|NCT03066440|559190598|FG001|Overall Study|Physician Decision|1|||
154935034|NCT03066440|559190597|FG000|Overall Study|Protocol Violation|0|||
154935035|NCT03066440|559190598|FG001|Overall Study|Protocol Violation|2|||
154935036|NCT00736333|559190599|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
154935037|NCT00736333|559190599|FG000|Overall Study|Data Missing|2|||
154935038|NCT00736333|559190599|FG000|Overall Study|Tumor Progression|75|||
155273047|NCT00882921|560432918|FG000|Overall Study|Lost to Follow-up|2|||
154935039|NCT00736333|559190599|FG000|Overall Study|Toxicity|6|||
154935040|NCT00736333|559190599|FG000|Overall Study|Withdrawal by Subject|10|||
154935041|NCT00736333|559190599|FG000|Overall Study|Death|7|||
155273048|NCT00882921|560432918|FG000|Overall Study|Termination By Investigator|3|||
155273049|NCT00882921|560432918|FG000|Overall Study|Withdrawal Of Consent|1|||
154935042|NCT00736333|559190599|FG000|Overall Study|Other|4|||
154935043|NCT04991311|559190601|FG000|Overall Study|Adverse Event|1|||
154935044|NCT00054275|559190603|FG000|Overall Study|Withdrawal by Subject|4|||
154935045|NCT00054275|559190603|FG000|Overall Study|Adverse Event|5|||
154935046|NCT00054275|559190603|FG000|Overall Study|Progressive disease in cycle 1|1|||
154935047|NCT00054275|559190603|FG000|Overall Study|Physician Decision|1|||
154935048|NCT00755937|559190604|FG000|Recruitment|Unknown if infliximab received|164|||
154935049|NCT00755937|559190604|FG000|Observational Follow-up|Lost to Follow-up|148|||
155273050|NCT02302066|560432919|FG000|Overall Study|Adverse Event|1|||
154935050|NCT03876873|559190605|FG000|Overall Study|Physician Decision|0|||
154935051|NCT03876873|559190606|FG001|Overall Study|Physician Decision|1|||
154935052|NCT01106352|559190607|FG000|Overall Study|Subjects untreated|0|||
154935053|NCT01106352|559190608|FG001|Overall Study|Subjects untreated|0|||
154935054|NCT01106352|559190609|FG002|Overall Study|Subjects untreated|0|||
154935055|NCT01106352|559190610|FG003|Overall Study|Subjects untreated|3|||
154935056|NCT01106352|559190611|FG004|Overall Study|Subjects untreated|4|||
154935057|NCT01106352|559190607|FG000|Overall Study|Sponsor Decision|1|||
154935058|NCT01106352|559190608|FG001|Overall Study|Sponsor Decision|0|||
154935059|NCT01106352|559190609|FG002|Overall Study|Sponsor Decision|0|||
154935060|NCT01106352|559190610|FG003|Overall Study|Sponsor Decision|0|||
154935061|NCT01106352|559190611|FG004|Overall Study|Sponsor Decision|0|||
154935062|NCT01106352|559190607|FG000|Overall Study|Too ill to come in for the visit|0|||
154935063|NCT01106352|559190608|FG001|Overall Study|Too ill to come in for the visit|0|||
154935064|NCT01106352|559190609|FG002|Overall Study|Too ill to come in for the visit|1|||
154935065|NCT01106352|559190610|FG003|Overall Study|Too ill to come in for the visit|0|||
154935066|NCT01106352|559190611|FG004|Overall Study|Too ill to come in for the visit|0|||
154935067|NCT01106352|559190607|FG000|Overall Study|Lost to Follow-up|0|||
154935068|NCT01106352|559190608|FG001|Overall Study|Lost to Follow-up|0|||
154935069|NCT01106352|559190609|FG002|Overall Study|Lost to Follow-up|0|||
154935070|NCT01106352|559190610|FG003|Overall Study|Lost to Follow-up|0|||
154935071|NCT01106352|559190611|FG004|Overall Study|Lost to Follow-up|1|||
154935072|NCT01106352|559190607|FG000|Overall Study|Death|0|||
154935073|NCT01106352|559190608|FG001|Overall Study|Death|0|||
154935074|NCT01106352|559190609|FG002|Overall Study|Death|1|||
154935075|NCT01106352|559190610|FG003|Overall Study|Death|3|||
154935076|NCT01106352|559190611|FG004|Overall Study|Death|1|||
154935077|NCT01106352|559190607|FG000|Overall Study|Disease progression|0|||
154935078|NCT01106352|559190608|FG001|Overall Study|Disease progression|0|||
154935079|NCT01106352|559190609|FG002|Overall Study|Disease progression|0|||
154935080|NCT01106352|559190610|FG003|Overall Study|Disease progression|1|||
154935081|NCT01106352|559190611|FG004|Overall Study|Disease progression|0|||
154935082|NCT01106352|559190607|FG000|Overall Study|Withdrawal by Subject|0|||
154935083|NCT01106352|559190608|FG001|Overall Study|Withdrawal by Subject|0|||
154935084|NCT01106352|559190609|FG002|Overall Study|Withdrawal by Subject|0|||
154935085|NCT01106352|559190610|FG003|Overall Study|Withdrawal by Subject|3|||
154935086|NCT01106352|559190611|FG004|Overall Study|Withdrawal by Subject|2|||
154935087|NCT01106352|559190607|FG000|Overall Study|Went on hospice|0|||
154935088|NCT01106352|559190608|FG001|Overall Study|Went on hospice|0|||
154935089|NCT01106352|559190609|FG002|Overall Study|Went on hospice|0|||
154935090|NCT01106352|559190610|FG003|Overall Study|Went on hospice|1|||
154935091|NCT01106352|559190611|FG004|Overall Study|Went on hospice|0|||
154935092|NCT01106352|559190607|FG000|Overall Study|Subject entered hospice|0|||
154935093|NCT01106352|559190608|FG001|Overall Study|Subject entered hospice|0|||
154935094|NCT01106352|559190609|FG002|Overall Study|Subject entered hospice|0|||
154935095|NCT01106352|559190610|FG003|Overall Study|Subject entered hospice|1|||
154935096|NCT01106352|559190611|FG004|Overall Study|Subject entered hospice|0|||
154935097|NCT01106352|559190607|FG000|Overall Study|Home hospice since July 2013|0|||
154935098|NCT01106352|559190608|FG001|Overall Study|Home hospice since July 2013|0|||
154935099|NCT01106352|559190609|FG002|Overall Study|Home hospice since July 2013|0|||
154935100|NCT01106352|559190610|FG003|Overall Study|Home hospice since July 2013|1|||
154935101|NCT01106352|559190611|FG004|Overall Study|Home hospice since July 2013|0|||
154935102|NCT03547531|559190612|FG000|Overall Study|not coming in data collection : sick|2|||
154935103|NCT03547531|559190613|FG001|Overall Study|not coming in data collection : sick|2|||
154935104|NCT03547531|559190612|FG000|Overall Study|having family occasion|0|||
154935105|NCT03547531|559190613|FG001|Overall Study|having family occasion|2|||
154935106|NCT03944707|559190614|FG000|Overall Study|Adverse Event|0|||
154935107|NCT03944707|559190615|FG001|Overall Study|Adverse Event|2|||
154935108|NCT03944707|559190614|FG000|Overall Study|Study terminated by sponsor|12|||
154935109|NCT03944707|559190615|FG001|Overall Study|Study terminated by sponsor|7|||
154935110|NCT03944707|559190614|FG000|Overall Study|Subject decision|0|||
154935111|NCT03944707|559190615|FG001|Overall Study|Subject decision|1|||
154935112|NCT02117479|559190624|FG000|Overall Study|Death|13|||
154935113|NCT02117479|559190625|FG001|Overall Study|Death|8|||
154935114|NCT02117479|559190624|FG000|Overall Study|Adverse Event|8|||
154935115|NCT02117479|559190625|FG001|Overall Study|Adverse Event|16|||
154935116|NCT02117479|559190624|FG000|Overall Study|Subject decision|8|||
154935117|NCT02117479|559190625|FG001|Overall Study|Subject decision|9|||
154935118|NCT02117479|559190624|FG000|Overall Study|Disease progression|104|||
154935119|NCT02117479|559190625|FG001|Overall Study|Disease progression|108|||
154935120|NCT02117479|559190624|FG000|Overall Study|Noncompliance with study treatment|1|||
154935121|NCT02117479|559190625|FG001|Overall Study|Noncompliance with study treatment|0|||
154935122|NCT02117479|559190624|FG000|Overall Study|Study terminated by the sponsor|4|||
154935123|NCT02117479|559190625|FG001|Overall Study|Study terminated by the sponsor|6|||
154935124|NCT02117479|559190624|FG000|Overall Study|Physician Decision|7|||
154935125|NCT02117479|559190625|FG001|Overall Study|Physician Decision|2|||
154935126|NCT02117479|559190624|FG000|Overall Study|Other unspecified|11|||
154935127|NCT02117479|559190625|FG001|Overall Study|Other unspecified|7|||
154935128|NCT02444182|559190626|FG000|Overall Study|non-compliance|2|||
154935129|NCT02444182|559190627|FG001|Overall Study|non-compliance|1|||
154935130|NCT02444182|559190626|FG000|Overall Study|Lost to Follow-up|0|||
154935131|NCT02444182|559190627|FG001|Overall Study|Lost to Follow-up|4|||
154935132|NCT01959230|559190628|FG000|Overall Study|Failure to follow study procedures|0|||
154935133|NCT01959230|559190629|FG001|Overall Study|Failure to follow study procedures|1|||
154935134|NCT01959230|559190628|FG000|Overall Study|Administrative reasons|2|||
154935135|NCT01959230|559190629|FG001|Overall Study|Administrative reasons|0|||
154935136|NCT01959230|559190628|FG000|Overall Study|Withdrawal by Subject|2|||
154935137|NCT01959230|559190629|FG001|Overall Study|Withdrawal by Subject|0|||
154935138|NCT01453374|559190630|FG000|Overall Study|Adverse Event|7|||
154935139|NCT01453374|559190630|FG000|Overall Study|Lack of Efficacy|1|||
154935140|NCT01453374|559190630|FG000|Overall Study|Lost to Follow-up|3|||
154935141|NCT01453374|559190630|FG000|Overall Study|Withdrawal by Subject|5|||
154935142|NCT01453374|559190630|FG000|Overall Study|Incarcerated|2|||
154935143|NCT02629133|559190633|FG000|Overall Study|Lost to Follow-up|3|||
154935144|NCT02629133|559190634|FG001|Overall Study|Lost to Follow-up|1|||
154935145|NCT02629133|559190633|FG000|Overall Study|Withdrawal by Subject|1|||
154935146|NCT02629133|559190634|FG001|Overall Study|Withdrawal by Subject|1|||
154935147|NCT01223196|559190635|FG000|Overall Study|Lost to Follow-up|2|||
154935148|NCT01223196|559190636|FG001|Overall Study|Lost to Follow-up|0|||
154935149|NCT01223196|559190635|FG000|Overall Study|Physician Decision|1|||
154935150|NCT01223196|559190636|FG001|Overall Study|Physician Decision|0|||
154935151|NCT01223196|559190635|FG000|Overall Study|Withdrawal by Subject|1|||
154935152|NCT01223196|559190636|FG001|Overall Study|Withdrawal by Subject|0|||
154935153|NCT02487979|559190637|FG000|Overall Study|Physician Decision|2|||
154935154|NCT02487979|559190637|FG000|Overall Study|Withdrawal by Subject|2|||
154935155|NCT02487979|559190637|FG000|Overall Study|Progressive Disease|17|||
154935156|NCT00447694|559190638|FG000|Overall Study|Adverse Event|2|||
154935157|NCT00447694|559190638|FG000|Overall Study|Abnormal laboratory value|1|||
154935158|NCT00447694|559190638|FG000|Overall Study|Abnormal test procedure result|1|||
154935159|NCT00447694|559190638|FG000|Overall Study|Withdrawal by Subject|2|||
154935160|NCT01965535|559190639|FG000|Overall Study|Lack of Efficacy|2|||
154935161|NCT01965535|559190640|FG001|Overall Study|Lack of Efficacy|1|||
154935162|NCT01169987|559190641|FG000|Overall Study|Withdrawal by Subject|3|||
154935163|NCT01169987|559190641|FG000|Overall Study|Lost to Follow-up|24|||
154935164|NCT01169987|559190641|FG000|Overall Study|Other|4|||
154935165|NCT00829439|559190642|FG000|Overall Study|Adverse Event|0|||
154935166|NCT00829439|559190643|FG001|Overall Study|Adverse Event|0|||
154935167|NCT00829439|559190644|FG002|Overall Study|Adverse Event|1|||
154935168|NCT00829439|559190645|FG003|Overall Study|Adverse Event|0|||
154935169|NCT00386100|559190646|FG000|Overall Study|Did not receive study medication|6|||
154935170|NCT00386100|559190647|FG001|Overall Study|Did not receive study medication|4|||
154935171|NCT00386100|559190646|FG000|Overall Study|Adverse Event|15|||
154935172|NCT00386100|559190647|FG001|Overall Study|Adverse Event|25|||
154935173|NCT00386100|559190646|FG000|Overall Study|Death|0|||
154935174|NCT00386100|559190647|FG001|Overall Study|Death|1|||
154935175|NCT00386100|559190646|FG000|Overall Study|Insufficient therapeutic effect|30|||
154935176|NCT00386100|559190647|FG001|Overall Study|Insufficient therapeutic effect|6|||
154935177|NCT00386100|559190646|FG000|Overall Study|Lost to Follow-up|29|||
154935178|NCT00386100|559190647|FG001|Overall Study|Lost to Follow-up|29|||
154935179|NCT00386100|559190646|FG000|Overall Study|Non-compliance|18|||
154935180|NCT00386100|559190647|FG001|Overall Study|Non-compliance|19|||
154935181|NCT00386100|559190646|FG000|Overall Study|Protocol Violation|5|||
154935182|NCT00386100|559190647|FG001|Overall Study|Protocol Violation|3|||
154935183|NCT00386100|559190646|FG000|Overall Study|Withdrawal by Subject|32|||
154935184|NCT00386100|559190647|FG001|Overall Study|Withdrawal by Subject|31|||
154935185|NCT00386100|559190646|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
154935186|NCT00386100|559190647|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
154935187|NCT00386100|559190646|FG000|Overall Study|BMD <2.5|1|||
154935188|NCT00386100|559190647|FG001|Overall Study|BMD <2.5|0|||
154935189|NCT00386100|559190646|FG000|Overall Study|Consecutive elevated Hba1C|1|||
154935190|NCT00386100|559190647|FG001|Overall Study|Consecutive elevated Hba1C|0|||
154935191|NCT00386100|559190646|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
154935192|NCT00386100|559190647|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
154935193|NCT00386100|559190646|FG000|Overall Study|Laboratory findings|1|||
154935194|NCT00386100|559190647|FG001|Overall Study|Laboratory findings|0|||
154935195|NCT00386100|559190646|FG000|Overall Study|Participant's concern due to CPK levels|1|||
154935196|NCT00386100|559190647|FG001|Overall Study|Participant's concern due to CPK levels|0|||
154935197|NCT00386100|559190646|FG000|Overall Study|Participant moving out of state|2|||
154935198|NCT00386100|559190647|FG001|Overall Study|Participant moving out of state|0|||
154935199|NCT00386100|559190646|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
154935200|NCT00386100|559190647|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
154935201|NCT00386100|559190646|FG000|Overall Study|Didn't meet entry criteria|1|||
154935202|NCT00386100|559190647|FG001|Overall Study|Didn't meet entry criteria|1|||
154935203|NCT00386100|559190646|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
155092560|NCT02336815|559773624|FG001|Overall Study|Other|5|||
154935204|NCT00386100|559190647|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
154935205|NCT00386100|559190646|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
154935206|NCT00386100|559190647|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
154935207|NCT00386100|559190646|FG000|Overall Study|Bad metabolic control & patient security|1|||
154935208|NCT00386100|559190647|FG001|Overall Study|Bad metabolic control & patient security|0|||
154935209|NCT00386100|559190646|FG000|Overall Study|Bone loss by DXA bone scan|1|||
154935210|NCT00386100|559190647|FG001|Overall Study|Bone loss by DXA bone scan|0|||
154935211|NCT00386100|559190646|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
154935212|NCT00386100|559190647|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
154935213|NCT00386100|559190646|FG000|Overall Study|7.6% bone loss|1|||
154935214|NCT00386100|559190647|FG001|Overall Study|7.6% bone loss|0|||
154935215|NCT00386100|559190646|FG000|Overall Study|Osteoporosis|0|||
154935216|NCT00386100|559190647|FG001|Overall Study|Osteoporosis|1|||
154935217|NCT00386100|559190646|FG000|Overall Study|Positive pregnancy test|1|||
154935218|NCT00386100|559190647|FG001|Overall Study|Positive pregnancy test|3|||
154935219|NCT00386100|559190646|FG000|Overall Study|Out of country for 5 months|1|||
154935220|NCT00386100|559190647|FG001|Overall Study|Out of country for 5 months|0|||
154935221|NCT00386100|559190646|FG000|Overall Study|Hb1Ac >8%|0|||
154935222|NCT00386100|559190647|FG001|Overall Study|Hb1Ac >8%|1|||
154935223|NCT00386100|559190646|FG000|Overall Study|Participant randomized in error|1|||
154935224|NCT00386100|559190647|FG001|Overall Study|Participant randomized in error|0|||
154935225|NCT02525562|559190648|FG000|Overall Study|Death|9|||
154935226|NCT02525562|559190649|FG001|Overall Study|Death|0|||
154935227|NCT02525562|559190650|FG002|Overall Study|Death|0|||
154935228|NCT02525562|559190648|FG000|Overall Study|Lost to Follow-up|19|||
154935229|NCT02525562|559190649|FG001|Overall Study|Lost to Follow-up|0|||
155273051|NCT02302066|560432920|FG001|Overall Study|Adverse Event|1|||
155273052|NCT02302066|560432921|FG002|Overall Study|Adverse Event|3|||
155273053|NCT02302066|560432922|FG003|Overall Study|Adverse Event|0|||
155273054|NCT02302066|560432919|FG000|Overall Study|Lost to Follow-up|4|||
155273055|NCT02302066|560432920|FG001|Overall Study|Lost to Follow-up|5|||
155273056|NCT02302066|560432921|FG002|Overall Study|Lost to Follow-up|24|||
154935230|NCT02525562|559190650|FG002|Overall Study|Lost to Follow-up|0|||
154935231|NCT02525562|559190648|FG000|Overall Study|Withdrawal by Subject|37|||
154935232|NCT02525562|559190649|FG001|Overall Study|Withdrawal by Subject|0|||
154935233|NCT02525562|559190650|FG002|Overall Study|Withdrawal by Subject|0|||
154935234|NCT02525562|559190648|FG000|Overall Study|Revision/Removal of Study Device|4|||
154935235|NCT02525562|559190649|FG001|Overall Study|Revision/Removal of Study Device|0|||
154935236|NCT02525562|559190650|FG002|Overall Study|Revision/Removal of Study Device|0|||
154935237|NCT02525562|559190648|FG000|Overall Study|Study Closed by Sponsor|154|||
154935238|NCT02525562|559190649|FG001|Overall Study|Study Closed by Sponsor|0|||
154935239|NCT02525562|559190650|FG002|Overall Study|Study Closed by Sponsor|0|||
154935240|NCT00886782|559190653|FG000|Overall Study|Disease progression|3|||
154935241|NCT00886782|559190654|FG001|Overall Study|Disease progression|3|||
154935242|NCT00886782|559190655|FG002|Overall Study|Disease progression|3|||
154935243|NCT00886782|559190653|FG000|Overall Study|Study drug toxicity|0|||
154935244|NCT00886782|559190654|FG001|Overall Study|Study drug toxicity|0|||
154935245|NCT00886782|559190655|FG002|Overall Study|Study drug toxicity|1|||
154935246|NCT00886782|559190653|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
154935247|NCT00886782|559190654|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
154935248|NCT00886782|559190655|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
154935249|NCT00849524|559190656|FG000|Overall Study|Lack of Efficacy|3|||
154935250|NCT02624518|559190657|FG000|Overall Study|Physician Decision|1|||
154935251|NCT03012815|559190658|FG000|Overall Study|Lost to Follow-up|1|||
154935252|NCT03012815|559190659|FG001|Overall Study|Lost to Follow-up|0|||
155273057|NCT02302066|560432922|FG003|Overall Study|Lost to Follow-up|7|||
155273058|NCT02302066|560432919|FG000|Overall Study|Withdrawal by Subject|25|||
155273059|NCT02302066|560432920|FG001|Overall Study|Withdrawal by Subject|58|||
155273060|NCT02302066|560432921|FG002|Overall Study|Withdrawal by Subject|124|||
155273061|NCT02302066|560432922|FG003|Overall Study|Withdrawal by Subject|33|||
155273062|NCT02302066|560432919|FG000|Overall Study|Pregnancy|2|||
155043352|NCT03026283|559590104|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
155273063|NCT02302066|560432920|FG001|Overall Study|Pregnancy|10|||
155273064|NCT02302066|560432921|FG002|Overall Study|Pregnancy|12|||
155273065|NCT02302066|560432922|FG003|Overall Study|Pregnancy|0|||
154935253|NCT03012815|559190658|FG000|Overall Study|Physician Decision|3|||
154935254|NCT03012815|559190659|FG001|Overall Study|Physician Decision|2|||
154935255|NCT03012815|559190658|FG000|Overall Study|Adverse Event|1|||
154935256|NCT03012815|559190659|FG001|Overall Study|Adverse Event|0|||
154935257|NCT00272961|559190660|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
154935258|NCT00272961|559190661|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
154935259|NCT00272961|559190662|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
154935260|NCT00272961|559190663|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
154935261|NCT00272961|559190664|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
155092561|NCT00069641|559773625|FG000|Overall Study|Death|1|||
155273066|NCT02302066|560432919|FG000|Overall Study|Reason Not Specified|1|||
154935262|NCT00272961|559190660|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
154935263|NCT00272961|559190661|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
154935264|NCT00272961|559190662|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
154935265|NCT00272961|559190663|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
154935266|NCT00272961|559190664|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
154935267|NCT00272961|559190660|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
154935268|NCT00272961|559190661|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
154935269|NCT00272961|559190662|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
154935270|NCT00272961|559190663|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
154935271|NCT00272961|559190664|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
154935272|NCT00272961|559190660|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
154935273|NCT00272961|559190661|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
154935274|NCT00272961|559190662|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
154935275|NCT00272961|559190663|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
154935276|NCT00272961|559190664|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
154935277|NCT00272961|559190660|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
154935278|NCT00272961|559190661|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
154935279|NCT00272961|559190662|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
154935280|NCT00272961|559190663|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
154935281|NCT00272961|559190664|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
154935282|NCT00272961|559190660|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
154935283|NCT00272961|559190661|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
154935284|NCT00272961|559190662|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
154935285|NCT00272961|559190663|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
154935286|NCT00272961|559190664|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
154935287|NCT00272961|559190660|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
154935288|NCT00272961|559190661|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
154935289|NCT00272961|559190662|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
154935290|NCT00272961|559190663|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
154935291|NCT00272961|559190664|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
154935292|NCT00272961|559190660|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
154935293|NCT00272961|559190661|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
154935294|NCT00272961|559190662|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
154935295|NCT00272961|559190663|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
154935296|NCT00272961|559190664|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
154935297|NCT02400905|559190665|FG000|Overall Study|Death|24|||
154935298|NCT02400905|559190665|FG000|Overall Study|Lost to Follow-up|18|||
154935299|NCT02400905|559190665|FG000|Overall Study|Withdrawal by Subject|16|||
154935300|NCT02400905|559190665|FG000|Overall Study|Physician Decision|4|||
154935301|NCT02400905|559190665|FG000|Overall Study|Other|1|||
154935302|NCT00879970|559190668|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
154935303|NCT00879970|559190669|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
154935304|NCT00879970|559190670|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
154935305|NCT00879970|559190671|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
154935306|NCT00879970|559190672|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
154935307|NCT00879970|559190668|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
154935308|NCT00879970|559190669|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
154935309|NCT00879970|559190670|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
154935310|NCT00879970|559190671|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
154935311|NCT00879970|559190672|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
154935312|NCT00879970|559190668|FG000|Period 1 TZD Randomization|Death|2|||
154935313|NCT00879970|559190669|FG001|Period 1 TZD Randomization|Death|1|||
154935314|NCT00879970|559190670|FG002|Period 1 TZD Randomization|Death|0|||
154935315|NCT00879970|559190671|FG003|Period 1 TZD Randomization|Death|0|||
154935316|NCT00879970|559190672|FG004|Period 1 TZD Randomization|Death|0|||
154935317|NCT00879970|559190668|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
154935318|NCT00879970|559190669|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
154935319|NCT00879970|559190670|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
154935320|NCT00879970|559190671|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
154935321|NCT00879970|559190672|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
154935322|NCT00879970|559190668|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
154935323|NCT00879970|559190669|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
154935324|NCT00879970|559190670|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
155273067|NCT02302066|560432920|FG001|Overall Study|Reason Not Specified|1|||
155273068|NCT02302066|560432921|FG002|Overall Study|Reason Not Specified|9|||
154935325|NCT00879970|559190671|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
154935326|NCT00879970|559190672|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
154935327|NCT00879970|559190668|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
154935328|NCT00879970|559190669|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
154935329|NCT00879970|559190670|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
154935330|NCT00879970|559190671|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
154935331|NCT00879970|559190672|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
154935332|NCT00879970|559190668|FG000|Period 2 Vitamin D Randomization|Death|0|||
154935333|NCT00879970|559190669|FG001|Period 2 Vitamin D Randomization|Death|0|||
154935334|NCT00879970|559190670|FG002|Period 2 Vitamin D Randomization|Death|0|||
154935335|NCT00879970|559190671|FG003|Period 2 Vitamin D Randomization|Death|2|||
154935336|NCT00879970|559190672|FG004|Period 2 Vitamin D Randomization|Death|0|||
154935337|NCT01749033|559190674|FG000|Overall Study|Did not receive allocated intervention|3|||
154935338|NCT01749033|559190675|FG001|Overall Study|Did not receive allocated intervention|3|||
154935339|NCT01749033|559190676|FG002|Overall Study|Did not receive allocated intervention|0|||
154935340|NCT01749033|559190674|FG000|Overall Study|Lost to Follow-up|0|||
154935341|NCT01749033|559190675|FG001|Overall Study|Lost to Follow-up|2|||
154935342|NCT01749033|559190676|FG002|Overall Study|Lost to Follow-up|1|||
154935343|NCT01256398|559190677|FG000|Overall Study|Withdrawal by Subject|1|||
154935344|NCT00061945|559190678|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
154935345|NCT00061945|559190679|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
154935346|NCT00061945|559190678|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
154935347|NCT00061945|559190679|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
154935348|NCT00061945|559190678|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
154935349|NCT00061945|559190679|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
154935350|NCT00061945|559190678|FG000|Course IV: Alemtuzumab|Early exits|6|||
154935351|NCT00061945|559190679|FG001|Course IV: Alemtuzumab|Early exits|15|||
154935352|NCT01039584|559190680|FG000|Overall Study|Withdrawal by Subject|4|||
154935353|NCT01039584|559190681|FG001|Overall Study|Withdrawal by Subject|2|||
154935354|NCT01039584|559190682|FG002|Overall Study|Withdrawal by Subject|1|||
154935355|NCT01039584|559190680|FG000|Overall Study|Protocol Violation|10|||
154935356|NCT01039584|559190681|FG001|Overall Study|Protocol Violation|4|||
154935357|NCT01039584|559190682|FG002|Overall Study|Protocol Violation|6|||
154935358|NCT01039584|559190680|FG000|Overall Study|Lost to Follow-up|5|||
154935359|NCT01039584|559190681|FG001|Overall Study|Lost to Follow-up|3|||
154935360|NCT01039584|559190682|FG002|Overall Study|Lost to Follow-up|4|||
154935361|NCT01039584|559190680|FG000|Overall Study|Negative Baseline culture for Candida|59|||
154935362|NCT01039584|559190681|FG001|Overall Study|Negative Baseline culture for Candida|59|||
154935363|NCT01039584|559190682|FG002|Overall Study|Negative Baseline culture for Candida|24|||
154935364|NCT01039584|559190680|FG000|Overall Study|Lack of Efficacy|7|||
154935365|NCT01039584|559190681|FG001|Overall Study|Lack of Efficacy|6|||
154935366|NCT01039584|559190682|FG002|Overall Study|Lack of Efficacy|10|||
154935367|NCT01039584|559190680|FG000|Overall Study|other|1|||
154935368|NCT01039584|559190681|FG001|Overall Study|other|3|||
154935369|NCT01039584|559190682|FG002|Overall Study|other|1|||
154935370|NCT01039584|559190680|FG000|Overall Study|Pap smear with significant pathology|10|||
154935371|NCT01039584|559190681|FG001|Overall Study|Pap smear with significant pathology|10|||
154935372|NCT01039584|559190682|FG002|Overall Study|Pap smear with significant pathology|3|||
154935373|NCT01039584|559190680|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
154935374|NCT01039584|559190681|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
154935375|NCT01039584|559190682|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
154935376|NCT04380701|559190687|FG000|Overall Study|Pregnancy|0|||
154935377|NCT04380701|559190688|FG001|Overall Study|Pregnancy|0|||
154935378|NCT04380701|559190689|FG002|Overall Study|Pregnancy|0|||
154935379|NCT04380701|559190690|FG003|Overall Study|Pregnancy|0|||
154935380|NCT04380701|559190691|FG004|Overall Study|Pregnancy|0|||
154935381|NCT04380701|559190692|FG005|Overall Study|Pregnancy|0|||
154935382|NCT04380701|559190693|FG006|Overall Study|Pregnancy|0|||
154935383|NCT04380701|559190694|FG007|Overall Study|Pregnancy|0|||
154935384|NCT04380701|559190695|FG008|Overall Study|Pregnancy|0|||
154935385|NCT04380701|559190696|FG009|Overall Study|Pregnancy|0|||
154935386|NCT04380701|559190697|FG010|Overall Study|Pregnancy|0|||
154935387|NCT04380701|559190698|FG011|Overall Study|Pregnancy|0|||
154935388|NCT04380701|559190699|FG012|Overall Study|Pregnancy|0|||
154935389|NCT04380701|559190700|FG013|Overall Study|Pregnancy|0|||
154935390|NCT04380701|559190701|FG014|Overall Study|Pregnancy|0|||
154935391|NCT04380701|559190702|FG015|Overall Study|Pregnancy|0|||
154935392|NCT04380701|559190703|FG016|Overall Study|Pregnancy|0|||
154935393|NCT04380701|559190704|FG017|Overall Study|Pregnancy|0|||
154935394|NCT04380701|559190705|FG018|Overall Study|Pregnancy|0|||
154935395|NCT04380701|559190706|FG019|Overall Study|Pregnancy|0|||
154935396|NCT04380701|559190707|FG020|Overall Study|Pregnancy|0|||
154935397|NCT04380701|559190708|FG021|Overall Study|Pregnancy|0|||
154935398|NCT04380701|559190709|FG022|Overall Study|Pregnancy|0|||
154935399|NCT04380701|559190710|FG023|Overall Study|Pregnancy|0|||
154935400|NCT04380701|559190711|FG024|Overall Study|Pregnancy|0|||
154935401|NCT04380701|559190712|FG025|Overall Study|Pregnancy|0|||
154935402|NCT04380701|559190713|FG026|Overall Study|Pregnancy|0|||
154935403|NCT04380701|559190714|FG027|Overall Study|Pregnancy|0|||
154935404|NCT04380701|559190715|FG028|Overall Study|Pregnancy|0|||
154935405|NCT04380701|559190716|FG029|Overall Study|Pregnancy|0|||
154935406|NCT04380701|559190717|FG030|Overall Study|Pregnancy|0|||
154935407|NCT04380701|559190718|FG031|Overall Study|Pregnancy|0|||
154935408|NCT04380701|559190719|FG032|Overall Study|Pregnancy|1|||
154935409|NCT04380701|559190720|FG033|Overall Study|Pregnancy|0|||
154935410|NCT04380701|559190687|FG000|Overall Study|Lost to Follow-up|0|||
154935411|NCT04380701|559190688|FG001|Overall Study|Lost to Follow-up|0|||
154935412|NCT04380701|559190689|FG002|Overall Study|Lost to Follow-up|0|||
154935413|NCT04380701|559190690|FG003|Overall Study|Lost to Follow-up|0|||
154935414|NCT04380701|559190691|FG004|Overall Study|Lost to Follow-up|0|||
154935415|NCT04380701|559190692|FG005|Overall Study|Lost to Follow-up|0|||
154935416|NCT04380701|559190693|FG006|Overall Study|Lost to Follow-up|0|||
154935417|NCT04380701|559190694|FG007|Overall Study|Lost to Follow-up|0|||
154935418|NCT04380701|559190695|FG008|Overall Study|Lost to Follow-up|0|||
154935419|NCT04380701|559190696|FG009|Overall Study|Lost to Follow-up|0|||
154935420|NCT04380701|559190697|FG010|Overall Study|Lost to Follow-up|0|||
154935421|NCT04380701|559190698|FG011|Overall Study|Lost to Follow-up|0|||
154935422|NCT04380701|559190699|FG012|Overall Study|Lost to Follow-up|0|||
154935423|NCT04380701|559190700|FG013|Overall Study|Lost to Follow-up|0|||
154935424|NCT04380701|559190701|FG014|Overall Study|Lost to Follow-up|0|||
154935425|NCT04380701|559190702|FG015|Overall Study|Lost to Follow-up|0|||
154935426|NCT04380701|559190703|FG016|Overall Study|Lost to Follow-up|0|||
154935427|NCT04380701|559190704|FG017|Overall Study|Lost to Follow-up|0|||
154935428|NCT04380701|559190705|FG018|Overall Study|Lost to Follow-up|0|||
154935429|NCT04380701|559190706|FG019|Overall Study|Lost to Follow-up|0|||
154935430|NCT04380701|559190707|FG020|Overall Study|Lost to Follow-up|1|||
154935431|NCT04380701|559190708|FG021|Overall Study|Lost to Follow-up|0|||
154935432|NCT04380701|559190709|FG022|Overall Study|Lost to Follow-up|0|||
154935433|NCT04380701|559190710|FG023|Overall Study|Lost to Follow-up|1|||
154935434|NCT04380701|559190711|FG024|Overall Study|Lost to Follow-up|0|||
154935435|NCT04380701|559190712|FG025|Overall Study|Lost to Follow-up|0|||
154935436|NCT04380701|559190713|FG026|Overall Study|Lost to Follow-up|0|||
154935437|NCT04380701|559190714|FG027|Overall Study|Lost to Follow-up|0|||
154935438|NCT04380701|559190715|FG028|Overall Study|Lost to Follow-up|0|||
154935439|NCT04380701|559190716|FG029|Overall Study|Lost to Follow-up|1|||
154935440|NCT04380701|559190717|FG030|Overall Study|Lost to Follow-up|0|||
154935441|NCT04380701|559190718|FG031|Overall Study|Lost to Follow-up|0|||
154935442|NCT04380701|559190719|FG032|Overall Study|Lost to Follow-up|0|||
154935443|NCT04380701|559190720|FG033|Overall Study|Lost to Follow-up|1|||
154935444|NCT04380701|559190687|FG000|Overall Study|Private reason(s)|0|||
154935445|NCT04380701|559190688|FG001|Overall Study|Private reason(s)|0|||
154935446|NCT04380701|559190689|FG002|Overall Study|Private reason(s)|0|||
154935447|NCT04380701|559190690|FG003|Overall Study|Private reason(s)|0|||
154935448|NCT04380701|559190691|FG004|Overall Study|Private reason(s)|0|||
154935449|NCT04380701|559190692|FG005|Overall Study|Private reason(s)|0|||
154935450|NCT04380701|559190693|FG006|Overall Study|Private reason(s)|1|||
154935451|NCT04380701|559190694|FG007|Overall Study|Private reason(s)|0|||
154935452|NCT04380701|559190695|FG008|Overall Study|Private reason(s)|1|||
154935453|NCT04380701|559190696|FG009|Overall Study|Private reason(s)|1|||
154935454|NCT04380701|559190697|FG010|Overall Study|Private reason(s)|0|||
154935455|NCT04380701|559190698|FG011|Overall Study|Private reason(s)|0|||
154935456|NCT04380701|559190699|FG012|Overall Study|Private reason(s)|0|||
154935457|NCT04380701|559190700|FG013|Overall Study|Private reason(s)|0|||
154935458|NCT04380701|559190701|FG014|Overall Study|Private reason(s)|0|||
154935459|NCT04380701|559190702|FG015|Overall Study|Private reason(s)|0|||
154935460|NCT04380701|559190703|FG016|Overall Study|Private reason(s)|0|||
154935461|NCT04380701|559190704|FG017|Overall Study|Private reason(s)|0|||
154935462|NCT04380701|559190705|FG018|Overall Study|Private reason(s)|0|||
154935463|NCT04380701|559190706|FG019|Overall Study|Private reason(s)|0|||
154935464|NCT04380701|559190707|FG020|Overall Study|Private reason(s)|0|||
154935465|NCT04380701|559190708|FG021|Overall Study|Private reason(s)|0|||
154935466|NCT04380701|559190709|FG022|Overall Study|Private reason(s)|0|||
154935467|NCT04380701|559190710|FG023|Overall Study|Private reason(s)|1|||
154935468|NCT04380701|559190711|FG024|Overall Study|Private reason(s)|0|||
154935469|NCT04380701|559190712|FG025|Overall Study|Private reason(s)|0|||
154935470|NCT04380701|559190713|FG026|Overall Study|Private reason(s)|0|||
154935471|NCT04380701|559190714|FG027|Overall Study|Private reason(s)|0|||
154935472|NCT04380701|559190715|FG028|Overall Study|Private reason(s)|0|||
154935473|NCT04380701|559190716|FG029|Overall Study|Private reason(s)|1|||
154935474|NCT04380701|559190717|FG030|Overall Study|Private reason(s)|0|||
154935475|NCT04380701|559190718|FG031|Overall Study|Private reason(s)|0|||
154935476|NCT04380701|559190719|FG032|Overall Study|Private reason(s)|0|||
154935477|NCT04380701|559190720|FG033|Overall Study|Private reason(s)|0|||
154935478|NCT04380701|559190687|FG000|Overall Study|Withdrawal by Subject|0|||
154935479|NCT04380701|559190688|FG001|Overall Study|Withdrawal by Subject|0|||
154935480|NCT04380701|559190689|FG002|Overall Study|Withdrawal by Subject|0|||
154935481|NCT04380701|559190690|FG003|Overall Study|Withdrawal by Subject|0|||
154935482|NCT04380701|559190691|FG004|Overall Study|Withdrawal by Subject|0|||
154935483|NCT04380701|559190692|FG005|Overall Study|Withdrawal by Subject|0|||
154935484|NCT04380701|559190693|FG006|Overall Study|Withdrawal by Subject|1|||
154935485|NCT04380701|559190694|FG007|Overall Study|Withdrawal by Subject|1|||
154935486|NCT04380701|559190695|FG008|Overall Study|Withdrawal by Subject|0|||
154935487|NCT04380701|559190696|FG009|Overall Study|Withdrawal by Subject|0|||
154935488|NCT04380701|559190697|FG010|Overall Study|Withdrawal by Subject|0|||
154935489|NCT04380701|559190698|FG011|Overall Study|Withdrawal by Subject|1|||
154935490|NCT04380701|559190699|FG012|Overall Study|Withdrawal by Subject|0|||
154935491|NCT04380701|559190700|FG013|Overall Study|Withdrawal by Subject|1|||
154935492|NCT04380701|559190701|FG014|Overall Study|Withdrawal by Subject|0|||
154935493|NCT04380701|559190702|FG015|Overall Study|Withdrawal by Subject|0|||
154935494|NCT04380701|559190703|FG016|Overall Study|Withdrawal by Subject|1|||
154935495|NCT04380701|559190704|FG017|Overall Study|Withdrawal by Subject|0|||
154935496|NCT04380701|559190705|FG018|Overall Study|Withdrawal by Subject|0|||
154935497|NCT04380701|559190706|FG019|Overall Study|Withdrawal by Subject|0|||
154935498|NCT04380701|559190707|FG020|Overall Study|Withdrawal by Subject|0|||
154935499|NCT04380701|559190708|FG021|Overall Study|Withdrawal by Subject|0|||
154935500|NCT04380701|559190709|FG022|Overall Study|Withdrawal by Subject|2|||
154935501|NCT04380701|559190710|FG023|Overall Study|Withdrawal by Subject|2|||
154935502|NCT04380701|559190711|FG024|Overall Study|Withdrawal by Subject|1|||
154935503|NCT04380701|559190712|FG025|Overall Study|Withdrawal by Subject|1|||
154935504|NCT04380701|559190713|FG026|Overall Study|Withdrawal by Subject|0|||
154935505|NCT04380701|559190714|FG027|Overall Study|Withdrawal by Subject|0|||
154935506|NCT04380701|559190715|FG028|Overall Study|Withdrawal by Subject|0|||
154935507|NCT04380701|559190716|FG029|Overall Study|Withdrawal by Subject|0|||
154935508|NCT04380701|559190717|FG030|Overall Study|Withdrawal by Subject|0|||
154935509|NCT04380701|559190718|FG031|Overall Study|Withdrawal by Subject|0|||
154935510|NCT04380701|559190719|FG032|Overall Study|Withdrawal by Subject|0|||
154935511|NCT04380701|559190720|FG033|Overall Study|Withdrawal by Subject|0|||
154935512|NCT04380701|559190687|FG000|Overall Study|Adverse Event|0|||
154935513|NCT04380701|559190688|FG001|Overall Study|Adverse Event|0|||
154935514|NCT04380701|559190689|FG002|Overall Study|Adverse Event|0|||
154935515|NCT04380701|559190690|FG003|Overall Study|Adverse Event|0|||
154935516|NCT04380701|559190691|FG004|Overall Study|Adverse Event|0|||
154935517|NCT04380701|559190692|FG005|Overall Study|Adverse Event|1|||
154935518|NCT04380701|559190693|FG006|Overall Study|Adverse Event|0|||
154935519|NCT04380701|559190694|FG007|Overall Study|Adverse Event|0|||
154935520|NCT04380701|559190695|FG008|Overall Study|Adverse Event|0|||
154935521|NCT04380701|559190696|FG009|Overall Study|Adverse Event|0|||
154935522|NCT04380701|559190697|FG010|Overall Study|Adverse Event|0|||
154935523|NCT04380701|559190698|FG011|Overall Study|Adverse Event|0|||
154935524|NCT04380701|559190699|FG012|Overall Study|Adverse Event|0|||
154935525|NCT04380701|559190700|FG013|Overall Study|Adverse Event|0|||
154935526|NCT04380701|559190701|FG014|Overall Study|Adverse Event|0|||
154935527|NCT04380701|559190702|FG015|Overall Study|Adverse Event|1|||
154935528|NCT04380701|559190703|FG016|Overall Study|Adverse Event|0|||
154935529|NCT04380701|559190704|FG017|Overall Study|Adverse Event|0|||
154935530|NCT04380701|559190705|FG018|Overall Study|Adverse Event|0|||
154935531|NCT04380701|559190706|FG019|Overall Study|Adverse Event|1|||
154935532|NCT04380701|559190707|FG020|Overall Study|Adverse Event|0|||
154935533|NCT04380701|559190708|FG021|Overall Study|Adverse Event|0|||
154935534|NCT04380701|559190709|FG022|Overall Study|Adverse Event|0|||
154935535|NCT04380701|559190710|FG023|Overall Study|Adverse Event|0|||
154935536|NCT04380701|559190711|FG024|Overall Study|Adverse Event|0|||
154935537|NCT04380701|559190712|FG025|Overall Study|Adverse Event|0|||
154935538|NCT04380701|559190713|FG026|Overall Study|Adverse Event|0|||
154935539|NCT04380701|559190714|FG027|Overall Study|Adverse Event|0|||
154935540|NCT04380701|559190715|FG028|Overall Study|Adverse Event|0|||
154935541|NCT04380701|559190716|FG029|Overall Study|Adverse Event|0|||
154935542|NCT04380701|559190717|FG030|Overall Study|Adverse Event|0|||
154935543|NCT04380701|559190718|FG031|Overall Study|Adverse Event|0|||
154935544|NCT04380701|559190719|FG032|Overall Study|Adverse Event|0|||
154935545|NCT04380701|559190720|FG033|Overall Study|Adverse Event|0|||
154935546|NCT04380701|559190687|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
154935547|NCT04380701|559190688|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
154935548|NCT04380701|559190689|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
154935549|NCT04380701|559190690|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
154935550|NCT04380701|559190691|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
154935551|NCT04380701|559190692|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
154935552|NCT04380701|559190693|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
154935553|NCT04380701|559190694|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
154935554|NCT04380701|559190695|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
154935555|NCT04380701|559190696|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
154935556|NCT04380701|559190697|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
154935557|NCT04380701|559190698|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
154935558|NCT04380701|559190699|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
154935559|NCT04380701|559190700|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
154935560|NCT04380701|559190701|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
155092562|NCT00069641|559773626|FG001|Overall Study|Death|0|||
154935561|NCT04380701|559190702|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
154935562|NCT04380701|559190703|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
154935563|NCT04380701|559190704|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
154935564|NCT04380701|559190705|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
154935565|NCT04380701|559190706|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
154935566|NCT04380701|559190707|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
154935567|NCT04380701|559190708|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
154935568|NCT04380701|559190709|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
154935569|NCT04380701|559190710|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
154935570|NCT04380701|559190711|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
154935571|NCT04380701|559190712|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
154935572|NCT04380701|559190713|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
154935573|NCT04380701|559190714|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
154935574|NCT04380701|559190715|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
154935575|NCT04380701|559190716|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
154935576|NCT04380701|559190717|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
154935577|NCT04380701|559190718|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
154935578|NCT04380701|559190719|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
154935579|NCT04380701|559190720|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
154935580|NCT04380701|559190687|FG000|Overall Study|Physician Decision|0|||
154935581|NCT04380701|559190688|FG001|Overall Study|Physician Decision|0|||
154935582|NCT04380701|559190689|FG002|Overall Study|Physician Decision|0|||
154935583|NCT04380701|559190690|FG003|Overall Study|Physician Decision|0|||
154935584|NCT04380701|559190691|FG004|Overall Study|Physician Decision|0|||
154935585|NCT04380701|559190692|FG005|Overall Study|Physician Decision|0|||
154935586|NCT04380701|559190693|FG006|Overall Study|Physician Decision|0|||
154935587|NCT04380701|559190694|FG007|Overall Study|Physician Decision|0|||
154935588|NCT04380701|559190695|FG008|Overall Study|Physician Decision|0|||
154935589|NCT04380701|559190696|FG009|Overall Study|Physician Decision|0|||
154935590|NCT04380701|559190697|FG010|Overall Study|Physician Decision|0|||
154935591|NCT04380701|559190698|FG011|Overall Study|Physician Decision|0|||
154935592|NCT04380701|559190699|FG012|Overall Study|Physician Decision|0|||
154935593|NCT04380701|559190700|FG013|Overall Study|Physician Decision|0|||
154935594|NCT04380701|559190701|FG014|Overall Study|Physician Decision|0|||
154935595|NCT04380701|559190702|FG015|Overall Study|Physician Decision|0|||
154935596|NCT04380701|559190703|FG016|Overall Study|Physician Decision|0|||
154935597|NCT04380701|559190704|FG017|Overall Study|Physician Decision|0|||
154935598|NCT04380701|559190705|FG018|Overall Study|Physician Decision|0|||
154935599|NCT04380701|559190706|FG019|Overall Study|Physician Decision|0|||
154935600|NCT04380701|559190707|FG020|Overall Study|Physician Decision|0|||
154935601|NCT04380701|559190708|FG021|Overall Study|Physician Decision|0|||
154935602|NCT04380701|559190709|FG022|Overall Study|Physician Decision|0|||
154935603|NCT04380701|559190710|FG023|Overall Study|Physician Decision|0|||
154935604|NCT04380701|559190711|FG024|Overall Study|Physician Decision|2|||
154935605|NCT04380701|559190712|FG025|Overall Study|Physician Decision|0|||
154935606|NCT04380701|559190713|FG026|Overall Study|Physician Decision|0|||
154935607|NCT04380701|559190714|FG027|Overall Study|Physician Decision|0|||
154935608|NCT04380701|559190715|FG028|Overall Study|Physician Decision|0|||
154935609|NCT04380701|559190716|FG029|Overall Study|Physician Decision|0|||
154935610|NCT04380701|559190717|FG030|Overall Study|Physician Decision|0|||
154935611|NCT04380701|559190718|FG031|Overall Study|Physician Decision|0|||
154935612|NCT04380701|559190719|FG032|Overall Study|Physician Decision|0|||
154935613|NCT04380701|559190720|FG033|Overall Study|Physician Decision|0|||
154935614|NCT04380701|559190687|FG000|Overall Study|Death|0|||
154935615|NCT04380701|559190688|FG001|Overall Study|Death|0|||
154935616|NCT04380701|559190689|FG002|Overall Study|Death|0|||
154935617|NCT04380701|559190690|FG003|Overall Study|Death|0|||
154935618|NCT04380701|559190691|FG004|Overall Study|Death|0|||
154935619|NCT04380701|559190692|FG005|Overall Study|Death|0|||
154935620|NCT04380701|559190693|FG006|Overall Study|Death|0|||
154935621|NCT04380701|559190694|FG007|Overall Study|Death|0|||
154935622|NCT04380701|559190695|FG008|Overall Study|Death|0|||
154935623|NCT04380701|559190696|FG009|Overall Study|Death|0|||
154935624|NCT04380701|559190697|FG010|Overall Study|Death|0|||
154935625|NCT04380701|559190698|FG011|Overall Study|Death|0|||
154935626|NCT04380701|559190699|FG012|Overall Study|Death|0|||
154935627|NCT04380701|559190700|FG013|Overall Study|Death|0|||
154935628|NCT04380701|559190701|FG014|Overall Study|Death|0|||
154935629|NCT04380701|559190702|FG015|Overall Study|Death|0|||
154935630|NCT04380701|559190703|FG016|Overall Study|Death|0|||
154935631|NCT04380701|559190704|FG017|Overall Study|Death|0|||
154935632|NCT04380701|559190705|FG018|Overall Study|Death|0|||
154935633|NCT04380701|559190706|FG019|Overall Study|Death|0|||
154935634|NCT04380701|559190707|FG020|Overall Study|Death|0|||
154935635|NCT04380701|559190708|FG021|Overall Study|Death|0|||
155273069|NCT02302066|560432922|FG003|Overall Study|Reason Not Specified|1|||
154935636|NCT04380701|559190709|FG022|Overall Study|Death|0|||
154935637|NCT04380701|559190710|FG023|Overall Study|Death|0|||
154935638|NCT04380701|559190711|FG024|Overall Study|Death|1|||
154935639|NCT04380701|559190712|FG025|Overall Study|Death|0|||
155273070|NCT02180438|560432932|FG000|Overall Study|Lost to Follow-up|1|||
155273071|NCT02058290|560432933|FG000|Overall Study|Protocol Violation|2|||
155273072|NCT02058290|560432934|FG001|Overall Study|Protocol Violation|1|||
155273073|NCT02058290|560432933|FG000|Overall Study|Physician Decision|1|||
155273074|NCT02058290|560432934|FG001|Overall Study|Physician Decision|0|||
155273075|NCT02058290|560432933|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
155273076|NCT02058290|560432934|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
155273077|NCT02058290|560432933|FG000|Overall Study|Withdrawal by Subject|0|||
155273078|NCT02058290|560432934|FG001|Overall Study|Withdrawal by Subject|1|||
155273079|NCT00785707|560432936|FG000|Overall Study|Lost to Follow-up|7|||
154935640|NCT04380701|559190713|FG026|Overall Study|Death|0|||
155273080|NCT00105586|560432939|FG000|Overall Study|Adverse Event|4|||
155273081|NCT00105586|560432940|FG001|Overall Study|Adverse Event|3|||
155273082|NCT00105586|560432939|FG000|Overall Study|Physician Decision|13|||
155273083|NCT00105586|560432940|FG001|Overall Study|Physician Decision|13|||
155273084|NCT02262260|560432943|FG000|Overall Study|Adverse Event|4|||
155273085|NCT02262260|560432944|FG001|Overall Study|Adverse Event|1|||
155273086|NCT02262260|560432943|FG000|Overall Study|Withdrawal of consent|4|||
155273087|NCT02262260|560432944|FG001|Overall Study|Withdrawal of consent|2|||
155273088|NCT02262260|560432943|FG000|Overall Study|Lost to Follow-up|1|||
155273089|NCT02262260|560432944|FG001|Overall Study|Lost to Follow-up|2|||
155273090|NCT02262260|560432943|FG000|Overall Study|Protocol deviation|2|||
155273091|NCT02262260|560432944|FG001|Overall Study|Protocol deviation|5|||
155273092|NCT01794117|560432945|FG000|Overall Study|Adverse Event|1|||
155273093|NCT01794117|560432946|FG001|Overall Study|Adverse Event|0|||
155273094|NCT01794117|560432947|FG002|Overall Study|Adverse Event|0|||
155273095|NCT01794117|560432948|FG003|Overall Study|Adverse Event|0|||
155273096|NCT01794117|560432945|FG000|Overall Study|Participant noncompliance|0|||
155273097|NCT01794117|560432946|FG001|Overall Study|Participant noncompliance|1|||
155273098|NCT01794117|560432947|FG002|Overall Study|Participant noncompliance|0|||
155273099|NCT01794117|560432948|FG003|Overall Study|Participant noncompliance|0|||
155273100|NCT01794117|560432945|FG000|Overall Study|Refused further treatment|0|||
155273101|NCT01794117|560432946|FG001|Overall Study|Refused further treatment|2|||
155273102|NCT01794117|560432947|FG002|Overall Study|Refused further treatment|0|||
155273103|NCT01794117|560432948|FG003|Overall Study|Refused further treatment|0|||
155273104|NCT04150029|560432951|FG000|Overall Study|Disease Relapse|0|||
155273105|NCT04150029|560432952|FG001|Overall Study|Disease Relapse|18|||
155273106|NCT04150029|560432951|FG000|Overall Study|Progressive Disease|2|||
155273107|NCT04150029|560432952|FG001|Overall Study|Progressive Disease|16|||
155273108|NCT04150029|560432951|FG000|Overall Study|Adverse Event|1|||
155273109|NCT04150029|560432952|FG001|Overall Study|Adverse Event|11|||
155273110|NCT04150029|560432951|FG000|Overall Study|Physician Decision|0|||
155273111|NCT04150029|560432952|FG001|Overall Study|Physician Decision|10|||
155273112|NCT04150029|560432951|FG000|Overall Study|Study Terminated by Sponsor|1|||
155273113|NCT04150029|560432952|FG001|Overall Study|Study Terminated by Sponsor|10|||
155273114|NCT04150029|560432951|FG000|Overall Study|Death|0|||
155273115|NCT04150029|560432952|FG001|Overall Study|Death|8|||
155273116|NCT04150029|560432951|FG000|Overall Study|Participant Decision|0|||
155273117|NCT04150029|560432952|FG001|Overall Study|Participant Decision|7|||
155273118|NCT04150029|560432951|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
155273119|NCT04150029|560432952|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
155273120|NCT02696902|560432953|FG000|Overall Study|Lost to Follow-up|0|||
155273121|NCT02696902|560432954|FG001|Overall Study|Lost to Follow-up|1|||
155273122|NCT02696902|560432955|FG002|Overall Study|Lost to Follow-up|1|||
155273123|NCT02696902|560432953|FG000|Overall Study|Withdrawal by Subject|0|||
154935641|NCT04380701|559190714|FG027|Overall Study|Death|0|||
154935642|NCT04380701|559190715|FG028|Overall Study|Death|0|||
154935643|NCT04380701|559190716|FG029|Overall Study|Death|0|||
154935644|NCT04380701|559190717|FG030|Overall Study|Death|0|||
154935645|NCT04380701|559190718|FG031|Overall Study|Death|0|||
154935646|NCT04380701|559190719|FG032|Overall Study|Death|0|||
154935647|NCT04380701|559190720|FG033|Overall Study|Death|0|||
154935648|NCT04380701|559190687|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935649|NCT04380701|559190688|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935650|NCT04380701|559190689|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155273124|NCT02696902|560432954|FG001|Overall Study|Withdrawal by Subject|0|||
155273125|NCT02696902|560432955|FG002|Overall Study|Withdrawal by Subject|1|||
155273126|NCT02696902|560432953|FG000|Overall Study|Death|19|||
155273127|NCT02696902|560432954|FG001|Overall Study|Death|3|||
155273128|NCT02696902|560432955|FG002|Overall Study|Death|24|||
155273129|NCT02696902|560432953|FG000|Overall Study|Participant not fit post-randomization|0|||
154935651|NCT04380701|559190690|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935652|NCT04380701|559190691|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
155273130|NCT02696902|560432954|FG001|Overall Study|Participant not fit post-randomization|0|||
155273131|NCT02696902|560432955|FG002|Overall Study|Participant not fit post-randomization|1|||
155273132|NCT02696902|560432953|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
154935653|NCT04380701|559190692|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935654|NCT04380701|559190693|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935655|NCT04380701|559190694|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935656|NCT04380701|559190695|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935657|NCT04380701|559190696|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935658|NCT04380701|559190697|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935659|NCT04380701|559190698|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935660|NCT04380701|559190699|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935661|NCT04380701|559190700|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935662|NCT04380701|559190701|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935663|NCT04380701|559190702|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935664|NCT04380701|559190703|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935665|NCT04380701|559190704|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935666|NCT04380701|559190705|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935667|NCT04380701|559190706|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935668|NCT04380701|559190707|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935669|NCT04380701|559190708|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
154935670|NCT04380701|559190709|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
154935671|NCT04380701|559190710|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
154935672|NCT04380701|559190711|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
154935673|NCT04380701|559190712|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935674|NCT04380701|559190713|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935675|NCT04380701|559190714|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935676|NCT04380701|559190715|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935677|NCT04380701|559190716|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935678|NCT04380701|559190717|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935679|NCT04380701|559190718|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935680|NCT04380701|559190719|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935681|NCT04380701|559190720|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
154935682|NCT03550794|559190721|FG000|Overall Study|No longer met inclusion criteria|1|||
154935683|NCT03550794|559190722|FG001|Overall Study|No longer met inclusion criteria|2|||
154935684|NCT03550794|559190721|FG000|Overall Study|Goals of care changed|1|||
154935685|NCT03550794|559190722|FG001|Overall Study|Goals of care changed|0|||
154935686|NCT03550794|559190721|FG000|Overall Study|Withdrawal by Subject|2|||
154935687|NCT03550794|559190722|FG001|Overall Study|Withdrawal by Subject|0|||
154935688|NCT03550794|559190721|FG000|Overall Study|Death|0|||
154935689|NCT03550794|559190722|FG001|Overall Study|Death|1|||
154935690|NCT01864525|559190723|FG000|Overall Study|Adverse Event|1|||
154935691|NCT01864525|559190724|FG001|Overall Study|Adverse Event|0|||
154935692|NCT01890785|559190725|FG000|Third Intervention|Withdrawal by Subject|0|||
154935693|NCT01890785|559190726|FG001|Third Intervention|Withdrawal by Subject|1|||
154935694|NCT01890785|559190727|FG002|Third Intervention|Withdrawal by Subject|0|||
154935695|NCT01890785|559190728|FG003|Third Intervention|Withdrawal by Subject|0|||
154935696|NCT01890785|559190729|FG004|Third Intervention|Withdrawal by Subject|0|||
154935697|NCT01890785|559190730|FG005|Third Intervention|Withdrawal by Subject|0|||
154935698|NCT03296553|559190731|FG000|Overall Study|Withdrawal by Subject|1|||
154935699|NCT03296553|559190732|FG001|Overall Study|Withdrawal by Subject|1|||
154935700|NCT03296553|559190731|FG000|Overall Study|Death|1|||
154935701|NCT03296553|559190732|FG001|Overall Study|Death|0|||
154935702|NCT00558519|559190733|FG000|Overall Study|Ph+|20|||
154935703|NCT00558519|559190733|FG000|Overall Study|Ineligible|1|||
154935704|NCT00558519|559190733|FG000|Overall Study|Insufficient data|1|||
154935705|NCT00558519|559190733|FG000|Overall Study|Never received treatment|1|||
154935706|NCT03001011|559190734|FG000|Overall Study|Adverse Event|9|||
154935707|NCT03001011|559190735|FG001|Overall Study|Adverse Event|3|||
154935708|NCT03001011|559190734|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
154935709|NCT03001011|559190735|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
154935710|NCT03001011|559190734|FG000|Overall Study|Other than specified above|3|||
154935711|NCT03001011|559190735|FG001|Overall Study|Other than specified above|8|||
154935712|NCT00065065|559190736|FG000|Overall Study|Adverse Event|3|||
154935713|NCT00065065|559190737|FG001|Overall Study|Adverse Event|2|||
154935714|NCT00065065|559190736|FG000|Overall Study|Withdrawal by Subject|1|||
154935715|NCT00065065|559190737|FG001|Overall Study|Withdrawal by Subject|5|||
154935716|NCT00065065|559190736|FG000|Overall Study|Lack of Efficacy|4|||
154935717|NCT00065065|559190737|FG001|Overall Study|Lack of Efficacy|11|||
154935718|NCT00065065|559190736|FG000|Overall Study|Other|2|||
154935719|NCT00065065|559190737|FG001|Overall Study|Other|2|||
154935720|NCT04363736|559190738|FG000|Overall Study|Withdrawal by Subject|1|||
154935721|NCT04363736|559190739|FG001|Overall Study|Withdrawal by Subject|0|||
154935722|NCT04363736|559190738|FG000|Overall Study|Lost to Follow-up|10|||
154935723|NCT04363736|559190739|FG001|Overall Study|Lost to Follow-up|7|||
154935724|NCT04363736|559190738|FG000|Overall Study|Death|8|||
154935725|NCT04363736|559190739|FG001|Overall Study|Death|6|||
154935726|NCT01050673|559190740|FG000|Overall Study|Physician Decision|4|||
154935727|NCT01050673|559190741|FG001|Overall Study|Physician Decision|5|||
154935728|NCT03125915|559190746|FG000|1 Month Follow up|Lost to Follow-up|3|||
154935729|NCT03125915|559190747|FG001|1 Month Follow up|Lost to Follow-up|3|||
154935730|NCT03125915|559190748|FG002|1 Month Follow up|Lost to Follow-up|2|||
154935731|NCT03125915|559190749|FG003|1 Month Follow up|Lost to Follow-up|3|||
155273133|NCT02696902|560432954|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
155273134|NCT02696902|560432955|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
155273135|NCT02696902|560432953|FG000|Overall Study|Principal investigator's decision|1|||
155273136|NCT02696902|560432954|FG001|Overall Study|Principal investigator's decision|0|||
155273137|NCT02696902|560432955|FG002|Overall Study|Principal investigator's decision|0|||
155273138|NCT02696902|560432953|FG000|Overall Study|Sponsor's decision|1|||
155273139|NCT02696902|560432954|FG001|Overall Study|Sponsor's decision|0|||
155273140|NCT02696902|560432955|FG002|Overall Study|Sponsor's decision|0|||
155273141|NCT02696902|560432953|FG000|Overall Study|Transferred to other hospital|1|||
155273142|NCT02696902|560432954|FG001|Overall Study|Transferred to other hospital|0|||
155273143|NCT02696902|560432955|FG002|Overall Study|Transferred to other hospital|0|||
155273144|NCT01233609|560432958|FG000|Overall Study|Death|1|||
155273145|NCT01233609|560432959|FG001|Overall Study|Death|0|||
155273146|NCT01233609|560432958|FG000|Overall Study|Lost to Follow-up|3|||
155273147|NCT01233609|560432959|FG001|Overall Study|Lost to Follow-up|1|||
155273148|NCT01233609|560432958|FG000|Overall Study|Adverse Event|2|||
155273149|NCT01233609|560432959|FG001|Overall Study|Adverse Event|1|||
155273150|NCT01233609|560432958|FG000|Overall Study|Withdrawal by Subject|3|||
155273151|NCT01233609|560432959|FG001|Overall Study|Withdrawal by Subject|0|||
155273152|NCT00735644|560432960|FG000|Overall Study|Did not receive study vaccine|0|||
155273153|NCT00735644|560432961|FG001|Overall Study|Did not receive study vaccine|1|||
155273154|NCT00735644|560432962|FG002|Overall Study|Did not receive study vaccine|0|||
155273155|NCT00735644|560432963|FG003|Overall Study|Did not receive study vaccine|0|||
155273156|NCT00735644|560432964|FG004|Overall Study|Did not receive study vaccine|0|||
155273157|NCT00735644|560432960|FG000|Overall Study|Withdrawal by Subject|0|||
155273158|NCT00735644|560432961|FG001|Overall Study|Withdrawal by Subject|1|||
155273159|NCT00735644|560432962|FG002|Overall Study|Withdrawal by Subject|1|||
155273160|NCT00735644|560432963|FG003|Overall Study|Withdrawal by Subject|1|||
155273161|NCT00735644|560432964|FG004|Overall Study|Withdrawal by Subject|0|||
155273162|NCT06385483|560432967|FG000|Overall Study|Withdrawal by Subject|2|||
155273163|NCT06385483|560432967|FG000|Overall Study|Never start protocol therapy|2|||
155273164|NCT06385483|560432967|FG000|Overall Study|Disease progression|15|||
155273165|NCT00654940|560434418|FG000|Period 1|Adverse Event|0|||
155273166|NCT00654940|560434419|FG001|Period 1|Adverse Event|1|||
155273167|NCT00654940|560434418|FG000|Period 1|Intolerable Pain Level|1|||
155273168|NCT00654940|560434419|FG001|Period 1|Intolerable Pain Level|0|||
155273169|NCT00802737|560434420|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
155273170|NCT00802737|560434421|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
155273171|NCT00802737|560434422|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
155273172|NCT00802737|560434420|FG000|Overall Study|Death|6|||
155273173|NCT00802737|560434421|FG001|Overall Study|Death|5|||
155273174|NCT00802737|560434422|FG002|Overall Study|Death|1|||
155273175|NCT00802737|560434420|FG000|Overall Study|Adverse Event|1|||
154935732|NCT03125915|559190746|FG000|3 Month Follow-up|Lost to Follow-up|6|||
154935733|NCT03125915|559190747|FG001|3 Month Follow-up|Lost to Follow-up|4|||
154935734|NCT03125915|559190748|FG002|3 Month Follow-up|Lost to Follow-up|4|||
154935735|NCT03125915|559190749|FG003|3 Month Follow-up|Lost to Follow-up|2|||
154935736|NCT03125915|559190746|FG000|6 Month Follow-up|Lost to Follow-up|7|||
154935737|NCT03125915|559190747|FG001|6 Month Follow-up|Lost to Follow-up|3|||
155273176|NCT00802737|560434421|FG001|Overall Study|Adverse Event|0|||
155273177|NCT00802737|560434422|FG002|Overall Study|Adverse Event|0|||
155273178|NCT00802737|560434420|FG000|Overall Study|Received Prohibited Therapy|1|||
155273179|NCT00802737|560434421|FG001|Overall Study|Received Prohibited Therapy|0|||
154935738|NCT03125915|559190748|FG002|6 Month Follow-up|Lost to Follow-up|6|||
154935739|NCT03125915|559190749|FG003|6 Month Follow-up|Lost to Follow-up|3|||
154935740|NCT04355767|559190750|FG000|Overall Study|Withdrawal by Subject|2|||
155273180|NCT00802737|560434422|FG002|Overall Study|Received Prohibited Therapy|0|||
155273181|NCT00802737|560434420|FG000|Overall Study|Ongoing CLL-Treatment|0|||
155273182|NCT00802737|560434421|FG001|Overall Study|Ongoing CLL-Treatment|1|||
155273183|NCT00802737|560434422|FG002|Overall Study|Ongoing CLL-Treatment|0|||
155273184|NCT00802737|560434420|FG000|Overall Study|Participant too Unwell|0|||
155273185|NCT00802737|560434421|FG001|Overall Study|Participant too Unwell|2|||
155273186|NCT00802737|560434422|FG002|Overall Study|Participant too Unwell|0|||
155273187|NCT00619476|560434428|FG000|Overall Study|Adverse Event|12|||
154935741|NCT04355767|559190751|FG001|Overall Study|Withdrawal by Subject|2|||
154935742|NCT04355767|559190750|FG000|Overall Study|Death|5|||
155273188|NCT00619476|560434429|FG001|Overall Study|Adverse Event|6|||
155273189|NCT00619476|560434430|FG002|Overall Study|Adverse Event|12|||
154935743|NCT04355767|559190751|FG001|Overall Study|Death|1|||
154935744|NCT01999322|559190752|FG000|Overall Study|Adverse Event|1|||
154935745|NCT01999322|559190753|FG001|Overall Study|Adverse Event|0|||
154935746|NCT01835470|559192648|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
154935747|NCT01835470|559192648|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
154935748|NCT01011907|559192649|FG000|Overall Study|Withdrawal by Subject|13|||
154935749|NCT01011907|559192650|FG001|Overall Study|Withdrawal by Subject|11|||
154935750|NCT01011907|559192649|FG000|Overall Study|Adverse Event|1|||
154935751|NCT01011907|559192650|FG001|Overall Study|Adverse Event|4|||
154935752|NCT00304954|559192653|FG000|Overall Study|Withdrawal by Subject|0|||
154935753|NCT00304954|559192654|FG001|Overall Study|Withdrawal by Subject|0|||
154935754|NCT00304954|559192655|FG002|Overall Study|Withdrawal by Subject|1|||
154935755|NCT00304954|559192656|FG003|Overall Study|Withdrawal by Subject|0|||
154935756|NCT00304954|559192653|FG000|Overall Study|Adverse Event|1|||
154935757|NCT00304954|559192654|FG001|Overall Study|Adverse Event|0|||
154935758|NCT00304954|559192655|FG002|Overall Study|Adverse Event|0|||
154935759|NCT00304954|559192656|FG003|Overall Study|Adverse Event|0|||
154935760|NCT01440647|559192657|FG000|Overall Study|Death|2|||
154935761|NCT01440647|559192658|FG001|Overall Study|Death|3|||
154935762|NCT00207714|559192672|FG000|Overall Study|Adverse Event|6|||
154935763|NCT00207714|559192673|FG001|Overall Study|Adverse Event|2|||
154935764|NCT00207714|559192674|FG002|Overall Study|Adverse Event|4|||
154935765|NCT00207714|559192675|FG003|Overall Study|Adverse Event|3|||
154935766|NCT00207714|559192676|FG004|Overall Study|Adverse Event|1|||
154935767|NCT00207714|559192672|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
154935768|NCT00207714|559192673|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
154935769|NCT00207714|559192674|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
154935770|NCT00207714|559192675|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
154935771|NCT00207714|559192676|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
154935772|NCT00207714|559192672|FG000|Overall Study|Other|3|||
154935773|NCT00207714|559192673|FG001|Overall Study|Other|2|||
154935774|NCT00207714|559192674|FG002|Overall Study|Other|5|||
154935775|NCT00207714|559192675|FG003|Overall Study|Other|1|||
154935776|NCT00207714|559192676|FG004|Overall Study|Other|0|||
154935777|NCT03627195|559192677|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
154935778|NCT03627195|559192678|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
154935779|NCT03627195|559192679|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
154935780|NCT03627195|559192680|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
154935781|NCT03627195|559192681|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
154935782|NCT03627195|559192682|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
154935783|NCT04242186|559192693|FG000|Overall Study|Death|5|||
154935784|NCT00550420|559192696|FG000|Overall Study|Adverse Event|28|||
154935785|NCT00550420|559192696|FG000|Overall Study|Lost to Follow-up|8|||
154935786|NCT00550420|559192696|FG000|Overall Study|Protocol Violation|11|||
154935787|NCT00550420|559192696|FG000|Overall Study|Withdrawal by Subject|30|||
154935788|NCT00550420|559192696|FG000|Overall Study|Still in study at termination|206|||
154935789|NCT00550420|559192696|FG000|Overall Study|Missing|2|||
154935790|NCT00550420|559192696|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
154935791|NCT00550420|559192696|FG000|Overall Study|Investigators opinion|1|||
154935792|NCT00550420|559192696|FG000|Overall Study|Lack of curative effect|1|||
154935793|NCT00550420|559192696|FG000|Overall Study|Unethical stop of enrollment|2|||
154935794|NCT00550420|559192696|FG000|Overall Study|Caregiver's decision to withdraw|1|||
154935795|NCT00550420|559192696|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
154935796|NCT00550420|559192696|FG000|Overall Study|Exclusion criteria|1|||
154935797|NCT00550420|559192696|FG000|Overall Study|Prohibited medicine|1|||
154935798|NCT00782275|559192697|FG000|Overall Study|Adverse Event|11|||
154935799|NCT00782275|559192697|FG000|Overall Study|Withdrawal by Subject|1|||
154935800|NCT00782275|559192697|FG000|Overall Study|Progressive Disease|21|||
154935801|NCT00782275|559192697|FG000|Overall Study|Physician Decision|4|||
154935802|NCT00782275|559192697|FG000|Overall Study|Not started treatment|1|||
154935803|NCT00782275|559192697|FG000|Overall Study|Other|3|||
154935804|NCT00331773|559192698|FG000|Overall Study|Withdrawal by Subject|6|||
154935805|NCT00331773|559192699|FG001|Overall Study|Withdrawal by Subject|4|||
154935806|NCT00331773|559192698|FG000|Overall Study|Protocol Violation|10|||
154935807|NCT00331773|559192699|FG001|Overall Study|Protocol Violation|3|||
154935808|NCT04378010|559192700|FG000|Overall Study|Adverse Event|8|||
155043353|NCT03026283|559590105|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155043354|NCT03026283|559590106|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
154935809|NCT04378010|559192701|FG001|Overall Study|Adverse Event|14|||
154935810|NCT04378010|559192702|FG002|Overall Study|Adverse Event|4|||
154935811|NCT04378010|559192700|FG000|Overall Study|Withdrawal by Subject|0|||
154935812|NCT04378010|559192701|FG001|Overall Study|Withdrawal by Subject|2|||
154935813|NCT04378010|559192702|FG002|Overall Study|Withdrawal by Subject|1|||
154935814|NCT04378010|559192700|FG000|Overall Study|Protocol Violation|2|||
154935815|NCT04378010|559192701|FG001|Overall Study|Protocol Violation|1|||
154935816|NCT04378010|559192702|FG002|Overall Study|Protocol Violation|4|||
154935817|NCT04378010|559192700|FG000|Overall Study|Study terminated by Sponsor|22|||
155092563|NCT00069641|559773627|FG002|Overall Study|Death|1|||
154935818|NCT04378010|559192701|FG001|Overall Study|Study terminated by Sponsor|16|||
154935819|NCT04378010|559192702|FG002|Overall Study|Study terminated by Sponsor|22|||
154935820|NCT04378010|559192700|FG000|Overall Study|Subject inability to complete study visit|0|||
154935821|NCT04378010|559192701|FG001|Overall Study|Subject inability to complete study visit|0|||
154935822|NCT04378010|559192702|FG002|Overall Study|Subject inability to complete study visit|1|||
154935823|NCT04378010|559192700|FG000|Overall Study|Subject never dosed|0|||
154935824|NCT04378010|559192701|FG001|Overall Study|Subject never dosed|1|||
154935825|NCT04378010|559192702|FG002|Overall Study|Subject never dosed|0|||
154935826|NCT01792284|559192703|FG000|Lead-in Period|Adverse Event|15|||
154935827|NCT01792284|559192704|FG001|Lead-in Period|Adverse Event|0|||
154935828|NCT01792284|559192705|FG002|Lead-in Period|Adverse Event|0|||
154935829|NCT01792284|559192703|FG000|Lead-in Period|Lost to Follow-up|2|||
154935830|NCT01792284|559192704|FG001|Lead-in Period|Lost to Follow-up|0|||
154935831|NCT01792284|559192705|FG002|Lead-in Period|Lost to Follow-up|0|||
154935832|NCT01792284|559192703|FG000|Lead-in Period|Protocol Violation|1|||
154935833|NCT01792284|559192704|FG001|Lead-in Period|Protocol Violation|0|||
154935834|NCT01792284|559192705|FG002|Lead-in Period|Protocol Violation|0|||
154935835|NCT01792284|559192703|FG000|Lead-in Period|Withdrawal by Subject|10|||
154935836|NCT01792284|559192704|FG001|Lead-in Period|Withdrawal by Subject|0|||
154935837|NCT01792284|559192705|FG002|Lead-in Period|Withdrawal by Subject|0|||
154935838|NCT01792284|559192703|FG000|Lead-in Period|Physician Decision|1|||
154935839|NCT01792284|559192704|FG001|Lead-in Period|Physician Decision|0|||
154935840|NCT01792284|559192705|FG002|Lead-in Period|Physician Decision|0|||
154935841|NCT01792284|559192703|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
154935842|NCT01792284|559192704|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
154935843|NCT01792284|559192705|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
154935844|NCT01792284|559192703|FG000|Randomization Period 1|Withdrawal by Subject|0|||
154935845|NCT01792284|559192704|FG001|Randomization Period 1|Withdrawal by Subject|1|||
154935846|NCT01792284|559192705|FG002|Randomization Period 1|Withdrawal by Subject|1|||
154935847|NCT01792284|559192703|FG000|Randomization Period 1|Physician Decision|0|||
154935848|NCT01792284|559192704|FG001|Randomization Period 1|Physician Decision|1|||
154935849|NCT01792284|559192705|FG002|Randomization Period 1|Physician Decision|1|||
154935850|NCT01792284|559192703|FG000|Randomization Period 1|Adverse Event|0|||
154935851|NCT01792284|559192704|FG001|Randomization Period 1|Adverse Event|0|||
154935852|NCT01792284|559192705|FG002|Randomization Period 1|Adverse Event|2|||
154935853|NCT01792284|559192703|FG000|Randomization Period 1|Lost to Follow-up|0|||
154935854|NCT01792284|559192704|FG001|Randomization Period 1|Lost to Follow-up|0|||
154935855|NCT01792284|559192705|FG002|Randomization Period 1|Lost to Follow-up|1|||
154935856|NCT01792284|559192703|FG000|Randomization Period 2|Protocol Violation|0|||
154935857|NCT01792284|559192704|FG001|Randomization Period 2|Protocol Violation|1|||
154935858|NCT01792284|559192705|FG002|Randomization Period 2|Protocol Violation|0|||
154935859|NCT01792284|559192703|FG000|Randomization Period 2|Withdrawal by Subject|0|||
154935860|NCT01792284|559192704|FG001|Randomization Period 2|Withdrawal by Subject|2|||
154935861|NCT01792284|559192705|FG002|Randomization Period 2|Withdrawal by Subject|0|||
154935862|NCT02019979|559192706|FG000|Overall Study|study terminated|14|||
154935863|NCT00379587|559192712|FG000|Overall Study|Lost to Follow-up|2|||
154935864|NCT01169649|559192716|FG000|Overall Study|Patient Not Treated|3|||
154935865|NCT02919475|559192717|FG000|Overall Study|Adverse Event|3|||
154935866|NCT02919475|559192718|FG001|Overall Study|Adverse Event|3|||
154935867|NCT02919475|559192719|FG002|Overall Study|Adverse Event|3|||
154935868|NCT02919475|559192720|FG003|Overall Study|Adverse Event|9|||
154935869|NCT02919475|559192721|FG004|Overall Study|Adverse Event|2|||
154935870|NCT02919475|559192717|FG000|Overall Study|Death|0|||
154935871|NCT02919475|559192718|FG001|Overall Study|Death|1|||
154935872|NCT02919475|559192719|FG002|Overall Study|Death|0|||
154935873|NCT02919475|559192720|FG003|Overall Study|Death|0|||
154935874|NCT02919475|559192721|FG004|Overall Study|Death|0|||
154935875|NCT02919475|559192717|FG000|Overall Study|Lost to Follow-up|0|||
154935876|NCT02919475|559192718|FG001|Overall Study|Lost to Follow-up|0|||
154935877|NCT02919475|559192719|FG002|Overall Study|Lost to Follow-up|0|||
154935878|NCT02919475|559192720|FG003|Overall Study|Lost to Follow-up|1|||
154935879|NCT02919475|559192721|FG004|Overall Study|Lost to Follow-up|0|||
154935880|NCT02919475|559192717|FG000|Overall Study|Withdrawal by Subject|2|||
154935881|NCT02919475|559192718|FG001|Overall Study|Withdrawal by Subject|3|||
154935882|NCT02919475|559192719|FG002|Overall Study|Withdrawal by Subject|1|||
154935883|NCT02919475|559192720|FG003|Overall Study|Withdrawal by Subject|2|||
154935884|NCT02919475|559192721|FG004|Overall Study|Withdrawal by Subject|2|||
154935885|NCT02919475|559192717|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
154935886|NCT02919475|559192718|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
154935887|NCT02919475|559192719|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
154935888|NCT02919475|559192720|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
154935889|NCT02919475|559192721|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
154935890|NCT02323295|559192722|FG000|Overall Study|Adverse Event|0|||
154935891|NCT02323295|559192723|FG001|Overall Study|Adverse Event|1|||
154935892|NCT02323295|559192722|FG000|Overall Study|Withdrawal by Subject|0|||
154935893|NCT02323295|559192723|FG001|Overall Study|Withdrawal by Subject|1|||
154935894|NCT02323295|559192722|FG000|Overall Study|Patient did not have surgery as planned.|0|||
154935895|NCT02323295|559192723|FG001|Overall Study|Patient did not have surgery as planned.|1|||
154935896|NCT02370784|559192724|FG000|Overall Study|Patient started prohibited medication|0|||
154935897|NCT02370784|559192725|FG001|Overall Study|Patient started prohibited medication|1|||
154935898|NCT01155063|559192729|FG000|Overall Study|Adverse Event|1|||
154935899|NCT01155063|559192729|FG000|Overall Study|Withdrawal by Subject|1|||
154935900|NCT01155063|559192729|FG000|Overall Study|Study terminated by sponsor|87|||
154935901|NCT01663714|559192730|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
154935902|NCT01663714|559192730|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
154935903|NCT01663714|559192730|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
154935904|NCT01663714|559192730|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
154935905|NCT01663714|559192730|FG000|Long-Term Follow-Up|Death|4|||
154935906|NCT01663714|559192730|FG000|Long-Term Follow-Up|Non-compliance|1|||
154935907|NCT02280421|559192731|FG000|Washout (2 Weeks)|Adverse Event|0|||
154935908|NCT02280421|559192732|FG001|Washout (2 Weeks)|Adverse Event|1|||
154935909|NCT02280421|559192731|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
154935910|NCT02280421|559192732|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
154935911|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
154935912|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
154935913|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
154935914|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
154935915|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
154935916|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
154935917|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
154935918|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
154935919|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
154935920|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
154935921|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
154935922|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
154935923|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
154935924|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
154935925|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
154935926|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
154935927|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
154935928|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
154935929|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
154935930|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
154935931|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
154935932|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
154935933|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
154935934|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
154935935|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
154935936|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
154935937|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
154935938|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
154935939|NCT01872689|559192736|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
154935940|NCT01872689|559192737|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
154935941|NCT01872689|559192738|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
154935942|NCT01872689|559192739|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
154935943|NCT01872689|559192736|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
154935944|NCT01872689|559192737|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
154935945|NCT01872689|559192738|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
154935946|NCT01872689|559192739|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
154935947|NCT01872689|559192736|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
154935948|NCT01872689|559192737|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
154935949|NCT01872689|559192738|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
154935950|NCT01872689|559192739|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
154935951|NCT01872689|559192736|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
154935952|NCT01872689|559192737|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
154935953|NCT01872689|559192738|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
154935954|NCT01872689|559192739|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
154935955|NCT01872689|559192736|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
154935956|NCT01872689|559192737|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
154935957|NCT01872689|559192738|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
154935958|NCT01872689|559192739|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
155092564|NCT02704208|559773628|FG000|Overall Study|Lost to Follow-up|42|||
155381932|NCT00986973|560833241|FG000|Overall Study|Withdrawn by study team|1|||
154935959|NCT01872689|559192736|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
154935960|NCT01872689|559192737|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
155273190|NCT00619476|560434431|FG003|Overall Study|Adverse Event|16|||
155273191|NCT00619476|560434428|FG000|Overall Study|Lack of Efficacy|6|||
155273192|NCT00619476|560434429|FG001|Overall Study|Lack of Efficacy|1|||
155273193|NCT00619476|560434430|FG002|Overall Study|Lack of Efficacy|1|||
155273194|NCT00619476|560434431|FG003|Overall Study|Lack of Efficacy|4|||
155273195|NCT00619476|560434428|FG000|Overall Study|Protocol Violation|5|||
155273196|NCT00619476|560434429|FG001|Overall Study|Protocol Violation|4|||
155273197|NCT00619476|560434430|FG002|Overall Study|Protocol Violation|4|||
155273198|NCT00619476|560434431|FG003|Overall Study|Protocol Violation|9|||
155273199|NCT00619476|560434428|FG000|Overall Study|Lost to Follow-up|1|||
155273200|NCT00619476|560434429|FG001|Overall Study|Lost to Follow-up|2|||
155273201|NCT00619476|560434430|FG002|Overall Study|Lost to Follow-up|0|||
155273202|NCT00619476|560434431|FG003|Overall Study|Lost to Follow-up|1|||
155273203|NCT00619476|560434428|FG000|Overall Study|Investigator Discretion|2|||
155273204|NCT00619476|560434429|FG001|Overall Study|Investigator Discretion|2|||
155273205|NCT00619476|560434430|FG002|Overall Study|Investigator Discretion|2|||
155273206|NCT00619476|560434431|FG003|Overall Study|Investigator Discretion|0|||
155273207|NCT00619476|560434428|FG000|Overall Study|Withdrawal by Subject|5|||
155273208|NCT00619476|560434429|FG001|Overall Study|Withdrawal by Subject|7|||
155273209|NCT00619476|560434430|FG002|Overall Study|Withdrawal by Subject|5|||
155273210|NCT00619476|560434431|FG003|Overall Study|Withdrawal by Subject|4|||
155273211|NCT01155388|560434432|FG000|Overall Study|Adverse Event|1|||
155273212|NCT01155388|560434433|FG001|Overall Study|Adverse Event|0|||
154935961|NCT01872689|559192738|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
154935962|NCT01872689|559192739|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
154935963|NCT01872689|559192736|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
155273213|NCT03884231|560434434|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
155273214|NCT03884231|560434434|FG000|Overall Study|Subject Withdrew Consent|1|||
155273215|NCT03884231|560434434|FG000|Overall Study|MRI Scan Not Performed|1|||
155273216|NCT00830947|560434435|FG000|Overall Study|Lost to Follow-up|4|||
155273217|NCT00830947|560434436|FG001|Overall Study|Lost to Follow-up|4|||
155273218|NCT00502996|560434451|FG000|Overall Study|Lost to Follow-up|9|||
155273219|NCT00502996|560434451|FG000|Overall Study|Protocol Violation|2|||
155273220|NCT00502996|560434451|FG000|Overall Study|Treatment failure|25|||
155273221|NCT00502996|560434451|FG000|Overall Study|Withdrawal Informed Consent|6|||
155273222|NCT00502996|560434451|FG000|Overall Study|Adverse Event|2|||
155273223|NCT01729728|560434452|FG000|Overall Study|Adverse Event|0|||
155273224|NCT01729728|560434453|FG001|Overall Study|Adverse Event|6|||
155273225|NCT01729728|560434454|FG002|Overall Study|Adverse Event|0|||
155273226|NCT01729728|560434452|FG000|Overall Study|Protocol Violation|1|||
155273227|NCT01729728|560434453|FG001|Overall Study|Protocol Violation|0|||
155273228|NCT01729728|560434454|FG002|Overall Study|Protocol Violation|1|||
155273229|NCT00672958|560434457|FG000|Overall Study|Adverse Event|11|||
155273230|NCT00672958|560434458|FG001|Overall Study|Adverse Event|9|||
155273231|NCT00672958|560434457|FG000|Overall Study|Lack of Efficacy|6|||
155273232|NCT00672958|560434458|FG001|Overall Study|Lack of Efficacy|11|||
155273233|NCT00672958|560434457|FG000|Overall Study|Non-compliance with study drug|2|||
155273234|NCT00672958|560434458|FG001|Overall Study|Non-compliance with study drug|3|||
155273235|NCT00672958|560434457|FG000|Overall Study|Protocol deviations|11|||
155273236|NCT00672958|560434458|FG001|Overall Study|Protocol deviations|5|||
155273237|NCT00672958|560434457|FG000|Overall Study|Voluntary withdrawal|12|||
155273238|NCT00672958|560434458|FG001|Overall Study|Voluntary withdrawal|8|||
155273239|NCT00672958|560434457|FG000|Overall Study|Lost to Follow-up|22|||
155273240|NCT00672958|560434458|FG001|Overall Study|Lost to Follow-up|17|||
155273241|NCT00672958|560434457|FG000|Overall Study|Reason not specified|0|||
155273242|NCT00672958|560434458|FG001|Overall Study|Reason not specified|3|||
155273243|NCT01964521|560434459|FG000|Overall Study|Lost to Follow-up|4|||
155273244|NCT00579982|560434460|FG000|Overall Study|Adverse Event|4|||
155273245|NCT00579982|560434460|FG000|Overall Study|Protocol Violation|4|||
155273246|NCT01551303|560434476|FG000|Overall Study|failed awareness check on vision test|4|||
155273247|NCT01551303|560434477|FG001|Overall Study|failed awareness check on vision test|7|||
154935964|NCT01872689|559192737|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
154935965|NCT01872689|559192738|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
155273248|NCT02141659|560434481|FG000|Overall Study|Major Protocol Deviation|0|||
155273249|NCT02141659|560434482|FG001|Overall Study|Major Protocol Deviation|1|||
155273250|NCT02141659|560434483|FG002|Overall Study|Major Protocol Deviation|0|||
155273251|NCT02141659|560434484|FG003|Overall Study|Major Protocol Deviation|0|||
155273252|NCT02141659|560434485|FG004|Overall Study|Major Protocol Deviation|0|||
155273253|NCT02141659|560434486|FG005|Overall Study|Major Protocol Deviation|0|||
155273254|NCT02141659|560434481|FG000|Overall Study|Lack of Efficacy|0|||
155273255|NCT02141659|560434482|FG001|Overall Study|Lack of Efficacy|0|||
155273256|NCT02141659|560434483|FG002|Overall Study|Lack of Efficacy|0|||
155273257|NCT02141659|560434484|FG003|Overall Study|Lack of Efficacy|0|||
155273258|NCT02141659|560434485|FG004|Overall Study|Lack of Efficacy|0|||
155273259|NCT02141659|560434486|FG005|Overall Study|Lack of Efficacy|1|||
155043355|NCT03026283|559590107|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
155043356|NCT03026283|559590100|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155043357|NCT03026283|559590101|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155043358|NCT03026283|559590102|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155043359|NCT03026283|559590103|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
155043360|NCT03026283|559590104|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
155043361|NCT03026283|559590105|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
155043362|NCT03026283|559590106|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155043363|NCT03026283|559590107|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
155043364|NCT03026283|559590100|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155043365|NCT03026283|559590101|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155043366|NCT03026283|559590102|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155043367|NCT03026283|559590103|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
155043368|NCT03026283|559590104|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155043369|NCT03026283|559590105|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
155043370|NCT03026283|559590106|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155043371|NCT03026283|559590107|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
155043372|NCT03026283|559590100|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043373|NCT03026283|559590101|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043374|NCT03026283|559590102|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043375|NCT03026283|559590103|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
155043376|NCT03026283|559590104|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043377|NCT03026283|559590105|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043378|NCT03026283|559590106|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043379|NCT03026283|559590107|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
155043380|NCT03026283|559590100|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155043381|NCT03026283|559590101|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155043382|NCT03026283|559590102|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155043383|NCT03026283|559590103|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155043384|NCT03026283|559590104|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
155043385|NCT03026283|559590105|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
155043386|NCT03026283|559590106|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155043387|NCT03026283|559590107|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
155043388|NCT00824655|559590108|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
155043389|NCT00824655|559590109|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
155043390|NCT00824655|559590108|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
155043391|NCT00824655|559590109|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
155043392|NCT03252145|559590110|FG000|Overall Study|Withdrawal by Subject|1|||
155043393|NCT03252145|559590111|FG001|Overall Study|Withdrawal by Subject|0|||
155043394|NCT03252145|559590110|FG000|Overall Study|Complicating Disease|1|||
155043395|NCT03252145|559590111|FG001|Overall Study|Complicating Disease|2|||
155043396|NCT03091738|559590112|FG000|Overall Study|Adverse Event|1|||
155043397|NCT03091738|559590112|FG000|Overall Study|Lost to Follow-up|1|||
155043398|NCT01763827|559590114|FG000|Overall Study|Withdrawal by Subject|1|||
155043399|NCT01763827|559590115|FG001|Overall Study|Withdrawal by Subject|0|||
155043400|NCT01763827|559590116|FG002|Overall Study|Withdrawal by Subject|0|||
155043401|NCT01763827|559590117|FG003|Overall Study|Withdrawal by Subject|0|||
155043402|NCT01763827|559590118|FG004|Overall Study|Withdrawal by Subject|2|||
155043403|NCT01763827|559590119|FG005|Overall Study|Withdrawal by Subject|0|||
155043404|NCT01763827|559590114|FG000|Overall Study|Decision by sponsor|2|||
155043405|NCT01763827|559590115|FG001|Overall Study|Decision by sponsor|0|||
155043406|NCT01763827|559590116|FG002|Overall Study|Decision by sponsor|3|||
155043407|NCT01763827|559590117|FG003|Overall Study|Decision by sponsor|0|||
155043408|NCT01763827|559590118|FG004|Overall Study|Decision by sponsor|2|||
155043409|NCT01763827|559590119|FG005|Overall Study|Decision by sponsor|1|||
155043410|NCT01763827|559590114|FG000|Overall Study|Lost to Follow-up|0|||
155043411|NCT01763827|559590115|FG001|Overall Study|Lost to Follow-up|1|||
155043412|NCT01763827|559590116|FG002|Overall Study|Lost to Follow-up|1|||
155043413|NCT01763827|559590117|FG003|Overall Study|Lost to Follow-up|1|||
155043414|NCT01763827|559590118|FG004|Overall Study|Lost to Follow-up|2|||
155043415|NCT01763827|559590119|FG005|Overall Study|Lost to Follow-up|1|||
155043416|NCT01826981|559590122|FG000|Overall Study|Lack of Efficacy|0|||
155043417|NCT01826981|559590123|FG001|Overall Study|Lack of Efficacy|1|||
155043418|NCT01826981|559590124|FG002|Overall Study|Lack of Efficacy|0|||
155043419|NCT01826981|559590125|FG003|Overall Study|Lack of Efficacy|0|||
155043420|NCT01826981|559590126|FG004|Overall Study|Lack of Efficacy|5|||
155043421|NCT01826981|559590127|FG005|Overall Study|Lack of Efficacy|0|||
155043422|NCT01826981|559590128|FG006|Overall Study|Lack of Efficacy|0|||
155043423|NCT01826981|559590129|FG007|Overall Study|Lack of Efficacy|8|||
155043424|NCT01826981|559590130|FG008|Overall Study|Lack of Efficacy|7|||
154935966|NCT01872689|559192739|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
154935967|NCT00751998|559192746|FG000|Overall Study|Lost to Follow-up|7|||
154935968|NCT00751998|559192746|FG000|Overall Study|Death|11|||
154935969|NCT00751998|559192746|FG000|Overall Study|Withdrawal by Subject|2|||
154935970|NCT01238822|559192748|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
154935971|NCT02598193|559192749|FG000|Overall Study|Adverse Event|13|||
154935972|NCT02598193|559192749|FG000|Overall Study|Withdrawal by Subject|1|||
154935973|NCT02598193|559192749|FG000|Overall Study|Listed in active lung transplant list|1|||
154935974|NCT02598193|559192749|FG000|Overall Study|Does not want to take Nintedanib|1|||
154935975|NCT02410837|559192750|FG000|Overall Study|Death|387|||
154935976|NCT02410837|559192750|FG000|Overall Study|Lost to Follow-up|50|||
154935977|NCT02410837|559192750|FG000|Overall Study|Withdrawal by Subject|44|||
154935978|NCT02410837|559192750|FG000|Overall Study|Physician Decision|6|||
154935979|NCT02410837|559192750|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
154935980|NCT00837577|559192751|FG000|Double-blind Period|Clinical Adverse Event|1|||
154935981|NCT00837577|559192752|FG001|Double-blind Period|Clinical Adverse Event|0|||
154935982|NCT00837577|559192751|FG000|Double-blind Period|Withdrawal by Subject|1|||
154935983|NCT00837577|559192752|FG001|Double-blind Period|Withdrawal by Subject|0|||
154935984|NCT00837577|559192751|FG000|Open-label Period|Clinical Adverse Event|2|||
154935985|NCT00837577|559192752|FG001|Open-label Period|Clinical Adverse Event|2|||
154935986|NCT00837577|559192751|FG000|Open-label Period|Laboratory Adverse Event|0|||
154935987|NCT00837577|559192752|FG001|Open-label Period|Laboratory Adverse Event|1|||
154935988|NCT00837577|559192751|FG000|Open-label Period|Lack of Efficacy|4|||
154935989|NCT00837577|559192752|FG001|Open-label Period|Lack of Efficacy|3|||
154935990|NCT00837577|559192751|FG000|Open-label Period|Withdrawal by Subject|1|||
155273260|NCT02141659|560434481|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273261|NCT02141659|560434482|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273262|NCT02141659|560434483|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273263|NCT02141659|560434484|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
155273264|NCT02141659|560434485|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
155273265|NCT02141659|560434486|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
155273266|NCT02471404|560434489|FG000|Overall Study|Adverse Event|7|||
155273267|NCT02471404|560434490|FG001|Overall Study|Adverse Event|1|||
155273268|NCT02471404|560434491|FG002|Overall Study|Adverse Event|2|||
155273269|NCT02471404|560434489|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
155273270|NCT02471404|560434490|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
155273271|NCT02471404|560434491|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
155273272|NCT02471404|560434489|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
155273273|NCT02471404|560434490|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155273274|NCT02471404|560434491|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
155273275|NCT02471404|560434489|FG000|Overall Study|Lost to Follow-up|1|||
155273276|NCT02471404|560434490|FG001|Overall Study|Lost to Follow-up|1|||
155273277|NCT02471404|560434491|FG002|Overall Study|Lost to Follow-up|3|||
155273278|NCT02471404|560434489|FG000|Overall Study|Protocol Violation|1|||
155273279|NCT02471404|560434490|FG001|Overall Study|Protocol Violation|0|||
155273280|NCT02471404|560434491|FG002|Overall Study|Protocol Violation|0|||
155273281|NCT02471404|560434489|FG000|Overall Study|Withdrawal by Subject|8|||
155273282|NCT02471404|560434490|FG001|Overall Study|Withdrawal by Subject|4|||
155273283|NCT02471404|560434491|FG002|Overall Study|Withdrawal by Subject|5|||
155273284|NCT02471404|560434489|FG000|Overall Study|Other reasons not specified|10|||
155273285|NCT02471404|560434490|FG001|Overall Study|Other reasons not specified|7|||
155273286|NCT02471404|560434491|FG002|Overall Study|Other reasons not specified|12|||
155273287|NCT01927731|560434492|FG000|Overall Study|Graft Failure|1|||
155273288|NCT01927731|560434493|FG001|Overall Study|Graft Failure|2|||
155273289|NCT01927731|560434492|FG000|Overall Study|Physician Decision|2|||
155273290|NCT01927731|560434493|FG001|Overall Study|Physician Decision|3|||
155273291|NCT01927731|560434492|FG000|Overall Study|Withdrawal by Subject|0|||
155273292|NCT01927731|560434493|FG001|Overall Study|Withdrawal by Subject|2|||
155273293|NCT01927731|560434492|FG000|Overall Study|Death|0|||
155273294|NCT01927731|560434493|FG001|Overall Study|Death|3|||
155273295|NCT00305864|560434498|FG000|Overall Study|Ineligible / No protocol treatment|0|||
155273296|NCT00305864|560434499|FG001|Overall Study|Ineligible / No protocol treatment|1|||
155273297|NCT00305864|560434500|FG002|Overall Study|Ineligible / No protocol treatment|1|||
155273298|NCT00305864|560434501|FG003|Overall Study|Ineligible / No protocol treatment|13|||
155273299|NCT02836613|560434504|FG000|Overall Study|Accidental drowning|1|||
155273300|NCT02836613|560434505|FG001|Overall Study|Accidental drowning|0|||
155273301|NCT02836613|560434504|FG000|Overall Study|Lost to Follow-up|0|||
155273302|NCT02836613|560434505|FG001|Overall Study|Lost to Follow-up|1|||
155273303|NCT02836613|560434504|FG000|Overall Study|Withdrawal by Subject|0|||
155273304|NCT02836613|560434505|FG001|Overall Study|Withdrawal by Subject|2|||
155273305|NCT01464255|560434506|FG000|Overall Study|unresolve corneal staining|0|||
155273306|NCT01464255|560434507|FG001|Overall Study|unresolve corneal staining|1|||
154935991|NCT00837577|559192752|FG001|Open-label Period|Withdrawal by Subject|2|||
154935992|NCT00837577|559192751|FG000|Open-label Period|Other Reason|1|||
154935993|NCT00837577|559192752|FG001|Open-label Period|Other Reason|1|||
155273307|NCT03881059|560434508|FG000|Treatment Period - Part A|Adverse Event|1|||
155273308|NCT03881059|560434509|FG001|Treatment Period - Part A|Adverse Event|3|||
155273309|NCT03881059|560434510|FG002|Treatment Period - Part A|Adverse Event|4|||
155273310|NCT03881059|560434508|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
155273311|NCT03881059|560434509|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
155273312|NCT03881059|560434510|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
155273313|NCT03881059|560434508|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
155273314|NCT03881059|560434509|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
155273315|NCT03881059|560434510|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
155273316|NCT03881059|560434508|FG000|Treatment Period - Part A|Other reasons|2|||
155273317|NCT03881059|560434509|FG001|Treatment Period - Part A|Other reasons|1|||
155273318|NCT03881059|560434510|FG002|Treatment Period - Part A|Other reasons|0|||
155273319|NCT03881059|560434508|FG000|Treatment Period - Part B|Adverse Event|0|||
155273320|NCT03881059|560434509|FG001|Treatment Period - Part B|Adverse Event|0|||
155273321|NCT03881059|560434510|FG002|Treatment Period - Part B|Adverse Event|3|||
155273322|NCT03881059|560434508|FG000|Treatment Period - Part B|Death|0|||
155273323|NCT03881059|560434509|FG001|Treatment Period - Part B|Death|1|||
155273324|NCT03881059|560434510|FG002|Treatment Period - Part B|Death|1|||
155273325|NCT03881059|560434508|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
155273326|NCT03881059|560434509|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
155273327|NCT03881059|560434510|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
155273328|NCT03881059|560434508|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
155273329|NCT03881059|560434509|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
155273330|NCT03881059|560434510|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
155273331|NCT03881059|560434508|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
155273332|NCT03881059|560434509|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
155273333|NCT03881059|560434510|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
155273334|NCT03881059|560434508|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
155273335|NCT03881059|560434509|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
155273336|NCT03881059|560434510|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
155273337|NCT03881059|560434508|FG000|Treatment Period - Part B|Other reasons|4|||
155273338|NCT03881059|560434509|FG001|Treatment Period - Part B|Other reasons|3|||
155273339|NCT03881059|560434510|FG002|Treatment Period - Part B|Other reasons|3|||
155273340|NCT02065570|560434511|FG000|Induction Study|Adverse Event|5|||
155273341|NCT02065570|560434512|FG001|Induction Study|Adverse Event|12|||
155273342|NCT02065570|560434513|FG002|Induction Study|Adverse Event|0|||
155273343|NCT02065570|560434514|FG003|Induction Study|Adverse Event|0|||
155273344|NCT02065570|560434511|FG000|Induction Study|Withdrawal by Subject|2|||
154935994|NCT01825876|559192756|FG000|Period 2|Withdrawal by Subject|0|||
154935995|NCT01825876|559192757|FG001|Period 2|Withdrawal by Subject|1|||
154935996|NCT01027884|559192761|FG000|Overall Study|Adverse Event|2|||
154935997|NCT01027884|559192762|FG001|Overall Study|Adverse Event|1|||
154935998|NCT01027884|559192761|FG000|Overall Study|Protocol Violation|1|||
154935999|NCT01027884|559192762|FG001|Overall Study|Protocol Violation|0|||
154936000|NCT01027884|559192761|FG000|Overall Study|Non-compliance|1|||
154936001|NCT01027884|559192762|FG001|Overall Study|Non-compliance|1|||
154936002|NCT01027884|559192761|FG000|Overall Study|Withdrawal by Subject|0|||
154936003|NCT01027884|559192762|FG001|Overall Study|Withdrawal by Subject|1|||
154936004|NCT01027884|559192761|FG000|Overall Study|Lost to Follow-up|0|||
154936005|NCT01027884|559192762|FG001|Overall Study|Lost to Follow-up|1|||
154936006|NCT01027884|559192761|FG000|Overall Study|Spinal fixation surgery|0|||
154936007|NCT01027884|559192762|FG001|Overall Study|Spinal fixation surgery|3|||
154936008|NCT03670537|559192764|FG000|Overall Study|Protocol Violation|1|||
154936009|NCT03636542|559192765|FG000|Overall Study|Lost to Follow-up|1|||
154936010|NCT03636542|559192766|FG001|Overall Study|Lost to Follow-up|1|||
154936011|NCT03636542|559192765|FG000|Overall Study|Physician Decision|0|||
154936012|NCT03636542|559192766|FG001|Overall Study|Physician Decision|1|||
154936013|NCT03636542|559192765|FG000|Overall Study|Withdrawal by Subject|1|||
154936014|NCT03636542|559192766|FG001|Overall Study|Withdrawal by Subject|0|||
154936015|NCT02059187|559192769|FG000|Overall Study|Adverse Event|0|||
155273345|NCT02065570|560434512|FG001|Induction Study|Withdrawal by Subject|3|||
155273346|NCT02065570|560434513|FG002|Induction Study|Withdrawal by Subject|0|||
155273347|NCT02065570|560434514|FG003|Induction Study|Withdrawal by Subject|0|||
155273348|NCT02065570|560434511|FG000|Induction Study|Lost to Follow-up|1|||
154936016|NCT02059187|559192770|FG001|Overall Study|Adverse Event|3|||
154936017|NCT02059187|559192769|FG000|Overall Study|Death|1|||
154936018|NCT02059187|559192770|FG001|Overall Study|Death|1|||
154936019|NCT02059187|559192769|FG000|Overall Study|Lost to Follow-up|9|||
155273349|NCT02065570|560434512|FG001|Induction Study|Lost to Follow-up|1|||
155273350|NCT02065570|560434513|FG002|Induction Study|Lost to Follow-up|0|||
155273351|NCT02065570|560434514|FG003|Induction Study|Lost to Follow-up|0|||
154936020|NCT02059187|559192770|FG001|Overall Study|Lost to Follow-up|8|||
154936021|NCT02059187|559192769|FG000|Overall Study|Non-compliance with study drug|1|||
154936022|NCT02059187|559192770|FG001|Overall Study|Non-compliance with study drug|0|||
154936023|NCT02059187|559192769|FG000|Overall Study|Physician Decision|1|||
155273352|NCT02065570|560434511|FG000|Induction Study|Other, Not Specified|6|||
155273353|NCT02065570|560434512|FG001|Induction Study|Other, Not Specified|5|||
155273354|NCT02065570|560434513|FG002|Induction Study|Other, Not Specified|0|||
155273355|NCT02065570|560434514|FG003|Induction Study|Other, Not Specified|0|||
155273356|NCT02065570|560434511|FG000|Maintenance Study|Adverse Event|0|||
155273357|NCT02065570|560434512|FG001|Maintenance Study|Adverse Event|0|||
155273358|NCT02065570|560434513|FG002|Maintenance Study|Adverse Event|8|||
155273359|NCT02065570|560434514|FG003|Maintenance Study|Adverse Event|8|||
155273360|NCT02065570|560434511|FG000|Maintenance Study|Withdrawal by Subject|0|||
155273361|NCT02065570|560434512|FG001|Maintenance Study|Withdrawal by Subject|0|||
155273362|NCT02065570|560434513|FG002|Maintenance Study|Withdrawal by Subject|1|||
155273363|NCT02065570|560434514|FG003|Maintenance Study|Withdrawal by Subject|4|||
155273364|NCT02065570|560434511|FG000|Maintenance Study|Lost to Follow-up|0|||
155273365|NCT02065570|560434512|FG001|Maintenance Study|Lost to Follow-up|0|||
155273366|NCT02065570|560434513|FG002|Maintenance Study|Lost to Follow-up|2|||
155273367|NCT02065570|560434514|FG003|Maintenance Study|Lost to Follow-up|2|||
155273368|NCT02065570|560434511|FG000|Maintenance Study|Other, Not Specified|0|||
155273369|NCT02065570|560434512|FG001|Maintenance Study|Other, Not Specified|0|||
155273370|NCT02065570|560434513|FG002|Maintenance Study|Other, Not Specified|11|||
155273371|NCT02065570|560434514|FG003|Maintenance Study|Other, Not Specified|5|||
155273372|NCT02743793|560434515|FG000|Overall Study|Death|1|||
155273373|NCT02743793|560434516|FG001|Overall Study|Death|1|||
155273374|NCT02743793|560434515|FG000|Overall Study|Withdrawal by Subject|0|||
155273375|NCT02743793|560434516|FG001|Overall Study|Withdrawal by Subject|1|||
155273376|NCT02743793|560434515|FG000|Overall Study|Screen Failure|4|||
155273377|NCT02743793|560434516|FG001|Overall Study|Screen Failure|0|||
155273378|NCT02743793|560434515|FG000|Overall Study|No Primary Care Physician|0|||
155273379|NCT02743793|560434516|FG001|Overall Study|No Primary Care Physician|1|||
155273380|NCT02743793|560434515|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
155273381|NCT02743793|560434516|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
155273382|NCT02743793|560434515|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
155273383|NCT02743793|560434516|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
155273384|NCT04276090|560434519|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
155273385|NCT04276090|560434520|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
155273386|NCT04642469|560434521|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
155273387|NCT04642469|560434522|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
155273388|NCT04642469|560434521|FG000|Overall Study|Death|1|||
155273389|NCT04642469|560434522|FG001|Overall Study|Death|2|||
155273390|NCT04642469|560434521|FG000|Overall Study|Study/site closed following amendment 1|11|||
155273391|NCT04642469|560434522|FG001|Overall Study|Study/site closed following amendment 1|11|||
155273392|NCT04642469|560434521|FG000|Overall Study|Other|1|||
155273393|NCT04642469|560434522|FG001|Overall Study|Other|1|||
155273394|NCT04642469|560434521|FG000|Overall Study|Withdrawal by Subject|1|||
155273395|NCT04642469|560434522|FG001|Overall Study|Withdrawal by Subject|0|||
155273396|NCT02066532|560434527|FG000|Phase II|Withdrawal by Subject|1|||
155273397|NCT02066532|560434528|FG001|Phase II|Withdrawal by Subject|0|||
155273398|NCT02066532|560434529|FG002|Phase II|Withdrawal by Subject|0|||
155273399|NCT02066532|560434530|FG003|Phase II|Withdrawal by Subject|0|||
155273400|NCT05033080|560434531|FG000|Overall Study|Adverse Event|4|||
155273401|NCT05033080|560434532|FG001|Overall Study|Adverse Event|4|||
155273402|NCT05033080|560434531|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
155273403|NCT05033080|560434532|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
155273404|NCT05033080|560434531|FG000|Overall Study|Lost to Follow-up|1|||
155273405|NCT05033080|560434532|FG001|Overall Study|Lost to Follow-up|0|||
155273406|NCT05033080|560434531|FG000|Overall Study|Other non-compliance|0|||
155273407|NCT05033080|560434532|FG001|Overall Study|Other non-compliance|1|||
155273408|NCT05033080|560434531|FG000|Overall Study|Physician Decision|0|||
155273409|NCT05033080|560434532|FG001|Overall Study|Physician Decision|1|||
155273410|NCT05033080|560434531|FG000|Overall Study|Other|1|||
155273411|NCT05033080|560434532|FG001|Overall Study|Other|1|||
155273412|NCT03560245|560434533|FG000|Overall Study|Withdrawal by Subject|3|||
155273413|NCT03560245|560434534|FG001|Overall Study|Withdrawal by Subject|2|||
155273414|NCT03560245|560434533|FG000|Overall Study|Adverse Event|1|||
155273415|NCT03560245|560434534|FG001|Overall Study|Adverse Event|1|||
155273416|NCT03560245|560434533|FG000|Overall Study|Protocol Violation|1|||
155273417|NCT03560245|560434534|FG001|Overall Study|Protocol Violation|0|||
155273418|NCT03560245|560434533|FG000|Overall Study|Death|0|||
155273419|NCT03560245|560434534|FG001|Overall Study|Death|1|||
155273420|NCT03560245|560434533|FG000|Overall Study|Lost to Follow-up|0|||
155273421|NCT03560245|560434534|FG001|Overall Study|Lost to Follow-up|1|||
155273422|NCT03560245|560434533|FG000|Overall Study|Physician Decision|0|||
155273423|NCT03560245|560434534|FG001|Overall Study|Physician Decision|1|||
155273424|NCT03560245|560434533|FG000|Overall Study|Other|0|||
155273425|NCT03560245|560434534|FG001|Overall Study|Other|1|||
155273426|NCT01680458|560434541|FG000|Overall Study|Protocol Violation|3|||
155273427|NCT02138747|560434542|FG000|Treatment Period 1|Adverse Event|10|||
155273428|NCT02138747|560434543|FG001|Treatment Period 1|Adverse Event|14|||
155273429|NCT02138747|560434544|FG002|Treatment Period 1|Adverse Event|2|||
155273430|NCT02138747|560434545|FG003|Treatment Period 1|Adverse Event|1|||
155273431|NCT02138747|560434542|FG000|Treatment Period 1|Lost to Follow-up|0|||
155273432|NCT02138747|560434543|FG001|Treatment Period 1|Lost to Follow-up|1|||
155273433|NCT02138747|560434544|FG002|Treatment Period 1|Lost to Follow-up|1|||
155273434|NCT02138747|560434545|FG003|Treatment Period 1|Lost to Follow-up|0|||
155273435|NCT02138747|560434542|FG000|Treatment Period 1|Protocol Violation|0|||
155273436|NCT02138747|560434543|FG001|Treatment Period 1|Protocol Violation|2|||
155273437|NCT02138747|560434544|FG002|Treatment Period 1|Protocol Violation|0|||
155273438|NCT02138747|560434545|FG003|Treatment Period 1|Protocol Violation|0|||
155273439|NCT02138747|560434542|FG000|Treatment Period 1|Withdrawal by Subject|8|||
155273440|NCT02138747|560434543|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155273441|NCT02138747|560434544|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155273442|NCT02138747|560434545|FG003|Treatment Period 1|Withdrawal by Subject|3|||
155273443|NCT02138747|560434542|FG000|Treatment Period 1|Other - Miscellaneous|2|||
155273444|NCT02138747|560434543|FG001|Treatment Period 1|Other - Miscellaneous|4|||
155273445|NCT02138747|560434544|FG002|Treatment Period 1|Other - Miscellaneous|0|||
155273446|NCT02138747|560434545|FG003|Treatment Period 1|Other - Miscellaneous|0|||
155273447|NCT02138747|560434542|FG000|Treatment Period 2|Adverse Event|6|||
155273448|NCT02138747|560434543|FG001|Treatment Period 2|Adverse Event|3|||
155273449|NCT02138747|560434544|FG002|Treatment Period 2|Adverse Event|1|||
155273450|NCT02138747|560434545|FG003|Treatment Period 2|Adverse Event|1|||
155273451|NCT02138747|560434542|FG000|Treatment Period 2|Lost to Follow-up|2|||
155273452|NCT02138747|560434543|FG001|Treatment Period 2|Lost to Follow-up|0|||
155273453|NCT02138747|560434544|FG002|Treatment Period 2|Lost to Follow-up|0|||
155273454|NCT02138747|560434545|FG003|Treatment Period 2|Lost to Follow-up|0|||
155273455|NCT02138747|560434542|FG000|Treatment Period 2|Protocol Violation|1|||
155273456|NCT02138747|560434543|FG001|Treatment Period 2|Protocol Violation|0|||
155273457|NCT02138747|560434544|FG002|Treatment Period 2|Protocol Violation|0|||
155273458|NCT02138747|560434545|FG003|Treatment Period 2|Protocol Violation|0|||
155273459|NCT02138747|560434542|FG000|Treatment Period 2|Withdrawal by Subject|5|||
155273460|NCT02138747|560434543|FG001|Treatment Period 2|Withdrawal by Subject|4|||
155273461|NCT02138747|560434544|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155273462|NCT02138747|560434545|FG003|Treatment Period 2|Withdrawal by Subject|2|||
155273463|NCT02138747|560434542|FG000|Treatment Period 2|Other - Miscellaneous|3|||
154936024|NCT02059187|559192770|FG001|Overall Study|Physician Decision|2|||
154936025|NCT02059187|559192769|FG000|Overall Study|Protocol Violation|1|||
154936026|NCT02059187|559192770|FG001|Overall Study|Protocol Violation|0|||
155273464|NCT02138747|560434543|FG001|Treatment Period 2|Other - Miscellaneous|0|||
155273465|NCT02138747|560434544|FG002|Treatment Period 2|Other - Miscellaneous|0|||
155273466|NCT02138747|560434545|FG003|Treatment Period 2|Other - Miscellaneous|0|||
155273467|NCT03406702|560434554|FG000|Overall Study|Missed Day 27 Dosing|1|||
155273468|NCT01040780|560436281|FG000|Overall Study|Protocol Violation|1|||
155273469|NCT01040780|560436282|FG001|Overall Study|Protocol Violation|3|||
155273470|NCT03681639|560436283|FG000|Overall Study|Death|4|||
155273471|NCT03681639|560436283|FG000|Overall Study|Lost to Follow-up|2|||
155273472|NCT03681639|560436283|FG000|Overall Study|Withdrawal by Subject|1|||
155273473|NCT03681639|560436283|FG000|Overall Study|Adverse Event|2|||
155273474|NCT01004250|560436286|FG000|Induction Therapy Period|Adverse Event|10|||
155273475|NCT01004250|560436286|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
155273476|NCT01004250|560436286|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
155273477|NCT01004250|560436286|FG000|Induction Therapy Period|Physician Decision|2|||
155273478|NCT01004250|560436286|FG000|Maintenance Therapy Period|Adverse Event|15|||
155273479|NCT01004250|560436286|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
155273480|NCT01004250|560436286|FG000|Maintenance Therapy Period|Protocol Violation|1|||
155273481|NCT01004250|560436286|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
155273482|NCT01004250|560436286|FG000|Maintenance Therapy Period|Physician Decision|4|||
155273483|NCT01004250|560436286|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
154936027|NCT02059187|559192769|FG000|Overall Study|Withdrawal by Subject|12|||
155273484|NCT03268590|560436287|FG000|Overall Study|Previously unknown exclusion criteria|1|||
155273485|NCT04076020|560436315|FG000|Overall Study|Death|4|||
155273486|NCT04076020|560436316|FG001|Overall Study|Death|6|||
155273487|NCT04076020|560436315|FG000|Overall Study|Withdrawal by Subject|12|||
155273488|NCT04076020|560436316|FG001|Overall Study|Withdrawal by Subject|8|||
155273489|NCT03537261|560436322|FG000|Overall Study|Lost to Follow-up|4|||
155273490|NCT03537261|560436323|FG001|Overall Study|Lost to Follow-up|5|||
155273491|NCT03537261|560436322|FG000|Overall Study|Withdrawal by Subject|4|||
155273492|NCT03537261|560436323|FG001|Overall Study|Withdrawal by Subject|6|||
155273493|NCT03537261|560436322|FG000|Overall Study|Did not return study questionnaires|0|||
155273494|NCT03537261|560436323|FG001|Overall Study|Did not return study questionnaires|1|||
155273495|NCT01316692|560436326|FG000|Overall Study|Adverse Event|5|||
155273496|NCT01316692|560436326|FG000|Overall Study|Disease Progression|7|||
155273497|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
155273498|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
155273499|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
155273500|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
155273501|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
155273502|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
155273503|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
155273504|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
155273505|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
155273506|NCT02001974|560436327|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
155273507|NCT02001974|560436328|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
155273508|NCT02001974|560436329|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
155273509|NCT00993317|560436330|FG000|Overall Study|Adverse Event|2|||
155273510|NCT00993317|560436331|FG001|Overall Study|Adverse Event|4|||
155273511|NCT00993317|560436330|FG000|Overall Study|Lack of Efficacy|18|||
155273512|NCT00993317|560436331|FG001|Overall Study|Lack of Efficacy|18|||
155273513|NCT00993317|560436330|FG000|Overall Study|Withdrawal by Subject|0|||
155273514|NCT00993317|560436331|FG001|Overall Study|Withdrawal by Subject|2|||
155273515|NCT00993317|560436330|FG000|Overall Study|Investigator's opinion|0|||
155273516|NCT00993317|560436331|FG001|Overall Study|Investigator's opinion|1|||
155273517|NCT00993317|560436330|FG000|Overall Study|Early study termination at the site|1|||
155273518|NCT00993317|560436331|FG001|Overall Study|Early study termination at the site|0|||
155273519|NCT01380990|560436332|FG000|Overall Study|Treatment Failure|1|||
155273520|NCT01380990|560436333|FG001|Overall Study|Treatment Failure|0|||
155273521|NCT01380990|560436332|FG000|Overall Study|Death|0|||
155273522|NCT01380990|560436333|FG001|Overall Study|Death|1|||
155273523|NCT04422639|560436336|FG000|Overall Study|Death|1|||
155273524|NCT04422639|560436337|FG001|Overall Study|Death|0|||
155273525|NCT04422639|560436336|FG000|Overall Study|study closed prior to completion of FU visits|0|||
155273526|NCT04422639|560436337|FG001|Overall Study|study closed prior to completion of FU visits|2|||
155273527|NCT02374593|560436339|FG000|Overall Study|non-compliant|2|||
155273528|NCT02374593|560436340|FG001|Overall Study|non-compliant|0|||
155273529|NCT01284140|560436341|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
155273530|NCT01284140|560436342|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
155273531|NCT01284140|560436341|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
155273532|NCT01284140|560436342|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
155273533|NCT01463293|560436343|FG000|Overall Study|Lost to Follow-up|1|||
155273534|NCT01463293|560436344|FG001|Overall Study|Lost to Follow-up|4|||
155273535|NCT01463293|560436345|FG002|Overall Study|Lost to Follow-up|5|||
155273536|NCT01463293|560436343|FG000|Overall Study|Adverse Event|1|||
155273537|NCT01463293|560436344|FG001|Overall Study|Adverse Event|2|||
155273538|NCT01463293|560436345|FG002|Overall Study|Adverse Event|0|||
155273539|NCT01463293|560436343|FG000|Overall Study|Withdrawal by Subject|4|||
155273540|NCT01463293|560436344|FG001|Overall Study|Withdrawal by Subject|10|||
155273541|NCT01463293|560436345|FG002|Overall Study|Withdrawal by Subject|5|||
155273542|NCT01463293|560436343|FG000|Overall Study|Other|0|||
155273543|NCT01463293|560436344|FG001|Overall Study|Other|0|||
155273544|NCT01463293|560436345|FG002|Overall Study|Other|2|||
154936028|NCT02059187|559192770|FG001|Overall Study|Withdrawal by Subject|8|||
154936029|NCT03751020|559192771|FG000|Overall Study|Withdrawal by Subject|2|||
154936030|NCT03751020|559192772|FG001|Overall Study|Withdrawal by Subject|0|||
154936031|NCT03751020|559192773|FG002|Overall Study|Withdrawal by Subject|0|||
154936032|NCT03751020|559192771|FG000|Overall Study|Lost to Follow-up|7|||
154936033|NCT03751020|559192772|FG001|Overall Study|Lost to Follow-up|4|||
154936034|NCT03751020|559192773|FG002|Overall Study|Lost to Follow-up|10|||
154936035|NCT01889862|559192774|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
154936036|NCT01889862|559192775|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
154936037|NCT01889862|559192776|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
154936038|NCT01889862|559192777|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
154936039|NCT01889862|559192778|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
155273545|NCT02796963|560436346|FG000|Overall Study|Lost to Follow-up|89|||
155273546|NCT02796963|560436347|FG001|Overall Study|Lost to Follow-up|76|||
155273547|NCT02796963|560436348|FG002|Overall Study|Lost to Follow-up|69|||
155273548|NCT02796963|560436349|FG003|Overall Study|Lost to Follow-up|72|||
155273549|NCT03192215|560436350|FG000|Overall Study|Death|28|||
155273550|NCT03192215|560436351|FG001|Overall Study|Death|23|||
155273551|NCT03192215|560436350|FG000|Overall Study|Lost to Follow-up|10|||
154936040|NCT01889862|559192774|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
154936041|NCT01889862|559192775|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
154936042|NCT01889862|559192776|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
154936043|NCT01889862|559192777|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
154936044|NCT01889862|559192778|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
155273552|NCT03192215|560436351|FG001|Overall Study|Lost to Follow-up|15|||
155273553|NCT03192215|560436350|FG000|Overall Study|Withdrawal by Subject|49|||
155273554|NCT03192215|560436351|FG001|Overall Study|Withdrawal by Subject|48|||
155273555|NCT03192215|560436350|FG000|Overall Study|Other as reported in analysis|4|||
154936045|NCT01889862|559192774|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
154936046|NCT01889862|559192775|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
154936047|NCT01889862|559192776|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
154936048|NCT01889862|559192777|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
154936049|NCT01889862|559192778|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
154936050|NCT01889862|559192774|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
154936051|NCT01889862|559192775|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
154936052|NCT01889862|559192776|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
154936053|NCT01889862|559192777|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
154936054|NCT01889862|559192778|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
154936055|NCT01889862|559192774|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
154936056|NCT01889862|559192775|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
154936057|NCT01889862|559192776|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
154936058|NCT01889862|559192777|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
154936059|NCT01889862|559192778|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
154936060|NCT01889862|559192774|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
154936061|NCT01889862|559192775|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
154936062|NCT01889862|559192776|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
154936063|NCT01889862|559192777|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
154936064|NCT01889862|559192778|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
154936065|NCT01889862|559192774|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
154936066|NCT01889862|559192775|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
154936067|NCT01889862|559192776|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
154936068|NCT01889862|559192777|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
154936069|NCT01889862|559192778|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
154936070|NCT01889862|559192774|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
154936071|NCT01889862|559192775|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
154936072|NCT01889862|559192776|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
154936073|NCT01889862|559192777|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
154936074|NCT01889862|559192778|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
154936075|NCT01889862|559192774|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
154936076|NCT01889862|559192775|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
154936077|NCT01889862|559192776|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
154936078|NCT01889862|559192777|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
154936079|NCT01889862|559192778|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
154936080|NCT01889862|559192774|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
154936081|NCT01889862|559192775|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
154936082|NCT01889862|559192776|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
154936083|NCT01889862|559192777|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
154936084|NCT01889862|559192778|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
154936085|NCT00033631|559192779|FG000|Overall Study|Protocol Violation|14|||
154936086|NCT00033631|559192780|FG001|Overall Study|Protocol Violation|11|||
154936087|NCT00033631|559192779|FG000|Overall Study|Withdrawal by Subject|4|||
154936088|NCT00033631|559192780|FG001|Overall Study|Withdrawal by Subject|4|||
154936089|NCT00078819|559192781|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
154936090|NCT00078819|559192782|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
154936091|NCT00078819|559192783|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
154936092|NCT00078819|559192784|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
154936093|NCT00078819|559192781|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
154936094|NCT00078819|559192782|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
154936095|NCT00078819|559192783|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
154936096|NCT00078819|559192784|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
154936097|NCT00078819|559192781|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
154936098|NCT00078819|559192782|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
154936099|NCT00078819|559192783|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
154936100|NCT00078819|559192784|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
154936101|NCT00078819|559192781|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
154936102|NCT00078819|559192782|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
154936103|NCT00078819|559192783|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
154936104|NCT00078819|559192784|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
154936105|NCT00078819|559192781|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
154936106|NCT00078819|559192782|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
154936107|NCT00078819|559192783|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
154936108|NCT00078819|559192784|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
154936109|NCT00078819|559192781|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
154936110|NCT00078819|559192782|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
154936111|NCT00078819|559192783|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
154936112|NCT00078819|559192784|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
154936113|NCT00078819|559192781|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
154936114|NCT00078819|559192782|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
154936115|NCT00078819|559192783|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
154936116|NCT00078819|559192784|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
154936117|NCT00078819|559192781|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
154936118|NCT00078819|559192782|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
154936119|NCT00078819|559192783|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
154936120|NCT00078819|559192784|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
154936121|NCT02217345|559192785|FG000|Overall Study|Lost to Follow-up|2|||
154936122|NCT02217345|559192786|FG001|Overall Study|Lost to Follow-up|1|||
154936123|NCT02217345|559192785|FG000|Overall Study|Withdrawal by Subject|3|||
154936124|NCT02217345|559192786|FG001|Overall Study|Withdrawal by Subject|2|||
154936125|NCT02217345|559192785|FG000|Overall Study|Adverse Event|2|||
154936126|NCT02217345|559192786|FG001|Overall Study|Adverse Event|1|||
154936127|NCT02217345|559192785|FG000|Overall Study|Physician Decision|0|||
154936128|NCT02217345|559192786|FG001|Overall Study|Physician Decision|1|||
154936129|NCT00971204|559192787|FG000|Overall Study|Did not meet all criteria-not treated|14|||
154936130|NCT00971204|559192787|FG000|Overall Study|Lost to Follow-up|10|||
154936131|NCT04130919|559192788|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
154936132|NCT04130919|559192789|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
154936133|NCT04130919|559192790|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
154936134|NCT04130919|559192791|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
154936135|NCT04130919|559192792|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
154936136|NCT04130919|559192793|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
154936137|NCT04130919|559192788|FG000|Blinded Treatment Phase|Adverse Event|0|||
154936138|NCT04130919|559192789|FG001|Blinded Treatment Phase|Adverse Event|0|||
154936139|NCT04130919|559192790|FG002|Blinded Treatment Phase|Adverse Event|1|||
154936140|NCT04130919|559192791|FG003|Blinded Treatment Phase|Adverse Event|0|||
154936141|NCT04130919|559192792|FG004|Blinded Treatment Phase|Adverse Event|0|||
154936142|NCT04130919|559192793|FG005|Blinded Treatment Phase|Adverse Event|0|||
154936143|NCT04130919|559192788|FG000|Blinded Treatment Phase|Disease worsening|0|||
154936144|NCT04130919|559192789|FG001|Blinded Treatment Phase|Disease worsening|0|||
154936145|NCT04130919|559192790|FG002|Blinded Treatment Phase|Disease worsening|1|||
154936146|NCT04130919|559192791|FG003|Blinded Treatment Phase|Disease worsening|0|||
154936147|NCT04130919|559192792|FG004|Blinded Treatment Phase|Disease worsening|0|||
154936148|NCT04130919|559192793|FG005|Blinded Treatment Phase|Disease worsening|0|||
154936149|NCT04130919|559192788|FG000|Blinded Treatment Phase|Investigator's decision|0|||
154936150|NCT04130919|559192789|FG001|Blinded Treatment Phase|Investigator's decision|1|||
154936151|NCT04130919|559192790|FG002|Blinded Treatment Phase|Investigator's decision|0|||
154936152|NCT04130919|559192791|FG003|Blinded Treatment Phase|Investigator's decision|0|||
154936153|NCT04130919|559192792|FG004|Blinded Treatment Phase|Investigator's decision|0|||
154936154|NCT04130919|559192793|FG005|Blinded Treatment Phase|Investigator's decision|0|||
154936155|NCT04130919|559192788|FG000|Blinded Treatment Phase|Withdrew consent|1|||
154936156|NCT04130919|559192789|FG001|Blinded Treatment Phase|Withdrew consent|0|||
154936157|NCT04130919|559192790|FG002|Blinded Treatment Phase|Withdrew consent|0|||
154936158|NCT04130919|559192791|FG003|Blinded Treatment Phase|Withdrew consent|0|||
154936159|NCT04130919|559192792|FG004|Blinded Treatment Phase|Withdrew consent|0|||
154936160|NCT04130919|559192793|FG005|Blinded Treatment Phase|Withdrew consent|0|||
154936161|NCT04130919|559192788|FG000|Open-label Treatment Phase|Withdrew consent|0|||
154936162|NCT04130919|559192789|FG001|Open-label Treatment Phase|Withdrew consent|0|||
154936163|NCT04130919|559192790|FG002|Open-label Treatment Phase|Withdrew consent|0|||
154936164|NCT04130919|559192791|FG003|Open-label Treatment Phase|Withdrew consent|1|||
154936165|NCT04130919|559192792|FG004|Open-label Treatment Phase|Withdrew consent|1|||
154936166|NCT04130919|559192793|FG005|Open-label Treatment Phase|Withdrew consent|1|||
154936167|NCT04130919|559192788|FG000|Open-label Treatment Phase|Disease worsening|0|||
154936168|NCT04130919|559192789|FG001|Open-label Treatment Phase|Disease worsening|0|||
154936169|NCT04130919|559192790|FG002|Open-label Treatment Phase|Disease worsening|0|||
154936170|NCT04130919|559192791|FG003|Open-label Treatment Phase|Disease worsening|1|||
154936171|NCT04130919|559192792|FG004|Open-label Treatment Phase|Disease worsening|0|||
154936172|NCT04130919|559192793|FG005|Open-label Treatment Phase|Disease worsening|1|||
154936173|NCT04130919|559192788|FG000|Open-label Treatment Phase|Investigator's decision|0|||
154936174|NCT04130919|559192789|FG001|Open-label Treatment Phase|Investigator's decision|0|||
154936175|NCT04130919|559192790|FG002|Open-label Treatment Phase|Investigator's decision|0|||
154936176|NCT04130919|559192791|FG003|Open-label Treatment Phase|Investigator's decision|1|||
154936177|NCT04130919|559192792|FG004|Open-label Treatment Phase|Investigator's decision|0|||
154936178|NCT04130919|559192793|FG005|Open-label Treatment Phase|Investigator's decision|0|||
154936179|NCT04130919|559192788|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
154936180|NCT04130919|559192789|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
154936181|NCT04130919|559192790|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
154936182|NCT04130919|559192791|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
154936183|NCT04130919|559192792|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
154936184|NCT04130919|559192793|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
154936185|NCT04130919|559192788|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
154936186|NCT04130919|559192789|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
154936187|NCT04130919|559192790|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
154936188|NCT04130919|559192791|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
154936189|NCT04130919|559192792|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
154936190|NCT04130919|559192793|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
154936191|NCT02729194|559192794|FG000|Overall Study|Withdrawal by Subject|3|||
154936192|NCT00845026|559192795|FG000|Study Period III|Adverse Event|23|||
154936193|NCT00845026|559192796|FG001|Study Period III|Adverse Event|19|||
154936194|NCT00845026|559192795|FG000|Study Period III|Perceived lack of efficacy|27|||
154936195|NCT00845026|559192796|FG001|Study Period III|Perceived lack of efficacy|15|||
154936196|NCT00845026|559192795|FG000|Study Period III|Withdrawal by Subject|19|||
154936197|NCT00845026|559192796|FG001|Study Period III|Withdrawal by Subject|15|||
154936198|NCT00845026|559192795|FG000|Study Period III|Entry Criteria not met|8|||
154936199|NCT00845026|559192796|FG001|Study Period III|Entry Criteria not met|11|||
154936200|NCT00845026|559192795|FG000|Study Period III|Lost to Follow-up|4|||
154936201|NCT00845026|559192796|FG001|Study Period III|Lost to Follow-up|5|||
154936202|NCT00845026|559192795|FG000|Study Period III|Protocol Violation|8|||
154936203|NCT00845026|559192796|FG001|Study Period III|Protocol Violation|1|||
154936204|NCT00845026|559192795|FG000|Study Period III|Scheduled conflict|3|||
154936205|NCT00845026|559192796|FG001|Study Period III|Scheduled conflict|1|||
154936206|NCT00845026|559192795|FG000|Study Period III|Subject is moving or has moved|2|||
154936207|NCT00845026|559192796|FG001|Study Period III|Subject is moving or has moved|4|||
154936208|NCT00845026|559192795|FG000|Study Period III|Transportation issues|1|||
154936209|NCT00845026|559192796|FG001|Study Period III|Transportation issues|1|||
154936210|NCT00845026|559192795|FG000|Study Period IV|Adverse Event|4|||
154936211|NCT00845026|559192796|FG001|Study Period IV|Adverse Event|0|||
154936212|NCT00845026|559192795|FG000|Study Period IV|Perceived lack of efficacy|2|||
154936213|NCT00845026|559192796|FG001|Study Period IV|Perceived lack of efficacy|1|||
154936214|NCT00845026|559192795|FG000|Study Period IV|Protocol Violation|3|||
154936215|NCT00845026|559192796|FG001|Study Period IV|Protocol Violation|1|||
154936216|NCT00845026|559192795|FG000|Study Period IV|Lost to Follow-up|1|||
154936217|NCT00845026|559192796|FG001|Study Period IV|Lost to Follow-up|0|||
154936218|NCT00845026|559192795|FG000|Study Period IV|Withdrawal by Subject|4|||
154936219|NCT00845026|559192796|FG001|Study Period IV|Withdrawal by Subject|1|||
154936220|NCT00845026|559192795|FG000|Study Period IV|Entry Criteria Not Met|1|||
154936221|NCT00845026|559192796|FG001|Study Period IV|Entry Criteria Not Met|0|||
154936222|NCT00845026|559192795|FG000|Study Period IV|Subject is moving or has moved|0|||
154936223|NCT00845026|559192796|FG001|Study Period IV|Subject is moving or has moved|1|||
154936224|NCT00845026|559192795|FG000|Study Period IV|Scheduling conflict|1|||
154936225|NCT00845026|559192796|FG001|Study Period IV|Scheduling conflict|0|||
154936226|NCT01325532|559192797|FG000|Overall Study|Withdrawal by Subject|2|||
154936227|NCT01325532|559192798|FG001|Overall Study|Withdrawal by Subject|0|||
154936228|NCT03672396|559192804|FG000|Overall Study|Withdrawal by Subject|4|||
154936229|NCT03672396|559192804|FG000|Overall Study|Physician Decision|1|||
154936230|NCT03672396|559192804|FG000|Overall Study|Adverse Event|1|||
154936231|NCT01254045|559192805|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
154936232|NCT01254045|559192806|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
154936233|NCT01254045|559192807|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
154936234|NCT01254045|559192808|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
154936235|NCT01254045|559192809|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
154936236|NCT01254045|559192810|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
154936237|NCT00520351|559192811|FG000|First Intervention|Withdrawal by Subject|1|||
154936238|NCT00520351|559192812|FG001|First Intervention|Withdrawal by Subject|1|||
154936239|NCT03797222|559192814|FG000|Overall Study|Withdrawal by Subject|1|||
154936240|NCT04288115|559192818|FG000|Overall Study|Withdrawal by Subject|0|||
154936241|NCT04288115|559192819|FG001|Overall Study|Withdrawal by Subject|1|||
154936242|NCT04288115|559192818|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
154936243|NCT04288115|559192819|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
154936244|NCT00729365|559192820|FG000|Overall Study|Physician Decision|33|||
154936245|NCT00729365|559192821|FG001|Overall Study|Physician Decision|6|||
154936246|NCT00729365|559192822|FG002|Overall Study|Physician Decision|7|||
154936247|NCT00295620|559192824|FG000|Overall Study|Lost to Follow-up|9|||
154936248|NCT00295620|559192825|FG001|Overall Study|Lost to Follow-up|5|||
154936249|NCT00295620|559192824|FG000|Overall Study|Withdrawal by Subject|37|||
155273556|NCT03192215|560436351|FG001|Overall Study|Other as reported in analysis|1|||
154936250|NCT00295620|559192825|FG001|Overall Study|Withdrawal by Subject|50|||
154936251|NCT00295620|559192824|FG000|Overall Study|Death|206|||
154936252|NCT00295620|559192825|FG001|Overall Study|Death|207|||
154936253|NCT00295620|559192824|FG000|Overall Study|Other reasons|10|||
154936254|NCT00295620|559192825|FG001|Overall Study|Other reasons|9|||
155273557|NCT02038764|560436354|FG000|Overall Study|Adverse Event|0|||
155273558|NCT02038764|560436355|FG001|Overall Study|Adverse Event|0|||
155273559|NCT02038764|560436356|FG002|Overall Study|Adverse Event|1|||
154936255|NCT00295620|559192824|FG000|Overall Study|Discontinuation by sponsor|580|||
154936256|NCT00295620|559192825|FG001|Overall Study|Discontinuation by sponsor|593|||
154936257|NCT00295620|559192824|FG000|Overall Study|Protocol Violation|30|||
154936258|NCT00295620|559192825|FG001|Overall Study|Protocol Violation|32|||
154936259|NCT01309828|559192826|FG000|Overall Study|Adverse Event|10|||
154936260|NCT01309828|559192827|FG001|Overall Study|Adverse Event|11|||
154936261|NCT01309828|559192826|FG000|Overall Study|Voluntary Withdrawal|5|||
154936262|NCT01309828|559192827|FG001|Overall Study|Voluntary Withdrawal|4|||
154936263|NCT01309828|559192826|FG000|Overall Study|Major Protocol Deviation|0|||
154936264|NCT01309828|559192827|FG001|Overall Study|Major Protocol Deviation|1|||
154936265|NCT01309828|559192826|FG000|Overall Study|Other|1|||
154936266|NCT01309828|559192827|FG001|Overall Study|Other|0|||
154936267|NCT00217971|559192828|FG000|Overall Study|Adverse Event|1|||
154936268|NCT00217971|559192829|FG001|Overall Study|Adverse Event|1|||
154936269|NCT00217971|559192828|FG000|Overall Study|Lost to Follow-up|15|||
154936270|NCT00217971|559192829|FG001|Overall Study|Lost to Follow-up|19|||
154936271|NCT00217971|559192828|FG000|Overall Study|Physician Decision|0|||
154936272|NCT00217971|559192829|FG001|Overall Study|Physician Decision|1|||
154936273|NCT00217971|559192828|FG000|Overall Study|Withdrawal by Subject|7|||
154936274|NCT00217971|559192829|FG001|Overall Study|Withdrawal by Subject|12|||
154936275|NCT00217971|559192828|FG000|Overall Study|non compliant|1|||
154936276|NCT00217971|559192829|FG001|Overall Study|non compliant|0|||
154936277|NCT02556632|559192830|FG000|Overall Study|Lost to Follow-up|1|||
154936278|NCT02556632|559192831|FG001|Overall Study|Lost to Follow-up|0|||
154936279|NCT02556632|559192832|FG002|Overall Study|Lost to Follow-up|0|||
154936280|NCT02556632|559192830|FG000|Overall Study|Disliked Intervention|1|||
154936281|NCT02556632|559192831|FG001|Overall Study|Disliked Intervention|1|||
154936282|NCT02556632|559192832|FG002|Overall Study|Disliked Intervention|1|||
154936283|NCT02556632|559192830|FG000|Overall Study|No Reason|1|||
154936284|NCT02556632|559192831|FG001|Overall Study|No Reason|0|||
154936285|NCT02556632|559192832|FG002|Overall Study|No Reason|1|||
154936286|NCT02556632|559192830|FG000|Overall Study|Personal Issues|0|||
154936287|NCT02556632|559192831|FG001|Overall Study|Personal Issues|1|||
154936288|NCT02556632|559192832|FG002|Overall Study|Personal Issues|1|||
154936289|NCT02556632|559192830|FG000|Overall Study|Changed Mind|0|||
154936290|NCT02556632|559192831|FG001|Overall Study|Changed Mind|1|||
154936291|NCT02556632|559192832|FG002|Overall Study|Changed Mind|0|||
154936292|NCT02556632|559192830|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
154936293|NCT02556632|559192831|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
154936294|NCT02556632|559192832|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
154936295|NCT02556632|559192830|FG000|Overall Study|Unrelated Adverse Event|1|||
154936296|NCT02556632|559192831|FG001|Overall Study|Unrelated Adverse Event|0|||
154936297|NCT02556632|559192832|FG002|Overall Study|Unrelated Adverse Event|3|||
154936298|NCT02556632|559192830|FG000|Overall Study|Related Adverse Event|0|||
154936299|NCT02556632|559192831|FG001|Overall Study|Related Adverse Event|1|||
154936300|NCT02556632|559192832|FG002|Overall Study|Related Adverse Event|0|||
154936301|NCT02556632|559192830|FG000|Overall Study|Possibly Related Adverse Event|0|||
154936302|NCT02556632|559192831|FG001|Overall Study|Possibly Related Adverse Event|0|||
154936303|NCT02556632|559192832|FG002|Overall Study|Possibly Related Adverse Event|1|||
154936304|NCT02556632|559192830|FG000|Overall Study|Did Not Start RT|0|||
154936305|NCT02556632|559192831|FG001|Overall Study|Did Not Start RT|1|||
154936306|NCT02556632|559192832|FG002|Overall Study|Did Not Start RT|0|||
154936307|NCT02556632|559192830|FG000|Overall Study|Ineligible|0|||
154936308|NCT02556632|559192831|FG001|Overall Study|Ineligible|1|||
154936309|NCT02556632|559192832|FG002|Overall Study|Ineligible|0|||
154936310|NCT02556632|559192830|FG000|Overall Study|Disliked Study Procedures|0|||
154936311|NCT02556632|559192831|FG001|Overall Study|Disliked Study Procedures|0|||
154936312|NCT02556632|559192832|FG002|Overall Study|Disliked Study Procedures|1|||
154936313|NCT02556632|559192830|FG000|Overall Study|Treatment or Change Delay|0|||
155273560|NCT02038764|560436357|FG003|Overall Study|Adverse Event|0|||
155273561|NCT02038764|560436358|FG004|Overall Study|Adverse Event|0|||
154936314|NCT02556632|559192831|FG001|Overall Study|Treatment or Change Delay|0|||
154936315|NCT02556632|559192832|FG002|Overall Study|Treatment or Change Delay|1|||
154936316|NCT00808015|559192833|FG000|Overall Study|Death|1|||
154936317|NCT00808015|559192833|FG000|Overall Study|Lack of Efficacy|58|||
155273562|NCT02038764|560436354|FG000|Overall Study|Lost to Follow-up|0|||
155273563|NCT02038764|560436355|FG001|Overall Study|Lost to Follow-up|1|||
154936318|NCT00808015|559192833|FG000|Overall Study|Lost to Follow-up|76|||
154936319|NCT00808015|559192833|FG000|Overall Study|Participants not willing to participate|158|||
154936320|NCT00808015|559192833|FG000|Overall Study|Adverse Event|22|||
154936321|NCT00808015|559192833|FG000|Overall Study|Other|25|||
154936322|NCT00808015|559192833|FG000|Overall Study|Enrolled but not treated|4|||
155273564|NCT02038764|560436356|FG002|Overall Study|Lost to Follow-up|0|||
155273565|NCT02038764|560436357|FG003|Overall Study|Lost to Follow-up|0|||
154936323|NCT00084617|559192845|FG000|Overall Study|Withdrawal by Subject|7|||
154936324|NCT00084617|559192845|FG000|Overall Study|Lack of Efficacy|1|||
155273566|NCT02038764|560436358|FG004|Overall Study|Lost to Follow-up|0|||
154936325|NCT00084617|559192845|FG000|Overall Study|Protocol Violation|1|||
154936326|NCT01625286|559192846|FG000|Overall Study|Adverse Event|0|||
154936327|NCT01625286|559192847|FG001|Overall Study|Adverse Event|0|||
154936328|NCT01625286|559192848|FG002|Overall Study|Adverse Event|0|||
154936329|NCT01625286|559192849|FG003|Overall Study|Adverse Event|0|||
154936330|NCT01625286|559192850|FG004|Overall Study|Adverse Event|1|||
154936331|NCT01625286|559192851|FG005|Overall Study|Adverse Event|2|||
154936332|NCT01625286|559192852|FG006|Overall Study|Adverse Event|1|||
154936333|NCT01625286|559192846|FG000|Overall Study|Death|0|||
154936334|NCT01625286|559192847|FG001|Overall Study|Death|0|||
154936335|NCT01625286|559192848|FG002|Overall Study|Death|1|||
154936336|NCT01625286|559192849|FG003|Overall Study|Death|1|||
154936337|NCT01625286|559192850|FG004|Overall Study|Death|0|||
154936338|NCT01625286|559192851|FG005|Overall Study|Death|11|||
154936339|NCT01625286|559192852|FG006|Overall Study|Death|16|||
154936340|NCT01625286|559192846|FG000|Overall Study|Withdrawal by Subject|0|||
154936341|NCT01625286|559192847|FG001|Overall Study|Withdrawal by Subject|1|||
154936342|NCT01625286|559192848|FG002|Overall Study|Withdrawal by Subject|0|||
154936343|NCT01625286|559192849|FG003|Overall Study|Withdrawal by Subject|1|||
154936344|NCT01625286|559192850|FG004|Overall Study|Withdrawal by Subject|0|||
154936345|NCT01625286|559192851|FG005|Overall Study|Withdrawal by Subject|0|||
154936346|NCT01625286|559192852|FG006|Overall Study|Withdrawal by Subject|1|||
154936347|NCT01625286|559192846|FG000|Overall Study|Any reason not specifically recorded|0|||
154936348|NCT01625286|559192847|FG001|Overall Study|Any reason not specifically recorded|0|||
154936349|NCT01625286|559192848|FG002|Overall Study|Any reason not specifically recorded|0|||
154936350|NCT01625286|559192849|FG003|Overall Study|Any reason not specifically recorded|0|||
154936351|NCT01625286|559192850|FG004|Overall Study|Any reason not specifically recorded|0|||
154936352|NCT01625286|559192851|FG005|Overall Study|Any reason not specifically recorded|1|||
155273567|NCT02038764|560436354|FG000|Overall Study|Withdrawal by Subject|0|||
155273568|NCT02038764|560436355|FG001|Overall Study|Withdrawal by Subject|0|||
155273569|NCT02038764|560436356|FG002|Overall Study|Withdrawal by Subject|0|||
155273570|NCT02038764|560436357|FG003|Overall Study|Withdrawal by Subject|0|||
155273571|NCT02038764|560436358|FG004|Overall Study|Withdrawal by Subject|1|||
155273572|NCT02038764|560436354|FG000|Overall Study|Other|1|||
155273573|NCT02038764|560436355|FG001|Overall Study|Other|0|||
155273574|NCT02038764|560436356|FG002|Overall Study|Other|1|||
155273575|NCT02038764|560436357|FG003|Overall Study|Other|0|||
155273576|NCT02038764|560436358|FG004|Overall Study|Other|0|||
155273577|NCT03853317|560436359|FG000|Overall Study|Progressive Disease|5|||
154936353|NCT01625286|559192852|FG006|Overall Study|Any reason not specifically recorded|0|||
154936354|NCT01625286|559192846|FG000|Overall Study|Progressive disease|6|||
154936355|NCT01625286|559192847|FG001|Overall Study|Progressive disease|3|||
154936356|NCT01625286|559192848|FG002|Overall Study|Progressive disease|4|||
154936357|NCT01625286|559192849|FG003|Overall Study|Progressive disease|5|||
154936358|NCT01625286|559192850|FG004|Overall Study|Progressive disease|5|||
154936359|NCT01625286|559192851|FG005|Overall Study|Progressive disease|0|||
154936360|NCT01625286|559192852|FG006|Overall Study|Progressive disease|0|||
154936361|NCT01625286|559192846|FG000|Overall Study|Lost to Follow-up|0|||
154936362|NCT01625286|559192847|FG001|Overall Study|Lost to Follow-up|0|||
154936363|NCT01625286|559192848|FG002|Overall Study|Lost to Follow-up|0|||
154936364|NCT01625286|559192849|FG003|Overall Study|Lost to Follow-up|0|||
154936365|NCT01625286|559192850|FG004|Overall Study|Lost to Follow-up|0|||
154936366|NCT01625286|559192851|FG005|Overall Study|Lost to Follow-up|0|||
154936367|NCT01625286|559192852|FG006|Overall Study|Lost to Follow-up|1|||
154936368|NCT00928135|559192853|FG000|Overall Study|Withdrawal by Subject|1|||
154936369|NCT00928135|559192854|FG001|Overall Study|Withdrawal by Subject|0|||
154936370|NCT01458119|559192855|FG000|Overall Study|Physician Decision|4|||
154936371|NCT01458119|559192855|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
154936372|NCT01458119|559192855|FG000|Overall Study|Pregnancy|1|||
154936373|NCT01458119|559192855|FG000|Overall Study|Death|2|||
154936374|NCT01458119|559192855|FG000|Overall Study|Adverse Event|1|||
154936375|NCT01458119|559192855|FG000|Overall Study|Consent Withdrawn by Participant|8|||
154936376|NCT01458119|559192855|FG000|Overall Study|Non-compliance With Study Drug|3|||
155273578|NCT03853317|560436359|FG000|Overall Study|Adverse Event|1|||
155273579|NCT03853317|560436359|FG000|Overall Study|Death|1|||
155273580|NCT03853317|560436359|FG000|Overall Study|other event|2|||
155273581|NCT04844918|560436361|FG000|Overall Study|Adverse Event|7|||
155273582|NCT04844918|560436362|FG001|Overall Study|Adverse Event|8|||
154936377|NCT03033069|559192856|FG000|Overall Study|Adverse Event|6|||
154936378|NCT03033069|559192857|FG001|Overall Study|Adverse Event|7|||
154936379|NCT03033069|559192858|FG002|Overall Study|Adverse Event|4|||
154936380|NCT03033069|559192859|FG003|Overall Study|Adverse Event|6|||
154936381|NCT03033069|559192856|FG000|Overall Study|Lack of Efficacy|0|||
154936382|NCT03033069|559192857|FG001|Overall Study|Lack of Efficacy|0|||
154936383|NCT03033069|559192858|FG002|Overall Study|Lack of Efficacy|1|||
154936384|NCT03033069|559192859|FG003|Overall Study|Lack of Efficacy|0|||
154936385|NCT03033069|559192856|FG000|Overall Study|Lost to Follow-up|6|||
154936386|NCT03033069|559192857|FG001|Overall Study|Lost to Follow-up|5|||
155273583|NCT04844918|560436363|FG002|Overall Study|Adverse Event|5|||
154936387|NCT03033069|559192858|FG002|Overall Study|Lost to Follow-up|5|||
154936388|NCT03033069|559192859|FG003|Overall Study|Lost to Follow-up|6|||
154936389|NCT03033069|559192856|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154936390|NCT03033069|559192857|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154936391|NCT03033069|559192858|FG002|Overall Study|Non-Compliance With Study Drug|1|||
154936392|NCT03033069|559192859|FG003|Overall Study|Non-Compliance With Study Drug|0|||
154936393|NCT03033069|559192856|FG000|Overall Study|Protocol Deviation|0|||
154936394|NCT03033069|559192857|FG001|Overall Study|Protocol Deviation|1|||
154936395|NCT03033069|559192858|FG002|Overall Study|Protocol Deviation|0|||
154936396|NCT03033069|559192859|FG003|Overall Study|Protocol Deviation|0|||
154936397|NCT03033069|559192856|FG000|Overall Study|Withdrawal by Subject|10|||
154936398|NCT03033069|559192857|FG001|Overall Study|Withdrawal by Subject|10|||
154936399|NCT03033069|559192858|FG002|Overall Study|Withdrawal by Subject|11|||
154936400|NCT03033069|559192859|FG003|Overall Study|Withdrawal by Subject|6|||
154936401|NCT03033069|559192856|FG000|Overall Study|Withdrawal By Caregiver|1|||
154936402|NCT03033069|559192857|FG001|Overall Study|Withdrawal By Caregiver|0|||
154936403|NCT03033069|559192858|FG002|Overall Study|Withdrawal By Caregiver|0|||
154936404|NCT03033069|559192859|FG003|Overall Study|Withdrawal By Caregiver|0|||
154936405|NCT03033069|559192856|FG000|Overall Study|Reason not Specified|0|||
154936406|NCT03033069|559192857|FG001|Overall Study|Reason not Specified|1|||
154936407|NCT03033069|559192858|FG002|Overall Study|Reason not Specified|0|||
154936408|NCT03033069|559192859|FG003|Overall Study|Reason not Specified|1|||
154936409|NCT03053622|559194652|FG000|Overall Study|Lost to Follow-up|0|||
154936410|NCT03053622|559194653|FG001|Overall Study|Lost to Follow-up|0|||
154936411|NCT03053622|559194654|FG002|Overall Study|Lost to Follow-up|0|||
154936412|NCT03053622|559194655|FG003|Overall Study|Lost to Follow-up|1|||
154936413|NCT02290028|559194658|FG000|Overall Study|Death|217|||
154936414|NCT02290028|559194658|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
154936415|NCT02290028|559194658|FG000|Overall Study|No longer under care of study physician|76|||
154936416|NCT02290028|559194658|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
154936417|NCT02290028|559194658|FG000|Overall Study|Withdrawal by Subject|52|||
154936418|NCT02290028|559194658|FG000|Overall Study|Study site closure|44|||
154936419|NCT02290028|559194658|FG000|Overall Study|Lost to Follow-up|34|||
154936420|NCT02290028|559194658|FG000|Overall Study|Miscellaneous|10|||
154936421|NCT02290028|559194658|FG000|Overall Study|Transition to EP PASSION|1295|||
154936422|NCT02290028|559194658|FG000|Overall Study|Planned study completion at 12 months|257|||
154936423|NCT03862625|559194664|FG000|Overall Study|Lost to Follow-up|0|||
154936424|NCT03862625|559194665|FG001|Overall Study|Lost to Follow-up|1|||
154936425|NCT01326702|559194666|FG000|Overall Study|Other|1|||
154936426|NCT01326702|559194667|FG001|Overall Study|Other|0|||
154936427|NCT01326702|559194668|FG002|Overall Study|Other|0|||
154936428|NCT01326702|559194669|FG003|Overall Study|Other|0|||
154936429|NCT01326702|559194670|FG004|Overall Study|Other|0|||
154936430|NCT01326702|559194671|FG005|Overall Study|Other|1|||
154936431|NCT01326702|559194672|FG006|Overall Study|Other|0|||
154936432|NCT01326702|559194666|FG000|Overall Study|progressive disease|1|||
154936433|NCT01326702|559194667|FG001|Overall Study|progressive disease|1|||
154936434|NCT01326702|559194668|FG002|Overall Study|progressive disease|3|||
154936435|NCT01326702|559194669|FG003|Overall Study|progressive disease|1|||
154936436|NCT01326702|559194670|FG004|Overall Study|progressive disease|3|||
154936437|NCT01326702|559194671|FG005|Overall Study|progressive disease|2|||
154936438|NCT01326702|559194672|FG006|Overall Study|progressive disease|3|||
154936439|NCT01326702|559194666|FG000|Overall Study|Death|0|||
154936440|NCT01326702|559194667|FG001|Overall Study|Death|1|||
154936441|NCT01326702|559194668|FG002|Overall Study|Death|0|||
154936442|NCT01326702|559194669|FG003|Overall Study|Death|0|||
154936443|NCT01326702|559194670|FG004|Overall Study|Death|0|||
154936444|NCT01326702|559194671|FG005|Overall Study|Death|0|||
154936445|NCT01326702|559194672|FG006|Overall Study|Death|0|||
154936446|NCT01326702|559194666|FG000|Overall Study|Adverse Event|0|||
154936447|NCT01326702|559194667|FG001|Overall Study|Adverse Event|0|||
154936448|NCT01326702|559194668|FG002|Overall Study|Adverse Event|1|||
154936449|NCT01326702|559194669|FG003|Overall Study|Adverse Event|1|||
154936450|NCT01326702|559194670|FG004|Overall Study|Adverse Event|0|||
154936451|NCT01326702|559194671|FG005|Overall Study|Adverse Event|3|||
154936452|NCT01326702|559194672|FG006|Overall Study|Adverse Event|1|||
155273584|NCT04844918|560436361|FG000|Overall Study|Physician Decision|0|||
154936453|NCT01326702|559194666|FG000|Overall Study|Withdrawal by Subject|0|||
154936454|NCT01326702|559194667|FG001|Overall Study|Withdrawal by Subject|0|||
154936455|NCT01326702|559194668|FG002|Overall Study|Withdrawal by Subject|1|||
154936456|NCT01326702|559194669|FG003|Overall Study|Withdrawal by Subject|0|||
154936457|NCT01326702|559194670|FG004|Overall Study|Withdrawal by Subject|1|||
154936458|NCT01326702|559194671|FG005|Overall Study|Withdrawal by Subject|1|||
154936459|NCT01326702|559194672|FG006|Overall Study|Withdrawal by Subject|3|||
154936460|NCT01326702|559194666|FG000|Overall Study|Not Treated|0|||
154936461|NCT01326702|559194667|FG001|Overall Study|Not Treated|0|||
154936462|NCT01326702|559194668|FG002|Overall Study|Not Treated|0|||
154936463|NCT01326702|559194669|FG003|Overall Study|Not Treated|1|||
154936464|NCT01326702|559194670|FG004|Overall Study|Not Treated|0|||
154936465|NCT01326702|559194671|FG005|Overall Study|Not Treated|1|||
154936466|NCT01326702|559194672|FG006|Overall Study|Not Treated|0|||
154936467|NCT02082912|559194673|FG000|Overall Study|Physician Decision|0|||
154936468|NCT02082912|559194674|FG001|Overall Study|Physician Decision|1|||
154936469|NCT02614703|559194676|FG000|Overall Study|Withdrawal by Subject|7|||
154936470|NCT02614703|559194677|FG001|Overall Study|Withdrawal by Subject|1|||
154936471|NCT02402933|559194678|FG000|Overall Study|Withdrawal by Subject|4|||
154936472|NCT02402933|559194678|FG000|Overall Study|Discontinued; Site Termination|10|||
154936473|NCT01835132|559194689|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
154936474|NCT00856778|559194690|FG000|Overall Study|Adverse Event|7|||
154936475|NCT00856778|559194690|FG000|Overall Study|Withdrawal by Subject|10|||
154936476|NCT00856778|559194690|FG000|Overall Study|Study deviation|2|||
154936477|NCT00856778|559194690|FG000|Overall Study|Lost to Follow-up|5|||
154936478|NCT01681771|559194691|FG000|Overall Study|Lost to Follow-up|4|||
154936479|NCT01681771|559194692|FG001|Overall Study|Lost to Follow-up|2|||
154936480|NCT00265083|559194693|FG000|Overall Study|Adverse Event|5|||
154936481|NCT00265083|559194694|FG001|Overall Study|Adverse Event|13|||
154936482|NCT00265083|559194695|FG002|Overall Study|Adverse Event|15|||
154936483|NCT00265083|559194693|FG000|Overall Study|Lost to Follow-up|3|||
154936484|NCT00265083|559194694|FG001|Overall Study|Lost to Follow-up|4|||
154936485|NCT00265083|559194695|FG002|Overall Study|Lost to Follow-up|4|||
154936486|NCT00265083|559194693|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
154936487|NCT00265083|559194694|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
154936488|NCT00265083|559194695|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
154936489|NCT00265083|559194693|FG000|Overall Study|Other|1|||
154936490|NCT00265083|559194694|FG001|Overall Study|Other|12|||
154936491|NCT00265083|559194695|FG002|Overall Study|Other|9|||
154936492|NCT03208933|559194696|FG000|Overall Study|Death|3|||
154936493|NCT03208933|559194696|FG000|Overall Study|Withdrawal by Subject|3|||
154936494|NCT03208933|559194696|FG000|Overall Study|Adverse Event|1|||
154936495|NCT03208933|559194696|FG000|Overall Study|Lost to Follow-up|2|||
154936496|NCT03208933|559194696|FG000|Overall Study|Physician Decision|3|||
154936497|NCT03208933|559194696|FG000|Overall Study|Protocol Violation|1|||
154936498|NCT00830063|559194705|FG000|Overall Study|Adverse Event|7|||
154936499|NCT00830063|559194706|FG001|Overall Study|Adverse Event|13|||
154936500|NCT00830063|559194707|FG002|Overall Study|Adverse Event|16|||
154936501|NCT00830063|559194708|FG003|Overall Study|Adverse Event|13|||
154936502|NCT00830063|559194705|FG000|Overall Study|Death|1|||
154936503|NCT00830063|559194706|FG001|Overall Study|Death|0|||
154936504|NCT00830063|559194707|FG002|Overall Study|Death|0|||
154936505|NCT00830063|559194708|FG003|Overall Study|Death|0|||
154936506|NCT00830063|559194705|FG000|Overall Study|Lost to Follow-up|0|||
154936507|NCT00830063|559194706|FG001|Overall Study|Lost to Follow-up|0|||
154936508|NCT00830063|559194707|FG002|Overall Study|Lost to Follow-up|3|||
154936509|NCT00830063|559194708|FG003|Overall Study|Lost to Follow-up|1|||
154936510|NCT00830063|559194705|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
154936511|NCT00830063|559194706|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
154936512|NCT00830063|559194707|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
154936513|NCT00830063|559194708|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
154936514|NCT00830063|559194705|FG000|Overall Study|Lack of Efficacy|51|||
154936515|NCT00830063|559194706|FG001|Overall Study|Lack of Efficacy|23|||
154936516|NCT00830063|559194707|FG002|Overall Study|Lack of Efficacy|25|||
155273585|NCT04844918|560436362|FG001|Overall Study|Physician Decision|1|||
155273586|NCT04844918|560436363|FG002|Overall Study|Physician Decision|0|||
155273587|NCT04844918|560436361|FG000|Overall Study|Withdrawal by Subject|6|||
155273588|NCT04844918|560436362|FG001|Overall Study|Withdrawal by Subject|3|||
155273589|NCT04844918|560436363|FG002|Overall Study|Withdrawal by Subject|3|||
155273590|NCT04844918|560436361|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
155273591|NCT04844918|560436362|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
155273592|NCT04844918|560436363|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
155273593|NCT01009047|560436367|FG000|Overall Study|Adverse Event|5|||
155273594|NCT01009047|560436368|FG001|Overall Study|Adverse Event|0|||
155273595|NCT01009047|560436367|FG000|Overall Study|Lost to Follow-up|0|||
155273596|NCT01009047|560436368|FG001|Overall Study|Lost to Follow-up|2|||
155273597|NCT01009047|560436367|FG000|Overall Study|Lack of Efficacy|4|||
155273598|NCT01009047|560436368|FG001|Overall Study|Lack of Efficacy|11|||
155381933|NCT00598273|560833242|FG000|Overall Study|Adverse Event|4|||
155043425|NCT01826981|559590131|FG009|Overall Study|Lack of Efficacy|0|||
154936517|NCT00830063|559194708|FG003|Overall Study|Lack of Efficacy|32|||
155043426|NCT01826981|559590132|FG010|Overall Study|Lack of Efficacy|1|||
155273599|NCT01009047|560436367|FG000|Overall Study|Withdrawal by consent|16|||
155273600|NCT01009047|560436368|FG001|Overall Study|Withdrawal by consent|11|||
155273601|NCT01009047|560436367|FG000|Overall Study|Other|3|||
154936518|NCT00830063|559194705|FG000|Overall Study|Other|5|||
154936519|NCT00830063|559194706|FG001|Overall Study|Other|5|||
154936520|NCT00830063|559194707|FG002|Overall Study|Other|8|||
154936521|NCT00830063|559194708|FG003|Overall Study|Other|6|||
154936522|NCT00830063|559194705|FG000|Overall Study|Withdrawal by Subject|16|||
155043427|NCT01826981|559590133|FG011|Overall Study|Lack of Efficacy|0|||
155273602|NCT01009047|560436368|FG001|Overall Study|Other|2|||
155273603|NCT04716881|560436370|FG000|Overall Study|Adverse Event|1|||
155273604|NCT04716881|560436370|FG000|Overall Study|Lost to Follow-up|1|||
155273605|NCT01630590|560436374|FG000|Overall Study|Adverse Event|9|||
155273606|NCT01630590|560436374|FG000|Overall Study|Lack of Efficacy|37|||
155273607|NCT01630590|560436374|FG000|Overall Study|Withdrawal by Subject|4|||
155273608|NCT01630590|560436374|FG000|Overall Study|2nd primary tumor|2|||
155273609|NCT01630590|560436374|FG000|Overall Study|Automobile accident|1|||
155273610|NCT01630590|560436374|FG000|Overall Study|Maximum benefit|4|||
155273611|NCT02366936|560436376|FG000|Overall Study|Withdrawal by Subject|2|||
155273612|NCT02366936|560436376|FG000|Overall Study|Lost to Follow-up|4|||
155273613|NCT02366936|560436376|FG000|Overall Study|Physician Decision|2|||
155273614|NCT01751113|560436377|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273615|NCT01751113|560436378|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273616|NCT01751113|560436379|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273617|NCT01751113|560436380|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
155273618|NCT01751113|560436381|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
155273619|NCT01751113|560436382|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155273620|NCT01751113|560436377|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273621|NCT01751113|560436378|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273622|NCT01751113|560436379|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273623|NCT01751113|560436380|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273624|NCT01751113|560436381|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
155273625|NCT01751113|560436382|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
155273626|NCT02878213|560436383|FG000|Overall Study|Withdrawal by Subject|2|||
155273627|NCT02878213|560436383|FG000|Overall Study|Adverse Event|1|||
155273628|NCT00363896|560436384|FG000|Overall Study|Withdrawal by Subject|29|||
155273629|NCT00363896|560436385|FG001|Overall Study|Withdrawal by Subject|16|||
155273630|NCT00363896|560436384|FG000|Overall Study|Adverse Event|24|||
155273631|NCT00363896|560436385|FG001|Overall Study|Adverse Event|13|||
155273632|NCT00363896|560436384|FG000|Overall Study|COPD exacerbation|13|||
155273633|NCT00363896|560436385|FG001|Overall Study|COPD exacerbation|7|||
155273634|NCT00363896|560436384|FG000|Overall Study|Lack of Efficacy|12|||
155273635|NCT00363896|560436385|FG001|Overall Study|Lack of Efficacy|8|||
155273636|NCT00363896|560436384|FG000|Overall Study|Protocol Violation|6|||
155273637|NCT00363896|560436385|FG001|Overall Study|Protocol Violation|1|||
155273638|NCT00363896|560436384|FG000|Overall Study|Lost to Follow-up|3|||
155273639|NCT00363896|560436385|FG001|Overall Study|Lost to Follow-up|0|||
155273640|NCT00363896|560436384|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
155273641|NCT00363896|560436385|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
155273642|NCT00363896|560436384|FG000|Overall Study|Other|1|||
155273643|NCT00363896|560436385|FG001|Overall Study|Other|2|||
155273644|NCT01558674|560436386|FG000|Part 1|Study Terminated by Sponsor|10|||
155273645|NCT01558674|560436387|FG001|Part 1|Study Terminated by Sponsor|0|||
155273646|NCT01558674|560436386|FG000|Part 1|Withdrawal by Subject|1|||
155273647|NCT01558674|560436387|FG001|Part 1|Withdrawal by Subject|0|||
155273648|NCT00785538|560436388|FG000|Treatment Period|Adverse Event|1|||
155273649|NCT00785538|560436389|FG001|Treatment Period|Adverse Event|2|||
155273650|NCT00785538|560436390|FG002|Treatment Period|Adverse Event|2|||
155273651|NCT00785538|560436391|FG003|Treatment Period|Adverse Event|0|||
155273652|NCT00785538|560436388|FG000|Treatment Period|Withdrawal by Subject|0|||
155273653|NCT00785538|560436389|FG001|Treatment Period|Withdrawal by Subject|0|||
155273654|NCT00785538|560436390|FG002|Treatment Period|Withdrawal by Subject|0|||
155273655|NCT00785538|560436391|FG003|Treatment Period|Withdrawal by Subject|1|||
155273656|NCT00322374|560436392|FG000|Starting Dose|Physician Decision|2|||
155273657|NCT00322374|560436393|FG001|Starting Dose|Physician Decision|0|||
155273658|NCT00322374|560436394|FG002|Starting Dose|Physician Decision|0|||
155273659|NCT00322374|560436395|FG003|Starting Dose|Physician Decision|0|||
155273660|NCT00322374|560436392|FG000|Starting Dose|Study Drug Toxicity|4|||
155273661|NCT00322374|560436393|FG001|Starting Dose|Study Drug Toxicity|0|||
155273662|NCT00322374|560436394|FG002|Starting Dose|Study Drug Toxicity|0|||
155273663|NCT00322374|560436395|FG003|Starting Dose|Study Drug Toxicity|0|||
155273664|NCT00322374|560436392|FG000|First Escalation|Documented Disease Progression|0|||
155273665|NCT00322374|560436393|FG001|First Escalation|Documented Disease Progression|6|||
155273666|NCT00322374|560436394|FG002|First Escalation|Documented Disease Progression|0|||
155273667|NCT00322374|560436395|FG003|First Escalation|Documented Disease Progression|0|||
155273668|NCT00322374|560436392|FG000|First Escalation|Physician Decision|0|||
155273669|NCT00322374|560436393|FG001|First Escalation|Physician Decision|12|||
155381934|NCT00598273|560833243|FG001|Overall Study|Adverse Event|5|||
155273670|NCT00322374|560436394|FG002|First Escalation|Physician Decision|0|||
155273671|NCT00322374|560436395|FG003|First Escalation|Physician Decision|0|||
155273672|NCT00322374|560436392|FG000|First Escalation|Study Drug Toxicity|0|||
155273673|NCT00322374|560436393|FG001|First Escalation|Study Drug Toxicity|11|||
155273674|NCT00322374|560436394|FG002|First Escalation|Study Drug Toxicity|0|||
155273675|NCT00322374|560436395|FG003|First Escalation|Study Drug Toxicity|0|||
155273676|NCT00322374|560436392|FG000|First Escalation|Participant Request|0|||
155273677|NCT00322374|560436393|FG001|First Escalation|Participant Request|1|||
155273678|NCT00322374|560436394|FG002|First Escalation|Participant Request|0|||
155273679|NCT00322374|560436395|FG003|First Escalation|Participant Request|0|||
155273680|NCT00322374|560436392|FG000|Second Escalation|Physician Decision|0|||
155273681|NCT00322374|560436393|FG001|Second Escalation|Physician Decision|0|||
155273682|NCT00322374|560436394|FG002|Second Escalation|Physician Decision|5|||
155273683|NCT00322374|560436395|FG003|Second Escalation|Physician Decision|0|||
155273684|NCT00322374|560436392|FG000|Second Escalation|Study Drug Toxicity|0|||
155273685|NCT00322374|560436393|FG001|Second Escalation|Study Drug Toxicity|0|||
155273686|NCT00322374|560436394|FG002|Second Escalation|Study Drug Toxicity|1|||
155273687|NCT00322374|560436395|FG003|Second Escalation|Study Drug Toxicity|0|||
155273688|NCT01000376|560436399|FG000|Cycle 1 Day 1|Adverse Event|1|||
155273689|NCT01000376|560436400|FG001|Cycle 1 Day 1|Adverse Event|0|||
155273690|NCT01000376|560436399|FG000|Cycle 1 Day 1|Progressive Disease|1|||
154936523|NCT00830063|559194706|FG001|Overall Study|Withdrawal by Subject|10|||
154936524|NCT00830063|559194707|FG002|Overall Study|Withdrawal by Subject|16|||
154936525|NCT00830063|559194708|FG003|Overall Study|Withdrawal by Subject|13|||
154936526|NCT00830063|559194705|FG000|Overall Study|Protocol Violation|1|||
154936527|NCT00830063|559194706|FG001|Overall Study|Protocol Violation|0|||
154936528|NCT00830063|559194707|FG002|Overall Study|Protocol Violation|3|||
154936529|NCT00830063|559194708|FG003|Overall Study|Protocol Violation|2|||
154936530|NCT00830063|559194705|FG000|Overall Study|Randomized But Not Treated|0|||
154936531|NCT00830063|559194706|FG001|Overall Study|Randomized But Not Treated|2|||
154936532|NCT00830063|559194707|FG002|Overall Study|Randomized But Not Treated|0|||
154936533|NCT00830063|559194708|FG003|Overall Study|Randomized But Not Treated|2|||
154936534|NCT01814761|559194709|FG000|Overall Study|Other Reasons|1|||
154936535|NCT01814761|559194710|FG001|Overall Study|Other Reasons|10|||
154936536|NCT01814761|559194709|FG000|Overall Study|Ocular Adverse Event|6|||
154936537|NCT01814761|559194710|FG001|Overall Study|Ocular Adverse Event|15|||
154936538|NCT01814761|559194709|FG000|Overall Study|Lost to Follow-up|1|||
154936539|NCT01814761|559194710|FG001|Overall Study|Lost to Follow-up|5|||
154936540|NCT01059071|559194711|FG000|Overall Study|Lack of Efficacy|1|||
154936541|NCT01059071|559194712|FG001|Overall Study|Lack of Efficacy|4|||
154936542|NCT01059071|559194713|FG002|Overall Study|Lack of Efficacy|2|||
154936543|NCT01059071|559194714|FG003|Overall Study|Lack of Efficacy|3|||
154936544|NCT01059071|559194711|FG000|Overall Study|Withdrawal by Subject|1|||
154936545|NCT01059071|559194712|FG001|Overall Study|Withdrawal by Subject|0|||
154936546|NCT01059071|559194713|FG002|Overall Study|Withdrawal by Subject|0|||
154936547|NCT01059071|559194714|FG003|Overall Study|Withdrawal by Subject|2|||
154936548|NCT01059071|559194711|FG000|Overall Study|Physician Decision|0|||
154936549|NCT01059071|559194712|FG001|Overall Study|Physician Decision|0|||
154936550|NCT01059071|559194713|FG002|Overall Study|Physician Decision|0|||
154936551|NCT01059071|559194714|FG003|Overall Study|Physician Decision|1|||
154936552|NCT02962882|559194715|FG000|Overall Study|Adverse Event|2|||
154936553|NCT02962882|559194715|FG000|Overall Study|Withdrawal by Subject|2|||
154936554|NCT02962882|559194715|FG000|Overall Study|Transfer from ICU|32|||
154936555|NCT03763331|559194716|FG000|Overall Study|Lost to Follow-up|1|||
154936556|NCT03763331|559194717|FG001|Overall Study|Lost to Follow-up|0|||
154936557|NCT03763331|559194716|FG000|Overall Study|Withdrawal by Subject|1|||
154936558|NCT03763331|559194717|FG001|Overall Study|Withdrawal by Subject|0|||
154936559|NCT03763331|559194716|FG000|Overall Study|Non-compliance|0|||
154936560|NCT03763331|559194717|FG001|Overall Study|Non-compliance|3|||
154936561|NCT00936884|559194718|FG000|Double-blind|Withdrawal by Subject|6|||
154936562|NCT00936884|559194719|FG001|Double-blind|Withdrawal by Subject|4|||
154936563|NCT00936884|559194720|FG002|Double-blind|Withdrawal by Subject|0|||
154936564|NCT00936884|559194718|FG000|Double-blind|Death|2|||
154936565|NCT00936884|559194719|FG001|Double-blind|Death|1|||
154936566|NCT00936884|559194720|FG002|Double-blind|Death|0|||
154936567|NCT00936884|559194718|FG000|Double-blind|Lack of Efficacy|1|||
154936568|NCT00936884|559194719|FG001|Double-blind|Lack of Efficacy|1|||
154936569|NCT00936884|559194720|FG002|Double-blind|Lack of Efficacy|0|||
154936570|NCT00936884|559194718|FG000|Double-blind|Adverse Event|1|||
154936571|NCT00936884|559194719|FG001|Double-blind|Adverse Event|0|||
154936572|NCT00936884|559194720|FG002|Double-blind|Adverse Event|0|||
154936573|NCT00936884|559194718|FG000|Double-blind|Physician Decision|1|||
154936574|NCT00936884|559194719|FG001|Double-blind|Physician Decision|0|||
155273691|NCT01000376|560436400|FG001|Cycle 1 Day 1|Progressive Disease|0|||
155273692|NCT02269943|560436401|FG000|Treatment Period|Death|0|||
154936575|NCT00936884|559194720|FG002|Double-blind|Physician Decision|0|||
154936576|NCT00936884|559194718|FG000|Double-blind|No post baseline diary entry|1|||
154936577|NCT00936884|559194719|FG001|Double-blind|No post baseline diary entry|0|||
154936578|NCT00936884|559194720|FG002|Double-blind|No post baseline diary entry|0|||
154936579|NCT00936884|559194718|FG000|Double-blind|Did not receive study drug|0|||
154936580|NCT00936884|559194719|FG001|Double-blind|Did not receive study drug|1|||
154936581|NCT00936884|559194720|FG002|Double-blind|Did not receive study drug|0|||
154936582|NCT04741503|559194721|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
154936583|NCT04741503|559194722|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
154936584|NCT04741503|559194723|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
155273693|NCT02269943|560436402|FG001|Treatment Period|Death|1|||
155273694|NCT02269943|560436401|FG000|Treatment Period|Adverse Event|1|||
155273695|NCT02269943|560436402|FG001|Treatment Period|Adverse Event|10|||
155273696|NCT02269943|560436401|FG000|Treatment Period|Progressive Disease|5|||
155273697|NCT02269943|560436402|FG001|Treatment Period|Progressive Disease|17|||
155273698|NCT02269943|560436401|FG000|Treatment Period|Symptomatic Deterioration|0|||
155273699|NCT02269943|560436402|FG001|Treatment Period|Symptomatic Deterioration|2|||
155273700|NCT02269943|560436401|FG000|Follow-Up Survival Period|Death|3|||
155273701|NCT02269943|560436402|FG001|Follow-Up Survival Period|Death|16|||
155273702|NCT02269943|560436401|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
155273703|NCT02269943|560436402|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
155273704|NCT02269943|560436401|FG000|Follow-Up Survival Period|Alive|2|||
155273705|NCT02269943|560436402|FG001|Follow-Up Survival Period|Alive|8|||
155273706|NCT04285229|560436404|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155273707|NCT04285229|560436405|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273708|NCT04285229|560436406|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273709|NCT04285229|560436407|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273710|NCT04285229|560436408|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273711|NCT04285229|560436409|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155273712|NCT04285229|560436404|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
155273713|NCT04285229|560436405|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
155273714|NCT04285229|560436406|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
155273715|NCT04285229|560436407|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
155273716|NCT04285229|560436408|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
155273717|NCT04285229|560436409|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
155273718|NCT04285229|560436404|FG000|Extended Treatment Period|Adverse Event|0|||
155273719|NCT04285229|560436405|FG001|Extended Treatment Period|Adverse Event|0|||
155273720|NCT04285229|560436406|FG002|Extended Treatment Period|Adverse Event|0|||
155273721|NCT04285229|560436407|FG003|Extended Treatment Period|Adverse Event|1|||
155273722|NCT04285229|560436408|FG004|Extended Treatment Period|Adverse Event|0|||
155273723|NCT04285229|560436409|FG005|Extended Treatment Period|Adverse Event|0|||
155273724|NCT04285229|560436404|FG000|Extended Treatment Period|Physician Decision|0|||
155273725|NCT04285229|560436405|FG001|Extended Treatment Period|Physician Decision|0|||
155273726|NCT04285229|560436406|FG002|Extended Treatment Period|Physician Decision|1|||
155273727|NCT04285229|560436407|FG003|Extended Treatment Period|Physician Decision|0|||
155273728|NCT04285229|560436408|FG004|Extended Treatment Period|Physician Decision|0|||
155273729|NCT04285229|560436409|FG005|Extended Treatment Period|Physician Decision|0|||
155273730|NCT04285229|560436404|FG000|Follow-up Period|Adverse Event|0|||
155273731|NCT04285229|560436405|FG001|Follow-up Period|Adverse Event|0|||
155273732|NCT04285229|560436406|FG002|Follow-up Period|Adverse Event|0|||
155273733|NCT04285229|560436407|FG003|Follow-up Period|Adverse Event|0|||
155273734|NCT04285229|560436408|FG004|Follow-up Period|Adverse Event|1|||
155273735|NCT04285229|560436409|FG005|Follow-up Period|Adverse Event|4|||
155273736|NCT04285229|560436404|FG000|Follow-up Period|Withdrawal by Subject|0|||
155273737|NCT04285229|560436405|FG001|Follow-up Period|Withdrawal by Subject|0|||
155273738|NCT04285229|560436406|FG002|Follow-up Period|Withdrawal by Subject|0|||
155273739|NCT04285229|560436407|FG003|Follow-up Period|Withdrawal by Subject|0|||
155273740|NCT04285229|560436408|FG004|Follow-up Period|Withdrawal by Subject|0|||
155273741|NCT04285229|560436409|FG005|Follow-up Period|Withdrawal by Subject|5|||
155273742|NCT04285229|560436404|FG000|Follow-up Period|Covid-19|0|||
155273743|NCT04285229|560436405|FG001|Follow-up Period|Covid-19|0|||
155273744|NCT04285229|560436406|FG002|Follow-up Period|Covid-19|0|||
155273745|NCT04285229|560436407|FG003|Follow-up Period|Covid-19|0|||
155273746|NCT04285229|560436408|FG004|Follow-up Period|Covid-19|0|||
155273747|NCT04285229|560436409|FG005|Follow-up Period|Covid-19|2|||
155273748|NCT04285229|560436404|FG000|Follow-up Period|Physician Decision|0|||
155273749|NCT04285229|560436405|FG001|Follow-up Period|Physician Decision|0|||
155273750|NCT04285229|560436406|FG002|Follow-up Period|Physician Decision|0|||
155273751|NCT04285229|560436407|FG003|Follow-up Period|Physician Decision|0|||
155273752|NCT04285229|560436408|FG004|Follow-up Period|Physician Decision|0|||
155273753|NCT04285229|560436409|FG005|Follow-up Period|Physician Decision|1|||
155273754|NCT04793464|560436410|FG000|Overall Study|Lost to Follow-up|458|||
155273755|NCT04793464|560436411|FG001|Overall Study|Lost to Follow-up|168|||
155273756|NCT04793464|560436412|FG002|Overall Study|Lost to Follow-up|5|||
155273757|NCT04793464|560436410|FG000|Overall Study|Withdrawal by Subject|43|||
155273758|NCT04793464|560436411|FG001|Overall Study|Withdrawal by Subject|15|||
155273759|NCT04793464|560436412|FG002|Overall Study|Withdrawal by Subject|0|||
155273760|NCT00845871|560436415|FG000|Assessment Period|Adverse Event|2|||
155273761|NCT00845871|560436415|FG000|Assessment Period|Abnormal laboratory values|1|||
155273762|NCT00845871|560436415|FG000|Assessment Period|Abnormal test procedure results|1|||
155273763|NCT00845871|560436415|FG000|Assessment Period|Patient withdrew consent|3|||
155273764|NCT04318093|560436418|FG000|Overall Study|Adverse Event|2|||
155273765|NCT04318093|560436419|FG001|Overall Study|Adverse Event|2|||
155273766|NCT04318093|560436418|FG000|Overall Study|Participant withdrew consent|1|||
155043428|NCT01826981|559590134|FG012|Overall Study|Lack of Efficacy|0|||
155043429|NCT01826981|559590135|FG013|Overall Study|Lack of Efficacy|3|||
155273767|NCT04318093|560436419|FG001|Overall Study|Participant withdrew consent|0|||
155273768|NCT04318093|560436418|FG000|Overall Study|Other reasons|0|||
155273769|NCT04318093|560436419|FG001|Overall Study|Other reasons|1|||
155273770|NCT00655551|560436424|FG000|All Periods Combined|Adverse Event|0|||
155273771|NCT00655551|560436425|FG001|All Periods Combined|Adverse Event|3|||
155273772|NCT00655551|560436426|FG002|All Periods Combined|Adverse Event|4|||
155273773|NCT00655551|560436424|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
155273774|NCT00655551|560436425|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
155273775|NCT00655551|560436426|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
155273776|NCT00655551|560436424|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
155273777|NCT00655551|560436425|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
155273778|NCT00655551|560436426|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
155273779|NCT00655551|560436424|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
155273780|NCT00655551|560436425|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
155273781|NCT00655551|560436426|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
155273782|NCT01734434|560436427|FG000|Overall Study|Death Infant|3|||
155273783|NCT01734434|560436428|FG001|Overall Study|Death Infant|1|||
155273784|NCT01734434|560436429|FG002|Overall Study|Death Infant|17|||
155273785|NCT01734434|560436430|FG003|Overall Study|Death Infant|5|||
155273786|NCT01734434|560436427|FG000|Overall Study|Lost to Follow-up|2|||
155273787|NCT01734434|560436428|FG001|Overall Study|Lost to Follow-up|9|||
155273788|NCT01734434|560436429|FG002|Overall Study|Lost to Follow-up|67|||
155273789|NCT01734434|560436430|FG003|Overall Study|Lost to Follow-up|11|||
155273790|NCT01734434|560436427|FG000|Overall Study|No Live Birth|1|||
155273791|NCT01734434|560436428|FG001|Overall Study|No Live Birth|2|||
155273792|NCT01734434|560436429|FG002|Overall Study|No Live Birth|32|||
155273793|NCT01734434|560436430|FG003|Overall Study|No Live Birth|6|||
155273794|NCT01734434|560436427|FG000|Overall Study|Withdrawal by Subject|4|||
155273795|NCT01734434|560436428|FG001|Overall Study|Withdrawal by Subject|0|||
155273796|NCT01734434|560436429|FG002|Overall Study|Withdrawal by Subject|8|||
155273797|NCT01734434|560436430|FG003|Overall Study|Withdrawal by Subject|1|||
155273798|NCT01734434|560436427|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
155273799|NCT01734434|560436428|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
155273800|NCT01734434|560436429|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
155273801|NCT01734434|560436430|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
155273802|NCT01734434|560436427|FG000|Overall Study|Subject Not Reachable|0|||
155273803|NCT01734434|560436428|FG001|Overall Study|Subject Not Reachable|0|||
155273804|NCT01734434|560436429|FG002|Overall Study|Subject Not Reachable|1|||
155273805|NCT01734434|560436430|FG003|Overall Study|Subject Not Reachable|0|||
155273806|NCT01734434|560436427|FG000|Overall Study|Treatment Defaulter|0|||
155273807|NCT01734434|560436428|FG001|Overall Study|Treatment Defaulter|0|||
155273808|NCT01734434|560436429|FG002|Overall Study|Treatment Defaulter|1|||
155273809|NCT01734434|560436430|FG003|Overall Study|Treatment Defaulter|0|||
155273810|NCT01734434|560436427|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
155273811|NCT01734434|560436428|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
155273812|NCT01734434|560436429|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
155273813|NCT01734434|560436430|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
155273814|NCT01734434|560436427|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
155273815|NCT01734434|560436428|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
155273816|NCT01734434|560436429|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
155273817|NCT01734434|560436430|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
155273818|NCT02855164|560436431|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273819|NCT02855164|560436432|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273820|NCT02855164|560436433|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
155273821|NCT02855164|560436434|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
155273822|NCT02855164|560436435|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
155273823|NCT02855164|560436436|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273824|NCT02855164|560436437|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273825|NCT02855164|560436438|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
155273826|NCT02855164|560436431|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
155273827|NCT02855164|560436432|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
155273828|NCT02855164|560436433|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
155273829|NCT02855164|560436434|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
155273830|NCT02855164|560436435|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
155273831|NCT02855164|560436436|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
155273832|NCT02855164|560436437|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
155273833|NCT02855164|560436438|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
155273834|NCT02855164|560436431|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
155273835|NCT02855164|560436432|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
155273836|NCT02855164|560436433|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
155273837|NCT02855164|560436434|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
155273838|NCT02855164|560436435|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
155381935|NCT00598273|560833244|FG002|Overall Study|Adverse Event|2|||
155273839|NCT02855164|560436436|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
155273840|NCT02855164|560436437|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
155273841|NCT02855164|560436438|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
155273842|NCT02855164|560436431|FG000|Part C (Randomized Set)|Adverse Event|0|||
155273843|NCT02855164|560436432|FG001|Part C (Randomized Set)|Adverse Event|0|||
155273844|NCT02855164|560436433|FG002|Part C (Randomized Set)|Adverse Event|0|||
155273845|NCT02855164|560436434|FG003|Part C (Randomized Set)|Adverse Event|0|||
155273846|NCT02855164|560436435|FG004|Part C (Randomized Set)|Adverse Event|0|||
155273847|NCT02855164|560436436|FG005|Part C (Randomized Set)|Adverse Event|5|||
155273848|NCT02855164|560436437|FG006|Part C (Randomized Set)|Adverse Event|9|||
155273849|NCT02855164|560436438|FG007|Part C (Randomized Set)|Adverse Event|2|||
155273850|NCT02855164|560436431|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
155273851|NCT02855164|560436432|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
155273852|NCT02855164|560436433|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
155273853|NCT02855164|560436434|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
155273854|NCT02855164|560436435|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
155273855|NCT02855164|560436436|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
155273856|NCT02855164|560436437|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
155273857|NCT02855164|560436438|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
155273858|NCT02855164|560436431|FG000|Part C (Randomized Set)|Physician Decision|0|||
155273859|NCT02855164|560436432|FG001|Part C (Randomized Set)|Physician Decision|0|||
155273860|NCT02855164|560436433|FG002|Part C (Randomized Set)|Physician Decision|0|||
155273861|NCT02855164|560436434|FG003|Part C (Randomized Set)|Physician Decision|0|||
155273862|NCT02855164|560436435|FG004|Part C (Randomized Set)|Physician Decision|0|||
155273863|NCT02855164|560436436|FG005|Part C (Randomized Set)|Physician Decision|1|||
155273864|NCT02855164|560436437|FG006|Part C (Randomized Set)|Physician Decision|0|||
155273865|NCT02855164|560436438|FG007|Part C (Randomized Set)|Physician Decision|1|||
155273866|NCT02855164|560436431|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273867|NCT02855164|560436432|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273868|NCT02855164|560436433|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273869|NCT02855164|560436434|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273870|NCT02855164|560436435|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
155273871|NCT02855164|560436436|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
155273872|NCT02855164|560436437|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
155273873|NCT02855164|560436438|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
155273874|NCT00876460|560436439|FG000|Combination Therapy Phase|Progressive disease|2|||
155273875|NCT00876460|560436440|FG001|Combination Therapy Phase|Progressive disease|3|||
155273876|NCT00876460|560436441|FG002|Combination Therapy Phase|Progressive disease|3|||
155273877|NCT00876460|560436442|FG003|Combination Therapy Phase|Progressive disease|3|||
155273878|NCT00876460|560436443|FG004|Combination Therapy Phase|Progressive disease|3|||
155273879|NCT00876460|560436444|FG005|Combination Therapy Phase|Progressive disease|1|||
155273880|NCT00876460|560436445|FG006|Combination Therapy Phase|Progressive disease|1|||
155273881|NCT00876460|560436446|FG007|Combination Therapy Phase|Progressive disease|1|||
155273882|NCT00876460|560436439|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
155273883|NCT00876460|560436440|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
155273884|NCT00876460|560436441|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
155273885|NCT00876460|560436442|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
155273886|NCT00876460|560436443|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
155273887|NCT00876460|560436444|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
155273888|NCT00876460|560436445|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
155273889|NCT00876460|560436446|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
155273890|NCT00876460|560436439|FG000|Combination Therapy Phase|Adverse Event|0|||
155273891|NCT00876460|560436440|FG001|Combination Therapy Phase|Adverse Event|2|||
155273892|NCT00876460|560436441|FG002|Combination Therapy Phase|Adverse Event|0|||
155273893|NCT00876460|560436442|FG003|Combination Therapy Phase|Adverse Event|2|||
155273894|NCT00876460|560436443|FG004|Combination Therapy Phase|Adverse Event|2|||
155273895|NCT00876460|560436444|FG005|Combination Therapy Phase|Adverse Event|0|||
155273896|NCT00876460|560436445|FG006|Combination Therapy Phase|Adverse Event|3|||
155273897|NCT00876460|560436446|FG007|Combination Therapy Phase|Adverse Event|2|||
155273898|NCT00876460|560436439|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
155273899|NCT00876460|560436440|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
155273900|NCT00876460|560436441|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
155273901|NCT00876460|560436442|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
155273902|NCT00876460|560436443|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
155273903|NCT00876460|560436444|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
155273904|NCT00876460|560436445|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
155273905|NCT00876460|560436446|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
155273906|NCT00876460|560436439|FG000|Combination Therapy Phase|Other reason not defined above|0|||
155273907|NCT00876460|560436440|FG001|Combination Therapy Phase|Other reason not defined above|0|||
155273908|NCT00876460|560436441|FG002|Combination Therapy Phase|Other reason not defined above|0|||
155273909|NCT00876460|560436442|FG003|Combination Therapy Phase|Other reason not defined above|0|||
155273910|NCT00876460|560436443|FG004|Combination Therapy Phase|Other reason not defined above|0|||
155273911|NCT00876460|560436444|FG005|Combination Therapy Phase|Other reason not defined above|0|||
155273912|NCT00876460|560436445|FG006|Combination Therapy Phase|Other reason not defined above|1|||
155273913|NCT00876460|560436446|FG007|Combination Therapy Phase|Other reason not defined above|2|||
155273914|NCT00876460|560436439|FG000|Combination Therapy Phase|Not treated|0|||
155273915|NCT00876460|560436440|FG001|Combination Therapy Phase|Not treated|0|||
155273916|NCT00876460|560436441|FG002|Combination Therapy Phase|Not treated|0|||
155273917|NCT00876460|560436442|FG003|Combination Therapy Phase|Not treated|0|||
155273918|NCT00876460|560436443|FG004|Combination Therapy Phase|Not treated|0|||
155273919|NCT00876460|560436444|FG005|Combination Therapy Phase|Not treated|0|||
155273920|NCT00876460|560436445|FG006|Combination Therapy Phase|Not treated|1|||
155273921|NCT00876460|560436446|FG007|Combination Therapy Phase|Not treated|0|||
155273922|NCT00876460|560436439|FG000|Mono Therapy Phase|Progressive disease|0|||
155273923|NCT00876460|560436440|FG001|Mono Therapy Phase|Progressive disease|0|||
155273924|NCT00876460|560436441|FG002|Mono Therapy Phase|Progressive disease|0|||
155273925|NCT00876460|560436442|FG003|Mono Therapy Phase|Progressive disease|0|||
155273926|NCT00876460|560436443|FG004|Mono Therapy Phase|Progressive disease|2|||
155273927|NCT00876460|560436444|FG005|Mono Therapy Phase|Progressive disease|0|||
155273928|NCT00876460|560436445|FG006|Mono Therapy Phase|Progressive disease|1|||
155273929|NCT00876460|560436446|FG007|Mono Therapy Phase|Progressive disease|3|||
155273930|NCT00876460|560436439|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
155273931|NCT00876460|560436440|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
155273932|NCT00876460|560436441|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
155273933|NCT00876460|560436442|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
155273934|NCT00876460|560436443|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
155273935|NCT00876460|560436444|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
154936585|NCT04741503|559194721|FG000|Initial Enrollment|Overquotas removed|0|||
154936586|NCT04741503|559194722|FG001|Initial Enrollment|Overquotas removed|0|||
154936587|NCT04741503|559194723|FG002|Initial Enrollment|Overquotas removed|186|||
154936588|NCT04741503|559194721|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
155273936|NCT00876460|560436445|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
155273937|NCT00876460|560436446|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
155273938|NCT00876460|560436439|FG000|Mono Therapy Phase|Adverse Event|0|||
155273939|NCT00876460|560436440|FG001|Mono Therapy Phase|Adverse Event|0|||
155273940|NCT00876460|560436441|FG002|Mono Therapy Phase|Adverse Event|0|||
155273941|NCT00876460|560436442|FG003|Mono Therapy Phase|Adverse Event|1|||
155273942|NCT00876460|560436443|FG004|Mono Therapy Phase|Adverse Event|0|||
155273943|NCT00876460|560436444|FG005|Mono Therapy Phase|Adverse Event|0|||
155273944|NCT00876460|560436445|FG006|Mono Therapy Phase|Adverse Event|0|||
155273945|NCT00876460|560436446|FG007|Mono Therapy Phase|Adverse Event|0|||
155273946|NCT02049710|560436451|FG000|Overall Study|Lost to Follow-up|319|||
155273947|NCT02049710|560436452|FG001|Overall Study|Lost to Follow-up|324|||
155273948|NCT00003458|560436453|FG000|Overall Study|Not evaluable|4|||
155273949|NCT01216293|560436454|FG000|Main Study|Adverse Event|1|||
155273950|NCT01216293|560436455|FG001|Main Study|Adverse Event|4|||
155273951|NCT01216293|560436456|FG002|Main Study|Adverse Event|2|||
155273952|NCT01216293|560436454|FG000|Main Study|Major Protocol Deviation|1|||
155273953|NCT01216293|560436455|FG001|Main Study|Major Protocol Deviation|0|||
155273954|NCT01216293|560436456|FG002|Main Study|Major Protocol Deviation|1|||
155273955|NCT01216293|560436454|FG000|Main Study|Lost to Follow-up|3|||
155273956|NCT01216293|560436455|FG001|Main Study|Lost to Follow-up|1|||
155273957|NCT01216293|560436456|FG002|Main Study|Lost to Follow-up|0|||
155273958|NCT01216293|560436454|FG000|Main Study|Voluntary Withdrawal|2|||
155273959|NCT01216293|560436455|FG001|Main Study|Voluntary Withdrawal|2|||
155273960|NCT01216293|560436456|FG002|Main Study|Voluntary Withdrawal|2|||
155273961|NCT01216293|560436454|FG000|Main Study|Other Reason Not Specified|0|||
155273962|NCT01216293|560436455|FG001|Main Study|Other Reason Not Specified|1|||
155273963|NCT01216293|560436456|FG002|Main Study|Other Reason Not Specified|1|||
155273964|NCT01216293|560436454|FG000|Main Study|Randomized, Not Treated|1|||
155273965|NCT01216293|560436455|FG001|Main Study|Randomized, Not Treated|0|||
155273966|NCT01216293|560436456|FG002|Main Study|Randomized, Not Treated|0|||
155273967|NCT01216293|560436454|FG000|Calcium Absorption Substudy|Adverse Event|0|||
155273968|NCT01216293|560436455|FG001|Calcium Absorption Substudy|Adverse Event|2|||
155273969|NCT01216293|560436456|FG002|Calcium Absorption Substudy|Adverse Event|0|||
155273970|NCT01216293|560436454|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
155273971|NCT01216293|560436455|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
155273972|NCT01216293|560436456|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
155273973|NCT01216293|560436454|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
155273974|NCT01216293|560436455|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
155273975|NCT01216293|560436456|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
155273976|NCT03391960|560436457|FG000|Overall Study|Protocol Violation|0|||
155273977|NCT03391960|560436458|FG001|Overall Study|Protocol Violation|0|||
155273978|NCT00581113|560438269|FG000|Overall Study|Withdrawal by Subject|0|||
155273979|NCT00581113|560438270|FG001|Overall Study|Withdrawal by Subject|1|||
155273980|NCT01818141|560438271|FG000|Overall Study|Withdrawal by Subject|2|||
155273981|NCT01818141|560438272|FG001|Overall Study|Withdrawal by Subject|0|||
155273982|NCT01818141|560438271|FG000|Overall Study|No baseline C.diff colonies|1|||
155273983|NCT01818141|560438272|FG001|Overall Study|No baseline C.diff colonies|1|||
155273984|NCT01818141|560438271|FG000|Overall Study|Lost to Follow-up|0|||
155273985|NCT01818141|560438272|FG001|Overall Study|Lost to Follow-up|2|||
155273986|NCT02169830|560438278|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
155273987|NCT02169830|560438279|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
155273988|NCT02169830|560438280|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
155273989|NCT02169830|560438278|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
155273990|NCT02169830|560438279|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155273991|NCT02169830|560438280|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155273992|NCT02169830|560438278|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
155273993|NCT02169830|560438279|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
155273994|NCT02169830|560438280|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155273995|NCT02169830|560438278|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
155273996|NCT02169830|560438279|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
155273997|NCT02169830|560438280|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
155273998|NCT02169830|560438278|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
155273999|NCT02169830|560438279|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
155274000|NCT02169830|560438280|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
155274001|NCT03204695|560438281|FG000|Overall Study|Death|1|||
155274002|NCT03204695|560438281|FG000|Overall Study|Participant was treated with another device|1|||
155274003|NCT03204695|560438281|FG000|Overall Study|Physician Decision|2|||
155274004|NCT04834362|560438282|FG000|Overall Study|Death|1|||
155274005|NCT04834362|560438283|FG001|Overall Study|Death|2|||
155274006|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
155274007|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274008|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274009|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274010|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
155274011|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
155274012|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274013|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274014|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274015|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
155274016|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
155274017|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274018|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274019|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274020|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
155274021|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
155274022|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274023|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274024|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274025|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
155274026|NCT02555371|560438286|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
155274027|NCT02555371|560438287|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274028|NCT02555371|560438288|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274029|NCT02555371|560438289|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274030|NCT02555371|560438290|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
155274031|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
155274032|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
155274033|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
155274034|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
155274035|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
155274036|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
155274037|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
155274038|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
155274039|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
155274040|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
155274041|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274042|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
155274043|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274044|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274045|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
155274046|NCT02555371|560438286|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
155274047|NCT02555371|560438287|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
155274048|NCT02555371|560438288|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
155274049|NCT02555371|560438289|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
155274050|NCT02555371|560438290|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
155274051|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274052|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274053|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274054|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
155274055|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
155274056|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274057|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274058|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274059|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
155274060|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
155274061|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274062|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274063|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274064|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
155274065|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
155274066|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274067|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274068|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274069|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
155274070|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
155274071|NCT02555371|560438286|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274072|NCT02555371|560438287|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274073|NCT02555371|560438288|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274074|NCT02555371|560438289|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
155274075|NCT02555371|560438290|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
155274076|NCT03095599|560438291|FG000|Overall Study|Withdrawal by Subject|1|||
155274077|NCT03095599|560438292|FG001|Overall Study|Withdrawal by Subject|0|||
155274078|NCT03095599|560438291|FG000|Overall Study|Lost to Follow-up|1|||
155274079|NCT03095599|560438292|FG001|Overall Study|Lost to Follow-up|0|||
155274080|NCT03095599|560438291|FG000|Overall Study|Withdrawal prior to vaccination|1|||
155274081|NCT03095599|560438292|FG001|Overall Study|Withdrawal prior to vaccination|0|||
155274082|NCT00742885|560438296|FG000|Overall Study|Lost to Follow-up|1|||
155274083|NCT00742885|560438297|FG001|Overall Study|Lost to Follow-up|0|||
155274084|NCT04781647|560438298|FG000|Overall Study|Study terminated by Sponsor|11|||
155274085|NCT04781647|560438299|FG001|Overall Study|Study terminated by Sponsor|9|||
155274086|NCT04781647|560438300|FG002|Overall Study|Study terminated by Sponsor|9|||
155274087|NCT04781647|560438298|FG000|Overall Study|Withdrawal by Subject|1|||
155274088|NCT04781647|560438299|FG001|Overall Study|Withdrawal by Subject|2|||
155274089|NCT04781647|560438300|FG002|Overall Study|Withdrawal by Subject|0|||
155274090|NCT04781647|560438298|FG000|Overall Study|Adverse Event|0|||
155274091|NCT04781647|560438299|FG001|Overall Study|Adverse Event|1|||
155274092|NCT04781647|560438300|FG002|Overall Study|Adverse Event|1|||
155274093|NCT04781647|560438298|FG000|Overall Study|Protocol Violation|1|||
155274094|NCT04781647|560438299|FG001|Overall Study|Protocol Violation|0|||
155274095|NCT04781647|560438300|FG002|Overall Study|Protocol Violation|0|||
155274096|NCT04781647|560438298|FG000|Overall Study|Pregnancy|0|||
155274097|NCT04781647|560438299|FG001|Overall Study|Pregnancy|0|||
155274098|NCT04781647|560438300|FG002|Overall Study|Pregnancy|1|||
155274099|NCT04781647|560438298|FG000|Overall Study|Virology rebounded|1|||
155274100|NCT04781647|560438299|FG001|Overall Study|Virology rebounded|0|||
155274101|NCT04781647|560438300|FG002|Overall Study|Virology rebounded|0|||
155274102|NCT00777803|560438301|FG000|Overall Study|Lost to Follow-up|12|||
155274103|NCT00777803|560438302|FG001|Overall Study|Lost to Follow-up|5|||
155274104|NCT00777803|560438301|FG000|Overall Study|Adverse Event|1|||
155274105|NCT00777803|560438302|FG001|Overall Study|Adverse Event|0|||
155274106|NCT00777803|560438301|FG000|Overall Study|Non-compliance|2|||
155274107|NCT00777803|560438302|FG001|Overall Study|Non-compliance|2|||
155274108|NCT01755689|560438303|FG000|Overall Study|Withdrawal by Subject|1|||
155274109|NCT01755689|560438304|FG001|Overall Study|Withdrawal by Subject|3|||
155274110|NCT01755689|560438305|FG002|Overall Study|Withdrawal by Subject|2|||
155274111|NCT01755689|560438306|FG003|Overall Study|Withdrawal by Subject|1|||
155274112|NCT01755689|560438307|FG004|Overall Study|Withdrawal by Subject|1|||
155274113|NCT01755689|560438303|FG000|Overall Study|Migrated/moved from study area|0|||
155274114|NCT01755689|560438304|FG001|Overall Study|Migrated/moved from study area|1|||
155274115|NCT01755689|560438305|FG002|Overall Study|Migrated/moved from study area|1|||
155274116|NCT01755689|560438306|FG003|Overall Study|Migrated/moved from study area|1|||
155274117|NCT01755689|560438307|FG004|Overall Study|Migrated/moved from study area|1|||
155274118|NCT01755689|560438303|FG000|Overall Study|Lost to Follow-up|1|||
155274119|NCT01755689|560438304|FG001|Overall Study|Lost to Follow-up|0|||
155274120|NCT01755689|560438305|FG002|Overall Study|Lost to Follow-up|1|||
155274121|NCT01755689|560438306|FG003|Overall Study|Lost to Follow-up|0|||
155274122|NCT01755689|560438307|FG004|Overall Study|Lost to Follow-up|2|||
155274123|NCT01755689|560438303|FG000|Overall Study|Pregnancy|1|||
155274124|NCT01755689|560438304|FG001|Overall Study|Pregnancy|1|||
155274125|NCT01755689|560438305|FG002|Overall Study|Pregnancy|2|||
155274126|NCT01755689|560438306|FG003|Overall Study|Pregnancy|4|||
155274127|NCT01755689|560438307|FG004|Overall Study|Pregnancy|2|||
155274128|NCT02930122|560438310|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
155274129|NCT02930122|560438311|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
155274130|NCT01995357|560438312|FG000|Period 5|Lack of Efficacy|1|||
155274131|NCT01995357|560438313|FG001|Period 5|Lack of Efficacy|0|||
155274132|NCT01995357|560438314|FG002|Period 5|Lack of Efficacy|0|||
155274133|NCT01995357|560438315|FG003|Period 5|Lack of Efficacy|0|||
155274134|NCT01995357|560438316|FG004|Period 5|Lack of Efficacy|0|||
155274135|NCT01995357|560438317|FG005|Period 5|Lack of Efficacy|0|||
155274136|NCT01995357|560438312|FG000|Period 5|Adverse Event|1|||
155274137|NCT01995357|560438313|FG001|Period 5|Adverse Event|0|||
155274138|NCT01995357|560438314|FG002|Period 5|Adverse Event|1|||
155274139|NCT01995357|560438315|FG003|Period 5|Adverse Event|0|||
155274140|NCT01995357|560438316|FG004|Period 5|Adverse Event|0|||
155274141|NCT01995357|560438317|FG005|Period 5|Adverse Event|0|||
155274142|NCT02609659|560438318|FG000|Overall Study|Adverse Event|1|||
155274143|NCT02609659|560438318|FG000|Overall Study|Lost to Follow-up|6|||
155274144|NCT02609659|560438318|FG000|Overall Study|Other|1|||
155274145|NCT03943589|560438319|FG000|Overall Study|Death|1|||
155274146|NCT03943589|560438319|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
155274147|NCT04329104|560438320|FG000|Efficacy Study|Withdrawal by Subject|0|||
155274148|NCT04329104|560438321|FG001|Efficacy Study|Withdrawal by Subject|0|||
155274149|NCT04329104|560438322|FG002|Efficacy Study|Withdrawal by Subject|0|||
155274150|NCT04329104|560438323|FG003|Efficacy Study|Withdrawal by Subject|5|||
155274151|NCT04329104|560438324|FG004|Efficacy Study|Withdrawal by Subject|6|||
155274152|NCT04329104|560438325|FG005|Efficacy Study|Withdrawal by Subject|8|||
155274153|NCT01474512|560438330|FG000|Induction Period|Adverse Event|6|||
155274154|NCT01474512|560438331|FG001|Induction Period|Adverse Event|10|||
155274155|NCT01474512|560438332|FG002|Induction Period|Adverse Event|10|||
155274156|NCT01474512|560438333|FG003|Induction Period|Adverse Event|0|||
155274157|NCT01474512|560438334|FG004|Induction Period|Adverse Event|0|||
155274158|NCT01474512|560438335|FG005|Induction Period|Adverse Event|0|||
155274159|NCT01474512|560438336|FG006|Induction Period|Adverse Event|0|||
155274160|NCT01474512|560438337|FG007|Induction Period|Adverse Event|0|||
155274161|NCT01474512|560438338|FG008|Induction Period|Adverse Event|0|||
155274162|NCT01474512|560438339|FG009|Induction Period|Adverse Event|0|||
155274163|NCT01474512|560438340|FG010|Induction Period|Adverse Event|0|||
155274164|NCT01474512|560438341|FG011|Induction Period|Adverse Event|0|||
155274165|NCT01474512|560438342|FG012|Induction Period|Adverse Event|0|||
155274166|NCT01474512|560438343|FG013|Induction Period|Adverse Event|0|||
155274167|NCT01474512|560438344|FG014|Induction Period|Adverse Event|0|||
155274168|NCT01474512|560438345|FG015|Induction Period|Adverse Event|0|||
155274169|NCT01474512|560438346|FG016|Induction Period|Adverse Event|0|||
155274170|NCT01474512|560438347|FG017|Induction Period|Adverse Event|0|||
155274171|NCT01474512|560438330|FG000|Induction Period|Lack of Efficacy|7|||
155274172|NCT01474512|560438331|FG001|Induction Period|Lack of Efficacy|1|||
155274173|NCT01474512|560438332|FG002|Induction Period|Lack of Efficacy|0|||
155274174|NCT01474512|560438333|FG003|Induction Period|Lack of Efficacy|0|||
155274175|NCT01474512|560438334|FG004|Induction Period|Lack of Efficacy|0|||
155274176|NCT01474512|560438335|FG005|Induction Period|Lack of Efficacy|0|||
155274177|NCT01474512|560438336|FG006|Induction Period|Lack of Efficacy|0|||
155274178|NCT01474512|560438337|FG007|Induction Period|Lack of Efficacy|0|||
155274179|NCT01474512|560438338|FG008|Induction Period|Lack of Efficacy|0|||
155274180|NCT01474512|560438339|FG009|Induction Period|Lack of Efficacy|0|||
155274181|NCT01474512|560438340|FG010|Induction Period|Lack of Efficacy|0|||
155274182|NCT01474512|560438341|FG011|Induction Period|Lack of Efficacy|0|||
155274183|NCT01474512|560438342|FG012|Induction Period|Lack of Efficacy|0|||
155274184|NCT01474512|560438343|FG013|Induction Period|Lack of Efficacy|0|||
155274185|NCT01474512|560438344|FG014|Induction Period|Lack of Efficacy|0|||
155274186|NCT01474512|560438345|FG015|Induction Period|Lack of Efficacy|0|||
155274187|NCT01474512|560438346|FG016|Induction Period|Lack of Efficacy|0|||
155274188|NCT01474512|560438347|FG017|Induction Period|Lack of Efficacy|0|||
155274189|NCT01474512|560438330|FG000|Induction Period|Withdrawal by Subject|6|||
155274190|NCT01474512|560438331|FG001|Induction Period|Withdrawal by Subject|6|||
155274191|NCT01474512|560438332|FG002|Induction Period|Withdrawal by Subject|5|||
155274192|NCT01474512|560438333|FG003|Induction Period|Withdrawal by Subject|0|||
155274193|NCT01474512|560438334|FG004|Induction Period|Withdrawal by Subject|0|||
155274194|NCT01474512|560438335|FG005|Induction Period|Withdrawal by Subject|0|||
155274195|NCT01474512|560438336|FG006|Induction Period|Withdrawal by Subject|0|||
155381936|NCT00598273|560833242|FG000|Overall Study|Death|6|||
155274196|NCT01474512|560438337|FG007|Induction Period|Withdrawal by Subject|0|||
155274197|NCT01474512|560438338|FG008|Induction Period|Withdrawal by Subject|0|||
155274198|NCT01474512|560438339|FG009|Induction Period|Withdrawal by Subject|0|||
155381937|NCT00598273|560833243|FG001|Overall Study|Death|12|||
155274199|NCT01474512|560438340|FG010|Induction Period|Withdrawal by Subject|0|||
155274200|NCT01474512|560438341|FG011|Induction Period|Withdrawal by Subject|0|||
155274201|NCT01474512|560438342|FG012|Induction Period|Withdrawal by Subject|0|||
155274202|NCT01474512|560438343|FG013|Induction Period|Withdrawal by Subject|0|||
155274203|NCT01474512|560438344|FG014|Induction Period|Withdrawal by Subject|0|||
155274204|NCT01474512|560438345|FG015|Induction Period|Withdrawal by Subject|0|||
155274205|NCT01474512|560438346|FG016|Induction Period|Withdrawal by Subject|0|||
155274206|NCT01474512|560438347|FG017|Induction Period|Withdrawal by Subject|0|||
155274207|NCT01474512|560438330|FG000|Induction Period|Protocol Violation|3|||
155274208|NCT01474512|560438331|FG001|Induction Period|Protocol Violation|6|||
155274209|NCT01474512|560438332|FG002|Induction Period|Protocol Violation|0|||
155274210|NCT01474512|560438333|FG003|Induction Period|Protocol Violation|0|||
155274211|NCT01474512|560438334|FG004|Induction Period|Protocol Violation|0|||
155274212|NCT01474512|560438335|FG005|Induction Period|Protocol Violation|0|||
155274213|NCT01474512|560438336|FG006|Induction Period|Protocol Violation|0|||
155274214|NCT01474512|560438337|FG007|Induction Period|Protocol Violation|0|||
155274215|NCT01474512|560438338|FG008|Induction Period|Protocol Violation|0|||
155274216|NCT01474512|560438339|FG009|Induction Period|Protocol Violation|0|||
155274217|NCT01474512|560438340|FG010|Induction Period|Protocol Violation|0|||
155274218|NCT01474512|560438341|FG011|Induction Period|Protocol Violation|0|||
155274219|NCT01474512|560438342|FG012|Induction Period|Protocol Violation|0|||
155274220|NCT01474512|560438343|FG013|Induction Period|Protocol Violation|0|||
155274221|NCT01474512|560438344|FG014|Induction Period|Protocol Violation|0|||
155274222|NCT01474512|560438345|FG015|Induction Period|Protocol Violation|0|||
155274223|NCT01474512|560438346|FG016|Induction Period|Protocol Violation|0|||
155274224|NCT01474512|560438347|FG017|Induction Period|Protocol Violation|0|||
155274225|NCT01474512|560438330|FG000|Induction Period|Sponsor Decision|1|||
155274226|NCT01474512|560438331|FG001|Induction Period|Sponsor Decision|1|||
155274227|NCT01474512|560438332|FG002|Induction Period|Sponsor Decision|1|||
155274228|NCT01474512|560438333|FG003|Induction Period|Sponsor Decision|0|||
155274229|NCT01474512|560438334|FG004|Induction Period|Sponsor Decision|0|||
155274230|NCT01474512|560438335|FG005|Induction Period|Sponsor Decision|0|||
155274231|NCT01474512|560438336|FG006|Induction Period|Sponsor Decision|0|||
155274232|NCT01474512|560438337|FG007|Induction Period|Sponsor Decision|0|||
155274233|NCT01474512|560438338|FG008|Induction Period|Sponsor Decision|0|||
155274234|NCT01474512|560438339|FG009|Induction Period|Sponsor Decision|0|||
155274235|NCT01474512|560438340|FG010|Induction Period|Sponsor Decision|0|||
155274236|NCT01474512|560438341|FG011|Induction Period|Sponsor Decision|0|||
155274237|NCT01474512|560438342|FG012|Induction Period|Sponsor Decision|0|||
155274238|NCT01474512|560438343|FG013|Induction Period|Sponsor Decision|0|||
155274239|NCT01474512|560438344|FG014|Induction Period|Sponsor Decision|0|||
155274240|NCT01474512|560438345|FG015|Induction Period|Sponsor Decision|0|||
155274241|NCT01474512|560438346|FG016|Induction Period|Sponsor Decision|0|||
155274242|NCT01474512|560438347|FG017|Induction Period|Sponsor Decision|0|||
155274243|NCT01474512|560438330|FG000|Induction Period|Lost to Follow-up|1|||
155274244|NCT01474512|560438331|FG001|Induction Period|Lost to Follow-up|0|||
155274245|NCT01474512|560438332|FG002|Induction Period|Lost to Follow-up|2|||
155274246|NCT01474512|560438333|FG003|Induction Period|Lost to Follow-up|0|||
155274247|NCT01474512|560438334|FG004|Induction Period|Lost to Follow-up|0|||
155274248|NCT01474512|560438335|FG005|Induction Period|Lost to Follow-up|0|||
155274249|NCT01474512|560438336|FG006|Induction Period|Lost to Follow-up|0|||
155274250|NCT01474512|560438337|FG007|Induction Period|Lost to Follow-up|0|||
155274251|NCT01474512|560438338|FG008|Induction Period|Lost to Follow-up|0|||
155274252|NCT01474512|560438339|FG009|Induction Period|Lost to Follow-up|0|||
155274253|NCT01474512|560438340|FG010|Induction Period|Lost to Follow-up|0|||
155274254|NCT01474512|560438341|FG011|Induction Period|Lost to Follow-up|0|||
155274255|NCT01474512|560438342|FG012|Induction Period|Lost to Follow-up|0|||
155274256|NCT01474512|560438343|FG013|Induction Period|Lost to Follow-up|0|||
155274257|NCT01474512|560438344|FG014|Induction Period|Lost to Follow-up|0|||
155274258|NCT01474512|560438345|FG015|Induction Period|Lost to Follow-up|0|||
155274259|NCT01474512|560438346|FG016|Induction Period|Lost to Follow-up|0|||
155274260|NCT01474512|560438347|FG017|Induction Period|Lost to Follow-up|0|||
155274261|NCT01474512|560438330|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274262|NCT01474512|560438331|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274263|NCT01474512|560438332|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274264|NCT01474512|560438333|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
155274265|NCT01474512|560438334|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
155274266|NCT01474512|560438335|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
155274267|NCT01474512|560438336|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
155274268|NCT01474512|560438337|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274269|NCT01474512|560438338|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274270|NCT01474512|560438339|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274271|NCT01474512|560438340|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274272|NCT01474512|560438341|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274273|NCT01474512|560438342|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155043430|NCT01826981|559590136|FG014|Overall Study|Lack of Efficacy|0|||
155274274|NCT01474512|560438343|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274275|NCT01474512|560438344|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274276|NCT01474512|560438345|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274277|NCT01474512|560438346|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274278|NCT01474512|560438347|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
155274279|NCT01474512|560438330|FG000|Maintenance Period|Adverse Event|0|||
155274280|NCT01474512|560438331|FG001|Maintenance Period|Adverse Event|0|||
155274281|NCT01474512|560438332|FG002|Maintenance Period|Adverse Event|0|||
155274282|NCT01474512|560438333|FG003|Maintenance Period|Adverse Event|4|||
155274283|NCT01474512|560438334|FG004|Maintenance Period|Adverse Event|2|||
155274284|NCT01474512|560438335|FG005|Maintenance Period|Adverse Event|7|||
155274285|NCT01474512|560438336|FG006|Maintenance Period|Adverse Event|0|||
155274286|NCT01474512|560438337|FG007|Maintenance Period|Adverse Event|19|||
155274287|NCT01474512|560438338|FG008|Maintenance Period|Adverse Event|1|||
155274288|NCT01474512|560438339|FG009|Maintenance Period|Adverse Event|3|||
155274289|NCT01474512|560438340|FG010|Maintenance Period|Adverse Event|0|||
155274290|NCT01474512|560438341|FG011|Maintenance Period|Adverse Event|0|||
155274291|NCT01474512|560438342|FG012|Maintenance Period|Adverse Event|0|||
155274292|NCT01474512|560438343|FG013|Maintenance Period|Adverse Event|0|||
155274293|NCT01474512|560438344|FG014|Maintenance Period|Adverse Event|0|||
155274294|NCT01474512|560438345|FG015|Maintenance Period|Adverse Event|0|||
155274295|NCT01474512|560438346|FG016|Maintenance Period|Adverse Event|0|||
155274296|NCT01474512|560438347|FG017|Maintenance Period|Adverse Event|0|||
155274297|NCT01474512|560438330|FG000|Maintenance Period|Withdrawal by Subject|0|||
155274298|NCT01474512|560438331|FG001|Maintenance Period|Withdrawal by Subject|0|||
155274299|NCT01474512|560438332|FG002|Maintenance Period|Withdrawal by Subject|0|||
155274300|NCT01474512|560438333|FG003|Maintenance Period|Withdrawal by Subject|6|||
155274301|NCT01474512|560438334|FG004|Maintenance Period|Withdrawal by Subject|2|||
155274302|NCT01474512|560438335|FG005|Maintenance Period|Withdrawal by Subject|3|||
155274303|NCT01474512|560438336|FG006|Maintenance Period|Withdrawal by Subject|1|||
155274304|NCT01474512|560438337|FG007|Maintenance Period|Withdrawal by Subject|6|||
155274305|NCT01474512|560438338|FG008|Maintenance Period|Withdrawal by Subject|3|||
155274306|NCT01474512|560438339|FG009|Maintenance Period|Withdrawal by Subject|1|||
155274307|NCT01474512|560438340|FG010|Maintenance Period|Withdrawal by Subject|0|||
155274308|NCT01474512|560438341|FG011|Maintenance Period|Withdrawal by Subject|0|||
155274309|NCT01474512|560438342|FG012|Maintenance Period|Withdrawal by Subject|0|||
155274310|NCT01474512|560438343|FG013|Maintenance Period|Withdrawal by Subject|0|||
155274311|NCT01474512|560438344|FG014|Maintenance Period|Withdrawal by Subject|0|||
155274312|NCT01474512|560438345|FG015|Maintenance Period|Withdrawal by Subject|0|||
155274313|NCT01474512|560438346|FG016|Maintenance Period|Withdrawal by Subject|0|||
155274314|NCT01474512|560438347|FG017|Maintenance Period|Withdrawal by Subject|0|||
155274315|NCT01474512|560438330|FG000|Maintenance Period|Lost to Follow-up|0|||
155274316|NCT01474512|560438331|FG001|Maintenance Period|Lost to Follow-up|0|||
155274317|NCT01474512|560438332|FG002|Maintenance Period|Lost to Follow-up|0|||
155274318|NCT01474512|560438333|FG003|Maintenance Period|Lost to Follow-up|3|||
155274319|NCT01474512|560438334|FG004|Maintenance Period|Lost to Follow-up|3|||
155274320|NCT01474512|560438335|FG005|Maintenance Period|Lost to Follow-up|0|||
155274321|NCT01474512|560438336|FG006|Maintenance Period|Lost to Follow-up|0|||
155274322|NCT01474512|560438337|FG007|Maintenance Period|Lost to Follow-up|2|||
155274323|NCT01474512|560438338|FG008|Maintenance Period|Lost to Follow-up|1|||
155274324|NCT01474512|560438339|FG009|Maintenance Period|Lost to Follow-up|1|||
155274325|NCT01474512|560438340|FG010|Maintenance Period|Lost to Follow-up|0|||
155274326|NCT01474512|560438341|FG011|Maintenance Period|Lost to Follow-up|0|||
155274327|NCT01474512|560438342|FG012|Maintenance Period|Lost to Follow-up|0|||
155274328|NCT01474512|560438343|FG013|Maintenance Period|Lost to Follow-up|0|||
155274329|NCT01474512|560438344|FG014|Maintenance Period|Lost to Follow-up|0|||
155274330|NCT01474512|560438345|FG015|Maintenance Period|Lost to Follow-up|0|||
155274331|NCT01474512|560438346|FG016|Maintenance Period|Lost to Follow-up|0|||
155274332|NCT01474512|560438347|FG017|Maintenance Period|Lost to Follow-up|0|||
155274333|NCT01474512|560438330|FG000|Maintenance Period|Death|0|||
155274334|NCT01474512|560438331|FG001|Maintenance Period|Death|0|||
155274335|NCT01474512|560438332|FG002|Maintenance Period|Death|0|||
155274336|NCT01474512|560438333|FG003|Maintenance Period|Death|0|||
155274337|NCT01474512|560438334|FG004|Maintenance Period|Death|0|||
155274338|NCT01474512|560438335|FG005|Maintenance Period|Death|2|||
155274339|NCT01474512|560438336|FG006|Maintenance Period|Death|0|||
155043431|NCT01826981|559590122|FG000|Overall Study|Lost to Follow-up|0|||
155043432|NCT01826981|559590123|FG001|Overall Study|Lost to Follow-up|0|||
155274340|NCT01474512|560438337|FG007|Maintenance Period|Death|0|||
155274341|NCT01474512|560438338|FG008|Maintenance Period|Death|0|||
155274342|NCT01474512|560438339|FG009|Maintenance Period|Death|0|||
155274343|NCT01474512|560438340|FG010|Maintenance Period|Death|0|||
155274344|NCT01474512|560438341|FG011|Maintenance Period|Death|0|||
155274345|NCT01474512|560438342|FG012|Maintenance Period|Death|0|||
155043433|NCT01826981|559590124|FG002|Overall Study|Lost to Follow-up|0|||
155274346|NCT01474512|560438343|FG013|Maintenance Period|Death|0|||
155274347|NCT01474512|560438344|FG014|Maintenance Period|Death|0|||
155043434|NCT01826981|559590125|FG003|Overall Study|Lost to Follow-up|0|||
155274348|NCT01474512|560438345|FG015|Maintenance Period|Death|0|||
155274349|NCT01474512|560438346|FG016|Maintenance Period|Death|0|||
155274350|NCT01474512|560438347|FG017|Maintenance Period|Death|0|||
155274351|NCT01474512|560438330|FG000|Maintenance Period|Physician Decision|0|||
155274352|NCT01474512|560438331|FG001|Maintenance Period|Physician Decision|0|||
155274353|NCT01474512|560438332|FG002|Maintenance Period|Physician Decision|0|||
155274354|NCT01474512|560438333|FG003|Maintenance Period|Physician Decision|0|||
155274355|NCT01474512|560438334|FG004|Maintenance Period|Physician Decision|0|||
155274356|NCT01474512|560438335|FG005|Maintenance Period|Physician Decision|1|||
155274357|NCT01474512|560438336|FG006|Maintenance Period|Physician Decision|0|||
155274358|NCT01474512|560438337|FG007|Maintenance Period|Physician Decision|2|||
155274359|NCT01474512|560438338|FG008|Maintenance Period|Physician Decision|0|||
155274360|NCT01474512|560438339|FG009|Maintenance Period|Physician Decision|0|||
155274361|NCT01474512|560438340|FG010|Maintenance Period|Physician Decision|0|||
155274362|NCT01474512|560438341|FG011|Maintenance Period|Physician Decision|0|||
155274363|NCT01474512|560438342|FG012|Maintenance Period|Physician Decision|0|||
155274364|NCT01474512|560438343|FG013|Maintenance Period|Physician Decision|0|||
155274365|NCT01474512|560438344|FG014|Maintenance Period|Physician Decision|0|||
155274366|NCT01474512|560438345|FG015|Maintenance Period|Physician Decision|0|||
155274367|NCT01474512|560438346|FG016|Maintenance Period|Physician Decision|0|||
155274368|NCT01474512|560438347|FG017|Maintenance Period|Physician Decision|0|||
155274369|NCT01474512|560438330|FG000|Maintenance Period|Clinical Relapse|0|||
155274370|NCT01474512|560438331|FG001|Maintenance Period|Clinical Relapse|0|||
155274371|NCT01474512|560438332|FG002|Maintenance Period|Clinical Relapse|0|||
155274372|NCT01474512|560438333|FG003|Maintenance Period|Clinical Relapse|1|||
155274373|NCT01474512|560438334|FG004|Maintenance Period|Clinical Relapse|0|||
155274374|NCT01474512|560438335|FG005|Maintenance Period|Clinical Relapse|0|||
155274375|NCT01474512|560438336|FG006|Maintenance Period|Clinical Relapse|0|||
155274376|NCT01474512|560438337|FG007|Maintenance Period|Clinical Relapse|0|||
155274377|NCT01474512|560438338|FG008|Maintenance Period|Clinical Relapse|0|||
155274378|NCT01474512|560438339|FG009|Maintenance Period|Clinical Relapse|0|||
155274379|NCT01474512|560438340|FG010|Maintenance Period|Clinical Relapse|0|||
155274380|NCT01474512|560438341|FG011|Maintenance Period|Clinical Relapse|0|||
155274381|NCT01474512|560438342|FG012|Maintenance Period|Clinical Relapse|0|||
155274382|NCT01474512|560438343|FG013|Maintenance Period|Clinical Relapse|0|||
155274383|NCT01474512|560438344|FG014|Maintenance Period|Clinical Relapse|0|||
155274384|NCT01474512|560438345|FG015|Maintenance Period|Clinical Relapse|0|||
155274385|NCT01474512|560438346|FG016|Maintenance Period|Clinical Relapse|0|||
155274386|NCT01474512|560438347|FG017|Maintenance Period|Clinical Relapse|0|||
155274387|NCT01474512|560438330|FG000|Maintenance Period|Lack of Efficacy|0|||
155274388|NCT01474512|560438331|FG001|Maintenance Period|Lack of Efficacy|0|||
155274389|NCT01474512|560438332|FG002|Maintenance Period|Lack of Efficacy|0|||
155274390|NCT01474512|560438333|FG003|Maintenance Period|Lack of Efficacy|1|||
155274391|NCT01474512|560438334|FG004|Maintenance Period|Lack of Efficacy|0|||
155274392|NCT01474512|560438335|FG005|Maintenance Period|Lack of Efficacy|0|||
155274393|NCT01474512|560438336|FG006|Maintenance Period|Lack of Efficacy|0|||
155274394|NCT01474512|560438337|FG007|Maintenance Period|Lack of Efficacy|11|||
155274395|NCT01474512|560438338|FG008|Maintenance Period|Lack of Efficacy|11|||
155274396|NCT01474512|560438339|FG009|Maintenance Period|Lack of Efficacy|12|||
155274397|NCT01474512|560438340|FG010|Maintenance Period|Lack of Efficacy|0|||
155274398|NCT01474512|560438341|FG011|Maintenance Period|Lack of Efficacy|0|||
155274399|NCT01474512|560438342|FG012|Maintenance Period|Lack of Efficacy|0|||
155274400|NCT01474512|560438343|FG013|Maintenance Period|Lack of Efficacy|0|||
155274401|NCT01474512|560438344|FG014|Maintenance Period|Lack of Efficacy|0|||
155274402|NCT01474512|560438345|FG015|Maintenance Period|Lack of Efficacy|0|||
155274403|NCT01474512|560438346|FG016|Maintenance Period|Lack of Efficacy|0|||
155274404|NCT01474512|560438347|FG017|Maintenance Period|Lack of Efficacy|0|||
155274405|NCT01474512|560438330|FG000|Maintenance Period|Protocol Violation|0|||
155274406|NCT01474512|560438331|FG001|Maintenance Period|Protocol Violation|0|||
155274407|NCT01474512|560438332|FG002|Maintenance Period|Protocol Violation|0|||
155274408|NCT01474512|560438333|FG003|Maintenance Period|Protocol Violation|1|||
155274409|NCT01474512|560438334|FG004|Maintenance Period|Protocol Violation|0|||
155274410|NCT01474512|560438335|FG005|Maintenance Period|Protocol Violation|0|||
155274411|NCT01474512|560438336|FG006|Maintenance Period|Protocol Violation|0|||
155274412|NCT01474512|560438337|FG007|Maintenance Period|Protocol Violation|1|||
155274413|NCT01474512|560438338|FG008|Maintenance Period|Protocol Violation|0|||
155274414|NCT01474512|560438339|FG009|Maintenance Period|Protocol Violation|1|||
155274415|NCT01474512|560438340|FG010|Maintenance Period|Protocol Violation|0|||
155274416|NCT01474512|560438341|FG011|Maintenance Period|Protocol Violation|0|||
155274417|NCT01474512|560438342|FG012|Maintenance Period|Protocol Violation|0|||
155274418|NCT01474512|560438343|FG013|Maintenance Period|Protocol Violation|0|||
155274419|NCT01474512|560438344|FG014|Maintenance Period|Protocol Violation|0|||
155274420|NCT01474512|560438345|FG015|Maintenance Period|Protocol Violation|0|||
155274421|NCT01474512|560438346|FG016|Maintenance Period|Protocol Violation|0|||
155274422|NCT01474512|560438347|FG017|Maintenance Period|Protocol Violation|0|||
155274423|NCT01474512|560438330|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
155274424|NCT01474512|560438331|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
155274425|NCT01474512|560438332|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
155274426|NCT01474512|560438333|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
155274427|NCT01474512|560438334|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
155274428|NCT01474512|560438335|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
155274429|NCT01474512|560438336|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
155274430|NCT01474512|560438337|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
155274431|NCT01474512|560438338|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
155274432|NCT01474512|560438339|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
155274433|NCT01474512|560438340|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
155274434|NCT01474512|560438341|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
155274435|NCT01474512|560438342|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
155274436|NCT01474512|560438343|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
155274437|NCT01474512|560438344|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
155274438|NCT01474512|560438345|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
155274439|NCT01474512|560438346|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
155274440|NCT01474512|560438347|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
155274441|NCT01474512|560438330|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
155274442|NCT01474512|560438331|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
155274443|NCT01474512|560438332|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
155274444|NCT01474512|560438333|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
155274445|NCT01474512|560438334|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
155274446|NCT01474512|560438335|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
155274447|NCT01474512|560438336|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
155274448|NCT01474512|560438337|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
155274449|NCT01474512|560438338|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
155274450|NCT01474512|560438339|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
155274451|NCT01474512|560438340|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
155274452|NCT01474512|560438341|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
155274453|NCT01474512|560438342|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
155274454|NCT01474512|560438343|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
155274455|NCT01474512|560438344|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
155274456|NCT01474512|560438345|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
155274457|NCT01474512|560438346|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
155274458|NCT01474512|560438347|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
155274459|NCT01474512|560438330|FG000|Long-Term Extension Period|Adverse Event|0|||
155274460|NCT01474512|560438331|FG001|Long-Term Extension Period|Adverse Event|0|||
155274461|NCT01474512|560438332|FG002|Long-Term Extension Period|Adverse Event|0|||
155274462|NCT01474512|560438333|FG003|Long-Term Extension Period|Adverse Event|0|||
155274463|NCT01474512|560438334|FG004|Long-Term Extension Period|Adverse Event|0|||
155274464|NCT01474512|560438335|FG005|Long-Term Extension Period|Adverse Event|0|||
155274465|NCT01474512|560438336|FG006|Long-Term Extension Period|Adverse Event|0|||
155274466|NCT01474512|560438337|FG007|Long-Term Extension Period|Adverse Event|0|||
155274467|NCT01474512|560438338|FG008|Long-Term Extension Period|Adverse Event|0|||
155274468|NCT01474512|560438339|FG009|Long-Term Extension Period|Adverse Event|0|||
155274469|NCT01474512|560438340|FG010|Long-Term Extension Period|Adverse Event|0|||
155274470|NCT01474512|560438341|FG011|Long-Term Extension Period|Adverse Event|1|||
155274471|NCT01474512|560438342|FG012|Long-Term Extension Period|Adverse Event|57|||
155274472|NCT01474512|560438343|FG013|Long-Term Extension Period|Adverse Event|58|||
155274473|NCT01474512|560438344|FG014|Long-Term Extension Period|Adverse Event|0|||
155274474|NCT01474512|560438345|FG015|Long-Term Extension Period|Adverse Event|0|||
155274475|NCT01474512|560438346|FG016|Long-Term Extension Period|Adverse Event|0|||
155274476|NCT01474512|560438347|FG017|Long-Term Extension Period|Adverse Event|0|||
155274477|NCT01474512|560438330|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
155274478|NCT01474512|560438331|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
155274479|NCT01474512|560438332|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
155274480|NCT01474512|560438333|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
155274481|NCT01474512|560438334|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
155274482|NCT01474512|560438335|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
155274483|NCT01474512|560438336|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
155274484|NCT01474512|560438337|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
155274485|NCT01474512|560438338|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
155274486|NCT01474512|560438339|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
155274487|NCT01474512|560438340|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
155274488|NCT01474512|560438341|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
155274489|NCT01474512|560438342|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
155274490|NCT01474512|560438343|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
155043435|NCT01826981|559590126|FG004|Overall Study|Lost to Follow-up|1|||
155274491|NCT01474512|560438344|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
155274492|NCT01474512|560438345|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
155274493|NCT01474512|560438346|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
155274494|NCT01474512|560438347|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
155274495|NCT01474512|560438330|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
155274496|NCT01474512|560438331|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
155274497|NCT01474512|560438332|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
155274498|NCT01474512|560438333|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
155274499|NCT01474512|560438334|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
155274500|NCT01474512|560438335|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
155274501|NCT01474512|560438336|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
155274502|NCT01474512|560438337|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
155274503|NCT01474512|560438338|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
155274504|NCT01474512|560438339|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
155274505|NCT01474512|560438340|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
155274506|NCT01474512|560438341|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
155274507|NCT01474512|560438342|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
155274508|NCT01474512|560438343|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
155274509|NCT01474512|560438344|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
155274510|NCT01474512|560438345|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
155274511|NCT01474512|560438346|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
155274512|NCT01474512|560438347|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
155274513|NCT01474512|560438330|FG000|Long-Term Extension Period|Physician Decision|0|||
155274514|NCT01474512|560438331|FG001|Long-Term Extension Period|Physician Decision|0|||
155274515|NCT01474512|560438332|FG002|Long-Term Extension Period|Physician Decision|0|||
155274516|NCT01474512|560438333|FG003|Long-Term Extension Period|Physician Decision|0|||
155274517|NCT01474512|560438334|FG004|Long-Term Extension Period|Physician Decision|0|||
155274518|NCT01474512|560438335|FG005|Long-Term Extension Period|Physician Decision|0|||
155274519|NCT01474512|560438336|FG006|Long-Term Extension Period|Physician Decision|0|||
155274520|NCT01474512|560438337|FG007|Long-Term Extension Period|Physician Decision|0|||
155274521|NCT01474512|560438338|FG008|Long-Term Extension Period|Physician Decision|0|||
155274522|NCT01474512|560438339|FG009|Long-Term Extension Period|Physician Decision|0|||
155274523|NCT01474512|560438340|FG010|Long-Term Extension Period|Physician Decision|0|||
155274524|NCT01474512|560438341|FG011|Long-Term Extension Period|Physician Decision|0|||
155274525|NCT01474512|560438342|FG012|Long-Term Extension Period|Physician Decision|21|||
155274526|NCT01474512|560438343|FG013|Long-Term Extension Period|Physician Decision|21|||
155274527|NCT01474512|560438344|FG014|Long-Term Extension Period|Physician Decision|0|||
155274528|NCT01474512|560438345|FG015|Long-Term Extension Period|Physician Decision|0|||
155274529|NCT01474512|560438346|FG016|Long-Term Extension Period|Physician Decision|0|||
155274530|NCT01474512|560438347|FG017|Long-Term Extension Period|Physician Decision|0|||
155274531|NCT01474512|560438330|FG000|Long-Term Extension Period|Clinical Relapse|0|||
155274532|NCT01474512|560438331|FG001|Long-Term Extension Period|Clinical Relapse|0|||
155274533|NCT01474512|560438332|FG002|Long-Term Extension Period|Clinical Relapse|0|||
155274534|NCT01474512|560438333|FG003|Long-Term Extension Period|Clinical Relapse|0|||
155274535|NCT01474512|560438334|FG004|Long-Term Extension Period|Clinical Relapse|0|||
155274536|NCT01474512|560438335|FG005|Long-Term Extension Period|Clinical Relapse|0|||
155274537|NCT01474512|560438336|FG006|Long-Term Extension Period|Clinical Relapse|0|||
155274538|NCT01474512|560438337|FG007|Long-Term Extension Period|Clinical Relapse|0|||
155274539|NCT01474512|560438338|FG008|Long-Term Extension Period|Clinical Relapse|0|||
155274540|NCT01474512|560438339|FG009|Long-Term Extension Period|Clinical Relapse|0|||
155274541|NCT01474512|560438340|FG010|Long-Term Extension Period|Clinical Relapse|0|||
155274542|NCT01474512|560438341|FG011|Long-Term Extension Period|Clinical Relapse|0|||
155274543|NCT01474512|560438342|FG012|Long-Term Extension Period|Clinical Relapse|9|||
155274544|NCT01474512|560438343|FG013|Long-Term Extension Period|Clinical Relapse|9|||
155274545|NCT01474512|560438344|FG014|Long-Term Extension Period|Clinical Relapse|0|||
155274546|NCT01474512|560438345|FG015|Long-Term Extension Period|Clinical Relapse|0|||
155274547|NCT01474512|560438346|FG016|Long-Term Extension Period|Clinical Relapse|0|||
155274548|NCT01474512|560438347|FG017|Long-Term Extension Period|Clinical Relapse|0|||
155274549|NCT01474512|560438330|FG000|Long-Term Extension Period|Death|0|||
155274550|NCT01474512|560438331|FG001|Long-Term Extension Period|Death|0|||
155274551|NCT01474512|560438332|FG002|Long-Term Extension Period|Death|0|||
155274552|NCT01474512|560438333|FG003|Long-Term Extension Period|Death|0|||
155274553|NCT01474512|560438334|FG004|Long-Term Extension Period|Death|0|||
155274554|NCT01474512|560438335|FG005|Long-Term Extension Period|Death|0|||
155274555|NCT01474512|560438336|FG006|Long-Term Extension Period|Death|0|||
155274556|NCT01474512|560438337|FG007|Long-Term Extension Period|Death|0|||
155274557|NCT01474512|560438338|FG008|Long-Term Extension Period|Death|0|||
155274558|NCT01474512|560438339|FG009|Long-Term Extension Period|Death|0|||
155274559|NCT01474512|560438340|FG010|Long-Term Extension Period|Death|0|||
155274560|NCT01474512|560438341|FG011|Long-Term Extension Period|Death|0|||
155274561|NCT01474512|560438342|FG012|Long-Term Extension Period|Death|9|||
155274562|NCT01474512|560438343|FG013|Long-Term Extension Period|Death|9|||
155274563|NCT01474512|560438344|FG014|Long-Term Extension Period|Death|0|||
155274564|NCT01474512|560438345|FG015|Long-Term Extension Period|Death|0|||
155274565|NCT01474512|560438346|FG016|Long-Term Extension Period|Death|0|||
155274566|NCT01474512|560438347|FG017|Long-Term Extension Period|Death|0|||
155274567|NCT01474512|560438330|FG000|Long-Term Extension Period|Sponsor Decision|0|||
155274568|NCT01474512|560438331|FG001|Long-Term Extension Period|Sponsor Decision|0|||
155274569|NCT01474512|560438332|FG002|Long-Term Extension Period|Sponsor Decision|0|||
155274570|NCT01474512|560438333|FG003|Long-Term Extension Period|Sponsor Decision|0|||
155274571|NCT01474512|560438334|FG004|Long-Term Extension Period|Sponsor Decision|0|||
155274572|NCT01474512|560438335|FG005|Long-Term Extension Period|Sponsor Decision|0|||
155274573|NCT01474512|560438336|FG006|Long-Term Extension Period|Sponsor Decision|0|||
155274574|NCT01474512|560438337|FG007|Long-Term Extension Period|Sponsor Decision|0|||
155274575|NCT01474512|560438338|FG008|Long-Term Extension Period|Sponsor Decision|0|||
155274576|NCT01474512|560438339|FG009|Long-Term Extension Period|Sponsor Decision|0|||
155274577|NCT01474512|560438340|FG010|Long-Term Extension Period|Sponsor Decision|0|||
155274578|NCT01474512|560438341|FG011|Long-Term Extension Period|Sponsor Decision|0|||
155274579|NCT01474512|560438342|FG012|Long-Term Extension Period|Sponsor Decision|6|||
155274580|NCT01474512|560438343|FG013|Long-Term Extension Period|Sponsor Decision|6|||
155274581|NCT01474512|560438344|FG014|Long-Term Extension Period|Sponsor Decision|0|||
155274582|NCT01474512|560438345|FG015|Long-Term Extension Period|Sponsor Decision|0|||
155274583|NCT01474512|560438346|FG016|Long-Term Extension Period|Sponsor Decision|0|||
155274584|NCT01474512|560438347|FG017|Long-Term Extension Period|Sponsor Decision|0|||
155274585|NCT01474512|560438330|FG000|Long-Term Extension Period|Protocol Violation|0|||
155274586|NCT01474512|560438331|FG001|Long-Term Extension Period|Protocol Violation|0|||
155274587|NCT01474512|560438332|FG002|Long-Term Extension Period|Protocol Violation|0|||
155274588|NCT01474512|560438333|FG003|Long-Term Extension Period|Protocol Violation|0|||
155274589|NCT01474512|560438334|FG004|Long-Term Extension Period|Protocol Violation|0|||
155274590|NCT01474512|560438335|FG005|Long-Term Extension Period|Protocol Violation|0|||
155274591|NCT01474512|560438336|FG006|Long-Term Extension Period|Protocol Violation|0|||
155274592|NCT01474512|560438337|FG007|Long-Term Extension Period|Protocol Violation|0|||
155274593|NCT01474512|560438338|FG008|Long-Term Extension Period|Protocol Violation|0|||
155274594|NCT01474512|560438339|FG009|Long-Term Extension Period|Protocol Violation|0|||
155274595|NCT01474512|560438340|FG010|Long-Term Extension Period|Protocol Violation|0|||
155274596|NCT01474512|560438341|FG011|Long-Term Extension Period|Protocol Violation|0|||
155274597|NCT01474512|560438342|FG012|Long-Term Extension Period|Protocol Violation|5|||
155274598|NCT01474512|560438343|FG013|Long-Term Extension Period|Protocol Violation|5|||
155274599|NCT01474512|560438344|FG014|Long-Term Extension Period|Protocol Violation|0|||
155274600|NCT01474512|560438345|FG015|Long-Term Extension Period|Protocol Violation|0|||
155274601|NCT01474512|560438346|FG016|Long-Term Extension Period|Protocol Violation|0|||
155274602|NCT01474512|560438347|FG017|Long-Term Extension Period|Protocol Violation|0|||
155274603|NCT01474512|560438330|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274604|NCT01474512|560438331|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274605|NCT01474512|560438332|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274606|NCT01474512|560438333|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274607|NCT01474512|560438334|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274608|NCT01474512|560438335|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274609|NCT01474512|560438336|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274610|NCT01474512|560438337|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274611|NCT01474512|560438338|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274612|NCT01474512|560438339|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274613|NCT01474512|560438340|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274614|NCT01474512|560438341|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274615|NCT01474512|560438342|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
155274616|NCT01474512|560438343|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
155274617|NCT01474512|560438344|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274618|NCT01474512|560438345|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274619|NCT01474512|560438346|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155043436|NCT01826981|559590127|FG005|Overall Study|Lost to Follow-up|1|||
155043437|NCT01826981|559590128|FG006|Overall Study|Lost to Follow-up|0|||
155043438|NCT01826981|559590129|FG007|Overall Study|Lost to Follow-up|1|||
155043439|NCT01826981|559590130|FG008|Overall Study|Lost to Follow-up|0|||
155043440|NCT01826981|559590131|FG009|Overall Study|Lost to Follow-up|1|||
155274620|NCT01474512|560438347|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
155274621|NCT01474512|560438330|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274622|NCT01474512|560438331|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274623|NCT01474512|560438332|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274624|NCT01474512|560438333|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274625|NCT01474512|560438334|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274626|NCT01474512|560438335|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155043441|NCT01826981|559590132|FG010|Overall Study|Lost to Follow-up|1|||
155043442|NCT01826981|559590133|FG011|Overall Study|Lost to Follow-up|1|||
155274627|NCT01474512|560438336|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274628|NCT01474512|560438337|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274629|NCT01474512|560438338|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274630|NCT01474512|560438339|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274631|NCT01474512|560438340|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274632|NCT01474512|560438341|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
155274633|NCT01474512|560438342|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274634|NCT01474512|560438343|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274635|NCT01474512|560438344|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274636|NCT01474512|560438345|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274637|NCT01474512|560438346|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274638|NCT01474512|560438347|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
155274639|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
155274640|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
155274641|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
155274642|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
155274643|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
155274644|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
155274645|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
155274646|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
155274647|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
155274648|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
155274649|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
155274650|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
155274651|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
155274652|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
155274653|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
155274654|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
155274655|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
155274656|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
155274657|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274658|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274659|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274660|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274661|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274662|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274663|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274664|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274665|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274666|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274667|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274668|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274669|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274670|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
155274671|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
155274672|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
155274673|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
155274674|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
155274675|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274676|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274677|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274678|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274679|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274680|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274681|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274682|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274683|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274684|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274685|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274686|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274687|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274688|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
155274689|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
155274690|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
155274691|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
155274692|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
155274693|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274694|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274695|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274696|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274697|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274698|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274699|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274700|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274701|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274702|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274703|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274704|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274705|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274706|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274707|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274708|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
155274709|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
155274710|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
155274711|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
155274712|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
155274713|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
155274714|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
155274715|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
155274716|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
155274717|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
155274718|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
155274719|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
155274720|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
155274721|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
155274722|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
155274723|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
155274724|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
155274725|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
155274726|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
155274727|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
155274728|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
155274729|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274730|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274731|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274732|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274733|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274734|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274735|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274736|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274737|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274738|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274739|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274740|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274741|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274742|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274743|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274744|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
155274745|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
155274746|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
155274747|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
155274748|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
155274749|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
155274750|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
155274751|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
155274752|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
155274753|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
155274754|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
155274755|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
155274756|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
155274757|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
155274758|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
155274759|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
155274760|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
155274761|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
155274762|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
155274763|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
155274764|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
155274765|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274766|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274767|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274768|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274769|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274770|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274771|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274772|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274773|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274774|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274775|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274776|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274777|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274778|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274779|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
155274780|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274781|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
155274782|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
155274783|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274784|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274785|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274786|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274787|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274788|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274789|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274790|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274791|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274792|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274793|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274794|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274795|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274796|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274797|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
155274798|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274799|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
155274800|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
155274801|NCT01474512|560438330|FG000|Post-Treatment Follow-Up|Death|0|||
155274802|NCT01474512|560438331|FG001|Post-Treatment Follow-Up|Death|0|||
155274803|NCT01474512|560438332|FG002|Post-Treatment Follow-Up|Death|0|||
155274804|NCT01474512|560438333|FG003|Post-Treatment Follow-Up|Death|0|||
155274805|NCT01474512|560438334|FG004|Post-Treatment Follow-Up|Death|0|||
155274806|NCT01474512|560438335|FG005|Post-Treatment Follow-Up|Death|0|||
155274807|NCT01474512|560438336|FG006|Post-Treatment Follow-Up|Death|0|||
155274808|NCT01474512|560438337|FG007|Post-Treatment Follow-Up|Death|0|||
155274809|NCT01474512|560438338|FG008|Post-Treatment Follow-Up|Death|0|||
155274810|NCT01474512|560438339|FG009|Post-Treatment Follow-Up|Death|0|||
155274811|NCT01474512|560438340|FG010|Post-Treatment Follow-Up|Death|0|||
155274812|NCT01474512|560438341|FG011|Post-Treatment Follow-Up|Death|0|||
155274813|NCT01474512|560438342|FG012|Post-Treatment Follow-Up|Death|0|||
155274814|NCT01474512|560438343|FG013|Post-Treatment Follow-Up|Death|0|||
155274815|NCT01474512|560438344|FG014|Post-Treatment Follow-Up|Death|0|||
155274816|NCT01474512|560438345|FG015|Post-Treatment Follow-Up|Death|0|||
155274817|NCT01474512|560438346|FG016|Post-Treatment Follow-Up|Death|1|||
155274818|NCT01474512|560438347|FG017|Post-Treatment Follow-Up|Death|0|||
155274819|NCT01238575|560438348|FG000|Overall Study|Lack of Efficacy|2|||
155274820|NCT01238575|560438349|FG001|Overall Study|Lack of Efficacy|4|||
155274821|NCT01238575|560438348|FG000|Overall Study|Adverse Event|2|||
155274822|NCT01238575|560438349|FG001|Overall Study|Adverse Event|0|||
155274823|NCT02254421|560438357|FG000|Overall Study|Randomized but Not Treated|1|||
155274824|NCT02254421|560438358|FG001|Overall Study|Randomized but Not Treated|0|||
155274825|NCT02254421|560438357|FG000|Overall Study|Death|0|||
155274826|NCT02254421|560438358|FG001|Overall Study|Death|2|||
155274827|NCT02254421|560438357|FG000|Overall Study|Withdrew Consent|1|||
155274828|NCT02254421|560438358|FG001|Overall Study|Withdrew Consent|1|||
155274829|NCT00867490|560438359|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
155274830|NCT00867490|560438359|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
155274831|NCT00867490|560438359|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
155274832|NCT00867490|560438359|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
155274833|NCT00867490|560438359|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
155274834|NCT00358150|560438360|FG000|Overall Study|Adverse Event|3|||
155274835|NCT00358150|560438360|FG000|Overall Study|Withdrawal by Subject|1|||
155274836|NCT00358150|560438360|FG000|Overall Study|Undefined|3|||
154936589|NCT04741503|559194722|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
154936590|NCT04741503|559194723|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
155274837|NCT00531011|560438361|FG000|Overall Study|Withdrawal by Subject|2|||
155274838|NCT00531011|560438362|FG001|Overall Study|Withdrawal by Subject|4|||
155274839|NCT00531011|560438361|FG000|Overall Study|Death|1|||
155274840|NCT00531011|560438362|FG001|Overall Study|Death|0|||
155274841|NCT00531011|560438361|FG000|Overall Study|Lost to Follow-up|1|||
155274842|NCT00531011|560438362|FG001|Overall Study|Lost to Follow-up|0|||
155274843|NCT00531011|560438361|FG000|Overall Study|Physician Decision|0|||
155274844|NCT00531011|560438362|FG001|Overall Study|Physician Decision|3|||
155274845|NCT02823964|560438363|FG000|Overall Study|Adverse Event|2|||
155274846|NCT02823964|560438363|FG000|Overall Study|Physician Decision|1|||
155274847|NCT02823964|560438363|FG000|Overall Study|Lack of Efficacy|1|||
155274848|NCT02823964|560438363|FG000|Overall Study|Withdrawal by Subject|1|||
155274849|NCT01177813|560438364|FG000|Overall Study|Adverse Event|8|||
155274850|NCT01177813|560438365|FG001|Overall Study|Adverse Event|2|||
155274851|NCT01177813|560438366|FG002|Overall Study|Adverse Event|4|||
155274852|NCT01177813|560438367|FG003|Overall Study|Adverse Event|6|||
155274853|NCT01177813|560438368|FG004|Overall Study|Adverse Event|3|||
155274854|NCT01177813|560438364|FG000|Overall Study|Lack of Efficacy|1|||
155274855|NCT01177813|560438365|FG001|Overall Study|Lack of Efficacy|0|||
155274856|NCT01177813|560438366|FG002|Overall Study|Lack of Efficacy|0|||
155274857|NCT01177813|560438367|FG003|Overall Study|Lack of Efficacy|0|||
155274858|NCT01177813|560438368|FG004|Overall Study|Lack of Efficacy|0|||
155274859|NCT01177813|560438364|FG000|Overall Study|Protocol Violation|3|||
155274860|NCT01177813|560438365|FG001|Overall Study|Protocol Violation|2|||
155274861|NCT01177813|560438366|FG002|Overall Study|Protocol Violation|2|||
155274862|NCT01177813|560438367|FG003|Overall Study|Protocol Violation|0|||
155274863|NCT01177813|560438368|FG004|Overall Study|Protocol Violation|1|||
155274864|NCT01177813|560438364|FG000|Overall Study|Lost to Follow-up|12|||
155274865|NCT01177813|560438365|FG001|Overall Study|Lost to Follow-up|5|||
155274866|NCT01177813|560438366|FG002|Overall Study|Lost to Follow-up|6|||
155274867|NCT01177813|560438367|FG003|Overall Study|Lost to Follow-up|3|||
155274868|NCT01177813|560438368|FG004|Overall Study|Lost to Follow-up|0|||
155274869|NCT01177813|560438364|FG000|Overall Study|Withdrawal by Subject|12|||
155274870|NCT01177813|560438365|FG001|Overall Study|Withdrawal by Subject|7|||
155274871|NCT01177813|560438366|FG002|Overall Study|Withdrawal by Subject|6|||
155274872|NCT01177813|560438367|FG003|Overall Study|Withdrawal by Subject|5|||
155274873|NCT01177813|560438368|FG004|Overall Study|Withdrawal by Subject|3|||
155274874|NCT01177813|560438364|FG000|Overall Study|Other reason not defined above|5|||
155274875|NCT01177813|560438365|FG001|Overall Study|Other reason not defined above|2|||
155274876|NCT01177813|560438366|FG002|Overall Study|Other reason not defined above|2|||
155274877|NCT01177813|560438367|FG003|Overall Study|Other reason not defined above|3|||
155274878|NCT01177813|560438368|FG004|Overall Study|Other reason not defined above|2|||
155274879|NCT04011384|560438375|FG000|Overall Study|Withdrawal by Subject|2|||
155274880|NCT04011384|560438376|FG001|Overall Study|Withdrawal by Subject|0|||
155274881|NCT00924469|560438378|FG000|Overall Study|Adverse Event|2|||
155274882|NCT00924469|560438379|FG001|Overall Study|Adverse Event|0|||
155274883|NCT00924469|560438378|FG000|Overall Study|Withdrawal by Subject|0|||
155274884|NCT00924469|560438379|FG001|Overall Study|Withdrawal by Subject|1|||
155274885|NCT00924469|560438378|FG000|Overall Study|Lost to Follow-up|0|||
155274886|NCT00924469|560438379|FG001|Overall Study|Lost to Follow-up|1|||
155274887|NCT04147260|560438382|FG000|Overall Study|Adverse Event|1|||
155274888|NCT04147260|560438383|FG001|Overall Study|Adverse Event|0|||
155274889|NCT04147260|560438384|FG002|Overall Study|Adverse Event|1|||
155274890|NCT04147260|560438385|FG003|Overall Study|Adverse Event|2|||
155274891|NCT04147260|560438386|FG004|Overall Study|Adverse Event|0|||
155274892|NCT04147260|560438382|FG000|Overall Study|Withdrawal by Subject|0|||
155274893|NCT04147260|560438383|FG001|Overall Study|Withdrawal by Subject|0|||
155274894|NCT04147260|560438384|FG002|Overall Study|Withdrawal by Subject|1|||
155274895|NCT04147260|560438385|FG003|Overall Study|Withdrawal by Subject|1|||
155274896|NCT04147260|560438386|FG004|Overall Study|Withdrawal by Subject|0|||
155274897|NCT00630058|560438387|FG000|Overall Study|Adverse Event|1|||
155274898|NCT00630058|560438388|FG001|Overall Study|Adverse Event|1|||
155274899|NCT00630058|560438387|FG000|Overall Study|Withdrawal by Subject|0|||
155274900|NCT00630058|560438388|FG001|Overall Study|Withdrawal by Subject|1|||
155274901|NCT00630058|560438387|FG000|Overall Study|stopping criteria|3|||
155274902|NCT00630058|560438388|FG001|Overall Study|stopping criteria|2|||
155274903|NCT01651936|560438389|FG000|Base Study|Adverse Event|3|||
155274904|NCT01651936|560438390|FG001|Base Study|Adverse Event|0|||
155274905|NCT01651936|560438391|FG002|Base Study|Adverse Event|0|||
155274906|NCT01651936|560438389|FG000|Base Study|Withdrawal by Subject|1|||
155274907|NCT01651936|560438390|FG001|Base Study|Withdrawal by Subject|1|||
155274908|NCT01651936|560438391|FG002|Base Study|Withdrawal by Subject|0|||
155274909|NCT01651936|560438389|FG000|Base Study|Early Escape|2|||
155274910|NCT01651936|560438390|FG001|Base Study|Early Escape|8|||
155274911|NCT01651936|560438391|FG002|Base Study|Early Escape|0|||
155274912|NCT01651936|560438389|FG000|Base Study|Study terminated by sponsor|21|||
155274913|NCT01651936|560438390|FG001|Base Study|Study terminated by sponsor|16|||
155274914|NCT01651936|560438391|FG002|Base Study|Study terminated by sponsor|0|||
155274915|NCT01651936|560438389|FG000|Extension Study|Lack of Efficacy|0|||
155274916|NCT01651936|560438390|FG001|Extension Study|Lack of Efficacy|0|||
155274917|NCT01651936|560438391|FG002|Extension Study|Lack of Efficacy|1|||
155274918|NCT01651936|560438389|FG000|Extension Study|Study terminated by sponsor|0|||
155274919|NCT01651936|560438390|FG001|Extension Study|Study terminated by sponsor|0|||
155274920|NCT01651936|560438391|FG002|Extension Study|Study terminated by sponsor|13|||
155274921|NCT03044353|560438392|FG000|Overall Study|Adverse Event|0|||
155274922|NCT03044353|560438393|FG001|Overall Study|Adverse Event|1|||
155274923|NCT03044353|560438394|FG002|Overall Study|Adverse Event|0|||
155274924|NCT01555021|560438401|FG000|Overall Study|Lost to Follow-up|1|||
155274925|NCT01555021|560438402|FG001|Overall Study|Lost to Follow-up|2|||
155274926|NCT02204293|560438403|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
155274927|NCT02204293|560438404|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
155274928|NCT02204293|560438405|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
155274929|NCT02204293|560438406|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
155274930|NCT02204293|560438407|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
155274931|NCT02204293|560438408|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
155274932|NCT02204293|560438403|FG000|Core Study Part I|Adverse Event|1|||
155274933|NCT02204293|560438404|FG001|Core Study Part I|Adverse Event|0|||
155274934|NCT02204293|560438405|FG002|Core Study Part I|Adverse Event|0|||
155274935|NCT02204293|560438406|FG003|Core Study Part I|Adverse Event|0|||
155274936|NCT02204293|560438407|FG004|Core Study Part I|Adverse Event|0|||
155274937|NCT02204293|560438408|FG005|Core Study Part I|Adverse Event|0|||
155274938|NCT02204293|560438403|FG000|Core Study Part I|Physician Decision|0|||
155274939|NCT02204293|560438404|FG001|Core Study Part I|Physician Decision|3|||
155274940|NCT02204293|560438405|FG002|Core Study Part I|Physician Decision|0|||
155274941|NCT02204293|560438406|FG003|Core Study Part I|Physician Decision|0|||
155274942|NCT02204293|560438407|FG004|Core Study Part I|Physician Decision|0|||
155274943|NCT02204293|560438408|FG005|Core Study Part I|Physician Decision|0|||
155274944|NCT02204293|560438403|FG000|LTE Phase|Study Suspended|0|||
155274945|NCT02204293|560438404|FG001|LTE Phase|Study Suspended|0|||
155274946|NCT02204293|560438405|FG002|LTE Phase|Study Suspended|0|||
155274947|NCT02204293|560438406|FG003|LTE Phase|Study Suspended|0|||
155274948|NCT02204293|560438407|FG004|LTE Phase|Study Suspended|0|||
155274949|NCT02204293|560438408|FG005|LTE Phase|Study Suspended|7|||
155274950|NCT01225835|560438409|FG000|Overall Study|Completed protocol|2|||
155274951|NCT01225835|560438410|FG001|Overall Study|Completed protocol|1|||
155274952|NCT01225835|560438409|FG000|Overall Study|Did not meet hCG criterion|2|||
155274953|NCT01225835|560438410|FG001|Overall Study|Did not meet hCG criterion|0|||
155274954|NCT01225835|560438409|FG000|Overall Study|Adverse Event|2|||
155274955|NCT01225835|560438410|FG001|Overall Study|Adverse Event|1|||
155274956|NCT01225835|560438409|FG000|Overall Study|Other|1|||
155274957|NCT01225835|560438410|FG001|Overall Study|Other|1|||
155274958|NCT02589392|560438413|FG000|Overall Study|Adverse Event|1|||
155274959|NCT02589392|560438414|FG001|Overall Study|Adverse Event|1|||
155274960|NCT02589392|560438413|FG000|Overall Study|Withdrawal by Subject|1|||
155274961|NCT02589392|560438414|FG001|Overall Study|Withdrawal by Subject|2|||
155274962|NCT02589392|560438413|FG000|Overall Study|Protocol Violation|1|||
155274963|NCT02589392|560438414|FG001|Overall Study|Protocol Violation|1|||
155274964|NCT02589392|560438413|FG000|Overall Study|Lost to Follow-up|2|||
155274965|NCT02589392|560438414|FG001|Overall Study|Lost to Follow-up|2|||
155274966|NCT02589392|560438413|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
155274967|NCT02589392|560438414|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
155274968|NCT01266993|560438415|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
155274969|NCT01266993|560438416|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
155274970|NCT01266993|560438415|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
155274971|NCT01266993|560438416|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
155274972|NCT03051659|560438417|FG000|Treatment Period|Withdrawal by Subject|0|||
155274973|NCT03051659|560438418|FG001|Treatment Period|Withdrawal by Subject|2|||
155274974|NCT03051659|560438417|FG000|Survival Follow-up|Lost to Follow-up|23|||
155274975|NCT03051659|560438418|FG001|Survival Follow-up|Lost to Follow-up|22|||
155274976|NCT02293837|560438419|FG000|Overall Study|Lost to Follow-up|0|||
155274977|NCT02293837|560438420|FG001|Overall Study|Lost to Follow-up|2|||
155274978|NCT02293837|560438421|FG002|Overall Study|Lost to Follow-up|1|||
155274979|NCT02293837|560438422|FG003|Overall Study|Lost to Follow-up|0|||
155274980|NCT02293837|560438419|FG000|Overall Study|Withdrawal by Subject|2|||
155274981|NCT02293837|560438420|FG001|Overall Study|Withdrawal by Subject|1|||
155274982|NCT02293837|560438421|FG002|Overall Study|Withdrawal by Subject|2|||
155274983|NCT02293837|560438422|FG003|Overall Study|Withdrawal by Subject|1|||
155274984|NCT02293837|560438419|FG000|Overall Study|COVID-19 Related|1|||
155274985|NCT02293837|560438420|FG001|Overall Study|COVID-19 Related|1|||
155274986|NCT02293837|560438421|FG002|Overall Study|COVID-19 Related|0|||
155274987|NCT02293837|560438422|FG003|Overall Study|COVID-19 Related|0|||
155274988|NCT02293837|560438419|FG000|Overall Study|Participant ill and could not be infused|0|||
155274989|NCT02293837|560438420|FG001|Overall Study|Participant ill and could not be infused|0|||
155274990|NCT02293837|560438421|FG002|Overall Study|Participant ill and could not be infused|1|||
155274991|NCT02293837|560438422|FG003|Overall Study|Participant ill and could not be infused|0|||
155274992|NCT04779242|560438423|FG000|Overall Study|Adverse Event|1|||
155274993|NCT04779242|560438424|FG001|Overall Study|Adverse Event|1|||
155274994|NCT04779242|560438423|FG000|Overall Study|Lost to Follow-up|2|||
155274995|NCT04779242|560438424|FG001|Overall Study|Lost to Follow-up|4|||
155274996|NCT04779242|560438423|FG000|Overall Study|Withdrawal by Subject|7|||
155274997|NCT04779242|560438424|FG001|Overall Study|Withdrawal by Subject|9|||
155274998|NCT04779242|560438423|FG000|Overall Study|Death|6|||
155274999|NCT04779242|560438424|FG001|Overall Study|Death|6|||
155275000|NCT04779242|560438423|FG000|Overall Study|COVID-19 related reasons|2|||
155275001|NCT04779242|560438424|FG001|Overall Study|COVID-19 related reasons|1|||
155275002|NCT04779242|560438423|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
155275003|NCT04779242|560438424|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
155275004|NCT04779242|560438423|FG000|Overall Study|Martial Law in Ukraine|2|||
155275005|NCT04779242|560438424|FG001|Overall Study|Martial Law in Ukraine|3|||
155275006|NCT03285113|560438425|FG000|Overall Study|Unable to implant leads|2|||
155275007|NCT01076088|560438427|FG000|Overall Study|Adverse Event|1|||
155275008|NCT01076088|560438428|FG001|Overall Study|Adverse Event|6|||
155275009|NCT01076088|560438429|FG002|Overall Study|Adverse Event|3|||
155275010|NCT01076088|560438430|FG003|Overall Study|Adverse Event|2|||
155275011|NCT01076088|560438431|FG004|Overall Study|Adverse Event|3|||
155275012|NCT01076088|560438432|FG005|Overall Study|Adverse Event|3|||
155275013|NCT01076088|560438427|FG000|Overall Study|Lost to Follow-up|1|||
155275014|NCT01076088|560438428|FG001|Overall Study|Lost to Follow-up|1|||
155275015|NCT01076088|560438429|FG002|Overall Study|Lost to Follow-up|0|||
155275016|NCT01076088|560438430|FG003|Overall Study|Lost to Follow-up|1|||
155275017|NCT01076088|560438431|FG004|Overall Study|Lost to Follow-up|1|||
155275018|NCT01076088|560438432|FG005|Overall Study|Lost to Follow-up|2|||
155275019|NCT01076088|560438427|FG000|Overall Study|Non-compliance with study drug|0|||
155275020|NCT01076088|560438428|FG001|Overall Study|Non-compliance with study drug|0|||
155275021|NCT01076088|560438429|FG002|Overall Study|Non-compliance with study drug|0|||
155275022|NCT01076088|560438430|FG003|Overall Study|Non-compliance with study drug|1|||
155275023|NCT01076088|560438431|FG004|Overall Study|Non-compliance with study drug|0|||
155275024|NCT01076088|560438432|FG005|Overall Study|Non-compliance with study drug|0|||
155275025|NCT01076088|560438427|FG000|Overall Study|Physician Decision|1|||
155275026|NCT01076088|560438428|FG001|Overall Study|Physician Decision|3|||
155275027|NCT01076088|560438429|FG002|Overall Study|Physician Decision|0|||
155275028|NCT01076088|560438430|FG003|Overall Study|Physician Decision|1|||
155275029|NCT01076088|560438431|FG004|Overall Study|Physician Decision|1|||
155275030|NCT01076088|560438432|FG005|Overall Study|Physician Decision|0|||
155275031|NCT01076088|560438427|FG000|Overall Study|Withdrawal by Subject|8|||
155275032|NCT01076088|560438428|FG001|Overall Study|Withdrawal by Subject|8|||
155275033|NCT01076088|560438429|FG002|Overall Study|Withdrawal by Subject|14|||
155275034|NCT01076088|560438430|FG003|Overall Study|Withdrawal by Subject|10|||
155275035|NCT01076088|560438431|FG004|Overall Study|Withdrawal by Subject|11|||
155275036|NCT01076088|560438432|FG005|Overall Study|Withdrawal by Subject|17|||
155275037|NCT01076088|560438427|FG000|Overall Study|Other protocol specified criteria|0|||
155275038|NCT01076088|560438428|FG001|Overall Study|Other protocol specified criteria|0|||
155275039|NCT01076088|560438429|FG002|Overall Study|Other protocol specified criteria|0|||
155275040|NCT01076088|560438430|FG003|Overall Study|Other protocol specified criteria|0|||
155275041|NCT01076088|560438431|FG004|Overall Study|Other protocol specified criteria|0|||
155275042|NCT01076088|560438432|FG005|Overall Study|Other protocol specified criteria|1|||
155275043|NCT03053492|560438435|FG000|Overall Study|Adverse Event|1|||
155275044|NCT03053492|560438436|FG001|Overall Study|Adverse Event|1|||
155275045|NCT03053492|560438435|FG000|Overall Study|Withdrawal by Subject|7|||
155275046|NCT03053492|560438436|FG001|Overall Study|Withdrawal by Subject|5|||
155275047|NCT00849680|560438439|FG000|Overall Study|Adverse Event|0|||
155275048|NCT00849680|560438440|FG001|Overall Study|Adverse Event|0|||
155275049|NCT00849680|560438441|FG002|Overall Study|Adverse Event|0|||
155275050|NCT00849680|560438442|FG003|Overall Study|Adverse Event|0|||
155275051|NCT00849680|560438443|FG004|Overall Study|Adverse Event|0|||
155275052|NCT00849680|560438444|FG005|Overall Study|Adverse Event|0|||
155275053|NCT00849680|560438445|FG006|Overall Study|Adverse Event|2|||
155275054|NCT00849680|560438446|FG007|Overall Study|Adverse Event|0|||
155275055|NCT00849680|560438439|FG000|Overall Study|Lost to Follow-up|7|||
155275056|NCT00849680|560438440|FG001|Overall Study|Lost to Follow-up|3|||
155275057|NCT00849680|560438441|FG002|Overall Study|Lost to Follow-up|12|||
155275058|NCT00849680|560438442|FG003|Overall Study|Lost to Follow-up|11|||
155275059|NCT00849680|560438443|FG004|Overall Study|Lost to Follow-up|8|||
155275060|NCT00849680|560438444|FG005|Overall Study|Lost to Follow-up|11|||
155275061|NCT00849680|560438445|FG006|Overall Study|Lost to Follow-up|12|||
155275062|NCT00849680|560438446|FG007|Overall Study|Lost to Follow-up|5|||
155275063|NCT00849680|560438439|FG000|Overall Study|Subject moved|1|||
155275064|NCT00849680|560438440|FG001|Overall Study|Subject moved|0|||
155275065|NCT00849680|560438441|FG002|Overall Study|Subject moved|3|||
155275066|NCT00849680|560438442|FG003|Overall Study|Subject moved|1|||
155275067|NCT00849680|560438443|FG004|Overall Study|Subject moved|0|||
155275068|NCT00849680|560438444|FG005|Overall Study|Subject moved|2|||
155275069|NCT00849680|560438445|FG006|Overall Study|Subject moved|2|||
155275070|NCT00849680|560438446|FG007|Overall Study|Subject moved|2|||
155275071|NCT00849680|560438439|FG000|Overall Study|Withdrawal by Subject|2|||
155275072|NCT00849680|560438440|FG001|Overall Study|Withdrawal by Subject|0|||
155275073|NCT00849680|560438441|FG002|Overall Study|Withdrawal by Subject|0|||
155275074|NCT00849680|560438442|FG003|Overall Study|Withdrawal by Subject|2|||
155275075|NCT00849680|560438443|FG004|Overall Study|Withdrawal by Subject|2|||
155275076|NCT00849680|560438444|FG005|Overall Study|Withdrawal by Subject|2|||
155275077|NCT00849680|560438445|FG006|Overall Study|Withdrawal by Subject|1|||
155275078|NCT00849680|560438446|FG007|Overall Study|Withdrawal by Subject|1|||
155275079|NCT00849680|560438439|FG000|Overall Study|Subject unable to comply with protocol|1|||
155275080|NCT00849680|560438440|FG001|Overall Study|Subject unable to comply with protocol|0|||
155275081|NCT00849680|560438441|FG002|Overall Study|Subject unable to comply with protocol|0|||
155275082|NCT00849680|560438442|FG003|Overall Study|Subject unable to comply with protocol|0|||
155275083|NCT00849680|560438443|FG004|Overall Study|Subject unable to comply with protocol|0|||
155275084|NCT00849680|560438444|FG005|Overall Study|Subject unable to comply with protocol|0|||
155275085|NCT00849680|560438445|FG006|Overall Study|Subject unable to comply with protocol|0|||
155275086|NCT00849680|560438446|FG007|Overall Study|Subject unable to comply with protocol|0|||
155275087|NCT03382600|560438448|FG000|Overall Study|Adverse Event|3|||
155275088|NCT03382600|560438449|FG001|Overall Study|Adverse Event|3|||
155275089|NCT03382600|560438448|FG000|Overall Study|Clinical Disease Progression|2|||
155275090|NCT03382600|560438449|FG001|Overall Study|Clinical Disease Progression|4|||
155275091|NCT03382600|560438448|FG000|Overall Study|Radiological Progression|40|||
155275092|NCT03382600|560438449|FG001|Overall Study|Radiological Progression|31|||
155275093|NCT03382600|560438448|FG000|Overall Study|Withdrawal by Subject|0|||
155275094|NCT03382600|560438449|FG001|Overall Study|Withdrawal by Subject|1|||
155275095|NCT03382600|560438448|FG000|Overall Study|Other|9|||
155275096|NCT03382600|560438449|FG001|Overall Study|Other|7|||
155275097|NCT01857622|560438454|FG000|Overall Study|Adverse Event|5|||
155275098|NCT01857622|560438455|FG001|Overall Study|Adverse Event|0|||
155275099|NCT01857622|560438456|FG002|Overall Study|Adverse Event|2|||
155275100|NCT01857622|560438454|FG000|Overall Study|Physician Decision|1|||
155275101|NCT01857622|560438455|FG001|Overall Study|Physician Decision|0|||
155275102|NCT01857622|560438456|FG002|Overall Study|Physician Decision|0|||
155275103|NCT01857622|560438454|FG000|Overall Study|Protocol Violation|4|||
155275104|NCT01857622|560438455|FG001|Overall Study|Protocol Violation|1|||
155275105|NCT01857622|560438456|FG002|Overall Study|Protocol Violation|0|||
155275106|NCT01857622|560438454|FG000|Overall Study|Withdrawal by Subject|1|||
155275107|NCT01857622|560438455|FG001|Overall Study|Withdrawal by Subject|0|||
155275108|NCT01857622|560438456|FG002|Overall Study|Withdrawal by Subject|0|||
155275109|NCT01291225|560438459|FG000|Overall Study|Lost to Follow-up|85|||
155275110|NCT01291225|560438460|FG001|Overall Study|Lost to Follow-up|39|||
155275111|NCT00514046|560438463|FG000|Overall Study|transferred to another protocol|2|||
155275112|NCT00514046|560438464|FG001|Overall Study|transferred to another protocol|1|||
155275113|NCT00514046|560438465|FG002|Overall Study|transferred to another protocol|3|||
155275114|NCT00514046|560438466|FG003|Overall Study|transferred to another protocol|0|||
155275115|NCT00514046|560438467|FG004|Overall Study|transferred to another protocol|1|||
155275116|NCT00514046|560438468|FG005|Overall Study|transferred to another protocol|0|||
155275117|NCT00514046|560438469|FG006|Overall Study|transferred to another protocol|0|||
155275118|NCT00514046|560438470|FG007|Overall Study|transferred to another protocol|0|||
155275119|NCT00514046|560438471|FG008|Overall Study|transferred to another protocol|0|||
155275120|NCT00514046|560438463|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
155275121|NCT00514046|560438464|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
155275122|NCT00514046|560438465|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
155275123|NCT00514046|560438466|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
155275124|NCT00514046|560438467|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
155275125|NCT00514046|560438468|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
155275126|NCT00514046|560438469|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
155275127|NCT00514046|560438470|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
155275128|NCT00514046|560438471|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
155275129|NCT00514046|560438463|FG000|Overall Study|Disease progression on study|0|||
155275130|NCT00514046|560438464|FG001|Overall Study|Disease progression on study|0|||
155275131|NCT00514046|560438465|FG002|Overall Study|Disease progression on study|2|||
155275132|NCT00514046|560438466|FG003|Overall Study|Disease progression on study|0|||
155275133|NCT00514046|560438467|FG004|Overall Study|Disease progression on study|0|||
155275134|NCT00514046|560438468|FG005|Overall Study|Disease progression on study|1|||
155275135|NCT00514046|560438469|FG006|Overall Study|Disease progression on study|0|||
155275136|NCT00514046|560438470|FG007|Overall Study|Disease progression on study|0|||
155275137|NCT00514046|560438471|FG008|Overall Study|Disease progression on study|0|||
155275138|NCT01163747|560438473|FG000|Overall Study|Adverse Event|0|||
155275139|NCT01163747|560438474|FG001|Overall Study|Adverse Event|5|||
155275140|NCT01163747|560438473|FG000|Overall Study|Insufficient Therapeutic Response|0|||
155275141|NCT01163747|560438474|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155275142|NCT01163747|560438473|FG000|Overall Study|Protocol Violation|0|||
155275143|NCT01163747|560438474|FG001|Overall Study|Protocol Violation|1|||
155275144|NCT01163747|560438473|FG000|Overall Study|Refused Treatment|6|||
155275145|NCT01163747|560438474|FG001|Overall Study|Refused Treatment|4|||
155275146|NCT02044458|560438478|FG000|Overall Study|Protocol Violation|3|||
155275147|NCT02044458|560438479|FG001|Overall Study|Protocol Violation|8|||
155275148|NCT01853254|560440377|FG000|Overall Study|Abnormal Laboratory Test|1|||
155275149|NCT01853254|560440377|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
155275150|NCT01853254|560440377|FG000|Overall Study|Death|1|||
155275151|NCT01853254|560440377|FG000|Overall Study|Failure to Return|43|||
155275152|NCT01853254|560440377|FG000|Overall Study|Insufficient Therapeutic Response|22|||
155275153|NCT01853254|560440377|FG000|Overall Study|Refusal of Treatment|1|||
155275154|NCT01853254|560440377|FG000|Overall Study|Other Protocol Violation|1|||
155275155|NCT01853254|560440377|FG000|Overall Study|Withdrawal of Consent|16|||
155275156|NCT01853254|560440377|FG000|Overall Study|Administrative/Other|16|||
155275157|NCT02462083|560440378|FG000|Overall Study|Sponsor request|39|||
155275158|NCT02462083|560440378|FG000|Overall Study|Withdrawal by Subject|87|||
155275159|NCT02462083|560440378|FG000|Overall Study|Lost to Follow-up|41|||
155275160|NCT02462083|560440378|FG000|Overall Study|Lack of Efficacy|151|||
155275161|NCT02462083|560440378|FG000|Overall Study|Pregnancy|1|||
155275162|NCT02462083|560440378|FG000|Overall Study|Protocol Violation|6|||
155275163|NCT02462083|560440378|FG000|Overall Study|Adverse Event|33|||
155275164|NCT02462083|560440378|FG000|Overall Study|Worsening condition|16|||
155275165|NCT02462083|560440378|FG000|Overall Study|Other than specified|45|||
155275166|NCT01642186|560440379|FG000|Overall Study|Death|0|||
155275167|NCT01642186|560440380|FG001|Overall Study|Death|2|||
155275168|NCT01642186|560440381|FG002|Overall Study|Death|2|||
155275169|NCT01642186|560440379|FG000|Overall Study|Lost to Follow-up|0|||
155275170|NCT01642186|560440380|FG001|Overall Study|Lost to Follow-up|0|||
155275171|NCT01642186|560440381|FG002|Overall Study|Lost to Follow-up|1|||
155275172|NCT00163215|560440382|FG000|Overall Study|Lack of Efficacy|3|||
155275173|NCT00163215|560440382|FG000|Overall Study|Withdrawal by Subject|5|||
155275174|NCT00163215|560440382|FG000|Overall Study|Other|7|||
155275175|NCT01668147|560440385|FG000|Overall Study|Withdrawal by Subject|6|||
155275176|NCT01809210|560440386|FG000|Overall Study|Withdrawal by Subject|0|||
155275177|NCT01809210|560440387|FG001|Overall Study|Withdrawal by Subject|0|||
155275178|NCT01809210|560440388|FG002|Overall Study|Withdrawal by Subject|1|||
155275179|NCT01809210|560440389|FG003|Overall Study|Withdrawal by Subject|1|||
155275180|NCT01809210|560440390|FG004|Overall Study|Withdrawal by Subject|1|||
155275181|NCT01809210|560440391|FG005|Overall Study|Withdrawal by Subject|0|||
155275182|NCT01809210|560440392|FG006|Overall Study|Withdrawal by Subject|4|||
155275183|NCT01809210|560440386|FG000|Overall Study|Death|1|||
155275184|NCT01809210|560440387|FG001|Overall Study|Death|1|||
155275185|NCT01809210|560440388|FG002|Overall Study|Death|2|||
155275186|NCT01809210|560440389|FG003|Overall Study|Death|0|||
155275187|NCT01809210|560440390|FG004|Overall Study|Death|1|||
155275188|NCT01809210|560440391|FG005|Overall Study|Death|3|||
155275189|NCT01809210|560440392|FG006|Overall Study|Death|1|||
155275190|NCT01115998|560440395|FG000|Overall Study|Lost to Follow-up|6|||
155275191|NCT01115998|560440396|FG001|Overall Study|Lost to Follow-up|6|||
155275192|NCT00224133|560440397|FG000|Overall Study|Adverse Event|93|||
155275193|NCT00224133|560440397|FG000|Overall Study|Protocol Violation|6|||
155275194|NCT00224133|560440397|FG000|Overall Study|Withdrawal by Subject|33|||
155275195|NCT00224133|560440397|FG000|Overall Study|Lack of Efficacy|58|||
155275196|NCT00224133|560440397|FG000|Overall Study|Lost to Follow-up|21|||
155275197|NCT00224133|560440397|FG000|Overall Study|Physician Decision|1|||
155275198|NCT00224133|560440397|FG000|Overall Study|Other|14|||
155275199|NCT01118962|560440404|FG000|Overall Study|Adverse Event|2|||
155275200|NCT01118962|560440404|FG000|Overall Study|Lack of Efficacy|1|||
155275201|NCT01118962|560440404|FG000|Overall Study|Protocol Violation|1|||
155275202|NCT01118962|560440404|FG000|Overall Study|Withdrawal by Subject|4|||
155275203|NCT01118962|560440404|FG000|Overall Study|Pregnancy|1|||
155275204|NCT01118962|560440404|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
155275205|NCT00593554|560440405|FG000|Overall Study|Death|1|||
155275206|NCT00593554|560440406|FG001|Overall Study|Death|2|||
155275207|NCT00593554|560440405|FG000|Overall Study|Physician Decision|0|||
155275208|NCT00593554|560440406|FG001|Overall Study|Physician Decision|1|||
155275209|NCT00593554|560440405|FG000|Overall Study|Withdrawal by Subject|1|||
155275210|NCT00593554|560440406|FG001|Overall Study|Withdrawal by Subject|0|||
155275211|NCT00593554|560440405|FG000|Overall Study|Disease Progression|1|||
155275212|NCT00593554|560440406|FG001|Overall Study|Disease Progression|2|||
155275213|NCT00795132|560440409|FG000|Overall Study|Death|1|||
155275214|NCT00795132|560440409|FG000|Overall Study|Relapse|2|||
154936591|NCT00597584|559194724|FG000|Overall Study|Adverse Event|4|||
155275215|NCT00962585|560440410|FG000|Overall Study|Adverse Event|0|||
155275216|NCT00962585|560440411|FG001|Overall Study|Adverse Event|2|||
155275217|NCT00962585|560440412|FG002|Overall Study|Adverse Event|1|||
155275218|NCT00962585|560440413|FG003|Overall Study|Adverse Event|0|||
155275219|NCT00962585|560440410|FG000|Overall Study|Lost to Follow-up|3|||
155275220|NCT00962585|560440411|FG001|Overall Study|Lost to Follow-up|0|||
155275221|NCT00962585|560440412|FG002|Overall Study|Lost to Follow-up|1|||
155275222|NCT00962585|560440413|FG003|Overall Study|Lost to Follow-up|0|||
155275223|NCT00962585|560440410|FG000|Overall Study|Protocol Violation|0|||
155275224|NCT00962585|560440411|FG001|Overall Study|Protocol Violation|0|||
155275225|NCT00962585|560440412|FG002|Overall Study|Protocol Violation|1|||
155275226|NCT00962585|560440413|FG003|Overall Study|Protocol Violation|0|||
155381938|NCT00598273|560833244|FG002|Overall Study|Death|8|||
155275227|NCT00962585|560440410|FG000|Overall Study|Withdrawal by Subject|1|||
155275228|NCT00962585|560440411|FG001|Overall Study|Withdrawal by Subject|0|||
155275229|NCT00962585|560440412|FG002|Overall Study|Withdrawal by Subject|0|||
155275230|NCT00962585|560440413|FG003|Overall Study|Withdrawal by Subject|0|||
155275231|NCT00962585|560440410|FG000|Overall Study|Withdrew Consent|2|||
155275232|NCT00962585|560440411|FG001|Overall Study|Withdrew Consent|0|||
155275233|NCT00962585|560440412|FG002|Overall Study|Withdrew Consent|0|||
155275234|NCT00962585|560440413|FG003|Overall Study|Withdrew Consent|0|||
155275235|NCT00262743|560440414|FG000|Overall Study|Adverse Event|0|||
155275236|NCT00262743|560440415|FG001|Overall Study|Adverse Event|9|||
155275237|NCT00262743|560440414|FG000|Overall Study|Disease progression|0|||
155275238|NCT00262743|560440415|FG001|Overall Study|Disease progression|3|||
155275239|NCT04430335|560440422|FG000|Overall Study|Withdrawal by Subject|1|||
155275240|NCT00179010|560440425|FG000|Overall Study|Muscle probe defective|1|||
155275241|NCT00179010|560440426|FG001|Overall Study|Muscle probe defective|1|||
155275242|NCT00179010|560440425|FG000|Overall Study|Failure to place arterial line|0|||
155275243|NCT00179010|560440426|FG001|Overall Study|Failure to place arterial line|1|||
155275244|NCT03249376|560440444|FG000|Overall Study|Adverse Event|11|||
155275245|NCT03249376|560440445|FG001|Overall Study|Adverse Event|5|||
155275246|NCT03249376|560440444|FG000|Overall Study|Lack of Efficacy|2|||
155275247|NCT03249376|560440445|FG001|Overall Study|Lack of Efficacy|4|||
155275248|NCT03249376|560440444|FG000|Overall Study|Protocol Violation|3|||
155275249|NCT03249376|560440445|FG001|Overall Study|Protocol Violation|2|||
155275250|NCT03249376|560440444|FG000|Overall Study|Physician Decision|0|||
155275251|NCT03249376|560440445|FG001|Overall Study|Physician Decision|2|||
155275252|NCT03249376|560440444|FG000|Overall Study|Withdrawal by Subject|3|||
155275253|NCT03249376|560440445|FG001|Overall Study|Withdrawal by Subject|9|||
155275254|NCT03249376|560440444|FG000|Overall Study|LTFU|2|||
155275255|NCT03249376|560440445|FG001|Overall Study|LTFU|1|||
155275256|NCT00627042|560440446|FG000|Overall Study|Withdrawal by Subject|2|||
155275257|NCT04747275|560440447|FG000|Overall Study|Study terminated|0|||
155275258|NCT04747275|560440448|FG001|Overall Study|Study terminated|1|||
155275259|NCT04254679|560440451|FG000|Overall Study|Protocol Violation|1|||
155275260|NCT04254679|560440452|FG001|Overall Study|Protocol Violation|1|||
155275261|NCT04254679|560440451|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
155275262|NCT04254679|560440452|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
155275263|NCT01388530|560440460|FG000|Overall Study|Lost to Follow-up|5|||
155275264|NCT05284019|560440461|FG000|Overall Study|Study terminated|2|||
155275265|NCT05284019|560440462|FG001|Overall Study|Study terminated|2|||
155275266|NCT05284019|560440463|FG002|Overall Study|Study terminated|2|||
155275267|NCT05284019|560440464|FG003|Overall Study|Study terminated|5|||
155275268|NCT05284019|560440465|FG004|Overall Study|Study terminated|15|||
155275269|NCT05284019|560440461|FG000|Overall Study|Withdrawal by Subject|0|||
155275270|NCT05284019|560440462|FG001|Overall Study|Withdrawal by Subject|0|||
155275271|NCT05284019|560440463|FG002|Overall Study|Withdrawal by Subject|0|||
155275272|NCT05284019|560440464|FG003|Overall Study|Withdrawal by Subject|1|||
155275273|NCT05284019|560440465|FG004|Overall Study|Withdrawal by Subject|1|||
155275274|NCT05284019|560440461|FG000|Overall Study|Lost to Follow-up|1|||
155275275|NCT05284019|560440462|FG001|Overall Study|Lost to Follow-up|0|||
155275276|NCT05284019|560440463|FG002|Overall Study|Lost to Follow-up|0|||
155275277|NCT05284019|560440464|FG003|Overall Study|Lost to Follow-up|2|||
155275278|NCT05284019|560440465|FG004|Overall Study|Lost to Follow-up|1|||
155275279|NCT01990300|560440466|FG000|Overall Study|Case Report Forms Uncollected|89|||
155275280|NCT01990300|560440466|FG000|Overall Study|Protocol Deviation|53|||
155275281|NCT02420327|560440467|FG000|Overall Study|Adverse Event|7|||
155275282|NCT02420327|560440467|FG000|Overall Study|Pregnancy|1|||
155275283|NCT02420327|560440467|FG000|Overall Study|Withdrawal by Subject|6|||
155275284|NCT02420327|560440467|FG000|Overall Study|Lost to Follow-up|1|||
155275285|NCT02420327|560440467|FG000|Overall Study|Protocol Violation|1|||
155275286|NCT01146574|560440470|FG000|Overall Study|Death|0|||
155275287|NCT01146574|560440471|FG001|Overall Study|Death|1|||
155275288|NCT01146574|560440472|FG002|Overall Study|Death|1|||
155275289|NCT01146574|560440473|FG003|Overall Study|Death|0|||
155275290|NCT01146574|560440474|FG004|Overall Study|Death|0|||
155275291|NCT01146574|560440475|FG005|Overall Study|Death|0|||
155275292|NCT01146574|560440476|FG006|Overall Study|Death|0|||
155275293|NCT01146574|560440470|FG000|Overall Study|Other reasons|0|||
155275294|NCT01146574|560440471|FG001|Overall Study|Other reasons|0|||
155275295|NCT01146574|560440472|FG002|Overall Study|Other reasons|3|||
155275296|NCT01146574|560440473|FG003|Overall Study|Other reasons|0|||
155275297|NCT01146574|560440474|FG004|Overall Study|Other reasons|0|||
155275298|NCT01146574|560440475|FG005|Overall Study|Other reasons|0|||
155275299|NCT01146574|560440476|FG006|Overall Study|Other reasons|0|||
155275300|NCT01146574|560440470|FG000|Overall Study|Kidney transplant|0|||
155275301|NCT01146574|560440471|FG001|Overall Study|Kidney transplant|0|||
155275302|NCT01146574|560440472|FG002|Overall Study|Kidney transplant|1|||
155275303|NCT01146574|560440473|FG003|Overall Study|Kidney transplant|1|||
155275304|NCT01146574|560440474|FG004|Overall Study|Kidney transplant|0|||
155275305|NCT01146574|560440475|FG005|Overall Study|Kidney transplant|0|||
155275306|NCT01146574|560440476|FG006|Overall Study|Kidney transplant|0|||
155275307|NCT01146574|560440470|FG000|Overall Study|Withdrew consent|0|||
155275308|NCT01146574|560440471|FG001|Overall Study|Withdrew consent|0|||
155275309|NCT01146574|560440472|FG002|Overall Study|Withdrew consent|1|||
155275310|NCT01146574|560440473|FG003|Overall Study|Withdrew consent|1|||
155275311|NCT01146574|560440474|FG004|Overall Study|Withdrew consent|2|||
155275312|NCT01146574|560440475|FG005|Overall Study|Withdrew consent|1|||
155275313|NCT01146574|560440476|FG006|Overall Study|Withdrew consent|1|||
155275314|NCT00683449|560440479|FG000|Overall Study|Lost to Follow-up|0|||
155275315|NCT00683449|560440480|FG001|Overall Study|Lost to Follow-up|1|||
155275316|NCT00683449|560440481|FG002|Overall Study|Lost to Follow-up|0|||
155275317|NCT00683449|560440482|FG003|Overall Study|Lost to Follow-up|0|||
155275318|NCT00683449|560440483|FG004|Overall Study|Lost to Follow-up|0|||
155275319|NCT01448044|560440486|FG000|Treatment Period|Adverse Event|4|||
155275320|NCT01448044|560440487|FG001|Treatment Period|Adverse Event|3|||
155275321|NCT01448044|560440486|FG000|Treatment Period|Lack of Efficacy|5|||
155275322|NCT01448044|560440487|FG001|Treatment Period|Lack of Efficacy|12|||
155275323|NCT01448044|560440486|FG000|Treatment Period|Subject requested discontinue study drug|1|||
155275324|NCT01448044|560440487|FG001|Treatment Period|Subject requested discontinue study drug|0|||
155275325|NCT01448044|560440486|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
155275326|NCT01448044|560440487|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
155275327|NCT01448044|560440486|FG000|Treatment Period|Participant does not meet study criteria|1|||
155275328|NCT01448044|560440487|FG001|Treatment Period|Participant does not meet study criteria|0|||
155275329|NCT01448044|560440486|FG000|Treatment Period|Lost to Follow-up|2|||
155275330|NCT01448044|560440487|FG001|Treatment Period|Lost to Follow-up|1|||
155275331|NCT01448044|560440486|FG000|Treatment Period|Other reason|2|||
155275332|NCT01448044|560440487|FG001|Treatment Period|Other reason|0|||
155275333|NCT01448044|560440486|FG000|Follow Up Period|Withdrawal by Subject|1|||
155275334|NCT01448044|560440487|FG001|Follow Up Period|Withdrawal by Subject|1|||
155275335|NCT01448044|560440486|FG000|Follow Up Period|Lost to Follow-up|6|||
155275336|NCT01448044|560440487|FG001|Follow Up Period|Lost to Follow-up|2|||
155275337|NCT01448044|560440486|FG000|Follow Up Period|Other|5|||
155275338|NCT01448044|560440487|FG001|Follow Up Period|Other|11|||
155275339|NCT00507026|560440488|FG000|Overall Study|Lack of Efficacy|6|||
155275340|NCT00507026|560440489|FG001|Overall Study|Lack of Efficacy|4|||
155275341|NCT00507026|560440490|FG002|Overall Study|Lack of Efficacy|21|||
155275342|NCT00507026|560440488|FG000|Overall Study|Withdrawal by Subject|2|||
155275343|NCT00507026|560440489|FG001|Overall Study|Withdrawal by Subject|0|||
155275344|NCT00507026|560440490|FG002|Overall Study|Withdrawal by Subject|0|||
155275345|NCT00507026|560440488|FG000|Overall Study|Investigator Decision|1|||
155275346|NCT00507026|560440489|FG001|Overall Study|Investigator Decision|0|||
155275347|NCT00507026|560440490|FG002|Overall Study|Investigator Decision|0|||
155275348|NCT00507026|560440488|FG000|Overall Study|Adverse Event|2|||
155275349|NCT00507026|560440489|FG001|Overall Study|Adverse Event|0|||
155275350|NCT00507026|560440490|FG002|Overall Study|Adverse Event|0|||
155275351|NCT00507026|560440488|FG000|Overall Study|Protocol Violation|1|||
155275352|NCT00507026|560440489|FG001|Overall Study|Protocol Violation|0|||
155275353|NCT00507026|560440490|FG002|Overall Study|Protocol Violation|0|||
155275354|NCT00507026|560440488|FG000|Overall Study|Other|1|||
155275355|NCT00507026|560440489|FG001|Overall Study|Other|0|||
155275356|NCT00507026|560440490|FG002|Overall Study|Other|0|||
155275357|NCT00681187|560440491|FG000|Overall Study|Withdrawal by Subject|1|||
155275358|NCT00681187|560440492|FG001|Overall Study|Withdrawal by Subject|0|||
155275359|NCT00681187|560440491|FG000|Overall Study|Death|0|||
155275360|NCT00681187|560440492|FG001|Overall Study|Death|1|||
155275361|NCT00681187|560440491|FG000|Overall Study|Adverse Event|0|||
155275362|NCT00681187|560440492|FG001|Overall Study|Adverse Event|1|||
155275363|NCT04230980|560440493|FG000|Overall Study|Lost to Follow-up|1|||
155275364|NCT04230980|560440494|FG001|Overall Study|Lost to Follow-up|2|||
155275365|NCT04230980|560440493|FG000|Overall Study|Adverse Event|0|||
155275366|NCT04230980|560440494|FG001|Overall Study|Adverse Event|1|||
155275367|NCT02372058|560440497|FG000|Overall Study|Withdrawal by Subject|3|||
154936592|NCT00597584|559194725|FG001|Overall Study|Adverse Event|2|||
155275368|NCT00318149|560440500|FG000|Overall Study|Adverse Event|0|||
155275369|NCT00318149|560440501|FG001|Overall Study|Adverse Event|0|||
155275370|NCT00318149|560440502|FG002|Overall Study|Adverse Event|0|||
155275371|NCT00318149|560440503|FG003|Overall Study|Adverse Event|0|||
155275372|NCT00318149|560440504|FG004|Overall Study|Adverse Event|0|||
155275373|NCT00318149|560440505|FG005|Overall Study|Adverse Event|2|||
155275374|NCT03541642|560440506|FG000|Overall Study|Withdrawal by Subject|1|||
155275375|NCT03541642|560440507|FG001|Overall Study|Withdrawal by Subject|2|||
155275376|NCT03541642|560440506|FG000|Overall Study|Lost to Follow-up|16|||
154936593|NCT00597584|559194724|FG000|Overall Study|Death|53|||
155275377|NCT03541642|560440507|FG001|Overall Study|Lost to Follow-up|12|||
155275378|NCT03541642|560440506|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
155275379|NCT03541642|560440507|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
155275380|NCT03523871|560440508|FG000|Overall Study|Death|1|||
155275381|NCT00219141|560440509|FG000|Overall Study|Adverse Event|4|||
155275382|NCT00219141|560440510|FG001|Overall Study|Adverse Event|10|||
155275383|NCT00219141|560440511|FG002|Overall Study|Adverse Event|5|||
155275384|NCT00219141|560440509|FG000|Overall Study|Lack of Efficacy|3|||
155275385|NCT00219141|560440510|FG001|Overall Study|Lack of Efficacy|2|||
155275386|NCT00219141|560440511|FG002|Overall Study|Lack of Efficacy|0|||
155275387|NCT00219141|560440509|FG000|Overall Study|Administrative problems|0|||
155275388|NCT00219141|560440510|FG001|Overall Study|Administrative problems|1|||
155275389|NCT00219141|560440511|FG002|Overall Study|Administrative problems|0|||
155275390|NCT00219141|560440509|FG000|Overall Study|Lost to Follow-up|2|||
155275391|NCT00219141|560440510|FG001|Overall Study|Lost to Follow-up|4|||
155275392|NCT00219141|560440511|FG002|Overall Study|Lost to Follow-up|1|||
155275393|NCT00219141|560440509|FG000|Overall Study|Protocol Violation|3|||
155275394|NCT00219141|560440510|FG001|Overall Study|Protocol Violation|1|||
155275395|NCT00219141|560440511|FG002|Overall Study|Protocol Violation|1|||
155275396|NCT00219141|560440509|FG000|Overall Study|Withdrawal by Subject|1|||
155275397|NCT00219141|560440510|FG001|Overall Study|Withdrawal by Subject|3|||
155275398|NCT00219141|560440511|FG002|Overall Study|Withdrawal by Subject|5|||
155275399|NCT00219141|560440509|FG000|Overall Study|Condition no longer requires study drug|1|||
155275400|NCT00219141|560440510|FG001|Overall Study|Condition no longer requires study drug|0|||
155275401|NCT00219141|560440511|FG002|Overall Study|Condition no longer requires study drug|0|||
155275402|NCT00972179|560440512|FG000|Overall Study|Noncompliance|1|||
155275403|NCT00972179|560440513|FG001|Overall Study|Noncompliance|0|||
155275404|NCT00972179|560440514|FG002|Overall Study|Noncompliance|0|||
155275405|NCT00972179|560440515|FG003|Overall Study|Noncompliance|0|||
155275406|NCT00972179|560440516|FG004|Overall Study|Noncompliance|1|||
155275407|NCT00972179|560440517|FG005|Overall Study|Noncompliance|0|||
155275408|NCT00972179|560440518|FG006|Overall Study|Noncompliance|1|||
155275409|NCT00972179|560440512|FG000|Overall Study|Withdrawal by Subject|0|||
155275410|NCT00972179|560440513|FG001|Overall Study|Withdrawal by Subject|3|||
155275411|NCT00972179|560440514|FG002|Overall Study|Withdrawal by Subject|0|||
155275412|NCT00972179|560440515|FG003|Overall Study|Withdrawal by Subject|1|||
155275413|NCT00972179|560440516|FG004|Overall Study|Withdrawal by Subject|0|||
155275414|NCT00972179|560440517|FG005|Overall Study|Withdrawal by Subject|0|||
155275415|NCT00972179|560440518|FG006|Overall Study|Withdrawal by Subject|2|||
155275416|NCT00972179|560440512|FG000|Overall Study|Administrative Decision|0|||
155275417|NCT00972179|560440513|FG001|Overall Study|Administrative Decision|0|||
155275418|NCT00972179|560440514|FG002|Overall Study|Administrative Decision|0|||
155275419|NCT00972179|560440515|FG003|Overall Study|Administrative Decision|0|||
155275420|NCT00972179|560440516|FG004|Overall Study|Administrative Decision|1|||
155275421|NCT00972179|560440517|FG005|Overall Study|Administrative Decision|0|||
155275422|NCT00972179|560440518|FG006|Overall Study|Administrative Decision|0|||
155275423|NCT00972179|560440512|FG000|Overall Study|Lost to Follow-up|0|||
155275424|NCT00972179|560440513|FG001|Overall Study|Lost to Follow-up|0|||
155275425|NCT00972179|560440514|FG002|Overall Study|Lost to Follow-up|1|||
155275426|NCT00972179|560440515|FG003|Overall Study|Lost to Follow-up|0|||
155275427|NCT00972179|560440516|FG004|Overall Study|Lost to Follow-up|0|||
155275428|NCT00972179|560440517|FG005|Overall Study|Lost to Follow-up|3|||
155275429|NCT00972179|560440518|FG006|Overall Study|Lost to Follow-up|1|||
155275430|NCT03055832|560440519|FG000|Week 2|Withdrawal by Subject|1|||
155275431|NCT03055832|560440520|FG001|Week 2|Withdrawal by Subject|0|||
155275432|NCT01994720|560440521|FG000|Overall Study|Withdrawal by Subject|46|||
155275433|NCT01994720|560440522|FG001|Overall Study|Withdrawal by Subject|56|||
155275434|NCT03619174|560440523|FG000|Overall Study|Lost to Follow-up|3|||
155275435|NCT03619174|560440524|FG001|Overall Study|Lost to Follow-up|0|||
155275436|NCT03619174|560440523|FG000|Overall Study|Withdrawal by Subject|4|||
155275437|NCT03619174|560440524|FG001|Overall Study|Withdrawal by Subject|3|||
155275438|NCT03619174|560440523|FG000|Overall Study|Pregnancy|1|||
155275439|NCT03619174|560440524|FG001|Overall Study|Pregnancy|1|||
155275440|NCT03619174|560440523|FG000|Overall Study|Discomfort during treatment|1|||
155275441|NCT03619174|560440524|FG001|Overall Study|Discomfort during treatment|0|||
155275442|NCT01012973|560440528|FG000|Overall Study|Adverse Event|5|||
155275443|NCT01012973|560440529|FG001|Overall Study|Adverse Event|5|||
155275444|NCT01012973|560440528|FG000|Overall Study|Lack of Efficacy|0|||
155275445|NCT01012973|560440529|FG001|Overall Study|Lack of Efficacy|5|||
155275446|NCT01012973|560440528|FG000|Overall Study|Lost to Follow-up|1|||
155275447|NCT01012973|560440529|FG001|Overall Study|Lost to Follow-up|0|||
155275448|NCT01012973|560440528|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
155275449|NCT01012973|560440529|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
155275450|NCT01012973|560440528|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
155275451|NCT01012973|560440529|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
155275452|NCT01012973|560440528|FG000|Overall Study|Protocol Violation|5|||
155275453|NCT01012973|560440529|FG001|Overall Study|Protocol Violation|2|||
155275454|NCT01012973|560440528|FG000|Overall Study|Withdrawal by Subject|4|||
155275455|NCT01012973|560440529|FG001|Overall Study|Withdrawal by Subject|6|||
155275456|NCT02061761|560440530|FG000|Overall Study|Disease progression|2|||
155275457|NCT02061761|560440531|FG001|Overall Study|Disease progression|8|||
155275458|NCT02061761|560440532|FG002|Overall Study|Disease progression|4|||
155275459|NCT02061761|560440533|FG003|Overall Study|Disease progression|5|||
155275460|NCT02061761|560440534|FG004|Overall Study|Disease progression|9|||
155275461|NCT02061761|560440535|FG005|Overall Study|Disease progression|3|||
155275462|NCT02061761|560440536|FG006|Overall Study|Disease progression|1|||
155275463|NCT02061761|560440537|FG007|Overall Study|Disease progression|2|||
155275464|NCT02061761|560440538|FG008|Overall Study|Disease progression|28|||
155275465|NCT02061761|560440530|FG000|Overall Study|Study Drug toxicity|0|||
155275466|NCT02061761|560440531|FG001|Overall Study|Study Drug toxicity|0|||
155275467|NCT02061761|560440532|FG002|Overall Study|Study Drug toxicity|0|||
155275468|NCT02061761|560440533|FG003|Overall Study|Study Drug toxicity|0|||
155275469|NCT02061761|560440534|FG004|Overall Study|Study Drug toxicity|0|||
155275470|NCT02061761|560440535|FG005|Overall Study|Study Drug toxicity|1|||
155275471|NCT02061761|560440536|FG006|Overall Study|Study Drug toxicity|0|||
155275472|NCT02061761|560440537|FG007|Overall Study|Study Drug toxicity|2|||
155275473|NCT02061761|560440538|FG008|Overall Study|Study Drug toxicity|6|||
155275474|NCT02061761|560440530|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
155275475|NCT02061761|560440531|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
155275476|NCT02061761|560440532|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
155275477|NCT02061761|560440533|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
155275478|NCT02061761|560440534|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
155275479|NCT02061761|560440535|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
155275480|NCT02061761|560440536|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
155275481|NCT02061761|560440537|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
155275482|NCT02061761|560440538|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
155275483|NCT02061761|560440530|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155275484|NCT02061761|560440531|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155275485|NCT02061761|560440532|FG002|Overall Study|Participant request to discontinue study treatment|2|||
155275486|NCT02061761|560440533|FG003|Overall Study|Participant request to discontinue study treatment|2|||
155275487|NCT02061761|560440534|FG004|Overall Study|Participant request to discontinue study treatment|0|||
155275488|NCT02061761|560440535|FG005|Overall Study|Participant request to discontinue study treatment|1|||
155275489|NCT02061761|560440536|FG006|Overall Study|Participant request to discontinue study treatment|0|||
155275490|NCT02061761|560440537|FG007|Overall Study|Participant request to discontinue study treatment|0|||
155275491|NCT02061761|560440538|FG008|Overall Study|Participant request to discontinue study treatment|2|||
155275492|NCT02061761|560440530|FG000|Overall Study|Withdrawal by Subject|0|||
155275493|NCT02061761|560440531|FG001|Overall Study|Withdrawal by Subject|0|||
155275494|NCT02061761|560440532|FG002|Overall Study|Withdrawal by Subject|0|||
155275495|NCT02061761|560440533|FG003|Overall Study|Withdrawal by Subject|0|||
155275496|NCT02061761|560440534|FG004|Overall Study|Withdrawal by Subject|0|||
155275497|NCT02061761|560440535|FG005|Overall Study|Withdrawal by Subject|0|||
155275498|NCT02061761|560440536|FG006|Overall Study|Withdrawal by Subject|0|||
155275499|NCT02061761|560440537|FG007|Overall Study|Withdrawal by Subject|0|||
155275500|NCT02061761|560440538|FG008|Overall Study|Withdrawal by Subject|2|||
155275501|NCT02061761|560440530|FG000|Overall Study|Maximum clinical benefit|0|||
155275502|NCT02061761|560440531|FG001|Overall Study|Maximum clinical benefit|0|||
155275503|NCT02061761|560440532|FG002|Overall Study|Maximum clinical benefit|0|||
155275504|NCT02061761|560440533|FG003|Overall Study|Maximum clinical benefit|1|||
155275505|NCT02061761|560440534|FG004|Overall Study|Maximum clinical benefit|0|||
155275506|NCT02061761|560440535|FG005|Overall Study|Maximum clinical benefit|0|||
155275507|NCT02061761|560440536|FG006|Overall Study|Maximum clinical benefit|0|||
154936594|NCT00597584|559194725|FG001|Overall Study|Death|30|||
154936595|NCT00597584|559194724|FG000|Overall Study|Lack of Efficacy|1|||
154936596|NCT00597584|559194725|FG001|Overall Study|Lack of Efficacy|0|||
154936597|NCT00597584|559194724|FG000|Overall Study|Lost to Follow-up|2|||
154936598|NCT00597584|559194725|FG001|Overall Study|Lost to Follow-up|4|||
154936599|NCT00597584|559194724|FG000|Overall Study|Physician Decision|3|||
154936600|NCT00597584|559194725|FG001|Overall Study|Physician Decision|0|||
154936601|NCT00597584|559194724|FG000|Overall Study|Pregnancy|2|||
154936602|NCT00597584|559194725|FG001|Overall Study|Pregnancy|0|||
154936603|NCT00597584|559194724|FG000|Overall Study|Withdrawal by Subject|44|||
154936604|NCT00597584|559194725|FG001|Overall Study|Withdrawal by Subject|12|||
154936605|NCT00597584|559194724|FG000|Overall Study|Discontinued Dialysis|0|||
154936606|NCT00597584|559194725|FG001|Overall Study|Discontinued Dialysis|1|||
154936607|NCT00597584|559194724|FG000|Overall Study|Lost ability to consent|1|||
155275508|NCT02061761|560440537|FG007|Overall Study|Maximum clinical benefit|0|||
155275509|NCT02061761|560440538|FG008|Overall Study|Maximum clinical benefit|6|||
155275510|NCT02061761|560440530|FG000|Overall Study|Participant no longer meets study criteria|0|||
155275511|NCT02061761|560440531|FG001|Overall Study|Participant no longer meets study criteria|0|||
155275512|NCT02061761|560440532|FG002|Overall Study|Participant no longer meets study criteria|0|||
155275513|NCT02061761|560440533|FG003|Overall Study|Participant no longer meets study criteria|0|||
155275514|NCT02061761|560440534|FG004|Overall Study|Participant no longer meets study criteria|0|||
155275515|NCT02061761|560440535|FG005|Overall Study|Participant no longer meets study criteria|0|||
154936608|NCT00597584|559194725|FG001|Overall Study|Lost ability to consent|1|||
154936609|NCT00597584|559194724|FG000|Overall Study|Never dosed|1|||
155275516|NCT02061761|560440536|FG006|Overall Study|Participant no longer meets study criteria|0|||
155275517|NCT02061761|560440537|FG007|Overall Study|Participant no longer meets study criteria|0|||
155275518|NCT02061761|560440538|FG008|Overall Study|Participant no longer meets study criteria|1|||
155275519|NCT02061761|560440530|FG000|Overall Study|Other reasons|0|||
155275520|NCT02061761|560440531|FG001|Overall Study|Other reasons|0|||
155275521|NCT02061761|560440532|FG002|Overall Study|Other reasons|0|||
155275522|NCT02061761|560440533|FG003|Overall Study|Other reasons|0|||
155275523|NCT02061761|560440534|FG004|Overall Study|Other reasons|2|||
155275524|NCT02061761|560440535|FG005|Overall Study|Other reasons|0|||
155275525|NCT02061761|560440536|FG006|Overall Study|Other reasons|0|||
155275526|NCT02061761|560440537|FG007|Overall Study|Other reasons|0|||
155275527|NCT02061761|560440538|FG008|Overall Study|Other reasons|6|||
155275528|NCT00967018|560440539|FG000|Overall Study|Adverse Event|2|||
155275529|NCT00967018|560440539|FG000|Overall Study|Physician Decision|7|||
155275530|NCT00967018|560440539|FG000|Overall Study|Lost to Follow-up|2|||
155275531|NCT00967018|560440539|FG000|Overall Study|Withdrawal by Subject|1|||
155275532|NCT00967018|560440539|FG000|Overall Study|Miscellaneous Reasons|9|||
155275533|NCT04170296|560440549|FG000|Overall Study|Adverse Event|1|||
155275534|NCT04170296|560440550|FG001|Overall Study|Adverse Event|0|||
155275535|NCT04170296|560440549|FG000|Overall Study|Withdrawal by Subject|3|||
155275536|NCT04170296|560440550|FG001|Overall Study|Withdrawal by Subject|2|||
155275537|NCT04170296|560440549|FG000|Overall Study|Lost to Follow-up|4|||
155275538|NCT04170296|560440550|FG001|Overall Study|Lost to Follow-up|2|||
155275539|NCT02468934|560440551|FG000|Overall Study|Withdrawal by Subject|4|||
155275540|NCT02468934|560440551|FG000|Overall Study|Screen Failure|3|||
155275541|NCT00383240|560440552|FG000|Overall Study|Adverse Event|4|||
155275542|NCT00383240|560440553|FG001|Overall Study|Adverse Event|6|||
155275543|NCT00383240|560440554|FG002|Overall Study|Adverse Event|9|||
155275544|NCT00383240|560440555|FG003|Overall Study|Adverse Event|7|||
155275545|NCT00383240|560440552|FG000|Overall Study|Treatment Failure|8|||
155275546|NCT00383240|560440553|FG001|Overall Study|Treatment Failure|13|||
155275547|NCT00383240|560440554|FG002|Overall Study|Treatment Failure|47|||
155275548|NCT00383240|560440555|FG003|Overall Study|Treatment Failure|46|||
155275549|NCT00383240|560440552|FG000|Overall Study|Lost to Follow-up|3|||
155275550|NCT00383240|560440553|FG001|Overall Study|Lost to Follow-up|0|||
155275551|NCT00383240|560440554|FG002|Overall Study|Lost to Follow-up|0|||
155275552|NCT00383240|560440555|FG003|Overall Study|Lost to Follow-up|2|||
155275553|NCT00383240|560440552|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
155275554|NCT00383240|560440553|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
155275555|NCT00383240|560440554|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
155275556|NCT00383240|560440555|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
155275557|NCT00383240|560440552|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
155275558|NCT00383240|560440553|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
155275559|NCT00383240|560440554|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
155275560|NCT00383240|560440555|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
155275561|NCT00383240|560440552|FG000|Overall Study|Protocol Violation|4|||
155275562|NCT00383240|560440553|FG001|Overall Study|Protocol Violation|5|||
155275563|NCT00383240|560440554|FG002|Overall Study|Protocol Violation|9|||
155275564|NCT00383240|560440555|FG003|Overall Study|Protocol Violation|6|||
155275565|NCT00383240|560440552|FG000|Overall Study|Did not meet protocol eligibility|9|||
155275566|NCT00383240|560440553|FG001|Overall Study|Did not meet protocol eligibility|4|||
155275567|NCT00383240|560440554|FG002|Overall Study|Did not meet protocol eligibility|9|||
155275568|NCT00383240|560440555|FG003|Overall Study|Did not meet protocol eligibility|3|||
155275569|NCT00383240|560440552|FG000|Overall Study|Administrative|1|||
155275570|NCT00383240|560440553|FG001|Overall Study|Administrative|1|||
155275571|NCT00383240|560440554|FG002|Overall Study|Administrative|0|||
155275572|NCT00383240|560440555|FG003|Overall Study|Administrative|0|||
155275573|NCT01370603|560440557|FG000|Period 1|Adverse Event|5|||
155275574|NCT01370603|560440558|FG001|Period 1|Adverse Event|3|||
155275575|NCT01370603|560440557|FG000|Period 1|Lost to Follow-up|2|||
155275576|NCT01370603|560440558|FG001|Period 1|Lost to Follow-up|0|||
155275577|NCT01370603|560440557|FG000|Period 1|Protocol Violation|2|||
155275578|NCT01370603|560440558|FG001|Period 1|Protocol Violation|2|||
155275579|NCT01370603|560440557|FG000|Period 1|Withdrawal by Subject|5|||
155275580|NCT01370603|560440558|FG001|Period 1|Withdrawal by Subject|5|||
155275581|NCT01370603|560440557|FG000|Crossover Washout|Adverse Event|2|||
155275582|NCT01370603|560440558|FG001|Crossover Washout|Adverse Event|1|||
155275583|NCT01370603|560440557|FG000|Crossover Washout|Lost to Follow-up|2|||
155275584|NCT01370603|560440558|FG001|Crossover Washout|Lost to Follow-up|0|||
155275585|NCT01370603|560440557|FG000|Crossover Washout|Protocol Violation|1|||
155275586|NCT01370603|560440558|FG001|Crossover Washout|Protocol Violation|0|||
155275587|NCT01370603|560440557|FG000|Crossover Washout|Withdrawal by Subject|4|||
155275588|NCT01370603|560440558|FG001|Crossover Washout|Withdrawal by Subject|1|||
155275589|NCT01370603|560440557|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
155275590|NCT01370603|560440558|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
155275591|NCT01370603|560440557|FG000|Period 2|Adverse Event|1|||
155275592|NCT01370603|560440558|FG001|Period 2|Adverse Event|4|||
155275593|NCT01370603|560440557|FG000|Period 2|Lost to Follow-up|1|||
155275594|NCT01370603|560440558|FG001|Period 2|Lost to Follow-up|0|||
155275595|NCT01370603|560440557|FG000|Period 2|Withdrawal by Subject|1|||
155275596|NCT01370603|560440558|FG001|Period 2|Withdrawal by Subject|0|||
155275597|NCT02133924|560440563|FG000|Overall Study|Death|38|||
155275598|NCT02133924|560440563|FG000|Overall Study|Physician Decision|1|||
155275599|NCT02133924|560440563|FG000|Overall Study|Withdrawal by Subject|3|||
155275600|NCT02924389|560440570|FG000|Overall Study|Lost to Follow-up|1|||
155275601|NCT02924389|560440571|FG001|Overall Study|Lost to Follow-up|0|||
155275602|NCT02924389|560440570|FG000|Overall Study|Physician Decision|2|||
155275603|NCT02924389|560440571|FG001|Overall Study|Physician Decision|0|||
155275604|NCT02924389|560440570|FG000|Overall Study|Withdrawal by Subject|3|||
155275605|NCT02924389|560440571|FG001|Overall Study|Withdrawal by Subject|0|||
155275606|NCT02924389|560440570|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
155275607|NCT02924389|560440571|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
155275608|NCT04714216|560442699|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
155275609|NCT04714216|560442699|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
155275610|NCT01349829|560442700|FG000|Overall Study|Lost to Follow-up|4|||
155275611|NCT01349829|560442701|FG001|Overall Study|Lost to Follow-up|8|||
155275612|NCT01349829|560442700|FG000|Overall Study|Consent withdrawal|3|||
155275613|NCT01349829|560442701|FG001|Overall Study|Consent withdrawal|8|||
155275614|NCT01349829|560442700|FG000|Overall Study|Migrated/moved|2|||
155275615|NCT01349829|560442701|FG001|Overall Study|Migrated/moved|7|||
155275616|NCT01852162|560442707|FG000|Overall Study|Adverse Event|1|||
155275617|NCT01852162|560442708|FG001|Overall Study|Adverse Event|0|||
155275618|NCT01852162|560442707|FG000|Overall Study|Withdrawal by Subject|3|||
155275619|NCT01852162|560442708|FG001|Overall Study|Withdrawal by Subject|1|||
155275620|NCT01500226|560442709|FG000|Overall Study|Adverse Event|31|||
155275621|NCT01500226|560442710|FG001|Overall Study|Adverse Event|38|||
155275622|NCT01500226|560442709|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
155275623|NCT01500226|560442710|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
155275624|NCT01500226|560442709|FG000|Overall Study|Withdrawal by Subject|93|||
155275625|NCT01500226|560442710|FG001|Overall Study|Withdrawal by Subject|96|||
155275626|NCT01500226|560442709|FG000|Overall Study|Death|12|||
155275627|NCT01500226|560442710|FG001|Overall Study|Death|4|||
155275628|NCT01500226|560442709|FG000|Overall Study|Disease Progression|16|||
155275629|NCT01500226|560442710|FG001|Overall Study|Disease Progression|14|||
155275630|NCT01500226|560442709|FG000|Overall Study|Protocol Violation|53|||
155275631|NCT01500226|560442710|FG001|Overall Study|Protocol Violation|39|||
155275632|NCT01500226|560442709|FG000|Overall Study|Physician Decision|17|||
155275633|NCT01500226|560442710|FG001|Overall Study|Physician Decision|15|||
155275634|NCT01500226|560442709|FG000|Overall Study|Lack of Efficacy|14|||
155275635|NCT01500226|560442710|FG001|Overall Study|Lack of Efficacy|30|||
155275636|NCT01500226|560442709|FG000|Overall Study|Lost to Follow-up|9|||
155275637|NCT01500226|560442710|FG001|Overall Study|Lost to Follow-up|5|||
155275638|NCT01500226|560442709|FG000|Overall Study|Other Reasons|19|||
155275639|NCT01500226|560442710|FG001|Overall Study|Other Reasons|16|||
155275640|NCT02955277|560442711|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
155275641|NCT02955277|560442712|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
155275642|NCT02955277|560442711|FG000|Post to Follow-up|Lost to Follow-up|8|||
155275643|NCT02955277|560442712|FG001|Post to Follow-up|Lost to Follow-up|11|||
155275644|NCT04212169|560442713|FG000|Overall Study|Adverse Event|0|||
155275645|NCT04212169|560442714|FG001|Overall Study|Adverse Event|0|||
155275646|NCT04212169|560442715|FG002|Overall Study|Adverse Event|0|||
155275647|NCT04212169|560442716|FG003|Overall Study|Adverse Event|2|||
155275648|NCT04212169|560442713|FG000|Overall Study|Lost to Follow-up|1|||
155275649|NCT04212169|560442714|FG001|Overall Study|Lost to Follow-up|0|||
155275650|NCT04212169|560442715|FG002|Overall Study|Lost to Follow-up|0|||
155275651|NCT04212169|560442716|FG003|Overall Study|Lost to Follow-up|2|||
155275652|NCT04212169|560442713|FG000|Overall Study|Withdrawal by Subject|10|||
155275653|NCT04212169|560442714|FG001|Overall Study|Withdrawal by Subject|2|||
155275654|NCT04212169|560442715|FG002|Overall Study|Withdrawal by Subject|5|||
155275655|NCT04212169|560442716|FG003|Overall Study|Withdrawal by Subject|7|||
155275656|NCT04212169|560442713|FG000|Overall Study|Other reason, unspecified|3|||
154936610|NCT00597584|559194725|FG001|Overall Study|Never dosed|0|||
155275657|NCT04212169|560442714|FG001|Overall Study|Other reason, unspecified|1|||
155275658|NCT04212169|560442715|FG002|Overall Study|Other reason, unspecified|0|||
155275659|NCT04212169|560442716|FG003|Overall Study|Other reason, unspecified|2|||
155275660|NCT02176928|560442717|FG000|Overall Study|Lost to Follow-up|2|||
155275661|NCT02176928|560442718|FG001|Overall Study|Lost to Follow-up|4|||
155275662|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275663|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
155275664|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
155275665|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
155275666|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
155275667|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
155275668|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275669|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275670|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275671|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
155275672|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275673|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275674|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275675|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
155275676|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
155275677|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275678|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275679|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275680|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275681|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
155275682|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275683|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
155275684|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
155275685|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
155275686|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
155275687|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
155275688|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275689|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275690|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275691|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
155275692|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
155275693|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275694|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275695|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
155275696|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
155275697|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275698|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275699|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275700|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275701|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
155275702|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275703|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275704|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
155275705|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
155275706|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275707|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275708|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275709|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275710|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275711|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
155275712|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275713|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275714|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275715|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275716|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
155275717|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275718|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275719|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275720|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275721|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
155275722|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275723|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275724|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275725|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
155275726|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
155275727|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
155275728|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275729|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275730|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275731|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
155275732|NCT02018861|560442719|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275733|NCT02018861|560442720|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275734|NCT02018861|560442721|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275735|NCT02018861|560442722|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
155275736|NCT02018861|560442723|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
155275737|NCT02018861|560442724|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275738|NCT02018861|560442725|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275739|NCT02018861|560442726|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275740|NCT02018861|560442727|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275741|NCT02018861|560442728|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
155275742|NCT02018861|560442719|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275743|NCT02018861|560442720|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275744|NCT02018861|560442721|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275745|NCT02018861|560442722|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275746|NCT02018861|560442723|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275747|NCT02018861|560442724|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275748|NCT02018861|560442725|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
155275749|NCT02018861|560442726|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
155275750|NCT02018861|560442727|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275751|NCT02018861|560442728|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
155275752|NCT02018861|560442719|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275753|NCT02018861|560442720|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275754|NCT02018861|560442721|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275755|NCT02018861|560442722|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275756|NCT02018861|560442723|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275757|NCT02018861|560442724|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275758|NCT02018861|560442725|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
155275759|NCT02018861|560442726|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
155275760|NCT02018861|560442727|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275761|NCT02018861|560442728|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
155275762|NCT02018861|560442719|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275763|NCT02018861|560442720|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275764|NCT02018861|560442721|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275765|NCT02018861|560442722|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275766|NCT02018861|560442723|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275767|NCT02018861|560442724|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275768|NCT02018861|560442725|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275769|NCT02018861|560442726|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275770|NCT02018861|560442727|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
155275771|NCT02018861|560442728|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
155275772|NCT02018861|560442719|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275773|NCT02018861|560442720|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275774|NCT02018861|560442721|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275775|NCT02018861|560442722|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275776|NCT02018861|560442723|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275777|NCT02018861|560442724|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275778|NCT02018861|560442725|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275779|NCT02018861|560442726|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275780|NCT02018861|560442727|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
155275781|NCT02018861|560442728|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
155275782|NCT02018861|560442719|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275783|NCT02018861|560442720|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275784|NCT02018861|560442721|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275785|NCT02018861|560442722|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275786|NCT02018861|560442723|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275787|NCT02018861|560442724|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275788|NCT02018861|560442725|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275789|NCT02018861|560442726|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275790|NCT02018861|560442727|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
155275791|NCT02018861|560442728|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
155275792|NCT02819479|560442732|FG000|Overall Study|Adverse Event|2|||
155275793|NCT00504348|560442733|FG000|Overall Study|Adverse Event|3|||
155381939|NCT00598273|560833242|FG000|Overall Study|Lost to Follow-up|8|||
155381940|NCT00598273|560833243|FG001|Overall Study|Lost to Follow-up|3|||
155381941|NCT00598273|560833244|FG002|Overall Study|Lost to Follow-up|5|||
155275794|NCT00504348|560442733|FG000|Overall Study|Lack of Efficacy|4|||
155275795|NCT00504348|560442733|FG000|Overall Study|Physician Decision|1|||
155275796|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
155275797|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
155275798|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
155275799|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
155275800|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
154936611|NCT00597584|559194724|FG000|Overall Study|Relocation|8|||
154936612|NCT00597584|559194725|FG001|Overall Study|Relocation|6|||
154936613|NCT00597584|559194724|FG000|Overall Study|Renal transplant|9|||
154936614|NCT00597584|559194725|FG001|Overall Study|Renal transplant|7|||
154936615|NCT02791659|559194737|FG000|Overall Study|Protocol Violation|0|||
154936616|NCT02791659|559194738|FG001|Overall Study|Protocol Violation|1|||
154936617|NCT01456052|559194739|FG000|Overall Study|Adverse Event|1|||
154936618|NCT01456052|559194740|FG001|Overall Study|Adverse Event|1|||
154936619|NCT01456052|559194741|FG002|Overall Study|Adverse Event|2|||
154936620|NCT01456052|559194739|FG000|Overall Study|Consent withdrawn|0|||
154936621|NCT01456052|559194740|FG001|Overall Study|Consent withdrawn|2|||
154936622|NCT01456052|559194741|FG002|Overall Study|Consent withdrawn|1|||
154936623|NCT01456052|559194739|FG000|Overall Study|Protocol Violation|0|||
154936624|NCT01456052|559194740|FG001|Overall Study|Protocol Violation|1|||
154936625|NCT01456052|559194741|FG002|Overall Study|Protocol Violation|0|||
154936626|NCT01456052|559194739|FG000|Overall Study|Physician Decision|1|||
154936627|NCT01456052|559194740|FG001|Overall Study|Physician Decision|0|||
154936628|NCT01456052|559194741|FG002|Overall Study|Physician Decision|1|||
154936629|NCT01456052|559194739|FG000|Overall Study|Treatment Failure|0|||
154936630|NCT01456052|559194740|FG001|Overall Study|Treatment Failure|1|||
154936631|NCT01456052|559194741|FG002|Overall Study|Treatment Failure|1|||
154936632|NCT02853929|559194744|FG000|Overall Study|Lost to Follow-up|3|||
154936633|NCT02853929|559194745|FG001|Overall Study|Lost to Follow-up|0|||
154936634|NCT02853929|559194744|FG000|Overall Study|Withdrawal by Subject|1|||
154936635|NCT02853929|559194745|FG001|Overall Study|Withdrawal by Subject|0|||
154936636|NCT02853929|559194744|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
154936637|NCT02853929|559194745|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
154936638|NCT02762565|559194746|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
154936639|NCT01113710|559194747|FG000|Overall Study|Adverse Event|64|||
154936640|NCT01113710|559194747|FG000|Overall Study|Lack of Efficacy|41|||
154936641|NCT01113710|559194747|FG000|Overall Study|No Information Available|40|||
154936642|NCT01113710|559194747|FG000|Overall Study|Withdrawal by Subject|28|||
154936643|NCT01113710|559194747|FG000|Overall Study|Lost to Follow-up|20|||
154936644|NCT01113710|559194747|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
154936645|NCT01113710|559194747|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
154936646|NCT01113710|559194747|FG000|Overall Study|Lack of Patient's Compliance|8|||
154936647|NCT01113710|559194747|FG000|Overall Study|Other|7|||
154936648|NCT01113710|559194747|FG000|Overall Study|Adverse Event/Other|5|||
154936649|NCT01113710|559194747|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
154936650|NCT01113710|559194747|FG000|Overall Study|Lack of Efficacy/Other|4|||
154936651|NCT01113710|559194747|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
154936652|NCT01113710|559194747|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
154936653|NCT01113710|559194747|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
154936654|NCT01113710|559194747|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
154936655|NCT01113710|559194747|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
154936656|NCT01113710|559194747|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
154936657|NCT01113710|559194747|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
154936658|NCT01113710|559194747|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
154936659|NCT01113710|559194747|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
154936660|NCT01113710|559194747|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
154936661|NCT01113710|559194747|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
154936662|NCT01113710|559194747|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
154936663|NCT01113710|559194747|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
154936664|NCT01042977|559194749|FG000|Overall Study|Adverse Event|4|||
154936665|NCT01042977|559194750|FG001|Overall Study|Adverse Event|12|||
154936666|NCT01042977|559194749|FG000|Overall Study|Death|2|||
154936667|NCT01042977|559194750|FG001|Overall Study|Death|1|||
154936668|NCT01042977|559194749|FG000|Overall Study|Withdrawal by Subject|8|||
154936669|NCT01042977|559194750|FG001|Overall Study|Withdrawal by Subject|16|||
154936670|NCT01042977|559194749|FG000|Overall Study|Lost to Follow-up|0|||
154936671|NCT01042977|559194750|FG001|Overall Study|Lost to Follow-up|2|||
155275801|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
155275802|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
155275803|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
154936672|NCT01042977|559194749|FG000|Overall Study|Poor/non-compliance|3|||
154936673|NCT01042977|559194750|FG001|Overall Study|Poor/non-compliance|4|||
155275804|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
155043443|NCT01826981|559590134|FG012|Overall Study|Lost to Follow-up|1|||
155275805|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
155275806|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
155275807|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
155275808|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
155275809|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
155275810|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
155275811|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
155275812|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
155275813|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
155275814|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
155275815|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
155275816|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
155275817|NCT02718417|560442736|FG000|Chemotherapy Phase (CP)|Other|2|||
155275818|NCT02718417|560442737|FG001|Chemotherapy Phase (CP)|Other|0|||
155275819|NCT02718417|560442738|FG002|Chemotherapy Phase (CP)|Other|1|||
155275820|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Adverse Event|21|||
155275821|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Adverse Event|26|||
155275822|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Adverse Event|0|||
155275823|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
155275824|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
155275825|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
155275826|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
155275827|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
155275828|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
155275829|NCT02718417|560442736|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
155275830|NCT02718417|560442737|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
155275831|NCT02718417|560442738|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
155275832|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Physician's decision|6|||
155275833|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Physician's decision|7|||
155275834|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Physician's decision|0|||
155275835|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Progressive disease|100|||
155275836|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Progressive disease|88|||
155275837|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Progressive disease|0|||
155275838|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Other|2|||
155275839|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Other|1|||
155275840|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Other|0|||
155275841|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
155275842|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
155275843|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
155275844|NCT02718417|560442736|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
155275845|NCT02718417|560442737|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
155275846|NCT02718417|560442738|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
155275847|NCT02718417|560442736|FG000|Observation Phase (OP)|Adverse Event|0|||
155275848|NCT02718417|560442737|FG001|Observation Phase (OP)|Adverse Event|0|||
155275849|NCT02718417|560442738|FG002|Observation Phase (OP)|Adverse Event|1|||
155275850|NCT02718417|560442736|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
155275851|NCT02718417|560442737|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
155275852|NCT02718417|560442738|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
155275853|NCT02718417|560442736|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
155275854|NCT02718417|560442737|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
155275855|NCT02718417|560442738|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
155275856|NCT02718417|560442736|FG000|Observation Phase (OP)|Physician Decision|0|||
155275857|NCT02718417|560442737|FG001|Observation Phase (OP)|Physician Decision|0|||
155275858|NCT02718417|560442738|FG002|Observation Phase (OP)|Physician Decision|9|||
155275859|NCT02718417|560442736|FG000|Observation Phase (OP)|Progressive disease|0|||
155275860|NCT02718417|560442737|FG001|Observation Phase (OP)|Progressive disease|0|||
155275861|NCT02718417|560442738|FG002|Observation Phase (OP)|Progressive disease|92|||
155275862|NCT02718417|560442736|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
155275863|NCT02718417|560442737|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
155275864|NCT02718417|560442738|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
155275865|NCT02718417|560442736|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
155275866|NCT02718417|560442737|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
155275867|NCT02718417|560442738|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
155275868|NCT02718417|560442736|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
155275869|NCT02718417|560442737|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
155275870|NCT02718417|560442738|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
155275871|NCT02718417|560442736|FG000|Observation Phase (OP)|Other|0|||
155043444|NCT01826981|559590135|FG013|Overall Study|Lost to Follow-up|0|||
155275872|NCT02718417|560442737|FG001|Observation Phase (OP)|Other|0|||
155381942|NCT00598273|560833242|FG000|Overall Study|Physician Decision|0|||
155275873|NCT02718417|560442738|FG002|Observation Phase (OP)|Other|7|||
155275874|NCT02718417|560442736|FG000|Follow-up Phase|Adverse Event|3|||
155275875|NCT02718417|560442737|FG001|Follow-up Phase|Adverse Event|1|||
155275876|NCT02718417|560442738|FG002|Follow-up Phase|Adverse Event|1|||
155275877|NCT02718417|560442736|FG000|Follow-up Phase|Other|4|||
155275878|NCT02718417|560442737|FG001|Follow-up Phase|Other|6|||
155275879|NCT02718417|560442738|FG002|Follow-up Phase|Other|4|||
155275880|NCT02718417|560442736|FG000|Follow-up Phase|Withdrawal by Subject|19|||
155275881|NCT02718417|560442737|FG001|Follow-up Phase|Withdrawal by Subject|17|||
155275882|NCT02718417|560442738|FG002|Follow-up Phase|Withdrawal by Subject|5|||
155275883|NCT02718417|560442736|FG000|Follow-up Phase|Study terminated by sponsor|100|||
155275884|NCT02718417|560442737|FG001|Follow-up Phase|Study terminated by sponsor|138|||
155275885|NCT02718417|560442738|FG002|Follow-up Phase|Study terminated by sponsor|6|||
155275886|NCT02718417|560442736|FG000|Follow-up Phase|Lost to Follow-up|2|||
155275887|NCT02718417|560442737|FG001|Follow-up Phase|Lost to Follow-up|3|||
155275888|NCT02718417|560442738|FG002|Follow-up Phase|Lost to Follow-up|0|||
155275889|NCT02718417|560442736|FG000|Follow-up Phase|Death leading to discontinuation|7|||
155275890|NCT02718417|560442737|FG001|Follow-up Phase|Death leading to discontinuation|7|||
155275891|NCT02718417|560442738|FG002|Follow-up Phase|Death leading to discontinuation|3|||
155275892|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
155275893|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
155275894|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
155275895|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
155275896|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
155275897|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
155275898|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
155275899|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
155275900|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
155275901|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
155275902|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
155275903|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
155275904|NCT02718417|560442736|FG000|Long-term Follow-up Phase|Other|0|||
155275905|NCT02718417|560442737|FG001|Long-term Follow-up Phase|Other|2|||
155275906|NCT02718417|560442738|FG002|Long-term Follow-up Phase|Other|0|||
155275907|NCT01023308|560442741|FG000|Overall Study|Abnormal test proceedure results|3|||
155275908|NCT01023308|560442742|FG001|Overall Study|Abnormal test proceedure results|8|||
155275909|NCT01023308|560442741|FG000|Overall Study|Administrative problems|2|||
155275910|NCT01023308|560442742|FG001|Overall Study|Administrative problems|1|||
155275911|NCT01023308|560442741|FG000|Overall Study|Adverse Event|130|||
155275912|NCT01023308|560442742|FG001|Overall Study|Adverse Event|66|||
155275913|NCT01023308|560442741|FG000|Overall Study|Death|21|||
155275914|NCT01023308|560442742|FG001|Overall Study|Death|17|||
155275915|NCT01023308|560442741|FG000|Overall Study|Disease progression|82|||
155275916|NCT01023308|560442742|FG001|Overall Study|Disease progression|153|||
155275917|NCT01023308|560442741|FG000|Overall Study|New Cancer therapy|4|||
155275918|NCT01023308|560442742|FG001|Overall Study|New Cancer therapy|7|||
155275919|NCT01023308|560442741|FG000|Overall Study|Protocol Violation|3|||
155275920|NCT01023308|560442742|FG001|Overall Study|Protocol Violation|4|||
155275921|NCT01023308|560442741|FG000|Overall Study|Untreated|5|||
155275922|NCT01023308|560442742|FG001|Overall Study|Untreated|5|||
155275923|NCT01023308|560442741|FG000|Overall Study|Lost to Follow-up|1|||
155275924|NCT01023308|560442742|FG001|Overall Study|Lost to Follow-up|0|||
155275925|NCT01023308|560442741|FG000|Overall Study|Withdrawal by Subject|34|||
155275926|NCT01023308|560442742|FG001|Overall Study|Withdrawal by Subject|18|||
155275927|NCT00551213|560442743|FG000|Overall Study|Adverse Event|6|||
155275928|NCT00551213|560442744|FG001|Overall Study|Adverse Event|3|||
155275929|NCT00551213|560442743|FG000|Overall Study|Progressive Disease|41|||
155275930|NCT00551213|560442744|FG001|Overall Study|Progressive Disease|12|||
155275931|NCT00551213|560442743|FG000|Overall Study|Withdrawal by Subject|2|||
155275932|NCT00551213|560442744|FG001|Overall Study|Withdrawal by Subject|0|||
155275933|NCT00551213|560442743|FG000|Overall Study|Not Treated|1|||
155275934|NCT00551213|560442744|FG001|Overall Study|Not Treated|2|||
155275935|NCT01890967|560442745|FG000|Overall Study|Adverse Event|3|||
155275936|NCT01890967|560442746|FG001|Overall Study|Adverse Event|3|||
155275937|NCT01890967|560442747|FG002|Overall Study|Adverse Event|3|||
155275938|NCT01890967|560442748|FG003|Overall Study|Adverse Event|2|||
155275939|NCT01890967|560442749|FG004|Overall Study|Adverse Event|1|||
155275940|NCT01890967|560442750|FG005|Overall Study|Adverse Event|7|||
155275941|NCT01890967|560442745|FG000|Overall Study|Death|1|||
155275942|NCT01890967|560442746|FG001|Overall Study|Death|0|||
155275943|NCT01890967|560442747|FG002|Overall Study|Death|0|||
155275944|NCT01890967|560442748|FG003|Overall Study|Death|0|||
155275945|NCT01890967|560442749|FG004|Overall Study|Death|0|||
155275946|NCT01890967|560442750|FG005|Overall Study|Death|0|||
155275947|NCT01890967|560442745|FG000|Overall Study|Lost to Follow-up|1|||
155275948|NCT01890967|560442746|FG001|Overall Study|Lost to Follow-up|1|||
155275949|NCT01890967|560442747|FG002|Overall Study|Lost to Follow-up|1|||
155275950|NCT01890967|560442748|FG003|Overall Study|Lost to Follow-up|1|||
155275951|NCT01890967|560442749|FG004|Overall Study|Lost to Follow-up|0|||
155275952|NCT01890967|560442750|FG005|Overall Study|Lost to Follow-up|1|||
155275953|NCT01890967|560442745|FG000|Overall Study|Protocol Violation|0|||
155275954|NCT01890967|560442746|FG001|Overall Study|Protocol Violation|3|||
155275955|NCT01890967|560442747|FG002|Overall Study|Protocol Violation|3|||
155275956|NCT01890967|560442748|FG003|Overall Study|Protocol Violation|2|||
155275957|NCT01890967|560442749|FG004|Overall Study|Protocol Violation|4|||
155275958|NCT01890967|560442750|FG005|Overall Study|Protocol Violation|1|||
155275959|NCT01890967|560442745|FG000|Overall Study|Sponsor Decision|2|||
155275960|NCT01890967|560442746|FG001|Overall Study|Sponsor Decision|0|||
155275961|NCT01890967|560442747|FG002|Overall Study|Sponsor Decision|1|||
155275962|NCT01890967|560442748|FG003|Overall Study|Sponsor Decision|3|||
155275963|NCT01890967|560442749|FG004|Overall Study|Sponsor Decision|2|||
155275964|NCT01890967|560442750|FG005|Overall Study|Sponsor Decision|3|||
155275965|NCT01890967|560442745|FG000|Overall Study|Withdrawal by Subject|3|||
155275966|NCT01890967|560442746|FG001|Overall Study|Withdrawal by Subject|4|||
155275967|NCT01890967|560442747|FG002|Overall Study|Withdrawal by Subject|2|||
155275968|NCT01890967|560442748|FG003|Overall Study|Withdrawal by Subject|3|||
155275969|NCT01890967|560442749|FG004|Overall Study|Withdrawal by Subject|3|||
155275970|NCT01890967|560442750|FG005|Overall Study|Withdrawal by Subject|1|||
155275971|NCT01383993|560442754|FG000|Overall Study|Adverse Event|1|||
155275972|NCT01383993|560442755|FG001|Overall Study|Adverse Event|1|||
155275973|NCT01383993|560442756|FG002|Overall Study|Adverse Event|0|||
155275974|NCT01383993|560442754|FG000|Overall Study|Withdrawal by Subject|0|||
155275975|NCT01383993|560442755|FG001|Overall Study|Withdrawal by Subject|0|||
155275976|NCT01383993|560442756|FG002|Overall Study|Withdrawal by Subject|1|||
155275977|NCT01383993|560442754|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
155275978|NCT01383993|560442755|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
155275979|NCT01383993|560442756|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
155275980|NCT01154036|560442769|FG000|Phase I|Physician Decision|0|||
155275981|NCT01154036|560442770|FG001|Phase I|Physician Decision|1|||
155275982|NCT01154036|560442771|FG002|Phase I|Physician Decision|0|||
155275983|NCT01154036|560442772|FG003|Phase I|Physician Decision|0|||
155275984|NCT01154036|560442773|FG004|Phase I|Physician Decision|0|||
155275985|NCT01154036|560442774|FG005|Phase I|Physician Decision|0|||
155275986|NCT01154036|560442775|FG006|Phase I|Physician Decision|0|||
155275987|NCT01154036|560442776|FG007|Phase I|Physician Decision|0|||
155275988|NCT01154036|560442769|FG000|Phase I|Lost to Follow-up|0|||
155275989|NCT01154036|560442770|FG001|Phase I|Lost to Follow-up|3|||
155275990|NCT01154036|560442771|FG002|Phase I|Lost to Follow-up|6|||
155275991|NCT01154036|560442772|FG003|Phase I|Lost to Follow-up|0|||
155275992|NCT01154036|560442773|FG004|Phase I|Lost to Follow-up|0|||
155275993|NCT01154036|560442774|FG005|Phase I|Lost to Follow-up|0|||
155275994|NCT01154036|560442775|FG006|Phase I|Lost to Follow-up|0|||
155275995|NCT01154036|560442776|FG007|Phase I|Lost to Follow-up|0|||
155275996|NCT01154036|560442769|FG000|Phase I|Protocol Violation|0|||
155275997|NCT01154036|560442770|FG001|Phase I|Protocol Violation|3|||
155275998|NCT01154036|560442771|FG002|Phase I|Protocol Violation|9|||
155275999|NCT01154036|560442772|FG003|Phase I|Protocol Violation|0|||
155276000|NCT01154036|560442773|FG004|Phase I|Protocol Violation|0|||
155276001|NCT01154036|560442774|FG005|Phase I|Protocol Violation|0|||
155276002|NCT01154036|560442775|FG006|Phase I|Protocol Violation|0|||
155276003|NCT01154036|560442776|FG007|Phase I|Protocol Violation|0|||
155276004|NCT01154036|560442769|FG000|Phase I|Withdrawal by Subject|2|||
155276005|NCT01154036|560442770|FG001|Phase I|Withdrawal by Subject|10|||
155276006|NCT01154036|560442771|FG002|Phase I|Withdrawal by Subject|29|||
155276007|NCT01154036|560442772|FG003|Phase I|Withdrawal by Subject|0|||
155276008|NCT01154036|560442773|FG004|Phase I|Withdrawal by Subject|0|||
155276009|NCT01154036|560442774|FG005|Phase I|Withdrawal by Subject|0|||
155276010|NCT01154036|560442775|FG006|Phase I|Withdrawal by Subject|0|||
155276011|NCT01154036|560442776|FG007|Phase I|Withdrawal by Subject|0|||
155276012|NCT01154036|560442769|FG000|Phase I|Adverse Event|1|||
155276013|NCT01154036|560442770|FG001|Phase I|Adverse Event|11|||
155276014|NCT01154036|560442771|FG002|Phase I|Adverse Event|12|||
155276015|NCT01154036|560442772|FG003|Phase I|Adverse Event|0|||
155276016|NCT01154036|560442773|FG004|Phase I|Adverse Event|0|||
155276017|NCT01154036|560442774|FG005|Phase I|Adverse Event|0|||
155276018|NCT01154036|560442775|FG006|Phase I|Adverse Event|0|||
155276019|NCT01154036|560442776|FG007|Phase I|Adverse Event|0|||
155276020|NCT01154036|560442769|FG000|Phase II|Adverse Event|0|||
155276021|NCT01154036|560442770|FG001|Phase II|Adverse Event|0|||
155276022|NCT01154036|560442771|FG002|Phase II|Adverse Event|0|||
155276023|NCT01154036|560442772|FG003|Phase II|Adverse Event|0|||
155276024|NCT01154036|560442773|FG004|Phase II|Adverse Event|1|||
155276025|NCT01154036|560442774|FG005|Phase II|Adverse Event|1|||
155276026|NCT01154036|560442775|FG006|Phase II|Adverse Event|1|||
155276027|NCT01154036|560442776|FG007|Phase II|Adverse Event|1|||
155276028|NCT01154036|560442769|FG000|Phase II|Physician Decision|0|||
155276029|NCT01154036|560442770|FG001|Phase II|Physician Decision|0|||
155276030|NCT01154036|560442771|FG002|Phase II|Physician Decision|0|||
155276031|NCT01154036|560442772|FG003|Phase II|Physician Decision|0|||
155276032|NCT01154036|560442773|FG004|Phase II|Physician Decision|0|||
155276033|NCT01154036|560442774|FG005|Phase II|Physician Decision|0|||
155276034|NCT01154036|560442775|FG006|Phase II|Physician Decision|1|||
155276035|NCT01154036|560442776|FG007|Phase II|Physician Decision|0|||
155276036|NCT01154036|560442769|FG000|Phase II|Lost to Follow-up|0|||
155276037|NCT01154036|560442770|FG001|Phase II|Lost to Follow-up|0|||
155276038|NCT01154036|560442771|FG002|Phase II|Lost to Follow-up|0|||
155276039|NCT01154036|560442772|FG003|Phase II|Lost to Follow-up|1|||
155276040|NCT01154036|560442773|FG004|Phase II|Lost to Follow-up|2|||
155276041|NCT01154036|560442774|FG005|Phase II|Lost to Follow-up|0|||
155276042|NCT01154036|560442775|FG006|Phase II|Lost to Follow-up|2|||
155276043|NCT01154036|560442776|FG007|Phase II|Lost to Follow-up|1|||
155276044|NCT01154036|560442769|FG000|Phase II|Protocol Violation|0|||
155276045|NCT01154036|560442770|FG001|Phase II|Protocol Violation|0|||
155276046|NCT01154036|560442771|FG002|Phase II|Protocol Violation|0|||
155276047|NCT01154036|560442772|FG003|Phase II|Protocol Violation|0|||
155276048|NCT01154036|560442773|FG004|Phase II|Protocol Violation|1|||
155276049|NCT01154036|560442774|FG005|Phase II|Protocol Violation|2|||
155276050|NCT01154036|560442775|FG006|Phase II|Protocol Violation|0|||
155276051|NCT01154036|560442776|FG007|Phase II|Protocol Violation|0|||
155276052|NCT01154036|560442769|FG000|Phase II|Withdrawal by Subject|0|||
155276053|NCT01154036|560442770|FG001|Phase II|Withdrawal by Subject|0|||
155276054|NCT01154036|560442771|FG002|Phase II|Withdrawal by Subject|0|||
155276055|NCT01154036|560442772|FG003|Phase II|Withdrawal by Subject|0|||
155276056|NCT01154036|560442773|FG004|Phase II|Withdrawal by Subject|4|||
155276057|NCT01154036|560442774|FG005|Phase II|Withdrawal by Subject|2|||
155276058|NCT01154036|560442775|FG006|Phase II|Withdrawal by Subject|5|||
155276059|NCT01154036|560442776|FG007|Phase II|Withdrawal by Subject|4|||
155276060|NCT02264574|560442777|FG000|Overall Study|Death|21|||
155276061|NCT02264574|560442778|FG001|Overall Study|Death|21|||
155276062|NCT02264574|560442777|FG000|Overall Study|Withdrawal by Subject|8|||
155276063|NCT02264574|560442778|FG001|Overall Study|Withdrawal by Subject|6|||
155276064|NCT02264574|560442777|FG000|Overall Study|Other, Not Specified|0|||
155276065|NCT02264574|560442778|FG001|Overall Study|Other, Not Specified|3|||
155276066|NCT00794820|560442783|FG000|Overall Study|Adverse Event|11|||
155276067|NCT00794820|560442783|FG000|Overall Study|Secondary Malignancies|2|||
155276068|NCT00794820|560442783|FG000|Overall Study|Resistant Disease|2|||
155276069|NCT00794820|560442783|FG000|Overall Study|Ineligible/Screen Failure|1|||
155276070|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
155276071|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
155276072|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
155276073|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
155276074|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155276075|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
155276076|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155276077|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155276078|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
155276079|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
155276080|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155276081|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155276082|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
155276083|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
155276084|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155276085|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155276086|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
155276087|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
155276088|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
155276089|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
155276090|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
155276091|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
155276092|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
155276093|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
155276094|NCT03230864|560442786|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
155276095|NCT03230864|560442787|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
155276096|NCT03230864|560442788|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
155276097|NCT03230864|560442789|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
155276098|NCT03230864|560442786|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
155276099|NCT03230864|560442787|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
155276100|NCT03230864|560442788|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
155276101|NCT03230864|560442789|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
155276102|NCT03230864|560442786|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155276103|NCT03230864|560442787|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155276104|NCT03230864|560442788|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
155276105|NCT03230864|560442789|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
155276106|NCT03230864|560442786|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
155276107|NCT03230864|560442787|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
155276108|NCT03230864|560442788|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
155276109|NCT03230864|560442789|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
155276110|NCT00432679|560442792|FG000|Overall Study|Adverse Event|2|||
155276111|NCT00432679|560442793|FG001|Overall Study|Adverse Event|1|||
155276112|NCT00432679|560442792|FG000|Overall Study|Withdrawal by Subject|3|||
155276113|NCT00432679|560442793|FG001|Overall Study|Withdrawal by Subject|2|||
155276114|NCT04102540|560442794|FG000|Overall Study|Withdrawn by PI|2|||
155276115|NCT04102540|560442794|FG000|Overall Study|Lost to Follow-up|6|||
155276116|NCT00280293|560442795|FG000|Overall Study|Protocol Violation|3|||
155276117|NCT00280293|560442796|FG001|Overall Study|Protocol Violation|0|||
155276118|NCT00280293|560442795|FG000|Overall Study|Physician Decision|5|||
155276119|NCT00280293|560442796|FG001|Overall Study|Physician Decision|4|||
155276120|NCT00280293|560442795|FG000|Overall Study|Lost to Follow-up|14|||
155276121|NCT00280293|560442796|FG001|Overall Study|Lost to Follow-up|12|||
155276122|NCT00280293|560442795|FG000|Overall Study|Withdrawal by Subject|3|||
155276123|NCT00280293|560442796|FG001|Overall Study|Withdrawal by Subject|5|||
155276124|NCT00280293|560442795|FG000|Overall Study|Incarceration/Legal Reasons|1|||
155276125|NCT00280293|560442796|FG001|Overall Study|Incarceration/Legal Reasons|1|||
155276126|NCT00280293|560442795|FG000|Overall Study|Adverse Event|0|||
155276127|NCT00280293|560442796|FG001|Overall Study|Adverse Event|1|||
155276128|NCT00610675|560442801|FG000|Overall Study|Untreated|4|||
155276129|NCT00610675|560442801|FG000|Overall Study|Adverse Event|67|||
155276130|NCT00610675|560442801|FG000|Overall Study|Insufficient Effect|31|||
155276131|NCT00610675|560442801|FG000|Overall Study|Withdrawal by Subject|28|||
155276132|NCT00610675|560442801|FG000|Overall Study|Reasons unrelated to trial|27|||
155276133|NCT00610675|560442801|FG000|Overall Study|Lack of Compliance|7|||
155276134|NCT00610675|560442801|FG000|Overall Study|Lost to Follow-up|31|||
155276135|NCT00610675|560442801|FG000|Overall Study|Other reason (not specified)|25|||
155276136|NCT01458249|560442802|FG000|Overall Study|Not treated|1|||
155276137|NCT01458249|560442802|FG000|Overall Study|Adverse Event|4|||
155276138|NCT01458249|560442802|FG000|Overall Study|Other|2|||
155276139|NCT01458249|560442802|FG000|Overall Study|Ongoing|1|||
155276140|NCT02056119|560442805|FG000|Overall Study|Death|1|||
155276141|NCT02056119|560442806|FG001|Overall Study|Death|2|||
155276142|NCT02056119|560442805|FG000|Overall Study|Intubated for less than 24 hrs|2|||
155276143|NCT02056119|560442806|FG001|Overall Study|Intubated for less than 24 hrs|7|||
155276144|NCT02056119|560442805|FG000|Overall Study|No aerosol treatments were given.|3|||
155276145|NCT02056119|560442806|FG001|Overall Study|No aerosol treatments were given.|2|||
155276146|NCT02056119|560442805|FG000|Overall Study|Received Metaneb treatment|0|||
155276147|NCT02056119|560442806|FG001|Overall Study|Received Metaneb treatment|2|||
155276148|NCT02056119|560442805|FG000|Overall Study|Protocol Violation|4|||
155276149|NCT02056119|560442806|FG001|Overall Study|Protocol Violation|7|||
155276150|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
155276151|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
155276152|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
155276153|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
155276154|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
155276155|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
155276156|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
155276157|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
155276158|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
155276159|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
155276160|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
155276161|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
155276162|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
155276163|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
155276164|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
155276165|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
155276166|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
155276167|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
155276168|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
155276169|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
155276170|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
155276171|NCT03220737|560442807|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276172|NCT03220737|560442808|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276173|NCT03220737|560442809|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
155276174|NCT03220737|560442810|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276175|NCT03220737|560442811|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155381943|NCT00598273|560833243|FG001|Overall Study|Physician Decision|0|||
155276176|NCT03220737|560442812|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155381944|NCT00598273|560833244|FG002|Overall Study|Physician Decision|1|||
155276177|NCT03220737|560442813|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
155276178|NCT03220737|560442807|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276179|NCT03220737|560442808|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276180|NCT03220737|560442809|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276181|NCT03220737|560442810|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276182|NCT03220737|560442811|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
155276183|NCT03220737|560442812|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276184|NCT03220737|560442813|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
155276185|NCT03220737|560442807|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
155276186|NCT03220737|560442808|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276187|NCT03220737|560442809|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276188|NCT03220737|560442810|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276189|NCT03220737|560442811|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276190|NCT03220737|560442812|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276191|NCT03220737|560442813|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
155276192|NCT03220737|560442807|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
155276193|NCT03220737|560442808|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276194|NCT03220737|560442809|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276195|NCT03220737|560442810|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276196|NCT03220737|560442811|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276197|NCT03220737|560442812|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276198|NCT03220737|560442813|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
155276199|NCT03220737|560442807|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
155276200|NCT03220737|560442808|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276201|NCT03220737|560442809|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276202|NCT03220737|560442810|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276203|NCT03220737|560442811|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276204|NCT03220737|560442812|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276205|NCT03220737|560442813|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
155276206|NCT01686932|560442821|FG000|Period 1|Adverse Event|1|||
155276207|NCT01686932|560442822|FG001|Period 1|Adverse Event|1|||
155276208|NCT01313923|560442827|FG000|Overall Study|Physician Decision|3|||
155276209|NCT03358329|560442828|FG000|Overall Study|Lost to Follow-up|2|||
155276210|NCT03358329|560442828|FG000|Overall Study|Withdrawal by Subject|2|||
155276211|NCT02982720|560442829|FG000|Overall Study|Adverse Event|3|||
155276212|NCT02982720|560442829|FG000|Overall Study|Death|1|||
155276213|NCT03875911|560442830|FG000|Overall Study|Lost to Follow-up|3|||
155276214|NCT03875911|560442831|FG001|Overall Study|Lost to Follow-up|6|||
155276215|NCT03875911|560442832|FG002|Overall Study|Lost to Follow-up|2|||
155276216|NCT03875911|560442830|FG000|Overall Study|Surgery cancelled|1|||
155276217|NCT03875911|560442831|FG001|Overall Study|Surgery cancelled|0|||
155276218|NCT03875911|560442832|FG002|Overall Study|Surgery cancelled|1|||
155276219|NCT03875911|560442830|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
155276220|NCT03875911|560442831|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
155276221|NCT03875911|560442832|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
155276222|NCT01231503|560442833|FG000|Overall Study|Adverse Event|0|||
155276223|NCT01231503|560442834|FG001|Overall Study|Adverse Event|0|||
155276224|NCT01231503|560442835|FG002|Overall Study|Adverse Event|0|||
155276225|NCT01231503|560442836|FG003|Overall Study|Adverse Event|0|||
155276226|NCT01231503|560442837|FG004|Overall Study|Adverse Event|0|||
155276227|NCT01231503|560442838|FG005|Overall Study|Adverse Event|1|||
155276228|NCT01231503|560442839|FG006|Overall Study|Adverse Event|0|||
155276229|NCT01231503|560442840|FG007|Overall Study|Adverse Event|0|||
155276230|NCT01231503|560442833|FG000|Overall Study|Adverse event, serious fatal|0|||
155276231|NCT01231503|560442834|FG001|Overall Study|Adverse event, serious fatal|0|||
155276232|NCT01231503|560442835|FG002|Overall Study|Adverse event, serious fatal|1|||
155276233|NCT01231503|560442836|FG003|Overall Study|Adverse event, serious fatal|1|||
155276234|NCT01231503|560442837|FG004|Overall Study|Adverse event, serious fatal|0|||
155276235|NCT01231503|560442838|FG005|Overall Study|Adverse event, serious fatal|1|||
155276236|NCT01231503|560442839|FG006|Overall Study|Adverse event, serious fatal|0|||
155276237|NCT01231503|560442840|FG007|Overall Study|Adverse event, serious fatal|0|||
155276238|NCT01231503|560442833|FG000|Overall Study|Withdrawal by Subject|6|||
155276239|NCT01231503|560442834|FG001|Overall Study|Withdrawal by Subject|3|||
155276240|NCT01231503|560442835|FG002|Overall Study|Withdrawal by Subject|3|||
155276241|NCT01231503|560442836|FG003|Overall Study|Withdrawal by Subject|1|||
155276242|NCT01231503|560442837|FG004|Overall Study|Withdrawal by Subject|3|||
155381945|NCT00598273|560833242|FG000|Overall Study|Withdrawal by Subject|12|||
155276243|NCT01231503|560442838|FG005|Overall Study|Withdrawal by Subject|5|||
155276244|NCT01231503|560442839|FG006|Overall Study|Withdrawal by Subject|1|||
155276245|NCT01231503|560442840|FG007|Overall Study|Withdrawal by Subject|2|||
155276246|NCT01231503|560442833|FG000|Overall Study|Lost to Follow-up|8|||
155276247|NCT01231503|560442834|FG001|Overall Study|Lost to Follow-up|10|||
155276248|NCT01231503|560442835|FG002|Overall Study|Lost to Follow-up|8|||
155276249|NCT01231503|560442836|FG003|Overall Study|Lost to Follow-up|5|||
155276250|NCT01231503|560442837|FG004|Overall Study|Lost to Follow-up|7|||
155276251|NCT01231503|560442838|FG005|Overall Study|Lost to Follow-up|9|||
155276252|NCT01231503|560442839|FG006|Overall Study|Lost to Follow-up|6|||
155276253|NCT01231503|560442840|FG007|Overall Study|Lost to Follow-up|6|||
155276254|NCT01231503|560442833|FG000|Overall Study|Protocol Violation|0|||
155276255|NCT01231503|560442834|FG001|Overall Study|Protocol Violation|0|||
155276256|NCT01231503|560442835|FG002|Overall Study|Protocol Violation|0|||
155276257|NCT01231503|560442836|FG003|Overall Study|Protocol Violation|1|||
155276258|NCT01231503|560442837|FG004|Overall Study|Protocol Violation|0|||
155276259|NCT01231503|560442838|FG005|Overall Study|Protocol Violation|0|||
155276260|NCT01231503|560442839|FG006|Overall Study|Protocol Violation|0|||
155276261|NCT01231503|560442840|FG007|Overall Study|Protocol Violation|0|||
155276262|NCT00287469|560442841|FG000|Overall Study|serious adverse event|1|||
155276263|NCT00287469|560442842|FG001|Overall Study|serious adverse event|6|||
155276264|NCT00287469|560442841|FG000|Overall Study|Adverse Event|1|||
155276265|NCT00287469|560442842|FG001|Overall Study|Adverse Event|1|||
155276266|NCT00287469|560442841|FG000|Overall Study|moved from area|144|||
155276267|NCT00287469|560442842|FG001|Overall Study|moved from area|138|||
155276268|NCT00287469|560442841|FG000|Overall Study|Lost to Follow-up|74|||
155276269|NCT00287469|560442842|FG001|Overall Study|Lost to Follow-up|69|||
155276270|NCT02207374|560442846|FG000|Overall Study|Withdrawal by Subject|5|||
155276271|NCT02207374|560442847|FG001|Overall Study|Withdrawal by Subject|9|||
155276272|NCT02207374|560442848|FG002|Overall Study|Withdrawal by Subject|4|||
155276273|NCT02207374|560442846|FG000|Overall Study|Death|1|||
155276274|NCT02207374|560442847|FG001|Overall Study|Death|0|||
155276275|NCT02207374|560442848|FG002|Overall Study|Death|1|||
155276276|NCT02207374|560442846|FG000|Overall Study|Missing follow-up information|0|||
155276277|NCT02207374|560442847|FG001|Overall Study|Missing follow-up information|1|||
155276278|NCT02207374|560442848|FG002|Overall Study|Missing follow-up information|1|||
155276279|NCT02087150|560442849|FG000|Overall Study|Death|0|||
155276280|NCT02087150|560442850|FG001|Overall Study|Death|1|||
155276281|NCT02087150|560442851|FG002|Overall Study|Death|0|||
155276282|NCT02087150|560442849|FG000|Overall Study|Lost to Follow-up|6|||
155276283|NCT02087150|560442850|FG001|Overall Study|Lost to Follow-up|13|||
155276284|NCT02087150|560442851|FG002|Overall Study|Lost to Follow-up|7|||
155276285|NCT02087150|560442849|FG000|Overall Study|Withdrawal by Subject|2|||
155276286|NCT02087150|560442850|FG001|Overall Study|Withdrawal by Subject|5|||
155276287|NCT02087150|560442851|FG002|Overall Study|Withdrawal by Subject|3|||
155276288|NCT02087150|560442849|FG000|Overall Study|Physician Decision|0|||
155276289|NCT02087150|560442850|FG001|Overall Study|Physician Decision|1|||
155276290|NCT02087150|560442851|FG002|Overall Study|Physician Decision|0|||
155276291|NCT02087150|560442849|FG000|Overall Study|Procedure not done|1|||
155276292|NCT02087150|560442850|FG001|Overall Study|Procedure not done|13|||
155276293|NCT02087150|560442851|FG002|Overall Study|Procedure not done|0|||
155276294|NCT02087150|560442849|FG000|Overall Study|F/U not completed w/in study window|0|||
155276295|NCT02087150|560442850|FG001|Overall Study|F/U not completed w/in study window|0|||
155276296|NCT02087150|560442851|FG002|Overall Study|F/U not completed w/in study window|1|||
155276297|NCT02087150|560442849|FG000|Overall Study|Other|1|||
155276298|NCT02087150|560442850|FG001|Overall Study|Other|0|||
155276299|NCT02087150|560442851|FG002|Overall Study|Other|0|||
155276300|NCT02087150|560442849|FG000|Overall Study|Pt moved out of town|0|||
155276301|NCT02087150|560442850|FG001|Overall Study|Pt moved out of town|1|||
155276302|NCT02087150|560442851|FG002|Overall Study|Pt moved out of town|0|||
155276303|NCT00393094|560442855|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
155276304|NCT00393094|560442855|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
155276305|NCT02019602|560442856|FG000|Screening Period|Ineligibility|4|||
155276306|NCT02019602|560442857|FG001|Screening Period|Ineligibility|0|||
155276307|NCT02019602|560442856|FG000|Screening Period|Adverse Event|1|||
155381946|NCT00598273|560833243|FG001|Overall Study|Withdrawal by Subject|10|||
155276308|NCT02019602|560442857|FG001|Screening Period|Adverse Event|0|||
155276309|NCT03653416|560442860|FG000|Overall Study|Protocol Violation|6|||
155276310|NCT03653416|560442861|FG001|Overall Study|Protocol Violation|1|||
155276311|NCT02788006|560442862|FG000|Overall Study|Patient not treated|1|||
155276312|NCT01435798|560442865|FG000|Overall Study|Withdrawal by Subject|1|||
155276313|NCT01556763|560442868|FG000|Overall Study|Withdrawal by Subject|0|||
155276314|NCT01556763|560442869|FG001|Overall Study|Withdrawal by Subject|1|||
155276315|NCT01556763|560442870|FG002|Overall Study|Withdrawal by Subject|0|||
155276316|NCT02258464|560442871|FG000|Overall Study|Progressive disease (PD)|9|||
155276317|NCT02258464|560442872|FG001|Overall Study|Progressive disease (PD)|17|||
155276318|NCT02258464|560442871|FG000|Overall Study|Study drug never administered|1|||
155276319|NCT02258464|560442872|FG001|Overall Study|Study drug never administered|1|||
155276320|NCT02258464|560442871|FG000|Overall Study|AE not related to clinical PD|1|||
155276321|NCT02258464|560442872|FG001|Overall Study|AE not related to clinical PD|3|||
155276322|NCT02258464|560442871|FG000|Overall Study|Withdrawal by Subject|5|||
155276323|NCT02258464|560442872|FG001|Overall Study|Withdrawal by Subject|4|||
155276324|NCT02258464|560442871|FG000|Overall Study|AE related to clinical PD|1|||
155276325|NCT02258464|560442872|FG001|Overall Study|AE related to clinical PD|0|||
155276326|NCT00776100|560442873|FG000|Overall Study|Disease Progression|1|||
155276327|NCT00776100|560442874|FG001|Overall Study|Disease Progression|0|||
155276328|NCT03567993|560442875|FG000|Overall Study|Lost to Follow-up|4|||
155276329|NCT03567993|560442876|FG001|Overall Study|Lost to Follow-up|2|||
155276330|NCT03567993|560442875|FG000|Overall Study|Death|1|||
155276331|NCT03567993|560442876|FG001|Overall Study|Death|1|||
155276332|NCT03567993|560442875|FG000|Overall Study|Withdrawal by Subject|1|||
155276333|NCT03567993|560442876|FG001|Overall Study|Withdrawal by Subject|0|||
155276334|NCT00903786|560442877|FG000|Overall Study|Physician Decision|6|||
155276335|NCT00903786|560442877|FG000|Overall Study|Lack of Efficacy|5|||
155276336|NCT00903786|560442877|FG000|Overall Study|Reason other than lack of efficacy|4|||
155276337|NCT02285595|560442878|FG000|Overall Study|Lost to Follow-up|14|||
155276338|NCT02285595|560442878|FG000|Overall Study|Withdrawal by Subject|1|||
155276339|NCT01960790|560442879|FG000|Overall Study|Survey forms could not be recovered|3|||
155276340|NCT01960790|560442879|FG000|Overall Study|Treat with Humira outside survey period|3|||
155276341|NCT01960790|560442879|FG000|Overall Study|Transferred to another hospital|4|||
155276342|NCT01960790|560442879|FG000|Overall Study|Unevaluable for safety|1|||
155276343|NCT00064025|560442880|FG000|Overall Study|Ineligible|4|||
155276344|NCT00064025|560442880|FG000|Overall Study|Inevaluable|3|||
155276345|NCT01644474|560442881|FG000|Overall Study|Poor compliance to protocol|1|||
155276346|NCT01644474|560442882|FG001|Overall Study|Poor compliance to protocol|0|||
155276347|NCT01644474|560442881|FG000|Overall Study|Consent withdrawn by participant|0|||
155276348|NCT01644474|560442882|FG001|Overall Study|Consent withdrawn by participant|1|||
155276349|NCT01644474|560442881|FG000|Overall Study|Participant moved|0|||
155276350|NCT01644474|560442882|FG001|Overall Study|Participant moved|1|||
155276351|NCT01644474|560442881|FG000|Overall Study|Adverse Event|4|||
155276352|NCT01644474|560442882|FG001|Overall Study|Adverse Event|5|||
155276353|NCT01644474|560442881|FG000|Overall Study|Site scheduling error|1|||
155276354|NCT01644474|560442882|FG001|Overall Study|Site scheduling error|1|||
155276355|NCT01644474|560442881|FG000|Overall Study|Protocol Violation|1|||
155276356|NCT01644474|560442882|FG001|Overall Study|Protocol Violation|0|||
155276357|NCT02711995|560444637|FG000|Washout (90 Days)|Conflicting medication|1|||
155276358|NCT00322868|560444638|FG000|Overall Study|disease progression|1|||
155276359|NCT03615482|560444639|FG000|Overall Study|Death|1|||
155276360|NCT03615482|560444640|FG001|Overall Study|Death|0|||
155276361|NCT03615482|560444639|FG000|Overall Study|Lost to Follow-up|7|||
155276362|NCT03615482|560444640|FG001|Overall Study|Lost to Follow-up|7|||
155276363|NCT03615482|560444639|FG000|Overall Study|Physician Decision|2|||
155276364|NCT03615482|560444640|FG001|Overall Study|Physician Decision|3|||
155276365|NCT03615482|560444639|FG000|Overall Study|Withdrawal by Subject|7|||
155276366|NCT03615482|560444640|FG001|Overall Study|Withdrawal by Subject|7|||
155276367|NCT00590980|560444661|FG000|Overall Study|Did not meet all inclusion criteria|10|||
155276368|NCT00506285|560444662|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
155276369|NCT00506285|560444663|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
155276370|NCT00506285|560444662|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
155276371|NCT00506285|560444663|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
155276372|NCT00506285|560444662|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
155276373|NCT00506285|560444663|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
155276374|NCT00506285|560444662|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
155276375|NCT00506285|560444663|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
155276376|NCT00506285|560444662|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
155276377|NCT00506285|560444663|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
155276378|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
155276379|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
155276380|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
155276381|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
155276382|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
155276383|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
155276384|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
155276385|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
155276386|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155276387|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
154936674|NCT01042977|559194749|FG000|Overall Study|Subject no longer meets study criteria|15|||
154936675|NCT01042977|559194750|FG001|Overall Study|Subject no longer meets study criteria|13|||
154936676|NCT01042977|559194749|FG000|Overall Study|Incorrect enrollment|6|||
155276388|NCT01646320|560444668|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
155276389|NCT01646320|560444669|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
155276390|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
155276391|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
155276392|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
154936677|NCT01042977|559194750|FG001|Overall Study|Incorrect enrollment|4|||
155276393|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
155276394|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
155276395|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
155276396|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
155276397|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
155276398|NCT01646320|560444668|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
155276399|NCT01646320|560444669|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
155276400|NCT01489020|560444670|FG000|Overall Study|Withdrawal by Subject|1|||
155276401|NCT01489020|560444671|FG001|Overall Study|Withdrawal by Subject|0|||
155276402|NCT01489020|560444672|FG002|Overall Study|Withdrawal by Subject|0|||
155276403|NCT01489020|560444673|FG003|Overall Study|Withdrawal by Subject|0|||
155276404|NCT01489020|560444674|FG004|Overall Study|Withdrawal by Subject|0|||
155276405|NCT01489020|560444675|FG005|Overall Study|Withdrawal by Subject|0|||
155276406|NCT01489020|560444670|FG000|Overall Study|Adverse Event|0|||
155276407|NCT01489020|560444671|FG001|Overall Study|Adverse Event|0|||
155276408|NCT01489020|560444672|FG002|Overall Study|Adverse Event|3|||
155276409|NCT01489020|560444673|FG003|Overall Study|Adverse Event|0|||
155276410|NCT01489020|560444674|FG004|Overall Study|Adverse Event|3|||
155276411|NCT01489020|560444675|FG005|Overall Study|Adverse Event|0|||
155276412|NCT01489020|560444670|FG000|Overall Study|Concomitant disease|0|||
155276413|NCT01489020|560444671|FG001|Overall Study|Concomitant disease|0|||
155276414|NCT01489020|560444672|FG002|Overall Study|Concomitant disease|0|||
155276415|NCT01489020|560444673|FG003|Overall Study|Concomitant disease|0|||
155276416|NCT01489020|560444674|FG004|Overall Study|Concomitant disease|3|||
155276417|NCT01489020|560444675|FG005|Overall Study|Concomitant disease|0|||
155276418|NCT02892409|560444676|FG000|Overall Study|Adverse Event|1|||
155276419|NCT02892409|560444677|FG001|Overall Study|Adverse Event|0|||
155276420|NCT02892409|560444676|FG000|Overall Study|Withdrawal by Subject|2|||
155276421|NCT02892409|560444677|FG001|Overall Study|Withdrawal by Subject|1|||
155276422|NCT02451930|560444679|FG000|Overall Study|Death|0|||
155276423|NCT02451930|560444680|FG001|Overall Study|Death|15|||
155276424|NCT02451930|560444679|FG000|Overall Study|Lost to Follow-up|0|||
155276425|NCT02451930|560444680|FG001|Overall Study|Lost to Follow-up|3|||
155276426|NCT02451930|560444679|FG000|Overall Study|Sponsor Decision|2|||
155276427|NCT02451930|560444680|FG001|Overall Study|Sponsor Decision|10|||
155276428|NCT02451930|560444679|FG000|Overall Study|Withdrawal by Subject|0|||
155276429|NCT02451930|560444680|FG001|Overall Study|Withdrawal by Subject|1|||
155276430|NCT02451930|560444679|FG000|Overall Study|Other|0|||
155276431|NCT02451930|560444680|FG001|Overall Study|Other|1|||
155276432|NCT02485353|560444683|FG000|Overall Study|Death|1|||
155276433|NCT02485353|560444683|FG000|Overall Study|Disease Progression|1|||
155276434|NCT01950273|560444691|FG000|Overall Study|Protocol Violation|1|||
155276435|NCT01950273|560444692|FG001|Overall Study|Protocol Violation|0|||
155276436|NCT01950273|560444691|FG000|Overall Study|Withdrawal by Subject|2|||
155276437|NCT01950273|560444692|FG001|Overall Study|Withdrawal by Subject|0|||
155276438|NCT01950273|560444691|FG000|Overall Study|Other not defined above|1|||
155276439|NCT01950273|560444692|FG001|Overall Study|Other not defined above|0|||
155276440|NCT00472186|560444693|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
155276441|NCT00472186|560444694|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
155276442|NCT01254565|560444695|FG000|Overall Study|Non-compliance to Study Procedures|0|||
155276443|NCT01254565|560444696|FG001|Overall Study|Non-compliance to Study Procedures|0|||
155276444|NCT01254565|560444697|FG002|Overall Study|Non-compliance to Study Procedures|0|||
155276445|NCT01254565|560444698|FG003|Overall Study|Non-compliance to Study Procedures|0|||
155276446|NCT01254565|560444699|FG004|Overall Study|Non-compliance to Study Procedures|1|||
155276447|NCT01254565|560444700|FG005|Overall Study|Non-compliance to Study Procedures|0|||
155276448|NCT01254565|560444695|FG000|Overall Study|Did not Receive Treatment|1|||
155276449|NCT01254565|560444696|FG001|Overall Study|Did not Receive Treatment|1|||
155276450|NCT01254565|560444697|FG002|Overall Study|Did not Receive Treatment|0|||
155276451|NCT01254565|560444698|FG003|Overall Study|Did not Receive Treatment|0|||
155276452|NCT01254565|560444699|FG004|Overall Study|Did not Receive Treatment|3|||
155276453|NCT01254565|560444700|FG005|Overall Study|Did not Receive Treatment|4|||
155276454|NCT01254565|560444695|FG000|Overall Study|Other|0|||
155276455|NCT01254565|560444696|FG001|Overall Study|Other|0|||
155276456|NCT01254565|560444697|FG002|Overall Study|Other|0|||
155276457|NCT01254565|560444698|FG003|Overall Study|Other|1|||
155276458|NCT01254565|560444699|FG004|Overall Study|Other|0|||
155276459|NCT01254565|560444700|FG005|Overall Study|Other|0|||
155276460|NCT03354637|560444705|FG000|Double-blind Period|Protocol Violation|2|||
155276461|NCT03354637|560444706|FG001|Double-blind Period|Protocol Violation|0|||
155276462|NCT03354637|560444707|FG002|Double-blind Period|Protocol Violation|0|||
155276463|NCT03354637|560444705|FG000|Double-blind Period|Adverse Event|1|||
155276464|NCT03354637|560444706|FG001|Double-blind Period|Adverse Event|2|||
155276465|NCT03354637|560444707|FG002|Double-blind Period|Adverse Event|0|||
155276466|NCT03354637|560444705|FG000|Double-blind Period|Lost to Follow-up|3|||
155276467|NCT03354637|560444706|FG001|Double-blind Period|Lost to Follow-up|4|||
155276468|NCT03354637|560444707|FG002|Double-blind Period|Lost to Follow-up|3|||
155276469|NCT03354637|560444705|FG000|Double-blind Period|Withdrawal by Subject|10|||
155276470|NCT03354637|560444706|FG001|Double-blind Period|Withdrawal by Subject|6|||
155276471|NCT03354637|560444707|FG002|Double-blind Period|Withdrawal by Subject|4|||
155276472|NCT03354637|560444705|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
155276473|NCT03354637|560444706|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
155276474|NCT03354637|560444707|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
155276475|NCT03354637|560444705|FG000|Open Label Extension|Adverse Event|0|||
155276476|NCT03354637|560444706|FG001|Open Label Extension|Adverse Event|0|||
155276477|NCT03354637|560444707|FG002|Open Label Extension|Adverse Event|1|||
155276478|NCT03354637|560444705|FG000|Open Label Extension|Lost to Follow-up|0|||
155276479|NCT03354637|560444706|FG001|Open Label Extension|Lost to Follow-up|0|||
155276480|NCT03354637|560444707|FG002|Open Label Extension|Lost to Follow-up|2|||
155276481|NCT03354637|560444705|FG000|Open Label Extension|Withdrawal by Subject|0|||
155276482|NCT03354637|560444706|FG001|Open Label Extension|Withdrawal by Subject|0|||
155276483|NCT03354637|560444707|FG002|Open Label Extension|Withdrawal by Subject|5|||
155276484|NCT03354637|560444705|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
155276485|NCT03354637|560444706|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
155276486|NCT03354637|560444707|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
155276487|NCT03354637|560444705|FG000|Open Label Extension|Subject Noncompliance|0|||
155276488|NCT03354637|560444706|FG001|Open Label Extension|Subject Noncompliance|0|||
155276489|NCT03354637|560444707|FG002|Open Label Extension|Subject Noncompliance|1|||
155276490|NCT03354637|560444705|FG000|Open Label Extension|Lack of Efficacy|0|||
155276491|NCT03354637|560444706|FG001|Open Label Extension|Lack of Efficacy|0|||
155276492|NCT03354637|560444707|FG002|Open Label Extension|Lack of Efficacy|1|||
155276493|NCT03354637|560444705|FG000|Open Label Extension|Physician Decision|0|||
155276494|NCT03354637|560444706|FG001|Open Label Extension|Physician Decision|0|||
155276495|NCT03354637|560444707|FG002|Open Label Extension|Physician Decision|1|||
155276496|NCT02726399|560444708|FG000|Overall Study|Participant Non-Compliance|1|||
155276497|NCT02726399|560444708|FG000|Overall Study|Adverse Event|2|||
155276498|NCT02726399|560444708|FG000|Overall Study|Progression of disease|4|||
155276499|NCT04006366|560444709|FG000|Overall Study|Withdrawal by Subject|1|||
155276500|NCT00997243|560444713|FG000|Overall Study|Early termination of study by sponsor|7|||
155276501|NCT02086552|560444716|FG000|Overall Study|Withdrawal by Subject|1|||
155276502|NCT02206152|560444717|FG000|Pre-Randomization|Withdrawal by Subject|2|||
155276503|NCT00478608|560444718|FG000|Overall Study|Adverse Event|1|||
155276504|NCT00478608|560444718|FG000|Overall Study|Serious Adverse Event|14|||
155276505|NCT00478608|560444718|FG000|Overall Study|Withdrawal by Subject|2|||
155276506|NCT00478608|560444718|FG000|Overall Study|Protocol Violation|3|||
155276507|NCT02080520|560444719|FG000|Overall Study|Self-reported symptoms|5|||
155276508|NCT02080520|560444720|FG001|Overall Study|Self-reported symptoms|6|||
155276509|NCT02080520|560444719|FG000|Overall Study|Unable to contact|2|||
155276510|NCT02080520|560444720|FG001|Overall Study|Unable to contact|1|||
155276511|NCT02080520|560444719|FG000|Overall Study|Initiated aspirin|2|||
155276512|NCT02080520|560444720|FG001|Overall Study|Initiated aspirin|0|||
155276513|NCT02080520|560444719|FG000|Overall Study|Atrial fibrillation|1|||
155276514|NCT02080520|560444720|FG001|Overall Study|Atrial fibrillation|1|||
155276515|NCT02080520|560444719|FG000|Overall Study|Cancer|1|||
155276516|NCT02080520|560444720|FG001|Overall Study|Cancer|2|||
155276517|NCT02080520|560444719|FG000|Overall Study|Not interested in study|1|||
154936678|NCT01042977|559194749|FG000|Overall Study|Safety|0|||
154936679|NCT01042977|559194750|FG001|Overall Study|Safety|2|||
154936680|NCT01042977|559194749|FG000|Overall Study|Administrative reason by sponsor|0|||
154936681|NCT01042977|559194750|FG001|Overall Study|Administrative reason by sponsor|1|||
154936682|NCT01042977|559194749|FG000|Overall Study|Various|3|||
154936683|NCT01042977|559194750|FG001|Overall Study|Various|0|||
154936684|NCT02499354|559194751|FG000|Overall Study|Withdrawal by Subject|1|||
154936685|NCT02499354|559194752|FG001|Overall Study|Withdrawal by Subject|0|||
154936686|NCT01677910|559194754|FG000|Double-Blind Treatment Period|Adverse Event|6|||
154936687|NCT01677910|559194755|FG001|Double-Blind Treatment Period|Adverse Event|2|||
154936688|NCT01677910|559194756|FG002|Double-Blind Treatment Period|Adverse Event|3|||
154936689|NCT01677910|559194757|FG003|Double-Blind Treatment Period|Adverse Event|0|||
154936690|NCT01677910|559194754|FG000|Double-Blind Treatment Period|Physician Decision|0|||
154936691|NCT01677910|559194755|FG001|Double-Blind Treatment Period|Physician Decision|0|||
154936692|NCT01677910|559194756|FG002|Double-Blind Treatment Period|Physician Decision|1|||
154936693|NCT01677910|559194757|FG003|Double-Blind Treatment Period|Physician Decision|0|||
154936694|NCT01677910|559194754|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
154936695|NCT01677910|559194755|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
155043445|NCT01826981|559590136|FG014|Overall Study|Lost to Follow-up|0|||
155276518|NCT02080520|560444720|FG001|Overall Study|Not interested in study|3|||
155276519|NCT02080520|560444719|FG000|Overall Study|Too busy|1|||
155276520|NCT02080520|560444720|FG001|Overall Study|Too busy|1|||
155276521|NCT02080520|560444719|FG000|Overall Study|Work-related injury|1|||
155276522|NCT02080520|560444720|FG001|Overall Study|Work-related injury|0|||
155276523|NCT02080520|560444719|FG000|Overall Study|Personal reasons|0|||
155276524|NCT02080520|560444720|FG001|Overall Study|Personal reasons|3|||
155276525|NCT00390455|560444721|FG000|Overall Study|Adverse Event|17|||
155276526|NCT00390455|560444722|FG001|Overall Study|Adverse Event|3|||
155276527|NCT00390455|560444721|FG000|Overall Study|Withdrawal by Subject|8|||
155276528|NCT00390455|560444722|FG001|Overall Study|Withdrawal by Subject|8|||
155276529|NCT00390455|560444721|FG000|Overall Study|Alternate Treatment|0|||
155276530|NCT00390455|560444722|FG001|Overall Study|Alternate Treatment|1|||
155276531|NCT00390455|560444721|FG000|Overall Study|Other Medical Reasons|7|||
155276532|NCT00390455|560444722|FG001|Overall Study|Other Medical Reasons|11|||
155276533|NCT02406261|560444725|FG000|Period 1|Lost to Follow-up|2|||
155276534|NCT02406261|560444726|FG001|Period 1|Lost to Follow-up|0|||
155276535|NCT02406261|560444725|FG000|Period 1|Adverse Event|1|||
155276536|NCT02406261|560444726|FG001|Period 1|Adverse Event|0|||
155276537|NCT02406261|560444725|FG000|Period 2|Physician Decision|0|||
155276538|NCT02406261|560444726|FG001|Period 2|Physician Decision|1|||
155276539|NCT02406261|560444725|FG000|Period 2|Protocol Violation|0|||
155276540|NCT02406261|560444726|FG001|Period 2|Protocol Violation|1|||
155276541|NCT02406261|560444725|FG000|Period 2|Withdrawal by Subject|0|||
155276542|NCT02406261|560444726|FG001|Period 2|Withdrawal by Subject|1|||
155276543|NCT01591460|560444732|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
155276544|NCT01591460|560444732|FG000|Overall Study|Futility Rule (Week 12)|7|||
155276545|NCT01591460|560444732|FG000|Overall Study|Futility Rule (Week 24)|3|||
155276546|NCT01591460|560444732|FG000|Overall Study|Rebound or Breakthrough|3|||
155276547|NCT01591460|560444732|FG000|Overall Study|Treatment Discontinued by Error|1|||
155276548|NCT01591460|560444732|FG000|Overall Study|Lost to Follow-up|1|||
155276549|NCT01591460|560444732|FG000|Overall Study|Noncompliance|1|||
155276550|NCT01591460|560444732|FG000|Overall Study|Participant Refusal|3|||
155276551|NCT01591460|560444732|FG000|Overall Study|Withdrawal by Subject|1|||
155276552|NCT01591460|560444732|FG000|Overall Study|Protocol Violation|1|||
155276553|NCT01567163|560444736|FG000|Overall Study|Progressive Disease|2|||
155276554|NCT01567163|560444736|FG000|Overall Study|Lost to Follow-up|2|||
155276555|NCT03405662|560444738|FG000|Overall Study|COVID-19 restriction|1|||
155276556|NCT03405662|560444739|FG001|Overall Study|COVID-19 restriction|0|||
155276557|NCT03405662|560444738|FG000|Overall Study|unblinding|0|||
155276558|NCT03405662|560444739|FG001|Overall Study|unblinding|1|||
155276559|NCT03405662|560444738|FG000|Overall Study|placement in memory care facility|0|||
155276560|NCT03405662|560444739|FG001|Overall Study|placement in memory care facility|2|||
155276561|NCT01348854|560444740|FG000|Overall Study|Lost to Follow-up|2|||
155276562|NCT01348854|560444741|FG001|Overall Study|Lost to Follow-up|1|||
155276563|NCT01348854|560444740|FG000|Overall Study|Withdrawal by Subject|1|||
155276564|NCT01348854|560444741|FG001|Overall Study|Withdrawal by Subject|0|||
155276565|NCT01720797|560444742|FG000|Overall Study|Withdrawal by Subject|3|||
155276566|NCT01720797|560444743|FG001|Overall Study|Withdrawal by Subject|0|||
155276567|NCT00983619|560444744|FG000|Overall Study|Lost to Follow-up|0|||
155276568|NCT00983619|560444745|FG001|Overall Study|Lost to Follow-up|1|||
155276569|NCT00983619|560444746|FG002|Overall Study|Lost to Follow-up|0|||
155276570|NCT00983619|560444747|FG003|Overall Study|Lost to Follow-up|0|||
155276571|NCT00983619|560444748|FG004|Overall Study|Lost to Follow-up|0|||
155276572|NCT00983619|560444749|FG005|Overall Study|Lost to Follow-up|2|||
155276573|NCT00983619|560444750|FG006|Overall Study|Lost to Follow-up|0|||
155276574|NCT00983619|560444751|FG007|Overall Study|Lost to Follow-up|0|||
155276575|NCT00983619|560444752|FG008|Overall Study|Lost to Follow-up|0|||
155276576|NCT00983619|560444753|FG009|Overall Study|Lost to Follow-up|0|||
155276577|NCT00983619|560444754|FG010|Overall Study|Lost to Follow-up|0|||
155276578|NCT00983619|560444755|FG011|Overall Study|Lost to Follow-up|2|||
155276579|NCT00983619|560444744|FG000|Overall Study|Withdrawal by Subject|2|||
155276580|NCT00983619|560444745|FG001|Overall Study|Withdrawal by Subject|1|||
155276581|NCT00983619|560444746|FG002|Overall Study|Withdrawal by Subject|1|||
155276582|NCT00983619|560444747|FG003|Overall Study|Withdrawal by Subject|3|||
155276583|NCT00983619|560444748|FG004|Overall Study|Withdrawal by Subject|1|||
155276584|NCT00983619|560444749|FG005|Overall Study|Withdrawal by Subject|23|||
155276585|NCT00983619|560444750|FG006|Overall Study|Withdrawal by Subject|0|||
155276586|NCT00983619|560444751|FG007|Overall Study|Withdrawal by Subject|0|||
155276587|NCT00983619|560444752|FG008|Overall Study|Withdrawal by Subject|0|||
155276588|NCT00983619|560444753|FG009|Overall Study|Withdrawal by Subject|0|||
155276589|NCT00983619|560444754|FG010|Overall Study|Withdrawal by Subject|1|||
155276590|NCT00983619|560444755|FG011|Overall Study|Withdrawal by Subject|1|||
155276591|NCT00983619|560444744|FG000|Overall Study|Death|0|||
155276592|NCT00983619|560444745|FG001|Overall Study|Death|2|||
155276593|NCT00983619|560444746|FG002|Overall Study|Death|2|||
155276594|NCT00983619|560444747|FG003|Overall Study|Death|1|||
155276595|NCT00983619|560444748|FG004|Overall Study|Death|2|||
155276596|NCT00983619|560444749|FG005|Overall Study|Death|30|||
155276597|NCT00983619|560444750|FG006|Overall Study|Death|1|||
155276598|NCT00983619|560444751|FG007|Overall Study|Death|0|||
155276599|NCT00983619|560444752|FG008|Overall Study|Death|1|||
155276600|NCT00983619|560444753|FG009|Overall Study|Death|2|||
155276601|NCT00983619|560444754|FG010|Overall Study|Death|9|||
155276602|NCT00983619|560444755|FG011|Overall Study|Death|8|||
155276603|NCT00983619|560444744|FG000|Overall Study|Other|1|||
155276604|NCT00983619|560444745|FG001|Overall Study|Other|0|||
155276605|NCT00983619|560444746|FG002|Overall Study|Other|0|||
155276606|NCT00983619|560444747|FG003|Overall Study|Other|1|||
155276607|NCT00983619|560444748|FG004|Overall Study|Other|0|||
155276608|NCT00983619|560444749|FG005|Overall Study|Other|12|||
155276609|NCT00983619|560444750|FG006|Overall Study|Other|2|||
155276610|NCT00983619|560444751|FG007|Overall Study|Other|2|||
155276611|NCT00983619|560444752|FG008|Overall Study|Other|0|||
155276612|NCT00983619|560444753|FG009|Overall Study|Other|1|||
155276613|NCT00983619|560444754|FG010|Overall Study|Other|1|||
155276614|NCT00983619|560444755|FG011|Overall Study|Other|0|||
155276615|NCT00724061|560444756|FG000|Dose Escalation Phase|Adverse Event|2|||
155276616|NCT00724061|560444756|FG000|Dose Escalation Phase|Disease Progression|3|||
155276617|NCT04827134|560444759|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
155276618|NCT04827134|560444760|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
155276619|NCT04827134|560444761|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
155276620|NCT04827134|560444762|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
155276621|NCT00688259|560444767|FG000|Overall Study|Lost to Follow-up|2|||
155276622|NCT00688259|560444768|FG001|Overall Study|Lost to Follow-up|4|||
155276623|NCT00688259|560444767|FG000|Overall Study|Physician Decision|1|||
155276624|NCT00688259|560444768|FG001|Overall Study|Physician Decision|0|||
155276625|NCT00688259|560444767|FG000|Overall Study|Withdrawal by Subject|2|||
155276626|NCT00688259|560444768|FG001|Overall Study|Withdrawal by Subject|0|||
155276627|NCT00688259|560444767|FG000|Overall Study|Declined Interview|2|||
155276628|NCT00688259|560444768|FG001|Overall Study|Declined Interview|3|||
155276629|NCT00688259|560444767|FG000|Overall Study|Hospitalized at Follow-up|0|||
155276630|NCT00688259|560444768|FG001|Overall Study|Hospitalized at Follow-up|1|||
155276631|NCT02443103|560444769|FG000|Overall Study|Adverse Event|2|||
155276632|NCT02443103|560444769|FG000|Overall Study|Noncompliance|1|||
155276633|NCT03207711|560444776|FG000|Overall Study|Withdrawal by Subject|1|||
155276634|NCT03207711|560444777|FG001|Overall Study|Withdrawal by Subject|2|||
155276635|NCT01083160|560444781|FG000|Overall Study|Adverse Event|1|||
155276636|NCT01267253|560444783|FG000|Overall Study|Ineligible - required test not done|1|||
155276637|NCT01267253|560444783|FG000|Overall Study|Inevaluable-never received study treatme|2|||
155276638|NCT00547911|560444786|FG000|Overall Study|Adverse Event|0|||
155276639|NCT00547911|560444787|FG001|Overall Study|Adverse Event|0|||
155276640|NCT00547911|560444788|FG002|Overall Study|Adverse Event|0|||
155276641|NCT00547911|560444789|FG003|Overall Study|Adverse Event|1|||
155276642|NCT00547911|560444790|FG004|Overall Study|Adverse Event|0|||
155276643|NCT00547911|560444791|FG005|Overall Study|Adverse Event|0|||
155276644|NCT04129580|560446061|FG000|Overall Study|Lost to Follow-up|14|||
155276645|NCT04129580|560446062|FG001|Overall Study|Lost to Follow-up|25|||
155276646|NCT03699124|560446063|FG000|Overall Study|Adverse Event|6|||
155276647|NCT03699124|560446064|FG001|Overall Study|Adverse Event|5|||
155276648|NCT03699124|560446065|FG002|Overall Study|Adverse Event|2|||
155276649|NCT03699124|560446063|FG000|Overall Study|Death|0|||
155276650|NCT03699124|560446064|FG001|Overall Study|Death|2|||
155276651|NCT03699124|560446065|FG002|Overall Study|Death|0|||
155276652|NCT03699124|560446063|FG000|Overall Study|Lost to Follow-up|20|||
155276653|NCT03699124|560446064|FG001|Overall Study|Lost to Follow-up|16|||
155276654|NCT03699124|560446065|FG002|Overall Study|Lost to Follow-up|15|||
155276655|NCT03699124|560446063|FG000|Overall Study|Protocol Violation|1|||
155276656|NCT03699124|560446064|FG001|Overall Study|Protocol Violation|0|||
155276657|NCT03699124|560446065|FG002|Overall Study|Protocol Violation|0|||
155276658|NCT03699124|560446063|FG000|Overall Study|Withdrawal by Subject|13|||
155276659|NCT03699124|560446064|FG001|Overall Study|Withdrawal by Subject|14|||
155276660|NCT03699124|560446065|FG002|Overall Study|Withdrawal by Subject|13|||
155276661|NCT03699124|560446063|FG000|Overall Study|Other reasons|5|||
155276662|NCT03699124|560446064|FG001|Overall Study|Other reasons|3|||
155276663|NCT03699124|560446065|FG002|Overall Study|Other reasons|10|||
155276664|NCT03595683|560446066|FG000|Overall Study|Adverse Event|1|||
155276665|NCT03595683|560446067|FG001|Overall Study|Adverse Event|0|||
155276666|NCT03595683|560446066|FG000|Overall Study|Pursue alternative therapy|1|||
155276667|NCT03595683|560446067|FG001|Overall Study|Pursue alternative therapy|1|||
155276668|NCT03595683|560446066|FG000|Overall Study|Progressive disease|1|||
155276669|NCT03595683|560446067|FG001|Overall Study|Progressive disease|3|||
155276670|NCT02561455|560446068|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
155276671|NCT02561455|560446069|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
155276672|NCT02561455|560446070|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
155276673|NCT02561455|560446071|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
155276674|NCT02561455|560446068|FG000|Overall Study|Withdrawal by Subject|1|||
155276675|NCT02561455|560446069|FG001|Overall Study|Withdrawal by Subject|0|||
155276676|NCT02561455|560446070|FG002|Overall Study|Withdrawal by Subject|1|||
155276677|NCT02561455|560446071|FG003|Overall Study|Withdrawal by Subject|0|||
155276678|NCT02561455|560446068|FG000|Overall Study|Disease Progression|0|||
155276679|NCT02561455|560446069|FG001|Overall Study|Disease Progression|1|||
155276680|NCT02561455|560446070|FG002|Overall Study|Disease Progression|0|||
155276681|NCT02561455|560446071|FG003|Overall Study|Disease Progression|0|||
155276682|NCT01951092|560446077|FG000|Overall Study|Lost to Follow-up|10|||
155276683|NCT01951092|560446077|FG000|Overall Study|Incarceration|1|||
155276684|NCT01951092|560446077|FG000|Overall Study|Transfer of Care|1|||
155276685|NCT00136916|560446078|FG000|Overall Study|Never received study treatment|3|||
155276686|NCT00136916|560446079|FG001|Overall Study|Never received study treatment|5|||
155276687|NCT00136916|560446078|FG000|Overall Study|Death|1|||
155276688|NCT00136916|560446079|FG001|Overall Study|Death|3|||
155276689|NCT00136916|560446078|FG000|Overall Study|Adverse Event|27|||
155276690|NCT00136916|560446079|FG001|Overall Study|Adverse Event|8|||
155276691|NCT00136916|560446078|FG000|Overall Study|Laboratory abnormality|0|||
155276692|NCT00136916|560446079|FG001|Overall Study|Laboratory abnormality|1|||
155276693|NCT00136916|560446078|FG000|Overall Study|Lack of Efficacy|13|||
155276694|NCT00136916|560446079|FG001|Overall Study|Lack of Efficacy|3|||
155276695|NCT00136916|560446078|FG000|Overall Study|Lost to Follow-up|12|||
155276696|NCT00136916|560446079|FG001|Overall Study|Lost to Follow-up|14|||
155276697|NCT00136916|560446078|FG000|Overall Study|Withdrawal by Subject|44|||
155276698|NCT00136916|560446079|FG001|Overall Study|Withdrawal by Subject|46|||
155276699|NCT00136916|560446078|FG000|Overall Study|Other|22|||
155276700|NCT00136916|560446079|FG001|Overall Study|Other|24|||
155276701|NCT00136916|560446078|FG000|Overall Study|Discontinued in follow up period|3|||
155276702|NCT00136916|560446079|FG001|Overall Study|Discontinued in follow up period|0|||
155276703|NCT01991197|560446080|FG000|Overall Study|Lost to Follow-up|1|||
155276704|NCT01991197|560446081|FG001|Overall Study|Lost to Follow-up|1|||
155276705|NCT01991197|560446080|FG000|Overall Study|Physician Decision|0|||
155276706|NCT01991197|560446081|FG001|Overall Study|Physician Decision|2|||
155276707|NCT01991197|560446080|FG000|Overall Study|Withdrawal by Subject|2|||
155276708|NCT01991197|560446081|FG001|Overall Study|Withdrawal by Subject|0|||
155276709|NCT01010217|560446082|FG000|Overall Study|Lost to Follow-up|4|||
155276710|NCT01010217|560446083|FG001|Overall Study|Lost to Follow-up|5|||
155276711|NCT01010217|560446084|FG002|Overall Study|Lost to Follow-up|1|||
155276712|NCT01010217|560446085|FG003|Overall Study|Lost to Follow-up|0|||
155276713|NCT01010217|560446086|FG004|Overall Study|Lost to Follow-up|0|||
155276714|NCT01010217|560446082|FG000|Overall Study|Withdrawal by Subject|1|||
155276715|NCT01010217|560446083|FG001|Overall Study|Withdrawal by Subject|0|||
155276716|NCT01010217|560446084|FG002|Overall Study|Withdrawal by Subject|0|||
155276717|NCT01010217|560446085|FG003|Overall Study|Withdrawal by Subject|0|||
155276718|NCT01010217|560446086|FG004|Overall Study|Withdrawal by Subject|0|||
155276719|NCT01010217|560446082|FG000|Overall Study|Physician Decision|0|||
155276720|NCT01010217|560446083|FG001|Overall Study|Physician Decision|0|||
155276721|NCT01010217|560446084|FG002|Overall Study|Physician Decision|0|||
155276722|NCT01010217|560446085|FG003|Overall Study|Physician Decision|6|||
155276723|NCT01010217|560446086|FG004|Overall Study|Physician Decision|3|||
155276724|NCT00577720|560446094|FG000|Overall Study|Adverse Event|2|||
155276725|NCT00577720|560446095|FG001|Overall Study|Adverse Event|1|||
155276726|NCT00577720|560446096|FG002|Overall Study|Adverse Event|0|||
155276727|NCT00577720|560446097|FG003|Overall Study|Adverse Event|4|||
155276728|NCT00577720|560446094|FG000|Overall Study|Lost to Follow-up|0|||
155276729|NCT00577720|560446095|FG001|Overall Study|Lost to Follow-up|0|||
155276730|NCT00577720|560446096|FG002|Overall Study|Lost to Follow-up|1|||
155276731|NCT00577720|560446097|FG003|Overall Study|Lost to Follow-up|0|||
155276732|NCT00577720|560446094|FG000|Overall Study|Protocol Violation|0|||
155276733|NCT00577720|560446095|FG001|Overall Study|Protocol Violation|0|||
155276734|NCT00577720|560446096|FG002|Overall Study|Protocol Violation|0|||
155276735|NCT00577720|560446097|FG003|Overall Study|Protocol Violation|1|||
155276736|NCT00577720|560446094|FG000|Overall Study|Withdrawal by Subject|2|||
155276737|NCT00577720|560446095|FG001|Overall Study|Withdrawal by Subject|0|||
155276738|NCT00577720|560446096|FG002|Overall Study|Withdrawal by Subject|0|||
155276739|NCT00577720|560446097|FG003|Overall Study|Withdrawal by Subject|2|||
155276740|NCT03246672|560446098|FG000|Overall Study|Lost to Follow-up|2|||
155276741|NCT03260504|560446099|FG000|Overall Study|Adverse Event|0|||
155276742|NCT03260504|560446100|FG001|Overall Study|Adverse Event|1|||
155276743|NCT01932996|560446101|FG000|Overall Study|Protocol Violation|2|||
155276744|NCT01932996|560446102|FG001|Overall Study|Protocol Violation|0|||
155276745|NCT00846742|560446105|FG000|Overall Study|Withdrawal by Subject|1|||
155276746|NCT05868954|560446111|FG000|Overall Study|Lost to Follow-up|0|||
155276747|NCT05868954|560446112|FG001|Overall Study|Lost to Follow-up|1|||
155276748|NCT05868954|560446111|FG000|Overall Study|Withdrawal by Subject|2|||
155276749|NCT05868954|560446112|FG001|Overall Study|Withdrawal by Subject|2|||
155276750|NCT05868954|560446111|FG000|Overall Study|Participant delivered|1|||
155276751|NCT05868954|560446112|FG001|Overall Study|Participant delivered|1|||
155276752|NCT05868954|560446111|FG000|Overall Study|Miscarriage|0|||
155276753|NCT05868954|560446112|FG001|Overall Study|Miscarriage|1|||
155276754|NCT03257995|560446118|FG000|Overall Study|Adverse Event|0|||
155276755|NCT03257995|560446119|FG001|Overall Study|Adverse Event|1|||
155276756|NCT03257995|560446120|FG002|Overall Study|Adverse Event|0|||
155276757|NCT03257995|560446121|FG003|Overall Study|Adverse Event|0|||
155276758|NCT03257995|560446122|FG004|Overall Study|Adverse Event|0|||
155276759|NCT03257995|560446123|FG005|Overall Study|Adverse Event|0|||
155276760|NCT03257995|560446118|FG000|Overall Study|Protocol deviation|0|||
155276761|NCT03257995|560446119|FG001|Overall Study|Protocol deviation|0|||
155276762|NCT03257995|560446120|FG002|Overall Study|Protocol deviation|0|||
155276763|NCT03257995|560446121|FG003|Overall Study|Protocol deviation|0|||
155276764|NCT03257995|560446122|FG004|Overall Study|Protocol deviation|0|||
155276765|NCT03257995|560446123|FG005|Overall Study|Protocol deviation|2|||
155276766|NCT02275533|560446124|FG000|Overall Study|Protocol Violation|2|||
155276767|NCT02275533|560446125|FG001|Overall Study|Protocol Violation|0|||
155276768|NCT02275533|560446124|FG000|Overall Study|Never received study treatment|1|||
155276769|NCT02275533|560446125|FG001|Overall Study|Never received study treatment|0|||
155276770|NCT01570868|560446126|FG000|Overall Study|Adverse Event|8|||
155276771|NCT01570868|560446127|FG001|Overall Study|Adverse Event|1|||
155276772|NCT01570868|560446126|FG000|Overall Study|FDA Recommendation|23|||
155276773|NCT01570868|560446127|FG001|Overall Study|FDA Recommendation|3|||
155276774|NCT01570868|560446126|FG000|Overall Study|Physician Decision|10|||
155276775|NCT01570868|560446127|FG001|Overall Study|Physician Decision|4|||
155276776|NCT01570868|560446126|FG000|Overall Study|Lost to Follow-up|1|||
155276777|NCT01570868|560446127|FG001|Overall Study|Lost to Follow-up|0|||
155276778|NCT01570868|560446126|FG000|Overall Study|Withdrawal by Subject|1|||
155276779|NCT01570868|560446127|FG001|Overall Study|Withdrawal by Subject|0|||
155276780|NCT04936308|560446128|FG000|Overall Study|Death|0|||
155276781|NCT04936308|560446129|FG001|Overall Study|Death|0|||
155276782|NCT04936308|560446130|FG002|Overall Study|Death|1|||
155276783|NCT04936308|560446128|FG000|Overall Study|Withdrawal by Subject|6|||
155276784|NCT04936308|560446129|FG001|Overall Study|Withdrawal by Subject|3|||
155276785|NCT04936308|560446130|FG002|Overall Study|Withdrawal by Subject|0|||
155276786|NCT04936308|560446128|FG000|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|0|||
155276787|NCT04936308|560446129|FG001|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
155276788|NCT04936308|560446130|FG002|Overall Study|Excluded from analysis (Enrolled and dosed at 2 sites)|1|||
155276789|NCT04936308|560446128|FG000|Overall Study|Completed protocol-required follow-up|1|||
155276790|NCT04936308|560446129|FG001|Overall Study|Completed protocol-required follow-up|2|||
155276791|NCT04936308|560446130|FG002|Overall Study|Completed protocol-required follow-up|2|||
155276792|NCT04936308|560446128|FG000|Overall Study|Discontinued study intervention and were being followed|2|||
155276793|NCT04936308|560446129|FG001|Overall Study|Discontinued study intervention and were being followed|2|||
155276794|NCT04936308|560446130|FG002|Overall Study|Discontinued study intervention and were being followed|4|||
155276795|NCT04936308|560446128|FG000|Overall Study|Other|3|||
155276796|NCT04936308|560446129|FG001|Overall Study|Other|0|||
155276797|NCT04936308|560446130|FG002|Overall Study|Other|2|||
155276798|NCT00932646|560446133|FG000|Overall Study|Adverse Event|2|||
155276799|NCT00932646|560446134|FG001|Overall Study|Adverse Event|1|||
155276800|NCT00932646|560446135|FG002|Overall Study|Adverse Event|1|||
155276801|NCT00932646|560446136|FG003|Overall Study|Adverse Event|1|||
155276802|NCT00932646|560446133|FG000|Overall Study|Lost to Follow-up|2|||
155276803|NCT00932646|560446134|FG001|Overall Study|Lost to Follow-up|1|||
155276804|NCT00932646|560446135|FG002|Overall Study|Lost to Follow-up|0|||
155276805|NCT00932646|560446136|FG003|Overall Study|Lost to Follow-up|0|||
155276806|NCT00932646|560446133|FG000|Overall Study|Withdrawal by Subject|1|||
155276807|NCT00932646|560446134|FG001|Overall Study|Withdrawal by Subject|1|||
155276808|NCT00932646|560446135|FG002|Overall Study|Withdrawal by Subject|3|||
155276809|NCT00932646|560446136|FG003|Overall Study|Withdrawal by Subject|0|||
155276810|NCT00653263|560446137|FG000|Overall Study|Withdrawal by Subject|1|||
155276811|NCT00653263|560446137|FG000|Overall Study|Physician Decision|1|||
155276812|NCT02611830|560446138|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
155276813|NCT02611830|560446139|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
155276814|NCT02611830|560446140|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
155276815|NCT02611830|560446141|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
155276816|NCT02611830|560446138|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
155276817|NCT02611830|560446139|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
155276818|NCT02611830|560446140|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
155276819|NCT02611830|560446141|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
155276820|NCT02611830|560446138|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
155276821|NCT02611830|560446139|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
155276822|NCT02611830|560446140|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
155276823|NCT02611830|560446141|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
155276824|NCT02611830|560446138|FG000|OL Induction Phase|Lack of Efficacy|9|||
155276825|NCT02611830|560446139|FG001|OL Induction Phase|Lack of Efficacy|0|||
155276826|NCT02611830|560446140|FG002|OL Induction Phase|Lack of Efficacy|0|||
155276827|NCT02611830|560446141|FG003|OL Induction Phase|Lack of Efficacy|0|||
155276828|NCT02611830|560446138|FG000|OL Induction Phase|Reason not specified|3|||
155276829|NCT02611830|560446139|FG001|OL Induction Phase|Reason not specified|0|||
155276830|NCT02611830|560446140|FG002|OL Induction Phase|Reason not specified|0|||
155276831|NCT02611830|560446141|FG003|OL Induction Phase|Reason not specified|0|||
155276832|NCT02611830|560446138|FG000|Maintenance Phase|Lack of Efficacy|0|||
155276833|NCT02611830|560446139|FG001|Maintenance Phase|Lack of Efficacy|29|||
155276834|NCT02611830|560446140|FG002|Maintenance Phase|Lack of Efficacy|18|||
155276835|NCT02611830|560446141|FG003|Maintenance Phase|Lack of Efficacy|6|||
155276836|NCT02611830|560446138|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155276837|NCT02611830|560446139|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
155276838|NCT02611830|560446140|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
155276839|NCT02611830|560446141|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
155276840|NCT02611830|560446138|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
155276841|NCT02611830|560446139|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
155276842|NCT02611830|560446140|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
155276843|NCT02611830|560446141|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
155276844|NCT02611830|560446138|FG000|Maintenance Phase|Lost to Follow-up|0|||
155276845|NCT02611830|560446139|FG001|Maintenance Phase|Lost to Follow-up|0|||
155276846|NCT02611830|560446140|FG002|Maintenance Phase|Lost to Follow-up|0|||
155276847|NCT02611830|560446141|FG003|Maintenance Phase|Lost to Follow-up|1|||
155276848|NCT02611830|560446138|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
155276849|NCT02611830|560446139|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
155276850|NCT02611830|560446140|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
155276851|NCT02611830|560446141|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
155276852|NCT02611830|560446138|FG000|Maintenance Phase|Pregnancy|0|||
155276853|NCT02611830|560446139|FG001|Maintenance Phase|Pregnancy|0|||
155276854|NCT02611830|560446140|FG002|Maintenance Phase|Pregnancy|1|||
155276855|NCT02611830|560446141|FG003|Maintenance Phase|Pregnancy|0|||
155276856|NCT02611830|560446138|FG000|Maintenance Phase|Reason not specified|0|||
155276857|NCT02611830|560446139|FG001|Maintenance Phase|Reason not specified|1|||
155276858|NCT02611830|560446140|FG002|Maintenance Phase|Reason not specified|4|||
155276859|NCT02611830|560446141|FG003|Maintenance Phase|Reason not specified|0|||
155276860|NCT04759885|560446146|FG000|Overall Study|Other|1|||
155276861|NCT04759885|560446147|FG001|Overall Study|Other|0|||
155276862|NCT04759885|560446148|FG002|Overall Study|Other|2|||
155276863|NCT04759885|560446149|FG003|Overall Study|Other|0|||
155276864|NCT04759885|560446150|FG004|Overall Study|Other|0|||
155276865|NCT04759885|560446146|FG000|Overall Study|Withdrawal by Subject|0|||
155276866|NCT04759885|560446147|FG001|Overall Study|Withdrawal by Subject|0|||
155276867|NCT04759885|560446148|FG002|Overall Study|Withdrawal by Subject|1|||
155276868|NCT04759885|560446149|FG003|Overall Study|Withdrawal by Subject|9|||
155276869|NCT04759885|560446150|FG004|Overall Study|Withdrawal by Subject|6|||
155276870|NCT04759885|560446146|FG000|Overall Study|Adverse Event|0|||
155276871|NCT04759885|560446147|FG001|Overall Study|Adverse Event|0|||
155276872|NCT04759885|560446148|FG002|Overall Study|Adverse Event|0|||
155276873|NCT04759885|560446149|FG003|Overall Study|Adverse Event|3|||
155276874|NCT04759885|560446150|FG004|Overall Study|Adverse Event|0|||
155276875|NCT04759885|560446146|FG000|Overall Study|Physician Decision|0|||
155276876|NCT04759885|560446147|FG001|Overall Study|Physician Decision|0|||
155276877|NCT04759885|560446148|FG002|Overall Study|Physician Decision|0|||
155276878|NCT04759885|560446149|FG003|Overall Study|Physician Decision|2|||
155276879|NCT04759885|560446150|FG004|Overall Study|Physician Decision|0|||
155276880|NCT00195715|560446151|FG000|Overall Study|Adverse Event|122|||
155276881|NCT00195715|560446151|FG000|Overall Study|Withdrawal by Subject|58|||
155276882|NCT00195715|560446151|FG000|Overall Study|Lost to Follow-up|27|||
155276883|NCT00195715|560446151|FG000|Overall Study|Protocol Violation|13|||
155276884|NCT00195715|560446151|FG000|Overall Study|Lack of Efficacy|93|||
155276885|NCT00195715|560446151|FG000|Overall Study|Pregnancy|14|||
155276886|NCT00195715|560446151|FG000|Overall Study|Investigative site closure|8|||
155276887|NCT00195715|560446151|FG000|Overall Study|Subject moved/relocated|7|||
155276888|NCT00195715|560446151|FG000|Overall Study|Subject non-compliance|6|||
155276889|NCT00195715|560446151|FG000|Overall Study|Subject started commercial Humira|5|||
155276890|NCT00195715|560446151|FG000|Overall Study|Subject choice|3|||
155276891|NCT00195715|560446151|FG000|Overall Study|Loss of response/no improvement|3|||
154936696|NCT01677910|559194756|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
154936697|NCT01677910|559194757|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
154936698|NCT01677910|559194754|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
154936699|NCT01677910|559194755|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
154936700|NCT01677910|559194756|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
154936701|NCT01677910|559194757|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
154936702|NCT01677910|559194754|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
154936703|NCT01677910|559194755|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
154936704|NCT01677910|559194756|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
155276892|NCT00195715|560446151|FG000|Overall Study|Sponsor stopped study|1|||
155276893|NCT00195715|560446151|FG000|Overall Study|Administrative reasons|2|||
155276894|NCT00195715|560446151|FG000|Overall Study|Investigator's decision|2|||
155276895|NCT00195715|560446151|FG000|Overall Study|Subject wants to get pregnant|4|||
155276896|NCT00195715|560446151|FG000|Overall Study|Use of prohibited medication|2|||
155276897|NCT00195715|560446151|FG000|Overall Study|Planned surgery|2|||
155276898|NCT00195715|560446151|FG000|Overall Study|Increased infection rate|1|||
155276899|NCT00195715|560446151|FG000|Overall Study|Ineligible|1|||
155276900|NCT00195715|560446151|FG000|Overall Study|Colonic stricture|1|||
155276901|NCT00195715|560446151|FG000|Overall Study|Sponsor discontinued trial|1|||
155276902|NCT00195715|560446151|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
154936705|NCT01677910|559194757|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
154936706|NCT01677910|559194754|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
154936707|NCT01677910|559194755|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
154936708|NCT01677910|559194756|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
154936709|NCT01677910|559194757|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
154936710|NCT01677910|559194754|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
154936711|NCT01677910|559194755|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
154936712|NCT01677910|559194756|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
154936713|NCT01677910|559194757|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
154936714|NCT01677910|559194754|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
154936715|NCT01677910|559194755|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
154936716|NCT01677910|559194756|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
154936717|NCT01677910|559194757|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
154936718|NCT01677910|559194754|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
154936719|NCT01677910|559194755|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
154936720|NCT01677910|559194756|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
154936721|NCT01677910|559194757|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
154936722|NCT01677910|559194754|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
154936723|NCT01677910|559194755|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
154936724|NCT01677910|559194756|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
154936725|NCT01677910|559194757|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
154936726|NCT01808209|559194760|FG000|Overall Study|Lost to Follow-up|0|||
154936727|NCT01808209|559194761|FG001|Overall Study|Lost to Follow-up|1|||
154936728|NCT01703741|559194762|FG000|Overall Study|Withdrawal by Subject|6|||
154936729|NCT01703741|559194762|FG000|Overall Study|Adverse Event|2|||
154936730|NCT01703741|559194762|FG000|Overall Study|Physician Decision|2|||
154936731|NCT01703741|559194762|FG000|Overall Study|Protocol Violation|1|||
154936732|NCT01703741|559194762|FG000|Overall Study|Lost to Follow-up|3|||
154936733|NCT01703741|559194762|FG000|Overall Study|Subject did not want to continue|2|||
154936734|NCT01703741|559194762|FG000|Overall Study|Subject cannot comply with study visits|1|||
154936735|NCT01703741|559194762|FG000|Overall Study|Subject started testosterone injections|1|||
154936736|NCT00368537|559194763|FG000|Randomization|No study drug dosed|13|||
154936737|NCT00368537|559194764|FG001|Randomization|No study drug dosed|6|||
154936738|NCT00368537|559194763|FG000|Baseline Participants|Lost to Follow-up|16|||
154936739|NCT00368537|559194764|FG001|Baseline Participants|Lost to Follow-up|17|||
155276903|NCT05822921|560446156|FG000|Overall Study|Lost to Follow-up|1|||
155276904|NCT05822921|560446157|FG001|Overall Study|Lost to Follow-up|1|||
155276905|NCT00544544|560446158|FG000|Overall Study|Withdrawal by Subject|1|||
155276906|NCT00544544|560446158|FG000|Overall Study|Adverse Event|1|||
155276907|NCT00544544|560446158|FG000|Overall Study|Lost to Follow-up|1|||
154936740|NCT00368537|559194763|FG000|Baseline Participants|Withdrawal by Subject|6|||
154936741|NCT00368537|559194764|FG001|Baseline Participants|Withdrawal by Subject|4|||
154936742|NCT00368537|559194763|FG000|Baseline Participants|Death|1|||
154936743|NCT00368537|559194764|FG001|Baseline Participants|Death|2|||
154936744|NCT00368537|559194763|FG000|Baseline Participants|No susceptibility|1|||
154936745|NCT00368537|559194764|FG001|Baseline Participants|No susceptibility|0|||
154936746|NCT00368537|559194763|FG000|Baseline Participants|Patient uncompliant|0|||
154936747|NCT00368537|559194764|FG001|Baseline Participants|Patient uncompliant|1|||
154936748|NCT00685919|559194775|FG000|Overall Study|Withdrawal by Subject|0|||
154936749|NCT00685919|559194776|FG001|Overall Study|Withdrawal by Subject|0|||
154936750|NCT00685919|559194777|FG002|Overall Study|Withdrawal by Subject|1|||
154936751|NCT00685919|559194778|FG003|Overall Study|Withdrawal by Subject|0|||
154936752|NCT00685919|559194775|FG000|Overall Study|Physician Decision|1|||
154936753|NCT00685919|559194776|FG001|Overall Study|Physician Decision|0|||
154936754|NCT00685919|559194777|FG002|Overall Study|Physician Decision|0|||
154936755|NCT00685919|559194778|FG003|Overall Study|Physician Decision|0|||
154936756|NCT01717456|559194781|FG000|End of Treatment|Physician Decision|0|||
154936757|NCT01717456|559194782|FG001|End of Treatment|Physician Decision|1|||
154936758|NCT01717456|559194781|FG000|End of Treatment|Lost to Follow-up|0|||
154936759|NCT01717456|559194782|FG001|End of Treatment|Lost to Follow-up|1|||
154936760|NCT01717456|559194781|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
154936761|NCT01717456|559194782|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
154936762|NCT02732561|559194788|FG000|Overall Study|Lost to Follow-up|1|||
154936763|NCT02732561|559194789|FG001|Overall Study|Lost to Follow-up|1|||
154936764|NCT02732561|559194788|FG000|Overall Study|Withdrawal by Subject|1|||
154936765|NCT02732561|559194789|FG001|Overall Study|Withdrawal by Subject|0|||
154936766|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
154936767|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
155043446|NCT01826981|559590122|FG000|Overall Study|Withdrew Consent|0|||
155043447|NCT01826981|559590123|FG001|Overall Study|Withdrew Consent|0|||
155043448|NCT01826981|559590124|FG002|Overall Study|Withdrew Consent|0|||
155276908|NCT02036515|560446164|FG000|Overall Study|Adverse Event|1|||
155276909|NCT02036515|560446165|FG001|Overall Study|Adverse Event|1|||
154936768|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
154936769|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
154936770|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
154936771|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
154936772|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
155276910|NCT02036515|560446166|FG002|Overall Study|Adverse Event|2|||
155276911|NCT02036515|560446164|FG000|Overall Study|Lost to Follow-up|0|||
155276912|NCT02036515|560446165|FG001|Overall Study|Lost to Follow-up|2|||
155276913|NCT02036515|560446166|FG002|Overall Study|Lost to Follow-up|0|||
155276914|NCT02036515|560446164|FG000|Overall Study|Non-compliance with study drug|0|||
155276915|NCT02036515|560446165|FG001|Overall Study|Non-compliance with study drug|0|||
155276916|NCT02036515|560446166|FG002|Overall Study|Non-compliance with study drug|2|||
155276917|NCT02036515|560446164|FG000|Overall Study|Screen failure|0|||
155276918|NCT02036515|560446165|FG001|Overall Study|Screen failure|2|||
155276919|NCT02036515|560446166|FG002|Overall Study|Screen failure|0|||
155276920|NCT02036515|560446164|FG000|Overall Study|Withdrawal by Subject|4|||
155276921|NCT02036515|560446165|FG001|Overall Study|Withdrawal by Subject|7|||
155276922|NCT02036515|560446166|FG002|Overall Study|Withdrawal by Subject|9|||
155276923|NCT02036515|560446164|FG000|Overall Study|Hyperglycemia|0|||
155276924|NCT02036515|560446165|FG001|Overall Study|Hyperglycemia|0|||
155276925|NCT02036515|560446166|FG002|Overall Study|Hyperglycemia|1|||
155276926|NCT01671748|560446173|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
155276927|NCT01671748|560446174|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
155276928|NCT01671748|560446173|FG000|4 Week run-in Phase|Adverse Event|1|||
155276929|NCT01671748|560446174|FG001|4 Week run-in Phase|Adverse Event|0|||
155276930|NCT01671748|560446173|FG000|4 Week run-in Phase|Not eligible|9|||
155276931|NCT01671748|560446174|FG001|4 Week run-in Phase|Not eligible|0|||
155276932|NCT04145349|560447533|FG000|Overall Study|Withdrawal by Subject|3|||
155276933|NCT04145349|560447534|FG001|Overall Study|Withdrawal by Subject|0|||
155276934|NCT04145349|560447533|FG000|Overall Study|Lost to Follow-up|0|||
155276935|NCT04145349|560447534|FG001|Overall Study|Lost to Follow-up|1|||
155276936|NCT04145349|560447533|FG000|Overall Study|On study treatment (Ongoing)|0|||
155276937|NCT04145349|560447534|FG001|Overall Study|On study treatment (Ongoing)|1|||
155276938|NCT00513019|560447535|FG000|Overall Study|Adverse Event|1|||
155276939|NCT00513019|560447536|FG001|Overall Study|Adverse Event|0|||
154936773|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
154936774|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
155276940|NCT00513019|560447535|FG000|Overall Study|Withdrawal by Subject|4|||
155276941|NCT00513019|560447536|FG001|Overall Study|Withdrawal by Subject|5|||
155276942|NCT05675709|560447540|FG000|Overall Study|incomplete outcome data|2|||
155276943|NCT05675709|560447541|FG001|Overall Study|incomplete outcome data|8|||
155276944|NCT05876351|560447544|FG000|Overall Study|Other than specified|2|||
155276945|NCT05876351|560447544|FG000|Overall Study|Study specific discontinuation criteria|1|||
155276946|NCT04168385|560447546|FG000|Overall Study|Withdrawal by Subject|1|||
155276947|NCT04168385|560447547|FG001|Overall Study|Withdrawal by Subject|0|||
155276948|NCT04168385|560447546|FG000|Overall Study|Adverse Event|2|||
155276949|NCT04168385|560447547|FG001|Overall Study|Adverse Event|1|||
155276950|NCT04168385|560447546|FG000|Overall Study|Liver transplant|3|||
155276951|NCT04168385|560447547|FG001|Overall Study|Liver transplant|1|||
155276952|NCT04168385|560447546|FG000|Overall Study|Listed for liver transplant|1|||
155276953|NCT04168385|560447547|FG001|Overall Study|Listed for liver transplant|0|||
155276954|NCT02748512|560447548|FG000|Overall Study|Lost to Follow-up|1|||
155276955|NCT02748512|560447549|FG001|Overall Study|Lost to Follow-up|1|||
155276956|NCT03415022|560447556|FG000|Overall Study|Withdrawal by Subject|1|||
154936775|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
154936776|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
154936777|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
154936778|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
154936779|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155276957|NCT03415022|560447557|FG001|Overall Study|Withdrawal by Subject|2|||
155276958|NCT03415022|560447556|FG000|Overall Study|COVID-19 Suspension|2|||
155276959|NCT03415022|560447557|FG001|Overall Study|COVID-19 Suspension|3|||
155276960|NCT03415022|560447556|FG000|Overall Study|Lost to Follow-up|2|||
155276961|NCT03415022|560447557|FG001|Overall Study|Lost to Follow-up|0|||
154936780|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
155043449|NCT01826981|559590125|FG003|Overall Study|Withdrew Consent|0|||
155043450|NCT01826981|559590126|FG004|Overall Study|Withdrew Consent|0|||
155043451|NCT01826981|559590127|FG005|Overall Study|Withdrew Consent|0|||
155276962|NCT03583541|560447563|FG000|Overall Study|Lost to Follow-up|31|||
155276963|NCT03583541|560447564|FG001|Overall Study|Lost to Follow-up|65|||
155276964|NCT00884286|560447565|FG000|Overall Study|Progressive disease|21|||
155276965|NCT00884286|560447566|FG001|Overall Study|Progressive disease|28|||
155276966|NCT00884286|560447565|FG000|Overall Study|Toxicity|4|||
155276967|NCT00884286|560447566|FG001|Overall Study|Toxicity|1|||
155276968|NCT00884286|560447565|FG000|Overall Study|Death|2|||
155276969|NCT00884286|560447566|FG001|Overall Study|Death|2|||
154936781|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
154936782|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
154936783|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
154936784|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
154936785|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
154936786|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
154936787|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
154936788|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
154936789|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
154936790|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
154936791|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
154936792|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
154936793|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
154936794|NCT00528879|559194794|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
154936795|NCT00528879|559194795|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
154936796|NCT00528879|559194796|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
154936797|NCT00528879|559194797|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
154936798|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
154936799|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
154936800|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
154936801|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
154936802|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
154936803|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
154936804|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
154936805|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
154936806|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
154936807|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
154936808|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
154936809|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
154936810|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
154936811|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
155276970|NCT00884286|560447565|FG000|Overall Study|Physician Decision|1|||
155276971|NCT00884286|560447566|FG001|Overall Study|Physician Decision|0|||
155276972|NCT00884286|560447565|FG000|Overall Study|Septic shock|1|||
155276973|NCT00884286|560447566|FG001|Overall Study|Septic shock|0|||
155276974|NCT00884286|560447565|FG000|Overall Study|Thrombus in right auricle|1|||
155276975|NCT00884286|560447566|FG001|Overall Study|Thrombus in right auricle|0|||
155276976|NCT00884286|560447565|FG000|Overall Study|Not treated|2|||
155276977|NCT00884286|560447566|FG001|Overall Study|Not treated|1|||
155276978|NCT00884286|560447565|FG000|Overall Study|Comprised lung carcinoma|0|||
155276979|NCT00884286|560447566|FG001|Overall Study|Comprised lung carcinoma|1|||
155276980|NCT01196104|560447567|FG000|Overall Study|Lost to Follow-up|1|||
155276981|NCT01196104|560447568|FG001|Overall Study|Lost to Follow-up|0|||
155276982|NCT01196104|560447567|FG000|Overall Study|Physician Decision|0|||
155276983|NCT01196104|560447568|FG001|Overall Study|Physician Decision|1|||
155276984|NCT01196104|560447567|FG000|Overall Study|Withdrawal by Subject|3|||
155276985|NCT01196104|560447568|FG001|Overall Study|Withdrawal by Subject|3|||
155276986|NCT01196104|560447567|FG000|Overall Study|Various|0|||
155276987|NCT01196104|560447568|FG001|Overall Study|Various|1|||
155276988|NCT01094171|560447573|FG000|Overall Study|Lost to Follow-up|2|||
155276989|NCT01094171|560447573|FG000|Overall Study|Informed consent withdrawal|4|||
155276990|NCT01094171|560447573|FG000|Overall Study|Migration from the study area|3|||
155276991|NCT01094171|560447573|FG000|Overall Study|Other|1|||
155276992|NCT00594932|560447574|FG000|First 3 Months|Withdrawal by Subject|1|||
155276993|NCT00594932|560447575|FG001|First 3 Months|Withdrawal by Subject|3|||
155276994|NCT00594932|560447574|FG000|Final 3 Months|Withdrawal by Subject|4|||
155276995|NCT00594932|560447575|FG001|Final 3 Months|Withdrawal by Subject|3|||
154936812|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
154936813|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
154936814|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
154936815|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
154936816|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
154936817|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
154936818|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
155276996|NCT01536145|560447576|FG000|Overall Study|Progressive disease|3|||
155276997|NCT01536145|560447577|FG001|Overall Study|Progressive disease|4|||
155276998|NCT01536145|560447578|FG002|Overall Study|Progressive disease|1|||
155276999|NCT01536145|560447579|FG003|Overall Study|Progressive disease|2|||
155277000|NCT01536145|560447580|FG004|Overall Study|Progressive disease|1|||
155277001|NCT01536145|560447581|FG005|Overall Study|Progressive disease|2|||
155277002|NCT01536145|560447582|FG006|Overall Study|Progressive disease|1|||
154936819|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
154936820|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
154936821|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
154936822|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
154936823|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
154936824|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
154936825|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
154936826|NCT00528879|559194794|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
154936827|NCT00528879|559194795|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
154936828|NCT00528879|559194796|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
154936829|NCT00528879|559194797|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
154936830|NCT01159769|559194800|FG000|Overall Study|Adverse Event|1|||
154936831|NCT03196791|559194801|FG000|Overall Study|Protocol Violation|7|||
154936832|NCT03196791|559194802|FG001|Overall Study|Protocol Violation|3|||
154936833|NCT03196791|559194801|FG000|Overall Study|Withdrawal by Subject|3|||
154936834|NCT03196791|559194802|FG001|Overall Study|Withdrawal by Subject|2|||
154936835|NCT03056001|559194807|FG000|Overall Study|Death|24|||
154936836|NCT00597207|559194808|FG000|Overall Study|Lost to Follow-up|5|||
154936837|NCT00597207|559194809|FG001|Overall Study|Lost to Follow-up|7|||
154936838|NCT03077828|559194810|FG000|Treatment Cycles|Death|1|||
154936839|NCT03077828|559194810|FG000|Treatment Cycles|Withdrawal by Subject|1|||
155277003|NCT01536145|560447583|FG007|Overall Study|Progressive disease|2|||
155277004|NCT01536145|560447584|FG008|Overall Study|Progressive disease|1|||
155277005|NCT01536145|560447585|FG009|Overall Study|Progressive disease|3|||
155277006|NCT01536145|560447586|FG010|Overall Study|Progressive disease|3|||
155277007|NCT01536145|560447576|FG000|Overall Study|Withdrawal by Subject|0|||
155277008|NCT01536145|560447577|FG001|Overall Study|Withdrawal by Subject|0|||
155277009|NCT01536145|560447578|FG002|Overall Study|Withdrawal by Subject|1|||
155277010|NCT01536145|560447579|FG003|Overall Study|Withdrawal by Subject|0|||
155277011|NCT01536145|560447580|FG004|Overall Study|Withdrawal by Subject|0|||
155277012|NCT01536145|560447581|FG005|Overall Study|Withdrawal by Subject|1|||
155277013|NCT01536145|560447582|FG006|Overall Study|Withdrawal by Subject|0|||
155277014|NCT01536145|560447583|FG007|Overall Study|Withdrawal by Subject|0|||
155277015|NCT01536145|560447584|FG008|Overall Study|Withdrawal by Subject|2|||
155277016|NCT01536145|560447585|FG009|Overall Study|Withdrawal by Subject|0|||
155277017|NCT01536145|560447586|FG010|Overall Study|Withdrawal by Subject|2|||
155277018|NCT01536145|560447576|FG000|Overall Study|Other|0|||
155277019|NCT01536145|560447577|FG001|Overall Study|Other|0|||
155277020|NCT01536145|560447578|FG002|Overall Study|Other|0|||
155277021|NCT01536145|560447579|FG003|Overall Study|Other|0|||
155277022|NCT01536145|560447580|FG004|Overall Study|Other|1|||
155277023|NCT01536145|560447581|FG005|Overall Study|Other|0|||
155277024|NCT01536145|560447582|FG006|Overall Study|Other|0|||
155277025|NCT01536145|560447583|FG007|Overall Study|Other|0|||
155277026|NCT01536145|560447584|FG008|Overall Study|Other|0|||
155277027|NCT01536145|560447585|FG009|Overall Study|Other|3|||
155277028|NCT01536145|560447586|FG010|Overall Study|Other|2|||
155277029|NCT01536145|560447576|FG000|Overall Study|Death|0|||
155277030|NCT01536145|560447577|FG001|Overall Study|Death|0|||
155277031|NCT01536145|560447578|FG002|Overall Study|Death|0|||
155277032|NCT01536145|560447579|FG003|Overall Study|Death|0|||
155277033|NCT01536145|560447580|FG004|Overall Study|Death|0|||
155277034|NCT01536145|560447581|FG005|Overall Study|Death|0|||
155277035|NCT01536145|560447582|FG006|Overall Study|Death|1|||
155277036|NCT01536145|560447583|FG007|Overall Study|Death|0|||
155277037|NCT01536145|560447584|FG008|Overall Study|Death|0|||
154936840|NCT03077828|559194810|FG000|Treatment Cycles|Screen Fail|2|||
154936841|NCT03077828|559194810|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
154936842|NCT03077828|559194810|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
154936843|NCT03077828|559194810|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
155277038|NCT01536145|560447585|FG009|Overall Study|Death|0|||
155277039|NCT01536145|560447586|FG010|Overall Study|Death|0|||
155277040|NCT01536145|560447576|FG000|Overall Study|Adverse Event|0|||
155277041|NCT01536145|560447577|FG001|Overall Study|Adverse Event|0|||
155277042|NCT01536145|560447578|FG002|Overall Study|Adverse Event|0|||
154936844|NCT03077828|559194810|FG000|Follow-up|Patients still in follow-up|15|||
155277043|NCT01536145|560447579|FG003|Overall Study|Adverse Event|0|||
155277044|NCT01536145|560447580|FG004|Overall Study|Adverse Event|0|||
155277045|NCT01536145|560447581|FG005|Overall Study|Adverse Event|0|||
155277046|NCT01536145|560447582|FG006|Overall Study|Adverse Event|0|||
155277047|NCT01536145|560447583|FG007|Overall Study|Adverse Event|2|||
155277048|NCT01536145|560447584|FG008|Overall Study|Adverse Event|0|||
154936845|NCT02766400|559194811|FG000|Overall Study|Death|1|||
154936846|NCT02766400|559194812|FG001|Overall Study|Death|2|||
155277049|NCT01536145|560447585|FG009|Overall Study|Adverse Event|0|||
155277050|NCT01536145|560447586|FG010|Overall Study|Adverse Event|3|||
155277051|NCT00088205|560447591|FG000|Overall Study|Adverse Event|4|||
155277052|NCT00088205|560447591|FG000|Overall Study|Progressive Disease|51|||
155277053|NCT00088205|560447591|FG000|Overall Study|Physician Decision|1|||
154936847|NCT02766400|559194811|FG000|Overall Study|Withdrawal by Subject|1|||
154936848|NCT02766400|559194812|FG001|Overall Study|Withdrawal by Subject|0|||
154936849|NCT01374906|559194813|FG000|Overall Study|Abnormal laboratory value(s)|0|||
154936850|NCT01374906|559194814|FG001|Overall Study|Abnormal laboratory value(s)|3|||
154936851|NCT01374906|559194813|FG000|Overall Study|Administrative problems|2|||
154936852|NCT01374906|559194814|FG001|Overall Study|Administrative problems|2|||
154936853|NCT01374906|559194813|FG000|Overall Study|Adverse Event|10|||
154936854|NCT01374906|559194814|FG001|Overall Study|Adverse Event|11|||
154936855|NCT01374906|559194813|FG000|Overall Study|Death|0|||
154936856|NCT01374906|559194814|FG001|Overall Study|Death|2|||
154936857|NCT01374906|559194813|FG000|Overall Study|Protocol Violation|2|||
154936858|NCT01374906|559194814|FG001|Overall Study|Protocol Violation|2|||
154936859|NCT01374906|559194813|FG000|Overall Study|Withdrawal by Subject|15|||
154936860|NCT01374906|559194814|FG001|Overall Study|Withdrawal by Subject|9|||
154936861|NCT01374906|559194813|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
154936862|NCT01374906|559194814|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
154936863|NCT00435825|559194817|FG000|Overall Study|Abnormality of Laboratory Test|0|||
154936864|NCT00435825|559194818|FG001|Overall Study|Abnormality of Laboratory Test|1|||
154936865|NCT00435825|559194819|FG002|Overall Study|Abnormality of Laboratory Test|0|||
154936866|NCT00435825|559194820|FG003|Overall Study|Abnormality of Laboratory Test|0|||
154936867|NCT00435825|559194817|FG000|Overall Study|Insufficient Therapeutic Response|3|||
154936868|NCT00435825|559194818|FG001|Overall Study|Insufficient Therapeutic Response|1|||
154936869|NCT00435825|559194819|FG002|Overall Study|Insufficient Therapeutic Response|0|||
154936870|NCT00435825|559194820|FG003|Overall Study|Insufficient Therapeutic Response|3|||
154936871|NCT00435825|559194817|FG000|Overall Study|Other Protocol Violation|1|||
154936872|NCT00435825|559194818|FG001|Overall Study|Other Protocol Violation|0|||
154936873|NCT00435825|559194819|FG002|Overall Study|Other Protocol Violation|0|||
154936874|NCT00435825|559194820|FG003|Overall Study|Other Protocol Violation|0|||
154936875|NCT00435825|559194817|FG000|Overall Study|Refused treatment|2|||
154936876|NCT00435825|559194818|FG001|Overall Study|Refused treatment|0|||
154936877|NCT00435825|559194819|FG002|Overall Study|Refused treatment|0|||
154936878|NCT00435825|559194820|FG003|Overall Study|Refused treatment|5|||
154936879|NCT00435825|559194817|FG000|Overall Study|Failure to return|5|||
154936880|NCT00435825|559194818|FG001|Overall Study|Failure to return|0|||
154936881|NCT00435825|559194819|FG002|Overall Study|Failure to return|4|||
154936882|NCT00435825|559194820|FG003|Overall Study|Failure to return|0|||
154936883|NCT00435825|559194817|FG000|Overall Study|Did not receive study drug|1|||
154936884|NCT00435825|559194818|FG001|Overall Study|Did not receive study drug|0|||
154936885|NCT00435825|559194819|FG002|Overall Study|Did not receive study drug|2|||
154936886|NCT00435825|559194820|FG003|Overall Study|Did not receive study drug|0|||
154936887|NCT00435825|559194817|FG000|Overall Study|Did not enter follow-up|0|||
154936888|NCT00435825|559194818|FG001|Overall Study|Did not enter follow-up|4|||
154936889|NCT00435825|559194819|FG002|Overall Study|Did not enter follow-up|1|||
154936890|NCT00435825|559194820|FG003|Overall Study|Did not enter follow-up|3|||
154936891|NCT00435825|559194817|FG000|Overall Study|Did not complete full follow-up period|6|||
154936892|NCT00435825|559194818|FG001|Overall Study|Did not complete full follow-up period|6|||
154936893|NCT00435825|559194819|FG002|Overall Study|Did not complete full follow-up period|4|||
154936894|NCT00435825|559194820|FG003|Overall Study|Did not complete full follow-up period|5|||
154936895|NCT02367781|559194823|FG000|Overall Study|Withdrawal by Subject|20|||
154936896|NCT02367781|559194824|FG001|Overall Study|Withdrawal by Subject|13|||
154936897|NCT02367781|559194823|FG000|Overall Study|Protocol Violation|0|||
154936898|NCT02367781|559194824|FG001|Overall Study|Protocol Violation|1|||
154936899|NCT02367781|559194823|FG000|Overall Study|Physician Decision|7|||
154936900|NCT02367781|559194824|FG001|Overall Study|Physician Decision|0|||
154936901|NCT02367781|559194823|FG000|Overall Study|Randomized in Error|5|||
154936902|NCT02367781|559194824|FG001|Overall Study|Randomized in Error|4|||
154936903|NCT02367781|559194823|FG000|Overall Study|Non-Compliance|1|||
154936904|NCT02367781|559194824|FG001|Overall Study|Non-Compliance|0|||
154936905|NCT02367781|559194823|FG000|Overall Study|Lost to Follow-up|1|||
154936906|NCT02367781|559194824|FG001|Overall Study|Lost to Follow-up|2|||
154936907|NCT02367781|559194823|FG000|Overall Study|Death|330|||
154936908|NCT02367781|559194824|FG001|Overall Study|Death|176|||
154936909|NCT02367781|559194823|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
154936910|NCT02367781|559194824|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
154936911|NCT02367781|559194823|FG000|Overall Study|Prolonged Hospitalization|1|||
154936912|NCT02367781|559194824|FG001|Overall Study|Prolonged Hospitalization|0|||
154936913|NCT02367781|559194823|FG000|Overall Study|Death Prior First Dose|1|||
154936914|NCT02367781|559194824|FG001|Overall Study|Death Prior First Dose|0|||
154936915|NCT02367781|559194823|FG000|Overall Study|Administrative-Change Facility|1|||
154936916|NCT02367781|559194824|FG001|Overall Study|Administrative-Change Facility|0|||
154936917|NCT02367781|559194823|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
154936918|NCT02367781|559194824|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
154936919|NCT02367781|559194823|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
154936920|NCT02367781|559194824|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
154936921|NCT02367781|559194823|FG000|Overall Study|Study Terminated by Sponsor|3|||
154936922|NCT02367781|559194824|FG001|Overall Study|Study Terminated by Sponsor|1|||
154936923|NCT02367781|559194823|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
154936924|NCT02367781|559194824|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
154936925|NCT02367781|559194823|FG000|Overall Study|Sponsor Decision|2|||
154936926|NCT02367781|559194824|FG001|Overall Study|Sponsor Decision|0|||
154936927|NCT02367781|559194823|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
154936928|NCT02367781|559194824|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
154936929|NCT00789828|559194825|FG000|Core Period (48 Weeks)|Administrative problems|0|||
154936930|NCT00789828|559194826|FG001|Core Period (48 Weeks)|Administrative problems|1|||
154936931|NCT00789828|559194825|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
154936932|NCT00789828|559194826|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
154936933|NCT00789828|559194825|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
154936934|NCT00789828|559194826|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
154936935|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
154936936|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
154936937|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
154936938|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
154936939|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
154936940|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
154936941|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
154936942|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
154936943|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|Death|1|||
154936944|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|Death|0|||
154936945|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
154936946|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
154936947|NCT00789828|559194825|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
154936948|NCT00789828|559194826|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
154936949|NCT02623426|559194827|FG000|Overall Study|Lost to Follow-up|0|||
154936950|NCT02623426|559194828|FG001|Overall Study|Lost to Follow-up|0|||
154936951|NCT02623426|559194829|FG002|Overall Study|Lost to Follow-up|1|||
154936952|NCT02623426|559194827|FG000|Overall Study|Withdrawal by Subject|1|||
154936953|NCT02623426|559194828|FG001|Overall Study|Withdrawal by Subject|2|||
154936954|NCT02623426|559194829|FG002|Overall Study|Withdrawal by Subject|2|||
154936955|NCT03751124|559194830|FG000|Overall Study|Adverse Event|4|||
154936956|NCT03751124|559194831|FG001|Overall Study|Adverse Event|3|||
154936957|NCT03751124|559194830|FG000|Overall Study|Protocol Deviation|0|||
154936958|NCT03751124|559194831|FG001|Overall Study|Protocol Deviation|1|||
154936959|NCT03751124|559194830|FG000|Overall Study|Lost to Follow-up|6|||
154936960|NCT03751124|559194831|FG001|Overall Study|Lost to Follow-up|4|||
154936961|NCT03751124|559194830|FG000|Overall Study|Withdrawal by Subject|6|||
154936962|NCT03751124|559194831|FG001|Overall Study|Withdrawal by Subject|8|||
154936963|NCT03751124|559194830|FG000|Overall Study|Lack of Efficacy|1|||
154936964|NCT03751124|559194831|FG001|Overall Study|Lack of Efficacy|1|||
154936965|NCT03751124|559194830|FG000|Overall Study|Pregnancy|0|||
154936966|NCT03751124|559194831|FG001|Overall Study|Pregnancy|1|||
154936967|NCT03751124|559194830|FG000|Overall Study|Other|9|||
154936968|NCT03751124|559194831|FG001|Overall Study|Other|9|||
154936969|NCT03751124|559194830|FG000|Overall Study|Participants who did not receive any study drug|0|||
154936970|NCT03751124|559194831|FG001|Overall Study|Participants who did not receive any study drug|1|||
154936971|NCT05458895|559194834|FG000|Overall Study|Withdrawal by Subject|8|||
154936972|NCT05458895|559194834|FG000|Overall Study|Lost to Follow-up|17|||
154936973|NCT05458895|559194834|FG000|Overall Study|Pregnancy|2|||
154936974|NCT05458895|559194834|FG000|Overall Study|Withdrawal by Study Team|1|||
154936975|NCT05166421|559194837|FG000|Overall Study|Other|3|||
154936976|NCT05166421|559194838|FG001|Overall Study|Other|1|||
154936977|NCT05166421|559194839|FG002|Overall Study|Other|1|||
154936978|NCT05166421|559194837|FG000|Overall Study|Withdrawal by Subject|5|||
154936979|NCT05166421|559194838|FG001|Overall Study|Withdrawal by Subject|3|||
154936980|NCT05166421|559194839|FG002|Overall Study|Withdrawal by Subject|6|||
154936981|NCT05166421|559194837|FG000|Overall Study|Lost to Follow-up|4|||
154936982|NCT05166421|559194838|FG001|Overall Study|Lost to Follow-up|1|||
154936983|NCT05166421|559194839|FG002|Overall Study|Lost to Follow-up|7|||
154936984|NCT01246986|559196819|FG000|Overall Study|Lost to Follow-up|0|||
154936985|NCT01246986|559196820|FG001|Overall Study|Lost to Follow-up|1|||
154936986|NCT01246986|559196821|FG002|Overall Study|Lost to Follow-up|3|||
154936987|NCT01246986|559196822|FG003|Overall Study|Lost to Follow-up|0|||
154936988|NCT01246986|559196823|FG004|Overall Study|Lost to Follow-up|0|||
154936989|NCT01246986|559196824|FG005|Overall Study|Lost to Follow-up|1|||
154936990|NCT01246986|559196825|FG006|Overall Study|Lost to Follow-up|0|||
154936991|NCT01246986|559196819|FG000|Overall Study|Withdrawal by Subject|3|||
154936992|NCT01246986|559196820|FG001|Overall Study|Withdrawal by Subject|4|||
154936993|NCT01246986|559196821|FG002|Overall Study|Withdrawal by Subject|3|||
154936994|NCT01246986|559196822|FG003|Overall Study|Withdrawal by Subject|0|||
154936995|NCT01246986|559196823|FG004|Overall Study|Withdrawal by Subject|4|||
154936996|NCT01246986|559196824|FG005|Overall Study|Withdrawal by Subject|0|||
154936997|NCT01246986|559196825|FG006|Overall Study|Withdrawal by Subject|0|||
154936998|NCT01406873|559196830|FG000|Overall Study|Withdrawal by Subject|1|||
154936999|NCT01406873|559196831|FG001|Overall Study|Withdrawal by Subject|1|||
154937000|NCT03990389|559196832|FG000|Overall Study|Lost to Follow-up|3|||
154937001|NCT03990389|559196833|FG001|Overall Study|Lost to Follow-up|0|||
154937002|NCT03770000|559196835|FG000|Overall Study|Premature discontinuation due to PD|0|||
154937003|NCT03770000|559196836|FG001|Overall Study|Premature discontinuation due to PD|0|||
154937004|NCT03770000|559196837|FG002|Overall Study|Premature discontinuation due to PD|1|||
154937005|NCT03770000|559196838|FG003|Overall Study|Premature discontinuation due to PD|3|||
154937006|NCT03770000|559196839|FG004|Overall Study|Premature discontinuation due to PD|2|||
154937007|NCT00833547|559196840|FG000|Overall Study|Withdrawal by Subject|2|||
154937008|NCT00833547|559196841|FG001|Overall Study|Withdrawal by Subject|2|||
154937009|NCT00686790|559196842|FG000|Overall Study|Adverse Event|2|||
154937010|NCT00686790|559196842|FG000|Overall Study|Withdrawal by Subject|1|||
154937011|NCT00686790|559196842|FG000|Overall Study|Death|1|||
154937012|NCT00686790|559196842|FG000|Overall Study|Lost to Follow-up|12|||
154937013|NCT00096382|559196843|FG000|Overall Study|Not treated|1|||
154937014|NCT00096382|559196844|FG001|Overall Study|Not treated|0|||
154937015|NCT00096382|559196843|FG000|Overall Study|Death during treatment|1|||
154937016|NCT00096382|559196844|FG001|Overall Study|Death during treatment|0|||
154937017|NCT00382291|559196845|FG000|Overall Study|Adverse Event|1|||
154937018|NCT00382291|559196846|FG001|Overall Study|Adverse Event|2|||
154937019|NCT00382291|559196847|FG002|Overall Study|Adverse Event|2|||
154937020|NCT00382291|559196845|FG000|Overall Study|Protocol Violation|1|||
154937021|NCT00382291|559196846|FG001|Overall Study|Protocol Violation|0|||
154937022|NCT00382291|559196847|FG002|Overall Study|Protocol Violation|0|||
154937023|NCT00382291|559196845|FG000|Overall Study|Temporary study suspension|2|||
154937024|NCT00382291|559196846|FG001|Overall Study|Temporary study suspension|2|||
154937025|NCT00382291|559196847|FG002|Overall Study|Temporary study suspension|5|||
155277054|NCT00088205|560447591|FG000|Overall Study|Death Due to Study Disease|4|||
155277055|NCT05199233|560447592|FG000|Overall Study|Lack of Efficacy|1|||
155277056|NCT02491892|560447597|FG000|Overall Study|Adverse Event|1|||
155277057|NCT02491892|560447598|FG001|Overall Study|Adverse Event|1|||
155277058|NCT02491892|560447597|FG000|Overall Study|Death|1|||
155277059|NCT02491892|560447598|FG001|Overall Study|Death|1|||
155277060|NCT02491892|560447597|FG000|Overall Study|Lack of Efficacy|37|||
154937026|NCT00382291|559196845|FG000|Overall Study|Withdrawal by Subject|0|||
154937027|NCT00382291|559196846|FG001|Overall Study|Withdrawal by Subject|2|||
154937028|NCT00382291|559196847|FG002|Overall Study|Withdrawal by Subject|0|||
154937029|NCT00382291|559196845|FG000|Overall Study|Physician Decision|0|||
154937030|NCT00382291|559196846|FG001|Overall Study|Physician Decision|1|||
154937031|NCT00382291|559196847|FG002|Overall Study|Physician Decision|0|||
154937032|NCT00382291|559196845|FG000|Overall Study|Lack of Efficacy|0|||
154937033|NCT00382291|559196846|FG001|Overall Study|Lack of Efficacy|0|||
154937034|NCT00382291|559196847|FG002|Overall Study|Lack of Efficacy|1|||
154937035|NCT01375010|559196848|FG000|Overall Study|Lost to Follow-up|8|||
154937036|NCT01375010|559196849|FG001|Overall Study|Lost to Follow-up|2|||
154937037|NCT01375010|559196848|FG000|Overall Study|Withdrawal by Subject|4|||
154937038|NCT01375010|559196849|FG001|Overall Study|Withdrawal by Subject|2|||
154937039|NCT02266706|559196850|FG000|Overall Study|Withdrawal by Subject|0|||
154937040|NCT02266706|559196851|FG001|Overall Study|Withdrawal by Subject|1|||
154937041|NCT02266706|559196852|FG002|Overall Study|Withdrawal by Subject|1|||
154937042|NCT02266706|559196853|FG003|Overall Study|Withdrawal by Subject|0|||
155277061|NCT02491892|560447598|FG001|Overall Study|Lack of Efficacy|36|||
154937043|NCT02266706|559196854|FG004|Overall Study|Withdrawal by Subject|0|||
154937044|NCT02266706|559196855|FG005|Overall Study|Withdrawal by Subject|1|||
154937045|NCT02266706|559196856|FG006|Overall Study|Withdrawal by Subject|0|||
154937046|NCT02266706|559196857|FG007|Overall Study|Withdrawal by Subject|0|||
154937047|NCT02266706|559196858|FG008|Overall Study|Withdrawal by Subject|0|||
154937048|NCT02266706|559196850|FG000|Overall Study|Screen failure|0|||
154937049|NCT02266706|559196851|FG001|Overall Study|Screen failure|0|||
154937050|NCT02266706|559196852|FG002|Overall Study|Screen failure|0|||
154937051|NCT02266706|559196853|FG003|Overall Study|Screen failure|0|||
154937052|NCT02266706|559196854|FG004|Overall Study|Screen failure|0|||
154937053|NCT02266706|559196855|FG005|Overall Study|Screen failure|1|||
154937054|NCT02266706|559196856|FG006|Overall Study|Screen failure|1|||
154937055|NCT02266706|559196857|FG007|Overall Study|Screen failure|0|||
154937056|NCT02266706|559196858|FG008|Overall Study|Screen failure|0|||
154937057|NCT02266706|559196850|FG000|Overall Study|Enrollment in another study|0|||
154937058|NCT02266706|559196851|FG001|Overall Study|Enrollment in another study|0|||
154937059|NCT02266706|559196852|FG002|Overall Study|Enrollment in another study|0|||
154937060|NCT02266706|559196853|FG003|Overall Study|Enrollment in another study|1|||
155277062|NCT02491892|560447597|FG000|Overall Study|Refused Treatment|1|||
155277063|NCT02491892|560447598|FG001|Overall Study|Refused Treatment|0|||
155277064|NCT02491892|560447597|FG000|Overall Study|Lost to Follow-up|1|||
155277065|NCT02491892|560447598|FG001|Overall Study|Lost to Follow-up|0|||
155277066|NCT01734850|560447599|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
155277067|NCT01734850|560447600|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
155277068|NCT01734850|560447601|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
155277069|NCT01734850|560447599|FG000|Overall Study|Not infused due to manufacturing failure|0|||
155277070|NCT01734850|560447600|FG001|Overall Study|Not infused due to manufacturing failure|0|||
155277071|NCT01734850|560447601|FG002|Overall Study|Not infused due to manufacturing failure|1|||
155277072|NCT03824938|560447602|FG000|Overall Study|Withdrawal by Subject|2|||
155277073|NCT03824938|560447603|FG001|Overall Study|Withdrawal by Subject|1|||
155277074|NCT03824938|560447604|FG002|Overall Study|Withdrawal by Subject|0|||
155277075|NCT03824938|560447605|FG003|Overall Study|Withdrawal by Subject|2|||
155277076|NCT03824938|560447606|FG004|Overall Study|Withdrawal by Subject|0|||
155277077|NCT03824938|560447607|FG005|Overall Study|Withdrawal by Subject|1|||
155277078|NCT03824938|560447602|FG000|Overall Study|Lost to Follow-up|0|||
155277079|NCT03824938|560447603|FG001|Overall Study|Lost to Follow-up|1|||
155277080|NCT03824938|560447604|FG002|Overall Study|Lost to Follow-up|0|||
155277081|NCT03824938|560447605|FG003|Overall Study|Lost to Follow-up|0|||
155277082|NCT03824938|560447606|FG004|Overall Study|Lost to Follow-up|1|||
155277083|NCT03824938|560447607|FG005|Overall Study|Lost to Follow-up|0|||
155277084|NCT00065468|560447611|FG000|Overall Study|Death|172|||
155277085|NCT00065468|560447612|FG001|Overall Study|Death|169|||
155277086|NCT00065468|560447613|FG002|Overall Study|Death|171|||
155277087|NCT00065468|560447611|FG000|Overall Study|Withdrawal by Subject|3|||
155277088|NCT00065468|560447612|FG001|Overall Study|Withdrawal by Subject|4|||
155277089|NCT00065468|560447613|FG002|Overall Study|Withdrawal by Subject|5|||
155277090|NCT00065468|560447611|FG000|Overall Study|Lost to Follow-up|5|||
155277091|NCT00065468|560447612|FG001|Overall Study|Lost to Follow-up|3|||
155277092|NCT00065468|560447613|FG002|Overall Study|Lost to Follow-up|2|||
155277093|NCT00065468|560447611|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
155277094|NCT00065468|560447612|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
155277095|NCT00065468|560447613|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
155277096|NCT00065468|560447611|FG000|Overall Study|Disease progression|0|||
155277097|NCT00065468|560447612|FG001|Overall Study|Disease progression|0|||
155277098|NCT00065468|560447613|FG002|Overall Study|Disease progression|1|||
155277099|NCT00065468|560447611|FG000|Overall Study|Other|14|||
155277100|NCT00065468|560447612|FG001|Overall Study|Other|24|||
155277101|NCT00065468|560447613|FG002|Overall Study|Other|18|||
155277102|NCT04496167|560447614|FG000|Overall Study|Adverse Event|6|||
155277103|NCT04496167|560447615|FG001|Overall Study|Adverse Event|2|||
155277104|NCT04496167|560447614|FG000|Overall Study|Withdrawal by Subject|7|||
155277105|NCT04496167|560447615|FG001|Overall Study|Withdrawal by Subject|6|||
155277106|NCT04496167|560447614|FG000|Overall Study|Lost to Follow-up|3|||
155277107|NCT04496167|560447615|FG001|Overall Study|Lost to Follow-up|5|||
155277108|NCT04496167|560447614|FG000|Overall Study|Not Treated|1|||
155277109|NCT04496167|560447615|FG001|Overall Study|Not Treated|2|||
155277110|NCT04496167|560447614|FG000|Overall Study|Other Than Specified|1|||
155277111|NCT04496167|560447615|FG001|Overall Study|Other Than Specified|1|||
155277112|NCT01058863|560447616|FG000|Overall Study|Lost to Follow-up|1|||
155277113|NCT01058863|560447616|FG000|Overall Study|Withdrawal by Subject|1|||
155277114|NCT01058863|560447616|FG000|Overall Study|Sponsor requested withdrawal|1|||
155277115|NCT01058863|560447616|FG000|Overall Study|Randomized in error|1|||
155277116|NCT03050398|560447621|FG000|Overall Study|Study terminated by sponsor|8|||
155277117|NCT05108649|560447622|FG000|Overall Study|Lost to Follow-up|0|||
155277118|NCT05108649|560447623|FG001|Overall Study|Lost to Follow-up|4|||
155277119|NCT05108649|560447624|FG002|Overall Study|Lost to Follow-up|3|||
155277120|NCT05108649|560447625|FG003|Overall Study|Lost to Follow-up|6|||
154937061|NCT02266706|559196854|FG004|Overall Study|Enrollment in another study|0|||
154937062|NCT02266706|559196855|FG005|Overall Study|Enrollment in another study|0|||
154937063|NCT02266706|559196856|FG006|Overall Study|Enrollment in another study|0|||
155277121|NCT05108649|560447622|FG000|Overall Study|Not Interested|1|||
155277122|NCT05108649|560447623|FG001|Overall Study|Not Interested|1|||
155277123|NCT05108649|560447624|FG002|Overall Study|Not Interested|0|||
155277124|NCT05108649|560447625|FG003|Overall Study|Not Interested|1|||
155277125|NCT05108649|560447622|FG000|Overall Study|Out of area|0|||
155277126|NCT05108649|560447623|FG001|Overall Study|Out of area|0|||
155277127|NCT05108649|560447624|FG002|Overall Study|Out of area|0|||
155277128|NCT05108649|560447625|FG003|Overall Study|Out of area|1|||
155277129|NCT05108649|560447622|FG000|Overall Study|PI decision|1|||
155277130|NCT05108649|560447623|FG001|Overall Study|PI decision|0|||
155277131|NCT05108649|560447624|FG002|Overall Study|PI decision|0|||
154937064|NCT02266706|559196857|FG007|Overall Study|Enrollment in another study|0|||
154937065|NCT02266706|559196858|FG008|Overall Study|Enrollment in another study|0|||
155277132|NCT05108649|560447625|FG003|Overall Study|PI decision|0|||
155277133|NCT05108649|560447622|FG000|Overall Study|Significant Non-Compliance|0|||
155277134|NCT05108649|560447623|FG001|Overall Study|Significant Non-Compliance|1|||
155277135|NCT05108649|560447624|FG002|Overall Study|Significant Non-Compliance|0|||
155277136|NCT05108649|560447625|FG003|Overall Study|Significant Non-Compliance|0|||
155277137|NCT05108649|560447622|FG000|Overall Study|Unable to adhere to study protocol|0|||
154937066|NCT01977352|559196859|FG000|Overall Study|Lost to Follow-up|1|||
154937067|NCT01977352|559196860|FG001|Overall Study|Lost to Follow-up|2|||
154937068|NCT00409188|559196861|FG000|Overall Study|Ongoing at data cut-off|383|||
154937069|NCT00409188|559196862|FG001|Overall Study|Ongoing at data cut-off|175|||
154937070|NCT02270983|559196863|FG000|Overall Study|Adverse Event|3|||
154937071|NCT02270983|559196864|FG001|Overall Study|Adverse Event|2|||
154937072|NCT02270983|559196865|FG002|Overall Study|Adverse Event|6|||
154937073|NCT02270983|559196863|FG000|Overall Study|Lack of Efficacy|2|||
154937074|NCT02270983|559196864|FG001|Overall Study|Lack of Efficacy|1|||
154937075|NCT02270983|559196865|FG002|Overall Study|Lack of Efficacy|1|||
154937076|NCT02270983|559196863|FG000|Overall Study|Withdrawal by Subject|1|||
154937077|NCT02270983|559196864|FG001|Overall Study|Withdrawal by Subject|0|||
154937078|NCT02270983|559196865|FG002|Overall Study|Withdrawal by Subject|2|||
154937079|NCT02270983|559196863|FG000|Overall Study|Lost to Follow-up|1|||
154937080|NCT02270983|559196864|FG001|Overall Study|Lost to Follow-up|1|||
154937081|NCT02270983|559196865|FG002|Overall Study|Lost to Follow-up|2|||
154937082|NCT02270983|559196863|FG000|Overall Study|Protocol Violation|1|||
154937083|NCT02270983|559196864|FG001|Overall Study|Protocol Violation|1|||
154937084|NCT02270983|559196865|FG002|Overall Study|Protocol Violation|1|||
154937085|NCT02270983|559196863|FG000|Overall Study|family emergency|0|||
154937086|NCT02270983|559196864|FG001|Overall Study|family emergency|1|||
154937087|NCT02270983|559196865|FG002|Overall Study|family emergency|0|||
154937088|NCT02270983|559196863|FG000|Overall Study|study procedure non-compliance|1|||
154937089|NCT02270983|559196864|FG001|Overall Study|study procedure non-compliance|0|||
154937090|NCT02270983|559196865|FG002|Overall Study|study procedure non-compliance|0|||
154937091|NCT02270983|559196863|FG000|Overall Study|moved away from study site|0|||
154937092|NCT02270983|559196864|FG001|Overall Study|moved away from study site|1|||
154937093|NCT02270983|559196865|FG002|Overall Study|moved away from study site|0|||
154937094|NCT00854620|559196869|FG000|Overall Study|Adverse Event|1|||
154937095|NCT03237611|559196871|FG000|Overall Study|Withdrawal by Subject|1|||
154937096|NCT03237611|559196871|FG000|Overall Study|Ineligible|1|||
154937097|NCT00534092|559196872|FG000|Overall Study|Lost to Follow-up|1|||
154937098|NCT00534092|559196873|FG001|Overall Study|Lost to Follow-up|0|||
154937099|NCT00534092|559196872|FG000|Overall Study|personal reasons/family concerns|1|||
154937100|NCT00534092|559196873|FG001|Overall Study|personal reasons/family concerns|0|||
154937101|NCT00275028|559196874|FG000|Overall Study|Withdrew consent before treatment began|1|||
154937102|NCT00275028|559196874|FG000|Overall Study|Withdrawal by Subject|5|||
154937103|NCT00275028|559196874|FG000|Overall Study|Adverse Event|9|||
154937104|NCT00275028|559196874|FG000|Overall Study|Progressive Disease|30|||
154937105|NCT00275028|559196874|FG000|Overall Study|Physician Decision|2|||
154937106|NCT01847313|559196878|FG000|Overall Study|Death|0|||
154937107|NCT01847313|559196879|FG001|Overall Study|Death|1|||
154937108|NCT01847313|559196878|FG000|Overall Study|Withdrawal by Subject|0|||
154937109|NCT01847313|559196879|FG001|Overall Study|Withdrawal by Subject|1|||
154937110|NCT00598559|559196880|FG000|Overall Study|Adverse Event|11|||
154937111|NCT00598559|559196881|FG001|Overall Study|Adverse Event|7|||
154937112|NCT00598559|559196882|FG002|Overall Study|Adverse Event|0|||
154937113|NCT00598559|559196880|FG000|Overall Study|Withdrawal by Subject|2|||
155043452|NCT01826981|559590128|FG006|Overall Study|Withdrew Consent|1|||
155043453|NCT01826981|559590129|FG007|Overall Study|Withdrew Consent|1|||
155043454|NCT01826981|559590130|FG008|Overall Study|Withdrew Consent|0|||
154937114|NCT00598559|559196881|FG001|Overall Study|Withdrawal by Subject|2|||
154937115|NCT00598559|559196882|FG002|Overall Study|Withdrawal by Subject|0|||
154937116|NCT00598559|559196880|FG000|Overall Study|Protocol Non-compliance|1|||
154937117|NCT00598559|559196881|FG001|Overall Study|Protocol Non-compliance|0|||
154937118|NCT00598559|559196882|FG002|Overall Study|Protocol Non-compliance|0|||
154937119|NCT00598559|559196880|FG000|Overall Study|Early discharge from hospital|9|||
154937120|NCT00598559|559196881|FG001|Overall Study|Early discharge from hospital|12|||
154937121|NCT00598559|559196882|FG002|Overall Study|Early discharge from hospital|3|||
154937122|NCT00598559|559196880|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
154937123|NCT00598559|559196881|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
154937124|NCT00598559|559196882|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
154937125|NCT00515073|559196887|FG000|Overall Study|Withdrawal by Subject|1|||
154937126|NCT00515073|559196887|FG000|Overall Study|Physician Decision|1|||
154937127|NCT02764489|559196888|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
154937128|NCT02764489|559196889|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
154937129|NCT02764489|559196888|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
154937130|NCT02764489|559196889|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
154937131|NCT02764489|559196888|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
154937132|NCT02764489|559196889|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
155043455|NCT01826981|559590131|FG009|Overall Study|Withdrew Consent|0|||
154937133|NCT02764489|559196888|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
154937134|NCT02764489|559196889|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
154937135|NCT00881959|559196890|FG000|Overall Study|Lost to Follow-up|2|||
154937136|NCT00881959|559196891|FG001|Overall Study|Lost to Follow-up|4|||
154937137|NCT03840811|559196892|FG000|Overall Study|Lost to Follow-up|0|||
155043456|NCT01826981|559590132|FG010|Overall Study|Withdrew Consent|0|||
154937138|NCT03840811|559196893|FG001|Overall Study|Lost to Follow-up|0|||
154937139|NCT03840811|559196894|FG002|Overall Study|Lost to Follow-up|1|||
154937140|NCT01904383|559196895|FG000|Overall Study|CRF not collected|117|||
154937141|NCT01904383|559196895|FG000|Overall Study|Reason not listed|147|||
154937142|NCT01904383|559196895|FG000|Overall Study|Lost to Follow-up|674|||
154937143|NCT01904383|559196895|FG000|Overall Study|Lack of Efficacy|370|||
154937144|NCT01904383|559196895|FG000|Overall Study|Improvement|141|||
154937145|NCT01904383|559196895|FG000|Overall Study|Adverse Event|271|||
154937146|NCT01904383|559196895|FG000|Overall Study|No patient visit after entry|54|||
154937147|NCT01625845|559196896|FG000|Overall Study|Adverse Event|1|||
154937148|NCT01625845|559196897|FG001|Overall Study|Adverse Event|2|||
154937149|NCT01625845|559196896|FG000|Overall Study|Lost to Follow-up|2|||
154937150|NCT01625845|559196897|FG001|Overall Study|Lost to Follow-up|1|||
154937151|NCT01625845|559196896|FG000|Overall Study|Withdrawal by Subject|2|||
154937152|NCT01625845|559196897|FG001|Overall Study|Withdrawal by Subject|0|||
154937153|NCT01294592|559196898|FG000|Overall Study|Adverse Event|28|||
154937154|NCT01294592|559196899|FG001|Overall Study|Adverse Event|13|||
154937155|NCT01294592|559196898|FG000|Overall Study|Lack of Efficacy|7|||
154937156|NCT01294592|559196899|FG001|Overall Study|Lack of Efficacy|5|||
154937157|NCT01294592|559196898|FG000|Overall Study|Protocol Violation|1|||
154937158|NCT01294592|559196899|FG001|Overall Study|Protocol Violation|7|||
154937159|NCT01294592|559196898|FG000|Overall Study|Lost to Follow-up|7|||
154937160|NCT01294592|559196899|FG001|Overall Study|Lost to Follow-up|9|||
154937161|NCT01294592|559196898|FG000|Overall Study|Physician Decision|6|||
154937162|NCT01294592|559196899|FG001|Overall Study|Physician Decision|11|||
154937163|NCT01294592|559196898|FG000|Overall Study|Withdrawal by Subject|28|||
154937164|NCT01294592|559196899|FG001|Overall Study|Withdrawal by Subject|28|||
154937165|NCT00623623|559196900|FG000|Overall Study|Previous enrolment into this study|1|||
154937166|NCT00623623|559196901|FG001|Overall Study|Previous enrolment into this study|1|||
154937167|NCT00693784|559196903|FG000|Overall Study|Lost to Follow-up|2|||
154937168|NCT00693784|559196903|FG000|Overall Study|Withdrawal by Subject|2|||
154937169|NCT02265952|559196904|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
154937170|NCT02265952|559196905|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
154937171|NCT02265952|559196904|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
154937172|NCT02265952|559196905|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
154937173|NCT00326885|559196909|FG000|Overall Study|Adverse Event|1|||
154937174|NCT00326885|559196909|FG000|Overall Study|Withdrawal by Subject|3|||
154937175|NCT00326885|559196909|FG000|Overall Study|Physician Decision|1|||
154937176|NCT00326885|559196909|FG000|Overall Study|Hospice withdrew consent|2|||
154937177|NCT04313283|559196910|FG000|Overall Study|did not complete intervention|4|||
154937178|NCT04356573|559196911|FG000|Overall Study|Didn't Qualify|1|||
154937179|NCT04356573|559196912|FG001|Overall Study|Didn't Qualify|0|||
154937180|NCT03650400|559196913|FG000|Overall Study|Study terminated by sponsor|0|||
154937181|NCT03650400|559196914|FG001|Overall Study|Study terminated by sponsor|5|||
154937182|NCT01170364|559196916|FG000|Overall Study|Protocol Violation|4|||
154937183|NCT01170364|559196917|FG001|Overall Study|Protocol Violation|1|||
154937184|NCT04132232|559196918|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
154937185|NCT04132232|559196919|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
154937186|NCT04132232|559196918|FG000|Overall Study|Lost to Follow-up|6|||
154937187|NCT04132232|559196919|FG001|Overall Study|Lost to Follow-up|7|||
154937188|NCT01368276|559196923|FG000|Overall Study|Death|1|||
154937189|NCT01368276|559196924|FG001|Overall Study|Death|10|||
154937190|NCT02041494|559196925|FG000|Overall Study|Death|1|||
154937191|NCT02041494|559196926|FG001|Overall Study|Death|3|||
154937192|NCT02041494|559196925|FG000|Overall Study|Lost to Follow-up|2|||
154937193|NCT02041494|559196926|FG001|Overall Study|Lost to Follow-up|6|||
154937194|NCT02041494|559196925|FG000|Overall Study|study terminated|16|||
154937195|NCT02041494|559196926|FG001|Overall Study|study terminated|11|||
154937196|NCT03341273|559196927|FG000|Overall Study|Lost to Follow-up|7|||
154937197|NCT03341273|559196928|FG001|Overall Study|Lost to Follow-up|7|||
154937198|NCT03341273|559196927|FG000|Overall Study|Withdrawal by Subject|4|||
154937199|NCT03341273|559196928|FG001|Overall Study|Withdrawal by Subject|2|||
154937200|NCT03341273|559196927|FG000|Overall Study|Physician Decision|1|||
154937201|NCT03341273|559196928|FG001|Overall Study|Physician Decision|0|||
154937202|NCT03341273|559196927|FG000|Overall Study|Protocol Violation|0|||
154937203|NCT03341273|559196928|FG001|Overall Study|Protocol Violation|1|||
154937204|NCT03341273|559196927|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
154937205|NCT03341273|559196928|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
154937206|NCT03341273|559196927|FG000|Overall Study|Became ineligible after enrollment|1|||
154937207|NCT03341273|559196928|FG001|Overall Study|Became ineligible after enrollment|0|||
154937208|NCT03341273|559196927|FG000|Overall Study|Not Eligible at Enrollment|0|||
154937209|NCT03341273|559196928|FG001|Overall Study|Not Eligible at Enrollment|1|||
154937210|NCT03341273|559196927|FG000|Overall Study|Participant incarcerated|1|||
155277138|NCT05108649|560447623|FG001|Overall Study|Unable to adhere to study protocol|2|||
154937211|NCT03341273|559196928|FG001|Overall Study|Participant incarcerated|0|||
154937212|NCT04126733|559196929|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
154937213|NCT04126733|559196929|FG000|Treatment Period|Adverse Event|8|||
154937214|NCT04126733|559196929|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
154937215|NCT04126733|559196929|FG000|Treatment Period|Physician Decision|5|||
154937216|NCT04126733|559196929|FG000|Treatment Period|Death|1|||
155277139|NCT05108649|560447624|FG002|Overall Study|Unable to adhere to study protocol|0|||
154937217|NCT04126733|559196929|FG000|Treatment Period|Other Reasons|2|||
154937218|NCT04126733|559196929|FG000|Active Follow-up Period|Death|13|||
154937219|NCT04126733|559196929|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
154937220|NCT04126733|559196929|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
154937221|NCT04126733|559196929|FG000|Active Follow-up Period|Other Reasons|1|||
154937222|NCT04126733|559196929|FG000|Long-term Follow-up Period|Death|22|||
154937223|NCT04126733|559196929|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
154937224|NCT04126733|559196929|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
154937225|NCT03726437|559196930|FG000|Overall Study|Lost to Follow-up|85|||
155277140|NCT05108649|560447625|FG003|Overall Study|Unable to adhere to study protocol|0|||
155277141|NCT00918749|560447628|FG000|Overall Study|Adverse Event|1|||
155277142|NCT00918749|560447629|FG001|Overall Study|Adverse Event|0|||
155277143|NCT00918749|560447630|FG002|Overall Study|Adverse Event|1|||
155277144|NCT00918749|560447628|FG000|Overall Study|Lost to Follow-up|0|||
155277145|NCT00918749|560447629|FG001|Overall Study|Lost to Follow-up|0|||
155277146|NCT00918749|560447630|FG002|Overall Study|Lost to Follow-up|1|||
155277147|NCT00918749|560447628|FG000|Overall Study|Withdrawal by Subject|5|||
155277148|NCT00918749|560447629|FG001|Overall Study|Withdrawal by Subject|3|||
155277149|NCT00918749|560447630|FG002|Overall Study|Withdrawal by Subject|5|||
155277150|NCT00918749|560447628|FG000|Overall Study|No Study Medication Taken|1|||
155277151|NCT00918749|560447629|FG001|Overall Study|No Study Medication Taken|0|||
155277152|NCT00918749|560447630|FG002|Overall Study|No Study Medication Taken|0|||
155277153|NCT01712789|560447631|FG000|Overall Study|Lack of Efficacy|2|||
155277154|NCT01712789|560447631|FG000|Overall Study|Lost to Follow-up|1|||
155277155|NCT01712789|560447631|FG000|Overall Study|Progressive Disease|504|||
155277156|NCT01712789|560447631|FG000|Overall Study|Death|57|||
155277157|NCT01712789|560447631|FG000|Overall Study|Adverse Event|52|||
155277158|NCT01712789|560447631|FG000|Overall Study|Miscellaneous|31|||
155277159|NCT01712789|560447631|FG000|Overall Study|Withdrawal by Subject|21|||
155277160|NCT01712789|560447631|FG000|Overall Study|Transition to Commercial Treatment|8|||
154937226|NCT03726437|559196931|FG001|Overall Study|Lost to Follow-up|76|||
154937227|NCT00267007|559196933|FG000|Overall Study|Withdrawal by Subject|6|||
154937228|NCT00267007|559196934|FG001|Overall Study|Withdrawal by Subject|0|||
154937229|NCT00267007|559196933|FG000|Overall Study|Lost to Follow-up|1|||
154937230|NCT00267007|559196934|FG001|Overall Study|Lost to Follow-up|0|||
154937231|NCT00267007|559196933|FG000|Overall Study|Non-compliance|0|||
154937232|NCT00267007|559196934|FG001|Overall Study|Non-compliance|1|||
154937233|NCT00267007|559196933|FG000|Overall Study|Adverse Event|1|||
154937234|NCT00267007|559196934|FG001|Overall Study|Adverse Event|0|||
154937235|NCT04133519|559196939|FG000|Overall Study|Withdrawal by Subject|5|||
154937236|NCT04133519|559196940|FG001|Overall Study|Withdrawal by Subject|4|||
154937237|NCT04133519|559196939|FG000|Overall Study|Protocol Violation|0|||
154937238|NCT04133519|559196940|FG001|Overall Study|Protocol Violation|1|||
155277161|NCT01712789|560447631|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
155277162|NCT03018106|560447632|FG000|Overall Study|Lost to Follow-up|0|||
155277163|NCT03018106|560447633|FG001|Overall Study|Lost to Follow-up|1|||
155277164|NCT02213055|560447636|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
155277165|NCT02213055|560447637|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
155277166|NCT02213055|560447636|FG000|Overall Study|Protocol was not Followed during Study|1|||
155277167|NCT02213055|560447637|FG001|Overall Study|Protocol was not Followed during Study|0|||
155277168|NCT02213055|560447636|FG000|Overall Study|Documentation Issue at Enrollment|1|||
155277169|NCT02213055|560447637|FG001|Overall Study|Documentation Issue at Enrollment|0|||
155277170|NCT02213055|560447636|FG000|Overall Study|Documentation Issue during Study|10|||
155277171|NCT02213055|560447637|FG001|Overall Study|Documentation Issue during Study|0|||
155277172|NCT02213055|560447636|FG000|Overall Study|Did not have Live Lice|8|||
155277173|NCT02213055|560447637|FG001|Overall Study|Did not have Live Lice|0|||
155277174|NCT02213055|560447636|FG000|Overall Study|Had another Treatment during the Study|3|||
155277175|NCT02213055|560447637|FG001|Overall Study|Had another Treatment during the Study|0|||
155277176|NCT02213055|560447636|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
155277177|NCT02213055|560447637|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
155277178|NCT02213055|560447636|FG000|Overall Study|Did not Return to School|5|||
155277179|NCT02213055|560447637|FG001|Overall Study|Did not Return to School|0|||
155277180|NCT02025205|560447639|FG000|Overall Study|Withdrawal by Subject|1|||
154937239|NCT04133519|559196939|FG000|Overall Study|Never started treatment|1|||
154937240|NCT04133519|559196940|FG001|Overall Study|Never started treatment|1|||
154937241|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937242|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
155043457|NCT01826981|559590133|FG011|Overall Study|Withdrew Consent|1|||
155277181|NCT02025205|560447640|FG001|Overall Study|Withdrawal by Subject|1|||
155277182|NCT02025205|560447639|FG000|Overall Study|Protocol Violation|2|||
154937243|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937244|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
154937245|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937246|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937247|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937248|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937249|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937250|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
154937251|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Adverse Event|0|||
154937252|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Adverse Event|1|||
154937253|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Adverse Event|1|||
154937254|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Adverse Event|1|||
154937255|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Adverse Event|1|||
154937256|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Adverse Event|1|||
154937257|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Adverse Event|0|||
154937258|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Adverse Event|0|||
154937259|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Adverse Event|0|||
154937260|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Adverse Event|0|||
154937261|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
154937262|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
154937263|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
154937264|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
154937265|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
154937266|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
154937267|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
154937268|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
154937269|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
154937270|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
154937271|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
154937272|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
154937273|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
154937274|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
154937275|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
154937276|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
154937277|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
154937278|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
154937279|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
154937280|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
154937281|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
154937282|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
154937283|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937284|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937285|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937286|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937287|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937288|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
154937289|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937290|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
154937291|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937292|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937293|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937294|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937295|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
154937296|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
154937297|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937298|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937299|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937300|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
154937301|NCT00950599|559196941|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
154937302|NCT00950599|559196942|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
154937303|NCT00950599|559196943|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
154937304|NCT00950599|559196944|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
154937305|NCT00950599|559196945|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
154937306|NCT00950599|559196946|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
155277183|NCT02025205|560447640|FG001|Overall Study|Protocol Violation|1|||
155277184|NCT02025205|560447639|FG000|Overall Study|Death|0|||
155277185|NCT02025205|560447640|FG001|Overall Study|Death|1|||
154937307|NCT00950599|559196947|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
154937308|NCT00950599|559196948|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
154937309|NCT00950599|559196949|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
154937310|NCT00950599|559196950|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
154937311|NCT00950599|559196941|FG000|Follow-Up Period|Adverse Event|0|||
154937312|NCT00950599|559196942|FG001|Follow-Up Period|Adverse Event|0|||
154937313|NCT00950599|559196943|FG002|Follow-Up Period|Adverse Event|0|||
154937314|NCT00950599|559196944|FG003|Follow-Up Period|Adverse Event|0|||
154937315|NCT00950599|559196945|FG004|Follow-Up Period|Adverse Event|0|||
154937316|NCT00950599|559196946|FG005|Follow-Up Period|Adverse Event|0|||
154937317|NCT00950599|559196947|FG006|Follow-Up Period|Adverse Event|0|||
154937318|NCT00950599|559196948|FG007|Follow-Up Period|Adverse Event|0|||
154937319|NCT00950599|559196949|FG008|Follow-Up Period|Adverse Event|1|||
154937320|NCT00950599|559196950|FG009|Follow-Up Period|Adverse Event|0|||
154937321|NCT00950599|559196941|FG000|Follow-Up Period|Lack of Efficacy|0|||
154937322|NCT00950599|559196942|FG001|Follow-Up Period|Lack of Efficacy|0|||
154937323|NCT00950599|559196943|FG002|Follow-Up Period|Lack of Efficacy|0|||
154937324|NCT00950599|559196944|FG003|Follow-Up Period|Lack of Efficacy|0|||
154937325|NCT00950599|559196945|FG004|Follow-Up Period|Lack of Efficacy|0|||
154937326|NCT00950599|559196946|FG005|Follow-Up Period|Lack of Efficacy|0|||
154937327|NCT00950599|559196947|FG006|Follow-Up Period|Lack of Efficacy|0|||
154937328|NCT00950599|559196948|FG007|Follow-Up Period|Lack of Efficacy|0|||
154937329|NCT00950599|559196949|FG008|Follow-Up Period|Lack of Efficacy|3|||
154937330|NCT00950599|559196950|FG009|Follow-Up Period|Lack of Efficacy|0|||
154937331|NCT00950599|559196941|FG000|Follow-Up Period|Lost to Follow-up|0|||
154937332|NCT00950599|559196942|FG001|Follow-Up Period|Lost to Follow-up|0|||
154937333|NCT00950599|559196943|FG002|Follow-Up Period|Lost to Follow-up|0|||
154937334|NCT00950599|559196944|FG003|Follow-Up Period|Lost to Follow-up|0|||
154937335|NCT00950599|559196945|FG004|Follow-Up Period|Lost to Follow-up|0|||
154937336|NCT00950599|559196946|FG005|Follow-Up Period|Lost to Follow-up|0|||
154937337|NCT00950599|559196947|FG006|Follow-Up Period|Lost to Follow-up|0|||
154937338|NCT00950599|559196948|FG007|Follow-Up Period|Lost to Follow-up|0|||
154937339|NCT00950599|559196949|FG008|Follow-Up Period|Lost to Follow-up|5|||
154937340|NCT00950599|559196950|FG009|Follow-Up Period|Lost to Follow-up|1|||
154937341|NCT00950599|559196941|FG000|Follow-Up Period|Physician Decision|0|||
154937342|NCT00950599|559196942|FG001|Follow-Up Period|Physician Decision|0|||
154937343|NCT00950599|559196943|FG002|Follow-Up Period|Physician Decision|0|||
154937344|NCT00950599|559196944|FG003|Follow-Up Period|Physician Decision|0|||
154937345|NCT00950599|559196945|FG004|Follow-Up Period|Physician Decision|0|||
154937346|NCT00950599|559196946|FG005|Follow-Up Period|Physician Decision|0|||
154937347|NCT00950599|559196947|FG006|Follow-Up Period|Physician Decision|0|||
154937348|NCT00950599|559196948|FG007|Follow-Up Period|Physician Decision|0|||
154937349|NCT00950599|559196949|FG008|Follow-Up Period|Physician Decision|1|||
154937350|NCT00950599|559196950|FG009|Follow-Up Period|Physician Decision|0|||
154937351|NCT00950599|559196941|FG000|Follow-Up Period|Poor/Noncompliance|0|||
154937352|NCT00950599|559196942|FG001|Follow-Up Period|Poor/Noncompliance|0|||
154937353|NCT00950599|559196943|FG002|Follow-Up Period|Poor/Noncompliance|0|||
154937354|NCT00950599|559196944|FG003|Follow-Up Period|Poor/Noncompliance|0|||
154937355|NCT00950599|559196945|FG004|Follow-Up Period|Poor/Noncompliance|0|||
154937356|NCT00950599|559196946|FG005|Follow-Up Period|Poor/Noncompliance|0|||
154937357|NCT00950599|559196947|FG006|Follow-Up Period|Poor/Noncompliance|0|||
154937358|NCT00950599|559196948|FG007|Follow-Up Period|Poor/Noncompliance|0|||
154937359|NCT00950599|559196949|FG008|Follow-Up Period|Poor/Noncompliance|1|||
154937360|NCT00950599|559196950|FG009|Follow-Up Period|Poor/Noncompliance|0|||
155277186|NCT02448719|560447643|FG000|Overall Study|Withdrawal by Subject|0|||
155277187|NCT02448719|560447644|FG001|Overall Study|Withdrawal by Subject|0|||
155277188|NCT02448719|560447645|FG002|Overall Study|Withdrawal by Subject|0|||
155277189|NCT02448719|560447646|FG003|Overall Study|Withdrawal by Subject|0|||
155277190|NCT02448719|560447647|FG004|Overall Study|Withdrawal by Subject|1|||
155277191|NCT02448719|560447648|FG005|Overall Study|Withdrawal by Subject|0|||
155277192|NCT02448719|560447649|FG006|Overall Study|Withdrawal by Subject|0|||
155277193|NCT02448719|560447650|FG007|Overall Study|Withdrawal by Subject|0|||
155277194|NCT02448719|560447651|FG008|Overall Study|Withdrawal by Subject|0|||
155277195|NCT02448719|560447652|FG009|Overall Study|Withdrawal by Subject|0|||
155277196|NCT02448719|560447653|FG010|Overall Study|Withdrawal by Subject|0|||
154937361|NCT00950599|559196941|FG000|Follow-Up Period|Subject withdrew Consent|0|||
154937362|NCT00950599|559196942|FG001|Follow-Up Period|Subject withdrew Consent|0|||
154937363|NCT00950599|559196943|FG002|Follow-Up Period|Subject withdrew Consent|0|||
154937364|NCT00950599|559196944|FG003|Follow-Up Period|Subject withdrew Consent|0|||
154937365|NCT00950599|559196945|FG004|Follow-Up Period|Subject withdrew Consent|0|||
154937366|NCT00950599|559196946|FG005|Follow-Up Period|Subject withdrew Consent|0|||
154937367|NCT00950599|559196947|FG006|Follow-Up Period|Subject withdrew Consent|0|||
154937368|NCT00950599|559196948|FG007|Follow-Up Period|Subject withdrew Consent|0|||
155277197|NCT01024751|560447654|FG000|Enrolled Participants|Ineligible at baseline|3|||
154937369|NCT00950599|559196949|FG008|Follow-Up Period|Subject withdrew Consent|2|||
154937370|NCT00950599|559196950|FG009|Follow-Up Period|Subject withdrew Consent|1|||
154937371|NCT01361607|559196953|FG000|Overall Study|Adverse Event|38|||
154937372|NCT01361607|559196954|FG001|Overall Study|Adverse Event|29|||
154937373|NCT01361607|559196953|FG000|Overall Study|Withdrawal by Subject|19|||
154937374|NCT01361607|559196954|FG001|Overall Study|Withdrawal by Subject|8|||
154937375|NCT01361607|559196953|FG000|Overall Study|Withdrawal by Investigator|5|||
154937376|NCT01361607|559196954|FG001|Overall Study|Withdrawal by Investigator|3|||
154937377|NCT01361607|559196953|FG000|Overall Study|Lost to Follow-up|1|||
154937378|NCT01361607|559196954|FG001|Overall Study|Lost to Follow-up|0|||
154937379|NCT01361607|559196953|FG000|Overall Study|Met Withdrawal Criteria|1|||
154937380|NCT01361607|559196954|FG001|Overall Study|Met Withdrawal Criteria|1|||
154937381|NCT01507831|559196955|FG000|Overall Study|Randomized but not treated|0|||
154937382|NCT01507831|559196956|FG001|Overall Study|Randomized but not treated|3|||
154937383|NCT01507831|559196955|FG000|Overall Study|Adverse Event|48|||
154937384|NCT01507831|559196956|FG001|Overall Study|Adverse Event|113|||
154937385|NCT01507831|559196955|FG000|Overall Study|Death|6|||
154937386|NCT01507831|559196956|FG001|Overall Study|Death|2|||
154937387|NCT01507831|559196955|FG000|Overall Study|Poor compliance to protocol|38|||
154937388|NCT01507831|559196956|FG001|Overall Study|Poor compliance to protocol|60|||
154937389|NCT01507831|559196955|FG000|Overall Study|Physician Decision|0|||
154937390|NCT01507831|559196956|FG001|Overall Study|Physician Decision|4|||
154937391|NCT01507831|559196955|FG000|Overall Study|Participant moved|5|||
154937392|NCT01507831|559196956|FG001|Overall Study|Participant moved|19|||
154937393|NCT01507831|559196955|FG000|Overall Study|Consent withdrawn by participant|34|||
154937394|NCT01507831|559196956|FG001|Overall Study|Consent withdrawn by participant|72|||
154937395|NCT01507831|559196955|FG000|Overall Study|Related to study drug administration|5|||
154937396|NCT01507831|559196956|FG001|Overall Study|Related to study drug administration|14|||
154937397|NCT01507831|559196955|FG000|Overall Study|Last visit outside protocol visit window|51|||
154937398|NCT01507831|559196956|FG001|Overall Study|Last visit outside protocol visit window|143|||
154937399|NCT01507831|559196955|FG000|Overall Study|Selection criteria finally not met|0|||
154937400|NCT01507831|559196956|FG001|Overall Study|Selection criteria finally not met|1|||
154937401|NCT01507831|559196955|FG000|Overall Study|Site closure|0|||
154937402|NCT01507831|559196956|FG001|Overall Study|Site closure|3|||
154937403|NCT01507831|559196955|FG000|Overall Study|Potential lost to follow-up|3|||
154937404|NCT01507831|559196956|FG001|Overall Study|Potential lost to follow-up|0|||
154937405|NCT01507831|559196955|FG000|Overall Study|Other|3|||
154937406|NCT01507831|559196956|FG001|Overall Study|Other|6|||
154937407|NCT01280981|559196957|FG000|Overall Study|Withdrawal by Subject|11|||
154937408|NCT01280981|559196957|FG000|Overall Study|Protocol Violation|2|||
154937409|NCT01280981|559196957|FG000|Overall Study|Lack of Efficacy|13|||
154937410|NCT01280981|559196957|FG000|Overall Study|Lost to Follow-up|3|||
154937411|NCT01280981|559196957|FG000|Overall Study|Adverse Event|6|||
154937412|NCT01280981|559196957|FG000|Overall Study|Irregular or discontinued menses|3|||
154937413|NCT01280981|559196957|FG000|Overall Study|Failed to return|45|||
154937414|NCT01280981|559196957|FG000|Overall Study|Non-compliance with protocol|3|||
154937415|NCT01280981|559196957|FG000|Overall Study|Withdrawal of consent|3|||
154937416|NCT01280981|559196957|FG000|Overall Study|Elective surgery|2|||
154937417|NCT01280981|559196957|FG000|Overall Study|Study site closure|1|||
154937418|NCT05037409|559196962|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
154937419|NCT05037409|559196963|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
154937420|NCT05037409|559196964|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
154937421|NCT03499249|559196965|FG000|Overall Study|Physician Decision|1|||
154937422|NCT00343642|559198326|FG000|Overall Study|Lost to Follow-up|0|||
154937423|NCT00343642|559198327|FG001|Overall Study|Lost to Follow-up|1|||
154937424|NCT00343642|559198328|FG002|Overall Study|Lost to Follow-up|0|||
154937425|NCT00343642|559198326|FG000|Overall Study|Pregnancy|1|||
154937426|NCT00343642|559198327|FG001|Overall Study|Pregnancy|0|||
154937427|NCT00343642|559198328|FG002|Overall Study|Pregnancy|2|||
154937428|NCT00343642|559198326|FG000|Overall Study|Withdrawal by Subject|2|||
154937429|NCT00343642|559198327|FG001|Overall Study|Withdrawal by Subject|3|||
154937430|NCT00343642|559198328|FG002|Overall Study|Withdrawal by Subject|4|||
154937431|NCT00343642|559198326|FG000|Overall Study|Adverse Event|0|||
154937432|NCT00343642|559198327|FG001|Overall Study|Adverse Event|0|||
154937433|NCT00343642|559198328|FG002|Overall Study|Adverse Event|1|||
154937434|NCT00343642|559198326|FG000|Overall Study|Flare up|6|||
154937435|NCT00343642|559198327|FG001|Overall Study|Flare up|4|||
154937436|NCT00343642|559198328|FG002|Overall Study|Flare up|0|||
154937437|NCT01963676|559198329|FG000|Overall Study|Withdrawal by Subject|1|||
154937438|NCT01963676|559198330|FG001|Overall Study|Withdrawal by Subject|0|||
154937439|NCT00766506|559198331|FG000|Overall Study|Use rescue medication after 3 hours|3|||
154937440|NCT00766506|559198332|FG001|Overall Study|Use rescue medication after 3 hours|0|||
154937441|NCT00766506|559198331|FG000|Overall Study|Other|2|||
154937442|NCT00766506|559198332|FG001|Overall Study|Other|2|||
154937443|NCT02595528|559198333|FG000|Overall Study|Withdrawal by Subject|1|||
154937444|NCT02595528|559198334|FG001|Overall Study|Withdrawal by Subject|2|||
154937445|NCT02595528|559198335|FG002|Overall Study|Withdrawal by Subject|1|||
154937446|NCT02595528|559198336|FG003|Overall Study|Withdrawal by Subject|3|||
154937447|NCT02595528|559198333|FG000|Overall Study|Lost to Follow-up|1|||
154937448|NCT02595528|559198334|FG001|Overall Study|Lost to Follow-up|1|||
154937449|NCT02595528|559198335|FG002|Overall Study|Lost to Follow-up|0|||
154937450|NCT02595528|559198336|FG003|Overall Study|Lost to Follow-up|1|||
154937451|NCT03202511|559198337|FG000|Overall Study|Withdrawal by Subject|1|||
154937452|NCT03202511|559198338|FG001|Overall Study|Withdrawal by Subject|0|||
154937453|NCT02736227|559198343|FG000|Overall Study|Withdrawal by Subject|0|||
154937454|NCT02736227|559198344|FG001|Overall Study|Withdrawal by Subject|0|||
154937455|NCT02736227|559198345|FG002|Overall Study|Withdrawal by Subject|1|||
154937456|NCT02736227|559198343|FG000|Overall Study|Physician Decision|0|||
154937457|NCT02736227|559198344|FG001|Overall Study|Physician Decision|0|||
154937458|NCT02736227|559198345|FG002|Overall Study|Physician Decision|5|||
154937459|NCT02736227|559198343|FG000|Overall Study|Non Compliant|0|||
154937460|NCT02736227|559198344|FG001|Overall Study|Non Compliant|0|||
154937461|NCT02736227|559198345|FG002|Overall Study|Non Compliant|2|||
154937462|NCT03870997|559198346|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
154937463|NCT03870997|559198347|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
154937464|NCT03870997|559198348|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
154937465|NCT03870997|559198349|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
154937466|NCT03870997|559198350|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
154937467|NCT03870997|559198351|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
154937468|NCT00986154|559198352|FG000|Overall Study|Death|136|||
154937469|NCT00986154|559198353|FG001|Overall Study|Death|127|||
154937470|NCT00986154|559198352|FG000|Overall Study|Lost to Follow-up|7|||
154937471|NCT00986154|559198353|FG001|Overall Study|Lost to Follow-up|4|||
154937472|NCT00986154|559198352|FG000|Overall Study|Withdrawal by Subject|32|||
154937473|NCT00986154|559198353|FG001|Overall Study|Withdrawal by Subject|33|||
154937474|NCT00986154|559198352|FG000|Overall Study|investigator/subject decide not continue|6|||
154937475|NCT00986154|559198353|FG001|Overall Study|investigator/subject decide not continue|3|||
154937476|NCT00986154|559198352|FG000|Overall Study|never received study drug|25|||
154937477|NCT00986154|559198353|FG001|Overall Study|never received study drug|27|||
154937478|NCT03840135|559198354|FG000|Overall Study|Protocol Violation|6|||
154937479|NCT03840135|559198355|FG001|Overall Study|Protocol Violation|1|||
154937480|NCT03840135|559198354|FG000|Overall Study|Withdrawal by Subject|1|||
154937481|NCT03840135|559198355|FG001|Overall Study|Withdrawal by Subject|0|||
154937482|NCT02741271|559198361|FG000|Overall Study|Lost to Follow-up|2|||
154937483|NCT02741271|559198362|FG001|Overall Study|Lost to Follow-up|0|||
154937484|NCT02741271|559198361|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154937485|NCT02741271|559198362|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
154937486|NCT02570165|559198363|FG000|Overall Study|Adverse Event|1|||
154937487|NCT02570165|559198364|FG001|Overall Study|Adverse Event|0|||
154937488|NCT02570165|559198365|FG002|Overall Study|Adverse Event|2|||
154937489|NCT02570165|559198366|FG003|Overall Study|Adverse Event|0|||
154937490|NCT02570165|559198367|FG004|Overall Study|Adverse Event|0|||
154937491|NCT02570165|559198368|FG005|Overall Study|Adverse Event|0|||
154937492|NCT02570165|559198369|FG006|Overall Study|Adverse Event|0|||
154937493|NCT02570165|559198363|FG000|Overall Study|Lack of Efficacy|0|||
154937494|NCT02570165|559198364|FG001|Overall Study|Lack of Efficacy|1|||
154937495|NCT02570165|559198365|FG002|Overall Study|Lack of Efficacy|0|||
154937496|NCT02570165|559198366|FG003|Overall Study|Lack of Efficacy|0|||
154937497|NCT02570165|559198367|FG004|Overall Study|Lack of Efficacy|4|||
154937498|NCT02570165|559198368|FG005|Overall Study|Lack of Efficacy|0|||
154937499|NCT02570165|559198369|FG006|Overall Study|Lack of Efficacy|0|||
154937500|NCT02570165|559198363|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
154937501|NCT02570165|559198364|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
154937502|NCT02570165|559198365|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
154937503|NCT02570165|559198366|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
154937504|NCT02570165|559198367|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
154937505|NCT02570165|559198368|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
154937506|NCT02570165|559198369|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
154937507|NCT02570165|559198363|FG000|Overall Study|Lost to Follow-up|0|||
154937508|NCT02570165|559198364|FG001|Overall Study|Lost to Follow-up|0|||
154937509|NCT02570165|559198365|FG002|Overall Study|Lost to Follow-up|1|||
154937510|NCT02570165|559198366|FG003|Overall Study|Lost to Follow-up|1|||
154937511|NCT02570165|559198367|FG004|Overall Study|Lost to Follow-up|0|||
154937512|NCT02570165|559198368|FG005|Overall Study|Lost to Follow-up|0|||
154937513|NCT02570165|559198369|FG006|Overall Study|Lost to Follow-up|0|||
154937514|NCT02570165|559198363|FG000|Overall Study|Physician Decision|0|||
154937515|NCT02570165|559198364|FG001|Overall Study|Physician Decision|1|||
154937516|NCT02570165|559198365|FG002|Overall Study|Physician Decision|0|||
154937517|NCT02570165|559198366|FG003|Overall Study|Physician Decision|0|||
154937518|NCT02570165|559198367|FG004|Overall Study|Physician Decision|0|||
154937519|NCT02570165|559198368|FG005|Overall Study|Physician Decision|0|||
154937520|NCT02570165|559198369|FG006|Overall Study|Physician Decision|0|||
154937521|NCT02570165|559198363|FG000|Overall Study|Withdrawal by Subject|0|||
154937522|NCT02570165|559198364|FG001|Overall Study|Withdrawal by Subject|0|||
154937523|NCT02570165|559198365|FG002|Overall Study|Withdrawal by Subject|0|||
154937524|NCT02570165|559198366|FG003|Overall Study|Withdrawal by Subject|2|||
154937525|NCT02570165|559198367|FG004|Overall Study|Withdrawal by Subject|1|||
154937526|NCT02570165|559198368|FG005|Overall Study|Withdrawal by Subject|0|||
154937527|NCT02570165|559198369|FG006|Overall Study|Withdrawal by Subject|0|||
154937528|NCT02570165|559198363|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
154937529|NCT02570165|559198364|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
154937530|NCT02570165|559198365|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
154937531|NCT02570165|559198366|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
154937532|NCT02570165|559198367|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
154937533|NCT02570165|559198368|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
154937534|NCT02570165|559198369|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
154937535|NCT02570165|559198363|FG000|Overall Study|Withdrawal Request by GSK|0|||
154937536|NCT02570165|559198364|FG001|Overall Study|Withdrawal Request by GSK|0|||
154937537|NCT02570165|559198365|FG002|Overall Study|Withdrawal Request by GSK|2|||
154937538|NCT02570165|559198366|FG003|Overall Study|Withdrawal Request by GSK|0|||
154937539|NCT02570165|559198367|FG004|Overall Study|Withdrawal Request by GSK|0|||
154937540|NCT02570165|559198368|FG005|Overall Study|Withdrawal Request by GSK|0|||
154937541|NCT02570165|559198369|FG006|Overall Study|Withdrawal Request by GSK|0|||
154937542|NCT01252238|559198374|FG000|Overall Study|Sponsor terminated study|4|||
154937543|NCT01252238|559198375|FG001|Overall Study|Sponsor terminated study|4|||
154937544|NCT01252238|559198376|FG002|Overall Study|Sponsor terminated study|4|||
154937545|NCT01610167|559198377|FG000|Overall Study|Scheduling conflict.|0|||
154937546|NCT01610167|559198378|FG001|Overall Study|Scheduling conflict.|0|||
154937547|NCT01610167|559198379|FG002|Overall Study|Scheduling conflict.|2|||
154937548|NCT03276962|559198385|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
154937549|NCT03276962|559198386|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
154937550|NCT03276962|559198387|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
154937551|NCT03276962|559198388|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
154937552|NCT03276962|559198389|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
154937553|NCT03276962|559198385|FG000|Overall Study|Protocol Deviation|2|||
154937554|NCT03276962|559198386|FG001|Overall Study|Protocol Deviation|0|||
154937555|NCT03276962|559198387|FG002|Overall Study|Protocol Deviation|1|||
154937556|NCT03276962|559198388|FG003|Overall Study|Protocol Deviation|2|||
154937557|NCT03276962|559198389|FG004|Overall Study|Protocol Deviation|1|||
154937558|NCT03276962|559198385|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
154937559|NCT03276962|559198386|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
154937560|NCT03276962|559198387|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
154937561|NCT03276962|559198388|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
154937562|NCT03276962|559198389|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
154937563|NCT03276962|559198385|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
154937564|NCT03276962|559198386|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
154937565|NCT03276962|559198387|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
154937566|NCT03276962|559198388|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
154937567|NCT03276962|559198389|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
154937568|NCT03276962|559198385|FG000|Overall Study|Lost to Follow-up|10|||
154937569|NCT03276962|559198386|FG001|Overall Study|Lost to Follow-up|10|||
154937570|NCT03276962|559198387|FG002|Overall Study|Lost to Follow-up|4|||
154937571|NCT03276962|559198388|FG003|Overall Study|Lost to Follow-up|6|||
154937572|NCT03276962|559198389|FG004|Overall Study|Lost to Follow-up|10|||
154937573|NCT03276962|559198385|FG000|Overall Study|Other|0|||
154937574|NCT03276962|559198386|FG001|Overall Study|Other|2|||
154937575|NCT03276962|559198387|FG002|Overall Study|Other|0|||
154937576|NCT03276962|559198388|FG003|Overall Study|Other|2|||
154937577|NCT03276962|559198389|FG004|Overall Study|Other|1|||
154937578|NCT00411762|559198390|FG000|Overall Study|Withdrawal by Subject|5|||
154937579|NCT04428502|559198391|FG000|Overall Study|Did not meet entrance criteria|14|||
154937580|NCT01358708|559198392|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
154937581|NCT01358708|559198393|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154937582|NCT01358708|559198392|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
154937583|NCT01358708|559198393|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
154937584|NCT01364298|559198397|FG000|Overall Study|Adverse Event|3|||
154937585|NCT01364298|559198398|FG001|Overall Study|Adverse Event|4|||
154937586|NCT01364298|559198397|FG000|Overall Study|Lack of adherence to treatment|1|||
154937587|NCT01364298|559198398|FG001|Overall Study|Lack of adherence to treatment|3|||
154937588|NCT01364298|559198397|FG000|Overall Study|Lack of Efficacy|1|||
154937589|NCT01364298|559198398|FG001|Overall Study|Lack of Efficacy|0|||
154937590|NCT01364298|559198397|FG000|Overall Study|Lost to Follow-up|5|||
154937591|NCT01364298|559198398|FG001|Overall Study|Lost to Follow-up|10|||
154937592|NCT01364298|559198397|FG000|Overall Study|Withdrawal by Subject|3|||
154937593|NCT01364298|559198398|FG001|Overall Study|Withdrawal by Subject|3|||
154937594|NCT01364298|559198397|FG000|Overall Study|Other|1|||
154937595|NCT01364298|559198398|FG001|Overall Study|Other|3|||
155043458|NCT01826981|559590134|FG012|Overall Study|Withdrew Consent|0|||
154937596|NCT03712228|559198399|FG000|Treatment Period 1|Lack of Efficacy|0|||
154937597|NCT03712228|559198400|FG001|Treatment Period 1|Lack of Efficacy|0|||
154937598|NCT03712228|559198401|FG002|Treatment Period 1|Lack of Efficacy|0|||
154937599|NCT03712228|559198402|FG003|Treatment Period 1|Lack of Efficacy|0|||
154937600|NCT03712228|559198403|FG004|Treatment Period 1|Lack of Efficacy|0|||
154937601|NCT03712228|559198404|FG005|Treatment Period 1|Lack of Efficacy|1|||
154937602|NCT03712228|559198399|FG000|Treatment Period 2|Pregnancy|0|||
154937603|NCT03712228|559198400|FG001|Treatment Period 2|Pregnancy|0|||
154937604|NCT03712228|559198401|FG002|Treatment Period 2|Pregnancy|0|||
154937605|NCT03712228|559198402|FG003|Treatment Period 2|Pregnancy|1|||
154937606|NCT03712228|559198403|FG004|Treatment Period 2|Pregnancy|0|||
154937607|NCT03712228|559198404|FG005|Treatment Period 2|Pregnancy|0|||
154937608|NCT03712228|559198399|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154937609|NCT03712228|559198400|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154937610|NCT03712228|559198401|FG002|Treatment Period 2|Withdrawal by Subject|0|||
154937611|NCT03712228|559198402|FG003|Treatment Period 2|Withdrawal by Subject|1|||
154937612|NCT03712228|559198403|FG004|Treatment Period 2|Withdrawal by Subject|0|||
154937613|NCT03712228|559198404|FG005|Treatment Period 2|Withdrawal by Subject|0|||
154937614|NCT01964105|559198405|FG000|Overall Study|Lost to Follow-up|2|||
154937615|NCT01964105|559198406|FG001|Overall Study|Lost to Follow-up|13|||
154937616|NCT01964105|559198407|FG002|Overall Study|Lost to Follow-up|0|||
154937617|NCT02295280|559198409|FG000|Overall Study|Adverse Event|0|||
154937618|NCT02295280|559198410|FG001|Overall Study|Adverse Event|1|||
154937619|NCT02875067|559198411|FG000|Overall Study|Withdrawal by Subject|1|||
154937620|NCT02875067|559198411|FG000|Overall Study|Withdrawal by Termination of Study|5|||
154937621|NCT01430104|559198412|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
154937622|NCT02713243|559198414|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
154937623|NCT02713243|559198415|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
154937624|NCT02713243|559198414|FG000|Overall Study|Administrative problems|0|||
154937625|NCT02713243|559198415|FG001|Overall Study|Administrative problems|1|||
154937626|NCT02713243|559198414|FG000|Overall Study|Protocol deviation|0|||
154937627|NCT02713243|559198415|FG001|Overall Study|Protocol deviation|1|||
154937628|NCT03056352|559198416|FG000|Overall Study|Lost to Follow-up|1|||
154937629|NCT02971605|559198417|FG000|Overall Study|Withdrawal by Subject|1|||
154937630|NCT03439293|559198418|FG000|Overall Study|Death|22|||
154937631|NCT03439293|559198418|FG000|Overall Study|Withdrawal by Subject|8|||
154937632|NCT03439293|559198418|FG000|Overall Study|Lost to Follow-up|2|||
154937633|NCT03439293|559198418|FG000|Overall Study|Reason Not Specified|28|||
154937634|NCT03439293|559198418|FG000|Overall Study|Missing|1|||
154937635|NCT00869089|559198424|FG000|Overall Study|Lost to Follow-up|1|||
154937636|NCT00869089|559198424|FG000|Overall Study|Withdrawal by Subject|1|||
154937637|NCT00869089|559198424|FG000|Overall Study|Screen Fail|1|||
154937638|NCT02475980|559198428|FG000|Overall Study|Lost to Follow-up|4|||
154937639|NCT02475980|559198428|FG000|Overall Study|Withdrawal by Subject|1|||
154937640|NCT05003167|559198436|FG000|Overall Study|Withdrawal by Subject|1|||
154937641|NCT00430638|559198437|FG000|Overall Study|Adverse Event|15|||
154937642|NCT00430638|559198438|FG001|Overall Study|Adverse Event|15|||
154937643|NCT00430638|559198437|FG000|Overall Study|Uncontrolled blood pressure|48|||
154937644|NCT00430638|559198438|FG001|Overall Study|Uncontrolled blood pressure|13|||
154937645|NCT00430638|559198437|FG000|Overall Study|Lost to Follow-up|1|||
154937646|NCT00430638|559198438|FG001|Overall Study|Lost to Follow-up|7|||
154937647|NCT00430638|559198437|FG000|Overall Study|Protocol Violation|6|||
154937648|NCT00430638|559198438|FG001|Overall Study|Protocol Violation|4|||
154937649|NCT00430638|559198437|FG000|Overall Study|Withdrawal by Subject|4|||
154937650|NCT00430638|559198438|FG001|Overall Study|Withdrawal by Subject|6|||
154937651|NCT00430638|559198437|FG000|Overall Study|Non-compliant|2|||
154937652|NCT00430638|559198438|FG001|Overall Study|Non-compliant|1|||
154937653|NCT00430638|559198437|FG000|Overall Study|Other|2|||
154937654|NCT00430638|559198438|FG001|Overall Study|Other|2|||
154937655|NCT01529749|559198439|FG000|Overall Study|Lost to Follow-up|0|||
154937656|NCT01529749|559198440|FG001|Overall Study|Lost to Follow-up|1|||
155043459|NCT01826981|559590135|FG013|Overall Study|Withdrew Consent|1|||
155043460|NCT01826981|559590136|FG014|Overall Study|Withdrew Consent|0|||
154937657|NCT01529749|559198441|FG002|Overall Study|Lost to Follow-up|1|||
154937658|NCT01529749|559198442|FG003|Overall Study|Lost to Follow-up|0|||
154937659|NCT01529749|559198439|FG000|Overall Study|Physician Decision|0|||
154937660|NCT01529749|559198440|FG001|Overall Study|Physician Decision|0|||
154937661|NCT01529749|559198441|FG002|Overall Study|Physician Decision|0|||
154937662|NCT01529749|559198442|FG003|Overall Study|Physician Decision|1|||
154937663|NCT01529749|559198439|FG000|Overall Study|Withdrawal by Subject|0|||
154937664|NCT01529749|559198440|FG001|Overall Study|Withdrawal by Subject|1|||
154937665|NCT01529749|559198441|FG002|Overall Study|Withdrawal by Subject|1|||
154937666|NCT01529749|559198442|FG003|Overall Study|Withdrawal by Subject|0|||
154937667|NCT01529749|559198439|FG000|Overall Study|Protocol Violation|0|||
154937668|NCT01529749|559198440|FG001|Overall Study|Protocol Violation|0|||
154937669|NCT01529749|559198441|FG002|Overall Study|Protocol Violation|0|||
154937670|NCT01529749|559198442|FG003|Overall Study|Protocol Violation|1|||
154937671|NCT02094937|559198443|FG000|8 Weeks in Period 1|Adverse Event|9|||
155043461|NCT01826981|559590122|FG000|Overall Study|Adverse Event|0|||
154937672|NCT02094937|559198444|FG001|8 Weeks in Period 1|Adverse Event|0|||
154937673|NCT02094937|559198445|FG002|8 Weeks in Period 1|Adverse Event|0|||
154937674|NCT02094937|559198446|FG003|8 Weeks in Period 1|Adverse Event|0|||
154937675|NCT02094937|559198443|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
154937676|NCT02094937|559198444|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
154937677|NCT02094937|559198445|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
154937678|NCT02094937|559198446|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
154937679|NCT02094937|559198443|FG000|8 Weeks in Period 1|Protocol Violation|2|||
154937680|NCT02094937|559198444|FG001|8 Weeks in Period 1|Protocol Violation|0|||
154937681|NCT02094937|559198445|FG002|8 Weeks in Period 1|Protocol Violation|0|||
154937682|NCT02094937|559198446|FG003|8 Weeks in Period 1|Protocol Violation|0|||
154937683|NCT02094937|559198443|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
154937684|NCT02094937|559198444|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
154937685|NCT02094937|559198445|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
154937686|NCT02094937|559198446|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
154937687|NCT02094937|559198443|FG000|8 Weeks in Period 1|Physician Decision|1|||
154937688|NCT02094937|559198444|FG001|8 Weeks in Period 1|Physician Decision|0|||
154937689|NCT02094937|559198445|FG002|8 Weeks in Period 1|Physician Decision|0|||
154937690|NCT02094937|559198446|FG003|8 Weeks in Period 1|Physician Decision|0|||
154937691|NCT02094937|559198443|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
154937692|NCT02094937|559198444|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
154937693|NCT02094937|559198445|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
154937694|NCT02094937|559198446|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
154937695|NCT02094937|559198443|FG000|12 Weeks in Period 2|Adverse Event|0|||
154937696|NCT02094937|559198444|FG001|12 Weeks in Period 2|Adverse Event|2|||
154937697|NCT02094937|559198445|FG002|12 Weeks in Period 2|Adverse Event|4|||
154937698|NCT02094937|559198446|FG003|12 Weeks in Period 2|Adverse Event|1|||
154937699|NCT02094937|559198443|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
154937700|NCT02094937|559198444|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
154937701|NCT02094937|559198445|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
154937702|NCT02094937|559198446|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
154937703|NCT02094937|559198443|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
154937704|NCT02094937|559198444|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
154937705|NCT02094937|559198445|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
154937706|NCT02094937|559198446|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
154937707|NCT02094937|559198443|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
154937708|NCT02094937|559198444|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
154937709|NCT02094937|559198445|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
154937710|NCT02094937|559198446|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
154937711|NCT02094937|559198443|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
154937712|NCT02094937|559198444|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
154937713|NCT02094937|559198445|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
154937714|NCT02094937|559198446|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
154937715|NCT01133392|559198447|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
154937716|NCT01133392|559198448|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
154937717|NCT01133392|559198447|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
154937718|NCT01133392|559198448|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
154937719|NCT00378482|559198449|FG000|Overall Study|Lost to Follow-up|1|||
154937720|NCT00378482|559198449|FG000|Overall Study|Lack of Efficacy|8|||
154937721|NCT00378482|559198449|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
154937722|NCT00378482|559198449|FG000|Overall Study|Withdrawal by Subject|4|||
154937723|NCT00378482|559198449|FG000|Overall Study|Adverse Event|9|||
154937724|NCT03185949|559198450|FG000|ITT Analysis|Withdrawal by Subject|4|||
154937725|NCT03185949|559198451|FG001|ITT Analysis|Withdrawal by Subject|3|||
154937726|NCT03185949|559198450|FG000|PP Analysis|Protocol Violation|2|||
154937727|NCT03185949|559198451|FG001|PP Analysis|Protocol Violation|2|||
154937728|NCT03185949|559198450|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
154937729|NCT03185949|559198451|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
154937730|NCT00555399|559198457|FG000|Overall Study|Withdrawal by Subject|0|||
154937731|NCT00555399|559198458|FG001|Overall Study|Withdrawal by Subject|0|||
154937732|NCT00555399|559198459|FG002|Overall Study|Withdrawal by Subject|1|||
154937733|NCT00555399|559198460|FG003|Overall Study|Withdrawal by Subject|0|||
154937734|NCT00555399|559198461|FG004|Overall Study|Withdrawal by Subject|0|||
154937735|NCT00555399|559198462|FG005|Overall Study|Withdrawal by Subject|0|||
154937736|NCT00555399|559198463|FG006|Overall Study|Withdrawal by Subject|0|||
154937737|NCT00555399|559198464|FG007|Overall Study|Withdrawal by Subject|0|||
154937738|NCT00555399|559198465|FG008|Overall Study|Withdrawal by Subject|0|||
154937739|NCT00555399|559198466|FG009|Overall Study|Withdrawal by Subject|0|||
154937740|NCT00555399|559198467|FG010|Overall Study|Withdrawal by Subject|0|||
154937741|NCT00555399|559198468|FG011|Overall Study|Withdrawal by Subject|1|||
154937742|NCT00555399|559198457|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
154937743|NCT00555399|559198458|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
154937744|NCT00555399|559198459|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
154937745|NCT00555399|559198460|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
154937746|NCT00555399|559198461|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
154937747|NCT00555399|559198462|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
154937748|NCT00555399|559198463|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
154937749|NCT00555399|559198464|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
154937750|NCT00555399|559198465|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
154937751|NCT00555399|559198466|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
154937752|NCT00555399|559198467|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
154937753|NCT00555399|559198468|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
154937754|NCT04639310|559198469|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
154937755|NCT04639310|559198470|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
154937756|NCT00860574|559199990|FG000|Overall Study|Death|2|||
154937757|NCT00860574|559199990|FG000|Overall Study|Relapse|1|||
154937758|NCT02496221|559199991|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
154937759|NCT02496221|559199992|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
154937760|NCT02496221|559199991|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
154937761|NCT02496221|559199992|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
154937762|NCT02496221|559199991|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
154937763|NCT02496221|559199992|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
154937764|NCT01335399|559199993|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
154937765|NCT01335399|559199994|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
154937766|NCT01335399|559199993|FG000|Pre-treatment Period|Participant request to discontinue|0|||
154937767|NCT01335399|559199994|FG001|Pre-treatment Period|Participant request to discontinue|1|||
154937768|NCT01335399|559199993|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
154937769|NCT01335399|559199994|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
154937770|NCT01335399|559199993|FG000|Pre-treatment Period|Consent withdrawal|3|||
154937771|NCT01335399|559199994|FG001|Pre-treatment Period|Consent withdrawal|0|||
154937772|NCT01335399|559199993|FG000|Treatment Period|Disease progression|117|||
154937773|NCT01335399|559199994|FG001|Treatment Period|Disease progression|145|||
154937774|NCT01335399|559199993|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
154937775|NCT01335399|559199994|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
154937776|NCT01335399|559199993|FG000|Treatment Period|Study drug toxicity|52|||
154937777|NCT01335399|559199994|FG001|Treatment Period|Study drug toxicity|64|||
154937778|NCT01335399|559199993|FG000|Treatment Period|Participant request to discontinue|30|||
154937779|NCT01335399|559199994|FG001|Treatment Period|Participant request to discontinue|22|||
154937780|NCT01335399|559199993|FG000|Treatment Period|Other reasons|30|||
154937781|NCT01335399|559199994|FG001|Treatment Period|Other reasons|30|||
154937782|NCT01335399|559199993|FG000|Treatment Period|Consent withdrawal|10|||
154937783|NCT01335399|559199994|FG001|Treatment Period|Consent withdrawal|7|||
154937784|NCT01335399|559199993|FG000|Treatment Period|Death|7|||
154937785|NCT01335399|559199994|FG001|Treatment Period|Death|6|||
154937786|NCT01335399|559199993|FG000|Treatment Period|Poor/Non-compliance|3|||
154937787|NCT01335399|559199994|FG001|Treatment Period|Poor/Non-compliance|4|||
154937788|NCT01335399|559199993|FG000|Treatment Period|Lost to Follow-up|2|||
154937789|NCT01335399|559199994|FG001|Treatment Period|Lost to Follow-up|2|||
154937790|NCT01335399|559199993|FG000|Treatment Period|Maximum clinical benefit|1|||
154937791|NCT01335399|559199994|FG001|Treatment Period|Maximum clinical benefit|1|||
154937792|NCT01335399|559199993|FG000|Treatment Period|No longer meet study criteria|1|||
154937793|NCT01335399|559199994|FG001|Treatment Period|No longer meet study criteria|1|||
154937794|NCT01335399|559199993|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
154937795|NCT01335399|559199994|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
154937796|NCT01120600|559199995|FG000|Overall Study|Adverse Event|7|||
154937797|NCT01120600|559199996|FG001|Overall Study|Adverse Event|7|||
154937798|NCT01120600|559199995|FG000|Overall Study|Excessive Bone Loss|0|||
154937799|NCT01120600|559199996|FG001|Overall Study|Excessive Bone Loss|4|||
154937800|NCT01120600|559199995|FG000|Overall Study|Lost to Follow-up|1|||
154937801|NCT01120600|559199996|FG001|Overall Study|Lost to Follow-up|3|||
154937802|NCT01120600|559199995|FG000|Overall Study|Physician Decision|1|||
154937803|NCT01120600|559199996|FG001|Overall Study|Physician Decision|3|||
154937804|NCT01120600|559199995|FG000|Overall Study|Protocol Violation|0|||
154937805|NCT01120600|559199996|FG001|Overall Study|Protocol Violation|4|||
154937806|NCT01120600|559199995|FG000|Overall Study|Withdrawal by Subject|10|||
154937807|NCT01120600|559199996|FG001|Overall Study|Withdrawal by Subject|11|||
154937808|NCT03877237|559199999|FG000|Overall Study|Adverse Event|1|||
154937809|NCT03877237|559200000|FG001|Overall Study|Adverse Event|2|||
154937810|NCT03877237|559199999|FG000|Overall Study|Death|3|||
154937811|NCT03877237|559200000|FG001|Overall Study|Death|2|||
154937812|NCT03877237|559199999|FG000|Overall Study|Physician Decision|1|||
154937813|NCT03877237|559200000|FG001|Overall Study|Physician Decision|0|||
154937814|NCT03877237|559199999|FG000|Overall Study|Withdrawal by Subject|0|||
154937815|NCT03877237|559200000|FG001|Overall Study|Withdrawal by Subject|2|||
154937816|NCT00566098|559200002|FG000|Collection of MILs|Withdrawal by Subject|1|||
154937817|NCT00566098|559200002|FG000|Collection of MILs|Relapsed|1|||
154937818|NCT00566098|559200002|FG000|Generation of MILs Product|Relapsed|1|||
154937819|NCT00566098|559200002|FG000|Administration of ASCT+MILs|Death|10|||
154937820|NCT00566098|559200002|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
154937821|NCT01690520|559200003|FG000|Overall Study|Death|25|||
154937822|NCT01690520|559200004|FG001|Overall Study|Death|21|||
154937823|NCT01690520|559200003|FG000|Overall Study|Lost to Follow-up|2|||
154937824|NCT01690520|559200004|FG001|Overall Study|Lost to Follow-up|3|||
154937825|NCT01690520|559200003|FG000|Overall Study|Withdrawal by Subject|2|||
154937826|NCT01690520|559200004|FG001|Overall Study|Withdrawal by Subject|0|||
154937827|NCT01690520|559200003|FG000|Overall Study|Relapse|0|||
154937828|NCT01690520|559200004|FG001|Overall Study|Relapse|1|||
154937829|NCT01690520|559200003|FG000|Overall Study|Other|0|||
154937830|NCT01690520|559200004|FG001|Overall Study|Other|1|||
154937831|NCT01690520|559200003|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
154937832|NCT01690520|559200004|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
154937833|NCT02236754|559200005|FG000|Overall Study|Withdrawal by Subject|1|||
154937834|NCT02236754|559200006|FG001|Overall Study|Withdrawal by Subject|0|||
154937835|NCT01270841|559200007|FG000|Overall Study|Adverse Event|0|||
154937836|NCT01270841|559200008|FG001|Overall Study|Adverse Event|1|||
154937837|NCT01270841|559200009|FG002|Overall Study|Adverse Event|0|||
154937838|NCT01270841|559200010|FG003|Overall Study|Adverse Event|3|||
154937839|NCT01270841|559200007|FG000|Overall Study|Withdrawal by Subject|3|||
154937840|NCT01270841|559200008|FG001|Overall Study|Withdrawal by Subject|2|||
154937841|NCT01270841|559200009|FG002|Overall Study|Withdrawal by Subject|3|||
154937842|NCT01270841|559200010|FG003|Overall Study|Withdrawal by Subject|3|||
154937843|NCT01270841|559200007|FG000|Overall Study|Lost to Follow-up|3|||
154937844|NCT01270841|559200008|FG001|Overall Study|Lost to Follow-up|1|||
154937845|NCT01270841|559200009|FG002|Overall Study|Lost to Follow-up|4|||
154937846|NCT01270841|559200010|FG003|Overall Study|Lost to Follow-up|2|||
154937847|NCT01270841|559200007|FG000|Overall Study|Physician Decision|0|||
154937848|NCT01270841|559200008|FG001|Overall Study|Physician Decision|1|||
154937849|NCT01270841|559200009|FG002|Overall Study|Physician Decision|0|||
154937850|NCT01270841|559200010|FG003|Overall Study|Physician Decision|0|||
154937851|NCT01270841|559200007|FG000|Overall Study|Did not qualify|6|||
154937852|NCT01270841|559200008|FG001|Overall Study|Did not qualify|3|||
154937853|NCT01270841|559200009|FG002|Overall Study|Did not qualify|4|||
154937854|NCT01270841|559200010|FG003|Overall Study|Did not qualify|5|||
154937855|NCT01270841|559200007|FG000|Overall Study|Protocol Violation|1|||
154937856|NCT01270841|559200008|FG001|Overall Study|Protocol Violation|5|||
154937857|NCT01270841|559200009|FG002|Overall Study|Protocol Violation|0|||
154937858|NCT01270841|559200010|FG003|Overall Study|Protocol Violation|0|||
154937859|NCT01270841|559200007|FG000|Overall Study|Enrolled in error|0|||
154937860|NCT01270841|559200008|FG001|Overall Study|Enrolled in error|1|||
154937861|NCT01270841|559200009|FG002|Overall Study|Enrolled in error|0|||
154937862|NCT01270841|559200010|FG003|Overall Study|Enrolled in error|0|||
154937863|NCT02092961|559200011|FG000|Overall Study|Not reported|1|||
154937864|NCT02092961|559200012|FG001|Overall Study|Not reported|0|||
154937865|NCT02092961|559200013|FG002|Overall Study|Not reported|1|||
154937866|NCT02092961|559200011|FG000|Overall Study|Study stopped|13|||
154937867|NCT02092961|559200012|FG001|Overall Study|Study stopped|9|||
154937868|NCT02092961|559200013|FG002|Overall Study|Study stopped|12|||
155277198|NCT01024751|560447655|FG001|Enrolled Participants|Ineligible at baseline|4|||
155277199|NCT01024751|560447654|FG000|Eligible Participants|Withdrawal by Subject|0|||
155277200|NCT01024751|560447655|FG001|Eligible Participants|Withdrawal by Subject|1|||
155277201|NCT01024751|560447654|FG000|Eligible Participants|Lost to Follow-up|0|||
155277202|NCT01024751|560447655|FG001|Eligible Participants|Lost to Follow-up|1|||
155277203|NCT01024751|560447654|FG000|Eligible Participants|Ineligible|0|||
155277204|NCT01024751|560447655|FG001|Eligible Participants|Ineligible|1|||
155277205|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277206|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
154937869|NCT02092961|559200011|FG000|Overall Study|Lack of therapeutic response|2|||
155277207|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277208|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
154937870|NCT02092961|559200012|FG001|Overall Study|Lack of therapeutic response|1|||
154937871|NCT02092961|559200013|FG002|Overall Study|Lack of therapeutic response|3|||
154937872|NCT02092961|559200011|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
154937873|NCT02092961|559200012|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
154937874|NCT02092961|559200013|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
154937875|NCT02092961|559200011|FG000|Overall Study|Adverse Event|2|||
154937876|NCT02092961|559200012|FG001|Overall Study|Adverse Event|4|||
154937877|NCT02092961|559200013|FG002|Overall Study|Adverse Event|0|||
154937878|NCT01886300|559200023|FG000|Overall Study|Trial terminated by sponsor|16|||
154937879|NCT00295854|559200024|FG000|Overall Study|Adverse Event|7|||
154937880|NCT00295854|559200025|FG001|Overall Study|Adverse Event|7|||
154937881|NCT00295854|559200026|FG002|Overall Study|Adverse Event|6|||
155277209|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277210|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
155277211|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277212|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277213|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277214|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277215|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
155277216|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
155277217|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277218|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277219|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277220|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277221|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277222|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
155277223|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277224|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277225|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277226|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
155277227|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277228|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277229|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
155277230|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277231|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277232|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277233|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277234|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277235|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277236|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277237|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
155277238|NCT02601937|560447659|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
155277239|NCT02601937|560447660|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277240|NCT02601937|560447661|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
155277241|NCT02601937|560447662|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277242|NCT02601937|560447663|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277243|NCT02601937|560447664|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
155277244|NCT02601937|560447665|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
155277245|NCT02601937|560447666|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277246|NCT02601937|560447667|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277247|NCT02601937|560447668|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277248|NCT02601937|560447669|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
155277249|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277250|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277251|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277252|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277253|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277254|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277255|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277256|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277257|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277258|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
154937882|NCT00295854|559200024|FG000|Overall Study|Protocol Violation|1|||
154937883|NCT00295854|559200025|FG001|Overall Study|Protocol Violation|1|||
154937884|NCT00295854|559200026|FG002|Overall Study|Protocol Violation|1|||
154937885|NCT00295854|559200024|FG000|Overall Study|Lost to Follow-up|2|||
154937886|NCT00295854|559200025|FG001|Overall Study|Lost to Follow-up|0|||
154937887|NCT00295854|559200026|FG002|Overall Study|Lost to Follow-up|1|||
154937888|NCT00295854|559200024|FG000|Overall Study|Withdrawal by Subject|3|||
154937889|NCT00295854|559200025|FG001|Overall Study|Withdrawal by Subject|7|||
154937890|NCT00295854|559200026|FG002|Overall Study|Withdrawal by Subject|4|||
154937891|NCT00295854|559200024|FG000|Overall Study|did not continue to meet criteria|1|||
154937892|NCT00295854|559200025|FG001|Overall Study|did not continue to meet criteria|1|||
154937893|NCT00295854|559200026|FG002|Overall Study|did not continue to meet criteria|2|||
154937894|NCT00295854|559200024|FG000|Overall Study|required a prohibited medication|1|||
154937895|NCT00295854|559200025|FG001|Overall Study|required a prohibited medication|0|||
154937896|NCT00295854|559200026|FG002|Overall Study|required a prohibited medication|0|||
154937897|NCT00295854|559200024|FG000|Overall Study|Other|3|||
154937898|NCT00295854|559200025|FG001|Overall Study|Other|5|||
154937899|NCT00295854|559200026|FG002|Overall Study|Other|1|||
154937900|NCT00672620|559200027|FG000|Overall Study|Adverse Event|7|||
154937901|NCT00672620|559200028|FG001|Overall Study|Adverse Event|7|||
154937902|NCT00672620|559200029|FG002|Overall Study|Adverse Event|12|||
154937903|NCT00672620|559200030|FG003|Overall Study|Adverse Event|17|||
154937904|NCT00672620|559200027|FG000|Overall Study|Lack of Efficacy|1|||
154937905|NCT00672620|559200028|FG001|Overall Study|Lack of Efficacy|2|||
154937906|NCT00672620|559200029|FG002|Overall Study|Lack of Efficacy|2|||
154937907|NCT00672620|559200030|FG003|Overall Study|Lack of Efficacy|0|||
154937908|NCT00672620|559200027|FG000|Overall Study|Noncompliance with Study Drug|3|||
154937909|NCT00672620|559200028|FG001|Overall Study|Noncompliance with Study Drug|4|||
154937910|NCT00672620|559200029|FG002|Overall Study|Noncompliance with Study Drug|0|||
154937911|NCT00672620|559200030|FG003|Overall Study|Noncompliance with Study Drug|2|||
154937912|NCT00672620|559200027|FG000|Overall Study|Protocol Deviations|5|||
154937913|NCT00672620|559200028|FG001|Overall Study|Protocol Deviations|7|||
154937914|NCT00672620|559200029|FG002|Overall Study|Protocol Deviations|2|||
154937915|NCT00672620|559200030|FG003|Overall Study|Protocol Deviations|5|||
154937916|NCT00672620|559200027|FG000|Overall Study|Withdrawal of Consent|6|||
154937917|NCT00672620|559200028|FG001|Overall Study|Withdrawal of Consent|12|||
154937918|NCT00672620|559200029|FG002|Overall Study|Withdrawal of Consent|5|||
154937919|NCT00672620|559200030|FG003|Overall Study|Withdrawal of Consent|6|||
154937920|NCT00672620|559200027|FG000|Overall Study|Lost to Follow-up|8|||
154937921|NCT00672620|559200028|FG001|Overall Study|Lost to Follow-up|19|||
154937922|NCT00672620|559200029|FG002|Overall Study|Lost to Follow-up|8|||
154937923|NCT00672620|559200030|FG003|Overall Study|Lost to Follow-up|11|||
154937924|NCT00672620|559200027|FG000|Overall Study|Reason not Specified|3|||
154937925|NCT00672620|559200028|FG001|Overall Study|Reason not Specified|3|||
154937926|NCT00672620|559200029|FG002|Overall Study|Reason not Specified|2|||
154937927|NCT00672620|559200030|FG003|Overall Study|Reason not Specified|1|||
154937928|NCT00738673|559200031|FG000|Overall Study|Adverse Event|1|||
154937929|NCT00738673|559200032|FG001|Overall Study|Adverse Event|0|||
154937930|NCT00738673|559200031|FG000|Overall Study|Lack of Efficacy|19|||
154937931|NCT00738673|559200032|FG001|Overall Study|Lack of Efficacy|8|||
154937932|NCT00738673|559200031|FG000|Overall Study|Protocol Violation|1|||
154937933|NCT00738673|559200032|FG001|Overall Study|Protocol Violation|2|||
154937934|NCT00738673|559200031|FG000|Overall Study|Withdrawal by Subject|3|||
154937935|NCT00738673|559200032|FG001|Overall Study|Withdrawal by Subject|1|||
154937936|NCT02622074|559200046|FG000|Overall Study|Death|4|||
154937937|NCT02622074|559200047|FG001|Overall Study|Death|0|||
154937938|NCT02622074|559200048|FG002|Overall Study|Death|0|||
154937939|NCT02622074|559200049|FG003|Overall Study|Death|1|||
154937940|NCT02622074|559200050|FG004|Overall Study|Death|1|||
154937941|NCT02622074|559200051|FG005|Overall Study|Death|0|||
154937942|NCT02622074|559200046|FG000|Overall Study|Withdrawal by Subject|0|||
154937943|NCT02622074|559200047|FG001|Overall Study|Withdrawal by Subject|1|||
154937944|NCT02622074|559200048|FG002|Overall Study|Withdrawal by Subject|0|||
154937945|NCT02622074|559200049|FG003|Overall Study|Withdrawal by Subject|0|||
154937946|NCT02622074|559200050|FG004|Overall Study|Withdrawal by Subject|0|||
154937947|NCT02622074|559200051|FG005|Overall Study|Withdrawal by Subject|0|||
154937948|NCT01205529|559200057|FG000|Overall Study|Procedure Cancelled|4|||
154937949|NCT01205529|559200057|FG000|Overall Study|Withdrawal by Subject|2|||
154937950|NCT01205529|559200057|FG000|Overall Study|Physician Decision|4|||
154937951|NCT01205529|559200057|FG000|Overall Study|Unstable post op|15|||
154937952|NCT01205529|559200057|FG000|Overall Study|No longer met criteria|30|||
154937953|NCT00667719|559200058|FG000|Overall Study|Adverse Event|39|||
154937954|NCT00667719|559200058|FG000|Overall Study|Abnormal Test Procedure|1|||
154937955|NCT00667719|559200058|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
154937956|NCT00667719|559200058|FG000|Overall Study|Protocol Violation|3|||
154937957|NCT00667719|559200058|FG000|Overall Study|Withdrawal by Subject|17|||
154937958|NCT00667719|559200058|FG000|Overall Study|Lost to Follow-up|8|||
154937959|NCT01827371|559200059|FG000|Overall Study|Adverse Event|0|||
154937960|NCT01827371|559200060|FG001|Overall Study|Adverse Event|0|||
154937961|NCT01827371|559200061|FG002|Overall Study|Adverse Event|4|||
154937962|NCT01827371|559200062|FG003|Overall Study|Adverse Event|2|||
154937963|NCT01827371|559200059|FG000|Overall Study|Lost to Follow-up|0|||
154937964|NCT01827371|559200060|FG001|Overall Study|Lost to Follow-up|2|||
154937965|NCT01827371|559200061|FG002|Overall Study|Lost to Follow-up|0|||
154937966|NCT01827371|559200062|FG003|Overall Study|Lost to Follow-up|4|||
154937967|NCT01827371|559200059|FG000|Overall Study|Protocol Violation|1|||
154937968|NCT01827371|559200060|FG001|Overall Study|Protocol Violation|0|||
154937969|NCT01827371|559200061|FG002|Overall Study|Protocol Violation|0|||
154937970|NCT01827371|559200062|FG003|Overall Study|Protocol Violation|0|||
154937971|NCT01827371|559200059|FG000|Overall Study|Withdrawal by Subject|1|||
154937972|NCT01827371|559200060|FG001|Overall Study|Withdrawal by Subject|2|||
154937973|NCT01827371|559200061|FG002|Overall Study|Withdrawal by Subject|2|||
154937974|NCT01827371|559200062|FG003|Overall Study|Withdrawal by Subject|3|||
154937975|NCT01827371|559200059|FG000|Overall Study|Physician Decision|0|||
154937976|NCT01827371|559200060|FG001|Overall Study|Physician Decision|1|||
154937977|NCT01827371|559200061|FG002|Overall Study|Physician Decision|0|||
154937978|NCT01827371|559200062|FG003|Overall Study|Physician Decision|1|||
154937979|NCT01827371|559200059|FG000|Overall Study|Temporary study halt to vaccinations|11|||
154937980|NCT01827371|559200060|FG001|Overall Study|Temporary study halt to vaccinations|2|||
154937981|NCT01827371|559200061|FG002|Overall Study|Temporary study halt to vaccinations|5|||
154937982|NCT01827371|559200062|FG003|Overall Study|Temporary study halt to vaccinations|13|||
154937983|NCT03063632|559200065|FG000|Overall Study|Death|4|||
154937984|NCT03063632|559200066|FG001|Overall Study|Death|6|||
154937985|NCT03063632|559200065|FG000|Overall Study|Lost to Follow-up|0|||
154937986|NCT03063632|559200066|FG001|Overall Study|Lost to Follow-up|1|||
154937987|NCT03063632|559200065|FG000|Overall Study|Withdrawal by Subject|0|||
154937988|NCT03063632|559200066|FG001|Overall Study|Withdrawal by Subject|2|||
154937989|NCT03063632|559200065|FG000|Overall Study|Physician Decision|2|||
154937990|NCT03063632|559200066|FG001|Overall Study|Physician Decision|0|||
154937991|NCT03063632|559200065|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
154937992|NCT03063632|559200066|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
154937993|NCT03652961|559200069|FG000|Overall Study|Lost to Follow-up|3|||
154937994|NCT03652961|559200069|FG000|Overall Study|Screen Failure|1|||
154937995|NCT00373685|559200070|FG000|Overall Study|Death|2|||
154937996|NCT00373685|559200071|FG001|Overall Study|Death|1|||
154937997|NCT00373685|559200070|FG000|Overall Study|Adverse Event|278|||
154937998|NCT00373685|559200071|FG001|Overall Study|Adverse Event|253|||
154937999|NCT00373685|559200070|FG000|Overall Study|Insufficient clinical response|169|||
154938000|NCT00373685|559200071|FG001|Overall Study|Insufficient clinical response|119|||
154938001|NCT00373685|559200070|FG000|Overall Study|Did not meet entrance criteria|167|||
154938002|NCT00373685|559200071|FG001|Overall Study|Did not meet entrance criteria|184|||
154938003|NCT00373685|559200070|FG000|Overall Study|Lost to follow up|83|||
154938004|NCT00373685|559200071|FG001|Overall Study|Lost to follow up|103|||
154938005|NCT00373685|559200070|FG000|Overall Study|No longer willing to participate|337|||
154938006|NCT00373685|559200071|FG001|Overall Study|No longer willing to participate|352|||
154938007|NCT00373685|559200070|FG000|Overall Study|Other|149|||
154938008|NCT00373685|559200071|FG001|Overall Study|Other|146|||
154938009|NCT00373685|559200070|FG000|Overall Study|Protocol Violation|191|||
154938010|NCT00373685|559200071|FG001|Overall Study|Protocol Violation|182|||
154938011|NCT00373685|559200070|FG000|Overall Study|Final Status Unknown|12|||
154938012|NCT00373685|559200071|FG001|Overall Study|Final Status Unknown|4|||
154938013|NCT00373685|559200070|FG000|Overall Study|Randomized, not treated|51|||
154938014|NCT00373685|559200071|FG001|Overall Study|Randomized, not treated|77|||
154938015|NCT01783496|559200072|FG000|Overall Study|Lost to Follow-up|0|||
154938016|NCT01783496|559200073|FG001|Overall Study|Lost to Follow-up|0|||
154938017|NCT01783496|559200074|FG002|Overall Study|Lost to Follow-up|0|||
154938018|NCT01783496|559200075|FG003|Overall Study|Lost to Follow-up|2|||
154938019|NCT01783496|559200076|FG004|Overall Study|Lost to Follow-up|0|||
154938020|NCT01783496|559200077|FG005|Overall Study|Lost to Follow-up|1|||
154938021|NCT01783496|559200072|FG000|Overall Study|Withdrawal by Subject|1|||
154938022|NCT01783496|559200073|FG001|Overall Study|Withdrawal by Subject|0|||
154938023|NCT01783496|559200074|FG002|Overall Study|Withdrawal by Subject|0|||
154938024|NCT01783496|559200075|FG003|Overall Study|Withdrawal by Subject|0|||
154938025|NCT01783496|559200076|FG004|Overall Study|Withdrawal by Subject|0|||
154938026|NCT01783496|559200077|FG005|Overall Study|Withdrawal by Subject|0|||
154938027|NCT00947011|559200078|FG000|Overall Study|Study was terminated,PI left institution|12|||
154938028|NCT05266456|559200079|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
154938029|NCT05266456|559200080|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
154938030|NCT05266456|559200081|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
154938031|NCT05266456|559200082|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
154938032|NCT05266456|559200079|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
154938033|NCT05266456|559200080|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
154938034|NCT05266456|559200081|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
154938035|NCT05266456|559200082|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
154938036|NCT05266456|559200079|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
154938037|NCT05266456|559200080|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
154938038|NCT05266456|559200081|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
154938039|NCT05266456|559200082|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
154938040|NCT05266456|559200079|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
154938041|NCT05266456|559200080|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
154938042|NCT05266456|559200081|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
154938043|NCT05266456|559200082|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
154938044|NCT05266456|559200079|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
154938045|NCT05266456|559200080|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
154938046|NCT05266456|559200081|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
154938047|NCT05266456|559200082|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
154938048|NCT00068237|559200083|FG000|Overall Study|Ineligible|3|||
154938049|NCT00068237|559200083|FG000|Overall Study|No protocol treatment received|2|||
154938050|NCT03124381|559200087|FG000|Overall Study|Lost to Follow-up|1|||
154938051|NCT03124381|559200088|FG001|Overall Study|Lost to Follow-up|1|||
154938052|NCT03124381|559200087|FG000|Overall Study|Withdrawal by Subject|6|||
154938053|NCT03124381|559200088|FG001|Overall Study|Withdrawal by Subject|3|||
154938054|NCT03124381|559200087|FG000|Overall Study|Protocol Violation|0|||
154938055|NCT03124381|559200088|FG001|Overall Study|Protocol Violation|1|||
154938056|NCT03124381|559200087|FG000|Overall Study|Adverse Event|1|||
154938057|NCT03124381|559200088|FG001|Overall Study|Adverse Event|1|||
154938058|NCT03124381|559200087|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
154938059|NCT03124381|559200088|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
154938060|NCT05017493|559200096|FG000|Overall Study|Withdrawal by Subject|26|||
154938061|NCT05017493|559200097|FG001|Overall Study|Withdrawal by Subject|0|||
154938062|NCT05017493|559200096|FG000|Overall Study|Physician Decision|15|||
154938063|NCT05017493|559200097|FG001|Overall Study|Physician Decision|0|||
154938064|NCT05017493|559200096|FG000|Overall Study|Protocol Violation|81|||
154938065|NCT05017493|559200097|FG001|Overall Study|Protocol Violation|0|||
154938066|NCT01154153|559200098|FG000|Overall Study|Poor compliance to protocol|2|||
154938067|NCT01154153|559200099|FG001|Overall Study|Poor compliance to protocol|0|||
154938068|NCT01154153|559200098|FG000|Overall Study|Unable to use labs|2|||
154938069|NCT01154153|559200099|FG001|Overall Study|Unable to use labs|3|||
154938070|NCT01154153|559200098|FG000|Overall Study|Withdrew consent|1|||
154938071|NCT01154153|559200099|FG001|Overall Study|Withdrew consent|0|||
154938072|NCT02473510|559200100|FG000|Overall Study|Lost to Follow-up|1|||
154938073|NCT02473510|559200101|FG001|Overall Study|Lost to Follow-up|2|||
154938074|NCT03940586|559200108|FG000|Overall Study|Death|3|||
154938075|NCT03940586|559200109|FG001|Overall Study|Death|2|||
154938076|NCT03940586|559200110|FG002|Overall Study|Death|0|||
154938077|NCT03940586|559200108|FG000|Overall Study|Physician Decision|1|||
154938078|NCT03940586|559200109|FG001|Overall Study|Physician Decision|0|||
154938079|NCT03940586|559200110|FG002|Overall Study|Physician Decision|1|||
154938080|NCT03940586|559200108|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
154938081|NCT03940586|559200109|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
154938082|NCT03940586|559200110|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
154938083|NCT03940586|559200108|FG000|Overall Study|Not Treated|0|||
154938084|NCT03940586|559200109|FG001|Overall Study|Not Treated|2|||
154938085|NCT03940586|559200110|FG002|Overall Study|Not Treated|0|||
154938086|NCT00964223|559200111|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
154938087|NCT02006147|559200112|FG000|Overall Study|Protocol Violation|1|||
154938088|NCT02006147|559200113|FG001|Overall Study|Protocol Violation|1|||
154938089|NCT02006147|559200114|FG002|Overall Study|Protocol Violation|0|||
154938090|NCT02006147|559200115|FG003|Overall Study|Protocol Violation|0|||
154938091|NCT02006147|559200112|FG000|Overall Study|Withdrawal by Subject|0|||
154938092|NCT02006147|559200113|FG001|Overall Study|Withdrawal by Subject|1|||
154938093|NCT02006147|559200114|FG002|Overall Study|Withdrawal by Subject|0|||
154938094|NCT02006147|559200115|FG003|Overall Study|Withdrawal by Subject|0|||
154938095|NCT02006147|559200112|FG000|Overall Study|Withdrawal by Sponsor|1|||
154938096|NCT02006147|559200113|FG001|Overall Study|Withdrawal by Sponsor|0|||
154938097|NCT02006147|559200114|FG002|Overall Study|Withdrawal by Sponsor|0|||
154938098|NCT02006147|559200115|FG003|Overall Study|Withdrawal by Sponsor|0|||
154938099|NCT03404206|559200116|FG000|Overall Study|Withdrawal by Subject|1|||
154938100|NCT03404206|559200117|FG001|Overall Study|Withdrawal by Subject|1|||
154938101|NCT03404206|559200118|FG002|Overall Study|Withdrawal by Subject|0|||
154938102|NCT03404206|559200116|FG000|Overall Study|Lost to Follow-up|3|||
154938103|NCT03404206|559200117|FG001|Overall Study|Lost to Follow-up|1|||
154938104|NCT03404206|559200118|FG002|Overall Study|Lost to Follow-up|0|||
155277259|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
155277260|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277261|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277262|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277263|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277264|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277265|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277266|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277267|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
155277268|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277269|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277270|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
155277271|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
154938105|NCT05478603|559200119|FG000|Overall Study|Withdrawal by Subject|0|||
154938106|NCT05478603|559200120|FG001|Overall Study|Withdrawal by Subject|1|||
154938107|NCT05478603|559200121|FG002|Overall Study|Withdrawal by Subject|0|||
154938108|NCT05478603|559200122|FG003|Overall Study|Withdrawal by Subject|0|||
154938109|NCT01010230|559200123|FG000|Overall Study|Withdrawal by Subject|6|||
154938110|NCT01010230|559200124|FG001|Overall Study|Withdrawal by Subject|5|||
154938111|NCT01010230|559200123|FG000|Overall Study|Lost to Follow-up|4|||
154938112|NCT01010230|559200124|FG001|Overall Study|Lost to Follow-up|2|||
154938113|NCT01585831|559200127|FG000|Overall Study|Physician Decision|0|||
154938114|NCT01585831|559200128|FG001|Overall Study|Physician Decision|1|||
154938115|NCT01585831|559200127|FG000|Overall Study|Withdrawal by Subject|2|||
154938116|NCT01585831|559200128|FG001|Overall Study|Withdrawal by Subject|1|||
154938117|NCT01123980|559200129|FG000|Overall Study|Adverse Event|1|||
154938118|NCT01123980|559200130|FG001|Overall Study|Adverse Event|1|||
154938119|NCT01123980|559200129|FG000|Overall Study|Lack of Efficacy|1|||
154938120|NCT01123980|559200130|FG001|Overall Study|Lack of Efficacy|0|||
154938121|NCT01123980|559200129|FG000|Overall Study|Physician Decision|0|||
154938122|NCT01123980|559200130|FG001|Overall Study|Physician Decision|1|||
154938123|NCT01123980|559200129|FG000|Overall Study|Lost to Follow-up|0|||
154938124|NCT01123980|559200130|FG001|Overall Study|Lost to Follow-up|6|||
154938125|NCT01123980|559200129|FG000|Overall Study|Protocol Violation|6|||
154938126|NCT01123980|559200130|FG001|Overall Study|Protocol Violation|6|||
154938127|NCT01123980|559200129|FG000|Overall Study|Withdrawal by Subject|5|||
154938128|NCT01123980|559200130|FG001|Overall Study|Withdrawal by Subject|3|||
154938129|NCT01123980|559200129|FG000|Overall Study|Unclassified|6|||
154938130|NCT01123980|559200130|FG001|Overall Study|Unclassified|7|||
154938131|NCT01225991|559200131|FG000|Overall Study|Withdrawal by Subject|6|||
154938132|NCT00579254|559200132|FG000|Overall Study|Lost to Follow-up|39|||
154938133|NCT00579254|559200132|FG000|Overall Study|Discontinued when study terminated|73|||
154938134|NCT03705169|559200133|FG000|Overall Study|Lost to Follow-up|0|||
154938135|NCT03705169|559200134|FG001|Overall Study|Lost to Follow-up|0|||
154938136|NCT03705169|559200135|FG002|Overall Study|Lost to Follow-up|0|||
154938137|NCT03705169|559200136|FG003|Overall Study|Lost to Follow-up|2|||
154938138|NCT03705169|559200137|FG004|Overall Study|Lost to Follow-up|0|||
154938139|NCT03705169|559200138|FG005|Overall Study|Lost to Follow-up|2|||
154938140|NCT03705169|559200139|FG006|Overall Study|Lost to Follow-up|1|||
154938141|NCT03705169|559200140|FG007|Overall Study|Lost to Follow-up|0|||
154938142|NCT03705169|559200141|FG008|Overall Study|Lost to Follow-up|0|||
154938143|NCT03705169|559200142|FG009|Overall Study|Lost to Follow-up|1|||
154938144|NCT03705169|559200133|FG000|Overall Study|Adverse Event|0|||
154938145|NCT03705169|559200134|FG001|Overall Study|Adverse Event|0|||
154938146|NCT03705169|559200135|FG002|Overall Study|Adverse Event|0|||
154938147|NCT03705169|559200136|FG003|Overall Study|Adverse Event|1|||
154938148|NCT03705169|559200137|FG004|Overall Study|Adverse Event|0|||
154938149|NCT03705169|559200138|FG005|Overall Study|Adverse Event|0|||
154938150|NCT03705169|559200139|FG006|Overall Study|Adverse Event|0|||
154938151|NCT03705169|559200140|FG007|Overall Study|Adverse Event|0|||
154938152|NCT03705169|559200141|FG008|Overall Study|Adverse Event|0|||
154938153|NCT03705169|559200142|FG009|Overall Study|Adverse Event|0|||
154938154|NCT03705169|559200133|FG000|Overall Study|Site Closure|0|||
154938155|NCT03705169|559200134|FG001|Overall Study|Site Closure|0|||
154938156|NCT03705169|559200135|FG002|Overall Study|Site Closure|0|||
154938157|NCT03705169|559200136|FG003|Overall Study|Site Closure|1|||
154938158|NCT03705169|559200137|FG004|Overall Study|Site Closure|0|||
154938159|NCT03705169|559200138|FG005|Overall Study|Site Closure|0|||
154938160|NCT03705169|559200139|FG006|Overall Study|Site Closure|0|||
154938161|NCT03705169|559200140|FG007|Overall Study|Site Closure|0|||
154938162|NCT03705169|559200141|FG008|Overall Study|Site Closure|0|||
154938163|NCT03705169|559200142|FG009|Overall Study|Site Closure|0|||
154938164|NCT03705169|559200133|FG000|Overall Study|Did not receive study treatment|0|||
154938165|NCT03705169|559200134|FG001|Overall Study|Did not receive study treatment|0|||
154938166|NCT03705169|559200135|FG002|Overall Study|Did not receive study treatment|0|||
154938167|NCT03705169|559200136|FG003|Overall Study|Did not receive study treatment|1|||
154938168|NCT03705169|559200137|FG004|Overall Study|Did not receive study treatment|0|||
154938169|NCT03705169|559200138|FG005|Overall Study|Did not receive study treatment|0|||
154938170|NCT03705169|559200139|FG006|Overall Study|Did not receive study treatment|0|||
154938171|NCT03705169|559200140|FG007|Overall Study|Did not receive study treatment|0|||
154938172|NCT03705169|559200141|FG008|Overall Study|Did not receive study treatment|0|||
154938173|NCT03705169|559200142|FG009|Overall Study|Did not receive study treatment|0|||
154938174|NCT03705169|559200133|FG000|Overall Study|Concerns about study visit compliance|0|||
154938175|NCT03705169|559200134|FG001|Overall Study|Concerns about study visit compliance|0|||
154938176|NCT03705169|559200135|FG002|Overall Study|Concerns about study visit compliance|0|||
155277272|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277273|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
154938177|NCT03705169|559200136|FG003|Overall Study|Concerns about study visit compliance|1|||
154938178|NCT03705169|559200137|FG004|Overall Study|Concerns about study visit compliance|0|||
154938179|NCT03705169|559200138|FG005|Overall Study|Concerns about study visit compliance|0|||
154938180|NCT03705169|559200139|FG006|Overall Study|Concerns about study visit compliance|0|||
154938181|NCT03705169|559200140|FG007|Overall Study|Concerns about study visit compliance|0|||
154938182|NCT03705169|559200141|FG008|Overall Study|Concerns about study visit compliance|0|||
154938183|NCT03705169|559200142|FG009|Overall Study|Concerns about study visit compliance|0|||
154938184|NCT03262233|559201701|FG000|Overall Study|Withdrawal by Subject|12|||
154938185|NCT03262233|559201702|FG001|Overall Study|Withdrawal by Subject|8|||
154938186|NCT03262233|559201703|FG002|Overall Study|Withdrawal by Subject|21|||
154938187|NCT03262233|559201704|FG003|Overall Study|Withdrawal by Subject|13|||
154938188|NCT03262233|559201701|FG000|Overall Study|Declined due to shock|1|||
154938189|NCT03262233|559201702|FG001|Overall Study|Declined due to shock|2|||
154938190|NCT03262233|559201703|FG002|Overall Study|Declined due to shock|2|||
154938191|NCT03262233|559201704|FG003|Overall Study|Declined due to shock|3|||
154938192|NCT03262233|559201701|FG000|Overall Study|Protocol Violation|5|||
154938193|NCT03262233|559201702|FG001|Overall Study|Protocol Violation|10|||
154938194|NCT03262233|559201703|FG002|Overall Study|Protocol Violation|2|||
154938195|NCT03262233|559201704|FG003|Overall Study|Protocol Violation|13|||
154938196|NCT03262233|559201701|FG000|Overall Study|data collection artifact|0|||
154938197|NCT03262233|559201702|FG001|Overall Study|data collection artifact|1|||
154938198|NCT03262233|559201703|FG002|Overall Study|data collection artifact|0|||
154938199|NCT03262233|559201704|FG003|Overall Study|data collection artifact|0|||
154938200|NCT01165242|559201707|FG000|Overall Study|Unreachable Subjects|1|||
154938201|NCT01165242|559201708|FG001|Overall Study|Unreachable Subjects|0|||
154938202|NCT01165242|559201709|FG002|Overall Study|Unreachable Subjects|0|||
154938203|NCT01165242|559201707|FG000|Overall Study|Incarcerated Subjects|0|||
154938204|NCT01165242|559201708|FG001|Overall Study|Incarcerated Subjects|1|||
154938205|NCT01165242|559201709|FG002|Overall Study|Incarcerated Subjects|0|||
154938206|NCT01165242|559201707|FG000|Overall Study|Visit 2 Declined by Subject|0|||
154938207|NCT01165242|559201708|FG001|Overall Study|Visit 2 Declined by Subject|0|||
154938208|NCT01165242|559201709|FG002|Overall Study|Visit 2 Declined by Subject|1|||
154938209|NCT01165242|559201707|FG000|Overall Study|Withdrawal by Subject|0|||
154938210|NCT01165242|559201708|FG001|Overall Study|Withdrawal by Subject|2|||
154938211|NCT01165242|559201709|FG002|Overall Study|Withdrawal by Subject|2|||
154938212|NCT01165242|559201707|FG000|Overall Study|Extended Holiday|0|||
154938213|NCT01165242|559201708|FG001|Overall Study|Extended Holiday|0|||
154938214|NCT01165242|559201709|FG002|Overall Study|Extended Holiday|1|||
154938215|NCT01165242|559201707|FG000|Overall Study|Lost to Follow-up|9|||
154938216|NCT01165242|559201708|FG001|Overall Study|Lost to Follow-up|7|||
154938217|NCT01165242|559201709|FG002|Overall Study|Lost to Follow-up|10|||
154938218|NCT03372083|559201710|FG000|Overall Study|Adverse Event|3|||
154938219|NCT03372083|559201710|FG000|Overall Study|Physician Decision|1|||
154938220|NCT03372083|559201710|FG000|Overall Study|Withdrawal by Subject|1|||
154938221|NCT02544633|559201713|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
154938222|NCT02544633|559201714|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
154938223|NCT02544633|559201715|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
154938224|NCT02544633|559201716|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
154938225|NCT02544633|559201713|FG000|Treatment Period|Adverse Event|7|||
154938226|NCT02544633|559201714|FG001|Treatment Period|Adverse Event|4|||
154938227|NCT02544633|559201715|FG002|Treatment Period|Adverse Event|0|||
154938228|NCT02544633|559201716|FG003|Treatment Period|Adverse Event|5|||
154938229|NCT02544633|559201713|FG000|Treatment Period|Lack of Efficacy|17|||
154938230|NCT02544633|559201714|FG001|Treatment Period|Lack of Efficacy|11|||
154938231|NCT02544633|559201715|FG002|Treatment Period|Lack of Efficacy|5|||
154938232|NCT02544633|559201716|FG003|Treatment Period|Lack of Efficacy|5|||
154938233|NCT02544633|559201713|FG000|Treatment Period|Global Deterioration of Health|3|||
154938234|NCT02544633|559201714|FG001|Treatment Period|Global Deterioration of Health|3|||
154938235|NCT02544633|559201715|FG002|Treatment Period|Global Deterioration of Health|0|||
154938236|NCT02544633|559201716|FG003|Treatment Period|Global Deterioration of Health|1|||
154938237|NCT02544633|559201713|FG000|Treatment Period|Withdrawal by Subject|1|||
154938238|NCT02544633|559201714|FG001|Treatment Period|Withdrawal by Subject|0|||
154938239|NCT02544633|559201715|FG002|Treatment Period|Withdrawal by Subject|0|||
154938240|NCT02544633|559201716|FG003|Treatment Period|Withdrawal by Subject|0|||
154938241|NCT02544633|559201713|FG000|Treatment Period|Lost to Follow-up|0|||
154938242|NCT02544633|559201714|FG001|Treatment Period|Lost to Follow-up|1|||
154938243|NCT02544633|559201715|FG002|Treatment Period|Lost to Follow-up|0|||
154938244|NCT02544633|559201716|FG003|Treatment Period|Lost to Follow-up|0|||
154938245|NCT02544633|559201713|FG000|Treatment Period|Death|0|||
154938246|NCT02544633|559201714|FG001|Treatment Period|Death|0|||
154938247|NCT02544633|559201715|FG002|Treatment Period|Death|1|||
154938248|NCT02544633|559201716|FG003|Treatment Period|Death|0|||
154938249|NCT02544633|559201713|FG000|Treatment Period|Non-compliance|0|||
154938250|NCT02544633|559201714|FG001|Treatment Period|Non-compliance|0|||
154938251|NCT02544633|559201715|FG002|Treatment Period|Non-compliance|1|||
154938252|NCT02544633|559201716|FG003|Treatment Period|Non-compliance|0|||
154938253|NCT02544633|559201713|FG000|Treatment Period|Clinical Disease Progression|0|||
154938254|NCT02544633|559201714|FG001|Treatment Period|Clinical Disease Progression|0|||
154938255|NCT02544633|559201715|FG002|Treatment Period|Clinical Disease Progression|0|||
154938256|NCT02544633|559201716|FG003|Treatment Period|Clinical Disease Progression|1|||
154938257|NCT02544633|559201713|FG000|Survival Follow-up Period|Death|12|||
154938258|NCT02544633|559201714|FG001|Survival Follow-up Period|Death|14|||
154938259|NCT02544633|559201715|FG002|Survival Follow-up Period|Death|3|||
154938260|NCT02544633|559201716|FG003|Survival Follow-up Period|Death|9|||
154938261|NCT02544633|559201713|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
154938262|NCT02544633|559201714|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
154938263|NCT02544633|559201715|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
154938264|NCT02544633|559201716|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
154938265|NCT02544633|559201713|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
154938266|NCT02544633|559201714|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
154938267|NCT02544633|559201715|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
154938268|NCT02544633|559201716|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
154938269|NCT02544633|559201713|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
154938270|NCT02544633|559201714|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
154938271|NCT02544633|559201715|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
154938272|NCT02544633|559201716|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
154938273|NCT01623830|559201717|FG000|Overall Study|Withdrawal by Subject|6|||
154938274|NCT01623830|559201718|FG001|Overall Study|Withdrawal by Subject|7|||
154938275|NCT01623830|559201717|FG000|Overall Study|Exclusion from Study|1|||
155277274|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277275|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277276|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277277|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277278|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277279|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
155277280|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
155277281|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
155277282|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277283|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277284|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277285|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277286|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277287|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277288|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
155277289|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
155277290|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
155277291|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
155277292|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
155277293|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Other|0|||
155277294|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Other|0|||
155277295|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Other|0|||
155277296|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Other|0|||
155277297|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Other|0|||
155277298|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Other|0|||
155277299|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Other|0|||
155277300|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Other|0|||
155277301|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Other|2|||
155277302|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Other|2|||
155277303|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Other|0|||
155277304|NCT02601937|560447659|FG000|Period 2: Dose Expansion Cohort|Death|0|||
155277305|NCT02601937|560447660|FG001|Period 2: Dose Expansion Cohort|Death|0|||
155277306|NCT02601937|560447661|FG002|Period 2: Dose Expansion Cohort|Death|0|||
155277307|NCT02601937|560447662|FG003|Period 2: Dose Expansion Cohort|Death|0|||
155277308|NCT02601937|560447663|FG004|Period 2: Dose Expansion Cohort|Death|0|||
155277309|NCT02601937|560447664|FG005|Period 2: Dose Expansion Cohort|Death|0|||
155277310|NCT02601937|560447665|FG006|Period 2: Dose Expansion Cohort|Death|0|||
155277311|NCT02601937|560447666|FG007|Period 2: Dose Expansion Cohort|Death|0|||
155277312|NCT02601937|560447667|FG008|Period 2: Dose Expansion Cohort|Death|1|||
155277313|NCT02601937|560447668|FG009|Period 2: Dose Expansion Cohort|Death|0|||
155277314|NCT02601937|560447669|FG010|Period 2: Dose Expansion Cohort|Death|0|||
155277315|NCT03038672|560449021|FG000|Initial Treatment|Unacceptable chemistry|0|||
155277316|NCT03038672|560449022|FG001|Initial Treatment|Unacceptable chemistry|1|||
155277317|NCT03038672|560449021|FG000|Initial Treatment|Progression prior to treatment|1|||
155277318|NCT03038672|560449022|FG001|Initial Treatment|Progression prior to treatment|0|||
155277319|NCT03038672|560449021|FG000|Initial Treatment|No treatment per protocol|1|||
155277320|NCT03038672|560449022|FG001|Initial Treatment|No treatment per protocol|0|||
155277321|NCT04423393|560449023|FG000|Overall Study|Withdrawal by Subject|0|||
155277322|NCT04423393|560449024|FG001|Overall Study|Withdrawal by Subject|0|||
155277323|NCT04423393|560449025|FG002|Overall Study|Withdrawal by Subject|0|||
155277324|NCT04423393|560449026|FG003|Overall Study|Withdrawal by Subject|0|||
155277325|NCT04423393|560449027|FG004|Overall Study|Withdrawal by Subject|0|||
155277326|NCT04423393|560449028|FG005|Overall Study|Withdrawal by Subject|1|||
155277327|NCT04423393|560449029|FG006|Overall Study|Withdrawal by Subject|0|||
155277328|NCT04423393|560449030|FG007|Overall Study|Withdrawal by Subject|0|||
155277329|NCT04423393|560449031|FG008|Overall Study|Withdrawal by Subject|0|||
155043462|NCT01826981|559590123|FG001|Overall Study|Adverse Event|0|||
155043463|NCT01826981|559590124|FG002|Overall Study|Adverse Event|0|||
154938276|NCT01623830|559201718|FG001|Overall Study|Exclusion from Study|2|||
154938277|NCT01605461|559201719|FG000|Overall Study|Lost to Follow-up|3|||
154938278|NCT01605461|559201719|FG000|Overall Study|Withdrawal by Subject|1|||
154938279|NCT02024698|559201720|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
154938280|NCT02024698|559201721|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
154938281|NCT01859390|559201725|FG000|Overall Study|Insufficient Sputum Collected|1|||
154938282|NCT01859390|559201726|FG001|Overall Study|Insufficient Sputum Collected|3|||
154938283|NCT01859390|559201725|FG000|Overall Study|Sample Missing Collection Date|0|||
154938284|NCT01859390|559201726|FG001|Overall Study|Sample Missing Collection Date|1|||
154938285|NCT01859390|559201725|FG000|Overall Study|Tube Cracked|0|||
154938286|NCT01859390|559201726|FG001|Overall Study|Tube Cracked|2|||
154938287|NCT01859390|559201725|FG000|Overall Study|Shipment Error|0|||
154938288|NCT01859390|559201726|FG001|Overall Study|Shipment Error|1|||
154938289|NCT03549130|559201728|FG000|Overall Study|Adverse Event|0|||
154938290|NCT03549130|559201729|FG001|Overall Study|Adverse Event|1|||
154938291|NCT03549130|559201728|FG000|Overall Study|Lost to Follow-up|0|||
154938292|NCT03549130|559201729|FG001|Overall Study|Lost to Follow-up|1|||
154938293|NCT01078623|559201730|FG000|Treatment Period 1|Adverse Event|1|||
154938294|NCT01078623|559201731|FG001|Treatment Period 1|Adverse Event|1|||
154938295|NCT01078623|559201732|FG002|Treatment Period 1|Adverse Event|1|||
154938296|NCT01078623|559201733|FG003|Treatment Period 1|Adverse Event|0|||
154938297|NCT01078623|559201734|FG004|Treatment Period 1|Adverse Event|0|||
154938298|NCT01078623|559201735|FG005|Treatment Period 1|Adverse Event|0|||
154938299|NCT01078623|559201736|FG006|Treatment Period 1|Adverse Event|1|||
154938300|NCT01078623|559201737|FG007|Treatment Period 1|Adverse Event|0|||
154938301|NCT01078623|559201738|FG008|Treatment Period 1|Adverse Event|1|||
154938302|NCT01078623|559201739|FG009|Treatment Period 1|Adverse Event|1|||
154938303|NCT01078623|559201740|FG010|Treatment Period 1|Adverse Event|0|||
154938304|NCT01078623|559201741|FG011|Treatment Period 1|Adverse Event|0|||
154938305|NCT01078623|559201742|FG012|Treatment Period 1|Adverse Event|0|||
154938306|NCT01078623|559201743|FG013|Treatment Period 1|Adverse Event|0|||
154938307|NCT01078623|559201744|FG014|Treatment Period 1|Adverse Event|0|||
154938308|NCT01078623|559201745|FG015|Treatment Period 1|Adverse Event|0|||
154938309|NCT01078623|559201746|FG016|Treatment Period 1|Adverse Event|0|||
154938310|NCT01078623|559201747|FG017|Treatment Period 1|Adverse Event|0|||
154938311|NCT01078623|559201748|FG018|Treatment Period 1|Adverse Event|0|||
154938312|NCT01078623|559201749|FG019|Treatment Period 1|Adverse Event|0|||
154938313|NCT01078623|559201730|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154938314|NCT01078623|559201731|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154938315|NCT01078623|559201732|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154938316|NCT01078623|559201733|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154938317|NCT01078623|559201734|FG004|Treatment Period 1|Withdrawal by Subject|0|||
154938318|NCT01078623|559201735|FG005|Treatment Period 1|Withdrawal by Subject|0|||
154938319|NCT01078623|559201736|FG006|Treatment Period 1|Withdrawal by Subject|0|||
154938320|NCT01078623|559201737|FG007|Treatment Period 1|Withdrawal by Subject|1|||
154938321|NCT01078623|559201738|FG008|Treatment Period 1|Withdrawal by Subject|0|||
154938322|NCT01078623|559201739|FG009|Treatment Period 1|Withdrawal by Subject|0|||
154938323|NCT01078623|559201740|FG010|Treatment Period 1|Withdrawal by Subject|1|||
154938324|NCT01078623|559201741|FG011|Treatment Period 1|Withdrawal by Subject|0|||
154938325|NCT01078623|559201742|FG012|Treatment Period 1|Withdrawal by Subject|0|||
154938326|NCT01078623|559201743|FG013|Treatment Period 1|Withdrawal by Subject|0|||
154938327|NCT01078623|559201744|FG014|Treatment Period 1|Withdrawal by Subject|0|||
154938328|NCT01078623|559201745|FG015|Treatment Period 1|Withdrawal by Subject|0|||
154938329|NCT01078623|559201746|FG016|Treatment Period 1|Withdrawal by Subject|0|||
154938330|NCT01078623|559201747|FG017|Treatment Period 1|Withdrawal by Subject|0|||
154938331|NCT01078623|559201748|FG018|Treatment Period 1|Withdrawal by Subject|0|||
154938332|NCT01078623|559201749|FG019|Treatment Period 1|Withdrawal by Subject|0|||
154938333|NCT01078623|559201730|FG000|Treatment Period 1|Protocol Violation|0|||
154938334|NCT01078623|559201731|FG001|Treatment Period 1|Protocol Violation|0|||
154938335|NCT01078623|559201732|FG002|Treatment Period 1|Protocol Violation|0|||
154938336|NCT01078623|559201733|FG003|Treatment Period 1|Protocol Violation|0|||
154938337|NCT01078623|559201734|FG004|Treatment Period 1|Protocol Violation|0|||
154938338|NCT01078623|559201735|FG005|Treatment Period 1|Protocol Violation|1|||
154938339|NCT01078623|559201736|FG006|Treatment Period 1|Protocol Violation|0|||
154938340|NCT01078623|559201737|FG007|Treatment Period 1|Protocol Violation|0|||
154938341|NCT01078623|559201738|FG008|Treatment Period 1|Protocol Violation|0|||
154938342|NCT01078623|559201739|FG009|Treatment Period 1|Protocol Violation|0|||
154938343|NCT01078623|559201740|FG010|Treatment Period 1|Protocol Violation|0|||
154938344|NCT01078623|559201741|FG011|Treatment Period 1|Protocol Violation|0|||
154938345|NCT01078623|559201742|FG012|Treatment Period 1|Protocol Violation|0|||
154938346|NCT01078623|559201743|FG013|Treatment Period 1|Protocol Violation|0|||
154938347|NCT01078623|559201744|FG014|Treatment Period 1|Protocol Violation|0|||
154938348|NCT01078623|559201745|FG015|Treatment Period 1|Protocol Violation|0|||
154938349|NCT01078623|559201746|FG016|Treatment Period 1|Protocol Violation|0|||
154938350|NCT01078623|559201747|FG017|Treatment Period 1|Protocol Violation|0|||
154938351|NCT01078623|559201748|FG018|Treatment Period 1|Protocol Violation|0|||
154938352|NCT01078623|559201749|FG019|Treatment Period 1|Protocol Violation|0|||
154938353|NCT01078623|559201730|FG000|Treatment Period 2|Adverse Event|0|||
154938354|NCT01078623|559201731|FG001|Treatment Period 2|Adverse Event|0|||
154938355|NCT01078623|559201732|FG002|Treatment Period 2|Adverse Event|0|||
154938356|NCT01078623|559201733|FG003|Treatment Period 2|Adverse Event|0|||
154938357|NCT01078623|559201734|FG004|Treatment Period 2|Adverse Event|0|||
154938358|NCT01078623|559201735|FG005|Treatment Period 2|Adverse Event|0|||
154938359|NCT01078623|559201736|FG006|Treatment Period 2|Adverse Event|1|||
154938360|NCT01078623|559201737|FG007|Treatment Period 2|Adverse Event|0|||
154938361|NCT01078623|559201738|FG008|Treatment Period 2|Adverse Event|0|||
154938362|NCT01078623|559201739|FG009|Treatment Period 2|Adverse Event|0|||
154938363|NCT01078623|559201740|FG010|Treatment Period 2|Adverse Event|0|||
154938364|NCT01078623|559201741|FG011|Treatment Period 2|Adverse Event|0|||
154938365|NCT01078623|559201742|FG012|Treatment Period 2|Adverse Event|0|||
154938366|NCT01078623|559201743|FG013|Treatment Period 2|Adverse Event|0|||
154938367|NCT01078623|559201744|FG014|Treatment Period 2|Adverse Event|0|||
154938368|NCT01078623|559201745|FG015|Treatment Period 2|Adverse Event|0|||
154938369|NCT01078623|559201746|FG016|Treatment Period 2|Adverse Event|0|||
154938370|NCT01078623|559201747|FG017|Treatment Period 2|Adverse Event|0|||
154938371|NCT01078623|559201748|FG018|Treatment Period 2|Adverse Event|1|||
154938372|NCT01078623|559201749|FG019|Treatment Period 2|Adverse Event|0|||
154938373|NCT01078623|559201730|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154938374|NCT01078623|559201731|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154938375|NCT01078623|559201732|FG002|Treatment Period 2|Withdrawal by Subject|0|||
154938376|NCT01078623|559201733|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154938377|NCT01078623|559201734|FG004|Treatment Period 2|Withdrawal by Subject|0|||
154938378|NCT01078623|559201735|FG005|Treatment Period 2|Withdrawal by Subject|1|||
154938379|NCT01078623|559201736|FG006|Treatment Period 2|Withdrawal by Subject|0|||
154938380|NCT01078623|559201737|FG007|Treatment Period 2|Withdrawal by Subject|0|||
154938381|NCT01078623|559201738|FG008|Treatment Period 2|Withdrawal by Subject|0|||
154938382|NCT01078623|559201739|FG009|Treatment Period 2|Withdrawal by Subject|0|||
154938383|NCT01078623|559201740|FG010|Treatment Period 2|Withdrawal by Subject|0|||
154938384|NCT01078623|559201741|FG011|Treatment Period 2|Withdrawal by Subject|0|||
154938385|NCT01078623|559201742|FG012|Treatment Period 2|Withdrawal by Subject|0|||
154938386|NCT01078623|559201743|FG013|Treatment Period 2|Withdrawal by Subject|0|||
154938387|NCT01078623|559201744|FG014|Treatment Period 2|Withdrawal by Subject|0|||
154938388|NCT01078623|559201745|FG015|Treatment Period 2|Withdrawal by Subject|0|||
154938389|NCT01078623|559201746|FG016|Treatment Period 2|Withdrawal by Subject|0|||
154938390|NCT01078623|559201747|FG017|Treatment Period 2|Withdrawal by Subject|0|||
154938391|NCT01078623|559201748|FG018|Treatment Period 2|Withdrawal by Subject|0|||
154938392|NCT01078623|559201749|FG019|Treatment Period 2|Withdrawal by Subject|0|||
154938393|NCT01078623|559201730|FG000|Treatment Period 3|Adverse Event|0|||
154938394|NCT01078623|559201731|FG001|Treatment Period 3|Adverse Event|0|||
154938395|NCT01078623|559201732|FG002|Treatment Period 3|Adverse Event|0|||
154938396|NCT01078623|559201733|FG003|Treatment Period 3|Adverse Event|0|||
154938397|NCT01078623|559201734|FG004|Treatment Period 3|Adverse Event|1|||
154938398|NCT01078623|559201735|FG005|Treatment Period 3|Adverse Event|0|||
154938399|NCT01078623|559201736|FG006|Treatment Period 3|Adverse Event|0|||
154938400|NCT01078623|559201737|FG007|Treatment Period 3|Adverse Event|0|||
154938401|NCT01078623|559201738|FG008|Treatment Period 3|Adverse Event|0|||
154938402|NCT01078623|559201739|FG009|Treatment Period 3|Adverse Event|0|||
154938403|NCT01078623|559201740|FG010|Treatment Period 3|Adverse Event|0|||
154938404|NCT01078623|559201741|FG011|Treatment Period 3|Adverse Event|0|||
154938405|NCT01078623|559201742|FG012|Treatment Period 3|Adverse Event|0|||
154938406|NCT01078623|559201743|FG013|Treatment Period 3|Adverse Event|1|||
154938407|NCT01078623|559201744|FG014|Treatment Period 3|Adverse Event|0|||
154938408|NCT01078623|559201745|FG015|Treatment Period 3|Adverse Event|0|||
154938409|NCT01078623|559201746|FG016|Treatment Period 3|Adverse Event|0|||
154938410|NCT01078623|559201747|FG017|Treatment Period 3|Adverse Event|0|||
154938411|NCT01078623|559201748|FG018|Treatment Period 3|Adverse Event|0|||
154938412|NCT01078623|559201749|FG019|Treatment Period 3|Adverse Event|0|||
154938413|NCT01078623|559201730|FG000|Treatment Period 4|Adverse Event|0|||
154938414|NCT01078623|559201731|FG001|Treatment Period 4|Adverse Event|0|||
154938415|NCT01078623|559201732|FG002|Treatment Period 4|Adverse Event|1|||
154938416|NCT01078623|559201733|FG003|Treatment Period 4|Adverse Event|0|||
154938417|NCT01078623|559201734|FG004|Treatment Period 4|Adverse Event|0|||
154938418|NCT01078623|559201735|FG005|Treatment Period 4|Adverse Event|0|||
154938419|NCT01078623|559201736|FG006|Treatment Period 4|Adverse Event|0|||
154938420|NCT01078623|559201737|FG007|Treatment Period 4|Adverse Event|0|||
154938421|NCT01078623|559201738|FG008|Treatment Period 4|Adverse Event|0|||
154938422|NCT01078623|559201739|FG009|Treatment Period 4|Adverse Event|0|||
154938423|NCT01078623|559201740|FG010|Treatment Period 4|Adverse Event|0|||
154938424|NCT01078623|559201741|FG011|Treatment Period 4|Adverse Event|0|||
154938425|NCT01078623|559201742|FG012|Treatment Period 4|Adverse Event|0|||
154938426|NCT01078623|559201743|FG013|Treatment Period 4|Adverse Event|0|||
154938427|NCT01078623|559201744|FG014|Treatment Period 4|Adverse Event|0|||
154938428|NCT01078623|559201745|FG015|Treatment Period 4|Adverse Event|0|||
154938429|NCT01078623|559201746|FG016|Treatment Period 4|Adverse Event|0|||
154938430|NCT01078623|559201747|FG017|Treatment Period 4|Adverse Event|0|||
154938431|NCT01078623|559201748|FG018|Treatment Period 4|Adverse Event|0|||
154938432|NCT01078623|559201749|FG019|Treatment Period 4|Adverse Event|0|||
154938433|NCT01078623|559201730|FG000|Treatment Period 4|Withdrawal by Subject|0|||
154938434|NCT01078623|559201731|FG001|Treatment Period 4|Withdrawal by Subject|0|||
154938435|NCT01078623|559201732|FG002|Treatment Period 4|Withdrawal by Subject|0|||
154938436|NCT01078623|559201733|FG003|Treatment Period 4|Withdrawal by Subject|0|||
154938437|NCT01078623|559201734|FG004|Treatment Period 4|Withdrawal by Subject|0|||
154938438|NCT01078623|559201735|FG005|Treatment Period 4|Withdrawal by Subject|0|||
154938439|NCT01078623|559201736|FG006|Treatment Period 4|Withdrawal by Subject|0|||
154938440|NCT01078623|559201737|FG007|Treatment Period 4|Withdrawal by Subject|0|||
154938441|NCT01078623|559201738|FG008|Treatment Period 4|Withdrawal by Subject|0|||
154938442|NCT01078623|559201739|FG009|Treatment Period 4|Withdrawal by Subject|0|||
154938443|NCT01078623|559201740|FG010|Treatment Period 4|Withdrawal by Subject|0|||
154938444|NCT01078623|559201741|FG011|Treatment Period 4|Withdrawal by Subject|0|||
154938445|NCT01078623|559201742|FG012|Treatment Period 4|Withdrawal by Subject|0|||
154938446|NCT01078623|559201743|FG013|Treatment Period 4|Withdrawal by Subject|0|||
154938447|NCT01078623|559201744|FG014|Treatment Period 4|Withdrawal by Subject|0|||
154938448|NCT01078623|559201745|FG015|Treatment Period 4|Withdrawal by Subject|1|||
154938449|NCT01078623|559201746|FG016|Treatment Period 4|Withdrawal by Subject|0|||
154938450|NCT01078623|559201747|FG017|Treatment Period 4|Withdrawal by Subject|0|||
154938451|NCT01078623|559201748|FG018|Treatment Period 4|Withdrawal by Subject|0|||
154938452|NCT01078623|559201749|FG019|Treatment Period 4|Withdrawal by Subject|0|||
154938453|NCT00463866|559201750|FG000|Overall Study|Adverse Event|70|||
154938454|NCT00463866|559201751|FG001|Overall Study|Adverse Event|93|||
154938455|NCT00463866|559201750|FG000|Overall Study|Withdrawal by Subject|81|||
154938456|NCT00463866|559201751|FG001|Overall Study|Withdrawal by Subject|79|||
154938457|NCT00463866|559201750|FG000|Overall Study|Lost to Follow-up|46|||
154938458|NCT00463866|559201751|FG001|Overall Study|Lost to Follow-up|55|||
154938459|NCT00463866|559201750|FG000|Overall Study|Incorrect Enrolment|64|||
154938460|NCT00463866|559201751|FG001|Overall Study|Incorrect Enrolment|66|||
154938461|NCT00463866|559201750|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
154938462|NCT00463866|559201751|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
154938463|NCT00463866|559201750|FG000|Overall Study|Safety Reason|1|||
154938464|NCT00463866|559201751|FG001|Overall Study|Safety Reason|3|||
154938465|NCT00463866|559201750|FG000|Overall Study|Mis-Randomization of subject|0|||
154938466|NCT00463866|559201751|FG001|Overall Study|Mis-Randomization of subject|1|||
154938467|NCT00463866|559201750|FG000|Overall Study|Other|22|||
154938468|NCT00463866|559201751|FG001|Overall Study|Other|22|||
154938469|NCT01084005|559201753|FG000|Overall Study|Adverse Event|1|||
154938470|NCT01084005|559201754|FG001|Overall Study|Adverse Event|8|||
154938471|NCT01084005|559201753|FG000|Overall Study|Protocol Violation|3|||
154938472|NCT01084005|559201754|FG001|Overall Study|Protocol Violation|7|||
154938473|NCT01084005|559201753|FG000|Overall Study|Withdrawal by Subject|1|||
154938474|NCT01084005|559201754|FG001|Overall Study|Withdrawal by Subject|1|||
154938475|NCT03568500|559201756|FG000|Overall Study|Lost to Follow-up|1|||
154938476|NCT03568500|559201757|FG001|Overall Study|Lost to Follow-up|1|||
154938477|NCT03568500|559201758|FG002|Overall Study|Lost to Follow-up|2|||
154938478|NCT03568500|559201756|FG000|Overall Study|Adverse Event|1|||
154938479|NCT03568500|559201757|FG001|Overall Study|Adverse Event|1|||
154938480|NCT03568500|559201758|FG002|Overall Study|Adverse Event|2|||
154938481|NCT03568500|559201756|FG000|Overall Study|Physician Decision|1|||
154938482|NCT03568500|559201757|FG001|Overall Study|Physician Decision|0|||
154938483|NCT03568500|559201758|FG002|Overall Study|Physician Decision|0|||
154938484|NCT03568500|559201756|FG000|Overall Study|Withdrawal by Subject|4|||
154938485|NCT03568500|559201757|FG001|Overall Study|Withdrawal by Subject|2|||
154938486|NCT03568500|559201758|FG002|Overall Study|Withdrawal by Subject|0|||
154938487|NCT03568500|559201756|FG000|Overall Study|Technical Problems|2|||
154938488|NCT03568500|559201757|FG001|Overall Study|Technical Problems|1|||
154938489|NCT03568500|559201758|FG002|Overall Study|Technical Problems|0|||
154938490|NCT03568500|559201756|FG000|Overall Study|Participant Noncompliance|1|||
154938491|NCT03568500|559201757|FG001|Overall Study|Participant Noncompliance|1|||
154938492|NCT03568500|559201758|FG002|Overall Study|Participant Noncompliance|0|||
154938493|NCT00472446|559201767|FG000|Overall Study|Protocol Violation|0|||
154938494|NCT00472446|559201768|FG001|Overall Study|Protocol Violation|0|||
154938495|NCT00472446|559201769|FG002|Overall Study|Protocol Violation|0|||
154938496|NCT00472446|559201770|FG003|Overall Study|Protocol Violation|1|||
154938497|NCT00472446|559201767|FG000|Overall Study|Reintervention|0|||
154938498|NCT00472446|559201768|FG001|Overall Study|Reintervention|0|||
154938499|NCT00472446|559201769|FG002|Overall Study|Reintervention|1|||
154938500|NCT00472446|559201770|FG003|Overall Study|Reintervention|1|||
154938501|NCT00472446|559201767|FG000|Overall Study|Questionnaires not returned|5|||
154938502|NCT00472446|559201768|FG001|Overall Study|Questionnaires not returned|6|||
154938503|NCT00472446|559201769|FG002|Overall Study|Questionnaires not returned|6|||
154938504|NCT00472446|559201770|FG003|Overall Study|Questionnaires not returned|4|||
154938505|NCT00910858|559201771|FG000|Pharmacokinetic Phase|Adverse Event|1|||
154938506|NCT00910858|559201772|FG001|Pharmacokinetic Phase|Adverse Event|0|||
154938507|NCT00910858|559201773|FG002|Pharmacokinetic Phase|Adverse Event|0|||
154938508|NCT00910858|559201771|FG000|Monotherapy Phase|Adverse Event|3|||
154938509|NCT00910858|559201772|FG001|Monotherapy Phase|Adverse Event|2|||
154938510|NCT00910858|559201773|FG002|Monotherapy Phase|Adverse Event|0|||
154938511|NCT00910858|559201771|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
154938512|NCT00910858|559201772|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
154938513|NCT00910858|559201773|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
154938514|NCT00910858|559201771|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
154938515|NCT00910858|559201772|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
154938516|NCT00910858|559201773|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
154938517|NCT00910858|559201771|FG000|Monotherapy Phase|Protocol Violation|1|||
154938518|NCT00910858|559201772|FG001|Monotherapy Phase|Protocol Violation|0|||
154938519|NCT00910858|559201773|FG002|Monotherapy Phase|Protocol Violation|0|||
154938520|NCT00910858|559201771|FG000|Monotherapy Phase|Other|3|||
154938521|NCT00910858|559201772|FG001|Monotherapy Phase|Other|4|||
154938522|NCT00910858|559201773|FG002|Monotherapy Phase|Other|2|||
154938523|NCT00910858|559201771|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
154938524|NCT00910858|559201772|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
154938525|NCT00910858|559201773|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
154938526|NCT00910858|559201771|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
154938527|NCT00910858|559201772|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
154938528|NCT00910858|559201773|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
154938529|NCT00910858|559201771|FG000|Combined Treatment Phase|Protocol Violation|1|||
154938530|NCT00910858|559201772|FG001|Combined Treatment Phase|Protocol Violation|0|||
154938531|NCT00910858|559201773|FG002|Combined Treatment Phase|Protocol Violation|0|||
154938532|NCT00910858|559201771|FG000|Combined Treatment Phase|Other|0|||
154938533|NCT00910858|559201772|FG001|Combined Treatment Phase|Other|2|||
154938534|NCT00910858|559201773|FG002|Combined Treatment Phase|Other|1|||
154938535|NCT01165684|559201777|FG000|Overall Study|Adverse Event|1|||
154938536|NCT01165684|559201778|FG001|Overall Study|Adverse Event|1|||
154938537|NCT01165684|559201777|FG000|Overall Study|Lack of Efficacy|2|||
154938538|NCT01165684|559201778|FG001|Overall Study|Lack of Efficacy|1|||
154938539|NCT01165684|559201777|FG000|Overall Study|Protocol Violation|7|||
154938540|NCT01165684|559201778|FG001|Overall Study|Protocol Violation|15|||
154938541|NCT01165684|559201777|FG000|Overall Study|Withdrawal Criteria|2|||
154938542|NCT01165684|559201778|FG001|Overall Study|Withdrawal Criteria|13|||
154938543|NCT01165684|559201777|FG000|Overall Study|Unclassified|16|||
154938544|NCT01165684|559201778|FG001|Overall Study|Unclassified|22|||
154938545|NCT02008721|559201779|FG000|Overall Study|Withdrawal by Subject|5|||
154938546|NCT02008721|559201780|FG001|Overall Study|Withdrawal by Subject|1|||
154938547|NCT02008721|559201779|FG000|Overall Study|Death|4|||
154938548|NCT02008721|559201780|FG001|Overall Study|Death|2|||
154938549|NCT02008721|559201779|FG000|Overall Study|Adverse Event|3|||
154938550|NCT02008721|559201780|FG001|Overall Study|Adverse Event|5|||
154938551|NCT02008721|559201779|FG000|Overall Study|Protocol Violation|3|||
154938552|NCT02008721|559201780|FG001|Overall Study|Protocol Violation|2|||
154938553|NCT01797120|559201783|FG000|Overall Study|Disesae progression|37|||
154938554|NCT01797120|559201784|FG001|Overall Study|Disesae progression|49|||
154938555|NCT01797120|559201783|FG000|Overall Study|Adverse Event|13|||
154938556|NCT01797120|559201784|FG001|Overall Study|Adverse Event|5|||
154938557|NCT01797120|559201783|FG000|Overall Study|Withdrawal by Subject|6|||
154938558|NCT01797120|559201784|FG001|Overall Study|Withdrawal by Subject|6|||
154938559|NCT01797120|559201783|FG000|Overall Study|Symptomatic progression|2|||
154938560|NCT01797120|559201784|FG001|Overall Study|Symptomatic progression|1|||
154938561|NCT01797120|559201783|FG000|Overall Study|Non-compliance|1|||
154938562|NCT01797120|559201784|FG001|Overall Study|Non-compliance|0|||
154938563|NCT01797120|559201783|FG000|Overall Study|Physician Decision|3|||
154938564|NCT01797120|559201784|FG001|Overall Study|Physician Decision|0|||
154938565|NCT01797120|559201783|FG000|Overall Study|still on treatment|2|||
154938566|NCT01797120|559201784|FG001|Overall Study|still on treatment|4|||
154938567|NCT01797120|559201783|FG000|Overall Study|never start protocol therapy|2|||
154938568|NCT01797120|559201784|FG001|Overall Study|never start protocol therapy|0|||
154938569|NCT03211156|559201785|FG000|Overall Study|Withdrawal by Subject|0|||
154938570|NCT03211156|559201786|FG001|Overall Study|Withdrawal by Subject|2|||
154938571|NCT03211156|559201785|FG000|Overall Study|Lost to Follow-up|1|||
154938572|NCT03211156|559201786|FG001|Overall Study|Lost to Follow-up|1|||
154938573|NCT03211156|559201785|FG000|Overall Study|Adverse Event|1|||
155043464|NCT01826981|559590125|FG003|Overall Study|Adverse Event|0|||
154938574|NCT03211156|559201786|FG001|Overall Study|Adverse Event|0|||
154938575|NCT04120194|559201790|FG000|Overall Study|Lost to Follow-up|11|||
154938576|NCT04120194|559201791|FG001|Overall Study|Lost to Follow-up|8|||
154938577|NCT04120194|559201790|FG000|Overall Study|Adverse Event|4|||
154938578|NCT04120194|559201791|FG001|Overall Study|Adverse Event|5|||
154938579|NCT04120194|559201790|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
154938580|NCT04120194|559201791|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
154938581|NCT04120194|559201790|FG000|Overall Study|Miscellaneous|4|||
154938582|NCT04120194|559201791|FG001|Overall Study|Miscellaneous|5|||
154938583|NCT02114931|559201792|FG000|Overall Study|Withdrawal by Subject|15|||
154938584|NCT02114931|559201793|FG001|Overall Study|Withdrawal by Subject|18|||
154938585|NCT02114931|559201792|FG000|Overall Study|Adverse Event|4|||
154938586|NCT02114931|559201793|FG001|Overall Study|Adverse Event|6|||
154938587|NCT02114931|559201792|FG000|Overall Study|Lost to Follow-up|3|||
154938588|NCT02114931|559201793|FG001|Overall Study|Lost to Follow-up|3|||
154938589|NCT02114931|559201792|FG000|Overall Study|Physician Decision|1|||
154938590|NCT02114931|559201793|FG001|Overall Study|Physician Decision|2|||
154938591|NCT02114931|559201792|FG000|Overall Study|Other|2|||
154938592|NCT02114931|559201793|FG001|Overall Study|Other|1|||
154938593|NCT03565211|559201794|FG000|Overall Study|Withdrawal by Subject|2|||
154938594|NCT03565211|559201794|FG000|Overall Study|Lost to Follow-up|1|||
154938595|NCT03565211|559201794|FG000|Overall Study|Adverse Event|44|||
154938596|NCT03565211|559201794|FG000|Overall Study|Personal issues|1|||
154938597|NCT00323609|559201795|FG000|Overall Study|Death|16|||
154938598|NCT00323609|559201796|FG001|Overall Study|Death|21|||
154938599|NCT00323609|559201797|FG002|Overall Study|Death|0|||
154938600|NCT00323609|559201798|FG003|Overall Study|Death|0|||
154938601|NCT00323609|559201795|FG000|Overall Study|Lost to Follow-up|9|||
154938602|NCT00323609|559201796|FG001|Overall Study|Lost to Follow-up|10|||
154938603|NCT00323609|559201797|FG002|Overall Study|Lost to Follow-up|0|||
154938604|NCT00323609|559201798|FG003|Overall Study|Lost to Follow-up|0|||
154938605|NCT00323609|559201795|FG000|Overall Study|Physician Decision|2|||
154938606|NCT00323609|559201796|FG001|Overall Study|Physician Decision|0|||
154938607|NCT00323609|559201797|FG002|Overall Study|Physician Decision|0|||
154938608|NCT00323609|559201798|FG003|Overall Study|Physician Decision|1|||
154938609|NCT00323609|559201795|FG000|Overall Study|Withdrawal by Subject|11|||
154938610|NCT00323609|559201796|FG001|Overall Study|Withdrawal by Subject|23|||
154938611|NCT00323609|559201797|FG002|Overall Study|Withdrawal by Subject|4|||
154938612|NCT00323609|559201798|FG003|Overall Study|Withdrawal by Subject|4|||
154938613|NCT00323609|559201795|FG000|Overall Study|Other non-VCF-related medical condition|3|||
154938614|NCT00323609|559201796|FG001|Overall Study|Other non-VCF-related medical condition|2|||
154938615|NCT00323609|559201797|FG002|Overall Study|Other non-VCF-related medical condition|0|||
154938616|NCT00323609|559201798|FG003|Overall Study|Other non-VCF-related medical condition|0|||
154938617|NCT00323609|559201795|FG000|Overall Study|Sponsor discontinued trial|29|||
154938618|NCT00323609|559201796|FG001|Overall Study|Sponsor discontinued trial|29|||
154938619|NCT00323609|559201797|FG002|Overall Study|Sponsor discontinued trial|0|||
154938620|NCT00323609|559201798|FG003|Overall Study|Sponsor discontinued trial|0|||
154938621|NCT00323609|559201795|FG000|Overall Study|Unrelenting or severe back pain|1|||
154938622|NCT00323609|559201796|FG001|Overall Study|Unrelenting or severe back pain|1|||
154938623|NCT00323609|559201797|FG002|Overall Study|Unrelenting or severe back pain|0|||
154938624|NCT00323609|559201798|FG003|Overall Study|Unrelenting or severe back pain|0|||
154938625|NCT00323609|559201795|FG000|Overall Study|Logistical withdrawal|9|||
154938626|NCT00323609|559201796|FG001|Overall Study|Logistical withdrawal|5|||
154938627|NCT00323609|559201797|FG002|Overall Study|Logistical withdrawal|0|||
154938628|NCT00323609|559201798|FG003|Overall Study|Logistical withdrawal|1|||
154938629|NCT00323609|559201795|FG000|Overall Study|Other reason|11|||
154938630|NCT00323609|559201796|FG001|Overall Study|Other reason|8|||
154938631|NCT00323609|559201797|FG002|Overall Study|Other reason|4|||
154938632|NCT00323609|559201798|FG003|Overall Study|Other reason|9|||
154938633|NCT00219557|559201803|FG000|Phase 1|Lack of Efficacy|3|||
154938634|NCT00219557|559201804|FG001|Phase 1|Lack of Efficacy|0|||
154938635|NCT00219557|559201805|FG002|Phase 1|Lack of Efficacy|0|||
154938636|NCT00219557|559201803|FG000|Phase 1|Adverse Event|2|||
154938637|NCT00219557|559201804|FG001|Phase 1|Adverse Event|0|||
154938638|NCT00219557|559201805|FG002|Phase 1|Adverse Event|0|||
154938639|NCT00219557|559201803|FG000|Phase 1|Withdrawal by Subject|1|||
154938640|NCT00219557|559201804|FG001|Phase 1|Withdrawal by Subject|0|||
154938641|NCT00219557|559201805|FG002|Phase 1|Withdrawal by Subject|0|||
154938642|NCT00219557|559201803|FG000|Phase 1|Started chemotherapy at other institute|1|||
154938643|NCT00219557|559201804|FG001|Phase 1|Started chemotherapy at other institute|0|||
154938644|NCT00219557|559201805|FG002|Phase 1|Started chemotherapy at other institute|0|||
154938645|NCT00219557|559201803|FG000|Phase 2|Lack of Efficacy|0|||
154938646|NCT00219557|559201804|FG001|Phase 2|Lack of Efficacy|21|||
154938647|NCT00219557|559201805|FG002|Phase 2|Lack of Efficacy|15|||
155043465|NCT01826981|559590126|FG004|Overall Study|Adverse Event|1|||
155043466|NCT01826981|559590127|FG005|Overall Study|Adverse Event|0|||
154938648|NCT00219557|559201803|FG000|Phase 2|Adverse Event|0|||
154938649|NCT00219557|559201804|FG001|Phase 2|Adverse Event|22|||
154938650|NCT00219557|559201805|FG002|Phase 2|Adverse Event|2|||
154938651|NCT00219557|559201803|FG000|Phase 2|Death|0|||
154938652|NCT00219557|559201804|FG001|Phase 2|Death|8|||
154938653|NCT00219557|559201805|FG002|Phase 2|Death|2|||
154938654|NCT00219557|559201803|FG000|Phase 2|Other|0|||
154938655|NCT00219557|559201804|FG001|Phase 2|Other|8|||
154938656|NCT00219557|559201805|FG002|Phase 2|Other|6|||
154938657|NCT00219557|559201803|FG000|Phase 2|Withdrawal by Subject|0|||
154938658|NCT00219557|559201804|FG001|Phase 2|Withdrawal by Subject|9|||
154938659|NCT00219557|559201805|FG002|Phase 2|Withdrawal by Subject|5|||
154938660|NCT00219557|559201803|FG000|Phase 2|Treatment not received|0|||
154938661|NCT00219557|559201804|FG001|Phase 2|Treatment not received|1|||
154938662|NCT00219557|559201805|FG002|Phase 2|Treatment not received|3|||
154938663|NCT01612156|559201810|FG000|Overall Study|Protocol Violation|2|||
155277330|NCT04423393|560449032|FG009|Overall Study|Withdrawal by Subject|0|||
155277331|NCT04423393|560449033|FG010|Overall Study|Withdrawal by Subject|0|||
154938664|NCT01612156|559201811|FG001|Overall Study|Protocol Violation|0|||
154938665|NCT00410410|559201812|FG000|Induction Period (IP)|Death|1|||
154938666|NCT00410410|559201813|FG001|Induction Period (IP)|Death|0|||
154938667|NCT00410410|559201814|FG002|Induction Period (IP)|Death|0|||
154938668|NCT00410410|559201815|FG003|Induction Period (IP)|Death|0|||
154938669|NCT00410410|559201816|FG004|Induction Period (IP)|Death|0|||
154938670|NCT00410410|559201817|FG005|Induction Period (IP)|Death|0|||
154938671|NCT00410410|559201818|FG006|Induction Period (IP)|Death|0|||
154938672|NCT00410410|559201819|FG007|Induction Period (IP)|Death|0|||
154938673|NCT00410410|559201820|FG008|Induction Period (IP)|Death|0|||
154938674|NCT00410410|559201812|FG000|Induction Period (IP)|Adverse Event|3|||
154938675|NCT00410410|559201813|FG001|Induction Period (IP)|Adverse Event|4|||
154938676|NCT00410410|559201814|FG002|Induction Period (IP)|Adverse Event|2|||
154938677|NCT00410410|559201815|FG003|Induction Period (IP)|Adverse Event|4|||
154938678|NCT00410410|559201816|FG004|Induction Period (IP)|Adverse Event|1|||
154938679|NCT00410410|559201817|FG005|Induction Period (IP)|Adverse Event|0|||
154938680|NCT00410410|559201818|FG006|Induction Period (IP)|Adverse Event|0|||
154938681|NCT00410410|559201819|FG007|Induction Period (IP)|Adverse Event|0|||
154938682|NCT00410410|559201820|FG008|Induction Period (IP)|Adverse Event|0|||
154938683|NCT00410410|559201812|FG000|Induction Period (IP)|Lack of Efficacy|26|||
154938684|NCT00410410|559201813|FG001|Induction Period (IP)|Lack of Efficacy|24|||
154938685|NCT00410410|559201814|FG002|Induction Period (IP)|Lack of Efficacy|8|||
154938686|NCT00410410|559201815|FG003|Induction Period (IP)|Lack of Efficacy|8|||
154938687|NCT00410410|559201816|FG004|Induction Period (IP)|Lack of Efficacy|7|||
154938688|NCT00410410|559201817|FG005|Induction Period (IP)|Lack of Efficacy|7|||
154938689|NCT00410410|559201818|FG006|Induction Period (IP)|Lack of Efficacy|0|||
154938690|NCT00410410|559201819|FG007|Induction Period (IP)|Lack of Efficacy|0|||
154938691|NCT00410410|559201820|FG008|Induction Period (IP)|Lack of Efficacy|0|||
154938692|NCT00410410|559201812|FG000|Induction Period (IP)|Lost to Follow-up|2|||
154938693|NCT00410410|559201813|FG001|Induction Period (IP)|Lost to Follow-up|2|||
154938694|NCT00410410|559201814|FG002|Induction Period (IP)|Lost to Follow-up|2|||
154938695|NCT00410410|559201815|FG003|Induction Period (IP)|Lost to Follow-up|3|||
154938696|NCT00410410|559201816|FG004|Induction Period (IP)|Lost to Follow-up|0|||
154938697|NCT00410410|559201817|FG005|Induction Period (IP)|Lost to Follow-up|1|||
154938698|NCT00410410|559201818|FG006|Induction Period (IP)|Lost to Follow-up|0|||
154938699|NCT00410410|559201819|FG007|Induction Period (IP)|Lost to Follow-up|0|||
154938700|NCT00410410|559201820|FG008|Induction Period (IP)|Lost to Follow-up|0|||
154938701|NCT00410410|559201812|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
154938702|NCT00410410|559201813|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
154938703|NCT00410410|559201814|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
154938704|NCT00410410|559201815|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
154938705|NCT00410410|559201816|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
154938706|NCT00410410|559201817|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
154938707|NCT00410410|559201818|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
154938708|NCT00410410|559201819|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
154938709|NCT00410410|559201820|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
154938710|NCT00410410|559201812|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938711|NCT00410410|559201813|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938712|NCT00410410|559201814|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
154938713|NCT00410410|559201815|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938714|NCT00410410|559201816|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938715|NCT00410410|559201817|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938716|NCT00410410|559201818|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938717|NCT00410410|559201819|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938718|NCT00410410|559201820|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
154938719|NCT00410410|559201812|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938720|NCT00410410|559201813|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938721|NCT00410410|559201814|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938722|NCT00410410|559201815|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938723|NCT00410410|559201816|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
154938724|NCT00410410|559201817|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
154938725|NCT00410410|559201818|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938726|NCT00410410|559201819|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938727|NCT00410410|559201820|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
154938728|NCT00410410|559201812|FG000|Induction Period (IP)|Other|0|||
154938729|NCT00410410|559201813|FG001|Induction Period (IP)|Other|0|||
154938730|NCT00410410|559201814|FG002|Induction Period (IP)|Other|1|||
154938731|NCT00410410|559201815|FG003|Induction Period (IP)|Other|0|||
154938732|NCT00410410|559201816|FG004|Induction Period (IP)|Other|0|||
154938733|NCT00410410|559201817|FG005|Induction Period (IP)|Other|0|||
154938734|NCT00410410|559201818|FG006|Induction Period (IP)|Other|0|||
154938735|NCT00410410|559201819|FG007|Induction Period (IP)|Other|0|||
154938736|NCT00410410|559201820|FG008|Induction Period (IP)|Other|0|||
154938737|NCT00410410|559201812|FG000|Maintenance Period (MP)|Death|0|||
154938738|NCT00410410|559201813|FG001|Maintenance Period (MP)|Death|0|||
154938739|NCT00410410|559201814|FG002|Maintenance Period (MP)|Death|0|||
154938740|NCT00410410|559201815|FG003|Maintenance Period (MP)|Death|0|||
154938741|NCT00410410|559201816|FG004|Maintenance Period (MP)|Death|0|||
154938742|NCT00410410|559201817|FG005|Maintenance Period (MP)|Death|0|||
154938743|NCT00410410|559201818|FG006|Maintenance Period (MP)|Death|1|||
154938744|NCT00410410|559201819|FG007|Maintenance Period (MP)|Death|0|||
154938745|NCT00410410|559201820|FG008|Maintenance Period (MP)|Death|0|||
154938746|NCT00410410|559201812|FG000|Maintenance Period (MP)|Adverse Event|0|||
154938747|NCT00410410|559201813|FG001|Maintenance Period (MP)|Adverse Event|0|||
154938748|NCT00410410|559201814|FG002|Maintenance Period (MP)|Adverse Event|0|||
154938749|NCT00410410|559201815|FG003|Maintenance Period (MP)|Adverse Event|0|||
154938750|NCT00410410|559201816|FG004|Maintenance Period (MP)|Adverse Event|0|||
154938751|NCT00410410|559201817|FG005|Maintenance Period (MP)|Adverse Event|0|||
154938752|NCT00410410|559201818|FG006|Maintenance Period (MP)|Adverse Event|1|||
154938753|NCT00410410|559201819|FG007|Maintenance Period (MP)|Adverse Event|3|||
154938754|NCT00410410|559201820|FG008|Maintenance Period (MP)|Adverse Event|0|||
154938755|NCT00410410|559201812|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
154938756|NCT00410410|559201813|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
154938757|NCT00410410|559201814|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
154938758|NCT00410410|559201815|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
154938759|NCT00410410|559201816|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
154938760|NCT00410410|559201817|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
154938761|NCT00410410|559201818|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
154938762|NCT00410410|559201819|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
154938763|NCT00410410|559201820|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
154938764|NCT00410410|559201812|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
154938765|NCT00410410|559201813|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
154938766|NCT00410410|559201814|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
154938767|NCT00410410|559201815|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
154938768|NCT00410410|559201816|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
154938769|NCT00410410|559201817|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
154938770|NCT00410410|559201818|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
154938771|NCT00410410|559201819|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
154938772|NCT00410410|559201820|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
154938773|NCT00410410|559201812|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938774|NCT00410410|559201813|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938775|NCT00410410|559201814|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938776|NCT00410410|559201815|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938777|NCT00410410|559201816|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938778|NCT00410410|559201817|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938779|NCT00410410|559201818|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
154938780|NCT00410410|559201819|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
154938781|NCT00410410|559201820|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
154938782|NCT00410410|559201812|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938783|NCT00410410|559201813|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938784|NCT00410410|559201814|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938785|NCT00410410|559201815|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938786|NCT00410410|559201816|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938787|NCT00410410|559201817|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938788|NCT00410410|559201818|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
154938789|NCT00410410|559201819|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
154938790|NCT00410410|559201820|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
154938791|NCT00410410|559201812|FG000|Open-Label Period (OL)|Death|0|||
154938792|NCT00410410|559201813|FG001|Open-Label Period (OL)|Death|0|||
154938793|NCT00410410|559201814|FG002|Open-Label Period (OL)|Death|0|||
154938794|NCT00410410|559201815|FG003|Open-Label Period (OL)|Death|0|||
154938795|NCT00410410|559201816|FG004|Open-Label Period (OL)|Death|0|||
154938796|NCT00410410|559201817|FG005|Open-Label Period (OL)|Death|0|||
154938797|NCT00410410|559201818|FG006|Open-Label Period (OL)|Death|0|||
154938798|NCT00410410|559201819|FG007|Open-Label Period (OL)|Death|0|||
154938799|NCT00410410|559201820|FG008|Open-Label Period (OL)|Death|1|||
154938800|NCT00410410|559201812|FG000|Open-Label Period (OL)|Adverse Event|0|||
154938801|NCT00410410|559201813|FG001|Open-Label Period (OL)|Adverse Event|0|||
154938802|NCT00410410|559201814|FG002|Open-Label Period (OL)|Adverse Event|0|||
154938803|NCT00410410|559201815|FG003|Open-Label Period (OL)|Adverse Event|0|||
154938804|NCT00410410|559201816|FG004|Open-Label Period (OL)|Adverse Event|0|||
154938805|NCT00410410|559201817|FG005|Open-Label Period (OL)|Adverse Event|0|||
154938806|NCT00410410|559201818|FG006|Open-Label Period (OL)|Adverse Event|0|||
154938807|NCT00410410|559201819|FG007|Open-Label Period (OL)|Adverse Event|0|||
154938808|NCT00410410|559201820|FG008|Open-Label Period (OL)|Adverse Event|10|||
154938809|NCT00410410|559201812|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
154938810|NCT00410410|559201813|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
154938811|NCT00410410|559201814|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
154938812|NCT00410410|559201815|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
154938813|NCT00410410|559201816|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
154938814|NCT00410410|559201817|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
154938815|NCT00410410|559201818|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
154938816|NCT00410410|559201819|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
155043467|NCT01826981|559590128|FG006|Overall Study|Adverse Event|0|||
155043468|NCT01826981|559590129|FG007|Overall Study|Adverse Event|0|||
155043469|NCT01826981|559590130|FG008|Overall Study|Adverse Event|0|||
155043470|NCT01826981|559590131|FG009|Overall Study|Adverse Event|0|||
155043471|NCT01826981|559590132|FG010|Overall Study|Adverse Event|0|||
155043472|NCT01826981|559590133|FG011|Overall Study|Adverse Event|0|||
155043473|NCT01826981|559590134|FG012|Overall Study|Adverse Event|0|||
155043474|NCT01826981|559590135|FG013|Overall Study|Adverse Event|0|||
155043475|NCT01826981|559590136|FG014|Overall Study|Adverse Event|0|||
155043476|NCT01826981|559590122|FG000|Overall Study|Upper G-I Haemorrhage|0|||
155043477|NCT01826981|559590123|FG001|Overall Study|Upper G-I Haemorrhage|0|||
155043478|NCT01826981|559590124|FG002|Overall Study|Upper G-I Haemorrhage|0|||
155043479|NCT01826981|559590125|FG003|Overall Study|Upper G-I Haemorrhage|0|||
155043480|NCT01826981|559590126|FG004|Overall Study|Upper G-I Haemorrhage|0|||
155043481|NCT01826981|559590127|FG005|Overall Study|Upper G-I Haemorrhage|0|||
155043482|NCT01826981|559590128|FG006|Overall Study|Upper G-I Haemorrhage|0|||
155043483|NCT01826981|559590129|FG007|Overall Study|Upper G-I Haemorrhage|0|||
155043484|NCT01826981|559590130|FG008|Overall Study|Upper G-I Haemorrhage|0|||
155043485|NCT01826981|559590131|FG009|Overall Study|Upper G-I Haemorrhage|0|||
155043486|NCT01826981|559590132|FG010|Overall Study|Upper G-I Haemorrhage|0|||
155043487|NCT01826981|559590133|FG011|Overall Study|Upper G-I Haemorrhage|0|||
155043488|NCT01826981|559590134|FG012|Overall Study|Upper G-I Haemorrhage|0|||
155043489|NCT01826981|559590135|FG013|Overall Study|Upper G-I Haemorrhage|1|||
155043490|NCT01826981|559590136|FG014|Overall Study|Upper G-I Haemorrhage|0|||
155043491|NCT01826981|559590122|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043492|NCT01826981|559590123|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043493|NCT01826981|559590124|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043494|NCT01826981|559590125|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043495|NCT01826981|559590126|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043496|NCT01826981|559590127|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043497|NCT01826981|559590128|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043498|NCT01826981|559590129|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
155043499|NCT01826981|559590130|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043500|NCT01826981|559590131|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043501|NCT01826981|559590132|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043502|NCT01826981|559590133|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043503|NCT01826981|559590134|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043504|NCT01826981|559590135|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043505|NCT01826981|559590136|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
155043506|NCT02384538|559590151|FG000|Overall Study|Adverse Event|1|||
155043507|NCT02384538|559590152|FG001|Overall Study|Adverse Event|4|||
155043508|NCT02384538|559590151|FG000|Overall Study|Lack of Efficacy|4|||
155043509|NCT02384538|559590152|FG001|Overall Study|Lack of Efficacy|4|||
155043510|NCT02384538|559590151|FG000|Overall Study|Withdrew Consent|0|||
155043511|NCT02384538|559590152|FG001|Overall Study|Withdrew Consent|4|||
155043512|NCT02384538|559590151|FG000|Overall Study|Other|1|||
155043513|NCT02384538|559590152|FG001|Overall Study|Other|3|||
155043514|NCT02187029|559590155|FG000|Overall Study|Adverse Event|0|||
155043515|NCT02187029|559590156|FG001|Overall Study|Adverse Event|1|||
155043516|NCT02187029|559590157|FG002|Overall Study|Adverse Event|1|||
155043517|NCT02187029|559590158|FG003|Overall Study|Adverse Event|0|||
155043518|NCT02187029|559590155|FG000|Overall Study|Study Terminated by Sponsor|0|||
155043519|NCT02187029|559590156|FG001|Overall Study|Study Terminated by Sponsor|0|||
155043520|NCT02187029|559590157|FG002|Overall Study|Study Terminated by Sponsor|10|||
155043521|NCT02187029|559590158|FG003|Overall Study|Study Terminated by Sponsor|3|||
155043522|NCT02187029|559590155|FG000|Overall Study|Withdrawal by Subject|1|||
155043523|NCT02187029|559590156|FG001|Overall Study|Withdrawal by Subject|0|||
155043524|NCT02187029|559590157|FG002|Overall Study|Withdrawal by Subject|0|||
155043525|NCT02187029|559590158|FG003|Overall Study|Withdrawal by Subject|0|||
155043526|NCT01763203|559590161|FG000|Overall Study|Death|4|||
155043527|NCT01763203|559590162|FG001|Overall Study|Death|7|||
155043528|NCT01763203|559590161|FG000|Overall Study|Lost to Follow-up|12|||
155043529|NCT01763203|559590162|FG001|Overall Study|Lost to Follow-up|12|||
155043530|NCT01763203|559590161|FG000|Overall Study|Withdrawal by Subject|8|||
155043531|NCT01763203|559590162|FG001|Overall Study|Withdrawal by Subject|12|||
154938817|NCT00410410|559201820|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
155043532|NCT01763203|559590161|FG000|Overall Study|Moved out of study region|7|||
155043533|NCT01763203|559590162|FG001|Overall Study|Moved out of study region|10|||
154938818|NCT00410410|559201812|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
154938819|NCT00410410|559201813|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
154938820|NCT00410410|559201814|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
154938821|NCT00410410|559201815|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
154938822|NCT00410410|559201816|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
154938823|NCT00410410|559201817|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
154938824|NCT00410410|559201818|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
154938825|NCT00410410|559201819|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
154938826|NCT00410410|559201820|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
154938827|NCT00410410|559201812|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938828|NCT00410410|559201813|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938829|NCT00410410|559201814|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938830|NCT00410410|559201815|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938831|NCT00410410|559201816|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938832|NCT00410410|559201817|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938833|NCT00410410|559201818|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938834|NCT00410410|559201819|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
154938835|NCT00410410|559201820|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
154938836|NCT00410410|559201812|FG000|Open-Label Period (OL)|Pregnancy|0|||
154938837|NCT00410410|559201813|FG001|Open-Label Period (OL)|Pregnancy|0|||
154938838|NCT00410410|559201814|FG002|Open-Label Period (OL)|Pregnancy|0|||
154938839|NCT00410410|559201815|FG003|Open-Label Period (OL)|Pregnancy|0|||
154938840|NCT00410410|559201816|FG004|Open-Label Period (OL)|Pregnancy|0|||
154938841|NCT00410410|559201817|FG005|Open-Label Period (OL)|Pregnancy|0|||
154938842|NCT00410410|559201818|FG006|Open-Label Period (OL)|Pregnancy|0|||
154938843|NCT00410410|559201819|FG007|Open-Label Period (OL)|Pregnancy|0|||
154938844|NCT00410410|559201820|FG008|Open-Label Period (OL)|Pregnancy|1|||
154938845|NCT00410410|559201812|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938846|NCT00410410|559201813|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938847|NCT00410410|559201814|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938848|NCT00410410|559201815|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938849|NCT00410410|559201816|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938850|NCT00410410|559201817|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938851|NCT00410410|559201818|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938852|NCT00410410|559201819|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
154938853|NCT00410410|559201820|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
154938854|NCT00410410|559201812|FG000|Open-Label Period (OL)|Other|0|||
154938855|NCT00410410|559201813|FG001|Open-Label Period (OL)|Other|0|||
154938856|NCT00410410|559201814|FG002|Open-Label Period (OL)|Other|0|||
154938857|NCT00410410|559201815|FG003|Open-Label Period (OL)|Other|0|||
154938858|NCT00410410|559201816|FG004|Open-Label Period (OL)|Other|0|||
154938859|NCT00410410|559201817|FG005|Open-Label Period (OL)|Other|0|||
154938860|NCT00410410|559201818|FG006|Open-Label Period (OL)|Other|0|||
154938861|NCT00410410|559201819|FG007|Open-Label Period (OL)|Other|0|||
154938862|NCT00410410|559201820|FG008|Open-Label Period (OL)|Other|7|||
154938863|NCT01023269|559201821|FG000|Overall Study|early termination of the study|2|||
154938864|NCT01023269|559201822|FG001|Overall Study|early termination of the study|0|||
154938865|NCT01953783|559201823|FG000|Overall Study|Progressive disease|2|||
154938866|NCT01789281|559201824|FG000|Overall Study|Disease progression|15|||
154938867|NCT01789281|559201825|FG001|Overall Study|Disease progression|4|||
154938868|NCT01789281|559201824|FG000|Overall Study|Adverse Event|5|||
154938869|NCT01789281|559201825|FG001|Overall Study|Adverse Event|5|||
154938870|NCT01789281|559201824|FG000|Overall Study|Withdrawal by Subject|1|||
154938871|NCT01789281|559201825|FG001|Overall Study|Withdrawal by Subject|0|||
154938872|NCT01789281|559201824|FG000|Overall Study|Lost to Follow-up|1|||
154938873|NCT01789281|559201825|FG001|Overall Study|Lost to Follow-up|0|||
154938874|NCT01789281|559201824|FG000|Overall Study|Administrative problems|0|||
154938875|NCT01789281|559201825|FG001|Overall Study|Administrative problems|1|||
154938876|NCT00106028|559201826|FG000|Overall Study|Adverse Event|3|||
154938877|NCT00106028|559201827|FG001|Overall Study|Adverse Event|2|||
154938878|NCT00106028|559201826|FG000|Overall Study|Protocol Violation|1|||
154938879|NCT00106028|559201827|FG001|Overall Study|Protocol Violation|1|||
154938880|NCT00106028|559201826|FG000|Overall Study|Withdrawal by Subject|2|||
154938881|NCT00106028|559201827|FG001|Overall Study|Withdrawal by Subject|8|||
154938882|NCT00106028|559201826|FG000|Overall Study|Lost to Follow-up|0|||
154938883|NCT00106028|559201827|FG001|Overall Study|Lost to Follow-up|1|||
154938884|NCT00814658|559201829|FG000|Overall Study|Lost to Follow-up|0|||
154938885|NCT00814658|559201830|FG001|Overall Study|Lost to Follow-up|1|||
154938886|NCT00814658|559201829|FG000|Overall Study|Physician Decision|1|||
154938887|NCT00814658|559201830|FG001|Overall Study|Physician Decision|0|||
154938888|NCT00814658|559201829|FG000|Overall Study|Adverse Event|3|||
154938889|NCT00814658|559201830|FG001|Overall Study|Adverse Event|3|||
154938890|NCT01141283|559201832|FG000|Overall Study|Adverse Event|56|||
154938891|NCT01141283|559201832|FG000|Overall Study|Lost to Follow-up|4|||
154938892|NCT01141283|559201832|FG000|Overall Study|Withdrawal by Subject|14|||
154938893|NCT01141283|559201832|FG000|Overall Study|Administrative|4|||
154938894|NCT01141283|559201832|FG000|Overall Study|Lack of Efficacy|10|||
154938895|NCT00545233|559201834|FG000|Overall Study|Adverse Event|10|||
154938896|NCT00545233|559201835|FG001|Overall Study|Adverse Event|5|||
154938897|NCT00545233|559201834|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
154938898|NCT00545233|559201835|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
154938899|NCT00545233|559201834|FG000|Overall Study|Protocol Violation|2|||
154938900|NCT00545233|559201835|FG001|Overall Study|Protocol Violation|0|||
154938901|NCT00545233|559201834|FG000|Overall Study|Refused Treatment|9|||
154938902|NCT00545233|559201835|FG001|Overall Study|Refused Treatment|7|||
154938903|NCT00545233|559201834|FG000|Overall Study|Failure to Return|4|||
154938904|NCT00545233|559201835|FG001|Overall Study|Failure to Return|6|||
154938905|NCT00545233|559201834|FG000|Overall Study|Insufficient response|14|||
154938906|NCT00545233|559201835|FG001|Overall Study|Insufficient response|15|||
154938907|NCT00545233|559201834|FG000|Overall Study|Physician Decision|2|||
154938908|NCT00545233|559201835|FG001|Overall Study|Physician Decision|1|||
154938909|NCT06371079|559201836|FG000|Overall Study|Missing data|88|||
154938910|NCT06371079|559201837|FG001|Overall Study|Missing data|247|||
154938911|NCT01238211|559201838|FG000|Overall Study|Continues active treatment|31|||
154938912|NCT01238211|559201838|FG000|Overall Study|Adverse Event|7|||
154938913|NCT01238211|559201838|FG000|Overall Study|Death|4|||
154938914|NCT01238211|559201838|FG000|Overall Study|Relapse/Progression|2|||
154938915|NCT01238211|559201838|FG000|Overall Study|Withdrawal by Subject|7|||
154938916|NCT01238211|559201838|FG000|Overall Study|Non-protocol treatment|4|||
154938917|NCT01238211|559201838|FG000|Overall Study|Investigator/Patient Decision|3|||
154938918|NCT00449930|559201839|FG000|Overall Study|Adverse Event|9|||
154938919|NCT00449930|559201840|FG001|Overall Study|Adverse Event|19|||
154938920|NCT00449930|559201839|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
154938921|NCT00449930|559201840|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
154938922|NCT00449930|559201839|FG000|Overall Study|Lack of Efficacy|10|||
154938923|NCT00449930|559201840|FG001|Overall Study|Lack of Efficacy|1|||
154938924|NCT00449930|559201839|FG000|Overall Study|Lost to Follow-up|9|||
154938925|NCT00449930|559201840|FG001|Overall Study|Lost to Follow-up|14|||
154938926|NCT00449930|559201839|FG000|Overall Study|Physician Decision|1|||
155043534|NCT01763203|559590161|FG000|Overall Study|Physician Decision|2|||
155043535|NCT01763203|559590162|FG001|Overall Study|Physician Decision|1|||
155043536|NCT02187861|559590163|FG000|Overall Study|Adverse Event|2|||
155043537|NCT02187861|559590164|FG001|Overall Study|Adverse Event|1|||
155043538|NCT02187861|559590165|FG002|Overall Study|Adverse Event|2|||
155043539|NCT02187861|559590166|FG003|Overall Study|Adverse Event|1|||
155043540|NCT02187861|559590163|FG000|Overall Study|Death|0|||
155043541|NCT02187861|559590164|FG001|Overall Study|Death|3|||
155043542|NCT02187861|559590165|FG002|Overall Study|Death|1|||
155043543|NCT02187861|559590166|FG003|Overall Study|Death|2|||
155043544|NCT02187861|559590163|FG000|Overall Study|Physician Decision|0|||
155043545|NCT02187861|559590164|FG001|Overall Study|Physician Decision|1|||
155043546|NCT02187861|559590165|FG002|Overall Study|Physician Decision|0|||
155043547|NCT02187861|559590166|FG003|Overall Study|Physician Decision|3|||
155043548|NCT02187861|559590163|FG000|Overall Study|Progressive Disease|4|||
155043549|NCT02187861|559590164|FG001|Overall Study|Progressive Disease|42|||
155043550|NCT02187861|559590165|FG002|Overall Study|Progressive Disease|19|||
155043551|NCT02187861|559590166|FG003|Overall Study|Progressive Disease|22|||
155043552|NCT02187861|559590163|FG000|Overall Study|Withdrawal by Subject|0|||
155043553|NCT02187861|559590164|FG001|Overall Study|Withdrawal by Subject|0|||
155043554|NCT02187861|559590165|FG002|Overall Study|Withdrawal by Subject|3|||
155043555|NCT02187861|559590166|FG003|Overall Study|Withdrawal by Subject|3|||
155043556|NCT02187861|559590163|FG000|Overall Study|Other|0|||
155043557|NCT02187861|559590164|FG001|Overall Study|Other|1|||
155043558|NCT02187861|559590165|FG002|Overall Study|Other|7|||
155043559|NCT02187861|559590166|FG003|Overall Study|Other|1|||
155043560|NCT02756819|559590167|FG000|Overall Study|Lost for observation|23|||
155043561|NCT02756819|559590167|FG000|Overall Study|Patient's unwillingness|16|||
155043562|NCT02756819|559590167|FG000|Overall Study|Insufficient efficacy|2|||
155043563|NCT02756819|559590167|FG000|Overall Study|Adverse Event|2|||
155043564|NCT02756819|559590167|FG000|Overall Study|Reason not Specified|9|||
155043565|NCT04217317|559590168|FG000|Overall Study|Lack of Efficacy|4|||
155043566|NCT04217317|559590168|FG000|Overall Study|Physician Decision|1|||
155043567|NCT02087943|559590169|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
155043568|NCT02087943|559590170|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
155043569|NCT02087943|559590171|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
154938927|NCT00449930|559201840|FG001|Overall Study|Physician Decision|2|||
154938928|NCT00449930|559201839|FG000|Overall Study|Protocol Violation|14|||
154938929|NCT00449930|559201840|FG001|Overall Study|Protocol Violation|15|||
154938930|NCT00449930|559201839|FG000|Overall Study|Withdrawal by Subject|16|||
154938931|NCT00449930|559201840|FG001|Overall Study|Withdrawal by Subject|23|||
155043570|NCT02087943|559590172|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
155043571|NCT02087943|559590173|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
154938932|NCT00449930|559201839|FG000|Overall Study|Glycemic discontinuation criteria|1|||
154938933|NCT00449930|559201840|FG001|Overall Study|Glycemic discontinuation criteria|1|||
155092565|NCT02704208|559773629|FG001|Overall Study|Lost to Follow-up|37|||
154938934|NCT02746705|559201841|FG000|Overall Study|Physician Decision|1|||
154938935|NCT02746705|559201842|FG001|Overall Study|Physician Decision|1|||
154938936|NCT02746705|559201841|FG000|Overall Study|Lost to Follow-up|1|||
154938937|NCT02746705|559201842|FG001|Overall Study|Lost to Follow-up|0|||
154938938|NCT02746705|559201841|FG000|Overall Study|outlier scores deemed not valid|0|||
154938939|NCT02746705|559201842|FG001|Overall Study|outlier scores deemed not valid|1|||
154938940|NCT05288673|559201843|FG000|Overall Study|Consent withdrawn by subject|0|||
154938941|NCT05288673|559201844|FG001|Overall Study|Consent withdrawn by subject|0|||
154938942|NCT05288673|559201845|FG002|Overall Study|Consent withdrawn by subject|1|||
154938943|NCT01504867|559201846|FG000|Overall Study|Inclusion criteria not met|2|||
154938944|NCT01504867|559201847|FG001|Overall Study|Inclusion criteria not met|2|||
154938945|NCT01504867|559201846|FG000|Overall Study|Consent revoked|5|||
154938946|NCT01504867|559201847|FG001|Overall Study|Consent revoked|1|||
154938947|NCT00571922|559201848|FG000|Overall Study|Completion unknown|36|||
154938948|NCT00571922|559201849|FG001|Overall Study|Completion unknown|36|||
154938949|NCT02533999|559201855|FG000|Overall Study|Lost to Follow-up|3|||
154938950|NCT02533999|559201856|FG001|Overall Study|Lost to Follow-up|5|||
154938951|NCT02533999|559201855|FG000|Overall Study|Protocol Violation|3|||
154938952|NCT02533999|559201856|FG001|Overall Study|Protocol Violation|0|||
154938953|NCT02533999|559201855|FG000|Overall Study|Adverse Event|0|||
154938954|NCT02533999|559201856|FG001|Overall Study|Adverse Event|1|||
154938955|NCT02533999|559201855|FG000|Overall Study|Randomized but intervention not received|0|||
154938956|NCT02533999|559201856|FG001|Overall Study|Randomized but intervention not received|1|||
154938957|NCT03210259|559201857|FG000|12-Week Run-in Period|Adverse Event|1|||
154938958|NCT03210259|559201858|FG001|12-Week Run-in Period|Adverse Event|0|||
154938959|NCT03210259|559201859|FG002|12-Week Run-in Period|Adverse Event|0|||
154938960|NCT03210259|559201857|FG000|12-Week Run-in Period|Death|1|||
154938961|NCT03210259|559201858|FG001|12-Week Run-in Period|Death|0|||
154938962|NCT03210259|559201859|FG002|12-Week Run-in Period|Death|0|||
154938963|NCT03210259|559201857|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
154938964|NCT03210259|559201858|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
154938965|NCT03210259|559201859|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
154938966|NCT03210259|559201857|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
154938967|NCT03210259|559201858|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
154938968|NCT03210259|559201859|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
154938969|NCT03210259|559201857|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
154938970|NCT03210259|559201858|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
154938971|NCT03210259|559201859|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
154938972|NCT03210259|559201857|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
154938973|NCT03210259|559201858|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
154938974|NCT03210259|559201859|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
154938975|NCT03210259|559201857|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
154938976|NCT03210259|559201858|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
154938977|NCT03210259|559201859|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
154938978|NCT03210259|559201857|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
154938979|NCT03210259|559201858|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
154938980|NCT03210259|559201859|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
154938981|NCT03210259|559201857|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
154938982|NCT03210259|559201858|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
154938983|NCT03210259|559201859|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
154938984|NCT03210259|559201857|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
154938985|NCT03210259|559201858|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
154938986|NCT03210259|559201859|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
154938987|NCT03210259|559201857|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
154938988|NCT03210259|559201858|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
154938989|NCT03210259|559201859|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
154938990|NCT00345683|559201865|FG000|Overall Study|Lost to Follow-up|19|||
154938991|NCT00345683|559201866|FG001|Overall Study|Lost to Follow-up|7|||
154938992|NCT00345683|559201865|FG000|Overall Study|Other|6|||
154938993|NCT00345683|559201866|FG001|Overall Study|Other|2|||
154938994|NCT00990093|559201869|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
154938995|NCT00990093|559201870|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
154938996|NCT00990093|559201869|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
154938997|NCT00990093|559201870|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
154938998|NCT00990093|559201869|FG000|Test Period 1 (1-14 Days)|Other|1|||
155043572|NCT02087943|559590169|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
155043573|NCT02087943|559590170|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
154938999|NCT00990093|559201870|FG001|Test Period 1 (1-14 Days)|Other|0|||
154939000|NCT00990093|559201869|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
154939001|NCT00990093|559201870|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
154939002|NCT00990093|559201869|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
154939003|NCT00990093|559201870|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
154939004|NCT00990093|559201869|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
154939005|NCT00990093|559201870|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
154939006|NCT00990093|559201869|FG000|Test Period 2 (15-28 Days)|Other|0|||
154939007|NCT00990093|559201870|FG001|Test Period 2 (15-28 Days)|Other|1|||
154939008|NCT04147611|559201872|FG000|Overall Study|Physician Decision|0|||
154939009|NCT04147611|559201873|FG001|Overall Study|Physician Decision|1|||
154939010|NCT00530439|559201874|FG000|Overall Study|GDM|9|||
154939011|NCT00530439|559201875|FG001|Overall Study|GDM|3|||
154939012|NCT00530439|559201874|FG000|Overall Study|Withdraw|18|||
154939013|NCT00530439|559201875|FG001|Overall Study|Withdraw|14|||
154939014|NCT00530439|559201874|FG000|Overall Study|Missed abortion|1|||
154939015|NCT00530439|559201875|FG001|Overall Study|Missed abortion|4|||
154939016|NCT00530439|559201874|FG000|Overall Study|Misclassification|2|||
154939017|NCT00530439|559201875|FG001|Overall Study|Misclassification|0|||
154939018|NCT00530439|559201874|FG000|Overall Study|Twin pregnancy|0|||
154939019|NCT00530439|559201875|FG001|Overall Study|Twin pregnancy|2|||
154939020|NCT00530439|559201874|FG000|Overall Study|Severe malformation/abortion|0|||
154939021|NCT00530439|559201875|FG001|Overall Study|Severe malformation/abortion|3|||
154939022|NCT04385199|559201880|FG000|Overall Study|Withdrawal by Subject|1|||
154939023|NCT04385199|559201881|FG001|Overall Study|Withdrawal by Subject|0|||
154939024|NCT04444752|559201882|FG000|Overall Study|Adverse Event|1|||
154939025|NCT04444752|559201883|FG001|Overall Study|Adverse Event|0|||
154939026|NCT04444752|559201884|FG002|Overall Study|Adverse Event|0|||
154939027|NCT04444752|559201885|FG003|Overall Study|Adverse Event|2|||
154939028|NCT04444752|559201882|FG000|Overall Study|Lost to Follow-up|2|||
154939029|NCT04444752|559201883|FG001|Overall Study|Lost to Follow-up|6|||
154939030|NCT04444752|559201884|FG002|Overall Study|Lost to Follow-up|2|||
154939031|NCT04444752|559201885|FG003|Overall Study|Lost to Follow-up|5|||
154939032|NCT04444752|559201882|FG000|Overall Study|Physician Decision|0|||
154939033|NCT04444752|559201883|FG001|Overall Study|Physician Decision|0|||
154939034|NCT04444752|559201884|FG002|Overall Study|Physician Decision|0|||
154939035|NCT04444752|559201885|FG003|Overall Study|Physician Decision|2|||
154939036|NCT04444752|559201882|FG000|Overall Study|Pregnancy|0|||
154939037|NCT04444752|559201883|FG001|Overall Study|Pregnancy|0|||
154939038|NCT04444752|559201884|FG002|Overall Study|Pregnancy|0|||
154939039|NCT04444752|559201885|FG003|Overall Study|Pregnancy|1|||
154939040|NCT04444752|559201882|FG000|Overall Study|Withdrawal by Subject|6|||
154939041|NCT04444752|559201883|FG001|Overall Study|Withdrawal by Subject|5|||
154939042|NCT04444752|559201884|FG002|Overall Study|Withdrawal by Subject|3|||
154939043|NCT04444752|559201885|FG003|Overall Study|Withdrawal by Subject|4|||
154939044|NCT04444752|559201882|FG000|Overall Study|Protocol Violation|1|||
154939045|NCT04444752|559201883|FG001|Overall Study|Protocol Violation|1|||
154939046|NCT04444752|559201884|FG002|Overall Study|Protocol Violation|0|||
154939047|NCT04444752|559201885|FG003|Overall Study|Protocol Violation|0|||
154939048|NCT04444752|559201882|FG000|Overall Study|Patient moving out of town|1|||
154939049|NCT04444752|559201883|FG001|Overall Study|Patient moving out of town|0|||
154939050|NCT04444752|559201884|FG002|Overall Study|Patient moving out of town|0|||
154939051|NCT04444752|559201885|FG003|Overall Study|Patient moving out of town|1|||
154939052|NCT04444752|559201882|FG000|Overall Study|Lack of Efficacy|0|||
154939053|NCT04444752|559201883|FG001|Overall Study|Lack of Efficacy|0|||
154939054|NCT04444752|559201884|FG002|Overall Study|Lack of Efficacy|0|||
154939055|NCT04444752|559201885|FG003|Overall Study|Lack of Efficacy|1|||
154939056|NCT04444752|559201882|FG000|Overall Study|Death|0|||
154939057|NCT04444752|559201883|FG001|Overall Study|Death|0|||
154939058|NCT04444752|559201884|FG002|Overall Study|Death|1|||
154939059|NCT04444752|559201885|FG003|Overall Study|Death|0|||
154939060|NCT02557672|559201886|FG000|Overall Study|Withdrawal by Subject|4|||
154939061|NCT02557672|559201887|FG001|Overall Study|Withdrawal by Subject|2|||
154939062|NCT00928252|559203291|FG000|Overall Study|Physician Decision|3|||
154939063|NCT02257632|559203292|FG000|Overall Study|Withdrawal by Subject|0|||
154939064|NCT02257632|559203293|FG001|Overall Study|Withdrawal by Subject|1|||
154939065|NCT02257632|559203292|FG000|Overall Study|Adverse Event|1|||
154939066|NCT02257632|559203293|FG001|Overall Study|Adverse Event|2|||
154939067|NCT02468557|559203294|FG000|Overall Study|Adverse Event|1|||
154939068|NCT02468557|559203294|FG000|Overall Study|Death|1|||
154939069|NCT02468557|559203294|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
154939070|NCT02468557|559203294|FG000|Overall Study|All Enrolled but Never Dosed|4|||
154939071|NCT03322462|559203298|FG000|Overall Study|Technical difficulties|2|||
154939072|NCT03322462|559203298|FG000|Overall Study|Other|1|||
154939073|NCT01393990|559203299|FG000|Overall Study|Adverse Event|0|||
154939074|NCT01393990|559203300|FG001|Overall Study|Adverse Event|0|||
154939075|NCT01393990|559203301|FG002|Overall Study|Adverse Event|0|||
154939076|NCT01393990|559203302|FG003|Overall Study|Adverse Event|0|||
154939077|NCT01393990|559203303|FG004|Overall Study|Adverse Event|0|||
154939078|NCT01393990|559203304|FG005|Overall Study|Adverse Event|0|||
154939079|NCT01393990|559203305|FG006|Overall Study|Adverse Event|0|||
154939080|NCT01393990|559203306|FG007|Overall Study|Adverse Event|0|||
154939081|NCT01393990|559203307|FG008|Overall Study|Adverse Event|0|||
154939082|NCT01393990|559203308|FG009|Overall Study|Adverse Event|0|||
154939083|NCT01393990|559203309|FG010|Overall Study|Adverse Event|0|||
154939084|NCT01393990|559203310|FG011|Overall Study|Adverse Event|0|||
154939085|NCT01393990|559203311|FG012|Overall Study|Adverse Event|0|||
154939086|NCT01393990|559203312|FG013|Overall Study|Adverse Event|0|||
154939087|NCT01393990|559203313|FG014|Overall Study|Adverse Event|1|||
154939088|NCT01393990|559203314|FG015|Overall Study|Adverse Event|1|||
154939089|NCT01393990|559203315|FG016|Overall Study|Adverse Event|0|||
154939090|NCT01393990|559203316|FG017|Overall Study|Adverse Event|0|||
154939091|NCT01393990|559203299|FG000|Overall Study|Progressive Disease|1|||
154939092|NCT01393990|559203300|FG001|Overall Study|Progressive Disease|0|||
154939093|NCT01393990|559203301|FG002|Overall Study|Progressive Disease|0|||
154939094|NCT01393990|559203302|FG003|Overall Study|Progressive Disease|1|||
154939095|NCT01393990|559203303|FG004|Overall Study|Progressive Disease|1|||
154939096|NCT01393990|559203304|FG005|Overall Study|Progressive Disease|1|||
154939097|NCT01393990|559203305|FG006|Overall Study|Progressive Disease|1|||
154939098|NCT01393990|559203306|FG007|Overall Study|Progressive Disease|1|||
154939099|NCT01393990|559203307|FG008|Overall Study|Progressive Disease|3|||
154939100|NCT01393990|559203308|FG009|Overall Study|Progressive Disease|1|||
154939101|NCT01393990|559203309|FG010|Overall Study|Progressive Disease|0|||
154939102|NCT01393990|559203310|FG011|Overall Study|Progressive Disease|0|||
154939103|NCT01393990|559203311|FG012|Overall Study|Progressive Disease|0|||
154939104|NCT01393990|559203312|FG013|Overall Study|Progressive Disease|1|||
154939105|NCT01393990|559203313|FG014|Overall Study|Progressive Disease|6|||
154939106|NCT01393990|559203314|FG015|Overall Study|Progressive Disease|1|||
154939107|NCT01393990|559203315|FG016|Overall Study|Progressive Disease|0|||
154939108|NCT01393990|559203316|FG017|Overall Study|Progressive Disease|0|||
154939109|NCT01393990|559203299|FG000|Overall Study|Death|0|||
154939110|NCT01393990|559203300|FG001|Overall Study|Death|0|||
154939111|NCT01393990|559203301|FG002|Overall Study|Death|0|||
154939112|NCT01393990|559203302|FG003|Overall Study|Death|0|||
154939113|NCT01393990|559203303|FG004|Overall Study|Death|1|||
154939114|NCT01393990|559203304|FG005|Overall Study|Death|0|||
154939115|NCT01393990|559203305|FG006|Overall Study|Death|0|||
154939116|NCT01393990|559203306|FG007|Overall Study|Death|0|||
154939117|NCT01393990|559203307|FG008|Overall Study|Death|0|||
154939118|NCT01393990|559203308|FG009|Overall Study|Death|0|||
154939119|NCT01393990|559203309|FG010|Overall Study|Death|0|||
154939120|NCT01393990|559203310|FG011|Overall Study|Death|0|||
154939121|NCT01393990|559203311|FG012|Overall Study|Death|0|||
154939122|NCT01393990|559203312|FG013|Overall Study|Death|1|||
154939123|NCT01393990|559203313|FG014|Overall Study|Death|1|||
154939124|NCT01393990|559203314|FG015|Overall Study|Death|0|||
154939125|NCT01393990|559203315|FG016|Overall Study|Death|0|||
154939126|NCT01393990|559203316|FG017|Overall Study|Death|0|||
154939127|NCT01393990|559203299|FG000|Overall Study|Withdrawal by Subject|0|||
154939128|NCT01393990|559203300|FG001|Overall Study|Withdrawal by Subject|0|||
154939129|NCT01393990|559203301|FG002|Overall Study|Withdrawal by Subject|0|||
154939130|NCT01393990|559203302|FG003|Overall Study|Withdrawal by Subject|0|||
154939131|NCT01393990|559203303|FG004|Overall Study|Withdrawal by Subject|0|||
154939132|NCT01393990|559203304|FG005|Overall Study|Withdrawal by Subject|0|||
154939133|NCT01393990|559203305|FG006|Overall Study|Withdrawal by Subject|0|||
154939134|NCT01393990|559203306|FG007|Overall Study|Withdrawal by Subject|0|||
154939135|NCT01393990|559203307|FG008|Overall Study|Withdrawal by Subject|0|||
154939136|NCT01393990|559203308|FG009|Overall Study|Withdrawal by Subject|0|||
154939137|NCT01393990|559203309|FG010|Overall Study|Withdrawal by Subject|0|||
154939138|NCT01393990|559203310|FG011|Overall Study|Withdrawal by Subject|0|||
154939139|NCT01393990|559203311|FG012|Overall Study|Withdrawal by Subject|0|||
154939140|NCT01393990|559203312|FG013|Overall Study|Withdrawal by Subject|0|||
154939141|NCT01393990|559203313|FG014|Overall Study|Withdrawal by Subject|1|||
154939142|NCT01393990|559203314|FG015|Overall Study|Withdrawal by Subject|1|||
154939143|NCT01393990|559203315|FG016|Overall Study|Withdrawal by Subject|0|||
154939144|NCT01393990|559203316|FG017|Overall Study|Withdrawal by Subject|0|||
154939145|NCT00434161|559203320|FG000|Overall Study|Adverse Event|5|||
154939146|NCT00434161|559203321|FG001|Overall Study|Adverse Event|1|||
154939147|NCT00434161|559203322|FG002|Overall Study|Adverse Event|4|||
154939148|NCT00434161|559203320|FG000|Overall Study|Lost to Follow-up|0|||
154939149|NCT00434161|559203321|FG001|Overall Study|Lost to Follow-up|1|||
154939150|NCT00434161|559203322|FG002|Overall Study|Lost to Follow-up|0|||
154939151|NCT00434161|559203320|FG000|Overall Study|Death|1|||
154939152|NCT00434161|559203321|FG001|Overall Study|Death|0|||
154939153|NCT00434161|559203322|FG002|Overall Study|Death|1|||
154939154|NCT00434161|559203320|FG000|Overall Study|Non-Compliance|1|||
154939155|NCT00434161|559203321|FG001|Overall Study|Non-Compliance|1|||
154939156|NCT00434161|559203322|FG002|Overall Study|Non-Compliance|0|||
154939157|NCT00434161|559203320|FG000|Overall Study|Withdrawal by Subject|2|||
154939158|NCT00434161|559203321|FG001|Overall Study|Withdrawal by Subject|0|||
154939159|NCT00434161|559203322|FG002|Overall Study|Withdrawal by Subject|3|||
154939160|NCT00434161|559203320|FG000|Overall Study|Logistical error study assessments|1|||
154939161|NCT00434161|559203321|FG001|Overall Study|Logistical error study assessments|0|||
154939162|NCT00434161|559203322|FG002|Overall Study|Logistical error study assessments|3|||
154939163|NCT01312779|559203323|FG000|Overall Study|Withdrawal by Subject|2|||
154939164|NCT01312779|559203323|FG000|Overall Study|Death|3|||
154939165|NCT01312779|559203323|FG000|Overall Study|Not Implanted with Device|27|||
154939166|NCT00506753|559203324|FG000|Overall Study|Lost to Follow-up|21|||
154939167|NCT00506753|559203325|FG001|Overall Study|Lost to Follow-up|15|||
154939168|NCT02451670|559203326|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
154939169|NCT02451670|559203327|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
154939170|NCT01706198|559203332|FG000|Overall Study|Adverse Event|12|||
154939171|NCT01706198|559203333|FG001|Overall Study|Adverse Event|15|||
154939172|NCT01706198|559203332|FG000|Overall Study|Protocol Violation|7|||
154939173|NCT01706198|559203333|FG001|Overall Study|Protocol Violation|5|||
154939174|NCT01706198|559203332|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
154939175|NCT01706198|559203333|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
154939176|NCT01706198|559203332|FG000|Overall Study|Lost to Follow-up|97|||
154939177|NCT01706198|559203333|FG001|Overall Study|Lost to Follow-up|93|||
154939178|NCT01706198|559203332|FG000|Overall Study|Physician Decision|23|||
154939179|NCT01706198|559203333|FG001|Overall Study|Physician Decision|37|||
154939180|NCT01706198|559203332|FG000|Overall Study|Withdrawal by Subject|23|||
154939181|NCT01706198|559203333|FG001|Overall Study|Withdrawal by Subject|31|||
154939182|NCT02480010|559203338|FG000|Overall Study|Adverse Event|3|||
154939183|NCT02480010|559203339|FG001|Overall Study|Adverse Event|1|||
154939184|NCT02480010|559203338|FG000|Overall Study|Death|1|||
154939185|NCT02480010|559203339|FG001|Overall Study|Death|0|||
154939186|NCT02480010|559203338|FG000|Overall Study|Insufficient therapeutic response|31|||
154939187|NCT02480010|559203339|FG001|Overall Study|Insufficient therapeutic response|29|||
154939188|NCT02480010|559203338|FG000|Overall Study|Refused Treatment|0|||
154939189|NCT02480010|559203339|FG001|Overall Study|Refused Treatment|3|||
154939190|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
154939191|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
154939192|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
154939193|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
154939194|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
154939195|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
154939196|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
154939197|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
154939198|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
154939199|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
154939200|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
154939201|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
154939202|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
154939203|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
154939204|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
154939205|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
154939206|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
154939207|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
154939208|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
154939209|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
154939210|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
154939211|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
154939212|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
154939213|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
154939214|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
154939215|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
154939216|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
154939217|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
154939218|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
154939219|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
154939220|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
154939221|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
154939222|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
154939223|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
154939224|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
154939225|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
154939226|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
154939227|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
154939228|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
154939229|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
154939230|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
154939231|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
154939232|NCT00606684|559203340|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
155092566|NCT03545672|559773630|FG000|Overall Study|Uncertain diagnosis|2|||
154966763|NCT00902538|559301137|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
154939233|NCT00606684|559203341|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155277332|NCT04423393|560449034|FG011|Overall Study|Withdrawal by Subject|0|||
155277333|NCT04423393|560449035|FG012|Overall Study|Withdrawal by Subject|0|||
155277334|NCT04423393|560449036|FG013|Overall Study|Withdrawal by Subject|1|||
155277335|NCT04423393|560449037|FG014|Overall Study|Withdrawal by Subject|0|||
155277336|NCT04423393|560449038|FG015|Overall Study|Withdrawal by Subject|0|||
155277337|NCT04423393|560449039|FG016|Overall Study|Withdrawal by Subject|0|||
155277338|NCT04423393|560449040|FG017|Overall Study|Withdrawal by Subject|0|||
155277339|NCT04423393|560449023|FG000|Overall Study|Sponsor Decision|0|||
155277340|NCT04423393|560449024|FG001|Overall Study|Sponsor Decision|0|||
155277341|NCT04423393|560449025|FG002|Overall Study|Sponsor Decision|0|||
155277342|NCT04423393|560449026|FG003|Overall Study|Sponsor Decision|0|||
155277343|NCT04423393|560449027|FG004|Overall Study|Sponsor Decision|0|||
155277344|NCT04423393|560449028|FG005|Overall Study|Sponsor Decision|0|||
155277345|NCT04423393|560449029|FG006|Overall Study|Sponsor Decision|0|||
155277346|NCT04423393|560449030|FG007|Overall Study|Sponsor Decision|0|||
155277347|NCT04423393|560449031|FG008|Overall Study|Sponsor Decision|0|||
155277348|NCT04423393|560449032|FG009|Overall Study|Sponsor Decision|0|||
155277349|NCT04423393|560449033|FG010|Overall Study|Sponsor Decision|0|||
155277350|NCT04423393|560449034|FG011|Overall Study|Sponsor Decision|0|||
155277351|NCT04423393|560449035|FG012|Overall Study|Sponsor Decision|0|||
155277352|NCT04423393|560449036|FG013|Overall Study|Sponsor Decision|1|||
155277353|NCT04423393|560449037|FG014|Overall Study|Sponsor Decision|0|||
155277354|NCT04423393|560449038|FG015|Overall Study|Sponsor Decision|0|||
155277355|NCT04423393|560449039|FG016|Overall Study|Sponsor Decision|0|||
155277356|NCT04423393|560449040|FG017|Overall Study|Sponsor Decision|0|||
155277357|NCT05220501|560449041|FG000|Overall Study|Withdrawal by Subject|11|||
155277358|NCT05220501|560449042|FG001|Overall Study|Withdrawal by Subject|21|||
155277359|NCT05220501|560449043|FG002|Overall Study|Withdrawal by Subject|32|||
155277360|NCT05220501|560449041|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
155277361|NCT05220501|560449042|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
155277362|NCT05220501|560449043|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
155277363|NCT01929993|560449044|FG000|Overall Study|Protocol Violation|4|||
155277364|NCT01929993|560449045|FG001|Overall Study|Protocol Violation|6|||
155277365|NCT01929993|560449044|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
155277366|NCT01929993|560449045|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
155277367|NCT01440049|560449050|FG000|Overall Study|Adverse Event|5|||
155277368|NCT02268552|560449051|FG000|Part 1|Death|1|||
155277369|NCT02268552|560449052|FG001|Part 1|Death|1|||
155277370|NCT02268552|560449053|FG002|Part 1|Death|1|||
155277371|NCT02268552|560449054|FG003|Part 1|Death|2|||
155277372|NCT02268552|560449055|FG004|Part 1|Death|0|||
155277373|NCT02268552|560449056|FG005|Part 1|Death|0|||
155277374|NCT02268552|560449057|FG006|Part 1|Death|0|||
155277375|NCT02268552|560449051|FG000|Part 1|Subject/guardian decision|0|||
155277376|NCT02268552|560449052|FG001|Part 1|Subject/guardian decision|0|||
155277377|NCT02268552|560449053|FG002|Part 1|Subject/guardian decision|0|||
155277378|NCT02268552|560449054|FG003|Part 1|Subject/guardian decision|1|||
155277379|NCT02268552|560449055|FG004|Part 1|Subject/guardian decision|0|||
155277380|NCT02268552|560449056|FG005|Part 1|Subject/guardian decision|0|||
155277381|NCT02268552|560449057|FG006|Part 1|Subject/guardian decision|0|||
155277382|NCT02268552|560449051|FG000|Part 2|Death|0|||
155277383|NCT02268552|560449052|FG001|Part 2|Death|0|||
155277384|NCT02268552|560449053|FG002|Part 2|Death|0|||
155277385|NCT02268552|560449054|FG003|Part 2|Death|0|||
155277386|NCT02268552|560449055|FG004|Part 2|Death|0|||
155277387|NCT02268552|560449056|FG005|Part 2|Death|0|||
155277388|NCT02268552|560449057|FG006|Part 2|Death|2|||
155277389|NCT02268552|560449051|FG000|Part 2|Subject/guardian decision|0|||
155277390|NCT02268552|560449052|FG001|Part 2|Subject/guardian decision|0|||
155277391|NCT02268552|560449053|FG002|Part 2|Subject/guardian decision|0|||
155277392|NCT02268552|560449054|FG003|Part 2|Subject/guardian decision|0|||
155277393|NCT02268552|560449055|FG004|Part 2|Subject/guardian decision|0|||
155277394|NCT02268552|560449056|FG005|Part 2|Subject/guardian decision|0|||
155277395|NCT02268552|560449057|FG006|Part 2|Subject/guardian decision|1|||
155277396|NCT02268552|560449051|FG000|Part 3 Extension|Death|0|||
155277397|NCT02268552|560449052|FG001|Part 3 Extension|Death|1|||
154939234|NCT00606684|559203342|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
155277398|NCT02268552|560449053|FG002|Part 3 Extension|Death|1|||
155277399|NCT02268552|560449054|FG003|Part 3 Extension|Death|1|||
155277400|NCT02268552|560449055|FG004|Part 3 Extension|Death|1|||
155277401|NCT02268552|560449056|FG005|Part 3 Extension|Death|1|||
155277402|NCT02268552|560449057|FG006|Part 3 Extension|Death|0|||
155277403|NCT02268552|560449051|FG000|Part 3 Extension|Early termination of trial|1|||
155277404|NCT02268552|560449052|FG001|Part 3 Extension|Early termination of trial|0|||
155277405|NCT02268552|560449053|FG002|Part 3 Extension|Early termination of trial|0|||
155277406|NCT02268552|560449054|FG003|Part 3 Extension|Early termination of trial|0|||
155277407|NCT02268552|560449055|FG004|Part 3 Extension|Early termination of trial|2|||
155277408|NCT02268552|560449056|FG005|Part 3 Extension|Early termination of trial|9|||
154939235|NCT00606684|559203343|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
154939236|NCT00606684|559203344|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
154939237|NCT00606684|559203345|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
154939238|NCT00606684|559203346|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
154939239|NCT00606684|559203340|FG000|Double-Blind Treatment Period|Adverse Event|0|||
154939240|NCT00606684|559203341|FG001|Double-Blind Treatment Period|Adverse Event|3|||
154939241|NCT00606684|559203342|FG002|Double-Blind Treatment Period|Adverse Event|2|||
154939242|NCT00606684|559203343|FG003|Double-Blind Treatment Period|Adverse Event|4|||
154939243|NCT00606684|559203344|FG004|Double-Blind Treatment Period|Adverse Event|2|||
154939244|NCT00606684|559203345|FG005|Double-Blind Treatment Period|Adverse Event|0|||
154939245|NCT00606684|559203346|FG006|Double-Blind Treatment Period|Adverse Event|1|||
154939246|NCT00606684|559203340|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
154939247|NCT00606684|559203341|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
154939248|NCT00606684|559203342|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
154939249|NCT00606684|559203343|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
155277409|NCT02268552|560449057|FG006|Part 3 Extension|Early termination of trial|11|||
155277410|NCT02268552|560449051|FG000|Part 3 Extension|Subject/guardian decision|0|||
155277411|NCT02268552|560449052|FG001|Part 3 Extension|Subject/guardian decision|0|||
155277412|NCT02268552|560449053|FG002|Part 3 Extension|Subject/guardian decision|0|||
155277413|NCT02268552|560449054|FG003|Part 3 Extension|Subject/guardian decision|0|||
155277414|NCT02268552|560449055|FG004|Part 3 Extension|Subject/guardian decision|0|||
155277415|NCT02268552|560449056|FG005|Part 3 Extension|Subject/guardian decision|0|||
155277416|NCT02268552|560449057|FG006|Part 3 Extension|Subject/guardian decision|1|||
155277417|NCT00661258|560449060|FG000|Overall Study|Death|1|||
155277418|NCT00661258|560449061|FG001|Overall Study|Death|0|||
155277419|NCT00661258|560449060|FG000|Overall Study|caught by police and in detox center|2|||
155277420|NCT00661258|560449061|FG001|Overall Study|caught by police and in detox center|1|||
155277421|NCT01708187|560449062|FG000|Overall Study|Lost to Follow-up|0|||
155277422|NCT01708187|560449063|FG001|Overall Study|Lost to Follow-up|1|||
155277423|NCT04242875|560449064|FG000|Overall Study|Adverse Event|2|||
155277424|NCT02408549|560449066|FG000|Overall Study|Adverse Event|15|||
155277425|NCT02408549|560449066|FG000|Overall Study|Death|4|||
155277426|NCT02408549|560449066|FG000|Overall Study|Lack of Efficacy|17|||
155277427|NCT02408549|560449066|FG000|Overall Study|Protocol Violation|4|||
155277428|NCT02408549|560449066|FG000|Overall Study|Lost to Follow-up|6|||
155277429|NCT02408549|560449066|FG000|Overall Study|Consent withdrawn|30|||
155277430|NCT02408549|560449066|FG000|Overall Study|Neurology research program closing at site|1|||
155277431|NCT02408549|560449066|FG000|Overall Study|Site closure|1|||
155277432|NCT02408549|560449066|FG000|Overall Study|Pregnancy|1|||
155277433|NCT02408549|560449066|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
155277434|NCT02408549|560449066|FG000|Overall Study|Subject moved to another place, far from site|1|||
155277435|NCT02408549|560449066|FG000|Overall Study|Study terminated at site|1|||
155277436|NCT00231894|560449067|FG000|Overall Study|Withdrawal by Subject|1|||
155277437|NCT00231894|560449068|FG001|Overall Study|Withdrawal by Subject|1|||
155277438|NCT01232556|560449071|FG000|Overall Study|Withdrawal by Subject|21|||
155277439|NCT01232556|560449072|FG001|Overall Study|Withdrawal by Subject|17|||
155277440|NCT01232556|560449071|FG000|Overall Study|Death|97|||
155277441|NCT01232556|560449072|FG001|Overall Study|Death|97|||
155277442|NCT01232556|560449071|FG000|Overall Study|Lost to Follow-up|0|||
155277443|NCT01232556|560449072|FG001|Overall Study|Lost to Follow-up|2|||
155277444|NCT01232556|560449071|FG000|Overall Study|Terminated by Sponsor|35|||
155277445|NCT01232556|560449072|FG001|Overall Study|Terminated by Sponsor|51|||
155277446|NCT01232556|560449071|FG000|Overall Study|Other|6|||
155277447|NCT01232556|560449072|FG001|Overall Study|Other|4|||
155277448|NCT01628510|560449073|FG000|Overall Study|Withdrawal by Subject|0|||
155277449|NCT01628510|560449074|FG001|Overall Study|Withdrawal by Subject|4|||
155277450|NCT01628510|560449073|FG000|Overall Study|Death|3|||
155277451|NCT01628510|560449074|FG001|Overall Study|Death|1|||
155277452|NCT04707391|560449075|FG000|Overall Study|Adverse Event|5|||
155277453|NCT04707391|560449076|FG001|Overall Study|Adverse Event|8|||
155277454|NCT04707391|560449075|FG000|Overall Study|Lost to Follow-up|44|||
155277455|NCT04707391|560449076|FG001|Overall Study|Lost to Follow-up|31|||
154939250|NCT00606684|559203344|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
154939251|NCT00606684|559203345|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
154939252|NCT00606684|559203346|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
155277456|NCT04707391|560449075|FG000|Overall Study|Protocol Violation|1|||
155277457|NCT04707391|560449076|FG001|Overall Study|Protocol Violation|5|||
155277458|NCT04707391|560449075|FG000|Overall Study|Withdrawal by Subject|27|||
155277459|NCT04707391|560449076|FG001|Overall Study|Withdrawal by Subject|25|||
155277460|NCT04707391|560449075|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
155277461|NCT04707391|560449076|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
154939253|NCT00606684|559203340|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155277462|NCT04707391|560449075|FG000|Overall Study|Other|0|||
155277463|NCT04707391|560449076|FG001|Overall Study|Other|2|||
154939254|NCT00606684|559203341|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
154939255|NCT00606684|559203342|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
154939256|NCT00606684|559203343|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
154939257|NCT00606684|559203344|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
154939258|NCT00606684|559203345|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
154939259|NCT00606684|559203346|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
154939260|NCT00606684|559203340|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
154939261|NCT00606684|559203341|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
154939262|NCT00606684|559203342|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
154939263|NCT00606684|559203343|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
154939264|NCT00606684|559203344|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
154939265|NCT00606684|559203345|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
154939266|NCT00606684|559203346|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
154939267|NCT00606684|559203340|FG000|Double-Blind Treatment Period|Physician Decision|0|||
154939268|NCT00606684|559203341|FG001|Double-Blind Treatment Period|Physician Decision|5|||
154939269|NCT00606684|559203342|FG002|Double-Blind Treatment Period|Physician Decision|1|||
154939270|NCT00606684|559203343|FG003|Double-Blind Treatment Period|Physician Decision|0|||
154939271|NCT00606684|559203344|FG004|Double-Blind Treatment Period|Physician Decision|3|||
154939272|NCT00606684|559203345|FG005|Double-Blind Treatment Period|Physician Decision|1|||
154939273|NCT00606684|559203346|FG006|Double-Blind Treatment Period|Physician Decision|2|||
154939274|NCT00606684|559203340|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154939275|NCT00606684|559203341|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
154939276|NCT00606684|559203342|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
154939277|NCT00606684|559203343|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
154939278|NCT00606684|559203344|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
154939279|NCT00606684|559203345|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
154939280|NCT00606684|559203346|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154939281|NCT01759381|559203347|FG000|Overall Study|Death|1|||
154939282|NCT01759381|559203348|FG001|Overall Study|Death|0|||
154939283|NCT03377556|559203349|FG000|Overall Study|Adverse Event|5|||
154939284|NCT03377556|559203349|FG000|Overall Study|Refusal unrelated to adverse events|1|||
154939285|NCT03377556|559203349|FG000|Overall Study|Progression/relapse|38|||
154939286|NCT03377556|559203349|FG000|Overall Study|Death|3|||
154939287|NCT00827827|559203350|FG000|Overall Study|Lost to Follow-up|3|||
154939288|NCT00827827|559203351|FG001|Overall Study|Lost to Follow-up|0|||
154939289|NCT00827827|559203350|FG000|Overall Study|Fall at home- hospitalization|1|||
154939290|NCT00827827|559203351|FG001|Overall Study|Fall at home- hospitalization|0|||
154939291|NCT00827827|559203350|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
154939292|NCT00827827|559203351|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
154939293|NCT00827827|559203350|FG000|Overall Study|Gout|1|||
154939294|NCT00827827|559203351|FG001|Overall Study|Gout|0|||
154939295|NCT00827827|559203350|FG000|Overall Study|Transportation issues|1|||
154939296|NCT00827827|559203351|FG001|Overall Study|Transportation issues|0|||
154939297|NCT00827827|559203350|FG000|Overall Study|Burned with water at home|1|||
154939298|NCT00827827|559203351|FG001|Overall Study|Burned with water at home|0|||
154939299|NCT00447603|559203357|FG000|Screening|Withdrawal by Subject|1|||
154939300|NCT00447603|559203358|FG001|Screening|Withdrawal by Subject|0|||
154939301|NCT00447603|559203359|FG002|Screening|Withdrawal by Subject|0|||
154939302|NCT00447603|559203357|FG000|Screening|Protocol Violation|1|||
154939303|NCT00447603|559203358|FG001|Screening|Protocol Violation|0|||
154939304|NCT00447603|559203359|FG002|Screening|Protocol Violation|0|||
155277464|NCT02500316|560449079|FG000|Overall Study|Adverse Event|3|||
155277465|NCT02500316|560449079|FG000|Overall Study|Lost to Follow-up|2|||
154939305|NCT00447603|559203357|FG000|Screening|Screen Failure|4|||
154939306|NCT00447603|559203358|FG001|Screening|Screen Failure|0|||
154939307|NCT00447603|559203359|FG002|Screening|Screen Failure|0|||
154939308|NCT00447603|559203357|FG000|Screening|Study Terminated by Sponsor|15|||
154939309|NCT00447603|559203358|FG001|Screening|Study Terminated by Sponsor|0|||
154939310|NCT00447603|559203359|FG002|Screening|Study Terminated by Sponsor|0|||
154939311|NCT00447603|559203357|FG000|Filter Period|Adverse Event|0|||
155277466|NCT02500316|560449079|FG000|Overall Study|Protocol Violation|1|||
155277467|NCT02500316|560449079|FG000|Overall Study|Withdrawal by Subject|15|||
154939312|NCT00447603|559203358|FG001|Filter Period|Adverse Event|0|||
155277468|NCT02500316|560449079|FG000|Overall Study|Final height achieved|5|||
155277469|NCT02500316|560449079|FG000|Overall Study|Due to war activity|1|||
155277470|NCT01406717|560449080|FG000|Overall Study|Subject non-compliance|4|||
155277471|NCT01406717|560449081|FG001|Overall Study|Subject non-compliance|3|||
154939313|NCT00447603|559203359|FG002|Filter Period|Adverse Event|1|||
154939314|NCT00447603|559203357|FG000|Filter Period|Screen Failure|0|||
154939315|NCT00447603|559203358|FG001|Filter Period|Screen Failure|3|||
154939316|NCT00447603|559203359|FG002|Filter Period|Screen Failure|4|||
155092567|NCT03545672|559773631|FG001|Overall Study|Uncertain diagnosis|1|||
155277472|NCT01406717|560449080|FG000|Overall Study|Protocol Violation|5|||
155277473|NCT01406717|560449081|FG001|Overall Study|Protocol Violation|1|||
155277474|NCT01406717|560449080|FG000|Overall Study|Lost to Follow-up|14|||
155277475|NCT01406717|560449081|FG001|Overall Study|Lost to Follow-up|8|||
155277476|NCT01406717|560449080|FG000|Overall Study|Withdrawal by Subject|19|||
155277477|NCT01406717|560449081|FG001|Overall Study|Withdrawal by Subject|15|||
155277478|NCT01406717|560449080|FG000|Overall Study|Adverse Event|1|||
155277479|NCT01406717|560449081|FG001|Overall Study|Adverse Event|2|||
155277480|NCT01406717|560449080|FG000|Overall Study|Lack of Efficacy|0|||
155277481|NCT01406717|560449081|FG001|Overall Study|Lack of Efficacy|1|||
155277482|NCT01406717|560449080|FG000|Overall Study|Non-completion of visit activity|0|||
155277483|NCT01406717|560449081|FG001|Overall Study|Non-completion of visit activity|1|||
155277484|NCT02040090|560449082|FG000|Overall Study|Adverse Event|2|||
155277485|NCT02040090|560449083|FG001|Overall Study|Adverse Event|0|||
155277486|NCT02040090|560449082|FG000|Overall Study|Physician Decision|1|||
155277487|NCT02040090|560449083|FG001|Overall Study|Physician Decision|0|||
155277488|NCT02040090|560449082|FG000|Overall Study|Withdrawal by Subject|0|||
155277489|NCT02040090|560449083|FG001|Overall Study|Withdrawal by Subject|1|||
155277490|NCT02040090|560449082|FG000|Overall Study|Lost to Follow-up|0|||
155277491|NCT02040090|560449083|FG001|Overall Study|Lost to Follow-up|1|||
155277492|NCT03370276|560449086|FG000|Overall Study|Death|0|||
155277493|NCT03370276|560449087|FG001|Overall Study|Death|2|||
155277494|NCT03370276|560449088|FG002|Overall Study|Death|5|||
155277495|NCT02584855|560449092|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
155277496|NCT02584855|560449093|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155277497|NCT02584855|560449094|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155277498|NCT02584855|560449095|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
155277499|NCT02584855|560449096|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
155277500|NCT02584855|560449097|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
155277501|NCT02584855|560449092|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
155277502|NCT02584855|560449093|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277503|NCT02584855|560449094|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277504|NCT02584855|560449095|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277505|NCT02584855|560449096|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277506|NCT02584855|560449097|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
155277507|NCT02584855|560449092|FG000|Open-Label Treatment Period|Adverse Event|14|||
155277508|NCT02584855|560449093|FG001|Open-Label Treatment Period|Adverse Event|0|||
155277509|NCT02584855|560449094|FG002|Open-Label Treatment Period|Adverse Event|0|||
155277510|NCT02584855|560449095|FG003|Open-Label Treatment Period|Adverse Event|0|||
155277511|NCT02584855|560449096|FG004|Open-Label Treatment Period|Adverse Event|0|||
155277512|NCT02584855|560449097|FG005|Open-Label Treatment Period|Adverse Event|0|||
154939317|NCT00447603|559203357|FG000|Filter Period|Study terminated by Sponsor|0|||
154939318|NCT00447603|559203358|FG001|Filter Period|Study terminated by Sponsor|1|||
154939319|NCT00447603|559203359|FG002|Filter Period|Study terminated by Sponsor|10|||
154939320|NCT01907737|559203368|FG000|Overall Study|Withdrawal by Subject|1|||
154939321|NCT00608205|559203389|FG000|Overall Study|Adverse Event|3|||
154939322|NCT00608205|559203390|FG001|Overall Study|Adverse Event|2|||
154939323|NCT00608205|559203389|FG000|Overall Study|Patient non-compliant|0|||
154939324|NCT00608205|559203390|FG001|Overall Study|Patient non-compliant|1|||
154939325|NCT01003886|559203391|FG000|Overall Study|Lack of Efficacy|5|||
154939326|NCT01003886|559203391|FG000|Overall Study|Lost to Follow-up|169|||
154939327|NCT01003886|559203391|FG000|Overall Study|Withdrawal by Subject|39|||
154939328|NCT01003886|559203391|FG000|Overall Study|Other|14|||
154939329|NCT01003886|559203391|FG000|Overall Study|Adverse Event|3|||
154939330|NCT00909727|559203409|FG000|Overall Study|Adverse Event|1|||
154939331|NCT00909727|559203410|FG001|Overall Study|Adverse Event|0|||
154939332|NCT00909727|559203409|FG000|Overall Study|Wrong Genotype|1|||
154939333|NCT00909727|559203410|FG001|Overall Study|Wrong Genotype|0|||
154939334|NCT00909727|559203409|FG000|Overall Study|Withdrawal of Consent|1|||
154939335|NCT00909727|559203410|FG001|Overall Study|Withdrawal of Consent|0|||
154939336|NCT00909727|559203409|FG000|Overall Study|Prohibited Medication|1|||
154939337|NCT00909727|559203410|FG001|Overall Study|Prohibited Medication|0|||
155277513|NCT02584855|560449092|FG000|Open-Label Treatment Period|Death|2|||
155277514|NCT02584855|560449093|FG001|Open-Label Treatment Period|Death|0|||
155277515|NCT02584855|560449094|FG002|Open-Label Treatment Period|Death|0|||
155277516|NCT02584855|560449095|FG003|Open-Label Treatment Period|Death|0|||
155277517|NCT02584855|560449096|FG004|Open-Label Treatment Period|Death|0|||
155277518|NCT02584855|560449097|FG005|Open-Label Treatment Period|Death|0|||
155381947|NCT00598273|560833244|FG002|Overall Study|Withdrawal by Subject|10|||
155277519|NCT02584855|560449092|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
155277520|NCT02584855|560449093|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
155277521|NCT02584855|560449094|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
155277522|NCT02584855|560449095|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
154939338|NCT00475852|559203421|FG000|Overall Study|Death|444|||
154939339|NCT00475852|559203422|FG001|Overall Study|Death|456|||
154939340|NCT00475852|559203421|FG000|Overall Study|Withdrawal by Subject|19|||
154939341|NCT00475852|559203422|FG001|Overall Study|Withdrawal by Subject|24|||
154939342|NCT00475852|559203421|FG000|Overall Study|Lost to Follow-up|54|||
154939343|NCT00475852|559203422|FG001|Overall Study|Lost to Follow-up|68|||
154939344|NCT02063698|559203423|FG000|Overall Study|did not complete booklet for days 2-8|1|||
154939345|NCT02063698|559203424|FG001|Overall Study|did not complete booklet for days 2-8|2|||
154939346|NCT01684722|559203425|FG000|Overall Study|Lost to Follow-up|78|||
154939347|NCT01684722|559203426|FG001|Overall Study|Lost to Follow-up|56|||
154939348|NCT01684722|559203427|FG002|Overall Study|Lost to Follow-up|75|||
154939349|NCT01684722|559203428|FG003|Overall Study|Lost to Follow-up|89|||
154939350|NCT01684722|559203425|FG000|Overall Study|Death|19|||
154939351|NCT01684722|559203426|FG001|Overall Study|Death|21|||
154939352|NCT01684722|559203427|FG002|Overall Study|Death|19|||
154939353|NCT01684722|559203428|FG003|Overall Study|Death|21|||
154939354|NCT01664494|559203429|FG000|Overall Study|Withdrawal by Subject|27|||
154939355|NCT01664494|559203429|FG000|Overall Study|Death|18|||
154939356|NCT01664494|559203429|FG000|Overall Study|Other|49|||
154939357|NCT01664494|559203429|FG000|Overall Study|Lost to Follow-up|99|||
154939358|NCT02974114|559203432|FG000|Overall Study|Other (Not specified)|0|||
154939359|NCT02974114|559203433|FG001|Overall Study|Other (Not specified)|1|||
154939360|NCT02974114|559203434|FG002|Overall Study|Other (Not specified)|2|||
154939361|NCT00479401|559203439|FG000|Overall Study|Adverse Event|24|||
154939362|NCT00479401|559203440|FG001|Overall Study|Adverse Event|20|||
154939363|NCT00479401|559203441|FG002|Overall Study|Adverse Event|4|||
154939364|NCT00479401|559203439|FG000|Overall Study|Lack of Efficacy|2|||
154939365|NCT00479401|559203440|FG001|Overall Study|Lack of Efficacy|2|||
154939366|NCT00479401|559203441|FG002|Overall Study|Lack of Efficacy|4|||
154939367|NCT00479401|559203439|FG000|Overall Study|Protocol Violation|2|||
154939368|NCT00479401|559203440|FG001|Overall Study|Protocol Violation|1|||
154939369|NCT00479401|559203441|FG002|Overall Study|Protocol Violation|1|||
154939370|NCT00479401|559203439|FG000|Overall Study|Lost to Follow-up|1|||
154939371|NCT00479401|559203440|FG001|Overall Study|Lost to Follow-up|1|||
154939372|NCT00479401|559203441|FG002|Overall Study|Lost to Follow-up|1|||
154939373|NCT00479401|559203439|FG000|Overall Study|Withdrawal by Subject|16|||
154939374|NCT00479401|559203440|FG001|Overall Study|Withdrawal by Subject|10|||
154939375|NCT00479401|559203441|FG002|Overall Study|Withdrawal by Subject|2|||
154939376|NCT00479401|559203439|FG000|Overall Study|Exclusion criteria, relocation|4|||
154939377|NCT00479401|559203440|FG001|Overall Study|Exclusion criteria, relocation|3|||
154939378|NCT00479401|559203441|FG002|Overall Study|Exclusion criteria, relocation|0|||
154939379|NCT02124746|559203442|FG000|Overall Study|Adverse Event|2|||
154939380|NCT02124746|559203443|FG001|Overall Study|Adverse Event|1|||
154939381|NCT02124746|559203444|FG002|Overall Study|Adverse Event|2|||
154939382|NCT02124746|559203442|FG000|Overall Study|Death|2|||
154939383|NCT02124746|559203443|FG001|Overall Study|Death|1|||
154939384|NCT02124746|559203444|FG002|Overall Study|Death|3|||
154939385|NCT02124746|559203442|FG000|Overall Study|Lack of Efficacy|3|||
154939386|NCT02124746|559203443|FG001|Overall Study|Lack of Efficacy|2|||
154939387|NCT02124746|559203444|FG002|Overall Study|Lack of Efficacy|2|||
154939388|NCT02124746|559203442|FG000|Overall Study|Physician Decision|6|||
154939389|NCT02124746|559203443|FG001|Overall Study|Physician Decision|4|||
154939390|NCT02124746|559203444|FG002|Overall Study|Physician Decision|5|||
154939391|NCT02124746|559203442|FG000|Overall Study|Non-Compliance with Study Drug|0|||
154939392|NCT02124746|559203443|FG001|Overall Study|Non-Compliance with Study Drug|1|||
154939393|NCT02124746|559203444|FG002|Overall Study|Non-Compliance with Study Drug|0|||
154939394|NCT02124746|559203442|FG000|Overall Study|Withdrawal by Subject|3|||
154939395|NCT02124746|559203443|FG001|Overall Study|Withdrawal by Subject|3|||
154939396|NCT02124746|559203444|FG002|Overall Study|Withdrawal by Subject|0|||
154939397|NCT02124746|559203442|FG000|Overall Study|Study Terminated by Sponsor|0|||
154939398|NCT02124746|559203443|FG001|Overall Study|Study Terminated by Sponsor|0|||
154939399|NCT02124746|559203444|FG002|Overall Study|Study Terminated by Sponsor|6|||
154939400|NCT02124746|559203442|FG000|Overall Study|Disease Progression|3|||
154939401|NCT02124746|559203443|FG001|Overall Study|Disease Progression|6|||
154939402|NCT02124746|559203444|FG002|Overall Study|Disease Progression|4|||
154939403|NCT03634488|559203450|FG000|Overall Study|Death|1|||
154939404|NCT03634488|559203451|FG001|Overall Study|Death|0|||
154939405|NCT03634488|559203452|FG002|Overall Study|Death|0|||
154939406|NCT03634488|559203450|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
154939407|NCT03634488|559203451|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
154939408|NCT03634488|559203452|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
154939409|NCT03182686|559203453|FG000|Overall Study|Lost to Follow-up|2|||
154939410|NCT03182686|559203454|FG001|Overall Study|Lost to Follow-up|0|||
154939411|NCT03182686|559203453|FG000|Overall Study|Adverse Event|2|||
154939412|NCT03182686|559203454|FG001|Overall Study|Adverse Event|0|||
154939413|NCT03182686|559203453|FG000|Overall Study|Withdrawal by Subject|3|||
154939414|NCT03182686|559203454|FG001|Overall Study|Withdrawal by Subject|0|||
154939415|NCT01154127|559203461|FG000|Period 1 (21 Days)|Adverse Event|3|||
154939416|NCT01154127|559203462|FG001|Period 1 (21 Days)|Adverse Event|4|||
154939417|NCT01154127|559203461|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
154939418|NCT01154127|559203462|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
154939419|NCT01154127|559203461|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
154939420|NCT01154127|559203462|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
154939421|NCT01154127|559203461|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
154939422|NCT01154127|559203462|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
154939423|NCT01154127|559203461|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
154939424|NCT01154127|559203462|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
154939425|NCT01697449|559203463|FG000|Overall Study|Disease progression|47|||
154939426|NCT01697449|559203463|FG000|Overall Study|Adverse Event|7|||
154939427|NCT01697449|559203463|FG000|Overall Study|Lost to Follow-up|5|||
154939428|NCT01697449|559203463|FG000|Overall Study|Withdrawal by Subject|2|||
154939429|NCT01697449|559203463|FG000|Overall Study|Physician Decision|1|||
154939430|NCT01697449|559203463|FG000|Overall Study|Death|2|||
154939431|NCT01697449|559203463|FG000|Overall Study|Other|1|||
154939432|NCT01697449|559203463|FG000|Overall Study|Missing|25|||
154939433|NCT01169844|559203464|FG000|Overall Study|Adverse Event|0|||
154939434|NCT01169844|559203465|FG001|Overall Study|Adverse Event|1|||
154939435|NCT01169844|559203464|FG000|Overall Study|Patient withdrew consent|4|||
154939436|NCT01169844|559203465|FG001|Overall Study|Patient withdrew consent|0|||
154939437|NCT01169844|559203464|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154939438|NCT01169844|559203465|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154939439|NCT00529568|559203467|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
154939440|NCT00529568|559203468|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
154939441|NCT00529568|559203469|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
154939442|NCT00529568|559203467|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
154939443|NCT00529568|559203468|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
154939444|NCT00529568|559203469|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
154939445|NCT00529568|559203467|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
154939446|NCT00529568|559203468|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
154939447|NCT00529568|559203469|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
154939448|NCT00529568|559203467|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
154939449|NCT00529568|559203468|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
154939450|NCT00529568|559203469|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
154939451|NCT00529568|559203467|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
154939452|NCT00529568|559203468|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
154939453|NCT00529568|559203469|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
154939454|NCT00529568|559203467|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
154939455|NCT00529568|559203468|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
154939456|NCT00529568|559203469|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
154939457|NCT00529568|559203467|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
154939458|NCT00529568|559203468|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
154939459|NCT00529568|559203469|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
154939460|NCT00529568|559203467|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
154939461|NCT00529568|559203468|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
154939462|NCT00529568|559203469|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
154939463|NCT00529568|559203467|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
154939464|NCT00529568|559203468|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
154939465|NCT00529568|559203469|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
154939466|NCT00529568|559203467|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
154939467|NCT00529568|559203468|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
154939468|NCT00529568|559203469|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
154939469|NCT00529568|559203467|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
154939470|NCT00529568|559203468|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
154939471|NCT00529568|559203469|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
154939472|NCT04049552|559203470|FG000|Overall Study|Lost to Follow-up|1|||
154939473|NCT00738920|559203472|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
154939474|NCT00738920|559203473|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
154939475|NCT00738920|559203474|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
154939476|NCT00738920|559203472|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
154939477|NCT00738920|559203473|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
154939478|NCT00738920|559203474|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
154939479|NCT00738920|559203472|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
154939480|NCT00738920|559203473|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
154939481|NCT00738920|559203474|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
154939482|NCT00738920|559203472|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
154939483|NCT00738920|559203473|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
154939484|NCT00738920|559203474|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
154939485|NCT00738920|559203472|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
155043574|NCT02087943|559590171|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
154939486|NCT00738920|559203473|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
154939487|NCT00738920|559203474|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
154939488|NCT00738920|559203472|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
154939489|NCT00738920|559203473|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
154939490|NCT00738920|559203474|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
154939491|NCT00738920|559203472|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
154939492|NCT00738920|559203473|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
154939493|NCT00738920|559203474|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
154939494|NCT00738920|559203472|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
154939495|NCT00738920|559203473|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
154939496|NCT00738920|559203474|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
154939497|NCT00738920|559203472|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
154939498|NCT00738920|559203473|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
154939499|NCT00738920|559203474|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
154939500|NCT00738920|559203472|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
154939501|NCT00738920|559203473|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
154939502|NCT00738920|559203474|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
154939503|NCT00331630|559205705|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
154939504|NCT00331630|559205705|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
154939505|NCT00331630|559205705|FG000|Follow up for 5 Years|Death|5|||
154939506|NCT00331630|559205705|FG000|Follow up for 5 Years|Data collection was stopped|24|||
154939507|NCT00720798|559205706|FG000|Overall Study|Adverse Event|304|||
154939508|NCT00720798|559205706|FG000|Overall Study|Death|39|||
154939509|NCT00720798|559205706|FG000|Overall Study|Insufficient Therapeutic Response|129|||
154939510|NCT00720798|559205706|FG000|Overall Study|Protocol Violation|4|||
154939511|NCT00720798|559205706|FG000|Overall Study|Refused Treatment|151|||
154939512|NCT00720798|559205706|FG000|Overall Study|Failure to Return|46|||
154939513|NCT00720798|559205706|FG000|Overall Study|Reason not Specified|83|||
154939514|NCT00433381|559205707|FG000|Overall Study|Ineligible / no protocol treatment|3|||
154939515|NCT00433381|559205708|FG001|Overall Study|Ineligible / no protocol treatment|3|||
154939516|NCT02806232|559205711|FG000|Overall Study|Lost to Follow-up|1|||
154939517|NCT02806232|559205712|FG001|Overall Study|Lost to Follow-up|2|||
154939518|NCT02806232|559205713|FG002|Overall Study|Lost to Follow-up|1|||
154939519|NCT02806232|559205714|FG003|Overall Study|Lost to Follow-up|0|||
154939520|NCT02806232|559205715|FG004|Overall Study|Lost to Follow-up|0|||
154939521|NCT02806232|559205716|FG005|Overall Study|Lost to Follow-up|1|||
154939522|NCT02806232|559205717|FG006|Overall Study|Lost to Follow-up|0|||
154939523|NCT02806232|559205718|FG007|Overall Study|Lost to Follow-up|0|||
154939524|NCT02806232|559205719|FG008|Overall Study|Lost to Follow-up|0|||
154939525|NCT02806232|559205711|FG000|Overall Study|Withdrawal by Subject|0|||
154939526|NCT02806232|559205712|FG001|Overall Study|Withdrawal by Subject|2|||
154939527|NCT02806232|559205713|FG002|Overall Study|Withdrawal by Subject|0|||
154939528|NCT02806232|559205714|FG003|Overall Study|Withdrawal by Subject|0|||
154939529|NCT02806232|559205715|FG004|Overall Study|Withdrawal by Subject|2|||
154939530|NCT02806232|559205716|FG005|Overall Study|Withdrawal by Subject|1|||
154939531|NCT02806232|559205717|FG006|Overall Study|Withdrawal by Subject|0|||
154939532|NCT02806232|559205718|FG007|Overall Study|Withdrawal by Subject|0|||
154939533|NCT02806232|559205719|FG008|Overall Study|Withdrawal by Subject|0|||
154939534|NCT01133821|559205720|FG000|Overall Study|Lost to Follow-up|8|||
154939535|NCT01133821|559205721|FG001|Overall Study|Lost to Follow-up|11|||
154939536|NCT01133821|559205720|FG000|Overall Study|Withdrawal by Subject|8|||
154939537|NCT01133821|559205721|FG001|Overall Study|Withdrawal by Subject|3|||
154939538|NCT01133821|559205720|FG000|Overall Study|preferred other treatment|1|||
154939539|NCT01133821|559205721|FG001|Overall Study|preferred other treatment|1|||
154939540|NCT01133821|559205720|FG000|Overall Study|Protocol Violation|0|||
154939541|NCT01133821|559205721|FG001|Overall Study|Protocol Violation|1|||
154939542|NCT01133821|559205720|FG000|Overall Study|Refused participation|1|||
154939543|NCT01133821|559205721|FG001|Overall Study|Refused participation|3|||
154939544|NCT03342898|559205724|FG000|Overall Study|Adverse Event|3|||
154939545|NCT03342898|559205725|FG001|Overall Study|Adverse Event|1|||
154939546|NCT03342898|559205726|FG002|Overall Study|Adverse Event|0|||
154939547|NCT03342898|559205724|FG000|Overall Study|Lost to Follow-up|44|||
154939548|NCT03342898|559205725|FG001|Overall Study|Lost to Follow-up|40|||
154939549|NCT03342898|559205726|FG002|Overall Study|Lost to Follow-up|42|||
154939550|NCT03342898|559205724|FG000|Overall Study|Withdrawal of Consent|5|||
154939551|NCT03342898|559205725|FG001|Overall Study|Withdrawal of Consent|9|||
154939552|NCT03342898|559205726|FG002|Overall Study|Withdrawal of Consent|11|||
154939553|NCT03342898|559205724|FG000|Overall Study|Death|0|||
154939554|NCT03342898|559205725|FG001|Overall Study|Death|1|||
154939555|NCT03342898|559205726|FG002|Overall Study|Death|1|||
154939556|NCT03342898|559205724|FG000|Overall Study|Reason not Specified|2|||
154939557|NCT03342898|559205725|FG001|Overall Study|Reason not Specified|2|||
154939558|NCT03342898|559205726|FG002|Overall Study|Reason not Specified|0|||
154939559|NCT01387282|559205727|FG000|Overall Study|Death|47|||
154939560|NCT01387282|559205728|FG001|Overall Study|Death|16|||
154939561|NCT01387282|559205727|FG000|Overall Study|Other|5|||
154939562|NCT01387282|559205728|FG001|Overall Study|Other|1|||
154939563|NCT01387282|559205727|FG000|Overall Study|Unrelated AE|6|||
154939564|NCT01387282|559205728|FG001|Overall Study|Unrelated AE|4|||
154939565|NCT01387282|559205727|FG000|Overall Study|Withdrawal by patient|33|||
154939566|NCT01387282|559205728|FG001|Overall Study|Withdrawal by patient|23|||
154939567|NCT01387282|559205727|FG000|Overall Study|Study drug-related AE|2|||
154939568|NCT01387282|559205728|FG001|Overall Study|Study drug-related AE|2|||
154939569|NCT01387282|559205727|FG000|Overall Study|Lost to Follow-up|4|||
154939570|NCT01387282|559205728|FG001|Overall Study|Lost to Follow-up|1|||
154939571|NCT03997448|559205729|FG000|Study Treatment|Disease Progression|1|||
154939572|NCT03997448|559205729|FG000|Study Treatment|Symptomatic Deterioration|1|||
154939573|NCT03997448|559205729|FG000|Follow up|Death|2|||
155043575|NCT02087943|559590172|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
155043576|NCT02087943|559590173|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
155043577|NCT02087943|559590169|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
155043578|NCT02087943|559590170|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
155043579|NCT02087943|559590171|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
155043580|NCT02087943|559590172|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
155043581|NCT02087943|559590173|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
155043582|NCT02087943|559590169|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
155043583|NCT02087943|559590170|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
155043584|NCT02087943|559590171|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
155043585|NCT02087943|559590172|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
155043586|NCT02087943|559590173|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
155043587|NCT02087943|559590169|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155043588|NCT02087943|559590170|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
155043589|NCT02087943|559590171|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155043590|NCT02087943|559590172|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155043591|NCT02087943|559590173|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
155043592|NCT02087943|559590169|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
155043593|NCT02087943|559590170|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
155043594|NCT02087943|559590171|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
155043595|NCT02087943|559590172|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
155043596|NCT02087943|559590173|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
155043597|NCT02087943|559590169|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
155043598|NCT02087943|559590170|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
155043599|NCT02087943|559590171|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
155043600|NCT02087943|559590172|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
155043601|NCT02087943|559590173|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
155043602|NCT02087943|559590169|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155043603|NCT02087943|559590170|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155043604|NCT02087943|559590171|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
155043605|NCT02087943|559590172|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155043606|NCT02087943|559590173|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
155043607|NCT02087943|559590169|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155043608|NCT02087943|559590170|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155043609|NCT02087943|559590171|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155043610|NCT02087943|559590172|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
155043611|NCT02087943|559590173|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
155043612|NCT02087943|559590169|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
155043613|NCT02087943|559590170|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
155043614|NCT02087943|559590171|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
155043615|NCT02087943|559590172|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
155043616|NCT02087943|559590173|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
155043617|NCT01690299|559590174|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
155043618|NCT01690299|559590175|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
155043619|NCT01690299|559590176|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
155043620|NCT01690299|559590177|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
155043621|NCT01690299|559590178|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
155043622|NCT01690299|559590179|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
155381948|NCT00598273|560833242|FG000|Overall Study|Noncompliance|3|||
155043623|NCT01690299|559590174|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
155043624|NCT01690299|559590175|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155043625|NCT01690299|559590176|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155043626|NCT01690299|559590177|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
154939574|NCT03997448|559205729|FG000|Follow up|study terminated|1|||
154939575|NCT01621490|559205732|FG000|Overall Study|Subject no longer meets study criteria|0|||
154939576|NCT01621490|559205733|FG001|Overall Study|Subject no longer meets study criteria|0|||
154939577|NCT01621490|559205734|FG002|Overall Study|Subject no longer meets study criteria|0|||
154939578|NCT01621490|559205735|FG003|Overall Study|Subject no longer meets study criteria|0|||
154939579|NCT01621490|559205736|FG004|Overall Study|Subject no longer meets study criteria|1|||
154939580|NCT01621490|559205737|FG005|Overall Study|Subject no longer meets study criteria|0|||
154939581|NCT01621490|559205738|FG006|Overall Study|Subject no longer meets study criteria|0|||
154939582|NCT01621490|559205739|FG007|Overall Study|Subject no longer meets study criteria|0|||
154939583|NCT01621490|559205740|FG008|Overall Study|Subject no longer meets study criteria|0|||
154939584|NCT01621490|559205741|FG009|Overall Study|Subject no longer meets study criteria|0|||
154939585|NCT01621490|559205742|FG010|Overall Study|Subject no longer meets study criteria|0|||
154939586|NCT01621490|559205732|FG000|Overall Study|Maximum clinical benefit|3|||
154939587|NCT01621490|559205733|FG001|Overall Study|Maximum clinical benefit|2|||
154939588|NCT01621490|559205734|FG002|Overall Study|Maximum clinical benefit|0|||
154939589|NCT01621490|559205735|FG003|Overall Study|Maximum clinical benefit|0|||
154939590|NCT01621490|559205736|FG004|Overall Study|Maximum clinical benefit|0|||
154939591|NCT01621490|559205737|FG005|Overall Study|Maximum clinical benefit|0|||
154939592|NCT01621490|559205738|FG006|Overall Study|Maximum clinical benefit|1|||
154939593|NCT01621490|559205739|FG007|Overall Study|Maximum clinical benefit|2|||
154939594|NCT01621490|559205740|FG008|Overall Study|Maximum clinical benefit|2|||
154939595|NCT01621490|559205741|FG009|Overall Study|Maximum clinical benefit|0|||
154939596|NCT01621490|559205742|FG010|Overall Study|Maximum clinical benefit|0|||
154939597|NCT01621490|559205732|FG000|Overall Study|Withdrawal by Subject|1|||
154939598|NCT01621490|559205733|FG001|Overall Study|Withdrawal by Subject|0|||
154939599|NCT01621490|559205734|FG002|Overall Study|Withdrawal by Subject|0|||
154939600|NCT01621490|559205735|FG003|Overall Study|Withdrawal by Subject|0|||
154939601|NCT01621490|559205736|FG004|Overall Study|Withdrawal by Subject|0|||
154939602|NCT01621490|559205737|FG005|Overall Study|Withdrawal by Subject|1|||
154939603|NCT01621490|559205738|FG006|Overall Study|Withdrawal by Subject|0|||
154939604|NCT01621490|559205739|FG007|Overall Study|Withdrawal by Subject|0|||
154939605|NCT01621490|559205740|FG008|Overall Study|Withdrawal by Subject|0|||
154939606|NCT01621490|559205741|FG009|Overall Study|Withdrawal by Subject|0|||
154939607|NCT01621490|559205742|FG010|Overall Study|Withdrawal by Subject|0|||
154939608|NCT01621490|559205732|FG000|Overall Study|Subject request to discontinue study|1|||
154939609|NCT01621490|559205733|FG001|Overall Study|Subject request to discontinue study|3|||
154939610|NCT01621490|559205734|FG002|Overall Study|Subject request to discontinue study|1|||
154939611|NCT01621490|559205735|FG003|Overall Study|Subject request to discontinue study|1|||
154939612|NCT01621490|559205736|FG004|Overall Study|Subject request to discontinue study|0|||
154939613|NCT01621490|559205737|FG005|Overall Study|Subject request to discontinue study|2|||
154939614|NCT01621490|559205738|FG006|Overall Study|Subject request to discontinue study|1|||
154939615|NCT01621490|559205739|FG007|Overall Study|Subject request to discontinue study|0|||
154939616|NCT01621490|559205740|FG008|Overall Study|Subject request to discontinue study|1|||
154939617|NCT01621490|559205741|FG009|Overall Study|Subject request to discontinue study|0|||
154939618|NCT01621490|559205742|FG010|Overall Study|Subject request to discontinue study|0|||
154939619|NCT01621490|559205732|FG000|Overall Study|Adverse event unrelated to study drug|1|||
154939620|NCT01621490|559205733|FG001|Overall Study|Adverse event unrelated to study drug|1|||
154939621|NCT01621490|559205734|FG002|Overall Study|Adverse event unrelated to study drug|0|||
154939622|NCT01621490|559205735|FG003|Overall Study|Adverse event unrelated to study drug|0|||
154939623|NCT01621490|559205736|FG004|Overall Study|Adverse event unrelated to study drug|0|||
154939624|NCT01621490|559205737|FG005|Overall Study|Adverse event unrelated to study drug|0|||
154939625|NCT01621490|559205738|FG006|Overall Study|Adverse event unrelated to study drug|0|||
154939626|NCT01621490|559205739|FG007|Overall Study|Adverse event unrelated to study drug|2|||
154939627|NCT01621490|559205740|FG008|Overall Study|Adverse event unrelated to study drug|0|||
154939628|NCT01621490|559205741|FG009|Overall Study|Adverse event unrelated to study drug|0|||
154939629|NCT01621490|559205742|FG010|Overall Study|Adverse event unrelated to study drug|0|||
154939630|NCT01621490|559205732|FG000|Overall Study|Disease progression|27|||
154939631|NCT01621490|559205733|FG001|Overall Study|Disease progression|28|||
154939632|NCT01621490|559205734|FG002|Overall Study|Disease progression|1|||
154939633|NCT01621490|559205735|FG003|Overall Study|Disease progression|5|||
154939634|NCT01621490|559205736|FG004|Overall Study|Disease progression|3|||
154939635|NCT01621490|559205737|FG005|Overall Study|Disease progression|8|||
154939636|NCT01621490|559205738|FG006|Overall Study|Disease progression|7|||
154939637|NCT01621490|559205739|FG007|Overall Study|Disease progression|1|||
154939638|NCT01621490|559205740|FG008|Overall Study|Disease progression|4|||
154939639|NCT01621490|559205741|FG009|Overall Study|Disease progression|1|||
154939640|NCT01621490|559205742|FG010|Overall Study|Disease progression|1|||
154939641|NCT01621490|559205732|FG000|Overall Study|Study drug toxicity|1|||
154939642|NCT01621490|559205733|FG001|Overall Study|Study drug toxicity|4|||
154939643|NCT01621490|559205734|FG002|Overall Study|Study drug toxicity|5|||
154939644|NCT01621490|559205735|FG003|Overall Study|Study drug toxicity|3|||
154939645|NCT01621490|559205736|FG004|Overall Study|Study drug toxicity|1|||
154939646|NCT01621490|559205737|FG005|Overall Study|Study drug toxicity|10|||
154939647|NCT01621490|559205738|FG006|Overall Study|Study drug toxicity|1|||
154939648|NCT01621490|559205739|FG007|Overall Study|Study drug toxicity|4|||
154939649|NCT01621490|559205740|FG008|Overall Study|Study drug toxicity|1|||
154939650|NCT01621490|559205741|FG009|Overall Study|Study drug toxicity|0|||
154939651|NCT01621490|559205742|FG010|Overall Study|Study drug toxicity|0|||
154939652|NCT01621490|559205732|FG000|Overall Study|Death|0|||
154939653|NCT01621490|559205733|FG001|Overall Study|Death|0|||
154939654|NCT01621490|559205734|FG002|Overall Study|Death|0|||
154939655|NCT01621490|559205735|FG003|Overall Study|Death|0|||
154939656|NCT01621490|559205736|FG004|Overall Study|Death|0|||
154939657|NCT01621490|559205737|FG005|Overall Study|Death|0|||
154939658|NCT01621490|559205738|FG006|Overall Study|Death|0|||
154939659|NCT01621490|559205739|FG007|Overall Study|Death|0|||
154939660|NCT01621490|559205740|FG008|Overall Study|Death|1|||
154939661|NCT01621490|559205741|FG009|Overall Study|Death|0|||
154939662|NCT01621490|559205742|FG010|Overall Study|Death|0|||
154939663|NCT01621490|559205732|FG000|Overall Study|Other reasons|7|||
154939664|NCT01621490|559205733|FG001|Overall Study|Other reasons|6|||
154939665|NCT01621490|559205734|FG002|Overall Study|Other reasons|4|||
154939666|NCT01621490|559205735|FG003|Overall Study|Other reasons|1|||
154939667|NCT01621490|559205736|FG004|Overall Study|Other reasons|1|||
154939668|NCT01621490|559205737|FG005|Overall Study|Other reasons|3|||
154939669|NCT01621490|559205738|FG006|Overall Study|Other reasons|1|||
154939670|NCT01621490|559205739|FG007|Overall Study|Other reasons|1|||
154939671|NCT01621490|559205740|FG008|Overall Study|Other reasons|1|||
154939672|NCT01621490|559205741|FG009|Overall Study|Other reasons|0|||
154939673|NCT01621490|559205742|FG010|Overall Study|Other reasons|0|||
154939674|NCT00461500|559205743|FG000|Overall Study|Adverse Event|1|||
154939675|NCT00461500|559205744|FG001|Overall Study|Adverse Event|0|||
154939676|NCT00461500|559205743|FG000|Overall Study|Lack of Efficacy|0|||
154939677|NCT00461500|559205744|FG001|Overall Study|Lack of Efficacy|1|||
154939678|NCT00461500|559205743|FG000|Overall Study|Expired Drug Treatment|1|||
154939679|NCT00461500|559205744|FG001|Overall Study|Expired Drug Treatment|1|||
154939680|NCT00461500|559205743|FG000|Overall Study|Study Stopped|1|||
154939681|NCT00461500|559205744|FG001|Overall Study|Study Stopped|2|||
154939682|NCT00461500|559205743|FG000|Overall Study|Drug Treatment Misuse|1|||
154939683|NCT00461500|559205744|FG001|Overall Study|Drug Treatment Misuse|0|||
154939684|NCT00461500|559205743|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
154939685|NCT00461500|559205744|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
154939686|NCT00461500|559205743|FG000|Overall Study|Lost to Follow-up|2|||
154939687|NCT00461500|559205744|FG001|Overall Study|Lost to Follow-up|2|||
154939688|NCT01513551|559205745|FG000|Overall Study|Death|0|||
154939689|NCT01513551|559205746|FG001|Overall Study|Death|1|||
154939690|NCT01513551|559205747|FG002|Overall Study|Death|0|||
154939691|NCT01513551|559205745|FG000|Overall Study|Lost to Follow-up|3|||
154939692|NCT01513551|559205746|FG001|Overall Study|Lost to Follow-up|5|||
154939693|NCT01513551|559205747|FG002|Overall Study|Lost to Follow-up|2|||
154939694|NCT01513551|559205745|FG000|Overall Study|Withdrawal by Subject|1|||
154939695|NCT01513551|559205746|FG001|Overall Study|Withdrawal by Subject|0|||
154939696|NCT01513551|559205747|FG002|Overall Study|Withdrawal by Subject|2|||
154939697|NCT01513551|559205745|FG000|Overall Study|Randomized but not vaccinated|0|||
154939698|NCT01513551|559205746|FG001|Overall Study|Randomized but not vaccinated|0|||
154939699|NCT01513551|559205747|FG002|Overall Study|Randomized but not vaccinated|1|||
154939700|NCT01267266|559205755|FG000|Enrollment Phase|Withdrawal by Subject|2|||
154939701|NCT01267266|559205756|FG001|Enrollment Phase|Withdrawal by Subject|0|||
154939702|NCT01267266|559205755|FG000|Lead-in Phase|Lack of Efficacy|20|||
154939703|NCT01267266|559205756|FG001|Lead-in Phase|Lack of Efficacy|0|||
154939704|NCT01267266|559205755|FG000|Lead-in Phase|Adverse Event|2|||
154939705|NCT01267266|559205756|FG001|Lead-in Phase|Adverse Event|0|||
154939706|NCT01267266|559205755|FG000|Lead-in Phase|Withdrawal by Subject|1|||
154939707|NCT01267266|559205756|FG001|Lead-in Phase|Withdrawal by Subject|0|||
154939708|NCT01335477|559205758|FG000|Overall Study|Adverse Event|30|||
154939709|NCT01335477|559205759|FG001|Overall Study|Adverse Event|42|||
154939710|NCT01335477|559205758|FG000|Overall Study|Non compliant with protocol|0|||
154939711|NCT01335477|559205759|FG001|Overall Study|Non compliant with protocol|2|||
154939712|NCT01335477|559205758|FG000|Overall Study|Lost to Follow-up|1|||
154939713|NCT01335477|559205759|FG001|Overall Study|Lost to Follow-up|2|||
155277523|NCT02584855|560449096|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
154939714|NCT01335477|559205758|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
154939715|NCT01335477|559205759|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
154939716|NCT01335477|559205758|FG000|Overall Study|Not treated|1|||
154939717|NCT01335477|559205759|FG001|Overall Study|Not treated|2|||
154939718|NCT01335477|559205758|FG000|Overall Study|Reason other than those stated above|2|||
154939719|NCT01335477|559205759|FG001|Overall Study|Reason other than those stated above|2|||
154939720|NCT00549198|559205760|FG000|Overall Study|Adverse Event|28|||
154939721|NCT00549198|559205761|FG001|Overall Study|Adverse Event|26|||
154939722|NCT00549198|559205760|FG000|Overall Study|Insufficient Viral Load Response|4|||
154939723|NCT00549198|559205761|FG001|Overall Study|Insufficient Viral Load Response|2|||
154939724|NCT00549198|559205760|FG000|Overall Study|Protocol-defined Virological Failure|7|||
154939725|NCT00549198|559205761|FG001|Overall Study|Protocol-defined Virological Failure|0|||
154939726|NCT00549198|559205760|FG000|Overall Study|Non-compliance|2|||
154939727|NCT00549198|559205761|FG001|Overall Study|Non-compliance|4|||
154939728|NCT00549198|559205760|FG000|Overall Study|Lost to Follow-up|7|||
154939729|NCT00549198|559205761|FG001|Overall Study|Lost to Follow-up|8|||
154939730|NCT00549198|559205760|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
154939731|NCT00549198|559205761|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
154939732|NCT00549198|559205760|FG000|Overall Study|Protocol Violation|7|||
154939733|NCT00549198|559205761|FG001|Overall Study|Protocol Violation|2|||
154939734|NCT00549198|559205760|FG000|Overall Study|Investigator Decision|4|||
154939735|NCT00549198|559205761|FG001|Overall Study|Investigator Decision|3|||
154939736|NCT00549198|559205760|FG000|Overall Study|Withdrawal by Subject|7|||
154939737|NCT00549198|559205761|FG001|Overall Study|Withdrawal by Subject|7|||
154939738|NCT00549198|559205760|FG000|Overall Study|Disease Progression|1|||
154939739|NCT00549198|559205761|FG001|Overall Study|Disease Progression|0|||
154939740|NCT00549198|559205760|FG000|Overall Study|Participant Moved|2|||
154939741|NCT00549198|559205761|FG001|Overall Study|Participant Moved|0|||
154939742|NCT00549198|559205760|FG000|Overall Study|Participant not able to perform Week 96|1|||
154939743|NCT00549198|559205761|FG001|Overall Study|Participant not able to perform Week 96|0|||
154939744|NCT00549198|559205760|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
154939745|NCT00549198|559205761|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
154939746|NCT00549198|559205760|FG000|Overall Study|Prohibited Medication|1|||
154939747|NCT00549198|559205761|FG001|Overall Study|Prohibited Medication|2|||
154939748|NCT00549198|559205760|FG000|Overall Study|Participant planning pregnancy|1|||
154939749|NCT00549198|559205761|FG001|Overall Study|Participant planning pregnancy|0|||
154939750|NCT00549198|559205760|FG000|Overall Study|Participant overweight, no scan possible|1|||
154939751|NCT00549198|559205761|FG001|Overall Study|Participant overweight, no scan possible|0|||
154939752|NCT00549198|559205760|FG000|Overall Study|No scan facilities|0|||
154939753|NCT00549198|559205761|FG001|Overall Study|No scan facilities|2|||
154939754|NCT00549198|559205760|FG000|Overall Study|Pregnancy|0|||
154939755|NCT00549198|559205761|FG001|Overall Study|Pregnancy|3|||
154939756|NCT00549198|559205760|FG000|Overall Study|Not Exposed to Study Drug|3|||
154939757|NCT00549198|559205761|FG001|Overall Study|Not Exposed to Study Drug|4|||
154939758|NCT01764854|559205764|FG000|Overall Study|Adverse Event|0|||
154939759|NCT01764854|559205765|FG001|Overall Study|Adverse Event|0|||
154939760|NCT01764854|559205766|FG002|Overall Study|Adverse Event|2|||
154939761|NCT01764854|559205767|FG003|Overall Study|Adverse Event|0|||
154939762|NCT01764854|559205764|FG000|Overall Study|Withdrawal by Subject|0|||
154939763|NCT01764854|559205765|FG001|Overall Study|Withdrawal by Subject|0|||
154939764|NCT01764854|559205766|FG002|Overall Study|Withdrawal by Subject|1|||
154939765|NCT01764854|559205767|FG003|Overall Study|Withdrawal by Subject|0|||
154939766|NCT01764854|559205764|FG000|Overall Study|relocation|0|||
154939767|NCT01764854|559205765|FG001|Overall Study|relocation|0|||
154939768|NCT01764854|559205766|FG002|Overall Study|relocation|2|||
154939769|NCT01764854|559205767|FG003|Overall Study|relocation|0|||
154939770|NCT01764854|559205764|FG000|Overall Study|Protocol Violation|0|||
154939771|NCT01764854|559205765|FG001|Overall Study|Protocol Violation|0|||
154939772|NCT01764854|559205766|FG002|Overall Study|Protocol Violation|1|||
154939773|NCT01764854|559205767|FG003|Overall Study|Protocol Violation|2|||
154939774|NCT00901628|559205776|FG000|Overall Study|disconnection of catheter|4|||
154939775|NCT00901628|559205777|FG001|Overall Study|disconnection of catheter|8|||
154939776|NCT00901628|559205776|FG000|Overall Study|disconnection of drain|0|||
154939777|NCT00901628|559205777|FG001|Overall Study|disconnection of drain|1|||
154939778|NCT00901628|559205776|FG000|Overall Study|peroneal nerve palsy|0|||
154939779|NCT00901628|559205777|FG001|Overall Study|peroneal nerve palsy|1|||
154939780|NCT05751629|559205780|FG000|Overall Study|Withdrawal by Subject|6|||
154939781|NCT05751629|559205780|FG000|Overall Study|Death|25|||
154939782|NCT05751629|559205780|FG000|Overall Study|Study Site Closed|9|||
154939783|NCT05751629|559205780|FG000|Overall Study|Physician Decision|1|||
154939784|NCT01909466|559205781|FG000|Overall Study|Lost to Follow-up|5|||
154939785|NCT01909466|559205782|FG001|Overall Study|Lost to Follow-up|7|||
155043627|NCT01690299|559590178|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155043628|NCT01690299|559590179|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155043629|NCT01690299|559590174|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
155043630|NCT01690299|559590175|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
155043631|NCT01690299|559590176|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155043632|NCT01690299|559590177|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155043633|NCT01690299|559590178|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155043634|NCT01690299|559590179|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
154939786|NCT01909466|559205781|FG000|Overall Study|Adverse Event|3|||
154939787|NCT01909466|559205782|FG001|Overall Study|Adverse Event|4|||
154939788|NCT01909466|559205781|FG000|Overall Study|Met Withdrawal Criteria|0|||
154939789|NCT01909466|559205782|FG001|Overall Study|Met Withdrawal Criteria|3|||
154939790|NCT01909466|559205781|FG000|Overall Study|Physician Decision|2|||
154939791|NCT01909466|559205782|FG001|Overall Study|Physician Decision|0|||
154939792|NCT01909466|559205781|FG000|Overall Study|Withdrawal by Subject|11|||
154939793|NCT01909466|559205782|FG001|Overall Study|Withdrawal by Subject|9|||
154939794|NCT01909466|559205781|FG000|Overall Study|Lack of Efficacy|1|||
154939795|NCT01909466|559205782|FG001|Overall Study|Lack of Efficacy|0|||
154939796|NCT02231710|559205783|FG000|Overall Study|Physician Decision|1|||
154939797|NCT01339910|559205784|FG000|Overall Study|Withdrawal by Subject|1|||
154939798|NCT01339910|559205785|FG001|Overall Study|Withdrawal by Subject|0|||
154939799|NCT01339910|559205784|FG000|Overall Study|Physician Decision|1|||
154939800|NCT01339910|559205785|FG001|Overall Study|Physician Decision|0|||
154939801|NCT01339910|559205784|FG000|Overall Study|Disease relapse|1|||
154939802|NCT01339910|559205785|FG001|Overall Study|Disease relapse|4|||
154939803|NCT00772577|559205791|FG000|Overall Study|Adverse Event|6|||
154939804|NCT00772577|559205792|FG001|Overall Study|Adverse Event|3|||
154939805|NCT00772577|559205791|FG000|Overall Study|Abnormal laboratory values|0|||
154939806|NCT00772577|559205792|FG001|Overall Study|Abnormal laboratory values|1|||
154939807|NCT00772577|559205791|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
154939808|NCT00772577|559205792|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
154939809|NCT00772577|559205791|FG000|Overall Study|Patient withdrew consent|8|||
154939810|NCT00772577|559205792|FG001|Overall Study|Patient withdrew consent|5|||
154939811|NCT00772577|559205791|FG000|Overall Study|Lost to Follow-up|4|||
154939812|NCT00772577|559205792|FG001|Overall Study|Lost to Follow-up|3|||
154939813|NCT00772577|559205791|FG000|Overall Study|Administrative problems|2|||
154939814|NCT00772577|559205792|FG001|Overall Study|Administrative problems|1|||
154939815|NCT00772577|559205791|FG000|Overall Study|Protocol Deviation|3|||
154939816|NCT00772577|559205792|FG001|Overall Study|Protocol Deviation|2|||
154939817|NCT02965820|559205793|FG000|Period 2, Second 30 Days|Adverse Event|1|||
154939818|NCT02965820|559205794|FG001|Period 2, Second 30 Days|Adverse Event|1|||
154939819|NCT01567306|559205795|FG000|Overall Study|Protocol Violation|2|||
154939820|NCT01567306|559205796|FG001|Overall Study|Protocol Violation|2|||
154939821|NCT01567306|559205797|FG002|Overall Study|Protocol Violation|0|||
154939822|NCT01567306|559205798|FG003|Overall Study|Protocol Violation|3|||
154939823|NCT01567306|559205799|FG004|Overall Study|Protocol Violation|1|||
154939824|NCT01567306|559205800|FG005|Overall Study|Protocol Violation|1|||
154939825|NCT01567306|559205795|FG000|Overall Study|Change site living|1|||
154939826|NCT01567306|559205796|FG001|Overall Study|Change site living|0|||
154939827|NCT01567306|559205797|FG002|Overall Study|Change site living|0|||
154939828|NCT01567306|559205798|FG003|Overall Study|Change site living|0|||
154939829|NCT01567306|559205799|FG004|Overall Study|Change site living|0|||
154939830|NCT01567306|559205800|FG005|Overall Study|Change site living|0|||
154939831|NCT01567306|559205795|FG000|Overall Study|Adverse Event|0|||
154939832|NCT01567306|559205796|FG001|Overall Study|Adverse Event|0|||
154939833|NCT01567306|559205797|FG002|Overall Study|Adverse Event|0|||
154939834|NCT01567306|559205798|FG003|Overall Study|Adverse Event|2|||
154939835|NCT01567306|559205799|FG004|Overall Study|Adverse Event|4|||
154939836|NCT01567306|559205800|FG005|Overall Study|Adverse Event|1|||
154939837|NCT01567306|559205795|FG000|Overall Study|Lost to Follow-up|0|||
154939838|NCT01567306|559205796|FG001|Overall Study|Lost to Follow-up|0|||
154939839|NCT01567306|559205797|FG002|Overall Study|Lost to Follow-up|0|||
154939840|NCT01567306|559205798|FG003|Overall Study|Lost to Follow-up|0|||
154939841|NCT01567306|559205799|FG004|Overall Study|Lost to Follow-up|2|||
154939842|NCT01567306|559205800|FG005|Overall Study|Lost to Follow-up|0|||
154939843|NCT01567306|559205795|FG000|Overall Study|Withdrawal by Subject|0|||
154939844|NCT01567306|559205796|FG001|Overall Study|Withdrawal by Subject|0|||
154939845|NCT01567306|559205797|FG002|Overall Study|Withdrawal by Subject|0|||
154939846|NCT01567306|559205798|FG003|Overall Study|Withdrawal by Subject|0|||
154939847|NCT01567306|559205799|FG004|Overall Study|Withdrawal by Subject|0|||
154939848|NCT01567306|559205800|FG005|Overall Study|Withdrawal by Subject|1|||
154939849|NCT00673361|559205803|FG000|Overall Study|Screen Failure|2|||
154939850|NCT00829413|559205804|FG000|Overall Study|No study drug admimnistered|13|||
154939851|NCT00829413|559205804|FG000|Overall Study|Training Patients|67|||
154939852|NCT00829413|559205804|FG000|Overall Study|No truth standard procedure available|9|||
154939853|NCT00829413|559205804|FG000|Overall Study|Technically inadequate truth standard|2|||
154939854|NCT00829413|559205804|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
154939855|NCT04272775|559205805|FG000|Overall Study|Study Terminated by Sponsor|1|||
154939856|NCT04272775|559205806|FG001|Overall Study|Study Terminated by Sponsor|0|||
154939857|NCT04272775|559205805|FG000|Overall Study|Protocol Violation|0|||
154939858|NCT04272775|559205806|FG001|Overall Study|Protocol Violation|1|||
154939859|NCT04272775|559205805|FG000|Overall Study|Symptomatic Deterioration|1|||
154939860|NCT04272775|559205806|FG001|Overall Study|Symptomatic Deterioration|1|||
154939861|NCT04272775|559205805|FG000|Overall Study|Withdrawal by Subject|1|||
154939862|NCT04272775|559205806|FG001|Overall Study|Withdrawal by Subject|2|||
154939863|NCT04272775|559205805|FG000|Overall Study|Adverse Event|1|||
154939864|NCT04272775|559205806|FG001|Overall Study|Adverse Event|2|||
154939865|NCT04272775|559205805|FG000|Overall Study|Progressive Disease|3|||
154939866|NCT04272775|559205806|FG001|Overall Study|Progressive Disease|1|||
154939867|NCT00575328|559205810|FG000|Overall Study|Adverse Event|1|||
154939868|NCT00575328|559205811|FG001|Overall Study|Adverse Event|1|||
154939869|NCT00575328|559205810|FG000|Overall Study|Lost to Follow-up|2|||
154939870|NCT00575328|559205811|FG001|Overall Study|Lost to Follow-up|1|||
154939871|NCT01722266|559205812|FG000|Overall Study|Withdrawal by Subject|1|||
154939872|NCT01722266|559205813|FG001|Overall Study|Withdrawal by Subject|2|||
154939873|NCT01722266|559205814|FG002|Overall Study|Withdrawal by Subject|0|||
154939874|NCT01722266|559205815|FG003|Overall Study|Withdrawal by Subject|0|||
154939875|NCT01722266|559205812|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
154939876|NCT01722266|559205813|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
154939877|NCT01722266|559205814|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
154939878|NCT01722266|559205815|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
154939879|NCT01722266|559205812|FG000|Overall Study|Dropped out due to Nausea|0|||
154939880|NCT01722266|559205813|FG001|Overall Study|Dropped out due to Nausea|0|||
154939881|NCT01722266|559205814|FG002|Overall Study|Dropped out due to Nausea|2|||
154939882|NCT01722266|559205815|FG003|Overall Study|Dropped out due to Nausea|0|||
154939883|NCT00124449|559205822|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
154939884|NCT00124449|559205823|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
154939885|NCT00124449|559205822|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
154939886|NCT00124449|559205823|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
154939887|NCT00124449|559205822|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
154939888|NCT00124449|559205823|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
154939889|NCT00124449|559205822|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
154939890|NCT00124449|559205823|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
154939891|NCT00124449|559205822|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
154939892|NCT00124449|559205823|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
154939893|NCT00124449|559205822|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
154939894|NCT00124449|559205823|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
154939895|NCT00124449|559205822|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
154939896|NCT00124449|559205823|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
154939897|NCT00124449|559205822|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
154939898|NCT00124449|559205823|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
154939899|NCT00124449|559205822|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
154939900|NCT00124449|559205823|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
154939901|NCT00124449|559205822|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
154939902|NCT00124449|559205823|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
154939903|NCT00124449|559205822|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
154939904|NCT00124449|559205823|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
154939905|NCT00124449|559205822|FG000|18-Month Untreated Observation Period|Relocated|1|||
154939906|NCT00124449|559205823|FG001|18-Month Untreated Observation Period|Relocated|0|||
154939907|NCT03811249|559205824|FG000|Overall Study|Withdrawal by Subject|44|||
154939908|NCT03811249|559205824|FG000|Overall Study|Missed Visit|24|||
154939909|NCT04304950|559205829|FG000|Overall Study|Lost to Follow-up|1|||
154939910|NCT04304950|559205830|FG001|Overall Study|Lost to Follow-up|1|||
154939911|NCT00408876|559205831|FG000|Overall Study|Adverse Event|9|||
154939912|NCT00408876|559205832|FG001|Overall Study|Adverse Event|17|||
154939913|NCT00408876|559205833|FG002|Overall Study|Adverse Event|27|||
154939914|NCT00408876|559205834|FG003|Overall Study|Adverse Event|10|||
154939915|NCT00408876|559205831|FG000|Overall Study|Withdrawal by Subject|3|||
154939916|NCT00408876|559205832|FG001|Overall Study|Withdrawal by Subject|6|||
154939917|NCT00408876|559205833|FG002|Overall Study|Withdrawal by Subject|6|||
154939918|NCT00408876|559205834|FG003|Overall Study|Withdrawal by Subject|14|||
154939919|NCT00408876|559205831|FG000|Overall Study|Lack of Efficacy|2|||
154939920|NCT00408876|559205832|FG001|Overall Study|Lack of Efficacy|4|||
154939921|NCT00408876|559205833|FG002|Overall Study|Lack of Efficacy|5|||
154939922|NCT00408876|559205834|FG003|Overall Study|Lack of Efficacy|6|||
154939923|NCT00408876|559205831|FG000|Overall Study|Lost to Follow-up|1|||
154939924|NCT00408876|559205832|FG001|Overall Study|Lost to Follow-up|6|||
154939925|NCT00408876|559205833|FG002|Overall Study|Lost to Follow-up|5|||
154939926|NCT00408876|559205834|FG003|Overall Study|Lost to Follow-up|2|||
154939927|NCT00408876|559205831|FG000|Overall Study|Protocol Violation|0|||
154939928|NCT00408876|559205832|FG001|Overall Study|Protocol Violation|3|||
154939929|NCT00408876|559205833|FG002|Overall Study|Protocol Violation|4|||
154939930|NCT00408876|559205834|FG003|Overall Study|Protocol Violation|3|||
154939931|NCT00408876|559205831|FG000|Overall Study|Physician Decision|1|||
154939932|NCT00408876|559205832|FG001|Overall Study|Physician Decision|0|||
154939933|NCT00408876|559205833|FG002|Overall Study|Physician Decision|3|||
154939934|NCT00408876|559205834|FG003|Overall Study|Physician Decision|0|||
154939935|NCT01337050|559205844|FG000|Overall Study|Death|0|||
154939936|NCT01337050|559205845|FG001|Overall Study|Death|0|||
154939937|NCT01337050|559205846|FG002|Overall Study|Death|4|||
154939938|NCT01337050|559205844|FG000|Overall Study|Other|4|||
154939939|NCT01337050|559205845|FG001|Overall Study|Other|6|||
154939940|NCT01337050|559205846|FG002|Overall Study|Other|8|||
154939941|NCT01337050|559205844|FG000|Overall Study|Participants refused further follow-up|0|||
154939942|NCT01337050|559205845|FG001|Overall Study|Participants refused further follow-up|7|||
155043635|NCT01690299|559590174|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
154939943|NCT01337050|559205846|FG002|Overall Study|Participants refused further follow-up|7|||
154939944|NCT00003102|559205847|FG000|Overall Study|Physician Decision|1|||
154939945|NCT00003102|559205848|FG001|Overall Study|Physician Decision|1|||
154939946|NCT00003102|559205849|FG002|Overall Study|Physician Decision|0|||
154939947|NCT00003102|559205847|FG000|Overall Study|Progressive Disease|0|||
154939948|NCT00003102|559205848|FG001|Overall Study|Progressive Disease|1|||
154939949|NCT00003102|559205849|FG002|Overall Study|Progressive Disease|0|||
154939950|NCT00003102|559205847|FG000|Overall Study|Adverse Event|0|||
154939951|NCT00003102|559205848|FG001|Overall Study|Adverse Event|1|||
154939952|NCT00003102|559205849|FG002|Overall Study|Adverse Event|1|||
154939953|NCT00003102|559205847|FG000|Overall Study|Death|0|||
154939954|NCT00003102|559205848|FG001|Overall Study|Death|0|||
154939955|NCT00003102|559205849|FG002|Overall Study|Death|1|||
154939956|NCT01559818|559205852|FG000|Overall Study|Physician Decision|1|||
154939957|NCT01559818|559205852|FG000|Overall Study|Pregnancy|1|||
154939958|NCT01559818|559205852|FG000|Overall Study|Study terminated by Sponsor|4|||
154939959|NCT01559818|559205852|FG000|Overall Study|Withdrawal by Subject|1|||
154939960|NCT00096486|559205853|FG000|Overall Study|Withdrawal by Subject|0|||
154939961|NCT00096486|559205854|FG001|Overall Study|Withdrawal by Subject|0|||
154939962|NCT00096486|559205855|FG002|Overall Study|Withdrawal by Subject|1|||
154939963|NCT00096486|559205856|FG003|Overall Study|Withdrawal by Subject|1|||
154939964|NCT00096486|559205853|FG000|Overall Study|Not Treated|0|||
154939965|NCT00096486|559205854|FG001|Overall Study|Not Treated|0|||
154939966|NCT00096486|559205855|FG002|Overall Study|Not Treated|1|||
154939967|NCT00096486|559205856|FG003|Overall Study|Not Treated|1|||
154939968|NCT01512979|559205857|FG000|Overall Study|Adverse Event|2|||
154939969|NCT01512979|559205858|FG001|Overall Study|Adverse Event|2|||
154939970|NCT01512979|559205857|FG000|Overall Study|Protocol Violation|1|||
154939971|NCT01512979|559205858|FG001|Overall Study|Protocol Violation|4|||
154939972|NCT01512979|559205857|FG000|Overall Study|Lost to Follow-up|2|||
154939973|NCT01512979|559205858|FG001|Overall Study|Lost to Follow-up|5|||
154939974|NCT01512979|559205857|FG000|Overall Study|Withdrawal by Subject|1|||
154939975|NCT01512979|559205858|FG001|Overall Study|Withdrawal by Subject|2|||
154939976|NCT01512979|559205857|FG000|Overall Study|Reason other than stated above|13|||
154939977|NCT01512979|559205858|FG001|Overall Study|Reason other than stated above|9|||
154939978|NCT04071626|559205859|FG000|Overall Study|Withdrawal by Subject|1|||
154939979|NCT04071626|559205860|FG001|Overall Study|Withdrawal by Subject|1|||
154939980|NCT04071626|559205859|FG000|Overall Study|Protocol Violation|0|||
154939981|NCT04071626|559205860|FG001|Overall Study|Protocol Violation|1|||
154939982|NCT00125359|559205861|FG000|Overall Study|Death|4|||
154939983|NCT00125359|559205861|FG000|Overall Study|Adverse Event|5|||
154939984|NCT00125359|559205861|FG000|Overall Study|Physician Decision|14|||
154939985|NCT01201356|559205862|FG000|Overall Study|Adverse Event|170|||
154939986|NCT01201356|559205862|FG000|Overall Study|Abnormal laboratory value(s)|51|||
154939987|NCT01201356|559205862|FG000|Overall Study|Abnormal test procedure result(s)|3|||
154939988|NCT01201356|559205862|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
154939989|NCT01201356|559205862|FG000|Overall Study|Condition no longer requires study drug|12|||
154939990|NCT01201356|559205862|FG000|Overall Study|Withdrawal by Subject|144|||
154939991|NCT01201356|559205862|FG000|Overall Study|Lost to Follow-up|50|||
154939992|NCT01201356|559205862|FG000|Overall Study|administrative problems|74|||
154939993|NCT01201356|559205862|FG000|Overall Study|Death|16|||
154939994|NCT01201356|559205862|FG000|Overall Study|Protocol Violation|12|||
154939995|NCT00811070|559205863|FG000|Overall Study|Death|0|||
154939996|NCT00811070|559205864|FG001|Overall Study|Death|0|||
154939997|NCT00811070|559205865|FG002|Overall Study|Death|0|||
154939998|NCT00811070|559205866|FG003|Overall Study|Death|2|||
154939999|NCT00811070|559205867|FG004|Overall Study|Death|5|||
154940000|NCT00811070|559205868|FG005|Overall Study|Death|0|||
154940001|NCT00811070|559205863|FG000|Overall Study|Other|1|||
154940002|NCT00811070|559205864|FG001|Overall Study|Other|0|||
154940003|NCT00811070|559205865|FG002|Overall Study|Other|0|||
154940004|NCT00811070|559205866|FG003|Overall Study|Other|0|||
154940005|NCT00811070|559205867|FG004|Overall Study|Other|0|||
154940006|NCT00811070|559205868|FG005|Overall Study|Other|0|||
154940007|NCT00811070|559205863|FG000|Overall Study|Withdrawal by Subject|0|||
154940008|NCT00811070|559205864|FG001|Overall Study|Withdrawal by Subject|1|||
154940009|NCT00811070|559205865|FG002|Overall Study|Withdrawal by Subject|0|||
154940010|NCT00811070|559205866|FG003|Overall Study|Withdrawal by Subject|0|||
154940011|NCT00811070|559205867|FG004|Overall Study|Withdrawal by Subject|0|||
155043636|NCT01690299|559590175|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
154940012|NCT00811070|559205868|FG005|Overall Study|Withdrawal by Subject|0|||
154940013|NCT00811070|559205863|FG000|Overall Study|Physician Decision|0|||
154940014|NCT00811070|559205864|FG001|Overall Study|Physician Decision|0|||
154940015|NCT00811070|559205865|FG002|Overall Study|Physician Decision|0|||
154940016|NCT00811070|559205866|FG003|Overall Study|Physician Decision|0|||
154940017|NCT00811070|559205867|FG004|Overall Study|Physician Decision|0|||
154940018|NCT00811070|559205868|FG005|Overall Study|Physician Decision|1|||
154940019|NCT00665626|559205873|FG000|Overall Study|Lack of Efficacy|8|||
154940020|NCT00665626|559205874|FG001|Overall Study|Lack of Efficacy|5|||
154940021|NCT00665626|559205873|FG000|Overall Study|Lost to Follow-up|0|||
154940022|NCT00665626|559205874|FG001|Overall Study|Lost to Follow-up|2|||
154940023|NCT00665626|559205873|FG000|Overall Study|Withdrawal by Subject|0|||
154940024|NCT00665626|559205874|FG001|Overall Study|Withdrawal by Subject|1|||
154940025|NCT00665626|559205873|FG000|Overall Study|Protocol Violation|0|||
154940026|NCT00665626|559205874|FG001|Overall Study|Protocol Violation|2|||
154940027|NCT00665626|559205873|FG000|Overall Study|Adverse Event|1|||
154940028|NCT00665626|559205874|FG001|Overall Study|Adverse Event|9|||
154940029|NCT00665626|559205873|FG000|Overall Study|Due to exclusion criteria|0|||
154940030|NCT00665626|559205874|FG001|Overall Study|Due to exclusion criteria|1|||
154940031|NCT00665626|559205873|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
154940032|NCT00665626|559205874|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
154940033|NCT00665626|559205873|FG000|Overall Study|Unably to comply with dosing regimen|0|||
154940034|NCT00665626|559205874|FG001|Overall Study|Unably to comply with dosing regimen|1|||
154940035|NCT00665626|559205873|FG000|Overall Study|Death|1|||
154940036|NCT00665626|559205874|FG001|Overall Study|Death|0|||
154940037|NCT00585039|559205875|FG000|Overall Study|medication spilled|2|||
154940038|NCT00585039|559205876|FG001|Overall Study|medication spilled|0|||
154940039|NCT01629693|559205879|FG000|Overall Study|Lost to Follow-up|2|||
154940040|NCT01629693|559205880|FG001|Overall Study|Lost to Follow-up|4|||
154940041|NCT01629693|559205879|FG000|Overall Study|Withdrawal by Subject|2|||
154940042|NCT01629693|559205880|FG001|Overall Study|Withdrawal by Subject|2|||
154940043|NCT01629693|559205879|FG000|Overall Study|Adverse Event|1|||
154940044|NCT01629693|559205880|FG001|Overall Study|Adverse Event|0|||
154940045|NCT01629693|559205879|FG000|Overall Study|Investigator decision|0|||
154940046|NCT01629693|559205880|FG001|Overall Study|Investigator decision|1|||
154940047|NCT01629693|559205879|FG000|Overall Study|Poor comfort of study lenses|0|||
154940048|NCT01629693|559205880|FG001|Overall Study|Poor comfort of study lenses|2|||
154940049|NCT01629693|559205879|FG000|Overall Study|Subject decision unrelated to AE|0|||
154940050|NCT01629693|559205880|FG001|Overall Study|Subject decision unrelated to AE|1|||
154940051|NCT04079842|559205882|FG000|Overall Study|Request of subject|2|||
154940052|NCT04079842|559205882|FG000|Overall Study|Unable to draw Arterial samples|1|||
154940053|NCT01025193|559205883|FG000|Overall Study|Protocol Violation|1|||
154940054|NCT01025193|559205883|FG000|Overall Study|Adverse Event|3|||
154940055|NCT02904200|559205884|FG000|Overall Study|Withdrawal by Subject|1|||
154940056|NCT02904200|559205885|FG001|Overall Study|Withdrawal by Subject|0|||
154940057|NCT02133352|559205888|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
154940058|NCT00185211|559205889|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
154940059|NCT00185211|559205890|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
154940060|NCT00185211|559205889|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
154940061|NCT00185211|559205890|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
154940062|NCT00185211|559205889|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
154940063|NCT00185211|559205890|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
154940064|NCT00185211|559205889|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
154940065|NCT00185211|559205890|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
154940066|NCT00185211|559205889|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
154940067|NCT00185211|559205890|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
154940068|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
154940069|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
154940070|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
154940071|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
154940072|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
154940073|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
154940074|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
154940075|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
154940076|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
154940077|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
154940078|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
154940079|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
154940080|NCT00185211|559205889|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
154940081|NCT00185211|559205890|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
154940082|NCT01759537|559205891|FG000|Overall Study|Death|1|||
154940083|NCT01759537|559205892|FG001|Overall Study|Death|1|||
154940084|NCT01759537|559205891|FG000|Overall Study|Pregnancy|1|||
154940085|NCT01759537|559205892|FG001|Overall Study|Pregnancy|1|||
154940086|NCT01759537|559205891|FG000|Overall Study|Lost to Follow-up|9|||
154940087|NCT01759537|559205892|FG001|Overall Study|Lost to Follow-up|9|||
154940088|NCT01759537|559205891|FG000|Overall Study|Accident involving jaw fracture|1|||
154940089|NCT01759537|559205892|FG001|Overall Study|Accident involving jaw fracture|1|||
154940090|NCT01759537|559205891|FG000|Overall Study|Subcrestal implant too coronal|1|||
154940091|NCT01759537|559205892|FG001|Overall Study|Subcrestal implant too coronal|1|||
154940092|NCT00420290|559205893|FG000|Overall Study|Adverse Event|3|||
154940093|NCT00420290|559205894|FG001|Overall Study|Adverse Event|1|||
154940094|NCT00420290|559205893|FG000|Overall Study|Withdrawal by Subject|0|||
154940095|NCT00420290|559205894|FG001|Overall Study|Withdrawal by Subject|2|||
154940096|NCT00420290|559205893|FG000|Overall Study|did not meet inclusion/exclusion|1|||
154940097|NCT00420290|559205894|FG001|Overall Study|did not meet inclusion/exclusion|1|||
154940098|NCT01806597|559208105|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
154940099|NCT01806597|559208106|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
154940100|NCT01806597|559208107|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
154940101|NCT01806597|559208108|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
154940102|NCT01806597|559208109|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
154940103|NCT01806597|559208110|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
154940104|NCT01806597|559208105|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
154940105|NCT01806597|559208106|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
154940106|NCT01806597|559208107|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
154940107|NCT01806597|559208108|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
154940108|NCT01806597|559208109|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
154940109|NCT01806597|559208110|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
154940110|NCT01806597|559208105|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
154940111|NCT01806597|559208106|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
154940112|NCT01806597|559208107|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
154940113|NCT01806597|559208108|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
154940114|NCT01806597|559208109|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
154940115|NCT01806597|559208110|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
154940116|NCT01806597|559208105|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
154940117|NCT01806597|559208106|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
154940118|NCT01806597|559208107|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
154940119|NCT01806597|559208108|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
154940120|NCT01806597|559208109|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
154940121|NCT01806597|559208110|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
154940122|NCT01806597|559208105|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
154940123|NCT01806597|559208106|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
154940124|NCT01806597|559208107|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
154940125|NCT01806597|559208108|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
154940126|NCT01806597|559208109|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
154940127|NCT01806597|559208110|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
155043637|NCT01690299|559590176|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
155043638|NCT01690299|559590177|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
155043639|NCT01690299|559590178|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
155043640|NCT01690299|559590179|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
155043641|NCT01690299|559590174|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
155043642|NCT01690299|559590175|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
155043643|NCT01690299|559590176|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
155043644|NCT01690299|559590177|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
155043645|NCT01690299|559590178|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
155043646|NCT01690299|559590179|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
155043647|NCT01690299|559590174|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
155043648|NCT01690299|559590175|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
155043649|NCT01690299|559590176|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
155043650|NCT01690299|559590177|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
155043651|NCT01690299|559590178|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
155043652|NCT01690299|559590179|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
155043653|NCT01690299|559590174|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155043654|NCT01690299|559590175|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155043655|NCT01690299|559590176|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155043656|NCT01690299|559590177|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
155043657|NCT01690299|559590178|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
155043658|NCT01690299|559590179|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
155043659|NCT01690299|559590174|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
155043660|NCT01690299|559590175|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
155043661|NCT01690299|559590176|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
155043662|NCT01690299|559590177|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
155043663|NCT01690299|559590178|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
154940128|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
154940129|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
154940130|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
154940131|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
154940132|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
154940133|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
154940134|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
154940135|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
154940136|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
154940137|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
154940138|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
154940139|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
154940140|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
154940141|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
154940142|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
154940143|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
154940144|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
154940145|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
154940146|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
154940147|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
154940148|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
154940149|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
154940150|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
154940151|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
154940152|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
154940153|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
154940154|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
154940155|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
154940156|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
154940157|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
154940158|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
154940159|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
154940160|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
154940161|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
154940162|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
154940163|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
154940164|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
154940165|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
154940166|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
154940167|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
154940168|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
154940169|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
154940170|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
154940171|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
154940172|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
154940173|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
154940174|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
154940175|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
154940176|NCT01806597|559208105|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
154940177|NCT01806597|559208106|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
154940178|NCT01806597|559208107|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
154940179|NCT01806597|559208108|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
154940180|NCT01806597|559208109|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
154940181|NCT01806597|559208110|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
154940182|NCT01806597|559208105|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
154940183|NCT01806597|559208106|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
154940184|NCT01806597|559208107|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
154940185|NCT01806597|559208108|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
154940186|NCT01806597|559208109|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
154940187|NCT01806597|559208110|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
154940188|NCT01806597|559208105|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
154940189|NCT01806597|559208106|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
154940190|NCT01806597|559208107|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
154940191|NCT01806597|559208108|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
154940192|NCT01806597|559208109|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
154940193|NCT01806597|559208110|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
154940194|NCT01806597|559208105|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
154940195|NCT01806597|559208106|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
154940196|NCT01806597|559208107|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
154940197|NCT01806597|559208108|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
154940198|NCT01806597|559208109|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
154940199|NCT01806597|559208110|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
154940200|NCT01806597|559208105|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
154940201|NCT01806597|559208106|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
154940202|NCT01806597|559208107|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
154940203|NCT01806597|559208108|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
154940204|NCT01806597|559208109|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
154940205|NCT01806597|559208110|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
154940206|NCT01806597|559208105|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
154940207|NCT01806597|559208106|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
154940208|NCT01806597|559208107|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
154940209|NCT01806597|559208108|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
154940210|NCT01806597|559208109|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
154940211|NCT01806597|559208110|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
154940212|NCT02038634|559208112|FG000|Overall Study|Lost to Follow-up|0|||
154940213|NCT02038634|559208113|FG001|Overall Study|Lost to Follow-up|1|||
154940214|NCT01473758|559208116|FG000|Cycle 1|Adverse Event|10|||
154940215|NCT01473758|559208117|FG001|Cycle 1|Adverse Event|2|||
154940216|NCT01473758|559208118|FG002|Cycle 1|Adverse Event|0|||
154940217|NCT01473758|559208119|FG003|Cycle 1|Adverse Event|0|||
154940218|NCT01473758|559208116|FG000|Cycle 1|Withdrawal by Subject|1|||
154940219|NCT01473758|559208117|FG001|Cycle 1|Withdrawal by Subject|1|||
154940220|NCT01473758|559208118|FG002|Cycle 1|Withdrawal by Subject|0|||
154940221|NCT01473758|559208119|FG003|Cycle 1|Withdrawal by Subject|0|||
154940222|NCT01473758|559208116|FG000|Cycle 2|Adverse Event|0|||
154940223|NCT01473758|559208117|FG001|Cycle 2|Adverse Event|0|||
154940224|NCT01473758|559208118|FG002|Cycle 2|Adverse Event|5|||
154940225|NCT01473758|559208119|FG003|Cycle 2|Adverse Event|0|||
154940226|NCT02763579|559208129|FG000|Global Period|Death|167|||
154940227|NCT02763579|559208130|FG001|Global Period|Death|151|||
154940228|NCT02763579|559208131|FG002|Global Period|Death|0|||
154940229|NCT02763579|559208132|FG003|Global Period|Death|0|||
154940230|NCT02763579|559208129|FG000|Global Period|Lost to Follow-up|2|||
154940231|NCT02763579|559208130|FG001|Global Period|Lost to Follow-up|4|||
154940232|NCT02763579|559208131|FG002|Global Period|Lost to Follow-up|0|||
154940233|NCT02763579|559208132|FG003|Global Period|Lost to Follow-up|0|||
154940234|NCT02763579|559208129|FG000|Global Period|Physician Decision|0|||
154940235|NCT02763579|559208130|FG001|Global Period|Physician Decision|2|||
154940236|NCT02763579|559208131|FG002|Global Period|Physician Decision|0|||
154940237|NCT02763579|559208132|FG003|Global Period|Physician Decision|0|||
154940238|NCT02763579|559208129|FG000|Global Period|Study Terminated By Sponsor|21|||
154940239|NCT02763579|559208130|FG001|Global Period|Study Terminated By Sponsor|26|||
154940240|NCT02763579|559208131|FG002|Global Period|Study Terminated By Sponsor|0|||
154940241|NCT02763579|559208132|FG003|Global Period|Study Terminated By Sponsor|0|||
154940242|NCT02763579|559208129|FG000|Global Period|Withdrawal by Subject|12|||
154940243|NCT02763579|559208130|FG001|Global Period|Withdrawal by Subject|18|||
154940244|NCT02763579|559208131|FG002|Global Period|Withdrawal by Subject|0|||
154940245|NCT02763579|559208132|FG003|Global Period|Withdrawal by Subject|0|||
154940246|NCT02763579|559208129|FG000|China Period|Death|0|||
154940247|NCT02763579|559208130|FG001|China Period|Death|0|||
154940248|NCT02763579|559208131|FG002|China Period|Death|46|||
154940249|NCT02763579|559208132|FG003|China Period|Death|48|||
154940250|NCT02763579|559208129|FG000|China Period|Lost to Follow-up|0|||
154940251|NCT02763579|559208130|FG001|China Period|Lost to Follow-up|0|||
154940252|NCT02763579|559208131|FG002|China Period|Lost to Follow-up|1|||
154940253|NCT02763579|559208132|FG003|China Period|Lost to Follow-up|1|||
154940254|NCT02763579|559208129|FG000|China Period|Physician Decision|0|||
154940255|NCT02763579|559208130|FG001|China Period|Physician Decision|0|||
154940256|NCT02763579|559208131|FG002|China Period|Physician Decision|0|||
154940257|NCT02763579|559208132|FG003|China Period|Physician Decision|1|||
154940258|NCT02763579|559208129|FG000|China Period|Study Terminated By Sponsor|0|||
154940259|NCT02763579|559208130|FG001|China Period|Study Terminated By Sponsor|0|||
154940260|NCT02763579|559208131|FG002|China Period|Study Terminated By Sponsor|3|||
154940261|NCT02763579|559208132|FG003|China Period|Study Terminated By Sponsor|4|||
154940262|NCT02763579|559208129|FG000|China Period|Withdrawal by Subject|0|||
154940263|NCT02763579|559208130|FG001|China Period|Withdrawal by Subject|0|||
154940264|NCT02763579|559208131|FG002|China Period|Withdrawal by Subject|3|||
154940265|NCT02763579|559208132|FG003|China Period|Withdrawal by Subject|3|||
154940266|NCT01034137|559208135|FG000|Overall Study|Adverse Event|9|||
154940267|NCT01034137|559208136|FG001|Overall Study|Adverse Event|10|||
154940268|NCT01034137|559208137|FG002|Overall Study|Adverse Event|8|||
154940269|NCT01034137|559208135|FG000|Overall Study|Withdrawal by Subject|4|||
154940270|NCT01034137|559208136|FG001|Overall Study|Withdrawal by Subject|3|||
154940271|NCT01034137|559208137|FG002|Overall Study|Withdrawal by Subject|3|||
154940272|NCT01034137|559208135|FG000|Overall Study|Lack of Efficacy|9|||
154940273|NCT01034137|559208136|FG001|Overall Study|Lack of Efficacy|4|||
154940274|NCT01034137|559208137|FG002|Overall Study|Lack of Efficacy|13|||
154940275|NCT01034137|559208135|FG000|Overall Study|Protocol Violation|2|||
154940276|NCT01034137|559208136|FG001|Overall Study|Protocol Violation|2|||
154940277|NCT01034137|559208137|FG002|Overall Study|Protocol Violation|1|||
154940278|NCT01034137|559208135|FG000|Overall Study|Refused treatment or did not cooperate|2|||
154940279|NCT01034137|559208136|FG001|Overall Study|Refused treatment or did not cooperate|0|||
154940280|NCT01034137|559208137|FG002|Overall Study|Refused treatment or did not cooperate|1|||
154940281|NCT01034137|559208135|FG000|Overall Study|Administrative or other|2|||
154940282|NCT01034137|559208136|FG001|Overall Study|Administrative or other|3|||
154940283|NCT01034137|559208137|FG002|Overall Study|Administrative or other|4|||
154940284|NCT03572933|559208138|FG000|Overall Study|Adverse Event|4|||
154940285|NCT03572933|559208139|FG001|Overall Study|Adverse Event|1|||
154940286|NCT03572933|559208138|FG000|Overall Study|Withdrawal by Subject|0|||
154940287|NCT03572933|559208139|FG001|Overall Study|Withdrawal by Subject|1|||
154940288|NCT00124020|559208153|FG000|Overall Study|Death|67|||
154940289|NCT00124020|559208154|FG001|Overall Study|Death|71|||
154940290|NCT00124020|559208153|FG000|Overall Study|Withdrawal by Subject|13|||
154940291|NCT00124020|559208154|FG001|Overall Study|Withdrawal by Subject|11|||
154940292|NCT00124020|559208153|FG000|Overall Study|Lost to Follow-up|5|||
154940293|NCT00124020|559208154|FG001|Overall Study|Lost to Follow-up|8|||
154940294|NCT00124020|559208153|FG000|Overall Study|Other|1|||
154940295|NCT00124020|559208154|FG001|Overall Study|Other|1|||
154940296|NCT00124020|559208153|FG000|Overall Study|Transfer to another hospital|2|||
154940297|NCT00124020|559208154|FG001|Overall Study|Transfer to another hospital|0|||
154940298|NCT00268346|559208155|FG000|Overall Study|Adverse Event|0|||
154940299|NCT00268346|559208156|FG001|Overall Study|Adverse Event|1|||
154940300|NCT00268346|559208155|FG000|Overall Study|Death|0|||
154940301|NCT00268346|559208156|FG001|Overall Study|Death|1|||
154940302|NCT00268346|559208155|FG000|Overall Study|Withdrawal by Subject|0|||
154940303|NCT00268346|559208156|FG001|Overall Study|Withdrawal by Subject|1|||
154940304|NCT01799590|559208157|FG000|Overall Study|Adverse Event|13|||
154940305|NCT01799590|559208158|FG001|Overall Study|Adverse Event|7|||
154940306|NCT01799590|559208159|FG002|Overall Study|Adverse Event|5|||
154940307|NCT01799590|559208157|FG000|Overall Study|Pregnancy|2|||
154940308|NCT01799590|559208158|FG001|Overall Study|Pregnancy|0|||
154940309|NCT01799590|559208159|FG002|Overall Study|Pregnancy|0|||
154940310|NCT01799590|559208157|FG000|Overall Study|Lack of Efficacy|3|||
154940311|NCT01799590|559208158|FG001|Overall Study|Lack of Efficacy|1|||
154940312|NCT01799590|559208159|FG002|Overall Study|Lack of Efficacy|3|||
154940313|NCT01799590|559208157|FG000|Overall Study|Participants convenience|4|||
154940314|NCT01799590|559208158|FG001|Overall Study|Participants convenience|4|||
154940315|NCT01799590|559208159|FG002|Overall Study|Participants convenience|2|||
154940316|NCT01799590|559208157|FG000|Overall Study|Aggravation of complications|0|||
154940317|NCT01799590|559208158|FG001|Overall Study|Aggravation of complications|1|||
155277524|NCT02584855|560449097|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
155277525|NCT02584855|560449092|FG000|Open-Label Treatment Period|Protocol Violation|1|||
154940318|NCT01799590|559208159|FG002|Overall Study|Aggravation of complications|1|||
154940319|NCT01799590|559208157|FG000|Overall Study|Using drugs with restricted days of use|0|||
154940320|NCT01799590|559208158|FG001|Overall Study|Using drugs with restricted days of use|3|||
154940321|NCT01799590|559208159|FG002|Overall Study|Using drugs with restricted days of use|2|||
154940322|NCT01799590|559208157|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
154940323|NCT01799590|559208158|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
154940324|NCT01799590|559208159|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
154940325|NCT01799590|559208157|FG000|Overall Study|Other|3|||
154940326|NCT01799590|559208158|FG001|Overall Study|Other|0|||
154940327|NCT01799590|559208159|FG002|Overall Study|Other|1|||
154940328|NCT00294723|559208160|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
154940329|NCT00294723|559208161|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
154940330|NCT00294723|559208162|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
154940331|NCT00294723|559208160|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
154940332|NCT00294723|559208161|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
154940333|NCT00294723|559208162|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
154940334|NCT00294723|559208160|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
154940335|NCT00294723|559208161|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
155277526|NCT02584855|560449093|FG001|Open-Label Treatment Period|Protocol Violation|0|||
155277527|NCT02584855|560449094|FG002|Open-Label Treatment Period|Protocol Violation|0|||
155277528|NCT02584855|560449095|FG003|Open-Label Treatment Period|Protocol Violation|0|||
154940336|NCT00294723|559208162|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
154940337|NCT00294723|559208160|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
154940338|NCT00294723|559208161|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
154940339|NCT00294723|559208162|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
154940340|NCT00294723|559208160|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
154940341|NCT00294723|559208161|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
154940342|NCT00294723|559208162|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
154940343|NCT00294723|559208160|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
154940344|NCT00294723|559208161|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
154940345|NCT00294723|559208162|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
154940346|NCT00294723|559208160|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
154940347|NCT00294723|559208161|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
154940348|NCT00294723|559208162|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
154940349|NCT00294723|559208160|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
154940350|NCT00294723|559208161|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
154940351|NCT00294723|559208162|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
154940352|NCT00294723|559208160|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
154940353|NCT00294723|559208161|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
154940354|NCT00294723|559208162|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
154940355|NCT00294723|559208160|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
154940356|NCT00294723|559208161|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
154940357|NCT00294723|559208162|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
154940358|NCT00294723|559208160|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
154940359|NCT00294723|559208161|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
154940360|NCT00294723|559208162|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
154940361|NCT00294723|559208160|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
154940362|NCT00294723|559208161|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
154940363|NCT00294723|559208162|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
154940364|NCT01967888|559208165|FG000|Overall Study|Lost to Follow-up|6|||
154940365|NCT01967888|559208166|FG001|Overall Study|Lost to Follow-up|4|||
154940366|NCT01967888|559208165|FG000|Overall Study|Withdrawal by Subject|1|||
154940367|NCT01967888|559208166|FG001|Overall Study|Withdrawal by Subject|1|||
154940368|NCT01967888|559208165|FG000|Overall Study|Did Not Have Transplant|1|||
154940369|NCT01967888|559208166|FG001|Overall Study|Did Not Have Transplant|0|||
154940370|NCT01967888|559208165|FG000|Overall Study|Research visit not done, data recorded|1|||
154940371|NCT01967888|559208166|FG001|Overall Study|Research visit not done, data recorded|0|||
154940372|NCT01967888|559208165|FG000|Overall Study|Subject excluded after randomization|1|||
154940373|NCT01967888|559208166|FG001|Overall Study|Subject excluded after randomization|0|||
154940374|NCT01967888|559208165|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
154940375|NCT01967888|559208166|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
154940376|NCT01967888|559208165|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
154940377|NCT01967888|559208166|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
154940378|NCT00891774|559208167|FG000|Overall Study|Lost to Follow-up|5|||
154940379|NCT00891774|559208167|FG000|Overall Study|Illness (Self/Mother)|3|||
154940380|NCT00891774|559208167|FG000|Overall Study|Withdrawal by Subject|2|||
154940381|NCT00891774|559208167|FG000|Overall Study|Protocol Violation|4|||
154940382|NCT03175120|559208170|FG000|Overall Study|Adverse Event|2|||
154940383|NCT03175120|559208171|FG001|Overall Study|Adverse Event|2|||
154940384|NCT03175120|559208170|FG000|Overall Study|Protocol Violation|5|||
154940385|NCT03175120|559208171|FG001|Overall Study|Protocol Violation|2|||
154940386|NCT03175120|559208170|FG000|Overall Study|Lost to Follow-up|1|||
154940387|NCT03175120|559208171|FG001|Overall Study|Lost to Follow-up|0|||
154940388|NCT03175120|559208170|FG000|Overall Study|Withdrawal by Subject|2|||
154940389|NCT03175120|559208171|FG001|Overall Study|Withdrawal by Subject|5|||
154940390|NCT03175120|559208170|FG000|Overall Study|Other|2|||
154940391|NCT03175120|559208171|FG001|Overall Study|Other|3|||
154940392|NCT03038113|559208172|FG000|Overall Study|Withdrawal by Subject|0|||
154940393|NCT03038113|559208173|FG001|Overall Study|Withdrawal by Subject|0|||
154940394|NCT03038113|559208174|FG002|Overall Study|Withdrawal by Subject|1|||
154940395|NCT03038113|559208175|FG003|Overall Study|Withdrawal by Subject|0|||
154940396|NCT03038113|559208176|FG004|Overall Study|Withdrawal by Subject|0|||
154940397|NCT03038113|559208177|FG005|Overall Study|Withdrawal by Subject|0|||
154940398|NCT03038113|559208178|FG006|Overall Study|Withdrawal by Subject|0|||
154940399|NCT03038113|559208179|FG007|Overall Study|Withdrawal by Subject|0|||
154940400|NCT03038113|559208180|FG008|Overall Study|Withdrawal by Subject|0|||
154940401|NCT03038113|559208181|FG009|Overall Study|Withdrawal by Subject|0|||
154940402|NCT03038113|559208182|FG010|Overall Study|Withdrawal by Subject|0|||
154940403|NCT03038113|559208183|FG011|Overall Study|Withdrawal by Subject|0|||
154940404|NCT03038113|559208184|FG012|Overall Study|Withdrawal by Subject|0|||
154940405|NCT03038113|559208185|FG013|Overall Study|Withdrawal by Subject|1|||
154940406|NCT03038113|559208172|FG000|Overall Study|Lost to Follow-up|0|||
154940407|NCT03038113|559208173|FG001|Overall Study|Lost to Follow-up|0|||
154940408|NCT03038113|559208174|FG002|Overall Study|Lost to Follow-up|0|||
154940409|NCT03038113|559208175|FG003|Overall Study|Lost to Follow-up|0|||
154940410|NCT03038113|559208176|FG004|Overall Study|Lost to Follow-up|0|||
154940411|NCT03038113|559208177|FG005|Overall Study|Lost to Follow-up|0|||
155043664|NCT01690299|559590179|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
154940412|NCT03038113|559208178|FG006|Overall Study|Lost to Follow-up|1|||
154940413|NCT03038113|559208179|FG007|Overall Study|Lost to Follow-up|0|||
154940414|NCT03038113|559208180|FG008|Overall Study|Lost to Follow-up|0|||
154940415|NCT03038113|559208181|FG009|Overall Study|Lost to Follow-up|0|||
154940416|NCT03038113|559208182|FG010|Overall Study|Lost to Follow-up|0|||
154940417|NCT03038113|559208183|FG011|Overall Study|Lost to Follow-up|0|||
154940418|NCT03038113|559208184|FG012|Overall Study|Lost to Follow-up|0|||
154940419|NCT03038113|559208185|FG013|Overall Study|Lost to Follow-up|0|||
154940420|NCT00553540|559208186|FG000|Overall Study|discharged after first visit|2|||
154940421|NCT00553540|559208187|FG001|Overall Study|discharged after first visit|5|||
154940422|NCT01755858|559208188|FG000|Overall Study|Adverse Event|1|||
154940423|NCT01755858|559208189|FG001|Overall Study|Adverse Event|1|||
154940424|NCT03882047|559208190|FG000|Overall Study|Adverse Event|0|||
154940425|NCT03882047|559208191|FG001|Overall Study|Adverse Event|2|||
154940426|NCT03882047|559208192|FG002|Overall Study|Adverse Event|2|||
154940427|NCT03882047|559208190|FG000|Overall Study|Treatment Failure|3|||
154940428|NCT03882047|559208191|FG001|Overall Study|Treatment Failure|3|||
154940429|NCT03882047|559208192|FG002|Overall Study|Treatment Failure|12|||
154940430|NCT03882047|559208190|FG000|Overall Study|Lost to Follow-up|0|||
154940431|NCT03882047|559208191|FG001|Overall Study|Lost to Follow-up|1|||
154940432|NCT03882047|559208192|FG002|Overall Study|Lost to Follow-up|0|||
154940433|NCT03882047|559208190|FG000|Overall Study|Did Not Wish to Continue|1|||
154940434|NCT03882047|559208191|FG001|Overall Study|Did Not Wish to Continue|4|||
154940435|NCT03882047|559208192|FG002|Overall Study|Did Not Wish to Continue|1|||
154940436|NCT03882047|559208190|FG000|Overall Study|Noncompliance With Protocol|2|||
154940437|NCT03882047|559208191|FG001|Overall Study|Noncompliance With Protocol|0|||
154940438|NCT03882047|559208192|FG002|Overall Study|Noncompliance With Protocol|0|||
154940439|NCT03882047|559208190|FG000|Overall Study|Did Not Meet Eligibility|0|||
154940440|NCT03882047|559208191|FG001|Overall Study|Did Not Meet Eligibility|0|||
154940441|NCT03882047|559208192|FG002|Overall Study|Did Not Meet Eligibility|1|||
154940442|NCT00723554|559208193|FG000|Overall Study|Adverse Event|12|||
154940443|NCT00723554|559208193|FG000|Overall Study|Investigator's judgement|5|||
154940444|NCT00723554|559208193|FG000|Overall Study|Inhaled medication other than iloprost|4|||
154940445|NCT00723554|559208193|FG000|Overall Study|Withdrawal of consent|3|||
154940446|NCT00723554|559208193|FG000|Overall Study|Other|3|||
154940447|NCT00723554|559208193|FG000|Overall Study|Lost to Follow-up|1|||
154940448|NCT00723554|559208193|FG000|Overall Study|Non-compliance|1|||
154940449|NCT01894984|559208199|FG000|Overall Study|Other|314|||
154940450|NCT01894984|559208200|FG001|Overall Study|Other|175|||
154940451|NCT00827359|559208201|FG000|Overall Study|Progressive Diseas|19|||
154940452|NCT00827359|559208201|FG000|Overall Study|Unacceptable Toxicity|5|||
154940453|NCT00827359|559208201|FG000|Overall Study|Ineligible|1|||
154940454|NCT02436135|559208202|FG000|Overall Study|Progressive Disease|3|||
154940455|NCT02436135|559208203|FG001|Overall Study|Progressive Disease|1|||
154940456|NCT02436135|559208202|FG000|Overall Study|Investigator Discretion|1|||
154940457|NCT02436135|559208203|FG001|Overall Study|Investigator Discretion|2|||
154940458|NCT02436135|559208202|FG000|Overall Study|Adverse Event|1|||
154940459|NCT02436135|559208203|FG001|Overall Study|Adverse Event|0|||
154940460|NCT02436135|559208202|FG000|Overall Study|Withdrawal by Participant|1|||
154940461|NCT02436135|559208203|FG001|Overall Study|Withdrawal by Participant|0|||
154940462|NCT02436135|559208202|FG000|Overall Study|Study Terminated By Sponsor|0|||
154940463|NCT02436135|559208203|FG001|Overall Study|Study Terminated By Sponsor|1|||
154940464|NCT01809314|559208204|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
154940465|NCT01809314|559208204|FG000|Overall Study|Adverse Event|6|||
154940466|NCT01809314|559208204|FG000|Overall Study|Insufficient Therapeutic Response|14|||
154940467|NCT01809314|559208204|FG000|Overall Study|Lost to Follow-up|724|||
154940468|NCT00297479|559208205|FG000|Overall Study|Lost to Follow-up|37|||
154940469|NCT00297479|559208206|FG001|Overall Study|Lost to Follow-up|54|||
154940470|NCT00297479|559208207|FG002|Overall Study|Lost to Follow-up|51|||
154940471|NCT03263819|559208208|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
154940472|NCT03263819|559208209|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
154940473|NCT01427803|559208210|FG000|Overall Study|Lost to Follow-up|32|||
154940474|NCT01427803|559208211|FG001|Overall Study|Lost to Follow-up|26|||
154940475|NCT01427803|559208210|FG000|Overall Study|Withdrawal by Subject|20|||
154940476|NCT01427803|559208211|FG001|Overall Study|Withdrawal by Subject|0|||
154940477|NCT01427803|559208210|FG000|Overall Study|Unable to complete full treatment period|6|||
154940478|NCT01427803|559208211|FG001|Overall Study|Unable to complete full treatment period|0|||
154940479|NCT01427803|559208210|FG000|Overall Study|Protocol Violation|1|||
154940480|NCT01427803|559208211|FG001|Overall Study|Protocol Violation|0|||
154940481|NCT01427803|559208210|FG000|Overall Study|Physician Decision|3|||
155043665|NCT01690299|559590174|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
154940482|NCT01427803|559208211|FG001|Overall Study|Physician Decision|0|||
154940483|NCT01427803|559208210|FG000|Overall Study|did not take product|1|||
154940484|NCT01427803|559208211|FG001|Overall Study|did not take product|0|||
154940485|NCT00863057|559208212|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
154940486|NCT00863057|559208213|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
155277529|NCT02584855|560449096|FG004|Open-Label Treatment Period|Protocol Violation|0|||
155277530|NCT02584855|560449097|FG005|Open-Label Treatment Period|Protocol Violation|0|||
155277531|NCT02584855|560449092|FG000|Open-Label Treatment Period|No PI Available|2|||
155277532|NCT02584855|560449093|FG001|Open-Label Treatment Period|No PI Available|0|||
155277533|NCT02584855|560449094|FG002|Open-Label Treatment Period|No PI Available|0|||
155277534|NCT02584855|560449095|FG003|Open-Label Treatment Period|No PI Available|0|||
155277535|NCT02584855|560449096|FG004|Open-Label Treatment Period|No PI Available|0|||
155277536|NCT02584855|560449097|FG005|Open-Label Treatment Period|No PI Available|0|||
155277537|NCT02584855|560449092|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
155277538|NCT02584855|560449093|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
155277539|NCT02584855|560449094|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
155277540|NCT02584855|560449095|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
155277541|NCT02584855|560449096|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
155277542|NCT02584855|560449097|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
155277543|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277544|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277545|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
155277546|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277547|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277548|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
155277549|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
155277550|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
155277551|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
155277552|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
155277553|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
155381949|NCT00598273|560833243|FG001|Overall Study|Noncompliance|2|||
155381950|NCT00598273|560833244|FG002|Overall Study|Noncompliance|3|||
155381951|NCT00598273|560833242|FG000|Overall Study|Relocation|0|||
155381952|NCT00598273|560833243|FG001|Overall Study|Relocation|2|||
155381953|NCT00598273|560833244|FG002|Overall Study|Relocation|4|||
155381954|NCT00598273|560833242|FG000|Overall Study|Renal transplant|1|||
155381955|NCT00598273|560833243|FG001|Overall Study|Renal transplant|0|||
155381956|NCT00598273|560833244|FG002|Overall Study|Renal transplant|1|||
155381957|NCT00598273|560833242|FG000|Overall Study|Site elected to close|1|||
155381958|NCT00598273|560833243|FG001|Overall Study|Site elected to close|0|||
155381959|NCT00598273|560833244|FG002|Overall Study|Site elected to close|0|||
155381960|NCT00598273|560833242|FG000|Overall Study|Started dialysis|6|||
155381961|NCT00598273|560833243|FG001|Overall Study|Started dialysis|4|||
155381962|NCT00598273|560833244|FG002|Overall Study|Started dialysis|5|||
155381963|NCT01590082|560833245|FG000|Overall Study|Withdrawal by Subject|1|||
155381964|NCT01590082|560833246|FG001|Overall Study|Withdrawal by Subject|0|||
155381965|NCT01590082|560833245|FG000|Overall Study|Ineligible|1|||
155381966|NCT01590082|560833246|FG001|Overall Study|Ineligible|0|||
155381967|NCT01210664|560833248|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
155381968|NCT01210664|560833249|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
155381969|NCT01210664|560833250|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
155381970|NCT01210664|560833251|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
155381971|NCT01210664|560833248|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381972|NCT01210664|560833249|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381973|NCT01210664|560833250|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
155381974|NCT01210664|560833251|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381975|NCT01210664|560833248|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381976|NCT01210664|560833249|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381977|NCT01210664|560833250|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
155381978|NCT01210664|560833251|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
155381979|NCT02891408|560833252|FG000|Overall Study|Lost to Follow-up|0|||
155381980|NCT02891408|560833253|FG001|Overall Study|Lost to Follow-up|0|||
155381981|NCT02891408|560833254|FG002|Overall Study|Lost to Follow-up|1|||
155381982|NCT02891408|560833255|FG003|Overall Study|Lost to Follow-up|0|||
155381983|NCT02891408|560833256|FG004|Overall Study|Lost to Follow-up|0|||
155381984|NCT02891408|560833257|FG005|Overall Study|Lost to Follow-up|0|||
155381985|NCT02891408|560833258|FG006|Overall Study|Lost to Follow-up|0|||
155381986|NCT02549196|560833259|FG000|Overall Study|Protocol Violation|0|||
155381987|NCT02549196|560833260|FG001|Overall Study|Protocol Violation|0|||
155381988|NCT02549196|560833261|FG002|Overall Study|Protocol Violation|0|||
155381989|NCT02549196|560833262|FG003|Overall Study|Protocol Violation|1|||
155381990|NCT02549196|560833259|FG000|Overall Study|Withdrawal by Subject|1|||
154940487|NCT00863057|559208214|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
154940488|NCT00863057|559208215|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
154940489|NCT00863057|559208212|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
155277554|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
155277555|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
154940490|NCT00863057|559208213|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
154940491|NCT00863057|559208214|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
154940492|NCT00863057|559208215|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
154940493|NCT00863057|559208212|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
154940494|NCT00863057|559208213|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
154940495|NCT00863057|559208214|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
154940496|NCT00863057|559208215|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
154940497|NCT00863057|559208212|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
154940498|NCT00863057|559208213|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
154940499|NCT00863057|559208214|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
154940500|NCT00863057|559208215|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
154940501|NCT03412019|559208218|FG000|Overall Study|Withdrawal by Subject|1|||
154940502|NCT03412019|559208219|FG001|Overall Study|Withdrawal by Subject|1|||
154940503|NCT01698320|559208224|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
154940504|NCT01698320|559208225|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
154940505|NCT01698320|559208226|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
154940506|NCT01698320|559208224|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
154940507|NCT01698320|559208225|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
154940508|NCT01698320|559208226|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
154940509|NCT01698320|559208224|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
154940510|NCT01698320|559208225|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
154940511|NCT01698320|559208226|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
154940512|NCT01698320|559208224|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
154940513|NCT01698320|559208225|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
154940514|NCT01698320|559208226|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
154940515|NCT01698320|559208224|FG000|12-Week Double-Blind Period|Adverse Event|0|||
154940516|NCT01698320|559208225|FG001|12-Week Double-Blind Period|Adverse Event|1|||
154940517|NCT01698320|559208226|FG002|12-Week Double-Blind Period|Adverse Event|1|||
154940518|NCT01698320|559208224|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
154940519|NCT01698320|559208225|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
154940520|NCT01698320|559208226|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
154940521|NCT01698320|559208224|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
154940522|NCT01698320|559208225|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
154940523|NCT01698320|559208226|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
154940524|NCT01698320|559208224|FG000|12-Week Double-Blind Period|Pregnancy|0|||
154940525|NCT01698320|559208225|FG001|12-Week Double-Blind Period|Pregnancy|1|||
154940526|NCT01698320|559208226|FG002|12-Week Double-Blind Period|Pregnancy|1|||
154940527|NCT01698320|559208224|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
154940528|NCT01698320|559208225|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
154940529|NCT01698320|559208226|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
154940530|NCT01698320|559208224|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
154940531|NCT01698320|559208225|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
154940532|NCT01698320|559208226|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
154940533|NCT01698320|559208224|FG000|40-Week Open-Label Period|Adverse Event|0|||
154940534|NCT01698320|559208225|FG001|40-Week Open-Label Period|Adverse Event|3|||
154940535|NCT01698320|559208226|FG002|40-Week Open-Label Period|Adverse Event|2|||
154940536|NCT01698320|559208224|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
154940537|NCT01698320|559208225|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
154940538|NCT01698320|559208226|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
154940539|NCT01698320|559208224|FG000|40-Week Open-Label Period|Pregnancy|0|||
154940540|NCT01698320|559208225|FG001|40-Week Open-Label Period|Pregnancy|2|||
154940541|NCT01698320|559208226|FG002|40-Week Open-Label Period|Pregnancy|1|||
154940542|NCT01698320|559208224|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
154940543|NCT01698320|559208225|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
154940544|NCT01698320|559208226|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
154940545|NCT01698320|559208224|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
154940546|NCT01698320|559208225|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
154940547|NCT01698320|559208226|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
154940548|NCT00686920|559208228|FG000|Overall Study|Death|45|||
154940549|NCT00686920|559208229|FG001|Overall Study|Death|14|||
154940550|NCT00686920|559208228|FG000|Overall Study|Liver Transplant|23|||
154940551|NCT00686920|559208229|FG001|Overall Study|Liver Transplant|8|||
154940552|NCT00686920|559208228|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
154940553|NCT00686920|559208229|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
154940554|NCT00686920|559208228|FG000|Overall Study|Withdrawal by Subject|23|||
154940555|NCT00686920|559208229|FG001|Overall Study|Withdrawal by Subject|5|||
154940556|NCT00686920|559208228|FG000|Overall Study|Protocol Violation|2|||
154940557|NCT00686920|559208229|FG001|Overall Study|Protocol Violation|1|||
154940558|NCT00686920|559208228|FG000|Overall Study|Adverse Event|10|||
154940559|NCT00686920|559208229|FG001|Overall Study|Adverse Event|2|||
154940560|NCT00686920|559208228|FG000|Overall Study|Personal Reason|0|||
154940561|NCT00686920|559208229|FG001|Overall Study|Personal Reason|1|||
154940562|NCT00686920|559208228|FG000|Overall Study|Lost to Follow-up|15|||
154940563|NCT00686920|559208229|FG001|Overall Study|Lost to Follow-up|3|||
154940564|NCT00686920|559208228|FG000|Overall Study|Moved to Another State|1|||
154940565|NCT00686920|559208229|FG001|Overall Study|Moved to Another State|0|||
154940566|NCT00686920|559208228|FG000|Overall Study|Transferred to Nursing Home|1|||
155277556|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
155277557|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277558|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277559|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277560|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
155277561|NCT02584855|560449092|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277562|NCT02584855|560449093|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
155277563|NCT02584855|560449094|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277564|NCT02584855|560449095|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277565|NCT02584855|560449096|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277566|NCT02584855|560449097|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
155277567|NCT02584855|560449092|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277568|NCT02584855|560449093|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277569|NCT02584855|560449094|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277570|NCT02584855|560449095|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277571|NCT02584855|560449096|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
155277572|NCT02584855|560449097|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155277573|NCT02584855|560449092|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
155277574|NCT02584855|560449093|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
155277575|NCT02584855|560449094|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
155277576|NCT02584855|560449095|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
155277577|NCT02584855|560449096|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
155277578|NCT02584855|560449097|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
155277579|NCT02337478|560449098|FG000|Overall Study|Lack of Efficacy|5|||
155277580|NCT00895843|560449099|FG000|Overall Study|Protocol Violation|12|||
155277581|NCT00895843|560449100|FG001|Overall Study|Protocol Violation|12|||
155277582|NCT04963062|560449104|FG000|Overall Study|withdrew by the study team|4|||
155277583|NCT04963062|560449105|FG001|Overall Study|withdrew by the study team|2|||
155277584|NCT03500172|560449108|FG000|Period 1: Baseline Randomization|Death|0|||
155277585|NCT03500172|560449109|FG001|Period 1: Baseline Randomization|Death|0|||
155277586|NCT03500172|560449110|FG002|Period 1: Baseline Randomization|Death|0|||
155277587|NCT03500172|560449111|FG003|Period 1: Baseline Randomization|Death|0|||
155277588|NCT03500172|560449112|FG004|Period 1: Baseline Randomization|Death|0|||
155277589|NCT03500172|560449113|FG005|Period 1: Baseline Randomization|Death|0|||
155277590|NCT03500172|560449114|FG006|Period 1: Baseline Randomization|Death|0|||
155277591|NCT03500172|560449115|FG007|Period 1: Baseline Randomization|Death|0|||
155277592|NCT03500172|560449116|FG008|Period 1: Baseline Randomization|Death|0|||
155277593|NCT03500172|560449117|FG009|Period 1: Baseline Randomization|Death|2|||
155277594|NCT03500172|560449118|FG010|Period 1: Baseline Randomization|Death|0|||
155277595|NCT03500172|560449108|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
155277596|NCT03500172|560449109|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
155277597|NCT03500172|560449110|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
155277598|NCT03500172|560449111|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
155277599|NCT03500172|560449112|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
155277600|NCT03500172|560449113|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
155277601|NCT03500172|560449114|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
155277602|NCT03500172|560449115|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
155277603|NCT03500172|560449116|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
155277604|NCT03500172|560449117|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
155277605|NCT03500172|560449118|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
155277606|NCT03500172|560449108|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
155277607|NCT03500172|560449109|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
155277608|NCT03500172|560449110|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
155277609|NCT03500172|560449111|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
155277610|NCT03500172|560449112|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
155277611|NCT03500172|560449113|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
155277612|NCT03500172|560449114|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
155277613|NCT03500172|560449115|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
155277614|NCT03500172|560449116|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
155381991|NCT02549196|560833260|FG001|Overall Study|Withdrawal by Subject|0|||
154940567|NCT00686920|559208229|FG001|Overall Study|Transferred to Nursing Home|0|||
154940568|NCT00686920|559208228|FG000|Overall Study|Noncompliance|9|||
154940569|NCT00686920|559208229|FG001|Overall Study|Noncompliance|0|||
154940570|NCT00686920|559208228|FG000|Overall Study|Principal Investigator Decision|2|||
154940571|NCT00686920|559208229|FG001|Overall Study|Principal Investigator Decision|0|||
154940572|NCT01107535|559208233|FG000|Overall Study|Death|5|||
154940573|NCT01155583|559208234|FG000|Phase I|Screen failure - did not start treatment|0|||
154940574|NCT01155583|559208235|FG001|Phase I|Screen failure - did not start treatment|0|||
154940575|NCT01155583|559208236|FG002|Phase I|Screen failure - did not start treatment|0|||
154940576|NCT01155583|559208237|FG003|Phase I|Screen failure - did not start treatment|0|||
154940577|NCT01155583|559208238|FG004|Phase I|Screen failure - did not start treatment|1|||
154940578|NCT01155583|559208239|FG005|Phase I|Screen failure - did not start treatment|0|||
154940579|NCT01155583|559208240|FG006|Phase I|Screen failure - did not start treatment|0|||
154940580|NCT01155583|559208241|FG007|Phase I|Screen failure - did not start treatment|2|||
154940581|NCT01155583|559208242|FG008|Phase I|Screen failure - did not start treatment|0|||
154940582|NCT01155583|559208234|FG000|Phase I|Withdrawal by Subject|0|||
154940583|NCT01155583|559208235|FG001|Phase I|Withdrawal by Subject|0|||
154940584|NCT01155583|559208236|FG002|Phase I|Withdrawal by Subject|0|||
154940585|NCT01155583|559208237|FG003|Phase I|Withdrawal by Subject|0|||
154940586|NCT01155583|559208238|FG004|Phase I|Withdrawal by Subject|0|||
154940587|NCT01155583|559208239|FG005|Phase I|Withdrawal by Subject|0|||
154940588|NCT01155583|559208240|FG006|Phase I|Withdrawal by Subject|0|||
154940589|NCT01155583|559208241|FG007|Phase I|Withdrawal by Subject|1|||
154940590|NCT01155583|559208242|FG008|Phase I|Withdrawal by Subject|0|||
154940591|NCT02040766|559208249|FG000|Overall Study|Adverse Event|1|||
154940592|NCT02040766|559208250|FG001|Overall Study|Adverse Event|1|||
154940593|NCT02040766|559208251|FG002|Overall Study|Adverse Event|1|||
154940594|NCT02040766|559208252|FG003|Overall Study|Adverse Event|0|||
154940595|NCT02040766|559208253|FG004|Overall Study|Adverse Event|2|||
154940596|NCT02040766|559208249|FG000|Overall Study|Withdrawal by Subject|4|||
154940597|NCT02040766|559208250|FG001|Overall Study|Withdrawal by Subject|3|||
154940598|NCT02040766|559208251|FG002|Overall Study|Withdrawal by Subject|2|||
154940599|NCT02040766|559208252|FG003|Overall Study|Withdrawal by Subject|3|||
154940600|NCT02040766|559208253|FG004|Overall Study|Withdrawal by Subject|2|||
154940601|NCT02040766|559208249|FG000|Overall Study|Non-compliance|0|||
154940602|NCT02040766|559208250|FG001|Overall Study|Non-compliance|1|||
154940603|NCT02040766|559208251|FG002|Overall Study|Non-compliance|0|||
154940604|NCT02040766|559208252|FG003|Overall Study|Non-compliance|0|||
154940605|NCT02040766|559208253|FG004|Overall Study|Non-compliance|0|||
154940606|NCT02040766|559208249|FG000|Overall Study|Protocol Violation|2|||
154940607|NCT02040766|559208250|FG001|Overall Study|Protocol Violation|1|||
154940608|NCT02040766|559208251|FG002|Overall Study|Protocol Violation|2|||
154940609|NCT02040766|559208252|FG003|Overall Study|Protocol Violation|3|||
154940610|NCT02040766|559208253|FG004|Overall Study|Protocol Violation|0|||
154940611|NCT02040766|559208249|FG000|Overall Study|Lost to Follow-up|4|||
154940612|NCT02040766|559208250|FG001|Overall Study|Lost to Follow-up|1|||
154940613|NCT02040766|559208251|FG002|Overall Study|Lost to Follow-up|3|||
154940614|NCT02040766|559208252|FG003|Overall Study|Lost to Follow-up|1|||
154940615|NCT02040766|559208253|FG004|Overall Study|Lost to Follow-up|4|||
154940616|NCT02040766|559208249|FG000|Overall Study|Not reported|1|||
154940617|NCT02040766|559208250|FG001|Overall Study|Not reported|0|||
154940618|NCT02040766|559208251|FG002|Overall Study|Not reported|0|||
154940619|NCT02040766|559208252|FG003|Overall Study|Not reported|0|||
154940620|NCT02040766|559208253|FG004|Overall Study|Not reported|0|||
154940621|NCT02040766|559208249|FG000|Overall Study|Lack of Efficacy|6|||
154940622|NCT02040766|559208250|FG001|Overall Study|Lack of Efficacy|3|||
154940623|NCT02040766|559208251|FG002|Overall Study|Lack of Efficacy|4|||
154940624|NCT02040766|559208252|FG003|Overall Study|Lack of Efficacy|6|||
154940625|NCT02040766|559208253|FG004|Overall Study|Lack of Efficacy|5|||
154940626|NCT00602030|559208254|FG000|Lead-in Phase|Disease Progression|2|||
154940627|NCT00602030|559208255|FG001|Lead-in Phase|Disease Progression|3|||
154940628|NCT00602030|559208256|FG002|Lead-in Phase|Disease Progression|0|||
154940629|NCT00602030|559208257|FG003|Lead-in Phase|Disease Progression|0|||
154940630|NCT00602030|559208258|FG004|Lead-in Phase|Disease Progression|0|||
154940631|NCT00602030|559208254|FG000|Lead-in Phase|Adverse Event|0|||
154940632|NCT00602030|559208255|FG001|Lead-in Phase|Adverse Event|2|||
154940633|NCT00602030|559208256|FG002|Lead-in Phase|Adverse Event|0|||
154940634|NCT00602030|559208257|FG003|Lead-in Phase|Adverse Event|0|||
154940635|NCT00602030|559208258|FG004|Lead-in Phase|Adverse Event|0|||
154940636|NCT00602030|559208254|FG000|Double-blind Phase|Disease progression|0|||
154940637|NCT00602030|559208255|FG001|Double-blind Phase|Disease progression|0|||
154940638|NCT00602030|559208256|FG002|Double-blind Phase|Disease progression|33|||
154940639|NCT00602030|559208257|FG003|Double-blind Phase|Disease progression|30|||
154940640|NCT00602030|559208258|FG004|Double-blind Phase|Disease progression|0|||
154940641|NCT00602030|559208254|FG000|Double-blind Phase|Adverse Event|0|||
154940642|NCT00602030|559208255|FG001|Double-blind Phase|Adverse Event|0|||
154940643|NCT00602030|559208256|FG002|Double-blind Phase|Adverse Event|9|||
154940644|NCT00602030|559208257|FG003|Double-blind Phase|Adverse Event|18|||
154940645|NCT00602030|559208258|FG004|Double-blind Phase|Adverse Event|0|||
154940646|NCT00602030|559208254|FG000|Double-blind Phase|Consent withdrawal|0|||
154940647|NCT00602030|559208255|FG001|Double-blind Phase|Consent withdrawal|0|||
155092568|NCT03545672|559773630|FG000|Overall Study|Protocol Violation|2|||
154940648|NCT00602030|559208256|FG002|Double-blind Phase|Consent withdrawal|4|||
154940649|NCT00602030|559208257|FG003|Double-blind Phase|Consent withdrawal|3|||
154940650|NCT00602030|559208258|FG004|Double-blind Phase|Consent withdrawal|0|||
154940651|NCT00602030|559208254|FG000|Double-blind Phase|Death|0|||
154940652|NCT00602030|559208255|FG001|Double-blind Phase|Death|0|||
154940653|NCT00602030|559208256|FG002|Double-blind Phase|Death|3|||
154940654|NCT00602030|559208257|FG003|Double-blind Phase|Death|3|||
154940655|NCT00602030|559208258|FG004|Double-blind Phase|Death|0|||
154940656|NCT00602030|559208254|FG000|Double-blind Phase|Administrative decision|0|||
154940657|NCT00602030|559208255|FG001|Double-blind Phase|Administrative decision|0|||
154940658|NCT00602030|559208256|FG002|Double-blind Phase|Administrative decision|0|||
154940659|NCT00602030|559208257|FG003|Double-blind Phase|Administrative decision|2|||
154940660|NCT00602030|559208258|FG004|Double-blind Phase|Administrative decision|0|||
154940661|NCT00602030|559208254|FG000|Double-blind Phase|Ineligibility|0|||
154940662|NCT00602030|559208255|FG001|Double-blind Phase|Ineligibility|0|||
154940663|NCT00602030|559208256|FG002|Double-blind Phase|Ineligibility|0|||
154940664|NCT00602030|559208257|FG003|Double-blind Phase|Ineligibility|1|||
155277615|NCT03500172|560449117|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
155277616|NCT03500172|560449118|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
155277617|NCT03500172|560449108|FG000|Period 2: Re-Randomization|Death|0|||
155277618|NCT03500172|560449109|FG001|Period 2: Re-Randomization|Death|0|||
155277619|NCT03500172|560449110|FG002|Period 2: Re-Randomization|Death|0|||
155277620|NCT03500172|560449111|FG003|Period 2: Re-Randomization|Death|4|||
155277621|NCT03500172|560449112|FG004|Period 2: Re-Randomization|Death|2|||
155277622|NCT03500172|560449113|FG005|Period 2: Re-Randomization|Death|0|||
155277623|NCT03500172|560449114|FG006|Period 2: Re-Randomization|Death|5|||
155277624|NCT03500172|560449115|FG007|Period 2: Re-Randomization|Death|2|||
155277625|NCT03500172|560449116|FG008|Period 2: Re-Randomization|Death|0|||
154940665|NCT00602030|559208258|FG004|Double-blind Phase|Ineligibility|0|||
154940666|NCT00602030|559208254|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
154940667|NCT00602030|559208255|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
154940668|NCT00602030|559208256|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
154940669|NCT00602030|559208257|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
154940670|NCT00602030|559208258|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
154940671|NCT00602030|559208254|FG000|Double-blind Phase|Reason not specified|0|||
154940672|NCT00602030|559208255|FG001|Double-blind Phase|Reason not specified|0|||
154940673|NCT00602030|559208256|FG002|Double-blind Phase|Reason not specified|4|||
154940674|NCT00602030|559208257|FG003|Double-blind Phase|Reason not specified|2|||
154940675|NCT00602030|559208258|FG004|Double-blind Phase|Reason not specified|0|||
154940676|NCT00602030|559208254|FG000|Crossover Phase|Disease Progression|0|||
154940677|NCT00602030|559208255|FG001|Crossover Phase|Disease Progression|0|||
154940678|NCT00602030|559208256|FG002|Crossover Phase|Disease Progression|0|||
154940679|NCT00602030|559208257|FG003|Crossover Phase|Disease Progression|0|||
154940680|NCT00602030|559208258|FG004|Crossover Phase|Disease Progression|11|||
154940681|NCT00602030|559208254|FG000|Crossover Phase|Adverse Event|0|||
154940682|NCT00602030|559208255|FG001|Crossover Phase|Adverse Event|0|||
154940683|NCT00602030|559208256|FG002|Crossover Phase|Adverse Event|0|||
154940684|NCT00602030|559208257|FG003|Crossover Phase|Adverse Event|0|||
154940685|NCT00602030|559208258|FG004|Crossover Phase|Adverse Event|3|||
154940686|NCT00602030|559208254|FG000|Crossover Phase|Consent withdrawal|0|||
154940687|NCT00602030|559208255|FG001|Crossover Phase|Consent withdrawal|0|||
154940688|NCT00602030|559208256|FG002|Crossover Phase|Consent withdrawal|0|||
154940689|NCT00602030|559208257|FG003|Crossover Phase|Consent withdrawal|0|||
154940690|NCT00602030|559208258|FG004|Crossover Phase|Consent withdrawal|2|||
154940691|NCT01138150|559208259|FG000|Overall Study|blood unable to be processed|0|||
154940692|NCT01138150|559208260|FG001|Overall Study|blood unable to be processed|1|||
154940693|NCT01138150|559208259|FG000|Overall Study|Physician Decision|1|||
154940694|NCT01138150|559208260|FG001|Overall Study|Physician Decision|0|||
154940695|NCT01580020|559208261|FG000|Overall Study|Lack of Efficacy|0|||
154940696|NCT01580020|559208262|FG001|Overall Study|Lack of Efficacy|5|||
155277626|NCT03500172|560449117|FG009|Period 2: Re-Randomization|Death|0|||
155277627|NCT03500172|560449118|FG010|Period 2: Re-Randomization|Death|0|||
155277628|NCT00996580|560449119|FG000|Overall Study|Adverse Event|466|||
155277629|NCT00996580|560449119|FG000|Overall Study|Lost to Follow-up|480|||
154940697|NCT01580020|559208263|FG002|Overall Study|Lack of Efficacy|0|||
154940698|NCT01580020|559208264|FG003|Overall Study|Lack of Efficacy|1|||
154940699|NCT01580020|559208261|FG000|Overall Study|Withdrawal by Subject|0|||
154940700|NCT01580020|559208262|FG001|Overall Study|Withdrawal by Subject|1|||
154940701|NCT01580020|559208263|FG002|Overall Study|Withdrawal by Subject|1|||
154940702|NCT01580020|559208264|FG003|Overall Study|Withdrawal by Subject|0|||
154940703|NCT01580020|559208261|FG000|Overall Study|Adverse Event|1|||
154940704|NCT01580020|559208262|FG001|Overall Study|Adverse Event|1|||
154940705|NCT01580020|559208263|FG002|Overall Study|Adverse Event|1|||
154940706|NCT01580020|559208264|FG003|Overall Study|Adverse Event|1|||
154940707|NCT01580020|559208261|FG000|Overall Study|Administrative Problems|0|||
154940708|NCT01580020|559208262|FG001|Overall Study|Administrative Problems|0|||
154940709|NCT01580020|559208263|FG002|Overall Study|Administrative Problems|1|||
154940710|NCT01580020|559208264|FG003|Overall Study|Administrative Problems|0|||
154940711|NCT01580020|559208261|FG000|Overall Study|Lost to Follow-up|0|||
154940712|NCT01580020|559208262|FG001|Overall Study|Lost to Follow-up|0|||
154940713|NCT01580020|559208263|FG002|Overall Study|Lost to Follow-up|1|||
154940714|NCT01580020|559208264|FG003|Overall Study|Lost to Follow-up|0|||
154940715|NCT01208402|559208271|FG000|Overall Study|Withdrawal by Subject|1|||
154940716|NCT01208402|559208272|FG001|Overall Study|Withdrawal by Subject|0|||
154940717|NCT01571635|559208273|FG000|Overall Study|Adverse Event|3|||
154940718|NCT01571635|559208274|FG001|Overall Study|Adverse Event|0|||
154940719|NCT01571635|559208275|FG002|Overall Study|Adverse Event|2|||
154940720|NCT01571635|559208276|FG003|Overall Study|Adverse Event|3|||
154940721|NCT01571635|559208277|FG004|Overall Study|Adverse Event|5|||
154940722|NCT01571635|559208273|FG000|Overall Study|Other reasons|2|||
154940723|NCT01571635|559208274|FG001|Overall Study|Other reasons|1|||
154940724|NCT01571635|559208275|FG002|Overall Study|Other reasons|2|||
154940725|NCT01571635|559208276|FG003|Overall Study|Other reasons|2|||
154940726|NCT01571635|559208277|FG004|Overall Study|Other reasons|1|||
154940727|NCT01571635|559208273|FG000|Overall Study|Study terminated by sponsor|0|||
154940728|NCT01571635|559208274|FG001|Overall Study|Study terminated by sponsor|4|||
154940729|NCT01571635|559208275|FG002|Overall Study|Study terminated by sponsor|1|||
154940730|NCT01571635|559208276|FG003|Overall Study|Study terminated by sponsor|3|||
154940731|NCT01571635|559208277|FG004|Overall Study|Study terminated by sponsor|1|||
154940732|NCT01571635|559208273|FG000|Overall Study|Withdrew consent|1|||
154940733|NCT01571635|559208274|FG001|Overall Study|Withdrew consent|1|||
154940734|NCT01571635|559208275|FG002|Overall Study|Withdrew consent|2|||
154940735|NCT01571635|559208276|FG003|Overall Study|Withdrew consent|3|||
154940736|NCT01571635|559208277|FG004|Overall Study|Withdrew consent|0|||
154940737|NCT01571635|559208273|FG000|Overall Study|Lack of Efficacy|0|||
154940738|NCT01571635|559208274|FG001|Overall Study|Lack of Efficacy|2|||
154940739|NCT01571635|559208275|FG002|Overall Study|Lack of Efficacy|0|||
154940740|NCT01571635|559208276|FG003|Overall Study|Lack of Efficacy|1|||
154940741|NCT01571635|559208277|FG004|Overall Study|Lack of Efficacy|2|||
154940742|NCT02868281|559208278|FG000|Overall Study|Adverse Event|2|||
154940743|NCT02868281|559208279|FG001|Overall Study|Adverse Event|2|||
154940744|NCT02868281|559208278|FG000|Overall Study|Protocol Violation|13|||
154940745|NCT02868281|559208279|FG001|Overall Study|Protocol Violation|10|||
154940746|NCT02868281|559208278|FG000|Overall Study|Lost to Follow-up|3|||
154940747|NCT02868281|559208279|FG001|Overall Study|Lost to Follow-up|6|||
154940748|NCT02868281|559208278|FG000|Overall Study|Withdrawal by Subject|11|||
154940749|NCT02868281|559208279|FG001|Overall Study|Withdrawal by Subject|15|||
154940750|NCT02868281|559208278|FG000|Overall Study|Physician Decision|2|||
154940751|NCT02868281|559208279|FG001|Overall Study|Physician Decision|0|||
154940752|NCT02868281|559208278|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
154940753|NCT02868281|559208279|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
154940754|NCT02868281|559208278|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
154940755|NCT02868281|559208279|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
154940756|NCT02868281|559208278|FG000|Overall Study|Long journey/moving away|1|||
154940757|NCT02868281|559208279|FG001|Overall Study|Long journey/moving away|1|||
154940758|NCT01335464|559208280|FG000|Overall Study|Adverse Event|15|||
154940759|NCT01335464|559208281|FG001|Overall Study|Adverse Event|25|||
154940760|NCT01335464|559208280|FG000|Overall Study|Non compliant with protocol|2|||
155277630|NCT00996580|560449119|FG000|Overall Study|Noncompliance with the protocol|137|||
155277631|NCT00996580|560449119|FG000|Overall Study|Physician Decision|5|||
155277632|NCT00996580|560449119|FG000|Overall Study|Pregnancy|68|||
155277633|NCT00996580|560449119|FG000|Overall Study|Protocol Violation|16|||
155277634|NCT00996580|560449119|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
155277635|NCT00996580|560449119|FG000|Overall Study|Withdrawal by Subject|217|||
155277636|NCT00996580|560449119|FG000|Overall Study|Other|29|||
155277637|NCT02218489|560449120|FG000|Overall Study|Withdrawal by Subject|4|||
155277638|NCT02218489|560449121|FG001|Overall Study|Withdrawal by Subject|3|||
155277639|NCT02218489|560449120|FG000|Overall Study|Lost to Follow-up|1|||
155277640|NCT02218489|560449121|FG001|Overall Study|Lost to Follow-up|0|||
155277641|NCT01778062|560449122|FG000|Overall Study|Adverse Event|1|||
155277642|NCT01778062|560449123|FG001|Overall Study|Adverse Event|3|||
155277643|NCT01778062|560449122|FG000|Overall Study|Consent Withdrawal|1|||
155277644|NCT01778062|560449123|FG001|Overall Study|Consent Withdrawal|5|||
155277645|NCT01778062|560449122|FG000|Overall Study|major protocol deviation|4|||
155277646|NCT01778062|560449123|FG001|Overall Study|major protocol deviation|3|||
154940761|NCT01335464|559208281|FG001|Overall Study|Non compliant with protocol|0|||
154940762|NCT01335464|559208280|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
154940763|NCT01335464|559208281|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
154940764|NCT01335464|559208280|FG000|Overall Study|Not treated|2|||
154940765|NCT01335464|559208281|FG001|Overall Study|Not treated|0|||
154940766|NCT01335464|559208280|FG000|Overall Study|Reason other than those stated above|1|||
154940767|NCT01335464|559208281|FG001|Overall Study|Reason other than those stated above|1|||
154940768|NCT01783730|559208282|FG000|Overall Study|Failed to meet inclusion criteria|6|||
154940769|NCT02151461|559208283|FG000|Overall Study|Adverse Event|5|||
154940770|NCT02151461|559208284|FG001|Overall Study|Adverse Event|1|||
154940771|NCT02151461|559208285|FG002|Overall Study|Adverse Event|0|||
155381992|NCT02549196|560833261|FG002|Overall Study|Withdrawal by Subject|1|||
154940772|NCT02151461|559208286|FG003|Overall Study|Adverse Event|2|||
154940773|NCT02151461|559208283|FG000|Overall Study|Lost to Follow-up|0|||
154940774|NCT02151461|559208284|FG001|Overall Study|Lost to Follow-up|0|||
154940775|NCT02151461|559208285|FG002|Overall Study|Lost to Follow-up|1|||
154940776|NCT02151461|559208286|FG003|Overall Study|Lost to Follow-up|1|||
154940777|NCT02151461|559208283|FG000|Overall Study|Withdrawal by Subject|1|||
154940778|NCT02151461|559208284|FG001|Overall Study|Withdrawal by Subject|0|||
154940779|NCT02151461|559208285|FG002|Overall Study|Withdrawal by Subject|1|||
154940780|NCT02151461|559208286|FG003|Overall Study|Withdrawal by Subject|1|||
154940781|NCT02151461|559208283|FG000|Overall Study|Treatment discontinuation|0|||
154940782|NCT02151461|559208284|FG001|Overall Study|Treatment discontinuation|0|||
154940783|NCT02151461|559208285|FG002|Overall Study|Treatment discontinuation|1|||
154940784|NCT02151461|559208286|FG003|Overall Study|Treatment discontinuation|0|||
154940785|NCT00931385|559208287|FG000|Overall Study|Adverse Event|2|||
154940786|NCT00931385|559208288|FG001|Overall Study|Adverse Event|1|||
154940787|NCT00931385|559208289|FG002|Overall Study|Adverse Event|0|||
154940788|NCT00931385|559208290|FG003|Overall Study|Adverse Event|3|||
154940789|NCT00931385|559208287|FG000|Overall Study|Protocol Violation|0|||
154940790|NCT00931385|559208288|FG001|Overall Study|Protocol Violation|0|||
154940791|NCT00931385|559208289|FG002|Overall Study|Protocol Violation|1|||
154940792|NCT00931385|559208290|FG003|Overall Study|Protocol Violation|0|||
154940793|NCT00931385|559208287|FG000|Overall Study|Withdrawal by Subject|0|||
154940794|NCT00931385|559208288|FG001|Overall Study|Withdrawal by Subject|1|||
154940795|NCT00931385|559208289|FG002|Overall Study|Withdrawal by Subject|0|||
154940796|NCT00931385|559208290|FG003|Overall Study|Withdrawal by Subject|1|||
154940797|NCT00931385|559208287|FG000|Overall Study|Lost to Follow-up|0|||
154940798|NCT00931385|559208288|FG001|Overall Study|Lost to Follow-up|0|||
154940799|NCT00931385|559208289|FG002|Overall Study|Lost to Follow-up|0|||
154940800|NCT00931385|559208290|FG003|Overall Study|Lost to Follow-up|1|||
154940801|NCT00458302|559209935|FG000|Overall Study|Adverse Event|4|||
154940802|NCT00458302|559209936|FG001|Overall Study|Adverse Event|14|||
154940803|NCT00458302|559209935|FG000|Overall Study|Pregnancy|2|||
154940804|NCT00458302|559209936|FG001|Overall Study|Pregnancy|1|||
154940805|NCT00458302|559209935|FG000|Overall Study|Protocol Violation|0|||
154940806|NCT00458302|559209936|FG001|Overall Study|Protocol Violation|2|||
154940807|NCT00458302|559209935|FG000|Overall Study|Withdrawal by Subject|6|||
154940808|NCT00458302|559209936|FG001|Overall Study|Withdrawal by Subject|4|||
154940809|NCT00458302|559209935|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
154940810|NCT00458302|559209936|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
154940811|NCT00458302|559209935|FG000|Overall Study|Study Termination By Sponsor|1|||
154940812|NCT00458302|559209936|FG001|Overall Study|Study Termination By Sponsor|0|||
154940813|NCT00458302|559209935|FG000|Overall Study|Lost to Follow-up|2|||
154940814|NCT00458302|559209936|FG001|Overall Study|Lost to Follow-up|0|||
154940815|NCT00458302|559209935|FG000|Overall Study|Other|4|||
154940816|NCT00458302|559209936|FG001|Overall Study|Other|2|||
154940817|NCT02482805|559209937|FG000|Overall Study|Lost to Follow-up|4|||
154940818|NCT02482805|559209938|FG001|Overall Study|Lost to Follow-up|4|||
154940819|NCT02482805|559209939|FG002|Overall Study|Lost to Follow-up|0|||
154940820|NCT01144663|559209940|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
154940821|NCT01144663|559209941|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
154940822|NCT01144663|559209942|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
154940823|NCT01144663|559209943|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
154940824|NCT01144663|559209940|FG000|Primary Vaccination Phase|Adverse Event|1|||
154940825|NCT01144663|559209941|FG001|Primary Vaccination Phase|Adverse Event|0|||
154940826|NCT01144663|559209942|FG002|Primary Vaccination Phase|Adverse Event|0|||
154940827|NCT01144663|559209943|FG003|Primary Vaccination Phase|Adverse Event|1|||
154940828|NCT01144663|559209940|FG000|Primary Vaccination Phase|Protocol Violation|2|||
154940829|NCT01144663|559209941|FG001|Primary Vaccination Phase|Protocol Violation|0|||
154940830|NCT01144663|559209942|FG002|Primary Vaccination Phase|Protocol Violation|1|||
154940831|NCT01144663|559209943|FG003|Primary Vaccination Phase|Protocol Violation|0|||
154940832|NCT01144663|559209940|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
154940833|NCT01144663|559209941|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
155043666|NCT01690299|559590175|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
155043667|NCT01690299|559590176|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
155043668|NCT01690299|559590177|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
154940834|NCT01144663|559209942|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
154940835|NCT01144663|559209943|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
154940836|NCT01144663|559209940|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
154940837|NCT01144663|559209941|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
154940838|NCT01144663|559209942|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
154940839|NCT01144663|559209943|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
154940840|NCT01144663|559209940|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
155381993|NCT02549196|560833262|FG003|Overall Study|Withdrawal by Subject|0|||
155381994|NCT01442779|560833263|FG000|Overall Study|Withdrawal by Subject|3|||
155381995|NCT01442779|560833263|FG000|Overall Study|Death|3|||
155381996|NCT01442779|560833263|FG000|Overall Study|Non-compliance|1|||
155381997|NCT05249829|560833264|FG000|Overall Study|Participant Relocation|0|||
155381998|NCT05249829|560833265|FG001|Overall Study|Participant Relocation|1|||
155381999|NCT05249829|560833266|FG002|Overall Study|Participant Relocation|2|||
155382000|NCT05249829|560833267|FG003|Overall Study|Participant Relocation|2|||
155382001|NCT05249829|560833264|FG000|Overall Study|Withdrawal by Subject|9|||
155382002|NCT05249829|560833265|FG001|Overall Study|Withdrawal by Subject|17|||
155382003|NCT05249829|560833266|FG002|Overall Study|Withdrawal by Subject|40|||
155382004|NCT05249829|560833267|FG003|Overall Study|Withdrawal by Subject|35|||
154940841|NCT01144663|559209941|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
154940842|NCT01144663|559209942|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
154940843|NCT01144663|559209943|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
154940844|NCT01144663|559209940|FG000|Primary Vaccination Phase|Other|0|||
154940845|NCT01144663|559209941|FG001|Primary Vaccination Phase|Other|1|||
154940846|NCT01144663|559209942|FG002|Primary Vaccination Phase|Other|0|||
155043669|NCT01690299|559590178|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
155043670|NCT01690299|559590179|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
155043671|NCT01690299|559590174|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155043672|NCT01690299|559590175|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155043673|NCT01690299|559590176|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155043674|NCT01690299|559590177|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155043675|NCT01690299|559590178|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
155043676|NCT01690299|559590179|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
155043677|NCT04313400|559590180|FG000|Overall Study|Withdrawal by Subject|0|||
155043678|NCT04313400|559590181|FG001|Overall Study|Withdrawal by Subject|0|||
155043679|NCT04313400|559590182|FG002|Overall Study|Withdrawal by Subject|0|||
155043680|NCT04313400|559590183|FG003|Overall Study|Withdrawal by Subject|0|||
155043681|NCT04313400|559590184|FG004|Overall Study|Withdrawal by Subject|0|||
155043682|NCT04313400|559590185|FG005|Overall Study|Withdrawal by Subject|4|||
155043683|NCT04313400|559590186|FG006|Overall Study|Withdrawal by Subject|1|||
155043684|NCT04313400|559590180|FG000|Overall Study|Adverse Event|0|||
155043685|NCT04313400|559590181|FG001|Overall Study|Adverse Event|0|||
155043686|NCT04313400|559590182|FG002|Overall Study|Adverse Event|0|||
155043687|NCT04313400|559590183|FG003|Overall Study|Adverse Event|0|||
155043688|NCT04313400|559590184|FG004|Overall Study|Adverse Event|0|||
155043689|NCT04313400|559590185|FG005|Overall Study|Adverse Event|1|||
155043690|NCT04313400|559590186|FG006|Overall Study|Adverse Event|0|||
155043691|NCT04313400|559590180|FG000|Overall Study|Lost to Follow-up|0|||
155043692|NCT04313400|559590181|FG001|Overall Study|Lost to Follow-up|0|||
155043693|NCT04313400|559590182|FG002|Overall Study|Lost to Follow-up|0|||
155043694|NCT04313400|559590183|FG003|Overall Study|Lost to Follow-up|0|||
155043695|NCT04313400|559590184|FG004|Overall Study|Lost to Follow-up|0|||
155043696|NCT04313400|559590185|FG005|Overall Study|Lost to Follow-up|1|||
155043697|NCT04313400|559590186|FG006|Overall Study|Lost to Follow-up|0|||
155043698|NCT00329745|559590187|FG000|Overall Study|Protocol Violation|1|||
155043699|NCT00329745|559590188|FG001|Overall Study|Protocol Violation|0|||
155043700|NCT00329745|559590187|FG000|Overall Study|Withdrawal by Subject|0|||
155043701|NCT00329745|559590188|FG001|Overall Study|Withdrawal by Subject|1|||
155043702|NCT00329745|559590187|FG000|Overall Study|Lost to Follow-up|86|||
155043703|NCT00329745|559590188|FG001|Overall Study|Lost to Follow-up|101|||
155043704|NCT01884545|559590189|FG000|Overall Study|Lost to Follow-up|6|||
155043705|NCT01884545|559590190|FG001|Overall Study|Lost to Follow-up|4|||
155043706|NCT01884545|559590191|FG002|Overall Study|Lost to Follow-up|9|||
155043707|NCT01884545|559590192|FG003|Overall Study|Lost to Follow-up|4|||
155043708|NCT01884545|559590189|FG000|Overall Study|Patient withdrawn|7|||
155043709|NCT01884545|559590190|FG001|Overall Study|Patient withdrawn|12|||
155043710|NCT01884545|559590191|FG002|Overall Study|Patient withdrawn|5|||
155043711|NCT01884545|559590192|FG003|Overall Study|Patient withdrawn|5|||
155382005|NCT05249829|560833264|FG000|Overall Study|Physician Decision|1|||
155382006|NCT05249829|560833265|FG001|Overall Study|Physician Decision|0|||
154940847|NCT01144663|559209943|FG003|Primary Vaccination Phase|Other|2|||
154940848|NCT01144663|559209940|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
154940849|NCT01144663|559209941|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
154940850|NCT01144663|559209942|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
154940851|NCT01144663|559209943|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
154940852|NCT01144663|559209940|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
154940853|NCT01144663|559209941|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
154940854|NCT01144663|559209942|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
154940855|NCT01144663|559209943|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
154940856|NCT01144663|559209940|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
154940857|NCT01144663|559209941|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
154940858|NCT01144663|559209942|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
154940859|NCT01144663|559209943|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
154940860|NCT01144663|559209940|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
154940861|NCT01144663|559209941|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
154940862|NCT01144663|559209942|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
155277647|NCT03958630|560449124|FG000|Overall Study|Withdrawal by Subject|0|||
155277648|NCT03958630|560449125|FG001|Overall Study|Withdrawal by Subject|0|||
155277649|NCT03958630|560449126|FG002|Overall Study|Withdrawal by Subject|1|||
155277650|NCT03958630|560449124|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
155277651|NCT03958630|560449125|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
155277652|NCT03958630|560449126|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
155277653|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
155277654|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
155277655|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
155277656|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
155277657|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
155277658|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
155277659|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
155277660|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
155277661|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
155277662|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
155277663|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
155277664|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
155277665|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
155277666|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
155277667|NCT01815736|560449127|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
155277668|NCT01815736|560449128|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
155277669|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
155277670|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
155277671|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
155277672|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
155277673|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
155277674|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
155277675|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
155277676|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
155277677|NCT01815736|560449127|FG000|Extension Treatment Phase- After Week 96|Death|1|||
155277678|NCT01815736|560449128|FG001|Extension Treatment Phase- After Week 96|Death|0|||
155277679|NCT04039503|560449129|FG000|Overall Study|Adverse Event|3|||
155277680|NCT04039503|560449130|FG001|Overall Study|Adverse Event|0|||
155277681|NCT04039503|560449131|FG002|Overall Study|Adverse Event|2|||
155277682|NCT04039503|560449132|FG003|Overall Study|Adverse Event|0|||
155277683|NCT04039503|560449129|FG000|Overall Study|Lost to Follow-up|0|||
155277684|NCT04039503|560449130|FG001|Overall Study|Lost to Follow-up|0|||
155277685|NCT04039503|560449131|FG002|Overall Study|Lost to Follow-up|1|||
155277686|NCT04039503|560449132|FG003|Overall Study|Lost to Follow-up|0|||
155277687|NCT04039503|560449129|FG000|Overall Study|Protocol Violation|0|||
155277688|NCT04039503|560449130|FG001|Overall Study|Protocol Violation|1|||
155277689|NCT04039503|560449131|FG002|Overall Study|Protocol Violation|2|||
155277690|NCT04039503|560449132|FG003|Overall Study|Protocol Violation|1|||
155277691|NCT04039503|560449129|FG000|Overall Study|Withdrawal by Subject|4|||
155277692|NCT04039503|560449130|FG001|Overall Study|Withdrawal by Subject|3|||
155277693|NCT04039503|560449131|FG002|Overall Study|Withdrawal by Subject|5|||
155277694|NCT04039503|560449132|FG003|Overall Study|Withdrawal by Subject|2|||
155277695|NCT03387514|560449134|FG000|Overall Study|Withdrawal by Subject|2|||
155277696|NCT03387514|560449134|FG000|Overall Study|Physician Decision|1|||
155277697|NCT03387514|560449134|FG000|Overall Study|Lost to Follow-up|2|||
155277698|NCT04157686|560449141|FG000|Overall Study|Adverse Event|1|||
155277699|NCT04157686|560449142|FG001|Overall Study|Adverse Event|0|||
155277700|NCT04157686|560449143|FG002|Overall Study|Adverse Event|1|||
155277701|NCT04157686|560449144|FG003|Overall Study|Adverse Event|0|||
155277702|NCT04157686|560449145|FG004|Overall Study|Adverse Event|1|||
155277703|NCT04157686|560449146|FG005|Overall Study|Adverse Event|0|||
155277704|NCT04157686|560449147|FG006|Overall Study|Adverse Event|0|||
155277705|NCT04157686|560449148|FG007|Overall Study|Adverse Event|0|||
155277706|NCT04157686|560449141|FG000|Overall Study|Pregnancy|0|||
155277707|NCT04157686|560449142|FG001|Overall Study|Pregnancy|1|||
155277708|NCT04157686|560449143|FG002|Overall Study|Pregnancy|3|||
155277709|NCT04157686|560449144|FG003|Overall Study|Pregnancy|0|||
155277710|NCT04157686|560449145|FG004|Overall Study|Pregnancy|0|||
155277711|NCT04157686|560449146|FG005|Overall Study|Pregnancy|0|||
155277712|NCT04157686|560449147|FG006|Overall Study|Pregnancy|3|||
155277713|NCT04157686|560449148|FG007|Overall Study|Pregnancy|0|||
155277714|NCT04157686|560449141|FG000|Overall Study|Lost to Follow-up|1|||
155277715|NCT04157686|560449142|FG001|Overall Study|Lost to Follow-up|2|||
155277716|NCT04157686|560449143|FG002|Overall Study|Lost to Follow-up|8|||
155277717|NCT04157686|560449144|FG003|Overall Study|Lost to Follow-up|6|||
155277718|NCT04157686|560449145|FG004|Overall Study|Lost to Follow-up|6|||
155277719|NCT04157686|560449146|FG005|Overall Study|Lost to Follow-up|3|||
155277720|NCT04157686|560449147|FG006|Overall Study|Lost to Follow-up|7|||
155277721|NCT04157686|560449148|FG007|Overall Study|Lost to Follow-up|9|||
155277722|NCT04157686|560449141|FG000|Overall Study|Lack of Efficacy|0|||
155277723|NCT04157686|560449142|FG001|Overall Study|Lack of Efficacy|0|||
155277724|NCT04157686|560449143|FG002|Overall Study|Lack of Efficacy|0|||
155277725|NCT04157686|560449144|FG003|Overall Study|Lack of Efficacy|0|||
155277726|NCT04157686|560449145|FG004|Overall Study|Lack of Efficacy|0|||
155277727|NCT04157686|560449146|FG005|Overall Study|Lack of Efficacy|2|||
155277728|NCT04157686|560449147|FG006|Overall Study|Lack of Efficacy|0|||
155277729|NCT04157686|560449148|FG007|Overall Study|Lack of Efficacy|1|||
155277730|NCT04157686|560449141|FG000|Overall Study|Withdrawal by Subject|10|||
155277731|NCT04157686|560449142|FG001|Overall Study|Withdrawal by Subject|10|||
155277732|NCT04157686|560449143|FG002|Overall Study|Withdrawal by Subject|12|||
155277733|NCT04157686|560449144|FG003|Overall Study|Withdrawal by Subject|20|||
155277734|NCT04157686|560449145|FG004|Overall Study|Withdrawal by Subject|12|||
155277735|NCT04157686|560449146|FG005|Overall Study|Withdrawal by Subject|11|||
155277736|NCT04157686|560449147|FG006|Overall Study|Withdrawal by Subject|18|||
155277737|NCT04157686|560449148|FG007|Overall Study|Withdrawal by Subject|24|||
155277738|NCT04157686|560449141|FG000|Overall Study|Physician Decision|0|||
155277739|NCT04157686|560449142|FG001|Overall Study|Physician Decision|0|||
155277740|NCT04157686|560449143|FG002|Overall Study|Physician Decision|1|||
155277741|NCT04157686|560449144|FG003|Overall Study|Physician Decision|0|||
155277742|NCT04157686|560449145|FG004|Overall Study|Physician Decision|1|||
155277743|NCT04157686|560449146|FG005|Overall Study|Physician Decision|0|||
155277744|NCT04157686|560449147|FG006|Overall Study|Physician Decision|3|||
155277745|NCT04157686|560449148|FG007|Overall Study|Physician Decision|0|||
155277746|NCT04157686|560449141|FG000|Overall Study|Death|0|||
155277747|NCT04157686|560449142|FG001|Overall Study|Death|0|||
155277748|NCT04157686|560449143|FG002|Overall Study|Death|0|||
155277749|NCT04157686|560449144|FG003|Overall Study|Death|2|||
155277750|NCT04157686|560449145|FG004|Overall Study|Death|0|||
155277751|NCT04157686|560449146|FG005|Overall Study|Death|0|||
155277752|NCT04157686|560449147|FG006|Overall Study|Death|0|||
155277753|NCT04157686|560449148|FG007|Overall Study|Death|0|||
155277754|NCT04157686|560449141|FG000|Overall Study|Protocol Violation|0|||
155277755|NCT04157686|560449142|FG001|Overall Study|Protocol Violation|0|||
155277756|NCT04157686|560449143|FG002|Overall Study|Protocol Violation|0|||
155277757|NCT04157686|560449144|FG003|Overall Study|Protocol Violation|0|||
155277758|NCT04157686|560449145|FG004|Overall Study|Protocol Violation|1|||
155277759|NCT04157686|560449146|FG005|Overall Study|Protocol Violation|0|||
155277760|NCT04157686|560449147|FG006|Overall Study|Protocol Violation|0|||
155277761|NCT04157686|560449148|FG007|Overall Study|Protocol Violation|0|||
155277762|NCT04157686|560449141|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
155277763|NCT04157686|560449142|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
155277764|NCT04157686|560449143|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
155277765|NCT04157686|560449144|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
155277766|NCT04157686|560449145|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
155277767|NCT04157686|560449146|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
155277768|NCT04157686|560449147|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
155277769|NCT04157686|560449148|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
155277770|NCT01388543|560449153|FG000|Day 14|Adverse Event|1|||
155277771|NCT01388543|560449154|FG001|Day 14|Adverse Event|4|||
155277772|NCT01556243|560449155|FG000|Overall Study|Ineligible|34|||
155277773|NCT01556243|560449155|FG000|Overall Study|Converted to mastectomy|14|||
155277774|NCT01556243|560449155|FG000|Overall Study|Unable to achieve negative margins|2|||
155277775|NCT01556243|560449155|FG000|Overall Study|Withdrawal by Subject|16|||
155277776|NCT04684914|560449156|FG000|Overall Study|Withdrawal by Subject|1|||
155277777|NCT04684914|560449157|FG001|Overall Study|Withdrawal by Subject|0|||
155043712|NCT01884545|559590189|FG000|Overall Study|Non-adherence|0|||
155277778|NCT04684914|560449156|FG000|Overall Study|Discontinued before receiving study treatment|1|||
155277779|NCT04684914|560449157|FG001|Overall Study|Discontinued before receiving study treatment|2|||
155277780|NCT03872388|560449160|FG000|Overall Study|Disease Progression|0|||
155277781|NCT03872388|560449161|FG001|Overall Study|Disease Progression|0|||
155277782|NCT03872388|560449162|FG002|Overall Study|Disease Progression|0|||
155277783|NCT03872388|560449163|FG003|Overall Study|Disease Progression|0|||
155277784|NCT03872388|560449164|FG004|Overall Study|Disease Progression|0|||
155277785|NCT03872388|560449165|FG005|Overall Study|Disease Progression|0|||
155277786|NCT03872388|560449166|FG006|Overall Study|Disease Progression|1|||
155277787|NCT03872388|560449167|FG007|Overall Study|Disease Progression|1|||
155277788|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Physician Decision|1|||
155277789|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Physician Decision|0|||
155277790|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Guardian decision|1|||
155277791|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Guardian decision|0|||
155277792|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Adverse Event|0|||
155277793|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Adverse Event|1|||
155277794|NCT05089656|560449169|FG000|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|6|||
155277795|NCT05089656|560449170|FG001|Period 1 - First Intervention (52 Weeks)|Protocol-specified withdrawal criterion met|4|||
155277796|NCT04191135|560449171|FG000|Induction Treatment|Not Treated|2|||
155277797|NCT04191135|560449172|FG001|Induction Treatment|Not Treated|0|||
155277798|NCT04191135|560449173|FG002|Induction Treatment|Not Treated|0|||
155277799|NCT04191135|560449171|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
155277800|NCT04191135|560449172|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
155277801|NCT04191135|560449173|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
155277802|NCT04191135|560449171|FG000|Induction Treatment|Adverse Event|25|||
155277803|NCT04191135|560449172|FG001|Induction Treatment|Adverse Event|0|||
155277804|NCT04191135|560449173|FG002|Induction Treatment|Adverse Event|0|||
155277805|NCT04191135|560449171|FG000|Induction Treatment|Clinical Progression|8|||
155277806|NCT04191135|560449172|FG001|Induction Treatment|Clinical Progression|0|||
155277807|NCT04191135|560449173|FG002|Induction Treatment|Clinical Progression|0|||
155277808|NCT04191135|560449171|FG000|Induction Treatment|Excluded Medication|1|||
155277809|NCT04191135|560449172|FG001|Induction Treatment|Excluded Medication|0|||
155277810|NCT04191135|560449173|FG002|Induction Treatment|Excluded Medication|0|||
155277811|NCT04191135|560449171|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
155277812|NCT04191135|560449172|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
155277813|NCT04191135|560449173|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
155277814|NCT04191135|560449171|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
155277815|NCT04191135|560449172|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
155277816|NCT04191135|560449173|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
155277817|NCT04191135|560449171|FG000|Induction Treatment|Physician Decision|2|||
155277818|NCT04191135|560449172|FG001|Induction Treatment|Physician Decision|0|||
155277819|NCT04191135|560449173|FG002|Induction Treatment|Physician Decision|0|||
155277820|NCT04191135|560449171|FG000|Induction Treatment|Progressive Disease|135|||
155277821|NCT04191135|560449172|FG001|Induction Treatment|Progressive Disease|0|||
155277822|NCT04191135|560449173|FG002|Induction Treatment|Progressive Disease|0|||
155277823|NCT04191135|560449171|FG000|Induction Treatment|Protocol Violation|10|||
155277824|NCT04191135|560449172|FG001|Induction Treatment|Protocol Violation|0|||
155277825|NCT04191135|560449173|FG002|Induction Treatment|Protocol Violation|0|||
155277826|NCT04191135|560449171|FG000|Induction Treatment|Withdrawal by Subject|4|||
155277827|NCT04191135|560449172|FG001|Induction Treatment|Withdrawal by Subject|0|||
155382007|NCT05249829|560833266|FG002|Overall Study|Physician Decision|0|||
155382008|NCT05249829|560833267|FG003|Overall Study|Physician Decision|0|||
155382009|NCT05249829|560833264|FG000|Overall Study|Lost to Follow-up|16|||
154940863|NCT01144663|559209943|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
154940864|NCT01144663|559209940|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
154940865|NCT01144663|559209941|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
154940866|NCT01144663|559209942|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
154940867|NCT01144663|559209943|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
154940868|NCT01144663|559209940|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
154940869|NCT01144663|559209941|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
154940870|NCT01144663|559209942|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
154940871|NCT01144663|559209943|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
154940872|NCT02049359|559209951|FG000|Overall Study|Lost to Follow-up|26|||
154940873|NCT02049359|559209952|FG001|Overall Study|Lost to Follow-up|19|||
154940874|NCT01405950|559209953|FG000|Overall Study|Withdrawal by Subject|1|||
154940875|NCT01405950|559209954|FG001|Overall Study|Withdrawal by Subject|0|||
154940876|NCT01405950|559209955|FG002|Overall Study|Withdrawal by Subject|0|||
154940877|NCT01405950|559209956|FG003|Overall Study|Withdrawal by Subject|0|||
154940878|NCT01381900|559209957|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
154940879|NCT01381900|559209958|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
154940880|NCT01381900|559209959|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
154940881|NCT01381900|559209957|FG000|Overall Study|Adverse Event|4|||
154940882|NCT01381900|559209958|FG001|Overall Study|Adverse Event|6|||
154940883|NCT01381900|559209959|FG002|Overall Study|Adverse Event|7|||
154940884|NCT01381900|559209957|FG000|Overall Study|Noncompliance with study drug|0|||
154940885|NCT01381900|559209958|FG001|Overall Study|Noncompliance with study drug|0|||
154940886|NCT01381900|559209959|FG002|Overall Study|Noncompliance with study drug|1|||
154940887|NCT01381900|559209957|FG000|Overall Study|Physician Decision|0|||
154940888|NCT01381900|559209958|FG001|Overall Study|Physician Decision|1|||
154940889|NCT01381900|559209959|FG002|Overall Study|Physician Decision|1|||
154940890|NCT01381900|559209957|FG000|Overall Study|Protocol Violation|0|||
155277828|NCT04191135|560449173|FG002|Induction Treatment|Withdrawal by Subject|0|||
155277829|NCT04191135|560449171|FG000|Randomized Treatment|Death|0|||
155277830|NCT04191135|560449172|FG001|Randomized Treatment|Death|50|||
155277831|NCT04191135|560449173|FG002|Randomized Treatment|Death|54|||
155043713|NCT01884545|559590190|FG001|Overall Study|Non-adherence|2|||
155382010|NCT05249829|560833265|FG001|Overall Study|Lost to Follow-up|16|||
155382011|NCT05249829|560833266|FG002|Overall Study|Lost to Follow-up|57|||
155382012|NCT05249829|560833267|FG003|Overall Study|Lost to Follow-up|60|||
155382013|NCT05249829|560833264|FG000|Overall Study|Adverse Event|2|||
155382014|NCT05249829|560833265|FG001|Overall Study|Adverse Event|2|||
155382015|NCT05249829|560833266|FG002|Overall Study|Adverse Event|2|||
155382016|NCT05249829|560833267|FG003|Overall Study|Adverse Event|2|||
155382017|NCT05249829|560833264|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
155382018|NCT05249829|560833265|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
155382019|NCT05249829|560833266|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
155382020|NCT05249829|560833267|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
155382021|NCT05249829|560833264|FG000|Overall Study|Protocol Violation|2|||
155382022|NCT05249829|560833265|FG001|Overall Study|Protocol Violation|0|||
155382023|NCT05249829|560833266|FG002|Overall Study|Protocol Violation|5|||
155382024|NCT05249829|560833267|FG003|Overall Study|Protocol Violation|3|||
155382025|NCT05249829|560833264|FG000|Overall Study|Death|0|||
155382026|NCT05249829|560833265|FG001|Overall Study|Death|1|||
155382027|NCT05249829|560833266|FG002|Overall Study|Death|2|||
155382028|NCT05249829|560833267|FG003|Overall Study|Death|4|||
155382029|NCT00196976|560833269|FG000|Primary Study|Migrated from study area|0|||
155382030|NCT00196976|560833270|FG001|Primary Study|Migrated from study area|0|||
155382031|NCT00196976|560833271|FG002|Primary Study|Migrated from study area|0|||
155382032|NCT00196976|560833272|FG003|Primary Study|Migrated from study area|0|||
154940891|NCT01381900|559209958|FG001|Overall Study|Protocol Violation|1|||
154940892|NCT01381900|559209959|FG002|Overall Study|Protocol Violation|1|||
154940893|NCT01381900|559209957|FG000|Overall Study|Withdrawal by Subject|0|||
154940894|NCT01381900|559209958|FG001|Overall Study|Withdrawal by Subject|0|||
154940895|NCT01381900|559209959|FG002|Overall Study|Withdrawal by Subject|1|||
154940896|NCT01381900|559209957|FG000|Overall Study|Early withdraw|3|||
154940897|NCT01381900|559209958|FG001|Overall Study|Early withdraw|1|||
154940898|NCT01381900|559209959|FG002|Overall Study|Early withdraw|1|||
154940899|NCT00387712|559209962|FG000|Overall Study|Physician Decision|6|||
154940900|NCT00387712|559209963|FG001|Overall Study|Physician Decision|4|||
154940901|NCT00387712|559209962|FG000|Overall Study|Lost to Follow-up|17|||
154940902|NCT00387712|559209963|FG001|Overall Study|Lost to Follow-up|20|||
155043714|NCT01884545|559590191|FG002|Overall Study|Non-adherence|0|||
155277832|NCT04191135|560449171|FG000|Randomized Treatment|Lost to Follow-up|0|||
155277833|NCT04191135|560449172|FG001|Randomized Treatment|Lost to Follow-up|0|||
155277834|NCT04191135|560449173|FG002|Randomized Treatment|Lost to Follow-up|1|||
155277835|NCT04191135|560449171|FG000|Randomized Treatment|Withdrawal by Subject|0|||
155277836|NCT04191135|560449172|FG001|Randomized Treatment|Withdrawal by Subject|2|||
155277837|NCT04191135|560449173|FG002|Randomized Treatment|Withdrawal by Subject|0|||
155277838|NCT04191135|560449171|FG000|Randomized Treatment|Ongoing in Trial|0|||
155277839|NCT04191135|560449172|FG001|Randomized Treatment|Ongoing in Trial|83|||
155277840|NCT04191135|560449173|FG002|Randomized Treatment|Ongoing in Trial|81|||
155277841|NCT00107380|560451010|FG000|Overall Study|Adverse Event|7|||
155277842|NCT00107380|560451010|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
155277843|NCT00107380|560451010|FG000|Overall Study|Progression/relapse|4|||
155277844|NCT00107380|560451010|FG000|Overall Study|Death|3|||
155277845|NCT00107380|560451010|FG000|Overall Study|Other - not protocol specified|7|||
155277846|NCT00107380|560451010|FG000|Overall Study|Ineligible|2|||
155277847|NCT03673098|560451011|FG000|Overall Study|Lost to Follow-up|2|||
155277848|NCT03673098|560451012|FG001|Overall Study|Lost to Follow-up|3|||
155277849|NCT03673098|560451011|FG000|Overall Study|Withdrawal by Subject|6|||
155277850|NCT03673098|560451012|FG001|Overall Study|Withdrawal by Subject|1|||
155277851|NCT03673098|560451011|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
155277852|NCT03673098|560451012|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
155277853|NCT01268059|560451013|FG000|Overall Study|Lost to Follow-up|0|||
155277854|NCT01268059|560451014|FG001|Overall Study|Lost to Follow-up|1|||
155277855|NCT01268059|560451015|FG002|Overall Study|Lost to Follow-up|0|||
155277856|NCT01268059|560451016|FG003|Overall Study|Lost to Follow-up|0|||
155277857|NCT01268059|560451013|FG000|Overall Study|Withdrawal by Subject|7|||
155382033|NCT00196976|560833273|FG004|Primary Study|Migrated from study area|0|||
155043715|NCT01884545|559590192|FG003|Overall Study|Non-adherence|0|||
155382034|NCT00196976|560833274|FG005|Primary Study|Migrated from study area|0|||
155382035|NCT00196976|560833275|FG006|Primary Study|Migrated from study area|0|||
155382036|NCT00196976|560833276|FG007|Primary Study|Migrated from study area|1|||
155382037|NCT00196976|560833277|FG008|Primary Study|Migrated from study area|0|||
155382038|NCT00196976|560833278|FG009|Primary Study|Migrated from study area|0|||
155382039|NCT00196976|560833279|FG010|Primary Study|Migrated from study area|0|||
154940903|NCT00387712|559209962|FG000|Overall Study|Withdrawal by Subject|6|||
154940904|NCT00387712|559209963|FG001|Overall Study|Withdrawal by Subject|12|||
154940905|NCT01772368|559209965|FG000|Overall Study|Adverse Event|1|||
154940906|NCT01772368|559209965|FG000|Overall Study|Withdrawal by Subject|3|||
155277858|NCT01268059|560451014|FG001|Overall Study|Withdrawal by Subject|4|||
155277859|NCT01268059|560451015|FG002|Overall Study|Withdrawal by Subject|0|||
155277860|NCT01268059|560451016|FG003|Overall Study|Withdrawal by Subject|0|||
154940907|NCT01772368|559209965|FG000|Overall Study|Protocol Violation|2|||
154940908|NCT01772368|559209965|FG000|Overall Study|Other|1|||
154940909|NCT03347695|559209982|FG000|Overall Study|Death|0|||
154940910|NCT03347695|559209983|FG001|Overall Study|Death|4|||
154940911|NCT03347695|559209982|FG000|Overall Study|Lost to Follow-up|0|||
154940912|NCT03347695|559209983|FG001|Overall Study|Lost to Follow-up|1|||
154940913|NCT04633837|559209984|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
154940914|NCT04633837|559209985|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
154940915|NCT02668783|559209986|FG000|Overall Study|Pregnancy|0|||
154940916|NCT02668783|559209987|FG001|Overall Study|Pregnancy|1|||
155043716|NCT02937636|559590194|FG000|Overall Study|Other (Not specified)|3|||
155277861|NCT01268059|560451013|FG000|Overall Study|Death|20|||
155277862|NCT01268059|560451014|FG001|Overall Study|Death|30|||
155277863|NCT01268059|560451015|FG002|Overall Study|Death|3|||
155277864|NCT01268059|560451016|FG003|Overall Study|Death|5|||
155277865|NCT01268059|560451013|FG000|Overall Study|Progression of disease|1|||
155277866|NCT01268059|560451014|FG001|Overall Study|Progression of disease|0|||
155277867|NCT01268059|560451015|FG002|Overall Study|Progression of disease|0|||
155277868|NCT01268059|560451016|FG003|Overall Study|Progression of disease|0|||
155277869|NCT03660943|560451017|FG000|Overall Study|Adverse Event|5|||
155277870|NCT03660943|560451018|FG001|Overall Study|Adverse Event|3|||
155277871|NCT03660943|560451017|FG000|Overall Study|Death|0|||
155277872|NCT03660943|560451018|FG001|Overall Study|Death|2|||
155277873|NCT03660943|560451017|FG000|Overall Study|Lost to Follow-up|7|||
155277874|NCT03660943|560451018|FG001|Overall Study|Lost to Follow-up|3|||
155277875|NCT03660943|560451017|FG000|Overall Study|Protocol Violation|3|||
155277876|NCT03660943|560451018|FG001|Overall Study|Protocol Violation|5|||
155277877|NCT03660943|560451017|FG000|Overall Study|Withdrawal by Subject|8|||
155277878|NCT03660943|560451018|FG001|Overall Study|Withdrawal by Subject|15|||
155277879|NCT03660943|560451017|FG000|Overall Study|Lack of Efficacy|9|||
155277880|NCT03660943|560451018|FG001|Overall Study|Lack of Efficacy|12|||
155277881|NCT03660943|560451017|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
155277882|NCT03660943|560451018|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
155277883|NCT01021878|560451019|FG000|Overall Study|Lost to Follow-up|4|||
155277884|NCT01021878|560451020|FG001|Overall Study|Lost to Follow-up|3|||
155277885|NCT01021878|560451019|FG000|Overall Study|Death|0|||
155277886|NCT01021878|560451020|FG001|Overall Study|Death|1|||
155277887|NCT01021878|560451019|FG000|Overall Study|Adverse Event|6|||
155277888|NCT01021878|560451020|FG001|Overall Study|Adverse Event|5|||
155277889|NCT01021878|560451019|FG000|Overall Study|Transplantation|6|||
155277890|NCT01021878|560451020|FG001|Overall Study|Transplantation|1|||
155277891|NCT01155726|560451021|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
155277892|NCT01155726|560451022|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
155277893|NCT01155726|560451023|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
155277894|NCT01155726|560451024|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
155277895|NCT00109928|560451037|FG000|Overall Study|Adverse Event|2|||
155277896|NCT00109928|560451037|FG000|Overall Study|Progression|6|||
155277897|NCT00109928|560451037|FG000|Overall Study|Death|2|||
155277898|NCT00109928|560451037|FG000|Overall Study|not protocol specified|2|||
155277899|NCT00109928|560451037|FG000|Overall Study|not eligible|1|||
155277900|NCT02411591|560451042|FG000|Overall Study|Adverse Event|0|||
155277901|NCT02411591|560451043|FG001|Overall Study|Adverse Event|4|||
155277902|NCT02411591|560451044|FG002|Overall Study|Adverse Event|2|||
155277903|NCT02411591|560451042|FG000|Overall Study|Withdrawal by Subject|0|||
155277904|NCT02411591|560451043|FG001|Overall Study|Withdrawal by Subject|3|||
155277905|NCT02411591|560451044|FG002|Overall Study|Withdrawal by Subject|0|||
155277906|NCT02411591|560451042|FG000|Overall Study|Physician Decision|0|||
155277907|NCT02411591|560451043|FG001|Overall Study|Physician Decision|3|||
155277908|NCT02411591|560451044|FG002|Overall Study|Physician Decision|1|||
155277909|NCT00598481|560451046|FG000|Treatment|Physician Decision|1|||
155277910|NCT01439711|560451047|FG000|Overall Study|Ineligible|13|||
155277911|NCT01439711|560451047|FG000|Overall Study|Cancel|3|||
155277912|NCT01439711|560451047|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
155277913|NCT01439711|560451047|FG000|Overall Study|Adverse Event|5|||
155277914|NCT01439711|560451047|FG000|Overall Study|Withdrawal by Subject|3|||
155277915|NCT01439711|560451047|FG000|Overall Study|Progression During Active Tx|3|||
155277916|NCT01439711|560451047|FG000|Overall Study|Noncompliance|3|||
155277917|NCT01439711|560451047|FG000|Overall Study|No MRI|9|||
155277918|NCT01603121|560451048|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
155043717|NCT02937636|559590195|FG001|Overall Study|Other (Not specified)|2|||
155277919|NCT01603121|560451049|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
155277920|NCT00738530|560451050|FG000|Overall Study|Death|220|||
155277921|NCT00738530|560451051|FG001|Overall Study|Death|224|||
155043718|NCT00770913|559590196|FG000|Overall Study|Adverse Event|1|||
155277922|NCT00738530|560451050|FG000|Overall Study|Lost to Follow-up|8|||
155277923|NCT00738530|560451051|FG001|Overall Study|Lost to Follow-up|6|||
154940917|NCT02668783|559209986|FG000|Overall Study|Protocol Violation|2|||
154940918|NCT02668783|559209987|FG001|Overall Study|Protocol Violation|1|||
155277924|NCT00738530|560451050|FG000|Overall Study|Withdrawal by Subject|6|||
155382040|NCT00196976|560833280|FG011|Primary Study|Migrated from study area|0|||
155382041|NCT00196976|560833281|FG012|Primary Study|Migrated from study area|0|||
155382042|NCT00196976|560833282|FG013|Primary Study|Migrated from study area|0|||
155382043|NCT00196976|560833269|FG000|Primary Study|Protocol Violation|0|||
155382044|NCT00196976|560833270|FG001|Primary Study|Protocol Violation|1|||
155382045|NCT00196976|560833271|FG002|Primary Study|Protocol Violation|1|||
155382046|NCT00196976|560833272|FG003|Primary Study|Protocol Violation|0|||
155382047|NCT00196976|560833273|FG004|Primary Study|Protocol Violation|0|||
155382048|NCT00196976|560833274|FG005|Primary Study|Protocol Violation|0|||
155382049|NCT00196976|560833275|FG006|Primary Study|Protocol Violation|0|||
155382050|NCT00196976|560833276|FG007|Primary Study|Protocol Violation|0|||
155382051|NCT00196976|560833277|FG008|Primary Study|Protocol Violation|0|||
155382052|NCT00196976|560833278|FG009|Primary Study|Protocol Violation|0|||
155382053|NCT00196976|560833279|FG010|Primary Study|Protocol Violation|0|||
155382054|NCT00196976|560833280|FG011|Primary Study|Protocol Violation|0|||
155382055|NCT00196976|560833281|FG012|Primary Study|Protocol Violation|0|||
155382056|NCT00196976|560833282|FG013|Primary Study|Protocol Violation|0|||
155382057|NCT00196976|560833269|FG000|Primary Study|Withdrawal by Subject|1|||
155382058|NCT00196976|560833270|FG001|Primary Study|Withdrawal by Subject|0|||
155382059|NCT00196976|560833271|FG002|Primary Study|Withdrawal by Subject|1|||
155382060|NCT00196976|560833272|FG003|Primary Study|Withdrawal by Subject|1|||
155382061|NCT00196976|560833273|FG004|Primary Study|Withdrawal by Subject|2|||
155382062|NCT00196976|560833274|FG005|Primary Study|Withdrawal by Subject|1|||
155382063|NCT00196976|560833275|FG006|Primary Study|Withdrawal by Subject|0|||
154940919|NCT02668783|559209986|FG000|Overall Study|Study terminated by sponsor|9|||
154940920|NCT02668783|559209987|FG001|Overall Study|Study terminated by sponsor|10|||
154940921|NCT02668783|559209986|FG000|Overall Study|Subject moved|1|||
154940922|NCT02668783|559209987|FG001|Overall Study|Subject moved|0|||
154940923|NCT02668783|559209986|FG000|Overall Study|Withdrawal by Subject|1|||
154940924|NCT02668783|559209987|FG001|Overall Study|Withdrawal by Subject|0|||
154940925|NCT00112489|559209988|FG000|Overall Study|Refused further treatment|8|||
154940926|NCT00112489|559209988|FG000|Overall Study|Adverse Event|12|||
154940927|NCT00112489|559209988|FG000|Overall Study|Death|2|||
154940928|NCT00112489|559209988|FG000|Overall Study|Other, Not Specified|9|||
154940929|NCT00112489|559209988|FG000|Overall Study|Patient never treated|2|||
154940930|NCT00112489|559209988|FG000|Overall Study|Ineligible|7|||
154940931|NCT02891200|559209993|FG000|Overall Study|Lost to Follow-up|31|||
154940932|NCT02891200|559209994|FG001|Overall Study|Lost to Follow-up|36|||
154940933|NCT02891200|559209993|FG000|Overall Study|Death|10|||
154940934|NCT02891200|559209994|FG001|Overall Study|Death|9|||
154940935|NCT02891200|559209993|FG000|Overall Study|Withdrawal by Subject|1|||
154940936|NCT02891200|559209994|FG001|Overall Study|Withdrawal by Subject|4|||
154940937|NCT04467697|559209996|FG000|Overall Study|Adverse Event|2|||
154940938|NCT04467697|559209996|FG000|Overall Study|Lost to Follow-up|6|||
154940939|NCT04467697|559209996|FG000|Overall Study|Withdrawal by Subject|9|||
154940940|NCT04467697|559209996|FG000|Overall Study|Protocol Violation|3|||
154940941|NCT03907280|559209997|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
154940942|NCT03907280|559209998|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
154940943|NCT03907280|559209999|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
154940944|NCT04480463|559210002|FG000|Overall Study|Death|0|||
154940945|NCT04480463|559210003|FG001|Overall Study|Death|1|||
154940946|NCT04480463|559210002|FG000|Overall Study|Adverse Event|6|||
154940947|NCT04480463|559210003|FG001|Overall Study|Adverse Event|8|||
154940948|NCT04480463|559210002|FG000|Overall Study|Lost to Follow-up|3|||
154940949|NCT04480463|559210003|FG001|Overall Study|Lost to Follow-up|2|||
154940950|NCT04480463|559210002|FG000|Overall Study|Physician Decision|2|||
154940951|NCT04480463|559210003|FG001|Overall Study|Physician Decision|5|||
154940952|NCT04480463|559210002|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
154940953|NCT04480463|559210003|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
154940954|NCT04480463|559210002|FG000|Overall Study|Protocol Violation|2|||
154940955|NCT04480463|559210003|FG001|Overall Study|Protocol Violation|1|||
154940956|NCT04480463|559210002|FG000|Overall Study|Withdrawal by Subject|6|||
154940957|NCT04480463|559210003|FG001|Overall Study|Withdrawal by Subject|7|||
154940958|NCT04480463|559210002|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
154940959|NCT04480463|559210003|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
154940960|NCT04480463|559210002|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
155043719|NCT00770913|559590197|FG001|Overall Study|Adverse Event|3|||
155043720|NCT00770913|559590198|FG002|Overall Study|Adverse Event|6|||
155382064|NCT00196976|560833276|FG007|Primary Study|Withdrawal by Subject|0|||
155382065|NCT00196976|560833277|FG008|Primary Study|Withdrawal by Subject|0|||
155382066|NCT00196976|560833278|FG009|Primary Study|Withdrawal by Subject|1|||
155382067|NCT00196976|560833279|FG010|Primary Study|Withdrawal by Subject|0|||
155382068|NCT00196976|560833280|FG011|Primary Study|Withdrawal by Subject|0|||
155382069|NCT00196976|560833281|FG012|Primary Study|Withdrawal by Subject|0|||
155382070|NCT00196976|560833282|FG013|Primary Study|Withdrawal by Subject|0|||
155382071|NCT00196976|560833269|FG000|Primary Study|Lost to Follow-up|0|||
155382072|NCT00196976|560833270|FG001|Primary Study|Lost to Follow-up|0|||
155382073|NCT00196976|560833271|FG002|Primary Study|Lost to Follow-up|0|||
155382074|NCT00196976|560833272|FG003|Primary Study|Lost to Follow-up|0|||
155382075|NCT00196976|560833273|FG004|Primary Study|Lost to Follow-up|1|||
155382076|NCT00196976|560833274|FG005|Primary Study|Lost to Follow-up|1|||
155382077|NCT00196976|560833275|FG006|Primary Study|Lost to Follow-up|0|||
155382078|NCT00196976|560833276|FG007|Primary Study|Lost to Follow-up|2|||
155382079|NCT00196976|560833277|FG008|Primary Study|Lost to Follow-up|0|||
155382080|NCT00196976|560833278|FG009|Primary Study|Lost to Follow-up|0|||
155382081|NCT00196976|560833279|FG010|Primary Study|Lost to Follow-up|0|||
155382082|NCT00196976|560833280|FG011|Primary Study|Lost to Follow-up|0|||
155382083|NCT00196976|560833281|FG012|Primary Study|Lost to Follow-up|0|||
155382084|NCT00196976|560833282|FG013|Primary Study|Lost to Follow-up|0|||
155382085|NCT00196976|560833269|FG000|Primary Study|Other|0|||
155382086|NCT00196976|560833270|FG001|Primary Study|Other|0|||
155382087|NCT00196976|560833271|FG002|Primary Study|Other|2|||
155382088|NCT00196976|560833272|FG003|Primary Study|Other|0|||
155382089|NCT00196976|560833273|FG004|Primary Study|Other|0|||
155382090|NCT00196976|560833274|FG005|Primary Study|Other|0|||
155382091|NCT00196976|560833275|FG006|Primary Study|Other|0|||
155382092|NCT00196976|560833276|FG007|Primary Study|Other|0|||
155382093|NCT00196976|560833277|FG008|Primary Study|Other|0|||
155382094|NCT00196976|560833278|FG009|Primary Study|Other|0|||
155382095|NCT00196976|560833279|FG010|Primary Study|Other|0|||
155382096|NCT00196976|560833280|FG011|Primary Study|Other|0|||
155382097|NCT00196976|560833281|FG012|Primary Study|Other|0|||
155382098|NCT00196976|560833282|FG013|Primary Study|Other|0|||
155382099|NCT00196976|560833269|FG000|Booster Study|Withdrawal by Subject|0|||
155382100|NCT00196976|560833270|FG001|Booster Study|Withdrawal by Subject|0|||
155382101|NCT00196976|560833271|FG002|Booster Study|Withdrawal by Subject|0|||
155382102|NCT00196976|560833272|FG003|Booster Study|Withdrawal by Subject|0|||
155382103|NCT00196976|560833273|FG004|Booster Study|Withdrawal by Subject|0|||
155382104|NCT00196976|560833274|FG005|Booster Study|Withdrawal by Subject|0|||
155382105|NCT00196976|560833275|FG006|Booster Study|Withdrawal by Subject|0|||
155382106|NCT00196976|560833276|FG007|Booster Study|Withdrawal by Subject|0|||
155382107|NCT00196976|560833277|FG008|Booster Study|Withdrawal by Subject|0|||
155382108|NCT00196976|560833278|FG009|Booster Study|Withdrawal by Subject|0|||
154940961|NCT04480463|559210003|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
154940962|NCT04480463|559210002|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
154940963|NCT04480463|559210003|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
154940964|NCT04480463|559210002|FG000|Overall Study|Other|6|||
154940965|NCT04480463|559210003|FG001|Overall Study|Other|4|||
154940966|NCT01399723|559210004|FG000|Overall Study|Lost to Follow-up|0|||
154940967|NCT01399723|559210005|FG001|Overall Study|Lost to Follow-up|1|||
154940968|NCT00752791|559210015|FG000|Overall Study|Adverse Event|7|||
154940969|NCT00752791|559210015|FG000|Overall Study|Withdrawal by Subject|1|||
154940970|NCT00752791|559210015|FG000|Overall Study|Physician Decision|1|||
154940971|NCT00752791|559210015|FG000|Overall Study|Death|1|||
154940972|NCT00752791|559210015|FG000|Overall Study|Renal transplant|3|||
154940973|NCT00752791|559210015|FG000|Overall Study|Switched to hemodialysis|2|||
154940974|NCT00752791|559210015|FG000|Overall Study|Protocol deviation|1|||
154940975|NCT01769378|559210018|FG000|Overall Study|Adverse Event|10|||
154940976|NCT01769378|559210019|FG001|Overall Study|Adverse Event|0|||
154940977|NCT01769378|559210018|FG000|Overall Study|Entry criteria not met|1|||
154940978|NCT01769378|559210019|FG001|Overall Study|Entry criteria not met|0|||
154940979|NCT01769378|559210018|FG000|Overall Study|Protocol Violation|1|||
154940980|NCT01769378|559210019|FG001|Overall Study|Protocol Violation|1|||
155382109|NCT00196976|560833279|FG010|Booster Study|Withdrawal by Subject|1|||
155382110|NCT00196976|560833280|FG011|Booster Study|Withdrawal by Subject|0|||
154940981|NCT01769378|559210018|FG000|Overall Study|Withdrawal by Subject|10|||
154940982|NCT01769378|559210019|FG001|Overall Study|Withdrawal by Subject|3|||
154940983|NCT01769378|559210018|FG000|Overall Study|Sponsor Decision|1|||
155043721|NCT00770913|559590196|FG000|Overall Study|Refusal to continue participation|6|||
155382111|NCT00196976|560833281|FG012|Booster Study|Withdrawal by Subject|0|||
155382112|NCT00196976|560833282|FG013|Booster Study|Withdrawal by Subject|0|||
155382113|NCT00196976|560833269|FG000|Booster Study|Lost to Follow-up|0|||
155382114|NCT00196976|560833270|FG001|Booster Study|Lost to Follow-up|0|||
155382115|NCT00196976|560833271|FG002|Booster Study|Lost to Follow-up|0|||
155382116|NCT00196976|560833272|FG003|Booster Study|Lost to Follow-up|0|||
155382117|NCT00196976|560833273|FG004|Booster Study|Lost to Follow-up|0|||
155382118|NCT00196976|560833274|FG005|Booster Study|Lost to Follow-up|0|||
155382119|NCT00196976|560833275|FG006|Booster Study|Lost to Follow-up|0|||
155382120|NCT00196976|560833276|FG007|Booster Study|Lost to Follow-up|0|||
155382121|NCT00196976|560833277|FG008|Booster Study|Lost to Follow-up|0|||
155382122|NCT00196976|560833278|FG009|Booster Study|Lost to Follow-up|0|||
155382123|NCT00196976|560833279|FG010|Booster Study|Lost to Follow-up|1|||
155382124|NCT00196976|560833280|FG011|Booster Study|Lost to Follow-up|2|||
155382125|NCT00196976|560833281|FG012|Booster Study|Lost to Follow-up|0|||
155382126|NCT00196976|560833282|FG013|Booster Study|Lost to Follow-up|0|||
154940984|NCT01769378|559210019|FG001|Overall Study|Sponsor Decision|0|||
154940985|NCT01769378|559210018|FG000|Overall Study|Lost to Follow-up|2|||
154940986|NCT01769378|559210019|FG001|Overall Study|Lost to Follow-up|0|||
154940987|NCT01977092|559210020|FG000|Overall Study|Death|3|||
154940988|NCT01977092|559210021|FG001|Overall Study|Death|4|||
154940989|NCT01977092|559210020|FG000|Overall Study|Lost to Follow-up|23|||
154940990|NCT01977092|559210021|FG001|Overall Study|Lost to Follow-up|14|||
154940991|NCT01977092|559210020|FG000|Overall Study|Withdrawal by Subject|2|||
154940992|NCT01977092|559210021|FG001|Overall Study|Withdrawal by Subject|1|||
154940993|NCT01977092|559210020|FG000|Overall Study|In prison|3|||
154940994|NCT01977092|559210021|FG001|Overall Study|In prison|11|||
154940995|NCT01958281|559210022|FG000|Overall Study|Lack of Efficacy|5|||
154940996|NCT01958281|559210023|FG001|Overall Study|Lack of Efficacy|2|||
154940997|NCT01958281|559210024|FG002|Overall Study|Lack of Efficacy|0|||
154940998|NCT01958281|559210022|FG000|Overall Study|Adverse Event|0|||
154940999|NCT01958281|559210023|FG001|Overall Study|Adverse Event|2|||
154941000|NCT01958281|559210024|FG002|Overall Study|Adverse Event|0|||
154941001|NCT01958281|559210022|FG000|Overall Study|Withdrew Consent|1|||
154941002|NCT01958281|559210023|FG001|Overall Study|Withdrew Consent|0|||
154941003|NCT01958281|559210024|FG002|Overall Study|Withdrew Consent|0|||
154941004|NCT02784106|559210027|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
154941005|NCT02784106|559210028|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
154941006|NCT02784106|559210029|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
154941007|NCT02784106|559210030|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
154941008|NCT02784106|559210027|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
154941009|NCT02784106|559210028|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
154941010|NCT02784106|559210029|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
154941011|NCT02784106|559210030|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
154941012|NCT02784106|559210027|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
154941013|NCT02784106|559210028|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
154941014|NCT02784106|559210029|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
154941015|NCT02784106|559210030|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
154941016|NCT02784106|559210027|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
154941017|NCT02784106|559210028|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
154941018|NCT02784106|559210029|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
154941019|NCT02784106|559210030|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
154941020|NCT02784106|559210027|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
154941021|NCT02784106|559210028|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
154941022|NCT02784106|559210029|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
154941023|NCT02784106|559210030|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
154941024|NCT02784106|559210027|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
154941025|NCT02784106|559210028|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
154941026|NCT02784106|559210029|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
154941027|NCT02784106|559210030|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
154941028|NCT02927847|559210032|FG000|Overall Study|Lost to Follow-up|1|||
154941029|NCT02927847|559210033|FG001|Overall Study|Lost to Follow-up|0|||
154941030|NCT02927847|559210032|FG000|Overall Study|Withdrawal by Subject|4|||
154941031|NCT02927847|559210033|FG001|Overall Study|Withdrawal by Subject|2|||
154941032|NCT02927847|559210032|FG000|Overall Study|PI withdrawn due to missed visits|1|||
154941033|NCT02927847|559210033|FG001|Overall Study|PI withdrawn due to missed visits|1|||
154941034|NCT00175019|559210037|FG000|Overall Study|Adverse Event|54|||
154941035|NCT00175019|559210038|FG001|Overall Study|Adverse Event|22|||
154941036|NCT00175019|559210039|FG002|Overall Study|Adverse Event|2|||
154941037|NCT00175019|559210037|FG000|Overall Study|Protocol Violation|6|||
154941038|NCT00175019|559210038|FG001|Overall Study|Protocol Violation|3|||
154941039|NCT00175019|559210039|FG002|Overall Study|Protocol Violation|3|||
154941040|NCT00175019|559210037|FG000|Overall Study|Lost to Follow-up|42|||
154941041|NCT00175019|559210038|FG001|Overall Study|Lost to Follow-up|39|||
154941042|NCT00175019|559210039|FG002|Overall Study|Lost to Follow-up|9|||
155092569|NCT03545672|559773631|FG001|Overall Study|Protocol Violation|2|||
154941043|NCT00175019|559210037|FG000|Overall Study|Did not continue under Amendment 4|1|||
154941044|NCT00175019|559210038|FG001|Overall Study|Did not continue under Amendment 4|1|||
154941045|NCT00175019|559210039|FG002|Overall Study|Did not continue under Amendment 4|2|||
154941046|NCT00175019|559210037|FG000|Overall Study|Personal Reason(s)|39|||
154941047|NCT00175019|559210038|FG001|Overall Study|Personal Reason(s)|31|||
154941048|NCT00175019|559210039|FG002|Overall Study|Personal Reason(s)|8|||
154941049|NCT00175019|559210037|FG000|Overall Study|Therapeutic Failure|10|||
154941050|NCT00175019|559210038|FG001|Overall Study|Therapeutic Failure|38|||
154941051|NCT00175019|559210039|FG002|Overall Study|Therapeutic Failure|22|||
155382127|NCT01535560|560833283|FG000|Overall Study|Adverse Event|12|||
155382128|NCT01535560|560833284|FG001|Overall Study|Adverse Event|7|||
155277925|NCT00738530|560451051|FG001|Overall Study|Withdrawal by Subject|8|||
155277926|NCT04179461|560451052|FG000|Overall Study|Lost to Follow-up|4|||
155277927|NCT03785340|560451053|FG000|Overall Study|Lost to Follow-up|2|||
155277928|NCT03785340|560451054|FG001|Overall Study|Lost to Follow-up|0|||
155277929|NCT03785340|560451053|FG000|Overall Study|Adverse Event|1|||
155277930|NCT03785340|560451054|FG001|Overall Study|Adverse Event|0|||
155277931|NCT01848834|560451055|FG000|Overall Study|Adverse Event|3|||
155277932|NCT01848834|560451056|FG001|Overall Study|Adverse Event|11|||
155277933|NCT01848834|560451057|FG002|Overall Study|Adverse Event|3|||
155277934|NCT01848834|560451058|FG003|Overall Study|Adverse Event|5|||
155277935|NCT01848834|560451059|FG004|Overall Study|Adverse Event|9|||
154941052|NCT00175019|559210037|FG000|Overall Study|Gout Flare|2|||
154941053|NCT00175019|559210038|FG001|Overall Study|Gout Flare|3|||
154941054|NCT00175019|559210039|FG002|Overall Study|Gout Flare|0|||
154941055|NCT00175019|559210037|FG000|Overall Study|Reason Not Specified|40|||
154941056|NCT00175019|559210038|FG001|Overall Study|Reason Not Specified|34|||
154941057|NCT00175019|559210039|FG002|Overall Study|Reason Not Specified|11|||
155277936|NCT01848834|560451055|FG000|Overall Study|Death|2|||
155277937|NCT01848834|560451056|FG001|Overall Study|Death|11|||
155277938|NCT01848834|560451057|FG002|Overall Study|Death|1|||
155277939|NCT01848834|560451058|FG003|Overall Study|Death|8|||
155277940|NCT01848834|560451059|FG004|Overall Study|Death|27|||
155277941|NCT01848834|560451055|FG000|Overall Study|Excluded Medication|5|||
155277942|NCT01848834|560451056|FG001|Overall Study|Excluded Medication|4|||
155277943|NCT01848834|560451057|FG002|Overall Study|Excluded Medication|3|||
155277944|NCT01848834|560451058|FG003|Overall Study|Excluded Medication|6|||
155277945|NCT01848834|560451059|FG004|Overall Study|Excluded Medication|6|||
155277946|NCT01848834|560451055|FG000|Overall Study|Lost to Follow-up|5|||
155277947|NCT01848834|560451056|FG001|Overall Study|Lost to Follow-up|5|||
155277948|NCT01848834|560451057|FG002|Overall Study|Lost to Follow-up|3|||
155277949|NCT01848834|560451058|FG003|Overall Study|Lost to Follow-up|0|||
155277950|NCT01848834|560451059|FG004|Overall Study|Lost to Follow-up|3|||
155277951|NCT01848834|560451055|FG000|Overall Study|Physician Decision|1|||
155277952|NCT01848834|560451056|FG001|Overall Study|Physician Decision|3|||
155277953|NCT01848834|560451057|FG002|Overall Study|Physician Decision|4|||
155277954|NCT01848834|560451058|FG003|Overall Study|Physician Decision|0|||
155277955|NCT01848834|560451059|FG004|Overall Study|Physician Decision|11|||
155277956|NCT01848834|560451055|FG000|Overall Study|Protocol Violation|0|||
155277957|NCT01848834|560451056|FG001|Overall Study|Protocol Violation|0|||
155277958|NCT01848834|560451057|FG002|Overall Study|Protocol Violation|0|||
155277959|NCT01848834|560451058|FG003|Overall Study|Protocol Violation|0|||
155277960|NCT01848834|560451059|FG004|Overall Study|Protocol Violation|1|||
155277961|NCT01848834|560451055|FG000|Overall Study|Sponsor Decision|1|||
155277962|NCT01848834|560451056|FG001|Overall Study|Sponsor Decision|1|||
155277963|NCT01848834|560451057|FG002|Overall Study|Sponsor Decision|0|||
155277964|NCT01848834|560451058|FG003|Overall Study|Sponsor Decision|1|||
155277965|NCT01848834|560451059|FG004|Overall Study|Sponsor Decision|1|||
155277966|NCT01848834|560451055|FG000|Overall Study|Withdrawal by Subject|2|||
155277967|NCT01848834|560451056|FG001|Overall Study|Withdrawal by Subject|13|||
155277968|NCT01848834|560451057|FG002|Overall Study|Withdrawal by Subject|10|||
155277969|NCT01848834|560451058|FG003|Overall Study|Withdrawal by Subject|6|||
155277970|NCT01848834|560451059|FG004|Overall Study|Withdrawal by Subject|36|||
155277971|NCT01513967|560451074|FG000|Overall Study|Pregnancy|0|||
155277972|NCT01513967|560451075|FG001|Overall Study|Pregnancy|0|||
155277973|NCT01513967|560451076|FG002|Overall Study|Pregnancy|0|||
154941058|NCT01405820|559210040|FG000|Randomized Treatment Period|Adverse Event|3|||
154941059|NCT01405820|559210041|FG001|Randomized Treatment Period|Adverse Event|3|||
154941060|NCT01405820|559210042|FG002|Randomized Treatment Period|Adverse Event|3|||
154941061|NCT01405820|559210043|FG003|Randomized Treatment Period|Adverse Event|0|||
154941062|NCT01405820|559210044|FG004|Randomized Treatment Period|Adverse Event|2|||
154941063|NCT01405820|559210045|FG005|Randomized Treatment Period|Adverse Event|1|||
154941064|NCT01405820|559210040|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
154941065|NCT01405820|559210041|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
154941066|NCT01405820|559210042|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
155277974|NCT01513967|560451077|FG003|Overall Study|Pregnancy|0|||
155277975|NCT01513967|560451078|FG004|Overall Study|Pregnancy|0|||
155277976|NCT01513967|560451079|FG005|Overall Study|Pregnancy|0|||
155277977|NCT01513967|560451080|FG006|Overall Study|Pregnancy|1|||
155277978|NCT01513967|560451081|FG007|Overall Study|Pregnancy|0|||
155277979|NCT01513967|560451074|FG000|Overall Study|missed a study visit|0|||
155277980|NCT01513967|560451075|FG001|Overall Study|missed a study visit|0|||
154941067|NCT01405820|559210043|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
154941068|NCT01405820|559210044|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
155277981|NCT01513967|560451076|FG002|Overall Study|missed a study visit|0|||
155277982|NCT01513967|560451077|FG003|Overall Study|missed a study visit|0|||
155277983|NCT01513967|560451078|FG004|Overall Study|missed a study visit|0|||
155277984|NCT01513967|560451079|FG005|Overall Study|missed a study visit|0|||
155277985|NCT01513967|560451080|FG006|Overall Study|missed a study visit|1|||
155277986|NCT01513967|560451081|FG007|Overall Study|missed a study visit|0|||
155277987|NCT01513967|560451074|FG000|Overall Study|excluded due to positive drug screen|0|||
154941069|NCT01405820|559210045|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
154941070|NCT01405820|559210040|FG000|Randomized Treatment Period|Other|2|||
154941071|NCT01405820|559210041|FG001|Randomized Treatment Period|Other|2|||
154941072|NCT01405820|559210042|FG002|Randomized Treatment Period|Other|1|||
154941073|NCT01405820|559210043|FG003|Randomized Treatment Period|Other|1|||
154941074|NCT01405820|559210044|FG004|Randomized Treatment Period|Other|0|||
154941075|NCT01405820|559210045|FG005|Randomized Treatment Period|Other|0|||
154941076|NCT01405820|559210040|FG000|Randomized Treatment Period|Physician Decision|0|||
154941077|NCT01405820|559210041|FG001|Randomized Treatment Period|Physician Decision|2|||
154941078|NCT01405820|559210042|FG002|Randomized Treatment Period|Physician Decision|1|||
154941079|NCT01405820|559210043|FG003|Randomized Treatment Period|Physician Decision|0|||
154941080|NCT01405820|559210044|FG004|Randomized Treatment Period|Physician Decision|0|||
154941081|NCT01405820|559210045|FG005|Randomized Treatment Period|Physician Decision|0|||
154941082|NCT01405820|559210040|FG000|Randomized Treatment Period|Rescue|0|||
154941083|NCT01405820|559210041|FG001|Randomized Treatment Period|Rescue|1|||
154941084|NCT01405820|559210042|FG002|Randomized Treatment Period|Rescue|13|||
154941085|NCT01405820|559210043|FG003|Randomized Treatment Period|Rescue|10|||
154941086|NCT01405820|559210044|FG004|Randomized Treatment Period|Rescue|8|||
154941087|NCT01405820|559210045|FG005|Randomized Treatment Period|Rescue|8|||
155382129|NCT01535560|560833283|FG000|Overall Study|Lost to Follow-up|1|||
155382130|NCT01535560|560833284|FG001|Overall Study|Lost to Follow-up|3|||
155382131|NCT01535560|560833283|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
155382132|NCT01535560|560833284|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
155382133|NCT01535560|560833283|FG000|Overall Study|Treatment Failure|21|||
155382134|NCT01535560|560833284|FG001|Overall Study|Treatment Failure|83|||
155382135|NCT01535560|560833283|FG000|Overall Study|Other|0|||
154941088|NCT01405820|559210040|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
154941089|NCT01405820|559210041|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
155382136|NCT01535560|560833284|FG001|Overall Study|Other|1|||
154941090|NCT01405820|559210042|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
154941091|NCT01405820|559210043|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
154941092|NCT01405820|559210044|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
154941093|NCT01405820|559210045|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
155382137|NCT01535560|560833283|FG000|Overall Study|Randomized in Error|0|||
155382138|NCT01535560|560833284|FG001|Overall Study|Randomized in Error|1|||
154941094|NCT01405820|559210040|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
154941095|NCT01405820|559210041|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
154941096|NCT01405820|559210042|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
154941097|NCT01405820|559210043|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
154941098|NCT01405820|559210044|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
154941099|NCT01405820|559210045|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
154941100|NCT01405820|559210040|FG000|Randomized Treatment Period|Death|0|||
154941101|NCT01405820|559210041|FG001|Randomized Treatment Period|Death|0|||
155382139|NCT02009761|560833285|FG000|Overall Study|Adverse Event|4|||
155382140|NCT02842827|560833288|FG000|Overall Study|Adverse Event|0|||
155382141|NCT02842827|560833289|FG001|Overall Study|Adverse Event|1|||
155382142|NCT02842827|560833290|FG002|Overall Study|Adverse Event|0|||
155382143|NCT02842827|560833291|FG003|Overall Study|Adverse Event|1|||
155382144|NCT02842827|560833292|FG004|Overall Study|Adverse Event|0|||
155382145|NCT02842827|560833293|FG005|Overall Study|Adverse Event|1|||
155382146|NCT02842827|560833294|FG006|Overall Study|Adverse Event|0|||
155382147|NCT02842827|560833295|FG007|Overall Study|Adverse Event|0|||
155382148|NCT02842827|560833288|FG000|Overall Study|Death|1|||
155382149|NCT02842827|560833289|FG001|Overall Study|Death|0|||
155382150|NCT02842827|560833290|FG002|Overall Study|Death|2|||
155382151|NCT02842827|560833291|FG003|Overall Study|Death|3|||
155382152|NCT02842827|560833292|FG004|Overall Study|Death|2|||
155382153|NCT02842827|560833293|FG005|Overall Study|Death|1|||
154941102|NCT01405820|559210042|FG002|Randomized Treatment Period|Death|0|||
154941103|NCT01405820|559210043|FG003|Randomized Treatment Period|Death|1|||
154941104|NCT01405820|559210044|FG004|Randomized Treatment Period|Death|0|||
154941105|NCT01405820|559210045|FG005|Randomized Treatment Period|Death|0|||
154941106|NCT01405820|559210040|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
154941107|NCT01405820|559210041|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
154941108|NCT01405820|559210042|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155043722|NCT00770913|559590197|FG001|Overall Study|Refusal to continue participation|4|||
154941109|NCT01405820|559210043|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
155382154|NCT02842827|560833294|FG006|Overall Study|Death|0|||
155382155|NCT02842827|560833295|FG007|Overall Study|Death|4|||
154941110|NCT01405820|559210044|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
155382156|NCT02842827|560833288|FG000|Overall Study|Physician Decision|1|||
155382157|NCT02842827|560833289|FG001|Overall Study|Physician Decision|3|||
155382158|NCT02842827|560833290|FG002|Overall Study|Physician Decision|0|||
155382159|NCT02842827|560833291|FG003|Overall Study|Physician Decision|0|||
155382160|NCT02842827|560833292|FG004|Overall Study|Physician Decision|1|||
155382161|NCT02842827|560833293|FG005|Overall Study|Physician Decision|4|||
155382162|NCT02842827|560833294|FG006|Overall Study|Physician Decision|2|||
155382163|NCT02842827|560833295|FG007|Overall Study|Physician Decision|1|||
155382164|NCT02842827|560833288|FG000|Overall Study|Protocol Defined Disease Progression|0|||
155382165|NCT02842827|560833289|FG001|Overall Study|Protocol Defined Disease Progression|0|||
155382166|NCT02842827|560833290|FG002|Overall Study|Protocol Defined Disease Progression|0|||
155382167|NCT02842827|560833291|FG003|Overall Study|Protocol Defined Disease Progression|0|||
155382168|NCT02842827|560833292|FG004|Overall Study|Protocol Defined Disease Progression|0|||
155382169|NCT02842827|560833293|FG005|Overall Study|Protocol Defined Disease Progression|1|||
155382170|NCT02842827|560833294|FG006|Overall Study|Protocol Defined Disease Progression|0|||
155382171|NCT02842827|560833295|FG007|Overall Study|Protocol Defined Disease Progression|0|||
155382172|NCT02842827|560833288|FG000|Overall Study|Participant Withdrawal of Consent|1|||
155382173|NCT02842827|560833289|FG001|Overall Study|Participant Withdrawal of Consent|2|||
155382174|NCT02842827|560833290|FG002|Overall Study|Participant Withdrawal of Consent|2|||
155382175|NCT02842827|560833291|FG003|Overall Study|Participant Withdrawal of Consent|2|||
155382176|NCT02842827|560833292|FG004|Overall Study|Participant Withdrawal of Consent|2|||
155382177|NCT02842827|560833293|FG005|Overall Study|Participant Withdrawal of Consent|1|||
155382178|NCT02842827|560833294|FG006|Overall Study|Participant Withdrawal of Consent|2|||
155382179|NCT02842827|560833295|FG007|Overall Study|Participant Withdrawal of Consent|1|||
155382180|NCT00825825|560833296|FG000|First Medication Period (14 Days)|Adverse Event|1|||
155382181|NCT00825825|560833297|FG001|First Medication Period (14 Days)|Adverse Event|0|||
155382182|NCT00825825|560833298|FG002|First Medication Period (14 Days)|Adverse Event|0|||
155382183|NCT00825825|560833299|FG003|First Medication Period (14 Days)|Adverse Event|0|||
155382184|NCT00825825|560833300|FG004|First Medication Period (14 Days)|Adverse Event|0|||
155382185|NCT00825825|560833301|FG005|First Medication Period (14 Days)|Adverse Event|1|||
155382186|NCT00825825|560833296|FG000|First Medication Period (14 Days)|Physician Decision|2|||
155382187|NCT00825825|560833297|FG001|First Medication Period (14 Days)|Physician Decision|0|||
155382188|NCT00825825|560833298|FG002|First Medication Period (14 Days)|Physician Decision|1|||
155382189|NCT00825825|560833299|FG003|First Medication Period (14 Days)|Physician Decision|0|||
155382190|NCT00825825|560833300|FG004|First Medication Period (14 Days)|Physician Decision|0|||
155382191|NCT00825825|560833301|FG005|First Medication Period (14 Days)|Physician Decision|1|||
155382192|NCT00825825|560833296|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
155382193|NCT00825825|560833297|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
155382194|NCT00825825|560833298|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
155382195|NCT00825825|560833299|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
155382196|NCT00825825|560833300|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
155382197|NCT00825825|560833301|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
155382198|NCT00825825|560833296|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
155382199|NCT00825825|560833297|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
155382200|NCT00825825|560833298|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
155382201|NCT00825825|560833299|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
155382202|NCT00825825|560833300|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
155043723|NCT00770913|559590198|FG002|Overall Study|Refusal to continue participation|5|||
155043724|NCT00770913|559590196|FG000|Overall Study|Physician Decision|0|||
155043725|NCT00770913|559590197|FG001|Overall Study|Physician Decision|1|||
155043726|NCT00770913|559590198|FG002|Overall Study|Physician Decision|1|||
155043727|NCT00770913|559590196|FG000|Overall Study|Protocol Violation|3|||
155043728|NCT00770913|559590197|FG001|Overall Study|Protocol Violation|0|||
155043729|NCT00770913|559590198|FG002|Overall Study|Protocol Violation|1|||
155043730|NCT00770913|559590196|FG000|Overall Study|Incorrect drug was allocated|1|||
155043731|NCT00770913|559590197|FG001|Overall Study|Incorrect drug was allocated|0|||
155043732|NCT00770913|559590198|FG002|Overall Study|Incorrect drug was allocated|0|||
155043733|NCT02347072|559590199|FG000|Overall Study|Adverse Event|2|||
155382203|NCT00825825|560833301|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
155382204|NCT00825825|560833296|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
154941111|NCT01405820|559210045|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
154941112|NCT01405820|559210040|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
154941113|NCT01405820|559210041|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
154941114|NCT01405820|559210042|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
154941115|NCT01405820|559210043|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
154941116|NCT01405820|559210044|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
154941117|NCT01405820|559210045|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
154941118|NCT01405820|559210040|FG000|Open-Label Treatment Period|Other|1|||
154941119|NCT01405820|559210041|FG001|Open-Label Treatment Period|Other|1|||
154941120|NCT01405820|559210042|FG002|Open-Label Treatment Period|Other|1|||
154941121|NCT01405820|559210043|FG003|Open-Label Treatment Period|Other|1|||
155382205|NCT00825825|560833297|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
154941122|NCT01405820|559210044|FG004|Open-Label Treatment Period|Other|1|||
155382206|NCT00825825|560833298|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
155382207|NCT00825825|560833299|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
155382208|NCT00825825|560833300|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
154941123|NCT01405820|559210045|FG005|Open-Label Treatment Period|Other|1|||
154941124|NCT01405820|559210040|FG000|Open-Label Treatment Period|Physician Decision|0|||
154941125|NCT01405820|559210041|FG001|Open-Label Treatment Period|Physician Decision|0|||
154941126|NCT01405820|559210042|FG002|Open-Label Treatment Period|Physician Decision|1|||
154941127|NCT01405820|559210043|FG003|Open-Label Treatment Period|Physician Decision|2|||
154941128|NCT01405820|559210044|FG004|Open-Label Treatment Period|Physician Decision|1|||
154941129|NCT01405820|559210045|FG005|Open-Label Treatment Period|Physician Decision|0|||
154941130|NCT01405820|559210040|FG000|Open-Label Treatment Period|Adverse Event|0|||
154941131|NCT01405820|559210041|FG001|Open-Label Treatment Period|Adverse Event|0|||
154941132|NCT01405820|559210042|FG002|Open-Label Treatment Period|Adverse Event|0|||
154941133|NCT01405820|559210043|FG003|Open-Label Treatment Period|Adverse Event|1|||
154941134|NCT01405820|559210044|FG004|Open-Label Treatment Period|Adverse Event|0|||
154941135|NCT01405820|559210045|FG005|Open-Label Treatment Period|Adverse Event|0|||
154941136|NCT03255031|559210050|FG000|Overall Study|Adverse Event|5|||
154941137|NCT03255031|559210051|FG001|Overall Study|Adverse Event|3|||
154941138|NCT03255031|559210050|FG000|Overall Study|Physician Decision|2|||
154941139|NCT03255031|559210051|FG001|Overall Study|Physician Decision|1|||
154941140|NCT03255031|559210050|FG000|Overall Study|Withdrawal by Subject|9|||
154941141|NCT03255031|559210051|FG001|Overall Study|Withdrawal by Subject|3|||
154941142|NCT01092702|559210052|FG000|Overall Study|Withdrawal by Subject|7|||
154941143|NCT01092702|559210052|FG000|Overall Study|Lost to Follow-up|2|||
154941144|NCT01841359|559210055|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
154941145|NCT01841359|559210055|FG000|Overall Study|Concommitant medical issues|2|||
154941146|NCT01841359|559210055|FG000|Overall Study|Adverse Event|3|||
155277988|NCT01513967|560451075|FG001|Overall Study|excluded due to positive drug screen|0|||
155277989|NCT01513967|560451076|FG002|Overall Study|excluded due to positive drug screen|0|||
155277990|NCT01513967|560451077|FG003|Overall Study|excluded due to positive drug screen|0|||
155277991|NCT01513967|560451078|FG004|Overall Study|excluded due to positive drug screen|0|||
155277992|NCT01513967|560451079|FG005|Overall Study|excluded due to positive drug screen|0|||
155277993|NCT01513967|560451080|FG006|Overall Study|excluded due to positive drug screen|0|||
155277994|NCT01513967|560451081|FG007|Overall Study|excluded due to positive drug screen|2|||
154941147|NCT01841359|559210055|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
154941148|NCT02168270|559210056|FG000|Overall Study|Lack of Efficacy|4|||
154941149|NCT00706706|559210057|FG000|Overall Study|Death|53|||
154941150|NCT00706706|559210057|FG000|Overall Study|Lost to Follow-up|7|||
154941151|NCT00706706|559210057|FG000|Overall Study|Study endpoint had reached|45|||
154941152|NCT00291330|559210058|FG000|Overall Study|Adverse Event|47|||
154941153|NCT00291330|559210059|FG001|Overall Study|Adverse Event|40|||
154941154|NCT00291330|559210058|FG000|Overall Study|Protocol Violation|13|||
154941155|NCT00291330|559210059|FG001|Overall Study|Protocol Violation|20|||
154941156|NCT00291330|559210058|FG000|Overall Study|Lost to Follow-up|16|||
154941157|NCT00291330|559210059|FG001|Overall Study|Lost to Follow-up|11|||
154941158|NCT00291330|559210058|FG000|Overall Study|Withdrawal by Subject|22|||
154941159|NCT00291330|559210059|FG001|Overall Study|Withdrawal by Subject|25|||
154941160|NCT00291330|559210058|FG000|Overall Study|Other|3|||
155277995|NCT01513967|560451074|FG000|Overall Study|Physician Decision|0|||
155277996|NCT01513967|560451075|FG001|Overall Study|Physician Decision|0|||
154941161|NCT00291330|559210059|FG001|Overall Study|Other|1|||
154941162|NCT02629965|559210062|FG000|Period 1|Adverse Event|1|||
155277997|NCT01513967|560451076|FG002|Overall Study|Physician Decision|0|||
155277998|NCT01513967|560451077|FG003|Overall Study|Physician Decision|0|||
155277999|NCT01513967|560451078|FG004|Overall Study|Physician Decision|0|||
155382209|NCT00825825|560833301|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
154941163|NCT02629965|559210063|FG001|Period 1|Adverse Event|0|||
154941164|NCT02629965|559210062|FG000|Period 1|Unexpected worsening of disease|2|||
154941165|NCT02629965|559210063|FG001|Period 1|Unexpected worsening of disease|0|||
154941166|NCT02629965|559210062|FG000|Period 1|Other than listed above|1|||
154941167|NCT02629965|559210063|FG001|Period 1|Other than listed above|2|||
154941168|NCT02629965|559210062|FG000|Period 2|Adverse Event|1|||
154941169|NCT02629965|559210063|FG001|Period 2|Adverse Event|0|||
154941170|NCT03443869|559210064|FG000|Overall Study|Death|3|||
154941171|NCT03443869|559210065|FG001|Overall Study|Death|3|||
154941172|NCT03443869|559210064|FG000|Overall Study|Withdrawal by Subject|34|||
154941173|NCT03443869|559210065|FG001|Overall Study|Withdrawal by Subject|22|||
154941174|NCT03443869|559210064|FG000|Overall Study|Lost to Follow-up|1|||
154941175|NCT03443869|559210065|FG001|Overall Study|Lost to Follow-up|2|||
154941176|NCT03443869|559210064|FG000|Overall Study|Physician Decision|3|||
155382210|NCT00825825|560833296|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
154941177|NCT03443869|559210065|FG001|Overall Study|Physician Decision|3|||
154941178|NCT03443869|559210064|FG000|Overall Study|Other|4|||
154941179|NCT03443869|559210065|FG001|Overall Study|Other|4|||
154941180|NCT02390219|559210066|FG000|Overall Study|Death|1|||
154941181|NCT02390219|559210066|FG000|Overall Study|Physician Decision|1|||
154941182|NCT02390219|559210066|FG000|Overall Study|Adverse Event|6|||
154941183|NCT02390219|559210066|FG000|Overall Study|Withdrawal by Subject|1|||
154941184|NCT02390219|559210066|FG000|Overall Study|Lost to Follow-up|2|||
154941185|NCT02390219|559210066|FG000|Overall Study|Other|2|||
154941186|NCT00299728|559210067|FG000|Overall Study|Lost to Follow-up|0|||
154941187|NCT00299728|559210068|FG001|Overall Study|Lost to Follow-up|1|||
154941188|NCT00299728|559210067|FG000|Overall Study|Withdrawal by Subject|0|||
154941189|NCT00299728|559210068|FG001|Overall Study|Withdrawal by Subject|1|||
154941190|NCT00299728|559210067|FG000|Overall Study|Progressive disease|0|||
154941191|NCT00299728|559210068|FG001|Overall Study|Progressive disease|1|||
154941192|NCT00580983|559210071|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
155043734|NCT02347072|559590199|FG000|Overall Study|Withdrawal by Subject|6|||
155043735|NCT02347072|559590199|FG000|Overall Study|Physician Decision|1|||
155043736|NCT02347072|559590199|FG000|Overall Study|Lost to Follow-up|2|||
155043737|NCT02347072|559590199|FG000|Overall Study|Protocol Violation|1|||
155043738|NCT02347072|559590199|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
155043739|NCT01134393|559590205|FG000|Overall Study|Adverse Event|18|||
155043740|NCT01134393|559590205|FG000|Overall Study|Lack of Efficacy|2|||
155043741|NCT01134393|559590205|FG000|Overall Study|Protocol Violation|12|||
155043742|NCT01134393|559590205|FG000|Overall Study|Lost to Follow-up|3|||
154941193|NCT01360632|559210072|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
154941194|NCT01360632|559210073|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
154941195|NCT01360632|559210074|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
154941196|NCT01360632|559210075|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
154941197|NCT01360632|559210076|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
154941198|NCT01360632|559210072|FG000|Phase A (8 Weeks)|Adverse Event|60|||
154941199|NCT01360632|559210073|FG001|Phase A (8 Weeks)|Adverse Event|0|||
154941200|NCT01360632|559210074|FG002|Phase A (8 Weeks)|Adverse Event|0|||
154941201|NCT01360632|559210075|FG003|Phase A (8 Weeks)|Adverse Event|0|||
154941202|NCT01360632|559210076|FG004|Phase A (8 Weeks)|Adverse Event|0|||
154941203|NCT01360632|559210072|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
154941204|NCT01360632|559210073|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
154941205|NCT01360632|559210074|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
154941206|NCT01360632|559210075|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
154941207|NCT01360632|559210076|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
154941208|NCT01360632|559210072|FG000|Phase A (8 Weeks)|Physician Decision|10|||
154941209|NCT01360632|559210073|FG001|Phase A (8 Weeks)|Physician Decision|0|||
154941210|NCT01360632|559210074|FG002|Phase A (8 Weeks)|Physician Decision|0|||
154941211|NCT01360632|559210075|FG003|Phase A (8 Weeks)|Physician Decision|0|||
154941212|NCT01360632|559210076|FG004|Phase A (8 Weeks)|Physician Decision|0|||
154941213|NCT01360632|559210072|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
154941214|NCT01360632|559210073|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
154941215|NCT01360632|559210074|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
154941216|NCT01360632|559210075|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
154941217|NCT01360632|559210076|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
154941218|NCT01360632|559210072|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
154941219|NCT01360632|559210073|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
154941220|NCT01360632|559210074|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
154941221|NCT01360632|559210075|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
154941222|NCT01360632|559210076|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
154941223|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
154941224|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
154941225|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
154941226|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
154941227|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
155043743|NCT01134393|559590205|FG000|Overall Study|Withdrawal by Subject|11|||
155043744|NCT01134393|559590205|FG000|Overall Study|Other|6|||
155043745|NCT01808222|559590209|FG000|Overall Study|mpMR scan was not performed|1|||
155043746|NCT00830518|559590215|FG000|Overall Study|Progressive Disease|18|||
155043747|NCT00830518|559590216|FG001|Overall Study|Progressive Disease|8|||
155043748|NCT00830518|559590215|FG000|Overall Study|Symptomatic Deterioration|4|||
155043749|NCT00830518|559590216|FG001|Overall Study|Symptomatic Deterioration|1|||
155043750|NCT00830518|559590215|FG000|Overall Study|Adverse Event|14|||
155043751|NCT00830518|559590216|FG001|Overall Study|Adverse Event|1|||
155043752|NCT00830518|559590215|FG000|Overall Study|Withdrawal by Patient|2|||
154941228|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Adverse Event|0|||
154941229|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Adverse Event|3|||
154941230|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Adverse Event|9|||
154941231|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Adverse Event|3|||
154941232|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Adverse Event|0|||
154941233|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
154941234|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155043753|NCT00830518|559590216|FG001|Overall Study|Withdrawal by Patient|0|||
155043754|NCT00830518|559590215|FG000|Overall Study|Reason not Specified|8|||
155043755|NCT00830518|559590216|FG001|Overall Study|Reason not Specified|1|||
154941235|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
155043756|NCT04318132|559590217|FG000|Overall Study|Protocol Violation|0|||
155043757|NCT04318132|559590218|FG001|Overall Study|Protocol Violation|0|||
155043758|NCT04318132|559590219|FG002|Overall Study|Protocol Violation|3|||
154941236|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
154941237|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
155043759|NCT04318132|559590220|FG003|Overall Study|Protocol Violation|0|||
155043760|NCT00586898|559590227|FG000|Overall Study|Adverse Event|1|||
155043761|NCT00586898|559590227|FG000|Overall Study|Patiemt Non-compliance|1|||
155043762|NCT00586898|559590227|FG000|Overall Study|Evaluable for Toxicity Only|5|||
155043763|NCT01994902|559590229|FG000|Test Period 1|Withdrawal by Subject|3|||
155043764|NCT01994902|559590230|FG001|Test Period 1|Withdrawal by Subject|0|||
155043765|NCT01994902|559590229|FG000|Test Period 1|device deficiency with adverse event|0|||
155043766|NCT01994902|559590230|FG001|Test Period 1|device deficiency with adverse event|1|||
155043767|NCT01994902|559590229|FG000|Test Period 1|Adverse Event|2|||
155043768|NCT01994902|559590230|FG001|Test Period 1|Adverse Event|1|||
155043769|NCT01994902|559590229|FG000|Test Period 1|Lack of Efficacy|0|||
155043770|NCT01994902|559590230|FG001|Test Period 1|Lack of Efficacy|1|||
155043771|NCT01994902|559590229|FG000|Test Period 1|bag too small|1|||
155043772|NCT01994902|559590230|FG001|Test Period 1|bag too small|0|||
155043773|NCT01994902|559590229|FG000|Test Period 2|Withdrawal by Subject|0|||
155043774|NCT01994902|559590230|FG001|Test Period 2|Withdrawal by Subject|2|||
155278000|NCT01513967|560451079|FG005|Overall Study|Physician Decision|1|||
155278001|NCT01513967|560451080|FG006|Overall Study|Physician Decision|0|||
155278002|NCT01513967|560451081|FG007|Overall Study|Physician Decision|0|||
154941238|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Physician Decision|0|||
154941239|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Physician Decision|0|||
154941240|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Physician Decision|0|||
154941241|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Physician Decision|1|||
154941242|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Physician Decision|0|||
154941243|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
154941244|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
154941245|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
154941246|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
154941247|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
154941248|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
154941249|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
154941250|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
154941251|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
154941252|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
154941253|NCT01360632|559210072|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
154941254|NCT01360632|559210073|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
154941255|NCT01360632|559210074|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
154941256|NCT01360632|559210075|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
154941257|NCT01360632|559210076|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
154941258|NCT01360632|559210072|FG000|Phase A+|Lost to Follow-up|0|||
154941259|NCT01360632|559210073|FG001|Phase A+|Lost to Follow-up|0|||
154941260|NCT01360632|559210074|FG002|Phase A+|Lost to Follow-up|0|||
154941261|NCT01360632|559210075|FG003|Phase A+|Lost to Follow-up|0|||
154941262|NCT01360632|559210076|FG004|Phase A+|Lost to Follow-up|2|||
154941263|NCT01360632|559210072|FG000|Phase A+|Adverse Event|0|||
154941264|NCT01360632|559210073|FG001|Phase A+|Adverse Event|0|||
154941265|NCT01360632|559210074|FG002|Phase A+|Adverse Event|0|||
154941266|NCT01360632|559210075|FG003|Phase A+|Adverse Event|0|||
154941267|NCT01360632|559210076|FG004|Phase A+|Adverse Event|2|||
154941268|NCT01360632|559210072|FG000|Phase A+|Met Withdrawal Criteria|0|||
154941269|NCT01360632|559210073|FG001|Phase A+|Met Withdrawal Criteria|0|||
154941270|NCT01360632|559210074|FG002|Phase A+|Met Withdrawal Criteria|0|||
154941271|NCT01360632|559210075|FG003|Phase A+|Met Withdrawal Criteria|0|||
154941272|NCT01360632|559210076|FG004|Phase A+|Met Withdrawal Criteria|7|||
154941273|NCT01360632|559210072|FG000|Phase A+|Physician Decision|0|||
154941274|NCT01360632|559210073|FG001|Phase A+|Physician Decision|0|||
154941275|NCT01360632|559210074|FG002|Phase A+|Physician Decision|0|||
154941276|NCT01360632|559210075|FG003|Phase A+|Physician Decision|0|||
154941277|NCT01360632|559210076|FG004|Phase A+|Physician Decision|3|||
154941278|NCT01360632|559210072|FG000|Phase A+|Withdrawal by Subject|0|||
154941279|NCT01360632|559210073|FG001|Phase A+|Withdrawal by Subject|0|||
154941280|NCT01360632|559210074|FG002|Phase A+|Withdrawal by Subject|0|||
154941281|NCT01360632|559210075|FG003|Phase A+|Withdrawal by Subject|0|||
154941282|NCT01360632|559210076|FG004|Phase A+|Withdrawal by Subject|8|||
154941283|NCT01360632|559210072|FG000|Phase A+|Protocol Deviation|0|||
154941284|NCT01360632|559210073|FG001|Phase A+|Protocol Deviation|0|||
154941285|NCT01360632|559210074|FG002|Phase A+|Protocol Deviation|0|||
154941286|NCT01360632|559210075|FG003|Phase A+|Protocol Deviation|0|||
154941287|NCT01360632|559210076|FG004|Phase A+|Protocol Deviation|3|||
154941288|NCT01298596|559210077|FG000|Overall Study|Withdrawal by Subject|1|||
155043775|NCT01994902|559590229|FG000|Test Period 2|Lack of Efficacy|0|||
155043776|NCT01994902|559590230|FG001|Test Period 2|Lack of Efficacy|1|||
155043777|NCT01994902|559590229|FG000|Test Period 2|Other|0|||
155278003|NCT02906202|560451082|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
154941289|NCT01298596|559210078|FG001|Overall Study|Withdrawal by Subject|1|||
154941290|NCT01298596|559210077|FG000|Overall Study|Death|5|||
154941291|NCT01298596|559210078|FG001|Overall Study|Death|3|||
154941292|NCT01298596|559210077|FG000|Overall Study|Lost to Follow-up|6|||
154941293|NCT01298596|559210078|FG001|Overall Study|Lost to Follow-up|14|||
154941294|NCT01298596|559210077|FG000|Overall Study|Referred for further management|16|||
154941295|NCT01298596|559210078|FG001|Overall Study|Referred for further management|15|||
154941296|NCT03740100|559210079|FG000|Overall Study|Adverse Event|1|||
154941297|NCT03740100|559210079|FG000|Overall Study|Death|1|||
154941298|NCT02046369|559210080|FG000|Overall Study|Adverse Event|3|||
154941299|NCT02046369|559210081|FG001|Overall Study|Adverse Event|3|||
154941300|NCT02046369|559210080|FG000|Overall Study|Lack of Efficacy|3|||
154941301|NCT02046369|559210081|FG001|Overall Study|Lack of Efficacy|3|||
154941302|NCT02046369|559210080|FG000|Overall Study|Lost to Follow-up|3|||
154941303|NCT02046369|559210081|FG001|Overall Study|Lost to Follow-up|3|||
154941304|NCT02046369|559210080|FG000|Overall Study|Protocol Violation|1|||
155278004|NCT01987830|560451083|FG000|Overall Study|Never received baseline scan|1|||
155278005|NCT01563978|560451086|FG000|Overall Study|Physician Decision|1|||
155278006|NCT01563978|560451087|FG001|Overall Study|Physician Decision|0|||
155278007|NCT01563978|560451086|FG000|Overall Study|Lost to Follow-up|1|||
155278008|NCT01563978|560451087|FG001|Overall Study|Lost to Follow-up|0|||
155278009|NCT01563978|560451086|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
155278010|NCT01563978|560451087|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
155278011|NCT01563978|560451086|FG000|Overall Study|Adverse Event|1|||
155278012|NCT01563978|560451087|FG001|Overall Study|Adverse Event|2|||
155278013|NCT05764239|560451088|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
155278014|NCT05764239|560451088|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
155278015|NCT05764239|560451088|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
155278016|NCT05764239|560451088|FG000|DEP (Part 1)|Adverse Event|1|||
155278017|NCT05764239|560451088|FG000|DEP (Part 1)|Lost to Follow-up|1|||
155278018|NCT05764239|560451088|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
155278019|NCT05764239|560451088|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
155278020|NCT05764239|560451088|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
155278021|NCT05764239|560451088|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
155278022|NCT00057811|560451090|FG000|Overall Study|Lack of Efficacy|1|||
155278023|NCT00057811|560451091|FG001|Overall Study|Lack of Efficacy|4|||
155278024|NCT00057811|560451090|FG000|Overall Study|Physician Decision|1|||
155278025|NCT00057811|560451091|FG001|Overall Study|Physician Decision|0|||
155278026|NCT00057811|560451090|FG000|Overall Study|Withdrawal by Subject|3|||
155278027|NCT00057811|560451091|FG001|Overall Study|Withdrawal by Subject|4|||
155278028|NCT00057811|560451090|FG000|Overall Study|Ineligible|4|||
155278029|NCT00057811|560451091|FG001|Overall Study|Ineligible|2|||
155278030|NCT00057811|560451090|FG000|Overall Study|Inevaluable|1|||
155278031|NCT00057811|560451091|FG001|Overall Study|Inevaluable|2|||
155278032|NCT00556374|560451092|FG000|Overall Study|Withdrawal by Subject|235|||
155278033|NCT00556374|560451093|FG001|Overall Study|Withdrawal by Subject|205|||
155278034|NCT00556374|560451092|FG000|Overall Study|Death|158|||
155278035|NCT00556374|560451093|FG001|Overall Study|Death|127|||
155278036|NCT00556374|560451092|FG000|Overall Study|Lost to Follow-up|24|||
155278037|NCT00556374|560451093|FG001|Overall Study|Lost to Follow-up|17|||
155278038|NCT00556374|560451092|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
155278039|NCT00556374|560451093|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
155278040|NCT04131907|560451094|FG000|Overall Study|Adverse Event|2|||
155278041|NCT04131907|560451095|FG001|Overall Study|Adverse Event|0|||
155278042|NCT04131907|560451096|FG002|Overall Study|Adverse Event|0|||
155278043|NCT04131907|560451094|FG000|Overall Study|Physician Decision|4|||
155278044|NCT04131907|560451095|FG001|Overall Study|Physician Decision|22|||
155278045|NCT04131907|560451096|FG002|Overall Study|Physician Decision|0|||
155278046|NCT04131907|560451094|FG000|Overall Study|Withdrawal by Subject|2|||
155278047|NCT04131907|560451095|FG001|Overall Study|Withdrawal by Subject|0|||
155278048|NCT04131907|560451096|FG002|Overall Study|Withdrawal by Subject|1|||
155278049|NCT04131907|560451094|FG000|Overall Study|Treatment failure|2|||
155278050|NCT04131907|560451095|FG001|Overall Study|Treatment failure|0|||
155043778|NCT01994902|559590230|FG001|Test Period 2|Other|3|||
155043779|NCT01085084|559590231|FG000|Overall Study|Withdrawal by Subject|1|||
154941305|NCT02046369|559210081|FG001|Overall Study|Protocol Violation|2|||
154941306|NCT02046369|559210080|FG000|Overall Study|Withdrawal by Subject|3|||
154941307|NCT02046369|559210081|FG001|Overall Study|Withdrawal by Subject|6|||
155043780|NCT01085084|559590232|FG001|Overall Study|Withdrawal by Subject|0|||
155043781|NCT01085084|559590233|FG002|Overall Study|Withdrawal by Subject|0|||
155043782|NCT01085084|559590231|FG000|Overall Study|Lost to Follow-up|2|||
154941308|NCT02046369|559210080|FG000|Overall Study|never received study drug|0|||
155043783|NCT01085084|559590232|FG001|Overall Study|Lost to Follow-up|1|||
155043784|NCT01085084|559590233|FG002|Overall Study|Lost to Follow-up|1|||
155278051|NCT04131907|560451096|FG002|Overall Study|Treatment failure|1|||
155278052|NCT05294419|560451097|FG000|Overall Study|Protocol Violation|4|||
155278053|NCT05294419|560451098|FG001|Overall Study|Protocol Violation|0|||
155278054|NCT05294419|560451099|FG002|Overall Study|Protocol Violation|0|||
155278055|NCT05294419|560451097|FG000|Overall Study|Lost to Follow-up|6|||
155278056|NCT05294419|560451098|FG001|Overall Study|Lost to Follow-up|0|||
155278057|NCT05294419|560451099|FG002|Overall Study|Lost to Follow-up|0|||
155278058|NCT05294419|560451097|FG000|Overall Study|Results voided after publishing|2|||
155278059|NCT05294419|560451098|FG001|Overall Study|Results voided after publishing|0|||
154941309|NCT02046369|559210081|FG001|Overall Study|never received study drug|1|||
154941310|NCT02046369|559210080|FG000|Overall Study|non compliance|1|||
154941311|NCT02046369|559210081|FG001|Overall Study|non compliance|0|||
154941312|NCT03120520|559210082|FG000|Overall Study|Lost to Follow-up|1|||
154941313|NCT03120520|559210083|FG001|Overall Study|Lost to Follow-up|1|||
154941314|NCT03120520|559210084|FG002|Overall Study|Lost to Follow-up|1|||
154941315|NCT03120520|559210085|FG003|Overall Study|Lost to Follow-up|1|||
154941316|NCT03120520|559210082|FG000|Overall Study|Withdrawal by Subject|3|||
154941317|NCT03120520|559210083|FG001|Overall Study|Withdrawal by Subject|2|||
154941318|NCT03120520|559210084|FG002|Overall Study|Withdrawal by Subject|3|||
154941319|NCT03120520|559210085|FG003|Overall Study|Withdrawal by Subject|2|||
154941320|NCT03120520|559210082|FG000|Overall Study|Other|0|||
154941321|NCT03120520|559210083|FG001|Overall Study|Other|1|||
154941322|NCT03120520|559210084|FG002|Overall Study|Other|0|||
154941323|NCT03120520|559210085|FG003|Overall Study|Other|0|||
154941324|NCT03387059|559210086|FG000|Overall Study|Study termination|5|||
154941325|NCT03387059|559210087|FG001|Overall Study|Study termination|4|||
154941326|NCT01715415|559210096|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
154941327|NCT01715415|559210097|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
154941328|NCT01715415|559210096|FG000|Double-blind Treatment|Adverse Event|3|||
154941329|NCT01715415|559210097|FG001|Double-blind Treatment|Adverse Event|0|||
154941330|NCT01715415|559210096|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
154941331|NCT01715415|559210097|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
154941332|NCT01715415|559210096|FG000|Double-blind Treatment|Other|1|||
154941333|NCT01715415|559210097|FG001|Double-blind Treatment|Other|0|||
154941334|NCT01715415|559210096|FG000|Open-label Treatment|Adverse Event|0|||
154941335|NCT01715415|559210097|FG001|Open-label Treatment|Adverse Event|1|||
154941336|NCT01715415|559210096|FG000|Open-label Treatment|Subject Noncompliant|0|||
154941337|NCT01715415|559210097|FG001|Open-label Treatment|Subject Noncompliant|1|||
154941338|NCT01466686|559211827|FG000|Overall Study|Withdrawal by Subject|1|||
154941339|NCT03273387|559211828|FG000|Overall Study|Death|2|||
154941340|NCT03273387|559211829|FG001|Overall Study|Death|2|||
154941341|NCT03273387|559211828|FG000|Overall Study|Withdrawal by Subject|1|||
154941342|NCT03273387|559211829|FG001|Overall Study|Withdrawal by Subject|1|||
154941343|NCT02884206|559211837|FG000|Valsartan Run-in Period|Death|1|||
154941344|NCT02884206|559211838|FG001|Valsartan Run-in Period|Death|0|||
154941345|NCT02884206|559211839|FG002|Valsartan Run-in Period|Death|0|||
154941346|NCT02884206|559211837|FG000|Valsartan Run-in Period|Adverse Event|31|||
154941347|NCT02884206|559211838|FG001|Valsartan Run-in Period|Adverse Event|0|||
154941348|NCT02884206|559211839|FG002|Valsartan Run-in Period|Adverse Event|0|||
154941349|NCT02884206|559211837|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
154941350|NCT02884206|559211838|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
154941351|NCT02884206|559211839|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
154941352|NCT02884206|559211837|FG000|Valsartan Run-in Period|Protocol deviation|4|||
154941353|NCT02884206|559211838|FG001|Valsartan Run-in Period|Protocol deviation|0|||
154941354|NCT02884206|559211839|FG002|Valsartan Run-in Period|Protocol deviation|0|||
154941355|NCT02884206|559211837|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
154941356|NCT02884206|559211838|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
154941357|NCT02884206|559211839|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
154941358|NCT02884206|559211837|FG000|Valsartan Run-in Period|Physician Decision|1|||
154941359|NCT02884206|559211838|FG001|Valsartan Run-in Period|Physician Decision|0|||
154941360|NCT02884206|559211839|FG002|Valsartan Run-in Period|Physician Decision|0|||
154941361|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Adverse Event|38|||
154941362|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Adverse Event|0|||
154941363|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Adverse Event|0|||
154941364|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Death|2|||
154941365|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Death|0|||
154941366|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Death|0|||
154941367|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
154941368|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
154941369|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
154941370|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
154941371|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
154941372|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
154941373|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
154941374|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
154941375|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
154941376|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Physician Decision|1|||
154941377|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Physician Decision|0|||
154941378|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Physician Decision|0|||
154941379|NCT02884206|559211837|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
154941380|NCT02884206|559211838|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
154941381|NCT02884206|559211839|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
154941382|NCT02884206|559211837|FG000|Double-Blind Period|Death|0|||
155043785|NCT01085084|559590231|FG000|Overall Study|Adverse Event|4|||
155043786|NCT01085084|559590232|FG001|Overall Study|Adverse Event|3|||
155043787|NCT01085084|559590233|FG002|Overall Study|Adverse Event|6|||
155043788|NCT01085084|559590231|FG000|Overall Study|Treatment Failure|0|||
155043789|NCT01085084|559590232|FG001|Overall Study|Treatment Failure|1|||
155043790|NCT01085084|559590233|FG002|Overall Study|Treatment Failure|2|||
155043791|NCT01905592|559590234|FG000|Overall Study|Disease Progression|51|||
155043792|NCT01905592|559590235|FG001|Overall Study|Disease Progression|110|||
155043793|NCT01905592|559590234|FG000|Overall Study|Toxicity|1|||
155043794|NCT01905592|559590235|FG001|Overall Study|Toxicity|16|||
155043795|NCT01905592|559590234|FG000|Overall Study|Physician Decision|0|||
155043796|NCT01905592|559590235|FG001|Overall Study|Physician Decision|2|||
155043797|NCT01905592|559590234|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
155043798|NCT01905592|559590235|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
155043799|NCT01905592|559590234|FG000|Overall Study|Protocol Violation|0|||
155043800|NCT01905592|559590235|FG001|Overall Study|Protocol Violation|1|||
155043801|NCT01905592|559590234|FG000|Overall Study|Sponsor's decision|1|||
155043802|NCT01905592|559590235|FG001|Overall Study|Sponsor's decision|1|||
155043803|NCT01905592|559590234|FG000|Overall Study|Not treated|7|||
155043804|NCT01905592|559590235|FG001|Overall Study|Not treated|3|||
155043805|NCT01905592|559590234|FG000|Overall Study|Withdrawal by Subject|10|||
155043806|NCT01905592|559590235|FG001|Overall Study|Withdrawal by Subject|2|||
155043807|NCT01483599|559590236|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
155043808|NCT01483599|559590237|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043809|NCT01483599|559590238|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043810|NCT01483599|559590239|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
155043811|NCT01483599|559590240|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
155043812|NCT01483599|559590241|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
155043813|NCT01483599|559590242|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
155043814|NCT01483599|559590243|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043815|NCT01483599|559590244|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043816|NCT01483599|559590245|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043817|NCT01483599|559590246|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043818|NCT01483599|559590247|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043819|NCT01483599|559590248|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043820|NCT01483599|559590249|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
155043821|NCT01483599|559590236|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043822|NCT01483599|559590237|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
155043823|NCT01483599|559590238|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043824|NCT01483599|559590239|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
155043825|NCT01483599|559590240|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043826|NCT01483599|559590241|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043827|NCT01483599|559590242|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
155043828|NCT01483599|559590243|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043829|NCT01483599|559590244|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043830|NCT01483599|559590245|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043831|NCT01483599|559590246|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043832|NCT01483599|559590247|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043833|NCT01483599|559590248|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043834|NCT01483599|559590249|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
155043835|NCT01483599|559590236|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
155043836|NCT01483599|559590237|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043837|NCT01483599|559590238|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043838|NCT01483599|559590239|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043839|NCT01483599|559590240|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043840|NCT01483599|559590241|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043841|NCT01483599|559590242|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043842|NCT01483599|559590243|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043843|NCT01483599|559590244|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043844|NCT01483599|559590245|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
154941383|NCT02884206|559211838|FG001|Double-Blind Period|Death|28|||
154941384|NCT02884206|559211839|FG002|Double-Blind Period|Death|39|||
154941385|NCT02884206|559211837|FG000|Double-Blind Period|Patient/guardian decision|0|||
154941386|NCT02884206|559211838|FG001|Double-Blind Period|Patient/guardian decision|10|||
154941387|NCT02884206|559211839|FG002|Double-Blind Period|Patient/guardian decision|13|||
154941388|NCT02884206|559211837|FG000|Double-Blind Period|Lost to Follow-up|0|||
154941389|NCT02884206|559211838|FG001|Double-Blind Period|Lost to Follow-up|4|||
155043845|NCT01483599|559590246|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043846|NCT01483599|559590247|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155153051|NCT00419393|559998524|FG000|Overall Study|Protocol Violation|5|||
154941390|NCT02884206|559211839|FG002|Double-Blind Period|Lost to Follow-up|4|||
154941391|NCT02884206|559211837|FG000|Double-Blind Period|Physician Decision|0|||
155043847|NCT01483599|559590248|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043848|NCT01483599|559590249|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
155043849|NCT01483599|559590236|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
155043850|NCT01483599|559590237|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
155043851|NCT01483599|559590238|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
155043852|NCT01483599|559590239|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
155043853|NCT01483599|559590240|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
155043854|NCT01483599|559590241|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
155043855|NCT01483599|559590242|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
155043856|NCT01483599|559590243|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
155043857|NCT01483599|559590244|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
155043858|NCT01483599|559590245|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
155043859|NCT01483599|559590246|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
155043860|NCT01483599|559590247|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
155043861|NCT01483599|559590248|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
155043862|NCT01483599|559590249|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
154941392|NCT02884206|559211838|FG001|Double-Blind Period|Physician Decision|2|||
154941393|NCT02884206|559211839|FG002|Double-Blind Period|Physician Decision|0|||
154941394|NCT02884206|559211837|FG000|Double-Blind Period|Adverse Event|0|||
154941395|NCT02884206|559211838|FG001|Double-Blind Period|Adverse Event|0|||
154941396|NCT02884206|559211839|FG002|Double-Blind Period|Adverse Event|3|||
154941397|NCT02884206|559211837|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
154941398|NCT02884206|559211838|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
154941399|NCT02884206|559211839|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
154941400|NCT02322879|559211840|FG000|First Intervention|Physician Decision|1|||
154941401|NCT02322879|559211841|FG001|First Intervention|Physician Decision|0|||
154941402|NCT03487796|559211842|FG000|Overall Study|Lost to Follow-up|18|||
154941403|NCT03487796|559211843|FG001|Overall Study|Lost to Follow-up|6|||
154941404|NCT01090765|559211844|FG000|Overall Study|Patient withdrew consent|0|||
154941405|NCT01090765|559211845|FG001|Overall Study|Patient withdrew consent|0|||
154941406|NCT01090765|559211846|FG002|Overall Study|Patient withdrew consent|0|||
154941407|NCT01090765|559211847|FG003|Overall Study|Patient withdrew consent|0|||
154941408|NCT01090765|559211848|FG004|Overall Study|Patient withdrew consent|1|||
154941409|NCT01090765|559211849|FG005|Overall Study|Patient withdrew consent|1|||
154941410|NCT01090765|559211844|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
154941411|NCT01090765|559211845|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
154941412|NCT01090765|559211846|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
154941413|NCT01090765|559211847|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
154941414|NCT01090765|559211848|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
154941415|NCT01090765|559211849|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
154941416|NCT01090765|559211844|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
154941417|NCT01090765|559211845|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
154941418|NCT01090765|559211846|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
154941419|NCT01090765|559211847|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
154941420|NCT01090765|559211848|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
154941421|NCT01090765|559211849|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
154941422|NCT00678392|559211850|FG000|Overall Study|Adverse Event|0|||
154941423|NCT00678392|559211851|FG001|Overall Study|Adverse Event|6|||
154941424|NCT00678392|559211850|FG000|Overall Study|Death|280|||
154941425|NCT00678392|559211851|FG001|Overall Study|Death|269|||
154941426|NCT00678392|559211850|FG000|Overall Study|Lost to Follow-up|15|||
154941427|NCT00678392|559211851|FG001|Overall Study|Lost to Follow-up|13|||
154941428|NCT00678392|559211850|FG000|Overall Study|Objective Progression or Relapse|3|||
154941429|NCT00678392|559211851|FG001|Overall Study|Objective Progression or Relapse|8|||
154941430|NCT00678392|559211850|FG000|Overall Study|Sponsor's Decision|1|||
154941431|NCT00678392|559211851|FG001|Overall Study|Sponsor's Decision|2|||
154941432|NCT00678392|559211850|FG000|Overall Study|Withdrawal by Subject|4|||
154941433|NCT00678392|559211851|FG001|Overall Study|Withdrawal by Subject|4|||
154941434|NCT00678392|559211850|FG000|Overall Study|Randomized But Not Treated|2|||
154941435|NCT00678392|559211851|FG001|Overall Study|Randomized But Not Treated|7|||
154941436|NCT00678392|559211850|FG000|Overall Study|Other|56|||
154941437|NCT00678392|559211851|FG001|Overall Study|Other|53|||
154941438|NCT03341507|559211852|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
154941439|NCT00718159|559211853|FG000|Overall Study|Progressive Disease|3|||
154941440|NCT00718159|559211854|FG001|Overall Study|Progressive Disease|3|||
154941441|NCT00718159|559211855|FG002|Overall Study|Progressive Disease|2|||
154941442|NCT00718159|559211856|FG003|Overall Study|Progressive Disease|0|||
154941443|NCT00718159|559211857|FG004|Overall Study|Progressive Disease|6|||
154941444|NCT00718159|559211858|FG005|Overall Study|Progressive Disease|0|||
154941445|NCT00718159|559211859|FG006|Overall Study|Progressive Disease|0|||
154941446|NCT00718159|559211853|FG000|Overall Study|Death due to Adverse Event|0|||
154941447|NCT00718159|559211854|FG001|Overall Study|Death due to Adverse Event|0|||
154941448|NCT00718159|559211855|FG002|Overall Study|Death due to Adverse Event|0|||
155382211|NCT00825825|560833297|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
154941449|NCT00718159|559211856|FG003|Overall Study|Death due to Adverse Event|2|||
154941450|NCT00718159|559211857|FG004|Overall Study|Death due to Adverse Event|2|||
154941451|NCT00718159|559211858|FG005|Overall Study|Death due to Adverse Event|0|||
154941452|NCT00718159|559211859|FG006|Overall Study|Death due to Adverse Event|0|||
154941453|NCT00718159|559211853|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
154941454|NCT00718159|559211854|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
154941455|NCT00718159|559211855|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
154941456|NCT00718159|559211856|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
154941457|NCT00718159|559211857|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
154941458|NCT00718159|559211858|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
154941459|NCT00718159|559211859|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
154941460|NCT00718159|559211853|FG000|Overall Study|Investigator Decision|0|||
154941461|NCT00718159|559211854|FG001|Overall Study|Investigator Decision|0|||
154941462|NCT00718159|559211855|FG002|Overall Study|Investigator Decision|0|||
155043863|NCT01483599|559590236|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
155043864|NCT01483599|559590237|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
155043865|NCT01483599|559590238|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
155043866|NCT01483599|559590239|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
155043867|NCT01483599|559590240|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
155043868|NCT01483599|559590241|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
155043869|NCT01483599|559590242|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
155043870|NCT01483599|559590243|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
155043871|NCT01483599|559590244|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
155043872|NCT01483599|559590245|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
155043873|NCT01483599|559590246|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
155043874|NCT01483599|559590247|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
155043875|NCT01483599|559590248|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
155043876|NCT01483599|559590249|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
154941463|NCT00718159|559211856|FG003|Overall Study|Investigator Decision|0|||
154941464|NCT00718159|559211857|FG004|Overall Study|Investigator Decision|0|||
154941465|NCT00718159|559211858|FG005|Overall Study|Investigator Decision|1|||
154941466|NCT00718159|559211859|FG006|Overall Study|Investigator Decision|1|||
154941467|NCT00415532|559211861|FG000|Treatment Period|Adverse Event|2|||
154941468|NCT00415532|559211862|FG001|Treatment Period|Adverse Event|3|||
154941469|NCT00415532|559211861|FG000|Treatment Period|Death|2|||
154941470|NCT00415532|559211862|FG001|Treatment Period|Death|1|||
154941471|NCT00415532|559211861|FG000|Treatment Period|Lost to Follow-up|1|||
154941472|NCT00415532|559211862|FG001|Treatment Period|Lost to Follow-up|1|||
154941473|NCT00415532|559211861|FG000|Treatment Period|Protocol Violation|1|||
154941474|NCT00415532|559211862|FG001|Treatment Period|Protocol Violation|0|||
154941475|NCT00415532|559211861|FG000|Treatment Period|Withdrawal by Subject|6|||
154941476|NCT00415532|559211862|FG001|Treatment Period|Withdrawal by Subject|6|||
154941477|NCT00415532|559211861|FG000|Treatment Period|Other|2|||
154941478|NCT00415532|559211862|FG001|Treatment Period|Other|2|||
154941479|NCT00415532|559211861|FG000|Treatment Period|Ineligibility determined|1|||
154941480|NCT00415532|559211862|FG001|Treatment Period|Ineligibility determined|1|||
154941481|NCT00415532|559211861|FG000|Treatment Period|Noncompliance|1|||
154941482|NCT00415532|559211862|FG001|Treatment Period|Noncompliance|1|||
154941483|NCT00415532|559211861|FG000|Treatment Period|Requirement for alternative therapy|1|||
154941484|NCT00415532|559211862|FG001|Treatment Period|Requirement for alternative therapy|0|||
154941485|NCT00415532|559211861|FG000|Safety Follow Up Period|Adverse Event|1|||
155043877|NCT01483599|559590236|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043878|NCT01483599|559590237|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043879|NCT01483599|559590238|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043880|NCT01483599|559590239|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043881|NCT01483599|559590240|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043882|NCT01483599|559590241|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043883|NCT01483599|559590242|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043884|NCT01483599|559590243|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155043885|NCT01483599|559590244|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155043886|NCT01483599|559590245|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043887|NCT01483599|559590246|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043888|NCT01483599|559590247|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
155043889|NCT01483599|559590248|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155043890|NCT01483599|559590249|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
155043891|NCT01483599|559590236|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043892|NCT01483599|559590237|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043893|NCT01483599|559590238|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
154941486|NCT00415532|559211862|FG001|Safety Follow Up Period|Adverse Event|3|||
154941487|NCT00415532|559211861|FG000|Safety Follow Up Period|Death|3|||
154941488|NCT00415532|559211862|FG001|Safety Follow Up Period|Death|0|||
154941489|NCT00415532|559211861|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
154941490|NCT00415532|559211862|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
154941491|NCT00415532|559211861|FG000|Safety Follow Up Period|Other|1|||
155278060|NCT05294419|560451099|FG002|Overall Study|Results voided after publishing|0|||
155278061|NCT00847301|560451100|FG000|Overall Study|Adverse Event|35|||
155278062|NCT00847301|560451100|FG000|Overall Study|Switch to other anticoagulants|16|||
155278063|NCT00847301|560451100|FG000|Overall Study|Lost to Follow-up|1|||
155278064|NCT00847301|560451100|FG000|Overall Study|No prescription after hospital discharge|1|||
155278065|NCT00847301|560451100|FG000|Overall Study|Other reason not defined above|1|||
155278066|NCT05708846|560451101|FG000|Overall Study|Death|5|||
155278067|NCT05708846|560451101|FG000|Overall Study|Withdrawal by Subject|20|||
155278068|NCT03621982|560451102|FG000|Overall Study|Withdrawal by Subject|1|||
154941492|NCT00415532|559211862|FG001|Safety Follow Up Period|Other|4|||
154941493|NCT00415532|559211861|FG000|Safety Follow Up Period|Ineligibility determined|1|||
154941494|NCT00415532|559211862|FG001|Safety Follow Up Period|Ineligibility determined|1|||
154941495|NCT00415532|559211861|FG000|Safety Follow Up Period|Noncompliance|1|||
154941496|NCT00415532|559211862|FG001|Safety Follow Up Period|Noncompliance|0|||
154941497|NCT00415532|559211861|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
155043894|NCT01483599|559590239|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155278069|NCT03621982|560451103|FG001|Overall Study|Withdrawal by Subject|0|||
155278070|NCT03621982|560451104|FG002|Overall Study|Withdrawal by Subject|0|||
155278071|NCT03621982|560451105|FG003|Overall Study|Withdrawal by Subject|1|||
155278072|NCT03621982|560451106|FG004|Overall Study|Withdrawal by Subject|0|||
155278073|NCT03621982|560451107|FG005|Overall Study|Withdrawal by Subject|1|||
155278074|NCT03621982|560451108|FG006|Overall Study|Withdrawal by Subject|1|||
155278075|NCT03621982|560451109|FG007|Overall Study|Withdrawal by Subject|0|||
155278076|NCT03621982|560451110|FG008|Overall Study|Withdrawal by Subject|1|||
155278077|NCT03621982|560451111|FG009|Overall Study|Withdrawal by Subject|0|||
155278078|NCT03621982|560451112|FG010|Overall Study|Withdrawal by Subject|2|||
155278079|NCT03621982|560451113|FG011|Overall Study|Withdrawal by Subject|1|||
155278080|NCT03621982|560451114|FG012|Overall Study|Withdrawal by Subject|2|||
155278081|NCT03621982|560451115|FG013|Overall Study|Withdrawal by Subject|2|||
155278082|NCT03621982|560451102|FG000|Overall Study|Investigator/Sponsor decision|0|||
155278083|NCT03621982|560451103|FG001|Overall Study|Investigator/Sponsor decision|0|||
155278084|NCT03621982|560451104|FG002|Overall Study|Investigator/Sponsor decision|0|||
155278085|NCT03621982|560451105|FG003|Overall Study|Investigator/Sponsor decision|0|||
155278086|NCT03621982|560451106|FG004|Overall Study|Investigator/Sponsor decision|0|||
155278087|NCT03621982|560451107|FG005|Overall Study|Investigator/Sponsor decision|0|||
155278088|NCT03621982|560451108|FG006|Overall Study|Investigator/Sponsor decision|0|||
155278089|NCT03621982|560451109|FG007|Overall Study|Investigator/Sponsor decision|0|||
155278090|NCT03621982|560451110|FG008|Overall Study|Investigator/Sponsor decision|0|||
155278091|NCT03621982|560451111|FG009|Overall Study|Investigator/Sponsor decision|0|||
155278092|NCT03621982|560451112|FG010|Overall Study|Investigator/Sponsor decision|0|||
155278093|NCT03621982|560451113|FG011|Overall Study|Investigator/Sponsor decision|4|||
155278094|NCT03621982|560451114|FG012|Overall Study|Investigator/Sponsor decision|0|||
155278095|NCT03621982|560451115|FG013|Overall Study|Investigator/Sponsor decision|2|||
155278096|NCT03621982|560451102|FG000|Overall Study|Death|2|||
155278097|NCT03621982|560451103|FG001|Overall Study|Death|4|||
155278098|NCT03621982|560451104|FG002|Overall Study|Death|4|||
155278099|NCT03621982|560451105|FG003|Overall Study|Death|3|||
155278100|NCT03621982|560451106|FG004|Overall Study|Death|8|||
155278101|NCT03621982|560451107|FG005|Overall Study|Death|4|||
155278102|NCT03621982|560451108|FG006|Overall Study|Death|6|||
155278103|NCT03621982|560451109|FG007|Overall Study|Death|3|||
155278104|NCT03621982|560451110|FG008|Overall Study|Death|0|||
155278105|NCT03621982|560451111|FG009|Overall Study|Death|3|||
155278106|NCT03621982|560451112|FG010|Overall Study|Death|8|||
155278107|NCT03621982|560451113|FG011|Overall Study|Death|4|||
155278108|NCT03621982|560451114|FG012|Overall Study|Death|2|||
155278109|NCT03621982|560451115|FG013|Overall Study|Death|2|||
155278110|NCT03621982|560451102|FG000|Overall Study|Lost to Follow-up|0|||
155278111|NCT03621982|560451103|FG001|Overall Study|Lost to Follow-up|0|||
155278112|NCT03621982|560451104|FG002|Overall Study|Lost to Follow-up|1|||
155278113|NCT03621982|560451105|FG003|Overall Study|Lost to Follow-up|0|||
155278114|NCT03621982|560451106|FG004|Overall Study|Lost to Follow-up|0|||
155278115|NCT03621982|560451107|FG005|Overall Study|Lost to Follow-up|0|||
155278116|NCT03621982|560451108|FG006|Overall Study|Lost to Follow-up|1|||
155278117|NCT03621982|560451109|FG007|Overall Study|Lost to Follow-up|0|||
155278118|NCT03621982|560451110|FG008|Overall Study|Lost to Follow-up|0|||
155278119|NCT03621982|560451111|FG009|Overall Study|Lost to Follow-up|1|||
155278120|NCT03621982|560451112|FG010|Overall Study|Lost to Follow-up|0|||
155278121|NCT03621982|560451113|FG011|Overall Study|Lost to Follow-up|0|||
155278122|NCT03621982|560451114|FG012|Overall Study|Lost to Follow-up|0|||
155278123|NCT03621982|560451115|FG013|Overall Study|Lost to Follow-up|0|||
155278124|NCT00238420|560451116|FG000|Overall Study|Protocol Violation|1|||
155278125|NCT00238420|560451117|FG001|Overall Study|Protocol Violation|1|||
155043895|NCT01483599|559590240|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043896|NCT01483599|559590241|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043897|NCT01483599|559590242|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043898|NCT01483599|559590243|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043899|NCT01483599|559590244|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
155043900|NCT01483599|559590245|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043901|NCT01483599|559590246|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043902|NCT01483599|559590247|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
155043903|NCT01483599|559590248|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
155043904|NCT01483599|559590249|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
155043905|NCT01483599|559590236|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043906|NCT01483599|559590237|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043907|NCT01483599|559590238|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043908|NCT01483599|559590239|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043909|NCT01483599|559590240|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043910|NCT01483599|559590241|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043911|NCT01483599|559590242|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043912|NCT01483599|559590243|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043913|NCT01483599|559590244|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
155043914|NCT01483599|559590245|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043915|NCT01483599|559590246|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
155043916|NCT01483599|559590247|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043917|NCT01483599|559590248|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
155043918|NCT01483599|559590249|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
155043919|NCT01483599|559590236|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043920|NCT01483599|559590237|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043921|NCT01483599|559590238|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043922|NCT01483599|559590239|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043923|NCT01483599|559590240|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043924|NCT01483599|559590241|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043925|NCT01483599|559590242|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043926|NCT01483599|559590243|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043927|NCT01483599|559590244|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
155043928|NCT01483599|559590245|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043929|NCT01483599|559590246|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043930|NCT01483599|559590247|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
155043931|NCT01483599|559590248|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
155043932|NCT01483599|559590249|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
155043933|NCT01483599|559590236|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
155043934|NCT01483599|559590237|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
155043935|NCT01483599|559590238|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
155043936|NCT01483599|559590239|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
155043937|NCT01483599|559590240|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
155043938|NCT01483599|559590241|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
155043939|NCT01483599|559590242|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
155043940|NCT01483599|559590243|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
155043941|NCT01483599|559590244|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
155043942|NCT01483599|559590245|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
155043943|NCT01483599|559590246|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
155043944|NCT01483599|559590247|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
155043945|NCT01483599|559590248|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
155043946|NCT01483599|559590249|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
155043947|NCT01962948|559591936|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
155382212|NCT00825825|560833298|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
155043948|NCT01962948|559591937|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
155043949|NCT01962948|559591938|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
155043950|NCT01962948|559591939|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
155043951|NCT00376532|559591940|FG000|Overall Study|Lack sufficient blood sample|6|||
155043952|NCT00376532|559591941|FG001|Overall Study|Lack sufficient blood sample|6|||
155043953|NCT02849704|559591942|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
155043954|NCT02849704|559591943|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
155382213|NCT00825825|560833299|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
155382214|NCT00825825|560833300|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
155043955|NCT02849704|559591942|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
155043956|NCT02849704|559591943|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
155043957|NCT02849704|559591942|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
155043958|NCT02849704|559591943|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
155043959|NCT00314808|559591949|FG000|Overall Study|Disease Progression without AE|4|||
155043960|NCT00314808|559591949|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
155043961|NCT02579382|559591950|FG000|Main Study Phase|Lost to Follow-up|0|||
155043962|NCT02579382|559591951|FG001|Main Study Phase|Lost to Follow-up|0|||
155043963|NCT02579382|559591952|FG002|Main Study Phase|Lost to Follow-up|2|||
155043964|NCT02579382|559591953|FG003|Main Study Phase|Lost to Follow-up|0|||
155043965|NCT02579382|559591950|FG000|Main Study Phase|Withdrew Consent|0|||
155043966|NCT02579382|559591951|FG001|Main Study Phase|Withdrew Consent|0|||
155043967|NCT02579382|559591952|FG002|Main Study Phase|Withdrew Consent|0|||
155043968|NCT02579382|559591953|FG003|Main Study Phase|Withdrew Consent|2|||
155043969|NCT02579382|559591950|FG000|Main Study Phase|Lack of Efficacy|0|||
155043970|NCT02579382|559591951|FG001|Main Study Phase|Lack of Efficacy|0|||
155043971|NCT02579382|559591952|FG002|Main Study Phase|Lack of Efficacy|0|||
155043972|NCT02579382|559591953|FG003|Main Study Phase|Lack of Efficacy|1|||
155043973|NCT02579382|559591950|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
155043974|NCT02579382|559591951|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
155043975|NCT02579382|559591952|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
155043976|NCT02579382|559591953|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
155043977|NCT02579382|559591950|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
155043978|NCT02579382|559591951|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
155043979|NCT02579382|559591952|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
155043980|NCT02579382|559591953|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
155043981|NCT02579382|559591950|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
155043982|NCT02579382|559591951|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
155043983|NCT02579382|559591952|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
155043984|NCT02579382|559591953|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
155043985|NCT02579382|559591950|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
155043986|NCT02579382|559591951|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
155043987|NCT02579382|559591952|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
155043988|NCT02579382|559591953|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
155043989|NCT02579382|559591950|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
155043990|NCT02579382|559591951|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
155043991|NCT02579382|559591952|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
155043992|NCT02579382|559591953|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
155043993|NCT02579382|559591950|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
155043994|NCT02579382|559591951|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
155043995|NCT02579382|559591952|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
155043996|NCT02579382|559591953|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
155043997|NCT03084302|559591956|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
155043998|NCT03084302|559591956|FG000|Overall Study|No valid objective monitor data|6|||
155043999|NCT01301079|559591958|FG000|Overall Study|Lost to Follow-up|2|||
155044000|NCT01301079|559591959|FG001|Overall Study|Lost to Follow-up|2|||
155044001|NCT00715299|559591972|FG000|Overall Study|Withdrawal by Subject|1|||
155382215|NCT00825825|560833301|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
155382216|NCT00825825|560833296|FG000|Third Medication Period (14 Days)|poor data quality|0|||
155382217|NCT00825825|560833297|FG001|Third Medication Period (14 Days)|poor data quality|1|||
154941498|NCT00415532|559211862|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
154941499|NCT01798485|559211863|FG000|Overall Study|Adverse Event|32|||
154941500|NCT01798485|559211864|FG001|Overall Study|Adverse Event|40|||
154941501|NCT01798485|559211863|FG000|Overall Study|Withdrawal by Subject|27|||
154941502|NCT01798485|559211864|FG001|Overall Study|Withdrawal by Subject|31|||
154941503|NCT01798485|559211863|FG000|Overall Study|Lost to Follow-up|0|||
154941504|NCT01798485|559211864|FG001|Overall Study|Lost to Follow-up|3|||
154941505|NCT01798485|559211863|FG000|Overall Study|Physician Decision|14|||
154941506|NCT01798485|559211864|FG001|Overall Study|Physician Decision|10|||
154941507|NCT01798485|559211863|FG000|Overall Study|Objective Disease Progression|152|||
155044002|NCT00715299|559591972|FG000|Overall Study|Adverse Event|3|||
155044003|NCT00715299|559591972|FG000|Overall Study|failed the pre-screen exercise test|2|||
155044004|NCT02020889|559591973|FG000|Overall Study|Adverse Event|0|||
155044005|NCT02020889|559591974|FG001|Overall Study|Adverse Event|1|||
155044006|NCT02020889|559591973|FG000|Overall Study|Lack of Efficacy|1|||
155044007|NCT02020889|559591974|FG001|Overall Study|Lack of Efficacy|0|||
155044008|NCT02020889|559591973|FG000|Overall Study|Lost to Follow-up|1|||
155044009|NCT02020889|559591974|FG001|Overall Study|Lost to Follow-up|0|||
154941508|NCT01798485|559211864|FG001|Overall Study|Objective Disease Progression|106|||
155044010|NCT02020889|559591973|FG000|Overall Study|Physician Decision|2|||
155044011|NCT02020889|559591974|FG001|Overall Study|Physician Decision|0|||
155044012|NCT02020889|559591973|FG000|Overall Study|Withdrawal by Subject|3|||
155044013|NCT02020889|559591974|FG001|Overall Study|Withdrawal by Subject|2|||
155044014|NCT01540981|559591975|FG000|Overall Study|Withdrawal by Subject|1|||
155044015|NCT01540981|559591976|FG001|Overall Study|Withdrawal by Subject|0|||
155044016|NCT00809094|559591977|FG000|Overall Study|Lost to Follow-up|0|||
155044017|NCT00809094|559591978|FG001|Overall Study|Lost to Follow-up|1|||
155044018|NCT02768792|559591980|FG000|Overall Study|Adverse Event|1|||
155044019|NCT05359952|559591982|FG000|Overall Study|Lost to Follow-up|1|||
155044020|NCT05359952|559591983|FG001|Overall Study|Lost to Follow-up|0|||
155044021|NCT03836209|559591984|FG000|Overall Study|Adverse Event|5|||
155044022|NCT03836209|559591985|FG001|Overall Study|Adverse Event|2|||
155044023|NCT03836209|559591984|FG000|Overall Study|Death|4|||
155044024|NCT03836209|559591985|FG001|Overall Study|Death|1|||
155044025|NCT03836209|559591984|FG000|Overall Study|Lack of Efficacy|7|||
155044026|NCT03836209|559591985|FG001|Overall Study|Lack of Efficacy|10|||
155044027|NCT03836209|559591984|FG000|Overall Study|Physician Decision|7|||
155044028|NCT03836209|559591985|FG001|Overall Study|Physician Decision|11|||
155044029|NCT03836209|559591984|FG000|Overall Study|Protocol Violation|0|||
155044030|NCT03836209|559591985|FG001|Overall Study|Protocol Violation|3|||
155044031|NCT03836209|559591984|FG000|Overall Study|Withdrawal by Subject|2|||
155044032|NCT03836209|559591985|FG001|Overall Study|Withdrawal by Subject|10|||
155044033|NCT03836209|559591984|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
155044034|NCT03836209|559591985|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
155044035|NCT05980013|559591986|FG000|Overall Study|Withdrawal by Subject|0|||
155044036|NCT05980013|559591987|FG001|Overall Study|Withdrawal by Subject|1|||
155044037|NCT05980013|559591986|FG000|Overall Study|Device Error|0|||
155044038|NCT05980013|559591987|FG001|Overall Study|Device Error|1|||
155044039|NCT03739710|559591988|FG000|Overall Study|Screen Failed|81|||
155044040|NCT01753115|559591989|FG000|Overall Study|Lost to Follow-up|3|||
155044041|NCT01753115|559591990|FG001|Overall Study|Lost to Follow-up|6|||
155044042|NCT01753115|559591991|FG002|Overall Study|Lost to Follow-up|8|||
155044043|NCT01753115|559591989|FG000|Overall Study|Withdrawal by Subject|6|||
155044044|NCT01753115|559591990|FG001|Overall Study|Withdrawal by Subject|5|||
155044045|NCT01753115|559591991|FG002|Overall Study|Withdrawal by Subject|6|||
155044046|NCT01753115|559591989|FG000|Overall Study|Subject non-compliant|3|||
155044047|NCT01753115|559591990|FG001|Overall Study|Subject non-compliant|3|||
155044048|NCT01753115|559591991|FG002|Overall Study|Subject non-compliant|0|||
155044049|NCT01753115|559591989|FG000|Overall Study|Used excluded drug|0|||
155044050|NCT01753115|559591990|FG001|Overall Study|Used excluded drug|1|||
155044051|NCT01753115|559591991|FG002|Overall Study|Used excluded drug|0|||
155044052|NCT01882803|559592003|FG000|Overall Study|Disease Progression|1|||
155044053|NCT01882803|559592003|FG000|Overall Study|Withdrawal by Subject|9|||
155044054|NCT01882803|559592003|FG000|Overall Study|Death|68|||
155044055|NCT01882803|559592003|FG000|Overall Study|Physician Decision|3|||
155044056|NCT01882803|559592003|FG000|Overall Study|Lost to Follow-up|3|||
155044057|NCT01882803|559592003|FG000|Overall Study|Follow-up Completed|39|||
155044058|NCT01882803|559592003|FG000|Overall Study|Study Terminated by the Sponsor|6|||
155044059|NCT01563913|559592004|FG000|Overall Study|Physician Decision|1|||
155044060|NCT01563913|559592005|FG001|Overall Study|Physician Decision|0|||
155044061|NCT01563913|559592004|FG000|Overall Study|Spouse Passed Away|1|||
155044062|NCT01563913|559592005|FG001|Overall Study|Spouse Passed Away|0|||
155044063|NCT02091414|559592008|FG000|Overall Study|Withdrawal by Subject|2|||
155044064|NCT02091414|559592008|FG000|Overall Study|Death|2|||
155044065|NCT03146741|559592013|FG000|Overall Study|Txp with non-HCV+ heart|4|||
155044066|NCT03146741|559592013|FG000|Overall Study|Listeted for MOT|2|||
155044067|NCT03146741|559592013|FG000|Overall Study|Physician Decision|2|||
155044068|NCT03146741|559592013|FG000|Overall Study|Awaiting txp|2|||
155044069|NCT03224624|559592014|FG000|Overall Study|Lost to Follow-up|9|||
155044070|NCT03224624|559592015|FG001|Overall Study|Lost to Follow-up|4|||
155044071|NCT03224624|559592014|FG000|Overall Study|Death|1|||
155044072|NCT03224624|559592015|FG001|Overall Study|Death|0|||
155044073|NCT01424241|559592018|FG000|Overall Study|Withdrawal by Subject|1|||
155044074|NCT01424241|559592018|FG000|Overall Study|Time constraints|2|||
155044075|NCT00551525|559592019|FG000|Overall Study|Protocol Violation|5|||
155044076|NCT04676724|559592020|FG000|Overall Study|Adverse Event|2|||
155044077|NCT04676724|559592021|FG001|Overall Study|Adverse Event|0|||
155044078|NCT04676724|559592020|FG000|Overall Study|Lost to Follow-up|1|||
155044079|NCT04676724|559592021|FG001|Overall Study|Lost to Follow-up|0|||
155044080|NCT04676724|559592020|FG000|Overall Study|Physician Decision|0|||
155044081|NCT04676724|559592021|FG001|Overall Study|Physician Decision|1|||
155044082|NCT04676724|559592020|FG000|Overall Study|Withdrawal by Subject|3|||
155044083|NCT04676724|559592021|FG001|Overall Study|Withdrawal by Subject|2|||
155044084|NCT02782377|559592024|FG000|Overall Study|Physician Decision|5|||
155044085|NCT00398047|559592028|FG000|Overall Study|all patient progressed before completion|3|||
155044086|NCT02521792|559592029|FG000|Overall Study|Study Terminated|6|||
155044087|NCT01188668|559592030|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
155278126|NCT00641186|560451120|FG000|Overall Study|Adverse Event|3|||
155278127|NCT00442286|560451121|FG000|Overall Study|Death|2|||
155278128|NCT00442286|560451122|FG001|Overall Study|Death|2|||
155278129|NCT00442286|560451121|FG000|Overall Study|Lost to Follow-up|1|||
155278130|NCT00442286|560451122|FG001|Overall Study|Lost to Follow-up|0|||
155278131|NCT00442286|560451121|FG000|Overall Study|Withdrawal by Subject|2|||
155278132|NCT00442286|560451122|FG001|Overall Study|Withdrawal by Subject|0|||
155278133|NCT00442286|560451121|FG000|Overall Study|System explanted|1|||
155278134|NCT00442286|560451122|FG001|Overall Study|System explanted|0|||
155278135|NCT00442286|560451121|FG000|Overall Study|Patient Injury|1|||
155278136|NCT00442286|560451122|FG001|Overall Study|Patient Injury|0|||
155278137|NCT03428815|560451125|FG000|Overall Study|Lost to Follow-up|2|||
155278138|NCT03428815|560451126|FG001|Overall Study|Lost to Follow-up|2|||
155278139|NCT03428815|560451125|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
155278140|NCT03428815|560451126|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
155278141|NCT03428815|560451125|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
155278142|NCT03428815|560451126|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
155278143|NCT05221749|560451127|FG000|Overall Study|Lost to Follow-up|2|||
155278144|NCT05221749|560451128|FG001|Overall Study|Lost to Follow-up|3|||
155278145|NCT02404493|560451129|FG000|Overall Study|Adverse Event|1|||
155278146|NCT02404493|560451130|FG001|Overall Study|Adverse Event|1|||
155278147|NCT04140890|560451133|FG000|Overall Study|Withdrawal by Subject|0|||
155278148|NCT04140890|560451134|FG001|Overall Study|Withdrawal by Subject|1|||
155278149|NCT01700348|560451135|FG000|Overall Study|Withdrawal by Subject|22|||
155278150|NCT01700348|560451135|FG000|Overall Study|Lost to Follow-up|1|||
155278151|NCT02102464|560451136|FG000|Randomized Study|Withdrawal by Subject|0|||
155278152|NCT02102464|560451137|FG001|Randomized Study|Withdrawal by Subject|1|||
155278153|NCT02102464|560451138|FG002|Randomized Study|Withdrawal by Subject|0|||
155278154|NCT01824472|560451147|FG000|Overall Study|Lost to Follow-up|0|||
155278155|NCT01824472|560451148|FG001|Overall Study|Lost to Follow-up|0|||
155278156|NCT01824472|560451149|FG002|Overall Study|Lost to Follow-up|1|||
155278157|NCT01824472|560451147|FG000|Overall Study|Withdrawal by Subject|1|||
155278158|NCT01824472|560451148|FG001|Overall Study|Withdrawal by Subject|5|||
155278159|NCT01824472|560451149|FG002|Overall Study|Withdrawal by Subject|3|||
155278160|NCT01824472|560451147|FG000|Overall Study|Ineligible post randomization&screening|0|||
155278161|NCT01824472|560451148|FG001|Overall Study|Ineligible post randomization&screening|2|||
155278162|NCT01824472|560451149|FG002|Overall Study|Ineligible post randomization&screening|0|||
155278163|NCT03040687|560451150|FG000|Overall Study|Withdrawal by Subject|1|||
155278164|NCT03040687|560451151|FG001|Overall Study|Withdrawal by Subject|0|||
155278165|NCT03040687|560451152|FG002|Overall Study|Withdrawal by Subject|0|||
155278166|NCT03317379|560451153|FG000|Overall Study|Lost to Follow-up|0|||
155278167|NCT03317379|560451154|FG001|Overall Study|Lost to Follow-up|3|||
155278168|NCT03317379|560451155|FG002|Overall Study|Lost to Follow-up|2|||
155278169|NCT02846558|560451156|FG000|Overall Study|Adverse Event|1|||
155278170|NCT02846558|560451157|FG001|Overall Study|Adverse Event|0|||
155278171|NCT02846558|560451158|FG002|Overall Study|Adverse Event|0|||
155278172|NCT02846558|560451159|FG003|Overall Study|Adverse Event|0|||
155278173|NCT02846558|560451156|FG000|Overall Study|Withdrawal by Subject|5|||
155278174|NCT02846558|560451157|FG001|Overall Study|Withdrawal by Subject|4|||
155278175|NCT02846558|560451158|FG002|Overall Study|Withdrawal by Subject|2|||
155278176|NCT02846558|560451159|FG003|Overall Study|Withdrawal by Subject|2|||
155278177|NCT02846558|560451156|FG000|Overall Study|Lost to Follow-up|2|||
155278178|NCT02846558|560451157|FG001|Overall Study|Lost to Follow-up|0|||
155278179|NCT02846558|560451158|FG002|Overall Study|Lost to Follow-up|0|||
155278180|NCT02846558|560451159|FG003|Overall Study|Lost to Follow-up|0|||
155278181|NCT04445155|560451160|FG000|Overall Study|Lost to Follow-up|11|||
155278182|NCT04445155|560451161|FG001|Overall Study|Lost to Follow-up|2|||
155278183|NCT04445155|560451162|FG002|Overall Study|Lost to Follow-up|3|||
155278184|NCT04445155|560451163|FG003|Overall Study|Lost to Follow-up|0|||
155278185|NCT04445155|560451160|FG000|Overall Study|Withdrawal by Subject|8|||
155278186|NCT04445155|560451161|FG001|Overall Study|Withdrawal by Subject|0|||
155278187|NCT04445155|560451162|FG002|Overall Study|Withdrawal by Subject|0|||
155278188|NCT04445155|560451163|FG003|Overall Study|Withdrawal by Subject|0|||
155278189|NCT04445155|560451160|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
155278190|NCT04445155|560451161|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
155278191|NCT04445155|560451162|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
155278192|NCT04445155|560451163|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
155278193|NCT04445155|560451160|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
155278194|NCT04445155|560451161|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
155278195|NCT04445155|560451162|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
155278196|NCT04445155|560451163|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
155382218|NCT00825825|560833298|FG002|Third Medication Period (14 Days)|poor data quality|0|||
155044088|NCT01188668|559592030|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
155044089|NCT01188668|559592030|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
155044090|NCT00303472|559592035|FG000|Treatment Period|Adverse Event|0|||
155044091|NCT00303472|559592036|FG001|Treatment Period|Adverse Event|0|||
155044092|NCT00303472|559592037|FG002|Treatment Period|Adverse Event|0|||
155044093|NCT00303472|559592038|FG003|Treatment Period|Adverse Event|0|||
155044094|NCT00303472|559592039|FG004|Treatment Period|Adverse Event|1|||
155044095|NCT00303472|559592040|FG005|Treatment Period|Adverse Event|0|||
155044096|NCT00303472|559592041|FG006|Treatment Period|Adverse Event|0|||
155044097|NCT00303472|559592035|FG000|Treatment Period|Death|0|||
155044098|NCT00303472|559592036|FG001|Treatment Period|Death|0|||
155044099|NCT00303472|559592037|FG002|Treatment Period|Death|0|||
155044100|NCT00303472|559592038|FG003|Treatment Period|Death|1|||
155044101|NCT00303472|559592039|FG004|Treatment Period|Death|0|||
155044102|NCT00303472|559592040|FG005|Treatment Period|Death|0|||
155044103|NCT00303472|559592041|FG006|Treatment Period|Death|1|||
155044104|NCT00303472|559592035|FG000|Treatment Period|Withdrawal by Subject|0|||
155044105|NCT00303472|559592036|FG001|Treatment Period|Withdrawal by Subject|0|||
155044106|NCT00303472|559592037|FG002|Treatment Period|Withdrawal by Subject|0|||
155044107|NCT00303472|559592038|FG003|Treatment Period|Withdrawal by Subject|1|||
155044108|NCT00303472|559592039|FG004|Treatment Period|Withdrawal by Subject|0|||
155044109|NCT00303472|559592040|FG005|Treatment Period|Withdrawal by Subject|1|||
155044110|NCT00303472|559592041|FG006|Treatment Period|Withdrawal by Subject|0|||
155044111|NCT00303472|559592035|FG000|Treatment Period|Other|0|||
155044112|NCT00303472|559592036|FG001|Treatment Period|Other|0|||
155044113|NCT00303472|559592037|FG002|Treatment Period|Other|0|||
155044114|NCT00303472|559592038|FG003|Treatment Period|Other|0|||
155044115|NCT00303472|559592039|FG004|Treatment Period|Other|1|||
155044116|NCT00303472|559592040|FG005|Treatment Period|Other|0|||
155044117|NCT00303472|559592041|FG006|Treatment Period|Other|1|||
155044118|NCT00303472|559592035|FG000|Treatment Period|Disease Progression (to AML)|0|||
155044119|NCT00303472|559592036|FG001|Treatment Period|Disease Progression (to AML)|0|||
155044120|NCT00303472|559592037|FG002|Treatment Period|Disease Progression (to AML)|0|||
155044121|NCT00303472|559592038|FG003|Treatment Period|Disease Progression (to AML)|0|||
155044122|NCT00303472|559592039|FG004|Treatment Period|Disease Progression (to AML)|1|||
155044123|NCT00303472|559592040|FG005|Treatment Period|Disease Progression (to AML)|0|||
155044124|NCT00303472|559592041|FG006|Treatment Period|Disease Progression (to AML)|0|||
155044125|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Adverse Event|1|||
155044126|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Adverse Event|0|||
155044127|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Adverse Event|1|||
155044128|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Adverse Event|0|||
155044129|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Adverse Event|0|||
155044130|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Adverse Event|0|||
155044131|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Adverse Event|0|||
155044132|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Death|2|||
155044133|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Death|0|||
155044134|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Death|1|||
155044135|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Death|0|||
155044136|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Death|0|||
155044137|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Death|0|||
155044138|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Death|0|||
155044139|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
155044140|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
155044141|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
155044142|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
155044143|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
155044144|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
155044145|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
155044146|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Physician Decision|0|||
155044147|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Physician Decision|4|||
155044148|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Physician Decision|2|||
155044149|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Physician Decision|3|||
155044150|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Physician Decision|2|||
155044151|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Physician Decision|0|||
155044152|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Physician Decision|0|||
155044153|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
155044154|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
155044155|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
155044156|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
155044157|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
155044158|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
155044159|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
155044160|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Other|0|||
155044161|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Other|2|||
154941509|NCT01798485|559211863|FG000|Overall Study|Death|25|||
155044162|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Other|4|||
155044163|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Other|2|||
155044164|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Other|1|||
155044165|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Other|0|||
155044166|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Other|0|||
155044167|NCT00303472|559592035|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
155044168|NCT00303472|559592036|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155044169|NCT00303472|559592037|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155044170|NCT00303472|559592038|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155044171|NCT00303472|559592039|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155044172|NCT00303472|559592040|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
155044173|NCT00303472|559592041|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
155044174|NCT00359294|559592052|FG000|Overall Study|Progressive disease|1|||
155044175|NCT00359294|559592053|FG001|Overall Study|Progressive disease|1|||
155044176|NCT00359294|559592054|FG002|Overall Study|Progressive disease|2|||
155044177|NCT00359294|559592055|FG003|Overall Study|Progressive disease|3|||
155044178|NCT00359294|559592056|FG004|Overall Study|Progressive disease|2|||
155044179|NCT00359294|559592052|FG000|Overall Study|Withdrawal by Subject|0|||
155044180|NCT00359294|559592053|FG001|Overall Study|Withdrawal by Subject|0|||
155044181|NCT00359294|559592054|FG002|Overall Study|Withdrawal by Subject|0|||
155044182|NCT00359294|559592055|FG003|Overall Study|Withdrawal by Subject|0|||
155044183|NCT00359294|559592056|FG004|Overall Study|Withdrawal by Subject|1|||
155044184|NCT00359294|559592052|FG000|Overall Study|Not treated|0|||
155044185|NCT00359294|559592053|FG001|Overall Study|Not treated|0|||
155044186|NCT00359294|559592054|FG002|Overall Study|Not treated|0|||
155044187|NCT00359294|559592055|FG003|Overall Study|Not treated|1|||
155044188|NCT00359294|559592056|FG004|Overall Study|Not treated|0|||
155044189|NCT00359294|559592052|FG000|Overall Study|Physician Decision|0|||
155044190|NCT00359294|559592053|FG001|Overall Study|Physician Decision|0|||
155044191|NCT00359294|559592054|FG002|Overall Study|Physician Decision|1|||
155044192|NCT00359294|559592055|FG003|Overall Study|Physician Decision|0|||
155044193|NCT00359294|559592056|FG004|Overall Study|Physician Decision|0|||
155044194|NCT04208412|559592059|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
155044195|NCT04208412|559592060|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
155044196|NCT04208412|559592059|FG000|Overall Study|Withdrawal by Subject|1|||
155044197|NCT04208412|559592060|FG001|Overall Study|Withdrawal by Subject|0|||
155044198|NCT04208412|559592059|FG000|Overall Study|Lost to Follow-up|0|||
155044199|NCT04208412|559592060|FG001|Overall Study|Lost to Follow-up|1|||
155044200|NCT02588092|559592063|FG000|Overall Study|Death|4|||
155044201|NCT02588092|559592064|FG001|Overall Study|Death|3|||
155044202|NCT02588092|559592065|FG002|Overall Study|Death|3|||
155044203|NCT02588092|559592066|FG003|Overall Study|Death|3|||
155044204|NCT02588092|559592067|FG004|Overall Study|Death|2|||
155044205|NCT02588092|559592068|FG005|Overall Study|Death|2|||
155044206|NCT02588092|559592069|FG006|Overall Study|Death|2|||
155044207|NCT02588092|559592070|FG007|Overall Study|Death|1|||
155044208|NCT02588092|559592071|FG008|Overall Study|Death|5|||
155044209|NCT02588092|559592072|FG009|Overall Study|Death|2|||
155044210|NCT02588092|559592063|FG000|Overall Study|Withdrawal by Subject|0|||
155044211|NCT02588092|559592064|FG001|Overall Study|Withdrawal by Subject|0|||
155044212|NCT02588092|559592065|FG002|Overall Study|Withdrawal by Subject|0|||
155044213|NCT02588092|559592066|FG003|Overall Study|Withdrawal by Subject|0|||
154941510|NCT01798485|559211864|FG001|Overall Study|Death|22|||
154941511|NCT01798485|559211863|FG000|Overall Study|Sponsor Decision|61|||
154941512|NCT01798485|559211864|FG001|Overall Study|Sponsor Decision|54|||
154941513|NCT01798485|559211863|FG000|Overall Study|Clinical Progression|35|||
154941514|NCT01798485|559211864|FG001|Overall Study|Clinical Progression|24|||
154941515|NCT01952574|559211865|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
154941516|NCT01952574|559211866|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
154941517|NCT01952574|559211867|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
154941518|NCT01952574|559211868|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
154941519|NCT01952574|559211869|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155044214|NCT02588092|559592067|FG004|Overall Study|Withdrawal by Subject|0|||
155044215|NCT02588092|559592068|FG005|Overall Study|Withdrawal by Subject|1|||
155044216|NCT02588092|559592069|FG006|Overall Study|Withdrawal by Subject|1|||
155044217|NCT02588092|559592070|FG007|Overall Study|Withdrawal by Subject|2|||
154941520|NCT01952574|559211870|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155044218|NCT02588092|559592071|FG008|Overall Study|Withdrawal by Subject|0|||
155044219|NCT02588092|559592072|FG009|Overall Study|Withdrawal by Subject|0|||
155044220|NCT02588092|559592063|FG000|Overall Study|Started Another Treatment|0|||
155044221|NCT02588092|559592064|FG001|Overall Study|Started Another Treatment|0|||
155044222|NCT02588092|559592065|FG002|Overall Study|Started Another Treatment|0|||
155044223|NCT02588092|559592066|FG003|Overall Study|Started Another Treatment|0|||
155044224|NCT02588092|559592067|FG004|Overall Study|Started Another Treatment|1|||
155044225|NCT02588092|559592068|FG005|Overall Study|Started Another Treatment|0|||
155044226|NCT02588092|559592069|FG006|Overall Study|Started Another Treatment|0|||
155044227|NCT02588092|559592070|FG007|Overall Study|Started Another Treatment|1|||
155044228|NCT02588092|559592071|FG008|Overall Study|Started Another Treatment|0|||
154941521|NCT01952574|559211871|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
154941522|NCT01952574|559211865|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
154941523|NCT01952574|559211866|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
155044229|NCT02588092|559592072|FG009|Overall Study|Started Another Treatment|0|||
155044230|NCT02588092|559592063|FG000|Overall Study|Sponsor Decision|0|||
155044231|NCT02588092|559592064|FG001|Overall Study|Sponsor Decision|0|||
155044232|NCT02588092|559592065|FG002|Overall Study|Sponsor Decision|0|||
155044233|NCT02588092|559592066|FG003|Overall Study|Sponsor Decision|0|||
155044234|NCT02588092|559592067|FG004|Overall Study|Sponsor Decision|0|||
155044235|NCT02588092|559592068|FG005|Overall Study|Sponsor Decision|0|||
155044236|NCT02588092|559592069|FG006|Overall Study|Sponsor Decision|0|||
155044237|NCT02588092|559592070|FG007|Overall Study|Sponsor Decision|0|||
155044238|NCT02588092|559592071|FG008|Overall Study|Sponsor Decision|1|||
155044239|NCT02588092|559592072|FG009|Overall Study|Sponsor Decision|1|||
155044240|NCT03882957|559592075|FG000|Overall Study|Did not complete all three arms|1|||
155044241|NCT03762681|559592076|FG000|Part 1|Withdrawal by Subject|0|||
155044242|NCT03762681|559592077|FG001|Part 1|Withdrawal by Subject|0|||
155044243|NCT03762681|559592078|FG002|Part 1|Withdrawal by Subject|0|||
155044244|NCT03762681|559592079|FG003|Part 1|Withdrawal by Subject|1|||
155044245|NCT03762681|559592080|FG004|Part 1|Withdrawal by Subject|0|||
155044246|NCT03762681|559592081|FG005|Part 1|Withdrawal by Subject|0|||
155044247|NCT03762681|559592082|FG006|Part 1|Withdrawal by Subject|0|||
155044248|NCT03762681|559592083|FG007|Part 1|Withdrawal by Subject|0|||
155044249|NCT03762681|559592076|FG000|Part 2a|Pandemic Travel Restrictions|0|||
155044250|NCT03762681|559592077|FG001|Part 2a|Pandemic Travel Restrictions|0|||
155044251|NCT03762681|559592078|FG002|Part 2a|Pandemic Travel Restrictions|0|||
155044252|NCT03762681|559592079|FG003|Part 2a|Pandemic Travel Restrictions|0|||
155044253|NCT03762681|559592080|FG004|Part 2a|Pandemic Travel Restrictions|0|||
155044254|NCT03762681|559592081|FG005|Part 2a|Pandemic Travel Restrictions|0|||
155044255|NCT03762681|559592082|FG006|Part 2a|Pandemic Travel Restrictions|0|||
155044256|NCT03762681|559592083|FG007|Part 2a|Pandemic Travel Restrictions|1|||
155044257|NCT03148067|559592087|FG000|Overall Study|Lost to Follow-up|3|||
155044258|NCT03148067|559592087|FG000|Overall Study|Death|1|||
155044259|NCT03337048|559592089|FG000|Overall Study|Withdrawal by Subject|2|||
155044260|NCT03337048|559592090|FG001|Overall Study|Withdrawal by Subject|0|||
155044261|NCT03337048|559592091|FG002|Overall Study|Withdrawal by Subject|0|||
155044262|NCT02070978|559592094|FG000|Overall Study|Adverse Event|6|||
155044263|NCT02070978|559592095|FG001|Overall Study|Adverse Event|2|||
155044264|NCT02070978|559592096|FG002|Overall Study|Adverse Event|0|||
155044265|NCT02070978|559592094|FG000|Overall Study|Lost to Follow-up|1|||
154941524|NCT01952574|559211867|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
154941525|NCT01952574|559211868|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
154941526|NCT01952574|559211869|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
154941527|NCT01952574|559211870|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
154941528|NCT01952574|559211871|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
154941529|NCT01952574|559211865|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
154941530|NCT01952574|559211866|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
154941531|NCT01952574|559211867|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
154941532|NCT01952574|559211868|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
154941533|NCT01952574|559211869|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
154941534|NCT01952574|559211870|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
154941535|NCT01952574|559211871|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
154941536|NCT01952574|559211865|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
154941537|NCT01952574|559211866|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
154941538|NCT01952574|559211867|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
154941539|NCT01952574|559211868|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
154941540|NCT01952574|559211869|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
154941541|NCT01952574|559211870|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
154941542|NCT01952574|559211871|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
154941543|NCT01952574|559211865|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
154941544|NCT01952574|559211866|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
154941545|NCT01952574|559211867|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
154941546|NCT01952574|559211868|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
155044266|NCT02070978|559592095|FG001|Overall Study|Lost to Follow-up|3|||
155044267|NCT02070978|559592096|FG002|Overall Study|Lost to Follow-up|4|||
155044268|NCT02070978|559592094|FG000|Overall Study|Withdrawal by Subject|3|||
155044269|NCT02070978|559592095|FG001|Overall Study|Withdrawal by Subject|5|||
155044270|NCT02070978|559592096|FG002|Overall Study|Withdrawal by Subject|3|||
155044271|NCT02070978|559592094|FG000|Overall Study|Protocol Violation|1|||
155044272|NCT02070978|559592095|FG001|Overall Study|Protocol Violation|0|||
155044273|NCT02070978|559592096|FG002|Overall Study|Protocol Violation|3|||
155044274|NCT02070978|559592094|FG000|Overall Study|Lack of Efficacy|0|||
155044275|NCT02070978|559592095|FG001|Overall Study|Lack of Efficacy|1|||
155044276|NCT02070978|559592096|FG002|Overall Study|Lack of Efficacy|0|||
155044277|NCT02070978|559592094|FG000|Overall Study|Death|0|||
155044278|NCT02070978|559592095|FG001|Overall Study|Death|0|||
155044279|NCT02070978|559592096|FG002|Overall Study|Death|2|||
155044280|NCT02070978|559592094|FG000|Overall Study|Un-specified|3|||
155044281|NCT02070978|559592095|FG001|Overall Study|Un-specified|2|||
155044282|NCT02070978|559592096|FG002|Overall Study|Un-specified|2|||
155044283|NCT02070978|559592094|FG000|Overall Study|Terminated by Sponsor|33|||
155044284|NCT02070978|559592095|FG001|Overall Study|Terminated by Sponsor|40|||
155044285|NCT02070978|559592096|FG002|Overall Study|Terminated by Sponsor|39|||
155044286|NCT02753816|559593886|FG000|Overall Study|Protocol Violation|0|||
155044287|NCT02753816|559593887|FG001|Overall Study|Protocol Violation|1|||
155044288|NCT02753816|559593888|FG002|Overall Study|Protocol Violation|0|||
155044289|NCT02259400|559593889|FG000|Overall Study|Death|0|||
155044290|NCT02259400|559593890|FG001|Overall Study|Death|2|||
155044291|NCT02372383|559593894|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
155044292|NCT02372383|559593895|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
154941547|NCT01952574|559211869|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
155278197|NCT00810641|560451166|FG000|Overall Study|Withdrawal by Subject|0|||
155278198|NCT00810641|560451167|FG001|Overall Study|Withdrawal by Subject|1|||
155278199|NCT00810641|560451168|FG002|Overall Study|Withdrawal by Subject|2|||
155278200|NCT02325713|560451171|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278201|NCT02325713|560451172|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278202|NCT02325713|560451173|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278203|NCT02325713|560451174|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278204|NCT02325713|560451175|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278205|NCT02325713|560451176|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278206|NCT02325713|560451177|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278207|NCT02325713|560451178|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
154941548|NCT01952574|559211870|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
154941549|NCT01952574|559211871|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
154941550|NCT01952574|559211865|FG000|Open-label Treatment Phase|Missing|0|||
154941551|NCT01952574|559211866|FG001|Open-label Treatment Phase|Missing|0|||
154941552|NCT01952574|559211867|FG002|Open-label Treatment Phase|Missing|0|||
154941553|NCT01952574|559211868|FG003|Open-label Treatment Phase|Missing|0|||
154941554|NCT01952574|559211869|FG004|Open-label Treatment Phase|Missing|4|||
154941555|NCT01952574|559211870|FG005|Open-label Treatment Phase|Missing|0|||
154941556|NCT01952574|559211871|FG006|Open-label Treatment Phase|Missing|0|||
154941557|NCT01952574|559211865|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
154941558|NCT01952574|559211866|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
154941559|NCT01952574|559211867|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
154941560|NCT01952574|559211868|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
154941561|NCT01952574|559211869|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
154941562|NCT01952574|559211870|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
154941563|NCT01952574|559211871|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
155044293|NCT02372383|559593896|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
155044294|NCT01255904|559593897|FG000|Overall Study|Physician Decision|1|||
155044295|NCT01255904|559593898|FG001|Overall Study|Physician Decision|4|||
155044296|NCT02061813|559593900|FG000|Overall Study|Withdrawal by Subject|1|||
155044297|NCT02061813|559593900|FG000|Overall Study|Protocol Violation|2|||
155044298|NCT01705080|559593901|FG000|Overall Study|Missed visit|10|||
155044299|NCT01705080|559593902|FG001|Overall Study|Missed visit|4|||
155044300|NCT01705080|559593903|FG002|Overall Study|Missed visit|1|||
155044301|NCT01705080|559593901|FG000|Overall Study|Death|4|||
155044302|NCT01705080|559593902|FG001|Overall Study|Death|4|||
155044303|NCT01705080|559593903|FG002|Overall Study|Death|6|||
155044304|NCT01705080|559593901|FG000|Overall Study|Withdrawal by Subject|61|||
155044305|NCT01705080|559593902|FG001|Overall Study|Withdrawal by Subject|44|||
155044306|NCT01705080|559593903|FG002|Overall Study|Withdrawal by Subject|9|||
155278208|NCT02325713|560451179|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278209|NCT02325713|560451180|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278210|NCT02325713|560451181|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
155278211|NCT02325713|560451182|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
154941564|NCT01952574|559211865|FG000|Open-label Treatment Phase|Death|0|||
154941565|NCT01952574|559211866|FG001|Open-label Treatment Phase|Death|0|||
154941566|NCT01952574|559211867|FG002|Open-label Treatment Phase|Death|0|||
154941567|NCT01952574|559211868|FG003|Open-label Treatment Phase|Death|0|||
154941568|NCT01952574|559211869|FG004|Open-label Treatment Phase|Death|1|||
155044307|NCT01704755|559593907|FG000|Overall Study|Adverse Event|4|||
155044308|NCT01704755|559593908|FG001|Overall Study|Adverse Event|1|||
155044309|NCT01704755|559593907|FG000|Overall Study|Lost to Follow-up|3|||
155044310|NCT01704755|559593908|FG001|Overall Study|Lost to Follow-up|4|||
155044311|NCT01704755|559593907|FG000|Overall Study|Withdrew consent|1|||
155044312|NCT01704755|559593908|FG001|Overall Study|Withdrew consent|1|||
155044313|NCT01704755|559593907|FG000|Overall Study|Other (not specified)|3|||
155044314|NCT01704755|559593908|FG001|Overall Study|Other (not specified)|1|||
155044315|NCT01704755|559593907|FG000|Overall Study|Withdrew consent and personal issues|1|||
155044316|NCT01704755|559593908|FG001|Overall Study|Withdrew consent and personal issues|0|||
155044317|NCT02075008|559593921|FG000|Overall Study|Technical problems|1|||
155044318|NCT02075008|559593921|FG000|Overall Study|Pregnancy|1|||
155044319|NCT02075008|559593921|FG000|Overall Study|Physician Decision|1|||
155044320|NCT02075008|559593921|FG000|Overall Study|Lost to Follow-up|1|||
155044321|NCT02075008|559593921|FG000|Overall Study|Lack of Efficacy|1|||
155044322|NCT02075008|559593921|FG000|Overall Study|Death|1|||
155044323|NCT02075008|559593921|FG000|Overall Study|Adverse Event|5|||
155044324|NCT02075008|559593921|FG000|Overall Study|Withdrawal by Subject|6|||
155044325|NCT02075008|559593921|FG000|Overall Study|Study terminated by Sponsor|159|||
155044326|NCT03130959|559593922|FG000|Overall Study|Disease progression|19|||
155044327|NCT03130959|559593923|FG001|Overall Study|Disease progression|7|||
155044328|NCT03130959|559593924|FG002|Overall Study|Disease progression|12|||
155044329|NCT03130959|559593925|FG003|Overall Study|Disease progression|7|||
155044330|NCT03130959|559593926|FG004|Overall Study|Disease progression|12|||
155044331|NCT03130959|559593927|FG005|Overall Study|Disease progression|3|||
155044332|NCT03130959|559593928|FG006|Overall Study|Disease progression|6|||
155044333|NCT03130959|559593929|FG007|Overall Study|Disease progression|3|||
155044334|NCT03130959|559593930|FG008|Overall Study|Disease progression|15|||
155044335|NCT03130959|559593931|FG009|Overall Study|Disease progression|8|||
155044336|NCT03130959|559593922|FG000|Overall Study|Study drug toxicity|2|||
155044337|NCT03130959|559593923|FG001|Overall Study|Study drug toxicity|2|||
155044338|NCT03130959|559593924|FG002|Overall Study|Study drug toxicity|1|||
155044339|NCT03130959|559593925|FG003|Overall Study|Study drug toxicity|2|||
155044340|NCT03130959|559593926|FG004|Overall Study|Study drug toxicity|1|||
155044341|NCT03130959|559593927|FG005|Overall Study|Study drug toxicity|1|||
155044342|NCT03130959|559593928|FG006|Overall Study|Study drug toxicity|3|||
155044343|NCT03130959|559593929|FG007|Overall Study|Study drug toxicity|0|||
155044344|NCT03130959|559593930|FG008|Overall Study|Study drug toxicity|3|||
155044345|NCT03130959|559593931|FG009|Overall Study|Study drug toxicity|3|||
155044346|NCT03130959|559593922|FG000|Overall Study|Other reasons|0|||
155044347|NCT03130959|559593923|FG001|Overall Study|Other reasons|0|||
155044348|NCT03130959|559593924|FG002|Overall Study|Other reasons|0|||
155044349|NCT03130959|559593925|FG003|Overall Study|Other reasons|0|||
155044350|NCT03130959|559593926|FG004|Overall Study|Other reasons|0|||
155044351|NCT03130959|559593927|FG005|Overall Study|Other reasons|1|||
155044352|NCT03130959|559593928|FG006|Overall Study|Other reasons|1|||
155044353|NCT03130959|559593929|FG007|Overall Study|Other reasons|0|||
155044354|NCT03130959|559593930|FG008|Overall Study|Other reasons|0|||
155044355|NCT03130959|559593931|FG009|Overall Study|Other reasons|0|||
155044356|NCT03130959|559593922|FG000|Overall Study|Subject request to discontinue therapy|0|||
155044357|NCT03130959|559593923|FG001|Overall Study|Subject request to discontinue therapy|0|||
155044358|NCT03130959|559593924|FG002|Overall Study|Subject request to discontinue therapy|1|||
155044359|NCT03130959|559593925|FG003|Overall Study|Subject request to discontinue therapy|1|||
155044360|NCT03130959|559593926|FG004|Overall Study|Subject request to discontinue therapy|0|||
155044361|NCT03130959|559593927|FG005|Overall Study|Subject request to discontinue therapy|0|||
155044362|NCT03130959|559593928|FG006|Overall Study|Subject request to discontinue therapy|1|||
155044363|NCT03130959|559593929|FG007|Overall Study|Subject request to discontinue therapy|1|||
155044364|NCT03130959|559593930|FG008|Overall Study|Subject request to discontinue therapy|0|||
155044365|NCT03130959|559593931|FG009|Overall Study|Subject request to discontinue therapy|0|||
155044366|NCT03130959|559593922|FG000|Overall Study|Not reported|0|||
155044367|NCT03130959|559593923|FG001|Overall Study|Not reported|0|||
155044368|NCT03130959|559593924|FG002|Overall Study|Not reported|0|||
155044369|NCT03130959|559593925|FG003|Overall Study|Not reported|1|||
155044370|NCT03130959|559593926|FG004|Overall Study|Not reported|0|||
155044371|NCT03130959|559593927|FG005|Overall Study|Not reported|1|||
155044372|NCT03130959|559593928|FG006|Overall Study|Not reported|0|||
155044373|NCT03130959|559593929|FG007|Overall Study|Not reported|0|||
155044374|NCT03130959|559593930|FG008|Overall Study|Not reported|0|||
155044375|NCT03130959|559593931|FG009|Overall Study|Not reported|1|||
155044376|NCT03130959|559593922|FG000|Overall Study|Adverse Event unrelated to drug|0|||
155044377|NCT03130959|559593923|FG001|Overall Study|Adverse Event unrelated to drug|0|||
155044378|NCT03130959|559593924|FG002|Overall Study|Adverse Event unrelated to drug|1|||
155044379|NCT03130959|559593925|FG003|Overall Study|Adverse Event unrelated to drug|1|||
155044380|NCT03130959|559593926|FG004|Overall Study|Adverse Event unrelated to drug|1|||
155044381|NCT03130959|559593927|FG005|Overall Study|Adverse Event unrelated to drug|0|||
155044382|NCT03130959|559593928|FG006|Overall Study|Adverse Event unrelated to drug|1|||
155044383|NCT03130959|559593929|FG007|Overall Study|Adverse Event unrelated to drug|0|||
155044384|NCT03130959|559593930|FG008|Overall Study|Adverse Event unrelated to drug|1|||
155044385|NCT03130959|559593931|FG009|Overall Study|Adverse Event unrelated to drug|1|||
155044386|NCT03130959|559593922|FG000|Overall Study|Participant withdrew consent|0|||
155044387|NCT03130959|559593923|FG001|Overall Study|Participant withdrew consent|1|||
154941569|NCT01952574|559211870|FG005|Open-label Treatment Phase|Death|0|||
154941570|NCT01952574|559211871|FG006|Open-label Treatment Phase|Death|0|||
154941571|NCT01952574|559211865|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
154941572|NCT01952574|559211866|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
154941573|NCT01952574|559211867|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
154941574|NCT01952574|559211868|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
154941575|NCT01952574|559211869|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
155278212|NCT02325713|560451183|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278213|NCT02325713|560451184|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278214|NCT02325713|560451185|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278215|NCT02325713|560451186|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
155278216|NCT02325713|560451171|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
155278217|NCT02325713|560451172|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278218|NCT02325713|560451173|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278219|NCT02325713|560451174|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278220|NCT02325713|560451175|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278221|NCT02325713|560451176|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278222|NCT02325713|560451177|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278223|NCT02325713|560451178|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278224|NCT02325713|560451179|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278225|NCT02325713|560451180|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278226|NCT02325713|560451181|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278227|NCT02325713|560451182|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278228|NCT02325713|560451183|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278229|NCT02325713|560451184|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278230|NCT02325713|560451185|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278231|NCT02325713|560451186|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
155278232|NCT02325713|560451171|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278233|NCT02325713|560451172|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278234|NCT02325713|560451173|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278235|NCT02325713|560451174|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278236|NCT02325713|560451175|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278237|NCT02325713|560451176|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278238|NCT02325713|560451177|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278239|NCT02325713|560451178|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278240|NCT02325713|560451179|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278241|NCT02325713|560451180|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
155278242|NCT02325713|560451181|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278243|NCT02325713|560451182|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278244|NCT02325713|560451183|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278245|NCT02325713|560451184|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278246|NCT02325713|560451185|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278247|NCT02325713|560451186|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
155278248|NCT03363659|560451187|FG000|Overall Study|Adverse Event|1|||
155278249|NCT03363659|560451187|FG000|Overall Study|Screen fail|1|||
155278250|NCT03363659|560451187|FG000|Overall Study|Withdrawal by Subject|1|||
155278251|NCT01213173|560451189|FG000|Overall Study|Protocol Violation|2|||
155278252|NCT01213173|560451190|FG001|Overall Study|Protocol Violation|0|||
155278253|NCT01213173|560451189|FG000|Overall Study|Adverse Event|4|||
155278254|NCT01213173|560451190|FG001|Overall Study|Adverse Event|8|||
155278255|NCT01213173|560451189|FG000|Overall Study|Withdrawal by Subject|5|||
155278256|NCT01213173|560451190|FG001|Overall Study|Withdrawal by Subject|5|||
155278257|NCT01213173|560451189|FG000|Overall Study|Incorrect Enrollment|1|||
155278258|NCT01213173|560451190|FG001|Overall Study|Incorrect Enrollment|3|||
155278259|NCT02253316|560451191|FG000|Consolidation|Progression|4|||
155278260|NCT02253316|560451192|FG001|Consolidation|Progression|0|||
155278261|NCT02253316|560451193|FG002|Consolidation|Progression|0|||
155278262|NCT02253316|560451191|FG000|Consolidation|Non-Compliance|1|||
155278263|NCT02253316|560451192|FG001|Consolidation|Non-Compliance|0|||
155278264|NCT02253316|560451193|FG002|Consolidation|Non-Compliance|0|||
155278265|NCT02253316|560451191|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
155278266|NCT02253316|560451192|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
155278267|NCT02253316|560451193|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
155278268|NCT02253316|560451191|FG000|Consolidation|Secondary Malignancy|2|||
155278269|NCT02253316|560451192|FG001|Consolidation|Secondary Malignancy|0|||
155278270|NCT02253316|560451193|FG002|Consolidation|Secondary Malignancy|0|||
155278271|NCT02253316|560451191|FG000|Consolidation|Adverse Event|7|||
155278272|NCT02253316|560451192|FG001|Consolidation|Adverse Event|0|||
155278273|NCT02253316|560451193|FG002|Consolidation|Adverse Event|0|||
155278274|NCT02253316|560451191|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
155278275|NCT02253316|560451192|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
155278276|NCT02253316|560451193|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
155278277|NCT02253316|560451191|FG000|Maintenance|Physician Decision|0|||
155278278|NCT02253316|560451192|FG001|Maintenance|Physician Decision|7|||
155278279|NCT02253316|560451193|FG002|Maintenance|Physician Decision|16|||
155278280|NCT02253316|560451191|FG000|Maintenance|Non-Compliance|0|||
155278281|NCT02253316|560451192|FG001|Maintenance|Non-Compliance|1|||
155278282|NCT02253316|560451193|FG002|Maintenance|Non-Compliance|1|||
155278283|NCT02253316|560451191|FG000|Maintenance|Secondary Malignancy|0|||
155278284|NCT02253316|560451192|FG001|Maintenance|Secondary Malignancy|2|||
155278285|NCT02253316|560451193|FG002|Maintenance|Secondary Malignancy|6|||
155278286|NCT02253316|560451191|FG000|Maintenance|Adverse Event|0|||
155278287|NCT02253316|560451192|FG001|Maintenance|Adverse Event|8|||
155278288|NCT02253316|560451193|FG002|Maintenance|Adverse Event|12|||
155278289|NCT02253316|560451191|FG000|Maintenance|Still receiving active treatment|0|||
155278290|NCT02253316|560451192|FG001|Maintenance|Still receiving active treatment|4|||
155278291|NCT02253316|560451193|FG002|Maintenance|Still receiving active treatment|0|||
155278292|NCT02353832|560451194|FG000|Overall Study|Ineligible after enrollment|1|||
155278293|NCT02353832|560451194|FG000|Overall Study|Lost to Follow-up|1|||
155278294|NCT00904150|560451195|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
155278295|NCT00904150|560451196|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
155278296|NCT00904150|560451195|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
155278297|NCT00904150|560451196|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
155278298|NCT02692235|560453123|FG000|Overall Study|Withdrawal by Subject|2|||
155278299|NCT02692235|560453124|FG001|Overall Study|Withdrawal by Subject|1|||
155278300|NCT02692235|560453123|FG000|Overall Study|Adverse Event|1|||
155278301|NCT02692235|560453124|FG001|Overall Study|Adverse Event|2|||
155278302|NCT00802841|560453125|FG000|Overall Study|Administrative problems|1|||
155278303|NCT00802841|560453126|FG001|Overall Study|Administrative problems|0|||
155278304|NCT00802841|560453125|FG000|Overall Study|Lost to Follow-up|2|||
154941576|NCT01952574|559211870|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
154941577|NCT01952574|559211871|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
154941578|NCT01952574|559211865|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
154941579|NCT01952574|559211866|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
154941580|NCT01952574|559211867|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
154941581|NCT01952574|559211868|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
154941582|NCT01952574|559211869|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
154941583|NCT01952574|559211870|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
154941584|NCT01952574|559211871|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
154941585|NCT00770991|559211875|FG000|Overall Study|Physician Decision|2|||
154941586|NCT00770991|559211876|FG001|Overall Study|Physician Decision|0|||
154941587|NCT00770991|559211875|FG000|Overall Study|Withdrawal by Subject|1|||
154941588|NCT00770991|559211876|FG001|Overall Study|Withdrawal by Subject|0|||
154941589|NCT00770991|559211875|FG000|Overall Study|Adverse Event|1|||
154941590|NCT00770991|559211876|FG001|Overall Study|Adverse Event|5|||
154941591|NCT00770991|559211875|FG000|Overall Study|Pregnancy|1|||
154941592|NCT00770991|559211876|FG001|Overall Study|Pregnancy|0|||
154941593|NCT03687125|559211877|FG000|Overall Study|Progressive Disease|2|||
154941594|NCT03687125|559211878|FG001|Overall Study|Progressive Disease|1|||
154941595|NCT03687125|559211877|FG000|Overall Study|Protocol Violation|1|||
154941596|NCT03687125|559211878|FG001|Overall Study|Protocol Violation|0|||
154941597|NCT01992107|559211879|FG000|Overall Study|Administrative reasons|2|||
154941598|NCT01992107|559211880|FG001|Overall Study|Administrative reasons|0|||
154941599|NCT01992107|559211881|FG002|Overall Study|Administrative reasons|0|||
154941600|NCT01992107|559211879|FG000|Overall Study|Adverse Event|0|||
154941601|NCT01992107|559211880|FG001|Overall Study|Adverse Event|1|||
154941602|NCT01992107|559211881|FG002|Overall Study|Adverse Event|0|||
154941603|NCT01992107|559211879|FG000|Overall Study|Lost to Follow-up|46|||
154941604|NCT01992107|559211880|FG001|Overall Study|Lost to Follow-up|22|||
154941605|NCT01992107|559211881|FG002|Overall Study|Lost to Follow-up|26|||
154941606|NCT01992107|559211879|FG000|Overall Study|noncompliance and were unavailable|7|||
154941607|NCT01992107|559211880|FG001|Overall Study|noncompliance and were unavailable|3|||
154941608|NCT01992107|559211881|FG002|Overall Study|noncompliance and were unavailable|2|||
154941609|NCT01992107|559211879|FG000|Overall Study|Withdrawal by Subject|13|||
154941610|NCT01992107|559211880|FG001|Overall Study|Withdrawal by Subject|7|||
154941611|NCT01992107|559211881|FG002|Overall Study|Withdrawal by Subject|8|||
154941612|NCT02022007|559211882|FG000|Overall Study|Withdrawal by Subject|1|||
154941613|NCT02022007|559211883|FG001|Overall Study|Withdrawal by Subject|1|||
154941614|NCT02022007|559211884|FG002|Overall Study|Withdrawal by Subject|1|||
154941615|NCT02022007|559211882|FG000|Overall Study|Noncompliant|0|||
155278305|NCT00802841|560453126|FG001|Overall Study|Lost to Follow-up|1|||
155278306|NCT00802841|560453125|FG000|Overall Study|Death|1|||
155278307|NCT00802841|560453126|FG001|Overall Study|Death|2|||
155278308|NCT00802841|560453125|FG000|Overall Study|Adverse Event|8|||
155278309|NCT00802841|560453126|FG001|Overall Study|Adverse Event|2|||
155278310|NCT00802841|560453125|FG000|Overall Study|Disease progression|7|||
155044388|NCT03130959|559593924|FG002|Overall Study|Participant withdrew consent|0|||
155044389|NCT03130959|559593925|FG003|Overall Study|Participant withdrew consent|2|||
155044390|NCT03130959|559593926|FG004|Overall Study|Participant withdrew consent|1|||
155044391|NCT03130959|559593927|FG005|Overall Study|Participant withdrew consent|0|||
155044392|NCT03130959|559593928|FG006|Overall Study|Participant withdrew consent|0|||
155044393|NCT03130959|559593929|FG007|Overall Study|Participant withdrew consent|0|||
155044394|NCT03130959|559593930|FG008|Overall Study|Participant withdrew consent|0|||
155044395|NCT03130959|559593931|FG009|Overall Study|Participant withdrew consent|2|||
155044396|NCT03130959|559593922|FG000|Overall Study|Administrative reason by sponsor|1|||
155044397|NCT03130959|559593923|FG001|Overall Study|Administrative reason by sponsor|0|||
155044398|NCT03130959|559593924|FG002|Overall Study|Administrative reason by sponsor|1|||
155044399|NCT03130959|559593925|FG003|Overall Study|Administrative reason by sponsor|0|||
155044400|NCT03130959|559593926|FG004|Overall Study|Administrative reason by sponsor|0|||
155044401|NCT03130959|559593927|FG005|Overall Study|Administrative reason by sponsor|0|||
155044402|NCT03130959|559593928|FG006|Overall Study|Administrative reason by sponsor|0|||
155044403|NCT03130959|559593929|FG007|Overall Study|Administrative reason by sponsor|0|||
155044404|NCT03130959|559593930|FG008|Overall Study|Administrative reason by sponsor|0|||
155044405|NCT03130959|559593931|FG009|Overall Study|Administrative reason by sponsor|0|||
155044406|NCT03130959|559593922|FG000|Overall Study|Lost to Follow-up|1|||
155044407|NCT03130959|559593923|FG001|Overall Study|Lost to Follow-up|0|||
155044408|NCT03130959|559593924|FG002|Overall Study|Lost to Follow-up|0|||
155044409|NCT03130959|559593925|FG003|Overall Study|Lost to Follow-up|0|||
155044410|NCT03130959|559593926|FG004|Overall Study|Lost to Follow-up|0|||
155044411|NCT03130959|559593927|FG005|Overall Study|Lost to Follow-up|0|||
155044412|NCT03130959|559593928|FG006|Overall Study|Lost to Follow-up|0|||
155044413|NCT03130959|559593929|FG007|Overall Study|Lost to Follow-up|0|||
155044414|NCT03130959|559593930|FG008|Overall Study|Lost to Follow-up|0|||
155044415|NCT03130959|559593931|FG009|Overall Study|Lost to Follow-up|0|||
155044416|NCT04446429|559593932|FG000|Overall Study|Lost to Follow-up|6|||
155044417|NCT04446429|559593933|FG001|Overall Study|Lost to Follow-up|0|||
155044418|NCT05205005|559593934|FG000|Overall Study|Withdrawal by Subject|1|||
155044419|NCT05205005|559593935|FG001|Overall Study|Withdrawal by Subject|0|||
155044420|NCT05205005|559593934|FG000|Overall Study|Adverse Event|1|||
155044421|NCT05205005|559593935|FG001|Overall Study|Adverse Event|0|||
155044422|NCT02821416|559593936|FG000|Overall Study|Adverse Event|0|||
155044423|NCT02821416|559593937|FG001|Overall Study|Adverse Event|1|||
155044424|NCT02821416|559593936|FG000|Overall Study|Withdrawal by Subject|2|||
155044425|NCT02821416|559593937|FG001|Overall Study|Withdrawal by Subject|0|||
155044426|NCT02821416|559593936|FG000|Overall Study|Lost to Follow-up|1|||
155044427|NCT02821416|559593937|FG001|Overall Study|Lost to Follow-up|0|||
155044428|NCT03042910|559593942|FG000|Overall Study|Adverse Event|1|||
155044429|NCT03042910|559593942|FG000|Overall Study|Disease Progression|2|||
155044430|NCT03042910|559593942|FG000|Overall Study|Withdrawal by Subject|3|||
155044431|NCT03042910|559593942|FG000|Overall Study|Enrolled but not treated|1|||
155044432|NCT02256917|559593943|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
155044433|NCT02256917|559593943|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
155044434|NCT02256917|559593943|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
155044435|NCT02256917|559593943|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
155044436|NCT02256917|559593943|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
155044437|NCT02933528|559593944|FG000|Overall Study|Lost to Follow-up|2|||
155044438|NCT00313586|559593947|FG000|Overall Study|Disease progression|14|||
155044439|NCT00313586|559593948|FG001|Overall Study|Disease progression|19|||
155044440|NCT00313586|559593949|FG002|Overall Study|Disease progression|10|||
155044441|NCT00313586|559593950|FG003|Overall Study|Disease progression|3|||
155044442|NCT00313586|559593947|FG000|Overall Study|Adverse Event|12|||
155044443|NCT00313586|559593948|FG001|Overall Study|Adverse Event|18|||
155044444|NCT00313586|559593949|FG002|Overall Study|Adverse Event|3|||
155044445|NCT00313586|559593950|FG003|Overall Study|Adverse Event|10|||
155044446|NCT00313586|559593947|FG000|Overall Study|Death|11|||
155044447|NCT00313586|559593948|FG001|Overall Study|Death|8|||
155044448|NCT00313586|559593949|FG002|Overall Study|Death|1|||
155044449|NCT00313586|559593950|FG003|Overall Study|Death|7|||
155044450|NCT00313586|559593947|FG000|Overall Study|Withdrawal by Subject|13|||
155044451|NCT00313586|559593948|FG001|Overall Study|Withdrawal by Subject|6|||
155044452|NCT00313586|559593949|FG002|Overall Study|Withdrawal by Subject|6|||
155044453|NCT00313586|559593950|FG003|Overall Study|Withdrawal by Subject|2|||
155044454|NCT00313586|559593947|FG000|Overall Study|Alternative therapy|3|||
155044455|NCT00313586|559593948|FG001|Overall Study|Alternative therapy|6|||
155044456|NCT00313586|559593949|FG002|Overall Study|Alternative therapy|2|||
155044457|NCT00313586|559593950|FG003|Overall Study|Alternative therapy|0|||
155044458|NCT00313586|559593947|FG000|Overall Study|Other complicating disease|2|||
155044459|NCT00313586|559593948|FG001|Overall Study|Other complicating disease|2|||
155044460|NCT00313586|559593949|FG002|Overall Study|Other complicating disease|0|||
155044461|NCT00313586|559593950|FG003|Overall Study|Other complicating disease|0|||
155044462|NCT00313586|559593947|FG000|Overall Study|Did not achieve HI-major/better response|10|||
155044463|NCT00313586|559593948|FG001|Overall Study|Did not achieve HI-major/better response|7|||
155278311|NCT00802841|560453126|FG001|Overall Study|Disease progression|3|||
154941616|NCT02022007|559211883|FG001|Overall Study|Noncompliant|0|||
154941617|NCT02022007|559211884|FG002|Overall Study|Noncompliant|1|||
154941618|NCT02087046|559211886|FG000|Overall Study|Adverse Event|4|||
154941619|NCT02087046|559211886|FG000|Overall Study|Death|1|||
154941620|NCT02087046|559211886|FG000|Overall Study|Lost to Follow-up|3|||
154941621|NCT02087046|559211886|FG000|Overall Study|Withdrawal by Subject|2|||
154941622|NCT02087046|559211886|FG000|Overall Study|Physician Decision|1|||
154941623|NCT02444533|559211887|FG000|Overall Study|Not able to complete forms|0|||
154941624|NCT02444533|559211888|FG001|Overall Study|Not able to complete forms|2|||
154941625|NCT02444533|559211887|FG000|Overall Study|Only gave post-procedure complications|2|||
154941626|NCT02444533|559211888|FG001|Overall Study|Only gave post-procedure complications|2|||
154941627|NCT03567057|559211889|FG000|Overall Study|Adverse Event|56|||
154941628|NCT03567057|559211890|FG001|Overall Study|Adverse Event|53|||
154941629|NCT03567057|559211891|FG002|Overall Study|Adverse Event|28|||
154941630|NCT03567057|559211889|FG000|Overall Study|Withdrawal by Subject|22|||
154941631|NCT03567057|559211890|FG001|Overall Study|Withdrawal by Subject|24|||
154941632|NCT03567057|559211891|FG002|Overall Study|Withdrawal by Subject|13|||
154941633|NCT03567057|559211889|FG000|Overall Study|Lost to Follow-up|3|||
154941634|NCT03567057|559211890|FG001|Overall Study|Lost to Follow-up|5|||
154941635|NCT03567057|559211891|FG002|Overall Study|Lost to Follow-up|2|||
154941636|NCT03567057|559211889|FG000|Overall Study|COVID-19 pandemic|4|||
154941637|NCT03567057|559211890|FG001|Overall Study|COVID-19 pandemic|3|||
154941638|NCT03567057|559211891|FG002|Overall Study|COVID-19 pandemic|0|||
154941639|NCT03567057|559211889|FG000|Overall Study|Non-compliance with study drug|4|||
154941640|NCT03567057|559211890|FG001|Overall Study|Non-compliance with study drug|2|||
154941641|NCT03567057|559211891|FG002|Overall Study|Non-compliance with study drug|0|||
154941642|NCT03567057|559211889|FG000|Overall Study|Lack of Efficacy|3|||
154941643|NCT03567057|559211890|FG001|Overall Study|Lack of Efficacy|0|||
154941644|NCT03567057|559211891|FG002|Overall Study|Lack of Efficacy|1|||
154941645|NCT03567057|559211889|FG000|Overall Study|Death|1|||
154941646|NCT03567057|559211890|FG001|Overall Study|Death|0|||
154941647|NCT03567057|559211891|FG002|Overall Study|Death|0|||
154941648|NCT03567057|559211889|FG000|Overall Study|Physician Decision|1|||
154941649|NCT03567057|559211890|FG001|Overall Study|Physician Decision|0|||
154941650|NCT03567057|559211891|FG002|Overall Study|Physician Decision|0|||
154941651|NCT03567057|559211889|FG000|Overall Study|Unstable medical condition|1|||
154941652|NCT03567057|559211890|FG001|Overall Study|Unstable medical condition|0|||
154941653|NCT03567057|559211891|FG002|Overall Study|Unstable medical condition|0|||
154941654|NCT03567057|559211889|FG000|Overall Study|Medical history event|0|||
154941655|NCT03567057|559211890|FG001|Overall Study|Medical history event|0|||
154941656|NCT03567057|559211891|FG002|Overall Study|Medical history event|1|||
154941657|NCT03567057|559211889|FG000|Overall Study|Other|0|||
154941658|NCT03567057|559211890|FG001|Overall Study|Other|0|||
154941659|NCT03567057|559211891|FG002|Overall Study|Other|1|||
154941660|NCT00886483|559211894|FG000|Overall Study|Lost to Follow-up|0|||
154941661|NCT00886483|559211895|FG001|Overall Study|Lost to Follow-up|1|||
154941662|NCT00886483|559211894|FG000|Overall Study|Pursue medications|1|||
154941663|NCT00886483|559211895|FG001|Overall Study|Pursue medications|2|||
154941664|NCT00886483|559211894|FG000|Overall Study|Distance to center, poor grades|1|||
154941665|NCT00886483|559211895|FG001|Overall Study|Distance to center, poor grades|0|||
154941666|NCT01001169|559211896|FG000|Overall Study|Withdrawal by Subject|2|||
154941667|NCT01001169|559211897|FG001|Overall Study|Withdrawal by Subject|1|||
154941668|NCT02536378|559211900|FG000|Overall Study|Physician Decision|0|||
154941669|NCT02536378|559211901|FG001|Overall Study|Physician Decision|2|||
154941670|NCT02536378|559211900|FG000|Overall Study|Withdrawal by Subject|0|||
154941671|NCT02536378|559211901|FG001|Overall Study|Withdrawal by Subject|1|||
154941672|NCT02536378|559211900|FG000|Overall Study|Death|1|||
154941673|NCT02536378|559211901|FG001|Overall Study|Death|2|||
154941674|NCT02536378|559211900|FG000|Overall Study|Patient refused further follow up|6|||
154941675|NCT02536378|559211901|FG001|Overall Study|Patient refused further follow up|2|||
154941676|NCT01271933|559211902|FG000|Single-Blind Phase|Lack of Efficacy|37|||
154941677|NCT01271933|559211903|FG001|Single-Blind Phase|Lack of Efficacy|0|||
154941678|NCT01271933|559211904|FG002|Single-Blind Phase|Lack of Efficacy|0|||
154941679|NCT01271933|559211902|FG000|Single-Blind Phase|Lost to Follow-up|10|||
154941680|NCT01271933|559211903|FG001|Single-Blind Phase|Lost to Follow-up|0|||
154941681|NCT01271933|559211904|FG002|Single-Blind Phase|Lost to Follow-up|0|||
154941682|NCT01271933|559211902|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
154941683|NCT01271933|559211903|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
154941684|NCT01271933|559211904|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
154941685|NCT01271933|559211902|FG000|Single-Blind Phase|Protocol Violation|3|||
154941686|NCT01271933|559211903|FG001|Single-Blind Phase|Protocol Violation|0|||
154941687|NCT01271933|559211904|FG002|Single-Blind Phase|Protocol Violation|0|||
155278312|NCT00802841|560453125|FG000|Overall Study|Withdrawal by Subject|9|||
154941688|NCT01271933|559211902|FG000|Single-Blind Phase|Adverse Event|52|||
154941689|NCT01271933|559211903|FG001|Single-Blind Phase|Adverse Event|0|||
154941690|NCT01271933|559211904|FG002|Single-Blind Phase|Adverse Event|0|||
154941691|NCT01271933|559211902|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
154941692|NCT01271933|559211903|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
155044464|NCT00313586|559593949|FG002|Overall Study|Did not achieve HI-major/better response|2|||
155044465|NCT00313586|559593950|FG003|Overall Study|Did not achieve HI-major/better response|1|||
155044466|NCT00313586|559593947|FG000|Overall Study|Physician Decision|2|||
155044467|NCT00313586|559593948|FG001|Overall Study|Physician Decision|1|||
155044468|NCT00313586|559593949|FG002|Overall Study|Physician Decision|0|||
155044469|NCT00313586|559593950|FG003|Overall Study|Physician Decision|0|||
155044470|NCT00313586|559593947|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
155044471|NCT00313586|559593948|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
155044472|NCT00313586|559593949|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
155044473|NCT00313586|559593950|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
155044474|NCT00313586|559593947|FG000|Overall Study|Lost insurance|0|||
155044475|NCT00313586|559593948|FG001|Overall Study|Lost insurance|1|||
155044476|NCT00313586|559593949|FG002|Overall Study|Lost insurance|0|||
155044477|NCT00313586|559593950|FG003|Overall Study|Lost insurance|0|||
155044478|NCT00313586|559593947|FG000|Overall Study|Moved|0|||
155044479|NCT00313586|559593948|FG001|Overall Study|Moved|1|||
155044480|NCT00313586|559593949|FG002|Overall Study|Moved|0|||
155044481|NCT00313586|559593950|FG003|Overall Study|Moved|0|||
155044482|NCT00313586|559593947|FG000|Overall Study|Death before starting treatment|1|||
154941693|NCT01271933|559211904|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
154941694|NCT01271933|559211902|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
154941695|NCT01271933|559211903|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
154941696|NCT01271933|559211904|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
154941697|NCT01271933|559211902|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
154941698|NCT01271933|559211903|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
154941699|NCT01271933|559211904|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
154941700|NCT01271933|559211902|FG000|Double-Blind Phase|Randomized but not treated|0|||
154941701|NCT01271933|559211903|FG001|Double-Blind Phase|Randomized but not treated|0|||
154941702|NCT01271933|559211904|FG002|Double-Blind Phase|Randomized but not treated|1|||
154941703|NCT01271933|559211902|FG000|Double-Blind Phase|Lack of Efficacy|0|||
154941704|NCT01271933|559211903|FG001|Double-Blind Phase|Lack of Efficacy|6|||
154941705|NCT01271933|559211904|FG002|Double-Blind Phase|Lack of Efficacy|9|||
154941706|NCT01271933|559211902|FG000|Double-Blind Phase|Lost to Follow-up|0|||
154941707|NCT01271933|559211903|FG001|Double-Blind Phase|Lost to Follow-up|1|||
154941708|NCT01271933|559211904|FG002|Double-Blind Phase|Lost to Follow-up|1|||
154941709|NCT01271933|559211902|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
154941710|NCT01271933|559211903|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
154941711|NCT01271933|559211904|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
154941712|NCT01271933|559211902|FG000|Double-Blind Phase|Adverse Event|0|||
154941713|NCT01271933|559211903|FG001|Double-Blind Phase|Adverse Event|3|||
154941714|NCT01271933|559211904|FG002|Double-Blind Phase|Adverse Event|0|||
154941715|NCT01271933|559211902|FG000|Double-Blind Phase|Participant request-personal reason|0|||
154941716|NCT01271933|559211903|FG001|Double-Blind Phase|Participant request-personal reason|1|||
154941717|NCT01271933|559211904|FG002|Double-Blind Phase|Participant request-personal reason|0|||
154941718|NCT03156270|559211905|FG000|Overall Study|Failed pre-treatment screening|1|||
154941719|NCT03156270|559211905|FG000|Overall Study|Lost to Follow-up|1|||
154941720|NCT00871169|559211906|FG000|Overall Study|Protocol Violation|1|||
154941721|NCT00871169|559211906|FG000|Overall Study|Patient did not receive study treatment|2|||
154941722|NCT01102777|559211909|FG000|Overall Study|Death|2|||
154941723|NCT01102777|559211910|FG001|Overall Study|Death|6|||
154941724|NCT01102777|559211909|FG000|Overall Study|Lost to Follow-up|7|||
154941725|NCT01102777|559211910|FG001|Overall Study|Lost to Follow-up|10|||
154941726|NCT02175966|559211915|FG000|Follow-up Period|Lack of Efficacy|10|||
154941727|NCT02175966|559211916|FG001|Follow-up Period|Lack of Efficacy|6|||
154941728|NCT01752920|559211917|FG000|Overall Study|Adverse Event|1|||
154941729|NCT01752920|559211918|FG001|Overall Study|Adverse Event|0|||
154941730|NCT01752920|559211919|FG002|Overall Study|Adverse Event|5|||
154941731|NCT01752920|559211920|FG003|Overall Study|Adverse Event|10|||
154941732|NCT01752920|559211917|FG000|Overall Study|Clinical Disease Progression|6|||
154941733|NCT01752920|559211918|FG001|Overall Study|Clinical Disease Progression|4|||
154941734|NCT01752920|559211919|FG002|Overall Study|Clinical Disease Progression|1|||
154941735|NCT01752920|559211920|FG003|Overall Study|Clinical Disease Progression|13|||
154941736|NCT01752920|559211917|FG000|Overall Study|Physician Decision|1|||
154941737|NCT01752920|559211918|FG001|Overall Study|Physician Decision|0|||
154941738|NCT01752920|559211919|FG002|Overall Study|Physician Decision|0|||
154941739|NCT01752920|559211920|FG003|Overall Study|Physician Decision|3|||
154941740|NCT01752920|559211917|FG000|Overall Study|Radiographic Disease Progression|20|||
154941741|NCT01752920|559211918|FG001|Overall Study|Radiographic Disease Progression|7|||
154941742|NCT01752920|559211919|FG002|Overall Study|Radiographic Disease Progression|12|||
154941743|NCT01752920|559211920|FG003|Overall Study|Radiographic Disease Progression|29|||
154941744|NCT01752920|559211917|FG000|Overall Study|Study Terminated by Sponsor|0|||
154941745|NCT01752920|559211918|FG001|Overall Study|Study Terminated by Sponsor|0|||
154941746|NCT01752920|559211919|FG002|Overall Study|Study Terminated by Sponsor|0|||
154941747|NCT01752920|559211920|FG003|Overall Study|Study Terminated by Sponsor|1|||
154941748|NCT01752920|559211917|FG000|Overall Study|Withdrawal by Subject|0|||
154941749|NCT01752920|559211918|FG001|Overall Study|Withdrawal by Subject|1|||
154941750|NCT01752920|559211919|FG002|Overall Study|Withdrawal by Subject|0|||
154941751|NCT01752920|559211920|FG003|Overall Study|Withdrawal by Subject|1|||
154941752|NCT01752920|559211917|FG000|Overall Study|Lack of clinical benefit|1|||
154941753|NCT01752920|559211918|FG001|Overall Study|Lack of clinical benefit|1|||
154941754|NCT01752920|559211919|FG002|Overall Study|Lack of clinical benefit|1|||
154941755|NCT01752920|559211920|FG003|Overall Study|Lack of clinical benefit|1|||
154941756|NCT00947856|559211925|FG000|Treatment Period|Progressive Disease|33|||
154941757|NCT00947856|559211926|FG001|Treatment Period|Progressive Disease|12|||
154941758|NCT00947856|559211925|FG000|Treatment Period|Adverse Event|15|||
154941759|NCT00947856|559211926|FG001|Treatment Period|Adverse Event|9|||
154941760|NCT00947856|559211925|FG000|Treatment Period|Physician Decision|14|||
154941761|NCT00947856|559211926|FG001|Treatment Period|Physician Decision|6|||
154941762|NCT00947856|559211925|FG000|Treatment Period|Study Stopped by Sponsor|4|||
154941763|NCT00947856|559211926|FG001|Treatment Period|Study Stopped by Sponsor|4|||
154941764|NCT00947856|559211925|FG000|Treatment Period|Withdrawal by Subject|12|||
154941765|NCT00947856|559211926|FG001|Treatment Period|Withdrawal by Subject|1|||
154941766|NCT00947856|559211925|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
154941767|NCT00947856|559211926|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
154941768|NCT00947856|559211925|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
154941769|NCT00947856|559211926|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
154941770|NCT00947856|559211925|FG000|Follow-up Period|Lost to Follow-up|7|||
154941771|NCT00947856|559211926|FG001|Follow-up Period|Lost to Follow-up|0|||
154941772|NCT00947856|559211925|FG000|Follow-up Period|Patient unavailable for site visits|1|||
154941773|NCT00947856|559211926|FG001|Follow-up Period|Patient unavailable for site visits|0|||
154941774|NCT00947856|559211925|FG000|Follow-up Period|Withdrawal by Subject|1|||
154941775|NCT00947856|559211926|FG001|Follow-up Period|Withdrawal by Subject|0|||
154941776|NCT00771901|559211927|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
154941777|NCT00771901|559211928|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
154941778|NCT00771901|559211929|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
154941779|NCT02280356|559211930|FG000|Overall Study|Not Treated|2|||
154941780|NCT02280356|559211930|FG000|Overall Study|Withdrawal by Subject|1|||
154941781|NCT02280356|559211930|FG000|Overall Study|Not evaluable|2|||
154941782|NCT01086215|559211934|FG000|Overall Study|Death|14|||
154941783|NCT01086215|559211935|FG001|Overall Study|Death|8|||
154941784|NCT01086215|559211936|FG002|Overall Study|Death|8|||
154941785|NCT01086215|559211937|FG003|Overall Study|Death|1|||
154941786|NCT01086215|559211934|FG000|Overall Study|Lost to Follow-up|22|||
154941787|NCT01086215|559211935|FG001|Overall Study|Lost to Follow-up|39|||
154941788|NCT01086215|559211936|FG002|Overall Study|Lost to Follow-up|18|||
154941789|NCT01086215|559211937|FG003|Overall Study|Lost to Follow-up|2|||
154941790|NCT03493698|559211942|FG000|Treatment Period C|Adverse Event|1|||
154941791|NCT03493698|559211942|FG000|Treatment Period C|Withdrawal by Subject|1|||
154941792|NCT00566709|559211943|FG000|Overall Study|Protocol Violation|5|||
154941793|NCT00566709|559211944|FG001|Overall Study|Protocol Violation|0|||
154941794|NCT01829295|559211945|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
154941795|NCT01829295|559211946|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
154941796|NCT01829295|559211947|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
154941797|NCT01829295|559211948|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
154941798|NCT01829295|559211945|FG000|6-12 Months|Adverse Event|0|||
154941799|NCT01829295|559211946|FG001|6-12 Months|Adverse Event|0|||
154941800|NCT01829295|559211947|FG002|6-12 Months|Adverse Event|3|||
154941801|NCT01829295|559211948|FG003|6-12 Months|Adverse Event|2|||
154941802|NCT01829295|559211945|FG000|6-12 Months|Lost to Follow-up|2|||
154941803|NCT01829295|559211946|FG001|6-12 Months|Lost to Follow-up|0|||
154941804|NCT01829295|559211947|FG002|6-12 Months|Lost to Follow-up|0|||
154941805|NCT01829295|559211948|FG003|6-12 Months|Lost to Follow-up|0|||
154941806|NCT01829295|559211945|FG000|6-12 Months|Withdrawal by Subject|2|||
154941807|NCT01829295|559211946|FG001|6-12 Months|Withdrawal by Subject|2|||
154941808|NCT01829295|559211947|FG002|6-12 Months|Withdrawal by Subject|0|||
154941809|NCT01829295|559211948|FG003|6-12 Months|Withdrawal by Subject|0|||
154941810|NCT02230085|559211951|FG000|Overall Study|Physician Decision|1|||
154941811|NCT02230085|559211951|FG000|Overall Study|Withdrawal by Subject|3|||
154941812|NCT02173301|559211952|FG000|Overall Study|Adverse Event|7|||
154941813|NCT02173301|559211953|FG001|Overall Study|Adverse Event|8|||
154941814|NCT02173301|559211954|FG002|Overall Study|Adverse Event|13|||
154941815|NCT02173301|559211955|FG003|Overall Study|Adverse Event|5|||
154941816|NCT02173301|559211952|FG000|Overall Study|Withdrawal by Subject|8|||
154941817|NCT02173301|559211953|FG001|Overall Study|Withdrawal by Subject|10|||
154941818|NCT02173301|559211954|FG002|Overall Study|Withdrawal by Subject|4|||
154941819|NCT02173301|559211955|FG003|Overall Study|Withdrawal by Subject|8|||
154941820|NCT02173301|559211952|FG000|Overall Study|Lost to Follow-up|4|||
154941821|NCT02173301|559211953|FG001|Overall Study|Lost to Follow-up|4|||
154941822|NCT02173301|559211954|FG002|Overall Study|Lost to Follow-up|2|||
154941823|NCT02173301|559211955|FG003|Overall Study|Lost to Follow-up|2|||
154941824|NCT02173301|559211952|FG000|Overall Study|Protocol Violation|0|||
154941825|NCT02173301|559211953|FG001|Overall Study|Protocol Violation|1|||
154941826|NCT02173301|559211954|FG002|Overall Study|Protocol Violation|0|||
154941827|NCT02173301|559211955|FG003|Overall Study|Protocol Violation|0|||
154941828|NCT02173301|559211952|FG000|Overall Study|Physician Decision|0|||
154941829|NCT02173301|559211953|FG001|Overall Study|Physician Decision|0|||
154941830|NCT02173301|559211954|FG002|Overall Study|Physician Decision|1|||
154941831|NCT02173301|559211955|FG003|Overall Study|Physician Decision|0|||
154941832|NCT02173301|559211952|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
154941833|NCT02173301|559211953|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
154941834|NCT02173301|559211954|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
154941835|NCT02173301|559211955|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
154941836|NCT02378506|559211958|FG000|Overall Study|Lack of Efficacy|3|||
155044483|NCT00313586|559593948|FG001|Overall Study|Death before starting treatment|0|||
154941837|NCT02378506|559211958|FG000|Overall Study|Withdrawal by Subject|4|||
154941838|NCT02378506|559211958|FG000|Overall Study|Protocol Violation|2|||
154941839|NCT02378506|559211958|FG000|Overall Study|Death|1|||
154941840|NCT02378506|559211958|FG000|Overall Study|Adverse Event|14|||
155044484|NCT00313586|559593949|FG002|Overall Study|Death before starting treatment|0|||
155044485|NCT00313586|559593950|FG003|Overall Study|Death before starting treatment|0|||
154941841|NCT02378506|559211958|FG000|Overall Study|Randomized But Not Treated|1|||
154941842|NCT02123459|559211960|FG000|Washout Period (1 Day)|Adverse Event|1|||
154941843|NCT02123459|559211961|FG001|Washout Period (1 Day)|Adverse Event|0|||
154941844|NCT02196506|559211966|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
154941845|NCT02196506|559211967|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
154941846|NCT02196506|559211968|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
154941847|NCT02196506|559211969|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
154941848|NCT02196506|559211966|FG000|Phase A|Withdrawal by Subject|34|||
154941849|NCT02196506|559211967|FG001|Phase A|Withdrawal by Subject|0|||
154941850|NCT02196506|559211968|FG002|Phase A|Withdrawal by Subject|0|||
155044486|NCT01639703|559593951|FG000|Overall Study|Withdrawal by Subject|5|||
155044487|NCT01639703|559593951|FG000|Overall Study|Other reason|7|||
155044488|NCT02087670|559593952|FG000|Overall Study|Withdrawal by Subject|3|||
155044489|NCT02087670|559593953|FG001|Overall Study|Withdrawal by Subject|2|||
155044490|NCT00264290|559593955|FG000|Intervention (8 Weeks)|Adverse Event|1|||
155044491|NCT00264290|559593956|FG001|Intervention (8 Weeks)|Adverse Event|0|||
155044492|NCT04472494|559593957|FG000|Pre-treatment|Other reasons|2|||
155044493|NCT04472494|559593958|FG001|Pre-treatment|Other reasons|0|||
155044494|NCT04472494|559593957|FG000|Treatment|Death|5|||
155044495|NCT04472494|559593958|FG001|Treatment|Death|2|||
155044496|NCT04472494|559593957|FG000|Treatment|Hospital discharge|1|||
155044497|NCT04472494|559593958|FG001|Treatment|Hospital discharge|1|||
155044498|NCT03519919|559593959|FG000|Overall Study|Withdrawal by Subject|1|||
155044499|NCT03519919|559593959|FG000|Overall Study|Lack of Efficacy|1|||
155044500|NCT03519919|559593959|FG000|Overall Study|Screen Failure|1|||
155044501|NCT03076996|559593960|FG000|Overall Study|Withdrawal by Subject|2|||
155044502|NCT03076996|559593960|FG000|Overall Study|Lost to Follow-up|3|||
155044503|NCT03076996|559593960|FG000|Overall Study|Literacy precluded participation|1|||
155044504|NCT00587795|559593961|FG000|Overall Study|Withdrawal by Subject|1|||
155044505|NCT00587795|559593962|FG001|Overall Study|Withdrawal by Subject|0|||
155044506|NCT02144077|559593963|FG000|Overall Study|Withdrawal by Subject|3|||
155044507|NCT02144077|559593964|FG001|Overall Study|Withdrawal by Subject|3|||
155044508|NCT02144077|559593963|FG000|Overall Study|Adverse Event|2|||
155044509|NCT02144077|559593964|FG001|Overall Study|Adverse Event|3|||
155044510|NCT02144077|559593963|FG000|Overall Study|Lost to Follow-up|2|||
155044511|NCT02144077|559593964|FG001|Overall Study|Lost to Follow-up|2|||
155044512|NCT02144077|559593963|FG000|Overall Study|Protocol Violation|1|||
155044513|NCT02144077|559593964|FG001|Overall Study|Protocol Violation|2|||
155044514|NCT02144077|559593963|FG000|Overall Study|Death|0|||
155044515|NCT02144077|559593964|FG001|Overall Study|Death|1|||
155044516|NCT02144077|559593963|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
155044517|NCT02144077|559593964|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
155044518|NCT00943592|559593965|FG000|Overall Study|Death|3|||
155044519|NCT01909973|559593966|FG000|Overall Study|Lost to Follow-up|1|||
155044520|NCT01909973|559593967|FG001|Overall Study|Lost to Follow-up|0|||
155044521|NCT00169104|559593970|FG000|Overall Study|Withdrawal by Subject|2|||
155044522|NCT00169104|559593971|FG001|Overall Study|Withdrawal by Subject|0|||
155044523|NCT00169104|559593970|FG000|Overall Study|Protocol Violation|0|||
155044524|NCT00169104|559593971|FG001|Overall Study|Protocol Violation|1|||
155044525|NCT00169104|559593970|FG000|Overall Study|Physician Decision|0|||
155044526|NCT00169104|559593971|FG001|Overall Study|Physician Decision|1|||
155044527|NCT00232557|559593972|FG000|Overall Study|Lost to Follow-up|3|||
155044528|NCT00232557|559593973|FG001|Overall Study|Lost to Follow-up|5|||
155044529|NCT02438280|559593976|FG000|Overall Study|Physician Decision|1|||
155044530|NCT02438280|559593977|FG001|Overall Study|Physician Decision|0|||
154941851|NCT02196506|559211969|FG003|Phase A|Withdrawal by Subject|0|||
154941852|NCT02196506|559211966|FG000|Phase A|Adverse Event|22|||
154941853|NCT02196506|559211967|FG001|Phase A|Adverse Event|0|||
154941854|NCT02196506|559211968|FG002|Phase A|Adverse Event|0|||
154941855|NCT02196506|559211969|FG003|Phase A|Adverse Event|0|||
154941856|NCT02196506|559211966|FG000|Phase A|Lost to Follow-up|9|||
154941857|NCT02196506|559211967|FG001|Phase A|Lost to Follow-up|0|||
154941858|NCT02196506|559211968|FG002|Phase A|Lost to Follow-up|0|||
154941859|NCT02196506|559211969|FG003|Phase A|Lost to Follow-up|0|||
154941860|NCT02196506|559211966|FG000|Phase A|Protocol deviation|12|||
154941861|NCT02196506|559211967|FG001|Phase A|Protocol deviation|0|||
154941862|NCT02196506|559211968|FG002|Phase A|Protocol deviation|0|||
154941863|NCT02196506|559211969|FG003|Phase A|Protocol deviation|0|||
154941864|NCT02196506|559211966|FG000|Phase A|Participant withdrawn by investigator|10|||
154941865|NCT02196506|559211967|FG001|Phase A|Participant withdrawn by investigator|0|||
154941866|NCT02196506|559211968|FG002|Phase A|Participant withdrawn by investigator|0|||
154941867|NCT02196506|559211969|FG003|Phase A|Participant withdrawn by investigator|0|||
154941868|NCT02196506|559211966|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
154941869|NCT02196506|559211967|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
154941870|NCT02196506|559211968|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
154941871|NCT02196506|559211969|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
154941872|NCT02196506|559211966|FG000|Phase B|Lack of Efficacy|0|||
154941873|NCT02196506|559211967|FG001|Phase B|Lack of Efficacy|1|||
155278313|NCT00802841|560453126|FG001|Overall Study|Withdrawal by Subject|5|||
154941874|NCT02196506|559211968|FG002|Phase B|Lack of Efficacy|2|||
154941875|NCT02196506|559211969|FG003|Phase B|Lack of Efficacy|0|||
154941876|NCT02196506|559211966|FG000|Phase B|Withdrawal by Participant|0|||
154941877|NCT02196506|559211967|FG001|Phase B|Withdrawal by Participant|8|||
155278314|NCT00802841|560453125|FG000|Overall Study|Protocol deviation|2|||
155278315|NCT00802841|560453126|FG001|Overall Study|Protocol deviation|6|||
155278316|NCT00802841|560453125|FG000|Overall Study|Treatment duration completed|66|||
155278317|NCT00802841|560453126|FG001|Overall Study|Treatment duration completed|76|||
155278318|NCT00432159|560453127|FG000|Overall Study|Death|0|||
155278319|NCT00432159|560453128|FG001|Overall Study|Death|1|||
155278320|NCT00432159|560453129|FG002|Overall Study|Death|0|||
155278321|NCT00432159|560453130|FG003|Overall Study|Death|0|||
155278322|NCT00432159|560453131|FG004|Overall Study|Death|0|||
155278323|NCT00432159|560453127|FG000|Overall Study|Failure|9|||
155278324|NCT00432159|560453128|FG001|Overall Study|Failure|5|||
155278325|NCT00432159|560453129|FG002|Overall Study|Failure|3|||
155278326|NCT00432159|560453130|FG003|Overall Study|Failure|2|||
155278327|NCT00432159|560453131|FG004|Overall Study|Failure|3|||
155278328|NCT00432159|560453127|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
155278329|NCT00432159|560453128|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
155278330|NCT00432159|560453129|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
155278331|NCT00432159|560453130|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
155278332|NCT00432159|560453131|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
155278333|NCT03850444|560453138|FG000|Overall Study|Adverse Event|16|||
155278334|NCT03850444|560453139|FG001|Overall Study|Adverse Event|10|||
155278335|NCT03850444|560453138|FG000|Overall Study|Death|87|||
155278336|NCT03850444|560453139|FG001|Overall Study|Death|107|||
155278337|NCT03850444|560453138|FG000|Overall Study|Lost to Follow-up|1|||
155278338|NCT03850444|560453139|FG001|Overall Study|Lost to Follow-up|1|||
155278339|NCT03850444|560453138|FG000|Overall Study|Withdrawal by Subject|1|||
155278340|NCT03850444|560453139|FG001|Overall Study|Withdrawal by Subject|5|||
155278341|NCT03850444|560453138|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
155278342|NCT03850444|560453139|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
155278343|NCT01518257|560453140|FG000|Overall Study|Lost to Follow-up|1|||
155278344|NCT01518257|560453141|FG001|Overall Study|Lost to Follow-up|0|||
155278345|NCT01518257|560453140|FG000|Overall Study|Other Miscellaneous Reason|1|||
155278346|NCT01518257|560453141|FG001|Overall Study|Other Miscellaneous Reason|0|||
155278347|NCT02107274|560453142|FG000|Treatment vs. Placebo|Adverse Event|3|||
155278348|NCT02107274|560453143|FG001|Treatment vs. Placebo|Adverse Event|0|||
155278349|NCT02107274|560453142|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
155278350|NCT02107274|560453143|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
155278351|NCT02107274|560453142|FG000|Control Phase|Lost to Follow-up|1|||
154941878|NCT02196506|559211968|FG002|Phase B|Withdrawal by Participant|1|||
154941879|NCT02196506|559211969|FG003|Phase B|Withdrawal by Participant|0|||
154941880|NCT02196506|559211966|FG000|Phase B|Adverse Event|0|||
154941881|NCT02196506|559211967|FG001|Phase B|Adverse Event|4|||
154941882|NCT02196506|559211968|FG002|Phase B|Adverse Event|1|||
154941883|NCT02196506|559211969|FG003|Phase B|Adverse Event|0|||
155278352|NCT02107274|560453143|FG001|Control Phase|Lost to Follow-up|1|||
155278353|NCT02107274|560453142|FG000|Control Phase|Death|2|||
155278354|NCT02107274|560453143|FG001|Control Phase|Death|0|||
155278355|NCT02107274|560453142|FG000|Control Phase|Adverse Event|0|||
155278356|NCT02107274|560453143|FG001|Control Phase|Adverse Event|1|||
155278357|NCT03158948|560453147|FG000|Overall Study|Death|1|||
155278358|NCT03158948|560453148|FG001|Overall Study|Death|1|||
155278359|NCT03158948|560453149|FG002|Overall Study|Death|3|||
154941884|NCT02196506|559211966|FG000|Phase B|Lost to Follow-up|0|||
154941885|NCT02196506|559211967|FG001|Phase B|Lost to Follow-up|2|||
154941886|NCT02196506|559211968|FG002|Phase B|Lost to Follow-up|1|||
154941887|NCT02196506|559211969|FG003|Phase B|Lost to Follow-up|0|||
154941888|NCT02196506|559211966|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
154941889|NCT02196506|559211967|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
154941890|NCT02196506|559211968|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
154941891|NCT02196506|559211969|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
154941892|NCT02196506|559211966|FG000|Phase A+|Withdrawal by Participant|0|||
154941893|NCT02196506|559211967|FG001|Phase A+|Withdrawal by Participant|0|||
154941894|NCT02196506|559211968|FG002|Phase A+|Withdrawal by Participant|0|||
154941895|NCT02196506|559211969|FG003|Phase A+|Withdrawal by Participant|5|||
154941896|NCT02196506|559211966|FG000|Phase A+|Adverse Event|0|||
154941897|NCT02196506|559211967|FG001|Phase A+|Adverse Event|0|||
154941898|NCT02196506|559211968|FG002|Phase A+|Adverse Event|0|||
154941899|NCT02196506|559211969|FG003|Phase A+|Adverse Event|1|||
154941900|NCT02196506|559211966|FG000|Phase A+|Lost to Follow-up|0|||
154941901|NCT02196506|559211967|FG001|Phase A+|Lost to Follow-up|0|||
154941902|NCT02196506|559211968|FG002|Phase A+|Lost to Follow-up|0|||
154941903|NCT02196506|559211969|FG003|Phase A+|Lost to Follow-up|6|||
154941904|NCT02196506|559211966|FG000|Phase A+|Participant withdrawn by investigator|0|||
154941905|NCT02196506|559211967|FG001|Phase A+|Participant withdrawn by investigator|0|||
154941906|NCT02196506|559211968|FG002|Phase A+|Participant withdrawn by investigator|0|||
154941907|NCT02196506|559211969|FG003|Phase A+|Participant withdrawn by investigator|1|||
154941908|NCT01606137|559211970|FG000|Overall Study|Adverse Event|85|||
154941909|NCT01606137|559211970|FG000|Overall Study|Withdrawal by Subject|74|||
154941910|NCT01606137|559211970|FG000|Overall Study|Lack of Efficacy|56|||
154941911|NCT01606137|559211970|FG000|Overall Study|Lost to Follow-up|15|||
154941912|NCT01606137|559211970|FG000|Overall Study|Protocol Violation|1|||
154941913|NCT01606137|559211970|FG000|Overall Study|Patient non-compliance|9|||
154941914|NCT01606137|559211970|FG000|Overall Study|Death|1|||
154941915|NCT01606137|559211970|FG000|Overall Study|Decreased/no pain|4|||
154941916|NCT01606137|559211970|FG000|Overall Study|Issues with driving|4|||
154941917|NCT01606137|559211970|FG000|Overall Study|multiple sclerosis less stable|1|||
154941918|NCT01606137|559211970|FG000|Overall Study|Increased bilirubin|1|||
154941919|NCT01606137|559211970|FG000|Overall Study|Spray causes nausea|1|||
154941920|NCT01606137|559211970|FG000|Overall Study|Not enough improvement|4|||
154941921|NCT01606137|559211970|FG000|Overall Study|Wanted to try another treatment|1|||
154941922|NCT01606137|559211970|FG000|Overall Study|Patient leaving country|1|||
154941923|NCT01606137|559211970|FG000|Overall Study|Personal reasons|1|||
154941924|NCT01606137|559211970|FG000|Overall Study|Unable to tolerate study med. taste|1|||
154941925|NCT01606137|559211970|FG000|Overall Study|Patient moving|1|||
154941926|NCT01606137|559211970|FG000|Overall Study|Unable to collect consistent data|1|||
154941927|NCT00254397|559211971|FG000|Overall Study|Disease Progression|4|||
154941928|NCT00254397|559211972|FG001|Overall Study|Disease Progression|1|||
154941929|NCT00254397|559211973|FG002|Overall Study|Disease Progression|16|||
154941930|NCT00254397|559211974|FG003|Overall Study|Disease Progression|23|||
154941931|NCT00254397|559211971|FG000|Overall Study|Non-Compliant|0|||
154941932|NCT00254397|559211972|FG001|Overall Study|Non-Compliant|0|||
154941933|NCT00254397|559211973|FG002|Overall Study|Non-Compliant|0|||
154941934|NCT00254397|559211974|FG003|Overall Study|Non-Compliant|1|||
154941935|NCT00254397|559211971|FG000|Overall Study|Adverse Event|2|||
154941936|NCT00254397|559211972|FG001|Overall Study|Adverse Event|0|||
154941937|NCT00254397|559211973|FG002|Overall Study|Adverse Event|3|||
154941938|NCT00254397|559211974|FG003|Overall Study|Adverse Event|1|||
154941939|NCT01070394|559211975|FG000|Overall Study|Adverse Event|6|||
154941940|NCT01070394|559211975|FG000|Overall Study|Withdrawal by Subject|1|||
154941941|NCT01015612|559211980|FG000|Overall Study|Death|113|||
154941942|NCT01015612|559211980|FG000|Overall Study|Withdrawal by Subject|40|||
154941943|NCT00066807|559211981|FG000|Overall Study|Study was terminated early|14|||
154941944|NCT00066807|559211982|FG001|Overall Study|Study was terminated early|15|||
154941945|NCT05028751|559211983|FG000|Overall Study|Study Terminated by Sponsor|3|||
154941946|NCT05028751|559211984|FG001|Overall Study|Study Terminated by Sponsor|0|||
154941947|NCT05028751|559211985|FG002|Overall Study|Study Terminated by Sponsor|0|||
154941948|NCT05028751|559211986|FG003|Overall Study|Study Terminated by Sponsor|0|||
154941949|NCT05028751|559211983|FG000|Overall Study|Death|9|||
154941950|NCT05028751|559211984|FG001|Overall Study|Death|3|||
154941951|NCT05028751|559211985|FG002|Overall Study|Death|2|||
154941952|NCT05028751|559211986|FG003|Overall Study|Death|4|||
154941953|NCT05028751|559211983|FG000|Overall Study|Withdrawal by Subject|0|||
154941954|NCT05028751|559211984|FG001|Overall Study|Withdrawal by Subject|0|||
154941955|NCT05028751|559211985|FG002|Overall Study|Withdrawal by Subject|1|||
154941956|NCT05028751|559211986|FG003|Overall Study|Withdrawal by Subject|0|||
154941957|NCT05028751|559211983|FG000|Overall Study|Miscellaneous|2|||
154941958|NCT05028751|559211984|FG001|Overall Study|Miscellaneous|0|||
154941959|NCT05028751|559211985|FG002|Overall Study|Miscellaneous|0|||
154941960|NCT05028751|559211986|FG003|Overall Study|Miscellaneous|0|||
154941961|NCT03586830|559211988|FG000|Overall Study|Site terminated by Sponsor|1|||
154941962|NCT03586830|559211989|FG001|Overall Study|Site terminated by Sponsor|4|||
154941963|NCT03586830|559211990|FG002|Overall Study|Site terminated by Sponsor|3|||
154941964|NCT03586830|559211991|FG003|Overall Study|Site terminated by Sponsor|3|||
154941965|NCT03586830|559211988|FG000|Overall Study|Lost to Follow-up|0|||
154941966|NCT03586830|559211989|FG001|Overall Study|Lost to Follow-up|2|||
154941967|NCT03586830|559211990|FG002|Overall Study|Lost to Follow-up|2|||
154941968|NCT03586830|559211991|FG003|Overall Study|Lost to Follow-up|1|||
154941969|NCT03586830|559211988|FG000|Overall Study|Withdrawal by Subject|1|||
154941970|NCT03586830|559211989|FG001|Overall Study|Withdrawal by Subject|0|||
154941971|NCT03586830|559211990|FG002|Overall Study|Withdrawal by Subject|3|||
154941972|NCT03586830|559211991|FG003|Overall Study|Withdrawal by Subject|1|||
154941973|NCT04578548|559211992|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
154941974|NCT04578548|559211993|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
154941975|NCT04578548|559211992|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
154941976|NCT04578548|559211993|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
154941977|NCT04578548|559211992|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
154941978|NCT04578548|559211993|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
154941979|NCT04578548|559211992|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
154941980|NCT04578548|559211993|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
154941981|NCT04578548|559211992|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
154941982|NCT04578548|559211993|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
154941983|NCT04578548|559211992|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
154941984|NCT04578548|559211993|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
154941985|NCT00395083|559211996|FG000|Overall Study|Withdrawal by Subject|6|||
154941986|NCT00395083|559211997|FG001|Overall Study|Withdrawal by Subject|5|||
154941987|NCT00395083|559211996|FG000|Overall Study|Developed another disease|4|||
154941988|NCT00395083|559211997|FG001|Overall Study|Developed another disease|3|||
154941989|NCT00972153|559211998|FG000|Overall Study|Equipment malfunction during case|0|||
154941990|NCT00972153|559211999|FG001|Overall Study|Equipment malfunction during case|1|||
154941991|NCT00972153|559212000|FG002|Overall Study|Equipment malfunction during case|0|||
154941992|NCT01077713|559212005|FG000|Overall Study|Withdrawal by Subject|1|||
154941993|NCT01077713|559212006|FG001|Overall Study|Withdrawal by Subject|2|||
154941994|NCT01077713|559212005|FG000|Overall Study|Progressive Disease (PD)|0|||
154941995|NCT01077713|559212006|FG001|Overall Study|Progressive Disease (PD)|1|||
154941996|NCT01077713|559212005|FG000|Overall Study|Death|28|||
154941997|NCT01077713|559212006|FG001|Overall Study|Death|29|||
154941998|NCT01077713|559212005|FG000|Overall Study|Lost to Follow-up|1|||
154941999|NCT01077713|559212006|FG001|Overall Study|Lost to Follow-up|1|||
154942000|NCT01077713|559212005|FG000|Overall Study|Adverse Event|2|||
154942001|NCT01077713|559212006|FG001|Overall Study|Adverse Event|1|||
154942002|NCT01077713|559212005|FG000|Overall Study|Other|4|||
154942003|NCT01077713|559212006|FG001|Overall Study|Other|2|||
154942004|NCT04136626|559212007|FG000|Treatment Phase|Withdrawal by Subject|1|||
154942005|NCT04136626|559212008|FG001|Treatment Phase|Withdrawal by Subject|9|||
154942006|NCT04136626|559212007|FG000|Treatment Phase|Adverse Event|1|||
154942007|NCT04136626|559212008|FG001|Treatment Phase|Adverse Event|0|||
154942008|NCT04136626|559212007|FG000|Treatment Phase|Lost to Follow-up|1|||
154942009|NCT04136626|559212008|FG001|Treatment Phase|Lost to Follow-up|5|||
154942010|NCT04136626|559212007|FG000|12-month Follow-up|Lost to Follow-up|8|||
154942011|NCT04136626|559212008|FG001|12-month Follow-up|Lost to Follow-up|7|||
154942012|NCT00628745|559212009|FG000|Overall Study|Withdrawal by Subject|63|||
154942013|NCT00628745|559212010|FG001|Overall Study|Withdrawal by Subject|3|||
154942014|NCT00628745|559212011|FG002|Overall Study|Withdrawal by Subject|9|||
154942015|NCT00628745|559212012|FG003|Overall Study|Withdrawal by Subject|2|||
154942016|NCT00628745|559212013|FG004|Overall Study|Withdrawal by Subject|69|||
154942017|NCT00628745|559212009|FG000|Overall Study|Does not meet inclusion criteria|0|||
154942018|NCT00628745|559212010|FG001|Overall Study|Does not meet inclusion criteria|12|||
154942019|NCT00628745|559212011|FG002|Overall Study|Does not meet inclusion criteria|0|||
154942020|NCT00628745|559212012|FG003|Overall Study|Does not meet inclusion criteria|0|||
154942021|NCT00628745|559212013|FG004|Overall Study|Does not meet inclusion criteria|18|||
154942022|NCT00628745|559212009|FG000|Overall Study|Participation in an interventional clinical trial|81|||
155044531|NCT04435808|559593980|FG000|Overall Study|Study stopped by DSMB|0|||
155044532|NCT04435808|559593981|FG001|Overall Study|Study stopped by DSMB|1|||
155044533|NCT02457195|559593982|FG000|Overall Study|Adverse Event|3|||
155044534|NCT02457195|559593982|FG000|Overall Study|Protocol Violation|2|||
155044535|NCT02457195|559593982|FG000|Overall Study|Withdrawal by Subject|4|||
155044536|NCT04819438|559593983|FG000|Overall Study|Withdrawal by Subject|1|||
155044537|NCT04819438|559593984|FG001|Overall Study|Withdrawal by Subject|0|||
155044538|NCT04819438|559593983|FG000|Overall Study|Adverse Event|0|||
155044539|NCT04819438|559593984|FG001|Overall Study|Adverse Event|1|||
155044540|NCT04819438|559593983|FG000|Overall Study|Protocol Violation|0|||
155044541|NCT04819438|559593984|FG001|Overall Study|Protocol Violation|1|||
155044542|NCT02869893|559593985|FG000|Overall Study|participant aversion to IV|5|||
155044543|NCT02869893|559593985|FG000|Overall Study|participant fear of MRI scanner|2|||
155044544|NCT03066778|559593986|FG000|Overall Study|Death|195|||
155044545|NCT03066778|559593987|FG001|Overall Study|Death|205|||
155044546|NCT03066778|559593986|FG000|Overall Study|Withdrawal by Subject|5|||
155044547|NCT03066778|559593987|FG001|Overall Study|Withdrawal by Subject|7|||
154942023|NCT00628745|559212010|FG001|Overall Study|Participation in an interventional clinical trial|4|||
154942024|NCT00628745|559212011|FG002|Overall Study|Participation in an interventional clinical trial|7|||
154942025|NCT00628745|559212012|FG003|Overall Study|Participation in an interventional clinical trial|0|||
154942026|NCT00628745|559212013|FG004|Overall Study|Participation in an interventional clinical trial|63|||
154942027|NCT00628745|559212009|FG000|Overall Study|Physician Decision|8|||
154942028|NCT00628745|559212010|FG001|Overall Study|Physician Decision|4|||
154942029|NCT00628745|559212011|FG002|Overall Study|Physician Decision|3|||
154942030|NCT00628745|559212012|FG003|Overall Study|Physician Decision|0|||
154942031|NCT00628745|559212013|FG004|Overall Study|Physician Decision|30|||
154942032|NCT00628745|559212009|FG000|Overall Study|Lost to Follow-up|109|||
154942033|NCT00628745|559212010|FG001|Overall Study|Lost to Follow-up|7|||
154942034|NCT00628745|559212011|FG002|Overall Study|Lost to Follow-up|7|||
154942035|NCT00628745|559212012|FG003|Overall Study|Lost to Follow-up|0|||
154942036|NCT00628745|559212013|FG004|Overall Study|Lost to Follow-up|498|||
154942037|NCT00628745|559212009|FG000|Overall Study|Death|197|||
154942038|NCT00628745|559212010|FG001|Overall Study|Death|81|||
154942039|NCT00628745|559212011|FG002|Overall Study|Death|12|||
154942040|NCT00628745|559212012|FG003|Overall Study|Death|4|||
154942041|NCT00628745|559212013|FG004|Overall Study|Death|939|||
154942042|NCT00628745|559212009|FG000|Overall Study|Participant transferred to another THAOS site|6|||
154942043|NCT00628745|559212010|FG001|Overall Study|Participant transferred to another THAOS site|0|||
154942044|NCT00628745|559212011|FG002|Overall Study|Participant transferred to another THAOS site|0|||
154942045|NCT00628745|559212012|FG003|Overall Study|Participant transferred to another THAOS site|0|||
154942046|NCT00628745|559212013|FG004|Overall Study|Participant transferred to another THAOS site|7|||
154942047|NCT00628745|559212009|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
154942048|NCT00628745|559212010|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
154942049|NCT00628745|559212011|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
154942050|NCT00628745|559212012|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
154942051|NCT00628745|559212013|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
154942052|NCT00628745|559212009|FG000|Overall Study|Site closure|152|||
154942053|NCT00628745|559212010|FG001|Overall Study|Site closure|146|||
154942054|NCT00628745|559212011|FG002|Overall Study|Site closure|6|||
154942055|NCT00628745|559212012|FG003|Overall Study|Site closure|8|||
154942056|NCT00628745|559212013|FG004|Overall Study|Site closure|691|||
154942057|NCT00628745|559212009|FG000|Overall Study|Duplicate participant|0|||
154942058|NCT00628745|559212010|FG001|Overall Study|Duplicate participant|0|||
154942059|NCT00628745|559212011|FG002|Overall Study|Duplicate participant|0|||
154942060|NCT00628745|559212012|FG003|Overall Study|Duplicate participant|0|||
154942061|NCT00628745|559212013|FG004|Overall Study|Duplicate participant|1|||
155044548|NCT00902746|559593988|FG000|Overall Study|Protocol Violation|7|||
155044549|NCT00902746|559593988|FG000|Overall Study|Withdrawal by Subject|16|||
155044550|NCT00902746|559593988|FG000|Overall Study|Adverse Event|8|||
155044551|NCT00902746|559593988|FG000|Overall Study|Lost to Follow-up|3|||
155044552|NCT00902746|559593988|FG000|Overall Study|Physician Decision|2|||
155044553|NCT01348100|559593993|FG000|Overall Study|Subject Withdrew Consent|0|||
155044554|NCT01348100|559593994|FG001|Overall Study|Subject Withdrew Consent|0|||
155044555|NCT01348100|559593995|FG002|Overall Study|Subject Withdrew Consent|2|||
155044556|NCT01348100|559593996|FG003|Overall Study|Subject Withdrew Consent|0|||
155044557|NCT01348100|559593997|FG004|Overall Study|Subject Withdrew Consent|1|||
155044558|NCT01348100|559593998|FG005|Overall Study|Subject Withdrew Consent|0|||
155044559|NCT01348100|559593999|FG006|Overall Study|Subject Withdrew Consent|1|||
155044560|NCT01348100|559593993|FG000|Overall Study|Protocol Deviation|0|||
155044561|NCT01348100|559593994|FG001|Overall Study|Protocol Deviation|0|||
155044562|NCT01348100|559593995|FG002|Overall Study|Protocol Deviation|0|||
155044563|NCT01348100|559593996|FG003|Overall Study|Protocol Deviation|1|||
155044564|NCT01348100|559593997|FG004|Overall Study|Protocol Deviation|0|||
155044565|NCT01348100|559593998|FG005|Overall Study|Protocol Deviation|0|||
155044566|NCT01348100|559593999|FG006|Overall Study|Protocol Deviation|0|||
155044567|NCT01348100|559593993|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155044568|NCT01348100|559593994|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155044569|NCT01348100|559593995|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155044570|NCT01348100|559593996|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155044571|NCT01348100|559593997|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155044572|NCT01348100|559593998|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155044573|NCT01348100|559593999|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155044574|NCT01348100|559593993|FG000|Overall Study|Lost to Follow-up|0|||
155044575|NCT01348100|559593994|FG001|Overall Study|Lost to Follow-up|0|||
155044576|NCT01348100|559593995|FG002|Overall Study|Lost to Follow-up|0|||
155044577|NCT01348100|559593996|FG003|Overall Study|Lost to Follow-up|0|||
155044578|NCT01348100|559593997|FG004|Overall Study|Lost to Follow-up|0|||
155044579|NCT01348100|559593998|FG005|Overall Study|Lost to Follow-up|0|||
155044580|NCT01348100|559593999|FG006|Overall Study|Lost to Follow-up|1|||
155044581|NCT01348100|559593993|FG000|Overall Study|Administrative Problems|0|||
155044582|NCT01348100|559593994|FG001|Overall Study|Administrative Problems|0|||
155044583|NCT01348100|559593995|FG002|Overall Study|Administrative Problems|0|||
155044584|NCT01348100|559593996|FG003|Overall Study|Administrative Problems|0|||
155044585|NCT01348100|559593997|FG004|Overall Study|Administrative Problems|0|||
155044586|NCT01348100|559593998|FG005|Overall Study|Administrative Problems|1|||
155044587|NCT01348100|559593999|FG006|Overall Study|Administrative Problems|1|||
155044588|NCT00524680|559594000|FG000|Overall Study|progression|0|||
155044589|NCT00524680|559594001|FG001|Overall Study|progression|0|||
155044590|NCT00524680|559594002|FG002|Overall Study|progression|0|||
155044591|NCT00524680|559594003|FG003|Overall Study|progression|1|||
155044592|NCT00524680|559594000|FG000|Overall Study|Adverse Event|2|||
155044593|NCT00524680|559594001|FG001|Overall Study|Adverse Event|0|||
155044594|NCT00524680|559594002|FG002|Overall Study|Adverse Event|0|||
155044595|NCT00524680|559594003|FG003|Overall Study|Adverse Event|1|||
155044596|NCT00524680|559594000|FG000|Overall Study|Other|0|||
155044597|NCT00524680|559594001|FG001|Overall Study|Other|1|||
155044598|NCT00524680|559594002|FG002|Overall Study|Other|2|||
155044599|NCT00524680|559594003|FG003|Overall Study|Other|3|||
155044600|NCT00524680|559594000|FG000|Overall Study|Withdrawal by Subject|1|||
155044601|NCT00524680|559594001|FG001|Overall Study|Withdrawal by Subject|0|||
155044602|NCT00524680|559594002|FG002|Overall Study|Withdrawal by Subject|1|||
155044603|NCT00524680|559594003|FG003|Overall Study|Withdrawal by Subject|1|||
155044604|NCT01146561|559594004|FG000|Overall Study|Withdrawal by Subject|1|||
155044605|NCT01146561|559594004|FG000|Overall Study|Lost to Follow-up|1|||
155044606|NCT00893971|559594007|FG000|Overall Study|Physician Decision|3|||
155044607|NCT00492232|559594008|FG000|Placebo Run-in|Adverse Event|0|||
155044608|NCT00492232|559594009|FG001|Placebo Run-in|Adverse Event|2|||
155044609|NCT00492232|559594008|FG000|Placebo Run-in|Protocol Violation|0|||
155044610|NCT00492232|559594009|FG001|Placebo Run-in|Protocol Violation|3|||
155044611|NCT00492232|559594008|FG000|Placebo Run-in|Lost to Follow-up|0|||
155044612|NCT00492232|559594009|FG001|Placebo Run-in|Lost to Follow-up|3|||
155044613|NCT00492232|559594008|FG000|Placebo Run-in|Withdrawal by Subject|0|||
155044614|NCT00492232|559594009|FG001|Placebo Run-in|Withdrawal by Subject|8|||
155044615|NCT00492232|559594008|FG000|Placebo Run-in|Pregnancy|0|||
155044616|NCT00492232|559594009|FG001|Placebo Run-in|Pregnancy|1|||
155044617|NCT00492232|559594008|FG000|Placebo Run-in|Entrance criteria not met|0|||
155044618|NCT00492232|559594009|FG001|Placebo Run-in|Entrance criteria not met|45|||
155044619|NCT00492232|559594008|FG000|Placebo Run-in|Other|0|||
155044620|NCT00492232|559594009|FG001|Placebo Run-in|Other|6|||
155044621|NCT00492232|559594008|FG000|Placebo Run-in|Missing|0|||
155044622|NCT00492232|559594009|FG001|Placebo Run-in|Missing|2|||
155044623|NCT00492232|559594008|FG000|Double-Blind Treatment|Adverse Event|1|||
155044624|NCT00492232|559594009|FG001|Double-Blind Treatment|Adverse Event|2|||
155044625|NCT00492232|559594008|FG000|Double-Blind Treatment|Protocol Violation|3|||
155044626|NCT00492232|559594009|FG001|Double-Blind Treatment|Protocol Violation|7|||
155044627|NCT00492232|559594008|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
155044628|NCT00492232|559594009|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
155044629|NCT00492232|559594008|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
155044630|NCT00492232|559594009|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
155044631|NCT00492232|559594008|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
155044632|NCT00492232|559594009|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
155044633|NCT00492232|559594008|FG000|Double-Blind Treatment|Other|6|||
155044634|NCT00492232|559594009|FG001|Double-Blind Treatment|Other|5|||
155044635|NCT00492232|559594008|FG000|Double-Blind Treatment|Randomized not treated|1|||
155044636|NCT00492232|559594009|FG001|Double-Blind Treatment|Randomized not treated|0|||
155044637|NCT00492232|559594008|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
155044638|NCT00492232|559594009|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155044639|NCT01416155|559594010|FG000|Overall Study|Adverse Event|8|||
155044640|NCT01416155|559594010|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
155044641|NCT01416155|559594010|FG000|Overall Study|Withdrawal by Subject|33|||
155044642|NCT01416155|559594010|FG000|Overall Study|Investigator decision|8|||
155044643|NCT01416155|559594010|FG000|Overall Study|Other|7|||
155044644|NCT00829829|559594014|FG000|Overall Study|Protocol Violation|0|||
155044645|NCT00829829|559594015|FG001|Overall Study|Protocol Violation|3|||
155044646|NCT00829829|559594016|FG002|Overall Study|Protocol Violation|0|||
155044647|NCT00829829|559594014|FG000|Overall Study|Adverse Event|4|||
155044648|NCT00829829|559594015|FG001|Overall Study|Adverse Event|4|||
155044649|NCT00829829|559594016|FG002|Overall Study|Adverse Event|3|||
155044650|NCT00829829|559594014|FG000|Overall Study|Withdrawal by Subject|8|||
155044651|NCT00829829|559594015|FG001|Overall Study|Withdrawal by Subject|4|||
155044652|NCT00829829|559594016|FG002|Overall Study|Withdrawal by Subject|2|||
155044653|NCT00829829|559594014|FG000|Overall Study|Decision by the Sponsor|1|||
155044654|NCT00829829|559594015|FG001|Overall Study|Decision by the Sponsor|0|||
155044655|NCT00829829|559594016|FG002|Overall Study|Decision by the Sponsor|2|||
155044656|NCT00829829|559594014|FG000|Overall Study|Lost to Follow-up|7|||
155044657|NCT00829829|559594015|FG001|Overall Study|Lost to Follow-up|3|||
155044658|NCT00829829|559594016|FG002|Overall Study|Lost to Follow-up|3|||
155044659|NCT00829829|559594014|FG000|Overall Study|Other than specified above|2|||
155044660|NCT00829829|559594015|FG001|Overall Study|Other than specified above|2|||
155044661|NCT00829829|559594016|FG002|Overall Study|Other than specified above|1|||
155044662|NCT02685072|559594017|FG000|Treatment Period|Lost to Follow-up|12|||
155044663|NCT02685072|559594018|FG001|Treatment Period|Lost to Follow-up|6|||
155044664|NCT02685072|559594017|FG000|Treatment Period|Withdrawal by Subject|1|||
155044665|NCT02685072|559594018|FG001|Treatment Period|Withdrawal by Subject|3|||
155044666|NCT02685072|559594017|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
155044667|NCT02685072|559594018|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
155044668|NCT00382109|559594021|FG000|Overall Study|Adverse Event|3|||
155044669|NCT00382109|559594022|FG001|Overall Study|Adverse Event|0|||
155044670|NCT00382109|559594021|FG000|Overall Study|Physician Decision|6|||
155044671|NCT00382109|559594022|FG001|Overall Study|Physician Decision|1|||
155044672|NCT00382109|559594021|FG000|Overall Study|Withdrawal by Subject|1|||
155044673|NCT00382109|559594022|FG001|Overall Study|Withdrawal by Subject|0|||
155044674|NCT00382109|559594021|FG000|Overall Study|ineligible|2|||
155044675|NCT00382109|559594022|FG001|Overall Study|ineligible|0|||
155044676|NCT00382109|559594021|FG000|Overall Study|Other|0|||
155044677|NCT00382109|559594022|FG001|Overall Study|Other|2|||
155044678|NCT00382109|559594021|FG000|Overall Study|consent withdrawal|0|||
155044679|NCT00382109|559594022|FG001|Overall Study|consent withdrawal|1|||
155044680|NCT01249833|559594023|FG000|Overall Study|Lost to Follow-up|0|||
155044681|NCT01249833|559594024|FG001|Overall Study|Lost to Follow-up|1|||
155044682|NCT03796676|559594025|FG000|Overall Study|Adverse Event|2|||
155044683|NCT03796676|559594026|FG001|Overall Study|Adverse Event|1|||
155044684|NCT03796676|559594027|FG002|Overall Study|Adverse Event|2|||
155044685|NCT03796676|559594025|FG000|Overall Study|Lost to Follow-up|2|||
155044686|NCT03796676|559594026|FG001|Overall Study|Lost to Follow-up|1|||
155044687|NCT03796676|559594027|FG002|Overall Study|Lost to Follow-up|0|||
155044688|NCT03796676|559594025|FG000|Overall Study|Protocol Violation|0|||
155044689|NCT03796676|559594026|FG001|Overall Study|Protocol Violation|0|||
155044690|NCT03796676|559594027|FG002|Overall Study|Protocol Violation|1|||
155044691|NCT03796676|559594025|FG000|Overall Study|Withdrawal by Subject|1|||
155044692|NCT03796676|559594026|FG001|Overall Study|Withdrawal by Subject|1|||
155044693|NCT03796676|559594027|FG002|Overall Study|Withdrawal by Subject|0|||
155044694|NCT03796676|559594025|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
155044695|NCT03796676|559594026|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
155044696|NCT03796676|559594027|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
155044697|NCT02772809|559594034|FG000|Overall Study|not completed some tasks|6|||
155044698|NCT00723697|559594035|FG000|Overall Study|Physician questionnaires not received|2|||
155044699|NCT00723697|559594035|FG000|Overall Study|Missing Informed Consent Form|10|||
155044700|NCT00723697|559594035|FG000|Overall Study|Other exclusion criteria applied|6|||
155044701|NCT00534105|559594036|FG000|Overall Study|Lost to Follow-up|23|||
155044702|NCT00534105|559594037|FG001|Overall Study|Lost to Follow-up|39|||
155044703|NCT01289574|559594038|FG000|Overall Study|Lack of Efficacy|4|||
155044704|NCT01289574|559594039|FG001|Overall Study|Lack of Efficacy|0|||
155044705|NCT01289574|559594040|FG002|Overall Study|Lack of Efficacy|1|||
155044706|NCT01289574|559594038|FG000|Overall Study|Lost to Follow-up|2|||
155278360|NCT03158948|560453150|FG003|Overall Study|Death|2|||
155278361|NCT03158948|560453147|FG000|Overall Study|Physician Decision|0|||
155278362|NCT03158948|560453148|FG001|Overall Study|Physician Decision|0|||
155278363|NCT03158948|560453149|FG002|Overall Study|Physician Decision|0|||
155278364|NCT03158948|560453150|FG003|Overall Study|Physician Decision|1|||
155278365|NCT05305040|560453151|FG000|Overall Study|Not Dosed|37|||
155278366|NCT05305040|560453152|FG001|Overall Study|Not Dosed|37|||
155278367|NCT05305040|560453151|FG000|Overall Study|Study Closure|34|||
155278368|NCT05305040|560453152|FG001|Overall Study|Study Closure|46|||
155278369|NCT05305040|560453151|FG000|Overall Study|Death|14|||
155278370|NCT05305040|560453152|FG001|Overall Study|Death|13|||
155278371|NCT05305040|560453151|FG000|Overall Study|Withdrawal by Subject|15|||
155278372|NCT05305040|560453152|FG001|Overall Study|Withdrawal by Subject|10|||
155278373|NCT05305040|560453151|FG000|Overall Study|Other|13|||
155278374|NCT05305040|560453152|FG001|Overall Study|Other|10|||
155278375|NCT05305040|560453151|FG000|Overall Study|Primary Malignancy Relapse|3|||
155044707|NCT01289574|559594039|FG001|Overall Study|Lost to Follow-up|0|||
155278376|NCT05305040|560453152|FG001|Overall Study|Primary Malignancy Relapse|4|||
155044708|NCT01289574|559594040|FG002|Overall Study|Lost to Follow-up|1|||
155044709|NCT01289574|559594038|FG000|Overall Study|Withdrawal by Subject|1|||
155278377|NCT05305040|560453151|FG000|Overall Study|Adverse Event|3|||
155278378|NCT05305040|560453152|FG001|Overall Study|Adverse Event|3|||
155044710|NCT01289574|559594039|FG001|Overall Study|Withdrawal by Subject|1|||
155044711|NCT01289574|559594040|FG002|Overall Study|Withdrawal by Subject|1|||
155044712|NCT01289574|559594038|FG000|Overall Study|Adverse Event|0|||
155044713|NCT01289574|559594039|FG001|Overall Study|Adverse Event|1|||
155044714|NCT01289574|559594040|FG002|Overall Study|Adverse Event|0|||
155044715|NCT01289574|559594038|FG000|Overall Study|Subject wanted alternate treatment|0|||
155278379|NCT05305040|560453151|FG000|Overall Study|Lost to Follow-up|2|||
155044716|NCT01289574|559594039|FG001|Overall Study|Subject wanted alternate treatment|1|||
155044717|NCT01289574|559594040|FG002|Overall Study|Subject wanted alternate treatment|0|||
155044718|NCT00978341|559594043|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
155044719|NCT00978341|559594044|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
155044720|NCT03035916|559594045|FG000|Overall Study|Puncture failed|0|||
155044721|NCT03035916|559594046|FG001|Overall Study|Puncture failed|2|||
155044722|NCT03035916|559594047|FG002|Overall Study|Puncture failed|0|||
155044723|NCT03885999|559594048|FG000|Overall Study|Adverse Event|1|||
155044724|NCT02452554|559594049|FG000|Overall Study|Death|2|||
155044725|NCT02452554|559594050|FG001|Overall Study|Death|1|||
155044726|NCT02452554|559594051|FG002|Overall Study|Death|0|||
155044727|NCT02452554|559594052|FG003|Overall Study|Death|0|||
155044728|NCT02452554|559594053|FG004|Overall Study|Death|0|||
155044729|NCT02452554|559594054|FG005|Overall Study|Death|0|||
155044730|NCT02452554|559594049|FG000|Overall Study|Lack of Efficacy|13|||
155044731|NCT02452554|559594050|FG001|Overall Study|Lack of Efficacy|14|||
154942062|NCT00628745|559212009|FG000|Overall Study|Missing|4|||
154942063|NCT00628745|559212010|FG001|Overall Study|Missing|3|||
154942064|NCT00628745|559212011|FG002|Overall Study|Missing|0|||
154942065|NCT00628745|559212012|FG003|Overall Study|Missing|0|||
154942066|NCT00628745|559212013|FG004|Overall Study|Missing|10|||
154942067|NCT00628745|559212009|FG000|Overall Study|Othe reasons|987|||
154942068|NCT00628745|559212010|FG001|Overall Study|Othe reasons|373|||
154942069|NCT00628745|559212011|FG002|Overall Study|Othe reasons|105|||
154942070|NCT00628745|559212012|FG003|Overall Study|Othe reasons|1|||
154942071|NCT00628745|559212013|FG004|Overall Study|Othe reasons|1772|||
154942072|NCT00671879|559214027|FG000|Overall Study|Withdrawal by Subject|0|||
154942073|NCT00671879|559214028|FG001|Overall Study|Withdrawal by Subject|4|||
154942074|NCT00671879|559214029|FG002|Overall Study|Withdrawal by Subject|6|||
154942075|NCT01628120|559214030|FG000|Overall Study|Withdrawal by Subject|7|||
154942076|NCT01628120|559214030|FG000|Overall Study|Adverse Event|12|||
154942077|NCT01628120|559214030|FG000|Overall Study|Lost to Follow-up|1|||
154942078|NCT01628120|559214030|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
154942079|NCT01628120|559214030|FG000|Overall Study|Non-compliant with Study Procedures|1|||
154942080|NCT01628120|559214030|FG000|Overall Study|Not Treated|3|||
154942081|NCT01628120|559214030|FG000|Overall Study|Sponsor Decision|5|||
154942082|NCT01628120|559214030|FG000|Overall Study|Switched Dialysis Method|2|||
154942083|NCT01628120|559214030|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
154942084|NCT01628120|559214030|FG000|Overall Study|Moved or Relocated|5|||
154942085|NCT01628120|559214030|FG000|Overall Study|Kidney Transplant|2|||
154942086|NCT01628120|559214030|FG000|Overall Study|Use of Standard of Care|1|||
154942087|NCT01927757|559214033|FG000|Overall Study|Withdrawal by Subject|14|||
154942088|NCT01927757|559214033|FG000|Overall Study|Lost to Follow-up|2|||
154942089|NCT01927757|559214033|FG000|Overall Study|Decision by Sponsor|2|||
154942090|NCT01927757|559214033|FG000|Overall Study|Other|1|||
154942091|NCT01927757|559214033|FG000|Overall Study|Ethical Reasons|4|||
154942092|NCT00444795|559214034|FG000|Overall Study|Not Treated|1|||
154942093|NCT00444795|559214034|FG000|Overall Study|Treated Prior to the Contract Date|2|||
154942094|NCT00988169|559214035|FG000|Overall Study|Withdrawal by Subject|1|||
154942095|NCT02637076|559214037|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
155044732|NCT02452554|559594051|FG002|Overall Study|Lack of Efficacy|9|||
155044733|NCT02452554|559594052|FG003|Overall Study|Lack of Efficacy|1|||
155044734|NCT02452554|559594053|FG004|Overall Study|Lack of Efficacy|5|||
155044735|NCT02452554|559594054|FG005|Overall Study|Lack of Efficacy|8|||
155044736|NCT02452554|559594049|FG000|Overall Study|Physician Decision|0|||
155044737|NCT02452554|559594050|FG001|Overall Study|Physician Decision|1|||
155044738|NCT02452554|559594051|FG002|Overall Study|Physician Decision|0|||
155044739|NCT02452554|559594052|FG003|Overall Study|Physician Decision|0|||
155044740|NCT02452554|559594053|FG004|Overall Study|Physician Decision|0|||
155044741|NCT02452554|559594054|FG005|Overall Study|Physician Decision|0|||
155044742|NCT02452554|559594049|FG000|Overall Study|Withdrawal by Subject|1|||
155044743|NCT02452554|559594050|FG001|Overall Study|Withdrawal by Subject|0|||
155044744|NCT02452554|559594051|FG002|Overall Study|Withdrawal by Subject|2|||
154942096|NCT02637076|559214038|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
154942097|NCT02637076|559214037|FG000|Overall Study|Withdrawal by Subject|0|||
154942098|NCT02637076|559214038|FG001|Overall Study|Withdrawal by Subject|4|||
154942099|NCT00130520|559214039|FG000|Overall Study|Adverse Event|11|||
154942100|NCT00130520|559214039|FG000|Overall Study|Death|1|||
154942101|NCT00130520|559214039|FG000|Overall Study|Physician Decision|1|||
154942102|NCT00130520|559214039|FG000|Overall Study|Withdrawal by Subject|1|||
154942103|NCT00130520|559214039|FG000|Overall Study|Disease Progression|23|||
154942104|NCT00130520|559214039|FG000|Overall Study|Protocol non-compliance|1|||
154942105|NCT00130520|559214039|FG000|Overall Study|Did not meet re-treatment criteria|1|||
154942106|NCT01464827|559214040|FG000|Overall Study|Adverse Event|0|||
155044745|NCT02452554|559594052|FG003|Overall Study|Withdrawal by Subject|0|||
155044746|NCT02452554|559594053|FG004|Overall Study|Withdrawal by Subject|0|||
155044747|NCT02452554|559594054|FG005|Overall Study|Withdrawal by Subject|1|||
155044748|NCT02452554|559594049|FG000|Overall Study|Ineligible|0|||
155278380|NCT05305040|560453152|FG001|Overall Study|Lost to Follow-up|1|||
154942107|NCT01464827|559214041|FG001|Overall Study|Adverse Event|0|||
154942108|NCT01464827|559214042|FG002|Overall Study|Adverse Event|0|||
154942109|NCT01464827|559214043|FG003|Overall Study|Adverse Event|0|||
154942110|NCT01464827|559214044|FG004|Overall Study|Adverse Event|0|||
154942111|NCT01464827|559214045|FG005|Overall Study|Adverse Event|0|||
154942112|NCT01464827|559214046|FG006|Overall Study|Adverse Event|0|||
154942113|NCT01464827|559214047|FG007|Overall Study|Adverse Event|0|||
154942114|NCT01464827|559214048|FG008|Overall Study|Adverse Event|0|||
154942115|NCT01464827|559214049|FG009|Overall Study|Adverse Event|0|||
154942116|NCT01464827|559214050|FG010|Overall Study|Adverse Event|0|||
154942117|NCT01464827|559214051|FG011|Overall Study|Adverse Event|0|||
154942118|NCT01464827|559214052|FG012|Overall Study|Adverse Event|1|||
154942119|NCT01464827|559214053|FG013|Overall Study|Adverse Event|0|||
154942120|NCT01464827|559214040|FG000|Overall Study|Withdrawal by Subject|1|||
154942121|NCT01464827|559214041|FG001|Overall Study|Withdrawal by Subject|0|||
154942122|NCT01464827|559214042|FG002|Overall Study|Withdrawal by Subject|0|||
154942123|NCT01464827|559214043|FG003|Overall Study|Withdrawal by Subject|0|||
154942124|NCT01464827|559214044|FG004|Overall Study|Withdrawal by Subject|1|||
155278381|NCT05305040|560453151|FG000|Overall Study|Graft versus host disease|2|||
155278382|NCT05305040|560453152|FG001|Overall Study|Graft versus host disease|0|||
155278383|NCT05305040|560453151|FG000|Overall Study|Investigator's Decision|1|||
155278384|NCT05305040|560453152|FG001|Overall Study|Investigator's Decision|1|||
155278385|NCT05305040|560453151|FG000|Overall Study|COVID-19 Reasons|1|||
155278386|NCT05305040|560453152|FG001|Overall Study|COVID-19 Reasons|0|||
155278387|NCT01195675|560453153|FG000|Overall Study|Adverse Event|1|||
155278388|NCT01195675|560453153|FG000|Overall Study|Withdrawal by Subject|2|||
155278389|NCT02424344|560453154|FG000|Overall Study|Lack of Efficacy|0|||
155278390|NCT02424344|560453155|FG001|Overall Study|Lack of Efficacy|1|||
155278391|NCT02424344|560453154|FG000|Overall Study|Withdrawal by Subject|2|||
155278392|NCT02424344|560453155|FG001|Overall Study|Withdrawal by Subject|1|||
155278393|NCT02424344|560453154|FG000|Overall Study|Lost to Follow-up|1|||
155278394|NCT02424344|560453155|FG001|Overall Study|Lost to Follow-up|0|||
155278395|NCT02424344|560453154|FG000|Overall Study|Adverse Event|4|||
155278396|NCT02424344|560453155|FG001|Overall Study|Adverse Event|8|||
155278397|NCT04730947|560453156|FG000|Overall Study|Withdrawal by Subject|0|||
155278398|NCT04730947|560453157|FG001|Overall Study|Withdrawal by Subject|1|||
155278399|NCT01174550|560453158|FG000|Overall Study|Death|75|||
155278400|NCT01174550|560453159|FG001|Overall Study|Death|74|||
155278401|NCT01174550|560453158|FG000|Overall Study|Lost to Follow-up|652|||
155278402|NCT01174550|560453159|FG001|Overall Study|Lost to Follow-up|510|||
155278403|NCT01174550|560453158|FG000|Overall Study|Withdrawal by Subject|543|||
155278404|NCT01174550|560453159|FG001|Overall Study|Withdrawal by Subject|289|||
155278405|NCT02123966|560453160|FG000|Overall Study|Intercurrent Illness|1|||
155278406|NCT01536262|560453161|FG000|Overall Study|Adverse Event|6|||
155278407|NCT01536262|560453162|FG001|Overall Study|Adverse Event|1|||
155278408|NCT01536262|560453163|FG002|Overall Study|Adverse Event|2|||
154942125|NCT01464827|559214045|FG005|Overall Study|Withdrawal by Subject|0|||
154942126|NCT01464827|559214046|FG006|Overall Study|Withdrawal by Subject|0|||
154942127|NCT01464827|559214047|FG007|Overall Study|Withdrawal by Subject|1|||
154942128|NCT01464827|559214048|FG008|Overall Study|Withdrawal by Subject|0|||
154942129|NCT01464827|559214049|FG009|Overall Study|Withdrawal by Subject|0|||
154942130|NCT01464827|559214050|FG010|Overall Study|Withdrawal by Subject|0|||
154942131|NCT01464827|559214051|FG011|Overall Study|Withdrawal by Subject|0|||
154942132|NCT01464827|559214052|FG012|Overall Study|Withdrawal by Subject|0|||
154942133|NCT01464827|559214053|FG013|Overall Study|Withdrawal by Subject|0|||
154942134|NCT01464827|559214040|FG000|Overall Study|Lost to Follow-up|0|||
154942135|NCT01464827|559214041|FG001|Overall Study|Lost to Follow-up|2|||
154942136|NCT01464827|559214042|FG002|Overall Study|Lost to Follow-up|0|||
154942137|NCT01464827|559214043|FG003|Overall Study|Lost to Follow-up|2|||
154942138|NCT01464827|559214044|FG004|Overall Study|Lost to Follow-up|3|||
154942139|NCT01464827|559214045|FG005|Overall Study|Lost to Follow-up|1|||
154942140|NCT01464827|559214046|FG006|Overall Study|Lost to Follow-up|2|||
154942141|NCT01464827|559214047|FG007|Overall Study|Lost to Follow-up|2|||
154942142|NCT01464827|559214048|FG008|Overall Study|Lost to Follow-up|0|||
154942143|NCT01464827|559214049|FG009|Overall Study|Lost to Follow-up|0|||
154942144|NCT01464827|559214050|FG010|Overall Study|Lost to Follow-up|0|||
154942145|NCT01464827|559214051|FG011|Overall Study|Lost to Follow-up|1|||
154942146|NCT01464827|559214052|FG012|Overall Study|Lost to Follow-up|0|||
154942147|NCT01464827|559214053|FG013|Overall Study|Lost to Follow-up|1|||
155278409|NCT01536262|560453161|FG000|Overall Study|Withdrawal by Subject|1|||
155278410|NCT01536262|560453162|FG001|Overall Study|Withdrawal by Subject|1|||
155278411|NCT01536262|560453163|FG002|Overall Study|Withdrawal by Subject|0|||
155278412|NCT01536262|560453161|FG000|Overall Study|Other than stated above|1|||
155278413|NCT01536262|560453162|FG001|Overall Study|Other than stated above|0|||
155278414|NCT01536262|560453163|FG002|Overall Study|Other than stated above|0|||
154942148|NCT01464827|559214040|FG000|Overall Study|Other|2|||
154942149|NCT01464827|559214041|FG001|Overall Study|Other|3|||
154942150|NCT01464827|559214042|FG002|Overall Study|Other|0|||
155278415|NCT01460381|560453167|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
155278416|NCT01460381|560453168|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
155278417|NCT01097655|560453169|FG000|Overall Study|Withdrawal by Subject|1|||
155278418|NCT01097655|560453169|FG000|Overall Study|Subject Documented Twice|1|||
155278419|NCT01097655|560453169|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
155278420|NCT05257837|560453170|FG000|Overall Study|Excluded (did not find the guns)|4|||
155278421|NCT05257837|560453171|FG001|Overall Study|Excluded (did not find the guns)|2|||
155278422|NCT05257837|560453172|FG002|Overall Study|Excluded (did not find the guns)|4|||
155278423|NCT05257837|560453173|FG003|Overall Study|Excluded (did not find the guns)|0|||
155278424|NCT01033643|560453174|FG000|Overall Study|Withdrew Consent|0|||
154942151|NCT01464827|559214043|FG003|Overall Study|Other|2|||
154942152|NCT01464827|559214044|FG004|Overall Study|Other|3|||
154942153|NCT01464827|559214045|FG005|Overall Study|Other|0|||
154942154|NCT01464827|559214046|FG006|Overall Study|Other|1|||
154942155|NCT01464827|559214047|FG007|Overall Study|Other|0|||
154942156|NCT01464827|559214048|FG008|Overall Study|Other|3|||
154942157|NCT01464827|559214049|FG009|Overall Study|Other|1|||
154942158|NCT01464827|559214050|FG010|Overall Study|Other|2|||
154942159|NCT01464827|559214051|FG011|Overall Study|Other|0|||
154942160|NCT01464827|559214052|FG012|Overall Study|Other|1|||
154942161|NCT01464827|559214053|FG013|Overall Study|Other|0|||
154942162|NCT01464827|559214040|FG000|Overall Study|Not Treated|0|||
154942163|NCT01464827|559214041|FG001|Overall Study|Not Treated|2|||
154942164|NCT01464827|559214042|FG002|Overall Study|Not Treated|0|||
154942165|NCT01464827|559214043|FG003|Overall Study|Not Treated|0|||
154942166|NCT01464827|559214044|FG004|Overall Study|Not Treated|1|||
154942167|NCT01464827|559214045|FG005|Overall Study|Not Treated|0|||
154942168|NCT01464827|559214046|FG006|Overall Study|Not Treated|1|||
154942169|NCT01464827|559214047|FG007|Overall Study|Not Treated|0|||
154942170|NCT01464827|559214048|FG008|Overall Study|Not Treated|0|||
154942171|NCT01464827|559214049|FG009|Overall Study|Not Treated|2|||
154942172|NCT01464827|559214050|FG010|Overall Study|Not Treated|0|||
154942173|NCT01464827|559214051|FG011|Overall Study|Not Treated|1|||
154942174|NCT01464827|559214052|FG012|Overall Study|Not Treated|0|||
154942175|NCT01464827|559214053|FG013|Overall Study|Not Treated|2|||
154942176|NCT00613574|559214054|FG000|Overall Study|Adverse Event|3|||
154942177|NCT00613574|559214054|FG000|Overall Study|Lost to Follow-up|2|||
154942178|NCT00613574|559214054|FG000|Overall Study|Other|1|||
154942179|NCT04604184|559214056|FG000|Overall Study|Adverse Event|5|||
154942180|NCT04604184|559214057|FG001|Overall Study|Adverse Event|5|||
154942181|NCT04604184|559214056|FG000|Overall Study|Death|2|||
154942182|NCT04604184|559214057|FG001|Overall Study|Death|1|||
154942183|NCT04604184|559214056|FG000|Overall Study|Withdrawal by Subject|1|||
154942184|NCT04604184|559214057|FG001|Overall Study|Withdrawal by Subject|3|||
154942185|NCT04604184|559214056|FG000|Overall Study|Not treated|2|||
154942186|NCT04604184|559214057|FG001|Overall Study|Not treated|2|||
154942187|NCT04604184|559214056|FG000|Overall Study|Due to sponsor decision|9|||
154942188|NCT04604184|559214057|FG001|Overall Study|Due to sponsor decision|7|||
154942189|NCT04604184|559214056|FG000|Overall Study|Physician Decision|0|||
154942190|NCT04604184|559214057|FG001|Overall Study|Physician Decision|1|||
154942191|NCT04604184|559214056|FG000|Overall Study|Transfer to healthcare|1|||
154942192|NCT04604184|559214057|FG001|Overall Study|Transfer to healthcare|0|||
154942193|NCT00582036|559214058|FG000|Overall Study|Withdrawal by Subject|0|||
154942194|NCT00582036|559214059|FG001|Overall Study|Withdrawal by Subject|1|||
154942195|NCT02711956|559214060|FG000|Overall Study|Adverse Event|0|||
154942196|NCT02711956|559214061|FG001|Overall Study|Adverse Event|0|||
154942197|NCT02711956|559214062|FG002|Overall Study|Adverse Event|0|||
154942198|NCT02711956|559214063|FG003|Overall Study|Adverse Event|1|||
154942199|NCT02711956|559214064|FG004|Overall Study|Adverse Event|2|||
154942200|NCT02711956|559214065|FG005|Overall Study|Adverse Event|0|||
154942201|NCT02711956|559214066|FG006|Overall Study|Adverse Event|0|||
154942202|NCT02711956|559214067|FG007|Overall Study|Adverse Event|1|||
154942203|NCT02711956|559214068|FG008|Overall Study|Adverse Event|1|||
154942204|NCT02711956|559214069|FG009|Overall Study|Adverse Event|1|||
154942205|NCT02711956|559214070|FG010|Overall Study|Adverse Event|1|||
155278425|NCT01033643|560453175|FG001|Overall Study|Withdrew Consent|3|||
154942206|NCT02711956|559214071|FG011|Overall Study|Adverse Event|0|||
154942207|NCT02711956|559214072|FG012|Overall Study|Adverse Event|0|||
154942208|NCT02711956|559214073|FG013|Overall Study|Adverse Event|0|||
154942209|NCT02711956|559214074|FG014|Overall Study|Adverse Event|2|||
154942210|NCT02711956|559214060|FG000|Overall Study|Physician Decision|0|||
154942211|NCT02711956|559214061|FG001|Overall Study|Physician Decision|0|||
154942212|NCT02711956|559214062|FG002|Overall Study|Physician Decision|0|||
154942213|NCT02711956|559214063|FG003|Overall Study|Physician Decision|2|||
154942214|NCT02711956|559214064|FG004|Overall Study|Physician Decision|0|||
154942215|NCT02711956|559214065|FG005|Overall Study|Physician Decision|0|||
154942216|NCT02711956|559214066|FG006|Overall Study|Physician Decision|0|||
154942217|NCT02711956|559214067|FG007|Overall Study|Physician Decision|0|||
154942218|NCT02711956|559214068|FG008|Overall Study|Physician Decision|0|||
154942219|NCT02711956|559214069|FG009|Overall Study|Physician Decision|0|||
154942220|NCT02711956|559214070|FG010|Overall Study|Physician Decision|0|||
154942221|NCT02711956|559214071|FG011|Overall Study|Physician Decision|0|||
154942222|NCT02711956|559214072|FG012|Overall Study|Physician Decision|0|||
154942223|NCT02711956|559214073|FG013|Overall Study|Physician Decision|0|||
154942224|NCT02711956|559214074|FG014|Overall Study|Physician Decision|0|||
154942225|NCT02711956|559214060|FG000|Overall Study|Withdrawal by Subject|0|||
154942226|NCT02711956|559214061|FG001|Overall Study|Withdrawal by Subject|0|||
154942227|NCT02711956|559214062|FG002|Overall Study|Withdrawal by Subject|0|||
154942228|NCT02711956|559214063|FG003|Overall Study|Withdrawal by Subject|0|||
154942229|NCT02711956|559214064|FG004|Overall Study|Withdrawal by Subject|0|||
154942230|NCT02711956|559214065|FG005|Overall Study|Withdrawal by Subject|0|||
154942231|NCT02711956|559214066|FG006|Overall Study|Withdrawal by Subject|1|||
154942232|NCT02711956|559214067|FG007|Overall Study|Withdrawal by Subject|0|||
154942233|NCT02711956|559214068|FG008|Overall Study|Withdrawal by Subject|0|||
154942234|NCT02711956|559214069|FG009|Overall Study|Withdrawal by Subject|0|||
154942235|NCT02711956|559214070|FG010|Overall Study|Withdrawal by Subject|0|||
154942236|NCT02711956|559214071|FG011|Overall Study|Withdrawal by Subject|1|||
154942237|NCT02711956|559214072|FG012|Overall Study|Withdrawal by Subject|6|||
154942238|NCT02711956|559214073|FG013|Overall Study|Withdrawal by Subject|0|||
154942239|NCT02711956|559214074|FG014|Overall Study|Withdrawal by Subject|1|||
154942240|NCT02711956|559214060|FG000|Overall Study|Clinical progression|1|||
154942241|NCT02711956|559214061|FG001|Overall Study|Clinical progression|0|||
154942242|NCT02711956|559214062|FG002|Overall Study|Clinical progression|0|||
154942243|NCT02711956|559214063|FG003|Overall Study|Clinical progression|0|||
154942244|NCT02711956|559214064|FG004|Overall Study|Clinical progression|0|||
154942245|NCT02711956|559214065|FG005|Overall Study|Clinical progression|0|||
154942246|NCT02711956|559214066|FG006|Overall Study|Clinical progression|1|||
154942247|NCT02711956|559214067|FG007|Overall Study|Clinical progression|0|||
154942248|NCT02711956|559214068|FG008|Overall Study|Clinical progression|1|||
154942249|NCT02711956|559214069|FG009|Overall Study|Clinical progression|0|||
154942250|NCT02711956|559214070|FG010|Overall Study|Clinical progression|0|||
154942251|NCT02711956|559214071|FG011|Overall Study|Clinical progression|2|||
154942252|NCT02711956|559214072|FG012|Overall Study|Clinical progression|4|||
154942253|NCT02711956|559214073|FG013|Overall Study|Clinical progression|1|||
154942254|NCT02711956|559214074|FG014|Overall Study|Clinical progression|1|||
154942255|NCT02711956|559214060|FG000|Overall Study|Radiographic progression|1|||
154942256|NCT02711956|559214061|FG001|Overall Study|Radiographic progression|1|||
154942257|NCT02711956|559214062|FG002|Overall Study|Radiographic progression|2|||
154942258|NCT02711956|559214063|FG003|Overall Study|Radiographic progression|0|||
154942259|NCT02711956|559214064|FG004|Overall Study|Radiographic progression|1|||
154942260|NCT02711956|559214065|FG005|Overall Study|Radiographic progression|0|||
154942261|NCT02711956|559214066|FG006|Overall Study|Radiographic progression|0|||
154942262|NCT02711956|559214067|FG007|Overall Study|Radiographic progression|0|||
154942263|NCT02711956|559214068|FG008|Overall Study|Radiographic progression|2|||
154942264|NCT02711956|559214069|FG009|Overall Study|Radiographic progression|1|||
154942265|NCT02711956|559214070|FG010|Overall Study|Radiographic progression|0|||
154942266|NCT02711956|559214071|FG011|Overall Study|Radiographic progression|5|||
155278426|NCT01033643|560453176|FG002|Overall Study|Withdrew Consent|0|||
155278427|NCT01033643|560453177|FG003|Overall Study|Withdrew Consent|0|||
155278428|NCT01033643|560453178|FG004|Overall Study|Withdrew Consent|0|||
155278429|NCT01033643|560453179|FG005|Overall Study|Withdrew Consent|1|||
155278430|NCT03639675|560453180|FG000|Overall Study|Withdrawal by Subject|1|||
155278431|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Death|0|||
155278432|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Death|2|||
155278433|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
155278434|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
155278435|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
155278436|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
155278437|NCT02459587|560453181|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
155278438|NCT02459587|560453182|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
155278439|NCT02459587|560453181|FG000|6-month Follow-up Assessment|Death|2|||
155278440|NCT02459587|560453182|FG001|6-month Follow-up Assessment|Death|1|||
155278441|NCT02459587|560453181|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
155278442|NCT02459587|560453182|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
155278443|NCT02459587|560453181|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
155278444|NCT02459587|560453182|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
154942267|NCT02711956|559214072|FG012|Overall Study|Radiographic progression|3|||
154942268|NCT02711956|559214073|FG013|Overall Study|Radiographic progression|0|||
154942269|NCT02711956|559214074|FG014|Overall Study|Radiographic progression|1|||
154942270|NCT02711956|559214060|FG000|Overall Study|PSA progression with clinical progression|0|||
155278445|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Death|2|||
154942271|NCT02711956|559214061|FG001|Overall Study|PSA progression with clinical progression|0|||
154942272|NCT02711956|559214062|FG002|Overall Study|PSA progression with clinical progression|0|||
154942273|NCT02711956|559214063|FG003|Overall Study|PSA progression with clinical progression|0|||
154942274|NCT02711956|559214064|FG004|Overall Study|PSA progression with clinical progression|1|||
155044749|NCT02452554|559594050|FG001|Overall Study|Ineligible|1|||
155044750|NCT02452554|559594051|FG002|Overall Study|Ineligible|0|||
155044751|NCT02452554|559594052|FG003|Overall Study|Ineligible|0|||
155044752|NCT02452554|559594053|FG004|Overall Study|Ineligible|0|||
155044753|NCT02452554|559594054|FG005|Overall Study|Ineligible|0|||
155044754|NCT02452554|559594049|FG000|Overall Study|Never Received Treatment|1|||
155044755|NCT02452554|559594050|FG001|Overall Study|Never Received Treatment|0|||
155044756|NCT02452554|559594051|FG002|Overall Study|Never Received Treatment|0|||
155044757|NCT02452554|559594052|FG003|Overall Study|Never Received Treatment|0|||
155044758|NCT02452554|559594053|FG004|Overall Study|Never Received Treatment|0|||
155044759|NCT02452554|559594054|FG005|Overall Study|Never Received Treatment|0|||
155044760|NCT01451554|559594055|FG000|Overall Study|Withdrawal by Subject|14|||
155044761|NCT01451554|559594056|FG001|Overall Study|Withdrawal by Subject|9|||
155044762|NCT02749799|559594057|FG000|Overall Study|Adverse Event|2|||
155044763|NCT02749799|559594057|FG000|Overall Study|Lost to Follow-up|4|||
155044764|NCT02749799|559594057|FG000|Overall Study|Protocol Violation|1|||
155044765|NCT02749799|559594057|FG000|Overall Study|Withdrawal by Subject|1|||
155044766|NCT00520767|559594058|FG000|Overall Study|Death|2|||
155044767|NCT03638466|559596038|FG000|Overall Study|Early Termination|0|||
155044768|NCT03638466|559596039|FG001|Overall Study|Early Termination|1|||
155044769|NCT02576977|559596040|FG000|Overall Study|Adverse Event|13|||
155044770|NCT02576977|559596041|FG001|Overall Study|Adverse Event|2|||
155044771|NCT02576977|559596040|FG000|Overall Study|Death|73|||
155044772|NCT02576977|559596041|FG001|Overall Study|Death|60|||
155044773|NCT02576977|559596040|FG000|Overall Study|Screen failure|1|||
155044774|NCT02576977|559596041|FG001|Overall Study|Screen failure|0|||
155044775|NCT02576977|559596040|FG000|Overall Study|Study Terminated at Selected Sites|27|||
155044776|NCT02576977|559596041|FG001|Overall Study|Study Terminated at Selected Sites|50|||
155044777|NCT02576977|559596040|FG000|Overall Study|Withdrawal by Subject|11|||
155044778|NCT02576977|559596041|FG001|Overall Study|Withdrawal by Subject|11|||
155044779|NCT02576977|559596040|FG000|Overall Study|Final Disposition Unknown|0|||
155044780|NCT02576977|559596041|FG001|Overall Study|Final Disposition Unknown|1|||
155044781|NCT02576977|559596040|FG000|Overall Study|Lost to Follow-up|1|||
155044782|NCT02576977|559596041|FG001|Overall Study|Lost to Follow-up|0|||
155044783|NCT02576977|559596040|FG000|Overall Study|Progressive Disease|0|||
155044784|NCT02576977|559596041|FG001|Overall Study|Progressive Disease|1|||
155044785|NCT03251482|559596044|FG000|Overall Study|Withdrawal by Subject|0|||
155044786|NCT03251482|559596045|FG001|Overall Study|Withdrawal by Subject|1|||
155044787|NCT03251482|559596046|FG002|Overall Study|Withdrawal by Subject|0|||
155044788|NCT03251482|559596047|FG003|Overall Study|Withdrawal by Subject|0|||
155044789|NCT03251482|559596048|FG004|Overall Study|Withdrawal by Subject|0|||
155044790|NCT02447328|559596051|FG000|Overall Study|Withdrawal by Subject|1|||
155044791|NCT02823470|559596054|FG000|Overall Study|Adverse Event|1|||
155044792|NCT02823470|559596055|FG001|Overall Study|Adverse Event|0|||
155044793|NCT02823470|559596054|FG000|Overall Study|Study terminated by sponsor|8|||
155044794|NCT02823470|559596055|FG001|Overall Study|Study terminated by sponsor|15|||
155044795|NCT02155309|559596056|FG000|Overall Study|Protocol Violation|0|||
155044796|NCT02155309|559596057|FG001|Overall Study|Protocol Violation|0|||
155044797|NCT02155309|559596058|FG002|Overall Study|Protocol Violation|1|||
155044798|NCT01073163|559596059|FG000|Overall Study|Adverse Event|1|||
155044799|NCT01073163|559596059|FG000|Overall Study|Disease Progression|1|||
155044800|NCT01073163|559596059|FG000|Overall Study|Early termination|1|||
155044801|NCT00703677|559596060|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
155044802|NCT01677182|559596061|FG000|Overall Study|Adverse Event|2|||
155044803|NCT01677182|559596062|FG001|Overall Study|Adverse Event|1|||
155044804|NCT01677182|559596063|FG002|Overall Study|Adverse Event|8|||
155044805|NCT01677182|559596061|FG000|Overall Study|Protocol Violation|5|||
155044806|NCT01677182|559596062|FG001|Overall Study|Protocol Violation|1|||
155044807|NCT01677182|559596063|FG002|Overall Study|Protocol Violation|4|||
155044808|NCT01677182|559596061|FG000|Overall Study|Lost to Follow-up|4|||
155044809|NCT01677182|559596062|FG001|Overall Study|Lost to Follow-up|0|||
155044810|NCT01677182|559596063|FG002|Overall Study|Lost to Follow-up|3|||
155044811|NCT01677182|559596061|FG000|Overall Study|Withdrawal by Subject|7|||
155044812|NCT01677182|559596062|FG001|Overall Study|Withdrawal by Subject|12|||
155044813|NCT01677182|559596063|FG002|Overall Study|Withdrawal by Subject|10|||
155044814|NCT01677182|559596061|FG000|Overall Study|Study termination|12|||
155044815|NCT01677182|559596062|FG001|Overall Study|Study termination|9|||
155044816|NCT01677182|559596063|FG002|Overall Study|Study termination|11|||
155044817|NCT01677182|559596061|FG000|Overall Study|Lack of Efficacy|3|||
155044818|NCT01677182|559596062|FG001|Overall Study|Lack of Efficacy|0|||
155044819|NCT01677182|559596063|FG002|Overall Study|Lack of Efficacy|1|||
155044820|NCT01677182|559596061|FG000|Overall Study|Other reasons|1|||
155044821|NCT01677182|559596062|FG001|Overall Study|Other reasons|5|||
155044822|NCT01677182|559596063|FG002|Overall Study|Other reasons|2|||
155044823|NCT02501161|559596064|FG000|Overall Study|Adverse Event|2|||
155044824|NCT02501161|559596065|FG001|Overall Study|Adverse Event|6|||
155044825|NCT02501161|559596064|FG000|Overall Study|Lost to Follow-up|7|||
155044826|NCT02501161|559596065|FG001|Overall Study|Lost to Follow-up|4|||
155044827|NCT02501161|559596064|FG000|Overall Study|Withdrawal by Subject|10|||
155044828|NCT02501161|559596065|FG001|Overall Study|Withdrawal by Subject|15|||
155044829|NCT02501161|559596064|FG000|Overall Study|Other|3|||
155044830|NCT02501161|559596065|FG001|Overall Study|Other|0|||
155044831|NCT00762762|559596066|FG000|Overall Study|Did not return for appointments|6|||
155044832|NCT00762762|559596067|FG001|Overall Study|Did not return for appointments|8|||
155044833|NCT02748057|559596068|FG000|Overall Study|Adverse Event|1|||
155044834|NCT02748057|559596069|FG001|Overall Study|Adverse Event|0|||
155044835|NCT02748057|559596068|FG000|Overall Study|Physician Decision|0|||
155044836|NCT02748057|559596069|FG001|Overall Study|Physician Decision|1|||
155044837|NCT02748057|559596068|FG000|Overall Study|Protocol Violation|2|||
155044838|NCT02748057|559596069|FG001|Overall Study|Protocol Violation|1|||
155044839|NCT02748057|559596068|FG000|Overall Study|Participant Moved|1|||
155044840|NCT02748057|559596069|FG001|Overall Study|Participant Moved|0|||
155044841|NCT02748057|559596068|FG000|Overall Study|Withdrawal by Subject|1|||
155044842|NCT02748057|559596069|FG001|Overall Study|Withdrawal by Subject|0|||
155044843|NCT01990573|559596073|FG000|Overall Study|Physician Decision|0|||
155044844|NCT01990573|559596074|FG001|Overall Study|Physician Decision|0|||
155044845|NCT01990573|559596075|FG002|Overall Study|Physician Decision|1|||
155044846|NCT00759655|559596078|FG000|Overall Study|Termination of the study by sponsor|1|||
155044847|NCT00905567|559596083|FG000|Washout|Withdrawal by Subject|0|||
155044848|NCT00905567|559596084|FG001|Washout|Withdrawal by Subject|1|||
155044849|NCT01473940|559596085|FG000|Induction Therapy|Death|0|||
155044850|NCT01473940|559596086|FG001|Induction Therapy|Death|0|||
155044851|NCT01473940|559596087|FG002|Induction Therapy|Death|1|||
155044852|NCT01473940|559596088|FG003|Induction Therapy|Death|1|||
155044853|NCT01473940|559596085|FG000|Induction Therapy|Progressive Disease|0|||
155044854|NCT01473940|559596086|FG001|Induction Therapy|Progressive Disease|1|||
155044855|NCT01473940|559596087|FG002|Induction Therapy|Progressive Disease|1|||
155044856|NCT01473940|559596088|FG003|Induction Therapy|Progressive Disease|0|||
155044857|NCT01473940|559596085|FG000|Maintenance Therapy|Progressive Disease|1|||
154942275|NCT02711956|559214065|FG005|Overall Study|PSA progression with clinical progression|0|||
154942276|NCT02711956|559214066|FG006|Overall Study|PSA progression with clinical progression|0|||
154942277|NCT02711956|559214067|FG007|Overall Study|PSA progression with clinical progression|0|||
154942278|NCT02711956|559214068|FG008|Overall Study|PSA progression with clinical progression|0|||
154942279|NCT02711956|559214069|FG009|Overall Study|PSA progression with clinical progression|0|||
154942280|NCT02711956|559214070|FG010|Overall Study|PSA progression with clinical progression|0|||
154942281|NCT02711956|559214071|FG011|Overall Study|PSA progression with clinical progression|0|||
154942282|NCT02711956|559214072|FG012|Overall Study|PSA progression with clinical progression|1|||
154942283|NCT02711956|559214073|FG013|Overall Study|PSA progression with clinical progression|1|||
154942284|NCT02711956|559214074|FG014|Overall Study|PSA progression with clinical progression|0|||
154942285|NCT02711956|559214060|FG000|Overall Study|PSA progression with radiographic progression|0|||
154942286|NCT02711956|559214061|FG001|Overall Study|PSA progression with radiographic progression|1|||
154942287|NCT02711956|559214062|FG002|Overall Study|PSA progression with radiographic progression|0|||
154942288|NCT02711956|559214063|FG003|Overall Study|PSA progression with radiographic progression|0|||
154942289|NCT02711956|559214064|FG004|Overall Study|PSA progression with radiographic progression|0|||
154942290|NCT02711956|559214065|FG005|Overall Study|PSA progression with radiographic progression|2|||
154942291|NCT02711956|559214066|FG006|Overall Study|PSA progression with radiographic progression|2|||
154942292|NCT02711956|559214067|FG007|Overall Study|PSA progression with radiographic progression|1|||
154942293|NCT02711956|559214068|FG008|Overall Study|PSA progression with radiographic progression|0|||
154942294|NCT02711956|559214069|FG009|Overall Study|PSA progression with radiographic progression|1|||
154942295|NCT02711956|559214070|FG010|Overall Study|PSA progression with radiographic progression|0|||
154942296|NCT02711956|559214071|FG011|Overall Study|PSA progression with radiographic progression|1|||
154942297|NCT02711956|559214072|FG012|Overall Study|PSA progression with radiographic progression|2|||
154942298|NCT02711956|559214073|FG013|Overall Study|PSA progression with radiographic progression|3|||
154942299|NCT02711956|559214074|FG014|Overall Study|PSA progression with radiographic progression|3|||
154942300|NCT05487456|559214075|FG000|Overall Study|Withdrawal by Subject|0|||
154942301|NCT05487456|559214076|FG001|Overall Study|Withdrawal by Subject|0|||
154942302|NCT05487456|559214077|FG002|Overall Study|Withdrawal by Subject|1|||
154942303|NCT05487456|559214078|FG003|Overall Study|Withdrawal by Subject|0|||
154942304|NCT01625377|559214081|FG000|Overall Study|Death|1|||
154942305|NCT01625377|559214082|FG001|Overall Study|Death|1|||
155044858|NCT01473940|559596086|FG001|Maintenance Therapy|Progressive Disease|2|||
155044859|NCT01473940|559596087|FG002|Maintenance Therapy|Progressive Disease|1|||
155044860|NCT01473940|559596088|FG003|Maintenance Therapy|Progressive Disease|4|||
155044861|NCT00534248|559596089|FG000|Overall Study|Adverse Event|19|||
155044862|NCT00534248|559596090|FG001|Overall Study|Adverse Event|29|||
155044863|NCT00534248|559596089|FG000|Overall Study|Lost to Follow-up|353|||
155044864|NCT00534248|559596090|FG001|Overall Study|Lost to Follow-up|375|||
155044865|NCT00534248|559596089|FG000|Overall Study|Other protocol specified criteria|13|||
155044866|NCT00534248|559596090|FG001|Overall Study|Other protocol specified criteria|3|||
155278446|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Death|0|||
155278447|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
154942306|NCT01625377|559214081|FG000|Overall Study|Administrative Problem|1|||
154942307|NCT01625377|559214082|FG001|Overall Study|Administrative Problem|1|||
154942308|NCT01625377|559214081|FG000|Overall Study|Protocol Violation|0|||
154942309|NCT01625377|559214082|FG001|Overall Study|Protocol Violation|3|||
154942310|NCT01625377|559214081|FG000|Overall Study|Adverse Event|3|||
154942311|NCT01625377|559214082|FG001|Overall Study|Adverse Event|16|||
154942312|NCT01625377|559214081|FG000|Overall Study|Graft loss|1|||
154942313|NCT01625377|559214082|FG001|Overall Study|Graft loss|0|||
154942314|NCT01625377|559214081|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
154942315|NCT01625377|559214082|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
154942316|NCT01625377|559214081|FG000|Overall Study|Abnormal laboratory values|1|||
154942317|NCT01625377|559214082|FG001|Overall Study|Abnormal laboratory values|0|||
154942318|NCT02043366|559214085|FG000|Overall Study|Lost to Follow-up|2|||
154942319|NCT02043366|559214086|FG001|Overall Study|Lost to Follow-up|2|||
154942320|NCT02043366|559214087|FG002|Overall Study|Lost to Follow-up|2|||
154942321|NCT02043366|559214088|FG003|Overall Study|Lost to Follow-up|2|||
154942322|NCT02043366|559214089|FG004|Overall Study|Lost to Follow-up|2|||
154942323|NCT02043366|559214090|FG005|Overall Study|Lost to Follow-up|2|||
154942324|NCT03294538|559214093|FG000|Overall Study|Adverse Event|0|||
154942325|NCT03294538|559214094|FG001|Overall Study|Adverse Event|1|||
154942326|NCT03294538|559214095|FG002|Overall Study|Adverse Event|1|||
154942327|NCT03294538|559214093|FG000|Overall Study|Lost to Follow-up|1|||
154942328|NCT03294538|559214094|FG001|Overall Study|Lost to Follow-up|0|||
154942329|NCT03294538|559214095|FG002|Overall Study|Lost to Follow-up|0|||
154942330|NCT03294538|559214093|FG000|Overall Study|Outside of Visit Window|4|||
154942331|NCT03294538|559214094|FG001|Overall Study|Outside of Visit Window|4|||
154942332|NCT03294538|559214095|FG002|Overall Study|Outside of Visit Window|1|||
154942333|NCT01489956|559214097|FG000|Overall Study|Lost to Follow-up|1|||
154942334|NCT01489956|559214098|FG001|Overall Study|Lost to Follow-up|0|||
154942335|NCT01489956|559214099|FG002|Overall Study|Lost to Follow-up|0|||
154942336|NCT01489956|559214097|FG000|Overall Study|Withdrawal by Subject|0|||
154942337|NCT01489956|559214098|FG001|Overall Study|Withdrawal by Subject|0|||
154942338|NCT01489956|559214099|FG002|Overall Study|Withdrawal by Subject|1|||
154942339|NCT01787825|559214101|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
154942340|NCT01787825|559214102|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
154942341|NCT01787825|559214101|FG000|Overall Study|Data Not Analyzable|5|||
154942342|NCT01787825|559214102|FG001|Overall Study|Data Not Analyzable|1|||
154942343|NCT01401478|559214118|FG000|Overall Study|Study drug not available|6|||
154942344|NCT01401478|559214118|FG000|Overall Study|Adverse Event|5|||
154942345|NCT01401478|559214118|FG000|Overall Study|Hyperphosphatemia|5|||
154942346|NCT01401478|559214118|FG000|Overall Study|Lost to Follow-up|5|||
154942347|NCT01401478|559214118|FG000|Overall Study|Kidney transplantation|3|||
154942348|NCT01401478|559214118|FG000|Overall Study|Withdrawal by Subject|3|||
154942349|NCT01401478|559214118|FG000|Overall Study|Blood samples not available|1|||
154942350|NCT01401478|559214118|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
154942351|NCT01401478|559214118|FG000|Overall Study|Low intact parathyroid hormone|1|||
154942352|NCT01401478|559214118|FG000|Overall Study|Serious adverse event|1|||
154942353|NCT01814137|559214119|FG000|Overall Study|Adverse Event|0|||
154942354|NCT01814137|559214120|FG001|Overall Study|Adverse Event|1|||
154942355|NCT01814137|559214119|FG000|Overall Study|Withdrawal by Subject|2|||
154942356|NCT01814137|559214120|FG001|Overall Study|Withdrawal by Subject|2|||
154942357|NCT01814137|559214119|FG000|Overall Study|Physician Decision|1|||
154942358|NCT01814137|559214120|FG001|Overall Study|Physician Decision|1|||
154942359|NCT01814137|559214119|FG000|Overall Study|Unclassified|2|||
154942360|NCT01814137|559214120|FG001|Overall Study|Unclassified|1|||
154942361|NCT01214603|559214121|FG000|Overall Study|Adverse Event|0|||
154942362|NCT01214603|559214122|FG001|Overall Study|Adverse Event|0|||
154942363|NCT01214603|559214123|FG002|Overall Study|Adverse Event|1|||
154942364|NCT01214603|559214121|FG000|Overall Study|Death|1|||
154942365|NCT01214603|559214122|FG001|Overall Study|Death|0|||
154942366|NCT01214603|559214123|FG002|Overall Study|Death|0|||
154942367|NCT01214603|559214121|FG000|Overall Study|Progressive Disease|4|||
154942368|NCT01214603|559214122|FG001|Overall Study|Progressive Disease|1|||
154942369|NCT01214603|559214123|FG002|Overall Study|Progressive Disease|3|||
154942370|NCT01507896|559214124|FG000|Overall Study|Withdrawal by Subject|1|||
154942371|NCT01507896|559214124|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
154942372|NCT00490061|559214125|FG000|Overall Study|Physician Decision|1|||
154942373|NCT01620983|559214140|FG000|Overall Study|Lost to Follow-up|8|||
154942374|NCT01620983|559214141|FG001|Overall Study|Lost to Follow-up|4|||
154942375|NCT01620983|559214142|FG002|Overall Study|Lost to Follow-up|9|||
154942376|NCT01620983|559214140|FG000|Overall Study|Withdrawal by Subject|6|||
154942377|NCT01620983|559214141|FG001|Overall Study|Withdrawal by Subject|8|||
154942378|NCT01620983|559214142|FG002|Overall Study|Withdrawal by Subject|1|||
154942379|NCT01620983|559214140|FG000|Overall Study|Death|2|||
154942380|NCT01620983|559214141|FG001|Overall Study|Death|0|||
154942381|NCT01620983|559214142|FG002|Overall Study|Death|0|||
154942382|NCT01620983|559214140|FG000|Overall Study|Physician Decision|3|||
154942383|NCT01620983|559214141|FG001|Overall Study|Physician Decision|10|||
154942384|NCT01620983|559214142|FG002|Overall Study|Physician Decision|5|||
155044867|NCT00534248|559596089|FG000|Overall Study|Physician Decision|10|||
155044868|NCT00534248|559596090|FG001|Overall Study|Physician Decision|7|||
155044869|NCT00534248|559596089|FG000|Overall Study|Protocol Violation|3|||
155044870|NCT00534248|559596090|FG001|Overall Study|Protocol Violation|4|||
155044871|NCT00534248|559596089|FG000|Overall Study|Withdrawal by Subject|263|||
155044872|NCT00534248|559596090|FG001|Overall Study|Withdrawal by Subject|255|||
155044873|NCT02532257|559596091|FG000|Overall Study|Adverse Event|2|||
155044874|NCT02532257|559596091|FG000|Overall Study|Physician Decision|4|||
155044875|NCT02532257|559596091|FG000|Overall Study|Withdrawal by Subject|3|||
155044876|NCT02532257|559596091|FG000|Overall Study|Progressive Disease|10|||
155044877|NCT02849171|559596092|FG000|Overall Study|Withdrawal by Subject|1|||
155044878|NCT02849171|559596092|FG000|Overall Study|Not treated|1|||
155044879|NCT02630563|559596096|FG000|Overall Study|Administrative|1|||
155044880|NCT00621257|559596097|FG000|Overall Study|Lost to Follow-up|4|||
155044881|NCT00621257|559596098|FG001|Overall Study|Lost to Follow-up|0|||
155044882|NCT00621257|559596099|FG002|Overall Study|Lost to Follow-up|2|||
155044883|NCT00621257|559596100|FG003|Overall Study|Lost to Follow-up|4|||
155044884|NCT00621257|559596101|FG004|Overall Study|Lost to Follow-up|7|||
155044885|NCT00621257|559596097|FG000|Overall Study|Adverse Event|0|||
155044886|NCT00621257|559596098|FG001|Overall Study|Adverse Event|1|||
155044887|NCT00621257|559596099|FG002|Overall Study|Adverse Event|1|||
155044888|NCT00621257|559596100|FG003|Overall Study|Adverse Event|0|||
155044889|NCT00621257|559596101|FG004|Overall Study|Adverse Event|0|||
155044890|NCT00621257|559596097|FG000|Overall Study|Physician Decision|0|||
155044891|NCT00621257|559596098|FG001|Overall Study|Physician Decision|2|||
155044892|NCT00621257|559596099|FG002|Overall Study|Physician Decision|0|||
155044893|NCT00621257|559596100|FG003|Overall Study|Physician Decision|1|||
155044894|NCT00621257|559596101|FG004|Overall Study|Physician Decision|1|||
155044895|NCT00621257|559596097|FG000|Overall Study|Withdrawal by Subject|0|||
155044896|NCT00621257|559596098|FG001|Overall Study|Withdrawal by Subject|0|||
155044897|NCT00621257|559596099|FG002|Overall Study|Withdrawal by Subject|0|||
155044898|NCT00621257|559596100|FG003|Overall Study|Withdrawal by Subject|1|||
155044899|NCT00621257|559596101|FG004|Overall Study|Withdrawal by Subject|1|||
155044900|NCT00929994|559596102|FG000|Overall Study|Withdrawal by Subject|1|||
155044901|NCT00929994|559596102|FG000|Overall Study|medical issue unrelated to intervention|4|||
155044902|NCT00929994|559596102|FG000|Overall Study|employment|1|||
155044903|NCT00694356|559596103|FG000|Overall Study|Adverse Event|1|||
155278448|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
154942385|NCT00798889|559214144|FG000|Overall Study|Adverse Event|53|||
154942386|NCT00798889|559214144|FG000|Overall Study|Protocol Violation|2|||
154942387|NCT00798889|559214144|FG000|Overall Study|Withdrawal by Subject|31|||
154942388|NCT00798889|559214144|FG000|Overall Study|Lost to Follow-up|1|||
154942389|NCT00798889|559214144|FG000|Overall Study|Lack of Efficacy|213|||
154942390|NCT00798889|559214144|FG000|Overall Study|Decision of Sponsor|11|||
154942391|NCT00798889|559214144|FG000|Overall Study|Enrolled, Not treated|3|||
154942392|NCT00617461|559214145|FG000|First Treatment Intervention Period|Adverse Event|2|||
154942393|NCT00617461|559214146|FG001|First Treatment Intervention Period|Adverse Event|0|||
154942394|NCT00617461|559214145|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
154942395|NCT00617461|559214146|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
154942396|NCT00617461|559214145|FG000|First Treatment Intervention Period|Protocol Violation|2|||
154942397|NCT00617461|559214146|FG001|First Treatment Intervention Period|Protocol Violation|1|||
154942398|NCT00617461|559214145|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
154942399|NCT00617461|559214146|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
154942400|NCT00617461|559214145|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
154942401|NCT00617461|559214146|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
154942402|NCT00617461|559214145|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
154942403|NCT00617461|559214146|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
154942404|NCT00617461|559214145|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
154942405|NCT00617461|559214146|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
154942406|NCT00617461|559214145|FG000|Second Treatment Intervention Period|Adverse Event|0|||
154942407|NCT00617461|559214146|FG001|Second Treatment Intervention Period|Adverse Event|1|||
154942408|NCT00617461|559214145|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
154942409|NCT00617461|559214146|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
154942410|NCT00617461|559214145|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
154942411|NCT00617461|559214146|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
155044904|NCT00694356|559596104|FG001|Overall Study|Adverse Event|0|||
155044905|NCT00694356|559596105|FG002|Overall Study|Adverse Event|0|||
155044906|NCT00694356|559596103|FG000|Overall Study|Progressive Disease|2|||
155044907|NCT00694356|559596104|FG001|Overall Study|Progressive Disease|6|||
155044908|NCT00694356|559596105|FG002|Overall Study|Progressive Disease|6|||
155044909|NCT01042392|559596106|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
155044910|NCT01042392|559596107|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
155044911|NCT01042392|559596108|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
155044912|NCT01042392|559596109|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
154942412|NCT00617461|559214145|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
154942413|NCT00617461|559214146|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
154942414|NCT01724359|559214147|FG000|Overall Study|Adverse Event|10|||
154942415|NCT01724359|559214147|FG000|Overall Study|Death|1|||
155044913|NCT01042392|559596106|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
155044914|NCT01042392|559596107|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
155044915|NCT01042392|559596108|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
155278449|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
155278450|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
155278451|NCT02459587|560453181|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
154942416|NCT01724359|559214147|FG000|Overall Study|Other|20|||
154942417|NCT05085964|559214148|FG000|Overall Study|Premature termination of study|21|||
154942418|NCT05085964|559214149|FG001|Overall Study|Premature termination of study|0|||
154942419|NCT00591253|559214154|FG000|Overall Study|Adverse Event|3|||
154942420|NCT00591253|559214155|FG001|Overall Study|Adverse Event|3|||
154942421|NCT00591253|559214156|FG002|Overall Study|Adverse Event|1|||
154942422|NCT00591253|559214154|FG000|Overall Study|Protocol Violation|2|||
154942423|NCT00591253|559214155|FG001|Overall Study|Protocol Violation|2|||
154942424|NCT00591253|559214156|FG002|Overall Study|Protocol Violation|2|||
154942425|NCT00591253|559214154|FG000|Overall Study|Lost to Follow-up|2|||
154942426|NCT00591253|559214155|FG001|Overall Study|Lost to Follow-up|4|||
154942427|NCT00591253|559214156|FG002|Overall Study|Lost to Follow-up|0|||
154942428|NCT00591253|559214154|FG000|Overall Study|Withdrawal by Subject|1|||
154942429|NCT00591253|559214155|FG001|Overall Study|Withdrawal by Subject|7|||
154942430|NCT00591253|559214156|FG002|Overall Study|Withdrawal by Subject|6|||
154942431|NCT00591253|559214154|FG000|Overall Study|Lack of Efficacy|1|||
154942432|NCT00591253|559214155|FG001|Overall Study|Lack of Efficacy|0|||
154942433|NCT00591253|559214156|FG002|Overall Study|Lack of Efficacy|3|||
154942434|NCT00591253|559214154|FG000|Overall Study|Other|5|||
154942435|NCT00591253|559214155|FG001|Overall Study|Other|5|||
154942436|NCT00591253|559214156|FG002|Overall Study|Other|3|||
154942437|NCT00252187|559214158|FG000|Overall Study|Adverse Event|3|||
154942438|NCT00252187|559214159|FG001|Overall Study|Adverse Event|1|||
154942439|NCT00252187|559214158|FG000|Overall Study|Withdrawal by Subject|1|||
154942440|NCT00252187|559214159|FG001|Overall Study|Withdrawal by Subject|0|||
154942441|NCT01875445|559214160|FG000|Overall Study|Lost to Follow-up|5|||
154942442|NCT01875445|559214161|FG001|Overall Study|Lost to Follow-up|0|||
154942443|NCT01875445|559214160|FG000|Overall Study|Withdrawal by Subject|2|||
154942444|NCT01875445|559214161|FG001|Overall Study|Withdrawal by Subject|0|||
155278452|NCT02459587|560453182|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
155278453|NCT01021332|560453185|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
155278454|NCT01021332|560453185|FG000|Overall Study|Adverse Event|43|||
155278455|NCT01021332|560453185|FG000|Overall Study|Lack of Efficacy|19|||
155278456|NCT01021332|560453185|FG000|Overall Study|Withdrawal of Consent|23|||
155278457|NCT01021332|560453185|FG000|Overall Study|Lost to Follow-up|4|||
155278458|NCT01021332|560453185|FG000|Overall Study|Protocol Violation|9|||
155278459|NCT01021332|560453185|FG000|Overall Study|Miscellaneous|3|||
155278460|NCT05343455|560453189|FG000|Overall Study|Withdrawal by Subject|4|||
155278461|NCT05343455|560453190|FG001|Overall Study|Withdrawal by Subject|9|||
155278462|NCT05343455|560453191|FG002|Overall Study|Withdrawal by Subject|7|||
155278463|NCT05343455|560453189|FG000|Overall Study|Adverse Event|2|||
155278464|NCT05343455|560453190|FG001|Overall Study|Adverse Event|1|||
155278465|NCT05343455|560453191|FG002|Overall Study|Adverse Event|2|||
155278466|NCT05343455|560453189|FG000|Overall Study|Lost to Follow-up|1|||
155278467|NCT05343455|560453190|FG001|Overall Study|Lost to Follow-up|1|||
155278468|NCT05343455|560453191|FG002|Overall Study|Lost to Follow-up|3|||
155278469|NCT05343455|560453189|FG000|Overall Study|Pregnancy|1|||
155278470|NCT05343455|560453190|FG001|Overall Study|Pregnancy|0|||
155278471|NCT05343455|560453191|FG002|Overall Study|Pregnancy|0|||
155278472|NCT05343455|560453189|FG000|Overall Study|Physician Decision|0|||
155278473|NCT05343455|560453190|FG001|Overall Study|Physician Decision|0|||
155278474|NCT05343455|560453191|FG002|Overall Study|Physician Decision|1|||
155278475|NCT05343455|560453189|FG000|Overall Study|Protocol Violation|0|||
154942445|NCT00593333|559214162|FG000|Overall Study|Lost to Follow-up|10|||
154942446|NCT00593333|559214163|FG001|Overall Study|Lost to Follow-up|11|||
154942447|NCT01738581|559214164|FG000|Overall Study|Lost to Follow-up|1|||
154942448|NCT01738581|559214165|FG001|Overall Study|Lost to Follow-up|0|||
154942449|NCT00210626|559214168|FG000|Overall Study|Adverse Event|1|||
154942450|NCT00210626|559214169|FG001|Overall Study|Adverse Event|2|||
154942451|NCT00210626|559214168|FG000|Overall Study|Protocol Violation|1|||
154942452|NCT00210626|559214169|FG001|Overall Study|Protocol Violation|5|||
154942453|NCT00210626|559214168|FG000|Overall Study|Lost to Follow-up|11|||
155278476|NCT05343455|560453190|FG001|Overall Study|Protocol Violation|1|||
155278477|NCT05343455|560453191|FG002|Overall Study|Protocol Violation|1|||
155278478|NCT00839917|560453192|FG000|Overall Study|Lost to Follow-up|1|||
155278479|NCT00839917|560453193|FG001|Overall Study|Lost to Follow-up|0|||
155278480|NCT00839917|560453192|FG000|Overall Study|Did not receive vaccine|0|||
155278481|NCT00839917|560453193|FG001|Overall Study|Did not receive vaccine|1|||
154942454|NCT00210626|559214169|FG001|Overall Study|Lost to Follow-up|11|||
154942455|NCT00210626|559214168|FG000|Overall Study|Death|1|||
154942456|NCT00210626|559214169|FG001|Overall Study|Death|0|||
154942457|NCT00210626|559214168|FG000|Overall Study|Withdrawal by Subject|29|||
154942458|NCT00210626|559214169|FG001|Overall Study|Withdrawal by Subject|20|||
154942459|NCT00210626|559214168|FG000|Overall Study|Physician Decision|0|||
154942460|NCT00210626|559214169|FG001|Overall Study|Physician Decision|2|||
154942461|NCT00210626|559214168|FG000|Overall Study|Sponser Request|1|||
154942462|NCT00210626|559214169|FG001|Overall Study|Sponser Request|0|||
154942463|NCT00210626|559214168|FG000|Overall Study|Other|4|||
154942464|NCT00210626|559214169|FG001|Overall Study|Other|5|||
154942465|NCT02191579|559214170|FG000|Treatment 1|Multiple Reasons Specified|27|||
154942466|NCT02191579|559214171|FG001|Treatment 1|Multiple Reasons Specified|58|||
154942467|NCT02191579|559214170|FG000|Treatment 2|Multiple Reasons Specified|0|||
154942468|NCT02191579|559214171|FG001|Treatment 2|Multiple Reasons Specified|25|||
154942469|NCT02862535|559214174|FG000|Overall Study|Death|7|||
154942470|NCT02862535|559214175|FG001|Overall Study|Death|3|||
154942471|NCT02862535|559214176|FG002|Overall Study|Death|2|||
154942472|NCT02862535|559214177|FG003|Overall Study|Death|5|||
154942473|NCT02862535|559214174|FG000|Overall Study|Study Terminated by Sponsor|1|||
154942474|NCT02862535|559214175|FG001|Overall Study|Study Terminated by Sponsor|3|||
154942475|NCT02862535|559214176|FG002|Overall Study|Study Terminated by Sponsor|8|||
154942476|NCT02862535|559214177|FG003|Overall Study|Study Terminated by Sponsor|5|||
154942477|NCT02862535|559214174|FG000|Overall Study|Enrolled, not Treated|1|||
154942478|NCT02862535|559214175|FG001|Overall Study|Enrolled, not Treated|0|||
154942479|NCT02862535|559214176|FG002|Overall Study|Enrolled, not Treated|0|||
154942480|NCT02862535|559214177|FG003|Overall Study|Enrolled, not Treated|1|||
154942481|NCT01965652|559214180|FG000|Overall Study|Adverse Event|40|||
154942482|NCT01965652|559214181|FG001|Overall Study|Adverse Event|37|||
154942483|NCT01965652|559214180|FG000|Overall Study|Withdrawal by Subject|62|||
154942484|NCT01965652|559214181|FG001|Overall Study|Withdrawal by Subject|69|||
154942485|NCT01965652|559214180|FG000|Overall Study|Lost to Follow-up|53|||
154942486|NCT01965652|559214181|FG001|Overall Study|Lost to Follow-up|40|||
154942487|NCT01965652|559214180|FG000|Overall Study|Protocol Violation|34|||
154942488|NCT01965652|559214181|FG001|Overall Study|Protocol Violation|38|||
154942489|NCT01965652|559214180|FG000|Overall Study|Death|3|||
154942490|NCT01965652|559214181|FG001|Overall Study|Death|4|||
154942491|NCT01965652|559214180|FG000|Overall Study|Other - Miscellaneous|18|||
154942492|NCT01965652|559214181|FG001|Overall Study|Other - Miscellaneous|21|||
154942493|NCT01965652|559214180|FG000|Overall Study|Pregnancy|0|||
154942494|NCT01965652|559214181|FG001|Overall Study|Pregnancy|1|||
154942495|NCT01121900|559214182|FG000|First Intervention Period|Adverse Event|1|||
154942496|NCT01121900|559214183|FG001|First Intervention Period|Adverse Event|1|||
154942497|NCT01121900|559214182|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
154942498|NCT01121900|559214183|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
154942499|NCT03469271|559214184|FG000|Overall Study|Withdrawal by Subject|2|||
154942500|NCT03469271|559214185|FG001|Overall Study|Withdrawal by Subject|0|||
154942501|NCT03469271|559214186|FG002|Overall Study|Withdrawal by Subject|0|||
154942502|NCT03469271|559214187|FG003|Overall Study|Withdrawal by Subject|1|||
154942503|NCT03361956|559214188|FG000|Overall Study|Adverse Event|1|||
154942504|NCT03361956|559214189|FG001|Overall Study|Adverse Event|0|||
154942505|NCT03361956|559214190|FG002|Overall Study|Adverse Event|1|||
154942506|NCT03361956|559214191|FG003|Overall Study|Adverse Event|1|||
154942507|NCT03361956|559214192|FG004|Overall Study|Adverse Event|0|||
154942508|NCT03361956|559214188|FG000|Overall Study|Other|0|||
154942509|NCT03361956|559214189|FG001|Overall Study|Other|0|||
154942510|NCT03361956|559214190|FG002|Overall Study|Other|0|||
154942511|NCT03361956|559214191|FG003|Overall Study|Other|1|||
154942512|NCT03361956|559214192|FG004|Overall Study|Other|0|||
154942513|NCT03361956|559214188|FG000|Overall Study|Withdrawal by Subject|2|||
154942514|NCT03361956|559214189|FG001|Overall Study|Withdrawal by Subject|2|||
154942515|NCT03361956|559214190|FG002|Overall Study|Withdrawal by Subject|2|||
154942516|NCT03361956|559214191|FG003|Overall Study|Withdrawal by Subject|0|||
154942517|NCT03361956|559214192|FG004|Overall Study|Withdrawal by Subject|3|||
154942518|NCT03361956|559214188|FG000|Overall Study|Disease Relapse|0|||
154942519|NCT03361956|559214189|FG001|Overall Study|Disease Relapse|0|||
154942520|NCT03361956|559214190|FG002|Overall Study|Disease Relapse|1|||
154942521|NCT03361956|559214191|FG003|Overall Study|Disease Relapse|0|||
154942522|NCT03361956|559214192|FG004|Overall Study|Disease Relapse|0|||
154942523|NCT03361956|559214188|FG000|Overall Study|Physician Decision|0|||
154942524|NCT03361956|559214189|FG001|Overall Study|Physician Decision|2|||
154942525|NCT03361956|559214190|FG002|Overall Study|Physician Decision|0|||
154942526|NCT03361956|559214191|FG003|Overall Study|Physician Decision|1|||
154942527|NCT03361956|559214192|FG004|Overall Study|Physician Decision|0|||
154942528|NCT03361956|559214188|FG000|Overall Study|Lost to Follow-up|0|||
154942529|NCT03361956|559214189|FG001|Overall Study|Lost to Follow-up|0|||
154942530|NCT03361956|559214190|FG002|Overall Study|Lost to Follow-up|1|||
154942531|NCT03361956|559214191|FG003|Overall Study|Lost to Follow-up|1|||
154942532|NCT03361956|559214192|FG004|Overall Study|Lost to Follow-up|2|||
154942533|NCT03760510|559214193|FG000|Overall Study|Not ventilated for 24 hours|105|||
155278482|NCT03468426|560453194|FG000|Overall Study|Progressive disease|3|||
155278483|NCT03468426|560453195|FG001|Overall Study|Progressive disease|0|||
155278484|NCT03468426|560453196|FG002|Overall Study|Progressive disease|4|||
155278485|NCT03468426|560453197|FG003|Overall Study|Progressive disease|20|||
155278486|NCT03468426|560453198|FG004|Overall Study|Progressive disease|23|||
155278487|NCT03468426|560453199|FG005|Overall Study|Progressive disease|15|||
155092570|NCT01959529|559773634|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
155278488|NCT03468426|560453200|FG006|Overall Study|Progressive disease|24|||
155278489|NCT03468426|560453201|FG007|Overall Study|Progressive disease|27|||
155278490|NCT03468426|560453202|FG008|Overall Study|Progressive disease|13|||
155278491|NCT03468426|560453203|FG009|Overall Study|Progressive disease|13|||
155278492|NCT03468426|560453204|FG010|Overall Study|Progressive disease|0|||
155278493|NCT03468426|560453194|FG000|Overall Study|Other adverse event or clinical progression|0|||
155278494|NCT03468426|560453195|FG001|Overall Study|Other adverse event or clinical progression|1|||
155278495|NCT03468426|560453196|FG002|Overall Study|Other adverse event or clinical progression|3|||
155278496|NCT03468426|560453197|FG003|Overall Study|Other adverse event or clinical progression|14|||
155278497|NCT03468426|560453198|FG004|Overall Study|Other adverse event or clinical progression|10|||
155278498|NCT03468426|560453199|FG005|Overall Study|Other adverse event or clinical progression|8|||
155278499|NCT03468426|560453200|FG006|Overall Study|Other adverse event or clinical progression|5|||
155278500|NCT03468426|560453201|FG007|Overall Study|Other adverse event or clinical progression|4|||
155278501|NCT03468426|560453202|FG008|Overall Study|Other adverse event or clinical progression|6|||
155278502|NCT03468426|560453203|FG009|Overall Study|Other adverse event or clinical progression|11|||
155278503|NCT03468426|560453204|FG010|Overall Study|Other adverse event or clinical progression|0|||
154942534|NCT03760510|559214194|FG001|Overall Study|Not ventilated for 24 hours|97|||
154942535|NCT04147715|559214196|FG000|Overall Study|Adverse Event|0|||
154942536|NCT04147715|559214197|FG001|Overall Study|Adverse Event|0|||
155278504|NCT03468426|560453194|FG000|Overall Study|Refused to continue taking trial medication|0|||
155278505|NCT03468426|560453195|FG001|Overall Study|Refused to continue taking trial medication|0|||
155278506|NCT03468426|560453196|FG002|Overall Study|Refused to continue taking trial medication|0|||
155278507|NCT03468426|560453197|FG003|Overall Study|Refused to continue taking trial medication|2|||
155278508|NCT03468426|560453198|FG004|Overall Study|Refused to continue taking trial medication|0|||
155278509|NCT03468426|560453199|FG005|Overall Study|Refused to continue taking trial medication|3|||
155278510|NCT03468426|560453200|FG006|Overall Study|Refused to continue taking trial medication|0|||
155278511|NCT03468426|560453201|FG007|Overall Study|Refused to continue taking trial medication|0|||
155278512|NCT03468426|560453202|FG008|Overall Study|Refused to continue taking trial medication|1|||
155278513|NCT03468426|560453203|FG009|Overall Study|Refused to continue taking trial medication|0|||
155278514|NCT03468426|560453204|FG010|Overall Study|Refused to continue taking trial medication|0|||
155278515|NCT03468426|560453194|FG000|Overall Study|Other than listed|0|||
155278516|NCT03468426|560453195|FG001|Overall Study|Other than listed|1|||
155278517|NCT03468426|560453196|FG002|Overall Study|Other than listed|0|||
155278518|NCT03468426|560453197|FG003|Overall Study|Other than listed|0|||
155278519|NCT03468426|560453198|FG004|Overall Study|Other than listed|2|||
155278520|NCT03468426|560453199|FG005|Overall Study|Other than listed|2|||
155278521|NCT03468426|560453200|FG006|Overall Study|Other than listed|0|||
155278522|NCT03468426|560453201|FG007|Overall Study|Other than listed|0|||
154942537|NCT04147715|559214198|FG002|Overall Study|Adverse Event|0|||
154942538|NCT04147715|559214199|FG003|Overall Study|Adverse Event|0|||
154942539|NCT04147715|559214200|FG004|Overall Study|Adverse Event|0|||
154942540|NCT04147715|559214201|FG005|Overall Study|Adverse Event|0|||
154942541|NCT04147715|559214202|FG006|Overall Study|Adverse Event|0|||
154942542|NCT04147715|559214203|FG007|Overall Study|Adverse Event|2|||
154942543|NCT04147715|559214204|FG008|Overall Study|Adverse Event|1|||
154942544|NCT04147715|559214205|FG009|Overall Study|Adverse Event|0|||
154942545|NCT04147715|559214206|FG010|Overall Study|Adverse Event|0|||
154942546|NCT04147715|559214207|FG011|Overall Study|Adverse Event|0|||
154942547|NCT02418910|559214209|FG000|Overall Study|Lost to Follow-up|3|||
154942548|NCT02418910|559214209|FG000|Overall Study|Withdrawal by Subject|4|||
154942549|NCT01855126|559214212|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
154942550|NCT01855126|559214213|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
154942551|NCT01855126|559214212|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
154942552|NCT01855126|559214213|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
154942553|NCT00895583|559214214|FG000|Overall Study|Adverse Event|28|||
154942554|NCT00895583|559214215|FG001|Overall Study|Adverse Event|4|||
154942555|NCT00895583|559214214|FG000|Overall Study|Death|2|||
154942556|NCT00895583|559214215|FG001|Overall Study|Death|1|||
154942557|NCT00895583|559214214|FG000|Overall Study|Physician Decision|3|||
154942558|NCT00895583|559214215|FG001|Overall Study|Physician Decision|1|||
154942559|NCT00895583|559214214|FG000|Overall Study|Lost to Follow-up|1|||
154942560|NCT00895583|559214215|FG001|Overall Study|Lost to Follow-up|3|||
155278523|NCT03468426|560453202|FG008|Overall Study|Other than listed|4|||
155278524|NCT03468426|560453203|FG009|Overall Study|Other than listed|4|||
155278525|NCT03468426|560453204|FG010|Overall Study|Other than listed|1|||
155278526|NCT03468426|560453194|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278527|NCT03468426|560453195|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154942561|NCT00895583|559214214|FG000|Overall Study|Protocol Violation|1|||
154942562|NCT00895583|559214215|FG001|Overall Study|Protocol Violation|0|||
154942563|NCT00895583|559214214|FG000|Overall Study|Withdrawal by Subject|4|||
154942564|NCT00895583|559214215|FG001|Overall Study|Withdrawal by Subject|2|||
154942565|NCT00895583|559214214|FG000|Overall Study|Lack of Efficacy|5|||
154942566|NCT00895583|559214215|FG001|Overall Study|Lack of Efficacy|0|||
154942567|NCT00895583|559214214|FG000|Overall Study|Other|0|||
154942568|NCT00895583|559214215|FG001|Overall Study|Other|1|||
154942569|NCT04345471|559214222|FG000|Overall Study|Adverse Event|8|||
154942570|NCT04345471|559214223|FG001|Overall Study|Adverse Event|5|||
154942571|NCT04345471|559214224|FG002|Overall Study|Adverse Event|6|||
154942572|NCT04345471|559214222|FG000|Overall Study|Lack of Efficacy|1|||
154942573|NCT04345471|559214223|FG001|Overall Study|Lack of Efficacy|1|||
154942574|NCT04345471|559214224|FG002|Overall Study|Lack of Efficacy|0|||
154942575|NCT04345471|559214222|FG000|Overall Study|Protocol Violation|0|||
154942576|NCT04345471|559214223|FG001|Overall Study|Protocol Violation|1|||
154942577|NCT04345471|559214224|FG002|Overall Study|Protocol Violation|2|||
154942578|NCT04345471|559214222|FG000|Overall Study|Withdrawal by Subject|10|||
154942579|NCT04345471|559214223|FG001|Overall Study|Withdrawal by Subject|5|||
154942580|NCT04345471|559214224|FG002|Overall Study|Withdrawal by Subject|10|||
154942581|NCT03016078|559214225|FG000|Overall Study|Protocol Violation|1|||
154942582|NCT03016078|559214225|FG000|Overall Study|Protocol Violation|1|||
154942583|NCT00982410|559215870|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
154942584|NCT00982410|559215871|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
154942585|NCT00982410|559215870|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
154942586|NCT00982410|559215871|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
154942587|NCT00982410|559215870|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
154942588|NCT00982410|559215871|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
154942589|NCT00982410|559215870|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
154942590|NCT00982410|559215871|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
154942591|NCT00982410|559215870|FG000|6-month Follow-up Assessment|participant no transportation|1|||
154942592|NCT00982410|559215871|FG001|6-month Follow-up Assessment|participant no transportation|0|||
154942593|NCT00982410|559215870|FG000|6-month Follow-up Assessment|incarceration|0|||
154942594|NCT00982410|559215871|FG001|6-month Follow-up Assessment|incarceration|2|||
154942595|NCT00982410|559215870|FG000|6-month Follow-up Assessment|patent surgery|0|||
154942596|NCT00982410|559215871|FG001|6-month Follow-up Assessment|patent surgery|1|||
154942597|NCT00982410|559215870|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
154942598|NCT00982410|559215871|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
154942599|NCT00982410|559215870|FG000|12-month Follow-up Assessment|Death|0|||
154942600|NCT00982410|559215871|FG001|12-month Follow-up Assessment|Death|2|||
154942601|NCT00982410|559215870|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
154942602|NCT00982410|559215871|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
154942603|NCT00982410|559215870|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
154942604|NCT00982410|559215871|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
154942605|NCT00982410|559215870|FG000|12-month Follow-up Assessment|incarceration|2|||
154942606|NCT00982410|559215871|FG001|12-month Follow-up Assessment|incarceration|1|||
154942607|NCT00982410|559215870|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
154942608|NCT00982410|559215871|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
154942609|NCT02034799|559215874|FG000|Overall Study|Withdrawal by Subject|0|||
154942610|NCT02034799|559215875|FG001|Overall Study|Withdrawal by Subject|2|||
154942611|NCT02034799|559215874|FG000|Overall Study|Lost to Follow-up|0|||
154942612|NCT02034799|559215875|FG001|Overall Study|Lost to Follow-up|1|||
154942613|NCT02034799|559215874|FG000|Overall Study|Death|2|||
154942614|NCT02034799|559215875|FG001|Overall Study|Death|1|||
154942615|NCT03381248|559215883|FG000|0-6 Months|Withdrawal by Subject|4|||
154942616|NCT03381248|559215884|FG001|0-6 Months|Withdrawal by Subject|1|||
154942617|NCT03381248|559215883|FG000|0-6 Months|Lost to Follow-up|3|||
154942618|NCT03381248|559215884|FG001|0-6 Months|Lost to Follow-up|2|||
154942619|NCT03381248|559215883|FG000|0-6 Months|Lack of Efficacy|1|||
154942620|NCT03381248|559215884|FG001|0-6 Months|Lack of Efficacy|0|||
154942621|NCT03381248|559215883|FG000|0-6 Months|Adverse Event|1|||
154942622|NCT03381248|559215884|FG001|0-6 Months|Adverse Event|0|||
154942623|NCT03381248|559215883|FG000|0-6 Months|Protocol Violation|2|||
154942624|NCT03381248|559215884|FG001|0-6 Months|Protocol Violation|1|||
154942625|NCT03381248|559215883|FG000|0-6 Months|Physician Decision|1|||
154942626|NCT03381248|559215884|FG001|0-6 Months|Physician Decision|0|||
154942627|NCT03381248|559215883|FG000|0-6 Months|Planning another procedure|1|||
154942628|NCT03381248|559215884|FG001|0-6 Months|Planning another procedure|2|||
154942629|NCT03381248|559215883|FG000|6-12 Months|Withdrawal by Subject|1|||
154942630|NCT03381248|559215884|FG001|6-12 Months|Withdrawal by Subject|3|||
154942631|NCT03381248|559215883|FG000|6-12 Months|Lost to Follow-up|0|||
154942632|NCT03381248|559215884|FG001|6-12 Months|Lost to Follow-up|2|||
154942633|NCT03381248|559215883|FG000|6-12 Months|Protocol Violation|3|||
154942634|NCT03381248|559215884|FG001|6-12 Months|Protocol Violation|2|||
154942635|NCT03381248|559215883|FG000|6-12 Months|Planning another procedure|6|||
154942636|NCT03381248|559215884|FG001|6-12 Months|Planning another procedure|2|||
154942637|NCT03381248|559215883|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
154942638|NCT03381248|559215884|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
154942639|NCT03381248|559215883|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
154942640|NCT03381248|559215884|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
154942641|NCT03381248|559215883|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
154942642|NCT03381248|559215884|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
154942643|NCT05188521|559215889|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
154942644|NCT05188521|559215890|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
154942645|NCT01341639|559215891|FG000|Infant Series|Protocol Violation|1|||
154942646|NCT01341639|559215892|FG001|Infant Series|Protocol Violation|0|||
154942647|NCT01341639|559215891|FG000|Infant Series|Not Vaccinated|0|||
154942648|NCT01341639|559215892|FG001|Infant Series|Not Vaccinated|1|||
154942649|NCT01341639|559215891|FG000|Infant Series|Adverse Event|0|||
154942650|NCT01341639|559215892|FG001|Infant Series|Adverse Event|5|||
154942651|NCT01341639|559215891|FG000|Infant Series|Withdrawal by Subject|11|||
154942652|NCT01341639|559215892|FG001|Infant Series|Withdrawal by Subject|8|||
154942653|NCT01341639|559215891|FG000|Infant Series|Lost to Follow-up|0|||
154942654|NCT01341639|559215892|FG001|Infant Series|Lost to Follow-up|2|||
154942655|NCT01341639|559215891|FG000|Infant Series|Site 0048 Participants|17|||
154942656|NCT01341639|559215892|FG001|Infant Series|Site 0048 Participants|16|||
154942657|NCT01341639|559215891|FG000|Interim Period|Withdrawal by Subject|6|||
154942658|NCT01341639|559215892|FG001|Interim Period|Withdrawal by Subject|7|||
154942659|NCT01341639|559215891|FG000|Interim Period|Lost to Follow-up|2|||
154942660|NCT01341639|559215892|FG001|Interim Period|Lost to Follow-up|0|||
154942661|NCT01341639|559215891|FG000|Interim Period|Physician Decision|0|||
154942662|NCT01341639|559215892|FG001|Interim Period|Physician Decision|1|||
154942663|NCT01341639|559215891|FG000|Interim Period|Protocol Violation|0|||
154942664|NCT01341639|559215892|FG001|Interim Period|Protocol Violation|1|||
154942665|NCT01341639|559215891|FG000|Post-Treatment|Withdrawal by Subject|0|||
154942666|NCT01341639|559215892|FG001|Post-Treatment|Withdrawal by Subject|1|||
154942667|NCT01341639|559215891|FG000|Post-Treatment|Adverse Event|0|||
154942668|NCT01341639|559215892|FG001|Post-Treatment|Adverse Event|2|||
154942669|NCT04582266|559215893|FG000|Overall Study|Lost to Follow-up|7|||
154942670|NCT04582266|559215894|FG001|Overall Study|Lost to Follow-up|5|||
154942671|NCT04582266|559215893|FG000|Overall Study|Withdrawal by Subject|1|||
154942672|NCT04582266|559215894|FG001|Overall Study|Withdrawal by Subject|0|||
154942673|NCT04582266|559215893|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
154942674|NCT04582266|559215894|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
154942675|NCT02224456|559215895|FG000|Overall Study|Lack of Efficacy|1|||
154942676|NCT02224456|559215895|FG000|Overall Study|Lost to Follow-up|15|||
154942677|NCT02224456|559215895|FG000|Overall Study|Withdrawal by Subject|9|||
154942678|NCT02224456|559215895|FG000|Overall Study|Physician Decision|3|||
154942679|NCT02224456|559215895|FG000|Overall Study|Death|2|||
154942680|NCT02224456|559215895|FG000|Overall Study|Pregnancy|4|||
154942681|NCT02224456|559215895|FG000|Overall Study|Protocol Violation|1|||
154942682|NCT02224456|559215895|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
154942683|NCT01241461|559215896|FG000|Overall Study|Progressive Disease|3|||
154942684|NCT01241461|559215897|FG001|Overall Study|Progressive Disease|6|||
154942685|NCT01379781|559215901|FG000|Overall Study|Lost to Follow-up|11|||
154942686|NCT01379781|559215902|FG001|Overall Study|Lost to Follow-up|8|||
154942687|NCT02247479|559215903|FG000|Overall Study|Adverse Event|8|||
154942688|NCT02247479|559215904|FG001|Overall Study|Adverse Event|9|||
154942689|NCT02247479|559215905|FG002|Overall Study|Adverse Event|8|||
154942690|NCT02247479|559215903|FG000|Overall Study|Death|5|||
154942691|NCT02247479|559215904|FG001|Overall Study|Death|4|||
154942692|NCT02247479|559215905|FG002|Overall Study|Death|6|||
154942693|NCT02247479|559215903|FG000|Overall Study|Lost to Follow-up|3|||
154942694|NCT02247479|559215904|FG001|Overall Study|Lost to Follow-up|3|||
154942695|NCT02247479|559215905|FG002|Overall Study|Lost to Follow-up|1|||
154942696|NCT02247479|559215903|FG000|Overall Study|Non-compliance|0|||
154942697|NCT02247479|559215904|FG001|Overall Study|Non-compliance|0|||
154942698|NCT02247479|559215905|FG002|Overall Study|Non-compliance|1|||
154942699|NCT02247479|559215903|FG000|Overall Study|Withdrawal by Subject|25|||
154942700|NCT02247479|559215904|FG001|Overall Study|Withdrawal by Subject|29|||
154942701|NCT02247479|559215905|FG002|Overall Study|Withdrawal by Subject|24|||
155278528|NCT03468426|560453196|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155278529|NCT03468426|560453197|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154942702|NCT02247479|559215903|FG000|Overall Study|Study Terminated by Sponsor|98|||
154942703|NCT02247479|559215904|FG001|Overall Study|Study Terminated by Sponsor|88|||
154942704|NCT02247479|559215905|FG002|Overall Study|Study Terminated by Sponsor|94|||
154942705|NCT02247479|559215903|FG000|Overall Study|Physician Decision|1|||
154942706|NCT02247479|559215904|FG001|Overall Study|Physician Decision|0|||
154942707|NCT02247479|559215905|FG002|Overall Study|Physician Decision|2|||
155278530|NCT03468426|560453198|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278531|NCT03468426|560453199|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278532|NCT03468426|560453200|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278533|NCT03468426|560453201|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278534|NCT03468426|560453202|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278535|NCT03468426|560453203|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154942708|NCT02247479|559215903|FG000|Overall Study|Unspecified Reason|2|||
154942709|NCT02247479|559215904|FG001|Overall Study|Unspecified Reason|5|||
154942710|NCT02247479|559215905|FG002|Overall Study|Unspecified Reason|2|||
154942711|NCT02497391|559215908|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
154942712|NCT02497391|559215909|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
154942713|NCT02497391|559215910|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
154942714|NCT02497391|559215911|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
154942715|NCT02497391|559215912|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
154942716|NCT02497391|559215913|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
154942717|NCT02497391|559215908|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
154942718|NCT02497391|559215909|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
154942719|NCT02497391|559215910|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
154942720|NCT02497391|559215911|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
154942721|NCT02497391|559215912|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
154942722|NCT02497391|559215913|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
154942723|NCT02497391|559215908|FG000|Period 3 (14 Days)|Adverse Event|0|||
154942724|NCT02497391|559215909|FG001|Period 3 (14 Days)|Adverse Event|1|||
154942725|NCT02497391|559215910|FG002|Period 3 (14 Days)|Adverse Event|0|||
154942726|NCT02497391|559215911|FG003|Period 3 (14 Days)|Adverse Event|0|||
154942727|NCT02497391|559215912|FG004|Period 3 (14 Days)|Adverse Event|0|||
154942728|NCT02497391|559215913|FG005|Period 3 (14 Days)|Adverse Event|0|||
154942729|NCT02497391|559215908|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
154942730|NCT02497391|559215909|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
154942731|NCT02497391|559215910|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
154942732|NCT02497391|559215911|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
154942733|NCT02497391|559215912|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
154942734|NCT02497391|559215913|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
154942735|NCT02497391|559215908|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
154942736|NCT02497391|559215909|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
154942737|NCT02497391|559215910|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
154942738|NCT02497391|559215911|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
154942739|NCT02497391|559215912|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
154942740|NCT02497391|559215913|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
154942741|NCT01664052|559215914|FG000|Phase 1|No device placement|6|||
154942742|NCT01664052|559215915|FG001|Phase 1|No device placement|0|||
154942743|NCT01664052|559215914|FG000|Phase 1|No HSG 1 hr post placement|1|||
154942744|NCT01664052|559215915|FG001|Phase 1|No HSG 1 hr post placement|0|||
154942745|NCT01664052|559215914|FG000|Phase 2|No device placement|0|||
154942746|NCT01664052|559215915|FG001|Phase 2|No device placement|4|||
154942747|NCT03740698|559215916|FG000|Overall Study|Physician Decision|0|||
154942748|NCT03740698|559215917|FG001|Overall Study|Physician Decision|1|||
154942749|NCT03740698|559215918|FG002|Overall Study|Physician Decision|1|||
154942750|NCT05216978|559215928|FG000|Overall Study|Withdrawal by Subject|3|||
154942751|NCT05216978|559215928|FG000|Overall Study|Lost to Follow-up|5|||
154942752|NCT00658320|559215930|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
154942753|NCT00658320|559215931|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
154942754|NCT00658320|559215930|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
154942755|NCT00658320|559215931|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
154942756|NCT00658320|559215930|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
154942757|NCT00658320|559215931|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
154942758|NCT00658320|559215930|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
154942759|NCT00658320|559215931|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
154942760|NCT02410252|559215939|FG000|Overall Study|Withdrawal by Subject|4|||
154942761|NCT02410252|559215939|FG000|Overall Study|Physician Decision|2|||
154942762|NCT01007916|559215947|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
154942763|NCT01007916|559215948|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
154942764|NCT01007916|559215947|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
154942765|NCT01007916|559215948|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
154942766|NCT01162499|559215949|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
154942767|NCT01162499|559215950|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
154942768|NCT02058628|559215951|FG000|Overall Study|Adverse Event|1|||
154942769|NCT02058628|559215952|FG001|Overall Study|Adverse Event|0|||
155278536|NCT03468426|560453204|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155278537|NCT03468426|560453194|FG000|Overall Study|missing reason|0|||
154942770|NCT02058628|559215951|FG000|Overall Study|Withdrawal by Subject|2|||
154942771|NCT02058628|559215952|FG001|Overall Study|Withdrawal by Subject|2|||
154942772|NCT02058628|559215951|FG000|Overall Study|Lost to Follow-up|2|||
154942773|NCT02058628|559215952|FG001|Overall Study|Lost to Follow-up|4|||
154942774|NCT02058628|559215951|FG000|Overall Study|Not in time schedule|0|||
155044916|NCT01042392|559596109|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
155044917|NCT01042392|559596106|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
155044918|NCT01042392|559596107|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
155044919|NCT01042392|559596108|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
155044920|NCT01042392|559596109|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
155044921|NCT01042392|559596106|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
155044922|NCT01042392|559596107|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
155044923|NCT01042392|559596108|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
155044924|NCT01042392|559596109|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
155044925|NCT01042392|559596106|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
155044926|NCT01042392|559596107|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
155044927|NCT01042392|559596108|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
155044928|NCT01042392|559596109|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
155044929|NCT01042392|559596106|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
155044930|NCT01042392|559596107|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
155044931|NCT01042392|559596108|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
155044932|NCT01042392|559596109|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
155044933|NCT01042392|559596106|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
155044934|NCT01042392|559596107|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
155044935|NCT01042392|559596108|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
155044936|NCT01042392|559596109|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
155044937|NCT01042392|559596106|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
155044938|NCT01042392|559596107|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
155044939|NCT01042392|559596108|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
155044940|NCT01042392|559596109|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
155044941|NCT01042392|559596106|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
155044942|NCT01042392|559596107|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
155044943|NCT01042392|559596108|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
155044944|NCT01042392|559596109|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
155044945|NCT00540644|559596110|FG000|Overall Study|Adverse Event|3|||
155044946|NCT00540644|559596111|FG001|Overall Study|Adverse Event|1|||
155044947|NCT00540644|559596110|FG000|Overall Study|Disease Progression|3|||
155044948|NCT00540644|559596111|FG001|Overall Study|Disease Progression|1|||
155044949|NCT00540644|559596110|FG000|Overall Study|Physician Decision|0|||
155044950|NCT00540644|559596111|FG001|Overall Study|Physician Decision|5|||
155044951|NCT00540644|559596110|FG000|Overall Study|Withdrawal by Subject|2|||
155044952|NCT00540644|559596111|FG001|Overall Study|Withdrawal by Subject|2|||
155044953|NCT00540644|559596110|FG000|Overall Study|Noncomplilance|1|||
155044954|NCT00540644|559596111|FG001|Overall Study|Noncomplilance|0|||
155044955|NCT02072941|559596112|FG000|Overall Study|Withdrawal by Subject|29|||
155044956|NCT02072941|559596113|FG001|Overall Study|Withdrawal by Subject|21|||
155044957|NCT02072941|559596112|FG000|Overall Study|Lost to Follow-up|4|||
155044958|NCT02072941|559596113|FG001|Overall Study|Lost to Follow-up|4|||
155044959|NCT02072941|559596112|FG000|Overall Study|Death|3|||
155044960|NCT02072941|559596113|FG001|Overall Study|Death|2|||
155044961|NCT02072941|559596112|FG000|Overall Study|Removed by Study Staff|2|||
155044962|NCT02072941|559596113|FG001|Overall Study|Removed by Study Staff|2|||
155044963|NCT00237692|559596114|FG000|Overall Study|Lost to Follow-up|9|||
155044964|NCT00237692|559596115|FG001|Overall Study|Lost to Follow-up|3|||
155044965|NCT00237692|559596116|FG002|Overall Study|Lost to Follow-up|5|||
155044966|NCT00237692|559596117|FG003|Overall Study|Lost to Follow-up|3|||
155044967|NCT00237692|559596114|FG000|Overall Study|Death|1|||
155044968|NCT00237692|559596115|FG001|Overall Study|Death|2|||
155044969|NCT00237692|559596116|FG002|Overall Study|Death|2|||
155044970|NCT00237692|559596117|FG003|Overall Study|Death|3|||
155044971|NCT00237692|559596114|FG000|Overall Study|Excluded - did not meet criteria|4|||
155044972|NCT00237692|559596115|FG001|Overall Study|Excluded - did not meet criteria|3|||
155044973|NCT00237692|559596116|FG002|Overall Study|Excluded - did not meet criteria|5|||
155044974|NCT00237692|559596117|FG003|Overall Study|Excluded - did not meet criteria|9|||
155044975|NCT00237692|559596114|FG000|Overall Study|Withdrawal by Subject|4|||
155044976|NCT00237692|559596115|FG001|Overall Study|Withdrawal by Subject|6|||
155044977|NCT00237692|559596116|FG002|Overall Study|Withdrawal by Subject|10|||
155044978|NCT00237692|559596117|FG003|Overall Study|Withdrawal by Subject|4|||
155044979|NCT01737879|559596118|FG000|Overall Study|Death|1|||
155044980|NCT01737879|559596118|FG000|Overall Study|Sponsor decision|40|||
155044981|NCT02081001|559596120|FG000|Overall Study|Adverse Event|0|||
155044982|NCT02081001|559596121|FG001|Overall Study|Adverse Event|0|||
155044983|NCT02081001|559596122|FG002|Overall Study|Adverse Event|0|||
155044984|NCT02081001|559596123|FG003|Overall Study|Adverse Event|0|||
155044985|NCT02081001|559596124|FG004|Overall Study|Adverse Event|1|||
155044986|NCT02081001|559596125|FG005|Overall Study|Adverse Event|0|||
155044987|NCT02081001|559596126|FG006|Overall Study|Adverse Event|0|||
155044988|NCT02081001|559596127|FG007|Overall Study|Adverse Event|0|||
154942775|NCT02058628|559215952|FG001|Overall Study|Not in time schedule|1|||
154942776|NCT02058628|559215951|FG000|Overall Study|The visit date was not in timeline|0|||
154942777|NCT02058628|559215952|FG001|Overall Study|The visit date was not in timeline|1|||
154942778|NCT02058628|559215951|FG000|Overall Study|A lot of time for study for participant|1|||
154942779|NCT02058628|559215952|FG001|Overall Study|A lot of time for study for participant|0|||
154942780|NCT02058628|559215951|FG000|Overall Study|Non compliance|1|||
154942781|NCT02058628|559215952|FG001|Overall Study|Non compliance|0|||
154942782|NCT00782509|559215954|FG000|Overall Study|Adverse Event|20|||
154942783|NCT00782509|559215955|FG001|Overall Study|Adverse Event|10|||
154942784|NCT00782509|559215956|FG002|Overall Study|Adverse Event|20|||
154942785|NCT00782509|559215954|FG000|Overall Study|Lost to Follow-up|1|||
154942786|NCT00782509|559215955|FG001|Overall Study|Lost to Follow-up|2|||
154942787|NCT00782509|559215956|FG002|Overall Study|Lost to Follow-up|3|||
154942788|NCT00782509|559215954|FG000|Overall Study|Withdrawal by Subject|3|||
154942789|NCT00782509|559215955|FG001|Overall Study|Withdrawal by Subject|5|||
154942790|NCT00782509|559215956|FG002|Overall Study|Withdrawal by Subject|8|||
154942791|NCT00782509|559215954|FG000|Overall Study|Non compliance with protocol|2|||
155044989|NCT02081001|559596128|FG008|Overall Study|Adverse Event|0|||
155044990|NCT02081001|559596129|FG009|Overall Study|Adverse Event|0|||
155044991|NCT02081001|559596130|FG010|Overall Study|Adverse Event|0|||
155044992|NCT02081001|559596131|FG011|Overall Study|Adverse Event|0|||
155044993|NCT01386944|559596138|FG000|Overall Study|Adverse Event|26|||
155044994|NCT01386944|559596138|FG000|Overall Study|Lack of Efficacy|14|||
155044995|NCT01386944|559596138|FG000|Overall Study|Lost to Follow-up|8|||
155044996|NCT01386944|559596138|FG000|Overall Study|Unspecified reason|8|||
155044997|NCT03883477|559596139|FG000|Overall Study|Death|1|||
155044998|NCT03883477|559596140|FG001|Overall Study|Death|0|||
155044999|NCT03883477|559596139|FG000|Overall Study|Protocol Violation|0|||
155045000|NCT03883477|559596140|FG001|Overall Study|Protocol Violation|1|||
155045001|NCT04186221|559596141|FG000|Overall Study|Death|1|||
155045002|NCT00531947|559596142|FG000|Overall Study|Adverse Event|5|||
155045003|NCT00531947|559596143|FG001|Overall Study|Adverse Event|10|||
155045004|NCT00531947|559596142|FG000|Overall Study|Lost to Follow-up|12|||
155045005|NCT00531947|559596143|FG001|Overall Study|Lost to Follow-up|9|||
155045006|NCT00531947|559596142|FG000|Overall Study|Withdrawal by Subject|14|||
155045007|NCT00531947|559596143|FG001|Overall Study|Withdrawal by Subject|19|||
155045008|NCT00531947|559596142|FG000|Overall Study|Protocol Violation|2|||
154942792|NCT00782509|559215955|FG001|Overall Study|Non compliance with protocol|0|||
154942793|NCT00782509|559215956|FG002|Overall Study|Non compliance with protocol|0|||
154942794|NCT00782509|559215954|FG000|Overall Study|Other reasons not stated above|5|||
154942795|NCT00782509|559215955|FG001|Overall Study|Other reasons not stated above|2|||
154942796|NCT00782509|559215956|FG002|Overall Study|Other reasons not stated above|3|||
154942797|NCT00782509|559215954|FG000|Overall Study|Lack of Efficacy|10|||
154942798|NCT00782509|559215955|FG001|Overall Study|Lack of Efficacy|5|||
154942799|NCT00782509|559215956|FG002|Overall Study|Lack of Efficacy|2|||
154942800|NCT01418352|559215957|FG000|Overall Study|Lost to Follow-up|2|||
154942801|NCT01418352|559215958|FG001|Overall Study|Lost to Follow-up|0|||
154942802|NCT01418352|559215959|FG002|Overall Study|Lost to Follow-up|0|||
154942803|NCT01418352|559215960|FG003|Overall Study|Lost to Follow-up|0|||
154942804|NCT01418352|559215957|FG000|Overall Study|Adverse Event|0|||
154942805|NCT01418352|559215958|FG001|Overall Study|Adverse Event|1|||
154942806|NCT01418352|559215959|FG002|Overall Study|Adverse Event|0|||
154942807|NCT01418352|559215960|FG003|Overall Study|Adverse Event|0|||
154942808|NCT01418352|559215957|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
154942809|NCT01418352|559215958|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
154942810|NCT01418352|559215959|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
154942811|NCT01418352|559215960|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
154942812|NCT01418352|559215957|FG000|Overall Study|Subject Withdrew Consent|0|||
154942813|NCT01418352|559215958|FG001|Overall Study|Subject Withdrew Consent|1|||
154942814|NCT01418352|559215959|FG002|Overall Study|Subject Withdrew Consent|2|||
154942815|NCT01418352|559215960|FG003|Overall Study|Subject Withdrew Consent|1|||
154942816|NCT01418352|559215957|FG000|Overall Study|Protocol Deviation|0|||
154942817|NCT01418352|559215958|FG001|Overall Study|Protocol Deviation|0|||
154942818|NCT01418352|559215959|FG002|Overall Study|Protocol Deviation|1|||
154942819|NCT01418352|559215960|FG003|Overall Study|Protocol Deviation|0|||
154942820|NCT01418352|559215957|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
154942821|NCT01418352|559215958|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
155382219|NCT00825825|560833299|FG003|Third Medication Period (14 Days)|poor data quality|0|||
155045009|NCT00531947|559596143|FG001|Overall Study|Protocol Violation|1|||
155045010|NCT00531947|559596142|FG000|Overall Study|Non-Compliance|4|||
155045011|NCT00531947|559596143|FG001|Overall Study|Non-Compliance|7|||
155045012|NCT00531947|559596142|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
155045013|NCT00531947|559596143|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
155045014|NCT02348008|559596152|FG000|Overall Study|Adverse Event|2|||
155045015|NCT02348008|559596153|FG001|Overall Study|Adverse Event|3|||
155045016|NCT02348008|559596154|FG002|Overall Study|Adverse Event|3|||
155045017|NCT02348008|559596152|FG000|Overall Study|Disease Progression|1|||
155045018|NCT02348008|559596153|FG001|Overall Study|Disease Progression|5|||
155045019|NCT02348008|559596154|FG002|Overall Study|Disease Progression|16|||
155045020|NCT02348008|559596152|FG000|Overall Study|Withdrawal by Subject|0|||
155045021|NCT02348008|559596153|FG001|Overall Study|Withdrawal by Subject|1|||
155045022|NCT02348008|559596154|FG002|Overall Study|Withdrawal by Subject|0|||
155045023|NCT02348008|559596152|FG000|Overall Study|Symptomatic Deterioration|0|||
155045024|NCT02348008|559596153|FG001|Overall Study|Symptomatic Deterioration|1|||
155045025|NCT02348008|559596154|FG002|Overall Study|Symptomatic Deterioration|0|||
155045026|NCT04399538|559596155|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
155045027|NCT04399538|559596156|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
155045028|NCT04399538|559596157|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
155045029|NCT04399538|559596158|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
155045030|NCT04399538|559596159|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
155045031|NCT04399538|559596155|FG000|Double-Blind Treatment|Adverse Event|0|||
155045032|NCT04399538|559596156|FG001|Double-Blind Treatment|Adverse Event|0|||
155045033|NCT04399538|559596157|FG002|Double-Blind Treatment|Adverse Event|0|||
155045034|NCT04399538|559596158|FG003|Double-Blind Treatment|Adverse Event|0|||
155045035|NCT04399538|559596159|FG004|Double-Blind Treatment|Adverse Event|1|||
155045036|NCT04399538|559596155|FG000|Follow-Up|Adverse Event|0|||
155045037|NCT04399538|559596156|FG001|Follow-Up|Adverse Event|0|||
155045038|NCT04399538|559596157|FG002|Follow-Up|Adverse Event|0|||
155045039|NCT04399538|559596158|FG003|Follow-Up|Adverse Event|0|||
155045040|NCT04399538|559596159|FG004|Follow-Up|Adverse Event|1|||
155045041|NCT04399538|559596155|FG000|Follow-Up|Withdrawal by Subject|0|||
155045042|NCT04399538|559596156|FG001|Follow-Up|Withdrawal by Subject|0|||
155045043|NCT04399538|559596157|FG002|Follow-Up|Withdrawal by Subject|0|||
155045044|NCT04399538|559596158|FG003|Follow-Up|Withdrawal by Subject|2|||
155045045|NCT04399538|559596159|FG004|Follow-Up|Withdrawal by Subject|0|||
155045046|NCT01588405|559596161|FG000|Overall Study|Adverse Event|1|||
155045047|NCT01588405|559596161|FG000|Overall Study|Clinical Worsening|1|||
155045048|NCT03268005|559596162|FG000|Overall Study|Death|2|||
155045049|NCT03268005|559596163|FG001|Overall Study|Death|1|||
155045050|NCT03268005|559596162|FG000|Overall Study|Lost to Follow-up|2|||
155045051|NCT03268005|559596163|FG001|Overall Study|Lost to Follow-up|2|||
155045052|NCT03268005|559596162|FG000|Overall Study|Withdrawal by Subject|11|||
155045053|NCT03268005|559596163|FG001|Overall Study|Withdrawal by Subject|11|||
155045054|NCT01926197|559596165|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
155045055|NCT01926197|559596166|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
155045056|NCT01926197|559596165|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
155045057|NCT01926197|559596166|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
155045058|NCT02756364|559596168|FG000|Overall Study|Site Terminated by Sponsor|24|||
155045059|NCT02756364|559596169|FG001|Overall Study|Site Terminated by Sponsor|30|||
155045060|NCT02756364|559596170|FG002|Overall Study|Site Terminated by Sponsor|21|||
155045061|NCT02756364|559596168|FG000|Overall Study|Death|20|||
154942822|NCT01418352|559215959|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
154942823|NCT01418352|559215960|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
154942824|NCT00585351|559215961|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
154942825|NCT00585351|559215962|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
154942826|NCT00585351|559215963|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
154942827|NCT00585351|559215964|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
154942828|NCT00585351|559215965|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
154942829|NCT00585351|559215966|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
154942830|NCT00585351|559215967|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
154942831|NCT00585351|559215968|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
154942832|NCT00585351|559215961|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
154942833|NCT00585351|559215962|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
154942834|NCT00585351|559215963|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
155045062|NCT02756364|559596169|FG001|Overall Study|Death|15|||
155045063|NCT02756364|559596170|FG002|Overall Study|Death|18|||
155045064|NCT02756364|559596168|FG000|Overall Study|Withdrawal by Patient|2|||
155045065|NCT02756364|559596169|FG001|Overall Study|Withdrawal by Patient|1|||
155045066|NCT02756364|559596170|FG002|Overall Study|Withdrawal by Patient|8|||
155045067|NCT02756364|559596168|FG000|Overall Study|Lost to Follow-up|0|||
155045068|NCT02756364|559596169|FG001|Overall Study|Lost to Follow-up|1|||
155045069|NCT02756364|559596170|FG002|Overall Study|Lost to Follow-up|1|||
155045070|NCT02223364|559596171|FG000|Overall Study|Protocol Violation|3|||
155045071|NCT02223364|559596172|FG001|Overall Study|Protocol Violation|0|||
155045072|NCT02223364|559596173|FG002|Overall Study|Protocol Violation|3|||
155045073|NCT02223364|559596171|FG000|Overall Study|subject expired before surgery|1|||
155045074|NCT02223364|559596172|FG001|Overall Study|subject expired before surgery|0|||
155045075|NCT02223364|559596173|FG002|Overall Study|subject expired before surgery|0|||
155045076|NCT02223364|559596171|FG000|Overall Study|Physician Decision|1|||
155045077|NCT02223364|559596172|FG001|Overall Study|Physician Decision|0|||
154942835|NCT00585351|559215964|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
154942836|NCT00585351|559215965|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
154942837|NCT00585351|559215966|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
154942838|NCT00585351|559215967|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
154942839|NCT00585351|559215968|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
154942840|NCT00585351|559215961|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
154942841|NCT00585351|559215962|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
154942842|NCT00585351|559215963|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
154942843|NCT00585351|559215964|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
154942844|NCT00585351|559215965|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
154942845|NCT00585351|559215966|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
154942846|NCT00585351|559215967|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
154942847|NCT00585351|559215968|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
154942848|NCT00585351|559215961|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
154942849|NCT00585351|559215962|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
154942850|NCT00585351|559215963|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
154942851|NCT00585351|559215964|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
155278538|NCT03468426|560453195|FG001|Overall Study|missing reason|0|||
155278539|NCT03468426|560453196|FG002|Overall Study|missing reason|0|||
155278540|NCT03468426|560453197|FG003|Overall Study|missing reason|0|||
154942852|NCT00585351|559215965|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
154942853|NCT00585351|559215966|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
154942854|NCT00585351|559215967|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
154942855|NCT00585351|559215968|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
154942856|NCT00585351|559215961|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155045078|NCT02223364|559596173|FG002|Overall Study|Physician Decision|0|||
155045079|NCT02984267|559596174|FG000|Overall Study|Protocol Violation|1|||
155045080|NCT02984267|559596175|FG001|Overall Study|Protocol Violation|0|||
155045081|NCT02984267|559596174|FG000|Overall Study|Withdrawal by Subject|0|||
155045082|NCT02984267|559596175|FG001|Overall Study|Withdrawal by Subject|1|||
155045083|NCT04811664|559596177|FG000|Overall Study|Lost to Follow-up|78|||
155045084|NCT04811664|559596178|FG001|Overall Study|Lost to Follow-up|125|||
155045085|NCT04811664|559596179|FG002|Overall Study|Lost to Follow-up|46|||
155045086|NCT04811664|559596177|FG000|Overall Study|Withdrawal by Subject|39|||
155045087|NCT04811664|559596178|FG001|Overall Study|Withdrawal by Subject|76|||
155045088|NCT04811664|559596179|FG002|Overall Study|Withdrawal by Subject|12|||
155045089|NCT04811664|559596177|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
155045090|NCT04811664|559596178|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
155045091|NCT04811664|559596179|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
155045092|NCT04811664|559596177|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
155045093|NCT04811664|559596178|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
155045094|NCT04811664|559596179|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
155045095|NCT04811664|559596177|FG000|Overall Study|Protocol Violation|0|||
154942857|NCT00585351|559215962|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
154942858|NCT00585351|559215963|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
154942859|NCT00585351|559215964|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
154942860|NCT00585351|559215965|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
155045096|NCT04811664|559596178|FG001|Overall Study|Protocol Violation|5|||
155045097|NCT04811664|559596179|FG002|Overall Study|Protocol Violation|11|||
155278541|NCT03468426|560453198|FG004|Overall Study|missing reason|0|||
155045098|NCT04811664|559596177|FG000|Overall Study|Study Terminated by Sponsor|4|||
155045099|NCT04811664|559596178|FG001|Overall Study|Study Terminated by Sponsor|3|||
155045100|NCT04811664|559596179|FG002|Overall Study|Study Terminated by Sponsor|34|||
155045101|NCT04811664|559596177|FG000|Overall Study|Early Study Closure|3|||
155045102|NCT04811664|559596178|FG001|Overall Study|Early Study Closure|7|||
155045103|NCT04811664|559596179|FG002|Overall Study|Early Study Closure|79|||
155278542|NCT03468426|560453199|FG005|Overall Study|missing reason|0|||
155278543|NCT03468426|560453200|FG006|Overall Study|missing reason|0|||
155278544|NCT03468426|560453201|FG007|Overall Study|missing reason|0|||
155278545|NCT03468426|560453202|FG008|Overall Study|missing reason|0|||
155278546|NCT03468426|560453203|FG009|Overall Study|missing reason|1|||
155278547|NCT03468426|560453204|FG010|Overall Study|missing reason|0|||
155278548|NCT02139982|560453205|FG000|Overall Study|Lack of Efficacy|0|||
155045104|NCT04811664|559596177|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
155045105|NCT04811664|559596178|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
155278549|NCT02139982|560453206|FG001|Overall Study|Lack of Efficacy|1|||
155278550|NCT02139982|560453207|FG002|Overall Study|Lack of Efficacy|0|||
155278551|NCT02139982|560453208|FG003|Overall Study|Lack of Efficacy|1|||
155278552|NCT02139982|560453209|FG004|Overall Study|Lack of Efficacy|0|||
155045106|NCT04811664|559596179|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
155045107|NCT02717442|559596180|FG000|Overall Study|Study Terminated by Sponsor|31|||
155045108|NCT02717442|559596181|FG001|Overall Study|Study Terminated by Sponsor|29|||
155045109|NCT02717442|559596180|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
155045110|NCT02717442|559596181|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
155045111|NCT02717442|559596180|FG000|Overall Study|Other - Not Specified|2|||
155045112|NCT02717442|559596181|FG001|Overall Study|Other - Not Specified|0|||
155045113|NCT01900899|559596184|FG000|Overall Study|Withdrawal by Subject|7|||
155045114|NCT01900899|559596185|FG001|Overall Study|Withdrawal by Subject|1|||
155045115|NCT01900899|559596184|FG000|Overall Study|Migrated from study area|2|||
155045116|NCT01900899|559596185|FG001|Overall Study|Migrated from study area|0|||
155045117|NCT02774005|559596186|FG000|Overall Study|Adverse Event|8|||
155045118|NCT02774005|559596186|FG000|Overall Study|Withdrawal by Subject|23|||
155045119|NCT02774005|559596186|FG000|Overall Study|Lost to Follow-up|7|||
155045120|NCT02774005|559596186|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
155045121|NCT02774005|559596186|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
155045122|NCT02774005|559596186|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
155045123|NCT02774005|559596186|FG000|Overall Study|Death|1|||
155045124|NCT02774005|559596186|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
155045125|NCT02774005|559596186|FG000|Overall Study|Lack of compliance with study medication|4|||
155045126|NCT02774005|559596186|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
155045127|NCT02774005|559596186|FG000|Overall Study|another study|1|||
155045128|NCT02774005|559596186|FG000|Overall Study|cardiologist imposed travel restriction|1|||
155045129|NCT01790516|559596187|FG000|Overall Study|Physician Decision|1|||
155045130|NCT01790516|559596188|FG001|Overall Study|Physician Decision|0|||
155045131|NCT01402986|559596189|FG000|Overall Study|Withdrawal by Subject|7|||
155045132|NCT01402986|559596190|FG001|Overall Study|Withdrawal by Subject|10|||
155045133|NCT01402986|559596191|FG002|Overall Study|Withdrawal by Subject|7|||
155045134|NCT01402986|559596192|FG003|Overall Study|Withdrawal by Subject|13|||
155045135|NCT01402986|559596189|FG000|Overall Study|Death|0|||
155045136|NCT01402986|559596190|FG001|Overall Study|Death|0|||
155045137|NCT01402986|559596191|FG002|Overall Study|Death|0|||
155045138|NCT01402986|559596192|FG003|Overall Study|Death|2|||
155045139|NCT01402986|559596189|FG000|Overall Study|Lost to Follow-up|0|||
155045140|NCT01402986|559596190|FG001|Overall Study|Lost to Follow-up|0|||
155045141|NCT01402986|559596191|FG002|Overall Study|Lost to Follow-up|0|||
155045142|NCT01402986|559596192|FG003|Overall Study|Lost to Follow-up|1|||
155045143|NCT01402986|559596189|FG000|Overall Study|Other|2|||
155045144|NCT01402986|559596190|FG001|Overall Study|Other|5|||
155045145|NCT01402986|559596191|FG002|Overall Study|Other|1|||
155045146|NCT01402986|559596192|FG003|Overall Study|Other|6|||
155045147|NCT03749109|559596193|FG000|Overall Study|Adverse Event|2|||
155045148|NCT03749109|559596194|FG001|Overall Study|Adverse Event|0|||
155045149|NCT03178851|559596195|FG000|Overall Study|Death|48|||
155045150|NCT03178851|559596196|FG001|Overall Study|Death|2|||
155045151|NCT03178851|559596197|FG002|Overall Study|Death|25|||
155045152|NCT03178851|559596195|FG000|Overall Study|Withdrawal by Subject|8|||
155045153|NCT03178851|559596196|FG001|Overall Study|Withdrawal by Subject|0|||
155045154|NCT03178851|559596197|FG002|Overall Study|Withdrawal by Subject|0|||
155045155|NCT03178851|559596195|FG000|Overall Study|Lost to Follow-up|5|||
155045156|NCT03178851|559596196|FG001|Overall Study|Lost to Follow-up|2|||
155045157|NCT03178851|559596197|FG002|Overall Study|Lost to Follow-up|0|||
155045158|NCT03178851|559596195|FG000|Overall Study|Adverse Event|0|||
155045159|NCT03178851|559596196|FG001|Overall Study|Adverse Event|0|||
155045160|NCT03178851|559596197|FG002|Overall Study|Adverse Event|1|||
155045161|NCT03178851|559596195|FG000|Overall Study|Study Termination by Sponsor|31|||
155045162|NCT03178851|559596196|FG001|Overall Study|Study Termination by Sponsor|7|||
155045163|NCT03178851|559596197|FG002|Overall Study|Study Termination by Sponsor|26|||
155045164|NCT02226120|559596198|FG000|Overall Study|Adverse Event|60|||
155045165|NCT02226120|559596198|FG000|Overall Study|Death|172|||
155045166|NCT02226120|559596198|FG000|Overall Study|Study terminated by sponsor|1|||
155045167|NCT02226120|559596198|FG000|Overall Study|Technical problems|4|||
155045168|NCT02226120|559596198|FG000|Overall Study|Lost to Follow-up|13|||
155045169|NCT02226120|559596198|FG000|Overall Study|Physician Decision|21|||
155045170|NCT02226120|559596198|FG000|Overall Study|Withdrawal by parent/guardian|36|||
155045171|NCT02226120|559596198|FG000|Overall Study|Non-compliance with study drug|10|||
155045172|NCT02226120|559596198|FG000|Overall Study|Protocol deviation|1|||
155045173|NCT02226120|559596198|FG000|Overall Study|missing treatment disposition pages|2|||
155045174|NCT03034135|559596199|FG000|Overall Study|Withdrawal by Subject|2|||
155045175|NCT02669043|559596204|FG000|Overall Study|Didn't meet I/E criteria|4|||
155045176|NCT00802672|559599227|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
155045177|NCT00802672|559599228|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
155278553|NCT02139982|560453210|FG005|Overall Study|Lack of Efficacy|0|||
155278554|NCT02139982|560453211|FG006|Overall Study|Lack of Efficacy|0|||
155278555|NCT02139982|560453212|FG007|Overall Study|Lack of Efficacy|0|||
155045178|NCT00802672|559599229|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
155045179|NCT00802672|559599227|FG000|Overall Study|Adverse Event|1|||
155045180|NCT00802672|559599228|FG001|Overall Study|Adverse Event|1|||
155045181|NCT00802672|559599229|FG002|Overall Study|Adverse Event|1|||
155045182|NCT00802672|559599227|FG000|Overall Study|Protocol Violation|2|||
155045183|NCT00802672|559599228|FG001|Overall Study|Protocol Violation|1|||
155045184|NCT00802672|559599229|FG002|Overall Study|Protocol Violation|1|||
155045185|NCT00802672|559599227|FG000|Overall Study|Lost to Follow-up|5|||
155045186|NCT00802672|559599228|FG001|Overall Study|Lost to Follow-up|5|||
155045187|NCT00802672|559599229|FG002|Overall Study|Lost to Follow-up|3|||
154942861|NCT00585351|559215966|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
154942862|NCT00585351|559215967|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
154942863|NCT00585351|559215968|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
154942864|NCT00585351|559215961|FG000|Enrollment Period (Intervention)|Death|0|||
154942865|NCT00585351|559215962|FG001|Enrollment Period (Intervention)|Death|0|||
154942866|NCT00585351|559215963|FG002|Enrollment Period (Intervention)|Death|0|||
154942867|NCT00585351|559215964|FG003|Enrollment Period (Intervention)|Death|0|||
154942868|NCT00585351|559215965|FG004|Enrollment Period (Intervention)|Death|1|||
154942869|NCT00585351|559215966|FG005|Enrollment Period (Intervention)|Death|0|||
154942870|NCT00585351|559215967|FG006|Enrollment Period (Intervention)|Death|1|||
154942871|NCT00585351|559215968|FG007|Enrollment Period (Intervention)|Death|0|||
154942872|NCT00585351|559215961|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
154942873|NCT00585351|559215962|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
155045188|NCT00802672|559599227|FG000|Overall Study|Withdrawal by Subject|1|||
155045189|NCT00802672|559599228|FG001|Overall Study|Withdrawal by Subject|1|||
155045190|NCT00802672|559599229|FG002|Overall Study|Withdrawal by Subject|2|||
155045191|NCT00802672|559599227|FG000|Overall Study|other|3|||
155045192|NCT00802672|559599228|FG001|Overall Study|other|1|||
155045193|NCT00802672|559599229|FG002|Overall Study|other|2|||
155045194|NCT04441788|559599231|FG000|Overall Study|Voluntary Withdrawl|0|||
155045195|NCT04441788|559599232|FG001|Overall Study|Voluntary Withdrawl|1|||
155045196|NCT04441788|559599233|FG002|Overall Study|Voluntary Withdrawl|0|||
155045197|NCT04441788|559599231|FG000|Overall Study|Ineligibility|1|||
155045198|NCT04441788|559599232|FG001|Overall Study|Ineligibility|0|||
155045199|NCT04441788|559599233|FG002|Overall Study|Ineligibility|0|||
155045200|NCT04441788|559599231|FG000|Overall Study|Adverse Event|0|||
155045201|NCT04441788|559599232|FG001|Overall Study|Adverse Event|0|||
155045202|NCT04441788|559599233|FG002|Overall Study|Adverse Event|4|||
155045203|NCT04441788|559599231|FG000|Overall Study|Study Terminated by Sponsor|16|||
155045204|NCT04441788|559599232|FG001|Overall Study|Study Terminated by Sponsor|16|||
155045205|NCT04441788|559599233|FG002|Overall Study|Study Terminated by Sponsor|12|||
155045206|NCT03859648|559599236|FG000|Overall Study|Lost to Follow-up|1|||
155045207|NCT03859648|559599236|FG000|Overall Study|Adverse Event|1|||
155045208|NCT02315664|559599237|FG000|Overall Study|Lost to Follow-up|1|||
155045209|NCT02315664|559599238|FG001|Overall Study|Lost to Follow-up|1|||
155045210|NCT02315664|559599237|FG000|Overall Study|Withdrawal by Subject|0|||
155045211|NCT02315664|559599238|FG001|Overall Study|Withdrawal by Subject|3|||
155045212|NCT00667992|559599243|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
155045213|NCT00667992|559599244|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
155045214|NCT00667992|559599243|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
155045215|NCT00667992|559599244|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
155045216|NCT00667992|559599243|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
155045217|NCT00667992|559599244|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
155045218|NCT00667992|559599243|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
155045219|NCT00667992|559599244|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
155045220|NCT00667992|559599243|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
155045221|NCT00667992|559599244|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
155045222|NCT00667992|559599243|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
155045223|NCT00667992|559599244|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
155045224|NCT00667992|559599243|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
155045225|NCT00667992|559599244|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
155045226|NCT00667992|559599243|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
155045227|NCT00667992|559599244|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
155045228|NCT00667992|559599243|FG000|Wash-out|Not within one doubling dilution|4|||
155045229|NCT00667992|559599244|FG001|Wash-out|Not within one doubling dilution|3|||
155045230|NCT00667992|559599243|FG000|Wash-out|Failure to wash-out|2|||
155045231|NCT00667992|559599244|FG001|Wash-out|Failure to wash-out|2|||
155045232|NCT00667992|559599243|FG000|Wash-out|Withdrawal by Subject|1|||
155045233|NCT00667992|559599244|FG001|Wash-out|Withdrawal by Subject|0|||
155045234|NCT00667992|559599243|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
155045235|NCT00667992|559599244|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
155045236|NCT00667992|559599243|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
155045237|NCT00667992|559599244|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
155045238|NCT04336475|559599245|FG000|Overall Study|pain|1|||
155045239|NCT04336475|559599246|FG001|Overall Study|pain|0|||
155045240|NCT04336475|559599245|FG000|Overall Study|upper respiratory infection|1|||
155045241|NCT04336475|559599246|FG001|Overall Study|upper respiratory infection|0|||
155045242|NCT04336475|559599245|FG000|Overall Study|Lost to Follow-up|0|||
155045243|NCT04336475|559599246|FG001|Overall Study|Lost to Follow-up|2|||
155045244|NCT02489448|559599249|FG000|Overall Study|Death|3|||
155045245|NCT02489448|559599249|FG000|Overall Study|Withdrawal by Subject|2|||
155045246|NCT02906579|559599258|FG000|Overall Study|Adverse Event|1|||
155045247|NCT02906579|559599258|FG000|Overall Study|Physician Decision|1|||
155045248|NCT02030119|559599259|FG000|Overall Study|Withdrawal by Subject|3|||
155045249|NCT02030119|559599260|FG001|Overall Study|Withdrawal by Subject|1|||
155045250|NCT02030119|559599261|FG002|Overall Study|Withdrawal by Subject|5|||
155045251|NCT02030119|559599262|FG003|Overall Study|Withdrawal by Subject|3|||
155045252|NCT02030119|559599259|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
155045253|NCT02030119|559599260|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
155045254|NCT02030119|559599261|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
155045255|NCT02030119|559599262|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
155045256|NCT02793947|559599263|FG000|Overall Study|Death|1|||
155045257|NCT02793947|559599264|FG001|Overall Study|Death|0|||
155045258|NCT02793947|559599263|FG000|Overall Study|Physician Decision|1|||
155045259|NCT02793947|559599264|FG001|Overall Study|Physician Decision|5|||
155045260|NCT02213380|559599269|FG000|Underwent Randomization|Withdrawal by Subject|2|||
155045261|NCT02213380|559599270|FG001|Underwent Randomization|Withdrawal by Subject|0|||
155045262|NCT02213380|559599269|FG000|Underwent Randomization|Not treated|3|||
155045263|NCT02213380|559599270|FG001|Underwent Randomization|Not treated|3|||
155045264|NCT02213380|559599269|FG000|Per-protocol Analysis|Protocol Violation|32|||
155045265|NCT02213380|559599270|FG001|Per-protocol Analysis|Protocol Violation|36|||
155045266|NCT01310127|559599275|FG000|Overall Study|Protocol Violation|1|||
155045267|NCT01310127|559599276|FG001|Overall Study|Protocol Violation|1|||
155045268|NCT01310127|559599275|FG000|Overall Study|advanced psc cataract outlier|1|||
155045269|NCT01310127|559599276|FG001|Overall Study|advanced psc cataract outlier|0|||
155045270|NCT01490840|559599277|FG000|Phase 1|Lost to Follow-up|1|||
155045271|NCT01490840|559599278|FG001|Phase 1|Lost to Follow-up|0|||
155045272|NCT01490840|559599277|FG000|Phase 1|Adverse Event|2|||
155045273|NCT01490840|559599278|FG001|Phase 1|Adverse Event|1|||
155045274|NCT01490840|559599277|FG000|Phase 1|Withdrawal by Subject|6|||
155045275|NCT01490840|559599278|FG001|Phase 1|Withdrawal by Subject|5|||
155045276|NCT01490840|559599277|FG000|Phase 1|Visit 6a omitted|1|||
155045277|NCT01490840|559599278|FG001|Phase 1|Visit 6a omitted|0|||
155045278|NCT01490840|559599277|FG000|Phase 2|Withdrawal by Subject|4|||
155045279|NCT01490840|559599278|FG001|Phase 2|Withdrawal by Subject|3|||
155045280|NCT01490840|559599277|FG000|Phase 2|Permanent interruption of fingolimod|0|||
155045281|NCT01490840|559599278|FG001|Phase 2|Permanent interruption of fingolimod|1|||
155045282|NCT01490840|559599277|FG000|Phase 2|Lost to Follow-up|1|||
155045283|NCT01490840|559599278|FG001|Phase 2|Lost to Follow-up|1|||
155045284|NCT01490840|559599277|FG000|Phase 2|Adverse Event|1|||
155045285|NCT01490840|559599278|FG001|Phase 2|Adverse Event|1|||
155045286|NCT01025284|559599282|FG000|Overall Study|Investigator Decision|0|||
155045287|NCT01025284|559599283|FG001|Overall Study|Investigator Decision|1|||
155045288|NCT01025284|559599284|FG002|Overall Study|Investigator Decision|0|||
155045289|NCT01025284|559599282|FG000|Overall Study|Withdrawal by Subject|0|||
155045290|NCT01025284|559599283|FG001|Overall Study|Withdrawal by Subject|1|||
155045291|NCT01025284|559599284|FG002|Overall Study|Withdrawal by Subject|0|||
155045292|NCT01465230|559599285|FG000|Overall Study|Withdrawal by Subject|2|||
155045293|NCT02542397|559599286|FG000|Overall Study|Death|2|||
155045294|NCT02542397|559599286|FG000|Overall Study|Physician Decision|6|||
155045295|NCT02542397|559599286|FG000|Overall Study|Withdrawal by Subject|6|||
155045296|NCT02542397|559599286|FG000|Overall Study|Lost to Follow-up|2|||
155045297|NCT01738919|559599292|FG000|Overall Study|Lost to Follow-up|1|||
155045298|NCT01738919|559599293|FG001|Overall Study|Lost to Follow-up|0|||
155045299|NCT01738919|559599292|FG000|Overall Study|Immigrated|0|||
155045300|NCT01738919|559599293|FG001|Overall Study|Immigrated|1|||
155382220|NCT00825825|560833300|FG004|Third Medication Period (14 Days)|poor data quality|0|||
155382221|NCT00825825|560833301|FG005|Third Medication Period (14 Days)|poor data quality|0|||
155382222|NCT01815138|560833302|FG000|Overall Study|Withdrawal by Subject|0|||
155382223|NCT01815138|560833303|FG001|Overall Study|Withdrawal by Subject|1|||
155045301|NCT01738919|559599292|FG000|Overall Study|Withdrawal by Subject|0|||
155045302|NCT01738919|559599293|FG001|Overall Study|Withdrawal by Subject|1|||
155045303|NCT01738919|559599292|FG000|Overall Study|Not treated in accordance to guidelines|0|||
155045304|NCT01738919|559599293|FG001|Overall Study|Not treated in accordance to guidelines|1|||
155045305|NCT00547248|559599294|FG000|Overall Study|Protocol Violation|0|||
155045306|NCT00547248|559599295|FG001|Overall Study|Protocol Violation|0|||
155045307|NCT00547248|559599296|FG002|Overall Study|Protocol Violation|1|||
155045308|NCT00547248|559599297|FG003|Overall Study|Protocol Violation|1|||
155045309|NCT00547248|559599294|FG000|Overall Study|Migrated/moved from study area|0|||
155045310|NCT00547248|559599295|FG001|Overall Study|Migrated/moved from study area|0|||
155278556|NCT02139982|560453213|FG008|Overall Study|Lack of Efficacy|0|||
155278557|NCT02139982|560453214|FG009|Overall Study|Lack of Efficacy|0|||
155278558|NCT04466618|560453226|FG000|Overall Study|Withdrawal by Subject|0|||
155278559|NCT04466618|560453227|FG001|Overall Study|Withdrawal by Subject|1|||
155278560|NCT01349907|560453228|FG000|Overall Study|Adverse Event|37|||
155278561|NCT01349907|560453229|FG001|Overall Study|Adverse Event|11|||
155278562|NCT01349907|560453228|FG000|Overall Study|Treatment failure|13|||
155278563|NCT01349907|560453229|FG001|Overall Study|Treatment failure|4|||
155278564|NCT01349907|560453228|FG000|Overall Study|Lost to Follow-up|25|||
155278565|NCT01349907|560453229|FG001|Overall Study|Lost to Follow-up|6|||
155278566|NCT01349907|560453228|FG000|Overall Study|Withdrawal by Subject|30|||
155278567|NCT01349907|560453229|FG001|Overall Study|Withdrawal by Subject|8|||
155278568|NCT01349907|560453228|FG000|Overall Study|Protocol Violation|33|||
155278569|NCT01349907|560453229|FG001|Overall Study|Protocol Violation|13|||
155278570|NCT01349907|560453228|FG000|Overall Study|Administrative|1|||
155278571|NCT01349907|560453229|FG001|Overall Study|Administrative|1|||
155278572|NCT02800928|560453232|FG000|Overall Study|Withdrawal by Subject|1|||
155278573|NCT02800928|560453233|FG001|Overall Study|Withdrawal by Subject|1|||
155278574|NCT02800928|560453232|FG000|Overall Study|Protocol Violation|1|||
155278575|NCT02800928|560453233|FG001|Overall Study|Protocol Violation|1|||
155278576|NCT02886728|560453234|FG000|Overall Study|Withdrew Consent|31|||
155278577|NCT02886728|560453235|FG001|Overall Study|Withdrew Consent|13|||
155278578|NCT02886728|560453236|FG002|Overall Study|Withdrew Consent|11|||
155278579|NCT02886728|560453237|FG003|Overall Study|Withdrew Consent|47|||
155278580|NCT02886728|560453234|FG000|Overall Study|Lost to Follow-up|12|||
155278581|NCT02886728|560453235|FG001|Overall Study|Lost to Follow-up|6|||
155278582|NCT02886728|560453236|FG002|Overall Study|Lost to Follow-up|13|||
155278583|NCT02886728|560453237|FG003|Overall Study|Lost to Follow-up|12|||
155278584|NCT02886728|560453234|FG000|Overall Study|Adverse Event|13|||
155278585|NCT02886728|560453235|FG001|Overall Study|Adverse Event|5|||
155278586|NCT02886728|560453236|FG002|Overall Study|Adverse Event|5|||
155278587|NCT02886728|560453237|FG003|Overall Study|Adverse Event|11|||
155278588|NCT02886728|560453234|FG000|Overall Study|Investigator's Discretion|11|||
155278589|NCT02886728|560453235|FG001|Overall Study|Investigator's Discretion|7|||
155278590|NCT02886728|560453236|FG002|Overall Study|Investigator's Discretion|5|||
155278591|NCT02886728|560453237|FG003|Overall Study|Investigator's Discretion|11|||
155278592|NCT02886728|560453234|FG000|Overall Study|Death|3|||
155278593|NCT02886728|560453235|FG001|Overall Study|Death|1|||
155278594|NCT02886728|560453236|FG002|Overall Study|Death|0|||
155278595|NCT02886728|560453237|FG003|Overall Study|Death|0|||
155278596|NCT02886728|560453234|FG000|Overall Study|Protocol Violation|0|||
155278597|NCT02886728|560453235|FG001|Overall Study|Protocol Violation|0|||
155278598|NCT02886728|560453236|FG002|Overall Study|Protocol Violation|0|||
155278599|NCT02886728|560453237|FG003|Overall Study|Protocol Violation|4|||
155278600|NCT02886728|560453234|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155278601|NCT02886728|560453235|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155278602|NCT02886728|560453236|FG002|Overall Study|Non-Compliance with Study Drug|1|||
155278603|NCT02886728|560453237|FG003|Overall Study|Non-Compliance with Study Drug|0|||
155278604|NCT02886728|560453234|FG000|Overall Study|Pregnancy|0|||
155278605|NCT02886728|560453235|FG001|Overall Study|Pregnancy|0|||
155278606|NCT02886728|560453236|FG002|Overall Study|Pregnancy|1|||
155278607|NCT02886728|560453237|FG003|Overall Study|Pregnancy|0|||
155278608|NCT02886728|560453234|FG000|Overall Study|Randomized but Not Dosed|1|||
155278609|NCT02886728|560453235|FG001|Overall Study|Randomized but Not Dosed|0|||
155278610|NCT02886728|560453236|FG002|Overall Study|Randomized but Not Dosed|0|||
155278611|NCT02886728|560453237|FG003|Overall Study|Randomized but Not Dosed|2|||
155278612|NCT01364727|560453242|FG000|Overall Study|Not Eligible|2|||
155278613|NCT01676220|560453243|FG000|Overall Study|Randomized But Not Treated|4|||
155382224|NCT01815138|560833302|FG000|Overall Study|Physician Decision|8|||
155278614|NCT01676220|560453244|FG001|Overall Study|Randomized But Not Treated|1|||
155278615|NCT01676220|560453243|FG000|Overall Study|Adverse Event|10|||
155278616|NCT01676220|560453244|FG001|Overall Study|Adverse Event|8|||
155278617|NCT01676220|560453243|FG000|Overall Study|Lack of Efficacy|2|||
155278618|NCT01676220|560453244|FG001|Overall Study|Lack of Efficacy|5|||
155278619|NCT01676220|560453243|FG000|Overall Study|Protocol Violation|11|||
155278620|NCT01676220|560453244|FG001|Overall Study|Protocol Violation|12|||
155278621|NCT01676220|560453243|FG000|Overall Study|Received Rescue Therapy|14|||
155278622|NCT01676220|560453244|FG001|Overall Study|Received Rescue Therapy|22|||
155278623|NCT01676220|560453243|FG000|Overall Study|Personal Reason|34|||
155278624|NCT01676220|560453244|FG001|Overall Study|Personal Reason|45|||
155278625|NCT01676220|560453243|FG000|Overall Study|Lost to Follow-up|11|||
155278626|NCT01676220|560453244|FG001|Overall Study|Lost to Follow-up|18|||
155278627|NCT01676220|560453243|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
155278628|NCT01676220|560453244|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
155278629|NCT01676220|560453243|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
155278630|NCT01676220|560453244|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
155278631|NCT01676220|560453243|FG000|Overall Study|Perceived Lack of Efficacy|3|||
155278632|NCT01676220|560453244|FG001|Overall Study|Perceived Lack of Efficacy|1|||
155382225|NCT01815138|560833303|FG001|Overall Study|Physician Decision|5|||
155382226|NCT02649946|560833309|FG000|Overall Study|Withdrawal by Subject|1|||
155382227|NCT02649946|560833310|FG001|Overall Study|Withdrawal by Subject|1|||
155382228|NCT02649946|560833309|FG000|Overall Study|Death|7|||
155382229|NCT02649946|560833310|FG001|Overall Study|Death|9|||
155382230|NCT02649946|560833309|FG000|Overall Study|Physician Decision|1|||
155382231|NCT02649946|560833310|FG001|Overall Study|Physician Decision|0|||
155382232|NCT02649946|560833309|FG000|Overall Study|Lost to Follow-up|2|||
155382233|NCT02649946|560833310|FG001|Overall Study|Lost to Follow-up|1|||
155382234|NCT02649946|560833309|FG000|Overall Study|Erroneously enrolled|1|||
155382235|NCT02649946|560833310|FG001|Overall Study|Erroneously enrolled|0|||
155382236|NCT02649946|560833309|FG000|Overall Study|Missed 6-month follow-up visit|0|||
155382237|NCT02649946|560833310|FG001|Overall Study|Missed 6-month follow-up visit|4|||
155382238|NCT00950950|560833311|FG000|Overall Study|Adverse Event|1|||
155382239|NCT00950950|560833312|FG001|Overall Study|Adverse Event|0|||
155382240|NCT00950950|560833311|FG000|Overall Study|Withdrawal by Subject|0|||
155382241|NCT00950950|560833312|FG001|Overall Study|Withdrawal by Subject|1|||
155382242|NCT01047293|560833315|FG000|Overall Study|DLT criteria not fulfilled|1|||
155382243|NCT01047293|560833316|FG001|Overall Study|DLT criteria not fulfilled|1|||
155382244|NCT01047293|560833317|FG002|Overall Study|DLT criteria not fulfilled|0|||
155382245|NCT01047293|560833318|FG003|Overall Study|DLT criteria not fulfilled|0|||
155382246|NCT01920854|560833322|FG000|Overall Study|Withdrawal by Subject|1|||
155382247|NCT01920854|560833323|FG001|Overall Study|Withdrawal by Subject|0|||
155382248|NCT01920854|560833324|FG002|Overall Study|Withdrawal by Subject|0|||
155382249|NCT01920854|560833325|FG003|Overall Study|Withdrawal by Subject|0|||
155382250|NCT01920854|560833326|FG004|Overall Study|Withdrawal by Subject|1|||
155382251|NCT01920854|560833327|FG005|Overall Study|Withdrawal by Subject|0|||
155382252|NCT01920854|560833328|FG006|Overall Study|Withdrawal by Subject|1|||
155382253|NCT00757783|560833329|FG000|Overall Study|Adverse Event|0|||
155382254|NCT00757783|560833330|FG001|Overall Study|Adverse Event|2|||
155382255|NCT00757783|560833329|FG000|Overall Study|Lost to Follow-up|1|||
155382256|NCT00757783|560833330|FG001|Overall Study|Lost to Follow-up|1|||
155382257|NCT00757783|560833329|FG000|Overall Study|Protocol Violation|1|||
155382258|NCT00757783|560833330|FG001|Overall Study|Protocol Violation|0|||
155382259|NCT00757783|560833329|FG000|Overall Study|Withdrawal by Subject|2|||
155382260|NCT00757783|560833330|FG001|Overall Study|Withdrawal by Subject|1|||
155382261|NCT00757783|560833329|FG000|Overall Study|Other|1|||
155382262|NCT00757783|560833330|FG001|Overall Study|Other|2|||
155382263|NCT02372136|560833331|FG000|Overall Study|Death|3|||
155382264|NCT02372136|560833332|FG001|Overall Study|Death|1|||
155382265|NCT03265938|560833333|FG000|Overall Study|Withdrawal by Subject|1|||
155382266|NCT03265938|560833333|FG000|Overall Study|Physician Decision|1|||
155382267|NCT03265938|560833333|FG000|Overall Study|friable mass|6|||
155382268|NCT01588496|560833334|FG000|Overall Study|Withdrawal by Subject|0|||
155382269|NCT01588496|560833335|FG001|Overall Study|Withdrawal by Subject|1|||
155382270|NCT01588496|560833336|FG002|Overall Study|Withdrawal by Subject|0|||
155382271|NCT03143166|560833337|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
155382272|NCT05924945|560833338|FG000|Overall Study|Withdrawal by Subject|3|||
155382273|NCT05924945|560833339|FG001|Overall Study|Withdrawal by Subject|4|||
155382274|NCT02471833|560833340|FG000|Overall Study|Lost to Follow-up|1|||
155382275|NCT02471833|560833341|FG001|Overall Study|Lost to Follow-up|0|||
155382276|NCT02471833|560833342|FG002|Overall Study|Lost to Follow-up|0|||
155382277|NCT02471833|560833340|FG000|Overall Study|Withdrawal by Subject|2|||
155382278|NCT02471833|560833341|FG001|Overall Study|Withdrawal by Subject|1|||
155382279|NCT02471833|560833342|FG002|Overall Study|Withdrawal by Subject|5|||
155382280|NCT03683823|560833357|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
155382281|NCT03683823|560833358|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
155382282|NCT03683823|560833357|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
155382283|NCT03683823|560833358|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
155382284|NCT03683823|560833357|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
155382285|NCT03683823|560833358|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
155382286|NCT01946438|560833361|FG000|Overall Study|Adverse Event|0|||
155382287|NCT01946438|560833362|FG001|Overall Study|Adverse Event|0|||
155382288|NCT01946438|560833363|FG002|Overall Study|Adverse Event|0|||
155382289|NCT01946438|560833364|FG003|Overall Study|Adverse Event|1|||
155382290|NCT01946438|560833361|FG000|Overall Study|Serious Adverse event|1|||
155382291|NCT01946438|560833362|FG001|Overall Study|Serious Adverse event|0|||
155382292|NCT01946438|560833363|FG002|Overall Study|Serious Adverse event|0|||
155382293|NCT01946438|560833364|FG003|Overall Study|Serious Adverse event|0|||
155382294|NCT01946438|560833361|FG000|Overall Study|Protocol Violation|0|||
155382295|NCT01946438|560833362|FG001|Overall Study|Protocol Violation|0|||
155382296|NCT01946438|560833363|FG002|Overall Study|Protocol Violation|1|||
155382297|NCT01946438|560833364|FG003|Overall Study|Protocol Violation|0|||
155382298|NCT01946438|560833361|FG000|Overall Study|Withdrawal by Subject|1|||
155382299|NCT01946438|560833362|FG001|Overall Study|Withdrawal by Subject|0|||
155382300|NCT01946438|560833363|FG002|Overall Study|Withdrawal by Subject|0|||
155382301|NCT01946438|560833364|FG003|Overall Study|Withdrawal by Subject|0|||
155382302|NCT05195489|560835263|FG000|Overall Study|Lost to Follow-up|1|||
155382303|NCT05195489|560835264|FG001|Overall Study|Lost to Follow-up|0|||
155382304|NCT05195489|560835263|FG000|Overall Study|Protocol Violation|0|||
155382305|NCT05195489|560835264|FG001|Overall Study|Protocol Violation|2|||
155382306|NCT05195489|560835263|FG000|Overall Study|Withdrawal by Subject|1|||
155382307|NCT05195489|560835264|FG001|Overall Study|Withdrawal by Subject|1|||
155382308|NCT05195489|560835263|FG000|Overall Study|Removed|0|||
155382309|NCT05195489|560835264|FG001|Overall Study|Removed|1|||
155382310|NCT01328717|560835273|FG000|Overall Study|Adverse Event|1|||
155382311|NCT00346268|560835274|FG000|Overall Study|Adverse Event|1|||
155382312|NCT00346268|560835275|FG001|Overall Study|Adverse Event|0|||
155382313|NCT00346268|560835274|FG000|Overall Study|Protocol Violation|1|||
155382314|NCT00346268|560835275|FG001|Overall Study|Protocol Violation|0|||
155382315|NCT00346268|560835274|FG000|Overall Study|Participant refused|0|||
155382316|NCT00346268|560835275|FG001|Overall Study|Participant refused|3|||
155382317|NCT00031551|560835276|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
155382318|NCT00031551|560835277|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
155382319|NCT02164383|560835278|FG000|Overall Study|Lost to Follow-up|1|||
155382320|NCT02164383|560835279|FG001|Overall Study|Lost to Follow-up|0|||
155382321|NCT01036763|560835280|FG000|Overall Study|Adverse Event|25|||
155382322|NCT01036763|560835280|FG000|Overall Study|Lost to Follow-up|28|||
155382323|NCT01036763|560835280|FG000|Overall Study|Other reason (not specified)|40|||
155382324|NCT01672723|560835281|FG000|First Intervention|Adverse Event|3|||
155382325|NCT01672723|560835282|FG001|First Intervention|Adverse Event|0|||
155382326|NCT00743275|560835283|FG000|Overall Study|Protocol Violation|0|||
155382327|NCT00743275|560835284|FG001|Overall Study|Protocol Violation|1|||
155382328|NCT02831387|560835290|FG000|Overall Study|Withdrawal by Subject|1|||
155382329|NCT02831387|560835291|FG001|Overall Study|Withdrawal by Subject|1|||
155382330|NCT02831387|560835290|FG000|Overall Study|Discontinued due to stock recovery|0|||
155382331|NCT02831387|560835291|FG001|Overall Study|Discontinued due to stock recovery|1|||
155382332|NCT00192647|560835292|FG000|Overall Study|Death|1|||
155382333|NCT00192647|560835293|FG001|Overall Study|Death|1|||
155382334|NCT00192647|560835292|FG000|Overall Study|Adverse Event|35|||
155382335|NCT00192647|560835293|FG001|Overall Study|Adverse Event|29|||
155382336|NCT00192647|560835292|FG000|Overall Study|Laboratory Test Abnormality|4|||
155382337|NCT00192647|560835293|FG001|Overall Study|Laboratory Test Abnormality|2|||
155382338|NCT00192647|560835292|FG000|Overall Study|Insufficient Therapeutic Response|53|||
155382339|NCT00192647|560835293|FG001|Overall Study|Insufficient Therapeutic Response|83|||
155382340|NCT00192647|560835292|FG000|Overall Study|Entry Criteria Violation|6|||
155382341|NCT00192647|560835293|FG001|Overall Study|Entry Criteria Violation|6|||
155382342|NCT00192647|560835292|FG000|Overall Study|Protocol Violation|3|||
155382343|NCT00192647|560835293|FG001|Overall Study|Protocol Violation|1|||
155382344|NCT00192647|560835292|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
155382345|NCT00192647|560835293|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
155382346|NCT00192647|560835292|FG000|Overall Study|Failure to Return|11|||
155382347|NCT00192647|560835293|FG001|Overall Study|Failure to Return|13|||
155382348|NCT00192647|560835292|FG000|Overall Study|Other/Administrative|5|||
155382349|NCT00192647|560835293|FG001|Overall Study|Other/Administrative|3|||
155382350|NCT00876928|560835294|FG000|Overall Study|Lost to Follow-up|2|||
155382351|NCT00876928|560835295|FG001|Overall Study|Lost to Follow-up|5|||
155382352|NCT00876928|560835294|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
155382353|NCT00876928|560835295|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
155382354|NCT01016977|560835303|FG000|Overall Study|Lost to Follow-up|1|||
155382355|NCT01016977|560835304|FG001|Overall Study|Lost to Follow-up|0|||
155382356|NCT01016977|560835303|FG000|Overall Study|Withdrawal by Subject|2|||
155382357|NCT01016977|560835304|FG001|Overall Study|Withdrawal by Subject|2|||
155382358|NCT02080221|560835305|FG000|Overall Study|Withdrawal by Subject|1|||
155382359|NCT02080221|560835305|FG000|Overall Study|Clinical Progression of Disease|1|||
155382360|NCT03184870|560835311|FG000|Initial Treatment|Death|6|||
155382361|NCT03184870|560835312|FG001|Initial Treatment|Death|6|||
155382362|NCT03184870|560835313|FG002|Initial Treatment|Death|8|||
155382363|NCT03184870|560835314|FG003|Initial Treatment|Death|8|||
155382364|NCT03184870|560835315|FG004|Initial Treatment|Death|6|||
155382365|NCT03184870|560835316|FG005|Initial Treatment|Death|6|||
155382366|NCT03184870|560835317|FG006|Initial Treatment|Death|6|||
155382367|NCT03184870|560835318|FG007|Initial Treatment|Death|7|||
155382368|NCT03184870|560835319|FG008|Initial Treatment|Death|1|||
155382369|NCT03184870|560835320|FG009|Initial Treatment|Death|2|||
155382370|NCT03184870|560835321|FG010|Initial Treatment|Death|26|||
155382371|NCT03184870|560835322|FG011|Initial Treatment|Death|28|||
155382372|NCT03184870|560835323|FG012|Initial Treatment|Death|10|||
155382373|NCT03184870|560835324|FG013|Initial Treatment|Death|33|||
155382374|NCT03184870|560835325|FG014|Initial Treatment|Death|34|||
155382375|NCT03184870|560835326|FG015|Initial Treatment|Death|26|||
155382376|NCT03184870|560835327|FG016|Initial Treatment|Death|20|||
155382377|NCT03184870|560835328|FG017|Initial Treatment|Death|18|||
155382378|NCT03184870|560835311|FG000|Initial Treatment|Other Reasons|2|||
155382379|NCT03184870|560835312|FG001|Initial Treatment|Other Reasons|2|||
155382380|NCT03184870|560835313|FG002|Initial Treatment|Other Reasons|0|||
155382381|NCT03184870|560835314|FG003|Initial Treatment|Other Reasons|1|||
155382382|NCT03184870|560835315|FG004|Initial Treatment|Other Reasons|0|||
155382383|NCT03184870|560835316|FG005|Initial Treatment|Other Reasons|0|||
155382384|NCT03184870|560835317|FG006|Initial Treatment|Other Reasons|0|||
155382385|NCT03184870|560835318|FG007|Initial Treatment|Other Reasons|2|||
155382386|NCT03184870|560835319|FG008|Initial Treatment|Other Reasons|0|||
155382387|NCT03184870|560835320|FG009|Initial Treatment|Other Reasons|0|||
155382388|NCT03184870|560835321|FG010|Initial Treatment|Other Reasons|4|||
155382389|NCT03184870|560835322|FG011|Initial Treatment|Other Reasons|2|||
155382390|NCT03184870|560835323|FG012|Initial Treatment|Other Reasons|2|||
155382391|NCT03184870|560835324|FG013|Initial Treatment|Other Reasons|0|||
155278633|NCT01676220|560453243|FG000|Overall Study|Non Serious Hypoglycemia|2|||
155278634|NCT01676220|560453244|FG001|Overall Study|Non Serious Hypoglycemia|0|||
155278635|NCT01676220|560453243|FG000|Overall Study|No More Need of Insulin|1|||
155278636|NCT01676220|560453244|FG001|Overall Study|No More Need of Insulin|0|||
155278637|NCT04227340|560453245|FG000|Overall Study|Withdrawal by Subject|3|||
155278638|NCT00750893|560453248|FG000|Overall Study|Adverse Event|5|||
155278639|NCT00750893|560453248|FG000|Overall Study|Withdrawal by Subject|10|||
155278640|NCT00750893|560453248|FG000|Overall Study|Lost to Follow-up|510|||
155278641|NCT00750893|560453248|FG000|Overall Study|Other|17|||
155278642|NCT01628874|560453255|FG000|Overall Study|Physician Decision|1|||
155278643|NCT01628874|560453256|FG001|Overall Study|Physician Decision|1|||
155278644|NCT01628874|560453255|FG000|Overall Study|Age >4 months|4|||
155278645|NCT01628874|560453256|FG001|Overall Study|Age >4 months|2|||
155278646|NCT01152554|560453258|FG000|Overall Study|Withdrawal by Subject|73|||
155278647|NCT01152554|560453259|FG001|Overall Study|Withdrawal by Subject|28|||
155278648|NCT01152554|560453258|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
155278649|NCT01152554|560453259|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
155278650|NCT01152554|560453258|FG000|Overall Study|Adverse Event|67|||
155278651|NCT01152554|560453259|FG001|Overall Study|Adverse Event|14|||
155278652|NCT01152554|560453258|FG000|Overall Study|Severe non-compliance to protocol|36|||
155278653|NCT01152554|560453259|FG001|Overall Study|Severe non-compliance to protocol|14|||
155278654|NCT01152554|560453258|FG000|Overall Study|Condition under investigation worsened|5|||
155278655|NCT01152554|560453259|FG001|Overall Study|Condition under investigation worsened|2|||
155278656|NCT01152554|560453258|FG000|Overall Study|Lack of Efficacy|20|||
155278657|NCT01152554|560453259|FG001|Overall Study|Lack of Efficacy|3|||
155278658|NCT01152554|560453258|FG000|Overall Study|Study-specific withdrawal criteria|17|||
155278659|NCT01152554|560453259|FG001|Overall Study|Study-specific withdrawal criteria|8|||
155278660|NCT01152554|560453258|FG000|Overall Study|Lost to Follow-up|87|||
155278661|NCT01152554|560453259|FG001|Overall Study|Lost to Follow-up|32|||
155278662|NCT01152554|560453258|FG000|Overall Study|Other|28|||
155278663|NCT01152554|560453259|FG001|Overall Study|Other|8|||
155278664|NCT01152554|560453258|FG000|Overall Study|Death|1|||
155278665|NCT01152554|560453259|FG001|Overall Study|Death|1|||
155278666|NCT02397460|560453260|FG000|Treatment Period 2|Adverse Event|0|||
155278667|NCT02397460|560453261|FG001|Treatment Period 2|Adverse Event|0|||
155278668|NCT02397460|560453262|FG002|Treatment Period 2|Adverse Event|0|||
155278669|NCT02397460|560453263|FG003|Treatment Period 2|Adverse Event|0|||
155278670|NCT02397460|560453264|FG004|Treatment Period 2|Adverse Event|0|||
155278671|NCT02397460|560453265|FG005|Treatment Period 2|Adverse Event|0|||
155278672|NCT02397460|560453266|FG006|Treatment Period 2|Adverse Event|0|||
155278673|NCT02397460|560453267|FG007|Treatment Period 2|Adverse Event|1|||
155278674|NCT02397460|560453260|FG000|Treatment Period 4|Adverse Event|0|||
155278675|NCT02397460|560453261|FG001|Treatment Period 4|Adverse Event|1|||
155278676|NCT02397460|560453262|FG002|Treatment Period 4|Adverse Event|0|||
155278677|NCT02397460|560453263|FG003|Treatment Period 4|Adverse Event|0|||
155278678|NCT02397460|560453264|FG004|Treatment Period 4|Adverse Event|0|||
155278679|NCT02397460|560453265|FG005|Treatment Period 4|Adverse Event|0|||
155278680|NCT02397460|560453266|FG006|Treatment Period 4|Adverse Event|0|||
155278681|NCT02397460|560453267|FG007|Treatment Period 4|Adverse Event|0|||
155278682|NCT02397460|560453260|FG000|Treatment Period 4|Physician Decision|0|||
155278683|NCT02397460|560453261|FG001|Treatment Period 4|Physician Decision|0|||
155278684|NCT02397460|560453262|FG002|Treatment Period 4|Physician Decision|0|||
155278685|NCT02397460|560453263|FG003|Treatment Period 4|Physician Decision|0|||
155382392|NCT03184870|560835325|FG014|Initial Treatment|Other Reasons|0|||
155382393|NCT03184870|560835326|FG015|Initial Treatment|Other Reasons|1|||
155278686|NCT02397460|560453264|FG004|Treatment Period 4|Physician Decision|1|||
155278687|NCT02397460|560453265|FG005|Treatment Period 4|Physician Decision|0|||
155278688|NCT02397460|560453266|FG006|Treatment Period 4|Physician Decision|0|||
155278689|NCT02397460|560453267|FG007|Treatment Period 4|Physician Decision|0|||
155278690|NCT01767129|560453271|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155278691|NCT01767129|560453272|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155278692|NCT01473420|560453273|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
155278693|NCT01473420|560453274|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
155278694|NCT01473420|560453273|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
155278695|NCT01473420|560453274|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
155278696|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
155382394|NCT03184870|560835327|FG016|Initial Treatment|Other Reasons|0|||
155382395|NCT03184870|560835328|FG017|Initial Treatment|Other Reasons|2|||
155382396|NCT03184870|560835311|FG000|Initial Treatment|Lost to Follow-up|2|||
155382397|NCT03184870|560835312|FG001|Initial Treatment|Lost to Follow-up|0|||
155382398|NCT03184870|560835313|FG002|Initial Treatment|Lost to Follow-up|0|||
155382399|NCT03184870|560835314|FG003|Initial Treatment|Lost to Follow-up|1|||
155382400|NCT03184870|560835315|FG004|Initial Treatment|Lost to Follow-up|1|||
155382401|NCT03184870|560835316|FG005|Initial Treatment|Lost to Follow-up|1|||
155382402|NCT03184870|560835317|FG006|Initial Treatment|Lost to Follow-up|0|||
155382403|NCT03184870|560835318|FG007|Initial Treatment|Lost to Follow-up|2|||
155382404|NCT03184870|560835319|FG008|Initial Treatment|Lost to Follow-up|0|||
155382405|NCT03184870|560835320|FG009|Initial Treatment|Lost to Follow-up|0|||
155382406|NCT03184870|560835321|FG010|Initial Treatment|Lost to Follow-up|2|||
155382407|NCT03184870|560835322|FG011|Initial Treatment|Lost to Follow-up|0|||
155382408|NCT03184870|560835323|FG012|Initial Treatment|Lost to Follow-up|2|||
155382409|NCT03184870|560835324|FG013|Initial Treatment|Lost to Follow-up|2|||
155382410|NCT03184870|560835325|FG014|Initial Treatment|Lost to Follow-up|0|||
155382411|NCT03184870|560835326|FG015|Initial Treatment|Lost to Follow-up|0|||
155382412|NCT03184870|560835327|FG016|Initial Treatment|Lost to Follow-up|2|||
155382413|NCT03184870|560835328|FG017|Initial Treatment|Lost to Follow-up|2|||
155382414|NCT03184870|560835311|FG000|Initial Treatment|Withdrawal by Subject|0|||
155382415|NCT03184870|560835312|FG001|Initial Treatment|Withdrawal by Subject|0|||
155382416|NCT03184870|560835313|FG002|Initial Treatment|Withdrawal by Subject|2|||
155382417|NCT03184870|560835314|FG003|Initial Treatment|Withdrawal by Subject|1|||
155382418|NCT03184870|560835315|FG004|Initial Treatment|Withdrawal by Subject|1|||
155382419|NCT03184870|560835316|FG005|Initial Treatment|Withdrawal by Subject|0|||
155382420|NCT03184870|560835317|FG006|Initial Treatment|Withdrawal by Subject|1|||
155382421|NCT03184870|560835318|FG007|Initial Treatment|Withdrawal by Subject|0|||
155382422|NCT03184870|560835319|FG008|Initial Treatment|Withdrawal by Subject|0|||
155382423|NCT03184870|560835320|FG009|Initial Treatment|Withdrawal by Subject|0|||
155382424|NCT03184870|560835321|FG010|Initial Treatment|Withdrawal by Subject|0|||
155382425|NCT03184870|560835322|FG011|Initial Treatment|Withdrawal by Subject|2|||
155382426|NCT03184870|560835323|FG012|Initial Treatment|Withdrawal by Subject|3|||
155382427|NCT03184870|560835324|FG013|Initial Treatment|Withdrawal by Subject|0|||
155382428|NCT03184870|560835325|FG014|Initial Treatment|Withdrawal by Subject|1|||
155382429|NCT03184870|560835326|FG015|Initial Treatment|Withdrawal by Subject|5|||
155382430|NCT03184870|560835327|FG016|Initial Treatment|Withdrawal by Subject|2|||
155382431|NCT03184870|560835328|FG017|Initial Treatment|Withdrawal by Subject|2|||
155382432|NCT03184870|560835311|FG000|Initial Treatment|Moved to crossover treatment|0|||
155382433|NCT03184870|560835312|FG001|Initial Treatment|Moved to crossover treatment|0|||
155382434|NCT03184870|560835313|FG002|Initial Treatment|Moved to crossover treatment|0|||
155382435|NCT03184870|560835314|FG003|Initial Treatment|Moved to crossover treatment|0|||
155382436|NCT03184870|560835315|FG004|Initial Treatment|Moved to crossover treatment|0|||
155382437|NCT03184870|560835316|FG005|Initial Treatment|Moved to crossover treatment|0|||
155382438|NCT03184870|560835317|FG006|Initial Treatment|Moved to crossover treatment|0|||
155382439|NCT03184870|560835318|FG007|Initial Treatment|Moved to crossover treatment|0|||
155382440|NCT03184870|560835319|FG008|Initial Treatment|Moved to crossover treatment|0|||
155382441|NCT03184870|560835320|FG009|Initial Treatment|Moved to crossover treatment|0|||
155382442|NCT03184870|560835321|FG010|Initial Treatment|Moved to crossover treatment|0|||
155382443|NCT03184870|560835322|FG011|Initial Treatment|Moved to crossover treatment|0|||
155382444|NCT03184870|560835323|FG012|Initial Treatment|Moved to crossover treatment|9|||
155382445|NCT03184870|560835324|FG013|Initial Treatment|Moved to crossover treatment|0|||
155382446|NCT03184870|560835325|FG014|Initial Treatment|Moved to crossover treatment|0|||
155382447|NCT03184870|560835326|FG015|Initial Treatment|Moved to crossover treatment|0|||
155382448|NCT03184870|560835327|FG016|Initial Treatment|Moved to crossover treatment|0|||
155382449|NCT03184870|560835328|FG017|Initial Treatment|Moved to crossover treatment|0|||
155382450|NCT03184870|560835311|FG000|Crossover Treatment|Other reasons|0|||
155382451|NCT03184870|560835312|FG001|Crossover Treatment|Other reasons|0|||
155382452|NCT03184870|560835313|FG002|Crossover Treatment|Other reasons|0|||
155382453|NCT03184870|560835314|FG003|Crossover Treatment|Other reasons|0|||
155382454|NCT03184870|560835315|FG004|Crossover Treatment|Other reasons|0|||
155382455|NCT03184870|560835316|FG005|Crossover Treatment|Other reasons|0|||
155382456|NCT03184870|560835317|FG006|Crossover Treatment|Other reasons|0|||
155382457|NCT03184870|560835318|FG007|Crossover Treatment|Other reasons|0|||
155382458|NCT03184870|560835319|FG008|Crossover Treatment|Other reasons|0|||
155382459|NCT03184870|560835320|FG009|Crossover Treatment|Other reasons|0|||
155382460|NCT03184870|560835321|FG010|Crossover Treatment|Other reasons|0|||
155382461|NCT03184870|560835322|FG011|Crossover Treatment|Other reasons|0|||
155382462|NCT03184870|560835323|FG012|Crossover Treatment|Other reasons|0|||
155382463|NCT03184870|560835324|FG013|Crossover Treatment|Other reasons|0|||
155382464|NCT03184870|560835325|FG014|Crossover Treatment|Other reasons|0|||
155382465|NCT03184870|560835326|FG015|Crossover Treatment|Other reasons|0|||
155382466|NCT03184870|560835327|FG016|Crossover Treatment|Other reasons|0|||
155382467|NCT03184870|560835328|FG017|Crossover Treatment|Other reasons|2|||
155382468|NCT03184870|560835311|FG000|Crossover Treatment|Death|0|||
155382469|NCT03184870|560835312|FG001|Crossover Treatment|Death|0|||
155382470|NCT03184870|560835313|FG002|Crossover Treatment|Death|0|||
155382471|NCT03184870|560835314|FG003|Crossover Treatment|Death|0|||
155382472|NCT03184870|560835315|FG004|Crossover Treatment|Death|0|||
155382473|NCT03184870|560835316|FG005|Crossover Treatment|Death|0|||
155382474|NCT03184870|560835317|FG006|Crossover Treatment|Death|0|||
155382475|NCT03184870|560835318|FG007|Crossover Treatment|Death|0|||
155382476|NCT03184870|560835319|FG008|Crossover Treatment|Death|0|||
155382477|NCT03184870|560835320|FG009|Crossover Treatment|Death|0|||
155382478|NCT03184870|560835321|FG010|Crossover Treatment|Death|0|||
155382479|NCT03184870|560835322|FG011|Crossover Treatment|Death|0|||
155382480|NCT03184870|560835323|FG012|Crossover Treatment|Death|0|||
155382481|NCT03184870|560835324|FG013|Crossover Treatment|Death|0|||
155382482|NCT03184870|560835325|FG014|Crossover Treatment|Death|0|||
155382483|NCT03184870|560835326|FG015|Crossover Treatment|Death|0|||
155382484|NCT03184870|560835327|FG016|Crossover Treatment|Death|0|||
155382485|NCT03184870|560835328|FG017|Crossover Treatment|Death|7|||
155382486|NCT05081388|560835329|FG000|Overall Study|Adverse Event|1|||
155382487|NCT05081388|560835330|FG001|Overall Study|Adverse Event|0|||
155382488|NCT05081388|560835331|FG002|Overall Study|Adverse Event|0|||
155382489|NCT05081388|560835332|FG003|Overall Study|Adverse Event|0|||
155382490|NCT05081388|560835333|FG004|Overall Study|Adverse Event|0|||
155382491|NCT05081388|560835329|FG000|Overall Study|Lost to Follow-up|0|||
155382492|NCT05081388|560835330|FG001|Overall Study|Lost to Follow-up|1|||
155382493|NCT05081388|560835331|FG002|Overall Study|Lost to Follow-up|0|||
155382494|NCT05081388|560835332|FG003|Overall Study|Lost to Follow-up|0|||
155382495|NCT05081388|560835333|FG004|Overall Study|Lost to Follow-up|0|||
155382496|NCT05081388|560835329|FG000|Overall Study|Subject decision|0|||
155382497|NCT05081388|560835330|FG001|Overall Study|Subject decision|0|||
155382498|NCT05081388|560835331|FG002|Overall Study|Subject decision|0|||
155382499|NCT05081388|560835332|FG003|Overall Study|Subject decision|1|||
155382500|NCT05081388|560835333|FG004|Overall Study|Subject decision|0|||
155382501|NCT03786783|560835334|FG000|Overall Study|Death|1|||
155382502|NCT03786783|560835334|FG000|Overall Study|Physician Decision|6|||
155382503|NCT03786783|560835334|FG000|Overall Study|Withdrawal by Subject|2|||
155382504|NCT03786783|560835334|FG000|Overall Study|Disease Progression|7|||
155382505|NCT03786783|560835334|FG000|Overall Study|Patient/Parent Refusal|4|||
155382506|NCT01776541|560835335|FG000|Overall Study|Administrative Reason|6|||
155382507|NCT01776541|560835336|FG001|Overall Study|Administrative Reason|2|||
155382508|NCT01776541|560835335|FG000|Overall Study|Death|4|||
154942874|NCT00585351|559215963|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
154942875|NCT00585351|559215964|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
154942876|NCT00585351|559215965|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
154942877|NCT00585351|559215966|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
154942878|NCT00585351|559215967|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
154942879|NCT00585351|559215968|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
154942880|NCT01821625|559215969|FG000|Overall Study|Withdrawal by Subject|2|||
154942881|NCT01821625|559215969|FG000|Overall Study|Lack of Efficacy|2|||
154942882|NCT01821625|559215969|FG000|Overall Study|Adverse Event|1|||
155278697|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
155278698|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
155278699|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
155278700|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
155278701|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
155278702|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
155278703|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
155278704|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
155278705|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
155278706|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
155278707|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
155278708|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
155278709|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
155278710|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
155278711|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
155278712|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
155278713|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
155278714|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
155278715|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
155278716|NCT01473420|560453273|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
155382509|NCT01776541|560835336|FG001|Overall Study|Death|0|||
155382510|NCT01776541|560835335|FG000|Overall Study|Lost to Follow-up|27|||
155382511|NCT01776541|560835336|FG001|Overall Study|Lost to Follow-up|48|||
155382512|NCT01776541|560835335|FG000|Overall Study|Unclassified|5|||
155382513|NCT01776541|560835336|FG001|Overall Study|Unclassified|4|||
155382514|NCT01776541|560835335|FG000|Overall Study|Protocol Violation|2|||
155382515|NCT01776541|560835336|FG001|Overall Study|Protocol Violation|1|||
155382516|NCT01776541|560835335|FG000|Overall Study|Withdrawal by Subject|12|||
155382517|NCT01776541|560835336|FG001|Overall Study|Withdrawal by Subject|20|||
155382518|NCT04279392|560835339|FG000|Overall Study|Physician Decision|1|||
155382519|NCT04279392|560835340|FG001|Overall Study|Physician Decision|0|||
155382520|NCT01171807|560835341|FG000|Overall Study|Treatment failure|2|||
155382521|NCT01171807|560835342|FG001|Overall Study|Treatment failure|4|||
155382522|NCT01171807|560835341|FG000|Overall Study|Non compliance|1|||
155382523|NCT01171807|560835342|FG001|Overall Study|Non compliance|0|||
155382524|NCT01171807|560835341|FG000|Overall Study|Lost to Follow-up|3|||
155382525|NCT01171807|560835342|FG001|Overall Study|Lost to Follow-up|0|||
155382526|NCT01901341|560835343|FG000|Overall Study|Adverse Event|4|||
155382527|NCT01901341|560835344|FG001|Overall Study|Adverse Event|2|||
155382528|NCT01901341|560835343|FG000|Overall Study|Lack of Efficacy|0|||
155382529|NCT01901341|560835344|FG001|Overall Study|Lack of Efficacy|2|||
155382530|NCT01901341|560835343|FG000|Overall Study|Lost to Follow-up|0|||
155382531|NCT01901341|560835344|FG001|Overall Study|Lost to Follow-up|1|||
155382532|NCT01901341|560835343|FG000|Overall Study|Protocol Violation|2|||
155045311|NCT00547248|559599296|FG002|Overall Study|Migrated/moved from study area|2|||
155045312|NCT00547248|559599297|FG003|Overall Study|Migrated/moved from study area|0|||
155045313|NCT00547248|559599294|FG000|Overall Study|Withdrawal by Subject|0|||
155045314|NCT00547248|559599295|FG001|Overall Study|Withdrawal by Subject|0|||
155045315|NCT00547248|559599296|FG002|Overall Study|Withdrawal by Subject|7|||
155045316|NCT00547248|559599297|FG003|Overall Study|Withdrawal by Subject|1|||
155045317|NCT02090283|559599301|FG000|Overall Study|Withdrawal by Subject|6|||
155045318|NCT02090283|559599302|FG001|Overall Study|Withdrawal by Subject|6|||
155045319|NCT02090283|559599303|FG002|Overall Study|Withdrawal by Subject|6|||
155045320|NCT02090283|559599301|FG000|Overall Study|Sponsor Terminated Study|6|||
155045321|NCT02090283|559599302|FG001|Overall Study|Sponsor Terminated Study|6|||
155045322|NCT02090283|559599303|FG002|Overall Study|Sponsor Terminated Study|1|||
155045323|NCT02090283|559599301|FG000|Overall Study|Lost to Follow-up|2|||
155045324|NCT02090283|559599302|FG001|Overall Study|Lost to Follow-up|2|||
155045325|NCT02090283|559599303|FG002|Overall Study|Lost to Follow-up|3|||
155045326|NCT02090283|559599301|FG000|Overall Study|Adverse Event|1|||
155045327|NCT02090283|559599302|FG001|Overall Study|Adverse Event|1|||
155045328|NCT02090283|559599303|FG002|Overall Study|Adverse Event|0|||
155045329|NCT02090283|559599301|FG000|Overall Study|Protocol Violation|2|||
155045330|NCT02090283|559599302|FG001|Overall Study|Protocol Violation|0|||
155045331|NCT02090283|559599303|FG002|Overall Study|Protocol Violation|0|||
155045332|NCT00697593|559599307|FG000|Overall Study|Adverse Event|3|||
155382533|NCT01901341|560835344|FG001|Overall Study|Protocol Violation|0|||
155382534|NCT01901341|560835343|FG000|Overall Study|Study Terminated by Sponsor|13|||
155382535|NCT01901341|560835344|FG001|Overall Study|Study Terminated by Sponsor|15|||
155382536|NCT01901341|560835343|FG000|Overall Study|Withdrawal by Subject|1|||
155382537|NCT01901341|560835344|FG001|Overall Study|Withdrawal by Subject|1|||
155382538|NCT04964388|560835345|FG000|Overall Study|Lost to Follow-up|3|||
155382539|NCT04964388|560835346|FG001|Overall Study|Lost to Follow-up|2|||
155382540|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
155382541|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
155382542|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
155382543|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
155382544|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
155382545|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
155382546|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
155382547|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
155382548|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
155382549|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
155382550|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
155382551|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
155382552|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
155382553|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
155382554|NCT00757588|560835347|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
155382555|NCT00757588|560835348|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
155382556|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
155382557|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
155382558|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
155045333|NCT00697593|559599307|FG000|Overall Study|Protocol Violation|1|||
155045334|NCT00697593|559599307|FG000|Overall Study|Lack of Efficacy|3|||
155045335|NCT00697593|559599307|FG000|Overall Study|Suspension of the study by sponsor|12|||
155045336|NCT03498313|559599308|FG000|Experimental Period 1|Adverse Event|1|||
155045337|NCT03498313|559599309|FG001|Experimental Period 1|Adverse Event|0|||
155045338|NCT03498313|559599310|FG002|Experimental Period 1|Adverse Event|0|||
155045339|NCT03498313|559599311|FG003|Experimental Period 1|Adverse Event|1|||
155382559|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
155382560|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
155382561|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
155382562|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
155045340|NCT03498313|559599312|FG004|Experimental Period 1|Adverse Event|0|||
155045341|NCT03498313|559599313|FG005|Experimental Period 1|Adverse Event|0|||
155045342|NCT03498313|559599308|FG000|Experimental Period 1|Withdrawal by Subject|0|||
155045343|NCT03498313|559599309|FG001|Experimental Period 1|Withdrawal by Subject|1|||
155045344|NCT03498313|559599310|FG002|Experimental Period 1|Withdrawal by Subject|0|||
155045345|NCT03498313|559599311|FG003|Experimental Period 1|Withdrawal by Subject|0|||
155045346|NCT03498313|559599312|FG004|Experimental Period 1|Withdrawal by Subject|0|||
155382563|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
155382564|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
155382565|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
155382566|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
155382567|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
155382568|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
155382569|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
155382570|NCT00757588|560835347|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
155382571|NCT00757588|560835348|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
155382572|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
155382573|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
155382574|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
155382575|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
155382576|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
155382577|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
155382578|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
155382579|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
155382580|NCT05478499|560835349|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
155382581|NCT05478499|560835350|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
155382582|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
155382583|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
155382584|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
155382585|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
155382586|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
155382587|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
155382588|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
155382589|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
155382590|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
155382591|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
155382592|NCT05478499|560835349|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
155382593|NCT05478499|560835350|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
155382594|NCT02476279|560835351|FG000|Overall Study|Lost to Follow-up|1|||
155382595|NCT02476279|560835352|FG001|Overall Study|Lost to Follow-up|1|||
155382596|NCT02208999|560835353|FG000|Overall Study|Lost to Follow-up|1|||
155382597|NCT00319839|560835354|FG000|Overall Study|Adverse Event|5|||
155382598|NCT00319839|560835354|FG000|Overall Study|Withdrawal by Subject|1|||
155382599|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
155382600|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
155382601|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
155382602|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
155382603|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
155382604|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
155382605|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
155382606|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382607|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382608|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382609|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382610|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
155382611|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382612|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
155382613|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382614|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382615|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382616|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
155045347|NCT03498313|559599313|FG005|Experimental Period 1|Withdrawal by Subject|0|||
155045348|NCT03498313|559599308|FG000|Washout Period 1|Anovulation|1|||
155045349|NCT03498313|559599309|FG001|Washout Period 1|Anovulation|0|||
155382617|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
155382618|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
155045350|NCT03498313|559599310|FG002|Washout Period 1|Anovulation|0|||
155045351|NCT03498313|559599311|FG003|Washout Period 1|Anovulation|0|||
155278717|NCT01473420|560453274|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
155278718|NCT04172987|560453275|FG000|Lead In Period|Adverse Event|1|||
155278719|NCT04172987|560453275|FG000|Lead In Period|Protocol Violation|1|||
155278720|NCT04172987|560453275|FG000|Period 1|Physician Decision|1|||
155278721|NCT04172987|560453275|FG000|Period 2|Adverse Event|5|||
155278722|NCT04172987|560453275|FG000|Period 2|Dosing Termination by Sponsor|4|||
154942883|NCT01821625|559215969|FG000|Overall Study|Medical contraindication|1|||
154942884|NCT00457665|559215975|FG000|12 Months|Drug allergy|1|||
154942885|NCT00457665|559215976|FG001|12 Months|Drug allergy|1|||
154942886|NCT00457665|559215975|FG000|12 Months|High HIV viral load|5|||
154942887|NCT00457665|559215976|FG001|12 Months|High HIV viral load|1|||
154942888|NCT00457665|559215975|FG000|12 Months|Lipodystrophy|2|||
154942889|NCT00457665|559215976|FG001|12 Months|Lipodystrophy|0|||
154942890|NCT00457665|559215975|FG000|12 Months|Withdrawal by Subject|0|||
154942891|NCT00457665|559215976|FG001|12 Months|Withdrawal by Subject|2|||
154942892|NCT00457665|559215975|FG000|12 Months|Abnormal Liver function tests|0|||
154942893|NCT00457665|559215976|FG001|12 Months|Abnormal Liver function tests|5|||
154942894|NCT00457665|559215975|FG000|24 Months|Withdrawal by Subject|3|||
154942895|NCT00457665|559215976|FG001|24 Months|Withdrawal by Subject|2|||
154942896|NCT00457665|559215975|FG000|24 Months|Lipodystrophy|1|||
154942897|NCT00457665|559215976|FG001|24 Months|Lipodystrophy|1|||
154942898|NCT00457665|559215975|FG000|24 Months|Abnormal liver function tests|1|||
154942899|NCT00457665|559215976|FG001|24 Months|Abnormal liver function tests|5|||
154942900|NCT00446654|559215977|FG000|Overall Study|Withdrawal by Subject|1|||
154942901|NCT00446654|559215978|FG001|Overall Study|Withdrawal by Subject|0|||
154942902|NCT00446654|559215977|FG000|Overall Study|Adverse Event|1|||
154942903|NCT00446654|559215978|FG001|Overall Study|Adverse Event|0|||
154942904|NCT02535000|559215979|FG000|Overall Study|Cancellation of surgery.|1|||
154942905|NCT02535000|559215980|FG001|Overall Study|Cancellation of surgery.|2|||
154942906|NCT01620489|559215984|FG000|Overall Study|Adverse Event|17|||
154942907|NCT01620489|559215985|FG001|Overall Study|Adverse Event|4|||
154942908|NCT01620489|559215984|FG000|Overall Study|Protocol Violation|0|||
154942909|NCT01620489|559215985|FG001|Overall Study|Protocol Violation|3|||
154942910|NCT01620489|559215984|FG000|Overall Study|Withdrawal Criteria|17|||
154942911|NCT01620489|559215985|FG001|Overall Study|Withdrawal Criteria|25|||
154942912|NCT01620489|559215984|FG000|Overall Study|Unclassified|1|||
154942913|NCT01620489|559215985|FG001|Overall Study|Unclassified|2|||
154942914|NCT01328054|559215988|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
154942915|NCT01328054|559215989|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
154942916|NCT01328054|559215988|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
154942917|NCT01328054|559215989|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
154942918|NCT01328054|559215988|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
154942919|NCT01328054|559215989|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
154942920|NCT00871728|559215990|FG000|Overall Study|Adverse Event|1|||
154942921|NCT00871728|559215990|FG000|Overall Study|Protocol Violation|7|||
154942922|NCT00871728|559215990|FG000|Overall Study|Lost to Follow-up|2|||
154942923|NCT00871728|559215990|FG000|Overall Study|Failed to Visit Hospital|4|||
154942924|NCT00871728|559215990|FG000|Overall Study|Participant Non-compliance|1|||
154942925|NCT00871728|559215990|FG000|Overall Study|Withdrawal of Informed Consent|5|||
154942926|NCT02472977|559215997|FG000|Overall Study|Disease progression|4|||
154942927|NCT02472977|559215998|FG001|Overall Study|Disease progression|25|||
154942928|NCT02472977|559215999|FG002|Overall Study|Disease progression|6|||
154942929|NCT02472977|559215997|FG000|Overall Study|Withdrawal by Subject|0|||
154942930|NCT02472977|559215998|FG001|Overall Study|Withdrawal by Subject|1|||
154942931|NCT02472977|559215999|FG002|Overall Study|Withdrawal by Subject|0|||
154942932|NCT02472977|559215997|FG000|Overall Study|Study drug toxicity|2|||
154942933|NCT02472977|559215998|FG001|Overall Study|Study drug toxicity|0|||
154942934|NCT02472977|559215999|FG002|Overall Study|Study drug toxicity|2|||
154942935|NCT02472977|559215997|FG000|Overall Study|Subject request to discontinue treatment|0|||
154942936|NCT02472977|559215998|FG001|Overall Study|Subject request to discontinue treatment|1|||
154942937|NCT02472977|559215999|FG002|Overall Study|Subject request to discontinue treatment|0|||
154942938|NCT02668302|559216003|FG000|Overall Study|Withdrawal by Subject|1|||
154942939|NCT02668302|559216004|FG001|Overall Study|Withdrawal by Subject|0|||
154942940|NCT03775681|559216005|FG000|Overall Study|Physician Decision|3|||
154942941|NCT00616928|559216006|FG000|Overall Study|Adverse Event|6|||
154942942|NCT00616928|559216007|FG001|Overall Study|Adverse Event|3|||
154942943|NCT00616928|559216008|FG002|Overall Study|Adverse Event|2|||
154942944|NCT00616928|559216009|FG003|Overall Study|Adverse Event|2|||
154942945|NCT00616928|559216006|FG000|Overall Study|Other|51|||
154942946|NCT00616928|559216007|FG001|Overall Study|Other|8|||
154942947|NCT00616928|559216008|FG002|Overall Study|Other|15|||
155278723|NCT01656759|560453276|FG000|Overall Study|Protocol Violation|2|||
154942948|NCT00616928|559216009|FG003|Overall Study|Other|5|||
154942949|NCT00616928|559216006|FG000|Overall Study|Lost to Follow-up|5|||
154942950|NCT00616928|559216007|FG001|Overall Study|Lost to Follow-up|7|||
154942951|NCT00616928|559216008|FG002|Overall Study|Lost to Follow-up|0|||
154942952|NCT00616928|559216009|FG003|Overall Study|Lost to Follow-up|0|||
154942953|NCT03558997|559216010|FG000|Overall Study|Adverse Event|0|||
155045352|NCT03498313|559599312|FG004|Washout Period 1|Anovulation|0|||
155045353|NCT03498313|559599313|FG005|Washout Period 1|Anovulation|0|||
155045354|NCT03498313|559599308|FG000|Washout Period 1|Withdrawal by Subject|0|||
155045355|NCT03498313|559599309|FG001|Washout Period 1|Withdrawal by Subject|3|||
155045356|NCT03498313|559599310|FG002|Washout Period 1|Withdrawal by Subject|0|||
155045357|NCT03498313|559599311|FG003|Washout Period 1|Withdrawal by Subject|1|||
155045358|NCT03498313|559599312|FG004|Washout Period 1|Withdrawal by Subject|0|||
155045359|NCT03498313|559599313|FG005|Washout Period 1|Withdrawal by Subject|1|||
155045360|NCT03498313|559599308|FG000|Experimental Period 2|Adverse Event|0|||
155045361|NCT03498313|559599309|FG001|Experimental Period 2|Adverse Event|0|||
155045362|NCT03498313|559599310|FG002|Experimental Period 2|Adverse Event|0|||
155045363|NCT03498313|559599311|FG003|Experimental Period 2|Adverse Event|0|||
155045364|NCT03498313|559599312|FG004|Experimental Period 2|Adverse Event|1|||
155045365|NCT03498313|559599313|FG005|Experimental Period 2|Adverse Event|2|||
155045366|NCT03498313|559599308|FG000|Washout Period 2|Physician Decision|1|||
155045367|NCT03498313|559599309|FG001|Washout Period 2|Physician Decision|0|||
155045368|NCT03498313|559599310|FG002|Washout Period 2|Physician Decision|0|||
155045369|NCT03498313|559599311|FG003|Washout Period 2|Physician Decision|1|||
155045370|NCT03498313|559599312|FG004|Washout Period 2|Physician Decision|0|||
155045371|NCT03498313|559599313|FG005|Washout Period 2|Physician Decision|1|||
155045372|NCT03498313|559599308|FG000|Washout Period 2|Withdrawal by Subject|3|||
155045373|NCT03498313|559599309|FG001|Washout Period 2|Withdrawal by Subject|2|||
155045374|NCT03498313|559599310|FG002|Washout Period 2|Withdrawal by Subject|0|||
155045375|NCT03498313|559599311|FG003|Washout Period 2|Withdrawal by Subject|0|||
155045376|NCT03498313|559599312|FG004|Washout Period 2|Withdrawal by Subject|2|||
155045377|NCT03498313|559599313|FG005|Washout Period 2|Withdrawal by Subject|0|||
155045378|NCT03498313|559599308|FG000|Washout Period 2|Anovulation|0|||
155045379|NCT03498313|559599309|FG001|Washout Period 2|Anovulation|0|||
155045380|NCT03498313|559599310|FG002|Washout Period 2|Anovulation|0|||
155045381|NCT03498313|559599311|FG003|Washout Period 2|Anovulation|0|||
155045382|NCT03498313|559599312|FG004|Washout Period 2|Anovulation|0|||
155045383|NCT03498313|559599313|FG005|Washout Period 2|Anovulation|1|||
155045384|NCT00184002|559599318|FG000|Overall Study|Adverse Event|9|||
155045385|NCT00184002|559599318|FG000|Overall Study|Death|3|||
155045386|NCT00184002|559599318|FG000|Overall Study|Physician Decision|1|||
155045387|NCT00184002|559599318|FG000|Overall Study|Withdrawal by Subject|4|||
155045388|NCT03117361|559599320|FG000|Overall Study|Progressive disease|5|||
155045389|NCT03117361|559599320|FG000|Overall Study|Death|1|||
155045390|NCT03117361|559599320|FG000|Overall Study|Physician Decision|2|||
155045391|NCT03117361|559599320|FG000|Overall Study|On study treatment at the end of study|1|||
155045392|NCT03117361|559599320|FG000|Overall Study|Treatment-related adverse event|1|||
155045393|NCT01869777|559599321|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
155045394|NCT00878800|559599322|FG000|Overall Study|Adverse Event|0|||
155045395|NCT00878800|559599323|FG001|Overall Study|Adverse Event|0|||
155045396|NCT00878800|559599324|FG002|Overall Study|Adverse Event|2|||
155045397|NCT00878800|559599325|FG003|Overall Study|Adverse Event|0|||
155045398|NCT00878800|559599326|FG004|Overall Study|Adverse Event|1|||
155045399|NCT00878800|559599322|FG000|Overall Study|Progressive disease|1|||
155045400|NCT00878800|559599323|FG001|Overall Study|Progressive disease|5|||
155045401|NCT00878800|559599324|FG002|Overall Study|Progressive disease|6|||
155045402|NCT00878800|559599325|FG003|Overall Study|Progressive disease|5|||
155045403|NCT00878800|559599326|FG004|Overall Study|Progressive disease|13|||
155045404|NCT00878800|559599322|FG000|Overall Study|Withdrew consent|1|||
155045405|NCT00878800|559599323|FG001|Overall Study|Withdrew consent|1|||
155045406|NCT00878800|559599324|FG002|Overall Study|Withdrew consent|0|||
155045407|NCT00878800|559599325|FG003|Overall Study|Withdrew consent|1|||
155045408|NCT00878800|559599326|FG004|Overall Study|Withdrew consent|1|||
155045409|NCT00878800|559599322|FG000|Overall Study|Death|0|||
155045410|NCT00878800|559599323|FG001|Overall Study|Death|0|||
155045411|NCT00878800|559599324|FG002|Overall Study|Death|1|||
155045412|NCT00878800|559599325|FG003|Overall Study|Death|0|||
155045413|NCT00878800|559599326|FG004|Overall Study|Death|0|||
155045414|NCT00878800|559599322|FG000|Overall Study|Other|1|||
155045415|NCT00878800|559599323|FG001|Overall Study|Other|1|||
155045416|NCT00878800|559599324|FG002|Overall Study|Other|0|||
155045417|NCT00878800|559599325|FG003|Overall Study|Other|0|||
155045418|NCT00878800|559599326|FG004|Overall Study|Other|1|||
155045419|NCT01247350|559599327|FG000|Overall Study|Adverse Event|0|||
155045420|NCT01247350|559599328|FG001|Overall Study|Adverse Event|0|||
155045421|NCT01247350|559599329|FG002|Overall Study|Adverse Event|1|||
155045422|NCT01247350|559599330|FG003|Overall Study|Adverse Event|0|||
155045423|NCT01247350|559599331|FG004|Overall Study|Adverse Event|0|||
155045424|NCT01247350|559599327|FG000|Overall Study|Withdrawal by Subject|0|||
155045425|NCT01247350|559599328|FG001|Overall Study|Withdrawal by Subject|0|||
155045426|NCT01247350|559599329|FG002|Overall Study|Withdrawal by Subject|0|||
155045427|NCT01247350|559599330|FG003|Overall Study|Withdrawal by Subject|1|||
155045428|NCT01247350|559599331|FG004|Overall Study|Withdrawal by Subject|0|||
155045429|NCT01247350|559599327|FG000|Overall Study|Entry criteria not met|0|||
155045430|NCT01247350|559599328|FG001|Overall Study|Entry criteria not met|0|||
155045431|NCT01247350|559599329|FG002|Overall Study|Entry criteria not met|0|||
155045432|NCT01247350|559599330|FG003|Overall Study|Entry criteria not met|0|||
155045433|NCT01247350|559599331|FG004|Overall Study|Entry criteria not met|1|||
155382619|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
155382620|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382621|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382622|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382623|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
155382624|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
155382625|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382626|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382627|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382628|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
155382629|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382630|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382631|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
155382632|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
155382633|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
155382634|NCT04494256|560835355|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382635|NCT04494256|560835356|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382636|NCT04494256|560835357|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382637|NCT04494256|560835358|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382638|NCT04494256|560835359|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
155382639|NCT04494256|560835360|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382640|NCT04494256|560835361|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
155382641|NCT04494256|560835355|FG000|Part 2: Open Label Period|Death|0|||
155382642|NCT04494256|560835356|FG001|Part 2: Open Label Period|Death|0|||
155382643|NCT04494256|560835357|FG002|Part 2: Open Label Period|Death|0|||
155382644|NCT04494256|560835358|FG003|Part 2: Open Label Period|Death|0|||
155382645|NCT04494256|560835359|FG004|Part 2: Open Label Period|Death|0|||
155382646|NCT04494256|560835360|FG005|Part 2: Open Label Period|Death|4|||
155382647|NCT04494256|560835361|FG006|Part 2: Open Label Period|Death|2|||
155382648|NCT04494256|560835355|FG000|Part 2: Open Label Period|Adverse Event|0|||
155382649|NCT04494256|560835356|FG001|Part 2: Open Label Period|Adverse Event|0|||
155382650|NCT04494256|560835357|FG002|Part 2: Open Label Period|Adverse Event|0|||
155382651|NCT04494256|560835358|FG003|Part 2: Open Label Period|Adverse Event|0|||
155382652|NCT04494256|560835359|FG004|Part 2: Open Label Period|Adverse Event|0|||
155382653|NCT04494256|560835360|FG005|Part 2: Open Label Period|Adverse Event|0|||
155382654|NCT04494256|560835361|FG006|Part 2: Open Label Period|Adverse Event|2|||
155382655|NCT04494256|560835355|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382656|NCT04494256|560835356|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382657|NCT04494256|560835357|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382658|NCT04494256|560835358|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382659|NCT04494256|560835359|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
155382660|NCT04494256|560835360|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
155382661|NCT04494256|560835361|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
155382662|NCT04494256|560835355|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382663|NCT04494256|560835356|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382664|NCT04494256|560835357|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382665|NCT04494256|560835358|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382666|NCT04494256|560835359|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382667|NCT04494256|560835360|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
155382668|NCT04494256|560835361|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
155382669|NCT04494256|560835355|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382670|NCT04494256|560835356|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382671|NCT04494256|560835357|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382672|NCT04494256|560835358|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155382673|NCT04494256|560835359|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
155045434|NCT02982863|559599332|FG000|Overall Study|Not eligible patients|809|||
155045435|NCT02982863|559599333|FG001|Overall Study|Not eligible patients|4261|||
155045436|NCT02982863|559599334|FG002|Overall Study|Not eligible patients|1852|||
155045437|NCT02982863|559599335|FG003|Overall Study|Not eligible patients|1400|||
155045438|NCT02982863|559599336|FG004|Overall Study|Not eligible patients|492|||
155045439|NCT02328937|559599339|FG000|Period 1|Lost to Follow-up|0|||
155382674|NCT04494256|560835360|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
155382675|NCT04494256|560835361|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
155382676|NCT04494256|560835355|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382677|NCT04494256|560835356|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382678|NCT04494256|560835357|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382679|NCT04494256|560835358|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382680|NCT04494256|560835359|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
155382681|NCT04494256|560835360|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
155382682|NCT04494256|560835361|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
155382683|NCT04494256|560835355|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382684|NCT04494256|560835356|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382685|NCT04494256|560835357|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382686|NCT04494256|560835358|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382687|NCT04494256|560835359|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
155382688|NCT04494256|560835360|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
155382689|NCT04494256|560835361|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
155382690|NCT00262951|560835362|FG000|Overall Study|Progressive disease/relapse|3|||
155382691|NCT00262951|560835362|FG000|Overall Study|Adverse Event|7|||
155382692|NCT00262951|560835362|FG000|Overall Study|Death|1|||
155382693|NCT00262951|560835362|FG000|Overall Study|Withdrawal by Subject|1|||
155382694|NCT00262951|560835362|FG000|Overall Study|Alternative treatment|3|||
155382695|NCT00262951|560835362|FG000|Overall Study|Off treatment for other disease|1|||
155382696|NCT01778023|560835363|FG000|Overall Study|Withdrawal by Subject|0|||
155382697|NCT01778023|560835364|FG001|Overall Study|Withdrawal by Subject|3|||
155382698|NCT00903630|560835365|FG000|Phase 2|Adverse Event|0|||
155382699|NCT00903630|560835366|FG001|Phase 2|Adverse Event|0|||
155382700|NCT00903630|560835367|FG002|Phase 2|Adverse Event|1|||
154942954|NCT03558997|559216011|FG001|Overall Study|Adverse Event|2|||
154942955|NCT03558997|559216012|FG002|Overall Study|Adverse Event|5|||
154942956|NCT03558997|559216013|FG003|Overall Study|Adverse Event|1|||
154942957|NCT03558997|559216010|FG000|Overall Study|Physician Decision|0|||
154942958|NCT03558997|559216011|FG001|Overall Study|Physician Decision|0|||
154942959|NCT03558997|559216012|FG002|Overall Study|Physician Decision|1|||
154942960|NCT03558997|559216013|FG003|Overall Study|Physician Decision|0|||
154942961|NCT03558997|559216010|FG000|Overall Study|Withdrawal by Subject|1|||
154942962|NCT03558997|559216011|FG001|Overall Study|Withdrawal by Subject|0|||
154942963|NCT03558997|559216012|FG002|Overall Study|Withdrawal by Subject|1|||
154942964|NCT03558997|559216013|FG003|Overall Study|Withdrawal by Subject|1|||
154942965|NCT03558997|559216010|FG000|Overall Study|Lost to Follow-up|0|||
154942966|NCT03558997|559216011|FG001|Overall Study|Lost to Follow-up|0|||
154942967|NCT03558997|559216012|FG002|Overall Study|Lost to Follow-up|1|||
154942968|NCT03558997|559216013|FG003|Overall Study|Lost to Follow-up|0|||
154942969|NCT04535583|559216027|FG000|Overall Study|Lost to Follow-up|1|||
154942970|NCT04535583|559216027|FG000|Overall Study|Physician Decision|1|||
154942971|NCT04535583|559216027|FG000|Overall Study|Withdrawal by Subject|1|||
154942972|NCT01078090|559216028|FG000|Overall Study|Lost to Follow-up|2363|||
154942973|NCT01078090|559216028|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
154942974|NCT01078090|559216028|FG000|Overall Study|Lack of Efficacy|1193|||
154942975|NCT01078090|559216028|FG000|Overall Study|ADR and lack of efficacy|61|||
154942976|NCT01078090|559216028|FG000|Overall Study|Other|523|||
154942977|NCT01748890|559216030|FG000|Overall Study|Insufficient recruitment for analysis|4|||
154942978|NCT02669264|559216031|FG000|Overall Study|Death|5|||
154942979|NCT02669264|559216032|FG001|Overall Study|Death|5|||
154942980|NCT02669264|559216033|FG002|Overall Study|Death|3|||
154942981|NCT02669264|559216034|FG003|Overall Study|Death|3|||
154942982|NCT02669264|559216035|FG004|Overall Study|Death|3|||
154942983|NCT02669264|559216036|FG005|Overall Study|Death|6|||
154942984|NCT02669264|559216037|FG006|Overall Study|Death|3|||
154942985|NCT02669264|559216031|FG000|Overall Study|Withdrawal by Subject|0|||
154942986|NCT02669264|559216032|FG001|Overall Study|Withdrawal by Subject|1|||
154942987|NCT02669264|559216033|FG002|Overall Study|Withdrawal by Subject|0|||
154942988|NCT02669264|559216034|FG003|Overall Study|Withdrawal by Subject|0|||
154942989|NCT02669264|559216035|FG004|Overall Study|Withdrawal by Subject|1|||
154942990|NCT02669264|559216036|FG005|Overall Study|Withdrawal by Subject|0|||
154942991|NCT02669264|559216037|FG006|Overall Study|Withdrawal by Subject|0|||
154942992|NCT02669264|559216031|FG000|Overall Study|Lost to Follow-up|0|||
154942993|NCT02669264|559216032|FG001|Overall Study|Lost to Follow-up|0|||
154942994|NCT02669264|559216033|FG002|Overall Study|Lost to Follow-up|0|||
154942995|NCT02669264|559216034|FG003|Overall Study|Lost to Follow-up|0|||
154942996|NCT02669264|559216035|FG004|Overall Study|Lost to Follow-up|1|||
154942997|NCT02669264|559216036|FG005|Overall Study|Lost to Follow-up|0|||
155382701|NCT01249274|560835371|FG000|Overall Study|Lost to Follow-up|3|||
154942998|NCT02669264|559216037|FG006|Overall Study|Lost to Follow-up|0|||
154942999|NCT02669264|559216031|FG000|Overall Study|Miscellaneous|0|||
154943000|NCT02669264|559216032|FG001|Overall Study|Miscellaneous|0|||
155382702|NCT01249274|560835372|FG001|Overall Study|Lost to Follow-up|4|||
155382703|NCT01249274|560835371|FG000|Overall Study|Received inpatient substance treatment|1|||
155382704|NCT01249274|560835372|FG001|Overall Study|Received inpatient substance treatment|2|||
155382705|NCT03451162|560835373|FG000|Overall Study|Lost to Follow-up|1|||
155382706|NCT03451162|560835374|FG001|Overall Study|Lost to Follow-up|0|||
155382707|NCT03451162|560835375|FG002|Overall Study|Lost to Follow-up|0|||
155382708|NCT03451162|560835376|FG003|Overall Study|Lost to Follow-up|0|||
155382709|NCT03451162|560835377|FG004|Overall Study|Lost to Follow-up|0|||
155382710|NCT03451162|560835373|FG000|Overall Study|Physician Decision|0|||
155382711|NCT03451162|560835374|FG001|Overall Study|Physician Decision|1|||
155382712|NCT03451162|560835375|FG002|Overall Study|Physician Decision|0|||
155382713|NCT03451162|560835376|FG003|Overall Study|Physician Decision|0|||
155382714|NCT03451162|560835377|FG004|Overall Study|Physician Decision|0|||
155382715|NCT03451162|560835373|FG000|Overall Study|Withdrawal by Subject|1|||
155382716|NCT03451162|560835374|FG001|Overall Study|Withdrawal by Subject|1|||
155382717|NCT03451162|560835375|FG002|Overall Study|Withdrawal by Subject|0|||
155382718|NCT03451162|560835376|FG003|Overall Study|Withdrawal by Subject|0|||
155382719|NCT03451162|560835377|FG004|Overall Study|Withdrawal by Subject|0|||
155382720|NCT03658668|560835378|FG000|Overall Study|Time Commitment|1|||
155382721|NCT03658668|560835379|FG001|Overall Study|Time Commitment|1|||
155382722|NCT04634825|560835380|FG000|Overall Study|Death|10|||
155382723|NCT04634825|560835381|FG001|Overall Study|Death|3|||
155382724|NCT04634825|560835380|FG000|Overall Study|Lost to Follow-up|1|||
155382725|NCT04634825|560835381|FG001|Overall Study|Lost to Follow-up|0|||
155382726|NCT04634825|560835380|FG000|Overall Study|Study terminated by sponsor|35|||
155382727|NCT04634825|560835381|FG001|Overall Study|Study terminated by sponsor|11|||
155382728|NCT04634825|560835380|FG000|Overall Study|Withdrawal by Subject|2|||
155382729|NCT04634825|560835381|FG001|Overall Study|Withdrawal by Subject|0|||
155382730|NCT00402597|560835384|FG000|Overall Study|Death|15|||
155382731|NCT00402597|560835385|FG001|Overall Study|Death|7|||
155382732|NCT00402597|560835386|FG002|Overall Study|Death|6|||
155382733|NCT00402597|560835387|FG003|Overall Study|Death|4|||
155382734|NCT00402597|560835388|FG004|Overall Study|Death|6|||
155382735|NCT00402597|560835384|FG000|Overall Study|Adverse Event|81|||
155382736|NCT00402597|560835385|FG001|Overall Study|Adverse Event|18|||
155382737|NCT00402597|560835386|FG002|Overall Study|Adverse Event|106|||
155382738|NCT00402597|560835387|FG003|Overall Study|Adverse Event|39|||
155382739|NCT00402597|560835388|FG004|Overall Study|Adverse Event|71|||
155382740|NCT00402597|560835384|FG000|Overall Study|Lost to Follow-up|8|||
155382741|NCT00402597|560835385|FG001|Overall Study|Lost to Follow-up|1|||
155382742|NCT00402597|560835386|FG002|Overall Study|Lost to Follow-up|8|||
155382743|NCT00402597|560835387|FG003|Overall Study|Lost to Follow-up|2|||
155382744|NCT00402597|560835388|FG004|Overall Study|Lost to Follow-up|3|||
155382745|NCT00402597|560835384|FG000|Overall Study|Withdrawal by Subject|57|||
155382746|NCT00402597|560835385|FG001|Overall Study|Withdrawal by Subject|16|||
155382747|NCT00402597|560835386|FG002|Overall Study|Withdrawal by Subject|65|||
155382748|NCT00402597|560835387|FG003|Overall Study|Withdrawal by Subject|15|||
155382749|NCT00402597|560835388|FG004|Overall Study|Withdrawal by Subject|24|||
155382750|NCT00402597|560835384|FG000|Overall Study|reason not specified|30|||
155382751|NCT00402597|560835385|FG001|Overall Study|reason not specified|4|||
155382752|NCT00402597|560835386|FG002|Overall Study|reason not specified|27|||
155382753|NCT00402597|560835387|FG003|Overall Study|reason not specified|14|||
155382754|NCT00402597|560835388|FG004|Overall Study|reason not specified|20|||
155382755|NCT01100034|560835389|FG000|Overall Study|Lost to Follow-up|11|||
155382756|NCT01100034|560835389|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
155382757|NCT01100034|560835389|FG000|Overall Study|Withdrawal by Subject|4|||
155382758|NCT01100034|560835389|FG000|Overall Study|Sponsor decision|21|||
155382759|NCT01100034|560835389|FG000|Overall Study|Participated in another clinical trial|1|||
155382760|NCT01100034|560835389|FG000|Overall Study|Participants moved to another hospital|4|||
155382761|NCT01100034|560835389|FG000|Overall Study|Site closed due to non-responsiveness|1|||
155382762|NCT01831856|560835390|FG000|Overall Study|Adverse Event|5|||
155382763|NCT01831856|560835391|FG001|Overall Study|Adverse Event|8|||
155382764|NCT01831856|560835390|FG000|Overall Study|Lack of Efficacy|13|||
155382765|NCT01831856|560835391|FG001|Overall Study|Lack of Efficacy|11|||
155382766|NCT01831856|560835390|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
155382767|NCT01831856|560835391|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
155382768|NCT00836095|560835393|FG000|Overall Study|Physician Decision|0|||
155382769|NCT00836095|560835394|FG001|Overall Study|Physician Decision|3|||
155382770|NCT01602562|560835396|FG000|Overall Study|Adverse Event|3|||
155382771|NCT01602562|560835397|FG001|Overall Study|Adverse Event|1|||
155382772|NCT01602562|560835396|FG000|Overall Study|Physician Decision|1|||
155382773|NCT01602562|560835397|FG001|Overall Study|Physician Decision|1|||
155382774|NCT01602562|560835396|FG000|Overall Study|Withdrawal by Subject|1|||
155382775|NCT01602562|560835397|FG001|Overall Study|Withdrawal by Subject|1|||
155382776|NCT02003573|560835401|FG000|Overall Study|Progressive disease|2|||
155382777|NCT02003573|560835402|FG001|Overall Study|Progressive disease|0|||
155382778|NCT02003573|560835403|FG002|Overall Study|Progressive disease|1|||
155382779|NCT02003573|560835401|FG000|Overall Study|Other Adverse event|0|||
155382780|NCT02003573|560835402|FG001|Overall Study|Other Adverse event|1|||
155382781|NCT02003573|560835403|FG002|Overall Study|Other Adverse event|1|||
155382782|NCT02003573|560835401|FG000|Overall Study|Refuse to take trial medication|0|||
155382783|NCT02003573|560835402|FG001|Overall Study|Refuse to take trial medication|1|||
155382784|NCT02003573|560835403|FG002|Overall Study|Refuse to take trial medication|1|||
155382785|NCT02003573|560835401|FG000|Overall Study|Other than specified|1|||
155382786|NCT02003573|560835402|FG001|Overall Study|Other than specified|2|||
155382787|NCT02003573|560835403|FG002|Overall Study|Other than specified|3|||
155382788|NCT05026710|560835410|FG000|Overall Study|No longer met eligibility criteria|3|||
155382789|NCT05026710|560835411|FG001|Overall Study|No longer met eligibility criteria|1|||
155382790|NCT00126503|560835414|FG000|Overall Study|disease progression|23|||
155382791|NCT00126503|560835415|FG001|Overall Study|disease progression|14|||
155382792|NCT00126503|560835414|FG000|Overall Study|Withdrawal by Subject|0|||
155382793|NCT00126503|560835415|FG001|Overall Study|Withdrawal by Subject|1|||
154943001|NCT02669264|559216033|FG002|Overall Study|Miscellaneous|0|||
154943002|NCT02669264|559216034|FG003|Overall Study|Miscellaneous|0|||
154943003|NCT02669264|559216035|FG004|Overall Study|Miscellaneous|0|||
154943004|NCT02669264|559216036|FG005|Overall Study|Miscellaneous|0|||
154943005|NCT02669264|559216037|FG006|Overall Study|Miscellaneous|2|||
154943006|NCT03529955|559216038|FG000|Overall Study|Adverse Event|1|||
154943007|NCT03529955|559216038|FG000|Overall Study|Lack of Efficacy|1|||
154943008|NCT04128696|559216039|FG000|Overall Study|Lost to Follow-up|3|||
154943009|NCT04128696|559216040|FG001|Overall Study|Lost to Follow-up|7|||
154943010|NCT04128696|559216039|FG000|Overall Study|Withdrawal by Subject|12|||
154943011|NCT04128696|559216040|FG001|Overall Study|Withdrawal by Subject|11|||
154943012|NCT04128696|559216039|FG000|Overall Study|Study Closed/Terminated|26|||
154943013|NCT04128696|559216040|FG001|Overall Study|Study Closed/Terminated|38|||
154943014|NCT04128696|559216039|FG000|Overall Study|Physician Decision|2|||
154943015|NCT04128696|559216040|FG001|Overall Study|Physician Decision|3|||
154943016|NCT03433001|559217672|FG000|Overall Study|Lack of Efficacy|109|||
154943017|NCT03433001|559217672|FG000|Overall Study|Adverse Event|69|||
154943018|NCT03433001|559217672|FG000|Overall Study|Withdrawal by Subject|10|||
154943019|NCT03433001|559217672|FG000|Overall Study|Death|12|||
154943020|NCT03433001|559217672|FG000|Overall Study|Lost to Follow-up|4|||
154943021|NCT03433001|559217672|FG000|Overall Study|Other|25|||
154943022|NCT01299038|559217676|FG000|Overall Study|Withdrawal by Subject|1|||
154943023|NCT01299038|559217677|FG001|Overall Study|Withdrawal by Subject|0|||
154943024|NCT00322556|559217682|FG000|Overall Study|Adverse Event|1|||
154943025|NCT00322556|559217682|FG000|Overall Study|Withdrawal by Subject|1|||
154943026|NCT00322556|559217682|FG000|Overall Study|Lost to Follow-up|3|||
154943027|NCT00322556|559217682|FG000|Overall Study|Other Reason|7|||
154943028|NCT02040428|559217683|FG000|Overall Study|Death|4|||
154943029|NCT02040428|559217684|FG001|Overall Study|Death|3|||
154943030|NCT02040428|559217683|FG000|Overall Study|Withdrawal by Subject|1|||
154943031|NCT02040428|559217684|FG001|Overall Study|Withdrawal by Subject|1|||
154943032|NCT00832078|559217685|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
154943033|NCT00832078|559217686|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
154943034|NCT00832078|559217685|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
154943035|NCT00832078|559217686|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
154943036|NCT02961920|559217687|FG000|Overall Study|did not achive stydy protocol schedule|1|||
154943037|NCT02961920|559217688|FG001|Overall Study|did not achive stydy protocol schedule|1|||
154943038|NCT01452529|559217689|FG000|Run-in Period|Adverse Event|96|||
154943039|NCT01452529|559217690|FG001|Run-in Period|Adverse Event|0|||
154943040|NCT01452529|559217691|FG002|Run-in Period|Adverse Event|0|||
154943041|NCT01452529|559217689|FG000|Run-in Period|Withdrawal by Subject|49|||
154943042|NCT01452529|559217690|FG001|Run-in Period|Withdrawal by Subject|0|||
154943043|NCT01452529|559217691|FG002|Run-in Period|Withdrawal by Subject|0|||
154943044|NCT01452529|559217689|FG000|Run-in Period|Lost to Follow-up|19|||
154943045|NCT01452529|559217690|FG001|Run-in Period|Lost to Follow-up|0|||
154943046|NCT01452529|559217691|FG002|Run-in Period|Lost to Follow-up|0|||
154943047|NCT01452529|559217689|FG000|Run-in Period|Lack of Efficacy|46|||
154943048|NCT01452529|559217690|FG001|Run-in Period|Lack of Efficacy|0|||
154943049|NCT01452529|559217691|FG002|Run-in Period|Lack of Efficacy|0|||
154943050|NCT01452529|559217689|FG000|Run-in Period|Confirmed or suspected diversion|23|||
155382794|NCT00126503|560835414|FG000|Overall Study|alternative therapy|1|||
155382795|NCT00126503|560835415|FG001|Overall Study|alternative therapy|1|||
154943051|NCT01452529|559217690|FG001|Run-in Period|Confirmed or suspected diversion|0|||
154943052|NCT01452529|559217691|FG002|Run-in Period|Confirmed or suspected diversion|0|||
154943053|NCT01452529|559217689|FG000|Run-in Period|Administrative|21|||
154943054|NCT01452529|559217690|FG001|Run-in Period|Administrative|0|||
154943055|NCT01452529|559217691|FG002|Run-in Period|Administrative|0|||
154943056|NCT01452529|559217689|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
154943057|NCT01452529|559217690|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
154943058|NCT01452529|559217691|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
155382796|NCT00126503|560835414|FG000|Overall Study|other complicating disease|4|||
154943059|NCT01452529|559217689|FG000|Double-blind (DB) Period|Adverse Event|0|||
154943060|NCT01452529|559217690|FG001|Double-blind (DB) Period|Adverse Event|18|||
155045440|NCT02328937|559599340|FG001|Period 1|Lost to Follow-up|0|||
155382797|NCT00126503|560835415|FG001|Overall Study|other complicating disease|1|||
155382798|NCT00126503|560835414|FG000|Overall Study|Death|3|||
155382799|NCT00126503|560835415|FG001|Overall Study|Death|0|||
155382800|NCT00126503|560835414|FG000|Overall Study|Adverse Event|13|||
155382801|NCT00126503|560835415|FG001|Overall Study|Adverse Event|3|||
155382802|NCT00126503|560835414|FG000|Overall Study|non-compliant|1|||
155382803|NCT00126503|560835415|FG001|Overall Study|non-compliant|0|||
155382804|NCT00126503|560835414|FG000|Overall Study|Physician Decision|2|||
155382805|NCT00126503|560835415|FG001|Overall Study|Physician Decision|1|||
155382806|NCT02523599|560835416|FG000|Overall Study|Adverse Event|1|||
155382807|NCT02523599|560835417|FG001|Overall Study|Adverse Event|0|||
155382808|NCT02523599|560835416|FG000|Overall Study|Physician Decision|1|||
154943061|NCT01452529|559217691|FG002|Double-blind (DB) Period|Adverse Event|11|||
154943062|NCT01452529|559217689|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
154943063|NCT01452529|559217690|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
154943064|NCT01452529|559217691|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
154943065|NCT01452529|559217689|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
154943066|NCT01452529|559217690|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
154943067|NCT01452529|559217691|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
154943068|NCT01452529|559217689|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
154943069|NCT01452529|559217690|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
154943070|NCT01452529|559217691|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
154943071|NCT01452529|559217689|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
154943072|NCT01452529|559217690|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
154943073|NCT01452529|559217691|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
154943074|NCT01452529|559217689|FG000|Double-blind (DB) Period|Administrative|0|||
154943075|NCT01452529|559217690|FG001|Double-blind (DB) Period|Administrative|11|||
154943076|NCT01452529|559217691|FG002|Double-blind (DB) Period|Administrative|7|||
154943077|NCT03551730|559217692|FG000|Overall Study|Adverse Event|1|||
154943078|NCT03551730|559217693|FG001|Overall Study|Adverse Event|0|||
154943079|NCT03551730|559217694|FG002|Overall Study|Adverse Event|0|||
154943080|NCT03551730|559217695|FG003|Overall Study|Adverse Event|0|||
154943081|NCT04527471|559217698|FG000|Overall Study|Adverse Event|1|||
154943082|NCT04527471|559217699|FG001|Overall Study|Adverse Event|0|||
154943083|NCT04527471|559217698|FG000|Overall Study|Lost to Follow-up|1|||
154943084|NCT04527471|559217699|FG001|Overall Study|Lost to Follow-up|0|||
154943085|NCT01165996|559217705|FG000|Overall Study|Death|1|||
154943086|NCT01165996|559217705|FG000|Overall Study|Physician Decision|1|||
154943087|NCT00096265|559217706|FG000|Overall Study|Ineligible|1|||
154943088|NCT00096265|559217707|FG001|Overall Study|Ineligible|0|||
154943089|NCT00096265|559217708|FG002|Overall Study|Ineligible|0|||
154943090|NCT01506323|559217709|FG000|Overall Study|Lost to Follow-up|5|||
154943091|NCT01506323|559217710|FG001|Overall Study|Lost to Follow-up|4|||
154943092|NCT01506323|559217709|FG000|Overall Study|Withdrawal by Subject|4|||
154943093|NCT01506323|559217710|FG001|Overall Study|Withdrawal by Subject|4|||
154943094|NCT01506323|559217709|FG000|Overall Study|Lack of Efficacy|1|||
154943095|NCT01506323|559217710|FG001|Overall Study|Lack of Efficacy|3|||
154943096|NCT01506323|559217709|FG000|Overall Study|Moved out of area|5|||
154943097|NCT01506323|559217710|FG001|Overall Study|Moved out of area|2|||
154943098|NCT01506323|559217709|FG000|Overall Study|Schedule or Transportation conflict|8|||
154943099|NCT01506323|559217710|FG001|Overall Study|Schedule or Transportation conflict|0|||
154943100|NCT01506323|559217709|FG000|Overall Study|Started another treatment|1|||
154943101|NCT01506323|559217710|FG001|Overall Study|Started another treatment|0|||
154943102|NCT02232074|559217711|FG000|Overall Study|Withdrawal by Subject|5|||
154943103|NCT02232074|559217712|FG001|Overall Study|Withdrawal by Subject|3|||
154943104|NCT02232074|559217711|FG000|Overall Study|No legal concerns at baseline|36|||
154943105|NCT02232074|559217712|FG001|Overall Study|No legal concerns at baseline|41|||
154943106|NCT02232074|559217711|FG000|Overall Study|deemed ineligible|0|||
154943107|NCT02232074|559217712|FG001|Overall Study|deemed ineligible|1|||
154943108|NCT00704418|559217714|FG000|Overall Study|Withdrawal by Subject|2|||
155382809|NCT02523599|560835417|FG001|Overall Study|Physician Decision|0|||
155382810|NCT02523599|560835416|FG000|Overall Study|Lost to Follow-up|4|||
154943109|NCT00704418|559217715|FG001|Overall Study|Withdrawal by Subject|0|||
154943110|NCT00704418|559217714|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
154943111|NCT00704418|559217715|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
154943112|NCT04081337|559217716|FG000|Overall Study|Adverse Event|0|||
154943113|NCT04081337|559217717|FG001|Overall Study|Adverse Event|1|||
154943114|NCT04081337|559217716|FG000|Overall Study|Withdrawal by Subject|2|||
154943115|NCT04081337|559217717|FG001|Overall Study|Withdrawal by Subject|0|||
154943116|NCT04081337|559217716|FG000|Overall Study|Physician Decision|1|||
154943117|NCT04081337|559217717|FG001|Overall Study|Physician Decision|2|||
154943118|NCT04081337|559217716|FG000|Overall Study|Lost to Follow-up|1|||
154943119|NCT04081337|559217717|FG001|Overall Study|Lost to Follow-up|0|||
154943120|NCT01579474|559217718|FG000|Overall Study|Adverse Event|1|||
154943121|NCT01579474|559217719|FG001|Overall Study|Adverse Event|13|||
155382811|NCT02523599|560835417|FG001|Overall Study|Lost to Follow-up|1|||
155382812|NCT02523599|560835416|FG000|Overall Study|Did not return for Day 30 visit|2|||
155382813|NCT02523599|560835417|FG001|Overall Study|Did not return for Day 30 visit|0|||
155382814|NCT03519971|560835418|FG000|Overall Study|Death|142|||
155382815|NCT03519971|560835419|FG001|Overall Study|Death|69|||
155382816|NCT03519971|560835418|FG000|Overall Study|Lost to Follow-up|0|||
155382817|NCT03519971|560835419|FG001|Overall Study|Lost to Follow-up|1|||
155382818|NCT03519971|560835418|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
155382819|NCT03519971|560835419|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
155382820|NCT03519971|560835418|FG000|Overall Study|Withdrawal by Subject|3|||
155382821|NCT03519971|560835419|FG001|Overall Study|Withdrawal by Subject|2|||
155382822|NCT03519971|560835418|FG000|Overall Study|Other|1|||
155382823|NCT03519971|560835419|FG001|Overall Study|Other|0|||
155382824|NCT03141905|560835420|FG000|Overall Study|Death|3|||
155382825|NCT03141905|560835421|FG001|Overall Study|Death|2|||
155382826|NCT03141905|560835420|FG000|Overall Study|Withdrawal by Subject|1|||
155382827|NCT03141905|560835421|FG001|Overall Study|Withdrawal by Subject|0|||
155382828|NCT03141905|560835420|FG000|Overall Study|Lost to Follow-up|3|||
155382829|NCT03141905|560835421|FG001|Overall Study|Lost to Follow-up|7|||
155382830|NCT03141905|560835420|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
155382831|NCT03141905|560835421|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
155382832|NCT05180500|560835422|FG000|Overall Study|Adverse Event|1|||
155382833|NCT05180500|560835423|FG001|Overall Study|Adverse Event|0|||
155382834|NCT05180500|560835422|FG000|Overall Study|Withdrawal by Subject|2|||
155382835|NCT05180500|560835423|FG001|Overall Study|Withdrawal by Subject|0|||
155382836|NCT04134845|560835428|FG000|Overall Study|withdrawl by PI|12|||
155382837|NCT04134845|560835429|FG001|Overall Study|withdrawl by PI|5|||
155382838|NCT04927884|560835430|FG000|Overall Study|Progressive Disease|2|||
155382839|NCT01775124|560835431|FG000|Core Period|Disease Progression|0|||
155382840|NCT01775124|560835432|FG001|Core Period|Disease Progression|1|||
155382841|NCT01775124|560835431|FG000|Core Period|Physician Decision|1|||
155382842|NCT01775124|560835432|FG001|Core Period|Physician Decision|1|||
155382843|NCT01775124|560835431|FG000|Core Period|Death|0|||
155382844|NCT01775124|560835432|FG001|Core Period|Death|1|||
155382845|NCT01775124|560835431|FG000|Core Period|Administrative problems|1|||
155382846|NCT01775124|560835432|FG001|Core Period|Administrative problems|0|||
155382847|NCT01775124|560835431|FG000|Core Period|Withdrawal by Subject|4|||
155382848|NCT01775124|560835432|FG001|Core Period|Withdrawal by Subject|2|||
155382849|NCT01775124|560835431|FG000|Core Period|Adverse Event|5|||
155382850|NCT01775124|560835432|FG001|Core Period|Adverse Event|5|||
155382851|NCT01775124|560835431|FG000|Extension Period|Adverse Event|3|||
155382852|NCT01775124|560835432|FG001|Extension Period|Adverse Event|2|||
155382853|NCT01775124|560835431|FG000|Extension Period|Physician Decision|0|||
155382854|NCT01775124|560835432|FG001|Extension Period|Physician Decision|2|||
155382855|NCT01775124|560835431|FG000|Extension Period|Administrative problems|0|||
155382856|NCT01775124|560835432|FG001|Extension Period|Administrative problems|1|||
155382857|NCT01775124|560835431|FG000|Extension Period|Lost to Follow-up|0|||
155382858|NCT01775124|560835432|FG001|Extension Period|Lost to Follow-up|1|||
155382859|NCT01775124|560835431|FG000|Extension Period|Withdrawal by Subject|9|||
155382860|NCT01775124|560835432|FG001|Extension Period|Withdrawal by Subject|12|||
155382861|NCT00727311|560835433|FG000|Overall Study|Did not receive drug|316|||
155382862|NCT00727311|560835433|FG000|Overall Study|Missing end of therapy data|205|||
154943122|NCT01579474|559217720|FG002|Overall Study|Adverse Event|2|||
154943123|NCT01579474|559217721|FG003|Overall Study|Adverse Event|0|||
154943124|NCT01579474|559217722|FG004|Overall Study|Adverse Event|0|||
154943125|NCT01579474|559217723|FG005|Overall Study|Adverse Event|1|||
154943126|NCT01579474|559217718|FG000|Overall Study|Lack of Efficacy|1|||
154943127|NCT01579474|559217719|FG001|Overall Study|Lack of Efficacy|0|||
154943128|NCT01579474|559217720|FG002|Overall Study|Lack of Efficacy|0|||
154943129|NCT01579474|559217721|FG003|Overall Study|Lack of Efficacy|0|||
154943130|NCT01579474|559217722|FG004|Overall Study|Lack of Efficacy|1|||
154943131|NCT01579474|559217723|FG005|Overall Study|Lack of Efficacy|0|||
154943132|NCT01579474|559217718|FG000|Overall Study|Withdrawal by Subject|1|||
154943133|NCT01579474|559217719|FG001|Overall Study|Withdrawal by Subject|0|||
154943134|NCT01579474|559217720|FG002|Overall Study|Withdrawal by Subject|0|||
154943135|NCT01579474|559217721|FG003|Overall Study|Withdrawal by Subject|0|||
154943136|NCT01579474|559217722|FG004|Overall Study|Withdrawal by Subject|0|||
154943137|NCT01579474|559217723|FG005|Overall Study|Withdrawal by Subject|0|||
155382863|NCT00727311|560835433|FG000|Overall Study|Adverse Event|58|||
155382864|NCT00727311|560835433|FG000|Overall Study|Lack of Efficacy|242|||
155382865|NCT00727311|560835433|FG000|Overall Study|Lost to Follow-up|73|||
155382866|NCT00727311|560835433|FG000|Overall Study|Withdrawal by Subject|77|||
155382867|NCT00727311|560835433|FG000|Overall Study|Other|97|||
155382868|NCT00727311|560835433|FG000|Overall Study|Multiple reasons|39|||
155382869|NCT03992846|560835434|FG000|Overall Study|Adverse Event|8|||
155382870|NCT03992846|560835435|FG001|Overall Study|Adverse Event|6|||
155382871|NCT03992846|560835436|FG002|Overall Study|Adverse Event|3|||
154943138|NCT02295774|559217725|FG000|Overall Study|Physician Decision|1|||
154943139|NCT02295774|559217725|FG000|Overall Study|Withdrawal by Subject|2|||
155382872|NCT03992846|560835434|FG000|Overall Study|Lost to Follow-up|0|||
155382873|NCT03992846|560835435|FG001|Overall Study|Lost to Follow-up|1|||
155382874|NCT03992846|560835436|FG002|Overall Study|Lost to Follow-up|1|||
155382875|NCT03992846|560835434|FG000|Overall Study|Pregnancy|2|||
155382876|NCT03992846|560835435|FG001|Overall Study|Pregnancy|0|||
155382877|NCT03992846|560835436|FG002|Overall Study|Pregnancy|1|||
155382878|NCT03992846|560835434|FG000|Overall Study|Protocol Violation|1|||
155382879|NCT03992846|560835435|FG001|Overall Study|Protocol Violation|2|||
155382880|NCT03992846|560835436|FG002|Overall Study|Protocol Violation|0|||
155382881|NCT03992846|560835434|FG000|Overall Study|Withdrawal by Subject|8|||
155382882|NCT03992846|560835435|FG001|Overall Study|Withdrawal by Subject|10|||
155382883|NCT03992846|560835436|FG002|Overall Study|Withdrawal by Subject|20|||
155382884|NCT03992846|560835434|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
155382885|NCT03992846|560835435|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
155382886|NCT03992846|560835436|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
155382887|NCT01177722|560837407|FG000|Overall Study|Serious Adverse Event|0|||
155382888|NCT01177722|560837408|FG001|Overall Study|Serious Adverse Event|0|||
155382889|NCT01177722|560837409|FG002|Overall Study|Serious Adverse Event|1|||
155382890|NCT01177722|560837410|FG003|Overall Study|Serious Adverse Event|0|||
155382891|NCT01177722|560837407|FG000|Overall Study|Protocol Violation|0|||
155382892|NCT01177722|560837408|FG001|Overall Study|Protocol Violation|0|||
155382893|NCT01177722|560837409|FG002|Overall Study|Protocol Violation|1|||
155382894|NCT01177722|560837410|FG003|Overall Study|Protocol Violation|0|||
155382895|NCT01177722|560837407|FG000|Overall Study|Lost to Follow-up|3|||
155382896|NCT01177722|560837408|FG001|Overall Study|Lost to Follow-up|4|||
155382897|NCT01177722|560837409|FG002|Overall Study|Lost to Follow-up|3|||
155382898|NCT01177722|560837410|FG003|Overall Study|Lost to Follow-up|1|||
155382899|NCT01177722|560837407|FG000|Overall Study|Withdrawal by Subject|10|||
155382900|NCT01177722|560837408|FG001|Overall Study|Withdrawal by Subject|6|||
155382901|NCT01177722|560837409|FG002|Overall Study|Withdrawal by Subject|4|||
155382902|NCT01177722|560837410|FG003|Overall Study|Withdrawal by Subject|6|||
155382903|NCT00484289|560837416|FG000|Long Term Phase|Adverse Event|1|||
155382904|NCT00484289|560837417|FG001|Long Term Phase|Adverse Event|17|||
155382905|NCT00484289|560837418|FG002|Long Term Phase|Adverse Event|5|||
155382906|NCT00484289|560837416|FG000|Long Term Phase|Withdrawal by Subject|0|||
155382907|NCT00484289|560837417|FG001|Long Term Phase|Withdrawal by Subject|7|||
155382908|NCT00484289|560837418|FG002|Long Term Phase|Withdrawal by Subject|6|||
155382909|NCT00484289|560837416|FG000|Long Term Phase|Inadequate response|2|||
155382910|NCT00484289|560837417|FG001|Long Term Phase|Inadequate response|7|||
155382911|NCT00484289|560837418|FG002|Long Term Phase|Inadequate response|4|||
155382912|NCT00484289|560837416|FG000|Long Term Phase|Other Reason|0|||
155382913|NCT00484289|560837417|FG001|Long Term Phase|Other Reason|5|||
155382914|NCT00484289|560837418|FG002|Long Term Phase|Other Reason|1|||
155382915|NCT00484289|560837416|FG000|Post Marketing Phase|Adverse Event|0|||
155382916|NCT00484289|560837417|FG001|Post Marketing Phase|Adverse Event|1|||
155382917|NCT00484289|560837418|FG002|Post Marketing Phase|Adverse Event|0|||
155382918|NCT01828073|560837419|FG000|Overall Study|Lost to Follow-up|1|||
155382919|NCT01828073|560837420|FG001|Overall Study|Lost to Follow-up|2|||
155382920|NCT03057977|560837428|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
155382921|NCT03057977|560837429|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
155382922|NCT03057977|560837428|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
155382923|NCT03057977|560837429|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
155382924|NCT03057977|560837428|FG000|Discontinuation From Treatment|Protocol Violation|6|||
155382925|NCT03057977|560837429|FG001|Discontinuation From Treatment|Protocol Violation|5|||
155382926|NCT03057977|560837428|FG000|Discontinuation From Treatment|Not treated|4|||
155382927|NCT03057977|560837429|FG001|Discontinuation From Treatment|Not treated|0|||
155382928|NCT03057977|560837428|FG000|Discontinuation From Treatment|Adverse Event|343|||
155382929|NCT03057977|560837429|FG001|Discontinuation From Treatment|Adverse Event|337|||
155382930|NCT03057977|560837428|FG000|Discontinuation From Treatment|Reason Unknown|0|||
155382931|NCT03057977|560837429|FG001|Discontinuation From Treatment|Reason Unknown|1|||
155382932|NCT03057977|560837428|FG000|Discontinuation From Treatment|Personal Reasons|1|||
155382933|NCT03057977|560837429|FG001|Discontinuation From Treatment|Personal Reasons|1|||
155382934|NCT03057977|560837428|FG000|Discontinuation From Treatment|Unblinded medication|1|||
155382935|NCT03057977|560837429|FG001|Discontinuation From Treatment|Unblinded medication|0|||
155382936|NCT03057977|560837428|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
155382937|NCT03057977|560837429|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
155382938|NCT03057977|560837428|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
155382939|NCT03057977|560837429|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
155382940|NCT03057977|560837428|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
155382941|NCT03057977|560837429|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
155382942|NCT03057977|560837428|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
155382943|NCT03057977|560837429|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
155382944|NCT03057977|560837428|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
155382945|NCT03057977|560837429|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
155382946|NCT03057977|560837428|FG000|Discontinuation From Treatment|Not attending study visit|3|||
155382947|NCT03057977|560837429|FG001|Discontinuation From Treatment|Not attending study visit|10|||
155382948|NCT03057977|560837428|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
155382949|NCT03057977|560837429|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
155382950|NCT03057977|560837428|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
155382951|NCT03057977|560837429|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
155382952|NCT03057977|560837428|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
155382953|NCT03057977|560837429|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
155382954|NCT03057977|560837428|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
155382955|NCT03057977|560837429|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
155382956|NCT03057977|560837428|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
155382957|NCT03057977|560837429|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
155382958|NCT01201317|560837430|FG000|Overall Study|Withdrawal by Subject|5|||
155382959|NCT01201317|560837431|FG001|Overall Study|Withdrawal by Subject|0|||
155382960|NCT01201317|560837432|FG002|Overall Study|Withdrawal by Subject|3|||
155382961|NCT01201317|560837430|FG000|Overall Study|Adverse Event|2|||
155382962|NCT01201317|560837431|FG001|Overall Study|Adverse Event|2|||
155382963|NCT01201317|560837432|FG002|Overall Study|Adverse Event|2|||
155382964|NCT01201317|560837430|FG000|Overall Study|Screen failure|1|||
155382965|NCT01201317|560837431|FG001|Overall Study|Screen failure|1|||
155382966|NCT01201317|560837432|FG002|Overall Study|Screen failure|0|||
155382967|NCT01201317|560837430|FG000|Overall Study|Protocol Violation|0|||
155382968|NCT01201317|560837431|FG001|Overall Study|Protocol Violation|1|||
155382969|NCT01201317|560837432|FG002|Overall Study|Protocol Violation|1|||
155382970|NCT01201317|560837430|FG000|Overall Study|Death|0|||
155382971|NCT01201317|560837431|FG001|Overall Study|Death|1|||
155382972|NCT01201317|560837432|FG002|Overall Study|Death|0|||
155382973|NCT01201317|560837430|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155382974|NCT01201317|560837431|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155382975|NCT01201317|560837432|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155382976|NCT01201317|560837430|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
155382977|NCT01201317|560837431|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
155382978|NCT01201317|560837432|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
155382979|NCT01201317|560837430|FG000|Overall Study|Decrease in renal function|0|||
155382980|NCT01201317|560837431|FG001|Overall Study|Decrease in renal function|1|||
155382981|NCT01201317|560837432|FG002|Overall Study|Decrease in renal function|0|||
155382982|NCT01201317|560837430|FG000|Overall Study|Lack of Efficacy|1|||
155382983|NCT01201317|560837431|FG001|Overall Study|Lack of Efficacy|0|||
155382984|NCT01201317|560837432|FG002|Overall Study|Lack of Efficacy|0|||
155382985|NCT01201317|560837430|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
155382986|NCT01201317|560837431|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
155382987|NCT01201317|560837432|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
155382988|NCT01350336|560837433|FG000|Overall Study|Lost to Follow-up|31|||
155382989|NCT01350336|560837433|FG000|Overall Study|Withdrawal by Subject|14|||
155382990|NCT01350336|560837433|FG000|Overall Study|Physician Decision|8|||
155382991|NCT01350336|560837433|FG000|Overall Study|Death|4|||
155382992|NCT02795429|560837435|FG000|Overall Study|Adverse Event|1|||
155382993|NCT02795429|560837436|FG001|Overall Study|Adverse Event|2|||
155382994|NCT02795429|560837437|FG002|Overall Study|Adverse Event|1|||
155382995|NCT02795429|560837438|FG003|Overall Study|Adverse Event|2|||
155382996|NCT02795429|560837439|FG004|Overall Study|Adverse Event|1|||
155382997|NCT02795429|560837435|FG000|Overall Study|Death|1|||
155382998|NCT02795429|560837436|FG001|Overall Study|Death|0|||
155382999|NCT02795429|560837437|FG002|Overall Study|Death|1|||
155383000|NCT02795429|560837438|FG003|Overall Study|Death|2|||
155383001|NCT02795429|560837439|FG004|Overall Study|Death|1|||
155383002|NCT02795429|560837435|FG000|Overall Study|Physician Decision|0|||
154943140|NCT01075763|559217726|FG000|Overall Study|Lost to Follow-up|2|||
154943141|NCT01075763|559217727|FG001|Overall Study|Lost to Follow-up|1|||
154943142|NCT01075763|559217726|FG000|Overall Study|Lack of Efficacy|0|||
154943143|NCT01075763|559217727|FG001|Overall Study|Lack of Efficacy|1|||
154943144|NCT01075763|559217726|FG000|Overall Study|Withdrawal by Subject|2|||
154943145|NCT01075763|559217727|FG001|Overall Study|Withdrawal by Subject|2|||
154943146|NCT00586521|559217728|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
154943147|NCT03083483|559217729|FG000|Overall Study|Adverse Event|1|||
154943148|NCT03083483|559217730|FG001|Overall Study|Adverse Event|1|||
154943149|NCT03083483|559217731|FG002|Overall Study|Adverse Event|1|||
154943150|NCT03083483|559217729|FG000|Overall Study|Lost to Follow-up|2|||
154943151|NCT03083483|559217730|FG001|Overall Study|Lost to Follow-up|1|||
154943152|NCT03083483|559217731|FG002|Overall Study|Lost to Follow-up|1|||
155383003|NCT02795429|560837436|FG001|Overall Study|Physician Decision|0|||
154943153|NCT03083483|559217729|FG000|Overall Study|technological issues|1|||
154943154|NCT03083483|559217730|FG001|Overall Study|technological issues|0|||
154943155|NCT03083483|559217731|FG002|Overall Study|technological issues|1|||
155045441|NCT02328937|559599341|FG002|Period 1|Lost to Follow-up|0|||
155278724|NCT01656759|560453277|FG001|Overall Study|Protocol Violation|3|||
155045442|NCT02328937|559599342|FG003|Period 1|Lost to Follow-up|1|||
155045443|NCT02328937|559599343|FG004|Period 1|Lost to Follow-up|0|||
155045444|NCT02328937|559599344|FG005|Period 1|Lost to Follow-up|0|||
155045445|NCT02328937|559599339|FG000|Period 2|Adverse Event|0|||
155045446|NCT02328937|559599340|FG001|Period 2|Adverse Event|0|||
155045447|NCT02328937|559599341|FG002|Period 2|Adverse Event|1|||
155045448|NCT02328937|559599342|FG003|Period 2|Adverse Event|0|||
155045449|NCT02328937|559599343|FG004|Period 2|Adverse Event|0|||
155045450|NCT02328937|559599344|FG005|Period 2|Adverse Event|0|||
155045451|NCT00435461|559599345|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
155045452|NCT00435461|559599346|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
155045453|NCT00435461|559599347|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
155045454|NCT00435461|559599345|FG000|Overall Study|Protocol Violation|6|||
155045455|NCT00435461|559599346|FG001|Overall Study|Protocol Violation|9|||
155045456|NCT00435461|559599347|FG002|Overall Study|Protocol Violation|10|||
155045457|NCT00435461|559599345|FG000|Overall Study|Participant randomized(inadequate score)|1|||
155045458|NCT00435461|559599346|FG001|Overall Study|Participant randomized(inadequate score)|0|||
155045459|NCT00435461|559599347|FG002|Overall Study|Participant randomized(inadequate score)|0|||
155045460|NCT00435461|559599345|FG000|Overall Study|Compliance less than 80 percent|1|||
155045461|NCT00435461|559599346|FG001|Overall Study|Compliance less than 80 percent|0|||
155045462|NCT00435461|559599347|FG002|Overall Study|Compliance less than 80 percent|0|||
155045463|NCT00435461|559599345|FG000|Overall Study|In error, two study medications switched|1|||
155045464|NCT00435461|559599346|FG001|Overall Study|In error, two study medications switched|0|||
155045465|NCT00435461|559599347|FG002|Overall Study|In error, two study medications switched|0|||
155045466|NCT00435461|559599345|FG000|Overall Study|Lack of Efficacy|2|||
155045467|NCT00435461|559599346|FG001|Overall Study|Lack of Efficacy|1|||
155045468|NCT00435461|559599347|FG002|Overall Study|Lack of Efficacy|0|||
155045469|NCT00435461|559599345|FG000|Overall Study|Withdrawal by Subject|1|||
155045470|NCT00435461|559599346|FG001|Overall Study|Withdrawal by Subject|0|||
155278725|NCT07083843|560453278|FG000|Intervention period.|Withdrawal by Subject|1|||
155278726|NCT07083843|560453279|FG001|Intervention period.|Withdrawal by Subject|0|||
155278727|NCT07083843|560453278|FG000|Intervention period.|Death|0|||
155278728|NCT07083843|560453279|FG001|Intervention period.|Death|1|||
155278729|NCT04988477|560453282|FG000|Overall Study|Death|1|||
155278730|NCT04988477|560453283|FG001|Overall Study|Death|0|||
155278731|NCT04988477|560453284|FG002|Overall Study|Death|0|||
155278732|NCT04988477|560453282|FG000|Overall Study|Lost to Follow-up|5|||
155278733|NCT04988477|560453283|FG001|Overall Study|Lost to Follow-up|2|||
155278734|NCT04988477|560453284|FG002|Overall Study|Lost to Follow-up|0|||
155278735|NCT04988477|560453282|FG000|Overall Study|Withdrawal by Subject|2|||
155278736|NCT04988477|560453283|FG001|Overall Study|Withdrawal by Subject|0|||
155278737|NCT04988477|560453284|FG002|Overall Study|Withdrawal by Subject|0|||
155278738|NCT05567952|560454675|FG000|Overall Study|Lost to Follow-up|3|||
155278739|NCT05567952|560454676|FG001|Overall Study|Lost to Follow-up|2|||
155278740|NCT05567952|560454675|FG000|Overall Study|Withdrawal by Subject|6|||
155278741|NCT05567952|560454676|FG001|Overall Study|Withdrawal by Subject|3|||
155278742|NCT05567952|560454675|FG000|Overall Study|Other|3|||
155278743|NCT05567952|560454676|FG001|Overall Study|Other|1|||
155278744|NCT03280563|560454678|FG000|Stage 1|Death|2|||
155278745|NCT03280563|560454679|FG001|Stage 1|Death|1|||
155278746|NCT03280563|560454680|FG002|Stage 1|Death|0|||
155278747|NCT03280563|560454681|FG003|Stage 1|Death|0|||
155278748|NCT03280563|560454682|FG004|Stage 1|Death|0|||
155278749|NCT03280563|560454683|FG005|Stage 1|Death|3|||
155278750|NCT03280563|560454684|FG006|Stage 1|Death|0|||
155278751|NCT03280563|560454685|FG007|Stage 1|Death|0|||
155278752|NCT03280563|560454686|FG008|Stage 1|Death|0|||
155278753|NCT03280563|560454678|FG000|Stage 1|Study Ended by Sponsor|0|||
155278754|NCT03280563|560454679|FG001|Stage 1|Study Ended by Sponsor|0|||
155278755|NCT03280563|560454680|FG002|Stage 1|Study Ended by Sponsor|1|||
155278756|NCT03280563|560454681|FG003|Stage 1|Study Ended by Sponsor|0|||
155278757|NCT03280563|560454682|FG004|Stage 1|Study Ended by Sponsor|0|||
155278758|NCT03280563|560454683|FG005|Stage 1|Study Ended by Sponsor|1|||
155278759|NCT03280563|560454684|FG006|Stage 1|Study Ended by Sponsor|0|||
155278760|NCT03280563|560454685|FG007|Stage 1|Study Ended by Sponsor|0|||
155045471|NCT00435461|559599347|FG002|Overall Study|Withdrawal by Subject|2|||
155045472|NCT00435461|559599345|FG000|Overall Study|Randomized in error|1|||
155045473|NCT00435461|559599346|FG001|Overall Study|Randomized in error|0|||
155045474|NCT00435461|559599347|FG002|Overall Study|Randomized in error|0|||
155045475|NCT00435461|559599345|FG000|Overall Study|Participant could not tolerate symptoms|0|||
155045476|NCT00435461|559599346|FG001|Overall Study|Participant could not tolerate symptoms|0|||
155045477|NCT00435461|559599347|FG002|Overall Study|Participant could not tolerate symptoms|1|||
155045478|NCT00435461|559599345|FG000|Overall Study|Participant could not swallow capsule|0|||
155045479|NCT00435461|559599346|FG001|Overall Study|Participant could not swallow capsule|0|||
155278761|NCT03280563|560454686|FG008|Stage 1|Study Ended by Sponsor|0|||
155278762|NCT03280563|560454678|FG000|Stage 1|Withdrawal by Subject|5|||
155278763|NCT03280563|560454679|FG001|Stage 1|Withdrawal by Subject|1|||
155383004|NCT02795429|560837437|FG002|Overall Study|Physician Decision|2|||
155383005|NCT02795429|560837438|FG003|Overall Study|Physician Decision|1|||
155383006|NCT02795429|560837439|FG004|Overall Study|Physician Decision|5|||
155383007|NCT02795429|560837435|FG000|Overall Study|Progressive disease|3|||
155383008|NCT02795429|560837436|FG001|Overall Study|Progressive disease|7|||
155383009|NCT02795429|560837437|FG002|Overall Study|Progressive disease|6|||
155383010|NCT02795429|560837438|FG003|Overall Study|Progressive disease|26|||
155383011|NCT02795429|560837439|FG004|Overall Study|Progressive disease|20|||
155383012|NCT02795429|560837435|FG000|Overall Study|Subject/guardian decision|1|||
155383013|NCT02795429|560837436|FG001|Overall Study|Subject/guardian decision|1|||
155383014|NCT02795429|560837437|FG002|Overall Study|Subject/guardian decision|1|||
155383015|NCT02795429|560837438|FG003|Overall Study|Subject/guardian decision|1|||
155383016|NCT02795429|560837439|FG004|Overall Study|Subject/guardian decision|3|||
155383017|NCT02079610|560837440|FG000|Overall Study|Withdrawal by Subject|1|||
155383018|NCT02079610|560837441|FG001|Overall Study|Withdrawal by Subject|1|||
155383019|NCT05220254|560837442|FG000|Overall Study|Withdrawal by Subject|4|||
155383020|NCT05220254|560837442|FG000|Overall Study|Removed due to ineligibility|1|||
155383021|NCT05220254|560837442|FG000|Overall Study|Lost to Follow-up|7|||
155383022|NCT00250679|560837446|FG000|Overall Study|Adverse Event|12|||
155383023|NCT00250679|560837447|FG001|Overall Study|Adverse Event|15|||
155383024|NCT00250679|560837448|FG002|Overall Study|Adverse Event|16|||
155383025|NCT00250679|560837446|FG000|Overall Study|Protocol Violation|2|||
155383026|NCT00250679|560837447|FG001|Overall Study|Protocol Violation|4|||
155383027|NCT00250679|560837448|FG002|Overall Study|Protocol Violation|3|||
155383028|NCT00250679|560837446|FG000|Overall Study|Withdrawal by Subject|15|||
155383029|NCT00250679|560837447|FG001|Overall Study|Withdrawal by Subject|18|||
155383030|NCT00250679|560837448|FG002|Overall Study|Withdrawal by Subject|15|||
155383031|NCT00250679|560837446|FG000|Overall Study|Lost to Follow-up|3|||
155383032|NCT00250679|560837447|FG001|Overall Study|Lost to Follow-up|4|||
155383033|NCT00250679|560837448|FG002|Overall Study|Lost to Follow-up|2|||
155383034|NCT00250679|560837446|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
155383035|NCT00250679|560837447|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
155383036|NCT00250679|560837448|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
155383037|NCT00250679|560837446|FG000|Overall Study|Lack of Efficacy|0|||
154943156|NCT02710071|559217735|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
154943157|NCT02710071|559217736|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
154943158|NCT02710071|559217735|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
154943159|NCT02710071|559217736|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
154943160|NCT00449072|559217744|FG000|Overall Study|Adverse Event|3|||
154943161|NCT00449072|559217745|FG001|Overall Study|Adverse Event|1|||
154943162|NCT00449072|559217744|FG000|Overall Study|Protocol Violation|14|||
154943163|NCT00449072|559217745|FG001|Overall Study|Protocol Violation|12|||
154943164|NCT00449072|559217744|FG000|Overall Study|Lost to Follow-up|5|||
154943165|NCT00449072|559217745|FG001|Overall Study|Lost to Follow-up|7|||
154943166|NCT00449072|559217744|FG000|Overall Study|Withdrawal by Subject|11|||
154943167|NCT00449072|559217745|FG001|Overall Study|Withdrawal by Subject|8|||
154943168|NCT00449072|559217744|FG000|Overall Study|Lack of Efficacy|1|||
154943169|NCT00449072|559217745|FG001|Overall Study|Lack of Efficacy|1|||
154943170|NCT00449072|559217744|FG000|Overall Study|Physician Decision|1|||
154943171|NCT00449072|559217745|FG001|Overall Study|Physician Decision|0|||
154943172|NCT00449072|559217744|FG000|Overall Study|Not treated|0|||
154943173|NCT00449072|559217745|FG001|Overall Study|Not treated|1|||
154943174|NCT00449072|559217744|FG000|Overall Study|Excluded medication|0|||
154943175|NCT00449072|559217745|FG001|Overall Study|Excluded medication|2|||
154943176|NCT00449072|559217744|FG000|Overall Study|Non-compliance|2|||
154943177|NCT00449072|559217745|FG001|Overall Study|Non-compliance|5|||
154943178|NCT00449072|559217744|FG000|Overall Study|Sponsor decision|1|||
154943179|NCT00449072|559217745|FG001|Overall Study|Sponsor decision|3|||
154943180|NCT00449072|559217744|FG000|Overall Study|Relocation|3|||
154943181|NCT00449072|559217745|FG001|Overall Study|Relocation|2|||
154943182|NCT02623959|559217746|FG000|Overall Study|Progression|0|||
154943183|NCT02623959|559217747|FG001|Overall Study|Progression|1|||
154943184|NCT00989261|559217748|FG000|Overall Study|Still in follow up|12|||
154943185|NCT00989261|559217749|FG001|Overall Study|Still in follow up|21|||
154943186|NCT00989261|559217748|FG000|Overall Study|Withdrawal by Subject|0|||
154943187|NCT00989261|559217749|FG001|Overall Study|Withdrawal by Subject|1|||
155045480|NCT00435461|559599347|FG002|Overall Study|Participant could not swallow capsule|1|||
155383038|NCT00250679|560837447|FG001|Overall Study|Lack of Efficacy|1|||
155383039|NCT00250679|560837448|FG002|Overall Study|Lack of Efficacy|3|||
154943188|NCT00989261|559217748|FG000|Overall Study|Lost to Follow-up|3|||
154943189|NCT00989261|559217749|FG001|Overall Study|Lost to Follow-up|0|||
155383040|NCT00250679|560837446|FG000|Overall Study|Technical Holter issues|1|||
155383041|NCT00250679|560837447|FG001|Overall Study|Technical Holter issues|0|||
155383042|NCT00250679|560837448|FG002|Overall Study|Technical Holter issues|2|||
154943190|NCT01238848|559217750|FG000|Overall Study|Physician Decision|13|||
154943191|NCT01238848|559217751|FG001|Overall Study|Physician Decision|5|||
155383043|NCT00250679|560837446|FG000|Overall Study|Moved|1|||
155383044|NCT00250679|560837447|FG001|Overall Study|Moved|1|||
155383045|NCT00250679|560837448|FG002|Overall Study|Moved|0|||
154943192|NCT03222141|559217756|FG000|Overall Study|Death|15|||
154943193|NCT03222141|559217756|FG000|Overall Study|Lost to Follow-up|3|||
154943194|NCT00441584|559217759|FG000|Overall Study|Lack of Efficacy|79|||
154943195|NCT00441584|559217759|FG000|Overall Study|Withdrawal by Subject|8|||
154943196|NCT00441584|559217759|FG000|Overall Study|Adverse Event|6|||
154943197|NCT00441584|559217759|FG000|Overall Study|Protocol Violation|5|||
154943198|NCT00441584|559217759|FG000|Overall Study|Lost to Follow-up|4|||
154943199|NCT00441584|559217759|FG000|Overall Study|Failure to meet eligibility criteria|3|||
154943200|NCT00619619|559217762|FG000|Overall Study|Physician Decision|0|||
154943201|NCT00619619|559217763|FG001|Overall Study|Physician Decision|0|||
154943202|NCT00619619|559217764|FG002|Overall Study|Physician Decision|1|||
154943203|NCT00619619|559217765|FG003|Overall Study|Physician Decision|0|||
154943204|NCT00619619|559217766|FG004|Overall Study|Physician Decision|0|||
154943205|NCT00619619|559217767|FG005|Overall Study|Physician Decision|0|||
154943206|NCT00619619|559217768|FG006|Overall Study|Physician Decision|0|||
154943207|NCT00619619|559217769|FG007|Overall Study|Physician Decision|0|||
154943208|NCT00619619|559217762|FG000|Overall Study|Protocol Violation|0|||
154943209|NCT00619619|559217763|FG001|Overall Study|Protocol Violation|0|||
154943210|NCT00619619|559217764|FG002|Overall Study|Protocol Violation|0|||
154943211|NCT00619619|559217765|FG003|Overall Study|Protocol Violation|1|||
154943212|NCT00619619|559217766|FG004|Overall Study|Protocol Violation|0|||
154943213|NCT00619619|559217767|FG005|Overall Study|Protocol Violation|0|||
154943214|NCT00619619|559217768|FG006|Overall Study|Protocol Violation|1|||
154943215|NCT00619619|559217769|FG007|Overall Study|Protocol Violation|1|||
154943216|NCT00619619|559217762|FG000|Overall Study|Adverse Event|0|||
154943217|NCT00619619|559217763|FG001|Overall Study|Adverse Event|0|||
154943218|NCT00619619|559217764|FG002|Overall Study|Adverse Event|0|||
154943219|NCT00619619|559217765|FG003|Overall Study|Adverse Event|0|||
154943220|NCT00619619|559217766|FG004|Overall Study|Adverse Event|2|||
154943221|NCT00619619|559217767|FG005|Overall Study|Adverse Event|0|||
154943222|NCT00619619|559217768|FG006|Overall Study|Adverse Event|0|||
154943223|NCT00619619|559217769|FG007|Overall Study|Adverse Event|2|||
154943224|NCT00952484|559217770|FG000|Overall Study|Withdrawal by Subject|0|||
154943225|NCT00952484|559217771|FG001|Overall Study|Withdrawal by Subject|1|||
154943226|NCT00952484|559217772|FG002|Overall Study|Withdrawal by Subject|0|||
154943227|NCT00696709|559217778|FG000|Overall Study|Withdrawal by Subject|1|||
154943228|NCT00696709|559217779|FG001|Overall Study|Withdrawal by Subject|2|||
154943229|NCT00696709|559217780|FG002|Overall Study|Withdrawal by Subject|1|||
154943230|NCT00696709|559217781|FG003|Overall Study|Withdrawal by Subject|4|||
154943231|NCT00696709|559217782|FG004|Overall Study|Withdrawal by Subject|3|||
154943232|NCT00696709|559217778|FG000|Overall Study|Protocol Violation|1|||
154943233|NCT00696709|559217779|FG001|Overall Study|Protocol Violation|0|||
154943234|NCT00696709|559217780|FG002|Overall Study|Protocol Violation|0|||
154943235|NCT00696709|559217781|FG003|Overall Study|Protocol Violation|0|||
154943236|NCT00696709|559217782|FG004|Overall Study|Protocol Violation|0|||
155278764|NCT03280563|560454680|FG002|Stage 1|Withdrawal by Subject|2|||
155278765|NCT03280563|560454681|FG003|Stage 1|Withdrawal by Subject|0|||
155278766|NCT03280563|560454682|FG004|Stage 1|Withdrawal by Subject|0|||
155278767|NCT03280563|560454683|FG005|Stage 1|Withdrawal by Subject|2|||
155278768|NCT03280563|560454684|FG006|Stage 1|Withdrawal by Subject|0|||
155278769|NCT03280563|560454685|FG007|Stage 1|Withdrawal by Subject|0|||
155278770|NCT03280563|560454686|FG008|Stage 1|Withdrawal by Subject|0|||
155278771|NCT03280563|560454678|FG000|Stage 1|Reason Not Specified|0|||
155278772|NCT03280563|560454679|FG001|Stage 1|Reason Not Specified|0|||
155278773|NCT03280563|560454680|FG002|Stage 1|Reason Not Specified|0|||
155278774|NCT03280563|560454681|FG003|Stage 1|Reason Not Specified|0|||
155278775|NCT03280563|560454682|FG004|Stage 1|Reason Not Specified|0|||
155278776|NCT03280563|560454683|FG005|Stage 1|Reason Not Specified|1|||
155278777|NCT03280563|560454684|FG006|Stage 1|Reason Not Specified|0|||
155278778|NCT03280563|560454685|FG007|Stage 1|Reason Not Specified|0|||
155278779|NCT03280563|560454686|FG008|Stage 1|Reason Not Specified|0|||
155278780|NCT03280563|560454678|FG000|Stage 1|Physician Decision|0|||
155278781|NCT03280563|560454679|FG001|Stage 1|Physician Decision|1|||
155278782|NCT03280563|560454680|FG002|Stage 1|Physician Decision|0|||
155278783|NCT03280563|560454681|FG003|Stage 1|Physician Decision|0|||
155278784|NCT03280563|560454682|FG004|Stage 1|Physician Decision|0|||
155278785|NCT03280563|560454683|FG005|Stage 1|Physician Decision|0|||
154943237|NCT00696709|559217778|FG000|Overall Study|Lost to Follow-up|1|||
154943238|NCT00696709|559217779|FG001|Overall Study|Lost to Follow-up|1|||
154943239|NCT00696709|559217780|FG002|Overall Study|Lost to Follow-up|0|||
155278786|NCT03280563|560454684|FG006|Stage 1|Physician Decision|0|||
155278787|NCT03280563|560454685|FG007|Stage 1|Physician Decision|0|||
155278788|NCT03280563|560454686|FG008|Stage 1|Physician Decision|0|||
155278789|NCT03280563|560454678|FG000|Stage 2|Death|0|||
155278790|NCT03280563|560454679|FG001|Stage 2|Death|0|||
155278791|NCT03280563|560454680|FG002|Stage 2|Death|0|||
155278792|NCT03280563|560454681|FG003|Stage 2|Death|0|||
155278793|NCT03280563|560454682|FG004|Stage 2|Death|0|||
154943240|NCT00696709|559217781|FG003|Overall Study|Lost to Follow-up|0|||
155278794|NCT03280563|560454683|FG005|Stage 2|Death|0|||
155278795|NCT03280563|560454684|FG006|Stage 2|Death|0|||
155278796|NCT03280563|560454685|FG007|Stage 2|Death|1|||
155045481|NCT00435461|559599345|FG000|Overall Study|Pregnancy|2|||
155045482|NCT00435461|559599346|FG001|Overall Study|Pregnancy|0|||
155045483|NCT00435461|559599347|FG002|Overall Study|Pregnancy|0|||
155045484|NCT00435461|559599345|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
155045485|NCT00435461|559599346|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
155045486|NCT00435461|559599347|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
155045487|NCT00435461|559599345|FG000|Overall Study|Participant ended study one day early|1|||
155045488|NCT00435461|559599346|FG001|Overall Study|Participant ended study one day early|0|||
155045489|NCT00435461|559599347|FG002|Overall Study|Participant ended study one day early|0|||
155045490|NCT00435461|559599345|FG000|Overall Study|Noncompliance with study requirements|1|||
155045491|NCT00435461|559599346|FG001|Overall Study|Noncompliance with study requirements|1|||
155045492|NCT00435461|559599347|FG002|Overall Study|Noncompliance with study requirements|1|||
155045493|NCT00435461|559599345|FG000|Overall Study|Adverse Event|1|||
155045494|NCT00435461|559599346|FG001|Overall Study|Adverse Event|2|||
155045495|NCT00435461|559599347|FG002|Overall Study|Adverse Event|6|||
155045496|NCT00435461|559599345|FG000|Overall Study|Non-Compliance of diary|2|||
155045497|NCT00435461|559599346|FG001|Overall Study|Non-Compliance of diary|0|||
155045498|NCT00435461|559599347|FG002|Overall Study|Non-Compliance of diary|1|||
155045499|NCT00435461|559599345|FG000|Overall Study|Lost to Follow-up|1|||
155045500|NCT00435461|559599346|FG001|Overall Study|Lost to Follow-up|1|||
155045501|NCT00435461|559599347|FG002|Overall Study|Lost to Follow-up|2|||
155045502|NCT01768559|559599348|FG000|Overall Study|Randomized but not treated|0|||
155278797|NCT03280563|560454686|FG008|Stage 2|Death|0|||
155278798|NCT03280563|560454678|FG000|Stage 2|Progressive Disease|0|||
155278799|NCT03280563|560454679|FG001|Stage 2|Progressive Disease|0|||
155278800|NCT03280563|560454680|FG002|Stage 2|Progressive Disease|0|||
155278801|NCT03280563|560454681|FG003|Stage 2|Progressive Disease|0|||
155278802|NCT03280563|560454682|FG004|Stage 2|Progressive Disease|0|||
155383046|NCT00250679|560837446|FG000|Overall Study|Non-compliance|1|||
155045503|NCT01768559|559599349|FG001|Overall Study|Randomized but not treated|0|||
155045504|NCT01768559|559599350|FG002|Overall Study|Randomized but not treated|1|||
155045505|NCT01768559|559599348|FG000|Overall Study|Adverse Event|15|||
155045506|NCT01768559|559599349|FG001|Overall Study|Adverse Event|2|||
155045507|NCT01768559|559599350|FG002|Overall Study|Adverse Event|5|||
155045508|NCT01768559|559599348|FG000|Overall Study|Lack of Efficacy|6|||
155045509|NCT01768559|559599349|FG001|Overall Study|Lack of Efficacy|4|||
155045510|NCT01768559|559599350|FG002|Overall Study|Lack of Efficacy|0|||
155045511|NCT01768559|559599348|FG000|Overall Study|Poor compliance to protocol|0|||
155045512|NCT01768559|559599349|FG001|Overall Study|Poor compliance to protocol|3|||
155045513|NCT01768559|559599350|FG002|Overall Study|Poor compliance to protocol|2|||
155045514|NCT01768559|559599348|FG000|Overall Study|Other than specified|9|||
155045515|NCT01768559|559599349|FG001|Overall Study|Other than specified|8|||
155045516|NCT01768559|559599350|FG002|Overall Study|Other than specified|5|||
155045517|NCT00685360|559599353|FG000|Overall Study|Lost to Follow-up|0|||
155045518|NCT00685360|559599354|FG001|Overall Study|Lost to Follow-up|1|||
155045519|NCT00685360|559599355|FG002|Overall Study|Lost to Follow-up|2|||
155045520|NCT00685360|559599353|FG000|Overall Study|Adverse Event|4|||
155045521|NCT00685360|559599354|FG001|Overall Study|Adverse Event|6|||
155045522|NCT00685360|559599355|FG002|Overall Study|Adverse Event|4|||
155045523|NCT00685360|559599353|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
155045524|NCT00685360|559599354|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
155045525|NCT00685360|559599355|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
155045526|NCT00685360|559599353|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
155045527|NCT00685360|559599354|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
155045528|NCT00685360|559599355|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
155045529|NCT00685360|559599353|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
155045530|NCT00685360|559599354|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
155045531|NCT00685360|559599355|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
155045532|NCT00685360|559599353|FG000|Overall Study|Protocol Deviation|0|||
155045533|NCT00685360|559599354|FG001|Overall Study|Protocol Deviation|1|||
155045534|NCT00685360|559599355|FG002|Overall Study|Protocol Deviation|1|||
155045535|NCT00547157|559599364|FG000|Overall Study|Other|1|||
155045536|NCT00547157|559599365|FG001|Overall Study|Other|0|||
155045537|NCT00547157|559599364|FG000|Overall Study|Death|38|||
155278803|NCT03280563|560454683|FG005|Stage 2|Progressive Disease|0|||
155278804|NCT03280563|560454684|FG006|Stage 2|Progressive Disease|2|||
155045538|NCT00547157|559599365|FG001|Overall Study|Death|18|||
155045539|NCT00547157|559599364|FG000|Overall Study|Withdrawal by Subject|3|||
155045540|NCT00547157|559599365|FG001|Overall Study|Withdrawal by Subject|1|||
155045541|NCT00547157|559599364|FG000|Overall Study|Administrative decision|3|||
155045542|NCT00547157|559599365|FG001|Overall Study|Administrative decision|2|||
155045543|NCT00547157|559599364|FG000|Overall Study|Lost to Follow-up|4|||
155045544|NCT00547157|559599365|FG001|Overall Study|Lost to Follow-up|2|||
155045545|NCT01151345|559599368|FG000|First Intervention Period|Protocol Violation|0|||
155278805|NCT03280563|560454685|FG007|Stage 2|Progressive Disease|0|||
155045546|NCT01151345|559599369|FG001|First Intervention Period|Protocol Violation|1|||
155045547|NCT01765569|559599370|FG000|Period B|Withdrawal by Subject|1|||
155045548|NCT01765569|559599370|FG000|Period C|Death|1|||
155045549|NCT01030718|559599371|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
155383047|NCT00250679|560837447|FG001|Overall Study|Non-compliance|1|||
155383048|NCT00250679|560837448|FG002|Overall Study|Non-compliance|0|||
155045550|NCT01030718|559599372|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
155045551|NCT01030718|559599373|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
155045552|NCT01030718|559599371|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
155045553|NCT01030718|559599372|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
155045554|NCT01030718|559599373|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
155045555|NCT01030718|559599371|FG000|Studies CA180-031 and -036 Combined|Death|0|||
155278806|NCT03280563|560454686|FG008|Stage 2|Progressive Disease|0|||
155278807|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Death|10|||
155278808|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Death|14|||
155278809|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Death|15|||
155278810|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Death|3|||
155278811|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Death|6|||
155278812|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Death|18|||
155278813|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Death|11|||
155278814|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Death|1|||
155278815|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Death|3|||
155278816|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
155278817|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
155278818|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
155278819|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278820|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278821|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
155278822|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278823|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
155278824|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
155278825|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278826|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278827|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278828|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278829|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
155278830|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278831|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278832|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278833|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
155278834|NCT03280563|560454678|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278835|NCT03280563|560454679|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
155278836|NCT03280563|560454680|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
155278837|NCT03280563|560454681|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278838|NCT03280563|560454682|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
155278839|NCT03280563|560454683|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
155278840|NCT03280563|560454684|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278841|NCT03280563|560454685|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278842|NCT03280563|560454686|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
155278843|NCT02065245|560454687|FG000|Infusion 1|Lost to Follow-up|0|||
155278844|NCT02065245|560454688|FG001|Infusion 1|Lost to Follow-up|0|||
155278845|NCT02065245|560454689|FG002|Infusion 1|Lost to Follow-up|0|||
155278846|NCT02065245|560454690|FG003|Infusion 1|Lost to Follow-up|0|||
155278847|NCT02065245|560454691|FG004|Infusion 1|Lost to Follow-up|0|||
155278848|NCT02065245|560454692|FG005|Infusion 1|Lost to Follow-up|0|||
155278849|NCT02065245|560454693|FG006|Infusion 1|Lost to Follow-up|1|||
155278850|NCT02065245|560454687|FG000|Infusion 1|Death|0|||
155278851|NCT02065245|560454688|FG001|Infusion 1|Death|0|||
155278852|NCT02065245|560454689|FG002|Infusion 1|Death|1|||
155278853|NCT02065245|560454690|FG003|Infusion 1|Death|0|||
155278854|NCT02065245|560454691|FG004|Infusion 1|Death|1|||
155278855|NCT02065245|560454692|FG005|Infusion 1|Death|0|||
155278856|NCT02065245|560454693|FG006|Infusion 1|Death|0|||
155278857|NCT02065245|560454687|FG000|Infusion 2|Death|0|||
155278858|NCT02065245|560454688|FG001|Infusion 2|Death|0|||
155278859|NCT02065245|560454689|FG002|Infusion 2|Death|0|||
155278860|NCT02065245|560454690|FG003|Infusion 2|Death|0|||
155278861|NCT02065245|560454691|FG004|Infusion 2|Death|0|||
155278862|NCT02065245|560454692|FG005|Infusion 2|Death|0|||
155278863|NCT02065245|560454693|FG006|Infusion 2|Death|1|||
155278864|NCT02065245|560454687|FG000|Infusion 3|Lost to Follow-up|1|||
155278865|NCT02065245|560454688|FG001|Infusion 3|Lost to Follow-up|1|||
155278866|NCT02065245|560454689|FG002|Infusion 3|Lost to Follow-up|0|||
155278867|NCT02065245|560454690|FG003|Infusion 3|Lost to Follow-up|0|||
155278868|NCT02065245|560454691|FG004|Infusion 3|Lost to Follow-up|0|||
155045556|NCT01030718|559599372|FG001|Studies CA180-031 and -036 Combined|Death|1|||
155045557|NCT01030718|559599373|FG002|Studies CA180-031 and -036 Combined|Death|0|||
155045558|NCT01030718|559599371|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
154943241|NCT00696709|559217782|FG004|Overall Study|Lost to Follow-up|0|||
154943242|NCT00696709|559217778|FG000|Overall Study|Adverse Event|0|||
154943243|NCT00696709|559217779|FG001|Overall Study|Adverse Event|0|||
154943244|NCT00696709|559217780|FG002|Overall Study|Adverse Event|0|||
154943245|NCT00696709|559217781|FG003|Overall Study|Adverse Event|1|||
154943246|NCT00696709|559217782|FG004|Overall Study|Adverse Event|0|||
154943247|NCT00321711|559217786|FG000|Part A|Adverse Event|3|||
154943248|NCT00321711|559217787|FG001|Part A|Adverse Event|3|||
154943249|NCT00321711|559217788|FG002|Part A|Adverse Event|2|||
154943250|NCT00321711|559217789|FG003|Part A|Adverse Event|0|||
154943251|NCT00321711|559217790|FG004|Part A|Adverse Event|0|||
154943252|NCT00321711|559217786|FG000|Part A|Withdrawal by Subject|1|||
154943253|NCT00321711|559217787|FG001|Part A|Withdrawal by Subject|1|||
154943254|NCT00321711|559217788|FG002|Part A|Withdrawal by Subject|1|||
154943255|NCT00321711|559217789|FG003|Part A|Withdrawal by Subject|0|||
154943256|NCT00321711|559217790|FG004|Part A|Withdrawal by Subject|0|||
154943257|NCT00321711|559217786|FG000|Part A|Disease progression|0|||
154943258|NCT00321711|559217787|FG001|Part A|Disease progression|1|||
154943259|NCT00321711|559217788|FG002|Part A|Disease progression|0|||
154943260|NCT00321711|559217789|FG003|Part A|Disease progression|0|||
154943261|NCT00321711|559217790|FG004|Part A|Disease progression|0|||
154943262|NCT00321711|559217786|FG000|Part A|Requirement for alternative therapy|0|||
154943263|NCT00321711|559217787|FG001|Part A|Requirement for alternative therapy|2|||
154943264|NCT00321711|559217788|FG002|Part A|Requirement for alternative therapy|1|||
154943265|NCT00321711|559217789|FG003|Part A|Requirement for alternative therapy|0|||
154943266|NCT00321711|559217790|FG004|Part A|Requirement for alternative therapy|0|||
154943267|NCT00321711|559217786|FG000|Part A|Physician Decision|0|||
154943268|NCT00321711|559217787|FG001|Part A|Physician Decision|1|||
154943269|NCT00321711|559217788|FG002|Part A|Physician Decision|3|||
154943270|NCT00321711|559217789|FG003|Part A|Physician Decision|0|||
154943271|NCT00321711|559217790|FG004|Part A|Physician Decision|0|||
154943272|NCT00321711|559217786|FG000|Part A|Other|1|||
154943273|NCT00321711|559217787|FG001|Part A|Other|2|||
154943274|NCT00321711|559217788|FG002|Part A|Other|3|||
154943275|NCT00321711|559217789|FG003|Part A|Other|0|||
154943276|NCT00321711|559217790|FG004|Part A|Other|0|||
154943277|NCT00321711|559217786|FG000|Part A|Protocol deviation|0|||
154943278|NCT00321711|559217787|FG001|Part A|Protocol deviation|0|||
154943279|NCT00321711|559217788|FG002|Part A|Protocol deviation|1|||
154943280|NCT00321711|559217789|FG003|Part A|Protocol deviation|0|||
154943281|NCT00321711|559217790|FG004|Part A|Protocol deviation|0|||
154943282|NCT00321711|559217786|FG000|Part B|Noncompliance|0|||
155278869|NCT02065245|560454692|FG005|Infusion 3|Lost to Follow-up|0|||
155278870|NCT02065245|560454693|FG006|Infusion 3|Lost to Follow-up|0|||
155278871|NCT03531905|560454694|FG000|Overall Study|Withdrawal by Subject|3|||
155278872|NCT03531905|560454695|FG001|Overall Study|Withdrawal by Subject|3|||
155278873|NCT03531905|560454696|FG002|Overall Study|Withdrawal by Subject|2|||
155278874|NCT03531905|560454694|FG000|Overall Study|Lost to Follow-up|2|||
155278875|NCT03531905|560454695|FG001|Overall Study|Lost to Follow-up|2|||
155278876|NCT03531905|560454696|FG002|Overall Study|Lost to Follow-up|1|||
155278877|NCT03531905|560454694|FG000|Overall Study|Participant was out of town|1|||
155278878|NCT03531905|560454695|FG001|Overall Study|Participant was out of town|0|||
155278879|NCT03531905|560454696|FG002|Overall Study|Participant was out of town|0|||
155278880|NCT03531905|560454694|FG000|Overall Study|Could not speak with the participant|1|||
155278881|NCT03531905|560454695|FG001|Overall Study|Could not speak with the participant|0|||
155278882|NCT03531905|560454696|FG002|Overall Study|Could not speak with the participant|0|||
155278883|NCT03303105|560454701|FG000|Overall Study|Adverse Event|0|||
155278884|NCT03303105|560454702|FG001|Overall Study|Adverse Event|2|||
155278885|NCT03303105|560454701|FG000|Overall Study|Lack of Efficacy|1|||
155278886|NCT03303105|560454702|FG001|Overall Study|Lack of Efficacy|0|||
155278887|NCT03303105|560454701|FG000|Overall Study|Protocol Violation|1|||
155278888|NCT03303105|560454702|FG001|Overall Study|Protocol Violation|0|||
155278889|NCT03303105|560454701|FG000|Overall Study|Withdrawal by Subject|0|||
154943283|NCT00321711|559217787|FG001|Part B|Noncompliance|0|||
155045559|NCT01030718|559599372|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
155045560|NCT01030718|559599373|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
154943284|NCT00321711|559217788|FG002|Part B|Noncompliance|0|||
154943285|NCT00321711|559217789|FG003|Part B|Noncompliance|0|||
154943286|NCT00321711|559217790|FG004|Part B|Noncompliance|1|||
154943287|NCT00321711|559217786|FG000|Part B|Adverse Event|0|||
154943288|NCT00321711|559217787|FG001|Part B|Adverse Event|0|||
155278890|NCT03303105|560454702|FG001|Overall Study|Withdrawal by Subject|2|||
155278891|NCT03527277|560454705|FG000|Overall Study|Withdrawal by Subject|5|||
155278892|NCT03527277|560454706|FG001|Overall Study|Withdrawal by Subject|0|||
155383049|NCT00250679|560837446|FG000|Overall Study|various single events: hip surgery,diary|3|||
154943289|NCT00321711|559217788|FG002|Part B|Adverse Event|0|||
154943290|NCT00321711|559217789|FG003|Part B|Adverse Event|2|||
154943291|NCT00321711|559217790|FG004|Part B|Adverse Event|1|||
155045561|NCT01030718|559599371|FG000|Study CA180-036 Only|insufficient effect|1|||
155383050|NCT00250679|560837447|FG001|Overall Study|various single events: hip surgery,diary|1|||
155383051|NCT00250679|560837448|FG002|Overall Study|various single events: hip surgery,diary|1|||
155383052|NCT00448279|560837450|FG000|Overall Study|Lost to Follow-up|2|||
155383053|NCT00448279|560837451|FG001|Overall Study|Lost to Follow-up|2|||
155383054|NCT00448279|560837450|FG000|Overall Study|Adverse Event|1|||
155383055|NCT00448279|560837451|FG001|Overall Study|Adverse Event|1|||
155383056|NCT00448279|560837450|FG000|Overall Study|Disease progression|16|||
155383057|NCT00448279|560837451|FG001|Overall Study|Disease progression|18|||
155383058|NCT00448279|560837450|FG000|Overall Study|Withdrawal by Subject|4|||
154943292|NCT00321711|559217786|FG000|Part B|Disease progression|0|||
154943293|NCT00321711|559217787|FG001|Part B|Disease progression|0|||
154943294|NCT00321711|559217788|FG002|Part B|Disease progression|0|||
154943295|NCT00321711|559217789|FG003|Part B|Disease progression|1|||
154943296|NCT00321711|559217790|FG004|Part B|Disease progression|0|||
154943297|NCT00321711|559217786|FG000|Part B|Physician Decision|0|||
154943298|NCT00321711|559217787|FG001|Part B|Physician Decision|0|||
154943299|NCT00321711|559217788|FG002|Part B|Physician Decision|0|||
154943300|NCT00321711|559217789|FG003|Part B|Physician Decision|1|||
154943301|NCT00321711|559217790|FG004|Part B|Physician Decision|2|||
154943302|NCT00321711|559217786|FG000|Part B|Death|0|||
154943303|NCT00321711|559217787|FG001|Part B|Death|0|||
154943304|NCT00321711|559217788|FG002|Part B|Death|0|||
154943305|NCT00321711|559217789|FG003|Part B|Death|2|||
154943306|NCT00321711|559217790|FG004|Part B|Death|1|||
154943307|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
154943308|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
154943309|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
154943310|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
154943311|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
154943312|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
154943313|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
154943314|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
154943315|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
154943316|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
154943317|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
154943318|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
154943319|NCT01227668|559217791|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
154943320|NCT01227668|559217792|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
154943321|NCT01227668|559217791|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
154943322|NCT01227668|559217792|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
154943323|NCT01227668|559217791|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
154943324|NCT01227668|559217792|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
154943325|NCT01227668|559217791|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
154943326|NCT01227668|559217792|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
154943327|NCT01227668|559217791|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
154943328|NCT01227668|559217792|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
154943329|NCT01227668|559217791|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
154943330|NCT01227668|559217792|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
154943331|NCT01261325|559217796|FG000|Overall Study|Lack of Efficacy|1|||
154943332|NCT01261325|559217797|FG001|Overall Study|Lack of Efficacy|1|||
154943333|NCT01261325|559217798|FG002|Overall Study|Lack of Efficacy|0|||
154943334|NCT01261325|559217796|FG000|Overall Study|Withdrawal by Subject|2|||
154943335|NCT01261325|559217797|FG001|Overall Study|Withdrawal by Subject|2|||
154943336|NCT01261325|559217798|FG002|Overall Study|Withdrawal by Subject|4|||
154943337|NCT01261325|559217796|FG000|Overall Study|SAE, non-fatal|1|||
154943338|NCT01261325|559217797|FG001|Overall Study|SAE, non-fatal|5|||
154943339|NCT01261325|559217798|FG002|Overall Study|SAE, non-fatal|1|||
154943340|NCT01261325|559217796|FG000|Overall Study|AE, non-serious non-fatal|9|||
154943341|NCT01261325|559217797|FG001|Overall Study|AE, non-serious non-fatal|15|||
154943342|NCT01261325|559217798|FG002|Overall Study|AE, non-serious non-fatal|13|||
154943343|NCT01261325|559217796|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
154943344|NCT01261325|559217797|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
154943345|NCT01261325|559217798|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
154943346|NCT01261325|559217796|FG000|Overall Study|Non Compliance|2|||
154943347|NCT01261325|559217797|FG001|Overall Study|Non Compliance|0|||
154943348|NCT01261325|559217798|FG002|Overall Study|Non Compliance|0|||
154943349|NCT01261325|559217796|FG000|Overall Study|Patient Randomized by Mistake|0|||
154943350|NCT01261325|559217797|FG001|Overall Study|Patient Randomized by Mistake|1|||
154943351|NCT01261325|559217798|FG002|Overall Study|Patient Randomized by Mistake|0|||
154943352|NCT01261325|559217796|FG000|Overall Study|Erroneously Randomized|1|||
155383059|NCT00448279|560837451|FG001|Overall Study|Withdrawal by Subject|3|||
154943353|NCT01261325|559217797|FG001|Overall Study|Erroneously Randomized|0|||
155383060|NCT00448279|560837450|FG000|Overall Study|Other|6|||
155383061|NCT00448279|560837451|FG001|Overall Study|Other|4|||
155383062|NCT00448279|560837450|FG000|Overall Study|Protocol Violation|0|||
155045562|NCT01030718|559599372|FG001|Study CA180-036 Only|insufficient effect|1|||
155045563|NCT01030718|559599373|FG002|Study CA180-036 Only|insufficient effect|5|||
155045564|NCT01030718|559599371|FG000|Study CA180-036 Only|Adverse Event|2|||
155045565|NCT01030718|559599372|FG001|Study CA180-036 Only|Adverse Event|3|||
155045566|NCT01030718|559599373|FG002|Study CA180-036 Only|Adverse Event|0|||
155045567|NCT01030718|559599371|FG000|Study CA180-036 Only|Death|0|||
155045568|NCT01030718|559599372|FG001|Study CA180-036 Only|Death|1|||
155045569|NCT01030718|559599373|FG002|Study CA180-036 Only|Death|0|||
155045570|NCT01030718|559599371|FG000|Study CA180-036 Only|Other Reasons|0|||
155045571|NCT01030718|559599372|FG001|Study CA180-036 Only|Other Reasons|2|||
155045572|NCT01030718|559599373|FG002|Study CA180-036 Only|Other Reasons|0|||
155045573|NCT00423813|559599374|FG000|Overall Study|Adverse Event|11|||
155045574|NCT00423813|559599375|FG001|Overall Study|Adverse Event|30|||
155045575|NCT00423813|559599376|FG002|Overall Study|Adverse Event|40|||
155045576|NCT00423813|559599374|FG000|Overall Study|Withdrawal by Subject|6|||
155045577|NCT00423813|559599375|FG001|Overall Study|Withdrawal by Subject|8|||
155045578|NCT00423813|559599376|FG002|Overall Study|Withdrawal by Subject|5|||
155045579|NCT00423813|559599374|FG000|Overall Study|Lost to Follow-up|5|||
155045580|NCT00423813|559599375|FG001|Overall Study|Lost to Follow-up|4|||
155045581|NCT00423813|559599376|FG002|Overall Study|Lost to Follow-up|4|||
155045582|NCT00423813|559599374|FG000|Overall Study|Lack of Efficacy|23|||
155045583|NCT00423813|559599375|FG001|Overall Study|Lack of Efficacy|18|||
155045584|NCT00423813|559599376|FG002|Overall Study|Lack of Efficacy|19|||
155045585|NCT00423813|559599374|FG000|Overall Study|Physician Decision|2|||
155045586|NCT00423813|559599375|FG001|Overall Study|Physician Decision|0|||
155045587|NCT00423813|559599376|FG002|Overall Study|Physician Decision|0|||
155045588|NCT00423813|559599374|FG000|Overall Study|Sponsor Decision|0|||
155045589|NCT00423813|559599375|FG001|Overall Study|Sponsor Decision|1|||
155045590|NCT00423813|559599376|FG002|Overall Study|Sponsor Decision|0|||
155278893|NCT03527277|560454705|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
155278894|NCT03527277|560454706|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
155278895|NCT03527277|560454705|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
155278896|NCT03527277|560454706|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
155278897|NCT01781611|560454707|FG000|Overall Study|Adverse Event|4|||
155278898|NCT01781611|560454708|FG001|Overall Study|Adverse Event|0|||
155278899|NCT01333943|560454709|FG000|Overall Study|Known neuropathy|1|||
155278900|NCT01333943|560454710|FG001|Overall Study|Known neuropathy|0|||
155278901|NCT02652130|560454717|FG000|Overall Study|Death|1|||
155278902|NCT02028884|560454718|FG000|Double-blind Period|Adverse Event|5|||
155278903|NCT02028884|560454719|FG001|Double-blind Period|Adverse Event|3|||
155278904|NCT02028884|560454720|FG002|Double-blind Period|Adverse Event|0|||
155278905|NCT02028884|560454718|FG000|Double-blind Period|Eligibility Violation|1|||
155278906|NCT02028884|560454719|FG001|Double-blind Period|Eligibility Violation|0|||
155278907|NCT02028884|560454720|FG002|Double-blind Period|Eligibility Violation|0|||
155278908|NCT02028884|560454718|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
155278909|NCT02028884|560454719|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
155278910|NCT02028884|560454720|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
155278911|NCT02028884|560454718|FG000|Double-blind Period|Withdrawal by Subject|2|||
155278912|NCT02028884|560454719|FG001|Double-blind Period|Withdrawal by Subject|0|||
155278913|NCT02028884|560454720|FG002|Double-blind Period|Withdrawal by Subject|0|||
155278914|NCT02028884|560454718|FG000|Open-label Extension Period|Adverse Event|3|||
155278915|NCT02028884|560454719|FG001|Open-label Extension Period|Adverse Event|1|||
155278916|NCT02028884|560454720|FG002|Open-label Extension Period|Adverse Event|0|||
155278917|NCT02028884|560454718|FG000|Open-label Extension Period|Lack of Efficacy|3|||
155278918|NCT02028884|560454719|FG001|Open-label Extension Period|Lack of Efficacy|0|||
155278919|NCT02028884|560454720|FG002|Open-label Extension Period|Lack of Efficacy|0|||
155278920|NCT02028884|560454718|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
155278921|NCT02028884|560454719|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
155278922|NCT02028884|560454720|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
155278923|NCT02028884|560454718|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155045591|NCT00423813|559599374|FG000|Overall Study|Protocol Violation|9|||
155045592|NCT00423813|559599375|FG001|Overall Study|Protocol Violation|4|||
155045593|NCT00423813|559599376|FG002|Overall Study|Protocol Violation|4|||
155045594|NCT00423813|559599374|FG000|Overall Study|Pregnancy|0|||
155278924|NCT02028884|560454719|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
155278925|NCT02028884|560454720|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
155278926|NCT02028884|560454718|FG000|Open-label Extension Period|Switched to another treatment option|3|||
155278927|NCT02028884|560454719|FG001|Open-label Extension Period|Switched to another treatment option|0|||
155045595|NCT00423813|559599375|FG001|Overall Study|Pregnancy|0|||
155045596|NCT00423813|559599376|FG002|Overall Study|Pregnancy|1|||
155045597|NCT00423813|559599374|FG000|Overall Study|Subject started night shift work|1|||
155045598|NCT00423813|559599375|FG001|Overall Study|Subject started night shift work|0|||
155045599|NCT00423813|559599376|FG002|Overall Study|Subject started night shift work|0|||
155045600|NCT00423813|559599374|FG000|Overall Study|Will start exclusionary medications|0|||
155383063|NCT00448279|560837451|FG001|Overall Study|Protocol Violation|1|||
155383064|NCT03907410|560837452|FG000|Overall Study|Lost to Follow-up|4|||
155383065|NCT03907410|560837453|FG001|Overall Study|Lost to Follow-up|1|||
155383066|NCT03907410|560837454|FG002|Overall Study|Lost to Follow-up|1|||
155383067|NCT03907410|560837452|FG000|Overall Study|Lost to follow-up and research burden|0|||
155383068|NCT03907410|560837453|FG001|Overall Study|Lost to follow-up and research burden|0|||
155383069|NCT03907410|560837454|FG002|Overall Study|Lost to follow-up and research burden|1|||
155383070|NCT01981473|560837455|FG000|Overall Study|Incorrect diagnosis of RA|0|||
155383071|NCT01981473|560837456|FG001|Overall Study|Incorrect diagnosis of RA|0|||
155383072|NCT01981473|560837457|FG002|Overall Study|Incorrect diagnosis of RA|1|||
155383073|NCT01981473|560837455|FG000|Overall Study|Received treatment for < 6 months|0|||
155383074|NCT01981473|560837456|FG001|Overall Study|Received treatment for < 6 months|0|||
155383075|NCT01981473|560837457|FG002|Overall Study|Received treatment for < 6 months|1|||
155383076|NCT01981473|560837455|FG000|Overall Study|Received treatment for >24 months|2|||
155383077|NCT01981473|560837456|FG001|Overall Study|Received treatment for >24 months|0|||
155383078|NCT01981473|560837457|FG002|Overall Study|Received treatment for >24 months|6|||
155383079|NCT04776148|560837458|FG000|Overall Study|Death|249|||
155383080|NCT04776148|560837459|FG001|Overall Study|Death|260|||
155383081|NCT04776148|560837458|FG000|Overall Study|Lost to Follow-up|0|||
155383082|NCT04776148|560837459|FG001|Overall Study|Lost to Follow-up|1|||
155383083|NCT04776148|560837458|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155383084|NCT04776148|560837459|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155383085|NCT04776148|560837458|FG000|Overall Study|Withdrawal by Subject|3|||
155383086|NCT04776148|560837459|FG001|Overall Study|Withdrawal by Subject|4|||
155383087|NCT04776148|560837458|FG000|Overall Study|Sponsor Decision|30|||
155383088|NCT04776148|560837459|FG001|Overall Study|Sponsor Decision|15|||
155383089|NCT00738582|560837460|FG000|Combination Therapy|Completed Combination Therapy|1|||
155383090|NCT00738582|560837461|FG001|Combination Therapy|Completed Combination Therapy|0|||
155383091|NCT00738582|560837460|FG000|Combination Therapy|Physician Decision|1|||
155383092|NCT00738582|560837461|FG001|Combination Therapy|Physician Decision|0|||
155383093|NCT00738582|560837460|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
155383094|NCT00738582|560837461|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
155383095|NCT00738582|560837460|FG000|Combination Therapy|Other|5|||
155383096|NCT00738582|560837461|FG001|Combination Therapy|Other|0|||
155383097|NCT00738582|560837460|FG000|Combination Therapy|Adverse Event|16|||
155383098|NCT00738582|560837461|FG001|Combination Therapy|Adverse Event|0|||
155383099|NCT00738582|560837460|FG000|Combination Therapy|Progressive Disease|9|||
155383100|NCT00738582|560837461|FG001|Combination Therapy|Progressive Disease|0|||
155383101|NCT00738582|560837460|FG000|Maintenance Therapy|Other|0|||
155383102|NCT00738582|560837461|FG001|Maintenance Therapy|Other|2|||
155383103|NCT00738582|560837460|FG000|Maintenance Therapy|Adverse Event|0|||
155383104|NCT00738582|560837461|FG001|Maintenance Therapy|Adverse Event|6|||
155383105|NCT00738582|560837460|FG000|Maintenance Therapy|Progressive Disease|0|||
155383106|NCT00738582|560837461|FG001|Maintenance Therapy|Progressive Disease|47|||
155383107|NCT00738582|560837460|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
155383108|NCT00738582|560837461|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
155383109|NCT02563522|560837462|FG000|Overall Study|Adverse Event|2|||
155383110|NCT02563522|560837463|FG001|Overall Study|Adverse Event|3|||
155383111|NCT02563522|560837462|FG000|Overall Study|Lost to Follow-up|1|||
155383112|NCT02563522|560837463|FG001|Overall Study|Lost to Follow-up|0|||
155383113|NCT02563522|560837462|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
155383114|NCT02563522|560837463|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
155383115|NCT01052103|560837464|FG000|Overall Study|Adverse Event|10|||
155383116|NCT01052103|560837465|FG001|Overall Study|Adverse Event|6|||
155383117|NCT01052103|560837464|FG000|Overall Study|Entry Criteria Not Met|3|||
155383118|NCT01052103|560837465|FG001|Overall Study|Entry Criteria Not Met|1|||
155383119|NCT01052103|560837464|FG000|Overall Study|Lost to Follow-up|3|||
155383120|NCT01052103|560837465|FG001|Overall Study|Lost to Follow-up|5|||
155383121|NCT01052103|560837464|FG000|Overall Study|Protocol Violation|10|||
155383122|NCT01052103|560837465|FG001|Overall Study|Protocol Violation|4|||
155383123|NCT01052103|560837464|FG000|Overall Study|Scheduling conflict|2|||
155383124|NCT01052103|560837465|FG001|Overall Study|Scheduling conflict|1|||
155383125|NCT01052103|560837464|FG000|Overall Study|Sponsor Decision|2|||
155383126|NCT01052103|560837465|FG001|Overall Study|Sponsor Decision|0|||
155383127|NCT01052103|560837464|FG000|Overall Study|Withdrawal by Subject|3|||
155383128|NCT01052103|560837465|FG001|Overall Study|Withdrawal by Subject|6|||
155045601|NCT00423813|559599375|FG001|Overall Study|Will start exclusionary medications|1|||
155383129|NCT01052103|560837464|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155383130|NCT01052103|560837465|FG001|Overall Study|Perceived Lack of Efficacy|0|||
155383131|NCT00799513|560837466|FG000|Overall Study|Physician Decision|1|||
155383132|NCT00799513|560837466|FG000|Overall Study|Adverse Event|1|||
155383133|NCT00666679|560837472|FG000|First Intervention|Lost to Follow-up|1|||
155383134|NCT00666679|560837473|FG001|First Intervention|Lost to Follow-up|0|||
155383135|NCT00666679|560837472|FG000|First Intervention|Protocol Violation|1|||
155045602|NCT00423813|559599376|FG002|Overall Study|Will start exclusionary medications|0|||
155383136|NCT00666679|560837473|FG001|First Intervention|Protocol Violation|0|||
154943354|NCT01261325|559217798|FG002|Overall Study|Erroneously Randomized|0|||
154943355|NCT01261325|559217796|FG000|Overall Study|Screen Failure|1|||
154943356|NCT01261325|559217797|FG001|Overall Study|Screen Failure|0|||
154943357|NCT01261325|559217798|FG002|Overall Study|Screen Failure|0|||
154943358|NCT01261325|559217796|FG000|Overall Study|Randomized in Error|0|||
154943359|NCT01261325|559217797|FG001|Overall Study|Randomized in Error|0|||
154943360|NCT01261325|559217798|FG002|Overall Study|Randomized in Error|1|||
154943361|NCT01261325|559217796|FG000|Overall Study|Protocol Violation|0|||
154943362|NCT01261325|559217797|FG001|Overall Study|Protocol Violation|3|||
154943363|NCT01261325|559217798|FG002|Overall Study|Protocol Violation|1|||
154943364|NCT01261325|559217796|FG000|Overall Study|Lost to Follow-up|0|||
154943365|NCT01261325|559217797|FG001|Overall Study|Lost to Follow-up|1|||
154943366|NCT01261325|559217798|FG002|Overall Study|Lost to Follow-up|3|||
154943367|NCT01261325|559217796|FG000|Overall Study|AE, serious fatal|0|||
154943368|NCT01261325|559217797|FG001|Overall Study|AE, serious fatal|0|||
154943369|NCT01261325|559217798|FG002|Overall Study|AE, serious fatal|2|||
154943370|NCT02330081|559217803|FG000|Overall Study|Adverse Event|1|||
154943371|NCT02330081|559217803|FG000|Overall Study|Donation did not meet criteria|1|||
154943372|NCT02330081|559217803|FG000|Overall Study|Protocol Violation|6|||
154943373|NCT02277769|559217804|FG000|Overall Study|Protocol Violation|3|||
154943374|NCT02277769|559217805|FG001|Overall Study|Protocol Violation|3|||
154943375|NCT02277769|559217806|FG002|Overall Study|Protocol Violation|5|||
154943376|NCT02277769|559217804|FG000|Overall Study|Lack of Efficacy|17|||
154943377|NCT02277769|559217805|FG001|Overall Study|Lack of Efficacy|0|||
154943378|NCT02277769|559217806|FG002|Overall Study|Lack of Efficacy|4|||
154943379|NCT02277769|559217804|FG000|Overall Study|Adverse Event|14|||
154943380|NCT02277769|559217805|FG001|Overall Study|Adverse Event|2|||
154943381|NCT02277769|559217806|FG002|Overall Study|Adverse Event|4|||
154943382|NCT02277769|559217804|FG000|Overall Study|Other than specified above|12|||
154943383|NCT02277769|559217805|FG001|Overall Study|Other than specified above|8|||
154943384|NCT02277769|559217806|FG002|Overall Study|Other than specified above|5|||
154943385|NCT01688037|559217807|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
154943386|NCT01688037|559217808|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
154943387|NCT01688037|559217809|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
154943388|NCT01688037|559217807|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
154943389|NCT01688037|559217808|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
154943390|NCT01688037|559217809|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
154943391|NCT01688037|559217807|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
154943392|NCT01688037|559217808|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
154943393|NCT01688037|559217809|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
154943394|NCT01688037|559217807|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
154943395|NCT01688037|559217808|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
154943396|NCT01688037|559217809|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
154943397|NCT01688037|559217807|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
154943398|NCT01688037|559217808|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
154943399|NCT01688037|559217809|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
154943400|NCT01688037|559217807|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
154943401|NCT01688037|559217808|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
154943402|NCT01688037|559217809|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
154943403|NCT01688037|559217807|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
154943404|NCT01688037|559217808|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
154943405|NCT01688037|559217809|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
154943406|NCT01688037|559217807|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
154943407|NCT01688037|559217808|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
155278928|NCT02028884|560454720|FG002|Open-label Extension Period|Switched to another treatment option|0|||
155278929|NCT00354029|560454721|FG000|Overall Study|Protocol Violation|4|||
155278930|NCT00354029|560454722|FG001|Overall Study|Protocol Violation|2|||
155278931|NCT00826280|560454723|FG000|Overall Study|Randomized but drug not received|1|||
155278932|NCT00826280|560454724|FG001|Overall Study|Randomized but drug not received|0|||
155278933|NCT00826280|560454725|FG002|Overall Study|Randomized but drug not received|1|||
155278934|NCT00826280|560454723|FG000|Overall Study|Adverse Event|1|||
155278935|NCT00826280|560454724|FG001|Overall Study|Adverse Event|3|||
155278936|NCT00826280|560454725|FG002|Overall Study|Adverse Event|0|||
154943408|NCT01688037|559217809|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
154943409|NCT01688037|559217807|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
154943410|NCT01688037|559217808|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
154943411|NCT01688037|559217809|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
154943412|NCT01688037|559217807|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
154943413|NCT01688037|559217808|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
154943414|NCT01688037|559217809|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
154943415|NCT03035227|559217810|FG000|Overall Study|study stopped due to PI leaving institut|1|||
155278937|NCT00826280|560454723|FG000|Overall Study|Lost to Follow-up|0|||
155278938|NCT00826280|560454724|FG001|Overall Study|Lost to Follow-up|1|||
155045603|NCT00423813|559599374|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
155045604|NCT00423813|559599375|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
155383137|NCT00666679|560837472|FG000|First Intervention|Withdrawal by Subject|1|||
155383138|NCT00666679|560837473|FG001|First Intervention|Withdrawal by Subject|0|||
155383139|NCT00666679|560837472|FG000|First Intervention|Randomized did not start treatment|1|||
155045605|NCT00423813|559599376|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
155045606|NCT01904032|559599377|FG000|Overall Study|Adverse Event|3|||
155383140|NCT00666679|560837473|FG001|First Intervention|Randomized did not start treatment|1|||
155383141|NCT00666679|560837472|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
155383142|NCT00666679|560837473|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
155383143|NCT00666679|560837472|FG000|Washout Period of 1 Week|Protocol Violation|0|||
155383144|NCT00666679|560837473|FG001|Washout Period of 1 Week|Protocol Violation|1|||
155383145|NCT00666679|560837472|FG000|Second Intervention|Adverse Event|1|||
155383146|NCT00666679|560837473|FG001|Second Intervention|Adverse Event|0|||
155383147|NCT00666679|560837472|FG000|Second Intervention|Death|0|||
155383148|NCT00666679|560837473|FG001|Second Intervention|Death|1|||
155383149|NCT00903006|560837474|FG000|Overall Study|Withdrawal by Subject|2|||
155383150|NCT00903006|560837475|FG001|Overall Study|Withdrawal by Subject|0|||
155383151|NCT00903006|560837476|FG002|Overall Study|Withdrawal by Subject|0|||
155383152|NCT00903006|560837477|FG003|Overall Study|Withdrawal by Subject|0|||
155383153|NCT00903006|560837474|FG000|Overall Study|Progressive Disease|0|||
155383154|NCT00903006|560837475|FG001|Overall Study|Progressive Disease|3|||
155383155|NCT00903006|560837476|FG002|Overall Study|Progressive Disease|1|||
155383156|NCT00903006|560837477|FG003|Overall Study|Progressive Disease|0|||
155383157|NCT03405792|560837478|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
155383158|NCT03405792|560837479|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
155383159|NCT03405792|560837478|FG000|Overall Study|o Did not receive pembrolizumab|1|||
155383160|NCT03405792|560837479|FG001|Overall Study|o Did not receive pembrolizumab|0|||
155383161|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
155383162|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
155383163|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
155383164|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
155383165|NCT00918580|560837480|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
155383166|NCT00918580|560837480|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
155383167|NCT00918580|560837480|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
155383168|NCT04882995|560837481|FG000|Overall Study|Withdrawal by Subject|1|||
155383169|NCT04882995|560837482|FG001|Overall Study|Withdrawal by Subject|2|||
155383170|NCT04882995|560837481|FG000|Overall Study|Protocol Violation|4|||
155383171|NCT04882995|560837482|FG001|Overall Study|Protocol Violation|4|||
155383172|NCT04882995|560837481|FG000|Overall Study|Surgery postponed due to COVID|1|||
155383173|NCT04882995|560837482|FG001|Overall Study|Surgery postponed due to COVID|1|||
155383174|NCT04371198|560837483|FG000|Overall Study|inadequate sample|4|||
155383175|NCT00372229|560837484|FG000|Study Phase|Graft loss|0|||
155383176|NCT00372229|560837485|FG001|Study Phase|Graft loss|3|||
155383177|NCT00372229|560837484|FG000|Study Phase|Protocol Violation|3|||
155383178|NCT00372229|560837485|FG001|Study Phase|Protocol Violation|4|||
155383179|NCT00372229|560837484|FG000|Study Phase|Consent withdrawn|16|||
155383180|NCT00372229|560837485|FG001|Study Phase|Consent withdrawn|14|||
155383181|NCT00372229|560837484|FG000|Study Phase|Refused treatment/did not cooperate|3|||
155383182|NCT00372229|560837485|FG001|Study Phase|Refused treatment/did not cooperate|1|||
155383183|NCT00372229|560837484|FG000|Study Phase|Death|3|||
155383184|NCT00372229|560837485|FG001|Study Phase|Death|2|||
155383185|NCT00372229|560837484|FG000|Study Phase|Reason not specified|3|||
155383186|NCT00372229|560837485|FG001|Study Phase|Reason not specified|2|||
155383187|NCT00372229|560837484|FG000|Study Phase|Lost to Follow-up|3|||
155383188|NCT00372229|560837485|FG001|Study Phase|Lost to Follow-up|3|||
155383189|NCT00372229|560837484|FG000|Follow-Up Phase|Graft loss|8|||
155383190|NCT00372229|560837485|FG001|Follow-Up Phase|Graft loss|7|||
155383191|NCT00372229|560837484|FG000|Follow-Up Phase|Consent withdrawn|13|||
155383192|NCT00372229|560837485|FG001|Follow-Up Phase|Consent withdrawn|19|||
155383193|NCT00372229|560837484|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
155045607|NCT01904032|559599378|FG001|Overall Study|Adverse Event|1|||
155383194|NCT00372229|560837485|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
155383195|NCT00372229|560837484|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
155045608|NCT01904032|559599377|FG000|Overall Study|Lost to Follow-up|4|||
155045609|NCT01904032|559599378|FG001|Overall Study|Lost to Follow-up|2|||
155045610|NCT00980655|559599380|FG000|Overall Study|Adverse Event|13|||
155383196|NCT00372229|560837485|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
155383197|NCT00372229|560837484|FG000|Follow-Up Phase|Death|9|||
155383198|NCT00372229|560837485|FG001|Follow-Up Phase|Death|12|||
155383199|NCT00372229|560837484|FG000|Follow-Up Phase|Administrative|1|||
155383200|NCT00372229|560837485|FG001|Follow-Up Phase|Administrative|0|||
155383201|NCT00372229|560837484|FG000|Follow-Up Phase|Reason not specified|2|||
155383202|NCT00372229|560837485|FG001|Follow-Up Phase|Reason not specified|3|||
155045611|NCT00980655|559599381|FG001|Overall Study|Adverse Event|31|||
155383203|NCT00372229|560837484|FG000|Follow-Up Phase|Lost to Follow-up|12|||
155045612|NCT00980655|559599380|FG000|Overall Study|Death|0|||
155045613|NCT00980655|559599381|FG001|Overall Study|Death|7|||
155045614|NCT00980655|559599380|FG000|Overall Study|Protocol Violation|2|||
155045615|NCT00980655|559599381|FG001|Overall Study|Protocol Violation|7|||
155045616|NCT00980655|559599380|FG000|Overall Study|Withdrawal by Subject|0|||
155045617|NCT00980655|559599381|FG001|Overall Study|Withdrawal by Subject|4|||
155045618|NCT00980655|559599380|FG000|Overall Study|Lost to Follow-up|0|||
155045619|NCT00980655|559599381|FG001|Overall Study|Lost to Follow-up|1|||
155383204|NCT00372229|560837485|FG001|Follow-Up Phase|Lost to Follow-up|10|||
155383205|NCT01347762|560837486|FG000|Overall Study|Lost to Follow-up|0|||
155383206|NCT01347762|560837487|FG001|Overall Study|Lost to Follow-up|1|||
155383207|NCT01347762|560837488|FG002|Overall Study|Lost to Follow-up|6|||
155383208|NCT01347762|560837489|FG003|Overall Study|Lost to Follow-up|5|||
155383209|NCT01347762|560837486|FG000|Overall Study|Withdrawal by Subject|4|||
155383210|NCT01347762|560837487|FG001|Overall Study|Withdrawal by Subject|1|||
155383211|NCT01347762|560837488|FG002|Overall Study|Withdrawal by Subject|3|||
155383212|NCT01347762|560837489|FG003|Overall Study|Withdrawal by Subject|3|||
155383213|NCT00701220|560837490|FG000|Overall Study|Withdrawal by Subject|0|||
155383214|NCT00701220|560837491|FG001|Overall Study|Withdrawal by Subject|2|||
155383215|NCT00701220|560837490|FG000|Overall Study|Protocol Violation|2|||
155383216|NCT00701220|560837491|FG001|Overall Study|Protocol Violation|0|||
155383217|NCT03235284|560837492|FG000|Overall Study|Adverse Event|1|||
155383218|NCT03235284|560837493|FG001|Overall Study|Adverse Event|2|||
155383219|NCT03235284|560837494|FG002|Overall Study|Adverse Event|1|||
155383220|NCT00690820|560837495|FG000|Period 1|Withdrawal by Subject|0|||
155383221|NCT00690820|560837496|FG001|Period 1|Withdrawal by Subject|1|||
155383222|NCT05208866|560837497|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
155383223|NCT04964414|560837500|FG000|Overall Study|Lost to Follow-up|10|||
155383224|NCT04964414|560837501|FG001|Overall Study|Lost to Follow-up|8|||
155383225|NCT04964414|560837500|FG000|Overall Study|Withdrawal by Subject|1|||
155383226|NCT04964414|560837501|FG001|Overall Study|Withdrawal by Subject|1|||
155383227|NCT03881553|560837502|FG000|Overall Study|Discharged prior to participation|1|||
155383228|NCT03881553|560837503|FG001|Overall Study|Discharged prior to participation|1|||
155383229|NCT03881553|560837504|FG002|Overall Study|Discharged prior to participation|0|||
155383230|NCT03881553|560837502|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
155383231|NCT03881553|560837503|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
155383232|NCT03881553|560837504|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
155383233|NCT02951767|560837507|FG000|Overall Study|Study Terminated By Sponsor|9|||
155383234|NCT02951767|560837507|FG000|Overall Study|Withdrawal by Subject|11|||
155383235|NCT02951767|560837507|FG000|Overall Study|Death|96|||
155383236|NCT02951767|560837507|FG000|Overall Study|Lost to Follow-up|2|||
155383237|NCT02951767|560837507|FG000|Overall Study|Physician Decision|1|||
155383238|NCT03426605|560837508|FG000|Overall Study|AML relapse or progression|2|||
155383239|NCT03426605|560837509|FG001|Overall Study|AML relapse or progression|1|||
155383240|NCT03426605|560837510|FG002|Overall Study|AML relapse or progression|2|||
155383241|NCT03426605|560837511|FG003|Overall Study|AML relapse or progression|2|||
155383242|NCT03426605|560837508|FG000|Overall Study|Treatment failure|3|||
155383243|NCT03426605|560837509|FG001|Overall Study|Treatment failure|2|||
155383244|NCT03426605|560837510|FG002|Overall Study|Treatment failure|0|||
155383245|NCT03426605|560837511|FG003|Overall Study|Treatment failure|0|||
155383246|NCT03426605|560837508|FG000|Overall Study|Adverse Event|1|||
155383247|NCT03426605|560837509|FG001|Overall Study|Adverse Event|0|||
155383248|NCT03426605|560837510|FG002|Overall Study|Adverse Event|1|||
155383249|NCT03426605|560837511|FG003|Overall Study|Adverse Event|1|||
155383250|NCT03426605|560837508|FG000|Overall Study|Withdrawal by Subject|0|||
155383251|NCT03426605|560837509|FG001|Overall Study|Withdrawal by Subject|0|||
155383252|NCT03426605|560837510|FG002|Overall Study|Withdrawal by Subject|1|||
155383253|NCT03426605|560837511|FG003|Overall Study|Withdrawal by Subject|1|||
155383254|NCT00609765|560837512|FG000|Overall Study|Study ended prior to 12 months|1|||
155383255|NCT02054520|560837513|FG000|Overall Study|Adverse Event|1|||
155383256|NCT02054520|560837514|FG001|Overall Study|Adverse Event|4|||
155045620|NCT00980655|559599380|FG000|Overall Study|Parent/legal guardian request|1|||
155045621|NCT00980655|559599381|FG001|Overall Study|Parent/legal guardian request|0|||
155383257|NCT02054520|560837515|FG002|Overall Study|Adverse Event|2|||
155383258|NCT02054520|560837516|FG003|Overall Study|Adverse Event|1|||
155383259|NCT02054520|560837517|FG004|Overall Study|Adverse Event|1|||
155383260|NCT02054520|560837518|FG005|Overall Study|Adverse Event|0|||
155383261|NCT02054520|560837513|FG000|Overall Study|Lack of Efficacy|7|||
155383262|NCT02054520|560837514|FG001|Overall Study|Lack of Efficacy|0|||
155383263|NCT02054520|560837515|FG002|Overall Study|Lack of Efficacy|2|||
155383264|NCT02054520|560837516|FG003|Overall Study|Lack of Efficacy|1|||
155383265|NCT02054520|560837517|FG004|Overall Study|Lack of Efficacy|3|||
155045622|NCT00980655|559599380|FG000|Overall Study|Other|0|||
155045623|NCT00980655|559599381|FG001|Overall Study|Other|1|||
155383266|NCT02054520|560837518|FG005|Overall Study|Lack of Efficacy|2|||
155383267|NCT02054520|560837513|FG000|Overall Study|Withdrawal by Subject|1|||
154943416|NCT03035227|559217811|FG001|Overall Study|study stopped due to PI leaving institut|1|||
154943417|NCT02100956|559217812|FG000|At Least One Week Between Injections|Adverse Event|0|||
154943418|NCT02100956|559217813|FG001|At Least One Week Between Injections|Adverse Event|1|||
154943419|NCT02220907|559217814|FG000|Overall Study|Adverse Event|7|||
154943420|NCT02220907|559217814|FG000|Overall Study|Physician Decision|1|||
154943421|NCT02220907|559217814|FG000|Overall Study|Withdrawal by Subject|2|||
154943422|NCT02220907|559217814|FG000|Overall Study|Conflict with the stopping criteria|1|||
154943423|NCT01098240|559217819|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
154943424|NCT01098240|559217820|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
154943425|NCT01098240|559217821|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
154943426|NCT01098240|559217819|FG000|Open-Label Phase|Protocol Violation|4|||
154943427|NCT01098240|559217820|FG001|Open-Label Phase|Protocol Violation|0|||
154943428|NCT01098240|559217821|FG002|Open-Label Phase|Protocol Violation|0|||
154943429|NCT01098240|559217819|FG000|Open-Label Phase|Lost to Follow-up|13|||
154943430|NCT01098240|559217820|FG001|Open-Label Phase|Lost to Follow-up|0|||
154943431|NCT01098240|559217821|FG002|Open-Label Phase|Lost to Follow-up|0|||
154943432|NCT01098240|559217819|FG000|Open-Label Phase|Other|19|||
154943433|NCT01098240|559217820|FG001|Open-Label Phase|Other|0|||
154943434|NCT01098240|559217821|FG002|Open-Label Phase|Other|0|||
154943435|NCT01098240|559217819|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
154943436|NCT01098240|559217820|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
154943437|NCT01098240|559217821|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
154943438|NCT01098240|559217819|FG000|Open-Label Phase|Pregnancy|1|||
154943439|NCT01098240|559217820|FG001|Open-Label Phase|Pregnancy|0|||
154943440|NCT01098240|559217821|FG002|Open-Label Phase|Pregnancy|0|||
155045624|NCT03597139|559599384|FG000|Overall Study|Adverse Event|3|||
155278939|NCT00826280|560454725|FG002|Overall Study|Lost to Follow-up|0|||
155278940|NCT00826280|560454723|FG000|Overall Study|Sponsor discontinued subject or study|1|||
155278941|NCT00826280|560454724|FG001|Overall Study|Sponsor discontinued subject or study|0|||
155278942|NCT00826280|560454725|FG002|Overall Study|Sponsor discontinued subject or study|0|||
155278943|NCT00826280|560454723|FG000|Overall Study|Reversible ischemic defect not present|43|||
155278944|NCT00826280|560454724|FG001|Overall Study|Reversible ischemic defect not present|40|||
155278945|NCT00826280|560454725|FG002|Overall Study|Reversible ischemic defect not present|44|||
155278946|NCT00826280|560454723|FG000|Overall Study|Interpretation Failure|1|||
155278947|NCT00826280|560454724|FG001|Overall Study|Interpretation Failure|0|||
155278948|NCT00826280|560454725|FG002|Overall Study|Interpretation Failure|0|||
155278949|NCT00826280|560454723|FG000|Overall Study|Machine Failure|1|||
155278950|NCT00826280|560454724|FG001|Overall Study|Machine Failure|1|||
155278951|NCT00826280|560454725|FG002|Overall Study|Machine Failure|0|||
155278952|NCT00826280|560454723|FG000|Overall Study|One or more non-interpretable scan|0|||
155278953|NCT00826280|560454724|FG001|Overall Study|One or more non-interpretable scan|1|||
155278954|NCT00826280|560454725|FG002|Overall Study|One or more non-interpretable scan|1|||
155278955|NCT01477749|560454733|FG000|Overall Study|Physician Decision|4|||
155278956|NCT04004208|560454738|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155278957|NCT04004208|560454739|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155278958|NCT04004208|560454738|FG000|Overall Study|Death|3|||
155278959|NCT04004208|560454739|FG001|Overall Study|Death|0|||
155278960|NCT04004208|560454738|FG000|Overall Study|COVID-19 pandemic|1|||
155278961|NCT04004208|560454739|FG001|Overall Study|COVID-19 pandemic|0|||
155278962|NCT04004208|560454738|FG000|Overall Study|Physician Decision|1|||
155278963|NCT04004208|560454739|FG001|Overall Study|Physician Decision|0|||
155278964|NCT04004208|560454738|FG000|Overall Study|Adverse Event|1|||
155278965|NCT04004208|560454739|FG001|Overall Study|Adverse Event|1|||
155278966|NCT01310868|560454741|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
155278967|NCT00873093|560454742|FG000|Overall Study|Adverse Event|0|||
155278968|NCT00873093|560454743|FG001|Overall Study|Adverse Event|2|||
155278969|NCT00873093|560454744|FG002|Overall Study|Adverse Event|0|||
155278970|NCT00873093|560454745|FG003|Overall Study|Adverse Event|0|||
155278971|NCT00873093|560454746|FG004|Overall Study|Adverse Event|0|||
155278972|NCT00873093|560454742|FG000|Overall Study|Death|0|||
155278973|NCT00873093|560454743|FG001|Overall Study|Death|3|||
155278974|NCT00873093|560454744|FG002|Overall Study|Death|2|||
155278975|NCT00873093|560454745|FG003|Overall Study|Death|0|||
155278976|NCT00873093|560454746|FG004|Overall Study|Death|0|||
155278977|NCT00873093|560454742|FG000|Overall Study|Physician Decision|0|||
155278978|NCT00873093|560454743|FG001|Overall Study|Physician Decision|17|||
155278979|NCT00873093|560454744|FG002|Overall Study|Physician Decision|10|||
155278980|NCT00873093|560454745|FG003|Overall Study|Physician Decision|10|||
155278981|NCT00873093|560454746|FG004|Overall Study|Physician Decision|2|||
155278982|NCT00873093|560454742|FG000|Overall Study|Withdrawal by Subject|1|||
155278983|NCT00873093|560454743|FG001|Overall Study|Withdrawal by Subject|4|||
155278984|NCT00873093|560454744|FG002|Overall Study|Withdrawal by Subject|4|||
155278985|NCT00873093|560454745|FG003|Overall Study|Withdrawal by Subject|0|||
155278986|NCT00873093|560454746|FG004|Overall Study|Withdrawal by Subject|0|||
155278987|NCT00873093|560454742|FG000|Overall Study|Ineligible|0|||
155278988|NCT00873093|560454743|FG001|Overall Study|Ineligible|1|||
155278989|NCT00873093|560454744|FG002|Overall Study|Ineligible|0|||
155383268|NCT02054520|560837514|FG001|Overall Study|Withdrawal by Subject|0|||
155383269|NCT02054520|560837515|FG002|Overall Study|Withdrawal by Subject|0|||
155383270|NCT02054520|560837516|FG003|Overall Study|Withdrawal by Subject|2|||
155383271|NCT02054520|560837517|FG004|Overall Study|Withdrawal by Subject|1|||
155383272|NCT02054520|560837518|FG005|Overall Study|Withdrawal by Subject|0|||
155383273|NCT02054520|560837513|FG000|Overall Study|Physician Decision|0|||
155383274|NCT02054520|560837514|FG001|Overall Study|Physician Decision|1|||
155383275|NCT02054520|560837515|FG002|Overall Study|Physician Decision|0|||
155383276|NCT02054520|560837516|FG003|Overall Study|Physician Decision|1|||
155383277|NCT02054520|560837517|FG004|Overall Study|Physician Decision|0|||
155383278|NCT02054520|560837518|FG005|Overall Study|Physician Decision|1|||
155383279|NCT02054520|560837513|FG000|Overall Study|Study terminated by Sponsor|0|||
155383280|NCT02054520|560837514|FG001|Overall Study|Study terminated by Sponsor|0|||
155383281|NCT02054520|560837515|FG002|Overall Study|Study terminated by Sponsor|2|||
155383282|NCT02054520|560837516|FG003|Overall Study|Study terminated by Sponsor|1|||
155383283|NCT02054520|560837517|FG004|Overall Study|Study terminated by Sponsor|0|||
155383284|NCT02054520|560837518|FG005|Overall Study|Study terminated by Sponsor|0|||
155383285|NCT01272804|560837519|FG000|Overall Study|Adverse Event|1|||
155383286|NCT01272804|560837520|FG001|Overall Study|Adverse Event|0|||
155383287|NCT01272804|560837521|FG002|Overall Study|Adverse Event|0|||
155383288|NCT01272804|560837522|FG003|Overall Study|Adverse Event|0|||
155383289|NCT01272804|560837523|FG004|Overall Study|Adverse Event|2|||
155383290|NCT01272804|560837524|FG005|Overall Study|Adverse Event|1|||
155383291|NCT02232243|560837525|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
155383292|NCT02232243|560837526|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
155383293|NCT02232243|560837527|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
155383294|NCT00490724|560837528|FG000|Period I|Physician Decision|0|||
155383295|NCT00490724|560837529|FG001|Period I|Physician Decision|0|||
155383296|NCT00490724|560837530|FG002|Period I|Physician Decision|1|||
155383297|NCT00490724|560837528|FG000|Period II|Treatment Discontinuation|3|||
155383298|NCT00490724|560837529|FG001|Period II|Treatment Discontinuation|1|||
155383299|NCT00490724|560837530|FG002|Period II|Treatment Discontinuation|3|||
155383300|NCT03218397|560837531|FG000|Overall Study|Prior positive blood culture|8|||
155383301|NCT03218397|560837532|FG001|Overall Study|Prior positive blood culture|13|||
155383302|NCT03218397|560837531|FG000|Overall Study|Comfort care|8|||
155383303|NCT03218397|560837532|FG001|Overall Study|Comfort care|5|||
155383304|NCT03218397|560837531|FG000|Overall Study|Comfort care and positive blood culture|1|||
155383305|NCT03218397|560837532|FG001|Overall Study|Comfort care and positive blood culture|0|||
155383306|NCT03218397|560837531|FG000|Overall Study|Comfort care and mixed culture|0|||
155383307|NCT03218397|560837532|FG001|Overall Study|Comfort care and mixed culture|1|||
155383308|NCT03218397|560837531|FG000|Overall Study|Mixed culture|2|||
155383309|NCT03218397|560837532|FG001|Overall Study|Mixed culture|2|||
155383310|NCT03218397|560837531|FG000|Overall Study|Inaccessible hospital records|2|||
155383311|NCT03218397|560837532|FG001|Overall Study|Inaccessible hospital records|5|||
154943441|NCT01098240|559217819|FG000|Open-Label Phase|Withdrawal by Subject|9|||
154943442|NCT01098240|559217820|FG001|Open-Label Phase|Withdrawal by Subject|0|||
154943443|NCT01098240|559217821|FG002|Open-Label Phase|Withdrawal by Subject|0|||
154943444|NCT01098240|559217819|FG000|Open-Label Phase|Adverse Event|12|||
154943445|NCT01098240|559217820|FG001|Open-Label Phase|Adverse Event|0|||
154943446|NCT01098240|559217821|FG002|Open-Label Phase|Adverse Event|0|||
154943447|NCT01098240|559217819|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
154943448|NCT01098240|559217820|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
154943449|NCT01098240|559217821|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
154943450|NCT01098240|559217819|FG000|Double-Blind Phase|Protocol Violation|0|||
154943451|NCT01098240|559217820|FG001|Double-Blind Phase|Protocol Violation|2|||
154943452|NCT01098240|559217821|FG002|Double-Blind Phase|Protocol Violation|4|||
154943453|NCT01098240|559217819|FG000|Double-Blind Phase|Lost to Follow-up|0|||
154943454|NCT01098240|559217820|FG001|Double-Blind Phase|Lost to Follow-up|2|||
154943455|NCT01098240|559217821|FG002|Double-Blind Phase|Lost to Follow-up|0|||
154943456|NCT01098240|559217819|FG000|Double-Blind Phase|Other|0|||
154943457|NCT01098240|559217820|FG001|Double-Blind Phase|Other|2|||
154943458|NCT01098240|559217821|FG002|Double-Blind Phase|Other|2|||
155383312|NCT03218397|560837531|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
155383313|NCT03218397|560837532|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
155383314|NCT03218397|560837531|FG000|Overall Study|Randomized during laboratory off hours|2|||
155383315|NCT03218397|560837532|FG001|Overall Study|Randomized during laboratory off hours|1|||
155383316|NCT01796548|560837533|FG000|Overall Study|Lost to Follow-up|1|||
155383317|NCT01796548|560837533|FG000|Overall Study|Other|2|||
155383318|NCT02457559|560837534|FG000|Overall Study|Progressive Disease|1|||
155383319|NCT02457559|560837535|FG001|Overall Study|Progressive Disease|2|||
154943459|NCT01098240|559217819|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
154943460|NCT01098240|559217820|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
154943461|NCT01098240|559217821|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
154943462|NCT01098240|559217819|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
154943463|NCT01098240|559217820|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
155045625|NCT03597139|559599385|FG001|Overall Study|Adverse Event|0|||
155383320|NCT02457559|560837536|FG002|Overall Study|Progressive Disease|3|||
155383321|NCT02457559|560837537|FG003|Overall Study|Progressive Disease|0|||
155383322|NCT02457559|560837538|FG004|Overall Study|Progressive Disease|0|||
155383323|NCT02457559|560837539|FG005|Overall Study|Progressive Disease|2|||
155383324|NCT02457559|560837540|FG006|Overall Study|Progressive Disease|1|||
155383325|NCT02457559|560837541|FG007|Overall Study|Progressive Disease|0|||
155383326|NCT02457559|560837542|FG008|Overall Study|Progressive Disease|1|||
155383327|NCT02457559|560837543|FG009|Overall Study|Progressive Disease|1|||
155383328|NCT02457559|560837544|FG010|Overall Study|Progressive Disease|1|||
155383329|NCT02457559|560837534|FG000|Overall Study|Investigator's Discretion|0|||
155383330|NCT02457559|560837535|FG001|Overall Study|Investigator's Discretion|0|||
155383331|NCT02457559|560837536|FG002|Overall Study|Investigator's Discretion|2|||
155383332|NCT02457559|560837537|FG003|Overall Study|Investigator's Discretion|0|||
155383333|NCT02457559|560837538|FG004|Overall Study|Investigator's Discretion|1|||
155383334|NCT02457559|560837539|FG005|Overall Study|Investigator's Discretion|0|||
155383335|NCT02457559|560837540|FG006|Overall Study|Investigator's Discretion|1|||
155383336|NCT02457559|560837541|FG007|Overall Study|Investigator's Discretion|0|||
155383337|NCT02457559|560837542|FG008|Overall Study|Investigator's Discretion|1|||
155383338|NCT02457559|560837543|FG009|Overall Study|Investigator's Discretion|0|||
155383339|NCT02457559|560837544|FG010|Overall Study|Investigator's Discretion|1|||
155383340|NCT02457559|560837534|FG000|Overall Study|Adverse Event|0|||
155383341|NCT02457559|560837535|FG001|Overall Study|Adverse Event|1|||
155383342|NCT02457559|560837536|FG002|Overall Study|Adverse Event|2|||
155383343|NCT02457559|560837537|FG003|Overall Study|Adverse Event|0|||
155383344|NCT02457559|560837538|FG004|Overall Study|Adverse Event|0|||
155383345|NCT02457559|560837539|FG005|Overall Study|Adverse Event|0|||
155383346|NCT02457559|560837540|FG006|Overall Study|Adverse Event|0|||
155383347|NCT02457559|560837541|FG007|Overall Study|Adverse Event|0|||
155383348|NCT02457559|560837542|FG008|Overall Study|Adverse Event|0|||
155383349|NCT02457559|560837543|FG009|Overall Study|Adverse Event|0|||
155383350|NCT02457559|560837544|FG010|Overall Study|Adverse Event|0|||
155383351|NCT02457559|560837534|FG000|Overall Study|Reason not Specified|1|||
155383352|NCT02457559|560837535|FG001|Overall Study|Reason not Specified|0|||
155383353|NCT02457559|560837536|FG002|Overall Study|Reason not Specified|0|||
155383354|NCT02457559|560837537|FG003|Overall Study|Reason not Specified|0|||
155383355|NCT02457559|560837538|FG004|Overall Study|Reason not Specified|0|||
155383356|NCT02457559|560837539|FG005|Overall Study|Reason not Specified|0|||
155383357|NCT02457559|560837540|FG006|Overall Study|Reason not Specified|0|||
155383358|NCT02457559|560837541|FG007|Overall Study|Reason not Specified|0|||
155383359|NCT02457559|560837542|FG008|Overall Study|Reason not Specified|0|||
155383360|NCT02457559|560837543|FG009|Overall Study|Reason not Specified|2|||
155383361|NCT02457559|560837544|FG010|Overall Study|Reason not Specified|0|||
155383362|NCT02457559|560837534|FG000|Overall Study|Death|0|||
155383363|NCT02457559|560837535|FG001|Overall Study|Death|0|||
155383364|NCT02457559|560837536|FG002|Overall Study|Death|0|||
155383365|NCT02457559|560837537|FG003|Overall Study|Death|0|||
155383366|NCT02457559|560837538|FG004|Overall Study|Death|0|||
155383367|NCT02457559|560837539|FG005|Overall Study|Death|0|||
155383368|NCT02457559|560837540|FG006|Overall Study|Death|0|||
155383369|NCT02457559|560837541|FG007|Overall Study|Death|0|||
154943464|NCT01098240|559217821|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
154943465|NCT01098240|559217819|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
154943466|NCT01098240|559217820|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
154943467|NCT01098240|559217821|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
154943468|NCT01098240|559217819|FG000|Double-Blind Phase|Adverse Event|0|||
154943469|NCT01098240|559217820|FG001|Double-Blind Phase|Adverse Event|3|||
154943470|NCT01098240|559217821|FG002|Double-Blind Phase|Adverse Event|3|||
154943471|NCT03280537|559217822|FG000|Overall Study|Withdrawal by Subject|2|||
154943472|NCT03280537|559217823|FG001|Overall Study|Withdrawal by Subject|4|||
154943473|NCT03083132|559217824|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
154943474|NCT03083132|559217825|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
154943475|NCT03083132|559217824|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
154943476|NCT03083132|559217825|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
154943477|NCT03083132|559217824|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
154943478|NCT03083132|559217825|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
154943479|NCT01588106|559217826|FG000|Overall Study|Withdrawal by Subject|5|||
154943480|NCT01588106|559217827|FG001|Overall Study|Withdrawal by Subject|4|||
155383370|NCT02457559|560837542|FG008|Overall Study|Death|1|||
155383371|NCT02457559|560837543|FG009|Overall Study|Death|1|||
155383372|NCT02457559|560837544|FG010|Overall Study|Death|0|||
155383373|NCT03866473|560837549|FG000|Phase 1|Death|1|||
155383374|NCT03866473|560837550|FG001|Phase 1|Death|0|||
155383375|NCT03866473|560837549|FG000|Phase 2|Death|0|||
155383376|NCT03866473|560837550|FG001|Phase 2|Death|2|||
155383377|NCT03866473|560837549|FG000|Phase 2|Dropped|1|||
155383378|NCT03866473|560837550|FG001|Phase 2|Dropped|1|||
155383379|NCT03866473|560837549|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
155383380|NCT03866473|560837550|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
155383381|NCT02495792|560837551|FG000|Overall Study|Lost to Follow-up|5|||
155383382|NCT02495792|560837552|FG001|Overall Study|Lost to Follow-up|9|||
155383383|NCT02495792|560837551|FG000|Overall Study|Protocol Violation|32|||
155383384|NCT02495792|560837552|FG001|Overall Study|Protocol Violation|31|||
155383385|NCT05590884|560837553|FG000|Overall Study|Withdrawal by Subject|1|||
155383386|NCT05590884|560837554|FG001|Overall Study|Withdrawal by Subject|0|||
155383387|NCT05590884|560837555|FG002|Overall Study|Withdrawal by Subject|0|||
155383388|NCT04443153|560837560|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
155383389|NCT04443153|560837561|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
155383390|NCT04443153|560837560|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
155383391|NCT04443153|560837561|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
155383392|NCT04443153|560837560|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
155383393|NCT04443153|560837561|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
155383394|NCT04443153|560837560|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
155383395|NCT04443153|560837561|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
155383396|NCT03110224|560837565|FG000|Overall Study|Death|3|||
155383397|NCT03110224|560837565|FG000|Overall Study|Lost to Follow-up|132|||
155383398|NCT03110224|560837565|FG000|Overall Study|Physician Decision|2|||
155383399|NCT03110224|560837565|FG000|Overall Study|Site Closed by Physician|35|||
155383400|NCT03110224|560837565|FG000|Overall Study|Site Closed by Sponsor|202|||
154943481|NCT02995837|559217828|FG000|Overall Study|Lost to Follow-up|9|||
154943482|NCT02995837|559217829|FG001|Overall Study|Lost to Follow-up|8|||
155383401|NCT03110224|560837565|FG000|Overall Study|Withdrawal by Subject|9|||
155383402|NCT05328167|560837566|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
155383403|NCT05328167|560837566|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
155383404|NCT00409773|560839488|FG000|Overall Study|Adverse Event|3|||
155383405|NCT00409773|560839489|FG001|Overall Study|Adverse Event|4|||
155383406|NCT00409773|560839490|FG002|Overall Study|Adverse Event|4|||
154943483|NCT03118739|559217830|FG000|Overall Study|Physician Decision|0|||
154943484|NCT03118739|559217831|FG001|Overall Study|Physician Decision|1|||
154943485|NCT03118739|559217830|FG000|Overall Study|Withdrawal by Subject|5|||
154943486|NCT03118739|559217831|FG001|Overall Study|Withdrawal by Subject|3|||
154943487|NCT03118739|559217830|FG000|Overall Study|Lost to Follow-up|2|||
154943488|NCT03118739|559217831|FG001|Overall Study|Lost to Follow-up|0|||
154943489|NCT01859702|559217832|FG000|Overall Study|Protocol deviation|3|||
154943490|NCT01859702|559217832|FG000|Overall Study|Adverse Event|2|||
154943491|NCT01893138|559217833|FG000|Double-Blind Period|Withdrawal by Subject|1|||
154943492|NCT01893138|559217834|FG001|Double-Blind Period|Withdrawal by Subject|1|||
154943493|NCT01893138|559217833|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
154943494|NCT01893138|559217834|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
154943495|NCT01893138|559217833|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
154943496|NCT01893138|559217834|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
154943497|NCT01893138|559217833|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
154943498|NCT01893138|559217834|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
154943499|NCT01893138|559217833|FG000|Open Label - Unblinded Period|Adverse Event|1|||
154943500|NCT01893138|559217834|FG001|Open Label - Unblinded Period|Adverse Event|0|||
154943501|NCT01326026|559217835|FG000|Overall Study|Adverse Event|4|||
154943502|NCT01326026|559217836|FG001|Overall Study|Adverse Event|3|||
154943503|NCT01326026|559217835|FG000|Overall Study|Withdrawal Criteria|5|||
154943504|NCT01326026|559217836|FG001|Overall Study|Withdrawal Criteria|7|||
154943505|NCT01326026|559217835|FG000|Overall Study|Other|3|||
154943506|NCT01326026|559217836|FG001|Overall Study|Other|3|||
154943507|NCT04317053|559217840|FG000|Overall Study|Withdrawn (screen failure)|4|||
154943508|NCT04317053|559217841|FG001|Overall Study|Withdrawn (screen failure)|2|||
154943509|NCT04274192|559217842|FG000|Overall Study|Protocol Violation|1|||
154943510|NCT04274192|559217843|FG001|Overall Study|Protocol Violation|0|||
154943511|NCT00289458|559217844|FG000|Overall Study|Death|1|||
154943512|NCT00289458|559217845|FG001|Overall Study|Death|0|||
154943513|NCT00289458|559217846|FG002|Overall Study|Death|0|||
154943514|NCT00289458|559217844|FG000|Overall Study|Physician Decision|3|||
154943515|NCT00289458|559217845|FG001|Overall Study|Physician Decision|4|||
154943516|NCT00289458|559217846|FG002|Overall Study|Physician Decision|2|||
154943517|NCT00289458|559217844|FG000|Overall Study|Withdrawal by Subject|2|||
154943518|NCT00289458|559217845|FG001|Overall Study|Withdrawal by Subject|2|||
154943519|NCT00289458|559217846|FG002|Overall Study|Withdrawal by Subject|4|||
154943520|NCT03507439|559217847|FG000|Overall Study|Other|2|||
154943521|NCT03507439|559217848|FG001|Overall Study|Other|1|||
154943522|NCT03507439|559217847|FG000|Overall Study|Withdrawal by Subject|1|||
154943523|NCT03507439|559217848|FG001|Overall Study|Withdrawal by Subject|0|||
154943524|NCT03507439|559217847|FG000|Overall Study|Death|1|||
154943525|NCT03507439|559217848|FG001|Overall Study|Death|1|||
154943526|NCT00874757|559217849|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
154943527|NCT01132118|559219217|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
154943528|NCT01132118|559219218|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
155045626|NCT03597139|559599384|FG000|Overall Study|Protocol Non-compliance|1|||
155045627|NCT03597139|559599385|FG001|Overall Study|Protocol Non-compliance|0|||
155045628|NCT05052697|559599386|FG000|Substudy A|Lost to Follow-up|0|||
155045629|NCT05052697|559599387|FG001|Substudy A|Lost to Follow-up|0|||
155045630|NCT05052697|559599388|FG002|Substudy A|Lost to Follow-up|0|||
155045631|NCT05052697|559599389|FG003|Substudy A|Lost to Follow-up|0|||
155045632|NCT05052697|559599390|FG004|Substudy A|Lost to Follow-up|0|||
155045633|NCT05052697|559599391|FG005|Substudy A|Lost to Follow-up|1|||
155045634|NCT05052697|559599392|FG006|Substudy A|Lost to Follow-up|0|||
155045635|NCT05052697|559599393|FG007|Substudy A|Lost to Follow-up|0|||
155045636|NCT05052697|559599394|FG008|Substudy A|Lost to Follow-up|0|||
155045637|NCT05052697|559599395|FG009|Substudy A|Lost to Follow-up|0|||
155045638|NCT05052697|559599396|FG010|Substudy A|Lost to Follow-up|0|||
155045639|NCT05052697|559599397|FG011|Substudy A|Lost to Follow-up|0|||
155383407|NCT00409773|560839491|FG003|Overall Study|Adverse Event|2|||
155383408|NCT00409773|560839492|FG004|Overall Study|Adverse Event|6|||
155383409|NCT00409773|560839488|FG000|Overall Study|Lost to Follow-up|6|||
155383410|NCT00409773|560839489|FG001|Overall Study|Lost to Follow-up|1|||
155383411|NCT00409773|560839490|FG002|Overall Study|Lost to Follow-up|2|||
155045640|NCT05052697|559599398|FG012|Substudy A|Lost to Follow-up|0|||
155045641|NCT05052697|559599399|FG013|Substudy A|Lost to Follow-up|0|||
155045642|NCT05052697|559599400|FG014|Substudy A|Lost to Follow-up|0|||
155045643|NCT05052697|559599401|FG015|Substudy A|Lost to Follow-up|2|||
155383412|NCT00409773|560839491|FG003|Overall Study|Lost to Follow-up|3|||
155383413|NCT00409773|560839492|FG004|Overall Study|Lost to Follow-up|1|||
155383414|NCT00409773|560839488|FG000|Overall Study|Physician Decision|0|||
155383415|NCT00409773|560839489|FG001|Overall Study|Physician Decision|0|||
155383416|NCT00409773|560839490|FG002|Overall Study|Physician Decision|0|||
155383417|NCT00409773|560839491|FG003|Overall Study|Physician Decision|2|||
155383418|NCT00409773|560839492|FG004|Overall Study|Physician Decision|0|||
155383419|NCT00409773|560839488|FG000|Overall Study|Protocol Violation|0|||
155383420|NCT00409773|560839489|FG001|Overall Study|Protocol Violation|2|||
155383421|NCT00409773|560839490|FG002|Overall Study|Protocol Violation|3|||
155383422|NCT00409773|560839491|FG003|Overall Study|Protocol Violation|3|||
155383423|NCT00409773|560839492|FG004|Overall Study|Protocol Violation|1|||
155383424|NCT00409773|560839488|FG000|Overall Study|Withdrawal by Subject|0|||
155383425|NCT00409773|560839489|FG001|Overall Study|Withdrawal by Subject|0|||
155383426|NCT00409773|560839490|FG002|Overall Study|Withdrawal by Subject|0|||
155383427|NCT00409773|560839491|FG003|Overall Study|Withdrawal by Subject|2|||
155383428|NCT00409773|560839492|FG004|Overall Study|Withdrawal by Subject|1|||
155383429|NCT00409773|560839488|FG000|Overall Study|Lack of Eligibility|0|||
155383430|NCT00409773|560839489|FG001|Overall Study|Lack of Eligibility|0|||
155383431|NCT00409773|560839490|FG002|Overall Study|Lack of Eligibility|0|||
155383432|NCT00409773|560839491|FG003|Overall Study|Lack of Eligibility|0|||
155383433|NCT00409773|560839492|FG004|Overall Study|Lack of Eligibility|1|||
155383434|NCT01919814|560839493|FG000|Overall Study|Adverse Event|1|||
155383435|NCT01919814|560839494|FG001|Overall Study|Adverse Event|0|||
155383436|NCT01919814|560839493|FG000|Overall Study|Protocol Violation|1|||
155383437|NCT01919814|560839494|FG001|Overall Study|Protocol Violation|0|||
155383438|NCT01919814|560839493|FG000|Overall Study|Withdrawal by Subject|1|||
155383439|NCT01919814|560839494|FG001|Overall Study|Withdrawal by Subject|0|||
155383440|NCT01440374|560839495|FG000|Part 1: Open-label Phase|Adverse Event|5|||
155383441|NCT01440374|560839496|FG001|Part 1: Open-label Phase|Adverse Event|0|||
155383442|NCT01440374|560839497|FG002|Part 1: Open-label Phase|Adverse Event|0|||
155383443|NCT01440374|560839498|FG003|Part 1: Open-label Phase|Adverse Event|0|||
155383444|NCT01440374|560839495|FG000|Part 1: Open-label Phase|Physician Decision|1|||
155383445|NCT01440374|560839496|FG001|Part 1: Open-label Phase|Physician Decision|0|||
155383446|NCT01440374|560839497|FG002|Part 1: Open-label Phase|Physician Decision|0|||
155383447|NCT01440374|560839498|FG003|Part 1: Open-label Phase|Physician Decision|0|||
155383448|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
155383449|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
155383450|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
155383451|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
155383452|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
155383453|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
155383454|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
155383455|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
155383456|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
155383457|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
155383458|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
155383459|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
155045644|NCT05052697|559599402|FG016|Substudy A|Lost to Follow-up|0|||
155045645|NCT05052697|559599403|FG017|Substudy A|Lost to Follow-up|0|||
155045646|NCT05052697|559599404|FG018|Substudy A|Lost to Follow-up|0|||
155045647|NCT05052697|559599405|FG019|Substudy A|Lost to Follow-up|0|||
155045648|NCT05052697|559599406|FG020|Substudy A|Lost to Follow-up|0|||
155045649|NCT05052697|559599407|FG021|Substudy A|Lost to Follow-up|0|||
155383460|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
155383461|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
155383462|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
155383463|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
155383464|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
155383465|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
155383466|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
155383467|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
155383468|NCT01440374|560839495|FG000|Part 2; Double-blind Phase|Not treated|0|||
155383469|NCT01440374|560839496|FG001|Part 2; Double-blind Phase|Not treated|0|||
155383470|NCT01440374|560839497|FG002|Part 2; Double-blind Phase|Not treated|1|||
155383471|NCT01440374|560839498|FG003|Part 2; Double-blind Phase|Not treated|0|||
155383472|NCT01440374|560839495|FG000|Part 3: Extension|Withdrawal by Subject|0|||
155383473|NCT01440374|560839496|FG001|Part 3: Extension|Withdrawal by Subject|0|||
155383474|NCT01440374|560839497|FG002|Part 3: Extension|Withdrawal by Subject|0|||
155383475|NCT01440374|560839498|FG003|Part 3: Extension|Withdrawal by Subject|5|||
155383476|NCT01440374|560839495|FG000|Part 3: Extension|Adverse Event|0|||
155383477|NCT01440374|560839496|FG001|Part 3: Extension|Adverse Event|0|||
155383478|NCT01440374|560839497|FG002|Part 3: Extension|Adverse Event|0|||
155383479|NCT01440374|560839498|FG003|Part 3: Extension|Adverse Event|13|||
155383480|NCT01440374|560839495|FG000|Part 3: Extension|Physician Decision|0|||
155383481|NCT01440374|560839496|FG001|Part 3: Extension|Physician Decision|0|||
155383482|NCT01440374|560839497|FG002|Part 3: Extension|Physician Decision|0|||
155383483|NCT01440374|560839498|FG003|Part 3: Extension|Physician Decision|14|||
155383484|NCT04812548|560839500|FG000|Overall Study|Adverse Event|2|||
155383485|NCT04812548|560839501|FG001|Overall Study|Adverse Event|7|||
155383486|NCT04812548|560839500|FG000|Overall Study|HSCT Planned|2|||
155383487|NCT04812548|560839501|FG001|Overall Study|HSCT Planned|3|||
155383488|NCT04812548|560839500|FG000|Overall Study|Progressive Disease|0|||
155383489|NCT04812548|560839501|FG001|Overall Study|Progressive Disease|2|||
155383490|NCT04812548|560839500|FG000|Overall Study|Death|0|||
155383491|NCT04812548|560839501|FG001|Overall Study|Death|1|||
155383492|NCT04812548|560839500|FG000|Overall Study|Post Study Access to Treatment|0|||
155383493|NCT04812548|560839501|FG001|Overall Study|Post Study Access to Treatment|1|||
155383494|NCT04812548|560839500|FG000|Overall Study|Withdrawal by Subject|0|||
155383495|NCT04812548|560839501|FG001|Overall Study|Withdrawal by Subject|1|||
155383496|NCT04812548|560839500|FG000|Overall Study|Physician Decision|1|||
155383497|NCT04812548|560839501|FG001|Overall Study|Physician Decision|0|||
155383498|NCT02141984|560839503|FG000|Overall Study|Lack of Efficacy|2|||
155383499|NCT01765192|560839506|FG000|Treatment Period 1|Adverse Event|0|||
155383500|NCT01765192|560839507|FG001|Treatment Period 1|Adverse Event|1|||
155383501|NCT01765192|560839506|FG000|Washout Period|Voluntary Withdrawal|1|||
155383502|NCT01765192|560839507|FG001|Washout Period|Voluntary Withdrawal|1|||
155383503|NCT01765192|560839506|FG000|Washout Period|Reason not specified|1|||
155383504|NCT01765192|560839507|FG001|Washout Period|Reason not specified|0|||
155383505|NCT01765192|560839506|FG000|Treatment Period 2|Reason not specified|0|||
155383506|NCT01765192|560839507|FG001|Treatment Period 2|Reason not specified|2|||
155383507|NCT01765192|560839506|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
155383508|NCT01765192|560839507|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
154943529|NCT01132118|559219217|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
154943530|NCT01132118|559219218|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
154943531|NCT01132118|559219217|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
154943532|NCT01132118|559219218|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
154943533|NCT00313703|559219220|FG000|Overall Study|Lost to Follow-up|11|||
154943534|NCT00313703|559219221|FG001|Overall Study|Lost to Follow-up|2|||
154943535|NCT00313703|559219222|FG002|Overall Study|Lost to Follow-up|5|||
154943536|NCT00313703|559219223|FG003|Overall Study|Lost to Follow-up|12|||
154943537|NCT01060670|559219224|FG000|Run In|screen failure|0|||
154943538|NCT01060670|559219225|FG001|Run In|screen failure|238|||
154943539|NCT00094302|559219226|FG000|Overall Study|Lost to Follow-up|43|||
154943540|NCT00094302|559219227|FG001|Overall Study|Lost to Follow-up|41|||
154943541|NCT00094302|559219226|FG000|Overall Study|Physician Decision|5|||
154943542|NCT00094302|559219227|FG001|Overall Study|Physician Decision|8|||
154943543|NCT00094302|559219226|FG000|Overall Study|Withdrawal by Subject|103|||
155383509|NCT04874415|560839510|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383510|NCT04874415|560839511|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383511|NCT04874415|560839512|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383512|NCT04874415|560839513|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383513|NCT04874415|560839514|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383514|NCT04874415|560839515|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
154943544|NCT00094302|559219227|FG001|Overall Study|Withdrawal by Subject|111|||
154943545|NCT00094302|559219226|FG000|Overall Study|Death|266|||
154943546|NCT00094302|559219227|FG001|Overall Study|Death|246|||
154943547|NCT01469364|559219237|FG000|Overall Study|Adverse Event|1|||
154943548|NCT01469364|559219237|FG000|Overall Study|Withdrawal by Subject|1|||
155383515|NCT04874415|560839516|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383516|NCT04874415|560839517|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383517|NCT04874415|560839518|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
155383518|NCT04874415|560839519|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383519|NCT04874415|560839520|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383520|NCT04874415|560839521|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383521|NCT04874415|560839522|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383522|NCT04874415|560839523|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
155383523|NCT04874415|560839524|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
155383524|NCT04874415|560839525|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
155383525|NCT04874415|560839510|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383526|NCT04874415|560839511|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383527|NCT04874415|560839512|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383528|NCT04874415|560839513|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383529|NCT04874415|560839514|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383530|NCT04874415|560839515|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383531|NCT04874415|560839516|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383532|NCT04874415|560839517|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383533|NCT04874415|560839518|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383534|NCT04874415|560839519|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
155383535|NCT04874415|560839520|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383536|NCT04874415|560839521|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383537|NCT04874415|560839522|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383538|NCT04874415|560839523|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383539|NCT04874415|560839524|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
155383540|NCT04874415|560839525|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
155383541|NCT04874415|560839510|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383542|NCT04874415|560839511|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383543|NCT04874415|560839512|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383544|NCT04874415|560839513|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383545|NCT04874415|560839514|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
155383546|NCT04874415|560839515|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383547|NCT04874415|560839516|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383548|NCT04874415|560839517|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383549|NCT04874415|560839518|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383550|NCT04874415|560839519|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383551|NCT04874415|560839520|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383552|NCT04874415|560839521|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383553|NCT04874415|560839522|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383554|NCT04874415|560839523|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383555|NCT04874415|560839524|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383556|NCT04874415|560839525|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
155383557|NCT05062759|560839528|FG000|Overall Study|Death|0|||
155383558|NCT05062759|560839529|FG001|Overall Study|Death|1|||
155383559|NCT05062759|560839528|FG000|Overall Study|Lost to Follow-up|1|||
155383560|NCT05062759|560839529|FG001|Overall Study|Lost to Follow-up|0|||
155383561|NCT04981366|560839530|FG000|Overall Study|Withdrawal by Subject|5|||
155383562|NCT04981366|560839531|FG001|Overall Study|Withdrawal by Subject|4|||
155383563|NCT04981366|560839532|FG002|Overall Study|Withdrawal by Subject|8|||
155383564|NCT04981366|560839530|FG000|Overall Study|Health issues unrelated to the trial|1|||
155383565|NCT04981366|560839531|FG001|Overall Study|Health issues unrelated to the trial|2|||
155383566|NCT04981366|560839532|FG002|Overall Study|Health issues unrelated to the trial|0|||
155383567|NCT03214094|560839533|FG000|Overall Study|Case Report Forms Uncollected|14|||
155383568|NCT03214094|560839533|FG000|Overall Study|Protocol Deviation|46|||
155383569|NCT00310037|560839534|FG000|Overall Study|Adverse Event|7|||
155383570|NCT00310037|560839535|FG001|Overall Study|Adverse Event|14|||
155383571|NCT00310037|560839534|FG000|Overall Study|Withdrawal by Subject|4|||
155383572|NCT00310037|560839535|FG001|Overall Study|Withdrawal by Subject|3|||
155383573|NCT00310037|560839534|FG000|Overall Study|Progression|6|||
155383574|NCT00310037|560839535|FG001|Overall Study|Progression|0|||
155383575|NCT00310037|560839534|FG000|Overall Study|Non-protocol treatment|1|||
154943549|NCT00220701|559219243|FG000|Overall Study|Lost to Follow-up|5|||
155383576|NCT00310037|560839535|FG001|Overall Study|Non-protocol treatment|0|||
155383577|NCT00440999|560839546|FG000|Overall Study|Adverse Event|0|||
155383578|NCT00440999|560839547|FG001|Overall Study|Adverse Event|2|||
155383579|NCT00440999|560839546|FG000|Overall Study|Lack of Efficacy|6|||
155383580|NCT00440999|560839547|FG001|Overall Study|Lack of Efficacy|7|||
155383581|NCT00440999|560839546|FG000|Overall Study|Lost to Follow-up|19|||
155383582|NCT00440999|560839547|FG001|Overall Study|Lost to Follow-up|12|||
155383583|NCT00440999|560839546|FG000|Overall Study|Protocol Violation|1|||
155383584|NCT00440999|560839547|FG001|Overall Study|Protocol Violation|0|||
155383585|NCT00440999|560839546|FG000|Overall Study|Withdrawal by Subject|2|||
155383586|NCT00440999|560839547|FG001|Overall Study|Withdrawal by Subject|5|||
155383587|NCT00440999|560839546|FG000|Overall Study|Subjets missed the visit|1|||
155383588|NCT00440999|560839547|FG001|Overall Study|Subjets missed the visit|0|||
155383589|NCT00440999|560839546|FG000|Overall Study|Mixed infection at entry|1|||
155383590|NCT00440999|560839547|FG001|Overall Study|Mixed infection at entry|0|||
155383591|NCT00440999|560839546|FG000|Overall Study|P. falciparum malaria|5|||
155383592|NCT00440999|560839547|FG001|Overall Study|P. falciparum malaria|14|||
155383593|NCT00440999|560839546|FG000|Overall Study|Subj left hosp without inform staff|0|||
155383594|NCT00440999|560839547|FG001|Overall Study|Subj left hosp without inform staff|1|||
155383595|NCT05559099|560839550|FG000|Overall Study|Death|5|||
155383596|NCT05559099|560839551|FG001|Overall Study|Death|4|||
155383597|NCT05559099|560839550|FG000|Overall Study|Lost to Follow-up|0|||
155383598|NCT05559099|560839551|FG001|Overall Study|Lost to Follow-up|2|||
155383599|NCT05559099|560839550|FG000|Overall Study|Adverse Event|1|||
155383600|NCT05559099|560839551|FG001|Overall Study|Adverse Event|1|||
155383601|NCT04018092|560839552|FG000|Overall Study|Withdrawal by Subject|1|||
155383602|NCT04018092|560839553|FG001|Overall Study|Withdrawal by Subject|1|||
155383603|NCT04018092|560839552|FG000|Overall Study|Withdrawal by Subject|1|||
155383604|NCT04018092|560839553|FG001|Overall Study|Withdrawal by Subject|1|||
155383605|NCT06469242|560839554|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
155383606|NCT06469242|560839555|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
155383607|NCT06469242|560839554|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
155383608|NCT06469242|560839555|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
155383609|NCT05041101|560839556|FG000|Overall Study|Adverse Event|1|||
155383610|NCT05041101|560839557|FG001|Overall Study|Adverse Event|0|||
155383611|NCT05041101|560839558|FG002|Overall Study|Adverse Event|0|||
155383612|NCT05041101|560839556|FG000|Overall Study|Diease Progression|5|||
155383613|NCT05041101|560839557|FG001|Overall Study|Diease Progression|0|||
155383614|NCT05041101|560839558|FG002|Overall Study|Diease Progression|0|||
155383615|NCT00211185|560839559|FG000|Overall Study|Death|2|||
155383616|NCT00211185|560839559|FG000|Overall Study|Disease progression|7|||
155383617|NCT00211185|560839559|FG000|Overall Study|Withdrawal by Subject|6|||
155383618|NCT00211185|560839559|FG000|Overall Study|Physician Decision|5|||
155383619|NCT00249002|560839560|FG000|Overall Study|Adverse Event|2|||
155383620|NCT00249002|560839560|FG000|Overall Study|Study cancellation|3|||
154943550|NCT00220701|559219244|FG001|Overall Study|Lost to Follow-up|4|||
154943551|NCT00634907|559219250|FG000|Overall Study|Withdrawal by Subject|3|||
154943552|NCT00634907|559219251|FG001|Overall Study|Withdrawal by Subject|0|||
154943553|NCT00634907|559219250|FG000|Overall Study|Physician Decision|3|||
154943554|NCT00634907|559219251|FG001|Overall Study|Physician Decision|9|||
154943555|NCT00634907|559219250|FG000|Overall Study|Withdrawal by Subject|11|||
154943556|NCT00634907|559219251|FG001|Overall Study|Withdrawal by Subject|8|||
154943557|NCT04041570|559219254|FG000|Overall Study|Moved from Area|0|||
154943558|NCT04041570|559219255|FG001|Overall Study|Moved from Area|2|||
154943559|NCT01338636|559219256|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
154943560|NCT02385526|559219257|FG000|Overall Study|Withdrawal by Subject|0|||
154943561|NCT02385526|559219258|FG001|Overall Study|Withdrawal by Subject|2|||
154943562|NCT02385526|559219259|FG002|Overall Study|Withdrawal by Subject|0|||
154943563|NCT02385526|559219257|FG000|Overall Study|Lost to Follow-up|0|||
154943564|NCT02385526|559219258|FG001|Overall Study|Lost to Follow-up|1|||
154943565|NCT02385526|559219259|FG002|Overall Study|Lost to Follow-up|0|||
154943566|NCT02385526|559219257|FG000|Overall Study|Physician Decision|1|||
155383621|NCT00249002|560839560|FG000|Overall Study|Other|2|||
155383622|NCT00069108|560839561|FG000|Overall Study|Withdrawal by Subject|5|||
155383623|NCT00069108|560839562|FG001|Overall Study|Withdrawal by Subject|9|||
155383624|NCT00069108|560839561|FG000|Overall Study|Adverse Event|64|||
154943567|NCT02385526|559219258|FG001|Overall Study|Physician Decision|0|||
154943568|NCT02385526|559219259|FG002|Overall Study|Physician Decision|0|||
154943569|NCT02385526|559219257|FG000|Overall Study|Protocol Violation|1|||
154943570|NCT02385526|559219258|FG001|Overall Study|Protocol Violation|0|||
154943571|NCT02385526|559219259|FG002|Overall Study|Protocol Violation|0|||
154943572|NCT03532009|559219262|FG000|Overall Study|Other|1|||
154943573|NCT03532009|559219263|FG001|Overall Study|Other|1|||
155383625|NCT00069108|560839562|FG001|Overall Study|Adverse Event|42|||
155383626|NCT00069108|560839561|FG000|Overall Study|Death|6|||
155383627|NCT00069108|560839562|FG001|Overall Study|Death|6|||
154943574|NCT03532009|559219262|FG000|Overall Study|Death|1|||
154943575|NCT03532009|559219263|FG001|Overall Study|Death|1|||
154943576|NCT03532009|559219262|FG000|Overall Study|Withdrawal by Patient|0|||
154943577|NCT03532009|559219263|FG001|Overall Study|Withdrawal by Patient|2|||
155383628|NCT00069108|560839561|FG000|Overall Study|Administration|15|||
155383629|NCT00069108|560839562|FG001|Overall Study|Administration|4|||
155383630|NCT00069108|560839561|FG000|Overall Study|Insufficient therapy|117|||
155045650|NCT05052697|559599408|FG022|Substudy A|Lost to Follow-up|0|||
155045651|NCT05052697|559599409|FG023|Substudy A|Lost to Follow-up|0|||
155045652|NCT05052697|559599410|FG024|Substudy A|Lost to Follow-up|0|||
155045653|NCT05052697|559599411|FG025|Substudy A|Lost to Follow-up|0|||
155045654|NCT05052697|559599412|FG026|Substudy A|Lost to Follow-up|0|||
155045655|NCT05052697|559599413|FG027|Substudy A|Lost to Follow-up|0|||
155045656|NCT05052697|559599414|FG028|Substudy A|Lost to Follow-up|0|||
155045657|NCT05052697|559599415|FG029|Substudy A|Lost to Follow-up|0|||
155045658|NCT05052697|559599416|FG030|Substudy A|Lost to Follow-up|0|||
155045659|NCT05052697|559599417|FG031|Substudy A|Lost to Follow-up|0|||
155045660|NCT05052697|559599418|FG032|Substudy A|Lost to Follow-up|0|||
155045661|NCT05052697|559599419|FG033|Substudy A|Lost to Follow-up|0|||
155045662|NCT05052697|559599386|FG000|Substudy A|No longer met eligibility criteria|0|||
155045663|NCT05052697|559599387|FG001|Substudy A|No longer met eligibility criteria|0|||
155045664|NCT05052697|559599388|FG002|Substudy A|No longer met eligibility criteria|0|||
155045665|NCT05052697|559599389|FG003|Substudy A|No longer met eligibility criteria|0|||
155045666|NCT05052697|559599390|FG004|Substudy A|No longer met eligibility criteria|0|||
155045667|NCT05052697|559599391|FG005|Substudy A|No longer met eligibility criteria|0|||
155045668|NCT05052697|559599392|FG006|Substudy A|No longer met eligibility criteria|0|||
155278990|NCT00873093|560454745|FG003|Overall Study|Ineligible|1|||
155278991|NCT00873093|560454746|FG004|Overall Study|Ineligible|0|||
155278992|NCT00146640|560454749|FG000|Overall Study|Adverse Event|12|||
155278993|NCT00146640|560454750|FG001|Overall Study|Adverse Event|10|||
155278994|NCT00146640|560454749|FG000|Overall Study|Medical Reasons|3|||
155278995|NCT00146640|560454750|FG001|Overall Study|Medical Reasons|0|||
155278996|NCT00146640|560454749|FG000|Overall Study|Non-Medical Reasons|8|||
155278997|NCT00146640|560454750|FG001|Overall Study|Non-Medical Reasons|4|||
155278998|NCT02117544|560454751|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
155278999|NCT02117544|560454752|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
155279000|NCT02059161|560454753|FG000|Overall Study|Pregnancy|0|||
155279001|NCT02059161|560454754|FG001|Overall Study|Pregnancy|2|||
155279002|NCT02059161|560454753|FG000|Overall Study|Adverse Event|2|||
155279003|NCT02059161|560454754|FG001|Overall Study|Adverse Event|6|||
155279004|NCT02059161|560454753|FG000|Overall Study|Lost to Follow-up|20|||
155279005|NCT02059161|560454754|FG001|Overall Study|Lost to Follow-up|12|||
155279006|NCT02059161|560454753|FG000|Overall Study|Physician Decision|4|||
155279007|NCT02059161|560454754|FG001|Overall Study|Physician Decision|4|||
155279008|NCT02059161|560454753|FG000|Overall Study|Protocol Violation|1|||
155279009|NCT02059161|560454754|FG001|Overall Study|Protocol Violation|1|||
155279010|NCT02059161|560454753|FG000|Overall Study|Withdrawal by Subject|16|||
155279011|NCT02059161|560454754|FG001|Overall Study|Withdrawal by Subject|13|||
155279012|NCT02059161|560454753|FG000|Overall Study|Randomized in error, no study drug|0|||
155279013|NCT02059161|560454754|FG001|Overall Study|Randomized in error, no study drug|1|||
155279014|NCT02059161|560454753|FG000|Overall Study|Non-compliance with study drug|6|||
155279015|NCT02059161|560454754|FG001|Overall Study|Non-compliance with study drug|2|||
155279016|NCT03486899|560454755|FG000|Overall Study|Lost to Follow-up|4|||
155279017|NCT03486899|560454756|FG001|Overall Study|Lost to Follow-up|1|||
155279018|NCT03486899|560454757|FG002|Overall Study|Lost to Follow-up|4|||
155279019|NCT03486899|560454758|FG003|Overall Study|Lost to Follow-up|3|||
155279020|NCT03486899|560454755|FG000|Overall Study|Death|1|||
155279021|NCT03486899|560454756|FG001|Overall Study|Death|0|||
155279022|NCT03486899|560454757|FG002|Overall Study|Death|0|||
155279023|NCT03486899|560454758|FG003|Overall Study|Death|1|||
155279024|NCT03486899|560454755|FG000|Overall Study|Adverse Event|0|||
155279025|NCT03486899|560454756|FG001|Overall Study|Adverse Event|2|||
155279026|NCT03486899|560454757|FG002|Overall Study|Adverse Event|0|||
155279027|NCT03486899|560454758|FG003|Overall Study|Adverse Event|2|||
155279028|NCT03486899|560454755|FG000|Overall Study|Withdrawal by Subject|3|||
155279029|NCT03486899|560454756|FG001|Overall Study|Withdrawal by Subject|7|||
155279030|NCT03486899|560454757|FG002|Overall Study|Withdrawal by Subject|4|||
155279031|NCT03486899|560454758|FG003|Overall Study|Withdrawal by Subject|3|||
155279032|NCT03486899|560454755|FG000|Overall Study|Other Reasons|0|||
155279033|NCT03486899|560454756|FG001|Overall Study|Other Reasons|1|||
155279034|NCT03486899|560454757|FG002|Overall Study|Other Reasons|0|||
155279035|NCT03486899|560454758|FG003|Overall Study|Other Reasons|1|||
155279036|NCT01723826|560454759|FG000|Overall Study|Adverse Event|4|||
155279037|NCT01723826|560454760|FG001|Overall Study|Adverse Event|1|||
155279038|NCT01723826|560454761|FG002|Overall Study|Adverse Event|4|||
155279039|NCT01723826|560454762|FG003|Overall Study|Adverse Event|5|||
155279040|NCT01723826|560454759|FG000|Overall Study|Death according to AE eCRF|2|||
155279041|NCT01723826|560454760|FG001|Overall Study|Death according to AE eCRF|3|||
155279042|NCT01723826|560454761|FG002|Overall Study|Death according to AE eCRF|3|||
155279043|NCT01723826|560454762|FG003|Overall Study|Death according to AE eCRF|7|||
155279044|NCT01723826|560454759|FG000|Overall Study|Lost to Follow-up|1|||
155279045|NCT01723826|560454760|FG001|Overall Study|Lost to Follow-up|3|||
155279046|NCT01723826|560454761|FG002|Overall Study|Lost to Follow-up|1|||
155279047|NCT01723826|560454762|FG003|Overall Study|Lost to Follow-up|1|||
155279048|NCT01723826|560454759|FG000|Overall Study|Non-compliance|0|||
155279049|NCT01723826|560454760|FG001|Overall Study|Non-compliance|1|||
155383631|NCT00069108|560839562|FG001|Overall Study|Insufficient therapy|144|||
155383632|NCT00069108|560839561|FG000|Overall Study|Violation criteria|1|||
155383633|NCT00069108|560839562|FG001|Overall Study|Violation criteria|4|||
155383634|NCT00069108|560839561|FG000|Overall Study|Refused treatment|5|||
155383635|NCT00069108|560839562|FG001|Overall Study|Refused treatment|10|||
155383636|NCT00986674|560839563|FG000|Overall Study|Lack of Efficacy|28|||
155383637|NCT00986674|560839564|FG001|Overall Study|Lack of Efficacy|25|||
155383638|NCT00986674|560839565|FG002|Overall Study|Lack of Efficacy|23|||
155383639|NCT00986674|560839563|FG000|Overall Study|Adverse Event|4|||
155383640|NCT00986674|560839564|FG001|Overall Study|Adverse Event|8|||
155383641|NCT00986674|560839565|FG002|Overall Study|Adverse Event|9|||
155383642|NCT00986674|560839563|FG000|Overall Study|Death|5|||
155383643|NCT00986674|560839564|FG001|Overall Study|Death|0|||
155383644|NCT00986674|560839565|FG002|Overall Study|Death|4|||
155383645|NCT00986674|560839563|FG000|Overall Study|Withdrawal by Subject|6|||
155383646|NCT00986674|560839564|FG001|Overall Study|Withdrawal by Subject|2|||
155383647|NCT00986674|560839565|FG002|Overall Study|Withdrawal by Subject|1|||
155383648|NCT00986674|560839563|FG000|Overall Study|alternative therapy|0|||
155383649|NCT00986674|560839564|FG001|Overall Study|alternative therapy|0|||
155383650|NCT00986674|560839565|FG002|Overall Study|alternative therapy|1|||
155383651|NCT00986674|560839563|FG000|Overall Study|not start protocol therapy|4|||
155383652|NCT00986674|560839564|FG001|Overall Study|not start protocol therapy|3|||
155383653|NCT00986674|560839565|FG002|Overall Study|not start protocol therapy|1|||
155383654|NCT00986674|560839563|FG000|Overall Study|unknown/not specify|0|||
155383655|NCT00986674|560839564|FG001|Overall Study|unknown/not specify|7|||
155383656|NCT00986674|560839565|FG002|Overall Study|unknown/not specify|9|||
155383657|NCT00842985|560839566|FG000|Screening|Did not meet entrance requirements|27|||
155383658|NCT00842985|560839566|FG000|First Intervention|Withdrawal by Subject|3|||
155383659|NCT00842985|560839566|FG000|First Intervention|Protocol Violation|3|||
155383660|NCT00842985|560839566|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
155383661|NCT00842985|560839566|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
155383662|NCT01037244|560839567|FG000|Overall Study|Adverse Event|3|||
155383663|NCT01037244|560839568|FG001|Overall Study|Adverse Event|2|||
154943578|NCT00368966|559219264|FG000|Infant Series|Withdrawal by Subject|11|||
154943579|NCT00368966|559219265|FG001|Infant Series|Withdrawal by Subject|6|||
155383664|NCT01037244|560839569|FG002|Overall Study|Adverse Event|6|||
155383665|NCT01037244|560839570|FG003|Overall Study|Adverse Event|3|||
154943580|NCT00368966|559219264|FG000|Infant Series|Protocol Violation|2|||
155383666|NCT01037244|560839567|FG000|Overall Study|Lack of Efficacy|1|||
154943581|NCT00368966|559219265|FG001|Infant Series|Protocol Violation|1|||
154943582|NCT00368966|559219264|FG000|Infant Series|Lost to Follow-up|2|||
154943583|NCT00368966|559219265|FG001|Infant Series|Lost to Follow-up|0|||
154943584|NCT00368966|559219264|FG000|Infant Series|Randomization error|0|||
154943585|NCT00368966|559219265|FG001|Infant Series|Randomization error|1|||
154943586|NCT00368966|559219264|FG000|Infant Series|Failed to meet eligibility criteria|0|||
154943587|NCT00368966|559219265|FG001|Infant Series|Failed to meet eligibility criteria|1|||
154943588|NCT00368966|559219264|FG000|Infant Series|Adverse Event|0|||
154943589|NCT00368966|559219265|FG001|Infant Series|Adverse Event|1|||
154943590|NCT00368966|559219264|FG000|Infant Series|Failed to return|1|||
154943591|NCT00368966|559219265|FG001|Infant Series|Failed to return|0|||
154943592|NCT00368966|559219264|FG000|After Infant|Failed to return|3|||
154943593|NCT00368966|559219265|FG001|After Infant|Failed to return|1|||
154943594|NCT00368966|559219264|FG000|After Infant|Adverse Event|1|||
154943595|NCT00368966|559219265|FG001|After Infant|Adverse Event|2|||
154943596|NCT00368966|559219264|FG000|After Infant|Withdrawal by Subject|1|||
154943597|NCT00368966|559219265|FG001|After Infant|Withdrawal by Subject|1|||
154943598|NCT00368966|559219264|FG000|After Infant|Death|1|||
154943599|NCT00368966|559219265|FG001|After Infant|Death|0|||
154943600|NCT00368966|559219264|FG000|After Infant|Lost to Follow-up|0|||
154943601|NCT00368966|559219265|FG001|After Infant|Lost to Follow-up|1|||
154943602|NCT00368966|559219264|FG000|Toddler Dose|Withdrawal by Subject|1|||
154943603|NCT00368966|559219265|FG001|Toddler Dose|Withdrawal by Subject|1|||
154943604|NCT00368966|559219264|FG000|Toddler Dose|Lost to Follow-up|0|||
154943605|NCT00368966|559219265|FG001|Toddler Dose|Lost to Follow-up|2|||
154943606|NCT02866175|559219266|FG000|Overall Study|Adverse Event|56|||
154943607|NCT02866175|559219267|FG001|Overall Study|Adverse Event|54|||
154943608|NCT02866175|559219266|FG000|Overall Study|Withdrawal by Subject|31|||
154943609|NCT02866175|559219267|FG001|Overall Study|Withdrawal by Subject|52|||
155383667|NCT01037244|560839568|FG001|Overall Study|Lack of Efficacy|1|||
155383668|NCT01037244|560839569|FG002|Overall Study|Lack of Efficacy|0|||
154943610|NCT02866175|559219266|FG000|Overall Study|Death|30|||
154943611|NCT02866175|559219267|FG001|Overall Study|Death|23|||
154943612|NCT02866175|559219266|FG000|Overall Study|Other|7|||
154943613|NCT02866175|559219267|FG001|Overall Study|Other|14|||
154943614|NCT02866175|559219266|FG000|Overall Study|Progressive disease|1|||
154943615|NCT02866175|559219267|FG001|Overall Study|Progressive disease|1|||
154943616|NCT02866175|559219266|FG000|Overall Study|Lost to Follow-up|2|||
154943617|NCT02866175|559219267|FG001|Overall Study|Lost to Follow-up|0|||
155383669|NCT01037244|560839570|FG003|Overall Study|Lack of Efficacy|1|||
155383670|NCT01037244|560839567|FG000|Overall Study|Lost to Follow-up|3|||
155383671|NCT01037244|560839568|FG001|Overall Study|Lost to Follow-up|3|||
155383672|NCT01037244|560839569|FG002|Overall Study|Lost to Follow-up|4|||
155383673|NCT01037244|560839570|FG003|Overall Study|Lost to Follow-up|4|||
155383674|NCT01037244|560839567|FG000|Overall Study|Withdrawal by Subject|1|||
155383675|NCT01037244|560839568|FG001|Overall Study|Withdrawal by Subject|5|||
154943618|NCT02866175|559219266|FG000|Overall Study|Lack of Efficacy|0|||
154943619|NCT02866175|559219267|FG001|Overall Study|Lack of Efficacy|1|||
154943620|NCT02866175|559219266|FG000|Overall Study|Physician Decision|3|||
154943621|NCT02866175|559219267|FG001|Overall Study|Physician Decision|15|||
154943622|NCT02866175|559219266|FG000|Overall Study|Did not receive treatment|5|||
154943623|NCT02866175|559219267|FG001|Overall Study|Did not receive treatment|15|||
154943624|NCT01694485|559219272|FG000|Overall Study|Withdrawal by Subject|20|||
154943625|NCT01694485|559219273|FG001|Overall Study|Withdrawal by Subject|6|||
154943626|NCT01694485|559219274|FG002|Overall Study|Withdrawal by Subject|7|||
154943627|NCT01694485|559219275|FG003|Overall Study|Withdrawal by Subject|25|||
154943628|NCT01694485|559219276|FG004|Overall Study|Withdrawal by Subject|18|||
154943629|NCT01694485|559219272|FG000|Overall Study|Sponsor Decision|3|||
154943630|NCT01694485|559219273|FG001|Overall Study|Sponsor Decision|0|||
154943631|NCT01694485|559219274|FG002|Overall Study|Sponsor Decision|0|||
154943632|NCT01694485|559219275|FG003|Overall Study|Sponsor Decision|2|||
154943633|NCT01694485|559219276|FG004|Overall Study|Sponsor Decision|0|||
154943634|NCT01694485|559219272|FG000|Overall Study|Lost to Follow-up|9|||
154943635|NCT01694485|559219273|FG001|Overall Study|Lost to Follow-up|1|||
154943636|NCT01694485|559219274|FG002|Overall Study|Lost to Follow-up|6|||
154943637|NCT01694485|559219275|FG003|Overall Study|Lost to Follow-up|10|||
154943638|NCT01694485|559219276|FG004|Overall Study|Lost to Follow-up|7|||
154943639|NCT01694485|559219272|FG000|Overall Study|Death|1|||
154943640|NCT01694485|559219273|FG001|Overall Study|Death|0|||
154943641|NCT01694485|559219274|FG002|Overall Study|Death|0|||
154943642|NCT01694485|559219275|FG003|Overall Study|Death|1|||
154943643|NCT01694485|559219276|FG004|Overall Study|Death|0|||
154943644|NCT02907203|559219277|FG000|Overall Study|Death|1|||
154943645|NCT02907203|559219277|FG000|Overall Study|Lost to Follow-up|3|||
154943646|NCT02907203|559219277|FG000|Overall Study|Withdrawal by Subject|3|||
154943647|NCT02907203|559219277|FG000|Overall Study|Surgical bypass|1|||
154943648|NCT01689974|559219279|FG000|Overall Study|Termination of Study|5|||
154943649|NCT01689974|559219280|FG001|Overall Study|Termination of Study|5|||
154943650|NCT00681863|559219281|FG000|Overall Study|Adverse Event|1|||
154943651|NCT00681863|559219281|FG000|Overall Study|Lost to Follow-up|2|||
154943652|NCT00681863|559219281|FG000|Overall Study|Lack of Efficacy|2|||
154943653|NCT00681863|559219281|FG000|Overall Study|Other|18|||
154943654|NCT01333033|559219282|FG000|Overall Study|Ineligible|0|||
154943655|NCT01333033|559219283|FG001|Overall Study|Ineligible|0|||
154943656|NCT01333033|559219284|FG002|Overall Study|Ineligible|0|||
154943657|NCT01333033|559219285|FG003|Overall Study|Ineligible|0|||
154943658|NCT01333033|559219286|FG004|Overall Study|Ineligible|6|||
154943659|NCT01333033|559219287|FG005|Overall Study|Ineligible|8|||
154943660|NCT01333033|559219282|FG000|Overall Study|Withdrawal by Subject|0|||
154943661|NCT01333033|559219283|FG001|Overall Study|Withdrawal by Subject|0|||
154943662|NCT01333033|559219284|FG002|Overall Study|Withdrawal by Subject|0|||
154943663|NCT01333033|559219285|FG003|Overall Study|Withdrawal by Subject|0|||
154943664|NCT01333033|559219286|FG004|Overall Study|Withdrawal by Subject|4|||
154943665|NCT01333033|559219287|FG005|Overall Study|Withdrawal by Subject|2|||
154943666|NCT01333033|559219282|FG000|Overall Study|PET inevaluable|0|||
154943667|NCT01333033|559219283|FG001|Overall Study|PET inevaluable|0|||
154943668|NCT01333033|559219284|FG002|Overall Study|PET inevaluable|0|||
154943669|NCT01333033|559219285|FG003|Overall Study|PET inevaluable|0|||
154943670|NCT01333033|559219286|FG004|Overall Study|PET inevaluable|2|||
154943671|NCT01333033|559219287|FG005|Overall Study|PET inevaluable|4|||
154943672|NCT01333033|559219282|FG000|Overall Study|Adverse Event|0|||
154943673|NCT01333033|559219283|FG001|Overall Study|Adverse Event|0|||
154943674|NCT01333033|559219284|FG002|Overall Study|Adverse Event|0|||
154943675|NCT01333033|559219285|FG003|Overall Study|Adverse Event|0|||
154943676|NCT01333033|559219286|FG004|Overall Study|Adverse Event|2|||
154943677|NCT01333033|559219287|FG005|Overall Study|Adverse Event|1|||
154943678|NCT01333033|559219282|FG000|Overall Study|Progression|0|||
155383676|NCT01037244|560839569|FG002|Overall Study|Withdrawal by Subject|3|||
154943679|NCT01333033|559219283|FG001|Overall Study|Progression|0|||
154943680|NCT01333033|559219284|FG002|Overall Study|Progression|0|||
154943681|NCT01333033|559219285|FG003|Overall Study|Progression|0|||
154943682|NCT01333033|559219286|FG004|Overall Study|Progression|0|||
154943683|NCT01333033|559219287|FG005|Overall Study|Progression|1|||
154943684|NCT01333033|559219282|FG000|Overall Study|MD Decision|0|||
154943685|NCT01333033|559219283|FG001|Overall Study|MD Decision|0|||
154943686|NCT01333033|559219284|FG002|Overall Study|MD Decision|0|||
154943687|NCT01333033|559219285|FG003|Overall Study|MD Decision|0|||
154943688|NCT01333033|559219286|FG004|Overall Study|MD Decision|0|||
154943689|NCT01333033|559219287|FG005|Overall Study|MD Decision|2|||
154943690|NCT01388647|559219290|FG000|Overall Study|Adverse Event|1|||
154943691|NCT01388647|559219291|FG001|Overall Study|Adverse Event|2|||
154943692|NCT01006707|559219292|FG000|Study Session 1|Lost to Follow-up|2|||
154943693|NCT01006707|559219293|FG001|Study Session 1|Lost to Follow-up|0|||
155383677|NCT01037244|560839570|FG003|Overall Study|Withdrawal by Subject|5|||
155383678|NCT01037244|560839567|FG000|Overall Study|Partner Withdrew Consent|2|||
155383679|NCT01037244|560839568|FG001|Overall Study|Partner Withdrew Consent|1|||
155383680|NCT01037244|560839569|FG002|Overall Study|Partner Withdrew Consent|0|||
155383681|NCT01037244|560839570|FG003|Overall Study|Partner Withdrew Consent|0|||
155383682|NCT01037244|560839567|FG000|Overall Study|Various|3|||
155383683|NCT01037244|560839568|FG001|Overall Study|Various|2|||
155383684|NCT01037244|560839569|FG002|Overall Study|Various|1|||
155383685|NCT01037244|560839570|FG003|Overall Study|Various|1|||
155383686|NCT01411215|560839571|FG000|Overall Study|Adverse Event|1|||
155383687|NCT01411215|560839572|FG001|Overall Study|Adverse Event|2|||
155383688|NCT01411215|560839571|FG000|Overall Study|Lack of Efficacy|2|||
155383689|NCT01411215|560839572|FG001|Overall Study|Lack of Efficacy|4|||
155383690|NCT01411215|560839571|FG000|Overall Study|Lost to Follow-up|12|||
155383691|NCT01411215|560839572|FG001|Overall Study|Lost to Follow-up|18|||
155383692|NCT01411215|560839571|FG000|Overall Study|Did not meet entrance criteria|0|||
155383693|NCT01411215|560839572|FG001|Overall Study|Did not meet entrance criteria|1|||
155383694|NCT01411215|560839571|FG000|Overall Study|Study terminated by sponsor|2|||
155383695|NCT01411215|560839572|FG001|Overall Study|Study terminated by sponsor|15|||
155383696|NCT01411215|560839571|FG000|Overall Study|Protocol Violation|3|||
155383697|NCT01411215|560839572|FG001|Overall Study|Protocol Violation|5|||
155383698|NCT01411215|560839571|FG000|Overall Study|Withdrawal by Subject|34|||
155383699|NCT01411215|560839572|FG001|Overall Study|Withdrawal by Subject|21|||
155383700|NCT01411215|560839571|FG000|Overall Study|Other|12|||
155383701|NCT01411215|560839572|FG001|Overall Study|Other|17|||
155383702|NCT01411215|560839571|FG000|Overall Study|Screen failure|0|||
155383703|NCT01411215|560839572|FG001|Overall Study|Screen failure|1|||
155383704|NCT04025580|560839573|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
155383705|NCT04025580|560839574|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
155383706|NCT04025580|560839575|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
155383707|NCT03305731|560839577|FG000|Overall Study|Protocol Violation|1|||
155383708|NCT01952054|560839578|FG000|Overall Study|Physician Decision|1|||
155383709|NCT01718353|560839581|FG000|Overall Study|Lost to Follow-up|0|||
155383710|NCT01718353|560839582|FG001|Overall Study|Lost to Follow-up|1|||
155383711|NCT01718353|560839581|FG000|Overall Study|Principal Investigator's Decision|10|||
155383712|NCT01718353|560839582|FG001|Overall Study|Principal Investigator's Decision|4|||
155383713|NCT01718353|560839581|FG000|Overall Study|Randomized but not treated|2|||
155383714|NCT01718353|560839582|FG001|Overall Study|Randomized but not treated|0|||
155383715|NCT01959516|560839583|FG000|Epoch 1|Adverse Event|4|||
155383716|NCT01959516|560839584|FG001|Epoch 1|Adverse Event|1|||
154943694|NCT01006707|559219294|FG002|Study Session 1|Lost to Follow-up|0|||
154943695|NCT01006707|559219292|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
154943696|NCT01006707|559219293|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
154943697|NCT01006707|559219294|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
154943698|NCT02750306|559219295|FG000|Overall Study|Withdrawal by Subject|5|||
154943699|NCT02750306|559219296|FG001|Overall Study|Withdrawal by Subject|2|||
154943700|NCT02750306|559219295|FG000|Overall Study|Protocol Violation|1|||
154943701|NCT02750306|559219296|FG001|Overall Study|Protocol Violation|0|||
154943702|NCT00760383|559219298|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
154943703|NCT00760383|559219299|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
154943704|NCT00192296|559219300|FG000|Overall Study|Withdrawal by Subject|0|||
154943705|NCT00192296|559219301|FG001|Overall Study|Withdrawal by Subject|1|||
154943706|NCT00192296|559219302|FG002|Overall Study|Withdrawal by Subject|0|||
154943707|NCT00192296|559219303|FG003|Overall Study|Withdrawal by Subject|0|||
154943708|NCT01842958|559219305|FG000|Overall Study|Lost to Follow-up|1|||
154943709|NCT01842958|559219306|FG001|Overall Study|Lost to Follow-up|1|||
154943710|NCT03361423|559219307|FG000|Overall Study|Withdrawal by Subject|4|||
154943711|NCT03361423|559219308|FG001|Overall Study|Withdrawal by Subject|3|||
154943712|NCT03361423|559219307|FG000|Overall Study|Did not treat|19|||
154943713|NCT03361423|559219308|FG001|Overall Study|Did not treat|18|||
154943714|NCT03361423|559219307|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
154943715|NCT03361423|559219308|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
154943716|NCT03361423|559219307|FG000|Overall Study|Missing data|4|||
154943717|NCT03361423|559219308|FG001|Overall Study|Missing data|1|||
154943718|NCT00818623|559219309|FG000|Overall Study|Adverse Event|1|||
154943719|NCT00818623|559219310|FG001|Overall Study|Adverse Event|0|||
154943720|NCT00818623|559219311|FG002|Overall Study|Adverse Event|1|||
155045669|NCT05052697|559599393|FG007|Substudy A|No longer met eligibility criteria|0|||
155383717|NCT01959516|560839583|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
155383718|NCT01959516|560839584|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
155383719|NCT01959516|560839583|FG000|Epoch 1|Subject withdrew consent|3|||
155383720|NCT01959516|560839584|FG001|Epoch 1|Subject withdrew consent|2|||
154943721|NCT00818623|559219312|FG003|Overall Study|Adverse Event|0|||
154943722|NCT00818623|559219313|FG004|Overall Study|Adverse Event|0|||
154943723|NCT00818623|559219314|FG005|Overall Study|Adverse Event|1|||
154943724|NCT00818623|559219315|FG006|Overall Study|Adverse Event|0|||
155383721|NCT01959516|560839583|FG000|Epoch 1|Administrative problems|1|||
155383722|NCT01959516|560839584|FG001|Epoch 1|Administrative problems|0|||
155383723|NCT01959516|560839583|FG000|Epoch 1|Use of prohibited treatment|1|||
155383724|NCT01959516|560839584|FG001|Epoch 1|Use of prohibited treatment|0|||
155383725|NCT01959516|560839583|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
155045670|NCT05052697|559599394|FG008|Substudy A|No longer met eligibility criteria|0|||
155045671|NCT05052697|559599395|FG009|Substudy A|No longer met eligibility criteria|0|||
155045672|NCT05052697|559599396|FG010|Substudy A|No longer met eligibility criteria|0|||
155045673|NCT05052697|559599397|FG011|Substudy A|No longer met eligibility criteria|0|||
155045674|NCT05052697|559599398|FG012|Substudy A|No longer met eligibility criteria|0|||
155045675|NCT05052697|559599399|FG013|Substudy A|No longer met eligibility criteria|1|||
155045676|NCT05052697|559599400|FG014|Substudy A|No longer met eligibility criteria|0|||
155045677|NCT05052697|559599401|FG015|Substudy A|No longer met eligibility criteria|0|||
155045678|NCT05052697|559599402|FG016|Substudy A|No longer met eligibility criteria|0|||
155045679|NCT05052697|559599403|FG017|Substudy A|No longer met eligibility criteria|0|||
155045680|NCT05052697|559599404|FG018|Substudy A|No longer met eligibility criteria|0|||
155279050|NCT01723826|560454761|FG002|Overall Study|Non-compliance|3|||
155279051|NCT01723826|560454762|FG003|Overall Study|Non-compliance|3|||
155279052|NCT01723826|560454759|FG000|Overall Study|Non-compliance With Study Drug|0|||
155279053|NCT01723826|560454760|FG001|Overall Study|Non-compliance With Study Drug|1|||
155279054|NCT01723826|560454761|FG002|Overall Study|Non-compliance With Study Drug|0|||
155279055|NCT01723826|560454762|FG003|Overall Study|Non-compliance With Study Drug|0|||
155279056|NCT01723826|560454759|FG000|Overall Study|Other Reason|8|||
155279057|NCT01723826|560454760|FG001|Overall Study|Other Reason|6|||
155279058|NCT01723826|560454761|FG002|Overall Study|Other Reason|12|||
155279059|NCT01723826|560454762|FG003|Overall Study|Other Reason|14|||
155279060|NCT01723826|560454759|FG000|Overall Study|Physician Decision|1|||
155279061|NCT01723826|560454760|FG001|Overall Study|Physician Decision|3|||
155279062|NCT01723826|560454761|FG002|Overall Study|Physician Decision|4|||
155279063|NCT01723826|560454762|FG003|Overall Study|Physician Decision|11|||
155279064|NCT01723826|560454759|FG000|Overall Study|Protocol Violation|1|||
155279065|NCT01723826|560454760|FG001|Overall Study|Protocol Violation|1|||
155279066|NCT01723826|560454761|FG002|Overall Study|Protocol Violation|3|||
155279067|NCT01723826|560454762|FG003|Overall Study|Protocol Violation|1|||
155279068|NCT01723826|560454759|FG000|Overall Study|Withdrawal by Subject|10|||
155279069|NCT01723826|560454760|FG001|Overall Study|Withdrawal by Subject|17|||
155279070|NCT01723826|560454761|FG002|Overall Study|Withdrawal by Subject|27|||
155279071|NCT01723826|560454762|FG003|Overall Study|Withdrawal by Subject|48|||
155279072|NCT03100838|560454773|FG000|Overall Study|Adverse Event|1|||
155279073|NCT03100838|560454774|FG001|Overall Study|Adverse Event|0|||
155279074|NCT03100838|560454775|FG002|Overall Study|Adverse Event|0|||
155279075|NCT03100838|560454776|FG003|Overall Study|Adverse Event|0|||
155279076|NCT03100838|560454773|FG000|Overall Study|Physician Decision|1|||
155279077|NCT03100838|560454774|FG001|Overall Study|Physician Decision|1|||
155279078|NCT03100838|560454775|FG002|Overall Study|Physician Decision|1|||
155279079|NCT03100838|560454776|FG003|Overall Study|Physician Decision|1|||
155279080|NCT03100838|560454773|FG000|Overall Study|Pregnancy|0|||
155279081|NCT03100838|560454774|FG001|Overall Study|Pregnancy|1|||
155279082|NCT03100838|560454775|FG002|Overall Study|Pregnancy|0|||
155279083|NCT03100838|560454776|FG003|Overall Study|Pregnancy|0|||
155279084|NCT03100838|560454773|FG000|Overall Study|Lost to Follow-up|0|||
155279085|NCT03100838|560454774|FG001|Overall Study|Lost to Follow-up|0|||
155279086|NCT03100838|560454775|FG002|Overall Study|Lost to Follow-up|1|||
155279087|NCT03100838|560454776|FG003|Overall Study|Lost to Follow-up|0|||
155279088|NCT01347645|560454777|FG000|Overall Study|Death|1|||
155279089|NCT01347645|560454778|FG001|Overall Study|Death|5|||
155279090|NCT01347645|560454779|FG002|Overall Study|Death|2|||
155279091|NCT01347645|560454780|FG003|Overall Study|Death|7|||
155279092|NCT01347645|560454781|FG004|Overall Study|Death|7|||
155279093|NCT01347645|560454777|FG000|Overall Study|Lost to Follow-up|1|||
155279094|NCT01347645|560454778|FG001|Overall Study|Lost to Follow-up|1|||
155279095|NCT01347645|560454779|FG002|Overall Study|Lost to Follow-up|0|||
155279096|NCT01347645|560454780|FG003|Overall Study|Lost to Follow-up|1|||
155383726|NCT01959516|560839584|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
155279097|NCT01347645|560454781|FG004|Overall Study|Lost to Follow-up|1|||
155279098|NCT01347645|560454777|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
155279099|NCT01347645|560454778|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
155279100|NCT01347645|560454779|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
155279101|NCT01347645|560454780|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
155279102|NCT01347645|560454781|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
155279103|NCT01347645|560454777|FG000|Overall Study|Other|1|||
155383727|NCT01959516|560839583|FG000|Epoch 1|Protocol deviation|0|||
155279104|NCT01347645|560454778|FG001|Overall Study|Other|0|||
155279105|NCT01347645|560454779|FG002|Overall Study|Other|0|||
155279106|NCT01347645|560454780|FG003|Overall Study|Other|0|||
155045681|NCT05052697|559599405|FG019|Substudy A|No longer met eligibility criteria|0|||
155383728|NCT01959516|560839584|FG001|Epoch 1|Protocol deviation|1|||
155383729|NCT01959516|560839583|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
155383730|NCT01959516|560839584|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
155383731|NCT01959516|560839583|FG000|Epoch 2|Subject withdrew consent|1|||
155383732|NCT01959516|560839584|FG001|Epoch 2|Subject withdrew consent|0|||
155383733|NCT01959516|560839583|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
155383734|NCT01959516|560839584|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
155383735|NCT00455325|560839585|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
155383736|NCT00455325|560839586|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
155383737|NCT00455325|560839587|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
155383738|NCT00455325|560839588|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
155383739|NCT00455325|560839585|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
155383740|NCT00455325|560839586|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
155383741|NCT00455325|560839587|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
155383742|NCT00455325|560839588|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
155383743|NCT00455325|560839585|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
155383744|NCT00455325|560839586|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
155383745|NCT00455325|560839587|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
155383746|NCT00455325|560839588|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
155383747|NCT00455325|560839585|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
155383748|NCT00455325|560839586|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
155383749|NCT00455325|560839587|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
155383750|NCT00455325|560839588|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
155383751|NCT00455325|560839585|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
155383752|NCT00455325|560839586|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
155383753|NCT00455325|560839587|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
155383754|NCT00455325|560839588|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
155383755|NCT00455325|560839585|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
155383756|NCT00455325|560839586|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
155383757|NCT00455325|560839587|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
155383758|NCT00455325|560839588|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
155383759|NCT00455325|560839585|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
155383760|NCT00455325|560839586|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
155383761|NCT00455325|560839587|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
155383762|NCT00455325|560839588|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
155383763|NCT02745392|560839595|FG000|Overall Study|Lost to Follow-up|0|||
155383764|NCT02745392|560839596|FG001|Overall Study|Lost to Follow-up|1|||
155383765|NCT02745392|560839597|FG002|Overall Study|Lost to Follow-up|0|||
155383766|NCT02745392|560839598|FG003|Overall Study|Lost to Follow-up|0|||
155045682|NCT05052697|559599406|FG020|Substudy A|No longer met eligibility criteria|0|||
155383767|NCT02004353|560839600|FG000|Overall Study|Voluntary participation|1334|||
155383768|NCT01691768|560839601|FG000|Overall Study|Death|0|||
155383769|NCT01691768|560839602|FG001|Overall Study|Death|2|||
155383770|NCT01691768|560839601|FG000|Overall Study|Lost to Follow-up|4|||
155383771|NCT01691768|560839602|FG001|Overall Study|Lost to Follow-up|3|||
155383772|NCT01691768|560839601|FG000|Overall Study|Withdrawal by Subject|10|||
155383773|NCT01691768|560839602|FG001|Overall Study|Withdrawal by Subject|9|||
155383774|NCT01691768|560839601|FG000|Overall Study|Relocated|0|||
155383775|NCT01691768|560839602|FG001|Overall Study|Relocated|1|||
155383776|NCT01691768|560839601|FG000|Overall Study|Investigator decision|1|||
155383777|NCT01691768|560839602|FG001|Overall Study|Investigator decision|1|||
154943725|NCT00818623|559219316|FG007|Overall Study|Adverse Event|0|||
154943726|NCT00818623|559219309|FG000|Overall Study|Bad prostate specific antigen response|0|||
154943727|NCT00818623|559219310|FG001|Overall Study|Bad prostate specific antigen response|3|||
154943728|NCT00818623|559219311|FG002|Overall Study|Bad prostate specific antigen response|2|||
154943729|NCT00818623|559219312|FG003|Overall Study|Bad prostate specific antigen response|5|||
154943730|NCT00818623|559219313|FG004|Overall Study|Bad prostate specific antigen response|0|||
154943731|NCT00818623|559219314|FG005|Overall Study|Bad prostate specific antigen response|1|||
154943732|NCT00818623|559219315|FG006|Overall Study|Bad prostate specific antigen response|0|||
154943733|NCT00818623|559219316|FG007|Overall Study|Bad prostate specific antigen response|0|||
154943734|NCT00818623|559219309|FG000|Overall Study|Withdrawal by Subject|0|||
154943735|NCT00818623|559219310|FG001|Overall Study|Withdrawal by Subject|1|||
155383778|NCT01759368|560839603|FG000|Overall Study|Lost to Follow-up|1|||
155383779|NCT01759368|560839604|FG001|Overall Study|Lost to Follow-up|0|||
155383780|NCT00336895|560839611|FG000|Overall Study|diarrhea|1|||
155383781|NCT00336895|560839611|FG000|Overall Study|nausea and upset stomach|1|||
155383782|NCT00336895|560839611|FG000|Overall Study|Physician Decision|1|||
155383783|NCT00336895|560839611|FG000|Overall Study|screen failed|1|||
155383784|NCT01959334|560839612|FG000|Second Dose|Adverse Event|1|||
155383785|NCT01959334|560839613|FG001|Second Dose|Adverse Event|0|||
155383786|NCT01959334|560839612|FG000|Third Dose|Adverse Event|0|||
155383787|NCT01959334|560839613|FG001|Third Dose|Adverse Event|1|||
155383788|NCT01768637|560839615|FG000|Overall Study|Lost to Follow-up|2|||
155383789|NCT01768637|560839616|FG001|Overall Study|Lost to Follow-up|7|||
155383790|NCT01768637|560839615|FG000|Overall Study|Difficult blood draw|1|||
155383791|NCT01768637|560839616|FG001|Overall Study|Difficult blood draw|0|||
155383792|NCT01007448|560839617|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
155045683|NCT05052697|559599407|FG021|Substudy A|No longer met eligibility criteria|0|||
155045684|NCT05052697|559599408|FG022|Substudy A|No longer met eligibility criteria|0|||
155045685|NCT05052697|559599409|FG023|Substudy A|No longer met eligibility criteria|0|||
155045686|NCT05052697|559599410|FG024|Substudy A|No longer met eligibility criteria|0|||
155045687|NCT05052697|559599411|FG025|Substudy A|No longer met eligibility criteria|0|||
155045688|NCT05052697|559599412|FG026|Substudy A|No longer met eligibility criteria|0|||
155045689|NCT05052697|559599413|FG027|Substudy A|No longer met eligibility criteria|0|||
155045690|NCT05052697|559599414|FG028|Substudy A|No longer met eligibility criteria|0|||
155045691|NCT05052697|559599415|FG029|Substudy A|No longer met eligibility criteria|0|||
155045692|NCT05052697|559599416|FG030|Substudy A|No longer met eligibility criteria|0|||
155045693|NCT05052697|559599417|FG031|Substudy A|No longer met eligibility criteria|0|||
155045694|NCT05052697|559599418|FG032|Substudy A|No longer met eligibility criteria|0|||
155045695|NCT05052697|559599419|FG033|Substudy A|No longer met eligibility criteria|0|||
155045696|NCT05052697|559599386|FG000|Substudy A|Not vaccinated|0|||
155045697|NCT05052697|559599387|FG001|Substudy A|Not vaccinated|0|||
155045698|NCT05052697|559599388|FG002|Substudy A|Not vaccinated|0|||
155045699|NCT05052697|559599389|FG003|Substudy A|Not vaccinated|1|||
155045700|NCT05052697|559599390|FG004|Substudy A|Not vaccinated|0|||
155045701|NCT05052697|559599391|FG005|Substudy A|Not vaccinated|0|||
155045702|NCT05052697|559599392|FG006|Substudy A|Not vaccinated|0|||
155045703|NCT05052697|559599393|FG007|Substudy A|Not vaccinated|0|||
155045704|NCT05052697|559599394|FG008|Substudy A|Not vaccinated|1|||
155045705|NCT05052697|559599395|FG009|Substudy A|Not vaccinated|0|||
155045706|NCT05052697|559599396|FG010|Substudy A|Not vaccinated|0|||
155045707|NCT05052697|559599397|FG011|Substudy A|Not vaccinated|0|||
155045708|NCT05052697|559599398|FG012|Substudy A|Not vaccinated|0|||
155045709|NCT05052697|559599399|FG013|Substudy A|Not vaccinated|0|||
155045710|NCT05052697|559599400|FG014|Substudy A|Not vaccinated|0|||
155045711|NCT05052697|559599401|FG015|Substudy A|Not vaccinated|0|||
155383793|NCT01007448|560839618|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
155383794|NCT01007448|560839617|FG000|Overall Study|Staph Skin Infection Flare|1|||
155383795|NCT01007448|560839618|FG001|Overall Study|Staph Skin Infection Flare|0|||
155383796|NCT01007448|560839617|FG000|Overall Study|Participant Leaving the Country|1|||
155383797|NCT01007448|560839618|FG001|Overall Study|Participant Leaving the Country|0|||
155383798|NCT01007448|560839617|FG000|Overall Study|Participant Given Prohibited Medication|1|||
155383799|NCT01007448|560839618|FG001|Overall Study|Participant Given Prohibited Medication|0|||
155383800|NCT01007448|560839617|FG000|Overall Study|Progressive Disease|1|||
155383801|NCT01007448|560839618|FG001|Overall Study|Progressive Disease|2|||
155383802|NCT01007448|560839617|FG000|Overall Study|Lack of Efficacy|2|||
155383803|NCT01007448|560839618|FG001|Overall Study|Lack of Efficacy|0|||
155383804|NCT01007448|560839617|FG000|Overall Study|Withdrawal by Subject|2|||
155383805|NCT01007448|560839618|FG001|Overall Study|Withdrawal by Subject|3|||
155383806|NCT01007448|560839617|FG000|Overall Study|Adverse Event|1|||
155383807|NCT01007448|560839618|FG001|Overall Study|Adverse Event|4|||
155383808|NCT01054170|560839619|FG000|Overall Study|Protocol Violation|1|||
155383809|NCT01054170|560839620|FG001|Overall Study|Protocol Violation|0|||
155383810|NCT01054170|560839619|FG000|Overall Study|Withdrawal by Subject|3|||
155383811|NCT01054170|560839620|FG001|Overall Study|Withdrawal by Subject|2|||
155383812|NCT01054170|560839619|FG000|Overall Study|Adverse Event|0|||
155383813|NCT01054170|560839620|FG001|Overall Study|Adverse Event|4|||
155383814|NCT02751320|560839621|FG000|Overall Study|Adverse Event|2|||
155383815|NCT02751320|560839621|FG000|Overall Study|Withdrawal by Subject|1|||
155383816|NCT01337115|560839625|FG000|Overall Study|Protocol Violation|2|||
155383817|NCT01337115|560839626|FG001|Overall Study|Protocol Violation|0|||
155383818|NCT03426267|560839633|FG000|Overall Study|Physician Decision|1|||
155383819|NCT03426267|560839634|FG001|Overall Study|Physician Decision|4|||
155383820|NCT03426267|560839633|FG000|Overall Study|Lost to Follow-up|1|||
155383821|NCT03426267|560839634|FG001|Overall Study|Lost to Follow-up|0|||
155383822|NCT03426267|560839633|FG000|Overall Study|Withdrawal by Subject|4|||
155045712|NCT05052697|559599402|FG016|Substudy A|Not vaccinated|0|||
155045713|NCT05052697|559599403|FG017|Substudy A|Not vaccinated|0|||
155045714|NCT05052697|559599404|FG018|Substudy A|Not vaccinated|0|||
155045715|NCT05052697|559599405|FG019|Substudy A|Not vaccinated|0|||
155383823|NCT03426267|560839634|FG001|Overall Study|Withdrawal by Subject|10|||
155383824|NCT03426267|560839633|FG000|Overall Study|Protocol Violation|1|||
155383825|NCT03426267|560839634|FG001|Overall Study|Protocol Violation|3|||
155383826|NCT03426267|560839633|FG000|Overall Study|Adverse Event|9|||
155383827|NCT03426267|560839634|FG001|Overall Study|Adverse Event|27|||
155383828|NCT03426267|560839633|FG000|Overall Study|Prohibited Treatment Intake|2|||
155383829|NCT03426267|560839634|FG001|Overall Study|Prohibited Treatment Intake|3|||
155045716|NCT05052697|559599406|FG020|Substudy A|Not vaccinated|0|||
155383830|NCT03426267|560839633|FG000|Overall Study|Lack of Efficacy|0|||
155045717|NCT05052697|559599407|FG021|Substudy A|Not vaccinated|0|||
155045718|NCT05052697|559599408|FG022|Substudy A|Not vaccinated|0|||
155045719|NCT05052697|559599409|FG023|Substudy A|Not vaccinated|0|||
155045720|NCT05052697|559599410|FG024|Substudy A|Not vaccinated|0|||
155383831|NCT03426267|560839634|FG001|Overall Study|Lack of Efficacy|25|||
155383832|NCT03426267|560839633|FG000|Overall Study|other|3|||
155383833|NCT03426267|560839634|FG001|Overall Study|other|0|||
155383834|NCT03801915|560839640|FG000|Overall Study|Screen failure|0|||
155383835|NCT03801915|560839641|FG001|Overall Study|Screen failure|0|||
155383836|NCT03801915|560839642|FG002|Overall Study|Screen failure|1|||
155383837|NCT03801915|560839640|FG000|Overall Study|Ineligible|1|||
155383838|NCT03801915|560839641|FG001|Overall Study|Ineligible|0|||
155383839|NCT03801915|560839642|FG002|Overall Study|Ineligible|0|||
155383840|NCT03801915|560839640|FG000|Overall Study|Physician Decision|2|||
155383841|NCT03801915|560839641|FG001|Overall Study|Physician Decision|1|||
155383842|NCT03801915|560839642|FG002|Overall Study|Physician Decision|0|||
155383843|NCT02308020|560839643|FG000|Overall Study|Lost to Follow-up|1|||
155383844|NCT02308020|560839644|FG001|Overall Study|Lost to Follow-up|7|||
155383845|NCT02308020|560839645|FG002|Overall Study|Lost to Follow-up|0|||
155383846|NCT02308020|560839646|FG003|Overall Study|Lost to Follow-up|0|||
155383847|NCT02308020|560839647|FG004|Overall Study|Lost to Follow-up|1|||
155383848|NCT02308020|560839648|FG005|Overall Study|Lost to Follow-up|2|||
155383849|NCT02308020|560839643|FG000|Overall Study|Sponsor Decision|0|||
155383850|NCT02308020|560839644|FG001|Overall Study|Sponsor Decision|8|||
155383851|NCT02308020|560839645|FG002|Overall Study|Sponsor Decision|0|||
155383852|NCT02308020|560839646|FG003|Overall Study|Sponsor Decision|2|||
155383853|NCT02308020|560839647|FG004|Overall Study|Sponsor Decision|2|||
155383854|NCT02308020|560839648|FG005|Overall Study|Sponsor Decision|1|||
155383855|NCT02308020|560839643|FG000|Overall Study|Withdrawal by Subject|3|||
155383856|NCT02308020|560839644|FG001|Overall Study|Withdrawal by Subject|5|||
155383857|NCT02308020|560839645|FG002|Overall Study|Withdrawal by Subject|3|||
155383858|NCT02308020|560839646|FG003|Overall Study|Withdrawal by Subject|2|||
155383859|NCT02308020|560839647|FG004|Overall Study|Withdrawal by Subject|1|||
155383860|NCT02308020|560839648|FG005|Overall Study|Withdrawal by Subject|2|||
155383861|NCT01211288|560839649|FG000|Overall Study|Lost to Follow-up|1|||
155383862|NCT01211288|560839650|FG001|Overall Study|Lost to Follow-up|1|||
155383863|NCT01270971|560839651|FG000|Overall Study|Withdrawal by Subject|24|||
155383864|NCT01270971|560839652|FG001|Overall Study|Withdrawal by Subject|11|||
155383865|NCT01270971|560839651|FG000|Overall Study|Lost to Follow-up|18|||
155383866|NCT01270971|560839652|FG001|Overall Study|Lost to Follow-up|5|||
155383867|NCT01270971|560839651|FG000|Overall Study|Adverse Event|1|||
155383868|NCT01270971|560839652|FG001|Overall Study|Adverse Event|2|||
155383869|NCT01270971|560839651|FG000|Overall Study|Non compliance|2|||
155383870|NCT01270971|560839652|FG001|Overall Study|Non compliance|2|||
155383871|NCT01270971|560839651|FG000|Overall Study|Non-specific|7|||
155383872|NCT01270971|560839652|FG001|Overall Study|Non-specific|3|||
155383873|NCT03333837|560839654|FG000|Overall Study|Adverse Event|2|||
155383874|NCT03333837|560839655|FG001|Overall Study|Adverse Event|1|||
155383875|NCT03333837|560839656|FG002|Overall Study|Adverse Event|1|||
155383876|NCT03333837|560839657|FG003|Overall Study|Adverse Event|1|||
155383877|NCT03333837|560839658|FG004|Overall Study|Adverse Event|0|||
155383878|NCT03333837|560839654|FG000|Overall Study|Caregiver withdrew|0|||
155383879|NCT03333837|560839655|FG001|Overall Study|Caregiver withdrew|2|||
155383880|NCT03333837|560839656|FG002|Overall Study|Caregiver withdrew|1|||
155383881|NCT03333837|560839657|FG003|Overall Study|Caregiver withdrew|0|||
155383882|NCT03333837|560839658|FG004|Overall Study|Caregiver withdrew|0|||
155383883|NCT03333837|560839654|FG000|Overall Study|Withdrawal by Subject|0|||
155383884|NCT03333837|560839655|FG001|Overall Study|Withdrawal by Subject|0|||
155383885|NCT03333837|560839656|FG002|Overall Study|Withdrawal by Subject|1|||
155383886|NCT03333837|560839657|FG003|Overall Study|Withdrawal by Subject|1|||
155383887|NCT03333837|560839658|FG004|Overall Study|Withdrawal by Subject|3|||
155383888|NCT03333837|560839654|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383889|NCT03333837|560839655|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383890|NCT03333837|560839656|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
155383891|NCT03333837|560839657|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383892|NCT03333837|560839658|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
155383893|NCT01551212|560839659|FG000|Overall Study|Graft loss/Retransplantation|0|||
154943736|NCT00818623|559219311|FG002|Overall Study|Withdrawal by Subject|1|||
154943737|NCT00818623|559219312|FG003|Overall Study|Withdrawal by Subject|0|||
154943738|NCT00818623|559219313|FG004|Overall Study|Withdrawal by Subject|0|||
154943739|NCT00818623|559219314|FG005|Overall Study|Withdrawal by Subject|1|||
154943740|NCT00818623|559219315|FG006|Overall Study|Withdrawal by Subject|1|||
154943741|NCT00818623|559219316|FG007|Overall Study|Withdrawal by Subject|1|||
155383894|NCT01551212|560839660|FG001|Overall Study|Graft loss/Retransplantation|1|||
155383895|NCT01551212|560839659|FG000|Overall Study|Administrative problems|1|||
155383896|NCT01551212|560839660|FG001|Overall Study|Administrative problems|2|||
154943742|NCT00818623|559219309|FG000|Overall Study|Protocol Violation|1|||
154943743|NCT00818623|559219310|FG001|Overall Study|Protocol Violation|0|||
155383897|NCT01551212|560839659|FG000|Overall Study|Lost to Follow-up|0|||
155383898|NCT01551212|560839660|FG001|Overall Study|Lost to Follow-up|1|||
155383899|NCT01551212|560839659|FG000|Overall Study|Protocol Violation|0|||
154943744|NCT00818623|559219311|FG002|Overall Study|Protocol Violation|0|||
154943745|NCT00818623|559219312|FG003|Overall Study|Protocol Violation|0|||
154943746|NCT00818623|559219313|FG004|Overall Study|Protocol Violation|1|||
154943747|NCT00818623|559219314|FG005|Overall Study|Protocol Violation|0|||
154943748|NCT00818623|559219315|FG006|Overall Study|Protocol Violation|1|||
154943749|NCT00818623|559219316|FG007|Overall Study|Protocol Violation|0|||
154943750|NCT00818623|559219309|FG000|Overall Study|Need of additional treatment|0|||
154943751|NCT00818623|559219310|FG001|Overall Study|Need of additional treatment|0|||
154943752|NCT00818623|559219311|FG002|Overall Study|Need of additional treatment|0|||
154943753|NCT00818623|559219312|FG003|Overall Study|Need of additional treatment|0|||
154943754|NCT00818623|559219313|FG004|Overall Study|Need of additional treatment|1|||
154943755|NCT00818623|559219314|FG005|Overall Study|Need of additional treatment|0|||
154943756|NCT00818623|559219315|FG006|Overall Study|Need of additional treatment|0|||
154943757|NCT00818623|559219316|FG007|Overall Study|Need of additional treatment|0|||
155045721|NCT05052697|559599411|FG025|Substudy A|Not vaccinated|0|||
155279107|NCT01347645|560454781|FG004|Overall Study|Other|1|||
155279108|NCT01347645|560454777|FG000|Overall Study|Withdrawal by Subject|0|||
155279109|NCT01347645|560454778|FG001|Overall Study|Withdrawal by Subject|0|||
155279110|NCT01347645|560454779|FG002|Overall Study|Withdrawal by Subject|0|||
155279111|NCT01347645|560454780|FG003|Overall Study|Withdrawal by Subject|3|||
155279112|NCT01347645|560454781|FG004|Overall Study|Withdrawal by Subject|3|||
155279113|NCT01347645|560454777|FG000|Overall Study|Physician Decision|0|||
155279114|NCT01347645|560454778|FG001|Overall Study|Physician Decision|0|||
155279115|NCT01347645|560454779|FG002|Overall Study|Physician Decision|0|||
155279116|NCT01347645|560454780|FG003|Overall Study|Physician Decision|0|||
155279117|NCT01347645|560454781|FG004|Overall Study|Physician Decision|1|||
155279118|NCT01347645|560454777|FG000|Overall Study|Adverse Event|0|||
155279119|NCT01347645|560454778|FG001|Overall Study|Adverse Event|0|||
155279120|NCT01347645|560454779|FG002|Overall Study|Adverse Event|0|||
155279121|NCT01347645|560454780|FG003|Overall Study|Adverse Event|1|||
155279122|NCT01347645|560454781|FG004|Overall Study|Adverse Event|1|||
155279123|NCT01141660|560454784|FG000|Overall Study|Physician Decision|0|||
154943758|NCT00818623|559219309|FG000|Overall Study|Lack of trial drug at site|0|||
154943759|NCT00818623|559219310|FG001|Overall Study|Lack of trial drug at site|0|||
155045722|NCT05052697|559599412|FG026|Substudy A|Not vaccinated|0|||
155045723|NCT05052697|559599413|FG027|Substudy A|Not vaccinated|0|||
155045724|NCT05052697|559599414|FG028|Substudy A|Not vaccinated|0|||
155045725|NCT05052697|559599415|FG029|Substudy A|Not vaccinated|0|||
155045726|NCT05052697|559599416|FG030|Substudy A|Not vaccinated|0|||
155045727|NCT05052697|559599417|FG031|Substudy A|Not vaccinated|0|||
155045728|NCT05052697|559599418|FG032|Substudy A|Not vaccinated|0|||
155045729|NCT05052697|559599419|FG033|Substudy A|Not vaccinated|0|||
155045730|NCT05052697|559599386|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045731|NCT05052697|559599387|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045732|NCT05052697|559599388|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045733|NCT05052697|559599389|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045734|NCT05052697|559599390|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045735|NCT05052697|559599391|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045736|NCT05052697|559599392|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045737|NCT05052697|559599393|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045738|NCT05052697|559599394|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045739|NCT05052697|559599395|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045740|NCT05052697|559599396|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045741|NCT05052697|559599397|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045742|NCT05052697|559599398|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045743|NCT05052697|559599399|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045744|NCT05052697|559599400|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045745|NCT05052697|559599401|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045746|NCT05052697|559599402|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045747|NCT05052697|559599403|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045748|NCT05052697|559599404|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
155045749|NCT05052697|559599405|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
155045750|NCT05052697|559599406|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045751|NCT05052697|559599407|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
155045752|NCT05052697|559599408|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
155045753|NCT05052697|559599409|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045754|NCT05052697|559599410|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045755|NCT05052697|559599411|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045756|NCT05052697|559599412|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155279124|NCT01141660|560454785|FG001|Overall Study|Physician Decision|12|||
155279125|NCT00209027|560454787|FG000|Overall Study|study terminated|10|||
155279126|NCT00209027|560454788|FG001|Overall Study|study terminated|0|||
154943760|NCT00818623|559219311|FG002|Overall Study|Lack of trial drug at site|0|||
155383900|NCT01551212|560839660|FG001|Overall Study|Protocol Violation|1|||
155383901|NCT01551212|560839659|FG000|Overall Study|Withdrawal by Subject|0|||
155383902|NCT01551212|560839660|FG001|Overall Study|Withdrawal by Subject|7|||
155383903|NCT01551212|560839659|FG000|Overall Study|Death|2|||
155383904|NCT01551212|560839660|FG001|Overall Study|Death|4|||
155383905|NCT01551212|560839659|FG000|Overall Study|Never Received Study Treatment|2|||
155383906|NCT01551212|560839660|FG001|Overall Study|Never Received Study Treatment|4|||
155383907|NCT04217590|560839661|FG000|Overall Study|Other|1|||
155383908|NCT04217590|560839662|FG001|Overall Study|Other|1|||
155383909|NCT04217590|560839661|FG000|Overall Study|Withdrawal by Subject|3|||
155383910|NCT04217590|560839662|FG001|Overall Study|Withdrawal by Subject|1|||
155383911|NCT04217590|560839661|FG000|Overall Study|Death|0|||
155383912|NCT04217590|560839662|FG001|Overall Study|Death|1|||
155383913|NCT01013285|560839663|FG000|Overall Study|Death|48|||
155383914|NCT01013285|560839664|FG001|Overall Study|Death|89|||
155383915|NCT00704405|560839665|FG000|Overall Study (NC Population)|Adverse Event|1|||
155383916|NCT00704405|560839666|FG001|Overall Study (NC Population)|Adverse Event|0|||
155383917|NCT00704405|560839667|FG002|Overall Study (NC Population)|Adverse Event|0|||
155383918|NCT00704405|560839668|FG003|Overall Study (NC Population)|Adverse Event|0|||
155383919|NCT00704405|560839669|FG004|Overall Study (NC Population)|Adverse Event|0|||
155383920|NCT00704405|560839665|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
155383921|NCT00704405|560839666|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
155383922|NCT00704405|560839667|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
155383923|NCT00704405|560839668|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
155383924|NCT00704405|560839669|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
155383925|NCT00704405|560839665|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383926|NCT00704405|560839666|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
155383927|NCT00704405|560839667|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383928|NCT00704405|560839668|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383929|NCT00704405|560839669|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
155383930|NCT00704405|560839665|FG000|Overall Study (NC Population)|Other|0|||
155383931|NCT00704405|560839666|FG001|Overall Study (NC Population)|Other|0|||
155383932|NCT00704405|560839667|FG002|Overall Study (NC Population)|Other|0|||
155383933|NCT00704405|560839668|FG003|Overall Study (NC Population)|Other|0|||
155383934|NCT00704405|560839669|FG004|Overall Study (NC Population)|Other|1|||
155383935|NCT00704405|560839665|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
155383936|NCT00704405|560839666|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
155383937|NCT00704405|560839667|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
155383938|NCT00704405|560839668|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
155383939|NCT00704405|560839669|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
155383940|NCT00704405|560839665|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
155383941|NCT00704405|560839666|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
155383942|NCT00704405|560839667|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
155383943|NCT00704405|560839668|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
155383944|NCT00704405|560839669|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
155383945|NCT01395888|560839670|FG000|2-week Run-in Period|Adverse Event|2|||
155383946|NCT01395888|560839671|FG001|2-week Run-in Period|Adverse Event|0|||
155383947|NCT01395888|560839672|FG002|2-week Run-in Period|Adverse Event|0|||
155383948|NCT01395888|560839670|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
155383949|NCT01395888|560839671|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
155383950|NCT01395888|560839672|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
155383951|NCT01395888|560839670|FG000|2-week Run-in Period|Lost to Follow-up|1|||
155383952|NCT01395888|560839671|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155383953|NCT01395888|560839672|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155383954|NCT01395888|560839670|FG000|2-week Run-in Period|Protocol Violation|2|||
155383955|NCT01395888|560839671|FG001|2-week Run-in Period|Protocol Violation|0|||
155383956|NCT01395888|560839672|FG002|2-week Run-in Period|Protocol Violation|0|||
155383957|NCT01395888|560839670|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
155383958|NCT01395888|560839671|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155383959|NCT01395888|560839672|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155383960|NCT01395888|560839670|FG000|Treatment Period (TP)|Adverse Event|0|||
155383961|NCT01395888|560839671|FG001|Treatment Period (TP)|Adverse Event|7|||
155383962|NCT01395888|560839672|FG002|Treatment Period (TP)|Adverse Event|6|||
155383963|NCT01395888|560839670|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
155383964|NCT01395888|560839671|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
155383965|NCT01395888|560839672|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
155383966|NCT01395888|560839670|FG000|Treatment Period (TP)|Protocol Violation|0|||
155383967|NCT01395888|560839671|FG001|Treatment Period (TP)|Protocol Violation|1|||
155383968|NCT01395888|560839672|FG002|Treatment Period (TP)|Protocol Violation|5|||
155383969|NCT01395888|560839670|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
155383970|NCT01395888|560839671|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
155383971|NCT01395888|560839672|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
155383972|NCT01395888|560839670|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
155383973|NCT01395888|560839671|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
155383974|NCT01395888|560839672|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
155383975|NCT02641496|560839673|FG000|Overall Study|Lost to Follow-up|13|||
155383976|NCT02641496|560839674|FG001|Overall Study|Lost to Follow-up|12|||
155383977|NCT02641496|560839673|FG000|Overall Study|Withdrawal by Subject|1|||
155383978|NCT02641496|560839674|FG001|Overall Study|Withdrawal by Subject|0|||
155383979|NCT03035201|560839675|FG000|Overall Study|Death|9|||
155383980|NCT03035201|560839676|FG001|Overall Study|Death|12|||
155383981|NCT03035201|560839677|FG002|Overall Study|Death|9|||
155383982|NCT03035201|560839678|FG003|Overall Study|Death|10|||
155383983|NCT03035201|560839675|FG000|Overall Study|Withdrawal by Subject|51|||
155383984|NCT03035201|560839676|FG001|Overall Study|Withdrawal by Subject|49|||
155383985|NCT03035201|560839677|FG002|Overall Study|Withdrawal by Subject|37|||
155383986|NCT03035201|560839678|FG003|Overall Study|Withdrawal by Subject|46|||
155383987|NCT03035201|560839675|FG000|Overall Study|Lost to Follow-up|67|||
155383988|NCT03035201|560839676|FG001|Overall Study|Lost to Follow-up|51|||
155383989|NCT03035201|560839677|FG002|Overall Study|Lost to Follow-up|64|||
155383990|NCT03035201|560839678|FG003|Overall Study|Lost to Follow-up|69|||
155383991|NCT03727438|560839685|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
155383992|NCT03727438|560839686|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
155383993|NCT03727438|560839685|FG000|Intervention Period|Excluded (health)|1|||
155383994|NCT03727438|560839686|FG001|Intervention Period|Excluded (health)|0|||
155383995|NCT03727438|560839685|FG000|Intervention Period|Withdrawal by Subject|3|||
155383996|NCT03727438|560839686|FG001|Intervention Period|Withdrawal by Subject|1|||
155383997|NCT03727438|560839685|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
155383998|NCT03727438|560839686|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
155383999|NCT03727438|560839685|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
155384000|NCT03727438|560839686|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
155384001|NCT03727438|560839685|FG000|8 Week Assessment|Withdrawal by Subject|6|||
154943761|NCT00818623|559219312|FG003|Overall Study|Lack of trial drug at site|0|||
154943762|NCT00818623|559219313|FG004|Overall Study|Lack of trial drug at site|2|||
154943763|NCT00818623|559219314|FG005|Overall Study|Lack of trial drug at site|0|||
154943764|NCT00818623|559219315|FG006|Overall Study|Lack of trial drug at site|1|||
154943765|NCT00818623|559219316|FG007|Overall Study|Lack of trial drug at site|0|||
154943766|NCT00818623|559219309|FG000|Overall Study|Disease progression|0|||
154943767|NCT00818623|559219310|FG001|Overall Study|Disease progression|0|||
154943768|NCT00818623|559219311|FG002|Overall Study|Disease progression|0|||
154943769|NCT00818623|559219312|FG003|Overall Study|Disease progression|0|||
154943770|NCT00818623|559219313|FG004|Overall Study|Disease progression|0|||
154943771|NCT00818623|559219314|FG005|Overall Study|Disease progression|0|||
154943772|NCT00818623|559219315|FG006|Overall Study|Disease progression|1|||
154943773|NCT00818623|559219316|FG007|Overall Study|Disease progression|0|||
154943774|NCT04317781|559219317|FG000|Overall Study|Adverse Event|1|||
154943775|NCT04317781|559219317|FG000|Overall Study|Disease relapse|1|||
154943776|NCT04317781|559219317|FG000|Overall Study|Withdrawal by Subject|1|||
154943777|NCT02087059|559219318|FG000|Overall Study|Disease Progression|1|||
154943778|NCT02087059|559219318|FG000|Overall Study|Adverse Event|5|||
154943779|NCT02087059|559219318|FG000|Overall Study|Lost to Follow-up|1|||
154943780|NCT01851590|559219320|FG000|Overall Study|Withdrawal by Subject|0|||
154943781|NCT01851590|559219321|FG001|Overall Study|Withdrawal by Subject|0|||
154943782|NCT01851590|559219322|FG002|Overall Study|Withdrawal by Subject|1|||
154943783|NCT01851590|559219320|FG000|Overall Study|Adverse Event|0|||
154943784|NCT01851590|559219321|FG001|Overall Study|Adverse Event|0|||
154943785|NCT01851590|559219322|FG002|Overall Study|Adverse Event|2|||
154943786|NCT01851590|559219320|FG000|Overall Study|Lack of Efficacy|0|||
154943787|NCT01851590|559219321|FG001|Overall Study|Lack of Efficacy|1|||
154943788|NCT01851590|559219322|FG002|Overall Study|Lack of Efficacy|0|||
154943789|NCT00310856|559219323|FG000|Overall Study|Withdrawal by Subject|2|||
154943790|NCT00310856|559219324|FG001|Overall Study|Withdrawal by Subject|2|||
154943791|NCT00310856|559219325|FG002|Overall Study|Withdrawal by Subject|2|||
154943792|NCT00310856|559219323|FG000|Overall Study|Lost to Follow-up|1|||
154943793|NCT00310856|559219324|FG001|Overall Study|Lost to Follow-up|2|||
154943794|NCT00310856|559219325|FG002|Overall Study|Lost to Follow-up|6|||
154943795|NCT00310856|559219323|FG000|Overall Study|Inappropriate enrollment|1|||
154943796|NCT00310856|559219324|FG001|Overall Study|Inappropriate enrollment|1|||
154943797|NCT00310856|559219325|FG002|Overall Study|Inappropriate enrollment|0|||
154943798|NCT00310856|559219323|FG000|Overall Study|Unable to classify|1|||
155384002|NCT03727438|560839686|FG001|8 Week Assessment|Withdrawal by Subject|1|||
155384003|NCT03727438|560839685|FG000|6 mo Assessment|did not complete assessment|10|||
155384004|NCT03727438|560839686|FG001|6 mo Assessment|did not complete assessment|11|||
155384005|NCT06729606|560839687|FG000|Overall Study|Adverse Event|0|||
154943799|NCT00310856|559219324|FG001|Overall Study|Unable to classify|0|||
154943800|NCT00310856|559219325|FG002|Overall Study|Unable to classify|0|||
154943801|NCT02843074|559219326|FG000|Overall Study|Withdrawal by Subject|5|||
154943802|NCT02843074|559219326|FG000|Overall Study|Progressive disease|1|||
155045757|NCT05052697|559599413|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045758|NCT05052697|559599414|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155384006|NCT06729606|560839688|FG001|Overall Study|Adverse Event|2|||
155384007|NCT06729606|560839687|FG000|Overall Study|Death|1|||
155045759|NCT05052697|559599415|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045760|NCT05052697|559599416|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045761|NCT05052697|559599417|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155384008|NCT06729606|560839688|FG001|Overall Study|Death|0|||
155384009|NCT06729606|560839687|FG000|Overall Study|Physician Decision|0|||
155384010|NCT06729606|560839688|FG001|Overall Study|Physician Decision|1|||
155384011|NCT06729606|560839687|FG000|Overall Study|Withdrawal by Subject|2|||
155045762|NCT05052697|559599418|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045763|NCT05052697|559599419|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
155045764|NCT05052697|559599386|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045765|NCT05052697|559599387|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045766|NCT05052697|559599388|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045767|NCT05052697|559599389|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045768|NCT05052697|559599390|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384012|NCT06729606|560839688|FG001|Overall Study|Withdrawal by Subject|4|||
155384013|NCT01201343|560841546|FG000|Overall Study|Adverse Event|6|||
155384014|NCT01201343|560841546|FG000|Overall Study|Withdrawal by Subject|5|||
155384015|NCT01201343|560841546|FG000|Overall Study|Lost to Follow-up|2|||
155384016|NCT01201343|560841546|FG000|Overall Study|Lack of Efficacy|2|||
155384017|NCT01201343|560841546|FG000|Overall Study|Participant wrongly included in trial|1|||
155384018|NCT01201343|560841546|FG000|Overall Study|Randomized, not treated|3|||
155384019|NCT01716117|560841547|FG000|Overall Study|Death|5|||
155045769|NCT05052697|559599391|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045770|NCT05052697|559599392|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045771|NCT05052697|559599393|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384020|NCT01716117|560841548|FG001|Overall Study|Death|2|||
155045772|NCT05052697|559599394|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045773|NCT05052697|559599395|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384021|NCT01716117|560841547|FG000|Overall Study|Withdrawal by Subject|2|||
155384022|NCT01716117|560841548|FG001|Overall Study|Withdrawal by Subject|0|||
155384023|NCT01557283|560841549|FG000|Overall Study|Lost to Follow-up|7|||
155384024|NCT01557283|560841549|FG000|Overall Study|Non-responder|19|||
155384025|NCT01557283|560841549|FG000|Overall Study|Adverse Event|7|||
155384026|NCT01557283|560841549|FG000|Overall Study|Lack of Efficacy|1|||
155384027|NCT01557283|560841549|FG000|Overall Study|Non-compliance|1|||
155384028|NCT01557283|560841549|FG000|Overall Study|Withdrawal by Subject|1|||
155384029|NCT01557283|560841549|FG000|Overall Study|Participant's weight too high for dose|1|||
155384030|NCT01557283|560841549|FG000|Overall Study|Worsening of psoriasis|1|||
155384031|NCT01557283|560841549|FG000|Overall Study|Other|6|||
155384032|NCT03645057|560841550|FG000|Randomization to Baseline|Lost to Follow-up|1|||
155384033|NCT03645057|560841551|FG001|Randomization to Baseline|Lost to Follow-up|0|||
155384034|NCT03645057|560841552|FG002|Randomization to Baseline|Lost to Follow-up|1|||
155384035|NCT03645057|560841553|FG003|Randomization to Baseline|Lost to Follow-up|0|||
155384036|NCT03645057|560841550|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
155384037|NCT03645057|560841551|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
155384038|NCT03645057|560841552|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
155384039|NCT03645057|560841553|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
155384040|NCT03645057|560841550|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
155384041|NCT03645057|560841551|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
155384042|NCT03645057|560841552|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
155384043|NCT03645057|560841553|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
155384044|NCT03645057|560841550|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
155384045|NCT03645057|560841551|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
155384046|NCT03645057|560841552|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
155384047|NCT03645057|560841553|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
155384048|NCT01873495|560841554|FG000|Overall Study|Withdrawal by Subject|1|||
155384049|NCT01873495|560841554|FG000|Overall Study|Physician Decision|3|||
155384050|NCT01873495|560841554|FG000|Overall Study|Adverse Event|1|||
155384051|NCT01873495|560841554|FG000|Overall Study|Removed for Transplantation|1|||
155045774|NCT05052697|559599396|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384052|NCT01873495|560841554|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
155384053|NCT04363801|560841556|FG000|Overall Study|Death|18|||
155384054|NCT04363801|560841557|FG001|Overall Study|Death|14|||
155384055|NCT04363801|560841558|FG002|Overall Study|Death|16|||
155384056|NCT04363801|560841559|FG003|Overall Study|Death|48|||
155384057|NCT04363801|560841560|FG004|Overall Study|Death|38|||
155384058|NCT04363801|560841556|FG000|Overall Study|Withdrawal by Subject|1|||
155384059|NCT04363801|560841557|FG001|Overall Study|Withdrawal by Subject|6|||
155384060|NCT04363801|560841558|FG002|Overall Study|Withdrawal by Subject|1|||
155384061|NCT04363801|560841559|FG003|Overall Study|Withdrawal by Subject|4|||
155384062|NCT04363801|560841560|FG004|Overall Study|Withdrawal by Subject|14|||
155384063|NCT04363801|560841556|FG000|Overall Study|Sponsor Decision|6|||
155384064|NCT04363801|560841557|FG001|Overall Study|Sponsor Decision|4|||
155384065|NCT04363801|560841558|FG002|Overall Study|Sponsor Decision|10|||
155384066|NCT04363801|560841559|FG003|Overall Study|Sponsor Decision|33|||
155384067|NCT04363801|560841560|FG004|Overall Study|Sponsor Decision|32|||
155384068|NCT04363801|560841556|FG000|Overall Study|Lost to Follow-up|0|||
155384069|NCT04363801|560841557|FG001|Overall Study|Lost to Follow-up|0|||
155384070|NCT04363801|560841558|FG002|Overall Study|Lost to Follow-up|1|||
155384071|NCT04363801|560841559|FG003|Overall Study|Lost to Follow-up|0|||
155384072|NCT04363801|560841560|FG004|Overall Study|Lost to Follow-up|1|||
155384073|NCT03864146|560841561|FG000|Overall Study|Lost to Follow-up|14|||
155384074|NCT03864146|560841562|FG001|Overall Study|Lost to Follow-up|23|||
155384075|NCT03864146|560841561|FG000|Overall Study|Withdrawal by Subject|3|||
155384076|NCT03864146|560841562|FG001|Overall Study|Withdrawal by Subject|2|||
155384077|NCT01112306|560841563|FG000|Overall Study|Death|175|||
155384078|NCT01112306|560841563|FG000|Overall Study|Lost to Follow-up|9|||
155384079|NCT01112306|560841563|FG000|Overall Study|Withdrawal by Subject|31|||
155384080|NCT01112306|560841563|FG000|Overall Study|Other|70|||
155384081|NCT00881608|560841564|FG000|Overall Study|Study prematurely terminated|11|||
155384082|NCT00655486|560841570|FG000|Overall Study|Adverse Event|10|||
155384083|NCT00655486|560841570|FG000|Overall Study|Lack of Efficacy|8|||
155384084|NCT00655486|560841570|FG000|Overall Study|Withdrawal by Subject|4|||
155384085|NCT00655486|560841570|FG000|Overall Study|Protocol Violation|1|||
155384086|NCT00655486|560841570|FG000|Overall Study|Unsatisfactory compliance|2|||
155384087|NCT00655486|560841570|FG000|Overall Study|Other: Pregnancy|1|||
155384088|NCT00655486|560841570|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
155384089|NCT00655486|560841570|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
155384090|NCT04218084|560841571|FG000|Overall Study|Adverse Event|7|||
155384091|NCT04218084|560841572|FG001|Overall Study|Adverse Event|2|||
155384092|NCT04218084|560841571|FG000|Overall Study|Withdrawal of Consent|4|||
155384093|NCT04218084|560841572|FG001|Overall Study|Withdrawal of Consent|5|||
155384094|NCT04218084|560841571|FG000|Overall Study|Physician Decision|1|||
155384095|NCT04218084|560841572|FG001|Overall Study|Physician Decision|1|||
155384096|NCT04218084|560841571|FG000|Overall Study|Lost to Follow-up|1|||
155384097|NCT04218084|560841572|FG001|Overall Study|Lost to Follow-up|1|||
155384098|NCT04218084|560841571|FG000|Overall Study|Non-compliance with study drug|1|||
155384099|NCT04218084|560841572|FG001|Overall Study|Non-compliance with study drug|1|||
155384100|NCT04218084|560841571|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
155384101|NCT04218084|560841572|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
155384102|NCT04218084|560841571|FG000|Overall Study|Other|0|||
155384103|NCT04218084|560841572|FG001|Overall Study|Other|1|||
155384104|NCT04218084|560841571|FG000|Overall Study|Ongoing at data cut-off date|62|||
155384105|NCT04218084|560841572|FG001|Overall Study|Ongoing at data cut-off date|58|||
155384106|NCT01205152|560841573|FG000|Overall Study|Death|1|||
155384107|NCT02783768|560841574|FG000|Overall Study|Lost to Follow-up|1|||
155384108|NCT02783768|560841575|FG001|Overall Study|Lost to Follow-up|0|||
155384109|NCT01853137|560841576|FG000|Overall Study|Lost to Follow-up|4|||
155384110|NCT01853137|560841577|FG001|Overall Study|Lost to Follow-up|1|||
155384111|NCT03401229|560841578|FG000|Overall Study|Lost to Follow-up|2|||
155384112|NCT03401229|560841579|FG001|Overall Study|Lost to Follow-up|1|||
155384113|NCT03401229|560841578|FG000|Overall Study|Other|1|||
155384114|NCT03401229|560841579|FG001|Overall Study|Other|3|||
155384115|NCT03401229|560841578|FG000|Overall Study|Adverse Event|8|||
155384116|NCT03401229|560841579|FG001|Overall Study|Adverse Event|6|||
155384117|NCT03401229|560841578|FG000|Overall Study|Withdrawal by Subject|29|||
155384118|NCT03401229|560841579|FG001|Overall Study|Withdrawal by Subject|26|||
155384119|NCT03401229|560841578|FG000|Overall Study|COVID-19|0|||
155384120|NCT03401229|560841579|FG001|Overall Study|COVID-19|1|||
155384121|NCT05333224|560841580|FG000|Overall Study - Infants|Lost to Follow-up|1|||
155384122|NCT05333224|560841581|FG001|Overall Study - Infants|Lost to Follow-up|1|||
155384123|NCT00848926|560841583|FG000|Treatment Period|Progressive disease|45|||
154943803|NCT02843074|559219326|FG000|Overall Study|Physician Decision|1|||
155384124|NCT00848926|560841583|FG000|Treatment Period|Adverse Event|20|||
155384125|NCT00848926|560841583|FG000|Treatment Period|Physician Decision|12|||
155384126|NCT00848926|560841583|FG000|Treatment Period|Withdrawal by Subject|7|||
154943804|NCT02843074|559219326|FG000|Overall Study|Lost to Follow-up|1|||
154943805|NCT02843074|559219326|FG000|Overall Study|Death|9|||
154943806|NCT01564758|559219327|FG000|Overall Study|Death|8|||
154943807|NCT01564758|559219327|FG000|Overall Study|Adverse Event|3|||
154943808|NCT01564758|559219327|FG000|Overall Study|Other|3|||
155384127|NCT00848926|560841583|FG000|Follow-up Period|Lost to Follow-up|7|||
155384128|NCT00848926|560841583|FG000|Follow-up Period|Withdrawal by Subject|3|||
155384129|NCT00848926|560841583|FG000|Follow-up Period|Other|2|||
155384130|NCT00966277|560841585|FG000|Overall Study|Withdrawal by Subject|3|||
155384131|NCT00966277|560841586|FG001|Overall Study|Withdrawal by Subject|0|||
155384132|NCT00966277|560841585|FG000|Overall Study|Ineligible|1|||
155384133|NCT00966277|560841586|FG001|Overall Study|Ineligible|3|||
155384134|NCT00966277|560841585|FG000|Overall Study|Treatment Plan Changed|0|||
155384135|NCT00966277|560841586|FG001|Overall Study|Treatment Plan Changed|1|||
155384136|NCT01127139|560841588|FG000|Overall Study|Adverse Event|40|||
155384137|NCT01127139|560841588|FG000|Overall Study|Incompliance|12|||
155384138|NCT01127139|560841588|FG000|Overall Study|Lack of Efficacy|4|||
155384139|NCT01127139|560841588|FG000|Overall Study|Reason not specified|1|||
155384140|NCT01136772|560841589|FG000|Overall Study|Adverse Event|15|||
155384141|NCT01136772|560841590|FG001|Overall Study|Adverse Event|14|||
155384142|NCT01136772|560841589|FG000|Overall Study|Lack of Efficacy|42|||
155384143|NCT01136772|560841590|FG001|Overall Study|Lack of Efficacy|39|||
155384144|NCT01136772|560841589|FG000|Overall Study|Administrative|14|||
155384145|NCT01136772|560841590|FG001|Overall Study|Administrative|12|||
155384146|NCT01136772|560841589|FG000|Overall Study|Withdrawal by Subject|33|||
155384147|NCT01136772|560841590|FG001|Overall Study|Withdrawal by Subject|36|||
155384148|NCT01136772|560841589|FG000|Overall Study|Did not receive injection|10|||
155384149|NCT01136772|560841590|FG001|Overall Study|Did not receive injection|7|||
155384150|NCT01136772|560841589|FG000|Overall Study|Did not follow up after first injection|2|||
155384151|NCT01136772|560841590|FG001|Overall Study|Did not follow up after first injection|2|||
155384152|NCT01498653|560841591|FG000|Overall Study|Adverse Event|2|||
155384153|NCT01498653|560841592|FG001|Overall Study|Adverse Event|2|||
155384154|NCT01498653|560841591|FG000|Overall Study|Lack of Efficacy|12|||
155384155|NCT01498653|560841592|FG001|Overall Study|Lack of Efficacy|26|||
155384156|NCT01498653|560841591|FG000|Overall Study|Protocol Violation|0|||
155384157|NCT01498653|560841592|FG001|Overall Study|Protocol Violation|4|||
155384158|NCT01498653|560841591|FG000|Overall Study|Lost to Follow-up|1|||
155384159|NCT01498653|560841592|FG001|Overall Study|Lost to Follow-up|0|||
155384160|NCT01498653|560841591|FG000|Overall Study|Physician Decision|2|||
155384161|NCT01498653|560841592|FG001|Overall Study|Physician Decision|0|||
155384162|NCT01498653|560841591|FG000|Overall Study|Withdrawal by Subject|2|||
155384163|NCT01498653|560841592|FG001|Overall Study|Withdrawal by Subject|3|||
155384164|NCT03421431|560841596|FG000|Overall Study|Adverse Event|2|||
155384165|NCT03421431|560841597|FG001|Overall Study|Adverse Event|1|||
155384166|NCT03421431|560841598|FG002|Overall Study|Adverse Event|12|||
155384167|NCT03421431|560841596|FG000|Overall Study|Lost to Follow-up|1|||
155384168|NCT03421431|560841597|FG001|Overall Study|Lost to Follow-up|1|||
155384169|NCT03421431|560841598|FG002|Overall Study|Lost to Follow-up|1|||
155384170|NCT03421431|560841596|FG000|Overall Study|Withdrawal by Subject|3|||
155384171|NCT03421431|560841597|FG001|Overall Study|Withdrawal by Subject|2|||
155384172|NCT03421431|560841598|FG002|Overall Study|Withdrawal by Subject|1|||
155384173|NCT03421431|560841596|FG000|Overall Study|Protocol Violation|0|||
155384174|NCT03421431|560841597|FG001|Overall Study|Protocol Violation|1|||
155384175|NCT03421431|560841598|FG002|Overall Study|Protocol Violation|0|||
155384176|NCT03421431|560841596|FG000|Overall Study|Participant met Stopping Rules|0|||
155384177|NCT03421431|560841597|FG001|Overall Study|Participant met Stopping Rules|1|||
155384178|NCT03421431|560841598|FG002|Overall Study|Participant met Stopping Rules|0|||
155384179|NCT02216357|560841600|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
155384180|NCT02216357|560841601|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
155384181|NCT00141726|560841605|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
155384182|NCT00235326|560841610|FG000|Overall Study|Lost to Follow-up|746|||
155384183|NCT00235326|560841611|FG001|Overall Study|Lost to Follow-up|1400|||
155384184|NCT01477333|560841614|FG000|Overall Study|Adverse Event|1|||
155384185|NCT01477333|560841614|FG000|Overall Study|Withdrawal by Subject|1|||
155384186|NCT01477333|560841614|FG000|Overall Study|Clinical Deterioration|1|||
155384187|NCT01178671|560841615|FG000|Overall Study|Adverse Event|4|||
155384188|NCT01178671|560841616|FG001|Overall Study|Adverse Event|6|||
155384189|NCT01178671|560841615|FG000|Overall Study|Protocol Violation|1|||
155384190|NCT01178671|560841616|FG001|Overall Study|Protocol Violation|1|||
155384191|NCT01178671|560841615|FG000|Overall Study|Lack of Efficacy|0|||
155384192|NCT01178671|560841616|FG001|Overall Study|Lack of Efficacy|1|||
155384193|NCT01178671|560841615|FG000|Overall Study|Lost to Follow-up|3|||
155384194|NCT01178671|560841616|FG001|Overall Study|Lost to Follow-up|1|||
155384195|NCT01178671|560841615|FG000|Overall Study|Physician Decision|4|||
155384196|NCT01178671|560841616|FG001|Overall Study|Physician Decision|6|||
155384197|NCT02435966|560841617|FG000|Overall Study|Withdrawal by Subject|0|||
155384198|NCT02435966|560841618|FG001|Overall Study|Withdrawal by Subject|1|||
155384199|NCT02435966|560841619|FG002|Overall Study|Withdrawal by Subject|0|||
155384200|NCT04620811|560841620|FG000|Overall Study|Withdrawal by Subject|18|||
155384201|NCT04620811|560841621|FG001|Overall Study|Withdrawal by Subject|15|||
155384202|NCT04620811|560841620|FG000|Overall Study|Adverse Event|6|||
155384203|NCT04620811|560841621|FG001|Overall Study|Adverse Event|11|||
155384204|NCT04620811|560841620|FG000|Overall Study|Lost to Follow-up|4|||
155384205|NCT04620811|560841621|FG001|Overall Study|Lost to Follow-up|8|||
155384206|NCT04620811|560841620|FG000|Overall Study|Physician Decision|1|||
155384207|NCT04620811|560841621|FG001|Overall Study|Physician Decision|4|||
155384208|NCT04620811|560841620|FG000|Overall Study|Sponsor Decision|0|||
155384209|NCT04620811|560841621|FG001|Overall Study|Sponsor Decision|1|||
155384210|NCT04620811|560841620|FG000|Overall Study|Elevation of ALT or AST|1|||
155384211|NCT04620811|560841621|FG001|Overall Study|Elevation of ALT or AST|0|||
155384212|NCT04620811|560841620|FG000|Overall Study|Other|3|||
155384213|NCT04620811|560841621|FG001|Overall Study|Other|5|||
155384214|NCT01078675|560841623|FG000|Overall Study|Withdrawal by Subject|7|||
155384215|NCT01078675|560841624|FG001|Overall Study|Withdrawal by Subject|3|||
155384216|NCT01078675|560841623|FG000|Overall Study|Protocol Violation|56|||
155384217|NCT01078675|560841624|FG001|Overall Study|Protocol Violation|0|||
155384218|NCT01078675|560841623|FG000|Overall Study|Provided in CRF for specific reasons|2|||
155384219|NCT01078675|560841624|FG001|Overall Study|Provided in CRF for specific reasons|3|||
155384220|NCT01078675|560841623|FG000|Overall Study|Adverse Event|3|||
155384221|NCT01078675|560841624|FG001|Overall Study|Adverse Event|0|||
155384222|NCT00928746|560841627|FG000|Overall Study|Adverse Event|2|||
155384223|NCT00928746|560841627|FG000|Overall Study|Protocol Violation|1|||
155384224|NCT00928746|560841627|FG000|Overall Study|Withdrawal by Subject|1|||
155384225|NCT00928746|560841627|FG000|Overall Study|Other|2|||
155384226|NCT02513303|560841632|FG000|Overall Study|Withdrawal by Subject|9|||
155384227|NCT02513303|560841633|FG001|Overall Study|Withdrawal by Subject|7|||
155384228|NCT02513303|560841634|FG002|Overall Study|Withdrawal by Subject|2|||
155384229|NCT02513303|560841632|FG000|Overall Study|Lost to Follow-up|2|||
155384230|NCT02513303|560841633|FG001|Overall Study|Lost to Follow-up|4|||
155384231|NCT02513303|560841634|FG002|Overall Study|Lost to Follow-up|0|||
155384232|NCT02513303|560841632|FG000|Overall Study|Adverse Event|0|||
155384233|NCT02513303|560841633|FG001|Overall Study|Adverse Event|1|||
155384234|NCT02513303|560841634|FG002|Overall Study|Adverse Event|0|||
155384235|NCT02513303|560841632|FG000|Overall Study|Physician Decision|1|||
155384236|NCT02513303|560841633|FG001|Overall Study|Physician Decision|1|||
155384237|NCT02513303|560841634|FG002|Overall Study|Physician Decision|0|||
155045775|NCT05052697|559599397|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045776|NCT05052697|559599398|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045777|NCT05052697|559599399|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045778|NCT05052697|559599400|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045779|NCT05052697|559599401|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045780|NCT05052697|559599402|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045781|NCT05052697|559599403|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
155045782|NCT05052697|559599404|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045783|NCT05052697|559599405|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045784|NCT05052697|559599406|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045785|NCT05052697|559599407|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045786|NCT05052697|559599408|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045787|NCT05052697|559599409|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045788|NCT05052697|559599410|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045789|NCT05052697|559599411|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045790|NCT05052697|559599412|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384238|NCT02513303|560841632|FG000|Overall Study|Death|8|||
155384239|NCT02513303|560841633|FG001|Overall Study|Death|4|||
155384240|NCT02513303|560841634|FG002|Overall Study|Death|2|||
155384241|NCT02581631|560841638|FG000|Overall Study|Disease progression|29|||
155384242|NCT02581631|560841639|FG001|Overall Study|Disease progression|19|||
155384243|NCT02581631|560841640|FG002|Overall Study|Disease progression|13|||
155384244|NCT02581631|560841641|FG003|Overall Study|Disease progression|5|||
155384245|NCT02581631|560841642|FG004|Overall Study|Disease progression|8|||
155384246|NCT02581631|560841638|FG000|Overall Study|Study drug toxicity|4|||
155384247|NCT02581631|560841639|FG001|Overall Study|Study drug toxicity|6|||
155384248|NCT02581631|560841640|FG002|Overall Study|Study drug toxicity|7|||
155384249|NCT02581631|560841641|FG003|Overall Study|Study drug toxicity|0|||
155384250|NCT02581631|560841642|FG004|Overall Study|Study drug toxicity|3|||
155384251|NCT02581631|560841638|FG000|Overall Study|AE unrelated to study drug|3|||
155384252|NCT02581631|560841639|FG001|Overall Study|AE unrelated to study drug|1|||
155384253|NCT02581631|560841640|FG002|Overall Study|AE unrelated to study drug|1|||
155384254|NCT02581631|560841641|FG003|Overall Study|AE unrelated to study drug|0|||
155384255|NCT02581631|560841642|FG004|Overall Study|AE unrelated to study drug|2|||
155384256|NCT02581631|560841638|FG000|Overall Study|Request to discontinue|1|||
155384257|NCT02581631|560841639|FG001|Overall Study|Request to discontinue|0|||
155384258|NCT02581631|560841640|FG002|Overall Study|Request to discontinue|3|||
155384259|NCT02581631|560841641|FG003|Overall Study|Request to discontinue|0|||
155384260|NCT02581631|560841642|FG004|Overall Study|Request to discontinue|1|||
155384261|NCT02581631|560841638|FG000|Overall Study|participant withdrew consent|3|||
155384262|NCT02581631|560841639|FG001|Overall Study|participant withdrew consent|0|||
155384263|NCT02581631|560841640|FG002|Overall Study|participant withdrew consent|1|||
155384264|NCT02581631|560841641|FG003|Overall Study|participant withdrew consent|0|||
155384265|NCT02581631|560841642|FG004|Overall Study|participant withdrew consent|0|||
155384266|NCT02581631|560841638|FG000|Overall Study|Maximum clinical benefit|1|||
155384267|NCT02581631|560841639|FG001|Overall Study|Maximum clinical benefit|7|||
155384268|NCT02581631|560841640|FG002|Overall Study|Maximum clinical benefit|1|||
155384269|NCT02581631|560841641|FG003|Overall Study|Maximum clinical benefit|3|||
155384270|NCT02581631|560841642|FG004|Overall Study|Maximum clinical benefit|13|||
155384271|NCT02581631|560841638|FG000|Overall Study|Other Reasons|1|||
155384272|NCT02581631|560841639|FG001|Overall Study|Other Reasons|0|||
155384273|NCT02581631|560841640|FG002|Overall Study|Other Reasons|2|||
155384274|NCT02581631|560841641|FG003|Overall Study|Other Reasons|2|||
155384275|NCT02581631|560841642|FG004|Overall Study|Other Reasons|3|||
155384276|NCT02581631|560841638|FG000|Overall Study|Poor/Non-Compliance|0|||
155384277|NCT02581631|560841639|FG001|Overall Study|Poor/Non-Compliance|0|||
155384278|NCT02581631|560841640|FG002|Overall Study|Poor/Non-Compliance|1|||
155384279|NCT02581631|560841641|FG003|Overall Study|Poor/Non-Compliance|0|||
155384280|NCT02581631|560841642|FG004|Overall Study|Poor/Non-Compliance|0|||
155384281|NCT01191268|560841646|FG000|Overall Study|Withdrawal by Subject|19|||
155384282|NCT01191268|560841647|FG001|Overall Study|Withdrawal by Subject|25|||
155384283|NCT01191268|560841648|FG002|Overall Study|Withdrawal by Subject|21|||
155384284|NCT01191268|560841646|FG000|Overall Study|Adverse Event|21|||
155384285|NCT01191268|560841647|FG001|Overall Study|Adverse Event|13|||
155384286|NCT01191268|560841648|FG002|Overall Study|Adverse Event|8|||
155384287|NCT01191268|560841646|FG000|Overall Study|Physician Decision|6|||
155384288|NCT01191268|560841647|FG001|Overall Study|Physician Decision|8|||
155384289|NCT01191268|560841648|FG002|Overall Study|Physician Decision|9|||
155384290|NCT01191268|560841646|FG000|Overall Study|Lost to Follow-up|8|||
155384291|NCT01191268|560841647|FG001|Overall Study|Lost to Follow-up|5|||
155384292|NCT01191268|560841648|FG002|Overall Study|Lost to Follow-up|9|||
155384293|NCT01191268|560841646|FG000|Overall Study|Entry Criteria Not Met|3|||
155384294|NCT01191268|560841647|FG001|Overall Study|Entry Criteria Not Met|1|||
155384295|NCT01191268|560841648|FG002|Overall Study|Entry Criteria Not Met|1|||
155384296|NCT01191268|560841646|FG000|Overall Study|Death|0|||
155384297|NCT01191268|560841647|FG001|Overall Study|Death|1|||
155384298|NCT01191268|560841648|FG002|Overall Study|Death|3|||
155384299|NCT01191268|560841646|FG000|Overall Study|Protocol Violation|1|||
155384300|NCT01191268|560841647|FG001|Overall Study|Protocol Violation|0|||
155384301|NCT01191268|560841648|FG002|Overall Study|Protocol Violation|1|||
155384302|NCT01191268|560841646|FG000|Overall Study|Sponsor Decision|0|||
155384303|NCT01191268|560841647|FG001|Overall Study|Sponsor Decision|2|||
155384304|NCT01191268|560841648|FG002|Overall Study|Sponsor Decision|0|||
155384305|NCT01313689|560841649|FG000|24-Week Randomization 1|Adverse Event|10|||
155384306|NCT01313689|560841650|FG001|24-Week Randomization 1|Adverse Event|5|||
155384307|NCT01313689|560841651|FG002|24-Week Randomization 1|Adverse Event|0|||
155384308|NCT01313689|560841652|FG003|24-Week Randomization 1|Adverse Event|0|||
155384309|NCT01313689|560841653|FG004|24-Week Randomization 1|Adverse Event|0|||
155384310|NCT01313689|560841649|FG000|24-Week Randomization 1|Physician Decision|4|||
155384311|NCT01313689|560841650|FG001|24-Week Randomization 1|Physician Decision|5|||
155384312|NCT01313689|560841651|FG002|24-Week Randomization 1|Physician Decision|0|||
155384313|NCT01313689|560841652|FG003|24-Week Randomization 1|Physician Decision|0|||
155384314|NCT01313689|560841653|FG004|24-Week Randomization 1|Physician Decision|0|||
155384315|NCT01313689|560841649|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
155384316|NCT01313689|560841650|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
155384317|NCT01313689|560841651|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
154943809|NCT01186978|559219328|FG000|Overall Study|Withdrawal by Subject|1|||
154943810|NCT01306253|559219329|FG000|Overall Study|Lost to Follow-up|1|||
154943811|NCT01306253|559219330|FG001|Overall Study|Lost to Follow-up|1|||
154943812|NCT00543439|559219331|FG000|Period 1|Adverse Event|0|||
154943813|NCT00543439|559219332|FG001|Period 1|Adverse Event|2|||
154943814|NCT00543439|559219333|FG002|Period 1|Adverse Event|1|||
154943815|NCT00543439|559219331|FG000|Period 1|Withdrawal by Subject|1|||
154943816|NCT00543439|559219332|FG001|Period 1|Withdrawal by Subject|1|||
154943817|NCT00543439|559219333|FG002|Period 1|Withdrawal by Subject|0|||
154943818|NCT00543439|559219331|FG000|Period 1|Physician Decision|0|||
154943819|NCT00543439|559219332|FG001|Period 1|Physician Decision|0|||
154943820|NCT00543439|559219333|FG002|Period 1|Physician Decision|1|||
154943821|NCT00543439|559219331|FG000|Period 2|Protocol Violation|1|||
154943822|NCT00543439|559219332|FG001|Period 2|Protocol Violation|0|||
154943823|NCT00543439|559219333|FG002|Period 2|Protocol Violation|1|||
154943824|NCT00543439|559219331|FG000|Period 2|Adverse Event|0|||
154943825|NCT00543439|559219332|FG001|Period 2|Adverse Event|1|||
154943826|NCT00543439|559219333|FG002|Period 2|Adverse Event|1|||
154943827|NCT01709383|559219338|FG000|Overall Study|Lost to Follow-up|1|||
154943828|NCT01709383|559219339|FG001|Overall Study|Lost to Follow-up|0|||
154943829|NCT03264066|559219340|FG000|Overall Study|Adverse Event|1|||
154943830|NCT03264066|559219341|FG001|Overall Study|Adverse Event|1|||
154943831|NCT03264066|559219342|FG002|Overall Study|Adverse Event|0|||
154943832|NCT03264066|559219343|FG003|Overall Study|Adverse Event|0|||
155384318|NCT01313689|560841652|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
155384319|NCT01313689|560841653|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
155384320|NCT01313689|560841649|FG000|24-Week Randomization 2|Adverse Event|0|||
155384321|NCT01313689|560841650|FG001|24-Week Randomization 2|Adverse Event|0|||
155384322|NCT01313689|560841651|FG002|24-Week Randomization 2|Adverse Event|2|||
155384323|NCT01313689|560841652|FG003|24-Week Randomization 2|Adverse Event|0|||
155384324|NCT01313689|560841653|FG004|24-Week Randomization 2|Adverse Event|8|||
155384325|NCT01313689|560841649|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
154943833|NCT03264066|559219344|FG004|Overall Study|Adverse Event|0|||
154943834|NCT03264066|559219345|FG005|Overall Study|Adverse Event|0|||
155384326|NCT01313689|560841650|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
155384327|NCT01313689|560841651|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
155384328|NCT01313689|560841652|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
155384329|NCT01313689|560841653|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
155384330|NCT01313689|560841649|FG000|24-Week Randomization 2|Physician Decision|0|||
155384331|NCT01313689|560841650|FG001|24-Week Randomization 2|Physician Decision|0|||
155384332|NCT01313689|560841651|FG002|24-Week Randomization 2|Physician Decision|0|||
155384333|NCT01313689|560841652|FG003|24-Week Randomization 2|Physician Decision|0|||
155384334|NCT01313689|560841653|FG004|24-Week Randomization 2|Physician Decision|4|||
155384335|NCT02481947|560841654|FG000|Overall Study|Withdrawal by Subject|24|||
155384336|NCT02481947|560841655|FG001|Overall Study|Withdrawal by Subject|10|||
155384337|NCT02481947|560841654|FG000|Overall Study|Lost to Follow-up|11|||
155384338|NCT02481947|560841655|FG001|Overall Study|Lost to Follow-up|5|||
155384339|NCT02481947|560841654|FG000|Overall Study|Adverse Event|6|||
155384340|NCT02481947|560841655|FG001|Overall Study|Adverse Event|11|||
155384341|NCT02481947|560841654|FG000|Overall Study|Physician Decision|4|||
155384342|NCT02481947|560841655|FG001|Overall Study|Physician Decision|5|||
155384343|NCT02481947|560841654|FG000|Overall Study|Protocol Violation|1|||
155384344|NCT02481947|560841655|FG001|Overall Study|Protocol Violation|5|||
155384345|NCT00551460|560841656|FG000|Overall Study|Adverse Event|1|||
155384346|NCT00551460|560841656|FG000|Overall Study|Withdrawal by Subject|1|||
155384347|NCT00551460|560841656|FG000|Overall Study|Physician Decision|1|||
155384348|NCT00551460|560841656|FG000|Overall Study|Death|7|||
155384349|NCT00551460|560841656|FG000|Overall Study|Ineligible|4|||
155384350|NCT00551460|560841656|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
155384351|NCT02027623|560841658|FG000|Overall Study|Lost to Follow-up|3|||
155384352|NCT02027623|560841659|FG001|Overall Study|Lost to Follow-up|3|||
155384353|NCT02027623|560841658|FG000|Overall Study|Withdrawal by Subject|6|||
155384354|NCT02027623|560841659|FG001|Overall Study|Withdrawal by Subject|9|||
155384355|NCT01886378|560841662|FG000|Overall Study|Adverse Event|1|||
155384356|NCT01886378|560841662|FG000|Overall Study|Withdrawal by Subject|4|||
155384357|NCT01740323|560841668|FG000|Overall Study|Adverse Event|1|||
155384358|NCT01740323|560841669|FG001|Overall Study|Adverse Event|0|||
155384359|NCT01740323|560841668|FG000|Overall Study|Randomized but did not take study drug|1|||
155384360|NCT01740323|560841669|FG001|Overall Study|Randomized but did not take study drug|0|||
155384361|NCT02112708|560841675|FG000|Baseline|Physician Decision|16|||
155384362|NCT02112708|560841676|FG001|Baseline|Physician Decision|11|||
155384363|NCT02112708|560841675|FG000|Baseline|Lost to Follow-up|12|||
155384364|NCT02112708|560841676|FG001|Baseline|Lost to Follow-up|0|||
155384365|NCT02112708|560841675|FG000|4 Month|Death|0|||
155384366|NCT02112708|560841676|FG001|4 Month|Death|1|||
155384367|NCT02112708|560841675|FG000|4 Month|Withdrawal by Subject|12|||
155384368|NCT02112708|560841676|FG001|4 Month|Withdrawal by Subject|0|||
155384369|NCT02374671|560841677|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
155384370|NCT02374671|560841678|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
155384371|NCT02374671|560841679|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
155384372|NCT02374671|560841677|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
155384373|NCT02374671|560841678|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
155384374|NCT02374671|560841679|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
155384375|NCT02374671|560841677|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
155384376|NCT02374671|560841678|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
155384377|NCT02374671|560841679|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
155384378|NCT02374671|560841677|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
155384379|NCT02374671|560841678|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
155384380|NCT02374671|560841679|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
155384381|NCT02374671|560841677|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
155384382|NCT02374671|560841678|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
155384383|NCT02374671|560841679|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
155384384|NCT00903682|560841680|FG000|Overall Study|Adverse Event|6|||
155384385|NCT00903682|560841681|FG001|Overall Study|Adverse Event|13|||
155384386|NCT00903682|560841680|FG000|Overall Study|Lost to Follow-up|1|||
155384387|NCT00903682|560841681|FG001|Overall Study|Lost to Follow-up|0|||
155384388|NCT00903682|560841680|FG000|Overall Study|Withdrawal by Subject|5|||
155384389|NCT00903682|560841681|FG001|Overall Study|Withdrawal by Subject|0|||
155384390|NCT00903682|560841680|FG000|Overall Study|Pregnancy|0|||
155384391|NCT00903682|560841681|FG001|Overall Study|Pregnancy|1|||
155384392|NCT00903682|560841680|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
155384393|NCT00903682|560841681|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
155384394|NCT00903682|560841680|FG000|Overall Study|Subject Non-Compliant|1|||
155384395|NCT00903682|560841681|FG001|Overall Study|Subject Non-Compliant|0|||
155384396|NCT00903682|560841680|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
155384397|NCT00903682|560841681|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
155384398|NCT00903682|560841680|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
155384399|NCT00903682|560841681|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
155384400|NCT03169101|560841682|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
154943835|NCT03264066|559219340|FG000|Overall Study|Death|12|||
154943836|NCT03264066|559219341|FG001|Overall Study|Death|12|||
154943837|NCT03264066|559219342|FG002|Overall Study|Death|8|||
154943838|NCT03264066|559219343|FG003|Overall Study|Death|10|||
154943839|NCT03264066|559219344|FG004|Overall Study|Death|6|||
154943840|NCT03264066|559219345|FG005|Overall Study|Death|1|||
154943841|NCT03264066|559219340|FG000|Overall Study|Lost to Follow-up|1|||
154943842|NCT03264066|559219341|FG001|Overall Study|Lost to Follow-up|0|||
154943843|NCT03264066|559219342|FG002|Overall Study|Lost to Follow-up|0|||
154943844|NCT03264066|559219343|FG003|Overall Study|Lost to Follow-up|0|||
154943845|NCT03264066|559219344|FG004|Overall Study|Lost to Follow-up|0|||
154943846|NCT03264066|559219345|FG005|Overall Study|Lost to Follow-up|0|||
154943847|NCT03264066|559219340|FG000|Overall Study|Progressive Disease|0|||
154943848|NCT03264066|559219341|FG001|Overall Study|Progressive Disease|2|||
154943849|NCT03264066|559219342|FG002|Overall Study|Progressive Disease|1|||
154943850|NCT03264066|559219343|FG003|Overall Study|Progressive Disease|0|||
154943851|NCT03264066|559219344|FG004|Overall Study|Progressive Disease|0|||
154943852|NCT03264066|559219345|FG005|Overall Study|Progressive Disease|0|||
154943853|NCT03264066|559219340|FG000|Overall Study|Study Terminated by Sponsor|5|||
154943854|NCT03264066|559219341|FG001|Overall Study|Study Terminated by Sponsor|5|||
154943855|NCT03264066|559219342|FG002|Overall Study|Study Terminated by Sponsor|8|||
154943856|NCT03264066|559219343|FG003|Overall Study|Study Terminated by Sponsor|5|||
154943857|NCT03264066|559219344|FG004|Overall Study|Study Terminated by Sponsor|1|||
154943858|NCT03264066|559219345|FG005|Overall Study|Study Terminated by Sponsor|2|||
154943859|NCT03264066|559219340|FG000|Overall Study|Withdrawal by Subject|1|||
154943860|NCT03264066|559219341|FG001|Overall Study|Withdrawal by Subject|0|||
154943861|NCT03264066|559219342|FG002|Overall Study|Withdrawal by Subject|0|||
154943862|NCT03264066|559219343|FG003|Overall Study|Withdrawal by Subject|5|||
154943863|NCT03264066|559219344|FG004|Overall Study|Withdrawal by Subject|0|||
154943864|NCT03264066|559219345|FG005|Overall Study|Withdrawal by Subject|0|||
154943865|NCT01484028|559219346|FG000|Period 1|Lost to Follow-up|0|||
154943866|NCT01484028|559219347|FG001|Period 1|Lost to Follow-up|1|||
154943867|NCT01484028|559219348|FG002|Period 1|Lost to Follow-up|0|||
154943868|NCT01484028|559219349|FG003|Period 1|Lost to Follow-up|0|||
154943869|NCT01484028|559219346|FG000|Period 1|Non-Compliance to Protocol|0|||
154943870|NCT01484028|559219347|FG001|Period 1|Non-Compliance to Protocol|1|||
154943871|NCT01484028|559219348|FG002|Period 1|Non-Compliance to Protocol|0|||
154943872|NCT01484028|559219349|FG003|Period 1|Non-Compliance to Protocol|1|||
154943873|NCT01484028|559219346|FG000|Period 1|Lens Discomfort|0|||
154943874|NCT01484028|559219347|FG001|Period 1|Lens Discomfort|1|||
154943875|NCT01484028|559219348|FG002|Period 1|Lens Discomfort|0|||
154943876|NCT01484028|559219349|FG003|Period 1|Lens Discomfort|0|||
154943877|NCT01193517|559219365|FG000|Overall Study|Early Progression|1|||
154943878|NCT01193517|559219366|FG001|Overall Study|Early Progression|0|||
154943879|NCT01193517|559219367|FG002|Overall Study|Early Progression|0|||
154943880|NCT01626885|559219370|FG000|Overall Study|Adverse Event|8|||
154943881|NCT01626885|559219370|FG000|Overall Study|Withdrawal by Subject|4|||
154943882|NCT00526890|559219371|FG000|Overall Study|Adverse Event|2|||
154943883|NCT04014959|559220782|FG000|Baseline MRI and Assessments|Physician Decision|2|||
154943884|NCT04014959|559220782|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
154943885|NCT04014959|559220782|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
154943886|NCT02004847|559220784|FG000|Overall Study|Protocol Violation|1|||
154943887|NCT02004847|559220785|FG001|Overall Study|Protocol Violation|1|||
154943888|NCT00759148|559220786|FG000|Overall Study|Adverse Event|1|||
154943889|NCT00759148|559220787|FG001|Overall Study|Adverse Event|6|||
154943890|NCT00759148|559220786|FG000|Overall Study|Withdrawal by Subject|3|||
154943891|NCT00759148|559220787|FG001|Overall Study|Withdrawal by Subject|7|||
154943892|NCT00759148|559220786|FG000|Overall Study|Lost to Follow-up|3|||
154943893|NCT00759148|559220787|FG001|Overall Study|Lost to Follow-up|9|||
154943894|NCT00759148|559220786|FG000|Overall Study|Treatment Failure|6|||
154943895|NCT00759148|559220787|FG001|Overall Study|Treatment Failure|10|||
154943896|NCT00759148|559220786|FG000|Overall Study|Reason not given|1|||
154943897|NCT00759148|559220787|FG001|Overall Study|Reason not given|0|||
154943898|NCT01644890|559220788|FG000|Overall Study|Adverse Event|7|||
154943899|NCT01644890|559220789|FG001|Overall Study|Adverse Event|20|||
154943900|NCT01644890|559220788|FG000|Overall Study|Death|1|||
154943901|NCT01644890|559220789|FG001|Overall Study|Death|3|||
154943902|NCT01644890|559220788|FG000|Overall Study|Physician Decision|3|||
154943903|NCT01644890|559220789|FG001|Overall Study|Physician Decision|9|||
154943904|NCT01644890|559220788|FG000|Overall Study|Protocol Violation|6|||
154943905|NCT01644890|559220789|FG001|Overall Study|Protocol Violation|7|||
154943906|NCT01644890|559220788|FG000|Overall Study|Withdrawal by Subject|19|||
154943907|NCT01644890|559220789|FG001|Overall Study|Withdrawal by Subject|27|||
154943908|NCT01644890|559220788|FG000|Overall Study|Progression Disease|160|||
154943909|NCT01644890|559220789|FG001|Overall Study|Progression Disease|131|||
154943910|NCT01644890|559220788|FG000|Overall Study|Clinical Progression|6|||
154943911|NCT01644890|559220789|FG001|Overall Study|Clinical Progression|6|||
154943912|NCT01644890|559220788|FG000|Overall Study|> 28 days since last dose of study drug|6|||
154943913|NCT01644890|559220789|FG001|Overall Study|> 28 days since last dose of study drug|3|||
155384401|NCT03169101|560841683|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
155384402|NCT03169101|560841684|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
155384403|NCT03169101|560841685|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
155384404|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
155384405|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
155384406|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
155384407|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
155384408|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
155384409|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
155384410|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
155384411|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
155384412|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
155384413|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
155384414|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
155384415|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
155384416|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
155384417|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
155384418|NCT00600886|560841688|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
155384419|NCT00600886|560841689|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
155384420|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
155384421|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
155384422|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
155384423|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
155384424|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
155384425|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
155384426|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
155384427|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
155384428|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
155384429|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
155384430|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
155384431|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
155384432|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Death|1|||
155384433|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Death|1|||
155384434|NCT00600886|560841688|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
155384435|NCT00600886|560841689|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
155384436|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
155384437|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
155384438|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
155384439|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
155384440|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
155384441|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
155384442|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
155384443|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
155384444|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
155384445|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
155384446|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
155384447|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
155384448|NCT00600886|560841688|FG000|Extension - After Crossover (CAS)|Death|1|||
155384449|NCT00600886|560841689|FG001|Extension - After Crossover (CAS)|Death|0|||
155384450|NCT01028027|560841690|FG000|Overall Study|Lost to Follow-up|4|||
155384451|NCT01028027|560841691|FG001|Overall Study|Lost to Follow-up|1|||
155384452|NCT01028027|560841690|FG000|Overall Study|Withdrawal by Subject|5|||
155384453|NCT01028027|560841691|FG001|Overall Study|Withdrawal by Subject|3|||
155384454|NCT01028027|560841690|FG000|Overall Study|Adverse Event|4|||
155384455|NCT01028027|560841691|FG001|Overall Study|Adverse Event|7|||
155384456|NCT01028027|560841690|FG000|Overall Study|Protocol Violation|3|||
155384457|NCT01028027|560841691|FG001|Overall Study|Protocol Violation|1|||
155384458|NCT01028027|560841690|FG000|Overall Study|Lack of Efficacy|0|||
155384459|NCT01028027|560841691|FG001|Overall Study|Lack of Efficacy|1|||
155384460|NCT02572843|560841698|FG000|Accrual|Brain metastasis retrospectively detected|1|||
155384461|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
155384462|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
155384463|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
155384464|NCT02572843|560841698|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
155384465|NCT02572843|560841698|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
155384466|NCT02572843|560841698|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
155384467|NCT02572843|560841698|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
155384468|NCT02572843|560841698|FG000|Surgery|lost to follow up|7|||
155384469|NCT02572843|560841698|FG000|Surgery|Death|1|||
155384470|NCT01078454|560841699|FG000|Overall Study|Adverse Event|1|||
155384471|NCT01078454|560841700|FG001|Overall Study|Adverse Event|1|||
155384472|NCT01078454|560841699|FG000|Overall Study|Death|0|||
155384473|NCT01078454|560841700|FG001|Overall Study|Death|1|||
155384474|NCT03440320|560843620|FG000|Overall Study|Withdrawal by Subject|0|||
155384475|NCT03440320|560843621|FG001|Overall Study|Withdrawal by Subject|1|||
155384476|NCT01912456|560843622|FG000|Period 1|Physician Decision|0|||
155384477|NCT01912456|560843623|FG001|Period 1|Physician Decision|0|||
155384478|NCT01912456|560843624|FG002|Period 1|Physician Decision|1|||
155384479|NCT01912456|560843625|FG003|Period 1|Physician Decision|0|||
155384480|NCT01912456|560843622|FG000|Period 1|non-compliance|1|||
155384481|NCT01912456|560843623|FG001|Period 1|non-compliance|0|||
155384482|NCT01912456|560843624|FG002|Period 1|non-compliance|0|||
155384483|NCT01912456|560843625|FG003|Period 1|non-compliance|1|||
155384484|NCT01912456|560843622|FG000|Period 1|Adverse Event|1|||
155384485|NCT01912456|560843623|FG001|Period 1|Adverse Event|0|||
155384486|NCT01912456|560843624|FG002|Period 1|Adverse Event|0|||
155384487|NCT01912456|560843625|FG003|Period 1|Adverse Event|1|||
155384488|NCT01912456|560843622|FG000|Period 1|Withdrawal by Subject|0|||
155384489|NCT01912456|560843623|FG001|Period 1|Withdrawal by Subject|1|||
155384490|NCT01912456|560843624|FG002|Period 1|Withdrawal by Subject|1|||
155384491|NCT01912456|560843625|FG003|Period 1|Withdrawal by Subject|1|||
155384492|NCT01912456|560843622|FG000|Period 2|Lack of Efficacy|0|||
155384493|NCT01912456|560843623|FG001|Period 2|Lack of Efficacy|2|||
155384494|NCT01912456|560843624|FG002|Period 2|Lack of Efficacy|0|||
155384495|NCT01912456|560843625|FG003|Period 2|Lack of Efficacy|0|||
155384496|NCT01912456|560843622|FG000|Period 2|Adverse Event|0|||
155384497|NCT01912456|560843623|FG001|Period 2|Adverse Event|0|||
155384498|NCT01912456|560843624|FG002|Period 2|Adverse Event|0|||
155384499|NCT01912456|560843625|FG003|Period 2|Adverse Event|1|||
155384500|NCT00001962|560843631|FG000|Overall Study|Lack of Efficacy|18|||
155384501|NCT00001962|560843631|FG000|Overall Study|Lack of Accrual|6|||
155384502|NCT00001962|560843631|FG000|Overall Study|Death|1|||
155384503|NCT00001962|560843631|FG000|Overall Study|Lost to Follow-up|2|||
155384504|NCT00001962|560843631|FG000|Overall Study|Adverse Event|1|||
155384505|NCT00171704|560843632|FG000|Overall Study|Adverse Event|24|||
155384506|NCT00171704|560843633|FG001|Overall Study|Adverse Event|33|||
155384507|NCT00171704|560843632|FG000|Overall Study|Disease Progression|14|||
155384508|NCT00171704|560843633|FG001|Overall Study|Disease Progression|9|||
155384509|NCT00171704|560843632|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
155384510|NCT00171704|560843633|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
155384511|NCT00171704|560843632|FG000|Overall Study|Administrative Problems|2|||
155384512|NCT00171704|560843633|FG001|Overall Study|Administrative Problems|1|||
155384513|NCT00171704|560843632|FG000|Overall Study|Death|2|||
155384514|NCT00171704|560843633|FG001|Overall Study|Death|2|||
155384515|NCT00171704|560843632|FG000|Overall Study|Withdrawal by Subject|1|||
155384516|NCT00171704|560843633|FG001|Overall Study|Withdrawal by Subject|3|||
155384517|NCT00171704|560843632|FG000|Overall Study|Protocol Violation|0|||
155384518|NCT00171704|560843633|FG001|Overall Study|Protocol Violation|1|||
155384519|NCT00320541|560843636|FG000|Overall Study|Adverse Event|21|||
155384520|NCT00320541|560843637|FG001|Overall Study|Adverse Event|19|||
155384521|NCT00320541|560843636|FG000|Overall Study|Protocol Violation|0|||
155384522|NCT00320541|560843637|FG001|Overall Study|Protocol Violation|1|||
155384523|NCT00320541|560843636|FG000|Overall Study|Withdrawal by Subject|12|||
155384524|NCT00320541|560843637|FG001|Overall Study|Withdrawal by Subject|16|||
155384525|NCT00320541|560843636|FG000|Overall Study|Physician Decision|9|||
155384526|NCT00320541|560843637|FG001|Overall Study|Physician Decision|13|||
155384527|NCT00320541|560843636|FG000|Overall Study|Other|3|||
155384528|NCT00320541|560843637|FG001|Overall Study|Other|4|||
155384529|NCT00320541|560843636|FG000|Overall Study|Sponsor Decision|2|||
155384530|NCT00320541|560843637|FG001|Overall Study|Sponsor Decision|1|||
155384531|NCT00320541|560843636|FG000|Overall Study|Death due to Study Disease|1|||
155384532|NCT00320541|560843637|FG001|Overall Study|Death due to Study Disease|3|||
155384533|NCT00320541|560843636|FG000|Overall Study|Death due to Adverse Event(s)|1|||
155384534|NCT00320541|560843637|FG001|Overall Study|Death due to Adverse Event(s)|0|||
155384535|NCT00320541|560843636|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
155384536|NCT00320541|560843637|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
155384537|NCT04281004|560843640|FG000|Overall Study|Physician Decision|1|||
155384538|NCT04281004|560843641|FG001|Overall Study|Physician Decision|0|||
155384539|NCT00701779|560843642|FG000|Overall Study|Adverse Event|6|||
155384540|NCT00701779|560843642|FG000|Overall Study|Lost to Follow-up|1|||
155384541|NCT00701779|560843642|FG000|Overall Study|Withdrawal by Subject|2|||
155384542|NCT02245672|560843643|FG000|Overall Study|Adverse Event|4|||
155384543|NCT02245672|560843644|FG001|Overall Study|Adverse Event|4|||
155384544|NCT02245672|560843645|FG002|Overall Study|Adverse Event|4|||
155384545|NCT02245672|560843643|FG000|Overall Study|Lost to Follow-up|3|||
155384546|NCT02245672|560843644|FG001|Overall Study|Lost to Follow-up|5|||
155384547|NCT02245672|560843645|FG002|Overall Study|Lost to Follow-up|1|||
155384548|NCT02245672|560843643|FG000|Overall Study|Withdrawal by Subject|6|||
155384549|NCT02245672|560843644|FG001|Overall Study|Withdrawal by Subject|3|||
154943914|NCT01644890|559220788|FG000|Overall Study|Other|8|||
154943915|NCT01644890|559220789|FG001|Overall Study|Other|9|||
154943916|NCT03031899|559220792|FG000|Overall Study|Protocol Violation|1|||
154943917|NCT03031899|559220792|FG000|Overall Study|lesion disappeared after stopping habit|1|||
154943918|NCT03705351|559220793|FG000|Overall Study|Study termination|3|||
154943919|NCT03705351|559220793|FG000|Overall Study|Death|1|||
154943920|NCT03705351|559220793|FG000|Overall Study|Lack of Efficacy|2|||
154943921|NCT03705351|559220793|FG000|Overall Study|Withdrawal by Subject|1|||
154943922|NCT00633152|559220796|FG000|Overall Study|Adverse Event|1|||
154943923|NCT00633152|559220797|FG001|Overall Study|Adverse Event|0|||
154943924|NCT00633152|559220796|FG000|Overall Study|Randomized, did not receive study drug|5|||
154943925|NCT00633152|559220797|FG001|Overall Study|Randomized, did not receive study drug|2|||
154943926|NCT00633152|559220796|FG000|Overall Study|Withdrawal by Subject|1|||
154943927|NCT00633152|559220797|FG001|Overall Study|Withdrawal by Subject|1|||
154943928|NCT00633152|559220796|FG000|Overall Study|Lost to Follow-up|4|||
154943929|NCT00633152|559220797|FG001|Overall Study|Lost to Follow-up|1|||
154943930|NCT00633152|559220796|FG000|Overall Study|Miscellaneous Other|3|||
154943931|NCT00633152|559220797|FG001|Overall Study|Miscellaneous Other|2|||
154943932|NCT02180061|559220798|FG000|Overall Study|Adverse Event|4|||
154943933|NCT02180061|559220799|FG001|Overall Study|Adverse Event|2|||
154943934|NCT02180061|559220798|FG000|Overall Study|Clinical Progression|5|||
154943935|NCT02180061|559220799|FG001|Overall Study|Clinical Progression|1|||
154943936|NCT02180061|559220798|FG000|Overall Study|Progressive Disease|15|||
154943937|NCT02180061|559220799|FG001|Overall Study|Progressive Disease|5|||
154943938|NCT02180061|559220798|FG000|Overall Study|Physician Decision|1|||
154943939|NCT02180061|559220799|FG001|Overall Study|Physician Decision|0|||
154943940|NCT00056160|559220802|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
154943941|NCT00056160|559220803|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
154943942|NCT00056160|559220802|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
154943943|NCT00056160|559220803|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
154943944|NCT00056160|559220802|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
154943945|NCT00056160|559220803|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
154943946|NCT00056160|559220802|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
154943947|NCT00056160|559220803|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
154943948|NCT00056160|559220802|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
154943949|NCT00056160|559220803|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
154943950|NCT00056160|559220802|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
154943951|NCT00056160|559220803|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
154943952|NCT00056160|559220802|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
154943953|NCT00056160|559220803|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
154943954|NCT00056160|559220802|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
154943955|NCT00056160|559220803|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
154943956|NCT00056160|559220802|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
154943957|NCT00056160|559220803|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
154943958|NCT00056160|559220802|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
154943959|NCT00056160|559220803|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
154943960|NCT00056160|559220802|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
154943961|NCT00056160|559220803|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
154943962|NCT00056160|559220802|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
154943963|NCT00056160|559220803|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
154943964|NCT00056160|559220802|FG000|Final Follow-up|Transferred into expanded access study.|3|||
154943965|NCT00056160|559220803|FG001|Final Follow-up|Transferred into expanded access study.|0|||
154943966|NCT00056160|559220802|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
154943967|NCT00056160|559220803|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
154943968|NCT00056160|559220802|FG000|Final Follow-up|Adverse Event|1|||
154943969|NCT00056160|559220803|FG001|Final Follow-up|Adverse Event|0|||
154943970|NCT01590433|559220807|FG000|Overall Study|Lost to Follow-up|20|||
154943971|NCT01590433|559220808|FG001|Overall Study|Lost to Follow-up|8|||
154943972|NCT01590433|559220807|FG000|Overall Study|Withdrawal by Subject|21|||
154943973|NCT01590433|559220808|FG001|Overall Study|Withdrawal by Subject|11|||
154943974|NCT01590433|559220807|FG000|Overall Study|Adverse Event|11|||
154943975|NCT01590433|559220808|FG001|Overall Study|Adverse Event|3|||
154943976|NCT00555009|559220809|FG000|Overall Study|Withdrawal by Subject|0|||
154943977|NCT00555009|559220810|FG001|Overall Study|Withdrawal by Subject|1|||
154943978|NCT00555009|559220809|FG000|Overall Study|Terminated by Sponsor|2|||
154943979|NCT00555009|559220810|FG001|Overall Study|Terminated by Sponsor|5|||
155045791|NCT05052697|559599413|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045792|NCT05052697|559599414|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
155279127|NCT02335268|560454789|FG000|Overall Study|Physician Decision|5|||
154943980|NCT03731182|559220819|FG000|Overall Study|Lost to Follow-up|2|||
154943981|NCT03731182|559220820|FG001|Overall Study|Lost to Follow-up|0|||
154943982|NCT03731182|559220819|FG000|Overall Study|Physician Decision|1|||
154943983|NCT03731182|559220820|FG001|Overall Study|Physician Decision|0|||
154943984|NCT03731182|559220819|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
155384550|NCT02245672|560843645|FG002|Overall Study|Withdrawal by Subject|0|||
155384551|NCT02245672|560843643|FG000|Overall Study|Randomized in error (not treated)|0|||
155384552|NCT02245672|560843644|FG001|Overall Study|Randomized in error (not treated)|1|||
155384553|NCT02245672|560843645|FG002|Overall Study|Randomized in error (not treated)|0|||
155384554|NCT01640054|560843646|FG000|Overall Study|Study-specific disc criteria|1|||
155384555|NCT01640054|560843646|FG000|Overall Study|Lack of Efficacy|3|||
155384556|NCT01640054|560843646|FG000|Overall Study|Adverse Event|2|||
155384557|NCT01620255|560843648|FG000|Overall Study|Withdrawal by Subject|4|||
155384558|NCT01620255|560843649|FG001|Overall Study|Withdrawal by Subject|1|||
155384559|NCT01620255|560843650|FG002|Overall Study|Withdrawal by Subject|1|||
155384560|NCT01620255|560843651|FG003|Overall Study|Withdrawal by Subject|2|||
155384561|NCT01620255|560843652|FG004|Overall Study|Withdrawal by Subject|4|||
155384562|NCT01620255|560843648|FG000|Overall Study|Participant underwent fecal transplant|0|||
155384563|NCT01620255|560843649|FG001|Overall Study|Participant underwent fecal transplant|0|||
155384564|NCT01620255|560843650|FG002|Overall Study|Participant underwent fecal transplant|1|||
155384565|NCT01620255|560843651|FG003|Overall Study|Participant underwent fecal transplant|0|||
155384566|NCT01620255|560843652|FG004|Overall Study|Participant underwent fecal transplant|0|||
155384567|NCT01620255|560843648|FG000|Overall Study|Non-compliance|0|||
155384568|NCT01620255|560843649|FG001|Overall Study|Non-compliance|1|||
155384569|NCT01620255|560843650|FG002|Overall Study|Non-compliance|0|||
155384570|NCT01620255|560843651|FG003|Overall Study|Non-compliance|0|||
155384571|NCT01620255|560843652|FG004|Overall Study|Non-compliance|0|||
155384572|NCT01620255|560843648|FG000|Overall Study|Adverse Event|0|||
155384573|NCT01620255|560843649|FG001|Overall Study|Adverse Event|4|||
155384574|NCT01620255|560843650|FG002|Overall Study|Adverse Event|0|||
155384575|NCT01620255|560843651|FG003|Overall Study|Adverse Event|1|||
155384576|NCT01620255|560843652|FG004|Overall Study|Adverse Event|1|||
155384577|NCT01620255|560843648|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
155384578|NCT01620255|560843649|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
155384579|NCT01620255|560843650|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
155384580|NCT01620255|560843651|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
155384581|NCT01620255|560843652|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
155384582|NCT01146054|560843655|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
155384583|NCT01146054|560843655|FG000|Overall Study|Rapid tumor progression|2|||
155384584|NCT01146054|560843655|FG000|Overall Study|Other illness precluded treatment|2|||
155384585|NCT01146054|560843655|FG000|Overall Study|Lost to Follow-up|1|||
155384586|NCT01155375|560843656|FG000|Overall Study|Adverse Event|1|||
155384587|NCT01155375|560843657|FG001|Overall Study|Adverse Event|0|||
155384588|NCT04335812|560843658|FG000|Overall Study|Withdrawal by Subject|1|||
155384589|NCT04335812|560843659|FG001|Overall Study|Withdrawal by Subject|3|||
155384590|NCT04335812|560843658|FG000|Overall Study|Lost to Follow-up|12|||
155384591|NCT04335812|560843659|FG001|Overall Study|Lost to Follow-up|12|||
155384592|NCT04335812|560843658|FG000|Overall Study|Did not engage in the intervention|22|||
155384593|NCT04335812|560843659|FG001|Overall Study|Did not engage in the intervention|18|||
155384594|NCT02901041|560843660|FG000|Overall Study|Withdrawal by PI|4|||
155384595|NCT02901041|560843661|FG001|Overall Study|Withdrawal by PI|8|||
155384596|NCT02901041|560843660|FG000|Overall Study|Withdrawal by Subject|7|||
155384597|NCT02901041|560843661|FG001|Overall Study|Withdrawal by Subject|3|||
155384598|NCT00975507|560843665|FG000|Overall Study|Adverse Event|1|||
155384599|NCT00975507|560843666|FG001|Overall Study|Adverse Event|0|||
155384600|NCT00975507|560843665|FG000|Overall Study|Lost to Follow-up|7|||
155384601|NCT00975507|560843666|FG001|Overall Study|Lost to Follow-up|1|||
155384602|NCT00975507|560843665|FG000|Overall Study|Protocol Violation|2|||
155384603|NCT00975507|560843666|FG001|Overall Study|Protocol Violation|0|||
155384604|NCT00975507|560843665|FG000|Overall Study|Withdrawal by Subject|10|||
155384605|NCT00975507|560843666|FG001|Overall Study|Withdrawal by Subject|3|||
155384606|NCT03818204|560843667|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384607|NCT03818204|560843668|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384608|NCT03818204|560843669|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384609|NCT03818204|560843670|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384610|NCT03818204|560843671|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
155384611|NCT03818204|560843672|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384612|NCT03818204|560843673|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384613|NCT03818204|560843674|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384614|NCT03818204|560843675|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384615|NCT03818204|560843676|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384616|NCT03818204|560843677|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384617|NCT03818204|560843678|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384618|NCT03818204|560843679|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384619|NCT03818204|560843680|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
155384620|NCT03818204|560843681|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
154943985|NCT03731182|559220820|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
154943986|NCT01751412|559220821|FG000|Overall Study|Disease Progression Before Treatment|1|||
154943987|NCT03734237|559220824|FG000|Overall Study|Lost to Follow-up|1|||
154943988|NCT03734237|559220825|FG001|Overall Study|Lost to Follow-up|3|||
154943989|NCT03734237|559220826|FG002|Overall Study|Lost to Follow-up|0|||
154943990|NCT03734237|559220824|FG000|Overall Study|Withdrawal by Subject|7|||
154943991|NCT03734237|559220825|FG001|Overall Study|Withdrawal by Subject|9|||
154943992|NCT03734237|559220826|FG002|Overall Study|Withdrawal by Subject|10|||
154943993|NCT01844583|559220827|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
154943994|NCT01844583|559220828|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
154943995|NCT02207621|559220830|FG000|Overall Study|Adverse Event|71|||
154943996|NCT02207621|559220831|FG001|Overall Study|Adverse Event|15|||
154943997|NCT02207621|559220832|FG002|Overall Study|Adverse Event|132|||
154943998|NCT02207621|559220830|FG000|Overall Study|Withdrawal by Subject|9|||
154943999|NCT02207621|559220831|FG001|Overall Study|Withdrawal by Subject|9|||
154944000|NCT02207621|559220832|FG002|Overall Study|Withdrawal by Subject|13|||
154944001|NCT02207621|559220830|FG000|Overall Study|Non-Compliant|3|||
154944002|NCT02207621|559220831|FG001|Overall Study|Non-Compliant|3|||
154944003|NCT02207621|559220832|FG002|Overall Study|Non-Compliant|1|||
154944004|NCT02207621|559220830|FG000|Overall Study|Lost to Follow-up|1|||
154944005|NCT02207621|559220831|FG001|Overall Study|Lost to Follow-up|0|||
154944006|NCT02207621|559220832|FG002|Overall Study|Lost to Follow-up|3|||
154944007|NCT02207621|559220830|FG000|Overall Study|Lack of Efficacy|10|||
154944008|NCT02207621|559220831|FG001|Overall Study|Lack of Efficacy|2|||
154944009|NCT02207621|559220832|FG002|Overall Study|Lack of Efficacy|4|||
154944010|NCT02207621|559220830|FG000|Overall Study|Disallowed Concurrent Medication|2|||
154944011|NCT02207621|559220831|FG001|Overall Study|Disallowed Concurrent Medication|5|||
154944012|NCT02207621|559220832|FG002|Overall Study|Disallowed Concurrent Medication|2|||
154944013|NCT02207621|559220830|FG000|Overall Study|Physician Decision|1|||
154944014|NCT02207621|559220831|FG001|Overall Study|Physician Decision|2|||
154944015|NCT02207621|559220832|FG002|Overall Study|Physician Decision|2|||
154944016|NCT02207621|559220830|FG000|Overall Study|Protocol Violation|4|||
154944017|NCT02207621|559220831|FG001|Overall Study|Protocol Violation|10|||
154944018|NCT02207621|559220832|FG002|Overall Study|Protocol Violation|6|||
154944019|NCT02207621|559220830|FG000|Overall Study|Death|2|||
154944020|NCT02207621|559220831|FG001|Overall Study|Death|0|||
154944021|NCT02207621|559220832|FG002|Overall Study|Death|0|||
154944022|NCT02207621|559220830|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
154944023|NCT02207621|559220831|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
154944024|NCT02207621|559220832|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
154944025|NCT00958256|559220835|FG000|Overall Study|Adverse Event|3|||
154944026|NCT03036579|559220836|FG000|2 Years|Lost to Follow-up|1|||
154944027|NCT03036579|559220837|FG001|2 Years|Lost to Follow-up|0|||
154944028|NCT03036579|559220836|FG000|3 Years|Lost to Follow-up|0|||
154944029|NCT03036579|559220837|FG001|3 Years|Lost to Follow-up|1|||
154944030|NCT05431153|559220838|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154944031|NCT05431153|559220839|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154944032|NCT05431153|559220840|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154944033|NCT05431153|559220841|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154944034|NCT05431153|559220842|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
154944035|NCT05431153|559220843|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154944036|NCT00576901|559220852|FG000|Overall Study|Withdrawal by Subject|1|||
155279128|NCT02335268|560454790|FG001|Overall Study|Physician Decision|1|||
154944037|NCT00576901|559220852|FG000|Overall Study|Disease course|1|||
154944038|NCT00576901|559220852|FG000|Overall Study|Protocol Violation|1|||
154944039|NCT02398188|559220853|FG000|Overall Study|Adverse Event|2|||
154944040|NCT02398188|559220854|FG001|Overall Study|Adverse Event|3|||
154944041|NCT02398188|559220853|FG000|Overall Study|Lost to Follow-up|5|||
154944042|NCT02398188|559220854|FG001|Overall Study|Lost to Follow-up|0|||
154944043|NCT02398188|559220853|FG000|Overall Study|Non-compliance|4|||
155279129|NCT02335268|560454789|FG000|Overall Study|Lack of Efficacy|2|||
155279130|NCT02335268|560454790|FG001|Overall Study|Lack of Efficacy|1|||
155279131|NCT02335268|560454789|FG000|Overall Study|Adverse Event|5|||
155279132|NCT02335268|560454790|FG001|Overall Study|Adverse Event|2|||
155279133|NCT02335268|560454789|FG000|Overall Study|increase blasts|2|||
155279134|NCT02335268|560454790|FG001|Overall Study|increase blasts|0|||
155279135|NCT02335268|560454789|FG000|Overall Study|Withdrawal by Subject|3|||
155279136|NCT02335268|560454790|FG001|Overall Study|Withdrawal by Subject|2|||
155279137|NCT03160079|560454799|FG000|Overall Study|Adverse Event|2|||
155279138|NCT03160079|560454800|FG001|Overall Study|Adverse Event|0|||
155279139|NCT03160079|560454799|FG000|Overall Study|Disease Progression|1|||
155279140|NCT03160079|560454800|FG001|Overall Study|Disease Progression|0|||
155279141|NCT03160079|560454799|FG000|Overall Study|Physician Decision|1|||
155279142|NCT03160079|560454800|FG001|Overall Study|Physician Decision|0|||
155279143|NCT01923428|560454811|FG000|Overall Study|Adverse Event|8|||
155279144|NCT01923428|560454812|FG001|Overall Study|Adverse Event|6|||
155279145|NCT01923428|560454813|FG002|Overall Study|Adverse Event|3|||
155384621|NCT03818204|560843682|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384622|NCT03818204|560843683|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384623|NCT03818204|560843684|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384624|NCT03818204|560843685|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
155384625|NCT03818204|560843667|FG000|Overall Study|Physician Decision|0|||
155384626|NCT03818204|560843668|FG001|Overall Study|Physician Decision|0|||
155384627|NCT03818204|560843669|FG002|Overall Study|Physician Decision|0|||
155384628|NCT03818204|560843670|FG003|Overall Study|Physician Decision|0|||
155384629|NCT03818204|560843671|FG004|Overall Study|Physician Decision|0|||
155384630|NCT03818204|560843672|FG005|Overall Study|Physician Decision|0|||
155384631|NCT03818204|560843673|FG006|Overall Study|Physician Decision|0|||
155384632|NCT03818204|560843674|FG007|Overall Study|Physician Decision|0|||
155384633|NCT03818204|560843675|FG008|Overall Study|Physician Decision|0|||
155384634|NCT03818204|560843676|FG009|Overall Study|Physician Decision|0|||
155384635|NCT03818204|560843677|FG010|Overall Study|Physician Decision|0|||
155384636|NCT03818204|560843678|FG011|Overall Study|Physician Decision|0|||
155384637|NCT03818204|560843679|FG012|Overall Study|Physician Decision|0|||
155384638|NCT03818204|560843680|FG013|Overall Study|Physician Decision|0|||
155384639|NCT03818204|560843681|FG014|Overall Study|Physician Decision|1|||
155384640|NCT03818204|560843682|FG015|Overall Study|Physician Decision|0|||
155384641|NCT03818204|560843683|FG016|Overall Study|Physician Decision|0|||
155384642|NCT03818204|560843684|FG017|Overall Study|Physician Decision|0|||
155384643|NCT03818204|560843685|FG018|Overall Study|Physician Decision|0|||
155384644|NCT00887250|560843686|FG000|Overall Study|Adverse Event|3|||
155384645|NCT00887250|560843687|FG001|Overall Study|Adverse Event|0|||
155384646|NCT00887250|560843688|FG002|Overall Study|Adverse Event|7|||
155384647|NCT00887250|560843686|FG000|Overall Study|Lack of Efficacy|9|||
155384648|NCT00887250|560843687|FG001|Overall Study|Lack of Efficacy|6|||
155384649|NCT00887250|560843688|FG002|Overall Study|Lack of Efficacy|1|||
155384650|NCT00887250|560843686|FG000|Overall Study|Lost to Follow-up|2|||
155384651|NCT00887250|560843687|FG001|Overall Study|Lost to Follow-up|3|||
155384652|NCT00887250|560843688|FG002|Overall Study|Lost to Follow-up|1|||
155384653|NCT00887250|560843686|FG000|Overall Study|Protocol Violation|2|||
155384654|NCT00887250|560843687|FG001|Overall Study|Protocol Violation|2|||
155384655|NCT00887250|560843688|FG002|Overall Study|Protocol Violation|1|||
155384656|NCT00887250|560843686|FG000|Overall Study|Withdrawal by Subject|2|||
155384657|NCT00887250|560843687|FG001|Overall Study|Withdrawal by Subject|1|||
155384658|NCT00887250|560843688|FG002|Overall Study|Withdrawal by Subject|2|||
155384659|NCT00887250|560843686|FG000|Overall Study|Patient uncooperative|0|||
155384660|NCT00887250|560843687|FG001|Overall Study|Patient uncooperative|0|||
155384661|NCT00887250|560843688|FG002|Overall Study|Patient uncooperative|1|||
155384662|NCT05754333|560843689|FG000|Overall Study|Miscellaneous|3|||
155384663|NCT05754333|560843690|FG001|Overall Study|Miscellaneous|0|||
155384664|NCT05754333|560843691|FG002|Overall Study|Miscellaneous|0|||
155384665|NCT05754333|560843692|FG003|Overall Study|Miscellaneous|0|||
155384666|NCT05754333|560843689|FG000|Overall Study|Lost to Follow-up|2|||
155384667|NCT05754333|560843690|FG001|Overall Study|Lost to Follow-up|1|||
155384668|NCT05754333|560843691|FG002|Overall Study|Lost to Follow-up|0|||
155384669|NCT05754333|560843692|FG003|Overall Study|Lost to Follow-up|1|||
155384670|NCT02070588|560843700|FG000|Overall Study|Withdrawal by Subject|29|||
155384671|NCT02070588|560843701|FG001|Overall Study|Withdrawal by Subject|1|||
155384672|NCT02070588|560843702|FG002|Overall Study|Withdrawal by Subject|0|||
155384673|NCT02070588|560843700|FG000|Overall Study|Writhdrawal due to early termination|9|||
155384674|NCT02070588|560843701|FG001|Overall Study|Writhdrawal due to early termination|0|||
155384675|NCT02070588|560843702|FG002|Overall Study|Writhdrawal due to early termination|0|||
155384676|NCT02070588|560843700|FG000|Overall Study|Adverse Event|1|||
155384677|NCT02070588|560843701|FG001|Overall Study|Adverse Event|0|||
155384678|NCT02070588|560843702|FG002|Overall Study|Adverse Event|0|||
155384679|NCT00819390|560843703|FG000|Overall Study|Lost to Follow-up|1|||
155384680|NCT00819390|560843704|FG001|Overall Study|Lost to Follow-up|1|||
155384681|NCT00819390|560843705|FG002|Overall Study|Lost to Follow-up|0|||
155384682|NCT00819390|560843706|FG003|Overall Study|Lost to Follow-up|0|||
155384683|NCT00819390|560843703|FG000|Overall Study|Withdrawal by Subject|2|||
155384684|NCT00819390|560843704|FG001|Overall Study|Withdrawal by Subject|0|||
155384685|NCT00819390|560843705|FG002|Overall Study|Withdrawal by Subject|0|||
155384686|NCT00819390|560843706|FG003|Overall Study|Withdrawal by Subject|0|||
155384687|NCT00819390|560843703|FG000|Overall Study|Adverse Event|0|||
155384688|NCT00819390|560843704|FG001|Overall Study|Adverse Event|0|||
155384689|NCT00819390|560843705|FG002|Overall Study|Adverse Event|1|||
155384690|NCT00819390|560843706|FG003|Overall Study|Adverse Event|0|||
155384691|NCT01209780|560843707|FG000|Overall Study|Adverse Event|0|||
155384692|NCT01209780|560843708|FG001|Overall Study|Adverse Event|1|||
155384693|NCT01209780|560843709|FG002|Overall Study|Adverse Event|0|||
155384694|NCT01209780|560843710|FG003|Overall Study|Adverse Event|0|||
155384695|NCT01209780|560843711|FG004|Overall Study|Adverse Event|0|||
155384696|NCT01209780|560843707|FG000|Overall Study|Withdrawal by Subject|9|||
155384697|NCT01209780|560843708|FG001|Overall Study|Withdrawal by Subject|2|||
155384698|NCT01209780|560843709|FG002|Overall Study|Withdrawal by Subject|1|||
155384699|NCT01209780|560843710|FG003|Overall Study|Withdrawal by Subject|1|||
155384700|NCT01209780|560843711|FG004|Overall Study|Withdrawal by Subject|0|||
155384701|NCT01209780|560843707|FG000|Overall Study|Lost to Follow-up|17|||
155384702|NCT01209780|560843708|FG001|Overall Study|Lost to Follow-up|12|||
155384703|NCT01209780|560843709|FG002|Overall Study|Lost to Follow-up|3|||
155384704|NCT01209780|560843710|FG003|Overall Study|Lost to Follow-up|9|||
155384705|NCT01209780|560843711|FG004|Overall Study|Lost to Follow-up|4|||
155384706|NCT01209780|560843707|FG000|Overall Study|Protocol Violation|0|||
155384707|NCT01209780|560843708|FG001|Overall Study|Protocol Violation|1|||
155384708|NCT01209780|560843709|FG002|Overall Study|Protocol Violation|0|||
155384709|NCT01209780|560843710|FG003|Overall Study|Protocol Violation|0|||
155384710|NCT01209780|560843711|FG004|Overall Study|Protocol Violation|0|||
155384711|NCT01209780|560843707|FG000|Overall Study|Inappropriate enrollment|0|||
155384712|NCT01209780|560843708|FG001|Overall Study|Inappropriate enrollment|2|||
155384713|NCT01209780|560843709|FG002|Overall Study|Inappropriate enrollment|0|||
155384714|NCT01209780|560843710|FG003|Overall Study|Inappropriate enrollment|0|||
155384715|NCT01209780|560843711|FG004|Overall Study|Inappropriate enrollment|1|||
155384716|NCT02709096|560843712|FG000|Overall Study|non-compliance|1|||
155384717|NCT02709096|560843713|FG001|Overall Study|non-compliance|1|||
155384718|NCT00818649|560843714|FG000|Overall Study|Declining performance status|2|||
155384719|NCT00818649|560843714|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
155384720|NCT00818649|560843714|FG000|Overall Study|Adverse Event|1|||
155384721|NCT00505284|560843715|FG000|Overall Study|Adverse Event|3|||
155384722|NCT00505284|560843716|FG001|Overall Study|Adverse Event|7|||
155384723|NCT00505284|560843717|FG002|Overall Study|Adverse Event|9|||
155384724|NCT00505284|560843718|FG003|Overall Study|Adverse Event|14|||
155384725|NCT00505284|560843719|FG004|Overall Study|Adverse Event|22|||
155384726|NCT00505284|560843715|FG000|Overall Study|Protocol Violation|0|||
155384727|NCT00505284|560843716|FG001|Overall Study|Protocol Violation|1|||
155384728|NCT00505284|560843717|FG002|Overall Study|Protocol Violation|1|||
155384729|NCT00505284|560843718|FG003|Overall Study|Protocol Violation|0|||
155384730|NCT00505284|560843719|FG004|Overall Study|Protocol Violation|0|||
155384731|NCT00505284|560843715|FG000|Overall Study|Withdrawal by Subject|2|||
155384732|NCT00505284|560843716|FG001|Overall Study|Withdrawal by Subject|6|||
155384733|NCT00505284|560843717|FG002|Overall Study|Withdrawal by Subject|1|||
155384734|NCT00505284|560843718|FG003|Overall Study|Withdrawal by Subject|0|||
155384735|NCT00505284|560843719|FG004|Overall Study|Withdrawal by Subject|6|||
155384736|NCT00505284|560843715|FG000|Overall Study|Lack of Efficacy|0|||
155384737|NCT00505284|560843716|FG001|Overall Study|Lack of Efficacy|1|||
155384738|NCT00505284|560843717|FG002|Overall Study|Lack of Efficacy|1|||
155384739|NCT00505284|560843718|FG003|Overall Study|Lack of Efficacy|1|||
155384740|NCT00505284|560843719|FG004|Overall Study|Lack of Efficacy|1|||
155384741|NCT00505284|560843715|FG000|Overall Study|Physician Decision|0|||
155384742|NCT00505284|560843716|FG001|Overall Study|Physician Decision|1|||
155384743|NCT00505284|560843717|FG002|Overall Study|Physician Decision|0|||
155384744|NCT00505284|560843718|FG003|Overall Study|Physician Decision|0|||
155384745|NCT00505284|560843719|FG004|Overall Study|Physician Decision|0|||
155384746|NCT00505284|560843715|FG000|Overall Study|Other|5|||
155384747|NCT00505284|560843716|FG001|Overall Study|Other|0|||
155384748|NCT00505284|560843717|FG002|Overall Study|Other|0|||
155384749|NCT00505284|560843718|FG003|Overall Study|Other|4|||
155384750|NCT00505284|560843719|FG004|Overall Study|Other|4|||
155384751|NCT03513588|560843720|FG000|Overall Study|Lost to Follow-up|0|||
155384752|NCT03513588|560843721|FG001|Overall Study|Lost to Follow-up|1|||
155384753|NCT03513588|560843722|FG002|Overall Study|Lost to Follow-up|1|||
155384754|NCT03513588|560843720|FG000|Overall Study|Study dosing paused by sponsor|1|||
155384755|NCT03513588|560843721|FG001|Overall Study|Study dosing paused by sponsor|1|||
155384756|NCT03513588|560843722|FG002|Overall Study|Study dosing paused by sponsor|0|||
155384757|NCT03513588|560843720|FG000|Overall Study|Death|0|||
155384758|NCT03513588|560843721|FG001|Overall Study|Death|0|||
155384759|NCT03513588|560843722|FG002|Overall Study|Death|1|||
155384760|NCT01275131|560843723|FG000|Period 1|Withdrawal by Subject|1|||
155384761|NCT01275131|560843724|FG001|Period 1|Withdrawal by Subject|0|||
155384762|NCT01275131|560843725|FG002|Period 1|Withdrawal by Subject|3|||
155384763|NCT01275131|560843726|FG003|Period 1|Withdrawal by Subject|2|||
155384764|NCT01275131|560843723|FG000|Period 1|Physician Decision|1|||
154944044|NCT02398188|559220854|FG001|Overall Study|Non-compliance|4|||
154944045|NCT02398188|559220853|FG000|Overall Study|Protocol Violation|6|||
155384765|NCT01275131|560843724|FG001|Period 1|Physician Decision|0|||
155384766|NCT01275131|560843725|FG002|Period 1|Physician Decision|0|||
155384767|NCT01275131|560843726|FG003|Period 1|Physician Decision|0|||
155384768|NCT01275131|560843723|FG000|Period 2 (Crossover)|Adverse Event|0|||
155384769|NCT01275131|560843724|FG001|Period 2 (Crossover)|Adverse Event|1|||
155384770|NCT01275131|560843725|FG002|Period 2 (Crossover)|Adverse Event|0|||
155384771|NCT01275131|560843726|FG003|Period 2 (Crossover)|Adverse Event|0|||
155384772|NCT01275131|560843723|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
155384773|NCT01275131|560843724|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
155384774|NCT01275131|560843725|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
155384775|NCT01275131|560843726|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
155384776|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
155384777|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
155384778|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
155384779|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
155384780|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
155384781|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
155384782|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
155384783|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
155384784|NCT00953745|560843729|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
155384785|NCT00953745|560843730|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
155384786|NCT00953745|560843729|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
155384787|NCT00953745|560843730|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
155384788|NCT03075410|560843732|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
155384789|NCT03075410|560843733|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384790|NCT03075410|560843734|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
155384791|NCT03075410|560843735|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384792|NCT03075410|560843736|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384793|NCT03075410|560843737|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384794|NCT03075410|560843738|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384795|NCT03075410|560843739|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384796|NCT03075410|560843740|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
155384797|NCT03075410|560843732|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
155384798|NCT03075410|560843733|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384799|NCT03075410|560843734|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384800|NCT03075410|560843735|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384801|NCT03075410|560843736|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384802|NCT03075410|560843737|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384803|NCT03075410|560843738|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384804|NCT03075410|560843739|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384805|NCT03075410|560843740|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
155384806|NCT02053792|560843741|FG000|Overall Study|Physician Decision|0|||
155384807|NCT02053792|560843742|FG001|Overall Study|Physician Decision|1|||
155384808|NCT02053792|560843741|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
155384809|NCT02053792|560843742|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
155384810|NCT02053792|560843741|FG000|Overall Study|Lack of Efficacy|1|||
154944046|NCT02398188|559220854|FG001|Overall Study|Protocol Violation|10|||
154944047|NCT02398188|559220853|FG000|Overall Study|Sponsor Decision|2|||
154944048|NCT02398188|559220854|FG001|Overall Study|Sponsor Decision|1|||
154944049|NCT02398188|559220853|FG000|Overall Study|Pregnancy|1|||
154944050|NCT02398188|559220854|FG001|Overall Study|Pregnancy|0|||
154944051|NCT02398188|559220853|FG000|Overall Study|Withdrawal by Subject|7|||
154944052|NCT02398188|559220854|FG001|Overall Study|Withdrawal by Subject|16|||
154944053|NCT01259869|559220855|FG000|Overall Study|Duplicated registration|1|||
154944054|NCT03209570|559220856|FG000|Overall Study|Death|1|||
154944055|NCT03209570|559220857|FG001|Overall Study|Death|0|||
154944056|NCT03209570|559220856|FG000|Overall Study|Incomplete Data|8|||
154944057|NCT03209570|559220857|FG001|Overall Study|Incomplete Data|10|||
154944058|NCT03209570|559220856|FG000|Overall Study|Protocol Violation|1|||
154944059|NCT03209570|559220857|FG001|Overall Study|Protocol Violation|0|||
154944060|NCT03209570|559220856|FG000|Overall Study|Withdrawal by Subject|0|||
154944061|NCT03209570|559220857|FG001|Overall Study|Withdrawal by Subject|3|||
154944062|NCT00755326|559220860|FG000|Overall Study|Lost to Follow-up|2|||
154944063|NCT00755326|559220861|FG001|Overall Study|Lost to Follow-up|3|||
154944064|NCT01829477|559220865|FG000|Overall Study|Study Terminated by Sponsor|15|||
154944065|NCT01829477|559220866|FG001|Overall Study|Study Terminated by Sponsor|15|||
154944066|NCT01829477|559220865|FG000|Overall Study|Withdrawal by Subject|1|||
154944067|NCT01829477|559220866|FG001|Overall Study|Withdrawal by Subject|0|||
154944068|NCT03465891|559220867|FG000|Overall Study|Withdrawal by Subject|0|||
154944069|NCT03465891|559220868|FG001|Overall Study|Withdrawal by Subject|1|||
154944070|NCT03465891|559220867|FG000|Overall Study|Disease progression|1|||
154944071|NCT03465891|559220868|FG001|Overall Study|Disease progression|0|||
154944072|NCT02737306|559220870|FG000|Overall Study|Adverse Event|3|||
154944073|NCT02737306|559220871|FG001|Overall Study|Adverse Event|0|||
154944074|NCT02737306|559220870|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
154944075|NCT02737306|559220871|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
154944076|NCT01336894|559220872|FG000|Follow-up|Study terminated prematurely|2|||
154944077|NCT01336894|559220873|FG001|Follow-up|Study terminated prematurely|7|||
154944078|NCT05034731|559220874|FG000|Overall Study|Screen fail|1|||
154944079|NCT05034731|559220875|FG001|Overall Study|Screen fail|1|||
154944080|NCT03937466|559220876|FG000|Overall Study|not eligbile after the 2-week diary|9|||
154944081|NCT03937466|559220876|FG000|Overall Study|never returned their diary|6|||
154944082|NCT03937466|559220876|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
155279146|NCT01923428|560454814|FG003|Overall Study|Adverse Event|3|||
155279147|NCT01923428|560454811|FG000|Overall Study|Withdrawal by Subject|5|||
155279148|NCT01923428|560454812|FG001|Overall Study|Withdrawal by Subject|3|||
155279149|NCT01923428|560454813|FG002|Overall Study|Withdrawal by Subject|0|||
155279150|NCT01923428|560454814|FG003|Overall Study|Withdrawal by Subject|4|||
155279151|NCT01923428|560454811|FG000|Overall Study|Lost to Follow-up|2|||
155279152|NCT01923428|560454812|FG001|Overall Study|Lost to Follow-up|1|||
155279153|NCT01923428|560454813|FG002|Overall Study|Lost to Follow-up|5|||
155279154|NCT01923428|560454814|FG003|Overall Study|Lost to Follow-up|0|||
155279155|NCT01923428|560454811|FG000|Overall Study|Protocol Violation|3|||
155279156|NCT01923428|560454812|FG001|Overall Study|Protocol Violation|0|||
155279157|NCT01923428|560454813|FG002|Overall Study|Protocol Violation|2|||
155279158|NCT01923428|560454814|FG003|Overall Study|Protocol Violation|1|||
155279159|NCT01923428|560454811|FG000|Overall Study|Non Compliance to treatment|1|||
155279160|NCT01923428|560454812|FG001|Overall Study|Non Compliance to treatment|2|||
155279161|NCT01923428|560454813|FG002|Overall Study|Non Compliance to treatment|0|||
155279162|NCT01923428|560454814|FG003|Overall Study|Non Compliance to treatment|1|||
155279163|NCT01923428|560454811|FG000|Overall Study|Lack of Efficacy|0|||
155279164|NCT01923428|560454812|FG001|Overall Study|Lack of Efficacy|0|||
155279165|NCT01923428|560454813|FG002|Overall Study|Lack of Efficacy|1|||
155279166|NCT01923428|560454814|FG003|Overall Study|Lack of Efficacy|1|||
155279167|NCT00946647|560454818|FG000|Phase 1 Part|Adverse Event|2|||
155279168|NCT00946647|560454819|FG001|Phase 1 Part|Adverse Event|5|||
155279169|NCT00946647|560454820|FG002|Phase 1 Part|Adverse Event|3|||
155279170|NCT00946647|560454821|FG003|Phase 1 Part|Adverse Event|0|||
155279171|NCT00946647|560454822|FG004|Phase 1 Part|Adverse Event|0|||
155279172|NCT00946647|560454818|FG000|Phase 1 Part|Disease progression|3|||
155279173|NCT00946647|560454819|FG001|Phase 1 Part|Disease progression|6|||
155279174|NCT00946647|560454820|FG002|Phase 1 Part|Disease progression|1|||
155279175|NCT00946647|560454821|FG003|Phase 1 Part|Disease progression|0|||
155279176|NCT00946647|560454822|FG004|Phase 1 Part|Disease progression|0|||
155279177|NCT00946647|560454818|FG000|Phase 1 Part|Withdrawal by Subject|1|||
155279178|NCT00946647|560454819|FG001|Phase 1 Part|Withdrawal by Subject|4|||
155279179|NCT00946647|560454820|FG002|Phase 1 Part|Withdrawal by Subject|3|||
155279180|NCT00946647|560454821|FG003|Phase 1 Part|Withdrawal by Subject|0|||
155279181|NCT00946647|560454822|FG004|Phase 1 Part|Withdrawal by Subject|0|||
155279182|NCT00946647|560454818|FG000|Phase 1 Part|Abnormal values|0|||
155279183|NCT00946647|560454819|FG001|Phase 1 Part|Abnormal values|2|||
155279184|NCT00946647|560454820|FG002|Phase 1 Part|Abnormal values|0|||
155279185|NCT00946647|560454821|FG003|Phase 1 Part|Abnormal values|0|||
155279186|NCT00946647|560454822|FG004|Phase 1 Part|Abnormal values|0|||
155279187|NCT00946647|560454818|FG000|Phase 1 Part|Reason missing|0|||
155279188|NCT00946647|560454819|FG001|Phase 1 Part|Reason missing|1|||
155279189|NCT00946647|560454820|FG002|Phase 1 Part|Reason missing|0|||
155279190|NCT00946647|560454821|FG003|Phase 1 Part|Reason missing|0|||
155279191|NCT00946647|560454822|FG004|Phase 1 Part|Reason missing|0|||
155279192|NCT00946647|560454818|FG000|Phase ll Part|Untreated|0|||
155279193|NCT00946647|560454819|FG001|Phase ll Part|Untreated|0|||
155279194|NCT00946647|560454820|FG002|Phase ll Part|Untreated|0|||
155279195|NCT00946647|560454821|FG003|Phase ll Part|Untreated|0|||
155279196|NCT00946647|560454822|FG004|Phase ll Part|Untreated|2|||
155279197|NCT00946647|560454818|FG000|Phase ll Part|Adverse Event|0|||
155279198|NCT00946647|560454819|FG001|Phase ll Part|Adverse Event|0|||
155279199|NCT00946647|560454820|FG002|Phase ll Part|Adverse Event|0|||
155279200|NCT00946647|560454821|FG003|Phase ll Part|Adverse Event|10|||
155279201|NCT00946647|560454822|FG004|Phase ll Part|Adverse Event|6|||
155279202|NCT00946647|560454818|FG000|Phase ll Part|Withdrawal by Subject|0|||
155279203|NCT00946647|560454819|FG001|Phase ll Part|Withdrawal by Subject|0|||
155279204|NCT00946647|560454820|FG002|Phase ll Part|Withdrawal by Subject|0|||
155279205|NCT00946647|560454821|FG003|Phase ll Part|Withdrawal by Subject|8|||
155279206|NCT00946647|560454822|FG004|Phase ll Part|Withdrawal by Subject|6|||
155279207|NCT00946647|560454818|FG000|Phase ll Part|Administrative problems|0|||
155279208|NCT00946647|560454819|FG001|Phase ll Part|Administrative problems|0|||
155279209|NCT00946647|560454820|FG002|Phase ll Part|Administrative problems|0|||
155279210|NCT00946647|560454821|FG003|Phase ll Part|Administrative problems|3|||
155279211|NCT00946647|560454822|FG004|Phase ll Part|Administrative problems|8|||
155279212|NCT00946647|560454818|FG000|Phase ll Part|Death|0|||
155279213|NCT00946647|560454819|FG001|Phase ll Part|Death|0|||
155279214|NCT00946647|560454820|FG002|Phase ll Part|Death|0|||
155279215|NCT00946647|560454821|FG003|Phase ll Part|Death|7|||
155279216|NCT00946647|560454822|FG004|Phase ll Part|Death|4|||
155279217|NCT00946647|560454818|FG000|Phase ll Part|Disease progression|0|||
155279218|NCT00946647|560454819|FG001|Phase ll Part|Disease progression|0|||
155279219|NCT00946647|560454820|FG002|Phase ll Part|Disease progression|0|||
155279220|NCT00946647|560454821|FG003|Phase ll Part|Disease progression|6|||
155279221|NCT00946647|560454822|FG004|Phase ll Part|Disease progression|14|||
155279222|NCT00946647|560454818|FG000|Phase ll Part|Protocol Violation|0|||
155279223|NCT00946647|560454819|FG001|Phase ll Part|Protocol Violation|0|||
155279224|NCT00946647|560454820|FG002|Phase ll Part|Protocol Violation|0|||
155279225|NCT00946647|560454821|FG003|Phase ll Part|Protocol Violation|4|||
155384811|NCT02053792|560843742|FG001|Overall Study|Lack of Efficacy|0|||
155384812|NCT02053792|560843741|FG000|Overall Study|Adverse Event|1|||
155384813|NCT02053792|560843742|FG001|Overall Study|Adverse Event|0|||
155384814|NCT02053792|560843741|FG000|Overall Study|Withdrawal by Subject|2|||
155384815|NCT02053792|560843742|FG001|Overall Study|Withdrawal by Subject|2|||
155384816|NCT02053792|560843741|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
155384817|NCT02053792|560843742|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
155384818|NCT02053792|560843741|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
155384819|NCT02053792|560843742|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
155384820|NCT01427751|560843743|FG000|Overall Study|Adverse Event|18|||
155384821|NCT01427751|560843744|FG001|Overall Study|Adverse Event|2|||
155384822|NCT01427751|560843743|FG000|Overall Study|No further treatment benefit expected|5|||
155384823|NCT01427751|560843744|FG001|Overall Study|No further treatment benefit expected|1|||
155384824|NCT01427751|560843743|FG000|Overall Study|Lost to Follow-up|3|||
155384825|NCT01427751|560843744|FG001|Overall Study|Lost to Follow-up|1|||
155384826|NCT01427751|560843743|FG000|Overall Study|Withdrawal of consent|2|||
155384827|NCT01427751|560843744|FG001|Overall Study|Withdrawal of consent|2|||
155384828|NCT01427751|560843743|FG000|Overall Study|Protocol Violation|6|||
155384829|NCT01427751|560843744|FG001|Overall Study|Protocol Violation|4|||
155384830|NCT01427751|560843743|FG000|Overall Study|Death|2|||
155384831|NCT01427751|560843744|FG001|Overall Study|Death|0|||
155384832|NCT01427751|560843743|FG000|Overall Study|Other miscellaneous reasons|6|||
155384833|NCT01427751|560843744|FG001|Overall Study|Other miscellaneous reasons|4|||
155384834|NCT00368992|560843751|FG000|Overall Study|Ineligible|5|||
155384835|NCT00368992|560843751|FG000|Overall Study|Refused treatment|3|||
155384836|NCT00368992|560843751|FG000|Overall Study|Lack of Efficacy|63|||
155384837|NCT00368992|560843751|FG000|Overall Study|Adverse Event|26|||
155384838|NCT00368992|560843751|FG000|Overall Study|Death|4|||
155384839|NCT00368992|560843751|FG000|Overall Study|Other|9|||
155384840|NCT00790751|560843752|FG000|Overall Study|Protocol non-compliance|16|||
155384841|NCT00790751|560843753|FG001|Overall Study|Protocol non-compliance|16|||
155384842|NCT00790751|560843754|FG002|Overall Study|Protocol non-compliance|10|||
155384843|NCT00790751|560843755|FG003|Overall Study|Protocol non-compliance|11|||
155384844|NCT00790751|560843752|FG000|Overall Study|Lost to Follow-up|4|||
155384845|NCT00790751|560843753|FG001|Overall Study|Lost to Follow-up|9|||
155384846|NCT00790751|560843754|FG002|Overall Study|Lost to Follow-up|4|||
155384847|NCT00790751|560843755|FG003|Overall Study|Lost to Follow-up|5|||
155384848|NCT00790751|560843752|FG000|Overall Study|Adverse Event|5|||
155384849|NCT00790751|560843753|FG001|Overall Study|Adverse Event|3|||
155384850|NCT00790751|560843754|FG002|Overall Study|Adverse Event|5|||
155384851|NCT00790751|560843755|FG003|Overall Study|Adverse Event|4|||
155384852|NCT00790751|560843752|FG000|Overall Study|Requirement for restricted medication|0|||
155384853|NCT00790751|560843753|FG001|Overall Study|Requirement for restricted medication|2|||
155384854|NCT00790751|560843754|FG002|Overall Study|Requirement for restricted medication|0|||
155384855|NCT00790751|560843755|FG003|Overall Study|Requirement for restricted medication|0|||
155384856|NCT00790751|560843752|FG000|Overall Study|Death|0|||
155384857|NCT00790751|560843753|FG001|Overall Study|Death|0|||
155384858|NCT00790751|560843754|FG002|Overall Study|Death|1|||
155384859|NCT00790751|560843755|FG003|Overall Study|Death|0|||
155384860|NCT00790751|560843752|FG000|Overall Study|Physician Decision|0|||
155384861|NCT00790751|560843753|FG001|Overall Study|Physician Decision|0|||
155384862|NCT00790751|560843754|FG002|Overall Study|Physician Decision|0|||
155384863|NCT00790751|560843755|FG003|Overall Study|Physician Decision|1|||
155384864|NCT02427464|560843756|FG000|Overall Study|Adverse Event|6|||
155384865|NCT02427464|560843757|FG001|Overall Study|Adverse Event|1|||
155384866|NCT02427464|560843756|FG000|Overall Study|Lost to Follow-up|16|||
155384867|NCT02427464|560843757|FG001|Overall Study|Lost to Follow-up|5|||
155384868|NCT02427464|560843756|FG000|Overall Study|Physician Decision|2|||
155384869|NCT02427464|560843757|FG001|Overall Study|Physician Decision|0|||
155384870|NCT02427464|560843756|FG000|Overall Study|Withdrawal by Subject|10|||
155384871|NCT02427464|560843757|FG001|Overall Study|Withdrawal by Subject|8|||
155384872|NCT02427464|560843756|FG000|Overall Study|Noncompliance|16|||
155384873|NCT02427464|560843757|FG001|Overall Study|Noncompliance|10|||
155384874|NCT05330312|560843761|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
155384875|NCT05330312|560843762|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
155384876|NCT05330312|560843763|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
155384877|NCT05330312|560843761|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
155384878|NCT05330312|560843762|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
155045793|NCT05052697|559599415|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384879|NCT05330312|560843763|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
155384880|NCT05330312|560843761|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
155384881|NCT05330312|560843762|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
155384882|NCT05330312|560843763|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
155384883|NCT05330312|560843761|FG000|Pivotal Investigation - Part 2|Death|1|||
155384884|NCT05330312|560843762|FG001|Pivotal Investigation - Part 2|Death|4|||
155384885|NCT05330312|560843763|FG002|Pivotal Investigation - Part 2|Death|0|||
155384886|NCT05227703|560843767|FG000|Overall Study|Adverse Event|2|||
155384887|NCT05227703|560843768|FG001|Overall Study|Adverse Event|6|||
155384888|NCT05227703|560843769|FG002|Overall Study|Adverse Event|4|||
155384889|NCT05227703|560843767|FG000|Overall Study|Lack of Efficacy|4|||
155384890|NCT05227703|560843768|FG001|Overall Study|Lack of Efficacy|0|||
155279226|NCT00946647|560454822|FG004|Phase ll Part|Protocol Violation|2|||
155279227|NCT00946647|560454818|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
155279228|NCT00946647|560454819|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
155279229|NCT00946647|560454820|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
155279230|NCT00946647|560454821|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
155279231|NCT00946647|560454822|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
155279232|NCT01368211|560454823|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
155279233|NCT01368211|560454824|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
155279234|NCT03990363|560454825|FG000|Overall Study|Withdrawal by Subject|10|||
155279235|NCT03990363|560454826|FG001|Overall Study|Withdrawal by Subject|9|||
155279236|NCT03990363|560454827|FG002|Overall Study|Withdrawal by Subject|18|||
155279237|NCT03990363|560454828|FG003|Overall Study|Withdrawal by Subject|11|||
155279238|NCT03990363|560454829|FG004|Overall Study|Withdrawal by Subject|9|||
155279239|NCT03990363|560454825|FG000|Overall Study|Physician Decision|1|||
155279240|NCT03990363|560454826|FG001|Overall Study|Physician Decision|0|||
155279241|NCT03990363|560454827|FG002|Overall Study|Physician Decision|0|||
155279242|NCT03990363|560454828|FG003|Overall Study|Physician Decision|0|||
155279243|NCT03990363|560454829|FG004|Overall Study|Physician Decision|0|||
155279244|NCT03990363|560454825|FG000|Overall Study|Adverse Event|1|||
155279245|NCT03990363|560454826|FG001|Overall Study|Adverse Event|3|||
155279246|NCT03990363|560454827|FG002|Overall Study|Adverse Event|2|||
155279247|NCT03990363|560454828|FG003|Overall Study|Adverse Event|2|||
155279248|NCT03990363|560454829|FG004|Overall Study|Adverse Event|0|||
155279249|NCT03990363|560454825|FG000|Overall Study|Death|14|||
155279250|NCT03990363|560454826|FG001|Overall Study|Death|8|||
155279251|NCT03990363|560454827|FG002|Overall Study|Death|14|||
155279252|NCT03990363|560454828|FG003|Overall Study|Death|10|||
155279253|NCT03990363|560454829|FG004|Overall Study|Death|11|||
155279254|NCT03990363|560454825|FG000|Overall Study|Failure to meet randomization criteria|0|||
155279255|NCT03990363|560454826|FG001|Overall Study|Failure to meet randomization criteria|1|||
155279256|NCT03990363|560454827|FG002|Overall Study|Failure to meet randomization criteria|1|||
155279257|NCT03990363|560454828|FG003|Overall Study|Failure to meet randomization criteria|0|||
155279258|NCT03990363|560454829|FG004|Overall Study|Failure to meet randomization criteria|0|||
155279259|NCT03990363|560454825|FG000|Overall Study|Lost to Follow-up|0|||
155279260|NCT03990363|560454826|FG001|Overall Study|Lost to Follow-up|0|||
155279261|NCT03990363|560454827|FG002|Overall Study|Lost to Follow-up|0|||
155279262|NCT03990363|560454828|FG003|Overall Study|Lost to Follow-up|1|||
155279263|NCT03990363|560454829|FG004|Overall Study|Lost to Follow-up|2|||
155279264|NCT03990363|560454825|FG000|Overall Study|Non-compliance with study drug|2|||
155279265|NCT03990363|560454826|FG001|Overall Study|Non-compliance with study drug|1|||
155279266|NCT03990363|560454827|FG002|Overall Study|Non-compliance with study drug|2|||
155279267|NCT03990363|560454828|FG003|Overall Study|Non-compliance with study drug|0|||
155279268|NCT03990363|560454829|FG004|Overall Study|Non-compliance with study drug|0|||
155279269|NCT03990363|560454825|FG000|Overall Study|Study terminated by sponsor|0|||
155279270|NCT03990363|560454826|FG001|Overall Study|Study terminated by sponsor|1|||
155279271|NCT03990363|560454827|FG002|Overall Study|Study terminated by sponsor|0|||
155279272|NCT03990363|560454828|FG003|Overall Study|Study terminated by sponsor|0|||
155279273|NCT03990363|560454829|FG004|Overall Study|Study terminated by sponsor|0|||
155279274|NCT03990363|560454825|FG000|Overall Study|Site terminated by sponsor|2|||
155279275|NCT03990363|560454826|FG001|Overall Study|Site terminated by sponsor|1|||
155279276|NCT03990363|560454827|FG002|Overall Study|Site terminated by sponsor|2|||
155279277|NCT03990363|560454828|FG003|Overall Study|Site terminated by sponsor|0|||
155279278|NCT03990363|560454829|FG004|Overall Study|Site terminated by sponsor|2|||
155279279|NCT03990363|560454825|FG000|Overall Study|Not categorized|5|||
155279280|NCT03990363|560454826|FG001|Overall Study|Not categorized|5|||
155279281|NCT03990363|560454827|FG002|Overall Study|Not categorized|3|||
155279282|NCT03990363|560454828|FG003|Overall Study|Not categorized|2|||
155279283|NCT03990363|560454829|FG004|Overall Study|Not categorized|2|||
155279284|NCT01349660|560454832|FG000|Overall Study|Still Receiving Study Treatment|0|||
155279285|NCT01349660|560454833|FG001|Overall Study|Still Receiving Study Treatment|0|||
155279286|NCT01349660|560454834|FG002|Overall Study|Still Receiving Study Treatment|1|||
155279287|NCT01349660|560454832|FG000|Overall Study|Disease Progression|2|||
155279288|NCT01349660|560454833|FG001|Overall Study|Disease Progression|4|||
155279289|NCT01349660|560454834|FG002|Overall Study|Disease Progression|50|||
155384891|NCT05227703|560843769|FG002|Overall Study|Lack of Efficacy|1|||
155384892|NCT05227703|560843767|FG000|Overall Study|Physician Decision|2|||
155279290|NCT01349660|560454832|FG000|Overall Study|Adverse Event|1|||
155279291|NCT01349660|560454833|FG001|Overall Study|Adverse Event|1|||
155279292|NCT01349660|560454834|FG002|Overall Study|Adverse Event|12|||
155279293|NCT01349660|560454832|FG000|Overall Study|Withdrawal by Subject|2|||
155384893|NCT05227703|560843768|FG001|Overall Study|Physician Decision|2|||
155384894|NCT05227703|560843769|FG002|Overall Study|Physician Decision|1|||
155384895|NCT05227703|560843767|FG000|Overall Study|Protocol Violation|2|||
155384896|NCT05227703|560843768|FG001|Overall Study|Protocol Violation|1|||
155384897|NCT05227703|560843769|FG002|Overall Study|Protocol Violation|0|||
155384898|NCT05227703|560843767|FG000|Overall Study|Withdrawal by Subject|17|||
155384899|NCT05227703|560843768|FG001|Overall Study|Withdrawal by Subject|26|||
155384900|NCT05227703|560843769|FG002|Overall Study|Withdrawal by Subject|32|||
155384901|NCT05227703|560843767|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
155384902|NCT05227703|560843768|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
155384903|NCT05227703|560843769|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
155384904|NCT05227703|560843767|FG000|Overall Study|Other|1|||
155384905|NCT05227703|560843768|FG001|Overall Study|Other|1|||
155384906|NCT05227703|560843769|FG002|Overall Study|Other|0|||
155384907|NCT03756129|560843774|FG000|Overall Study|Adverse Event|1|||
155384908|NCT03756129|560843775|FG001|Overall Study|Adverse Event|1|||
155384909|NCT03756129|560843776|FG002|Overall Study|Adverse Event|0|||
155384910|NCT03756129|560843777|FG003|Overall Study|Adverse Event|2|||
155384911|NCT03756129|560843778|FG004|Overall Study|Adverse Event|0|||
155384912|NCT03756129|560843779|FG005|Overall Study|Adverse Event|0|||
155384913|NCT03756129|560843774|FG000|Overall Study|Withdrawal by Subject|2|||
155384914|NCT03756129|560843775|FG001|Overall Study|Withdrawal by Subject|1|||
155384915|NCT03756129|560843776|FG002|Overall Study|Withdrawal by Subject|3|||
155384916|NCT03756129|560843777|FG003|Overall Study|Withdrawal by Subject|1|||
155384917|NCT03756129|560843778|FG004|Overall Study|Withdrawal by Subject|1|||
155384918|NCT03756129|560843779|FG005|Overall Study|Withdrawal by Subject|3|||
155384919|NCT03756129|560843774|FG000|Overall Study|Lost to Follow-up|0|||
155384920|NCT03756129|560843775|FG001|Overall Study|Lost to Follow-up|0|||
155384921|NCT03756129|560843776|FG002|Overall Study|Lost to Follow-up|0|||
155384922|NCT03756129|560843777|FG003|Overall Study|Lost to Follow-up|0|||
155384923|NCT03756129|560843778|FG004|Overall Study|Lost to Follow-up|0|||
155384924|NCT03756129|560843779|FG005|Overall Study|Lost to Follow-up|1|||
155384925|NCT03756129|560843774|FG000|Overall Study|Physician Decision|0|||
155384926|NCT03756129|560843775|FG001|Overall Study|Physician Decision|0|||
155384927|NCT03756129|560843776|FG002|Overall Study|Physician Decision|0|||
155384928|NCT03756129|560843777|FG003|Overall Study|Physician Decision|0|||
155384929|NCT03756129|560843778|FG004|Overall Study|Physician Decision|0|||
155384930|NCT03756129|560843779|FG005|Overall Study|Physician Decision|1|||
155384931|NCT03464097|560843782|FG000|Overall Study|Withdrawal by Subject|15|||
155384932|NCT03464097|560843783|FG001|Overall Study|Withdrawal by Subject|13|||
155384933|NCT03464097|560843784|FG002|Overall Study|Withdrawal by Subject|11|||
155384934|NCT03464097|560843782|FG000|Overall Study|Study terminated by sponsor|47|||
155384935|NCT03464097|560843783|FG001|Overall Study|Study terminated by sponsor|44|||
155384936|NCT03464097|560843784|FG002|Overall Study|Study terminated by sponsor|40|||
155384937|NCT03464097|560843782|FG000|Overall Study|Pregnancy|0|||
155384938|NCT03464097|560843783|FG001|Overall Study|Pregnancy|1|||
155384939|NCT03464097|560843784|FG002|Overall Study|Pregnancy|0|||
155384940|NCT03464097|560843782|FG000|Overall Study|Other reasons|5|||
155384941|NCT03464097|560843783|FG001|Overall Study|Other reasons|12|||
155384942|NCT03464097|560843784|FG002|Overall Study|Other reasons|14|||
155384943|NCT03464097|560843782|FG000|Overall Study|Lost to Follow-up|0|||
155384944|NCT03464097|560843783|FG001|Overall Study|Lost to Follow-up|1|||
155384945|NCT03464097|560843784|FG002|Overall Study|Lost to Follow-up|1|||
155384946|NCT03464097|560843782|FG000|Overall Study|Lack of Efficacy|11|||
155384947|NCT03464097|560843783|FG001|Overall Study|Lack of Efficacy|18|||
155384948|NCT03464097|560843784|FG002|Overall Study|Lack of Efficacy|30|||
155384949|NCT03464097|560843782|FG000|Overall Study|Death|1|||
155384950|NCT03464097|560843783|FG001|Overall Study|Death|0|||
155384951|NCT03464097|560843784|FG002|Overall Study|Death|0|||
155384952|NCT03464097|560843782|FG000|Overall Study|Adverse Event|13|||
155384953|NCT03464097|560843783|FG001|Overall Study|Adverse Event|6|||
155384954|NCT03464097|560843784|FG002|Overall Study|Adverse Event|8|||
155384955|NCT05572021|560843785|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
155384956|NCT05572021|560843786|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
155384957|NCT03432260|560843787|FG000|Overall Study|Lost to Follow-up|1|||
155384958|NCT03432260|560843788|FG001|Overall Study|Lost to Follow-up|1|||
155045794|NCT05052697|559599416|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
155384959|NCT03432260|560843789|FG002|Overall Study|Lost to Follow-up|0|||
155384960|NCT03432260|560843790|FG003|Overall Study|Lost to Follow-up|0|||
155384961|NCT03432260|560843791|FG004|Overall Study|Lost to Follow-up|1|||
155384962|NCT02186847|560843792|FG000|Overall Study|Protocol Violation|3|||
155384963|NCT02186847|560843793|FG001|Overall Study|Protocol Violation|0|||
155384964|NCT03319849|560843794|FG000|Overall Study|Adverse Event|1|||
155384965|NCT03319849|560843795|FG001|Overall Study|Adverse Event|0|||
155384966|NCT03319849|560843794|FG000|Overall Study|Physician Decision|0|||
155384967|NCT03319849|560843795|FG001|Overall Study|Physician Decision|1|||
155384968|NCT03319849|560843794|FG000|Overall Study|Withdrawal by Subject|0|||
155384969|NCT03319849|560843795|FG001|Overall Study|Withdrawal by Subject|1|||
155384970|NCT03319849|560843794|FG000|Overall Study|COVID-19|0|||
155384971|NCT03319849|560843795|FG001|Overall Study|COVID-19|1|||
155384972|NCT03319849|560843794|FG000|Overall Study|Other|1|||
155384973|NCT03319849|560843795|FG001|Overall Study|Other|2|||
155384974|NCT03319849|560843794|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
155384975|NCT03319849|560843795|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
155384976|NCT03319849|560843794|FG000|Overall Study|Lost to Follow-up|0|||
155384977|NCT03319849|560843795|FG001|Overall Study|Lost to Follow-up|2|||
155384978|NCT00112047|560843796|FG000|Randomized Phase|Lost to Follow-up|26|||
155384979|NCT00112047|560843797|FG001|Randomized Phase|Lost to Follow-up|33|||
155384980|NCT00112047|560843796|FG000|Randomized Phase|Adverse Event|10|||
155384981|NCT00112047|560843797|FG001|Randomized Phase|Adverse Event|10|||
155384982|NCT00112047|560843796|FG000|Randomized Phase|Withrawal of consent|10|||
155384983|NCT00112047|560843797|FG001|Randomized Phase|Withrawal of consent|18|||
155384984|NCT00112047|560843796|FG000|Randomized Phase|Sub-optimal virological response|3|||
155384985|NCT00112047|560843797|FG001|Randomized Phase|Sub-optimal virological response|13|||
155279294|NCT01349660|560454833|FG001|Overall Study|Withdrawal by Subject|0|||
155279295|NCT01349660|560454834|FG002|Overall Study|Withdrawal by Subject|9|||
155279296|NCT01349660|560454832|FG000|Overall Study|Death|1|||
155279297|NCT01349660|560454833|FG001|Overall Study|Death|1|||
155279298|NCT01349660|560454834|FG002|Overall Study|Death|0|||
155279299|NCT01349660|560454832|FG000|Overall Study|Non-Permitted Interventions|0|||
155279300|NCT01349660|560454833|FG001|Overall Study|Non-Permitted Interventions|0|||
155279301|NCT01349660|560454834|FG002|Overall Study|Non-Permitted Interventions|2|||
155279302|NCT01349660|560454832|FG000|Overall Study|Study Compliance|0|||
155279303|NCT01349660|560454833|FG001|Overall Study|Study Compliance|0|||
155279304|NCT01349660|560454834|FG002|Overall Study|Study Compliance|1|||
155279305|NCT01349660|560454832|FG000|Overall Study|Declining Performance Status|0|||
155279306|NCT01349660|560454833|FG001|Overall Study|Declining Performance Status|0|||
155279307|NCT01349660|560454834|FG002|Overall Study|Declining Performance Status|1|||
155279308|NCT04630756|560454835|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
155279309|NCT04630756|560454836|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
155279310|NCT04630756|560454837|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
155279311|NCT02388074|560454838|FG000|Overall Study|Lost in Transit|2|||
155279312|NCT02388074|560454838|FG000|Overall Study|Sample Not Returned|1|||
155279313|NCT01939158|560456206|FG000|Overall Study|Adverse Event|1|||
155279314|NCT01939158|560456207|FG001|Overall Study|Adverse Event|0|||
155279315|NCT01939158|560456208|FG002|Overall Study|Adverse Event|0|||
155279316|NCT01939158|560456209|FG003|Overall Study|Adverse Event|0|||
155279317|NCT01939158|560456206|FG000|Overall Study|Withdrawal by Subject|22|||
155279318|NCT01939158|560456207|FG001|Overall Study|Withdrawal by Subject|25|||
155279319|NCT01939158|560456208|FG002|Overall Study|Withdrawal by Subject|15|||
155279320|NCT01939158|560456209|FG003|Overall Study|Withdrawal by Subject|17|||
155279321|NCT01939158|560456206|FG000|Overall Study|Migrated/moved from study area|5|||
155279322|NCT01939158|560456207|FG001|Overall Study|Migrated/moved from study area|7|||
155279323|NCT01939158|560456208|FG002|Overall Study|Migrated/moved from study area|3|||
155279324|NCT01939158|560456209|FG003|Overall Study|Migrated/moved from study area|6|||
155279325|NCT01939158|560456206|FG000|Overall Study|Lost to Follow-up|18|||
155279326|NCT01939158|560456207|FG001|Overall Study|Lost to Follow-up|17|||
155279327|NCT01939158|560456208|FG002|Overall Study|Lost to Follow-up|17|||
155279328|NCT01939158|560456209|FG003|Overall Study|Lost to Follow-up|17|||
155279329|NCT01939158|560456206|FG000|Overall Study|Death|0|||
155279330|NCT01939158|560456207|FG001|Overall Study|Death|0|||
155279331|NCT01939158|560456208|FG002|Overall Study|Death|1|||
155279332|NCT01939158|560456209|FG003|Overall Study|Death|1|||
155279333|NCT01939158|560456206|FG000|Overall Study|No longer meets eligibility criteria|0|||
155279334|NCT01939158|560456207|FG001|Overall Study|No longer meets eligibility criteria|0|||
155279335|NCT01939158|560456208|FG002|Overall Study|No longer meets eligibility criteria|1|||
155279336|NCT01939158|560456209|FG003|Overall Study|No longer meets eligibility criteria|0|||
155279337|NCT01939158|560456206|FG000|Overall Study|Other|1|||
155279338|NCT01939158|560456207|FG001|Overall Study|Other|3|||
155279339|NCT01939158|560456208|FG002|Overall Study|Other|4|||
155279340|NCT01939158|560456209|FG003|Overall Study|Other|3|||
155279341|NCT05310084|560456210|FG000|Overall Study|Withdrawal by Subject|2|||
155279342|NCT05310084|560456211|FG001|Overall Study|Withdrawal by Subject|3|||
155279343|NCT05310084|560456210|FG000|Overall Study|Participant availability|0|||
155279344|NCT05310084|560456211|FG001|Overall Study|Participant availability|4|||
155279345|NCT05310084|560456210|FG000|Overall Study|Lost to Follow-up|1|||
155279346|NCT05310084|560456211|FG001|Overall Study|Lost to Follow-up|1|||
155279347|NCT05310084|560456210|FG000|Overall Study|Adverse Event|1|||
155279348|NCT05310084|560456211|FG001|Overall Study|Adverse Event|1|||
155279349|NCT05310084|560456210|FG000|Overall Study|Randomized but not vaccinated|4|||
155384986|NCT00112047|560843796|FG000|Randomized Phase|Noncompliance|8|||
155384987|NCT00112047|560843797|FG001|Randomized Phase|Noncompliance|4|||
155384988|NCT00112047|560843796|FG000|Randomized Phase|Protocol Violation|2|||
155384989|NCT00112047|560843797|FG001|Randomized Phase|Protocol Violation|0|||
155384990|NCT00112047|560843796|FG000|Randomized Phase|Pregnancy|3|||
155384991|NCT00112047|560843797|FG001|Randomized Phase|Pregnancy|1|||
155384992|NCT00112047|560843796|FG000|Randomized Phase|Death|1|||
155384993|NCT00112047|560843797|FG001|Randomized Phase|Death|3|||
155384994|NCT00112047|560843796|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
155384995|NCT00112047|560843797|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
155384996|NCT00112047|560843796|FG000|Randomized Phase|Inability to swallow pills|0|||
155384997|NCT00112047|560843797|FG001|Randomized Phase|Inability to swallow pills|1|||
155384998|NCT00112047|560843796|FG000|Randomized Phase|Incarceration|3|||
155384999|NCT00112047|560843797|FG001|Randomized Phase|Incarceration|2|||
155385000|NCT00112047|560843796|FG000|Randomized Phase|Moved out of State|0|||
155385001|NCT00112047|560843797|FG001|Randomized Phase|Moved out of State|1|||
155385002|NCT00112047|560843796|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
155385003|NCT00112047|560843797|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
155385004|NCT00112047|560843796|FG000|Randomized Phase|High Hepatitis B DNA|0|||
155385005|NCT00112047|560843797|FG001|Randomized Phase|High Hepatitis B DNA|1|||
155385006|NCT00112047|560843796|FG000|Atripla Phase|Adverse Event|2|||
155385007|NCT00112047|560843797|FG001|Atripla Phase|Adverse Event|1|||
155385008|NCT00112047|560843796|FG000|Atripla Phase|Lost to Follow-up|5|||
155385009|NCT00112047|560843797|FG001|Atripla Phase|Lost to Follow-up|7|||
155385010|NCT00112047|560843796|FG000|Atripla Phase|Pregnancy|0|||
155385011|NCT00112047|560843797|FG001|Atripla Phase|Pregnancy|1|||
155385012|NCT00112047|560843796|FG000|Atripla Phase|Death|0|||
155385013|NCT00112047|560843797|FG001|Atripla Phase|Death|2|||
155385014|NCT00112047|560843796|FG000|Atripla Phase|Withdrew consent|7|||
155385015|NCT00112047|560843797|FG001|Atripla Phase|Withdrew consent|7|||
155385016|NCT00112047|560843796|FG000|Atripla Phase|Sub-optimal virological response|0|||
155385017|NCT00112047|560843797|FG001|Atripla Phase|Sub-optimal virological response|1|||
155385018|NCT00112047|560843796|FG000|Atripla Phase|Non-compliance|1|||
155385019|NCT00112047|560843797|FG001|Atripla Phase|Non-compliance|0|||
155385020|NCT00112047|560843796|FG000|Atripla Phase|Other|3|||
155385021|NCT00112047|560843797|FG001|Atripla Phase|Other|1|||
155385022|NCT01307579|560843798|FG000|Overall Study|Death|3|||
155385023|NCT01307579|560843799|FG001|Overall Study|Death|6|||
155385024|NCT01307579|560843798|FG000|Overall Study|Physician Decision|26|||
155385025|NCT01307579|560843799|FG001|Overall Study|Physician Decision|29|||
155385026|NCT01307579|560843798|FG000|Overall Study|Withdrawal by Subject|7|||
155385027|NCT01307579|560843799|FG001|Overall Study|Withdrawal by Subject|3|||
155385028|NCT01307579|560843798|FG000|Overall Study|Institutional diagnosis of IFD|21|||
155385029|NCT01307579|560843799|FG001|Overall Study|Institutional diagnosis of IFD|36|||
155385030|NCT01307579|560843798|FG000|Overall Study|Begin conditioning for HSCT|42|||
155385031|NCT01307579|560843799|FG001|Overall Study|Begin conditioning for HSCT|44|||
155385032|NCT01307579|560843798|FG000|Overall Study|Refractory or relapsed AML|38|||
155385033|NCT01307579|560843799|FG001|Overall Study|Refractory or relapsed AML|23|||
155385034|NCT01307579|560843798|FG000|Overall Study|Ineligible|3|||
155385035|NCT01307579|560843799|FG001|Overall Study|Ineligible|4|||
155385036|NCT03170349|560843802|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
155385037|NCT03170349|560843802|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
155385038|NCT03170349|560843802|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
155385039|NCT03170349|560843802|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
155385040|NCT03170349|560843802|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
155385041|NCT03170349|560843802|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
155385042|NCT03170349|560843802|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
155385043|NCT03170349|560843802|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
155385044|NCT03170349|560843802|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
155385045|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
155385046|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
155385047|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
155385048|NCT03170349|560843802|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
155385049|NCT03170349|560843802|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
155385050|NCT03170349|560843802|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
155385051|NCT03170349|560843802|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
155385052|NCT03938545|560845017|FG000|Overall Study|Lost to Follow-up|0|||
155385053|NCT03938545|560845018|FG001|Overall Study|Lost to Follow-up|0|||
154944083|NCT03937466|559220876|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
154944084|NCT00622908|559220877|FG000|Overall Study|Protocol Violation|1|||
154944085|NCT00622908|559220878|FG001|Overall Study|Protocol Violation|0|||
154944086|NCT00622908|559220877|FG000|Overall Study|Adverse Event|0|||
154944087|NCT00622908|559220878|FG001|Overall Study|Adverse Event|1|||
154944088|NCT00622908|559220877|FG000|Overall Study|Lack of Efficacy|1|||
155385054|NCT03938545|560845019|FG002|Overall Study|Lost to Follow-up|0|||
155385055|NCT03938545|560845020|FG003|Overall Study|Lost to Follow-up|1|||
155385056|NCT03938545|560845017|FG000|Overall Study|Non-compliance with study drug|0|||
154944089|NCT00622908|559220878|FG001|Overall Study|Lack of Efficacy|7|||
154944090|NCT00622908|559220877|FG000|Overall Study|Lost to Follow-up|1|||
155385057|NCT03938545|560845018|FG001|Overall Study|Non-compliance with study drug|0|||
155385058|NCT03938545|560845019|FG002|Overall Study|Non-compliance with study drug|1|||
155385059|NCT03938545|560845020|FG003|Overall Study|Non-compliance with study drug|0|||
155385060|NCT03938545|560845017|FG000|Overall Study|Pregnancy|1|||
155385061|NCT03938545|560845018|FG001|Overall Study|Pregnancy|0|||
155385062|NCT03938545|560845019|FG002|Overall Study|Pregnancy|0|||
155385063|NCT03938545|560845020|FG003|Overall Study|Pregnancy|0|||
155385064|NCT03938545|560845017|FG000|Overall Study|Study terminated by sponsor|6|||
155385065|NCT03938545|560845018|FG001|Overall Study|Study terminated by sponsor|4|||
155385066|NCT03938545|560845019|FG002|Overall Study|Study terminated by sponsor|2|||
155385067|NCT03938545|560845020|FG003|Overall Study|Study terminated by sponsor|4|||
155385068|NCT03938545|560845017|FG000|Overall Study|Withdrawal by Subject|0|||
155385069|NCT03938545|560845018|FG001|Overall Study|Withdrawal by Subject|1|||
155385070|NCT03938545|560845019|FG002|Overall Study|Withdrawal by Subject|0|||
155385071|NCT03938545|560845020|FG003|Overall Study|Withdrawal by Subject|0|||
155385072|NCT03938545|560845017|FG000|Overall Study|Adverse Event|1|||
155385073|NCT03938545|560845018|FG001|Overall Study|Adverse Event|0|||
155385074|NCT03938545|560845019|FG002|Overall Study|Adverse Event|0|||
155385075|NCT03938545|560845020|FG003|Overall Study|Adverse Event|0|||
155385076|NCT01060540|560845021|FG000|Overall Study|Withdrawal by Subject|10|||
155385077|NCT01060540|560845022|FG001|Overall Study|Withdrawal by Subject|20|||
155385078|NCT01060540|560845021|FG000|Overall Study|Lost to Follow-up|52|||
155385079|NCT01060540|560845022|FG001|Overall Study|Lost to Follow-up|43|||
155385080|NCT01060540|560845021|FG000|Overall Study|Death|2|||
155385081|NCT01060540|560845022|FG001|Overall Study|Death|1|||
155385082|NCT01060540|560845021|FG000|Overall Study|Physician Decision|0|||
155385083|NCT01060540|560845022|FG001|Overall Study|Physician Decision|1|||
155385084|NCT01222507|560845026|FG000|Overall Study|Physician Decision|1|||
155385085|NCT01222507|560845026|FG000|Overall Study|Withdrawal by Subject|1|||
155385086|NCT02647320|560845027|FG000|Overall Study|Adverse Event|0|||
155385087|NCT02647320|560845028|FG001|Overall Study|Adverse Event|1|||
155385088|NCT02647320|560845029|FG002|Overall Study|Adverse Event|3|||
155385089|NCT02647320|560845030|FG003|Overall Study|Adverse Event|2|||
155385090|NCT02647320|560845031|FG004|Overall Study|Adverse Event|1|||
155385091|NCT02647320|560845027|FG000|Overall Study|Protocol Violation|0|||
155385092|NCT02647320|560845028|FG001|Overall Study|Protocol Violation|0|||
155385093|NCT02647320|560845029|FG002|Overall Study|Protocol Violation|3|||
155385094|NCT02647320|560845030|FG003|Overall Study|Protocol Violation|0|||
155385095|NCT02647320|560845031|FG004|Overall Study|Protocol Violation|0|||
155385096|NCT02647320|560845027|FG000|Overall Study|Withdrawal by Subject|7|||
155385097|NCT02647320|560845028|FG001|Overall Study|Withdrawal by Subject|4|||
155385098|NCT02647320|560845029|FG002|Overall Study|Withdrawal by Subject|2|||
155385099|NCT02647320|560845030|FG003|Overall Study|Withdrawal by Subject|2|||
155385100|NCT02647320|560845031|FG004|Overall Study|Withdrawal by Subject|7|||
155385101|NCT02647320|560845027|FG000|Overall Study|Persistent hyperglycemia|0|||
155385102|NCT02647320|560845028|FG001|Overall Study|Persistent hyperglycemia|1|||
155385103|NCT02647320|560845029|FG002|Overall Study|Persistent hyperglycemia|1|||
155385104|NCT02647320|560845030|FG003|Overall Study|Persistent hyperglycemia|1|||
155385105|NCT02647320|560845031|FG004|Overall Study|Persistent hyperglycemia|1|||
155385106|NCT02647320|560845027|FG000|Overall Study|Study terminated by sponsor|1|||
155385107|NCT02647320|560845028|FG001|Overall Study|Study terminated by sponsor|1|||
155385108|NCT02647320|560845029|FG002|Overall Study|Study terminated by sponsor|1|||
155385109|NCT02647320|560845030|FG003|Overall Study|Study terminated by sponsor|1|||
155385110|NCT02647320|560845031|FG004|Overall Study|Study terminated by sponsor|2|||
155385111|NCT02647320|560845027|FG000|Overall Study|Reason not provided|0|||
155385112|NCT02647320|560845028|FG001|Overall Study|Reason not provided|0|||
155385113|NCT02647320|560845029|FG002|Overall Study|Reason not provided|1|||
155385114|NCT02647320|560845030|FG003|Overall Study|Reason not provided|0|||
155385115|NCT02647320|560845031|FG004|Overall Study|Reason not provided|2|||
155385116|NCT02647320|560845027|FG000|Overall Study|Lost to Follow-up|1|||
155385117|NCT02647320|560845028|FG001|Overall Study|Lost to Follow-up|1|||
155385118|NCT02647320|560845029|FG002|Overall Study|Lost to Follow-up|0|||
155385119|NCT02647320|560845030|FG003|Overall Study|Lost to Follow-up|0|||
155385120|NCT02647320|560845031|FG004|Overall Study|Lost to Follow-up|0|||
155385121|NCT02647320|560845027|FG000|Overall Study|Develop anemia|1|||
155385122|NCT02647320|560845028|FG001|Overall Study|Develop anemia|0|||
155385123|NCT02647320|560845029|FG002|Overall Study|Develop anemia|0|||
155385124|NCT02647320|560845030|FG003|Overall Study|Develop anemia|0|||
155385125|NCT02647320|560845031|FG004|Overall Study|Develop anemia|0|||
155385126|NCT02647320|560845027|FG000|Overall Study|Lack of Efficacy|0|||
155385127|NCT02647320|560845028|FG001|Overall Study|Lack of Efficacy|0|||
155385128|NCT02647320|560845029|FG002|Overall Study|Lack of Efficacy|0|||
155385129|NCT02647320|560845030|FG003|Overall Study|Lack of Efficacy|1|||
155385130|NCT02647320|560845031|FG004|Overall Study|Lack of Efficacy|0|||
155385131|NCT02647320|560845027|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
155385132|NCT02647320|560845028|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
155385133|NCT02647320|560845029|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
155385134|NCT02647320|560845030|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
155385135|NCT02647320|560845031|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
155385136|NCT00596427|560845032|FG000|Overall Study|Withdrawal by Subject|2|||
155385137|NCT00596427|560845033|FG001|Overall Study|Withdrawal by Subject|2|||
155385138|NCT00596427|560845032|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
155385139|NCT00596427|560845033|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
155385140|NCT00596427|560845032|FG000|Overall Study|Protocol Violation|1|||
155385141|NCT00596427|560845033|FG001|Overall Study|Protocol Violation|0|||
155385142|NCT02401867|560845038|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
155385143|NCT02401867|560845038|FG000|Analysis|Cervical assay could not be conducted|9|||
155385144|NCT01650246|560845039|FG000|Overall Study|Adverse Event|23|||
155385145|NCT01650246|560845039|FG000|Overall Study|Protocol Violation|5|||
155385146|NCT01650246|560845039|FG000|Overall Study|Sponsor terminated study|53|||
155385147|NCT01650246|560845039|FG000|Overall Study|Lost to Follow-up|5|||
155385148|NCT01650246|560845039|FG000|Overall Study|Withdrawal by Subject|26|||
155385149|NCT01650246|560845039|FG000|Overall Study|Death|1|||
155385150|NCT01650246|560845039|FG000|Overall Study|Lack of Efficacy|30|||
155385151|NCT00081770|560845040|FG000|Overall Study|Adverse Event|130|||
155385152|NCT00081770|560845041|FG001|Overall Study|Adverse Event|98|||
155385153|NCT00081770|560845042|FG002|Overall Study|Adverse Event|136|||
155385154|NCT00081770|560845040|FG000|Overall Study|Lack of Efficacy|262|||
155385155|NCT00081770|560845041|FG001|Overall Study|Lack of Efficacy|357|||
155385156|NCT00081770|560845042|FG002|Overall Study|Lack of Efficacy|211|||
155385157|NCT00081770|560845040|FG000|Overall Study|Lost to Follow-up|45|||
155385158|NCT00081770|560845041|FG001|Overall Study|Lost to Follow-up|34|||
155385159|NCT00081770|560845042|FG002|Overall Study|Lost to Follow-up|45|||
155385160|NCT00081770|560845040|FG000|Overall Study|Protocol Violation|15|||
155385161|NCT00081770|560845041|FG001|Overall Study|Protocol Violation|10|||
155385162|NCT00081770|560845042|FG002|Overall Study|Protocol Violation|10|||
155385163|NCT00081770|560845040|FG000|Overall Study|Withdrawal by Subject|45|||
155385164|NCT00081770|560845041|FG001|Overall Study|Withdrawal by Subject|40|||
155385165|NCT00081770|560845042|FG002|Overall Study|Withdrawal by Subject|42|||
155385166|NCT00081770|560845040|FG000|Overall Study|Did not meet protocol eligibility|2|||
155385167|NCT00081770|560845041|FG001|Overall Study|Did not meet protocol eligibility|0|||
155385168|NCT00081770|560845042|FG002|Overall Study|Did not meet protocol eligibility|3|||
155385169|NCT00081770|560845040|FG000|Overall Study|Administrative|1|||
155385170|NCT00081770|560845041|FG001|Overall Study|Administrative|0|||
155385171|NCT00081770|560845042|FG002|Overall Study|Administrative|1|||
155385172|NCT00081770|560845040|FG000|Overall Study|Other|2|||
155385173|NCT00081770|560845041|FG001|Overall Study|Other|7|||
155385174|NCT00081770|560845042|FG002|Overall Study|Other|8|||
155385175|NCT03435497|560845044|FG000|Overall Study|Lost to Follow-up|1|||
155385176|NCT03435497|560845045|FG001|Overall Study|Lost to Follow-up|0|||
155385177|NCT03435497|560845044|FG000|Overall Study|Death|1|||
155385178|NCT03435497|560845045|FG001|Overall Study|Death|0|||
155385179|NCT03435497|560845044|FG000|Overall Study|Withdrawal by Subject|0|||
155385180|NCT03435497|560845045|FG001|Overall Study|Withdrawal by Subject|4|||
155385181|NCT03435497|560845044|FG000|Overall Study|Wrong survey administered|0|||
155385182|NCT03435497|560845045|FG001|Overall Study|Wrong survey administered|2|||
155385183|NCT01614197|560845054|FG000|Overall Study|Withdrawal by Subject|0|||
155385184|NCT01614197|560845055|FG001|Overall Study|Withdrawal by Subject|1|||
155385185|NCT01614197|560845056|FG002|Overall Study|Withdrawal by Subject|0|||
155385186|NCT01614197|560845057|FG003|Overall Study|Withdrawal by Subject|0|||
155385187|NCT03628898|560845059|FG000|Overall Study|Device deficiency|1|||
155385188|NCT03442985|560845060|FG000|Overall Study|Sponsor Request|55|||
155385189|NCT03442985|560845061|FG001|Overall Study|Sponsor Request|60|||
155385190|NCT03442985|560845062|FG002|Overall Study|Sponsor Request|54|||
155385191|NCT03442985|560845060|FG000|Overall Study|Lost to Follow-up|5|||
155385192|NCT03442985|560845061|FG001|Overall Study|Lost to Follow-up|2|||
155385193|NCT03442985|560845062|FG002|Overall Study|Lost to Follow-up|7|||
155385194|NCT03442985|560845060|FG000|Overall Study|Withdrawal by Subject|2|||
155385195|NCT03442985|560845061|FG001|Overall Study|Withdrawal by Subject|3|||
155385196|NCT03442985|560845062|FG002|Overall Study|Withdrawal by Subject|4|||
155385197|NCT03442985|560845060|FG000|Overall Study|Adverse Event|0|||
155385198|NCT03442985|560845061|FG001|Overall Study|Adverse Event|1|||
155385199|NCT03442985|560845062|FG002|Overall Study|Adverse Event|0|||
155385200|NCT01217957|560845065|FG000|Phase 1|Withdrawal by Patient|1|||
155385201|NCT01217957|560845066|FG001|Phase 1|Withdrawal by Patient|0|||
155385202|NCT01217957|560845067|FG002|Phase 1|Withdrawal by Patient|1|||
155045795|NCT05052697|559599417|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045796|NCT05052697|559599418|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
155385203|NCT01217957|560845068|FG003|Phase 1|Withdrawal by Patient|1|||
155385204|NCT01217957|560845069|FG004|Phase 1|Withdrawal by Patient|0|||
155385205|NCT01217957|560845065|FG000|Phase 2|Withdrawal by Patient|0|||
155385206|NCT01217957|560845066|FG001|Phase 2|Withdrawal by Patient|0|||
155385207|NCT01217957|560845067|FG002|Phase 2|Withdrawal by Patient|0|||
155385208|NCT01217957|560845068|FG003|Phase 2|Withdrawal by Patient|0|||
155385209|NCT01217957|560845069|FG004|Phase 2|Withdrawal by Patient|1|||
155385210|NCT00971932|560845070|FG000|Overall Study|Withdrawal by Subject|1|||
155385211|NCT00971932|560845070|FG000|Overall Study|Investigator's decision|2|||
155385212|NCT00971932|560845070|FG000|Overall Study|Ongoing|4|||
155385213|NCT01206777|560845074|FG000|Overall Study|Death|1|||
155385214|NCT01206777|560845074|FG000|Overall Study|Adverse Event|1|||
155385215|NCT00824161|560845083|FG000|Overall Study|Withdrawal by Subject|1|||
155385216|NCT00824161|560845083|FG000|Overall Study|Screen Failure|1|||
155385217|NCT04754477|560845084|FG000|Overall Study|Withdrawal by Subject|1|||
155385218|NCT00655863|560845085|FG000|Overall Study|Lost to Follow-up|0|||
155385219|NCT00655863|560845086|FG001|Overall Study|Lost to Follow-up|0|||
155385220|NCT00655863|560845087|FG002|Overall Study|Lost to Follow-up|1|||
155385221|NCT02203695|560845092|FG000|Overall Study|Patient withdrew consent|1|||
155385222|NCT02203695|560845093|FG001|Overall Study|Patient withdrew consent|1|||
155385223|NCT02203695|560845092|FG000|Overall Study|Started non-study treatment|1|||
155385224|NCT02203695|560845093|FG001|Overall Study|Started non-study treatment|0|||
155385225|NCT01122862|560845094|FG000|Period 1|Protocol Violation|0|||
155385226|NCT01122862|560845095|FG001|Period 1|Protocol Violation|1|||
155385227|NCT01122862|560845096|FG002|Period 1|Protocol Violation|0|||
155385228|NCT01122862|560845094|FG000|Period 2|Adverse Event|0|||
155385229|NCT01122862|560845095|FG001|Period 2|Adverse Event|0|||
155385230|NCT01122862|560845096|FG002|Period 2|Adverse Event|1|||
155385231|NCT00846391|560845097|FG000|Overall Study|Physician Decision|0|||
155385232|NCT00846391|560845098|FG001|Overall Study|Physician Decision|0|||
155385233|NCT00846391|560845099|FG002|Overall Study|Physician Decision|1|||
155385234|NCT00846391|560845097|FG000|Overall Study|Study Terminated by Sponsor|1|||
155385235|NCT00846391|560845098|FG001|Overall Study|Study Terminated by Sponsor|2|||
155385236|NCT00846391|560845099|FG002|Overall Study|Study Terminated by Sponsor|2|||
155385237|NCT01790126|560845103|FG000|Overall Study|PSA Progression|12|||
155385238|NCT01790126|560845104|FG001|Overall Study|PSA Progression|16|||
155385239|NCT01790126|560845105|FG002|Overall Study|PSA Progression|16|||
155385240|NCT01790126|560845103|FG000|Overall Study|Other|5|||
155385241|NCT01790126|560845104|FG001|Overall Study|Other|4|||
155385242|NCT01790126|560845105|FG002|Overall Study|Other|8|||
155385243|NCT01790126|560845103|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
155385244|NCT01790126|560845104|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
155385245|NCT01790126|560845105|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
155385246|NCT01790126|560845103|FG000|Overall Study|Withdrawal by Physician|1|||
155385247|NCT01790126|560845104|FG001|Overall Study|Withdrawal by Physician|1|||
155385248|NCT01790126|560845105|FG002|Overall Study|Withdrawal by Physician|2|||
155385249|NCT01790126|560845103|FG000|Overall Study|Withdrawal by Subject|3|||
155385250|NCT01790126|560845104|FG001|Overall Study|Withdrawal by Subject|1|||
155385251|NCT01790126|560845105|FG002|Overall Study|Withdrawal by Subject|2|||
155385252|NCT01790126|560845103|FG000|Overall Study|Lost to Follow-up|1|||
155385253|NCT01790126|560845104|FG001|Overall Study|Lost to Follow-up|0|||
155385254|NCT01790126|560845105|FG002|Overall Study|Lost to Follow-up|1|||
155385255|NCT01790126|560845103|FG000|Overall Study|Adverse Event|0|||
155385256|NCT01790126|560845104|FG001|Overall Study|Adverse Event|2|||
155385257|NCT01790126|560845105|FG002|Overall Study|Adverse Event|0|||
155385258|NCT01790126|560845103|FG000|Overall Study|Death|2|||
155385259|NCT01790126|560845104|FG001|Overall Study|Death|0|||
155385260|NCT01790126|560845105|FG002|Overall Study|Death|0|||
155385261|NCT01790126|560845103|FG000|Overall Study|Radiographic Progression|3|||
155385262|NCT01790126|560845104|FG001|Overall Study|Radiographic Progression|1|||
155385263|NCT01790126|560845105|FG002|Overall Study|Radiographic Progression|0|||
155385264|NCT01636960|560845108|FG000|Induction Phase|Adverse Event|2|||
155385265|NCT01636960|560845108|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
155385266|NCT01636960|560845108|FG000|Maintenance Phase|Adverse Event|3|||
155385267|NCT01636960|560845108|FG000|Maintenance Phase|Progressive disease|1|||
155385268|NCT01580969|560845109|FG000|Overall Study|Physician Decision|3|||
155385269|NCT01580969|560845110|FG001|Overall Study|Physician Decision|0|||
155385270|NCT01580969|560845111|FG002|Overall Study|Physician Decision|0|||
155385271|NCT01745848|560845112|FG000|Overall Study|Adverse Event|6|||
155385272|NCT06338462|560845116|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
155385273|NCT01001832|560845120|FG000|Short-term Period|Adverse Event|2|||
155385274|NCT01001832|560845121|FG001|Short-term Period|Adverse Event|3|||
155385275|NCT01001832|560845120|FG000|Long-term Period|Adverse Event|2|||
155385276|NCT01001832|560845121|FG001|Long-term Period|Adverse Event|1|||
155385277|NCT01001832|560845120|FG000|Long-term Period|Withdrawal by Subject|1|||
155385278|NCT01001832|560845121|FG001|Long-term Period|Withdrawal by Subject|0|||
155385279|NCT01001832|560845120|FG000|Long-term Period|Lack of Efficacy|0|||
155385280|NCT01001832|560845121|FG001|Long-term Period|Lack of Efficacy|2|||
155385281|NCT01001832|560845120|FG000|Long-term Period|Other|1|||
155385282|NCT01001832|560845121|FG001|Long-term Period|Other|2|||
155385283|NCT01001832|560845120|FG000|Follow-up Period|Withdrawal by Subject|1|||
154944091|NCT00622908|559220878|FG001|Overall Study|Lost to Follow-up|0|||
154944092|NCT00622908|559220877|FG000|Overall Study|Refusal|0|||
155385284|NCT01001832|560845121|FG001|Follow-up Period|Withdrawal by Subject|0|||
155385285|NCT01001832|560845120|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
155385286|NCT01001832|560845121|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
155385287|NCT01001832|560845120|FG000|Follow-up Period|Other|2|||
155385288|NCT01001832|560845121|FG001|Follow-up Period|Other|1|||
155385289|NCT03581825|560845130|FG000|Period 1|Lens Discomfort|1|||
155385290|NCT03581825|560845131|FG001|Period 1|Lens Discomfort|0|||
155385291|NCT03581825|560845130|FG000|Period 2|Unsatisfactory Vision to Test|0|||
155385292|NCT03581825|560845131|FG001|Period 2|Unsatisfactory Vision to Test|1|||
155385293|NCT03110185|560845133|FG000|Overall Study|Death|0|||
155385294|NCT03110185|560845134|FG001|Overall Study|Death|1|||
155385295|NCT03110185|560845133|FG000|Overall Study|Withdrawal by Subject|2|||
155385296|NCT03110185|560845134|FG001|Overall Study|Withdrawal by Subject|7|||
155385297|NCT03110185|560845133|FG000|Overall Study|Time Constraints|0|||
155385298|NCT03110185|560845134|FG001|Overall Study|Time Constraints|6|||
155385299|NCT03110185|560845133|FG000|Overall Study|Conflict with care|5|||
155385300|NCT03110185|560845134|FG001|Overall Study|Conflict with care|12|||
155385301|NCT03110185|560845133|FG000|Overall Study|Protocol Violation|1|||
155385302|NCT03110185|560845134|FG001|Overall Study|Protocol Violation|4|||
155385303|NCT03110185|560845133|FG000|Overall Study|MRI Incompatible|2|||
155385304|NCT03110185|560845134|FG001|Overall Study|MRI Incompatible|0|||
155385305|NCT03110185|560845133|FG000|Overall Study|Patient Refusal|0|||
155385306|NCT03110185|560845134|FG001|Overall Study|Patient Refusal|1|||
155279350|NCT05310084|560456211|FG001|Overall Study|Randomized but not vaccinated|2|||
155279351|NCT00924664|560456213|FG000|Overall Study|Adverse Event|23|||
155279352|NCT00924664|560456214|FG001|Overall Study|Adverse Event|39|||
155279353|NCT00924664|560456213|FG000|Overall Study|Lack of Efficacy|10|||
155279354|NCT00924664|560456214|FG001|Overall Study|Lack of Efficacy|15|||
155279355|NCT00924664|560456213|FG000|Overall Study|Lost to Follow-up|10|||
155279356|NCT00924664|560456214|FG001|Overall Study|Lost to Follow-up|12|||
155279357|NCT00924664|560456213|FG000|Overall Study|Withdrawal by Subject|47|||
155279358|NCT00924664|560456214|FG001|Overall Study|Withdrawal by Subject|71|||
155279359|NCT00924664|560456213|FG000|Overall Study|Protocol Violation|2|||
155279360|NCT00924664|560456214|FG001|Overall Study|Protocol Violation|5|||
155279361|NCT00924664|560456213|FG000|Overall Study|Pregnancy|1|||
155279362|NCT00924664|560456214|FG001|Overall Study|Pregnancy|1|||
155279363|NCT00924664|560456213|FG000|Overall Study|Death|0|||
155279364|NCT00924664|560456214|FG001|Overall Study|Death|2|||
155279365|NCT00924664|560456213|FG000|Overall Study|Study terminated by sponsor|199|||
155279366|NCT00924664|560456214|FG001|Overall Study|Study terminated by sponsor|330|||
155279367|NCT00924664|560456213|FG000|Overall Study|Other|29|||
155279368|NCT00924664|560456214|FG001|Overall Study|Other|52|||
155279369|NCT00924664|560456213|FG000|Overall Study|Randomized but not Treated|1|||
155279370|NCT00924664|560456214|FG001|Overall Study|Randomized but not Treated|0|||
155279371|NCT01598987|560456215|FG000|Baseline to Month 12|Administrative problems|2|||
155279372|NCT01598987|560456215|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
155279373|NCT01598987|560456215|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
155279374|NCT01598987|560456215|FG000|Baseline to 24 Month|Administrative problems|2|||
155279375|NCT01598987|560456215|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
155279376|NCT02724020|560456225|FG000|Overall Study|Death|16|||
155279377|NCT02724020|560456226|FG001|Overall Study|Death|18|||
155279378|NCT02724020|560456227|FG002|Overall Study|Death|19|||
155279379|NCT02724020|560456225|FG000|Overall Study|Lost to Follow-up|0|||
155279380|NCT02724020|560456226|FG001|Overall Study|Lost to Follow-up|3|||
155279381|NCT02724020|560456227|FG002|Overall Study|Lost to Follow-up|0|||
155279382|NCT02724020|560456225|FG000|Overall Study|Site Terminated by Sponsor|15|||
155279383|NCT02724020|560456226|FG001|Overall Study|Site Terminated by Sponsor|8|||
155279384|NCT02724020|560456227|FG002|Overall Study|Site Terminated by Sponsor|8|||
155279385|NCT02724020|560456225|FG000|Overall Study|Withdrawal by Subject|1|||
155279386|NCT02724020|560456226|FG001|Overall Study|Withdrawal by Subject|3|||
155279387|NCT02724020|560456227|FG002|Overall Study|Withdrawal by Subject|5|||
155279388|NCT00425503|560456228|FG000|Overall Study|Adverse Event|2|||
155279389|NCT00425503|560456228|FG000|Overall Study|Protocol Violation|1|||
155279390|NCT01925170|560456229|FG000|Overall Study|Unverified cancer status|53|||
155279391|NCT02839681|560456232|FG000|Overall Study|Death|2|||
155279392|NCT01653847|560456233|FG000|Overall Study|Withdrawal by Subject|1|||
155279393|NCT01653847|560456234|FG001|Overall Study|Withdrawal by Subject|0|||
155279394|NCT00801242|560456239|FG000|Overall Study|Adverse Event|10|||
155279395|NCT00801242|560456239|FG000|Overall Study|Withdrawal by Subject|13|||
155279396|NCT00801242|560456239|FG000|Overall Study|Protocol Violation|5|||
155279397|NCT00801242|560456239|FG000|Overall Study|Physician Decision|3|||
155385307|NCT04737187|560845142|FG000|Overall Study|Switched to marketed drug|32|||
155385308|NCT04737187|560845143|FG001|Overall Study|Switched to marketed drug|4|||
155385309|NCT04737187|560845142|FG000|Overall Study|Radiological Progressive Disease|145|||
155385310|NCT04737187|560845143|FG001|Overall Study|Radiological Progressive Disease|146|||
155385311|NCT04737187|560845142|FG000|Overall Study|Clinical Progressive Disease|20|||
155385312|NCT04737187|560845143|FG001|Overall Study|Clinical Progressive Disease|20|||
155279398|NCT00801242|560456239|FG000|Overall Study|Lost to Follow-up|1|||
155279399|NCT00801242|560456239|FG000|Overall Study|Miscellaneous reasons|20|||
155279400|NCT02554513|560456240|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
155279401|NCT02554513|560456241|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
155279402|NCT00184028|560456242|FG000|Overall Study|Death|1|||
155385313|NCT04737187|560845142|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
155385314|NCT04737187|560845143|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
155385315|NCT04737187|560845142|FG000|Overall Study|Adverse Event|16|||
155385316|NCT04737187|560845143|FG001|Overall Study|Adverse Event|16|||
155385317|NCT04737187|560845142|FG000|Overall Study|Physician Decision|2|||
155385318|NCT04737187|560845143|FG001|Overall Study|Physician Decision|0|||
155385319|NCT04737187|560845142|FG000|Overall Study|Withdrawal by Subject|5|||
155385320|NCT04737187|560845143|FG001|Overall Study|Withdrawal by Subject|8|||
155385321|NCT00345293|560845144|FG000|Overall Study|Unable to access line for sample|1|||
155385322|NCT00345293|560845145|FG001|Overall Study|Unable to access line for sample|0|||
155385323|NCT00345293|560845144|FG000|Overall Study|Withdrawal by Subject|1|||
155385324|NCT00345293|560845145|FG001|Overall Study|Withdrawal by Subject|0|||
155385325|NCT04873232|560845147|FG000|Overall Study|Lost to Follow-up|1|||
155385326|NCT04873232|560845148|FG001|Overall Study|Lost to Follow-up|4|||
155385327|NCT04873232|560845147|FG000|Overall Study|Withdrawal by Subject|1|||
155385328|NCT04873232|560845148|FG001|Overall Study|Withdrawal by Subject|0|||
155385329|NCT01340196|560847075|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
155385330|NCT00604279|560847080|FG000|Overall Study|Lack of Efficacy|22|||
155385331|NCT00604279|560847081|FG001|Overall Study|Lack of Efficacy|9|||
155385332|NCT00604279|560847080|FG000|Overall Study|Lost to Follow-up|9|||
155385333|NCT00604279|560847081|FG001|Overall Study|Lost to Follow-up|14|||
155385334|NCT00604279|560847080|FG000|Overall Study|Pregnancy|2|||
155385335|NCT00604279|560847081|FG001|Overall Study|Pregnancy|0|||
155385336|NCT00604279|560847080|FG000|Overall Study|Protocol Violation|3|||
155385337|NCT00604279|560847081|FG001|Overall Study|Protocol Violation|1|||
155385338|NCT00604279|560847080|FG000|Overall Study|Withdrawal by Subject|16|||
155385339|NCT00604279|560847081|FG001|Overall Study|Withdrawal by Subject|5|||
155385340|NCT00604279|560847080|FG000|Overall Study|Adverse Event|4|||
155385341|NCT00604279|560847081|FG001|Overall Study|Adverse Event|5|||
155385342|NCT00604279|560847080|FG000|Overall Study|Other|8|||
155385343|NCT00604279|560847081|FG001|Overall Study|Other|4|||
155385344|NCT00355056|560847082|FG000|Randomization Period|Early Termination|4|||
155385345|NCT00355056|560847083|FG001|Randomization Period|Early Termination|6|||
155385346|NCT00816400|560847084|FG000|Overall Study|Death|2|||
155385347|NCT00816400|560847085|FG001|Overall Study|Death|3|||
155385348|NCT00816400|560847086|FG002|Overall Study|Death|3|||
155045797|NCT05052697|559599419|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
155045798|NCT05052697|559599386|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045799|NCT05052697|559599387|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045800|NCT05052697|559599388|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045801|NCT05052697|559599389|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045802|NCT05052697|559599390|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045803|NCT05052697|559599391|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045804|NCT05052697|559599392|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045805|NCT05052697|559599393|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045806|NCT05052697|559599394|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045807|NCT05052697|559599395|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045808|NCT05052697|559599396|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045809|NCT05052697|559599397|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045810|NCT05052697|559599398|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045811|NCT05052697|559599399|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045812|NCT05052697|559599400|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045813|NCT05052697|559599401|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045814|NCT05052697|559599402|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045815|NCT05052697|559599403|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045816|NCT05052697|559599404|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045817|NCT05052697|559599405|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
155045818|NCT05052697|559599406|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155385349|NCT00816400|560847087|FG003|Overall Study|Death|3|||
155385350|NCT00816400|560847088|FG004|Overall Study|Death|2|||
155385351|NCT00816400|560847089|FG005|Overall Study|Death|3|||
155045819|NCT05052697|559599407|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045820|NCT05052697|559599408|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045821|NCT05052697|559599409|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155385352|NCT00816400|560847090|FG006|Overall Study|Death|2|||
155385353|NCT00816400|560847091|FG007|Overall Study|Death|5|||
155385354|NCT00816400|560847092|FG008|Overall Study|Death|6|||
155385355|NCT00816400|560847084|FG000|Overall Study|In hospice care at the end of the study|0|||
155385356|NCT00816400|560847085|FG001|Overall Study|In hospice care at the end of the study|0|||
155385357|NCT00816400|560847086|FG002|Overall Study|In hospice care at the end of the study|2|||
155385358|NCT00816400|560847087|FG003|Overall Study|In hospice care at the end of the study|0|||
155385359|NCT00816400|560847088|FG004|Overall Study|In hospice care at the end of the study|0|||
155385360|NCT00816400|560847089|FG005|Overall Study|In hospice care at the end of the study|0|||
155385361|NCT00816400|560847090|FG006|Overall Study|In hospice care at the end of the study|0|||
155279403|NCT00184028|560456242|FG000|Overall Study|Lack of Efficacy|4|||
155279404|NCT00184028|560456242|FG000|Overall Study|Adverse Event|2|||
155279405|NCT00184028|560456242|FG000|Overall Study|Withdrawal by Subject|1|||
155279406|NCT00184028|560456242|FG000|Overall Study|Non-compliance|2|||
155279407|NCT00388362|560456243|FG000|Enrolled|Ineligible|1|||
155279408|NCT00388362|560456243|FG000|Enrolled|Adverse Event|9|||
155279409|NCT00388362|560456243|FG000|Enrolled|Death|1|||
155279410|NCT00388362|560456243|FG000|Enrolled|Loss insurance|1|||
155279411|NCT00388362|560456243|FG000|Enrolled|Withdrawal by Subject|1|||
155279412|NCT00388362|560456243|FG000|Remained on Study Median of 514 Days|Death|2|||
155279413|NCT03259373|560456246|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
155279414|NCT03259373|560456247|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
155279415|NCT03259373|560456246|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
155279416|NCT03259373|560456247|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
155279417|NCT03259373|560456246|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
155279418|NCT03259373|560456247|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
155279419|NCT03259373|560456246|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
155279420|NCT03259373|560456247|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
155279421|NCT03259373|560456246|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
155279422|NCT03259373|560456247|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
154944093|NCT00622908|559220878|FG001|Overall Study|Refusal|1|||
154944094|NCT00622908|559220877|FG000|Overall Study|Termination by study sponser|0|||
154944095|NCT00622908|559220878|FG001|Overall Study|Termination by study sponser|1|||
154944096|NCT00299156|559220881|FG000|Period 2 (Randomized)|Screen Failure|0|||
154944097|NCT00299156|559220882|FG001|Period 2 (Randomized)|Screen Failure|1|||
154944098|NCT00299156|559220883|FG002|Period 2 (Randomized)|Screen Failure|0|||
154944099|NCT01725451|559220884|FG000|Period 1|Withdrawal by Subject|1|||
154944100|NCT01725451|559220885|FG001|Period 1|Withdrawal by Subject|0|||
154944101|NCT01725451|559220886|FG002|Period 1|Withdrawal by Subject|0|||
154944102|NCT01725451|559220887|FG003|Period 1|Withdrawal by Subject|0|||
154944103|NCT01725451|559220884|FG000|Washout From Period 3|Protocol Violation|0|||
154944104|NCT01725451|559220885|FG001|Washout From Period 3|Protocol Violation|0|||
154944105|NCT01725451|559220886|FG002|Washout From Period 3|Protocol Violation|1|||
154944106|NCT01725451|559220887|FG003|Washout From Period 3|Protocol Violation|0|||
154944107|NCT01725451|559220884|FG000|Washout From Period 3|Adverse Event|0|||
154944108|NCT01725451|559220885|FG001|Washout From Period 3|Adverse Event|1|||
154944109|NCT01725451|559220886|FG002|Washout From Period 3|Adverse Event|0|||
154944110|NCT01725451|559220887|FG003|Washout From Period 3|Adverse Event|0|||
154944111|NCT01725451|559220884|FG000|Period 4|Adverse Event|0|||
154944112|NCT01725451|559220885|FG001|Period 4|Adverse Event|0|||
154944113|NCT01725451|559220886|FG002|Period 4|Adverse Event|1|||
154944114|NCT01725451|559220887|FG003|Period 4|Adverse Event|0|||
154944115|NCT00358826|559220891|FG000|Core Study|Adverse Event|1|||
154944116|NCT00358826|559220892|FG001|Core Study|Adverse Event|3|||
154944117|NCT00358826|559220893|FG002|Core Study|Adverse Event|1|||
154944118|NCT00358826|559220894|FG003|Core Study|Adverse Event|1|||
154944119|NCT00358826|559220895|FG004|Core Study|Adverse Event|0|||
154944120|NCT00358826|559220896|FG005|Core Study|Adverse Event|0|||
154944121|NCT00358826|559220897|FG006|Core Study|Adverse Event|0|||
154944122|NCT00358826|559220898|FG007|Core Study|Adverse Event|0|||
154944123|NCT00358826|559220891|FG000|Core Study|Withdrawal by Subject|2|||
154944124|NCT00358826|559220892|FG001|Core Study|Withdrawal by Subject|2|||
154944125|NCT00358826|559220893|FG002|Core Study|Withdrawal by Subject|0|||
154944126|NCT00358826|559220894|FG003|Core Study|Withdrawal by Subject|0|||
154944127|NCT00358826|559220895|FG004|Core Study|Withdrawal by Subject|0|||
154944128|NCT00358826|559220896|FG005|Core Study|Withdrawal by Subject|0|||
154944129|NCT00358826|559220897|FG006|Core Study|Withdrawal by Subject|0|||
154944130|NCT00358826|559220898|FG007|Core Study|Withdrawal by Subject|0|||
154944131|NCT00358826|559220891|FG000|Core Study|Lost to Follow-up|0|||
154944132|NCT00358826|559220892|FG001|Core Study|Lost to Follow-up|0|||
154944133|NCT00358826|559220893|FG002|Core Study|Lost to Follow-up|0|||
154944134|NCT00358826|559220894|FG003|Core Study|Lost to Follow-up|1|||
154944135|NCT00358826|559220895|FG004|Core Study|Lost to Follow-up|0|||
154944136|NCT00358826|559220896|FG005|Core Study|Lost to Follow-up|0|||
154944137|NCT00358826|559220897|FG006|Core Study|Lost to Follow-up|0|||
154944138|NCT00358826|559220898|FG007|Core Study|Lost to Follow-up|0|||
154944139|NCT00358826|559220891|FG000|Core Study|Physician Decision|0|||
154944140|NCT00358826|559220892|FG001|Core Study|Physician Decision|0|||
154944141|NCT00358826|559220893|FG002|Core Study|Physician Decision|1|||
154944142|NCT00358826|559220894|FG003|Core Study|Physician Decision|0|||
154944143|NCT00358826|559220895|FG004|Core Study|Physician Decision|0|||
154944144|NCT00358826|559220896|FG005|Core Study|Physician Decision|0|||
154944145|NCT00358826|559220897|FG006|Core Study|Physician Decision|0|||
155045822|NCT05052697|559599410|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155385362|NCT00816400|560847091|FG007|Overall Study|In hospice care at the end of the study|0|||
155385363|NCT00816400|560847092|FG008|Overall Study|In hospice care at the end of the study|0|||
155385364|NCT01072877|560847096|FG000|Overall Study|Lost to Follow-up|1|||
155385365|NCT01072877|560847097|FG001|Overall Study|Lost to Follow-up|1|||
155385366|NCT01072877|560847098|FG002|Overall Study|Lost to Follow-up|0|||
155385367|NCT01072877|560847099|FG003|Overall Study|Lost to Follow-up|2|||
155385368|NCT01072877|560847100|FG004|Overall Study|Lost to Follow-up|0|||
155385369|NCT00601419|560847101|FG000|Overall Study|Lost to Follow-up|3|||
155385370|NCT00601419|560847101|FG000|Overall Study|Missed Visits|1|||
155385371|NCT01786174|560847102|FG000|Overall Study|Discontinued Study Drug|2|||
155385372|NCT01786174|560847103|FG001|Overall Study|Discontinued Study Drug|0|||
155385373|NCT00995020|560847104|FG000|Overall Study|margin analysis not performed|2|||
155385374|NCT00995020|560847105|FG001|Overall Study|margin analysis not performed|5|||
155385375|NCT00995020|560847104|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
155385376|NCT00995020|560847105|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
155385377|NCT00876694|560847111|FG000|Overall Study|Adverse Event|10|||
155385378|NCT00876694|560847112|FG001|Overall Study|Adverse Event|7|||
155385379|NCT00876694|560847111|FG000|Overall Study|Subject withdrew consent|6|||
155385380|NCT00876694|560847112|FG001|Overall Study|Subject withdrew consent|4|||
155385381|NCT00876694|560847111|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155385382|NCT00876694|560847112|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155385383|NCT00876694|560847111|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155385384|NCT00876694|560847112|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155385385|NCT00876694|560847111|FG000|Overall Study|Administrative problems|1|||
155385386|NCT00876694|560847112|FG001|Overall Study|Administrative problems|1|||
155385387|NCT00876694|560847111|FG000|Overall Study|Death|1|||
155385388|NCT00876694|560847112|FG001|Overall Study|Death|0|||
155385389|NCT00288509|560847113|FG000|Treatment Cycle 1|Adverse Event|1|||
155385390|NCT00288509|560847113|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
155385391|NCT00288509|560847113|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
155385392|NCT00288509|560847113|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
155385393|NCT00288509|560847113|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
155385394|NCT00288509|560847113|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
155385395|NCT00288509|560847113|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
155385396|NCT00288509|560847113|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
155385397|NCT00288509|560847113|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
155385398|NCT00288509|560847113|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
155385399|NCT00288509|560847113|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
155385400|NCT00288509|560847113|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
155385401|NCT00288509|560847113|FG000|Treatment Cycle 4|Physician Decision|4|||
155385402|NCT00288509|560847113|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
155385403|NCT02382016|560847114|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
155385404|NCT02382016|560847115|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
155385405|NCT02382016|560847114|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
155385406|NCT02382016|560847115|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
155385407|NCT02382016|560847114|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
155385408|NCT02382016|560847115|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
155385409|NCT02382016|560847114|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
155385410|NCT02382016|560847115|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
155385411|NCT02382016|560847114|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
155385412|NCT02382016|560847115|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
155385413|NCT02382016|560847114|FG000|Open-label (OL) Treatment Period|Death|4|||
155385414|NCT02382016|560847115|FG001|Open-label (OL) Treatment Period|Death|0|||
155385415|NCT02382016|560847114|FG000|OL Extension Period|Physician Decision|3|||
155385416|NCT02382016|560847115|FG001|OL Extension Period|Physician Decision|0|||
155385417|NCT02382016|560847114|FG000|OL Extension Period|Death|2|||
155385418|NCT02382016|560847115|FG001|OL Extension Period|Death|0|||
155385419|NCT02382016|560847114|FG000|OL Extension Period|Withdrawal by Subject|1|||
155385420|NCT02382016|560847115|FG001|OL Extension Period|Withdrawal by Subject|0|||
155385421|NCT00084266|560847116|FG000|Overall Study|Death|42|||
155385422|NCT00084266|560847117|FG001|Overall Study|Death|39|||
155385423|NCT00084266|560847116|FG000|Overall Study|Adverse Event|8|||
155385424|NCT00084266|560847117|FG001|Overall Study|Adverse Event|5|||
155385425|NCT00084266|560847116|FG000|Overall Study|Lack of Efficacy|2|||
155385426|NCT00084266|560847117|FG001|Overall Study|Lack of Efficacy|4|||
155385427|NCT00084266|560847116|FG000|Overall Study|Lost to Follow-up|5|||
155385428|NCT00084266|560847117|FG001|Overall Study|Lost to Follow-up|3|||
155385429|NCT00084266|560847116|FG000|Overall Study|Participant not willing to participate|3|||
155385430|NCT00084266|560847117|FG001|Overall Study|Participant not willing to participate|8|||
155385431|NCT00084266|560847116|FG000|Overall Study|Other|360|||
155385432|NCT00084266|560847117|FG001|Overall Study|Other|344|||
155385433|NCT00084266|560847116|FG000|Overall Study|Randomized not treated|21|||
155385434|NCT00084266|560847117|FG001|Overall Study|Randomized not treated|20|||
155385435|NCT00730171|560847118|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
155385436|NCT00730171|560847118|FG000|Overall Study|Adverse Event|193|||
155385437|NCT00730171|560847118|FG000|Overall Study|Protocol Violation|48|||
155385438|NCT00730171|560847118|FG000|Overall Study|Withdrawal by Subject|202|||
155385439|NCT00730171|560847118|FG000|Overall Study|Lost to Follow-up|121|||
155385440|NCT00730171|560847118|FG000|Overall Study|Insufficient Therapeutic Response|141|||
155385441|NCT00730171|560847118|FG000|Overall Study|Other|61|||
155385442|NCT01215422|560847119|FG000|Overall Study|Relocation|1|||
155385443|NCT01215422|560847120|FG001|Overall Study|Relocation|0|||
155385444|NCT01215422|560847121|FG002|Overall Study|Relocation|0|||
155385445|NCT01215422|560847122|FG003|Overall Study|Relocation|0|||
155385446|NCT01215422|560847119|FG000|Overall Study|Failed intubations|0|||
155385447|NCT01215422|560847120|FG001|Overall Study|Failed intubations|0|||
155385448|NCT01215422|560847121|FG002|Overall Study|Failed intubations|3|||
155385449|NCT01215422|560847122|FG003|Overall Study|Failed intubations|8|||
155385450|NCT01215422|560847119|FG000|Overall Study|Did not complete all intubations|7|||
155385451|NCT01215422|560847120|FG001|Overall Study|Did not complete all intubations|0|||
155385452|NCT01215422|560847121|FG002|Overall Study|Did not complete all intubations|0|||
155385453|NCT01215422|560847122|FG003|Overall Study|Did not complete all intubations|0|||
155385454|NCT01729156|560847123|FG000|Overall Study|Withdrawal by Subject|1|||
155385455|NCT01729156|560847124|FG001|Overall Study|Withdrawal by Subject|0|||
155385456|NCT01729156|560847125|FG002|Overall Study|Withdrawal by Subject|0|||
155385457|NCT01386788|560847130|FG000|Overall Study|Lost to Follow-up|2|||
155385458|NCT00462865|560847133|FG000|Overall Study|Adverse Event|1|||
155385459|NCT02120625|560847134|FG000|Overall Study|Physician Decision|2|||
155385460|NCT00120406|560847135|FG000|Overall Study|Death|9|||
155385461|NCT00120406|560847136|FG001|Overall Study|Death|4|||
155385462|NCT00120406|560847135|FG000|Overall Study|Withdrawal by Subject|5|||
155385463|NCT00120406|560847136|FG001|Overall Study|Withdrawal by Subject|7|||
155385464|NCT00120406|560847135|FG000|Overall Study|Lost to Follow-up|5|||
155385465|NCT00120406|560847136|FG001|Overall Study|Lost to Follow-up|2|||
155385466|NCT00120406|560847135|FG000|Overall Study|received non-study stent|0|||
155385467|NCT00120406|560847136|FG001|Overall Study|received non-study stent|2|||
155385468|NCT00120406|560847135|FG000|Overall Study|patient moved but has not withdrawn|0|||
155385469|NCT00120406|560847136|FG001|Overall Study|patient moved but has not withdrawn|1|||
155385470|NCT06336603|560847137|FG000|Overall Study|Withdrawal by Subject|1|||
155385471|NCT06336603|560847137|FG000|Overall Study|Lost to Follow-up|2|||
155385472|NCT00762970|560847143|FG000|Overall Study|Withdrawal by Subject|7|||
155385473|NCT00762970|560847144|FG001|Overall Study|Withdrawal by Subject|4|||
155385474|NCT00762970|560847145|FG002|Overall Study|Withdrawal by Subject|0|||
155385475|NCT00762970|560847143|FG000|Overall Study|Protocol Violation|3|||
155385476|NCT00762970|560847144|FG001|Overall Study|Protocol Violation|1|||
155385477|NCT00762970|560847145|FG002|Overall Study|Protocol Violation|1|||
155385478|NCT00762970|560847143|FG000|Overall Study|Lost to Follow-up|1|||
155385479|NCT00762970|560847144|FG001|Overall Study|Lost to Follow-up|2|||
155385480|NCT00762970|560847145|FG002|Overall Study|Lost to Follow-up|0|||
155385481|NCT00762970|560847143|FG000|Overall Study|Difficulty of handling lens|1|||
155385482|NCT00762970|560847144|FG001|Overall Study|Difficulty of handling lens|2|||
155385483|NCT00762970|560847145|FG002|Overall Study|Difficulty of handling lens|0|||
155385484|NCT01295034|560847146|FG000|Overall Study|Lost to Follow-up|5|||
155385485|NCT01295034|560847147|FG001|Overall Study|Lost to Follow-up|5|||
155385486|NCT00879762|560847148|FG000|Overall Study|Lost to Follow-up|3|||
155385487|NCT00879762|560847149|FG001|Overall Study|Lost to Follow-up|1|||
155385488|NCT01313637|560847154|FG000|Overall Study|Adverse Event|17|||
155385489|NCT01313637|560847155|FG001|Overall Study|Adverse Event|24|||
155385490|NCT01313637|560847156|FG002|Overall Study|Adverse Event|25|||
155385491|NCT01313637|560847157|FG003|Overall Study|Adverse Event|18|||
155385492|NCT01313637|560847154|FG000|Overall Study|Lack of Efficacy|44|||
155385493|NCT01313637|560847155|FG001|Overall Study|Lack of Efficacy|38|||
155385494|NCT01313637|560847156|FG002|Overall Study|Lack of Efficacy|37|||
155385495|NCT01313637|560847157|FG003|Overall Study|Lack of Efficacy|24|||
155385496|NCT01313637|560847154|FG000|Overall Study|Protocol Violation|4|||
155385497|NCT01313637|560847155|FG001|Overall Study|Protocol Violation|3|||
155385498|NCT01313637|560847156|FG002|Overall Study|Protocol Violation|11|||
155385499|NCT01313637|560847157|FG003|Overall Study|Protocol Violation|5|||
155385500|NCT01313637|560847154|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
155385501|NCT01313637|560847155|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
155385502|NCT01313637|560847156|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
155385503|NCT01313637|560847157|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
155385504|NCT01313637|560847154|FG000|Overall Study|Lost to Follow-up|0|||
155385505|NCT01313637|560847155|FG001|Overall Study|Lost to Follow-up|2|||
155385506|NCT01313637|560847156|FG002|Overall Study|Lost to Follow-up|1|||
155385507|NCT01313637|560847157|FG003|Overall Study|Lost to Follow-up|3|||
155385508|NCT01313637|560847154|FG000|Overall Study|Withdrawal by Subject|11|||
155385509|NCT01313637|560847155|FG001|Overall Study|Withdrawal by Subject|13|||
155385510|NCT01313637|560847156|FG002|Overall Study|Withdrawal by Subject|18|||
155385511|NCT01313637|560847157|FG003|Overall Study|Withdrawal by Subject|15|||
155385512|NCT00795951|560847163|FG000|Overall Study|Lost to Follow-up|1|||
155385513|NCT00795951|560847163|FG000|Overall Study|Withdrawal by Subject|1|||
155279423|NCT03259373|560456246|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
155279424|NCT03259373|560456247|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
155279425|NCT05893797|560456248|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
155279426|NCT05893797|560456248|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
155279427|NCT05893797|560456248|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
155279428|NCT05893797|560456248|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
155279429|NCT04770220|560456249|FG000|Overall Study|Adverse Event|2|||
155279430|NCT04770220|560456250|FG001|Overall Study|Adverse Event|11|||
155279431|NCT04770220|560456249|FG000|Overall Study|Withdrawal by Subject|5|||
155279432|NCT04770220|560456250|FG001|Overall Study|Withdrawal by Subject|11|||
155279433|NCT04770220|560456249|FG000|Overall Study|Lost to Follow-up|4|||
155279434|NCT04770220|560456250|FG001|Overall Study|Lost to Follow-up|3|||
155279435|NCT04770220|560456249|FG000|Overall Study|not otherwise specified|2|||
155279436|NCT04770220|560456250|FG001|Overall Study|not otherwise specified|3|||
155279437|NCT04770220|560456249|FG000|Overall Study|Physician Decision|1|||
155279438|NCT04770220|560456250|FG001|Overall Study|Physician Decision|3|||
155279439|NCT04894903|560456252|FG000|Overall Study|Death|1|||
155279440|NCT04894903|560456253|FG001|Overall Study|Death|0|||
154944146|NCT00358826|559220898|FG007|Core Study|Physician Decision|0|||
155279441|NCT04894903|560456252|FG000|Overall Study|Pregnancy|1|||
155279442|NCT04894903|560456253|FG001|Overall Study|Pregnancy|0|||
155279443|NCT04894903|560456252|FG000|Overall Study|Withdrawal by Subject|1|||
155279444|NCT04894903|560456253|FG001|Overall Study|Withdrawal by Subject|1|||
155279445|NCT04894903|560456252|FG000|Overall Study|moved or exited health system|1|||
155279446|NCT04894903|560456253|FG001|Overall Study|moved or exited health system|3|||
155279447|NCT01822353|560456254|FG000|Overall Study|Adverse Event|1|||
155279448|NCT01822353|560456255|FG001|Overall Study|Adverse Event|3|||
155279449|NCT01822353|560456256|FG002|Overall Study|Adverse Event|1|||
155279450|NCT01822353|560456254|FG000|Overall Study|Pregnancy|0|||
155279451|NCT01822353|560456255|FG001|Overall Study|Pregnancy|1|||
155279452|NCT01822353|560456256|FG002|Overall Study|Pregnancy|0|||
155279453|NCT01822353|560456254|FG000|Overall Study|Withdrawal by Subject|3|||
155279454|NCT01822353|560456255|FG001|Overall Study|Withdrawal by Subject|1|||
155279455|NCT01822353|560456256|FG002|Overall Study|Withdrawal by Subject|0|||
155279456|NCT04320615|560456257|FG000|Overall Study|Withdrawal by Subject|4|||
155279457|NCT04320615|560456258|FG001|Overall Study|Withdrawal by Subject|10|||
155279458|NCT04320615|560456257|FG000|Overall Study|Physician Decision|2|||
155279459|NCT04320615|560456258|FG001|Overall Study|Physician Decision|0|||
155279460|NCT04320615|560456257|FG000|Overall Study|Other|2|||
155279461|NCT04320615|560456258|FG001|Overall Study|Other|0|||
155279462|NCT04320615|560456257|FG000|Overall Study|Lost to Follow-up|5|||
155279463|NCT04320615|560456258|FG001|Overall Study|Lost to Follow-up|23|||
155279464|NCT04320615|560456257|FG000|Overall Study|Death|35|||
155279465|NCT04320615|560456258|FG001|Overall Study|Death|71|||
155279466|NCT01857323|560456260|FG000|Overall Study|Adverse Event|1|||
155279467|NCT01857323|560456260|FG000|Overall Study|Withdrawal by Subject|3|||
155279468|NCT01857323|560456260|FG000|Overall Study|Non-compliance|1|||
155279469|NCT01857323|560456260|FG000|Overall Study|Protocol Violation|6|||
155279470|NCT01857323|560456260|FG000|Overall Study|Lost to Follow-up|1|||
155279471|NCT01857323|560456260|FG000|Overall Study|Other|4|||
155279472|NCT01857323|560456260|FG000|Overall Study|Did not complete 180 doses|48|||
155279473|NCT03873246|560456261|FG000|Overall Study|Adverse Event|1|||
155279474|NCT03873246|560456262|FG001|Overall Study|Adverse Event|3|||
155279475|NCT03873246|560456263|FG002|Overall Study|Adverse Event|3|||
155279476|NCT03873246|560456261|FG000|Overall Study|Lost to Follow-up|4|||
155279477|NCT03873246|560456262|FG001|Overall Study|Lost to Follow-up|4|||
155279478|NCT03873246|560456263|FG002|Overall Study|Lost to Follow-up|5|||
155279479|NCT03873246|560456261|FG000|Overall Study|Protocol Violation|0|||
155279480|NCT03873246|560456262|FG001|Overall Study|Protocol Violation|1|||
155279481|NCT03873246|560456263|FG002|Overall Study|Protocol Violation|0|||
155279482|NCT03873246|560456261|FG000|Overall Study|Withdrawal by Subject|0|||
155279483|NCT03873246|560456262|FG001|Overall Study|Withdrawal by Subject|4|||
155279484|NCT03873246|560456263|FG002|Overall Study|Withdrawal by Subject|1|||
155279485|NCT02107443|560456264|FG000|Overall Study|Death|42|||
155279486|NCT02107443|560456265|FG001|Overall Study|Death|30|||
155279487|NCT02107443|560456264|FG000|Overall Study|Study Protocol Violation|3|||
155279488|NCT02107443|560456265|FG001|Overall Study|Study Protocol Violation|1|||
155279489|NCT02107443|560456264|FG000|Overall Study|Registered but Not Eligible|0|||
155279490|NCT02107443|560456265|FG001|Overall Study|Registered but Not Eligible|1|||
155279491|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
155279492|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
155279493|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
155279494|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
155279495|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Changed Mind|2|||
155279496|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Changed Mind|0|||
155279497|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
155279498|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
155279499|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
155385514|NCT04572841|560847164|FG000|Overall Study|Adverse Event|1|||
155385515|NCT04572841|560847165|FG001|Overall Study|Adverse Event|1|||
155385516|NCT04572841|560847164|FG000|Overall Study|Withdrawal by Subject|2|||
155385517|NCT04572841|560847165|FG001|Overall Study|Withdrawal by Subject|1|||
155385518|NCT01323647|560847168|FG000|Overall Study|Migrated/moved from study area|2|||
155385519|NCT01323647|560847169|FG001|Overall Study|Migrated/moved from study area|0|||
155385520|NCT01323647|560847168|FG000|Overall Study|Withdrawal by Subject|5|||
155385521|NCT01323647|560847169|FG001|Overall Study|Withdrawal by Subject|0|||
155385522|NCT01323647|560847168|FG000|Overall Study|Lost to Follow-up|2|||
155385523|NCT01323647|560847169|FG001|Overall Study|Lost to Follow-up|0|||
155385524|NCT00712673|560847170|FG000|Overall Study|Adverse Event|3|||
155385525|NCT00712673|560847171|FG001|Overall Study|Adverse Event|3|||
155385526|NCT00712673|560847172|FG002|Overall Study|Adverse Event|21|||
155385527|NCT00712673|560847173|FG003|Overall Study|Adverse Event|26|||
155385528|NCT00712673|560847170|FG000|Overall Study|Lack of Efficacy|2|||
155385529|NCT00712673|560847171|FG001|Overall Study|Lack of Efficacy|8|||
155385530|NCT00712673|560847172|FG002|Overall Study|Lack of Efficacy|8|||
155385531|NCT00712673|560847173|FG003|Overall Study|Lack of Efficacy|6|||
155385532|NCT00712673|560847170|FG000|Overall Study|Poor Compliance to Protocol|3|||
155385533|NCT00712673|560847171|FG001|Overall Study|Poor Compliance to Protocol|3|||
155385534|NCT00712673|560847172|FG002|Overall Study|Poor Compliance to Protocol|4|||
155385535|NCT00712673|560847173|FG003|Overall Study|Poor Compliance to Protocol|16|||
155385536|NCT00712673|560847170|FG000|Overall Study|Lost to Follow-up|1|||
155385537|NCT00712673|560847171|FG001|Overall Study|Lost to Follow-up|0|||
155385538|NCT00712673|560847172|FG002|Overall Study|Lost to Follow-up|2|||
155385539|NCT00712673|560847173|FG003|Overall Study|Lost to Follow-up|0|||
155385540|NCT00712673|560847170|FG000|Overall Study|Withdrawal by Subject|6|||
155385541|NCT00712673|560847171|FG001|Overall Study|Withdrawal by Subject|7|||
155385542|NCT00712673|560847172|FG002|Overall Study|Withdrawal by Subject|15|||
155385543|NCT00712673|560847173|FG003|Overall Study|Withdrawal by Subject|20|||
155385544|NCT00712673|560847170|FG000|Overall Study|Familial and Personal Reasons|5|||
155385545|NCT00712673|560847171|FG001|Overall Study|Familial and Personal Reasons|0|||
155385546|NCT00712673|560847172|FG002|Overall Study|Familial and Personal Reasons|5|||
155385547|NCT00712673|560847173|FG003|Overall Study|Familial and Personal Reasons|2|||
155385548|NCT00712673|560847170|FG000|Overall Study|Investigator's Decision|1|||
155385549|NCT00712673|560847171|FG001|Overall Study|Investigator's Decision|0|||
155385550|NCT00712673|560847172|FG002|Overall Study|Investigator's Decision|0|||
155385551|NCT00712673|560847173|FG003|Overall Study|Investigator's Decision|0|||
155385552|NCT00712673|560847170|FG000|Overall Study|Protocol Violation|0|||
155385553|NCT00712673|560847171|FG001|Overall Study|Protocol Violation|0|||
155385554|NCT00712673|560847172|FG002|Overall Study|Protocol Violation|2|||
155385555|NCT00712673|560847173|FG003|Overall Study|Protocol Violation|0|||
155385556|NCT01774110|560847174|FG000|Overall Study|Lost to Follow-up|7|||
155385557|NCT00640016|560847175|FG000|Overall Study|Withdrawal by Subject|0|||
155385558|NCT00640016|560847176|FG001|Overall Study|Withdrawal by Subject|1|||
155385559|NCT00640016|560847177|FG002|Overall Study|Withdrawal by Subject|0|||
155385560|NCT00640016|560847178|FG003|Overall Study|Withdrawal by Subject|0|||
155385561|NCT00640016|560847175|FG000|Overall Study|Study termination|2|||
155385562|NCT00640016|560847176|FG001|Overall Study|Study termination|1|||
155385563|NCT00640016|560847177|FG002|Overall Study|Study termination|3|||
155385564|NCT00640016|560847178|FG003|Overall Study|Study termination|2|||
155385565|NCT00640016|560847175|FG000|Overall Study|Adverse Event|0|||
155385566|NCT00640016|560847176|FG001|Overall Study|Adverse Event|0|||
155385567|NCT00640016|560847177|FG002|Overall Study|Adverse Event|0|||
155385568|NCT00640016|560847178|FG003|Overall Study|Adverse Event|1|||
155385569|NCT02924064|560847180|FG000|Overall Study|Adverse Event|2|||
155385570|NCT02924064|560847181|FG001|Overall Study|Adverse Event|2|||
155385571|NCT02924064|560847180|FG000|Overall Study|Lost to Follow-up|0|||
155385572|NCT02924064|560847181|FG001|Overall Study|Lost to Follow-up|2|||
155385573|NCT02924064|560847180|FG000|Overall Study|Physician Decision|0|||
155385574|NCT02924064|560847181|FG001|Overall Study|Physician Decision|2|||
155385575|NCT02924064|560847180|FG000|Overall Study|Protocol Violation|1|||
155385576|NCT02924064|560847181|FG001|Overall Study|Protocol Violation|3|||
155385577|NCT02924064|560847180|FG000|Overall Study|Withdrawal by Subject|4|||
155385578|NCT02924064|560847181|FG001|Overall Study|Withdrawal by Subject|5|||
155385579|NCT02924064|560847180|FG000|Overall Study|Other|17|||
155385580|NCT02924064|560847181|FG001|Overall Study|Other|29|||
155385581|NCT02699983|560847182|FG000|Overall Study|Withdrawal by Subject|1|||
155385582|NCT02699983|560847183|FG001|Overall Study|Withdrawal by Subject|0|||
155385583|NCT03575143|560847184|FG000|Overall Study|Lost to Follow-up|0|||
155385584|NCT03575143|560847185|FG001|Overall Study|Lost to Follow-up|0|||
155385585|NCT03575143|560847186|FG002|Overall Study|Lost to Follow-up|4|||
155385586|NCT03575143|560847184|FG000|Overall Study|Withdrawal by Subject|0|||
155385587|NCT03575143|560847185|FG001|Overall Study|Withdrawal by Subject|0|||
155385588|NCT03575143|560847186|FG002|Overall Study|Withdrawal by Subject|5|||
155385589|NCT03575143|560847184|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
155385590|NCT03575143|560847185|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
155385591|NCT03575143|560847186|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
155385592|NCT00261846|560847189|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
155385593|NCT00261846|560847190|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
155385594|NCT00261846|560847191|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
155385595|NCT00261846|560847192|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385596|NCT00261846|560847193|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385597|NCT00261846|560847194|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385598|NCT00261846|560847195|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385599|NCT00261846|560847196|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385600|NCT00261846|560847197|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385601|NCT00261846|560847198|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385602|NCT00261846|560847199|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385603|NCT00261846|560847200|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
155385604|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385605|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385606|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385607|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
155385608|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385609|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385610|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385611|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385612|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
155385613|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385614|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385615|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
155385616|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385617|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385618|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385619|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
155385620|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
155385621|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
155385622|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
155385623|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
155385624|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385625|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
155385626|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385627|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
155385628|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385629|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385630|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385631|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
155385632|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385633|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385634|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385635|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385636|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
155385637|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385638|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
155385639|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
155385640|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
155385641|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
155385642|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
155385643|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
155385644|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
155385645|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
155385646|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
155385647|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
155385648|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
155385649|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
155385650|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
155385651|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
155385652|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
155385653|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
155385654|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
155385655|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
155045823|NCT05052697|559599411|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045824|NCT05052697|559599412|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045825|NCT05052697|559599413|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045826|NCT05052697|559599414|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155385656|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
155385657|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
155385658|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
155385659|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
155385660|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
155385661|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
155385662|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
155385663|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
155385664|NCT00261846|560847189|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385665|NCT00261846|560847190|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385666|NCT00261846|560847191|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385667|NCT00261846|560847192|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
155385668|NCT00261846|560847193|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
155385669|NCT00261846|560847194|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
155385670|NCT00261846|560847195|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
155385671|NCT00261846|560847196|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
155385672|NCT00261846|560847197|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
155385673|NCT00261846|560847198|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
155385674|NCT00261846|560847199|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
155385675|NCT00261846|560847200|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
155385676|NCT02294227|560847201|FG000|Overall Study|Death|0|||
155385677|NCT02294227|560847202|FG001|Overall Study|Death|0|||
155385678|NCT02294227|560847203|FG002|Overall Study|Death|1|||
155385679|NCT02294227|560847201|FG000|Overall Study|Subject/Guardian Decision|6|||
155385680|NCT02294227|560847202|FG001|Overall Study|Subject/Guardian Decision|3|||
155385681|NCT02294227|560847203|FG002|Overall Study|Subject/Guardian Decision|7|||
155385682|NCT02294227|560847201|FG000|Overall Study|Physician Decision|1|||
155385683|NCT02294227|560847202|FG001|Overall Study|Physician Decision|2|||
155385684|NCT02294227|560847203|FG002|Overall Study|Physician Decision|1|||
155385685|NCT02294227|560847201|FG000|Overall Study|Lost to Follow-up|1|||
155385686|NCT02294227|560847202|FG001|Overall Study|Lost to Follow-up|0|||
155385687|NCT02294227|560847203|FG002|Overall Study|Lost to Follow-up|0|||
155385688|NCT02294227|560847201|FG000|Overall Study|Lack of Efficacy|11|||
155385689|NCT02294227|560847202|FG001|Overall Study|Lack of Efficacy|12|||
155385690|NCT02294227|560847203|FG002|Overall Study|Lack of Efficacy|8|||
155385691|NCT02294227|560847201|FG000|Overall Study|Adverse Event|6|||
155385692|NCT02294227|560847202|FG001|Overall Study|Adverse Event|8|||
155385693|NCT02294227|560847203|FG002|Overall Study|Adverse Event|2|||
155385694|NCT00887432|560847206|FG000|Overall Study|Start Excluded Therapy|3|||
155385695|NCT00887432|560847207|FG001|Overall Study|Start Excluded Therapy|0|||
155385696|NCT00887432|560847206|FG000|Overall Study|Did not complete treatment|6|||
155385697|NCT00887432|560847207|FG001|Overall Study|Did not complete treatment|8|||
155385698|NCT00887432|560847206|FG000|Overall Study|Protocol Violation|2|||
155385699|NCT00887432|560847207|FG001|Overall Study|Protocol Violation|3|||
155385700|NCT00887432|560847206|FG000|Overall Study|Withdrawal by Subject|3|||
155385701|NCT00887432|560847207|FG001|Overall Study|Withdrawal by Subject|2|||
155385702|NCT00887432|560847206|FG000|Overall Study|Lost to Follow-up|1|||
155385703|NCT00887432|560847207|FG001|Overall Study|Lost to Follow-up|0|||
155385704|NCT00887432|560847206|FG000|Overall Study|No reason provided|0|||
155385705|NCT00887432|560847207|FG001|Overall Study|No reason provided|1|||
155385706|NCT00899548|560847208|FG000|Overall Study|Physician Decision|3|||
155385707|NCT04781387|560847212|FG000|Overall Study|Withdrawal by Subject|1|||
155385708|NCT04781387|560847213|FG001|Overall Study|Withdrawal by Subject|0|||
155385709|NCT04781387|560847214|FG002|Overall Study|Withdrawal by Subject|1|||
155385710|NCT04781387|560847212|FG000|Overall Study|Lost to Follow-up|1|||
155385711|NCT04781387|560847213|FG001|Overall Study|Lost to Follow-up|0|||
155385712|NCT04781387|560847214|FG002|Overall Study|Lost to Follow-up|0|||
155385713|NCT00679627|560847215|FG000|Overall Study|Death|41|||
155385714|NCT00679627|560847216|FG001|Overall Study|Death|29|||
155385715|NCT00679627|560847215|FG000|Overall Study|Adverse Event|43|||
155385716|NCT00679627|560847216|FG001|Overall Study|Adverse Event|53|||
155385717|NCT00679627|560847215|FG000|Overall Study|Withdrawal by Subject|168|||
155385718|NCT00679627|560847216|FG001|Overall Study|Withdrawal by Subject|172|||
155385719|NCT00679627|560847215|FG000|Overall Study|Lost to Follow-up|22|||
155385720|NCT00679627|560847216|FG001|Overall Study|Lost to Follow-up|26|||
155385721|NCT00679627|560847215|FG000|Overall Study|Early Study Closure|425|||
155385722|NCT00679627|560847216|FG001|Overall Study|Early Study Closure|405|||
155385723|NCT00448123|560847217|FG000|Overall Study|Lost to Follow-up|9|||
155385724|NCT00448123|560847218|FG001|Overall Study|Lost to Follow-up|6|||
155385725|NCT00448123|560847217|FG000|Overall Study|Physician Decision|6|||
155385726|NCT00448123|560847218|FG001|Overall Study|Physician Decision|6|||
155385727|NCT02318797|560847219|FG000|Overall Study|Death|3|||
155385728|NCT02318797|560847220|FG001|Overall Study|Death|6|||
155385729|NCT02318797|560847219|FG000|Overall Study|Lost to Follow-up|85|||
155385730|NCT02318797|560847220|FG001|Overall Study|Lost to Follow-up|96|||
155385731|NCT01079741|560847226|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385732|NCT01079741|560847227|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
155385733|NCT01079741|560847228|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385734|NCT01079741|560847229|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385735|NCT01079741|560847230|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
155385736|NCT01079741|560847226|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385737|NCT01079741|560847227|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385738|NCT01079741|560847228|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385739|NCT01079741|560847229|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
155385740|NCT01079741|560847230|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
155385741|NCT00511472|560847231|FG000|Overall Study|Clinical Adverse Event|1|||
155385742|NCT00511472|560847232|FG001|Overall Study|Clinical Adverse Event|2|||
155385743|NCT00511472|560847231|FG000|Overall Study|Laboratory Adverse Event|0|||
155385744|NCT00511472|560847232|FG001|Overall Study|Laboratory Adverse Event|2|||
155385745|NCT00511472|560847231|FG000|Overall Study|Not reported|2|||
155385746|NCT00511472|560847232|FG001|Overall Study|Not reported|2|||
155385747|NCT00446992|560847233|FG000|Overall Study|Adverse Event|11|||
155385748|NCT00446992|560847233|FG000|Overall Study|Lost to Follow-up|5|||
155385749|NCT00406653|560847234|FG000|Induction Period|Adverse Event|1|||
155385750|NCT00406653|560847235|FG001|Induction Period|Adverse Event|10|||
155385751|NCT00406653|560847236|FG002|Induction Period|Adverse Event|4|||
155385752|NCT00406653|560847237|FG003|Induction Period|Adverse Event|11|||
155385753|NCT00406653|560847238|FG004|Induction Period|Adverse Event|0|||
155385754|NCT00406653|560847239|FG005|Induction Period|Adverse Event|0|||
155385755|NCT00406653|560847240|FG006|Induction Period|Adverse Event|0|||
155385756|NCT00406653|560847234|FG000|Induction Period|Lack of Efficacy|11|||
155385757|NCT00406653|560847235|FG001|Induction Period|Lack of Efficacy|14|||
155385758|NCT00406653|560847236|FG002|Induction Period|Lack of Efficacy|8|||
155385759|NCT00406653|560847237|FG003|Induction Period|Lack of Efficacy|10|||
155385760|NCT00406653|560847238|FG004|Induction Period|Lack of Efficacy|0|||
155385761|NCT00406653|560847239|FG005|Induction Period|Lack of Efficacy|0|||
155385762|NCT00406653|560847240|FG006|Induction Period|Lack of Efficacy|0|||
155385763|NCT00406653|560847234|FG000|Induction Period|Lost to Follow-up|0|||
155385764|NCT00406653|560847235|FG001|Induction Period|Lost to Follow-up|2|||
155385765|NCT00406653|560847236|FG002|Induction Period|Lost to Follow-up|0|||
155385766|NCT00406653|560847237|FG003|Induction Period|Lost to Follow-up|0|||
155385767|NCT00406653|560847238|FG004|Induction Period|Lost to Follow-up|0|||
155385768|NCT00406653|560847239|FG005|Induction Period|Lost to Follow-up|0|||
155385769|NCT00406653|560847240|FG006|Induction Period|Lost to Follow-up|0|||
155385770|NCT00406653|560847234|FG000|Induction Period|Withdrawal of Consent|2|||
155385771|NCT00406653|560847235|FG001|Induction Period|Withdrawal of Consent|5|||
155385772|NCT00406653|560847236|FG002|Induction Period|Withdrawal of Consent|1|||
155385773|NCT00406653|560847237|FG003|Induction Period|Withdrawal of Consent|2|||
155385774|NCT00406653|560847238|FG004|Induction Period|Withdrawal of Consent|0|||
155385775|NCT00406653|560847239|FG005|Induction Period|Withdrawal of Consent|0|||
155385776|NCT00406653|560847240|FG006|Induction Period|Withdrawal of Consent|0|||
155385777|NCT00406653|560847234|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385778|NCT00406653|560847235|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385779|NCT00406653|560847236|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385780|NCT00406653|560847237|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
155385781|NCT00406653|560847238|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385782|NCT00406653|560847239|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385783|NCT00406653|560847240|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
155385784|NCT00406653|560847234|FG000|Induction Period|Pregnancy|1|||
155385785|NCT00406653|560847235|FG001|Induction Period|Pregnancy|0|||
155385786|NCT00406653|560847236|FG002|Induction Period|Pregnancy|0|||
155385787|NCT00406653|560847237|FG003|Induction Period|Pregnancy|0|||
155385788|NCT00406653|560847238|FG004|Induction Period|Pregnancy|0|||
155385789|NCT00406653|560847239|FG005|Induction Period|Pregnancy|0|||
155385790|NCT00406653|560847240|FG006|Induction Period|Pregnancy|0|||
155385791|NCT00406653|560847234|FG000|Induction Period|Declined participation but followup done|0|||
155385792|NCT00406653|560847235|FG001|Induction Period|Declined participation but followup done|2|||
155385793|NCT00406653|560847236|FG002|Induction Period|Declined participation but followup done|1|||
155385794|NCT00406653|560847237|FG003|Induction Period|Declined participation but followup done|1|||
155385795|NCT00406653|560847238|FG004|Induction Period|Declined participation but followup done|0|||
155385796|NCT00406653|560847239|FG005|Induction Period|Declined participation but followup done|0|||
155385797|NCT00406653|560847240|FG006|Induction Period|Declined participation but followup done|0|||
155385798|NCT00406653|560847234|FG000|Induction Period|Given prohibited drug|0|||
155385799|NCT00406653|560847235|FG001|Induction Period|Given prohibited drug|1|||
155385800|NCT00406653|560847236|FG002|Induction Period|Given prohibited drug|2|||
155385801|NCT00406653|560847237|FG003|Induction Period|Given prohibited drug|0|||
155385802|NCT00406653|560847238|FG004|Induction Period|Given prohibited drug|0|||
155385803|NCT00406653|560847239|FG005|Induction Period|Given prohibited drug|0|||
155385804|NCT00406653|560847240|FG006|Induction Period|Given prohibited drug|0|||
155385805|NCT00406653|560847234|FG000|Induction Period|Incarcerated|0|||
155385806|NCT00406653|560847235|FG001|Induction Period|Incarcerated|0|||
155385807|NCT00406653|560847236|FG002|Induction Period|Incarcerated|1|||
155385808|NCT00406653|560847237|FG003|Induction Period|Incarcerated|0|||
155279500|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
155279501|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
155279502|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
155279503|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
155279504|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
155279505|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Other Medical|9|||
155279506|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Other Medical|5|||
155279507|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Disease Progression|4|||
155279508|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Disease Progression|2|||
155279509|NCT02107443|560456264|FG000|Overall Study|Withdrawal: Personal Issues|0|||
155279510|NCT02107443|560456265|FG001|Overall Study|Withdrawal: Personal Issues|3|||
155279511|NCT00885495|560456266|FG000|Overall Study|Adverse Event|1|||
155279512|NCT00885495|560456267|FG001|Overall Study|Adverse Event|2|||
155279513|NCT00885495|560456266|FG000|Overall Study|Protocol Violation|0|||
155279514|NCT00885495|560456267|FG001|Overall Study|Protocol Violation|1|||
155279515|NCT00885495|560456266|FG000|Overall Study|Withdrawal by Subject|1|||
155279516|NCT00885495|560456267|FG001|Overall Study|Withdrawal by Subject|0|||
155279517|NCT01400893|560456268|FG000|Overall Study|Death|27|||
155279518|NCT01400893|560456269|FG001|Overall Study|Death|21|||
155279519|NCT01400893|560456268|FG000|Overall Study|Lost to Follow-up|0|||
155279520|NCT01400893|560456269|FG001|Overall Study|Lost to Follow-up|6|||
155279521|NCT00519636|560456270|FG000|Treatment Period 1|Adverse Event|1|||
155279522|NCT00519636|560456271|FG001|Treatment Period 1|Adverse Event|0|||
155279523|NCT00519636|560456272|FG002|Treatment Period 1|Adverse Event|1|||
155279524|NCT00519636|560456273|FG003|Treatment Period 1|Adverse Event|0|||
155279525|NCT00519636|560456270|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
155279526|NCT00519636|560456271|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
155279527|NCT00519636|560456272|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
155279528|NCT00519636|560456273|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
155279529|NCT00519636|560456270|FG000|Washout Period|Adverse Event|2|||
155279530|NCT00519636|560456271|FG001|Washout Period|Adverse Event|1|||
155279531|NCT00519636|560456272|FG002|Washout Period|Adverse Event|1|||
155279532|NCT00519636|560456273|FG003|Washout Period|Adverse Event|0|||
155279533|NCT00519636|560456270|FG000|Washout Period|Lost to Follow-up|1|||
155279534|NCT00519636|560456271|FG001|Washout Period|Lost to Follow-up|0|||
155279535|NCT00519636|560456272|FG002|Washout Period|Lost to Follow-up|0|||
155279536|NCT00519636|560456273|FG003|Washout Period|Lost to Follow-up|0|||
155279537|NCT00519636|560456270|FG000|Washout Period|Protocol Violation|0|||
155279538|NCT00519636|560456271|FG001|Washout Period|Protocol Violation|0|||
155279539|NCT00519636|560456272|FG002|Washout Period|Protocol Violation|1|||
155279540|NCT00519636|560456273|FG003|Washout Period|Protocol Violation|2|||
155279541|NCT00519636|560456270|FG000|Washout Period|Withdrawal by Subject|1|||
155279542|NCT00519636|560456271|FG001|Washout Period|Withdrawal by Subject|0|||
155279543|NCT00519636|560456272|FG002|Washout Period|Withdrawal by Subject|1|||
155279544|NCT00519636|560456273|FG003|Washout Period|Withdrawal by Subject|0|||
155279545|NCT00519636|560456270|FG000|Washout Period|Failed to meet continuation criteria|14|||
155279546|NCT00519636|560456271|FG001|Washout Period|Failed to meet continuation criteria|11|||
155279547|NCT00519636|560456272|FG002|Washout Period|Failed to meet continuation criteria|9|||
155279548|NCT00519636|560456273|FG003|Washout Period|Failed to meet continuation criteria|3|||
155279549|NCT00519636|560456270|FG000|Washout Period|Out of pollen area > 48 hours|1|||
155279550|NCT00519636|560456271|FG001|Washout Period|Out of pollen area > 48 hours|0|||
155279551|NCT00519636|560456272|FG002|Washout Period|Out of pollen area > 48 hours|0|||
155279552|NCT00519636|560456273|FG003|Washout Period|Out of pollen area > 48 hours|0|||
155279553|NCT00519636|560456270|FG000|Washout Period|Participating in study at another site|1|||
155279554|NCT00519636|560456271|FG001|Washout Period|Participating in study at another site|0|||
155279555|NCT00519636|560456272|FG002|Washout Period|Participating in study at another site|0|||
155279556|NCT00519636|560456273|FG003|Washout Period|Participating in study at another site|0|||
155279557|NCT00519636|560456270|FG000|Washout Period|Non-compliant|0|||
155279558|NCT00519636|560456271|FG001|Washout Period|Non-compliant|1|||
155279559|NCT00519636|560456272|FG002|Washout Period|Non-compliant|0|||
155279560|NCT00519636|560456273|FG003|Washout Period|Non-compliant|0|||
155279561|NCT00519636|560456270|FG000|Washout Period|Per doctors request|0|||
155279562|NCT00519636|560456271|FG001|Washout Period|Per doctors request|1|||
155279563|NCT00519636|560456272|FG002|Washout Period|Per doctors request|0|||
155279564|NCT00519636|560456273|FG003|Washout Period|Per doctors request|0|||
155279565|NCT00519636|560456270|FG000|Washout Period|Subject randomized in error|0|||
155279566|NCT00519636|560456271|FG001|Washout Period|Subject randomized in error|0|||
155279567|NCT00519636|560456272|FG002|Washout Period|Subject randomized in error|1|||
155279568|NCT00519636|560456273|FG003|Washout Period|Subject randomized in error|0|||
155279569|NCT00519636|560456270|FG000|Washout Period|Prohibited medications|0|||
155279570|NCT00519636|560456271|FG001|Washout Period|Prohibited medications|0|||
155279571|NCT00519636|560456272|FG002|Washout Period|Prohibited medications|1|||
155279572|NCT00519636|560456273|FG003|Washout Period|Prohibited medications|0|||
155279573|NCT00519636|560456270|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
155385809|NCT00406653|560847238|FG004|Induction Period|Incarcerated|0|||
155385810|NCT00406653|560847239|FG005|Induction Period|Incarcerated|0|||
155385811|NCT00406653|560847240|FG006|Induction Period|Incarcerated|0|||
155385812|NCT00406653|560847234|FG000|Induction Period|Patient relocated|0|||
155385813|NCT00406653|560847235|FG001|Induction Period|Patient relocated|0|||
155385814|NCT00406653|560847236|FG002|Induction Period|Patient relocated|1|||
155385815|NCT00406653|560847237|FG003|Induction Period|Patient relocated|0|||
155385816|NCT00406653|560847238|FG004|Induction Period|Patient relocated|0|||
155385817|NCT00406653|560847239|FG005|Induction Period|Patient relocated|0|||
155385818|NCT00406653|560847240|FG006|Induction Period|Patient relocated|0|||
155385819|NCT00406653|560847234|FG000|Maintenance Period|Adverse Event|0|||
155385820|NCT00406653|560847235|FG001|Maintenance Period|Adverse Event|0|||
155385821|NCT00406653|560847236|FG002|Maintenance Period|Adverse Event|0|||
155385822|NCT00406653|560847237|FG003|Maintenance Period|Adverse Event|0|||
155385823|NCT00406653|560847238|FG004|Maintenance Period|Adverse Event|1|||
155385824|NCT00406653|560847239|FG005|Maintenance Period|Adverse Event|1|||
155385825|NCT00406653|560847240|FG006|Maintenance Period|Adverse Event|0|||
155385826|NCT00406653|560847234|FG000|Maintenance Period|Lack of Efficacy|0|||
155385827|NCT00406653|560847235|FG001|Maintenance Period|Lack of Efficacy|0|||
155385828|NCT00406653|560847236|FG002|Maintenance Period|Lack of Efficacy|0|||
155385829|NCT00406653|560847237|FG003|Maintenance Period|Lack of Efficacy|0|||
155385830|NCT00406653|560847238|FG004|Maintenance Period|Lack of Efficacy|20|||
155385831|NCT00406653|560847239|FG005|Maintenance Period|Lack of Efficacy|26|||
155385832|NCT00406653|560847240|FG006|Maintenance Period|Lack of Efficacy|0|||
155385833|NCT00406653|560847234|FG000|Maintenance Period|Lost to Follow-up|0|||
155385834|NCT00406653|560847235|FG001|Maintenance Period|Lost to Follow-up|0|||
155385835|NCT00406653|560847236|FG002|Maintenance Period|Lost to Follow-up|0|||
155385836|NCT00406653|560847237|FG003|Maintenance Period|Lost to Follow-up|0|||
155385837|NCT00406653|560847238|FG004|Maintenance Period|Lost to Follow-up|2|||
155385838|NCT00406653|560847239|FG005|Maintenance Period|Lost to Follow-up|1|||
155385839|NCT00406653|560847240|FG006|Maintenance Period|Lost to Follow-up|0|||
155385840|NCT00406653|560847234|FG000|Maintenance Period|Withdrawal of Consent|0|||
155385841|NCT00406653|560847235|FG001|Maintenance Period|Withdrawal of Consent|0|||
155385842|NCT00406653|560847236|FG002|Maintenance Period|Withdrawal of Consent|0|||
155385843|NCT00406653|560847237|FG003|Maintenance Period|Withdrawal of Consent|0|||
155385844|NCT00406653|560847238|FG004|Maintenance Period|Withdrawal of Consent|2|||
155385845|NCT00406653|560847239|FG005|Maintenance Period|Withdrawal of Consent|0|||
155385846|NCT00406653|560847240|FG006|Maintenance Period|Withdrawal of Consent|0|||
155385847|NCT00406653|560847234|FG000|Maintenance Period|Pregnancy|0|||
155385848|NCT00406653|560847235|FG001|Maintenance Period|Pregnancy|0|||
155385849|NCT00406653|560847236|FG002|Maintenance Period|Pregnancy|0|||
155385850|NCT00406653|560847237|FG003|Maintenance Period|Pregnancy|0|||
155385851|NCT00406653|560847238|FG004|Maintenance Period|Pregnancy|0|||
155385852|NCT00406653|560847239|FG005|Maintenance Period|Pregnancy|1|||
155385853|NCT00406653|560847240|FG006|Maintenance Period|Pregnancy|0|||
155385854|NCT00406653|560847234|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
155385855|NCT00406653|560847235|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
155385856|NCT00406653|560847236|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
155385857|NCT00406653|560847237|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
155385858|NCT00406653|560847238|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
155385859|NCT00406653|560847239|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
155385860|NCT00406653|560847240|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
155385861|NCT00406653|560847234|FG000|Maintenance Period|Error in disease score evaluation|0|||
155385862|NCT00406653|560847235|FG001|Maintenance Period|Error in disease score evaluation|0|||
155385863|NCT00406653|560847236|FG002|Maintenance Period|Error in disease score evaluation|0|||
155385864|NCT00406653|560847237|FG003|Maintenance Period|Error in disease score evaluation|0|||
155385865|NCT00406653|560847238|FG004|Maintenance Period|Error in disease score evaluation|1|||
155385866|NCT00406653|560847239|FG005|Maintenance Period|Error in disease score evaluation|0|||
155385867|NCT00406653|560847240|FG006|Maintenance Period|Error in disease score evaluation|0|||
155385868|NCT00406653|560847234|FG000|Open-Label Period|Death|0|||
155385869|NCT00406653|560847235|FG001|Open-Label Period|Death|0|||
155385870|NCT00406653|560847236|FG002|Open-Label Period|Death|0|||
155385871|NCT00406653|560847237|FG003|Open-Label Period|Death|0|||
155385872|NCT00406653|560847238|FG004|Open-Label Period|Death|0|||
155385873|NCT00406653|560847239|FG005|Open-Label Period|Death|0|||
155385874|NCT00406653|560847240|FG006|Open-Label Period|Death|1|||
155385875|NCT00406653|560847234|FG000|Open-Label Period|Adverse Event|0|||
155385876|NCT00406653|560847235|FG001|Open-Label Period|Adverse Event|0|||
155385877|NCT00406653|560847236|FG002|Open-Label Period|Adverse Event|0|||
155385878|NCT00406653|560847237|FG003|Open-Label Period|Adverse Event|0|||
155385879|NCT00406653|560847238|FG004|Open-Label Period|Adverse Event|0|||
155385880|NCT00406653|560847239|FG005|Open-Label Period|Adverse Event|0|||
155385881|NCT00406653|560847240|FG006|Open-Label Period|Adverse Event|18|||
155385882|NCT00406653|560847234|FG000|Open-Label Period|Lack of Efficacy|0|||
155385883|NCT00406653|560847235|FG001|Open-Label Period|Lack of Efficacy|0|||
155385884|NCT00406653|560847236|FG002|Open-Label Period|Lack of Efficacy|0|||
155385885|NCT00406653|560847237|FG003|Open-Label Period|Lack of Efficacy|0|||
155385886|NCT00406653|560847238|FG004|Open-Label Period|Lack of Efficacy|0|||
155385887|NCT00406653|560847239|FG005|Open-Label Period|Lack of Efficacy|0|||
155385888|NCT00406653|560847240|FG006|Open-Label Period|Lack of Efficacy|160|||
155385889|NCT00406653|560847234|FG000|Open-Label Period|Lost to Follow-up|0|||
155385890|NCT00406653|560847235|FG001|Open-Label Period|Lost to Follow-up|0|||
155385891|NCT00406653|560847236|FG002|Open-Label Period|Lost to Follow-up|0|||
155385892|NCT00406653|560847237|FG003|Open-Label Period|Lost to Follow-up|0|||
155385893|NCT00406653|560847238|FG004|Open-Label Period|Lost to Follow-up|0|||
155385894|NCT00406653|560847239|FG005|Open-Label Period|Lost to Follow-up|0|||
155385895|NCT00406653|560847240|FG006|Open-Label Period|Lost to Follow-up|6|||
155385896|NCT00406653|560847234|FG000|Open-Label Period|Withdrawal of Consent|0|||
155385897|NCT00406653|560847235|FG001|Open-Label Period|Withdrawal of Consent|0|||
155385898|NCT00406653|560847236|FG002|Open-Label Period|Withdrawal of Consent|0|||
155385899|NCT00406653|560847237|FG003|Open-Label Period|Withdrawal of Consent|0|||
155385900|NCT00406653|560847238|FG004|Open-Label Period|Withdrawal of Consent|0|||
155385901|NCT00406653|560847239|FG005|Open-Label Period|Withdrawal of Consent|0|||
155385902|NCT00406653|560847240|FG006|Open-Label Period|Withdrawal of Consent|11|||
155385903|NCT00406653|560847234|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385904|NCT00406653|560847235|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385905|NCT00406653|560847236|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385906|NCT00406653|560847237|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385907|NCT00406653|560847238|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385908|NCT00406653|560847239|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
155385909|NCT00406653|560847240|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
155385910|NCT00406653|560847234|FG000|Open-Label Period|Pregnancy|0|||
155385911|NCT00406653|560847235|FG001|Open-Label Period|Pregnancy|0|||
155385912|NCT00406653|560847236|FG002|Open-Label Period|Pregnancy|0|||
155385913|NCT00406653|560847237|FG003|Open-Label Period|Pregnancy|0|||
155385914|NCT00406653|560847238|FG004|Open-Label Period|Pregnancy|0|||
155385915|NCT00406653|560847239|FG005|Open-Label Period|Pregnancy|0|||
155385916|NCT00406653|560847240|FG006|Open-Label Period|Pregnancy|2|||
155385917|NCT00406653|560847234|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
155385918|NCT00406653|560847235|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
155385919|NCT00406653|560847236|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
155385920|NCT00406653|560847237|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
155385921|NCT00406653|560847238|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
155385922|NCT00406653|560847239|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
155385923|NCT00406653|560847240|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
155385924|NCT00406653|560847234|FG000|Open-Label Period|Declined participation but followup done|0|||
155385925|NCT00406653|560847235|FG001|Open-Label Period|Declined participation but followup done|0|||
155385926|NCT00406653|560847236|FG002|Open-Label Period|Declined participation but followup done|0|||
155385927|NCT00406653|560847237|FG003|Open-Label Period|Declined participation but followup done|0|||
155385928|NCT00406653|560847238|FG004|Open-Label Period|Declined participation but followup done|0|||
155385929|NCT00406653|560847239|FG005|Open-Label Period|Declined participation but followup done|0|||
155385930|NCT00406653|560847240|FG006|Open-Label Period|Declined participation but followup done|8|||
155385931|NCT00406653|560847234|FG000|Open-Label Period|Discontinued by Sponsor|0|||
155385932|NCT00406653|560847235|FG001|Open-Label Period|Discontinued by Sponsor|0|||
155385933|NCT00406653|560847236|FG002|Open-Label Period|Discontinued by Sponsor|0|||
155385934|NCT00406653|560847237|FG003|Open-Label Period|Discontinued by Sponsor|0|||
155385935|NCT00406653|560847238|FG004|Open-Label Period|Discontinued by Sponsor|0|||
155385936|NCT00406653|560847239|FG005|Open-Label Period|Discontinued by Sponsor|0|||
155385937|NCT00406653|560847240|FG006|Open-Label Period|Discontinued by Sponsor|1|||
155385938|NCT00406653|560847234|FG000|Open-Label Period|Refused followup|0|||
155385939|NCT00406653|560847235|FG001|Open-Label Period|Refused followup|0|||
155385940|NCT00406653|560847236|FG002|Open-Label Period|Refused followup|0|||
155385941|NCT00406653|560847237|FG003|Open-Label Period|Refused followup|0|||
155385942|NCT00406653|560847238|FG004|Open-Label Period|Refused followup|0|||
155385943|NCT00406653|560847239|FG005|Open-Label Period|Refused followup|0|||
155385944|NCT00406653|560847240|FG006|Open-Label Period|Refused followup|1|||
155385945|NCT00940108|560847241|FG000|Overall Study|Adverse Event|2|||
155385946|NCT00940108|560847242|FG001|Overall Study|Adverse Event|4|||
155385947|NCT00940108|560847243|FG002|Overall Study|Adverse Event|0|||
155385948|NCT00940108|560847244|FG003|Overall Study|Adverse Event|2|||
155385949|NCT00940108|560847241|FG000|Overall Study|Withdrew Consent|2|||
155385950|NCT00940108|560847242|FG001|Overall Study|Withdrew Consent|1|||
155385951|NCT00940108|560847243|FG002|Overall Study|Withdrew Consent|0|||
155385952|NCT00940108|560847244|FG003|Overall Study|Withdrew Consent|1|||
155385953|NCT00940108|560847241|FG000|Overall Study|Dose 2 contraindicated|1|||
155385954|NCT00940108|560847242|FG001|Overall Study|Dose 2 contraindicated|1|||
155385955|NCT00940108|560847243|FG002|Overall Study|Dose 2 contraindicated|0|||
155385956|NCT00940108|560847244|FG003|Overall Study|Dose 2 contraindicated|1|||
155385957|NCT00940108|560847241|FG000|Overall Study|Declined further vaccination|0|||
155385958|NCT00940108|560847242|FG001|Overall Study|Declined further vaccination|1|||
155385959|NCT00940108|560847243|FG002|Overall Study|Declined further vaccination|3|||
155385960|NCT00940108|560847244|FG003|Overall Study|Declined further vaccination|0|||
155385961|NCT00940108|560847241|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
155385962|NCT00940108|560847242|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
155385963|NCT00940108|560847243|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
155385964|NCT00940108|560847244|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
155385965|NCT00940108|560847241|FG000|Overall Study|Viral illness after Dose 1|0|||
155385966|NCT00940108|560847242|FG001|Overall Study|Viral illness after Dose 1|1|||
155385967|NCT00940108|560847243|FG002|Overall Study|Viral illness after Dose 1|0|||
155385968|NCT00940108|560847244|FG003|Overall Study|Viral illness after Dose 1|0|||
155385969|NCT00940108|560847241|FG000|Overall Study|Diagnosed with H1N1|0|||
155385970|NCT00940108|560847242|FG001|Overall Study|Diagnosed with H1N1|0|||
155385971|NCT00940108|560847243|FG002|Overall Study|Diagnosed with H1N1|0|||
155385972|NCT00940108|560847244|FG003|Overall Study|Diagnosed with H1N1|1|||
155385973|NCT01668667|560847245|FG000|Overall Study|Adverse Event|3|||
155385974|NCT01668667|560847246|FG001|Overall Study|Adverse Event|6|||
155385975|NCT01668667|560847247|FG002|Overall Study|Adverse Event|4|||
155385976|NCT01668667|560847248|FG003|Overall Study|Adverse Event|4|||
155385977|NCT01668667|560847245|FG000|Overall Study|Lack of Efficacy|3|||
155385978|NCT01668667|560847246|FG001|Overall Study|Lack of Efficacy|2|||
155385979|NCT01668667|560847247|FG002|Overall Study|Lack of Efficacy|2|||
155385980|NCT01668667|560847248|FG003|Overall Study|Lack of Efficacy|3|||
155385981|NCT01668667|560847245|FG000|Overall Study|Protocol Violation|6|||
155385982|NCT01668667|560847246|FG001|Overall Study|Protocol Violation|10|||
155385983|NCT01668667|560847247|FG002|Overall Study|Protocol Violation|12|||
155385984|NCT01668667|560847248|FG003|Overall Study|Protocol Violation|5|||
155385985|NCT01668667|560847245|FG000|Overall Study|Lost to Follow-up|9|||
155385986|NCT01668667|560847246|FG001|Overall Study|Lost to Follow-up|4|||
155385987|NCT01668667|560847247|FG002|Overall Study|Lost to Follow-up|7|||
155385988|NCT01668667|560847248|FG003|Overall Study|Lost to Follow-up|6|||
155385989|NCT01668667|560847245|FG000|Overall Study|Physician Decision|3|||
155385990|NCT01668667|560847246|FG001|Overall Study|Physician Decision|0|||
155385991|NCT01668667|560847247|FG002|Overall Study|Physician Decision|1|||
155385992|NCT01668667|560847248|FG003|Overall Study|Physician Decision|0|||
155385993|NCT01668667|560847245|FG000|Overall Study|Withdrawal by Subject|7|||
155385994|NCT01668667|560847246|FG001|Overall Study|Withdrawal by Subject|4|||
155385995|NCT01668667|560847247|FG002|Overall Study|Withdrawal by Subject|5|||
155385996|NCT01668667|560847248|FG003|Overall Study|Withdrawal by Subject|5|||
155385997|NCT04576455|560847249|FG000|Overall Study|Ongoing in the Study|48|||
155385998|NCT04576455|560847250|FG001|Overall Study|Ongoing in the Study|58|||
155385999|NCT04576455|560847249|FG000|Overall Study|Death|83|||
155386000|NCT04576455|560847250|FG001|Overall Study|Death|77|||
155386001|NCT04576455|560847249|FG000|Overall Study|Lost to Follow-up|4|||
155386002|NCT04576455|560847250|FG001|Overall Study|Lost to Follow-up|5|||
155386003|NCT04576455|560847249|FG000|Overall Study|Withdrawal by Subject|16|||
155386004|NCT04576455|560847250|FG001|Overall Study|Withdrawal by Subject|12|||
155386005|NCT01256658|560849010|FG000|Period 1|Lost to Follow-up|837|||
155386006|NCT01256658|560849011|FG001|Period 1|Lost to Follow-up|661|||
155386007|NCT01256658|560849010|FG000|Period 1|Withdrawal by Subject|35|||
155386008|NCT01256658|560849011|FG001|Period 1|Withdrawal by Subject|43|||
155386009|NCT01256658|560849010|FG000|Period 1|Death|48|||
155386010|NCT01256658|560849011|FG001|Period 1|Death|44|||
155386011|NCT00719563|560849016|FG000|Overall Study|Adverse Event|16|||
155386012|NCT00719563|560849017|FG001|Overall Study|Adverse Event|13|||
155386013|NCT00719563|560849016|FG000|Overall Study|Medical condition changed|3|||
155386014|NCT00719563|560849017|FG001|Overall Study|Medical condition changed|5|||
155386015|NCT00719563|560849016|FG000|Overall Study|Lack of Efficacy|3|||
155386016|NCT00719563|560849017|FG001|Overall Study|Lack of Efficacy|7|||
155386017|NCT00719563|560849016|FG000|Overall Study|Personal reasons|6|||
155386018|NCT00719563|560849017|FG001|Overall Study|Personal reasons|7|||
155045827|NCT05052697|559599415|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155386019|NCT00719563|560849016|FG000|Overall Study|Unknown reasons|4|||
155386020|NCT00719563|560849017|FG001|Overall Study|Unknown reasons|6|||
155386021|NCT00719563|560849016|FG000|Overall Study|Noncompliant|1|||
155386022|NCT00719563|560849017|FG001|Overall Study|Noncompliant|1|||
155386023|NCT00719563|560849016|FG000|Overall Study|Lost to Follow-up|5|||
155386024|NCT00719563|560849017|FG001|Overall Study|Lost to Follow-up|3|||
155386025|NCT02986334|560849019|FG000|Overall Study|Withdrawal by Subject|0|||
155386026|NCT02986334|560849020|FG001|Overall Study|Withdrawal by Subject|1|||
155386027|NCT02986334|560849021|FG002|Overall Study|Withdrawal by Subject|2|||
155386028|NCT02986334|560849019|FG000|Overall Study|Lost to Follow-up|1|||
155386029|NCT02986334|560849020|FG001|Overall Study|Lost to Follow-up|2|||
155386030|NCT02986334|560849021|FG002|Overall Study|Lost to Follow-up|1|||
155386031|NCT02986334|560849019|FG000|Overall Study|Adverse Event|0|||
155386032|NCT02986334|560849020|FG001|Overall Study|Adverse Event|2|||
155386033|NCT02986334|560849021|FG002|Overall Study|Adverse Event|1|||
155386034|NCT02986334|560849019|FG000|Overall Study|non compliance in phone ratings|2|||
155386035|NCT02986334|560849020|FG001|Overall Study|non compliance in phone ratings|1|||
155386036|NCT02986334|560849021|FG002|Overall Study|non compliance in phone ratings|2|||
155386037|NCT02986334|560849019|FG000|Overall Study|undisclosed comorbidities|0|||
155386038|NCT02986334|560849020|FG001|Overall Study|undisclosed comorbidities|1|||
155386039|NCT02986334|560849021|FG002|Overall Study|undisclosed comorbidities|1|||
155386040|NCT04142450|560849022|FG000|Overall Study|Screen Failure|1|||
155386041|NCT04142450|560849022|FG000|Overall Study|Lost to Follow-up|1|||
155386042|NCT01480674|560849023|FG000|Overall Study|Death|23|||
155386043|NCT01480674|560849023|FG000|Overall Study|Lost to Follow-up|2|||
155386044|NCT01480674|560849023|FG000|Overall Study|visit not done|10|||
155386045|NCT03249714|560849024|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
155386046|NCT03249714|560849025|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
155386047|NCT03249714|560849024|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
155386048|NCT03249714|560849025|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
155386049|NCT03249714|560849024|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
155386050|NCT03249714|560849025|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
155386051|NCT03249714|560849024|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
155386052|NCT03249714|560849025|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
155386053|NCT01138007|560849029|FG000|Overall Study|Adverse Event|4|||
155386054|NCT01138007|560849030|FG001|Overall Study|Adverse Event|12|||
155386055|NCT01138007|560849031|FG002|Overall Study|Adverse Event|9|||
155386056|NCT01138007|560849029|FG000|Overall Study|Lack of Efficacy|2|||
155386057|NCT01138007|560849030|FG001|Overall Study|Lack of Efficacy|0|||
155386058|NCT01138007|560849031|FG002|Overall Study|Lack of Efficacy|6|||
155386059|NCT01138007|560849029|FG000|Overall Study|Protocol Violation|2|||
155386060|NCT01138007|560849030|FG001|Overall Study|Protocol Violation|3|||
155386061|NCT01138007|560849031|FG002|Overall Study|Protocol Violation|2|||
155386062|NCT01138007|560849029|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
155386063|NCT01138007|560849030|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
155386064|NCT01138007|560849031|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
155386065|NCT01138007|560849029|FG000|Overall Study|Lost to Follow-up|3|||
155386066|NCT01138007|560849030|FG001|Overall Study|Lost to Follow-up|3|||
155386067|NCT01138007|560849031|FG002|Overall Study|Lost to Follow-up|5|||
155386068|NCT01138007|560849029|FG000|Overall Study|Physician Decision|0|||
155386069|NCT01138007|560849030|FG001|Overall Study|Physician Decision|5|||
155386070|NCT01138007|560849031|FG002|Overall Study|Physician Decision|3|||
155386071|NCT01138007|560849029|FG000|Overall Study|Withdrawal by Subject|5|||
155386072|NCT01138007|560849030|FG001|Overall Study|Withdrawal by Subject|6|||
155386073|NCT01138007|560849031|FG002|Overall Study|Withdrawal by Subject|15|||
155386074|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
155386075|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
155386076|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
155386077|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
155386078|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
155386079|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
155386080|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
155386081|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
155386082|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
155386083|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
155386084|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
155386085|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
155386086|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
155386087|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
155386088|NCT03548987|560849032|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
155386089|NCT03548987|560849033|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
155386090|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
155386091|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
155386092|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
155386093|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
155386094|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
155386095|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
155386096|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
155386097|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
155386098|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
155386099|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
155386100|NCT03548987|560849032|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
155386101|NCT03548987|560849033|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
155386102|NCT04661878|560849034|FG000|Overall Study|Lost to Follow-up|6|||
155386103|NCT04661878|560849035|FG001|Overall Study|Lost to Follow-up|5|||
155386104|NCT05580588|560849036|FG000|Overall Study|Lack of Efficacy|12|||
155386105|NCT03603028|560849039|FG000|Overall Study|Withdrawal by Subject|1|||
155386106|NCT02768870|560849042|FG000|Overall Study|Death|1|||
155386107|NCT02768870|560849042|FG000|Overall Study|Reoperation|6|||
155386108|NCT02768870|560849042|FG000|Overall Study|Lost to Follow-up|1|||
155386109|NCT02768870|560849042|FG000|Overall Study|Exit|4|||
155386110|NCT02963610|560849043|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
155279574|NCT00519636|560456271|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
155279575|NCT00519636|560456272|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
155279576|NCT00519636|560456273|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
155279577|NCT00519636|560456270|FG000|Treatment Period 2|Subject randomized in error|0|||
155279578|NCT00519636|560456271|FG001|Treatment Period 2|Subject randomized in error|1|||
155279579|NCT00519636|560456272|FG002|Treatment Period 2|Subject randomized in error|0|||
155279580|NCT00519636|560456273|FG003|Treatment Period 2|Subject randomized in error|0|||
155279581|NCT00519636|560456270|FG000|Treatment Period 2|Per doctors request|0|||
155386111|NCT00063154|560849044|FG000|Overall Study|Disease progression|27|||
155386112|NCT00063154|560849044|FG000|Overall Study|Adverse Event|2|||
155386113|NCT00063154|560849044|FG000|Overall Study|Physician Decision|10|||
155386114|NCT00063154|560849044|FG000|Overall Study|Death|3|||
155386115|NCT00063154|560849044|FG000|Overall Study|Reason unspecified|1|||
155386116|NCT00063154|560849044|FG000|Overall Study|Did not receive treatment|8|||
155386117|NCT01287065|560849045|FG000|Treatment Period 1|Adverse Event|0|||
155386118|NCT01287065|560849046|FG001|Treatment Period 1|Adverse Event|0|||
155386119|NCT01287065|560849047|FG002|Treatment Period 1|Adverse Event|0|||
155386120|NCT01287065|560849048|FG003|Treatment Period 1|Adverse Event|0|||
155386121|NCT01287065|560849049|FG004|Treatment Period 1|Adverse Event|1|||
155386122|NCT01287065|560849050|FG005|Treatment Period 1|Adverse Event|0|||
155386123|NCT01287065|560849045|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155386124|NCT01287065|560849046|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155386125|NCT01287065|560849047|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155386126|NCT01287065|560849048|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155386127|NCT01287065|560849049|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155386128|NCT01287065|560849050|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155386129|NCT02875977|560849051|FG000|Overall Study|Lost to Follow-up|42|||
155386130|NCT02875977|560849052|FG001|Overall Study|Lost to Follow-up|29|||
155386131|NCT01259726|560849053|FG000|Overall Study|Death|1|||
155386132|NCT01259726|560849054|FG001|Overall Study|Death|0|||
155386133|NCT01259726|560849055|FG002|Overall Study|Death|0|||
155386134|NCT01259726|560849056|FG003|Overall Study|Death|0|||
155386135|NCT01259726|560849053|FG000|Overall Study|Physician Decision|2|||
155386136|NCT01259726|560849054|FG001|Overall Study|Physician Decision|0|||
155386137|NCT01259726|560849055|FG002|Overall Study|Physician Decision|1|||
155386138|NCT01259726|560849056|FG003|Overall Study|Physician Decision|1|||
155386139|NCT01259726|560849053|FG000|Overall Study|Withdrawal by Subject|1|||
155386140|NCT01259726|560849054|FG001|Overall Study|Withdrawal by Subject|3|||
155386141|NCT01259726|560849055|FG002|Overall Study|Withdrawal by Subject|2|||
155386142|NCT01259726|560849056|FG003|Overall Study|Withdrawal by Subject|1|||
155386143|NCT01259726|560849053|FG000|Overall Study|Lost to Follow-up|1|||
155386144|NCT01259726|560849054|FG001|Overall Study|Lost to Follow-up|1|||
155386145|NCT01259726|560849055|FG002|Overall Study|Lost to Follow-up|1|||
155386146|NCT01259726|560849056|FG003|Overall Study|Lost to Follow-up|3|||
155386147|NCT01211197|560849058|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155279582|NCT00519636|560456271|FG001|Treatment Period 2|Per doctors request|0|||
155279583|NCT00519636|560456272|FG002|Treatment Period 2|Per doctors request|1|||
155279584|NCT00519636|560456273|FG003|Treatment Period 2|Per doctors request|0|||
155279585|NCT00519636|560456270|FG000|Treatment Period 2|Subject misrandomized|0|||
155279586|NCT00519636|560456271|FG001|Treatment Period 2|Subject misrandomized|0|||
155279587|NCT00519636|560456272|FG002|Treatment Period 2|Subject misrandomized|0|||
155279588|NCT00519636|560456273|FG003|Treatment Period 2|Subject misrandomized|1|||
155279589|NCT00519636|560456270|FG000|Post Study Period|Subject randomized in error|0|||
155386148|NCT01211197|560849059|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386149|NCT01211197|560849060|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
154944147|NCT00358826|559220891|FG000|MDCT Substudy|Adverse Event|0|||
154944148|NCT00358826|559220892|FG001|MDCT Substudy|Adverse Event|0|||
154944149|NCT00358826|559220893|FG002|MDCT Substudy|Adverse Event|0|||
154944150|NCT00358826|559220894|FG003|MDCT Substudy|Adverse Event|0|||
154944151|NCT00358826|559220895|FG004|MDCT Substudy|Adverse Event|1|||
155279590|NCT00519636|560456271|FG001|Post Study Period|Subject randomized in error|0|||
155279591|NCT00519636|560456272|FG002|Post Study Period|Subject randomized in error|0|||
155386150|NCT01211197|560849061|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386151|NCT01211197|560849062|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386152|NCT01211197|560849063|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155386153|NCT01211197|560849058|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
155386154|NCT01211197|560849059|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
155386155|NCT01211197|560849060|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
155386156|NCT01211197|560849061|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
155386157|NCT01211197|560849062|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
155386158|NCT01211197|560849063|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
154944152|NCT00358826|559220896|FG005|MDCT Substudy|Adverse Event|0|||
154944153|NCT00358826|559220897|FG006|MDCT Substudy|Adverse Event|0|||
155386159|NCT01776424|560849066|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
155386160|NCT01776424|560849067|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
155386161|NCT01776424|560849068|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
155386162|NCT01776424|560849066|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
155386163|NCT01776424|560849067|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
155386164|NCT01776424|560849068|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
155386165|NCT01776424|560849066|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
155386166|NCT01776424|560849067|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
155386167|NCT01776424|560849068|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
155386168|NCT01776424|560849066|FG000|LTOLE Part (Open Label)|Refused|5|||
155386169|NCT01776424|560849067|FG001|LTOLE Part (Open Label)|Refused|2|||
155386170|NCT01776424|560849068|FG002|LTOLE Part (Open Label)|Refused|11|||
155386171|NCT01776424|560849066|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
155279592|NCT00519636|560456273|FG003|Post Study Period|Subject randomized in error|1|||
155279593|NCT04504916|560456274|FG000|Overall Study|Study terminated|7|||
155279594|NCT04504916|560456275|FG001|Overall Study|Study terminated|8|||
155279595|NCT04504916|560456274|FG000|Overall Study|Death|54|||
155279596|NCT04504916|560456275|FG001|Overall Study|Death|18|||
155279597|NCT04504916|560456274|FG000|Overall Study|Lost to Follow-up|1|||
155279598|NCT04504916|560456275|FG001|Overall Study|Lost to Follow-up|1|||
155279599|NCT04504916|560456274|FG000|Overall Study|Withdrawal by Subject|8|||
155279600|NCT04504916|560456275|FG001|Overall Study|Withdrawal by Subject|4|||
155279601|NCT04504916|560456274|FG000|Overall Study|Did not agree to follow-up|0|||
155279602|NCT04504916|560456275|FG001|Overall Study|Did not agree to follow-up|1|||
155279603|NCT03057834|560456278|FG000|Overall Study|Withdrawal by Subject|25|||
155279604|NCT03057834|560456279|FG001|Overall Study|Withdrawal by Subject|29|||
155279605|NCT00003509|560456280|FG000|Overall Study|Not evaluable|5|||
155279606|NCT05593211|560456289|FG000|Overall Study|Withdrawal by Subject|1|||
155279607|NCT03077620|560456293|FG000|Overall Study|Unable to place lumbar catheter|1|||
155279608|NCT03077620|560456294|FG001|Overall Study|Unable to place lumbar catheter|0|||
155279609|NCT03077620|560456295|FG002|Overall Study|Unable to place lumbar catheter|1|||
155279610|NCT03077620|560456296|FG003|Overall Study|Unable to place lumbar catheter|0|||
155279611|NCT03077620|560456293|FG000|Overall Study|Withdrawal by Subject|0|||
155279612|NCT03077620|560456294|FG001|Overall Study|Withdrawal by Subject|1|||
155279613|NCT03077620|560456295|FG002|Overall Study|Withdrawal by Subject|0|||
155279614|NCT03077620|560456296|FG003|Overall Study|Withdrawal by Subject|0|||
155279615|NCT03077620|560456293|FG000|Overall Study|Physician Decision|0|||
155279616|NCT03077620|560456294|FG001|Overall Study|Physician Decision|0|||
155279617|NCT03077620|560456295|FG002|Overall Study|Physician Decision|1|||
155279618|NCT03077620|560456296|FG003|Overall Study|Physician Decision|0|||
155279619|NCT03225846|560456297|FG000|Overall Study|Adverse Event|0|||
155279620|NCT03225846|560456298|FG001|Overall Study|Adverse Event|0|||
155279621|NCT03225846|560456299|FG002|Overall Study|Adverse Event|0|||
155279622|NCT03225846|560456300|FG003|Overall Study|Adverse Event|0|||
155279623|NCT03225846|560456301|FG004|Overall Study|Adverse Event|0|||
155279624|NCT03225846|560456302|FG005|Overall Study|Adverse Event|0|||
155279625|NCT03225846|560456303|FG006|Overall Study|Adverse Event|6|||
155279626|NCT03225846|560456297|FG000|Overall Study|Withdrawal by Subject|0|||
155279627|NCT03225846|560456298|FG001|Overall Study|Withdrawal by Subject|1|||
155279628|NCT03225846|560456299|FG002|Overall Study|Withdrawal by Subject|0|||
155279629|NCT03225846|560456300|FG003|Overall Study|Withdrawal by Subject|0|||
155279630|NCT03225846|560456301|FG004|Overall Study|Withdrawal by Subject|0|||
155279631|NCT03225846|560456302|FG005|Overall Study|Withdrawal by Subject|0|||
155279632|NCT03225846|560456303|FG006|Overall Study|Withdrawal by Subject|0|||
155279633|NCT03225846|560456297|FG000|Overall Study|Death|0|||
155279634|NCT03225846|560456298|FG001|Overall Study|Death|1|||
155279635|NCT03225846|560456299|FG002|Overall Study|Death|0|||
155279636|NCT03225846|560456300|FG003|Overall Study|Death|0|||
155279637|NCT03225846|560456301|FG004|Overall Study|Death|0|||
155279638|NCT03225846|560456302|FG005|Overall Study|Death|0|||
155279639|NCT03225846|560456303|FG006|Overall Study|Death|0|||
155279640|NCT03225846|560456297|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279641|NCT03225846|560456298|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279642|NCT03225846|560456299|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
155279643|NCT03225846|560456300|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279644|NCT03225846|560456301|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279645|NCT03225846|560456302|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279646|NCT03225846|560456303|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
155279647|NCT03225846|560456297|FG000|Overall Study|Patient decision|0|||
155279648|NCT03225846|560456298|FG001|Overall Study|Patient decision|0|||
155386172|NCT01776424|560849067|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
155386173|NCT01776424|560849068|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
155386174|NCT02019927|560849071|FG000|Overall Study|Lost to Follow-up|2|||
155386175|NCT02019927|560849072|FG001|Overall Study|Lost to Follow-up|4|||
155279649|NCT03225846|560456299|FG002|Overall Study|Patient decision|0|||
155279650|NCT03225846|560456300|FG003|Overall Study|Patient decision|0|||
155279651|NCT03225846|560456301|FG004|Overall Study|Patient decision|0|||
155279652|NCT03225846|560456302|FG005|Overall Study|Patient decision|0|||
155279653|NCT03225846|560456303|FG006|Overall Study|Patient decision|1|||
155279654|NCT04248465|560456304|FG000|Randomized-Controlled Period|Death|12|||
155279655|NCT04248465|560456305|FG001|Randomized-Controlled Period|Death|5|||
155279656|NCT04248465|560456304|FG000|Randomized-Controlled Period|Adverse Event|2|||
155279657|NCT04248465|560456305|FG001|Randomized-Controlled Period|Adverse Event|0|||
155279658|NCT04248465|560456304|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
155279659|NCT04248465|560456305|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
155279660|NCT04248465|560456304|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
155279661|NCT04248465|560456305|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
155279662|NCT04248465|560456304|FG000|Randomized-Controlled Period|Physician Decision|1|||
155279663|NCT04248465|560456305|FG001|Randomized-Controlled Period|Physician Decision|1|||
155279664|NCT04248465|560456304|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
155279665|NCT04248465|560456305|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
155279666|NCT04248465|560456304|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
155279667|NCT04248465|560456305|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
155279668|NCT04248465|560456304|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
155279669|NCT04248465|560456305|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
155279670|NCT01254890|560456306|FG000|Overall Study|Ineligible|0|||
155279671|NCT01254890|560456307|FG001|Overall Study|Ineligible|3|||
155279672|NCT01254890|560456306|FG000|Overall Study|Withdrawal by Subject|1|||
155279673|NCT01254890|560456307|FG001|Overall Study|Withdrawal by Subject|2|||
155279674|NCT01254890|560456306|FG000|Overall Study|Disease Progression|0|||
155279675|NCT01254890|560456307|FG001|Overall Study|Disease Progression|5|||
155279676|NCT00245011|560456311|FG000|Overall Study|Lack of Efficacy|1|||
155279677|NCT00550173|560456312|FG000|Overall Study|Death|45|||
155279678|NCT00550173|560456313|FG001|Overall Study|Death|38|||
155279679|NCT00550173|560456314|FG002|Overall Study|Death|50|||
155279680|NCT00550173|560456312|FG000|Overall Study|Physician Decision|1|||
155279681|NCT00550173|560456313|FG001|Overall Study|Physician Decision|2|||
155279682|NCT00550173|560456314|FG002|Overall Study|Physician Decision|2|||
155279683|NCT00550173|560456312|FG000|Overall Study|Withdrawal by Subject|9|||
155279684|NCT00550173|560456313|FG001|Overall Study|Withdrawal by Subject|12|||
155279685|NCT00550173|560456314|FG002|Overall Study|Withdrawal by Subject|17|||
155279686|NCT00550173|560456312|FG000|Overall Study|Sponsor Decision|13|||
155279687|NCT00550173|560456313|FG001|Overall Study|Sponsor Decision|7|||
155279688|NCT00550173|560456314|FG002|Overall Study|Sponsor Decision|1|||
155279689|NCT00550173|560456312|FG000|Overall Study|Lost to Follow-up|4|||
155279690|NCT00550173|560456313|FG001|Overall Study|Lost to Follow-up|4|||
155279691|NCT00550173|560456314|FG002|Overall Study|Lost to Follow-up|3|||
155279692|NCT02419755|560456318|FG000|Overall Study|Death|1|||
155279693|NCT02419755|560456319|FG001|Overall Study|Death|3|||
155279694|NCT02419755|560456318|FG000|Overall Study|Relapse|0|||
155279695|NCT02419755|560456319|FG001|Overall Study|Relapse|1|||
155279696|NCT02419755|560456318|FG000|Overall Study|Ineligible|1|||
155279697|NCT02419755|560456319|FG001|Overall Study|Ineligible|0|||
155279698|NCT02419755|560456318|FG000|Overall Study|Withdrawal by Subject|1|||
155279699|NCT02419755|560456319|FG001|Overall Study|Withdrawal by Subject|0|||
155279700|NCT06403605|560456323|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
155279701|NCT06403605|560456324|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
155279702|NCT06403605|560456323|FG000|Follow-up|Adverse Event|4|||
155279703|NCT06403605|560456324|FG001|Follow-up|Adverse Event|2|||
155279704|NCT06403605|560456323|FG000|Follow-up|Withdrawal by Subject|2|||
155279705|NCT06403605|560456324|FG001|Follow-up|Withdrawal by Subject|3|||
155279706|NCT06403605|560456323|FG000|Follow-up|Lost to Follow-up|1|||
155279707|NCT06403605|560456324|FG001|Follow-up|Lost to Follow-up|0|||
155279708|NCT06403605|560456323|FG000|Follow-up|Death|1|||
155279709|NCT06403605|560456324|FG001|Follow-up|Death|0|||
155279710|NCT06403605|560456323|FG000|Follow-up|Other reasons|0|||
154944154|NCT00358826|559220898|FG007|MDCT Substudy|Adverse Event|0|||
155045828|NCT05052697|559599416|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155279711|NCT06403605|560456324|FG001|Follow-up|Other reasons|4|||
155279712|NCT04213846|560457728|FG000|Overall Study|Withdrawal by Subject|7|||
155279713|NCT04213846|560457729|FG001|Overall Study|Withdrawal by Subject|6|||
155279714|NCT04213846|560457728|FG000|Overall Study|Lost to Follow-up|15|||
155279715|NCT04213846|560457729|FG001|Overall Study|Lost to Follow-up|21|||
155279716|NCT04096365|560457742|FG000|Overall Study|Adverse Event|1|||
155279717|NCT02401529|560457743|FG000|Overall Study|Lost to Follow-up|2|||
155279718|NCT02401529|560457744|FG001|Overall Study|Lost to Follow-up|1|||
155279719|NCT02401529|560457743|FG000|Overall Study|Physician Decision|2|||
155279720|NCT02401529|560457744|FG001|Overall Study|Physician Decision|6|||
155279721|NCT02401529|560457743|FG000|Overall Study|Protocol Violation|5|||
155279722|NCT02401529|560457744|FG001|Overall Study|Protocol Violation|0|||
155279723|NCT02491411|560457747|FG000|Overall Study|Physician Decision|4|||
155279724|NCT01036087|560457749|FG000|Overall Study|Adverse Event|2|||
155279725|NCT01036087|560457749|FG000|Overall Study|Lack of Efficacy|1|||
155279726|NCT02206685|560457751|FG000|Overall Study|Surgery cancelled/changed|2|||
155386176|NCT02019927|560849073|FG002|Overall Study|Lost to Follow-up|1|||
155386177|NCT02019927|560849074|FG003|Overall Study|Lost to Follow-up|2|||
155045829|NCT05052697|559599417|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045830|NCT05052697|559599418|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045831|NCT05052697|559599419|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
155045832|NCT05052697|559599386|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045833|NCT05052697|559599387|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045834|NCT05052697|559599388|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155279727|NCT02206685|560457752|FG001|Overall Study|Surgery cancelled/changed|3|||
155279728|NCT02206685|560457751|FG000|Overall Study|Withdrawal by Subject|1|||
155279729|NCT02206685|560457752|FG001|Overall Study|Withdrawal by Subject|2|||
155279730|NCT02206685|560457751|FG000|Overall Study|Protocol Violation|2|||
155279731|NCT02206685|560457752|FG001|Overall Study|Protocol Violation|2|||
155279732|NCT01616563|560457753|FG000|Overall Study|Lost to Follow-up|40|||
155279733|NCT00072475|560457754|FG000|Overall Study|Adverse Event|44|||
155279734|NCT00072475|560457754|FG000|Overall Study|Death|3|||
155279735|NCT00072475|560457754|FG000|Overall Study|Withdrawal by Subject|46|||
155279736|NCT00072475|560457754|FG000|Overall Study|Patient/Investigator Decision|4|||
155279737|NCT01450943|560457757|FG000|Overall Study|Screen failure, loss to follow-up|2|||
155279738|NCT01450943|560457758|FG001|Overall Study|Screen failure, loss to follow-up|7|||
155279739|NCT01450943|560457759|FG002|Overall Study|Screen failure, loss to follow-up|6|||
155279740|NCT04822298|560457761|FG000|Overall Study|Death|3|||
155279741|NCT00465361|560457762|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
155279742|NCT01625338|560457766|FG000|Overall Study|Enrolled but not Treated|0|||
155279743|NCT01625338|560457767|FG001|Overall Study|Enrolled but not Treated|0|||
155279744|NCT01625338|560457768|FG002|Overall Study|Enrolled but not Treated|1|||
155279745|NCT01625338|560457766|FG000|Overall Study|Efficacy Failure|27|||
155279746|NCT01625338|560457767|FG001|Overall Study|Efficacy Failure|39|||
155279747|NCT01625338|560457768|FG002|Overall Study|Efficacy Failure|31|||
155279748|NCT01625338|560457766|FG000|Overall Study|Lost to Follow-up|3|||
155279749|NCT01625338|560457767|FG001|Overall Study|Lost to Follow-up|3|||
155279750|NCT01625338|560457768|FG002|Overall Study|Lost to Follow-up|2|||
155279751|NCT01625338|560457766|FG000|Overall Study|Investigator Decision|0|||
155279752|NCT01625338|560457767|FG001|Overall Study|Investigator Decision|2|||
155279753|NCT01625338|560457768|FG002|Overall Study|Investigator Decision|1|||
155279754|NCT01625338|560457766|FG000|Overall Study|Subject Withdrew Consent|1|||
155279755|NCT01625338|560457767|FG001|Overall Study|Subject Withdrew Consent|0|||
155279756|NCT01625338|560457768|FG002|Overall Study|Subject Withdrew Consent|2|||
155279757|NCT01625338|560457766|FG000|Overall Study|Adverse Event|1|||
155279758|NCT01625338|560457767|FG001|Overall Study|Adverse Event|0|||
155279759|NCT01625338|560457768|FG002|Overall Study|Adverse Event|1|||
155279760|NCT01625338|560457766|FG000|Overall Study|Study Discontinued by Sponsor|0|||
155279761|NCT01625338|560457767|FG001|Overall Study|Study Discontinued by Sponsor|0|||
155279762|NCT01625338|560457768|FG002|Overall Study|Study Discontinued by Sponsor|1|||
155279763|NCT01789203|560457769|FG000|Overall Study|Adverse Event|2|||
155279764|NCT01789203|560457770|FG001|Overall Study|Adverse Event|2|||
155279765|NCT01789203|560457769|FG000|Overall Study|Withdrawal by Subject|1|||
155279766|NCT01789203|560457770|FG001|Overall Study|Withdrawal by Subject|0|||
155279767|NCT01789203|560457769|FG000|Overall Study|Death|1|||
155279768|NCT01789203|560457770|FG001|Overall Study|Death|0|||
155279769|NCT01789203|560457769|FG000|Overall Study|Protocol Violation|2|||
155279770|NCT01789203|560457770|FG001|Overall Study|Protocol Violation|1|||
155279771|NCT01789203|560457769|FG000|Overall Study|Other|1|||
155279772|NCT01789203|560457770|FG001|Overall Study|Other|1|||
155279773|NCT01789203|560457769|FG000|Overall Study|patient non-adherent|2|||
155279774|NCT01789203|560457770|FG001|Overall Study|patient non-adherent|0|||
155279775|NCT02403674|560457777|FG000|Base Study|Death|1|||
155279776|NCT02403674|560457778|FG001|Base Study|Death|4|||
155279777|NCT02403674|560457777|FG000|Base Study|Adverse Event|11|||
155279778|NCT02403674|560457778|FG001|Base Study|Adverse Event|26|||
155279779|NCT02403674|560457777|FG000|Base Study|Lack of Efficacy|31|||
155279780|NCT02403674|560457778|FG001|Base Study|Lack of Efficacy|23|||
155279781|NCT02403674|560457777|FG000|Base Study|Lost to Follow-up|6|||
155279782|NCT02403674|560457778|FG001|Base Study|Lost to Follow-up|8|||
155045835|NCT05052697|559599389|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155279783|NCT02403674|560457777|FG000|Base Study|Withdrawal by Subject|10|||
155386178|NCT02019927|560849075|FG004|Overall Study|Lost to Follow-up|3|||
155279784|NCT02403674|560457778|FG001|Base Study|Withdrawal by Subject|17|||
155279785|NCT02403674|560457777|FG000|Base Study|Physician Decision|2|||
155279786|NCT02403674|560457778|FG001|Base Study|Physician Decision|2|||
155279787|NCT02403674|560457777|FG000|Base Study|Pregnancy|2|||
155279788|NCT02403674|560457778|FG001|Base Study|Pregnancy|2|||
155279789|NCT02403674|560457777|FG000|Base Study|Protocol Violation|8|||
155279790|NCT02403674|560457778|FG001|Base Study|Protocol Violation|4|||
155279791|NCT02403674|560457777|FG000|Base Study|Non-Compliance with study drug|1|||
155279792|NCT02403674|560457778|FG001|Base Study|Non-Compliance with study drug|4|||
155279793|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
155279794|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
155279795|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
155279796|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
155279797|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
155279798|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
155279799|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
155279800|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
155279801|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
155279802|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
155279803|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
155279804|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
155279805|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Death|1|||
155279806|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Death|0|||
155279807|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
155279808|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
155279809|NCT02403674|560457777|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
155279810|NCT02403674|560457778|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
155279811|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
155279812|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
155279813|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
155279814|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
155279815|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
155279816|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
155279817|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
155279818|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
155279819|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
155279820|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
155279821|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Death|2|||
155279822|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Death|2|||
155279823|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
155279824|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
155279825|NCT02403674|560457777|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
155279826|NCT02403674|560457778|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
155279827|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
155279828|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
155279829|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
155279830|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
155279831|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
155279832|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
155279833|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
155279834|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
155279835|NCT02403674|560457777|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
155279836|NCT02403674|560457778|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
155279837|NCT03487666|560457780|FG000|Overall Study|Disease progression|4|||
155279838|NCT03487666|560457781|FG001|Overall Study|Disease progression|2|||
155279839|NCT03487666|560457782|FG002|Overall Study|Disease progression|0|||
155279840|NCT03487666|560457780|FG000|Overall Study|Adverse Event|0|||
155279841|NCT03487666|560457781|FG001|Overall Study|Adverse Event|0|||
155279842|NCT03487666|560457782|FG002|Overall Study|Adverse Event|1|||
155279843|NCT03201757|560457783|FG000|Overall Study|Withdrawal by Subject|133|||
155279844|NCT03201757|560457783|FG000|Overall Study|Adverse Event|44|||
155279845|NCT03201757|560457783|FG000|Overall Study|Lost to Follow-up|37|||
155279846|NCT03201757|560457783|FG000|Overall Study|Pregnancy|2|||
155279847|NCT03201757|560457783|FG000|Overall Study|Lack of Efficacy|1|||
155279848|NCT03201757|560457783|FG000|Overall Study|Protocol Violation|20|||
155279849|NCT03201757|560457783|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
155279850|NCT03201757|560457783|FG000|Overall Study|Not Yet Determined|5|||
155279851|NCT03201757|560457783|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
155279852|NCT03201757|560457783|FG000|Overall Study|Other|20|||
155279853|NCT01254305|560457784|FG000|Overall Study|Adverse Event|6|||
155279854|NCT01254305|560457785|FG001|Overall Study|Adverse Event|3|||
155279855|NCT01254305|560457786|FG002|Overall Study|Adverse Event|2|||
155279856|NCT01254305|560457784|FG000|Overall Study|Lack of Efficacy|1|||
155279857|NCT01254305|560457785|FG001|Overall Study|Lack of Efficacy|0|||
155279858|NCT01254305|560457786|FG002|Overall Study|Lack of Efficacy|1|||
155279859|NCT01254305|560457784|FG000|Overall Study|Protocol Violation|1|||
155279860|NCT01254305|560457785|FG001|Overall Study|Protocol Violation|7|||
155279861|NCT01254305|560457786|FG002|Overall Study|Protocol Violation|3|||
155279862|NCT01254305|560457784|FG000|Overall Study|Withdrawal by Subject|4|||
155279863|NCT01254305|560457785|FG001|Overall Study|Withdrawal by Subject|2|||
155279864|NCT01254305|560457786|FG002|Overall Study|Withdrawal by Subject|4|||
155279865|NCT01254305|560457784|FG000|Overall Study|Lost to Follow-up|10|||
155279866|NCT01254305|560457785|FG001|Overall Study|Lost to Follow-up|6|||
155279867|NCT01254305|560457786|FG002|Overall Study|Lost to Follow-up|5|||
155386179|NCT02019927|560849076|FG005|Overall Study|Lost to Follow-up|1|||
155386180|NCT00928447|560849085|FG000|Overall Study|Withdrawal by Subject|1|||
155386181|NCT00928447|560849085|FG000|Overall Study|Investigator's decision|1|||
155386182|NCT01259284|560849086|FG000|Overall Study|Study Termination|2|||
155386183|NCT01259284|560849087|FG001|Overall Study|Study Termination|0|||
155386184|NCT01259284|560849088|FG002|Overall Study|Study Termination|0|||
155386185|NCT00069238|560849089|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
155386186|NCT00069238|560849090|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
155386187|NCT00069238|560849091|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
155386188|NCT00069238|560849089|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
155386189|NCT00069238|560849090|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
155386190|NCT00069238|560849091|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
155386191|NCT00069238|560849089|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
155386192|NCT00069238|560849090|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
155386193|NCT00069238|560849091|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
155386194|NCT00926211|560849093|FG000|Overall Study|Lost to Follow-up|1|||
155386195|NCT01032382|560849094|FG000|Overall Study|Disease dissemination|1|||
155386196|NCT01032382|560849095|FG001|Overall Study|Disease dissemination|1|||
155386197|NCT01032382|560849094|FG000|Overall Study|Treatment failure|3|||
155386198|NCT01032382|560849095|FG001|Overall Study|Treatment failure|1|||
155386199|NCT01032382|560849094|FG000|Overall Study|Index lesion relapse|1|||
155386200|NCT01032382|560849095|FG001|Overall Study|Index lesion relapse|3|||
155386201|NCT04508023|560849096|FG000|Overall Study|Withdrawal by Subject|1|||
155386202|NCT04508023|560849097|FG001|Overall Study|Withdrawal by Subject|2|||
155386203|NCT02988622|560849098|FG000|Overall Study|Lost to Follow-up|17|||
155386204|NCT03261700|560849099|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
155386205|NCT03261700|560849100|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
155386206|NCT00983931|560849101|FG000|14 Day Washout Period|Physician Decision|1|||
155386207|NCT01281969|560849104|FG000|Overall Study|not randomized didn't meet criteria|0|||
155386208|NCT01281969|560849105|FG001|Overall Study|not randomized didn't meet criteria|0|||
155386209|NCT01281969|560849106|FG002|Overall Study|not randomized didn't meet criteria|7|||
155386210|NCT01281969|560849104|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
155386211|NCT01281969|560849105|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
155386212|NCT01281969|560849106|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
155386213|NCT01281969|560849104|FG000|Overall Study|not randomized, child consent not given|0|||
155386214|NCT01281969|560849105|FG001|Overall Study|not randomized, child consent not given|0|||
155386215|NCT01281969|560849106|FG002|Overall Study|not randomized, child consent not given|2|||
155386216|NCT01723254|560849108|FG000|Overall Study|Conflict with work schedule|0|||
155386217|NCT01723254|560849109|FG001|Overall Study|Conflict with work schedule|0|||
155386218|NCT01723254|560849110|FG002|Overall Study|Conflict with work schedule|0|||
155386219|NCT01723254|560849111|FG003|Overall Study|Conflict with work schedule|0|||
155386220|NCT01723254|560849112|FG004|Overall Study|Conflict with work schedule|0|||
155386221|NCT01723254|560849113|FG005|Overall Study|Conflict with work schedule|0|||
155386222|NCT01723254|560849114|FG006|Overall Study|Conflict with work schedule|0|||
155386223|NCT01723254|560849115|FG007|Overall Study|Conflict with work schedule|1|||
155386224|NCT01723254|560849108|FG000|Overall Study|Personal issues|0|||
155386225|NCT01723254|560849109|FG001|Overall Study|Personal issues|0|||
155386226|NCT01723254|560849110|FG002|Overall Study|Personal issues|0|||
155386227|NCT01723254|560849111|FG003|Overall Study|Personal issues|0|||
155386228|NCT01723254|560849112|FG004|Overall Study|Personal issues|0|||
155386229|NCT01723254|560849113|FG005|Overall Study|Personal issues|1|||
155386230|NCT01723254|560849114|FG006|Overall Study|Personal issues|0|||
155386231|NCT01723254|560849115|FG007|Overall Study|Personal issues|0|||
155386232|NCT01723254|560849108|FG000|Overall Study|No longer have time to participate|0|||
155386233|NCT01723254|560849109|FG001|Overall Study|No longer have time to participate|0|||
155386234|NCT01723254|560849110|FG002|Overall Study|No longer have time to participate|0|||
155386235|NCT01723254|560849111|FG003|Overall Study|No longer have time to participate|1|||
155386236|NCT01723254|560849112|FG004|Overall Study|No longer have time to participate|0|||
155386237|NCT01723254|560849113|FG005|Overall Study|No longer have time to participate|0|||
155386238|NCT01723254|560849114|FG006|Overall Study|No longer have time to participate|0|||
155386239|NCT01723254|560849115|FG007|Overall Study|No longer have time to participate|0|||
155386240|NCT01723254|560849108|FG000|Overall Study|Move/Left to another country/city|0|||
155386241|NCT01723254|560849109|FG001|Overall Study|Move/Left to another country/city|0|||
155386242|NCT01723254|560849110|FG002|Overall Study|Move/Left to another country/city|2|||
155386243|NCT01723254|560849111|FG003|Overall Study|Move/Left to another country/city|1|||
155386244|NCT01723254|560849112|FG004|Overall Study|Move/Left to another country/city|1|||
155386245|NCT01723254|560849113|FG005|Overall Study|Move/Left to another country/city|0|||
155386246|NCT01723254|560849114|FG006|Overall Study|Move/Left to another country/city|0|||
155386247|NCT01723254|560849115|FG007|Overall Study|Move/Left to another country/city|0|||
155386248|NCT01723254|560849108|FG000|Overall Study|Protocol Violation|0|||
155386249|NCT01723254|560849109|FG001|Overall Study|Protocol Violation|1|||
155386250|NCT01723254|560849110|FG002|Overall Study|Protocol Violation|0|||
155386251|NCT01723254|560849111|FG003|Overall Study|Protocol Violation|0|||
154944155|NCT00358826|559220891|FG000|MDCT Substudy|Lost to Follow-up|0|||
155279868|NCT01254305|560457784|FG000|Overall Study|Other Reasons|0|||
155279869|NCT01254305|560457785|FG001|Overall Study|Other Reasons|0|||
155279870|NCT01254305|560457786|FG002|Overall Study|Other Reasons|2|||
155279871|NCT02297503|560457787|FG000|Overall Study|Withdrawal by Subject|1|||
155279872|NCT02297503|560457788|FG001|Overall Study|Withdrawal by Subject|1|||
155279873|NCT02297503|560457787|FG000|Overall Study|Protocol Violation|1|||
155279874|NCT02297503|560457788|FG001|Overall Study|Protocol Violation|0|||
155279875|NCT02297503|560457787|FG000|Overall Study|Pregnancy|0|||
155279876|NCT02297503|560457788|FG001|Overall Study|Pregnancy|1|||
155279877|NCT02297503|560457787|FG000|Overall Study|Lost to Follow-up|0|||
155279878|NCT02297503|560457788|FG001|Overall Study|Lost to Follow-up|1|||
155279879|NCT02297503|560457787|FG000|Overall Study|Medical reason|0|||
155279880|NCT02297503|560457788|FG001|Overall Study|Medical reason|1|||
155279881|NCT00765362|560457789|FG000|Overall Study|Death|9|||
155279882|NCT00765362|560457789|FG000|Overall Study|Adverse Event|2|||
155279883|NCT00765362|560457789|FG000|Overall Study|Protocol Violation|18|||
155279884|NCT00765362|560457789|FG000|Overall Study|Withdrawal by Subject|13|||
155279885|NCT00765362|560457789|FG000|Overall Study|Lost to Follow-up|95|||
155279886|NCT03930186|560457790|FG000|Weeks 0 to 16|Adverse Event|6|||
155279887|NCT03930186|560457790|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
155279888|NCT03930186|560457790|FG000|Weeks 16 to 32|Adverse Event|1|||
155279889|NCT03930186|560457790|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
155279890|NCT03019458|560457795|FG000|Overall Study|Death|0|||
155279891|NCT03019458|560457796|FG001|Overall Study|Death|1|||
155279892|NCT00557505|560457797|FG000|Overall Study|Death|0|||
155279893|NCT00557505|560457798|FG001|Overall Study|Death|0|||
155279894|NCT00557505|560457799|FG002|Overall Study|Death|0|||
155279895|NCT00557505|560457800|FG003|Overall Study|Death|0|||
155279896|NCT00557505|560457801|FG004|Overall Study|Death|0|||
155279897|NCT00557505|560457802|FG005|Overall Study|Death|0|||
155279898|NCT00557505|560457803|FG006|Overall Study|Death|0|||
155279899|NCT00557505|560457804|FG007|Overall Study|Death|0|||
155279900|NCT00557505|560457805|FG008|Overall Study|Death|1|||
155279901|NCT00557505|560457797|FG000|Overall Study|Adverse Event|0|||
155279902|NCT00557505|560457798|FG001|Overall Study|Adverse Event|0|||
155279903|NCT00557505|560457799|FG002|Overall Study|Adverse Event|1|||
155279904|NCT00557505|560457800|FG003|Overall Study|Adverse Event|0|||
155279905|NCT00557505|560457801|FG004|Overall Study|Adverse Event|0|||
155279906|NCT00557505|560457802|FG005|Overall Study|Adverse Event|0|||
155279907|NCT00557505|560457803|FG006|Overall Study|Adverse Event|1|||
155279908|NCT00557505|560457804|FG007|Overall Study|Adverse Event|0|||
155279909|NCT00557505|560457805|FG008|Overall Study|Adverse Event|0|||
155279910|NCT00557505|560457797|FG000|Overall Study|Global deterioration of health|1|||
155279911|NCT00557505|560457798|FG001|Overall Study|Global deterioration of health|0|||
155279912|NCT00557505|560457799|FG002|Overall Study|Global deterioration of health|0|||
155279913|NCT00557505|560457800|FG003|Overall Study|Global deterioration of health|0|||
155279914|NCT00557505|560457801|FG004|Overall Study|Global deterioration of health|0|||
155279915|NCT00557505|560457802|FG005|Overall Study|Global deterioration of health|0|||
155279916|NCT00557505|560457803|FG006|Overall Study|Global deterioration of health|0|||
155279917|NCT00557505|560457804|FG007|Overall Study|Global deterioration of health|0|||
155279918|NCT00557505|560457805|FG008|Overall Study|Global deterioration of health|0|||
155279919|NCT00557505|560457797|FG000|Overall Study|Objective progression or relapse|2|||
155279920|NCT00557505|560457798|FG001|Overall Study|Objective progression or relapse|3|||
155279921|NCT00557505|560457799|FG002|Overall Study|Objective progression or relapse|3|||
155279922|NCT00557505|560457800|FG003|Overall Study|Objective progression or relapse|2|||
155279923|NCT00557505|560457801|FG004|Overall Study|Objective progression or relapse|2|||
155279924|NCT00557505|560457802|FG005|Overall Study|Objective progression or relapse|3|||
155279925|NCT00557505|560457803|FG006|Overall Study|Objective progression or relapse|2|||
155279926|NCT00557505|560457804|FG007|Overall Study|Objective progression or relapse|5|||
155279927|NCT00557505|560457805|FG008|Overall Study|Objective progression or relapse|15|||
155279928|NCT00557505|560457797|FG000|Overall Study|Withdrawal by Subject|0|||
155279929|NCT00557505|560457798|FG001|Overall Study|Withdrawal by Subject|0|||
155279930|NCT00557505|560457799|FG002|Overall Study|Withdrawal by Subject|0|||
155279931|NCT00557505|560457800|FG003|Overall Study|Withdrawal by Subject|1|||
155279932|NCT00557505|560457801|FG004|Overall Study|Withdrawal by Subject|0|||
155279933|NCT00557505|560457802|FG005|Overall Study|Withdrawal by Subject|0|||
155279934|NCT00557505|560457803|FG006|Overall Study|Withdrawal by Subject|0|||
155279935|NCT00557505|560457804|FG007|Overall Study|Withdrawal by Subject|0|||
155279936|NCT00557505|560457805|FG008|Overall Study|Withdrawal by Subject|1|||
155279937|NCT00031447|560457806|FG000|Overall Study|Lost to Follow-up|0|||
155279938|NCT00031447|560457807|FG001|Overall Study|Lost to Follow-up|1|||
155279939|NCT00031447|560457806|FG000|Overall Study|Non-compliant|1|||
155279940|NCT00031447|560457807|FG001|Overall Study|Non-compliant|1|||
155279941|NCT00031447|560457806|FG000|Overall Study|Re-activation of Disease|2|||
155279942|NCT00031447|560457807|FG001|Overall Study|Re-activation of Disease|1|||
155279943|NCT00031447|560457806|FG000|Overall Study|Disruption of blinded study drug supply|7|||
155279944|NCT00031447|560457807|FG001|Overall Study|Disruption of blinded study drug supply|4|||
155386252|NCT01723254|560849112|FG004|Overall Study|Protocol Violation|0|||
155386253|NCT01723254|560849113|FG005|Overall Study|Protocol Violation|0|||
155386254|NCT01723254|560849114|FG006|Overall Study|Protocol Violation|0|||
155386255|NCT01723254|560849115|FG007|Overall Study|Protocol Violation|0|||
155386256|NCT01723254|560849108|FG000|Overall Study|Withdrawal by Subject|1|||
155386257|NCT01723254|560849109|FG001|Overall Study|Withdrawal by Subject|2|||
155386258|NCT01723254|560849110|FG002|Overall Study|Withdrawal by Subject|1|||
155386259|NCT01723254|560849111|FG003|Overall Study|Withdrawal by Subject|0|||
155386260|NCT01723254|560849112|FG004|Overall Study|Withdrawal by Subject|1|||
155386261|NCT01723254|560849113|FG005|Overall Study|Withdrawal by Subject|1|||
155386262|NCT01723254|560849114|FG006|Overall Study|Withdrawal by Subject|1|||
155386263|NCT01723254|560849115|FG007|Overall Study|Withdrawal by Subject|2|||
155386264|NCT04640077|560849119|FG000|Period 1|Withdrawal by Subject|4|||
155386265|NCT04640077|560849120|FG001|Period 1|Withdrawal by Subject|5|||
155386266|NCT04640077|560849121|FG002|Period 1|Withdrawal by Subject|0|||
155386267|NCT04640077|560849119|FG000|Period 1|Adverse Event|1|||
155386268|NCT04640077|560849120|FG001|Period 1|Adverse Event|1|||
155386269|NCT04640077|560849121|FG002|Period 1|Adverse Event|0|||
155386270|NCT04640077|560849119|FG000|Period 1|Screen Failure|2|||
155386271|NCT04640077|560849120|FG001|Period 1|Screen Failure|0|||
155386272|NCT04640077|560849121|FG002|Period 1|Screen Failure|0|||
155386273|NCT04640077|560849119|FG000|Period 2|Withdrawal by Subject|0|||
155386274|NCT04640077|560849120|FG001|Period 2|Withdrawal by Subject|0|||
155386275|NCT04640077|560849121|FG002|Period 2|Withdrawal by Subject|18|||
155386276|NCT04640077|560849119|FG000|Period 2|Adverse Event|0|||
155386277|NCT04640077|560849120|FG001|Period 2|Adverse Event|0|||
155386278|NCT04640077|560849121|FG002|Period 2|Adverse Event|6|||
155386279|NCT04640077|560849119|FG000|Period 2|Lost to Follow-up|0|||
155386280|NCT04640077|560849120|FG001|Period 2|Lost to Follow-up|0|||
155386281|NCT04640077|560849121|FG002|Period 2|Lost to Follow-up|2|||
155386282|NCT04640077|560849119|FG000|Period 2|Death|0|||
155386283|NCT04640077|560849120|FG001|Period 2|Death|0|||
155386284|NCT04640077|560849121|FG002|Period 2|Death|2|||
155386285|NCT04640077|560849119|FG000|Period 2|Progressive Disease|0|||
155386286|NCT04640077|560849120|FG001|Period 2|Progressive Disease|0|||
155386287|NCT04640077|560849121|FG002|Period 2|Progressive Disease|1|||
155386288|NCT04640077|560849119|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
155386289|NCT04640077|560849120|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
155386290|NCT04640077|560849121|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
155386291|NCT01257425|560849122|FG000|Overall Study|Lack of Efficacy|3|||
155386292|NCT01257425|560849123|FG001|Overall Study|Lack of Efficacy|3|||
155386293|NCT01257425|560849122|FG000|Overall Study|Adverse Event|1|||
155386294|NCT01257425|560849123|FG001|Overall Study|Adverse Event|1|||
155386295|NCT01257425|560849122|FG000|Overall Study|Protocol Violation|1|||
155386296|NCT01257425|560849123|FG001|Overall Study|Protocol Violation|1|||
155386297|NCT01257425|560849122|FG000|Overall Study|Withdrawal by Subject|0|||
155386298|NCT01257425|560849123|FG001|Overall Study|Withdrawal by Subject|1|||
155386299|NCT01257425|560849122|FG000|Overall Study|Death|1|||
155386300|NCT01257425|560849123|FG001|Overall Study|Death|0|||
155386301|NCT02409368|560849125|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
155386302|NCT02409368|560849126|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
155386303|NCT02409368|560849127|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
155386304|NCT02409368|560849128|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
155386305|NCT02409368|560849125|FG000|ECOG Reclassification|Death|1|||
155386306|NCT02409368|560849126|FG001|ECOG Reclassification|Death|5|||
155386307|NCT02409368|560849127|FG002|ECOG Reclassification|Death|0|||
155386308|NCT02409368|560849128|FG003|ECOG Reclassification|Death|0|||
155386309|NCT02409368|560849125|FG000|ECOG Reclassification|Disease Progression|113|||
155386310|NCT02409368|560849126|FG001|ECOG Reclassification|Disease Progression|382|||
155386311|NCT02409368|560849127|FG002|ECOG Reclassification|Disease Progression|70|||
155386312|NCT02409368|560849128|FG003|ECOG Reclassification|Disease Progression|1|||
155386313|NCT02409368|560849125|FG000|ECOG Reclassification|Lost to Follow-up|1|||
155386314|NCT02409368|560849126|FG001|ECOG Reclassification|Lost to Follow-up|5|||
155386315|NCT02409368|560849127|FG002|ECOG Reclassification|Lost to Follow-up|0|||
155386316|NCT02409368|560849128|FG003|ECOG Reclassification|Lost to Follow-up|0|||
155386317|NCT02409368|560849125|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
155386318|NCT02409368|560849126|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
155386319|NCT02409368|560849127|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
155386320|NCT02409368|560849128|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
155386321|NCT02409368|560849125|FG000|ECOG Reclassification|Poor/non-compliance|0|||
155386322|NCT02409368|560849126|FG001|ECOG Reclassification|Poor/non-compliance|3|||
155386323|NCT02409368|560849127|FG002|ECOG Reclassification|Poor/non-compliance|2|||
155386324|NCT02409368|560849128|FG003|ECOG Reclassification|Poor/non-compliance|0|||
155386325|NCT02409368|560849125|FG000|ECOG Reclassification|Study drug toxicity|17|||
155386326|NCT02409368|560849126|FG001|ECOG Reclassification|Study drug toxicity|42|||
155386327|NCT02409368|560849127|FG002|ECOG Reclassification|Study drug toxicity|7|||
155386328|NCT02409368|560849128|FG003|ECOG Reclassification|Study drug toxicity|0|||
155386329|NCT02409368|560849125|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
155386330|NCT02409368|560849126|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
155386331|NCT02409368|560849127|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
155386332|NCT02409368|560849128|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
155386333|NCT02409368|560849125|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
155386334|NCT02409368|560849126|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
155386335|NCT02409368|560849127|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
155386336|NCT02409368|560849128|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
155386337|NCT02409368|560849125|FG000|ECOG Reclassification|Participant withdrew consent|2|||
155386338|NCT02409368|560849126|FG001|ECOG Reclassification|Participant withdrew consent|3|||
155386339|NCT02409368|560849127|FG002|ECOG Reclassification|Participant withdrew consent|4|||
155386340|NCT02409368|560849128|FG003|ECOG Reclassification|Participant withdrew consent|0|||
155386341|NCT02409368|560849125|FG000|ECOG Reclassification|Other Reasons|5|||
155386342|NCT02409368|560849126|FG001|ECOG Reclassification|Other Reasons|26|||
155386343|NCT02409368|560849127|FG002|ECOG Reclassification|Other Reasons|2|||
155386344|NCT02409368|560849128|FG003|ECOG Reclassification|Other Reasons|0|||
155386345|NCT02409368|560849125|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
155386346|NCT02409368|560849126|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
155386347|NCT02409368|560849127|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
155386348|NCT02409368|560849128|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
155386349|NCT02240693|560849130|FG000|Overall Study|Adverse Event|0|||
155386350|NCT02240693|560849131|FG001|Overall Study|Adverse Event|0|||
155386351|NCT02240693|560849132|FG002|Overall Study|Adverse Event|0|||
155386352|NCT02240693|560849133|FG003|Overall Study|Adverse Event|0|||
155386353|NCT02240693|560849134|FG004|Overall Study|Adverse Event|1|||
155386354|NCT02240693|560849130|FG000|Overall Study|Withdrawal by Subject|0|||
155386355|NCT02240693|560849131|FG001|Overall Study|Withdrawal by Subject|0|||
155386356|NCT02240693|560849132|FG002|Overall Study|Withdrawal by Subject|2|||
155386357|NCT02240693|560849133|FG003|Overall Study|Withdrawal by Subject|1|||
155386358|NCT02240693|560849134|FG004|Overall Study|Withdrawal by Subject|0|||
155386359|NCT02240693|560849130|FG000|Overall Study|Other than specified|0|||
155386360|NCT02240693|560849131|FG001|Overall Study|Other than specified|0|||
155386361|NCT02240693|560849132|FG002|Overall Study|Other than specified|2|||
155386362|NCT02240693|560849133|FG003|Overall Study|Other than specified|0|||
155386363|NCT02240693|560849134|FG004|Overall Study|Other than specified|0|||
155386364|NCT03343301|560849135|FG000|Overall Study|Withdrawal by Subject|1|||
155386365|NCT03343301|560849136|FG001|Overall Study|Withdrawal by Subject|1|||
155386366|NCT03343301|560849135|FG000|Overall Study|Death|0|||
155386367|NCT03343301|560849136|FG001|Overall Study|Death|2|||
155386368|NCT03343301|560849135|FG000|Overall Study|Other|0|||
155386369|NCT03343301|560849136|FG001|Overall Study|Other|6|||
155386370|NCT03343301|560849135|FG000|Overall Study|Missing|2|||
155386371|NCT03343301|560849136|FG001|Overall Study|Missing|0|||
155386372|NCT02668185|560849137|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
155386373|NCT02668185|560849138|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
155386374|NCT02668185|560849137|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
155386375|NCT02668185|560849138|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
155386376|NCT02668185|560849137|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
155386377|NCT02668185|560849138|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
155386378|NCT02668185|560849137|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
155386379|NCT02668185|560849138|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
155386380|NCT01013597|560849139|FG000|Overall Study|Withdrawal by Subject|1|||
155386381|NCT00427895|560849140|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386382|NCT00427895|560849141|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386383|NCT00427895|560849142|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386384|NCT00427895|560849143|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
155386385|NCT00427895|560849144|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386386|NCT00427895|560849145|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386387|NCT00427895|560849146|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386388|NCT00427895|560849147|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
155386389|NCT00427895|560849140|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386390|NCT00427895|560849141|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386391|NCT00427895|560849142|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386392|NCT00427895|560849143|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386393|NCT00427895|560849144|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386394|NCT00427895|560849145|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386395|NCT00427895|560849146|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
155386396|NCT00427895|560849147|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
155386397|NCT00427895|560849140|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386398|NCT00427895|560849141|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386399|NCT00427895|560849142|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386400|NCT00427895|560849143|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
155279945|NCT00519779|560457813|FG000|Overall Study|Withdrawal by Subject|0|||
155279946|NCT00519779|560457814|FG001|Overall Study|Withdrawal by Subject|1|||
155279947|NCT01561079|560457815|FG000|Overall Study|Physician Decision|17|||
155279948|NCT01561079|560457815|FG000|Overall Study|Withdrawal by Subject|59|||
155279949|NCT01561079|560457815|FG000|Overall Study|Protocol Violation|2|||
155279950|NCT01123161|560457818|FG000|Overall Study|Lost to Follow-up|1|||
155279951|NCT01123161|560457819|FG001|Overall Study|Lost to Follow-up|0|||
155279952|NCT01123161|560457818|FG000|Overall Study|Withdrawal by Subject|1|||
155279953|NCT01123161|560457819|FG001|Overall Study|Withdrawal by Subject|0|||
155279954|NCT00664521|560457820|FG000|Overall Study|Adverse Event|4|||
155279955|NCT00664521|560457821|FG001|Overall Study|Adverse Event|1|||
155279956|NCT00664521|560457820|FG000|Overall Study|Lost to Follow-up|1|||
155279957|NCT00664521|560457821|FG001|Overall Study|Lost to Follow-up|0|||
155279958|NCT00664521|560457820|FG000|Overall Study|Other|1|||
155279959|NCT00664521|560457821|FG001|Overall Study|Other|0|||
155279960|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
155279961|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155279962|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155279963|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155279964|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155279965|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
155279966|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
155279967|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
155279968|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
155279969|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
155279970|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155279971|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
155279972|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155279973|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155279974|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155279975|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155279976|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155279977|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155279978|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279979|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279980|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279981|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279982|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
155279983|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
155279984|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279985|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279986|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279987|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279988|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155279989|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155279990|NCT01323660|560457822|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
155279991|NCT01323660|560457823|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155279992|NCT01323660|560457824|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155279993|NCT01323660|560457825|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155279994|NCT01323660|560457826|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
155279995|NCT01323660|560457827|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155279996|NCT01323660|560457822|FG000|Washout Period (14 Days)|Adverse Event|0|||
155279997|NCT01323660|560457823|FG001|Washout Period (14 Days)|Adverse Event|0|||
155279998|NCT01323660|560457824|FG002|Washout Period (14 Days)|Adverse Event|0|||
155279999|NCT01323660|560457825|FG003|Washout Period (14 Days)|Adverse Event|0|||
155280000|NCT01323660|560457826|FG004|Washout Period (14 Days)|Adverse Event|1|||
155280001|NCT01323660|560457827|FG005|Washout Period (14 Days)|Adverse Event|0|||
155280002|NCT01323660|560457822|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
155280003|NCT01323660|560457823|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
155280004|NCT01323660|560457824|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
155280005|NCT01323660|560457825|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
155280006|NCT01323660|560457826|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
155280007|NCT01323660|560457827|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
155280008|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155280009|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155280010|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155280011|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155280012|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155280013|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
155280014|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
155045836|NCT05052697|559599390|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155386401|NCT00427895|560849144|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386402|NCT00427895|560849145|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386403|NCT00427895|560849146|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
155386404|NCT00427895|560849147|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
155386405|NCT00427895|560849140|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
155386406|NCT00427895|560849141|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
155386407|NCT00427895|560849142|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
155386408|NCT00427895|560849143|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
155386409|NCT00427895|560849144|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
155386410|NCT00427895|560849145|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
155386411|NCT00427895|560849146|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
155386412|NCT00427895|560849147|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
155386413|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386414|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
155386415|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
155386416|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
155386417|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386418|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386419|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386420|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
155386421|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
155386422|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386423|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
155386424|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
155386425|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386426|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386427|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386428|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
155386429|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
155386430|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
155386431|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386432|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386433|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386434|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386435|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386436|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
155386437|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
155386438|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
155386439|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
155386440|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
155386441|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386442|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386443|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386444|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
155386445|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386446|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386447|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386448|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
155386449|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
154944156|NCT00358826|559220892|FG001|MDCT Substudy|Lost to Follow-up|0|||
154944157|NCT00358826|559220893|FG002|MDCT Substudy|Lost to Follow-up|0|||
154944158|NCT00358826|559220894|FG003|MDCT Substudy|Lost to Follow-up|0|||
154944159|NCT00358826|559220895|FG004|MDCT Substudy|Lost to Follow-up|0|||
154944160|NCT00358826|559220896|FG005|MDCT Substudy|Lost to Follow-up|1|||
155280015|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155280016|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
155280017|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
155280018|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155280019|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
155280020|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280021|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280022|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280023|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280024|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
155280025|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
155280026|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155280027|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155280028|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155045837|NCT05052697|559599391|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155386450|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386451|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386452|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
155386453|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
155386454|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
155386455|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
155386456|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
155386457|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386458|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386459|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386460|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
155386461|NCT00427895|560849140|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386462|NCT00427895|560849141|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386463|NCT00427895|560849142|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
155386464|NCT00427895|560849143|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
155386465|NCT00427895|560849144|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386466|NCT00427895|560849145|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386467|NCT00427895|560849146|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386468|NCT00427895|560849147|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
155386469|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386470|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
155386471|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
155386472|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
155386473|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386474|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386475|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386476|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
155386477|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
155386478|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
155386479|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386480|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
155386481|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386482|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386483|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386484|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
155386485|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
155386486|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
155386487|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
155386488|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
155386489|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386490|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386491|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386492|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
155386493|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386494|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
155386495|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386496|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386497|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386498|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386499|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386500|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
155386501|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Death|1|||
155386502|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Death|0|||
155386503|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Death|0|||
155386504|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Death|0|||
155386505|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Death|0|||
155386506|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Death|0|||
155386507|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Death|0|||
155386508|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Death|0|||
155386509|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386510|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386511|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
155386512|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
155386513|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386514|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386515|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386516|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
155386517|NCT00427895|560849140|FG000|Vax 1/Year 1 Follow-up|Other|0|||
155386518|NCT00427895|560849141|FG001|Vax 1/Year 1 Follow-up|Other|0|||
154944161|NCT00358826|559220897|FG006|MDCT Substudy|Lost to Follow-up|0|||
154944162|NCT00358826|559220898|FG007|MDCT Substudy|Lost to Follow-up|0|||
155386519|NCT00427895|560849142|FG002|Vax 1/Year 1 Follow-up|Other|0|||
155386520|NCT00427895|560849143|FG003|Vax 1/Year 1 Follow-up|Other|2|||
155386521|NCT00427895|560849144|FG004|Vax 1/Year 1 Follow-up|Other|0|||
155386522|NCT00427895|560849145|FG005|Vax 1/Year 1 Follow-up|Other|0|||
155386523|NCT00427895|560849146|FG006|Vax 1/Year 1 Follow-up|Other|0|||
155386524|NCT00427895|560849147|FG007|Vax 1/Year 1 Follow-up|Other|0|||
155386525|NCT00427895|560849140|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
155386526|NCT00427895|560849141|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
155386527|NCT00427895|560849142|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
155386528|NCT00427895|560849143|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
155386529|NCT00427895|560849144|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386530|NCT00427895|560849145|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386531|NCT00427895|560849146|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386532|NCT00427895|560849147|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
155386533|NCT00585195|560849149|FG000|Overall Study|Adverse Event|0|||
155386534|NCT00585195|560849150|FG001|Overall Study|Adverse Event|0|||
155386535|NCT00585195|560849151|FG002|Overall Study|Adverse Event|0|||
155386536|NCT00585195|560849152|FG003|Overall Study|Adverse Event|0|||
155386537|NCT00585195|560849153|FG004|Overall Study|Adverse Event|2|||
155386538|NCT00585195|560849154|FG005|Overall Study|Adverse Event|1|||
155386539|NCT00585195|560849155|FG006|Overall Study|Adverse Event|0|||
155386540|NCT00585195|560849156|FG007|Overall Study|Adverse Event|1|||
155386541|NCT00585195|560849157|FG008|Overall Study|Adverse Event|0|||
155386542|NCT00585195|560849158|FG009|Overall Study|Adverse Event|0|||
155386543|NCT00585195|560849159|FG010|Overall Study|Adverse Event|3|||
155386544|NCT00585195|560849160|FG011|Overall Study|Adverse Event|0|||
155386545|NCT00585195|560849161|FG012|Overall Study|Adverse Event|8|||
155386546|NCT00585195|560849162|FG013|Overall Study|Adverse Event|6|||
155386547|NCT00585195|560849163|FG014|Overall Study|Adverse Event|4|||
155386548|NCT00585195|560849164|FG015|Overall Study|Adverse Event|1|||
155386549|NCT00585195|560849165|FG016|Overall Study|Adverse Event|14|||
155386550|NCT00585195|560849166|FG017|Overall Study|Adverse Event|9|||
155386551|NCT00585195|560849167|FG018|Overall Study|Adverse Event|2|||
155386552|NCT00585195|560849168|FG019|Overall Study|Adverse Event|3|||
155386553|NCT00585195|560849169|FG020|Overall Study|Adverse Event|1|||
155386554|NCT00585195|560849149|FG000|Overall Study|Progressive Disease|2|||
155386555|NCT00585195|560849150|FG001|Overall Study|Progressive Disease|2|||
155386556|NCT00585195|560849151|FG002|Overall Study|Progressive Disease|5|||
155386557|NCT00585195|560849152|FG003|Overall Study|Progressive Disease|4|||
155386558|NCT00585195|560849153|FG004|Overall Study|Progressive Disease|6|||
155386559|NCT00585195|560849154|FG005|Overall Study|Progressive Disease|4|||
155386560|NCT00585195|560849155|FG006|Overall Study|Progressive Disease|6|||
155386561|NCT00585195|560849156|FG007|Overall Study|Progressive Disease|3|||
155386562|NCT00585195|560849157|FG008|Overall Study|Progressive Disease|0|||
155386563|NCT00585195|560849158|FG009|Overall Study|Progressive Disease|5|||
155386564|NCT00585195|560849159|FG010|Overall Study|Progressive Disease|2|||
155386565|NCT00585195|560849160|FG011|Overall Study|Progressive Disease|25|||
155386566|NCT00585195|560849161|FG012|Overall Study|Progressive Disease|29|||
155386567|NCT00585195|560849162|FG013|Overall Study|Progressive Disease|26|||
155386568|NCT00585195|560849163|FG014|Overall Study|Progressive Disease|21|||
155386569|NCT00585195|560849164|FG015|Overall Study|Progressive Disease|12|||
155386570|NCT00585195|560849165|FG016|Overall Study|Progressive Disease|94|||
155386571|NCT00585195|560849166|FG017|Overall Study|Progressive Disease|42|||
155386572|NCT00585195|560849167|FG018|Overall Study|Progressive Disease|4|||
155386573|NCT00585195|560849168|FG019|Overall Study|Progressive Disease|9|||
155386574|NCT00585195|560849169|FG020|Overall Study|Progressive Disease|8|||
155386575|NCT00585195|560849149|FG000|Overall Study|Withdrawal by Subject|1|||
155386576|NCT00585195|560849150|FG001|Overall Study|Withdrawal by Subject|1|||
155386577|NCT00585195|560849151|FG002|Overall Study|Withdrawal by Subject|2|||
155386578|NCT00585195|560849152|FG003|Overall Study|Withdrawal by Subject|2|||
155386579|NCT00585195|560849153|FG004|Overall Study|Withdrawal by Subject|0|||
155386580|NCT00585195|560849154|FG005|Overall Study|Withdrawal by Subject|0|||
155386581|NCT00585195|560849155|FG006|Overall Study|Withdrawal by Subject|0|||
155386582|NCT00585195|560849156|FG007|Overall Study|Withdrawal by Subject|1|||
155386583|NCT00585195|560849157|FG008|Overall Study|Withdrawal by Subject|0|||
155386584|NCT00585195|560849158|FG009|Overall Study|Withdrawal by Subject|0|||
155386585|NCT00585195|560849159|FG010|Overall Study|Withdrawal by Subject|3|||
155386586|NCT00585195|560849160|FG011|Overall Study|Withdrawal by Subject|8|||
155386587|NCT00585195|560849161|FG012|Overall Study|Withdrawal by Subject|15|||
155386588|NCT00585195|560849162|FG013|Overall Study|Withdrawal by Subject|0|||
155386589|NCT00585195|560849163|FG014|Overall Study|Withdrawal by Subject|3|||
155386590|NCT00585195|560849164|FG015|Overall Study|Withdrawal by Subject|0|||
155386591|NCT00585195|560849165|FG016|Overall Study|Withdrawal by Subject|7|||
155386592|NCT00585195|560849166|FG017|Overall Study|Withdrawal by Subject|1|||
155386593|NCT00585195|560849167|FG018|Overall Study|Withdrawal by Subject|2|||
155386594|NCT00585195|560849168|FG019|Overall Study|Withdrawal by Subject|2|||
155386595|NCT00585195|560849169|FG020|Overall Study|Withdrawal by Subject|0|||
155386596|NCT00585195|560849149|FG000|Overall Study|Other|0|||
155386597|NCT00585195|560849150|FG001|Overall Study|Other|1|||
155386598|NCT00585195|560849151|FG002|Overall Study|Other|1|||
155280029|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155280030|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155280031|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155280032|NCT01323660|560457822|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155280033|NCT01323660|560457823|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155280034|NCT01323660|560457824|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155280035|NCT01323660|560457825|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155280036|NCT01323660|560457826|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
155280037|NCT01323660|560457827|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155280038|NCT00751790|560457831|FG000|Overall Study|Lost to Follow-up|1|||
155280039|NCT00751790|560457831|FG000|Overall Study|Death|3|||
155280040|NCT00751790|560457831|FG000|Overall Study|Withdrawal by Subject|1|||
155280041|NCT01106976|560457835|FG000|Overall Study|Lost to Follow-up|8|||
155280042|NCT00051311|560457852|FG000|Overall Study|Starting new study|0|||
155280043|NCT00051311|560457853|FG001|Overall Study|Starting new study|1|||
155280044|NCT00051311|560457852|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
155280045|NCT00051311|560457853|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
155280046|NCT00051311|560457852|FG000|Overall Study|Death of recipient|8|||
155280047|NCT00051311|560457853|FG001|Overall Study|Death of recipient|8|||
155280048|NCT00051311|560457852|FG000|Overall Study|Recipient taken off study|4|||
155280049|NCT00051311|560457853|FG001|Overall Study|Recipient taken off study|4|||
155280050|NCT04990440|560457854|FG000|Overall Study|Sponsor's Decision|0|||
155280051|NCT04990440|560457855|FG001|Overall Study|Sponsor's Decision|0|||
155280052|NCT04990440|560457856|FG002|Overall Study|Sponsor's Decision|1|||
155280053|NCT04170023|560457857|FG000|LTE Period|Withdrawal by Subject|1|||
155280054|NCT04170023|560457858|FG001|LTE Period|Withdrawal by Subject|0|||
155280055|NCT04170023|560457859|FG002|LTE Period|Withdrawal by Subject|0|||
155280056|NCT04170023|560457857|FG000|LTE Period|Study Termination|11|||
155280057|NCT04170023|560457858|FG001|LTE Period|Study Termination|11|||
155280058|NCT04170023|560457859|FG002|LTE Period|Study Termination|5|||
155280059|NCT03712098|560457860|FG000|Overall Study|Lost to Follow-up|3|||
155280060|NCT03712098|560457861|FG001|Overall Study|Lost to Follow-up|7|||
155280061|NCT03712098|560457860|FG000|Overall Study|Withdrawal by Subject|9|||
155280062|NCT03712098|560457861|FG001|Overall Study|Withdrawal by Subject|4|||
155280063|NCT03712098|560457860|FG000|Overall Study|Protocol Violation|2|||
155280064|NCT03712098|560457861|FG001|Overall Study|Protocol Violation|1|||
155280065|NCT03566680|560457862|FG000|Overall Study|Pregnancy|1|||
155280066|NCT03566680|560457862|FG000|Overall Study|Lost to Follow-up|13|||
155280067|NCT03566680|560457862|FG000|Overall Study|Withdrawal by Subject|3|||
155280068|NCT03836664|560457866|FG000|Overall Study|Didn't complete forms and lost drug|3|||
155280069|NCT03836664|560457867|FG001|Overall Study|Didn't complete forms and lost drug|3|||
155280070|NCT02550873|560457869|FG000|Randomized Double Blind|Adverse Event|3|||
155280071|NCT02550873|560457870|FG001|Randomized Double Blind|Adverse Event|1|||
155280072|NCT02550873|560457871|FG002|Randomized Double Blind|Adverse Event|0|||
155280073|NCT02550873|560457869|FG000|Randomized Double Blind|Disease progression|1|||
155280074|NCT02550873|560457870|FG001|Randomized Double Blind|Disease progression|1|||
155280075|NCT02550873|560457871|FG002|Randomized Double Blind|Disease progression|0|||
155280076|NCT02550873|560457869|FG000|Open Label Extension|Study ongoing|0|||
155280077|NCT02550873|560457870|FG001|Open Label Extension|Study ongoing|0|||
155280078|NCT02550873|560457871|FG002|Open Label Extension|Study ongoing|111|||
155280079|NCT02684903|560457875|FG000|Overall Study|COVID-19 shutdown of lab|4|||
155280080|NCT02684903|560457876|FG001|Overall Study|COVID-19 shutdown of lab|6|||
155280081|NCT02684903|560457875|FG000|Overall Study|Lost to Follow-up|31|||
155280082|NCT02684903|560457876|FG001|Overall Study|Lost to Follow-up|41|||
155280083|NCT00394095|560459727|FG000|Screening|Withdrawal by Subject|1|||
155280084|NCT00394095|560459728|FG001|Screening|Withdrawal by Subject|0|||
155280085|NCT00394095|560459727|FG000|Randomized|Withdrawal by Subject|5|||
155280086|NCT00394095|560459728|FG001|Randomized|Withdrawal by Subject|1|||
155280087|NCT00394095|560459727|FG000|Randomized|Adverse Event|1|||
155280088|NCT00394095|560459728|FG001|Randomized|Adverse Event|1|||
155280089|NCT00394095|560459727|FG000|Randomized|Overdose|1|||
155280090|NCT00394095|560459728|FG001|Randomized|Overdose|0|||
155280091|NCT00394095|560459727|FG000|Randomized|Lost to Follow-up|1|||
155280092|NCT00394095|560459728|FG001|Randomized|Lost to Follow-up|2|||
155280093|NCT01106287|560459729|FG000|Overall Study|Adverse Event|1|||
155280094|NCT01106287|560459730|FG001|Overall Study|Adverse Event|0|||
155280095|NCT01106287|560459731|FG002|Overall Study|Adverse Event|0|||
155280096|NCT01106287|560459732|FG003|Overall Study|Adverse Event|0|||
155280097|NCT05406791|560459735|FG000|Overall Study|Lost to Follow-up|13|||
155280098|NCT05406791|560459736|FG001|Overall Study|Lost to Follow-up|10|||
155280099|NCT00515086|560459737|FG000|Overall Study|Adverse Event|1|||
155280100|NCT00515086|560459738|FG001|Overall Study|Adverse Event|1|||
155280101|NCT00515086|560459739|FG002|Overall Study|Adverse Event|2|||
155280102|NCT00515086|560459740|FG003|Overall Study|Adverse Event|3|||
155280103|NCT00515086|560459737|FG000|Overall Study|Administrative|1|||
155280104|NCT00515086|560459738|FG001|Overall Study|Administrative|1|||
155280105|NCT00515086|560459739|FG002|Overall Study|Administrative|0|||
155386599|NCT00585195|560849152|FG003|Overall Study|Other|1|||
155386600|NCT00585195|560849153|FG004|Overall Study|Other|0|||
155386601|NCT00585195|560849154|FG005|Overall Study|Other|1|||
155386602|NCT00585195|560849155|FG006|Overall Study|Other|0|||
155386603|NCT00585195|560849156|FG007|Overall Study|Other|0|||
155386604|NCT00585195|560849157|FG008|Overall Study|Other|2|||
155386605|NCT00585195|560849158|FG009|Overall Study|Other|1|||
155386606|NCT00585195|560849159|FG010|Overall Study|Other|0|||
155386607|NCT00585195|560849160|FG011|Overall Study|Other|19|||
155386608|NCT00585195|560849161|FG012|Overall Study|Other|24|||
155386609|NCT00585195|560849162|FG013|Overall Study|Other|7|||
155386610|NCT00585195|560849163|FG014|Overall Study|Other|11|||
155386611|NCT00585195|560849164|FG015|Overall Study|Other|3|||
155386612|NCT00585195|560849165|FG016|Overall Study|Other|28|||
155386613|NCT00585195|560849166|FG017|Overall Study|Other|12|||
155386614|NCT00585195|560849167|FG018|Overall Study|Other|10|||
155386615|NCT00585195|560849168|FG019|Overall Study|Other|4|||
155386616|NCT00585195|560849169|FG020|Overall Study|Other|2|||
155386617|NCT00585195|560849149|FG000|Overall Study|Randomized not treated|0|||
155386618|NCT00585195|560849150|FG001|Overall Study|Randomized not treated|0|||
155386619|NCT00585195|560849151|FG002|Overall Study|Randomized not treated|1|||
155386620|NCT00585195|560849152|FG003|Overall Study|Randomized not treated|0|||
155386621|NCT00585195|560849153|FG004|Overall Study|Randomized not treated|1|||
155386622|NCT00585195|560849154|FG005|Overall Study|Randomized not treated|0|||
155386623|NCT00585195|560849155|FG006|Overall Study|Randomized not treated|1|||
155386624|NCT00585195|560849156|FG007|Overall Study|Randomized not treated|0|||
155386625|NCT00585195|560849157|FG008|Overall Study|Randomized not treated|0|||
155386626|NCT00585195|560849158|FG009|Overall Study|Randomized not treated|0|||
155386627|NCT00585195|560849159|FG010|Overall Study|Randomized not treated|2|||
155386628|NCT00585195|560849160|FG011|Overall Study|Randomized not treated|0|||
155386629|NCT00585195|560849161|FG012|Overall Study|Randomized not treated|0|||
155386630|NCT00585195|560849162|FG013|Overall Study|Randomized not treated|0|||
155386631|NCT00585195|560849163|FG014|Overall Study|Randomized not treated|0|||
155386632|NCT00585195|560849164|FG015|Overall Study|Randomized not treated|1|||
155386633|NCT00585195|560849165|FG016|Overall Study|Randomized not treated|0|||
155386634|NCT00585195|560849166|FG017|Overall Study|Randomized not treated|1|||
155386635|NCT00585195|560849167|FG018|Overall Study|Randomized not treated|3|||
155386636|NCT00585195|560849168|FG019|Overall Study|Randomized not treated|0|||
155386637|NCT00585195|560849169|FG020|Overall Study|Randomized not treated|2|||
155386638|NCT00585195|560849149|FG000|Overall Study|Death|0|||
155386639|NCT00585195|560849150|FG001|Overall Study|Death|0|||
155386640|NCT00585195|560849151|FG002|Overall Study|Death|0|||
155386641|NCT00585195|560849152|FG003|Overall Study|Death|0|||
155386642|NCT00585195|560849153|FG004|Overall Study|Death|0|||
155386643|NCT00585195|560849154|FG005|Overall Study|Death|0|||
155386644|NCT00585195|560849155|FG006|Overall Study|Death|0|||
155386645|NCT00585195|560849156|FG007|Overall Study|Death|0|||
155386646|NCT00585195|560849157|FG008|Overall Study|Death|1|||
155386647|NCT00585195|560849158|FG009|Overall Study|Death|0|||
155386648|NCT00585195|560849159|FG010|Overall Study|Death|1|||
155386649|NCT00585195|560849160|FG011|Overall Study|Death|1|||
155386650|NCT00585195|560849161|FG012|Overall Study|Death|7|||
155386651|NCT00585195|560849162|FG013|Overall Study|Death|2|||
155386652|NCT00585195|560849163|FG014|Overall Study|Death|8|||
155386653|NCT00585195|560849164|FG015|Overall Study|Death|2|||
155386654|NCT00585195|560849165|FG016|Overall Study|Death|11|||
155386655|NCT00585195|560849166|FG017|Overall Study|Death|0|||
155045838|NCT05052697|559599392|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045839|NCT05052697|559599393|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155386656|NCT00585195|560849167|FG018|Overall Study|Death|0|||
155386657|NCT00585195|560849168|FG019|Overall Study|Death|0|||
155386658|NCT00585195|560849169|FG020|Overall Study|Death|1|||
155386659|NCT00585195|560849149|FG000|Overall Study|Lost to Follow-up|0|||
155386660|NCT00585195|560849150|FG001|Overall Study|Lost to Follow-up|0|||
155386661|NCT00585195|560849151|FG002|Overall Study|Lost to Follow-up|0|||
155386662|NCT00585195|560849152|FG003|Overall Study|Lost to Follow-up|0|||
155386663|NCT00585195|560849153|FG004|Overall Study|Lost to Follow-up|0|||
155386664|NCT00585195|560849154|FG005|Overall Study|Lost to Follow-up|0|||
155386665|NCT00585195|560849155|FG006|Overall Study|Lost to Follow-up|0|||
155386666|NCT00585195|560849156|FG007|Overall Study|Lost to Follow-up|0|||
155386667|NCT00585195|560849157|FG008|Overall Study|Lost to Follow-up|0|||
155386668|NCT00585195|560849158|FG009|Overall Study|Lost to Follow-up|0|||
155386669|NCT00585195|560849159|FG010|Overall Study|Lost to Follow-up|0|||
155386670|NCT00585195|560849160|FG011|Overall Study|Lost to Follow-up|0|||
155386671|NCT00585195|560849161|FG012|Overall Study|Lost to Follow-up|1|||
155386672|NCT00585195|560849162|FG013|Overall Study|Lost to Follow-up|0|||
155386673|NCT00585195|560849163|FG014|Overall Study|Lost to Follow-up|0|||
155386674|NCT00585195|560849164|FG015|Overall Study|Lost to Follow-up|0|||
155386675|NCT00585195|560849165|FG016|Overall Study|Lost to Follow-up|0|||
155386676|NCT00585195|560849166|FG017|Overall Study|Lost to Follow-up|2|||
155386677|NCT00585195|560849167|FG018|Overall Study|Lost to Follow-up|0|||
155386678|NCT00585195|560849168|FG019|Overall Study|Lost to Follow-up|0|||
155280106|NCT00515086|560459740|FG003|Overall Study|Administrative|0|||
155280107|NCT00515086|560459737|FG000|Overall Study|Withdrawal by Subject|1|||
155280108|NCT00515086|560459738|FG001|Overall Study|Withdrawal by Subject|0|||
155280109|NCT00515086|560459739|FG002|Overall Study|Withdrawal by Subject|0|||
155280110|NCT00515086|560459740|FG003|Overall Study|Withdrawal by Subject|1|||
155280111|NCT00515086|560459737|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
155280112|NCT00515086|560459738|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155280113|NCT00515086|560459739|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
155280114|NCT00515086|560459740|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155280115|NCT00515086|560459737|FG000|Overall Study|Lost to Follow-up|1|||
155280116|NCT00515086|560459738|FG001|Overall Study|Lost to Follow-up|0|||
155280117|NCT00515086|560459739|FG002|Overall Study|Lost to Follow-up|0|||
155280118|NCT00515086|560459740|FG003|Overall Study|Lost to Follow-up|0|||
155280119|NCT00515086|560459737|FG000|Overall Study|Study drug no longer required|0|||
155280120|NCT00515086|560459738|FG001|Overall Study|Study drug no longer required|1|||
155280121|NCT00515086|560459739|FG002|Overall Study|Study drug no longer required|0|||
155280122|NCT00515086|560459740|FG003|Overall Study|Study drug no longer required|0|||
155280123|NCT00515086|560459737|FG000|Overall Study|Death|2|||
155280124|NCT00515086|560459738|FG001|Overall Study|Death|0|||
155280125|NCT00515086|560459739|FG002|Overall Study|Death|0|||
155280126|NCT00515086|560459740|FG003|Overall Study|Death|0|||
155280127|NCT01636362|560459741|FG000|Overall Study|Physician Decision|6|||
155280128|NCT01636362|560459741|FG000|Overall Study|Subject healed, not returning|1|||
155280129|NCT01636362|560459741|FG000|Overall Study|Withdrawal by Subject|1|||
155280130|NCT03330119|560459742|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
155280131|NCT03330119|560459743|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
155280132|NCT00550732|560459747|FG000|Overall Study|Death|4|||
155280133|NCT00550732|560459747|FG000|Overall Study|Withdrawal by Subject|2|||
155280134|NCT00550732|560459747|FG000|Overall Study|Physician Decision|2|||
155280135|NCT00550732|560459747|FG000|Overall Study|Lost to Follow-up|1|||
155280136|NCT00550732|560459747|FG000|Overall Study|Palliative care|1|||
155280137|NCT00550732|560459747|FG000|Overall Study|Adverse Event|1|||
155280138|NCT00926393|560459749|FG000|Overall Study|Withdrawal by Subject|1|||
155280139|NCT00926393|560459750|FG001|Overall Study|Withdrawal by Subject|2|||
155280140|NCT00926393|560459749|FG000|Overall Study|Adverse Event|1|||
155280141|NCT00926393|560459750|FG001|Overall Study|Adverse Event|1|||
155280142|NCT01403987|560459752|FG000|Overall Study|Residents forgot their secret PIN|18|||
155280143|NCT01403987|560459753|FG001|Overall Study|Residents forgot their secret PIN|17|||
155280144|NCT01403987|560459754|FG002|Overall Study|Residents forgot their secret PIN|18|||
155280145|NCT00180674|560459756|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
155280146|NCT00180674|560459756|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
155280147|NCT03302910|560459757|FG000|Overall Study|Protocol Violation|1|||
155280148|NCT03302910|560459758|FG001|Overall Study|Protocol Violation|0|||
155280149|NCT00953160|560459760|FG000|Overall Study|Lost to Follow-up|23|||
155280150|NCT00953160|560459760|FG000|Overall Study|Withdrawal by Subject|4|||
155280151|NCT02179918|560459761|FG000|Overall Study|Death|0|||
155280152|NCT02179918|560459762|FG001|Overall Study|Death|0|||
155280153|NCT02179918|560459763|FG002|Overall Study|Death|0|||
155280154|NCT02179918|560459764|FG003|Overall Study|Death|1|||
155280155|NCT02179918|560459765|FG004|Overall Study|Death|0|||
155280156|NCT02179918|560459761|FG000|Overall Study|Lost to Follow-up|0|||
155280157|NCT02179918|560459762|FG001|Overall Study|Lost to Follow-up|0|||
155280158|NCT02179918|560459763|FG002|Overall Study|Lost to Follow-up|1|||
155280159|NCT02179918|560459764|FG003|Overall Study|Lost to Follow-up|0|||
155280160|NCT02179918|560459765|FG004|Overall Study|Lost to Follow-up|0|||
155280161|NCT02179918|560459761|FG000|Overall Study|Progressive Disease|4|||
155280162|NCT02179918|560459762|FG001|Overall Study|Progressive Disease|1|||
155280163|NCT02179918|560459763|FG002|Overall Study|Progressive Disease|1|||
155280164|NCT02179918|560459764|FG003|Overall Study|Progressive Disease|2|||
155280165|NCT02179918|560459765|FG004|Overall Study|Progressive Disease|6|||
155280166|NCT02179918|560459761|FG000|Overall Study|Other|0|||
155280167|NCT02179918|560459762|FG001|Overall Study|Other|1|||
155280168|NCT02179918|560459763|FG002|Overall Study|Other|0|||
155280169|NCT02179918|560459764|FG003|Overall Study|Other|0|||
155280170|NCT02179918|560459765|FG004|Overall Study|Other|1|||
155280171|NCT02179918|560459761|FG000|Overall Study|Subject refused further follow-up|0|||
155280172|NCT02179918|560459762|FG001|Overall Study|Subject refused further follow-up|1|||
155280173|NCT02179918|560459763|FG002|Overall Study|Subject refused further follow-up|0|||
155280174|NCT02179918|560459764|FG003|Overall Study|Subject refused further follow-up|0|||
155280175|NCT02179918|560459765|FG004|Overall Study|Subject refused further follow-up|1|||
155280176|NCT02118714|560459770|FG000|Overall Study|Lost to Follow-up|2|||
155280177|NCT02118714|560459770|FG000|Overall Study|Protocol Violation|1|||
155280178|NCT02954575|560459771|FG000|Overall Study|Withdrawal by Subject|2|||
155280179|NCT02954575|560459771|FG000|Overall Study|Adverse Event|1|||
155280180|NCT00570661|560459773|FG000|Overall Study|Disease worsening|5|||
155280181|NCT00570661|560459773|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
155280182|NCT00570661|560459773|FG000|Overall Study|Adverse Event|1|||
155280183|NCT01066156|560459774|FG000|Overall Study|ineligible|2|||
155280184|NCT01066156|560459774|FG000|Overall Study|Lost to Follow-up|7|||
155280185|NCT01066156|560459774|FG000|Overall Study|Withdrawal by Subject|1|||
155280186|NCT01734382|560459778|FG000|Part 1|Adverse Event|2|||
155280187|NCT01734382|560459779|FG001|Part 1|Adverse Event|0|||
155280188|NCT01734382|560459780|FG002|Part 1|Adverse Event|0|||
155280189|NCT01734382|560459778|FG000|Part 2|Adverse Event|0|||
155280190|NCT01734382|560459779|FG001|Part 2|Adverse Event|0|||
155280191|NCT01734382|560459780|FG002|Part 2|Adverse Event|1|||
155280192|NCT01734382|560459778|FG000|Part 2|Lack of Efficacy|0|||
155280193|NCT01734382|560459779|FG001|Part 2|Lack of Efficacy|1|||
155280194|NCT01734382|560459780|FG002|Part 2|Lack of Efficacy|1|||
155280195|NCT01734382|560459778|FG000|Part 2|Other|0|||
155280196|NCT01734382|560459779|FG001|Part 2|Other|0|||
155280197|NCT01734382|560459780|FG002|Part 2|Other|1|||
155280198|NCT01734382|560459778|FG000|Part 2|Physician Decision|0|||
155280199|NCT01734382|560459779|FG001|Part 2|Physician Decision|0|||
155280200|NCT01734382|560459780|FG002|Part 2|Physician Decision|3|||
155280201|NCT01734382|560459778|FG000|Part 2|Protocol Violation|0|||
155280202|NCT01734382|560459779|FG001|Part 2|Protocol Violation|1|||
155280203|NCT01734382|560459780|FG002|Part 2|Protocol Violation|0|||
155280204|NCT01734382|560459778|FG000|Part 2|Withdrawal by Subject|0|||
155280205|NCT01734382|560459779|FG001|Part 2|Withdrawal by Subject|0|||
155280206|NCT01734382|560459780|FG002|Part 2|Withdrawal by Subject|1|||
155280207|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
155280208|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
155280209|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
155280210|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
155280211|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
155280212|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
155280213|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
155280214|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
155280215|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
155280216|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
155280217|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
155280218|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
155280219|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
155280220|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
155280221|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
155280222|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
155280223|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
155280224|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
155280225|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
155280226|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
155280227|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
155280228|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
155280229|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
155280230|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
155280231|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
155280232|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
155280233|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
155280234|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
155280235|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
155280236|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
155280237|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
155280238|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
155280239|NCT03890120|560459781|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
155280240|NCT03890120|560459782|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
155280241|NCT03890120|560459783|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
155280242|NCT03890120|560459784|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
155280243|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
155280244|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
155280245|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
155280246|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
155280247|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
155280248|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
155280249|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
155280250|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
155280251|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
155280252|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
155386679|NCT00585195|560849169|FG020|Overall Study|Lost to Follow-up|0|||
155386680|NCT00585195|560849149|FG000|Overall Study|Site Terminated by Sponsor|0|||
155386681|NCT00585195|560849150|FG001|Overall Study|Site Terminated by Sponsor|0|||
155386682|NCT00585195|560849151|FG002|Overall Study|Site Terminated by Sponsor|0|||
155386683|NCT00585195|560849152|FG003|Overall Study|Site Terminated by Sponsor|0|||
155386684|NCT00585195|560849153|FG004|Overall Study|Site Terminated by Sponsor|0|||
155386685|NCT00585195|560849154|FG005|Overall Study|Site Terminated by Sponsor|0|||
155386686|NCT00585195|560849155|FG006|Overall Study|Site Terminated by Sponsor|0|||
155386687|NCT00585195|560849156|FG007|Overall Study|Site Terminated by Sponsor|0|||
155386688|NCT00585195|560849157|FG008|Overall Study|Site Terminated by Sponsor|0|||
155386689|NCT00585195|560849158|FG009|Overall Study|Site Terminated by Sponsor|0|||
155386690|NCT00585195|560849159|FG010|Overall Study|Site Terminated by Sponsor|0|||
155386691|NCT00585195|560849160|FG011|Overall Study|Site Terminated by Sponsor|0|||
155386692|NCT00585195|560849161|FG012|Overall Study|Site Terminated by Sponsor|1|||
155386693|NCT00585195|560849162|FG013|Overall Study|Site Terminated by Sponsor|0|||
155386694|NCT00585195|560849163|FG014|Overall Study|Site Terminated by Sponsor|0|||
155386695|NCT00585195|560849164|FG015|Overall Study|Site Terminated by Sponsor|0|||
155386696|NCT00585195|560849165|FG016|Overall Study|Site Terminated by Sponsor|0|||
155386697|NCT00585195|560849166|FG017|Overall Study|Site Terminated by Sponsor|0|||
155386698|NCT00585195|560849167|FG018|Overall Study|Site Terminated by Sponsor|0|||
155386699|NCT00585195|560849168|FG019|Overall Study|Site Terminated by Sponsor|0|||
155386700|NCT00585195|560849169|FG020|Overall Study|Site Terminated by Sponsor|0|||
155386701|NCT00585195|560849149|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
155386702|NCT00585195|560849150|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
155386703|NCT00585195|560849151|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
155386704|NCT00585195|560849152|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
155386705|NCT00585195|560849153|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
155386706|NCT00585195|560849154|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
155386707|NCT00585195|560849155|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
155386708|NCT00585195|560849156|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
155386709|NCT00585195|560849157|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
155386710|NCT00585195|560849158|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
155386711|NCT00585195|560849159|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
155386712|NCT00585195|560849160|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
155386713|NCT00585195|560849161|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
155386714|NCT00585195|560849162|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
155386715|NCT00585195|560849163|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
155386716|NCT00585195|560849164|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
155386717|NCT00585195|560849165|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
155386718|NCT00585195|560849166|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
155386719|NCT00585195|560849167|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
155386720|NCT00585195|560849168|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
155386721|NCT00585195|560849169|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
155386722|NCT00770341|560849170|FG000|Overall Study|Did not meet eligibility criteria|1|||
155386723|NCT00770341|560849171|FG001|Overall Study|Did not meet eligibility criteria|0|||
155386724|NCT00770341|560849172|FG002|Overall Study|Did not meet eligibility criteria|0|||
155386725|NCT00770341|560849170|FG000|Overall Study|Withdrawal by Subject|0|||
155386726|NCT00770341|560849171|FG001|Overall Study|Withdrawal by Subject|1|||
155386727|NCT00770341|560849172|FG002|Overall Study|Withdrawal by Subject|0|||
155386728|NCT00770341|560849170|FG000|Overall Study|Clinical Adverse Event|3|||
155386729|NCT00770341|560849171|FG001|Overall Study|Clinical Adverse Event|1|||
155386730|NCT00770341|560849172|FG002|Overall Study|Clinical Adverse Event|2|||
155386731|NCT00770341|560849170|FG000|Overall Study|Laboratory adverse event|3|||
155386732|NCT00770341|560849171|FG001|Overall Study|Laboratory adverse event|3|||
155386733|NCT00770341|560849172|FG002|Overall Study|Laboratory adverse event|0|||
155386734|NCT00770341|560849170|FG000|Overall Study|Lack of Efficacy|3|||
155386735|NCT00770341|560849171|FG001|Overall Study|Lack of Efficacy|0|||
155386736|NCT00770341|560849172|FG002|Overall Study|Lack of Efficacy|1|||
155386737|NCT00770341|560849170|FG000|Overall Study|Other|1|||
155386738|NCT00770341|560849171|FG001|Overall Study|Other|0|||
155386739|NCT00770341|560849172|FG002|Overall Study|Other|0|||
155386740|NCT00770341|560849170|FG000|Overall Study|Not treated|1|||
155386741|NCT00770341|560849171|FG001|Overall Study|Not treated|0|||
155386742|NCT00770341|560849172|FG002|Overall Study|Not treated|0|||
155386743|NCT02796560|560849178|FG000|Overall Study|Adverse Event|2|||
155386744|NCT02796560|560849179|FG001|Overall Study|Adverse Event|0|||
155386745|NCT02796560|560849178|FG000|Overall Study|Withdrawal by Subject|2|||
155386746|NCT02796560|560849179|FG001|Overall Study|Withdrawal by Subject|2|||
155386747|NCT02533570|560849181|FG000|Overall Study|Adverse Event|0|||
155386748|NCT02533570|560849182|FG001|Overall Study|Adverse Event|1|||
155386749|NCT02533570|560849183|FG002|Overall Study|Adverse Event|1|||
155386750|NCT00529958|560849184|FG000|2-Year Follow-up|Lost to Follow-up|1|||
155386751|NCT00529958|560849185|FG001|2-Year Follow-up|Lost to Follow-up|2|||
155386752|NCT00529958|560849186|FG002|2-Year Follow-up|Lost to Follow-up|2|||
155386753|NCT00529958|560849184|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
155386754|NCT00529958|560849185|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
155045840|NCT05052697|559599394|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045841|NCT05052697|559599395|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045842|NCT05052697|559599396|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155280253|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
155280254|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
155280255|NCT03890120|560459781|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
155280256|NCT03890120|560459782|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
155280257|NCT03890120|560459783|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
155280258|NCT03890120|560459784|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
155280259|NCT04537949|560459785|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
155280260|NCT04537949|560459786|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
155280261|NCT04537949|560459787|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
155280262|NCT04537949|560459788|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
155280263|NCT04537949|560459789|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
155280264|NCT04537949|560459790|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
155280265|NCT04537949|560459791|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
155280266|NCT04537949|560459792|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
155280267|NCT04537949|560459785|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
155280268|NCT04537949|560459786|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
155280269|NCT04537949|560459787|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
155280270|NCT04537949|560459788|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
155280271|NCT04537949|560459789|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
155280272|NCT04537949|560459790|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
155280273|NCT04537949|560459791|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
155280274|NCT04537949|560459792|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
155280275|NCT04537949|560459785|FG000|Follow-up Phase|Lost to Follow-up|0|||
155280276|NCT04537949|560459786|FG001|Follow-up Phase|Lost to Follow-up|3|||
155280277|NCT04537949|560459787|FG002|Follow-up Phase|Lost to Follow-up|0|||
155280278|NCT04537949|560459788|FG003|Follow-up Phase|Lost to Follow-up|0|||
155280279|NCT04537949|560459789|FG004|Follow-up Phase|Lost to Follow-up|0|||
155280280|NCT04537949|560459790|FG005|Follow-up Phase|Lost to Follow-up|0|||
155280281|NCT04537949|560459791|FG006|Follow-up Phase|Lost to Follow-up|0|||
155280282|NCT04537949|560459792|FG007|Follow-up Phase|Lost to Follow-up|0|||
155280283|NCT04537949|560459785|FG000|Follow-up Phase|personal reasons|0|||
155280284|NCT04537949|560459786|FG001|Follow-up Phase|personal reasons|0|||
155280285|NCT04537949|560459787|FG002|Follow-up Phase|personal reasons|0|||
155280286|NCT04537949|560459788|FG003|Follow-up Phase|personal reasons|1|||
155280287|NCT04537949|560459789|FG004|Follow-up Phase|personal reasons|1|||
155280288|NCT04537949|560459790|FG005|Follow-up Phase|personal reasons|0|||
155280289|NCT04537949|560459791|FG006|Follow-up Phase|personal reasons|0|||
155280290|NCT04537949|560459792|FG007|Follow-up Phase|personal reasons|0|||
155280291|NCT04537949|560459785|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155280292|NCT04537949|560459786|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155280293|NCT04537949|560459787|FG002|Follow-up Phase|Withdrawal by Subject|0|||
155280294|NCT04537949|560459788|FG003|Follow-up Phase|Withdrawal by Subject|0|||
155280295|NCT04537949|560459789|FG004|Follow-up Phase|Withdrawal by Subject|1|||
155280296|NCT04537949|560459790|FG005|Follow-up Phase|Withdrawal by Subject|0|||
155280297|NCT04537949|560459791|FG006|Follow-up Phase|Withdrawal by Subject|0|||
155280298|NCT04537949|560459792|FG007|Follow-up Phase|Withdrawal by Subject|0|||
155280299|NCT04003974|560459793|FG000|Overall Study|Missing|1|||
155280300|NCT04003974|560459794|FG001|Overall Study|Missing|0|||
155280301|NCT04003974|560459793|FG000|Overall Study|Withdrawal by Subject|0|||
155280302|NCT04003974|560459794|FG001|Overall Study|Withdrawal by Subject|2|||
155280303|NCT02400307|560459795|FG000|Overall Study|Enrolled and Never Dosed|1|||
155280304|NCT02400307|560459796|FG001|Overall Study|Enrolled and Never Dosed|0|||
155280305|NCT01052662|560459799|FG000|Overall Study|Lost to Follow-up|15|||
155280306|NCT01052662|560459800|FG001|Overall Study|Lost to Follow-up|13|||
155280307|NCT01052662|560459801|FG002|Overall Study|Lost to Follow-up|18|||
155280308|NCT01052662|560459799|FG000|Overall Study|Withdrawal by Subject|3|||
155280309|NCT01052662|560459800|FG001|Overall Study|Withdrawal by Subject|2|||
155280310|NCT01052662|560459801|FG002|Overall Study|Withdrawal by Subject|1|||
155280311|NCT01052662|560459799|FG000|Overall Study|Pharmacy issue|1|||
155280312|NCT01052662|560459800|FG001|Overall Study|Pharmacy issue|3|||
155280313|NCT01052662|560459801|FG002|Overall Study|Pharmacy issue|3|||
155280314|NCT01052662|560459799|FG000|Overall Study|Adverse Event|1|||
155280315|NCT01052662|560459800|FG001|Overall Study|Adverse Event|1|||
155280316|NCT01052662|560459801|FG002|Overall Study|Adverse Event|0|||
155280317|NCT01052662|560459799|FG000|Overall Study|Legal Problem|2|||
155280318|NCT01052662|560459800|FG001|Overall Study|Legal Problem|0|||
155280319|NCT01052662|560459801|FG002|Overall Study|Legal Problem|0|||
155280320|NCT01052662|560459799|FG000|Overall Study|Administrative|0|||
155280321|NCT01052662|560459800|FG001|Overall Study|Administrative|3|||
155280322|NCT01052662|560459801|FG002|Overall Study|Administrative|0|||
155386755|NCT00529958|560849186|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
155386756|NCT00529958|560849184|FG000|5-Year Follow-up|Lost to Follow-up|2|||
155045843|NCT05052697|559599397|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155280323|NCT00479674|560459804|FG000|Overall Study|Adverse Event|18|||
155280324|NCT00479674|560459804|FG000|Overall Study|Withdrawal by Subject|6|||
155280325|NCT00479674|560459804|FG000|Overall Study|Physician Decision|14|||
155280326|NCT00479674|560459804|FG000|Overall Study|none provided|3|||
155280327|NCT02478359|560459806|FG000|Overall Study|Disenrolled from health plan|106|||
155280328|NCT02478359|560459807|FG001|Overall Study|Disenrolled from health plan|65|||
155280329|NCT03293485|560459811|FG000|Overall Study|Death|1|||
155280330|NCT03293485|560459811|FG000|Overall Study|Screen Failure|2|||
155280331|NCT03293485|560459811|FG000|Overall Study|Withdrawal by Subject|2|||
155280332|NCT03023332|560459812|FG000|Overall Study|Withdrawal by Subject|10|||
155280333|NCT03023332|560459813|FG001|Overall Study|Withdrawal by Subject|5|||
155280334|NCT03023332|560459814|FG002|Overall Study|Withdrawal by Subject|4|||
155280335|NCT03023332|560459815|FG003|Overall Study|Withdrawal by Subject|7|||
155280336|NCT03023332|560459812|FG000|Overall Study|Lost to Follow-up|13|||
155280337|NCT03023332|560459813|FG001|Overall Study|Lost to Follow-up|16|||
155280338|NCT03023332|560459814|FG002|Overall Study|Lost to Follow-up|8|||
155280339|NCT03023332|560459815|FG003|Overall Study|Lost to Follow-up|13|||
155280340|NCT03023332|560459812|FG000|Overall Study|Death|1|||
155280341|NCT03023332|560459813|FG001|Overall Study|Death|0|||
155280342|NCT03023332|560459814|FG002|Overall Study|Death|0|||
155280343|NCT03023332|560459815|FG003|Overall Study|Death|0|||
155280344|NCT02013687|560459816|FG000|Overall Study|Lost to Follow-up|0|||
155280345|NCT02013687|560459817|FG001|Overall Study|Lost to Follow-up|0|||
155280346|NCT02013687|560459818|FG002|Overall Study|Lost to Follow-up|1|||
155280347|NCT02013687|560459819|FG003|Overall Study|Lost to Follow-up|0|||
155280348|NCT02013687|560459816|FG000|Overall Study|Protocol Violation|0|||
155280349|NCT02013687|560459817|FG001|Overall Study|Protocol Violation|0|||
155280350|NCT02013687|560459818|FG002|Overall Study|Protocol Violation|0|||
155280351|NCT02013687|560459819|FG003|Overall Study|Protocol Violation|1|||
155280352|NCT02013687|560459816|FG000|Overall Study|Withdrawal by Subject|0|||
155280353|NCT02013687|560459817|FG001|Overall Study|Withdrawal by Subject|0|||
155280354|NCT02013687|560459818|FG002|Overall Study|Withdrawal by Subject|0|||
155280355|NCT02013687|560459819|FG003|Overall Study|Withdrawal by Subject|1|||
155280356|NCT02013687|560459816|FG000|Overall Study|Missed visits due to patient travel|0|||
155280357|NCT02013687|560459817|FG001|Overall Study|Missed visits due to patient travel|0|||
155280358|NCT02013687|560459818|FG002|Overall Study|Missed visits due to patient travel|1|||
155280359|NCT02013687|560459819|FG003|Overall Study|Missed visits due to patient travel|0|||
155280360|NCT01782326|560459820|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
155280361|NCT01782326|560459821|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
155280362|NCT01782326|560459820|FG000|Planned Treatment Epoch|Death|29|||
155280363|NCT01782326|560459821|FG001|Planned Treatment Epoch|Death|30|||
155280364|NCT01782326|560459820|FG000|Planned Treatment Epoch|Physician Decision|18|||
155280365|NCT01782326|560459821|FG001|Planned Treatment Epoch|Physician Decision|16|||
155280366|NCT01782326|560459820|FG000|Planned Treatment Epoch|Protocol deviation|2|||
155280367|NCT01782326|560459821|FG001|Planned Treatment Epoch|Protocol deviation|3|||
155280368|NCT01782326|560459820|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
155280369|NCT01782326|560459821|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
155280370|NCT01782326|560459820|FG000|Planned Treatment Epoch|Technical problems|0|||
155280371|NCT01782326|560459821|FG001|Planned Treatment Epoch|Technical problems|4|||
155280372|NCT01782326|560459820|FG000|Double-blind Treatment|Adverse Event|129|||
155280373|NCT01782326|560459821|FG001|Double-blind Treatment|Adverse Event|145|||
155280374|NCT01782326|560459820|FG000|Double-blind Treatment|Subject/guardian decision|111|||
155280375|NCT01782326|560459821|FG001|Double-blind Treatment|Subject/guardian decision|125|||
155280376|NCT01782326|560459820|FG000|Double-blind Treatment|Lack of Efficacy|17|||
155280377|NCT01782326|560459821|FG001|Double-blind Treatment|Lack of Efficacy|22|||
155280378|NCT01782326|560459820|FG000|Double-blind Treatment|Physician Decision|13|||
155280379|NCT01782326|560459821|FG001|Double-blind Treatment|Physician Decision|16|||
155280380|NCT01782326|560459820|FG000|Double-blind Treatment|Protocol deviation|8|||
155280381|NCT01782326|560459821|FG001|Double-blind Treatment|Protocol deviation|7|||
155280382|NCT01782326|560459820|FG000|Double-blind Treatment|Technical problems|0|||
155280383|NCT01782326|560459821|FG001|Double-blind Treatment|Technical problems|5|||
155280384|NCT03633903|560459822|FG000|Overall Study|Withdrawal by Subject|1|||
155280385|NCT03633903|560459823|FG001|Overall Study|Withdrawal by Subject|2|||
155280386|NCT03633903|560459822|FG000|Overall Study|Lost to Follow-up|5|||
155280387|NCT03633903|560459823|FG001|Overall Study|Lost to Follow-up|5|||
155280388|NCT05968482|560459824|FG000|First Crossover Period|Withdrawal by Subject|0|||
155280389|NCT05968482|560459825|FG001|First Crossover Period|Withdrawal by Subject|0|||
155280390|NCT05968482|560459826|FG002|First Crossover Period|Withdrawal by Subject|1|||
155280391|NCT05968482|560459827|FG003|First Crossover Period|Withdrawal by Subject|0|||
155280392|NCT05968482|560459828|FG004|First Crossover Period|Withdrawal by Subject|0|||
155280393|NCT05968482|560459829|FG005|First Crossover Period|Withdrawal by Subject|0|||
155280394|NCT05968482|560459824|FG000|First Crossover Period|Adverse Event|0|||
155280395|NCT05968482|560459825|FG001|First Crossover Period|Adverse Event|0|||
155280396|NCT05968482|560459826|FG002|First Crossover Period|Adverse Event|0|||
155280397|NCT05968482|560459827|FG003|First Crossover Period|Adverse Event|0|||
155280398|NCT05968482|560459828|FG004|First Crossover Period|Adverse Event|0|||
155280399|NCT05968482|560459829|FG005|First Crossover Period|Adverse Event|1|||
155280400|NCT05968482|560459824|FG000|Second Crossover Period|Withdrawal by Subject|0|||
155280401|NCT05968482|560459825|FG001|Second Crossover Period|Withdrawal by Subject|0|||
155280402|NCT05968482|560459826|FG002|Second Crossover Period|Withdrawal by Subject|0|||
155280403|NCT05968482|560459827|FG003|Second Crossover Period|Withdrawal by Subject|0|||
155280404|NCT05968482|560459828|FG004|Second Crossover Period|Withdrawal by Subject|1|||
155280405|NCT05968482|560459829|FG005|Second Crossover Period|Withdrawal by Subject|0|||
155280406|NCT05968482|560459824|FG000|Third Crossover Period|Adverse Event|0|||
155280407|NCT05968482|560459825|FG001|Third Crossover Period|Adverse Event|0|||
155280408|NCT05968482|560459826|FG002|Third Crossover Period|Adverse Event|0|||
155280409|NCT05968482|560459827|FG003|Third Crossover Period|Adverse Event|0|||
155280410|NCT05968482|560459828|FG004|Third Crossover Period|Adverse Event|1|||
155280411|NCT05968482|560459829|FG005|Third Crossover Period|Adverse Event|0|||
155280412|NCT05968482|560459824|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
155280413|NCT05968482|560459825|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
155280414|NCT05968482|560459826|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
155280415|NCT05968482|560459827|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
155280416|NCT05968482|560459828|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
155280417|NCT05968482|560459829|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
155280418|NCT02559817|560459830|FG000|Treatment Period|Adverse Event|1|||
155280419|NCT02559817|560459831|FG001|Treatment Period|Adverse Event|0|||
155280420|NCT02559817|560459832|FG002|Treatment Period|Adverse Event|1|||
155280421|NCT02559817|560459833|FG003|Treatment Period|Adverse Event|0|||
155280422|NCT02559817|560459834|FG004|Treatment Period|Adverse Event|0|||
155280423|NCT02559817|560459830|FG000|Treatment Period|Lack of Efficacy|0|||
155280424|NCT02559817|560459831|FG001|Treatment Period|Lack of Efficacy|1|||
155280425|NCT02559817|560459832|FG002|Treatment Period|Lack of Efficacy|0|||
155280426|NCT02559817|560459833|FG003|Treatment Period|Lack of Efficacy|0|||
155280427|NCT02559817|560459834|FG004|Treatment Period|Lack of Efficacy|0|||
155280428|NCT02559817|560459830|FG000|Treatment Period|Lost to Follow-up|0|||
155280429|NCT02559817|560459831|FG001|Treatment Period|Lost to Follow-up|1|||
155280430|NCT02559817|560459832|FG002|Treatment Period|Lost to Follow-up|0|||
155280431|NCT02559817|560459833|FG003|Treatment Period|Lost to Follow-up|1|||
155280432|NCT02559817|560459834|FG004|Treatment Period|Lost to Follow-up|0|||
155280433|NCT02559817|560459830|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
155280434|NCT02559817|560459831|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
155280435|NCT02559817|560459832|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
155280436|NCT02559817|560459833|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
155280437|NCT02559817|560459834|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
155280438|NCT02559817|560459830|FG000|Treatment Period|Protocol Violation|0|||
155280439|NCT02559817|560459831|FG001|Treatment Period|Protocol Violation|0|||
155280440|NCT02559817|560459832|FG002|Treatment Period|Protocol Violation|0|||
155280441|NCT02559817|560459833|FG003|Treatment Period|Protocol Violation|1|||
155280442|NCT02559817|560459834|FG004|Treatment Period|Protocol Violation|0|||
155280443|NCT01657682|560459835|FG000|Overall Study|Lost to Follow-up|1|||
155280444|NCT01657682|560459836|FG001|Overall Study|Lost to Follow-up|0|||
155280445|NCT01657682|560459837|FG002|Overall Study|Lost to Follow-up|0|||
155280446|NCT01657682|560459835|FG000|Overall Study|Withdrawal by Subject|0|||
155280447|NCT01657682|560459836|FG001|Overall Study|Withdrawal by Subject|1|||
155280448|NCT01657682|560459837|FG002|Overall Study|Withdrawal by Subject|1|||
155280449|NCT01657682|560459835|FG000|Overall Study|Adverse Event|0|||
155280450|NCT01657682|560459836|FG001|Overall Study|Adverse Event|1|||
155280451|NCT01657682|560459837|FG002|Overall Study|Adverse Event|0|||
155280452|NCT03389893|560459838|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
155280453|NCT03389893|560459839|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
155280454|NCT03389893|560459840|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
155280455|NCT03389893|560459841|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
155280456|NCT03389893|560459838|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
155280457|NCT03389893|560459839|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
155280458|NCT03389893|560459840|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
155280459|NCT03389893|560459841|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
155280460|NCT03389893|560459838|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
155386757|NCT00529958|560849185|FG001|5-Year Follow-up|Lost to Follow-up|3|||
155280461|NCT03389893|560459839|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
155280462|NCT03389893|560459840|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
155280463|NCT03389893|560459841|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
155280464|NCT03389893|560459838|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
155386758|NCT00529958|560849186|FG002|5-Year Follow-up|Lost to Follow-up|1|||
155386759|NCT00529958|560849184|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
155386760|NCT00529958|560849185|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
155386761|NCT00529958|560849186|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
155386762|NCT03816332|560849187|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
155386763|NCT03816332|560849187|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
155386764|NCT03534284|560849190|FG000|Overall Study|Death|2|||
155386765|NCT03534284|560849191|FG001|Overall Study|Death|3|||
155386766|NCT03534284|560849192|FG002|Overall Study|Death|3|||
155386767|NCT03534284|560849190|FG000|Overall Study|Withdrawal by Subject|5|||
155386768|NCT03534284|560849191|FG001|Overall Study|Withdrawal by Subject|0|||
155386769|NCT03534284|560849192|FG002|Overall Study|Withdrawal by Subject|0|||
155386770|NCT03316300|560849193|FG000|Overall Study|Withdrawal by Subject|3|||
155386771|NCT03316300|560849194|FG001|Overall Study|Withdrawal by Subject|2|||
155386772|NCT03316300|560849193|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
155386773|NCT03316300|560849194|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
155386774|NCT03316300|560849193|FG000|Overall Study|Adverse Event|1|||
155386775|NCT03316300|560849194|FG001|Overall Study|Adverse Event|0|||
155386776|NCT03316300|560849193|FG000|Overall Study|COVID-19|0|||
155386777|NCT03316300|560849194|FG001|Overall Study|COVID-19|1|||
155386778|NCT03164564|560849195|FG000|Overall Study|Death|3|||
155386779|NCT03164564|560849196|FG001|Overall Study|Death|0|||
155386780|NCT03164564|560849195|FG000|Overall Study|Withdrawal by Subject|20|||
155386781|NCT03164564|560849196|FG001|Overall Study|Withdrawal by Subject|15|||
155386782|NCT03164564|560849195|FG000|Overall Study|Lost to Follow-up|2|||
155386783|NCT03164564|560849196|FG001|Overall Study|Lost to Follow-up|0|||
155386784|NCT03164564|560849195|FG000|Overall Study|Physician Decision|0|||
155386785|NCT03164564|560849196|FG001|Overall Study|Physician Decision|1|||
155386786|NCT03164564|560849195|FG000|Overall Study|Adverse Event|0|||
155386787|NCT03164564|560849196|FG001|Overall Study|Adverse Event|1|||
155386788|NCT03164564|560849195|FG000|Overall Study|Ongoing|1586|||
155386789|NCT03164564|560849196|FG001|Overall Study|Ongoing|1586|||
155386790|NCT00294554|560851534|FG000|Overall Study|Lack of Efficacy|0|||
155386791|NCT00294554|560851535|FG001|Overall Study|Lack of Efficacy|1|||
155386792|NCT00294554|560851534|FG000|Overall Study|Physician Decision|0|||
155386793|NCT00294554|560851535|FG001|Overall Study|Physician Decision|1|||
155386794|NCT02544217|560851536|FG000|Overall Study|Withdrawal by Subject|1|||
155386795|NCT02544217|560851537|FG001|Overall Study|Withdrawal by Subject|1|||
155386796|NCT02544217|560851538|FG002|Overall Study|Withdrawal by Subject|0|||
155386797|NCT02544217|560851539|FG003|Overall Study|Withdrawal by Subject|0|||
155386798|NCT02544217|560851540|FG004|Overall Study|Withdrawal by Subject|0|||
155386799|NCT02544217|560851541|FG005|Overall Study|Withdrawal by Subject|0|||
155386800|NCT00887679|560851542|FG000|Overall Study|Withdrawal by Subject|1|||
155386801|NCT00887679|560851542|FG000|Overall Study|Lost to Follow-up|4|||
155386802|NCT00887679|560851542|FG000|Overall Study|Physician Decision|5|||
155386803|NCT02683941|560851543|FG000|Double-blind Phase|Adverse Event|0|||
155386804|NCT02683941|560851544|FG001|Double-blind Phase|Adverse Event|1|||
155386805|NCT02683941|560851543|FG000|Double-blind Phase|Withdrawal by Subject|4|||
154944163|NCT00358826|559220891|FG000|MDCT Substudy|Withdrawal by Subject|0|||
154944164|NCT00358826|559220892|FG001|MDCT Substudy|Withdrawal by Subject|0|||
155280465|NCT03389893|560459839|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
155280466|NCT03389893|560459840|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
155280467|NCT03389893|560459841|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
155280468|NCT01719861|560459845|FG000|Cycle 1|Death|4|||
155280469|NCT01719861|560459845|FG000|Cycle 2|Death|1|||
155280470|NCT02034435|560459856|FG000|Overall Study|Withdrawal by Subject|1|||
155280471|NCT02034435|560459857|FG001|Overall Study|Withdrawal by Subject|0|||
155280472|NCT02034435|560459858|FG002|Overall Study|Withdrawal by Subject|0|||
155280473|NCT02034435|560459859|FG003|Overall Study|Withdrawal by Subject|0|||
155280474|NCT02034435|560459856|FG000|Overall Study|Illness|0|||
155280475|NCT02034435|560459857|FG001|Overall Study|Illness|2|||
155280476|NCT02034435|560459858|FG002|Overall Study|Illness|0|||
155280477|NCT02034435|560459859|FG003|Overall Study|Illness|0|||
155280478|NCT02034435|560459856|FG000|Overall Study|Inadequate IV access|1|||
155280479|NCT02034435|560459857|FG001|Overall Study|Inadequate IV access|0|||
155280480|NCT02034435|560459858|FG002|Overall Study|Inadequate IV access|0|||
155280481|NCT02034435|560459859|FG003|Overall Study|Inadequate IV access|1|||
155280482|NCT00772928|560459860|FG000|Overall Study|Lost to Follow-up|9|||
155280483|NCT00772928|560459861|FG001|Overall Study|Lost to Follow-up|6|||
155280484|NCT00772928|560459860|FG000|Overall Study|Protocol Violation|10|||
155280485|NCT00772928|560459861|FG001|Overall Study|Protocol Violation|12|||
155386806|NCT02683941|560851544|FG001|Double-blind Phase|Withdrawal by Subject|2|||
155386807|NCT02683941|560851543|FG000|Double-blind Phase|Lost to Follow-up|1|||
155386808|NCT02683941|560851544|FG001|Double-blind Phase|Lost to Follow-up|0|||
155280486|NCT00772928|560459860|FG000|Overall Study|Withdrawal by Subject|25|||
155280487|NCT00772928|560459861|FG001|Overall Study|Withdrawal by Subject|22|||
155280488|NCT00772928|560459860|FG000|Overall Study|Did not receive vaccine|0|||
155386809|NCT02683941|560851543|FG000|Double-blind Phase|Disease Progression|5|||
155386810|NCT02683941|560851544|FG001|Double-blind Phase|Disease Progression|2|||
155386811|NCT02683941|560851543|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
155386812|NCT02683941|560851544|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
155386813|NCT02683941|560851543|FG000|Open-label Treatment Phase|Disease Progression|1|||
155386814|NCT02683941|560851544|FG001|Open-label Treatment Phase|Disease Progression|2|||
155386815|NCT02683941|560851543|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
155386816|NCT02683941|560851544|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
155386817|NCT02683941|560851543|FG000|Open-label Treatment Phase|Other|1|||
155386818|NCT02683941|560851544|FG001|Open-label Treatment Phase|Other|0|||
155386819|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
155386820|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
155386821|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
155386822|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
155386823|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
155280489|NCT00772928|560459861|FG001|Overall Study|Did not receive vaccine|1|||
155280490|NCT04955626|560459867|FG000|Blinded Period|Lost to Follow-up|28|||
155280491|NCT04955626|560459868|FG001|Blinded Period|Lost to Follow-up|28|||
155280492|NCT04955626|560459869|FG002|Blinded Period|Lost to Follow-up|7|||
155280493|NCT04955626|560459870|FG003|Blinded Period|Lost to Follow-up|14|||
155280494|NCT04955626|560459871|FG004|Blinded Period|Lost to Follow-up|3|||
155280495|NCT04955626|560459872|FG005|Blinded Period|Lost to Follow-up|2|||
155280496|NCT04955626|560459873|FG006|Blinded Period|Lost to Follow-up|6|||
155280497|NCT04955626|560459874|FG007|Blinded Period|Lost to Follow-up|4|||
155280498|NCT04955626|560459875|FG008|Blinded Period|Lost to Follow-up|5|||
155280499|NCT04955626|560459876|FG009|Blinded Period|Lost to Follow-up|8|||
155280500|NCT04955626|560459877|FG010|Blinded Period|Lost to Follow-up|10|||
155280501|NCT04955626|560459878|FG011|Blinded Period|Lost to Follow-up|32|||
155280502|NCT04955626|560459879|FG012|Blinded Period|Lost to Follow-up|0|||
155280503|NCT04955626|560459880|FG013|Blinded Period|Lost to Follow-up|0|||
155280504|NCT04955626|560459881|FG014|Blinded Period|Lost to Follow-up|0|||
155280505|NCT04955626|560459882|FG015|Blinded Period|Lost to Follow-up|12|||
155280506|NCT04955626|560459883|FG016|Blinded Period|Lost to Follow-up|2|||
155280507|NCT04955626|560459884|FG017|Blinded Period|Lost to Follow-up|5|||
155280508|NCT04955626|560459885|FG018|Blinded Period|Lost to Follow-up|0|||
155280509|NCT04955626|560459886|FG019|Blinded Period|Lost to Follow-up|0|||
155280510|NCT04955626|560459887|FG020|Blinded Period|Lost to Follow-up|0|||
155280511|NCT04955626|560459888|FG021|Blinded Period|Lost to Follow-up|0|||
155280512|NCT04955626|560459889|FG022|Blinded Period|Lost to Follow-up|0|||
155280513|NCT04955626|560459890|FG023|Blinded Period|Lost to Follow-up|0|||
155280514|NCT04955626|560459891|FG024|Blinded Period|Lost to Follow-up|3|||
155280515|NCT04955626|560459892|FG025|Blinded Period|Lost to Follow-up|1|||
155280516|NCT04955626|560459893|FG026|Blinded Period|Lost to Follow-up|2|||
155280517|NCT04955626|560459894|FG027|Blinded Period|Lost to Follow-up|2|||
155280518|NCT04955626|560459895|FG028|Blinded Period|Lost to Follow-up|2|||
155280519|NCT04955626|560459896|FG029|Blinded Period|Lost to Follow-up|0|||
155280520|NCT04955626|560459897|FG030|Blinded Period|Lost to Follow-up|0|||
155280521|NCT04955626|560459898|FG031|Blinded Period|Lost to Follow-up|0|||
155280522|NCT04955626|560459899|FG032|Blinded Period|Lost to Follow-up|0|||
155280523|NCT04955626|560459900|FG033|Blinded Period|Lost to Follow-up|0|||
155280524|NCT04955626|560459901|FG034|Blinded Period|Lost to Follow-up|0|||
155280525|NCT04955626|560459902|FG035|Blinded Period|Lost to Follow-up|0|||
155280526|NCT04955626|560459867|FG000|Blinded Period|Protocol Violation|5|||
155280527|NCT04955626|560459868|FG001|Blinded Period|Protocol Violation|14|||
155280528|NCT04955626|560459869|FG002|Blinded Period|Protocol Violation|0|||
155280529|NCT04955626|560459870|FG003|Blinded Period|Protocol Violation|1|||
155280530|NCT04955626|560459871|FG004|Blinded Period|Protocol Violation|2|||
155280531|NCT04955626|560459872|FG005|Blinded Period|Protocol Violation|2|||
155280532|NCT04955626|560459873|FG006|Blinded Period|Protocol Violation|0|||
155280533|NCT04955626|560459874|FG007|Blinded Period|Protocol Violation|0|||
155280534|NCT04955626|560459875|FG008|Blinded Period|Protocol Violation|0|||
155280535|NCT04955626|560459876|FG009|Blinded Period|Protocol Violation|4|||
155280536|NCT04955626|560459877|FG010|Blinded Period|Protocol Violation|6|||
155280537|NCT04955626|560459878|FG011|Blinded Period|Protocol Violation|1|||
155280538|NCT04955626|560459879|FG012|Blinded Period|Protocol Violation|0|||
155280539|NCT04955626|560459880|FG013|Blinded Period|Protocol Violation|0|||
155280540|NCT04955626|560459881|FG014|Blinded Period|Protocol Violation|2|||
155280541|NCT04955626|560459882|FG015|Blinded Period|Protocol Violation|6|||
155280542|NCT04955626|560459883|FG016|Blinded Period|Protocol Violation|4|||
155280543|NCT04955626|560459884|FG017|Blinded Period|Protocol Violation|6|||
155280544|NCT04955626|560459885|FG018|Blinded Period|Protocol Violation|0|||
155280545|NCT04955626|560459886|FG019|Blinded Period|Protocol Violation|1|||
155280546|NCT04955626|560459887|FG020|Blinded Period|Protocol Violation|0|||
155280547|NCT04955626|560459888|FG021|Blinded Period|Protocol Violation|1|||
155280548|NCT04955626|560459889|FG022|Blinded Period|Protocol Violation|0|||
155280549|NCT04955626|560459890|FG023|Blinded Period|Protocol Violation|0|||
155280550|NCT04955626|560459891|FG024|Blinded Period|Protocol Violation|4|||
155280551|NCT04955626|560459892|FG025|Blinded Period|Protocol Violation|6|||
155280552|NCT04955626|560459893|FG026|Blinded Period|Protocol Violation|5|||
155280553|NCT04955626|560459894|FG027|Blinded Period|Protocol Violation|3|||
155280554|NCT04955626|560459895|FG028|Blinded Period|Protocol Violation|4|||
155386824|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
155386825|NCT02683941|560851543|FG000|Open-label Follow-up Phase|Other|8|||
155386826|NCT02683941|560851544|FG001|Open-label Follow-up Phase|Other|1|||
155386827|NCT02075541|560851546|FG000|Overall Study|Serious Adverse Event|1|||
155386828|NCT02075541|560851547|FG001|Overall Study|Serious Adverse Event|4|||
155386829|NCT02075541|560851546|FG000|Overall Study|Protocol Violation|1|||
155386830|NCT02075541|560851547|FG001|Overall Study|Protocol Violation|0|||
155386831|NCT02075541|560851546|FG000|Overall Study|Withdrawal by Subject|1|||
155386832|NCT02075541|560851547|FG001|Overall Study|Withdrawal by Subject|3|||
155386833|NCT02075541|560851546|FG000|Overall Study|Sponsor study termination|0|||
155386834|NCT02075541|560851547|FG001|Overall Study|Sponsor study termination|1|||
155386835|NCT02075541|560851546|FG000|Overall Study|Other- unable to perform study procedure|1|||
155386836|NCT02075541|560851547|FG001|Overall Study|Other- unable to perform study procedure|0|||
155386837|NCT02434939|560851548|FG000|Overall Study|Lack of Efficacy|34|||
155386838|NCT02434939|560851549|FG001|Overall Study|Lack of Efficacy|48|||
155386839|NCT02434939|560851548|FG000|Overall Study|Withdrawal by Subject|3|||
155386840|NCT02434939|560851549|FG001|Overall Study|Withdrawal by Subject|0|||
155386841|NCT02434939|560851548|FG000|Overall Study|Adverse Event|0|||
155386842|NCT02434939|560851549|FG001|Overall Study|Adverse Event|1|||
155386843|NCT03181451|560851550|FG000|Overall Study|Adverse Event|0|||
155386844|NCT03181451|560851551|FG001|Overall Study|Adverse Event|1|||
155386845|NCT03181451|560851552|FG002|Overall Study|Adverse Event|0|||
155386846|NCT03181451|560851550|FG000|Overall Study|Withdrawal by Subject|0|||
155386847|NCT03181451|560851551|FG001|Overall Study|Withdrawal by Subject|1|||
155386848|NCT03181451|560851552|FG002|Overall Study|Withdrawal by Subject|0|||
155386849|NCT01326533|560851553|FG000|Overall Study|Lost to Follow-up|2|||
155386850|NCT01326533|560851554|FG001|Overall Study|Lost to Follow-up|0|||
155386851|NCT01326533|560851553|FG000|Overall Study|Withdrawal by Subject|1|||
155386852|NCT01326533|560851554|FG001|Overall Study|Withdrawal by Subject|0|||
155386853|NCT01326533|560851553|FG000|Overall Study|Adverse Event|1|||
155386854|NCT01326533|560851554|FG001|Overall Study|Adverse Event|0|||
155386855|NCT04079803|560851555|FG000|Overall Study|Withdrawal by Subject|0|||
155386856|NCT04079803|560851556|FG001|Overall Study|Withdrawal by Subject|0|||
155386857|NCT04079803|560851557|FG002|Overall Study|Withdrawal by Subject|1|||
155386858|NCT00807235|560851565|FG000|Overall Study|Adverse Event|1|||
155386859|NCT00807235|560851566|FG001|Overall Study|Adverse Event|0|||
155386860|NCT01242800|560851569|FG000|Overall Study|Patient refusal|0|||
155386861|NCT01242800|560851570|FG001|Overall Study|Patient refusal|10|||
155386862|NCT01242800|560851569|FG000|Overall Study|Physician Decision|0|||
155386863|NCT01242800|560851570|FG001|Overall Study|Physician Decision|1|||
155386864|NCT01242800|560851569|FG000|Overall Study|Disease progression|0|||
155386865|NCT01242800|560851570|FG001|Overall Study|Disease progression|3|||
155386866|NCT01242800|560851569|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
155386867|NCT01242800|560851570|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
155386868|NCT01242800|560851569|FG000|Overall Study|Reasons not reported|0|||
155386869|NCT01242800|560851570|FG001|Overall Study|Reasons not reported|4|||
155386870|NCT00511901|560851579|FG000|Overall Study|Withdrawal by Subject|1|||
155386871|NCT00511901|560851580|FG001|Overall Study|Withdrawal by Subject|3|||
155386872|NCT02447172|560851581|FG000|Overall Study|Adverse Event|11|||
155386873|NCT02447172|560851582|FG001|Overall Study|Adverse Event|8|||
155386874|NCT02447172|560851583|FG002|Overall Study|Adverse Event|7|||
155386875|NCT02447172|560851581|FG000|Overall Study|Death|3|||
155386876|NCT02447172|560851582|FG001|Overall Study|Death|1|||
155386877|NCT02447172|560851583|FG002|Overall Study|Death|0|||
155386878|NCT02447172|560851581|FG000|Overall Study|Protocol Violation|2|||
155386879|NCT02447172|560851582|FG001|Overall Study|Protocol Violation|1|||
155386880|NCT02447172|560851583|FG002|Overall Study|Protocol Violation|2|||
155386881|NCT02447172|560851581|FG000|Overall Study|Lost to Follow-up|7|||
155386882|NCT02447172|560851582|FG001|Overall Study|Lost to Follow-up|4|||
155386883|NCT02447172|560851583|FG002|Overall Study|Lost to Follow-up|4|||
155386884|NCT02447172|560851581|FG000|Overall Study|Withdrawal by Subject|5|||
155386885|NCT02447172|560851582|FG001|Overall Study|Withdrawal by Subject|1|||
155386886|NCT02447172|560851583|FG002|Overall Study|Withdrawal by Subject|3|||
155386887|NCT02447172|560851581|FG000|Overall Study|protocol specific treatment unrelated|3|||
155386888|NCT02447172|560851582|FG001|Overall Study|protocol specific treatment unrelated|0|||
155386889|NCT02447172|560851583|FG002|Overall Study|protocol specific treatment unrelated|2|||
155386890|NCT01204398|560851587|FG000|Overall Study|Adverse Event|1|||
155386891|NCT03562247|560851588|FG000|Overall Study|Lost to Follow-up|3|||
155386892|NCT03562247|560851589|FG001|Overall Study|Lost to Follow-up|1|||
155386893|NCT03562247|560851590|FG002|Overall Study|Lost to Follow-up|1|||
155386894|NCT01296347|560851591|FG000|Allocation|Withdrawal by Subject|1|||
155386895|NCT01296347|560851592|FG001|Allocation|Withdrawal by Subject|2|||
155386896|NCT01296347|560851591|FG000|Allocation|Lack of Efficacy|1|||
155386897|NCT01296347|560851592|FG001|Allocation|Lack of Efficacy|2|||
155386898|NCT01296347|560851591|FG000|Allocation|not received infusion|1|||
155386899|NCT01296347|560851592|FG001|Allocation|not received infusion|0|||
155386900|NCT01296347|560851591|FG000|6 Week Follow up|Death|0|||
155386901|NCT01296347|560851592|FG001|6 Week Follow up|Death|1|||
155386902|NCT01296347|560851591|FG000|3 Month Follow up|Death|1|||
155386903|NCT01296347|560851592|FG001|3 Month Follow up|Death|0|||
155386904|NCT01296347|560851591|FG000|3 Month Follow up|Lost to Follow-up|0|||
155386905|NCT01296347|560851592|FG001|3 Month Follow up|Lost to Follow-up|1|||
155386906|NCT01296347|560851591|FG000|6 Month Follow up|Death|2|||
155386907|NCT01296347|560851592|FG001|6 Month Follow up|Death|1|||
155386908|NCT01296347|560851591|FG000|6 Month Follow up|Lost to Follow-up|0|||
155386909|NCT01296347|560851592|FG001|6 Month Follow up|Lost to Follow-up|1|||
155386910|NCT01296347|560851591|FG000|12 Month Follow up|Lost to Follow-up|3|||
155386911|NCT01296347|560851592|FG001|12 Month Follow up|Lost to Follow-up|1|||
155386912|NCT01296347|560851591|FG000|12 Month Follow up|Death|1|||
155386913|NCT01296347|560851592|FG001|12 Month Follow up|Death|1|||
155386914|NCT01296347|560851591|FG000|12 Month Follow up|Withdrawal by Subject|0|||
155386915|NCT01296347|560851592|FG001|12 Month Follow up|Withdrawal by Subject|1|||
155386916|NCT01163916|560851595|FG000|Overall Study|Withdrawal by Subject|2|||
155386917|NCT01163916|560851596|FG001|Overall Study|Withdrawal by Subject|0|||
155386918|NCT01163916|560851597|FG002|Overall Study|Withdrawal by Subject|2|||
155386919|NCT01163916|560851595|FG000|Overall Study|Adverse Event|2|||
155386920|NCT01163916|560851596|FG001|Overall Study|Adverse Event|0|||
155386921|NCT01163916|560851597|FG002|Overall Study|Adverse Event|1|||
155386922|NCT01163916|560851595|FG000|Overall Study|Lack of Efficacy|2|||
155386923|NCT01163916|560851596|FG001|Overall Study|Lack of Efficacy|0|||
155386924|NCT01163916|560851597|FG002|Overall Study|Lack of Efficacy|1|||
155386925|NCT01163916|560851595|FG000|Overall Study|Other|24|||
155386926|NCT01163916|560851596|FG001|Overall Study|Other|4|||
155386927|NCT01163916|560851597|FG002|Overall Study|Other|16|||
154944165|NCT00358826|559220893|FG002|MDCT Substudy|Withdrawal by Subject|0|||
154944166|NCT00358826|559220894|FG003|MDCT Substudy|Withdrawal by Subject|0|||
154944167|NCT00358826|559220895|FG004|MDCT Substudy|Withdrawal by Subject|0|||
154944168|NCT00358826|559220896|FG005|MDCT Substudy|Withdrawal by Subject|1|||
154944169|NCT00358826|559220897|FG006|MDCT Substudy|Withdrawal by Subject|0|||
154944170|NCT00358826|559220898|FG007|MDCT Substudy|Withdrawal by Subject|0|||
154944171|NCT00903383|559220902|FG000|Overall Study|Adverse Event|1|||
154944172|NCT00903383|559220903|FG001|Overall Study|Adverse Event|2|||
155280555|NCT04955626|560459896|FG029|Blinded Period|Protocol Violation|3|||
155280556|NCT04955626|560459897|FG030|Blinded Period|Protocol Violation|0|||
155280557|NCT04955626|560459898|FG031|Blinded Period|Protocol Violation|0|||
155280558|NCT04955626|560459899|FG032|Blinded Period|Protocol Violation|0|||
155280559|NCT04955626|560459900|FG033|Blinded Period|Protocol Violation|0|||
155280560|NCT04955626|560459901|FG034|Blinded Period|Protocol Violation|0|||
155280561|NCT04955626|560459902|FG035|Blinded Period|Protocol Violation|0|||
155280562|NCT04955626|560459867|FG000|Blinded Period|Death|0|||
155280563|NCT04955626|560459868|FG001|Blinded Period|Death|2|||
155280564|NCT04955626|560459869|FG002|Blinded Period|Death|0|||
155280565|NCT04955626|560459870|FG003|Blinded Period|Death|0|||
155280566|NCT04955626|560459871|FG004|Blinded Period|Death|0|||
155280567|NCT04955626|560459872|FG005|Blinded Period|Death|0|||
155280568|NCT04955626|560459873|FG006|Blinded Period|Death|0|||
155280569|NCT04955626|560459874|FG007|Blinded Period|Death|2|||
155280570|NCT04955626|560459875|FG008|Blinded Period|Death|1|||
155280571|NCT04955626|560459876|FG009|Blinded Period|Death|1|||
155280572|NCT04955626|560459877|FG010|Blinded Period|Death|0|||
155280573|NCT04955626|560459878|FG011|Blinded Period|Death|2|||
155280574|NCT04955626|560459879|FG012|Blinded Period|Death|0|||
155280575|NCT04955626|560459880|FG013|Blinded Period|Death|0|||
155280576|NCT04955626|560459881|FG014|Blinded Period|Death|0|||
155280577|NCT04955626|560459882|FG015|Blinded Period|Death|0|||
155280578|NCT04955626|560459883|FG016|Blinded Period|Death|0|||
155280579|NCT04955626|560459884|FG017|Blinded Period|Death|0|||
155280580|NCT04955626|560459885|FG018|Blinded Period|Death|0|||
155280581|NCT04955626|560459886|FG019|Blinded Period|Death|0|||
155280582|NCT04955626|560459887|FG020|Blinded Period|Death|0|||
155280583|NCT04955626|560459888|FG021|Blinded Period|Death|0|||
155280584|NCT04955626|560459889|FG022|Blinded Period|Death|0|||
155280585|NCT04955626|560459890|FG023|Blinded Period|Death|1|||
155280586|NCT04955626|560459891|FG024|Blinded Period|Death|0|||
155280587|NCT04955626|560459892|FG025|Blinded Period|Death|0|||
155280588|NCT04955626|560459893|FG026|Blinded Period|Death|1|||
155280589|NCT04955626|560459894|FG027|Blinded Period|Death|1|||
155280590|NCT04955626|560459895|FG028|Blinded Period|Death|0|||
155386928|NCT00423930|560851598|FG000|Overall Study|Withdrawal by Subject|2|||
154944173|NCT00903383|559220904|FG002|Overall Study|Adverse Event|3|||
154944174|NCT00903383|559220905|FG003|Overall Study|Adverse Event|1|||
155280591|NCT04955626|560459896|FG029|Blinded Period|Death|1|||
155386929|NCT04002401|560851599|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
155386930|NCT04002401|560851599|FG000|Overall Study|Death|10|||
155386931|NCT04002401|560851599|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
155386932|NCT04002401|560851599|FG000|Overall Study|Enrolled but Never Treated|1|||
155386933|NCT04002401|560851599|FG000|Overall Study|Lost to Follow-up|1|||
155386934|NCT02337751|560851600|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
155280592|NCT04955626|560459897|FG030|Blinded Period|Death|0|||
155280593|NCT04955626|560459898|FG031|Blinded Period|Death|0|||
155386935|NCT02337751|560851601|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
155386936|NCT02337751|560851600|FG000|Overall Study|Voluntary Withdrawal|6|||
155386937|NCT02337751|560851601|FG001|Overall Study|Voluntary Withdrawal|8|||
155386938|NCT02337751|560851600|FG000|Overall Study|Lack of Efficacy|2|||
155386939|NCT02337751|560851601|FG001|Overall Study|Lack of Efficacy|5|||
155386940|NCT02337751|560851600|FG000|Overall Study|Investigator's Judgement|1|||
155386941|NCT02337751|560851601|FG001|Overall Study|Investigator's Judgement|0|||
155386942|NCT01910181|560851602|FG000|Overall Study|Death|37|||
155386943|NCT01910181|560851602|FG000|Overall Study|Lost to Follow-up|3|||
155386944|NCT01910181|560851602|FG000|Overall Study|Study Terminated by Sponsor|6|||
155386945|NCT02656823|560851603|FG000|Overall Study|Adverse Event|3|||
155386946|NCT02656823|560851603|FG000|Overall Study|Lost to Follow-up|2|||
155386947|NCT01340651|560851607|FG000|Overall Study|Adverse Event|3|||
155386948|NCT01340651|560851607|FG000|Overall Study|Consent Withdrawn|2|||
155386949|NCT01340651|560851607|FG000|Overall Study|Commercial Supply per Sponsor|12|||
155386950|NCT01315353|560851608|FG000|Overall Study|Death|2|||
155386951|NCT01315353|560851609|FG001|Overall Study|Death|1|||
155386952|NCT01315353|560851610|FG002|Overall Study|Death|0|||
155386953|NCT01315353|560851608|FG000|Overall Study|Withdrawal by Subject|2|||
155386954|NCT01315353|560851609|FG001|Overall Study|Withdrawal by Subject|6|||
155386955|NCT01315353|560851610|FG002|Overall Study|Withdrawal by Subject|1|||
155386956|NCT01315353|560851608|FG000|Overall Study|Lost to Follow-up|13|||
155386957|NCT01315353|560851609|FG001|Overall Study|Lost to Follow-up|6|||
155386958|NCT01315353|560851610|FG002|Overall Study|Lost to Follow-up|6|||
155386959|NCT01315353|560851608|FG000|Overall Study|Unwilling to adhere to requirements|5|||
155386960|NCT01315353|560851609|FG001|Overall Study|Unwilling to adhere to requirements|5|||
155386961|NCT01315353|560851610|FG002|Overall Study|Unwilling to adhere to requirements|4|||
155386962|NCT01315353|560851608|FG000|Overall Study|Site closing|7|||
155386963|NCT01315353|560851609|FG001|Overall Study|Site closing|4|||
155386964|NCT01315353|560851610|FG002|Overall Study|Site closing|0|||
155386965|NCT01315353|560851608|FG000|Overall Study|Taken off study by site in error|0|||
155386966|NCT01315353|560851609|FG001|Overall Study|Taken off study by site in error|1|||
155386967|NCT01315353|560851610|FG002|Overall Study|Taken off study by site in error|0|||
155386968|NCT01315353|560851608|FG000|Overall Study|Inadvertent randomization/assignment|0|||
155386969|NCT01315353|560851609|FG001|Overall Study|Inadvertent randomization/assignment|0|||
155386970|NCT01315353|560851610|FG002|Overall Study|Inadvertent randomization/assignment|2|||
155386971|NCT03567434|560851611|FG000|Overall Study|Lost to Follow-up|1|||
155386972|NCT03567434|560851612|FG001|Overall Study|Lost to Follow-up|3|||
155386973|NCT01009580|560851613|FG000|Overall Study|Adverse Event|4|||
155386974|NCT01009580|560851614|FG001|Overall Study|Adverse Event|4|||
155386975|NCT01009580|560851613|FG000|Overall Study|Lack of Efficacy|0|||
155386976|NCT01009580|560851614|FG001|Overall Study|Lack of Efficacy|1|||
155386977|NCT01009580|560851613|FG000|Overall Study|Protocol Violation|2|||
155386978|NCT01009580|560851614|FG001|Overall Study|Protocol Violation|3|||
155386979|NCT01009580|560851613|FG000|Overall Study|Withdrawal Criteria|4|||
155386980|NCT01009580|560851614|FG001|Overall Study|Withdrawal Criteria|6|||
155386981|NCT01009580|560851613|FG000|Overall Study|Unclassified|17|||
155386982|NCT01009580|560851614|FG001|Overall Study|Unclassified|21|||
155386983|NCT04469270|560851617|FG000|Overall Study|Adverse Event|2|||
155386984|NCT04469270|560851618|FG001|Overall Study|Adverse Event|0|||
155386985|NCT04469270|560851617|FG000|Overall Study|Lost to Follow-up|4|||
155386986|NCT04469270|560851618|FG001|Overall Study|Lost to Follow-up|3|||
155386987|NCT04469270|560851617|FG000|Overall Study|Withdrawal by Subject|7|||
155386988|NCT04469270|560851618|FG001|Overall Study|Withdrawal by Subject|3|||
155386989|NCT04469270|560851617|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
155386990|NCT04469270|560851618|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
155386991|NCT04469270|560851617|FG000|Overall Study|missing|1|||
155386992|NCT04469270|560851618|FG001|Overall Study|missing|0|||
155386993|NCT05269355|560851626|FG000|Overall Study|Progressive Disease|104|||
155386994|NCT05269355|560851627|FG001|Overall Study|Progressive Disease|68|||
155386995|NCT05269355|560851626|FG000|Overall Study|Study Terminated by Sponsor|87|||
155386996|NCT05269355|560851627|FG001|Overall Study|Study Terminated by Sponsor|29|||
155386997|NCT05269355|560851626|FG000|Overall Study|Adverse Event|15|||
155386998|NCT05269355|560851627|FG001|Overall Study|Adverse Event|8|||
155386999|NCT05269355|560851626|FG000|Overall Study|Withdrawal by Subject|18|||
155387000|NCT05269355|560851627|FG001|Overall Study|Withdrawal by Subject|5|||
155387001|NCT05269355|560851626|FG000|Overall Study|Physician Decision|6|||
155387002|NCT05269355|560851627|FG001|Overall Study|Physician Decision|4|||
155387003|NCT05269355|560851626|FG000|Overall Study|Death|3|||
155387004|NCT05269355|560851627|FG001|Overall Study|Death|5|||
155387005|NCT05269355|560851626|FG000|Overall Study|Other Than Specified|5|||
155387006|NCT05269355|560851627|FG001|Overall Study|Other Than Specified|1|||
155387007|NCT05269355|560851626|FG000|Overall Study|Randomized But Not Treated|1|||
155387008|NCT05269355|560851627|FG001|Overall Study|Randomized But Not Treated|0|||
155387009|NCT03705832|560851628|FG000|Overall Study|Physician Decision|0|||
155387010|NCT03705832|560851629|FG001|Overall Study|Physician Decision|1|||
155387011|NCT03705832|560851628|FG000|Overall Study|Withdrawal by Subject|1|||
155387012|NCT03705832|560851629|FG001|Overall Study|Withdrawal by Subject|0|||
155387013|NCT01050790|560851630|FG000|Overall Study|Adverse Event|1|||
155387014|NCT01880528|560851631|FG000|Overall Study|Other|1|||
155387015|NCT01880528|560851632|FG001|Overall Study|Other|1|||
155387016|NCT00081497|560851633|FG000|Overall Study|Adverse Event|2|||
155387017|NCT00081497|560851634|FG001|Overall Study|Adverse Event|0|||
155387018|NCT00081497|560851633|FG000|Overall Study|Death|0|||
155387019|NCT00081497|560851634|FG001|Overall Study|Death|1|||
155387020|NCT00081497|560851633|FG000|Overall Study|Withdrawal by Subject|1|||
155387021|NCT00081497|560851634|FG001|Overall Study|Withdrawal by Subject|0|||
155387022|NCT00081497|560851633|FG000|Overall Study|Non-compliance|0|||
155387023|NCT00081497|560851634|FG001|Overall Study|Non-compliance|1|||
155387024|NCT01439360|560851635|FG000|Overall Study|Adverse Event|4|||
155387025|NCT01439360|560851636|FG001|Overall Study|Adverse Event|16|||
155387026|NCT01439360|560851635|FG000|Overall Study|Lost to Follow-up|43|||
155387027|NCT01439360|560851636|FG001|Overall Study|Lost to Follow-up|58|||
155387028|NCT01439360|560851635|FG000|Overall Study|Others|10|||
155387029|NCT01439360|560851636|FG001|Overall Study|Others|5|||
155387030|NCT01439360|560851635|FG000|Overall Study|Protocol Violation|1|||
155387031|NCT01439360|560851636|FG001|Overall Study|Protocol Violation|0|||
155387032|NCT01439360|560851635|FG000|Overall Study|Withdrawal by Subject|140|||
155387033|NCT01439360|560851636|FG001|Overall Study|Withdrawal by Subject|129|||
155387034|NCT02390245|560851638|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
155387035|NCT02390245|560851639|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
155387036|NCT02390245|560851640|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
155387037|NCT02390245|560851638|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
155387038|NCT02390245|560851639|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
155387039|NCT02390245|560851640|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
155387040|NCT05437510|560851643|FG000|Overall Study|Adverse Event|2|||
155387041|NCT05437510|560851644|FG001|Overall Study|Adverse Event|1|||
155387042|NCT05437510|560851643|FG000|Overall Study|Protocol Deviation|1|||
155387043|NCT05437510|560851644|FG001|Overall Study|Protocol Deviation|6|||
155387044|NCT05437510|560851643|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
155387045|NCT05437510|560851644|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
155387046|NCT05437510|560851643|FG000|Overall Study|Lost to Follow-up|265|||
155387047|NCT05437510|560851644|FG001|Overall Study|Lost to Follow-up|358|||
155387048|NCT03573401|560851645|FG000|Overall Study|Withdrawal by Subject|2|||
155387049|NCT03573401|560851646|FG001|Overall Study|Withdrawal by Subject|0|||
155387050|NCT03573401|560851645|FG000|Overall Study|Subject non-compliance with study schedule|1|||
155387051|NCT03573401|560851646|FG001|Overall Study|Subject non-compliance with study schedule|0|||
155387052|NCT03573401|560851645|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
155387053|NCT03573401|560851646|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
155387054|NCT03573401|560851645|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
155387055|NCT03573401|560851646|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
155387056|NCT05677893|560852934|FG000|Overall Study|Withdrawal by Subject|0|||
155387057|NCT05677893|560852935|FG001|Overall Study|Withdrawal by Subject|0|||
155387058|NCT05677893|560852936|FG002|Overall Study|Withdrawal by Subject|0|||
155387059|NCT05677893|560852937|FG003|Overall Study|Withdrawal by Subject|0|||
155387060|NCT05677893|560852938|FG004|Overall Study|Withdrawal by Subject|1|||
155387061|NCT05677893|560852939|FG005|Overall Study|Withdrawal by Subject|1|||
155387062|NCT05677893|560852940|FG006|Overall Study|Withdrawal by Subject|0|||
155387063|NCT05677893|560852934|FG000|Overall Study|Others|1|||
155387064|NCT05677893|560852935|FG001|Overall Study|Others|0|||
155387065|NCT05677893|560852936|FG002|Overall Study|Others|0|||
155387066|NCT05677893|560852937|FG003|Overall Study|Others|0|||
155387067|NCT05677893|560852938|FG004|Overall Study|Others|0|||
155387068|NCT05677893|560852939|FG005|Overall Study|Others|0|||
155387069|NCT05677893|560852940|FG006|Overall Study|Others|0|||
155387070|NCT03217266|560852941|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
155387071|NCT03217266|560852942|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
155387072|NCT03217266|560852943|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
155387073|NCT03217266|560852944|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
155387074|NCT03217266|560852941|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
155387075|NCT03217266|560852942|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
155387076|NCT03217266|560852943|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
155387077|NCT03217266|560852944|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
155387078|NCT03217266|560852941|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
155387079|NCT03217266|560852942|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
155387080|NCT03217266|560852943|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
155387081|NCT03217266|560852944|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
155387082|NCT02101034|560852945|FG000|Overall Study|Enrolled but did not start treatment|0|||
155387083|NCT02101034|560852946|FG001|Overall Study|Enrolled but did not start treatment|0|||
155387084|NCT02101034|560852947|FG002|Overall Study|Enrolled but did not start treatment|1|||
154944175|NCT00903383|559220902|FG000|Overall Study|Physician Decision|1|||
154944176|NCT00903383|559220903|FG001|Overall Study|Physician Decision|2|||
154944177|NCT00903383|559220904|FG002|Overall Study|Physician Decision|0|||
154944178|NCT00903383|559220905|FG003|Overall Study|Physician Decision|0|||
154944179|NCT00903383|559220902|FG000|Overall Study|Lost to Follow-up|0|||
154944180|NCT00903383|559220903|FG001|Overall Study|Lost to Follow-up|0|||
154944181|NCT00903383|559220904|FG002|Overall Study|Lost to Follow-up|0|||
154944182|NCT00903383|559220905|FG003|Overall Study|Lost to Follow-up|1|||
154944183|NCT00903383|559220902|FG000|Overall Study|Decision of Sponsor|1|||
154944184|NCT00903383|559220903|FG001|Overall Study|Decision of Sponsor|0|||
154944185|NCT00903383|559220904|FG002|Overall Study|Decision of Sponsor|0|||
154944186|NCT00903383|559220905|FG003|Overall Study|Decision of Sponsor|0|||
154944187|NCT00903383|559220902|FG000|Overall Study|Withdrawal by Subject|4|||
154944188|NCT00903383|559220903|FG001|Overall Study|Withdrawal by Subject|1|||
154944189|NCT00903383|559220904|FG002|Overall Study|Withdrawal by Subject|0|||
154944190|NCT00903383|559220905|FG003|Overall Study|Withdrawal by Subject|2|||
154944191|NCT00903383|559220902|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
154944192|NCT00903383|559220903|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
154944193|NCT00903383|559220904|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
155280594|NCT04955626|560459899|FG032|Blinded Period|Death|0|||
154944194|NCT00903383|559220905|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
154944195|NCT00903383|559220902|FG000|Overall Study|Patient Decision|0|||
154944196|NCT00903383|559220903|FG001|Overall Study|Patient Decision|0|||
154944197|NCT00903383|559220904|FG002|Overall Study|Patient Decision|0|||
154944198|NCT00903383|559220905|FG003|Overall Study|Patient Decision|1|||
154944199|NCT02015793|559220910|FG000|Overall Study|Adverse Event|3|||
154944200|NCT02015793|559220911|FG001|Overall Study|Adverse Event|3|||
154944201|NCT02015793|559220910|FG000|Overall Study|Withdrawal by Subject|1|||
154944202|NCT02015793|559220911|FG001|Overall Study|Withdrawal by Subject|1|||
154944203|NCT00320593|559220912|FG000|Overall Study|Lost to Follow-up|3|||
154944204|NCT00320593|559220913|FG001|Overall Study|Lost to Follow-up|0|||
154944205|NCT00320593|559220912|FG000|Overall Study|Moved to another state|1|||
154944206|NCT00320593|559220913|FG001|Overall Study|Moved to another state|0|||
154944207|NCT00320593|559220912|FG000|Overall Study|Withdrawal by Subject|2|||
154944208|NCT00320593|559220913|FG001|Overall Study|Withdrawal by Subject|1|||
155280595|NCT04955626|560459900|FG033|Blinded Period|Death|0|||
155280596|NCT04955626|560459901|FG034|Blinded Period|Death|0|||
155280597|NCT04955626|560459902|FG035|Blinded Period|Death|0|||
155280598|NCT04955626|560459867|FG000|Blinded Period|Adverse Event|0|||
155280599|NCT04955626|560459868|FG001|Blinded Period|Adverse Event|1|||
155280600|NCT04955626|560459869|FG002|Blinded Period|Adverse Event|1|||
155280601|NCT04955626|560459870|FG003|Blinded Period|Adverse Event|1|||
155280602|NCT04955626|560459871|FG004|Blinded Period|Adverse Event|0|||
155280603|NCT04955626|560459872|FG005|Blinded Period|Adverse Event|0|||
155280604|NCT04955626|560459873|FG006|Blinded Period|Adverse Event|0|||
155280605|NCT04955626|560459874|FG007|Blinded Period|Adverse Event|0|||
155280606|NCT04955626|560459875|FG008|Blinded Period|Adverse Event|0|||
155280607|NCT04955626|560459876|FG009|Blinded Period|Adverse Event|1|||
155280608|NCT04955626|560459877|FG010|Blinded Period|Adverse Event|1|||
155280609|NCT04955626|560459878|FG011|Blinded Period|Adverse Event|0|||
155280610|NCT04955626|560459879|FG012|Blinded Period|Adverse Event|0|||
155280611|NCT04955626|560459880|FG013|Blinded Period|Adverse Event|0|||
155280612|NCT04955626|560459881|FG014|Blinded Period|Adverse Event|0|||
155280613|NCT04955626|560459882|FG015|Blinded Period|Adverse Event|0|||
155280614|NCT04955626|560459883|FG016|Blinded Period|Adverse Event|0|||
155280615|NCT04955626|560459884|FG017|Blinded Period|Adverse Event|0|||
155280616|NCT04955626|560459885|FG018|Blinded Period|Adverse Event|1|||
155280617|NCT04955626|560459886|FG019|Blinded Period|Adverse Event|0|||
155280618|NCT04955626|560459887|FG020|Blinded Period|Adverse Event|0|||
155280619|NCT04955626|560459888|FG021|Blinded Period|Adverse Event|0|||
155280620|NCT04955626|560459889|FG022|Blinded Period|Adverse Event|0|||
155280621|NCT04955626|560459890|FG023|Blinded Period|Adverse Event|0|||
155280622|NCT04955626|560459891|FG024|Blinded Period|Adverse Event|0|||
155280623|NCT04955626|560459892|FG025|Blinded Period|Adverse Event|0|||
155280624|NCT04955626|560459893|FG026|Blinded Period|Adverse Event|1|||
155280625|NCT04955626|560459894|FG027|Blinded Period|Adverse Event|0|||
155280626|NCT04955626|560459895|FG028|Blinded Period|Adverse Event|0|||
155280627|NCT04955626|560459896|FG029|Blinded Period|Adverse Event|0|||
155280628|NCT04955626|560459897|FG030|Blinded Period|Adverse Event|0|||
154944209|NCT00320593|559220912|FG000|Overall Study|Withdrawal by clinical center|1|||
154944210|NCT00320593|559220913|FG001|Overall Study|Withdrawal by clinical center|0|||
154944211|NCT00283686|559220914|FG000|Overall Study|Death|1|||
154944212|NCT00283686|559220915|FG001|Overall Study|Death|1|||
154944213|NCT00283686|559220916|FG002|Overall Study|Death|1|||
154944214|NCT00283686|559220917|FG003|Overall Study|Death|0|||
154944215|NCT00283686|559220914|FG000|Overall Study|Lost to Follow-up|21|||
155280629|NCT04955626|560459898|FG031|Blinded Period|Adverse Event|0|||
155280630|NCT04955626|560459899|FG032|Blinded Period|Adverse Event|0|||
155280631|NCT04955626|560459900|FG033|Blinded Period|Adverse Event|0|||
155280632|NCT04955626|560459901|FG034|Blinded Period|Adverse Event|0|||
155280633|NCT04955626|560459902|FG035|Blinded Period|Adverse Event|0|||
155387085|NCT02101034|560852948|FG003|Overall Study|Enrolled but did not start treatment|0|||
155387086|NCT02101034|560852949|FG004|Overall Study|Enrolled but did not start treatment|0|||
155387087|NCT01390181|560852950|FG000|Overall Study|Lost to Follow-up|1|||
155387088|NCT01390181|560852950|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
155387089|NCT01101477|560852951|FG000|Overall Study|Protocol Violation|5|||
155387090|NCT01101477|560852952|FG001|Overall Study|Protocol Violation|3|||
155387091|NCT01101477|560852953|FG002|Overall Study|Protocol Violation|1|||
155387092|NCT00720941|560852954|FG000|Overall Study|Protocol Violation|1|||
155387093|NCT00720941|560852955|FG001|Overall Study|Protocol Violation|2|||
155387094|NCT00720941|560852954|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
155387095|NCT00720941|560852955|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
155387096|NCT00720941|560852954|FG000|Overall Study|Lost to Follow-up|20|||
155387097|NCT00720941|560852955|FG001|Overall Study|Lost to Follow-up|15|||
155387098|NCT00720941|560852954|FG000|Overall Study|Physician Decision|14|||
155387099|NCT00720941|560852955|FG001|Overall Study|Physician Decision|12|||
155387100|NCT00720941|560852954|FG000|Overall Study|Withdrawal by Subject|29|||
155387101|NCT00720941|560852955|FG001|Overall Study|Withdrawal by Subject|36|||
155387102|NCT01717989|560852960|FG000|Overall Study|Ineligibility determined|6|||
155387103|NCT01717989|560852960|FG000|Overall Study|Protocol deviation|6|||
155387104|NCT01717989|560852960|FG000|Overall Study|Withdrawal by Subject|11|||
155387105|NCT01717989|560852960|FG000|Overall Study|Physician Decision|2|||
155387106|NCT01717989|560852960|FG000|Overall Study|Lost to Follow-up|11|||
155387107|NCT01717989|560852960|FG000|Overall Study|Death|439|||
155387108|NCT01717989|560852960|FG000|Overall Study|Protocol-specified criteria|551|||
155387109|NCT01717989|560852960|FG000|Overall Study|Other|40|||
155387110|NCT03224325|560852961|FG000|Overall Study|Adverse Event|1|||
155387111|NCT03224325|560852962|FG001|Overall Study|Adverse Event|0|||
155387112|NCT03224325|560852963|FG002|Overall Study|Adverse Event|0|||
155387113|NCT03224325|560852964|FG003|Overall Study|Adverse Event|0|||
155387114|NCT03224325|560852965|FG004|Overall Study|Adverse Event|0|||
155387115|NCT03224325|560852966|FG005|Overall Study|Adverse Event|0|||
155387116|NCT03224325|560852967|FG006|Overall Study|Adverse Event|1|||
155387117|NCT03224325|560852961|FG000|Overall Study|Withdrawal by Subject|0|||
155387118|NCT03224325|560852962|FG001|Overall Study|Withdrawal by Subject|0|||
155387119|NCT03224325|560852963|FG002|Overall Study|Withdrawal by Subject|0|||
155387120|NCT03224325|560852964|FG003|Overall Study|Withdrawal by Subject|1|||
155387121|NCT03224325|560852965|FG004|Overall Study|Withdrawal by Subject|0|||
155387122|NCT03224325|560852966|FG005|Overall Study|Withdrawal by Subject|0|||
155387123|NCT03224325|560852967|FG006|Overall Study|Withdrawal by Subject|0|||
155387124|NCT02598557|560852968|FG000|Overall Study|Withdrawal by Subject|1|||
155387125|NCT02598557|560852969|FG001|Overall Study|Withdrawal by Subject|0|||
155387126|NCT02598557|560852970|FG002|Overall Study|Withdrawal by Subject|1|||
155387127|NCT02598557|560852968|FG000|Overall Study|Participant did not start treatment|2|||
155387128|NCT02598557|560852969|FG001|Overall Study|Participant did not start treatment|1|||
155387129|NCT02598557|560852970|FG002|Overall Study|Participant did not start treatment|1|||
155387130|NCT02598557|560852968|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
155387131|NCT02598557|560852969|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
155387132|NCT02598557|560852970|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
155387133|NCT02598557|560852968|FG000|Overall Study|Adverse Event|1|||
155387134|NCT02598557|560852969|FG001|Overall Study|Adverse Event|1|||
155387135|NCT02598557|560852970|FG002|Overall Study|Adverse Event|0|||
155387136|NCT02864381|560852971|FG000|Overall Study|Death|58|||
155387137|NCT02864381|560852972|FG001|Overall Study|Death|61|||
155387138|NCT02864381|560852971|FG000|Overall Study|Withdrew Consent|5|||
155387139|NCT02864381|560852972|FG001|Overall Study|Withdrew Consent|6|||
155387140|NCT02864381|560852971|FG000|Overall Study|Reason Unknown|7|||
155387141|NCT02864381|560852972|FG001|Overall Study|Reason Unknown|3|||
155387142|NCT02864381|560852971|FG000|Overall Study|Lost to Follow-up|1|||
155387143|NCT02864381|560852972|FG001|Overall Study|Lost to Follow-up|1|||
155387144|NCT02864381|560852971|FG000|Overall Study|Investigator's Discretion|1|||
155387145|NCT02864381|560852972|FG001|Overall Study|Investigator's Discretion|0|||
155387146|NCT02864381|560852971|FG000|Overall Study|Protocol Violation|0|||
155387147|NCT02864381|560852972|FG001|Overall Study|Protocol Violation|1|||
155387148|NCT00667355|560852973|FG000|Overall Study|Adverse Event|5|||
155387149|NCT00667355|560852973|FG000|Overall Study|Lost to Follow-up|1|||
155387150|NCT00667355|560852973|FG000|Overall Study|Other reason was not specified|5|||
155387151|NCT00687973|560852976|FG000|Overall Study|Adverse Event|18|||
155387152|NCT00687973|560852977|FG001|Overall Study|Adverse Event|28|||
155387153|NCT00687973|560852976|FG000|Overall Study|Lack of Efficacy|2|||
155387154|NCT00687973|560852977|FG001|Overall Study|Lack of Efficacy|3|||
155387155|NCT00687973|560852976|FG000|Overall Study|Protocol Violation|1|||
155387156|NCT00687973|560852977|FG001|Overall Study|Protocol Violation|2|||
155387157|NCT00687973|560852976|FG000|Overall Study|Administrative Reasons|0|||
155387158|NCT00687973|560852977|FG001|Overall Study|Administrative Reasons|2|||
155387159|NCT00687973|560852976|FG000|Overall Study|Withdrawal by Subject|3|||
155387160|NCT00687973|560852977|FG001|Overall Study|Withdrawal by Subject|3|||
155387161|NCT00731120|560852979|FG000|Overall Study|Adverse Event|7|||
155387162|NCT00731120|560852980|FG001|Overall Study|Adverse Event|6|||
155387163|NCT00731120|560852981|FG002|Overall Study|Adverse Event|8|||
155387164|NCT00731120|560852979|FG000|Overall Study|Lack of Efficacy|4|||
155387165|NCT00731120|560852980|FG001|Overall Study|Lack of Efficacy|5|||
155387166|NCT00731120|560852981|FG002|Overall Study|Lack of Efficacy|4|||
155387167|NCT00731120|560852979|FG000|Overall Study|Noncompliance with Study Drug|3|||
155387168|NCT00731120|560852980|FG001|Overall Study|Noncompliance with Study Drug|3|||
155387169|NCT00731120|560852981|FG002|Overall Study|Noncompliance with Study Drug|1|||
155387170|NCT00731120|560852979|FG000|Overall Study|Protocol Deviations|1|||
155387171|NCT00731120|560852980|FG001|Overall Study|Protocol Deviations|6|||
155387172|NCT00731120|560852981|FG002|Overall Study|Protocol Deviations|1|||
155387173|NCT00731120|560852979|FG000|Overall Study|Withdrawal of Consent|13|||
155387174|NCT00731120|560852980|FG001|Overall Study|Withdrawal of Consent|8|||
155387175|NCT00731120|560852981|FG002|Overall Study|Withdrawal of Consent|4|||
155387176|NCT00731120|560852979|FG000|Overall Study|Lost to Follow-up|10|||
155387177|NCT00731120|560852980|FG001|Overall Study|Lost to Follow-up|15|||
155387178|NCT00731120|560852981|FG002|Overall Study|Lost to Follow-up|17|||
155387179|NCT00731120|560852979|FG000|Overall Study|Other|4|||
155387180|NCT00731120|560852980|FG001|Overall Study|Other|0|||
155387181|NCT00731120|560852981|FG002|Overall Study|Other|1|||
155387182|NCT01012713|560852990|FG000|Overall Study|Lack of Efficacy|3|||
155387183|NCT00985153|560852991|FG000|Overall Study|Lost to Follow-up|16|||
155387184|NCT00985153|560852992|FG001|Overall Study|Lost to Follow-up|19|||
155387185|NCT00985153|560852993|FG002|Overall Study|Lost to Follow-up|17|||
155387186|NCT00985153|560852994|FG003|Overall Study|Lost to Follow-up|20|||
155387187|NCT00985153|560852991|FG000|Overall Study|Protocol Violation|3|||
155387188|NCT00985153|560852992|FG001|Overall Study|Protocol Violation|2|||
155387189|NCT00985153|560852993|FG002|Overall Study|Protocol Violation|4|||
155387190|NCT00985153|560852994|FG003|Overall Study|Protocol Violation|3|||
155387191|NCT00985153|560852991|FG000|Overall Study|Withdrawal by Subject|6|||
155387192|NCT00985153|560852992|FG001|Overall Study|Withdrawal by Subject|11|||
155387193|NCT00985153|560852993|FG002|Overall Study|Withdrawal by Subject|11|||
155387194|NCT00985153|560852994|FG003|Overall Study|Withdrawal by Subject|10|||
155387195|NCT00985153|560852991|FG000|Overall Study|Missed One or More Bleeds|7|||
155387196|NCT00985153|560852992|FG001|Overall Study|Missed One or More Bleeds|7|||
155387197|NCT00985153|560852993|FG002|Overall Study|Missed One or More Bleeds|8|||
155387198|NCT00985153|560852994|FG003|Overall Study|Missed One or More Bleeds|10|||
155387199|NCT00985153|560852991|FG000|Overall Study|Incomplete Safety Follow-up|3|||
155387200|NCT00985153|560852992|FG001|Overall Study|Incomplete Safety Follow-up|5|||
155387201|NCT00985153|560852993|FG002|Overall Study|Incomplete Safety Follow-up|4|||
155387202|NCT00985153|560852994|FG003|Overall Study|Incomplete Safety Follow-up|4|||
155387203|NCT03370471|560852995|FG000|Overall Study|Withdrawal by Subject|6|||
155045844|NCT05052697|559599398|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045845|NCT05052697|559599399|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045846|NCT05052697|559599400|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045847|NCT05052697|559599401|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045848|NCT05052697|559599402|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045849|NCT05052697|559599403|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
155045850|NCT05052697|559599404|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045851|NCT05052697|559599405|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045852|NCT05052697|559599406|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045853|NCT05052697|559599407|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045854|NCT05052697|559599408|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045855|NCT05052697|559599409|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045856|NCT05052697|559599410|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045857|NCT05052697|559599411|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
155045858|NCT05052697|559599412|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045859|NCT05052697|559599413|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
155045860|NCT05052697|559599414|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045861|NCT05052697|559599415|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045862|NCT05052697|559599416|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155387204|NCT03370471|560852996|FG001|Overall Study|Withdrawal by Subject|1|||
155387205|NCT03370471|560852995|FG000|Overall Study|Unable to access veins for blood draw|0|||
155387206|NCT03370471|560852996|FG001|Overall Study|Unable to access veins for blood draw|1|||
155387207|NCT03370471|560852995|FG000|Overall Study|Screen fail|1|||
155387208|NCT03370471|560852996|FG001|Overall Study|Screen fail|0|||
155387209|NCT00561951|560852998|FG000|Overall Study|Adverse Event|11|||
155045863|NCT05052697|559599417|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045864|NCT05052697|559599418|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155045865|NCT05052697|559599419|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
155387210|NCT00561951|560852999|FG001|Overall Study|Adverse Event|14|||
155387211|NCT00561951|560853000|FG002|Overall Study|Adverse Event|14|||
155387212|NCT00561951|560852998|FG000|Overall Study|Lack of Efficacy|5|||
155387213|NCT00561951|560852999|FG001|Overall Study|Lack of Efficacy|3|||
155387214|NCT00561951|560853000|FG002|Overall Study|Lack of Efficacy|2|||
155387215|NCT00561951|560852998|FG000|Overall Study|Lost to Follow-up|1|||
155387216|NCT00561951|560852999|FG001|Overall Study|Lost to Follow-up|1|||
155387217|NCT00561951|560853000|FG002|Overall Study|Lost to Follow-up|0|||
155387218|NCT00561951|560852998|FG000|Overall Study|Withdrawal by Subject|10|||
155387219|NCT00561951|560852999|FG001|Overall Study|Withdrawal by Subject|9|||
155387220|NCT00561951|560853000|FG002|Overall Study|Withdrawal by Subject|10|||
155387221|NCT00561951|560852998|FG000|Overall Study|Protocol Violation|4|||
155387222|NCT00561951|560852999|FG001|Overall Study|Protocol Violation|3|||
155387223|NCT00561951|560853000|FG002|Overall Study|Protocol Violation|4|||
155387224|NCT00561951|560852998|FG000|Overall Study|Physician Decision|1|||
155387225|NCT00561951|560852999|FG001|Overall Study|Physician Decision|0|||
155387226|NCT00561951|560853000|FG002|Overall Study|Physician Decision|0|||
155387227|NCT00561951|560852998|FG000|Overall Study|Pregnancy|0|||
155387228|NCT00561951|560852999|FG001|Overall Study|Pregnancy|1|||
155387229|NCT00561951|560853000|FG002|Overall Study|Pregnancy|0|||
155387230|NCT00561951|560852998|FG000|Overall Study|Meet Withdrawal Criterion|0|||
155387231|NCT00561951|560852999|FG001|Overall Study|Meet Withdrawal Criterion|1|||
155387232|NCT00561951|560853000|FG002|Overall Study|Meet Withdrawal Criterion|1|||
155387233|NCT00561951|560852998|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
155387234|NCT00561951|560852999|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
155387235|NCT00561951|560853000|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
155387236|NCT01765179|560853001|FG000|Overall Study|Adverse Event|3|||
155387237|NCT01765179|560853001|FG000|Overall Study|Lost to Follow-up|5|||
155387238|NCT01765179|560853001|FG000|Overall Study|Non-compliance with study drug|2|||
155387239|NCT01765179|560853001|FG000|Overall Study|Protocol Violation|1|||
155387240|NCT01765179|560853001|FG000|Overall Study|Withdrawal by Subject|8|||
155387241|NCT01765179|560853001|FG000|Overall Study|Hematocrit >54%|3|||
155387242|NCT01765179|560853001|FG000|Overall Study|prohibited med|1|||
155387243|NCT01765179|560853001|FG000|Overall Study|Out of country unable to finish study|1|||
155387244|NCT01765179|560853001|FG000|Overall Study|lack of venous access|1|||
155387245|NCT01765179|560853001|FG000|Overall Study|work conflict|1|||
155387246|NCT01765179|560853001|FG000|Overall Study|Ca elevated 10.6|1|||
155387247|NCT02640157|560853002|FG000|Overall Study|Adverse Event|2|||
155387248|NCT02640157|560853003|FG001|Overall Study|Adverse Event|2|||
155387249|NCT02640157|560853004|FG002|Overall Study|Adverse Event|1|||
155387250|NCT02640157|560853002|FG000|Overall Study|Withdrew consent|2|||
155387251|NCT02640157|560853003|FG001|Overall Study|Withdrew consent|0|||
155387252|NCT02640157|560853004|FG002|Overall Study|Withdrew consent|2|||
155387253|NCT02640157|560853002|FG000|Overall Study|Lost to Follow-up|9|||
155387254|NCT02640157|560853003|FG001|Overall Study|Lost to Follow-up|2|||
155387255|NCT02640157|560853004|FG002|Overall Study|Lost to Follow-up|7|||
155387256|NCT02640157|560853002|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
155387257|NCT02640157|560853003|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
155387258|NCT02640157|560853004|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
155387259|NCT01596621|560853005|FG000|Overall Study|Death|4|||
155387260|NCT01596621|560853005|FG000|Overall Study|Withdrawal by Subject|9|||
155387261|NCT01596621|560853005|FG000|Overall Study|Disease Progression|49|||
155387262|NCT01596621|560853005|FG000|Overall Study|Lost to Follow-up|3|||
155387263|NCT01596621|560853005|FG000|Overall Study|Other than specified|13|||
155387264|NCT00710021|560853006|FG000|Overall Study|Lost to Follow-up|1|||
155387265|NCT00710021|560853007|FG001|Overall Study|Lost to Follow-up|0|||
155387266|NCT00710021|560853008|FG002|Overall Study|Lost to Follow-up|0|||
155387267|NCT00710021|560853006|FG000|Overall Study|Subject's Decision|0|||
155387268|NCT00710021|560853007|FG001|Overall Study|Subject's Decision|1|||
155387269|NCT00710021|560853008|FG002|Overall Study|Subject's Decision|0|||
155387270|NCT00710021|560853006|FG000|Overall Study|Subject misrandomized|0|||
155387271|NCT00710021|560853007|FG001|Overall Study|Subject misrandomized|1|||
155387272|NCT00710021|560853008|FG002|Overall Study|Subject misrandomized|1|||
155387273|NCT00710021|560853006|FG000|Overall Study|Physician Decision|0|||
155387274|NCT00710021|560853007|FG001|Overall Study|Physician Decision|1|||
155387275|NCT00710021|560853008|FG002|Overall Study|Physician Decision|0|||
155387276|NCT01679405|560853009|FG000|Overall Study|Death|2|||
155387277|NCT01679405|560853010|FG001|Overall Study|Death|5|||
154944216|NCT00283686|559220915|FG001|Overall Study|Lost to Follow-up|31|||
154944217|NCT00283686|559220916|FG002|Overall Study|Lost to Follow-up|26|||
154944218|NCT00283686|559220917|FG003|Overall Study|Lost to Follow-up|20|||
154944219|NCT00283686|559220914|FG000|Overall Study|Less than full participation|7|||
154944220|NCT00283686|559220915|FG001|Overall Study|Less than full participation|9|||
154944221|NCT00283686|559220916|FG002|Overall Study|Less than full participation|6|||
154944222|NCT00283686|559220917|FG003|Overall Study|Less than full participation|12|||
154944223|NCT01076166|559220918|FG000|Overall Study|Adverse Event|3|||
154944224|NCT01076166|559220918|FG000|Overall Study|Symptoms improved/resolved|6|||
155387278|NCT04677179|560853011|FG000|Induction Treatment Period|Adverse Event|1|||
155387279|NCT04677179|560853012|FG001|Induction Treatment Period|Adverse Event|0|||
155387280|NCT04677179|560853013|FG002|Induction Treatment Period|Adverse Event|0|||
155387281|NCT04677179|560853014|FG003|Induction Treatment Period|Adverse Event|0|||
155387282|NCT04677179|560853015|FG004|Induction Treatment Period|Adverse Event|0|||
155387283|NCT04677179|560853016|FG005|Induction Treatment Period|Adverse Event|0|||
155045866|NCT05052697|559599386|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045867|NCT05052697|559599387|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045868|NCT05052697|559599388|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045869|NCT05052697|559599389|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045870|NCT05052697|559599390|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045871|NCT05052697|559599391|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045872|NCT05052697|559599392|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045873|NCT05052697|559599393|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045874|NCT05052697|559599394|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155280634|NCT04955626|560459867|FG000|Blinded Period|No longer meets eligibility criteria|1|||
155045875|NCT05052697|559599395|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045876|NCT05052697|559599396|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045877|NCT05052697|559599397|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045878|NCT05052697|559599398|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045879|NCT05052697|559599399|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045880|NCT05052697|559599400|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045881|NCT05052697|559599401|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045882|NCT05052697|559599402|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045883|NCT05052697|559599403|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045884|NCT05052697|559599404|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045885|NCT05052697|559599405|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045886|NCT05052697|559599406|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045887|NCT05052697|559599407|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045888|NCT05052697|559599408|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045889|NCT05052697|559599409|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045890|NCT05052697|559599410|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045891|NCT05052697|559599411|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045892|NCT05052697|559599412|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045893|NCT05052697|559599413|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045894|NCT05052697|559599414|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
155045895|NCT05052697|559599415|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155045896|NCT05052697|559599416|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
155045897|NCT05052697|559599417|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
155280635|NCT04955626|560459868|FG001|Blinded Period|No longer meets eligibility criteria|2|||
155280636|NCT04955626|560459869|FG002|Blinded Period|No longer meets eligibility criteria|0|||
155280637|NCT04955626|560459870|FG003|Blinded Period|No longer meets eligibility criteria|1|||
155280638|NCT04955626|560459871|FG004|Blinded Period|No longer meets eligibility criteria|0|||
155280639|NCT04955626|560459872|FG005|Blinded Period|No longer meets eligibility criteria|0|||
155280640|NCT04955626|560459873|FG006|Blinded Period|No longer meets eligibility criteria|0|||
155280641|NCT04955626|560459874|FG007|Blinded Period|No longer meets eligibility criteria|0|||
155280642|NCT04955626|560459875|FG008|Blinded Period|No longer meets eligibility criteria|1|||
155280643|NCT04955626|560459876|FG009|Blinded Period|No longer meets eligibility criteria|0|||
155280644|NCT04955626|560459877|FG010|Blinded Period|No longer meets eligibility criteria|1|||
155280645|NCT04955626|560459878|FG011|Blinded Period|No longer meets eligibility criteria|1|||
155280646|NCT04955626|560459879|FG012|Blinded Period|No longer meets eligibility criteria|0|||
155280647|NCT04955626|560459880|FG013|Blinded Period|No longer meets eligibility criteria|0|||
155280648|NCT04955626|560459881|FG014|Blinded Period|No longer meets eligibility criteria|0|||
155280649|NCT04955626|560459882|FG015|Blinded Period|No longer meets eligibility criteria|3|||
155280650|NCT04955626|560459883|FG016|Blinded Period|No longer meets eligibility criteria|0|||
155280651|NCT04955626|560459884|FG017|Blinded Period|No longer meets eligibility criteria|2|||
155280652|NCT04955626|560459885|FG018|Blinded Period|No longer meets eligibility criteria|0|||
155280653|NCT04955626|560459886|FG019|Blinded Period|No longer meets eligibility criteria|0|||
155280654|NCT04955626|560459887|FG020|Blinded Period|No longer meets eligibility criteria|0|||
155280655|NCT04955626|560459888|FG021|Blinded Period|No longer meets eligibility criteria|0|||
155280656|NCT04955626|560459889|FG022|Blinded Period|No longer meets eligibility criteria|0|||
155280657|NCT04955626|560459890|FG023|Blinded Period|No longer meets eligibility criteria|0|||
155280658|NCT04955626|560459891|FG024|Blinded Period|No longer meets eligibility criteria|1|||
155280659|NCT04955626|560459892|FG025|Blinded Period|No longer meets eligibility criteria|0|||
155280660|NCT04955626|560459893|FG026|Blinded Period|No longer meets eligibility criteria|0|||
155280661|NCT04955626|560459894|FG027|Blinded Period|No longer meets eligibility criteria|1|||
155280662|NCT04955626|560459895|FG028|Blinded Period|No longer meets eligibility criteria|0|||
155280663|NCT04955626|560459896|FG029|Blinded Period|No longer meets eligibility criteria|0|||
155280664|NCT04955626|560459897|FG030|Blinded Period|No longer meets eligibility criteria|0|||
155045898|NCT05052697|559599418|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
155045899|NCT05052697|559599419|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
155387284|NCT04677179|560853017|FG006|Induction Treatment Period|Adverse Event|0|||
155387285|NCT04677179|560853018|FG007|Induction Treatment Period|Adverse Event|0|||
155387286|NCT04677179|560853019|FG008|Induction Treatment Period|Adverse Event|0|||
155387287|NCT04677179|560853020|FG009|Induction Treatment Period|Adverse Event|0|||
155387288|NCT04677179|560853011|FG000|Induction Treatment Period|Physician Decision|1|||
155387289|NCT04677179|560853012|FG001|Induction Treatment Period|Physician Decision|0|||
155387290|NCT04677179|560853013|FG002|Induction Treatment Period|Physician Decision|1|||
155387291|NCT04677179|560853014|FG003|Induction Treatment Period|Physician Decision|0|||
155387292|NCT04677179|560853015|FG004|Induction Treatment Period|Physician Decision|0|||
155387293|NCT04677179|560853016|FG005|Induction Treatment Period|Physician Decision|0|||
155387294|NCT04677179|560853017|FG006|Induction Treatment Period|Physician Decision|0|||
155387295|NCT04677179|560853018|FG007|Induction Treatment Period|Physician Decision|0|||
155387296|NCT04677179|560853019|FG008|Induction Treatment Period|Physician Decision|0|||
155387297|NCT04677179|560853020|FG009|Induction Treatment Period|Physician Decision|0|||
155387298|NCT04677179|560853011|FG000|Induction Treatment Period|Protocol Violation|0|||
154944225|NCT01211769|559220921|FG000|Overall Study|Lost to Follow-up|7|||
154944226|NCT01211769|559220922|FG001|Overall Study|Lost to Follow-up|9|||
154944227|NCT01211769|559220923|FG002|Overall Study|Lost to Follow-up|5|||
154944228|NCT01211769|559220924|FG003|Overall Study|Lost to Follow-up|9|||
154944229|NCT01211769|559220921|FG000|Overall Study|Physician Decision|2|||
154944230|NCT01211769|559220922|FG001|Overall Study|Physician Decision|0|||
154944231|NCT01211769|559220923|FG002|Overall Study|Physician Decision|2|||
154944232|NCT01211769|559220924|FG003|Overall Study|Physician Decision|1|||
154944233|NCT01211769|559220921|FG000|Overall Study|Adverse Event|0|||
154944234|NCT01211769|559220922|FG001|Overall Study|Adverse Event|1|||
154944235|NCT01211769|559220923|FG002|Overall Study|Adverse Event|1|||
154944236|NCT01211769|559220924|FG003|Overall Study|Adverse Event|1|||
154944237|NCT00947427|559220925|FG000|Overall Study|Withdrawal by Subject|1|||
154944238|NCT00947427|559220926|FG001|Overall Study|Withdrawal by Subject|3|||
154944239|NCT00947427|559220925|FG000|Overall Study|Protocol Violation|0|||
154944240|NCT00947427|559220926|FG001|Overall Study|Protocol Violation|1|||
154944241|NCT02115256|559220929|FG000|Overall Study|Withdrawal by Subject|0|||
154944242|NCT02115256|559220930|FG001|Overall Study|Withdrawal by Subject|1|||
154944243|NCT00146770|559220931|FG000|Overall Study|Adverse Event|2|||
154944244|NCT00146770|559220932|FG001|Overall Study|Adverse Event|0|||
154944245|NCT00146770|559220931|FG000|Overall Study|Pregnancy|1|||
154944246|NCT00146770|559220932|FG001|Overall Study|Pregnancy|0|||
154944247|NCT00146770|559220931|FG000|Overall Study|Withdrawal by Subject|2|||
154944248|NCT00146770|559220932|FG001|Overall Study|Withdrawal by Subject|0|||
154944249|NCT02427607|559220933|FG000|Overall Study|Withdrawal by Subject|1|||
154944250|NCT02826603|559220934|FG000|Overall Study|Adverse Event|17|||
154944251|NCT02826603|559220935|FG001|Overall Study|Adverse Event|9|||
154944252|NCT02826603|559220934|FG000|Overall Study|Lack of Efficacy|4|||
154944253|NCT02826603|559220935|FG001|Overall Study|Lack of Efficacy|9|||
154944254|NCT02826603|559220934|FG000|Overall Study|Lost to Follow-up|13|||
154944255|NCT02826603|559220935|FG001|Overall Study|Lost to Follow-up|12|||
154944256|NCT02826603|559220934|FG000|Overall Study|Noncompliance with treatment|0|||
154944257|NCT02826603|559220935|FG001|Overall Study|Noncompliance with treatment|2|||
154944258|NCT02826603|559220934|FG000|Overall Study|Physician Decision|1|||
154944259|NCT02826603|559220935|FG001|Overall Study|Physician Decision|7|||
154944260|NCT02826603|559220934|FG000|Overall Study|Pregnancy|1|||
154944261|NCT02826603|559220935|FG001|Overall Study|Pregnancy|2|||
154944262|NCT02826603|559220934|FG000|Overall Study|Protocol Violation|3|||
154944263|NCT02826603|559220935|FG001|Overall Study|Protocol Violation|3|||
154944264|NCT02826603|559220934|FG000|Overall Study|Withdrawal by Subject|20|||
154944265|NCT02826603|559220935|FG001|Overall Study|Withdrawal by Subject|19|||
154944266|NCT02826603|559220934|FG000|Overall Study|Death|2|||
154944267|NCT02826603|559220935|FG001|Overall Study|Death|0|||
154944268|NCT02826603|559220934|FG000|Overall Study|New therapy for study indication|0|||
154944269|NCT02826603|559220935|FG001|Overall Study|New therapy for study indication|1|||
154944270|NCT00905489|559220936|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
154944271|NCT00905489|559220936|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
154944272|NCT00905489|559220936|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
154944273|NCT00583596|559220937|FG000|Overall Study|Lost to Follow-up|110|||
155387299|NCT04677179|560853012|FG001|Induction Treatment Period|Protocol Violation|1|||
155387300|NCT04677179|560853013|FG002|Induction Treatment Period|Protocol Violation|0|||
154944274|NCT00583596|559220937|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
154944275|NCT00583596|559220937|FG000|Overall Study|Death|2|||
154944276|NCT00583596|559220937|FG000|Overall Study|Withdrawal by Subject|6|||
154944277|NCT00583596|559220937|FG000|Overall Study|Lost to Follow-up|94|||
154944278|NCT00583596|559220937|FG000|Overall Study|Data not complete|1|||
154944279|NCT00583596|559220937|FG000|Overall Study|Not consented|15|||
154944280|NCT00583596|559220937|FG000|Overall Study|Outside f-up window|26|||
154944281|NCT01533428|559220940|FG000|Overall Study|Adverse Event|0|||
154944282|NCT01533428|559220941|FG001|Overall Study|Adverse Event|1|||
154944283|NCT01533428|559220940|FG000|Overall Study|Lost to Follow-up|2|||
154944284|NCT01533428|559220941|FG001|Overall Study|Lost to Follow-up|1|||
155280665|NCT04955626|560459898|FG031|Blinded Period|No longer meets eligibility criteria|0|||
155280666|NCT04955626|560459899|FG032|Blinded Period|No longer meets eligibility criteria|0|||
155280667|NCT04955626|560459900|FG033|Blinded Period|No longer meets eligibility criteria|0|||
155280668|NCT04955626|560459901|FG034|Blinded Period|No longer meets eligibility criteria|0|||
155280669|NCT04955626|560459902|FG035|Blinded Period|No longer meets eligibility criteria|0|||
155280670|NCT04955626|560459867|FG000|Blinded Period|Other|54|||
155280671|NCT04955626|560459868|FG001|Blinded Period|Other|3|||
155280672|NCT04955626|560459869|FG002|Blinded Period|Other|4|||
155280673|NCT04955626|560459870|FG003|Blinded Period|Other|2|||
155280674|NCT04955626|560459871|FG004|Blinded Period|Other|0|||
155280675|NCT04955626|560459872|FG005|Blinded Period|Other|0|||
155280676|NCT04955626|560459873|FG006|Blinded Period|Other|2|||
155280677|NCT04955626|560459874|FG007|Blinded Period|Other|2|||
155280678|NCT04955626|560459875|FG008|Blinded Period|Other|1|||
155280679|NCT04955626|560459876|FG009|Blinded Period|Other|0|||
155280680|NCT04955626|560459877|FG010|Blinded Period|Other|1|||
155280681|NCT04955626|560459878|FG011|Blinded Period|Other|1|||
155280682|NCT04955626|560459879|FG012|Blinded Period|Other|0|||
155280683|NCT04955626|560459880|FG013|Blinded Period|Other|0|||
155280684|NCT04955626|560459881|FG014|Blinded Period|Other|0|||
155280685|NCT04955626|560459882|FG015|Blinded Period|Other|0|||
155280686|NCT04955626|560459883|FG016|Blinded Period|Other|0|||
155280687|NCT04955626|560459884|FG017|Blinded Period|Other|1|||
155280688|NCT04955626|560459885|FG018|Blinded Period|Other|0|||
155280689|NCT04955626|560459886|FG019|Blinded Period|Other|0|||
155280690|NCT04955626|560459887|FG020|Blinded Period|Other|0|||
155280691|NCT04955626|560459888|FG021|Blinded Period|Other|0|||
155280692|NCT04955626|560459889|FG022|Blinded Period|Other|0|||
155280693|NCT04955626|560459890|FG023|Blinded Period|Other|0|||
155280694|NCT04955626|560459891|FG024|Blinded Period|Other|0|||
155280695|NCT04955626|560459892|FG025|Blinded Period|Other|0|||
155280696|NCT04955626|560459893|FG026|Blinded Period|Other|2|||
155280697|NCT04955626|560459894|FG027|Blinded Period|Other|0|||
155280698|NCT04955626|560459895|FG028|Blinded Period|Other|0|||
155280699|NCT04955626|560459896|FG029|Blinded Period|Other|0|||
155280700|NCT04955626|560459897|FG030|Blinded Period|Other|0|||
155280701|NCT04955626|560459898|FG031|Blinded Period|Other|0|||
155280702|NCT04955626|560459899|FG032|Blinded Period|Other|0|||
155280703|NCT04955626|560459900|FG033|Blinded Period|Other|0|||
155280704|NCT04955626|560459901|FG034|Blinded Period|Other|0|||
155280705|NCT04955626|560459902|FG035|Blinded Period|Other|0|||
155280706|NCT04955626|560459867|FG000|Blinded Period|Physician Decision|1|||
155280707|NCT04955626|560459868|FG001|Blinded Period|Physician Decision|1|||
155280708|NCT04955626|560459869|FG002|Blinded Period|Physician Decision|0|||
155280709|NCT04955626|560459870|FG003|Blinded Period|Physician Decision|3|||
155280710|NCT04955626|560459871|FG004|Blinded Period|Physician Decision|0|||
155280711|NCT04955626|560459872|FG005|Blinded Period|Physician Decision|0|||
155280712|NCT04955626|560459873|FG006|Blinded Period|Physician Decision|1|||
155280713|NCT04955626|560459874|FG007|Blinded Period|Physician Decision|1|||
155280714|NCT04955626|560459875|FG008|Blinded Period|Physician Decision|0|||
155280715|NCT04955626|560459876|FG009|Blinded Period|Physician Decision|0|||
155280716|NCT04955626|560459877|FG010|Blinded Period|Physician Decision|0|||
155280717|NCT04955626|560459878|FG011|Blinded Period|Physician Decision|5|||
155280718|NCT04955626|560459879|FG012|Blinded Period|Physician Decision|0|||
155280719|NCT04955626|560459880|FG013|Blinded Period|Physician Decision|0|||
155280720|NCT04955626|560459881|FG014|Blinded Period|Physician Decision|0|||
155280721|NCT04955626|560459882|FG015|Blinded Period|Physician Decision|0|||
155280722|NCT04955626|560459883|FG016|Blinded Period|Physician Decision|0|||
155280723|NCT04955626|560459884|FG017|Blinded Period|Physician Decision|0|||
155280724|NCT04955626|560459885|FG018|Blinded Period|Physician Decision|0|||
155280725|NCT04955626|560459886|FG019|Blinded Period|Physician Decision|0|||
155280726|NCT04955626|560459887|FG020|Blinded Period|Physician Decision|0|||
155280727|NCT04955626|560459888|FG021|Blinded Period|Physician Decision|0|||
155280728|NCT04955626|560459889|FG022|Blinded Period|Physician Decision|0|||
155280729|NCT04955626|560459890|FG023|Blinded Period|Physician Decision|0|||
155280730|NCT04955626|560459891|FG024|Blinded Period|Physician Decision|0|||
155280731|NCT04955626|560459892|FG025|Blinded Period|Physician Decision|0|||
155280732|NCT04955626|560459893|FG026|Blinded Period|Physician Decision|0|||
155280733|NCT04955626|560459894|FG027|Blinded Period|Physician Decision|0|||
155280734|NCT04955626|560459895|FG028|Blinded Period|Physician Decision|0|||
155280735|NCT04955626|560459896|FG029|Blinded Period|Physician Decision|0|||
155280736|NCT04955626|560459897|FG030|Blinded Period|Physician Decision|0|||
155280737|NCT04955626|560459898|FG031|Blinded Period|Physician Decision|0|||
155280738|NCT04955626|560459899|FG032|Blinded Period|Physician Decision|0|||
155280739|NCT04955626|560459900|FG033|Blinded Period|Physician Decision|0|||
155280740|NCT04955626|560459901|FG034|Blinded Period|Physician Decision|0|||
155280741|NCT04955626|560459902|FG035|Blinded Period|Physician Decision|0|||
155280742|NCT04955626|560459867|FG000|Blinded Period|Withdrawal by Subject|26|||
155280743|NCT04955626|560459868|FG001|Blinded Period|Withdrawal by Subject|62|||
155280744|NCT04955626|560459869|FG002|Blinded Period|Withdrawal by Subject|14|||
155280745|NCT04955626|560459870|FG003|Blinded Period|Withdrawal by Subject|16|||
155280746|NCT04955626|560459871|FG004|Blinded Period|Withdrawal by Subject|1|||
155387301|NCT04677179|560853014|FG003|Induction Treatment Period|Protocol Violation|0|||
155387302|NCT04677179|560853015|FG004|Induction Treatment Period|Protocol Violation|0|||
155387303|NCT04677179|560853016|FG005|Induction Treatment Period|Protocol Violation|0|||
155387304|NCT04677179|560853017|FG006|Induction Treatment Period|Protocol Violation|0|||
155387305|NCT04677179|560853018|FG007|Induction Treatment Period|Protocol Violation|0|||
155387306|NCT04677179|560853019|FG008|Induction Treatment Period|Protocol Violation|0|||
155387307|NCT04677179|560853020|FG009|Induction Treatment Period|Protocol Violation|0|||
155387308|NCT04677179|560853011|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
155387309|NCT04677179|560853012|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
155387310|NCT04677179|560853013|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
155387311|NCT04677179|560853014|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
155387312|NCT04677179|560853015|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
155387313|NCT04677179|560853016|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
155387314|NCT04677179|560853017|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
155387315|NCT04677179|560853018|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
155387316|NCT04677179|560853019|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
155387317|NCT04677179|560853020|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
155387318|NCT04677179|560853011|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
155387319|NCT04677179|560853012|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
155387320|NCT04677179|560853013|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
155387321|NCT04677179|560853014|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
155387322|NCT04677179|560853015|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
155387323|NCT04677179|560853016|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
155387324|NCT04677179|560853017|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
155387325|NCT04677179|560853018|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
155387326|NCT04677179|560853019|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
155387327|NCT04677179|560853020|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
155387328|NCT04677179|560853011|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
155387329|NCT04677179|560853012|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
155387330|NCT04677179|560853013|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
155387331|NCT04677179|560853014|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
155387332|NCT04677179|560853015|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
155387333|NCT04677179|560853016|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
155387334|NCT04677179|560853017|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
155387335|NCT04677179|560853018|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
155387336|NCT04677179|560853019|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
155387337|NCT04677179|560853020|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
155387338|NCT04677179|560853011|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387339|NCT04677179|560853012|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387340|NCT04677179|560853013|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387341|NCT04677179|560853014|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
155387342|NCT04677179|560853015|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387343|NCT04677179|560853016|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387344|NCT04677179|560853017|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387345|NCT04677179|560853018|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387346|NCT04677179|560853019|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387347|NCT04677179|560853020|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
155387348|NCT04677179|560853011|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387349|NCT04677179|560853012|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387350|NCT04677179|560853013|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387351|NCT04677179|560853014|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
155387352|NCT04677179|560853015|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
155387353|NCT04677179|560853016|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
155387354|NCT04677179|560853017|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387355|NCT04677179|560853018|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387356|NCT04677179|560853019|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387357|NCT04677179|560853020|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
155387358|NCT04677179|560853011|FG000|Extension Treatment Period|Lack of Efficacy|0|||
155387359|NCT04677179|560853012|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155387360|NCT04677179|560853013|FG002|Extension Treatment Period|Lack of Efficacy|0|||
155387361|NCT04677179|560853014|FG003|Extension Treatment Period|Lack of Efficacy|0|||
155387362|NCT04677179|560853015|FG004|Extension Treatment Period|Lack of Efficacy|0|||
155387363|NCT04677179|560853016|FG005|Extension Treatment Period|Lack of Efficacy|0|||
155387364|NCT04677179|560853017|FG006|Extension Treatment Period|Lack of Efficacy|6|||
155387365|NCT04677179|560853018|FG007|Extension Treatment Period|Lack of Efficacy|0|||
155387366|NCT04677179|560853019|FG008|Extension Treatment Period|Lack of Efficacy|0|||
155387367|NCT04677179|560853020|FG009|Extension Treatment Period|Lack of Efficacy|0|||
155387368|NCT04677179|560853011|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
155387369|NCT04677179|560853012|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155387370|NCT04677179|560853013|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155387371|NCT04677179|560853014|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
155387372|NCT04677179|560853015|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
155387373|NCT04677179|560853016|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
155387374|NCT04677179|560853017|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
155387375|NCT04677179|560853018|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
155387376|NCT04677179|560853019|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
155387377|NCT04677179|560853020|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
155387378|NCT04677179|560853011|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
155387379|NCT04677179|560853012|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
155387380|NCT04677179|560853013|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
155387381|NCT04677179|560853014|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
155387382|NCT04677179|560853015|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
155387383|NCT04677179|560853016|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
155387384|NCT04677179|560853017|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
155387385|NCT04677179|560853018|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
155387386|NCT04677179|560853019|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
155387387|NCT04677179|560853020|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
155387388|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
155387389|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
155387390|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
155387391|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
155387392|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
155387393|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
155387394|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
155387395|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
155387396|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
155387397|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
155387398|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387399|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387400|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387401|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387402|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387403|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387404|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387405|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
155387406|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
155387407|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
155387408|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387409|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387410|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387411|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387412|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387413|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387414|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387415|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
155387416|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387417|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155387418|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387419|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387420|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387421|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387422|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387423|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155045900|NCT05052697|559599386|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155387424|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387425|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
155387426|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
155387427|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155387428|NCT04677179|560853011|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387429|NCT04677179|560853012|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387430|NCT04677179|560853013|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387431|NCT04677179|560853014|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387432|NCT04677179|560853015|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387433|NCT04677179|560853016|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155387434|NCT04677179|560853017|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
155045901|NCT05052697|559599387|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045902|NCT05052697|559599388|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045903|NCT05052697|559599389|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045904|NCT05052697|559599390|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045905|NCT05052697|559599391|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045906|NCT05052697|559599392|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045907|NCT05052697|559599393|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045908|NCT05052697|559599394|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045909|NCT05052697|559599395|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045910|NCT05052697|559599396|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155280747|NCT04955626|560459872|FG005|Blinded Period|Withdrawal by Subject|2|||
155280748|NCT04955626|560459873|FG006|Blinded Period|Withdrawal by Subject|9|||
155280749|NCT04955626|560459874|FG007|Blinded Period|Withdrawal by Subject|5|||
155280750|NCT04955626|560459875|FG008|Blinded Period|Withdrawal by Subject|3|||
155280751|NCT04955626|560459876|FG009|Blinded Period|Withdrawal by Subject|15|||
155280752|NCT04955626|560459877|FG010|Blinded Period|Withdrawal by Subject|11|||
155280753|NCT04955626|560459878|FG011|Blinded Period|Withdrawal by Subject|7|||
155280754|NCT04955626|560459879|FG012|Blinded Period|Withdrawal by Subject|2|||
155280755|NCT04955626|560459880|FG013|Blinded Period|Withdrawal by Subject|0|||
155280756|NCT04955626|560459881|FG014|Blinded Period|Withdrawal by Subject|1|||
155280757|NCT04955626|560459882|FG015|Blinded Period|Withdrawal by Subject|11|||
155280758|NCT04955626|560459883|FG016|Blinded Period|Withdrawal by Subject|2|||
155280759|NCT04955626|560459884|FG017|Blinded Period|Withdrawal by Subject|5|||
155280760|NCT04955626|560459885|FG018|Blinded Period|Withdrawal by Subject|0|||
155280761|NCT04955626|560459886|FG019|Blinded Period|Withdrawal by Subject|0|||
155280762|NCT04955626|560459887|FG020|Blinded Period|Withdrawal by Subject|1|||
155280763|NCT04955626|560459888|FG021|Blinded Period|Withdrawal by Subject|0|||
155280764|NCT04955626|560459889|FG022|Blinded Period|Withdrawal by Subject|0|||
155280765|NCT04955626|560459890|FG023|Blinded Period|Withdrawal by Subject|0|||
155280766|NCT04955626|560459891|FG024|Blinded Period|Withdrawal by Subject|5|||
155280767|NCT04955626|560459892|FG025|Blinded Period|Withdrawal by Subject|1|||
155280768|NCT04955626|560459893|FG026|Blinded Period|Withdrawal by Subject|5|||
155280769|NCT04955626|560459894|FG027|Blinded Period|Withdrawal by Subject|1|||
155280770|NCT04955626|560459895|FG028|Blinded Period|Withdrawal by Subject|4|||
155280771|NCT04955626|560459896|FG029|Blinded Period|Withdrawal by Subject|2|||
155280772|NCT04955626|560459897|FG030|Blinded Period|Withdrawal by Subject|0|||
155280773|NCT04955626|560459898|FG031|Blinded Period|Withdrawal by Subject|0|||
155280774|NCT04955626|560459899|FG032|Blinded Period|Withdrawal by Subject|0|||
155280775|NCT04955626|560459900|FG033|Blinded Period|Withdrawal by Subject|0|||
155280776|NCT04955626|560459901|FG034|Blinded Period|Withdrawal by Subject|0|||
155280777|NCT04955626|560459902|FG035|Blinded Period|Withdrawal by Subject|0|||
155280778|NCT04955626|560459867|FG000|Blinded Period|Refused further study procedures|0|||
155280779|NCT04955626|560459868|FG001|Blinded Period|Refused further study procedures|0|||
155280780|NCT04955626|560459869|FG002|Blinded Period|Refused further study procedures|0|||
155280781|NCT04955626|560459870|FG003|Blinded Period|Refused further study procedures|0|||
155280782|NCT04955626|560459871|FG004|Blinded Period|Refused further study procedures|0|||
155280783|NCT04955626|560459872|FG005|Blinded Period|Refused further study procedures|0|||
155280784|NCT04955626|560459873|FG006|Blinded Period|Refused further study procedures|1|||
155280785|NCT04955626|560459874|FG007|Blinded Period|Refused further study procedures|0|||
155280786|NCT04955626|560459875|FG008|Blinded Period|Refused further study procedures|0|||
155280787|NCT04955626|560459876|FG009|Blinded Period|Refused further study procedures|0|||
155280788|NCT04955626|560459877|FG010|Blinded Period|Refused further study procedures|0|||
155280789|NCT04955626|560459878|FG011|Blinded Period|Refused further study procedures|2|||
155280790|NCT04955626|560459879|FG012|Blinded Period|Refused further study procedures|0|||
155280791|NCT04955626|560459880|FG013|Blinded Period|Refused further study procedures|0|||
155280792|NCT04955626|560459881|FG014|Blinded Period|Refused further study procedures|0|||
155280793|NCT04955626|560459882|FG015|Blinded Period|Refused further study procedures|0|||
155280794|NCT04955626|560459883|FG016|Blinded Period|Refused further study procedures|0|||
155280795|NCT04955626|560459884|FG017|Blinded Period|Refused further study procedures|0|||
155280796|NCT04955626|560459885|FG018|Blinded Period|Refused further study procedures|0|||
155280797|NCT04955626|560459886|FG019|Blinded Period|Refused further study procedures|0|||
155280798|NCT04955626|560459887|FG020|Blinded Period|Refused further study procedures|0|||
155280799|NCT04955626|560459888|FG021|Blinded Period|Refused further study procedures|0|||
155280800|NCT04955626|560459889|FG022|Blinded Period|Refused further study procedures|0|||
155280801|NCT04955626|560459890|FG023|Blinded Period|Refused further study procedures|0|||
155280802|NCT04955626|560459891|FG024|Blinded Period|Refused further study procedures|0|||
155280803|NCT04955626|560459892|FG025|Blinded Period|Refused further study procedures|0|||
155280804|NCT04955626|560459893|FG026|Blinded Period|Refused further study procedures|0|||
155280805|NCT04955626|560459894|FG027|Blinded Period|Refused further study procedures|0|||
155280806|NCT04955626|560459895|FG028|Blinded Period|Refused further study procedures|0|||
155280807|NCT04955626|560459896|FG029|Blinded Period|Refused further study procedures|0|||
155280808|NCT04955626|560459897|FG030|Blinded Period|Refused further study procedures|0|||
155387435|NCT04677179|560853018|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
155387436|NCT04677179|560853019|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
155387437|NCT04677179|560853020|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
155387438|NCT01536015|560853021|FG000|Overall Study|Adverse Event|1|||
155387439|NCT01536015|560853022|FG001|Overall Study|Adverse Event|4|||
155387440|NCT01536015|560853021|FG000|Overall Study|Lost to Follow-up|0|||
155387441|NCT01536015|560853022|FG001|Overall Study|Lost to Follow-up|1|||
155387442|NCT01536015|560853021|FG000|Overall Study|Inclusion Criterion not met|2|||
155387443|NCT01536015|560853022|FG001|Overall Study|Inclusion Criterion not met|0|||
155387444|NCT01536015|560853021|FG000|Overall Study|Study closure|5|||
155387445|NCT01536015|560853022|FG001|Overall Study|Study closure|5|||
155387446|NCT01201265|560853025|FG000|Overall Study|Death|14|||
155387447|NCT01201265|560853025|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155387448|NCT01201265|560853025|FG000|Overall Study|Lost to Follow-up|10|||
155387449|NCT01201265|560853025|FG000|Overall Study|Withdrawal by Subject|7|||
155387450|NCT01201265|560853025|FG000|Overall Study|Disease Progression|4|||
155387451|NCT02041520|560853026|FG000|Overall Study|Adverse Event|2|||
155387452|NCT02041520|560853027|FG001|Overall Study|Adverse Event|1|||
155387453|NCT02041520|560853026|FG000|Overall Study|Withdrawal by Subject|3|||
155387454|NCT02041520|560853027|FG001|Overall Study|Withdrawal by Subject|4|||
155387455|NCT02041520|560853026|FG000|Overall Study|Protocol Violation|1|||
155387456|NCT02041520|560853027|FG001|Overall Study|Protocol Violation|0|||
155387457|NCT02041520|560853026|FG000|Overall Study|Lost to Follow-up|0|||
155387458|NCT02041520|560853027|FG001|Overall Study|Lost to Follow-up|1|||
155387459|NCT02041520|560853026|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
155387460|NCT02041520|560853027|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
155387461|NCT00413972|560853028|FG000|Overall Study|Adverse Event|2|||
155387462|NCT00413972|560853029|FG001|Overall Study|Adverse Event|1|||
155387463|NCT00413972|560853030|FG002|Overall Study|Adverse Event|0|||
155387464|NCT00413972|560853031|FG003|Overall Study|Adverse Event|0|||
155387465|NCT00413972|560853028|FG000|Overall Study|Lost to Follow-up|1|||
155387466|NCT00413972|560853029|FG001|Overall Study|Lost to Follow-up|2|||
155387467|NCT00413972|560853030|FG002|Overall Study|Lost to Follow-up|1|||
155387468|NCT00413972|560853031|FG003|Overall Study|Lost to Follow-up|0|||
155387469|NCT00413972|560853028|FG000|Overall Study|Withdrawal by Subject|4|||
155387470|NCT00413972|560853029|FG001|Overall Study|Withdrawal by Subject|5|||
154944285|NCT01533428|559220940|FG000|Overall Study|Withdrawal by Subject|7|||
154944286|NCT01533428|559220941|FG001|Overall Study|Withdrawal by Subject|6|||
154944287|NCT00669955|559220946|FG000|Overall Study|Adverse Event|3|||
154944288|NCT00669955|559220947|FG001|Overall Study|Adverse Event|5|||
154944289|NCT00669955|559220946|FG000|Overall Study|Death|0|||
154944290|NCT00669955|559220947|FG001|Overall Study|Death|1|||
154944291|NCT00669955|559220946|FG000|Overall Study|Withdrawal by Subject|2|||
154944292|NCT00669955|559220947|FG001|Overall Study|Withdrawal by Subject|3|||
154944293|NCT00669955|559220946|FG000|Overall Study|Lost to Follow-up|5|||
154944294|NCT00669955|559220947|FG001|Overall Study|Lost to Follow-up|7|||
154944295|NCT00669955|559220946|FG000|Overall Study|Protocol Violation|2|||
154944296|NCT00669955|559220947|FG001|Overall Study|Protocol Violation|7|||
154944297|NCT00669955|559220946|FG000|Overall Study|Investigator Sponsor Judgement|0|||
154944298|NCT00669955|559220947|FG001|Overall Study|Investigator Sponsor Judgement|1|||
154944299|NCT00669955|559220946|FG000|Overall Study|not compliant with study drug/visit|2|||
154944300|NCT00669955|559220947|FG001|Overall Study|not compliant with study drug/visit|3|||
154944301|NCT01073020|559222754|FG000|Overall Study|Withdrawal by Subject|6|||
154944302|NCT01073020|559222755|FG001|Overall Study|Withdrawal by Subject|4|||
154944303|NCT01073020|559222756|FG002|Overall Study|Withdrawal by Subject|1|||
154944304|NCT01073020|559222757|FG003|Overall Study|Withdrawal by Subject|2|||
154944305|NCT01073020|559222754|FG000|Overall Study|Physician Decision|1|||
154944306|NCT01073020|559222755|FG001|Overall Study|Physician Decision|0|||
154944307|NCT01073020|559222756|FG002|Overall Study|Physician Decision|2|||
154944308|NCT01073020|559222757|FG003|Overall Study|Physician Decision|0|||
154944309|NCT01073020|559222754|FG000|Overall Study|Death|0|||
154944310|NCT01073020|559222755|FG001|Overall Study|Death|1|||
154944311|NCT01073020|559222756|FG002|Overall Study|Death|0|||
154944312|NCT01073020|559222757|FG003|Overall Study|Death|0|||
155045911|NCT05052697|559599397|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
154944313|NCT00836927|559222760|FG000|Overall Study|Progressive disease|2|||
154944314|NCT00836927|559222761|FG001|Overall Study|Progressive disease|0|||
155387471|NCT00413972|560853030|FG002|Overall Study|Withdrawal by Subject|7|||
155387472|NCT00413972|560853031|FG003|Overall Study|Withdrawal by Subject|2|||
155387473|NCT00413972|560853028|FG000|Overall Study|Protocol Violation|0|||
155387474|NCT00413972|560853029|FG001|Overall Study|Protocol Violation|0|||
155387475|NCT00413972|560853030|FG002|Overall Study|Protocol Violation|2|||
155387476|NCT00413972|560853031|FG003|Overall Study|Protocol Violation|0|||
155387477|NCT00413972|560853028|FG000|Overall Study|Other|0|||
155387478|NCT00413972|560853029|FG001|Overall Study|Other|0|||
155387479|NCT00413972|560853030|FG002|Overall Study|Other|0|||
155387480|NCT00413972|560853031|FG003|Overall Study|Other|1|||
154944315|NCT00836927|559222762|FG002|Overall Study|Progressive disease|0|||
155045912|NCT05052697|559599398|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045913|NCT05052697|559599399|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045914|NCT05052697|559599400|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045915|NCT05052697|559599401|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045916|NCT05052697|559599402|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155280809|NCT04955626|560459898|FG031|Blinded Period|Refused further study procedures|0|||
155280810|NCT04955626|560459899|FG032|Blinded Period|Refused further study procedures|0|||
155280811|NCT04955626|560459900|FG033|Blinded Period|Refused further study procedures|0|||
155280812|NCT04955626|560459901|FG034|Blinded Period|Refused further study procedures|0|||
155280813|NCT04955626|560459902|FG035|Blinded Period|Refused further study procedures|0|||
155280814|NCT04955626|560459867|FG000|Blinded Period|Participants entered open label period|4544|||
155280815|NCT04955626|560459868|FG001|Blinded Period|Participants entered open label period|4906|||
155280816|NCT04955626|560459869|FG002|Blinded Period|Participants entered open label period|0|||
155280817|NCT04955626|560459870|FG003|Blinded Period|Participants entered open label period|0|||
155280818|NCT04955626|560459871|FG004|Blinded Period|Participants entered open label period|0|||
155280819|NCT04955626|560459872|FG005|Blinded Period|Participants entered open label period|0|||
155280820|NCT04955626|560459873|FG006|Blinded Period|Participants entered open label period|0|||
155280821|NCT04955626|560459874|FG007|Blinded Period|Participants entered open label period|0|||
155280822|NCT04955626|560459875|FG008|Blinded Period|Participants entered open label period|0|||
155280823|NCT04955626|560459876|FG009|Blinded Period|Participants entered open label period|0|||
155280824|NCT04955626|560459877|FG010|Blinded Period|Participants entered open label period|0|||
155280825|NCT04955626|560459878|FG011|Blinded Period|Participants entered open label period|0|||
155280826|NCT04955626|560459879|FG012|Blinded Period|Participants entered open label period|0|||
155280827|NCT04955626|560459880|FG013|Blinded Period|Participants entered open label period|0|||
155280828|NCT04955626|560459881|FG014|Blinded Period|Participants entered open label period|0|||
155280829|NCT04955626|560459882|FG015|Blinded Period|Participants entered open label period|0|||
155280830|NCT04955626|560459883|FG016|Blinded Period|Participants entered open label period|0|||
155280831|NCT04955626|560459884|FG017|Blinded Period|Participants entered open label period|0|||
155280832|NCT04955626|560459885|FG018|Blinded Period|Participants entered open label period|0|||
155280833|NCT04955626|560459886|FG019|Blinded Period|Participants entered open label period|0|||
155280834|NCT04955626|560459887|FG020|Blinded Period|Participants entered open label period|0|||
155280835|NCT04955626|560459888|FG021|Blinded Period|Participants entered open label period|0|||
155280836|NCT04955626|560459889|FG022|Blinded Period|Participants entered open label period|0|||
155280837|NCT04955626|560459890|FG023|Blinded Period|Participants entered open label period|0|||
155280838|NCT04955626|560459891|FG024|Blinded Period|Participants entered open label period|0|||
155280839|NCT04955626|560459892|FG025|Blinded Period|Participants entered open label period|0|||
155280840|NCT04955626|560459893|FG026|Blinded Period|Participants entered open label period|0|||
155280841|NCT04955626|560459894|FG027|Blinded Period|Participants entered open label period|0|||
155280842|NCT04955626|560459895|FG028|Blinded Period|Participants entered open label period|0|||
155280843|NCT04955626|560459896|FG029|Blinded Period|Participants entered open label period|0|||
155280844|NCT04955626|560459897|FG030|Blinded Period|Participants entered open label period|0|||
155280845|NCT04955626|560459898|FG031|Blinded Period|Participants entered open label period|0|||
155280846|NCT04955626|560459899|FG032|Blinded Period|Participants entered open label period|0|||
155280847|NCT04955626|560459900|FG033|Blinded Period|Participants entered open label period|0|||
155280848|NCT04955626|560459901|FG034|Blinded Period|Participants entered open label period|0|||
155280849|NCT04955626|560459902|FG035|Blinded Period|Participants entered open label period|0|||
155280850|NCT04955626|560459867|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
155280851|NCT04955626|560459868|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
155280852|NCT04955626|560459869|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
155280853|NCT04955626|560459870|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
155280854|NCT04955626|560459871|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
155280855|NCT04955626|560459872|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
155280856|NCT04955626|560459873|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
155280857|NCT04955626|560459874|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
155280858|NCT04955626|560459875|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
155280859|NCT04955626|560459876|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
155280860|NCT04955626|560459877|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
155280861|NCT04955626|560459878|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
155280862|NCT04955626|560459879|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
155280863|NCT04955626|560459880|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
155280864|NCT04955626|560459881|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
155387481|NCT01898923|560853034|FG000|Overall Study|Lack of Efficacy|5|||
155280865|NCT04955626|560459882|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
155280866|NCT04955626|560459883|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
155280867|NCT04955626|560459884|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
155280868|NCT04955626|560459885|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
155387482|NCT01898923|560853035|FG001|Overall Study|Lack of Efficacy|6|||
155387483|NCT01898923|560853034|FG000|Overall Study|Adverse Event|3|||
155045917|NCT05052697|559599403|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045918|NCT05052697|559599404|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045919|NCT05052697|559599405|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045920|NCT05052697|559599406|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045921|NCT05052697|559599407|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045922|NCT05052697|559599408|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155280869|NCT04955626|560459886|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
155280870|NCT04955626|560459887|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
155280871|NCT04955626|560459888|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
155280872|NCT04955626|560459889|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
155280873|NCT04955626|560459890|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
155280874|NCT04955626|560459891|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
155280875|NCT04955626|560459892|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
155280876|NCT04955626|560459893|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
155280877|NCT04955626|560459894|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
155280878|NCT04955626|560459895|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
155280879|NCT04955626|560459896|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
155280880|NCT04955626|560459897|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
155280881|NCT04955626|560459898|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
155280882|NCT04955626|560459899|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
155280883|NCT04955626|560459900|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
155280884|NCT04955626|560459901|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
155280885|NCT04955626|560459902|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
155280886|NCT04955626|560459867|FG000|Blinded Period|Medication error|0|||
155280887|NCT04955626|560459868|FG001|Blinded Period|Medication error|0|||
155280888|NCT04955626|560459869|FG002|Blinded Period|Medication error|0|||
155280889|NCT04955626|560459870|FG003|Blinded Period|Medication error|0|||
155280890|NCT04955626|560459871|FG004|Blinded Period|Medication error|0|||
155280891|NCT04955626|560459872|FG005|Blinded Period|Medication error|0|||
155280892|NCT04955626|560459873|FG006|Blinded Period|Medication error|0|||
155280893|NCT04955626|560459874|FG007|Blinded Period|Medication error|0|||
155280894|NCT04955626|560459875|FG008|Blinded Period|Medication error|0|||
155280895|NCT04955626|560459876|FG009|Blinded Period|Medication error|0|||
155280896|NCT04955626|560459877|FG010|Blinded Period|Medication error|2|||
155280897|NCT04955626|560459878|FG011|Blinded Period|Medication error|0|||
155280898|NCT04955626|560459879|FG012|Blinded Period|Medication error|0|||
155280899|NCT04955626|560459880|FG013|Blinded Period|Medication error|0|||
155280900|NCT04955626|560459881|FG014|Blinded Period|Medication error|0|||
155280901|NCT04955626|560459882|FG015|Blinded Period|Medication error|0|||
155280902|NCT04955626|560459883|FG016|Blinded Period|Medication error|0|||
155280903|NCT04955626|560459884|FG017|Blinded Period|Medication error|0|||
155280904|NCT04955626|560459885|FG018|Blinded Period|Medication error|0|||
155280905|NCT04955626|560459886|FG019|Blinded Period|Medication error|0|||
155280906|NCT04955626|560459887|FG020|Blinded Period|Medication error|0|||
155280907|NCT04955626|560459888|FG021|Blinded Period|Medication error|0|||
155280908|NCT04955626|560459889|FG022|Blinded Period|Medication error|0|||
155280909|NCT04955626|560459890|FG023|Blinded Period|Medication error|0|||
155280910|NCT04955626|560459891|FG024|Blinded Period|Medication error|0|||
155280911|NCT04955626|560459892|FG025|Blinded Period|Medication error|0|||
155280912|NCT04955626|560459893|FG026|Blinded Period|Medication error|0|||
155280913|NCT04955626|560459894|FG027|Blinded Period|Medication error|0|||
154944316|NCT00836927|559222763|FG003|Overall Study|Progressive disease|1|||
154944317|NCT00836927|559222764|FG004|Overall Study|Progressive disease|1|||
154944318|NCT00836927|559222760|FG000|Overall Study|Withdrawal by Subject|1|||
154944319|NCT00836927|559222761|FG001|Overall Study|Withdrawal by Subject|0|||
154944320|NCT00836927|559222762|FG002|Overall Study|Withdrawal by Subject|0|||
154944321|NCT00836927|559222763|FG003|Overall Study|Withdrawal by Subject|0|||
154944322|NCT00836927|559222764|FG004|Overall Study|Withdrawal by Subject|0|||
154944323|NCT00614055|559222766|FG000|Overall Study|Adverse Event|1|||
154944324|NCT00614055|559222767|FG001|Overall Study|Adverse Event|0|||
154944325|NCT00614055|559222768|FG002|Overall Study|Adverse Event|0|||
154944326|NCT00614055|559222766|FG000|Overall Study|Protocol Violation|2|||
154944327|NCT00614055|559222767|FG001|Overall Study|Protocol Violation|2|||
154944328|NCT00614055|559222768|FG002|Overall Study|Protocol Violation|1|||
154944329|NCT00614055|559222766|FG000|Overall Study|Lack of Efficacy|0|||
154944330|NCT00614055|559222767|FG001|Overall Study|Lack of Efficacy|0|||
155280914|NCT04955626|560459895|FG028|Blinded Period|Medication error|4|||
155280915|NCT04955626|560459896|FG029|Blinded Period|Medication error|0|||
155280916|NCT04955626|560459897|FG030|Blinded Period|Medication error|0|||
155280917|NCT04955626|560459898|FG031|Blinded Period|Medication error|0|||
155280918|NCT04955626|560459899|FG032|Blinded Period|Medication error|0|||
155280919|NCT04955626|560459900|FG033|Blinded Period|Medication error|0|||
154944331|NCT00614055|559222768|FG002|Overall Study|Lack of Efficacy|2|||
154944332|NCT00614055|559222766|FG000|Overall Study|Unclassified|1|||
154944333|NCT00614055|559222767|FG001|Overall Study|Unclassified|4|||
154944334|NCT00614055|559222768|FG002|Overall Study|Unclassified|2|||
154944335|NCT02637557|559222779|FG000|Overall Study|Adverse Event|3|||
155387484|NCT01898923|560853035|FG001|Overall Study|Adverse Event|1|||
155387485|NCT01898923|560853034|FG000|Overall Study|Lost to Follow-up|0|||
155387486|NCT01898923|560853035|FG001|Overall Study|Lost to Follow-up|1|||
155387487|NCT01898923|560853034|FG000|Overall Study|Withdrawal by Subject|4|||
155387488|NCT01898923|560853035|FG001|Overall Study|Withdrawal by Subject|7|||
155387489|NCT01898923|560853034|FG000|Overall Study|Physician Decision|3|||
155387490|NCT01898923|560853035|FG001|Overall Study|Physician Decision|4|||
155387491|NCT01898923|560853034|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
155387492|NCT01898923|560853035|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
155387493|NCT02678247|560853038|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
155387494|NCT02678247|560853039|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
155387495|NCT02678247|560853038|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
155387496|NCT02678247|560853039|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
155387497|NCT02678247|560853038|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
155387498|NCT02678247|560853039|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
155387499|NCT02678247|560853038|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
155387500|NCT02678247|560853039|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
155387501|NCT02678247|560853038|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
155387502|NCT02678247|560853039|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
155387503|NCT02678247|560853038|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
155387504|NCT02678247|560853039|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
155387505|NCT00723021|560853042|FG000|Intervention Period 4|Adverse Event|0|||
155387506|NCT00723021|560853043|FG001|Intervention Period 4|Adverse Event|0|||
155387507|NCT00723021|560853044|FG002|Intervention Period 4|Adverse Event|0|||
155387508|NCT00723021|560853045|FG003|Intervention Period 4|Adverse Event|0|||
155387509|NCT00723021|560853046|FG004|Intervention Period 4|Adverse Event|1|||
155387510|NCT02739360|560853048|FG000|Overall Study|Adverse Event|1|||
155387511|NCT02739360|560853048|FG000|Overall Study|Study terminated by Sponsor|2|||
155387512|NCT00026208|560853051|FG000|Overall Study|Complications of auto accident|1|||
155387513|NCT00026208|560853052|FG001|Overall Study|Complications of auto accident|0|||
155387514|NCT02881957|560853061|FG000|Overall Study|Comfort care|0|||
155387515|NCT02881957|560853062|FG001|Overall Study|Comfort care|1|||
154944336|NCT02637557|559222780|FG001|Overall Study|Adverse Event|1|||
154944337|NCT02637557|559222781|FG002|Overall Study|Adverse Event|3|||
154944338|NCT02637557|559222782|FG003|Overall Study|Adverse Event|3|||
154944339|NCT02637557|559222779|FG000|Overall Study|Lost to Follow-up|1|||
154944340|NCT02637557|559222780|FG001|Overall Study|Lost to Follow-up|1|||
154944341|NCT02637557|559222781|FG002|Overall Study|Lost to Follow-up|0|||
154944342|NCT02637557|559222782|FG003|Overall Study|Lost to Follow-up|1|||
154944343|NCT02637557|559222779|FG000|Overall Study|Physician Decision|1|||
154944344|NCT02637557|559222780|FG001|Overall Study|Physician Decision|0|||
154944345|NCT02637557|559222781|FG002|Overall Study|Physician Decision|0|||
154944346|NCT02637557|559222782|FG003|Overall Study|Physician Decision|0|||
154944347|NCT02637557|559222779|FG000|Overall Study|Protocol Violation|2|||
154944348|NCT02637557|559222780|FG001|Overall Study|Protocol Violation|0|||
154944349|NCT02637557|559222781|FG002|Overall Study|Protocol Violation|2|||
154944350|NCT02637557|559222782|FG003|Overall Study|Protocol Violation|1|||
154944351|NCT02637557|559222779|FG000|Overall Study|Withdrawal by Subject|1|||
154944352|NCT02637557|559222780|FG001|Overall Study|Withdrawal by Subject|3|||
154944353|NCT02637557|559222781|FG002|Overall Study|Withdrawal by Subject|4|||
154944354|NCT02637557|559222782|FG003|Overall Study|Withdrawal by Subject|2|||
154944355|NCT02006706|559222783|FG000|Overall Study|Lost to Follow-up|1|||
154944356|NCT01673009|559222784|FG000|Overall Study|Physician Decision|5|||
154944357|NCT01673009|559222784|FG000|Overall Study|Withdrawal by Subject|8|||
154944358|NCT04161144|559222786|FG000|Overall Study|Withdrawal by Subject|0|||
154944359|NCT04161144|559222787|FG001|Overall Study|Withdrawal by Subject|1|||
154944360|NCT04161144|559222786|FG000|Overall Study|Protocol Violation|1|||
154944361|NCT04161144|559222787|FG001|Overall Study|Protocol Violation|0|||
154944362|NCT02848599|559222790|FG000|Overall Study|Protocol Violation|7|||
154944363|NCT02848599|559222791|FG001|Overall Study|Protocol Violation|9|||
154944364|NCT04828161|559222792|FG000|Overall Study|Withdrawal by Subject|0|||
154944365|NCT04828161|559222793|FG001|Overall Study|Withdrawal by Subject|3|||
154944366|NCT04828161|559222794|FG002|Overall Study|Withdrawal by Subject|3|||
154944367|NCT04828161|559222795|FG003|Overall Study|Withdrawal by Subject|4|||
154944368|NCT04828161|559222792|FG000|Overall Study|Lost to Follow-up|1|||
154944369|NCT04828161|559222793|FG001|Overall Study|Lost to Follow-up|4|||
154944370|NCT04828161|559222794|FG002|Overall Study|Lost to Follow-up|2|||
154944371|NCT04828161|559222795|FG003|Overall Study|Lost to Follow-up|2|||
154944372|NCT04828161|559222792|FG000|Overall Study|Other|2|||
154944373|NCT04828161|559222793|FG001|Overall Study|Other|0|||
154944374|NCT04828161|559222794|FG002|Overall Study|Other|2|||
155387516|NCT02881957|560853061|FG000|Overall Study|Concurrent trial enrollment|0|||
155387517|NCT02881957|560853062|FG001|Overall Study|Concurrent trial enrollment|1|||
155387518|NCT02881957|560853061|FG000|Overall Study|Discharged within 48 hours|0|||
154944375|NCT04828161|559222795|FG003|Overall Study|Other|0|||
155387519|NCT02881957|560853062|FG001|Overall Study|Discharged within 48 hours|1|||
155387520|NCT02881957|560853061|FG000|Overall Study|Withdrawal by Subject|2|||
155387521|NCT02881957|560853062|FG001|Overall Study|Withdrawal by Subject|1|||
155387522|NCT02881957|560853061|FG000|Overall Study|Protocol Violation|1|||
155387523|NCT02881957|560853062|FG001|Overall Study|Protocol Violation|0|||
155387524|NCT02254278|560853063|FG000|Overall Study|Protocol Violation|1|||
155387525|NCT02254278|560853064|FG001|Overall Study|Protocol Violation|1|||
155387526|NCT00826111|560854878|FG000|Overall Study|Lost to Follow-up|0|||
155387527|NCT00826111|560854879|FG001|Overall Study|Lost to Follow-up|1|||
155387528|NCT00826111|560854878|FG000|Overall Study|Protocol Violation|1|||
155387529|NCT00826111|560854879|FG001|Overall Study|Protocol Violation|0|||
155387530|NCT00826111|560854878|FG000|Overall Study|Withdrawal by Subject|5|||
155387531|NCT00826111|560854879|FG001|Overall Study|Withdrawal by Subject|0|||
155387532|NCT00826111|560854878|FG000|Overall Study|Physician Decision|1|||
155387533|NCT00826111|560854879|FG001|Overall Study|Physician Decision|1|||
155387534|NCT02805725|560854880|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387535|NCT02805725|560854881|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387536|NCT02805725|560854882|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
155387537|NCT02805725|560854883|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387538|NCT02805725|560854884|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
155387539|NCT02805725|560854880|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
155387540|NCT02805725|560854881|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
155387541|NCT02805725|560854882|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
155387542|NCT02805725|560854883|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
155387543|NCT02805725|560854884|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
155387544|NCT02805725|560854880|FG000|Phase II|Protocol Violation|0|||
155387545|NCT02805725|560854881|FG001|Phase II|Protocol Violation|0|||
155387546|NCT02805725|560854882|FG002|Phase II|Protocol Violation|0|||
155387547|NCT02805725|560854883|FG003|Phase II|Protocol Violation|0|||
155387548|NCT02805725|560854884|FG004|Phase II|Protocol Violation|6|||
155387549|NCT01195545|560854885|FG000|Overall Study|Protocol Violation|4|||
155387550|NCT03511053|560854889|FG000|Overall Study|Withdrawal by Subject|1|||
155387551|NCT02425644|560854890|FG000|Overall Study|Lost to Follow-up|2|||
155387552|NCT02425644|560854891|FG001|Overall Study|Lost to Follow-up|3|||
155387553|NCT02425644|560854890|FG000|Overall Study|Withdrawal by Subject|41|||
155387554|NCT02425644|560854891|FG001|Overall Study|Withdrawal by Subject|36|||
155387555|NCT02425644|560854890|FG000|Overall Study|Lack of Efficacy|3|||
155387556|NCT02425644|560854891|FG001|Overall Study|Lack of Efficacy|10|||
155387557|NCT02425644|560854890|FG000|Overall Study|Adverse Event|13|||
155387558|NCT02425644|560854891|FG001|Overall Study|Adverse Event|3|||
155387559|NCT02425644|560854890|FG000|Overall Study|Death|0|||
155387560|NCT02425644|560854891|FG001|Overall Study|Death|2|||
155387561|NCT02425644|560854890|FG000|Overall Study|Other|18|||
155387562|NCT02425644|560854891|FG001|Overall Study|Other|17|||
155387563|NCT02720536|560854892|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
155387564|NCT02720536|560854892|FG000|Overall Study|PR - pregnancy|2|||
155387565|NCT02720536|560854892|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
155387566|NCT02720536|560854892|FG000|Overall Study|PR - death|1|||
155387567|NCT02720536|560854892|FG000|Overall Study|PR - adverse event|1|||
155387568|NCT02720536|560854892|FG000|Overall Study|PR - abnormal lab value(s)|1|||
155387569|NCT02720536|560854892|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
155387570|NCT01028222|560854893|FG000|Overall Study|Protocol deviation|1|||
155387571|NCT01028222|560854894|FG001|Overall Study|Protocol deviation|0|||
155387572|NCT01028222|560854893|FG000|Overall Study|Disease progression|33|||
155387573|NCT01028222|560854894|FG001|Overall Study|Disease progression|9|||
155387574|NCT01028222|560854893|FG000|Overall Study|Administrative problems|1|||
155387575|NCT01028222|560854894|FG001|Overall Study|Administrative problems|1|||
155387576|NCT01028222|560854893|FG000|Overall Study|Lost to Follow-up|0|||
155387577|NCT01028222|560854894|FG001|Overall Study|Lost to Follow-up|1|||
155387578|NCT01028222|560854893|FG000|Overall Study|Withdrawal by Subject|1|||
155387579|NCT01028222|560854894|FG001|Overall Study|Withdrawal by Subject|0|||
155387580|NCT01028222|560854893|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
155387581|NCT01028222|560854894|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
155387582|NCT01028222|560854893|FG000|Overall Study|Adverse Event|2|||
155387583|NCT01028222|560854894|FG001|Overall Study|Adverse Event|0|||
155387584|NCT00146328|560854895|FG000|Overall Study|Adverse Event|39|||
155387585|NCT00146328|560854896|FG001|Overall Study|Adverse Event|48|||
155387586|NCT00146328|560854897|FG002|Overall Study|Adverse Event|79|||
155387587|NCT00146328|560854895|FG000|Overall Study|Protocol Violation|11|||
155387588|NCT00146328|560854896|FG001|Overall Study|Protocol Violation|6|||
155387589|NCT00146328|560854897|FG002|Overall Study|Protocol Violation|12|||
155387590|NCT00146328|560854895|FG000|Overall Study|Lost to Follow-up|7|||
155387591|NCT00146328|560854896|FG001|Overall Study|Lost to Follow-up|4|||
155387592|NCT00146328|560854897|FG002|Overall Study|Lost to Follow-up|7|||
155387593|NCT00146328|560854895|FG000|Overall Study|Withdrawal by Subject|16|||
155387594|NCT00146328|560854896|FG001|Overall Study|Withdrawal by Subject|16|||
154944376|NCT04828161|559222792|FG000|Overall Study|Death|0|||
155387595|NCT00146328|560854897|FG002|Overall Study|Withdrawal by Subject|22|||
155387596|NCT00146328|560854895|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
155387597|NCT00146328|560854896|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
155387598|NCT00146328|560854897|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
155387599|NCT00146328|560854895|FG000|Overall Study|Trial ended/site closed|8|||
155387600|NCT00146328|560854896|FG001|Overall Study|Trial ended/site closed|2|||
155387601|NCT00146328|560854897|FG002|Overall Study|Trial ended/site closed|19|||
155387602|NCT00146328|560854895|FG000|Overall Study|Patient decision to end|0|||
154944377|NCT04828161|559222793|FG001|Overall Study|Death|0|||
154944378|NCT04828161|559222794|FG002|Overall Study|Death|0|||
154944379|NCT04828161|559222795|FG003|Overall Study|Death|2|||
154944380|NCT02352337|559222796|FG000|Overall Study|Patients never treated|4|||
154944381|NCT02352337|559222797|FG001|Overall Study|Patients never treated|1|||
154944382|NCT02352337|559222798|FG002|Overall Study|Patients never treated|2|||
154944383|NCT02458638|559222801|FG000|Overall Study|Death|309|||
154944384|NCT02458638|559222801|FG000|Overall Study|End of Cohort/End of Study|67|||
154944385|NCT02458638|559222801|FG000|Overall Study|Lost to Follow-up|31|||
154944386|NCT02458638|559222801|FG000|Overall Study|Other Reasons|4|||
154944387|NCT02458638|559222801|FG000|Overall Study|Physician Decision|1|||
154944388|NCT02458638|559222801|FG000|Overall Study|Withdrawal by Subject|47|||
154944389|NCT00135707|559222811|FG000|Overall Study|Lost to Follow-up|94|||
154944390|NCT00135707|559222812|FG001|Overall Study|Lost to Follow-up|89|||
154944391|NCT00135707|559222811|FG000|Overall Study|Withdrawal by Subject|0|||
154944392|NCT00135707|559222812|FG001|Overall Study|Withdrawal by Subject|1|||
154944393|NCT00135707|559222811|FG000|Overall Study|Institutional review board request|1|||
154944394|NCT00135707|559222812|FG001|Overall Study|Institutional review board request|0|||
154944395|NCT01612000|559222819|FG000|Overall Study|Lost to Follow-up|6|||
154944396|NCT01612000|559222820|FG001|Overall Study|Lost to Follow-up|4|||
154944397|NCT01612000|559222821|FG002|Overall Study|Lost to Follow-up|4|||
154944398|NCT01612000|559222822|FG003|Overall Study|Lost to Follow-up|8|||
154944399|NCT01612000|559222819|FG000|Overall Study|Physician Decision|0|||
154944400|NCT01612000|559222820|FG001|Overall Study|Physician Decision|0|||
154944401|NCT01612000|559222821|FG002|Overall Study|Physician Decision|1|||
154944402|NCT01612000|559222822|FG003|Overall Study|Physician Decision|0|||
154944403|NCT01612000|559222819|FG000|Overall Study|Withdrawal by Subject|3|||
154944404|NCT01612000|559222820|FG001|Overall Study|Withdrawal by Subject|1|||
154944405|NCT01612000|559222821|FG002|Overall Study|Withdrawal by Subject|2|||
154944406|NCT01612000|559222822|FG003|Overall Study|Withdrawal by Subject|2|||
154944407|NCT02173704|559222823|FG000|Overall Study|Adverse Event|1|||
154944408|NCT02173704|559222824|FG001|Overall Study|Adverse Event|0|||
154944409|NCT02173704|559222823|FG000|Overall Study|Lost to Follow-up|1|||
154944410|NCT02173704|559222824|FG001|Overall Study|Lost to Follow-up|0|||
154944411|NCT02173704|559222823|FG000|Overall Study|Other|1|||
154944412|NCT02173704|559222824|FG001|Overall Study|Other|0|||
154944413|NCT02173704|559222823|FG000|Overall Study|Protocol Violation|1|||
154944414|NCT02173704|559222824|FG001|Overall Study|Protocol Violation|0|||
154944415|NCT02173704|559222823|FG000|Overall Study|Withdrawal by Subject|9|||
154944416|NCT02173704|559222824|FG001|Overall Study|Withdrawal by Subject|4|||
154944417|NCT01180244|559222835|FG000|Overall Study|Lack of Efficacy|0|||
154944418|NCT01180244|559222836|FG001|Overall Study|Lack of Efficacy|7|||
154944419|NCT01180244|559222835|FG000|Overall Study|Physician Decision|3|||
154944420|NCT01180244|559222836|FG001|Overall Study|Physician Decision|0|||
154944421|NCT01180244|559222835|FG000|Overall Study|Adverse Event|1|||
154944422|NCT01180244|559222836|FG001|Overall Study|Adverse Event|0|||
154944423|NCT01180244|559222835|FG000|Overall Study|Withdrawal by Subject|0|||
154944424|NCT01180244|559222836|FG001|Overall Study|Withdrawal by Subject|1|||
154944425|NCT01180244|559222835|FG000|Overall Study|Protocol Violation|1|||
154944426|NCT01180244|559222836|FG001|Overall Study|Protocol Violation|0|||
154944427|NCT01180244|559222835|FG000|Overall Study|Lost to Follow-up|1|||
154944428|NCT01180244|559222836|FG001|Overall Study|Lost to Follow-up|0|||
154944429|NCT00620763|559222839|FG000|Period: First Intervention|Withdrawal by Subject|0|||
154944430|NCT00620763|559222840|FG001|Period: First Intervention|Withdrawal by Subject|2|||
154944431|NCT00620763|559222839|FG000|Period: First Intervention|Protocol Violation|0|||
154944432|NCT00620763|559222840|FG001|Period: First Intervention|Protocol Violation|3|||
154944433|NCT00620763|559222839|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
154944434|NCT00620763|559222840|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
154944435|NCT01595009|559222841|FG000|Core|Patients completed per protocol|85|||
155387603|NCT00146328|560854896|FG001|Overall Study|Patient decision to end|1|||
154944436|NCT01595009|559222842|FG001|Core|Patients completed per protocol|44|||
154944437|NCT01595009|559222843|FG002|Core|Patients completed per protocol|0|||
154944438|NCT01595009|559222844|FG003|Core|Patients completed per protocol|0|||
154944439|NCT01595009|559222841|FG000|Core|Adverse Event|19|||
154944440|NCT01595009|559222842|FG001|Core|Adverse Event|23|||
154944441|NCT01595009|559222843|FG002|Core|Adverse Event|0|||
154944442|NCT01595009|559222844|FG003|Core|Adverse Event|0|||
154944443|NCT01595009|559222841|FG000|Core|Disease progression|14|||
154944444|NCT01595009|559222842|FG001|Core|Disease progression|26|||
154944445|NCT01595009|559222843|FG002|Core|Disease progression|0|||
155387604|NCT00146328|560854897|FG002|Overall Study|Patient decision to end|6|||
155387605|NCT00146328|560854895|FG000|Overall Study|Enroll into other trial|2|||
155387606|NCT00146328|560854896|FG001|Overall Study|Enroll into other trial|4|||
155387607|NCT00146328|560854897|FG002|Overall Study|Enroll into other trial|2|||
155387608|NCT00146328|560854895|FG000|Overall Study|Death|0|||
155387609|NCT00146328|560854896|FG001|Overall Study|Death|1|||
155387610|NCT00146328|560854897|FG002|Overall Study|Death|1|||
155387611|NCT00146328|560854895|FG000|Overall Study|Moved|2|||
155387612|NCT00146328|560854896|FG001|Overall Study|Moved|0|||
155387613|NCT00146328|560854897|FG002|Overall Study|Moved|0|||
155387614|NCT00146328|560854895|FG000|Overall Study|Interaction with other medication|2|||
155387615|NCT00146328|560854896|FG001|Overall Study|Interaction with other medication|0|||
155387616|NCT00146328|560854897|FG002|Overall Study|Interaction with other medication|1|||
155387617|NCT00300781|560854898|FG000|Overall Study|Disease Progression|55|||
155387618|NCT00300781|560854899|FG001|Overall Study|Disease Progression|52|||
155387619|NCT00300781|560854898|FG000|Overall Study|Adverse Event|5|||
155387620|NCT00300781|560854899|FG001|Overall Study|Adverse Event|6|||
155387621|NCT00300781|560854898|FG000|Overall Study|Withdrawal by Subject|1|||
155387622|NCT00300781|560854899|FG001|Overall Study|Withdrawal by Subject|2|||
155387623|NCT00300781|560854898|FG000|Overall Study|Physician Decision|1|||
155387624|NCT00300781|560854899|FG001|Overall Study|Physician Decision|0|||
155387625|NCT00300781|560854898|FG000|Overall Study|Not Recorded|0|||
155387626|NCT00300781|560854899|FG001|Overall Study|Not Recorded|1|||
155387627|NCT00300781|560854898|FG000|Overall Study|Symptomatic Deterioration|1|||
155387628|NCT00300781|560854899|FG001|Overall Study|Symptomatic Deterioration|0|||
155387629|NCT00300781|560854898|FG000|Overall Study|Lost to Follow-up|0|||
155387630|NCT00300781|560854899|FG001|Overall Study|Lost to Follow-up|1|||
155387631|NCT00792805|560854900|FG000|Overall Study|Adverse Event|12|||
155387632|NCT00792805|560854901|FG001|Overall Study|Adverse Event|10|||
155387633|NCT00792805|560854902|FG002|Overall Study|Adverse Event|10|||
155387634|NCT00792805|560854900|FG000|Overall Study|Subject withdrew consent|5|||
155387635|NCT00792805|560854901|FG001|Overall Study|Subject withdrew consent|6|||
155387636|NCT00792805|560854902|FG002|Overall Study|Subject withdrew consent|5|||
155387637|NCT00792805|560854900|FG000|Overall Study|Administrative problems|2|||
155387638|NCT00792805|560854901|FG001|Overall Study|Administrative problems|0|||
155387639|NCT00792805|560854902|FG002|Overall Study|Administrative problems|4|||
155387640|NCT00792805|560854900|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155387641|NCT00792805|560854901|FG001|Overall Study|Abnormal test procedure result(s)|2|||
155387642|NCT00792805|560854902|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155387643|NCT00792805|560854900|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155387644|NCT00792805|560854901|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155387645|NCT00792805|560854902|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
155387646|NCT00792805|560854900|FG000|Overall Study|Lost to Follow-up|1|||
155387647|NCT00792805|560854901|FG001|Overall Study|Lost to Follow-up|1|||
155387648|NCT00792805|560854902|FG002|Overall Study|Lost to Follow-up|6|||
155387649|NCT00792805|560854900|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155387650|NCT00792805|560854901|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155387651|NCT00792805|560854902|FG002|Overall Study|Abnormal laboratory value(s)|1|||
155387652|NCT00792805|560854900|FG000|Overall Study|Protocol deviation|0|||
155280920|NCT04955626|560459901|FG034|Blinded Period|Medication error|0|||
155280921|NCT04955626|560459902|FG035|Blinded Period|Medication error|0|||
155280922|NCT04955626|560459867|FG000|Open-Label Period|Lost to Follow-up|109|||
155280923|NCT04955626|560459868|FG001|Open-Label Period|Lost to Follow-up|41|||
155280924|NCT04955626|560459869|FG002|Open-Label Period|Lost to Follow-up|0|||
155280925|NCT04955626|560459870|FG003|Open-Label Period|Lost to Follow-up|0|||
155280926|NCT04955626|560459871|FG004|Open-Label Period|Lost to Follow-up|0|||
155280927|NCT04955626|560459872|FG005|Open-Label Period|Lost to Follow-up|0|||
155280928|NCT04955626|560459873|FG006|Open-Label Period|Lost to Follow-up|0|||
155280929|NCT04955626|560459874|FG007|Open-Label Period|Lost to Follow-up|0|||
155387653|NCT00792805|560854901|FG001|Overall Study|Protocol deviation|1|||
155280930|NCT04955626|560459875|FG008|Open-Label Period|Lost to Follow-up|0|||
155280931|NCT04955626|560459876|FG009|Open-Label Period|Lost to Follow-up|0|||
155280932|NCT04955626|560459877|FG010|Open-Label Period|Lost to Follow-up|0|||
155280933|NCT04955626|560459878|FG011|Open-Label Period|Lost to Follow-up|0|||
155280934|NCT04955626|560459879|FG012|Open-Label Period|Lost to Follow-up|0|||
155387654|NCT00792805|560854902|FG002|Overall Study|Protocol deviation|1|||
155387655|NCT02072434|560854906|FG000|Overall Study|Protocol Violation|10|||
155387656|NCT02072434|560854907|FG001|Overall Study|Protocol Violation|9|||
155387657|NCT02072434|560854906|FG000|Overall Study|Physician Decision|5|||
155387658|NCT02072434|560854907|FG001|Overall Study|Physician Decision|10|||
155387659|NCT02072434|560854906|FG000|Overall Study|Adverse event, serious fatal|1|||
155387660|NCT02072434|560854907|FG001|Overall Study|Adverse event, serious fatal|6|||
155387661|NCT02072434|560854906|FG000|Overall Study|Adverse Event|7|||
155387662|NCT02072434|560854907|FG001|Overall Study|Adverse Event|6|||
155387663|NCT02072434|560854906|FG000|Overall Study|Withdrawal by Subject|17|||
154944446|NCT01595009|559222844|FG003|Core|Disease progression|0|||
154944447|NCT01595009|559222841|FG000|Core|Withdrawal by Subject|4|||
155387664|NCT02072434|560854907|FG001|Overall Study|Withdrawal by Subject|29|||
155045923|NCT05052697|559599409|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045924|NCT05052697|559599410|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045925|NCT05052697|559599411|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045926|NCT05052697|559599412|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155387665|NCT02072434|560854906|FG000|Overall Study|Other|14|||
155387666|NCT02072434|560854907|FG001|Overall Study|Other|29|||
155387667|NCT02072434|560854906|FG000|Overall Study|Lost to Follow-up|0|||
155387668|NCT02072434|560854907|FG001|Overall Study|Lost to Follow-up|1|||
155387669|NCT02525861|560854910|FG000|Overall Study|Adverse Event|1|||
155387670|NCT02525861|560854911|FG001|Overall Study|Adverse Event|0|||
155387671|NCT02525861|560854910|FG000|Overall Study|Withdrawal by Subject|0|||
155387672|NCT02525861|560854911|FG001|Overall Study|Withdrawal by Subject|1|||
155387673|NCT02525861|560854910|FG000|Overall Study|Physician Decision|0|||
155387674|NCT02525861|560854911|FG001|Overall Study|Physician Decision|1|||
155387675|NCT00888433|560854912|FG000|Overall Study|Withdrawal by Subject|1|||
155387676|NCT00888433|560854913|FG001|Overall Study|Withdrawal by Subject|2|||
155387677|NCT00888433|560854912|FG000|Overall Study|Missed Visit|2|||
155387678|NCT00888433|560854913|FG001|Overall Study|Missed Visit|1|||
155387679|NCT00402363|560854916|FG000|Overall Study|Adverse Event|9|||
155387680|NCT00402363|560854917|FG001|Overall Study|Adverse Event|14|||
155387681|NCT00402363|560854918|FG002|Overall Study|Adverse Event|2|||
155387682|NCT00402363|560854919|FG003|Overall Study|Adverse Event|2|||
155387683|NCT00402363|560854916|FG000|Overall Study|Withdrew Consent|10|||
155387684|NCT00402363|560854917|FG001|Overall Study|Withdrew Consent|5|||
155387685|NCT00402363|560854918|FG002|Overall Study|Withdrew Consent|2|||
155387686|NCT00402363|560854919|FG003|Overall Study|Withdrew Consent|1|||
155387687|NCT00402363|560854916|FG000|Overall Study|Protocol Violation|3|||
155387688|NCT00402363|560854917|FG001|Overall Study|Protocol Violation|5|||
155387689|NCT00402363|560854918|FG002|Overall Study|Protocol Violation|0|||
155387690|NCT00402363|560854919|FG003|Overall Study|Protocol Violation|3|||
155387691|NCT00402363|560854916|FG000|Overall Study|Lost to Follow-up|5|||
155387692|NCT00402363|560854917|FG001|Overall Study|Lost to Follow-up|4|||
155387693|NCT00402363|560854918|FG002|Overall Study|Lost to Follow-up|0|||
155387694|NCT00402363|560854919|FG003|Overall Study|Lost to Follow-up|2|||
155045927|NCT05052697|559599413|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045928|NCT05052697|559599414|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
155045929|NCT05052697|559599415|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
155387695|NCT00402363|560854916|FG000|Overall Study|"Captured as Other"|6|||
155387696|NCT00402363|560854917|FG001|Overall Study|"Captured as Other"|2|||
155387697|NCT00402363|560854918|FG002|Overall Study|"Captured as Other"|2|||
155387698|NCT00402363|560854919|FG003|Overall Study|"Captured as Other"|2|||
155387699|NCT00937833|560854929|FG000|Overall Study|Protocol Violation|1|||
155387700|NCT00937833|560854930|FG001|Overall Study|Protocol Violation|2|||
155387701|NCT00937833|560854929|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
155387702|NCT00937833|560854930|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
155387703|NCT00937833|560854929|FG000|Overall Study|Lost to Follow-up|10|||
155387704|NCT00937833|560854930|FG001|Overall Study|Lost to Follow-up|8|||
155387705|NCT00937833|560854929|FG000|Overall Study|Withdrawal by Subject|4|||
155045930|NCT05052697|559599416|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
155045931|NCT05052697|559599417|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
155045932|NCT05052697|559599418|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
155045933|NCT05052697|559599419|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
155045934|NCT05052697|559599386|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045935|NCT05052697|559599387|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045936|NCT05052697|559599388|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045937|NCT05052697|559599389|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045938|NCT05052697|559599390|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045939|NCT05052697|559599391|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045940|NCT05052697|559599392|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045941|NCT05052697|559599393|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045942|NCT05052697|559599394|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045943|NCT05052697|559599395|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045944|NCT05052697|559599396|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045945|NCT05052697|559599397|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045946|NCT05052697|559599398|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045947|NCT05052697|559599399|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045948|NCT05052697|559599400|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155387706|NCT00937833|560854930|FG001|Overall Study|Withdrawal by Subject|6|||
155387707|NCT03278106|560854932|FG000|Overall Study|No protocol treatment|1|||
155387708|NCT02175004|560854933|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
155387709|NCT02175004|560854934|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
155387710|NCT02175004|560854933|FG000|Overall Study|Investigator Judgment|1|||
155387711|NCT02175004|560854934|FG001|Overall Study|Investigator Judgment|4|||
154944448|NCT01595009|559222842|FG001|Core|Withdrawal by Subject|17|||
154944449|NCT01595009|559222843|FG002|Core|Withdrawal by Subject|0|||
154944450|NCT01595009|559222844|FG003|Core|Withdrawal by Subject|0|||
154944451|NCT01595009|559222841|FG000|Core|Death|3|||
154944452|NCT01595009|559222842|FG001|Core|Death|6|||
154944453|NCT01595009|559222843|FG002|Core|Death|0|||
154944454|NCT01595009|559222844|FG003|Core|Death|0|||
155045949|NCT05052697|559599401|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045950|NCT05052697|559599402|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045951|NCT05052697|559599403|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045952|NCT05052697|559599404|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155387712|NCT02175004|560854933|FG000|Overall Study|Voluntary Withdrawal|6|||
155387713|NCT02175004|560854934|FG001|Overall Study|Voluntary Withdrawal|19|||
155387714|NCT02175004|560854933|FG000|Overall Study|Liver Transplant|1|||
155387715|NCT02175004|560854934|FG001|Overall Study|Liver Transplant|0|||
155387716|NCT02175004|560854933|FG000|Overall Study|Disease Progression|1|||
155387717|NCT02175004|560854934|FG001|Overall Study|Disease Progression|0|||
155387718|NCT02175004|560854933|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
155387719|NCT02175004|560854934|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
155387720|NCT01607554|560854935|FG000|Overall Study|Disease progression|2|||
155387721|NCT00162032|560854936|FG000|Overall Study|Lost to Follow-up|4|||
155387722|NCT00162032|560854937|FG001|Overall Study|Lost to Follow-up|2|||
155387723|NCT00162032|560854936|FG000|Overall Study|Reason not specified|1|||
155387724|NCT00162032|560854937|FG001|Overall Study|Reason not specified|0|||
155387725|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
155387726|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
155387727|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
155387728|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
155387729|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
155387730|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
155387731|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
155387732|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
155387733|NCT03952806|560854938|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
155387734|NCT03952806|560854939|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
155387735|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
155387736|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
155387737|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
155387738|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
155387739|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
155387740|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
155387741|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
155387742|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
155387743|NCT03952806|560854938|FG000|OLE Phase (48 Weeks)|Other|16|||
155387744|NCT03952806|560854939|FG001|OLE Phase (48 Weeks)|Other|13|||
155387745|NCT01137955|560854940|FG000|Overall Study|Withdrawal by Subject|5|||
155387746|NCT01137955|560854941|FG001|Overall Study|Withdrawal by Subject|4|||
155387747|NCT02027701|560854942|FG000|Overall Study|Adverse Event|3|||
155387748|NCT02027701|560854942|FG000|Overall Study|Lack of Efficacy|8|||
155387749|NCT02027701|560854942|FG000|Overall Study|Physician Decision|2|||
155387750|NCT02027701|560854942|FG000|Overall Study|Withdrawal by Subject|3|||
155387751|NCT00756470|560854943|FG000|Overall Study|Withdrawal by Subject|1|||
155387752|NCT00756470|560854943|FG000|Overall Study|Adverse Event|4|||
155387753|NCT00820027|560854944|FG000|Overall Study|Adverse Event|15|||
155387754|NCT00820027|560854945|FG001|Overall Study|Adverse Event|8|||
155387755|NCT00820027|560854946|FG002|Overall Study|Adverse Event|10|||
155387756|NCT00820027|560854947|FG003|Overall Study|Adverse Event|5|||
154944455|NCT01595009|559222841|FG000|Core|Lost to Follow-up|1|||
154944456|NCT01595009|559222842|FG001|Core|Lost to Follow-up|2|||
154944457|NCT01595009|559222843|FG002|Core|Lost to Follow-up|0|||
154944458|NCT01595009|559222844|FG003|Core|Lost to Follow-up|0|||
154944459|NCT01595009|559222841|FG000|Core|Protocol deviation|0|||
154944460|NCT01595009|559222842|FG001|Core|Protocol deviation|1|||
154944461|NCT01595009|559222843|FG002|Core|Protocol deviation|0|||
154944462|NCT01595009|559222844|FG003|Core|Protocol deviation|0|||
154944463|NCT01595009|559222841|FG000|Core|Administrative problems|0|||
154944464|NCT01595009|559222842|FG001|Core|Administrative problems|1|||
154944465|NCT01595009|559222843|FG002|Core|Administrative problems|0|||
154944466|NCT01595009|559222844|FG003|Core|Administrative problems|0|||
155045953|NCT05052697|559599405|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
154944467|NCT01595009|559222841|FG000|Extension|Administrative problems|0|||
154944468|NCT01595009|559222842|FG001|Extension|Administrative problems|0|||
154944469|NCT01595009|559222843|FG002|Extension|Administrative problems|0|||
154944470|NCT01595009|559222844|FG003|Extension|Administrative problems|1|||
154944471|NCT01595009|559222841|FG000|Extension|Patients completed per protocol|0|||
154944472|NCT01595009|559222842|FG001|Extension|Patients completed per protocol|0|||
154944473|NCT01595009|559222843|FG002|Extension|Patients completed per protocol|0|||
154944474|NCT01595009|559222844|FG003|Extension|Patients completed per protocol|2|||
154944475|NCT01595009|559222841|FG000|Extension|Disease progression|0|||
154944476|NCT01595009|559222842|FG001|Extension|Disease progression|0|||
154944477|NCT01595009|559222843|FG002|Extension|Disease progression|4|||
154944478|NCT01595009|559222844|FG003|Extension|Disease progression|7|||
154944479|NCT01595009|559222841|FG000|Extension|Adverse Event|0|||
154944480|NCT01595009|559222842|FG001|Extension|Adverse Event|0|||
154944481|NCT01595009|559222843|FG002|Extension|Adverse Event|0|||
154944482|NCT01595009|559222844|FG003|Extension|Adverse Event|1|||
154944483|NCT00729859|559222845|FG000|Overall Study|Adverse Event|0|||
154944484|NCT00729859|559222846|FG001|Overall Study|Adverse Event|1|||
154944485|NCT00729859|559222847|FG002|Overall Study|Adverse Event|0|||
154944486|NCT00729859|559222845|FG000|Overall Study|Withdrawal by Subject|0|||
154944487|NCT00729859|559222846|FG001|Overall Study|Withdrawal by Subject|1|||
154944488|NCT00729859|559222847|FG002|Overall Study|Withdrawal by Subject|0|||
154944489|NCT04956666|559222848|FG000|Overall Study|Adverse Event|18|||
154944490|NCT04956666|559222848|FG000|Overall Study|Physician Decision|5|||
154944491|NCT02623829|559222856|FG000|Overall Study|Lost to Follow-up|1|||
154944492|NCT02623829|559222857|FG001|Overall Study|Lost to Follow-up|1|||
154944493|NCT00662025|559222858|FG000|Overall Study|Objective progression or relapse|51|||
154944494|NCT00662025|559222858|FG000|Overall Study|Adverse Event|7|||
154944495|NCT00662025|559222858|FG000|Overall Study|Withdrawal by Subject|1|||
154944496|NCT00662025|559222858|FG000|Overall Study|Results of other clinical study|2|||
154944497|NCT00662025|559222858|FG000|Overall Study|Target lesion cannot be evaluated|1|||
154944498|NCT00662025|559222858|FG000|Overall Study|Domestic circumstances|1|||
154944499|NCT00384033|559222868|FG000|Overall Study|Adverse Event|10|||
154944500|NCT00384033|559222869|FG001|Overall Study|Adverse Event|8|||
154944501|NCT00384033|559222870|FG002|Overall Study|Adverse Event|11|||
154944502|NCT00384033|559222871|FG003|Overall Study|Adverse Event|20|||
154944503|NCT00384033|559222868|FG000|Overall Study|Failed to return|1|||
154944504|NCT00384033|559222869|FG001|Overall Study|Failed to return|3|||
154944505|NCT00384033|559222870|FG002|Overall Study|Failed to return|2|||
154944506|NCT00384033|559222871|FG003|Overall Study|Failed to return|2|||
154944507|NCT00384033|559222868|FG000|Overall Study|Physician Decision|1|||
154944508|NCT00384033|559222869|FG001|Overall Study|Physician Decision|0|||
154944509|NCT00384033|559222870|FG002|Overall Study|Physician Decision|0|||
154944510|NCT00384033|559222871|FG003|Overall Study|Physician Decision|0|||
154944511|NCT00384033|559222868|FG000|Overall Study|Lost to Follow-up|6|||
154944512|NCT00384033|559222869|FG001|Overall Study|Lost to Follow-up|12|||
154944513|NCT00384033|559222870|FG002|Overall Study|Lost to Follow-up|7|||
154944514|NCT00384033|559222871|FG003|Overall Study|Lost to Follow-up|7|||
154944515|NCT00384033|559222868|FG000|Overall Study|Other|2|||
154944516|NCT00384033|559222869|FG001|Overall Study|Other|0|||
154944517|NCT00384033|559222870|FG002|Overall Study|Other|0|||
154944518|NCT00384033|559222871|FG003|Overall Study|Other|0|||
154944519|NCT00384033|559222868|FG000|Overall Study|Protocol Violation|5|||
154944520|NCT00384033|559222869|FG001|Overall Study|Protocol Violation|0|||
154944521|NCT00384033|559222870|FG002|Overall Study|Protocol Violation|5|||
154944522|NCT00384033|559222871|FG003|Overall Study|Protocol Violation|6|||
154944523|NCT00384033|559222868|FG000|Overall Study|Withdrawal by Subject|6|||
154944524|NCT00384033|559222869|FG001|Overall Study|Withdrawal by Subject|2|||
154944525|NCT00384033|559222870|FG002|Overall Study|Withdrawal by Subject|5|||
154944526|NCT00384033|559222871|FG003|Overall Study|Withdrawal by Subject|2|||
154944527|NCT00384033|559222868|FG000|Overall Study|Lack of Efficacy|7|||
154944528|NCT00384033|559222869|FG001|Overall Study|Lack of Efficacy|3|||
154944529|NCT00384033|559222870|FG002|Overall Study|Lack of Efficacy|3|||
154944530|NCT00384033|559222871|FG003|Overall Study|Lack of Efficacy|1|||
154944531|NCT00384033|559222868|FG000|Overall Study|Randomized but not treated|3|||
154944532|NCT00384033|559222869|FG001|Overall Study|Randomized but not treated|7|||
154944533|NCT00384033|559222870|FG002|Overall Study|Randomized but not treated|10|||
154944534|NCT00384033|559222871|FG003|Overall Study|Randomized but not treated|2|||
154944535|NCT02162758|559222873|FG000|Overall Study|Study termination|0|||
154944536|NCT02162758|559222874|FG001|Overall Study|Study termination|1|||
154944537|NCT01166568|559222880|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
154944538|NCT01166568|559222881|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
154944539|NCT01166568|559222882|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
154944540|NCT01166568|559222880|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
154944541|NCT01166568|559222881|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
154944542|NCT01166568|559222882|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
154944543|NCT01166568|559222880|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
155387757|NCT00820027|560854944|FG000|Overall Study|Lack of Efficacy|2|||
154944544|NCT01166568|559222881|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
154944545|NCT01166568|559222882|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
154944546|NCT01716754|559222883|FG000|Overall Study|Death|0|||
154944547|NCT01716754|559222884|FG001|Overall Study|Death|0|||
154944548|NCT01716754|559222885|FG002|Overall Study|Death|0|||
154944549|NCT01716754|559222886|FG003|Overall Study|Death|1|||
155280935|NCT04955626|560459880|FG013|Open-Label Period|Lost to Follow-up|0|||
155280936|NCT04955626|560459881|FG014|Open-Label Period|Lost to Follow-up|0|||
155280937|NCT04955626|560459882|FG015|Open-Label Period|Lost to Follow-up|0|||
155280938|NCT04955626|560459883|FG016|Open-Label Period|Lost to Follow-up|0|||
155280939|NCT04955626|560459884|FG017|Open-Label Period|Lost to Follow-up|0|||
155280940|NCT04955626|560459885|FG018|Open-Label Period|Lost to Follow-up|0|||
155280941|NCT04955626|560459886|FG019|Open-Label Period|Lost to Follow-up|0|||
155280942|NCT04955626|560459887|FG020|Open-Label Period|Lost to Follow-up|0|||
155280943|NCT04955626|560459888|FG021|Open-Label Period|Lost to Follow-up|0|||
155280944|NCT04955626|560459889|FG022|Open-Label Period|Lost to Follow-up|0|||
155280945|NCT04955626|560459890|FG023|Open-Label Period|Lost to Follow-up|0|||
155280946|NCT04955626|560459891|FG024|Open-Label Period|Lost to Follow-up|0|||
155280947|NCT04955626|560459892|FG025|Open-Label Period|Lost to Follow-up|0|||
155280948|NCT04955626|560459893|FG026|Open-Label Period|Lost to Follow-up|0|||
155280949|NCT04955626|560459894|FG027|Open-Label Period|Lost to Follow-up|0|||
155280950|NCT04955626|560459895|FG028|Open-Label Period|Lost to Follow-up|0|||
155280951|NCT04955626|560459896|FG029|Open-Label Period|Lost to Follow-up|0|||
155280952|NCT04955626|560459897|FG030|Open-Label Period|Lost to Follow-up|0|||
155280953|NCT04955626|560459898|FG031|Open-Label Period|Lost to Follow-up|0|||
155280954|NCT04955626|560459899|FG032|Open-Label Period|Lost to Follow-up|0|||
155280955|NCT04955626|560459900|FG033|Open-Label Period|Lost to Follow-up|0|||
155280956|NCT04955626|560459901|FG034|Open-Label Period|Lost to Follow-up|0|||
155280957|NCT04955626|560459902|FG035|Open-Label Period|Lost to Follow-up|0|||
155280958|NCT04955626|560459867|FG000|Open-Label Period|Protocol Violation|377|||
155280959|NCT04955626|560459868|FG001|Open-Label Period|Protocol Violation|48|||
155280960|NCT04955626|560459869|FG002|Open-Label Period|Protocol Violation|0|||
155280961|NCT04955626|560459870|FG003|Open-Label Period|Protocol Violation|0|||
155280962|NCT04955626|560459871|FG004|Open-Label Period|Protocol Violation|0|||
155280963|NCT04955626|560459872|FG005|Open-Label Period|Protocol Violation|0|||
155280964|NCT04955626|560459873|FG006|Open-Label Period|Protocol Violation|0|||
155280965|NCT04955626|560459874|FG007|Open-Label Period|Protocol Violation|0|||
155280966|NCT04955626|560459875|FG008|Open-Label Period|Protocol Violation|0|||
155280967|NCT04955626|560459876|FG009|Open-Label Period|Protocol Violation|0|||
155280968|NCT04955626|560459877|FG010|Open-Label Period|Protocol Violation|0|||
155280969|NCT04955626|560459878|FG011|Open-Label Period|Protocol Violation|0|||
155280970|NCT04955626|560459879|FG012|Open-Label Period|Protocol Violation|0|||
155280971|NCT04955626|560459880|FG013|Open-Label Period|Protocol Violation|0|||
155280972|NCT04955626|560459881|FG014|Open-Label Period|Protocol Violation|0|||
155280973|NCT04955626|560459882|FG015|Open-Label Period|Protocol Violation|0|||
155280974|NCT04955626|560459883|FG016|Open-Label Period|Protocol Violation|0|||
155280975|NCT04955626|560459884|FG017|Open-Label Period|Protocol Violation|0|||
155280976|NCT04955626|560459885|FG018|Open-Label Period|Protocol Violation|0|||
155280977|NCT04955626|560459886|FG019|Open-Label Period|Protocol Violation|0|||
155280978|NCT04955626|560459887|FG020|Open-Label Period|Protocol Violation|0|||
155280979|NCT04955626|560459888|FG021|Open-Label Period|Protocol Violation|0|||
155280980|NCT04955626|560459889|FG022|Open-Label Period|Protocol Violation|0|||
155280981|NCT04955626|560459890|FG023|Open-Label Period|Protocol Violation|0|||
155280982|NCT04955626|560459891|FG024|Open-Label Period|Protocol Violation|0|||
155280983|NCT04955626|560459892|FG025|Open-Label Period|Protocol Violation|0|||
155280984|NCT04955626|560459893|FG026|Open-Label Period|Protocol Violation|0|||
155280985|NCT04955626|560459894|FG027|Open-Label Period|Protocol Violation|0|||
155280986|NCT04955626|560459895|FG028|Open-Label Period|Protocol Violation|0|||
155280987|NCT04955626|560459896|FG029|Open-Label Period|Protocol Violation|0|||
155280988|NCT04955626|560459897|FG030|Open-Label Period|Protocol Violation|0|||
155280989|NCT04955626|560459898|FG031|Open-Label Period|Protocol Violation|0|||
155280990|NCT04955626|560459899|FG032|Open-Label Period|Protocol Violation|0|||
155280991|NCT04955626|560459900|FG033|Open-Label Period|Protocol Violation|0|||
155280992|NCT04955626|560459901|FG034|Open-Label Period|Protocol Violation|0|||
155280993|NCT04955626|560459902|FG035|Open-Label Period|Protocol Violation|0|||
155280994|NCT04955626|560459867|FG000|Open-Label Period|Death|5|||
155280995|NCT04955626|560459868|FG001|Open-Label Period|Death|5|||
155280996|NCT04955626|560459869|FG002|Open-Label Period|Death|0|||
155280997|NCT04955626|560459870|FG003|Open-Label Period|Death|0|||
155280998|NCT04955626|560459871|FG004|Open-Label Period|Death|0|||
155280999|NCT04955626|560459872|FG005|Open-Label Period|Death|0|||
155281000|NCT04955626|560459873|FG006|Open-Label Period|Death|0|||
155281001|NCT04955626|560459874|FG007|Open-Label Period|Death|0|||
155281002|NCT04955626|560459875|FG008|Open-Label Period|Death|0|||
154944550|NCT01716754|559222883|FG000|Overall Study|Protocol deviation|0|||
155281003|NCT04955626|560459876|FG009|Open-Label Period|Death|0|||
155281004|NCT04955626|560459877|FG010|Open-Label Period|Death|0|||
155281005|NCT04955626|560459878|FG011|Open-Label Period|Death|0|||
155387758|NCT00820027|560854945|FG001|Overall Study|Lack of Efficacy|1|||
155281006|NCT04955626|560459879|FG012|Open-Label Period|Death|0|||
155281007|NCT04955626|560459880|FG013|Open-Label Period|Death|0|||
155281008|NCT04955626|560459881|FG014|Open-Label Period|Death|0|||
155281009|NCT04955626|560459882|FG015|Open-Label Period|Death|0|||
155281010|NCT04955626|560459883|FG016|Open-Label Period|Death|0|||
155387759|NCT00820027|560854946|FG002|Overall Study|Lack of Efficacy|2|||
155387760|NCT00820027|560854947|FG003|Overall Study|Lack of Efficacy|2|||
155387761|NCT00820027|560854944|FG000|Overall Study|Physician Decision|0|||
155387762|NCT00820027|560854945|FG001|Overall Study|Physician Decision|1|||
155387763|NCT00820027|560854946|FG002|Overall Study|Physician Decision|1|||
155387764|NCT00820027|560854947|FG003|Overall Study|Physician Decision|0|||
155387765|NCT00820027|560854944|FG000|Overall Study|Protocol Violation|3|||
155387766|NCT00820027|560854945|FG001|Overall Study|Protocol Violation|0|||
155387767|NCT00820027|560854946|FG002|Overall Study|Protocol Violation|4|||
155387768|NCT00820027|560854947|FG003|Overall Study|Protocol Violation|0|||
155387769|NCT00820027|560854944|FG000|Overall Study|Withdrawal by Subject|6|||
155387770|NCT00820027|560854945|FG001|Overall Study|Withdrawal by Subject|4|||
155387771|NCT00820027|560854946|FG002|Overall Study|Withdrawal by Subject|4|||
155387772|NCT00820027|560854947|FG003|Overall Study|Withdrawal by Subject|6|||
155387773|NCT02604433|560854948|FG000|Overall Study|Withdrawal by Subject|37|||
155387774|NCT02604433|560854949|FG001|Overall Study|Withdrawal by Subject|16|||
155387775|NCT02604433|560854948|FG000|Overall Study|Adverse Event|4|||
155387776|NCT02604433|560854949|FG001|Overall Study|Adverse Event|0|||
155387777|NCT02604433|560854948|FG000|Overall Study|Other reasons|3|||
155387778|NCT02604433|560854949|FG001|Overall Study|Other reasons|5|||
155387779|NCT02604433|560854948|FG000|Overall Study|Death|4|||
155387780|NCT02604433|560854949|FG001|Overall Study|Death|1|||
155387781|NCT02604433|560854948|FG000|Overall Study|Transition to Rollover Protocol|169|||
155387782|NCT02604433|560854949|FG001|Overall Study|Transition to Rollover Protocol|82|||
155387783|NCT02604433|560854948|FG000|Overall Study|Physician Decision|1|||
155387784|NCT02604433|560854949|FG001|Overall Study|Physician Decision|1|||
155387785|NCT02604433|560854948|FG000|Overall Study|Lack of Efficacy|0|||
155387786|NCT02604433|560854949|FG001|Overall Study|Lack of Efficacy|1|||
155387787|NCT03285178|560854950|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
155387788|NCT03285178|560854951|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387789|NCT03285178|560854952|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387790|NCT03285178|560854953|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387791|NCT03285178|560854954|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387792|NCT03285178|560854955|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387793|NCT03285178|560854956|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
155387794|NCT03285178|560854950|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
155387795|NCT03285178|560854951|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387796|NCT03285178|560854952|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387797|NCT03285178|560854953|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387798|NCT03285178|560854954|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387799|NCT03285178|560854955|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387800|NCT03285178|560854956|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
155387801|NCT03285178|560854950|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
155387802|NCT03285178|560854951|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
155387803|NCT03285178|560854952|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
155387804|NCT03285178|560854953|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
155387805|NCT03285178|560854954|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
155387806|NCT03285178|560854955|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
155387807|NCT03285178|560854956|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
155387808|NCT03285178|560854950|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
155387809|NCT03285178|560854951|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387810|NCT03285178|560854952|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387811|NCT03285178|560854953|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387812|NCT03285178|560854954|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387813|NCT03285178|560854955|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387814|NCT03285178|560854956|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
155387815|NCT03285178|560854950|FG000|Single-Blind Run-In Period|Physician Decision|2|||
155387816|NCT03285178|560854951|FG001|Single-Blind Run-In Period|Physician Decision|0|||
155387817|NCT03285178|560854952|FG002|Single-Blind Run-In Period|Physician Decision|0|||
155387818|NCT03285178|560854953|FG003|Single-Blind Run-In Period|Physician Decision|0|||
155387819|NCT03285178|560854954|FG004|Single-Blind Run-In Period|Physician Decision|0|||
155387820|NCT03285178|560854955|FG005|Single-Blind Run-In Period|Physician Decision|0|||
155387821|NCT03285178|560854956|FG006|Single-Blind Run-In Period|Physician Decision|0|||
155387822|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387823|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
155387824|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
155387825|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387826|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387827|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387828|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
155387829|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155387830|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Adverse Event|0|||
155387831|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155387832|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Adverse Event|0|||
155387833|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Adverse Event|0|||
155387834|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Adverse Event|0|||
155387835|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Adverse Event|2|||
155387836|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387837|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155387838|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387839|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387840|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
155387841|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387842|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
155387843|NCT03285178|560854950|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155387844|NCT03285178|560854951|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155387845|NCT03285178|560854952|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155387846|NCT03285178|560854953|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155387847|NCT03285178|560854954|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155387848|NCT03285178|560854955|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155387849|NCT03285178|560854956|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155387850|NCT03285178|560854950|FG000|Double-Blind Treatment Period|COVID-19|0|||
155387851|NCT03285178|560854951|FG001|Double-Blind Treatment Period|COVID-19|0|||
155387852|NCT03285178|560854952|FG002|Double-Blind Treatment Period|COVID-19|1|||
155387853|NCT03285178|560854953|FG003|Double-Blind Treatment Period|COVID-19|0|||
155387854|NCT03285178|560854954|FG004|Double-Blind Treatment Period|COVID-19|0|||
155387855|NCT03285178|560854955|FG005|Double-Blind Treatment Period|COVID-19|0|||
155387856|NCT03285178|560854956|FG006|Double-Blind Treatment Period|COVID-19|0|||
155387857|NCT01128738|560854957|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
155387858|NCT01128738|560854958|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
155387859|NCT01128738|560854957|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
155387860|NCT01128738|560854958|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
155387861|NCT01128738|560854957|FG000|Second TP|Lost to Follow-up|0|||
155387862|NCT01128738|560854958|FG001|Second TP|Lost to Follow-up|1|||
155387863|NCT01128738|560854957|FG000|Second TP|Withdrawal by Subject|0|||
155387864|NCT01128738|560854958|FG001|Second TP|Withdrawal by Subject|2|||
155387865|NCT00325039|560854961|FG000|Overall Study|Lost to Follow-up|18|||
155387866|NCT00325039|560854962|FG001|Overall Study|Lost to Follow-up|14|||
155387867|NCT01009203|560854964|FG000|Overall Study|Withdrawal by Subject|1|||
155387868|NCT01009203|560854964|FG000|Overall Study|Adverse Event|5|||
155387869|NCT01009203|560854964|FG000|Overall Study|Treatment-unrelated death|1|||
155387870|NCT00892723|560854968|FG000|Overall Study|Lost to Follow-up|1|||
155387871|NCT00892723|560854969|FG001|Overall Study|Lost to Follow-up|3|||
155387872|NCT00892723|560854970|FG002|Overall Study|Lost to Follow-up|1|||
155387873|NCT00892723|560854968|FG000|Overall Study|Withdrawal by Subject|1|||
155387874|NCT00892723|560854969|FG001|Overall Study|Withdrawal by Subject|1|||
155387875|NCT00892723|560854970|FG002|Overall Study|Withdrawal by Subject|1|||
155387876|NCT02974088|560854971|FG000|Overall Study|Lost to Follow-up|0|||
155387877|NCT02974088|560854972|FG001|Overall Study|Lost to Follow-up|2|||
155387878|NCT02974088|560854971|FG000|Overall Study|Adverse Event|0|||
155387879|NCT02974088|560854972|FG001|Overall Study|Adverse Event|1|||
155387880|NCT00150969|560854975|FG000|24 Month Main Study|Adverse Event|3|||
155387881|NCT00150969|560854976|FG001|24 Month Main Study|Adverse Event|4|||
155387882|NCT00150969|560854975|FG000|24 Month Main Study|Death|1|||
155387883|NCT00150969|560854976|FG001|24 Month Main Study|Death|1|||
155387884|NCT00150969|560854975|FG000|24 Month Main Study|Lack of Efficacy|1|||
155387885|NCT00150969|560854976|FG001|24 Month Main Study|Lack of Efficacy|8|||
155387886|NCT00150969|560854975|FG000|24 Month Main Study|Lost to Follow-up|3|||
155387887|NCT00150969|560854976|FG001|24 Month Main Study|Lost to Follow-up|2|||
155387888|NCT00150969|560854975|FG000|24 Month Main Study|Protocol Violation|4|||
155387889|NCT00150969|560854976|FG001|24 Month Main Study|Protocol Violation|2|||
155387890|NCT00150969|560854975|FG000|24 Month Main Study|Withdrawal by Subject|7|||
155387891|NCT00150969|560854976|FG001|24 Month Main Study|Withdrawal by Subject|4|||
155387892|NCT00150969|560854975|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
155387893|NCT00150969|560854976|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
155387894|NCT00150969|560854975|FG000|24-48 Month Extension|Lack of Efficacy|0|||
155387895|NCT00150969|560854976|FG001|24-48 Month Extension|Lack of Efficacy|1|||
154944551|NCT01716754|559222884|FG001|Overall Study|Protocol deviation|2|||
155045954|NCT05052697|559599406|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045955|NCT05052697|559599407|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045956|NCT05052697|559599408|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045957|NCT05052697|559599409|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045958|NCT05052697|559599410|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045959|NCT05052697|559599411|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045960|NCT05052697|559599412|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045961|NCT05052697|559599413|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155281011|NCT04955626|560459884|FG017|Open-Label Period|Death|0|||
155281012|NCT04955626|560459885|FG018|Open-Label Period|Death|0|||
155281013|NCT04955626|560459886|FG019|Open-Label Period|Death|0|||
155281014|NCT04955626|560459887|FG020|Open-Label Period|Death|0|||
155281015|NCT04955626|560459888|FG021|Open-Label Period|Death|0|||
155281016|NCT04955626|560459889|FG022|Open-Label Period|Death|0|||
155281017|NCT04955626|560459890|FG023|Open-Label Period|Death|0|||
155281018|NCT04955626|560459891|FG024|Open-Label Period|Death|0|||
155281019|NCT04955626|560459892|FG025|Open-Label Period|Death|0|||
155281020|NCT04955626|560459893|FG026|Open-Label Period|Death|0|||
155281021|NCT04955626|560459894|FG027|Open-Label Period|Death|0|||
155281022|NCT04955626|560459895|FG028|Open-Label Period|Death|0|||
155281023|NCT04955626|560459896|FG029|Open-Label Period|Death|0|||
155281024|NCT04955626|560459897|FG030|Open-Label Period|Death|0|||
155281025|NCT04955626|560459898|FG031|Open-Label Period|Death|0|||
155281026|NCT04955626|560459899|FG032|Open-Label Period|Death|0|||
155281027|NCT04955626|560459900|FG033|Open-Label Period|Death|0|||
155281028|NCT04955626|560459901|FG034|Open-Label Period|Death|0|||
155281029|NCT04955626|560459902|FG035|Open-Label Period|Death|0|||
155281030|NCT04955626|560459867|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
155281031|NCT04955626|560459868|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
155281032|NCT04955626|560459869|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
155281033|NCT04955626|560459870|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
155281034|NCT04955626|560459871|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
155281035|NCT04955626|560459872|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
155281036|NCT04955626|560459873|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
155281037|NCT04955626|560459874|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
155281038|NCT04955626|560459875|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
155281039|NCT04955626|560459876|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
155281040|NCT04955626|560459877|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
155281041|NCT04955626|560459878|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
155281042|NCT04955626|560459879|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
155281043|NCT04955626|560459880|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
155281044|NCT04955626|560459881|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
155281045|NCT04955626|560459882|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
155281046|NCT04955626|560459883|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
155281047|NCT04955626|560459884|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
155281048|NCT04955626|560459885|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
155281049|NCT04955626|560459886|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
155281050|NCT04955626|560459887|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
155281051|NCT04955626|560459888|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
155281052|NCT04955626|560459889|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
155281053|NCT04955626|560459890|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
155281054|NCT04955626|560459891|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
155281055|NCT04955626|560459892|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
155281056|NCT04955626|560459893|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
155281057|NCT04955626|560459894|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
155281058|NCT04955626|560459895|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
155281059|NCT04955626|560459896|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
155281060|NCT04955626|560459897|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
155281061|NCT04955626|560459898|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
155281062|NCT04955626|560459899|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
155281063|NCT04955626|560459900|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
155045962|NCT05052697|559599414|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155281064|NCT04955626|560459901|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
155281065|NCT04955626|560459902|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
155281066|NCT04955626|560459867|FG000|Open-Label Period|Other|621|||
155281067|NCT04955626|560459868|FG001|Open-Label Period|Other|429|||
155281068|NCT04955626|560459869|FG002|Open-Label Period|Other|0|||
155281069|NCT04955626|560459870|FG003|Open-Label Period|Other|0|||
155281070|NCT04955626|560459871|FG004|Open-Label Period|Other|0|||
155281071|NCT04955626|560459872|FG005|Open-Label Period|Other|0|||
155281072|NCT04955626|560459873|FG006|Open-Label Period|Other|0|||
155281073|NCT04955626|560459874|FG007|Open-Label Period|Other|0|||
155281074|NCT04955626|560459875|FG008|Open-Label Period|Other|0|||
155045963|NCT05052697|559599415|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045964|NCT05052697|559599416|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045965|NCT05052697|559599417|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045966|NCT05052697|559599418|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
155045967|NCT05052697|559599419|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
155045968|NCT05052697|559599386|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045969|NCT05052697|559599387|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045970|NCT05052697|559599388|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045971|NCT05052697|559599389|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045972|NCT05052697|559599390|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045973|NCT05052697|559599391|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045974|NCT05052697|559599392|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045975|NCT05052697|559599393|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045976|NCT05052697|559599394|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045977|NCT05052697|559599395|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045978|NCT05052697|559599396|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045979|NCT05052697|559599397|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045980|NCT05052697|559599398|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045981|NCT05052697|559599399|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
154944552|NCT01716754|559222885|FG002|Overall Study|Protocol deviation|7|||
154944553|NCT01716754|559222886|FG003|Overall Study|Protocol deviation|2|||
155045982|NCT05052697|559599400|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045983|NCT05052697|559599401|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045984|NCT05052697|559599402|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045985|NCT05052697|559599403|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045986|NCT05052697|559599404|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045987|NCT05052697|559599405|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045988|NCT05052697|559599406|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045989|NCT05052697|559599407|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045990|NCT05052697|559599408|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045991|NCT05052697|559599409|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045992|NCT05052697|559599410|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045993|NCT05052697|559599411|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045994|NCT05052697|559599412|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045995|NCT05052697|559599413|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155045996|NCT05052697|559599414|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
155045997|NCT05052697|559599415|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
155045998|NCT05052697|559599416|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
155045999|NCT05052697|559599417|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155046000|NCT05052697|559599418|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155046001|NCT05052697|559599419|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
155046002|NCT03275389|559599420|FG000|Overall Study|Lost to Follow-up|10|||
155046003|NCT03275389|559599421|FG001|Overall Study|Lost to Follow-up|10|||
155046004|NCT03275389|559599422|FG002|Overall Study|Lost to Follow-up|19|||
155046005|NCT03275389|559599423|FG003|Overall Study|Lost to Follow-up|12|||
155046006|NCT03275389|559599424|FG004|Overall Study|Lost to Follow-up|11|||
154944554|NCT01716754|559222883|FG000|Overall Study|Non-compliance with study treatment|0|||
154944555|NCT01716754|559222884|FG001|Overall Study|Non-compliance with study treatment|0|||
154944556|NCT01716754|559222885|FG002|Overall Study|Non-compliance with study treatment|1|||
154944557|NCT01716754|559222886|FG003|Overall Study|Non-compliance with study treatment|0|||
154944558|NCT01716754|559222883|FG000|Overall Study|Physician Decision|1|||
154944559|NCT01716754|559222884|FG001|Overall Study|Physician Decision|0|||
154944560|NCT01716754|559222885|FG002|Overall Study|Physician Decision|0|||
154944561|NCT01716754|559222886|FG003|Overall Study|Physician Decision|0|||
154944562|NCT01716754|559222883|FG000|Overall Study|Lost to Follow-up|1|||
154944563|NCT01716754|559222884|FG001|Overall Study|Lost to Follow-up|0|||
154944564|NCT01716754|559222885|FG002|Overall Study|Lost to Follow-up|0|||
154944565|NCT01716754|559222886|FG003|Overall Study|Lost to Follow-up|1|||
154944566|NCT01716754|559222883|FG000|Overall Study|Adverse Event|4|||
154944567|NCT01716754|559222884|FG001|Overall Study|Adverse Event|2|||
154944568|NCT01716754|559222885|FG002|Overall Study|Adverse Event|2|||
154944569|NCT01716754|559222886|FG003|Overall Study|Adverse Event|1|||
154944570|NCT01716754|559222883|FG000|Overall Study|Withdrawal by Subject|5|||
154944571|NCT01716754|559222884|FG001|Overall Study|Withdrawal by Subject|0|||
154944572|NCT01716754|559222885|FG002|Overall Study|Withdrawal by Subject|4|||
154944573|NCT01716754|559222886|FG003|Overall Study|Withdrawal by Subject|3|||
154944574|NCT02110706|559222904|FG000|Overall Study|Adverse Event|2|||
154944575|NCT02110706|559222905|FG001|Overall Study|Adverse Event|3|||
155046007|NCT03275389|559599425|FG005|Overall Study|Lost to Follow-up|12|||
155046008|NCT03275389|559599426|FG006|Overall Study|Lost to Follow-up|21|||
155046009|NCT03275389|559599427|FG007|Overall Study|Lost to Follow-up|15|||
155046010|NCT03275389|559599428|FG008|Overall Study|Lost to Follow-up|12|||
155281075|NCT04955626|560459876|FG009|Open-Label Period|Other|0|||
155281076|NCT04955626|560459877|FG010|Open-Label Period|Other|0|||
155046011|NCT03275389|559599429|FG009|Overall Study|Lost to Follow-up|14|||
155046012|NCT03275389|559599420|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046013|NCT03275389|559599421|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046014|NCT03275389|559599422|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046015|NCT03275389|559599423|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046016|NCT03275389|559599424|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046017|NCT03275389|559599425|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
155046018|NCT03275389|559599426|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046019|NCT03275389|559599427|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046020|NCT03275389|559599428|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
155046021|NCT03275389|559599429|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
155046022|NCT03275389|559599420|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
155046023|NCT03275389|559599421|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155046024|NCT03275389|559599422|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
155046025|NCT03275389|559599423|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
155046026|NCT03275389|559599424|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155046027|NCT03275389|559599425|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155046028|NCT03275389|559599426|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155046029|NCT03275389|559599427|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
155046030|NCT03275389|559599428|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155046031|NCT03275389|559599429|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155046032|NCT03275389|559599420|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046033|NCT03275389|559599421|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155046034|NCT03275389|559599422|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046035|NCT03275389|559599423|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
155046036|NCT03275389|559599424|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046037|NCT03275389|559599425|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046038|NCT03275389|559599426|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155046039|NCT03275389|559599427|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046040|NCT03275389|559599428|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046041|NCT03275389|559599429|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155046042|NCT03275389|559599420|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046043|NCT03275389|559599421|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046044|NCT03275389|559599422|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155046045|NCT03275389|559599423|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046046|NCT03275389|559599424|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046047|NCT03275389|559599425|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046048|NCT03275389|559599426|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046049|NCT03275389|559599427|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046050|NCT03275389|559599428|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155046051|NCT03275389|559599429|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155046052|NCT03275389|559599420|FG000|Overall Study|Other|0|||
155046053|NCT03275389|559599421|FG001|Overall Study|Other|4|||
155046054|NCT03275389|559599422|FG002|Overall Study|Other|3|||
155046055|NCT03275389|559599423|FG003|Overall Study|Other|2|||
155046056|NCT03275389|559599424|FG004|Overall Study|Other|2|||
155046057|NCT03275389|559599425|FG005|Overall Study|Other|2|||
155046058|NCT03275389|559599426|FG006|Overall Study|Other|0|||
155046059|NCT03275389|559599427|FG007|Overall Study|Other|0|||
155046060|NCT03275389|559599428|FG008|Overall Study|Other|1|||
155046061|NCT03275389|559599429|FG009|Overall Study|Other|0|||
155046062|NCT02427802|559599430|FG000|Overall Study|Adverse Event|11|||
155046063|NCT02427802|559599431|FG001|Overall Study|Adverse Event|3|||
155046064|NCT02427802|559599432|FG002|Overall Study|Adverse Event|7|||
155046065|NCT02427802|559599430|FG000|Overall Study|Death|0|||
155046066|NCT02427802|559599431|FG001|Overall Study|Death|4|||
155046067|NCT02427802|559599432|FG002|Overall Study|Death|1|||
155046068|NCT02427802|559599430|FG000|Overall Study|Lost to Follow-up|13|||
155046069|NCT02427802|559599431|FG001|Overall Study|Lost to Follow-up|8|||
155046070|NCT02427802|559599432|FG002|Overall Study|Lost to Follow-up|8|||
155046071|NCT02427802|559599430|FG000|Overall Study|Physician Decision|4|||
155046072|NCT02427802|559599431|FG001|Overall Study|Physician Decision|2|||
155046073|NCT02427802|559599432|FG002|Overall Study|Physician Decision|4|||
155046074|NCT02427802|559599430|FG000|Overall Study|Withdrawal by Subject|10|||
155046075|NCT02427802|559599431|FG001|Overall Study|Withdrawal by Subject|5|||
155046076|NCT02427802|559599432|FG002|Overall Study|Withdrawal by Subject|11|||
155046077|NCT02427802|559599430|FG000|Overall Study|Protocol Violation|3|||
155046078|NCT02427802|559599431|FG001|Overall Study|Protocol Violation|1|||
155046079|NCT02427802|559599432|FG002|Overall Study|Protocol Violation|1|||
155046080|NCT02427802|559599430|FG000|Overall Study|protocol specific treatment unrelated|18|||
155046081|NCT02427802|559599431|FG001|Overall Study|protocol specific treatment unrelated|11|||
155046082|NCT02427802|559599432|FG002|Overall Study|protocol specific treatment unrelated|11|||
154944576|NCT02110706|559222904|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
154944577|NCT02110706|559222905|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
154944578|NCT01348542|559222911|FG000|Overall Study|Withdrawal by Subject|3|||
154944579|NCT01348542|559222912|FG001|Overall Study|Withdrawal by Subject|0|||
154944580|NCT01789320|559222918|FG000|Overall Study|Re-enrolled into study|1|||
154944581|NCT01789320|559222918|FG000|Overall Study|Lost to Follow-up|1|||
154944582|NCT00859469|559222923|FG000|Overall Study|Adverse Event|2|||
154944583|NCT00859469|559222923|FG000|Overall Study|Lack of Efficacy|9|||
154944584|NCT00859469|559222923|FG000|Overall Study|Withdrawal by Subject|1|||
154944585|NCT00859469|559222923|FG000|Overall Study|Death|16|||
154944586|NCT01309919|559222924|FG000|Overall Study|Did not receive a postpartum IUD|17|||
154944587|NCT01309919|559222925|FG001|Overall Study|Did not receive a postpartum IUD|48|||
154944588|NCT02102490|559222926|FG000|Overall Study|Death|6|||
154944589|NCT02102490|559222926|FG000|Overall Study|Lost to Follow-up|1|||
154944590|NCT00095199|559222929|FG000|Overall Study|Adverse Event|40|||
154944591|NCT00095199|559222930|FG001|Overall Study|Adverse Event|22|||
154944592|NCT00095199|559222931|FG002|Overall Study|Adverse Event|26|||
154944593|NCT00095199|559222932|FG003|Overall Study|Adverse Event|11|||
154944594|NCT00095199|559222929|FG000|Overall Study|Progressive disease|213|||
154944595|NCT00095199|559222930|FG001|Overall Study|Progressive disease|179|||
154944596|NCT00095199|559222931|FG002|Overall Study|Progressive disease|105|||
154944597|NCT00095199|559222932|FG003|Overall Study|Progressive disease|98|||
154944598|NCT00095199|559222929|FG000|Overall Study|Death|10|||
154944599|NCT00095199|559222930|FG001|Overall Study|Death|6|||
154944600|NCT00095199|559222931|FG002|Overall Study|Death|11|||
154944601|NCT00095199|559222932|FG003|Overall Study|Death|9|||
154944602|NCT00095199|559222929|FG000|Overall Study|Withdrawal by Subject|21|||
154944603|NCT00095199|559222930|FG001|Overall Study|Withdrawal by Subject|16|||
154944604|NCT00095199|559222931|FG002|Overall Study|Withdrawal by Subject|13|||
154944605|NCT00095199|559222932|FG003|Overall Study|Withdrawal by Subject|22|||
154944606|NCT00095199|559222929|FG000|Overall Study|Protocol Violation|4|||
154944607|NCT00095199|559222930|FG001|Overall Study|Protocol Violation|4|||
154944608|NCT00095199|559222931|FG002|Overall Study|Protocol Violation|2|||
154944609|NCT00095199|559222932|FG003|Overall Study|Protocol Violation|0|||
154944610|NCT00095199|559222929|FG000|Overall Study|Liver function test results elevated|0|||
154944611|NCT00095199|559222930|FG001|Overall Study|Liver function test results elevated|0|||
154944612|NCT00095199|559222931|FG002|Overall Study|Liver function test results elevated|1|||
154944613|NCT00095199|559222932|FG003|Overall Study|Liver function test results elevated|1|||
154944614|NCT00095199|559222929|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
154944615|NCT00095199|559222930|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
154944616|NCT00095199|559222931|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
154944617|NCT00095199|559222932|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
154944618|NCT00095199|559222929|FG000|Overall Study|Physician Decision|5|||
154944619|NCT00095199|559222930|FG001|Overall Study|Physician Decision|6|||
154944620|NCT00095199|559222931|FG002|Overall Study|Physician Decision|1|||
154944621|NCT00095199|559222932|FG003|Overall Study|Physician Decision|1|||
154944622|NCT00095199|559222929|FG000|Overall Study|Not eligible|1|||
154944623|NCT00095199|559222930|FG001|Overall Study|Not eligible|7|||
154944624|NCT00095199|559222931|FG002|Overall Study|Not eligible|0|||
154944625|NCT00095199|559222932|FG003|Overall Study|Not eligible|1|||
154944626|NCT00095199|559222929|FG000|Overall Study|Started Palliative Radiotherapy|1|||
154944627|NCT00095199|559222930|FG001|Overall Study|Started Palliative Radiotherapy|0|||
154944628|NCT00095199|559222931|FG002|Overall Study|Started Palliative Radiotherapy|0|||
154944629|NCT00095199|559222932|FG003|Overall Study|Started Palliative Radiotherapy|0|||
154944630|NCT00095199|559222929|FG000|Overall Study|Started radiotherapy regimen|0|||
154944631|NCT00095199|559222930|FG001|Overall Study|Started radiotherapy regimen|1|||
154944632|NCT00095199|559222931|FG002|Overall Study|Started radiotherapy regimen|0|||
154944633|NCT00095199|559222932|FG003|Overall Study|Started radiotherapy regimen|0|||
154944634|NCT00095199|559222929|FG000|Overall Study|Primary tumor removed in other surgery|0|||
154944635|NCT00095199|559222930|FG001|Overall Study|Primary tumor removed in other surgery|1|||
154944636|NCT00095199|559222931|FG002|Overall Study|Primary tumor removed in other surgery|0|||
154944637|NCT00095199|559222932|FG003|Overall Study|Primary tumor removed in other surgery|0|||
154944638|NCT00095199|559222929|FG000|Overall Study|Data inadvertently lost by site|1|||
154944639|NCT00095199|559222930|FG001|Overall Study|Data inadvertently lost by site|0|||
154944640|NCT00095199|559222931|FG002|Overall Study|Data inadvertently lost by site|0|||
154944641|NCT00095199|559222932|FG003|Overall Study|Data inadvertently lost by site|0|||
154944642|NCT03896490|559222967|FG000|Overall Study|Withdrawal by Subject|1|||
154944643|NCT03896490|559222968|FG001|Overall Study|Withdrawal by Subject|1|||
154944644|NCT01890707|559222969|FG000|Overall Study|Lost to Follow-up|1|||
154944645|NCT01890707|559222970|FG001|Overall Study|Lost to Follow-up|1|||
154944646|NCT00385541|559222971|FG000|Overall Study|severe pain, clinician requested unblind|0|||
154944647|NCT00385541|559222972|FG001|Overall Study|severe pain, clinician requested unblind|1|||
154944648|NCT03329027|559224718|FG000|Overall Study|Lost to Follow-up|1|||
154944649|NCT03329027|559224719|FG001|Overall Study|Lost to Follow-up|0|||
154944650|NCT03329027|559224720|FG002|Overall Study|Lost to Follow-up|1|||
155046083|NCT02634983|559599433|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
155046084|NCT02634983|559599434|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
155046085|NCT00467558|559599435|FG000|Overall Study|Lost to Follow-up|2|||
155046086|NCT00467558|559599436|FG001|Overall Study|Lost to Follow-up|0|||
155046087|NCT05188729|559599438|FG000|Overall Study|Withdrawal by Subject|0|||
155046088|NCT05188729|559599439|FG001|Overall Study|Withdrawal by Subject|0|||
155046089|NCT05188729|559599440|FG002|Overall Study|Withdrawal by Subject|0|||
155046090|NCT05188729|559599441|FG003|Overall Study|Withdrawal by Subject|0|||
155046091|NCT05188729|559599442|FG004|Overall Study|Withdrawal by Subject|0|||
155046092|NCT05188729|559599443|FG005|Overall Study|Withdrawal by Subject|0|||
155046093|NCT05188729|559599444|FG006|Overall Study|Withdrawal by Subject|0|||
155046094|NCT05188729|559599445|FG007|Overall Study|Withdrawal by Subject|0|||
155046095|NCT05188729|559599446|FG008|Overall Study|Withdrawal by Subject|0|||
155046096|NCT05188729|559599447|FG009|Overall Study|Withdrawal by Subject|1|||
155046097|NCT05188729|559599448|FG010|Overall Study|Withdrawal by Subject|0|||
155046098|NCT05188729|559599449|FG011|Overall Study|Withdrawal by Subject|0|||
155046099|NCT05188729|559599450|FG012|Overall Study|Withdrawal by Subject|0|||
155046100|NCT05188729|559599438|FG000|Overall Study|Lost to Follow-up|0|||
155046101|NCT05188729|559599439|FG001|Overall Study|Lost to Follow-up|0|||
155046102|NCT05188729|559599440|FG002|Overall Study|Lost to Follow-up|0|||
155046103|NCT05188729|559599441|FG003|Overall Study|Lost to Follow-up|0|||
155046104|NCT05188729|559599442|FG004|Overall Study|Lost to Follow-up|0|||
155046105|NCT05188729|559599443|FG005|Overall Study|Lost to Follow-up|0|||
155046106|NCT05188729|559599444|FG006|Overall Study|Lost to Follow-up|0|||
155046107|NCT05188729|559599445|FG007|Overall Study|Lost to Follow-up|0|||
155046108|NCT05188729|559599446|FG008|Overall Study|Lost to Follow-up|0|||
155046109|NCT05188729|559599447|FG009|Overall Study|Lost to Follow-up|0|||
155046110|NCT05188729|559599448|FG010|Overall Study|Lost to Follow-up|1|||
155046111|NCT05188729|559599449|FG011|Overall Study|Lost to Follow-up|1|||
155046112|NCT05188729|559599450|FG012|Overall Study|Lost to Follow-up|0|||
155046113|NCT00577772|559601129|FG000|Overall Study|Lost to Follow-up|0|||
155046114|NCT00577772|559601130|FG001|Overall Study|Lost to Follow-up|1|||
155046115|NCT00572455|559601131|FG000|Stage I (14 Days)|Adverse Event|0|||
155046116|NCT00572455|559601132|FG001|Stage I (14 Days)|Adverse Event|0|||
155046117|NCT00572455|559601133|FG002|Stage I (14 Days)|Adverse Event|0|||
155046118|NCT00572455|559601134|FG003|Stage I (14 Days)|Adverse Event|0|||
155046119|NCT00572455|559601135|FG004|Stage I (14 Days)|Adverse Event|0|||
155046120|NCT00572455|559601136|FG005|Stage I (14 Days)|Adverse Event|3|||
155046121|NCT00572455|559601137|FG006|Stage I (14 Days)|Adverse Event|0|||
155046122|NCT00572455|559601138|FG007|Stage I (14 Days)|Adverse Event|0|||
155046123|NCT00572455|559601139|FG008|Stage I (14 Days)|Adverse Event|0|||
155046124|NCT00572455|559601140|FG009|Stage I (14 Days)|Adverse Event|0|||
155046125|NCT00572455|559601141|FG010|Stage I (14 Days)|Adverse Event|0|||
155046126|NCT00572455|559601142|FG011|Stage I (14 Days)|Adverse Event|0|||
155046127|NCT00572455|559601143|FG012|Stage I (14 Days)|Adverse Event|0|||
155046128|NCT00572455|559601144|FG013|Stage I (14 Days)|Adverse Event|0|||
155046129|NCT00572455|559601131|FG000|Stage I (14 Days)|Other|0|||
155046130|NCT00572455|559601132|FG001|Stage I (14 Days)|Other|0|||
155046131|NCT00572455|559601133|FG002|Stage I (14 Days)|Other|0|||
155046132|NCT00572455|559601134|FG003|Stage I (14 Days)|Other|0|||
155046133|NCT00572455|559601135|FG004|Stage I (14 Days)|Other|1|||
155046134|NCT00572455|559601136|FG005|Stage I (14 Days)|Other|0|||
155046135|NCT00572455|559601137|FG006|Stage I (14 Days)|Other|0|||
155046136|NCT00572455|559601138|FG007|Stage I (14 Days)|Other|0|||
155046137|NCT00572455|559601139|FG008|Stage I (14 Days)|Other|0|||
155046138|NCT00572455|559601140|FG009|Stage I (14 Days)|Other|0|||
155281077|NCT04955626|560459878|FG011|Open-Label Period|Other|0|||
155046139|NCT00572455|559601141|FG010|Stage I (14 Days)|Other|0|||
155046140|NCT00572455|559601142|FG011|Stage I (14 Days)|Other|0|||
155046141|NCT00572455|559601143|FG012|Stage I (14 Days)|Other|0|||
155046142|NCT00572455|559601144|FG013|Stage I (14 Days)|Other|0|||
155046143|NCT00572455|559601131|FG000|Stage II (28 Days)|Adverse Event|0|||
155046144|NCT00572455|559601132|FG001|Stage II (28 Days)|Adverse Event|0|||
155046145|NCT00572455|559601133|FG002|Stage II (28 Days)|Adverse Event|0|||
155046146|NCT00572455|559601134|FG003|Stage II (28 Days)|Adverse Event|0|||
155046147|NCT00572455|559601135|FG004|Stage II (28 Days)|Adverse Event|0|||
155046148|NCT00572455|559601136|FG005|Stage II (28 Days)|Adverse Event|0|||
155281078|NCT04955626|560459879|FG012|Open-Label Period|Other|0|||
155281079|NCT04955626|560459880|FG013|Open-Label Period|Other|0|||
155046149|NCT00572455|559601137|FG006|Stage II (28 Days)|Adverse Event|0|||
155046150|NCT00572455|559601138|FG007|Stage II (28 Days)|Adverse Event|0|||
155046151|NCT00572455|559601139|FG008|Stage II (28 Days)|Adverse Event|1|||
155046152|NCT00572455|559601140|FG009|Stage II (28 Days)|Adverse Event|3|||
155281080|NCT04955626|560459881|FG014|Open-Label Period|Other|0|||
155046153|NCT00572455|559601141|FG010|Stage II (28 Days)|Adverse Event|3|||
155046154|NCT00572455|559601142|FG011|Stage II (28 Days)|Adverse Event|4|||
155046155|NCT00572455|559601143|FG012|Stage II (28 Days)|Adverse Event|5|||
155046156|NCT00572455|559601144|FG013|Stage II (28 Days)|Adverse Event|1|||
155046157|NCT00572455|559601131|FG000|Stage II (28 Days)|Death|0|||
155046158|NCT00572455|559601132|FG001|Stage II (28 Days)|Death|0|||
155281081|NCT04955626|560459882|FG015|Open-Label Period|Other|0|||
155046159|NCT00572455|559601133|FG002|Stage II (28 Days)|Death|0|||
155046160|NCT00572455|559601134|FG003|Stage II (28 Days)|Death|0|||
155046161|NCT00572455|559601135|FG004|Stage II (28 Days)|Death|0|||
155046162|NCT00572455|559601136|FG005|Stage II (28 Days)|Death|0|||
155046163|NCT00572455|559601137|FG006|Stage II (28 Days)|Death|0|||
155046164|NCT00572455|559601138|FG007|Stage II (28 Days)|Death|0|||
155046165|NCT00572455|559601139|FG008|Stage II (28 Days)|Death|1|||
155046166|NCT00572455|559601140|FG009|Stage II (28 Days)|Death|0|||
155046167|NCT00572455|559601141|FG010|Stage II (28 Days)|Death|0|||
155046168|NCT00572455|559601142|FG011|Stage II (28 Days)|Death|0|||
155046169|NCT00572455|559601143|FG012|Stage II (28 Days)|Death|0|||
155046170|NCT00572455|559601144|FG013|Stage II (28 Days)|Death|0|||
155046171|NCT00572455|559601131|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
155046172|NCT00572455|559601132|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
155046173|NCT00572455|559601133|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
155046174|NCT00572455|559601134|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
155046175|NCT00572455|559601135|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
155046176|NCT00572455|559601136|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
155046177|NCT00572455|559601137|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
155046178|NCT00572455|559601138|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
155046179|NCT00572455|559601139|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
155046180|NCT00572455|559601140|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
155046181|NCT00572455|559601141|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
155046182|NCT00572455|559601142|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
155046183|NCT00572455|559601143|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
155046184|NCT00572455|559601144|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
155046185|NCT00572455|559601131|FG000|Stage II (28 Days)|Other|0|||
155046186|NCT00572455|559601132|FG001|Stage II (28 Days)|Other|0|||
155046187|NCT00572455|559601133|FG002|Stage II (28 Days)|Other|0|||
155046188|NCT00572455|559601134|FG003|Stage II (28 Days)|Other|0|||
155046189|NCT00572455|559601135|FG004|Stage II (28 Days)|Other|0|||
155046190|NCT00572455|559601136|FG005|Stage II (28 Days)|Other|0|||
155046191|NCT00572455|559601137|FG006|Stage II (28 Days)|Other|0|||
155046192|NCT00572455|559601138|FG007|Stage II (28 Days)|Other|0|||
155046193|NCT00572455|559601139|FG008|Stage II (28 Days)|Other|1|||
155046194|NCT00572455|559601140|FG009|Stage II (28 Days)|Other|0|||
155046195|NCT00572455|559601141|FG010|Stage II (28 Days)|Other|0|||
155046196|NCT00572455|559601142|FG011|Stage II (28 Days)|Other|0|||
155046197|NCT00572455|559601143|FG012|Stage II (28 Days)|Other|0|||
155046198|NCT00572455|559601144|FG013|Stage II (28 Days)|Other|0|||
155046199|NCT00572455|559601131|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
155046200|NCT00572455|559601132|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
155046201|NCT00572455|559601133|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
155046202|NCT00572455|559601134|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
155046203|NCT00572455|559601135|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
155046204|NCT00572455|559601136|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
155046205|NCT00572455|559601137|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
155046206|NCT00572455|559601138|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
155046207|NCT00572455|559601139|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
155046208|NCT00572455|559601140|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
155046209|NCT00572455|559601141|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
155046210|NCT00572455|559601142|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
155046211|NCT00572455|559601143|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
155046212|NCT00572455|559601144|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
155046213|NCT04152083|559601151|FG000|Overall Study|Lost to Follow-up|2|||
155046214|NCT04152083|559601152|FG001|Overall Study|Lost to Follow-up|1|||
155046215|NCT04152083|559601151|FG000|Overall Study|Adverse Event|1|||
155046216|NCT04152083|559601152|FG001|Overall Study|Adverse Event|0|||
155046217|NCT04152083|559601151|FG000|Overall Study|Randomized but not treated|3|||
155046218|NCT04152083|559601152|FG001|Overall Study|Randomized but not treated|2|||
155046219|NCT01308463|559601153|FG000|Overall Study|Study Discontinued|23|||
155387896|NCT00150969|560854975|FG000|24-48 Month Extension|Adverse Event|1|||
155046220|NCT01308463|559601153|FG000|Overall Study|Death|4|||
155046221|NCT01308463|559601153|FG000|Overall Study|Revision|2|||
155046222|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
155046223|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
155046224|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
155046225|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
155046226|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
155046227|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
155046228|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
155046229|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
155046230|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
155046231|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
155046232|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
155387897|NCT00150969|560854976|FG001|24-48 Month Extension|Adverse Event|3|||
155046233|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
155046234|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
155046235|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
155046236|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Death|1|||
155046237|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Death|0|||
155046238|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
155046239|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
155046240|NCT00105989|559601155|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
155046241|NCT00105989|559601156|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
155046242|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
155046243|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
155046244|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
155046245|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
155046246|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
155046247|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
155046248|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
155046249|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
155046250|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
155046251|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
155046252|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
155046253|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
155046254|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
155046255|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
155046256|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Death|0|||
155046257|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Death|0|||
155046258|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
155046259|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
155046260|NCT00105989|559601155|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
155046261|NCT00105989|559601156|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
155046262|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
155046263|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
155046264|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
155046265|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
155046266|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
155046267|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
155046268|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
155046269|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
155046270|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
155046271|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
155046272|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
155046273|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
155046274|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
155046275|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
155046276|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
155046277|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
155046278|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
155046279|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
155046280|NCT00105989|559601155|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
155046281|NCT00105989|559601156|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
155046282|NCT03280056|559601157|FG000|Overall Study|Withdrawal by Subject|12|||
155046283|NCT03280056|559601158|FG001|Overall Study|Withdrawal by Subject|14|||
155046284|NCT03280056|559601157|FG000|Overall Study|Death|9|||
155046285|NCT03280056|559601158|FG001|Overall Study|Death|2|||
155046286|NCT03280056|559601157|FG000|Overall Study|Adverse Event|1|||
155046287|NCT03280056|559601158|FG001|Overall Study|Adverse Event|3|||
155046288|NCT03280056|559601157|FG000|Overall Study|Lost to Follow-up|1|||
155046289|NCT03280056|559601158|FG001|Overall Study|Lost to Follow-up|1|||
155046290|NCT03280056|559601157|FG000|Overall Study|Physician Decision|0|||
155046291|NCT03280056|559601158|FG001|Overall Study|Physician Decision|1|||
155046292|NCT03280056|559601157|FG000|Overall Study|Early Discontinuation|1|||
155046293|NCT03280056|559601158|FG001|Overall Study|Early Discontinuation|0|||
155046294|NCT04607135|559601159|FG000|Overall Study|Physician Decision|1|||
155046295|NCT04607135|559601159|FG000|Overall Study|Withdrawal by Subject|1|||
155046296|NCT04607135|559601159|FG000|Overall Study|Equipment not working|3|||
155046297|NCT03465709|559601160|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
155046298|NCT03465709|559601160|FG000|Overall Study|Withdrawal by Subject|3|||
155046299|NCT00705341|559601161|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
155046300|NCT00705341|559601162|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
155046301|NCT00705341|559601163|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
155046302|NCT00705341|559601164|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
155046303|NCT00705341|559601161|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
155046304|NCT00705341|559601162|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
155046305|NCT00705341|559601163|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
155046306|NCT00705341|559601164|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
155046307|NCT03665077|559601167|FG000|Overall Study|Lost to Follow-up|2|||
155046308|NCT03665077|559601167|FG000|Overall Study|Physician Decision|2|||
155046309|NCT02959918|559601172|FG000|Overall Study|Adverse Event|1|||
155046310|NCT02959918|559601173|FG001|Overall Study|Adverse Event|1|||
155046311|NCT02959918|559601174|FG002|Overall Study|Adverse Event|2|||
155046312|NCT02959918|559601175|FG003|Overall Study|Adverse Event|0|||
155046313|NCT02959918|559601176|FG004|Overall Study|Adverse Event|0|||
155046314|NCT02959918|559601177|FG005|Overall Study|Adverse Event|2|||
155046315|NCT02959918|559601178|FG006|Overall Study|Adverse Event|2|||
155046316|NCT02959918|559601179|FG007|Overall Study|Adverse Event|1|||
155046317|NCT02959918|559601180|FG008|Overall Study|Adverse Event|2|||
155046318|NCT02959918|559601181|FG009|Overall Study|Adverse Event|1|||
155046319|NCT02959918|559601182|FG010|Overall Study|Adverse Event|1|||
155046320|NCT02959918|559601183|FG011|Overall Study|Adverse Event|3|||
155046321|NCT02959918|559601184|FG012|Overall Study|Adverse Event|2|||
155046322|NCT02959918|559601185|FG013|Overall Study|Adverse Event|4|||
155046323|NCT02959918|559601172|FG000|Overall Study|Lost to Follow-up|0|||
155046324|NCT02959918|559601173|FG001|Overall Study|Lost to Follow-up|0|||
155046325|NCT02959918|559601174|FG002|Overall Study|Lost to Follow-up|0|||
155046326|NCT02959918|559601175|FG003|Overall Study|Lost to Follow-up|0|||
155046327|NCT02959918|559601176|FG004|Overall Study|Lost to Follow-up|0|||
155046328|NCT02959918|559601177|FG005|Overall Study|Lost to Follow-up|0|||
155046329|NCT02959918|559601178|FG006|Overall Study|Lost to Follow-up|0|||
155046330|NCT02959918|559601179|FG007|Overall Study|Lost to Follow-up|0|||
155046331|NCT02959918|559601180|FG008|Overall Study|Lost to Follow-up|0|||
155046332|NCT02959918|559601181|FG009|Overall Study|Lost to Follow-up|1|||
155046333|NCT02959918|559601182|FG010|Overall Study|Lost to Follow-up|0|||
155046334|NCT02959918|559601183|FG011|Overall Study|Lost to Follow-up|0|||
155046335|NCT02959918|559601184|FG012|Overall Study|Lost to Follow-up|1|||
155387898|NCT00150969|560854975|FG000|24-48 Month Extension|Other Reason|81|||
155387899|NCT00150969|560854976|FG001|24-48 Month Extension|Other Reason|91|||
155387900|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
155387901|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
154944651|NCT03329027|559224718|FG000|Overall Study|Protocol Violation|9|||
154944652|NCT03329027|559224719|FG001|Overall Study|Protocol Violation|5|||
154944653|NCT03329027|559224720|FG002|Overall Study|Protocol Violation|7|||
154944654|NCT02761980|559224721|FG000|Overall Study|Adverse Event|4|||
154944655|NCT02761980|559224722|FG001|Overall Study|Adverse Event|6|||
154944656|NCT02761980|559224723|FG002|Overall Study|Adverse Event|5|||
154944657|NCT02761980|559224724|FG003|Overall Study|Adverse Event|6|||
154944658|NCT02761980|559224721|FG000|Overall Study|Withdrawal by Subject|0|||
154944659|NCT02761980|559224722|FG001|Overall Study|Withdrawal by Subject|1|||
154944660|NCT02761980|559224723|FG002|Overall Study|Withdrawal by Subject|0|||
154944661|NCT02761980|559224724|FG003|Overall Study|Withdrawal by Subject|0|||
154944662|NCT02761980|559224721|FG000|Overall Study|Other|0|||
154944663|NCT02761980|559224722|FG001|Overall Study|Other|0|||
154944664|NCT02761980|559224723|FG002|Overall Study|Other|1|||
154944665|NCT02761980|559224724|FG003|Overall Study|Other|0|||
154944666|NCT01767597|559224725|FG000|Overall Study|Incomplete intervention|3|||
154944667|NCT01767597|559224726|FG001|Overall Study|Incomplete intervention|1|||
154944668|NCT01767597|559224725|FG000|Overall Study|Withdrawal by Subject|1|||
154944669|NCT01767597|559224726|FG001|Overall Study|Withdrawal by Subject|0|||
154944670|NCT03355742|559224727|FG000|Overall Study|Lost to Follow-up|4|||
154944671|NCT03355742|559224727|FG000|Overall Study|Withdrawal by Subject|29|||
154944672|NCT03355742|559224727|FG000|Overall Study|Physician Decision|6|||
155387902|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
154944673|NCT03355742|559224727|FG000|Overall Study|Death|55|||
154944674|NCT03355742|559224727|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
154944675|NCT04820842|559224730|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
154944676|NCT04820842|559224731|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
154944677|NCT04820842|559224732|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
154944678|NCT04820842|559224733|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
155046336|NCT02959918|559601185|FG013|Overall Study|Lost to Follow-up|0|||
155046337|NCT02959918|559601172|FG000|Overall Study|Withdrawal by Subject|0|||
155046338|NCT02959918|559601173|FG001|Overall Study|Withdrawal by Subject|0|||
155046339|NCT02959918|559601174|FG002|Overall Study|Withdrawal by Subject|1|||
155046340|NCT02959918|559601175|FG003|Overall Study|Withdrawal by Subject|2|||
155046341|NCT02959918|559601176|FG004|Overall Study|Withdrawal by Subject|0|||
155046342|NCT02959918|559601177|FG005|Overall Study|Withdrawal by Subject|0|||
155046343|NCT02959918|559601178|FG006|Overall Study|Withdrawal by Subject|1|||
155046344|NCT02959918|559601179|FG007|Overall Study|Withdrawal by Subject|0|||
155046345|NCT02959918|559601180|FG008|Overall Study|Withdrawal by Subject|1|||
154944679|NCT04820842|559224734|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
154944680|NCT04820842|559224735|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
154944681|NCT04820842|559224736|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
154944682|NCT04820842|559224730|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
154944683|NCT04820842|559224731|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
154944684|NCT04820842|559224732|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
154944685|NCT04820842|559224733|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944686|NCT04820842|559224734|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944687|NCT04820842|559224735|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944688|NCT04820842|559224736|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944689|NCT04820842|559224730|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
154944690|NCT04820842|559224731|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
154944691|NCT04820842|559224732|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
154944692|NCT04820842|559224733|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
154944693|NCT04820842|559224734|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
154944694|NCT04820842|559224735|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
154944695|NCT04820842|559224736|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
154944696|NCT04820842|559224730|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944697|NCT04820842|559224731|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944698|NCT04820842|559224732|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944699|NCT04820842|559224733|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
154944700|NCT04820842|559224734|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944701|NCT04820842|559224735|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
154944702|NCT04820842|559224736|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
154944703|NCT01691508|559224737|FG000|Overall Study|Adverse Event|3|||
154944704|NCT01691508|559224738|FG001|Overall Study|Adverse Event|3|||
154944705|NCT01691508|559224737|FG000|Overall Study|Withdrawal by Subject|1|||
154944706|NCT01691508|559224738|FG001|Overall Study|Withdrawal by Subject|0|||
154944707|NCT01296932|559224739|FG000|Overall Study|Dose limiting toxicity|0|||
154944708|NCT01296932|559224740|FG001|Overall Study|Dose limiting toxicity|0|||
154944709|NCT01296932|559224741|FG002|Overall Study|Dose limiting toxicity|0|||
154944710|NCT01296932|559224742|FG003|Overall Study|Dose limiting toxicity|0|||
154944711|NCT01296932|559224743|FG004|Overall Study|Dose limiting toxicity|0|||
154944712|NCT01296932|559224744|FG005|Overall Study|Dose limiting toxicity|0|||
154944713|NCT01296932|559224745|FG006|Overall Study|Dose limiting toxicity|1|||
154944714|NCT01296932|559224746|FG007|Overall Study|Dose limiting toxicity|0|||
154944715|NCT01296932|559224747|FG008|Overall Study|Dose limiting toxicity|1|||
154944716|NCT01296932|559224739|FG000|Overall Study|Progressive disease|2|||
154944717|NCT01296932|559224740|FG001|Overall Study|Progressive disease|0|||
154944718|NCT01296932|559224741|FG002|Overall Study|Progressive disease|1|||
154944719|NCT01296932|559224742|FG003|Overall Study|Progressive disease|1|||
154944720|NCT01296932|559224743|FG004|Overall Study|Progressive disease|2|||
154944721|NCT01296932|559224744|FG005|Overall Study|Progressive disease|3|||
154944722|NCT01296932|559224745|FG006|Overall Study|Progressive disease|1|||
154944723|NCT01296932|559224746|FG007|Overall Study|Progressive disease|0|||
154944724|NCT01296932|559224747|FG008|Overall Study|Progressive disease|0|||
154944725|NCT01296932|559224739|FG000|Overall Study|Withdrawal by Subject|0|||
154944726|NCT01296932|559224740|FG001|Overall Study|Withdrawal by Subject|0|||
154944727|NCT01296932|559224741|FG002|Overall Study|Withdrawal by Subject|1|||
154944728|NCT01296932|559224742|FG003|Overall Study|Withdrawal by Subject|1|||
154944729|NCT01296932|559224743|FG004|Overall Study|Withdrawal by Subject|0|||
154944730|NCT01296932|559224744|FG005|Overall Study|Withdrawal by Subject|0|||
154944731|NCT01296932|559224745|FG006|Overall Study|Withdrawal by Subject|3|||
154944732|NCT01296932|559224746|FG007|Overall Study|Withdrawal by Subject|0|||
154944733|NCT01296932|559224747|FG008|Overall Study|Withdrawal by Subject|0|||
154944734|NCT01296932|559224739|FG000|Overall Study|Adverse Event|1|||
154944735|NCT01296932|559224740|FG001|Overall Study|Adverse Event|1|||
154944736|NCT01296932|559224741|FG002|Overall Study|Adverse Event|1|||
154944737|NCT01296932|559224742|FG003|Overall Study|Adverse Event|2|||
154944738|NCT01296932|559224743|FG004|Overall Study|Adverse Event|1|||
154944739|NCT01296932|559224744|FG005|Overall Study|Adverse Event|0|||
154944740|NCT01296932|559224745|FG006|Overall Study|Adverse Event|0|||
155387903|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
154944741|NCT01296932|559224746|FG007|Overall Study|Adverse Event|0|||
154944742|NCT01296932|559224747|FG008|Overall Study|Adverse Event|1|||
154944743|NCT01296932|559224739|FG000|Overall Study|Investigator decision|0|||
154944744|NCT01296932|559224740|FG001|Overall Study|Investigator decision|1|||
154944745|NCT01296932|559224741|FG002|Overall Study|Investigator decision|0|||
154944746|NCT01296932|559224742|FG003|Overall Study|Investigator decision|1|||
154944747|NCT01296932|559224743|FG004|Overall Study|Investigator decision|0|||
154944748|NCT01296932|559224744|FG005|Overall Study|Investigator decision|0|||
154944749|NCT01296932|559224745|FG006|Overall Study|Investigator decision|1|||
154944750|NCT01296932|559224746|FG007|Overall Study|Investigator decision|0|||
154944751|NCT01296932|559224747|FG008|Overall Study|Investigator decision|1|||
154944752|NCT01296932|559224739|FG000|Overall Study|No clinical benefit anymore|0|||
154944753|NCT01296932|559224740|FG001|Overall Study|No clinical benefit anymore|1|||
154944754|NCT01296932|559224741|FG002|Overall Study|No clinical benefit anymore|0|||
154944755|NCT01296932|559224742|FG003|Overall Study|No clinical benefit anymore|0|||
154944756|NCT01296932|559224743|FG004|Overall Study|No clinical benefit anymore|0|||
154944757|NCT01296932|559224744|FG005|Overall Study|No clinical benefit anymore|0|||
154944758|NCT01296932|559224745|FG006|Overall Study|No clinical benefit anymore|0|||
154944759|NCT01296932|559224746|FG007|Overall Study|No clinical benefit anymore|0|||
154944760|NCT01296932|559224747|FG008|Overall Study|No clinical benefit anymore|0|||
154944761|NCT01296932|559224739|FG000|Overall Study|Physician Decision|0|||
154944762|NCT01296932|559224740|FG001|Overall Study|Physician Decision|0|||
154944763|NCT01296932|559224741|FG002|Overall Study|Physician Decision|1|||
154944764|NCT01296932|559224742|FG003|Overall Study|Physician Decision|0|||
154944765|NCT01296932|559224743|FG004|Overall Study|Physician Decision|0|||
154944766|NCT01296932|559224744|FG005|Overall Study|Physician Decision|0|||
154944767|NCT01296932|559224745|FG006|Overall Study|Physician Decision|0|||
154944768|NCT01296932|559224746|FG007|Overall Study|Physician Decision|0|||
154944769|NCT01296932|559224747|FG008|Overall Study|Physician Decision|0|||
154944770|NCT01296932|559224739|FG000|Overall Study|IV problems, administration not possible|0|||
154944771|NCT01296932|559224740|FG001|Overall Study|IV problems, administration not possible|0|||
154944772|NCT01296932|559224741|FG002|Overall Study|IV problems, administration not possible|1|||
154944773|NCT01296932|559224742|FG003|Overall Study|IV problems, administration not possible|0|||
154944774|NCT01296932|559224743|FG004|Overall Study|IV problems, administration not possible|0|||
154944775|NCT01296932|559224744|FG005|Overall Study|IV problems, administration not possible|0|||
154944776|NCT01296932|559224745|FG006|Overall Study|IV problems, administration not possible|0|||
154944777|NCT01296932|559224746|FG007|Overall Study|IV problems, administration not possible|0|||
154944778|NCT01296932|559224747|FG008|Overall Study|IV problems, administration not possible|0|||
154944779|NCT01296932|559224739|FG000|Overall Study|per protocol|0|||
154944780|NCT01296932|559224740|FG001|Overall Study|per protocol|0|||
154944781|NCT01296932|559224741|FG002|Overall Study|per protocol|1|||
154944782|NCT01296932|559224742|FG003|Overall Study|per protocol|1|||
154944783|NCT01296932|559224743|FG004|Overall Study|per protocol|0|||
154944784|NCT01296932|559224744|FG005|Overall Study|per protocol|0|||
154944785|NCT01296932|559224745|FG006|Overall Study|per protocol|0|||
154944786|NCT01296932|559224746|FG007|Overall Study|per protocol|0|||
154944787|NCT01296932|559224747|FG008|Overall Study|per protocol|0|||
154944788|NCT01296932|559224739|FG000|Overall Study|Low benefit and too many side effects|0|||
154944789|NCT01296932|559224740|FG001|Overall Study|Low benefit and too many side effects|0|||
154944790|NCT01296932|559224741|FG002|Overall Study|Low benefit and too many side effects|0|||
154944791|NCT01296932|559224742|FG003|Overall Study|Low benefit and too many side effects|0|||
154944792|NCT01296932|559224743|FG004|Overall Study|Low benefit and too many side effects|0|||
154944793|NCT01296932|559224744|FG005|Overall Study|Low benefit and too many side effects|0|||
154944794|NCT01296932|559224745|FG006|Overall Study|Low benefit and too many side effects|0|||
154944795|NCT01296932|559224746|FG007|Overall Study|Low benefit and too many side effects|1|||
154944796|NCT01296932|559224747|FG008|Overall Study|Low benefit and too many side effects|0|||
154944797|NCT01296932|559224739|FG000|Overall Study|No adequate treatment response|0|||
154944798|NCT01296932|559224740|FG001|Overall Study|No adequate treatment response|0|||
154944799|NCT01296932|559224741|FG002|Overall Study|No adequate treatment response|0|||
154944800|NCT01296932|559224742|FG003|Overall Study|No adequate treatment response|0|||
154944801|NCT01296932|559224743|FG004|Overall Study|No adequate treatment response|0|||
154944802|NCT01296932|559224744|FG005|Overall Study|No adequate treatment response|0|||
154944803|NCT01296932|559224745|FG006|Overall Study|No adequate treatment response|0|||
154944804|NCT01296932|559224746|FG007|Overall Study|No adequate treatment response|1|||
154944805|NCT01296932|559224747|FG008|Overall Study|No adequate treatment response|0|||
154944806|NCT01296932|559224739|FG000|Overall Study|Dosage already reduced, AE still present|0|||
154944807|NCT01296932|559224740|FG001|Overall Study|Dosage already reduced, AE still present|0|||
154944808|NCT01296932|559224741|FG002|Overall Study|Dosage already reduced, AE still present|0|||
154944809|NCT01296932|559224742|FG003|Overall Study|Dosage already reduced, AE still present|0|||
154944810|NCT01296932|559224743|FG004|Overall Study|Dosage already reduced, AE still present|0|||
154944811|NCT01296932|559224744|FG005|Overall Study|Dosage already reduced, AE still present|0|||
154944812|NCT01296932|559224745|FG006|Overall Study|Dosage already reduced, AE still present|0|||
155046346|NCT02959918|559601181|FG009|Overall Study|Withdrawal by Subject|1|||
155046347|NCT02959918|559601182|FG010|Overall Study|Withdrawal by Subject|2|||
154944813|NCT01296932|559224746|FG007|Overall Study|Dosage already reduced, AE still present|0|||
154944814|NCT01296932|559224747|FG008|Overall Study|Dosage already reduced, AE still present|1|||
154944815|NCT03093454|559224750|FG000|Overall Study|Withdrawal by Subject|1|||
154944816|NCT03093454|559224751|FG001|Overall Study|Withdrawal by Subject|1|||
154944817|NCT03093454|559224750|FG000|Overall Study|Scheduling conflict|3|||
154944818|NCT03093454|559224751|FG001|Overall Study|Scheduling conflict|1|||
154944819|NCT03093454|559224750|FG000|Overall Study|Physician Decision|2|||
154944820|NCT03093454|559224751|FG001|Overall Study|Physician Decision|1|||
154944821|NCT02524379|559224755|FG000|Overall Study|Death|1|||
154944822|NCT01829464|559224756|FG000|Overall Study|Adverse Event|1|||
154944823|NCT01829464|559224757|FG001|Overall Study|Adverse Event|0|||
154944824|NCT01829464|559224758|FG002|Overall Study|Adverse Event|0|||
154944825|NCT01829464|559224756|FG000|Overall Study|Lost to Follow-up|0|||
154944826|NCT01829464|559224757|FG001|Overall Study|Lost to Follow-up|0|||
154944827|NCT01829464|559224758|FG002|Overall Study|Lost to Follow-up|1|||
154944828|NCT01829464|559224756|FG000|Overall Study|Withdrawal by Subject|2|||
154944829|NCT01829464|559224757|FG001|Overall Study|Withdrawal by Subject|0|||
154944830|NCT01829464|559224758|FG002|Overall Study|Withdrawal by Subject|0|||
154944831|NCT01829464|559224756|FG000|Overall Study|Study terminated by sponsor|25|||
154944832|NCT01829464|559224757|FG001|Overall Study|Study terminated by sponsor|28|||
154944833|NCT01829464|559224758|FG002|Overall Study|Study terminated by sponsor|25|||
154944834|NCT01829464|559224756|FG000|Overall Study|Lack of Efficacy|0|||
154944835|NCT01829464|559224757|FG001|Overall Study|Lack of Efficacy|1|||
154944836|NCT01829464|559224758|FG002|Overall Study|Lack of Efficacy|0|||
154944837|NCT00635778|559224759|FG000|Overall Study|Adverse Event|1|||
154944838|NCT00635778|559224760|FG001|Overall Study|Adverse Event|0|||
154944839|NCT00635778|559224761|FG002|Overall Study|Adverse Event|0|||
154944840|NCT00635778|559224762|FG003|Overall Study|Adverse Event|3|||
154944841|NCT00635778|559224763|FG004|Overall Study|Adverse Event|3|||
154944842|NCT00635778|559224764|FG005|Overall Study|Adverse Event|6|||
154944843|NCT00635778|559224765|FG006|Overall Study|Adverse Event|1|||
154944844|NCT00635778|559224759|FG000|Overall Study|Withdrawal by Subject|0|||
154944845|NCT00635778|559224760|FG001|Overall Study|Withdrawal by Subject|0|||
154944846|NCT00635778|559224761|FG002|Overall Study|Withdrawal by Subject|0|||
154944847|NCT00635778|559224762|FG003|Overall Study|Withdrawal by Subject|1|||
154944848|NCT00635778|559224763|FG004|Overall Study|Withdrawal by Subject|0|||
154944849|NCT00635778|559224764|FG005|Overall Study|Withdrawal by Subject|1|||
154944850|NCT00635778|559224765|FG006|Overall Study|Withdrawal by Subject|1|||
154944851|NCT00635778|559224759|FG000|Overall Study|Progressive disease|0|||
154944852|NCT00635778|559224760|FG001|Overall Study|Progressive disease|3|||
154944853|NCT00635778|559224761|FG002|Overall Study|Progressive disease|3|||
154944854|NCT00635778|559224762|FG003|Overall Study|Progressive disease|4|||
154944855|NCT00635778|559224763|FG004|Overall Study|Progressive disease|5|||
154944856|NCT00635778|559224764|FG005|Overall Study|Progressive disease|14|||
154944857|NCT00635778|559224765|FG006|Overall Study|Progressive disease|4|||
154944858|NCT00812253|559224766|FG000|Overall Study|Withdrawal by Subject|3|||
154944859|NCT00812253|559224767|FG001|Overall Study|Withdrawal by Subject|2|||
154944860|NCT00812253|559224766|FG000|Overall Study|Protocol Violation|1|||
154944861|NCT00812253|559224767|FG001|Overall Study|Protocol Violation|1|||
154944862|NCT00812253|559224766|FG000|Overall Study|Lost to Follow-up|2|||
154944863|NCT00812253|559224767|FG001|Overall Study|Lost to Follow-up|0|||
154944864|NCT01884025|559224768|FG000|Overall Study|Lost to Follow-up|3|||
154944865|NCT01884025|559224769|FG001|Overall Study|Lost to Follow-up|4|||
154944866|NCT01700621|559224775|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
154944867|NCT01700621|559224776|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
154944868|NCT01700621|559224775|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
154944869|NCT01700621|559224776|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
154944870|NCT01700621|559224775|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
154944871|NCT01700621|559224776|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
154944872|NCT02035137|559224779|FG000|Overall Study|Physician Decision|0|||
154944873|NCT02035137|559224780|FG001|Overall Study|Physician Decision|0|||
155046348|NCT02959918|559601183|FG011|Overall Study|Withdrawal by Subject|3|||
155046349|NCT02959918|559601184|FG012|Overall Study|Withdrawal by Subject|1|||
155046350|NCT02959918|559601185|FG013|Overall Study|Withdrawal by Subject|1|||
155046351|NCT02959918|559601172|FG000|Overall Study|Protocol Violation|0|||
154944874|NCT02035137|559224781|FG002|Overall Study|Physician Decision|1|||
154944875|NCT02035137|559224779|FG000|Overall Study|Withdrawal by Subject|0|||
154944876|NCT02035137|559224780|FG001|Overall Study|Withdrawal by Subject|1|||
155046352|NCT02959918|559601173|FG001|Overall Study|Protocol Violation|0|||
155046353|NCT02959918|559601174|FG002|Overall Study|Protocol Violation|1|||
154944877|NCT02035137|559224781|FG002|Overall Study|Withdrawal by Subject|2|||
154944878|NCT02035137|559224779|FG000|Overall Study|Ineligible|0|||
154944879|NCT02035137|559224780|FG001|Overall Study|Ineligible|1|||
155046354|NCT02959918|559601175|FG003|Overall Study|Protocol Violation|0|||
154944880|NCT02035137|559224781|FG002|Overall Study|Ineligible|2|||
154944881|NCT02035137|559224779|FG000|Overall Study|Disease progression prior to treatment start|2|||
154944882|NCT02035137|559224780|FG001|Overall Study|Disease progression prior to treatment start|0|||
154944883|NCT02035137|559224781|FG002|Overall Study|Disease progression prior to treatment start|0|||
154944884|NCT03349333|559224788|FG000|Overall Study|Progression of Disease|36|||
154944885|NCT03349333|559224788|FG000|Overall Study|Adverse Event|11|||
154944886|NCT03349333|559224788|FG000|Overall Study|Other|6|||
154944887|NCT03349333|559224788|FG000|Overall Study|Withdrawal by Subject|5|||
154944888|NCT03349333|559224788|FG000|Overall Study|Conditions interfere with participation|2|||
154944889|NCT03349333|559224788|FG000|Overall Study|Physician Decision|2|||
154944890|NCT03349333|559224788|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
154944891|NCT03349333|559224788|FG000|Overall Study|Patients in treatment less than 24 month|8|||
154944892|NCT02985151|559224789|FG000|Original Randomization|Withdrawal by Subject|0|||
154944893|NCT02985151|559224790|FG001|Original Randomization|Withdrawal by Subject|1|||
154944894|NCT02116803|559224797|FG000|Overall Study|Adverse Event|2|||
154944895|NCT02116803|559224798|FG001|Overall Study|Adverse Event|1|||
154944896|NCT02116803|559224797|FG000|Overall Study|Physician Decision|1|||
154944897|NCT02116803|559224798|FG001|Overall Study|Physician Decision|0|||
154944898|NCT02116803|559224797|FG000|Overall Study|Progressive disease|4|||
154944899|NCT02116803|559224798|FG001|Overall Study|Progressive disease|0|||
154944900|NCT02116803|559224797|FG000|Overall Study|Study terminated by sponsor|2|||
154944901|NCT02116803|559224798|FG001|Overall Study|Study terminated by sponsor|1|||
154944902|NCT02116803|559224797|FG000|Overall Study|Death|1|||
154944903|NCT02116803|559224798|FG001|Overall Study|Death|0|||
154944904|NCT03213210|559224799|FG000|Overall Study|Lost to Follow-up|2|||
154944905|NCT03213210|559224799|FG000|Overall Study|Study termination|3|||
154944906|NCT02540356|559224800|FG000|Overall Study|Terminated due to disease progression|1|||
154944907|NCT02540356|559224801|FG001|Overall Study|Terminated due to disease progression|0|||
154944908|NCT00684671|559224802|FG000|Overall Study|Adverse Event|1|||
154944909|NCT00684671|559224803|FG001|Overall Study|Adverse Event|0|||
154944910|NCT00684671|559224804|FG002|Overall Study|Adverse Event|0|||
154944911|NCT00684671|559224802|FG000|Overall Study|Lost to Follow-up|1|||
154944912|NCT00684671|559224803|FG001|Overall Study|Lost to Follow-up|0|||
154944913|NCT00684671|559224804|FG002|Overall Study|Lost to Follow-up|0|||
154944914|NCT00684671|559224802|FG000|Overall Study|Alcoholic dependance|1|||
154944915|NCT00684671|559224803|FG001|Overall Study|Alcoholic dependance|0|||
154944916|NCT00684671|559224804|FG002|Overall Study|Alcoholic dependance|0|||
154944917|NCT00481247|559224807|FG000|Overall Study|Death|0|||
154944918|NCT00481247|559224808|FG001|Overall Study|Death|1|||
154944919|NCT00481247|559224807|FG000|Overall Study|Disease progression|18|||
154944920|NCT00481247|559224808|FG001|Overall Study|Disease progression|22|||
154944921|NCT00481247|559224807|FG000|Overall Study|Intolerance|42|||
154944922|NCT00481247|559224808|FG001|Overall Study|Intolerance|17|||
154944923|NCT00481247|559224807|FG000|Overall Study|Treatment failure|10|||
154944924|NCT00481247|559224808|FG001|Overall Study|Treatment failure|14|||
154944925|NCT00481247|559224807|FG000|Overall Study|AE unrelated to study drug|13|||
154944926|NCT00481247|559224808|FG001|Overall Study|AE unrelated to study drug|4|||
154944927|NCT00481247|559224807|FG000|Overall Study|Withdrawal by Subject|8|||
154944928|NCT00481247|559224808|FG001|Overall Study|Withdrawal by Subject|13|||
154944929|NCT00481247|559224807|FG000|Overall Study|Pregnancy|2|||
154944930|NCT00481247|559224808|FG001|Overall Study|Pregnancy|1|||
154944931|NCT00481247|559224807|FG000|Overall Study|Lost to Follow-up|1|||
154944932|NCT00481247|559224808|FG001|Overall Study|Lost to Follow-up|2|||
154944933|NCT00481247|559224807|FG000|Overall Study|Poor compliance/noncompliance|1|||
154944934|NCT00481247|559224808|FG001|Overall Study|Poor compliance/noncompliance|7|||
154944935|NCT00481247|559224807|FG000|Overall Study|Administrative reason by sponsor|157|||
154944936|NCT00481247|559224808|FG001|Overall Study|Administrative reason by sponsor|162|||
154944937|NCT00481247|559224807|FG000|Overall Study|Varied|6|||
154944938|NCT00481247|559224808|FG001|Overall Study|Varied|15|||
154944939|NCT00481247|559224807|FG000|Overall Study|Did not receive treatment|1|||
154944940|NCT00481247|559224808|FG001|Overall Study|Did not receive treatment|2|||
155046355|NCT02959918|559601176|FG004|Overall Study|Protocol Violation|0|||
155046356|NCT02959918|559601177|FG005|Overall Study|Protocol Violation|1|||
154944941|NCT02649231|559224811|FG000|Overall Study|Adverse Event|0|||
154944942|NCT02649231|559224812|FG001|Overall Study|Adverse Event|0|||
154944943|NCT02649231|559224813|FG002|Overall Study|Adverse Event|0|||
154944944|NCT02649231|559224814|FG003|Overall Study|Adverse Event|1|||
154944945|NCT02649231|559224811|FG000|Overall Study|Lost to Follow-up|2|||
154944946|NCT02649231|559224812|FG001|Overall Study|Lost to Follow-up|1|||
154944947|NCT02649231|559224813|FG002|Overall Study|Lost to Follow-up|1|||
154944948|NCT02649231|559224814|FG003|Overall Study|Lost to Follow-up|0|||
154944949|NCT02649231|559224811|FG000|Overall Study|Withdrawal by Subject|0|||
154944950|NCT02649231|559224812|FG001|Overall Study|Withdrawal by Subject|1|||
154944951|NCT02649231|559224813|FG002|Overall Study|Withdrawal by Subject|0|||
154944952|NCT02649231|559224814|FG003|Overall Study|Withdrawal by Subject|1|||
154944953|NCT02649231|559224811|FG000|Overall Study|Protocol Violation|2|||
154944954|NCT02649231|559224812|FG001|Overall Study|Protocol Violation|1|||
154944955|NCT02649231|559224813|FG002|Overall Study|Protocol Violation|1|||
154944956|NCT02649231|559224814|FG003|Overall Study|Protocol Violation|0|||
154944957|NCT02970669|559224815|FG000|Double-blind Period|Adverse Event|4|||
155387904|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
155387905|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
155387906|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
155387907|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
155387908|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
155387909|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
155387910|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
155387911|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
155387912|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
155387913|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
155387914|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
154944958|NCT02970669|559224816|FG001|Double-blind Period|Adverse Event|0|||
154944959|NCT02970669|559224815|FG000|Double-blind Period|Death|1|||
154944960|NCT02970669|559224816|FG001|Double-blind Period|Death|0|||
154944961|NCT02970669|559224815|FG000|Double-blind Period|Study terminated by sponsor|1|||
154944962|NCT02970669|559224816|FG001|Double-blind Period|Study terminated by sponsor|2|||
154944963|NCT02970669|559224815|FG000|Double-blind Period|Physician Decision|0|||
154944964|NCT02970669|559224816|FG001|Double-blind Period|Physician Decision|2|||
154944965|NCT02970669|559224815|FG000|Double-blind Period|Withdrawal by Subject|2|||
154944966|NCT02970669|559224816|FG001|Double-blind Period|Withdrawal by Subject|2|||
154944967|NCT02970669|559224815|FG000|Open-label Period|Withdrawal by Subject|2|||
154944968|NCT02970669|559224816|FG001|Open-label Period|Withdrawal by Subject|2|||
154944969|NCT02970669|559224815|FG000|Open-label Period|Adverse Event|1|||
154944970|NCT02970669|559224816|FG001|Open-label Period|Adverse Event|0|||
154944971|NCT02970669|559224815|FG000|Open-label Period|Physician Decision|1|||
154944972|NCT02970669|559224816|FG001|Open-label Period|Physician Decision|0|||
154944973|NCT02611752|559224819|FG000|Overall Study|Adverse Event|0|||
154944974|NCT02611752|559224820|FG001|Overall Study|Adverse Event|1|||
154944975|NCT01214330|559224821|FG000|Overall Study|Withdrawal by Subject|2|||
154944976|NCT01214330|559224821|FG000|Overall Study|Withdrawal by Subject|2|||
154944977|NCT00249821|559224822|FG000|Overall Study|Technical problem|0|||
154944978|NCT00249821|559224823|FG001|Overall Study|Technical problem|1|||
154944979|NCT01411995|559224824|FG000|Overall Study|Failed IUD insertion|0|||
154944980|NCT01411995|559224825|FG001|Overall Study|Failed IUD insertion|1|||
154944981|NCT01185288|559224827|FG000|Overall Study|Adverse Event|7|||
154944982|NCT01185288|559224828|FG001|Overall Study|Adverse Event|6|||
154944983|NCT01185288|559224827|FG000|Overall Study|Withdrawal by Subject|6|||
154944984|NCT01185288|559224828|FG001|Overall Study|Withdrawal by Subject|4|||
154944985|NCT01185288|559224827|FG000|Overall Study|Lost to Follow-up|2|||
154944986|NCT01185288|559224828|FG001|Overall Study|Lost to Follow-up|5|||
154944987|NCT01185288|559224827|FG000|Overall Study|Lack of Efficacy|2|||
154944988|NCT01185288|559224828|FG001|Overall Study|Lack of Efficacy|0|||
154944989|NCT01185288|559224827|FG000|Overall Study|Investigator discretion|1|||
154944990|NCT01185288|559224828|FG001|Overall Study|Investigator discretion|0|||
154944991|NCT01185288|559224827|FG000|Overall Study|Did not meet inclusion criteria|1|||
154944992|NCT01185288|559224828|FG001|Overall Study|Did not meet inclusion criteria|0|||
154944993|NCT01185288|559224827|FG000|Overall Study|Noncompliance|0|||
154944994|NCT01185288|559224828|FG001|Overall Study|Noncompliance|1|||
154944995|NCT00278512|559224829|FG000|Overall Study|Death|1|||
154944996|NCT00278512|559224830|FG001|Overall Study|Death|0|||
154944997|NCT01626859|559224831|FG000|Overall Study|Adverse Event|1|||
154944998|NCT01626859|559224832|FG001|Overall Study|Adverse Event|3|||
154944999|NCT01626859|559224833|FG002|Overall Study|Adverse Event|2|||
154945000|NCT01626859|559224831|FG000|Overall Study|Physician Decision|0|||
154945001|NCT01626859|559224832|FG001|Overall Study|Physician Decision|1|||
154945002|NCT01626859|559224833|FG002|Overall Study|Physician Decision|0|||
154945003|NCT01626859|559224831|FG000|Overall Study|Withdrawal by Subject|1|||
154945004|NCT01626859|559224832|FG001|Overall Study|Withdrawal by Subject|4|||
154945005|NCT01626859|559224833|FG002|Overall Study|Withdrawal by Subject|2|||
154945006|NCT01620177|559224834|FG000|Overall Study|Failure at Screening Visit|43|||
154945007|NCT01620177|559224834|FG000|Overall Study|Withdrawal by Subject|26|||
154945008|NCT01620177|559224834|FG000|Overall Study|Lost to Follow-up|7|||
154945009|NCT01620177|559224834|FG000|Overall Study|Physician Decision|2|||
154945010|NCT01620177|559224834|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
154945011|NCT00814320|559224839|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
154945012|NCT00814320|559224840|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
154945013|NCT00814320|559224839|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
154945014|NCT00814320|559224840|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
154945015|NCT00814320|559224839|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
154945016|NCT00814320|559224840|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
154945017|NCT00814320|559224839|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
154945018|NCT00814320|559224840|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
154945019|NCT00814320|559224839|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
154945020|NCT00814320|559224840|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
154945021|NCT00814320|559224839|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
154945022|NCT00814320|559224840|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
154945023|NCT00814320|559224839|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
154945024|NCT00814320|559224840|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
154945025|NCT00814320|559224839|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
154945026|NCT00814320|559224840|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
154945027|NCT00814320|559224839|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
154945028|NCT00814320|559224840|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
154945029|NCT00814320|559224839|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
154945030|NCT00814320|559224840|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
154945031|NCT00491504|559224841|FG000|Overall Study|Adverse Event|0|||
154945032|NCT00491504|559224842|FG001|Overall Study|Adverse Event|1|||
154945033|NCT00491504|559224843|FG002|Overall Study|Adverse Event|0|||
154945034|NCT00491504|559224844|FG003|Overall Study|Adverse Event|0|||
154945035|NCT00491504|559224841|FG000|Overall Study|Withdrawal by Subject|0|||
154945036|NCT00491504|559224842|FG001|Overall Study|Withdrawal by Subject|0|||
154945037|NCT00491504|559224843|FG002|Overall Study|Withdrawal by Subject|1|||
154945038|NCT00491504|559224844|FG003|Overall Study|Withdrawal by Subject|2|||
154945039|NCT00491504|559224841|FG000|Overall Study|Protocol Violation|0|||
154945040|NCT00491504|559224842|FG001|Overall Study|Protocol Violation|0|||
154945041|NCT00491504|559224843|FG002|Overall Study|Protocol Violation|3|||
154945042|NCT00491504|559224844|FG003|Overall Study|Protocol Violation|2|||
154945043|NCT00656019|559224847|FG000|Overall Study|Not Eligible|10|||
154945044|NCT00656019|559224848|FG001|Overall Study|Not Eligible|0|||
154945045|NCT00656019|559224849|FG002|Overall Study|Not Eligible|0|||
154945046|NCT00656019|559224850|FG003|Overall Study|Not Eligible|0|||
154945047|NCT00656019|559224847|FG000|Overall Study|Withdrawal by Subject|2|||
154945048|NCT00656019|559224848|FG001|Overall Study|Withdrawal by Subject|0|||
154945049|NCT00656019|559224849|FG002|Overall Study|Withdrawal by Subject|0|||
154945050|NCT00656019|559224850|FG003|Overall Study|Withdrawal by Subject|0|||
154945051|NCT00656019|559224847|FG000|Overall Study|Lost to Follow-up|2|||
154945052|NCT00656019|559224848|FG001|Overall Study|Lost to Follow-up|1|||
154945053|NCT00656019|559224849|FG002|Overall Study|Lost to Follow-up|0|||
154945054|NCT00656019|559224850|FG003|Overall Study|Lost to Follow-up|0|||
154945055|NCT02789111|559224859|FG000|Overall Study|Withdrawal by Subject|1|||
154945056|NCT02789111|559224860|FG001|Overall Study|Withdrawal by Subject|4|||
154945057|NCT03271528|559224861|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
154945058|NCT03271528|559224862|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
154945059|NCT03271528|559224861|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
154945060|NCT03271528|559224862|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
154945061|NCT03271528|559224861|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
154945062|NCT03271528|559224862|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
154945063|NCT03271528|559224861|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
154945064|NCT03271528|559224862|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
154945065|NCT03271528|559224861|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
154945066|NCT03271528|559224862|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
154945067|NCT03271528|559224861|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
154945068|NCT03271528|559224862|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
154945069|NCT03271528|559224861|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
154945070|NCT03271528|559224862|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
154945071|NCT01618305|559224865|FG000|Overall Study|Death|0|||
154945072|NCT01618305|559224866|FG001|Overall Study|Death|1|||
154945073|NCT01618305|559224865|FG000|Overall Study|Lost to Follow-up|11|||
154945074|NCT01618305|559224866|FG001|Overall Study|Lost to Follow-up|7|||
154945075|NCT01618305|559224865|FG000|Overall Study|Protocol Violation|1|||
154945076|NCT01618305|559224866|FG001|Overall Study|Protocol Violation|0|||
154945077|NCT01618305|559224865|FG000|Overall Study|Withdrawal by Subject|3|||
154945078|NCT01618305|559224866|FG001|Overall Study|Withdrawal by Subject|2|||
155281082|NCT04955626|560459883|FG016|Open-Label Period|Other|0|||
154945079|NCT01960816|559224867|FG000|Overall Study|Lost to Follow-up|1|||
154945080|NCT01736553|559224886|FG000|Overall Study|Death|12|||
154945081|NCT01736553|559224887|FG001|Overall Study|Death|0|||
154945082|NCT01736553|559224886|FG000|Overall Study|Withdrawal by Subject|5|||
154945083|NCT01736553|559224887|FG001|Overall Study|Withdrawal by Subject|2|||
154945084|NCT01736553|559224886|FG000|Overall Study|Lost to Follow-up|2|||
154945085|NCT01736553|559224887|FG001|Overall Study|Lost to Follow-up|2|||
154945086|NCT01896297|559224890|FG000|Overall Study|Died in post treatment phase|1|||
154945087|NCT00003782|559224891|FG000|Overall Study|No follow up data|30|||
154945088|NCT00003782|559224892|FG001|Overall Study|No follow up data|31|||
155387915|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
155387916|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
155387917|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
155387918|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
155387919|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
155387920|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
155387921|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
155387922|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
155387923|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
155387924|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
155387925|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
155387926|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
154945089|NCT00003782|559224893|FG002|Overall Study|No follow up data|26|||
154945090|NCT00929708|559224895|FG000|Overall Study|Protocol Violation|2|||
154945091|NCT00929708|559224896|FG001|Overall Study|Protocol Violation|1|||
154945092|NCT00929708|559224897|FG002|Overall Study|Protocol Violation|1|||
154945093|NCT00929708|559224898|FG003|Overall Study|Protocol Violation|1|||
154945094|NCT00929708|559224899|FG004|Overall Study|Protocol Violation|1|||
154945095|NCT00929708|559224895|FG000|Overall Study|Withdrawal by Subject|2|||
154945096|NCT00929708|559224896|FG001|Overall Study|Withdrawal by Subject|0|||
154945097|NCT00929708|559224897|FG002|Overall Study|Withdrawal by Subject|0|||
154945098|NCT00929708|559224898|FG003|Overall Study|Withdrawal by Subject|2|||
154945099|NCT00929708|559224899|FG004|Overall Study|Withdrawal by Subject|1|||
154945100|NCT00929708|559224895|FG000|Overall Study|Adverse Event|0|||
154945101|NCT00929708|559224896|FG001|Overall Study|Adverse Event|0|||
154945102|NCT00929708|559224897|FG002|Overall Study|Adverse Event|0|||
154945103|NCT00929708|559224898|FG003|Overall Study|Adverse Event|0|||
154945104|NCT00929708|559224899|FG004|Overall Study|Adverse Event|3|||
154945105|NCT00929708|559224895|FG000|Overall Study|Physician Decision|0|||
154945106|NCT00929708|559224896|FG001|Overall Study|Physician Decision|2|||
154945107|NCT00929708|559224897|FG002|Overall Study|Physician Decision|2|||
154945108|NCT00929708|559224898|FG003|Overall Study|Physician Decision|2|||
154945109|NCT00929708|559224899|FG004|Overall Study|Physician Decision|1|||
154945110|NCT00929708|559224895|FG000|Overall Study|Lost to Follow-up|0|||
154945111|NCT00929708|559224896|FG001|Overall Study|Lost to Follow-up|0|||
154945112|NCT00929708|559224897|FG002|Overall Study|Lost to Follow-up|0|||
154945113|NCT00929708|559224898|FG003|Overall Study|Lost to Follow-up|1|||
154945114|NCT00929708|559224899|FG004|Overall Study|Lost to Follow-up|0|||
154945115|NCT02154529|559224900|FG000|Overall Study|Death|1|||
154945116|NCT02154529|559224901|FG001|Overall Study|Death|1|||
154945117|NCT02154529|559224902|FG002|Overall Study|Death|5|||
154945118|NCT02154529|559224903|FG003|Overall Study|Death|1|||
154945119|NCT02154529|559224900|FG000|Overall Study|Termination of study by sponsor|2|||
154945120|NCT02154529|559224901|FG001|Overall Study|Termination of study by sponsor|2|||
154945121|NCT02154529|559224902|FG002|Overall Study|Termination of study by sponsor|3|||
154945122|NCT02154529|559224903|FG003|Overall Study|Termination of study by sponsor|1|||
154945123|NCT02154529|559224900|FG000|Overall Study|Lost to Follow-up|1|||
154945124|NCT02154529|559224901|FG001|Overall Study|Lost to Follow-up|0|||
154945125|NCT02154529|559224902|FG002|Overall Study|Lost to Follow-up|0|||
154945126|NCT02154529|559224903|FG003|Overall Study|Lost to Follow-up|0|||
154945127|NCT00101582|559226908|FG000|Overall Study|Ineligibility determined|0|||
154945128|NCT00101582|559226909|FG001|Overall Study|Ineligibility determined|1|||
154945129|NCT00101582|559226908|FG000|Overall Study|Adverse Event|1|||
154945130|NCT00101582|559226909|FG001|Overall Study|Adverse Event|4|||
154945131|NCT00101582|559226908|FG000|Overall Study|Withdrawal by Subject|6|||
154945132|NCT00101582|559226909|FG001|Overall Study|Withdrawal by Subject|4|||
154945133|NCT00101582|559226908|FG000|Overall Study|Physician Decision|1|||
154945134|NCT00101582|559226909|FG001|Overall Study|Physician Decision|0|||
154945135|NCT00101582|559226908|FG000|Overall Study|Death|3|||
155387927|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
155387928|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
155387929|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
155387930|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Other|10|||
155387931|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Other|7|||
155387932|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Other|8|||
154945136|NCT00101582|559226909|FG001|Overall Study|Death|5|||
154945137|NCT00101582|559226908|FG000|Overall Study|Other|0|||
154945138|NCT00101582|559226909|FG001|Overall Study|Other|1|||
154945139|NCT01907087|559226910|FG000|Overall Study|Withdrawal by Subject|1|||
154945140|NCT01919190|559226912|FG000|Overall Study|Intra-op findings, etc.|3|||
154945141|NCT01919190|559226913|FG001|Overall Study|Intra-op findings, etc.|0|||
154945142|NCT02146430|559226914|FG000|Overall Study|Protocol Violation|5|||
154945143|NCT02146430|559226915|FG001|Overall Study|Protocol Violation|4|||
154945144|NCT02146430|559226916|FG002|Overall Study|Protocol Violation|8|||
154945145|NCT02146430|559226917|FG003|Overall Study|Protocol Violation|6|||
154945146|NCT02146430|559226914|FG000|Overall Study|Lack of Efficacy|13|||
154945147|NCT02146430|559226915|FG001|Overall Study|Lack of Efficacy|11|||
155046357|NCT02959918|559601178|FG006|Overall Study|Protocol Violation|0|||
155046358|NCT02959918|559601179|FG007|Overall Study|Protocol Violation|0|||
155046359|NCT02959918|559601180|FG008|Overall Study|Protocol Violation|2|||
155046360|NCT02959918|559601181|FG009|Overall Study|Protocol Violation|1|||
155046361|NCT02959918|559601182|FG010|Overall Study|Protocol Violation|0|||
155046362|NCT02959918|559601183|FG011|Overall Study|Protocol Violation|1|||
155046363|NCT02959918|559601184|FG012|Overall Study|Protocol Violation|1|||
155046364|NCT02959918|559601185|FG013|Overall Study|Protocol Violation|0|||
155046365|NCT02959918|559601172|FG000|Overall Study|Stopping Rule Met|1|||
155046366|NCT02959918|559601173|FG001|Overall Study|Stopping Rule Met|0|||
155046367|NCT02959918|559601174|FG002|Overall Study|Stopping Rule Met|3|||
155046368|NCT02959918|559601175|FG003|Overall Study|Stopping Rule Met|4|||
155046369|NCT02959918|559601176|FG004|Overall Study|Stopping Rule Met|5|||
155046370|NCT02959918|559601177|FG005|Overall Study|Stopping Rule Met|3|||
155046371|NCT02959918|559601178|FG006|Overall Study|Stopping Rule Met|2|||
155046372|NCT02959918|559601179|FG007|Overall Study|Stopping Rule Met|4|||
155046373|NCT02959918|559601180|FG008|Overall Study|Stopping Rule Met|1|||
155046374|NCT02959918|559601181|FG009|Overall Study|Stopping Rule Met|1|||
155046375|NCT02959918|559601182|FG010|Overall Study|Stopping Rule Met|3|||
155046376|NCT02959918|559601183|FG011|Overall Study|Stopping Rule Met|5|||
155046377|NCT02959918|559601184|FG012|Overall Study|Stopping Rule Met|2|||
155046378|NCT02959918|559601185|FG013|Overall Study|Stopping Rule Met|1|||
155046379|NCT02959918|559601172|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
155046380|NCT02959918|559601173|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
155046381|NCT02959918|559601174|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
155046382|NCT02959918|559601175|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
155046383|NCT02959918|559601176|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046384|NCT02959918|559601177|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046385|NCT02959918|559601178|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046386|NCT02959918|559601179|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046387|NCT02959918|559601180|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046388|NCT02959918|559601181|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046389|NCT02959918|559601182|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046390|NCT02959918|559601183|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046391|NCT02959918|559601184|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046392|NCT02959918|559601185|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
155046393|NCT02959918|559601172|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046394|NCT02959918|559601173|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046395|NCT02959918|559601174|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046396|NCT02959918|559601175|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046397|NCT02959918|559601176|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046398|NCT02959918|559601177|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046399|NCT02959918|559601178|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046400|NCT02959918|559601179|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
155046401|NCT02959918|559601180|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046402|NCT02959918|559601181|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046403|NCT02959918|559601182|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046404|NCT02959918|559601183|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046405|NCT02959918|559601184|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046406|NCT02959918|559601185|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
155046407|NCT02959918|559601172|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046408|NCT02959918|559601173|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046409|NCT02959918|559601174|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046410|NCT02959918|559601175|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046411|NCT02959918|559601176|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046412|NCT02959918|559601177|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046413|NCT02959918|559601178|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046414|NCT02959918|559601179|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046415|NCT02959918|559601180|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
155046416|NCT02959918|559601181|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046417|NCT02959918|559601182|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046418|NCT02959918|559601183|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155281083|NCT04955626|560459884|FG017|Open-Label Period|Other|0|||
155046419|NCT02959918|559601184|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046420|NCT02959918|559601185|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
155046421|NCT02959918|559601172|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046422|NCT02959918|559601173|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046423|NCT02959918|559601174|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046424|NCT02959918|559601175|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046425|NCT02959918|559601176|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046426|NCT02959918|559601177|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046427|NCT02959918|559601178|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046428|NCT02959918|559601179|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046429|NCT02959918|559601180|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046430|NCT02959918|559601181|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
155046431|NCT02959918|559601182|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046432|NCT02959918|559601183|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046433|NCT02959918|559601184|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046434|NCT02959918|559601185|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
155046435|NCT00837967|559601186|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
155046436|NCT00837967|559601187|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
155046437|NCT02504320|559601188|FG000|Treatment Period 1|Positive Drug Screen|0|||
155046438|NCT02504320|559601189|FG001|Treatment Period 1|Positive Drug Screen|0|||
155046439|NCT02504320|559601190|FG002|Treatment Period 1|Positive Drug Screen|1|||
155046440|NCT02504320|559601191|FG003|Treatment Period 1|Positive Drug Screen|0|||
155046441|NCT02504320|559601188|FG000|Treatment Period 2|Positive Drug Screen|0|||
155046442|NCT02504320|559601189|FG001|Treatment Period 2|Positive Drug Screen|1|||
155046443|NCT02504320|559601190|FG002|Treatment Period 2|Positive Drug Screen|0|||
155046444|NCT02504320|559601191|FG003|Treatment Period 2|Positive Drug Screen|0|||
155046445|NCT02504320|559601188|FG000|Treatment Period 3|Positive Drug Screen|0|||
155046446|NCT02504320|559601189|FG001|Treatment Period 3|Positive Drug Screen|0|||
155046447|NCT02504320|559601190|FG002|Treatment Period 3|Positive Drug Screen|0|||
155046448|NCT02504320|559601191|FG003|Treatment Period 3|Positive Drug Screen|1|||
155046449|NCT02504320|559601188|FG000|Treatment Period 3|Adverse Event|0|||
155046450|NCT02504320|559601189|FG001|Treatment Period 3|Adverse Event|0|||
155046451|NCT02504320|559601190|FG002|Treatment Period 3|Adverse Event|1|||
155046452|NCT02504320|559601191|FG003|Treatment Period 3|Adverse Event|0|||
155046453|NCT00941304|559601192|FG000|Overall Study|Lost to Follow-up|1|||
155046454|NCT00941304|559601193|FG001|Overall Study|Lost to Follow-up|0|||
155046455|NCT00941304|559601194|FG002|Overall Study|Lost to Follow-up|0|||
155046456|NCT00941304|559601195|FG003|Overall Study|Lost to Follow-up|0|||
155046457|NCT00941304|559601196|FG004|Overall Study|Lost to Follow-up|0|||
155046458|NCT01408901|559601197|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
155046459|NCT01408901|559601198|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
155046460|NCT01408901|559601199|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
155046461|NCT01408901|559601200|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
155046462|NCT01408901|559601197|FG000|6-Week Follow-Up|Death|1|||
155046463|NCT01408901|559601198|FG001|6-Week Follow-Up|Death|0|||
155046464|NCT01408901|559601199|FG002|6-Week Follow-Up|Death|0|||
155046465|NCT01408901|559601200|FG003|6-Week Follow-Up|Death|0|||
155046466|NCT01408901|559601197|FG000|6-Week Follow-Up|Cancelled visit|0|||
155046467|NCT01408901|559601198|FG001|6-Week Follow-Up|Cancelled visit|1|||
155046468|NCT01408901|559601199|FG002|6-Week Follow-Up|Cancelled visit|0|||
155046469|NCT01408901|559601200|FG003|6-Week Follow-Up|Cancelled visit|2|||
155046470|NCT01408901|559601197|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
155046471|NCT01408901|559601198|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
155046472|NCT01408901|559601199|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
155046473|NCT01408901|559601200|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
155046474|NCT01408901|559601197|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
155046475|NCT01408901|559601198|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
155046476|NCT01408901|559601199|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
155046477|NCT01408901|559601200|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
155046478|NCT01408901|559601197|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
155046479|NCT01408901|559601198|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
155046480|NCT01408901|559601199|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
155046481|NCT01408901|559601200|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
155046482|NCT01408901|559601197|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
155046483|NCT01408901|559601198|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
155046484|NCT01408901|559601199|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
155046485|NCT01408901|559601200|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
155046486|NCT01408901|559601197|FG000|26-Week Follow-Up|Death|0|||
155046487|NCT01408901|559601198|FG001|26-Week Follow-Up|Death|1|||
155046488|NCT01408901|559601199|FG002|26-Week Follow-Up|Death|0|||
155046489|NCT01408901|559601200|FG003|26-Week Follow-Up|Death|0|||
155046490|NCT01436227|559601204|FG000|Overall Study|Adverse Event|7|||
155046491|NCT01436227|559601204|FG000|Overall Study|Death|1|||
155046492|NCT01436227|559601204|FG000|Overall Study|Lack of Efficacy|1|||
155046493|NCT01436227|559601204|FG000|Overall Study|Lost to Follow-up|3|||
155046494|NCT01436227|559601204|FG000|Overall Study|Physician Decision|1|||
155046495|NCT01436227|559601204|FG000|Overall Study|Withdrawal by Subject|7|||
155046496|NCT01436227|559601204|FG000|Overall Study|Disease progression, relapse|6|||
154945148|NCT02146430|559226916|FG002|Overall Study|Lack of Efficacy|8|||
154945149|NCT02146430|559226917|FG003|Overall Study|Lack of Efficacy|5|||
154945150|NCT02146430|559226914|FG000|Overall Study|Adverse Event|20|||
154945151|NCT02146430|559226915|FG001|Overall Study|Adverse Event|40|||
154945152|NCT02146430|559226916|FG002|Overall Study|Adverse Event|32|||
154945153|NCT02146430|559226917|FG003|Overall Study|Adverse Event|49|||
154945154|NCT02146430|559226914|FG000|Overall Study|Reason missing or not reported|2|||
154945155|NCT02146430|559226915|FG001|Overall Study|Reason missing or not reported|3|||
154945156|NCT02146430|559226916|FG002|Overall Study|Reason missing or not reported|4|||
154945157|NCT02146430|559226917|FG003|Overall Study|Reason missing or not reported|5|||
154945158|NCT02146430|559226914|FG000|Overall Study|Withdrawal by Subject|27|||
154945159|NCT02146430|559226915|FG001|Overall Study|Withdrawal by Subject|29|||
154945160|NCT02146430|559226916|FG002|Overall Study|Withdrawal by Subject|30|||
154945161|NCT02146430|559226917|FG003|Overall Study|Withdrawal by Subject|34|||
154945162|NCT03312530|559226918|FG000|Overall Study|Death|5|||
154945163|NCT03312530|559226919|FG001|Overall Study|Death|5|||
154945164|NCT03312530|559226920|FG002|Overall Study|Death|4|||
154945165|NCT03312530|559226921|FG003|Overall Study|Death|10|||
154945166|NCT03312530|559226922|FG004|Overall Study|Death|8|||
154945167|NCT03312530|559226918|FG000|Overall Study|Lost to Follow-up|0|||
154945168|NCT03312530|559226919|FG001|Overall Study|Lost to Follow-up|0|||
154945169|NCT03312530|559226920|FG002|Overall Study|Lost to Follow-up|0|||
154945170|NCT03312530|559226921|FG003|Overall Study|Lost to Follow-up|1|||
154945171|NCT03312530|559226922|FG004|Overall Study|Lost to Follow-up|0|||
154945172|NCT03312530|559226918|FG000|Overall Study|Participant in another sponsor study.|0|||
154945173|NCT03312530|559226919|FG001|Overall Study|Participant in another sponsor study.|0|||
154945174|NCT03312530|559226920|FG002|Overall Study|Participant in another sponsor study.|0|||
154945175|NCT03312530|559226921|FG003|Overall Study|Participant in another sponsor study.|1|||
154945176|NCT03312530|559226922|FG004|Overall Study|Participant in another sponsor study.|0|||
154945177|NCT03312530|559226918|FG000|Overall Study|Study terminated by sponsor|1|||
154945178|NCT03312530|559226919|FG001|Overall Study|Study terminated by sponsor|0|||
154945179|NCT03312530|559226920|FG002|Overall Study|Study terminated by sponsor|2|||
154945180|NCT03312530|559226921|FG003|Overall Study|Study terminated by sponsor|3|||
154945181|NCT03312530|559226922|FG004|Overall Study|Study terminated by sponsor|7|||
154945182|NCT03312530|559226918|FG000|Overall Study|Withdrawal by Subject|0|||
154945183|NCT03312530|559226919|FG001|Overall Study|Withdrawal by Subject|1|||
154945184|NCT03312530|559226920|FG002|Overall Study|Withdrawal by Subject|0|||
154945185|NCT03312530|559226921|FG003|Overall Study|Withdrawal by Subject|0|||
154945186|NCT03312530|559226922|FG004|Overall Study|Withdrawal by Subject|0|||
154945187|NCT03312530|559226918|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
154945188|NCT03312530|559226919|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
154945189|NCT03312530|559226920|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
154945190|NCT03312530|559226921|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
154945191|NCT03312530|559226922|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
154945192|NCT03093324|559226923|FG000|Overall Study|Adverse Event|4|||
154945193|NCT03093324|559226924|FG001|Overall Study|Adverse Event|15|||
154945194|NCT03093324|559226923|FG000|Overall Study|Lost to Follow-up|1|||
154945195|NCT03093324|559226924|FG001|Overall Study|Lost to Follow-up|0|||
154945196|NCT03093324|559226923|FG000|Overall Study|Protocol Deviation|2|||
154945197|NCT03093324|559226924|FG001|Overall Study|Protocol Deviation|2|||
154945198|NCT03093324|559226923|FG000|Overall Study|Withdrawal by Subject|2|||
154945199|NCT03093324|559226924|FG001|Overall Study|Withdrawal by Subject|2|||
154945200|NCT04583579|559226926|FG000|Overall Study|Lost to Follow-up|4|||
154945201|NCT04700449|559226929|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
154945202|NCT04700449|559226930|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
154945203|NCT04700449|559226931|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
154945204|NCT04700449|559226932|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
154945205|NCT04700449|559226929|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
154945206|NCT04700449|559226930|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
154945207|NCT04700449|559226931|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
154945208|NCT04700449|559226932|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
154945209|NCT04700449|559226929|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
154945210|NCT04700449|559226930|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
154945211|NCT04700449|559226931|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
154945212|NCT04700449|559226932|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
154945213|NCT04700449|559226929|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
155281084|NCT04955626|560459885|FG018|Open-Label Period|Other|0|||
155281085|NCT04955626|560459886|FG019|Open-Label Period|Other|0|||
155281086|NCT04955626|560459887|FG020|Open-Label Period|Other|0|||
155281087|NCT04955626|560459888|FG021|Open-Label Period|Other|0|||
155281088|NCT04955626|560459889|FG022|Open-Label Period|Other|0|||
155281089|NCT04955626|560459890|FG023|Open-Label Period|Other|0|||
154945214|NCT04700449|559226930|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
154945215|NCT04700449|559226931|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
154945216|NCT04700449|559226932|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
154945217|NCT04700449|559226929|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
154945218|NCT04700449|559226930|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
154945219|NCT04700449|559226931|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
154945220|NCT04700449|559226932|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
154945221|NCT04700449|559226929|FG000|Stage 1: Double-Blind Period|Other|0|||
154945222|NCT04700449|559226930|FG001|Stage 1: Double-Blind Period|Other|0|||
154945223|NCT04700449|559226931|FG002|Stage 1: Double-Blind Period|Other|1|||
154945224|NCT04700449|559226932|FG003|Stage 1: Double-Blind Period|Other|0|||
154945225|NCT04700449|559226929|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
154945226|NCT04700449|559226930|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
154945227|NCT04700449|559226931|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
154945228|NCT04700449|559226932|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
154945229|NCT04700449|559226929|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
154945230|NCT04700449|559226930|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
154945231|NCT04700449|559226931|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
154945232|NCT04700449|559226932|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
154945233|NCT04700449|559226929|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
154945234|NCT04700449|559226930|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
154945235|NCT04700449|559226931|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
154945236|NCT04700449|559226932|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
154945237|NCT04700449|559226929|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
154945238|NCT04700449|559226930|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
154945239|NCT04700449|559226931|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
154945240|NCT04700449|559226932|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
154945241|NCT04700449|559226929|FG000|Stage 2 Sub-study 1|Other|1|||
154945242|NCT04700449|559226930|FG001|Stage 2 Sub-study 1|Other|2|||
154945243|NCT04700449|559226931|FG002|Stage 2 Sub-study 1|Other|0|||
154945244|NCT04700449|559226932|FG003|Stage 2 Sub-study 1|Other|0|||
154945245|NCT04700449|559226929|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
154945246|NCT04700449|559226930|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
154945247|NCT04700449|559226931|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
154945248|NCT04700449|559226932|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
154945249|NCT04700449|559226929|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
154945250|NCT04700449|559226930|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
154945251|NCT04700449|559226931|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
154945252|NCT04700449|559226932|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
154945253|NCT04700449|559226929|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
155046497|NCT04865419|559601205|FG000|Overall Study|Other|1|||
155046498|NCT04865419|559601206|FG001|Overall Study|Other|2|||
155046499|NCT04865419|559601207|FG002|Overall Study|Other|2|||
155046500|NCT04865419|559601208|FG003|Overall Study|Other|1|||
155046501|NCT04865419|559601209|FG004|Overall Study|Other|3|||
155387933|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Other|8|||
155387934|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Other|0|||
155387935|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
155387936|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
155387937|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
155387938|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
155387939|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
155387940|NCT00615836|560854977|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
155387941|NCT00615836|560854978|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387942|NCT00615836|560854979|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387943|NCT00615836|560854980|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387944|NCT00615836|560854981|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
155387945|NCT01630434|560854982|FG000|Overall Study|Donor lungs turned down|1|||
155387946|NCT01630434|560854983|FG001|Overall Study|Donor lungs turned down|0|||
155387947|NCT01630434|560854982|FG000|Overall Study|Protocol Violation|9|||
155387948|NCT01630434|560854983|FG001|Overall Study|Protocol Violation|4|||
155387949|NCT01630434|560854982|FG000|Overall Study|Death|20|||
155046502|NCT04865419|559601210|FG005|Overall Study|Other|0|||
155046503|NCT04865419|559601211|FG006|Overall Study|Other|0|||
154945254|NCT04700449|559226930|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
154945255|NCT04700449|559226931|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
154945256|NCT04700449|559226932|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
154945257|NCT04700449|559226929|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
154945258|NCT04700449|559226930|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
155046504|NCT04865419|559601212|FG007|Overall Study|Other|1|||
154945259|NCT04700449|559226931|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
154945260|NCT04700449|559226932|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
154945261|NCT04700449|559226929|FG000|Stage 2 Sub-study 2|Other|0|||
154945262|NCT04700449|559226930|FG001|Stage 2 Sub-study 2|Other|0|||
155046505|NCT04865419|559601213|FG008|Overall Study|Other|0|||
155387950|NCT01630434|560854983|FG001|Overall Study|Death|26|||
155387951|NCT02121834|560854985|FG000|Overall Study|Protocol Violation|0|||
155387952|NCT02121834|560854986|FG001|Overall Study|Protocol Violation|1|||
155387953|NCT02121834|560854987|FG002|Overall Study|Protocol Violation|0|||
155387954|NCT02121834|560854988|FG003|Overall Study|Protocol Violation|0|||
155387955|NCT02121834|560854989|FG004|Overall Study|Protocol Violation|0|||
155387956|NCT02121834|560854990|FG005|Overall Study|Protocol Violation|0|||
155387957|NCT02121834|560854991|FG006|Overall Study|Protocol Violation|0|||
155387958|NCT02121834|560854985|FG000|Overall Study|Withdrawal by Subject|0|||
155387959|NCT02121834|560854986|FG001|Overall Study|Withdrawal by Subject|1|||
155387960|NCT02121834|560854987|FG002|Overall Study|Withdrawal by Subject|1|||
155387961|NCT02121834|560854988|FG003|Overall Study|Withdrawal by Subject|0|||
155387962|NCT02121834|560854989|FG004|Overall Study|Withdrawal by Subject|0|||
155387963|NCT02121834|560854990|FG005|Overall Study|Withdrawal by Subject|0|||
155387964|NCT02121834|560854991|FG006|Overall Study|Withdrawal by Subject|0|||
155387965|NCT02121834|560854985|FG000|Overall Study|Lost to Follow-up|0|||
155387966|NCT02121834|560854986|FG001|Overall Study|Lost to Follow-up|0|||
155387967|NCT02121834|560854987|FG002|Overall Study|Lost to Follow-up|1|||
155387968|NCT02121834|560854988|FG003|Overall Study|Lost to Follow-up|0|||
155387969|NCT02121834|560854989|FG004|Overall Study|Lost to Follow-up|0|||
155387970|NCT02121834|560854990|FG005|Overall Study|Lost to Follow-up|0|||
155387971|NCT02121834|560854991|FG006|Overall Study|Lost to Follow-up|0|||
155387972|NCT02578862|560854992|FG000|Overall Study|Withdrawal by Subject|0|||
155387973|NCT02578862|560854993|FG001|Overall Study|Withdrawal by Subject|1|||
155387974|NCT02578862|560854992|FG000|Overall Study|Unplanned unilateral procedure|0|||
155387975|NCT02578862|560854993|FG001|Overall Study|Unplanned unilateral procedure|1|||
155387976|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
155387977|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
155387978|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Death|0|||
155387979|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Death|2|||
155387980|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155387981|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
155387982|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
155387983|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
155387984|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
155387985|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
155387986|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
155387987|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
155387988|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
155387989|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
155387990|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
155387991|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
155387992|NCT00343252|560855000|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
155387993|NCT00343252|560855001|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
155387994|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
155387995|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
155387996|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Death|3|||
155387997|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Death|3|||
155387998|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155387999|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155388000|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
155388001|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
155388002|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
155388003|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
155388004|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
155388005|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
155388006|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
155388007|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
155388008|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
155388009|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
155388010|NCT00343252|560855000|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
155388011|NCT00343252|560855001|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
155388012|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
155388013|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
155388014|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Death|4|||
154945263|NCT04700449|559226931|FG002|Stage 2 Sub-study 2|Other|0|||
154945264|NCT04700449|559226932|FG003|Stage 2 Sub-study 2|Other|5|||
155388015|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Death|5|||
154945265|NCT00356200|559226933|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
155388016|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
155388017|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
155046506|NCT04865419|559601214|FG009|Overall Study|Other|0|||
155046507|NCT04865419|559601215|FG010|Overall Study|Other|0|||
155046508|NCT04865419|559601205|FG000|Overall Study|Withdrawal by Subject|0|||
155046509|NCT04865419|559601206|FG001|Overall Study|Withdrawal by Subject|1|||
155046510|NCT04865419|559601207|FG002|Overall Study|Withdrawal by Subject|1|||
155046511|NCT04865419|559601208|FG003|Overall Study|Withdrawal by Subject|0|||
155046512|NCT04865419|559601209|FG004|Overall Study|Withdrawal by Subject|0|||
155046513|NCT04865419|559601210|FG005|Overall Study|Withdrawal by Subject|0|||
155046514|NCT04865419|559601211|FG006|Overall Study|Withdrawal by Subject|0|||
155046515|NCT04865419|559601212|FG007|Overall Study|Withdrawal by Subject|1|||
155046516|NCT04865419|559601213|FG008|Overall Study|Withdrawal by Subject|2|||
155046517|NCT04865419|559601214|FG009|Overall Study|Withdrawal by Subject|1|||
155046518|NCT04865419|559601215|FG010|Overall Study|Withdrawal by Subject|0|||
155046519|NCT04865419|559601205|FG000|Overall Study|Study terminated by Sponsor|0|||
155046520|NCT04865419|559601206|FG001|Overall Study|Study terminated by Sponsor|0|||
155046521|NCT04865419|559601207|FG002|Overall Study|Study terminated by Sponsor|0|||
155046522|NCT04865419|559601208|FG003|Overall Study|Study terminated by Sponsor|2|||
155046523|NCT04865419|559601209|FG004|Overall Study|Study terminated by Sponsor|2|||
154945266|NCT00356200|559226934|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
154945267|NCT00356200|559226933|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
154945268|NCT00356200|559226934|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
154945269|NCT01000337|559226935|FG000|Overall Study|Lost to Follow-up|4|||
154945270|NCT01000337|559226936|FG001|Overall Study|Lost to Follow-up|3|||
154945271|NCT02752776|559226937|FG000|Overall Study|Adverse Event|15|||
154945272|NCT02752776|559226938|FG001|Overall Study|Adverse Event|23|||
154945273|NCT02752776|559226939|FG002|Overall Study|Adverse Event|11|||
154945274|NCT02752776|559226937|FG000|Overall Study|Lack of Efficacy|2|||
154945275|NCT02752776|559226938|FG001|Overall Study|Lack of Efficacy|6|||
154945276|NCT02752776|559226939|FG002|Overall Study|Lack of Efficacy|14|||
154945277|NCT02752776|559226937|FG000|Overall Study|Lost to Follow-up|11|||
154945278|NCT02752776|559226938|FG001|Overall Study|Lost to Follow-up|12|||
154945279|NCT02752776|559226939|FG002|Overall Study|Lost to Follow-up|4|||
154945280|NCT02752776|559226937|FG000|Overall Study|Non-compliance with study treatment|0|||
154945281|NCT02752776|559226938|FG001|Overall Study|Non-compliance with study treatment|0|||
154945282|NCT02752776|559226939|FG002|Overall Study|Non-compliance with study treatment|1|||
154945283|NCT02752776|559226937|FG000|Overall Study|Physician Decision|2|||
154945284|NCT02752776|559226938|FG001|Overall Study|Physician Decision|6|||
154945285|NCT02752776|559226939|FG002|Overall Study|Physician Decision|2|||
154945286|NCT02752776|559226937|FG000|Overall Study|Pregnancy|1|||
154945287|NCT02752776|559226938|FG001|Overall Study|Pregnancy|6|||
154945288|NCT02752776|559226939|FG002|Overall Study|Pregnancy|3|||
154945289|NCT02752776|559226937|FG000|Overall Study|Protocol Violation|10|||
154945290|NCT02752776|559226938|FG001|Overall Study|Protocol Violation|13|||
154945291|NCT02752776|559226939|FG002|Overall Study|Protocol Violation|6|||
154945292|NCT02752776|559226937|FG000|Overall Study|Subject/guardian decision|8|||
154945293|NCT02752776|559226938|FG001|Overall Study|Subject/guardian decision|6|||
154945294|NCT02752776|559226939|FG002|Overall Study|Subject/guardian decision|4|||
154945295|NCT02752776|559226937|FG000|Overall Study|Death|0|||
154945296|NCT02752776|559226938|FG001|Overall Study|Death|0|||
154945297|NCT02752776|559226939|FG002|Overall Study|Death|1|||
154945298|NCT02752776|559226937|FG000|Overall Study|Withdrawal by Subject|3|||
154945299|NCT02752776|559226938|FG001|Overall Study|Withdrawal by Subject|4|||
154945300|NCT02752776|559226939|FG002|Overall Study|Withdrawal by Subject|2|||
154945301|NCT01816477|559226940|FG000|Overall Study|Withdrawal by Subject|13|||
154945302|NCT01816477|559226941|FG001|Overall Study|Withdrawal by Subject|1|||
154945303|NCT01816477|559226940|FG000|Overall Study|Unable to tolerate catheter placement|3|||
154945304|NCT01816477|559226941|FG001|Overall Study|Unable to tolerate catheter placement|0|||
154945305|NCT04471935|559226942|FG000|Overall Study|Withdrawal by Subject|1|||
154945306|NCT04471935|559226942|FG000|Overall Study|Deemed ineligible to participate|1|||
154945307|NCT01399736|559226943|FG000|Overall Study|Withdrawal by Subject|4|||
154945308|NCT01399736|559226944|FG001|Overall Study|Withdrawal by Subject|2|||
154945309|NCT01399736|559226943|FG000|Overall Study|Lost to Follow-up|0|||
154945310|NCT01399736|559226944|FG001|Overall Study|Lost to Follow-up|2|||
155046524|NCT04865419|559601210|FG005|Overall Study|Study terminated by Sponsor|0|||
155388018|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
154945311|NCT03335371|559226945|FG000|Overall Study|Lost to Follow-up|0|||
154945312|NCT03335371|559226946|FG001|Overall Study|Lost to Follow-up|0|||
155046525|NCT04865419|559601211|FG006|Overall Study|Study terminated by Sponsor|0|||
155046526|NCT04865419|559601212|FG007|Overall Study|Study terminated by Sponsor|0|||
155046527|NCT04865419|559601213|FG008|Overall Study|Study terminated by Sponsor|0|||
155046528|NCT04865419|559601214|FG009|Overall Study|Study terminated by Sponsor|0|||
154945313|NCT03335371|559226947|FG002|Overall Study|Lost to Follow-up|0|||
154945314|NCT03335371|559226948|FG003|Overall Study|Lost to Follow-up|0|||
154945315|NCT03335371|559226949|FG004|Overall Study|Lost to Follow-up|1|||
154945316|NCT03335371|559226945|FG000|Overall Study|Withdrawal by Subject|0|||
154945317|NCT03335371|559226946|FG001|Overall Study|Withdrawal by Subject|0|||
154945318|NCT03335371|559226947|FG002|Overall Study|Withdrawal by Subject|0|||
155388019|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
155388020|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
154945319|NCT03335371|559226948|FG003|Overall Study|Withdrawal by Subject|0|||
154945320|NCT03335371|559226949|FG004|Overall Study|Withdrawal by Subject|1|||
154945321|NCT03335371|559226945|FG000|Overall Study|Randomization Error|0|||
154945322|NCT03335371|559226946|FG001|Overall Study|Randomization Error|0|||
154945323|NCT03335371|559226947|FG002|Overall Study|Randomization Error|1|||
154945324|NCT03335371|559226948|FG003|Overall Study|Randomization Error|0|||
154945325|NCT03335371|559226949|FG004|Overall Study|Randomization Error|0|||
154945326|NCT04128007|559226950|FG000|Overall Study|Withdrawal by Subject|9|||
154945327|NCT04128007|559226951|FG001|Overall Study|Withdrawal by Subject|6|||
154945328|NCT04128007|559226950|FG000|Overall Study|Protocol Violation|1|||
154945329|NCT04128007|559226951|FG001|Overall Study|Protocol Violation|0|||
154945330|NCT04128007|559226950|FG000|Overall Study|Lost to Follow-up|8|||
154945331|NCT04128007|559226951|FG001|Overall Study|Lost to Follow-up|7|||
154945332|NCT04128007|559226950|FG000|Overall Study|Adverse Event|5|||
154945333|NCT04128007|559226951|FG001|Overall Study|Adverse Event|2|||
154945334|NCT04128007|559226950|FG000|Overall Study|Not reported|0|||
154945335|NCT04128007|559226951|FG001|Overall Study|Not reported|2|||
154945336|NCT00638157|559226954|FG000|Overall Study|Adverse Event|0|||
154945337|NCT00638157|559226955|FG001|Overall Study|Adverse Event|1|||
154945338|NCT00638157|559226954|FG000|Overall Study|Clinical (symptomatic) failure|1|||
154945339|NCT00638157|559226955|FG001|Overall Study|Clinical (symptomatic) failure|1|||
154945340|NCT00638157|559226954|FG000|Overall Study|Microbiological failure|1|||
154945341|NCT00638157|559226955|FG001|Overall Study|Microbiological failure|0|||
154945342|NCT00638157|559226954|FG000|Overall Study|Lost to Follow-up|1|||
154945343|NCT00638157|559226955|FG001|Overall Study|Lost to Follow-up|0|||
154945344|NCT00638157|559226954|FG000|Overall Study|Physician Decision|1|||
154945345|NCT00638157|559226955|FG001|Overall Study|Physician Decision|0|||
154945346|NCT00638157|559226954|FG000|Overall Study|Other|1|||
154945347|NCT00638157|559226955|FG001|Overall Study|Other|2|||
154945348|NCT00638157|559226954|FG000|Overall Study|Randomized, not treated|2|||
154945349|NCT00638157|559226955|FG001|Overall Study|Randomized, not treated|0|||
154945350|NCT00437281|559226956|FG000|Overall Study|Adverse Event|0|||
154945351|NCT00437281|559226957|FG001|Overall Study|Adverse Event|0|||
154945352|NCT00437281|559226958|FG002|Overall Study|Adverse Event|0|||
154945353|NCT00437281|559226959|FG003|Overall Study|Adverse Event|1|||
154945354|NCT00437281|559226960|FG004|Overall Study|Adverse Event|0|||
154945355|NCT00437281|559226961|FG005|Overall Study|Adverse Event|1|||
154945356|NCT00437281|559226962|FG006|Overall Study|Adverse Event|0|||
154945357|NCT00437281|559226963|FG007|Overall Study|Adverse Event|0|||
154945358|NCT00437281|559226964|FG008|Overall Study|Adverse Event|0|||
154945359|NCT00437281|559226965|FG009|Overall Study|Adverse Event|1|||
154945360|NCT00437281|559226966|FG010|Overall Study|Adverse Event|0|||
154945361|NCT00437281|559226967|FG011|Overall Study|Adverse Event|0|||
154945362|NCT00437281|559226968|FG012|Overall Study|Adverse Event|0|||
154945363|NCT00437281|559226969|FG013|Overall Study|Adverse Event|1|||
154945364|NCT00437281|559226970|FG014|Overall Study|Adverse Event|1|||
154945365|NCT00437281|559226971|FG015|Overall Study|Adverse Event|0|||
155281090|NCT04955626|560459891|FG024|Open-Label Period|Other|0|||
155281091|NCT04955626|560459892|FG025|Open-Label Period|Other|0|||
155281092|NCT04955626|560459893|FG026|Open-Label Period|Other|0|||
155281093|NCT04955626|560459894|FG027|Open-Label Period|Other|0|||
155281094|NCT04955626|560459895|FG028|Open-Label Period|Other|0|||
155281095|NCT04955626|560459896|FG029|Open-Label Period|Other|0|||
155281096|NCT04955626|560459897|FG030|Open-Label Period|Other|0|||
155281097|NCT04955626|560459898|FG031|Open-Label Period|Other|0|||
155281098|NCT04955626|560459899|FG032|Open-Label Period|Other|0|||
155281099|NCT04955626|560459900|FG033|Open-Label Period|Other|0|||
155281100|NCT04955626|560459901|FG034|Open-Label Period|Other|0|||
155281101|NCT04955626|560459902|FG035|Open-Label Period|Other|0|||
155281102|NCT04955626|560459867|FG000|Open-Label Period|Physician Decision|2|||
155281103|NCT04955626|560459868|FG001|Open-Label Period|Physician Decision|0|||
155388021|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
155388022|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
154945366|NCT00437281|559226972|FG016|Overall Study|Adverse Event|0|||
154945367|NCT00437281|559226973|FG017|Overall Study|Adverse Event|0|||
154945368|NCT00437281|559226974|FG018|Overall Study|Adverse Event|1|||
154945369|NCT00437281|559226975|FG019|Overall Study|Adverse Event|0|||
154945370|NCT00437281|559226956|FG000|Overall Study|Lost to Follow-up|0|||
154945371|NCT00437281|559226957|FG001|Overall Study|Lost to Follow-up|0|||
154945372|NCT00437281|559226958|FG002|Overall Study|Lost to Follow-up|0|||
155281104|NCT04955626|560459869|FG002|Open-Label Period|Physician Decision|0|||
155281105|NCT04955626|560459870|FG003|Open-Label Period|Physician Decision|0|||
154945373|NCT00437281|559226959|FG003|Overall Study|Lost to Follow-up|0|||
154945374|NCT00437281|559226960|FG004|Overall Study|Lost to Follow-up|0|||
154945375|NCT00437281|559226961|FG005|Overall Study|Lost to Follow-up|0|||
154945376|NCT00437281|559226962|FG006|Overall Study|Lost to Follow-up|0|||
154945377|NCT00437281|559226963|FG007|Overall Study|Lost to Follow-up|0|||
155281106|NCT04955626|560459871|FG004|Open-Label Period|Physician Decision|0|||
155046529|NCT04865419|559601215|FG010|Overall Study|Study terminated by Sponsor|1|||
155046530|NCT04865419|559601205|FG000|Overall Study|Death|3|||
155388023|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
155388024|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
155388025|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
155388026|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
155388027|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
155388028|NCT00343252|560855000|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
155388029|NCT00343252|560855001|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
155388030|NCT00394953|560855004|FG000|First Treatment Period|Adverse Event|1|||
155388031|NCT00394953|560855005|FG001|First Treatment Period|Adverse Event|2|||
155388032|NCT00394953|560855004|FG000|First Treatment Period|Death|6|||
155388033|NCT00394953|560855005|FG001|First Treatment Period|Death|7|||
155046531|NCT04865419|559601206|FG001|Overall Study|Death|1|||
155046532|NCT04865419|559601207|FG002|Overall Study|Death|4|||
155046533|NCT04865419|559601208|FG003|Overall Study|Death|2|||
155046534|NCT04865419|559601209|FG004|Overall Study|Death|5|||
155046535|NCT04865419|559601210|FG005|Overall Study|Death|2|||
155046536|NCT04865419|559601211|FG006|Overall Study|Death|1|||
155046537|NCT04865419|559601212|FG007|Overall Study|Death|1|||
155046538|NCT04865419|559601213|FG008|Overall Study|Death|2|||
155046539|NCT04865419|559601214|FG009|Overall Study|Death|2|||
155046540|NCT04865419|559601215|FG010|Overall Study|Death|1|||
155046541|NCT04865419|559601205|FG000|Overall Study|Lost to Follow-up|0|||
155046542|NCT04865419|559601206|FG001|Overall Study|Lost to Follow-up|0|||
155046543|NCT04865419|559601207|FG002|Overall Study|Lost to Follow-up|0|||
155046544|NCT04865419|559601208|FG003|Overall Study|Lost to Follow-up|0|||
155046545|NCT04865419|559601209|FG004|Overall Study|Lost to Follow-up|0|||
155046546|NCT04865419|559601210|FG005|Overall Study|Lost to Follow-up|0|||
155046547|NCT04865419|559601211|FG006|Overall Study|Lost to Follow-up|0|||
155046548|NCT04865419|559601212|FG007|Overall Study|Lost to Follow-up|0|||
155046549|NCT04865419|559601213|FG008|Overall Study|Lost to Follow-up|0|||
155046550|NCT04865419|559601214|FG009|Overall Study|Lost to Follow-up|1|||
155046551|NCT04865419|559601215|FG010|Overall Study|Lost to Follow-up|0|||
155046552|NCT03853291|559601216|FG000|Overall Study|Lost to Follow-up|1|||
155046553|NCT03853291|559601217|FG001|Overall Study|Lost to Follow-up|2|||
155046554|NCT03853291|559601218|FG002|Overall Study|Lost to Follow-up|0|||
155046555|NCT03853291|559601219|FG003|Overall Study|Lost to Follow-up|0|||
155046556|NCT03853291|559601220|FG004|Overall Study|Lost to Follow-up|0|||
155046557|NCT03853291|559601221|FG005|Overall Study|Lost to Follow-up|0|||
155046558|NCT03853291|559601216|FG000|Overall Study|Determined to be ineligible|1|||
155046559|NCT03853291|559601217|FG001|Overall Study|Determined to be ineligible|1|||
155046560|NCT03853291|559601218|FG002|Overall Study|Determined to be ineligible|0|||
155046561|NCT03853291|559601219|FG003|Overall Study|Determined to be ineligible|0|||
155046562|NCT03853291|559601220|FG004|Overall Study|Determined to be ineligible|0|||
155046563|NCT03853291|559601221|FG005|Overall Study|Determined to be ineligible|0|||
155046564|NCT01658904|559601229|FG000|Overall Study|Principal Investigator discretion|2|||
155046565|NCT01658904|559601230|FG001|Overall Study|Principal Investigator discretion|0|||
155046566|NCT01658904|559601231|FG002|Overall Study|Principal Investigator discretion|0|||
155046567|NCT02383355|559601236|FG000|Overall Study|Adverse Event|2|||
155046568|NCT02383355|559601237|FG001|Overall Study|Adverse Event|0|||
155046569|NCT04074330|559601242|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
155046570|NCT04074330|559601243|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
155046571|NCT04074330|559601244|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
155046572|NCT04074330|559601245|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
155046573|NCT04074330|559601246|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
155046574|NCT04074330|559601247|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
155046575|NCT04074330|559601248|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
155046576|NCT04074330|559601249|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
155046577|NCT04074330|559601250|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
155046578|NCT04074330|559601251|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
155046579|NCT04074330|559601242|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155388034|NCT00394953|560855004|FG000|First Treatment Period|Lack of Efficacy|1|||
155388035|NCT00394953|560855005|FG001|First Treatment Period|Lack of Efficacy|1|||
155388036|NCT00394953|560855004|FG000|First Treatment Period|Withdrawal by Subject|6|||
155046580|NCT04074330|559601243|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155046581|NCT04074330|559601244|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155046582|NCT04074330|559601245|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
155046583|NCT04074330|559601246|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155046584|NCT04074330|559601247|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155046585|NCT04074330|559601248|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
155046586|NCT04074330|559601249|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
155046587|NCT04074330|559601250|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155046588|NCT04074330|559601251|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
155388037|NCT00394953|560855005|FG001|First Treatment Period|Withdrawal by Subject|3|||
155388038|NCT00394953|560855004|FG000|First Treatment Period|Lost to Follow-up|0|||
155388039|NCT00394953|560855005|FG001|First Treatment Period|Lost to Follow-up|1|||
155388040|NCT00394953|560855004|FG000|First Treatment Period|Renal transplant|11|||
155388041|NCT00394953|560855005|FG001|First Treatment Period|Renal transplant|7|||
155388042|NCT00394953|560855004|FG000|First Treatment Period|Not defined|4|||
155388043|NCT00394953|560855005|FG001|First Treatment Period|Not defined|1|||
155388044|NCT00394953|560855004|FG000|Second Treatment Period|Adverse Event|2|||
155388045|NCT00394953|560855005|FG001|Second Treatment Period|Adverse Event|5|||
155388046|NCT00394953|560855004|FG000|Second Treatment Period|Death|8|||
154945378|NCT00437281|559226964|FG008|Overall Study|Lost to Follow-up|0|||
154945379|NCT00437281|559226965|FG009|Overall Study|Lost to Follow-up|0|||
154945380|NCT00437281|559226966|FG010|Overall Study|Lost to Follow-up|0|||
154945381|NCT00437281|559226967|FG011|Overall Study|Lost to Follow-up|0|||
154945382|NCT00437281|559226968|FG012|Overall Study|Lost to Follow-up|0|||
154945383|NCT00437281|559226969|FG013|Overall Study|Lost to Follow-up|0|||
154945384|NCT00437281|559226970|FG014|Overall Study|Lost to Follow-up|0|||
154945385|NCT00437281|559226971|FG015|Overall Study|Lost to Follow-up|0|||
154945386|NCT00437281|559226972|FG016|Overall Study|Lost to Follow-up|0|||
154945387|NCT00437281|559226973|FG017|Overall Study|Lost to Follow-up|0|||
154945388|NCT00437281|559226974|FG018|Overall Study|Lost to Follow-up|0|||
154945389|NCT00437281|559226975|FG019|Overall Study|Lost to Follow-up|1|||
154945390|NCT00876733|559226978|FG000|Overall Study|Adverse Event|34|||
154945391|NCT00876733|559226979|FG001|Overall Study|Adverse Event|20|||
154945392|NCT00876733|559226980|FG002|Overall Study|Adverse Event|10|||
154945393|NCT00876733|559226981|FG003|Overall Study|Adverse Event|3|||
154945394|NCT00876733|559226978|FG000|Overall Study|Lack of Efficacy|17|||
154945395|NCT00876733|559226979|FG001|Overall Study|Lack of Efficacy|9|||
154945396|NCT00876733|559226980|FG002|Overall Study|Lack of Efficacy|10|||
154945397|NCT00876733|559226981|FG003|Overall Study|Lack of Efficacy|1|||
154945398|NCT00876733|559226978|FG000|Overall Study|Lost to Follow-up|26|||
154945399|NCT00876733|559226979|FG001|Overall Study|Lost to Follow-up|10|||
154945400|NCT00876733|559226980|FG002|Overall Study|Lost to Follow-up|3|||
154945401|NCT00876733|559226981|FG003|Overall Study|Lost to Follow-up|2|||
154945402|NCT00876733|559226978|FG000|Overall Study|Data not available|14|||
154945403|NCT00876733|559226979|FG001|Overall Study|Data not available|3|||
154945404|NCT00876733|559226980|FG002|Overall Study|Data not available|7|||
154945405|NCT00876733|559226981|FG003|Overall Study|Data not available|1|||
154945406|NCT03521999|559226982|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
154945407|NCT03521999|559226983|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
154945408|NCT03521999|559226982|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
154945409|NCT03521999|559226983|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
154945410|NCT03521999|559226982|FG000|Completed 3 Month Follow up|Death|0|||
154945411|NCT03521999|559226983|FG001|Completed 3 Month Follow up|Death|1|||
154945412|NCT03521999|559226982|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
154945413|NCT03521999|559226983|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
154945414|NCT05476679|559226986|FG000|Overall Study|Withdrawal by Subject|0|||
154945415|NCT05476679|559226987|FG001|Overall Study|Withdrawal by Subject|0|||
154945416|NCT05476679|559226988|FG002|Overall Study|Withdrawal by Subject|0|||
154945417|NCT05476679|559226989|FG003|Overall Study|Withdrawal by Subject|1|||
154945418|NCT05476679|559226990|FG004|Overall Study|Withdrawal by Subject|0|||
154945419|NCT05476679|559226986|FG000|Overall Study|Lost to Follow-up|0|||
154945420|NCT05476679|559226987|FG001|Overall Study|Lost to Follow-up|0|||
154945421|NCT05476679|559226988|FG002|Overall Study|Lost to Follow-up|0|||
154945422|NCT05476679|559226989|FG003|Overall Study|Lost to Follow-up|1|||
154945423|NCT05476679|559226990|FG004|Overall Study|Lost to Follow-up|0|||
154945424|NCT03402893|559226991|FG000|Overall Study|Withdrawal by Subject|1|||
154945425|NCT00686036|559226994|FG000|Overall Study|Adverse Event|3|||
154945426|NCT00686036|559226995|FG001|Overall Study|Adverse Event|0|||
154945427|NCT00686036|559226994|FG000|Overall Study|Withdrawal by Subject|3|||
154945428|NCT00686036|559226995|FG001|Overall Study|Withdrawal by Subject|1|||
154945429|NCT00686036|559226994|FG000|Overall Study|Study terminated by AstraZeneca|2|||
154945430|NCT00686036|559226995|FG001|Overall Study|Study terminated by AstraZeneca|1|||
154945431|NCT00686036|559226994|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
154945432|NCT00686036|559226995|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
154945433|NCT00686036|559226994|FG000|Overall Study|Other reasons not identified|0|||
154945434|NCT00686036|559226995|FG001|Overall Study|Other reasons not identified|4|||
154945435|NCT01937364|559226996|FG000|Overall Study|Adverse Event|2|||
154945436|NCT01937364|559226997|FG001|Overall Study|Adverse Event|1|||
154945437|NCT00467584|559226998|FG000|Overall Study|Withdrawal by Subject|4|||
154945438|NCT00467584|559226999|FG001|Overall Study|Withdrawal by Subject|5|||
154945439|NCT00467584|559227000|FG002|Overall Study|Withdrawal by Subject|1|||
154945440|NCT02482571|559227001|FG000|Overall Study|Adverse Event|1|||
154945441|NCT02482571|559227001|FG000|Overall Study|Scanner or Respiract failure|3|||
154945442|NCT02482571|559227001|FG000|Overall Study|Withdrawal by Subject|4|||
154945443|NCT00926289|559227005|FG000|Overall Study|Adverse Event|9|||
154945444|NCT00926289|559227006|FG001|Overall Study|Adverse Event|11|||
154945445|NCT00926289|559227005|FG000|Overall Study|Protocol Violation|8|||
155388047|NCT00394953|560855005|FG001|Second Treatment Period|Death|4|||
155046589|NCT04074330|559601242|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046590|NCT04074330|559601243|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046591|NCT04074330|559601244|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
155046592|NCT04074330|559601245|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046593|NCT04074330|559601246|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046594|NCT04074330|559601247|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046595|NCT04074330|559601248|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046596|NCT04074330|559601249|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046597|NCT04074330|559601250|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046598|NCT04074330|559601251|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
155046599|NCT04074330|559601242|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046600|NCT04074330|559601243|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046601|NCT04074330|559601244|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046602|NCT04074330|559601245|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046603|NCT04074330|559601246|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046604|NCT04074330|559601247|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
155046605|NCT04074330|559601248|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046606|NCT04074330|559601249|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
155046607|NCT04074330|559601250|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046608|NCT04074330|559601251|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
155046609|NCT04074330|559601242|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155046610|NCT04074330|559601243|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155046611|NCT04074330|559601244|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155046612|NCT04074330|559601245|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155046613|NCT04074330|559601246|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
155046614|NCT04074330|559601247|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
155046615|NCT04074330|559601248|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155046616|NCT04074330|559601249|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155046617|NCT04074330|559601250|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155046618|NCT04074330|559601251|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
155046619|NCT04074330|559601242|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155046620|NCT04074330|559601243|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155046621|NCT04074330|559601244|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155046622|NCT04074330|559601245|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155046623|NCT04074330|559601246|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155046624|NCT04074330|559601247|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
155046625|NCT04074330|559601248|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155046626|NCT04074330|559601249|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155046627|NCT04074330|559601250|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155046628|NCT04074330|559601251|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
155046629|NCT04074330|559601242|FG000|Dose Expansion (up to 42 Months)|Death|0|||
155046630|NCT04074330|559601243|FG001|Dose Expansion (up to 42 Months)|Death|0|||
155046631|NCT04074330|559601244|FG002|Dose Expansion (up to 42 Months)|Death|0|||
155046632|NCT04074330|559601245|FG003|Dose Expansion (up to 42 Months)|Death|0|||
155046633|NCT04074330|559601246|FG004|Dose Expansion (up to 42 Months)|Death|0|||
155046634|NCT04074330|559601247|FG005|Dose Expansion (up to 42 Months)|Death|0|||
155046635|NCT04074330|559601248|FG006|Dose Expansion (up to 42 Months)|Death|0|||
155046636|NCT04074330|559601249|FG007|Dose Expansion (up to 42 Months)|Death|0|||
155046637|NCT04074330|559601250|FG008|Dose Expansion (up to 42 Months)|Death|1|||
155046638|NCT04074330|559601251|FG009|Dose Expansion (up to 42 Months)|Death|0|||
155046639|NCT04074330|559601242|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046640|NCT04074330|559601243|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046641|NCT04074330|559601244|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046642|NCT04074330|559601245|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046643|NCT04074330|559601246|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155281107|NCT04955626|560459872|FG005|Open-Label Period|Physician Decision|0|||
155281108|NCT04955626|560459873|FG006|Open-Label Period|Physician Decision|0|||
155281109|NCT04955626|560459874|FG007|Open-Label Period|Physician Decision|0|||
155281110|NCT04955626|560459875|FG008|Open-Label Period|Physician Decision|0|||
155281111|NCT04955626|560459876|FG009|Open-Label Period|Physician Decision|0|||
155281112|NCT04955626|560459877|FG010|Open-Label Period|Physician Decision|0|||
155281113|NCT04955626|560459878|FG011|Open-Label Period|Physician Decision|0|||
155281114|NCT04955626|560459879|FG012|Open-Label Period|Physician Decision|0|||
155281115|NCT04955626|560459880|FG013|Open-Label Period|Physician Decision|0|||
155281116|NCT04955626|560459881|FG014|Open-Label Period|Physician Decision|0|||
155046644|NCT04074330|559601247|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046645|NCT04074330|559601248|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046646|NCT04074330|559601249|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
155046647|NCT04074330|559601250|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
155046648|NCT04074330|559601251|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
155046649|NCT00972283|559601255|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
155046650|NCT00972283|559601256|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
155046651|NCT00972283|559601255|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
155046652|NCT00972283|559601256|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
155046653|NCT00972283|559601255|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
155046654|NCT00972283|559601256|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
155046655|NCT00972283|559601255|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
155046656|NCT00972283|559601256|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
155046657|NCT00972283|559601255|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
155046658|NCT00972283|559601256|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
155046659|NCT00972283|559601255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
155046660|NCT00972283|559601256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
155046661|NCT00972283|559601255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
155046662|NCT00972283|559601256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
155046663|NCT00972283|559601255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
155046664|NCT00972283|559601256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
155046665|NCT00972283|559601255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
155046666|NCT00972283|559601256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
155046667|NCT00972283|559601255|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
155046668|NCT00972283|559601256|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
155046669|NCT02903420|559601264|FG000|Overall Study|Death|3|||
155046670|NCT03162328|559601265|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
155046671|NCT03162328|559601266|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
155046672|NCT03162328|559601267|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
155046673|NCT03162328|559601265|FG000|Screening Period|Withdrawal by Subject|1|||
155046674|NCT03162328|559601266|FG001|Screening Period|Withdrawal by Subject|0|||
155046675|NCT03162328|559601267|FG002|Screening Period|Withdrawal by Subject|0|||
155046676|NCT03162328|559601265|FG000|Study Period|Withdrawal by Subject|0|||
155046677|NCT03162328|559601266|FG001|Study Period|Withdrawal by Subject|0|||
155046678|NCT03162328|559601267|FG002|Study Period|Withdrawal by Subject|1|||
155046679|NCT03092791|559601268|FG000|Overall Study|Lost to Follow-up|0|||
155046680|NCT03092791|559601269|FG001|Overall Study|Lost to Follow-up|0|||
155281117|NCT04955626|560459882|FG015|Open-Label Period|Physician Decision|0|||
155281118|NCT04955626|560459883|FG016|Open-Label Period|Physician Decision|0|||
155281119|NCT04955626|560459884|FG017|Open-Label Period|Physician Decision|0|||
155281120|NCT04955626|560459885|FG018|Open-Label Period|Physician Decision|0|||
155281121|NCT04955626|560459886|FG019|Open-Label Period|Physician Decision|0|||
155281122|NCT04955626|560459887|FG020|Open-Label Period|Physician Decision|0|||
155281123|NCT04955626|560459888|FG021|Open-Label Period|Physician Decision|0|||
155281124|NCT04955626|560459889|FG022|Open-Label Period|Physician Decision|0|||
155281125|NCT04955626|560459890|FG023|Open-Label Period|Physician Decision|0|||
155281126|NCT04955626|560459891|FG024|Open-Label Period|Physician Decision|0|||
155281127|NCT04955626|560459892|FG025|Open-Label Period|Physician Decision|0|||
155281128|NCT04955626|560459893|FG026|Open-Label Period|Physician Decision|0|||
155281129|NCT04955626|560459894|FG027|Open-Label Period|Physician Decision|0|||
155281130|NCT04955626|560459895|FG028|Open-Label Period|Physician Decision|0|||
155281131|NCT04955626|560459896|FG029|Open-Label Period|Physician Decision|0|||
155281132|NCT04955626|560459897|FG030|Open-Label Period|Physician Decision|0|||
155281133|NCT04955626|560459898|FG031|Open-Label Period|Physician Decision|0|||
155281134|NCT04955626|560459899|FG032|Open-Label Period|Physician Decision|0|||
155281135|NCT04955626|560459900|FG033|Open-Label Period|Physician Decision|0|||
155281136|NCT04955626|560459901|FG034|Open-Label Period|Physician Decision|0|||
155281137|NCT04955626|560459902|FG035|Open-Label Period|Physician Decision|0|||
155281138|NCT04955626|560459867|FG000|Open-Label Period|Withdrawal by Subject|135|||
155281139|NCT04955626|560459868|FG001|Open-Label Period|Withdrawal by Subject|25|||
155281140|NCT04955626|560459869|FG002|Open-Label Period|Withdrawal by Subject|0|||
155281141|NCT04955626|560459870|FG003|Open-Label Period|Withdrawal by Subject|0|||
155281142|NCT04955626|560459871|FG004|Open-Label Period|Withdrawal by Subject|0|||
155281143|NCT04955626|560459872|FG005|Open-Label Period|Withdrawal by Subject|0|||
155281144|NCT04955626|560459873|FG006|Open-Label Period|Withdrawal by Subject|0|||
155281145|NCT04955626|560459874|FG007|Open-Label Period|Withdrawal by Subject|0|||
155281146|NCT04955626|560459875|FG008|Open-Label Period|Withdrawal by Subject|0|||
155281147|NCT04955626|560459876|FG009|Open-Label Period|Withdrawal by Subject|0|||
155281148|NCT04955626|560459877|FG010|Open-Label Period|Withdrawal by Subject|0|||
155388048|NCT00394953|560855004|FG000|Second Treatment Period|Lack of Efficacy|9|||
155046681|NCT03092791|559601270|FG002|Overall Study|Lost to Follow-up|0|||
155388049|NCT00394953|560855005|FG001|Second Treatment Period|Lack of Efficacy|47|||
154945446|NCT00926289|559227006|FG001|Overall Study|Protocol Violation|12|||
154945447|NCT00926289|559227005|FG000|Overall Study|Lost to Follow-up|3|||
154945448|NCT00926289|559227006|FG001|Overall Study|Lost to Follow-up|6|||
154945449|NCT00926289|559227005|FG000|Overall Study|Withdrawal by Subject|4|||
154945450|NCT00926289|559227006|FG001|Overall Study|Withdrawal by Subject|4|||
154945451|NCT00926289|559227005|FG000|Overall Study|Other|1|||
154945452|NCT00926289|559227006|FG001|Overall Study|Other|3|||
154945453|NCT04104646|559227007|FG000|Overall Study|Withdrawal by Subject|1|||
154945454|NCT04104646|559227008|FG001|Overall Study|Withdrawal by Subject|1|||
155281149|NCT04955626|560459878|FG011|Open-Label Period|Withdrawal by Subject|0|||
155281150|NCT04955626|560459879|FG012|Open-Label Period|Withdrawal by Subject|0|||
155281151|NCT04955626|560459880|FG013|Open-Label Period|Withdrawal by Subject|0|||
155281152|NCT04955626|560459881|FG014|Open-Label Period|Withdrawal by Subject|0|||
155281153|NCT04955626|560459882|FG015|Open-Label Period|Withdrawal by Subject|0|||
155281154|NCT04955626|560459883|FG016|Open-Label Period|Withdrawal by Subject|0|||
155281155|NCT04955626|560459884|FG017|Open-Label Period|Withdrawal by Subject|0|||
155281156|NCT04955626|560459885|FG018|Open-Label Period|Withdrawal by Subject|0|||
155281157|NCT04955626|560459886|FG019|Open-Label Period|Withdrawal by Subject|0|||
155281158|NCT04955626|560459887|FG020|Open-Label Period|Withdrawal by Subject|0|||
155281159|NCT04955626|560459888|FG021|Open-Label Period|Withdrawal by Subject|0|||
155281160|NCT04955626|560459889|FG022|Open-Label Period|Withdrawal by Subject|0|||
155281161|NCT04955626|560459890|FG023|Open-Label Period|Withdrawal by Subject|0|||
155281162|NCT04955626|560459891|FG024|Open-Label Period|Withdrawal by Subject|0|||
155281163|NCT04955626|560459892|FG025|Open-Label Period|Withdrawal by Subject|0|||
155281164|NCT04955626|560459893|FG026|Open-Label Period|Withdrawal by Subject|0|||
155281165|NCT04955626|560459894|FG027|Open-Label Period|Withdrawal by Subject|0|||
155281166|NCT04955626|560459895|FG028|Open-Label Period|Withdrawal by Subject|0|||
155281167|NCT04955626|560459896|FG029|Open-Label Period|Withdrawal by Subject|0|||
155281168|NCT04955626|560459897|FG030|Open-Label Period|Withdrawal by Subject|0|||
155281169|NCT04955626|560459898|FG031|Open-Label Period|Withdrawal by Subject|0|||
155281170|NCT04955626|560459899|FG032|Open-Label Period|Withdrawal by Subject|0|||
155281171|NCT04955626|560459900|FG033|Open-Label Period|Withdrawal by Subject|0|||
155281172|NCT04955626|560459901|FG034|Open-Label Period|Withdrawal by Subject|0|||
155281173|NCT04955626|560459902|FG035|Open-Label Period|Withdrawal by Subject|0|||
155281174|NCT04955626|560459867|FG000|Open-Label Period|Refused further study procedures|1|||
155281175|NCT04955626|560459868|FG001|Open-Label Period|Refused further study procedures|0|||
155281176|NCT04955626|560459869|FG002|Open-Label Period|Refused further study procedures|0|||
155281177|NCT04955626|560459870|FG003|Open-Label Period|Refused further study procedures|0|||
155281178|NCT04955626|560459871|FG004|Open-Label Period|Refused further study procedures|0|||
155281179|NCT04955626|560459872|FG005|Open-Label Period|Refused further study procedures|0|||
155281180|NCT04955626|560459873|FG006|Open-Label Period|Refused further study procedures|0|||
155281181|NCT04955626|560459874|FG007|Open-Label Period|Refused further study procedures|0|||
155281182|NCT04955626|560459875|FG008|Open-Label Period|Refused further study procedures|0|||
155281183|NCT04955626|560459876|FG009|Open-Label Period|Refused further study procedures|0|||
155281184|NCT04955626|560459877|FG010|Open-Label Period|Refused further study procedures|0|||
155281185|NCT04955626|560459878|FG011|Open-Label Period|Refused further study procedures|0|||
155281186|NCT04955626|560459879|FG012|Open-Label Period|Refused further study procedures|0|||
155281187|NCT04955626|560459880|FG013|Open-Label Period|Refused further study procedures|0|||
155281188|NCT04955626|560459881|FG014|Open-Label Period|Refused further study procedures|0|||
155281189|NCT04955626|560459882|FG015|Open-Label Period|Refused further study procedures|0|||
155281190|NCT04955626|560459883|FG016|Open-Label Period|Refused further study procedures|0|||
155281191|NCT04955626|560459884|FG017|Open-Label Period|Refused further study procedures|0|||
155281192|NCT04955626|560459885|FG018|Open-Label Period|Refused further study procedures|0|||
155281193|NCT04955626|560459886|FG019|Open-Label Period|Refused further study procedures|0|||
155281194|NCT04955626|560459887|FG020|Open-Label Period|Refused further study procedures|0|||
155281195|NCT04955626|560459888|FG021|Open-Label Period|Refused further study procedures|0|||
155281196|NCT04955626|560459889|FG022|Open-Label Period|Refused further study procedures|0|||
155281197|NCT04955626|560459890|FG023|Open-Label Period|Refused further study procedures|0|||
155281198|NCT04955626|560459891|FG024|Open-Label Period|Refused further study procedures|0|||
155281199|NCT04955626|560459892|FG025|Open-Label Period|Refused further study procedures|0|||
155281200|NCT04955626|560459893|FG026|Open-Label Period|Refused further study procedures|0|||
155281201|NCT04955626|560459894|FG027|Open-Label Period|Refused further study procedures|0|||
155281202|NCT04955626|560459895|FG028|Open-Label Period|Refused further study procedures|0|||
155281203|NCT04955626|560459896|FG029|Open-Label Period|Refused further study procedures|0|||
155281204|NCT04955626|560459897|FG030|Open-Label Period|Refused further study procedures|0|||
155281205|NCT04955626|560459898|FG031|Open-Label Period|Refused further study procedures|0|||
155281206|NCT04955626|560459899|FG032|Open-Label Period|Refused further study procedures|0|||
155281207|NCT04955626|560459900|FG033|Open-Label Period|Refused further study procedures|0|||
154945455|NCT04104646|559227007|FG000|Overall Study|Lost to Follow-up|1|||
154945456|NCT04104646|559227008|FG001|Overall Study|Lost to Follow-up|0|||
154945457|NCT04104646|559227007|FG000|Overall Study|Physician Decision|2|||
155046682|NCT03092791|559601271|FG003|Overall Study|Lost to Follow-up|0|||
155046683|NCT03092791|559601272|FG004|Overall Study|Lost to Follow-up|0|||
155046684|NCT03092791|559601273|FG005|Overall Study|Lost to Follow-up|0|||
155046685|NCT03092791|559601274|FG006|Overall Study|Lost to Follow-up|1|||
155046686|NCT03092791|559601275|FG007|Overall Study|Lost to Follow-up|0|||
155046687|NCT03092791|559601268|FG000|Overall Study|Withdrawal of Consent|0|||
155046688|NCT03092791|559601269|FG001|Overall Study|Withdrawal of Consent|0|||
155046689|NCT03092791|559601270|FG002|Overall Study|Withdrawal of Consent|0|||
155046690|NCT03092791|559601271|FG003|Overall Study|Withdrawal of Consent|0|||
155046691|NCT03092791|559601272|FG004|Overall Study|Withdrawal of Consent|4|||
155046692|NCT03092791|559601273|FG005|Overall Study|Withdrawal of Consent|12|||
155046693|NCT03092791|559601274|FG006|Overall Study|Withdrawal of Consent|6|||
155046694|NCT03092791|559601275|FG007|Overall Study|Withdrawal of Consent|4|||
155046695|NCT03092791|559601268|FG000|Overall Study|Study Termination|0|||
155046696|NCT03092791|559601269|FG001|Overall Study|Study Termination|0|||
155046697|NCT03092791|559601270|FG002|Overall Study|Study Termination|0|||
155046698|NCT03092791|559601271|FG003|Overall Study|Study Termination|0|||
155046699|NCT03092791|559601272|FG004|Overall Study|Study Termination|55|||
155046700|NCT03092791|559601273|FG005|Overall Study|Study Termination|46|||
155046701|NCT03092791|559601274|FG006|Overall Study|Study Termination|53|||
155046702|NCT03092791|559601275|FG007|Overall Study|Study Termination|55|||
155046703|NCT03092791|559601268|FG000|Overall Study|Death|0|||
155046704|NCT03092791|559601269|FG001|Overall Study|Death|0|||
155046705|NCT03092791|559601270|FG002|Overall Study|Death|0|||
155046706|NCT03092791|559601271|FG003|Overall Study|Death|0|||
155046707|NCT03092791|559601272|FG004|Overall Study|Death|0|||
155046708|NCT03092791|559601273|FG005|Overall Study|Death|1|||
155046709|NCT03092791|559601274|FG006|Overall Study|Death|0|||
155046710|NCT03092791|559601275|FG007|Overall Study|Death|1|||
155046711|NCT03092791|559601268|FG000|Overall Study|Reason Not Specified|0|||
155046712|NCT03092791|559601269|FG001|Overall Study|Reason Not Specified|0|||
155046713|NCT03092791|559601270|FG002|Overall Study|Reason Not Specified|0|||
155046714|NCT03092791|559601271|FG003|Overall Study|Reason Not Specified|0|||
155046715|NCT03092791|559601272|FG004|Overall Study|Reason Not Specified|1|||
155046716|NCT03092791|559601273|FG005|Overall Study|Reason Not Specified|1|||
155046717|NCT03092791|559601274|FG006|Overall Study|Reason Not Specified|0|||
155281208|NCT04955626|560459901|FG034|Open-Label Period|Refused further study procedures|0|||
155281209|NCT04955626|560459902|FG035|Open-Label Period|Refused further study procedures|0|||
155281210|NCT04955626|560459867|FG000|Open-Label Period|Adverse Event|1|||
155281211|NCT04955626|560459868|FG001|Open-Label Period|Adverse Event|0|||
155281212|NCT04955626|560459869|FG002|Open-Label Period|Adverse Event|0|||
155281213|NCT04955626|560459870|FG003|Open-Label Period|Adverse Event|0|||
155281214|NCT04955626|560459871|FG004|Open-Label Period|Adverse Event|0|||
155281215|NCT04955626|560459872|FG005|Open-Label Period|Adverse Event|0|||
155281216|NCT04955626|560459873|FG006|Open-Label Period|Adverse Event|0|||
155281217|NCT04955626|560459874|FG007|Open-Label Period|Adverse Event|0|||
155281218|NCT04955626|560459875|FG008|Open-Label Period|Adverse Event|0|||
155281219|NCT04955626|560459876|FG009|Open-Label Period|Adverse Event|0|||
155281220|NCT04955626|560459877|FG010|Open-Label Period|Adverse Event|0|||
155281221|NCT04955626|560459878|FG011|Open-Label Period|Adverse Event|0|||
155281222|NCT04955626|560459879|FG012|Open-Label Period|Adverse Event|0|||
155281223|NCT04955626|560459880|FG013|Open-Label Period|Adverse Event|0|||
155281224|NCT04955626|560459881|FG014|Open-Label Period|Adverse Event|0|||
155281225|NCT04955626|560459882|FG015|Open-Label Period|Adverse Event|0|||
155281226|NCT04955626|560459883|FG016|Open-Label Period|Adverse Event|0|||
155281227|NCT04955626|560459884|FG017|Open-Label Period|Adverse Event|0|||
155281228|NCT04955626|560459885|FG018|Open-Label Period|Adverse Event|0|||
155281229|NCT04955626|560459886|FG019|Open-Label Period|Adverse Event|0|||
155281230|NCT04955626|560459887|FG020|Open-Label Period|Adverse Event|0|||
155281231|NCT04955626|560459888|FG021|Open-Label Period|Adverse Event|0|||
155281232|NCT04955626|560459889|FG022|Open-Label Period|Adverse Event|0|||
155281233|NCT04955626|560459890|FG023|Open-Label Period|Adverse Event|0|||
155388050|NCT00394953|560855004|FG000|Second Treatment Period|Withdrawal by Subject|3|||
155388051|NCT00394953|560855005|FG001|Second Treatment Period|Withdrawal by Subject|3|||
155388052|NCT00394953|560855004|FG000|Second Treatment Period|Lost to Follow-up|0|||
155046718|NCT03092791|559601275|FG007|Overall Study|Reason Not Specified|0|||
155046719|NCT02182830|559601276|FG000|Overall Study|Not Treated|1|||
155046720|NCT02182830|559601277|FG001|Overall Study|Not Treated|1|||
155046721|NCT02182830|559601276|FG000|Overall Study|Trial stopped, reason missing|3|||
155046722|NCT02182830|559601277|FG001|Overall Study|Trial stopped, reason missing|3|||
155046723|NCT02182830|559601276|FG000|Overall Study|Consent withdrawn|8|||
155281234|NCT04955626|560459891|FG024|Open-Label Period|Adverse Event|0|||
155046724|NCT02182830|559601277|FG001|Overall Study|Consent withdrawn|8|||
155046725|NCT02182830|559601276|FG000|Overall Study|Lost to Follow-up|3|||
155281235|NCT04955626|560459892|FG025|Open-Label Period|Adverse Event|0|||
155281236|NCT04955626|560459893|FG026|Open-Label Period|Adverse Event|0|||
155281237|NCT04955626|560459894|FG027|Open-Label Period|Adverse Event|0|||
155281238|NCT04955626|560459895|FG028|Open-Label Period|Adverse Event|0|||
155046726|NCT02182830|559601277|FG001|Overall Study|Lost to Follow-up|3|||
154945458|NCT04104646|559227008|FG001|Overall Study|Physician Decision|0|||
154945459|NCT01498484|559227009|FG000|Overall Study|Death|6|||
154945460|NCT01498484|559227010|FG001|Overall Study|Death|3|||
154945461|NCT01498484|559227011|FG002|Overall Study|Death|1|||
154945462|NCT01498484|559227012|FG003|Overall Study|Death|1|||
154945463|NCT01498484|559227013|FG004|Overall Study|Death|0|||
154945464|NCT01498484|559227014|FG005|Overall Study|Death|0|||
154945465|NCT01498484|559227015|FG006|Overall Study|Death|10|||
154945466|NCT01498484|559227016|FG007|Overall Study|Death|1|||
154945467|NCT01498484|559227017|FG008|Overall Study|Death|0|||
154945468|NCT01498484|559227009|FG000|Overall Study|Physician Decision|3|||
154945469|NCT01498484|559227010|FG001|Overall Study|Physician Decision|2|||
154945470|NCT01498484|559227011|FG002|Overall Study|Physician Decision|1|||
154945471|NCT01498484|559227012|FG003|Overall Study|Physician Decision|1|||
154945472|NCT01498484|559227013|FG004|Overall Study|Physician Decision|0|||
154945473|NCT01498484|559227014|FG005|Overall Study|Physician Decision|0|||
154945474|NCT01498484|559227015|FG006|Overall Study|Physician Decision|8|||
154945475|NCT01498484|559227016|FG007|Overall Study|Physician Decision|13|||
154945476|NCT01498484|559227017|FG008|Overall Study|Physician Decision|1|||
154945477|NCT01498484|559227009|FG000|Overall Study|Adverse Event|0|||
154945478|NCT01498484|559227010|FG001|Overall Study|Adverse Event|0|||
154945479|NCT01498484|559227011|FG002|Overall Study|Adverse Event|0|||
154945480|NCT01498484|559227012|FG003|Overall Study|Adverse Event|0|||
154945481|NCT01498484|559227013|FG004|Overall Study|Adverse Event|0|||
154945482|NCT01498484|559227014|FG005|Overall Study|Adverse Event|1|||
154945483|NCT01498484|559227015|FG006|Overall Study|Adverse Event|0|||
154945484|NCT01498484|559227016|FG007|Overall Study|Adverse Event|0|||
154945485|NCT01498484|559227017|FG008|Overall Study|Adverse Event|0|||
154945486|NCT01498484|559227009|FG000|Overall Study|Withdrawal by Subject|0|||
154945487|NCT01498484|559227010|FG001|Overall Study|Withdrawal by Subject|0|||
154945488|NCT01498484|559227011|FG002|Overall Study|Withdrawal by Subject|0|||
154945489|NCT01498484|559227012|FG003|Overall Study|Withdrawal by Subject|1|||
154945490|NCT01498484|559227013|FG004|Overall Study|Withdrawal by Subject|0|||
154945491|NCT01498484|559227014|FG005|Overall Study|Withdrawal by Subject|0|||
154945492|NCT01498484|559227015|FG006|Overall Study|Withdrawal by Subject|1|||
154945493|NCT01498484|559227016|FG007|Overall Study|Withdrawal by Subject|0|||
154945494|NCT01498484|559227017|FG008|Overall Study|Withdrawal by Subject|0|||
154945495|NCT01498484|559227009|FG000|Overall Study|Other|5|||
154945496|NCT01498484|559227010|FG001|Overall Study|Other|2|||
154945497|NCT01498484|559227011|FG002|Overall Study|Other|0|||
154945498|NCT01498484|559227012|FG003|Overall Study|Other|0|||
154945499|NCT01498484|559227013|FG004|Overall Study|Other|1|||
154945500|NCT01498484|559227014|FG005|Overall Study|Other|0|||
154945501|NCT01498484|559227015|FG006|Overall Study|Other|3|||
154945502|NCT01498484|559227016|FG007|Overall Study|Other|0|||
154945503|NCT01498484|559227017|FG008|Overall Study|Other|1|||
154945504|NCT00319956|559227018|FG000|Overall Study|Death|20|||
154945505|NCT00319956|559227019|FG001|Overall Study|Death|24|||
154945506|NCT01199601|559227020|FG000|Overall Study|Lost to Follow-up|47|||
154945507|NCT01199601|559227021|FG001|Overall Study|Lost to Follow-up|66|||
154945508|NCT01199601|559227020|FG000|Overall Study|Withdrawal by Subject|15|||
154945509|NCT01199601|559227021|FG001|Overall Study|Withdrawal by Subject|3|||
154945510|NCT01199601|559227020|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
154945511|NCT01199601|559227021|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
154945512|NCT02607800|559227022|FG000|Overall Study|Lost to Follow-up|7|||
154945513|NCT02607800|559227023|FG001|Overall Study|Lost to Follow-up|10|||
154945514|NCT02607800|559227022|FG000|Overall Study|Withdrew Consent|2|||
154945515|NCT02607800|559227023|FG001|Overall Study|Withdrew Consent|0|||
154945516|NCT02607800|559227022|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
154945517|NCT02607800|559227023|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
154945518|NCT00753714|559227024|FG000|Overall Study|Lack of Efficacy|21|||
154945519|NCT00753714|559227025|FG001|Overall Study|Lack of Efficacy|34|||
154945520|NCT00753714|559227024|FG000|Overall Study|Adverse Event|26|||
154945521|NCT00753714|559227025|FG001|Overall Study|Adverse Event|18|||
154945522|NCT00753714|559227024|FG000|Overall Study|Protocol Violation|1|||
154945523|NCT00753714|559227025|FG001|Overall Study|Protocol Violation|0|||
154945524|NCT00753714|559227024|FG000|Overall Study|Lost to Follow-up|0|||
154945525|NCT00753714|559227025|FG001|Overall Study|Lost to Follow-up|1|||
154945526|NCT00753714|559227024|FG000|Overall Study|Withdrawal by Subject|2|||
154945527|NCT00753714|559227025|FG001|Overall Study|Withdrawal by Subject|1|||
154945528|NCT00753714|559227024|FG000|Overall Study|Death|3|||
154945529|NCT00753714|559227025|FG001|Overall Study|Death|3|||
154945530|NCT00753714|559227024|FG000|Overall Study|Other|7|||
154945531|NCT00753714|559227025|FG001|Overall Study|Other|5|||
154945532|NCT03387098|559227026|FG000|Overall Study|progressive disease|1|||
154945533|NCT03387098|559227026|FG000|Overall Study|Withdrawal by Subject|2|||
154945534|NCT03387098|559227026|FG000|Overall Study|study terminated by sponsor|1|||
154945535|NCT02974153|559227027|FG000|Overall Study|Adverse Event|6|||
154945536|NCT02974153|559227028|FG001|Overall Study|Adverse Event|0|||
154945537|NCT02974153|559227029|FG002|Overall Study|Adverse Event|1|||
154945538|NCT02974153|559227027|FG000|Overall Study|Lack of Efficacy|6|||
154945539|NCT02974153|559227028|FG001|Overall Study|Lack of Efficacy|5|||
154945540|NCT02974153|559227029|FG002|Overall Study|Lack of Efficacy|10|||
154945541|NCT02974153|559227027|FG000|Overall Study|Lost to Follow-up|9|||
154945542|NCT02974153|559227028|FG001|Overall Study|Lost to Follow-up|10|||
154945543|NCT02974153|559227029|FG002|Overall Study|Lost to Follow-up|17|||
154945544|NCT02974153|559227027|FG000|Overall Study|Physician Decision|0|||
154945545|NCT02974153|559227028|FG001|Overall Study|Physician Decision|2|||
154945546|NCT02974153|559227029|FG002|Overall Study|Physician Decision|1|||
154945547|NCT02974153|559227027|FG000|Overall Study|Withdrawal by Subject|9|||
154945548|NCT02974153|559227028|FG001|Overall Study|Withdrawal by Subject|16|||
154945549|NCT02974153|559227029|FG002|Overall Study|Withdrawal by Subject|11|||
154945550|NCT02974153|559227027|FG000|Overall Study|Study Burden|8|||
154945551|NCT02974153|559227028|FG001|Overall Study|Study Burden|7|||
154945552|NCT02974153|559227029|FG002|Overall Study|Study Burden|3|||
154945553|NCT02974153|559227027|FG000|Overall Study|Other|14|||
154945554|NCT02974153|559227028|FG001|Overall Study|Other|8|||
154945555|NCT02974153|559227029|FG002|Overall Study|Other|7|||
154945556|NCT01202747|559227030|FG000|Overall Study|Withdrawal by Subject|1|||
154945557|NCT01446913|559227031|FG000|Overall Study|Significant illness|1|||
154945558|NCT01446913|559227032|FG001|Overall Study|Significant illness|1|||
154945559|NCT01446913|559227033|FG002|Overall Study|Significant illness|1|||
154945560|NCT01446913|559227031|FG000|Overall Study|Withdrawal by Subject|5|||
154945561|NCT01446913|559227032|FG001|Overall Study|Withdrawal by Subject|3|||
154945562|NCT01446913|559227033|FG002|Overall Study|Withdrawal by Subject|5|||
154945563|NCT01446913|559227031|FG000|Overall Study|Physician Decision|0|||
154945564|NCT01446913|559227032|FG001|Overall Study|Physician Decision|0|||
154945565|NCT01446913|559227033|FG002|Overall Study|Physician Decision|2|||
154945566|NCT01446913|559227031|FG000|Overall Study|Lost to Follow-up|3|||
154945567|NCT01446913|559227032|FG001|Overall Study|Lost to Follow-up|5|||
154945568|NCT01446913|559227033|FG002|Overall Study|Lost to Follow-up|3|||
154945569|NCT02521948|559227034|FG000|Overall Study|Adverse Event|2|||
154945570|NCT02521948|559227034|FG000|Overall Study|Death|4|||
154945571|NCT02521948|559227034|FG000|Overall Study|Lost to Follow-up|1|||
154945572|NCT02521948|559227034|FG000|Overall Study|Did not attend one or both follow-ups|6|||
154945573|NCT00423800|559227035|FG000|Overall Study|Protocol Violation|0|||
154945574|NCT00423800|559227036|FG001|Overall Study|Protocol Violation|1|||
154945575|NCT04000009|559227037|FG000|Overall Study|Adverse Event|13|||
154945576|NCT04000009|559227037|FG000|Overall Study|Lack of Efficacy|7|||
154945577|NCT04000009|559227037|FG000|Overall Study|Lost to Follow-up|8|||
154945578|NCT04000009|559227037|FG000|Overall Study|Noncompliance with study drug|4|||
154945579|NCT04000009|559227037|FG000|Overall Study|Physician Decision|1|||
154945580|NCT04000009|559227037|FG000|Overall Study|Use of prohibited medication|3|||
154945581|NCT04000009|559227037|FG000|Overall Study|Pregnancy|1|||
154945582|NCT04000009|559227037|FG000|Overall Study|Withdrawal by Subject|22|||
154945583|NCT04000009|559227037|FG000|Overall Study|Study terminated by sponsor|98|||
154945584|NCT04000009|559227037|FG000|Overall Study|Not further specified|8|||
154945585|NCT02292238|559227038|FG000|Overall Study|Protocol Violation|1|||
154945586|NCT02292238|559227039|FG001|Overall Study|Protocol Violation|2|||
154945587|NCT02292238|559227038|FG000|Overall Study|Withdrawal by Subject|2|||
154945588|NCT02292238|559227039|FG001|Overall Study|Withdrawal by Subject|1|||
154945589|NCT02292238|559227038|FG000|Overall Study|Lost to Follow-up|1|||
154945590|NCT02292238|559227039|FG001|Overall Study|Lost to Follow-up|0|||
154945591|NCT02292238|559227038|FG000|Overall Study|Physician Decision|0|||
154945592|NCT02292238|559227039|FG001|Overall Study|Physician Decision|1|||
154945593|NCT01754259|559227042|FG000|Overall Study|Withdrawal by Subject|2|||
154945594|NCT01754259|559227043|FG001|Overall Study|Withdrawal by Subject|4|||
154945595|NCT01754259|559227042|FG000|Overall Study|Adverse Event|3|||
154945596|NCT01754259|559227043|FG001|Overall Study|Adverse Event|1|||
154945597|NCT01754259|559227042|FG000|Overall Study|Lost to Follow-up|0|||
154945598|NCT01754259|559227043|FG001|Overall Study|Lost to Follow-up|1|||
154945599|NCT00619385|559227044|FG000|Overall Study|Adverse Event|0|||
154945600|NCT00619385|559227045|FG001|Overall Study|Adverse Event|0|||
154945601|NCT00619385|559227046|FG002|Overall Study|Adverse Event|3|||
154945602|NCT00619385|559227044|FG000|Overall Study|Other|1|||
154945603|NCT00619385|559227045|FG001|Overall Study|Other|2|||
154945604|NCT00619385|559227046|FG002|Overall Study|Other|1|||
154945605|NCT02041702|559227049|FG000|Overall Study|Lost to Follow-up|1|||
154945606|NCT02041702|559227050|FG001|Overall Study|Lost to Follow-up|6|||
154945607|NCT02041702|559227049|FG000|Overall Study|Death|4|||
154945608|NCT02041702|559227050|FG001|Overall Study|Death|0|||
154945609|NCT02041702|559227049|FG000|Overall Study|Withdrawal by Subject|4|||
154945610|NCT02041702|559227050|FG001|Overall Study|Withdrawal by Subject|3|||
154945611|NCT02041702|559227049|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
155281239|NCT04955626|560459896|FG029|Open-Label Period|Adverse Event|0|||
155281240|NCT04955626|560459897|FG030|Open-Label Period|Adverse Event|0|||
155281241|NCT04955626|560459898|FG031|Open-Label Period|Adverse Event|0|||
155281242|NCT04955626|560459899|FG032|Open-Label Period|Adverse Event|0|||
155281243|NCT04955626|560459900|FG033|Open-Label Period|Adverse Event|0|||
155281244|NCT04955626|560459901|FG034|Open-Label Period|Adverse Event|0|||
155281245|NCT04955626|560459902|FG035|Open-Label Period|Adverse Event|0|||
155046727|NCT00913770|559601278|FG000|Overall Study|Unable to contact|24|||
155046728|NCT00913770|559601279|FG001|Overall Study|Unable to contact|19|||
155046729|NCT00913770|559601280|FG002|Overall Study|Unable to contact|13|||
155046730|NCT00913770|559601278|FG000|Overall Study|Refused|11|||
155046731|NCT00913770|559601279|FG001|Overall Study|Refused|10|||
155046732|NCT00913770|559601280|FG002|Overall Study|Refused|8|||
155046733|NCT01990768|559601281|FG000|Intervention Started|Found to be ineligible|14|||
155046734|NCT01990768|559601282|FG001|Intervention Started|Found to be ineligible|13|||
155046735|NCT01990768|559601283|FG002|Intervention Started|Found to be ineligible|11|||
155046736|NCT01990768|559601281|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
155046737|NCT01990768|559601282|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
155046738|NCT01990768|559601283|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
155046739|NCT01990768|559601281|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
155046740|NCT01990768|559601282|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
155046741|NCT01990768|559601283|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
155046742|NCT01990768|559601281|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
155046743|NCT01990768|559601282|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
155388053|NCT00394953|560855005|FG001|Second Treatment Period|Lost to Follow-up|1|||
155388054|NCT00394953|560855004|FG000|Second Treatment Period|Renal transplant|4|||
155388055|NCT00394953|560855005|FG001|Second Treatment Period|Renal transplant|6|||
155388056|NCT00394953|560855004|FG000|Second Treatment Period|Not defined|3|||
155388057|NCT00394953|560855005|FG001|Second Treatment Period|Not defined|8|||
155388058|NCT03021954|560855013|FG000|Overall Study|Lost to Follow-up|10|||
155388059|NCT03021954|560855014|FG001|Overall Study|Lost to Follow-up|43|||
155388060|NCT03021954|560855013|FG000|Overall Study|Subjects had avulsion trauma|4|||
155388061|NCT03021954|560855014|FG001|Overall Study|Subjects had avulsion trauma|1|||
155388062|NCT02196714|560855017|FG000|Overall Study|Protocol Violation|0|||
155388063|NCT02196714|560855018|FG001|Overall Study|Protocol Violation|0|||
155388064|NCT02196714|560855019|FG002|Overall Study|Protocol Violation|1|||
155388065|NCT02196714|560855020|FG003|Overall Study|Protocol Violation|0|||
155388066|NCT01592864|560855022|FG000|Overall Study|Withdrawal by Subject|0|||
155388067|NCT01592864|560855023|FG001|Overall Study|Withdrawal by Subject|1|||
155388068|NCT03353350|560855028|FG000|30-week Core Treatment Period|Protocol Violation|1|||
155388069|NCT03353350|560855029|FG001|30-week Core Treatment Period|Protocol Violation|1|||
155388070|NCT03353350|560855030|FG002|30-week Core Treatment Period|Protocol Violation|1|||
155388071|NCT03353350|560855031|FG003|30-week Core Treatment Period|Protocol Violation|0|||
155388072|NCT03353350|560855028|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
155388073|NCT03353350|560855029|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
155388074|NCT03353350|560855030|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
155388075|NCT03353350|560855031|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
155388076|NCT03353350|560855028|FG000|30-week Core Treatment Period|Adverse Event|0|||
155388077|NCT03353350|560855029|FG001|30-week Core Treatment Period|Adverse Event|4|||
155046744|NCT01990768|559601283|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
155046745|NCT01990768|559601281|FG000|Intervention Started|Patient care priority|1|||
155046746|NCT01990768|559601282|FG001|Intervention Started|Patient care priority|2|||
155046747|NCT01990768|559601283|FG002|Intervention Started|Patient care priority|3|||
155046748|NCT01990768|559601281|FG000|Intervention Started|IV lost|2|||
155046749|NCT01990768|559601282|FG001|Intervention Started|IV lost|2|||
155281246|NCT04955626|560459867|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
155281247|NCT04955626|560459868|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
155281248|NCT04955626|560459869|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
155281249|NCT04955626|560459870|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
155281250|NCT04955626|560459871|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
155281251|NCT04955626|560459872|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
155281252|NCT04955626|560459873|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
155281253|NCT04955626|560459874|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
155281254|NCT04955626|560459875|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
155281255|NCT04955626|560459876|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
155281256|NCT04955626|560459877|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
155281257|NCT04955626|560459878|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
155281258|NCT04955626|560459879|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
155281259|NCT04955626|560459880|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
155281260|NCT04955626|560459881|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
155281261|NCT04955626|560459882|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
155281262|NCT04955626|560459883|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
155281263|NCT04955626|560459884|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
155281264|NCT04955626|560459885|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
155281265|NCT04955626|560459886|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
155281266|NCT04955626|560459887|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
155281267|NCT04955626|560459888|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
155281268|NCT04955626|560459889|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
154945612|NCT02041702|559227050|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
154945613|NCT02041702|559227049|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
154945614|NCT02041702|559227050|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
154945615|NCT00203307|559227051|FG000|First Intervention|Adverse Event|2|||
154945616|NCT00203307|559227052|FG001|First Intervention|Adverse Event|0|||
154945617|NCT03730103|559227053|FG000|Overall Study|Did not meet inclusion criteria|0|||
154945618|NCT03730103|559227054|FG001|Overall Study|Did not meet inclusion criteria|5|||
154945619|NCT01488578|559227055|FG000|Overall Study|Protocol Violation|1836|||
154945620|NCT02308111|559227056|FG000|Overall Study|Adverse Event|31|||
154945621|NCT02308111|559227057|FG001|Overall Study|Adverse Event|19|||
154945622|NCT02308111|559227056|FG000|Overall Study|Death|9|||
154945623|NCT02308111|559227057|FG001|Overall Study|Death|6|||
154945624|NCT02308111|559227056|FG000|Overall Study|Lost to Follow-up|2|||
154945625|NCT02308111|559227057|FG001|Overall Study|Lost to Follow-up|7|||
154945626|NCT02308111|559227056|FG000|Overall Study|Physician Decision|6|||
154945627|NCT02308111|559227057|FG001|Overall Study|Physician Decision|17|||
154945628|NCT02308111|559227056|FG000|Overall Study|Protocol Violation|0|||
154945629|NCT02308111|559227057|FG001|Overall Study|Protocol Violation|1|||
154945630|NCT02308111|559227056|FG000|Overall Study|Withdrawal by Subject|28|||
154945631|NCT02308111|559227057|FG001|Overall Study|Withdrawal by Subject|38|||
154945632|NCT02308111|559227056|FG000|Overall Study|Study Terminated by Sponsor|72|||
154945633|NCT02308111|559227057|FG001|Overall Study|Study Terminated by Sponsor|61|||
154945634|NCT02308111|559227056|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
154945635|NCT02308111|559227057|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
154945636|NCT02308111|559227056|FG000|Overall Study|Site Closure|3|||
154945637|NCT02308111|559227057|FG001|Overall Study|Site Closure|3|||
154945638|NCT02308111|559227056|FG000|Overall Study|Non-compliance with Study Drug|3|||
154945639|NCT02308111|559227057|FG001|Overall Study|Non-compliance with Study Drug|1|||
154945640|NCT02308111|559227056|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
154945641|NCT02308111|559227057|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
154945642|NCT02308111|559227056|FG000|Overall Study|Liver Transplant|3|||
154945643|NCT02308111|559227057|FG001|Overall Study|Liver Transplant|3|||
154945644|NCT02308111|559227056|FG000|Overall Study|Liver Transplant Waitlist|2|||
154945645|NCT02308111|559227057|FG001|Overall Study|Liver Transplant Waitlist|2|||
154945646|NCT02308111|559227056|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
154945647|NCT02308111|559227057|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
154945648|NCT00717756|559227058|FG000|Overall Study|Withdrawal by Subject|1|||
154945649|NCT01873859|559227063|FG000|Overall Study|Withdrawal by Subject|0|||
154945650|NCT01873859|559227064|FG001|Overall Study|Withdrawal by Subject|4|||
154945651|NCT01364870|559227065|FG000|Overall Study|Withdrawal by Subject|13|||
154945652|NCT01364870|559227066|FG001|Overall Study|Withdrawal by Subject|24|||
154945653|NCT01364870|559227067|FG002|Overall Study|Withdrawal by Subject|10|||
154945654|NCT01364870|559227065|FG000|Overall Study|Adverse Event|8|||
154945655|NCT01364870|559227066|FG001|Overall Study|Adverse Event|6|||
154945656|NCT01364870|559227067|FG002|Overall Study|Adverse Event|4|||
154945657|NCT01364870|559227065|FG000|Overall Study|Protocol Violation|1|||
154945658|NCT01364870|559227066|FG001|Overall Study|Protocol Violation|0|||
154945659|NCT01364870|559227067|FG002|Overall Study|Protocol Violation|0|||
154945660|NCT03977584|559227068|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
154945661|NCT03977584|559227069|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
154945662|NCT03977584|559227070|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
154945663|NCT00745251|559227074|FG000|Overall Study|Adverse Event|1|||
154945664|NCT00745251|559227075|FG001|Overall Study|Adverse Event|2|||
154945665|NCT00745251|559227074|FG000|Overall Study|Withdrawal by Subject|1|||
154945666|NCT00745251|559227075|FG001|Overall Study|Withdrawal by Subject|1|||
154945667|NCT03850509|559227076|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
154945668|NCT03850509|559227077|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
154945669|NCT02666430|559227078|FG000|Period 1|Lost to Follow-up|1|||
154945670|NCT02666430|559227079|FG001|Period 1|Lost to Follow-up|0|||
154945671|NCT02666430|559227078|FG000|Period 1|Adverse Event|0|||
154945672|NCT02666430|559227079|FG001|Period 1|Adverse Event|1|||
154945673|NCT02666430|559227078|FG000|Period 2|Withdrawal by Subject|1|||
154945674|NCT02666430|559227079|FG001|Period 2|Withdrawal by Subject|4|||
155046750|NCT01990768|559601283|FG002|Intervention Started|IV lost|2|||
154945675|NCT02666430|559227078|FG000|Period 3|Lost to Follow-up|1|||
154945676|NCT02666430|559227079|FG001|Period 3|Lost to Follow-up|0|||
154945677|NCT03828461|559227080|FG000|Overall Study|Lost to Follow-up|1|||
154945678|NCT03828461|559227080|FG000|Overall Study|Withdrawal by Subject|3|||
154945679|NCT01565083|559227081|FG000|Overall Study|Withdrawal by Subject|6|||
154945680|NCT01565083|559227082|FG001|Overall Study|Withdrawal by Subject|4|||
154945681|NCT01565083|559227081|FG000|Overall Study|Lost to Follow-up|2|||
155046751|NCT01990768|559601281|FG000|Intervention Started|Required CPR|1|||
154945682|NCT01565083|559227082|FG001|Overall Study|Lost to Follow-up|7|||
154945683|NCT01565083|559227081|FG000|Overall Study|Death|22|||
154945684|NCT01565083|559227082|FG001|Overall Study|Death|23|||
155046752|NCT01990768|559601282|FG001|Intervention Started|Required CPR|1|||
155046753|NCT01990768|559601283|FG002|Intervention Started|Required CPR|0|||
155046754|NCT01990768|559601281|FG000|Intervention Started|Seizure or hx of seizure|0|||
155046755|NCT01990768|559601282|FG001|Intervention Started|Seizure or hx of seizure|0|||
155046756|NCT01990768|559601283|FG002|Intervention Started|Seizure or hx of seizure|2|||
155046757|NCT01990768|559601281|FG000|Intervention Started|Discovered to be pregnant|0|||
155046758|NCT01990768|559601282|FG001|Intervention Started|Discovered to be pregnant|1|||
155046759|NCT01990768|559601283|FG002|Intervention Started|Discovered to be pregnant|0|||
155046760|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
155046761|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
155046762|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
155046763|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
155046764|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
155046765|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
155046766|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
155046767|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
155046768|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
155046769|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
155046770|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
155046771|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
155046772|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Death|3|||
155046773|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Death|1|||
155046774|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Death|1|||
155046775|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Discharged|2|||
155046776|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Discharged|1|||
155046777|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Discharged|0|||
155046778|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
155046779|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
155046780|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
155046781|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
155046782|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
155046783|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
155046784|NCT01990768|559601281|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
155046785|NCT01990768|559601282|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
155046786|NCT01990768|559601283|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
155046787|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
155046788|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
155046789|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
155046790|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
155046791|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
155046792|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
155046793|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
155046794|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
155046795|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
155046796|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
155046797|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
155046798|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
155046799|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
155046800|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
155046801|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
155046802|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
155046803|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
155046804|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
155046805|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
155046806|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
155046807|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
155046808|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
155046809|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
155046810|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
155046811|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
155046812|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
155046813|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
155046814|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
155046815|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
155281269|NCT04955626|560459890|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
155281270|NCT04955626|560459891|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
155281271|NCT04955626|560459892|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
155046816|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
155046817|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
155046818|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
155046819|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
155046820|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
155046821|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
155046822|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
155046823|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
155046824|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
155046825|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
155046826|NCT01990768|559601281|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
155046827|NCT01990768|559601282|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
155046828|NCT01990768|559601283|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
155046829|NCT01990768|559601281|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
155046830|NCT01990768|559601282|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
155046831|NCT01990768|559601283|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
155046832|NCT01990768|559601281|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
154945685|NCT01565083|559227081|FG000|Overall Study|Other|3|||
154945686|NCT01565083|559227082|FG001|Overall Study|Other|5|||
154945687|NCT01118728|559227083|FG000|Overall Study|Adverse Event|17|||
154945688|NCT01118728|559227083|FG000|Overall Study|Lack of Efficacy|27|||
154945689|NCT01118728|559227083|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
154945690|NCT01118728|559227083|FG000|Overall Study|Withdrawal by Subject|3|||
154945691|NCT01118728|559227083|FG000|Overall Study|Lost to Follow-up|4|||
154945692|NCT03495869|559227091|FG000|Overall Study|Lost to Follow-up|4|||
154945693|NCT03495869|559227092|FG001|Overall Study|Lost to Follow-up|17|||
154945694|NCT03495869|559227093|FG002|Overall Study|Lost to Follow-up|8|||
154945695|NCT03495869|559227094|FG003|Overall Study|Lost to Follow-up|14|||
154945696|NCT03495869|559227091|FG000|Overall Study|Withdrawal by Subject|0|||
154945697|NCT03495869|559227092|FG001|Overall Study|Withdrawal by Subject|3|||
154945698|NCT03495869|559227093|FG002|Overall Study|Withdrawal by Subject|0|||
154945699|NCT03495869|559227094|FG003|Overall Study|Withdrawal by Subject|3|||
154945700|NCT03495869|559227091|FG000|Overall Study|Dropped from study|0|||
154945701|NCT03495869|559227092|FG001|Overall Study|Dropped from study|7|||
154945702|NCT03495869|559227093|FG002|Overall Study|Dropped from study|2|||
154945703|NCT03495869|559227094|FG003|Overall Study|Dropped from study|4|||
154945704|NCT04680052|559228203|FG000|Overall Study|Ongoing|244|||
154945705|NCT04680052|559228204|FG001|Overall Study|Ongoing|229|||
154945706|NCT04680052|559228205|FG002|Overall Study|Ongoing|39|||
154945707|NCT04680052|559228206|FG003|Overall Study|Ongoing|46|||
154945708|NCT04680052|559228203|FG000|Overall Study|Death|15|||
154945709|NCT04680052|559228204|FG001|Overall Study|Death|22|||
154945710|NCT04680052|559228205|FG002|Overall Study|Death|7|||
155046833|NCT01990768|559601282|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
155281272|NCT04955626|560459893|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
155281273|NCT04955626|560459894|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
155281274|NCT04955626|560459895|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
155281275|NCT04955626|560459896|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
155281276|NCT04955626|560459897|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
155281277|NCT04955626|560459898|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
155281278|NCT04955626|560459899|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
155281279|NCT04955626|560459900|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
155281280|NCT04955626|560459901|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
155281281|NCT04955626|560459902|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
155281282|NCT04955626|560459867|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281283|NCT04955626|560459868|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
155281284|NCT04955626|560459869|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281285|NCT04955626|560459870|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281286|NCT04955626|560459871|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281287|NCT04955626|560459872|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281288|NCT04955626|560459873|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281289|NCT04955626|560459874|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281290|NCT04955626|560459875|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281291|NCT04955626|560459876|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281292|NCT04955626|560459877|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281293|NCT04955626|560459878|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281294|NCT04955626|560459879|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
154945711|NCT04680052|559228206|FG003|Overall Study|Death|1|||
154945712|NCT04680052|559228203|FG000|Overall Study|Lost to Follow-up|3|||
154945713|NCT04680052|559228204|FG001|Overall Study|Lost to Follow-up|2|||
155046834|NCT01990768|559601283|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
155046835|NCT01990768|559601281|FG000|6-Month Follow-up|No contact information|5|||
155046836|NCT01990768|559601282|FG001|6-Month Follow-up|No contact information|6|||
155046837|NCT01990768|559601283|FG002|6-Month Follow-up|No contact information|5|||
155046838|NCT01990768|559601281|FG000|6-Month Follow-up|Homeless|4|||
155046839|NCT01990768|559601282|FG001|6-Month Follow-up|Homeless|3|||
155046840|NCT01990768|559601283|FG002|6-Month Follow-up|Homeless|6|||
155046841|NCT01990768|559601281|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
155046842|NCT01990768|559601282|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
155046843|NCT01990768|559601283|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
155046844|NCT01990768|559601281|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
155046845|NCT01990768|559601282|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
155046846|NCT01990768|559601283|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
155046847|NCT01990768|559601281|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
155046848|NCT01990768|559601282|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
155046849|NCT01990768|559601283|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
155046850|NCT00334295|559601284|FG000|Overall Study|Patients received fewer than 3 injection|5|||
155046851|NCT04162795|559601292|FG000|Overall Study|Other|16|||
155046852|NCT04162795|559601292|FG000|Overall Study|Screen failures|10|||
155046853|NCT02029274|559601293|FG000|Overall Study|Adverse Event|1|||
155046854|NCT02029274|559601294|FG001|Overall Study|Adverse Event|0|||
155046855|NCT02029274|559601295|FG002|Overall Study|Adverse Event|2|||
155046856|NCT02029274|559601296|FG003|Overall Study|Adverse Event|2|||
155046857|NCT00845676|559601297|FG000|Overall Study|Virologic breakthrough at week 20|1|||
155046858|NCT00845676|559601297|FG000|Overall Study|Adverse Event|1|||
155046859|NCT00248833|559601299|FG000|Overall Study|Adverse Event|2|||
155046860|NCT00248833|559601300|FG001|Overall Study|Adverse Event|0|||
155046861|NCT00248833|559601301|FG002|Overall Study|Adverse Event|0|||
155046862|NCT00248833|559601299|FG000|Overall Study|Withdrawal by Subject|0|||
155046863|NCT00248833|559601300|FG001|Overall Study|Withdrawal by Subject|1|||
155046864|NCT00248833|559601301|FG002|Overall Study|Withdrawal by Subject|1|||
155046865|NCT00248833|559601299|FG000|Overall Study|Lost to Follow-up|1|||
155046866|NCT00248833|559601300|FG001|Overall Study|Lost to Follow-up|1|||
155046867|NCT00248833|559601301|FG002|Overall Study|Lost to Follow-up|1|||
155046868|NCT00248833|559601299|FG000|Overall Study|Other|0|||
155046869|NCT00248833|559601300|FG001|Overall Study|Other|1|||
155046870|NCT00248833|559601301|FG002|Overall Study|Other|0|||
155046871|NCT01243177|559601302|FG000|Overall Study|Lack of Efficacy|47|||
155046872|NCT01243177|559601303|FG001|Overall Study|Lack of Efficacy|31|||
155046873|NCT01243177|559601302|FG000|Overall Study|Protocol Violation|11|||
155046874|NCT01243177|559601303|FG001|Overall Study|Protocol Violation|10|||
155046875|NCT01243177|559601302|FG000|Overall Study|Lost to Follow-up|15|||
155046876|NCT01243177|559601303|FG001|Overall Study|Lost to Follow-up|18|||
155046877|NCT01243177|559601302|FG000|Overall Study|Withdrawal by Subject|46|||
155046878|NCT01243177|559601303|FG001|Overall Study|Withdrawal by Subject|38|||
155046879|NCT01243177|559601302|FG000|Overall Study|AE, serious fatal|0|||
155046880|NCT01243177|559601303|FG001|Overall Study|AE, serious fatal|1|||
155046881|NCT01243177|559601302|FG000|Overall Study|SAE, non-fatal|7|||
155046882|NCT01243177|559601303|FG001|Overall Study|SAE, non-fatal|9|||
155046883|NCT01243177|559601302|FG000|Overall Study|AE, non-serious non-fatal|40|||
155046884|NCT01243177|559601303|FG001|Overall Study|AE, non-serious non-fatal|58|||
155046885|NCT01243177|559601302|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
155046886|NCT01243177|559601303|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
155046887|NCT01243177|559601302|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155046888|NCT01243177|559601303|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
155046889|NCT01243177|559601302|FG000|Overall Study|Other Reason|11|||
155046890|NCT01243177|559601303|FG001|Overall Study|Other Reason|12|||
155046891|NCT02636439|559601304|FG000|Overall Study|Adverse Event|2|||
155281295|NCT04955626|560459880|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281296|NCT04955626|560459881|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281297|NCT04955626|560459882|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281298|NCT04955626|560459883|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281299|NCT04955626|560459884|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155046892|NCT02636439|559601305|FG001|Overall Study|Adverse Event|2|||
155046893|NCT02636439|559601304|FG000|Overall Study|Lost to Follow-up|1|||
155046894|NCT02636439|559601305|FG001|Overall Study|Lost to Follow-up|0|||
155046895|NCT02636439|559601304|FG000|Overall Study|Non-compliance|1|||
155046896|NCT02636439|559601305|FG001|Overall Study|Non-compliance|1|||
155046897|NCT02636439|559601304|FG000|Overall Study|Personal reasons|2|||
155046898|NCT02636439|559601305|FG001|Overall Study|Personal reasons|0|||
155046899|NCT02494401|559601306|FG000|Overall Study|Lost to Follow-up|22|||
155046900|NCT02494401|559601307|FG001|Overall Study|Lost to Follow-up|25|||
155046901|NCT02494401|559601306|FG000|Overall Study|Withdrawal by Subject|3|||
155046902|NCT02494401|559601307|FG001|Overall Study|Withdrawal by Subject|2|||
155046903|NCT04530838|559602777|FG000|Overall Study|Other|2|||
155281300|NCT04955626|560459885|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155046904|NCT04530838|559602778|FG001|Overall Study|Other|1|||
155046905|NCT04530838|559602779|FG002|Overall Study|Other|0|||
155046906|NCT04530838|559602777|FG000|Overall Study|Physician Decision|0|||
155046907|NCT04530838|559602778|FG001|Overall Study|Physician Decision|0|||
155046908|NCT04530838|559602779|FG002|Overall Study|Physician Decision|1|||
155046909|NCT04530838|559602777|FG000|Overall Study|Death|0|||
155046910|NCT04530838|559602778|FG001|Overall Study|Death|0|||
155046911|NCT04530838|559602779|FG002|Overall Study|Death|1|||
155046912|NCT04530838|559602777|FG000|Overall Study|Adverse Event|0|||
155046913|NCT04530838|559602778|FG001|Overall Study|Adverse Event|1|||
155046914|NCT04530838|559602779|FG002|Overall Study|Adverse Event|0|||
155046915|NCT04530838|559602777|FG000|Overall Study|No longer meets eligibility criteria|1|||
155046916|NCT04530838|559602778|FG001|Overall Study|No longer meets eligibility criteria|0|||
155046917|NCT04530838|559602779|FG002|Overall Study|No longer meets eligibility criteria|2|||
155046918|NCT04530838|559602777|FG000|Overall Study|Withdrawal by parent/guardian|5|||
155046919|NCT04530838|559602778|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155046920|NCT04530838|559602779|FG002|Overall Study|Withdrawal by parent/guardian|2|||
155046921|NCT00803712|559602780|FG000|Overall Study|Noncompliance|3|||
155046922|NCT00803712|559602781|FG001|Overall Study|Noncompliance|0|||
155046923|NCT00803712|559602780|FG000|Overall Study|Adverse Event|5|||
155046924|NCT00803712|559602781|FG001|Overall Study|Adverse Event|0|||
155046925|NCT00803712|559602780|FG000|Overall Study|Death|8|||
155046926|NCT00803712|559602781|FG001|Overall Study|Death|7|||
155046927|NCT00803712|559602780|FG000|Overall Study|Lost to Follow-up|3|||
155046928|NCT00803712|559602781|FG001|Overall Study|Lost to Follow-up|1|||
155046929|NCT00803712|559602780|FG000|Overall Study|Withdrawal by Subject|2|||
155046930|NCT00803712|559602781|FG001|Overall Study|Withdrawal by Subject|4|||
155046931|NCT00803712|559602780|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
155046932|NCT00803712|559602781|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
155046933|NCT00803712|559602780|FG000|Overall Study|Protocol criteria (other)|0|||
155046934|NCT00803712|559602781|FG001|Overall Study|Protocol criteria (other)|2|||
155046935|NCT00803712|559602780|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
155046936|NCT00803712|559602781|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
155046937|NCT00803712|559602780|FG000|Overall Study|Administrative decision|2|||
155046938|NCT00803712|559602781|FG001|Overall Study|Administrative decision|3|||
155046939|NCT00803712|559602780|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
155046940|NCT00803712|559602781|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
155046941|NCT02861664|559602788|FG000|Overall Study|Withdrawal of Consent|0|||
155046942|NCT02861664|559602789|FG001|Overall Study|Withdrawal of Consent|1|||
155046943|NCT00905632|559602790|FG000|Overall Study|Adverse Event|0|||
155046944|NCT00905632|559602791|FG001|Overall Study|Adverse Event|0|||
155046945|NCT00905632|559602792|FG002|Overall Study|Adverse Event|0|||
155046946|NCT00905632|559602793|FG003|Overall Study|Adverse Event|0|||
155046947|NCT00905632|559602794|FG004|Overall Study|Adverse Event|0|||
155046948|NCT00905632|559602795|FG005|Overall Study|Adverse Event|1|||
155046949|NCT00905632|559602796|FG006|Overall Study|Adverse Event|4|||
155046950|NCT02964338|559602803|FG000|Overall Study|Sponsor terminated study for futility|12|||
155046951|NCT02964338|559602804|FG001|Overall Study|Sponsor terminated study for futility|15|||
155046952|NCT02964338|559602805|FG002|Overall Study|Sponsor terminated study for futility|14|||
155046953|NCT02964338|559602803|FG000|Overall Study|Lack of Efficacy|0|||
155046954|NCT02964338|559602804|FG001|Overall Study|Lack of Efficacy|3|||
155046955|NCT02964338|559602805|FG002|Overall Study|Lack of Efficacy|0|||
155046956|NCT02964338|559602803|FG000|Overall Study|Lost to Follow-up|1|||
155046957|NCT02964338|559602804|FG001|Overall Study|Lost to Follow-up|0|||
155046958|NCT02964338|559602805|FG002|Overall Study|Lost to Follow-up|3|||
155046959|NCT02964338|559602803|FG000|Overall Study|Protocol Violation|0|||
155046960|NCT02964338|559602804|FG001|Overall Study|Protocol Violation|1|||
155046961|NCT02964338|559602805|FG002|Overall Study|Protocol Violation|0|||
155046962|NCT02964338|559602803|FG000|Overall Study|Withdrawal by Subject|1|||
155046963|NCT02964338|559602804|FG001|Overall Study|Withdrawal by Subject|3|||
155388078|NCT03353350|560855030|FG002|30-week Core Treatment Period|Adverse Event|2|||
155388079|NCT03353350|560855031|FG003|30-week Core Treatment Period|Adverse Event|3|||
155388080|NCT03353350|560855028|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
155046964|NCT02964338|559602805|FG002|Overall Study|Withdrawal by Subject|1|||
155046965|NCT02964338|559602803|FG000|Overall Study|Adverse Event|2|||
155046966|NCT02964338|559602804|FG001|Overall Study|Adverse Event|1|||
155046967|NCT02964338|559602805|FG002|Overall Study|Adverse Event|1|||
155046968|NCT02964338|559602803|FG000|Overall Study|Non-compliant with e-diary|0|||
155046969|NCT02964338|559602804|FG001|Overall Study|Non-compliant with e-diary|1|||
155046970|NCT02964338|559602805|FG002|Overall Study|Non-compliant with e-diary|0|||
155046971|NCT02964338|559602803|FG000|Overall Study|Did not meet criteria|1|||
155046972|NCT02964338|559602804|FG001|Overall Study|Did not meet criteria|0|||
155046973|NCT02964338|559602805|FG002|Overall Study|Did not meet criteria|0|||
155046974|NCT02239640|559602806|FG000|Overall Study|Withdrawal by Subject|3|||
155046975|NCT02239640|559602806|FG000|Overall Study|Lost to Follow-up|72|||
155388081|NCT03353350|560855029|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
155388082|NCT03353350|560855030|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
155388083|NCT03353350|560855031|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
155388084|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
155388085|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
155388086|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
155388087|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
155388088|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
155388089|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
155388090|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
155046976|NCT02239640|559602806|FG000|Overall Study|Death|142|||
155046977|NCT02171429|559602812|FG000|Overall Study|Other|0|||
155046978|NCT02171429|559602813|FG001|Overall Study|Other|1|||
155046979|NCT02171429|559602814|FG002|Overall Study|Other|1|||
155046980|NCT02171429|559602812|FG000|Overall Study|Non-Compliance|0|||
155046981|NCT02171429|559602813|FG001|Overall Study|Non-Compliance|0|||
155046982|NCT02171429|559602814|FG002|Overall Study|Non-Compliance|1|||
155046983|NCT02171429|559602812|FG000|Overall Study|Physician Decision|0|||
155046984|NCT02171429|559602813|FG001|Overall Study|Physician Decision|0|||
155046985|NCT02171429|559602814|FG002|Overall Study|Physician Decision|1|||
155046986|NCT02171429|559602812|FG000|Overall Study|Withdrawal by Subject|1|||
155046987|NCT02171429|559602813|FG001|Overall Study|Withdrawal by Subject|1|||
155046988|NCT02171429|559602814|FG002|Overall Study|Withdrawal by Subject|1|||
155046989|NCT02171429|559602812|FG000|Overall Study|Lost to Follow-up|0|||
155388091|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
154945714|NCT04680052|559228205|FG002|Overall Study|Lost to Follow-up|0|||
154945715|NCT04680052|559228206|FG003|Overall Study|Lost to Follow-up|1|||
154945716|NCT04680052|559228203|FG000|Overall Study|Withdrawal by Subject|11|||
154945717|NCT04680052|559228204|FG001|Overall Study|Withdrawal by Subject|19|||
154945718|NCT04680052|559228205|FG002|Overall Study|Withdrawal by Subject|7|||
154945719|NCT04680052|559228206|FG003|Overall Study|Withdrawal by Subject|5|||
154945720|NCT04680052|559228203|FG000|Overall Study|Missing|0|||
154945721|NCT04680052|559228204|FG001|Overall Study|Missing|1|||
154945722|NCT04680052|559228205|FG002|Overall Study|Missing|0|||
154945723|NCT04680052|559228206|FG003|Overall Study|Missing|0|||
154945724|NCT04680052|559228203|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
154945725|NCT04680052|559228204|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
154945726|NCT04680052|559228205|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
154945727|NCT04680052|559228206|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
154945728|NCT04680052|559228203|FG000|Overall Study|Physician Decision|0|||
154945729|NCT04680052|559228204|FG001|Overall Study|Physician Decision|1|||
154945730|NCT04680052|559228205|FG002|Overall Study|Physician Decision|0|||
154945731|NCT04680052|559228206|FG003|Overall Study|Physician Decision|0|||
154945732|NCT05342753|559228212|FG000|Overall Study|Withdrawal by Subject|6|||
154945733|NCT05342753|559228212|FG000|Overall Study|Lost to Follow-up|1|||
154945734|NCT02489318|559228213|FG000|Randomized|Withdrawal by Subject|0|||
154945735|NCT02489318|559228214|FG001|Randomized|Withdrawal by Subject|1|||
154945736|NCT02489318|559228213|FG000|Treated|Adverse Event|19|||
154945737|NCT02489318|559228214|FG001|Treated|Adverse Event|62|||
154945738|NCT02489318|559228213|FG000|Treated|Death|13|||
154945739|NCT02489318|559228214|FG001|Treated|Death|11|||
154945740|NCT02489318|559228213|FG000|Treated|Physician Decision|4|||
154945741|NCT02489318|559228214|FG001|Treated|Physician Decision|6|||
154945742|NCT02489318|559228213|FG000|Treated|Protocol Violation|1|||
154945743|NCT02489318|559228214|FG001|Treated|Protocol Violation|2|||
154945744|NCT02489318|559228213|FG000|Treated|Withdrawal by Subject|37|||
154945745|NCT02489318|559228214|FG001|Treated|Withdrawal by Subject|36|||
154945746|NCT02489318|559228213|FG000|Treated|Other: Progressive Disease|245|||
154945747|NCT02489318|559228214|FG001|Treated|Other: Progressive Disease|138|||
154945748|NCT02489318|559228213|FG000|Treated|Other|0|||
154945749|NCT02489318|559228214|FG001|Treated|Other|2|||
154945750|NCT02489318|559228213|FG000|Treated|Ongoing|0|||
154945751|NCT02489318|559228214|FG001|Treated|Ongoing|267|||
154945752|NCT05218655|559228215|FG000|Overall Study|Adverse Event|6|||
154945753|NCT05218655|559228215|FG000|Overall Study|Sponsor's decision|85|||
154945754|NCT05218655|559228215|FG000|Overall Study|Death|1|||
154945755|NCT05218655|559228215|FG000|Overall Study|Lost to Follow-up|3|||
155046990|NCT02171429|559602813|FG001|Overall Study|Lost to Follow-up|1|||
155046991|NCT02171429|559602814|FG002|Overall Study|Lost to Follow-up|0|||
155046992|NCT02171429|559602812|FG000|Overall Study|Death|0|||
154945756|NCT05218655|559228215|FG000|Overall Study|Withdrawal by Subject|3|||
154945757|NCT05218655|559228215|FG000|Overall Study|Other than specified|3|||
154945758|NCT03901963|559228216|FG000|Overall Study|Lost to Follow-up|1|||
154945759|NCT03901963|559228217|FG001|Overall Study|Lost to Follow-up|1|||
154945760|NCT03901963|559228216|FG000|Overall Study|Physician Decision|1|||
154945761|NCT03901963|559228217|FG001|Overall Study|Physician Decision|2|||
154945762|NCT03901963|559228216|FG000|Overall Study|Protocol Violation|1|||
154945763|NCT03901963|559228217|FG001|Overall Study|Protocol Violation|1|||
155046993|NCT02171429|559602813|FG001|Overall Study|Death|0|||
155046994|NCT02171429|559602814|FG002|Overall Study|Death|1|||
155046995|NCT01724177|559602819|FG000|Overall Study|Adverse Event|8|||
155046996|NCT01724177|559602819|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
155046997|NCT01724177|559602819|FG000|Overall Study|Nervous participant|1|||
155046998|NCT01724177|559602819|FG000|Overall Study|Serious Adverse Event Related|1|||
155046999|NCT00305227|559602822|FG000|Overall Study|Lost to Follow-up|7|||
155047000|NCT00305227|559602823|FG001|Overall Study|Lost to Follow-up|6|||
155047001|NCT00206427|559602827|FG000|Overall Study|Adverse Event|2|||
155047002|NCT04085601|559602828|FG000|Overall Study|Lost to Follow-up|1|||
155047003|NCT04085601|559602829|FG001|Overall Study|Lost to Follow-up|0|||
155047004|NCT04085601|559602828|FG000|Overall Study|Death|1|||
155047005|NCT04085601|559602829|FG001|Overall Study|Death|1|||
155047006|NCT03492437|559602830|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155047007|NCT03492437|559602831|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155047008|NCT03872843|559602832|FG000|Overall Study|Lost to Follow-up|5|||
155047009|NCT03872843|559602833|FG001|Overall Study|Lost to Follow-up|7|||
155047010|NCT00281697|559602834|FG000|Overall Study|> 60 days since last dose of study drug|4|||
155047011|NCT00281697|559602835|FG001|Overall Study|> 60 days since last dose of study drug|4|||
155047012|NCT00281697|559602834|FG000|Overall Study|Adverse Event|54|||
155047013|NCT00281697|559602835|FG001|Overall Study|Adverse Event|15|||
155047014|NCT00281697|559602834|FG000|Overall Study|Death|8|||
155047015|NCT00281697|559602835|FG001|Overall Study|Death|3|||
155047016|NCT00281697|559602834|FG000|Overall Study|Disease progression|279|||
155047017|NCT00281697|559602835|FG001|Overall Study|Disease progression|149|||
155047018|NCT00281697|559602834|FG000|Overall Study|Other|5|||
155047019|NCT00281697|559602835|FG001|Overall Study|Other|6|||
155047020|NCT00281697|559602834|FG000|Overall Study|Physician's decision to withdraw|15|||
155047021|NCT00281697|559602835|FG001|Overall Study|Physician's decision to withdraw|12|||
155047022|NCT00281697|559602834|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
155047023|NCT00281697|559602835|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
155047024|NCT00281697|559602834|FG000|Overall Study|Did not receive study drug|3|||
155047025|NCT00281697|559602835|FG001|Overall Study|Did not receive study drug|2|||
155047026|NCT00632125|559602836|FG000|Overall Study|Death|82|||
155047027|NCT00632125|559602836|FG000|Overall Study|Withdrawal by Subject|44|||
155047028|NCT00632125|559602836|FG000|Overall Study|Adverse Event|36|||
155047029|NCT00632125|559602836|FG000|Overall Study|Renal transplantation|17|||
155047030|NCT00632125|559602836|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
155047031|NCT00632125|559602836|FG000|Overall Study|Non-compliance|8|||
155047032|NCT00632125|559602836|FG000|Overall Study|Development of uncontrolled hypertension|5|||
155047033|NCT00632125|559602836|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
155047034|NCT05133323|559602837|FG000|Overall Study|Lack of Efficacy|0|||
155047035|NCT05133323|559602838|FG001|Overall Study|Lack of Efficacy|0|||
155047036|NCT05133323|559602839|FG002|Overall Study|Lack of Efficacy|1|||
155047037|NCT05133323|559602837|FG000|Overall Study|Withdrawal by Subject|2|||
155047038|NCT05133323|559602838|FG001|Overall Study|Withdrawal by Subject|1|||
155047039|NCT05133323|559602839|FG002|Overall Study|Withdrawal by Subject|0|||
155047040|NCT00856999|559602842|FG000|Overall Study|Withdrawal by Subject|5|||
155047041|NCT02465437|559602843|FG000|Overall Study|Physician Decision|0|||
155047042|NCT02465437|559602844|FG001|Overall Study|Physician Decision|0|||
155047043|NCT02465437|559602845|FG002|Overall Study|Physician Decision|1|||
155047044|NCT02465437|559602846|FG003|Overall Study|Physician Decision|0|||
155047045|NCT02465437|559602843|FG000|Overall Study|Withdrawal by Subject|1|||
155047046|NCT02465437|559602844|FG001|Overall Study|Withdrawal by Subject|0|||
155047047|NCT02465437|559602845|FG002|Overall Study|Withdrawal by Subject|0|||
155047048|NCT02465437|559602846|FG003|Overall Study|Withdrawal by Subject|1|||
155047049|NCT02465437|559602843|FG000|Overall Study|Adverse Event|0|||
155281301|NCT04955626|560459886|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281302|NCT04955626|560459887|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281303|NCT04955626|560459888|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281304|NCT04955626|560459889|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281305|NCT04955626|560459890|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155047050|NCT02465437|559602844|FG001|Overall Study|Adverse Event|1|||
155047051|NCT02465437|559602845|FG002|Overall Study|Adverse Event|0|||
155047052|NCT02465437|559602846|FG003|Overall Study|Adverse Event|0|||
155047053|NCT00003483|559602847|FG000|Overall Study|Not evaluable|1|||
155047054|NCT02609386|559602848|FG000|Overall Study|Withdrawal by Subject|6|||
155047055|NCT02609386|559602849|FG001|Overall Study|Withdrawal by Subject|1|||
155047056|NCT02609386|559602848|FG000|Overall Study|Lost to Follow-up|3|||
155047057|NCT02609386|559602849|FG001|Overall Study|Lost to Follow-up|5|||
155047058|NCT02609386|559602848|FG000|Overall Study|Death|19|||
155047059|NCT02609386|559602849|FG001|Overall Study|Death|9|||
155047060|NCT02609386|559602848|FG000|Overall Study|Physician Decision|0|||
155047061|NCT02609386|559602849|FG001|Overall Study|Physician Decision|2|||
155281306|NCT04955626|560459891|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155047062|NCT00103662|559602850|FG000|Overall Study|Entered Rescue Procedure|0|||
155047063|NCT00103662|559602851|FG001|Overall Study|Entered Rescue Procedure|7|||
155047064|NCT00103662|559602850|FG000|Overall Study|Death|7|||
155047065|NCT00103662|559602851|FG001|Overall Study|Death|7|||
155047066|NCT00103662|559602850|FG000|Overall Study|Elective Withdrawal|5|||
155047067|NCT00103662|559602851|FG001|Overall Study|Elective Withdrawal|5|||
155047068|NCT00103662|559602850|FG000|Overall Study|Lost to Follow-up|0|||
155047069|NCT00103662|559602851|FG001|Overall Study|Lost to Follow-up|1|||
155047070|NCT00103662|559602850|FG000|Overall Study|Other|6|||
155047071|NCT00103662|559602851|FG001|Overall Study|Other|9|||
155047072|NCT00103662|559602850|FG000|Overall Study|Failed mobilization|0|||
155047073|NCT00103662|559602851|FG001|Overall Study|Failed mobilization|4|||
155047074|NCT00103662|559602850|FG000|Overall Study|Intercurrent illness|1|||
155047075|NCT00103662|559602851|FG001|Overall Study|Intercurrent illness|0|||
155047076|NCT00610168|559602852|FG000|Overall Study|Withdrawal by Subject|2|||
155047077|NCT00610168|559602853|FG001|Overall Study|Withdrawal by Subject|0|||
155047078|NCT01135524|559602854|FG000|Overall Study|Withdrawal by Subject|14|||
155047079|NCT01135524|559602854|FG000|Overall Study|Adverse Event|20|||
155047080|NCT01135524|559602854|FG000|Overall Study|Lost to Follow-up|3|||
155047081|NCT01135524|559602854|FG000|Overall Study|Administrative|151|||
155047082|NCT01135524|559602854|FG000|Overall Study|Lack of Efficacy|8|||
155047083|NCT03318003|559602855|FG000|Overall Study|Withdrawal by Subject|1|||
155047084|NCT03318003|559602856|FG001|Overall Study|Withdrawal by Subject|1|||
155047085|NCT03318003|559602855|FG000|Overall Study|fetal loss|0|||
155047086|NCT03318003|559602856|FG001|Overall Study|fetal loss|1|||
155047087|NCT01059773|559602857|FG000|Overall Study|Adverse Event|2|||
155047088|NCT01059773|559602858|FG001|Overall Study|Adverse Event|2|||
155047089|NCT01059773|559602857|FG000|Overall Study|Withdrawal by Subject|1|||
155047090|NCT01059773|559602858|FG001|Overall Study|Withdrawal by Subject|5|||
155047091|NCT01059773|559602857|FG000|Overall Study|Lost to Follow-up|1|||
155047092|NCT01059773|559602858|FG001|Overall Study|Lost to Follow-up|1|||
155047093|NCT01059773|559602857|FG000|Overall Study|Pregnancy|1|||
155047094|NCT01059773|559602858|FG001|Overall Study|Pregnancy|1|||
155047095|NCT01059773|559602857|FG000|Overall Study|Protocol Violation|6|||
155047096|NCT01059773|559602858|FG001|Overall Study|Protocol Violation|2|||
155047097|NCT01059773|559602857|FG000|Overall Study|Physician Decision|5|||
155047098|NCT01059773|559602858|FG001|Overall Study|Physician Decision|4|||
155047099|NCT01059773|559602857|FG000|Overall Study|Lack of Efficacy|3|||
155047100|NCT01059773|559602858|FG001|Overall Study|Lack of Efficacy|3|||
155047101|NCT01059773|559602857|FG000|Overall Study|Death|0|||
155047102|NCT01059773|559602858|FG001|Overall Study|Death|1|||
155047103|NCT01059773|559602857|FG000|Overall Study|Malignancy including squamous cell skin|0|||
155047104|NCT01059773|559602858|FG001|Overall Study|Malignancy including squamous cell skin|1|||
155047105|NCT01059773|559602857|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
155047106|NCT01059773|559602858|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
155047107|NCT01059773|559602857|FG000|Overall Study|Other|1|||
155047108|NCT01059773|559602858|FG001|Overall Study|Other|3|||
155047109|NCT01029262|559602861|FG000|Overall Study|Adverse Event|9|||
155047110|NCT01029262|559602862|FG001|Overall Study|Adverse Event|52|||
155047111|NCT01029262|559602861|FG000|Overall Study|Lack of therapeutic effect|57|||
155047112|NCT01029262|559602862|FG001|Overall Study|Lack of therapeutic effect|76|||
155047113|NCT01029262|559602861|FG000|Overall Study|Withdrawal by Subject|10|||
154945764|NCT03901963|559228216|FG000|Overall Study|Withdrawal by Subject|4|||
154945765|NCT03901963|559228217|FG001|Overall Study|Withdrawal by Subject|11|||
154945766|NCT03901963|559228216|FG000|Overall Study|Ongoing|84|||
154945767|NCT03901963|559228217|FG001|Overall Study|Ongoing|73|||
154945768|NCT03901963|559228216|FG000|Overall Study|Randomized but not treated|3|||
154945769|NCT03901963|559228217|FG001|Overall Study|Randomized but not treated|3|||
154945770|NCT02854436|559228218|FG000|Overall Study|Adverse Event|1|||
154945771|NCT02854436|559228218|FG000|Overall Study|Death|208|||
154945772|NCT02854436|559228218|FG000|Overall Study|Lost to Follow-up|5|||
154945773|NCT02854436|559228218|FG000|Overall Study|Withdrawal by Subject|24|||
154945774|NCT02854436|559228218|FG000|Overall Study|Other|45|||
154945775|NCT02854436|559228218|FG000|Overall Study|Physician Decision|6|||
154945776|NCT02909673|559228219|FG000|Overall Study|Did not meet inclusion criteria|129|||
155047114|NCT01029262|559602862|FG001|Overall Study|Withdrawal by Subject|17|||
155047115|NCT01029262|559602861|FG000|Overall Study|Protocol Violation|2|||
155047116|NCT01029262|559602862|FG001|Overall Study|Protocol Violation|3|||
154945777|NCT02909673|559228220|FG001|Overall Study|Did not meet inclusion criteria|29|||
154945778|NCT02909673|559228219|FG000|Overall Study|Surveys lost by scanner|95|||
154945779|NCT02909673|559228220|FG001|Overall Study|Surveys lost by scanner|2|||
154945780|NCT02909673|559228219|FG000|Overall Study|Tracking info missing|0|||
155047117|NCT01029262|559602861|FG000|Overall Study|Miscellaneous|1|||
155047118|NCT01029262|559602862|FG001|Overall Study|Miscellaneous|9|||
155047119|NCT01029262|559602861|FG000|Overall Study|Death|0|||
155047120|NCT01029262|559602862|FG001|Overall Study|Death|3|||
155047121|NCT00807612|559602865|FG000|Overall Study|Death|8|||
155047122|NCT00807612|559602865|FG000|Overall Study|Study early termination|5|||
155047123|NCT00807612|559602865|FG000|Overall Study|Withdrawal by Subject|1|||
155047124|NCT04892446|559602866|FG000|Overall Study|Death|4|||
155047125|NCT04892446|559602867|FG001|Overall Study|Death|4|||
155047126|NCT04892446|559602868|FG002|Overall Study|Death|0|||
155047127|NCT04892446|559602866|FG000|Overall Study|Withdrew consent|3|||
155047128|NCT04892446|559602867|FG001|Overall Study|Withdrew consent|0|||
155047129|NCT04892446|559602868|FG002|Overall Study|Withdrew consent|1|||
155047130|NCT04892446|559602866|FG000|Overall Study|Investigator's discretion|1|||
155047131|NCT04892446|559602867|FG001|Overall Study|Investigator's discretion|1|||
155047132|NCT04892446|559602868|FG002|Overall Study|Investigator's discretion|0|||
155047133|NCT04892446|559602866|FG000|Overall Study|Study terminated by sponsor|0|||
155047134|NCT04892446|559602867|FG001|Overall Study|Study terminated by sponsor|0|||
155047135|NCT04892446|559602868|FG002|Overall Study|Study terminated by sponsor|2|||
155047136|NCT03293394|559602869|FG000|Follow-up (6 Months)|Adverse Event|4|||
155047137|NCT03293394|559602870|FG001|Follow-up (6 Months)|Adverse Event|2|||
155047138|NCT02497404|559602871|FG000|Overall Study|Adverse Event|1|||
155047139|NCT04978337|559602872|FG000|Overall Study|Withdrawal by Subject|0|||
155047140|NCT04978337|559602873|FG001|Overall Study|Withdrawal by Subject|1|||
155047141|NCT05446142|559602874|FG000|Period 2|Adverse Event|1|||
155047142|NCT05446142|559602875|FG001|Period 2|Adverse Event|0|||
155047143|NCT05446142|559602876|FG002|Period 2|Adverse Event|0|||
155047144|NCT05446142|559602877|FG003|Period 2|Adverse Event|0|||
155047145|NCT05446142|559602878|FG004|Period 2|Adverse Event|0|||
155047146|NCT05446142|559602879|FG005|Period 2|Adverse Event|0|||
155047147|NCT04633226|559602883|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155047148|NCT04633226|559602883|FG000|Overall Study|Randomized by mistake without study treatment|1|||
155047149|NCT00184093|559602887|FG000|Overall Study|Adverse Event|3|||
155047150|NCT00184093|559602887|FG000|Overall Study|Lost to Follow-up|3|||
155047151|NCT00184093|559602887|FG000|Overall Study|Physician Decision|1|||
155047152|NCT00184093|559602887|FG000|Overall Study|Withdrawal by Subject|2|||
155047153|NCT01903993|559602888|FG000|Overall Study|Death|118|||
155047154|NCT01903993|559602889|FG001|Overall Study|Death|121|||
155047155|NCT01903993|559602888|FG000|Overall Study|Withdrawal by Subject|15|||
155047156|NCT01903993|559602889|FG001|Overall Study|Withdrawal by Subject|4|||
155047157|NCT01903993|559602888|FG000|Overall Study|Lost to Follow-up|2|||
155047158|NCT01903993|559602889|FG001|Overall Study|Lost to Follow-up|3|||
155047159|NCT01903993|559602888|FG000|Overall Study|Study Terminated by Sponsor|8|||
155047160|NCT01903993|559602889|FG001|Overall Study|Study Terminated by Sponsor|14|||
155047161|NCT01903993|559602888|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
155047162|NCT01903993|559602889|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
155047163|NCT05095311|559602890|FG000|Overall Study|Lost to Follow-up|7|||
155047164|NCT05095311|559602891|FG001|Overall Study|Lost to Follow-up|0|||
155047165|NCT05095311|559602892|FG002|Overall Study|Lost to Follow-up|0|||
155047166|NCT03124537|559602893|FG000|Overall Study|Lost to Follow-up|3|||
155047167|NCT03124537|559602894|FG001|Overall Study|Lost to Follow-up|5|||
155047168|NCT03124537|559602893|FG000|Overall Study|App Crash, Incomplete Data|7|||
155047169|NCT03124537|559602894|FG001|Overall Study|App Crash, Incomplete Data|8|||
155047170|NCT03681184|559602895|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
155047171|NCT03681184|559602896|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
155047172|NCT02787083|559602897|FG000|Overall Study|Adverse Event|1|||
155047173|NCT02787083|559602898|FG001|Overall Study|Adverse Event|0|||
155047174|NCT02787083|559602897|FG000|Overall Study|Withdrawal by Subject|2|||
155047175|NCT02787083|559602898|FG001|Overall Study|Withdrawal by Subject|2|||
155047176|NCT00282152|559602899|FG000|Overall Study|Withdrawal by Subject|1|||
155047177|NCT00282152|559602900|FG001|Overall Study|Withdrawal by Subject|0|||
155047178|NCT03301831|559602901|FG000|Overall Study|Lost to Follow-up|5|||
155047179|NCT03301831|559602902|FG001|Overall Study|Lost to Follow-up|3|||
155047180|NCT03301831|559602901|FG000|Overall Study|Protocol Violation|4|||
155047181|NCT03301831|559602902|FG001|Overall Study|Protocol Violation|0|||
155047182|NCT03301831|559602901|FG000|Overall Study|Withdrawal by Subject|11|||
155047183|NCT03301831|559602902|FG001|Overall Study|Withdrawal by Subject|0|||
155047184|NCT03373461|559602905|FG000|Part 2|Adverse Event|0|||
155047185|NCT03373461|559602906|FG001|Part 2|Adverse Event|1|||
155047186|NCT03373461|559602907|FG002|Part 2|Adverse Event|0|||
155047187|NCT03373461|559602908|FG003|Part 2|Adverse Event|0|||
155047188|NCT03373461|559602909|FG004|Part 2|Adverse Event|1|||
155047189|NCT01972464|559602914|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
155047190|NCT01972464|559602915|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
155047191|NCT01972464|559602914|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
155047192|NCT01972464|559602915|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
155047193|NCT01972464|559602914|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
155047194|NCT01972464|559602915|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
155047195|NCT01972464|559602914|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
155047196|NCT01972464|559602915|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
155047197|NCT03335813|559604506|FG000|Overall Study|Withdrawal by Subject|1|||
155047198|NCT00327340|559604510|FG000|Overall Study|Withdrawal by Subject|1|||
155047199|NCT00327340|559604511|FG001|Overall Study|Withdrawal by Subject|5|||
155281307|NCT04955626|560459892|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155047200|NCT00327340|559604510|FG000|Overall Study|Physician Decision|1|||
155047201|NCT00327340|559604511|FG001|Overall Study|Physician Decision|1|||
155388092|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Adverse Event|1|||
154945781|NCT02909673|559228220|FG001|Overall Study|Tracking info missing|5|||
154945782|NCT05014204|559228221|FG000|Overall Study|Withdrawal by Subject|1|||
154945783|NCT05014204|559228221|FG000|Overall Study|Physician Decision|1|||
154945784|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
154945785|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
154945786|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945787|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945788|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945789|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
154945790|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
154945791|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945792|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945793|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945794|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945795|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945796|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945797|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
154945798|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945799|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945800|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945801|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945802|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945803|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
154945804|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
154945805|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945806|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945807|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945808|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945809|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945810|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945811|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
154945812|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
154945813|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945814|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945815|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945816|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945817|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945818|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
154945819|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945820|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945821|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945822|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945823|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945824|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945825|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
154945826|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945827|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945828|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945829|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945830|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945831|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
154945832|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
154945833|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945834|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945835|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945836|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945837|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
155388093|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Adverse Event|0|||
155388094|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Adverse Event|0|||
154945838|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945839|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
154945840|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945841|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945842|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945843|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
155047202|NCT00327340|559604510|FG000|Overall Study|Disease Progression|10|||
155047203|NCT00327340|559604511|FG001|Overall Study|Disease Progression|19|||
155047204|NCT00327340|559604510|FG000|Overall Study|Symptomatic Disease|0|||
155047205|NCT00327340|559604511|FG001|Overall Study|Symptomatic Disease|2|||
155047206|NCT00327340|559604510|FG000|Overall Study|Adverse Event|3|||
155047207|NCT00327340|559604511|FG001|Overall Study|Adverse Event|3|||
155047208|NCT00613821|559604522|FG000|Overall Study|Withdrawal by Subject|1|||
155047209|NCT00613821|559604523|FG001|Overall Study|Withdrawal by Subject|0|||
155047210|NCT00613821|559604522|FG000|Overall Study|Physician Decision|1|||
155047211|NCT00613821|559604523|FG001|Overall Study|Physician Decision|1|||
155047212|NCT01266824|559604525|FG000|Overall Study|Study terminated prior to completion|2|||
155047213|NCT01266824|559604526|FG001|Overall Study|Study terminated prior to completion|3|||
155047214|NCT02302846|559604527|FG000|Overall Study|Withdrawal by Subject|1|||
155047215|NCT00411450|559604528|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
155047216|NCT00397189|559604529|FG000|3 Weeks Period|Lost to Follow-up|5|||
155047217|NCT00397189|559604530|FG001|3 Weeks Period|Lost to Follow-up|4|||
155047218|NCT00397189|559604529|FG000|3 Weeks Period|Adverse Event|3|||
155047219|NCT00397189|559604530|FG001|3 Weeks Period|Adverse Event|2|||
155047220|NCT00397189|559604529|FG000|3 Weeks Period|Withdrawal by Subject|13|||
155047221|NCT00397189|559604530|FG001|3 Weeks Period|Withdrawal by Subject|9|||
155047222|NCT00397189|559604529|FG000|3 Weeks Period|Physician Decision|0|||
155047223|NCT00397189|559604530|FG001|3 Weeks Period|Physician Decision|2|||
155047224|NCT00397189|559604529|FG000|3 Weeks Period|Protocol Violation|0|||
155047225|NCT00397189|559604530|FG001|3 Weeks Period|Protocol Violation|3|||
155047226|NCT00397189|559604529|FG000|3 Weeks Period|Other|0|||
155047227|NCT00397189|559604530|FG001|3 Weeks Period|Other|2|||
155047228|NCT01716663|559604531|FG000|Overall Study|Withdrawn prior to procedure|4|||
155047229|NCT01716663|559604531|FG000|Overall Study|Treated with non-study catheter|2|||
155047230|NCT00141518|559604535|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
155047231|NCT00141518|559604536|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
155047232|NCT00141518|559604537|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
155047233|NCT00141518|559604535|FG000|Overall Study|Adverse Event|7|||
155047234|NCT00141518|559604536|FG001|Overall Study|Adverse Event|5|||
155047235|NCT00141518|559604537|FG002|Overall Study|Adverse Event|2|||
155047236|NCT00141518|559604535|FG000|Overall Study|Withdrawal by Subject|2|||
155047237|NCT00141518|559604536|FG001|Overall Study|Withdrawal by Subject|0|||
155047238|NCT00141518|559604537|FG002|Overall Study|Withdrawal by Subject|2|||
154945844|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945845|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945846|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
154945847|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945848|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945849|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945850|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945851|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945852|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945853|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
154945854|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
154945855|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
154945856|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
154945857|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945858|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945859|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
154945860|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
154945861|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945862|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945863|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945864|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945865|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945866|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945867|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
154945868|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945869|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
154945870|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
155047239|NCT00141518|559604535|FG000|Overall Study|Protocol Violation|1|||
155047240|NCT00141518|559604536|FG001|Overall Study|Protocol Violation|1|||
155047241|NCT00141518|559604537|FG002|Overall Study|Protocol Violation|2|||
155047242|NCT00141518|559604535|FG000|Overall Study|Lack of Efficacy|5|||
155047243|NCT00141518|559604536|FG001|Overall Study|Lack of Efficacy|0|||
155047244|NCT00141518|559604537|FG002|Overall Study|Lack of Efficacy|0|||
155047245|NCT01806168|559604538|FG000|Overall Study|Adverse Event|1|||
155047246|NCT01806168|559604539|FG001|Overall Study|Adverse Event|0|||
155047247|NCT01806168|559604540|FG002|Overall Study|Adverse Event|0|||
154945871|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945872|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945873|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
154945874|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945875|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945876|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945877|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945878|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945879|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945880|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945881|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
154945882|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
154945883|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945884|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945885|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945886|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945887|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
154945888|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945889|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945890|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945891|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945892|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945893|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945894|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945895|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
154945896|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945897|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945898|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945899|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
154945900|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
154945901|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945902|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945903|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
154945904|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
154945905|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945906|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945907|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945908|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945909|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
154945910|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945911|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945912|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945913|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945914|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945915|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945916|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945917|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
154945918|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
154945919|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945920|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945921|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945922|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945923|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
154945924|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945925|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945926|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945927|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945928|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945929|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945930|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945931|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945932|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
154945933|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945934|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
155388095|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Adverse Event|1|||
155047248|NCT01806168|559604538|FG000|Overall Study|Withdrawal by Subject|0|||
155047249|NCT01806168|559604539|FG001|Overall Study|Withdrawal by Subject|1|||
155047250|NCT01806168|559604540|FG002|Overall Study|Withdrawal by Subject|2|||
155047251|NCT01806168|559604538|FG000|Overall Study|Protocol Violation|0|||
155047252|NCT01806168|559604539|FG001|Overall Study|Protocol Violation|0|||
155047253|NCT01806168|559604540|FG002|Overall Study|Protocol Violation|1|||
155047254|NCT03904420|559604543|FG000|Overall Study|Study terminated|2|||
155047255|NCT03904420|559604544|FG001|Overall Study|Study terminated|2|||
155047256|NCT00614874|559604545|FG000|Overall Study|Protocol Violation|1|||
155047257|NCT00614874|559604545|FG000|Overall Study|Withdrawal by Subject|1|||
155047258|NCT01468454|559604546|FG000|Overall Study|Did not have surgery after PET|9|||
155047259|NCT02620787|559604547|FG000|Overall Study|Adverse Event|1|||
155047260|NCT02620787|559604548|FG001|Overall Study|Adverse Event|0|||
155047261|NCT02620787|559604547|FG000|Overall Study|Eligibility Criteria Not Met|1|||
155047262|NCT02620787|559604548|FG001|Overall Study|Eligibility Criteria Not Met|0|||
155047263|NCT01896193|559604551|FG000|Overall Study|Lack of Efficacy|20|||
155047264|NCT01896193|559604552|FG001|Overall Study|Lack of Efficacy|11|||
155047265|NCT01896193|559604551|FG000|Overall Study|Protocol Violation|0|||
155047266|NCT01896193|559604552|FG001|Overall Study|Protocol Violation|1|||
155047267|NCT01896193|559604551|FG000|Overall Study|Withdrew Consent|1|||
155047268|NCT01896193|559604552|FG001|Overall Study|Withdrew Consent|0|||
155047269|NCT01048541|559604558|FG000|Overall Study|Withdrawal by Subject|1|||
155047270|NCT01048541|559604559|FG001|Overall Study|Withdrawal by Subject|0|||
155047271|NCT01300247|559604560|FG000|Overall Study|Death|1|||
155047272|NCT01300247|559604561|FG001|Overall Study|Death|1|||
155047273|NCT01300247|559604560|FG000|Overall Study|Lost to Follow-up|2|||
155047274|NCT01300247|559604561|FG001|Overall Study|Lost to Follow-up|0|||
155047275|NCT01300247|559604560|FG000|Overall Study|Withdrawal by Subject|1|||
155047276|NCT01300247|559604561|FG001|Overall Study|Withdrawal by Subject|0|||
155047277|NCT01300247|559604560|FG000|Overall Study|Non-Compliance|0|||
155047278|NCT01300247|559604561|FG001|Overall Study|Non-Compliance|1|||
155047279|NCT00922116|559604562|FG000|Overall Study|Adverse Event|4|||
155047280|NCT00922116|559604562|FG000|Overall Study|Death|1|||
155047281|NCT00922116|559604562|FG000|Overall Study|Lost to Follow-up|1|||
155047282|NCT00922116|559604562|FG000|Overall Study|Withdrawal by Subject|4|||
155047283|NCT00922116|559604562|FG000|Overall Study|Other|5|||
155047284|NCT03193047|559604566|FG000|Overall Study|Physician Decision|1|||
155047285|NCT03193047|559604567|FG001|Overall Study|Physician Decision|0|||
155047286|NCT03193047|559604566|FG000|Overall Study|Participant Left State|1|||
155047287|NCT03193047|559604567|FG001|Overall Study|Participant Left State|0|||
155047288|NCT01509664|559604569|FG000|Overall Study|Lost to Follow-up|15|||
155047289|NCT01509664|559604570|FG001|Overall Study|Lost to Follow-up|21|||
155047290|NCT03173456|559604572|FG000|Baseline|Medication dispensing system malfunction'|0|||
155047291|NCT03173456|559604573|FG001|Baseline|Medication dispensing system malfunction'|1|||
155047292|NCT03173456|559604574|FG002|Baseline|Medication dispensing system malfunction'|0|||
155047293|NCT03173456|559604575|FG003|Baseline|Medication dispensing system malfunction'|0|||
155047294|NCT03173456|559604576|FG004|Baseline|Medication dispensing system malfunction'|2|||
155047295|NCT03173456|559604572|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
155047296|NCT03173456|559604573|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
155047297|NCT03173456|559604574|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
155047298|NCT03173456|559604575|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
155047299|NCT03173456|559604576|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
155047300|NCT01733121|559604577|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
155047301|NCT01733121|559604578|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
155047302|NCT01733121|559604577|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
155047303|NCT01733121|559604578|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
155047304|NCT01733121|559604577|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
155047305|NCT01733121|559604578|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
155047306|NCT01733121|559604577|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
155047307|NCT01733121|559604578|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
155047308|NCT03061188|559604581|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
155047309|NCT03061188|559604582|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
155047310|NCT03061188|559604583|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
155047311|NCT03061188|559604584|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
155047312|NCT03061188|559604581|FG000|On Follow-up for 3 Years|Death|0|||
155047313|NCT03061188|559604582|FG001|On Follow-up for 3 Years|Death|3|||
155047314|NCT03061188|559604583|FG002|On Follow-up for 3 Years|Death|5|||
155047315|NCT03061188|559604584|FG003|On Follow-up for 3 Years|Death|4|||
155047316|NCT03061188|559604581|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
155047317|NCT03061188|559604582|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
155047318|NCT03061188|559604583|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
155047319|NCT03061188|559604584|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
155047320|NCT02306850|559604590|FG000|Overall Study|Lack of Efficacy|2|||
155047321|NCT02420262|559604591|FG000|Overall Study|Adverse Event|1|||
155047322|NCT02420262|559604592|FG001|Overall Study|Adverse Event|0|||
155047323|NCT02420262|559604591|FG000|Overall Study|Withdrawal by Subject|1|||
155047324|NCT02420262|559604592|FG001|Overall Study|Withdrawal by Subject|4|||
155388096|NCT03353350|560855028|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
155388097|NCT03353350|560855029|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
155388098|NCT03353350|560855030|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
155388099|NCT03353350|560855031|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
155388100|NCT03037619|560855032|FG000|Overall Study|Lost to Follow-up|0|||
155388101|NCT03037619|560855033|FG001|Overall Study|Lost to Follow-up|1|||
155388102|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
155388103|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
155388104|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
155388105|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
155388106|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
155388107|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
155388108|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
155388109|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
155388110|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
155388111|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
155388112|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
155388113|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
155388114|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
155388115|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
155388116|NCT01294683|560855036|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
155388117|NCT01294683|560855037|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
155388118|NCT01294683|560855036|FG000|Post Crossover (Period III)|Adverse Event|6|||
155388119|NCT01294683|560855037|FG001|Post Crossover (Period III)|Adverse Event|6|||
154945935|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945936|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945937|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
154945938|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945939|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945940|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945941|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
154945942|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945943|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945944|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945945|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945946|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945947|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945948|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945949|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945950|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945951|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
154945952|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945953|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945954|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945955|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945956|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945957|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945958|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945959|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
154945960|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
154945961|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945962|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945963|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945964|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945965|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
154945966|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945967|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945968|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945969|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945970|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945971|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945972|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945973|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
154945974|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945975|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
155047325|NCT02420262|559604591|FG000|Overall Study|Unclassified|0|||
155047326|NCT02420262|559604592|FG001|Overall Study|Unclassified|1|||
155047327|NCT01210222|559604593|FG000|Overall Study|Ineligible|2|||
155047328|NCT01210222|559604593|FG000|Overall Study|Never treated|1|||
155047329|NCT02098395|559604596|FG000|Overall Study|Protocol Violation|2|||
155047330|NCT02098395|559604597|FG001|Overall Study|Protocol Violation|2|||
155047331|NCT02098395|559604598|FG002|Overall Study|Protocol Violation|0|||
155047332|NCT02098395|559604599|FG003|Overall Study|Protocol Violation|7|||
155047333|NCT02098395|559604596|FG000|Overall Study|Withdrawal by Subject|10|||
155047334|NCT02098395|559604597|FG001|Overall Study|Withdrawal by Subject|10|||
155047335|NCT02098395|559604598|FG002|Overall Study|Withdrawal by Subject|5|||
155047336|NCT02098395|559604599|FG003|Overall Study|Withdrawal by Subject|13|||
155047337|NCT02098395|559604596|FG000|Overall Study|Adverse Event|12|||
155047338|NCT02098395|559604597|FG001|Overall Study|Adverse Event|19|||
155047339|NCT02098395|559604598|FG002|Overall Study|Adverse Event|34|||
155047340|NCT02098395|559604599|FG003|Overall Study|Adverse Event|2|||
155047341|NCT02098395|559604596|FG000|Overall Study|Lost to Follow-up|2|||
155047342|NCT02098395|559604597|FG001|Overall Study|Lost to Follow-up|1|||
155047343|NCT02098395|559604598|FG002|Overall Study|Lost to Follow-up|0|||
155047344|NCT02098395|559604599|FG003|Overall Study|Lost to Follow-up|3|||
155047345|NCT02098395|559604596|FG000|Overall Study|Unclassified|0|||
155047346|NCT02098395|559604597|FG001|Overall Study|Unclassified|0|||
155047347|NCT02098395|559604598|FG002|Overall Study|Unclassified|3|||
155047348|NCT02098395|559604599|FG003|Overall Study|Unclassified|2|||
155047349|NCT00110357|559604605|FG000|Overall Study|Deterioration without progression|2|||
155047350|NCT00110357|559604606|FG001|Overall Study|Deterioration without progression|0|||
155047351|NCT00110357|559604605|FG000|Overall Study|Disease progression/relapse|20|||
155047352|NCT00110357|559604606|FG001|Overall Study|Disease progression/relapse|15|||
155047353|NCT00110357|559604605|FG000|Overall Study|Study Closure|1|||
155047354|NCT00110357|559604606|FG001|Overall Study|Study Closure|0|||
155047355|NCT00110357|559604605|FG000|Overall Study|Study Drug Toxicity|1|||
155047356|NCT00110357|559604606|FG001|Overall Study|Study Drug Toxicity|3|||
155047357|NCT00110357|559604605|FG000|Overall Study|Withdrawal by Subject|3|||
155047358|NCT00110357|559604606|FG001|Overall Study|Withdrawal by Subject|1|||
155047359|NCT02360280|559604607|FG000|Overall Study|Withdrawal by Subject|2|||
155047360|NCT02360280|559604608|FG001|Overall Study|Withdrawal by Subject|0|||
155047361|NCT02360280|559604607|FG000|Overall Study|Adverse Event|0|||
155047362|NCT02360280|559604608|FG001|Overall Study|Adverse Event|1|||
155047363|NCT02360280|559604607|FG000|Overall Study|Lost to Follow-up|1|||
155047364|NCT02360280|559604608|FG001|Overall Study|Lost to Follow-up|0|||
155047365|NCT05415462|559604615|FG000|Overall Study|Death|18|||
155047366|NCT05415462|559604616|FG001|Overall Study|Death|10|||
155047367|NCT05415462|559604615|FG000|Overall Study|Lost to Follow-up|72|||
155047368|NCT05415462|559604616|FG001|Overall Study|Lost to Follow-up|64|||
155047369|NCT05415462|559604615|FG000|Overall Study|Physician Decision|5|||
155047370|NCT05415462|559604616|FG001|Overall Study|Physician Decision|5|||
155047371|NCT05415462|559604615|FG000|Overall Study|Protocol Deviation|1|||
155047372|NCT05415462|559604616|FG001|Overall Study|Protocol Deviation|0|||
155047373|NCT05415462|559604615|FG000|Overall Study|Withdrawal by Subject|129|||
155047374|NCT05415462|559604616|FG001|Overall Study|Withdrawal by Subject|101|||
155047375|NCT05415462|559604615|FG000|Overall Study|Other Than Specified|8|||
155047376|NCT05415462|559604616|FG001|Overall Study|Other Than Specified|8|||
155047377|NCT02998996|559604639|FG000|Overall Study|Lost to Follow-up|0|||
155047378|NCT02998996|559604640|FG001|Overall Study|Lost to Follow-up|0|||
155047379|NCT02998996|559604641|FG002|Overall Study|Lost to Follow-up|1|||
155047380|NCT02998996|559604642|FG003|Overall Study|Lost to Follow-up|0|||
155047381|NCT02998996|559604643|FG004|Overall Study|Lost to Follow-up|0|||
155047382|NCT02998996|559604644|FG005|Overall Study|Lost to Follow-up|0|||
155047383|NCT02998996|559604639|FG000|Overall Study|Pregnancy|0|||
155047384|NCT02998996|559604640|FG001|Overall Study|Pregnancy|1|||
155047385|NCT02998996|559604641|FG002|Overall Study|Pregnancy|0|||
155047386|NCT02998996|559604642|FG003|Overall Study|Pregnancy|0|||
155047387|NCT02998996|559604643|FG004|Overall Study|Pregnancy|0|||
155047388|NCT02998996|559604644|FG005|Overall Study|Pregnancy|0|||
155047389|NCT02998996|559604639|FG000|Overall Study|Family reasons|0|||
155047390|NCT02998996|559604640|FG001|Overall Study|Family reasons|0|||
155047391|NCT02998996|559604641|FG002|Overall Study|Family reasons|0|||
155047392|NCT02998996|559604642|FG003|Overall Study|Family reasons|0|||
155047393|NCT02998996|559604643|FG004|Overall Study|Family reasons|1|||
155047394|NCT02998996|559604644|FG005|Overall Study|Family reasons|0|||
155047395|NCT01087203|559604646|FG000|Overall Study|Lost to Follow-up|2|||
155047396|NCT01087203|559604647|FG001|Overall Study|Lost to Follow-up|0|||
155047397|NCT01087203|559604646|FG000|Overall Study|Withdrawal by Subject|2|||
155047398|NCT01087203|559604647|FG001|Overall Study|Withdrawal by Subject|6|||
155047399|NCT01087203|559604646|FG000|Overall Study|Lack of Efficacy|1|||
155047400|NCT01087203|559604647|FG001|Overall Study|Lack of Efficacy|2|||
155047401|NCT01087203|559604646|FG000|Overall Study|Study terminated by sponsor|27|||
155047402|NCT01087203|559604647|FG001|Overall Study|Study terminated by sponsor|27|||
155047403|NCT03283930|559604655|FG000|Overall Study|Scheduling conflict|8|||
155047404|NCT03283930|559604656|FG001|Overall Study|Scheduling conflict|10|||
155047405|NCT03283930|559604655|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
155047406|NCT03283930|559604656|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
155047407|NCT03283930|559604655|FG000|Overall Study|Technical software issue|2|||
155047408|NCT03283930|559604656|FG001|Overall Study|Technical software issue|2|||
155047409|NCT00805129|559604660|FG000|Overall Study|Not treated|1|||
155047410|NCT01429298|559604663|FG000|Overall Study|Protocol Violation|4|||
155047411|NCT01429298|559604664|FG001|Overall Study|Protocol Violation|6|||
155047412|NCT02500719|559604665|FG000|Overall Study|Lost to Follow-up|2|||
155047413|NCT02500719|559604666|FG001|Overall Study|Lost to Follow-up|3|||
155047414|NCT02500719|559604665|FG000|Overall Study|Trauma history|1|||
155047415|NCT02500719|559604666|FG001|Overall Study|Trauma history|0|||
155047416|NCT02500719|559604665|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
155047417|NCT02500719|559604666|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
155047418|NCT02500719|559604665|FG000|Overall Study|Did not meet criteria for PTSD|0|||
155047419|NCT02500719|559604666|FG001|Overall Study|Did not meet criteria for PTSD|1|||
155047420|NCT02500719|559604665|FG000|Overall Study|Claustrophobia|0|||
155047421|NCT02500719|559604666|FG001|Overall Study|Claustrophobia|1|||
155047422|NCT02500719|559604665|FG000|Overall Study|History of head trauma|0|||
155047423|NCT02500719|559604666|FG001|Overall Study|History of head trauma|1|||
155047424|NCT00585325|559604667|FG000|Overall Study|Withdrawal by Subject|1|||
155047425|NCT00585325|559604668|FG001|Overall Study|Withdrawal by Subject|1|||
155047426|NCT00154375|559604669|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
155047427|NCT00154375|559604670|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
155047428|NCT00154375|559604669|FG000|Overall Study|Adverse Event|18|||
155047429|NCT00154375|559604670|FG001|Overall Study|Adverse Event|20|||
155047430|NCT00154375|559604669|FG000|Overall Study|Withdrawal by Subject|14|||
155047431|NCT00154375|559604670|FG001|Overall Study|Withdrawal by Subject|10|||
155047432|NCT00154375|559604669|FG000|Overall Study|Death|5|||
155047433|NCT00154375|559604670|FG001|Overall Study|Death|13|||
155047434|NCT00154375|559604669|FG000|Overall Study|Study drug no longer required|5|||
155047435|NCT00154375|559604670|FG001|Overall Study|Study drug no longer required|3|||
155047436|NCT00154375|559604669|FG000|Overall Study|Lost to Follow-up|2|||
155047437|NCT00154375|559604670|FG001|Overall Study|Lost to Follow-up|1|||
155047438|NCT00154375|559604669|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155047439|NCT00154375|559604670|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155047440|NCT00154375|559604669|FG000|Overall Study|Protocol Violation|0|||
155047441|NCT00154375|559604670|FG001|Overall Study|Protocol Violation|1|||
155047442|NCT00154375|559604669|FG000|Overall Study|Suspected progression of disease|44|||
155047443|NCT00154375|559604670|FG001|Overall Study|Suspected progression of disease|30|||
155047444|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
155047445|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
155047446|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
155047447|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
155047448|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
155047449|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
155047450|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
155047451|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
155047452|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
155047453|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
155047454|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
155047455|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
155047456|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
155047457|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
155047458|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
155047459|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
155047460|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
155047461|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
155047462|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
155047463|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
155047464|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
155047465|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
155047466|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
155047467|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
155047468|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
155047469|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
155047470|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
155047471|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
155047472|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
155047473|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
155047474|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
155047475|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
155047476|NCT03538691|559604671|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
155047477|NCT03538691|559604672|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
155047478|NCT03538691|559604673|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
155047479|NCT03538691|559604674|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
155047480|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
155047481|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
155047482|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
155047483|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
155047484|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
155047485|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
155047486|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
155047487|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
155047488|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
155047489|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
155047490|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
155047491|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
155047492|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
155047493|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
155047494|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
155047495|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
155047496|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
155047497|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
155047498|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
155047499|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
155047500|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
155047501|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
155047502|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
155047503|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
155047504|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
155047505|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
155047506|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
155047507|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
155047508|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
155047509|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
155047510|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
155047511|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
155047512|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
155047513|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
155047514|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
155047515|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
155047516|NCT03538691|559604671|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155047517|NCT03538691|559604672|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
155047518|NCT03538691|559604673|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155047519|NCT03538691|559604674|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155047520|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
155047521|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
155047522|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
155047523|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
155047524|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
155047525|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
155047526|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
155047527|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
155047528|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
155047529|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
155047530|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
155047531|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
155047532|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
155281308|NCT04955626|560459893|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281309|NCT04955626|560459894|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281310|NCT04955626|560459895|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
154945976|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945977|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945978|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945979|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
154945980|NCT04033445|559228222|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945981|NCT04033445|559228223|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945982|NCT04033445|559228224|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945983|NCT04033445|559228225|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945984|NCT04033445|559228226|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945985|NCT04033445|559228227|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945986|NCT04033445|559228228|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945987|NCT04033445|559228229|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
154945988|NCT04033445|559228230|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945989|NCT04033445|559228231|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945990|NCT04033445|559228232|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945991|NCT04033445|559228233|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945992|NCT04033445|559228234|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945993|NCT04033445|559228235|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
154945994|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154945995|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154945996|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154945997|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154945998|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154945999|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154946000|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154946001|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154946002|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
154946003|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
154946004|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
154946005|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
154946006|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
154946007|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
154946008|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946009|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946010|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946011|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946012|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946013|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946014|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946015|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946016|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
154946017|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
154946018|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
154946019|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
154946020|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
154946021|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
154946022|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946023|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946024|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946025|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946026|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946027|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946028|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946029|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946030|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946031|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946032|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
154946033|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
154946034|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
154946035|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
154946036|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946037|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
155092571|NCT01959529|559773635|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
155281311|NCT04955626|560459896|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155047533|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
155047534|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
155047535|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
155047536|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
155047537|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
155047538|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
155047539|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
155047540|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
155047541|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
155047542|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
155047543|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
155047544|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
155047545|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
155047546|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
155047547|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
155047548|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
155047549|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
155047550|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
155047551|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
155047552|NCT03538691|559604671|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155047553|NCT03538691|559604672|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
155047554|NCT03538691|559604673|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
155047555|NCT03538691|559604674|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
155047556|NCT00792116|559604679|FG000|Overall Study|Lost to Follow-up|0|||
155047557|NCT00792116|559604680|FG001|Overall Study|Lost to Follow-up|1|||
155047558|NCT00792116|559604679|FG000|Overall Study|Discontnued intervention|1|||
155047559|NCT00792116|559604680|FG001|Overall Study|Discontnued intervention|0|||
155047560|NCT02453256|559604681|FG000|Double Blind Period|Death|1|||
155047561|NCT02453256|559604682|FG001|Double Blind Period|Death|1|||
155047562|NCT02453256|559604681|FG000|Double Blind Period|Adverse Event|3|||
155047563|NCT02453256|559604682|FG001|Double Blind Period|Adverse Event|2|||
155047564|NCT02453256|559604681|FG000|Double Blind Period|Withdrawal by Subject|9|||
155047565|NCT02453256|559604682|FG001|Double Blind Period|Withdrawal by Subject|5|||
155047566|NCT02453256|559604681|FG000|Double Blind Period|Other|0|||
155047567|NCT02453256|559604682|FG001|Double Blind Period|Other|1|||
155047568|NCT02453256|559604681|FG000|Open Label Period|Adverse Event|1|||
155047569|NCT02453256|559604682|FG001|Open Label Period|Adverse Event|3|||
155047570|NCT02453256|559604681|FG000|Open Label Period|Death|0|||
155047571|NCT02453256|559604682|FG001|Open Label Period|Death|1|||
155047572|NCT02453256|559604681|FG000|Open Label Period|Lost to Follow-up|1|||
155047573|NCT02453256|559604682|FG001|Open Label Period|Lost to Follow-up|0|||
155047574|NCT02453256|559604681|FG000|Open Label Period|Other|0|||
155047575|NCT02453256|559604682|FG001|Open Label Period|Other|2|||
155047576|NCT02453256|559604681|FG000|Open Label Period|Withdrawal by Subject|5|||
155047577|NCT02453256|559604682|FG001|Open Label Period|Withdrawal by Subject|1|||
155047578|NCT01066871|559604684|FG000|Overall Study|Lost to Follow-up|0|||
155047579|NCT01066871|559604685|FG001|Overall Study|Lost to Follow-up|2|||
155047580|NCT01066871|559604686|FG002|Overall Study|Lost to Follow-up|2|||
155047581|NCT01066871|559604687|FG003|Overall Study|Lost to Follow-up|0|||
155047582|NCT01066871|559604684|FG000|Overall Study|Protocol Violation|1|||
155047583|NCT01066871|559604685|FG001|Overall Study|Protocol Violation|0|||
155047584|NCT01066871|559604686|FG002|Overall Study|Protocol Violation|3|||
155047585|NCT01066871|559604687|FG003|Overall Study|Protocol Violation|2|||
155047586|NCT01066871|559604684|FG000|Overall Study|Lack of Efficacy|0|||
155047587|NCT01066871|559604685|FG001|Overall Study|Lack of Efficacy|0|||
155047588|NCT01066871|559604686|FG002|Overall Study|Lack of Efficacy|0|||
155047589|NCT01066871|559604687|FG003|Overall Study|Lack of Efficacy|1|||
155047590|NCT01066871|559604684|FG000|Overall Study|Withdrawal by Subject|3|||
155047591|NCT01066871|559604685|FG001|Overall Study|Withdrawal by Subject|1|||
155047592|NCT01066871|559604686|FG002|Overall Study|Withdrawal by Subject|0|||
155047593|NCT01066871|559604687|FG003|Overall Study|Withdrawal by Subject|0|||
155047594|NCT01066871|559604684|FG000|Overall Study|Other|0|||
155047595|NCT01066871|559604685|FG001|Overall Study|Other|2|||
155047596|NCT01066871|559604686|FG002|Overall Study|Other|1|||
155047597|NCT01066871|559604687|FG003|Overall Study|Other|2|||
155047598|NCT01639144|559606310|FG000|Overall Study|Withdrawal by Subject|4|||
155047599|NCT01639144|559606311|FG001|Overall Study|Withdrawal by Subject|2|||
155047600|NCT01639144|559606310|FG000|Overall Study|Physician Decision|2|||
155281312|NCT04955626|560459897|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155047601|NCT01639144|559606311|FG001|Overall Study|Physician Decision|0|||
155047602|NCT01639144|559606310|FG000|Overall Study|Met postoperative exclusion criteria|4|||
155047603|NCT01639144|559606311|FG001|Overall Study|Met postoperative exclusion criteria|3|||
155047604|NCT02121795|559606315|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
155047605|NCT02121795|559606316|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
155047606|NCT02121795|559606315|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
155047607|NCT02121795|559606316|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
155047608|NCT02121795|559606315|FG000|Double-Blind Phase|Lost to Follow-up|7|||
155047609|NCT02121795|559606316|FG001|Double-Blind Phase|Lost to Follow-up|4|||
155047610|NCT02121795|559606315|FG000|Double-Blind Phase|Physician Decision|2|||
155047611|NCT02121795|559606316|FG001|Double-Blind Phase|Physician Decision|5|||
155047612|NCT02121795|559606315|FG000|Double-Blind Phase|Adverse Event|5|||
155047613|NCT02121795|559606316|FG001|Double-Blind Phase|Adverse Event|0|||
155047614|NCT02121795|559606315|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
155047615|NCT02121795|559606316|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
155047616|NCT02121795|559606315|FG000|Double-Blind Phase|Protocol Violation|0|||
155047617|NCT02121795|559606316|FG001|Double-Blind Phase|Protocol Violation|3|||
155047618|NCT02121795|559606315|FG000|Double-Blind Phase|Death|1|||
155047619|NCT02121795|559606316|FG001|Double-Blind Phase|Death|1|||
155047620|NCT02121795|559606315|FG000|Open-Label Phase|Physician Decision|8|||
155047621|NCT02121795|559606316|FG001|Open-Label Phase|Physician Decision|8|||
155047622|NCT02121795|559606315|FG000|Open-Label Phase|Withdrawal by Subject|3|||
155047623|NCT02121795|559606316|FG001|Open-Label Phase|Withdrawal by Subject|2|||
155047624|NCT02121795|559606315|FG000|Open-Label Phase|Lost to Follow-up|1|||
155047625|NCT02121795|559606316|FG001|Open-Label Phase|Lost to Follow-up|0|||
155047626|NCT01001910|559606319|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
155047627|NCT03060291|559606322|FG000|3-month Follow-up|Declined to respond|8|||
155047628|NCT03060291|559606323|FG001|3-month Follow-up|Declined to respond|10|||
155047629|NCT03060291|559606324|FG002|3-month Follow-up|Declined to respond|2|||
155047630|NCT03060291|559606322|FG000|6-month Follow-up|Declined to respond|7|||
155047631|NCT03060291|559606323|FG001|6-month Follow-up|Declined to respond|13|||
155047632|NCT03060291|559606324|FG002|6-month Follow-up|Declined to respond|4|||
155047633|NCT03060291|559606322|FG000|12-month Follow-up|Declined to respond|7|||
155047634|NCT03060291|559606323|FG001|12-month Follow-up|Declined to respond|16|||
155281313|NCT04955626|560459898|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281314|NCT04955626|560459899|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281315|NCT04955626|560459900|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281316|NCT04955626|560459901|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281317|NCT04955626|560459902|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
155281318|NCT05194735|560461541|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
155281319|NCT05194735|560461542|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
155281320|NCT05194735|560461543|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
155047635|NCT03060291|559606324|FG002|12-month Follow-up|Declined to respond|6|||
155047636|NCT00618826|559606325|FG000|Overall Study|Adverse Event|1|||
155047637|NCT02105285|559606328|FG000|Overall Study|Adverse Event|1|||
155047638|NCT02105285|559606329|FG001|Overall Study|Adverse Event|1|||
155047639|NCT02105285|559606330|FG002|Overall Study|Adverse Event|0|||
155047640|NCT02105285|559606328|FG000|Overall Study|Protocol Violation|0|||
155047641|NCT02105285|559606329|FG001|Overall Study|Protocol Violation|1|||
155047642|NCT02105285|559606330|FG002|Overall Study|Protocol Violation|0|||
155047643|NCT02105285|559606328|FG000|Overall Study|Withdrawal by Subject|1|||
155047644|NCT02105285|559606329|FG001|Overall Study|Withdrawal by Subject|0|||
155047645|NCT02105285|559606330|FG002|Overall Study|Withdrawal by Subject|0|||
155047646|NCT02364388|559606331|FG000|Overall Study|Protocol Violation|1|||
155047647|NCT02364388|559606331|FG000|Overall Study|Technical Failure|3|||
155281321|NCT05194735|560461541|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
155281322|NCT05194735|560461542|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
155281323|NCT05194735|560461543|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
155047648|NCT02364388|559606331|FG000|Overall Study|No OA/US data|2|||
155047649|NCT02364388|559606331|FG000|Overall Study|No Biopsy|2|||
155047650|NCT03231306|559606332|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
155047651|NCT03231306|559606332|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
155047652|NCT03231306|559606332|FG000|Overall Study|Treatment delay > 21 days|2|||
155047653|NCT03231306|559606332|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
155047654|NCT03231306|559606332|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
155047655|NCT03231306|559606332|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
155047656|NCT03231306|559606332|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
155047657|NCT03231306|559606332|FG000|Overall Study|More than 1 Reason|2|||
155047658|NCT02585713|559606333|FG000|Overall Study|Withdrew prior to treatment|2|||
155047659|NCT02585713|559606334|FG001|Overall Study|Withdrew prior to treatment|7|||
155047660|NCT02585713|559606333|FG000|Overall Study|Other|3|||
155047661|NCT02585713|559606334|FG001|Overall Study|Other|1|||
155047662|NCT02609984|559606340|FG000|Overall Study|Death|29|||
155047663|NCT02609984|559606341|FG001|Overall Study|Death|26|||
155047664|NCT02609984|559606340|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
155047665|NCT02609984|559606341|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
155047666|NCT02609984|559606340|FG000|Overall Study|Lost to Follow-up|1|||
155047667|NCT02609984|559606341|FG001|Overall Study|Lost to Follow-up|2|||
155047668|NCT02609984|559606340|FG000|Overall Study|Withdrawal by Subject|0|||
155047669|NCT02609984|559606341|FG001|Overall Study|Withdrawal by Subject|1|||
155047670|NCT02609984|559606340|FG000|Overall Study|Disease Progression|2|||
155047671|NCT02609984|559606341|FG001|Overall Study|Disease Progression|0|||
155047672|NCT01843803|559606343|FG000|Overall Study|not a Veteran, did not see provider|1|||
155047673|NCT01843803|559606344|FG001|Overall Study|not a Veteran, did not see provider|3|||
155047674|NCT00784719|559606350|FG000|Overall Study|Adverse Event|0|||
155047675|NCT00784719|559606351|FG001|Overall Study|Adverse Event|2|||
155047676|NCT00784719|559606352|FG002|Overall Study|Adverse Event|0|||
155047677|NCT00784719|559606353|FG003|Overall Study|Adverse Event|0|||
155047678|NCT00784719|559606354|FG004|Overall Study|Adverse Event|1|||
155047679|NCT00784719|559606355|FG005|Overall Study|Adverse Event|1|||
155047680|NCT00784719|559606356|FG006|Overall Study|Adverse Event|1|||
155047681|NCT00784719|559606350|FG000|Overall Study|Lost to Follow-up|0|||
155047682|NCT00784719|559606351|FG001|Overall Study|Lost to Follow-up|0|||
155047683|NCT00784719|559606352|FG002|Overall Study|Lost to Follow-up|0|||
155047684|NCT00784719|559606353|FG003|Overall Study|Lost to Follow-up|0|||
155047685|NCT00784719|559606354|FG004|Overall Study|Lost to Follow-up|1|||
155047686|NCT00784719|559606355|FG005|Overall Study|Lost to Follow-up|1|||
155047687|NCT00784719|559606356|FG006|Overall Study|Lost to Follow-up|0|||
155047688|NCT00784719|559606350|FG000|Overall Study|Other|2|||
155047689|NCT00784719|559606351|FG001|Overall Study|Other|1|||
155047690|NCT00784719|559606352|FG002|Overall Study|Other|1|||
155047691|NCT00784719|559606353|FG003|Overall Study|Other|0|||
155047692|NCT00784719|559606354|FG004|Overall Study|Other|2|||
155047693|NCT00784719|559606355|FG005|Overall Study|Other|1|||
155047694|NCT00784719|559606356|FG006|Overall Study|Other|3|||
155047695|NCT00784719|559606350|FG000|Overall Study|Withdrawal by Subject|1|||
155047696|NCT00784719|559606351|FG001|Overall Study|Withdrawal by Subject|0|||
155047697|NCT00784719|559606352|FG002|Overall Study|Withdrawal by Subject|0|||
155047698|NCT00784719|559606353|FG003|Overall Study|Withdrawal by Subject|0|||
155047699|NCT00784719|559606354|FG004|Overall Study|Withdrawal by Subject|2|||
155047700|NCT00784719|559606355|FG005|Overall Study|Withdrawal by Subject|0|||
155047701|NCT00784719|559606356|FG006|Overall Study|Withdrawal by Subject|1|||
155047702|NCT05285787|559606359|FG000|Overall Study|Withdrawal by Subject|1|||
155047703|NCT04004260|559606360|FG000|Overall Study|Withdrawal by Subject|7|||
155047704|NCT04004260|559606361|FG001|Overall Study|Withdrawal by Subject|3|||
155047705|NCT04004260|559606360|FG000|Overall Study|Lost to Follow-up|22|||
155047706|NCT04004260|559606361|FG001|Overall Study|Lost to Follow-up|12|||
155047707|NCT04004260|559606360|FG000|Overall Study|Did not engage in intervention|13|||
155047708|NCT04004260|559606361|FG001|Overall Study|Did not engage in intervention|17|||
155281324|NCT05194735|560461541|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
155281325|NCT05194735|560461542|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
155281326|NCT05194735|560461543|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
155281327|NCT05194735|560461541|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
155281328|NCT05194735|560461542|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
155281329|NCT05194735|560461543|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
155281330|NCT00731042|560461544|FG000|Second Intervention|Did not meet inclusion criteria|0|||
155281331|NCT00731042|560461545|FG001|Second Intervention|Did not meet inclusion criteria|2|||
155281332|NCT01256476|560461546|FG000|Overall Study|Adverse Event|2|||
155281333|NCT01256476|560461547|FG001|Overall Study|Adverse Event|1|||
155281334|NCT01256476|560461546|FG000|Overall Study|Withdrawal by Subject|2|||
155281335|NCT01256476|560461547|FG001|Overall Study|Withdrawal by Subject|1|||
155281336|NCT01256476|560461546|FG000|Overall Study|Lost to Follow-up|1|||
155281337|NCT01256476|560461547|FG001|Overall Study|Lost to Follow-up|2|||
155281338|NCT01256476|560461546|FG000|Overall Study|Persistent ALT or AST elevation|1|||
155047709|NCT03382418|559606365|FG000|Overall Study|Withdrawal by Subject|1|||
155047710|NCT03382418|559606366|FG001|Overall Study|Withdrawal by Subject|0|||
155047711|NCT03382418|559606367|FG002|Overall Study|Withdrawal by Subject|0|||
155047712|NCT03382418|559606365|FG000|Overall Study|Lost to Follow-up|2|||
155047713|NCT03382418|559606366|FG001|Overall Study|Lost to Follow-up|3|||
155047714|NCT03382418|559606367|FG002|Overall Study|Lost to Follow-up|0|||
155047715|NCT02472886|559606369|FG000|Overall Study|Lack of Efficacy|0|||
155047716|NCT02472886|559606370|FG001|Overall Study|Lack of Efficacy|2|||
155047717|NCT02472886|559606371|FG002|Overall Study|Lack of Efficacy|1|||
155047718|NCT01051817|559606372|FG000|Overall Study|Adverse Event|0|||
155047719|NCT01051817|559606373|FG001|Overall Study|Adverse Event|2|||
155047720|NCT01051817|559606372|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
155047721|NCT01051817|559606373|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
155047722|NCT01051817|559606372|FG000|Overall Study|Withdrawal by Subject|3|||
155047723|NCT01051817|559606373|FG001|Overall Study|Withdrawal by Subject|5|||
155047724|NCT01051817|559606372|FG000|Overall Study|Protocol Violation|0|||
155047725|NCT01051817|559606373|FG001|Overall Study|Protocol Violation|1|||
155047726|NCT04533438|559606377|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
155047727|NCT04533438|559606378|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
155047728|NCT02137226|559606380|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
155047729|NCT02137226|559606381|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
155047730|NCT02137226|559606382|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
155047731|NCT02137226|559606383|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
155047732|NCT02137226|559606384|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
155047733|NCT02137226|559606380|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
155047734|NCT02137226|559606381|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
155047735|NCT02137226|559606382|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
155047736|NCT02137226|559606383|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
155047737|NCT02137226|559606384|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
155047738|NCT02137226|559606380|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
155047739|NCT02137226|559606381|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
155047740|NCT02137226|559606382|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
155047741|NCT02137226|559606383|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
155047742|NCT02137226|559606384|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
155047743|NCT02137226|559606380|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
155047744|NCT02137226|559606381|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
155047745|NCT02137226|559606382|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
155047746|NCT02137226|559606383|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
155047747|NCT02137226|559606384|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
155047748|NCT02137226|559606380|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
155047749|NCT02137226|559606381|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155047750|NCT02137226|559606382|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155047751|NCT02137226|559606383|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155047752|NCT02137226|559606384|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
155047753|NCT02137226|559606380|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
155047754|NCT02137226|559606381|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
155047755|NCT02137226|559606382|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
155047756|NCT02137226|559606383|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
155047757|NCT02137226|559606384|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
155047758|NCT02137226|559606380|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
155047759|NCT02137226|559606381|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
155047760|NCT02137226|559606382|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
155047761|NCT02137226|559606383|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
155047762|NCT02137226|559606384|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
155047763|NCT02137226|559606380|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
155047764|NCT02137226|559606381|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
155047765|NCT02137226|559606382|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
155047766|NCT02137226|559606383|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
155047767|NCT02137226|559606384|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
155047768|NCT02137226|559606380|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
155047769|NCT02137226|559606381|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
155047770|NCT02137226|559606382|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
155047771|NCT02137226|559606383|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
155047772|NCT02137226|559606384|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
154946038|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946039|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946040|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946041|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946042|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946043|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946044|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946045|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
154946046|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
154946047|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
155047773|NCT02137226|559606380|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155047774|NCT02137226|559606381|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
154946048|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
155047775|NCT02137226|559606382|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
155047776|NCT02137226|559606383|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155047777|NCT02137226|559606384|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
155047778|NCT02137226|559606380|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155047779|NCT02137226|559606381|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155047780|NCT02137226|559606382|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
155047781|NCT02137226|559606383|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155047782|NCT02137226|559606384|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
155047783|NCT02137226|559606380|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
155047784|NCT02137226|559606381|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
155047785|NCT02137226|559606382|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
155047786|NCT02137226|559606383|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
155047787|NCT02137226|559606384|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
155047788|NCT01398358|559606389|FG000|Overall Study|Lost to Follow-up|11|||
155047789|NCT01398358|559606390|FG001|Overall Study|Lost to Follow-up|21|||
155047790|NCT01398358|559606391|FG002|Overall Study|Lost to Follow-up|18|||
155047791|NCT01398358|559606389|FG000|Overall Study|Withdrawal by Subject|3|||
155047792|NCT01398358|559606390|FG001|Overall Study|Withdrawal by Subject|2|||
155047793|NCT01398358|559606391|FG002|Overall Study|Withdrawal by Subject|2|||
155047794|NCT01398358|559606389|FG000|Overall Study|no longer eligible|1|||
155047795|NCT01398358|559606390|FG001|Overall Study|no longer eligible|0|||
155047796|NCT01398358|559606391|FG002|Overall Study|no longer eligible|1|||
155047797|NCT00003896|559606394|FG000|Overall Study|Adverse Event|16|||
155047798|NCT00003896|559606394|FG000|Overall Study|Withdrawal by Subject|1|||
155047799|NCT00003896|559606394|FG000|Overall Study|Lack of Efficacy|1|||
155047800|NCT00003896|559606394|FG000|Overall Study|Death|3|||
155388120|NCT01294683|560855036|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
155388121|NCT01294683|560855037|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
155388122|NCT01294683|560855036|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
155388123|NCT01294683|560855037|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
155388124|NCT01294683|560855036|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
155388125|NCT01294683|560855037|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
155388126|NCT01881750|560855038|FG000|Overall Study|Changes in concomitant therapies|2|||
155388127|NCT01881750|560855039|FG001|Overall Study|Changes in concomitant therapies|3|||
155388128|NCT01881750|560855038|FG000|Overall Study|Lost to Follow-up|0|||
155388129|NCT01881750|560855039|FG001|Overall Study|Lost to Follow-up|1|||
155388130|NCT00307125|560855040|FG000|Screening Phase|Adverse Event|1|||
155388131|NCT00307125|560855041|FG001|Screening Phase|Adverse Event|0|||
155047801|NCT00003896|559606394|FG000|Overall Study|not protocol specified|3|||
155047802|NCT00003896|559606394|FG000|Overall Study|ineligible|5|||
155047803|NCT00985686|559606395|FG000|Overall Study|Lost to Follow-up|1|||
155047804|NCT00985686|559606396|FG001|Overall Study|Lost to Follow-up|1|||
155047805|NCT00985686|559606397|FG002|Overall Study|Lost to Follow-up|0|||
155047806|NCT00985686|559606398|FG003|Overall Study|Lost to Follow-up|2|||
155388132|NCT00307125|560855042|FG002|Screening Phase|Adverse Event|0|||
155388133|NCT00307125|560855040|FG000|Screening Phase|Protocol Violation|27|||
155388134|NCT00307125|560855041|FG001|Screening Phase|Protocol Violation|0|||
154946049|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
154946050|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946051|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946052|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946053|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946054|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946055|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946056|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946057|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946058|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
154946059|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
154946060|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
154946061|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
154946062|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
154946063|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
154946064|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
155047807|NCT03134911|559606399|FG000|Overall Study|Screen failure|31|||
155047808|NCT03134911|559606399|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
155047809|NCT02559570|559606400|FG000|Overall Study|Adverse Event|0|||
155047810|NCT02559570|559606401|FG001|Overall Study|Adverse Event|2|||
155047811|NCT02559570|559606402|FG002|Overall Study|Adverse Event|0|||
155047812|NCT02559570|559606403|FG003|Overall Study|Adverse Event|1|||
155047813|NCT02559570|559606404|FG004|Overall Study|Adverse Event|0|||
155388135|NCT00307125|560855042|FG002|Screening Phase|Protocol Violation|0|||
155388136|NCT00307125|560855040|FG000|Screening Phase|Lost to Follow-up|87|||
155388137|NCT00307125|560855041|FG001|Screening Phase|Lost to Follow-up|0|||
155388138|NCT00307125|560855042|FG002|Screening Phase|Lost to Follow-up|0|||
155047814|NCT02559570|559606400|FG000|Overall Study|Withdrawal of Consent|0|||
155047815|NCT02559570|559606401|FG001|Overall Study|Withdrawal of Consent|0|||
155047816|NCT02559570|559606402|FG002|Overall Study|Withdrawal of Consent|1|||
155047817|NCT02559570|559606403|FG003|Overall Study|Withdrawal of Consent|2|||
155047818|NCT02559570|559606404|FG004|Overall Study|Withdrawal of Consent|1|||
155047819|NCT02559570|559606400|FG000|Overall Study|Lost to Follow-up|1|||
155047820|NCT02559570|559606401|FG001|Overall Study|Lost to Follow-up|0|||
155388139|NCT00307125|560855040|FG000|Screening Phase|Death|10|||
155047821|NCT02559570|559606402|FG002|Overall Study|Lost to Follow-up|0|||
155047822|NCT02559570|559606403|FG003|Overall Study|Lost to Follow-up|0|||
155047823|NCT02559570|559606404|FG004|Overall Study|Lost to Follow-up|0|||
155047824|NCT02559570|559606400|FG000|Overall Study|Protocol Violation|1|||
155047825|NCT02559570|559606401|FG001|Overall Study|Protocol Violation|0|||
155047826|NCT02559570|559606402|FG002|Overall Study|Protocol Violation|0|||
155047827|NCT02559570|559606403|FG003|Overall Study|Protocol Violation|0|||
155047828|NCT02559570|559606404|FG004|Overall Study|Protocol Violation|1|||
155047829|NCT02559570|559606400|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155047830|NCT02559570|559606401|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155047831|NCT02559570|559606402|FG002|Overall Study|Other Miscellaneous Reasons|1|||
155047832|NCT02559570|559606403|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155047833|NCT02559570|559606404|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155047834|NCT00571662|559606409|FG000|Overall Study|Withdrawal by Subject|2|||
155047835|NCT00571662|559606409|FG000|Overall Study|psychiatric instability|1|||
155047836|NCT00571662|559606409|FG000|Overall Study|Adverse Event|5|||
155047837|NCT02588664|559606410|FG000|Overall Study|Death|56|||
155047838|NCT02588664|559606411|FG001|Overall Study|Death|55|||
155047839|NCT02588664|559606410|FG000|Overall Study|Lost to Follow-up|1305|||
155047840|NCT02588664|559606411|FG001|Overall Study|Lost to Follow-up|990|||
155047841|NCT00396383|559606414|FG000|Overall Study|Death|2|||
155047842|NCT00396383|559606414|FG000|Overall Study|Lost to Follow-up|1|||
155047843|NCT01839916|559606415|FG000|Overall Study|Death|9|||
155047844|NCT01839916|559606415|FG000|Overall Study|Physician Decision|17|||
155047845|NCT01839916|559606415|FG000|Overall Study|Relapse|12|||
155047846|NCT01839916|559606415|FG000|Overall Study|GVHD|2|||
155047847|NCT01839916|559606415|FG000|Overall Study|Graft Failure|1|||
155047848|NCT02385110|559606418|FG000|Overall Study|Early Death|1|||
155047849|NCT02385110|559606419|FG001|Overall Study|Early Death|0|||
155047850|NCT00534638|559606420|FG000|Overall Study|Withdrawal by Subject|3|||
155047851|NCT00534638|559606421|FG001|Overall Study|Withdrawal by Subject|4|||
155047852|NCT00534638|559606420|FG000|Overall Study|Migrated/moved from study area|13|||
155047853|NCT00534638|559606421|FG001|Overall Study|Migrated/moved from study area|11|||
155047854|NCT00534638|559606420|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
155047855|NCT00534638|559606421|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
155047856|NCT00534638|559606420|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
155047857|NCT00534638|559606421|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
155047858|NCT00534638|559606420|FG000|Overall Study|Other|1685|||
155047859|NCT00534638|559606421|FG001|Overall Study|Other|902|||
155047860|NCT02710084|559606426|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
155047861|NCT02710084|559606427|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
155047862|NCT00181883|559606428|FG000|Overall Study|Lack of Efficacy|2|||
155388140|NCT00307125|560855041|FG001|Screening Phase|Death|0|||
155388141|NCT00307125|560855042|FG002|Screening Phase|Death|0|||
155388142|NCT00307125|560855040|FG000|Screening Phase|Withdrawal by Subject|77|||
155388143|NCT00307125|560855041|FG001|Screening Phase|Withdrawal by Subject|0|||
155388144|NCT00307125|560855042|FG002|Screening Phase|Withdrawal by Subject|0|||
155388145|NCT00307125|560855040|FG000|Screening Phase|Physician Decision|26|||
155388146|NCT00307125|560855041|FG001|Screening Phase|Physician Decision|0|||
155388147|NCT00307125|560855042|FG002|Screening Phase|Physician Decision|0|||
155388148|NCT00307125|560855040|FG000|Screening Phase|Sponsor Decision|4|||
155388149|NCT00307125|560855041|FG001|Screening Phase|Sponsor Decision|0|||
155388150|NCT00307125|560855042|FG002|Screening Phase|Sponsor Decision|0|||
155388151|NCT00307125|560855040|FG000|Screening Phase|Study Terminated|17|||
155388152|NCT00307125|560855041|FG001|Screening Phase|Study Terminated|0|||
155047863|NCT00181883|559606428|FG000|Overall Study|Treatment Limiting AEs|3|||
155047864|NCT00181883|559606428|FG000|Overall Study|Withdrawal by Subject|4|||
155388153|NCT00307125|560855042|FG002|Screening Phase|Study Terminated|0|||
155047865|NCT00181883|559606428|FG000|Overall Study|Lost to Follow-up|1|||
155047866|NCT05305989|559606429|FG000|Overall Study|Other|3|||
155047867|NCT05305989|559606430|FG001|Overall Study|Other|2|||
155047868|NCT05305989|559606431|FG002|Overall Study|Other|0|||
155047869|NCT05305989|559606429|FG000|Overall Study|Sponsor decision|2|||
155047870|NCT05305989|559606430|FG001|Overall Study|Sponsor decision|1|||
155047871|NCT05305989|559606431|FG002|Overall Study|Sponsor decision|0|||
155388154|NCT00307125|560855040|FG000|Screening Phase|Graft Loss|3|||
155388155|NCT00307125|560855041|FG001|Screening Phase|Graft Loss|0|||
155047872|NCT05305989|559606429|FG000|Overall Study|Protocol Violation|0|||
155047873|NCT05305989|559606430|FG001|Overall Study|Protocol Violation|1|||
155047874|NCT05305989|559606431|FG002|Overall Study|Protocol Violation|0|||
155092572|NCT01959529|559773634|FG000|Overall Study|Lost to Follow-up|4|||
155047875|NCT05305989|559606429|FG000|Overall Study|Investigator decision|1|||
155047876|NCT05305989|559606430|FG001|Overall Study|Investigator decision|2|||
155047877|NCT05305989|559606431|FG002|Overall Study|Investigator decision|0|||
155047878|NCT05305989|559606429|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
155047879|NCT05305989|559606430|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
155047880|NCT05305989|559606431|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
155047881|NCT05305989|559606429|FG000|Overall Study|Adverse Event|1|||
155047882|NCT05305989|559606430|FG001|Overall Study|Adverse Event|1|||
155047883|NCT05305989|559606431|FG002|Overall Study|Adverse Event|0|||
155047884|NCT05305989|559606429|FG000|Overall Study|Enrolled but never dosed|3|||
155047885|NCT05305989|559606430|FG001|Overall Study|Enrolled but never dosed|2|||
155047886|NCT05305989|559606431|FG002|Overall Study|Enrolled but never dosed|1|||
155047887|NCT01124292|559606432|FG000|Overall Study|Lost to Follow-up|2|||
155047888|NCT01124292|559606433|FG001|Overall Study|Lost to Follow-up|4|||
155047889|NCT01124292|559606434|FG002|Overall Study|Lost to Follow-up|3|||
155047890|NCT01124292|559606432|FG000|Overall Study|Physician Decision|0|||
155047891|NCT01124292|559606433|FG001|Overall Study|Physician Decision|3|||
155047892|NCT01124292|559606434|FG002|Overall Study|Physician Decision|2|||
155047893|NCT01124292|559606432|FG000|Overall Study|Withdrawal by Subject|0|||
155047894|NCT01124292|559606433|FG001|Overall Study|Withdrawal by Subject|6|||
155047895|NCT01124292|559606434|FG002|Overall Study|Withdrawal by Subject|2|||
155047896|NCT01124292|559606432|FG000|Overall Study|medical issue unrelated to the study|0|||
155047897|NCT01124292|559606433|FG001|Overall Study|medical issue unrelated to the study|0|||
155047898|NCT01124292|559606434|FG002|Overall Study|medical issue unrelated to the study|2|||
155047899|NCT01124292|559606432|FG000|Overall Study|piercing track closed|0|||
155047900|NCT01124292|559606433|FG001|Overall Study|piercing track closed|2|||
155047901|NCT01124292|559606434|FG002|Overall Study|piercing track closed|1|||
155047902|NCT00481767|559606436|FG000|Overall Study|Withdrawal by Subject|16|||
155047903|NCT00481767|559606437|FG001|Overall Study|Withdrawal by Subject|11|||
155047904|NCT00481767|559606436|FG000|Overall Study|Lost to Follow-up|16|||
155047905|NCT00481767|559606437|FG001|Overall Study|Lost to Follow-up|10|||
155047906|NCT01366638|559606438|FG000|Overall Study|Withdrawal by Subject|0|||
155047907|NCT01366638|559606439|FG001|Overall Study|Withdrawal by Subject|0|||
155047908|NCT01366638|559606440|FG002|Overall Study|Withdrawal by Subject|6|||
155047909|NCT01366638|559606438|FG000|Overall Study|Other|1|||
155047910|NCT01366638|559606439|FG001|Overall Study|Other|0|||
155047911|NCT01366638|559606440|FG002|Overall Study|Other|0|||
155047912|NCT00636636|559606441|FG000|Overall Study|Other reason|4|||
155047913|NCT00636636|559606442|FG001|Overall Study|Other reason|6|||
155047914|NCT00636636|559606441|FG000|Overall Study|Adverse Event|19|||
155047915|NCT00636636|559606442|FG001|Overall Study|Adverse Event|8|||
155047916|NCT00636636|559606441|FG000|Overall Study|Lack of Efficacy|7|||
155047917|NCT00636636|559606442|FG001|Overall Study|Lack of Efficacy|12|||
155047918|NCT00636636|559606441|FG000|Overall Study|Protocol Violation|2|||
155047919|NCT00636636|559606442|FG001|Overall Study|Protocol Violation|2|||
155047920|NCT00636636|559606441|FG000|Overall Study|Lost to Follow-up|0|||
155047921|NCT00636636|559606442|FG001|Overall Study|Lost to Follow-up|1|||
155047922|NCT00636636|559606441|FG000|Overall Study|Death|0|||
155047923|NCT00636636|559606442|FG001|Overall Study|Death|1|||
155047924|NCT00636636|559606441|FG000|Overall Study|Withdrawal by Subject|4|||
155047925|NCT00636636|559606442|FG001|Overall Study|Withdrawal by Subject|9|||
155047926|NCT00524173|559606443|FG000|Overall Study|Lost to Follow-up|0|||
155047927|NCT00524173|559606444|FG001|Overall Study|Lost to Follow-up|1|||
155047928|NCT00524173|559606443|FG000|Overall Study|Death|1|||
155047929|NCT00524173|559606444|FG001|Overall Study|Death|0|||
155047930|NCT00524173|559606443|FG000|Overall Study|Had not reached endpoint at study close|4|||
155047931|NCT00524173|559606444|FG001|Overall Study|Had not reached endpoint at study close|1|||
155047932|NCT01554163|559606445|FG000|Overall Study|Adverse Event|3|||
155047933|NCT01554163|559606446|FG001|Overall Study|Adverse Event|0|||
155047934|NCT01554163|559606445|FG000|Overall Study|Lack of Efficacy|1|||
155047935|NCT01554163|559606446|FG001|Overall Study|Lack of Efficacy|0|||
155047936|NCT01554163|559606445|FG000|Overall Study|Lost to Follow-up|1|||
155047937|NCT01554163|559606446|FG001|Overall Study|Lost to Follow-up|0|||
155047938|NCT01554163|559606445|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155047939|NCT01554163|559606446|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155047940|NCT01554163|559606445|FG000|Overall Study|Protocol Violation|0|||
155047941|NCT01554163|559606446|FG001|Overall Study|Protocol Violation|4|||
155047942|NCT01554163|559606445|FG000|Overall Study|Withdrawal by Subject|1|||
155047943|NCT01554163|559606446|FG001|Overall Study|Withdrawal by Subject|5|||
155047944|NCT01554163|559606445|FG000|Overall Study|Not Treated|1|||
155047945|NCT01554163|559606446|FG001|Overall Study|Not Treated|0|||
155047946|NCT01941537|559606447|FG000|Overall Study|Lack of Efficacy|1|||
155047947|NCT01941537|559606448|FG001|Overall Study|Lack of Efficacy|2|||
155047948|NCT01941537|559606447|FG000|Overall Study|Lost to Follow-up|1|||
155047949|NCT01941537|559606448|FG001|Overall Study|Lost to Follow-up|0|||
155047950|NCT01941537|559606447|FG000|Overall Study|Pregnancy|1|||
155047951|NCT01941537|559606448|FG001|Overall Study|Pregnancy|0|||
155047952|NCT01941537|559606447|FG000|Overall Study|Adverse Event|1|||
155047953|NCT01941537|559606448|FG001|Overall Study|Adverse Event|0|||
155047954|NCT01941537|559606447|FG000|Overall Study|Withdrawal by Subject|0|||
155047955|NCT01941537|559606448|FG001|Overall Study|Withdrawal by Subject|1|||
155047956|NCT05259163|559608653|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
155047957|NCT05259163|559608654|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
155047958|NCT05251233|559608655|FG000|Overall Study|Disease progression - did not start treatment|0|||
155047959|NCT05251233|559608656|FG001|Overall Study|Disease progression - did not start treatment|0|||
155047960|NCT05251233|559608657|FG002|Overall Study|Disease progression - did not start treatment|5|||
155047961|NCT05251233|559608655|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
155047962|NCT05251233|559608656|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
155047963|NCT05251233|559608657|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
155047964|NCT05251233|559608655|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
155047965|NCT05251233|559608656|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
155047966|NCT05251233|559608657|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
155047967|NCT05251233|559608655|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
155047968|NCT05251233|559608656|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
155047969|NCT05251233|559608657|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
155047970|NCT05251233|559608655|FG000|Overall Study|Death - did not start treatment|3|||
155047971|NCT05251233|559608656|FG001|Overall Study|Death - did not start treatment|0|||
155047972|NCT05251233|559608657|FG002|Overall Study|Death - did not start treatment|0|||
155047973|NCT05251233|559608655|FG000|Overall Study|Withdrawal by Subject|2|||
155047974|NCT05251233|559608656|FG001|Overall Study|Withdrawal by Subject|2|||
155047975|NCT05251233|559608657|FG002|Overall Study|Withdrawal by Subject|0|||
155047976|NCT05251233|559608655|FG000|Overall Study|Other complicating disease|2|||
155047977|NCT05251233|559608656|FG001|Overall Study|Other complicating disease|1|||
155047978|NCT05251233|559608657|FG002|Overall Study|Other complicating disease|0|||
155047979|NCT05251233|559608655|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
155047980|NCT05251233|559608656|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
155047981|NCT05251233|559608657|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
155047982|NCT05251233|559608655|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
155047983|NCT05251233|559608656|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
155047984|NCT05251233|559608657|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
155047985|NCT00452439|559608659|FG000|Overall Study|Lost to Follow-up|1|||
155047986|NCT00452439|559608660|FG001|Overall Study|Lost to Follow-up|1|||
155047987|NCT00452439|559608659|FG000|Overall Study|Refused Treatment|4|||
155047988|NCT00452439|559608660|FG001|Overall Study|Refused Treatment|3|||
155047989|NCT00452439|559608659|FG000|Overall Study|Death|3|||
155047990|NCT00452439|559608660|FG001|Overall Study|Death|1|||
155047991|NCT00452439|559608659|FG000|Overall Study|Bone Marrow Transplant|0|||
155047992|NCT00452439|559608660|FG001|Overall Study|Bone Marrow Transplant|1|||
155047993|NCT00452439|559608659|FG000|Overall Study|Too Ill to Continue|0|||
155047994|NCT00452439|559608660|FG001|Overall Study|Too Ill to Continue|1|||
155047995|NCT00452439|559608659|FG000|Overall Study|Failed to achieve complete response|2|||
155047996|NCT00452439|559608660|FG001|Overall Study|Failed to achieve complete response|0|||
155047997|NCT00452439|559608659|FG000|Overall Study|Relapse|3|||
155047998|NCT00452439|559608660|FG001|Overall Study|Relapse|0|||
155047999|NCT00452439|559608659|FG000|Overall Study|Fracture|1|||
155048000|NCT00452439|559608660|FG001|Overall Study|Fracture|0|||
155048001|NCT01381926|559608661|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
155048002|NCT01381926|559608662|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
155048003|NCT01381926|559608661|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
155048004|NCT01381926|559608662|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
155048005|NCT02624947|559608667|FG000|Maternal Participants|Adverse Event|5|||
155048006|NCT02624947|559608668|FG001|Maternal Participants|Adverse Event|0|||
155048007|NCT02624947|559608667|FG000|Maternal Participants|Investigator Decision|5|||
155048008|NCT02624947|559608668|FG001|Maternal Participants|Investigator Decision|3|||
155048009|NCT02624947|559608667|FG000|Maternal Participants|Lost to Follow-up|54|||
155048010|NCT02624947|559608668|FG001|Maternal Participants|Lost to Follow-up|24|||
155048011|NCT02624947|559608667|FG000|Maternal Participants|Non Compliance|8|||
155048012|NCT02624947|559608668|FG001|Maternal Participants|Non Compliance|5|||
155048013|NCT02624947|559608667|FG000|Maternal Participants|Sponsor Request|1|||
155048014|NCT02624947|559608668|FG001|Maternal Participants|Sponsor Request|1|||
155048015|NCT02624947|559608667|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
155048016|NCT02624947|559608668|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
155048017|NCT02624947|559608667|FG000|Maternal Participants|Miscellaneous|23|||
155048018|NCT02624947|559608668|FG001|Maternal Participants|Miscellaneous|15|||
155048019|NCT02624947|559608667|FG000|Infant Participants|Adverse Event|18|||
155048020|NCT02624947|559608668|FG001|Infant Participants|Adverse Event|11|||
155048021|NCT02624947|559608667|FG000|Infant Participants|Investigator Decision|5|||
155048022|NCT02624947|559608668|FG001|Infant Participants|Investigator Decision|4|||
155048023|NCT02624947|559608667|FG000|Infant Participants|Lost to Follow-up|93|||
155048024|NCT02624947|559608668|FG001|Infant Participants|Lost to Follow-up|58|||
155048025|NCT02624947|559608667|FG000|Infant Participants|Non Compliance|17|||
155048026|NCT02624947|559608668|FG001|Infant Participants|Non Compliance|7|||
155048027|NCT02624947|559608667|FG000|Infant Participants|Sponsor Request|0|||
155048028|NCT02624947|559608668|FG001|Infant Participants|Sponsor Request|1|||
155048029|NCT02624947|559608667|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
155048030|NCT02624947|559608668|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
155048031|NCT02624947|559608667|FG000|Infant Participants|Miscellaneous|50|||
155048032|NCT02624947|559608668|FG001|Infant Participants|Miscellaneous|26|||
155048033|NCT03654729|559608677|FG000|Overall Study|Death|9|||
155048034|NCT03654729|559608678|FG001|Overall Study|Death|9|||
155048035|NCT03654729|559608679|FG002|Overall Study|Death|16|||
155048036|NCT03654729|559608677|FG000|Overall Study|Withdrawal by Subject|8|||
155048037|NCT03654729|559608678|FG001|Overall Study|Withdrawal by Subject|6|||
155048038|NCT03654729|559608679|FG002|Overall Study|Withdrawal by Subject|4|||
155048039|NCT03654729|559608677|FG000|Overall Study|Study terminated by Sponsor|3|||
155048040|NCT03654729|559608678|FG001|Overall Study|Study terminated by Sponsor|5|||
155048041|NCT03654729|559608679|FG002|Overall Study|Study terminated by Sponsor|4|||
155048042|NCT03654729|559608677|FG000|Overall Study|Not reported|2|||
155048043|NCT03654729|559608678|FG001|Overall Study|Not reported|4|||
155048044|NCT03654729|559608679|FG002|Overall Study|Not reported|5|||
155048045|NCT03654729|559608677|FG000|Overall Study|Progressive disease|3|||
155048046|NCT03654729|559608678|FG001|Overall Study|Progressive disease|0|||
155048047|NCT03654729|559608679|FG002|Overall Study|Progressive disease|0|||
155048048|NCT03654729|559608677|FG000|Overall Study|Lost to Follow-up|2|||
155048049|NCT03654729|559608678|FG001|Overall Study|Lost to Follow-up|0|||
155048050|NCT03654729|559608679|FG002|Overall Study|Lost to Follow-up|0|||
155048051|NCT03654729|559608677|FG000|Overall Study|Physician Decision|2|||
155048052|NCT03654729|559608678|FG001|Overall Study|Physician Decision|0|||
155048053|NCT03654729|559608679|FG002|Overall Study|Physician Decision|0|||
155048054|NCT03654729|559608677|FG000|Overall Study|Protocol Violation|1|||
155048055|NCT03654729|559608678|FG001|Overall Study|Protocol Violation|1|||
155048056|NCT03654729|559608679|FG002|Overall Study|Protocol Violation|0|||
155048057|NCT03654729|559608677|FG000|Overall Study|Non-compliance with study drug|0|||
155048058|NCT03654729|559608678|FG001|Overall Study|Non-compliance with study drug|1|||
155048059|NCT03654729|559608679|FG002|Overall Study|Non-compliance with study drug|0|||
155048060|NCT03654729|559608677|FG000|Overall Study|Site terminated by Sponsor|1|||
155048061|NCT03654729|559608678|FG001|Overall Study|Site terminated by Sponsor|0|||
155048062|NCT03654729|559608679|FG002|Overall Study|Site terminated by Sponsor|0|||
155048063|NCT00463801|559608686|FG000|Overall Study|Protocol Violation|1|||
155048064|NCT00463801|559608686|FG000|Overall Study|Lack of Efficacy|2|||
155048065|NCT00463801|559608686|FG000|Overall Study|Adverse Event|4|||
155048066|NCT00463801|559608686|FG000|Overall Study|Lost to Follow-up|5|||
155048067|NCT00463801|559608686|FG000|Overall Study|No longer require therapy|1|||
155048068|NCT00669318|559608687|FG000|Overall Study|Withdrawal by Subject|2|||
155048069|NCT00215644|559608691|FG000|Overall Study|Disease Progression|28|||
155048070|NCT00215644|559608692|FG001|Overall Study|Disease Progression|10|||
155048071|NCT00215644|559608691|FG000|Overall Study|Adverse Event|2|||
155048072|NCT00215644|559608692|FG001|Overall Study|Adverse Event|9|||
155048073|NCT00215644|559608691|FG000|Overall Study|Death|1|||
155048074|NCT00215644|559608692|FG001|Overall Study|Death|2|||
155048075|NCT00215644|559608691|FG000|Overall Study|Withdrawal by Subject|1|||
155048076|NCT00215644|559608692|FG001|Overall Study|Withdrawal by Subject|0|||
155281339|NCT01256476|560461547|FG001|Overall Study|Persistent ALT or AST elevation|0|||
155281340|NCT01256476|560461546|FG000|Overall Study|Physician Decision|0|||
155281341|NCT01256476|560461547|FG001|Overall Study|Physician Decision|1|||
155281342|NCT01256476|560461546|FG000|Overall Study|Subject non-compliance|0|||
155281343|NCT01256476|560461547|FG001|Overall Study|Subject non-compliance|1|||
155048077|NCT00215644|559608691|FG000|Overall Study|Other|3|||
155281344|NCT01256476|560461546|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
155281345|NCT01256476|560461547|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
155281346|NCT04034238|560461550|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
155281347|NCT04034238|560461551|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155048078|NCT00215644|559608692|FG001|Overall Study|Other|15|||
155048079|NCT00215644|559608691|FG000|Overall Study|Randomized but Not Treated|1|||
155048080|NCT00215644|559608692|FG001|Overall Study|Randomized but Not Treated|0|||
155048081|NCT03512353|559608695|FG000|Overall Study|Sponsor Decision|3|||
155048082|NCT03512353|559608695|FG000|Overall Study|Death|1|||
155048083|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
155048084|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
155048085|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
155281348|NCT04034238|560461552|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155281349|NCT04034238|560461553|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155281350|NCT04034238|560461550|FG000|Dose Escalation Phase|Screen failures|0|||
155281351|NCT04034238|560461551|FG001|Dose Escalation Phase|Screen failures|0|||
155281352|NCT04034238|560461552|FG002|Dose Escalation Phase|Screen failures|0|||
155048086|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
155048087|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
155048088|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
155048089|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
155048090|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
155048091|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
155048092|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
155048093|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
155048094|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
155048095|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
155048096|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
155048097|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
155048098|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
155048099|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
155048100|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
155048101|NCT03569098|559608696|FG000|Double-Blind Treatment Cycle 1|Other|1|||
155048102|NCT03569098|559608697|FG001|Double-Blind Treatment Cycle 1|Other|0|||
155048103|NCT03569098|559608698|FG002|Double-Blind Treatment Cycle 1|Other|1|||
155048104|NCT03569098|559608696|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
155048105|NCT03569098|559608697|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
155048106|NCT03569098|559608698|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
155048107|NCT03569098|559608696|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
155048108|NCT03569098|559608697|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
155048109|NCT03569098|559608698|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
155048110|NCT03569098|559608696|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
155048111|NCT03569098|559608697|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
155048112|NCT03569098|559608698|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
155048113|NCT03569098|559608696|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
155048114|NCT03569098|559608697|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
155048115|NCT03569098|559608698|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
155048116|NCT03569098|559608696|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
155048117|NCT03569098|559608697|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
155048118|NCT03569098|559608698|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
155048119|NCT03569098|559608696|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
155048120|NCT03569098|559608697|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
155048121|NCT03569098|559608698|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
155048122|NCT02581488|559608701|FG000|Overall Study|Adverse Event|6|||
155048123|NCT02581488|559608702|FG001|Overall Study|Adverse Event|7|||
155048124|NCT02581488|559608701|FG000|Overall Study|Lost to Follow-up|1|||
155048125|NCT02581488|559608702|FG001|Overall Study|Lost to Follow-up|0|||
155048126|NCT02581488|559608701|FG000|Overall Study|Withdrawal by Subject|1|||
155048127|NCT02581488|559608702|FG001|Overall Study|Withdrawal by Subject|0|||
155048128|NCT02581488|559608701|FG000|Overall Study|Non-Compliance|1|||
155048129|NCT02581488|559608702|FG001|Overall Study|Non-Compliance|0|||
155048130|NCT02581488|559608701|FG000|Overall Study|Protocol Violation|0|||
155048131|NCT02581488|559608702|FG001|Overall Study|Protocol Violation|4|||
155048132|NCT04534517|559608706|FG000|Overall Study|Adverse Event|1|||
155048133|NCT04534517|559608706|FG000|Overall Study|Withdrawal by Subject|1|||
155048134|NCT04534517|559608706|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155048135|NCT04534517|559608706|FG000|Overall Study|COVID-19 Related|1|||
155048136|NCT00872521|559608707|FG000|Completed PAD Induction|Patient choice|0|||
155048137|NCT00872521|559608708|FG001|Completed PAD Induction|Patient choice|1|||
155048138|NCT00872521|559608709|FG002|Completed PAD Induction|Patient choice|0|||
155048139|NCT00872521|559608707|FG000|Completed PAD Induction|Disease progression|0|||
155048140|NCT00872521|559608708|FG001|Completed PAD Induction|Disease progression|2|||
155048141|NCT00872521|559608709|FG002|Completed PAD Induction|Disease progression|0|||
155048142|NCT00872521|559608707|FG000|Completed PAD Induction|Adverse Event|4|||
155048143|NCT00872521|559608708|FG001|Completed PAD Induction|Adverse Event|0|||
155048144|NCT00872521|559608709|FG002|Completed PAD Induction|Adverse Event|0|||
155048145|NCT00872521|559608707|FG000|Completed PAD Induction|Death|1|||
155048146|NCT00872521|559608708|FG001|Completed PAD Induction|Death|1|||
155048147|NCT00872521|559608709|FG002|Completed PAD Induction|Death|0|||
155048148|NCT00872521|559608707|FG000|Primary Endpoint Analysis|Other|1|||
155048149|NCT00872521|559608708|FG001|Primary Endpoint Analysis|Other|2|||
155048150|NCT00872521|559608709|FG002|Primary Endpoint Analysis|Other|0|||
155048151|NCT00872521|559608707|FG000|Primary Endpoint Analysis|Patient choice|0|||
155281353|NCT04034238|560461553|FG003|Dose Escalation Phase|Screen failures|2|||
155281354|NCT04034238|560461550|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
155048152|NCT00872521|559608708|FG001|Primary Endpoint Analysis|Patient choice|1|||
155048153|NCT00872521|559608709|FG002|Primary Endpoint Analysis|Patient choice|0|||
155048154|NCT00872521|559608707|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
155048155|NCT00872521|559608708|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
155048156|NCT00872521|559608709|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
155048157|NCT00872521|559608707|FG000|Primary Endpoint Analysis|Patient response missing|0|||
155048158|NCT00872521|559608708|FG001|Primary Endpoint Analysis|Patient response missing|0|||
155048159|NCT00872521|559608709|FG002|Primary Endpoint Analysis|Patient response missing|1|||
155048160|NCT00872521|559608707|FG000|Completed 3-month Follow up|Other|0|||
155388156|NCT00307125|560855042|FG002|Screening Phase|Graft Loss|0|||
155388157|NCT00307125|560855040|FG000|Screening Phase|Graft Failure|8|||
155388158|NCT00307125|560855041|FG001|Screening Phase|Graft Failure|0|||
155388159|NCT00307125|560855042|FG002|Screening Phase|Graft Failure|0|||
155388160|NCT00307125|560855040|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
155388161|NCT00307125|560855041|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
155388162|NCT00307125|560855042|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
155388163|NCT00307125|560855040|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
155388164|NCT00307125|560855041|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
155388165|NCT00307125|560855042|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
155388166|NCT00307125|560855040|FG000|Screening Phase|Moved or transferred facilities|34|||
155388167|NCT00307125|560855041|FG001|Screening Phase|Moved or transferred facilities|0|||
155388168|NCT00307125|560855042|FG002|Screening Phase|Moved or transferred facilities|0|||
155388169|NCT00307125|560855040|FG000|Screening Phase|Received Pancreas Transplant|8|||
155388170|NCT00307125|560855041|FG001|Screening Phase|Received Pancreas Transplant|0|||
155388171|NCT00307125|560855042|FG002|Screening Phase|Received Pancreas Transplant|0|||
155388172|NCT00307125|560855040|FG000|Screening Phase|Ineligible for pilot|4|||
155388173|NCT00307125|560855041|FG001|Screening Phase|Ineligible for pilot|0|||
155388174|NCT00307125|560855042|FG002|Screening Phase|Ineligible for pilot|0|||
155388175|NCT00307125|560855040|FG000|Screening Phase|Try to get pregnant|1|||
155388176|NCT00307125|560855041|FG001|Screening Phase|Try to get pregnant|0|||
155388177|NCT00307125|560855042|FG002|Screening Phase|Try to get pregnant|0|||
155388178|NCT00307125|560855040|FG000|Screening Phase|Developed acute leukemia|1|||
155388179|NCT00307125|560855041|FG001|Screening Phase|Developed acute leukemia|0|||
155388180|NCT00307125|560855042|FG002|Screening Phase|Developed acute leukemia|0|||
155388181|NCT00307125|560855040|FG000|Screening Phase|Metastatic colon cancer|1|||
155388182|NCT00307125|560855041|FG001|Screening Phase|Metastatic colon cancer|0|||
155388183|NCT00307125|560855042|FG002|Screening Phase|Metastatic colon cancer|0|||
155388184|NCT00307125|560855040|FG000|Screening Phase|Malignancy|1|||
155388185|NCT00307125|560855041|FG001|Screening Phase|Malignancy|0|||
155388186|NCT00307125|560855042|FG002|Screening Phase|Malignancy|0|||
155388187|NCT00307125|560855040|FG000|Screening Phase|PAK|1|||
155388188|NCT00307125|560855041|FG001|Screening Phase|PAK|0|||
155388189|NCT00307125|560855042|FG002|Screening Phase|PAK|0|||
155388190|NCT00307125|560855040|FG000|Screening Phase|Ineligible|1|||
155388191|NCT00307125|560855041|FG001|Screening Phase|Ineligible|0|||
155388192|NCT00307125|560855042|FG002|Screening Phase|Ineligible|0|||
155388193|NCT00307125|560855040|FG000|Screening Phase|Screen Error|1|||
155388194|NCT00307125|560855041|FG001|Screening Phase|Screen Error|0|||
155388195|NCT00307125|560855042|FG002|Screening Phase|Screen Error|0|||
155388196|NCT00307125|560855040|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
155388197|NCT00307125|560855041|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
155388198|NCT00307125|560855042|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
155388199|NCT00307125|560855040|FG000|Screening Phase|AMR and treated with rituximab|1|||
155388200|NCT00307125|560855041|FG001|Screening Phase|AMR and treated with rituximab|0|||
155388201|NCT00307125|560855042|FG002|Screening Phase|AMR and treated with rituximab|0|||
155388202|NCT00307125|560855040|FG000|Screening Phase|Coronary artery bypass|1|||
155388203|NCT00307125|560855041|FG001|Screening Phase|Coronary artery bypass|0|||
155388204|NCT00307125|560855042|FG002|Screening Phase|Coronary artery bypass|0|||
155388205|NCT00307125|560855040|FG000|Pilot Phase|Lost to Follow-up|0|||
155388206|NCT00307125|560855041|FG001|Pilot Phase|Lost to Follow-up|1|||
155388207|NCT00307125|560855042|FG002|Pilot Phase|Lost to Follow-up|0|||
155388208|NCT00307125|560855040|FG000|Pilot Phase|Withdrawal by Subject|0|||
155388209|NCT00307125|560855041|FG001|Pilot Phase|Withdrawal by Subject|1|||
155388210|NCT00307125|560855042|FG002|Pilot Phase|Withdrawal by Subject|1|||
155388211|NCT00051363|560855043|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
155388212|NCT00051363|560855044|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
155388213|NCT00051363|560855043|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
155388214|NCT00051363|560855044|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
155388215|NCT00051363|560855043|FG000|Overall Study|Death|2|||
155388216|NCT00051363|560855044|FG001|Overall Study|Death|2|||
155048161|NCT00872521|559608708|FG001|Completed 3-month Follow up|Other|2|||
155388217|NCT00051363|560855043|FG000|Overall Study|Excluded Pre-Randomization|2|||
155048162|NCT00872521|559608709|FG002|Completed 3-month Follow up|Other|0|||
155048163|NCT00872521|559608707|FG000|Completed 3-month Follow up|Physician Decision|0|||
155388218|NCT00051363|560855044|FG001|Overall Study|Excluded Pre-Randomization|5|||
155388219|NCT01290601|560855045|FG000|Overall Study|Adverse Event|0|||
155388220|NCT01290601|560855046|FG001|Overall Study|Adverse Event|2|||
155388221|NCT01290601|560855047|FG002|Overall Study|Adverse Event|0|||
155388222|NCT01290601|560855048|FG003|Overall Study|Adverse Event|0|||
155388223|NCT01290601|560855045|FG000|Overall Study|Lack of Efficacy|2|||
155388224|NCT01290601|560855046|FG001|Overall Study|Lack of Efficacy|1|||
155388225|NCT01290601|560855047|FG002|Overall Study|Lack of Efficacy|0|||
155388226|NCT01290601|560855048|FG003|Overall Study|Lack of Efficacy|0|||
154946065|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946066|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946067|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946068|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946069|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946070|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946071|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946072|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946073|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946074|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946075|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946076|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
154946077|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
154946078|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946079|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946080|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946081|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946082|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946083|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946084|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946085|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946086|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
154946087|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
154946088|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
154946089|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
154946090|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
154946091|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
154946092|NCT04033445|559228222|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946093|NCT04033445|559228223|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946094|NCT04033445|559228224|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946095|NCT04033445|559228225|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946096|NCT04033445|559228226|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946097|NCT04033445|559228227|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946098|NCT04033445|559228228|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946099|NCT04033445|559228229|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946100|NCT04033445|559228230|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946101|NCT04033445|559228231|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
154946102|NCT04033445|559228232|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946103|NCT04033445|559228233|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
154946104|NCT04033445|559228234|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
154946105|NCT04033445|559228235|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
154946106|NCT02985957|559228236|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154946107|NCT02985957|559228237|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154946108|NCT02985957|559228238|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154946109|NCT02985957|559228239|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154946110|NCT02985957|559228240|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
154946111|NCT02985957|559228241|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154946112|NCT02985957|559228242|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154946113|NCT02985957|559228236|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
154946114|NCT02985957|559228237|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
154946115|NCT02985957|559228238|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
154946116|NCT02985957|559228239|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
154946117|NCT02985957|559228240|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
154946118|NCT02985957|559228241|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
155388227|NCT01290601|560855045|FG000|Overall Study|Lost to Follow-up|7|||
155388228|NCT01290601|560855046|FG001|Overall Study|Lost to Follow-up|2|||
155388229|NCT01290601|560855047|FG002|Overall Study|Lost to Follow-up|0|||
155388230|NCT01290601|560855048|FG003|Overall Study|Lost to Follow-up|0|||
155388231|NCT01290601|560855045|FG000|Overall Study|Other|1|||
155388232|NCT01290601|560855046|FG001|Overall Study|Other|0|||
154946119|NCT02985957|559228242|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
154946120|NCT02985957|559228236|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154946121|NCT02985957|559228237|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154946122|NCT02985957|559228238|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154946123|NCT02985957|559228239|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154946124|NCT02985957|559228240|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154946125|NCT02985957|559228241|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154946126|NCT02985957|559228242|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
154946127|NCT02985957|559228236|FG000|Treatment Period|Death|0|||
154946128|NCT02985957|559228237|FG001|Treatment Period|Death|0|||
154946129|NCT02985957|559228238|FG002|Treatment Period|Death|0|||
154946130|NCT02985957|559228239|FG003|Treatment Period|Death|0|||
154946131|NCT02985957|559228240|FG004|Treatment Period|Death|1|||
154946132|NCT02985957|559228241|FG005|Treatment Period|Death|0|||
154946133|NCT02985957|559228242|FG006|Treatment Period|Death|0|||
154946134|NCT02985957|559228236|FG000|Treatment Period|Participant withdrew consent|0|||
154946135|NCT02985957|559228237|FG001|Treatment Period|Participant withdrew consent|0|||
154946136|NCT02985957|559228238|FG002|Treatment Period|Participant withdrew consent|0|||
154946137|NCT02985957|559228239|FG003|Treatment Period|Participant withdrew consent|1|||
154946138|NCT02985957|559228240|FG004|Treatment Period|Participant withdrew consent|3|||
154946139|NCT02985957|559228241|FG005|Treatment Period|Participant withdrew consent|0|||
154946140|NCT02985957|559228242|FG006|Treatment Period|Participant withdrew consent|1|||
154946141|NCT02985957|559228236|FG000|Treatment Period|Lost to Follow-up|0|||
154946142|NCT02985957|559228237|FG001|Treatment Period|Lost to Follow-up|0|||
154946143|NCT02985957|559228238|FG002|Treatment Period|Lost to Follow-up|0|||
154946144|NCT02985957|559228239|FG003|Treatment Period|Lost to Follow-up|0|||
154946145|NCT02985957|559228240|FG004|Treatment Period|Lost to Follow-up|1|||
154946146|NCT02985957|559228241|FG005|Treatment Period|Lost to Follow-up|0|||
154946147|NCT02985957|559228242|FG006|Treatment Period|Lost to Follow-up|0|||
154946148|NCT02985957|559228236|FG000|Treatment Period|Other reasons|0|||
154946149|NCT02985957|559228237|FG001|Treatment Period|Other reasons|0|||
154946150|NCT02985957|559228238|FG002|Treatment Period|Other reasons|1|||
154946151|NCT02985957|559228239|FG003|Treatment Period|Other reasons|3|||
154946152|NCT02985957|559228240|FG004|Treatment Period|Other reasons|5|||
154946153|NCT02985957|559228241|FG005|Treatment Period|Other reasons|0|||
154946154|NCT02985957|559228242|FG006|Treatment Period|Other reasons|1|||
154946155|NCT02985957|559228236|FG000|Treatment Period|Not reported|0|||
154946156|NCT02985957|559228237|FG001|Treatment Period|Not reported|2|||
154946157|NCT02985957|559228238|FG002|Treatment Period|Not reported|2|||
154946158|NCT02985957|559228239|FG003|Treatment Period|Not reported|5|||
154946159|NCT02985957|559228240|FG004|Treatment Period|Not reported|0|||
154946160|NCT02985957|559228241|FG005|Treatment Period|Not reported|0|||
154946161|NCT02985957|559228242|FG006|Treatment Period|Not reported|0|||
154946162|NCT02985957|559228236|FG000|Treatment Period|Maximum clinical benefit|0|||
154946163|NCT02985957|559228237|FG001|Treatment Period|Maximum clinical benefit|0|||
154946164|NCT02985957|559228238|FG002|Treatment Period|Maximum clinical benefit|1|||
154946165|NCT02985957|559228239|FG003|Treatment Period|Maximum clinical benefit|1|||
154946166|NCT02985957|559228240|FG004|Treatment Period|Maximum clinical benefit|0|||
154946167|NCT02985957|559228241|FG005|Treatment Period|Maximum clinical benefit|0|||
154946168|NCT02985957|559228242|FG006|Treatment Period|Maximum clinical benefit|2|||
154946169|NCT02985957|559228236|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
154946170|NCT02985957|559228237|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
154946171|NCT02985957|559228238|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
154946172|NCT02985957|559228239|FG003|Treatment Period|Adverse event unrelated to study drug|2|||
154946173|NCT02985957|559228240|FG004|Treatment Period|Adverse event unrelated to study drug|8|||
154946174|NCT02985957|559228241|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
154946175|NCT02985957|559228242|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
154946176|NCT02985957|559228236|FG000|Treatment Period|Study drug toxicity|1|||
154946177|NCT02985957|559228237|FG001|Treatment Period|Study drug toxicity|23|||
154946178|NCT02985957|559228238|FG002|Treatment Period|Study drug toxicity|20|||
154946179|NCT02985957|559228239|FG003|Treatment Period|Study drug toxicity|12|||
154946180|NCT02985957|559228240|FG004|Treatment Period|Study drug toxicity|20|||
155388233|NCT01290601|560855047|FG002|Overall Study|Other|0|||
154946181|NCT02985957|559228241|FG005|Treatment Period|Study drug toxicity|3|||
154946182|NCT02985957|559228242|FG006|Treatment Period|Study drug toxicity|5|||
154946183|NCT02985957|559228236|FG000|Treatment Period|Disease progression|0|||
155388234|NCT01290601|560855048|FG003|Overall Study|Other|0|||
155388235|NCT01290601|560855045|FG000|Overall Study|Protocol Violation|1|||
154946184|NCT02985957|559228237|FG001|Treatment Period|Disease progression|16|||
154946185|NCT02985957|559228238|FG002|Treatment Period|Disease progression|20|||
155048164|NCT00872521|559608708|FG001|Completed 3-month Follow up|Physician Decision|1|||
155388236|NCT01290601|560855046|FG001|Overall Study|Protocol Violation|0|||
155048165|NCT00872521|559608709|FG002|Completed 3-month Follow up|Physician Decision|0|||
155048166|NCT00872521|559608707|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
155048167|NCT00872521|559608708|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
155048168|NCT00872521|559608709|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
155048169|NCT01089127|559608713|FG000|Overall Study|Adverse Event|5|||
155048170|NCT01089127|559608714|FG001|Overall Study|Adverse Event|1|||
155048171|NCT01089127|559608715|FG002|Overall Study|Adverse Event|1|||
155048172|NCT01089127|559608716|FG003|Overall Study|Adverse Event|0|||
155048173|NCT01089127|559608717|FG004|Overall Study|Adverse Event|0|||
155048174|NCT01089127|559608718|FG005|Overall Study|Adverse Event|1|||
155048175|NCT01089127|559608713|FG000|Overall Study|Subject withdrew consent|0|||
155048176|NCT01089127|559608714|FG001|Overall Study|Subject withdrew consent|1|||
155048177|NCT01089127|559608715|FG002|Overall Study|Subject withdrew consent|1|||
155048178|NCT01089127|559608716|FG003|Overall Study|Subject withdrew consent|1|||
155048179|NCT01089127|559608717|FG004|Overall Study|Subject withdrew consent|0|||
155048180|NCT01089127|559608718|FG005|Overall Study|Subject withdrew consent|2|||
155048181|NCT01089127|559608713|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155048182|NCT01089127|559608714|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155048183|NCT01089127|559608715|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155048184|NCT01089127|559608716|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155048185|NCT01089127|559608717|FG004|Overall Study|Abnormal test procedure result(s)|0|||
155048186|NCT01089127|559608718|FG005|Overall Study|Abnormal test procedure result(s)|0|||
155048187|NCT01089127|559608713|FG000|Overall Study|Lost to Follow-up|1|||
155048188|NCT01089127|559608714|FG001|Overall Study|Lost to Follow-up|1|||
155048189|NCT01089127|559608715|FG002|Overall Study|Lost to Follow-up|0|||
155048190|NCT01089127|559608716|FG003|Overall Study|Lost to Follow-up|0|||
155048191|NCT01089127|559608717|FG004|Overall Study|Lost to Follow-up|1|||
155048192|NCT01089127|559608718|FG005|Overall Study|Lost to Follow-up|0|||
155048193|NCT01089127|559608713|FG000|Overall Study|Protocol deviation|0|||
155048194|NCT01089127|559608714|FG001|Overall Study|Protocol deviation|1|||
155048195|NCT01089127|559608715|FG002|Overall Study|Protocol deviation|0|||
155048196|NCT01089127|559608716|FG003|Overall Study|Protocol deviation|0|||
155048197|NCT01089127|559608717|FG004|Overall Study|Protocol deviation|1|||
155048198|NCT01089127|559608718|FG005|Overall Study|Protocol deviation|0|||
155048199|NCT03200548|559608719|FG000|Overall Study|Withdrawal by Subject|5|||
155048200|NCT03200548|559608720|FG001|Overall Study|Withdrawal by Subject|11|||
155048201|NCT03200548|559608721|FG002|Overall Study|Withdrawal by Subject|7|||
155048202|NCT03200548|559608722|FG003|Overall Study|Withdrawal by Subject|6|||
155048203|NCT00511810|559608725|FG000|Overall Study|Lost to Follow-up|1|||
155048204|NCT00511810|559608726|FG001|Overall Study|Lost to Follow-up|2|||
155048205|NCT00511810|559608725|FG000|Overall Study|Lack of Efficacy|0|||
155048206|NCT00511810|559608726|FG001|Overall Study|Lack of Efficacy|2|||
155048207|NCT00511810|559608725|FG000|Overall Study|Refused second scn|0|||
155048208|NCT00511810|559608726|FG001|Overall Study|Refused second scn|1|||
155048209|NCT02896569|559608727|FG000|Overall Study|Lost to Follow-up|2|||
155048210|NCT02896569|559608728|FG001|Overall Study|Lost to Follow-up|1|||
155048211|NCT02896569|559608727|FG000|Overall Study|Physician Decision|1|||
155048212|NCT02896569|559608728|FG001|Overall Study|Physician Decision|3|||
155048213|NCT02896569|559608727|FG000|Overall Study|Adverse Event|0|||
155048214|NCT02896569|559608728|FG001|Overall Study|Adverse Event|1|||
155048215|NCT02896569|559608727|FG000|Overall Study|Withdrawal by Subject|1|||
155048216|NCT02896569|559608728|FG001|Overall Study|Withdrawal by Subject|0|||
155048217|NCT01462630|559608729|FG000|Overall Study|Did not initiate therapy|3|||
155048218|NCT01462630|559608729|FG000|Overall Study|Death|1|||
155048219|NCT01462630|559608729|FG000|Overall Study|Protocol Violation|2|||
155048220|NCT01462630|559608729|FG000|Overall Study|Adverse Event|1|||
155048221|NCT02592447|559608730|FG000|Overall Study|Lost to Follow-up|1|||
155048222|NCT02592447|559608731|FG001|Overall Study|Lost to Follow-up|0|||
155048223|NCT02592447|559608730|FG000|Overall Study|Ineligible after randomization|1|||
155048224|NCT02592447|559608731|FG001|Overall Study|Ineligible after randomization|0|||
155048225|NCT02592447|559608730|FG000|Overall Study|Withdrawal by Subject|0|||
155048226|NCT02592447|559608731|FG001|Overall Study|Withdrawal by Subject|1|||
155048227|NCT03428100|559608732|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
155048228|NCT03428100|559608733|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048229|NCT03428100|559608734|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
155048230|NCT03428100|559608735|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
155048231|NCT03428100|559608736|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048232|NCT03428100|559608737|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048233|NCT03428100|559608738|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048234|NCT03428100|559608739|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155388237|NCT01290601|560855047|FG002|Overall Study|Protocol Violation|0|||
155388238|NCT01290601|560855048|FG003|Overall Study|Protocol Violation|0|||
155048235|NCT03428100|559608740|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048236|NCT03428100|559608741|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048237|NCT03428100|559608742|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048238|NCT03428100|559608743|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048239|NCT03428100|559608744|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048240|NCT03428100|559608745|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048241|NCT03428100|559608746|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048242|NCT03428100|559608747|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048243|NCT03428100|559608748|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048244|NCT03428100|559608749|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048245|NCT03428100|559608750|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
155048246|NCT03428100|559608732|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
155048247|NCT03428100|559608733|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
155048248|NCT03428100|559608734|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
155048249|NCT03428100|559608735|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
155048250|NCT03428100|559608736|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048251|NCT03428100|559608737|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048252|NCT03428100|559608738|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048253|NCT03428100|559608739|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048254|NCT03428100|559608740|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048255|NCT03428100|559608741|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048256|NCT03428100|559608742|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048257|NCT03428100|559608743|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155281355|NCT04034238|560461551|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
155281356|NCT04034238|560461552|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
155281357|NCT04034238|560461553|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
155281358|NCT04034238|560461550|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
155281359|NCT04034238|560461551|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
155281360|NCT04034238|560461552|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
155281361|NCT04034238|560461553|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
155281362|NCT01345292|560461554|FG000|Overall Study|Withdrawal by Subject|2|||
155281363|NCT01345292|560461555|FG001|Overall Study|Withdrawal by Subject|0|||
155281364|NCT01345292|560461556|FG002|Overall Study|Withdrawal by Subject|1|||
155281365|NCT01244763|560461562|FG000|Overall Study|Adverse Event|1|||
155281366|NCT01244763|560461563|FG001|Overall Study|Adverse Event|0|||
155281367|NCT01244763|560461564|FG002|Overall Study|Adverse Event|0|||
155281368|NCT01244763|560461565|FG003|Overall Study|Adverse Event|0|||
155281369|NCT01244763|560461566|FG004|Overall Study|Adverse Event|0|||
155281370|NCT01244763|560461567|FG005|Overall Study|Adverse Event|1|||
155281371|NCT01244763|560461562|FG000|Overall Study|Death|1|||
155281372|NCT01244763|560461563|FG001|Overall Study|Death|0|||
155281373|NCT01244763|560461564|FG002|Overall Study|Death|1|||
155281374|NCT01244763|560461565|FG003|Overall Study|Death|0|||
155281375|NCT01244763|560461566|FG004|Overall Study|Death|2|||
155281376|NCT01244763|560461567|FG005|Overall Study|Death|0|||
155281377|NCT01244763|560461562|FG000|Overall Study|Physician Decision|0|||
155281378|NCT01244763|560461563|FG001|Overall Study|Physician Decision|0|||
155281379|NCT01244763|560461564|FG002|Overall Study|Physician Decision|1|||
155281380|NCT01244763|560461565|FG003|Overall Study|Physician Decision|0|||
155281381|NCT01244763|560461566|FG004|Overall Study|Physician Decision|0|||
155281382|NCT01244763|560461567|FG005|Overall Study|Physician Decision|0|||
155281383|NCT01244763|560461562|FG000|Overall Study|Withdrawal by Subject|1|||
155281384|NCT01244763|560461563|FG001|Overall Study|Withdrawal by Subject|2|||
155281385|NCT01244763|560461564|FG002|Overall Study|Withdrawal by Subject|0|||
155281386|NCT01244763|560461565|FG003|Overall Study|Withdrawal by Subject|1|||
155281387|NCT01244763|560461566|FG004|Overall Study|Withdrawal by Subject|1|||
155281388|NCT01244763|560461567|FG005|Overall Study|Withdrawal by Subject|2|||
155281389|NCT01244763|560461562|FG000|Overall Study|Lost to Follow-up|0|||
155281390|NCT01244763|560461563|FG001|Overall Study|Lost to Follow-up|1|||
155281391|NCT01244763|560461564|FG002|Overall Study|Lost to Follow-up|0|||
155281392|NCT01244763|560461565|FG003|Overall Study|Lost to Follow-up|0|||
155281393|NCT01244763|560461566|FG004|Overall Study|Lost to Follow-up|0|||
155281394|NCT01244763|560461567|FG005|Overall Study|Lost to Follow-up|0|||
155281395|NCT01244763|560461562|FG000|Overall Study|Enrolled into the Extension Study|0|||
155281396|NCT01244763|560461563|FG001|Overall Study|Enrolled into the Extension Study|0|||
155281397|NCT01244763|560461564|FG002|Overall Study|Enrolled into the Extension Study|0|||
155281398|NCT01244763|560461565|FG003|Overall Study|Enrolled into the Extension Study|0|||
155281399|NCT01244763|560461566|FG004|Overall Study|Enrolled into the Extension Study|0|||
155281400|NCT01244763|560461567|FG005|Overall Study|Enrolled into the Extension Study|1|||
155281401|NCT02271594|560461568|FG000|Overall Study|Study closed; recruiting failure|19|||
155281402|NCT02271594|560461569|FG001|Overall Study|Study closed; recruiting failure|12|||
155281403|NCT02015663|560461580|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
155281404|NCT02015663|560461581|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
155281405|NCT02015663|560461580|FG000|Overall Study|Withdrawal by Subject|1|||
155048258|NCT03428100|559608744|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048259|NCT03428100|559608745|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048260|NCT03428100|559608746|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048261|NCT03428100|559608747|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048262|NCT03428100|559608748|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048263|NCT03428100|559608749|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048264|NCT03428100|559608750|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
155048265|NCT03428100|559608732|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048266|NCT03428100|559608733|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
155048267|NCT03428100|559608734|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
155048268|NCT03428100|559608735|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048269|NCT03428100|559608736|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048270|NCT03428100|559608737|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048271|NCT03428100|559608738|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048272|NCT03428100|559608739|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048273|NCT03428100|559608740|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048274|NCT03428100|559608741|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048275|NCT03428100|559608742|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048276|NCT03428100|559608743|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048277|NCT03428100|559608744|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048278|NCT03428100|559608745|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048279|NCT03428100|559608746|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048280|NCT03428100|559608747|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048281|NCT03428100|559608748|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048282|NCT03428100|559608749|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048283|NCT03428100|559608750|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
155048284|NCT03428100|559608732|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
155048285|NCT03428100|559608733|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048286|NCT03428100|559608734|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048287|NCT03428100|559608735|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048288|NCT03428100|559608736|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048289|NCT03428100|559608737|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048290|NCT03428100|559608738|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048291|NCT03428100|559608739|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048292|NCT03428100|559608740|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048293|NCT03428100|559608741|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048294|NCT03428100|559608742|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048295|NCT03428100|559608743|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048296|NCT03428100|559608744|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048297|NCT03428100|559608745|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048298|NCT03428100|559608746|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048299|NCT03428100|559608747|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155281406|NCT02015663|560461581|FG001|Overall Study|Withdrawal by Subject|0|||
155281407|NCT02015663|560461580|FG000|Overall Study|Protocol Violation|0|||
155281408|NCT02015663|560461581|FG001|Overall Study|Protocol Violation|1|||
155281409|NCT02015663|560461580|FG000|Overall Study|Adverse Event|3|||
155281410|NCT02015663|560461581|FG001|Overall Study|Adverse Event|0|||
155281411|NCT02015663|560461580|FG000|Overall Study|Administrative problems|10|||
155281412|NCT02015663|560461581|FG001|Overall Study|Administrative problems|11|||
155281413|NCT01818700|560461582|FG000|Overall Study|Adverse Event|67|||
155281414|NCT01818700|560461582|FG000|Overall Study|Lack of Efficacy|2|||
155281415|NCT01818700|560461582|FG000|Overall Study|Lost to Follow-up|5|||
155281416|NCT01818700|560461582|FG000|Overall Study|Withdrawal by Subject|27|||
155281417|NCT01818700|560461582|FG000|Overall Study|Protocol Violation|2|||
155281418|NCT01818700|560461582|FG000|Overall Study|Other|1|||
155281419|NCT02412761|560461583|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155281420|NCT02412761|560461584|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155281421|NCT02412761|560461585|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155281422|NCT02412761|560461586|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155281423|NCT02412761|560461587|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155281424|NCT02412761|560461588|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155281425|NCT01627340|560461591|FG000|Overall Study|Adverse Event|1|||
155281426|NCT01627340|560461592|FG001|Overall Study|Adverse Event|0|||
155281427|NCT01627340|560461591|FG000|Overall Study|Lost to Follow-up|8|||
155281428|NCT01627340|560461592|FG001|Overall Study|Lost to Follow-up|4|||
155281429|NCT01627340|560461591|FG000|Overall Study|Pregnancy|1|||
155281430|NCT01627340|560461592|FG001|Overall Study|Pregnancy|0|||
155048300|NCT03428100|559608748|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048301|NCT03428100|559608749|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048302|NCT03428100|559608750|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
155048303|NCT03428100|559608732|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048304|NCT03428100|559608733|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
155048305|NCT03428100|559608734|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048306|NCT03428100|559608735|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048307|NCT03428100|559608736|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048308|NCT03428100|559608737|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048309|NCT03428100|559608738|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048310|NCT03428100|559608739|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048311|NCT03428100|559608740|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048312|NCT03428100|559608741|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048313|NCT03428100|559608742|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048314|NCT03428100|559608743|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048315|NCT03428100|559608744|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048316|NCT03428100|559608745|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048317|NCT03428100|559608746|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048318|NCT03428100|559608747|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048319|NCT03428100|559608748|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048320|NCT03428100|559608749|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048321|NCT03428100|559608750|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
155048322|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048323|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048324|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048325|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048326|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048327|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
155048328|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155048329|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
155048330|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155048331|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048332|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155048333|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048334|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
155048335|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155048336|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155048337|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
155048338|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
155048339|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048340|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
155048341|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
155048342|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
155048343|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
155048344|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
155048345|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
155048346|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
155048347|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
155048348|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
155048349|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
155048350|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
155048351|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
155048352|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
155048353|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
155048354|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
155048355|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
155048356|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
155048357|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
155048358|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
155048359|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
155048360|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155048361|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155048362|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155048363|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155048364|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
155388239|NCT02571049|560855049|FG000|Screening|Did not meet entry criteria|2|||
154946186|NCT02985957|559228239|FG003|Treatment Period|Disease progression|40|||
154946187|NCT02985957|559228240|FG004|Treatment Period|Disease progression|29|||
154946188|NCT02985957|559228241|FG005|Treatment Period|Disease progression|11|||
154946189|NCT02985957|559228242|FG006|Treatment Period|Disease progression|28|||
154946190|NCT02985957|559228236|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
154946191|NCT02985957|559228237|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
154946192|NCT02985957|559228238|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
154946193|NCT02985957|559228239|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
154946194|NCT02985957|559228240|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
154946195|NCT02985957|559228241|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
154946196|NCT02985957|559228242|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
154946197|NCT02985957|559228236|FG000|Treatment Period|Poor/Non-Compliance|0|||
154946198|NCT02985957|559228237|FG001|Treatment Period|Poor/Non-Compliance|0|||
154946199|NCT02985957|559228238|FG002|Treatment Period|Poor/Non-Compliance|0|||
154946200|NCT02985957|559228239|FG003|Treatment Period|Poor/Non-Compliance|0|||
154946201|NCT02985957|559228240|FG004|Treatment Period|Poor/Non-Compliance|1|||
154946202|NCT02985957|559228241|FG005|Treatment Period|Poor/Non-Compliance|1|||
154946203|NCT02985957|559228242|FG006|Treatment Period|Poor/Non-Compliance|0|||
154946204|NCT05845645|559228243|FG000|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946205|NCT05845645|559228244|FG001|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946206|NCT05845645|559228245|FG002|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|1|||
154946207|NCT05845645|559228246|FG003|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946208|NCT05845645|559228247|FG004|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946209|NCT05845645|559228248|FG005|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946210|NCT05845645|559228249|FG006|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946211|NCT05845645|559228250|FG007|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946212|NCT05845645|559228251|FG008|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946213|NCT05845645|559228252|FG009|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946214|NCT05845645|559228253|FG010|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946215|NCT05845645|559228254|FG011|Part A: P5 (Day 24,Elevated Gastric pH)|Consent Withdrawn (not due to adverse event)|0|||
154946216|NCT05845645|559228243|FG000|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946217|NCT05845645|559228244|FG001|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946218|NCT05845645|559228245|FG002|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946219|NCT05845645|559228246|FG003|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946220|NCT05845645|559228247|FG004|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946221|NCT05845645|559228248|FG005|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946222|NCT05845645|559228249|FG006|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946223|NCT05845645|559228250|FG007|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946224|NCT05845645|559228251|FG008|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946225|NCT05845645|559228252|FG009|Part B- Period 1 (Day 1)|Adverse Event|1|||
154946226|NCT05845645|559228253|FG010|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946227|NCT05845645|559228254|FG011|Part B- Period 1 (Day 1)|Adverse Event|0|||
154946228|NCT03748641|559228258|FG000|Overall Study|Ongoing|155|||
154946229|NCT03748641|559228259|FG001|Overall Study|Ongoing|148|||
154946230|NCT03748641|559228260|FG002|Overall Study|Ongoing|66|||
154946231|NCT03748641|559228261|FG003|Overall Study|Ongoing|79|||
154946232|NCT03748641|559228262|FG004|Overall Study|Ongoing|84|||
154946233|NCT03748641|559228258|FG000|Overall Study|Death|54|||
154946234|NCT03748641|559228259|FG001|Overall Study|Death|59|||
154946235|NCT03748641|559228260|FG002|Overall Study|Death|51|||
154946236|NCT03748641|559228261|FG003|Overall Study|Death|42|||
154946237|NCT03748641|559228262|FG004|Overall Study|Death|9|||
154946238|NCT03748641|559228258|FG000|Overall Study|Lost to Follow-up|0|||
154946239|NCT03748641|559228259|FG001|Overall Study|Lost to Follow-up|2|||
154946240|NCT03748641|559228260|FG002|Overall Study|Lost to Follow-up|1|||
154946241|NCT03748641|559228261|FG003|Overall Study|Lost to Follow-up|0|||
154946242|NCT03748641|559228262|FG004|Overall Study|Lost to Follow-up|0|||
154946243|NCT03748641|559228258|FG000|Overall Study|Withdrawal by Subject|3|||
155281431|NCT01627340|560461591|FG000|Overall Study|Withdrawal by Subject|2|||
155281432|NCT01627340|560461592|FG001|Overall Study|Withdrawal by Subject|0|||
155281433|NCT01272011|560461593|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
155281434|NCT01272011|560461594|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
155281435|NCT01272011|560461595|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
155281436|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
155281437|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
155281438|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
155281439|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
155281440|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
155388240|NCT02571049|560855050|FG001|Screening|Did not meet entry criteria|2|||
155388241|NCT02571049|560855049|FG000|Randomization|No migraine attack|0|||
155388242|NCT02571049|560855050|FG001|Randomization|No migraine attack|1|||
155388243|NCT02571049|560855049|FG000|Randomization|Adverse Event|0|||
155388244|NCT02571049|560855050|FG001|Randomization|Adverse Event|1|||
155388245|NCT00973362|560856170|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
155388246|NCT00973362|560856171|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
154946244|NCT03748641|559228259|FG001|Overall Study|Withdrawal by Subject|2|||
154946245|NCT03748641|559228260|FG002|Overall Study|Withdrawal by Subject|5|||
154946246|NCT03748641|559228261|FG003|Overall Study|Withdrawal by Subject|3|||
154946247|NCT03748641|559228262|FG004|Overall Study|Withdrawal by Subject|2|||
154946248|NCT02549495|559228263|FG000|Overall Study|Death|2|||
154946249|NCT02549495|559228263|FG000|Overall Study|Withdrawal by Subject|5|||
154946250|NCT02549495|559228263|FG000|Overall Study|Physician Decision|22|||
154946251|NCT02549495|559228263|FG000|Overall Study|Lost to Follow-up|6|||
154946252|NCT02549495|559228263|FG000|Overall Study|Protocol Violation|6|||
154946253|NCT03495986|559228264|FG000|Overall Study|Physician Decision|1|||
154946254|NCT03495986|559228265|FG001|Overall Study|Physician Decision|0|||
154946255|NCT03495986|559228264|FG000|Overall Study|Withdrawal by Subject|1|||
154946256|NCT03495986|559228265|FG001|Overall Study|Withdrawal by Subject|1|||
154946257|NCT03495986|559228264|FG000|Overall Study|Withdrawal by Subject|1|||
154946258|NCT03495986|559228265|FG001|Overall Study|Withdrawal by Subject|0|||
154946259|NCT02365597|559228266|FG000|Overall Study|Lost to Follow-up|0|||
154946260|NCT02365597|559228267|FG001|Overall Study|Lost to Follow-up|1|||
154946261|NCT02365597|559228268|FG002|Overall Study|Lost to Follow-up|0|||
154946262|NCT02365597|559228269|FG003|Overall Study|Lost to Follow-up|1|||
154946263|NCT02365597|559228266|FG000|Overall Study|Withdrawal by Subject|1|||
154946264|NCT02365597|559228267|FG001|Overall Study|Withdrawal by Subject|8|||
154946265|NCT02365597|559228268|FG002|Overall Study|Withdrawal by Subject|5|||
154946266|NCT02365597|559228269|FG003|Overall Study|Withdrawal by Subject|1|||
154946267|NCT02365597|559228266|FG000|Overall Study|Sponsor's decision|1|||
154946268|NCT02365597|559228267|FG001|Overall Study|Sponsor's decision|3|||
154946269|NCT02365597|559228268|FG002|Overall Study|Sponsor's decision|13|||
154946270|NCT02365597|559228269|FG003|Overall Study|Sponsor's decision|0|||
154946271|NCT02365597|559228266|FG000|Overall Study|Other|0|||
154946272|NCT02365597|559228267|FG001|Overall Study|Other|4|||
154946273|NCT02365597|559228268|FG002|Overall Study|Other|0|||
154946274|NCT02365597|559228269|FG003|Overall Study|Other|0|||
154946275|NCT02365597|559228266|FG000|Overall Study|Enrolled but not treated|0|||
154946276|NCT02365597|559228267|FG001|Overall Study|Enrolled but not treated|1|||
154946277|NCT02365597|559228268|FG002|Overall Study|Enrolled but not treated|1|||
154946278|NCT02365597|559228269|FG003|Overall Study|Enrolled but not treated|0|||
154946279|NCT02365597|559228266|FG000|Overall Study|Ongoing|0|||
154946280|NCT02365597|559228267|FG001|Overall Study|Ongoing|0|||
154946281|NCT02365597|559228268|FG002|Overall Study|Ongoing|0|||
154946282|NCT02365597|559228269|FG003|Overall Study|Ongoing|17|||
154946283|NCT04309474|559228270|FG000|Overall Study|Randomized but not treated|0|||
154946284|NCT04309474|559228271|FG001|Overall Study|Randomized but not treated|2|||
154946285|NCT04309474|559228270|FG000|Overall Study|Adverse Event|4|||
155048365|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
155048366|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
155048367|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155048368|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155388247|NCT00973362|560856170|FG000|Baseline Evaluation|No colposcopy visit|62|||
155388248|NCT00973362|560856171|FG001|Baseline Evaluation|No colposcopy visit|0|||
155388249|NCT00973362|560856170|FG000|Baseline Evaluation|Inevaluable|686|||
155388250|NCT00973362|560856171|FG001|Baseline Evaluation|Inevaluable|223|||
155388251|NCT00973362|560856170|FG000|3-Year Follow-up|Lost to Follow-up|17|||
155388252|NCT00973362|560856171|FG001|3-Year Follow-up|Lost to Follow-up|0|||
155388253|NCT05116046|560856172|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155388254|NCT05116046|560856173|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155388255|NCT05116046|560856174|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155388256|NCT05116046|560856172|FG000|Overall Study|Study terminated by sponsor|14|||
155388257|NCT05116046|560856173|FG001|Overall Study|Study terminated by sponsor|16|||
155388258|NCT05116046|560856174|FG002|Overall Study|Study terminated by sponsor|1|||
155388259|NCT00146757|560856175|FG000|Overall Study|Death|1|||
155388260|NCT00146757|560856176|FG001|Overall Study|Death|0|||
155388261|NCT00146757|560856175|FG000|Overall Study|Adverse Event|1|||
154946286|NCT04309474|559228271|FG001|Overall Study|Adverse Event|1|||
154946287|NCT04309474|559228270|FG000|Overall Study|Withdrawal by Subject|6|||
154946288|NCT04309474|559228271|FG001|Overall Study|Withdrawal by Subject|9|||
155388262|NCT00146757|560856176|FG001|Overall Study|Adverse Event|0|||
154946289|NCT04309474|559228270|FG000|Overall Study|Lost to Follow-up|1|||
154946290|NCT04309474|559228271|FG001|Overall Study|Lost to Follow-up|2|||
154946291|NCT04309474|559228270|FG000|Overall Study|Not disclosed|10|||
154946292|NCT04309474|559228271|FG001|Overall Study|Not disclosed|6|||
154946293|NCT04670068|559228272|FG000|Overall Study|Progressive Disease|1|||
154946294|NCT04670068|559228273|FG001|Overall Study|Progressive Disease|1|||
154946295|NCT04670068|559228272|FG000|Overall Study|Withdrawal by Subject|1|||
154946296|NCT04670068|559228273|FG001|Overall Study|Withdrawal by Subject|0|||
154946297|NCT04684524|559228274|FG000|Overall Study|Other|2|||
154946298|NCT04684524|559228275|FG001|Overall Study|Other|0|||
154946299|NCT04684524|559228274|FG000|Overall Study|Withdrawal by Subject|5|||
154946300|NCT04684524|559228275|FG001|Overall Study|Withdrawal by Subject|3|||
154946301|NCT04684524|559228274|FG000|Overall Study|Adverse Event|1|||
154946302|NCT04684524|559228275|FG001|Overall Study|Adverse Event|1|||
154946303|NCT04182204|559228279|FG000|Safety Run-in|Lost to Follow-up|1|||
154946304|NCT04182204|559228280|FG001|Safety Run-in|Lost to Follow-up|0|||
154946305|NCT04182204|559228281|FG002|Safety Run-in|Lost to Follow-up|0|||
154946306|NCT04182204|559228279|FG000|Safety Run-in|Withdrawal by Subject|2|||
154946307|NCT04182204|559228280|FG001|Safety Run-in|Withdrawal by Subject|0|||
154946308|NCT04182204|559228281|FG002|Safety Run-in|Withdrawal by Subject|0|||
154946309|NCT04182204|559228279|FG000|Safety Run-in|Death|7|||
154946310|NCT04182204|559228280|FG001|Safety Run-in|Death|0|||
154946311|NCT04182204|559228281|FG002|Safety Run-in|Death|0|||
154946312|NCT04182204|559228279|FG000|Randomized Controlled Trial|Lost to Follow-up|0|||
154946313|NCT04182204|559228280|FG001|Randomized Controlled Trial|Lost to Follow-up|1|||
154946314|NCT04182204|559228281|FG002|Randomized Controlled Trial|Lost to Follow-up|2|||
154946315|NCT04182204|559228279|FG000|Randomized Controlled Trial|Withdrawal by Subject|0|||
154946316|NCT04182204|559228280|FG001|Randomized Controlled Trial|Withdrawal by Subject|10|||
154946317|NCT04182204|559228281|FG002|Randomized Controlled Trial|Withdrawal by Subject|6|||
154946318|NCT04182204|559228279|FG000|Randomized Controlled Trial|Death|0|||
154946319|NCT04182204|559228280|FG001|Randomized Controlled Trial|Death|83|||
154946320|NCT04182204|559228281|FG002|Randomized Controlled Trial|Death|66|||
154946321|NCT05876091|559228282|FG000|Sessions 2-5: Tobacco Flavors|Lost to Follow-up|1|||
154946322|NCT03466411|559228283|FG000|Overall Study|Lost to Follow-up|0|||
154946323|NCT03466411|559228284|FG001|Overall Study|Lost to Follow-up|1|||
154946324|NCT03466411|559228285|FG002|Overall Study|Lost to Follow-up|1|||
154946325|NCT03466411|559228286|FG003|Overall Study|Lost to Follow-up|0|||
154946326|NCT03466411|559228287|FG004|Overall Study|Lost to Follow-up|0|||
154946327|NCT03466411|559228288|FG005|Overall Study|Lost to Follow-up|0|||
154946328|NCT03466411|559228289|FG006|Overall Study|Lost to Follow-up|1|||
154946329|NCT03466411|559228290|FG007|Overall Study|Lost to Follow-up|1|||
154946330|NCT03466411|559228291|FG008|Overall Study|Lost to Follow-up|0|||
154946331|NCT03466411|559228292|FG009|Overall Study|Lost to Follow-up|1|||
154946332|NCT03466411|559228293|FG010|Overall Study|Lost to Follow-up|1|||
154946333|NCT03466411|559228294|FG011|Overall Study|Lost to Follow-up|1|||
154946334|NCT03466411|559228295|FG012|Overall Study|Lost to Follow-up|0|||
154946335|NCT03466411|559228283|FG000|Overall Study|Withdrawal by Subject|14|||
154946336|NCT03466411|559228284|FG001|Overall Study|Withdrawal by Subject|7|||
154946337|NCT03466411|559228285|FG002|Overall Study|Withdrawal by Subject|8|||
154946338|NCT03466411|559228286|FG003|Overall Study|Withdrawal by Subject|4|||
154946339|NCT03466411|559228287|FG004|Overall Study|Withdrawal by Subject|6|||
154946340|NCT03466411|559228288|FG005|Overall Study|Withdrawal by Subject|3|||
154946341|NCT03466411|559228289|FG006|Overall Study|Withdrawal by Subject|6|||
154946342|NCT03466411|559228290|FG007|Overall Study|Withdrawal by Subject|9|||
154946343|NCT03466411|559228291|FG008|Overall Study|Withdrawal by Subject|6|||
154946344|NCT03466411|559228292|FG009|Overall Study|Withdrawal by Subject|11|||
154946345|NCT03466411|559228293|FG010|Overall Study|Withdrawal by Subject|14|||
154946346|NCT03466411|559228294|FG011|Overall Study|Withdrawal by Subject|12|||
154946347|NCT03466411|559228295|FG012|Overall Study|Withdrawal by Subject|7|||
154946348|NCT03466411|559228283|FG000|Overall Study|Other|1|||
154946349|NCT03466411|559228284|FG001|Overall Study|Other|1|||
154946350|NCT03466411|559228285|FG002|Overall Study|Other|0|||
154946351|NCT03466411|559228286|FG003|Overall Study|Other|1|||
154946352|NCT03466411|559228287|FG004|Overall Study|Other|2|||
154946353|NCT03466411|559228288|FG005|Overall Study|Other|0|||
154946354|NCT03466411|559228289|FG006|Overall Study|Other|0|||
154946355|NCT03466411|559228290|FG007|Overall Study|Other|0|||
154946356|NCT03466411|559228291|FG008|Overall Study|Other|0|||
154946357|NCT03466411|559228292|FG009|Overall Study|Other|1|||
154946358|NCT03466411|559228293|FG010|Overall Study|Other|2|||
155281441|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
154946359|NCT03466411|559228294|FG011|Overall Study|Other|0|||
154946360|NCT03466411|559228295|FG012|Overall Study|Other|0|||
154946361|NCT03466411|559228283|FG000|Overall Study|Randomized but not Treated|0|||
154946362|NCT03466411|559228284|FG001|Overall Study|Randomized but not Treated|0|||
154946363|NCT03466411|559228285|FG002|Overall Study|Randomized but not Treated|0|||
154946364|NCT03466411|559228286|FG003|Overall Study|Randomized but not Treated|0|||
154946365|NCT03466411|559228287|FG004|Overall Study|Randomized but not Treated|0|||
154946366|NCT03466411|559228288|FG005|Overall Study|Randomized but not Treated|0|||
154946367|NCT03466411|559228289|FG006|Overall Study|Randomized but not Treated|1|||
154946368|NCT03466411|559228290|FG007|Overall Study|Randomized but not Treated|0|||
154946369|NCT03466411|559228291|FG008|Overall Study|Randomized but not Treated|0|||
154946370|NCT03466411|559228292|FG009|Overall Study|Randomized but not Treated|0|||
154946371|NCT03466411|559228293|FG010|Overall Study|Randomized but not Treated|0|||
154946372|NCT03466411|559228294|FG011|Overall Study|Randomized but not Treated|0|||
155388263|NCT02076178|560856180|FG000|Oral Phase|Adverse Event|0|||
155388264|NCT02076178|560856181|FG001|Oral Phase|Adverse Event|7|||
155388265|NCT02076178|560856180|FG000|Oral Phase|Withdrawal by Subject|0|||
155388266|NCT02076178|560856181|FG001|Oral Phase|Withdrawal by Subject|4|||
155388267|NCT02076178|560856180|FG000|Oral Phase|Physician Decision|0|||
155388268|NCT02076178|560856181|FG001|Oral Phase|Physician Decision|1|||
155388269|NCT02076178|560856180|FG000|Injection Phase|Protocol defined stopping criteria|1|||
155388270|NCT02076178|560856181|FG001|Injection Phase|Protocol defined stopping criteria|0|||
155388271|NCT02076178|560856180|FG000|Injection Phase|Withdrawal by Subject|0|||
155388272|NCT02076178|560856181|FG001|Injection Phase|Withdrawal by Subject|3|||
155388273|NCT02076178|560856180|FG000|Injection Phase|Physician Decision|0|||
155048369|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155048370|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155048371|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
155048372|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
155048373|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
155048374|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
155048375|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
155048376|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155048377|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
155048378|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
155048379|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048380|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048381|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048382|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048383|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155388274|NCT02076178|560856181|FG001|Injection Phase|Physician Decision|3|||
155388275|NCT02076178|560856180|FG000|Injection Phase|Lost to Follow-up|0|||
155388276|NCT02076178|560856181|FG001|Injection Phase|Lost to Follow-up|1|||
155388277|NCT01026454|560856182|FG000|Second Intervention|Pregnancy|1|||
155388278|NCT01026454|560856183|FG001|Second Intervention|Pregnancy|1|||
155388279|NCT02893930|560856184|FG000|Overall Study|Adverse Event|3|||
155388280|NCT02893930|560856184|FG000|Overall Study|Death|1|||
155388281|NCT02893930|560856184|FG000|Overall Study|Disease progression|5|||
155388282|NCT02893930|560856184|FG000|Overall Study|Withdrawal by Subject|2|||
155388283|NCT02893930|560856184|FG000|Overall Study|Physician Decision|1|||
155388284|NCT02893930|560856184|FG000|Overall Study|Ineligible|1|||
155388285|NCT01142596|560856185|FG000|Overall Study|Withdrawal by Subject|9|||
155388286|NCT01142596|560856186|FG001|Overall Study|Withdrawal by Subject|35|||
155388287|NCT01142596|560856185|FG000|Overall Study|Adverse Event|8|||
155388288|NCT01142596|560856186|FG001|Overall Study|Adverse Event|35|||
155388289|NCT01142596|560856185|FG000|Overall Study|Lack of Efficacy|5|||
155388290|NCT01142596|560856186|FG001|Overall Study|Lack of Efficacy|9|||
155388291|NCT01142596|560856185|FG000|Overall Study|Lost to Follow-up|2|||
155388292|NCT01142596|560856186|FG001|Overall Study|Lost to Follow-up|3|||
155388293|NCT01142596|560856185|FG000|Overall Study|Other reason (not specified)|5|||
155388294|NCT01142596|560856186|FG001|Overall Study|Other reason (not specified)|4|||
155388295|NCT02349360|560856187|FG000|Overall Study|Withdrawal by Subject|0|||
155388296|NCT02349360|560856188|FG001|Overall Study|Withdrawal by Subject|1|||
155388297|NCT01054846|560856189|FG000|Overall Study|Lost to Follow-up|76|||
155388298|NCT01054846|560856190|FG001|Overall Study|Lost to Follow-up|17|||
155388299|NCT02446886|560856199|FG000|Overall Study|Adverse Event|1|||
155388300|NCT02446886|560856200|FG001|Overall Study|Adverse Event|3|||
155388301|NCT02446886|560856199|FG000|Overall Study|Withdrawal by Subject|1|||
155388302|NCT02446886|560856200|FG001|Overall Study|Withdrawal by Subject|1|||
155388303|NCT01971203|560856203|FG000|Overall Study|Protocol Violation|3|||
155388304|NCT01971203|560856204|FG001|Overall Study|Protocol Violation|2|||
155388305|NCT01971203|560856203|FG000|Overall Study|Withdrawal by Subject|5|||
154946373|NCT03466411|559228295|FG012|Overall Study|Randomized but not Treated|0|||
154946374|NCT03462719|559228296|FG000|Overall Study|Withdrawal by Subject|4|||
154946375|NCT03462719|559228297|FG001|Overall Study|Withdrawal by Subject|3|||
154946376|NCT03462719|559228296|FG000|Overall Study|Ongoing|87|||
154946377|NCT03462719|559228297|FG001|Overall Study|Ongoing|72|||
154946378|NCT02829918|559228298|FG000|Overall Study|Death|2|||
154946379|NCT02829918|559228298|FG000|Overall Study|Withdrawal by Subject|4|||
154946380|NCT02829918|559228298|FG000|Overall Study|Adverse Event|1|||
154946381|NCT02829918|559228298|FG000|Overall Study|Progression|1|||
154946382|NCT02257736|559228299|FG000|Overall Study|Progressive disease|365|||
154946383|NCT02257736|559228300|FG001|Overall Study|Progressive disease|327|||
155048384|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048385|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155388306|NCT01971203|560856204|FG001|Overall Study|Withdrawal by Subject|6|||
155388307|NCT01971203|560856203|FG000|Overall Study|Adverse Event|1|||
155388308|NCT01971203|560856204|FG001|Overall Study|Adverse Event|0|||
154946384|NCT02257736|559228299|FG000|Overall Study|Adverse Event|45|||
154946385|NCT02257736|559228300|FG001|Overall Study|Adverse Event|56|||
155388309|NCT00775450|560856211|FG000|Overall Study|Serious Adverse Event|2|||
155388310|NCT00775450|560856212|FG001|Overall Study|Serious Adverse Event|0|||
154946386|NCT02257736|559228299|FG000|Overall Study|Withdrawal by Subject|21|||
154946387|NCT02257736|559228300|FG001|Overall Study|Withdrawal by Subject|38|||
154946388|NCT02257736|559228299|FG000|Overall Study|Death|11|||
154946389|NCT02257736|559228300|FG001|Overall Study|Death|6|||
154946390|NCT02257736|559228299|FG000|Overall Study|Physician Decision|5|||
154946391|NCT02257736|559228300|FG001|Overall Study|Physician Decision|9|||
154946392|NCT02257736|559228299|FG000|Overall Study|Non-Compliance with study drug|1|||
154946393|NCT02257736|559228300|FG001|Overall Study|Non-Compliance with study drug|2|||
154946394|NCT02257736|559228299|FG000|Overall Study|Protocol Violation|1|||
154946395|NCT02257736|559228300|FG001|Overall Study|Protocol Violation|0|||
154946396|NCT02257736|559228299|FG000|Overall Study|Other|1|||
154946397|NCT02257736|559228300|FG001|Overall Study|Other|7|||
154946398|NCT02257736|559228299|FG000|Overall Study|Randomized, not treated|1|||
154946399|NCT02257736|559228300|FG001|Overall Study|Randomized, not treated|2|||
154946400|NCT04471428|559228618|FG000|Overall Study|Withdrawal by Subject|29|||
154946401|NCT04471428|559228619|FG001|Overall Study|Withdrawal by Subject|4|||
154946402|NCT04471428|559228618|FG000|Overall Study|Physician Decision|0|||
154946403|NCT04471428|559228619|FG001|Overall Study|Physician Decision|1|||
154946404|NCT04471428|559228618|FG000|Overall Study|Reason Not Specified|0|||
154946405|NCT04471428|559228619|FG001|Overall Study|Reason Not Specified|2|||
154946406|NCT04471428|559228618|FG000|Overall Study|Death|131|||
154946407|NCT04471428|559228619|FG001|Overall Study|Death|147|||
154946408|NCT04471428|559228618|FG000|Overall Study|Lost to Follow-up|0|||
154946409|NCT04471428|559228619|FG001|Overall Study|Lost to Follow-up|3|||
154946410|NCT04471428|559228618|FG000|Overall Study|Study Terminated by Sponsor|20|||
154946411|NCT04471428|559228619|FG001|Overall Study|Study Terminated by Sponsor|29|||
154946412|NCT03290079|559228620|FG000|Overall Study|Death|2|||
154946413|NCT03390504|559228621|FG000|Overall Study|Lost to Follow-up|2|||
154946414|NCT03390504|559228622|FG001|Overall Study|Lost to Follow-up|4|||
154946415|NCT03390504|559228623|FG002|Overall Study|Lost to Follow-up|0|||
154946416|NCT03390504|559228624|FG003|Overall Study|Lost to Follow-up|1|||
154946417|NCT03390504|559228621|FG000|Overall Study|Withdrawal by Subject|3|||
154946418|NCT03390504|559228622|FG001|Overall Study|Withdrawal by Subject|15|||
154946419|NCT03390504|559228623|FG002|Overall Study|Withdrawal by Subject|5|||
154946420|NCT03390504|559228624|FG003|Overall Study|Withdrawal by Subject|2|||
154946421|NCT03390504|559228621|FG000|Overall Study|Other|1|||
154946422|NCT03390504|559228622|FG001|Overall Study|Other|2|||
154946423|NCT03390504|559228623|FG002|Overall Study|Other|2|||
154946424|NCT03390504|559228624|FG003|Overall Study|Other|6|||
154946425|NCT03095352|559228628|FG000|Treatment assigned at enrollment|Withdrawal by Subject|1|||
154946426|NCT03095352|559228629|FG001|Treatment assigned at enrollment|Withdrawal by Subject|0|||
154946427|NCT02779855|559228630|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
154946428|NCT02779855|559228631|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
154946429|NCT02779855|559228632|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
154946430|NCT05431686|559228639|FG000|Overall Study|unable to schedule|10|||
154946431|NCT05328375|559230030|FG000|Overall Study|Withdrawal by Subject|0|||
154946432|NCT05328375|559230031|FG001|Overall Study|Withdrawal by Subject|1|||
154946433|NCT05514119|559230036|FG000|Overall Study|Ineligible due to disease progression|1|||
154946434|NCT02178709|559230037|FG000|Overall Study|Adverse Event|5|||
154946435|NCT02178709|559230037|FG000|Overall Study|Death|2|||
154946436|NCT02178709|559230037|FG000|Overall Study|Withdrawal by Subject|2|||
154946437|NCT02178709|559230037|FG000|Overall Study|Physician Decision|2|||
154946438|NCT02178709|559230037|FG000|Overall Study|Disease Progression|5|||
154946439|NCT02946385|559230038|FG000|Overall Study|Lost to Follow-up|0|||
154946440|NCT02946385|559230039|FG001|Overall Study|Lost to Follow-up|0|||
154946441|NCT02946385|559230040|FG002|Overall Study|Lost to Follow-up|3|||
154946442|NCT02946385|559230041|FG003|Overall Study|Lost to Follow-up|0|||
154946443|NCT02946385|559230042|FG004|Overall Study|Lost to Follow-up|2|||
154946444|NCT02946385|559230043|FG005|Overall Study|Lost to Follow-up|1|||
154946445|NCT04849988|559230046|FG000|Overall Study|Lack of Efficacy|3|||
154946446|NCT04849988|559230047|FG001|Overall Study|Lack of Efficacy|4|||
154946447|NCT04849988|559230048|FG002|Overall Study|Lack of Efficacy|1|||
154946448|NCT04849988|559230049|FG003|Overall Study|Lack of Efficacy|4|||
154946449|NCT04849988|559230046|FG000|Overall Study|Other reasons|1|||
154946450|NCT04849988|559230047|FG001|Overall Study|Other reasons|2|||
154946451|NCT04849988|559230048|FG002|Overall Study|Other reasons|2|||
154946452|NCT04849988|559230049|FG003|Overall Study|Other reasons|1|||
154946453|NCT01893905|559230056|FG000|Overall Study|Withdrawal by Subject|1|||
154946454|NCT01893905|559230057|FG001|Overall Study|Withdrawal by Subject|0|||
155388311|NCT00775450|560856213|FG002|Overall Study|Serious Adverse Event|0|||
154946455|NCT01893905|559230056|FG000|Overall Study|Adverse Event|9|||
154946456|NCT01893905|559230057|FG001|Overall Study|Adverse Event|3|||
154946457|NCT01893905|559230056|FG000|Overall Study|Lack of Efficacy|5|||
154946458|NCT01893905|559230057|FG001|Overall Study|Lack of Efficacy|7|||
154946459|NCT01893905|559230056|FG000|Overall Study|Lost to Follow-up|1|||
154946460|NCT01893905|559230057|FG001|Overall Study|Lost to Follow-up|0|||
154946461|NCT01893905|559230056|FG000|Overall Study|Protocol Violation|6|||
155048386|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
155048387|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048388|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048389|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048390|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
155048391|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
155048392|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048393|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
155048394|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048395|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048396|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
155048397|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
155048398|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
155048399|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
155048400|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
155048401|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
155048402|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
155048403|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
155048404|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
155048405|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
155048406|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
155048407|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
155048408|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
155048409|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
155048410|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
155048411|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
155048412|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
155048413|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
155048414|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
155048415|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
155048416|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
155048417|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048418|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048419|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048420|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048421|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048422|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048423|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
155048424|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048425|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048426|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048427|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048428|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048429|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048430|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048431|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048432|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048433|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048434|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
155048435|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
155048436|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155048437|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155048438|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155048439|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
155048440|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
155048441|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
155048442|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
155048443|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
155048444|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
155048445|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
155048446|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
155048447|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
155048448|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
155048449|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
155388312|NCT00775450|560856214|FG003|Overall Study|Serious Adverse Event|0|||
155388313|NCT00775450|560856215|FG004|Overall Study|Serious Adverse Event|0|||
155048450|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
155048451|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
155048452|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
155048453|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
155048454|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
155048455|NCT03428100|559608732|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048456|NCT03428100|559608733|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048457|NCT03428100|559608734|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048458|NCT03428100|559608735|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048459|NCT03428100|559608736|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155048460|NCT03428100|559608737|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048461|NCT03428100|559608738|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
155048462|NCT03428100|559608739|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155048463|NCT03428100|559608740|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048464|NCT03428100|559608741|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
155048465|NCT03428100|559608742|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
155048466|NCT03428100|559608743|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
155048467|NCT03428100|559608744|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155048468|NCT03428100|559608745|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
155048469|NCT03428100|559608746|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
155048470|NCT03428100|559608747|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048471|NCT03428100|559608748|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
155048472|NCT03428100|559608749|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
155048473|NCT03428100|559608750|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
155048474|NCT02258659|559608753|FG000|Overall Study|Withdrawal by Subject|1|||
155048475|NCT03990051|559608754|FG000|Masked Period|Lost to Follow-up|1|||
155048476|NCT03990051|559608755|FG001|Masked Period|Lost to Follow-up|0|||
155048477|NCT03990051|559608754|FG000|Long Term Period|Death|1|||
155048478|NCT03990051|559608755|FG001|Long Term Period|Death|1|||
155388314|NCT00775450|560856211|FG000|Overall Study|Protocol Violation|0|||
155388315|NCT00775450|560856212|FG001|Overall Study|Protocol Violation|0|||
155388316|NCT00775450|560856213|FG002|Overall Study|Protocol Violation|0|||
155388317|NCT00775450|560856214|FG003|Overall Study|Protocol Violation|0|||
155388318|NCT00775450|560856215|FG004|Overall Study|Protocol Violation|1|||
155388319|NCT00775450|560856211|FG000|Overall Study|Withdrawal by Subject|1|||
155388320|NCT00775450|560856212|FG001|Overall Study|Withdrawal by Subject|0|||
155388321|NCT00775450|560856213|FG002|Overall Study|Withdrawal by Subject|0|||
155388322|NCT00775450|560856214|FG003|Overall Study|Withdrawal by Subject|0|||
155388323|NCT00775450|560856215|FG004|Overall Study|Withdrawal by Subject|1|||
155388324|NCT01055262|560856225|FG000|Overall Study|Adverse Event|5|||
155388325|NCT01055262|560856225|FG000|Overall Study|Protocol Violation|3|||
155388326|NCT01055262|560856225|FG000|Overall Study|Uncooperativeness|1|||
155388327|NCT00752622|560856226|FG000|Induction Phase|Adverse Event|3|||
155388328|NCT00752622|560856226|FG000|Induction Phase|Other|3|||
155388329|NCT00752622|560856226|FG000|Induction Phase|Non-responder|14|||
154946462|NCT01893905|559230057|FG001|Overall Study|Protocol Violation|1|||
154946463|NCT01893905|559230056|FG000|Overall Study|Lack of adherence to treatment|2|||
154946464|NCT01893905|559230057|FG001|Overall Study|Lack of adherence to treatment|0|||
154946465|NCT01893905|559230056|FG000|Overall Study|Other reason|1|||
154946466|NCT01893905|559230057|FG001|Overall Study|Other reason|3|||
154946467|NCT01768858|559230058|FG000|Overall Study|Lost to Follow-up|9|||
154946468|NCT01768858|559230058|FG000|Overall Study|Lack of Efficacy|8|||
154946469|NCT01768858|559230058|FG000|Overall Study|Serious Adverse Event|1|||
154946470|NCT01768858|559230058|FG000|Overall Study|Participant moved to Germany|1|||
154946471|NCT01768858|559230058|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
154946472|NCT01768858|559230058|FG000|Overall Study|Exanthema|1|||
154946473|NCT01768858|559230058|FG000|Overall Study|Withdrawal by Subject|1|||
154946474|NCT02742090|559230060|FG000|Overall Study|Adverse Event|10|||
154946475|NCT02742090|559230060|FG000|Overall Study|Death|3|||
154946476|NCT02742090|559230060|FG000|Overall Study|Disease Progression|25|||
154946477|NCT02742090|559230060|FG000|Overall Study|Investigator's Decision|1|||
154946478|NCT02742090|559230060|FG000|Overall Study|Lost to Follow-up|1|||
155048479|NCT03990051|559608754|FG000|Long Term Period|Lost to Follow-up|7|||
155388330|NCT00752622|560856226|FG000|Induction Phase|Withdrawal by Subject|1|||
155388331|NCT00752622|560856226|FG000|Induction Phase|Premature study termination|14|||
155388332|NCT00752622|560856226|FG000|Observational Phase|Premature Study Termination|36|||
155388333|NCT00752622|560856226|FG000|Observational Phase|Non-responder|2|||
154946479|NCT02742090|559230060|FG000|Overall Study|Non-compliance with Study|1|||
154946480|NCT02742090|559230060|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
155388334|NCT00752622|560856226|FG000|Observational Phase|Withdrawal by Subject|2|||
155388335|NCT00752622|560856226|FG000|Observational Phase|Adverse Event|1|||
155388336|NCT00752622|560856226|FG000|Observational Phase|Other|2|||
155388337|NCT00752622|560856226|FG000|Interventional Phase|Non-responder|2|||
155388338|NCT00752622|560856226|FG000|Interventional Phase|Physician Decision|1|||
155388339|NCT00752622|560856226|FG000|Interventional Phase|Premature Study Termination|5|||
155388340|NCT00392327|560856229|FG000|Overall Study|Death|1|||
155388341|NCT00392327|560856230|FG001|Overall Study|Death|0|||
155388342|NCT00392327|560856231|FG002|Overall Study|Death|1|||
155388343|NCT00392327|560856232|FG003|Overall Study|Death|0|||
155388344|NCT00392327|560856233|FG004|Overall Study|Death|0|||
155388345|NCT00392327|560856234|FG005|Overall Study|Death|0|||
155388346|NCT00392327|560856235|FG006|Overall Study|Death|0|||
155388347|NCT00392327|560856236|FG007|Overall Study|Death|0|||
155388348|NCT00392327|560856229|FG000|Overall Study|Lack of Efficacy|8|||
155388349|NCT00392327|560856230|FG001|Overall Study|Lack of Efficacy|8|||
155388350|NCT00392327|560856231|FG002|Overall Study|Lack of Efficacy|9|||
155388351|NCT00392327|560856232|FG003|Overall Study|Lack of Efficacy|6|||
155388352|NCT00392327|560856233|FG004|Overall Study|Lack of Efficacy|3|||
155388353|NCT00392327|560856234|FG005|Overall Study|Lack of Efficacy|3|||
155388354|NCT00392327|560856235|FG006|Overall Study|Lack of Efficacy|3|||
155388355|NCT00392327|560856236|FG007|Overall Study|Lack of Efficacy|3|||
155388356|NCT00392327|560856229|FG000|Overall Study|Physician Decision|3|||
155388357|NCT00392327|560856230|FG001|Overall Study|Physician Decision|5|||
155388358|NCT00392327|560856231|FG002|Overall Study|Physician Decision|2|||
155388359|NCT00392327|560856232|FG003|Overall Study|Physician Decision|2|||
155388360|NCT00392327|560856233|FG004|Overall Study|Physician Decision|0|||
155388361|NCT00392327|560856234|FG005|Overall Study|Physician Decision|1|||
155388362|NCT00392327|560856235|FG006|Overall Study|Physician Decision|5|||
155388363|NCT00392327|560856236|FG007|Overall Study|Physician Decision|3|||
155388364|NCT00392327|560856229|FG000|Overall Study|Protocol Violation|0|||
155388365|NCT00392327|560856230|FG001|Overall Study|Protocol Violation|0|||
155388366|NCT00392327|560856231|FG002|Overall Study|Protocol Violation|1|||
155388367|NCT00392327|560856232|FG003|Overall Study|Protocol Violation|0|||
155388368|NCT00392327|560856233|FG004|Overall Study|Protocol Violation|0|||
155388369|NCT00392327|560856234|FG005|Overall Study|Protocol Violation|0|||
155388370|NCT00392327|560856235|FG006|Overall Study|Protocol Violation|0|||
155388371|NCT00392327|560856236|FG007|Overall Study|Protocol Violation|0|||
155388372|NCT00392327|560856229|FG000|Overall Study|Withdrawal by Subject|3|||
155388373|NCT00392327|560856230|FG001|Overall Study|Withdrawal by Subject|2|||
155388374|NCT00392327|560856231|FG002|Overall Study|Withdrawal by Subject|4|||
155388375|NCT00392327|560856232|FG003|Overall Study|Withdrawal by Subject|6|||
155388376|NCT00392327|560856233|FG004|Overall Study|Withdrawal by Subject|0|||
155388377|NCT00392327|560856234|FG005|Overall Study|Withdrawal by Subject|1|||
154946481|NCT02742090|559230060|FG000|Overall Study|Withdrawal by Subject|4|||
154946482|NCT02742090|559230060|FG000|Overall Study|Reason Not Specified|1|||
154946483|NCT02192905|559230067|FG000|Overall Study|Lost to Follow-up|1|||
154946484|NCT00862979|559230070|FG000|Overall Study|Adverse Event|6|||
154946485|NCT00862979|559230071|FG001|Overall Study|Adverse Event|3|||
154946486|NCT00862979|559230070|FG000|Overall Study|Protocol Violation|0|||
154946487|NCT00862979|559230071|FG001|Overall Study|Protocol Violation|1|||
154946488|NCT00862979|559230070|FG000|Overall Study|Patient withdrew consent|2|||
154946489|NCT00862979|559230071|FG001|Overall Study|Patient withdrew consent|1|||
154946490|NCT00862979|559230070|FG000|Overall Study|Administrative problems|0|||
154946491|NCT00862979|559230071|FG001|Overall Study|Administrative problems|1|||
154946492|NCT00862979|559230070|FG000|Overall Study|Death|0|||
154946493|NCT00862979|559230071|FG001|Overall Study|Death|1|||
154946494|NCT02688400|559230073|FG000|Overall Study|Protocol Violation|2|||
154946495|NCT02688400|559230074|FG001|Overall Study|Protocol Violation|5|||
154946496|NCT02688400|559230073|FG000|Overall Study|Lack of Efficacy|7|||
154946497|NCT02688400|559230074|FG001|Overall Study|Lack of Efficacy|7|||
154946498|NCT02688400|559230073|FG000|Overall Study|Adverse Event|21|||
154946499|NCT02688400|559230074|FG001|Overall Study|Adverse Event|12|||
155048480|NCT03990051|559608755|FG001|Long Term Period|Lost to Follow-up|2|||
155048481|NCT01411852|559608756|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
155048482|NCT01411852|559608757|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
155388378|NCT00392327|560856235|FG006|Overall Study|Withdrawal by Subject|1|||
155388379|NCT00392327|560856236|FG007|Overall Study|Withdrawal by Subject|5|||
155388380|NCT00392327|560856229|FG000|Overall Study|Ineligible|0|||
155388381|NCT00392327|560856230|FG001|Overall Study|Ineligible|4|||
155388382|NCT00392327|560856231|FG002|Overall Study|Ineligible|3|||
155388383|NCT00392327|560856232|FG003|Overall Study|Ineligible|2|||
155388384|NCT00392327|560856233|FG004|Overall Study|Ineligible|0|||
155388385|NCT00392327|560856234|FG005|Overall Study|Ineligible|0|||
155388386|NCT00392327|560856235|FG006|Overall Study|Ineligible|0|||
155388387|NCT00392327|560856236|FG007|Overall Study|Ineligible|0|||
155092573|NCT01959529|559773635|FG001|Overall Study|Lost to Follow-up|1|||
155388388|NCT00178126|560856237|FG000|Overall Study|Lost to Follow-up|21|||
155388389|NCT00178126|560856238|FG001|Overall Study|Lost to Follow-up|21|||
155388390|NCT00178126|560856237|FG000|Overall Study|did not receive intervention|4|||
155048483|NCT01411852|559608756|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
155048484|NCT01411852|559608757|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
155048485|NCT01411852|559608756|FG000|Prehospital Intervention Phase|Found to be under age|0|||
155048486|NCT01411852|559608757|FG001|Prehospital Intervention Phase|Found to be under age|1|||
155048487|NCT01411852|559608756|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
155048488|NCT01411852|559608757|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
155048489|NCT01411852|559608756|FG000|Hospital Intervention Phase|Severe head injury|5|||
155048490|NCT01411852|559608757|FG001|Hospital Intervention Phase|Severe head injury|4|||
155048491|NCT01411852|559608756|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
155048492|NCT01411852|559608757|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
155048493|NCT01411852|559608756|FG000|Hospital Intervention Phase|Miscommunication error|1|||
155048494|NCT01411852|559608757|FG001|Hospital Intervention Phase|Miscommunication error|2|||
155048495|NCT01411852|559608756|FG000|Hospital Intervention Phase|CPR administered|3|||
155048496|NCT01411852|559608757|FG001|Hospital Intervention Phase|CPR administered|1|||
155048497|NCT01411852|559608756|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
155048498|NCT01411852|559608757|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
155048499|NCT01411852|559608756|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
155048500|NCT01411852|559608757|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
155048501|NCT01411852|559608756|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
155048502|NCT01411852|559608757|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
155048503|NCT01411852|559608756|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
155048504|NCT01411852|559608757|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
155048505|NCT01411852|559608756|FG000|Hospital Intervention Phase|Other ineligible|2|||
155048506|NCT01411852|559608757|FG001|Hospital Intervention Phase|Other ineligible|2|||
155048507|NCT01411852|559608756|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
155048508|NCT01411852|559608757|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
155048509|NCT01411852|559608756|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
155048510|NCT01411852|559608757|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
155048511|NCT01411852|559608756|FG000|Hospital Intervention Phase|Vascular access failed|1|||
155048512|NCT01411852|559608757|FG001|Hospital Intervention Phase|Vascular access failed|0|||
155048513|NCT00272844|559608758|FG000|Overall Study|Withdrawal by Subject|5|||
155048514|NCT03743025|559608761|FG000|Overall Study|Surgery was cancelled|2|||
155048515|NCT03743025|559608762|FG001|Overall Study|Surgery was cancelled|1|||
155048516|NCT00791700|559608763|FG000|Overall Study|Insufficient clinical response|1|||
155048517|NCT00791700|559608764|FG001|Overall Study|Insufficient clinical response|4|||
155048518|NCT00791700|559608765|FG002|Overall Study|Insufficient clinical response|1|||
155048519|NCT00791700|559608766|FG003|Overall Study|Insufficient clinical response|8|||
155048520|NCT00791700|559608763|FG000|Overall Study|No longer willing to participate|1|||
155048521|NCT00791700|559608764|FG001|Overall Study|No longer willing to participate|1|||
155048522|NCT00791700|559608765|FG002|Overall Study|No longer willing to participate|0|||
155048523|NCT00791700|559608766|FG003|Overall Study|No longer willing to participate|8|||
155048524|NCT00791700|559608763|FG000|Overall Study|Non-compliance with study treatment|0|||
155048525|NCT00791700|559608764|FG001|Overall Study|Non-compliance with study treatment|2|||
155048526|NCT00791700|559608765|FG002|Overall Study|Non-compliance with study treatment|0|||
155048527|NCT00791700|559608766|FG003|Overall Study|Non-compliance with study treatment|4|||
155048528|NCT00791700|559608763|FG000|Overall Study|Withdrawn due to pregnancy|0|||
155048529|NCT00791700|559608764|FG001|Overall Study|Withdrawn due to pregnancy|0|||
155048530|NCT00791700|559608765|FG002|Overall Study|Withdrawn due to pregnancy|0|||
155048531|NCT00791700|559608766|FG003|Overall Study|Withdrawn due to pregnancy|1|||
155048532|NCT00791700|559608763|FG000|Overall Study|Other|0|||
155048533|NCT00791700|559608764|FG001|Overall Study|Other|1|||
155048534|NCT00791700|559608765|FG002|Overall Study|Other|0|||
155048535|NCT00791700|559608766|FG003|Overall Study|Other|1|||
155048536|NCT00791700|559608763|FG000|Overall Study|Death|0|||
155048537|NCT00791700|559608764|FG001|Overall Study|Death|0|||
155048538|NCT00791700|559608765|FG002|Overall Study|Death|0|||
155048539|NCT00791700|559608766|FG003|Overall Study|Death|1|||
155048540|NCT00791700|559608763|FG000|Overall Study|Lost to Follow-up|4|||
155048541|NCT00791700|559608764|FG001|Overall Study|Lost to Follow-up|3|||
155048542|NCT00791700|559608765|FG002|Overall Study|Lost to Follow-up|4|||
155281442|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
155281443|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
155048543|NCT00791700|559608766|FG003|Overall Study|Lost to Follow-up|6|||
155281444|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
155281445|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
155281446|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
155281447|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
155281448|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
155048544|NCT00791700|559608763|FG000|Overall Study|Adverse Event|0|||
155048545|NCT00791700|559608764|FG001|Overall Study|Adverse Event|0|||
155048546|NCT00791700|559608765|FG002|Overall Study|Adverse Event|1|||
155388391|NCT00178126|560856238|FG001|Overall Study|did not receive intervention|6|||
155388392|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
155388393|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
155388394|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
155388395|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
155388396|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
155388397|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
155388398|NCT00421707|560856239|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
155388399|NCT00421707|560856240|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
155388400|NCT00421707|560856239|FG000|Period 2: Washout|Adverse Event|1|||
155388401|NCT00421707|560856240|FG001|Period 2: Washout|Adverse Event|1|||
155388402|NCT00421707|560856239|FG000|Period 2: Washout|Withdrawal by Subject|0|||
155388403|NCT00421707|560856240|FG001|Period 2: Washout|Withdrawal by Subject|1|||
155388404|NCT00421707|560856239|FG000|Period 2: Washout|Lost to Follow-up|0|||
155388405|NCT00421707|560856240|FG001|Period 2: Washout|Lost to Follow-up|1|||
155388406|NCT00421707|560856239|FG000|Period 2: Washout|Other: Pregnancy|0|||
154946500|NCT02688400|559230073|FG000|Overall Study|Withdrawal by Subject|15|||
154946501|NCT02688400|559230074|FG001|Overall Study|Withdrawal by Subject|13|||
154946502|NCT02688400|559230073|FG000|Overall Study|No study medication intake|1|||
154946503|NCT02688400|559230074|FG001|Overall Study|No study medication intake|4|||
154946504|NCT02688400|559230073|FG000|Overall Study|Lost to Follow-up|0|||
154946505|NCT02688400|559230074|FG001|Overall Study|Lost to Follow-up|3|||
154946506|NCT01027143|559230075|FG000|Overall Study|Lost to Follow-up|9|||
154946507|NCT01027143|559230076|FG001|Overall Study|Lost to Follow-up|4|||
154946508|NCT00992407|559230079|FG000|Overall Study|Protocol Violation|2|||
154946509|NCT00992407|559230080|FG001|Overall Study|Protocol Violation|1|||
154946510|NCT00992407|559230079|FG000|Overall Study|Lost to Follow-up|3|||
154946511|NCT00992407|559230080|FG001|Overall Study|Lost to Follow-up|3|||
154946512|NCT00992407|559230079|FG000|Overall Study|Adverse Event|3|||
154946513|NCT00992407|559230080|FG001|Overall Study|Adverse Event|2|||
154946514|NCT00992407|559230079|FG000|Overall Study|protocol Violation & Adverse events|2|||
154946515|NCT00992407|559230080|FG001|Overall Study|protocol Violation & Adverse events|4|||
154946516|NCT00992407|559230079|FG000|Overall Study|Other|2|||
154946517|NCT00992407|559230080|FG001|Overall Study|Other|0|||
154946518|NCT00992407|559230079|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
154946519|NCT00992407|559230080|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
154946520|NCT00992407|559230079|FG000|Overall Study|Study medication not administered|17|||
154946521|NCT00992407|559230080|FG001|Overall Study|Study medication not administered|13|||
154946522|NCT03738332|559230081|FG000|Overall Study|Withdrawal by Subject|1|||
154946523|NCT01521559|559230082|FG000|Overall Study|Adverse Event|0|||
154946524|NCT01521559|559230083|FG001|Overall Study|Adverse Event|4|||
154946525|NCT01521559|559230082|FG000|Overall Study|Death|1|||
154946526|NCT01521559|559230083|FG001|Overall Study|Death|0|||
154946527|NCT01521559|559230082|FG000|Overall Study|Withdrawal by Subject|9|||
154946528|NCT01521559|559230083|FG001|Overall Study|Withdrawal by Subject|11|||
154946529|NCT01521559|559230082|FG000|Overall Study|Lost to Follow-up|3|||
154946530|NCT01521559|559230083|FG001|Overall Study|Lost to Follow-up|1|||
154946531|NCT01521559|559230082|FG000|Overall Study|Protocol Violation|1|||
154946532|NCT01521559|559230083|FG001|Overall Study|Protocol Violation|0|||
154946533|NCT01521559|559230082|FG000|Overall Study|Other|1|||
154946534|NCT01521559|559230083|FG001|Overall Study|Other|2|||
154946535|NCT02336737|559230084|FG000|Overall Study|Withdrawal by Subject|5|||
154946536|NCT02336737|559230084|FG000|Overall Study|Physician Decision|8|||
154946537|NCT02228382|559230085|FG000|Overall Study|Death|5|||
154946538|NCT02228382|559230086|FG001|Overall Study|Death|7|||
154946539|NCT02228382|559230087|FG002|Overall Study|Death|5|||
154946540|NCT02228382|559230088|FG003|Overall Study|Death|0|||
154946541|NCT02228382|559230089|FG004|Overall Study|Death|2|||
154946542|NCT02228382|559230085|FG000|Overall Study|Participant refused further follow-up|0|||
154946543|NCT02228382|559230086|FG001|Overall Study|Participant refused further follow-up|0|||
154946544|NCT02228382|559230087|FG002|Overall Study|Participant refused further follow-up|1|||
154946545|NCT02228382|559230088|FG003|Overall Study|Participant refused further follow-up|0|||
154946546|NCT02228382|559230089|FG004|Overall Study|Participant refused further follow-up|0|||
155388407|NCT00421707|560856240|FG001|Period 2: Washout|Other: Pregnancy|1|||
154946547|NCT02228382|559230085|FG000|Overall Study|Study terminated by sponsor|3|||
154946548|NCT02228382|559230086|FG001|Overall Study|Study terminated by sponsor|5|||
154946549|NCT02228382|559230087|FG002|Overall Study|Study terminated by sponsor|7|||
154946550|NCT02228382|559230088|FG003|Overall Study|Study terminated by sponsor|0|||
154946551|NCT02228382|559230089|FG004|Overall Study|Study terminated by sponsor|0|||
154946552|NCT02228382|559230085|FG000|Overall Study|Lost to Follow-up|0|||
154946553|NCT02228382|559230086|FG001|Overall Study|Lost to Follow-up|0|||
154946554|NCT02228382|559230087|FG002|Overall Study|Lost to Follow-up|3|||
154946555|NCT02228382|559230088|FG003|Overall Study|Lost to Follow-up|1|||
154946556|NCT02228382|559230089|FG004|Overall Study|Lost to Follow-up|0|||
155388408|NCT00421707|560856239|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
155388409|NCT00421707|560856240|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
155048547|NCT00791700|559608766|FG003|Overall Study|Adverse Event|1|||
155048548|NCT01720524|559608769|FG000|Part A|Insufficient Clinical Response|2|||
155048549|NCT01720524|559608770|FG001|Part A|Insufficient Clinical Response|4|||
155048550|NCT01720524|559608769|FG000|Part A|Adverse Event|2|||
155048551|NCT01720524|559608770|FG001|Part A|Adverse Event|2|||
155048552|NCT01720524|559608769|FG000|Part A|Death|2|||
155048553|NCT01720524|559608770|FG001|Part A|Death|1|||
155048554|NCT01720524|559608769|FG000|Part A|Lost to Follow-up|0|||
155048555|NCT01720524|559608770|FG001|Part A|Lost to Follow-up|1|||
155048556|NCT01720524|559608769|FG000|Part A|Missed 28 day follow-up visit|1|||
155048557|NCT01720524|559608770|FG001|Part A|Missed 28 day follow-up visit|1|||
155048558|NCT01720524|559608769|FG000|Part A|Withdrawal by Subject|0|||
155048559|NCT01720524|559608770|FG001|Part A|Withdrawal by Subject|1|||
155048560|NCT01720524|559608769|FG000|Part A|Other|0|||
155048561|NCT01720524|559608770|FG001|Part A|Other|1|||
155048562|NCT01720524|559608769|FG000|Part A|Lost to Follow-up|0|||
155048563|NCT01720524|559608770|FG001|Part A|Lost to Follow-up|1|||
155048564|NCT01720524|559608769|FG000|Part B|No longer willing to participate in study|1|||
155048565|NCT01720524|559608770|FG001|Part B|No longer willing to participate in study|4|||
155048566|NCT01720524|559608769|FG000|Part B|Other|2|||
155048567|NCT01720524|559608770|FG001|Part B|Other|0|||
155048568|NCT01720524|559608769|FG000|Part B|Lost to Follow-up|2|||
155048569|NCT01720524|559608770|FG001|Part B|Lost to Follow-up|3|||
155048570|NCT01720524|559608769|FG000|Part B|Death|0|||
155048571|NCT01720524|559608770|FG001|Part B|Death|2|||
155048572|NCT00996034|559608771|FG000|Overall Study|Lost to Follow-up|2|||
155048573|NCT00996034|559608771|FG000|Overall Study|withdrawn by PI|1|||
155048574|NCT00158262|559608775|FG000|Overall Study|Lost to Follow-up|1|||
155048575|NCT00158262|559608776|FG001|Overall Study|Lost to Follow-up|1|||
155048576|NCT00527826|559608777|FG000|Overall Study|Adverse Event|10|||
155048577|NCT00527826|559608778|FG001|Overall Study|Adverse Event|10|||
155048578|NCT00527826|559608777|FG000|Overall Study|Lost to Follow-up|3|||
155048579|NCT00527826|559608778|FG001|Overall Study|Lost to Follow-up|2|||
155048580|NCT00527826|559608777|FG000|Overall Study|Withdrawal by Subject|5|||
155048581|NCT00527826|559608778|FG001|Overall Study|Withdrawal by Subject|8|||
155048582|NCT00527826|559608777|FG000|Overall Study|Inclusion Criteria Not Met|3|||
155048583|NCT00527826|559608778|FG001|Overall Study|Inclusion Criteria Not Met|3|||
155048584|NCT00527826|559608777|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
155048585|NCT00527826|559608778|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
155048586|NCT00527826|559608777|FG000|Overall Study|Additional Intake of Viani forte|0|||
155281449|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
155281450|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
155281451|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
155281452|NCT02240680|560461598|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
155281453|NCT02240680|560461599|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
155281454|NCT02240680|560461600|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
155281455|NCT02240680|560461601|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
155281456|NCT02240680|560461598|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
155281457|NCT02240680|560461599|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
155281458|NCT02240680|560461600|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
155281459|NCT02240680|560461601|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
155281460|NCT02240680|560461598|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
155281461|NCT02240680|560461599|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
155281462|NCT02240680|560461600|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
155281463|NCT02240680|560461601|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
155281464|NCT02240680|560461598|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
155281465|NCT02240680|560461599|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
155281466|NCT02240680|560461600|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
155281467|NCT02240680|560461601|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
155281468|NCT01657032|560461602|FG000|Overall Study|Lost to Follow-up|0|||
155281469|NCT01657032|560461603|FG001|Overall Study|Lost to Follow-up|7|||
155281470|NCT00958009|560461611|FG000|Overall Study|Adverse Event|1|||
155281471|NCT00958009|560461611|FG000|Overall Study|Subject found device difficult to use|1|||
155281472|NCT00087490|560461612|FG000|Overall Study|Death|6|||
155281473|NCT00087490|560461613|FG001|Overall Study|Death|4|||
155281474|NCT00087490|560461612|FG000|Overall Study|Adverse Event|3|||
155281475|NCT00087490|560461613|FG001|Overall Study|Adverse Event|8|||
155281476|NCT00087490|560461612|FG000|Overall Study|Lack of Efficacy|0|||
155281477|NCT00087490|560461613|FG001|Overall Study|Lack of Efficacy|2|||
155281478|NCT00087490|560461612|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
155281479|NCT00087490|560461613|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
155281480|NCT00087490|560461612|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
155048587|NCT00527826|559608778|FG001|Overall Study|Additional Intake of Viani forte|1|||
155048588|NCT00527826|559608777|FG000|Overall Study|Participant moved away|0|||
155048589|NCT00527826|559608778|FG001|Overall Study|Participant moved away|1|||
155048590|NCT01421641|559608779|FG000|Overall Study|Protocol Violation|2|||
155048591|NCT01421641|559608780|FG001|Overall Study|Protocol Violation|2|||
155048592|NCT02420119|559608782|FG000|Overall Study|insufficient laboratory data|5|||
155048593|NCT01808261|559608783|FG000|Overall Study|Physician Decision|0|||
155048594|NCT01808261|559608784|FG001|Overall Study|Physician Decision|2|||
155048595|NCT01808261|559608783|FG000|Overall Study|Study Closed/Terminated|25|||
155048596|NCT01808261|559608784|FG001|Overall Study|Study Closed/Terminated|23|||
155048597|NCT01808261|559608783|FG000|Overall Study|Adverse event, non-fatal|2|||
155048598|NCT01808261|559608784|FG001|Overall Study|Adverse event, non-fatal|0|||
155048599|NCT01808261|559608783|FG000|Overall Study|Consent withdrawn by subject|6|||
155048600|NCT01808261|559608784|FG001|Overall Study|Consent withdrawn by subject|7|||
155048601|NCT01808261|559608783|FG000|Overall Study|Lost to Follow-up|3|||
155048602|NCT01808261|559608784|FG001|Overall Study|Lost to Follow-up|1|||
155048603|NCT04501952|559608787|FG000|Overall Study|Adverse Event|0|||
155048604|NCT04501952|559608788|FG001|Overall Study|Adverse Event|3|||
155048605|NCT04501952|559608787|FG000|Overall Study|Investigator's Discretion|0|||
155048606|NCT04501952|559608788|FG001|Overall Study|Investigator's Discretion|1|||
155048607|NCT04501952|559608787|FG000|Overall Study|Protocol Violation|1|||
155048608|NCT04501952|559608788|FG001|Overall Study|Protocol Violation|1|||
155048609|NCT04501952|559608787|FG000|Overall Study|Withdrew Consent|5|||
155048610|NCT04501952|559608788|FG001|Overall Study|Withdrew Consent|4|||
155048611|NCT04501952|559608787|FG000|Overall Study|Lost to Follow-up|7|||
155048612|NCT04501952|559608788|FG001|Overall Study|Lost to Follow-up|2|||
155048613|NCT04501952|559608787|FG000|Overall Study|Randomized and Never Treated|13|||
155048614|NCT04501952|559608788|FG001|Overall Study|Randomized and Never Treated|9|||
155048615|NCT02080364|559608789|FG000|Baseline Period|Protocol Violation|2|||
155048616|NCT02080364|559608790|FG001|Baseline Period|Protocol Violation|1|||
155048617|NCT02080364|559608791|FG002|Baseline Period|Protocol Violation|0|||
155048618|NCT02080364|559608792|FG003|Baseline Period|Protocol Violation|0|||
155048619|NCT02080364|559608789|FG000|Baseline Period|Other|0|||
155048620|NCT02080364|559608790|FG001|Baseline Period|Other|1|||
155048621|NCT02080364|559608791|FG002|Baseline Period|Other|1|||
155048622|NCT02080364|559608792|FG003|Baseline Period|Other|0|||
155048623|NCT02080364|559608789|FG000|Treatment Period|Adverse Event|10|||
155048624|NCT02080364|559608790|FG001|Treatment Period|Adverse Event|15|||
155048625|NCT02080364|559608791|FG002|Treatment Period|Adverse Event|11|||
155048626|NCT02080364|559608792|FG003|Treatment Period|Adverse Event|14|||
155048627|NCT02080364|559608789|FG000|Treatment Period|Lost to Follow-up|2|||
155048628|NCT02080364|559608790|FG001|Treatment Period|Lost to Follow-up|3|||
155048629|NCT02080364|559608791|FG002|Treatment Period|Lost to Follow-up|5|||
155048630|NCT02080364|559608792|FG003|Treatment Period|Lost to Follow-up|0|||
155048631|NCT02080364|559608789|FG000|Treatment Period|Protocol Violation|5|||
155048632|NCT02080364|559608790|FG001|Treatment Period|Protocol Violation|3|||
155048633|NCT02080364|559608791|FG002|Treatment Period|Protocol Violation|5|||
155048634|NCT02080364|559608792|FG003|Treatment Period|Protocol Violation|1|||
155048635|NCT02080364|559608789|FG000|Treatment Period|Withdrawal by Subject|16|||
155281481|NCT00087490|560461613|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
155281482|NCT00087490|560461612|FG000|Overall Study|Randomized but not treated|7|||
155281483|NCT00087490|560461613|FG001|Overall Study|Randomized but not treated|18|||
155281484|NCT00761774|560461614|FG000|Overall Study|Adverse Event|17|||
155281485|NCT00761774|560461614|FG000|Overall Study|Lack of Efficacy|37|||
155281486|NCT00761774|560461614|FG000|Overall Study|Lost to Follow-up|2|||
155281487|NCT00761774|560461614|FG000|Overall Study|Withdrawal by Subject|9|||
155281488|NCT00761774|560461614|FG000|Overall Study|Non-compliance|4|||
155281489|NCT00761774|560461614|FG000|Overall Study|End of study|2|||
155281490|NCT00761774|560461614|FG000|Overall Study|Reclassification of seizures|1|||
155281491|NCT00761774|560461614|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
155281492|NCT00761774|560461614|FG000|Overall Study|Sponsor decision|1|||
155281493|NCT00761774|560461614|FG000|Overall Study|Investigator clinical judgement|1|||
155281494|NCT00761774|560461614|FG000|Overall Study|Patient moved out of study area|1|||
155281495|NCT00761774|560461614|FG000|Overall Study|Coordinator leaving site|1|||
155281496|NCT00761774|560461614|FG000|Overall Study|Subject IP non-compliance|1|||
155281497|NCT00761774|560461614|FG000|Overall Study|IP stopped by hospital physician|1|||
155281498|NCT01077024|560461615|FG000|Overall Study|Lost to Follow-up|20|||
155048636|NCT02080364|559608790|FG001|Treatment Period|Withdrawal by Subject|16|||
155048637|NCT02080364|559608791|FG002|Treatment Period|Withdrawal by Subject|15|||
155048638|NCT02080364|559608792|FG003|Treatment Period|Withdrawal by Subject|10|||
155048639|NCT02080364|559608789|FG000|Treatment Period|Study Terminated by Sponsor|0|||
155281499|NCT01077024|560461616|FG001|Overall Study|Lost to Follow-up|14|||
155048640|NCT02080364|559608790|FG001|Treatment Period|Study Terminated by Sponsor|0|||
155048641|NCT02080364|559608791|FG002|Treatment Period|Study Terminated by Sponsor|180|||
155048642|NCT02080364|559608792|FG003|Treatment Period|Study Terminated by Sponsor|183|||
155048643|NCT02080364|559608789|FG000|Treatment Period|Other|14|||
155048644|NCT02080364|559608790|FG001|Treatment Period|Other|12|||
155281500|NCT01077024|560461615|FG000|Overall Study|Withdrawal by Subject|0|||
155048645|NCT02080364|559608791|FG002|Treatment Period|Other|21|||
155048646|NCT02080364|559608792|FG003|Treatment Period|Other|16|||
155092574|NCT01959529|559773634|FG000|Overall Study|Other|70|||
155048647|NCT02256839|559608793|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
155048648|NCT02256839|559608794|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
155048649|NCT00436826|559608795|FG000|Double Blind Period (DBP)|Adverse Event|2|||
155048650|NCT00436826|559608796|FG001|Double Blind Period (DBP)|Adverse Event|0|||
155048651|NCT00436826|559608797|FG002|Double Blind Period (DBP)|Adverse Event|0|||
155048652|NCT00436826|559608798|FG003|Double Blind Period (DBP)|Adverse Event|0|||
155048653|NCT00436826|559608799|FG004|Double Blind Period (DBP)|Adverse Event|0|||
155048654|NCT00436826|559608800|FG005|Double Blind Period (DBP)|Adverse Event|0|||
155048655|NCT00436826|559608795|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
155048656|NCT00436826|559608796|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
155048657|NCT00436826|559608797|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
155048658|NCT00436826|559608798|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
155048659|NCT00436826|559608799|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
155048660|NCT00436826|559608800|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
155048661|NCT00436826|559608795|FG000|Double Blind Period (DBP)|Other|10|||
155048662|NCT00436826|559608796|FG001|Double Blind Period (DBP)|Other|11|||
155048663|NCT00436826|559608797|FG002|Double Blind Period (DBP)|Other|0|||
155048664|NCT00436826|559608798|FG003|Double Blind Period (DBP)|Other|0|||
155048665|NCT00436826|559608799|FG004|Double Blind Period (DBP)|Other|0|||
155048666|NCT00436826|559608800|FG005|Double Blind Period (DBP)|Other|0|||
155048667|NCT00436826|559608795|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155048668|NCT00436826|559608796|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155048669|NCT00436826|559608797|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155048670|NCT00436826|559608798|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
155048671|NCT00436826|559608799|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155048672|NCT00436826|559608800|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
155048673|NCT00436826|559608795|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155048674|NCT00436826|559608796|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155048675|NCT00436826|559608797|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
155048676|NCT00436826|559608798|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
155048677|NCT00436826|559608799|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155048678|NCT00436826|559608800|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
155048679|NCT00436826|559608795|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155048680|NCT00436826|559608796|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155048681|NCT00436826|559608797|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155048682|NCT00436826|559608798|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
155048683|NCT00436826|559608799|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
155048684|NCT00436826|559608800|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
155048685|NCT05464420|559608802|FG000|Overall Study|Death|0|||
155048686|NCT05464420|559608803|FG001|Overall Study|Death|0|||
155048687|NCT05464420|559608804|FG002|Overall Study|Death|0|||
155048688|NCT05464420|559608805|FG003|Overall Study|Death|1|||
155048689|NCT05464420|559608802|FG000|Overall Study|Lost to Follow-up|16|||
155048690|NCT05464420|559608803|FG001|Overall Study|Lost to Follow-up|11|||
155048691|NCT05464420|559608804|FG002|Overall Study|Lost to Follow-up|11|||
155048692|NCT05464420|559608805|FG003|Overall Study|Lost to Follow-up|11|||
155281501|NCT01077024|560461616|FG001|Overall Study|Withdrawal by Subject|2|||
155281502|NCT01077024|560461615|FG000|Overall Study|Incarcerated|7|||
155281503|NCT01077024|560461616|FG001|Overall Study|Incarcerated|8|||
155281504|NCT01077024|560461615|FG000|Overall Study|Other|4|||
155281505|NCT01077024|560461616|FG001|Overall Study|Other|4|||
155281506|NCT03379233|560461617|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
155281507|NCT03379233|560461618|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
155281508|NCT02300311|560461619|FG000|Overall Study|Other than the reason specified|1|||
155281509|NCT02300311|560461620|FG001|Overall Study|Other than the reason specified|0|||
155281510|NCT02300311|560461619|FG000|Overall Study|Refused to continue taking medication|18|||
155281511|NCT02300311|560461620|FG001|Overall Study|Refused to continue taking medication|0|||
155281512|NCT02687919|560461621|FG000|Overall Study|Withdrawal by Subject|6|||
155281513|NCT02687919|560461622|FG001|Overall Study|Withdrawal by Subject|6|||
155281514|NCT02687919|560461621|FG000|Overall Study|Protocol Violation|2|||
155281515|NCT02687919|560461622|FG001|Overall Study|Protocol Violation|0|||
155281516|NCT00848211|560461623|FG000|Overall Study|Protocol Violation|0|||
155281517|NCT00848211|560461624|FG001|Overall Study|Protocol Violation|1|||
155281518|NCT00848211|560461625|FG002|Overall Study|Protocol Violation|1|||
155281519|NCT00848211|560461626|FG003|Overall Study|Protocol Violation|0|||
155281520|NCT00848211|560461623|FG000|Overall Study|Adverse Event|0|||
155281521|NCT00848211|560461624|FG001|Overall Study|Adverse Event|0|||
155281522|NCT00848211|560461625|FG002|Overall Study|Adverse Event|0|||
155281523|NCT00848211|560461626|FG003|Overall Study|Adverse Event|0|||
155281524|NCT00419003|560461627|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
155281525|NCT00419003|560461628|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
155281526|NCT00419003|560461627|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
155281527|NCT00419003|560461628|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
154946557|NCT02228382|559230085|FG000|Overall Study|Withdrawal by Subject|0|||
154946558|NCT02228382|559230086|FG001|Overall Study|Withdrawal by Subject|3|||
154946559|NCT02228382|559230087|FG002|Overall Study|Withdrawal by Subject|2|||
154946560|NCT02228382|559230088|FG003|Overall Study|Withdrawal by Subject|1|||
154946561|NCT02228382|559230089|FG004|Overall Study|Withdrawal by Subject|0|||
154946562|NCT02228382|559230085|FG000|Overall Study|Other|2|||
154946563|NCT02228382|559230086|FG001|Overall Study|Other|3|||
154946564|NCT02228382|559230087|FG002|Overall Study|Other|3|||
154946565|NCT02228382|559230088|FG003|Overall Study|Other|0|||
154946566|NCT02228382|559230089|FG004|Overall Study|Other|0|||
154946567|NCT02396381|559230090|FG000|Overall Study|Adverse Event|3|||
154946568|NCT02396381|559230091|FG001|Overall Study|Adverse Event|2|||
154946569|NCT02396381|559230090|FG000|Overall Study|Withdrawal by Subject|33|||
154946570|NCT02396381|559230091|FG001|Overall Study|Withdrawal by Subject|24|||
154946571|NCT02396381|559230090|FG000|Overall Study|Lost to Follow-up|49|||
154946572|NCT02396381|559230091|FG001|Overall Study|Lost to Follow-up|31|||
154946573|NCT02396381|559230090|FG000|Overall Study|Protocol Violation|1|||
154946574|NCT02396381|559230091|FG001|Overall Study|Protocol Violation|0|||
154946575|NCT02396381|559230090|FG000|Overall Study|Site terminated by sponsor|7|||
154946576|NCT02396381|559230091|FG001|Overall Study|Site terminated by sponsor|8|||
154946577|NCT02396381|559230090|FG000|Overall Study|Physician Decision|5|||
154946578|NCT02396381|559230091|FG001|Overall Study|Physician Decision|5|||
154946579|NCT02396381|559230090|FG000|Overall Study|Pregnancy|2|||
154946580|NCT02396381|559230091|FG001|Overall Study|Pregnancy|0|||
154946581|NCT02396381|559230090|FG000|Overall Study|Non-compliance with study procedures|1|||
154946582|NCT02396381|559230091|FG001|Overall Study|Non-compliance with study procedures|0|||
154946583|NCT02396381|559230090|FG000|Overall Study|Moved out of town/state|1|||
154946584|NCT02396381|559230091|FG001|Overall Study|Moved out of town/state|3|||
154946585|NCT02396381|559230090|FG000|Overall Study|Could not complete visit|1|||
154946586|NCT02396381|559230091|FG001|Overall Study|Could not complete visit|0|||
154946587|NCT02396381|559230090|FG000|Overall Study|Possible conflict of interest|1|||
154946588|NCT02396381|559230091|FG001|Overall Study|Possible conflict of interest|0|||
154946589|NCT02396381|559230090|FG000|Overall Study|Randomization/Screening Error|3|||
154946590|NCT02396381|559230091|FG001|Overall Study|Randomization/Screening Error|1|||
154946591|NCT00275002|559230092|FG000|Overall Study|Death|1|||
154946592|NCT00275002|559230093|FG001|Overall Study|Death|0|||
154946593|NCT00275002|559230092|FG000|Overall Study|Disease progression|21|||
154946594|NCT00275002|559230093|FG001|Overall Study|Disease progression|15|||
154946595|NCT00275002|559230092|FG000|Overall Study|Adverse Event|0|||
154946596|NCT00275002|559230093|FG001|Overall Study|Adverse Event|1|||
154946597|NCT02918162|559230095|FG000|Overall Study|Withdrawal by Subject|1|||
154946598|NCT02918162|559230095|FG000|Overall Study|Omental Disease|1|||
154946599|NCT00395226|559230096|FG000|Overall Study|Adverse Event|4|||
154946600|NCT00395226|559230097|FG001|Overall Study|Adverse Event|3|||
154946601|NCT00395226|559230096|FG000|Overall Study|Withdrawal by Subject|0|||
154946602|NCT00395226|559230097|FG001|Overall Study|Withdrawal by Subject|1|||
154946603|NCT00395226|559230096|FG000|Overall Study|Lost to Follow-up|0|||
154946604|NCT00395226|559230097|FG001|Overall Study|Lost to Follow-up|1|||
154946605|NCT02655237|559230100|FG000|Overall Study|Adverse Event|10|||
155281528|NCT02531438|560461629|FG000|Overall Study|Adverse Event|7|||
155281529|NCT02531438|560461630|FG001|Overall Study|Adverse Event|9|||
155281530|NCT02531438|560461629|FG000|Overall Study|Lost to Follow-up|0|||
155281531|NCT02531438|560461630|FG001|Overall Study|Lost to Follow-up|3|||
155281532|NCT02531438|560461629|FG000|Overall Study|Withdrawal by Subject|7|||
155281533|NCT02531438|560461630|FG001|Overall Study|Withdrawal by Subject|8|||
155281534|NCT02531438|560461629|FG000|Overall Study|Physician Decision|0|||
155281535|NCT02531438|560461630|FG001|Overall Study|Physician Decision|1|||
155281536|NCT02531438|560461629|FG000|Overall Study|Death|6|||
155281537|NCT02531438|560461630|FG001|Overall Study|Death|3|||
155281538|NCT02531438|560461629|FG000|Overall Study|Randomized, but Not Treated|4|||
155281539|NCT02531438|560461630|FG001|Overall Study|Randomized, but Not Treated|0|||
155281540|NCT02531438|560461629|FG000|Overall Study|Missed EOT/PTE Visit|5|||
155281541|NCT02531438|560461630|FG001|Overall Study|Missed EOT/PTE Visit|2|||
155281542|NCT02531438|560461629|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
154946606|NCT02655237|559230101|FG001|Overall Study|Adverse Event|7|||
154946607|NCT02655237|559230100|FG000|Overall Study|Protocol Deviation|2|||
154946608|NCT02655237|559230101|FG001|Overall Study|Protocol Deviation|0|||
154946609|NCT02655237|559230100|FG000|Overall Study|Withdrawal by Participant|1|||
154946610|NCT02655237|559230101|FG001|Overall Study|Withdrawal by Participant|2|||
154946611|NCT02655237|559230100|FG000|Overall Study|Lack of Efficacy|0|||
154946612|NCT02655237|559230101|FG001|Overall Study|Lack of Efficacy|1|||
154946613|NCT02655237|559230100|FG000|Overall Study|Recovery Leading to Surgery|2|||
154946614|NCT02655237|559230101|FG001|Overall Study|Recovery Leading to Surgery|1|||
154946615|NCT02655237|559230100|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
155281543|NCT02531438|560461630|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
154946616|NCT02655237|559230101|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
155048693|NCT05464420|559608802|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
155048694|NCT05464420|559608803|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
155048695|NCT05464420|559608804|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
155048696|NCT05464420|559608805|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
155048697|NCT05464420|559608802|FG000|Overall Study|Withdrawal by Subject|4|||
155048698|NCT05464420|559608803|FG001|Overall Study|Withdrawal by Subject|8|||
155048699|NCT05464420|559608804|FG002|Overall Study|Withdrawal by Subject|3|||
155048700|NCT05464420|559608805|FG003|Overall Study|Withdrawal by Subject|1|||
155048701|NCT05464420|559608802|FG000|Overall Study|Protocol Violation|0|||
155048702|NCT05464420|559608803|FG001|Overall Study|Protocol Violation|0|||
155048703|NCT05464420|559608804|FG002|Overall Study|Protocol Violation|1|||
155048704|NCT05464420|559608805|FG003|Overall Study|Protocol Violation|1|||
155048705|NCT05464420|559608802|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
155048706|NCT05464420|559608803|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
155048707|NCT05464420|559608804|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
155048708|NCT05464420|559608805|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
155048709|NCT01383018|559608813|FG000|Overall Study|Adverse Event|14|||
155048710|NCT01383018|559608813|FG000|Overall Study|Death|10|||
155048711|NCT01383018|559608813|FG000|Overall Study|Lost to Follow-up|5|||
155048712|NCT01383018|559608813|FG000|Overall Study|Physician Decision|5|||
155048713|NCT01383018|559608813|FG000|Overall Study|Withdrawal by Subject|9|||
155048714|NCT01383018|559608813|FG000|Overall Study|Subject not implanted|76|||
155048715|NCT01383018|559608813|FG000|Overall Study|Missed Visit|247|||
155048716|NCT01383018|559608813|FG000|Overall Study|Site closed early-not compliance related|7|||
155048717|NCT01383018|559608813|FG000|Overall Study|Patient moved away from site|1|||
155048718|NCT01383018|559608813|FG000|Overall Study|Subject Incarcerated|1|||
155048719|NCT00320788|559608814|FG000|Overall Study|Adverse Event|0|||
155048720|NCT00320788|559608815|FG001|Overall Study|Adverse Event|0|||
155048721|NCT00320788|559608816|FG002|Overall Study|Adverse Event|0|||
155048722|NCT00320788|559608817|FG003|Overall Study|Adverse Event|1|||
155048723|NCT00320788|559608818|FG004|Overall Study|Adverse Event|0|||
155048724|NCT00320788|559608814|FG000|Overall Study|Death|0|||
155048725|NCT00320788|559608815|FG001|Overall Study|Death|0|||
155048726|NCT00320788|559608816|FG002|Overall Study|Death|1|||
155048727|NCT00320788|559608817|FG003|Overall Study|Death|0|||
155048728|NCT00320788|559608818|FG004|Overall Study|Death|1|||
155048729|NCT00320788|559608814|FG000|Overall Study|Lost to Follow-up|0|||
155048730|NCT00320788|559608815|FG001|Overall Study|Lost to Follow-up|2|||
155048731|NCT00320788|559608816|FG002|Overall Study|Lost to Follow-up|1|||
155048732|NCT00320788|559608817|FG003|Overall Study|Lost to Follow-up|0|||
155048733|NCT00320788|559608818|FG004|Overall Study|Lost to Follow-up|0|||
155048734|NCT00320788|559608814|FG000|Overall Study|Decision by the Sponsor|1|||
155048735|NCT00320788|559608815|FG001|Overall Study|Decision by the Sponsor|1|||
155048736|NCT00320788|559608816|FG002|Overall Study|Decision by the Sponsor|0|||
155048737|NCT00320788|559608817|FG003|Overall Study|Decision by the Sponsor|0|||
155048738|NCT00320788|559608818|FG004|Overall Study|Decision by the Sponsor|1|||
155048739|NCT00320788|559608814|FG000|Overall Study|Other|1|||
155048740|NCT00320788|559608815|FG001|Overall Study|Other|2|||
155048741|NCT00320788|559608816|FG002|Overall Study|Other|1|||
155048742|NCT00320788|559608817|FG003|Overall Study|Other|1|||
155048743|NCT00320788|559608818|FG004|Overall Study|Other|1|||
155048744|NCT00320788|559608814|FG000|Overall Study|Physician Decision|1|||
155048745|NCT00320788|559608815|FG001|Overall Study|Physician Decision|1|||
155048746|NCT00320788|559608816|FG002|Overall Study|Physician Decision|0|||
155048747|NCT00320788|559608817|FG003|Overall Study|Physician Decision|0|||
155048748|NCT00320788|559608818|FG004|Overall Study|Physician Decision|0|||
155048749|NCT00320788|559608814|FG000|Overall Study|Protocol Violation|0|||
155048750|NCT00320788|559608815|FG001|Overall Study|Protocol Violation|0|||
155048751|NCT00320788|559608816|FG002|Overall Study|Protocol Violation|0|||
155048752|NCT00320788|559608817|FG003|Overall Study|Protocol Violation|0|||
155048753|NCT00320788|559608818|FG004|Overall Study|Protocol Violation|1|||
155048754|NCT00320788|559608814|FG000|Overall Study|Withdrawal by Subject|3|||
155048755|NCT00320788|559608815|FG001|Overall Study|Withdrawal by Subject|0|||
155048756|NCT00320788|559608816|FG002|Overall Study|Withdrawal by Subject|0|||
155048757|NCT00320788|559608817|FG003|Overall Study|Withdrawal by Subject|3|||
155048758|NCT00320788|559608818|FG004|Overall Study|Withdrawal by Subject|1|||
155048759|NCT04346199|559608819|FG000|Overall Study|Death|8|||
155048760|NCT04346199|559608820|FG001|Overall Study|Death|9|||
155048761|NCT04346199|559608819|FG000|Overall Study|Lost to Follow-up|0|||
155048762|NCT04346199|559608820|FG001|Overall Study|Lost to Follow-up|1|||
155048763|NCT04346199|559608819|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
155048764|NCT04346199|559608820|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
155048765|NCT04346199|559608819|FG000|Overall Study|Withdrawal by Subject|5|||
155048766|NCT04346199|559608820|FG001|Overall Study|Withdrawal by Subject|1|||
155048767|NCT00627926|559608821|FG000|Overall Study|Adverse Event|26|||
155048768|NCT00627926|559608822|FG001|Overall Study|Adverse Event|37|||
155048769|NCT00627926|559608823|FG002|Overall Study|Adverse Event|36|||
155048770|NCT00627926|559608821|FG000|Overall Study|Death|1|||
155048771|NCT00627926|559608822|FG001|Overall Study|Death|0|||
155048772|NCT00627926|559608823|FG002|Overall Study|Death|0|||
155048773|NCT00627926|559608821|FG000|Overall Study|Lost to Follow-up|4|||
155048774|NCT00627926|559608822|FG001|Overall Study|Lost to Follow-up|3|||
155048775|NCT00627926|559608823|FG002|Overall Study|Lost to Follow-up|4|||
155048776|NCT00627926|559608821|FG000|Overall Study|Withdrawal by Subject|2|||
155048777|NCT00627926|559608822|FG001|Overall Study|Withdrawal by Subject|1|||
155048778|NCT00627926|559608823|FG002|Overall Study|Withdrawal by Subject|0|||
155048779|NCT00627926|559608821|FG000|Overall Study|Lack of Efficacy|118|||
155048780|NCT00627926|559608822|FG001|Overall Study|Lack of Efficacy|40|||
155048781|NCT00627926|559608823|FG002|Overall Study|Lack of Efficacy|38|||
155048782|NCT00627926|559608821|FG000|Overall Study|Noncompliance/unspecified|8|||
155048783|NCT00627926|559608822|FG001|Overall Study|Noncompliance/unspecified|23|||
155048784|NCT00627926|559608823|FG002|Overall Study|Noncompliance/unspecified|17|||
155048785|NCT03414229|559608824|FG000|Overall Study|Adverse Event|1|||
155048786|NCT03414229|559608825|FG001|Overall Study|Adverse Event|0|||
155048787|NCT03414229|559608826|FG002|Overall Study|Adverse Event|2|||
155048788|NCT03414229|559608827|FG003|Overall Study|Adverse Event|1|||
155048789|NCT03414229|559608824|FG000|Overall Study|Lack of Efficacy|7|||
155048790|NCT03414229|559608825|FG001|Overall Study|Lack of Efficacy|4|||
155048791|NCT03414229|559608826|FG002|Overall Study|Lack of Efficacy|1|||
155048792|NCT03414229|559608827|FG003|Overall Study|Lack of Efficacy|9|||
155048793|NCT03414229|559608824|FG000|Overall Study|Change in therapy|1|||
155048794|NCT03414229|559608825|FG001|Overall Study|Change in therapy|0|||
155048795|NCT03414229|559608826|FG002|Overall Study|Change in therapy|0|||
155048796|NCT03414229|559608827|FG003|Overall Study|Change in therapy|0|||
155048797|NCT03414229|559608824|FG000|Overall Study|Pregnancy|0|||
155048798|NCT03414229|559608825|FG001|Overall Study|Pregnancy|0|||
155048799|NCT03414229|559608826|FG002|Overall Study|Pregnancy|1|||
155048800|NCT03414229|559608827|FG003|Overall Study|Pregnancy|0|||
155048801|NCT03414229|559608824|FG000|Overall Study|Withdrawal by Subject|0|||
155048802|NCT03414229|559608825|FG001|Overall Study|Withdrawal by Subject|1|||
155048803|NCT03414229|559608826|FG002|Overall Study|Withdrawal by Subject|1|||
155048804|NCT03414229|559608827|FG003|Overall Study|Withdrawal by Subject|0|||
155048805|NCT05568797|559608830|FG000|Overall Study|Adverse Event|0|||
155048806|NCT05568797|559608831|FG001|Overall Study|Adverse Event|8|||
155048807|NCT05568797|559608830|FG000|Overall Study|Lost to Follow-up|2|||
155048808|NCT05568797|559608831|FG001|Overall Study|Lost to Follow-up|3|||
155048809|NCT05568797|559608830|FG000|Overall Study|Withdrawal by Subject|1|||
155048810|NCT05568797|559608831|FG001|Overall Study|Withdrawal by Subject|10|||
155048811|NCT05568797|559608830|FG000|Overall Study|Other|2|||
155048812|NCT05568797|559608831|FG001|Overall Study|Other|2|||
155048813|NCT00099632|559608832|FG000|Overall Study|Lost to Follow-up|1|||
155048814|NCT00099632|559608833|FG001|Overall Study|Lost to Follow-up|0|||
155048815|NCT00099632|559608834|FG002|Overall Study|Lost to Follow-up|3|||
155048816|NCT00099632|559608835|FG003|Overall Study|Lost to Follow-up|1|||
155048817|NCT00099632|559608836|FG004|Overall Study|Lost to Follow-up|1|||
155048818|NCT00099632|559608837|FG005|Overall Study|Lost to Follow-up|0|||
155048819|NCT00099632|559608832|FG000|Overall Study|Withdrawal by Subject|0|||
155048820|NCT00099632|559608833|FG001|Overall Study|Withdrawal by Subject|1|||
155048821|NCT00099632|559608834|FG002|Overall Study|Withdrawal by Subject|0|||
155048822|NCT00099632|559608835|FG003|Overall Study|Withdrawal by Subject|0|||
155048823|NCT00099632|559608836|FG004|Overall Study|Withdrawal by Subject|0|||
155048824|NCT00099632|559608837|FG005|Overall Study|Withdrawal by Subject|1|||
155048825|NCT00099632|559608832|FG000|Overall Study|Protocol Violation|0|||
155048826|NCT00099632|559608833|FG001|Overall Study|Protocol Violation|0|||
155048827|NCT00099632|559608834|FG002|Overall Study|Protocol Violation|0|||
155048828|NCT00099632|559608835|FG003|Overall Study|Protocol Violation|0|||
155048829|NCT00099632|559608836|FG004|Overall Study|Protocol Violation|0|||
155048830|NCT00099632|559608837|FG005|Overall Study|Protocol Violation|1|||
155048831|NCT02797678|559608838|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
155048832|NCT02797678|559608839|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
155048833|NCT02797678|559608840|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
155048834|NCT02797678|559608841|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
155048835|NCT02797678|559608838|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
155048836|NCT02797678|559608839|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
155048837|NCT02797678|559608840|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
155048838|NCT02797678|559608841|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
155048839|NCT02797678|559608838|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
155281544|NCT01653743|560461631|FG000|Overall Study|Withdrawal by Subject|1|||
155048840|NCT02797678|559608839|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
155281545|NCT01653743|560461632|FG001|Overall Study|Withdrawal by Subject|0|||
155281546|NCT01653743|560461631|FG000|Overall Study|Investigator discretion|3|||
155048841|NCT02797678|559608840|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
155048842|NCT02797678|559608841|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
155048843|NCT03131687|559608842|FG000|Overall Study|Adverse Event|0|||
155388410|NCT00421707|560856239|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
155388411|NCT00421707|560856240|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
155388412|NCT00421707|560856239|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
155388413|NCT00421707|560856240|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
155388414|NCT05056987|560856241|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
155388415|NCT05056987|560856242|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
155388416|NCT05056987|560856241|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
155388417|NCT05056987|560856242|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
155388418|NCT01575028|560856243|FG000|Overall Study|Physician Decision|0|||
155388419|NCT01575028|560856244|FG001|Overall Study|Physician Decision|1|||
155388420|NCT01182194|560856245|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
155388421|NCT01182194|560856246|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
155388422|NCT01948908|560856247|FG000|Overall Study|Protocol Violation|1|||
155388423|NCT01948908|560856248|FG001|Overall Study|Protocol Violation|0|||
155388424|NCT01948908|560856249|FG002|Overall Study|Protocol Violation|2|||
155388425|NCT01585987|560856250|FG000|Randomized|Withdrawal by Subject|0|||
155388426|NCT01585987|560856251|FG001|Randomized|Withdrawal by Subject|4|||
155388427|NCT01585987|560856250|FG000|Randomized|No longer met criteria|0|||
155388428|NCT01585987|560856251|FG001|Randomized|No longer met criteria|2|||
155388429|NCT01585987|560856250|FG000|Treated|Disease Progression|39|||
155388430|NCT01585987|560856251|FG001|Treated|Disease Progression|36|||
155388431|NCT01585987|560856250|FG000|Treated|Study Drug Toxicity|9|||
155388432|NCT01585987|560856251|FG001|Treated|Study Drug Toxicity|5|||
155388433|NCT01585987|560856250|FG000|Treated|Adverse Event|3|||
155388434|NCT01585987|560856251|FG001|Treated|Adverse Event|0|||
155388435|NCT01585987|560856250|FG000|Treated|Withdrawal by Subject|1|||
155388436|NCT01585987|560856251|FG001|Treated|Withdrawal by Subject|2|||
155388437|NCT01585987|560856250|FG000|Treated|Death|1|||
155388438|NCT01585987|560856251|FG001|Treated|Death|0|||
155388439|NCT01585987|560856250|FG000|Treated|Lost to Follow-up|0|||
155388440|NCT01585987|560856251|FG001|Treated|Lost to Follow-up|1|||
155388441|NCT01585987|560856250|FG000|Treated|Maximum Clinical Benefit|0|||
155388442|NCT01585987|560856251|FG001|Treated|Maximum Clinical Benefit|1|||
155388443|NCT01585987|560856250|FG000|Treated|Non-Specified|1|||
155388444|NCT01585987|560856251|FG001|Treated|Non-Specified|2|||
155388445|NCT01585987|560856250|FG000|Treated|Subject Request|0|||
154946617|NCT02655237|559230100|FG000|Overall Study|Randomized but Not Treated|1|||
154946618|NCT02655237|559230101|FG001|Overall Study|Randomized but Not Treated|0|||
154946619|NCT03679741|559230102|FG000|Period 1|No longer meet eligibility criteria|1|||
154946620|NCT03679741|559230103|FG001|Period 1|No longer meet eligibility criteria|0|||
154946621|NCT03679741|559230102|FG000|Period 1|Lost to Follow-up|0|||
154946622|NCT03679741|559230103|FG001|Period 1|Lost to Follow-up|1|||
154946623|NCT03679741|559230102|FG000|Period 1|Adverse Event|1|||
154946624|NCT03679741|559230103|FG001|Period 1|Adverse Event|1|||
154946625|NCT03679741|559230102|FG000|Period 1|Withdrawal by Subject|0|||
154946626|NCT03679741|559230103|FG001|Period 1|Withdrawal by Subject|1|||
154946627|NCT03679741|559230102|FG000|Period 2|Adverse Event|2|||
154946628|NCT03679741|559230103|FG001|Period 2|Adverse Event|1|||
154946629|NCT03679741|559230102|FG000|Period 2|Withdrawal by Subject|1|||
154946630|NCT03679741|559230103|FG001|Period 2|Withdrawal by Subject|1|||
154946631|NCT02227862|559230107|FG000|Overall Study|Protocol Violation|7|||
154946632|NCT02227862|559230108|FG001|Overall Study|Protocol Violation|9|||
154946633|NCT02227862|559230107|FG000|Overall Study|Other|0|||
154946634|NCT02227862|559230108|FG001|Overall Study|Other|2|||
154946635|NCT02227862|559230107|FG000|Overall Study|Adverse Event|4|||
154946636|NCT02227862|559230108|FG001|Overall Study|Adverse Event|3|||
154946637|NCT02227862|559230107|FG000|Overall Study|Withdrawal by Subject|7|||
154946638|NCT02227862|559230108|FG001|Overall Study|Withdrawal by Subject|6|||
154946639|NCT02227862|559230107|FG000|Overall Study|Lost to Follow-up|1|||
154946640|NCT02227862|559230108|FG001|Overall Study|Lost to Follow-up|2|||
154946641|NCT00783796|559230109|FG000|Overall Study|Did not receive any stent|4|||
154946642|NCT00783796|559230109|FG000|Overall Study|Received non-XIENCE V stent|1|||
154946643|NCT00783796|559230109|FG000|Overall Study|Received commercial XIENCE V stent|1|||
155388446|NCT01585987|560856251|FG001|Treated|Subject Request|1|||
155388447|NCT01585987|560856250|FG000|Treated|Poor/Non-Compliance|0|||
155388448|NCT01585987|560856251|FG001|Treated|Poor/Non-Compliance|1|||
155388449|NCT03291587|560856252|FG000|Overall Study|Lost to Follow-up|62|||
155388450|NCT03291587|560856253|FG001|Overall Study|Lost to Follow-up|43|||
155388451|NCT03291587|560856252|FG000|Overall Study|Refused to Answer|5|||
154946644|NCT01215942|559230113|FG000|Treatment Period|Adverse Event|15|||
154946645|NCT01215942|559230114|FG001|Treatment Period|Adverse Event|26|||
154946646|NCT01215942|559230113|FG000|Treatment Period|Death|2|||
154946647|NCT01215942|559230114|FG001|Treatment Period|Death|4|||
154946648|NCT01215942|559230113|FG000|Treatment Period|Lack of Efficacy|23|||
154946649|NCT01215942|559230114|FG001|Treatment Period|Lack of Efficacy|62|||
154946650|NCT01215942|559230113|FG000|Treatment Period|Lost to Follow-up|3|||
155388452|NCT03291587|560856253|FG001|Overall Study|Refused to Answer|2|||
155388453|NCT03291587|560856252|FG000|Overall Study|Death|2|||
155388454|NCT03291587|560856253|FG001|Overall Study|Death|4|||
155388455|NCT03291587|560856252|FG000|Overall Study|Not interested in participating|8|||
155048844|NCT03131687|559608843|FG001|Overall Study|Adverse Event|1|||
155048845|NCT03131687|559608844|FG002|Overall Study|Adverse Event|0|||
155048846|NCT03131687|559608845|FG003|Overall Study|Adverse Event|1|||
155048847|NCT03131687|559608846|FG004|Overall Study|Adverse Event|2|||
155048848|NCT03131687|559608847|FG005|Overall Study|Adverse Event|2|||
155048849|NCT03131687|559608842|FG000|Overall Study|Death|1|||
155048850|NCT03131687|559608843|FG001|Overall Study|Death|0|||
155048851|NCT03131687|559608844|FG002|Overall Study|Death|0|||
155048852|NCT03131687|559608845|FG003|Overall Study|Death|0|||
155048853|NCT03131687|559608846|FG004|Overall Study|Death|0|||
155048854|NCT03131687|559608847|FG005|Overall Study|Death|0|||
155048855|NCT03131687|559608842|FG000|Overall Study|Withdrawal by Subject|3|||
155048856|NCT03131687|559608843|FG001|Overall Study|Withdrawal by Subject|3|||
155048857|NCT03131687|559608844|FG002|Overall Study|Withdrawal by Subject|3|||
155048858|NCT03131687|559608845|FG003|Overall Study|Withdrawal by Subject|1|||
155048859|NCT03131687|559608846|FG004|Overall Study|Withdrawal by Subject|2|||
155048860|NCT03131687|559608847|FG005|Overall Study|Withdrawal by Subject|1|||
155048861|NCT03131687|559608842|FG000|Overall Study|Lost to Follow-up|1|||
155048862|NCT03131687|559608843|FG001|Overall Study|Lost to Follow-up|4|||
155048863|NCT03131687|559608844|FG002|Overall Study|Lost to Follow-up|0|||
155048864|NCT03131687|559608845|FG003|Overall Study|Lost to Follow-up|1|||
155048865|NCT03131687|559608846|FG004|Overall Study|Lost to Follow-up|4|||
155048866|NCT03131687|559608847|FG005|Overall Study|Lost to Follow-up|2|||
155048867|NCT03131687|559608842|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
155048868|NCT03131687|559608843|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
155048869|NCT03131687|559608844|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
155048870|NCT03131687|559608845|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
155048871|NCT03131687|559608846|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
155048872|NCT03131687|559608847|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
155048873|NCT03131687|559608842|FG000|Overall Study|Principle Investigator Decision|0|||
155048874|NCT03131687|559608843|FG001|Overall Study|Principle Investigator Decision|1|||
155048875|NCT03131687|559608844|FG002|Overall Study|Principle Investigator Decision|0|||
155048876|NCT03131687|559608845|FG003|Overall Study|Principle Investigator Decision|0|||
155048877|NCT03131687|559608846|FG004|Overall Study|Principle Investigator Decision|0|||
155048878|NCT03131687|559608847|FG005|Overall Study|Principle Investigator Decision|0|||
155048879|NCT03131687|559608842|FG000|Overall Study|Inadvertent Enrollment|0|||
155048880|NCT03131687|559608843|FG001|Overall Study|Inadvertent Enrollment|0|||
155048881|NCT03131687|559608844|FG002|Overall Study|Inadvertent Enrollment|0|||
155048882|NCT03131687|559608845|FG003|Overall Study|Inadvertent Enrollment|1|||
155048883|NCT03131687|559608846|FG004|Overall Study|Inadvertent Enrollment|0|||
155048884|NCT03131687|559608847|FG005|Overall Study|Inadvertent Enrollment|0|||
155048885|NCT01237327|559608850|FG000|Overall Study|Protocol Violation: Core Study|1|||
155048886|NCT01237327|559608851|FG001|Overall Study|Protocol Violation: Core Study|0|||
155048887|NCT01237327|559608850|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
155048888|NCT01237327|559608851|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
155048889|NCT01237327|559608850|FG000|Overall Study|Progression of Disease: Core Study|18|||
155048890|NCT01237327|559608851|FG001|Overall Study|Progression of Disease: Core Study|22|||
155048891|NCT01237327|559608850|FG000|Overall Study|Progression of Disease: Extension Study|15|||
155048892|NCT01237327|559608851|FG001|Overall Study|Progression of Disease: Extension Study|13|||
155048893|NCT01237327|559608850|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
155048894|NCT01237327|559608851|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
155048895|NCT01237327|559608850|FG000|Overall Study|Withdrawal by Subject|1|||
155048896|NCT01237327|559608851|FG001|Overall Study|Withdrawal by Subject|3|||
155048897|NCT01237327|559608850|FG000|Overall Study|Lost to Follow-up|3|||
155048898|NCT01237327|559608851|FG001|Overall Study|Lost to Follow-up|0|||
155048899|NCT03300180|559608852|FG000|Baseline|Withdrawal by Subject|4|||
155048900|NCT03300180|559608853|FG001|Baseline|Withdrawal by Subject|6|||
155048901|NCT03300180|559608854|FG002|Baseline|Withdrawal by Subject|4|||
155048902|NCT03300180|559608852|FG000|6 Month Outcome|Withdrawal by Subject|12|||
155048903|NCT03300180|559608853|FG001|6 Month Outcome|Withdrawal by Subject|12|||
155048904|NCT03300180|559608854|FG002|6 Month Outcome|Withdrawal by Subject|19|||
155048905|NCT03300180|559608852|FG000|6 Month Outcome|Death|2|||
155048906|NCT03300180|559608853|FG001|6 Month Outcome|Death|4|||
155048907|NCT03300180|559608854|FG002|6 Month Outcome|Death|3|||
155048908|NCT03300180|559608852|FG000|6 Month Outcome|Missed Assessment|43|||
155048909|NCT03300180|559608853|FG001|6 Month Outcome|Missed Assessment|52|||
155048910|NCT03300180|559608854|FG002|6 Month Outcome|Missed Assessment|46|||
155048911|NCT03300180|559608852|FG000|12 Month Outcome|Withdrawal by Subject|3|||
155048912|NCT03300180|559608853|FG001|12 Month Outcome|Withdrawal by Subject|6|||
155048913|NCT03300180|559608854|FG002|12 Month Outcome|Withdrawal by Subject|6|||
155281547|NCT01653743|560461632|FG001|Overall Study|Investigator discretion|0|||
155281548|NCT01318811|560461635|FG000|Overall Study|Physician Decision|1|||
155048914|NCT03300180|559608852|FG000|12 Month Outcome|Death|9|||
155048915|NCT03300180|559608853|FG001|12 Month Outcome|Death|6|||
155048916|NCT03300180|559608854|FG002|12 Month Outcome|Death|6|||
155048917|NCT03300180|559608852|FG000|12 Month Outcome|Missed Assessment|62|||
155388456|NCT03291587|560856253|FG001|Overall Study|Not interested in participating|6|||
155388457|NCT03291587|560856252|FG000|Overall Study|Too busy to participate|4|||
155388458|NCT03291587|560856253|FG001|Overall Study|Too busy to participate|2|||
155388459|NCT00796120|560856255|FG000|Overall Study|Death|3|||
155388460|NCT00796120|560856256|FG001|Overall Study|Death|0|||
155388461|NCT00796120|560856255|FG000|Overall Study|Adverse Event|11|||
155388462|NCT00796120|560856256|FG001|Overall Study|Adverse Event|6|||
155388463|NCT00796120|560856255|FG000|Overall Study|Progressive disease|22|||
155388464|NCT00796120|560856256|FG001|Overall Study|Progressive disease|13|||
155388465|NCT00796120|560856255|FG000|Overall Study|Participant refusal|3|||
155388466|NCT00796120|560856256|FG001|Overall Study|Participant refusal|4|||
155388467|NCT00796120|560856255|FG000|Overall Study|Other|6|||
155388468|NCT00796120|560856256|FG001|Overall Study|Other|17|||
155388469|NCT00796120|560856255|FG000|Overall Study|Physician Decision|16|||
155388470|NCT00796120|560856256|FG001|Overall Study|Physician Decision|17|||
155388471|NCT00796120|560856255|FG000|Overall Study|Randomized but not treated|0|||
155388472|NCT00796120|560856256|FG001|Overall Study|Randomized but not treated|3|||
155388473|NCT02520284|560856259|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
155388474|NCT02520284|560856260|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
155388475|NCT02520284|560856261|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
155388476|NCT02520284|560856259|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
155388477|NCT02520284|560856260|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
155388478|NCT02520284|560856261|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
155388479|NCT02520284|560856259|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
155388480|NCT02520284|560856260|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
155388481|NCT02520284|560856261|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
155388482|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
155388483|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
155388484|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
155388485|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
154946651|NCT01215942|559230114|FG001|Treatment Period|Lost to Follow-up|4|||
154946652|NCT01215942|559230113|FG000|Treatment Period|Withdrawal by Subject|17|||
154946653|NCT01215942|559230114|FG001|Treatment Period|Withdrawal by Subject|40|||
154946654|NCT01215942|559230113|FG000|Treatment Period|Physician Decision|5|||
154946655|NCT01215942|559230114|FG001|Treatment Period|Physician Decision|5|||
154946656|NCT01215942|559230113|FG000|Treatment Period|Protocol Violation|0|||
154946657|NCT01215942|559230114|FG001|Treatment Period|Protocol Violation|1|||
154946658|NCT01215942|559230113|FG000|Treatment Period|Sponsor Decision|349|||
154946659|NCT01215942|559230114|FG001|Treatment Period|Sponsor Decision|530|||
154946660|NCT01215942|559230113|FG000|Post-Treatment Follow-Up Period|Death|0|||
154946661|NCT01215942|559230114|FG001|Post-Treatment Follow-Up Period|Death|1|||
154946662|NCT01215942|559230113|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
154946663|NCT01215942|559230114|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
154946664|NCT01215942|559230113|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
154946665|NCT01215942|559230114|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
154946666|NCT01215942|559230113|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
154946667|NCT01215942|559230114|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
154946668|NCT01215942|559230113|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
154946669|NCT01215942|559230114|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
154946670|NCT03305055|559230115|FG000|Overall Study|Withdrawal by Subject|0|||
154946671|NCT03305055|559230116|FG001|Overall Study|Withdrawal by Subject|1|||
154946672|NCT03305055|559230115|FG000|Overall Study|Adverse Event|1|||
154946673|NCT03305055|559230116|FG001|Overall Study|Adverse Event|1|||
154946674|NCT00113490|559230117|FG000|Overall Study|Withdrawal by Subject|1|||
154946675|NCT00113490|559230118|FG001|Overall Study|Withdrawal by Subject|3|||
154946676|NCT00113490|559230117|FG000|Overall Study|Lost to Follow-up|1|||
154946677|NCT00113490|559230118|FG001|Overall Study|Lost to Follow-up|0|||
154946678|NCT00819247|559230119|FG000|Overall Study|Adverse Event|0|||
154946679|NCT00819247|559230120|FG001|Overall Study|Adverse Event|5|||
154946680|NCT00819247|559230121|FG002|Overall Study|Adverse Event|3|||
154946681|NCT00819247|559230119|FG000|Overall Study|Insufficient testosterone response|5|||
154946682|NCT00819247|559230120|FG001|Overall Study|Insufficient testosterone response|8|||
155388486|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
155388487|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
155388488|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
155388489|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
154946683|NCT00819247|559230121|FG002|Overall Study|Insufficient testosterone response|10|||
154946684|NCT00819247|559230119|FG000|Overall Study|Withdrawal by Subject|1|||
154946685|NCT00819247|559230120|FG001|Overall Study|Withdrawal by Subject|0|||
154946686|NCT00819247|559230121|FG002|Overall Study|Withdrawal by Subject|0|||
154946687|NCT00819247|559230119|FG000|Overall Study|Protocol Violation|1|||
154946688|NCT00819247|559230120|FG001|Overall Study|Protocol Violation|0|||
155388490|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
155388491|NCT02520284|560856259|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
155388492|NCT02520284|560856260|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
155388493|NCT02520284|560856261|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
155388494|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
155388495|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
155388496|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
155388497|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
155388498|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
155388499|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
155388500|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
155388501|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
155388502|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
155388503|NCT02520284|560856259|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
155388504|NCT02520284|560856260|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
155388505|NCT02520284|560856261|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
155388506|NCT03737474|560856262|FG000|Overall Study|Adverse Event|18|||
155388507|NCT03737474|560856263|FG001|Overall Study|Adverse Event|48|||
155388508|NCT03737474|560856262|FG000|Overall Study|Lack of Efficacy|1|||
155388509|NCT03737474|560856263|FG001|Overall Study|Lack of Efficacy|3|||
155388510|NCT03737474|560856262|FG000|Overall Study|Protocol Violation|0|||
155388511|NCT03737474|560856263|FG001|Overall Study|Protocol Violation|8|||
155388512|NCT03737474|560856262|FG000|Overall Study|Withdrawal by Subject|5|||
155388513|NCT03737474|560856263|FG001|Overall Study|Withdrawal by Subject|20|||
155388514|NCT03737474|560856262|FG000|Overall Study|Non-compliance With Study Drug|0|||
155388515|NCT03737474|560856263|FG001|Overall Study|Non-compliance With Study Drug|1|||
155388516|NCT03737474|560856262|FG000|Overall Study|Physician Decision|1|||
155388517|NCT03737474|560856263|FG001|Overall Study|Physician Decision|4|||
155388518|NCT01139658|560856266|FG000|Overall Study|Adverse Event|10|||
155388519|NCT01139658|560856267|FG001|Overall Study|Adverse Event|27|||
155388520|NCT01139658|560856266|FG000|Overall Study|Lack of Efficacy|15|||
155388521|NCT01139658|560856267|FG001|Overall Study|Lack of Efficacy|7|||
155388522|NCT01139658|560856266|FG000|Overall Study|Withdrawal by Subject|2|||
155388523|NCT01139658|560856267|FG001|Overall Study|Withdrawal by Subject|4|||
155388524|NCT01139658|560856266|FG000|Overall Study|No documentation of treatment|1|||
155388525|NCT01139658|560856267|FG001|Overall Study|No documentation of treatment|0|||
155388526|NCT01139658|560856266|FG000|Overall Study|Other|28|||
155388527|NCT01139658|560856267|FG001|Overall Study|Other|75|||
155388528|NCT00971243|560856268|FG000|Double Blind Period|Adverse Event|2|||
155388529|NCT00971243|560856269|FG001|Double Blind Period|Adverse Event|3|||
155388530|NCT00971243|560856270|FG002|Double Blind Period|Adverse Event|2|||
155388531|NCT00971243|560856271|FG003|Double Blind Period|Adverse Event|2|||
155388532|NCT00971243|560856272|FG004|Double Blind Period|Adverse Event|3|||
155388533|NCT00971243|560856268|FG000|Double Blind Period|Lost to Follow-up|0|||
155388534|NCT00971243|560856269|FG001|Double Blind Period|Lost to Follow-up|1|||
155388535|NCT00971243|560856270|FG002|Double Blind Period|Lost to Follow-up|1|||
155388536|NCT00971243|560856271|FG003|Double Blind Period|Lost to Follow-up|0|||
155388537|NCT00971243|560856272|FG004|Double Blind Period|Lost to Follow-up|1|||
155388538|NCT00971243|560856268|FG000|Double Blind Period|Physician Decision|10|||
155388539|NCT00971243|560856269|FG001|Double Blind Period|Physician Decision|6|||
155388540|NCT00971243|560856270|FG002|Double Blind Period|Physician Decision|7|||
155388541|NCT00971243|560856271|FG003|Double Blind Period|Physician Decision|6|||
155388542|NCT00971243|560856272|FG004|Double Blind Period|Physician Decision|7|||
155388543|NCT00971243|560856268|FG000|Double Blind Period|Protocol Violation|2|||
155388544|NCT00971243|560856269|FG001|Double Blind Period|Protocol Violation|0|||
155388545|NCT00971243|560856270|FG002|Double Blind Period|Protocol Violation|3|||
155388546|NCT00971243|560856271|FG003|Double Blind Period|Protocol Violation|2|||
155388547|NCT00971243|560856272|FG004|Double Blind Period|Protocol Violation|2|||
155388548|NCT00971243|560856268|FG000|Double Blind Period|Withdrawal by Subject|4|||
155388549|NCT00971243|560856269|FG001|Double Blind Period|Withdrawal by Subject|1|||
155388550|NCT00971243|560856270|FG002|Double Blind Period|Withdrawal by Subject|4|||
155388551|NCT00971243|560856271|FG003|Double Blind Period|Withdrawal by Subject|4|||
155388552|NCT00971243|560856272|FG004|Double Blind Period|Withdrawal by Subject|4|||
155388553|NCT00971243|560856268|FG000|Double Blind Period|Other reasons|1|||
155388554|NCT00971243|560856269|FG001|Double Blind Period|Other reasons|0|||
155388555|NCT00971243|560856270|FG002|Double Blind Period|Other reasons|2|||
155388556|NCT00971243|560856271|FG003|Double Blind Period|Other reasons|0|||
155388557|NCT00971243|560856272|FG004|Double Blind Period|Other reasons|1|||
155388558|NCT00971243|560856268|FG000|Open-label Period|Adverse Event|1|||
155388559|NCT00971243|560856269|FG001|Open-label Period|Adverse Event|0|||
155388560|NCT00971243|560856270|FG002|Open-label Period|Adverse Event|1|||
155388561|NCT00971243|560856271|FG003|Open-label Period|Adverse Event|1|||
155388562|NCT00971243|560856272|FG004|Open-label Period|Adverse Event|0|||
155388563|NCT00971243|560856268|FG000|Open-label Period|Physician Decision|5|||
155048918|NCT03300180|559608853|FG001|12 Month Outcome|Missed Assessment|59|||
155048919|NCT03300180|559608854|FG002|12 Month Outcome|Missed Assessment|58|||
155048920|NCT03300180|559608852|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
155048921|NCT03300180|559608853|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
155048922|NCT03300180|559608854|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
155048923|NCT03300180|559608852|FG000|18 Month Outcome Assessment|Death|8|||
155048924|NCT03300180|559608853|FG001|18 Month Outcome Assessment|Death|5|||
155048925|NCT03300180|559608854|FG002|18 Month Outcome Assessment|Death|5|||
155048926|NCT03300180|559608852|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
155048927|NCT03300180|559608853|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
155048928|NCT03300180|559608854|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
155048929|NCT03300180|559608852|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
155048930|NCT03300180|559608853|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
155048931|NCT03300180|559608854|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
155048932|NCT03300180|559608852|FG000|24 Month Outcome Assessment|Death|13|||
155048933|NCT03300180|559608853|FG001|24 Month Outcome Assessment|Death|13|||
155048934|NCT03300180|559608854|FG002|24 Month Outcome Assessment|Death|3|||
155048935|NCT03300180|559608852|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
155048936|NCT03300180|559608853|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
155048937|NCT03300180|559608854|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
155048938|NCT02557516|559608859|FG000|Overall Study|Adverse Event|1|||
155048939|NCT02557516|559608860|FG001|Overall Study|Adverse Event|0|||
155048940|NCT02557516|559608861|FG002|Overall Study|Adverse Event|2|||
155048941|NCT02557516|559608862|FG003|Overall Study|Adverse Event|1|||
155048942|NCT02557516|559608859|FG000|Overall Study|Disease progression|0|||
155048943|NCT02557516|559608860|FG001|Overall Study|Disease progression|2|||
155048944|NCT02557516|559608861|FG002|Overall Study|Disease progression|0|||
155048945|NCT02557516|559608862|FG003|Overall Study|Disease progression|0|||
155048946|NCT02557516|559608859|FG000|Overall Study|Physician Decision|0|||
155048947|NCT02557516|559608860|FG001|Overall Study|Physician Decision|2|||
155388564|NCT00971243|560856269|FG001|Open-label Period|Physician Decision|9|||
155388565|NCT00971243|560856270|FG002|Open-label Period|Physician Decision|3|||
155388566|NCT00971243|560856271|FG003|Open-label Period|Physician Decision|7|||
155388567|NCT00971243|560856272|FG004|Open-label Period|Physician Decision|2|||
155388568|NCT00971243|560856268|FG000|Open-label Period|Protocol Violation|1|||
155388569|NCT00971243|560856269|FG001|Open-label Period|Protocol Violation|1|||
155388570|NCT00971243|560856270|FG002|Open-label Period|Protocol Violation|1|||
155388571|NCT00971243|560856271|FG003|Open-label Period|Protocol Violation|0|||
155388572|NCT00971243|560856272|FG004|Open-label Period|Protocol Violation|1|||
155388573|NCT00971243|560856268|FG000|Open-label Period|Withdrawal by Subject|1|||
155388574|NCT00971243|560856269|FG001|Open-label Period|Withdrawal by Subject|0|||
155388575|NCT00971243|560856270|FG002|Open-label Period|Withdrawal by Subject|0|||
155388576|NCT00971243|560856271|FG003|Open-label Period|Withdrawal by Subject|2|||
155388577|NCT00971243|560856272|FG004|Open-label Period|Withdrawal by Subject|1|||
155388578|NCT00971243|560856268|FG000|Open-label Period|Other reason|0|||
155388579|NCT00971243|560856269|FG001|Open-label Period|Other reason|0|||
155388580|NCT00971243|560856270|FG002|Open-label Period|Other reason|0|||
155388581|NCT00971243|560856271|FG003|Open-label Period|Other reason|0|||
155388582|NCT00971243|560856272|FG004|Open-label Period|Other reason|2|||
155388583|NCT00803270|560856273|FG000|Overall Study|Lost to Follow-up|1|||
155388584|NCT00803270|560856274|FG001|Overall Study|Lost to Follow-up|2|||
155388585|NCT02903368|560856277|FG000|Part 1|Adverse Event|3|||
155388586|NCT02903368|560856278|FG001|Part 1|Adverse Event|0|||
155388587|NCT02903368|560856279|FG002|Part 1|Adverse Event|0|||
155388588|NCT02903368|560856280|FG003|Part 1|Adverse Event|0|||
155388589|NCT02903368|560856277|FG000|Part 1|Withdrawal by Subject|1|||
155388590|NCT02903368|560856278|FG001|Part 1|Withdrawal by Subject|0|||
155388591|NCT02903368|560856279|FG002|Part 1|Withdrawal by Subject|0|||
155388592|NCT02903368|560856280|FG003|Part 1|Withdrawal by Subject|0|||
155388593|NCT02903368|560856277|FG000|Part 2|Adverse Event|0|||
155388594|NCT02903368|560856278|FG001|Part 2|Adverse Event|0|||
155388595|NCT02903368|560856279|FG002|Part 2|Adverse Event|5|||
155388596|NCT02903368|560856280|FG003|Part 2|Adverse Event|0|||
155388597|NCT02903368|560856277|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
155388598|NCT02903368|560856278|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
155388599|NCT02903368|560856279|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
155388600|NCT02903368|560856280|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
155388601|NCT02903368|560856277|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
155048948|NCT02557516|559608861|FG002|Overall Study|Physician Decision|0|||
155048949|NCT02557516|559608862|FG003|Overall Study|Physician Decision|0|||
155048950|NCT02557516|559608859|FG000|Overall Study|Sponsor decision|0|||
155048951|NCT02557516|559608860|FG001|Overall Study|Sponsor decision|1|||
155048952|NCT02557516|559608861|FG002|Overall Study|Sponsor decision|2|||
155048953|NCT02557516|559608862|FG003|Overall Study|Sponsor decision|8|||
155048954|NCT01919164|559609968|FG000|Overall Study|Adverse Event|6|||
155388602|NCT02903368|560856278|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
154946689|NCT00819247|559230121|FG002|Overall Study|Protocol Violation|1|||
154946690|NCT00819247|559230119|FG000|Overall Study|Mistakenly withdrawn|0|||
154946691|NCT00819247|559230120|FG001|Overall Study|Mistakenly withdrawn|1|||
154946692|NCT00819247|559230121|FG002|Overall Study|Mistakenly withdrawn|0|||
154946693|NCT00819247|559230119|FG000|Overall Study|Bad prostate-specific antigen response|3|||
154946694|NCT00819247|559230120|FG001|Overall Study|Bad prostate-specific antigen response|2|||
154946695|NCT00819247|559230121|FG002|Overall Study|Bad prostate-specific antigen response|0|||
154946696|NCT00819247|559230119|FG000|Overall Study|Other|1|||
154946697|NCT00819247|559230120|FG001|Overall Study|Other|0|||
154946698|NCT00819247|559230121|FG002|Overall Study|Other|0|||
154946699|NCT03500484|559230122|FG000|Overall Study|Adverse Event|2|||
154946700|NCT03500484|559230123|FG001|Overall Study|Adverse Event|0|||
154946701|NCT03500484|559230122|FG000|Overall Study|Physician Decision|1|||
154946702|NCT03500484|559230123|FG001|Overall Study|Physician Decision|0|||
154946703|NCT03500484|559230122|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
154946704|NCT03500484|559230123|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
154946705|NCT02795104|559230124|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
154946706|NCT02795104|559230125|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
154946707|NCT02795104|559230126|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
154946708|NCT02795104|559230124|FG000|Overall Study|Withdrawal by Subject|0|||
154946709|NCT02795104|559230125|FG001|Overall Study|Withdrawal by Subject|2|||
154946710|NCT02795104|559230126|FG002|Overall Study|Withdrawal by Subject|0|||
154946711|NCT02795104|559230124|FG000|Overall Study|Lost to Follow-up|0|||
154946712|NCT02795104|559230125|FG001|Overall Study|Lost to Follow-up|0|||
154946713|NCT02795104|559230126|FG002|Overall Study|Lost to Follow-up|1|||
154946714|NCT00948675|559230127|FG000|Overall Study|Lost to Follow-up|1|||
154946715|NCT00948675|559230128|FG001|Overall Study|Lost to Follow-up|0|||
154946716|NCT01654380|559230132|FG000|Part B, Period 1|Physician Decision|0|||
154946717|NCT01654380|559230133|FG001|Part B, Period 1|Physician Decision|0|||
154946718|NCT01654380|559230134|FG002|Part B, Period 1|Physician Decision|1|||
154946719|NCT01654380|559230135|FG003|Part B, Period 1|Physician Decision|0|||
154946720|NCT04652453|559230138|FG000|Overall Study|Death|8|||
154946721|NCT04652453|559230139|FG001|Overall Study|Death|2|||
154946722|NCT04652453|559230140|FG002|Overall Study|Death|0|||
154946723|NCT04652453|559230138|FG000|Overall Study|Hospice|5|||
154946724|NCT04652453|559230139|FG001|Overall Study|Hospice|5|||
154946725|NCT04652453|559230140|FG002|Overall Study|Hospice|0|||
154946726|NCT04652453|559230138|FG000|Overall Study|Withdrawal by Subject|2|||
154946727|NCT04652453|559230139|FG001|Overall Study|Withdrawal by Subject|0|||
154946728|NCT04652453|559230140|FG002|Overall Study|Withdrawal by Subject|0|||
154946729|NCT04543136|559230141|FG000|Overall Study|Withdrawal by Subject|0|||
154946730|NCT04543136|559230142|FG001|Overall Study|Withdrawal by Subject|1|||
154946731|NCT04543136|559230143|FG002|Overall Study|Withdrawal by Subject|0|||
154946732|NCT04543136|559230144|FG003|Overall Study|Withdrawal by Subject|1|||
154946733|NCT04543136|559230145|FG004|Overall Study|Withdrawal by Subject|0|||
154946734|NCT04543136|559230146|FG005|Overall Study|Withdrawal by Subject|0|||
154946735|NCT00601354|559230152|FG000|Overall Study|Lost to Follow-up|4|||
154946736|NCT00601354|559230153|FG001|Overall Study|Lost to Follow-up|5|||
154946737|NCT04799158|559230154|FG000|Run-In Period|Adverse Event|6|||
154946738|NCT04799158|559230155|FG001|Run-In Period|Adverse Event|0|||
154946739|NCT04799158|559230156|FG002|Run-In Period|Adverse Event|0|||
154946740|NCT04799158|559230157|FG003|Run-In Period|Adverse Event|0|||
154946741|NCT04799158|559230158|FG004|Run-In Period|Adverse Event|0|||
154946742|NCT04799158|559230154|FG000|Run-In Period|Lost to Follow-up|4|||
154946743|NCT04799158|559230155|FG001|Run-In Period|Lost to Follow-up|0|||
154946744|NCT04799158|559230156|FG002|Run-In Period|Lost to Follow-up|0|||
154946745|NCT04799158|559230157|FG003|Run-In Period|Lost to Follow-up|0|||
154946746|NCT04799158|559230158|FG004|Run-In Period|Lost to Follow-up|0|||
154946747|NCT04799158|559230154|FG000|Run-In Period|Significant Protocol Deviation|1|||
154946748|NCT04799158|559230155|FG001|Run-In Period|Significant Protocol Deviation|0|||
154946749|NCT04799158|559230156|FG002|Run-In Period|Significant Protocol Deviation|0|||
154946750|NCT04799158|559230157|FG003|Run-In Period|Significant Protocol Deviation|0|||
154946751|NCT04799158|559230158|FG004|Run-In Period|Significant Protocol Deviation|0|||
154946752|NCT04799158|559230154|FG000|Run-In Period|Withdrawal by Subject|11|||
154946753|NCT04799158|559230155|FG001|Run-In Period|Withdrawal by Subject|0|||
154946754|NCT04799158|559230156|FG002|Run-In Period|Withdrawal by Subject|0|||
155048955|NCT01919164|559609969|FG001|Overall Study|Adverse Event|4|||
155048956|NCT01919164|559609970|FG002|Overall Study|Adverse Event|9|||
154946755|NCT04799158|559230157|FG003|Run-In Period|Withdrawal by Subject|0|||
154946756|NCT04799158|559230158|FG004|Run-In Period|Withdrawal by Subject|0|||
154946757|NCT04799158|559230154|FG000|Run-In Period|Miscellaneous|3|||
155048957|NCT01919164|559609971|FG003|Overall Study|Adverse Event|3|||
154946758|NCT04799158|559230155|FG001|Run-In Period|Miscellaneous|0|||
154946759|NCT04799158|559230156|FG002|Run-In Period|Miscellaneous|0|||
154946760|NCT04799158|559230157|FG003|Run-In Period|Miscellaneous|0|||
155048958|NCT01919164|559609972|FG004|Overall Study|Adverse Event|2|||
154946761|NCT04799158|559230158|FG004|Run-In Period|Miscellaneous|0|||
155048959|NCT01919164|559609968|FG000|Overall Study|Lost to Follow-up|2|||
155048960|NCT01919164|559609969|FG001|Overall Study|Lost to Follow-up|2|||
155048961|NCT01919164|559609970|FG002|Overall Study|Lost to Follow-up|2|||
155048962|NCT01919164|559609971|FG003|Overall Study|Lost to Follow-up|0|||
155048963|NCT01919164|559609972|FG004|Overall Study|Lost to Follow-up|4|||
155048964|NCT01919164|559609968|FG000|Overall Study|Death|1|||
155048965|NCT01919164|559609969|FG001|Overall Study|Death|0|||
155048966|NCT01919164|559609970|FG002|Overall Study|Death|0|||
155048967|NCT01919164|559609971|FG003|Overall Study|Death|0|||
155048968|NCT01919164|559609972|FG004|Overall Study|Death|0|||
155048969|NCT01919164|559609968|FG000|Overall Study|Protocol Violation|6|||
155048970|NCT01919164|559609969|FG001|Overall Study|Protocol Violation|0|||
155048971|NCT01919164|559609970|FG002|Overall Study|Protocol Violation|3|||
155048972|NCT01919164|559609971|FG003|Overall Study|Protocol Violation|2|||
155048973|NCT01919164|559609972|FG004|Overall Study|Protocol Violation|2|||
155048974|NCT01919164|559609968|FG000|Overall Study|Disease progression|2|||
155048975|NCT01919164|559609969|FG001|Overall Study|Disease progression|2|||
155048976|NCT01919164|559609970|FG002|Overall Study|Disease progression|1|||
155048977|NCT01919164|559609971|FG003|Overall Study|Disease progression|2|||
155388603|NCT02903368|560856279|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
155388604|NCT02903368|560856280|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
155388605|NCT02903368|560856277|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
155388606|NCT02903368|560856278|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
155388607|NCT02903368|560856279|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
155388608|NCT02903368|560856280|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
155388609|NCT06515483|560856281|FG000|Overall Study|Subject withdraw due to family issues|1|||
155388610|NCT06515483|560856282|FG001|Overall Study|Subject withdraw due to family issues|0|||
155388611|NCT00147823|560856288|FG000|Overall Study|Lost to Follow-up|6|||
155388612|NCT00147823|560856289|FG001|Overall Study|Lost to Follow-up|12|||
155388613|NCT00147823|560856288|FG000|Overall Study|Physician Decision|1|||
155388614|NCT00147823|560856289|FG001|Overall Study|Physician Decision|0|||
155388615|NCT00147823|560856288|FG000|Overall Study|Withdrawal by Subject|0|||
155388616|NCT00147823|560856289|FG001|Overall Study|Withdrawal by Subject|1|||
155388617|NCT00147823|560856288|FG000|Overall Study|Did not receive vitoss due to infection|6|||
155388618|NCT00147823|560856289|FG001|Overall Study|Did not receive vitoss due to infection|2|||
155388619|NCT03769181|560858644|FG000|Overall Study|Adverse Event|1|||
155388620|NCT03769181|560858645|FG001|Overall Study|Adverse Event|0|||
155388621|NCT03769181|560858646|FG002|Overall Study|Adverse Event|2|||
155388622|NCT03769181|560858647|FG003|Overall Study|Adverse Event|4|||
155388623|NCT03769181|560858644|FG000|Overall Study|Withdrawal by Subject|1|||
155388624|NCT03769181|560858645|FG001|Overall Study|Withdrawal by Subject|0|||
155388625|NCT03769181|560858646|FG002|Overall Study|Withdrawal by Subject|2|||
155388626|NCT03769181|560858647|FG003|Overall Study|Withdrawal by Subject|1|||
155388627|NCT03769181|560858644|FG000|Overall Study|Progressive disease|9|||
155388628|NCT03769181|560858645|FG001|Overall Study|Progressive disease|7|||
155388629|NCT03769181|560858646|FG002|Overall Study|Progressive disease|13|||
155388630|NCT03769181|560858647|FG003|Overall Study|Progressive disease|6|||
155388631|NCT03769181|560858644|FG000|Overall Study|Other - Unspecified|2|||
155388632|NCT03769181|560858645|FG001|Overall Study|Other - Unspecified|1|||
155388633|NCT03769181|560858646|FG002|Overall Study|Other - Unspecified|0|||
155388634|NCT03769181|560858647|FG003|Overall Study|Other - Unspecified|0|||
155388635|NCT01485354|560858648|FG000|Overall Study|Withdrawal by Subject|5|||
155388636|NCT03566810|560858649|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
155388637|NCT03566810|560858650|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
155388638|NCT03566810|560858651|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
155388639|NCT03566810|560858652|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
155388640|NCT03338192|560858654|FG000|Year One to Year Two|High Blood Pressure|7|||
155388641|NCT03338192|560858655|FG001|Year One to Year Two|High Blood Pressure|1|||
155388642|NCT03338192|560858654|FG000|Year One to Year Two|HIV +|1|||
155388643|NCT03338192|560858655|FG001|Year One to Year Two|HIV +|0|||
155048978|NCT01919164|559609972|FG004|Overall Study|Disease progression|1|||
155048979|NCT01919164|559609968|FG000|Overall Study|Withdrew consent|13|||
155048980|NCT01919164|559609969|FG001|Overall Study|Withdrew consent|13|||
155048981|NCT01919164|559609970|FG002|Overall Study|Withdrew consent|14|||
155048982|NCT01919164|559609971|FG003|Overall Study|Withdrew consent|14|||
155048983|NCT01919164|559609972|FG004|Overall Study|Withdrew consent|9|||
155048984|NCT01919164|559609968|FG000|Overall Study|Other Un-specified|13|||
155048985|NCT01919164|559609969|FG001|Overall Study|Other Un-specified|9|||
155388644|NCT03338192|560858654|FG000|Year Two to Year Four|High Blood Pressure|1|||
155048986|NCT01919164|559609970|FG002|Overall Study|Other Un-specified|8|||
155048987|NCT01919164|559609971|FG003|Overall Study|Other Un-specified|7|||
155048988|NCT01919164|559609972|FG004|Overall Study|Other Un-specified|15|||
155048989|NCT00588146|559609974|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
155048990|NCT00588146|559609975|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
155388645|NCT03338192|560858655|FG001|Year Two to Year Four|High Blood Pressure|0|||
155388646|NCT03338192|560858654|FG000|Year Two to Year Four|HIV +|2|||
155388647|NCT03338192|560858655|FG001|Year Two to Year Four|HIV +|0|||
155388648|NCT03338192|560858654|FG000|Year Four to Year Six|High Blood Pressure|2|||
155388649|NCT03338192|560858655|FG001|Year Four to Year Six|High Blood Pressure|1|||
155388650|NCT00985166|560858658|FG000|Overall Study|Lost to Follow-up|3|||
155388651|NCT00985166|560858659|FG001|Overall Study|Lost to Follow-up|2|||
155388652|NCT00985166|560858660|FG002|Overall Study|Lost to Follow-up|2|||
155388653|NCT00985166|560858658|FG000|Overall Study|Withdrawal by Subject|3|||
155388654|NCT00985166|560858659|FG001|Overall Study|Withdrawal by Subject|2|||
155388655|NCT00985166|560858660|FG002|Overall Study|Withdrawal by Subject|0|||
155388656|NCT00985166|560858658|FG000|Overall Study|Test not done|2|||
155388657|NCT00985166|560858659|FG001|Overall Study|Test not done|0|||
155388658|NCT00985166|560858660|FG002|Overall Study|Test not done|4|||
155388659|NCT00985166|560858658|FG000|Overall Study|Other|1|||
155388660|NCT00985166|560858659|FG001|Overall Study|Other|0|||
155388661|NCT00985166|560858660|FG002|Overall Study|Other|1|||
155388662|NCT00567268|560858661|FG000|Overall Study|Protocol Violation|7|||
154946762|NCT04799158|559230154|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
154946763|NCT04799158|559230155|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
154946764|NCT04799158|559230156|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
154946765|NCT04799158|559230157|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
154946766|NCT04799158|559230158|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
154946767|NCT04799158|559230154|FG000|On-Demand Treatment Period|Adverse Event|0|||
154946768|NCT04799158|559230155|FG001|On-Demand Treatment Period|Adverse Event|1|||
154946769|NCT04799158|559230156|FG002|On-Demand Treatment Period|Adverse Event|0|||
154946770|NCT04799158|559230157|FG003|On-Demand Treatment Period|Adverse Event|0|||
154946771|NCT04799158|559230158|FG004|On-Demand Treatment Period|Adverse Event|1|||
154946772|NCT04799158|559230154|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
154946773|NCT04799158|559230155|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
154946774|NCT04799158|559230156|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
154946775|NCT04799158|559230157|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
154946776|NCT04799158|559230158|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
154946777|NCT04799158|559230154|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
154946778|NCT04799158|559230155|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
154946779|NCT04799158|559230156|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
154946780|NCT04799158|559230157|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
154946781|NCT04799158|559230158|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
154946782|NCT04799158|559230154|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
154946783|NCT04799158|559230155|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
154946784|NCT04799158|559230156|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
154946785|NCT04799158|559230157|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
154946786|NCT04799158|559230158|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
154946787|NCT04799158|559230154|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
154946788|NCT04799158|559230155|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
154946789|NCT04799158|559230156|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
154946790|NCT04799158|559230157|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
154946791|NCT04799158|559230158|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
154946792|NCT04799158|559230154|FG000|On-Demand Treatment Period|Miscellaneous|0|||
154946793|NCT04799158|559230155|FG001|On-Demand Treatment Period|Miscellaneous|0|||
154946794|NCT04799158|559230156|FG002|On-Demand Treatment Period|Miscellaneous|0|||
154946795|NCT04799158|559230157|FG003|On-Demand Treatment Period|Miscellaneous|0|||
154946796|NCT04799158|559230158|FG004|On-Demand Treatment Period|Miscellaneous|1|||
154946797|NCT00936975|559230159|FG000|Overall Study|Withdrawal by Subject|1|||
154946798|NCT00936975|559230159|FG000|Overall Study|Disease progression|3|||
154946799|NCT00936975|559230159|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
154946800|NCT01656889|559230163|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
154946801|NCT01656889|559230164|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
154946802|NCT01656889|559230163|FG000|Treatment Period, 12 Weeks|Death|0|||
154946803|NCT01656889|559230164|FG001|Treatment Period, 12 Weeks|Death|1|||
154946804|NCT01656889|559230163|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
154946805|NCT01656889|559230164|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
154946806|NCT01656889|559230163|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
154946807|NCT01656889|559230164|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
154946808|NCT01656889|559230163|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
154946809|NCT01656889|559230164|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
154946810|NCT01656889|559230163|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
154946811|NCT01656889|559230164|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
154946812|NCT01656889|559230163|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
155388663|NCT00567268|560858661|FG000|Overall Study|Lost to Follow-up|36|||
154946813|NCT01656889|559230164|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
155048991|NCT02100839|559609976|FG000|Multiple Ascending Dose|Adverse Event|2|||
155048992|NCT02100839|559609977|FG001|Multiple Ascending Dose|Adverse Event|0|||
155048993|NCT02100839|559609976|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
155048994|NCT02100839|559609977|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
155048995|NCT03272347|559609981|FG000|Overall Study|Death|0|||
155048996|NCT03272347|559609982|FG001|Overall Study|Death|0|||
155048997|NCT03272347|559609983|FG002|Overall Study|Death|0|||
155048998|NCT03272347|559609984|FG003|Overall Study|Death|1|||
155048999|NCT03272347|559609981|FG000|Overall Study|Lost to Follow-up|1|||
155049000|NCT03272347|559609982|FG001|Overall Study|Lost to Follow-up|3|||
155049001|NCT03272347|559609983|FG002|Overall Study|Lost to Follow-up|5|||
155049002|NCT03272347|559609984|FG003|Overall Study|Lost to Follow-up|1|||
155049003|NCT03272347|559609981|FG000|Overall Study|Physician Decision|4|||
155049004|NCT03272347|559609982|FG001|Overall Study|Physician Decision|2|||
155049005|NCT03272347|559609983|FG002|Overall Study|Physician Decision|5|||
155049006|NCT03272347|559609984|FG003|Overall Study|Physician Decision|4|||
155049007|NCT03272347|559609981|FG000|Overall Study|Screen Failure|1|||
155049008|NCT03272347|559609982|FG001|Overall Study|Screen Failure|0|||
155049009|NCT03272347|559609983|FG002|Overall Study|Screen Failure|0|||
155049010|NCT03272347|559609984|FG003|Overall Study|Screen Failure|0|||
155049011|NCT03272347|559609981|FG000|Overall Study|Withdrawal by Subject|5|||
155049012|NCT03272347|559609982|FG001|Overall Study|Withdrawal by Subject|1|||
155049013|NCT03272347|559609983|FG002|Overall Study|Withdrawal by Subject|2|||
155049014|NCT03272347|559609984|FG003|Overall Study|Withdrawal by Subject|1|||
155049015|NCT00940888|559609985|FG000|Overall Study|Unsuccessful Implant|4|||
155049016|NCT00940888|559609985|FG000|Overall Study|Death|461|||
155049017|NCT00940888|559609985|FG000|Overall Study|Withdrawn - Non-Death|364|||
155049018|NCT00940888|559609985|FG000|Overall Study|Lost to Follow-up|6|||
155049019|NCT01409915|559609987|FG000|Overall Study|Adverse Event|0|||
155049020|NCT01409915|559609988|FG001|Overall Study|Adverse Event|2|||
155049021|NCT01409915|559609987|FG000|Overall Study|Withdrawal by Subject|0|||
155049022|NCT01409915|559609988|FG001|Overall Study|Withdrawal by Subject|1|||
155049023|NCT01409915|559609987|FG000|Overall Study|Protocol Violation|1|||
155049024|NCT01409915|559609988|FG001|Overall Study|Protocol Violation|0|||
155281549|NCT01318811|560461636|FG001|Overall Study|Physician Decision|1|||
155281550|NCT01318811|560461635|FG000|Overall Study|CRRT stopped for head CT|0|||
155281551|NCT01318811|560461636|FG001|Overall Study|CRRT stopped for head CT|1|||
155281552|NCT01318811|560461635|FG000|Overall Study|Death|0|||
155281553|NCT01318811|560461636|FG001|Overall Study|Death|1|||
155281554|NCT01318811|560461635|FG000|Overall Study|CRRT stopped for head MRI|0|||
155281555|NCT01318811|560461636|FG001|Overall Study|CRRT stopped for head MRI|1|||
155281556|NCT00811187|560461637|FG000|Overall Study|Unable to place device / procedure abort|3|||
155281557|NCT00811187|560461638|FG001|Overall Study|Unable to place device / procedure abort|3|||
155281558|NCT00131911|560461639|FG000|Overall Study|Withdrawal by Subject|1|||
155281559|NCT00131911|560461640|FG001|Overall Study|Withdrawal by Subject|0|||
155281560|NCT02825043|560461641|FG000|Overall Study|Lost to Follow-up|4|||
155281561|NCT00329303|560461642|FG000|Overall Study|Lack of Efficacy|1|||
155281562|NCT00329303|560461643|FG001|Overall Study|Lack of Efficacy|0|||
155281563|NCT00329303|560461642|FG000|Overall Study|Decision of the sponsor|0|||
155281564|NCT00329303|560461643|FG001|Overall Study|Decision of the sponsor|1|||
155281565|NCT00329303|560461642|FG000|Overall Study|Patient no longer available|1|||
155281566|NCT00329303|560461643|FG001|Overall Study|Patient no longer available|0|||
155281567|NCT00329303|560461642|FG000|Overall Study|Patient relocated|0|||
155281568|NCT00329303|560461643|FG001|Overall Study|Patient relocated|1|||
155281569|NCT03582137|560461647|FG000|Overall Study|Adverse Event|1|||
155281570|NCT03582137|560461648|FG001|Overall Study|Adverse Event|0|||
155281571|NCT03704298|560461650|FG000|Overall Study|Death|3|||
155281572|NCT03704298|560461651|FG001|Overall Study|Death|1|||
155281573|NCT03704298|560461652|FG002|Overall Study|Death|1|||
155281574|NCT03704298|560461653|FG003|Overall Study|Death|0|||
155281575|NCT03704298|560461650|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
155281576|NCT03704298|560461651|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
155281577|NCT03704298|560461652|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
155281578|NCT03704298|560461653|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
155281579|NCT03704298|560461650|FG000|Overall Study|Withdrawal by Subject|1|||
155281580|NCT03704298|560461651|FG001|Overall Study|Withdrawal by Subject|0|||
155281581|NCT03704298|560461652|FG002|Overall Study|Withdrawal by Subject|0|||
155281582|NCT03704298|560461653|FG003|Overall Study|Withdrawal by Subject|0|||
155281583|NCT03704298|560461650|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
155281584|NCT03704298|560461651|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
155049025|NCT01239394|559609989|FG000|Overall Study|Adverse Event|1|||
155281585|NCT03704298|560461652|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
155049026|NCT01307891|559609996|FG000|Overall Study|Progressive Disease|3|||
155049027|NCT01307891|559609997|FG001|Overall Study|Progressive Disease|1|||
155049028|NCT04194489|559609998|FG000|Overall Study|Withdrawal by Subject|5|||
155049029|NCT04194489|559609998|FG000|Overall Study|Lost to Follow-up|48|||
155049030|NCT00377637|559610001|FG000|Induction Phase|Adverse Event|12|||
155049031|NCT00377637|559610002|FG001|Induction Phase|Adverse Event|21|||
155049032|NCT00377637|559610003|FG002|Induction Phase|Adverse Event|0|||
155388664|NCT00567268|560858661|FG000|Overall Study|No Visit After First Day of Treatment|2|||
155388665|NCT00567268|560858661|FG000|Overall Study|No Drug Administration|4|||
155388666|NCT00567268|560858661|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
155388667|NCT01117454|560858662|FG000|Overall Study|Pregnancy|0|||
155388668|NCT01117454|560858663|FG001|Overall Study|Pregnancy|1|||
155388669|NCT02276872|560858666|FG000|Overall Study|Adverse Event|1|||
155388670|NCT02276872|560858667|FG001|Overall Study|Adverse Event|0|||
155388671|NCT02276872|560858668|FG002|Overall Study|Adverse Event|0|||
155388672|NCT04175808|560858669|FG000|Part A|Miscellaneous|2|||
155388673|NCT04175808|560858670|FG001|Part A|Miscellaneous|0|||
155388674|NCT04175808|560858671|FG002|Part A|Miscellaneous|0|||
155388675|NCT04175808|560858672|FG003|Part A|Miscellaneous|0|||
155388676|NCT04175808|560858673|FG004|Part A|Miscellaneous|0|||
155388677|NCT04175808|560858674|FG005|Part A|Miscellaneous|0|||
155388678|NCT04175808|560858675|FG006|Part A|Miscellaneous|0|||
155388679|NCT00818389|560858677|FG000|Overall Study|Death|1|||
155388680|NCT00818389|560858678|FG001|Overall Study|Death|3|||
155388681|NCT00818389|560858677|FG000|Overall Study|ALS Disease Progression|1|||
155388682|NCT00818389|560858678|FG001|Overall Study|ALS Disease Progression|0|||
155388683|NCT00818389|560858677|FG000|Overall Study|Withdrawal by Subject|2|||
155388684|NCT00818389|560858678|FG001|Overall Study|Withdrawal by Subject|2|||
155388685|NCT00818389|560858677|FG000|Overall Study|Adverse Event|0|||
155388686|NCT00818389|560858678|FG001|Overall Study|Adverse Event|1|||
155388687|NCT04263909|560858679|FG000|Overall Study|Physician Decision|1|||
155388688|NCT04263909|560858680|FG001|Overall Study|Physician Decision|0|||
155388689|NCT04263909|560858681|FG002|Overall Study|Physician Decision|0|||
155388690|NCT04263909|560858679|FG000|Overall Study|Adverse Event|3|||
155388691|NCT04263909|560858680|FG001|Overall Study|Adverse Event|0|||
155388692|NCT04263909|560858681|FG002|Overall Study|Adverse Event|0|||
155388693|NCT04263909|560858679|FG000|Overall Study|Protocol Violation|5|||
155388694|NCT04263909|560858680|FG001|Overall Study|Protocol Violation|0|||
155388695|NCT04263909|560858681|FG002|Overall Study|Protocol Violation|0|||
155388696|NCT00068588|560858682|FG000|Overall Study|Adverse Event|0|||
155388697|NCT00068588|560858683|FG001|Overall Study|Adverse Event|0|||
155388698|NCT00068588|560858684|FG002|Overall Study|Adverse Event|2|||
155388699|NCT00068588|560858682|FG000|Overall Study|Withdrawal by Subject|0|||
155388700|NCT00068588|560858683|FG001|Overall Study|Withdrawal by Subject|0|||
155388701|NCT00068588|560858684|FG002|Overall Study|Withdrawal by Subject|1|||
154946814|NCT01656889|559230163|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
154946815|NCT01656889|559230164|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
154946816|NCT01656889|559230163|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
154946817|NCT01656889|559230164|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
154946818|NCT01656889|559230163|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
154946819|NCT01656889|559230164|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
154946820|NCT02486796|559230165|FG000|Overall Study|Withdrawal by Subject|1|||
154946821|NCT02486796|559230166|FG001|Overall Study|Withdrawal by Subject|1|||
154946822|NCT02486796|559230165|FG000|Overall Study|Physician Decision|1|||
154946823|NCT02486796|559230166|FG001|Overall Study|Physician Decision|0|||
154946824|NCT00679783|559230171|FG000|Overall Study|Adverse Event|0|||
154946825|NCT00679783|559230172|FG001|Overall Study|Adverse Event|0|||
154946826|NCT00679783|559230173|FG002|Overall Study|Adverse Event|0|||
154946827|NCT00679783|559230174|FG003|Overall Study|Adverse Event|3|||
154946828|NCT00679783|559230175|FG004|Overall Study|Adverse Event|0|||
154946829|NCT00679783|559230176|FG005|Overall Study|Adverse Event|0|||
154946830|NCT00679783|559230177|FG006|Overall Study|Adverse Event|1|||
154946831|NCT00679783|559230171|FG000|Overall Study|Lack of Efficacy|0|||
154946832|NCT00679783|559230172|FG001|Overall Study|Lack of Efficacy|1|||
154946833|NCT00679783|559230173|FG002|Overall Study|Lack of Efficacy|0|||
154946834|NCT00679783|559230174|FG003|Overall Study|Lack of Efficacy|2|||
154946835|NCT00679783|559230175|FG004|Overall Study|Lack of Efficacy|0|||
154946836|NCT00679783|559230176|FG005|Overall Study|Lack of Efficacy|0|||
155388702|NCT00068588|560858682|FG000|Overall Study|Poor KPS|0|||
155388703|NCT00068588|560858683|FG001|Overall Study|Poor KPS|0|||
155388704|NCT00068588|560858684|FG002|Overall Study|Poor KPS|1|||
155388705|NCT03840486|560858685|FG000|Overall Study|Withdrawal by Subject|0|||
155388706|NCT03840486|560858686|FG001|Overall Study|Withdrawal by Subject|1|||
155388707|NCT03840486|560858687|FG002|Overall Study|Withdrawal by Subject|0|||
155388708|NCT03840486|560858688|FG003|Overall Study|Withdrawal by Subject|0|||
155388709|NCT03840486|560858689|FG004|Overall Study|Withdrawal by Subject|0|||
155388710|NCT03840486|560858690|FG005|Overall Study|Withdrawal by Subject|0|||
154946837|NCT00679783|559230177|FG006|Overall Study|Lack of Efficacy|0|||
154946838|NCT00679783|559230171|FG000|Overall Study|Withdrawal by Subject|0|||
154946839|NCT00679783|559230172|FG001|Overall Study|Withdrawal by Subject|0|||
155388711|NCT03840486|560858691|FG006|Overall Study|Withdrawal by Subject|0|||
155388712|NCT03840486|560858692|FG007|Overall Study|Withdrawal by Subject|0|||
155388713|NCT03840486|560858693|FG008|Overall Study|Withdrawal by Subject|0|||
155388714|NCT03840486|560858694|FG009|Overall Study|Withdrawal by Subject|0|||
155388715|NCT03840486|560858695|FG010|Overall Study|Withdrawal by Subject|0|||
155388716|NCT03840486|560858696|FG011|Overall Study|Withdrawal by Subject|0|||
155388717|NCT01978262|560858697|FG000|Overall Study|Withdrawal by Subject|9|||
155388718|NCT01978262|560858697|FG000|Overall Study|Lost to Follow-up|2|||
155388719|NCT02982187|560858698|FG000|Overall Study|Withdrawal by Subject|0|||
155388720|NCT02982187|560858699|FG001|Overall Study|Withdrawal by Subject|0|||
155388721|NCT02982187|560858700|FG002|Overall Study|Withdrawal by Subject|0|||
155388722|NCT02982187|560858701|FG003|Overall Study|Withdrawal by Subject|0|||
155388723|NCT02982187|560858702|FG004|Overall Study|Withdrawal by Subject|0|||
155388724|NCT02982187|560858703|FG005|Overall Study|Withdrawal by Subject|0|||
155388725|NCT02982187|560858704|FG006|Overall Study|Withdrawal by Subject|1|||
155388726|NCT02982187|560858705|FG007|Overall Study|Withdrawal by Subject|0|||
155388727|NCT01128894|560858706|FG000|Overall Study|Adverse Event|31|||
155388728|NCT01128894|560858707|FG001|Overall Study|Adverse Event|41|||
155388729|NCT01128894|560858706|FG000|Overall Study|Protocol Violation|2|||
155388730|NCT01128894|560858707|FG001|Overall Study|Protocol Violation|1|||
155388731|NCT01128894|560858706|FG000|Overall Study|Noncompliance|4|||
155388732|NCT01128894|560858707|FG001|Overall Study|Noncompliance|5|||
155388733|NCT01128894|560858706|FG000|Overall Study|Lost to Follow-up|8|||
155388734|NCT01128894|560858707|FG001|Overall Study|Lost to Follow-up|8|||
155388735|NCT01128894|560858706|FG000|Overall Study|Withdrawal by Subject|10|||
155388736|NCT01128894|560858707|FG001|Overall Study|Withdrawal by Subject|12|||
155388737|NCT01128894|560858706|FG000|Overall Study|Physician Decision|2|||
155388738|NCT01128894|560858707|FG001|Overall Study|Physician Decision|1|||
155388739|NCT01128894|560858706|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
155388740|NCT01128894|560858707|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
155388741|NCT03437278|560858708|FG000|Overall Study|Adverse Event|0|||
155388742|NCT03437278|560858709|FG001|Overall Study|Adverse Event|0|||
155388743|NCT03437278|560858710|FG002|Overall Study|Adverse Event|1|||
155388744|NCT03437278|560858708|FG000|Overall Study|Progressive disease|1|||
155388745|NCT03437278|560858709|FG001|Overall Study|Progressive disease|0|||
155388746|NCT03437278|560858710|FG002|Overall Study|Progressive disease|0|||
155388747|NCT03437278|560858708|FG000|Overall Study|Physician Decision|1|||
155388748|NCT03437278|560858709|FG001|Overall Study|Physician Decision|0|||
155388749|NCT03437278|560858710|FG002|Overall Study|Physician Decision|1|||
155388750|NCT02202551|560858711|FG000|Overall Study|Adverse Event|8|||
155388751|NCT02202551|560858712|FG001|Overall Study|Adverse Event|19|||
155388752|NCT02202551|560858713|FG002|Overall Study|Adverse Event|5|||
155388753|NCT02202551|560858714|FG003|Overall Study|Adverse Event|9|||
155388754|NCT02202551|560858711|FG000|Overall Study|Death|3|||
155388755|NCT02202551|560858712|FG001|Overall Study|Death|2|||
155388756|NCT02202551|560858713|FG002|Overall Study|Death|1|||
155388757|NCT02202551|560858714|FG003|Overall Study|Death|1|||
155388758|NCT02202551|560858711|FG000|Overall Study|Lost to Follow-up|0|||
155388759|NCT02202551|560858712|FG001|Overall Study|Lost to Follow-up|1|||
155388760|NCT02202551|560858713|FG002|Overall Study|Lost to Follow-up|0|||
155388761|NCT02202551|560858714|FG003|Overall Study|Lost to Follow-up|1|||
155388762|NCT02202551|560858711|FG000|Overall Study|Needed to take excluded medication|0|||
155388763|NCT02202551|560858712|FG001|Overall Study|Needed to take excluded medication|2|||
155388764|NCT02202551|560858713|FG002|Overall Study|Needed to take excluded medication|0|||
155388765|NCT02202551|560858714|FG003|Overall Study|Needed to take excluded medication|1|||
155388766|NCT02202551|560858711|FG000|Overall Study|Subject moved away|0|||
155388767|NCT02202551|560858712|FG001|Overall Study|Subject moved away|1|||
154946840|NCT00679783|559230173|FG002|Overall Study|Withdrawal by Subject|1|||
154946841|NCT00679783|559230174|FG003|Overall Study|Withdrawal by Subject|1|||
154946842|NCT00679783|559230175|FG004|Overall Study|Withdrawal by Subject|0|||
154946843|NCT00679783|559230176|FG005|Overall Study|Withdrawal by Subject|0|||
154946844|NCT00679783|559230177|FG006|Overall Study|Withdrawal by Subject|0|||
154946845|NCT00679783|559230171|FG000|Overall Study|Not Captured|0|||
154946846|NCT00679783|559230172|FG001|Overall Study|Not Captured|0|||
154946847|NCT00679783|559230173|FG002|Overall Study|Not Captured|0|||
154946848|NCT00679783|559230174|FG003|Overall Study|Not Captured|5|||
154946849|NCT00679783|559230175|FG004|Overall Study|Not Captured|0|||
154946850|NCT00679783|559230176|FG005|Overall Study|Not Captured|0|||
154946851|NCT00679783|559230177|FG006|Overall Study|Not Captured|0|||
154946852|NCT00679783|559230171|FG000|Overall Study|Ongoing at data cut-off|2|||
155049033|NCT00377637|559610004|FG003|Induction Phase|Adverse Event|0|||
155388768|NCT02202551|560858713|FG002|Overall Study|Subject moved away|0|||
155388769|NCT02202551|560858714|FG003|Overall Study|Subject moved away|0|||
155388770|NCT02202551|560858711|FG000|Overall Study|DBS surgery|3|||
154946853|NCT00679783|559230172|FG001|Overall Study|Ongoing at data cut-off|2|||
154946854|NCT00679783|559230173|FG002|Overall Study|Ongoing at data cut-off|0|||
155049034|NCT00377637|559610001|FG000|Induction Phase|Deterioration/serum creatinine|2|||
155388771|NCT02202551|560858712|FG001|Overall Study|DBS surgery|0|||
155388772|NCT02202551|560858713|FG002|Overall Study|DBS surgery|0|||
155388773|NCT02202551|560858714|FG003|Overall Study|DBS surgery|0|||
155388774|NCT02202551|560858711|FG000|Overall Study|Dyskinesia upon taper|1|||
155388775|NCT02202551|560858712|FG001|Overall Study|Dyskinesia upon taper|0|||
154946855|NCT00679783|559230174|FG003|Overall Study|Ongoing at data cut-off|9|||
154946856|NCT00679783|559230175|FG004|Overall Study|Ongoing at data cut-off|1|||
155388776|NCT02202551|560858713|FG002|Overall Study|Dyskinesia upon taper|0|||
154946857|NCT00679783|559230176|FG005|Overall Study|Ongoing at data cut-off|0|||
154946858|NCT00679783|559230177|FG006|Overall Study|Ongoing at data cut-off|0|||
154946859|NCT02626949|559230178|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
154946860|NCT02626949|559230179|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
154946861|NCT02626949|559230178|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
154946862|NCT02626949|559230179|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
154946863|NCT02626949|559230178|FG000|Enrolled|Lost to Follow-up|7|||
154946864|NCT02626949|559230179|FG001|Enrolled|Lost to Follow-up|6|||
154946865|NCT02626949|559230178|FG000|Enrolled|Withdrawal by Subject|3|||
154946866|NCT02626949|559230179|FG001|Enrolled|Withdrawal by Subject|2|||
154946867|NCT01691859|559232185|FG000|Overall Study|Adverse Event|19|||
154946868|NCT01691859|559232185|FG000|Overall Study|Lack of Efficacy|11|||
154946869|NCT01691859|559232185|FG000|Overall Study|Protocol Violation|4|||
154946870|NCT01691859|559232185|FG000|Overall Study|Product commercially available|221|||
154946871|NCT01691859|559232185|FG000|Overall Study|Study closed/terminated|50|||
154946872|NCT01691859|559232185|FG000|Overall Study|Lost to Follow-up|5|||
154946873|NCT01691859|559232185|FG000|Overall Study|Physician Decision|6|||
154946874|NCT01691859|559232185|FG000|Overall Study|Withdrawal by Subject|31|||
154946875|NCT00278200|559232186|FG000|Overall Study|Death|1|||
154946876|NCT00278200|559232187|FG001|Overall Study|Death|3|||
154946877|NCT00278200|559232186|FG000|Overall Study|Physician Decision|0|||
154946878|NCT00278200|559232187|FG001|Overall Study|Physician Decision|1|||
154946879|NCT03519256|559232195|FG000|Overall Study|Disease recurrence|4|||
154946880|NCT03519256|559232196|FG001|Overall Study|Disease recurrence|4|||
154946881|NCT03519256|559232197|FG002|Overall Study|Disease recurrence|5|||
154946882|NCT03519256|559232198|FG003|Overall Study|Disease recurrence|2|||
154946883|NCT03519256|559232195|FG000|Overall Study|Study drug toxicity|0|||
154946884|NCT03519256|559232196|FG001|Overall Study|Study drug toxicity|2|||
154946885|NCT03519256|559232197|FG002|Overall Study|Study drug toxicity|5|||
154946886|NCT03519256|559232198|FG003|Overall Study|Study drug toxicity|2|||
154946887|NCT03519256|559232195|FG000|Overall Study|Adverse event unrelated to study drug|0|||
154946888|NCT03519256|559232196|FG001|Overall Study|Adverse event unrelated to study drug|1|||
154946889|NCT03519256|559232197|FG002|Overall Study|Adverse event unrelated to study drug|1|||
154946890|NCT03519256|559232198|FG003|Overall Study|Adverse event unrelated to study drug|0|||
154946891|NCT03519256|559232195|FG000|Overall Study|Participant request to discontinue study treatment|0|||
154946892|NCT03519256|559232196|FG001|Overall Study|Participant request to discontinue study treatment|0|||
154946893|NCT03519256|559232197|FG002|Overall Study|Participant request to discontinue study treatment|0|||
154946894|NCT03519256|559232198|FG003|Overall Study|Participant request to discontinue study treatment|2|||
154946895|NCT03519256|559232195|FG000|Overall Study|Other reasons|0|||
154946896|NCT03519256|559232196|FG001|Overall Study|Other reasons|0|||
154946897|NCT03519256|559232197|FG002|Overall Study|Other reasons|2|||
154946898|NCT03519256|559232198|FG003|Overall Study|Other reasons|0|||
154946899|NCT03519256|559232195|FG000|Overall Study|Disease progression|6|||
154946900|NCT03519256|559232196|FG001|Overall Study|Disease progression|3|||
154946901|NCT03519256|559232197|FG002|Overall Study|Disease progression|2|||
154946902|NCT03519256|559232198|FG003|Overall Study|Disease progression|1|||
154946903|NCT03519256|559232195|FG000|Overall Study|Lost to Follow-up|0|||
154946904|NCT03519256|559232196|FG001|Overall Study|Lost to Follow-up|1|||
154946905|NCT03519256|559232197|FG002|Overall Study|Lost to Follow-up|0|||
154946906|NCT03519256|559232198|FG003|Overall Study|Lost to Follow-up|0|||
154946907|NCT00421174|559232199|FG000|Overall Study|Withdrawal by Subject|0|||
154946908|NCT00421174|559232200|FG001|Overall Study|Withdrawal by Subject|1|||
154946909|NCT00421174|559232199|FG000|Overall Study|Ineligible due to infection|2|||
154946910|NCT00421174|559232200|FG001|Overall Study|Ineligible due to infection|0|||
154946911|NCT02750761|559232202|FG000|Overall Study|Lost to Follow-up|0|||
154946912|NCT02750761|559232203|FG001|Overall Study|Lost to Follow-up|0|||
154946913|NCT02750761|559232204|FG002|Overall Study|Lost to Follow-up|1|||
154946914|NCT02750761|559232205|FG003|Overall Study|Lost to Follow-up|0|||
154946915|NCT02750761|559232206|FG004|Overall Study|Lost to Follow-up|0|||
154946916|NCT02750761|559232207|FG005|Overall Study|Lost to Follow-up|0|||
154946917|NCT01506947|559232209|FG000|Overall Study|Lost to Follow-up|7|||
154946918|NCT01506947|559232209|FG000|Overall Study|Adverse Event|5|||
154946919|NCT01506947|559232209|FG000|Overall Study|Death|1|||
154946920|NCT01506947|559232209|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
154946921|NCT01802879|559232213|FG000|Overall Study|Administrative problems|2|||
155049035|NCT00377637|559610002|FG001|Induction Phase|Deterioration/serum creatinine|0|||
154946922|NCT01802879|559232213|FG000|Overall Study|Disease progression|6|||
154946923|NCT00266409|559232214|FG000|Overall Study|Lack of Efficacy|2|||
154946924|NCT00266409|559232215|FG001|Overall Study|Lack of Efficacy|6|||
154946925|NCT00266409|559232216|FG002|Overall Study|Lack of Efficacy|1|||
154946926|NCT00266409|559232217|FG003|Overall Study|Lack of Efficacy|2|||
154946927|NCT00266409|559232214|FG000|Overall Study|Adverse Event|7|||
154946928|NCT00266409|559232215|FG001|Overall Study|Adverse Event|2|||
154946929|NCT00266409|559232216|FG002|Overall Study|Adverse Event|1|||
154946930|NCT00266409|559232217|FG003|Overall Study|Adverse Event|1|||
154946931|NCT00266409|559232214|FG000|Overall Study|Lost to Follow-up|18|||
155049036|NCT00377637|559610003|FG002|Induction Phase|Deterioration/serum creatinine|0|||
155049037|NCT00377637|559610004|FG003|Induction Phase|Deterioration/serum creatinine|0|||
155049038|NCT00377637|559610001|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
155049039|NCT00377637|559610002|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
155049040|NCT00377637|559610003|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
155049041|NCT00377637|559610004|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
155049042|NCT00377637|559610001|FG000|Induction Phase|Lost to Follow-up|2|||
155049043|NCT00377637|559610002|FG001|Induction Phase|Lost to Follow-up|1|||
155049044|NCT00377637|559610003|FG002|Induction Phase|Lost to Follow-up|0|||
155049045|NCT00377637|559610004|FG003|Induction Phase|Lost to Follow-up|0|||
155049046|NCT00377637|559610001|FG000|Induction Phase|Death|1|||
155049047|NCT00377637|559610002|FG001|Induction Phase|Death|3|||
155049048|NCT00377637|559610003|FG002|Induction Phase|Death|0|||
155049049|NCT00377637|559610004|FG003|Induction Phase|Death|0|||
155049050|NCT00377637|559610001|FG000|Induction Phase|Withdrawal by Subject|5|||
155049051|NCT00377637|559610002|FG001|Induction Phase|Withdrawal by Subject|6|||
155049052|NCT00377637|559610003|FG002|Induction Phase|Withdrawal by Subject|0|||
155049053|NCT00377637|559610004|FG003|Induction Phase|Withdrawal by Subject|0|||
155049054|NCT00377637|559610001|FG000|Induction Phase|Physician Decision|3|||
155049055|NCT00377637|559610002|FG001|Induction Phase|Physician Decision|1|||
155049056|NCT00377637|559610003|FG002|Induction Phase|Physician Decision|0|||
155049057|NCT00377637|559610004|FG003|Induction Phase|Physician Decision|0|||
155049058|NCT00377637|559610001|FG000|Induction Phase|Sponsor decision|1|||
155049059|NCT00377637|559610002|FG001|Induction Phase|Sponsor decision|2|||
155049060|NCT00377637|559610003|FG002|Induction Phase|Sponsor decision|0|||
155049061|NCT00377637|559610004|FG003|Induction Phase|Sponsor decision|0|||
155388777|NCT02202551|560858714|FG003|Overall Study|Dyskinesia upon taper|0|||
155388778|NCT02202551|560858711|FG000|Overall Study|Lack of Efficacy|0|||
155388779|NCT02202551|560858712|FG001|Overall Study|Lack of Efficacy|1|||
155388780|NCT02202551|560858713|FG002|Overall Study|Lack of Efficacy|0|||
154946932|NCT00266409|559232215|FG001|Overall Study|Lost to Follow-up|21|||
154946933|NCT00266409|559232216|FG002|Overall Study|Lost to Follow-up|6|||
154946934|NCT00266409|559232217|FG003|Overall Study|Lost to Follow-up|8|||
154946935|NCT00266409|559232214|FG000|Overall Study|Withdrawal by Subject|6|||
154946936|NCT00266409|559232215|FG001|Overall Study|Withdrawal by Subject|10|||
154946937|NCT00266409|559232216|FG002|Overall Study|Withdrawal by Subject|3|||
154946938|NCT00266409|559232217|FG003|Overall Study|Withdrawal by Subject|9|||
154946939|NCT00266409|559232214|FG000|Overall Study|Protocol Violation|5|||
154946940|NCT00266409|559232215|FG001|Overall Study|Protocol Violation|3|||
154946941|NCT00266409|559232216|FG002|Overall Study|Protocol Violation|4|||
154946942|NCT00266409|559232217|FG003|Overall Study|Protocol Violation|2|||
154946943|NCT00266409|559232214|FG000|Overall Study|Other|7|||
154946944|NCT00266409|559232215|FG001|Overall Study|Other|4|||
154946945|NCT00266409|559232216|FG002|Overall Study|Other|2|||
154946946|NCT00266409|559232217|FG003|Overall Study|Other|0|||
154946947|NCT01766921|559232223|FG000|Overall Study|Administrative Reason|5|||
154946948|NCT01766921|559232224|FG001|Overall Study|Administrative Reason|5|||
154946949|NCT01766921|559232223|FG000|Overall Study|Death|1|||
154946950|NCT01766921|559232224|FG001|Overall Study|Death|1|||
154946951|NCT01766921|559232223|FG000|Overall Study|Lost to Follow-up|1|||
154946952|NCT01766921|559232224|FG001|Overall Study|Lost to Follow-up|3|||
154946953|NCT01766921|559232223|FG000|Overall Study|Unclassified|2|||
154946954|NCT01766921|559232224|FG001|Overall Study|Unclassified|2|||
154946955|NCT01766921|559232223|FG000|Overall Study|Protocol Violation|1|||
154946956|NCT01766921|559232224|FG001|Overall Study|Protocol Violation|1|||
154946957|NCT01766921|559232223|FG000|Overall Study|Withdrawal by Subject|14|||
154946958|NCT01766921|559232224|FG001|Overall Study|Withdrawal by Subject|5|||
154946959|NCT01901055|559232227|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
154946960|NCT01901055|559232228|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
154946961|NCT01901055|559232227|FG000|Randomization But Not Titrated|Physician Decision|0|||
154946962|NCT01901055|559232228|FG001|Randomization But Not Titrated|Physician Decision|1|||
154946963|NCT01901055|559232227|FG000|Started Protocol to Week 6|Physician Decision|2|||
154946964|NCT01901055|559232228|FG001|Started Protocol to Week 6|Physician Decision|1|||
154946965|NCT01901055|559232227|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
154946966|NCT01901055|559232228|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
154946967|NCT01901055|559232227|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
154946968|NCT01901055|559232228|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
154946969|NCT01901055|559232227|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
154946970|NCT01901055|559232228|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
154946971|NCT01901055|559232227|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
155049062|NCT00377637|559610001|FG000|Induction Phase|Non-Compliance|1|||
155049063|NCT00377637|559610002|FG001|Induction Phase|Non-Compliance|0|||
155049064|NCT00377637|559610003|FG002|Induction Phase|Non-Compliance|0|||
155049065|NCT00377637|559610004|FG003|Induction Phase|Non-Compliance|0|||
155049066|NCT00377637|559610001|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
154946972|NCT01901055|559232228|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
154946973|NCT01901055|559232227|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
154946974|NCT01901055|559232228|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
154946975|NCT01901055|559232227|FG000|Week 24|Withdrawal by Subject|13|||
154946976|NCT01901055|559232228|FG001|Week 24|Withdrawal by Subject|19|||
154946977|NCT01901055|559232227|FG000|Week 24|Physician Decision|1|||
154946978|NCT01901055|559232228|FG001|Week 24|Physician Decision|0|||
154946979|NCT01901055|559232227|FG000|Week 36|Withdrawal by Subject|0|||
154946980|NCT01901055|559232228|FG001|Week 36|Withdrawal by Subject|5|||
154946981|NCT03019965|559232231|FG000|Overall Study|Withdrawal by Subject|1|||
154946982|NCT03019965|559232232|FG001|Overall Study|Withdrawal by Subject|0|||
154946983|NCT03019965|559232231|FG000|Overall Study|Protocol Violation|1|||
154946984|NCT03019965|559232232|FG001|Overall Study|Protocol Violation|3|||
154946985|NCT03019965|559232231|FG000|Overall Study|viral or fungal infection|3|||
154946986|NCT03019965|559232232|FG001|Overall Study|viral or fungal infection|4|||
154946987|NCT03019965|559232231|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
154946988|NCT03019965|559232232|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
154946989|NCT03019965|559232231|FG000|Overall Study|Physician Decision|1|||
154946990|NCT03019965|559232232|FG001|Overall Study|Physician Decision|1|||
154946991|NCT01179919|559232233|FG000|Overall Study|Protocol Violation|1|||
154946992|NCT01179919|559232233|FG000|Overall Study|Adverse Event|1|||
154946993|NCT01325207|559232234|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
154946994|NCT01325207|559232235|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
154946995|NCT01325207|559232236|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
154946996|NCT01325207|559232237|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
154946997|NCT01325207|559232238|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
154946998|NCT01325207|559232239|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
154946999|NCT01325207|559232234|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
154947000|NCT01325207|559232235|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
154947001|NCT01325207|559232236|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
154947002|NCT01325207|559232237|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
154947003|NCT01325207|559232238|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
154947004|NCT01325207|559232239|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
154947005|NCT01325207|559232234|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
154947006|NCT01325207|559232235|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
154947007|NCT01325207|559232236|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
154947008|NCT01325207|559232237|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
154947009|NCT01325207|559232238|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
154947010|NCT01325207|559232239|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
154947011|NCT01325207|559232234|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
154947012|NCT01325207|559232235|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
154947013|NCT01325207|559232236|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
154947014|NCT01325207|559232237|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
154947015|NCT01325207|559232238|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
154947016|NCT01325207|559232239|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
154947017|NCT01325207|559232234|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
154947018|NCT01325207|559232235|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
154947019|NCT01325207|559232236|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
154947020|NCT01325207|559232237|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
154947021|NCT01325207|559232238|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
154947022|NCT01325207|559232239|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
154947023|NCT01325207|559232234|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
154947024|NCT01325207|559232235|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
155281586|NCT03704298|560461653|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
155281587|NCT00558753|560461654|FG000|Overall Study|Lost to Follow-up|5|||
155281588|NCT00558753|560461655|FG001|Overall Study|Lost to Follow-up|7|||
155281589|NCT01670500|560461661|FG000|Overall Study|Withdrawal by Subject|1|||
155281590|NCT01670500|560461662|FG001|Overall Study|Withdrawal by Subject|0|||
155281591|NCT03658811|560461664|FG000|Overall Study|Lost to Follow-up|3|||
155281592|NCT04951479|560461667|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
155281593|NCT04209790|560461668|FG000|Overall Study|Physician Decision|1|||
155281594|NCT04060680|560461670|FG000|Overall Study|Unsuccessful implant|17|||
155281595|NCT04060680|560461671|FG001|Overall Study|Unsuccessful implant|2|||
155281596|NCT04060680|560461670|FG000|Overall Study|Adverse Event|3|||
155281597|NCT04060680|560461671|FG001|Overall Study|Adverse Event|0|||
155281598|NCT04060680|560461670|FG000|Overall Study|Death|2|||
155281599|NCT04060680|560461671|FG001|Overall Study|Death|0|||
155281600|NCT04060680|560461670|FG000|Overall Study|Study product no longer in use|1|||
155281601|NCT04060680|560461671|FG001|Overall Study|Study product no longer in use|0|||
155281602|NCT04060680|560461670|FG000|Overall Study|Withdrawal by Subject|1|||
155049067|NCT00377637|559610002|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
155049068|NCT00377637|559610003|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
155049069|NCT00377637|559610004|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
155049070|NCT00377637|559610001|FG000|Maintenance Phase|Adverse Event|0|||
155388781|NCT02202551|560858714|FG003|Overall Study|Lack of Efficacy|0|||
155388782|NCT02202551|560858711|FG000|Overall Study|Physician Decision|1|||
155388783|NCT02202551|560858712|FG001|Overall Study|Physician Decision|0|||
155388784|NCT02202551|560858713|FG002|Overall Study|Physician Decision|0|||
155388785|NCT02202551|560858714|FG003|Overall Study|Physician Decision|0|||
155049071|NCT00377637|559610002|FG001|Maintenance Phase|Adverse Event|0|||
155049072|NCT00377637|559610003|FG002|Maintenance Phase|Adverse Event|29|||
155049073|NCT00377637|559610004|FG003|Maintenance Phase|Adverse Event|43|||
155049074|NCT00377637|559610001|FG000|Maintenance Phase|Physician Decision|0|||
155049075|NCT00377637|559610002|FG001|Maintenance Phase|Physician Decision|0|||
155049076|NCT00377637|559610003|FG002|Maintenance Phase|Physician Decision|5|||
155049077|NCT00377637|559610004|FG003|Maintenance Phase|Physician Decision|4|||
155049078|NCT00377637|559610001|FG000|Maintenance Phase|Lost to Follow-up|0|||
155049079|NCT00377637|559610002|FG001|Maintenance Phase|Lost to Follow-up|0|||
155049080|NCT00377637|559610003|FG002|Maintenance Phase|Lost to Follow-up|3|||
155049081|NCT00377637|559610004|FG003|Maintenance Phase|Lost to Follow-up|1|||
155049082|NCT00377637|559610001|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155049083|NCT00377637|559610002|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155049084|NCT00377637|559610003|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155049085|NCT00377637|559610004|FG003|Maintenance Phase|Withdrawal by Subject|3|||
155049086|NCT00377637|559610001|FG000|Maintenance Phase|Sponsor decision|0|||
155049087|NCT00377637|559610002|FG001|Maintenance Phase|Sponsor decision|0|||
155049088|NCT00377637|559610003|FG002|Maintenance Phase|Sponsor decision|2|||
155049089|NCT00377637|559610004|FG003|Maintenance Phase|Sponsor decision|3|||
155049090|NCT00377637|559610001|FG000|Maintenance Phase|Non-compliance|0|||
155049091|NCT00377637|559610002|FG001|Maintenance Phase|Non-compliance|0|||
155049092|NCT00377637|559610003|FG002|Maintenance Phase|Non-compliance|1|||
155049093|NCT00377637|559610004|FG003|Maintenance Phase|Non-compliance|1|||
155049094|NCT00377637|559610001|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
155049095|NCT00377637|559610002|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
155049096|NCT00377637|559610003|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
155049097|NCT00377637|559610004|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
155049098|NCT00377637|559610001|FG000|Maintenance Phase|Death|0|||
155049099|NCT00377637|559610002|FG001|Maintenance Phase|Death|0|||
155049100|NCT00377637|559610003|FG002|Maintenance Phase|Death|0|||
155049101|NCT00377637|559610004|FG003|Maintenance Phase|Death|1|||
155049102|NCT00493012|559610005|FG000|Overall Study|Lost to Follow-up|18|||
155049103|NCT00493012|559610006|FG001|Overall Study|Lost to Follow-up|17|||
155049104|NCT04147247|559610007|FG000|Overall Study|Progressive disease|3|||
155049105|NCT04147247|559610008|FG001|Overall Study|Progressive disease|3|||
155049106|NCT04147247|559610009|FG002|Overall Study|Progressive disease|4|||
155049107|NCT04147247|559610010|FG003|Overall Study|Progressive disease|4|||
155049108|NCT04147247|559610011|FG004|Overall Study|Progressive disease|3|||
155049109|NCT04147247|559610007|FG000|Overall Study|Physician Decision|0|||
155049110|NCT04147247|559610008|FG001|Overall Study|Physician Decision|1|||
155049111|NCT04147247|559610009|FG002|Overall Study|Physician Decision|0|||
155049112|NCT04147247|559610010|FG003|Overall Study|Physician Decision|0|||
155049113|NCT04147247|559610011|FG004|Overall Study|Physician Decision|0|||
155049114|NCT04147247|559610007|FG000|Overall Study|Clinical Disease Progression|0|||
155049115|NCT04147247|559610008|FG001|Overall Study|Clinical Disease Progression|0|||
155049116|NCT04147247|559610009|FG002|Overall Study|Clinical Disease Progression|0|||
155049117|NCT04147247|559610010|FG003|Overall Study|Clinical Disease Progression|0|||
155049118|NCT04147247|559610011|FG004|Overall Study|Clinical Disease Progression|1|||
155049119|NCT04147247|559610007|FG000|Overall Study|Adverse Event|0|||
155049120|NCT04147247|559610008|FG001|Overall Study|Adverse Event|0|||
155049121|NCT04147247|559610009|FG002|Overall Study|Adverse Event|1|||
155049122|NCT04147247|559610010|FG003|Overall Study|Adverse Event|0|||
155049123|NCT04147247|559610011|FG004|Overall Study|Adverse Event|1|||
155049124|NCT02915159|559610012|FG000|Overall Study|Participant no longer meets criteria|2|||
155049125|NCT02915159|559610013|FG001|Overall Study|Participant no longer meets criteria|0|||
155049126|NCT02915159|559610012|FG000|Overall Study|poor/non-compliance|1|||
155049127|NCT02915159|559610013|FG001|Overall Study|poor/non-compliance|0|||
155388786|NCT02202551|560858711|FG000|Overall Study|Site closure|3|||
155388787|NCT02202551|560858712|FG001|Overall Study|Site closure|0|||
155049128|NCT02915159|559610012|FG000|Overall Study|Participant withdrew consent|5|||
155049129|NCT02915159|559610013|FG001|Overall Study|Participant withdrew consent|1|||
155049130|NCT02915159|559610012|FG000|Overall Study|Request to discontinue treatment|1|||
155049131|NCT02915159|559610013|FG001|Overall Study|Request to discontinue treatment|2|||
155049132|NCT02915159|559610012|FG000|Overall Study|Adverse Event|2|||
155049133|NCT02915159|559610013|FG001|Overall Study|Adverse Event|2|||
155049134|NCT02915159|559610012|FG000|Overall Study|Lack of Efficacy|0|||
155049135|NCT02915159|559610013|FG001|Overall Study|Lack of Efficacy|3|||
155388788|NCT02202551|560858713|FG002|Overall Study|Site closure|0|||
155388789|NCT02202551|560858714|FG003|Overall Study|Site closure|1|||
155388790|NCT02202551|560858711|FG000|Overall Study|Unable to complete visits per protocol|1|||
155388791|NCT02202551|560858712|FG001|Overall Study|Unable to complete visits per protocol|0|||
155388792|NCT02202551|560858713|FG002|Overall Study|Unable to complete visits per protocol|0|||
155388793|NCT02202551|560858714|FG003|Overall Study|Unable to complete visits per protocol|0|||
155388794|NCT02202551|560858711|FG000|Overall Study|Worsening Dyskinesia|0|||
154947025|NCT01325207|559232236|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
154947026|NCT01325207|559232237|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
154947027|NCT01325207|559232238|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
154947028|NCT01325207|559232239|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
154947029|NCT01325207|559232234|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
154947030|NCT01325207|559232235|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
154947031|NCT01325207|559232236|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
154947032|NCT01325207|559232237|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
154947033|NCT01325207|559232238|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
154947034|NCT01325207|559232239|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
154947035|NCT00698685|559232240|FG000|Overall Study|Sister withdrew as donor|1|||
154947036|NCT00698685|559232240|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
154947037|NCT00708422|559232241|FG000|Overall Study|Adverse Event|3|||
154947038|NCT00708422|559232242|FG001|Overall Study|Adverse Event|1|||
154947039|NCT00708422|559232241|FG000|Overall Study|Withdrawal by Subject|1|||
154947040|NCT00708422|559232242|FG001|Overall Study|Withdrawal by Subject|0|||
154947041|NCT01254409|559232243|FG000|Overall Study|Adverse Event|0|||
154947042|NCT01254409|559232244|FG001|Overall Study|Adverse Event|1|||
154947043|NCT01254409|559232245|FG002|Overall Study|Adverse Event|0|||
154947044|NCT01254409|559232246|FG003|Overall Study|Adverse Event|0|||
154947045|NCT00337571|559232249|FG000|Overall Study|Lack of Efficacy|3|||
154947046|NCT00337571|559232250|FG001|Overall Study|Lack of Efficacy|0|||
154947047|NCT00337571|559232251|FG002|Overall Study|Lack of Efficacy|0|||
154947048|NCT00337571|559232252|FG003|Overall Study|Lack of Efficacy|0|||
154947049|NCT00337571|559232249|FG000|Overall Study|Adverse Event|4|||
154947050|NCT00337571|559232250|FG001|Overall Study|Adverse Event|5|||
154947051|NCT00337571|559232251|FG002|Overall Study|Adverse Event|8|||
154947052|NCT00337571|559232252|FG003|Overall Study|Adverse Event|4|||
154947053|NCT00337571|559232249|FG000|Overall Study|Withdrawal by Subject|2|||
154947054|NCT00337571|559232250|FG001|Overall Study|Withdrawal by Subject|2|||
154947055|NCT00337571|559232251|FG002|Overall Study|Withdrawal by Subject|1|||
154947056|NCT00337571|559232252|FG003|Overall Study|Withdrawal by Subject|0|||
154947057|NCT00337571|559232249|FG000|Overall Study|Lost to Follow-up|3|||
154947058|NCT00337571|559232250|FG001|Overall Study|Lost to Follow-up|1|||
154947059|NCT00337571|559232251|FG002|Overall Study|Lost to Follow-up|0|||
154947060|NCT00337571|559232252|FG003|Overall Study|Lost to Follow-up|1|||
154947061|NCT00337571|559232249|FG000|Overall Study|Poor/noncompliance|1|||
154947062|NCT00337571|559232250|FG001|Overall Study|Poor/noncompliance|1|||
154947063|NCT00337571|559232251|FG002|Overall Study|Poor/noncompliance|1|||
154947064|NCT00337571|559232252|FG003|Overall Study|Poor/noncompliance|1|||
154947065|NCT00337571|559232249|FG000|Overall Study|No longer met study criteria|1|||
154947066|NCT00337571|559232250|FG001|Overall Study|No longer met study criteria|0|||
154947067|NCT00337571|559232251|FG002|Overall Study|No longer met study criteria|0|||
154947068|NCT00337571|559232252|FG003|Overall Study|No longer met study criteria|0|||
154947069|NCT00337571|559232249|FG000|Overall Study|High Potassium level|0|||
154947070|NCT00337571|559232250|FG001|Overall Study|High Potassium level|0|||
154947071|NCT00337571|559232251|FG002|Overall Study|High Potassium level|0|||
154947072|NCT00337571|559232252|FG003|Overall Study|High Potassium level|1|||
154947073|NCT01974895|559232258|FG000|Overall Study|Protocol Violation|1|||
154947074|NCT01974895|559232259|FG001|Overall Study|Protocol Violation|0|||
154947075|NCT01974895|559232258|FG000|Overall Study|Lost to Follow-up|4|||
154947076|NCT01974895|559232259|FG001|Overall Study|Lost to Follow-up|6|||
154947077|NCT01974895|559232258|FG000|Overall Study|Withdrawal by Subject|0|||
154947078|NCT01974895|559232259|FG001|Overall Study|Withdrawal by Subject|1|||
154947079|NCT01974895|559232258|FG000|Overall Study|Other (Missed Visit)|1|||
154947080|NCT01974895|559232259|FG001|Overall Study|Other (Missed Visit)|0|||
154947081|NCT01974895|559232258|FG000|Overall Study|Other (Reason unknown)|9|||
154947082|NCT01974895|559232259|FG001|Overall Study|Other (Reason unknown)|8|||
155388795|NCT02202551|560858712|FG001|Overall Study|Worsening Dyskinesia|0|||
154947083|NCT00635154|559232260|FG000|Overall Study|Alternative Treatment|8|||
154947084|NCT00635154|559232260|FG000|Overall Study|Other|4|||
154947085|NCT00635154|559232260|FG000|Overall Study|Still on treatment|21|||
155388796|NCT02202551|560858713|FG002|Overall Study|Worsening Dyskinesia|0|||
155388797|NCT02202551|560858714|FG003|Overall Study|Worsening Dyskinesia|1|||
155049136|NCT00823264|559610014|FG000|Overall Study|Protocol Violation|2|||
154947086|NCT01513148|559232261|FG000|Overall Study|Protocol Violation|2|||
154947087|NCT01513148|559232262|FG001|Overall Study|Protocol Violation|2|||
154947088|NCT03552757|559232263|FG000|Overall Study|Withdrawal by Subject|10|||
155049137|NCT00823264|559610015|FG001|Overall Study|Protocol Violation|0|||
155049138|NCT01714544|559610016|FG000|Overall Study|Lost to Follow-up|1|||
155049139|NCT01714544|559610016|FG000|Overall Study|Physician Decision|1|||
155049140|NCT01714544|559610016|FG000|Overall Study|Withdrawal by Subject|1|||
155049141|NCT00666211|559610017|FG000|Overall Study|Withdrawal by Subject|10|||
155049142|NCT00666211|559610018|FG001|Overall Study|Withdrawal by Subject|13|||
155049143|NCT00666211|559610017|FG000|Overall Study|went off medication, no more pain|1|||
155049144|NCT00666211|559610018|FG001|Overall Study|went off medication, no more pain|0|||
155049145|NCT00666211|559610017|FG000|Overall Study|patient non-compliant|6|||
155049146|NCT00666211|559610018|FG001|Overall Study|patient non-compliant|6|||
155049147|NCT00666211|559610017|FG000|Overall Study|disease progression|1|||
155049148|NCT00666211|559610018|FG001|Overall Study|disease progression|8|||
155049149|NCT00666211|559610017|FG000|Overall Study|Lost to Follow-up|2|||
155049150|NCT00666211|559610018|FG001|Overall Study|Lost to Follow-up|0|||
155049151|NCT00666211|559610017|FG000|Overall Study|toxicity|0|||
155049152|NCT00666211|559610018|FG001|Overall Study|toxicity|2|||
155049153|NCT00666211|559610017|FG000|Overall Study|hospital admission|0|||
155049154|NCT00666211|559610018|FG001|Overall Study|hospital admission|5|||
155049155|NCT00666211|559610017|FG000|Overall Study|Death|0|||
155049156|NCT00666211|559610018|FG001|Overall Study|Death|2|||
155049157|NCT00666211|559610017|FG000|Overall Study|off tx for other complicating disease|0|||
155049158|NCT00666211|559610018|FG001|Overall Study|off tx for other complicating disease|1|||
155049159|NCT00666211|559610017|FG000|Overall Study|Physician Decision|0|||
155049160|NCT00666211|559610018|FG001|Overall Study|Physician Decision|1|||
155049161|NCT03373760|559610023|FG000|Overall Study|Adverse Event|8|||
155049162|NCT03373760|559610023|FG000|Overall Study|Disease Progression|46|||
155049163|NCT03373760|559610023|FG000|Overall Study|Death|4|||
155049164|NCT00003537|559610026|FG000|Overall Study|Not evalauable|1|||
155049165|NCT05225558|559610032|FG000|Overall Study|Withdrawal by Subject|4|||
155049166|NCT05225558|559610033|FG001|Overall Study|Withdrawal by Subject|3|||
155049167|NCT05225558|559610032|FG000|Overall Study|Adverse Event|1|||
155049168|NCT05225558|559610033|FG001|Overall Study|Adverse Event|0|||
155049169|NCT05225558|559610032|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
155049170|NCT05225558|559610033|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
155049171|NCT05225558|559610032|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
155049172|NCT05225558|559610033|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
155049173|NCT00875563|559610035|FG000|Overall Study|Death|4|||
155049174|NCT00875563|559610035|FG000|Overall Study|Withdrawal by Subject|7|||
155049175|NCT00875563|559610035|FG000|Overall Study|No long-term (3-5 year) consent|6|||
155049176|NCT00875563|559610035|FG000|Overall Study|Still be eligible for follow-up|7|||
155049177|NCT00313846|559610036|FG000|Overall Study|Withdrawal by Subject|2|||
155049178|NCT00313846|559610037|FG001|Overall Study|Withdrawal by Subject|0|||
155049179|NCT00313846|559610036|FG000|Overall Study|Adverse Event|1|||
155049180|NCT00313846|559610037|FG001|Overall Study|Adverse Event|8|||
155049181|NCT00313846|559610036|FG000|Overall Study|Administrative|2|||
155049182|NCT00313846|559610037|FG001|Overall Study|Administrative|3|||
155049183|NCT03478371|559610038|FG000|Overall Study|non-compliance|1|||
155049184|NCT03478371|559610038|FG000|Overall Study|Lost to Follow-up|4|||
155049185|NCT06060496|559610042|FG000|Overall Study|Withdrawal by Subject|2|||
155049186|NCT06060496|559610042|FG000|Overall Study|Lost to Follow-up|2|||
155049187|NCT02028507|559610043|FG000|Overall Study|Progressive Disease|122|||
155049188|NCT02028507|559610044|FG001|Overall Study|Progressive Disease|90|||
155049189|NCT02028507|559610045|FG002|Overall Study|Progressive Disease|102|||
155049190|NCT02028507|559610046|FG003|Overall Study|Progressive Disease|89|||
155049191|NCT02028507|559610043|FG000|Overall Study|Adverse Event|8|||
155049192|NCT02028507|559610044|FG001|Overall Study|Adverse Event|25|||
155049193|NCT02028507|559610045|FG002|Overall Study|Adverse Event|3|||
155049194|NCT02028507|559610046|FG003|Overall Study|Adverse Event|16|||
155049195|NCT02028507|559610043|FG000|Overall Study|Withdrawal by Subject|6|||
155049196|NCT02028507|559610044|FG001|Overall Study|Withdrawal by Subject|8|||
155049197|NCT02028507|559610045|FG002|Overall Study|Withdrawal by Subject|5|||
155049198|NCT02028507|559610046|FG003|Overall Study|Withdrawal by Subject|9|||
155049199|NCT02028507|559610043|FG000|Overall Study|Protocol Violation|2|||
155049200|NCT02028507|559610044|FG001|Overall Study|Protocol Violation|4|||
155049201|NCT02028507|559610045|FG002|Overall Study|Protocol Violation|1|||
155049202|NCT02028507|559610046|FG003|Overall Study|Protocol Violation|3|||
155049203|NCT02028507|559610043|FG000|Overall Study|Physician Decision|0|||
155049204|NCT02028507|559610044|FG001|Overall Study|Physician Decision|4|||
155049205|NCT02028507|559610045|FG002|Overall Study|Physician Decision|0|||
155049206|NCT02028507|559610046|FG003|Overall Study|Physician Decision|0|||
155049207|NCT02028507|559610043|FG000|Overall Study|Death|1|||
155049208|NCT02028507|559610044|FG001|Overall Study|Death|0|||
155049209|NCT02028507|559610045|FG002|Overall Study|Death|1|||
155049210|NCT02028507|559610046|FG003|Overall Study|Death|3|||
155049211|NCT02028507|559610043|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
155049212|NCT02028507|559610044|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
155388798|NCT02202551|560858711|FG000|Overall Study|Protocol Violation|0|||
155388799|NCT02202551|560858712|FG001|Overall Study|Protocol Violation|1|||
155388800|NCT02202551|560858713|FG002|Overall Study|Protocol Violation|0|||
155388801|NCT02202551|560858714|FG003|Overall Study|Protocol Violation|0|||
155049213|NCT02028507|559610045|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
155049214|NCT02028507|559610046|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
155049215|NCT02028507|559610043|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
155049216|NCT02028507|559610044|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
155049217|NCT02028507|559610045|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
155049218|NCT02028507|559610046|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
155049219|NCT02028507|559610043|FG000|Overall Study|Randomized But Not Treated|3|||
155049220|NCT02028507|559610044|FG001|Overall Study|Randomized But Not Treated|6|||
155049221|NCT02028507|559610045|FG002|Overall Study|Randomized But Not Treated|0|||
155049222|NCT02028507|559610046|FG003|Overall Study|Randomized But Not Treated|4|||
155049223|NCT02028507|559610043|FG000|Overall Study|Enzyme defect|0|||
155049224|NCT02028507|559610044|FG001|Overall Study|Enzyme defect|0|||
155049225|NCT02028507|559610045|FG002|Overall Study|Enzyme defect|0|||
155049226|NCT02028507|559610046|FG003|Overall Study|Enzyme defect|1|||
155049227|NCT02028507|559610043|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
155049228|NCT02028507|559610044|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
155049229|NCT02028507|559610045|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
155049230|NCT02028507|559610046|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
155049231|NCT02028507|559610043|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
155049232|NCT02028507|559610044|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
155049233|NCT02028507|559610045|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
155049234|NCT02028507|559610046|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
155049235|NCT02401035|559610049|FG000|Overall Study|Withdrawal by Subject|1|||
155049236|NCT02401035|559610050|FG001|Overall Study|Withdrawal by Subject|0|||
155049237|NCT00869128|559610051|FG000|Overall Study|lack of Compliance|6|||
155049238|NCT00869128|559610052|FG001|Overall Study|lack of Compliance|6|||
155049239|NCT01118663|559610053|FG000|Overall Study|Adverse Event|2|||
155049240|NCT01118663|559610054|FG001|Overall Study|Adverse Event|1|||
155049241|NCT01118663|559610053|FG000|Overall Study|Withdrawal by Subject|0|||
155049242|NCT01118663|559610054|FG001|Overall Study|Withdrawal by Subject|1|||
155049243|NCT03046953|559610061|FG000|Overall Study|Relapse/progressive disease|21|||
155049244|NCT03046953|559610061|FG000|Overall Study|Death|2|||
155049245|NCT03046953|559610061|FG000|Overall Study|Withdrawal by Subject|3|||
155049246|NCT04039204|559610062|FG000|Overall Study|Withdrawal by Subject|0|||
155049247|NCT04039204|559610063|FG001|Overall Study|Withdrawal by Subject|2|||
155049248|NCT01189461|559610065|FG000|Overall Study|Lack of Efficacy|13|||
155049249|NCT01189461|559610065|FG000|Overall Study|Lost to Follow-up|1|||
155049250|NCT01189461|559610065|FG000|Overall Study|Withdrawal by Subject|6|||
155049251|NCT01189461|559610065|FG000|Overall Study|Protocol Violation|1|||
155049252|NCT01189461|559610065|FG000|Overall Study|Adverse Event|2|||
155049253|NCT01189461|559610065|FG000|Overall Study|Did not meet entrance criteria|3|||
155049254|NCT01189461|559610065|FG000|Overall Study|Other|8|||
155049255|NCT02716584|559610067|FG000|Overall Study|Lost to Follow-up|8|||
155049256|NCT02716584|559610068|FG001|Overall Study|Lost to Follow-up|5|||
155049257|NCT00420628|559610069|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
155049258|NCT00420628|559610070|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
155049259|NCT00420628|559610069|FG000|Overall Study|Lost to Follow-up|3|||
155049260|NCT00420628|559610070|FG001|Overall Study|Lost to Follow-up|2|||
155049261|NCT00420628|559610069|FG000|Overall Study|Adverse Event|1|||
155049262|NCT00420628|559610070|FG001|Overall Study|Adverse Event|0|||
155049263|NCT00656175|559610073|FG000|Overall Study|Adverse Event|1|||
155049264|NCT00656175|559610074|FG001|Overall Study|Adverse Event|0|||
155049265|NCT00656175|559610073|FG000|Overall Study|Transportation issues|0|||
155049266|NCT00656175|559610074|FG001|Overall Study|Transportation issues|1|||
155049267|NCT01868165|559610075|FG000|Overall Study|Withdrawal by Subject|36|||
155388802|NCT02202551|560858711|FG000|Overall Study|Sponsor's decision|2|||
155049268|NCT01868165|559610075|FG000|Overall Study|Physician Decision|2|||
155388803|NCT02202551|560858712|FG001|Overall Study|Sponsor's decision|0|||
155049269|NCT01868165|559610075|FG000|Overall Study|Lost to Follow-up|3|||
155049270|NCT01868165|559610075|FG000|Overall Study|Death|4|||
155049271|NCT01216332|559610078|FG000|Overall Study|Withdrawal by Subject|4|||
155049272|NCT01216332|559610079|FG001|Overall Study|Withdrawal by Subject|0|||
155388804|NCT02202551|560858713|FG002|Overall Study|Sponsor's decision|0|||
155388805|NCT02202551|560858714|FG003|Overall Study|Sponsor's decision|0|||
155388806|NCT02202551|560858711|FG000|Overall Study|Subject unwilling to proceed|1|||
155388807|NCT02202551|560858712|FG001|Overall Study|Subject unwilling to proceed|5|||
155388808|NCT02202551|560858713|FG002|Overall Study|Subject unwilling to proceed|3|||
155388809|NCT02202551|560858714|FG003|Overall Study|Subject unwilling to proceed|5|||
155049273|NCT00103285|559611991|FG000|Induction|Adverse Event|14|||
155049274|NCT00103285|559611992|FG001|Induction|Adverse Event|0|||
155049275|NCT00103285|559611993|FG002|Induction|Adverse Event|0|||
155049276|NCT00103285|559611994|FG003|Induction|Adverse Event|0|||
155049277|NCT00103285|559611995|FG004|Induction|Adverse Event|0|||
155049278|NCT00103285|559611996|FG005|Induction|Adverse Event|0|||
155049279|NCT00103285|559611997|FG006|Induction|Adverse Event|0|||
155049280|NCT00103285|559611998|FG007|Induction|Adverse Event|0|||
155049281|NCT00103285|559611991|FG000|Induction|Death|24|||
155049282|NCT00103285|559611992|FG001|Induction|Death|0|||
155049283|NCT00103285|559611993|FG002|Induction|Death|0|||
155049284|NCT00103285|559611994|FG003|Induction|Death|0|||
155049285|NCT00103285|559611995|FG004|Induction|Death|0|||
155049286|NCT00103285|559611996|FG005|Induction|Death|0|||
155049287|NCT00103285|559611997|FG006|Induction|Death|0|||
155049288|NCT00103285|559611998|FG007|Induction|Death|0|||
155049289|NCT00103285|559611991|FG000|Induction|Physician Decision|103|||
155049290|NCT00103285|559611992|FG001|Induction|Physician Decision|0|||
155049291|NCT00103285|559611993|FG002|Induction|Physician Decision|0|||
155049292|NCT00103285|559611994|FG003|Induction|Physician Decision|0|||
155049293|NCT00103285|559611995|FG004|Induction|Physician Decision|0|||
155049294|NCT00103285|559611996|FG005|Induction|Physician Decision|0|||
155049295|NCT00103285|559611997|FG006|Induction|Physician Decision|0|||
155049296|NCT00103285|559611998|FG007|Induction|Physician Decision|0|||
155049297|NCT00103285|559611991|FG000|Induction|Withdrawal by Subject|1|||
155049298|NCT00103285|559611992|FG001|Induction|Withdrawal by Subject|0|||
155049299|NCT00103285|559611993|FG002|Induction|Withdrawal by Subject|0|||
155049300|NCT00103285|559611994|FG003|Induction|Withdrawal by Subject|0|||
155049301|NCT00103285|559611995|FG004|Induction|Withdrawal by Subject|0|||
155049302|NCT00103285|559611996|FG005|Induction|Withdrawal by Subject|0|||
155049303|NCT00103285|559611997|FG006|Induction|Withdrawal by Subject|0|||
155049304|NCT00103285|559611998|FG007|Induction|Withdrawal by Subject|0|||
155049305|NCT00103285|559611991|FG000|Induction|Ineligible|43|||
155049306|NCT00103285|559611992|FG001|Induction|Ineligible|0|||
155049307|NCT00103285|559611993|FG002|Induction|Ineligible|0|||
155049308|NCT00103285|559611994|FG003|Induction|Ineligible|0|||
155049309|NCT00103285|559611995|FG004|Induction|Ineligible|0|||
155049310|NCT00103285|559611996|FG005|Induction|Ineligible|0|||
155049311|NCT00103285|559611997|FG006|Induction|Ineligible|0|||
155049312|NCT00103285|559611998|FG007|Induction|Ineligible|0|||
155049313|NCT00103285|559611991|FG000|Induction|Refusal|906|||
155049314|NCT00103285|559611992|FG001|Induction|Refusal|0|||
155049315|NCT00103285|559611993|FG002|Induction|Refusal|0|||
155049316|NCT00103285|559611994|FG003|Induction|Refusal|0|||
155049317|NCT00103285|559611995|FG004|Induction|Refusal|0|||
155049318|NCT00103285|559611996|FG005|Induction|Refusal|0|||
155049319|NCT00103285|559611997|FG006|Induction|Refusal|0|||
155049320|NCT00103285|559611998|FG007|Induction|Refusal|0|||
155049321|NCT00103285|559611991|FG000|Induction|Other|258|||
155049322|NCT00103285|559611992|FG001|Induction|Other|0|||
155049323|NCT00103285|559611993|FG002|Induction|Other|0|||
155049324|NCT00103285|559611994|FG003|Induction|Other|0|||
155049325|NCT00103285|559611995|FG004|Induction|Other|0|||
155049326|NCT00103285|559611996|FG005|Induction|Other|0|||
155049327|NCT00103285|559611997|FG006|Induction|Other|0|||
155049328|NCT00103285|559611998|FG007|Induction|Other|0|||
155049329|NCT00103285|559611991|FG000|Response Assignment|Adverse Event|0|||
155049330|NCT00103285|559611992|FG001|Response Assignment|Adverse Event|8|||
155049331|NCT00103285|559611993|FG002|Response Assignment|Adverse Event|3|||
155049332|NCT00103285|559611994|FG003|Response Assignment|Adverse Event|2|||
155049333|NCT00103285|559611995|FG004|Response Assignment|Adverse Event|3|||
155049334|NCT00103285|559611996|FG005|Response Assignment|Adverse Event|1|||
155049335|NCT00103285|559611997|FG006|Response Assignment|Adverse Event|1|||
155049336|NCT00103285|559611998|FG007|Response Assignment|Adverse Event|2|||
155049337|NCT00103285|559611991|FG000|Response Assignment|Death|0|||
155049338|NCT00103285|559611992|FG001|Response Assignment|Death|5|||
155049339|NCT00103285|559611993|FG002|Response Assignment|Death|2|||
155049340|NCT00103285|559611994|FG003|Response Assignment|Death|2|||
155049341|NCT00103285|559611995|FG004|Response Assignment|Death|3|||
155049342|NCT00103285|559611996|FG005|Response Assignment|Death|1|||
155049343|NCT00103285|559611997|FG006|Response Assignment|Death|0|||
155049344|NCT00103285|559611998|FG007|Response Assignment|Death|8|||
155049345|NCT00103285|559611991|FG000|Response Assignment|Lost to Follow-up|0|||
155049346|NCT00103285|559611992|FG001|Response Assignment|Lost to Follow-up|9|||
155049347|NCT00103285|559611993|FG002|Response Assignment|Lost to Follow-up|5|||
155049348|NCT00103285|559611994|FG003|Response Assignment|Lost to Follow-up|5|||
155049349|NCT00103285|559611995|FG004|Response Assignment|Lost to Follow-up|1|||
155049350|NCT00103285|559611996|FG005|Response Assignment|Lost to Follow-up|2|||
155049351|NCT00103285|559611997|FG006|Response Assignment|Lost to Follow-up|2|||
155049352|NCT00103285|559611998|FG007|Response Assignment|Lost to Follow-up|5|||
155049353|NCT00103285|559611991|FG000|Response Assignment|Physician Decision|0|||
155049354|NCT00103285|559611992|FG001|Response Assignment|Physician Decision|13|||
155049355|NCT00103285|559611993|FG002|Response Assignment|Physician Decision|14|||
155049356|NCT00103285|559611994|FG003|Response Assignment|Physician Decision|9|||
155049357|NCT00103285|559611995|FG004|Response Assignment|Physician Decision|13|||
155049358|NCT00103285|559611996|FG005|Response Assignment|Physician Decision|7|||
155049359|NCT00103285|559611997|FG006|Response Assignment|Physician Decision|4|||
155092575|NCT01959529|559773635|FG001|Overall Study|Other|68|||
155388810|NCT02202551|560858711|FG000|Overall Study|Subject consent withdrawn|0|||
155388811|NCT02202551|560858712|FG001|Overall Study|Subject consent withdrawn|3|||
154947089|NCT03552757|559232264|FG001|Overall Study|Withdrawal by Subject|5|||
154947090|NCT03552757|559232265|FG002|Overall Study|Withdrawal by Subject|12|||
154947091|NCT03552757|559232263|FG000|Overall Study|Lost to Follow-up|2|||
154947092|NCT03552757|559232264|FG001|Overall Study|Lost to Follow-up|7|||
154947093|NCT03552757|559232265|FG002|Overall Study|Lost to Follow-up|7|||
154947094|NCT03552757|559232263|FG000|Overall Study|Death|1|||
154947095|NCT03552757|559232264|FG001|Overall Study|Death|1|||
154947096|NCT03552757|559232265|FG002|Overall Study|Death|1|||
154947097|NCT02192099|559232268|FG000|Overall Study|Adverse Event|1|||
154947098|NCT02192099|559232268|FG000|Overall Study|Lost to Follow-up|2|||
154947099|NCT02192099|559232268|FG000|Overall Study|Physician Decision|1|||
154947100|NCT02192099|559232268|FG000|Overall Study|Pregnancy|1|||
154947101|NCT02192099|559232268|FG000|Overall Study|Protocol Violation|8|||
154947102|NCT02192099|559232268|FG000|Overall Study|Study Terminated by Sponsor|32|||
154947103|NCT02192099|559232268|FG000|Overall Study|Withdrawal by Subject|11|||
154947104|NCT02192099|559232268|FG000|Overall Study|Miscellaneous Reasons|5|||
154947105|NCT00386009|559232269|FG000|Overall Study|Adverse Event|0|||
154947106|NCT00386009|559232270|FG001|Overall Study|Adverse Event|2|||
154947107|NCT00386009|559232269|FG000|Overall Study|Death|1|||
154947108|NCT00386009|559232270|FG001|Overall Study|Death|0|||
154947109|NCT00386009|559232269|FG000|Overall Study|Entry Criteria Not Met|0|||
154947110|NCT00386009|559232270|FG001|Overall Study|Entry Criteria Not Met|2|||
154947111|NCT00386009|559232269|FG000|Overall Study|Lost to Follow-up|1|||
154947112|NCT00386009|559232270|FG001|Overall Study|Lost to Follow-up|1|||
154947113|NCT00386009|559232269|FG000|Overall Study|Protocol Violation|1|||
154947114|NCT00386009|559232270|FG001|Overall Study|Protocol Violation|0|||
154947115|NCT00386009|559232269|FG000|Overall Study|Sponsor Decision|1|||
154947116|NCT00386009|559232270|FG001|Overall Study|Sponsor Decision|1|||
154947117|NCT00386009|559232269|FG000|Overall Study|Withdrawal by Subject|5|||
154947118|NCT00386009|559232270|FG001|Overall Study|Withdrawal by Subject|4|||
154947119|NCT06331156|559232276|FG000|Overall Study|Adverse Event|1|||
154947120|NCT06331156|559232277|FG001|Overall Study|Adverse Event|0|||
154947121|NCT06331156|559232276|FG000|Overall Study|Lost to Follow-up|1|||
154947122|NCT06331156|559232277|FG001|Overall Study|Lost to Follow-up|0|||
154947123|NCT06331156|559232276|FG000|Overall Study|Migrated / Moved from the study area|4|||
154947124|NCT06331156|559232277|FG001|Overall Study|Migrated / Moved from the study area|3|||
154947125|NCT06331156|559232276|FG000|Overall Study|Other|7|||
154947126|NCT06331156|559232277|FG001|Overall Study|Other|0|||
154947127|NCT06331156|559232276|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
154947128|NCT06331156|559232277|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
154947129|NCT02978326|559232282|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
154947130|NCT02978326|559232283|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
154947131|NCT02978326|559232284|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
154947132|NCT02978326|559232282|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
154947133|NCT02978326|559232283|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
154947134|NCT02978326|559232284|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
154947135|NCT02978326|559232282|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
154947136|NCT02978326|559232283|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
154947137|NCT02978326|559232284|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
154947138|NCT02978326|559232282|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
154947139|NCT02978326|559232283|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
154947140|NCT02978326|559232284|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
154947141|NCT01862328|559232293|FG000|Overall Study|Progressive Disease|3|||
154947142|NCT01862328|559232294|FG001|Overall Study|Progressive Disease|11|||
154947143|NCT01862328|559232295|FG002|Overall Study|Progressive Disease|5|||
154947144|NCT01862328|559232296|FG003|Overall Study|Progressive Disease|6|||
154947145|NCT01862328|559232297|FG004|Overall Study|Progressive Disease|7|||
154947146|NCT01862328|559232298|FG005|Overall Study|Progressive Disease|4|||
154947147|NCT01862328|559232299|FG006|Overall Study|Progressive Disease|3|||
154947148|NCT01862328|559232293|FG000|Overall Study|Adverse Event|0|||
154947149|NCT01862328|559232294|FG001|Overall Study|Adverse Event|4|||
154947150|NCT01862328|559232295|FG002|Overall Study|Adverse Event|0|||
154947151|NCT01862328|559232296|FG003|Overall Study|Adverse Event|1|||
154947152|NCT01862328|559232297|FG004|Overall Study|Adverse Event|0|||
154947153|NCT01862328|559232298|FG005|Overall Study|Adverse Event|2|||
154947154|NCT01862328|559232299|FG006|Overall Study|Adverse Event|4|||
154947155|NCT01862328|559232293|FG000|Overall Study|Other|0|||
154947156|NCT01862328|559232294|FG001|Overall Study|Other|2|||
154947157|NCT01862328|559232295|FG002|Overall Study|Other|1|||
154947158|NCT01862328|559232296|FG003|Overall Study|Other|0|||
155049360|NCT00103285|559611998|FG007|Response Assignment|Physician Decision|35|||
154947159|NCT01862328|559232297|FG004|Overall Study|Other|4|||
154947160|NCT01862328|559232298|FG005|Overall Study|Other|0|||
154947161|NCT01862328|559232299|FG006|Overall Study|Other|1|||
154947162|NCT01862328|559232293|FG000|Overall Study|Withdrawal by Subject|1|||
154947163|NCT01862328|559232294|FG001|Overall Study|Withdrawal by Subject|1|||
154947164|NCT01862328|559232295|FG002|Overall Study|Withdrawal by Subject|0|||
155049361|NCT00103285|559611991|FG000|Response Assignment|Protocol Violation|0|||
155049362|NCT00103285|559611992|FG001|Response Assignment|Protocol Violation|2|||
155049363|NCT00103285|559611993|FG002|Response Assignment|Protocol Violation|0|||
155049364|NCT00103285|559611994|FG003|Response Assignment|Protocol Violation|0|||
155049365|NCT00103285|559611995|FG004|Response Assignment|Protocol Violation|0|||
155049366|NCT00103285|559611996|FG005|Response Assignment|Protocol Violation|0|||
155049367|NCT00103285|559611997|FG006|Response Assignment|Protocol Violation|0|||
155049368|NCT00103285|559611998|FG007|Response Assignment|Protocol Violation|0|||
155049369|NCT00103285|559611991|FG000|Response Assignment|Withdrawal by Subject|0|||
155049370|NCT00103285|559611992|FG001|Response Assignment|Withdrawal by Subject|4|||
155049371|NCT00103285|559611993|FG002|Response Assignment|Withdrawal by Subject|1|||
155049372|NCT00103285|559611994|FG003|Response Assignment|Withdrawal by Subject|1|||
155049373|NCT00103285|559611995|FG004|Response Assignment|Withdrawal by Subject|2|||
155049374|NCT00103285|559611996|FG005|Response Assignment|Withdrawal by Subject|2|||
155049375|NCT00103285|559611997|FG006|Response Assignment|Withdrawal by Subject|0|||
155049376|NCT00103285|559611998|FG007|Response Assignment|Withdrawal by Subject|2|||
155049377|NCT00103285|559611991|FG000|Response Assignment|Ineligible|0|||
155049378|NCT00103285|559611992|FG001|Response Assignment|Ineligible|8|||
155049379|NCT00103285|559611993|FG002|Response Assignment|Ineligible|6|||
155049380|NCT00103285|559611994|FG003|Response Assignment|Ineligible|2|||
155049381|NCT00103285|559611995|FG004|Response Assignment|Ineligible|0|||
155049382|NCT00103285|559611996|FG005|Response Assignment|Ineligible|3|||
155049383|NCT00103285|559611997|FG006|Response Assignment|Ineligible|1|||
155049384|NCT00103285|559611998|FG007|Response Assignment|Ineligible|5|||
155049385|NCT00103285|559611991|FG000|Response Assignment|Refusal|0|||
155049386|NCT00103285|559611992|FG001|Response Assignment|Refusal|53|||
155049387|NCT00103285|559611993|FG002|Response Assignment|Refusal|5|||
155049388|NCT00103285|559611994|FG003|Response Assignment|Refusal|3|||
155049389|NCT00103285|559611995|FG004|Response Assignment|Refusal|25|||
155049390|NCT00103285|559611996|FG005|Response Assignment|Refusal|15|||
155049391|NCT00103285|559611997|FG006|Response Assignment|Refusal|30|||
155049392|NCT00103285|559611998|FG007|Response Assignment|Refusal|10|||
155049393|NCT00103285|559611991|FG000|Response Assignment|Other|0|||
155049394|NCT00103285|559611992|FG001|Response Assignment|Other|30|||
155049395|NCT00103285|559611993|FG002|Response Assignment|Other|48|||
155049396|NCT00103285|559611994|FG003|Response Assignment|Other|38|||
155049397|NCT00103285|559611995|FG004|Response Assignment|Other|37|||
155049398|NCT00103285|559611996|FG005|Response Assignment|Other|17|||
155049399|NCT00103285|559611997|FG006|Response Assignment|Other|11|||
155049400|NCT00103285|559611998|FG007|Response Assignment|Other|53|||
155049401|NCT01971567|559612007|FG000|Overall Study|Withdrawal by Subject|3|||
155049402|NCT01971567|559612008|FG001|Overall Study|Withdrawal by Subject|2|||
155049403|NCT01971567|559612007|FG000|Overall Study|Lost to Follow-up|1|||
155049404|NCT01971567|559612008|FG001|Overall Study|Lost to Follow-up|0|||
155049405|NCT00391872|559612009|FG000|Overall Study|Protocol Violation|7|||
155049406|NCT00391872|559612010|FG001|Overall Study|Protocol Violation|2|||
155049407|NCT00391872|559612009|FG000|Overall Study|Withdrawal by Subject|296|||
155049408|NCT00391872|559612010|FG001|Overall Study|Withdrawal by Subject|249|||
155049409|NCT00391872|559612009|FG000|Overall Study|Reason unknown|2|||
155049410|NCT00391872|559612010|FG001|Overall Study|Reason unknown|4|||
155049411|NCT00391872|559612009|FG000|Overall Study|Lost to Follow-up|2|||
155049412|NCT00391872|559612010|FG001|Overall Study|Lost to Follow-up|0|||
155049413|NCT00524771|559612011|FG000|Overall Study|Protocol Violation|220|||
155049414|NCT00524771|559612012|FG001|Overall Study|Protocol Violation|585|||
155049415|NCT01957579|559612013|FG000|Overall Study|Withdrawal of concent|0|||
155049416|NCT01957579|559612014|FG001|Overall Study|Withdrawal of concent|1|||
155049417|NCT01957579|559612015|FG002|Overall Study|Withdrawal of concent|0|||
155049418|NCT01957579|559612016|FG003|Overall Study|Withdrawal of concent|0|||
155049419|NCT01957579|559612013|FG000|Overall Study|Death|0|||
155049420|NCT01957579|559612014|FG001|Overall Study|Death|0|||
155049421|NCT01957579|559612015|FG002|Overall Study|Death|2|||
155049422|NCT01957579|559612016|FG003|Overall Study|Death|0|||
155049423|NCT01000974|559612018|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
155281603|NCT04060680|560461671|FG001|Overall Study|Withdrawal by Subject|0|||
155281604|NCT05617040|560461672|FG000|Overall Study|Adverse Event|0|||
155049424|NCT01000974|559612019|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
155049425|NCT01000974|559612020|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
155049426|NCT01000974|559612018|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
155049427|NCT01000974|559612019|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
155049428|NCT01000974|559612020|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
155049429|NCT01000974|559612018|FG000|Primary Vaccination Phase|Protocol Violation|40|||
155049430|NCT01000974|559612019|FG001|Primary Vaccination Phase|Protocol Violation|3|||
155049431|NCT01000974|559612020|FG002|Primary Vaccination Phase|Protocol Violation|2|||
155049432|NCT01000974|559612018|FG000|Primary Vaccination Phase|Adverse Event|14|||
155049433|NCT01000974|559612019|FG001|Primary Vaccination Phase|Adverse Event|2|||
155049434|NCT01000974|559612020|FG002|Primary Vaccination Phase|Adverse Event|2|||
155049435|NCT01000974|559612018|FG000|Primary Vaccination Phase|Other|4|||
155049436|NCT01000974|559612019|FG001|Primary Vaccination Phase|Other|9|||
155388812|NCT02202551|560858713|FG002|Overall Study|Subject consent withdrawn|1|||
155388813|NCT02202551|560858714|FG003|Overall Study|Subject consent withdrawn|2|||
155388814|NCT02202551|560858711|FG000|Overall Study|eGFR<50mL/min/m2|2|||
155388815|NCT02202551|560858712|FG001|Overall Study|eGFR<50mL/min/m2|2|||
155388816|NCT02202551|560858713|FG002|Overall Study|eGFR<50mL/min/m2|0|||
155388817|NCT02202551|560858714|FG003|Overall Study|eGFR<50mL/min/m2|1|||
155388818|NCT02349451|560858715|FG000|Overall Study|Withdrawal by Subject|0|||
155388819|NCT02349451|560858716|FG001|Overall Study|Withdrawal by Subject|1|||
155388820|NCT02349451|560858717|FG002|Overall Study|Withdrawal by Subject|2|||
155388821|NCT02349451|560858718|FG003|Overall Study|Withdrawal by Subject|1|||
155388822|NCT02168842|560858719|FG000|Overall Study|Withdrawal by Subject|5|||
155388823|NCT02168842|560858720|FG001|Overall Study|Withdrawal by Subject|3|||
155388824|NCT02168842|560858719|FG000|Overall Study|Lost to Follow-up|0|||
155388825|NCT02168842|560858720|FG001|Overall Study|Lost to Follow-up|2|||
155388826|NCT02168842|560858719|FG000|Overall Study|Death|2|||
155388827|NCT02168842|560858720|FG001|Overall Study|Death|1|||
155388828|NCT02168842|560858719|FG000|Overall Study|Physician Decision|1|||
155388829|NCT02168842|560858720|FG001|Overall Study|Physician Decision|2|||
155388830|NCT02147353|560858721|FG000|Overall Study|Lost to Follow-up|2|||
155388831|NCT02147353|560858722|FG001|Overall Study|Lost to Follow-up|0|||
155388832|NCT02147353|560858721|FG000|Overall Study|unable to make visits|4|||
155388833|NCT02147353|560858722|FG001|Overall Study|unable to make visits|0|||
155388834|NCT02147353|560858721|FG000|Overall Study|medication noncompliance|3|||
155388835|NCT02147353|560858722|FG001|Overall Study|medication noncompliance|0|||
155388836|NCT01794923|560858738|FG000|Overall Study|Adverse Event|0|||
155388837|NCT01794923|560858739|FG001|Overall Study|Adverse Event|0|||
155388838|NCT01794923|560858740|FG002|Overall Study|Adverse Event|1|||
155388839|NCT01749540|560858741|FG000|Overall Study|Protocol Violation|0|||
155388840|NCT01749540|560858742|FG001|Overall Study|Protocol Violation|0|||
155388841|NCT01749540|560858743|FG002|Overall Study|Protocol Violation|0|||
155388842|NCT01749540|560858744|FG003|Overall Study|Protocol Violation|0|||
155388843|NCT01749540|560858745|FG004|Overall Study|Protocol Violation|0|||
155388844|NCT01749540|560858746|FG005|Overall Study|Protocol Violation|1|||
155388845|NCT01749540|560858747|FG006|Overall Study|Protocol Violation|1|||
155388846|NCT01749540|560858741|FG000|Overall Study|Withdrawal by Subject|0|||
155388847|NCT01749540|560858742|FG001|Overall Study|Withdrawal by Subject|0|||
155388848|NCT01749540|560858743|FG002|Overall Study|Withdrawal by Subject|0|||
155388849|NCT01749540|560858744|FG003|Overall Study|Withdrawal by Subject|1|||
155388850|NCT01749540|560858745|FG004|Overall Study|Withdrawal by Subject|0|||
155388851|NCT01749540|560858746|FG005|Overall Study|Withdrawal by Subject|0|||
155388852|NCT01749540|560858747|FG006|Overall Study|Withdrawal by Subject|0|||
155388853|NCT01749540|560858741|FG000|Overall Study|Initiated into extension study A536-06|0|||
155388854|NCT01749540|560858742|FG001|Overall Study|Initiated into extension study A536-06|0|||
155388855|NCT01749540|560858743|FG002|Overall Study|Initiated into extension study A536-06|0|||
155388856|NCT01749540|560858744|FG003|Overall Study|Initiated into extension study A536-06|0|||
155388857|NCT01749540|560858745|FG004|Overall Study|Initiated into extension study A536-06|0|||
155388858|NCT01749540|560858746|FG005|Overall Study|Initiated into extension study A536-06|2|||
155388859|NCT01749540|560858747|FG006|Overall Study|Initiated into extension study A536-06|24|||
155388860|NCT00576836|560858759|FG000|Overall Study|Death|0|||
155388861|NCT00576836|560858760|FG001|Overall Study|Death|1|||
155388862|NCT00576836|560858759|FG000|Overall Study|Physician Decision|0|||
155388863|NCT00576836|560858760|FG001|Overall Study|Physician Decision|1|||
155388864|NCT00894686|560858761|FG000|Overall Study|Withdrawal by Subject|50|||
155388865|NCT00894686|560858761|FG000|Overall Study|Physician Decision|1|||
155388866|NCT00894686|560858761|FG000|Overall Study|Other|5|||
155388867|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
155388868|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
155388869|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388870|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388871|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388872|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
155388873|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388874|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
155388875|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388876|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388877|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388878|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
155388879|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155388880|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
155388881|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155388882|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
155388883|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
154947165|NCT01862328|559232296|FG003|Overall Study|Withdrawal by Subject|0|||
154947166|NCT01862328|559232297|FG004|Overall Study|Withdrawal by Subject|1|||
154947167|NCT01862328|559232298|FG005|Overall Study|Withdrawal by Subject|1|||
154947168|NCT01862328|559232299|FG006|Overall Study|Withdrawal by Subject|1|||
154947169|NCT01862328|559232293|FG000|Overall Study|Symptomatic Deterioration|0|||
154947170|NCT01862328|559232294|FG001|Overall Study|Symptomatic Deterioration|0|||
154947171|NCT01862328|559232295|FG002|Overall Study|Symptomatic Deterioration|0|||
154947172|NCT01862328|559232296|FG003|Overall Study|Symptomatic Deterioration|0|||
154947173|NCT01862328|559232297|FG004|Overall Study|Symptomatic Deterioration|0|||
154947174|NCT01862328|559232298|FG005|Overall Study|Symptomatic Deterioration|0|||
154947175|NCT01862328|559232299|FG006|Overall Study|Symptomatic Deterioration|1|||
154947176|NCT03276975|559232300|FG000|Overall Study|Withdrawal by Subject|1|||
154947177|NCT03276975|559232301|FG001|Overall Study|Withdrawal by Subject|0|||
154947178|NCT01485536|559232304|FG000|Overall Study|Withdrawal by Subject|3|||
154947179|NCT01485536|559232304|FG000|Overall Study|Adverse Event|1|||
154947180|NCT00673790|559232305|FG000|Overall Study|Adverse Event|23|||
154947181|NCT00673790|559232306|FG001|Overall Study|Adverse Event|14|||
154947182|NCT00673790|559232307|FG002|Overall Study|Adverse Event|2|||
154947183|NCT00673790|559232305|FG000|Overall Study|Lack of Efficacy|2|||
154947184|NCT00673790|559232306|FG001|Overall Study|Lack of Efficacy|2|||
154947185|NCT00673790|559232307|FG002|Overall Study|Lack of Efficacy|2|||
154947186|NCT00673790|559232305|FG000|Overall Study|Protocol Violation|6|||
154947187|NCT00673790|559232306|FG001|Overall Study|Protocol Violation|9|||
154947188|NCT00673790|559232307|FG002|Overall Study|Protocol Violation|1|||
154947189|NCT00673790|559232305|FG000|Overall Study|Withdrawal by Subject|7|||
154947190|NCT00673790|559232306|FG001|Overall Study|Withdrawal by Subject|4|||
155281605|NCT05617040|560461673|FG001|Overall Study|Adverse Event|1|||
155281606|NCT05617040|560461674|FG002|Overall Study|Adverse Event|0|||
155281607|NCT05617040|560461672|FG000|Overall Study|Death|0|||
155281608|NCT05617040|560461673|FG001|Overall Study|Death|0|||
155281609|NCT05617040|560461674|FG002|Overall Study|Death|1|||
155281610|NCT02711826|560461675|FG000|Overall Study|Physician Decision|0|||
155281611|NCT02711826|560461676|FG001|Overall Study|Physician Decision|0|||
155281612|NCT02711826|560461677|FG002|Overall Study|Physician Decision|0|||
155281613|NCT02711826|560461678|FG003|Overall Study|Physician Decision|1|||
155281614|NCT02711826|560461679|FG004|Overall Study|Physician Decision|0|||
155281615|NCT02711826|560461675|FG000|Overall Study|Withdrawal by Subject|0|||
155281616|NCT02711826|560461676|FG001|Overall Study|Withdrawal by Subject|1|||
155281617|NCT02711826|560461677|FG002|Overall Study|Withdrawal by Subject|0|||
155281618|NCT02711826|560461678|FG003|Overall Study|Withdrawal by Subject|4|||
155281619|NCT02711826|560461679|FG004|Overall Study|Withdrawal by Subject|0|||
155281620|NCT02711826|560461675|FG000|Overall Study|Failure to manufacture cellular product|0|||
155281621|NCT02711826|560461676|FG001|Overall Study|Failure to manufacture cellular product|0|||
155281622|NCT02711826|560461677|FG002|Overall Study|Failure to manufacture cellular product|5|||
155281623|NCT02711826|560461678|FG003|Overall Study|Failure to manufacture cellular product|0|||
155281624|NCT02711826|560461679|FG004|Overall Study|Failure to manufacture cellular product|0|||
155281625|NCT02711826|560461675|FG000|Overall Study|Infusion canceled for active infection|0|||
155281626|NCT02711826|560461676|FG001|Overall Study|Infusion canceled for active infection|1|||
155281627|NCT02711826|560461677|FG002|Overall Study|Infusion canceled for active infection|0|||
155281628|NCT02711826|560461678|FG003|Overall Study|Infusion canceled for active infection|0|||
155281629|NCT02711826|560461679|FG004|Overall Study|Infusion canceled for active infection|0|||
155281630|NCT02711826|560461675|FG000|Overall Study|Screen failures|0|||
155281631|NCT02711826|560461676|FG001|Overall Study|Screen failures|0|||
155281632|NCT02711826|560461677|FG002|Overall Study|Screen failures|0|||
155281633|NCT02711826|560461678|FG003|Overall Study|Screen failures|4|||
155281634|NCT02711826|560461679|FG004|Overall Study|Screen failures|0|||
155281635|NCT00729690|560461680|FG000|Overall Study|IT Catheter Malfunction|0|||
155281636|NCT00729690|560461681|FG001|Overall Study|IT Catheter Malfunction|2|||
155281637|NCT00729690|560461682|FG002|Overall Study|IT Catheter Malfunction|2|||
155281638|NCT02169219|560461683|FG000|Overall Study|Lack of Efficacy|6|||
155281639|NCT02507219|560461687|FG000|Overall Study|Physician Decision|1|||
155281640|NCT02507219|560461688|FG001|Overall Study|Physician Decision|0|||
155281641|NCT02507219|560461689|FG002|Overall Study|Physician Decision|0|||
155281642|NCT02507219|560461690|FG003|Overall Study|Physician Decision|0|||
155281643|NCT02507219|560461691|FG004|Overall Study|Physician Decision|0|||
155281644|NCT02507219|560461692|FG005|Overall Study|Physician Decision|0|||
155281645|NCT02507219|560461687|FG000|Overall Study|Withdrawal by Subject|0|||
155388884|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
154947191|NCT00673790|559232307|FG002|Overall Study|Withdrawal by Subject|1|||
154947192|NCT00673790|559232305|FG000|Overall Study|Lost to Follow-up|6|||
154947193|NCT00673790|559232306|FG001|Overall Study|Lost to Follow-up|6|||
154947194|NCT00673790|559232307|FG002|Overall Study|Lost to Follow-up|5|||
154947195|NCT00673790|559232305|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
154947196|NCT00673790|559232306|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
155281646|NCT02507219|560461688|FG001|Overall Study|Withdrawal by Subject|0|||
155281647|NCT02507219|560461689|FG002|Overall Study|Withdrawal by Subject|0|||
155049437|NCT01000974|559612020|FG002|Primary Vaccination Phase|Other|12|||
155049438|NCT01000974|559612018|FG000|Booster Vaccination Phase|Protocol Violation|0|||
155049439|NCT01000974|559612019|FG001|Booster Vaccination Phase|Protocol Violation|0|||
155049440|NCT01000974|559612020|FG002|Booster Vaccination Phase|Protocol Violation|2|||
155049441|NCT01000974|559612018|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
155049442|NCT01000974|559612019|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
155049443|NCT01000974|559612020|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
155049444|NCT01000974|559612018|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
155049445|NCT01000974|559612019|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
155049446|NCT01000974|559612020|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
155049447|NCT01000974|559612018|FG000|Booster Vaccination Phase|Other|24|||
155049448|NCT01000974|559612019|FG001|Booster Vaccination Phase|Other|6|||
155049449|NCT01000974|559612020|FG002|Booster Vaccination Phase|Other|4|||
155049450|NCT03365934|559612021|FG000|Overall Study|Adverse Event|1|||
155049451|NCT03365934|559612021|FG000|Overall Study|Withdrawal by Subject|1|||
155049452|NCT02937740|559612023|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
155049453|NCT02937740|559612024|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
155049454|NCT02937740|559612023|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
155049455|NCT02937740|559612024|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
155049456|NCT02937740|559612023|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
155049457|NCT02937740|559612024|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
155049458|NCT02937740|559612023|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
155049459|NCT02937740|559612024|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
155049460|NCT02937740|559612023|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
155049461|NCT02937740|559612024|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
155049462|NCT02937740|559612023|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
155049463|NCT02937740|559612024|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
155049464|NCT02291029|559612028|FG000|Overall Study|Withdrawal by Subject|0|||
155049465|NCT02291029|559612029|FG001|Overall Study|Withdrawal by Subject|0|||
155049466|NCT02291029|559612030|FG002|Overall Study|Withdrawal by Subject|1|||
155049467|NCT02291029|559612031|FG003|Overall Study|Withdrawal by Subject|0|||
155049468|NCT02291029|559612032|FG004|Overall Study|Withdrawal by Subject|0|||
155049469|NCT02291029|559612033|FG005|Overall Study|Withdrawal by Subject|0|||
155049470|NCT02291029|559612028|FG000|Overall Study|Adverse Event|0|||
155049471|NCT02291029|559612029|FG001|Overall Study|Adverse Event|1|||
155049472|NCT02291029|559612030|FG002|Overall Study|Adverse Event|0|||
155049473|NCT02291029|559612031|FG003|Overall Study|Adverse Event|0|||
155049474|NCT02291029|559612032|FG004|Overall Study|Adverse Event|0|||
155049475|NCT02291029|559612033|FG005|Overall Study|Adverse Event|0|||
155049476|NCT00522548|559612035|FG000|Overall Study|Adverse Event|2|||
155049477|NCT00522548|559612036|FG001|Overall Study|Adverse Event|2|||
155049478|NCT00522548|559612035|FG000|Overall Study|Withdrawal by Subject|0|||
155049479|NCT00522548|559612036|FG001|Overall Study|Withdrawal by Subject|2|||
155049480|NCT03506438|559612037|FG000|Overall Study|Lost to Follow-up|8|||
155049481|NCT03506438|559612038|FG001|Overall Study|Lost to Follow-up|7|||
155049482|NCT03506438|559612039|FG002|Overall Study|Lost to Follow-up|8|||
155049483|NCT03506438|559612040|FG003|Overall Study|Lost to Follow-up|7|||
155049484|NCT03506438|559612041|FG004|Overall Study|Lost to Follow-up|0|||
155049485|NCT03506438|559612042|FG005|Overall Study|Lost to Follow-up|0|||
155049486|NCT01128296|559612043|FG000|Overall Study|Physician Decision|0|||
155049487|NCT01128296|559612044|FG001|Overall Study|Physician Decision|0|||
155049488|NCT01128296|559612045|FG002|Overall Study|Physician Decision|0|||
155049489|NCT01128296|559612046|FG003|Overall Study|Physician Decision|0|||
155049490|NCT01128296|559612047|FG004|Overall Study|Physician Decision|0|||
155049491|NCT01128296|559612048|FG005|Overall Study|Physician Decision|3|||
155049492|NCT01128296|559612043|FG000|Overall Study|Withdrawal by Subject|0|||
155049493|NCT01128296|559612044|FG001|Overall Study|Withdrawal by Subject|0|||
155049494|NCT01128296|559612045|FG002|Overall Study|Withdrawal by Subject|0|||
155049495|NCT01128296|559612046|FG003|Overall Study|Withdrawal by Subject|0|||
155049496|NCT01128296|559612047|FG004|Overall Study|Withdrawal by Subject|0|||
155049497|NCT01128296|559612048|FG005|Overall Study|Withdrawal by Subject|2|||
155049498|NCT04155463|559612049|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
155049499|NCT04155463|559612050|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
155049500|NCT00113295|559612051|FG000|Overall Study|Adverse Event|4|||
155049501|NCT00113295|559612052|FG001|Overall Study|Adverse Event|1|||
155049502|NCT00113295|559612051|FG000|Overall Study|Unrelated Medical Illness|1|||
155049503|NCT00113295|559612052|FG001|Overall Study|Unrelated Medical Illness|0|||
155049504|NCT01914393|559612053|FG000|Overall Study|Protocol Violation|11|||
155049505|NCT01914393|559612054|FG001|Overall Study|Protocol Violation|3|||
155049506|NCT01914393|559612055|FG002|Overall Study|Protocol Violation|19|||
155049507|NCT01914393|559612053|FG000|Overall Study|Lack of Efficacy|11|||
155049508|NCT01914393|559612054|FG001|Overall Study|Lack of Efficacy|16|||
155281648|NCT02507219|560461690|FG003|Overall Study|Withdrawal by Subject|0|||
155049509|NCT01914393|559612055|FG002|Overall Study|Lack of Efficacy|5|||
155049510|NCT01914393|559612053|FG000|Overall Study|no reason given|14|||
155049511|NCT01914393|559612054|FG001|Overall Study|no reason given|8|||
155049512|NCT01914393|559612055|FG002|Overall Study|no reason given|16|||
155049513|NCT01914393|559612053|FG000|Overall Study|Adverse Event|29|||
155049514|NCT01914393|559612054|FG001|Overall Study|Adverse Event|18|||
155049515|NCT01914393|559612055|FG002|Overall Study|Adverse Event|31|||
155049516|NCT01914393|559612053|FG000|Overall Study|Withdrawal by Subject|38|||
155049517|NCT01914393|559612054|FG001|Overall Study|Withdrawal by Subject|20|||
155049518|NCT01914393|559612055|FG002|Overall Study|Withdrawal by Subject|47|||
155049519|NCT01914393|559612053|FG000|Overall Study|Lost to Follow-up|12|||
155049520|NCT01914393|559612054|FG001|Overall Study|Lost to Follow-up|6|||
155049521|NCT01914393|559612055|FG002|Overall Study|Lost to Follow-up|19|||
155049522|NCT01914393|559612053|FG000|Overall Study|subject never dosed|0|||
155049523|NCT01914393|559612054|FG001|Overall Study|subject never dosed|0|||
155049524|NCT01914393|559612055|FG002|Overall Study|subject never dosed|1|||
155049525|NCT02806713|559612056|FG000|Overall Study|Urethral injury during procedure|1|||
155049526|NCT02806713|559612057|FG001|Overall Study|Urethral injury during procedure|0|||
155049527|NCT02806713|559612056|FG000|Overall Study|cancelled surgery|1|||
155049528|NCT02806713|559612057|FG001|Overall Study|cancelled surgery|2|||
155049529|NCT02999789|559612060|FG000|Overall Study|Withdrawal by Subject|0|||
155049530|NCT02999789|559612061|FG001|Overall Study|Withdrawal by Subject|1|||
155049531|NCT02999789|559612060|FG000|Overall Study|Became ineligible|1|||
155049532|NCT02999789|559612061|FG001|Overall Study|Became ineligible|2|||
155049533|NCT02824224|559612064|FG000|Overall Study|Discontinued, IUS expulsion|0|||
155049534|NCT02824224|559612065|FG001|Overall Study|Discontinued, IUS expulsion|1|||
155049535|NCT02824224|559612064|FG000|Overall Study|Did not show up for allocation visit|2|||
155049536|NCT02824224|559612065|FG001|Overall Study|Did not show up for allocation visit|0|||
155049537|NCT00368108|559612066|FG000|Overall Study|Adverse Event|38|||
155049538|NCT00368108|559612067|FG001|Overall Study|Adverse Event|26|||
155049539|NCT00368108|559612068|FG002|Overall Study|Adverse Event|44|||
155049540|NCT00368108|559612066|FG000|Overall Study|Abnormal Laboratory Value|0|||
155049541|NCT00368108|559612067|FG001|Overall Study|Abnormal Laboratory Value|0|||
155049542|NCT00368108|559612068|FG002|Overall Study|Abnormal Laboratory Value|3|||
155388885|NCT03267940|560858762|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
155388886|NCT03267940|560858763|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
155388887|NCT03267940|560858764|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388888|NCT03267940|560858765|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388889|NCT03267940|560858766|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388890|NCT03267940|560858767|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
155388891|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388892|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388893|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388894|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
155388895|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
155388896|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
155388897|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
155388898|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
155388899|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
155388900|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
155388901|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
155388902|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
155388903|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
155388904|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
155388905|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
155388906|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
155388907|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
155388908|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
155388909|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
155388910|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
155388911|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
155049543|NCT00368108|559612066|FG000|Overall Study|Protocol Violation|5|||
155049544|NCT00368108|559612067|FG001|Overall Study|Protocol Violation|9|||
155049545|NCT00368108|559612068|FG002|Overall Study|Protocol Violation|9|||
155388912|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
155388913|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
155388914|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
155049546|NCT00368108|559612066|FG000|Overall Study|Withdrawal by Subject|9|||
155049547|NCT00368108|559612067|FG001|Overall Study|Withdrawal by Subject|3|||
155049548|NCT00368108|559612068|FG002|Overall Study|Withdrawal by Subject|5|||
155049549|NCT00368108|559612066|FG000|Overall Study|Lack of Efficacy|7|||
155049550|NCT00368108|559612067|FG001|Overall Study|Lack of Efficacy|8|||
154947197|NCT00673790|559232307|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
154947198|NCT00673790|559232305|FG000|Overall Study|Poor compliance|1|||
154947199|NCT00673790|559232306|FG001|Overall Study|Poor compliance|0|||
154947200|NCT00673790|559232307|FG002|Overall Study|Poor compliance|0|||
154947201|NCT00673790|559232305|FG000|Overall Study|Participated in two Nebivolol studies|0|||
154947202|NCT00673790|559232306|FG001|Overall Study|Participated in two Nebivolol studies|0|||
154947203|NCT00673790|559232307|FG002|Overall Study|Participated in two Nebivolol studies|1|||
154947204|NCT00673790|559232305|FG000|Overall Study|Unconfirmed pregnancy|0|||
154947205|NCT00673790|559232306|FG001|Overall Study|Unconfirmed pregnancy|1|||
154947206|NCT00673790|559232307|FG002|Overall Study|Unconfirmed pregnancy|0|||
154947207|NCT00673790|559232305|FG000|Overall Study|Randomization criteria not met|0|||
154947208|NCT00673790|559232306|FG001|Overall Study|Randomization criteria not met|1|||
154947209|NCT00673790|559232307|FG002|Overall Study|Randomization criteria not met|0|||
154947210|NCT00306384|559232308|FG000|Overall Study|Adverse Event|103|||
154947211|NCT00306384|559232309|FG001|Overall Study|Adverse Event|87|||
154947212|NCT00306384|559232310|FG002|Overall Study|Adverse Event|40|||
154947213|NCT00306384|559232308|FG000|Overall Study|Major protocol deviation|43|||
154947214|NCT00306384|559232309|FG001|Overall Study|Major protocol deviation|51|||
154947215|NCT00306384|559232310|FG002|Overall Study|Major protocol deviation|18|||
154947216|NCT00306384|559232308|FG000|Overall Study|Lost to Follow-up|57|||
154947217|NCT00306384|559232309|FG001|Overall Study|Lost to Follow-up|41|||
154947218|NCT00306384|559232310|FG002|Overall Study|Lost to Follow-up|35|||
154947219|NCT00306384|559232308|FG000|Overall Study|Voluntary withdrawal|199|||
154947220|NCT00306384|559232309|FG001|Overall Study|Voluntary withdrawal|187|||
154947221|NCT00306384|559232310|FG002|Overall Study|Voluntary withdrawal|91|||
154947222|NCT00306384|559232308|FG000|Overall Study|Study termination|1|||
154947223|NCT00306384|559232309|FG001|Overall Study|Study termination|0|||
154947224|NCT00306384|559232310|FG002|Overall Study|Study termination|1|||
154947225|NCT00306384|559232308|FG000|Overall Study|Pregnancy|3|||
154947226|NCT00306384|559232309|FG001|Overall Study|Pregnancy|1|||
154947227|NCT00306384|559232310|FG002|Overall Study|Pregnancy|1|||
154947228|NCT00306384|559232308|FG000|Overall Study|Lack of Efficacy|26|||
154947229|NCT00306384|559232309|FG001|Overall Study|Lack of Efficacy|40|||
154947230|NCT00306384|559232310|FG002|Overall Study|Lack of Efficacy|38|||
154947231|NCT00306384|559232308|FG000|Overall Study|Investigator discretion|28|||
154947232|NCT00306384|559232309|FG001|Overall Study|Investigator discretion|31|||
154947233|NCT00306384|559232310|FG002|Overall Study|Investigator discretion|21|||
154947234|NCT00306384|559232308|FG000|Overall Study|Other|80|||
154947235|NCT00306384|559232309|FG001|Overall Study|Other|70|||
154947236|NCT00306384|559232310|FG002|Overall Study|Other|32|||
154947237|NCT00306384|559232308|FG000|Overall Study|Site closure|2|||
154947238|NCT00306384|559232309|FG001|Overall Study|Site closure|0|||
154947239|NCT00306384|559232310|FG002|Overall Study|Site closure|0|||
154947240|NCT00601484|559232311|FG000|Overall Study|Adverse Event|0|||
154947241|NCT00601484|559232312|FG001|Overall Study|Adverse Event|1|||
154947242|NCT00601484|559232311|FG000|Overall Study|Lost to Follow-up|4|||
154947243|NCT00601484|559232312|FG001|Overall Study|Lost to Follow-up|3|||
154947244|NCT00601484|559232311|FG000|Overall Study|Lack of Efficacy|0|||
154947245|NCT00601484|559232312|FG001|Overall Study|Lack of Efficacy|2|||
154947246|NCT00601484|559232311|FG000|Overall Study|Withdrawal by Subject|1|||
154947247|NCT00601484|559232312|FG001|Overall Study|Withdrawal by Subject|1|||
154947248|NCT00601484|559232311|FG000|Overall Study|Randomized, but not treated|0|||
154947249|NCT00601484|559232312|FG001|Overall Study|Randomized, but not treated|1|||
154947250|NCT03504852|559232313|FG000|Overall Study|Withdrawal of informed consent|2|||
154947251|NCT03504852|559232314|FG001|Overall Study|Withdrawal of informed consent|1|||
154947252|NCT03504852|559232315|FG002|Overall Study|Withdrawal of informed consent|0|||
154947253|NCT03504852|559232313|FG000|Overall Study|Withdrawal by Subject|5|||
154947254|NCT03504852|559232314|FG001|Overall Study|Withdrawal by Subject|5|||
154947255|NCT03504852|559232315|FG002|Overall Study|Withdrawal by Subject|1|||
154947256|NCT03504852|559232313|FG000|Overall Study|Lost to Follow-up|4|||
154947257|NCT03504852|559232314|FG001|Overall Study|Lost to Follow-up|1|||
155281649|NCT02507219|560461691|FG004|Overall Study|Withdrawal by Subject|1|||
154947258|NCT03504852|559232315|FG002|Overall Study|Lost to Follow-up|0|||
154947259|NCT03504852|559232313|FG000|Overall Study|New therapy for study indication|1|||
154947260|NCT03504852|559232314|FG001|Overall Study|New therapy for study indication|0|||
155281650|NCT02507219|560461692|FG005|Overall Study|Withdrawal by Subject|0|||
155281651|NCT02886936|560461693|FG000|Overall Study|Lost to Follow-up|4|||
155281652|NCT02886936|560461694|FG001|Overall Study|Lost to Follow-up|3|||
155281653|NCT02886936|560461695|FG002|Overall Study|Lost to Follow-up|0|||
155281654|NCT04562779|560461696|FG000|Overall Study|Lost to Follow-up|7|||
155281655|NCT04562779|560461697|FG001|Overall Study|Lost to Follow-up|5|||
155281656|NCT04562779|560461698|FG002|Overall Study|Lost to Follow-up|10|||
155281657|NCT04562779|560461696|FG000|Overall Study|Protocol Violation|2|||
155281658|NCT04562779|560461697|FG001|Overall Study|Protocol Violation|2|||
155281659|NCT04562779|560461698|FG002|Overall Study|Protocol Violation|0|||
155281660|NCT02320721|560461699|FG000|Overall Study|Adverse Event|6|||
155281661|NCT02320721|560461700|FG001|Overall Study|Adverse Event|6|||
155281662|NCT02320721|560461699|FG000|Overall Study|Lack of Efficacy|2|||
155049551|NCT00368108|559612068|FG002|Overall Study|Lack of Efficacy|5|||
155049552|NCT00368108|559612066|FG000|Overall Study|Physician Decision|2|||
155049553|NCT00368108|559612067|FG001|Overall Study|Physician Decision|0|||
155049554|NCT00368108|559612068|FG002|Overall Study|Physician Decision|1|||
155049555|NCT00368108|559612066|FG000|Overall Study|Other|3|||
155049556|NCT00368108|559612067|FG001|Overall Study|Other|7|||
155049557|NCT00368108|559612068|FG002|Overall Study|Other|1|||
155388915|NCT03267940|560858762|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
155388916|NCT03267940|560858763|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
155388917|NCT03267940|560858764|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
155388918|NCT03267940|560858765|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
155388919|NCT03267940|560858766|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
155388920|NCT03267940|560858767|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
155388921|NCT01074216|560858768|FG000|Overall Study|Physician Decision|1|||
155388922|NCT01074216|560858768|FG000|Overall Study|Not Treated|12|||
155388923|NCT01323634|560858769|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
155388924|NCT01323634|560858770|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
155388925|NCT01323634|560858771|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
155388926|NCT01323634|560858769|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
155388927|NCT01323634|560858770|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
155388928|NCT01323634|560858771|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
155388929|NCT01323634|560858769|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
155388930|NCT01323634|560858770|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155388931|NCT01323634|560858771|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155388932|NCT01323634|560858769|FG000|2-week Run-in Period|Physician Decision|5|||
155388933|NCT01323634|560858770|FG001|2-week Run-in Period|Physician Decision|0|||
155388934|NCT01323634|560858771|FG002|2-week Run-in Period|Physician Decision|0|||
155388935|NCT01323634|560858769|FG000|2-week Run-in Period|Protocol Violation|1|||
155388936|NCT01323634|560858770|FG001|2-week Run-in Period|Protocol Violation|0|||
155388937|NCT01323634|560858771|FG002|2-week Run-in Period|Protocol Violation|0|||
155388938|NCT01323634|560858769|FG000|2-week Run-in Period|Adverse Event|1|||
155388939|NCT01323634|560858770|FG001|2-week Run-in Period|Adverse Event|0|||
155388940|NCT01323634|560858771|FG002|2-week Run-in Period|Adverse Event|0|||
155388941|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
155388942|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
155388943|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
155388944|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155388945|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155388946|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
155388947|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154947261|NCT03504852|559232315|FG002|Overall Study|New therapy for study indication|0|||
154947262|NCT03504852|559232313|FG000|Overall Study|Lack of Efficacy|1|||
154947263|NCT03504852|559232314|FG001|Overall Study|Lack of Efficacy|2|||
154947264|NCT03504852|559232315|FG002|Overall Study|Lack of Efficacy|0|||
154947265|NCT03504852|559232313|FG000|Overall Study|Death|0|||
154947266|NCT03504852|559232314|FG001|Overall Study|Death|1|||
154947267|NCT03504852|559232315|FG002|Overall Study|Death|0|||
154947268|NCT03504852|559232313|FG000|Overall Study|Adverse Event|4|||
154947269|NCT03504852|559232314|FG001|Overall Study|Adverse Event|8|||
154947270|NCT03504852|559232315|FG002|Overall Study|Adverse Event|2|||
154947271|NCT02928848|559232316|FG000|Arm 2|Withdrawal by Subject|1|||
154947272|NCT02928848|559232317|FG001|Arm 2|Withdrawal by Subject|0|||
154947273|NCT00969332|559232318|FG000|Overall Study|Physician Decision|8|||
154947274|NCT00969332|559232318|FG000|Overall Study|Withdrawal by Subject|3|||
154947275|NCT00576199|559232319|FG000|Overall Study|Adverse Event|12|||
154947276|NCT00576199|559232319|FG000|Overall Study|Insufficient Therapeutic Response|14|||
154947277|NCT00576199|559232319|FG000|Overall Study|Refused Treatment|2|||
154947278|NCT00576199|559232319|FG000|Overall Study|Reason Unspecified|2|||
154947279|NCT00663871|559232320|FG000|Overall Study|Lost to Follow-up|5|||
154947280|NCT00663871|559232321|FG001|Overall Study|Lost to Follow-up|5|||
154947281|NCT00663871|559232320|FG000|Overall Study|Withdrawal by Subject|5|||
154947282|NCT00663871|559232321|FG001|Overall Study|Withdrawal by Subject|2|||
154947283|NCT00582309|559232324|FG000|Overall Study|Protocol Violation|0|||
155049558|NCT02299388|559612075|FG000|Overall Study|Withdrawal by Subject|0|||
155388948|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
155388949|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
155388950|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155388951|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
154947284|NCT00582309|559232325|FG001|Overall Study|Protocol Violation|0|||
154947285|NCT00582309|559232326|FG002|Overall Study|Protocol Violation|2|||
155049559|NCT02299388|559612076|FG001|Overall Study|Withdrawal by Subject|1|||
155049560|NCT03334188|559612079|FG000|Overall Study|Withdrawal by Subject|0|||
154947286|NCT03922477|559232327|FG000|Overall Study|Death|9|||
154947287|NCT03922477|559232327|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
154947288|NCT03922477|559232327|FG000|Overall Study|Physician Decision|1|||
155049561|NCT03334188|559612080|FG001|Overall Study|Withdrawal by Subject|1|||
155049562|NCT03334188|559612079|FG000|Overall Study|Death|1|||
155049563|NCT03334188|559612080|FG001|Overall Study|Death|0|||
155049564|NCT03334188|559612079|FG000|Overall Study|Never had qualifying clinic visit|7|||
155049565|NCT03334188|559612080|FG001|Overall Study|Never had qualifying clinic visit|7|||
155049566|NCT01093586|559612085|FG000|Overall Study|Failed to engraft|3|||
155049567|NCT03442088|559612086|FG000|Overall Study|Adverse Event|1|||
155049568|NCT03442088|559612086|FG000|Overall Study|Lack of Efficacy|2|||
155049569|NCT03442088|559612086|FG000|Overall Study|Lost to Follow-up|2|||
155049570|NCT01001520|559612087|FG000|Medication Period 1|Withdrawal by Subject|2|||
155049571|NCT01001520|559612088|FG001|Medication Period 1|Withdrawal by Subject|2|||
155049572|NCT01001520|559612087|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
155049573|NCT01001520|559612088|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
155049574|NCT01001520|559612087|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
155049575|NCT01001520|559612088|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
155049576|NCT01001520|559612087|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
155049577|NCT01001520|559612088|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
155049578|NCT01001520|559612087|FG000|Washout Period|Withdrawal by Subject|2|||
155049579|NCT01001520|559612088|FG001|Washout Period|Withdrawal by Subject|1|||
155049580|NCT01001520|559612087|FG000|Medication Period 2|Withdrawal by Subject|0|||
155049581|NCT01001520|559612088|FG001|Medication Period 2|Withdrawal by Subject|3|||
155049582|NCT00357877|559612089|FG000|Overall Study|Death|2|||
155049583|NCT00357877|559612090|FG001|Overall Study|Death|1|||
155049584|NCT00357877|559612089|FG000|Overall Study|Lost to Follow-up|20|||
155049585|NCT00357877|559612090|FG001|Overall Study|Lost to Follow-up|23|||
155049586|NCT00357877|559612089|FG000|Overall Study|Withdrawal by Subject|3|||
155049587|NCT00357877|559612090|FG001|Overall Study|Withdrawal by Subject|3|||
155049588|NCT00357877|559612089|FG000|Overall Study|Administrative withdrawal|1|||
155049589|NCT00357877|559612090|FG001|Overall Study|Administrative withdrawal|1|||
155049590|NCT00357877|559612089|FG000|Overall Study|Other|0|||
155049591|NCT00357877|559612090|FG001|Overall Study|Other|2|||
155049592|NCT01051557|559612093|FG000|Overall Study|Physician Decision|1|||
155049593|NCT01051557|559612094|FG001|Overall Study|Physician Decision|0|||
155049594|NCT01051557|559612095|FG002|Overall Study|Physician Decision|0|||
155049595|NCT01051557|559612096|FG003|Overall Study|Physician Decision|0|||
155049596|NCT01051557|559612097|FG004|Overall Study|Physician Decision|0|||
155049597|NCT01051557|559612098|FG005|Overall Study|Physician Decision|0|||
155049598|NCT01051557|559612099|FG006|Overall Study|Physician Decision|0|||
155049599|NCT01051557|559612093|FG000|Overall Study|disease progression|3|||
155049600|NCT01051557|559612094|FG001|Overall Study|disease progression|3|||
155049601|NCT01051557|559612095|FG002|Overall Study|disease progression|5|||
155049602|NCT01051557|559612096|FG003|Overall Study|disease progression|2|||
155049603|NCT01051557|559612097|FG004|Overall Study|disease progression|4|||
155049604|NCT01051557|559612098|FG005|Overall Study|disease progression|3|||
155049605|NCT01051557|559612099|FG006|Overall Study|disease progression|1|||
155049606|NCT01051557|559612093|FG000|Overall Study|Withdrawal by Subject|0|||
155049607|NCT01051557|559612094|FG001|Overall Study|Withdrawal by Subject|0|||
155049608|NCT01051557|559612095|FG002|Overall Study|Withdrawal by Subject|1|||
155049609|NCT01051557|559612096|FG003|Overall Study|Withdrawal by Subject|0|||
155049610|NCT01051557|559612097|FG004|Overall Study|Withdrawal by Subject|2|||
155049611|NCT01051557|559612098|FG005|Overall Study|Withdrawal by Subject|0|||
155049612|NCT01051557|559612099|FG006|Overall Study|Withdrawal by Subject|1|||
155049613|NCT01051557|559612093|FG000|Overall Study|Adverse Event|0|||
155049614|NCT01051557|559612094|FG001|Overall Study|Adverse Event|0|||
155049615|NCT01051557|559612095|FG002|Overall Study|Adverse Event|0|||
155049616|NCT01051557|559612096|FG003|Overall Study|Adverse Event|1|||
155049617|NCT01051557|559612097|FG004|Overall Study|Adverse Event|1|||
155049618|NCT01051557|559612098|FG005|Overall Study|Adverse Event|3|||
155049619|NCT01051557|559612099|FG006|Overall Study|Adverse Event|4|||
155049620|NCT04668209|559612100|FG000|Overall Study|Withdrawal by Subject|2|||
155049621|NCT04668209|559612101|FG001|Overall Study|Withdrawal by Subject|2|||
155049622|NCT04668209|559612100|FG000|Overall Study|Lost to Follow-up|3|||
155049623|NCT04668209|559612101|FG001|Overall Study|Lost to Follow-up|4|||
155049624|NCT04668209|559612100|FG000|Overall Study|Subject Expired|2|||
155049625|NCT04668209|559612101|FG001|Overall Study|Subject Expired|0|||
155049626|NCT04668209|559612100|FG000|Overall Study|Withdrawn from study|0|||
155049627|NCT04668209|559612101|FG001|Overall Study|Withdrawn from study|1|||
155049628|NCT04668209|559612100|FG000|Overall Study|Adverse Event|0|||
155049629|NCT04668209|559612101|FG001|Overall Study|Adverse Event|1|||
155049630|NCT00613366|559612108|FG000|Overall Study|Withdrawal by Subject|3|||
155049631|NCT00613366|559612109|FG001|Overall Study|Withdrawal by Subject|2|||
155388952|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155049632|NCT02907463|559612110|FG000|Overall Study|Lost to Follow-up|17|||
155049633|NCT02907463|559612110|FG000|Overall Study|Death|10|||
155049634|NCT02907463|559612110|FG000|Overall Study|Withdrawal by Subject|4|||
155049635|NCT02907463|559612110|FG000|Overall Study|MIS Approach was not used|2|||
155049636|NCT02907463|559612110|FG000|Overall Study|Not Implanted with Study Device|2|||
155049637|NCT02907463|559612110|FG000|Overall Study|Device Explanted|1|||
155049638|NCT02907463|559612110|FG000|Overall Study|Missing Exit Form|1|||
155049639|NCT01447407|559612113|FG000|Overall Study|Withdrawal by Subject|2|||
155049640|NCT01447407|559612114|FG001|Overall Study|Withdrawal by Subject|0|||
155049641|NCT01447407|559612115|FG002|Overall Study|Withdrawal by Subject|0|||
155049642|NCT01447407|559612116|FG003|Overall Study|Withdrawal by Subject|1|||
155049643|NCT01447407|559612113|FG000|Overall Study|Physician Decision|0|||
155049644|NCT01447407|559612114|FG001|Overall Study|Physician Decision|0|||
155049645|NCT01447407|559612115|FG002|Overall Study|Physician Decision|1|||
155049646|NCT01447407|559612116|FG003|Overall Study|Physician Decision|1|||
155049647|NCT00268983|559612117|FG000|Overall Study|Death|3|||
155049648|NCT00268983|559612118|FG001|Overall Study|Death|0|||
155049649|NCT02532374|559612121|FG000|Overall Study|Withdrawal by Subject|1|||
155049650|NCT02532374|559612121|FG000|Overall Study|Physician Decision|1|||
155049651|NCT01348139|559612122|FG000|Period 1|Adverse Event|1|||
155049652|NCT01348139|559612123|FG001|Period 1|Adverse Event|0|||
155049653|NCT01348139|559612124|FG002|Period 1|Adverse Event|0|||
155049654|NCT01348139|559612125|FG003|Period 1|Adverse Event|0|||
155049655|NCT01348139|559612126|FG004|Period 1|Adverse Event|0|||
155049656|NCT01348139|559612127|FG005|Period 1|Adverse Event|0|||
155049657|NCT02762084|559612130|FG000|Overall Study|Withdrawal by Subject|1|||
155049658|NCT02762084|559612131|FG001|Overall Study|Withdrawal by Subject|0|||
155049659|NCT02762084|559612132|FG002|Overall Study|Withdrawal by Subject|0|||
155049660|NCT02762084|559612130|FG000|Overall Study|Adverse Event|0|||
155049661|NCT02762084|559612131|FG001|Overall Study|Adverse Event|0|||
155049662|NCT02762084|559612132|FG002|Overall Study|Adverse Event|1|||
155049663|NCT03006562|559612133|FG000|Overall Study|Lost to Follow-up|0|||
155049664|NCT03006562|559612134|FG001|Overall Study|Lost to Follow-up|1|||
155049665|NCT02427841|559612143|FG000|Overall Study|Lack of Efficacy|5|||
155049666|NCT02427841|559612143|FG000|Overall Study|Physician Decision|2|||
155049667|NCT02427841|559612143|FG000|Overall Study|Withdrawal by Subject|1|||
155049668|NCT01765296|559612144|FG000|Overall Study|Protocol Violation|0|||
155049669|NCT01765296|559612145|FG001|Overall Study|Protocol Violation|5|||
155049670|NCT01765296|559612146|FG002|Overall Study|Protocol Violation|4|||
155049671|NCT01765296|559612144|FG000|Overall Study|Withdrawal by Subject|4|||
155049672|NCT01765296|559612145|FG001|Overall Study|Withdrawal by Subject|2|||
155049673|NCT01765296|559612146|FG002|Overall Study|Withdrawal by Subject|2|||
155049674|NCT01765296|559612144|FG000|Overall Study|Adverse Event|1|||
155049675|NCT01765296|559612145|FG001|Overall Study|Adverse Event|13|||
155049676|NCT01765296|559612146|FG002|Overall Study|Adverse Event|5|||
155049677|NCT01765296|559612144|FG000|Overall Study|Lack of Efficacy|0|||
155049678|NCT01765296|559612145|FG001|Overall Study|Lack of Efficacy|0|||
155049679|NCT01765296|559612146|FG002|Overall Study|Lack of Efficacy|2|||
155049680|NCT03257436|559612147|FG000|Overall Study|Withdrawal by Subject|76|||
155049681|NCT03257436|559612147|FG000|Overall Study|Death|19|||
155049682|NCT01619852|559612148|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
155049683|NCT01619852|559612149|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
155049684|NCT01619852|559612148|FG000|3 Month Follow up|Lost to Follow-up|31|||
155049685|NCT01619852|559612149|FG001|3 Month Follow up|Lost to Follow-up|34|||
155049686|NCT00970489|559612150|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
155049687|NCT00970489|559612151|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
155049688|NCT02659943|559612152|FG000|Overall Study|Switched to alternative treatment|1|||
155281663|NCT02320721|560461700|FG001|Overall Study|Lack of Efficacy|0|||
155281664|NCT02320721|560461699|FG000|Overall Study|Poor compliance to protocol|3|||
155281665|NCT02320721|560461700|FG001|Overall Study|Poor compliance to protocol|7|||
155281666|NCT02320721|560461699|FG000|Overall Study|Randomized but not treated|0|||
155281667|NCT02320721|560461700|FG001|Overall Study|Randomized but not treated|1|||
155281668|NCT02320721|560461699|FG000|Overall Study|Hypoglycemia|1|||
155281669|NCT02320721|560461700|FG001|Overall Study|Hypoglycemia|0|||
155281670|NCT02320721|560461699|FG000|Overall Study|Other than specified above|15|||
155281671|NCT02320721|560461700|FG001|Overall Study|Other than specified above|20|||
155281672|NCT03173248|560461701|FG000|Overall Study|Death|28|||
155281673|NCT03173248|560461702|FG001|Overall Study|Death|46|||
155281674|NCT03173248|560461701|FG000|Overall Study|Lost to Follow-up|0|||
155281675|NCT03173248|560461702|FG001|Overall Study|Lost to Follow-up|1|||
155281676|NCT03173248|560461701|FG000|Overall Study|Withdrawal by Subject|6|||
155281677|NCT03173248|560461702|FG001|Overall Study|Withdrawal by Subject|4|||
155281678|NCT03173248|560461701|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
155281679|NCT03173248|560461702|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
155281680|NCT01544582|560461703|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
155281681|NCT01544582|560461704|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
155281682|NCT01544582|560461705|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
155281683|NCT01544582|560461706|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
155281684|NCT01544582|560461703|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
155281685|NCT01544582|560461704|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
155281686|NCT01544582|560461705|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
155281687|NCT01544582|560461706|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
155388953|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
155388954|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
155388955|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
155388956|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155388957|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
155388958|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
154947289|NCT03922477|559232327|FG000|Overall Study|Withdrawal by Subject|2|||
154947290|NCT03111147|559232331|FG000|Overall Study|Lost to Follow-up|2|||
154947291|NCT03111147|559232332|FG001|Overall Study|Lost to Follow-up|5|||
154947292|NCT03111147|559232331|FG000|Overall Study|Withdrawal by Subject|4|||
154947293|NCT03111147|559232332|FG001|Overall Study|Withdrawal by Subject|3|||
154947294|NCT03111147|559232331|FG000|Overall Study|Protocol Violation|2|||
154947295|NCT03111147|559232332|FG001|Overall Study|Protocol Violation|1|||
154947296|NCT03111147|559232331|FG000|Overall Study|Death|1|||
154947297|NCT03111147|559232332|FG001|Overall Study|Death|1|||
154947298|NCT01463683|559232333|FG000|Overall Study|Adverse Event|2|||
154947299|NCT01463683|559232334|FG001|Overall Study|Adverse Event|0|||
154947300|NCT01463683|559232335|FG002|Overall Study|Adverse Event|0|||
154947301|NCT01463683|559232333|FG000|Overall Study|Lost to Follow-up|10|||
154947302|NCT01463683|559232334|FG001|Overall Study|Lost to Follow-up|9|||
154947303|NCT01463683|559232335|FG002|Overall Study|Lost to Follow-up|7|||
154947304|NCT01463683|559232333|FG000|Overall Study|Physician Decision|0|||
154947305|NCT01463683|559232334|FG001|Overall Study|Physician Decision|3|||
154947306|NCT01463683|559232335|FG002|Overall Study|Physician Decision|1|||
154947307|NCT01463683|559232333|FG000|Overall Study|Pregnancy|2|||
154947308|NCT01463683|559232334|FG001|Overall Study|Pregnancy|2|||
154947309|NCT01463683|559232335|FG002|Overall Study|Pregnancy|1|||
154947310|NCT01463683|559232333|FG000|Overall Study|Withdrawal by Subject|5|||
154947311|NCT01463683|559232334|FG001|Overall Study|Withdrawal by Subject|17|||
154947312|NCT01463683|559232335|FG002|Overall Study|Withdrawal by Subject|2|||
154947313|NCT03384745|559232338|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
154947314|NCT03384745|559232339|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
154947315|NCT03384745|559232340|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
154947316|NCT03384745|559232341|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
154947317|NCT03384745|559232342|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
154947318|NCT03384745|559232343|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
154947319|NCT03384745|559232338|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
154947320|NCT03384745|559232339|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
154947321|NCT03384745|559232340|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
154947322|NCT03384745|559232341|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
154947323|NCT03384745|559232342|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
154947324|NCT03384745|559232343|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
154947325|NCT03384745|559232338|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
154947326|NCT03384745|559232339|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
154947327|NCT03384745|559232340|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
154947328|NCT03384745|559232341|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
154947329|NCT03384745|559232342|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
154947330|NCT03384745|559232343|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
154947331|NCT03384745|559232338|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
154947332|NCT03384745|559232339|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
154947333|NCT03384745|559232340|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
154947334|NCT03384745|559232341|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
154947335|NCT03384745|559232342|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
154947336|NCT03384745|559232343|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
154947337|NCT03384745|559232338|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
154947338|NCT03384745|559232339|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
154947339|NCT03384745|559232340|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
154947340|NCT03384745|559232341|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
154947341|NCT03384745|559232342|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
154947342|NCT03384745|559232343|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
154947343|NCT03384745|559232338|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
154947344|NCT03384745|559232339|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
154947345|NCT03384745|559232340|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
155388959|NCT01323634|560858769|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
154947346|NCT03384745|559232341|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
154947347|NCT03384745|559232342|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
154947348|NCT03384745|559232343|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
154947349|NCT03384745|559232338|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
154947350|NCT03384745|559232339|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
154947351|NCT03384745|559232340|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
154947352|NCT03384745|559232341|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
154947353|NCT03384745|559232342|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
154947354|NCT03384745|559232343|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
154947355|NCT03384745|559232338|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
154947356|NCT03384745|559232339|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
154947357|NCT03384745|559232340|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
154947358|NCT03384745|559232341|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
154947359|NCT03384745|559232342|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
154947360|NCT03384745|559232343|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
154947361|NCT03384745|559232338|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
154947362|NCT03384745|559232339|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
154947363|NCT03384745|559232340|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
154947364|NCT03384745|559232341|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
154947365|NCT03384745|559232342|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
154947366|NCT03384745|559232343|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
154947367|NCT03384745|559232338|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
154947368|NCT03384745|559232339|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
154947369|NCT03384745|559232340|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
154947370|NCT03384745|559232341|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
154947371|NCT03384745|559232342|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
154947372|NCT03384745|559232343|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
154947373|NCT03384745|559232338|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
154947374|NCT03384745|559232339|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
154947375|NCT03384745|559232340|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
154947376|NCT03384745|559232341|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
154947377|NCT03384745|559232342|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
154947378|NCT03384745|559232343|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
154947379|NCT01058421|559232344|FG000|1 Month Outcomes|Death|10|||
154947380|NCT01058421|559232345|FG001|1 Month Outcomes|Death|6|||
154947381|NCT01058421|559232344|FG000|1 Month Outcomes|Lost to Follow-up|8|||
154947382|NCT01058421|559232345|FG001|1 Month Outcomes|Lost to Follow-up|7|||
154947383|NCT01058421|559232344|FG000|1 Month Outcomes|Remained in Hospital|5|||
154947384|NCT01058421|559232345|FG001|1 Month Outcomes|Remained in Hospital|12|||
154947385|NCT01058421|559232344|FG000|1 Month Outcomes|Remained in Other Facility|16|||
154947386|NCT01058421|559232345|FG001|1 Month Outcomes|Remained in Other Facility|17|||
154947387|NCT01058421|559232344|FG000|3 Month Outcomes|Death|3|||
154947388|NCT01058421|559232345|FG001|3 Month Outcomes|Death|5|||
154947389|NCT01058421|559232344|FG000|3 Month Outcomes|Lost to Follow-up|12|||
154947390|NCT01058421|559232345|FG001|3 Month Outcomes|Lost to Follow-up|11|||
154947391|NCT01058421|559232344|FG000|3 Month Outcomes|Remained in Hospital|0|||
154947392|NCT01058421|559232345|FG001|3 Month Outcomes|Remained in Hospital|2|||
154947393|NCT01058421|559232344|FG000|3 Month Outcomes|Remained in Other Facility|5|||
154947394|NCT01058421|559232345|FG001|3 Month Outcomes|Remained in Other Facility|8|||
154947395|NCT01058421|559232344|FG000|6 Month Outcomes|Death|2|||
154947396|NCT01058421|559232345|FG001|6 Month Outcomes|Death|2|||
154947397|NCT01058421|559232344|FG000|6 Month Outcomes|Lost to Follow-up|16|||
154947398|NCT01058421|559232345|FG001|6 Month Outcomes|Lost to Follow-up|21|||
154947399|NCT01058421|559232344|FG000|6 Month Outcomes|Remained in Other Facility|1|||
154947400|NCT01058421|559232345|FG001|6 Month Outcomes|Remained in Other Facility|3|||
154947401|NCT02984683|559232346|FG000|Overall Study|Adverse Event|3|||
154947402|NCT02984683|559232347|FG001|Overall Study|Adverse Event|3|||
154947403|NCT02984683|559232346|FG000|Overall Study|Withdrawal by Subject|1|||
154947404|NCT02984683|559232347|FG001|Overall Study|Withdrawal by Subject|0|||
154947405|NCT02984683|559232346|FG000|Overall Study|Disease progression|7|||
154947406|NCT02984683|559232347|FG001|Overall Study|Disease progression|9|||
154947407|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
154947408|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
154947409|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
154947410|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
154947411|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
154947412|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
154947413|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
154947414|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
154947415|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
154947416|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
154947417|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
154947418|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
155049689|NCT02659943|559612153|FG001|Overall Study|Switched to alternative treatment|1|||
155049690|NCT02659943|559612154|FG002|Overall Study|Switched to alternative treatment|0|||
155049691|NCT02659943|559612155|FG003|Overall Study|Switched to alternative treatment|2|||
155049692|NCT02659943|559612156|FG004|Overall Study|Switched to alternative treatment|1|||
155049693|NCT02659943|559612157|FG005|Overall Study|Switched to alternative treatment|0|||
155049694|NCT02659943|559612158|FG006|Overall Study|Switched to alternative treatment|1|||
155049695|NCT02659943|559612152|FG000|Overall Study|Disease progression on study|0|||
155049696|NCT02659943|559612153|FG001|Overall Study|Disease progression on study|1|||
155049697|NCT02659943|559612154|FG002|Overall Study|Disease progression on study|1|||
155049698|NCT02659943|559612155|FG003|Overall Study|Disease progression on study|1|||
155049699|NCT02659943|559612156|FG004|Overall Study|Disease progression on study|1|||
155049700|NCT02659943|559612157|FG005|Overall Study|Disease progression on study|4|||
155049701|NCT02659943|559612158|FG006|Overall Study|Disease progression on study|0|||
155049702|NCT02659943|559612152|FG000|Overall Study|Patient's condition per principal investigator|0|||
155049703|NCT02659943|559612153|FG001|Overall Study|Patient's condition per principal investigator|0|||
155049704|NCT02659943|559612154|FG002|Overall Study|Patient's condition per principal investigator|0|||
155049705|NCT02659943|559612155|FG003|Overall Study|Patient's condition per principal investigator|0|||
155049706|NCT02659943|559612156|FG004|Overall Study|Patient's condition per principal investigator|0|||
155049707|NCT02659943|559612157|FG005|Overall Study|Patient's condition per principal investigator|1|||
155049708|NCT02659943|559612158|FG006|Overall Study|Patient's condition per principal investigator|0|||
155049709|NCT02659943|559612152|FG000|Overall Study|Ineligible|0|||
155049710|NCT02659943|559612153|FG001|Overall Study|Ineligible|0|||
155049711|NCT02659943|559612154|FG002|Overall Study|Ineligible|0|||
155049712|NCT02659943|559612155|FG003|Overall Study|Ineligible|0|||
155049713|NCT02659943|559612156|FG004|Overall Study|Ineligible|0|||
155049714|NCT02659943|559612157|FG005|Overall Study|Ineligible|0|||
155049715|NCT02659943|559612158|FG006|Overall Study|Ineligible|1|||
155049716|NCT02659943|559612152|FG000|Overall Study|No longer meets eligibility|0|||
155049717|NCT02659943|559612153|FG001|Overall Study|No longer meets eligibility|0|||
155049718|NCT02659943|559612154|FG002|Overall Study|No longer meets eligibility|0|||
155049719|NCT02659943|559612155|FG003|Overall Study|No longer meets eligibility|0|||
155049720|NCT02659943|559612156|FG004|Overall Study|No longer meets eligibility|0|||
155049721|NCT02659943|559612157|FG005|Overall Study|No longer meets eligibility|0|||
155049722|NCT02659943|559612158|FG006|Overall Study|No longer meets eligibility|1|||
155049723|NCT02659943|559612152|FG000|Overall Study|No treatment, per protocol|0|||
155049724|NCT02659943|559612153|FG001|Overall Study|No treatment, per protocol|0|||
155049725|NCT02659943|559612154|FG002|Overall Study|No treatment, per protocol|0|||
155049726|NCT02659943|559612155|FG003|Overall Study|No treatment, per protocol|0|||
155049727|NCT02659943|559612156|FG004|Overall Study|No treatment, per protocol|0|||
155049728|NCT02659943|559612157|FG005|Overall Study|No treatment, per protocol|0|||
155049729|NCT02659943|559612158|FG006|Overall Study|No treatment, per protocol|3|||
155049730|NCT01096160|559612159|FG000|Overall Study|Adverse Event|0|||
155049731|NCT01096160|559612160|FG001|Overall Study|Adverse Event|0|||
155049732|NCT01096160|559612161|FG002|Overall Study|Adverse Event|1|||
155049733|NCT01096160|559612162|FG003|Overall Study|Adverse Event|0|||
155049734|NCT01096160|559612163|FG004|Overall Study|Adverse Event|0|||
155049735|NCT01096160|559612164|FG005|Overall Study|Adverse Event|0|||
155049736|NCT01096160|559612165|FG006|Overall Study|Adverse Event|0|||
155049737|NCT01096160|559612166|FG007|Overall Study|Adverse Event|0|||
155049738|NCT01096160|559612167|FG008|Overall Study|Adverse Event|0|||
155049739|NCT01096160|559612168|FG009|Overall Study|Adverse Event|1|||
155049740|NCT01096160|559612159|FG000|Overall Study|Met stopping criteria per protocol|0|||
155049741|NCT01096160|559612160|FG001|Overall Study|Met stopping criteria per protocol|0|||
155049742|NCT01096160|559612161|FG002|Overall Study|Met stopping criteria per protocol|0|||
155049743|NCT01096160|559612162|FG003|Overall Study|Met stopping criteria per protocol|0|||
155049744|NCT01096160|559612163|FG004|Overall Study|Met stopping criteria per protocol|1|||
155049745|NCT01096160|559612164|FG005|Overall Study|Met stopping criteria per protocol|0|||
155049746|NCT01096160|559612165|FG006|Overall Study|Met stopping criteria per protocol|2|||
155049747|NCT01096160|559612166|FG007|Overall Study|Met stopping criteria per protocol|0|||
155049748|NCT01096160|559612167|FG008|Overall Study|Met stopping criteria per protocol|2|||
155049749|NCT01096160|559612168|FG009|Overall Study|Met stopping criteria per protocol|0|||
155049750|NCT00627497|559612169|FG000|Overall Study|Lost to Follow-up|1|||
155049751|NCT00627497|559612170|FG001|Overall Study|Lost to Follow-up|1|||
155049752|NCT00627497|559612171|FG002|Overall Study|Lost to Follow-up|0|||
155049753|NCT00627497|559612172|FG003|Overall Study|Lost to Follow-up|0|||
155049754|NCT01556932|559612173|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
155049755|NCT01556932|559612174|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
155049756|NCT00991289|559612175|FG000|Overall Study|Adverse Event|1|||
155049757|NCT00991289|559612175|FG000|Overall Study|Physician Decision|2|||
155049758|NCT00991289|559612175|FG000|Overall Study|Withdrawal by Subject|3|||
155049759|NCT00991289|559612175|FG000|Overall Study|Lost to Follow-up|4|||
155049760|NCT00991289|559612175|FG000|Overall Study|Protocol Violation|2|||
155049761|NCT04826484|559614068|FG000|Overall Study|Lost to Follow-up|2|||
155049762|NCT04826484|559614069|FG001|Overall Study|Lost to Follow-up|0|||
155049763|NCT02250300|559614073|FG000|Expansion Phase|Death|6|||
155049764|NCT02250300|559614074|FG001|Expansion Phase|Death|7|||
155049765|NCT02250300|559614075|FG002|Expansion Phase|Death|0|||
155049766|NCT02250300|559614076|FG003|Expansion Phase|Death|0|||
155049767|NCT01845597|559614077|FG000|Overall Study|Death|8|||
155049768|NCT01845597|559614077|FG000|Overall Study|Lost to Follow-up|22|||
155049769|NCT01516736|559614079|FG000|Overall Study|Withdrawal by Subject|10|||
155049770|NCT01516736|559614080|FG001|Overall Study|Withdrawal by Subject|4|||
155049771|NCT01516736|559614079|FG000|Overall Study|Adverse Event|4|||
155049772|NCT01516736|559614080|FG001|Overall Study|Adverse Event|5|||
155049773|NCT01516736|559614079|FG000|Overall Study|Death|3|||
155049774|NCT01516736|559614080|FG001|Overall Study|Death|1|||
155049775|NCT01516736|559614079|FG000|Overall Study|Physician Decision|2|||
155049776|NCT01516736|559614080|FG001|Overall Study|Physician Decision|1|||
155049777|NCT01516736|559614079|FG000|Overall Study|Lack of Efficacy|1|||
155049778|NCT01516736|559614080|FG001|Overall Study|Lack of Efficacy|0|||
155049779|NCT01516736|559614079|FG000|Overall Study|Protocol Violation|0|||
155049780|NCT01516736|559614080|FG001|Overall Study|Protocol Violation|1|||
155049781|NCT01516736|559614079|FG000|Overall Study|Other (not specified)|0|||
155049782|NCT01516736|559614080|FG001|Overall Study|Other (not specified)|1|||
155049783|NCT02781818|559614083|FG000|Overall Study|Lost to Follow-up|4|||
155049784|NCT02781818|559614084|FG001|Overall Study|Lost to Follow-up|2|||
155049785|NCT02781818|559614085|FG002|Overall Study|Lost to Follow-up|1|||
155049786|NCT01877668|559614086|FG000|Overall Study|Death|0|||
155049787|NCT01877668|559614087|FG001|Overall Study|Death|0|||
155049788|NCT01877668|559614088|FG002|Overall Study|Death|0|||
155049789|NCT01877668|559614089|FG003|Overall Study|Death|1|||
155049790|NCT01877668|559614090|FG004|Overall Study|Death|0|||
155049791|NCT01877668|559614086|FG000|Overall Study|No longer met study criteria|1|||
155049792|NCT01877668|559614087|FG001|Overall Study|No longer met study criteria|0|||
155049793|NCT01877668|559614088|FG002|Overall Study|No longer met study criteria|1|||
155049794|NCT01877668|559614089|FG003|Overall Study|No longer met study criteria|0|||
155049795|NCT01877668|559614090|FG004|Overall Study|No longer met study criteria|0|||
155049796|NCT01877668|559614086|FG000|Overall Study|Insufficient clinical response|0|||
155049797|NCT01877668|559614087|FG001|Overall Study|Insufficient clinical response|1|||
155049798|NCT01877668|559614088|FG002|Overall Study|Insufficient clinical response|2|||
155049799|NCT01877668|559614089|FG003|Overall Study|Insufficient clinical response|2|||
155049800|NCT01877668|559614090|FG004|Overall Study|Insufficient clinical response|0|||
155049801|NCT01877668|559614086|FG000|Overall Study|Lost to Follow-up|0|||
155049802|NCT01877668|559614087|FG001|Overall Study|Lost to Follow-up|2|||
155049803|NCT01877668|559614088|FG002|Overall Study|Lost to Follow-up|1|||
155049804|NCT01877668|559614089|FG003|Overall Study|Lost to Follow-up|0|||
155049805|NCT01877668|559614090|FG004|Overall Study|Lost to Follow-up|0|||
155049806|NCT01877668|559614086|FG000|Overall Study|Withdrawal by Subject|2|||
155049807|NCT01877668|559614087|FG001|Overall Study|Withdrawal by Subject|0|||
155049808|NCT01877668|559614088|FG002|Overall Study|Withdrawal by Subject|3|||
155049809|NCT01877668|559614089|FG003|Overall Study|Withdrawal by Subject|2|||
155049810|NCT01877668|559614090|FG004|Overall Study|Withdrawal by Subject|2|||
155049811|NCT01877668|559614086|FG000|Overall Study|Other|1|||
155049812|NCT01877668|559614087|FG001|Overall Study|Other|1|||
155049813|NCT01877668|559614088|FG002|Overall Study|Other|1|||
155049814|NCT01877668|559614089|FG003|Overall Study|Other|1|||
155049815|NCT01877668|559614090|FG004|Overall Study|Other|3|||
155049816|NCT01877668|559614086|FG000|Overall Study|Protocol Violation|1|||
155049817|NCT01877668|559614087|FG001|Overall Study|Protocol Violation|1|||
155049818|NCT01877668|559614088|FG002|Overall Study|Protocol Violation|0|||
155049819|NCT01877668|559614089|FG003|Overall Study|Protocol Violation|0|||
155049820|NCT01877668|559614090|FG004|Overall Study|Protocol Violation|3|||
155049821|NCT01877668|559614086|FG000|Overall Study|Adverse event related to study drug|2|||
155049822|NCT01877668|559614087|FG001|Overall Study|Adverse event related to study drug|2|||
155049823|NCT01877668|559614088|FG002|Overall Study|Adverse event related to study drug|2|||
155049824|NCT01877668|559614089|FG003|Overall Study|Adverse event related to study drug|2|||
155049825|NCT01877668|559614090|FG004|Overall Study|Adverse event related to study drug|1|||
155049826|NCT01877668|559614086|FG000|Overall Study|Adverse event unrelated to study drug|4|||
155049827|NCT01877668|559614087|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155049828|NCT01877668|559614088|FG002|Overall Study|Adverse event unrelated to study drug|2|||
155049829|NCT01877668|559614089|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155049830|NCT01877668|559614090|FG004|Overall Study|Adverse event unrelated to study drug|1|||
155049831|NCT01223404|559614091|FG000|First Intervention (1 Day)|Adverse Event|0|||
155049832|NCT01223404|559614092|FG001|First Intervention (1 Day)|Adverse Event|0|||
155049833|NCT01223404|559614093|FG002|First Intervention (1 Day)|Adverse Event|0|||
155049834|NCT01223404|559614094|FG003|First Intervention (1 Day)|Adverse Event|1|||
155049835|NCT01223404|559614095|FG004|First Intervention (1 Day)|Adverse Event|0|||
155049836|NCT01223404|559614096|FG005|First Intervention (1 Day)|Adverse Event|0|||
155049837|NCT01223404|559614091|FG000|Second Intervention (1 Day)|Adverse Event|1|||
155049838|NCT01223404|559614092|FG001|Second Intervention (1 Day)|Adverse Event|0|||
155049839|NCT01223404|559614093|FG002|Second Intervention (1 Day)|Adverse Event|0|||
155049840|NCT01223404|559614094|FG003|Second Intervention (1 Day)|Adverse Event|0|||
155049841|NCT01223404|559614095|FG004|Second Intervention (1 Day)|Adverse Event|0|||
155049842|NCT01223404|559614096|FG005|Second Intervention (1 Day)|Adverse Event|0|||
155049843|NCT01223404|559614091|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
154947419|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
154947420|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
154947421|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
154947422|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
154947423|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
154947424|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
154947425|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
154947426|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
154947427|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
154947428|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
154947429|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
154947430|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
154947431|NCT00455533|559232350|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
154947432|NCT00455533|559232351|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
154947433|NCT00455533|559232352|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
154947434|NCT00455533|559232350|FG000|Period Two: Randomized Period|Death|0|||
154947435|NCT00455533|559232351|FG001|Period Two: Randomized Period|Death|0|||
154947436|NCT00455533|559232352|FG002|Period Two: Randomized Period|Death|3|||
154947437|NCT00455533|559232350|FG000|Period Two: Randomized Period|Disease Progression|0|||
154947438|NCT00455533|559232351|FG001|Period Two: Randomized Period|Disease Progression|1|||
154947439|NCT00455533|559232352|FG002|Period Two: Randomized Period|Disease Progression|1|||
154947440|NCT00455533|559232350|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
154947441|NCT00455533|559232351|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
154947442|NCT00455533|559232352|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
154947443|NCT00455533|559232350|FG000|Period Two: Randomized Period|Other - need reasons|0|||
154947444|NCT00455533|559232351|FG001|Period Two: Randomized Period|Other - need reasons|1|||
154947445|NCT00455533|559232352|FG002|Period Two: Randomized Period|Other - need reasons|0|||
154947446|NCT00455533|559232350|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
154947447|NCT00455533|559232351|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
154947448|NCT00455533|559232352|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
154947449|NCT00455533|559232350|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
154947450|NCT00455533|559232351|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
154947451|NCT00455533|559232352|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
154947452|NCT04634409|559232355|FG000|Overall Study|Death|0|||
154947453|NCT04634409|559232356|FG001|Overall Study|Death|0|||
154947454|NCT04634409|559232357|FG002|Overall Study|Death|0|||
154947455|NCT04634409|559232358|FG003|Overall Study|Death|0|||
154947456|NCT04634409|559232359|FG004|Overall Study|Death|0|||
154947457|NCT04634409|559232360|FG005|Overall Study|Death|0|||
154947458|NCT04634409|559232361|FG006|Overall Study|Death|0|||
154947459|NCT04634409|559232362|FG007|Overall Study|Death|0|||
154947460|NCT04634409|559232363|FG008|Overall Study|Death|0|||
154947461|NCT04634409|559232364|FG009|Overall Study|Death|0|||
154947462|NCT04634409|559232365|FG010|Overall Study|Death|1|||
154947463|NCT04634409|559232366|FG011|Overall Study|Death|0|||
154947464|NCT04634409|559232367|FG012|Overall Study|Death|1|||
154947465|NCT04634409|559232368|FG013|Overall Study|Death|0|||
154947466|NCT04634409|559232369|FG014|Overall Study|Death|0|||
154947467|NCT04634409|559232370|FG015|Overall Study|Death|0|||
154947468|NCT04634409|559232371|FG016|Overall Study|Death|0|||
154947469|NCT04634409|559232372|FG017|Overall Study|Death|0|||
154947470|NCT04634409|559232373|FG018|Overall Study|Death|0|||
154947471|NCT04634409|559232374|FG019|Overall Study|Death|0|||
154947472|NCT04634409|559232375|FG020|Overall Study|Death|0|||
154947473|NCT04634409|559232376|FG021|Overall Study|Death|0|||
154947474|NCT04634409|559232377|FG022|Overall Study|Death|0|||
154947475|NCT04634409|559232378|FG023|Overall Study|Death|0|||
154947476|NCT04634409|559232379|FG024|Overall Study|Death|0|||
154947477|NCT04634409|559232380|FG025|Overall Study|Death|0|||
154947478|NCT04634409|559232381|FG026|Overall Study|Death|0|||
154947479|NCT04634409|559232355|FG000|Overall Study|Adverse Event|0|||
154947480|NCT04634409|559232356|FG001|Overall Study|Adverse Event|0|||
155281688|NCT01544582|560461703|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
154947481|NCT04634409|559232357|FG002|Overall Study|Adverse Event|1|||
154947482|NCT04634409|559232358|FG003|Overall Study|Adverse Event|0|||
154947483|NCT04634409|559232359|FG004|Overall Study|Adverse Event|0|||
154947484|NCT04634409|559232360|FG005|Overall Study|Adverse Event|1|||
154947485|NCT04634409|559232361|FG006|Overall Study|Adverse Event|0|||
154947486|NCT04634409|559232362|FG007|Overall Study|Adverse Event|0|||
154947487|NCT04634409|559232363|FG008|Overall Study|Adverse Event|0|||
154947488|NCT04634409|559232364|FG009|Overall Study|Adverse Event|0|||
154947489|NCT04634409|559232365|FG010|Overall Study|Adverse Event|0|||
154947490|NCT04634409|559232366|FG011|Overall Study|Adverse Event|0|||
154947491|NCT04634409|559232367|FG012|Overall Study|Adverse Event|0|||
154947492|NCT04634409|559232368|FG013|Overall Study|Adverse Event|0|||
155388960|NCT01323634|560858770|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
155388961|NCT01323634|560858771|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
155388962|NCT01759407|560858772|FG000|Overall Study|Protocol Violation|0|||
155388963|NCT01759407|560858773|FG001|Overall Study|Protocol Violation|2|||
155388964|NCT02092220|560858778|FG000|Period 1|Unrelated Illness|0|||
155388965|NCT02092220|560858779|FG001|Period 1|Unrelated Illness|2|||
155388966|NCT02092220|560858778|FG000|Period 2|Severe Hypoglycaemia|1|||
154947493|NCT04634409|559232369|FG014|Overall Study|Adverse Event|0|||
154947494|NCT04634409|559232370|FG015|Overall Study|Adverse Event|0|||
154947495|NCT04634409|559232371|FG016|Overall Study|Adverse Event|0|||
154947496|NCT04634409|559232372|FG017|Overall Study|Adverse Event|0|||
154947497|NCT04634409|559232373|FG018|Overall Study|Adverse Event|0|||
154947498|NCT04634409|559232374|FG019|Overall Study|Adverse Event|0|||
154947499|NCT04634409|559232375|FG020|Overall Study|Adverse Event|0|||
154947500|NCT04634409|559232376|FG021|Overall Study|Adverse Event|0|||
154947501|NCT04634409|559232377|FG022|Overall Study|Adverse Event|0|||
154947502|NCT04634409|559232378|FG023|Overall Study|Adverse Event|0|||
154947503|NCT04634409|559232379|FG024|Overall Study|Adverse Event|0|||
154947504|NCT04634409|559232380|FG025|Overall Study|Adverse Event|0|||
154947505|NCT04634409|559232381|FG026|Overall Study|Adverse Event|0|||
154947506|NCT04634409|559232355|FG000|Overall Study|Lost to Follow-up|3|||
154947507|NCT04634409|559232356|FG001|Overall Study|Lost to Follow-up|1|||
154947508|NCT04634409|559232357|FG002|Overall Study|Lost to Follow-up|1|||
154947509|NCT04634409|559232358|FG003|Overall Study|Lost to Follow-up|3|||
154947510|NCT04634409|559232359|FG004|Overall Study|Lost to Follow-up|1|||
154947511|NCT04634409|559232360|FG005|Overall Study|Lost to Follow-up|1|||
154947512|NCT04634409|559232361|FG006|Overall Study|Lost to Follow-up|1|||
154947513|NCT04634409|559232362|FG007|Overall Study|Lost to Follow-up|3|||
154947514|NCT04634409|559232363|FG008|Overall Study|Lost to Follow-up|3|||
154947515|NCT04634409|559232364|FG009|Overall Study|Lost to Follow-up|11|||
154947516|NCT04634409|559232365|FG010|Overall Study|Lost to Follow-up|8|||
154947517|NCT04634409|559232366|FG011|Overall Study|Lost to Follow-up|15|||
154947518|NCT04634409|559232367|FG012|Overall Study|Lost to Follow-up|3|||
154947519|NCT04634409|559232368|FG013|Overall Study|Lost to Follow-up|2|||
154947520|NCT04634409|559232369|FG014|Overall Study|Lost to Follow-up|7|||
154947521|NCT04634409|559232370|FG015|Overall Study|Lost to Follow-up|0|||
154947522|NCT04634409|559232371|FG016|Overall Study|Lost to Follow-up|0|||
154947523|NCT04634409|559232372|FG017|Overall Study|Lost to Follow-up|0|||
154947524|NCT04634409|559232373|FG018|Overall Study|Lost to Follow-up|0|||
154947525|NCT04634409|559232374|FG019|Overall Study|Lost to Follow-up|0|||
154947526|NCT04634409|559232375|FG020|Overall Study|Lost to Follow-up|0|||
154947527|NCT04634409|559232376|FG021|Overall Study|Lost to Follow-up|0|||
154947528|NCT04634409|559232377|FG022|Overall Study|Lost to Follow-up|0|||
154947529|NCT04634409|559232378|FG023|Overall Study|Lost to Follow-up|0|||
154947530|NCT04634409|559232379|FG024|Overall Study|Lost to Follow-up|0|||
154947531|NCT04634409|559232380|FG025|Overall Study|Lost to Follow-up|0|||
154947532|NCT04634409|559232381|FG026|Overall Study|Lost to Follow-up|0|||
154947533|NCT04634409|559232355|FG000|Overall Study|Withdrawal by Subject|3|||
154947534|NCT04634409|559232356|FG001|Overall Study|Withdrawal by Subject|1|||
154947535|NCT04634409|559232357|FG002|Overall Study|Withdrawal by Subject|6|||
154947536|NCT04634409|559232358|FG003|Overall Study|Withdrawal by Subject|4|||
154947537|NCT04634409|559232359|FG004|Overall Study|Withdrawal by Subject|2|||
154947538|NCT04634409|559232360|FG005|Overall Study|Withdrawal by Subject|0|||
154947539|NCT04634409|559232361|FG006|Overall Study|Withdrawal by Subject|0|||
154947540|NCT04634409|559232362|FG007|Overall Study|Withdrawal by Subject|2|||
154947541|NCT04634409|559232363|FG008|Overall Study|Withdrawal by Subject|3|||
154947542|NCT04634409|559232364|FG009|Overall Study|Withdrawal by Subject|2|||
154947543|NCT04634409|559232365|FG010|Overall Study|Withdrawal by Subject|3|||
154947544|NCT04634409|559232366|FG011|Overall Study|Withdrawal by Subject|2|||
154947545|NCT04634409|559232367|FG012|Overall Study|Withdrawal by Subject|2|||
154947546|NCT04634409|559232368|FG013|Overall Study|Withdrawal by Subject|1|||
154947547|NCT04634409|559232369|FG014|Overall Study|Withdrawal by Subject|5|||
154947548|NCT04634409|559232370|FG015|Overall Study|Withdrawal by Subject|0|||
154947549|NCT04634409|559232371|FG016|Overall Study|Withdrawal by Subject|0|||
154947550|NCT04634409|559232372|FG017|Overall Study|Withdrawal by Subject|1|||
154947551|NCT04634409|559232373|FG018|Overall Study|Withdrawal by Subject|0|||
154947552|NCT04634409|559232374|FG019|Overall Study|Withdrawal by Subject|0|||
154947553|NCT04634409|559232375|FG020|Overall Study|Withdrawal by Subject|0|||
154947554|NCT04634409|559232376|FG021|Overall Study|Withdrawal by Subject|0|||
154947555|NCT04634409|559232377|FG022|Overall Study|Withdrawal by Subject|0|||
154947556|NCT04634409|559232378|FG023|Overall Study|Withdrawal by Subject|1|||
154947557|NCT04634409|559232379|FG024|Overall Study|Withdrawal by Subject|0|||
154947558|NCT04634409|559232380|FG025|Overall Study|Withdrawal by Subject|0|||
154947559|NCT04634409|559232381|FG026|Overall Study|Withdrawal by Subject|0|||
154947560|NCT04634409|559232355|FG000|Overall Study|Other - As reported by Investigator|1|||
154947561|NCT04634409|559232356|FG001|Overall Study|Other - As reported by Investigator|0|||
154947562|NCT04634409|559232357|FG002|Overall Study|Other - As reported by Investigator|0|||
154947563|NCT04634409|559232358|FG003|Overall Study|Other - As reported by Investigator|0|||
155049844|NCT01223404|559614092|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155049845|NCT01223404|559614093|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155049846|NCT01223404|559614094|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
155049847|NCT01223404|559614095|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155049848|NCT01223404|559614096|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
155049849|NCT00954122|559614097|FG000|Overall Study|Withdrawal by Subject|5|||
155049850|NCT00954122|559614097|FG000|Overall Study|Adverse Event|1|||
155049851|NCT00954122|559614097|FG000|Overall Study|Safety Reason|1|||
155049852|NCT02019550|559614102|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155049853|NCT02019550|559614103|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
155049854|NCT02750332|559614104|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155049855|NCT02750332|559614105|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155049856|NCT02485483|559614106|FG000|Overall Study|Depression at baseline|15|||
154947564|NCT04634409|559232359|FG004|Overall Study|Other - As reported by Investigator|0|||
154947565|NCT04634409|559232360|FG005|Overall Study|Other - As reported by Investigator|0|||
154947566|NCT04634409|559232361|FG006|Overall Study|Other - As reported by Investigator|0|||
154947567|NCT04634409|559232362|FG007|Overall Study|Other - As reported by Investigator|6|||
154947568|NCT04634409|559232363|FG008|Overall Study|Other - As reported by Investigator|4|||
154947569|NCT04634409|559232364|FG009|Overall Study|Other - As reported by Investigator|0|||
154947570|NCT04634409|559232365|FG010|Overall Study|Other - As reported by Investigator|1|||
154947571|NCT04634409|559232366|FG011|Overall Study|Other - As reported by Investigator|2|||
154947572|NCT04634409|559232367|FG012|Overall Study|Other - As reported by Investigator|2|||
154947573|NCT04634409|559232368|FG013|Overall Study|Other - As reported by Investigator|1|||
154947574|NCT04634409|559232369|FG014|Overall Study|Other - As reported by Investigator|0|||
154947575|NCT04634409|559232370|FG015|Overall Study|Other - As reported by Investigator|0|||
154947576|NCT04634409|559232371|FG016|Overall Study|Other - As reported by Investigator|0|||
154947577|NCT04634409|559232372|FG017|Overall Study|Other - As reported by Investigator|0|||
154947578|NCT04634409|559232373|FG018|Overall Study|Other - As reported by Investigator|0|||
154947579|NCT04634409|559232374|FG019|Overall Study|Other - As reported by Investigator|0|||
154947580|NCT04634409|559232375|FG020|Overall Study|Other - As reported by Investigator|0|||
154947581|NCT04634409|559232376|FG021|Overall Study|Other - As reported by Investigator|0|||
154947582|NCT04634409|559232377|FG022|Overall Study|Other - As reported by Investigator|0|||
154947583|NCT04634409|559232378|FG023|Overall Study|Other - As reported by Investigator|0|||
154947584|NCT04634409|559232379|FG024|Overall Study|Other - As reported by Investigator|0|||
154947585|NCT04634409|559232380|FG025|Overall Study|Other - As reported by Investigator|0|||
154947586|NCT04634409|559232381|FG026|Overall Study|Other - As reported by Investigator|0|||
154947587|NCT05456529|559233936|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
154947588|NCT05456529|559233936|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
154947589|NCT05456529|559233936|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
154947590|NCT05456529|559233936|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
154947591|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
154947592|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
154947593|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Physician Decision|2|||
154947594|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
154947595|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
154947596|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
154947597|NCT05456529|559233936|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
154947598|NCT00576381|559233940|FG000|Overall Study|Reoperation|3|||
154947599|NCT00576381|559233940|FG000|Overall Study|Adverse Event|4|||
154947600|NCT00797108|559233944|FG000|Overall Study|Adverse Event|1|||
154947601|NCT00797108|559233945|FG001|Overall Study|Adverse Event|0|||
154947602|NCT00797108|559233946|FG002|Overall Study|Adverse Event|3|||
154947603|NCT00797108|559233944|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
154947604|NCT00797108|559233945|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
154947605|NCT00797108|559233946|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
154947606|NCT00797108|559233944|FG000|Overall Study|Global Deterioration of Health Status|0|||
154947607|NCT00797108|559233945|FG001|Overall Study|Global Deterioration of Health Status|1|||
154947608|NCT00797108|559233946|FG002|Overall Study|Global Deterioration of Health Status|0|||
154947609|NCT00797108|559233944|FG000|Overall Study|Lack of Efficacy|1|||
154947610|NCT00797108|559233945|FG001|Overall Study|Lack of Efficacy|0|||
154947611|NCT00797108|559233946|FG002|Overall Study|Lack of Efficacy|1|||
154947612|NCT00797108|559233944|FG000|Overall Study|Other|0|||
154947613|NCT00797108|559233945|FG001|Overall Study|Other|0|||
154947614|NCT00797108|559233946|FG002|Overall Study|Other|2|||
154947615|NCT00797108|559233944|FG000|Overall Study|Randomized but not Treated|2|||
154947616|NCT00797108|559233945|FG001|Overall Study|Randomized but not Treated|0|||
154947617|NCT00797108|559233946|FG002|Overall Study|Randomized but not Treated|0|||
154947618|NCT02518113|559233947|FG000|Overall Study|Adverse Event|1|||
154947619|NCT02518113|559233948|FG001|Overall Study|Adverse Event|0|||
154947620|NCT02518113|559233949|FG002|Overall Study|Adverse Event|1|||
155049857|NCT02485483|559614107|FG001|Overall Study|Depression at baseline|0|||
155049858|NCT02485483|559614106|FG000|Overall Study|Discontinued after baseline|39|||
155049859|NCT02485483|559614107|FG001|Overall Study|Discontinued after baseline|0|||
155049860|NCT00130689|559614112|FG000|Overall Study|Progressive Disease|29|||
155049861|NCT00130689|559614112|FG000|Overall Study|Death|1|||
155049862|NCT00130689|559614112|FG000|Overall Study|Clinical Deterioration|4|||
155049863|NCT00130689|559614112|FG000|Overall Study|Withdrawal by Subject|3|||
155049864|NCT00130689|559614112|FG000|Overall Study|Ineligible|6|||
155049865|NCT04878055|559614113|FG000|Overall Study|Patient transferred in another department|0|||
155049866|NCT04878055|559614114|FG001|Overall Study|Patient transferred in another department|2|||
155049867|NCT04878055|559614113|FG000|Overall Study|Physician Decision|1|||
155049868|NCT04878055|559614114|FG001|Overall Study|Physician Decision|1|||
155049869|NCT04878055|559614113|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
155049870|NCT04878055|559614114|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
155049871|NCT04878055|559614113|FG000|Overall Study|Adverse Event|12|||
155049872|NCT04878055|559614114|FG001|Overall Study|Adverse Event|7|||
155049873|NCT04878055|559614113|FG000|Overall Study|Other|5|||
155049874|NCT04878055|559614114|FG001|Overall Study|Other|0|||
155049875|NCT04878055|559614113|FG000|Overall Study|Withdrawal by Subject|7|||
155049876|NCT04878055|559614114|FG001|Overall Study|Withdrawal by Subject|3|||
155049877|NCT04878055|559614113|FG000|Overall Study|Lost to Follow-up|10|||
155049878|NCT04878055|559614114|FG001|Overall Study|Lost to Follow-up|1|||
155049879|NCT01178125|559614116|FG000|Overall Study|Lost to Follow-up|397|||
155049880|NCT01178125|559614116|FG000|Overall Study|Adverse Event|244|||
155049881|NCT01178125|559614116|FG000|Overall Study|Withdrawal by Subject|209|||
155049882|NCT01178125|559614116|FG000|Overall Study|Noncompliance|184|||
155049883|NCT01178125|559614116|FG000|Overall Study|Pregnancy|55|||
155049884|NCT01178125|559614116|FG000|Overall Study|Other Reason|39|||
155049885|NCT01178125|559614116|FG000|Overall Study|Sponsor Decision|28|||
155049886|NCT01178125|559614116|FG000|Overall Study|Protocol Violation|17|||
155049887|NCT01178125|559614116|FG000|Overall Study|Investigator Decision|5|||
155049888|NCT00369915|559614117|FG000|Overall Study|expected side effects|2|||
155049889|NCT00369915|559614118|FG001|Overall Study|expected side effects|1|||
155049890|NCT00369915|559614117|FG000|Overall Study|Withdrawal by Subject|4|||
155049891|NCT00369915|559614118|FG001|Overall Study|Withdrawal by Subject|1|||
155049892|NCT00369915|559614117|FG000|Overall Study|W/drawl by investigators|0|||
155049893|NCT00369915|559614118|FG001|Overall Study|W/drawl by investigators|1|||
155049894|NCT01719380|559614121|FG000|Overall Study|Adverse Event|0|||
155049895|NCT01719380|559614122|FG001|Overall Study|Adverse Event|0|||
155049896|NCT01719380|559614123|FG002|Overall Study|Adverse Event|1|||
155049897|NCT01719380|559614124|FG003|Overall Study|Adverse Event|2|||
155049898|NCT01719380|559614125|FG004|Overall Study|Adverse Event|0|||
155049899|NCT01719380|559614126|FG005|Overall Study|Adverse Event|1|||
155049900|NCT01719380|559614127|FG006|Overall Study|Adverse Event|0|||
155049901|NCT01719380|559614128|FG007|Overall Study|Adverse Event|1|||
155049902|NCT01719380|559614129|FG008|Overall Study|Adverse Event|4|||
155049903|NCT01719380|559614130|FG009|Overall Study|Adverse Event|3|||
155049904|NCT01719380|559614121|FG000|Overall Study|Death|0|||
155049905|NCT01719380|559614122|FG001|Overall Study|Death|1|||
155049906|NCT01719380|559614123|FG002|Overall Study|Death|0|||
155049907|NCT01719380|559614124|FG003|Overall Study|Death|0|||
155049908|NCT01719380|559614125|FG004|Overall Study|Death|0|||
155049909|NCT01719380|559614126|FG005|Overall Study|Death|0|||
155049910|NCT01719380|559614127|FG006|Overall Study|Death|0|||
155049911|NCT01719380|559614128|FG007|Overall Study|Death|0|||
155049912|NCT01719380|559614129|FG008|Overall Study|Death|3|||
155049913|NCT01719380|559614130|FG009|Overall Study|Death|3|||
155049914|NCT01719380|559614121|FG000|Overall Study|Participant/Guardian Decision|0|||
155049915|NCT01719380|559614122|FG001|Overall Study|Participant/Guardian Decision|0|||
155049916|NCT01719380|559614123|FG002|Overall Study|Participant/Guardian Decision|1|||
155049917|NCT01719380|559614124|FG003|Overall Study|Participant/Guardian Decision|0|||
155388967|NCT02092220|560858779|FG001|Period 2|Severe Hypoglycaemia|0|||
155388968|NCT02092220|560858778|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
155388969|NCT02092220|560858779|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
155388970|NCT00960531|560858780|FG000|Overall Study|Lack of Efficacy|1|||
155388971|NCT00960531|560858781|FG001|Overall Study|Lack of Efficacy|0|||
155049918|NCT01719380|559614125|FG004|Overall Study|Participant/Guardian Decision|0|||
155049919|NCT01719380|559614126|FG005|Overall Study|Participant/Guardian Decision|0|||
155049920|NCT01719380|559614127|FG006|Overall Study|Participant/Guardian Decision|0|||
155049921|NCT01719380|559614128|FG007|Overall Study|Participant/Guardian Decision|0|||
155049922|NCT01719380|559614129|FG008|Overall Study|Participant/Guardian Decision|2|||
155049923|NCT01719380|559614130|FG009|Overall Study|Participant/Guardian Decision|2|||
155049924|NCT01719380|559614121|FG000|Overall Study|Physician Decision|0|||
155049925|NCT01719380|559614122|FG001|Overall Study|Physician Decision|0|||
155049926|NCT01719380|559614123|FG002|Overall Study|Physician Decision|2|||
155049927|NCT01719380|559614124|FG003|Overall Study|Physician Decision|0|||
155049928|NCT01719380|559614125|FG004|Overall Study|Physician Decision|0|||
155049929|NCT01719380|559614126|FG005|Overall Study|Physician Decision|0|||
155049930|NCT01719380|559614127|FG006|Overall Study|Physician Decision|0|||
155049931|NCT01719380|559614128|FG007|Overall Study|Physician Decision|0|||
155049932|NCT01719380|559614129|FG008|Overall Study|Physician Decision|1|||
155388972|NCT00960531|560858782|FG002|Overall Study|Lack of Efficacy|0|||
155388973|NCT00960531|560858783|FG003|Overall Study|Lack of Efficacy|0|||
155388974|NCT00960531|560858784|FG004|Overall Study|Lack of Efficacy|0|||
155388975|NCT00960531|560858785|FG005|Overall Study|Lack of Efficacy|0|||
155388976|NCT00960531|560858786|FG006|Overall Study|Lack of Efficacy|0|||
155388977|NCT00960531|560858787|FG007|Overall Study|Lack of Efficacy|0|||
155388978|NCT00960531|560858788|FG008|Overall Study|Lack of Efficacy|0|||
155388979|NCT00960531|560858789|FG009|Overall Study|Lack of Efficacy|0|||
155388980|NCT00960531|560858780|FG000|Overall Study|Withdrawal by Subject|1|||
155388981|NCT00960531|560858781|FG001|Overall Study|Withdrawal by Subject|0|||
155388982|NCT00960531|560858782|FG002|Overall Study|Withdrawal by Subject|5|||
155388983|NCT00960531|560858783|FG003|Overall Study|Withdrawal by Subject|2|||
155388984|NCT00960531|560858784|FG004|Overall Study|Withdrawal by Subject|0|||
155388985|NCT00960531|560858785|FG005|Overall Study|Withdrawal by Subject|0|||
155388986|NCT00960531|560858786|FG006|Overall Study|Withdrawal by Subject|2|||
155388987|NCT00960531|560858787|FG007|Overall Study|Withdrawal by Subject|0|||
155388988|NCT00960531|560858788|FG008|Overall Study|Withdrawal by Subject|1|||
155388989|NCT00960531|560858789|FG009|Overall Study|Withdrawal by Subject|0|||
155388990|NCT00960531|560858780|FG000|Overall Study|Caregiver Request|2|||
155388991|NCT00960531|560858781|FG001|Overall Study|Caregiver Request|0|||
155388992|NCT00960531|560858782|FG002|Overall Study|Caregiver Request|6|||
155388993|NCT00960531|560858783|FG003|Overall Study|Caregiver Request|5|||
154947621|NCT02518113|559233950|FG003|Overall Study|Adverse Event|0|||
154947622|NCT02518113|559233947|FG000|Overall Study|Death|1|||
154947623|NCT02518113|559233948|FG001|Overall Study|Death|2|||
154947624|NCT02518113|559233949|FG002|Overall Study|Death|0|||
154947625|NCT02518113|559233950|FG003|Overall Study|Death|0|||
154947626|NCT02518113|559233947|FG000|Overall Study|Physician Decision|0|||
154947627|NCT02518113|559233948|FG001|Overall Study|Physician Decision|1|||
154947628|NCT02518113|559233949|FG002|Overall Study|Physician Decision|0|||
154947629|NCT02518113|559233950|FG003|Overall Study|Physician Decision|0|||
154947630|NCT02518113|559233947|FG000|Overall Study|Progressive Disease|1|||
154947631|NCT02518113|559233948|FG001|Overall Study|Progressive Disease|2|||
154947632|NCT02518113|559233949|FG002|Overall Study|Progressive Disease|3|||
154947633|NCT02518113|559233950|FG003|Overall Study|Progressive Disease|0|||
154947634|NCT00287118|559233951|FG000|Overall Study|Adverse Event|30|||
154947635|NCT00287118|559233951|FG000|Overall Study|Death|1|||
154947636|NCT00287118|559233951|FG000|Overall Study|Lack of Efficacy|11|||
154947637|NCT00287118|559233951|FG000|Overall Study|Lost to Follow-up|1|||
154947638|NCT00287118|559233951|FG000|Overall Study|Protocol Violation|2|||
154947639|NCT00287118|559233951|FG000|Overall Study|Other|7|||
154947640|NCT02324465|559233952|FG000|Overall Study|device failure|0|||
154947641|NCT02324465|559233953|FG001|Overall Study|device failure|1|||
154947642|NCT01631864|559233954|FG000|Overall Study|Withdrawal by Subject|0|||
154947643|NCT01631864|559233955|FG001|Overall Study|Withdrawal by Subject|1|||
154947644|NCT01631864|559233954|FG000|Overall Study|Adverse Event|2|||
154947645|NCT01631864|559233955|FG001|Overall Study|Adverse Event|3|||
154947646|NCT01031537|559233956|FG000|Overall Study|medical reasons not related to study|3|||
154947647|NCT01031537|559233956|FG000|Overall Study|Lack of Efficacy|1|||
154947648|NCT01031537|559233956|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
154947649|NCT01031537|559233956|FG000|Overall Study|moved, met exclusion criteria|10|||
154947650|NCT01031537|559233956|FG000|Overall Study|Withdrawal by Subject|5|||
154947651|NCT01031537|559233956|FG000|Overall Study|PI removal, no longer met eligibility|12|||
154947652|NCT01860976|559233980|FG000|Blinded Treatment|Adverse Event|1|||
154947653|NCT01860976|559233981|FG001|Blinded Treatment|Adverse Event|3|||
154947654|NCT01860976|559233980|FG000|Blinded Treatment|Lack of Efficacy|5|||
154947655|NCT01860976|559233981|FG001|Blinded Treatment|Lack of Efficacy|12|||
154947656|NCT01860976|559233980|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
154947657|NCT01860976|559233981|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
154947658|NCT01860976|559233980|FG000|Blinded Treatment|Withdrawal by Subject|3|||
154947659|NCT01860976|559233981|FG001|Blinded Treatment|Withdrawal by Subject|5|||
154947660|NCT01860976|559233980|FG000|Blinded Treatment|Subject no longer met criteria|1|||
154947661|NCT01860976|559233981|FG001|Blinded Treatment|Subject no longer met criteria|0|||
154947662|NCT01860976|559233980|FG000|Blinded Treatment|Entered Open-Label in error|0|||
154947663|NCT01860976|559233981|FG001|Blinded Treatment|Entered Open-Label in error|1|||
154947664|NCT01860976|559233980|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
154947665|NCT01860976|559233981|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
154947666|NCT01860976|559233980|FG000|Open-Label|Adverse Event|2|||
154947667|NCT01860976|559233981|FG001|Open-Label|Adverse Event|4|||
154947668|NCT01860976|559233980|FG000|Open-Label|Lack of Efficacy|16|||
154947669|NCT01860976|559233981|FG001|Open-Label|Lack of Efficacy|8|||
154947670|NCT01860976|559233980|FG000|Open-Label|Lost to Follow-up|1|||
154947671|NCT01860976|559233981|FG001|Open-Label|Lost to Follow-up|2|||
154947672|NCT01860976|559233980|FG000|Open-Label|Subject request discontinue treatment|4|||
154947673|NCT01860976|559233981|FG001|Open-Label|Subject request discontinue treatment|3|||
154947674|NCT01860976|559233980|FG000|Open-Label|Withdrawal by Subject|4|||
154947675|NCT01860976|559233981|FG001|Open-Label|Withdrawal by Subject|1|||
154947676|NCT01860976|559233980|FG000|Open-Label|Other Reasons|1|||
154947677|NCT01860976|559233981|FG001|Open-Label|Other Reasons|1|||
154947678|NCT01860976|559233980|FG000|Long Term Extension|Adverse Event|4|||
154947679|NCT01860976|559233981|FG001|Long Term Extension|Adverse Event|0|||
154947680|NCT01860976|559233980|FG000|Long Term Extension|Lack of Efficacy|2|||
154947681|NCT01860976|559233981|FG001|Long Term Extension|Lack of Efficacy|0|||
154947682|NCT01860976|559233980|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
154947683|NCT01860976|559233981|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
154947684|NCT01860976|559233980|FG000|Long Term Extension|Lost to Follow-up|2|||
154947685|NCT01860976|559233981|FG001|Long Term Extension|Lost to Follow-up|0|||
154947686|NCT01860976|559233980|FG000|Long Term Extension|subject withdrew consent|7|||
154947687|NCT01860976|559233981|FG001|Long Term Extension|subject withdrew consent|0|||
154947688|NCT00419926|559233982|FG000|Overall Study|Withdrawal by Subject|7|||
154947689|NCT00419926|559233983|FG001|Overall Study|Withdrawal by Subject|3|||
154947690|NCT00419926|559233982|FG000|Overall Study|Administrative Problem|4|||
154947691|NCT00419926|559233983|FG001|Overall Study|Administrative Problem|4|||
154947692|NCT00419926|559233982|FG000|Overall Study|Lost to Follow-up|1|||
154947693|NCT00419926|559233983|FG001|Overall Study|Lost to Follow-up|2|||
154947694|NCT00419926|559233982|FG000|Overall Study|Death|2|||
154947695|NCT00419926|559233983|FG001|Overall Study|Death|1|||
154947696|NCT02153398|559233985|FG000|Overall Study|Withdrawal by Subject|1|||
154947697|NCT02153398|559233986|FG001|Overall Study|Withdrawal by Subject|0|||
154947698|NCT02153398|559233987|FG002|Overall Study|Withdrawal by Subject|0|||
154947699|NCT02153398|559233988|FG003|Overall Study|Withdrawal by Subject|0|||
154947700|NCT02153398|559233989|FG004|Overall Study|Withdrawal by Subject|0|||
154947701|NCT02153398|559233985|FG000|Overall Study|Adverse Event|0|||
154947702|NCT02153398|559233986|FG001|Overall Study|Adverse Event|0|||
154947703|NCT02153398|559233987|FG002|Overall Study|Adverse Event|1|||
154947704|NCT02153398|559233988|FG003|Overall Study|Adverse Event|1|||
154947705|NCT02153398|559233989|FG004|Overall Study|Adverse Event|0|||
154947706|NCT02374918|559233990|FG000|Overall Study|Protocol Violation|2|||
154947707|NCT02374918|559233991|FG001|Overall Study|Protocol Violation|0|||
154947708|NCT02374918|559233992|FG002|Overall Study|Protocol Violation|2|||
154947709|NCT02374918|559233993|FG003|Overall Study|Protocol Violation|1|||
154947710|NCT02374918|559233990|FG000|Overall Study|Withdrawal by Subject|1|||
154947711|NCT02374918|559233991|FG001|Overall Study|Withdrawal by Subject|1|||
154947712|NCT02374918|559233992|FG002|Overall Study|Withdrawal by Subject|1|||
154947713|NCT02374918|559233993|FG003|Overall Study|Withdrawal by Subject|0|||
154947714|NCT02374918|559233990|FG000|Overall Study|Lack of Efficacy|0|||
154947715|NCT02374918|559233991|FG001|Overall Study|Lack of Efficacy|0|||
154947716|NCT02374918|559233992|FG002|Overall Study|Lack of Efficacy|1|||
154947717|NCT02374918|559233993|FG003|Overall Study|Lack of Efficacy|1|||
154947718|NCT02204371|559233994|FG000|Overall Study|Adverse Event|1|||
154947719|NCT03594123|559233997|FG000|Overall Study|Lost to Follow-up|0|||
154947720|NCT03594123|559233998|FG001|Overall Study|Lost to Follow-up|1|||
154947721|NCT03594123|559233997|FG000|Overall Study|Adverse Event|8|||
154947722|NCT03594123|559233998|FG001|Overall Study|Adverse Event|5|||
154947723|NCT03594123|559233997|FG000|Overall Study|Site Terminated by Sponsor|4|||
154947724|NCT03594123|559233998|FG001|Overall Study|Site Terminated by Sponsor|1|||
154947725|NCT03594123|559233997|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
154947726|NCT03594123|559233998|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
154947727|NCT03594123|559233997|FG000|Overall Study|Lack of Efficacy|1|||
154947728|NCT03594123|559233998|FG001|Overall Study|Lack of Efficacy|0|||
154947729|NCT03594123|559233997|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
154947730|NCT03594123|559233998|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
154947731|NCT03365375|559233999|FG000|Overall Study|Withdrawal by Subject|0|||
154947732|NCT03365375|559234000|FG001|Overall Study|Withdrawal by Subject|1|||
154947733|NCT03365375|559233999|FG000|Overall Study|Lost to Follow-up|0|||
154947734|NCT03365375|559234000|FG001|Overall Study|Lost to Follow-up|4|||
154947735|NCT02483975|559234001|FG000|Overall Study|Adverse Event|0|||
154947736|NCT02483975|559234002|FG001|Overall Study|Adverse Event|1|||
154947737|NCT02483975|559234001|FG000|Overall Study|Lost to Follow-up|0|||
154947738|NCT02483975|559234002|FG001|Overall Study|Lost to Follow-up|1|||
154947739|NCT02483975|559234001|FG000|Overall Study|Physician Decision|2|||
154947740|NCT02483975|559234002|FG001|Overall Study|Physician Decision|0|||
154947741|NCT00818883|559234003|FG000|Overall Study|Adverse Event|28|||
154947742|NCT00818883|559234004|FG001|Overall Study|Adverse Event|19|||
154947743|NCT00818883|559234003|FG000|Overall Study|Protocol Violation|2|||
154947744|NCT00818883|559234004|FG001|Overall Study|Protocol Violation|2|||
154947745|NCT00818883|559234003|FG000|Overall Study|Lost to Follow-up|3|||
154947746|NCT00818883|559234004|FG001|Overall Study|Lost to Follow-up|2|||
154947747|NCT00818883|559234003|FG000|Overall Study|Withdrawal by Subject|16|||
154947748|NCT00818883|559234004|FG001|Overall Study|Withdrawal by Subject|14|||
155049933|NCT01719380|559614130|FG009|Overall Study|Physician Decision|1|||
154947749|NCT00818883|559234003|FG000|Overall Study|Lack of Efficacy|0|||
154947750|NCT00818883|559234004|FG001|Overall Study|Lack of Efficacy|2|||
155388994|NCT00960531|560858784|FG004|Overall Study|Caregiver Request|0|||
155388995|NCT00960531|560858785|FG005|Overall Study|Caregiver Request|2|||
155388996|NCT00960531|560858786|FG006|Overall Study|Caregiver Request|3|||
155388997|NCT00960531|560858787|FG007|Overall Study|Caregiver Request|1|||
155388998|NCT00960531|560858788|FG008|Overall Study|Caregiver Request|3|||
155388999|NCT00960531|560858789|FG009|Overall Study|Caregiver Request|0|||
155389000|NCT00960531|560858780|FG000|Overall Study|Investigator Request|0|||
155389001|NCT00960531|560858781|FG001|Overall Study|Investigator Request|0|||
155389002|NCT00960531|560858782|FG002|Overall Study|Investigator Request|1|||
155389003|NCT00960531|560858783|FG003|Overall Study|Investigator Request|0|||
155389004|NCT00960531|560858784|FG004|Overall Study|Investigator Request|0|||
155389005|NCT00960531|560858785|FG005|Overall Study|Investigator Request|0|||
155389006|NCT00960531|560858786|FG006|Overall Study|Investigator Request|0|||
155389007|NCT00960531|560858787|FG007|Overall Study|Investigator Request|0|||
155389008|NCT00960531|560858788|FG008|Overall Study|Investigator Request|0|||
155389009|NCT00960531|560858789|FG009|Overall Study|Investigator Request|0|||
155389010|NCT00960531|560858780|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
155389011|NCT00960531|560858781|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155389012|NCT00960531|560858782|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
155389013|NCT00960531|560858783|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155389014|NCT00960531|560858784|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
155389015|NCT00960531|560858785|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
155389016|NCT00960531|560858786|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
155389017|NCT00960531|560858787|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
155389018|NCT00960531|560858788|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
155389019|NCT00960531|560858789|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
155389020|NCT00960531|560858780|FG000|Overall Study|Lost to Follow-up|0|||
155389021|NCT00960531|560858781|FG001|Overall Study|Lost to Follow-up|0|||
155389022|NCT00960531|560858782|FG002|Overall Study|Lost to Follow-up|1|||
155389023|NCT00960531|560858783|FG003|Overall Study|Lost to Follow-up|0|||
155389024|NCT00960531|560858784|FG004|Overall Study|Lost to Follow-up|0|||
155389025|NCT00960531|560858785|FG005|Overall Study|Lost to Follow-up|0|||
155389026|NCT00960531|560858786|FG006|Overall Study|Lost to Follow-up|1|||
155389027|NCT00960531|560858787|FG007|Overall Study|Lost to Follow-up|0|||
155389028|NCT00960531|560858788|FG008|Overall Study|Lost to Follow-up|0|||
155389029|NCT00960531|560858789|FG009|Overall Study|Lost to Follow-up|0|||
155389030|NCT00960531|560858780|FG000|Overall Study|Failed to Return|2|||
155389031|NCT00960531|560858781|FG001|Overall Study|Failed to Return|0|||
155389032|NCT00960531|560858782|FG002|Overall Study|Failed to Return|0|||
155389033|NCT00960531|560858783|FG003|Overall Study|Failed to Return|0|||
154947751|NCT00818883|559234003|FG000|Overall Study|Other|2|||
154947752|NCT00818883|559234004|FG001|Overall Study|Other|7|||
154947753|NCT00290745|559234009|FG000|Overall Study|Withdrawal by Subject|4|||
154947754|NCT00290745|559234009|FG000|Overall Study|Physician Decision|2|||
154947755|NCT00290745|559234009|FG000|Overall Study|Surgery after 3 months for progression|3|||
154947756|NCT00290745|559234009|FG000|Overall Study|Baseline MRI not available|3|||
154947757|NCT02187042|559234012|FG000|Overall Study|Death|1|||
154947758|NCT02187042|559234013|FG001|Overall Study|Death|1|||
154947759|NCT02187042|559234012|FG000|Overall Study|Toxicity|6|||
154947760|NCT02187042|559234013|FG001|Overall Study|Toxicity|5|||
154947761|NCT02187042|559234012|FG000|Overall Study|Participant choice|1|||
154947762|NCT02187042|559234013|FG001|Overall Study|Participant choice|0|||
154947763|NCT02187042|559234012|FG000|Overall Study|Doctor choice|1|||
154947764|NCT02187042|559234013|FG001|Overall Study|Doctor choice|0|||
154947765|NCT02187042|559234012|FG000|Overall Study|Progressive disease|4|||
154947766|NCT02187042|559234013|FG001|Overall Study|Progressive disease|8|||
154947767|NCT00108732|559234014|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
154947768|NCT00108732|559234014|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
154947769|NCT00108732|559234014|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
154947770|NCT00108732|559234014|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
154947771|NCT00108732|559234014|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
154947772|NCT00108732|559234014|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
155389034|NCT00960531|560858784|FG004|Overall Study|Failed to Return|0|||
155389035|NCT00960531|560858785|FG005|Overall Study|Failed to Return|0|||
155389036|NCT00960531|560858786|FG006|Overall Study|Failed to Return|0|||
155389037|NCT00960531|560858787|FG007|Overall Study|Failed to Return|2|||
155389038|NCT00960531|560858788|FG008|Overall Study|Failed to Return|0|||
155389039|NCT00960531|560858789|FG009|Overall Study|Failed to Return|0|||
154947773|NCT00108732|559234014|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
154947774|NCT01659567|559234015|FG000|Overall Study|Lack of Efficacy|22|||
154947775|NCT01659567|559234015|FG000|Overall Study|Switched to Pegferon|6|||
155389040|NCT00960531|560858780|FG000|Overall Study|Adverse Event (AE)|2|||
155389041|NCT00960531|560858781|FG001|Overall Study|Adverse Event (AE)|0|||
155389042|NCT00960531|560858782|FG002|Overall Study|Adverse Event (AE)|0|||
155389043|NCT00960531|560858783|FG003|Overall Study|Adverse Event (AE)|0|||
155389044|NCT00960531|560858784|FG004|Overall Study|Adverse Event (AE)|0|||
155389045|NCT00960531|560858785|FG005|Overall Study|Adverse Event (AE)|1|||
154947776|NCT01659567|559234015|FG000|Overall Study|Adverse Event|12|||
154947777|NCT01659567|559234015|FG000|Overall Study|Good result at early stage of treatment|5|||
154947778|NCT01659567|559234015|FG000|Overall Study|Withdrawal by Subject|64|||
154947779|NCT01659567|559234015|FG000|Overall Study|Progression of the main disease|1|||
154947780|NCT01659567|559234015|FG000|Overall Study|Other|13|||
154947781|NCT01915732|559234026|FG000|Overall Study|Withdrawal by Subject|18|||
154947782|NCT01915732|559234027|FG001|Overall Study|Withdrawal by Subject|18|||
154947783|NCT01915732|559234026|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
154947784|NCT01915732|559234027|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
154947785|NCT01915732|559234026|FG000|Overall Study|Adverse Event|12|||
154947786|NCT01915732|559234027|FG001|Overall Study|Adverse Event|4|||
154947787|NCT01915732|559234026|FG000|Overall Study|Protocol Violation|5|||
154947788|NCT01915732|559234027|FG001|Overall Study|Protocol Violation|5|||
154947789|NCT01915732|559234026|FG000|Overall Study|Lack of Efficacy|6|||
154947790|NCT01915732|559234027|FG001|Overall Study|Lack of Efficacy|11|||
154947791|NCT01915732|559234026|FG000|Overall Study|Lost to Follow-up|22|||
154947792|NCT01915732|559234027|FG001|Overall Study|Lost to Follow-up|26|||
154947793|NCT01915732|559234026|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
154947794|NCT01915732|559234027|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
154947795|NCT01915732|559234026|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
154947796|NCT01915732|559234027|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
154947797|NCT01915732|559234026|FG000|Overall Study|Drug Release Error|1|||
154947798|NCT01915732|559234027|FG001|Overall Study|Drug Release Error|0|||
154947799|NCT01915732|559234026|FG000|Overall Study|Recovered|1|||
154947800|NCT01915732|559234027|FG001|Overall Study|Recovered|0|||
154947801|NCT01915732|559234026|FG000|Overall Study|Pregnancy|1|||
154947802|NCT01915732|559234027|FG001|Overall Study|Pregnancy|0|||
154947803|NCT01915732|559234026|FG000|Overall Study|Poor Perceived Efficacy|1|||
154947804|NCT01915732|559234027|FG001|Overall Study|Poor Perceived Efficacy|0|||
154947805|NCT01915732|559234026|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
154947806|NCT01915732|559234027|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
154947807|NCT01915732|559234026|FG000|Overall Study|Got Well|0|||
154947808|NCT01915732|559234027|FG001|Overall Study|Got Well|1|||
154947809|NCT01915732|559234026|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
154947810|NCT01915732|559234027|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
154947811|NCT01915732|559234026|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
154947812|NCT01915732|559234027|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
154947813|NCT01915732|559234026|FG000|Overall Study|Job Transfer|0|||
154947814|NCT01915732|559234027|FG001|Overall Study|Job Transfer|1|||
154947815|NCT01915732|559234026|FG000|Overall Study|Improper Facial Procedure|0|||
154947816|NCT01915732|559234027|FG001|Overall Study|Improper Facial Procedure|1|||
154947817|NCT01915732|559234026|FG000|Overall Study|Poor Conscious Effect|0|||
154947818|NCT01915732|559234027|FG001|Overall Study|Poor Conscious Effect|1|||
154947819|NCT00449150|559234033|FG000|Overall Study|Adverse Event|11|||
154947820|NCT00449150|559234034|FG001|Overall Study|Adverse Event|18|||
154947821|NCT00449150|559234035|FG002|Overall Study|Adverse Event|9|||
154947822|NCT00449150|559234033|FG000|Overall Study|Lack of Efficacy|1|||
154947823|NCT00449150|559234034|FG001|Overall Study|Lack of Efficacy|2|||
154947824|NCT00449150|559234035|FG002|Overall Study|Lack of Efficacy|2|||
154947825|NCT00449150|559234033|FG000|Overall Study|Other|16|||
154947826|NCT00449150|559234034|FG001|Overall Study|Other|13|||
154947827|NCT00449150|559234035|FG002|Overall Study|Other|14|||
155281689|NCT01544582|560461704|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
155281690|NCT01544582|560461705|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
155281691|NCT01544582|560461706|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
155281692|NCT01544582|560461703|FG000|Analysis Population|Physician Decision|0|||
155281693|NCT01544582|560461704|FG001|Analysis Population|Physician Decision|13|||
155281694|NCT01544582|560461705|FG002|Analysis Population|Physician Decision|10|||
155281695|NCT01544582|560461706|FG003|Analysis Population|Physician Decision|9|||
155281696|NCT01544582|560461703|FG000|Analysis Population|Safety Reason|0|||
155281697|NCT01544582|560461704|FG001|Analysis Population|Safety Reason|33|||
155281698|NCT01544582|560461705|FG002|Analysis Population|Safety Reason|31|||
155281699|NCT01544582|560461706|FG003|Analysis Population|Safety Reason|8|||
155281700|NCT01544582|560461703|FG000|Analysis Population|Effectiveness Reason|0|||
155281701|NCT01544582|560461704|FG001|Analysis Population|Effectiveness Reason|48|||
155281702|NCT01544582|560461705|FG002|Analysis Population|Effectiveness Reason|29|||
155281703|NCT01544582|560461706|FG003|Analysis Population|Effectiveness Reason|12|||
155281704|NCT01544582|560461703|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
155281705|NCT01544582|560461704|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
155281706|NCT01544582|560461705|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
154947828|NCT00449150|559234033|FG000|Overall Study|Withdrawal by Subject|17|||
154947829|NCT00449150|559234034|FG001|Overall Study|Withdrawal by Subject|18|||
154947830|NCT00449150|559234035|FG002|Overall Study|Withdrawal by Subject|21|||
154947831|NCT00449150|559234033|FG000|Overall Study|Protocol Violation|1|||
154947832|NCT00449150|559234034|FG001|Overall Study|Protocol Violation|2|||
154947833|NCT00449150|559234035|FG002|Overall Study|Protocol Violation|1|||
155049934|NCT01719380|559614121|FG000|Overall Study|Lack of Efficacy|2|||
155049935|NCT01719380|559614122|FG001|Overall Study|Lack of Efficacy|6|||
155049936|NCT01719380|559614123|FG002|Overall Study|Lack of Efficacy|5|||
155049937|NCT01719380|559614124|FG003|Overall Study|Lack of Efficacy|6|||
155049938|NCT01719380|559614125|FG004|Overall Study|Lack of Efficacy|3|||
155049939|NCT01719380|559614126|FG005|Overall Study|Lack of Efficacy|7|||
155049940|NCT01719380|559614127|FG006|Overall Study|Lack of Efficacy|10|||
155049941|NCT01719380|559614128|FG007|Overall Study|Lack of Efficacy|6|||
155049942|NCT01719380|559614129|FG008|Overall Study|Lack of Efficacy|39|||
155049943|NCT01719380|559614130|FG009|Overall Study|Lack of Efficacy|42|||
155049944|NCT01719380|559614121|FG000|Overall Study|Progressive Disease|0|||
155049945|NCT01719380|559614122|FG001|Overall Study|Progressive Disease|0|||
155049946|NCT01719380|559614123|FG002|Overall Study|Progressive Disease|0|||
155049947|NCT01719380|559614124|FG003|Overall Study|Progressive Disease|0|||
155049948|NCT01719380|559614125|FG004|Overall Study|Progressive Disease|0|||
155049949|NCT01719380|559614126|FG005|Overall Study|Progressive Disease|0|||
155049950|NCT01719380|559614127|FG006|Overall Study|Progressive Disease|0|||
155049951|NCT01719380|559614128|FG007|Overall Study|Progressive Disease|0|||
155049952|NCT01719380|559614129|FG008|Overall Study|Progressive Disease|1|||
155049953|NCT01719380|559614130|FG009|Overall Study|Progressive Disease|0|||
155049954|NCT03361306|559614138|FG000|Overall Study|Death|6|||
155049955|NCT00807885|559614144|FG000|Overall Study|Lost to Follow-up|0|||
155049956|NCT00807885|559614145|FG001|Overall Study|Lost to Follow-up|0|||
155049957|NCT00807885|559614146|FG002|Overall Study|Lost to Follow-up|0|||
155049958|NCT00807885|559614147|FG003|Overall Study|Lost to Follow-up|0|||
155049959|NCT00807885|559614148|FG004|Overall Study|Lost to Follow-up|0|||
155049960|NCT00807885|559614149|FG005|Overall Study|Lost to Follow-up|1|||
155049961|NCT00807885|559614150|FG006|Overall Study|Lost to Follow-up|0|||
155049962|NCT00807885|559614151|FG007|Overall Study|Lost to Follow-up|0|||
155049963|NCT00807885|559614152|FG008|Overall Study|Lost to Follow-up|0|||
155049964|NCT03489343|559614153|FG000|Overall Study|Documented progressive disease|1|||
155049965|NCT03489343|559614154|FG001|Overall Study|Documented progressive disease|0|||
155049966|NCT03489343|559614155|FG002|Overall Study|Documented progressive disease|3|||
155049967|NCT03489343|559614156|FG003|Overall Study|Documented progressive disease|1|||
155049968|NCT03489343|559614157|FG004|Overall Study|Documented progressive disease|3|||
155049969|NCT03489343|559614158|FG005|Overall Study|Documented progressive disease|5|||
155049970|NCT03489343|559614159|FG006|Overall Study|Documented progressive disease|4|||
155049971|NCT03489343|559614153|FG000|Overall Study|Adverse Event|0|||
155049972|NCT03489343|559614154|FG001|Overall Study|Adverse Event|1|||
155049973|NCT03489343|559614155|FG002|Overall Study|Adverse Event|0|||
155049974|NCT03489343|559614156|FG003|Overall Study|Adverse Event|0|||
155049975|NCT03489343|559614157|FG004|Overall Study|Adverse Event|0|||
155049976|NCT03489343|559614158|FG005|Overall Study|Adverse Event|1|||
155049977|NCT03489343|559614159|FG006|Overall Study|Adverse Event|0|||
155049978|NCT03489343|559614153|FG000|Overall Study|Withdrawal by Subject|0|||
155049979|NCT03489343|559614154|FG001|Overall Study|Withdrawal by Subject|0|||
155049980|NCT03489343|559614155|FG002|Overall Study|Withdrawal by Subject|0|||
155049981|NCT03489343|559614156|FG003|Overall Study|Withdrawal by Subject|1|||
155049982|NCT03489343|559614157|FG004|Overall Study|Withdrawal by Subject|0|||
155049983|NCT03489343|559614158|FG005|Overall Study|Withdrawal by Subject|1|||
155049984|NCT03489343|559614159|FG006|Overall Study|Withdrawal by Subject|1|||
155049985|NCT03489343|559614153|FG000|Overall Study|Clinical progression|0|||
155049986|NCT03489343|559614154|FG001|Overall Study|Clinical progression|0|||
155049987|NCT03489343|559614155|FG002|Overall Study|Clinical progression|0|||
155049988|NCT03489343|559614156|FG003|Overall Study|Clinical progression|1|||
155049989|NCT03489343|559614157|FG004|Overall Study|Clinical progression|0|||
155049990|NCT03489343|559614158|FG005|Overall Study|Clinical progression|0|||
155049991|NCT03489343|559614159|FG006|Overall Study|Clinical progression|1|||
155049992|NCT01630135|559614161|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
155049993|NCT01630135|559614162|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
155049994|NCT04767373|559614164|FG000|Overall Study|Death|6|||
155389046|NCT00960531|560858786|FG006|Overall Study|Adverse Event (AE)|2|||
155389047|NCT00960531|560858787|FG007|Overall Study|Adverse Event (AE)|0|||
155389048|NCT00960531|560858788|FG008|Overall Study|Adverse Event (AE)|2|||
155389049|NCT00960531|560858789|FG009|Overall Study|Adverse Event (AE)|0|||
155049995|NCT04767373|559614165|FG001|Overall Study|Death|3|||
155049996|NCT04767373|559614164|FG000|Overall Study|Lost to Follow-up|67|||
155049997|NCT04767373|559614165|FG001|Overall Study|Lost to Follow-up|35|||
155389050|NCT00960531|560858780|FG000|Overall Study|Reason not Specified|2|||
155049998|NCT04767373|559614164|FG000|Overall Study|Physician Decision|15|||
155049999|NCT04767373|559614165|FG001|Overall Study|Physician Decision|4|||
155050000|NCT04767373|559614164|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155050001|NCT04767373|559614165|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155050002|NCT04767373|559614164|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
155050003|NCT04767373|559614165|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
155050004|NCT04767373|559614164|FG000|Overall Study|Other|1|||
155389051|NCT00960531|560858781|FG001|Overall Study|Reason not Specified|1|||
155389052|NCT00960531|560858782|FG002|Overall Study|Reason not Specified|13|||
155050005|NCT04767373|559614165|FG001|Overall Study|Other|2|||
155050006|NCT01502033|559614166|FG000|Overall Study|1 participant had scalp discomfort|1|||
155050007|NCT01502033|559614166|FG000|Overall Study|1 participant had worsening depression|1|||
155050008|NCT01502033|559614166|FG000|Overall Study|1 participant went back to school|1|||
155050009|NCT02658669|559614167|FG000|Overall Study|Lost to Follow-up|7|||
155050010|NCT02658669|559614168|FG001|Overall Study|Lost to Follow-up|5|||
155050011|NCT00838097|559614169|FG000|Overall Study|Ineligibility determined|6|||
155050012|NCT00838097|559614169|FG000|Overall Study|Adverse Event|2|||
155050013|NCT00838097|559614169|FG000|Overall Study|Withdrawal by Subject|3|||
155050014|NCT00838097|559614169|FG000|Overall Study|Requirement for alternative therapy|2|||
155050015|NCT00838097|559614169|FG000|Overall Study|Physician Decision|4|||
155050016|NCT00838097|559614169|FG000|Overall Study|Lost to Follow-up|11|||
155050017|NCT00838097|559614169|FG000|Overall Study|Death|6|||
155050018|NCT00838097|559614169|FG000|Overall Study|Protocol-specified criteria|142|||
155050019|NCT02149264|559614170|FG000|Overall Study|Withdrawal by Subject|9|||
155050020|NCT02149264|559614170|FG000|Overall Study|Adverse Event|7|||
155050021|NCT02149264|559614170|FG000|Overall Study|Physician Decision|3|||
155050022|NCT02149264|559614170|FG000|Overall Study|Protocol Violation|1|||
155050023|NCT02824627|559614173|FG000|Overall Study|Adverse Event|1|||
155050024|NCT02824627|559614174|FG001|Overall Study|Adverse Event|2|||
155050025|NCT02824627|559614173|FG000|Overall Study|Lost to Follow-up|2|||
155050026|NCT02824627|559614174|FG001|Overall Study|Lost to Follow-up|1|||
155050027|NCT01938846|559614175|FG000|Overall Study|Progressive disease|26|||
155050028|NCT01938846|559614176|FG001|Overall Study|Progressive disease|18|||
155050029|NCT01938846|559614177|FG002|Overall Study|Progressive disease|16|||
155050030|NCT01938846|559614175|FG000|Overall Study|Adverse Event|8|||
155050031|NCT01938846|559614176|FG001|Overall Study|Adverse Event|4|||
155050032|NCT01938846|559614177|FG002|Overall Study|Adverse Event|3|||
155050033|NCT01938846|559614175|FG000|Overall Study|Withdrawal by Subject|2|||
155050034|NCT01938846|559614176|FG001|Overall Study|Withdrawal by Subject|2|||
155050035|NCT01938846|559614177|FG002|Overall Study|Withdrawal by Subject|1|||
155050036|NCT01938846|559614175|FG000|Overall Study|Other than listed|5|||
155050037|NCT01938846|559614176|FG001|Overall Study|Other than listed|1|||
155050038|NCT01938846|559614177|FG002|Overall Study|Other than listed|4|||
155050039|NCT02499120|559614178|FG000|Overall Study|Death|52|||
155050040|NCT02499120|559614179|FG001|Overall Study|Death|43|||
155050041|NCT02499120|559614178|FG000|Overall Study|Lost to Follow-up|1|||
155050042|NCT02499120|559614179|FG001|Overall Study|Lost to Follow-up|2|||
155050043|NCT02499120|559614178|FG000|Overall Study|Participant refused further follow-up|1|||
155050044|NCT02499120|559614179|FG001|Overall Study|Participant refused further follow-up|0|||
155050045|NCT02499120|559614178|FG000|Overall Study|Withdrawal by Subject|2|||
155050046|NCT02499120|559614179|FG001|Overall Study|Withdrawal by Subject|5|||
155050047|NCT02499120|559614178|FG000|Overall Study|Other|9|||
155050048|NCT02499120|559614179|FG001|Overall Study|Other|10|||
155050049|NCT01801111|559614193|FG000|Overall Study|Adverse Event|12|||
155050050|NCT01801111|559614193|FG000|Overall Study|Death|8|||
155050051|NCT01801111|559614193|FG000|Overall Study|Physician Decision|5|||
155050052|NCT01801111|559614193|FG000|Overall Study|Other|1|||
155050053|NCT01801111|559614193|FG000|Overall Study|Withdrawal by Subject|4|||
155050054|NCT01801111|559614193|FG000|Overall Study|Study Terminated by Sponsor|27|||
155050055|NCT01801111|559614193|FG000|Overall Study|Progressive Disease|81|||
155050056|NCT01210482|559614194|FG000|Overall Study|Protocol Violation|1|||
155050057|NCT01210482|559614194|FG000|Overall Study|Case Report Forms were not collected|18|||
155050058|NCT01210482|559614194|FG000|Overall Study|Duplicated|2|||
155050059|NCT01210482|559614194|FG000|Overall Study|No Drug Administration|28|||
155050060|NCT01223937|559614195|FG000|Overall Study|Withdrawal by Subject|3|||
155050061|NCT01223937|559614196|FG001|Overall Study|Withdrawal by Subject|2|||
155050062|NCT01223937|559614195|FG000|Overall Study|Lost to Follow-up|1|||
155050063|NCT01223937|559614196|FG001|Overall Study|Lost to Follow-up|4|||
155050064|NCT01223937|559614195|FG000|Overall Study|Adverse Event|1|||
155050065|NCT01223937|559614196|FG001|Overall Study|Adverse Event|4|||
155050066|NCT01223937|559614195|FG000|Overall Study|Protocol Violation|8|||
155050067|NCT01223937|559614196|FG001|Overall Study|Protocol Violation|7|||
155050068|NCT01223937|559614195|FG000|Overall Study|Other|4|||
155281707|NCT01544582|560461706|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
155050069|NCT01223937|559614196|FG001|Overall Study|Other|1|||
155050070|NCT05176717|559614197|FG000|Overall Study|Sponsor Decision|1|||
155050071|NCT05176717|559614198|FG001|Overall Study|Sponsor Decision|2|||
155050072|NCT05176717|559614199|FG002|Overall Study|Sponsor Decision|2|||
155281708|NCT01544582|560461703|FG000|Analysis Population|Lost to Follow-up|0|||
155050073|NCT03284853|559614200|FG000|Overall Study|Adverse Event|40|||
155050074|NCT03284853|559614201|FG001|Overall Study|Adverse Event|4|||
155050075|NCT03284853|559614200|FG000|Overall Study|Withdrawal by Subject|5|||
155281709|NCT01544582|560461704|FG001|Analysis Population|Lost to Follow-up|6|||
155281710|NCT01544582|560461705|FG002|Analysis Population|Lost to Follow-up|6|||
155050076|NCT03284853|559614201|FG001|Overall Study|Withdrawal by Subject|1|||
155050077|NCT03284853|559614200|FG000|Overall Study|Lost to Follow-up|1|||
155050078|NCT03284853|559614201|FG001|Overall Study|Lost to Follow-up|0|||
155050079|NCT03284853|559614200|FG000|Overall Study|Lack of Efficacy|1|||
155389053|NCT00960531|560858783|FG003|Overall Study|Reason not Specified|1|||
155389054|NCT00960531|560858784|FG004|Overall Study|Reason not Specified|2|||
155389055|NCT00960531|560858785|FG005|Overall Study|Reason not Specified|0|||
155389056|NCT00960531|560858786|FG006|Overall Study|Reason not Specified|16|||
155389057|NCT00960531|560858787|FG007|Overall Study|Reason not Specified|0|||
155389058|NCT00960531|560858788|FG008|Overall Study|Reason not Specified|8|||
155389059|NCT00960531|560858789|FG009|Overall Study|Reason not Specified|1|||
155389060|NCT00593957|560858790|FG000|Overall Study|Physician Decision|0|||
155389061|NCT00593957|560858791|FG001|Overall Study|Physician Decision|1|||
155389062|NCT00593957|560858792|FG002|Overall Study|Physician Decision|2|||
155389063|NCT02411578|560858793|FG000|Crossover Trial Phase|Pregnancy|0|||
155389064|NCT02411578|560858794|FG001|Crossover Trial Phase|Pregnancy|1|||
155389065|NCT00494481|560858795|FG000|Overall Study|Condition under investigation worsened|11|||
155389066|NCT00494481|560858796|FG001|Overall Study|Condition under investigation worsened|13|||
155389067|NCT00494481|560858795|FG000|Overall Study|Adverse Event|15|||
155389068|NCT00494481|560858796|FG001|Overall Study|Adverse Event|11|||
155389069|NCT00494481|560858795|FG000|Overall Study|Other|1|||
155389070|NCT00494481|560858796|FG001|Overall Study|Other|0|||
155389071|NCT00494481|560858795|FG000|Overall Study|Never received IP|2|||
155389072|NCT00494481|560858796|FG001|Overall Study|Never received IP|0|||
155389073|NCT00332189|560858797|FG000|Overall Study|Adverse Event|3|||
155389074|NCT00332189|560858797|FG000|Overall Study|Uncooperative/Noncompliant|3|||
154947834|NCT02246478|559234036|FG000|Multiple-dose Phase|Protocol Violation|1|||
154947835|NCT02246478|559234037|FG001|Multiple-dose Phase|Protocol Violation|0|||
154947836|NCT02246478|559234038|FG002|Multiple-dose Phase|Protocol Violation|0|||
154947837|NCT02246478|559234039|FG003|Multiple-dose Phase|Protocol Violation|1|||
154947838|NCT00429923|559234041|FG000|Overall Study|Adverse Event|0|||
154947839|NCT00429923|559234042|FG001|Overall Study|Adverse Event|2|||
154947840|NCT00429923|559234043|FG002|Overall Study|Adverse Event|3|||
154947841|NCT00429923|559234041|FG000|Overall Study|Lack of Efficacy|4|||
154947842|NCT00429923|559234042|FG001|Overall Study|Lack of Efficacy|1|||
154947843|NCT00429923|559234043|FG002|Overall Study|Lack of Efficacy|33|||
154947844|NCT00429923|559234041|FG000|Overall Study|Lost to Follow-up|0|||
154947845|NCT00429923|559234042|FG001|Overall Study|Lost to Follow-up|0|||
154947846|NCT00429923|559234043|FG002|Overall Study|Lost to Follow-up|2|||
154947847|NCT00429923|559234041|FG000|Overall Study|Withdrew Consent|1|||
154947848|NCT00429923|559234042|FG001|Overall Study|Withdrew Consent|0|||
154947849|NCT00429923|559234043|FG002|Overall Study|Withdrew Consent|1|||
154947850|NCT00429923|559234041|FG000|Overall Study|Early Termination|0|||
154947851|NCT00429923|559234042|FG001|Overall Study|Early Termination|1|||
154947852|NCT00429923|559234043|FG002|Overall Study|Early Termination|0|||
154947853|NCT00662129|559234044|FG000|Overall Study|Protocol Violation|1|||
154947854|NCT00662129|559234044|FG000|Overall Study|Cancel prior to beginning treatment|1|||
154947855|NCT00662129|559234044|FG000|Overall Study|Ineligible|1|||
154947856|NCT00329602|559234047|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
154947857|NCT00329602|559234048|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
154947858|NCT00329602|559234049|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
154947859|NCT00329602|559234047|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
154947860|NCT00329602|559234048|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
154947861|NCT00329602|559234049|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
154947862|NCT00329602|559234047|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
154947863|NCT00329602|559234048|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
154947864|NCT00329602|559234049|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
154947865|NCT00329602|559234047|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
154947866|NCT00329602|559234048|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
154947867|NCT00329602|559234049|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
154947868|NCT00329602|559234047|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
154947869|NCT00329602|559234048|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
154947870|NCT00329602|559234049|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
154947871|NCT00329602|559234047|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
154947872|NCT00329602|559234048|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
154947873|NCT00329602|559234049|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
154947874|NCT02579096|559234050|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
154947875|NCT02579096|559234051|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
154947876|NCT02579096|559234050|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
154947877|NCT02579096|559234051|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
154947878|NCT02579096|559234050|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
154947879|NCT02579096|559234051|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
154947880|NCT02579096|559234050|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
155389075|NCT00332189|560858797|FG000|Overall Study|Withdrawal by Subject|9|||
155389076|NCT00332189|560858797|FG000|Overall Study|Lack of Efficacy|4|||
155389077|NCT00332189|560858797|FG000|Overall Study|Moved out of country|2|||
155389078|NCT02370043|560858798|FG000|Overall Study|Withdrawal by Subject|0|||
155389079|NCT02370043|560858799|FG001|Overall Study|Withdrawal by Subject|0|||
154947881|NCT02579096|559234051|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
154947882|NCT02579096|559234050|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
154947883|NCT02579096|559234051|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
154947884|NCT02579096|559234050|FG000|Phase 2, Weeks 25 - 48|Death|2|||
154947885|NCT02579096|559234051|FG001|Phase 2, Weeks 25 - 48|Death|4|||
154947886|NCT02579096|559234050|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
154947887|NCT02579096|559234051|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
154947888|NCT02579096|559234050|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
154947889|NCT02579096|559234051|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
154947890|NCT02579096|559234050|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
154947891|NCT02579096|559234051|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
154947892|NCT02579096|559234050|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
154947893|NCT02579096|559234051|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
154947894|NCT02579096|559234050|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
154947895|NCT02579096|559234051|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
154947896|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Death|3|||
154947897|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Death|2|||
154947898|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
154947899|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
154947900|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
154947901|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
154947902|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
154947903|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
154947904|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
154947905|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
154947906|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
154947907|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
154947908|NCT02579096|559234050|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
154947909|NCT02579096|559234051|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
154947910|NCT02729896|559234054|FG000|Overall Study|Death|0|||
154947911|NCT02729896|559234055|FG001|Overall Study|Death|2|||
154947912|NCT02729896|559234056|FG002|Overall Study|Death|13|||
154947913|NCT02729896|559234054|FG000|Overall Study|Lost to Follow-up|0|||
154947914|NCT02729896|559234055|FG001|Overall Study|Lost to Follow-up|2|||
154947915|NCT02729896|559234056|FG002|Overall Study|Lost to Follow-up|3|||
154947916|NCT02729896|559234054|FG000|Overall Study|Other|0|||
154947917|NCT02729896|559234055|FG001|Overall Study|Other|2|||
154947918|NCT02729896|559234056|FG002|Overall Study|Other|0|||
154947919|NCT02729896|559234054|FG000|Overall Study|Physician Decision|1|||
154947920|NCT02729896|559234055|FG001|Overall Study|Physician Decision|2|||
154947921|NCT02729896|559234056|FG002|Overall Study|Physician Decision|3|||
154947922|NCT02729896|559234054|FG000|Overall Study|Progressive Disease|0|||
154947923|NCT02729896|559234055|FG001|Overall Study|Progressive Disease|1|||
154947924|NCT02729896|559234056|FG002|Overall Study|Progressive Disease|0|||
154947925|NCT02729896|559234054|FG000|Overall Study|Withdrawal by Subject|1|||
154947926|NCT02729896|559234055|FG001|Overall Study|Withdrawal by Subject|0|||
154947927|NCT02729896|559234056|FG002|Overall Study|Withdrawal by Subject|3|||
154947928|NCT01592370|559234060|FG000|Overall Study|Disease Progression|62|||
154947929|NCT01592370|559234061|FG001|Overall Study|Disease Progression|16|||
154947930|NCT01592370|559234062|FG002|Overall Study|Disease Progression|52|||
154947931|NCT01592370|559234063|FG003|Overall Study|Disease Progression|3|||
154947932|NCT01592370|559234064|FG004|Overall Study|Disease Progression|3|||
154947933|NCT01592370|559234065|FG005|Overall Study|Disease Progression|31|||
154947934|NCT01592370|559234066|FG006|Overall Study|Disease Progression|14|||
154947935|NCT01592370|559234060|FG000|Overall Study|Study Drug Toxicity|14|||
154947936|NCT01592370|559234061|FG001|Overall Study|Study Drug Toxicity|3|||
154947937|NCT01592370|559234062|FG002|Overall Study|Study Drug Toxicity|0|||
154947938|NCT01592370|559234063|FG003|Overall Study|Study Drug Toxicity|0|||
154947939|NCT01592370|559234064|FG004|Overall Study|Study Drug Toxicity|0|||
154947940|NCT01592370|559234065|FG005|Overall Study|Study Drug Toxicity|0|||
154947941|NCT01592370|559234066|FG006|Overall Study|Study Drug Toxicity|1|||
154947942|NCT01592370|559234060|FG000|Overall Study|AE unrelated to study drug|4|||
154947943|NCT01592370|559234061|FG001|Overall Study|AE unrelated to study drug|3|||
154947944|NCT01592370|559234062|FG002|Overall Study|AE unrelated to study drug|0|||
154947945|NCT01592370|559234063|FG003|Overall Study|AE unrelated to study drug|0|||
154947946|NCT01592370|559234064|FG004|Overall Study|AE unrelated to study drug|0|||
154947947|NCT01592370|559234065|FG005|Overall Study|AE unrelated to study drug|0|||
154947948|NCT01592370|559234066|FG006|Overall Study|AE unrelated to study drug|1|||
154947949|NCT01592370|559234060|FG000|Overall Study|Request to discontinue study treatment|5|||
155281711|NCT01544582|560461706|FG003|Analysis Population|Lost to Follow-up|5|||
154947950|NCT01592370|559234061|FG001|Overall Study|Request to discontinue study treatment|0|||
155281712|NCT01544582|560461703|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
155281713|NCT01544582|560461704|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
154947951|NCT01592370|559234062|FG002|Overall Study|Request to discontinue study treatment|2|||
154947952|NCT01592370|559234063|FG003|Overall Study|Request to discontinue study treatment|0|||
155050080|NCT03284853|559614201|FG001|Overall Study|Lack of Efficacy|0|||
155050081|NCT03284853|559614200|FG000|Overall Study|Disallowed Concurrent Medication|1|||
155050082|NCT03284853|559614201|FG001|Overall Study|Disallowed Concurrent Medication|1|||
155050083|NCT03284853|559614200|FG000|Overall Study|Protocol Violation|3|||
155050084|NCT03284853|559614201|FG001|Overall Study|Protocol Violation|3|||
155050085|NCT03284853|559614200|FG000|Overall Study|Death|0|||
155050086|NCT03284853|559614201|FG001|Overall Study|Death|1|||
155050087|NCT03284853|559614200|FG000|Overall Study|Other - Reason not reported in CSR|4|||
155050088|NCT03284853|559614201|FG001|Overall Study|Other - Reason not reported in CSR|3|||
155050089|NCT00765817|559614202|FG000|Overall Study|Adverse Event|13|||
155050090|NCT00765817|559614203|FG001|Overall Study|Adverse Event|1|||
155050091|NCT00765817|559614202|FG000|Overall Study|Death|0|||
155050092|NCT00765817|559614203|FG001|Overall Study|Death|1|||
155050093|NCT00765817|559614202|FG000|Overall Study|Entry criteria not met|2|||
155050094|NCT00765817|559614203|FG001|Overall Study|Entry criteria not met|2|||
155050095|NCT00765817|559614202|FG000|Overall Study|Loss of glucose control|0|||
155050096|NCT00765817|559614203|FG001|Overall Study|Loss of glucose control|2|||
155050097|NCT00765817|559614202|FG000|Overall Study|Lost to Follow-up|1|||
155050098|NCT00765817|559614203|FG001|Overall Study|Lost to Follow-up|3|||
155050099|NCT00765817|559614202|FG000|Overall Study|Physician Decision|2|||
155050100|NCT00765817|559614203|FG001|Overall Study|Physician Decision|1|||
155050101|NCT00765817|559614202|FG000|Overall Study|Protocol Violation|1|||
155050102|NCT00765817|559614203|FG001|Overall Study|Protocol Violation|1|||
155050103|NCT00765817|559614202|FG000|Overall Study|Subject decision|7|||
155050104|NCT00765817|559614203|FG001|Overall Study|Subject decision|11|||
155050105|NCT02308228|559614205|FG000|Overall Study|Adverse Event|3|||
155050106|NCT02308228|559614206|FG001|Overall Study|Adverse Event|4|||
155050107|NCT02308228|559614205|FG000|Overall Study|Withdrawal by Subject|5|||
155050108|NCT02308228|559614206|FG001|Overall Study|Withdrawal by Subject|3|||
155050109|NCT02143024|559614207|FG000|Overall Study|Lost to Follow-up|1|||
155050110|NCT02143024|559614208|FG001|Overall Study|Lost to Follow-up|1|||
155050111|NCT02143024|559614207|FG000|Overall Study|Withdrawal by Subject|1|||
155050112|NCT02143024|559614208|FG001|Overall Study|Withdrawal by Subject|0|||
155050113|NCT06597084|559614209|FG000|Overall Study|Withdrawal by Subject|4|||
155050114|NCT06597084|559614210|FG001|Overall Study|Withdrawal by Subject|9|||
155050115|NCT06597084|559614209|FG000|Overall Study|Consent was not given by the patient until V2|0|||
155050116|NCT06597084|559614210|FG001|Overall Study|Consent was not given by the patient until V2|3|||
155050117|NCT06597084|559614209|FG000|Overall Study|Physician Decision|1|||
155050118|NCT06597084|559614210|FG001|Overall Study|Physician Decision|0|||
155050119|NCT06597084|559614209|FG000|Overall Study|Adverse Event|3|||
155050120|NCT06597084|559614210|FG001|Overall Study|Adverse Event|2|||
155050121|NCT06597084|559614209|FG000|Overall Study|Death|4|||
155050122|NCT06597084|559614210|FG001|Overall Study|Death|0|||
155050123|NCT06597084|559614209|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
155050124|NCT06597084|559614210|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
155050125|NCT06597084|559614209|FG000|Overall Study|Lost to Follow-up|4|||
155050126|NCT06597084|559614210|FG001|Overall Study|Lost to Follow-up|2|||
155050127|NCT06597084|559614209|FG000|Overall Study|Other. Not specified|1|||
155050128|NCT06597084|559614210|FG001|Overall Study|Other. Not specified|0|||
155050129|NCT03999749|559614213|FG000|Overall Study|Toxicity|16|||
155050130|NCT03999749|559614213|FG000|Overall Study|Withdrawal by Subject|3|||
155050131|NCT03999749|559614213|FG000|Overall Study|Disease progression|26|||
155050132|NCT03999749|559614213|FG000|Overall Study|Physician Decision|4|||
155050133|NCT03999749|559614213|FG000|Overall Study|Death|5|||
155050134|NCT03999749|559614213|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
155050135|NCT00255164|559614214|FG000|Overall Study|Adverse Event|10|||
155050136|NCT00255164|559614215|FG001|Overall Study|Adverse Event|6|||
155050137|NCT00255164|559614216|FG002|Overall Study|Adverse Event|9|||
155050138|NCT00255164|559614214|FG000|Overall Study|Lost to Follow-up|4|||
155050139|NCT00255164|559614215|FG001|Overall Study|Lost to Follow-up|3|||
155050140|NCT00255164|559614216|FG002|Overall Study|Lost to Follow-up|4|||
155050141|NCT00255164|559614214|FG000|Overall Study|Withdrawal by Subject|18|||
155050142|NCT00255164|559614215|FG001|Overall Study|Withdrawal by Subject|17|||
155050143|NCT00255164|559614216|FG002|Overall Study|Withdrawal by Subject|8|||
155050144|NCT00255164|559614214|FG000|Overall Study|Noncompliance|0|||
155050145|NCT00255164|559614215|FG001|Overall Study|Noncompliance|1|||
155050146|NCT00255164|559614216|FG002|Overall Study|Noncompliance|2|||
155050147|NCT00255164|559614214|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
155050148|NCT00255164|559614215|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
155050149|NCT00255164|559614216|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
155050150|NCT00255164|559614214|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
155050151|NCT00255164|559614215|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
155050152|NCT00255164|559614216|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
155050153|NCT00255164|559614214|FG000|Overall Study|Possible Barrett's Esophagus|1|||
155050154|NCT00255164|559614215|FG001|Overall Study|Possible Barrett's Esophagus|3|||
155050155|NCT00255164|559614216|FG002|Overall Study|Possible Barrett's Esophagus|8|||
155050156|NCT00255164|559614214|FG000|Overall Study|Esophageal Stricture|0|||
155389080|NCT02370043|560858800|FG002|Overall Study|Withdrawal by Subject|0|||
155389081|NCT02370043|560858801|FG003|Overall Study|Withdrawal by Subject|0|||
155389082|NCT02370043|560858802|FG004|Overall Study|Withdrawal by Subject|1|||
155389083|NCT02370043|560858803|FG005|Overall Study|Withdrawal by Subject|1|||
155389084|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
155389085|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
155389086|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
155389087|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
155389088|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
155389089|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
155389090|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
155389091|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
155389092|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
155389093|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
155389094|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
155389095|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
155389096|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
155389097|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
155389098|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
155389099|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
155389100|NCT01231516|560858804|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
155389101|NCT01231516|560858805|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
155389102|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
155389103|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
155389104|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
154947953|NCT01592370|559234064|FG004|Overall Study|Request to discontinue study treatment|1|||
154947954|NCT01592370|559234065|FG005|Overall Study|Request to discontinue study treatment|2|||
154947955|NCT01592370|559234066|FG006|Overall Study|Request to discontinue study treatment|0|||
154947956|NCT01592370|559234060|FG000|Overall Study|Withdrew consent|1|||
154947957|NCT01592370|559234061|FG001|Overall Study|Withdrew consent|2|||
154947958|NCT01592370|559234062|FG002|Overall Study|Withdrew consent|1|||
154947959|NCT01592370|559234063|FG003|Overall Study|Withdrew consent|1|||
154947960|NCT01592370|559234064|FG004|Overall Study|Withdrew consent|0|||
154947961|NCT01592370|559234065|FG005|Overall Study|Withdrew consent|0|||
154947962|NCT01592370|559234066|FG006|Overall Study|Withdrew consent|0|||
154947963|NCT01592370|559234060|FG000|Overall Study|Maximum clinical benefit|11|||
154947964|NCT01592370|559234061|FG001|Overall Study|Maximum clinical benefit|1|||
154947965|NCT01592370|559234062|FG002|Overall Study|Maximum clinical benefit|7|||
154947966|NCT01592370|559234063|FG003|Overall Study|Maximum clinical benefit|1|||
154947967|NCT01592370|559234064|FG004|Overall Study|Maximum clinical benefit|0|||
154947968|NCT01592370|559234065|FG005|Overall Study|Maximum clinical benefit|0|||
154947969|NCT01592370|559234066|FG006|Overall Study|Maximum clinical benefit|0|||
154947970|NCT01592370|559234060|FG000|Overall Study|No longer meets study criteria|1|||
154947971|NCT01592370|559234061|FG001|Overall Study|No longer meets study criteria|0|||
155050157|NCT00255164|559614215|FG001|Overall Study|Esophageal Stricture|0|||
155050158|NCT00255164|559614216|FG002|Overall Study|Esophageal Stricture|1|||
155050159|NCT00255164|559614214|FG000|Overall Study|Therapeutic Failure|11|||
155281714|NCT01544582|560461705|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
155281715|NCT01544582|560461706|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
155281716|NCT01544582|560461703|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
155281717|NCT01544582|560461704|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
155281718|NCT01544582|560461705|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
155281719|NCT01544582|560461706|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
155281720|NCT01544582|560461703|FG000|Analysis Population|Intolerance|0|||
155281721|NCT01544582|560461704|FG001|Analysis Population|Intolerance|1|||
155281722|NCT01544582|560461705|FG002|Analysis Population|Intolerance|0|||
155281723|NCT01544582|560461706|FG003|Analysis Population|Intolerance|0|||
155281724|NCT01544582|560461703|FG000|Analysis Population|Liver Transplantation|0|||
155281725|NCT01544582|560461704|FG001|Analysis Population|Liver Transplantation|0|||
155281726|NCT01544582|560461705|FG002|Analysis Population|Liver Transplantation|1|||
155281727|NCT01544582|560461706|FG003|Analysis Population|Liver Transplantation|0|||
155281728|NCT01544582|560461703|FG000|Analysis Population|No Social Insurance|0|||
155281729|NCT01544582|560461704|FG001|Analysis Population|No Social Insurance|0|||
155281730|NCT01544582|560461705|FG002|Analysis Population|No Social Insurance|1|||
155281731|NCT01544582|560461706|FG003|Analysis Population|No Social Insurance|0|||
155281732|NCT01544582|560461703|FG000|Analysis Population|Poor Adherence|0|||
155281733|NCT01544582|560461704|FG001|Analysis Population|Poor Adherence|0|||
155281734|NCT01544582|560461705|FG002|Analysis Population|Poor Adherence|1|||
155281735|NCT01544582|560461706|FG003|Analysis Population|Poor Adherence|0|||
155389105|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
155050160|NCT00255164|559614215|FG001|Overall Study|Therapeutic Failure|2|||
155389106|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
155389107|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
155389108|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
155389109|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
155389110|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
155389111|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
155389112|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
155389113|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
155389114|NCT01231516|560858804|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
155389115|NCT01231516|560858805|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
155389116|NCT05266586|560858808|FG000|Overall Study|Adverse Event|2|||
155389117|NCT05266586|560858809|FG001|Overall Study|Adverse Event|2|||
155389118|NCT05266586|560858810|FG002|Overall Study|Adverse Event|1|||
155389119|NCT05266586|560858808|FG000|Overall Study|Withdrawal by Subject|1|||
155389120|NCT05266586|560858809|FG001|Overall Study|Withdrawal by Subject|0|||
155389121|NCT05266586|560858810|FG002|Overall Study|Withdrawal by Subject|1|||
155389122|NCT05266586|560858808|FG000|Overall Study|Non-compliance with study drug|0|||
155389123|NCT05266586|560858809|FG001|Overall Study|Non-compliance with study drug|1|||
155389124|NCT05266586|560858810|FG002|Overall Study|Non-compliance with study drug|0|||
155389125|NCT05266586|560858808|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
155389126|NCT05266586|560858809|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
155389127|NCT05266586|560858810|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
155389128|NCT02225353|560858811|FG000|Overall Study|Lost to Follow-up|0|||
155389129|NCT02225353|560858812|FG001|Overall Study|Lost to Follow-up|1|||
155389130|NCT02225353|560858813|FG002|Overall Study|Lost to Follow-up|3|||
155389131|NCT02225353|560858811|FG000|Overall Study|Protocol Violation|4|||
155389132|NCT02225353|560858812|FG001|Overall Study|Protocol Violation|5|||
155389133|NCT02225353|560858813|FG002|Overall Study|Protocol Violation|12|||
155389134|NCT03707925|560858814|FG000|Overall Study|Inevaluable|1|||
155389135|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Other|1|||
154947972|NCT01592370|559234062|FG002|Overall Study|No longer meets study criteria|0|||
154947973|NCT01592370|559234063|FG003|Overall Study|No longer meets study criteria|0|||
154947974|NCT01592370|559234064|FG004|Overall Study|No longer meets study criteria|0|||
154947975|NCT01592370|559234065|FG005|Overall Study|No longer meets study criteria|0|||
154947976|NCT01592370|559234066|FG006|Overall Study|No longer meets study criteria|0|||
154947977|NCT01592370|559234060|FG000|Overall Study|Other Reasons|6|||
154947978|NCT01592370|559234061|FG001|Overall Study|Other Reasons|0|||
154947979|NCT01592370|559234062|FG002|Overall Study|Other Reasons|10|||
154947980|NCT01592370|559234063|FG003|Overall Study|Other Reasons|0|||
154947981|NCT01592370|559234064|FG004|Overall Study|Other Reasons|0|||
154947982|NCT01592370|559234065|FG005|Overall Study|Other Reasons|1|||
154947983|NCT01592370|559234066|FG006|Overall Study|Other Reasons|0|||
154947984|NCT01592370|559234060|FG000|Overall Study|Not Treated|0|||
154947985|NCT01592370|559234061|FG001|Overall Study|Not Treated|0|||
154947986|NCT01592370|559234062|FG002|Overall Study|Not Treated|0|||
154947987|NCT01592370|559234063|FG003|Overall Study|Not Treated|0|||
154947988|NCT01592370|559234064|FG004|Overall Study|Not Treated|2|||
154947989|NCT01592370|559234065|FG005|Overall Study|Not Treated|2|||
154947990|NCT01592370|559234066|FG006|Overall Study|Not Treated|0|||
154947991|NCT02415959|559234067|FG000|Overall Study|Adverse Event|0|||
154947992|NCT02415959|559234068|FG001|Overall Study|Adverse Event|1|||
154947993|NCT02415959|559234069|FG002|Overall Study|Adverse Event|0|||
154947994|NCT02415959|559234070|FG003|Overall Study|Adverse Event|0|||
154947995|NCT02415959|559234071|FG004|Overall Study|Adverse Event|0|||
154947996|NCT02415959|559234067|FG000|Overall Study|Protocol Violation|0|||
154947997|NCT02415959|559234068|FG001|Overall Study|Protocol Violation|0|||
154947998|NCT02415959|559234069|FG002|Overall Study|Protocol Violation|0|||
154947999|NCT02415959|559234070|FG003|Overall Study|Protocol Violation|1|||
154948000|NCT02415959|559234071|FG004|Overall Study|Protocol Violation|0|||
154948001|NCT01048333|559234072|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
154948002|NCT01048333|559234073|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
154948003|NCT01048333|559234074|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
154948004|NCT01048333|559234075|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
154948005|NCT01048333|559234076|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
154948006|NCT01048333|559234077|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
154948007|NCT02260492|559234079|FG000|Overall Study|Adverse Event|6|||
154948008|NCT02260492|559234080|FG001|Overall Study|Adverse Event|1|||
154948009|NCT02260492|559234081|FG002|Overall Study|Adverse Event|2|||
154948010|NCT02260492|559234079|FG000|Overall Study|Death|0|||
154948011|NCT02260492|559234080|FG001|Overall Study|Death|1|||
155389136|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Other|0|||
155389137|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
155389138|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
154948012|NCT02260492|559234081|FG002|Overall Study|Death|0|||
154948013|NCT02260492|559234079|FG000|Overall Study|Lost to Follow-up|12|||
154948014|NCT02260492|559234080|FG001|Overall Study|Lost to Follow-up|9|||
154948015|NCT02260492|559234081|FG002|Overall Study|Lost to Follow-up|0|||
154948016|NCT02260492|559234079|FG000|Overall Study|Physician Decision|2|||
154948017|NCT02260492|559234080|FG001|Overall Study|Physician Decision|0|||
154948018|NCT02260492|559234081|FG002|Overall Study|Physician Decision|1|||
154948019|NCT02260492|559234079|FG000|Overall Study|Withdrawal by Subject|3|||
154948020|NCT02260492|559234080|FG001|Overall Study|Withdrawal by Subject|2|||
154948021|NCT02260492|559234081|FG002|Overall Study|Withdrawal by Subject|2|||
154948022|NCT03131999|559234082|FG000|Overall Study|Withdrawal by Subject|0|||
154948023|NCT03131999|559234083|FG001|Overall Study|Withdrawal by Subject|1|||
154948024|NCT00996736|559234084|FG000|Overall Study|Death|1|||
154948025|NCT00996736|559234085|FG001|Overall Study|Death|1|||
154948026|NCT00996736|559234084|FG000|Overall Study|Lost to Follow-up|15|||
154948027|NCT00996736|559234085|FG001|Overall Study|Lost to Follow-up|14|||
154948028|NCT00996736|559234084|FG000|Overall Study|Visit not within 3-month window|5|||
154948029|NCT00996736|559234085|FG001|Overall Study|Visit not within 3-month window|3|||
154948030|NCT02346201|559234087|FG000|Overall Study|Adverse Event|3|||
154948031|NCT02346201|559234088|FG001|Overall Study|Adverse Event|2|||
154948032|NCT02346201|559234087|FG000|Overall Study|Lost to Follow-up|1|||
154948033|NCT02346201|559234088|FG001|Overall Study|Lost to Follow-up|0|||
154948034|NCT02346201|559234087|FG000|Overall Study|Withdrawal by Subject|6|||
154948035|NCT02346201|559234088|FG001|Overall Study|Withdrawal by Subject|3|||
154948036|NCT02346201|559234087|FG000|Overall Study|Unavailable for future follow-up|0|||
154948037|NCT02346201|559234088|FG001|Overall Study|Unavailable for future follow-up|1|||
154948038|NCT02346201|559234087|FG000|Overall Study|Physician Decision|0|||
154948039|NCT02346201|559234088|FG001|Overall Study|Physician Decision|1|||
154948040|NCT02346201|559234087|FG000|Overall Study|Missed final visit|0|||
154948041|NCT02346201|559234088|FG001|Overall Study|Missed final visit|2|||
154948042|NCT01497938|559234089|FG000|Overall Study|Adverse Event|0|||
154948043|NCT01497938|559234090|FG001|Overall Study|Adverse Event|1|||
154948044|NCT01497938|559234089|FG000|Overall Study|Physician Decision|0|||
154948045|NCT01497938|559234090|FG001|Overall Study|Physician Decision|1|||
154948046|NCT01497938|559234089|FG000|Overall Study|Withdrawal by Subject|4|||
154948047|NCT01497938|559234090|FG001|Overall Study|Withdrawal by Subject|0|||
154948048|NCT01497938|559234089|FG000|Overall Study|Device Violation|1|||
154948049|NCT01497938|559234090|FG001|Overall Study|Device Violation|0|||
154948050|NCT03708211|559234091|FG000|Overall Study|Progressive Disease|10|||
154948051|NCT03708211|559234092|FG001|Overall Study|Progressive Disease|7|||
154948052|NCT03708211|559234091|FG000|Overall Study|Withdrawal by Subject|0|||
154948053|NCT03708211|559234092|FG001|Overall Study|Withdrawal by Subject|1|||
154948054|NCT03708211|559234091|FG000|Overall Study|Other|2|||
154948055|NCT03708211|559234092|FG001|Overall Study|Other|0|||
154948056|NCT00462982|559234097|FG000|Overall Study|Adverse Event|1|||
154948057|NCT00462982|559234097|FG000|Overall Study|Patient Not Treated|2|||
154948058|NCT05200858|559234100|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
154948059|NCT05200858|559234101|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
154948060|NCT05200858|559234102|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
154948061|NCT05200858|559234103|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
154948062|NCT02683187|559234104|FG000|Overall Study|Failed IV access|3|||
154948063|NCT02683187|559234104|FG000|Overall Study|Withdrawal by Subject|5|||
154948064|NCT01739790|559235987|FG000|Overall Study|Early Trial Termination|2|||
154948065|NCT01739790|559235988|FG001|Overall Study|Early Trial Termination|4|||
154948066|NCT03471078|559235992|FG000|Overall Study|Withdrawal by Subject|9|||
154948067|NCT03471078|559235993|FG001|Overall Study|Withdrawal by Subject|1|||
154948068|NCT03471078|559235992|FG000|Overall Study|Adverse Event|4|||
154948069|NCT03471078|559235993|FG001|Overall Study|Adverse Event|1|||
154948070|NCT03471078|559235992|FG000|Overall Study|Physician Decision|3|||
154948071|NCT03471078|559235993|FG001|Overall Study|Physician Decision|2|||
154948072|NCT03471078|559235992|FG000|Overall Study|Death|2|||
154948073|NCT03471078|559235993|FG001|Overall Study|Death|0|||
154948074|NCT03471078|559235992|FG000|Overall Study|Other|3|||
154948075|NCT03471078|559235993|FG001|Overall Study|Other|2|||
154948076|NCT05568225|559236003|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
154948077|NCT05568225|559236004|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
154948078|NCT05568225|559236005|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
154948079|NCT05568225|559236003|FG000|Primary Treatment Period|Physician Decision|0|||
154948080|NCT05568225|559236004|FG001|Primary Treatment Period|Physician Decision|1|||
154948081|NCT05568225|559236005|FG002|Primary Treatment Period|Physician Decision|0|||
154948082|NCT05568225|559236003|FG000|Primary Treatment Period|Disease progression|0|||
154948083|NCT05568225|559236004|FG001|Primary Treatment Period|Disease progression|1|||
154948084|NCT05568225|559236005|FG002|Primary Treatment Period|Disease progression|0|||
154948085|NCT05568225|559236003|FG000|Primary Treatment Period|Lack of Efficacy|0|||
154948086|NCT05568225|559236004|FG001|Primary Treatment Period|Lack of Efficacy|1|||
154948087|NCT05568225|559236005|FG002|Primary Treatment Period|Lack of Efficacy|0|||
154948088|NCT05568225|559236003|FG000|Primary Treatment Period|Withdrawal of conset|1|||
155389139|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
155389140|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
155389141|NCT02876835|560858815|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
155389142|NCT02876835|560858816|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
155389143|NCT01117857|560858817|FG000|Overall Study|Lost to Follow-up|4|||
155389144|NCT01117857|560858817|FG000|Overall Study|Withdrawal by Subject|4|||
155389145|NCT01117857|560858817|FG000|Overall Study|Physician Decision|1|||
154948089|NCT05568225|559236004|FG001|Primary Treatment Period|Withdrawal of conset|0|||
154948090|NCT05568225|559236005|FG002|Primary Treatment Period|Withdrawal of conset|4|||
154948091|NCT05568225|559236003|FG000|Primary Treatment Period|Adverse Event|1|||
154948092|NCT05568225|559236004|FG001|Primary Treatment Period|Adverse Event|0|||
154948093|NCT05568225|559236005|FG002|Primary Treatment Period|Adverse Event|0|||
154948094|NCT05568225|559236003|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
154948095|NCT05568225|559236004|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
154948096|NCT05568225|559236005|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
154948097|NCT05568225|559236003|FG000|Extension Treatment Period|Protocol Violation|0|||
154948098|NCT05568225|559236004|FG001|Extension Treatment Period|Protocol Violation|0|||
154948099|NCT05568225|559236005|FG002|Extension Treatment Period|Protocol Violation|1|||
154948100|NCT05568225|559236003|FG000|Extension Treatment Period|Lack of Efficacy|0|||
154948101|NCT05568225|559236004|FG001|Extension Treatment Period|Lack of Efficacy|0|||
154948102|NCT05568225|559236005|FG002|Extension Treatment Period|Lack of Efficacy|1|||
154948103|NCT02207231|559236016|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
154948104|NCT02207231|559236017|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
154948105|NCT02207231|559236018|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
154948106|NCT02207231|559236019|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
154948107|NCT02207231|559236016|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
154948108|NCT02207231|559236017|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
154948109|NCT02207231|559236018|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
154948110|NCT02207231|559236019|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
154948111|NCT02207231|559236016|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
154948112|NCT02207231|559236017|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
154948113|NCT02207231|559236018|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
154948114|NCT02207231|559236019|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
154948115|NCT02207231|559236016|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
154948116|NCT02207231|559236017|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
154948117|NCT02207231|559236018|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
154948118|NCT02207231|559236019|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
154948119|NCT02207231|559236016|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
154948120|NCT02207231|559236017|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
154948121|NCT02207231|559236018|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
154948122|NCT02207231|559236019|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
154948123|NCT02207231|559236016|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
154948124|NCT02207231|559236017|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
154948125|NCT02207231|559236018|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
154948126|NCT02207231|559236019|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
154948127|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
154948128|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
154948129|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
154948130|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
154948131|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
154948132|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
154948133|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
154948134|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
154948135|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
154948136|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
154948137|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
154948138|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
154948139|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
154948140|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
154948141|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
154948142|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
154948143|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
154948144|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
155389146|NCT04683731|560858818|FG000|Overall Study|Withdrawal by Subject|1|||
155389147|NCT04683731|560858819|FG001|Overall Study|Withdrawal by Subject|0|||
155389148|NCT04683731|560858820|FG002|Overall Study|Withdrawal by Subject|3|||
155389149|NCT04683731|560858821|FG003|Overall Study|Withdrawal by Subject|2|||
154948145|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
154948146|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
155281736|NCT01544582|560461703|FG000|Analysis Population|Poor Participant Compliance|0|||
154948147|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
154948148|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
154948149|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
154948150|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
154948151|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
154948152|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
154948153|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
154948154|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
154948155|NCT02207231|559236016|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
154948156|NCT02207231|559236017|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
154948157|NCT02207231|559236018|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
154948158|NCT02207231|559236019|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
154948159|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
154948160|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
154948161|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
154948162|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
154948163|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
154948164|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
154948165|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
154948166|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
154948167|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
154948168|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
154948169|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
154948170|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
155050161|NCT00255164|559614216|FG002|Overall Study|Therapeutic Failure|3|||
155281737|NCT01544582|560461704|FG001|Analysis Population|Poor Participant Compliance|1|||
155281738|NCT01544582|560461705|FG002|Analysis Population|Poor Participant Compliance|0|||
155281739|NCT01544582|560461706|FG003|Analysis Population|Poor Participant Compliance|0|||
155281740|NCT01544582|560461703|FG000|Analysis Population|Programmed Surgery|0|||
155281741|NCT01544582|560461704|FG001|Analysis Population|Programmed Surgery|1|||
155281742|NCT01544582|560461705|FG002|Analysis Population|Programmed Surgery|0|||
155281743|NCT01544582|560461706|FG003|Analysis Population|Programmed Surgery|0|||
155281744|NCT01544582|560461703|FG000|Analysis Population|Participant in Jail|0|||
155281745|NCT01544582|560461704|FG001|Analysis Population|Participant in Jail|0|||
155281746|NCT01544582|560461705|FG002|Analysis Population|Participant in Jail|1|||
155281747|NCT01544582|560461706|FG003|Analysis Population|Participant in Jail|0|||
155281748|NCT02624778|560463919|FG000|Overall Study|Lost to Follow-up|0|||
155281749|NCT02624778|560463920|FG001|Overall Study|Lost to Follow-up|0|||
155281750|NCT02624778|560463921|FG002|Overall Study|Lost to Follow-up|1|||
155281751|NCT02624778|560463922|FG003|Overall Study|Lost to Follow-up|0|||
155281752|NCT02624778|560463923|FG004|Overall Study|Lost to Follow-up|0|||
155281753|NCT02624778|560463924|FG005|Overall Study|Lost to Follow-up|0|||
155281754|NCT02624778|560463925|FG006|Overall Study|Lost to Follow-up|0|||
155281755|NCT02624778|560463926|FG007|Overall Study|Lost to Follow-up|0|||
155281756|NCT02624778|560463927|FG008|Overall Study|Lost to Follow-up|0|||
155281757|NCT02624778|560463919|FG000|Overall Study|Withdrawal by Subject|0|||
155281758|NCT02624778|560463920|FG001|Overall Study|Withdrawal by Subject|1|||
155281759|NCT02624778|560463921|FG002|Overall Study|Withdrawal by Subject|0|||
155281760|NCT02624778|560463922|FG003|Overall Study|Withdrawal by Subject|0|||
155281761|NCT02624778|560463923|FG004|Overall Study|Withdrawal by Subject|0|||
155281762|NCT02624778|560463924|FG005|Overall Study|Withdrawal by Subject|1|||
155281763|NCT02624778|560463925|FG006|Overall Study|Withdrawal by Subject|1|||
155281764|NCT02624778|560463926|FG007|Overall Study|Withdrawal by Subject|1|||
155281765|NCT02624778|560463927|FG008|Overall Study|Withdrawal by Subject|1|||
155281766|NCT02624778|560463919|FG000|Overall Study|Adverse Event|0|||
155281767|NCT02624778|560463920|FG001|Overall Study|Adverse Event|0|||
155281768|NCT02624778|560463921|FG002|Overall Study|Adverse Event|0|||
155281769|NCT02624778|560463922|FG003|Overall Study|Adverse Event|0|||
155281770|NCT02624778|560463923|FG004|Overall Study|Adverse Event|0|||
155281771|NCT02624778|560463924|FG005|Overall Study|Adverse Event|0|||
155281772|NCT02624778|560463925|FG006|Overall Study|Adverse Event|0|||
155281773|NCT02624778|560463926|FG007|Overall Study|Adverse Event|0|||
155281774|NCT02624778|560463927|FG008|Overall Study|Adverse Event|2|||
155281775|NCT02624778|560463919|FG000|Overall Study|Death|0|||
155281776|NCT02624778|560463920|FG001|Overall Study|Death|0|||
155281777|NCT02624778|560463921|FG002|Overall Study|Death|0|||
155281778|NCT02624778|560463922|FG003|Overall Study|Death|0|||
155281779|NCT02624778|560463923|FG004|Overall Study|Death|0|||
155281780|NCT02624778|560463924|FG005|Overall Study|Death|0|||
155281781|NCT02624778|560463925|FG006|Overall Study|Death|1|||
155281782|NCT02624778|560463926|FG007|Overall Study|Death|0|||
155389150|NCT04683731|560858818|FG000|Overall Study|Determined patient was not eligible|3|||
155389151|NCT04683731|560858819|FG001|Overall Study|Determined patient was not eligible|3|||
155389152|NCT04683731|560858820|FG002|Overall Study|Determined patient was not eligible|12|||
155389153|NCT04683731|560858821|FG003|Overall Study|Determined patient was not eligible|3|||
155050162|NCT03677869|559614217|FG000|Overall Study|Withdrawal by Subject|1|||
155050163|NCT05219968|559614218|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
155050164|NCT05219968|559614219|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155050165|NCT05219968|559614220|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155050166|NCT05219968|559614221|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155050167|NCT05219968|559614222|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
155050168|NCT05219968|559614218|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
155050169|NCT05219968|559614219|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
155050170|NCT05219968|559614220|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
155050171|NCT05219968|559614221|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
155050172|NCT05219968|559614222|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
155050173|NCT05219968|559614218|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
155050174|NCT05219968|559614219|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
155050175|NCT05219968|559614220|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
155050176|NCT05219968|559614221|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
155050177|NCT05219968|559614222|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
155050178|NCT05219968|559614218|FG000|Week 24 Treatment Period|Adverse Event|3|||
155050179|NCT05219968|559614219|FG001|Week 24 Treatment Period|Adverse Event|0|||
155050180|NCT05219968|559614220|FG002|Week 24 Treatment Period|Adverse Event|0|||
155050181|NCT05219968|559614221|FG003|Week 24 Treatment Period|Adverse Event|0|||
155050182|NCT05219968|559614222|FG004|Week 24 Treatment Period|Adverse Event|0|||
155050183|NCT05219968|559614218|FG000|Week 24 Treatment Period|Physician Decision|0|||
155050184|NCT05219968|559614219|FG001|Week 24 Treatment Period|Physician Decision|1|||
155050185|NCT05219968|559614220|FG002|Week 24 Treatment Period|Physician Decision|0|||
155050186|NCT05219968|559614221|FG003|Week 24 Treatment Period|Physician Decision|0|||
155050187|NCT05219968|559614222|FG004|Week 24 Treatment Period|Physician Decision|0|||
155050188|NCT05219968|559614218|FG000|Week 24 Treatment Period|Other, not specified|3|||
155050189|NCT05219968|559614219|FG001|Week 24 Treatment Period|Other, not specified|0|||
155050190|NCT05219968|559614220|FG002|Week 24 Treatment Period|Other, not specified|0|||
155050191|NCT05219968|559614221|FG003|Week 24 Treatment Period|Other, not specified|0|||
155050192|NCT05219968|559614222|FG004|Week 24 Treatment Period|Other, not specified|0|||
155050193|NCT05219968|559614218|FG000|Safety Extension Period|Treatment administration failure|0|||
155050194|NCT05219968|559614219|FG001|Safety Extension Period|Treatment administration failure|0|||
155050195|NCT05219968|559614220|FG002|Safety Extension Period|Treatment administration failure|0|||
155050196|NCT05219968|559614221|FG003|Safety Extension Period|Treatment administration failure|1|||
155050197|NCT05219968|559614222|FG004|Safety Extension Period|Treatment administration failure|4|||
155050198|NCT05219968|559614218|FG000|Safety Extension Period|Bilateral dislodgement|0|||
155050199|NCT05219968|559614219|FG001|Safety Extension Period|Bilateral dislodgement|0|||
155050200|NCT05219968|559614220|FG002|Safety Extension Period|Bilateral dislodgement|4|||
155050201|NCT05219968|559614221|FG003|Safety Extension Period|Bilateral dislodgement|0|||
155050202|NCT05219968|559614222|FG004|Safety Extension Period|Bilateral dislodgement|1|||
155050203|NCT05219968|559614218|FG000|Safety Extension Period|Withdrawal by Subject|0|||
155050204|NCT05219968|559614219|FG001|Safety Extension Period|Withdrawal by Subject|0|||
155050205|NCT05219968|559614220|FG002|Safety Extension Period|Withdrawal by Subject|2|||
155050206|NCT05219968|559614221|FG003|Safety Extension Period|Withdrawal by Subject|0|||
155050207|NCT05219968|559614222|FG004|Safety Extension Period|Withdrawal by Subject|4|||
155050208|NCT05219968|559614218|FG000|Safety Extension Period|Adverse Event|0|||
155050209|NCT05219968|559614219|FG001|Safety Extension Period|Adverse Event|0|||
155050210|NCT05219968|559614220|FG002|Safety Extension Period|Adverse Event|2|||
155050211|NCT05219968|559614221|FG003|Safety Extension Period|Adverse Event|1|||
155050212|NCT05219968|559614222|FG004|Safety Extension Period|Adverse Event|1|||
155050213|NCT05219968|559614218|FG000|Safety Extension Period|Lost to Follow-up|0|||
155050214|NCT05219968|559614219|FG001|Safety Extension Period|Lost to Follow-up|0|||
155050215|NCT05219968|559614220|FG002|Safety Extension Period|Lost to Follow-up|0|||
155050216|NCT05219968|559614221|FG003|Safety Extension Period|Lost to Follow-up|1|||
155050217|NCT05219968|559614222|FG004|Safety Extension Period|Lost to Follow-up|0|||
155389154|NCT01411839|560858822|FG000|Overall Study|Lost to Follow-up|4|||
155050218|NCT04587336|559614225|FG000|Overall Study|Lost to Follow-up|1|||
155050219|NCT04587336|559614226|FG001|Overall Study|Lost to Follow-up|0|||
155050220|NCT02492165|559615794|FG000|Overall Study|Withdrawal by Subject|0|||
155050221|NCT02492165|559615795|FG001|Overall Study|Withdrawal by Subject|1|||
155050222|NCT02492165|559615796|FG002|Overall Study|Withdrawal by Subject|0|||
155050223|NCT02492165|559615797|FG003|Overall Study|Withdrawal by Subject|0|||
155050224|NCT01697800|559615798|FG000|Overall Study|Death|0|||
155050225|NCT01697800|559615799|FG001|Overall Study|Death|1|||
155050226|NCT00943397|559615800|FG000|Overall Study|Adverse Event|0|||
155389155|NCT01411839|560858823|FG001|Overall Study|Lost to Follow-up|3|||
155389156|NCT03282240|560858824|FG000|Overall Study|Adverse Event|2|||
155389157|NCT03282240|560858825|FG001|Overall Study|Adverse Event|2|||
155389158|NCT03282240|560858826|FG002|Overall Study|Adverse Event|0|||
155389159|NCT03282240|560858824|FG000|Overall Study|Lost to Follow-up|3|||
155389160|NCT03282240|560858825|FG001|Overall Study|Lost to Follow-up|0|||
155389161|NCT03282240|560858826|FG002|Overall Study|Lost to Follow-up|0|||
155389162|NCT03282240|560858824|FG000|Overall Study|Protocol Deviation|4|||
155389163|NCT03282240|560858825|FG001|Overall Study|Protocol Deviation|1|||
155389164|NCT03282240|560858826|FG002|Overall Study|Protocol Deviation|2|||
155389165|NCT03282240|560858824|FG000|Overall Study|Withdrawal by Subject|1|||
155389166|NCT03282240|560858825|FG001|Overall Study|Withdrawal by Subject|0|||
155389167|NCT03282240|560858826|FG002|Overall Study|Withdrawal by Subject|1|||
155389168|NCT01675479|560858827|FG000|Overall Study|Lost to Follow-up|11|||
155389169|NCT02910739|560858828|FG000|Overall Study|Adverse Event|1|||
155389170|NCT02910739|560858829|FG001|Overall Study|Adverse Event|0|||
155389171|NCT02910739|560858830|FG002|Overall Study|Adverse Event|0|||
155389172|NCT02910739|560858831|FG003|Overall Study|Adverse Event|0|||
155389173|NCT01572922|560858832|FG000|Overall Study|Adverse Event|1|||
155389174|NCT01572922|560858832|FG000|Overall Study|Protocol Violation|1|||
155389175|NCT01572922|560858832|FG000|Overall Study|Death|1|||
155389176|NCT00959647|560858834|FG000|Overall Study|Adverse Event|2|||
155389177|NCT00959647|560858834|FG000|Overall Study|Progressive disease|6|||
155389178|NCT00959647|560858834|FG000|Overall Study|Study terminated by sponsor|4|||
155389179|NCT00959647|560858834|FG000|Overall Study|Withdrawal by Subject|7|||
155389180|NCT05959629|560858837|FG000|Overall Study|partially necrotic/technical issues|2|||
155389181|NCT05959629|560858838|FG001|Overall Study|partially necrotic/technical issues|2|||
155389182|NCT04751656|560860037|FG000|Overall Study|Lost to Follow-up|1|||
155389183|NCT01103245|560860040|FG000|Overall Study|Withdrawal by Subject|1|||
155389184|NCT01103245|560860041|FG001|Overall Study|Withdrawal by Subject|0|||
155389185|NCT01103245|560860042|FG002|Overall Study|Withdrawal by Subject|3|||
155389186|NCT01103245|560860043|FG003|Overall Study|Withdrawal by Subject|0|||
155389187|NCT01103245|560860040|FG000|Overall Study|Inadequate IV access|1|||
155389188|NCT01103245|560860041|FG001|Overall Study|Inadequate IV access|0|||
155389189|NCT01103245|560860042|FG002|Overall Study|Inadequate IV access|0|||
155389190|NCT01103245|560860043|FG003|Overall Study|Inadequate IV access|0|||
155389191|NCT01103245|560860040|FG000|Overall Study|Adverse Event|0|||
155389192|NCT01103245|560860041|FG001|Overall Study|Adverse Event|2|||
155389193|NCT01103245|560860042|FG002|Overall Study|Adverse Event|1|||
155389194|NCT01103245|560860043|FG003|Overall Study|Adverse Event|0|||
155389195|NCT01103245|560860040|FG000|Overall Study|Physician Decision|1|||
155389196|NCT01103245|560860041|FG001|Overall Study|Physician Decision|0|||
155389197|NCT01103245|560860042|FG002|Overall Study|Physician Decision|0|||
155389198|NCT01103245|560860043|FG003|Overall Study|Physician Decision|0|||
155389199|NCT01444651|560860045|FG000|Overall Study|Adverse Event|3|||
155389200|NCT01444651|560860046|FG001|Overall Study|Adverse Event|2|||
155389201|NCT01444651|560860045|FG000|Overall Study|Lost to Follow-up|5|||
155389202|NCT01444651|560860046|FG001|Overall Study|Lost to Follow-up|5|||
155389203|NCT01444651|560860045|FG000|Overall Study|Non-fasting|2|||
155389204|NCT01444651|560860046|FG001|Overall Study|Non-fasting|1|||
155389205|NCT01444651|560860045|FG000|Overall Study|Missing data|1|||
155389206|NCT01444651|560860046|FG001|Overall Study|Missing data|1|||
155389207|NCT01929980|560860047|FG000|Overall Study|Physician Decision|1|||
155389208|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
154948171|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
154948172|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
154948173|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
154948174|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
154948175|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
154948176|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
154948177|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
154948178|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
155050227|NCT00943397|559615801|FG001|Overall Study|Adverse Event|6|||
155389209|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
155389210|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
155389211|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
155389212|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
155389213|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
155050228|NCT00943397|559615800|FG000|Overall Study|Lost to Follow-up|0|||
155050229|NCT00943397|559615801|FG001|Overall Study|Lost to Follow-up|4|||
155389214|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
155389215|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
155389216|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
155389217|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
155389218|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
155389219|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
155050230|NCT00943397|559615800|FG000|Overall Study|Protocol Violation|2|||
155050231|NCT00943397|559615801|FG001|Overall Study|Protocol Violation|5|||
155050232|NCT00943397|559615800|FG000|Overall Study|Withdrawal by Subject|1|||
155050233|NCT00943397|559615801|FG001|Overall Study|Withdrawal by Subject|1|||
155050234|NCT00943397|559615800|FG000|Overall Study|Site terminated and other|12|||
155050235|NCT00943397|559615801|FG001|Overall Study|Site terminated and other|56|||
155050236|NCT01968811|559615802|FG000|Overall Study|Protocol Violation|4|||
155050237|NCT01968811|559615802|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
155389220|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Death|3|||
155389221|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Death|1|||
155389222|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
155050238|NCT02948829|559615803|FG000|Overall Study|Lost to Follow-up|2|||
155050239|NCT02948829|559615803|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
155050240|NCT02948829|559615803|FG000|Overall Study|Pregnancy|1|||
155050241|NCT02948829|559615803|FG000|Overall Study|Other: Reason not Specified|8|||
155050242|NCT01004978|559615804|FG000|Overall Study|Disease progression|31|||
155050243|NCT01004978|559615805|FG001|Overall Study|Disease progression|48|||
155050244|NCT01004978|559615804|FG000|Overall Study|Adverse Event|42|||
155050245|NCT01004978|559615805|FG001|Overall Study|Adverse Event|22|||
155050246|NCT01004978|559615804|FG000|Overall Study|Death|3|||
155050247|NCT01004978|559615805|FG001|Overall Study|Death|2|||
155050248|NCT01004978|559615804|FG000|Overall Study|Withdrawal by Subject|16|||
155050249|NCT01004978|559615805|FG001|Overall Study|Withdrawal by Subject|16|||
155050250|NCT01004978|559615804|FG000|Overall Study|Alternative therapy|4|||
155050251|NCT01004978|559615805|FG001|Overall Study|Alternative therapy|8|||
155389223|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
155389224|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Adverse Event|7|||
155389225|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Adverse Event|8|||
155389226|NCT03236246|560860048|FG000|24-Week Dose Titration Period|Captured as Other|1|||
155389227|NCT03236246|560860049|FG001|24-Week Dose Titration Period|Captured as Other|2|||
155389228|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
155389229|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
155389230|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
155389231|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
155389232|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
155389233|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
155389234|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Death|0|||
155389235|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Death|1|||
155389236|NCT03236246|560860048|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
155389237|NCT03236246|560860049|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
155389238|NCT01676909|560860054|FG000|Overall Study|Withdrawal by Subject|3|||
155389239|NCT01676909|560860055|FG001|Overall Study|Withdrawal by Subject|5|||
155389240|NCT01676909|560860054|FG000|Overall Study|Lost to Follow-up|15|||
155389241|NCT01676909|560860055|FG001|Overall Study|Lost to Follow-up|9|||
155389242|NCT04615247|560860056|FG000|Overall Study|Adverse Event|0|||
155389243|NCT04615247|560860057|FG001|Overall Study|Adverse Event|2|||
155389244|NCT04615247|560860056|FG000|Overall Study|Withdrawal by Subject|1|||
155389245|NCT04615247|560860057|FG001|Overall Study|Withdrawal by Subject|1|||
155389246|NCT00823901|560860060|FG000|Overall Study|Adverse Event|1|||
155389247|NCT00823901|560860061|FG001|Overall Study|Adverse Event|1|||
155389248|NCT00823901|560860060|FG000|Overall Study|Lack of Efficacy|1|||
155389249|NCT00823901|560860061|FG001|Overall Study|Lack of Efficacy|0|||
155389250|NCT00823901|560860060|FG000|Overall Study|Lost to Follow-up|2|||
155389251|NCT00823901|560860061|FG001|Overall Study|Lost to Follow-up|1|||
155389252|NCT01369511|560860062|FG000|Overall Study|Adverse Event|1|||
155389253|NCT01369511|560860063|FG001|Overall Study|Adverse Event|1|||
155389254|NCT01369511|560860064|FG002|Overall Study|Adverse Event|5|||
155389255|NCT01369511|560860065|FG003|Overall Study|Adverse Event|0|||
155389256|NCT01369511|560860062|FG000|Overall Study|Entry criteria not met|2|||
155389257|NCT01369511|560860063|FG001|Overall Study|Entry criteria not met|0|||
155389258|NCT01369511|560860064|FG002|Overall Study|Entry criteria not met|0|||
155389259|NCT01369511|560860065|FG003|Overall Study|Entry criteria not met|1|||
155389260|NCT01369511|560860062|FG000|Overall Study|Lost to Follow-up|0|||
155389261|NCT01369511|560860063|FG001|Overall Study|Lost to Follow-up|1|||
155389262|NCT01369511|560860064|FG002|Overall Study|Lost to Follow-up|1|||
155389263|NCT01369511|560860065|FG003|Overall Study|Lost to Follow-up|2|||
155050252|NCT01004978|559615804|FG000|Overall Study|Physician Decision|6|||
155050253|NCT01004978|559615805|FG001|Overall Study|Physician Decision|3|||
155050254|NCT01004978|559615804|FG000|Overall Study|Other complicating disease|2|||
155050255|NCT01004978|559615805|FG001|Overall Study|Other complicating disease|2|||
155050256|NCT01004978|559615804|FG000|Overall Study|Protocol Violation|2|||
155050257|NCT01004978|559615805|FG001|Overall Study|Protocol Violation|3|||
155389264|NCT01369511|560860062|FG000|Overall Study|Protocol Violation|0|||
155389265|NCT01369511|560860063|FG001|Overall Study|Protocol Violation|1|||
155389266|NCT01369511|560860064|FG002|Overall Study|Protocol Violation|0|||
155389267|NCT01369511|560860065|FG003|Overall Study|Protocol Violation|2|||
155389268|NCT01369511|560860062|FG000|Overall Study|Physician Decision|3|||
155389269|NCT01369511|560860063|FG001|Overall Study|Physician Decision|4|||
155389270|NCT01369511|560860064|FG002|Overall Study|Physician Decision|0|||
155389271|NCT01369511|560860065|FG003|Overall Study|Physician Decision|0|||
155389272|NCT01369511|560860062|FG000|Overall Study|Sponsor decision|2|||
155389273|NCT01369511|560860063|FG001|Overall Study|Sponsor decision|0|||
155389274|NCT01369511|560860064|FG002|Overall Study|Sponsor decision|1|||
155389275|NCT01369511|560860065|FG003|Overall Study|Sponsor decision|0|||
155389276|NCT01369511|560860062|FG000|Overall Study|Withdrawal by Subject|5|||
155389277|NCT01369511|560860063|FG001|Overall Study|Withdrawal by Subject|6|||
155389278|NCT01369511|560860064|FG002|Overall Study|Withdrawal by Subject|4|||
155389279|NCT01369511|560860065|FG003|Overall Study|Withdrawal by Subject|6|||
155389280|NCT01376349|560860067|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
155389281|NCT01376349|560860068|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
155389282|NCT01376349|560860069|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
155389283|NCT01376349|560860067|FG000|Raondomized Treatment|Adverse Event|13|||
155389284|NCT01376349|560860068|FG001|Raondomized Treatment|Adverse Event|17|||
155389285|NCT01376349|560860069|FG002|Raondomized Treatment|Adverse Event|14|||
155389286|NCT01376349|560860067|FG000|Raondomized Treatment|Unkown|1|||
155389287|NCT01376349|560860068|FG001|Raondomized Treatment|Unkown|2|||
155389288|NCT01376349|560860069|FG002|Raondomized Treatment|Unkown|1|||
155389289|NCT01376349|560860067|FG000|Raondomized Treatment|Alternative Treatment|0|||
155389290|NCT01376349|560860068|FG001|Raondomized Treatment|Alternative Treatment|0|||
155389291|NCT01376349|560860069|FG002|Raondomized Treatment|Alternative Treatment|1|||
155389292|NCT00718640|560860070|FG000|Overall Study|Adverse Event|4|||
155389293|NCT00718640|560860070|FG000|Overall Study|Death|1|||
155389294|NCT00718640|560860070|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
155389295|NCT05193500|560860073|FG000|Overall Study|Withdrawal by Subject|7|||
155389296|NCT05193500|560860074|FG001|Overall Study|Withdrawal by Subject|4|||
155389297|NCT05193500|560860075|FG002|Overall Study|Withdrawal by Subject|3|||
155389298|NCT05193500|560860076|FG003|Overall Study|Withdrawal by Subject|5|||
155389299|NCT01176773|560860078|FG000|Overall Study|Screen Failure|2|||
155389300|NCT01176773|560860078|FG000|Overall Study|Withdrew consent|1|||
155389301|NCT01498289|560860083|FG000|Overall Study|Adverse Event|16|||
155389302|NCT01498289|560860084|FG001|Overall Study|Adverse Event|18|||
155389303|NCT01498289|560860083|FG000|Overall Study|Death|6|||
155389304|NCT01498289|560860084|FG001|Overall Study|Death|8|||
155389305|NCT01498289|560860083|FG000|Overall Study|Withdrawal unrelated to AE|16|||
155389306|NCT01498289|560860084|FG001|Overall Study|Withdrawal unrelated to AE|16|||
155389307|NCT01498289|560860083|FG000|Overall Study|Progression/relapse|53|||
155389308|NCT01498289|560860084|FG001|Overall Study|Progression/relapse|59|||
155389309|NCT01498289|560860083|FG000|Overall Study|Not protocol specified|7|||
155389310|NCT01498289|560860084|FG001|Overall Study|Not protocol specified|2|||
155389311|NCT01498289|560860083|FG000|Overall Study|Reason under review|0|||
155389312|NCT01498289|560860084|FG001|Overall Study|Reason under review|1|||
155389313|NCT01423253|560860085|FG000|Overall Study|Adverse Event|2|||
155389314|NCT01423253|560860085|FG000|Overall Study|Lack of Efficacy|2|||
155389315|NCT01423253|560860085|FG000|Overall Study|Lost to Follow-up|1|||
155389316|NCT01423253|560860085|FG000|Overall Study|Protocol Violation|2|||
155389317|NCT01423253|560860085|FG000|Overall Study|Withdrawal by Subject|2|||
155389318|NCT02804178|560860089|FG000|Overall Study|Adverse Event|1|||
155389319|NCT02513745|560860094|FG000|Overall Study|Criteria at time of surgery not met.|3|||
155389320|NCT02513745|560860095|FG001|Overall Study|Criteria at time of surgery not met.|3|||
155389321|NCT01116882|560860096|FG000|30-day|Lost to Follow-up|50|||
155389322|NCT01116882|560860097|FG001|30-day|Lost to Follow-up|21|||
155389323|NCT01116882|560860096|FG000|30-day|Withdrawal by Subject|2|||
155050258|NCT01004978|559615804|FG000|Overall Study|Non-compliance|3|||
155050259|NCT01004978|559615805|FG001|Overall Study|Non-compliance|2|||
155050260|NCT01004978|559615804|FG000|Overall Study|Ineligible|1|||
155050261|NCT01004978|559615805|FG001|Overall Study|Ineligible|0|||
155050262|NCT01004978|559615804|FG000|Overall Study|Unblinded|0|||
155050263|NCT01004978|559615805|FG001|Overall Study|Unblinded|1|||
155050264|NCT01004978|559615804|FG000|Overall Study|Performance status worsening|0|||
155050265|NCT01004978|559615805|FG001|Overall Study|Performance status worsening|1|||
155050266|NCT01004978|559615804|FG000|Overall Study|Never started treatment|8|||
155389324|NCT01116882|560860097|FG001|30-day|Withdrawal by Subject|4|||
155389325|NCT01116882|560860096|FG000|30-day|Other Reasons|16|||
155389326|NCT01116882|560860097|FG001|30-day|Other Reasons|6|||
155389327|NCT01116882|560860096|FG000|12-month|Lost to Follow-up|111|||
155389328|NCT01116882|560860097|FG001|12-month|Lost to Follow-up|42|||
155389329|NCT01116882|560860096|FG000|12-month|Other Reasons|151|||
155389330|NCT01116882|560860097|FG001|12-month|Other Reasons|49|||
155389331|NCT01116882|560860096|FG000|12-month|Withdrawal by Subject|5|||
155389332|NCT01116882|560860097|FG001|12-month|Withdrawal by Subject|8|||
155050267|NCT01004978|559615805|FG001|Overall Study|Never started treatment|9|||
155050268|NCT00249873|559615806|FG000|Overall Study|Not treated|7|||
155389333|NCT00547365|560860098|FG000|Overall Study|Physician Decision|1|||
155389334|NCT00547365|560860098|FG000|Overall Study|Lost to Follow-up|1|||
155389335|NCT00547365|560860098|FG000|Overall Study|Protocol Violation|2|||
155050269|NCT00249873|559615807|FG001|Overall Study|Not treated|8|||
155050270|NCT00249873|559615806|FG000|Overall Study|Significant thrombocytopenia|9|||
155050271|NCT00249873|559615807|FG001|Overall Study|Significant thrombocytopenia|8|||
155050272|NCT00249873|559615806|FG000|Overall Study|Severe allergic reaction|8|||
155050273|NCT00249873|559615807|FG001|Overall Study|Severe allergic reaction|1|||
155050274|NCT00249873|559615806|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
155050275|NCT00249873|559615807|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
155050276|NCT00249873|559615806|FG000|Overall Study|Other Serious Adverse Event|86|||
155050277|NCT00249873|559615807|FG001|Overall Study|Other Serious Adverse Event|97|||
155050278|NCT00249873|559615806|FG000|Overall Study|Qualifying condition not present|20|||
155050279|NCT00249873|559615807|FG001|Overall Study|Qualifying condition not present|23|||
155050280|NCT00249873|559615806|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
155050281|NCT00249873|559615807|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
155050282|NCT00249873|559615806|FG000|Overall Study|Withdrawal by Subject|504|||
155050283|NCT00249873|559615807|FG001|Overall Study|Withdrawal by Subject|466|||
155050284|NCT00249873|559615806|FG000|Overall Study|Lost to Follow-up|4|||
155050285|NCT00249873|559615807|FG001|Overall Study|Lost to Follow-up|7|||
155050286|NCT00249873|559615806|FG000|Overall Study|Minor bleeding|99|||
155050287|NCT00249873|559615807|FG001|Overall Study|Minor bleeding|37|||
155050288|NCT00249873|559615806|FG000|Overall Study|Non-compliance|41|||
155050289|NCT00249873|559615807|FG001|Overall Study|Non-compliance|46|||
155050290|NCT00249873|559615806|FG000|Overall Study|Other non serious Adverse Event|112|||
155050291|NCT00249873|559615807|FG001|Overall Study|Other non serious Adverse Event|108|||
155050292|NCT00249873|559615806|FG000|Overall Study|Other contraindicated medication|1|||
155050293|NCT00249873|559615807|FG001|Overall Study|Other contraindicated medication|0|||
155050294|NCT00249873|559615806|FG000|Overall Study|Patient not wish to continue after May08|3|||
155050295|NCT00249873|559615807|FG001|Overall Study|Patient not wish to continue after May08|4|||
155050296|NCT00249873|559615806|FG000|Overall Study|Physician withdrew consent|59|||
155050297|NCT00249873|559615807|FG001|Overall Study|Physician withdrew consent|60|||
155050298|NCT00249873|559615806|FG000|Overall Study|Open label clopidogrel required|31|||
155050299|NCT00249873|559615807|FG001|Overall Study|Open label clopidogrel required|42|||
155050300|NCT00249873|559615806|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
155050301|NCT00249873|559615807|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
155050302|NCT00249873|559615806|FG000|Overall Study|Oral anticoagulant required|159|||
155050303|NCT00249873|559615807|FG001|Overall Study|Oral anticoagulant required|157|||
155050304|NCT00249873|559615806|FG000|Overall Study|Study drug intolerance|5|||
155050305|NCT00249873|559615807|FG001|Overall Study|Study drug intolerance|0|||
155050306|NCT00249873|559615806|FG000|Overall Study|Surgery/ procedure|9|||
155050307|NCT00249873|559615807|FG001|Overall Study|Surgery/ procedure|9|||
155050308|NCT00249873|559615806|FG000|Overall Study|Event related to cardiac condition|12|||
155050309|NCT00249873|559615807|FG001|Overall Study|Event related to cardiac condition|21|||
155050310|NCT00249873|559615806|FG000|Overall Study|Thromboembolic/outcome event|82|||
155050311|NCT00249873|559615807|FG001|Overall Study|Thromboembolic/outcome event|122|||
155050312|NCT02254772|559615810|FG000|Overall Study|Ineligible|1|||
155050313|NCT02254772|559615810|FG000|Overall Study|Withdrawal by Subject|1|||
155050314|NCT00447772|559615811|FG000|Overall Study|Lack of Efficacy|3|||
155050315|NCT00447772|559615811|FG000|Overall Study|Insufficient compliance|6|||
155050316|NCT00447772|559615811|FG000|Overall Study|Discontinuation of drug therapy|1|||
155050317|NCT00447772|559615811|FG000|Overall Study|Lost to Follow-up|9|||
155050318|NCT00447772|559615811|FG000|Overall Study|Withdrawal by Subject|1|||
155050319|NCT00447772|559615811|FG000|Overall Study|Unable to attend all study visits|2|||
155050320|NCT00447772|559615811|FG000|Overall Study|Adverse Event|1|||
155050321|NCT00447772|559615811|FG000|Overall Study|Patient relocated|1|||
155050322|NCT00447772|559615811|FG000|Overall Study|Incomplete documentation at visit 1|1|||
155050323|NCT00447772|559615811|FG000|Overall Study|Chemotherapy for lung cancer|1|||
155050324|NCT00447772|559615811|FG000|Overall Study|Premature re-injection required|1|||
155050325|NCT01576575|559615812|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
155050326|NCT01576575|559615812|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
155050327|NCT01576575|559615812|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
155050328|NCT01723072|559615817|FG000|Overall Study|Withdrawal by Subject|7|||
155050329|NCT01723072|559615818|FG001|Overall Study|Withdrawal by Subject|13|||
155050330|NCT01723072|559615817|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
155050331|NCT01723072|559615818|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
155050332|NCT01723072|559615817|FG000|Overall Study|Other|4|||
155050333|NCT01723072|559615818|FG001|Overall Study|Other|3|||
155050334|NCT01841970|559615819|FG000|Overall Study|Withdrawal by Subject|1|||
155050335|NCT01841970|559615819|FG000|Overall Study|Physician Decision|2|||
155050336|NCT01841970|559615819|FG000|Overall Study|Lost to Follow-up|8|||
155050337|NCT01610037|559615826|FG000|All Patients|Adverse Event|27|||
155281783|NCT02624778|560463927|FG008|Overall Study|Death|0|||
155281784|NCT02624778|560463919|FG000|Overall Study|Physician Decision|0|||
155050338|NCT01610037|559615827|FG001|All Patients|Adverse Event|22|||
155050339|NCT01610037|559615828|FG002|All Patients|Adverse Event|26|||
155050340|NCT01610037|559615826|FG000|All Patients|Withdrawal by Subject|12|||
155389336|NCT00547365|560860098|FG000|Overall Study|death (not related to study)|4|||
155389337|NCT00504881|560860101|FG000|Overall Study|Lack of Efficacy|1|||
155389338|NCT00504881|560860102|FG001|Overall Study|Lack of Efficacy|5|||
155389339|NCT00504881|560860101|FG000|Overall Study|Lost to Follow-up|0|||
155050341|NCT01610037|559615827|FG001|All Patients|Withdrawal by Subject|10|||
155050342|NCT01610037|559615828|FG002|All Patients|Withdrawal by Subject|20|||
155050343|NCT01610037|559615826|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
155050344|NCT01610037|559615827|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
155050345|NCT01610037|559615828|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
155050346|NCT01610037|559615826|FG000|All Patients|Death|4|||
155050347|NCT01610037|559615827|FG001|All Patients|Death|2|||
155050348|NCT01610037|559615828|FG002|All Patients|Death|1|||
155050349|NCT01610037|559615826|FG000|All Patients|Protocol deviation|4|||
155050350|NCT01610037|559615827|FG001|All Patients|Protocol deviation|3|||
155050351|NCT01610037|559615828|FG002|All Patients|Protocol deviation|3|||
155050352|NCT01610037|559615826|FG000|All Patients|Abnormal laboratory value|1|||
155050353|NCT01610037|559615827|FG001|All Patients|Abnormal laboratory value|1|||
155050354|NCT01610037|559615828|FG002|All Patients|Abnormal laboratory value|0|||
155050355|NCT01610037|559615826|FG000|All Patients|Administrative problems|1|||
155050356|NCT01610037|559615827|FG001|All Patients|Administrative problems|4|||
155050357|NCT01610037|559615828|FG002|All Patients|Administrative problems|4|||
155050358|NCT01610037|559615826|FG000|All Patients|Lost to Follow-up|1|||
155050359|NCT01610037|559615827|FG001|All Patients|Lost to Follow-up|0|||
155050360|NCT01610037|559615828|FG002|All Patients|Lost to Follow-up|0|||
155050361|NCT01610037|559615826|FG000|All Patients|Abnormal test procedure result(s)|0|||
155050362|NCT01610037|559615827|FG001|All Patients|Abnormal test procedure result(s)|1|||
155050363|NCT01610037|559615828|FG002|All Patients|Abnormal test procedure result(s)|3|||
155050364|NCT01610037|559615826|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
155050365|NCT01610037|559615827|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
155050366|NCT01610037|559615828|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
155050367|NCT01610037|559615826|FG000|Treatment and Follow up Period|Death|10|||
155050368|NCT01610037|559615827|FG001|Treatment and Follow up Period|Death|5|||
155050369|NCT01610037|559615828|FG002|Treatment and Follow up Period|Death|4|||
155050370|NCT01610037|559615826|FG000|Treatment and Follow up Period|Administrative problems|1|||
155050371|NCT01610037|559615827|FG001|Treatment and Follow up Period|Administrative problems|3|||
155050372|NCT01610037|559615828|FG002|Treatment and Follow up Period|Administrative problems|2|||
155050373|NCT01610037|559615826|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
155050374|NCT01610037|559615827|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
155050375|NCT01610037|559615828|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
155050376|NCT00274742|559615833|FG000|Overall Study|Adverse Event|0|||
155050377|NCT00274742|559615834|FG001|Overall Study|Adverse Event|4|||
155050378|NCT00274742|559615835|FG002|Overall Study|Adverse Event|1|||
155050379|NCT00274742|559615836|FG003|Overall Study|Adverse Event|4|||
155050380|NCT00274742|559615837|FG004|Overall Study|Adverse Event|12|||
155050381|NCT00274742|559615838|FG005|Overall Study|Adverse Event|3|||
155050382|NCT00274742|559615833|FG000|Overall Study|Lost to Follow-up|0|||
155050383|NCT00274742|559615834|FG001|Overall Study|Lost to Follow-up|0|||
155050384|NCT00274742|559615835|FG002|Overall Study|Lost to Follow-up|0|||
155050385|NCT00274742|559615836|FG003|Overall Study|Lost to Follow-up|0|||
155050386|NCT00274742|559615837|FG004|Overall Study|Lost to Follow-up|1|||
155050387|NCT00274742|559615838|FG005|Overall Study|Lost to Follow-up|0|||
155050388|NCT00274742|559615833|FG000|Overall Study|End of Study|0|||
155050389|NCT00274742|559615834|FG001|Overall Study|End of Study|0|||
155050390|NCT00274742|559615835|FG002|Overall Study|End of Study|0|||
155050391|NCT00274742|559615836|FG003|Overall Study|End of Study|1|||
155050392|NCT00274742|559615837|FG004|Overall Study|End of Study|0|||
155050393|NCT00274742|559615838|FG005|Overall Study|End of Study|0|||
155050394|NCT00274742|559615833|FG000|Overall Study|Disease Progression|0|||
155050395|NCT00274742|559615834|FG001|Overall Study|Disease Progression|1|||
155389340|NCT00504881|560860102|FG001|Overall Study|Lost to Follow-up|2|||
155389341|NCT00504881|560860101|FG000|Overall Study|Withdrawal by Subject|1|||
155050396|NCT00274742|559615835|FG002|Overall Study|Disease Progression|1|||
155050397|NCT00274742|559615836|FG003|Overall Study|Disease Progression|0|||
155050398|NCT00274742|559615837|FG004|Overall Study|Disease Progression|1|||
155050399|NCT00274742|559615838|FG005|Overall Study|Disease Progression|0|||
155050400|NCT00274742|559615833|FG000|Overall Study|Other|0|||
155050401|NCT00274742|559615834|FG001|Overall Study|Other|3|||
155050402|NCT00274742|559615835|FG002|Overall Study|Other|0|||
155050403|NCT00274742|559615836|FG003|Overall Study|Other|0|||
155050404|NCT00274742|559615837|FG004|Overall Study|Other|2|||
155050405|NCT00274742|559615838|FG005|Overall Study|Other|0|||
155389342|NCT00504881|560860102|FG001|Overall Study|Withdrawal by Subject|4|||
155050406|NCT00149396|559615839|FG000|Overall Study|Death|15|||
155050407|NCT00149396|559615839|FG000|Overall Study|Withdrawal by Subject|1|||
155050408|NCT00149396|559615839|FG000|Overall Study|Subject noncompliance|2|||
155050409|NCT00149396|559615839|FG000|Overall Study|other treatment|5|||
155050410|NCT00327717|559615840|FG000|Overall Study|Adverse Event|6|||
155050411|NCT00327717|559615841|FG001|Overall Study|Adverse Event|6|||
155050412|NCT00327717|559615840|FG000|Overall Study|Lack of Efficacy|0|||
155050413|NCT00327717|559615841|FG001|Overall Study|Lack of Efficacy|1|||
155050414|NCT00327717|559615840|FG000|Overall Study|Withdrawal by Subject|3|||
155050415|NCT00327717|559615841|FG001|Overall Study|Withdrawal by Subject|7|||
155050416|NCT02983045|559615842|FG000|Overall Study|Withdrawal by Subject|0|||
155050417|NCT02983045|559615843|FG001|Overall Study|Withdrawal by Subject|1|||
155050418|NCT02983045|559615844|FG002|Overall Study|Withdrawal by Subject|0|||
155050419|NCT02983045|559615845|FG003|Overall Study|Withdrawal by Subject|5|||
155050420|NCT02983045|559615846|FG004|Overall Study|Withdrawal by Subject|0|||
155050421|NCT02983045|559615847|FG005|Overall Study|Withdrawal by Subject|72|||
155050422|NCT02983045|559615848|FG006|Overall Study|Withdrawal by Subject|0|||
155050423|NCT02983045|559615849|FG007|Overall Study|Withdrawal by Subject|0|||
155050424|NCT02983045|559615850|FG008|Overall Study|Withdrawal by Subject|0|||
155050425|NCT02983045|559615851|FG009|Overall Study|Withdrawal by Subject|2|||
155050426|NCT02983045|559615842|FG000|Overall Study|Lost to Follow-up|0|||
155050427|NCT02983045|559615843|FG001|Overall Study|Lost to Follow-up|0|||
155050428|NCT02983045|559615844|FG002|Overall Study|Lost to Follow-up|0|||
155050429|NCT02983045|559615845|FG003|Overall Study|Lost to Follow-up|0|||
155050430|NCT02983045|559615846|FG004|Overall Study|Lost to Follow-up|0|||
155050431|NCT02983045|559615847|FG005|Overall Study|Lost to Follow-up|10|||
155050432|NCT02983045|559615848|FG006|Overall Study|Lost to Follow-up|0|||
155050433|NCT02983045|559615849|FG007|Overall Study|Lost to Follow-up|0|||
155050434|NCT02983045|559615850|FG008|Overall Study|Lost to Follow-up|0|||
155050435|NCT02983045|559615851|FG009|Overall Study|Lost to Follow-up|0|||
155050436|NCT03311841|559615858|FG000|14-day Wash-out|Adverse Event|0|||
155050437|NCT03311841|559615859|FG001|14-day Wash-out|Adverse Event|1|||
155050438|NCT03311841|559615860|FG002|14-day Wash-out|Adverse Event|0|||
155050439|NCT03311841|559615861|FG003|14-day Wash-out|Adverse Event|0|||
155050440|NCT03311841|559615862|FG004|14-day Wash-out|Adverse Event|0|||
155050441|NCT03311841|559615858|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
155050442|NCT03311841|559615859|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
155050443|NCT03311841|559615860|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
155050444|NCT03311841|559615861|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
155050445|NCT03311841|559615862|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
155050446|NCT00977613|559615879|FG000|Overall Study|Lost to Follow-up|16|||
155050447|NCT01598610|559615884|FG000|Overall Study|Adverse Event|1|||
155050448|NCT02989402|559615892|FG000|Overall Study|Adverse event, or serious adverse event|4|||
155050449|NCT02989402|559615892|FG000|Overall Study|Death|2|||
155050450|NCT02989402|559615892|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
155050451|NCT02989402|559615892|FG000|Overall Study|Lost to Follow-up|8|||
155050452|NCT02989402|559615892|FG000|Overall Study|Patient no longer on monotherapy|1|||
155050453|NCT02989402|559615892|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
155050454|NCT02989402|559615892|FG000|Overall Study|Withdrawal by Subject|7|||
155050455|NCT02989402|559615892|FG000|Overall Study|Other|2|||
155050456|NCT03066830|559615893|FG000|Overall Study|At the Participant's own Request|16|||
155050457|NCT03066830|559615894|FG001|Overall Study|At the Participant's own Request|17|||
155050458|NCT03066830|559615893|FG000|Overall Study|Other|3|||
155050459|NCT03066830|559615894|FG001|Overall Study|Other|0|||
155050460|NCT03066830|559615893|FG000|Overall Study|Poor Compliance to Protocol|1|||
155050461|NCT03066830|559615894|FG001|Overall Study|Poor Compliance to Protocol|0|||
155050462|NCT03066830|559615893|FG000|Overall Study|Adverse Event|2|||
155050463|NCT03066830|559615894|FG001|Overall Study|Adverse Event|2|||
155050464|NCT03066830|559615893|FG000|Overall Study|Lost to Follow-up|11|||
155050465|NCT03066830|559615894|FG001|Overall Study|Lost to Follow-up|3|||
155050466|NCT02039778|559615896|FG000|Overall Study|Death|2|||
155050467|NCT02039778|559615896|FG000|Overall Study|Withdrawal by Subject|1|||
155050468|NCT02039778|559615896|FG000|Overall Study|Never started the protocol treatment|1|||
155050469|NCT01670045|559615906|FG000|Overall Study|Withdrawal by Subject|3|||
155050470|NCT01670045|559615906|FG000|Overall Study|Adverse Event|1|||
155389343|NCT00504881|560860101|FG000|Overall Study|Non-Compliance|1|||
155389344|NCT00504881|560860102|FG001|Overall Study|Non-Compliance|0|||
155389345|NCT00504881|560860101|FG000|Overall Study|No Birth Control|0|||
155389346|NCT00504881|560860102|FG001|Overall Study|No Birth Control|1|||
155389347|NCT00504881|560860101|FG000|Overall Study|Safety Visit not performed|0|||
155050471|NCT01670045|559615906|FG000|Overall Study|Death|1|||
155050472|NCT01670045|559615906|FG000|Overall Study|Lost to Follow-up|11|||
155050473|NCT00753675|559615909|FG000|Overall Study|other reason|11|||
155050474|NCT00753675|559615910|FG001|Overall Study|other reason|12|||
155050475|NCT00753675|559615911|FG002|Overall Study|other reason|13|||
155050476|NCT00753675|559615909|FG000|Overall Study|Death|1|||
155050477|NCT00753675|559615910|FG001|Overall Study|Death|2|||
155050478|NCT00753675|559615911|FG002|Overall Study|Death|4|||
155050479|NCT00753675|559615909|FG000|Overall Study|Adverse Event|11|||
155050480|NCT00753675|559615910|FG001|Overall Study|Adverse Event|9|||
155050481|NCT00753675|559615911|FG002|Overall Study|Adverse Event|4|||
155389348|NCT00504881|560860102|FG001|Overall Study|Safety Visit not performed|1|||
155389349|NCT00504881|560860101|FG000|Overall Study|AE, serious fatal|0|||
155050482|NCT00753675|559615909|FG000|Overall Study|Objective progression of disease|35|||
155389350|NCT00504881|560860102|FG001|Overall Study|AE, serious fatal|1|||
155389351|NCT00504881|560860101|FG000|Overall Study|SAE, non-fatal|2|||
155389352|NCT00504881|560860102|FG001|Overall Study|SAE, non-fatal|6|||
155389353|NCT00504881|560860101|FG000|Overall Study|AE, non-serious non-fatal|4|||
155389354|NCT00504881|560860102|FG001|Overall Study|AE, non-serious non-fatal|14|||
155389355|NCT00504881|560860101|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155389356|NCT00504881|560860102|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
155389357|NCT00504881|560860101|FG000|Overall Study|AE of unknown type|1|||
155389358|NCT00504881|560860102|FG001|Overall Study|AE of unknown type|0|||
155389359|NCT01777269|560860103|FG000|Overall Study|Adverse Event|24|||
155389360|NCT01777269|560860104|FG001|Overall Study|Adverse Event|33|||
155389361|NCT01777269|560860103|FG000|Overall Study|Lack of Efficacy|8|||
155389362|NCT01777269|560860104|FG001|Overall Study|Lack of Efficacy|10|||
155389363|NCT01777269|560860103|FG000|Overall Study|Protocol Violation|4|||
155389364|NCT01777269|560860104|FG001|Overall Study|Protocol Violation|4|||
155389365|NCT01777269|560860103|FG000|Overall Study|Participants reached stopping criteria|1|||
155389366|NCT01777269|560860104|FG001|Overall Study|Participants reached stopping criteria|1|||
155389367|NCT01777269|560860103|FG000|Overall Study|Lost to Follow-up|4|||
155389368|NCT01777269|560860104|FG001|Overall Study|Lost to Follow-up|0|||
155389369|NCT01777269|560860103|FG000|Overall Study|Physician Decision|5|||
155389370|NCT01777269|560860104|FG001|Overall Study|Physician Decision|2|||
155389371|NCT01777269|560860103|FG000|Overall Study|Withdrawal by Subject|9|||
155389372|NCT01777269|560860104|FG001|Overall Study|Withdrawal by Subject|9|||
155389373|NCT00753272|560860112|FG000|Overall Study|Adverse Event|878|||
155389374|NCT00753272|560860113|FG001|Overall Study|Adverse Event|869|||
155389375|NCT00753272|560860112|FG000|Overall Study|Protocol Violation|28|||
155389376|NCT00753272|560860113|FG001|Overall Study|Protocol Violation|46|||
155389377|NCT00753272|560860112|FG000|Overall Study|Withdrawal by Subject|2481|||
155389378|NCT00753272|560860113|FG001|Overall Study|Withdrawal by Subject|2407|||
155389379|NCT00753272|560860112|FG000|Overall Study|Lost to Follow-up|491|||
155389380|NCT00753272|560860113|FG001|Overall Study|Lost to Follow-up|497|||
155389381|NCT00753272|560860112|FG000|Overall Study|Other|1104|||
155389382|NCT00753272|560860113|FG001|Overall Study|Other|1088|||
155389383|NCT01193920|560860114|FG000|Overall Study|Withdrawal by Subject|1|||
155389384|NCT01193920|560860115|FG001|Overall Study|Withdrawal by Subject|0|||
155389385|NCT01193920|560860116|FG002|Overall Study|Withdrawal by Subject|5|||
155389386|NCT01193920|560860117|FG003|Overall Study|Withdrawal by Subject|1|||
155389387|NCT01193920|560860118|FG004|Overall Study|Withdrawal by Subject|3|||
155389388|NCT01193920|560860119|FG005|Overall Study|Withdrawal by Subject|1|||
155389389|NCT01193920|560860120|FG006|Overall Study|Withdrawal by Subject|3|||
155389390|NCT01193920|560860121|FG007|Overall Study|Withdrawal by Subject|0|||
155389391|NCT01193920|560860122|FG008|Overall Study|Withdrawal by Subject|1|||
155389392|NCT01193920|560860123|FG009|Overall Study|Withdrawal by Subject|0|||
155389393|NCT01193920|560860114|FG000|Overall Study|Lost to Follow-up|1|||
155389394|NCT01193920|560860115|FG001|Overall Study|Lost to Follow-up|0|||
155389395|NCT01193920|560860116|FG002|Overall Study|Lost to Follow-up|1|||
155050483|NCT00753675|559615910|FG001|Overall Study|Objective progression of disease|35|||
155050484|NCT00753675|559615911|FG002|Overall Study|Objective progression of disease|35|||
155050485|NCT00753675|559615909|FG000|Overall Study|Withdrawal by Subject|0|||
155050486|NCT00753675|559615910|FG001|Overall Study|Withdrawal by Subject|1|||
155050487|NCT00753675|559615911|FG002|Overall Study|Withdrawal by Subject|0|||
155050488|NCT00753675|559615909|FG000|Overall Study|Lost to Follow-up|1|||
155050489|NCT00753675|559615910|FG001|Overall Study|Lost to Follow-up|0|||
155050490|NCT00753675|559615911|FG002|Overall Study|Lost to Follow-up|0|||
155050491|NCT01462110|559615912|FG000|Overall Study|Adverse Event|1|||
155050492|NCT01462110|559615913|FG001|Overall Study|Adverse Event|0|||
155050493|NCT05279131|559615915|FG000|Overall Study|Lost to Follow-up|1|||
155050494|NCT05279131|559615915|FG000|Overall Study|Death|1|||
155050495|NCT05279131|559615915|FG000|Overall Study|Physician Decision|1|||
155050496|NCT00672633|559615927|FG000|Overall Study|Withdrawal by Subject|0|||
155050497|NCT00672633|559615928|FG001|Overall Study|Withdrawal by Subject|1|||
155050498|NCT02282163|559615932|FG000|Overall Study|Protocol Violation|1|||
155389396|NCT01193920|560860117|FG003|Overall Study|Lost to Follow-up|1|||
155389397|NCT01193920|560860118|FG004|Overall Study|Lost to Follow-up|3|||
155050499|NCT00964028|559615933|FG000|Overall Study|Withdrawal by Subject|0|||
155389398|NCT01193920|560860119|FG005|Overall Study|Lost to Follow-up|3|||
155050500|NCT00964028|559615934|FG001|Overall Study|Withdrawal by Subject|1|||
155050501|NCT03472521|559615935|FG000|Overall Study|Lost to Follow-up|3|||
155389399|NCT01193920|560860120|FG006|Overall Study|Lost to Follow-up|1|||
155389400|NCT01193920|560860121|FG007|Overall Study|Lost to Follow-up|0|||
155389401|NCT01193920|560860122|FG008|Overall Study|Lost to Follow-up|2|||
155050502|NCT03472521|559615936|FG001|Overall Study|Lost to Follow-up|2|||
155050503|NCT03472521|559615935|FG000|Overall Study|Discontinued intervention|3|||
155050504|NCT03472521|559615936|FG001|Overall Study|Discontinued intervention|1|||
155050505|NCT01603407|559615937|FG000|Overall Study|Adverse Event|1|||
155389402|NCT01193920|560860123|FG009|Overall Study|Lost to Follow-up|3|||
155389403|NCT01193920|560860114|FG000|Overall Study|Protocol Violation|1|||
155389404|NCT01193920|560860115|FG001|Overall Study|Protocol Violation|0|||
155389405|NCT01193920|560860116|FG002|Overall Study|Protocol Violation|0|||
155389406|NCT01193920|560860117|FG003|Overall Study|Protocol Violation|0|||
155389407|NCT01193920|560860118|FG004|Overall Study|Protocol Violation|0|||
155389408|NCT01193920|560860119|FG005|Overall Study|Protocol Violation|0|||
155389409|NCT01193920|560860120|FG006|Overall Study|Protocol Violation|0|||
155389410|NCT01193920|560860121|FG007|Overall Study|Protocol Violation|0|||
155389411|NCT01193920|560860122|FG008|Overall Study|Protocol Violation|0|||
155389412|NCT01193920|560860123|FG009|Overall Study|Protocol Violation|0|||
155389413|NCT01193920|560860114|FG000|Overall Study|Death|0|||
155389414|NCT01193920|560860115|FG001|Overall Study|Death|0|||
155389415|NCT01193920|560860116|FG002|Overall Study|Death|0|||
155389416|NCT01193920|560860117|FG003|Overall Study|Death|1|||
155389417|NCT01193920|560860118|FG004|Overall Study|Death|0|||
155389418|NCT01193920|560860119|FG005|Overall Study|Death|0|||
155389419|NCT01193920|560860120|FG006|Overall Study|Death|2|||
155389420|NCT01193920|560860121|FG007|Overall Study|Death|3|||
155389421|NCT01193920|560860122|FG008|Overall Study|Death|2|||
155389422|NCT01193920|560860123|FG009|Overall Study|Death|4|||
155389423|NCT01193920|560860114|FG000|Overall Study|Unable to classify|0|||
155389424|NCT01193920|560860115|FG001|Overall Study|Unable to classify|0|||
155389425|NCT01193920|560860116|FG002|Overall Study|Unable to classify|0|||
155389426|NCT01193920|560860117|FG003|Overall Study|Unable to classify|1|||
155389427|NCT01193920|560860118|FG004|Overall Study|Unable to classify|0|||
155389428|NCT01193920|560860119|FG005|Overall Study|Unable to classify|0|||
155389429|NCT01193920|560860120|FG006|Overall Study|Unable to classify|0|||
155389430|NCT01193920|560860121|FG007|Overall Study|Unable to classify|1|||
155389431|NCT01193920|560860122|FG008|Overall Study|Unable to classify|0|||
155389432|NCT01193920|560860123|FG009|Overall Study|Unable to classify|0|||
155389433|NCT00883051|560860127|FG000|Overall Study|Lost to Follow-up|0|||
154948179|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
154948180|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
154948181|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
154948182|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
154948183|NCT02207231|559236016|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
154948184|NCT02207231|559236017|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
154948185|NCT02207231|559236018|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
154948186|NCT02207231|559236019|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
154948187|NCT01290263|559236023|FG000|Overall Study|Adverse Event|0|||
154948188|NCT01290263|559236024|FG001|Overall Study|Adverse Event|0|||
154948189|NCT01290263|559236025|FG002|Overall Study|Adverse Event|0|||
154948190|NCT01290263|559236026|FG003|Overall Study|Adverse Event|1|||
154948191|NCT01290263|559236027|FG004|Overall Study|Adverse Event|1|||
154948192|NCT01290263|559236023|FG000|Overall Study|Lack of Efficacy|8|||
154948193|NCT01290263|559236024|FG001|Overall Study|Lack of Efficacy|2|||
154948194|NCT01290263|559236025|FG002|Overall Study|Lack of Efficacy|7|||
154948195|NCT01290263|559236026|FG003|Overall Study|Lack of Efficacy|24|||
154948196|NCT01290263|559236027|FG004|Overall Study|Lack of Efficacy|33|||
154948197|NCT01290263|559236023|FG000|Overall Study|Withdrawal by Subject|3|||
154948198|NCT01290263|559236024|FG001|Overall Study|Withdrawal by Subject|1|||
154948199|NCT01290263|559236025|FG002|Overall Study|Withdrawal by Subject|0|||
154948200|NCT01290263|559236026|FG003|Overall Study|Withdrawal by Subject|1|||
154948201|NCT01290263|559236027|FG004|Overall Study|Withdrawal by Subject|2|||
154948202|NCT01290263|559236023|FG000|Overall Study|Participant Non-Compliance|0|||
154948203|NCT01290263|559236024|FG001|Overall Study|Participant Non-Compliance|0|||
154948204|NCT01290263|559236025|FG002|Overall Study|Participant Non-Compliance|0|||
154948205|NCT01290263|559236026|FG003|Overall Study|Participant Non-Compliance|1|||
154948206|NCT01290263|559236027|FG004|Overall Study|Participant Non-Compliance|1|||
154948207|NCT02309099|559236030|FG000|Overall Study|Adverse Event|2|||
154948208|NCT02309099|559236031|FG001|Overall Study|Adverse Event|0|||
154948209|NCT02819362|559236033|FG000|Overall Study|On-site MRI could not be performed|70|||
154948210|NCT01545076|559236034|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
154948211|NCT01545076|559236035|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
154948212|NCT01545076|559236036|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
154948213|NCT01545076|559236037|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
154948214|NCT01545076|559236038|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
154948215|NCT01545076|559236034|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
154948216|NCT01545076|559236035|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
154948217|NCT01545076|559236036|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
154948218|NCT01545076|559236037|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
154948219|NCT01545076|559236038|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
155389434|NCT00883051|560860128|FG001|Overall Study|Lost to Follow-up|0|||
155389435|NCT00883051|560860129|FG002|Overall Study|Lost to Follow-up|0|||
155389436|NCT00883051|560860130|FG003|Overall Study|Lost to Follow-up|0|||
155389437|NCT00883051|560860131|FG004|Overall Study|Lost to Follow-up|1|||
155389438|NCT00883051|560860127|FG000|Overall Study|Did not use study medication|24|||
155389439|NCT00883051|560860128|FG001|Overall Study|Did not use study medication|22|||
155389440|NCT00883051|560860129|FG002|Overall Study|Did not use study medication|29|||
155389441|NCT00883051|560860130|FG003|Overall Study|Did not use study medication|29|||
155050506|NCT01603407|559615938|FG001|Overall Study|Adverse Event|1|||
155050507|NCT01603407|559615939|FG002|Overall Study|Adverse Event|1|||
155050508|NCT01603407|559615937|FG000|Overall Study|Protocol Violation|2|||
155050509|NCT01603407|559615938|FG001|Overall Study|Protocol Violation|2|||
155389442|NCT00883051|560860131|FG004|Overall Study|Did not use study medication|17|||
155389443|NCT01335009|560860134|FG000|Overall Study|Too ill to travel to study sites|1|||
155389444|NCT01335009|560860135|FG001|Overall Study|Too ill to travel to study sites|0|||
155389445|NCT01335009|560860134|FG000|Overall Study|Death|28|||
155389446|NCT01335009|560860135|FG001|Overall Study|Death|32|||
155389447|NCT01335009|560860134|FG000|Overall Study|Withdrawal by Subject|1|||
155389448|NCT01335009|560860135|FG001|Overall Study|Withdrawal by Subject|1|||
155389449|NCT01335009|560860134|FG000|Overall Study|Lost to Follow-up|1|||
155389450|NCT01335009|560860135|FG001|Overall Study|Lost to Follow-up|0|||
155389451|NCT04824521|560860136|FG000|Overall Study|Lost to Follow-up|1|||
155389452|NCT01598311|560860137|FG000|Overall Study|Physician Decision|4|||
155389453|NCT01598311|560860138|FG001|Overall Study|Physician Decision|5|||
155389454|NCT01598311|560860137|FG000|Overall Study|Adverse Event|9|||
155389455|NCT01598311|560860138|FG001|Overall Study|Adverse Event|13|||
155389456|NCT01598311|560860137|FG000|Overall Study|Lost to Follow-up|7|||
155389457|NCT01598311|560860138|FG001|Overall Study|Lost to Follow-up|12|||
155389458|NCT01598311|560860137|FG000|Overall Study|Withdrawal by Subject|9|||
155389459|NCT01598311|560860138|FG001|Overall Study|Withdrawal by Subject|13|||
155389460|NCT01598311|560860137|FG000|Overall Study|No reason provided.|0|||
155389461|NCT01598311|560860138|FG001|Overall Study|No reason provided.|5|||
155389462|NCT01598311|560860137|FG000|Overall Study|Randomized but never treated|8|||
155389463|NCT01598311|560860138|FG001|Overall Study|Randomized but never treated|5|||
155389464|NCT01598311|560860137|FG000|Overall Study|Treated but no confirmed CDAD|9|||
155389465|NCT01598311|560860138|FG001|Overall Study|Treated but no confirmed CDAD|8|||
155389466|NCT01598311|560860137|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
155389467|NCT01598311|560860138|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
155050510|NCT01603407|559615939|FG002|Overall Study|Protocol Violation|0|||
155050511|NCT01603407|559615937|FG000|Overall Study|Withdrawal by Subject|8|||
155050512|NCT01603407|559615938|FG001|Overall Study|Withdrawal by Subject|5|||
155050513|NCT01603407|559615939|FG002|Overall Study|Withdrawal by Subject|7|||
155050514|NCT01603407|559615937|FG000|Overall Study|Lost to Follow-up|0|||
155050515|NCT01603407|559615938|FG001|Overall Study|Lost to Follow-up|3|||
155050516|NCT01603407|559615939|FG002|Overall Study|Lost to Follow-up|2|||
155050517|NCT00490971|559615942|FG000|Acute/Continuation|Adverse Event|62|||
155050518|NCT00490971|559615943|FG001|Acute/Continuation|Adverse Event|13|||
155050519|NCT00490971|559615944|FG002|Acute/Continuation|Adverse Event|0|||
155050520|NCT00490971|559615945|FG003|Acute/Continuation|Adverse Event|0|||
155050521|NCT00490971|559615946|FG004|Acute/Continuation|Adverse Event|0|||
155050522|NCT00490971|559615942|FG000|Acute/Continuation|Death|2|||
155050523|NCT00490971|559615943|FG001|Acute/Continuation|Death|0|||
155050524|NCT00490971|559615944|FG002|Acute/Continuation|Death|0|||
155050525|NCT00490971|559615945|FG003|Acute/Continuation|Death|0|||
155050526|NCT00490971|559615946|FG004|Acute/Continuation|Death|0|||
155050527|NCT00490971|559615942|FG000|Acute/Continuation|Lack of Efficacy|106|||
155050528|NCT00490971|559615943|FG001|Acute/Continuation|Lack of Efficacy|12|||
155050529|NCT00490971|559615944|FG002|Acute/Continuation|Lack of Efficacy|0|||
155050530|NCT00490971|559615945|FG003|Acute/Continuation|Lack of Efficacy|0|||
155050531|NCT00490971|559615946|FG004|Acute/Continuation|Lack of Efficacy|0|||
155050532|NCT00490971|559615942|FG000|Acute/Continuation|Lost to Follow-up|23|||
155050533|NCT00490971|559615943|FG001|Acute/Continuation|Lost to Follow-up|7|||
155050534|NCT00490971|559615944|FG002|Acute/Continuation|Lost to Follow-up|0|||
155389468|NCT00688103|560860139|FG000|Overall Study|Adverse Event|4|||
155389469|NCT00688103|560860140|FG001|Overall Study|Adverse Event|1|||
155389470|NCT00688103|560860139|FG000|Overall Study|Lack of Efficacy|11|||
155389471|NCT00688103|560860140|FG001|Overall Study|Lack of Efficacy|1|||
155389472|NCT00688103|560860139|FG000|Overall Study|Withdrawal by Subject|4|||
155389473|NCT00688103|560860140|FG001|Overall Study|Withdrawal by Subject|2|||
155389474|NCT00688103|560860139|FG000|Overall Study|complex reasons|11|||
155389475|NCT00688103|560860140|FG001|Overall Study|complex reasons|9|||
155050535|NCT00490971|559615945|FG003|Acute/Continuation|Lost to Follow-up|0|||
155050536|NCT00490971|559615946|FG004|Acute/Continuation|Lost to Follow-up|0|||
155389476|NCT03144804|560860141|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
155050537|NCT00490971|559615942|FG000|Acute/Continuation|Protocol Violation|10|||
155050538|NCT00490971|559615943|FG001|Acute/Continuation|Protocol Violation|2|||
155050539|NCT00490971|559615944|FG002|Acute/Continuation|Protocol Violation|0|||
155050540|NCT00490971|559615945|FG003|Acute/Continuation|Protocol Violation|0|||
155050541|NCT00490971|559615946|FG004|Acute/Continuation|Protocol Violation|0|||
155389477|NCT04223856|560860142|FG000|Overall Study|Progressive disease|153|||
155389478|NCT04223856|560860143|FG001|Overall Study|Progressive disease|73|||
155389479|NCT04223856|560860142|FG000|Overall Study|Adverse Event|97|||
155389480|NCT04223856|560860143|FG001|Overall Study|Adverse Event|62|||
155050542|NCT00490971|559615942|FG000|Acute/Continuation|Withdrawal by Subject|92|||
155050543|NCT00490971|559615943|FG001|Acute/Continuation|Withdrawal by Subject|24|||
155050544|NCT00490971|559615944|FG002|Acute/Continuation|Withdrawal by Subject|0|||
155050545|NCT00490971|559615945|FG003|Acute/Continuation|Withdrawal by Subject|0|||
155050546|NCT00490971|559615946|FG004|Acute/Continuation|Withdrawal by Subject|0|||
155050547|NCT00490971|559615942|FG000|Acute/Continuation|Other|11|||
155050548|NCT00490971|559615943|FG001|Acute/Continuation|Other|4|||
155050549|NCT00490971|559615944|FG002|Acute/Continuation|Other|0|||
155050550|NCT00490971|559615945|FG003|Acute/Continuation|Other|0|||
155050551|NCT00490971|559615946|FG004|Acute/Continuation|Other|0|||
155050552|NCT00490971|559615942|FG000|Maintenance|Adverse Event|0|||
155050553|NCT00490971|559615943|FG001|Maintenance|Adverse Event|0|||
155389481|NCT04223856|560860142|FG000|Overall Study|Physician Decision|9|||
155389482|NCT04223856|560860143|FG001|Overall Study|Physician Decision|28|||
155389483|NCT04223856|560860142|FG000|Overall Study|Withdrawal by Subject|22|||
155389484|NCT04223856|560860143|FG001|Overall Study|Withdrawal by Subject|24|||
155389485|NCT04223856|560860142|FG000|Overall Study|Other|7|||
155389486|NCT04223856|560860143|FG001|Overall Study|Other|2|||
155389487|NCT04223856|560860142|FG000|Overall Study|Randomized but not treated|2|||
155389488|NCT04223856|560860143|FG001|Overall Study|Randomized but not treated|11|||
155389489|NCT04223856|560860142|FG000|Overall Study|On-treatment|144|||
155389490|NCT04223856|560860143|FG001|Overall Study|On-treatment|0|||
155389491|NCT03078907|560862526|FG000|Overall Study|Adverse Event|2|||
155389492|NCT03078907|560862527|FG001|Overall Study|Adverse Event|0|||
155389493|NCT03078907|560862526|FG000|Overall Study|Other|1|||
155389494|NCT03078907|560862527|FG001|Overall Study|Other|0|||
155389495|NCT03078907|560862526|FG000|Overall Study|Protocol Violation|0|||
155389496|NCT03078907|560862527|FG001|Overall Study|Protocol Violation|1|||
155389497|NCT01955122|560862528|FG000|Overall Study|Physician Decision|5|||
155389498|NCT01955122|560862529|FG001|Overall Study|Physician Decision|5|||
155389499|NCT01672788|560862530|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
155050554|NCT00490971|559615944|FG002|Maintenance|Adverse Event|4|||
155050555|NCT00490971|559615945|FG003|Maintenance|Adverse Event|5|||
155050556|NCT00490971|559615946|FG004|Maintenance|Adverse Event|7|||
155050557|NCT00490971|559615942|FG000|Maintenance|Death|0|||
155050558|NCT00490971|559615943|FG001|Maintenance|Death|0|||
155050559|NCT00490971|559615944|FG002|Maintenance|Death|0|||
155050560|NCT00490971|559615945|FG003|Maintenance|Death|2|||
155050561|NCT00490971|559615946|FG004|Maintenance|Death|0|||
155050562|NCT00490971|559615942|FG000|Maintenance|Lost to Follow-up|0|||
155050563|NCT00490971|559615943|FG001|Maintenance|Lost to Follow-up|0|||
155050564|NCT00490971|559615944|FG002|Maintenance|Lost to Follow-up|5|||
155050565|NCT00490971|559615945|FG003|Maintenance|Lost to Follow-up|8|||
155050566|NCT00490971|559615946|FG004|Maintenance|Lost to Follow-up|10|||
155050567|NCT00490971|559615942|FG000|Maintenance|Pregnancy|0|||
155050568|NCT00490971|559615943|FG001|Maintenance|Pregnancy|0|||
155050569|NCT00490971|559615944|FG002|Maintenance|Pregnancy|1|||
155050570|NCT00490971|559615945|FG003|Maintenance|Pregnancy|0|||
155050571|NCT00490971|559615946|FG004|Maintenance|Pregnancy|0|||
155050572|NCT00490971|559615942|FG000|Maintenance|Protocol Violation|0|||
155050573|NCT00490971|559615943|FG001|Maintenance|Protocol Violation|0|||
155050574|NCT00490971|559615944|FG002|Maintenance|Protocol Violation|4|||
155050575|NCT00490971|559615945|FG003|Maintenance|Protocol Violation|1|||
155050576|NCT00490971|559615946|FG004|Maintenance|Protocol Violation|1|||
155050577|NCT00490971|559615942|FG000|Maintenance|Withdrawal by Subject|0|||
155050578|NCT00490971|559615943|FG001|Maintenance|Withdrawal by Subject|0|||
155050579|NCT00490971|559615944|FG002|Maintenance|Withdrawal by Subject|26|||
155050580|NCT00490971|559615945|FG003|Maintenance|Withdrawal by Subject|28|||
155050581|NCT00490971|559615946|FG004|Maintenance|Withdrawal by Subject|18|||
155050582|NCT00490971|559615942|FG000|Maintenance|Other|0|||
155389500|NCT01672788|560862531|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
155389501|NCT01672788|560862532|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
155389502|NCT01672788|560862533|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
155389503|NCT03329196|560862538|FG000|Overall Study|Adverse Event|10|||
155389504|NCT03329196|560862539|FG001|Overall Study|Adverse Event|5|||
155389505|NCT03329196|560862538|FG000|Overall Study|Physician Decision|2|||
155389506|NCT03329196|560862539|FG001|Overall Study|Physician Decision|2|||
155050583|NCT00490971|559615943|FG001|Maintenance|Other|0|||
155050584|NCT00490971|559615944|FG002|Maintenance|Other|11|||
155050585|NCT00490971|559615945|FG003|Maintenance|Other|9|||
155050586|NCT00490971|559615946|FG004|Maintenance|Other|3|||
155050587|NCT04754542|559615952|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
155050588|NCT04754542|559615953|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
155050589|NCT02358031|559617665|FG000|Overall Study|Death|253|||
155050590|NCT02358031|559617666|FG001|Overall Study|Death|237|||
155050591|NCT02358031|559617667|FG002|Overall Study|Death|266|||
155050592|NCT02358031|559617665|FG000|Overall Study|Lost to Follow-up|1|||
155050593|NCT02358031|559617666|FG001|Overall Study|Lost to Follow-up|1|||
155050594|NCT02358031|559617667|FG002|Overall Study|Lost to Follow-up|0|||
155389507|NCT03329196|560862538|FG000|Overall Study|Withdrawal by Subject|11|||
155389508|NCT03329196|560862539|FG001|Overall Study|Withdrawal by Subject|3|||
155389509|NCT03329196|560862538|FG000|Overall Study|Hepatic function abnormalities|0|||
155389510|NCT03329196|560862539|FG001|Overall Study|Hepatic function abnormalities|1|||
155389511|NCT03329196|560862538|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
155389512|NCT03329196|560862539|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
155389513|NCT03329196|560862538|FG000|Overall Study|Difficult to control Hb|2|||
155389514|NCT03329196|560862539|FG001|Overall Study|Difficult to control Hb|3|||
155389515|NCT03329196|560862538|FG000|Overall Study|Dialysis or renal transplant|13|||
155389516|NCT03329196|560862539|FG001|Overall Study|Dialysis or renal transplant|15|||
155050595|NCT02358031|559617665|FG000|Overall Study|Withdrawal by Subject|19|||
155050596|NCT02358031|559617666|FG001|Overall Study|Withdrawal by Subject|14|||
155389517|NCT02464228|560862540|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
155389518|NCT02464228|560862541|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
155389519|NCT02464228|560862542|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
155389520|NCT02464228|560862543|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
155389521|NCT02464228|560862540|FG000|Overall Study|Physician Decision|2|||
155050597|NCT02358031|559617667|FG002|Overall Study|Withdrawal by Subject|18|||
155050598|NCT02358031|559617665|FG000|Overall Study|Sponsor Decision|26|||
155050599|NCT02358031|559617666|FG001|Overall Study|Sponsor Decision|28|||
155050600|NCT02358031|559617667|FG002|Overall Study|Sponsor Decision|16|||
155050601|NCT01212094|559617668|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
155050602|NCT01212094|559617669|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
155050603|NCT01212094|559617670|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
155050604|NCT01212094|559617668|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
155050605|NCT01212094|559617669|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
155050606|NCT01212094|559617670|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
155050607|NCT01212094|559617668|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
155050608|NCT01212094|559617669|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
155050609|NCT01212094|559617670|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
155050610|NCT01212094|559617668|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
155050611|NCT01212094|559617669|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
155050612|NCT01212094|559617670|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
155050613|NCT01212094|559617668|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
155050614|NCT01212094|559617669|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
155050615|NCT01212094|559617670|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
155050616|NCT01212094|559617668|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
155050617|NCT01212094|559617669|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
155050618|NCT01212094|559617670|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
155050619|NCT05664581|559617674|FG000|Overall Study|Withdrawal by Subject|2|||
155050620|NCT03101150|559617675|FG000|Overall Study|Lost to Follow-up|2|||
155050621|NCT03101150|559617676|FG001|Overall Study|Lost to Follow-up|4|||
155050622|NCT03101150|559617675|FG000|Overall Study|Miscarriage|3|||
155050623|NCT03101150|559617676|FG001|Overall Study|Miscarriage|6|||
155050624|NCT01317641|559617680|FG000|Overall Study|Not treated|0|||
155050625|NCT01317641|559617681|FG001|Overall Study|Not treated|0|||
155050626|NCT01317641|559617682|FG002|Overall Study|Not treated|0|||
155050627|NCT01317641|559617683|FG003|Overall Study|Not treated|0|||
155050628|NCT01317641|559617684|FG004|Overall Study|Not treated|0|||
155050629|NCT01317641|559617685|FG005|Overall Study|Not treated|0|||
155050630|NCT01317641|559617686|FG006|Overall Study|Not treated|0|||
155050631|NCT01317641|559617687|FG007|Overall Study|Not treated|1|||
155050632|NCT01317641|559617688|FG008|Overall Study|Not treated|1|||
155389522|NCT02464228|560862541|FG001|Overall Study|Physician Decision|0|||
155389523|NCT02464228|560862542|FG002|Overall Study|Physician Decision|1|||
155389524|NCT02464228|560862543|FG003|Overall Study|Physician Decision|0|||
155389525|NCT02464228|560862540|FG000|Overall Study|Miscellaneous|1|||
155389526|NCT02464228|560862541|FG001|Overall Study|Miscellaneous|0|||
155389527|NCT02464228|560862542|FG002|Overall Study|Miscellaneous|1|||
155389528|NCT02464228|560862543|FG003|Overall Study|Miscellaneous|0|||
155389529|NCT02464228|560862540|FG000|Overall Study|Adverse Event|9|||
155389530|NCT02464228|560862541|FG001|Overall Study|Adverse Event|0|||
155389531|NCT02464228|560862542|FG002|Overall Study|Adverse Event|3|||
155389532|NCT02464228|560862543|FG003|Overall Study|Adverse Event|0|||
155389533|NCT02464228|560862540|FG000|Overall Study|Withdrawal by Subject|1|||
155389534|NCT02464228|560862541|FG001|Overall Study|Withdrawal by Subject|1|||
155050633|NCT01317641|559617680|FG000|Overall Study|Adverse Event|0|||
155050634|NCT01317641|559617681|FG001|Overall Study|Adverse Event|1|||
155050635|NCT01317641|559617682|FG002|Overall Study|Adverse Event|0|||
155050636|NCT01317641|559617683|FG003|Overall Study|Adverse Event|1|||
155050637|NCT01317641|559617684|FG004|Overall Study|Adverse Event|0|||
155389535|NCT02464228|560862542|FG002|Overall Study|Withdrawal by Subject|1|||
155050638|NCT01317641|559617685|FG005|Overall Study|Adverse Event|0|||
155050639|NCT01317641|559617686|FG006|Overall Study|Adverse Event|2|||
155050640|NCT01317641|559617687|FG007|Overall Study|Adverse Event|1|||
155050641|NCT01317641|559617688|FG008|Overall Study|Adverse Event|0|||
155389536|NCT02464228|560862543|FG003|Overall Study|Withdrawal by Subject|0|||
155389537|NCT02464228|560862540|FG000|Overall Study|Disease Progression|22|||
155389538|NCT02464228|560862541|FG001|Overall Study|Disease Progression|12|||
155389539|NCT02464228|560862542|FG002|Overall Study|Disease Progression|5|||
154948220|NCT01545076|559236034|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
154948221|NCT01545076|559236035|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
154948222|NCT01545076|559236036|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
154948223|NCT01545076|559236037|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
154948224|NCT01545076|559236038|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
154948225|NCT01545076|559236034|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
154948226|NCT01545076|559236035|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
154948227|NCT01545076|559236036|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
154948228|NCT01545076|559236037|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
154948229|NCT01545076|559236038|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
154948230|NCT01545076|559236034|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
154948231|NCT01545076|559236035|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
154948232|NCT01545076|559236036|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
154948233|NCT01545076|559236037|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
154948234|NCT01545076|559236038|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
154948235|NCT01545076|559236034|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
154948236|NCT01545076|559236035|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
154948237|NCT01545076|559236036|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
154948238|NCT01545076|559236037|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
154948239|NCT01545076|559236038|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
154948240|NCT01545076|559236034|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
154948241|NCT01545076|559236035|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
154948242|NCT01545076|559236036|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
154948243|NCT01545076|559236037|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
154948244|NCT01545076|559236038|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
154948245|NCT01545076|559236034|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
154948246|NCT01545076|559236035|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
154948247|NCT01545076|559236036|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
154948248|NCT01545076|559236037|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
154948249|NCT01545076|559236038|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
154948250|NCT01545076|559236034|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
154948251|NCT01545076|559236035|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
154948252|NCT01545076|559236036|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
154948253|NCT01545076|559236037|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
154948254|NCT01545076|559236038|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
154948255|NCT00262600|559236039|FG000|Overall Study|Lost to Follow-up|17|||
154948256|NCT00262600|559236040|FG001|Overall Study|Lost to Follow-up|31|||
154948257|NCT00262600|559236041|FG002|Overall Study|Lost to Follow-up|41|||
154948258|NCT00262600|559236039|FG000|Overall Study|Withdrawal by Subject|128|||
154948259|NCT00262600|559236040|FG001|Overall Study|Withdrawal by Subject|145|||
154948260|NCT00262600|559236041|FG002|Overall Study|Withdrawal by Subject|139|||
154948261|NCT00262600|559236039|FG000|Overall Study|Not Treated|32|||
154948262|NCT00262600|559236040|FG001|Overall Study|Not Treated|17|||
154948263|NCT00262600|559236041|FG002|Overall Study|Not Treated|24|||
154948264|NCT00262600|559236039|FG000|Overall Study|Other|58|||
154948265|NCT00262600|559236040|FG001|Overall Study|Other|59|||
154948266|NCT00262600|559236041|FG002|Overall Study|Other|62|||
154948267|NCT02710123|559236042|FG000|Overall Study|Lost to Follow-up|3|||
154948268|NCT02710123|559236043|FG001|Overall Study|Lost to Follow-up|4|||
154948269|NCT02710123|559236042|FG000|Overall Study|Withdrawal by Subject|1|||
154948270|NCT02710123|559236043|FG001|Overall Study|Withdrawal by Subject|1|||
154948271|NCT02710123|559236042|FG000|Overall Study|Illness unrelated to study intervention|1|||
154948272|NCT02710123|559236043|FG001|Overall Study|Illness unrelated to study intervention|0|||
154948273|NCT05381948|559236044|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
154948274|NCT05381948|559236045|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
154948275|NCT05381948|559236046|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
154948276|NCT05381948|559236044|FG000|Overall Study|Adverse Event: Non-ocular|0|||
154948277|NCT05381948|559236045|FG001|Overall Study|Adverse Event: Non-ocular|1|||
154948278|NCT05381948|559236046|FG002|Overall Study|Adverse Event: Non-ocular|0|||
154948279|NCT05381948|559236044|FG000|Overall Study|Lost to Follow-up|1|||
154948280|NCT05381948|559236045|FG001|Overall Study|Lost to Follow-up|0|||
154948281|NCT05381948|559236046|FG002|Overall Study|Lost to Follow-up|0|||
154948282|NCT05381948|559236044|FG000|Overall Study|Protocol Deviation|0|||
154948283|NCT05381948|559236045|FG001|Overall Study|Protocol Deviation|2|||
154948284|NCT05381948|559236046|FG002|Overall Study|Protocol Deviation|0|||
154948285|NCT05381948|559236044|FG000|Overall Study|Withdrawal by Subject|1|||
154948286|NCT05381948|559236045|FG001|Overall Study|Withdrawal by Subject|0|||
154948287|NCT05381948|559236046|FG002|Overall Study|Withdrawal by Subject|1|||
154948288|NCT05381948|559236044|FG000|Overall Study|Death|0|||
154948289|NCT05381948|559236045|FG001|Overall Study|Death|2|||
155050642|NCT01317641|559617680|FG000|Overall Study|Protocol Violation|1|||
155389540|NCT02464228|560862543|FG003|Overall Study|Disease Progression|2|||
155389541|NCT02952001|560862546|FG000|Overall Study|Adverse Event|3|||
155389542|NCT02952001|560862547|FG001|Overall Study|Adverse Event|0|||
154948290|NCT05381948|559236046|FG002|Overall Study|Death|0|||
154948291|NCT05381948|559236044|FG000|Overall Study|Discontinued study without receiving study drug|0|||
154948292|NCT05381948|559236045|FG001|Overall Study|Discontinued study without receiving study drug|0|||
154948293|NCT05381948|559236046|FG002|Overall Study|Discontinued study without receiving study drug|1|||
154948294|NCT04471207|559236047|FG000|Overall Study|Lost to Follow-up|4|||
154948295|NCT04471207|559236048|FG001|Overall Study|Lost to Follow-up|1|||
154948296|NCT04471207|559236047|FG000|Overall Study|Medication Contraindication|0|||
154948297|NCT04471207|559236048|FG001|Overall Study|Medication Contraindication|1|||
154948298|NCT04471207|559236047|FG000|Overall Study|Loss of Interest|2|||
154948299|NCT04471207|559236048|FG001|Overall Study|Loss of Interest|1|||
154948300|NCT04471207|559236047|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
154948301|NCT04471207|559236048|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
154948302|NCT04471207|559236047|FG000|Overall Study|Scheduling Conflicts|3|||
154948303|NCT04471207|559236048|FG001|Overall Study|Scheduling Conflicts|1|||
154948304|NCT04471207|559236047|FG000|Overall Study|Physician Decision|1|||
154948305|NCT04471207|559236048|FG001|Overall Study|Physician Decision|0|||
154948306|NCT04471207|559236047|FG000|Overall Study|Unwilling to Use System|0|||
154948307|NCT04471207|559236048|FG001|Overall Study|Unwilling to Use System|1|||
154948308|NCT02132247|559236051|FG000|Overall Study|Protocol Violation|1|||
154948309|NCT02132247|559236052|FG001|Overall Study|Protocol Violation|0|||
154948310|NCT00561730|559236053|FG000|Overall Study|Adverse Event|2|||
154948311|NCT00561730|559236053|FG000|Overall Study|Handling of the drug|1|||
154948312|NCT00561730|559236053|FG000|Overall Study|Lost to Follow-up|5|||
154948313|NCT00561730|559236053|FG000|Overall Study|Not specified reasons|1|||
154948314|NCT00520741|559236058|FG000|Overall Study|Adverse Event|16|||
154948315|NCT00520741|559236059|FG001|Overall Study|Adverse Event|56|||
154948316|NCT00520741|559236058|FG000|Overall Study|Lack of Efficacy|11|||
154948317|NCT00520741|559236059|FG001|Overall Study|Lack of Efficacy|30|||
154948318|NCT00520741|559236058|FG000|Overall Study|Withdrawal by Subject|0|||
154948319|NCT00520741|559236059|FG001|Overall Study|Withdrawal by Subject|11|||
154948320|NCT00520741|559236058|FG000|Overall Study|Protocol Violation|2|||
154948321|NCT00520741|559236059|FG001|Overall Study|Protocol Violation|15|||
154948322|NCT00520741|559236058|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
154948323|NCT00520741|559236059|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
154948324|NCT00520741|559236058|FG000|Overall Study|Lost to Follow-up|4|||
154948325|NCT00520741|559236059|FG001|Overall Study|Lost to Follow-up|4|||
154948326|NCT00520741|559236058|FG000|Overall Study|Other reasons for premature termination|0|||
154948327|NCT00520741|559236059|FG001|Overall Study|Other reasons for premature termination|6|||
154948328|NCT01505530|559236060|FG000|Overall Study|Progressive Disease|19|||
154948329|NCT01505530|559236061|FG001|Overall Study|Progressive Disease|17|||
154948330|NCT01505530|559236062|FG002|Overall Study|Progressive Disease|18|||
154948331|NCT01505530|559236060|FG000|Overall Study|Adverse Event|1|||
154948332|NCT01505530|559236061|FG001|Overall Study|Adverse Event|1|||
154948333|NCT01505530|559236062|FG002|Overall Study|Adverse Event|0|||
154948334|NCT01505530|559236060|FG000|Overall Study|Withdrawal by Subject|7|||
154948335|NCT01505530|559236061|FG001|Overall Study|Withdrawal by Subject|8|||
154948336|NCT01505530|559236062|FG002|Overall Study|Withdrawal by Subject|6|||
154948337|NCT01505530|559236060|FG000|Overall Study|Physician Decision|6|||
154948338|NCT01505530|559236061|FG001|Overall Study|Physician Decision|2|||
154948339|NCT01505530|559236062|FG002|Overall Study|Physician Decision|5|||
154948340|NCT01505530|559236060|FG000|Overall Study|Sponsor Decision|1|||
154948341|NCT01505530|559236061|FG001|Overall Study|Sponsor Decision|8|||
154948342|NCT01505530|559236062|FG002|Overall Study|Sponsor Decision|7|||
154948343|NCT01505530|559236060|FG000|Overall Study|Death|7|||
154948344|NCT01505530|559236061|FG001|Overall Study|Death|6|||
154948345|NCT01505530|559236062|FG002|Overall Study|Death|5|||
154948346|NCT01505530|559236060|FG000|Overall Study|entry criteria not met|0|||
155389543|NCT02952001|560862546|FG000|Overall Study|Prohibited therapy|10|||
155389544|NCT02952001|560862547|FG001|Overall Study|Prohibited therapy|3|||
154948347|NCT01505530|559236061|FG001|Overall Study|entry criteria not met|1|||
154948348|NCT01505530|559236062|FG002|Overall Study|entry criteria not met|0|||
154948349|NCT01153984|559236063|FG000|Overall Study|Withdrawal by Subject|1|||
154948350|NCT01153984|559236063|FG000|Overall Study|Adverse Event|1|||
154948351|NCT00973700|559236064|FG000|Overall Study|Withdrawal by Subject|2|||
154948352|NCT00973700|559236065|FG001|Overall Study|Withdrawal by Subject|2|||
154948353|NCT00973700|559236066|FG002|Overall Study|Withdrawal by Subject|8|||
154948354|NCT00973700|559236067|FG003|Overall Study|Withdrawal by Subject|4|||
154948355|NCT00973700|559236068|FG004|Overall Study|Withdrawal by Subject|4|||
154948356|NCT00973700|559236064|FG000|Overall Study|Lost to Follow-up|5|||
154948357|NCT00973700|559236065|FG001|Overall Study|Lost to Follow-up|0|||
154948358|NCT00973700|559236066|FG002|Overall Study|Lost to Follow-up|1|||
154948359|NCT00973700|559236067|FG003|Overall Study|Lost to Follow-up|8|||
155389545|NCT02952001|560862546|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
154948360|NCT00973700|559236068|FG004|Overall Study|Lost to Follow-up|5|||
155050643|NCT01317641|559617681|FG001|Overall Study|Protocol Violation|0|||
155050644|NCT01317641|559617682|FG002|Overall Study|Protocol Violation|0|||
155050645|NCT01317641|559617683|FG003|Overall Study|Protocol Violation|0|||
155050646|NCT01317641|559617684|FG004|Overall Study|Protocol Violation|0|||
155050647|NCT01317641|559617685|FG005|Overall Study|Protocol Violation|0|||
155050648|NCT01317641|559617686|FG006|Overall Study|Protocol Violation|0|||
155050649|NCT01317641|559617687|FG007|Overall Study|Protocol Violation|0|||
155050650|NCT01317641|559617688|FG008|Overall Study|Protocol Violation|0|||
155050651|NCT01317641|559617680|FG000|Overall Study|Disease progression|0|||
155050652|NCT01317641|559617681|FG001|Overall Study|Disease progression|0|||
155050653|NCT01317641|559617682|FG002|Overall Study|Disease progression|0|||
155050654|NCT01317641|559617683|FG003|Overall Study|Disease progression|0|||
155050655|NCT01317641|559617684|FG004|Overall Study|Disease progression|0|||
155050656|NCT01317641|559617685|FG005|Overall Study|Disease progression|0|||
155050657|NCT01317641|559617686|FG006|Overall Study|Disease progression|0|||
155050658|NCT01317641|559617687|FG007|Overall Study|Disease progression|3|||
155050659|NCT01317641|559617688|FG008|Overall Study|Disease progression|4|||
155050660|NCT01317641|559617680|FG000|Overall Study|Withdrawal by Subject|0|||
155050661|NCT01317641|559617681|FG001|Overall Study|Withdrawal by Subject|0|||
155050662|NCT01317641|559617682|FG002|Overall Study|Withdrawal by Subject|0|||
155050663|NCT01317641|559617683|FG003|Overall Study|Withdrawal by Subject|0|||
155050664|NCT01317641|559617684|FG004|Overall Study|Withdrawal by Subject|0|||
155050665|NCT01317641|559617685|FG005|Overall Study|Withdrawal by Subject|0|||
155050666|NCT01317641|559617686|FG006|Overall Study|Withdrawal by Subject|1|||
155050667|NCT01317641|559617687|FG007|Overall Study|Withdrawal by Subject|0|||
155050668|NCT01317641|559617688|FG008|Overall Study|Withdrawal by Subject|0|||
155050669|NCT04980014|559617689|FG000|Overall Study|Participants who are Duplicated|1|||
155050670|NCT04980014|559617689|FG000|Overall Study|Follow-up Failure|13|||
155050671|NCT04980014|559617689|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
155050672|NCT04980014|559617689|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
155050673|NCT04980014|559617689|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
155050674|NCT00715559|559617690|FG000|Overall Study|medication not tolerated - nausea|1|||
155050675|NCT00758498|559617691|FG000|Overall Study|Adverse Event|2|||
155050676|NCT00758498|559617692|FG001|Overall Study|Adverse Event|2|||
155050677|NCT00758498|559617693|FG002|Overall Study|Adverse Event|3|||
155050678|NCT00758498|559617691|FG000|Overall Study|Subject legally detained out of state|1|||
155050679|NCT00758498|559617692|FG001|Overall Study|Subject legally detained out of state|0|||
155050680|NCT00758498|559617693|FG002|Overall Study|Subject legally detained out of state|0|||
155050681|NCT00758498|559617691|FG000|Overall Study|Withdrawal by Subject|0|||
155050682|NCT00758498|559617692|FG001|Overall Study|Withdrawal by Subject|0|||
155050683|NCT00758498|559617693|FG002|Overall Study|Withdrawal by Subject|1|||
155050684|NCT00758498|559617691|FG000|Overall Study|Noncompliance to study procedures|0|||
155050685|NCT00758498|559617692|FG001|Overall Study|Noncompliance to study procedures|0|||
155050686|NCT00758498|559617693|FG002|Overall Study|Noncompliance to study procedures|1|||
155050687|NCT02317991|559617694|FG000|Overall Study|Adverse Event|12|||
155050688|NCT02317991|559617694|FG000|Overall Study|Death|4|||
155050689|NCT02317991|559617694|FG000|Overall Study|Withdrawal by Subject|8|||
155050690|NCT02317991|559617694|FG000|Overall Study|Progressive Disease|41|||
155050691|NCT00707057|559617695|FG000|Overall Study|Withdrawal by Subject|8|||
155050692|NCT00707057|559617696|FG001|Overall Study|Withdrawal by Subject|3|||
155050693|NCT00707057|559617695|FG000|Overall Study|Dosed incorrectly|0|||
155050694|NCT00707057|559617696|FG001|Overall Study|Dosed incorrectly|1|||
155050695|NCT01302418|559617697|FG000|Overall Study|Protocol Violation|9|||
155050696|NCT01302418|559617697|FG000|Overall Study|Non-evaluable|9|||
155050697|NCT02787304|559617704|FG000|Overall Study|Adverse Event|9|||
155050698|NCT02787304|559617705|FG001|Overall Study|Adverse Event|3|||
155050699|NCT02787304|559617706|FG002|Overall Study|Adverse Event|8|||
155050700|NCT02787304|559617707|FG003|Overall Study|Adverse Event|1|||
155050701|NCT02787304|559617704|FG000|Overall Study|Withdrawal by Subject|1|||
155050702|NCT02787304|559617705|FG001|Overall Study|Withdrawal by Subject|4|||
155050703|NCT02787304|559617706|FG002|Overall Study|Withdrawal by Subject|0|||
155050704|NCT02787304|559617707|FG003|Overall Study|Withdrawal by Subject|0|||
155050705|NCT02787304|559617704|FG000|Overall Study|Lost to Follow-up|1|||
155050706|NCT02787304|559617705|FG001|Overall Study|Lost to Follow-up|0|||
155050707|NCT02787304|559617706|FG002|Overall Study|Lost to Follow-up|0|||
155050708|NCT02787304|559617707|FG003|Overall Study|Lost to Follow-up|1|||
155050709|NCT02787304|559617704|FG000|Overall Study|Noncompliance with study drug|0|||
155050710|NCT02787304|559617705|FG001|Overall Study|Noncompliance with study drug|0|||
155050711|NCT02787304|559617706|FG002|Overall Study|Noncompliance with study drug|1|||
155050712|NCT02787304|559617707|FG003|Overall Study|Noncompliance with study drug|0|||
155389546|NCT02952001|560862547|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
155389547|NCT01794520|560862552|FG000|Overall Study|Adverse events- related to progression|0|||
155050713|NCT02787304|559617704|FG000|Overall Study|Physician Decision|0|||
155050714|NCT02787304|559617705|FG001|Overall Study|Physician Decision|0|||
155050715|NCT02787304|559617706|FG002|Overall Study|Physician Decision|1|||
155050716|NCT02787304|559617707|FG003|Overall Study|Physician Decision|0|||
155389548|NCT01794520|560862553|FG001|Overall Study|Adverse events- related to progression|0|||
155389549|NCT01794520|560862554|FG002|Overall Study|Adverse events- related to progression|1|||
155389550|NCT01794520|560862555|FG003|Overall Study|Adverse events- related to progression|2|||
155389551|NCT01794520|560862556|FG004|Overall Study|Adverse events- related to progression|0|||
155389552|NCT01794520|560862557|FG005|Overall Study|Adverse events- related to progression|1|||
155389553|NCT01794520|560862558|FG006|Overall Study|Adverse events- related to progression|0|||
155050717|NCT02787304|559617704|FG000|Overall Study|Study terminated by sponsor|25|||
155050718|NCT02787304|559617705|FG001|Overall Study|Study terminated by sponsor|31|||
155050719|NCT02787304|559617706|FG002|Overall Study|Study terminated by sponsor|31|||
155050720|NCT02787304|559617707|FG003|Overall Study|Study terminated by sponsor|32|||
155050721|NCT04771013|559617710|FG000|Overall Study|Withdrawal by Subject|2|||
155050722|NCT04771013|559617711|FG001|Overall Study|Withdrawal by Subject|0|||
155050723|NCT04771013|559617710|FG000|Overall Study|Death|0|||
155050724|NCT04771013|559617711|FG001|Overall Study|Death|5|||
155050725|NCT04771013|559617710|FG000|Overall Study|Referred to another hospital before day 20|0|||
155050726|NCT04771013|559617711|FG001|Overall Study|Referred to another hospital before day 20|1|||
155050727|NCT00823134|559617714|FG000|Overall Study|Invalid measurement|1|||
155050728|NCT01519817|559617718|FG000|Overall Study|Withdrawal by Subject|1|||
155050729|NCT01519817|559617719|FG001|Overall Study|Withdrawal by Subject|0|||
155050730|NCT01519817|559617720|FG002|Overall Study|Withdrawal by Subject|0|||
155050731|NCT01519817|559617721|FG003|Overall Study|Withdrawal by Subject|0|||
155050732|NCT01519817|559617718|FG000|Overall Study|Off study due to infection|0|||
155050733|NCT01519817|559617719|FG001|Overall Study|Off study due to infection|0|||
155050734|NCT01519817|559617720|FG002|Overall Study|Off study due to infection|0|||
155050735|NCT01519817|559617721|FG003|Overall Study|Off study due to infection|1|||
155050736|NCT02922153|559617722|FG000|Overall Study|Death|8|||
155050737|NCT02922153|559617723|FG001|Overall Study|Death|1|||
155050738|NCT02922153|559617722|FG000|Overall Study|Lost to Follow-up|1|||
155050739|NCT02922153|559617723|FG001|Overall Study|Lost to Follow-up|0|||
155050740|NCT02922153|559617722|FG000|Overall Study|Physician Decision|1|||
155050741|NCT02922153|559617723|FG001|Overall Study|Physician Decision|1|||
155050742|NCT00956839|559617724|FG000|Overall Study|Lost to Follow-up|3|||
155050743|NCT00956839|559617725|FG001|Overall Study|Lost to Follow-up|0|||
155050744|NCT00956839|559617726|FG002|Overall Study|Lost to Follow-up|3|||
155050745|NCT02692586|559617727|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
155050746|NCT02692586|559617727|FG000|Overall Study|Received adjunctive thrombolytics|2|||
155050747|NCT03316586|559617735|FG000|Overall Study|Adverse Event|2|||
155050748|NCT03316586|559617735|FG000|Overall Study|Physician Decision|3|||
155050749|NCT03316586|559617735|FG000|Overall Study|Lack of Efficacy|10|||
155050750|NCT03316586|559617735|FG000|Overall Study|still on treatment|1|||
155050751|NCT03316586|559617735|FG000|Overall Study|Patient needed radiation therapy|1|||
155050752|NCT03316586|559617735|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
155050753|NCT01053741|559617738|FG000|2nd Study Intervention|Physician Decision|0|||
155050754|NCT01053741|559617739|FG001|2nd Study Intervention|Physician Decision|1|||
155050755|NCT00994110|559617740|FG000|Overall Study|Withdrawal by Subject|9|||
155050756|NCT00994110|559617741|FG001|Overall Study|Withdrawal by Subject|9|||
155050757|NCT00994110|559617740|FG000|Overall Study|Not Treated|4|||
155050758|NCT00994110|559617741|FG001|Overall Study|Not Treated|8|||
155050759|NCT00994110|559617740|FG000|Overall Study|Adverse Event|1|||
155050760|NCT00994110|559617741|FG001|Overall Study|Adverse Event|0|||
155050761|NCT00994110|559617740|FG000|Overall Study|Patient not resected|41|||
155050762|NCT00994110|559617741|FG001|Overall Study|Patient not resected|52|||
155050763|NCT00994110|559617740|FG000|Overall Study|Pt not eligible|10|||
155050764|NCT00994110|559617741|FG001|Overall Study|Pt not eligible|5|||
155050765|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
155050766|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155050767|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155050768|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155050769|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
155050770|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
155050771|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155050772|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155050773|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155389554|NCT01794520|560862552|FG000|Overall Study|Adverse event- not related to progression|1|||
155050774|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
155050775|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
155050776|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155050777|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155050778|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155050779|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
155050780|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
155050781|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155050782|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155050783|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155389555|NCT01794520|560862553|FG001|Overall Study|Adverse event- not related to progression|1|||
155389556|NCT01794520|560862554|FG002|Overall Study|Adverse event- not related to progression|0|||
155389557|NCT01794520|560862555|FG003|Overall Study|Adverse event- not related to progression|0|||
155389558|NCT01794520|560862556|FG004|Overall Study|Adverse event- not related to progression|2|||
155389559|NCT01794520|560862557|FG005|Overall Study|Adverse event- not related to progression|0|||
155389560|NCT01794520|560862558|FG006|Overall Study|Adverse event- not related to progression|0|||
155389561|NCT01794520|560862552|FG000|Overall Study|Progressive disease|5|||
155389562|NCT01794520|560862553|FG001|Overall Study|Progressive disease|6|||
155389563|NCT01794520|560862554|FG002|Overall Study|Progressive disease|2|||
155389564|NCT01794520|560862555|FG003|Overall Study|Progressive disease|5|||
155389565|NCT01794520|560862556|FG004|Overall Study|Progressive disease|27|||
155389566|NCT01794520|560862557|FG005|Overall Study|Progressive disease|18|||
155389567|NCT01794520|560862558|FG006|Overall Study|Progressive disease|0|||
155389568|NCT01794520|560862552|FG000|Overall Study|Withdrew consent|0|||
155389569|NCT01794520|560862553|FG001|Overall Study|Withdrew consent|0|||
155389570|NCT01794520|560862554|FG002|Overall Study|Withdrew consent|1|||
155389571|NCT01794520|560862555|FG003|Overall Study|Withdrew consent|1|||
155389572|NCT01794520|560862556|FG004|Overall Study|Withdrew consent|0|||
155389573|NCT01794520|560862557|FG005|Overall Study|Withdrew consent|0|||
155389574|NCT01794520|560862558|FG006|Overall Study|Withdrew consent|0|||
155389575|NCT01794520|560862552|FG000|Overall Study|Lost to Follow-up|0|||
155389576|NCT01794520|560862553|FG001|Overall Study|Lost to Follow-up|0|||
155389577|NCT01794520|560862554|FG002|Overall Study|Lost to Follow-up|0|||
155389578|NCT01794520|560862555|FG003|Overall Study|Lost to Follow-up|0|||
155389579|NCT01794520|560862556|FG004|Overall Study|Lost to Follow-up|1|||
155389580|NCT01794520|560862557|FG005|Overall Study|Lost to Follow-up|0|||
155389581|NCT01794520|560862558|FG006|Overall Study|Lost to Follow-up|0|||
155389582|NCT01794520|560862552|FG000|Overall Study|Toxicity|0|||
155389583|NCT01794520|560862553|FG001|Overall Study|Toxicity|2|||
155389584|NCT01794520|560862554|FG002|Overall Study|Toxicity|0|||
155389585|NCT01794520|560862555|FG003|Overall Study|Toxicity|0|||
155389586|NCT01794520|560862556|FG004|Overall Study|Toxicity|0|||
155389587|NCT01794520|560862557|FG005|Overall Study|Toxicity|0|||
155389588|NCT01794520|560862558|FG006|Overall Study|Toxicity|0|||
155389589|NCT01794520|560862552|FG000|Overall Study|Study terminated by sponsor|0|||
155389590|NCT01794520|560862553|FG001|Overall Study|Study terminated by sponsor|0|||
155389591|NCT01794520|560862554|FG002|Overall Study|Study terminated by sponsor|1|||
155389592|NCT01794520|560862555|FG003|Overall Study|Study terminated by sponsor|0|||
155389593|NCT01794520|560862556|FG004|Overall Study|Study terminated by sponsor|1|||
155389594|NCT01794520|560862557|FG005|Overall Study|Study terminated by sponsor|0|||
155389595|NCT01794520|560862558|FG006|Overall Study|Study terminated by sponsor|7|||
155389596|NCT01794520|560862552|FG000|Overall Study|Death|0|||
155389597|NCT01794520|560862553|FG001|Overall Study|Death|0|||
155389598|NCT01794520|560862554|FG002|Overall Study|Death|0|||
155389599|NCT01794520|560862555|FG003|Overall Study|Death|0|||
155389600|NCT01794520|560862556|FG004|Overall Study|Death|1|||
155389601|NCT01794520|560862557|FG005|Overall Study|Death|0|||
155389602|NCT01794520|560862558|FG006|Overall Study|Death|22|||
155389603|NCT01794520|560862552|FG000|Overall Study|Other, not specified|0|||
155389604|NCT01794520|560862553|FG001|Overall Study|Other, not specified|0|||
155389605|NCT01794520|560862554|FG002|Overall Study|Other, not specified|1|||
155389606|NCT01794520|560862555|FG003|Overall Study|Other, not specified|1|||
155389607|NCT01794520|560862556|FG004|Overall Study|Other, not specified|4|||
155389608|NCT01794520|560862557|FG005|Overall Study|Other, not specified|1|||
155389609|NCT01794520|560862558|FG006|Overall Study|Other, not specified|2|||
155389610|NCT04796896|560862560|FG000|Overall Study|Adverse Event|1|||
154948361|NCT00973700|559236064|FG000|Overall Study|Inappropriate enrolment|0|||
154948362|NCT00973700|559236065|FG001|Overall Study|Inappropriate enrolment|0|||
154948363|NCT00973700|559236066|FG002|Overall Study|Inappropriate enrolment|0|||
154948364|NCT00973700|559236067|FG003|Overall Study|Inappropriate enrolment|4|||
154948365|NCT00973700|559236068|FG004|Overall Study|Inappropriate enrolment|0|||
154948366|NCT00973700|559236064|FG000|Overall Study|Unable to Classify|0|||
154948367|NCT00973700|559236065|FG001|Overall Study|Unable to Classify|0|||
154948368|NCT00973700|559236066|FG002|Overall Study|Unable to Classify|1|||
154948369|NCT00973700|559236067|FG003|Overall Study|Unable to Classify|2|||
154948370|NCT00973700|559236068|FG004|Overall Study|Unable to Classify|1|||
154948371|NCT01618266|559236077|FG000|Overall Study|Lost to Follow-up|9|||
154948372|NCT01618266|559236077|FG000|Overall Study|Treatment satisfaction|10|||
154948373|NCT01618266|559236077|FG000|Overall Study|Other reasons|11|||
154948374|NCT01618266|559236077|FG000|Overall Study|Lack of Efficacy|23|||
154948375|NCT01618266|559236077|FG000|Overall Study|Protocol Violation|43|||
154948376|NCT00626925|559236078|FG000|Overall Study|Lost to Follow-up|1|||
154948377|NCT00626925|559236079|FG001|Overall Study|Lost to Follow-up|2|||
155050784|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
155389611|NCT04796896|560862561|FG001|Overall Study|Adverse Event|0|||
154948378|NCT00626925|559236078|FG000|Overall Study|relapse|1|||
154948379|NCT00626925|559236079|FG001|Overall Study|relapse|0|||
154948380|NCT00626925|559236078|FG000|Overall Study|Adverse effect|6|||
155389612|NCT04796896|560862562|FG002|Overall Study|Adverse Event|0|||
155050785|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
155050786|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155050787|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155050788|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155050789|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
155050790|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
155050791|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155050792|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155050793|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155050794|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
155050795|NCT01111565|559617742|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
155050796|NCT01111565|559617743|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155050797|NCT01111565|559617744|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155050798|NCT01111565|559617745|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155050799|NCT01111565|559617746|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
155050800|NCT01111565|559617742|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155050801|NCT01111565|559617743|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155050802|NCT01111565|559617744|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155050803|NCT01111565|559617745|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
155050804|NCT01111565|559617746|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
155050805|NCT01111565|559617742|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155050806|NCT01111565|559617743|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155050807|NCT01111565|559617744|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
155050808|NCT01111565|559617745|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155050809|NCT01111565|559617746|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155050810|NCT01111565|559617742|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
155050811|NCT01111565|559617743|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
155050812|NCT01111565|559617744|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
155050813|NCT01111565|559617745|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
155050814|NCT01111565|559617746|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
155050815|NCT01111565|559617742|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155050816|NCT01111565|559617743|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155050817|NCT01111565|559617744|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155050818|NCT01111565|559617745|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
155050819|NCT01111565|559617746|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
155050820|NCT01111565|559617742|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155050821|NCT01111565|559617743|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155050822|NCT01111565|559617744|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155050823|NCT01111565|559617745|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
155050824|NCT01111565|559617746|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
155050825|NCT04131712|559617747|FG000|Overall Study|COVID related|0|||
155050826|NCT04131712|559617748|FG001|Overall Study|COVID related|0|||
155050827|NCT04131712|559617749|FG002|Overall Study|COVID related|2|||
155050828|NCT04131712|559617750|FG003|Overall Study|COVID related|0|||
155050829|NCT04131712|559617747|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
155050830|NCT04131712|559617748|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
155050831|NCT04131712|559617749|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
155050832|NCT04131712|559617750|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
155050833|NCT00766597|559617751|FG000|Overall Study|Unexpected closure of study|4|||
155050834|NCT00766597|559617751|FG000|Overall Study|Without CCR5-tropic virus|5|||
155050835|NCT01254656|559617752|FG000|Overall Study|Discontinued due to termination of study|40|||
155050836|NCT01254656|559617753|FG001|Overall Study|Discontinued due to termination of study|39|||
155050837|NCT01254656|559617754|FG002|Overall Study|Discontinued due to termination of study|13|||
155050838|NCT01254656|559617752|FG000|Overall Study|Lack of Efficacy|3|||
155050839|NCT01254656|559617753|FG001|Overall Study|Lack of Efficacy|0|||
155050840|NCT01254656|559617754|FG002|Overall Study|Lack of Efficacy|0|||
155050841|NCT01254656|559617752|FG000|Overall Study|Lost to Follow-up|1|||
155050842|NCT01254656|559617753|FG001|Overall Study|Lost to Follow-up|0|||
155050843|NCT01254656|559617754|FG002|Overall Study|Lost to Follow-up|2|||
155050844|NCT01254656|559617752|FG000|Overall Study|Withdrawal by Subject|2|||
155050845|NCT01254656|559617753|FG001|Overall Study|Withdrawal by Subject|2|||
155050846|NCT01254656|559617754|FG002|Overall Study|Withdrawal by Subject|1|||
155050847|NCT01254656|559617752|FG000|Overall Study|Pregnancy|0|||
155050848|NCT01254656|559617753|FG001|Overall Study|Pregnancy|0|||
155050849|NCT01254656|559617754|FG002|Overall Study|Pregnancy|2|||
155050850|NCT01254656|559617752|FG000|Overall Study|Adverse Event|1|||
155050851|NCT01254656|559617753|FG001|Overall Study|Adverse Event|1|||
155050852|NCT01254656|559617754|FG002|Overall Study|Adverse Event|0|||
155389613|NCT04796896|560862563|FG003|Overall Study|Adverse Event|0|||
155389614|NCT04796896|560862564|FG004|Overall Study|Adverse Event|0|||
155389615|NCT04796896|560862565|FG005|Overall Study|Adverse Event|1|||
155389616|NCT04796896|560862566|FG006|Overall Study|Adverse Event|1|||
155389617|NCT04796896|560862567|FG007|Overall Study|Adverse Event|0|||
155389618|NCT04796896|560862568|FG008|Overall Study|Adverse Event|1|||
155389619|NCT04796896|560862569|FG009|Overall Study|Adverse Event|1|||
155389620|NCT04796896|560862570|FG010|Overall Study|Adverse Event|1|||
155389621|NCT04796896|560862571|FG011|Overall Study|Adverse Event|0|||
155389622|NCT04796896|560862560|FG000|Overall Study|Lost to Follow-up|24|||
155389623|NCT04796896|560862561|FG001|Overall Study|Lost to Follow-up|15|||
155389624|NCT04796896|560862562|FG002|Overall Study|Lost to Follow-up|6|||
155389625|NCT04796896|560862563|FG003|Overall Study|Lost to Follow-up|4|||
155389626|NCT04796896|560862564|FG004|Overall Study|Lost to Follow-up|21|||
155389627|NCT04796896|560862565|FG005|Overall Study|Lost to Follow-up|55|||
155389628|NCT04796896|560862566|FG006|Overall Study|Lost to Follow-up|237|||
155389629|NCT04796896|560862567|FG007|Overall Study|Lost to Follow-up|52|||
155389630|NCT04796896|560862568|FG008|Overall Study|Lost to Follow-up|221|||
155389631|NCT04796896|560862569|FG009|Overall Study|Lost to Follow-up|43|||
155389632|NCT04796896|560862570|FG010|Overall Study|Lost to Follow-up|142|||
155389633|NCT04796896|560862571|FG011|Overall Study|Lost to Follow-up|18|||
155389634|NCT04796896|560862560|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
155389635|NCT04796896|560862561|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
155389636|NCT04796896|560862562|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
155389637|NCT04796896|560862563|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
155389638|NCT04796896|560862564|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
155389639|NCT04796896|560862565|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
155389640|NCT04796896|560862566|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
155389641|NCT04796896|560862567|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
155389642|NCT04796896|560862568|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
155389643|NCT04796896|560862569|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
155389644|NCT04796896|560862570|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
155389645|NCT04796896|560862571|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
155389646|NCT04796896|560862560|FG000|Overall Study|Physician Decision|1|||
155389647|NCT04796896|560862561|FG001|Overall Study|Physician Decision|0|||
155389648|NCT04796896|560862562|FG002|Overall Study|Physician Decision|0|||
155389649|NCT04796896|560862563|FG003|Overall Study|Physician Decision|0|||
155389650|NCT04796896|560862564|FG004|Overall Study|Physician Decision|0|||
155389651|NCT04796896|560862565|FG005|Overall Study|Physician Decision|3|||
155389652|NCT04796896|560862566|FG006|Overall Study|Physician Decision|18|||
155389653|NCT04796896|560862567|FG007|Overall Study|Physician Decision|1|||
155389654|NCT04796896|560862568|FG008|Overall Study|Physician Decision|7|||
155389655|NCT04796896|560862569|FG009|Overall Study|Physician Decision|0|||
155389656|NCT04796896|560862570|FG010|Overall Study|Physician Decision|5|||
155389657|NCT04796896|560862571|FG011|Overall Study|Physician Decision|0|||
155389658|NCT04796896|560862560|FG000|Overall Study|Withdrawal by Subject|36|||
155389659|NCT04796896|560862561|FG001|Overall Study|Withdrawal by Subject|31|||
155389660|NCT04796896|560862562|FG002|Overall Study|Withdrawal by Subject|11|||
155389661|NCT04796896|560862563|FG003|Overall Study|Withdrawal by Subject|8|||
155389662|NCT04796896|560862564|FG004|Overall Study|Withdrawal by Subject|16|||
155389663|NCT04796896|560862565|FG005|Overall Study|Withdrawal by Subject|162|||
155389664|NCT04796896|560862566|FG006|Overall Study|Withdrawal by Subject|299|||
155389665|NCT04796896|560862567|FG007|Overall Study|Withdrawal by Subject|149|||
155389666|NCT04796896|560862568|FG008|Overall Study|Withdrawal by Subject|303|||
155389667|NCT04796896|560862569|FG009|Overall Study|Withdrawal by Subject|94|||
155389668|NCT04796896|560862570|FG010|Overall Study|Withdrawal by Subject|192|||
155389669|NCT04796896|560862571|FG011|Overall Study|Withdrawal by Subject|16|||
155389670|NCT04796896|560862560|FG000|Overall Study|Other Than Specified|6|||
155389671|NCT04796896|560862561|FG001|Overall Study|Other Than Specified|5|||
155389672|NCT04796896|560862562|FG002|Overall Study|Other Than Specified|3|||
155389673|NCT04796896|560862563|FG003|Overall Study|Other Than Specified|2|||
155389674|NCT04796896|560862564|FG004|Overall Study|Other Than Specified|6|||
155389675|NCT04796896|560862565|FG005|Overall Study|Other Than Specified|31|||
155389676|NCT04796896|560862566|FG006|Overall Study|Other Than Specified|86|||
155389677|NCT04796896|560862567|FG007|Overall Study|Other Than Specified|66|||
155389678|NCT04796896|560862568|FG008|Overall Study|Other Than Specified|388|||
155389679|NCT04796896|560862569|FG009|Overall Study|Other Than Specified|48|||
155389680|NCT04796896|560862570|FG010|Overall Study|Other Than Specified|258|||
155389681|NCT04796896|560862571|FG011|Overall Study|Other Than Specified|4|||
155389682|NCT04796896|560862560|FG000|Overall Study|Protocol Deviation|0|||
155389683|NCT04796896|560862561|FG001|Overall Study|Protocol Deviation|0|||
155389684|NCT04796896|560862562|FG002|Overall Study|Protocol Deviation|0|||
155389685|NCT04796896|560862563|FG003|Overall Study|Protocol Deviation|1|||
155389686|NCT04796896|560862564|FG004|Overall Study|Protocol Deviation|1|||
155389687|NCT04796896|560862565|FG005|Overall Study|Protocol Deviation|2|||
155389688|NCT04796896|560862566|FG006|Overall Study|Protocol Deviation|2|||
155389689|NCT04796896|560862567|FG007|Overall Study|Protocol Deviation|2|||
155389690|NCT04796896|560862568|FG008|Overall Study|Protocol Deviation|2|||
155389691|NCT04796896|560862569|FG009|Overall Study|Protocol Deviation|1|||
155389692|NCT04796896|560862570|FG010|Overall Study|Protocol Deviation|0|||
155389693|NCT04796896|560862571|FG011|Overall Study|Protocol Deviation|0|||
155389694|NCT04796896|560862560|FG000|Overall Study|Missing|0|||
155389695|NCT04796896|560862561|FG001|Overall Study|Missing|0|||
155389696|NCT04796896|560862562|FG002|Overall Study|Missing|0|||
155389697|NCT04796896|560862563|FG003|Overall Study|Missing|0|||
155389698|NCT04796896|560862564|FG004|Overall Study|Missing|0|||
155389699|NCT04796896|560862565|FG005|Overall Study|Missing|0|||
155389700|NCT04796896|560862566|FG006|Overall Study|Missing|2|||
155389701|NCT04796896|560862567|FG007|Overall Study|Missing|1|||
155389702|NCT04796896|560862568|FG008|Overall Study|Missing|2|||
155389703|NCT04796896|560862569|FG009|Overall Study|Missing|1|||
155389704|NCT04796896|560862570|FG010|Overall Study|Missing|1|||
155389705|NCT04796896|560862571|FG011|Overall Study|Missing|0|||
155389706|NCT04796896|560862560|FG000|Overall Study|Death|0|||
155389707|NCT04796896|560862561|FG001|Overall Study|Death|0|||
155389708|NCT04796896|560862562|FG002|Overall Study|Death|0|||
155389709|NCT04796896|560862563|FG003|Overall Study|Death|0|||
155389710|NCT04796896|560862564|FG004|Overall Study|Death|0|||
155389711|NCT04796896|560862565|FG005|Overall Study|Death|0|||
155389712|NCT04796896|560862566|FG006|Overall Study|Death|0|||
155389713|NCT04796896|560862567|FG007|Overall Study|Death|0|||
155389714|NCT04796896|560862568|FG008|Overall Study|Death|1|||
155389715|NCT04796896|560862569|FG009|Overall Study|Death|0|||
155389716|NCT04796896|560862570|FG010|Overall Study|Death|0|||
155389717|NCT04796896|560862571|FG011|Overall Study|Death|0|||
155389718|NCT02021292|560862572|FG000|Overall Study|Physician Decision|0|||
155389719|NCT02021292|560862573|FG001|Overall Study|Physician Decision|1|||
155389720|NCT02021292|560862572|FG000|Overall Study|Lost to Follow-up|0|||
155389721|NCT02021292|560862573|FG001|Overall Study|Lost to Follow-up|1|||
155389722|NCT02021292|560862572|FG000|Overall Study|Death|0|||
155389723|NCT02021292|560862573|FG001|Overall Study|Death|1|||
155389724|NCT05972733|560862576|FG000|Overall Study|Lost to Follow-up|2|||
155389725|NCT05972733|560862576|FG000|Overall Study|Withdrawal by Subject|1|||
155389726|NCT01177787|560862577|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
155389727|NCT01177787|560862577|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
155389728|NCT01177787|560862577|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
155389729|NCT01637623|560862578|FG000|Overall Study|Lost to Follow-up|0|||
155389730|NCT01637623|560862579|FG001|Overall Study|Lost to Follow-up|0|||
155389731|NCT01637623|560862580|FG002|Overall Study|Lost to Follow-up|2|||
155389732|NCT01637623|560862578|FG000|Overall Study|Physician Decision|1|||
155389733|NCT01637623|560862579|FG001|Overall Study|Physician Decision|0|||
155389734|NCT01637623|560862580|FG002|Overall Study|Physician Decision|1|||
155389735|NCT02824263|560862581|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
155389736|NCT02824263|560862582|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
155389737|NCT02824263|560862581|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
155389738|NCT02824263|560862582|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
155389739|NCT00568321|560862583|FG000|Overall Study|Adverse Event|1|||
154948381|NCT00626925|559236079|FG001|Overall Study|Adverse effect|2|||
154948382|NCT00626925|559236078|FG000|Overall Study|Lack of Efficacy|1|||
154948383|NCT00626925|559236079|FG001|Overall Study|Lack of Efficacy|4|||
154948384|NCT00626925|559236078|FG000|Overall Study|Time constraints|3|||
154948385|NCT00626925|559236079|FG001|Overall Study|Time constraints|1|||
154948386|NCT00625807|559236080|FG000|Overall Study|schedule conflict|2|||
154948387|NCT00625807|559236081|FG001|Overall Study|schedule conflict|8|||
154948388|NCT01966042|559236082|FG000|Overall Study|Death|2|||
154948389|NCT03267264|559236083|FG000|Overall Study|Withdrawal by Subject|1|||
154948390|NCT03267264|559236084|FG001|Overall Study|Withdrawal by Subject|0|||
155389740|NCT00568321|560862584|FG001|Overall Study|Adverse Event|0|||
155389741|NCT00568321|560862585|FG002|Overall Study|Adverse Event|0|||
155389742|NCT00568321|560862583|FG000|Overall Study|Lack of Efficacy|8|||
155389743|NCT00568321|560862584|FG001|Overall Study|Lack of Efficacy|5|||
155389744|NCT00568321|560862585|FG002|Overall Study|Lack of Efficacy|6|||
155050853|NCT01254656|559617752|FG000|Overall Study|Death|0|||
155389745|NCT00568321|560862583|FG000|Overall Study|Lost to Follow-up|0|||
155389746|NCT00568321|560862584|FG001|Overall Study|Lost to Follow-up|0|||
155389747|NCT00568321|560862585|FG002|Overall Study|Lost to Follow-up|1|||
154948391|NCT03267264|559236085|FG002|Overall Study|Withdrawal by Subject|2|||
154948392|NCT03267264|559236086|FG003|Overall Study|Withdrawal by Subject|4|||
155389748|NCT00568321|560862583|FG000|Overall Study|Withdrawal by Subject|2|||
155389749|NCT00568321|560862584|FG001|Overall Study|Withdrawal by Subject|0|||
155389750|NCT00568321|560862585|FG002|Overall Study|Withdrawal by Subject|0|||
155389751|NCT00568321|560862583|FG000|Overall Study|Protocol Violation|0|||
155389752|NCT00568321|560862584|FG001|Overall Study|Protocol Violation|0|||
155389753|NCT00568321|560862585|FG002|Overall Study|Protocol Violation|1|||
155389754|NCT00568321|560862583|FG000|Overall Study|Randomized, not treated|2|||
155389755|NCT00568321|560862584|FG001|Overall Study|Randomized, not treated|0|||
155389756|NCT00568321|560862585|FG002|Overall Study|Randomized, not treated|1|||
155389757|NCT01180998|560862588|FG000|Overall Study|Poor Vision|0|||
155389758|NCT01180998|560862589|FG001|Overall Study|Poor Vision|2|||
155389759|NCT01180998|560862590|FG002|Overall Study|Poor Vision|2|||
155389760|NCT01180998|560862588|FG000|Overall Study|Lost to Follow-up|0|||
155389761|NCT01180998|560862589|FG001|Overall Study|Lost to Follow-up|0|||
155389762|NCT01180998|560862590|FG002|Overall Study|Lost to Follow-up|1|||
155389763|NCT01180998|560862588|FG000|Overall Study|Protocol Violation|1|||
155389764|NCT01180998|560862589|FG001|Overall Study|Protocol Violation|2|||
155389765|NCT01180998|560862590|FG002|Overall Study|Protocol Violation|0|||
155389766|NCT01180998|560862588|FG000|Overall Study|Withdrawal by Subject|0|||
155389767|NCT01180998|560862589|FG001|Overall Study|Withdrawal by Subject|0|||
155389768|NCT01180998|560862590|FG002|Overall Study|Withdrawal by Subject|1|||
155389769|NCT01180998|560862588|FG000|Overall Study|Poor comfort|3|||
155389770|NCT01180998|560862589|FG001|Overall Study|Poor comfort|0|||
155389771|NCT01180998|560862590|FG002|Overall Study|Poor comfort|4|||
155389772|NCT01180998|560862588|FG000|Overall Study|Poor lens handling|0|||
155389773|NCT01180998|560862589|FG001|Overall Study|Poor lens handling|0|||
155389774|NCT01180998|560862590|FG002|Overall Study|Poor lens handling|2|||
155389775|NCT01176968|560862591|FG000|Overall Study|Adverse Event|10|||
155389776|NCT01176968|560862592|FG001|Overall Study|Adverse Event|11|||
155389777|NCT01176968|560862591|FG000|Overall Study|Death|2|||
155389778|NCT01176968|560862592|FG001|Overall Study|Death|3|||
155389779|NCT01176968|560862591|FG000|Overall Study|Lack of Efficacy|0|||
155389780|NCT01176968|560862592|FG001|Overall Study|Lack of Efficacy|1|||
155389781|NCT01176968|560862591|FG000|Overall Study|Lost to Follow-up|16|||
155389782|NCT01176968|560862592|FG001|Overall Study|Lost to Follow-up|14|||
155389783|NCT01176968|560862591|FG000|Overall Study|Withdrawal by Subject|48|||
155389784|NCT01176968|560862592|FG001|Overall Study|Withdrawal by Subject|48|||
155389785|NCT01176968|560862591|FG000|Overall Study|Protocol Violation|2|||
155389786|NCT01176968|560862592|FG001|Overall Study|Protocol Violation|1|||
155389787|NCT01176968|560862591|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155389788|NCT01176968|560862592|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
155389789|NCT01176968|560862591|FG000|Overall Study|Study terminated by sponsor|0|||
155389790|NCT01176968|560862592|FG001|Overall Study|Study terminated by sponsor|1|||
155389791|NCT01176968|560862591|FG000|Overall Study|Reason not defined|5|||
155389792|NCT01176968|560862592|FG001|Overall Study|Reason not defined|3|||
155389793|NCT04658186|560862593|FG000|Overall Study|Adverse Event|4|||
155389794|NCT04658186|560862594|FG001|Overall Study|Adverse Event|18|||
155389795|NCT04658186|560862595|FG002|Overall Study|Adverse Event|15|||
155389796|NCT04658186|560862593|FG000|Overall Study|Lack of Efficacy|1|||
155389797|NCT04658186|560862594|FG001|Overall Study|Lack of Efficacy|1|||
155389798|NCT04658186|560862595|FG002|Overall Study|Lack of Efficacy|0|||
155389799|NCT04658186|560862593|FG000|Overall Study|Protocol Violation|0|||
155389800|NCT04658186|560862594|FG001|Overall Study|Protocol Violation|0|||
155389801|NCT04658186|560862595|FG002|Overall Study|Protocol Violation|1|||
155389802|NCT04658186|560862593|FG000|Overall Study|Lost to Follow-up|0|||
155389803|NCT04658186|560862594|FG001|Overall Study|Lost to Follow-up|0|||
155389804|NCT04658186|560862595|FG002|Overall Study|Lost to Follow-up|2|||
155389805|NCT04658186|560862593|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
155389806|NCT04658186|560862594|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
155389807|NCT04658186|560862595|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
155389808|NCT04658186|560862593|FG000|Overall Study|Participant is Moving in Another Province|0|||
155389809|NCT04658186|560862594|FG001|Overall Study|Participant is Moving in Another Province|1|||
155389810|NCT04658186|560862595|FG002|Overall Study|Participant is Moving in Another Province|0|||
155389811|NCT04658186|560862593|FG000|Overall Study|Non-Compliance|0|||
155389812|NCT04658186|560862594|FG001|Overall Study|Non-Compliance|1|||
155389813|NCT04658186|560862595|FG002|Overall Study|Non-Compliance|1|||
155389814|NCT04658186|560862593|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
155389815|NCT04658186|560862594|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
155389816|NCT04658186|560862595|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
155389817|NCT04658186|560862593|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
154948393|NCT02492958|559236087|FG000|Overall Study|Withdrawal by Subject|0|||
155389818|NCT04658186|560862594|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
155389819|NCT04658186|560862595|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
155389820|NCT04658186|560862593|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
155389821|NCT04658186|560862594|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
155389822|NCT04658186|560862595|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
155389823|NCT04658186|560862593|FG000|Overall Study|PI Decision due to Participant Safety|0|||
155389824|NCT04658186|560862594|FG001|Overall Study|PI Decision due to Participant Safety|0|||
155389825|NCT04658186|560862595|FG002|Overall Study|PI Decision due to Participant Safety|1|||
155389826|NCT04658186|560862593|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
155389827|NCT04658186|560862594|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
155389828|NCT04658186|560862595|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
155389829|NCT04098068|560862596|FG000|Overall Study|Disease Progression|7|||
154948394|NCT02492958|559236088|FG001|Overall Study|Withdrawal by Subject|0|||
155389830|NCT04098068|560862596|FG000|Overall Study|Withdrawal by Subject|2|||
155389831|NCT04098068|560862596|FG000|Overall Study|New Cancer Diagnosis|1|||
155389832|NCT03871829|560862597|FG000|Overall Study|Lost to Follow-up|0|||
155389833|NCT03871829|560862598|FG001|Overall Study|Lost to Follow-up|1|||
155389834|NCT03871829|560862597|FG000|Overall Study|Withdrawal by Subject|1|||
155389835|NCT03871829|560862598|FG001|Overall Study|Withdrawal by Subject|1|||
155389836|NCT03871829|560862597|FG000|Overall Study|Death|12|||
155389837|NCT03871829|560862598|FG001|Overall Study|Death|8|||
155389838|NCT03871829|560862597|FG000|Overall Study|Study terminated by sponsor|31|||
155389839|NCT03871829|560862598|FG001|Overall Study|Study terminated by sponsor|34|||
155389840|NCT02993523|560862599|FG000|Overall Study|Withdrew Consent|0|||
155389841|NCT02993523|560862600|FG001|Overall Study|Withdrew Consent|0|||
155389842|NCT02993523|560862601|FG002|Overall Study|Withdrew Consent|2|||
155389843|NCT02993523|560862602|FG003|Overall Study|Withdrew Consent|9|||
155389844|NCT02993523|560862603|FG004|Overall Study|Withdrew Consent|0|||
155389845|NCT02993523|560862599|FG000|Overall Study|Lost to Follow-up|0|||
155389846|NCT02993523|560862600|FG001|Overall Study|Lost to Follow-up|0|||
155389847|NCT02993523|560862601|FG002|Overall Study|Lost to Follow-up|3|||
155389848|NCT02993523|560862602|FG003|Overall Study|Lost to Follow-up|6|||
155389849|NCT02993523|560862603|FG004|Overall Study|Lost to Follow-up|0|||
155389850|NCT02993523|560862599|FG000|Overall Study|Death|1|||
155389851|NCT02993523|560862600|FG001|Overall Study|Death|1|||
155389852|NCT02993523|560862601|FG002|Overall Study|Death|138|||
155389853|NCT02993523|560862602|FG003|Overall Study|Death|222|||
155389854|NCT02993523|560862603|FG004|Overall Study|Death|6|||
155389855|NCT02993523|560862599|FG000|Overall Study|Reason not Specified|0|||
155389856|NCT02993523|560862600|FG001|Overall Study|Reason not Specified|0|||
155389857|NCT02993523|560862601|FG002|Overall Study|Reason not Specified|1|||
155389858|NCT02993523|560862602|FG003|Overall Study|Reason not Specified|1|||
155389859|NCT02993523|560862603|FG004|Overall Study|Reason not Specified|0|||
155389860|NCT03694418|560862604|FG000|Overall Study|Lost to Follow-up|115|||
155389861|NCT03694418|560862605|FG001|Overall Study|Lost to Follow-up|23|||
155389862|NCT03694418|560862606|FG002|Overall Study|Lost to Follow-up|12|||
155389863|NCT03694418|560862607|FG003|Overall Study|Lost to Follow-up|12|||
155389864|NCT03694418|560862608|FG004|Overall Study|Lost to Follow-up|13|||
155389865|NCT04288778|560862625|FG000|Overall Study|Withdrawal by Subject|2|||
155389866|NCT04288778|560862625|FG000|Overall Study|Adverse Event|5|||
155389867|NCT04288778|560862625|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155389868|NCT04288778|560862625|FG000|Overall Study|Other|1|||
155389869|NCT04288778|560862625|FG000|Overall Study|Started but not treated|2|||
155389870|NCT04485104|560862626|FG000|Overall Study|Physician Decision|2|||
155389871|NCT04485104|560862627|FG001|Overall Study|Physician Decision|0|||
155389872|NCT04485104|560862626|FG000|Overall Study|Decision by sponsor|0|||
155389873|NCT04485104|560862627|FG001|Overall Study|Decision by sponsor|1|||
155389874|NCT04442737|560862628|FG000|Overall Study|Lost to Follow-up|1|||
155389875|NCT04442737|560862629|FG001|Overall Study|Lost to Follow-up|3|||
155389876|NCT04442737|560862628|FG000|Overall Study|Withdrawal by Subject|3|||
155389877|NCT04442737|560862629|FG001|Overall Study|Withdrawal by Subject|2|||
155389878|NCT04442737|560862628|FG000|Overall Study|Adverse Event|3|||
155389879|NCT04442737|560862629|FG001|Overall Study|Adverse Event|2|||
155389880|NCT04442737|560862628|FG000|Overall Study|Death|0|||
155389881|NCT04442737|560862629|FG001|Overall Study|Death|1|||
155389882|NCT04442737|560862628|FG000|Overall Study|Protocol Violation|0|||
155389883|NCT04442737|560862629|FG001|Overall Study|Protocol Violation|2|||
155389884|NCT04442737|560862628|FG000|Overall Study|Other|1|||
155389885|NCT04442737|560862629|FG001|Overall Study|Other|1|||
155389886|NCT00744523|560862630|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
155389887|NCT00744523|560862631|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
155389888|NCT01139021|560862632|FG000|Overall Study|Adverse Event|0|||
155389889|NCT01139021|560862633|FG001|Overall Study|Adverse Event|0|||
155389890|NCT01139021|560862634|FG002|Overall Study|Adverse Event|0|||
155389891|NCT01139021|560862635|FG003|Overall Study|Adverse Event|0|||
155389892|NCT01139021|560862636|FG004|Overall Study|Adverse Event|1|||
155389893|NCT01139021|560862637|FG005|Overall Study|Adverse Event|0|||
155389894|NCT01139021|560862632|FG000|Overall Study|Lost to Follow-up|0|||
155389895|NCT01139021|560862633|FG001|Overall Study|Lost to Follow-up|0|||
155389896|NCT01139021|560862634|FG002|Overall Study|Lost to Follow-up|0|||
155389897|NCT01139021|560862635|FG003|Overall Study|Lost to Follow-up|0|||
155389898|NCT01139021|560862636|FG004|Overall Study|Lost to Follow-up|2|||
155389899|NCT01139021|560862637|FG005|Overall Study|Lost to Follow-up|0|||
155389900|NCT01139021|560862632|FG000|Overall Study|Protocol Violation|1|||
155389901|NCT01139021|560862633|FG001|Overall Study|Protocol Violation|0|||
155389902|NCT01139021|560862634|FG002|Overall Study|Protocol Violation|0|||
155389903|NCT01139021|560862635|FG003|Overall Study|Protocol Violation|0|||
155389904|NCT01139021|560862636|FG004|Overall Study|Protocol Violation|2|||
155389905|NCT01139021|560862637|FG005|Overall Study|Protocol Violation|0|||
155389906|NCT01139021|560862632|FG000|Overall Study|Withdrawal by Subject|0|||
155389907|NCT01139021|560862633|FG001|Overall Study|Withdrawal by Subject|0|||
155389908|NCT01139021|560862634|FG002|Overall Study|Withdrawal by Subject|0|||
155389909|NCT01139021|560862635|FG003|Overall Study|Withdrawal by Subject|1|||
155389910|NCT01139021|560862636|FG004|Overall Study|Withdrawal by Subject|4|||
155389911|NCT01139021|560862637|FG005|Overall Study|Withdrawal by Subject|0|||
155389912|NCT05057247|560862642|FG000|Overall Study|Death|4|||
155389913|NCT05057247|560862642|FG000|Overall Study|Physician Decision|3|||
155389914|NCT05057247|560862642|FG000|Overall Study|Progressive Disease|7|||
155389915|NCT05057247|560862642|FG000|Overall Study|Withdrawal by Subject|3|||
155389916|NCT05057247|560862642|FG000|Overall Study|Adverse Event|6|||
155389917|NCT05057247|560862642|FG000|Overall Study|Subject Non-Compliance|1|||
155389918|NCT05057247|560862642|FG000|Overall Study|On treatment|2|||
155389919|NCT00784693|560862644|FG000|Overall Study|Lost to Follow-up|0|||
155389920|NCT00784693|560862645|FG001|Overall Study|Lost to Follow-up|1|||
155389921|NCT00784693|560862644|FG000|Overall Study|Lack of Efficacy|1|||
155389922|NCT00784693|560862645|FG001|Overall Study|Lack of Efficacy|1|||
155389923|NCT00784693|560862644|FG000|Overall Study|Withdrawal by Subject|0|||
155389924|NCT00784693|560862645|FG001|Overall Study|Withdrawal by Subject|4|||
155389925|NCT00784693|560862644|FG000|Overall Study|Randomized but not Treated|1|||
155389926|NCT00784693|560862645|FG001|Overall Study|Randomized but not Treated|0|||
155389927|NCT00784693|560862644|FG000|Overall Study|Other|1|||
155389928|NCT00784693|560862645|FG001|Overall Study|Other|0|||
155389929|NCT05458479|560862646|FG000|Overall Study|Lost to Follow-up|1|||
155389930|NCT03588728|560862649|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
155389931|NCT03588728|560862650|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
155389932|NCT03588728|560862651|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
155389933|NCT03588728|560862652|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
155389934|NCT03588728|560862649|FG000|Overall Study|Lab shut down due to COVID-19|0|||
155389935|NCT03588728|560862650|FG001|Overall Study|Lab shut down due to COVID-19|0|||
155389936|NCT03588728|560862651|FG002|Overall Study|Lab shut down due to COVID-19|0|||
155389937|NCT03588728|560862652|FG003|Overall Study|Lab shut down due to COVID-19|1|||
155389938|NCT03588728|560862649|FG000|Overall Study|multiple technical issues|1|||
155389939|NCT03588728|560862650|FG001|Overall Study|multiple technical issues|0|||
155389940|NCT03588728|560862651|FG002|Overall Study|multiple technical issues|0|||
155389941|NCT03588728|560862652|FG003|Overall Study|multiple technical issues|0|||
155389942|NCT03588728|560862649|FG000|Overall Study|Hospitalized for COVID|1|||
155389943|NCT03588728|560862650|FG001|Overall Study|Hospitalized for COVID|0|||
155389944|NCT03588728|560862651|FG002|Overall Study|Hospitalized for COVID|0|||
155389945|NCT03588728|560862652|FG003|Overall Study|Hospitalized for COVID|0|||
155389946|NCT03588728|560862649|FG000|Overall Study|Schedule change unable to attend sessions|1|||
155389947|NCT03588728|560862650|FG001|Overall Study|Schedule change unable to attend sessions|0|||
155389948|NCT03588728|560862651|FG002|Overall Study|Schedule change unable to attend sessions|0|||
155389949|NCT03588728|560862652|FG003|Overall Study|Schedule change unable to attend sessions|0|||
155389950|NCT01388790|560862653|FG000|Overall Study|Ongoing at data cut-off date|8|||
155389951|NCT00908232|560862654|FG000|Cycle 1 to 4|Death|5|||
155389952|NCT00908232|560862655|FG001|Cycle 1 to 4|Death|0|||
155389953|NCT00908232|560862656|FG002|Cycle 1 to 4|Death|0|||
155389954|NCT00908232|560862657|FG003|Cycle 1 to 4|Death|0|||
155389955|NCT00908232|560862654|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
155389956|NCT00908232|560862655|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
155389957|NCT00908232|560862656|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
155389958|NCT00908232|560862657|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
155389959|NCT00908232|560862654|FG000|Cycle 1 to 4|Progressive Disease|6|||
155389960|NCT00908232|560862655|FG001|Cycle 1 to 4|Progressive Disease|0|||
155389961|NCT00908232|560862656|FG002|Cycle 1 to 4|Progressive Disease|0|||
155389962|NCT00908232|560862657|FG003|Cycle 1 to 4|Progressive Disease|0|||
155389963|NCT00908232|560862654|FG000|Cycle 1 to 4|Adverse Event|12|||
155389964|NCT00908232|560862655|FG001|Cycle 1 to 4|Adverse Event|0|||
155389965|NCT00908232|560862656|FG002|Cycle 1 to 4|Adverse Event|0|||
155389966|NCT00908232|560862657|FG003|Cycle 1 to 4|Adverse Event|0|||
155389967|NCT00908232|560862654|FG000|Cycle 1 to 4|Other|1|||
155389968|NCT00908232|560862655|FG001|Cycle 1 to 4|Other|0|||
155389969|NCT00908232|560862656|FG002|Cycle 1 to 4|Other|0|||
155389970|NCT00908232|560862657|FG003|Cycle 1 to 4|Other|0|||
155389971|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
155389972|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
155389973|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
155389974|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
155389975|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
155389976|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
155389977|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
155389978|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
155389979|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
155389980|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
155389981|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
155389982|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
155389983|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
155050854|NCT01254656|559617753|FG001|Overall Study|Death|1|||
155050855|NCT01254656|559617754|FG002|Overall Study|Death|0|||
155050856|NCT01265394|559617778|FG000|Overall Study|Subjects withdrawn|37|||
155050857|NCT00716456|559617780|FG000|Overall Study|Adverse Event|0|||
155389984|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
155389985|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
155389986|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
155389987|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
155389988|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
155389989|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
155389990|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
155389991|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
155389992|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
155389993|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
155389994|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
155389995|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
155389996|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
155389997|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
155389998|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
155389999|NCT00908232|560862654|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
155390000|NCT00908232|560862655|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
155390001|NCT00908232|560862656|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
155390002|NCT00908232|560862657|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
155390003|NCT03153137|560862658|FG000|Overall Study|Lost to Follow-up|1|||
155390004|NCT03153137|560862659|FG001|Overall Study|Lost to Follow-up|0|||
155390005|NCT03153137|560862658|FG000|Overall Study|Withdrawal by Subject|2|||
155390006|NCT03153137|560862659|FG001|Overall Study|Withdrawal by Subject|1|||
155390007|NCT03153137|560862658|FG000|Overall Study|Physician Decision|0|||
155390008|NCT03153137|560862659|FG001|Overall Study|Physician Decision|3|||
155390009|NCT00195507|560862663|FG000|Overall Study|Adverse Event|24|||
155390010|NCT00195507|560862664|FG001|Overall Study|Adverse Event|13|||
155390011|NCT00195507|560862663|FG000|Overall Study|Death|0|||
155390012|NCT00195507|560862664|FG001|Overall Study|Death|1|||
155390013|NCT00195507|560862663|FG000|Overall Study|Failed to Return|4|||
155390014|NCT00195507|560862664|FG001|Overall Study|Failed to Return|3|||
155390015|NCT00195507|560862663|FG000|Overall Study|Physician Decision|1|||
155390016|NCT00195507|560862664|FG001|Overall Study|Physician Decision|2|||
155390017|NCT00195507|560862663|FG000|Overall Study|Lost to Follow-up|3|||
155390018|NCT00195507|560862664|FG001|Overall Study|Lost to Follow-up|2|||
155390019|NCT00195507|560862663|FG000|Overall Study|Protocol Violation|5|||
155390020|NCT00195507|560862664|FG001|Overall Study|Protocol Violation|4|||
155390021|NCT00195507|560862663|FG000|Overall Study|Lack of Efficacy|40|||
155390022|NCT00195507|560862664|FG001|Overall Study|Lack of Efficacy|67|||
155390023|NCT00195507|560862663|FG000|Overall Study|Withdrawal by Subject|16|||
155390024|NCT00195507|560862664|FG001|Overall Study|Withdrawal by Subject|23|||
155390025|NCT00195507|560862663|FG000|Overall Study|Protocol Deviation|6|||
155390026|NCT00195507|560862664|FG001|Overall Study|Protocol Deviation|3|||
155390027|NCT00528866|560862665|FG000|Overall Study|Protocol Violation|6|||
155390028|NCT00993915|560862669|FG000|Overall Study|Insufficient clinical response|3|||
155390029|NCT00993915|560862669|FG000|Overall Study|Withdrawal by Subject|2|||
155390030|NCT00993915|560862669|FG000|Overall Study|Other|1|||
155390031|NCT00993915|560862669|FG000|Overall Study|Ongoing|3|||
155390032|NCT01386658|560862670|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
155390033|NCT01386658|560862671|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
155390034|NCT01386658|560862670|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
155390035|NCT01386658|560862671|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
155390036|NCT02465463|560862677|FG000|Overall Study|Lost to Follow-up|2|||
155390037|NCT02465463|560862678|FG001|Overall Study|Lost to Follow-up|1|||
155390038|NCT02465463|560862677|FG000|Overall Study|Death|1|||
155050858|NCT00716456|559617781|FG001|Overall Study|Adverse Event|2|||
155050859|NCT00716456|559617782|FG002|Overall Study|Adverse Event|0|||
155050860|NCT04556760|559617783|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155050861|NCT04556760|559617784|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
155050862|NCT04556760|559617785|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155050863|NCT04556760|559617786|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155390039|NCT02465463|560862678|FG001|Overall Study|Death|0|||
155390040|NCT02465463|560862677|FG000|Overall Study|Protocol Violation|1|||
155390041|NCT02465463|560862678|FG001|Overall Study|Protocol Violation|0|||
155390042|NCT01067326|560862681|FG000|Overall Study|Adverse Event|0|||
155390043|NCT01067326|560862682|FG001|Overall Study|Adverse Event|2|||
155390044|NCT01067326|560862681|FG000|Overall Study|Withdrawal by Subject|1|||
155050864|NCT04556760|559617787|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155390045|NCT01067326|560862682|FG001|Overall Study|Withdrawal by Subject|0|||
155390046|NCT01067326|560862681|FG000|Overall Study|Early Study Termination|1|||
155390047|NCT01067326|560862682|FG001|Overall Study|Early Study Termination|1|||
155390048|NCT01230788|560862687|FG000|Overall Study|Prescribed exclusion drug|1|||
155390049|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
155390050|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
155390051|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Death|0|||
155390052|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Death|1|||
155390053|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
155390054|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
155390055|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
155390056|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
155390057|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
155390058|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
155390059|NCT00323297|560862688|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
155390060|NCT00323297|560862689|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
155390061|NCT00323297|560862688|FG000|Part B (Open-label)|Death|0|||
155390062|NCT00323297|560862689|FG001|Part B (Open-label)|Death|1|||
155390063|NCT00323297|560862688|FG000|Part B (Open-label)|Reason unspecified|0|||
155390064|NCT00323297|560862689|FG001|Part B (Open-label)|Reason unspecified|1|||
155390065|NCT00323297|560862688|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
155390066|NCT00323297|560862689|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
155390067|NCT00323297|560862688|FG000|Part B (Open-label)|Lack of Efficacy|3|||
155390068|NCT00323297|560862689|FG001|Part B (Open-label)|Lack of Efficacy|1|||
155390069|NCT00323297|560862688|FG000|Part B (Open-label)|Adverse Event|5|||
155390070|NCT00323297|560862689|FG001|Part B (Open-label)|Adverse Event|5|||
155390071|NCT00323297|560862688|FG000|Part B (Open-label)|Protocol Violation|0|||
155390072|NCT00323297|560862689|FG001|Part B (Open-label)|Protocol Violation|1|||
155390073|NCT00564018|560862690|FG000|Overall Study|Withdrawal by Subject|2|||
155390074|NCT00564018|560862691|FG001|Overall Study|Withdrawal by Subject|3|||
155390075|NCT00564018|560862692|FG002|Overall Study|Withdrawal by Subject|1|||
155390076|NCT00986440|560862693|FG000|Overall Study|Progressive disease|27|||
155390077|NCT00986440|560862694|FG001|Overall Study|Progressive disease|37|||
155050865|NCT04556760|559617788|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
155390078|NCT00986440|560862693|FG000|Overall Study|Serious adverse event or adverse event|9|||
155050866|NCT04556760|559617783|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155050867|NCT04556760|559617784|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155050868|NCT04556760|559617785|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155050869|NCT04556760|559617786|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
155050870|NCT04556760|559617787|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155050871|NCT04556760|559617788|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
155050872|NCT02849743|559617790|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
155050873|NCT02849743|559617791|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
155390079|NCT00986440|560862694|FG001|Overall Study|Serious adverse event or adverse event|2|||
155390080|NCT00986440|560862693|FG000|Overall Study|Withdrawal by Subject|1|||
155390081|NCT00986440|560862694|FG001|Overall Study|Withdrawal by Subject|2|||
155390082|NCT00986440|560862693|FG000|Overall Study|Screen failure (not dosed)|4|||
155390083|NCT00986440|560862694|FG001|Overall Study|Screen failure (not dosed)|2|||
155390084|NCT00954421|560862702|FG000|Screening|screen failures|3|||
155390085|NCT00954421|560862702|FG000|6 Months of DBS|Withdrawal by Subject|1|||
155390086|NCT00954421|560862702|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
155390087|NCT03231943|560862705|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390088|NCT03231943|560862706|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
155390089|NCT03231943|560862707|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
155390090|NCT03231943|560862708|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390091|NCT03231943|560862709|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390092|NCT03231943|560862710|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390093|NCT03231943|560862711|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390094|NCT03231943|560862712|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390095|NCT03231943|560862713|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390096|NCT03231943|560862714|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390097|NCT03231943|560862715|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390098|NCT03231943|560862716|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390099|NCT03231943|560862717|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
155390100|NCT03231943|560862705|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155050874|NCT02849743|559617790|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
155390101|NCT03231943|560862706|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
155390102|NCT03231943|560862707|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390103|NCT03231943|560862708|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390104|NCT03231943|560862709|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390105|NCT03231943|560862710|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390106|NCT03231943|560862711|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390107|NCT03231943|560862712|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390108|NCT03231943|560862713|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390109|NCT03231943|560862714|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390110|NCT03231943|560862715|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390111|NCT03231943|560862716|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390112|NCT03231943|560862717|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
155390113|NCT03231943|560862705|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
155390114|NCT03231943|560862706|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390115|NCT03231943|560862707|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390116|NCT03231943|560862708|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390117|NCT03231943|560862709|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390118|NCT03231943|560862710|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390119|NCT03231943|560862711|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390120|NCT03231943|560862712|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390121|NCT03231943|560862713|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390122|NCT03231943|560862714|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390123|NCT03231943|560862715|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390124|NCT03231943|560862716|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390125|NCT03231943|560862717|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
155390126|NCT03231943|560862705|FG000|Part 2|Adverse Event|0|||
155390127|NCT03231943|560862706|FG001|Part 2|Adverse Event|0|||
155390128|NCT03231943|560862707|FG002|Part 2|Adverse Event|0|||
155390129|NCT03231943|560862708|FG003|Part 2|Adverse Event|0|||
155390130|NCT03231943|560862709|FG004|Part 2|Adverse Event|0|||
155390131|NCT03231943|560862710|FG005|Part 2|Adverse Event|0|||
155390132|NCT03231943|560862711|FG006|Part 2|Adverse Event|0|||
155390133|NCT03231943|560862712|FG007|Part 2|Adverse Event|0|||
155390134|NCT03231943|560862713|FG008|Part 2|Adverse Event|0|||
155390135|NCT03231943|560862714|FG009|Part 2|Adverse Event|0|||
155390136|NCT03231943|560862715|FG010|Part 2|Adverse Event|1|||
155390137|NCT03231943|560862716|FG011|Part 2|Adverse Event|0|||
155390138|NCT03231943|560862717|FG012|Part 2|Adverse Event|0|||
155390139|NCT03231943|560862705|FG000|Part 2|Withdrawal by Subject|0|||
155390140|NCT03231943|560862706|FG001|Part 2|Withdrawal by Subject|0|||
155390141|NCT03231943|560862707|FG002|Part 2|Withdrawal by Subject|0|||
155390142|NCT03231943|560862708|FG003|Part 2|Withdrawal by Subject|0|||
155390143|NCT03231943|560862709|FG004|Part 2|Withdrawal by Subject|0|||
155390144|NCT03231943|560862710|FG005|Part 2|Withdrawal by Subject|0|||
155390145|NCT03231943|560862711|FG006|Part 2|Withdrawal by Subject|0|||
155390146|NCT03231943|560862712|FG007|Part 2|Withdrawal by Subject|0|||
155390147|NCT03231943|560862713|FG008|Part 2|Withdrawal by Subject|0|||
155390148|NCT03231943|560862714|FG009|Part 2|Withdrawal by Subject|0|||
155390149|NCT03231943|560862715|FG010|Part 2|Withdrawal by Subject|0|||
155390150|NCT03231943|560862716|FG011|Part 2|Withdrawal by Subject|1|||
155390151|NCT03231943|560862717|FG012|Part 2|Withdrawal by Subject|0|||
154948395|NCT02492958|559236089|FG002|Overall Study|Withdrawal by Subject|1|||
154948396|NCT02492958|559236090|FG003|Overall Study|Withdrawal by Subject|0|||
154948397|NCT02492958|559236087|FG000|Overall Study|Adverse Event|1|||
154948398|NCT02492958|559236088|FG001|Overall Study|Adverse Event|0|||
154948399|NCT02492958|559236089|FG002|Overall Study|Adverse Event|1|||
154948400|NCT02492958|559236090|FG003|Overall Study|Adverse Event|0|||
154948401|NCT03522948|559236091|FG000|Overall Study|Lost to Follow-up|1|||
154948402|NCT00712010|559236092|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
154948403|NCT01946165|559236093|FG000|Overall Study|Physician Decision|2|||
154948404|NCT01946165|559236094|FG001|Overall Study|Physician Decision|0|||
154948405|NCT01946165|559236093|FG000|Overall Study|Withdrawal by Subject|0|||
154948406|NCT01946165|559236094|FG001|Overall Study|Withdrawal by Subject|2|||
154948407|NCT00536575|559236097|FG000|Overall Study|Withdrawal by Subject|1|||
154948408|NCT00536575|559236097|FG000|Overall Study|Death|1|||
154948409|NCT00865709|559236106|FG000|Treatment|Adverse Event|9|||
154948410|NCT00865709|559236107|FG001|Treatment|Adverse Event|6|||
154948411|NCT00865709|559236106|FG000|Treatment|Withdrawal by Subject|10|||
154948412|NCT00865709|559236107|FG001|Treatment|Withdrawal by Subject|7|||
155390152|NCT00658684|560862718|FG000|Overall Study|Adverse Event|10|||
155390153|NCT00658684|560862719|FG001|Overall Study|Adverse Event|8|||
155390154|NCT00658684|560862720|FG002|Overall Study|Adverse Event|2|||
155390155|NCT00658684|560862721|FG003|Overall Study|Adverse Event|0|||
155390156|NCT00658684|560862718|FG000|Overall Study|Withdrawal by Subject|6|||
155390157|NCT00658684|560862719|FG001|Overall Study|Withdrawal by Subject|4|||
154948413|NCT00865709|559236106|FG000|Treatment|Physician Decision|3|||
154948414|NCT00865709|559236107|FG001|Treatment|Physician Decision|2|||
154948415|NCT00865709|559236106|FG000|Treatment|Surgery|8|||
154948416|NCT00865709|559236107|FG001|Treatment|Surgery|3|||
154948417|NCT01265784|559236108|FG000|Overall Study|Lost to Follow-up|5|||
154948418|NCT01265784|559236109|FG001|Overall Study|Lost to Follow-up|3|||
155390158|NCT00658684|560862720|FG002|Overall Study|Withdrawal by Subject|1|||
155390159|NCT00658684|560862721|FG003|Overall Study|Withdrawal by Subject|1|||
155390160|NCT00658684|560862718|FG000|Overall Study|Lack of Efficacy|1|||
155050875|NCT02849743|559617791|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155050876|NCT02168491|559617798|FG000|Overall Study|Withdrawal by Subject|1|||
155050877|NCT00809445|559617799|FG000|1 Month Follow-up|Lost contact|1|||
155050878|NCT00809445|559617800|FG001|1 Month Follow-up|Lost contact|2|||
155050879|NCT00809445|559617801|FG002|1 Month Follow-up|Lost contact|1|||
155050880|NCT00809445|559617799|FG000|1 Month Follow-up|Withdrew consent|1|||
155050881|NCT00809445|559617800|FG001|1 Month Follow-up|Withdrew consent|1|||
155050882|NCT00809445|559617801|FG002|1 Month Follow-up|Withdrew consent|1|||
155050883|NCT00809445|559617799|FG000|1 Month Follow-up|Death|0|||
155050884|NCT00809445|559617800|FG001|1 Month Follow-up|Death|1|||
155050885|NCT00809445|559617801|FG002|1 Month Follow-up|Death|1|||
155050886|NCT00809445|559617799|FG000|1 Month Follow-up|Incarcerated|0|||
155050887|NCT00809445|559617800|FG001|1 Month Follow-up|Incarcerated|0|||
155390161|NCT00658684|560862719|FG001|Overall Study|Lack of Efficacy|1|||
155390162|NCT00658684|560862720|FG002|Overall Study|Lack of Efficacy|0|||
155390163|NCT00658684|560862721|FG003|Overall Study|Lack of Efficacy|0|||
155390164|NCT00658684|560862718|FG000|Overall Study|Protocol Violation|1|||
155390165|NCT00658684|560862719|FG001|Overall Study|Protocol Violation|1|||
155390166|NCT00658684|560862720|FG002|Overall Study|Protocol Violation|0|||
155390167|NCT00658684|560862721|FG003|Overall Study|Protocol Violation|0|||
155390168|NCT00658684|560862718|FG000|Overall Study|Pregnancy|1|||
155390169|NCT00658684|560862719|FG001|Overall Study|Pregnancy|1|||
155390170|NCT00658684|560862720|FG002|Overall Study|Pregnancy|0|||
155390171|NCT00658684|560862721|FG003|Overall Study|Pregnancy|0|||
155390172|NCT03226275|560862724|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
155390173|NCT03226275|560862725|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
155390174|NCT03226275|560862726|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
155390175|NCT03226275|560862727|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
155390176|NCT03226275|560862724|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
155390177|NCT03226275|560862725|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
155390178|NCT03226275|560862726|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
155390179|NCT03226275|560862727|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
155390180|NCT03442114|560862728|FG000|Overall Study|Lost to Follow-up|13|||
155390181|NCT03442114|560862729|FG001|Overall Study|Lost to Follow-up|13|||
155390182|NCT03442114|560862728|FG000|Overall Study|Physician Decision|2|||
155390183|NCT03442114|560862729|FG001|Overall Study|Physician Decision|2|||
155390184|NCT03442114|560862728|FG000|Overall Study|Protocol Violation|0|||
155390185|NCT03442114|560862729|FG001|Overall Study|Protocol Violation|2|||
155390186|NCT03442114|560862728|FG000|Overall Study|Withdrawal by Subject|1|||
155390187|NCT03442114|560862729|FG001|Overall Study|Withdrawal by Subject|3|||
155390188|NCT03442114|560862728|FG000|Overall Study|Guardianship Change|0|||
155390189|NCT03442114|560862729|FG001|Overall Study|Guardianship Change|1|||
155390190|NCT01128361|560864259|FG000|Overall Study|Lost to Follow-up|0|||
155390191|NCT01128361|560864260|FG001|Overall Study|Lost to Follow-up|1|||
155390192|NCT01128361|560864259|FG000|Overall Study|Withdrawal by Subject|5|||
155390193|NCT01128361|560864260|FG001|Overall Study|Withdrawal by Subject|2|||
155390194|NCT01681628|560864263|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
155390195|NCT01681628|560864264|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
155390196|NCT01681628|560864263|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
155390197|NCT01681628|560864264|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
155390198|NCT01681628|560864263|FG000|19 Months Follow-up|Death|1|||
155390199|NCT01681628|560864264|FG001|19 Months Follow-up|Death|0|||
155390200|NCT01681628|560864263|FG000|19 Months Follow-up|Lost to Follow-up|61|||
155390201|NCT01681628|560864264|FG001|19 Months Follow-up|Lost to Follow-up|43|||
155390202|NCT04356183|560864277|FG000|Overall Study|Lost to Follow-up|1|||
155390203|NCT04356183|560864278|FG001|Overall Study|Lost to Follow-up|0|||
155390204|NCT04356183|560864277|FG000|Overall Study|Withdrawal by Subject|1|||
155390205|NCT04356183|560864278|FG001|Overall Study|Withdrawal by Subject|1|||
155050888|NCT00809445|559617801|FG002|1 Month Follow-up|Incarcerated|1|||
155050889|NCT00809445|559617799|FG000|6 Month Follow-up|Lost contact|16|||
155390206|NCT05736211|560864279|FG000|Overall Study|Lost to Follow-up|6|||
155390207|NCT05736211|560864280|FG001|Overall Study|Lost to Follow-up|0|||
155390208|NCT02634346|560864283|FG000|Overall Study|Withdrawal by Subject|8|||
155390209|NCT02634346|560864284|FG001|Overall Study|Withdrawal by Subject|9|||
155390210|NCT02634346|560864285|FG002|Overall Study|Withdrawal by Subject|8|||
155390211|NCT02634346|560864283|FG000|Overall Study|Adverse Event|2|||
155390212|NCT02634346|560864284|FG001|Overall Study|Adverse Event|2|||
155390213|NCT02634346|560864285|FG002|Overall Study|Adverse Event|7|||
155390214|NCT02634346|560864283|FG000|Overall Study|Lack of Efficacy|1|||
155390215|NCT02634346|560864284|FG001|Overall Study|Lack of Efficacy|2|||
155390216|NCT02634346|560864285|FG002|Overall Study|Lack of Efficacy|8|||
155390217|NCT02634346|560864283|FG000|Overall Study|Lost to Follow-up|1|||
155390218|NCT02634346|560864284|FG001|Overall Study|Lost to Follow-up|0|||
155390219|NCT02634346|560864285|FG002|Overall Study|Lost to Follow-up|0|||
155050890|NCT00809445|559617800|FG001|6 Month Follow-up|Lost contact|14|||
155050891|NCT00809445|559617801|FG002|6 Month Follow-up|Lost contact|14|||
155050892|NCT00809445|559617799|FG000|6 Month Follow-up|Death|2|||
155390220|NCT02634346|560864283|FG000|Overall Study|Protocol Violation|0|||
155390221|NCT02634346|560864284|FG001|Overall Study|Protocol Violation|1|||
155390222|NCT02634346|560864285|FG002|Overall Study|Protocol Violation|0|||
155390223|NCT00992511|560864286|FG000|Overall Study|Migrated/moved from study area|1|||
155390224|NCT00992511|560864287|FG001|Overall Study|Migrated/moved from study area|0|||
155390225|NCT00992511|560864288|FG002|Overall Study|Migrated/moved from study area|1|||
155390226|NCT00992511|560864289|FG003|Overall Study|Migrated/moved from study area|2|||
155390227|NCT00992511|560864286|FG000|Overall Study|Lost to Follow-up|1|||
155390228|NCT00992511|560864287|FG001|Overall Study|Lost to Follow-up|0|||
155390229|NCT00992511|560864288|FG002|Overall Study|Lost to Follow-up|0|||
155390230|NCT00992511|560864289|FG003|Overall Study|Lost to Follow-up|2|||
155390231|NCT00992511|560864286|FG000|Overall Study|Withdrawal by Subject|0|||
155390232|NCT00992511|560864287|FG001|Overall Study|Withdrawal by Subject|0|||
155390233|NCT00992511|560864288|FG002|Overall Study|Withdrawal by Subject|1|||
155390234|NCT00992511|560864289|FG003|Overall Study|Withdrawal by Subject|1|||
155390235|NCT02076113|560864292|FG000|Overall Study|Lost to Follow-up|4|||
155390236|NCT02076113|560864293|FG001|Overall Study|Lost to Follow-up|1|||
155390237|NCT02076113|560864292|FG000|Overall Study|Withdrawal by Subject|2|||
155390238|NCT02076113|560864293|FG001|Overall Study|Withdrawal by Subject|3|||
155390239|NCT02076113|560864292|FG000|Overall Study|Death|1|||
155390240|NCT02076113|560864293|FG001|Overall Study|Death|3|||
155390241|NCT00769860|560864301|FG000|Overall Study|Withdrawal by Subject|2|||
155390242|NCT00769860|560864302|FG001|Overall Study|Withdrawal by Subject|0|||
155390243|NCT00412971|560864308|FG000|Overall Study|Lost to Follow-up|17|||
155390244|NCT00412971|560864309|FG001|Overall Study|Lost to Follow-up|9|||
155390245|NCT00412971|560864308|FG000|Overall Study|Protocol Violation|13|||
155390246|NCT00412971|560864309|FG001|Overall Study|Protocol Violation|1|||
155390247|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
155390248|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
155390249|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
155390250|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
155390251|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
155390252|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
155390253|NCT01106404|560864310|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
155390254|NCT01106404|560864311|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
155390255|NCT02430051|560864313|FG000|Overall Study|Withdrawal by Subject|6|||
155390256|NCT02430051|560864314|FG001|Overall Study|Withdrawal by Subject|3|||
155390257|NCT02430051|560864313|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
155390258|NCT02430051|560864314|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
155390259|NCT02430051|560864313|FG000|Overall Study|Protocol Violation|1|||
155390260|NCT02430051|560864314|FG001|Overall Study|Protocol Violation|0|||
155390261|NCT02030405|560864320|FG000|Overall Study|Withdrawal by Subject|1|||
155390262|NCT02030405|560864320|FG000|Overall Study|Lost to Follow-up|1|||
155390263|NCT00132496|560864321|FG000|Overall Study|Withdrawal by Subject|1|||
155390264|NCT00132496|560864322|FG001|Overall Study|Withdrawal by Subject|2|||
155390265|NCT00132496|560864321|FG000|Overall Study|Physician Decision|1|||
155390266|NCT00132496|560864322|FG001|Overall Study|Physician Decision|0|||
155390267|NCT00388154|560864325|FG000|Overall Study|Withdrawal by Subject|1|||
155390268|NCT04526197|560864329|FG000|Period 1|Adverse Event|0|||
155390269|NCT04526197|560864330|FG001|Period 1|Adverse Event|1|||
155390270|NCT04526197|560864329|FG000|Period 1|Withdrawal by Subject|1|||
155390271|NCT04526197|560864330|FG001|Period 1|Withdrawal by Subject|0|||
155390272|NCT04526197|560864329|FG000|Period 2|Adverse Event|0|||
155390273|NCT04526197|560864330|FG001|Period 2|Adverse Event|1|||
155390274|NCT04526197|560864329|FG000|Period 2|Withdrawal by Subject|0|||
155390275|NCT04526197|560864330|FG001|Period 2|Withdrawal by Subject|1|||
155050893|NCT00809445|559617800|FG001|6 Month Follow-up|Death|1|||
155050894|NCT00809445|559617801|FG002|6 Month Follow-up|Death|1|||
155050895|NCT00809445|559617799|FG000|6 Month Follow-up|Incarcerated|6|||
155050896|NCT00809445|559617800|FG001|6 Month Follow-up|Incarcerated|8|||
155050897|NCT00809445|559617801|FG002|6 Month Follow-up|Incarcerated|8|||
155050898|NCT00809445|559617799|FG000|6 Month Follow-up|Withdrew consent|0|||
155050899|NCT00809445|559617800|FG001|6 Month Follow-up|Withdrew consent|0|||
155050900|NCT00809445|559617801|FG002|6 Month Follow-up|Withdrew consent|1|||
155390276|NCT01209143|560864331|FG000|Overall Study|Adverse Event|2|||
155390277|NCT01209143|560864332|FG001|Overall Study|Adverse Event|1|||
155390278|NCT01209143|560864331|FG000|Overall Study|Death|0|||
155390279|NCT01209143|560864332|FG001|Overall Study|Death|1|||
155390280|NCT01209143|560864331|FG000|Overall Study|Physician Decision|3|||
155390281|NCT01209143|560864332|FG001|Overall Study|Physician Decision|1|||
155390282|NCT01209143|560864331|FG000|Overall Study|Lost to Follow-up|1|||
155390283|NCT01209143|560864332|FG001|Overall Study|Lost to Follow-up|0|||
155390284|NCT01209143|560864331|FG000|Overall Study|Withdrawal by Subject|2|||
155390285|NCT01209143|560864332|FG001|Overall Study|Withdrawal by Subject|1|||
155390286|NCT01209143|560864331|FG000|Overall Study|Disease progression|11|||
155390287|NCT01209143|560864332|FG001|Overall Study|Disease progression|16|||
155050901|NCT03874013|559617802|FG000|Overall Study|Adverse Event|0|||
155390288|NCT00381303|560864335|FG000|Overall Study|Lost to Follow-up|25|||
155390289|NCT00381303|560864336|FG001|Overall Study|Lost to Follow-up|9|||
155390290|NCT00381303|560864335|FG000|Overall Study|AE/HIV-related event|22|||
155390291|NCT00381303|560864336|FG001|Overall Study|AE/HIV-related event|6|||
155390292|NCT00381303|560864335|FG000|Overall Study|Non-Adherence|13|||
155390293|NCT00381303|560864336|FG001|Overall Study|Non-Adherence|6|||
155390294|NCT00381303|560864335|FG000|Overall Study|Withdrawal by Subject|13|||
155390295|NCT00381303|560864336|FG001|Overall Study|Withdrawal by Subject|6|||
155390296|NCT00381303|560864335|FG000|Overall Study|Virologic failure|6|||
154948419|NCT01265784|559236110|FG002|Overall Study|Lost to Follow-up|2|||
154948420|NCT01265784|559236108|FG000|Overall Study|Withdrawal by Subject|0|||
154948421|NCT01265784|559236109|FG001|Overall Study|Withdrawal by Subject|5|||
154948422|NCT01265784|559236110|FG002|Overall Study|Withdrawal by Subject|0|||
154948423|NCT01265784|559236108|FG000|Overall Study|Physician Decision|1|||
154948424|NCT01265784|559236109|FG001|Overall Study|Physician Decision|0|||
154948425|NCT01265784|559236110|FG002|Overall Study|Physician Decision|1|||
154948426|NCT01265784|559236108|FG000|Overall Study|Adverse Event|1|||
154948427|NCT01265784|559236109|FG001|Overall Study|Adverse Event|0|||
154948428|NCT01265784|559236110|FG002|Overall Study|Adverse Event|0|||
154948429|NCT01265784|559236108|FG000|Overall Study|Death|3|||
154948430|NCT01265784|559236109|FG001|Overall Study|Death|0|||
154948431|NCT01265784|559236110|FG002|Overall Study|Death|0|||
154948432|NCT01265784|559236108|FG000|Overall Study|Protocol Violation|2|||
154948433|NCT01265784|559236109|FG001|Overall Study|Protocol Violation|0|||
154948434|NCT01265784|559236110|FG002|Overall Study|Protocol Violation|0|||
154948435|NCT01265784|559236108|FG000|Overall Study|Incorrectly Randomized|0|||
154948436|NCT01265784|559236109|FG001|Overall Study|Incorrectly Randomized|0|||
154948437|NCT01265784|559236110|FG002|Overall Study|Incorrectly Randomized|1|||
154948438|NCT04333095|559236113|FG000|Overall Study|Protocol Violation|4|||
154948439|NCT04333095|559236114|FG001|Overall Study|Protocol Violation|0|||
154948440|NCT04333095|559236113|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
154948441|NCT04333095|559236114|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
154948442|NCT04333095|559236113|FG000|Overall Study|Mini Sternotomy|4|||
154948443|NCT04333095|559236114|FG001|Overall Study|Mini Sternotomy|5|||
154948444|NCT00984295|559236115|FG000|Overall Study|Lost to Follow-up|31|||
154948445|NCT00984295|559236116|FG001|Overall Study|Lost to Follow-up|12|||
154948446|NCT00984295|559236117|FG002|Overall Study|Lost to Follow-up|13|||
154948447|NCT00984295|559236115|FG000|Overall Study|Protocol Violation|2|||
154948448|NCT00984295|559236116|FG001|Overall Study|Protocol Violation|1|||
154948449|NCT00984295|559236117|FG002|Overall Study|Protocol Violation|4|||
154948450|NCT00984295|559236115|FG000|Overall Study|Withdrawal by Subject|18|||
154948451|NCT00984295|559236116|FG001|Overall Study|Withdrawal by Subject|9|||
154948452|NCT00984295|559236117|FG002|Overall Study|Withdrawal by Subject|12|||
154948453|NCT00984295|559236115|FG000|Overall Study|CAE - discontinued test vaccine|0|||
154948454|NCT00984295|559236116|FG001|Overall Study|CAE - discontinued test vaccine|1|||
154948455|NCT00984295|559236117|FG002|Overall Study|CAE - discontinued test vaccine|3|||
154948456|NCT00984295|559236115|FG000|Overall Study|Missed one or more blood samplings|3|||
154948457|NCT00984295|559236116|FG001|Overall Study|Missed one or more blood samplings|7|||
154948458|NCT00984295|559236117|FG002|Overall Study|Missed one or more blood samplings|2|||
154948459|NCT00984295|559236115|FG000|Overall Study|Incomplete safety follow-up|11|||
154948460|NCT00984295|559236116|FG001|Overall Study|Incomplete safety follow-up|2|||
154948461|NCT00984295|559236117|FG002|Overall Study|Incomplete safety follow-up|3|||
154948462|NCT03740165|559236118|FG000|Overall Study|Death|232|||
154948463|NCT03740165|559236119|FG001|Overall Study|Death|242|||
154948464|NCT03740165|559236120|FG002|Overall Study|Death|229|||
154948465|NCT03740165|559236118|FG000|Overall Study|Lost to Follow-up|0|||
154948466|NCT03740165|559236119|FG001|Overall Study|Lost to Follow-up|0|||
154948467|NCT03740165|559236120|FG002|Overall Study|Lost to Follow-up|1|||
154948468|NCT03740165|559236118|FG000|Overall Study|Withdrawal by Subject|7|||
154948469|NCT03740165|559236119|FG001|Overall Study|Withdrawal by Subject|4|||
154948470|NCT03740165|559236120|FG002|Overall Study|Withdrawal by Subject|3|||
155050902|NCT03874013|559617803|FG001|Overall Study|Adverse Event|1|||
154948471|NCT03740165|559236118|FG000|Overall Study|Ongoing in Study|216|||
154948472|NCT03740165|559236119|FG001|Overall Study|Ongoing in Study|212|||
154948473|NCT03740165|559236120|FG002|Overall Study|Ongoing in Study|221|||
154948474|NCT03049618|559236121|FG000|Overall Study|Death|1|||
154948475|NCT03049618|559236122|FG001|Overall Study|Death|0|||
154948476|NCT03049618|559236121|FG000|Overall Study|Lack of Efficacy|1|||
154948477|NCT03049618|559236122|FG001|Overall Study|Lack of Efficacy|2|||
154948478|NCT04582539|559236123|FG000|Overall Study|Death|1|||
154948479|NCT04582539|559236124|FG001|Overall Study|Death|1|||
155390297|NCT00381303|560864336|FG001|Overall Study|Virologic failure|4|||
155390298|NCT00381303|560864335|FG000|Overall Study|Ineligible to continue the trial|2|||
155390299|NCT00381303|560864336|FG001|Overall Study|Ineligible to continue the trial|1|||
154948480|NCT04582539|559236125|FG002|Overall Study|Death|0|||
154948481|NCT04582539|559236126|FG003|Overall Study|Death|1|||
154948482|NCT04582539|559236127|FG004|Overall Study|Death|0|||
154948483|NCT04582539|559236123|FG000|Overall Study|Lost to Follow-up|1|||
154948484|NCT04582539|559236124|FG001|Overall Study|Lost to Follow-up|0|||
155390300|NCT00381303|560864335|FG000|Overall Study|Pregnancy|2|||
155390301|NCT00381303|560864336|FG001|Overall Study|Pregnancy|0|||
155390302|NCT00381303|560864335|FG000|Overall Study|Physician Decision|1|||
155390303|NCT00381303|560864336|FG001|Overall Study|Physician Decision|0|||
155390304|NCT00381303|560864335|FG000|Overall Study|Physician's decision to close the site|3|||
155390305|NCT00381303|560864336|FG001|Overall Study|Physician's decision to close the site|1|||
155390306|NCT00381303|560864335|FG000|Overall Study|Subject moved out of state|2|||
155390307|NCT00381303|560864336|FG001|Overall Study|Subject moved out of state|0|||
155390308|NCT00381303|560864335|FG000|Overall Study|Subject taking too many different meds|1|||
155390309|NCT00381303|560864336|FG001|Overall Study|Subject taking too many different meds|0|||
155390310|NCT00381303|560864335|FG000|Overall Study|No virologic response by week 12|1|||
155390311|NCT00381303|560864336|FG001|Overall Study|No virologic response by week 12|0|||
155390312|NCT00381303|560864335|FG000|Overall Study|Subject was too busy for appointments|1|||
155390313|NCT00381303|560864336|FG001|Overall Study|Subject was too busy for appointments|0|||
155390314|NCT00381303|560864335|FG000|Overall Study|Subject did not continue visits|1|||
155390315|NCT00381303|560864336|FG001|Overall Study|Subject did not continue visits|0|||
155390316|NCT00381303|560864335|FG000|Overall Study|Subject primary physician's decision|1|||
155390317|NCT00381303|560864336|FG001|Overall Study|Subject primary physician's decision|0|||
155390318|NCT01136811|560864337|FG000|Overall Study|Physician Decision|11|||
155390319|NCT01211522|560864338|FG000|Overall Study|Withdrawal by Subject|3|||
155390320|NCT01211522|560864339|FG001|Overall Study|Withdrawal by Subject|7|||
155390321|NCT01211522|560864340|FG002|Overall Study|Withdrawal by Subject|5|||
155390322|NCT01145755|560864342|FG000|Overall Study|Adverse Event|2|||
155390323|NCT01145755|560864343|FG001|Overall Study|Adverse Event|4|||
155390324|NCT01145755|560864344|FG002|Overall Study|Adverse Event|2|||
155390325|NCT01145755|560864342|FG000|Overall Study|Withdrawal by Subject|2|||
155390326|NCT01145755|560864343|FG001|Overall Study|Withdrawal by Subject|2|||
155390327|NCT01145755|560864344|FG002|Overall Study|Withdrawal by Subject|2|||
155390328|NCT01145755|560864342|FG000|Overall Study|Lost to Follow-up|2|||
155390329|NCT01145755|560864343|FG001|Overall Study|Lost to Follow-up|3|||
155390330|NCT01145755|560864344|FG002|Overall Study|Lost to Follow-up|1|||
155390331|NCT01145755|560864342|FG000|Overall Study|Protocol Violation|0|||
155390332|NCT01145755|560864343|FG001|Overall Study|Protocol Violation|3|||
155390333|NCT01145755|560864344|FG002|Overall Study|Protocol Violation|1|||
155390334|NCT01145755|560864342|FG000|Overall Study|Study Closure|14|||
155390335|NCT01145755|560864343|FG001|Overall Study|Study Closure|14|||
155390336|NCT01145755|560864344|FG002|Overall Study|Study Closure|17|||
155390337|NCT01145755|560864342|FG000|Overall Study|Lack of Efficacy|0|||
155390338|NCT01145755|560864343|FG001|Overall Study|Lack of Efficacy|1|||
155390339|NCT01145755|560864344|FG002|Overall Study|Lack of Efficacy|0|||
155390340|NCT01145755|560864342|FG000|Overall Study|Patient could not swollow medication|0|||
155390341|NCT01145755|560864343|FG001|Overall Study|Patient could not swollow medication|0|||
155390342|NCT01145755|560864344|FG002|Overall Study|Patient could not swollow medication|1|||
155390343|NCT01145755|560864342|FG000|Overall Study|Withdrawal by Subject|0|||
155390344|NCT01145755|560864343|FG001|Overall Study|Withdrawal by Subject|0|||
155390345|NCT01145755|560864344|FG002|Overall Study|Withdrawal by Subject|1|||
155390346|NCT01145755|560864342|FG000|Overall Study|Positive urine ethanol|0|||
155390347|NCT01145755|560864343|FG001|Overall Study|Positive urine ethanol|1|||
155390348|NCT01145755|560864344|FG002|Overall Study|Positive urine ethanol|0|||
155390349|NCT00372385|560864350|FG000|Overall Study|Adverse Event|6|||
155390350|NCT00372385|560864351|FG001|Overall Study|Adverse Event|11|||
155390351|NCT00372385|560864352|FG002|Overall Study|Adverse Event|9|||
155390352|NCT00372385|560864353|FG003|Overall Study|Adverse Event|7|||
155390353|NCT00372385|560864350|FG000|Overall Study|Noncompliance|0|||
155390354|NCT00372385|560864351|FG001|Overall Study|Noncompliance|1|||
155390355|NCT00372385|560864352|FG002|Overall Study|Noncompliance|1|||
155390356|NCT00372385|560864353|FG003|Overall Study|Noncompliance|1|||
155390357|NCT00372385|560864350|FG000|Overall Study|Physician Decision|1|||
155390358|NCT00372385|560864351|FG001|Overall Study|Physician Decision|0|||
155390359|NCT00372385|560864352|FG002|Overall Study|Physician Decision|0|||
155390360|NCT00372385|560864353|FG003|Overall Study|Physician Decision|0|||
154948485|NCT04582539|559236125|FG002|Overall Study|Lost to Follow-up|0|||
154948486|NCT04582539|559236126|FG003|Overall Study|Lost to Follow-up|0|||
155390361|NCT00372385|560864350|FG000|Overall Study|Lost to Follow-up|2|||
155390362|NCT00372385|560864351|FG001|Overall Study|Lost to Follow-up|0|||
155390363|NCT00372385|560864352|FG002|Overall Study|Lost to Follow-up|0|||
155390364|NCT00372385|560864353|FG003|Overall Study|Lost to Follow-up|0|||
155390365|NCT00372385|560864350|FG000|Overall Study|Withdrawal by Subject|2|||
155390366|NCT00372385|560864351|FG001|Overall Study|Withdrawal by Subject|1|||
155390367|NCT00372385|560864352|FG002|Overall Study|Withdrawal by Subject|0|||
155390368|NCT00372385|560864353|FG003|Overall Study|Withdrawal by Subject|0|||
155390369|NCT00372385|560864350|FG000|Overall Study|Refusal of Treatment|3|||
155390370|NCT00372385|560864351|FG001|Overall Study|Refusal of Treatment|6|||
155390371|NCT00372385|560864352|FG002|Overall Study|Refusal of Treatment|0|||
155390372|NCT00372385|560864353|FG003|Overall Study|Refusal of Treatment|0|||
155390373|NCT00372385|560864350|FG000|Overall Study|No Response|1|||
155390374|NCT00372385|560864351|FG001|Overall Study|No Response|1|||
155390375|NCT00372385|560864352|FG002|Overall Study|No Response|0|||
155390376|NCT00372385|560864353|FG003|Overall Study|No Response|0|||
155390377|NCT00372385|560864350|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
155390378|NCT00372385|560864351|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
155390379|NCT00372385|560864352|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
155390380|NCT00372385|560864353|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
155390381|NCT00372385|560864350|FG000|Overall Study|Virologic Stopping Rule|17|||
155390382|NCT00372385|560864351|FG001|Overall Study|Virologic Stopping Rule|0|||
155390383|NCT00372385|560864352|FG002|Overall Study|Virologic Stopping Rule|0|||
155390384|NCT00372385|560864353|FG003|Overall Study|Virologic Stopping Rule|0|||
155390385|NCT01966471|560864354|FG000|Overall Study|Death|44|||
155390386|NCT01966471|560864355|FG001|Overall Study|Death|56|||
155390387|NCT01966471|560864354|FG000|Overall Study|Lost to Follow-up|46|||
155390388|NCT01966471|560864355|FG001|Overall Study|Lost to Follow-up|39|||
155390389|NCT01966471|560864354|FG000|Overall Study|Various reasons|4|||
155390390|NCT01966471|560864355|FG001|Overall Study|Various reasons|4|||
155390391|NCT01966471|560864354|FG000|Overall Study|Physician Decision|7|||
155390392|NCT01966471|560864355|FG001|Overall Study|Physician Decision|5|||
155390393|NCT01966471|560864354|FG000|Overall Study|Study Terminated By Sponsor|758|||
155390394|NCT01966471|560864355|FG001|Overall Study|Study Terminated By Sponsor|773|||
155390395|NCT01966471|560864354|FG000|Overall Study|Withdrawal by Subject|59|||
155390396|NCT01966471|560864355|FG001|Overall Study|Withdrawal by Subject|51|||
155390397|NCT01030198|560864360|FG000|Overall Study|Could not measure efficacy accurately|0|||
155390398|NCT01030198|560864361|FG001|Overall Study|Could not measure efficacy accurately|7|||
155390399|NCT02279862|560864362|FG000|Overall Study|Study drug toxicity|3|||
155390400|NCT02279862|560864363|FG001|Overall Study|Study drug toxicity|6|||
155390401|NCT02279862|560864362|FG000|Overall Study|No longer meets criteria|0|||
155390402|NCT02279862|560864363|FG001|Overall Study|No longer meets criteria|1|||
155390403|NCT02279862|560864362|FG000|Overall Study|Administrative reason by sponsor|0|||
155390404|NCT02279862|560864363|FG001|Overall Study|Administrative reason by sponsor|1|||
155390405|NCT02279862|560864362|FG000|Overall Study|Disease progression|5|||
155390406|NCT02279862|560864363|FG001|Overall Study|Disease progression|2|||
155390407|NCT02279862|560864362|FG000|Overall Study|Study closed by sponsor|16|||
155390408|NCT02279862|560864363|FG001|Overall Study|Study closed by sponsor|13|||
155390409|NCT02279862|560864362|FG000|Overall Study|Other|1|||
155390410|NCT02279862|560864363|FG001|Overall Study|Other|2|||
155390411|NCT02279862|560864362|FG000|Overall Study|Withdrawal by Subject|1|||
155390412|NCT02279862|560864363|FG001|Overall Study|Withdrawal by Subject|0|||
155390413|NCT03431857|560864364|FG000|Overall Study|Death|6|||
155390414|NCT03431857|560864364|FG000|Overall Study|Lost to Follow-up|41|||
155390415|NCT03431857|560864364|FG000|Overall Study|Adverse Event|6|||
155390416|NCT03431857|560864364|FG000|Overall Study|Withdrawal by Subject|1|||
155390417|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
155390418|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
155390419|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
155050903|NCT00661089|559617807|FG000|Overall Study|1 subject withdrawal|0|||
155050904|NCT00661089|559617808|FG001|Overall Study|1 subject withdrawal|1|||
155050905|NCT00661089|559617807|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
155050906|NCT00661089|559617808|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
155050907|NCT00321906|559617814|FG000|Overall Study|Adverse Event|36|||
155050908|NCT00321906|559617815|FG001|Overall Study|Adverse Event|44|||
155050909|NCT00321906|559617814|FG000|Overall Study|Death|9|||
155050910|NCT00321906|559617815|FG001|Overall Study|Death|6|||
155050911|NCT00321906|559617814|FG000|Overall Study|Lost to Follow-up|1|||
155050912|NCT00321906|559617815|FG001|Overall Study|Lost to Follow-up|2|||
155050913|NCT00321906|559617814|FG000|Overall Study|Withdrawal by Subject|0|||
155050914|NCT00321906|559617815|FG001|Overall Study|Withdrawal by Subject|4|||
155390420|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
155390421|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
155050915|NCT02899065|559617816|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
155050916|NCT02899065|559617817|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
155050917|NCT02899065|559617816|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
155050918|NCT02899065|559617817|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
155050919|NCT02899065|559617816|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
155050920|NCT02899065|559617817|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
155390422|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
155390423|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
155390424|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
155390425|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
155390426|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
155390427|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
155050921|NCT00186485|559617818|FG000|Overall Study|Lost to Follow-up|3|||
155281785|NCT02624778|560463920|FG001|Overall Study|Physician Decision|0|||
155281786|NCT02624778|560463921|FG002|Overall Study|Physician Decision|0|||
155281787|NCT02624778|560463922|FG003|Overall Study|Physician Decision|0|||
155281788|NCT02624778|560463923|FG004|Overall Study|Physician Decision|0|||
155281789|NCT02624778|560463924|FG005|Overall Study|Physician Decision|0|||
155281790|NCT02624778|560463925|FG006|Overall Study|Physician Decision|0|||
155281791|NCT02624778|560463926|FG007|Overall Study|Physician Decision|3|||
155281792|NCT02624778|560463927|FG008|Overall Study|Physician Decision|3|||
155281793|NCT05296629|560463928|FG000|Overall Study|Withdrawal by Subject|3|||
155281794|NCT05296629|560463929|FG001|Overall Study|Withdrawal by Subject|10|||
155281795|NCT05296629|560463930|FG002|Overall Study|Withdrawal by Subject|4|||
155281796|NCT05296629|560463928|FG000|Overall Study|Lost to Follow-up|2|||
155281797|NCT05296629|560463929|FG001|Overall Study|Lost to Follow-up|7|||
155281798|NCT05296629|560463930|FG002|Overall Study|Lost to Follow-up|1|||
155281799|NCT05296629|560463928|FG000|Overall Study|Adverse Event|0|||
155281800|NCT05296629|560463929|FG001|Overall Study|Adverse Event|4|||
155281801|NCT05296629|560463930|FG002|Overall Study|Adverse Event|2|||
155281802|NCT05296629|560463928|FG000|Overall Study|Protocol Violation|0|||
155281803|NCT05296629|560463929|FG001|Overall Study|Protocol Violation|2|||
155281804|NCT05296629|560463930|FG002|Overall Study|Protocol Violation|0|||
155281805|NCT00231179|560463931|FG000|Overall Study|Lost to Follow-up|21|||
155281806|NCT00231179|560463932|FG001|Overall Study|Lost to Follow-up|21|||
155281807|NCT00231179|560463931|FG000|Overall Study|Withdrawal by Subject|3|||
155281808|NCT00231179|560463932|FG001|Overall Study|Withdrawal by Subject|3|||
155281809|NCT04610684|560463935|FG000|Study Treatment|Withdrawal by Subject|1|||
155281810|NCT04610684|560463935|FG000|Study Treatment|Disease Progression|2|||
155281811|NCT04610684|560463935|FG000|Follow up|Death|2|||
155281812|NCT04610684|560463935|FG000|Follow up|Withdrawal by Subject|1|||
155281813|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
155281814|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
155281815|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
155281816|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
155281817|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
155281818|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
155281819|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
155281820|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
155281821|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
155281822|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
155281823|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
155281824|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
155281825|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
155281826|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
155281827|NCT04672460|560463936|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
155281828|NCT04672460|560463937|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
155281829|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
155281830|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
155281831|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
154948487|NCT04582539|559236127|FG004|Overall Study|Lost to Follow-up|0|||
154948488|NCT04582539|559236123|FG000|Overall Study|Study Terminated by Sponsor|1|||
154948489|NCT04582539|559236124|FG001|Overall Study|Study Terminated by Sponsor|3|||
154948490|NCT04582539|559236125|FG002|Overall Study|Study Terminated by Sponsor|2|||
154948491|NCT04582539|559236126|FG003|Overall Study|Study Terminated by Sponsor|2|||
154948492|NCT04582539|559236127|FG004|Overall Study|Study Terminated by Sponsor|3|||
154948493|NCT04582539|559236123|FG000|Overall Study|Physician Decision|0|||
154948494|NCT04582539|559236124|FG001|Overall Study|Physician Decision|1|||
154948495|NCT04582539|559236125|FG002|Overall Study|Physician Decision|0|||
154948496|NCT04582539|559236126|FG003|Overall Study|Physician Decision|0|||
154948497|NCT04582539|559236127|FG004|Overall Study|Physician Decision|0|||
154948498|NCT04582539|559236123|FG000|Overall Study|Withdrawal by Subject|1|||
154948499|NCT04582539|559236124|FG001|Overall Study|Withdrawal by Subject|0|||
154948500|NCT04582539|559236125|FG002|Overall Study|Withdrawal by Subject|2|||
154948501|NCT04582539|559236126|FG003|Overall Study|Withdrawal by Subject|1|||
154948502|NCT04582539|559236127|FG004|Overall Study|Withdrawal by Subject|0|||
154948503|NCT04582539|559236123|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
154948504|NCT04582539|559236124|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
154948505|NCT04582539|559236125|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
154948506|NCT04582539|559236126|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
154948507|NCT04582539|559236127|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
154948508|NCT00788957|559236136|FG000|Part 1|Death|8|||
154948509|NCT00788957|559236137|FG001|Part 1|Death|0|||
154948510|NCT00788957|559236138|FG002|Part 1|Death|0|||
154948511|NCT00788957|559236139|FG003|Part 1|Death|0|||
154948512|NCT00788957|559236140|FG004|Part 1|Death|0|||
154948513|NCT00788957|559236141|FG005|Part 1|Death|0|||
155390428|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
155390429|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
155390430|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
155390431|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
155390432|NCT01323621|560864365|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
155390433|NCT01323621|560864366|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
155390434|NCT01323621|560864367|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
155390435|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
155390436|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
155390437|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
155390438|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
155390439|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
155390440|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
155390441|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
155390442|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
155390443|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
155390444|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155390445|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155390446|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155390447|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
155390448|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
155390449|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
155390450|NCT01323621|560864365|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155390451|NCT01323621|560864366|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
155390452|NCT01323621|560864367|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
155390453|NCT01119001|560864368|FG000|Overall Study|Withdrawal by Subject|2|||
155390454|NCT04343248|560864369|FG000|Overall Study|Withdrawal by Subject|5|||
154948514|NCT00788957|559236136|FG000|Part 1|Lost to Follow-up|1|||
154948515|NCT00788957|559236137|FG001|Part 1|Lost to Follow-up|0|||
154948516|NCT00788957|559236138|FG002|Part 1|Lost to Follow-up|0|||
154948517|NCT00788957|559236139|FG003|Part 1|Lost to Follow-up|0|||
154948518|NCT00788957|559236140|FG004|Part 1|Lost to Follow-up|0|||
154948519|NCT00788957|559236141|FG005|Part 1|Lost to Follow-up|0|||
154948520|NCT00788957|559236136|FG000|Part 2|Withdrawal by Subject|0|||
154948521|NCT00788957|559236137|FG001|Part 2|Withdrawal by Subject|9|||
154948522|NCT00788957|559236138|FG002|Part 2|Withdrawal by Subject|5|||
154948523|NCT00788957|559236139|FG003|Part 2|Withdrawal by Subject|3|||
154948524|NCT00788957|559236140|FG004|Part 2|Withdrawal by Subject|0|||
154948525|NCT00788957|559236141|FG005|Part 2|Withdrawal by Subject|0|||
154948526|NCT00788957|559236136|FG000|Part 2|Death|0|||
154948527|NCT00788957|559236137|FG001|Part 2|Death|32|||
154948528|NCT00788957|559236138|FG002|Part 2|Death|35|||
154948529|NCT00788957|559236139|FG003|Part 2|Death|37|||
154948530|NCT00788957|559236140|FG004|Part 2|Death|0|||
154948531|NCT00788957|559236141|FG005|Part 2|Death|0|||
154948532|NCT00788957|559236136|FG000|Part 2|Lost to Follow-up|0|||
154948533|NCT00788957|559236137|FG001|Part 2|Lost to Follow-up|0|||
154948534|NCT00788957|559236138|FG002|Part 2|Lost to Follow-up|3|||
154948535|NCT00788957|559236139|FG003|Part 2|Lost to Follow-up|0|||
154948536|NCT00788957|559236140|FG004|Part 2|Lost to Follow-up|0|||
154948537|NCT00788957|559236141|FG005|Part 2|Lost to Follow-up|0|||
154948538|NCT00788957|559236136|FG000|Part 2|On-study at time of data cut-off|0|||
154948539|NCT00788957|559236137|FG001|Part 2|On-study at time of data cut-off|1|||
154948540|NCT00788957|559236138|FG002|Part 2|On-study at time of data cut-off|1|||
154948541|NCT00788957|559236139|FG003|Part 2|On-study at time of data cut-off|1|||
154948542|NCT00788957|559236140|FG004|Part 2|On-study at time of data cut-off|0|||
154948543|NCT00788957|559236141|FG005|Part 2|On-study at time of data cut-off|0|||
154948544|NCT00788957|559236136|FG000|Part 3|Withdrawal by Subject|0|||
154948545|NCT00788957|559236137|FG001|Part 3|Withdrawal by Subject|0|||
154948546|NCT00788957|559236138|FG002|Part 3|Withdrawal by Subject|0|||
154948547|NCT00788957|559236139|FG003|Part 3|Withdrawal by Subject|0|||
154948548|NCT00788957|559236140|FG004|Part 3|Withdrawal by Subject|0|||
154948549|NCT00788957|559236141|FG005|Part 3|Withdrawal by Subject|2|||
154948550|NCT00788957|559236136|FG000|Part 3|Death|0|||
155050922|NCT03771963|559617825|FG000|Overall Study|Lost to Follow-up|22|||
155050923|NCT03771963|559617825|FG000|Overall Study|Withdrawal of Consent|10|||
155050924|NCT01026948|559617826|FG000|Overall Study|Physician Decision|8|||
155050925|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
155050926|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
155050927|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Adverse Event|57|||
155092576|NCT01959529|559773634|FG000|Overall Study|Hypoglycaemia|1|||
155390455|NCT04343248|560864370|FG001|Overall Study|Withdrawal by Subject|6|||
154948551|NCT00788957|559236137|FG001|Part 3|Death|0|||
154948552|NCT00788957|559236138|FG002|Part 3|Death|0|||
154948553|NCT00788957|559236139|FG003|Part 3|Death|0|||
154948554|NCT00788957|559236140|FG004|Part 3|Death|8|||
155050928|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Adverse Event|49|||
155390456|NCT04343248|560864369|FG000|Overall Study|Death|1|||
155390457|NCT04343248|560864370|FG001|Overall Study|Death|2|||
155390458|NCT04343248|560864369|FG000|Overall Study|Lost to Follow-up|9|||
155390459|NCT04343248|560864370|FG001|Overall Study|Lost to Follow-up|6|||
155390460|NCT04343248|560864369|FG000|Overall Study|Physician Decision|0|||
155390461|NCT04343248|560864370|FG001|Overall Study|Physician Decision|1|||
155390462|NCT04343248|560864369|FG000|Overall Study|Adverse Event|1|||
155390463|NCT04343248|560864370|FG001|Overall Study|Adverse Event|0|||
155390464|NCT05245097|560864375|FG000|Overall Study|Adverse Event|13|||
155390465|NCT05245097|560864376|FG001|Overall Study|Adverse Event|2|||
155390466|NCT05245097|560864375|FG000|Overall Study|Protocol Violation|8|||
155390467|NCT05245097|560864376|FG001|Overall Study|Protocol Violation|6|||
155390468|NCT05245097|560864375|FG000|Overall Study|Withdrawal by Subject|18|||
155390469|NCT05245097|560864376|FG001|Overall Study|Withdrawal by Subject|0|||
155390470|NCT05245097|560864375|FG000|Overall Study|Death|6|||
155390471|NCT05245097|560864376|FG001|Overall Study|Death|7|||
155390472|NCT05245097|560864375|FG000|Overall Study|Physician Decision|6|||
155390473|NCT05245097|560864376|FG001|Overall Study|Physician Decision|0|||
155390474|NCT05245097|560864375|FG000|Overall Study|Relocation|4|||
155390475|NCT05245097|560864376|FG001|Overall Study|Relocation|3|||
155390476|NCT03604523|560864381|FG000|Overall Study|Physician Decision|1|||
155390477|NCT03604523|560864382|FG001|Overall Study|Physician Decision|0|||
155390478|NCT00458341|560864383|FG000|Cycle 1|Adverse Event|1|||
155390479|NCT00458341|560864384|FG001|Cycle 1|Adverse Event|0|||
155390480|NCT05461794|560864385|FG000|Overall Study|Withdrawal by Subject|1|||
155390481|NCT05461794|560864386|FG001|Overall Study|Withdrawal by Subject|1|||
155390482|NCT05461794|560864387|FG002|Overall Study|Withdrawal by Subject|3|||
155390483|NCT05461794|560864385|FG000|Overall Study|Study Terminated By Sponsor|18|||
155390484|NCT05461794|560864386|FG001|Overall Study|Study Terminated By Sponsor|13|||
155390485|NCT05461794|560864387|FG002|Overall Study|Study Terminated By Sponsor|16|||
155390486|NCT05461794|560864385|FG000|Overall Study|Death|20|||
155390487|NCT05461794|560864386|FG001|Overall Study|Death|5|||
155390488|NCT05461794|560864387|FG002|Overall Study|Death|19|||
155390489|NCT02730598|560864394|FG000|Overall Study|Withdrawal by Subject|3|||
155390490|NCT02730598|560864395|FG001|Overall Study|Withdrawal by Subject|3|||
155390491|NCT02730598|560864394|FG000|Overall Study|Protocol Violation|0|||
155390492|NCT02730598|560864395|FG001|Overall Study|Protocol Violation|1|||
155390493|NCT02730598|560864394|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
155390494|NCT02730598|560864395|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
155390495|NCT00810394|560864396|FG000|Overall Study|Withdrawal by Subject|3|||
155390496|NCT03254485|560864397|FG000|Overall Study|Adverse Event|3|||
155390497|NCT03254485|560864398|FG001|Overall Study|Adverse Event|0|||
155390498|NCT03254485|560864399|FG002|Overall Study|Adverse Event|0|||
155390499|NCT03254485|560864400|FG003|Overall Study|Adverse Event|6|||
155390500|NCT03254485|560864397|FG000|Overall Study|Protocol Violation|6|||
155390501|NCT03254485|560864398|FG001|Overall Study|Protocol Violation|0|||
155050929|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
155050930|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
155050931|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Site closure|3|||
155050932|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Site closure|2|||
155050933|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
155050934|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
155050935|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Physician Decision|48|||
155050936|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Physician Decision|38|||
155050937|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
155050938|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
155050939|NCT01705977|559617827|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
155050940|NCT01705977|559617828|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
155390502|NCT03254485|560864399|FG002|Overall Study|Protocol Violation|0|||
155390503|NCT03254485|560864400|FG003|Overall Study|Protocol Violation|2|||
155390504|NCT03254485|560864397|FG000|Overall Study|Withdrawal by Subject|1|||
155390505|NCT03254485|560864398|FG001|Overall Study|Withdrawal by Subject|0|||
155390506|NCT03254485|560864399|FG002|Overall Study|Withdrawal by Subject|0|||
155390507|NCT03254485|560864400|FG003|Overall Study|Withdrawal by Subject|4|||
155390508|NCT03254485|560864397|FG000|Overall Study|Death|0|||
155390509|NCT03254485|560864398|FG001|Overall Study|Death|0|||
155390510|NCT03254485|560864399|FG002|Overall Study|Death|0|||
155390511|NCT03254485|560864400|FG003|Overall Study|Death|1|||
155390512|NCT03254485|560864397|FG000|Overall Study|Lost to Follow-up|1|||
155390513|NCT03254485|560864398|FG001|Overall Study|Lost to Follow-up|0|||
155390514|NCT03254485|560864399|FG002|Overall Study|Lost to Follow-up|0|||
155390515|NCT03254485|560864400|FG003|Overall Study|Lost to Follow-up|0|||
155050941|NCT01705977|559617827|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
155050942|NCT01705977|559617828|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
155390516|NCT03254485|560864397|FG000|Overall Study|Other|1|||
155390517|NCT03254485|560864398|FG001|Overall Study|Other|0|||
155390518|NCT03254485|560864399|FG002|Overall Study|Other|0|||
155390519|NCT03254485|560864400|FG003|Overall Study|Other|2|||
155281832|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
155281833|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
155281834|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
155281835|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
155281836|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
155281837|NCT04672460|560463936|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
155281838|NCT04672460|560463937|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
155281839|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
155281840|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
155281841|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
155281842|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
155281843|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
155281844|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
155281845|NCT04672460|560463936|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
155281846|NCT04672460|560463937|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
155281847|NCT02949271|560463938|FG000|Overall Study|Lack of Efficacy|5|||
155281848|NCT02949271|560463939|FG001|Overall Study|Lack of Efficacy|4|||
155281849|NCT02949271|560463938|FG000|Overall Study|Lost to Follow-up|3|||
155281850|NCT02949271|560463939|FG001|Overall Study|Lost to Follow-up|6|||
155281851|NCT02949271|560463938|FG000|Overall Study|Physician Decision|5|||
155281852|NCT02949271|560463939|FG001|Overall Study|Physician Decision|5|||
155281853|NCT02949271|560463938|FG000|Overall Study|Protocol Violation|6|||
155281854|NCT02949271|560463939|FG001|Overall Study|Protocol Violation|3|||
155281855|NCT02949271|560463938|FG000|Overall Study|Withdrawal by Subject|1|||
155281856|NCT02949271|560463939|FG001|Overall Study|Withdrawal by Subject|0|||
155281857|NCT02949271|560463938|FG000|Overall Study|Delivered prior to intervention|7|||
155281858|NCT02949271|560463939|FG001|Overall Study|Delivered prior to intervention|9|||
155281859|NCT02949271|560463938|FG000|Overall Study|Outside the window for cervical dilation|2|||
155281860|NCT02949271|560463939|FG001|Overall Study|Outside the window for cervical dilation|3|||
155281861|NCT02373813|560463942|FG000|Run-In Period|Other, Not Specified|5|||
155281862|NCT02373813|560463943|FG001|Run-In Period|Other, Not Specified|0|||
155281863|NCT02373813|560463944|FG002|Run-In Period|Other, Not Specified|0|||
155281864|NCT02373813|560463945|FG003|Run-In Period|Other, Not Specified|0|||
155281865|NCT02373813|560463942|FG000|Run-In Period|Withdrawal by Subject|16|||
155281866|NCT02373813|560463943|FG001|Run-In Period|Withdrawal by Subject|0|||
155281867|NCT02373813|560463944|FG002|Run-In Period|Withdrawal by Subject|0|||
155281868|NCT02373813|560463945|FG003|Run-In Period|Withdrawal by Subject|0|||
155281869|NCT02373813|560463942|FG000|Run-In Period|Decision by Sponsor|11|||
155281870|NCT02373813|560463943|FG001|Run-In Period|Decision by Sponsor|0|||
155281871|NCT02373813|560463944|FG002|Run-In Period|Decision by Sponsor|0|||
155281872|NCT02373813|560463945|FG003|Run-In Period|Decision by Sponsor|0|||
155281873|NCT02373813|560463942|FG000|Run-In Period|Protocol Violation|75|||
155281874|NCT02373813|560463943|FG001|Run-In Period|Protocol Violation|0|||
155281875|NCT02373813|560463944|FG002|Run-In Period|Protocol Violation|0|||
155281876|NCT02373813|560463945|FG003|Run-In Period|Protocol Violation|0|||
155281877|NCT02373813|560463942|FG000|Run-In Period|Lost to Follow-up|2|||
155281878|NCT02373813|560463943|FG001|Run-In Period|Lost to Follow-up|0|||
155281879|NCT02373813|560463944|FG002|Run-In Period|Lost to Follow-up|0|||
155281880|NCT02373813|560463945|FG003|Run-In Period|Lost to Follow-up|0|||
155281881|NCT02373813|560463942|FG000|Run-In Period|Adverse Event|3|||
155281882|NCT02373813|560463943|FG001|Run-In Period|Adverse Event|0|||
155281883|NCT02373813|560463944|FG002|Run-In Period|Adverse Event|0|||
155281884|NCT02373813|560463945|FG003|Run-In Period|Adverse Event|0|||
155281885|NCT02373813|560463942|FG000|Run-In Period|Noncompliance|1|||
155281886|NCT02373813|560463943|FG001|Run-In Period|Noncompliance|0|||
155281887|NCT02373813|560463944|FG002|Run-In Period|Noncompliance|0|||
155281888|NCT02373813|560463945|FG003|Run-In Period|Noncompliance|0|||
155281889|NCT02373813|560463942|FG000|Run-In Period|Ineligibility Determined|3|||
155281890|NCT02373813|560463943|FG001|Run-In Period|Ineligibility Determined|0|||
155281891|NCT02373813|560463944|FG002|Run-In Period|Ineligibility Determined|0|||
155281892|NCT02373813|560463945|FG003|Run-In Period|Ineligibility Determined|0|||
155281893|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
155281894|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
155281895|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
155281896|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
155281897|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155281898|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
155281899|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
155281900|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
155281901|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155281902|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155281903|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
155281904|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
155390520|NCT00467285|560864401|FG000|Overall Study|Lost to Follow-up|4|||
155390521|NCT00467285|560864402|FG001|Overall Study|Lost to Follow-up|4|||
155050943|NCT01705977|559617827|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
155390522|NCT03891524|560864403|FG000|Overall Study|Death|0|||
155390523|NCT03891524|560864404|FG001|Overall Study|Death|0|||
155390524|NCT03891524|560864405|FG002|Overall Study|Death|0|||
155390525|NCT03891524|560864406|FG003|Overall Study|Death|0|||
155390526|NCT03891524|560864407|FG004|Overall Study|Death|0|||
155390527|NCT03891524|560864408|FG005|Overall Study|Death|0|||
155390528|NCT03891524|560864409|FG006|Overall Study|Death|0|||
155390529|NCT03891524|560864410|FG007|Overall Study|Death|1|||
155390530|NCT03891524|560864403|FG000|Overall Study|Withdrawal by Subject|0|||
155390531|NCT03891524|560864404|FG001|Overall Study|Withdrawal by Subject|1|||
155390532|NCT03891524|560864405|FG002|Overall Study|Withdrawal by Subject|2|||
155390533|NCT03891524|560864406|FG003|Overall Study|Withdrawal by Subject|1|||
155390534|NCT03891524|560864407|FG004|Overall Study|Withdrawal by Subject|2|||
155390535|NCT03891524|560864408|FG005|Overall Study|Withdrawal by Subject|2|||
155390536|NCT03891524|560864409|FG006|Overall Study|Withdrawal by Subject|2|||
155390537|NCT03891524|560864410|FG007|Overall Study|Withdrawal by Subject|1|||
155390538|NCT02958267|560864412|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
155390539|NCT02958267|560864413|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
155050944|NCT01705977|559617828|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
155050945|NCT01705977|559617827|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
155050946|NCT01705977|559617828|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
155390540|NCT02958267|560864412|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
155390541|NCT02958267|560864413|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
155390542|NCT02958267|560864412|FG000|Follow-up Visits|Additional treatment pursued|2|||
155390543|NCT02958267|560864413|FG001|Follow-up Visits|Additional treatment pursued|1|||
155390544|NCT00475033|560864414|FG000|Infant Series|Failed to return|3|||
155390545|NCT00475033|560864415|FG001|Infant Series|Failed to return|4|||
155390546|NCT00475033|560864414|FG000|Infant Series|Parent or legal guardian request|1|||
155390547|NCT00475033|560864415|FG001|Infant Series|Parent or legal guardian request|5|||
155390548|NCT00475033|560864414|FG000|Infant Series|Protocol Violation|1|||
155390549|NCT00475033|560864415|FG001|Infant Series|Protocol Violation|2|||
155390550|NCT00475033|560864414|FG000|Infant Series|Lost to Follow-up|2|||
155390551|NCT00475033|560864415|FG001|Infant Series|Lost to Follow-up|0|||
155390552|NCT00475033|560864414|FG000|Infant Series|Adverse Event|0|||
155390553|NCT00475033|560864415|FG001|Infant Series|Adverse Event|2|||
155390554|NCT00475033|560864414|FG000|After the Infant Series|Adverse Event|0|||
155390555|NCT00475033|560864415|FG001|After the Infant Series|Adverse Event|4|||
155390556|NCT00475033|560864414|FG000|After the Infant Series|Parent or legal guardian request|2|||
155390557|NCT00475033|560864415|FG001|After the Infant Series|Parent or legal guardian request|2|||
155390558|NCT00475033|560864414|FG000|After the Infant Series|Failed to return|2|||
155390559|NCT00475033|560864415|FG001|After the Infant Series|Failed to return|1|||
155390560|NCT00475033|560864414|FG000|After the Infant Series|Protocol Violation|1|||
155390561|NCT00475033|560864415|FG001|After the Infant Series|Protocol Violation|0|||
155390562|NCT00475033|560864414|FG000|After the Infant Series|Lost to Follow-up|1|||
155390563|NCT00475033|560864415|FG001|After the Infant Series|Lost to Follow-up|0|||
155390564|NCT00475033|560864414|FG000|After the Infant Series|Other|0|||
155390565|NCT00475033|560864415|FG001|After the Infant Series|Other|1|||
155390566|NCT00475033|560864414|FG000|Toddler Dose|Parent or legal guardian request|2|||
155390567|NCT00475033|560864415|FG001|Toddler Dose|Parent or legal guardian request|0|||
155390568|NCT00475033|560864414|FG000|Toddler Dose|Failed to return|1|||
155390569|NCT00475033|560864415|FG001|Toddler Dose|Failed to return|0|||
155390570|NCT00475033|560864414|FG000|Toddler Dose|Lost to Follow-up|1|||
155390571|NCT00475033|560864415|FG001|Toddler Dose|Lost to Follow-up|0|||
155390572|NCT00047320|560864416|FG000|Overall Study|Lack of Efficacy|8|||
155390573|NCT00047320|560864416|FG000|Overall Study|Lost to Follow-up|1|||
155390574|NCT00047320|560864416|FG000|Overall Study|Physician Decision|8|||
155390575|NCT00047320|560864416|FG000|Overall Study|Withdrawal by Subject|9|||
155390576|NCT00047320|560864416|FG000|Overall Study|Ineligible|2|||
155390577|NCT04821869|560864417|FG000|Overall Study|Adverse Event|4|||
155390578|NCT04821869|560864417|FG000|Overall Study|Withdrawal by Subject|2|||
155390579|NCT04821869|560864417|FG000|Overall Study|Did not meet FEV1 criteria|1|||
155390580|NCT04614662|560865766|FG000|Overall Study|Withdrawal by Subject|0|||
155390581|NCT04614662|560865767|FG001|Overall Study|Withdrawal by Subject|1|||
155390582|NCT01603082|560865768|FG000|Overall Study|Adverse Event|0|||
155390583|NCT01603082|560865769|FG001|Overall Study|Adverse Event|1|||
155050947|NCT01705977|559617827|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
155390584|NCT01603082|560865768|FG000|Overall Study|Withdrawal by Subject|1|||
155050948|NCT01705977|559617828|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
155390585|NCT01603082|560865769|FG001|Overall Study|Withdrawal by Subject|0|||
155390586|NCT01603082|560865768|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
155390587|NCT01603082|560865769|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
155390588|NCT01862640|560865778|FG000|Overall Study|Adverse Event|4|||
155390589|NCT01862640|560865779|FG001|Overall Study|Adverse Event|10|||
155390590|NCT01862640|560865780|FG002|Overall Study|Adverse Event|6|||
155050949|NCT03360019|559617832|FG000|Overall Study|Withdrawal by Subject|2|||
155050950|NCT03360019|559617833|FG001|Overall Study|Withdrawal by Subject|0|||
155050951|NCT03360019|559617834|FG002|Overall Study|Withdrawal by Subject|0|||
155050952|NCT03360019|559617832|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
155050953|NCT03360019|559617833|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
155050954|NCT03360019|559617834|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
155050955|NCT02106351|559617835|FG000|Treatment Cycle 1|Adverse Event|2|||
155050956|NCT02106351|559617836|FG001|Treatment Cycle 1|Adverse Event|0|||
155050957|NCT02106351|559617837|FG002|Treatment Cycle 1|Adverse Event|0|||
155050958|NCT02106351|559617835|FG000|Treatment Cycle 1|Consent withdrawn|1|||
155050959|NCT02106351|559617836|FG001|Treatment Cycle 1|Consent withdrawn|0|||
155050960|NCT02106351|559617837|FG002|Treatment Cycle 1|Consent withdrawn|2|||
155050961|NCT02106351|559617835|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
155050962|NCT02106351|559617836|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
155050963|NCT02106351|559617837|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
155050964|NCT02106351|559617835|FG000|Treatment Cycle 1|Other|0|||
155390591|NCT01862640|560865781|FG003|Overall Study|Adverse Event|8|||
155390592|NCT01862640|560865778|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155050965|NCT02106351|559617836|FG001|Treatment Cycle 1|Other|3|||
155050966|NCT02106351|559617837|FG002|Treatment Cycle 1|Other|1|||
155050967|NCT02106351|559617835|FG000|Treatment Cycle 1|Randomised but not treated|1|||
155050968|NCT02106351|559617836|FG001|Treatment Cycle 1|Randomised but not treated|0|||
155050969|NCT02106351|559617837|FG002|Treatment Cycle 1|Randomised but not treated|1|||
155050970|NCT02106351|559617835|FG000|Treatment Cycle 2|Adverse Event|0|||
155050971|NCT02106351|559617836|FG001|Treatment Cycle 2|Adverse Event|2|||
155050972|NCT02106351|559617837|FG002|Treatment Cycle 2|Adverse Event|0|||
155050973|NCT02106351|559617835|FG000|Treatment Cycle 2|Consent withdrawn|0|||
155050974|NCT02106351|559617836|FG001|Treatment Cycle 2|Consent withdrawn|1|||
155050975|NCT02106351|559617837|FG002|Treatment Cycle 2|Consent withdrawn|1|||
155390593|NCT01862640|560865779|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
155390594|NCT01862640|560865780|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
155390595|NCT01862640|560865781|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
155390596|NCT01862640|560865778|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
155390597|NCT01862640|560865779|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
155390598|NCT01862640|560865780|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
155390599|NCT01862640|560865781|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
155390600|NCT01862640|560865778|FG000|Overall Study|Withdrawal by Subject|2|||
155390601|NCT01862640|560865779|FG001|Overall Study|Withdrawal by Subject|4|||
155390602|NCT01862640|560865780|FG002|Overall Study|Withdrawal by Subject|8|||
155390603|NCT01862640|560865781|FG003|Overall Study|Withdrawal by Subject|5|||
155390604|NCT01862640|560865778|FG000|Overall Study|Protocol Deviation|0|||
155390605|NCT01862640|560865779|FG001|Overall Study|Protocol Deviation|0|||
155390606|NCT01862640|560865780|FG002|Overall Study|Protocol Deviation|1|||
155390607|NCT01862640|560865781|FG003|Overall Study|Protocol Deviation|0|||
155390608|NCT05085665|560865782|FG000|Overall Study|Physician Decision|2|||
155390609|NCT01774084|560865783|FG000|Overall Study|Personal reasons|1|||
155390610|NCT01774084|560865784|FG001|Overall Study|Personal reasons|0|||
155390611|NCT03026127|560865785|FG000|CRISP R61|Adverse Event|5|||
155390612|NCT03026127|560865786|FG001|CRISP R61|Adverse Event|0|||
155390613|NCT03026127|560865787|FG002|CRISP R61|Adverse Event|0|||
155390614|NCT03026127|560865785|FG000|CRISP R61|Lost to Follow-up|2|||
155390615|NCT03026127|560865786|FG001|CRISP R61|Lost to Follow-up|0|||
155390616|NCT03026127|560865787|FG002|CRISP R61|Lost to Follow-up|0|||
155390617|NCT03026127|560865785|FG000|CRISP R61|Dropped before therapy|5|||
155050976|NCT02106351|559617835|FG000|Treatment Cycle 2|Other|0|||
155050977|NCT02106351|559617836|FG001|Treatment Cycle 2|Other|2|||
155050978|NCT02106351|559617837|FG002|Treatment Cycle 2|Other|2|||
155050979|NCT02106351|559617835|FG000|Treatment Cycle 3|Adverse Event|0|||
155050980|NCT02106351|559617836|FG001|Treatment Cycle 3|Adverse Event|1|||
155050981|NCT02106351|559617837|FG002|Treatment Cycle 3|Adverse Event|0|||
155050982|NCT02106351|559617835|FG000|Treatment Cycle 3|Consent withdrawn|0|||
155281905|NCT02373813|560463942|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155281906|NCT02373813|560463943|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
155281907|NCT02373813|560463944|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
155281908|NCT02373813|560463945|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
155281909|NCT01511536|560463947|FG000|Phase 1|Other|0|||
155281910|NCT01511536|560463948|FG001|Phase 1|Other|1|||
155281911|NCT01511536|560463949|FG002|Phase 1|Other|0|||
155281912|NCT01511536|560463947|FG000|Phase 2|Other|0|||
155281913|NCT01511536|560463948|FG001|Phase 2|Other|0|||
155281914|NCT01511536|560463949|FG002|Phase 2|Other|9|||
155281915|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
155390618|NCT03026127|560865786|FG001|CRISP R61|Dropped before therapy|0|||
155390619|NCT03026127|560865787|FG002|CRISP R61|Dropped before therapy|0|||
155390620|NCT03026127|560865785|FG000|CRISP R33|Lost to Follow-up|0|||
155390621|NCT03026127|560865786|FG001|CRISP R33|Lost to Follow-up|5|||
155390622|NCT03026127|560865787|FG002|CRISP R33|Lost to Follow-up|4|||
155390623|NCT03026127|560865785|FG000|CRISP R33|Adverse Event|0|||
155390624|NCT03026127|560865786|FG001|CRISP R33|Adverse Event|9|||
155390625|NCT03026127|560865787|FG002|CRISP R33|Adverse Event|5|||
155390626|NCT03026127|560865785|FG000|CRISP R33|Withdrawal by Subject|0|||
155390627|NCT03026127|560865786|FG001|CRISP R33|Withdrawal by Subject|9|||
155390628|NCT03026127|560865787|FG002|CRISP R33|Withdrawal by Subject|1|||
154948555|NCT00788957|559236141|FG005|Part 3|Death|8|||
154948556|NCT00788957|559236136|FG000|Part 3|On-study at time of data cut-off|0|||
154948557|NCT00788957|559236137|FG001|Part 3|On-study at time of data cut-off|0|||
154948558|NCT00788957|559236138|FG002|Part 3|On-study at time of data cut-off|0|||
154948559|NCT00788957|559236139|FG003|Part 3|On-study at time of data cut-off|0|||
154948560|NCT00788957|559236140|FG004|Part 3|On-study at time of data cut-off|1|||
154948561|NCT00788957|559236141|FG005|Part 3|On-study at time of data cut-off|0|||
154948562|NCT02275364|559236142|FG000|Period 1|Withdrawal by Subject|1|||
154948563|NCT02275364|559236143|FG001|Period 1|Withdrawal by Subject|0|||
154948564|NCT02275364|559236142|FG000|Period 1|Other reason|1|||
154948565|NCT02275364|559236143|FG001|Period 1|Other reason|0|||
154948566|NCT00510510|559236144|FG000|Overall Study|Adverse Event|4|||
154948567|NCT00510510|559236145|FG001|Overall Study|Adverse Event|3|||
154948568|NCT00510510|559236146|FG002|Overall Study|Adverse Event|6|||
154948569|NCT00510510|559236144|FG000|Overall Study|Lack of Efficacy|0|||
154948570|NCT00510510|559236145|FG001|Overall Study|Lack of Efficacy|1|||
154948571|NCT00510510|559236146|FG002|Overall Study|Lack of Efficacy|1|||
154948572|NCT00510510|559236144|FG000|Overall Study|Subjects no longer requires study drug|0|||
154948573|NCT00510510|559236145|FG001|Overall Study|Subjects no longer requires study drug|0|||
154948574|NCT00510510|559236146|FG002|Overall Study|Subjects no longer requires study drug|2|||
154948575|NCT00510510|559236144|FG000|Overall Study|Withdrawal by Subject|1|||
154948576|NCT00510510|559236145|FG001|Overall Study|Withdrawal by Subject|2|||
154948577|NCT00510510|559236146|FG002|Overall Study|Withdrawal by Subject|3|||
154948578|NCT00510510|559236144|FG000|Overall Study|Lost to Follow-up|0|||
154948579|NCT00510510|559236145|FG001|Overall Study|Lost to Follow-up|0|||
154948580|NCT00510510|559236146|FG002|Overall Study|Lost to Follow-up|1|||
154948581|NCT00510510|559236144|FG000|Overall Study|Protocol Violation|0|||
154948582|NCT00510510|559236145|FG001|Overall Study|Protocol Violation|3|||
154948583|NCT00510510|559236146|FG002|Overall Study|Protocol Violation|4|||
154948584|NCT01200394|559236147|FG000|Overall Study|Adverse Event|0|||
154948585|NCT01200394|559236148|FG001|Overall Study|Adverse Event|14|||
154948586|NCT01200394|559236147|FG000|Overall Study|Death|1|||
154948587|NCT01200394|559236148|FG001|Overall Study|Death|0|||
154948588|NCT01200394|559236147|FG000|Overall Study|Lost to Follow-up|0|||
154948589|NCT01200394|559236148|FG001|Overall Study|Lost to Follow-up|1|||
154948590|NCT01200394|559236147|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
154948591|NCT01200394|559236148|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
154948592|NCT01200394|559236147|FG000|Overall Study|Protocol Violation|0|||
154948593|NCT01200394|559236148|FG001|Overall Study|Protocol Violation|3|||
154948594|NCT01200394|559236147|FG000|Overall Study|Withdrawal by Subject|0|||
154948595|NCT01200394|559236148|FG001|Overall Study|Withdrawal by Subject|5|||
154948596|NCT01200394|559236147|FG000|Overall Study|Other|0|||
154948597|NCT01200394|559236148|FG001|Overall Study|Other|1|||
154948598|NCT00319449|559236149|FG000|Overall Study|Subject did not wish to continue|1|||
154948599|NCT00319449|559236150|FG001|Overall Study|Subject did not wish to continue|0|||
154948600|NCT00319449|559236149|FG000|Overall Study|Noncompliance with the protocol|1|||
154948601|NCT00319449|559236150|FG001|Overall Study|Noncompliance with the protocol|0|||
154948602|NCT00365352|559236151|FG000|Overall Study|Adverse Event|6|||
154948603|NCT00365352|559236152|FG001|Overall Study|Adverse Event|7|||
154948604|NCT00365352|559236153|FG002|Overall Study|Adverse Event|8|||
154948605|NCT00365352|559236151|FG000|Overall Study|Participant Withdrew Consent|8|||
154948606|NCT00365352|559236152|FG001|Overall Study|Participant Withdrew Consent|3|||
154948607|NCT00365352|559236153|FG002|Overall Study|Participant Withdrew Consent|4|||
154948608|NCT00365352|559236151|FG000|Overall Study|Lack of Efficacy|3|||
154948609|NCT00365352|559236152|FG001|Overall Study|Lack of Efficacy|0|||
154948610|NCT00365352|559236153|FG002|Overall Study|Lack of Efficacy|0|||
154948611|NCT00365352|559236151|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
154948612|NCT00365352|559236152|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
154948613|NCT00365352|559236153|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
154948614|NCT00365352|559236151|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
154948615|NCT00365352|559236152|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
154948616|NCT00365352|559236153|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
154948617|NCT00365352|559236151|FG000|Overall Study|Lost to Follow-up|1|||
154948618|NCT00365352|559236152|FG001|Overall Study|Lost to Follow-up|1|||
154948619|NCT00365352|559236153|FG002|Overall Study|Lost to Follow-up|0|||
155092577|NCT01959529|559773635|FG001|Overall Study|Hypoglycaemia|1|||
155390629|NCT03026127|560865785|FG000|CRISP R33|Lack of Efficacy|0|||
154948620|NCT00365352|559236151|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
154948621|NCT00365352|559236152|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
155390630|NCT03026127|560865786|FG001|CRISP R33|Lack of Efficacy|3|||
155390631|NCT03026127|560865787|FG002|CRISP R33|Lack of Efficacy|2|||
155390632|NCT03026127|560865785|FG000|CRISP R33|Physician Decision|0|||
155390633|NCT03026127|560865786|FG001|CRISP R33|Physician Decision|3|||
155390634|NCT03026127|560865787|FG002|CRISP R33|Physician Decision|1|||
155390635|NCT03026127|560865785|FG000|CRISP R33|Transportation|0|||
155390636|NCT03026127|560865786|FG001|CRISP R33|Transportation|2|||
155390637|NCT03026127|560865787|FG002|CRISP R33|Transportation|1|||
155390638|NCT03027557|560865788|FG000|Overall Study|Adverse Event|1|||
155390639|NCT03027557|560865789|FG001|Overall Study|Adverse Event|0|||
155390640|NCT03027557|560865790|FG002|Overall Study|Adverse Event|0|||
155390641|NCT01699789|560865793|FG000|Overall Study|Withdrawal by Subject|18|||
155390642|NCT01699789|560865794|FG001|Overall Study|Withdrawal by Subject|23|||
155390643|NCT01699789|560865793|FG000|Overall Study|Death|1|||
155390644|NCT01699789|560865794|FG001|Overall Study|Death|2|||
155390645|NCT01699789|560865793|FG000|Overall Study|Lost to Follow-up|83|||
155390646|NCT01699789|560865794|FG001|Overall Study|Lost to Follow-up|101|||
155390647|NCT04226833|560865797|FG000|Overall Study|Death|0|||
155390648|NCT04226833|560865798|FG001|Overall Study|Death|0|||
155390649|NCT04226833|560865799|FG002|Overall Study|Death|1|||
155390650|NCT04226833|560865800|FG003|Overall Study|Death|0|||
155390651|NCT00364156|560865803|FG000|Overall Study|Withdrawal by Subject|73|||
155390652|NCT00364156|560865804|FG001|Overall Study|Withdrawal by Subject|80|||
155390653|NCT00364156|560865803|FG000|Overall Study|Protocol Violation|6|||
155390654|NCT00364156|560865804|FG001|Overall Study|Protocol Violation|1|||
155390655|NCT01050205|560865805|FG000|Overall Study|Lost to Follow-up|7|||
155390656|NCT01050205|560865806|FG001|Overall Study|Lost to Follow-up|1|||
155390657|NCT01050205|560865805|FG000|Overall Study|Withdrawal by Subject|1|||
155390658|NCT01050205|560865806|FG001|Overall Study|Withdrawal by Subject|1|||
155390659|NCT01050205|560865805|FG000|Overall Study|Relocated from area|1|||
155390660|NCT01050205|560865806|FG001|Overall Study|Relocated from area|2|||
155390661|NCT01050205|560865805|FG000|Overall Study|Discontinued Intervention|2|||
155390662|NCT01050205|560865806|FG001|Overall Study|Discontinued Intervention|0|||
155390663|NCT00403754|560865809|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
155390664|NCT00403754|560865810|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
155390665|NCT00403754|560865811|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
155390666|NCT00403754|560865812|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
155390667|NCT00403754|560865809|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
155390668|NCT00403754|560865810|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
155390669|NCT00403754|560865811|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
155390670|NCT00403754|560865812|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
155390671|NCT01891721|560865817|FG000|Overall Study|Lost to Follow-up|10|||
155390672|NCT01891721|560865818|FG001|Overall Study|Lost to Follow-up|5|||
155390673|NCT01891721|560865819|FG002|Overall Study|Lost to Follow-up|1|||
155390674|NCT00633061|560865820|FG000|Overall Study|Study closed|86|||
155390675|NCT00633061|560865821|FG001|Overall Study|Study closed|0|||
155390676|NCT02000427|560865822|FG000|Overall Study|Death|22|||
155390677|NCT02708095|560865823|FG000|Overall Study|Adverse Event|4|||
155390678|NCT02708095|560865824|FG001|Overall Study|Adverse Event|10|||
155390679|NCT02708095|560865825|FG002|Overall Study|Adverse Event|11|||
155390680|NCT02708095|560865823|FG000|Overall Study|Lack of Efficacy|9|||
155390681|NCT02708095|560865824|FG001|Overall Study|Lack of Efficacy|3|||
155390682|NCT02708095|560865825|FG002|Overall Study|Lack of Efficacy|0|||
155390683|NCT02708095|560865823|FG000|Overall Study|Lost to Follow-up|2|||
155390684|NCT02708095|560865824|FG001|Overall Study|Lost to Follow-up|0|||
155390685|NCT02708095|560865825|FG002|Overall Study|Lost to Follow-up|0|||
155390686|NCT02708095|560865823|FG000|Overall Study|Physician Decision|2|||
155390687|NCT02708095|560865824|FG001|Overall Study|Physician Decision|3|||
155390688|NCT02708095|560865825|FG002|Overall Study|Physician Decision|2|||
155390689|NCT02708095|560865823|FG000|Overall Study|Protocol Violation|0|||
155390690|NCT02708095|560865824|FG001|Overall Study|Protocol Violation|0|||
155390691|NCT02708095|560865825|FG002|Overall Study|Protocol Violation|1|||
155390692|NCT02708095|560865823|FG000|Overall Study|Withdrawal by Subject|5|||
155390693|NCT02708095|560865824|FG001|Overall Study|Withdrawal by Subject|3|||
154948622|NCT00365352|559236153|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
154948623|NCT02109133|559236154|FG000|Overall Study|Lost to Follow-up|1|||
154948624|NCT02109133|559236155|FG001|Overall Study|Lost to Follow-up|0|||
154948625|NCT02448771|559236156|FG000|Overall Study|Disease Progression|30|||
155390694|NCT02708095|560865825|FG002|Overall Study|Withdrawal by Subject|4|||
155390695|NCT05125679|560865826|FG000|Overall Study|Study Terminated by Sponsor|2|||
155390696|NCT05125679|560865827|FG001|Overall Study|Study Terminated by Sponsor|5|||
155390697|NCT03829319|560865840|FG000|Overall Study|Sponsor's Decision|4|||
155390698|NCT03829319|560865841|FG001|Overall Study|Sponsor's Decision|90|||
155390699|NCT03829319|560865842|FG002|Overall Study|Sponsor's Decision|102|||
155390700|NCT03829319|560865840|FG000|Overall Study|Withdrawal by Subject|1|||
155390701|NCT03829319|560865841|FG001|Overall Study|Withdrawal by Subject|5|||
155390702|NCT03829319|560865842|FG002|Overall Study|Withdrawal by Subject|4|||
155390703|NCT03829319|560865840|FG000|Overall Study|Physician Decision|0|||
155390704|NCT03829319|560865841|FG001|Overall Study|Physician Decision|3|||
155390705|NCT03829319|560865842|FG002|Overall Study|Physician Decision|0|||
155390706|NCT03829319|560865840|FG000|Overall Study|Lost to Follow-up|0|||
155390707|NCT03829319|560865841|FG001|Overall Study|Lost to Follow-up|0|||
155281916|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
155281917|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
155281918|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
155281919|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
155281920|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
155281921|NCT01764386|560463953|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
155281922|NCT01764386|560463954|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
155281923|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
155281924|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
155281925|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
155281926|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
155281927|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
155281928|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
155281929|NCT01764386|560463953|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
155281930|NCT01764386|560463954|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
155281931|NCT02703532|560463956|FG000|Overall Study|Withdrawal by Subject|0|||
155281932|NCT02703532|560463957|FG001|Overall Study|Withdrawal by Subject|1|||
155281933|NCT02703532|560463958|FG002|Overall Study|Withdrawal by Subject|0|||
155281934|NCT02703532|560463959|FG003|Overall Study|Withdrawal by Subject|1|||
155281935|NCT02703532|560463956|FG000|Overall Study|Lost to Follow-up|2|||
155281936|NCT02703532|560463957|FG001|Overall Study|Lost to Follow-up|0|||
154948626|NCT02448771|559236156|FG000|Overall Study|Unacceptable Toxicity|1|||
154948627|NCT02448771|559236156|FG000|Overall Study|Physician Decision|3|||
154948628|NCT02448771|559236156|FG000|Overall Study|Started new therapy|2|||
154948629|NCT03968224|559236157|FG000|Overall Study|Lost to Follow-up|11|||
154948630|NCT03968224|559236158|FG001|Overall Study|Lost to Follow-up|18|||
154948631|NCT00770315|559236160|FG000|Overall Study|Adverse Event|11|||
154948632|NCT00770315|559236161|FG001|Overall Study|Adverse Event|17|||
154948633|NCT00770315|559236162|FG002|Overall Study|Adverse Event|16|||
154948634|NCT00770315|559236163|FG003|Overall Study|Adverse Event|6|||
154948635|NCT00770315|559236160|FG000|Overall Study|Lost to Follow-up|9|||
154948636|NCT00770315|559236161|FG001|Overall Study|Lost to Follow-up|5|||
154948637|NCT00770315|559236162|FG002|Overall Study|Lost to Follow-up|10|||
154948638|NCT00770315|559236163|FG003|Overall Study|Lost to Follow-up|3|||
154948639|NCT00770315|559236160|FG000|Overall Study|Withdrawal by Subject|13|||
154948640|NCT00770315|559236161|FG001|Overall Study|Withdrawal by Subject|17|||
154948641|NCT00770315|559236162|FG002|Overall Study|Withdrawal by Subject|24|||
154948642|NCT00770315|559236163|FG003|Overall Study|Withdrawal by Subject|20|||
154948643|NCT00770315|559236160|FG000|Overall Study|Noncompliance with Protocol|7|||
154948644|NCT00770315|559236161|FG001|Overall Study|Noncompliance with Protocol|4|||
154948645|NCT00770315|559236162|FG002|Overall Study|Noncompliance with Protocol|7|||
154948646|NCT00770315|559236163|FG003|Overall Study|Noncompliance with Protocol|9|||
154948647|NCT04256421|559236164|FG000|Overall Study|Death|171|||
154948648|NCT04256421|559236165|FG001|Overall Study|Death|180|||
154948649|NCT04256421|559236164|FG000|Overall Study|Lost to Follow-up|1|||
155281937|NCT02703532|560463958|FG002|Overall Study|Lost to Follow-up|2|||
155281938|NCT02703532|560463959|FG003|Overall Study|Lost to Follow-up|0|||
155281939|NCT03738241|560463960|FG000|Overall Study|Withdrawal by Subject|0|||
155281940|NCT03738241|560463961|FG001|Overall Study|Withdrawal by Subject|0|||
155281941|NCT03738241|560463962|FG002|Overall Study|Withdrawal by Subject|0|||
155281942|NCT03738241|560463963|FG003|Overall Study|Withdrawal by Subject|0|||
155281943|NCT03738241|560463964|FG004|Overall Study|Withdrawal by Subject|0|||
155281944|NCT03738241|560463965|FG005|Overall Study|Withdrawal by Subject|0|||
155281945|NCT03738241|560463966|FG006|Overall Study|Withdrawal by Subject|0|||
155281946|NCT03738241|560463967|FG007|Overall Study|Withdrawal by Subject|0|||
155281947|NCT03738241|560463968|FG008|Overall Study|Withdrawal by Subject|0|||
155281948|NCT03738241|560463969|FG009|Overall Study|Withdrawal by Subject|1|||
155281949|NCT03738241|560463960|FG000|Overall Study|Physician Decision|0|||
155281950|NCT03738241|560463961|FG001|Overall Study|Physician Decision|0|||
155281951|NCT03738241|560463962|FG002|Overall Study|Physician Decision|0|||
155281952|NCT03738241|560463963|FG003|Overall Study|Physician Decision|0|||
155281953|NCT03738241|560463964|FG004|Overall Study|Physician Decision|0|||
155281954|NCT03738241|560463965|FG005|Overall Study|Physician Decision|0|||
155281955|NCT03738241|560463966|FG006|Overall Study|Physician Decision|0|||
155281956|NCT03738241|560463967|FG007|Overall Study|Physician Decision|0|||
155281957|NCT03738241|560463968|FG008|Overall Study|Physician Decision|1|||
155281958|NCT03738241|560463969|FG009|Overall Study|Physician Decision|0|||
155281959|NCT03738241|560463960|FG000|Overall Study|Adverse Event|1|||
155281960|NCT03738241|560463961|FG001|Overall Study|Adverse Event|0|||
155390708|NCT03829319|560865842|FG002|Overall Study|Lost to Follow-up|1|||
154948650|NCT04256421|559236165|FG001|Overall Study|Lost to Follow-up|1|||
154948651|NCT04256421|559236164|FG000|Overall Study|Withdrawal by Subject|9|||
155281961|NCT03738241|560463962|FG002|Overall Study|Adverse Event|0|||
155050983|NCT02106351|559617836|FG001|Treatment Cycle 3|Consent withdrawn|0|||
155390709|NCT03829319|560865840|FG000|Overall Study|Death|8|||
155390710|NCT03829319|560865841|FG001|Overall Study|Death|277|||
155390711|NCT03829319|560865842|FG002|Overall Study|Death|266|||
155390712|NCT01210118|560865847|FG000|Overall Study|Lost to Follow-up|1|||
155390713|NCT01210118|560865848|FG001|Overall Study|Lost to Follow-up|1|||
155390714|NCT01210118|560865847|FG000|Overall Study|Protocol Violation|1|||
155050984|NCT02106351|559617837|FG002|Treatment Cycle 3|Consent withdrawn|2|||
155050985|NCT02106351|559617835|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
155050986|NCT02106351|559617836|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
155050987|NCT02106351|559617837|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
155050988|NCT02106351|559617835|FG000|Treatment Cycle 3|Other|0|||
155050989|NCT02106351|559617836|FG001|Treatment Cycle 3|Other|2|||
155050990|NCT02106351|559617837|FG002|Treatment Cycle 3|Other|3|||
155050991|NCT02106351|559617835|FG000|Treatment Cycle 4|Consent withdrawn|0|||
155050992|NCT02106351|559617836|FG001|Treatment Cycle 4|Consent withdrawn|0|||
155050993|NCT02106351|559617837|FG002|Treatment Cycle 4|Consent withdrawn|2|||
155050994|NCT02106351|559617835|FG000|Treatment Cycle 4|Other|0|||
155050995|NCT02106351|559617836|FG001|Treatment Cycle 4|Other|1|||
155050996|NCT02106351|559617837|FG002|Treatment Cycle 4|Other|0|||
155050997|NCT00069823|559617838|FG000|Overall Study|Did not have follow-up diary cards|6|||
155050998|NCT00069823|559617839|FG001|Overall Study|Did not have follow-up diary cards|3|||
155050999|NCT00520039|559617842|FG000|Overall Study|Exclusion criteria met at first visit|7|||
155051000|NCT00520039|559617843|FG001|Overall Study|Exclusion criteria met at first visit|5|||
155051001|NCT03560869|559617844|FG000|Overall Study|Withdrawal by Subject|3|||
155051002|NCT03560869|559617845|FG001|Overall Study|Withdrawal by Subject|4|||
155051003|NCT03560869|559617844|FG000|Overall Study|Screening failure|4|||
155390715|NCT01210118|560865848|FG001|Overall Study|Protocol Violation|1|||
155390716|NCT01210118|560865847|FG000|Overall Study|Spontaneous abortion|1|||
155390717|NCT01210118|560865848|FG001|Overall Study|Spontaneous abortion|3|||
155390718|NCT00777946|560865849|FG000|Overall Study|Adverse Event|11|||
155390719|NCT00777946|560865850|FG001|Overall Study|Adverse Event|1|||
155390720|NCT00777946|560865851|FG002|Overall Study|Adverse Event|3|||
155390721|NCT00777946|560865849|FG000|Overall Study|Lack of Efficacy|0|||
155390722|NCT00777946|560865850|FG001|Overall Study|Lack of Efficacy|0|||
155390723|NCT00777946|560865851|FG002|Overall Study|Lack of Efficacy|9|||
155390724|NCT00777946|560865849|FG000|Overall Study|Condition no longer required study drug|1|||
155390725|NCT00777946|560865850|FG001|Overall Study|Condition no longer required study drug|0|||
155390726|NCT00777946|560865851|FG002|Overall Study|Condition no longer required study drug|0|||
155390727|NCT00777946|560865849|FG000|Overall Study|Patient withdrew consent|3|||
155390728|NCT00777946|560865850|FG001|Overall Study|Patient withdrew consent|2|||
155390729|NCT00777946|560865851|FG002|Overall Study|Patient withdrew consent|3|||
155390730|NCT00777946|560865849|FG000|Overall Study|Lost to Follow-up|3|||
155390731|NCT00777946|560865850|FG001|Overall Study|Lost to Follow-up|1|||
155390732|NCT00777946|560865851|FG002|Overall Study|Lost to Follow-up|0|||
155390733|NCT00777946|560865849|FG000|Overall Study|Protocol deviation|2|||
155390734|NCT00777946|560865850|FG001|Overall Study|Protocol deviation|1|||
155390735|NCT00777946|560865851|FG002|Overall Study|Protocol deviation|1|||
155390736|NCT00777946|560865849|FG000|Overall Study|Randomized in error|1|||
155390737|NCT00777946|560865850|FG001|Overall Study|Randomized in error|1|||
155390738|NCT00777946|560865851|FG002|Overall Study|Randomized in error|0|||
155390739|NCT01079130|560865852|FG000|Overall Study|Adverse Event|1|||
155390740|NCT01079130|560865853|FG001|Overall Study|Adverse Event|1|||
155390741|NCT01079130|560865854|FG002|Overall Study|Adverse Event|0|||
155390742|NCT01079130|560865855|FG003|Overall Study|Adverse Event|1|||
155390743|NCT01079130|560865856|FG004|Overall Study|Adverse Event|5|||
155390744|NCT01079130|560865857|FG005|Overall Study|Adverse Event|1|||
155390745|NCT01079130|560865852|FG000|Overall Study|Administrative problems|1|||
155390746|NCT01079130|560865853|FG001|Overall Study|Administrative problems|3|||
155390747|NCT01079130|560865854|FG002|Overall Study|Administrative problems|0|||
155390748|NCT01079130|560865855|FG003|Overall Study|Administrative problems|0|||
155390749|NCT01079130|560865856|FG004|Overall Study|Administrative problems|0|||
155051004|NCT03560869|559617845|FG001|Overall Study|Screening failure|4|||
155390750|NCT01079130|560865857|FG005|Overall Study|Administrative problems|1|||
155390751|NCT01079130|560865852|FG000|Overall Study|Withdrawal by Subject|0|||
155390752|NCT01079130|560865853|FG001|Overall Study|Withdrawal by Subject|1|||
155390753|NCT01079130|560865854|FG002|Overall Study|Withdrawal by Subject|0|||
155051005|NCT03560869|559617844|FG000|Overall Study|Withdrawal by PI|0|||
155051006|NCT03560869|559617845|FG001|Overall Study|Withdrawal by PI|1|||
155051007|NCT00325819|559617846|FG000|Overall Study|Study product lost in mail|2|||
155051008|NCT00325819|559617847|FG001|Overall Study|Study product lost in mail|1|||
155051009|NCT00325819|559617846|FG000|Overall Study|Did not take a dose of study product|4|||
155390754|NCT01079130|560865855|FG003|Overall Study|Withdrawal by Subject|0|||
155390755|NCT01079130|560865856|FG004|Overall Study|Withdrawal by Subject|1|||
155390756|NCT01079130|560865857|FG005|Overall Study|Withdrawal by Subject|3|||
155390757|NCT01079130|560865852|FG000|Overall Study|Protocol deviation|0|||
155390758|NCT01079130|560865853|FG001|Overall Study|Protocol deviation|2|||
155390759|NCT01079130|560865854|FG002|Overall Study|Protocol deviation|1|||
155390760|NCT01079130|560865855|FG003|Overall Study|Protocol deviation|2|||
154948652|NCT04256421|559236165|FG001|Overall Study|Withdrawal by Subject|10|||
154948653|NCT04256421|559236164|FG000|Overall Study|Ongoing in Study|66|||
154948654|NCT04256421|559236165|FG001|Overall Study|Ongoing in Study|52|||
154948655|NCT02785913|559237848|FG000|Overall Study|Adverse Event|5|||
154948656|NCT02785913|559237848|FG000|Overall Study|Death|2|||
154948657|NCT02785913|559237848|FG000|Overall Study|Progression|18|||
155281962|NCT03738241|560463963|FG003|Overall Study|Adverse Event|0|||
155281963|NCT03738241|560463964|FG004|Overall Study|Adverse Event|0|||
155281964|NCT03738241|560463965|FG005|Overall Study|Adverse Event|0|||
155281965|NCT03738241|560463966|FG006|Overall Study|Adverse Event|0|||
155281966|NCT03738241|560463967|FG007|Overall Study|Adverse Event|0|||
155281967|NCT03738241|560463968|FG008|Overall Study|Adverse Event|0|||
155281968|NCT03738241|560463969|FG009|Overall Study|Adverse Event|0|||
155281969|NCT03169361|560463970|FG000|Overall Study|Protocol Violation|32|||
155281970|NCT02788656|560463971|FG000|Overall Study|Withdrawal by Subject|1|||
155281971|NCT02788656|560463972|FG001|Overall Study|Withdrawal by Subject|0|||
155281972|NCT00495469|560463977|FG000|Overall Study|Adverse Event|0|||
155281973|NCT00495469|560463978|FG001|Overall Study|Adverse Event|1|||
155281974|NCT00495469|560463979|FG002|Overall Study|Adverse Event|3|||
155281975|NCT00495469|560463980|FG003|Overall Study|Adverse Event|0|||
155281976|NCT00495469|560463981|FG004|Overall Study|Adverse Event|1|||
155281977|NCT00495469|560463982|FG005|Overall Study|Adverse Event|1|||
155281978|NCT00495469|560463983|FG006|Overall Study|Adverse Event|1|||
155281979|NCT00495469|560463977|FG000|Overall Study|Lost to Follow-up|1|||
155281980|NCT00495469|560463978|FG001|Overall Study|Lost to Follow-up|1|||
155281981|NCT00495469|560463979|FG002|Overall Study|Lost to Follow-up|3|||
155281982|NCT00495469|560463980|FG003|Overall Study|Lost to Follow-up|1|||
155281983|NCT00495469|560463981|FG004|Overall Study|Lost to Follow-up|0|||
155281984|NCT00495469|560463982|FG005|Overall Study|Lost to Follow-up|0|||
155281985|NCT00495469|560463983|FG006|Overall Study|Lost to Follow-up|0|||
155281986|NCT00495469|560463977|FG000|Overall Study|Protocol Violation|0|||
155281987|NCT00495469|560463978|FG001|Overall Study|Protocol Violation|0|||
155281988|NCT00495469|560463979|FG002|Overall Study|Protocol Violation|0|||
155281989|NCT00495469|560463980|FG003|Overall Study|Protocol Violation|0|||
155281990|NCT00495469|560463981|FG004|Overall Study|Protocol Violation|1|||
155281991|NCT00495469|560463982|FG005|Overall Study|Protocol Violation|2|||
155281992|NCT00495469|560463983|FG006|Overall Study|Protocol Violation|0|||
155281993|NCT00495469|560463977|FG000|Overall Study|Withdrawal by Subject|5|||
155281994|NCT00495469|560463978|FG001|Overall Study|Withdrawal by Subject|3|||
155281995|NCT00495469|560463979|FG002|Overall Study|Withdrawal by Subject|1|||
155281996|NCT00495469|560463980|FG003|Overall Study|Withdrawal by Subject|3|||
155281997|NCT00495469|560463981|FG004|Overall Study|Withdrawal by Subject|3|||
155281998|NCT00495469|560463982|FG005|Overall Study|Withdrawal by Subject|2|||
155281999|NCT00495469|560463983|FG006|Overall Study|Withdrawal by Subject|3|||
155282000|NCT00495469|560463977|FG000|Overall Study|Lack of Efficacy|0|||
155282001|NCT00495469|560463978|FG001|Overall Study|Lack of Efficacy|0|||
155282002|NCT00495469|560463979|FG002|Overall Study|Lack of Efficacy|0|||
155282003|NCT00495469|560463980|FG003|Overall Study|Lack of Efficacy|0|||
155282004|NCT00495469|560463981|FG004|Overall Study|Lack of Efficacy|0|||
155282005|NCT00495469|560463982|FG005|Overall Study|Lack of Efficacy|0|||
155282006|NCT00495469|560463983|FG006|Overall Study|Lack of Efficacy|1|||
155282007|NCT00495469|560463977|FG000|Overall Study|Liver function test abnormality|0|||
155282008|NCT00495469|560463978|FG001|Overall Study|Liver function test abnormality|1|||
155282009|NCT00495469|560463979|FG002|Overall Study|Liver function test abnormality|0|||
155282010|NCT00495469|560463980|FG003|Overall Study|Liver function test abnormality|0|||
155282011|NCT00495469|560463981|FG004|Overall Study|Liver function test abnormality|0|||
155282012|NCT00495469|560463982|FG005|Overall Study|Liver function test abnormality|0|||
155282013|NCT00495469|560463983|FG006|Overall Study|Liver function test abnormality|0|||
155282014|NCT00495469|560463977|FG000|Overall Study|ST depression at randomisation in ECG|0|||
155282015|NCT00495469|560463978|FG001|Overall Study|ST depression at randomisation in ECG|1|||
155282016|NCT00495469|560463979|FG002|Overall Study|ST depression at randomisation in ECG|0|||
155282017|NCT00495469|560463980|FG003|Overall Study|ST depression at randomisation in ECG|0|||
155282018|NCT00495469|560463981|FG004|Overall Study|ST depression at randomisation in ECG|0|||
155282019|NCT00495469|560463982|FG005|Overall Study|ST depression at randomisation in ECG|0|||
155282020|NCT00495469|560463983|FG006|Overall Study|ST depression at randomisation in ECG|0|||
155282021|NCT03929302|560463988|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
155282022|NCT03929302|560463989|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
155282023|NCT03929302|560463990|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
155282024|NCT03929302|560463988|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
155282025|NCT03929302|560463989|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
155282026|NCT03929302|560463990|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
155282027|NCT03929302|560463988|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
155282028|NCT03929302|560463989|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
154948658|NCT02785913|559237848|FG000|Overall Study|Not protocol specified|1|||
154948659|NCT01052116|559237849|FG000|Overall Study|Lost to Follow-up|11|||
155282029|NCT03929302|560463990|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
155390761|NCT01079130|560865856|FG004|Overall Study|Protocol deviation|0|||
155390762|NCT01079130|560865857|FG005|Overall Study|Protocol deviation|0|||
155390763|NCT01079130|560865852|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155390764|NCT01079130|560865853|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155390765|NCT01079130|560865854|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155390766|NCT01079130|560865855|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155390767|NCT01079130|560865856|FG004|Overall Study|Abnormal test procedure result(s)|1|||
155390768|NCT01079130|560865857|FG005|Overall Study|Abnormal test procedure result(s)|0|||
155390769|NCT01079130|560865852|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155390770|NCT01079130|560865853|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155390771|NCT01079130|560865854|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155390772|NCT01079130|560865855|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155390773|NCT01079130|560865856|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
155390774|NCT01079130|560865857|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
155390775|NCT01079130|560865852|FG000|Overall Study|Lost to Follow-up|0|||
155390776|NCT01079130|560865853|FG001|Overall Study|Lost to Follow-up|0|||
155390777|NCT01079130|560865854|FG002|Overall Study|Lost to Follow-up|0|||
155390778|NCT01079130|560865855|FG003|Overall Study|Lost to Follow-up|0|||
155390779|NCT01079130|560865856|FG004|Overall Study|Lost to Follow-up|1|||
155390780|NCT01079130|560865857|FG005|Overall Study|Lost to Follow-up|0|||
155390781|NCT01696942|560865878|FG000|Overall Study|Withdrawal by Subject|1|||
155390782|NCT01696942|560865879|FG001|Overall Study|Withdrawal by Subject|0|||
155390783|NCT01696942|560865878|FG000|Overall Study|Protocol Violation|1|||
155390784|NCT01696942|560865879|FG001|Overall Study|Protocol Violation|2|||
155390785|NCT01696942|560865878|FG000|Overall Study|screen failure|0|||
155390786|NCT01696942|560865879|FG001|Overall Study|screen failure|1|||
155390787|NCT01422850|560865880|FG000|Overall Study|Physician Decision|3|||
155390788|NCT04484831|560865881|FG000|Overall Study|Withdrawal by Subject|1|||
155390789|NCT04484831|560865882|FG001|Overall Study|Withdrawal by Subject|0|||
155390790|NCT02244996|560865884|FG000|Overall Study|Lack of Efficacy|2|||
155390791|NCT02244996|560865885|FG001|Overall Study|Lack of Efficacy|6|||
155390792|NCT00174265|560865886|FG000|Overall Study|Adverse Event|7|||
155390793|NCT00174265|560865887|FG001|Overall Study|Adverse Event|4|||
155390794|NCT00174265|560865886|FG000|Overall Study|Lack of Efficacy|2|||
155390795|NCT00174265|560865887|FG001|Overall Study|Lack of Efficacy|2|||
155390796|NCT00174265|560865886|FG000|Overall Study|Withdrawal by Subject|3|||
155390797|NCT00174265|560865887|FG001|Overall Study|Withdrawal by Subject|5|||
155390798|NCT00174265|560865886|FG000|Overall Study|Lost to Follow-up|1|||
155390799|NCT00174265|560865887|FG001|Overall Study|Lost to Follow-up|0|||
155390800|NCT00174265|560865886|FG000|Overall Study|Other (Not specified)|16|||
155390801|NCT00174265|560865887|FG001|Overall Study|Other (Not specified)|10|||
155390802|NCT03471871|560865889|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390803|NCT03471871|560865890|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390804|NCT03471871|560865891|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
155390805|NCT03471871|560865892|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390806|NCT03471871|560865893|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
155390807|NCT03471871|560865889|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
155390808|NCT03471871|560865890|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
155390809|NCT03471871|560865891|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
155390810|NCT03471871|560865892|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
155390811|NCT03471871|560865893|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
155390812|NCT03471871|560865889|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155390813|NCT03471871|560865890|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155390814|NCT03471871|560865891|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
154948660|NCT01052116|559237850|FG001|Overall Study|Lost to Follow-up|17|||
154948661|NCT01052116|559237849|FG000|Overall Study|Withdrawal by Subject|3|||
154948662|NCT01052116|559237850|FG001|Overall Study|Withdrawal by Subject|6|||
154948663|NCT01052116|559237849|FG000|Overall Study|Spirometry not performed|0|||
154948664|NCT01052116|559237850|FG001|Overall Study|Spirometry not performed|4|||
154948665|NCT01402908|559237851|FG000|Overall Study|Withdrawal by Subject|30|||
154948666|NCT01402908|559237852|FG001|Overall Study|Withdrawal by Subject|17|||
154948667|NCT01402908|559237851|FG000|Overall Study|Lost to Follow-up|3|||
154948668|NCT01402908|559237852|FG001|Overall Study|Lost to Follow-up|1|||
154948669|NCT01402908|559237851|FG000|Overall Study|Physician Decision|1|||
154948670|NCT01402908|559237852|FG001|Overall Study|Physician Decision|0|||
155390815|NCT03471871|560865892|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
155390816|NCT03471871|560865893|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
154948671|NCT02581345|559237853|FG000|Part 1: up to Week 16|Adverse Event|3|||
154948672|NCT02581345|559237854|FG001|Part 1: up to Week 16|Adverse Event|8|||
155390817|NCT03471871|560865889|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390818|NCT03471871|560865890|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390819|NCT03471871|560865891|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390820|NCT03471871|560865892|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
155390821|NCT03471871|560865893|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
155390822|NCT03471871|560865889|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390823|NCT03471871|560865890|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390824|NCT03471871|560865891|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390825|NCT03471871|560865892|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
155390826|NCT03471871|560865893|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
155390827|NCT03040622|560865894|FG000|Overall Study|unable to implant device|3|||
155390828|NCT02818920|560865895|FG000|Overall Study|Unresectable|4|||
155390829|NCT02818920|560865895|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
155390830|NCT02818920|560865895|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
155390831|NCT02818920|560865895|FG000|Overall Study|Adverse Event|3|||
155390832|NCT02818920|560865895|FG000|Overall Study|Developed Other Disease|1|||
155390833|NCT02818920|560865895|FG000|Overall Study|Refused Further Treatment|1|||
155390834|NCT00445068|560865896|FG000|Overall Study|Disease progression|26|||
155390835|NCT00445068|560865896|FG000|Overall Study|Adverse Event|5|||
155390836|NCT00445068|560865896|FG000|Overall Study|Abnormal laboratory value|2|||
155390837|NCT00445068|560865896|FG000|Overall Study|Withdrawal by Subject|2|||
155390838|NCT00445068|560865896|FG000|Overall Study|Death|1|||
155390839|NCT02673619|560865897|FG000|Overall Study|Lost to Follow-up|1|||
155390840|NCT02673619|560865898|FG001|Overall Study|Lost to Follow-up|0|||
155390841|NCT02673619|560865899|FG002|Overall Study|Lost to Follow-up|0|||
155390842|NCT02673619|560865900|FG003|Overall Study|Lost to Follow-up|0|||
155390843|NCT02673619|560865897|FG000|Overall Study|Withdrawal by Subject|1|||
155390844|NCT02673619|560865898|FG001|Overall Study|Withdrawal by Subject|1|||
155390845|NCT02673619|560865899|FG002|Overall Study|Withdrawal by Subject|1|||
155390846|NCT02673619|560865900|FG003|Overall Study|Withdrawal by Subject|0|||
155390847|NCT02673619|560865897|FG000|Overall Study|Adverse Event|0|||
155390848|NCT02673619|560865898|FG001|Overall Study|Adverse Event|0|||
155390849|NCT02673619|560865899|FG002|Overall Study|Adverse Event|1|||
155390850|NCT02673619|560865900|FG003|Overall Study|Adverse Event|0|||
155390851|NCT02673619|560865897|FG000|Overall Study|Lack of Efficacy|0|||
155390852|NCT02673619|560865898|FG001|Overall Study|Lack of Efficacy|0|||
154948673|NCT02581345|559237855|FG002|Part 1: up to Week 16|Adverse Event|0|||
154948674|NCT02581345|559237856|FG003|Part 1: up to Week 16|Adverse Event|0|||
154948675|NCT02581345|559237853|FG000|Part 1: up to Week 16|Physician Decision|2|||
154948676|NCT02581345|559237854|FG001|Part 1: up to Week 16|Physician Decision|4|||
154948677|NCT02581345|559237855|FG002|Part 1: up to Week 16|Physician Decision|0|||
154948678|NCT02581345|559237856|FG003|Part 1: up to Week 16|Physician Decision|0|||
154948679|NCT02581345|559237853|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
154948680|NCT02581345|559237854|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
154948681|NCT02581345|559237855|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
154948682|NCT02581345|559237856|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
154948683|NCT02581345|559237853|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
154948684|NCT02581345|559237854|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
154948685|NCT02581345|559237855|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
154948686|NCT02581345|559237856|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
154948687|NCT02581345|559237853|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
154948688|NCT02581345|559237854|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
154948689|NCT02581345|559237855|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
154948690|NCT02581345|559237856|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
154948691|NCT02581345|559237853|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
154948692|NCT02581345|559237854|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
154948693|NCT02581345|559237855|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
154948694|NCT02581345|559237856|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
154948695|NCT02581345|559237853|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
154948696|NCT02581345|559237854|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
154948697|NCT02581345|559237855|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
155390853|NCT02673619|560865899|FG002|Overall Study|Lack of Efficacy|1|||
155390854|NCT02673619|560865900|FG003|Overall Study|Lack of Efficacy|0|||
154948698|NCT02581345|559237856|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
154948699|NCT02581345|559237853|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
154948700|NCT02581345|559237854|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
154948701|NCT02581345|559237855|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
154948702|NCT02581345|559237856|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
154948703|NCT02581345|559237853|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
154948704|NCT02581345|559237854|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
155051010|NCT00325819|559617847|FG001|Overall Study|Did not take a dose of study product|9|||
155390855|NCT03444324|560865901|FG000|Overall Study|Withdrawal by Subject|0|||
155390856|NCT03444324|560865902|FG001|Overall Study|Withdrawal by Subject|1|||
154948705|NCT02581345|559237855|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
154948706|NCT02581345|559237856|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
154948707|NCT02581345|559237853|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
155051011|NCT00325819|559617846|FG000|Overall Study|Lost to Follow-up|3|||
155051012|NCT00325819|559617847|FG001|Overall Study|Lost to Follow-up|3|||
155051013|NCT02058589|559617849|FG000|Overall Study|Serious Adverse Event|1|||
155051014|NCT02058589|559617850|FG001|Overall Study|Serious Adverse Event|1|||
155051015|NCT02058589|559617849|FG000|Overall Study|Non-Serious Adverse Event|1|||
155051016|NCT02058589|559617850|FG001|Overall Study|Non-Serious Adverse Event|0|||
155051017|NCT02058589|559617849|FG000|Overall Study|Withdrawal by Subject|0|||
155051018|NCT02058589|559617850|FG001|Overall Study|Withdrawal by Subject|1|||
155051019|NCT00419757|559619565|FG000|Overall Study|Adverse Event|1|||
155051020|NCT00419757|559619566|FG001|Overall Study|Adverse Event|4|||
155051021|NCT00419757|559619565|FG000|Overall Study|Lost to Follow-up|1|||
155051022|NCT00419757|559619566|FG001|Overall Study|Lost to Follow-up|4|||
155051023|NCT00419757|559619565|FG000|Overall Study|Withdrawal by Subject|7|||
155051024|NCT00419757|559619566|FG001|Overall Study|Withdrawal by Subject|1|||
155051025|NCT00419757|559619565|FG000|Overall Study|Protocol Violation|2|||
155051026|NCT00419757|559619566|FG001|Overall Study|Protocol Violation|3|||
155051027|NCT00419757|559619565|FG000|Overall Study|Study specific discontinuation criteria|4|||
155051028|NCT00419757|559619566|FG001|Overall Study|Study specific discontinuation criteria|8|||
155051029|NCT00419757|559619565|FG000|Overall Study|Multiple reasons|3|||
155051030|NCT00419757|559619566|FG001|Overall Study|Multiple reasons|1|||
155390857|NCT03444324|560865901|FG000|Overall Study|Lost to Follow-up|4|||
155390858|NCT03444324|560865902|FG001|Overall Study|Lost to Follow-up|2|||
155390859|NCT03444324|560865901|FG000|Overall Study|Protocol Violation|0|||
155390860|NCT03444324|560865902|FG001|Overall Study|Protocol Violation|1|||
155390861|NCT03444324|560865901|FG000|Overall Study|Lack of Trial Compliance|1|||
155390862|NCT03444324|560865902|FG001|Overall Study|Lack of Trial Compliance|1|||
155390863|NCT03444324|560865901|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
155390864|NCT03444324|560865902|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
155390865|NCT06071754|560865906|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
155390866|NCT00234494|560867839|FG000|Overall Study|Protocol Violation|2|||
155390867|NCT00293722|560867842|FG000|Overall Study|Other|427|||
155390868|NCT04498169|560867846|FG000|Study Completion|Adverse Event|1|||
155390869|NCT04498169|560867847|FG001|Study Completion|Adverse Event|1|||
155390870|NCT06069778|560867848|FG000|Overall Study|Withdrawal by Subject|1|||
155390871|NCT03801902|560867849|FG000|Overall Study|Did not receive protocol treatment.|1|||
155390872|NCT03801902|560867850|FG001|Overall Study|Did not receive protocol treatment.|0|||
155390873|NCT03801902|560867851|FG002|Overall Study|Did not receive protocol treatment.|0|||
155390874|NCT03801902|560867852|FG003|Overall Study|Did not receive protocol treatment.|0|||
155390875|NCT02260882|560867853|FG000|Overall Study|Protocol Violation|0|||
155390876|NCT02260882|560867854|FG001|Overall Study|Protocol Violation|1|||
155390877|NCT02119325|560867855|FG000|Washout Period 1|Adverse Event|0|||
155390878|NCT02119325|560867856|FG001|Washout Period 1|Adverse Event|1|||
155390879|NCT00954174|560867865|FG000|Overall Study|Adverse Event|28|||
155390880|NCT00954174|560867866|FG001|Overall Study|Adverse Event|23|||
155390881|NCT00954174|560867867|FG002|Overall Study|Adverse Event|4|||
155390882|NCT00954174|560867868|FG003|Overall Study|Adverse Event|9|||
155390883|NCT00954174|560867865|FG000|Overall Study|Death|4|||
155390884|NCT00954174|560867866|FG001|Overall Study|Death|2|||
155390885|NCT00954174|560867867|FG002|Overall Study|Death|0|||
155390886|NCT00954174|560867868|FG003|Overall Study|Death|0|||
155390887|NCT00954174|560867865|FG000|Overall Study|Lack of Efficacy|32|||
155390888|NCT00954174|560867866|FG001|Overall Study|Lack of Efficacy|22|||
155390889|NCT00954174|560867867|FG002|Overall Study|Lack of Efficacy|8|||
155390890|NCT00954174|560867868|FG003|Overall Study|Lack of Efficacy|6|||
155390891|NCT00954174|560867865|FG000|Overall Study|Withdrawal by Subject|14|||
155390892|NCT00954174|560867866|FG001|Overall Study|Withdrawal by Subject|10|||
155390893|NCT00954174|560867867|FG002|Overall Study|Withdrawal by Subject|4|||
155390894|NCT00954174|560867868|FG003|Overall Study|Withdrawal by Subject|3|||
155390895|NCT00954174|560867865|FG000|Overall Study|Medical Reason|4|||
155390896|NCT00954174|560867866|FG001|Overall Study|Medical Reason|2|||
155390897|NCT00954174|560867867|FG002|Overall Study|Medical Reason|1|||
155051031|NCT01051921|559619567|FG000|Overall Study|Physician Decision|9|||
155051032|NCT01051921|559619567|FG000|Overall Study|Adverse Event|8|||
155390898|NCT00954174|560867868|FG003|Overall Study|Medical Reason|0|||
155390899|NCT00954174|560867865|FG000|Overall Study|Ineligible|40|||
155390900|NCT00954174|560867866|FG001|Overall Study|Ineligible|47|||
155051033|NCT01051921|559619567|FG000|Overall Study|Withdrawal by Subject|7|||
155051034|NCT01051921|559619567|FG000|Overall Study|Lost to Follow-up|4|||
155051035|NCT01051921|559619567|FG000|Overall Study|virological failure|1|||
155051036|NCT01051921|559619567|FG000|Overall Study|patient moved|1|||
155051037|NCT00379834|559619572|FG000|Overall Study|Time constraints|2|||
155390901|NCT00954174|560867867|FG002|Overall Study|Ineligible|7|||
155390902|NCT00954174|560867868|FG003|Overall Study|Ineligible|4|||
155390903|NCT00954174|560867865|FG000|Overall Study|Never Treated|4|||
155390904|NCT00954174|560867866|FG001|Overall Study|Never Treated|17|||
155390905|NCT00954174|560867867|FG002|Overall Study|Never Treated|0|||
155390906|NCT00954174|560867868|FG003|Overall Study|Never Treated|3|||
155390907|NCT02234323|560867869|FG000|All Enrolled|Not Treated: Completed study in database|2|||
155282030|NCT02459964|560463992|FG000|Overall Study|Withdrawal by Subject|0|||
155282031|NCT02459964|560463993|FG001|Overall Study|Withdrawal by Subject|0|||
155282032|NCT02459964|560463994|FG002|Overall Study|Withdrawal by Subject|1|||
155282033|NCT02459964|560463992|FG000|Overall Study|Abnormal EKG changes|0|||
155282034|NCT02459964|560463993|FG001|Overall Study|Abnormal EKG changes|0|||
155282035|NCT02459964|560463994|FG002|Overall Study|Abnormal EKG changes|1|||
155282036|NCT02256969|560464002|FG000|Overall Study|Screenfailed or withdrew|2|||
155282037|NCT02256969|560464003|FG001|Overall Study|Screenfailed or withdrew|1|||
155282038|NCT02256969|560464004|FG002|Overall Study|Screenfailed or withdrew|1|||
154948708|NCT02581345|559237854|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
154948709|NCT02581345|559237855|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
154948710|NCT02581345|559237856|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
154948711|NCT02581345|559237853|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
155282039|NCT01427907|560464008|FG000|Overall Study|Withdrawal by Subject|3|||
155282040|NCT01427907|560464009|FG001|Overall Study|Withdrawal by Subject|4|||
155282041|NCT01813422|560464013|FG000|Overall Study|Withdrawal by Subject|14|||
155282042|NCT01813422|560464014|FG001|Overall Study|Withdrawal by Subject|8|||
155282043|NCT01813422|560464013|FG000|Overall Study|Death|2|||
155282044|NCT01813422|560464014|FG001|Overall Study|Death|3|||
155282045|NCT01813422|560464013|FG000|Overall Study|Sponsor Decision|2|||
155282046|NCT01813422|560464014|FG001|Overall Study|Sponsor Decision|1|||
154948712|NCT02581345|559237854|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
154948713|NCT02581345|559237855|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
154948714|NCT02581345|559237856|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
154948715|NCT02581345|559237853|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
154948716|NCT02581345|559237854|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
154948717|NCT02581345|559237855|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
154948718|NCT02581345|559237856|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
154948719|NCT00502775|559237857|FG000|Overall Study|Adverse Event|1|||
154948720|NCT00502775|559237858|FG001|Overall Study|Adverse Event|2|||
155282047|NCT01813422|560464013|FG000|Overall Study|Lost to Follow-up|2|||
155282048|NCT01813422|560464014|FG001|Overall Study|Lost to Follow-up|4|||
155282049|NCT02015195|560464015|FG000|Overall Study|Adverse Event|0|||
155282050|NCT02015195|560464016|FG001|Overall Study|Adverse Event|0|||
155282051|NCT02015195|560464017|FG002|Overall Study|Adverse Event|0|||
155390908|NCT02234323|560867869|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
155390909|NCT02234323|560867869|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
155390910|NCT02234323|560867869|FG000|All Treated|Death|1|||
155390911|NCT02234323|560867869|FG000|All Treated|Physician Decision|5|||
155390912|NCT02234323|560867869|FG000|All Treated|Lack of Efficacy|3|||
155390913|NCT02234323|560867869|FG000|All Treated|Exceeded lab value limit|2|||
155390914|NCT02234323|560867869|FG000|All Treated|Other|7|||
155390915|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
155390916|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
155390917|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
155390918|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
155390919|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
155390920|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
155390921|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
154948721|NCT00502775|559237859|FG002|Overall Study|Adverse Event|1|||
154948722|NCT00502775|559237857|FG000|Overall Study|Protocol Violation|1|||
154948723|NCT00502775|559237858|FG001|Overall Study|Protocol Violation|5|||
154948724|NCT00502775|559237859|FG002|Overall Study|Protocol Violation|2|||
154948725|NCT00502775|559237857|FG000|Overall Study|Withdrawal by Subject|1|||
154948726|NCT00502775|559237858|FG001|Overall Study|Withdrawal by Subject|1|||
154948727|NCT00502775|559237859|FG002|Overall Study|Withdrawal by Subject|2|||
154948728|NCT00502775|559237857|FG000|Overall Study|Sponsor Terminated Study|1|||
154948729|NCT00502775|559237858|FG001|Overall Study|Sponsor Terminated Study|0|||
154948730|NCT00502775|559237859|FG002|Overall Study|Sponsor Terminated Study|1|||
154948731|NCT00502775|559237857|FG000|Overall Study|Non-compliance with eDiary|4|||
154948732|NCT00502775|559237858|FG001|Overall Study|Non-compliance with eDiary|1|||
154948733|NCT00502775|559237859|FG002|Overall Study|Non-compliance with eDiary|1|||
154948734|NCT00502775|559237857|FG000|Overall Study|Subject unable to swallow capsule|1|||
154948735|NCT00502775|559237858|FG001|Overall Study|Subject unable to swallow capsule|0|||
154948736|NCT00502775|559237859|FG002|Overall Study|Subject unable to swallow capsule|1|||
154948737|NCT00502775|559237857|FG000|Overall Study|Logpad compliance <80%|1|||
154948738|NCT00502775|559237858|FG001|Overall Study|Logpad compliance <80%|0|||
154948739|NCT00502775|559237859|FG002|Overall Study|Logpad compliance <80%|0|||
154948740|NCT00502775|559237857|FG000|Overall Study|Randomized in error|0|||
155282052|NCT02015195|560464018|FG003|Overall Study|Adverse Event|1|||
155282053|NCT02015195|560464019|FG004|Overall Study|Adverse Event|0|||
155282054|NCT02015195|560464020|FG005|Overall Study|Adverse Event|0|||
155282055|NCT02015195|560464021|FG006|Overall Study|Adverse Event|0|||
155282056|NCT02303574|560464029|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155390922|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
155390923|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Death|1|||
155390924|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Death|1|||
155390925|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
155390926|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
155390927|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
155390928|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
155390929|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
155390930|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
155390931|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
155390932|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
155390933|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
155390934|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
155390935|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
155390936|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
155390937|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
155390938|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
155390939|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
155390940|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
155390941|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
155390942|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
155390943|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
155390944|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
155390945|NCT00559585|560867870|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
155390946|NCT00559585|560867871|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
155390947|NCT00559585|560867870|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
155390948|NCT00559585|560867871|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
155390949|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
155390950|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
155390951|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
155390952|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
155390953|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
155390954|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
155390955|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
155390956|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
155390957|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
155390958|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
155390959|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
155390960|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
155390961|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
155390962|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
155390963|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
155390964|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
155390965|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
155390966|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
155390967|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
155390968|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
155390969|NCT00559585|560867870|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
155390970|NCT00559585|560867871|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
155390971|NCT04209621|560867872|FG000|Overall Study|Death|1|||
155390972|NCT04209621|560867872|FG000|Overall Study|Study Terminated Early|2|||
155390973|NCT02249767|560867873|FG000|Overall Study|Did not use medication|8|||
155390974|NCT02249767|560867874|FG001|Overall Study|Did not use medication|9|||
155390975|NCT02249767|560867875|FG002|Overall Study|Did not use medication|8|||
155390976|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
155390977|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
155390978|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390979|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390980|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
155390981|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390982|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390983|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
155390984|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390985|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
155390986|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390987|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390988|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390989|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390990|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
155390991|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
155390992|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390993|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390994|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390995|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390996|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
155390997|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390998|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155390999|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155391000|NCT01372410|560867876|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391001|NCT01372410|560867877|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391002|NCT01372410|560867878|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391003|NCT01372410|560867879|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391004|NCT01372410|560867880|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391005|NCT01372410|560867881|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391006|NCT01372410|560867882|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
155391007|NCT01372410|560867883|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
155391008|NCT01372410|560867876|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
155391009|NCT01372410|560867877|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391010|NCT01372410|560867878|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391011|NCT01372410|560867879|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391012|NCT01372410|560867880|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391013|NCT01372410|560867881|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391014|NCT01372410|560867882|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
155391015|NCT01372410|560867883|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
155391016|NCT01372410|560867876|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391017|NCT01372410|560867877|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391018|NCT01372410|560867878|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391019|NCT01372410|560867879|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391020|NCT01372410|560867880|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
155391021|NCT01372410|560867881|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391022|NCT01372410|560867882|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391023|NCT01372410|560867883|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
155391024|NCT01372410|560867876|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391025|NCT01372410|560867877|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391026|NCT01372410|560867878|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391027|NCT01372410|560867879|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391028|NCT01372410|560867880|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
155391029|NCT01372410|560867881|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
155391030|NCT01372410|560867882|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
155391031|NCT01372410|560867883|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
155391032|NCT01372410|560867876|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391033|NCT01372410|560867877|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391034|NCT01372410|560867878|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391035|NCT01372410|560867879|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391036|NCT01372410|560867880|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391037|NCT01372410|560867881|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391038|NCT01372410|560867882|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
155391039|NCT01372410|560867883|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
155391040|NCT01372410|560867876|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391041|NCT01372410|560867877|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391042|NCT01372410|560867878|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
155391043|NCT01372410|560867879|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391044|NCT01372410|560867880|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391045|NCT01372410|560867881|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391046|NCT01372410|560867882|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391047|NCT01372410|560867883|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
155391048|NCT01372410|560867876|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391049|NCT01372410|560867877|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391050|NCT01372410|560867878|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391051|NCT01372410|560867879|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391052|NCT01372410|560867880|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391053|NCT01372410|560867881|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
155391054|NCT01372410|560867882|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391055|NCT01372410|560867883|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
155391056|NCT02644941|560867884|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
155391057|NCT02644941|560867885|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
155391058|NCT04585646|560867886|FG000|First Intervention|Physician Decision|1|||
155391059|NCT04585646|560867887|FG001|First Intervention|Physician Decision|0|||
155391060|NCT04585646|560867886|FG000|First Intervention|Lost to Follow-up|0|||
155391061|NCT04585646|560867887|FG001|First Intervention|Lost to Follow-up|3|||
155391062|NCT04585646|560867886|FG000|First Intervention|Withdrawal by Subject|0|||
155391063|NCT04585646|560867887|FG001|First Intervention|Withdrawal by Subject|1|||
155391064|NCT01145495|560867888|FG000|Overall Study|Adverse Event|6|||
155391065|NCT01145495|560867888|FG000|Overall Study|Withdrawal by Subject|6|||
155391066|NCT01145495|560867888|FG000|Overall Study|Disease progression after respone|2|||
155391067|NCT01886313|560867891|FG000|Overall Study|Adverse Event|1|||
155391068|NCT01886313|560867892|FG001|Overall Study|Adverse Event|1|||
155391069|NCT03294109|560867899|FG000|Overall Study|Withdrawal by Subject|6|||
155391070|NCT03294109|560867900|FG001|Overall Study|Withdrawal by Subject|5|||
155391071|NCT01717768|560867903|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391072|NCT01717768|560867904|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
155391073|NCT01717768|560867905|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391074|NCT01717768|560867906|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391075|NCT01717768|560867907|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391076|NCT01717768|560867908|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391077|NCT01717768|560867909|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391078|NCT01717768|560867910|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391079|NCT01717768|560867911|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391080|NCT01717768|560867912|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391081|NCT01717768|560867913|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391082|NCT01717768|560867914|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
155391083|NCT01717768|560867903|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391084|NCT01717768|560867904|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391085|NCT01717768|560867905|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391086|NCT01717768|560867906|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391087|NCT01717768|560867907|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391088|NCT01717768|560867908|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391089|NCT01717768|560867909|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391090|NCT01717768|560867910|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391091|NCT01717768|560867911|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391092|NCT01717768|560867912|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391093|NCT01717768|560867913|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
155391094|NCT01717768|560867914|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
155391095|NCT01717768|560867903|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391096|NCT01717768|560867904|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391097|NCT01717768|560867905|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391098|NCT01717768|560867906|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391099|NCT01717768|560867907|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391100|NCT01717768|560867908|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391101|NCT01717768|560867909|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391102|NCT01717768|560867910|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
155391103|NCT01717768|560867911|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391104|NCT01717768|560867912|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391105|NCT01717768|560867913|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391106|NCT01717768|560867914|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
155391107|NCT01717768|560867903|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391108|NCT01717768|560867904|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
154948741|NCT00502775|559237858|FG001|Overall Study|Randomized in error|1|||
154948742|NCT00502775|559237859|FG002|Overall Study|Randomized in error|1|||
154948743|NCT00502775|559237857|FG000|Overall Study|Non-compliance|0|||
154948744|NCT00502775|559237858|FG001|Overall Study|Non-compliance|2|||
154948745|NCT00502775|559237859|FG002|Overall Study|Non-compliance|2|||
154948746|NCT00502775|559237857|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
154948747|NCT00502775|559237858|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
154948748|NCT00502775|559237859|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
154948749|NCT00502775|559237857|FG000|Overall Study|Declining pollen counts|0|||
154948750|NCT00502775|559237858|FG001|Overall Study|Declining pollen counts|1|||
154948751|NCT00502775|559237859|FG002|Overall Study|Declining pollen counts|1|||
155391109|NCT01717768|560867905|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391110|NCT01717768|560867906|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391111|NCT01717768|560867907|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
154948752|NCT00502775|559237857|FG000|Overall Study|Subject in jail|0|||
155391112|NCT01717768|560867908|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391113|NCT01717768|560867909|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391114|NCT01717768|560867910|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391115|NCT01717768|560867911|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391116|NCT01717768|560867912|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
155051038|NCT01325350|559619575|FG000|Overall Study|Adverse Event|3|||
155051039|NCT01325350|559619576|FG001|Overall Study|Adverse Event|3|||
155051040|NCT01325350|559619577|FG002|Overall Study|Adverse Event|3|||
155051041|NCT01325350|559619578|FG003|Overall Study|Adverse Event|1|||
155051042|NCT01325350|559619579|FG004|Overall Study|Adverse Event|2|||
155051043|NCT01325350|559619575|FG000|Overall Study|Pregnancy|0|||
155051044|NCT01325350|559619576|FG001|Overall Study|Pregnancy|0|||
155051045|NCT01325350|559619577|FG002|Overall Study|Pregnancy|1|||
155051046|NCT01325350|559619578|FG003|Overall Study|Pregnancy|0|||
155051047|NCT01325350|559619579|FG004|Overall Study|Pregnancy|1|||
155051048|NCT01325350|559619575|FG000|Overall Study|Lost to Follow-up|1|||
155051049|NCT01325350|559619576|FG001|Overall Study|Lost to Follow-up|0|||
155051050|NCT01325350|559619577|FG002|Overall Study|Lost to Follow-up|5|||
155051051|NCT01325350|559619578|FG003|Overall Study|Lost to Follow-up|1|||
155051052|NCT01325350|559619579|FG004|Overall Study|Lost to Follow-up|5|||
155051053|NCT01325350|559619575|FG000|Overall Study|Personal Reasons|2|||
155051054|NCT01325350|559619576|FG001|Overall Study|Personal Reasons|1|||
155051055|NCT01325350|559619577|FG002|Overall Study|Personal Reasons|6|||
155051056|NCT01325350|559619578|FG003|Overall Study|Personal Reasons|5|||
155051057|NCT01325350|559619579|FG004|Overall Study|Personal Reasons|3|||
155051058|NCT01325350|559619575|FG000|Overall Study|Protocol Violation|0|||
155051059|NCT01325350|559619576|FG001|Overall Study|Protocol Violation|0|||
155051060|NCT01325350|559619577|FG002|Overall Study|Protocol Violation|0|||
155051061|NCT01325350|559619578|FG003|Overall Study|Protocol Violation|1|||
155051062|NCT01325350|559619579|FG004|Overall Study|Protocol Violation|0|||
155051063|NCT01325350|559619575|FG000|Overall Study|Withdrawal by Subject|0|||
155051064|NCT01325350|559619576|FG001|Overall Study|Withdrawal by Subject|0|||
155051065|NCT01325350|559619577|FG002|Overall Study|Withdrawal by Subject|1|||
155391117|NCT01717768|560867913|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391118|NCT01717768|560867914|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
155391119|NCT00448435|560867915|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
155391120|NCT00448435|560867916|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155391121|NCT04195581|560867919|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
155391122|NCT04195581|560867919|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
155391123|NCT04195581|560867919|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
155391124|NCT04195581|560867919|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
155391125|NCT04195581|560867919|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
155391126|NCT04195581|560867919|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
155391127|NCT00821431|560867920|FG000|Overall Study|Adverse Event|6|||
155391128|NCT00821431|560867921|FG001|Overall Study|Adverse Event|3|||
155391129|NCT00821431|560867920|FG000|Overall Study|Withdrawal by Subject|5|||
155391130|NCT00821431|560867921|FG001|Overall Study|Withdrawal by Subject|0|||
155391131|NCT00821431|560867920|FG000|Overall Study|Lost to Follow-up|1|||
155391132|NCT00821431|560867921|FG001|Overall Study|Lost to Follow-up|0|||
155391133|NCT00821431|560867920|FG000|Overall Study|Protocol Violation|3|||
155391134|NCT00821431|560867921|FG001|Overall Study|Protocol Violation|1|||
155391135|NCT00821431|560867920|FG000|Overall Study|Physician Decision|0|||
155391136|NCT00821431|560867921|FG001|Overall Study|Physician Decision|1|||
155391137|NCT01387230|560867922|FG000|Overall Study|Adverse Event|0|||
155391138|NCT01387230|560867923|FG001|Overall Study|Adverse Event|1|||
155391139|NCT01387230|560867924|FG002|Overall Study|Adverse Event|3|||
155391140|NCT01387230|560867922|FG000|Overall Study|Lack of Efficacy|8|||
155391141|NCT01387230|560867923|FG001|Overall Study|Lack of Efficacy|5|||
155391142|NCT01387230|560867924|FG002|Overall Study|Lack of Efficacy|4|||
155391143|NCT01387230|560867922|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
155391144|NCT01387230|560867923|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
155391145|NCT01387230|560867924|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
155391146|NCT01387230|560867922|FG000|Overall Study|Lost to Follow-up|0|||
155391147|NCT01387230|560867923|FG001|Overall Study|Lost to Follow-up|0|||
155391148|NCT01387230|560867924|FG002|Overall Study|Lost to Follow-up|1|||
155391149|NCT01387230|560867922|FG000|Overall Study|Withdrawal by Subject|4|||
155391150|NCT01387230|560867923|FG001|Overall Study|Withdrawal by Subject|1|||
155391151|NCT01387230|560867924|FG002|Overall Study|Withdrawal by Subject|0|||
155391152|NCT01182766|560867930|FG000|Overall Study|Lost to Follow-up|32|||
155051066|NCT01325350|559619578|FG003|Overall Study|Withdrawal by Subject|1|||
155051067|NCT01325350|559619579|FG004|Overall Study|Withdrawal by Subject|0|||
155051068|NCT01325350|559619575|FG000|Overall Study|Did Not Receive Treatment|0|||
155051069|NCT01325350|559619576|FG001|Overall Study|Did Not Receive Treatment|1|||
155051070|NCT01325350|559619577|FG002|Overall Study|Did Not Receive Treatment|1|||
155051071|NCT01325350|559619578|FG003|Overall Study|Did Not Receive Treatment|0|||
155391153|NCT01182766|560867931|FG001|Overall Study|Lost to Follow-up|36|||
155391154|NCT01182766|560867932|FG002|Overall Study|Lost to Follow-up|29|||
155391155|NCT01182766|560867930|FG000|Overall Study|Withdrawal by Subject|14|||
155391156|NCT01182766|560867931|FG001|Overall Study|Withdrawal by Subject|3|||
155391157|NCT01182766|560867932|FG002|Overall Study|Withdrawal by Subject|6|||
155391158|NCT01182766|560867930|FG000|Overall Study|Physician Decision|1|||
155391159|NCT01182766|560867931|FG001|Overall Study|Physician Decision|0|||
155391160|NCT01182766|560867932|FG002|Overall Study|Physician Decision|0|||
155391161|NCT01182766|560867930|FG000|Overall Study|Non-compliance|1|||
155391162|NCT01182766|560867931|FG001|Overall Study|Non-compliance|1|||
155391163|NCT01182766|560867932|FG002|Overall Study|Non-compliance|1|||
155391164|NCT01009554|560867935|FG000|Overall Study|Adverse Event|1|||
155391165|NCT01009554|560867936|FG001|Overall Study|Adverse Event|1|||
155391166|NCT01009554|560867935|FG000|Overall Study|Withdrawal by Subject|1|||
155391167|NCT01009554|560867936|FG001|Overall Study|Withdrawal by Subject|3|||
155391168|NCT01009554|560867935|FG000|Overall Study|Noncompliant with Study Product|0|||
155391169|NCT01009554|560867936|FG001|Overall Study|Noncompliant with Study Product|3|||
155391170|NCT01605253|560867937|FG000|Overall Study|Physician Decision|3|||
155391171|NCT01605253|560867938|FG001|Overall Study|Physician Decision|2|||
155391172|NCT01605253|560867937|FG000|Overall Study|Lost to Follow-up|3|||
155391173|NCT01605253|560867938|FG001|Overall Study|Lost to Follow-up|1|||
155391174|NCT02554903|560867939|FG000|Overall Study|Death|1|||
155391175|NCT02554903|560867940|FG001|Overall Study|Death|1|||
155391176|NCT02554903|560867939|FG000|Overall Study|Physician Decision|2|||
155391177|NCT02554903|560867940|FG001|Overall Study|Physician Decision|2|||
155391178|NCT02554903|560867939|FG000|Overall Study|Heart Transplant|1|||
155391179|NCT02554903|560867940|FG001|Overall Study|Heart Transplant|2|||
155391180|NCT02973048|560867941|FG000|Overall Study|Epidural catheter insertion failure|1|||
155391181|NCT02973048|560867942|FG001|Overall Study|Epidural catheter insertion failure|0|||
155391182|NCT02973048|560867941|FG000|Overall Study|Withdrawal by Subject|0|||
155391183|NCT02973048|560867942|FG001|Overall Study|Withdrawal by Subject|3|||
155391184|NCT04427501|560867946|FG000|Overall Study|Death|0|||
155391185|NCT04427501|560867947|FG001|Overall Study|Death|0|||
155391186|NCT04427501|560867948|FG002|Overall Study|Death|0|||
155391187|NCT04427501|560867949|FG003|Overall Study|Death|0|||
155391188|NCT04427501|560867950|FG004|Overall Study|Death|0|||
155391189|NCT04427501|560867951|FG005|Overall Study|Death|15|||
155391190|NCT04427501|560867952|FG006|Overall Study|Death|0|||
155391191|NCT04427501|560867953|FG007|Overall Study|Death|0|||
155391192|NCT04427501|560867954|FG008|Overall Study|Death|0|||
154948753|NCT00502775|559237858|FG001|Overall Study|Subject in jail|1|||
154948754|NCT00502775|559237859|FG002|Overall Study|Subject in jail|0|||
154948755|NCT00502775|559237857|FG000|Overall Study|Subject took disallowed drug|0|||
154948756|NCT00502775|559237858|FG001|Overall Study|Subject took disallowed drug|0|||
154948757|NCT00502775|559237859|FG002|Overall Study|Subject took disallowed drug|1|||
154948758|NCT04373434|559237863|FG000|Overall Study|Lost to Follow-up|37|||
154948759|NCT04373434|559237864|FG001|Overall Study|Lost to Follow-up|32|||
154948760|NCT04373434|559237863|FG000|Overall Study|Refused at 9 months|1|||
154948761|NCT04373434|559237864|FG001|Overall Study|Refused at 9 months|2|||
154948762|NCT04373434|559237863|FG000|Overall Study|Refused at 4 months|7|||
154948763|NCT04373434|559237864|FG001|Overall Study|Refused at 4 months|3|||
154948764|NCT04373434|559237863|FG000|Overall Study|Excluded|2|||
154948765|NCT04373434|559237864|FG001|Overall Study|Excluded|0|||
154948766|NCT00527423|559237865|FG000|Overall Study|Protocol Violation|1|||
154948767|NCT00527423|559237865|FG000|Overall Study|Adverse Event|5|||
154948768|NCT00527423|559237865|FG000|Overall Study|Physician Decision|4|||
154948769|NCT00527423|559237865|FG000|Overall Study|Withdrawal by Subject|10|||
154948770|NCT00527423|559237865|FG000|Overall Study|Lost to Follow-up|4|||
154948771|NCT00527423|559237865|FG000|Overall Study|OTHER|4|||
154948772|NCT00527423|559237865|FG000|Overall Study|Death|9|||
154948773|NCT03702621|559237866|FG000|Overall Study|Physician Decision|6|||
154948774|NCT03702621|559237867|FG001|Overall Study|Physician Decision|6|||
154948775|NCT03194464|559237870|FG000|Overall Study|data not usable|2|||
154948776|NCT03444038|559237871|FG000|Overall Study|Adverse Event|12|||
154948777|NCT03444038|559237871|FG000|Overall Study|Withdrawal by Subject|7|||
154948778|NCT03444038|559237871|FG000|Overall Study|Lost to Follow-up|1|||
155391193|NCT04427501|560867955|FG009|Overall Study|Death|0|||
155391194|NCT04427501|560867956|FG010|Overall Study|Death|0|||
155391195|NCT04427501|560867957|FG011|Overall Study|Death|0|||
154948779|NCT03444038|559237871|FG000|Overall Study|Physician Decision|2|||
154948780|NCT03444038|559237871|FG000|Overall Study|Lack of Efficacy|7|||
154948781|NCT02354586|559237874|FG000|Overall Study|Death|230|||
155391196|NCT04427501|560867946|FG000|Overall Study|Lost to Follow-up|5|||
155391197|NCT04427501|560867947|FG001|Overall Study|Lost to Follow-up|1|||
155391198|NCT04427501|560867948|FG002|Overall Study|Lost to Follow-up|2|||
154948782|NCT02354586|559237874|FG000|Overall Study|Withdrawal by Subject|59|||
154948783|NCT02354586|559237874|FG000|Overall Study|Lost to Follow-up|11|||
154948784|NCT02354586|559237874|FG000|Overall Study|Sponsor decision|51|||
154948785|NCT02354586|559237874|FG000|Overall Study|Site closure|2|||
155391199|NCT04427501|560867949|FG003|Overall Study|Lost to Follow-up|0|||
155391200|NCT04427501|560867950|FG004|Overall Study|Lost to Follow-up|2|||
155391201|NCT04427501|560867951|FG005|Overall Study|Lost to Follow-up|11|||
154948786|NCT02354586|559237874|FG000|Overall Study|Intercurrent illness|1|||
154948787|NCT02354586|559237874|FG000|Overall Study|Protocol Violation|3|||
154948788|NCT02354586|559237874|FG000|Overall Study|Physician Decision|13|||
154948789|NCT02354586|559237874|FG000|Overall Study|Lack of Efficacy|86|||
154948790|NCT02354586|559237874|FG000|Overall Study|Adverse Event|7|||
154948791|NCT00721409|559237877|FG000|Overall Study|Global deterioration of health status|2|||
154948792|NCT00721409|559237878|FG001|Overall Study|Global deterioration of health status|6|||
154948793|NCT00721409|559237879|FG002|Overall Study|Global deterioration of health status|3|||
154948794|NCT00721409|559237877|FG000|Overall Study|Death|0|||
154948795|NCT00721409|559237878|FG001|Overall Study|Death|1|||
154948796|NCT00721409|559237879|FG002|Overall Study|Death|0|||
154948797|NCT00721409|559237877|FG000|Overall Study|Randomized not Treated|0|||
154948798|NCT00721409|559237878|FG001|Overall Study|Randomized not Treated|1|||
154948799|NCT00721409|559237879|FG002|Overall Study|Randomized not Treated|4|||
154948800|NCT00721409|559237877|FG000|Overall Study|Reason not specified|1|||
154948801|NCT00721409|559237878|FG001|Overall Study|Reason not specified|0|||
154948802|NCT00721409|559237879|FG002|Overall Study|Reason not specified|2|||
154948803|NCT00721409|559237877|FG000|Overall Study|Adverse Event|0|||
154948804|NCT00721409|559237878|FG001|Overall Study|Adverse Event|13|||
154948805|NCT00721409|559237879|FG002|Overall Study|Adverse Event|2|||
154948806|NCT00721409|559237877|FG000|Overall Study|Lost to Follow-up|0|||
154948807|NCT00721409|559237878|FG001|Overall Study|Lost to Follow-up|0|||
154948808|NCT00721409|559237879|FG002|Overall Study|Lost to Follow-up|1|||
154948809|NCT00721409|559237877|FG000|Overall Study|Withdrawal by Subject|1|||
154948810|NCT00721409|559237878|FG001|Overall Study|Withdrawal by Subject|6|||
154948811|NCT00721409|559237879|FG002|Overall Study|Withdrawal by Subject|5|||
154948812|NCT00721409|559237877|FG000|Overall Study|Objective progression or relapse|8|||
154948813|NCT00721409|559237878|FG001|Overall Study|Objective progression or relapse|55|||
154948814|NCT00721409|559237879|FG002|Overall Study|Objective progression or relapse|62|||
154948815|NCT01957488|559237881|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
154948816|NCT01957488|559237882|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
154948817|NCT01957488|559237883|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
154948818|NCT01957488|559237884|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
154948819|NCT01957488|559237885|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
154948820|NCT01957488|559237886|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
154948821|NCT01957488|559237881|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
154948822|NCT01957488|559237882|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
154948823|NCT01957488|559237883|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
154948824|NCT01957488|559237884|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
154948825|NCT01957488|559237885|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
154948826|NCT01957488|559237886|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
154948827|NCT01957488|559237881|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
154948828|NCT01957488|559237882|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
154948829|NCT01957488|559237883|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
154948830|NCT01957488|559237884|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
154948831|NCT01957488|559237885|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
154948832|NCT01957488|559237886|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
154948833|NCT01957488|559237881|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
154948834|NCT01957488|559237882|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
154948835|NCT01957488|559237883|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
154948836|NCT01957488|559237884|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
154948837|NCT01957488|559237885|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
154948838|NCT01957488|559237886|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
154948839|NCT01957488|559237881|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
154948840|NCT01957488|559237882|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
154948841|NCT01957488|559237883|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
154948842|NCT01957488|559237884|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
154948843|NCT01957488|559237885|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
154948844|NCT01957488|559237886|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
154948845|NCT01957488|559237881|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
154948846|NCT01957488|559237882|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
154948847|NCT01957488|559237883|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
154948848|NCT01957488|559237884|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
154948849|NCT01957488|559237885|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
154948850|NCT01957488|559237886|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
154948851|NCT01957488|559237881|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
154948852|NCT01957488|559237882|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
154948853|NCT01957488|559237883|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
154948854|NCT01957488|559237884|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
155391202|NCT04427501|560867952|FG006|Overall Study|Lost to Follow-up|10|||
154948855|NCT01957488|559237885|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
154948856|NCT01957488|559237886|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
154948857|NCT01957488|559237881|FG000|Test Period 2 (2 Weeks)|Other|1|||
155391203|NCT04427501|560867953|FG007|Overall Study|Lost to Follow-up|10|||
155391204|NCT04427501|560867954|FG008|Overall Study|Lost to Follow-up|2|||
155391205|NCT04427501|560867955|FG009|Overall Study|Lost to Follow-up|5|||
155391206|NCT04427501|560867956|FG010|Overall Study|Lost to Follow-up|2|||
155391207|NCT04427501|560867957|FG011|Overall Study|Lost to Follow-up|0|||
155391208|NCT04427501|560867946|FG000|Overall Study|Physician Decision|0|||
155391209|NCT04427501|560867947|FG001|Overall Study|Physician Decision|3|||
155391210|NCT04427501|560867948|FG002|Overall Study|Physician Decision|0|||
155391211|NCT04427501|560867949|FG003|Overall Study|Physician Decision|0|||
155391212|NCT04427501|560867950|FG004|Overall Study|Physician Decision|0|||
155391213|NCT04427501|560867951|FG005|Overall Study|Physician Decision|0|||
155391214|NCT04427501|560867952|FG006|Overall Study|Physician Decision|2|||
155391215|NCT04427501|560867953|FG007|Overall Study|Physician Decision|0|||
155391216|NCT04427501|560867954|FG008|Overall Study|Physician Decision|0|||
155391217|NCT04427501|560867955|FG009|Overall Study|Physician Decision|0|||
155391218|NCT04427501|560867956|FG010|Overall Study|Physician Decision|0|||
155391219|NCT04427501|560867957|FG011|Overall Study|Physician Decision|0|||
155391220|NCT04427501|560867946|FG000|Overall Study|Withdrawal by Subject|9|||
155391221|NCT04427501|560867947|FG001|Overall Study|Withdrawal by Subject|2|||
155391222|NCT04427501|560867948|FG002|Overall Study|Withdrawal by Subject|2|||
155391223|NCT04427501|560867949|FG003|Overall Study|Withdrawal by Subject|3|||
155391224|NCT04427501|560867950|FG004|Overall Study|Withdrawal by Subject|7|||
155391225|NCT04427501|560867951|FG005|Overall Study|Withdrawal by Subject|25|||
155391226|NCT04427501|560867952|FG006|Overall Study|Withdrawal by Subject|15|||
155391227|NCT04427501|560867953|FG007|Overall Study|Withdrawal by Subject|7|||
155391228|NCT04427501|560867954|FG008|Overall Study|Withdrawal by Subject|4|||
155391229|NCT04427501|560867955|FG009|Overall Study|Withdrawal by Subject|1|||
155391230|NCT04427501|560867956|FG010|Overall Study|Withdrawal by Subject|4|||
155391231|NCT04427501|560867957|FG011|Overall Study|Withdrawal by Subject|0|||
155391232|NCT04427501|560867946|FG000|Overall Study|Other - as reported by the investigator|1|||
155391233|NCT04427501|560867947|FG001|Overall Study|Other - as reported by the investigator|0|||
155391234|NCT04427501|560867948|FG002|Overall Study|Other - as reported by the investigator|0|||
155391235|NCT04427501|560867949|FG003|Overall Study|Other - as reported by the investigator|0|||
155391236|NCT04427501|560867950|FG004|Overall Study|Other - as reported by the investigator|0|||
155391237|NCT04427501|560867951|FG005|Overall Study|Other - as reported by the investigator|6|||
155391238|NCT04427501|560867952|FG006|Overall Study|Other - as reported by the investigator|6|||
155391239|NCT04427501|560867953|FG007|Overall Study|Other - as reported by the investigator|0|||
155391240|NCT04427501|560867954|FG008|Overall Study|Other - as reported by the investigator|0|||
155391241|NCT04427501|560867955|FG009|Overall Study|Other - as reported by the investigator|0|||
155391242|NCT04427501|560867956|FG010|Overall Study|Other - as reported by the investigator|0|||
155391243|NCT04427501|560867957|FG011|Overall Study|Other - as reported by the investigator|0|||
155391244|NCT04427501|560867946|FG000|Overall Study|Other|0|||
155391245|NCT04427501|560867947|FG001|Overall Study|Other|0|||
155391246|NCT04427501|560867948|FG002|Overall Study|Other|0|||
155391247|NCT04427501|560867949|FG003|Overall Study|Other|0|||
155391248|NCT04427501|560867950|FG004|Overall Study|Other|0|||
155391249|NCT04427501|560867951|FG005|Overall Study|Other|0|||
155391250|NCT04427501|560867952|FG006|Overall Study|Other|0|||
155391251|NCT04427501|560867953|FG007|Overall Study|Other|0|||
155391252|NCT04427501|560867954|FG008|Overall Study|Other|0|||
155391253|NCT04427501|560867955|FG009|Overall Study|Other|0|||
155391254|NCT04427501|560867956|FG010|Overall Study|Other|0|||
155391255|NCT04427501|560867957|FG011|Overall Study|Other|1|||
155391256|NCT03170154|560867958|FG000|Overall Study|Lost to Follow-up|4|||
155391257|NCT03170154|560867958|FG000|Overall Study|Death|2|||
155391258|NCT03170154|560867958|FG000|Overall Study|Withdrawal by Subject|2|||
155051072|NCT01325350|559619579|FG004|Overall Study|Did Not Receive Treatment|1|||
155051073|NCT01716806|559619584|FG000|Overall Study|Patient withdrawal of consent|4|||
155051074|NCT01716806|559619585|FG001|Overall Study|Patient withdrawal of consent|2|||
155051075|NCT01716806|559619586|FG002|Overall Study|Patient withdrawal of consent|4|||
155391259|NCT01906346|560867959|FG000|Overall Study|AEs|1|||
155391260|NCT04936841|560867962|FG000|Overall Study|Death|1|||
155391261|NCT00639223|560867963|FG000|Overall Study|Lost to Follow-up|0|||
155391262|NCT00639223|560867964|FG001|Overall Study|Lost to Follow-up|2|||
155391263|NCT01163721|560867966|FG000|Overall Study|Adverse Event|5|||
155391264|NCT01163721|560867967|FG001|Overall Study|Adverse Event|6|||
155391265|NCT01163721|560867966|FG000|Overall Study|Withdrawal by Subject|3|||
155391266|NCT01163721|560867967|FG001|Overall Study|Withdrawal by Subject|4|||
155391267|NCT01163721|560867966|FG000|Overall Study|Lost to Follow-up|0|||
155391268|NCT01163721|560867967|FG001|Overall Study|Lost to Follow-up|1|||
155391269|NCT01163721|560867966|FG000|Overall Study|Physician Decision|0|||
155391270|NCT01163721|560867967|FG001|Overall Study|Physician Decision|1|||
155391271|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391272|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391273|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391274|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
155391275|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
155391276|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391277|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391278|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391279|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
155391280|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
155391281|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391282|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391283|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391284|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
155391285|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
155391286|NCT04484259|560867975|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391287|NCT04484259|560867976|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391288|NCT04484259|560867977|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391289|NCT04484259|560867978|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
155391290|NCT04484259|560867979|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
155391291|NCT04484259|560867975|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391292|NCT04484259|560867976|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391293|NCT04484259|560867977|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391294|NCT04484259|560867978|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
155391295|NCT04484259|560867979|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
155391296|NCT04484259|560867975|FG000|Randomized Treatment|Withdrawal by Subject|1|||
155391297|NCT04484259|560867976|FG001|Randomized Treatment|Withdrawal by Subject|0|||
155391298|NCT04484259|560867977|FG002|Randomized Treatment|Withdrawal by Subject|0|||
155391299|NCT04484259|560867978|FG003|Randomized Treatment|Withdrawal by Subject|0|||
155391300|NCT04484259|560867979|FG004|Randomized Treatment|Withdrawal by Subject|0|||
155391301|NCT03951220|560867980|FG000|Overall Study|Withdrawal by Subject|9|||
155391302|NCT03951220|560867981|FG001|Overall Study|Withdrawal by Subject|2|||
155391303|NCT03951220|560867982|FG002|Overall Study|Withdrawal by Subject|0|||
155391304|NCT04498832|560867983|FG000|Overall Study|Adverse Event|1|||
155391305|NCT04498832|560867984|FG001|Overall Study|Adverse Event|3|||
155391306|NCT04498832|560867983|FG000|Overall Study|Withdrawal by Subject|0|||
155391307|NCT04498832|560867984|FG001|Overall Study|Withdrawal by Subject|1|||
155391308|NCT06268288|560867989|FG000|Overall Study|Withdrawal by Subject|1|||
155391309|NCT06268288|560867990|FG001|Overall Study|Withdrawal by Subject|2|||
155391310|NCT02146326|560867993|FG000|Overall Study|Lost to Follow-up|3|||
155391311|NCT02146326|560867994|FG001|Overall Study|Lost to Follow-up|3|||
155391312|NCT02146326|560867995|FG002|Overall Study|Lost to Follow-up|11|||
155391313|NCT02146326|560867996|FG003|Overall Study|Lost to Follow-up|19|||
155391314|NCT02146326|560867993|FG000|Overall Study|Withdrawal by Subject|2|||
155391315|NCT02146326|560867994|FG001|Overall Study|Withdrawal by Subject|1|||
155391316|NCT02146326|560867995|FG002|Overall Study|Withdrawal by Subject|15|||
155391317|NCT02146326|560867996|FG003|Overall Study|Withdrawal by Subject|11|||
155391318|NCT02146326|560867993|FG000|Overall Study|Separated from mental health center|23|||
155391319|NCT02146326|560867994|FG001|Overall Study|Separated from mental health center|33|||
155391320|NCT02146326|560867995|FG002|Overall Study|Separated from mental health center|0|||
155391321|NCT02146326|560867996|FG003|Overall Study|Separated from mental health center|0|||
155391322|NCT02146326|560867993|FG000|Overall Study|Incarcerated|0|||
155391323|NCT02146326|560867994|FG001|Overall Study|Incarcerated|0|||
155391324|NCT02146326|560867995|FG002|Overall Study|Incarcerated|3|||
155391325|NCT02146326|560867996|FG003|Overall Study|Incarcerated|8|||
155391326|NCT02146326|560867993|FG000|Overall Study|Death|0|||
155391327|NCT02146326|560867994|FG001|Overall Study|Death|0|||
155391328|NCT02146326|560867995|FG002|Overall Study|Death|4|||
155391329|NCT02146326|560867996|FG003|Overall Study|Death|4|||
155391330|NCT02146326|560867993|FG000|Overall Study|Unable to complete interview|0|||
155391331|NCT02146326|560867994|FG001|Overall Study|Unable to complete interview|0|||
155391332|NCT02146326|560867995|FG002|Overall Study|Unable to complete interview|10|||
154948858|NCT01957488|559237882|FG001|Test Period 2 (2 Weeks)|Other|0|||
154948859|NCT01957488|559237883|FG002|Test Period 2 (2 Weeks)|Other|0|||
154948860|NCT01957488|559237884|FG003|Test Period 2 (2 Weeks)|Other|0|||
155391333|NCT02146326|560867996|FG003|Overall Study|Unable to complete interview|6|||
155391334|NCT03153111|560867997|FG000|Overall Study|Death|2|||
155391335|NCT03153111|560867998|FG001|Overall Study|Death|5|||
155391336|NCT03153111|560867997|FG000|Overall Study|Lost to Follow-up|1|||
155391337|NCT03153111|560867998|FG001|Overall Study|Lost to Follow-up|0|||
155391338|NCT03153111|560867997|FG000|Overall Study|Physician Decision|5|||
155391339|NCT03153111|560867998|FG001|Overall Study|Physician Decision|1|||
155391340|NCT03153111|560867997|FG000|Overall Study|Withdrawal by Subject|3|||
155391341|NCT03153111|560867998|FG001|Overall Study|Withdrawal by Subject|3|||
155391342|NCT05066724|560867999|FG000|Overall Study|Adverse Event|1|||
155391343|NCT05066724|560867999|FG000|Overall Study|Non-Compliance With Study Drug|5|||
155391344|NCT05066724|560867999|FG000|Overall Study|Withdrawal by Subject|6|||
155391345|NCT05066724|560867999|FG000|Overall Study|Physician Decision|2|||
155391346|NCT01313117|560868000|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
155391347|NCT01313117|560868000|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
155391348|NCT03602261|560868005|FG000|Overall Study|Adverse Event|5|||
155391349|NCT03602261|560868006|FG001|Overall Study|Adverse Event|1|||
155391350|NCT03602261|560868005|FG000|Overall Study|Physician Decision|1|||
154948861|NCT01957488|559237885|FG004|Test Period 2 (2 Weeks)|Other|0|||
154948862|NCT01957488|559237886|FG005|Test Period 2 (2 Weeks)|Other|0|||
154948863|NCT01957488|559237881|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
154948864|NCT01957488|559237882|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
154948865|NCT01957488|559237883|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
154948866|NCT01957488|559237884|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
154948867|NCT01957488|559237885|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
154948868|NCT01957488|559237886|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
154948869|NCT01957488|559237881|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
154948870|NCT01957488|559237882|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
154948871|NCT01957488|559237883|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
154948872|NCT01957488|559237884|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
154948873|NCT01957488|559237885|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
154948874|NCT01957488|559237886|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
154948875|NCT01957488|559237881|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
154948876|NCT01957488|559237882|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
154948877|NCT01957488|559237883|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
154948878|NCT01957488|559237884|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
154948879|NCT01957488|559237885|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
154948880|NCT01957488|559237886|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
154948881|NCT01957488|559237881|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
154948882|NCT01957488|559237882|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
154948883|NCT01957488|559237883|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
154948884|NCT01957488|559237884|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
154948885|NCT01957488|559237885|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
154948886|NCT01957488|559237886|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
154948887|NCT01957488|559237881|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
154948888|NCT01957488|559237882|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
154948889|NCT01957488|559237883|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
154948890|NCT01957488|559237884|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
154948891|NCT01957488|559237885|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
154948892|NCT01957488|559237886|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
154948893|NCT02402166|559237887|FG000|Overall Study|Adverse Event|2|||
154948894|NCT02402166|559237887|FG000|Overall Study|Withdrawal by Subject|2|||
154948895|NCT02402166|559237887|FG000|Overall Study|Lost to Follow-up|1|||
154948896|NCT03803943|559237894|FG000|Overall Study|Withdrawal by Subject|2|||
154948897|NCT03803943|559237895|FG001|Overall Study|Withdrawal by Subject|2|||
154948898|NCT03803943|559237896|FG002|Overall Study|Withdrawal by Subject|2|||
154948899|NCT03803943|559237897|FG003|Overall Study|Withdrawal by Subject|2|||
154948900|NCT01781286|559237898|FG000|Overall Study|Lost to Follow-up|0|||
154948901|NCT01781286|559237899|FG001|Overall Study|Lost to Follow-up|0|||
154948902|NCT01781286|559237900|FG002|Overall Study|Lost to Follow-up|0|||
154948903|NCT01781286|559237901|FG003|Overall Study|Lost to Follow-up|0|||
154948904|NCT01781286|559237902|FG004|Overall Study|Lost to Follow-up|0|||
154948905|NCT01781286|559237903|FG005|Overall Study|Lost to Follow-up|1|||
154948906|NCT01781286|559237898|FG000|Overall Study|Time Constraints|2|||
154948907|NCT01781286|559237899|FG001|Overall Study|Time Constraints|0|||
154948908|NCT01781286|559237900|FG002|Overall Study|Time Constraints|2|||
154948909|NCT01781286|559237901|FG003|Overall Study|Time Constraints|0|||
154948910|NCT01781286|559237902|FG004|Overall Study|Time Constraints|0|||
154948911|NCT01781286|559237903|FG005|Overall Study|Time Constraints|0|||
154948912|NCT01781286|559237898|FG000|Overall Study|Noncompliance|0|||
154948913|NCT01781286|559237899|FG001|Overall Study|Noncompliance|0|||
154948914|NCT01781286|559237900|FG002|Overall Study|Noncompliance|0|||
154948915|NCT01781286|559237901|FG003|Overall Study|Noncompliance|1|||
154948916|NCT01781286|559237902|FG004|Overall Study|Noncompliance|0|||
154948917|NCT01781286|559237903|FG005|Overall Study|Noncompliance|0|||
154948918|NCT00995410|559237904|FG000|Overall Study|Adverse Event|51|||
154948919|NCT00995410|559237904|FG000|Overall Study|Withdrawal by Subject|7|||
154948920|NCT00995410|559237904|FG000|Overall Study|Lost to Follow-up|2|||
154948921|NCT00995410|559237904|FG000|Overall Study|Misc|28|||
154948922|NCT02166697|559237905|FG000|Overall Study|Protocol Violation|347|||
154948923|NCT02720510|559237908|FG000|Overall Study|Study Terminated by the sponsor|2|||
154948924|NCT02720510|559237909|FG001|Overall Study|Study Terminated by the sponsor|0|||
154948925|NCT02720510|559237908|FG000|Overall Study|Adverse Event|0|||
155391351|NCT03602261|560868006|FG001|Overall Study|Physician Decision|0|||
155391352|NCT03602261|560868005|FG000|Overall Study|Withdrawal by Subject|1|||
155391353|NCT03602261|560868006|FG001|Overall Study|Withdrawal by Subject|1|||
155391354|NCT03602261|560868005|FG000|Overall Study|Lack of Efficacy|0|||
155391355|NCT03602261|560868006|FG001|Overall Study|Lack of Efficacy|1|||
155391356|NCT03602261|560868005|FG000|Overall Study|Subject moving out of state|1|||
155391357|NCT03602261|560868006|FG001|Overall Study|Subject moving out of state|0|||
155391358|NCT01306890|560869440|FG000|Overall Study|Adverse Event|2|||
155391359|NCT01306890|560869440|FG000|Overall Study|Death|1223|||
155391360|NCT01306890|560869440|FG000|Overall Study|Lost to Follow-up|58|||
155391361|NCT01306890|560869440|FG000|Overall Study|Withdrawal by Subject|88|||
155391362|NCT01306890|560869440|FG000|Overall Study|Unspecified reasons|104|||
155391363|NCT01306890|560869440|FG000|Overall Study|Study Termination|3|||
155391364|NCT01306890|560869440|FG000|Overall Study|No discontinuation documentation|41|||
155391365|NCT02217436|560869441|FG000|Overall Study|Protocol Violation|1|||
155391366|NCT02217436|560869442|FG001|Overall Study|Protocol Violation|1|||
155391367|NCT02217436|560869441|FG000|Overall Study|Incomplete data|0|||
155391368|NCT02217436|560869442|FG001|Overall Study|Incomplete data|1|||
155391369|NCT04641299|560869457|FG000|Overall Study|Adverse Event|0|||
155391370|NCT04641299|560869458|FG001|Overall Study|Adverse Event|0|||
155391371|NCT04641299|560869459|FG002|Overall Study|Adverse Event|2|||
155391372|NCT04641299|560869460|FG003|Overall Study|Adverse Event|0|||
155391373|NCT04641299|560869457|FG000|Overall Study|Lost to Follow-up|0|||
155391374|NCT04641299|560869458|FG001|Overall Study|Lost to Follow-up|1|||
155391375|NCT04641299|560869459|FG002|Overall Study|Lost to Follow-up|0|||
155391376|NCT04641299|560869460|FG003|Overall Study|Lost to Follow-up|0|||
155391377|NCT04641299|560869457|FG000|Overall Study|Withdrawal by Subject|1|||
155391378|NCT04641299|560869458|FG001|Overall Study|Withdrawal by Subject|0|||
155391379|NCT04641299|560869459|FG002|Overall Study|Withdrawal by Subject|0|||
155391380|NCT04641299|560869460|FG003|Overall Study|Withdrawal by Subject|0|||
155391381|NCT04641299|560869457|FG000|Overall Study|Reason not given|1|||
155391382|NCT04641299|560869458|FG001|Overall Study|Reason not given|0|||
155391383|NCT04641299|560869459|FG002|Overall Study|Reason not given|0|||
155391384|NCT04641299|560869460|FG003|Overall Study|Reason not given|0|||
155391385|NCT01890148|560869464|FG000|Overall Study|Adverse Event|1|||
155391386|NCT01215175|560869465|FG000|Overall Study|Lost to Follow-up|0|||
155391387|NCT01215175|560869466|FG001|Overall Study|Lost to Follow-up|1|||
155391388|NCT01215175|560869467|FG002|Overall Study|Lost to Follow-up|0|||
155391389|NCT01215175|560869468|FG003|Overall Study|Lost to Follow-up|1|||
155391390|NCT01215175|560869469|FG004|Overall Study|Lost to Follow-up|0|||
155391391|NCT01920594|560869470|FG000|Overall Study|Adverse Event|4|||
155391392|NCT01920594|560869471|FG001|Overall Study|Adverse Event|2|||
155391393|NCT01920594|560869470|FG000|Overall Study|Lost to Follow-up|1|||
155391394|NCT01920594|560869471|FG001|Overall Study|Lost to Follow-up|0|||
155391395|NCT01920594|560869470|FG000|Overall Study|Recovery|2|||
155391396|NCT01920594|560869471|FG001|Overall Study|Recovery|0|||
155391397|NCT01920594|560869470|FG000|Overall Study|Investigator discretion|0|||
155391398|NCT01920594|560869471|FG001|Overall Study|Investigator discretion|1|||
155391399|NCT00929656|560869472|FG000|Overall Study|Lost to Follow-up|0|||
155391400|NCT00929656|560869473|FG001|Overall Study|Lost to Follow-up|1|||
155391401|NCT01990534|560869474|FG000|Overall Study|Death|22|||
155391402|NCT01990534|560869474|FG000|Overall Study|Progressive disease|3|||
155391403|NCT01990534|560869474|FG000|Overall Study|Protocol Violation|1|||
155391404|NCT01990534|560869474|FG000|Overall Study|Withdrawal of Informed Consent|2|||
155391405|NCT01990534|560869474|FG000|Overall Study|Symptomatic Deterioration|1|||
155391406|NCT01990534|560869474|FG000|Overall Study|Withdrawal by Subject|3|||
155391407|NCT01990534|560869474|FG000|Overall Study|Reason not Specified|2|||
155391408|NCT01990534|560869474|FG000|Overall Study|Lost to Follow-up|1|||
155391409|NCT01831544|560869475|FG000|Overall Study|Death|1|||
155391410|NCT01831544|560869475|FG000|Overall Study|Still on original MVAD device|2|||
155391411|NCT03422172|560869476|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
155391412|NCT03422172|560869476|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
155391413|NCT03422172|560869476|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
155391414|NCT04147234|560869477|FG000|Overall Study|Clinical deterioration|0|||
155391415|NCT04147234|560869478|FG001|Overall Study|Clinical deterioration|0|||
155391416|NCT04147234|560869479|FG002|Overall Study|Clinical deterioration|1|||
155391417|NCT04147234|560869480|FG003|Overall Study|Clinical deterioration|0|||
155391418|NCT04147234|560869481|FG004|Overall Study|Clinical deterioration|0|||
155391419|NCT04147234|560869482|FG005|Overall Study|Clinical deterioration|0|||
155391420|NCT04147234|560869483|FG006|Overall Study|Clinical deterioration|0|||
155391421|NCT04147234|560869477|FG000|Overall Study|Withdrawal by Subject|0|||
155391422|NCT04147234|560869478|FG001|Overall Study|Withdrawal by Subject|1|||
155391423|NCT04147234|560869479|FG002|Overall Study|Withdrawal by Subject|1|||
155391424|NCT04147234|560869480|FG003|Overall Study|Withdrawal by Subject|0|||
155391425|NCT04147234|560869481|FG004|Overall Study|Withdrawal by Subject|0|||
155391426|NCT04147234|560869482|FG005|Overall Study|Withdrawal by Subject|0|||
155391427|NCT04147234|560869483|FG006|Overall Study|Withdrawal by Subject|0|||
155391428|NCT04147234|560869477|FG000|Overall Study|Clinical disease progression|1|||
155391429|NCT04147234|560869478|FG001|Overall Study|Clinical disease progression|3|||
155391430|NCT04147234|560869479|FG002|Overall Study|Clinical disease progression|1|||
155391431|NCT04147234|560869480|FG003|Overall Study|Clinical disease progression|1|||
155391432|NCT04147234|560869481|FG004|Overall Study|Clinical disease progression|0|||
155391433|NCT04147234|560869482|FG005|Overall Study|Clinical disease progression|1|||
155391434|NCT04147234|560869483|FG006|Overall Study|Clinical disease progression|0|||
155391435|NCT04147234|560869477|FG000|Overall Study|Objective disease progression|6|||
155391436|NCT04147234|560869478|FG001|Overall Study|Objective disease progression|4|||
155391437|NCT04147234|560869479|FG002|Overall Study|Objective disease progression|3|||
155391438|NCT04147234|560869480|FG003|Overall Study|Objective disease progression|3|||
155051076|NCT01716806|559619587|FG003|Overall Study|Patient withdrawal of consent|3|||
155051077|NCT01716806|559619588|FG004|Overall Study|Patient withdrawal of consent|2|||
155051078|NCT01716806|559619589|FG005|Overall Study|Patient withdrawal of consent|0|||
155051079|NCT01716806|559619584|FG000|Overall Study|Lost to Follow-up|3|||
155051080|NCT01716806|559619585|FG001|Overall Study|Lost to Follow-up|3|||
155051081|NCT01716806|559619586|FG002|Overall Study|Lost to Follow-up|0|||
155051082|NCT01716806|559619587|FG003|Overall Study|Lost to Follow-up|2|||
155051083|NCT01716806|559619588|FG004|Overall Study|Lost to Follow-up|1|||
155051084|NCT01716806|559619589|FG005|Overall Study|Lost to Follow-up|0|||
155051085|NCT01716806|559619584|FG000|Overall Study|Death|13|||
155051086|NCT01716806|559619585|FG001|Overall Study|Death|9|||
155051087|NCT01716806|559619586|FG002|Overall Study|Death|12|||
155051088|NCT01716806|559619587|FG003|Overall Study|Death|4|||
155051089|NCT01716806|559619588|FG004|Overall Study|Death|10|||
155051090|NCT01716806|559619589|FG005|Overall Study|Death|5|||
155051091|NCT01716806|559619584|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155051092|NCT01716806|559619585|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155051093|NCT01716806|559619586|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155051094|NCT01716806|559619587|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
155051095|NCT01716806|559619588|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
155051096|NCT01716806|559619589|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
155051097|NCT01716806|559619584|FG000|Overall Study|PI decision|0|||
155051098|NCT01716806|559619585|FG001|Overall Study|PI decision|0|||
155051099|NCT01716806|559619586|FG002|Overall Study|PI decision|0|||
155051100|NCT01716806|559619587|FG003|Overall Study|PI decision|0|||
155051101|NCT01716806|559619588|FG004|Overall Study|PI decision|1|||
155051102|NCT01716806|559619589|FG005|Overall Study|PI decision|0|||
155051103|NCT01716806|559619584|FG000|Overall Study|Change in performance status|1|||
155051104|NCT01716806|559619585|FG001|Overall Study|Change in performance status|0|||
155051105|NCT01716806|559619586|FG002|Overall Study|Change in performance status|0|||
155051106|NCT01716806|559619587|FG003|Overall Study|Change in performance status|0|||
155051107|NCT01716806|559619588|FG004|Overall Study|Change in performance status|0|||
155051108|NCT01716806|559619589|FG005|Overall Study|Change in performance status|0|||
155051109|NCT01716806|559619584|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
155051110|NCT01716806|559619585|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
155051111|NCT01716806|559619586|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
155391439|NCT04147234|560869481|FG004|Overall Study|Objective disease progression|5|||
155051112|NCT01716806|559619587|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
155051113|NCT01716806|559619588|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
155051114|NCT01716806|559619589|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
155051115|NCT01716806|559619584|FG000|Overall Study|Sponsor direction|7|||
155051116|NCT01716806|559619585|FG001|Overall Study|Sponsor direction|8|||
155051117|NCT01716806|559619586|FG002|Overall Study|Sponsor direction|5|||
155051118|NCT01716806|559619587|FG003|Overall Study|Sponsor direction|12|||
155051119|NCT01716806|559619588|FG004|Overall Study|Sponsor direction|16|||
155051120|NCT01716806|559619589|FG005|Overall Study|Sponsor direction|1|||
155051121|NCT03934216|559619590|FG000|Overall Study|Other Reasons|5|||
155051122|NCT03934216|559619591|FG001|Overall Study|Other Reasons|5|||
155051123|NCT03934216|559619590|FG000|Overall Study|Adverse Event|22|||
155051124|NCT03934216|559619591|FG001|Overall Study|Adverse Event|11|||
155051125|NCT03934216|559619590|FG000|Overall Study|Lack of Efficacy|8|||
155051126|NCT03934216|559619591|FG001|Overall Study|Lack of Efficacy|7|||
155051127|NCT03934216|559619590|FG000|Overall Study|Lost to Follow-up|2|||
155051128|NCT03934216|559619591|FG001|Overall Study|Lost to Follow-up|0|||
155051129|NCT03934216|559619590|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155051130|NCT03934216|559619591|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155051131|NCT03934216|559619590|FG000|Overall Study|Pregnancy|1|||
155391440|NCT04147234|560869482|FG005|Overall Study|Objective disease progression|2|||
155391441|NCT04147234|560869483|FG006|Overall Study|Objective disease progression|3|||
155391442|NCT04147234|560869477|FG000|Overall Study|Adverse Event|0|||
155391443|NCT04147234|560869478|FG001|Overall Study|Adverse Event|0|||
155051132|NCT03934216|559619591|FG001|Overall Study|Pregnancy|0|||
155051133|NCT03934216|559619590|FG000|Overall Study|Withdrawal by Subject|18|||
155051134|NCT03934216|559619591|FG001|Overall Study|Withdrawal by Subject|6|||
155051135|NCT03934216|559619590|FG000|Overall Study|Randomized but not treated|1|||
155391444|NCT04147234|560869479|FG002|Overall Study|Adverse Event|0|||
155391445|NCT04147234|560869480|FG003|Overall Study|Adverse Event|0|||
155051136|NCT03934216|559619591|FG001|Overall Study|Randomized but not treated|1|||
155391446|NCT04147234|560869481|FG004|Overall Study|Adverse Event|1|||
155391447|NCT04147234|560869482|FG005|Overall Study|Adverse Event|0|||
155391448|NCT04147234|560869483|FG006|Overall Study|Adverse Event|0|||
155391449|NCT05104476|560869494|FG000|Overall Study|Randomized But Not Treated|1|||
155391450|NCT05104476|560869495|FG001|Overall Study|Randomized But Not Treated|2|||
155391451|NCT05104476|560869494|FG000|Overall Study|Adverse Event|2|||
155391452|NCT05104476|560869495|FG001|Overall Study|Adverse Event|2|||
155391453|NCT05104476|560869494|FG000|Overall Study|Withdrawal by Subject|3|||
155391454|NCT05104476|560869495|FG001|Overall Study|Withdrawal by Subject|3|||
155391455|NCT05104476|560869494|FG000|Overall Study|Other Than Specified|0|||
155391456|NCT05104476|560869495|FG001|Overall Study|Other Than Specified|3|||
155391457|NCT02170389|560869498|FG000|Overall Study|Study terminated prior to start of treat|1|||
155391458|NCT02596620|560869501|FG000|Overall Study|Lost to Follow-up|1|||
155391459|NCT02596620|560869502|FG001|Overall Study|Lost to Follow-up|1|||
155391460|NCT01054144|560869503|FG000|Overall Study|Death|2|||
155391461|NCT02310672|560869507|FG000|Overall Study|Death|1|||
155391462|NCT02310672|560869507|FG000|Overall Study|Lost to Follow-up|1|||
155391463|NCT02310672|560869507|FG000|Overall Study|Withdrawal by Subject|1|||
155391464|NCT02310672|560869507|FG000|Overall Study|Sponsor's decision|12|||
155391465|NCT04704336|560869511|FG000|Overall Study|Death|2|||
155391466|NCT04704336|560869512|FG001|Overall Study|Death|2|||
155391467|NCT04704336|560869511|FG000|Overall Study|Lost to Follow-up|33|||
155391468|NCT04704336|560869512|FG001|Overall Study|Lost to Follow-up|40|||
155391469|NCT03118674|560869513|FG000|Overall Study|Lost to Follow-up|2|||
155391470|NCT03118674|560869513|FG000|Overall Study|Screen Faliure|8|||
155391471|NCT03118674|560869513|FG000|Overall Study|Withdrawal by Subject|5|||
155391472|NCT00867113|560869514|FG000|Treatment Period|Adverse Event|15|||
155391473|NCT00867113|560869514|FG000|Treatment Period|Death|2|||
155391474|NCT00867113|560869514|FG000|Treatment Period|Withdrawal by Subject|19|||
155391475|NCT00867113|560869514|FG000|Treatment Period|Lost to Follow-up|3|||
155391476|NCT00867113|560869514|FG000|Treatment Period|Administrative problems|1|||
155391477|NCT00867113|560869514|FG000|Treatment Period|Disease progression/relapse|1|||
155391478|NCT00867113|560869514|FG000|Treatment Period|Protocol Violation|4|||
155391479|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Death|1|||
155391480|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
155391481|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
155391482|NCT00867113|560869514|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
155391483|NCT02178553|560869516|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
155391484|NCT02178553|560869517|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
155391485|NCT02178553|560869516|FG000|Overall Study|Physician Decision|0|||
155391486|NCT02178553|560869517|FG001|Overall Study|Physician Decision|4|||
155391487|NCT02178553|560869516|FG000|Overall Study|Technical problem with injection|1|||
155391488|NCT02178553|560869517|FG001|Overall Study|Technical problem with injection|3|||
155391489|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
155391490|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
155391491|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
155391492|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
155391493|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
155391494|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
155391495|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
155391496|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
155391497|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
155391498|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
155391499|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
155391500|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
155391501|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
154948926|NCT02720510|559237909|FG001|Overall Study|Adverse Event|1|||
154948927|NCT02720510|559237908|FG000|Overall Study|Physician Decision|1|||
154948928|NCT02720510|559237909|FG001|Overall Study|Physician Decision|2|||
154948929|NCT01047345|559237914|FG000|Base Study|Adverse Event|3|||
154948930|NCT01047345|559237915|FG001|Base Study|Adverse Event|0|||
154948931|NCT01047345|559237916|FG002|Base Study|Adverse Event|0|||
154948932|NCT01047345|559237914|FG000|Base Study|Lost to Follow-up|4|||
154948933|NCT01047345|559237915|FG001|Base Study|Lost to Follow-up|1|||
155051137|NCT01396083|559619597|FG000|Overall Study|Adverse Event|2|||
155391502|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
155051138|NCT01396083|559619598|FG001|Overall Study|Adverse Event|28|||
155051139|NCT01396083|559619597|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
154948934|NCT01047345|559237916|FG002|Base Study|Lost to Follow-up|0|||
155391503|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
155051140|NCT01396083|559619598|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
155391504|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
155391505|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
155391506|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
155391507|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
155391508|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
155391509|NCT01641809|560869519|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
155391510|NCT01641809|560869520|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
155391511|NCT01641809|560869521|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
155391512|NCT01641809|560869522|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
155391513|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
155391514|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
155391515|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
155391516|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
155391517|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
155391518|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
155391519|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
155391520|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
155391521|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
155391522|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
155391523|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
155391524|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
155391525|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
155391526|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
155391527|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
155391528|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
155391529|NCT01641809|560869519|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
155391530|NCT01641809|560869520|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
155391531|NCT01641809|560869521|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
155391532|NCT01641809|560869522|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
155391533|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
155391534|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
155391535|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
155391536|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
155391537|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
155391538|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
155391539|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
155391540|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
155391541|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
155391542|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
155391543|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
155391544|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
155391545|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
155391546|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
155391547|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
155391548|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
155391549|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
155391550|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
155391551|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
155391552|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
155391553|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
155391554|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
155391555|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
155391556|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
155391557|NCT01641809|560869519|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
155391558|NCT01641809|560869520|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
155391559|NCT01641809|560869521|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
155391560|NCT01641809|560869522|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
155391561|NCT00651157|560869528|FG000|Overall Study|Death|1|||
155391562|NCT00651157|560869528|FG000|Overall Study|Protocol Violation|1|||
155391563|NCT00688181|560869530|FG000|Overall Study|Lost to Follow-up|17|||
155391564|NCT00688181|560869530|FG000|Overall Study|Unknown Reason|4|||
155391565|NCT00688181|560869530|FG000|Overall Study|Non-clinical Reason|2|||
155391566|NCT01472380|560869534|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
155391567|NCT01472380|560869534|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
155391568|NCT02511678|560869535|FG000|Overall Study|Withdrawal by Subject|2|||
155391569|NCT02511678|560869535|FG000|Overall Study|Lost to Follow-up|4|||
155391570|NCT02511678|560869535|FG000|Overall Study|Death|19|||
155391571|NCT02511678|560869535|FG000|Overall Study|Adverse Event|1|||
155391572|NCT02511678|560869535|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
155391573|NCT02511678|560869535|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
154948935|NCT01047345|559237914|FG000|Base Study|Protocol Violation|3|||
154948936|NCT01047345|559237915|FG001|Base Study|Protocol Violation|1|||
154948937|NCT01047345|559237916|FG002|Base Study|Protocol Violation|0|||
154948938|NCT01047345|559237914|FG000|Base Study|Withdrawal by Subject|12|||
154948939|NCT01047345|559237915|FG001|Base Study|Withdrawal by Subject|4|||
154948940|NCT01047345|559237916|FG002|Base Study|Withdrawal by Subject|0|||
154948941|NCT01047345|559237914|FG000|Extension|Withdrawal by Subject|0|||
154948942|NCT01047345|559237915|FG001|Extension|Withdrawal by Subject|0|||
154948943|NCT01047345|559237916|FG002|Extension|Withdrawal by Subject|1|||
154948944|NCT01047345|559237914|FG000|Extension|Lost to Follow-up|0|||
154948945|NCT01047345|559237915|FG001|Extension|Lost to Follow-up|0|||
154948946|NCT01047345|559237916|FG002|Extension|Lost to Follow-up|5|||
154948947|NCT00282256|559237917|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
154948948|NCT00282256|559237917|FG000|Extension Treatment Period|Adverse Event|2|||
154948949|NCT00806156|559237918|FG000|Overall Study|Death|35|||
154948950|NCT00806156|559237919|FG001|Overall Study|Death|95|||
154948951|NCT00806156|559237918|FG000|Overall Study|Did not meet eligibility criteria|1|||
154948952|NCT00806156|559237919|FG001|Overall Study|Did not meet eligibility criteria|0|||
154948953|NCT00806156|559237918|FG000|Overall Study|Study terminated by Sponsor|2|||
154948954|NCT00806156|559237919|FG001|Overall Study|Study terminated by Sponsor|40|||
154948955|NCT00806156|559237918|FG000|Overall Study|Consent withdrawn by subject|1|||
154948956|NCT00806156|559237919|FG001|Overall Study|Consent withdrawn by subject|3|||
154948957|NCT00806156|559237918|FG000|Overall Study|Lost to Follow-up|0|||
154948958|NCT00806156|559237919|FG001|Overall Study|Lost to Follow-up|1|||
154948959|NCT01890915|559237927|FG000|Overall Study|Adverse Event|1|||
154948960|NCT01890915|559237928|FG001|Overall Study|Adverse Event|0|||
154948961|NCT01890915|559237927|FG000|Overall Study|Protocol Violation|2|||
154948962|NCT01890915|559237928|FG001|Overall Study|Protocol Violation|0|||
154948963|NCT01890915|559237927|FG000|Overall Study|Equipment Malfunction|0|||
154948964|NCT01890915|559237928|FG001|Overall Study|Equipment Malfunction|1|||
154948965|NCT02114697|559237929|FG000|Overall Study|Study terminated|5|||
154948966|NCT02114697|559237930|FG001|Overall Study|Study terminated|4|||
154948967|NCT00424489|559237931|FG000|Overall Study|Death|3|||
154948968|NCT01984242|559237932|FG000|Overall Study|Death|52|||
154948969|NCT01984242|559237933|FG001|Overall Study|Death|50|||
154948970|NCT01984242|559237934|FG002|Overall Study|Death|52|||
154948971|NCT01984242|559237932|FG000|Overall Study|Withdrawal by Subject|5|||
154948972|NCT01984242|559237933|FG001|Overall Study|Withdrawal by Subject|3|||
154948973|NCT01984242|559237934|FG002|Overall Study|Withdrawal by Subject|10|||
154948974|NCT01984242|559237932|FG000|Overall Study|Physician Decision|0|||
154948975|NCT01984242|559237933|FG001|Overall Study|Physician Decision|0|||
154948976|NCT01984242|559237934|FG002|Overall Study|Physician Decision|1|||
154948977|NCT01984242|559237932|FG000|Overall Study|Lost to Follow-up|4|||
154948978|NCT01984242|559237933|FG001|Overall Study|Lost to Follow-up|0|||
154948979|NCT01984242|559237934|FG002|Overall Study|Lost to Follow-up|3|||
154948980|NCT01984242|559237932|FG000|Overall Study|Sponsor Decision|1|||
154948981|NCT01984242|559237933|FG001|Overall Study|Sponsor Decision|0|||
154948982|NCT01984242|559237934|FG002|Overall Study|Sponsor Decision|0|||
154948983|NCT01984242|559237932|FG000|Overall Study|Non-Compliance|1|||
154948984|NCT01984242|559237933|FG001|Overall Study|Non-Compliance|0|||
154948985|NCT01984242|559237934|FG002|Overall Study|Non-Compliance|0|||
154948986|NCT01984242|559237932|FG000|Overall Study|Study terminated by Sponsor|38|||
154948987|NCT01984242|559237933|FG001|Overall Study|Study terminated by Sponsor|50|||
154948988|NCT01984242|559237934|FG002|Overall Study|Study terminated by Sponsor|34|||
154948989|NCT01984242|559237932|FG000|Overall Study|Disease Progression|0|||
154948990|NCT01984242|559237933|FG001|Overall Study|Disease Progression|0|||
154948991|NCT01984242|559237934|FG002|Overall Study|Disease Progression|1|||
154948992|NCT00770510|559237940|FG000|Overall Study|Lost to Follow-up|2|||
154948993|NCT00770510|559237940|FG000|Overall Study|Pregnancy|1|||
154948994|NCT00770510|559237940|FG000|Overall Study|Withdrawal by Subject|2|||
154948995|NCT05030753|559237954|FG000|9-week|Lost to Follow-up|10|||
154948996|NCT05030753|559237955|FG001|9-week|Lost to Follow-up|7|||
154948997|NCT05030753|559237954|FG000|9-week|Withdrawal by Subject|1|||
154948998|NCT05030753|559237955|FG001|9-week|Withdrawal by Subject|0|||
154948999|NCT05030753|559237954|FG000|9-week|Excluded from analysis due to missing covariates|2|||
154949000|NCT05030753|559237955|FG001|9-week|Excluded from analysis due to missing covariates|1|||
155051141|NCT01396083|559619597|FG000|Overall Study|Consent withdrawn|4|||
154949001|NCT05030753|559237954|FG000|6-month post intervention|Lost to Follow-up|5|||
154949002|NCT05030753|559237955|FG001|6-month post intervention|Lost to Follow-up|4|||
154949003|NCT05030753|559237954|FG000|6-month post intervention|Withdrawal by Subject|4|||
154949004|NCT05030753|559237955|FG001|6-month post intervention|Withdrawal by Subject|0|||
154949005|NCT05030753|559237954|FG000|18-month post intervention|Lost to Follow-up|3|||
154949006|NCT05030753|559237955|FG001|18-month post intervention|Lost to Follow-up|1|||
154949007|NCT00720122|559237964|FG000|Overall Study|Lost to Follow-up|1|||
154949008|NCT00720122|559237964|FG000|Overall Study|Physician Decision|1|||
154949009|NCT00720122|559237964|FG000|Overall Study|Withdrawal by Subject|7|||
155051142|NCT01396083|559619598|FG001|Overall Study|Consent withdrawn|5|||
154949010|NCT03072459|559237965|FG000|Overall Study|Device revised/removed|1|||
155391574|NCT02511678|560869535|FG000|Overall Study|Required Radiofrequency Ablation|1|||
155391575|NCT02511678|560869535|FG000|Overall Study|Biopsy was Negative|1|||
155391576|NCT02511678|560869535|FG000|Overall Study|Protocol Violation|1|||
155391577|NCT02511678|560869535|FG000|Overall Study|Received Radiation Treatment|1|||
155391578|NCT01295281|560869536|FG000|First Intervention (7 Days)|Death|0|||
155391579|NCT01295281|560869537|FG001|First Intervention (7 Days)|Death|1|||
155391580|NCT00292461|560869538|FG000|Overall Study|Adverse Event|4|||
155391581|NCT00292461|560869539|FG001|Overall Study|Adverse Event|2|||
155391582|NCT00292461|560869538|FG000|Overall Study|Lack of Efficacy|1|||
155391583|NCT00292461|560869539|FG001|Overall Study|Lack of Efficacy|0|||
155391584|NCT00292461|560869538|FG000|Overall Study|Withdrawal by Subject|0|||
155391585|NCT00292461|560869539|FG001|Overall Study|Withdrawal by Subject|1|||
155391586|NCT00292461|560869538|FG000|Overall Study|Protocol Violation|4|||
155391587|NCT00292461|560869539|FG001|Overall Study|Protocol Violation|3|||
155391588|NCT00292461|560869538|FG000|Overall Study|Lost to Follow-up|1|||
155391589|NCT00292461|560869539|FG001|Overall Study|Lost to Follow-up|0|||
155391590|NCT03049735|560869541|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
155391591|NCT03049735|560869542|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
155391592|NCT03049735|560869543|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
155391593|NCT03049735|560869541|FG000|Overall Study|Other|5|||
155391594|NCT03049735|560869542|FG001|Overall Study|Other|3|||
155391595|NCT03049735|560869543|FG002|Overall Study|Other|1|||
155391596|NCT03049735|560869541|FG000|Overall Study|Lack of Efficacy|4|||
155391597|NCT03049735|560869542|FG001|Overall Study|Lack of Efficacy|0|||
155391598|NCT03049735|560869543|FG002|Overall Study|Lack of Efficacy|3|||
155391599|NCT03049735|560869541|FG000|Overall Study|Protocol deviation|1|||
155391600|NCT03049735|560869542|FG001|Overall Study|Protocol deviation|0|||
155391601|NCT03049735|560869543|FG002|Overall Study|Protocol deviation|0|||
155391602|NCT03049735|560869541|FG000|Overall Study|Pregnancy|0|||
155391603|NCT03049735|560869542|FG001|Overall Study|Pregnancy|0|||
155391604|NCT03049735|560869543|FG002|Overall Study|Pregnancy|1|||
155391605|NCT03049735|560869541|FG000|Overall Study|Adverse Event|7|||
155391606|NCT03049735|560869542|FG001|Overall Study|Adverse Event|18|||
155391607|NCT03049735|560869543|FG002|Overall Study|Adverse Event|5|||
155391608|NCT03049735|560869541|FG000|Overall Study|Withdrawal by Subject|10|||
155391609|NCT03049735|560869542|FG001|Overall Study|Withdrawal by Subject|3|||
155391610|NCT03049735|560869543|FG002|Overall Study|Withdrawal by Subject|7|||
155391611|NCT03049735|560869541|FG000|Overall Study|Lost to Follow-up|1|||
155391612|NCT03049735|560869542|FG001|Overall Study|Lost to Follow-up|5|||
155391613|NCT03049735|560869543|FG002|Overall Study|Lost to Follow-up|5|||
155391614|NCT02684357|560869546|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
155391615|NCT02684357|560869547|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
155391616|NCT02684357|560869548|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
155391617|NCT02684357|560869549|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
155391618|NCT02684357|560869550|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
155391619|NCT02684357|560869551|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
155391620|NCT02684357|560869546|FG000|Part A|Lost to Follow-up|0|||
155391621|NCT02684357|560869547|FG001|Part A|Lost to Follow-up|2|||
155391622|NCT02684357|560869548|FG002|Part A|Lost to Follow-up|2|||
155391623|NCT02684357|560869549|FG003|Part A|Lost to Follow-up|0|||
155391624|NCT02684357|560869550|FG004|Part A|Lost to Follow-up|0|||
155391625|NCT02684357|560869551|FG005|Part A|Lost to Follow-up|0|||
155391626|NCT02684357|560869546|FG000|Part A|Withdrawal by Subject|3|||
155391627|NCT02684357|560869547|FG001|Part A|Withdrawal by Subject|0|||
155391628|NCT02684357|560869548|FG002|Part A|Withdrawal by Subject|0|||
155391629|NCT02684357|560869549|FG003|Part A|Withdrawal by Subject|0|||
155391630|NCT02684357|560869550|FG004|Part A|Withdrawal by Subject|0|||
155391631|NCT02684357|560869551|FG005|Part A|Withdrawal by Subject|0|||
155391632|NCT02684357|560869546|FG000|Part A|Other|0|||
155391633|NCT02684357|560869547|FG001|Part A|Other|1|||
155391634|NCT02684357|560869548|FG002|Part A|Other|0|||
155391635|NCT02684357|560869549|FG003|Part A|Other|0|||
155391636|NCT02684357|560869550|FG004|Part A|Other|0|||
155391637|NCT02684357|560869551|FG005|Part A|Other|0|||
155391638|NCT02684357|560869546|FG000|Part B|Adverse Event (Other)|0|||
155051143|NCT01396083|559619597|FG000|Overall Study|Protocol deviation(s)|0|||
155051144|NCT01396083|559619598|FG001|Overall Study|Protocol deviation(s)|1|||
155391639|NCT02684357|560869547|FG001|Part B|Adverse Event (Other)|0|||
155391640|NCT02684357|560869548|FG002|Part B|Adverse Event (Other)|0|||
155391641|NCT02684357|560869549|FG003|Part B|Adverse Event (Other)|1|||
155391642|NCT02684357|560869550|FG004|Part B|Adverse Event (Other)|1|||
155391643|NCT02684357|560869551|FG005|Part B|Adverse Event (Other)|1|||
155391644|NCT02684357|560869546|FG000|Part B|Lost to Follow-up|0|||
155391645|NCT02684357|560869547|FG001|Part B|Lost to Follow-up|0|||
155391646|NCT02684357|560869548|FG002|Part B|Lost to Follow-up|0|||
155391647|NCT02684357|560869549|FG003|Part B|Lost to Follow-up|1|||
155391648|NCT02684357|560869550|FG004|Part B|Lost to Follow-up|1|||
155391649|NCT02684357|560869551|FG005|Part B|Lost to Follow-up|7|||
155391650|NCT02684357|560869546|FG000|Part B|Withdrawal by Subject|0|||
155391651|NCT02684357|560869547|FG001|Part B|Withdrawal by Subject|0|||
155391652|NCT02684357|560869548|FG002|Part B|Withdrawal by Subject|0|||
155051145|NCT01396083|559619597|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155051146|NCT01396083|559619598|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155051147|NCT01396083|559619597|FG000|Overall Study|Administrative problems|1|||
155051148|NCT01396083|559619598|FG001|Overall Study|Administrative problems|0|||
155051149|NCT01396083|559619597|FG000|Overall Study|Lost to Follow-up|1|||
155051150|NCT01396083|559619598|FG001|Overall Study|Lost to Follow-up|0|||
155051151|NCT00619827|559619599|FG000|Overall Study|Adverse Event|1|||
155051152|NCT00619827|559619600|FG001|Overall Study|Adverse Event|2|||
155051153|NCT00619827|559619599|FG000|Overall Study|Withdrawal by Subject|2|||
155051154|NCT00619827|559619600|FG001|Overall Study|Withdrawal by Subject|2|||
155051155|NCT01063855|559619602|FG000|Overall Study|Adverse Event|4|||
155051156|NCT01063855|559619603|FG001|Overall Study|Adverse Event|4|||
155051157|NCT01063855|559619602|FG000|Overall Study|Death|0|||
155282057|NCT02303574|560464030|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282058|NCT02303574|560464031|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
155282059|NCT02303574|560464032|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
154949011|NCT03072459|559237965|FG000|Overall Study|Subject not able to return|1|||
154949012|NCT02097121|559237970|FG000|Overall Study|Other, not specified|4|||
154949013|NCT02097121|559237971|FG001|Overall Study|Other, not specified|2|||
154949014|NCT02097121|559237972|FG002|Overall Study|Other, not specified|3|||
154949015|NCT02097121|559237970|FG000|Overall Study|Lack of Efficacy|2|||
154949016|NCT02097121|559237971|FG001|Overall Study|Lack of Efficacy|1|||
154949017|NCT02097121|559237972|FG002|Overall Study|Lack of Efficacy|3|||
154949018|NCT02097121|559237970|FG000|Overall Study|Withdrawal by Subject|0|||
154949019|NCT02097121|559237971|FG001|Overall Study|Withdrawal by Subject|1|||
154949020|NCT02097121|559237972|FG002|Overall Study|Withdrawal by Subject|2|||
154949021|NCT02097121|559237970|FG000|Overall Study|Adverse Event|0|||
154949022|NCT02097121|559237971|FG001|Overall Study|Adverse Event|1|||
154949023|NCT02097121|559237972|FG002|Overall Study|Adverse Event|0|||
154949024|NCT02097121|559237970|FG000|Overall Study|Lost to Follow-up|1|||
154949025|NCT02097121|559237971|FG001|Overall Study|Lost to Follow-up|1|||
154949026|NCT02097121|559237972|FG002|Overall Study|Lost to Follow-up|2|||
154949027|NCT03595657|559237973|FG000|Overall Study|Adverse Event|14|||
154949028|NCT03595657|559237973|FG000|Overall Study|Death|1|||
154949029|NCT03595657|559237973|FG000|Overall Study|Lack of Efficacy|40|||
154949030|NCT03595657|559237973|FG000|Overall Study|Withdrawal by Subject|10|||
154949031|NCT03595657|559237973|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
154949032|NCT03595657|559237973|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
154949033|NCT01066052|559237974|FG000|Overall Study|Enrolled But Not Treated|3|||
154949034|NCT01066052|559237975|FG001|Overall Study|Enrolled But Not Treated|0|||
154949035|NCT01835145|559237976|FG000|Overall Study|Ineligible prior to treatment|1|||
154949036|NCT01835145|559237977|FG001|Overall Study|Ineligible prior to treatment|0|||
154949037|NCT04094870|559237978|FG000|Overall Study|Lost to Follow-up|1|||
154949038|NCT04094870|559237979|FG001|Overall Study|Lost to Follow-up|1|||
154949039|NCT02708277|559237980|FG000|Overall Study|Lost to Follow-up|7|||
154949040|NCT02708277|559237981|FG001|Overall Study|Lost to Follow-up|4|||
154949041|NCT02739984|559237982|FG000|Overall Study|Sponsor Decision|1|||
154949042|NCT02739984|559237983|FG001|Overall Study|Sponsor Decision|0|||
154949043|NCT02739984|559237982|FG000|Overall Study|Withdrawal by Subject|1|||
154949044|NCT02739984|559237983|FG001|Overall Study|Withdrawal by Subject|1|||
154949045|NCT02739984|559237982|FG000|Overall Study|Death|0|||
154949046|NCT02739984|559237983|FG001|Overall Study|Death|1|||
154949047|NCT02739984|559237982|FG000|Overall Study|Lost to Follow-up|3|||
154949048|NCT02739984|559237983|FG001|Overall Study|Lost to Follow-up|0|||
154949049|NCT00409578|559237988|FG000|Overall Study|Adverse Event|27|||
154949050|NCT00409578|559237989|FG001|Overall Study|Adverse Event|37|||
154949051|NCT00409578|559237990|FG002|Overall Study|Adverse Event|25|||
154949052|NCT00409578|559237991|FG003|Overall Study|Adverse Event|33|||
154949053|NCT00409578|559237988|FG000|Overall Study|Abnormal laboratory value(s)|2|||
154949054|NCT00409578|559237989|FG001|Overall Study|Abnormal laboratory value(s)|2|||
154949055|NCT00409578|559237990|FG002|Overall Study|Abnormal laboratory value(s)|2|||
154949056|NCT00409578|559237991|FG003|Overall Study|Abnormal laboratory value(s)|4|||
154949057|NCT00409578|559237988|FG000|Overall Study|Lack of Efficacy|0|||
154949058|NCT00409578|559237989|FG001|Overall Study|Lack of Efficacy|0|||
154949059|NCT00409578|559237990|FG002|Overall Study|Lack of Efficacy|0|||
154949060|NCT00409578|559237991|FG003|Overall Study|Lack of Efficacy|2|||
155051158|NCT01063855|559619603|FG001|Overall Study|Death|1|||
155051159|NCT01063855|559619602|FG000|Overall Study|Lost to Follow-up|8|||
155051160|NCT01063855|559619603|FG001|Overall Study|Lost to Follow-up|4|||
155282060|NCT02303574|560464033|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282061|NCT02303574|560464034|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282062|NCT02303574|560464035|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
154949061|NCT00409578|559237988|FG000|Overall Study|Subject no longer requires study drug|0|||
154949062|NCT00409578|559237989|FG001|Overall Study|Subject no longer requires study drug|0|||
154949063|NCT00409578|559237990|FG002|Overall Study|Subject no longer requires study drug|0|||
154949064|NCT00409578|559237991|FG003|Overall Study|Subject no longer requires study drug|1|||
154949065|NCT00409578|559237988|FG000|Overall Study|Withdrawal by Subject|8|||
155051161|NCT01063855|559619602|FG000|Overall Study|Pregnancy|1|||
155051162|NCT01063855|559619603|FG001|Overall Study|Pregnancy|0|||
155051163|NCT01063855|559619602|FG000|Overall Study|Lack of Efficacy|0|||
155051164|NCT01063855|559619603|FG001|Overall Study|Lack of Efficacy|1|||
155051165|NCT01063855|559619602|FG000|Overall Study|Withdrawal by Subject|11|||
155051166|NCT01063855|559619603|FG001|Overall Study|Withdrawal by Subject|8|||
155051167|NCT01063855|559619602|FG000|Overall Study|Reason not specified|13|||
155051168|NCT01063855|559619603|FG001|Overall Study|Reason not specified|11|||
155051169|NCT00735709|559619604|FG000|Overall Study|Adverse Event|2|||
155051170|NCT00735709|559619605|FG001|Overall Study|Adverse Event|3|||
155282063|NCT02303574|560464036|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282064|NCT02303574|560464037|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282065|NCT02303574|560464038|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
155282066|NCT02303574|560464029|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282067|NCT02303574|560464030|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282068|NCT02303574|560464031|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282069|NCT02303574|560464032|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282070|NCT02303574|560464033|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282071|NCT02303574|560464034|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282072|NCT02303574|560464035|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282073|NCT02303574|560464036|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
155282074|NCT02303574|560464037|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282075|NCT02303574|560464038|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
155282076|NCT00994279|560464043|FG000|Overall Study|Withdrawal by Subject|2|||
155391653|NCT02684357|560869549|FG003|Part B|Withdrawal by Subject|0|||
154949066|NCT00409578|559237989|FG001|Overall Study|Withdrawal by Subject|15|||
155051171|NCT00735709|559619606|FG002|Overall Study|Adverse Event|1|||
155051172|NCT00735709|559619607|FG003|Overall Study|Adverse Event|5|||
155051173|NCT00735709|559619604|FG000|Overall Study|Lack of Efficacy|8|||
155051174|NCT00735709|559619605|FG001|Overall Study|Lack of Efficacy|4|||
155051175|NCT00735709|559619606|FG002|Overall Study|Lack of Efficacy|2|||
155051176|NCT00735709|559619607|FG003|Overall Study|Lack of Efficacy|3|||
155051177|NCT00735709|559619604|FG000|Overall Study|Noncompliance|0|||
155051178|NCT00735709|559619605|FG001|Overall Study|Noncompliance|0|||
155051179|NCT00735709|559619606|FG002|Overall Study|Noncompliance|1|||
155051180|NCT00735709|559619607|FG003|Overall Study|Noncompliance|0|||
155051181|NCT00735709|559619604|FG000|Overall Study|Protocol deviations|1|||
155051182|NCT00735709|559619605|FG001|Overall Study|Protocol deviations|2|||
155051183|NCT00735709|559619606|FG002|Overall Study|Protocol deviations|1|||
155051184|NCT00735709|559619607|FG003|Overall Study|Protocol deviations|1|||
155051185|NCT00735709|559619604|FG000|Overall Study|Voluntary Withdrawal|1|||
155051186|NCT00735709|559619605|FG001|Overall Study|Voluntary Withdrawal|3|||
155051187|NCT00735709|559619606|FG002|Overall Study|Voluntary Withdrawal|5|||
155051188|NCT00735709|559619607|FG003|Overall Study|Voluntary Withdrawal|7|||
155051189|NCT00735709|559619604|FG000|Overall Study|Lost to Follow-up|0|||
155051190|NCT00735709|559619605|FG001|Overall Study|Lost to Follow-up|1|||
155051191|NCT00735709|559619606|FG002|Overall Study|Lost to Follow-up|1|||
155051192|NCT00735709|559619607|FG003|Overall Study|Lost to Follow-up|1|||
155051193|NCT00735709|559619604|FG000|Overall Study|Excluded medication|1|||
155051194|NCT00735709|559619605|FG001|Overall Study|Excluded medication|0|||
155051195|NCT00735709|559619606|FG002|Overall Study|Excluded medication|0|||
155051196|NCT00735709|559619607|FG003|Overall Study|Excluded medication|1|||
155051197|NCT01165307|559619609|FG000|Overall Study|Lost to Follow-up|11|||
155051198|NCT01165307|559619610|FG001|Overall Study|Lost to Follow-up|3|||
155051199|NCT01165307|559619609|FG000|Overall Study|Withdrawal by Subject|2|||
155051200|NCT01165307|559619610|FG001|Overall Study|Withdrawal by Subject|0|||
155051201|NCT01165307|559619609|FG000|Overall Study|Subject not available for contact|1|||
155051202|NCT01165307|559619610|FG001|Overall Study|Subject not available for contact|0|||
155051203|NCT03234036|559619611|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
155282077|NCT00994279|560464044|FG001|Overall Study|Withdrawal by Subject|2|||
155282078|NCT00994279|560464043|FG000|Overall Study|Toxicity|1|||
154949067|NCT00409578|559237990|FG002|Overall Study|Withdrawal by Subject|16|||
154949068|NCT00409578|559237991|FG003|Overall Study|Withdrawal by Subject|17|||
154949069|NCT00409578|559237988|FG000|Overall Study|Lost to Follow-up|2|||
154949070|NCT00409578|559237989|FG001|Overall Study|Lost to Follow-up|0|||
154949071|NCT00409578|559237990|FG002|Overall Study|Lost to Follow-up|2|||
154949072|NCT00409578|559237991|FG003|Overall Study|Lost to Follow-up|2|||
154949073|NCT00409578|559237988|FG000|Overall Study|Administrative problems|8|||
154949074|NCT00409578|559237989|FG001|Overall Study|Administrative problems|9|||
154949075|NCT00409578|559237990|FG002|Overall Study|Administrative problems|2|||
154949076|NCT00409578|559237991|FG003|Overall Study|Administrative problems|4|||
154949077|NCT00409578|559237988|FG000|Overall Study|Death|2|||
155051204|NCT03234036|559619612|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
154949078|NCT00409578|559237989|FG001|Overall Study|Death|4|||
154949079|NCT00409578|559237990|FG002|Overall Study|Death|4|||
154949080|NCT00409578|559237991|FG003|Overall Study|Death|2|||
155051205|NCT03234036|559619613|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
155051206|NCT03234036|559619614|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
155051207|NCT02163395|559619619|FG000|Overall Study|Withdrawal by Subject|1|||
155051208|NCT02163395|559619619|FG000|Overall Study|Lost to Follow-up|3|||
155051209|NCT02163395|559619619|FG000|Overall Study|Adverse Event|1|||
155051210|NCT02683239|559619637|FG000|Overall Study|Protocol Violation|35|||
155051211|NCT02683239|559619638|FG001|Overall Study|Protocol Violation|23|||
155051212|NCT02683239|559619639|FG002|Overall Study|Protocol Violation|26|||
155051213|NCT02683239|559619640|FG003|Overall Study|Protocol Violation|4|||
155051214|NCT02683239|559619641|FG004|Overall Study|Protocol Violation|35|||
155051215|NCT02683239|559619642|FG005|Overall Study|Protocol Violation|4|||
155051216|NCT02683239|559619643|FG006|Overall Study|Protocol Violation|5|||
155051217|NCT02683239|559619637|FG000|Overall Study|Adverse Event|64|||
155051218|NCT02683239|559619638|FG001|Overall Study|Adverse Event|39|||
155051219|NCT02683239|559619639|FG002|Overall Study|Adverse Event|42|||
155391654|NCT02684357|560869550|FG004|Part B|Withdrawal by Subject|2|||
155391655|NCT02684357|560869551|FG005|Part B|Withdrawal by Subject|4|||
155391656|NCT02684357|560869546|FG000|Part B|Other|0|||
155391657|NCT02684357|560869547|FG001|Part B|Other|0|||
155391658|NCT02684357|560869548|FG002|Part B|Other|0|||
155391659|NCT02684357|560869549|FG003|Part B|Other|1|||
155391660|NCT02684357|560869550|FG004|Part B|Other|0|||
155391661|NCT02684357|560869551|FG005|Part B|Other|1|||
155391662|NCT01853982|560869552|FG000|Overall Study|Withdrawal by Subject|1|||
155391663|NCT01853982|560869553|FG001|Overall Study|Withdrawal by Subject|0|||
155051220|NCT02683239|559619640|FG003|Overall Study|Adverse Event|16|||
155051221|NCT02683239|559619641|FG004|Overall Study|Adverse Event|189|||
155051222|NCT02683239|559619642|FG005|Overall Study|Adverse Event|9|||
155051223|NCT02683239|559619643|FG006|Overall Study|Adverse Event|9|||
155051224|NCT02683239|559619637|FG000|Overall Study|Physician Decision|38|||
155051225|NCT02683239|559619638|FG001|Overall Study|Physician Decision|19|||
155051226|NCT02683239|559619639|FG002|Overall Study|Physician Decision|14|||
155051227|NCT02683239|559619640|FG003|Overall Study|Physician Decision|73|||
155051228|NCT02683239|559619641|FG004|Overall Study|Physician Decision|143|||
155051229|NCT02683239|559619642|FG005|Overall Study|Physician Decision|14|||
155051230|NCT02683239|559619643|FG006|Overall Study|Physician Decision|15|||
155051231|NCT02683239|559619637|FG000|Overall Study|Withdrawal by Subject|187|||
155051232|NCT02683239|559619638|FG001|Overall Study|Withdrawal by Subject|99|||
155051233|NCT02683239|559619639|FG002|Overall Study|Withdrawal by Subject|91|||
155051234|NCT02683239|559619640|FG003|Overall Study|Withdrawal by Subject|18|||
155051235|NCT02683239|559619641|FG004|Overall Study|Withdrawal by Subject|248|||
155051236|NCT02683239|559619642|FG005|Overall Study|Withdrawal by Subject|22|||
155051237|NCT02683239|559619643|FG006|Overall Study|Withdrawal by Subject|28|||
155051238|NCT02683239|559619637|FG000|Overall Study|Lost to Follow-up|77|||
155051239|NCT02683239|559619638|FG001|Overall Study|Lost to Follow-up|24|||
155051240|NCT02683239|559619639|FG002|Overall Study|Lost to Follow-up|25|||
155051241|NCT02683239|559619640|FG003|Overall Study|Lost to Follow-up|7|||
155051242|NCT02683239|559619641|FG004|Overall Study|Lost to Follow-up|88|||
155051243|NCT02683239|559619642|FG005|Overall Study|Lost to Follow-up|8|||
155051244|NCT02683239|559619643|FG006|Overall Study|Lost to Follow-up|11|||
155051245|NCT02683239|559619637|FG000|Overall Study|Death|9|||
155051246|NCT02683239|559619638|FG001|Overall Study|Death|5|||
155051247|NCT02683239|559619639|FG002|Overall Study|Death|8|||
155051248|NCT02683239|559619640|FG003|Overall Study|Death|0|||
155051249|NCT02683239|559619641|FG004|Overall Study|Death|12|||
155051250|NCT02683239|559619642|FG005|Overall Study|Death|1|||
155051251|NCT02683239|559619643|FG006|Overall Study|Death|0|||
155051252|NCT02683239|559619637|FG000|Overall Study|Lack of Efficacy|50|||
155051253|NCT02683239|559619638|FG001|Overall Study|Lack of Efficacy|23|||
155051254|NCT02683239|559619639|FG002|Overall Study|Lack of Efficacy|12|||
155051255|NCT02683239|559619640|FG003|Overall Study|Lack of Efficacy|2|||
155051256|NCT02683239|559619641|FG004|Overall Study|Lack of Efficacy|29|||
155051257|NCT02683239|559619642|FG005|Overall Study|Lack of Efficacy|2|||
155051258|NCT02683239|559619643|FG006|Overall Study|Lack of Efficacy|3|||
155051259|NCT02683239|559619637|FG000|Overall Study|Missing data|0|||
155051260|NCT02683239|559619638|FG001|Overall Study|Missing data|1|||
155051261|NCT02683239|559619639|FG002|Overall Study|Missing data|1|||
155051262|NCT02683239|559619640|FG003|Overall Study|Missing data|0|||
155051263|NCT02683239|559619641|FG004|Overall Study|Missing data|1|||
155051264|NCT02683239|559619642|FG005|Overall Study|Missing data|0|||
155051265|NCT02683239|559619643|FG006|Overall Study|Missing data|0|||
155051266|NCT00521365|559619646|FG000|Overall Study|Adverse Event|3|||
155391664|NCT01853982|560869552|FG000|Overall Study|Death|1|||
155051267|NCT00521365|559619646|FG000|Overall Study|Lost to Follow-up|6|||
155051268|NCT00521365|559619646|FG000|Overall Study|Protocol deviation|2|||
155051269|NCT00521365|559619646|FG000|Overall Study|Drug compliance|3|||
155051270|NCT00521365|559619646|FG000|Overall Study|Usage of not allowed drugs|6|||
155051271|NCT03627832|559619647|FG000|Overall Study|Withdrawal by Subject|10|||
155051272|NCT03627832|559619648|FG001|Overall Study|Withdrawal by Subject|1|||
155051273|NCT03150082|559619652|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
155391665|NCT01853982|560869553|FG001|Overall Study|Death|0|||
155391666|NCT01853982|560869552|FG000|Overall Study|Lost to Follow-up|0|||
155391667|NCT01853982|560869553|FG001|Overall Study|Lost to Follow-up|1|||
155391668|NCT00390910|560869554|FG000|Overall Study|Adverse Event|1|||
155391669|NCT00390910|560869555|FG001|Overall Study|Adverse Event|0|||
155051274|NCT03150082|559619653|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
155391670|NCT00390910|560869556|FG002|Overall Study|Adverse Event|0|||
155391671|NCT00390910|560869554|FG000|Overall Study|Lost to Follow-up|0|||
155391672|NCT00390910|560869555|FG001|Overall Study|Lost to Follow-up|1|||
155391673|NCT00390910|560869556|FG002|Overall Study|Lost to Follow-up|5|||
155051275|NCT01718483|559619654|FG000|Overall Study|Withdrawal by Subject|14|||
155051276|NCT01718483|559619655|FG001|Overall Study|Withdrawal by Subject|12|||
155051277|NCT01718483|559619654|FG000|Overall Study|Adverse Event|5|||
155051278|NCT01718483|559619655|FG001|Overall Study|Adverse Event|12|||
155282079|NCT00994279|560464044|FG001|Overall Study|Toxicity|0|||
155282080|NCT00994279|560464043|FG000|Overall Study|Multiple reasons|1|||
155282081|NCT00994279|560464044|FG001|Overall Study|Multiple reasons|3|||
155282082|NCT01606189|560464045|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282083|NCT01606189|560464046|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282084|NCT01606189|560464047|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282085|NCT01606189|560464048|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282086|NCT01606189|560464049|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
155282087|NCT01606189|560464050|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
155282088|NCT01606189|560464045|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282089|NCT01606189|560464046|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282090|NCT01606189|560464047|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282091|NCT01606189|560464048|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282092|NCT01606189|560464049|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
155282093|NCT01606189|560464050|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
155282094|NCT00859014|560464051|FG000|Overall Study|Death|4|||
155282095|NCT00859014|560464051|FG000|Overall Study|Lost to Follow-up|1|||
155282096|NCT00162942|560464052|FG000|Overall Study|Adverse Event|10|||
155282097|NCT00162942|560464053|FG001|Overall Study|Adverse Event|6|||
155282098|NCT00162942|560464052|FG000|Overall Study|Death|1|||
155282099|NCT00162942|560464053|FG001|Overall Study|Death|0|||
155282100|NCT00162942|560464052|FG000|Overall Study|Withdrawal by Subject|3|||
155282101|NCT00162942|560464053|FG001|Overall Study|Withdrawal by Subject|6|||
155282102|NCT00162942|560464052|FG000|Overall Study|Physician Decision|1|||
155282103|NCT00162942|560464053|FG001|Overall Study|Physician Decision|0|||
155282104|NCT00162942|560464052|FG000|Overall Study|Enter Open-Label Study|76|||
155282105|NCT00162942|560464053|FG001|Overall Study|Enter Open-Label Study|35|||
155282106|NCT00162942|560464052|FG000|Overall Study|Alternate Therapy|6|||
155282107|NCT00162942|560464053|FG001|Overall Study|Alternate Therapy|2|||
155282108|NCT00162942|560464052|FG000|Overall Study|Lack of Efficacy|1|||
155282109|NCT00162942|560464053|FG001|Overall Study|Lack of Efficacy|0|||
155282110|NCT00162942|560464052|FG000|Overall Study|Flare During Active Treatment|7|||
155282111|NCT00162942|560464053|FG001|Overall Study|Flare During Active Treatment|3|||
155282112|NCT00162942|560464052|FG000|Overall Study|2 or more consecutive treatments missed|1|||
155282113|NCT00162942|560464053|FG001|Overall Study|2 or more consecutive treatments missed|0|||
155282114|NCT01354938|560464054|FG000|Overall Study|Lost to Follow-up|1|||
155282115|NCT01167023|560464055|FG000|Overall Study|Lost to Follow-up|0|||
155282116|NCT01167023|560464056|FG001|Overall Study|Lost to Follow-up|1|||
155282117|NCT01167023|560464057|FG002|Overall Study|Lost to Follow-up|1|||
155282118|NCT01167023|560464055|FG000|Overall Study|Screen Failure|0|||
155282119|NCT01167023|560464056|FG001|Overall Study|Screen Failure|1|||
155282120|NCT01167023|560464057|FG002|Overall Study|Screen Failure|0|||
155282121|NCT01167023|560464055|FG000|Overall Study|Sponsor Decision|0|||
155282122|NCT01167023|560464056|FG001|Overall Study|Sponsor Decision|1|||
155282123|NCT01167023|560464057|FG002|Overall Study|Sponsor Decision|0|||
155282124|NCT01167023|560464055|FG000|Overall Study|Withdrawal by Subject|0|||
155282125|NCT01167023|560464056|FG001|Overall Study|Withdrawal by Subject|0|||
155282126|NCT01167023|560464057|FG002|Overall Study|Withdrawal by Subject|1|||
155282127|NCT00410384|560464058|FG000|Overall Study|Withdrawal by Subject|28|||
155282128|NCT00410384|560464059|FG001|Overall Study|Withdrawal by Subject|17|||
155282129|NCT00410384|560464060|FG002|Overall Study|Withdrawal by Subject|20|||
155282130|NCT00410384|560464058|FG000|Overall Study|Adverse Event|23|||
155282131|NCT00410384|560464059|FG001|Overall Study|Adverse Event|18|||
155282132|NCT00410384|560464060|FG002|Overall Study|Adverse Event|23|||
155282133|NCT00410384|560464058|FG000|Overall Study|Lack of Efficacy|20|||
155282134|NCT00410384|560464059|FG001|Overall Study|Lack of Efficacy|12|||
155391674|NCT00390910|560869554|FG000|Overall Study|Withdrawal by Subject|1|||
155391675|NCT00390910|560869555|FG001|Overall Study|Withdrawal by Subject|3|||
155051279|NCT01718483|559619654|FG000|Overall Study|Lost to Follow-up|8|||
155282135|NCT00410384|560464060|FG002|Overall Study|Lack of Efficacy|17|||
155282136|NCT00410384|560464058|FG000|Overall Study|Lack of Compliance|2|||
155282137|NCT00410384|560464059|FG001|Overall Study|Lack of Compliance|2|||
155282138|NCT00410384|560464060|FG002|Overall Study|Lack of Compliance|2|||
155391676|NCT00390910|560869556|FG002|Overall Study|Withdrawal by Subject|2|||
155391677|NCT00390910|560869554|FG000|Overall Study|Migrated/moved from study area|0|||
155391678|NCT00390910|560869555|FG001|Overall Study|Migrated/moved from study area|0|||
155391679|NCT00390910|560869556|FG002|Overall Study|Migrated/moved from study area|3|||
155391680|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
155391681|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391682|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391683|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391684|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391685|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
155391686|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
155391687|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
155391688|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391689|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391690|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391691|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
155391692|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391693|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
155391694|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391695|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391696|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391697|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
155391698|NCT01839487|560869557|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
155391699|NCT01839487|560869558|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391700|NCT01839487|560869559|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391701|NCT01839487|560869560|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391702|NCT01839487|560869561|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
155391703|NCT01839487|560869562|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
154949081|NCT00409578|559237988|FG000|Overall Study|Protocol Violation|3|||
154949082|NCT00409578|559237989|FG001|Overall Study|Protocol Violation|2|||
154949083|NCT00409578|559237990|FG002|Overall Study|Protocol Violation|3|||
154949084|NCT00409578|559237991|FG003|Overall Study|Protocol Violation|1|||
154949085|NCT00409578|559237988|FG000|Overall Study|Missing|0|||
154949086|NCT00409578|559237989|FG001|Overall Study|Missing|1|||
154949087|NCT00409578|559237990|FG002|Overall Study|Missing|0|||
154949088|NCT00409578|559237991|FG003|Overall Study|Missing|1|||
154949089|NCT01298570|559239473|FG000|Overall Study|Disease progression, relapse during acti|64|||
154949090|NCT01298570|559239474|FG001|Overall Study|Disease progression, relapse during acti|40|||
154949091|NCT01298570|559239473|FG000|Overall Study|Adverse Event|20|||
154949092|NCT01298570|559239474|FG001|Overall Study|Adverse Event|2|||
154949093|NCT01298570|559239473|FG000|Overall Study|Withdrawal by Subject|21|||
154949094|NCT01298570|559239474|FG001|Overall Study|Withdrawal by Subject|6|||
154949095|NCT01298570|559239473|FG000|Overall Study|Treatment delay > 4 weeks|4|||
154949096|NCT01298570|559239474|FG001|Overall Study|Treatment delay > 4 weeks|5|||
154949097|NCT01298570|559239473|FG000|Overall Study|Physician Decision|4|||
154949098|NCT01298570|559239474|FG001|Overall Study|Physician Decision|2|||
154949099|NCT01298570|559239473|FG000|Overall Study|Other complicating disease|2|||
154949100|NCT01298570|559239474|FG001|Overall Study|Other complicating disease|1|||
154949101|NCT01298570|559239473|FG000|Overall Study|Surgery|2|||
154949102|NCT01298570|559239474|FG001|Overall Study|Surgery|1|||
154949103|NCT01298570|559239473|FG000|Overall Study|Symptomatic progression/deterioration|3|||
154949104|NCT01298570|559239474|FG001|Overall Study|Symptomatic progression/deterioration|2|||
154949105|NCT01298570|559239473|FG000|Overall Study|Death|0|||
154949106|NCT01298570|559239474|FG001|Overall Study|Death|1|||
154949107|NCT01298570|559239473|FG000|Overall Study|Ineligibility|0|||
154949108|NCT01298570|559239474|FG001|Overall Study|Ineligibility|1|||
154949109|NCT02841709|559239475|FG000|5th Intervention|Adverse Event|2|||
154949110|NCT02841709|559239476|FG001|5th Intervention|Adverse Event|0|||
154949111|NCT02841709|559239477|FG002|5th Intervention|Adverse Event|0|||
154949112|NCT02841709|559239478|FG003|5th Intervention|Adverse Event|0|||
154949113|NCT02841709|559239479|FG004|5th Intervention|Adverse Event|2|||
154949114|NCT01929109|559239480|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
154949115|NCT01929109|559239481|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
154949116|NCT01929109|559239482|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
154949117|NCT01929109|559239483|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
154949118|NCT01929109|559239484|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
154949119|NCT00076102|559239485|FG000|Overall Study|Clinical progression|1|||
154949120|NCT00076102|559239485|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
154949121|NCT00076102|559239485|FG000|Overall Study|plexiform neurofibroma surgery|1|||
154949122|NCT00076102|559239485|FG000|Overall Study|refusal of further therapy|2|||
154949123|NCT02016300|559239496|FG000|Overall Study|Lost to Follow-up|0|||
154949124|NCT02016300|559239497|FG001|Overall Study|Lost to Follow-up|3|||
155051280|NCT01718483|559619655|FG001|Overall Study|Lost to Follow-up|3|||
155051281|NCT01718483|559619654|FG000|Overall Study|Protocol Violation|4|||
155051282|NCT01718483|559619655|FG001|Overall Study|Protocol Violation|2|||
155051283|NCT01718483|559619654|FG000|Overall Study|Other|1|||
155051284|NCT01718483|559619655|FG001|Overall Study|Other|4|||
155051285|NCT01718483|559619654|FG000|Overall Study|Pregnancy|1|||
155051286|NCT01718483|559619655|FG001|Overall Study|Pregnancy|1|||
155051287|NCT01718483|559619654|FG000|Overall Study|Lack of Efficacy|1|||
155051288|NCT01718483|559619655|FG001|Overall Study|Lack of Efficacy|0|||
155051289|NCT04547140|559619658|FG000|Overall Study|Adverse Event|0|||
155051290|NCT04547140|559619659|FG001|Overall Study|Adverse Event|1|||
155051291|NCT04547140|559619658|FG000|Overall Study|Withdrawal by Subject|0|||
155051292|NCT04547140|559619659|FG001|Overall Study|Withdrawal by Subject|1|||
155051293|NCT04547140|559619658|FG000|Overall Study|Lost to Follow-up|3|||
155051294|NCT04547140|559619659|FG001|Overall Study|Lost to Follow-up|1|||
155051295|NCT04547140|559619658|FG000|Overall Study|Death|2|||
155051296|NCT04547140|559619659|FG001|Overall Study|Death|1|||
155051297|NCT04547140|559619658|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
155051298|NCT04547140|559619659|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
155051299|NCT04547140|559619658|FG000|Overall Study|Pregnancy|1|||
155051300|NCT04547140|559619659|FG001|Overall Study|Pregnancy|0|||
155051301|NCT04547140|559619658|FG000|Overall Study|Reason Not Specified|4|||
155051302|NCT04547140|559619659|FG001|Overall Study|Reason Not Specified|1|||
155051303|NCT02119299|559619660|FG000|Overall Study|Withdrawal by Subject|7|||
155051304|NCT02119299|559619660|FG000|Overall Study|Lack of Efficacy|1|||
155051305|NCT02119299|559619660|FG000|Overall Study|Pregnancy|1|||
155051306|NCT04613739|559619663|FG000|Overall Study|Lost to Follow-up|6|||
155051307|NCT04613739|559619664|FG001|Overall Study|Lost to Follow-up|9|||
155051308|NCT04613739|559619663|FG000|Overall Study|potentially duplicative/fraudulent|1|||
155051309|NCT04613739|559619664|FG001|Overall Study|potentially duplicative/fraudulent|3|||
155051310|NCT00735943|559619669|FG000|Overall Study|Lost to Follow-up|1|||
155051311|NCT00735943|559619669|FG000|Overall Study|Adverse Event|1|||
155051312|NCT00115778|559619672|FG000|Overall Study|Withdrawal by Subject|0|||
155051313|NCT00115778|559619673|FG001|Overall Study|Withdrawal by Subject|1|||
155051314|NCT01607593|559619674|FG000|Overall Study|Adverse Event|15|||
155051315|NCT01607593|559619674|FG000|Overall Study|Lack of Efficacy|16|||
155051316|NCT01607593|559619674|FG000|Overall Study|Lost to Follow-up|25|||
155051317|NCT01607593|559619674|FG000|Overall Study|Continuation|33|||
155051318|NCT01607593|559619674|FG000|Overall Study|Other|4|||
155051319|NCT03713684|559619679|FG000|Overall Study|Adverse Event|1|||
155051320|NCT03713684|559619680|FG001|Overall Study|Adverse Event|3|||
155051321|NCT03713684|559619681|FG002|Overall Study|Adverse Event|1|||
155051322|NCT03713684|559619682|FG003|Overall Study|Adverse Event|0|||
155051323|NCT03713684|559619679|FG000|Overall Study|Poor compliance to protocol|2|||
155051324|NCT03713684|559619680|FG001|Overall Study|Poor compliance to protocol|1|||
155051325|NCT03713684|559619681|FG002|Overall Study|Poor compliance to protocol|0|||
155051326|NCT03713684|559619682|FG003|Overall Study|Poor compliance to protocol|1|||
155051327|NCT03713684|559619679|FG000|Overall Study|Withdrawal by Subject|14|||
155051328|NCT03713684|559619680|FG001|Overall Study|Withdrawal by Subject|6|||
155051329|NCT03713684|559619681|FG002|Overall Study|Withdrawal by Subject|14|||
155051330|NCT03713684|559619682|FG003|Overall Study|Withdrawal by Subject|16|||
155051331|NCT03713684|559619679|FG000|Overall Study|Other than specified|69|||
155051332|NCT03713684|559619680|FG001|Overall Study|Other than specified|77|||
155051333|NCT03713684|559619681|FG002|Overall Study|Other than specified|73|||
155051334|NCT03713684|559619682|FG003|Overall Study|Other than specified|70|||
155051335|NCT00528424|559619683|FG000|Overall Study|Lost to Follow-up|13|||
155051336|NCT00528424|559619683|FG000|Overall Study|Withdrew consent|2|||
155051337|NCT00528424|559619683|FG000|Overall Study|Administrative reason|2|||
155051338|NCT00528424|559619683|FG000|Overall Study|Other|12|||
155051339|NCT02515630|559619684|FG000|Overall Study|Withdrawal by Subject|5|||
155051340|NCT02515630|559619684|FG000|Overall Study|Adverse Event|4|||
155391704|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
155391705|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
155051341|NCT02515630|559619684|FG000|Overall Study|Physician Decision|4|||
155051342|NCT02515630|559619684|FG000|Overall Study|Death|2|||
155051343|NCT02515630|559619684|FG000|Overall Study|Disease Progression|1|||
155051344|NCT01064414|559619687|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
155051345|NCT01064414|559619688|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
155051346|NCT01064414|559619689|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
155391706|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
155391707|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
155051347|NCT01064414|559619687|FG000|Core Period: Baseline to Week 26|Death|0|||
155051348|NCT01064414|559619688|FG001|Core Period: Baseline to Week 26|Death|1|||
155051349|NCT01064414|559619689|FG002|Core Period: Baseline to Week 26|Death|0|||
155051350|NCT01064414|559619687|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
155051351|NCT01064414|559619688|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
155051352|NCT01064414|559619689|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
155391708|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
155051353|NCT01064414|559619687|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
155391709|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
155051354|NCT01064414|559619688|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
155051355|NCT01064414|559619689|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
155051356|NCT01064414|559619687|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155051357|NCT01064414|559619688|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155051358|NCT01064414|559619689|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155391710|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
155391711|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
155391712|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
155051359|NCT01064414|559619687|FG000|Core Period: Baseline to Week 26|Other|4|||
155051360|NCT01064414|559619688|FG001|Core Period: Baseline to Week 26|Other|7|||
155051361|NCT01064414|559619689|FG002|Core Period: Baseline to Week 26|Other|2|||
155051362|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
155391713|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
155391714|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
155391715|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
155391716|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391717|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391718|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
155391719|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391720|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
155391721|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
155391722|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
155391723|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
155391724|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
155391725|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
155391726|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
155391727|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
155391728|NCT01839487|560869557|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
155391729|NCT01839487|560869558|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
155391730|NCT01839487|560869559|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
155391731|NCT01839487|560869560|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
155391732|NCT01839487|560869561|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
155391733|NCT01839487|560869562|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
155391734|NCT03872453|560871124|FG000|Overall Study|Adverse Event|1|||
155391735|NCT03872453|560871125|FG001|Overall Study|Adverse Event|1|||
155391736|NCT03872453|560871126|FG002|Overall Study|Adverse Event|0|||
155391737|NCT03872453|560871127|FG003|Overall Study|Adverse Event|0|||
155391738|NCT03872453|560871124|FG000|Overall Study|Lost to Follow-up|8|||
155391739|NCT03872453|560871125|FG001|Overall Study|Lost to Follow-up|7|||
155391740|NCT03872453|560871126|FG002|Overall Study|Lost to Follow-up|4|||
155391741|NCT03872453|560871127|FG003|Overall Study|Lost to Follow-up|4|||
155391742|NCT03872453|560871124|FG000|Overall Study|Never Treated Migraine|19|||
155391743|NCT03872453|560871125|FG001|Overall Study|Never Treated Migraine|17|||
155391744|NCT03872453|560871126|FG002|Overall Study|Never Treated Migraine|13|||
155391745|NCT03872453|560871127|FG003|Overall Study|Never Treated Migraine|12|||
155391746|NCT03872453|560871124|FG000|Overall Study|Pregnancy|1|||
155391747|NCT03872453|560871125|FG001|Overall Study|Pregnancy|0|||
155391748|NCT03872453|560871126|FG002|Overall Study|Pregnancy|0|||
155051363|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155051364|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
155051365|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Death|0|||
155391749|NCT03872453|560871127|FG003|Overall Study|Pregnancy|0|||
155391750|NCT03872453|560871124|FG000|Overall Study|Protocol Deviation|2|||
155391751|NCT03872453|560871125|FG001|Overall Study|Protocol Deviation|0|||
155391752|NCT03872453|560871126|FG002|Overall Study|Protocol Deviation|0|||
155391753|NCT03872453|560871127|FG003|Overall Study|Protocol Deviation|2|||
155391754|NCT03872453|560871124|FG000|Overall Study|Withdrawal by Subject|0|||
155391755|NCT03872453|560871125|FG001|Overall Study|Withdrawal by Subject|1|||
155051366|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Death|1|||
155051367|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Death|0|||
155051368|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
155051369|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155391756|NCT03872453|560871126|FG002|Overall Study|Withdrawal by Subject|2|||
155391757|NCT03872453|560871127|FG003|Overall Study|Withdrawal by Subject|0|||
155391758|NCT03872453|560871124|FG000|Overall Study|Other Than Specified|1|||
155391759|NCT03872453|560871125|FG001|Overall Study|Other Than Specified|0|||
155391760|NCT03872453|560871126|FG002|Overall Study|Other Than Specified|0|||
155391761|NCT03872453|560871127|FG003|Overall Study|Other Than Specified|0|||
155391762|NCT00352885|560871128|FG000|Overall Study|Withdrawal by Subject|0|||
155391763|NCT00352885|560871129|FG001|Overall Study|Withdrawal by Subject|3|||
155391764|NCT00352885|560871128|FG000|Overall Study|Development of major depression|0|||
155391765|NCT00352885|560871129|FG001|Overall Study|Development of major depression|1|||
155391766|NCT00352885|560871128|FG000|Overall Study|Progression of metastatic melanoma|5|||
155391767|NCT00352885|560871129|FG001|Overall Study|Progression of metastatic melanoma|3|||
155391768|NCT00352885|560871128|FG000|Overall Study|Side effects of IL-2 administration|1|||
155391769|NCT00352885|560871129|FG001|Overall Study|Side effects of IL-2 administration|0|||
155391770|NCT01678209|560871130|FG000|Overall Study|could not scan twice|1|||
155391771|NCT01678209|560871131|FG001|Overall Study|could not scan twice|1|||
155391772|NCT01678209|560871132|FG002|Overall Study|could not scan twice|1|||
155391773|NCT01678209|560871130|FG000|Overall Study|scheduling conflicts|0|||
155391774|NCT01678209|560871131|FG001|Overall Study|scheduling conflicts|0|||
155391775|NCT01678209|560871132|FG002|Overall Study|scheduling conflicts|1|||
155391776|NCT01678209|560871130|FG000|Overall Study|screen fail|16|||
155391777|NCT01678209|560871131|FG001|Overall Study|screen fail|17|||
155391778|NCT01678209|560871132|FG002|Overall Study|screen fail|16|||
155391779|NCT03756350|560871136|FG000|Overall Study|Lost to Follow-up|1|||
155391780|NCT00928564|560871140|FG000|Overall Study|Lost to Follow-up|6|||
155391781|NCT00928564|560871141|FG001|Overall Study|Lost to Follow-up|0|||
155391782|NCT03434353|560871144|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
155391783|NCT03434353|560871145|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
155391784|NCT03434353|560871146|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
155391785|NCT03434353|560871147|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
155391786|NCT03434353|560871148|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
155391787|NCT03434353|560871144|FG000|Overall Study|Withdrew consent|1|||
155391788|NCT03434353|560871145|FG001|Overall Study|Withdrew consent|0|||
155391789|NCT03434353|560871146|FG002|Overall Study|Withdrew consent|3|||
155391790|NCT03434353|560871147|FG003|Overall Study|Withdrew consent|0|||
155391791|NCT03434353|560871148|FG004|Overall Study|Withdrew consent|0|||
155391792|NCT03434353|560871144|FG000|Overall Study|Adverse Event|1|||
155391793|NCT03434353|560871145|FG001|Overall Study|Adverse Event|0|||
155391794|NCT03434353|560871146|FG002|Overall Study|Adverse Event|0|||
155391795|NCT03434353|560871147|FG003|Overall Study|Adverse Event|0|||
155391796|NCT03434353|560871148|FG004|Overall Study|Adverse Event|1|||
155391797|NCT03434353|560871144|FG000|Overall Study|Lost to Follow-up|2|||
155391798|NCT03434353|560871145|FG001|Overall Study|Lost to Follow-up|0|||
155391799|NCT03434353|560871146|FG002|Overall Study|Lost to Follow-up|0|||
155391800|NCT03434353|560871147|FG003|Overall Study|Lost to Follow-up|0|||
155391801|NCT03434353|560871148|FG004|Overall Study|Lost to Follow-up|0|||
155391802|NCT03739762|560871149|FG000|Overall Study|Lost to Follow-up|1|||
155391803|NCT03739762|560871150|FG001|Overall Study|Lost to Follow-up|1|||
155391804|NCT03739762|560871149|FG000|Overall Study|Withdrawal by Subject|2|||
155391805|NCT03739762|560871150|FG001|Overall Study|Withdrawal by Subject|6|||
155391806|NCT01521897|560871153|FG000|Overall Study|Protocol Violation|18|||
155391807|NCT01521897|560871153|FG000|Overall Study|Lost to Follow-up|5|||
155391808|NCT00385203|560871154|FG000|Overall Study|Adverse Event|5|||
155391809|NCT00385203|560871155|FG001|Overall Study|Adverse Event|4|||
155391810|NCT00385203|560871154|FG000|Overall Study|Death|1|||
155391811|NCT00385203|560871155|FG001|Overall Study|Death|0|||
155391812|NCT00385203|560871154|FG000|Overall Study|Condition under investigation worsened|18|||
155391813|NCT00385203|560871155|FG001|Overall Study|Condition under investigation worsened|3|||
155391814|NCT00385203|560871154|FG000|Overall Study|Incorrect enrollment|2|||
155391815|NCT00385203|560871155|FG001|Overall Study|Incorrect enrollment|0|||
155391816|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
155391817|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
155391818|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
155391819|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
155391820|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
155391821|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
155391822|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
155391823|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
155391824|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
155391825|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
155391826|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391827|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
155391828|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391829|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391830|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
155391831|NCT03308942|560871156|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
155391832|NCT03308942|560871157|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
155391833|NCT03308942|560871158|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
155391834|NCT03308942|560871159|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
155051370|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155051371|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
155051372|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155051373|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155051374|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155051375|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155051376|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155051377|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
155051378|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155051379|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155051380|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155051381|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155051382|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155051383|NCT01064414|559619687|FG000|Extension Period: Week 26 to Week 52|Other|5|||
155051384|NCT01064414|559619688|FG001|Extension Period: Week 26 to Week 52|Other|2|||
155051385|NCT01064414|559619689|FG002|Extension Period: Week 26 to Week 52|Other|1|||
155051386|NCT02185417|559619690|FG000|Overall Study|Death|448|||
155051387|NCT02185417|559619691|FG001|Overall Study|Death|446|||
155051388|NCT02185417|559619692|FG002|Overall Study|Death|0|||
155051389|NCT02185417|559619690|FG000|Overall Study|Withdrawal by Subject|7|||
155051390|NCT02185417|559619691|FG001|Overall Study|Withdrawal by Subject|12|||
155051391|NCT02185417|559619692|FG002|Overall Study|Withdrawal by Subject|0|||
155051392|NCT02595502|559619695|FG000|Period 1|Adverse Event|0|||
155051393|NCT02595502|559619696|FG001|Period 1|Adverse Event|1|||
155051394|NCT02595502|559619695|FG000|Period 1|Withdrawal by Subject|1|||
155051395|NCT02595502|559619696|FG001|Period 1|Withdrawal by Subject|0|||
155051396|NCT02595502|559619695|FG000|Period 1|Lost to Follow-up|0|||
155051397|NCT02595502|559619696|FG001|Period 1|Lost to Follow-up|1|||
155051398|NCT02595502|559619695|FG000|Period 2|Adverse Event|1|||
155051399|NCT02595502|559619696|FG001|Period 2|Adverse Event|1|||
155051400|NCT02595502|559619695|FG000|Period 2|Received incorrect lens at Period 1|0|||
155051401|NCT02595502|559619696|FG001|Period 2|Received incorrect lens at Period 1|1|||
155051402|NCT02595502|559619695|FG000|Period 3|Protocol Violation|0|||
155051403|NCT02595502|559619696|FG001|Period 3|Protocol Violation|1|||
155051404|NCT02595502|559619695|FG000|Period 3|Lost to Follow-up|1|||
155051405|NCT02595502|559619696|FG001|Period 3|Lost to Follow-up|0|||
155282139|NCT00410384|560464058|FG000|Overall Study|Lost to Follow-up|4|||
155282140|NCT00410384|560464059|FG001|Overall Study|Lost to Follow-up|6|||
155282141|NCT00410384|560464060|FG002|Overall Study|Lost to Follow-up|6|||
155282142|NCT00410384|560464058|FG000|Overall Study|Protocol Violation|6|||
155282143|NCT00410384|560464059|FG001|Overall Study|Protocol Violation|6|||
155282144|NCT00410384|560464060|FG002|Overall Study|Protocol Violation|6|||
155282145|NCT00410384|560464058|FG000|Overall Study|Physician Decision|3|||
155282146|NCT00410384|560464059|FG001|Overall Study|Physician Decision|3|||
155282147|NCT00410384|560464060|FG002|Overall Study|Physician Decision|4|||
155282148|NCT00410384|560464058|FG000|Overall Study|Other|3|||
155282149|NCT00410384|560464059|FG001|Overall Study|Other|8|||
155282150|NCT00410384|560464060|FG002|Overall Study|Other|4|||
155282151|NCT00577629|560464063|FG000|Treatment Period|Death|1|||
155282152|NCT00577629|560464063|FG000|Long Term Follow-Up|Death|15|||
155282153|NCT00577629|560464063|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
155282154|NCT00577629|560464063|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
155282155|NCT00577629|560464063|FG000|Long Term Follow-Up|Physician Decision|1|||
155282156|NCT01027871|560464064|FG000|Overall Study|Physician Decision|1|||
155282157|NCT01027871|560464065|FG001|Overall Study|Physician Decision|5|||
155282158|NCT01027871|560464066|FG002|Overall Study|Physician Decision|0|||
155282159|NCT01027871|560464064|FG000|Overall Study|Protocol Violation|0|||
155282160|NCT01027871|560464065|FG001|Overall Study|Protocol Violation|2|||
155282161|NCT01027871|560464066|FG002|Overall Study|Protocol Violation|2|||
155282162|NCT01027871|560464064|FG000|Overall Study|Withdrawal by Subject|1|||
155282163|NCT01027871|560464065|FG001|Overall Study|Withdrawal by Subject|2|||
155282164|NCT01027871|560464066|FG002|Overall Study|Withdrawal by Subject|2|||
155282165|NCT01027871|560464064|FG000|Overall Study|Adverse Event|0|||
155282166|NCT01027871|560464065|FG001|Overall Study|Adverse Event|2|||
155282167|NCT01027871|560464066|FG002|Overall Study|Adverse Event|2|||
155282168|NCT01027871|560464064|FG000|Overall Study|Sponsor Decision|0|||
155051406|NCT02595502|559619695|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
155051407|NCT02595502|559619696|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
155051408|NCT03075267|559619697|FG000|Overall Study|Protocol Violation|1|||
155051409|NCT03075267|559619698|FG001|Overall Study|Protocol Violation|0|||
155051410|NCT03075267|559619699|FG002|Overall Study|Protocol Violation|0|||
155051411|NCT01566604|559619700|FG000|Overall Study|Patient's inability to use the device|1|||
155282169|NCT01027871|560464065|FG001|Overall Study|Sponsor Decision|2|||
155282170|NCT01027871|560464066|FG002|Overall Study|Sponsor Decision|0|||
155282171|NCT01027871|560464064|FG000|Overall Study|Discontinued Prior to Treatment|0|||
155282172|NCT01027871|560464065|FG001|Overall Study|Discontinued Prior to Treatment|0|||
155391835|NCT03308942|560871160|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
155391836|NCT03308942|560871156|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391837|NCT03308942|560871157|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391838|NCT03308942|560871158|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391839|NCT03308942|560871159|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
155391840|NCT03308942|560871160|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
155391841|NCT03308942|560871156|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391842|NCT03308942|560871157|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391843|NCT03308942|560871158|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391844|NCT03308942|560871159|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
155391845|NCT03308942|560871160|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
155391846|NCT03308942|560871156|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391847|NCT03308942|560871157|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391848|NCT03308942|560871158|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391849|NCT03308942|560871159|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
155391850|NCT03308942|560871160|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
155391851|NCT01131351|560871161|FG000|Overall Study|Adverse Event|0|||
155391852|NCT01131351|560871162|FG001|Overall Study|Adverse Event|2|||
155391853|NCT01131351|560871161|FG000|Overall Study|Protocol Deviation|0|||
155391854|NCT01131351|560871162|FG001|Overall Study|Protocol Deviation|1|||
155391855|NCT02194062|560871163|FG000|Overall Study|Lost to Follow-up|2|||
155391856|NCT02194062|560871164|FG001|Overall Study|Lost to Follow-up|2|||
155391857|NCT02194062|560871165|FG002|Overall Study|Lost to Follow-up|5|||
155391858|NCT01008696|560871169|FG000|Overall Study|Participant's evasion of hospital visit|5|||
155391859|NCT01008696|560871170|FG001|Overall Study|Participant's evasion of hospital visit|4|||
155391860|NCT01008696|560871169|FG000|Overall Study|Withdrawal by Subject|2|||
155391861|NCT01008696|560871170|FG001|Overall Study|Withdrawal by Subject|4|||
155391862|NCT01008696|560871169|FG000|Overall Study|Physician Decision|5|||
155391863|NCT01008696|560871170|FG001|Overall Study|Physician Decision|1|||
155391864|NCT01008696|560871169|FG000|Overall Study|Adverse Event|1|||
155391865|NCT01008696|560871170|FG001|Overall Study|Adverse Event|0|||
155391866|NCT01008696|560871169|FG000|Overall Study|Participants' non-cooperation|2|||
155391867|NCT01008696|560871170|FG001|Overall Study|Participants' non-cooperation|3|||
155391868|NCT01008696|560871169|FG000|Overall Study|Other|2|||
155391869|NCT01008696|560871170|FG001|Overall Study|Other|3|||
155391870|NCT01008696|560871169|FG000|Overall Study|Other|0|||
155391871|NCT01008696|560871170|FG001|Overall Study|Other|2|||
155391872|NCT04964960|560871171|FG000|Overall Study|Withdrawal by Subject|1|||
155391873|NCT04964960|560871171|FG000|Overall Study|Did not complete cycles|1|||
155391874|NCT02960854|560871172|FG000|Overall Study|Not Disclosed|2|||
155391875|NCT02960854|560871173|FG001|Overall Study|Not Disclosed|2|||
155391876|NCT02960854|560871172|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
155391877|NCT02960854|560871173|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
155391878|NCT02960854|560871172|FG000|Overall Study|Subject Withdrew Consent|0|||
155391879|NCT02960854|560871173|FG001|Overall Study|Subject Withdrew Consent|1|||
155391880|NCT02960854|560871172|FG000|Overall Study|Death|4|||
155391881|NCT02960854|560871173|FG001|Overall Study|Death|6|||
155391882|NCT00221195|560871174|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
155391883|NCT00221195|560871175|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
155391884|NCT00221195|560871174|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
155391885|NCT00221195|560871175|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
155391886|NCT00221195|560871174|FG000|Washout Period (Months 7-9)|Death|0|||
155391887|NCT00221195|560871175|FG001|Washout Period (Months 7-9)|Death|1|||
154949125|NCT05301751|559239498|FG000|Overall Study|Withdrawal by Subject|0|||
154949126|NCT05301751|559239499|FG001|Overall Study|Withdrawal by Subject|0|||
154949127|NCT05301751|559239500|FG002|Overall Study|Withdrawal by Subject|1|||
154949128|NCT05301751|559239501|FG003|Overall Study|Withdrawal by Subject|0|||
154949129|NCT06165744|559239504|FG000|Overall Study|Non device-related adverse event|1|||
154949130|NCT01546987|559239505|FG000|Overall Study|Protocol Violation|3|||
154949131|NCT01546987|559239506|FG001|Overall Study|Protocol Violation|4|||
154949132|NCT02270736|559239507|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
155391888|NCT00221195|560871174|FG000|Therapy 2 (Months 10-15)|Death|1|||
154949133|NCT02270736|559239508|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
154949134|NCT02270736|559239509|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
155391889|NCT00221195|560871175|FG001|Therapy 2 (Months 10-15)|Death|0|||
155391890|NCT00221195|560871174|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
155391891|NCT00221195|560871175|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
155391892|NCT00833911|560871177|FG000|Titration|Adverse Event|18|||
155391893|NCT00833911|560871177|FG000|Titration|Withdrawal by Subject|3|||
155391894|NCT00833911|560871177|FG000|Maintenance Phase I|Adverse Event|73|||
155391895|NCT00833911|560871177|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
155391896|NCT00833911|560871177|FG000|Maintenance Phase I|Physician Decision|10|||
155391897|NCT00833911|560871177|FG000|Maintenance Phase I|Lack of Efficacy|4|||
155391898|NCT00833911|560871177|FG000|Maintenance Phase II|Adverse Event|6|||
155391899|NCT00833911|560871177|FG000|Maintenance Phase II|Physician Decision|2|||
155391900|NCT00833911|560871177|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
155391901|NCT00833911|560871177|FG000|Maintenance Phase II|Lack of Efficacy|1|||
155391902|NCT01383161|560871178|FG000|Overall Study|Adverse Event|5|||
155391903|NCT01383161|560871179|FG001|Overall Study|Adverse Event|1|||
155391904|NCT01383161|560871178|FG000|Overall Study|Withdrawal by Subject|0|||
155391905|NCT01383161|560871179|FG001|Overall Study|Withdrawal by Subject|2|||
155391906|NCT01383161|560871178|FG000|Overall Study|Lack of Efficacy|0|||
155391907|NCT01383161|560871179|FG001|Overall Study|Lack of Efficacy|1|||
155391908|NCT01423812|560871188|FG000|Overall Study|Lost to Follow-up|2|||
155391909|NCT01423812|560871189|FG001|Overall Study|Lost to Follow-up|2|||
155391910|NCT01423812|560871188|FG000|Overall Study|Withdrawal by Subject|1|||
155391911|NCT01423812|560871189|FG001|Overall Study|Withdrawal by Subject|2|||
155391912|NCT03942406|560871190|FG000|Overall Study|Lost to Follow-up|4|||
155391913|NCT03942406|560871191|FG001|Overall Study|Lost to Follow-up|5|||
155391914|NCT03942406|560871192|FG002|Overall Study|Lost to Follow-up|3|||
155391915|NCT03942406|560871193|FG003|Overall Study|Lost to Follow-up|7|||
155391916|NCT03942406|560871194|FG004|Overall Study|Lost to Follow-up|1|||
155391917|NCT03942406|560871195|FG005|Overall Study|Lost to Follow-up|0|||
155391918|NCT03942406|560871196|FG006|Overall Study|Lost to Follow-up|0|||
155391919|NCT03942406|560871190|FG000|Overall Study|Withdrawal by Subject|3|||
155391920|NCT03942406|560871191|FG001|Overall Study|Withdrawal by Subject|1|||
155391921|NCT03942406|560871192|FG002|Overall Study|Withdrawal by Subject|1|||
155391922|NCT03942406|560871193|FG003|Overall Study|Withdrawal by Subject|3|||
155391923|NCT03942406|560871194|FG004|Overall Study|Withdrawal by Subject|0|||
155391924|NCT03942406|560871195|FG005|Overall Study|Withdrawal by Subject|0|||
155391925|NCT03942406|560871196|FG006|Overall Study|Withdrawal by Subject|0|||
155391926|NCT03942406|560871190|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
155391927|NCT03942406|560871191|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
155391928|NCT03942406|560871192|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
155391929|NCT03942406|560871193|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
155391930|NCT03942406|560871194|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
155391931|NCT03942406|560871195|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
155391932|NCT03942406|560871196|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
155391933|NCT01207596|560871197|FG000|Overall Study|Physician Decision|4|||
155391934|NCT01207596|560871197|FG000|Overall Study|Lack of Efficacy|1|||
155391935|NCT01207596|560871197|FG000|Overall Study|Adverse Event|3|||
155391936|NCT01207596|560871197|FG000|Overall Study|Withdrawal by Subject|1|||
155391937|NCT00216203|560871198|FG000|Overall Study|Withdrawal by Subject|2|||
155391938|NCT03155373|560871208|FG000|Overall Study|No longer required surgery|1|||
155391939|NCT03155373|560871208|FG000|Overall Study|Protocol Violation|1|||
155391940|NCT03155373|560871208|FG000|Overall Study|Death|2|||
155391941|NCT03155373|560871208|FG000|Overall Study|Withdrawal by Subject|3|||
155391942|NCT02616614|560871209|FG000|Overall Study|Withdrawal by Subject|10|||
155391943|NCT02616614|560871210|FG001|Overall Study|Withdrawal by Subject|5|||
155391944|NCT02616614|560871211|FG002|Overall Study|Withdrawal by Subject|6|||
155391945|NCT02616614|560871209|FG000|Overall Study|Physician Decision|2|||
155391946|NCT02616614|560871210|FG001|Overall Study|Physician Decision|1|||
155391947|NCT02616614|560871211|FG002|Overall Study|Physician Decision|0|||
155391948|NCT02616614|560871209|FG000|Overall Study|Adverse Event|1|||
155391949|NCT02616614|560871210|FG001|Overall Study|Adverse Event|4|||
155391950|NCT02616614|560871211|FG002|Overall Study|Adverse Event|1|||
155391951|NCT02616614|560871209|FG000|Overall Study|Protocol Violation|0|||
155391952|NCT02616614|560871210|FG001|Overall Study|Protocol Violation|3|||
155391953|NCT02616614|560871211|FG002|Overall Study|Protocol Violation|1|||
155391954|NCT02616614|560871209|FG000|Overall Study|Prohibited Medication|12|||
155391955|NCT02616614|560871210|FG001|Overall Study|Prohibited Medication|9|||
155391956|NCT02616614|560871211|FG002|Overall Study|Prohibited Medication|5|||
155391957|NCT02616614|560871209|FG000|Overall Study|More than 3 applications missed|6|||
154949135|NCT02270736|559239510|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
154949136|NCT02270736|559239511|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
154949137|NCT02270736|559239507|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
154949138|NCT02270736|559239508|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
154949139|NCT02270736|559239509|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
154949140|NCT02270736|559239510|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
155391958|NCT02616614|560871210|FG001|Overall Study|More than 3 applications missed|8|||
155391959|NCT02616614|560871211|FG002|Overall Study|More than 3 applications missed|1|||
154949141|NCT02270736|559239511|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
154949142|NCT02270736|559239507|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
154949143|NCT02270736|559239508|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
155391960|NCT02616614|560871209|FG000|Overall Study|Lost to Follow-up|31|||
155391961|NCT02616614|560871210|FG001|Overall Study|Lost to Follow-up|28|||
155391962|NCT02616614|560871211|FG002|Overall Study|Lost to Follow-up|13|||
155391963|NCT02616614|560871209|FG000|Overall Study|Pregnancy|2|||
155391964|NCT02616614|560871210|FG001|Overall Study|Pregnancy|0|||
154949144|NCT02270736|559239509|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
154949145|NCT02270736|559239510|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
154949146|NCT02270736|559239511|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
154949147|NCT02270736|559239507|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
154949148|NCT02270736|559239508|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
154949149|NCT02270736|559239509|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
154949150|NCT02270736|559239510|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
154949151|NCT02270736|559239511|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
155282173|NCT01027871|560464066|FG002|Overall Study|Discontinued Prior to Treatment|1|||
155282174|NCT03782727|560464067|FG000|Overall Study|Lost to Follow-up|32|||
155282175|NCT04887285|560464070|FG000|Overall Study|Lost to Follow-up|0|||
155282176|NCT04887285|560464071|FG001|Overall Study|Lost to Follow-up|2|||
155282177|NCT04887285|560464072|FG002|Overall Study|Lost to Follow-up|3|||
155282178|NCT04640571|560464073|FG000|Overall Study|Withdrawal by Subject|0|||
155282179|NCT04640571|560464074|FG001|Overall Study|Withdrawal by Subject|0|||
155282180|NCT04640571|560464075|FG002|Overall Study|Withdrawal by Subject|0|||
155282181|NCT04640571|560464076|FG003|Overall Study|Withdrawal by Subject|0|||
155282182|NCT04640571|560464077|FG004|Overall Study|Withdrawal by Subject|0|||
155282183|NCT04640571|560464078|FG005|Overall Study|Withdrawal by Subject|2|||
155282184|NCT02820051|560464079|FG000|Overall Study|Lost to Follow-up|7|||
155282185|NCT02820051|560464080|FG001|Overall Study|Lost to Follow-up|4|||
155282186|NCT02338609|560464081|FG000|Overall Study|Physician Decision|1|||
155282187|NCT02338609|560464081|FG000|Overall Study|Death|1|||
155282188|NCT00832780|560464082|FG000|Overall Study|Death|16|||
155282189|NCT00832780|560464082|FG000|Overall Study|Lost to Follow-up|4|||
155282190|NCT00832780|560464082|FG000|Overall Study|no reason given|2|||
155282191|NCT00832780|560464082|FG000|Overall Study|other complicating condition|2|||
155282192|NCT00832780|560464082|FG000|Overall Study|Physician Decision|1|||
155282193|NCT05705167|560464085|FG000|Overall Study|Randomised but not Treated|0|||
155282194|NCT05705167|560464086|FG001|Overall Study|Randomised but not Treated|2|||
155282195|NCT05705167|560464087|FG002|Overall Study|Randomised but not Treated|0|||
155282196|NCT05705167|560464088|FG003|Overall Study|Randomised but not Treated|7|||
155282197|NCT05705167|560464089|FG004|Overall Study|Randomised but not Treated|0|||
155282198|NCT05705167|560464090|FG005|Overall Study|Randomised but not Treated|0|||
155282199|NCT05705167|560464091|FG006|Overall Study|Randomised but not Treated|0|||
155282200|NCT05705167|560464085|FG000|Overall Study|Death|0|||
155282201|NCT05705167|560464086|FG001|Overall Study|Death|0|||
155282202|NCT05705167|560464087|FG002|Overall Study|Death|3|||
155282203|NCT05705167|560464088|FG003|Overall Study|Death|0|||
155282204|NCT05705167|560464089|FG004|Overall Study|Death|1|||
155282205|NCT05705167|560464090|FG005|Overall Study|Death|1|||
155282206|NCT05705167|560464091|FG006|Overall Study|Death|1|||
155282207|NCT05705167|560464085|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282208|NCT05705167|560464086|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282209|NCT05705167|560464087|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
155282210|NCT05705167|560464088|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
155282211|NCT05705167|560464089|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282212|NCT05705167|560464090|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
155282213|NCT05705167|560464091|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
155282214|NCT04736056|560464092|FG000|Overall Study|Death|0|||
155282215|NCT04736056|560464093|FG001|Overall Study|Death|0|||
155282216|NCT04736056|560464094|FG002|Overall Study|Death|0|||
155282217|NCT04736056|560464095|FG003|Overall Study|Death|1|||
155282218|NCT04736056|560464092|FG000|Overall Study|Lost to Follow-up|1|||
155282219|NCT04736056|560464093|FG001|Overall Study|Lost to Follow-up|0|||
155282220|NCT04736056|560464094|FG002|Overall Study|Lost to Follow-up|1|||
155282221|NCT04736056|560464095|FG003|Overall Study|Lost to Follow-up|1|||
155282222|NCT04736056|560464092|FG000|Overall Study|Withdrawal by Subject|2|||
155282223|NCT04736056|560464093|FG001|Overall Study|Withdrawal by Subject|0|||
155282224|NCT04736056|560464094|FG002|Overall Study|Withdrawal by Subject|0|||
155282225|NCT04736056|560464095|FG003|Overall Study|Withdrawal by Subject|0|||
155282226|NCT04736056|560464092|FG000|Overall Study|Physician Decision|1|||
155282227|NCT04736056|560464093|FG001|Overall Study|Physician Decision|0|||
155282228|NCT04736056|560464094|FG002|Overall Study|Physician Decision|1|||
155282229|NCT04736056|560464095|FG003|Overall Study|Physician Decision|0|||
155282230|NCT04529538|560464096|FG000|Overall Study|Lost to Follow-up|3|||
155282231|NCT04529538|560464097|FG001|Overall Study|Lost to Follow-up|2|||
155282232|NCT04529538|560464098|FG002|Overall Study|Lost to Follow-up|1|||
155282233|NCT04529538|560464099|FG003|Overall Study|Lost to Follow-up|0|||
155282234|NCT04529538|560464100|FG004|Overall Study|Lost to Follow-up|1|||
155282235|NCT04529538|560464101|FG005|Overall Study|Lost to Follow-up|1|||
155282236|NCT04529538|560464102|FG006|Overall Study|Lost to Follow-up|2|||
155282237|NCT04529538|560464103|FG007|Overall Study|Lost to Follow-up|0|||
155282238|NCT04529538|560464096|FG000|Overall Study|Not eligible at enrollment|0|||
155282239|NCT04529538|560464097|FG001|Overall Study|Not eligible at enrollment|1|||
155282240|NCT04529538|560464098|FG002|Overall Study|Not eligible at enrollment|2|||
155282241|NCT04529538|560464099|FG003|Overall Study|Not eligible at enrollment|1|||
155051412|NCT01566604|559619701|FG001|Overall Study|Patient's inability to use the device|0|||
155051413|NCT01566604|559619700|FG000|Overall Study|Administrative problems|1|||
155051414|NCT01566604|559619701|FG001|Overall Study|Administrative problems|0|||
155051415|NCT01566604|559619700|FG000|Overall Study|Lack of Efficacy|1|||
155051416|NCT01566604|559619701|FG001|Overall Study|Lack of Efficacy|2|||
155051417|NCT01566604|559619700|FG000|Overall Study|Protocol deviation|2|||
155051418|NCT01566604|559619701|FG001|Overall Study|Protocol deviation|0|||
155051419|NCT01566604|559619700|FG000|Overall Study|Abnormal laboratory value|2|||
155391965|NCT02616614|560871211|FG002|Overall Study|Pregnancy|1|||
155391966|NCT02616614|560871209|FG000|Overall Study|Other|1|||
155391967|NCT02616614|560871210|FG001|Overall Study|Other|2|||
155391968|NCT02616614|560871211|FG002|Overall Study|Other|1|||
155391969|NCT02748018|560871212|FG000|Study Period|Adverse Event|1|||
155391970|NCT02748018|560871213|FG001|Study Period|Adverse Event|3|||
155391971|NCT02748018|560871214|FG002|Study Period|Adverse Event|4|||
155391972|NCT02748018|560871215|FG003|Study Period|Adverse Event|0|||
155391973|NCT02748018|560871216|FG004|Study Period|Adverse Event|3|||
155391974|NCT02748018|560871217|FG005|Study Period|Adverse Event|3|||
155391975|NCT02748018|560871212|FG000|Study Period|Withdrawal by Subject|7|||
155391976|NCT02748018|560871213|FG001|Study Period|Withdrawal by Subject|4|||
155391977|NCT02748018|560871214|FG002|Study Period|Withdrawal by Subject|4|||
155391978|NCT02748018|560871215|FG003|Study Period|Withdrawal by Subject|11|||
155391979|NCT02748018|560871216|FG004|Study Period|Withdrawal by Subject|12|||
155391980|NCT02748018|560871217|FG005|Study Period|Withdrawal by Subject|10|||
155391981|NCT02748018|560871212|FG000|Study Period|Pregnancy|0|||
155391982|NCT02748018|560871213|FG001|Study Period|Pregnancy|1|||
155391983|NCT02748018|560871214|FG002|Study Period|Pregnancy|0|||
155391984|NCT02748018|560871215|FG003|Study Period|Pregnancy|0|||
155391985|NCT02748018|560871216|FG004|Study Period|Pregnancy|1|||
155391986|NCT02748018|560871217|FG005|Study Period|Pregnancy|0|||
155391987|NCT02748018|560871212|FG000|Study Period|Physician Decision|2|||
155391988|NCT02748018|560871213|FG001|Study Period|Physician Decision|2|||
155391989|NCT02748018|560871214|FG002|Study Period|Physician Decision|1|||
155391990|NCT02748018|560871215|FG003|Study Period|Physician Decision|0|||
155391991|NCT02748018|560871216|FG004|Study Period|Physician Decision|2|||
155391992|NCT02748018|560871217|FG005|Study Period|Physician Decision|0|||
155391993|NCT02748018|560871212|FG000|Study Period|Lost to Follow-up|0|||
155391994|NCT02748018|560871213|FG001|Study Period|Lost to Follow-up|0|||
155391995|NCT02748018|560871214|FG002|Study Period|Lost to Follow-up|0|||
155391996|NCT02748018|560871215|FG003|Study Period|Lost to Follow-up|2|||
155391997|NCT02748018|560871216|FG004|Study Period|Lost to Follow-up|0|||
155391998|NCT02748018|560871217|FG005|Study Period|Lost to Follow-up|1|||
155391999|NCT02748018|560871212|FG000|Continuation Period|Adverse Event|2|||
155392000|NCT02748018|560871213|FG001|Continuation Period|Adverse Event|0|||
155392001|NCT02748018|560871214|FG002|Continuation Period|Adverse Event|1|||
155392002|NCT02748018|560871215|FG003|Continuation Period|Adverse Event|1|||
155392003|NCT02748018|560871216|FG004|Continuation Period|Adverse Event|1|||
155392004|NCT02748018|560871217|FG005|Continuation Period|Adverse Event|4|||
155392005|NCT02748018|560871212|FG000|Continuation Period|Withdrawal by Subject|3|||
155392006|NCT02748018|560871213|FG001|Continuation Period|Withdrawal by Subject|5|||
155392007|NCT02748018|560871214|FG002|Continuation Period|Withdrawal by Subject|3|||
155392008|NCT02748018|560871215|FG003|Continuation Period|Withdrawal by Subject|9|||
155392009|NCT02748018|560871216|FG004|Continuation Period|Withdrawal by Subject|11|||
155392010|NCT02748018|560871217|FG005|Continuation Period|Withdrawal by Subject|1|||
155392011|NCT02748018|560871212|FG000|Continuation Period|Lost to Follow-up|0|||
155392012|NCT02748018|560871213|FG001|Continuation Period|Lost to Follow-up|2|||
155392013|NCT02748018|560871214|FG002|Continuation Period|Lost to Follow-up|1|||
155392014|NCT02748018|560871215|FG003|Continuation Period|Lost to Follow-up|0|||
155392015|NCT02748018|560871216|FG004|Continuation Period|Lost to Follow-up|1|||
155392016|NCT02748018|560871217|FG005|Continuation Period|Lost to Follow-up|0|||
155392017|NCT02748018|560871212|FG000|Continuation Period|Pregnancy|1|||
155392018|NCT02748018|560871213|FG001|Continuation Period|Pregnancy|2|||
155392019|NCT02748018|560871214|FG002|Continuation Period|Pregnancy|0|||
155392020|NCT02748018|560871215|FG003|Continuation Period|Pregnancy|0|||
155392021|NCT02748018|560871216|FG004|Continuation Period|Pregnancy|0|||
155051420|NCT01566604|559619701|FG001|Overall Study|Abnormal laboratory value|0|||
155051421|NCT01566604|559619700|FG000|Overall Study|Death|4|||
155051422|NCT01566604|559619701|FG001|Overall Study|Death|1|||
155051423|NCT01566604|559619700|FG000|Overall Study|Adverse Event|4|||
155051424|NCT01566604|559619701|FG001|Overall Study|Adverse Event|2|||
155051425|NCT01566604|559619700|FG000|Overall Study|Withdrawal by Subject|9|||
155051426|NCT01566604|559619701|FG001|Overall Study|Withdrawal by Subject|6|||
155051427|NCT00873730|559621468|FG000|Overall Study|Protocol Deviation|5|||
155051428|NCT00873730|559621469|FG001|Overall Study|Protocol Deviation|2|||
155392022|NCT02748018|560871217|FG005|Continuation Period|Pregnancy|0|||
155392023|NCT02748018|560871212|FG000|Continuation Period|Physician Decision|0|||
155392024|NCT02748018|560871213|FG001|Continuation Period|Physician Decision|1|||
155392025|NCT02748018|560871214|FG002|Continuation Period|Physician Decision|2|||
155392026|NCT02748018|560871215|FG003|Continuation Period|Physician Decision|0|||
155392027|NCT02748018|560871216|FG004|Continuation Period|Physician Decision|2|||
155392028|NCT02748018|560871217|FG005|Continuation Period|Physician Decision|1|||
155392029|NCT02748018|560871212|FG000|Continuation Period|Protocol Violation|0|||
155392030|NCT02748018|560871213|FG001|Continuation Period|Protocol Violation|1|||
155392031|NCT02748018|560871214|FG002|Continuation Period|Protocol Violation|0|||
155392032|NCT02748018|560871215|FG003|Continuation Period|Protocol Violation|0|||
155392033|NCT02748018|560871216|FG004|Continuation Period|Protocol Violation|0|||
155392034|NCT02748018|560871217|FG005|Continuation Period|Protocol Violation|0|||
155392035|NCT02856893|560871218|FG000|Overall Study|Lack of Efficacy|27|||
155392036|NCT02856893|560871219|FG001|Overall Study|Lack of Efficacy|15|||
155392037|NCT02856893|560871220|FG002|Overall Study|Lack of Efficacy|19|||
155392038|NCT02856893|560871218|FG000|Overall Study|Death|1|||
155392039|NCT02856893|560871219|FG001|Overall Study|Death|0|||
155392040|NCT02856893|560871220|FG002|Overall Study|Death|0|||
155392041|NCT02856893|560871218|FG000|Overall Study|Adverse Event|2|||
155392042|NCT02856893|560871219|FG001|Overall Study|Adverse Event|0|||
155392043|NCT02856893|560871220|FG002|Overall Study|Adverse Event|0|||
155392044|NCT02856893|560871218|FG000|Overall Study|Physician Decision|0|||
155392045|NCT02856893|560871219|FG001|Overall Study|Physician Decision|2|||
155392046|NCT02856893|560871220|FG002|Overall Study|Physician Decision|3|||
155392047|NCT02856893|560871218|FG000|Overall Study|Withdrawal by Subject|1|||
155392048|NCT02856893|560871219|FG001|Overall Study|Withdrawal by Subject|1|||
155392049|NCT02856893|560871220|FG002|Overall Study|Withdrawal by Subject|0|||
155392050|NCT02856893|560871218|FG000|Overall Study|Other reasons|2|||
155392051|NCT02856893|560871219|FG001|Overall Study|Other reasons|1|||
155392052|NCT02856893|560871220|FG002|Overall Study|Other reasons|2|||
155392053|NCT01324323|560871228|FG000|Overall Study|Withdrawal by Subject|1|||
155392054|NCT00537485|560871229|FG000|Overall Study|Adverse Event|10|||
155392055|NCT00537485|560871230|FG001|Overall Study|Adverse Event|5|||
155392056|NCT00537485|560871229|FG000|Overall Study|Withdrawal by Subject|3|||
155392057|NCT00537485|560871230|FG001|Overall Study|Withdrawal by Subject|2|||
155392058|NCT00537485|560871229|FG000|Overall Study|Withdrawal by Subject|1|||
155392059|NCT00537485|560871230|FG001|Overall Study|Withdrawal by Subject|3|||
155392060|NCT00537485|560871229|FG000|Overall Study|Physician Decision|1|||
155392061|NCT00537485|560871230|FG001|Overall Study|Physician Decision|0|||
155392062|NCT01601847|560871234|FG000|Overall Study|Death|1|||
155392063|NCT01601847|560871235|FG001|Overall Study|Death|0|||
155392064|NCT01601847|560871234|FG000|Overall Study|Withdrawal by Subject|11|||
155392065|NCT01601847|560871235|FG001|Overall Study|Withdrawal by Subject|7|||
155392066|NCT01601847|560871234|FG000|Overall Study|Lost to Follow-up|1|||
155392067|NCT01601847|560871235|FG001|Overall Study|Lost to Follow-up|3|||
155392068|NCT00631189|560871236|FG000|Initial Phase|Protocol Violation|347|||
155392069|NCT00631189|560871237|FG001|Initial Phase|Protocol Violation|0|||
155392070|NCT00631189|560871238|FG002|Initial Phase|Protocol Violation|0|||
155392071|NCT00631189|560871239|FG003|Initial Phase|Protocol Violation|0|||
155392072|NCT00631189|560871236|FG000|Initial Phase|Withdrawal by Subject|4|||
155392073|NCT00631189|560871237|FG001|Initial Phase|Withdrawal by Subject|0|||
155392074|NCT00631189|560871238|FG002|Initial Phase|Withdrawal by Subject|0|||
155392075|NCT00631189|560871239|FG003|Initial Phase|Withdrawal by Subject|0|||
155392076|NCT00631189|560871236|FG000|Treatment Phase|Withdrawal by Subject|0|||
155392077|NCT00631189|560871237|FG001|Treatment Phase|Withdrawal by Subject|2|||
155392078|NCT00631189|560871238|FG002|Treatment Phase|Withdrawal by Subject|1|||
155392079|NCT00631189|560871239|FG003|Treatment Phase|Withdrawal by Subject|1|||
155392080|NCT00631189|560871236|FG000|Treatment Phase|Protocol Violation|0|||
155392081|NCT00631189|560871237|FG001|Treatment Phase|Protocol Violation|1|||
155392082|NCT00631189|560871238|FG002|Treatment Phase|Protocol Violation|6|||
155392083|NCT00631189|560871239|FG003|Treatment Phase|Protocol Violation|2|||
155392084|NCT00631189|560871236|FG000|Treatment Phase|Adverse Event|0|||
155392085|NCT00631189|560871237|FG001|Treatment Phase|Adverse Event|3|||
155392086|NCT00631189|560871238|FG002|Treatment Phase|Adverse Event|2|||
155392087|NCT00631189|560871239|FG003|Treatment Phase|Adverse Event|4|||
154949152|NCT02270736|559239507|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
154949153|NCT02270736|559239508|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
154949154|NCT02270736|559239509|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
154949155|NCT02270736|559239510|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
155392088|NCT00631189|560871236|FG000|Treatment Phase|Lost to Follow-up|0|||
155392089|NCT00631189|560871237|FG001|Treatment Phase|Lost to Follow-up|1|||
155392090|NCT00631189|560871238|FG002|Treatment Phase|Lost to Follow-up|0|||
155392091|NCT00631189|560871239|FG003|Treatment Phase|Lost to Follow-up|0|||
155392092|NCT00631189|560871236|FG000|Treatment Phase|Pregnancy|0|||
155392093|NCT00631189|560871237|FG001|Treatment Phase|Pregnancy|0|||
155392094|NCT00631189|560871238|FG002|Treatment Phase|Pregnancy|1|||
155392095|NCT00631189|560871239|FG003|Treatment Phase|Pregnancy|0|||
155392096|NCT00631189|560871236|FG000|Treatment Phase|patient did not take pravastatin|0|||
155392097|NCT00631189|560871237|FG001|Treatment Phase|patient did not take pravastatin|0|||
155392098|NCT00631189|560871238|FG002|Treatment Phase|patient did not take pravastatin|1|||
154949156|NCT02270736|559239511|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
154949157|NCT02270736|559239507|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
155392099|NCT00631189|560871239|FG003|Treatment Phase|patient did not take pravastatin|0|||
155392100|NCT04464265|560871240|FG000|Overall Study|Physician Decision|2|||
155392101|NCT01284062|560871241|FG000|Overall Study|Adverse Event|4|||
155392102|NCT01284062|560871242|FG001|Overall Study|Adverse Event|5|||
155392103|NCT01284062|560871243|FG002|Overall Study|Adverse Event|0|||
155392104|NCT01284062|560871244|FG003|Overall Study|Adverse Event|5|||
155392105|NCT01284062|560871241|FG000|Overall Study|Lack of Efficacy|3|||
155392106|NCT01284062|560871242|FG001|Overall Study|Lack of Efficacy|2|||
155392107|NCT01284062|560871243|FG002|Overall Study|Lack of Efficacy|2|||
155392108|NCT01284062|560871244|FG003|Overall Study|Lack of Efficacy|1|||
155392109|NCT01284062|560871241|FG000|Overall Study|Medication error without adverse event|0|||
155392110|NCT01284062|560871242|FG001|Overall Study|Medication error without adverse event|0|||
155392111|NCT01284062|560871243|FG002|Overall Study|Medication error without adverse event|1|||
155392112|NCT01284062|560871244|FG003|Overall Study|Medication error without adverse event|0|||
155392113|NCT01284062|560871241|FG000|Overall Study|Protocol Violation|1|||
155392114|NCT01284062|560871242|FG001|Overall Study|Protocol Violation|0|||
155392115|NCT01284062|560871243|FG002|Overall Study|Protocol Violation|0|||
155392116|NCT01284062|560871244|FG003|Overall Study|Protocol Violation|2|||
155392117|NCT01284062|560871241|FG000|Overall Study|Withdrawal by Subject|3|||
155392118|NCT01284062|560871242|FG001|Overall Study|Withdrawal by Subject|1|||
155392119|NCT01284062|560871243|FG002|Overall Study|Withdrawal by Subject|2|||
155392120|NCT01284062|560871244|FG003|Overall Study|Withdrawal by Subject|5|||
155392121|NCT01284062|560871241|FG000|Overall Study|Other|0|||
155392122|NCT01284062|560871242|FG001|Overall Study|Other|0|||
155392123|NCT01284062|560871243|FG002|Overall Study|Other|0|||
155392124|NCT01284062|560871244|FG003|Overall Study|Other|1|||
155392125|NCT01284062|560871241|FG000|Overall Study|Site Closed|0|||
155392126|NCT01284062|560871242|FG001|Overall Study|Site Closed|0|||
155392127|NCT01284062|560871243|FG002|Overall Study|Site Closed|1|||
155392128|NCT01284062|560871244|FG003|Overall Study|Site Closed|0|||
155392129|NCT00974090|560871245|FG000|Period 1: Double Blind Period|Adverse Event|2|||
155392130|NCT00974090|560871246|FG001|Period 1: Double Blind Period|Adverse Event|1|||
155392131|NCT00974090|560871245|FG000|Period 1: Double Blind Period|Physician Decision|1|||
155392132|NCT00974090|560871246|FG001|Period 1: Double Blind Period|Physician Decision|0|||
155392133|NCT00974090|560871245|FG000|Period 2: Open-label Period|Adverse Event|4|||
155392134|NCT00974090|560871246|FG001|Period 2: Open-label Period|Adverse Event|6|||
155392135|NCT00974090|560871245|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
155392136|NCT00974090|560871246|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
155392137|NCT00974090|560871245|FG000|Period 2: Open-label Period|Physician Decision|0|||
155392138|NCT00974090|560871246|FG001|Period 2: Open-label Period|Physician Decision|3|||
155392139|NCT00974090|560871245|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
155392140|NCT00974090|560871246|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
155392141|NCT01026142|560871251|FG000|Overall Study|Death|136|||
155392142|NCT01026142|560871252|FG001|Overall Study|Death|134|||
155392143|NCT01026142|560871251|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
155392144|NCT01026142|560871252|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
155392145|NCT00634010|560871253|FG000|Overall Study|Adverse Event|2|||
155392146|NCT00634010|560871254|FG001|Overall Study|Adverse Event|5|||
155392147|NCT00634010|560871253|FG000|Overall Study|Withdrawal by Subject|5|||
155392148|NCT00634010|560871254|FG001|Overall Study|Withdrawal by Subject|6|||
155392149|NCT00634010|560871253|FG000|Overall Study|Physician Decision|1|||
155392150|NCT00634010|560871254|FG001|Overall Study|Physician Decision|1|||
155392151|NCT00634010|560871253|FG000|Overall Study|Disease Progression|1|||
155392152|NCT00634010|560871254|FG001|Overall Study|Disease Progression|1|||
155392153|NCT00634010|560871253|FG000|Overall Study|Non-Compliant|1|||
155392154|NCT00634010|560871254|FG001|Overall Study|Non-Compliant|1|||
155392155|NCT01019317|560871255|FG000|Overall Study|Not Eligible|4|||
155392156|NCT01012739|560871256|FG000|Treatment Period 1|Adverse Event|0|||
155392157|NCT01012739|560871257|FG001|Treatment Period 1|Adverse Event|0|||
155392158|NCT01012739|560871258|FG002|Treatment Period 1|Adverse Event|0|||
155392159|NCT01012739|560871259|FG003|Treatment Period 1|Adverse Event|1|||
155392160|NCT01012739|560871256|FG000|Treatment Period 2|Abnormal test procedure results|0|||
155392161|NCT01012739|560871257|FG001|Treatment Period 2|Abnormal test procedure results|0|||
155392162|NCT01012739|560871258|FG002|Treatment Period 2|Abnormal test procedure results|0|||
155392163|NCT01012739|560871259|FG003|Treatment Period 2|Abnormal test procedure results|1|||
155392164|NCT04540133|560871260|FG000|Overall Study|Lost to Follow-up|1|||
155392165|NCT04540133|560871261|FG001|Overall Study|Lost to Follow-up|0|||
155392166|NCT04029480|560871262|FG000|Overall Study|Physician Decision|0|||
155392167|NCT04029480|560871263|FG001|Overall Study|Physician Decision|0|||
155051429|NCT00873730|559621468|FG000|Overall Study|Adverse Event|0|||
155392168|NCT04029480|560871264|FG002|Overall Study|Physician Decision|2|||
155392169|NCT04029480|560871265|FG003|Overall Study|Physician Decision|1|||
155392170|NCT04029480|560871262|FG000|Overall Study|Withdrawal by Subject|2|||
155392171|NCT04029480|560871263|FG001|Overall Study|Withdrawal by Subject|0|||
155392172|NCT04029480|560871264|FG002|Overall Study|Withdrawal by Subject|1|||
155392173|NCT04029480|560871265|FG003|Overall Study|Withdrawal by Subject|1|||
155392174|NCT04786119|560871266|FG000|Overall Study|Withdrawal by Subject|4|||
155392175|NCT04786119|560871267|FG001|Overall Study|Withdrawal by Subject|5|||
155392176|NCT04786119|560871266|FG000|Overall Study|Lost to Follow-up|5|||
155392177|NCT04786119|560871267|FG001|Overall Study|Lost to Follow-up|5|||
155392178|NCT04786119|560871266|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
155392179|NCT04786119|560871267|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
155392180|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
155392181|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
155392182|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
155392183|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
155392184|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
155392185|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
155392186|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
155392187|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
155392188|NCT01658826|560871278|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
155392189|NCT01658826|560871279|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
155392190|NCT01658826|560871278|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
155392191|NCT01658826|560871279|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
155392192|NCT01658826|560871278|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
155392193|NCT01658826|560871279|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
155392194|NCT01658826|560871278|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
155392195|NCT01658826|560871279|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
155392196|NCT01658826|560871278|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
155392197|NCT01658826|560871279|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
155392198|NCT00866697|560871283|FG000|Overall Study|Study closed/terminated|156|||
155392199|NCT00866697|560871284|FG001|Overall Study|Study closed/terminated|138|||
155392200|NCT00866697|560871283|FG000|Overall Study|Lost to Follow-up|22|||
155392201|NCT00866697|560871284|FG001|Overall Study|Lost to Follow-up|28|||
155392202|NCT00866697|560871283|FG000|Overall Study|Physician Decision|3|||
155392203|NCT00866697|560871284|FG001|Overall Study|Physician Decision|5|||
155392204|NCT00866697|560871283|FG000|Overall Study|Withdrawal by Subject|33|||
155392205|NCT00866697|560871284|FG001|Overall Study|Withdrawal by Subject|57|||
155392206|NCT00447382|560871285|FG000|Overall Study|Adverse Event|1|||
155392207|NCT00447382|560871286|FG001|Overall Study|Adverse Event|1|||
155392208|NCT00447382|560871285|FG000|Overall Study|Lack of Efficacy|1|||
155392209|NCT00447382|560871286|FG001|Overall Study|Lack of Efficacy|0|||
155392210|NCT00447382|560871285|FG000|Overall Study|Protocol Violation|2|||
155392211|NCT00447382|560871286|FG001|Overall Study|Protocol Violation|0|||
155392212|NCT00447382|560871285|FG000|Overall Study|Unclassified|2|||
155392213|NCT00447382|560871286|FG001|Overall Study|Unclassified|5|||
155392214|NCT02408861|560871287|FG000|Overall Study|Death|0|||
155392215|NCT02408861|560871288|FG001|Overall Study|Death|3|||
155392216|NCT02408861|560871289|FG002|Overall Study|Death|1|||
155392217|NCT02408861|560871290|FG003|Overall Study|Death|2|||
155392218|NCT02408861|560871291|FG004|Overall Study|Death|4|||
155392219|NCT02408861|560871292|FG005|Overall Study|Death|1|||
155392220|NCT02408861|560871293|FG006|Overall Study|Death|0|||
155392221|NCT02408861|560871287|FG000|Overall Study|Lost to Follow-up|0|||
155392222|NCT02408861|560871288|FG001|Overall Study|Lost to Follow-up|0|||
155392223|NCT02408861|560871289|FG002|Overall Study|Lost to Follow-up|1|||
155392224|NCT02408861|560871290|FG003|Overall Study|Lost to Follow-up|1|||
155392225|NCT02408861|560871291|FG004|Overall Study|Lost to Follow-up|4|||
155392226|NCT02408861|560871292|FG005|Overall Study|Lost to Follow-up|2|||
155392227|NCT02408861|560871293|FG006|Overall Study|Lost to Follow-up|1|||
155392228|NCT02408861|560871287|FG000|Overall Study|Disease Progression|0|||
155392229|NCT02408861|560871288|FG001|Overall Study|Disease Progression|0|||
155392230|NCT02408861|560871289|FG002|Overall Study|Disease Progression|1|||
155392231|NCT02408861|560871290|FG003|Overall Study|Disease Progression|0|||
154949158|NCT02270736|559239508|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
154949159|NCT02270736|559239509|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
154949160|NCT02270736|559239510|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
154949161|NCT02270736|559239511|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
154949162|NCT02270736|559239507|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
155392232|NCT02408861|560871291|FG004|Overall Study|Disease Progression|3|||
155392233|NCT02408861|560871292|FG005|Overall Study|Disease Progression|1|||
155392234|NCT02408861|560871293|FG006|Overall Study|Disease Progression|1|||
155392235|NCT02408861|560871287|FG000|Overall Study|Adverse Event|1|||
155392236|NCT02408861|560871288|FG001|Overall Study|Adverse Event|0|||
155392237|NCT02408861|560871289|FG002|Overall Study|Adverse Event|1|||
155392238|NCT02408861|560871290|FG003|Overall Study|Adverse Event|0|||
155392239|NCT02408861|560871291|FG004|Overall Study|Adverse Event|2|||
155392240|NCT02408861|560871292|FG005|Overall Study|Adverse Event|0|||
155392241|NCT02408861|560871293|FG006|Overall Study|Adverse Event|0|||
155392242|NCT02408861|560871287|FG000|Overall Study|Physician Decision|1|||
155392243|NCT02408861|560871288|FG001|Overall Study|Physician Decision|1|||
155392244|NCT02408861|560871289|FG002|Overall Study|Physician Decision|1|||
155392245|NCT02408861|560871290|FG003|Overall Study|Physician Decision|0|||
155392246|NCT02408861|560871291|FG004|Overall Study|Physician Decision|0|||
155392247|NCT02408861|560871292|FG005|Overall Study|Physician Decision|1|||
155392248|NCT02408861|560871293|FG006|Overall Study|Physician Decision|0|||
155392249|NCT02408861|560871287|FG000|Overall Study|Protocol Violation|1|||
155392250|NCT02408861|560871288|FG001|Overall Study|Protocol Violation|0|||
155392251|NCT02408861|560871289|FG002|Overall Study|Protocol Violation|0|||
155392252|NCT02408861|560871290|FG003|Overall Study|Protocol Violation|0|||
155392253|NCT02408861|560871291|FG004|Overall Study|Protocol Violation|0|||
155392254|NCT02408861|560871292|FG005|Overall Study|Protocol Violation|0|||
155392255|NCT02408861|560871293|FG006|Overall Study|Protocol Violation|0|||
155392256|NCT02408861|560871287|FG000|Overall Study|Withdrawal by Subject|0|||
155392257|NCT02408861|560871288|FG001|Overall Study|Withdrawal by Subject|0|||
155392258|NCT02408861|560871289|FG002|Overall Study|Withdrawal by Subject|0|||
155392259|NCT02408861|560871290|FG003|Overall Study|Withdrawal by Subject|0|||
155392260|NCT02408861|560871291|FG004|Overall Study|Withdrawal by Subject|1|||
155392261|NCT02408861|560871292|FG005|Overall Study|Withdrawal by Subject|1|||
155392262|NCT02408861|560871293|FG006|Overall Study|Withdrawal by Subject|0|||
155392263|NCT02408861|560871287|FG000|Overall Study|Other Treatment|0|||
155392264|NCT02408861|560871288|FG001|Overall Study|Other Treatment|0|||
155392265|NCT02408861|560871289|FG002|Overall Study|Other Treatment|0|||
155392266|NCT02408861|560871290|FG003|Overall Study|Other Treatment|0|||
155392267|NCT02408861|560871291|FG004|Overall Study|Other Treatment|0|||
155392268|NCT02408861|560871292|FG005|Overall Study|Other Treatment|1|||
155392269|NCT02408861|560871293|FG006|Overall Study|Other Treatment|1|||
155392270|NCT04567615|560871294|FG000|Randomization|Participant withdrew consent|1|||
155392271|NCT04567615|560871295|FG001|Randomization|Participant withdrew consent|0|||
155392272|NCT04567615|560871296|FG002|Randomization|Participant withdrew consent|0|||
155392273|NCT04567615|560871294|FG000|Randomization|Adverse event unrelated to study drug|0|||
155392274|NCT04567615|560871295|FG001|Randomization|Adverse event unrelated to study drug|1|||
155392275|NCT04567615|560871296|FG002|Randomization|Adverse event unrelated to study drug|0|||
155392276|NCT04567615|560871294|FG000|Treatment Period|Participant Withdrew Consent|2|||
155392277|NCT04567615|560871295|FG001|Treatment Period|Participant Withdrew Consent|5|||
155392278|NCT04567615|560871296|FG002|Treatment Period|Participant Withdrew Consent|1|||
155392279|NCT04567615|560871294|FG000|Treatment Period|Death|1|||
155392280|NCT04567615|560871295|FG001|Treatment Period|Death|2|||
155392281|NCT04567615|560871296|FG002|Treatment Period|Death|0|||
155392282|NCT04567615|560871294|FG000|Treatment Period|Lost to Follow-up|0|||
155392283|NCT04567615|560871295|FG001|Treatment Period|Lost to Follow-up|1|||
155392284|NCT04567615|560871296|FG002|Treatment Period|Lost to Follow-up|0|||
155392285|NCT04567615|560871294|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155392286|NCT04567615|560871295|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
155392287|NCT04567615|560871296|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155392288|NCT04567615|560871294|FG000|Treatment Period|Disease Progression|85|||
155392289|NCT04567615|560871295|FG001|Treatment Period|Disease Progression|63|||
155392290|NCT04567615|560871296|FG002|Treatment Period|Disease Progression|16|||
155392291|NCT04567615|560871294|FG000|Treatment Period|Study Drug Toxicity|3|||
155392292|NCT04567615|560871295|FG001|Treatment Period|Study Drug Toxicity|10|||
155392293|NCT04567615|560871296|FG002|Treatment Period|Study Drug Toxicity|4|||
155392294|NCT04567615|560871294|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
155392295|NCT04567615|560871295|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
155392296|NCT04567615|560871296|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
155392297|NCT04567615|560871294|FG000|Treatment Period|Other Reasons|1|||
155392298|NCT04567615|560871295|FG001|Treatment Period|Other Reasons|2|||
155392299|NCT04567615|560871296|FG002|Treatment Period|Other Reasons|0|||
155392300|NCT04567615|560871294|FG000|Treatment Period|Still On-going Treatment|21|||
155392301|NCT04567615|560871295|FG001|Treatment Period|Still On-going Treatment|22|||
155392302|NCT04567615|560871296|FG002|Treatment Period|Still On-going Treatment|2|||
155392303|NCT05028517|560871297|FG000|Overall Study|Lost to Follow-up|13|||
155392304|NCT05028517|560871298|FG001|Overall Study|Lost to Follow-up|20|||
155392305|NCT05028517|560871299|FG002|Overall Study|Lost to Follow-up|12|||
155392306|NCT05028517|560871297|FG000|Overall Study|Withdrawal by Subject|0|||
155392307|NCT05028517|560871298|FG001|Overall Study|Withdrawal by Subject|0|||
155392308|NCT05028517|560871299|FG002|Overall Study|Withdrawal by Subject|1|||
155392309|NCT04890054|560872875|FG000|Overall Study|Lost to Follow-up|202|||
155392310|NCT04890054|560872876|FG001|Overall Study|Lost to Follow-up|219|||
155392311|NCT00523718|560872879|FG000|Overall Study|Withdrawal by Subject|1|||
155392312|NCT00523718|560872880|FG001|Overall Study|Withdrawal by Subject|0|||
155051430|NCT00873730|559621469|FG001|Overall Study|Adverse Event|2|||
155392313|NCT00523718|560872879|FG000|Overall Study|Protocol Violation|2|||
155392314|NCT00523718|560872880|FG001|Overall Study|Protocol Violation|0|||
155392315|NCT01436071|560872881|FG000|Overall Study|Adverse Event|1|||
155392316|NCT01436071|560872882|FG001|Overall Study|Adverse Event|0|||
155392317|NCT01436071|560872881|FG000|Overall Study|Lack of Efficacy|16|||
155051431|NCT00873730|559621468|FG000|Overall Study|Withdrawal by Subject|0|||
155051432|NCT00873730|559621469|FG001|Overall Study|Withdrawal by Subject|1|||
155051433|NCT00873730|559621468|FG000|Overall Study|Sponsor decision|1|||
155051434|NCT00873730|559621469|FG001|Overall Study|Sponsor decision|0|||
155051435|NCT00048035|559621472|FG000|Core Period|Early Withdrawals|4|||
155051436|NCT00048035|559621473|FG001|Core Period|Early Withdrawals|2|||
155051437|NCT00048035|559621474|FG002|Core Period|Early Withdrawals|1|||
155051438|NCT00048035|559621475|FG003|Core Period|Early Withdrawals|1|||
155051439|NCT00048035|559621476|FG004|Core Period|Early Withdrawals|1|||
155051440|NCT00048035|559621477|FG005|Core Period|Early Withdrawals|1|||
155051441|NCT00048035|559621478|FG006|Core Period|Early Withdrawals|0|||
155051442|NCT00048035|559621479|FG007|Core Period|Early Withdrawals|0|||
155051443|NCT00048035|559621472|FG000|Extension Year 1|Early Withdrawals|0|||
155051444|NCT00048035|559621473|FG001|Extension Year 1|Early Withdrawals|0|||
155051445|NCT00048035|559621474|FG002|Extension Year 1|Early Withdrawals|0|||
155051446|NCT00048035|559621475|FG003|Extension Year 1|Early Withdrawals|0|||
155051447|NCT00048035|559621476|FG004|Extension Year 1|Early Withdrawals|0|||
155051448|NCT00048035|559621477|FG005|Extension Year 1|Early Withdrawals|0|||
155051449|NCT00048035|559621478|FG006|Extension Year 1|Early Withdrawals|11|||
155051450|NCT00048035|559621479|FG007|Extension Year 1|Early Withdrawals|11|||
155051451|NCT00048035|559621472|FG000|Extension Year 2|Early Withdrawals|0|||
155051452|NCT00048035|559621473|FG001|Extension Year 2|Early Withdrawals|0|||
155282242|NCT04529538|560464100|FG004|Overall Study|Not eligible at enrollment|0|||
155282243|NCT04529538|560464101|FG005|Overall Study|Not eligible at enrollment|0|||
155282244|NCT04529538|560464102|FG006|Overall Study|Not eligible at enrollment|0|||
155282245|NCT04529538|560464103|FG007|Overall Study|Not eligible at enrollment|1|||
155282246|NCT04529538|560464096|FG000|Overall Study|Withdrawal by Subject|0|||
155282247|NCT04529538|560464097|FG001|Overall Study|Withdrawal by Subject|1|||
155282248|NCT04529538|560464098|FG002|Overall Study|Withdrawal by Subject|1|||
155282249|NCT04529538|560464099|FG003|Overall Study|Withdrawal by Subject|2|||
155282250|NCT04529538|560464100|FG004|Overall Study|Withdrawal by Subject|0|||
155282251|NCT04529538|560464101|FG005|Overall Study|Withdrawal by Subject|2|||
155282252|NCT04529538|560464102|FG006|Overall Study|Withdrawal by Subject|3|||
155282253|NCT04529538|560464103|FG007|Overall Study|Withdrawal by Subject|0|||
155282254|NCT04529538|560464096|FG000|Overall Study|Other|0|||
155282255|NCT04529538|560464097|FG001|Overall Study|Other|1|||
155282256|NCT04529538|560464098|FG002|Overall Study|Other|0|||
155282257|NCT04529538|560464099|FG003|Overall Study|Other|0|||
155282258|NCT04529538|560464100|FG004|Overall Study|Other|0|||
155282259|NCT04529538|560464101|FG005|Overall Study|Other|0|||
155282260|NCT04529538|560464102|FG006|Overall Study|Other|0|||
155282261|NCT04529538|560464103|FG007|Overall Study|Other|0|||
155282262|NCT04529538|560464096|FG000|Overall Study|Adverse Event|0|||
155282263|NCT04529538|560464097|FG001|Overall Study|Adverse Event|0|||
155282264|NCT04529538|560464098|FG002|Overall Study|Adverse Event|0|||
155282265|NCT04529538|560464099|FG003|Overall Study|Adverse Event|1|||
155282266|NCT04529538|560464100|FG004|Overall Study|Adverse Event|0|||
155282267|NCT04529538|560464101|FG005|Overall Study|Adverse Event|0|||
155282268|NCT04529538|560464102|FG006|Overall Study|Adverse Event|0|||
155282269|NCT04529538|560464103|FG007|Overall Study|Adverse Event|0|||
155282270|NCT04529538|560464096|FG000|Overall Study|Protocol Deviation|0|||
155282271|NCT04529538|560464097|FG001|Overall Study|Protocol Deviation|0|||
155282272|NCT04529538|560464098|FG002|Overall Study|Protocol Deviation|0|||
155282273|NCT04529538|560464099|FG003|Overall Study|Protocol Deviation|1|||
155282274|NCT04529538|560464100|FG004|Overall Study|Protocol Deviation|0|||
155282275|NCT04529538|560464101|FG005|Overall Study|Protocol Deviation|0|||
155282276|NCT04529538|560464102|FG006|Overall Study|Protocol Deviation|0|||
155282277|NCT04529538|560464103|FG007|Overall Study|Protocol Deviation|0|||
155282278|NCT04529538|560464096|FG000|Overall Study|Physician Decision|0|||
155282279|NCT04529538|560464097|FG001|Overall Study|Physician Decision|0|||
155282280|NCT04529538|560464098|FG002|Overall Study|Physician Decision|0|||
155282281|NCT04529538|560464099|FG003|Overall Study|Physician Decision|0|||
155282282|NCT04529538|560464100|FG004|Overall Study|Physician Decision|0|||
155282283|NCT04529538|560464101|FG005|Overall Study|Physician Decision|1|||
155282284|NCT04529538|560464102|FG006|Overall Study|Physician Decision|0|||
155282285|NCT04529538|560464103|FG007|Overall Study|Physician Decision|1|||
155282286|NCT00114959|560464106|FG000|Overall Study|Lack of Efficacy|6|||
155051453|NCT00048035|559621474|FG002|Extension Year 2|Early Withdrawals|0|||
155051454|NCT00048035|559621475|FG003|Extension Year 2|Early Withdrawals|0|||
155051455|NCT00048035|559621476|FG004|Extension Year 2|Early Withdrawals|0|||
155051456|NCT00048035|559621477|FG005|Extension Year 2|Early Withdrawals|0|||
155051457|NCT00048035|559621478|FG006|Extension Year 2|Early Withdrawals|3|||
155051458|NCT00048035|559621479|FG007|Extension Year 2|Early Withdrawals|3|||
155282287|NCT00114959|560464106|FG000|Overall Study|Physician Decision|1|||
155282288|NCT00114959|560464106|FG000|Overall Study|Death|1|||
155282289|NCT03706690|560464107|FG000|Overall Study|Withdrawal by Subject|8|||
155282290|NCT03706690|560464108|FG001|Overall Study|Withdrawal by Subject|8|||
155282291|NCT03706690|560464107|FG000|Overall Study|Death|143|||
155282292|NCT03706690|560464108|FG001|Overall Study|Death|75|||
155282293|NCT03706690|560464107|FG000|Overall Study|Ongoing at DCO|121|||
155392318|NCT01436071|560872882|FG001|Overall Study|Lack of Efficacy|7|||
155392319|NCT01436071|560872881|FG000|Overall Study|Protocol Violation|0|||
155392320|NCT01436071|560872882|FG001|Overall Study|Protocol Violation|1|||
155392321|NCT01436071|560872881|FG000|Overall Study|Lost to Follow-up|3|||
155392322|NCT01436071|560872882|FG001|Overall Study|Lost to Follow-up|1|||
155392323|NCT01436071|560872881|FG000|Overall Study|Physician Decision|1|||
155392324|NCT01436071|560872882|FG001|Overall Study|Physician Decision|0|||
155392325|NCT01436071|560872881|FG000|Overall Study|Withdrawal by Subject|2|||
155392326|NCT01436071|560872882|FG001|Overall Study|Withdrawal by Subject|2|||
154949163|NCT02270736|559239508|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
154949164|NCT02270736|559239509|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
154949165|NCT02270736|559239510|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
154949166|NCT02270736|559239511|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
154949167|NCT02270736|559239507|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
154949168|NCT02270736|559239508|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
154949169|NCT02270736|559239509|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
154949170|NCT02270736|559239510|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
154949171|NCT02270736|559239511|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
154949172|NCT02270736|559239507|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
154949173|NCT02270736|559239508|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
154949174|NCT02270736|559239509|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
154949175|NCT02270736|559239510|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
154949176|NCT02270736|559239511|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
154949177|NCT02446132|559239524|FG000|Overall Study|Adverse Event|10|||
154949178|NCT02446132|559239525|FG001|Overall Study|Adverse Event|27|||
154949179|NCT02446132|559239526|FG002|Overall Study|Adverse Event|27|||
154949180|NCT02446132|559239524|FG000|Overall Study|Death|2|||
154949181|NCT02446132|559239525|FG001|Overall Study|Death|13|||
154949182|NCT02446132|559239526|FG002|Overall Study|Death|10|||
154949183|NCT02446132|559239524|FG000|Overall Study|Lack of Efficacy|1|||
154949184|NCT02446132|559239525|FG001|Overall Study|Lack of Efficacy|10|||
154949185|NCT02446132|559239526|FG002|Overall Study|Lack of Efficacy|6|||
154949186|NCT02446132|559239524|FG000|Overall Study|Lost to Follow-up|2|||
154949187|NCT02446132|559239525|FG001|Overall Study|Lost to Follow-up|4|||
154949188|NCT02446132|559239526|FG002|Overall Study|Lost to Follow-up|5|||
154949189|NCT02446132|559239524|FG000|Overall Study|Non-compliance With Study Drug|2|||
154949190|NCT02446132|559239525|FG001|Overall Study|Non-compliance With Study Drug|2|||
154949191|NCT02446132|559239526|FG002|Overall Study|Non-compliance With Study Drug|3|||
154949192|NCT02446132|559239524|FG000|Overall Study|Physician Decision|1|||
154949193|NCT02446132|559239525|FG001|Overall Study|Physician Decision|8|||
154949194|NCT02446132|559239526|FG002|Overall Study|Physician Decision|13|||
154949195|NCT02446132|559239524|FG000|Overall Study|Protocol Deviation|0|||
154949196|NCT02446132|559239525|FG001|Overall Study|Protocol Deviation|0|||
154949197|NCT02446132|559239526|FG002|Overall Study|Protocol Deviation|1|||
154949198|NCT02446132|559239524|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
154949199|NCT02446132|559239525|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
154949200|NCT02446132|559239526|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
154949201|NCT02446132|559239524|FG000|Overall Study|Study Terminated by Sponsor|4|||
154949202|NCT02446132|559239525|FG001|Overall Study|Study Terminated by Sponsor|35|||
154949203|NCT02446132|559239526|FG002|Overall Study|Study Terminated by Sponsor|58|||
154949204|NCT02446132|559239524|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
154949205|NCT02446132|559239525|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
154949206|NCT02446132|559239526|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
154949207|NCT02446132|559239524|FG000|Overall Study|Withdrawal by Subject|11|||
154949208|NCT02446132|559239525|FG001|Overall Study|Withdrawal by Subject|29|||
154949209|NCT02446132|559239526|FG002|Overall Study|Withdrawal by Subject|25|||
154949210|NCT02446132|559239524|FG000|Overall Study|Reason not Specified|4|||
154949211|NCT02446132|559239525|FG001|Overall Study|Reason not Specified|16|||
154949212|NCT02446132|559239526|FG002|Overall Study|Reason not Specified|10|||
154949213|NCT02446132|559239524|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
154949214|NCT02446132|559239525|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
154949215|NCT02446132|559239526|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
154949216|NCT00810368|559239527|FG000|Overall Study|Lost to Follow-up|4|||
154949217|NCT00810368|559239528|FG001|Overall Study|Lost to Follow-up|2|||
154949218|NCT00810368|559239527|FG000|Overall Study|Lack of Efficacy|2|||
154949219|NCT00810368|559239528|FG001|Overall Study|Lack of Efficacy|0|||
155392327|NCT01436071|560872881|FG000|Overall Study|Did Not Receive Trial Medication|3|||
155392328|NCT01436071|560872882|FG001|Overall Study|Did Not Receive Trial Medication|3|||
155392329|NCT03808688|560872885|FG000|Overall Study|Adverse Event|13|||
154949220|NCT00623103|559239529|FG000|Overall Study|Adverse Event|70|||
154949221|NCT00623103|559239530|FG001|Overall Study|Adverse Event|60|||
155051459|NCT04110314|559621480|FG000|Overall Study|Did not meet inclusion criteria|35255|||
155392330|NCT03808688|560872886|FG001|Overall Study|Adverse Event|17|||
155392331|NCT03808688|560872885|FG000|Overall Study|Lack of Efficacy|2|||
155392332|NCT03808688|560872886|FG001|Overall Study|Lack of Efficacy|0|||
155392333|NCT03808688|560872885|FG000|Overall Study|Lost to Follow-up|0|||
155392334|NCT03808688|560872886|FG001|Overall Study|Lost to Follow-up|2|||
155392335|NCT03808688|560872885|FG000|Overall Study|Withdrawal by Subject|1|||
155392336|NCT03808688|560872886|FG001|Overall Study|Withdrawal by Subject|0|||
155392337|NCT03808688|560872885|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
155392338|NCT03808688|560872886|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
155392339|NCT03808688|560872885|FG000|Overall Study|IOP Too High|1|||
155392340|NCT03808688|560872886|FG001|Overall Study|IOP Too High|1|||
155392341|NCT03808688|560872885|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
155392342|NCT03808688|560872886|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
155392343|NCT03808688|560872885|FG000|Overall Study|Visit Out of Window|0|||
155392344|NCT03808688|560872886|FG001|Overall Study|Visit Out of Window|1|||
155392345|NCT03808688|560872885|FG000|Overall Study|Medication Non-Compliance|0|||
155392346|NCT03808688|560872886|FG001|Overall Study|Medication Non-Compliance|1|||
155392347|NCT01940354|560872887|FG000|Overall Study|Withdrawal by Subject|4|||
155392348|NCT01940354|560872888|FG001|Overall Study|Withdrawal by Subject|2|||
155392349|NCT01096342|560872889|FG000|Overall Study|Protocol Violation|1|||
155392350|NCT00909792|560872890|FG000|Period 1|Did not meet inclusion criteria|0|||
155392351|NCT00909792|560872891|FG001|Period 1|Did not meet inclusion criteria|1|||
155392352|NCT00909792|560872890|FG000|Period 2|Biomicroscopy|1|||
155392353|NCT00909792|560872891|FG001|Period 2|Biomicroscopy|0|||
155392354|NCT00909792|560872890|FG000|Period 2|Lost to Follow-up|0|||
155392355|NCT00909792|560872891|FG001|Period 2|Lost to Follow-up|1|||
155392356|NCT01448213|560872896|FG000|Overall Study|Lost to Follow-up|12|||
155392357|NCT01448213|560872897|FG001|Overall Study|Lost to Follow-up|10|||
155392358|NCT01448213|560872896|FG000|Overall Study|Adverse Event|4|||
155392359|NCT01448213|560872897|FG001|Overall Study|Adverse Event|10|||
155392360|NCT01448213|560872896|FG000|Overall Study|Protocol Violation|1|||
155392361|NCT01448213|560872897|FG001|Overall Study|Protocol Violation|2|||
155392362|NCT04906616|560872902|FG000|Overall Study|Divorce|3|||
155392363|NCT04906616|560872903|FG001|Overall Study|Divorce|2|||
155392364|NCT00607880|560872904|FG000|Overall Study|Unable to place port due to occlusion|1|||
155392365|NCT00607880|560872905|FG001|Overall Study|Unable to place port due to occlusion|0|||
155392366|NCT04606771|560872907|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
155392367|NCT04606771|560872908|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
155392368|NCT04606771|560872907|FG000|Overall Study|Death|5|||
155392369|NCT04606771|560872908|FG001|Overall Study|Death|6|||
155392370|NCT04606771|560872907|FG000|Overall Study|Wrong randomisation|0|||
155392371|NCT04606771|560872908|FG001|Overall Study|Wrong randomisation|1|||
154949222|NCT00623103|559239529|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154949223|NCT00623103|559239530|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
154949224|NCT00623103|559239529|FG000|Overall Study|Withdrawal by Subject|18|||
154949225|NCT00623103|559239530|FG001|Overall Study|Withdrawal by Subject|24|||
154949226|NCT00623103|559239529|FG000|Overall Study|Lost to Follow-up|4|||
154949227|NCT00623103|559239530|FG001|Overall Study|Lost to Follow-up|1|||
154949228|NCT00623103|559239529|FG000|Overall Study|Administrative problems|2|||
154949229|NCT00623103|559239530|FG001|Overall Study|Administrative problems|4|||
154949230|NCT00623103|559239529|FG000|Overall Study|Death|11|||
154949231|NCT00623103|559239530|FG001|Overall Study|Death|11|||
154949232|NCT00623103|559239529|FG000|Overall Study|Protocol deviation|2|||
154949233|NCT00623103|559239530|FG001|Overall Study|Protocol deviation|1|||
154949234|NCT01424722|559239534|FG000|Overall Study|Sponsor terminated investigation|2258|||
154949235|NCT02684578|559239535|FG000|Overall Study|Withdrawal by Subject|10|||
154949236|NCT02684578|559239536|FG001|Overall Study|Withdrawal by Subject|7|||
154949237|NCT02684578|559239535|FG000|Overall Study|Lost to Follow-up|0|||
154949238|NCT02684578|559239536|FG001|Overall Study|Lost to Follow-up|3|||
154949239|NCT02684578|559239535|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
154949240|NCT02684578|559239536|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
154949241|NCT02684578|559239535|FG000|Overall Study|Missing follow-up data|0|||
154949242|NCT02684578|559239536|FG001|Overall Study|Missing follow-up data|1|||
155392372|NCT01754857|560872910|FG000|Overall Study|Adverse Event|7|||
155392373|NCT01754857|560872910|FG000|Overall Study|Disease progression|3|||
155392374|NCT01754857|560872910|FG000|Overall Study|Physician Decision|2|||
155392375|NCT01754857|560872910|FG000|Overall Study|Withdrawal by Subject|3|||
155392376|NCT01754857|560872910|FG000|Overall Study|other complicating disease|1|||
155392377|NCT01754857|560872910|FG000|Overall Study|ineligible to continue onto maintenance|1|||
155392378|NCT01754857|560872910|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
155392379|NCT01754857|560872910|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
155392380|NCT03083847|560872913|FG000|Main|Physician Decision|0|||
155392381|NCT03083847|560872914|FG001|Main|Physician Decision|0|||
155392382|NCT03083847|560872915|FG002|Main|Physician Decision|0|||
155392383|NCT03083847|560872916|FG003|Main|Physician Decision|0|||
155392384|NCT03083847|560872917|FG004|Main|Physician Decision|0|||
155392385|NCT03083847|560872918|FG005|Main|Physician Decision|1|||
154949243|NCT03499964|559239539|FG000|Overall Study|Lack of Efficacy|6|||
154949244|NCT03499964|559239540|FG001|Overall Study|Lack of Efficacy|26|||
155392386|NCT03083847|560872919|FG006|Main|Physician Decision|0|||
155392387|NCT03083847|560872920|FG007|Main|Physician Decision|0|||
155392388|NCT03083847|560872921|FG008|Main|Physician Decision|0|||
155392389|NCT03083847|560872922|FG009|Main|Physician Decision|0|||
155392390|NCT03083847|560872913|FG000|Main|Pregnancy|0|||
155392391|NCT03083847|560872914|FG001|Main|Pregnancy|0|||
155392392|NCT03083847|560872915|FG002|Main|Pregnancy|0|||
155392393|NCT03083847|560872916|FG003|Main|Pregnancy|0|||
155392394|NCT03083847|560872917|FG004|Main|Pregnancy|0|||
155392395|NCT03083847|560872918|FG005|Main|Pregnancy|0|||
155392396|NCT03083847|560872919|FG006|Main|Pregnancy|0|||
155392397|NCT03083847|560872920|FG007|Main|Pregnancy|1|||
155392398|NCT03083847|560872921|FG008|Main|Pregnancy|0|||
155392399|NCT03083847|560872922|FG009|Main|Pregnancy|0|||
155392400|NCT03083847|560872913|FG000|Main|Adverse Event|0|||
155392401|NCT03083847|560872914|FG001|Main|Adverse Event|0|||
155392402|NCT03083847|560872915|FG002|Main|Adverse Event|0|||
155392403|NCT03083847|560872916|FG003|Main|Adverse Event|0|||
155392404|NCT03083847|560872917|FG004|Main|Adverse Event|0|||
155392405|NCT03083847|560872918|FG005|Main|Adverse Event|0|||
155392406|NCT03083847|560872919|FG006|Main|Adverse Event|0|||
155392407|NCT03083847|560872920|FG007|Main|Adverse Event|2|||
155392408|NCT03083847|560872921|FG008|Main|Adverse Event|0|||
155392409|NCT03083847|560872922|FG009|Main|Adverse Event|0|||
155392410|NCT03083847|560872913|FG000|Main|Withdrawal by Subject|0|||
155392411|NCT03083847|560872914|FG001|Main|Withdrawal by Subject|0|||
155392412|NCT03083847|560872915|FG002|Main|Withdrawal by Subject|0|||
155392413|NCT03083847|560872916|FG003|Main|Withdrawal by Subject|0|||
155392414|NCT03083847|560872917|FG004|Main|Withdrawal by Subject|0|||
155392415|NCT03083847|560872918|FG005|Main|Withdrawal by Subject|0|||
155392416|NCT03083847|560872919|FG006|Main|Withdrawal by Subject|1|||
155392417|NCT03083847|560872920|FG007|Main|Withdrawal by Subject|1|||
155392418|NCT03083847|560872921|FG008|Main|Withdrawal by Subject|0|||
155392419|NCT03083847|560872922|FG009|Main|Withdrawal by Subject|0|||
155392420|NCT01214187|560872923|FG000|Overall Study|Adverse Event|6|||
155392421|NCT01214187|560872924|FG001|Overall Study|Adverse Event|2|||
155392422|NCT01214187|560872923|FG000|Overall Study|Death|1|||
155392423|NCT01214187|560872924|FG001|Overall Study|Death|1|||
155392424|NCT01214187|560872923|FG000|Overall Study|Withdrawal by Subject|0|||
155392425|NCT01214187|560872924|FG001|Overall Study|Withdrawal by Subject|3|||
155392426|NCT01233869|560872925|FG000|Initial Treatment Period (24 Months)|Death|1|||
155392427|NCT01233869|560872926|FG001|Initial Treatment Period (24 Months)|Death|0|||
155392428|NCT01233869|560872927|FG002|Initial Treatment Period (24 Months)|Death|0|||
155392429|NCT01233869|560872928|FG003|Initial Treatment Period (24 Months)|Death|0|||
155392430|NCT01233869|560872925|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
155392431|NCT01233869|560872926|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
155392432|NCT01233869|560872927|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
155392433|NCT01233869|560872928|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
155392434|NCT01233869|560872925|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
155392435|NCT01233869|560872926|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
155392436|NCT01233869|560872927|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
155392437|NCT01233869|560872928|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
155392438|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
155392439|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
154949245|NCT03499964|559239539|FG000|Overall Study|Adverse Event|1|||
154949246|NCT03499964|559239540|FG001|Overall Study|Adverse Event|0|||
154949247|NCT03499964|559239539|FG000|Overall Study|Death|1|||
154949248|NCT03499964|559239540|FG001|Overall Study|Death|0|||
154949249|NCT03499964|559239539|FG000|Overall Study|Withdrawal by Subject|2|||
154949250|NCT03499964|559239540|FG001|Overall Study|Withdrawal by Subject|1|||
154949251|NCT03499964|559239539|FG000|Overall Study|Lost to Follow-up|1|||
154949252|NCT03499964|559239540|FG001|Overall Study|Lost to Follow-up|0|||
154949253|NCT02224391|559239541|FG000|Overall Study|Lost to Follow-up|26|||
155392440|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
155392441|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
155392442|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
155392443|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
155392444|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
155392445|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
155392446|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Other|3|||
155392447|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Other|0|||
155392448|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Other|0|||
155392449|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Other|3|||
155392450|NCT01233869|560872925|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
155392451|NCT01233869|560872926|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
155392452|NCT01233869|560872927|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
155392453|NCT01233869|560872928|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
155392454|NCT03189862|560872934|FG000|Overall Study|Withdrawal by Subject|1|||
155392455|NCT03189862|560872935|FG001|Overall Study|Withdrawal by Subject|0|||
155392456|NCT03189862|560872934|FG000|Overall Study|Lost to Follow-up|54|||
155392457|NCT03189862|560872935|FG001|Overall Study|Lost to Follow-up|62|||
155392458|NCT02545322|560872936|FG000|Overall Study|Withdrawal by Subject|3|||
155392459|NCT03690141|560872937|FG000|Overall Study|Adverse Event|5|||
155392460|NCT03690141|560872937|FG000|Overall Study|Withdrawal by Subject|3|||
155392461|NCT03690141|560872937|FG000|Overall Study|Physician Decision|4|||
155051460|NCT04110314|559621481|FG001|Overall Study|Did not meet inclusion criteria|35104|||
155051461|NCT04110314|559621482|FG002|Overall Study|Did not meet inclusion criteria|35636|||
155051462|NCT04110314|559621483|FG003|Overall Study|Did not meet inclusion criteria|35135|||
155051463|NCT04110314|559621484|FG004|Overall Study|Did not meet inclusion criteria|35247|||
155051464|NCT04110314|559621485|FG005|Overall Study|Did not meet inclusion criteria|35727|||
155051465|NCT05137717|559621490|FG000|Overall Study|Death|2|||
155051466|NCT05137717|559621490|FG000|Overall Study|Withdrawal by Subject|6|||
155051467|NCT02619617|559621491|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
155051468|NCT02619617|559621492|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
155051469|NCT02619617|559621491|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
155051470|NCT02619617|559621492|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
155051471|NCT00509899|559621494|FG000|Overall Study|Progressive disease|1|||
154949254|NCT02224391|559239542|FG001|Overall Study|Lost to Follow-up|19|||
154949255|NCT02224391|559239541|FG000|Overall Study|Withdrawal by Subject|6|||
154949256|NCT02224391|559239542|FG001|Overall Study|Withdrawal by Subject|5|||
154949257|NCT00084084|559239544|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
154949258|NCT00084084|559239544|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
154949259|NCT00454636|559239545|FG000|Overall Study|Adverse Event|10|||
154949260|NCT00454636|559239546|FG001|Overall Study|Adverse Event|6|||
154949261|NCT00454636|559239547|FG002|Overall Study|Adverse Event|9|||
155051472|NCT00509899|559621495|FG001|Overall Study|Progressive disease|3|||
155051473|NCT00509899|559621496|FG002|Overall Study|Progressive disease|5|||
155051474|NCT00509899|559621497|FG003|Overall Study|Progressive disease|1|||
155051475|NCT00509899|559621498|FG004|Overall Study|Progressive disease|0|||
155051476|NCT00509899|559621499|FG005|Overall Study|Progressive disease|1|||
155051477|NCT00509899|559621500|FG006|Overall Study|Progressive disease|0|||
155051478|NCT00509899|559621501|FG007|Overall Study|Progressive disease|0|||
155051479|NCT00509899|559621494|FG000|Overall Study|Unacceptable Toxicity|1|||
155392462|NCT03690141|560872937|FG000|Overall Study|Disease progression|4|||
155392463|NCT00041067|560872938|FG000|Overall Study|Adverse Event|20|||
155392464|NCT00041067|560872938|FG000|Overall Study|Progression|19|||
155392465|NCT00041067|560872938|FG000|Overall Study|Patient refusal|12|||
155392466|NCT00041067|560872938|FG000|Overall Study|Other reasons|23|||
155392467|NCT00041067|560872938|FG000|Overall Study|Ineligible|2|||
155392468|NCT00778622|560872939|FG000|Overall Study|Adverse Event|5|||
155392469|NCT00778622|560872940|FG001|Overall Study|Adverse Event|4|||
155392470|NCT00778622|560872941|FG002|Overall Study|Adverse Event|7|||
155392471|NCT00778622|560872939|FG000|Overall Study|Withdrawal by Subject|4|||
155392472|NCT00778622|560872940|FG001|Overall Study|Withdrawal by Subject|5|||
155392473|NCT00778622|560872941|FG002|Overall Study|Withdrawal by Subject|5|||
155392474|NCT00778622|560872939|FG000|Overall Study|Lost to Follow-up|3|||
155392475|NCT00778622|560872940|FG001|Overall Study|Lost to Follow-up|3|||
155392476|NCT00778622|560872941|FG002|Overall Study|Lost to Follow-up|2|||
155392477|NCT00778622|560872939|FG000|Overall Study|Protocol Violation|0|||
155392478|NCT00778622|560872940|FG001|Overall Study|Protocol Violation|3|||
155392479|NCT00778622|560872941|FG002|Overall Study|Protocol Violation|0|||
155392480|NCT00778622|560872939|FG000|Overall Study|Lack of Efficacy|2|||
155392481|NCT00778622|560872940|FG001|Overall Study|Lack of Efficacy|0|||
155392482|NCT00778622|560872941|FG002|Overall Study|Lack of Efficacy|0|||
155392483|NCT00778622|560872939|FG000|Overall Study|immigration|1|||
154949262|NCT00454636|559239548|FG003|Overall Study|Adverse Event|15|||
154949263|NCT00454636|559239545|FG000|Overall Study|Disease Progression|11|||
154949264|NCT00454636|559239546|FG001|Overall Study|Disease Progression|12|||
154949265|NCT00454636|559239547|FG002|Overall Study|Disease Progression|4|||
155051480|NCT00509899|559621495|FG001|Overall Study|Unacceptable Toxicity|0|||
155392484|NCT00778622|560872940|FG001|Overall Study|immigration|0|||
155051481|NCT00509899|559621496|FG002|Overall Study|Unacceptable Toxicity|0|||
155051482|NCT00509899|559621497|FG003|Overall Study|Unacceptable Toxicity|2|||
155051483|NCT00509899|559621498|FG004|Overall Study|Unacceptable Toxicity|0|||
155051484|NCT00509899|559621499|FG005|Overall Study|Unacceptable Toxicity|0|||
155392485|NCT00778622|560872941|FG002|Overall Study|immigration|0|||
155392486|NCT00778622|560872939|FG000|Overall Study|Other|1|||
155392487|NCT00778622|560872940|FG001|Overall Study|Other|0|||
155392488|NCT00778622|560872941|FG002|Overall Study|Other|1|||
155051485|NCT00509899|559621500|FG006|Overall Study|Unacceptable Toxicity|0|||
155392489|NCT04744285|560872942|FG000|Overall Study|Withdrawal by Subject|1|||
155392490|NCT04744285|560872943|FG001|Overall Study|Withdrawal by Subject|1|||
155392491|NCT04744285|560872944|FG002|Overall Study|Withdrawal by Subject|2|||
154949266|NCT00454636|559239548|FG003|Overall Study|Disease Progression|11|||
154949267|NCT00454636|559239545|FG000|Overall Study|Protocol Violation|3|||
155051486|NCT00509899|559621501|FG007|Overall Study|Unacceptable Toxicity|0|||
155051487|NCT00509899|559621494|FG000|Overall Study|Withdrawal by Subject|6|||
155051488|NCT00509899|559621495|FG001|Overall Study|Withdrawal by Subject|2|||
155051489|NCT00509899|559621496|FG002|Overall Study|Withdrawal by Subject|3|||
155051490|NCT00509899|559621497|FG003|Overall Study|Withdrawal by Subject|0|||
155051491|NCT00509899|559621498|FG004|Overall Study|Withdrawal by Subject|3|||
155051492|NCT00509899|559621499|FG005|Overall Study|Withdrawal by Subject|2|||
155051493|NCT00509899|559621500|FG006|Overall Study|Withdrawal by Subject|0|||
155051494|NCT00509899|559621501|FG007|Overall Study|Withdrawal by Subject|0|||
155051495|NCT00509899|559621494|FG000|Overall Study|Physician Decision|4|||
155051496|NCT00509899|559621495|FG001|Overall Study|Physician Decision|2|||
155051497|NCT00509899|559621496|FG002|Overall Study|Physician Decision|7|||
155051498|NCT00509899|559621497|FG003|Overall Study|Physician Decision|0|||
155051499|NCT00509899|559621498|FG004|Overall Study|Physician Decision|1|||
155051500|NCT00509899|559621499|FG005|Overall Study|Physician Decision|4|||
155051501|NCT00509899|559621500|FG006|Overall Study|Physician Decision|0|||
155051502|NCT00509899|559621501|FG007|Overall Study|Physician Decision|0|||
155392492|NCT04744285|560872945|FG003|Overall Study|Withdrawal by Subject|1|||
155392493|NCT01822522|560872946|FG000|Overall Study|Adverse Event|1|||
155392494|NCT01822522|560872947|FG001|Overall Study|Adverse Event|1|||
155392495|NCT01822522|560872948|FG002|Overall Study|Adverse Event|1|||
155392496|NCT01822522|560872949|FG003|Overall Study|Adverse Event|0|||
155392497|NCT01822522|560872950|FG004|Overall Study|Adverse Event|0|||
155392498|NCT01822522|560872951|FG005|Overall Study|Adverse Event|1|||
155392499|NCT01822522|560872946|FG000|Overall Study|Death|3|||
155392500|NCT01822522|560872947|FG001|Overall Study|Death|0|||
155392501|NCT01822522|560872948|FG002|Overall Study|Death|2|||
155392502|NCT01822522|560872949|FG003|Overall Study|Death|0|||
155392503|NCT01822522|560872950|FG004|Overall Study|Death|0|||
155392504|NCT01822522|560872951|FG005|Overall Study|Death|0|||
155392505|NCT01822522|560872946|FG000|Overall Study|Lost to Follow-up|0|||
155392506|NCT01822522|560872947|FG001|Overall Study|Lost to Follow-up|0|||
155392507|NCT01822522|560872948|FG002|Overall Study|Lost to Follow-up|1|||
155392508|NCT01822522|560872949|FG003|Overall Study|Lost to Follow-up|1|||
155392509|NCT01822522|560872950|FG004|Overall Study|Lost to Follow-up|0|||
155392510|NCT01822522|560872951|FG005|Overall Study|Lost to Follow-up|1|||
155392511|NCT01822522|560872946|FG000|Overall Study|Withdrawal by Subject|0|||
155392512|NCT01822522|560872947|FG001|Overall Study|Withdrawal by Subject|0|||
155392513|NCT01822522|560872948|FG002|Overall Study|Withdrawal by Subject|0|||
155392514|NCT01822522|560872949|FG003|Overall Study|Withdrawal by Subject|1|||
155392515|NCT01822522|560872950|FG004|Overall Study|Withdrawal by Subject|0|||
155392516|NCT01822522|560872951|FG005|Overall Study|Withdrawal by Subject|0|||
155392517|NCT01822522|560872946|FG000|Overall Study|Lack of Efficacy|0|||
155392518|NCT01822522|560872947|FG001|Overall Study|Lack of Efficacy|0|||
155392519|NCT01822522|560872948|FG002|Overall Study|Lack of Efficacy|0|||
155392520|NCT01822522|560872949|FG003|Overall Study|Lack of Efficacy|0|||
155392521|NCT01822522|560872950|FG004|Overall Study|Lack of Efficacy|0|||
155392522|NCT01822522|560872951|FG005|Overall Study|Lack of Efficacy|2|||
155392523|NCT01807923|560872952|FG000|Overall Study|Adverse Event|2|||
155392524|NCT01807923|560872953|FG001|Overall Study|Adverse Event|1|||
155392525|NCT01807923|560872954|FG002|Overall Study|Adverse Event|2|||
155392526|NCT01807923|560872952|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155392527|NCT01807923|560872953|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
155392528|NCT01807923|560872954|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
155392529|NCT01807923|560872952|FG000|Overall Study|Physician Decision|0|||
155392530|NCT01807923|560872953|FG001|Overall Study|Physician Decision|0|||
155392531|NCT01807923|560872954|FG002|Overall Study|Physician Decision|1|||
155392532|NCT01807923|560872952|FG000|Overall Study|Not Eligible (Genotype)|0|||
155392533|NCT01807923|560872953|FG001|Overall Study|Not Eligible (Genotype)|0|||
155392534|NCT01807923|560872954|FG002|Overall Study|Not Eligible (Genotype)|1|||
155051503|NCT00509899|559621494|FG000|Overall Study|Intercurrent Illness|1|||
155051504|NCT00509899|559621495|FG001|Overall Study|Intercurrent Illness|0|||
155392535|NCT01807923|560872952|FG000|Overall Study|Randomized But Not Treated|3|||
155392536|NCT01807923|560872953|FG001|Overall Study|Randomized But Not Treated|2|||
155392537|NCT01807923|560872954|FG002|Overall Study|Randomized But Not Treated|5|||
155392538|NCT03836807|560872960|FG000|Overall Study|Physician Decision|1|||
155392539|NCT03836807|560872961|FG001|Overall Study|Physician Decision|0|||
155392540|NCT00685685|560872962|FG000|Washout Period of 7 Days|Adverse Event|2|||
155051505|NCT00509899|559621496|FG002|Overall Study|Intercurrent Illness|0|||
155051506|NCT00509899|559621497|FG003|Overall Study|Intercurrent Illness|1|||
155392541|NCT00685685|560872963|FG001|Washout Period of 7 Days|Adverse Event|0|||
155392542|NCT00685685|560872962|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155392543|NCT00685685|560872963|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155392544|NCT04029116|560872964|FG000|Overall Study|Adverse Event|0|||
155392545|NCT04029116|560872965|FG001|Overall Study|Adverse Event|2|||
155392546|NCT04029116|560872964|FG000|Overall Study|Lost to Follow-up|3|||
155051507|NCT00509899|559621498|FG004|Overall Study|Intercurrent Illness|0|||
155051508|NCT00509899|559621499|FG005|Overall Study|Intercurrent Illness|1|||
155392547|NCT04029116|560872965|FG001|Overall Study|Lost to Follow-up|5|||
155392548|NCT04029116|560872964|FG000|Overall Study|Physician Decision|2|||
155392549|NCT04029116|560872965|FG001|Overall Study|Physician Decision|0|||
155392550|NCT04029116|560872964|FG000|Overall Study|Pregnancy|1|||
155392551|NCT04029116|560872965|FG001|Overall Study|Pregnancy|2|||
155392552|NCT04029116|560872964|FG000|Overall Study|Withdrawal by Subject|4|||
155392553|NCT04029116|560872965|FG001|Overall Study|Withdrawal by Subject|6|||
155392554|NCT04029116|560872964|FG000|Overall Study|Other|2|||
155392555|NCT04029116|560872965|FG001|Overall Study|Other|1|||
155392556|NCT02469896|560872968|FG000|Overall Study|Withdrawal by Subject|2|||
155392557|NCT02469896|560872969|FG001|Overall Study|Withdrawal by Subject|0|||
155392558|NCT02510560|560872970|FG000|Overall Study|Discontinued from Treatment|27|||
155392559|NCT02510560|560872971|FG001|Overall Study|Discontinued from Treatment|18|||
155392560|NCT02510560|560872972|FG002|Overall Study|Discontinued from Treatment|19|||
155392561|NCT02510560|560872970|FG000|Overall Study|Other|4|||
155392562|NCT02510560|560872971|FG001|Overall Study|Other|4|||
155392563|NCT02510560|560872972|FG002|Overall Study|Other|3|||
155392564|NCT00882310|560872973|FG000|Overall Study|Screen Failure|10|||
155392565|NCT00882310|560872973|FG000|Overall Study|Never received treatment|1|||
155392566|NCT00882310|560872973|FG000|Overall Study|Death|6|||
155392567|NCT00882310|560872973|FG000|Overall Study|Progression of disease|4|||
155392568|NCT00882310|560872973|FG000|Overall Study|Adverse Event|1|||
155392569|NCT04233164|560872978|FG000|Overall Study|Unable to obtain specimen|0|||
155392570|NCT04233164|560872979|FG001|Overall Study|Unable to obtain specimen|1|||
155392571|NCT02014740|560872980|FG000|Overall Study|Lost to Follow-up|4|||
155392572|NCT02014740|560872981|FG001|Overall Study|Lost to Follow-up|4|||
155392573|NCT02014740|560872980|FG000|Overall Study|Withdrawal by Subject|2|||
155392574|NCT02014740|560872981|FG001|Overall Study|Withdrawal by Subject|1|||
155392575|NCT03684642|560872982|FG000|Overall Study|Adverse Event|6|||
155392576|NCT03684642|560872983|FG001|Overall Study|Adverse Event|15|||
155392577|NCT03684642|560872984|FG002|Overall Study|Adverse Event|11|||
155392578|NCT03684642|560872982|FG000|Overall Study|Withdrawal by Subject|35|||
155392579|NCT03684642|560872983|FG001|Overall Study|Withdrawal by Subject|53|||
155392580|NCT03684642|560872984|FG002|Overall Study|Withdrawal by Subject|23|||
155392581|NCT03684642|560872982|FG000|Overall Study|Lack of Efficacy|0|||
155392582|NCT03684642|560872983|FG001|Overall Study|Lack of Efficacy|0|||
155392583|NCT03684642|560872984|FG002|Overall Study|Lack of Efficacy|1|||
155392584|NCT03684642|560872982|FG000|Overall Study|Poor compliance to protocol|0|||
155392585|NCT03684642|560872983|FG001|Overall Study|Poor compliance to protocol|4|||
155392586|NCT03684642|560872984|FG002|Overall Study|Poor compliance to protocol|1|||
155392587|NCT03684642|560872982|FG000|Overall Study|Other than specified|62|||
155392588|NCT03684642|560872983|FG001|Overall Study|Other than specified|60|||
155392589|NCT03684642|560872984|FG002|Overall Study|Other than specified|67|||
155392590|NCT03684642|560872982|FG000|Overall Study|Randomized and not treated|0|||
155392591|NCT03684642|560872983|FG001|Overall Study|Randomized and not treated|0|||
155392592|NCT03684642|560872984|FG002|Overall Study|Randomized and not treated|1|||
155392593|NCT03684642|560872982|FG000|Overall Study|Missing completion status but alive at last contact|0|||
155392594|NCT03684642|560872983|FG001|Overall Study|Missing completion status but alive at last contact|1|||
155392595|NCT03684642|560872984|FG002|Overall Study|Missing completion status but alive at last contact|2|||
155392596|NCT01843218|560872987|FG000|Overall Study|Withdrawal by Subject|5|||
155392597|NCT01431534|560872988|FG000|Treatment Phase|Adverse Event|0|||
155392598|NCT01431534|560872989|FG001|Treatment Phase|Adverse Event|0|||
155392599|NCT01431534|560872990|FG002|Treatment Phase|Adverse Event|1|||
155392600|NCT01431534|560872988|FG000|Treatment Phase|Progressive Disease|4|||
155392601|NCT01431534|560872989|FG001|Treatment Phase|Progressive Disease|3|||
155392602|NCT01431534|560872990|FG002|Treatment Phase|Progressive Disease|10|||
155392603|NCT04201821|560872993|FG000|Overall Study|Withdrawal by Subject|2|||
155392604|NCT01395316|560872994|FG000|Overall Study|Lost to Follow-up|2|||
155392605|NCT01395316|560872994|FG000|Overall Study|poor MRI quality|1|||
155392606|NCT02540538|560872995|FG000|Overall Study|Pregnancy|0|||
155392607|NCT02540538|560872996|FG001|Overall Study|Pregnancy|1|||
155392608|NCT02540538|560872997|FG002|Overall Study|Pregnancy|0|||
155392609|NCT02846532|560872998|FG000|Overall Study|Lost to Follow-up|0|||
154949268|NCT00454636|559239546|FG001|Overall Study|Protocol Violation|2|||
154949269|NCT00454636|559239547|FG002|Overall Study|Protocol Violation|3|||
155392610|NCT02846532|560872999|FG001|Overall Study|Lost to Follow-up|1|||
155392611|NCT02846532|560873000|FG002|Overall Study|Lost to Follow-up|1|||
155392612|NCT02846532|560872998|FG000|Overall Study|Withdrawal by Subject|1|||
155392613|NCT02846532|560872999|FG001|Overall Study|Withdrawal by Subject|2|||
155392614|NCT02846532|560873000|FG002|Overall Study|Withdrawal by Subject|0|||
155392615|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
155392616|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
155392617|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
155392618|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
155392619|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
155392620|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
155392621|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
155392622|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
155392623|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
155392624|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
155392625|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
155392626|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
155392627|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
155392628|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
155392629|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
155392630|NCT04908189|560873002|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
155392631|NCT04908189|560873003|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
155392632|NCT04908189|560873004|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
155392633|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
155392634|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
155392635|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
155392636|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
155392637|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
155392638|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
155392639|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
155392640|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
155392641|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
155392642|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
155392643|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
155392644|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
155392645|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
155392646|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
155392647|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
155392648|NCT04908189|560873002|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
155392649|NCT04908189|560873003|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
155392650|NCT04908189|560873004|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
155392651|NCT04598477|560873006|FG000|Overall Study|Adverse Event|2|||
155392652|NCT04598477|560873007|FG001|Overall Study|Adverse Event|0|||
155392653|NCT04598477|560873006|FG000|Overall Study|Death|0|||
155392654|NCT04598477|560873007|FG001|Overall Study|Death|1|||
155392655|NCT04598477|560873006|FG000|Overall Study|Lost to Follow-up|1|||
155392656|NCT04598477|560873007|FG001|Overall Study|Lost to Follow-up|0|||
155392657|NCT04598477|560873006|FG000|Overall Study|Physician Decision|7|||
155392658|NCT04598477|560873007|FG001|Overall Study|Physician Decision|2|||
155392659|NCT04598477|560873006|FG000|Overall Study|Pregnancy|0|||
155392660|NCT04598477|560873007|FG001|Overall Study|Pregnancy|1|||
155392661|NCT04598477|560873006|FG000|Overall Study|Requires Prohibited Medication|0|||
155392662|NCT04598477|560873007|FG001|Overall Study|Requires Prohibited Medication|1|||
155392663|NCT04598477|560873006|FG000|Overall Study|Study Terminated by Sponsor|18|||
155392664|NCT04598477|560873007|FG001|Overall Study|Study Terminated by Sponsor|12|||
155392665|NCT04598477|560873006|FG000|Overall Study|Withdrawal by Subject|16|||
155392666|NCT04598477|560873007|FG001|Overall Study|Withdrawal by Subject|12|||
155392667|NCT04598477|560873006|FG000|Overall Study|Other|15|||
155392668|NCT04598477|560873007|FG001|Overall Study|Other|8|||
155392669|NCT05359003|560873008|FG000|Overall Study|Withdrawal by Subject|1|||
155392670|NCT05359003|560873009|FG001|Overall Study|Withdrawal by Subject|3|||
155392671|NCT05579990|560873015|FG000|Overall Study|Lost to Follow-up|3|||
155392672|NCT00607022|560873016|FG000|Overall Study|Withdrawal by Subject|1|||
155392673|NCT00607022|560873017|FG001|Overall Study|Withdrawal by Subject|0|||
155392674|NCT00607022|560873018|FG002|Overall Study|Withdrawal by Subject|0|||
155392675|NCT01313650|560873019|FG000|Overall Study|Adverse Event|9|||
155392676|NCT01313650|560873020|FG001|Overall Study|Adverse Event|34|||
155392677|NCT01313650|560873021|FG002|Overall Study|Adverse Event|24|||
155392678|NCT01313650|560873022|FG003|Overall Study|Adverse Event|23|||
155392679|NCT01313650|560873019|FG000|Overall Study|Lack of Efficacy|37|||
155392680|NCT01313650|560873020|FG001|Overall Study|Lack of Efficacy|20|||
155392681|NCT01313650|560873021|FG002|Overall Study|Lack of Efficacy|32|||
155392682|NCT01313650|560873022|FG003|Overall Study|Lack of Efficacy|20|||
155392683|NCT01313650|560873019|FG000|Overall Study|Lost to Follow-up|1|||
155392684|NCT01313650|560873020|FG001|Overall Study|Lost to Follow-up|0|||
155392685|NCT01313650|560873021|FG002|Overall Study|Lost to Follow-up|3|||
155392686|NCT01313650|560873022|FG003|Overall Study|Lost to Follow-up|2|||
155392687|NCT01313650|560873019|FG000|Overall Study|Withdrawal by Subject|16|||
155051509|NCT00509899|559621500|FG006|Overall Study|Intercurrent Illness|0|||
155051510|NCT00509899|559621501|FG007|Overall Study|Intercurrent Illness|0|||
155051511|NCT00509899|559621494|FG000|Overall Study|Death|2|||
155392688|NCT01313650|560873020|FG001|Overall Study|Withdrawal by Subject|20|||
155392689|NCT01313650|560873021|FG002|Overall Study|Withdrawal by Subject|15|||
155392690|NCT01313650|560873022|FG003|Overall Study|Withdrawal by Subject|15|||
155392691|NCT01313650|560873019|FG000|Overall Study|Protocol Violation|4|||
155392692|NCT01313650|560873020|FG001|Overall Study|Protocol Violation|7|||
155392693|NCT01313650|560873021|FG002|Overall Study|Protocol Violation|5|||
155392694|NCT01313650|560873022|FG003|Overall Study|Protocol Violation|6|||
155392695|NCT01313650|560873019|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
155392696|NCT01313650|560873020|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
155392697|NCT01313650|560873021|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
155392698|NCT01313650|560873022|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
155392699|NCT04313153|560874767|FG000|Overall Study|Adverse Event (includes Death)|14|||
155392700|NCT04313153|560874768|FG001|Overall Study|Adverse Event (includes Death)|19|||
155392701|NCT04313153|560874769|FG002|Overall Study|Adverse Event (includes Death)|10|||
155392702|NCT04313153|560874767|FG000|Overall Study|Physician Decision|4|||
155392703|NCT04313153|560874768|FG001|Overall Study|Physician Decision|2|||
155392704|NCT04313153|560874769|FG002|Overall Study|Physician Decision|1|||
155392705|NCT04313153|560874767|FG000|Overall Study|Withdrawal by Subject|7|||
155392706|NCT04313153|560874768|FG001|Overall Study|Withdrawal by Subject|6|||
155392707|NCT04313153|560874769|FG002|Overall Study|Withdrawal by Subject|2|||
155392708|NCT04313153|560874767|FG000|Overall Study|Lack of Efficacy|3|||
155392709|NCT04313153|560874768|FG001|Overall Study|Lack of Efficacy|3|||
155392710|NCT04313153|560874769|FG002|Overall Study|Lack of Efficacy|0|||
155392711|NCT04313153|560874767|FG000|Overall Study|Lost to Follow-up|1|||
155392712|NCT04313153|560874768|FG001|Overall Study|Lost to Follow-up|0|||
155392713|NCT04313153|560874769|FG002|Overall Study|Lost to Follow-up|2|||
155392714|NCT04313153|560874767|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
155392715|NCT04313153|560874768|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
155392716|NCT04313153|560874769|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
155392717|NCT04313153|560874767|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
155392718|NCT04313153|560874768|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
155392719|NCT04313153|560874769|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
155392720|NCT04313153|560874767|FG000|Overall Study|Change in Dialysis Modality|0|||
155392721|NCT04313153|560874768|FG001|Overall Study|Change in Dialysis Modality|1|||
155392722|NCT04313153|560874769|FG002|Overall Study|Change in Dialysis Modality|2|||
155392723|NCT04313153|560874767|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
155392724|NCT04313153|560874768|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
155392725|NCT04313153|560874769|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
155392726|NCT04313153|560874767|FG000|Overall Study|Other|5|||
155392727|NCT04313153|560874768|FG001|Overall Study|Other|3|||
155392728|NCT04313153|560874769|FG002|Overall Study|Other|2|||
155392729|NCT05586269|560874770|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
155392730|NCT05586269|560874771|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
155392731|NCT05586269|560874772|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
155392732|NCT05586269|560874773|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
155392733|NCT05586269|560874770|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
155392734|NCT05586269|560874771|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
155392735|NCT05586269|560874772|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
155392736|NCT05586269|560874773|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
155392737|NCT04752475|560874774|FG000|Overall Study|Withdrawal by Subject|1|||
155392738|NCT04752475|560874775|FG001|Overall Study|Withdrawal by Subject|1|||
155392739|NCT03335163|560874785|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
155392740|NCT03335163|560874785|FG000|Overall Study|Withdrawal by Subject|18|||
155392741|NCT02020863|560874789|FG000|Overall Study|Discovery of Metastatic disease|4|||
155392742|NCT02020863|560874789|FG000|Overall Study|Team chose not to place an a line|1|||
155392743|NCT01016964|560874790|FG000|Overall Study|Lost to Follow-up|3|||
155392744|NCT01016964|560874791|FG001|Overall Study|Lost to Follow-up|3|||
155392745|NCT00702845|560874793|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
155392746|NCT00702845|560874794|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
155392747|NCT00702845|560874793|FG000|Overall Study|Too high ovarian response|5|||
155392748|NCT00702845|560874794|FG001|Overall Study|Too high ovarian response|1|||
155392749|NCT00702845|560874793|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
155392750|NCT00702845|560874794|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
155392751|NCT00702845|560874793|FG000|Overall Study|Insufficient ovarian response|1|||
155392752|NCT00702845|560874794|FG001|Overall Study|Insufficient ovarian response|0|||
155392753|NCT00702845|560874793|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
155392754|NCT00702845|560874794|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
155392755|NCT00702845|560874793|FG000|Overall Study|No or abnormal fertilization|4|||
155392756|NCT00702845|560874794|FG001|Overall Study|No or abnormal fertilization|2|||
155392757|NCT00702845|560874793|FG000|Overall Study|Patient's decision|2|||
155392758|NCT00702845|560874794|FG001|Overall Study|Patient's decision|1|||
155392759|NCT00702845|560874793|FG000|Overall Study|Not randomized|0|||
155392760|NCT00702845|560874794|FG001|Overall Study|Not randomized|1|||
155392761|NCT00440700|560874795|FG000|Overall Study|Withdrawal by Subject|8|||
155392762|NCT00440700|560874796|FG001|Overall Study|Withdrawal by Subject|8|||
155392763|NCT00440700|560874797|FG002|Overall Study|Withdrawal by Subject|4|||
155392764|NCT01524133|560874800|FG000|Treatment Phase|Withdrawal by Subject|13|||
155392765|NCT01524133|560874801|FG001|Treatment Phase|Withdrawal by Subject|28|||
155392766|NCT01524133|560874802|FG002|Treatment Phase|Withdrawal by Subject|31|||
155392767|NCT01524133|560874800|FG000|Treatment Phase|Physician Decision|6|||
155392768|NCT01524133|560874801|FG001|Treatment Phase|Physician Decision|3|||
155392769|NCT01524133|560874802|FG002|Treatment Phase|Physician Decision|3|||
155392770|NCT01524133|560874800|FG000|Treatment Phase|Lost to Follow-up|0|||
155392771|NCT01524133|560874801|FG001|Treatment Phase|Lost to Follow-up|1|||
155392772|NCT01524133|560874802|FG002|Treatment Phase|Lost to Follow-up|2|||
155392773|NCT01524133|560874800|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
155392774|NCT01524133|560874801|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
155392775|NCT01524133|560874802|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
155392776|NCT01524133|560874800|FG000|Overall Study 52 Weeks|Physician Decision|1|||
155392777|NCT01524133|560874801|FG001|Overall Study 52 Weeks|Physician Decision|0|||
155392778|NCT01524133|560874802|FG002|Overall Study 52 Weeks|Physician Decision|2|||
155392779|NCT01524133|560874800|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
155392780|NCT01524133|560874801|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
155051512|NCT00509899|559621495|FG001|Overall Study|Death|2|||
155051513|NCT00509899|559621496|FG002|Overall Study|Death|3|||
155051514|NCT00509899|559621497|FG003|Overall Study|Death|0|||
155051515|NCT00509899|559621498|FG004|Overall Study|Death|1|||
155051516|NCT00509899|559621499|FG005|Overall Study|Death|1|||
155051517|NCT00509899|559621500|FG006|Overall Study|Death|1|||
155051518|NCT00509899|559621501|FG007|Overall Study|Death|1|||
155051519|NCT00509899|559621494|FG000|Overall Study|Lack of Efficacy|1|||
155051520|NCT00509899|559621495|FG001|Overall Study|Lack of Efficacy|0|||
155051521|NCT00509899|559621496|FG002|Overall Study|Lack of Efficacy|2|||
155051522|NCT00509899|559621497|FG003|Overall Study|Lack of Efficacy|0|||
155051523|NCT00509899|559621498|FG004|Overall Study|Lack of Efficacy|0|||
155051524|NCT00509899|559621499|FG005|Overall Study|Lack of Efficacy|1|||
155051525|NCT00509899|559621500|FG006|Overall Study|Lack of Efficacy|0|||
155051526|NCT00509899|559621501|FG007|Overall Study|Lack of Efficacy|0|||
155051527|NCT01711983|559621504|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
155051528|NCT01711983|559621504|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
155051529|NCT01711983|559621504|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
155051530|NCT01711983|559621504|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
155051531|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051532|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
155051533|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
155051534|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051535|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155392781|NCT01524133|560874802|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
155392782|NCT00056862|560874811|FG000|Overall Study|Protocol Violation|1|||
155392783|NCT00056862|560874812|FG001|Overall Study|Protocol Violation|0|||
155392784|NCT03974334|560874818|FG000|Overall Study|Lost to Follow-up|1|||
155392785|NCT00931944|560874820|FG000|Overall Study|Adverse Event|4|||
155392786|NCT00931944|560874820|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
155392787|NCT00931944|560874820|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
155392788|NCT00931944|560874820|FG000|Overall Study|Death|28|||
155392789|NCT00931944|560874820|FG000|Overall Study|Other|2|||
155392790|NCT01109173|560874821|FG000|Overall Study|Adverse Event|15|||
155392791|NCT01109173|560874822|FG001|Overall Study|Adverse Event|17|||
155392792|NCT01109173|560874823|FG002|Overall Study|Adverse Event|9|||
155392793|NCT01109173|560874824|FG003|Overall Study|Adverse Event|6|||
155392794|NCT01109173|560874821|FG000|Overall Study|Lost to Follow-up|0|||
155392795|NCT01109173|560874822|FG001|Overall Study|Lost to Follow-up|1|||
155392796|NCT01109173|560874823|FG002|Overall Study|Lost to Follow-up|0|||
155392797|NCT01109173|560874824|FG003|Overall Study|Lost to Follow-up|0|||
155392798|NCT01109173|560874821|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
155392799|NCT01109173|560874822|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
155392800|NCT01109173|560874823|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
155392801|NCT01109173|560874824|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
155051536|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051537|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051538|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051539|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155392802|NCT01109173|560874821|FG000|Overall Study|Noncompliance|0|||
155392803|NCT01109173|560874822|FG001|Overall Study|Noncompliance|1|||
155392804|NCT01109173|560874823|FG002|Overall Study|Noncompliance|0|||
155392805|NCT01109173|560874824|FG003|Overall Study|Noncompliance|0|||
155392806|NCT01109173|560874821|FG000|Overall Study|Treatment Failure|25|||
155392807|NCT01109173|560874822|FG001|Overall Study|Treatment Failure|32|||
155392808|NCT01109173|560874823|FG002|Overall Study|Treatment Failure|69|||
155392809|NCT01109173|560874824|FG003|Overall Study|Treatment Failure|64|||
155392810|NCT01109173|560874821|FG000|Overall Study|Protocol Violation|4|||
155392811|NCT01109173|560874822|FG001|Overall Study|Protocol Violation|5|||
155392812|NCT01109173|560874823|FG002|Overall Study|Protocol Violation|1|||
155392813|NCT01109173|560874824|FG003|Overall Study|Protocol Violation|2|||
155392814|NCT01109173|560874821|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
155392815|NCT01109173|560874822|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
155392816|NCT01109173|560874823|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
155392817|NCT01109173|560874824|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
155392818|NCT01109173|560874821|FG000|Overall Study|Not Specifiied|5|||
155392819|NCT01109173|560874822|FG001|Overall Study|Not Specifiied|4|||
155392820|NCT01109173|560874823|FG002|Overall Study|Not Specifiied|9|||
155392821|NCT01109173|560874824|FG003|Overall Study|Not Specifiied|14|||
155392822|NCT04178967|560874830|FG000|Induction Period|Adverse Event|4|||
155392823|NCT04178967|560874831|FG001|Induction Period|Adverse Event|6|||
155392824|NCT04178967|560874832|FG002|Induction Period|Adverse Event|0|||
155392825|NCT04178967|560874833|FG003|Induction Period|Adverse Event|0|||
155392826|NCT04178967|560874834|FG004|Induction Period|Adverse Event|0|||
155392827|NCT04178967|560874835|FG005|Induction Period|Adverse Event|0|||
155392828|NCT04178967|560874836|FG006|Induction Period|Adverse Event|0|||
155392829|NCT04178967|560874837|FG007|Induction Period|Adverse Event|0|||
155392830|NCT04178967|560874838|FG008|Induction Period|Adverse Event|0|||
155392831|NCT04178967|560874839|FG009|Induction Period|Adverse Event|0|||
155392832|NCT04178967|560874840|FG010|Induction Period|Adverse Event|0|||
155392833|NCT04178967|560874830|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
155392834|NCT04178967|560874831|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
155392835|NCT04178967|560874832|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
155392836|NCT04178967|560874833|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
155392837|NCT04178967|560874834|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
155392838|NCT04178967|560874835|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
155392839|NCT04178967|560874836|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
155392840|NCT04178967|560874837|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
155392841|NCT04178967|560874838|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
155392842|NCT04178967|560874839|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
155392843|NCT04178967|560874840|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
155392844|NCT04178967|560874830|FG000|Induction Period|Lack of Efficacy|4|||
155392845|NCT04178967|560874831|FG001|Induction Period|Lack of Efficacy|1|||
155392846|NCT04178967|560874832|FG002|Induction Period|Lack of Efficacy|0|||
155392847|NCT04178967|560874833|FG003|Induction Period|Lack of Efficacy|0|||
155392848|NCT04178967|560874834|FG004|Induction Period|Lack of Efficacy|0|||
155392849|NCT04178967|560874835|FG005|Induction Period|Lack of Efficacy|0|||
155392850|NCT04178967|560874836|FG006|Induction Period|Lack of Efficacy|0|||
154949270|NCT00454636|559239548|FG003|Overall Study|Protocol Violation|3|||
154949271|NCT00454636|559239545|FG000|Overall Study|Death|6|||
154949272|NCT00454636|559239546|FG001|Overall Study|Death|1|||
154949273|NCT00454636|559239547|FG002|Overall Study|Death|1|||
154949274|NCT00454636|559239548|FG003|Overall Study|Death|1|||
154949275|NCT00454636|559239545|FG000|Overall Study|Patient refusal|1|||
154949276|NCT00454636|559239546|FG001|Overall Study|Patient refusal|1|||
154949277|NCT00454636|559239547|FG002|Overall Study|Patient refusal|3|||
154949278|NCT00454636|559239548|FG003|Overall Study|Patient refusal|2|||
154949279|NCT00454636|559239545|FG000|Overall Study|Lost to Follow-up|0|||
154949280|NCT00454636|559239546|FG001|Overall Study|Lost to Follow-up|1|||
154949281|NCT00454636|559239547|FG002|Overall Study|Lost to Follow-up|0|||
154949282|NCT00454636|559239548|FG003|Overall Study|Lost to Follow-up|0|||
154949283|NCT01531205|559239552|FG000|Overall Study|Did not proceed to surgery|1|||
154949284|NCT01089647|559239553|FG000|Overall Study|Lost to Follow-up|2|||
154949285|NCT01089647|559239554|FG001|Overall Study|Lost to Follow-up|2|||
154949286|NCT01089647|559239553|FG000|Overall Study|Withdrawal by Subject|2|||
154949287|NCT01089647|559239554|FG001|Overall Study|Withdrawal by Subject|1|||
155392851|NCT04178967|560874837|FG007|Induction Period|Lack of Efficacy|0|||
155392852|NCT04178967|560874838|FG008|Induction Period|Lack of Efficacy|0|||
155392853|NCT04178967|560874839|FG009|Induction Period|Lack of Efficacy|0|||
155392854|NCT04178967|560874840|FG010|Induction Period|Lack of Efficacy|0|||
155392855|NCT04178967|560874830|FG000|Induction Period|Protocol Violation|0|||
155392856|NCT04178967|560874831|FG001|Induction Period|Protocol Violation|6|||
155392857|NCT04178967|560874832|FG002|Induction Period|Protocol Violation|0|||
155392858|NCT04178967|560874833|FG003|Induction Period|Protocol Violation|0|||
155392859|NCT04178967|560874834|FG004|Induction Period|Protocol Violation|0|||
154949288|NCT01089647|559239553|FG000|Overall Study|Adverse Event|0|||
154949289|NCT01089647|559239554|FG001|Overall Study|Adverse Event|1|||
154949290|NCT00995553|559239555|FG000|Overall Study|Withdrawal by Subject|2|||
154949291|NCT00995553|559239556|FG001|Overall Study|Withdrawal by Subject|6|||
155392860|NCT04178967|560874835|FG005|Induction Period|Protocol Violation|0|||
155392861|NCT04178967|560874836|FG006|Induction Period|Protocol Violation|0|||
155392862|NCT04178967|560874837|FG007|Induction Period|Protocol Violation|0|||
154949292|NCT02001558|559239557|FG000|Overall Study|Lost to Follow-up|8|||
154949293|NCT02001558|559239558|FG001|Overall Study|Lost to Follow-up|14|||
154949294|NCT04117607|559239559|FG000|Overall Study|Early Termination|0|||
154949295|NCT04117607|559239560|FG001|Overall Study|Early Termination|1|||
154949296|NCT04117607|559239561|FG002|Overall Study|Early Termination|0|||
154949297|NCT04117607|559239562|FG003|Overall Study|Early Termination|0|||
154949298|NCT04117607|559239563|FG004|Overall Study|Early Termination|0|||
154949299|NCT04117607|559239564|FG005|Overall Study|Early Termination|0|||
154949300|NCT04117607|559239565|FG006|Overall Study|Early Termination|1|||
154949301|NCT04117607|559239566|FG007|Overall Study|Early Termination|0|||
154949302|NCT04117607|559239567|FG008|Overall Study|Early Termination|0|||
154949303|NCT04117607|559239568|FG009|Overall Study|Early Termination|0|||
154949304|NCT04117607|559239569|FG010|Overall Study|Early Termination|0|||
154949305|NCT04117607|559239570|FG011|Overall Study|Early Termination|0|||
154949306|NCT04117607|559239571|FG012|Overall Study|Early Termination|0|||
155282294|NCT03706690|560464108|FG001|Overall Study|Ongoing at DCO|52|||
155282295|NCT03803774|560464109|FG000|Dose Escalation|Withdrawal by Subject|0|||
155282296|NCT03803774|560464110|FG001|Dose Escalation|Withdrawal by Subject|0|||
155282297|NCT03803774|560464111|FG002|Dose Escalation|Withdrawal by Subject|0|||
155282298|NCT03803774|560464112|FG003|Dose Escalation|Withdrawal by Subject|1|||
155282299|NCT03803774|560464113|FG004|Dose Escalation|Withdrawal by Subject|0|||
155282300|NCT04482855|560464117|FG000|Overall Study|Lost to Follow-up|1|||
155282301|NCT04482855|560464118|FG001|Overall Study|Lost to Follow-up|0|||
155282302|NCT04482855|560464117|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
155282303|NCT04482855|560464118|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
155282304|NCT04482855|560464117|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
155282305|NCT04482855|560464118|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
155282306|NCT03212365|560464123|FG000|Overall Study|Discharged prior to Xa level|12|||
155282307|NCT03212365|560464124|FG001|Overall Study|Discharged prior to Xa level|8|||
155282308|NCT03212365|560464123|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
155282309|NCT03212365|560464124|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
155282310|NCT03212365|560464123|FG000|Overall Study|Refused study medication|3|||
155282311|NCT03212365|560464124|FG001|Overall Study|Refused study medication|0|||
155282312|NCT03212365|560464123|FG000|Overall Study|Initiated heparin infusion on floor|1|||
155282313|NCT03212365|560464124|FG001|Overall Study|Initiated heparin infusion on floor|1|||
155282314|NCT03212365|560464123|FG000|Overall Study|Unexpected return to OR|1|||
155282315|NCT03212365|560464124|FG001|Overall Study|Unexpected return to OR|1|||
155282316|NCT03212365|560464123|FG000|Overall Study|Medication distribution error|1|||
155282317|NCT03212365|560464124|FG001|Overall Study|Medication distribution error|0|||
155282318|NCT03212365|560464123|FG000|Overall Study|Required epidural placement|1|||
155282319|NCT03212365|560464124|FG001|Overall Study|Required epidural placement|0|||
155282320|NCT03212365|560464123|FG000|Overall Study|Withdrawal by Subject|0|||
155282321|NCT03212365|560464124|FG001|Overall Study|Withdrawal by Subject|1|||
155282322|NCT03212365|560464123|FG000|Overall Study|developed acute renal failure|0|||
155282323|NCT03212365|560464124|FG001|Overall Study|developed acute renal failure|1|||
155282324|NCT00665561|560464125|FG000|Overall Study|Death recorded on subject summary pages|75|||
155282325|NCT00665561|560464126|FG001|Overall Study|Death recorded on subject summary pages|75|||
155282326|NCT00665561|560464125|FG000|Overall Study|Does not meet entrance criteria|19|||
155282327|NCT00665561|560464126|FG001|Overall Study|Does not meet entrance criteria|21|||
155282328|NCT00665561|560464125|FG000|Overall Study|Lost to Follow-up|203|||
155282329|NCT00665561|560464126|FG001|Overall Study|Lost to Follow-up|264|||
155282330|NCT00665561|560464125|FG000|Overall Study|Withdrawal by Subject|74|||
155282331|NCT00665561|560464126|FG001|Overall Study|Withdrawal by Subject|65|||
155282332|NCT00665561|560464125|FG000|Overall Study|Other|123|||
155282333|NCT00665561|560464126|FG001|Overall Study|Other|108|||
155282334|NCT00665561|560464125|FG000|Overall Study|Site closed|8|||
155282335|NCT00665561|560464126|FG001|Overall Study|Site closed|0|||
155282336|NCT00665561|560464125|FG000|Overall Study|Withdrawn due to pregnancy|0|||
155282337|NCT00665561|560464126|FG001|Overall Study|Withdrawn due to pregnancy|1|||
155282338|NCT02337361|560464127|FG000|3-month Follow-up|Lost to Follow-up|19|||
155282339|NCT02337361|560464128|FG001|3-month Follow-up|Lost to Follow-up|14|||
155282340|NCT02337361|560464127|FG000|6-month Follow-up|Lost to Follow-up|2|||
155282341|NCT02337361|560464128|FG001|6-month Follow-up|Lost to Follow-up|4|||
155282342|NCT00701311|560464131|FG000|Overall Study|Lack of Efficacy|3|||
155282343|NCT00701311|560464131|FG000|Overall Study|Adverse Event|3|||
155282344|NCT00701311|560464131|FG000|Overall Study|Withdrawal by Subject|2|||
154949307|NCT04117607|559239572|FG013|Overall Study|Early Termination|0|||
154949308|NCT00950807|559239575|FG000|Treatment Period 1|Lack of Efficacy|1|||
154949309|NCT00950807|559239576|FG001|Treatment Period 1|Lack of Efficacy|0|||
155282345|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
155282346|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
155282347|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
155282348|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
154949310|NCT00950807|559239577|FG002|Treatment Period 1|Lack of Efficacy|0|||
154949311|NCT00950807|559239578|FG003|Treatment Period 1|Lack of Efficacy|0|||
154949312|NCT00950807|559239579|FG004|Treatment Period 1|Lack of Efficacy|0|||
154949313|NCT00950807|559239580|FG005|Treatment Period 1|Lack of Efficacy|1|||
154949314|NCT00950807|559239581|FG006|Treatment Period 1|Lack of Efficacy|0|||
154949315|NCT00950807|559239582|FG007|Treatment Period 1|Lack of Efficacy|0|||
154949316|NCT00950807|559239583|FG008|Treatment Period 1|Lack of Efficacy|0|||
154949317|NCT00950807|559239584|FG009|Treatment Period 1|Lack of Efficacy|0|||
154949318|NCT00950807|559239575|FG000|Treatment Period 1|Protocol Violation|1|||
154949319|NCT00950807|559239576|FG001|Treatment Period 1|Protocol Violation|0|||
154949320|NCT00950807|559239577|FG002|Treatment Period 1|Protocol Violation|0|||
154949321|NCT00950807|559239578|FG003|Treatment Period 1|Protocol Violation|0|||
154949322|NCT00950807|559239579|FG004|Treatment Period 1|Protocol Violation|0|||
154949323|NCT00950807|559239580|FG005|Treatment Period 1|Protocol Violation|0|||
154949324|NCT00950807|559239581|FG006|Treatment Period 1|Protocol Violation|0|||
154949325|NCT00950807|559239582|FG007|Treatment Period 1|Protocol Violation|0|||
154949326|NCT00950807|559239583|FG008|Treatment Period 1|Protocol Violation|0|||
154949327|NCT00950807|559239584|FG009|Treatment Period 1|Protocol Violation|0|||
154949328|NCT00950807|559239575|FG000|Treatment Period 1|Lost to Follow-up|0|||
154949329|NCT00950807|559239576|FG001|Treatment Period 1|Lost to Follow-up|0|||
154949330|NCT00950807|559239577|FG002|Treatment Period 1|Lost to Follow-up|1|||
155282349|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
155282350|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
155282351|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
155282352|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
155282353|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
155282354|NCT05397470|560464132|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
155282355|NCT05397470|560464133|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
155282356|NCT05397470|560464134|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
155282357|NCT05397470|560464132|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
155282358|NCT05397470|560464133|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
155282359|NCT05397470|560464134|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
155282360|NCT05397470|560464132|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
155282361|NCT05397470|560464133|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
155282362|NCT05397470|560464134|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
155282363|NCT05397470|560464132|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
155282364|NCT05397470|560464133|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
155282365|NCT05397470|560464134|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
155282366|NCT02153788|560465753|FG000|Overall Study|Physician Decision|2|||
155282367|NCT02153788|560465754|FG001|Overall Study|Physician Decision|1|||
155282368|NCT05458102|560465761|FG000|Overall Study|Withdrew consent|2|||
155282369|NCT05458102|560465762|FG001|Overall Study|Withdrew consent|0|||
155282370|NCT05458102|560465761|FG000|Overall Study|Adverse Event|1|||
155282371|NCT05458102|560465762|FG001|Overall Study|Adverse Event|0|||
155282372|NCT05458102|560465761|FG000|Overall Study|Enrolled but never treated|1|||
155282373|NCT05458102|560465762|FG001|Overall Study|Enrolled but never treated|0|||
155282374|NCT05458102|560465761|FG000|Overall Study|Protocol Violation|1|||
155282375|NCT05458102|560465762|FG001|Overall Study|Protocol Violation|0|||
155282376|NCT03239210|560465765|FG000|Overall Study|Lost to Follow-up|2|||
155282377|NCT03239210|560465766|FG001|Overall Study|Lost to Follow-up|2|||
155282378|NCT03239210|560465765|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
155282379|NCT03239210|560465766|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
155282380|NCT03239210|560465765|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
155282381|NCT03239210|560465766|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
155282382|NCT01575860|560465767|FG000|Overall Study|Withdrawal by Subject|1|||
155282383|NCT01575860|560465767|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
155282384|NCT00278564|560465769|FG000|Overall Study|Lack of Efficacy|4|||
155282385|NCT01094743|560465770|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
155282386|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
155282387|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
155282388|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
155282389|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
155282390|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
155282391|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
155282392|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
155282393|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
155282394|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
155282395|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
155282396|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
155282397|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
155051540|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155392863|NCT04178967|560874838|FG008|Induction Period|Protocol Violation|0|||
155392864|NCT04178967|560874839|FG009|Induction Period|Protocol Violation|0|||
155392865|NCT04178967|560874840|FG010|Induction Period|Protocol Violation|0|||
155392866|NCT04178967|560874830|FG000|Induction Period|Withdrawal by Subject|6|||
155392867|NCT04178967|560874831|FG001|Induction Period|Withdrawal by Subject|4|||
155392868|NCT04178967|560874832|FG002|Induction Period|Withdrawal by Subject|0|||
155392869|NCT04178967|560874833|FG003|Induction Period|Withdrawal by Subject|0|||
155392870|NCT04178967|560874834|FG004|Induction Period|Withdrawal by Subject|0|||
155392871|NCT04178967|560874835|FG005|Induction Period|Withdrawal by Subject|0|||
155392872|NCT04178967|560874836|FG006|Induction Period|Withdrawal by Subject|0|||
155392873|NCT04178967|560874837|FG007|Induction Period|Withdrawal by Subject|0|||
155392874|NCT04178967|560874838|FG008|Induction Period|Withdrawal by Subject|0|||
155392875|NCT04178967|560874839|FG009|Induction Period|Withdrawal by Subject|0|||
155392876|NCT04178967|560874840|FG010|Induction Period|Withdrawal by Subject|0|||
155392877|NCT04178967|560874830|FG000|Induction Period|Lost to Follow-up|2|||
155392878|NCT04178967|560874831|FG001|Induction Period|Lost to Follow-up|0|||
155392879|NCT04178967|560874832|FG002|Induction Period|Lost to Follow-up|0|||
155392880|NCT04178967|560874833|FG003|Induction Period|Lost to Follow-up|0|||
155392881|NCT04178967|560874834|FG004|Induction Period|Lost to Follow-up|0|||
155392882|NCT04178967|560874835|FG005|Induction Period|Lost to Follow-up|0|||
155392883|NCT04178967|560874836|FG006|Induction Period|Lost to Follow-up|0|||
155392884|NCT04178967|560874837|FG007|Induction Period|Lost to Follow-up|0|||
155392885|NCT04178967|560874838|FG008|Induction Period|Lost to Follow-up|0|||
155392886|NCT04178967|560874839|FG009|Induction Period|Lost to Follow-up|0|||
155392887|NCT04178967|560874840|FG010|Induction Period|Lost to Follow-up|0|||
155392888|NCT04178967|560874830|FG000|Induction Period|Participant Missed Study Visits|0|||
155392889|NCT04178967|560874831|FG001|Induction Period|Participant Missed Study Visits|1|||
155392890|NCT04178967|560874832|FG002|Induction Period|Participant Missed Study Visits|0|||
155392891|NCT04178967|560874833|FG003|Induction Period|Participant Missed Study Visits|0|||
155392892|NCT04178967|560874834|FG004|Induction Period|Participant Missed Study Visits|0|||
155392893|NCT04178967|560874835|FG005|Induction Period|Participant Missed Study Visits|0|||
155392894|NCT04178967|560874836|FG006|Induction Period|Participant Missed Study Visits|0|||
155392895|NCT04178967|560874837|FG007|Induction Period|Participant Missed Study Visits|0|||
155392896|NCT04178967|560874838|FG008|Induction Period|Participant Missed Study Visits|0|||
155392897|NCT04178967|560874839|FG009|Induction Period|Participant Missed Study Visits|0|||
155392898|NCT04178967|560874840|FG010|Induction Period|Participant Missed Study Visits|0|||
155392899|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392900|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392901|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392902|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392903|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392904|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
155392905|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
155392906|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
154949331|NCT00950807|559239578|FG003|Treatment Period 1|Lost to Follow-up|0|||
154949332|NCT00950807|559239579|FG004|Treatment Period 1|Lost to Follow-up|0|||
154949333|NCT00950807|559239580|FG005|Treatment Period 1|Lost to Follow-up|0|||
154949334|NCT00950807|559239581|FG006|Treatment Period 1|Lost to Follow-up|0|||
154949335|NCT00950807|559239582|FG007|Treatment Period 1|Lost to Follow-up|0|||
154949336|NCT00950807|559239583|FG008|Treatment Period 1|Lost to Follow-up|0|||
154949337|NCT00950807|559239584|FG009|Treatment Period 1|Lost to Follow-up|0|||
154949338|NCT00950807|559239575|FG000|Treatment Period 1|Withdrawal by Subject|1|||
154949339|NCT00950807|559239576|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154949340|NCT00950807|559239577|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154949341|NCT00950807|559239578|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154949342|NCT00950807|559239579|FG004|Treatment Period 1|Withdrawal by Subject|1|||
154949343|NCT00950807|559239580|FG005|Treatment Period 1|Withdrawal by Subject|0|||
154949344|NCT00950807|559239581|FG006|Treatment Period 1|Withdrawal by Subject|0|||
154949345|NCT00950807|559239582|FG007|Treatment Period 1|Withdrawal by Subject|0|||
154949346|NCT00950807|559239583|FG008|Treatment Period 1|Withdrawal by Subject|1|||
154949347|NCT00950807|559239584|FG009|Treatment Period 1|Withdrawal by Subject|0|||
154949348|NCT00950807|559239575|FG000|Treatment Period 1|Adverse Event|0|||
154949349|NCT00950807|559239576|FG001|Treatment Period 1|Adverse Event|0|||
155051541|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051542|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155392907|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392908|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392909|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
155392910|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155051543|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
154949350|NCT00950807|559239577|FG002|Treatment Period 1|Adverse Event|0|||
155392911|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392912|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392913|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392914|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392915|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
155392916|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392917|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392918|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392919|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392920|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155392921|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392922|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392923|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392924|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
155392925|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392926|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392927|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155051544|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155392928|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392929|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392930|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392931|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
155392932|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392933|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392934|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392935|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392936|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392937|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392938|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
155392939|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392940|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392941|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392942|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
155392943|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392944|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392945|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392946|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392947|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
155392948|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
155392949|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392950|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
155392951|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392952|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392953|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
155392954|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392955|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392956|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392957|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392958|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392959|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
155392960|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
155392961|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
155392962|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392963|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392964|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
155392965|NCT04178967|560874830|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392966|NCT04178967|560874831|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392967|NCT04178967|560874832|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392968|NCT04178967|560874833|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
155051545|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155051546|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
155051547|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
155051548|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051549|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155392969|NCT04178967|560874834|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392970|NCT04178967|560874835|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
155392971|NCT04178967|560874836|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
155392972|NCT04178967|560874837|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
155392973|NCT04178967|560874838|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392974|NCT04178967|560874839|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392975|NCT04178967|560874840|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
155392976|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392977|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392978|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392979|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392980|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392981|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392982|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392983|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392984|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
155392985|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
155392986|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
155392987|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392988|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392989|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392990|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392991|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392992|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392993|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392994|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
155392995|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
155392996|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
155392997|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
155392998|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155392999|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393000|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393001|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393002|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393003|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393004|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393005|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393006|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393007|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
155393008|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155393009|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393010|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393011|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393012|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393013|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393014|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393015|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393016|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
155393017|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
155393018|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
155393019|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
155393020|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393021|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393022|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
154949351|NCT00950807|559239578|FG003|Treatment Period 1|Adverse Event|0|||
154949352|NCT00950807|559239579|FG004|Treatment Period 1|Adverse Event|0|||
154949353|NCT00950807|559239580|FG005|Treatment Period 1|Adverse Event|1|||
154949354|NCT00950807|559239581|FG006|Treatment Period 1|Adverse Event|0|||
154949355|NCT00950807|559239582|FG007|Treatment Period 1|Adverse Event|0|||
154949356|NCT00950807|559239583|FG008|Treatment Period 1|Adverse Event|0|||
154949357|NCT00950807|559239584|FG009|Treatment Period 1|Adverse Event|0|||
154949358|NCT00950807|559239575|FG000|Washout Period 1|Lack of Efficacy|0|||
154949359|NCT00950807|559239576|FG001|Washout Period 1|Lack of Efficacy|0|||
154949360|NCT00950807|559239577|FG002|Washout Period 1|Lack of Efficacy|0|||
154949361|NCT00950807|559239578|FG003|Washout Period 1|Lack of Efficacy|0|||
154949362|NCT00950807|559239579|FG004|Washout Period 1|Lack of Efficacy|0|||
154949363|NCT00950807|559239580|FG005|Washout Period 1|Lack of Efficacy|0|||
154949364|NCT00950807|559239581|FG006|Washout Period 1|Lack of Efficacy|1|||
154949365|NCT00950807|559239582|FG007|Washout Period 1|Lack of Efficacy|0|||
154949366|NCT00950807|559239583|FG008|Washout Period 1|Lack of Efficacy|0|||
155282398|NCT02851511|560465771|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
155282399|NCT02851511|560465772|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
155282400|NCT02851511|560465773|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
155282401|NCT02851511|560465774|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
155282402|NCT02851511|560465771|FG000|Phase I|Physician Decision|0|||
155282403|NCT02851511|560465772|FG001|Phase I|Physician Decision|0|||
155282404|NCT02851511|560465773|FG002|Phase I|Physician Decision|0|||
155282405|NCT02851511|560465774|FG003|Phase I|Physician Decision|1|||
155282406|NCT02851511|560465771|FG000|Phase I|Withdrawal by Subject|2|||
155282407|NCT02851511|560465772|FG001|Phase I|Withdrawal by Subject|1|||
155282408|NCT02851511|560465773|FG002|Phase I|Withdrawal by Subject|0|||
155282409|NCT02851511|560465774|FG003|Phase I|Withdrawal by Subject|3|||
155282410|NCT02851511|560465771|FG000|Phase II|Physician Decision|18|||
155282411|NCT02851511|560465772|FG001|Phase II|Physician Decision|16|||
155282412|NCT02851511|560465773|FG002|Phase II|Physician Decision|0|||
155282413|NCT02851511|560465774|FG003|Phase II|Physician Decision|0|||
155282414|NCT02851511|560465771|FG000|Phase II|Withdrawal by Subject|18|||
155282415|NCT02851511|560465772|FG001|Phase II|Withdrawal by Subject|16|||
155282416|NCT02851511|560465773|FG002|Phase II|Withdrawal by Subject|0|||
155282417|NCT02851511|560465774|FG003|Phase II|Withdrawal by Subject|0|||
155282418|NCT02851511|560465771|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
155282419|NCT02851511|560465772|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
155282420|NCT02851511|560465773|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
155282421|NCT02851511|560465774|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
155282422|NCT02851511|560465771|FG000|Phase II|Lost to Follow-up|0|||
155282423|NCT02851511|560465772|FG001|Phase II|Lost to Follow-up|1|||
155282424|NCT02851511|560465773|FG002|Phase II|Lost to Follow-up|0|||
155282425|NCT02851511|560465774|FG003|Phase II|Lost to Follow-up|0|||
155282426|NCT00372567|560465775|FG000|Phase 3 Study|Adverse Event|5|||
155282427|NCT00372567|560465776|FG001|Phase 3 Study|Adverse Event|1|||
155282428|NCT00372567|560465777|FG002|Phase 3 Study|Adverse Event|1|||
155282429|NCT00372567|560465775|FG000|Phase 3 Study|Death|1|||
155282430|NCT00372567|560465776|FG001|Phase 3 Study|Death|1|||
155282431|NCT00372567|560465777|FG002|Phase 3 Study|Death|0|||
155282432|NCT00372567|560465775|FG000|Phase 3 Study|Protocol Violation|0|||
155282433|NCT00372567|560465776|FG001|Phase 3 Study|Protocol Violation|0|||
155282434|NCT00372567|560465777|FG002|Phase 3 Study|Protocol Violation|1|||
155282435|NCT00372567|560465775|FG000|Phase 3 Study|Objective progression or relapse|10|||
155282436|NCT00372567|560465776|FG001|Phase 3 Study|Objective progression or relapse|13|||
155282437|NCT00372567|560465777|FG002|Phase 3 Study|Objective progression or relapse|4|||
155282438|NCT00372567|560465775|FG000|Phase 3 Study|Global deterioration of health status|0|||
155282439|NCT00372567|560465776|FG001|Phase 3 Study|Global deterioration of health status|1|||
155282440|NCT00372567|560465777|FG002|Phase 3 Study|Global deterioration of health status|0|||
155282441|NCT00372567|560465775|FG000|Phase 3 Study|Other|2|||
155282442|NCT00372567|560465776|FG001|Phase 3 Study|Other|2|||
155282443|NCT00372567|560465777|FG002|Phase 3 Study|Other|1|||
155282444|NCT00372567|560465775|FG000|Phase 3 Study|study terminated by sponsor|13|||
155282445|NCT00372567|560465776|FG001|Phase 3 Study|study terminated by sponsor|8|||
155282446|NCT00372567|560465777|FG002|Phase 3 Study|study terminated by sponsor|5|||
155282447|NCT03278028|560465781|FG000|Overall Study|Lost to Follow-up|1|||
155282448|NCT03278028|560465782|FG001|Overall Study|Lost to Follow-up|0|||
155282449|NCT03278028|560465781|FG000|Overall Study|Withdrawal by Subject|3|||
155282450|NCT03278028|560465782|FG001|Overall Study|Withdrawal by Subject|1|||
155282451|NCT03278028|560465781|FG000|Overall Study|Pregnancy|0|||
155282452|NCT03278028|560465782|FG001|Overall Study|Pregnancy|1|||
155282453|NCT00372528|560465784|FG000|Overall Study|Lack of Efficacy|1|||
155282454|NCT00372528|560465784|FG000|Overall Study|Adverse Event|1|||
155282455|NCT00372528|560465784|FG000|Overall Study|Study Terminated by Sponsor|18|||
155282456|NCT00372528|560465784|FG000|Overall Study|Other|1|||
155282457|NCT01417000|560465785|FG000|Overall Study|Death|59|||
155282458|NCT01417000|560465786|FG001|Overall Study|Death|28|||
155282459|NCT01417000|560465785|FG000|Overall Study|Lost to Follow-up|1|||
155282460|NCT01417000|560465786|FG001|Overall Study|Lost to Follow-up|0|||
155282461|NCT01417000|560465785|FG000|Overall Study|Study Terminated by Sponsor|1|||
155282462|NCT01417000|560465786|FG001|Overall Study|Study Terminated by Sponsor|1|||
155282463|NCT00562965|560465787|FG000|Overall Study|Withdrawal by Subject|0|||
155282464|NCT00562965|560465788|FG001|Overall Study|Withdrawal by Subject|1|||
155282465|NCT00562965|560465787|FG000|Overall Study|Death|2|||
155282466|NCT00562965|560465788|FG001|Overall Study|Death|4|||
155282467|NCT00562965|560465787|FG000|Overall Study|Lost to Follow-up|1|||
155282468|NCT00562965|560465788|FG001|Overall Study|Lost to Follow-up|0|||
155282469|NCT00562965|560465787|FG000|Overall Study|Other|0|||
155282470|NCT00562965|560465788|FG001|Overall Study|Other|1|||
155282471|NCT00965484|560465791|FG000|Overall Study|Protocol Violation|1|||
155282472|NCT00965484|560465791|FG000|Overall Study|Withdrawal by Subject|1|||
155282473|NCT01124617|560465792|FG000|Overall Study|Adverse Event|5|||
155282474|NCT01124617|560465793|FG001|Overall Study|Adverse Event|2|||
155282475|NCT01124617|560465792|FG000|Overall Study|Lack of Efficacy|2|||
155282476|NCT01124617|560465793|FG001|Overall Study|Lack of Efficacy|1|||
155051550|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051551|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051552|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051553|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051554|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051555|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051556|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051557|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051558|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051559|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155051560|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155282477|NCT01124617|560465792|FG000|Overall Study|Protocol Violation|1|||
155282478|NCT01124617|560465793|FG001|Overall Study|Protocol Violation|1|||
155282479|NCT01124617|560465792|FG000|Overall Study|Withdrawal by Subject|9|||
155282480|NCT01124617|560465793|FG001|Overall Study|Withdrawal by Subject|1|||
155282481|NCT01124617|560465792|FG000|Overall Study|Other|2|||
155282482|NCT01124617|560465793|FG001|Overall Study|Other|1|||
155282483|NCT00945477|560465794|FG000|Overall Study|Adverse Event|3|||
155282484|NCT00945477|560465794|FG000|Overall Study|Lack of Efficacy|2|||
155282485|NCT00945477|560465794|FG000|Overall Study|Withdrawal by Subject|1|||
155282486|NCT04796935|560465799|FG000|Overall Study|Withdrawal by Subject|0|||
155282487|NCT04796935|560465800|FG001|Overall Study|Withdrawal by Subject|1|||
155282488|NCT04796935|560465799|FG000|Overall Study|Physician Decision|0|||
155282489|NCT04796935|560465800|FG001|Overall Study|Physician Decision|1|||
155282490|NCT04796935|560465799|FG000|Overall Study|Device not available|1|||
155282491|NCT04796935|560465800|FG001|Overall Study|Device not available|0|||
155282492|NCT04796935|560465799|FG000|Overall Study|Trained provider not available|1|||
155282493|NCT04796935|560465800|FG001|Overall Study|Trained provider not available|0|||
155282494|NCT01253200|560465801|FG000|Overall Study|Death|1|||
155282495|NCT01253200|560465802|FG001|Overall Study|Death|0|||
155282496|NCT01253200|560465803|FG002|Overall Study|Death|0|||
155282497|NCT01253200|560465804|FG003|Overall Study|Death|0|||
155282498|NCT01253200|560465805|FG004|Overall Study|Death|0|||
155282499|NCT01253200|560465801|FG000|Overall Study|Lost to Follow-up|1|||
155282500|NCT01253200|560465802|FG001|Overall Study|Lost to Follow-up|1|||
155282501|NCT01253200|560465803|FG002|Overall Study|Lost to Follow-up|0|||
155282502|NCT01253200|560465804|FG003|Overall Study|Lost to Follow-up|0|||
155282503|NCT01253200|560465805|FG004|Overall Study|Lost to Follow-up|0|||
155282504|NCT01253200|560465801|FG000|Overall Study|Withdrawal by Subject|2|||
155282505|NCT01253200|560465802|FG001|Overall Study|Withdrawal by Subject|0|||
155282506|NCT01253200|560465803|FG002|Overall Study|Withdrawal by Subject|0|||
155282507|NCT01253200|560465804|FG003|Overall Study|Withdrawal by Subject|0|||
155282508|NCT01253200|560465805|FG004|Overall Study|Withdrawal by Subject|0|||
155282509|NCT01253200|560465801|FG000|Overall Study|Protocol Violation|1|||
155282510|NCT01253200|560465802|FG001|Overall Study|Protocol Violation|4|||
155282511|NCT01253200|560465803|FG002|Overall Study|Protocol Violation|0|||
155282512|NCT01253200|560465804|FG003|Overall Study|Protocol Violation|0|||
155282513|NCT01253200|560465805|FG004|Overall Study|Protocol Violation|5|||
155282514|NCT01253200|560465801|FG000|Overall Study|intents|10|||
155282515|NCT01253200|560465802|FG001|Overall Study|intents|10|||
155282516|NCT01253200|560465803|FG002|Overall Study|intents|1|||
155282517|NCT01253200|560465804|FG003|Overall Study|intents|3|||
155282518|NCT01253200|560465805|FG004|Overall Study|intents|0|||
155282519|NCT01253200|560465801|FG000|Overall Study|Attempts|6|||
155282520|NCT01253200|560465802|FG001|Overall Study|Attempts|4|||
155282521|NCT01253200|560465803|FG002|Overall Study|Attempts|1|||
155282522|NCT01253200|560465804|FG003|Overall Study|Attempts|2|||
155282523|NCT01253200|560465805|FG004|Overall Study|Attempts|0|||
155282524|NCT02049437|560465806|FG000|Period 1|Adverse Event|1|||
155282525|NCT02049437|560465807|FG001|Period 1|Adverse Event|1|||
155282526|NCT02049437|560465806|FG000|Period 1|Adverse Event|1|||
155282527|NCT02049437|560465807|FG001|Period 1|Adverse Event|0|||
155282528|NCT00783718|560465808|FG000|Induction Phase|Adverse Event|4|||
155282529|NCT00783718|560465809|FG001|Induction Phase|Adverse Event|0|||
155282530|NCT00783718|560465810|FG002|Induction Phase|Adverse Event|7|||
155282531|NCT00783718|560465811|FG003|Induction Phase|Adverse Event|0|||
155282532|NCT00783718|560465812|FG004|Induction Phase|Adverse Event|0|||
155282533|NCT00783718|560465813|FG005|Induction Phase|Adverse Event|0|||
155282534|NCT00783718|560465814|FG006|Induction Phase|Adverse Event|0|||
155282535|NCT00783718|560465808|FG000|Induction Phase|Protocol Violation|1|||
155051561|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
155282536|NCT00783718|560465809|FG001|Induction Phase|Protocol Violation|1|||
155282537|NCT00783718|560465810|FG002|Induction Phase|Protocol Violation|6|||
155282538|NCT00783718|560465811|FG003|Induction Phase|Protocol Violation|0|||
155282539|NCT00783718|560465812|FG004|Induction Phase|Protocol Violation|0|||
155282540|NCT00783718|560465813|FG005|Induction Phase|Protocol Violation|0|||
155282541|NCT00783718|560465814|FG006|Induction Phase|Protocol Violation|0|||
155282542|NCT00783718|560465808|FG000|Induction Phase|Lack of Efficacy|5|||
155282543|NCT00783718|560465809|FG001|Induction Phase|Lack of Efficacy|2|||
155282544|NCT00783718|560465810|FG002|Induction Phase|Lack of Efficacy|14|||
155282545|NCT00783718|560465811|FG003|Induction Phase|Lack of Efficacy|0|||
155282546|NCT00783718|560465812|FG004|Induction Phase|Lack of Efficacy|0|||
155282547|NCT00783718|560465813|FG005|Induction Phase|Lack of Efficacy|0|||
155282548|NCT00783718|560465814|FG006|Induction Phase|Lack of Efficacy|0|||
155282549|NCT00783718|560465808|FG000|Induction Phase|Withdrawal by Subject|3|||
155282550|NCT00783718|560465809|FG001|Induction Phase|Withdrawal by Subject|4|||
155282551|NCT00783718|560465810|FG002|Induction Phase|Withdrawal by Subject|8|||
155282552|NCT00783718|560465811|FG003|Induction Phase|Withdrawal by Subject|0|||
155282553|NCT00783718|560465812|FG004|Induction Phase|Withdrawal by Subject|0|||
155282554|NCT00783718|560465813|FG005|Induction Phase|Withdrawal by Subject|0|||
155282555|NCT00783718|560465814|FG006|Induction Phase|Withdrawal by Subject|0|||
155282556|NCT00783718|560465808|FG000|Induction Phase|Lost to Follow-up|1|||
155282557|NCT00783718|560465809|FG001|Induction Phase|Lost to Follow-up|0|||
155282558|NCT00783718|560465810|FG002|Induction Phase|Lost to Follow-up|1|||
155282559|NCT00783718|560465811|FG003|Induction Phase|Lost to Follow-up|0|||
155282560|NCT00783718|560465812|FG004|Induction Phase|Lost to Follow-up|0|||
155282561|NCT00783718|560465813|FG005|Induction Phase|Lost to Follow-up|0|||
155282562|NCT00783718|560465814|FG006|Induction Phase|Lost to Follow-up|0|||
155282563|NCT00783718|560465808|FG000|Maintenance Phase|Adverse Event|12|||
155282564|NCT00783718|560465809|FG001|Maintenance Phase|Adverse Event|0|||
155282565|NCT00783718|560465810|FG002|Maintenance Phase|Adverse Event|0|||
155282566|NCT00783718|560465811|FG003|Maintenance Phase|Adverse Event|15|||
155282567|NCT00783718|560465812|FG004|Maintenance Phase|Adverse Event|7|||
155282568|NCT00783718|560465813|FG005|Maintenance Phase|Adverse Event|6|||
155282569|NCT00783718|560465814|FG006|Maintenance Phase|Adverse Event|16|||
155282570|NCT00783718|560465808|FG000|Maintenance Phase|Protocol Violation|1|||
155282571|NCT00783718|560465809|FG001|Maintenance Phase|Protocol Violation|0|||
155282572|NCT00783718|560465810|FG002|Maintenance Phase|Protocol Violation|0|||
155282573|NCT00783718|560465811|FG003|Maintenance Phase|Protocol Violation|0|||
155282574|NCT00783718|560465812|FG004|Maintenance Phase|Protocol Violation|0|||
155282575|NCT00783718|560465813|FG005|Maintenance Phase|Protocol Violation|0|||
155282576|NCT00783718|560465814|FG006|Maintenance Phase|Protocol Violation|2|||
155282577|NCT00783718|560465808|FG000|Maintenance Phase|Lack of Efficacy|83|||
155282578|NCT00783718|560465809|FG001|Maintenance Phase|Lack of Efficacy|0|||
155282579|NCT00783718|560465810|FG002|Maintenance Phase|Lack of Efficacy|0|||
155282580|NCT00783718|560465811|FG003|Maintenance Phase|Lack of Efficacy|61|||
155282581|NCT00783718|560465812|FG004|Maintenance Phase|Lack of Efficacy|31|||
155282582|NCT00783718|560465813|FG005|Maintenance Phase|Lack of Efficacy|33|||
155282583|NCT00783718|560465814|FG006|Maintenance Phase|Lack of Efficacy|155|||
155282584|NCT00783718|560465808|FG000|Maintenance Phase|Withdrawal by Subject|6|||
155282585|NCT00783718|560465809|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155282586|NCT00783718|560465810|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155282587|NCT00783718|560465811|FG003|Maintenance Phase|Withdrawal by Subject|2|||
155282588|NCT00783718|560465812|FG004|Maintenance Phase|Withdrawal by Subject|5|||
155282589|NCT00783718|560465813|FG005|Maintenance Phase|Withdrawal by Subject|2|||
155282590|NCT00783718|560465814|FG006|Maintenance Phase|Withdrawal by Subject|20|||
155282591|NCT00783718|560465808|FG000|Maintenance Phase|Lost to Follow-up|3|||
155282592|NCT00783718|560465809|FG001|Maintenance Phase|Lost to Follow-up|0|||
155282593|NCT00783718|560465810|FG002|Maintenance Phase|Lost to Follow-up|0|||
155282594|NCT00783718|560465811|FG003|Maintenance Phase|Lost to Follow-up|0|||
155282595|NCT00783718|560465812|FG004|Maintenance Phase|Lost to Follow-up|2|||
155282596|NCT00783718|560465813|FG005|Maintenance Phase|Lost to Follow-up|0|||
155282597|NCT00783718|560465814|FG006|Maintenance Phase|Lost to Follow-up|2|||
155282598|NCT01163149|560465820|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
155282599|NCT01163149|560465821|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155282600|NCT01163149|560465822|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
155282601|NCT01163149|560465820|FG000|Extension Treatment Period|Adverse Event|0|||
155282602|NCT01163149|560465821|FG001|Extension Treatment Period|Adverse Event|1|||
155282603|NCT01163149|560465822|FG002|Extension Treatment Period|Adverse Event|0|||
155282604|NCT01163149|560465820|FG000|Extension Treatment Period|Noncompliance|0|||
155282605|NCT01163149|560465821|FG001|Extension Treatment Period|Noncompliance|0|||
155282606|NCT01163149|560465822|FG002|Extension Treatment Period|Noncompliance|1|||
155282607|NCT01192295|560465823|FG000|Overall Study|Adverse Event|3|||
155282608|NCT01192295|560465824|FG001|Overall Study|Adverse Event|7|||
155282609|NCT01192295|560465823|FG000|Overall Study|Withdrawal by Subject|3|||
155282610|NCT01192295|560465824|FG001|Overall Study|Withdrawal by Subject|4|||
155282611|NCT01192295|560465823|FG000|Overall Study|Lost to Follow-up|0|||
155282612|NCT01192295|560465824|FG001|Overall Study|Lost to Follow-up|1|||
155282613|NCT01192295|560465823|FG000|Overall Study|Lack of Efficacy|0|||
155282614|NCT01192295|560465824|FG001|Overall Study|Lack of Efficacy|5|||
155282615|NCT01192295|560465823|FG000|Overall Study|Administrative|4|||
155282616|NCT01192295|560465824|FG001|Overall Study|Administrative|6|||
155282617|NCT00630539|560465825|FG000|Overall Study|Adverse Event|1|||
155282618|NCT00630539|560465826|FG001|Overall Study|Adverse Event|3|||
155282619|NCT00630539|560465827|FG002|Overall Study|Adverse Event|1|||
154949367|NCT00950807|559239584|FG009|Washout Period 1|Lack of Efficacy|0|||
154949368|NCT00950807|559239575|FG000|Washout Period 1|Withdrawal by Subject|0|||
154949369|NCT00950807|559239576|FG001|Washout Period 1|Withdrawal by Subject|0|||
154949370|NCT00950807|559239577|FG002|Washout Period 1|Withdrawal by Subject|0|||
154949371|NCT00950807|559239578|FG003|Washout Period 1|Withdrawal by Subject|0|||
154949372|NCT00950807|559239579|FG004|Washout Period 1|Withdrawal by Subject|0|||
154949373|NCT00950807|559239580|FG005|Washout Period 1|Withdrawal by Subject|0|||
154949374|NCT00950807|559239581|FG006|Washout Period 1|Withdrawal by Subject|0|||
155051562|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
155051563|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
155051564|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051565|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051566|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051567|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051568|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051569|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051570|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051571|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051572|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051573|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155282620|NCT00630539|560465828|FG003|Overall Study|Adverse Event|2|||
155282621|NCT00630539|560465825|FG000|Overall Study|Withdrawal by Subject|0|||
155282622|NCT00630539|560465826|FG001|Overall Study|Withdrawal by Subject|1|||
155282623|NCT00630539|560465827|FG002|Overall Study|Withdrawal by Subject|0|||
155282624|NCT00630539|560465828|FG003|Overall Study|Withdrawal by Subject|1|||
155282625|NCT01700530|560465831|FG000|Overall Study|Withdrawal by Subject|0|||
155282626|NCT01700530|560465832|FG001|Overall Study|Withdrawal by Subject|3|||
155282627|NCT01700530|560465833|FG002|Overall Study|Withdrawal by Subject|1|||
155282628|NCT04159896|560465837|FG000|Overall Study|Lack of Efficacy|7|||
155282629|NCT04159896|560465837|FG000|Overall Study|Withdrawal by Subject|1|||
155282630|NCT04159896|560465837|FG000|Overall Study|Adverse Event|1|||
155282631|NCT04159896|560465837|FG000|Overall Study|A transient ischaemic attack|1|||
155282632|NCT01449721|560465838|FG000|Overall Study|Physician Decision|0|||
155282633|NCT01449721|560465839|FG001|Overall Study|Physician Decision|1|||
155282634|NCT01449721|560465838|FG000|Overall Study|Physician Decision|0|||
155282635|NCT01449721|560465839|FG001|Overall Study|Physician Decision|1|||
155282636|NCT01342887|560465841|FG000|Overall Study|Death|2|||
155282637|NCT02698436|560465846|FG000|Overall Study|Adverse Event|1|||
155282638|NCT02698436|560465847|FG001|Overall Study|Adverse Event|0|||
155282639|NCT02698436|560465846|FG000|Overall Study|Withdrawal by Subject|3|||
155282640|NCT02698436|560465847|FG001|Overall Study|Withdrawal by Subject|3|||
155282641|NCT02698436|560465846|FG000|Overall Study|Lost to Follow-up|2|||
155282642|NCT02698436|560465847|FG001|Overall Study|Lost to Follow-up|4|||
155282643|NCT02698436|560465846|FG000|Overall Study|Non-compliance with study regimen|1|||
155282644|NCT02698436|560465847|FG001|Overall Study|Non-compliance with study regimen|0|||
155282645|NCT00097370|560465852|FG000|Stage 1|Adverse Event|3|||
155282646|NCT00097370|560465852|FG000|Stage 1|Withdrawal by Subject|1|||
155282647|NCT00097370|560465852|FG000|Stage 1|Lack of Efficacy|2|||
155282648|NCT00097370|560465852|FG000|Stage 2|Adverse Event|5|||
155282649|NCT00097370|560465852|FG000|Stage 2|Withdrawal by Subject|1|||
155282650|NCT00097370|560465852|FG000|Stage 2|Lack of Efficacy|3|||
155282651|NCT00097370|560465852|FG000|Stage 2|Pregnancy|1|||
155282652|NCT00097370|560465852|FG000|Stage 2|Sponsor Terminated Study|2|||
155282653|NCT00097370|560465852|FG000|Stage 2|Lost to Follow-up|1|||
155282654|NCT00097370|560465852|FG000|Stage 3|Adverse Event|2|||
155282655|NCT00097370|560465852|FG000|Stage 3|Withdrawal by Subject|3|||
155282656|NCT00097370|560465852|FG000|Stage 3|Lack of Efficacy|1|||
155282657|NCT00097370|560465852|FG000|Stage 3|Sponsor Terminated Study|52|||
155282658|NCT00097370|560465852|FG000|Stage 3|Lost to Follow-up|1|||
155282659|NCT01394991|560465853|FG000|Overall Study|Adverse Event|0|||
155282660|NCT01394991|560465854|FG001|Overall Study|Adverse Event|4|||
155282661|NCT01394991|560465853|FG000|Overall Study|Lack of Efficacy|5|||
155282662|NCT01394991|560465854|FG001|Overall Study|Lack of Efficacy|7|||
155282663|NCT01394991|560465853|FG000|Overall Study|Lost to Follow-up|6|||
155282664|NCT01394991|560465854|FG001|Overall Study|Lost to Follow-up|8|||
155282665|NCT01394991|560465853|FG000|Overall Study|Physician Decision|1|||
155282666|NCT01394991|560465854|FG001|Overall Study|Physician Decision|3|||
155282667|NCT01394991|560465853|FG000|Overall Study|Protocol Violation|1|||
155282668|NCT01394991|560465854|FG001|Overall Study|Protocol Violation|1|||
155282669|NCT01394991|560465853|FG000|Overall Study|Withdrawal by Subject|20|||
155282670|NCT01394991|560465854|FG001|Overall Study|Withdrawal by Subject|17|||
155282671|NCT01394991|560465853|FG000|Overall Study|Chemotherapy Termination|10|||
155282672|NCT01394991|560465854|FG001|Overall Study|Chemotherapy Termination|15|||
155282673|NCT01394991|560465853|FG000|Overall Study|Disease Progression|7|||
155282674|NCT01394991|560465854|FG001|Overall Study|Disease Progression|7|||
155282675|NCT01394991|560465853|FG000|Overall Study|Prematurely Termination of Trial|9|||
155282676|NCT01394991|560465854|FG001|Overall Study|Prematurely Termination of Trial|10|||
155393023|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393024|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393025|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393026|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393027|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393028|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393029|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
155393030|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
155393031|NCT04178967|560874830|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393032|NCT04178967|560874831|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393033|NCT04178967|560874832|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393034|NCT04178967|560874833|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393035|NCT04178967|560874834|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393036|NCT04178967|560874835|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393037|NCT04178967|560874836|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393038|NCT04178967|560874837|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393039|NCT04178967|560874838|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393040|NCT04178967|560874839|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
155393041|NCT04178967|560874840|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
155393042|NCT05211739|560874841|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
155393043|NCT05211739|560874842|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
155393044|NCT05211739|560874841|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
155393045|NCT05211739|560874842|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
155393046|NCT05211739|560874841|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
155393047|NCT05211739|560874842|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
155393048|NCT05211739|560874841|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
155393049|NCT05211739|560874842|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
154949375|NCT00950807|559239582|FG007|Washout Period 1|Withdrawal by Subject|0|||
154949376|NCT00950807|559239583|FG008|Washout Period 1|Withdrawal by Subject|1|||
154949377|NCT00950807|559239584|FG009|Washout Period 1|Withdrawal by Subject|0|||
154949378|NCT00950807|559239575|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
154949379|NCT00950807|559239576|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949380|NCT00950807|559239577|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949381|NCT00950807|559239578|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949382|NCT00950807|559239579|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949383|NCT00950807|559239580|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949384|NCT00950807|559239581|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
154949385|NCT00950807|559239582|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
154949386|NCT00950807|559239583|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949387|NCT00950807|559239584|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
154949388|NCT00950807|559239575|FG000|Washout Period 1|Adverse Event|2|||
154949389|NCT00950807|559239576|FG001|Washout Period 1|Adverse Event|0|||
154949390|NCT00950807|559239577|FG002|Washout Period 1|Adverse Event|0|||
154949391|NCT00950807|559239578|FG003|Washout Period 1|Adverse Event|1|||
154949392|NCT00950807|559239579|FG004|Washout Period 1|Adverse Event|1|||
154949393|NCT00950807|559239580|FG005|Washout Period 1|Adverse Event|0|||
154949394|NCT00950807|559239581|FG006|Washout Period 1|Adverse Event|0|||
154949395|NCT00950807|559239582|FG007|Washout Period 1|Adverse Event|0|||
154949396|NCT00950807|559239583|FG008|Washout Period 1|Adverse Event|0|||
154949397|NCT00950807|559239584|FG009|Washout Period 1|Adverse Event|0|||
154949398|NCT00950807|559239575|FG000|Treatment Period 2|Lack of Efficacy|1|||
154949399|NCT00950807|559239576|FG001|Treatment Period 2|Lack of Efficacy|0|||
154949400|NCT00950807|559239577|FG002|Treatment Period 2|Lack of Efficacy|0|||
154949401|NCT00950807|559239578|FG003|Treatment Period 2|Lack of Efficacy|0|||
154949402|NCT00950807|559239579|FG004|Treatment Period 2|Lack of Efficacy|0|||
154949403|NCT00950807|559239580|FG005|Treatment Period 2|Lack of Efficacy|0|||
154949404|NCT00950807|559239581|FG006|Treatment Period 2|Lack of Efficacy|0|||
154949405|NCT00950807|559239582|FG007|Treatment Period 2|Lack of Efficacy|0|||
154949406|NCT00950807|559239583|FG008|Treatment Period 2|Lack of Efficacy|0|||
154949407|NCT00950807|559239584|FG009|Treatment Period 2|Lack of Efficacy|0|||
154949408|NCT00950807|559239575|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155051574|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155051575|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155393050|NCT00628251|560874843|FG000|Randomised Part|Withdrawal by Subject|0|||
155393051|NCT00628251|560874844|FG001|Randomised Part|Withdrawal by Subject|0|||
154949409|NCT00950807|559239576|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154949410|NCT00950807|559239577|FG002|Treatment Period 2|Withdrawal by Subject|0|||
154949411|NCT00950807|559239578|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154949412|NCT00950807|559239579|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155393052|NCT00628251|560874845|FG002|Randomised Part|Withdrawal by Subject|1|||
155393053|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
155393054|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
155393055|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
155393056|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
155393057|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
155393058|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
155393059|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
155393060|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
155393061|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
155393062|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
155393063|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
155393064|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
155393065|NCT00628251|560874843|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
155393066|NCT00628251|560874844|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
155393067|NCT00628251|560874845|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
155393068|NCT00728481|560874846|FG000|Overall Study|Withdrawal by Subject|0|||
155393069|NCT00728481|560874847|FG001|Overall Study|Withdrawal by Subject|1|||
155393070|NCT00728481|560874846|FG000|Overall Study|Adverse Event|0|||
155393071|NCT00728481|560874847|FG001|Overall Study|Adverse Event|1|||
155393072|NCT00728481|560874846|FG000|Overall Study|Study medication non-compliance|0|||
155393073|NCT00728481|560874847|FG001|Overall Study|Study medication non-compliance|2|||
155393074|NCT00728481|560874846|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
155393075|NCT00728481|560874847|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
155393076|NCT01251120|560874851|FG000|Overall Study|Lack of Efficacy|0|||
155393077|NCT01251120|560874852|FG001|Overall Study|Lack of Efficacy|1|||
155393078|NCT01968070|560874853|FG000|Period 1|Withdrawal by Subject|0|||
155393079|NCT01968070|560874854|FG001|Period 1|Withdrawal by Subject|1|||
155393080|NCT01968070|560874855|FG002|Period 1|Withdrawal by Subject|0|||
155393081|NCT01968070|560874856|FG003|Period 1|Withdrawal by Subject|0|||
155393082|NCT01968070|560874857|FG004|Period 1|Withdrawal by Subject|0|||
155393083|NCT01968070|560874858|FG005|Period 1|Withdrawal by Subject|0|||
155393084|NCT01968070|560874859|FG006|Period 1|Withdrawal by Subject|1|||
155393085|NCT01968070|560874860|FG007|Period 1|Withdrawal by Subject|0|||
155393086|NCT01968070|560874861|FG008|Period 1|Withdrawal by Subject|0|||
155393087|NCT01968070|560874862|FG009|Period 1|Withdrawal by Subject|0|||
154949413|NCT00950807|559239580|FG005|Treatment Period 2|Withdrawal by Subject|0|||
154949414|NCT00950807|559239581|FG006|Treatment Period 2|Withdrawal by Subject|1|||
154949415|NCT00950807|559239582|FG007|Treatment Period 2|Withdrawal by Subject|2|||
154949416|NCT00950807|559239583|FG008|Treatment Period 2|Withdrawal by Subject|0|||
154949417|NCT00950807|559239584|FG009|Treatment Period 2|Withdrawal by Subject|0|||
154949418|NCT00950807|559239575|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
154949419|NCT00950807|559239576|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949420|NCT00950807|559239577|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949421|NCT00950807|559239578|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949422|NCT00950807|559239579|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949423|NCT00950807|559239580|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949424|NCT00950807|559239581|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949425|NCT00950807|559239582|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949426|NCT00950807|559239583|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949427|NCT00950807|559239584|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
154949428|NCT00950807|559239575|FG000|Treatment Period 2|Adverse Event|0|||
154949429|NCT00950807|559239576|FG001|Treatment Period 2|Adverse Event|1|||
154949430|NCT00950807|559239577|FG002|Treatment Period 2|Adverse Event|0|||
154949431|NCT00950807|559239578|FG003|Treatment Period 2|Adverse Event|1|||
154949432|NCT00950807|559239579|FG004|Treatment Period 2|Adverse Event|0|||
154949433|NCT00950807|559239580|FG005|Treatment Period 2|Adverse Event|1|||
154949434|NCT00950807|559239581|FG006|Treatment Period 2|Adverse Event|0|||
154949435|NCT00950807|559239582|FG007|Treatment Period 2|Adverse Event|1|||
154949436|NCT00950807|559239583|FG008|Treatment Period 2|Adverse Event|0|||
154949437|NCT00950807|559239584|FG009|Treatment Period 2|Adverse Event|0|||
154949438|NCT00950807|559239575|FG000|Washout Period 2|Lack of Efficacy|1|||
154949439|NCT00950807|559239576|FG001|Washout Period 2|Lack of Efficacy|0|||
154949440|NCT00950807|559239577|FG002|Washout Period 2|Lack of Efficacy|0|||
154949441|NCT00950807|559239578|FG003|Washout Period 2|Lack of Efficacy|0|||
154949442|NCT00950807|559239579|FG004|Washout Period 2|Lack of Efficacy|0|||
154949443|NCT00950807|559239580|FG005|Washout Period 2|Lack of Efficacy|0|||
154949444|NCT00950807|559239581|FG006|Washout Period 2|Lack of Efficacy|0|||
154949445|NCT00950807|559239582|FG007|Washout Period 2|Lack of Efficacy|0|||
154949446|NCT00950807|559239583|FG008|Washout Period 2|Lack of Efficacy|0|||
154949447|NCT00950807|559239584|FG009|Washout Period 2|Lack of Efficacy|0|||
154949448|NCT00950807|559239575|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155393088|NCT01968070|560874863|FG010|Period 1|Withdrawal by Subject|0|||
155393089|NCT01968070|560874864|FG011|Period 1|Withdrawal by Subject|0|||
155393090|NCT01968070|560874865|FG012|Period 1|Withdrawal by Subject|0|||
155393091|NCT01968070|560874866|FG013|Period 1|Withdrawal by Subject|0|||
155393092|NCT01968070|560874867|FG014|Period 1|Withdrawal by Subject|0|||
155393093|NCT01968070|560874868|FG015|Period 1|Withdrawal by Subject|1|||
155393094|NCT01968070|560874869|FG016|Period 1|Withdrawal by Subject|0|||
155393095|NCT01968070|560874870|FG017|Period 1|Withdrawal by Subject|0|||
155393096|NCT01968070|560874853|FG000|Period 1|Protocol Violation|0|||
155393097|NCT01968070|560874854|FG001|Period 1|Protocol Violation|0|||
155393098|NCT01968070|560874855|FG002|Period 1|Protocol Violation|0|||
155393099|NCT01968070|560874856|FG003|Period 1|Protocol Violation|1|||
155393100|NCT01968070|560874857|FG004|Period 1|Protocol Violation|1|||
155393101|NCT01968070|560874858|FG005|Period 1|Protocol Violation|0|||
155393102|NCT01968070|560874859|FG006|Period 1|Protocol Violation|0|||
155393103|NCT01968070|560874860|FG007|Period 1|Protocol Violation|0|||
155393104|NCT01968070|560874861|FG008|Period 1|Protocol Violation|0|||
155393105|NCT01968070|560874862|FG009|Period 1|Protocol Violation|0|||
155393106|NCT01968070|560874863|FG010|Period 1|Protocol Violation|0|||
155393107|NCT01968070|560874864|FG011|Period 1|Protocol Violation|0|||
155393108|NCT01968070|560874865|FG012|Period 1|Protocol Violation|0|||
155393109|NCT01968070|560874866|FG013|Period 1|Protocol Violation|0|||
155393110|NCT01968070|560874867|FG014|Period 1|Protocol Violation|0|||
155393111|NCT01968070|560874868|FG015|Period 1|Protocol Violation|0|||
155393112|NCT01968070|560874869|FG016|Period 1|Protocol Violation|0|||
155393113|NCT01968070|560874870|FG017|Period 1|Protocol Violation|0|||
155393114|NCT01968070|560874853|FG000|Period 1|Lost to Follow-up|0|||
155393115|NCT01968070|560874854|FG001|Period 1|Lost to Follow-up|0|||
155393116|NCT01968070|560874855|FG002|Period 1|Lost to Follow-up|0|||
155393117|NCT01968070|560874856|FG003|Period 1|Lost to Follow-up|1|||
155393118|NCT01968070|560874857|FG004|Period 1|Lost to Follow-up|0|||
155393119|NCT01968070|560874858|FG005|Period 1|Lost to Follow-up|0|||
155393120|NCT01968070|560874859|FG006|Period 1|Lost to Follow-up|0|||
155393121|NCT01968070|560874860|FG007|Period 1|Lost to Follow-up|0|||
155393122|NCT01968070|560874861|FG008|Period 1|Lost to Follow-up|0|||
155393123|NCT01968070|560874862|FG009|Period 1|Lost to Follow-up|0|||
155393124|NCT01968070|560874863|FG010|Period 1|Lost to Follow-up|0|||
155393125|NCT01968070|560874864|FG011|Period 1|Lost to Follow-up|0|||
155393126|NCT01968070|560874865|FG012|Period 1|Lost to Follow-up|0|||
155393127|NCT01968070|560874866|FG013|Period 1|Lost to Follow-up|0|||
155393128|NCT01968070|560874867|FG014|Period 1|Lost to Follow-up|0|||
155393129|NCT01968070|560874868|FG015|Period 1|Lost to Follow-up|0|||
155393130|NCT01968070|560874869|FG016|Period 1|Lost to Follow-up|0|||
155393131|NCT01968070|560874870|FG017|Period 1|Lost to Follow-up|0|||
155393132|NCT01968070|560874853|FG000|Period 1|Adverse Event|0|||
155393133|NCT01968070|560874854|FG001|Period 1|Adverse Event|0|||
155393134|NCT01968070|560874855|FG002|Period 1|Adverse Event|0|||
155393135|NCT01968070|560874856|FG003|Period 1|Adverse Event|0|||
155393136|NCT01968070|560874857|FG004|Period 1|Adverse Event|0|||
155393137|NCT01968070|560874858|FG005|Period 1|Adverse Event|0|||
155393138|NCT01968070|560874859|FG006|Period 1|Adverse Event|1|||
155393139|NCT01968070|560874860|FG007|Period 1|Adverse Event|0|||
155393140|NCT01968070|560874861|FG008|Period 1|Adverse Event|0|||
155393141|NCT01968070|560874862|FG009|Period 1|Adverse Event|0|||
155393142|NCT01968070|560874863|FG010|Period 1|Adverse Event|0|||
155393143|NCT01968070|560874864|FG011|Period 1|Adverse Event|0|||
155393144|NCT01968070|560874865|FG012|Period 1|Adverse Event|0|||
155393145|NCT01968070|560874866|FG013|Period 1|Adverse Event|0|||
155393146|NCT01968070|560874867|FG014|Period 1|Adverse Event|0|||
155393147|NCT01968070|560874868|FG015|Period 1|Adverse Event|0|||
155393148|NCT01968070|560874869|FG016|Period 1|Adverse Event|0|||
155393149|NCT01968070|560874870|FG017|Period 1|Adverse Event|0|||
155393150|NCT01968070|560874853|FG000|Period 1|Physician Decision|0|||
155393151|NCT01968070|560874854|FG001|Period 1|Physician Decision|0|||
155393152|NCT01968070|560874855|FG002|Period 1|Physician Decision|0|||
155393153|NCT01968070|560874856|FG003|Period 1|Physician Decision|0|||
155393154|NCT01968070|560874857|FG004|Period 1|Physician Decision|0|||
155393155|NCT01968070|560874858|FG005|Period 1|Physician Decision|0|||
155393156|NCT01968070|560874859|FG006|Period 1|Physician Decision|0|||
155393157|NCT01968070|560874860|FG007|Period 1|Physician Decision|0|||
155393158|NCT01968070|560874861|FG008|Period 1|Physician Decision|0|||
154949449|NCT00950807|559239576|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
154949450|NCT00950807|559239577|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
154949451|NCT00950807|559239578|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
155393159|NCT01968070|560874862|FG009|Period 1|Physician Decision|0|||
155393160|NCT01968070|560874863|FG010|Period 1|Physician Decision|0|||
155393161|NCT01968070|560874864|FG011|Period 1|Physician Decision|1|||
155393162|NCT01968070|560874865|FG012|Period 1|Physician Decision|0|||
155393163|NCT01968070|560874866|FG013|Period 1|Physician Decision|0|||
155393164|NCT01968070|560874867|FG014|Period 1|Physician Decision|0|||
155393165|NCT01968070|560874868|FG015|Period 1|Physician Decision|0|||
155393166|NCT01968070|560874869|FG016|Period 1|Physician Decision|0|||
155393167|NCT01968070|560874870|FG017|Period 1|Physician Decision|0|||
154949452|NCT00950807|559239579|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
154949453|NCT00950807|559239580|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
154949454|NCT00950807|559239581|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
154949455|NCT00950807|559239582|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
155282677|NCT03073005|560465856|FG000|Overall Study|Death|6|||
155282678|NCT03073005|560465857|FG001|Overall Study|Death|0|||
155282679|NCT03073005|560465858|FG002|Overall Study|Death|7|||
155282680|NCT03073005|560465859|FG003|Overall Study|Death|0|||
155282681|NCT03073005|560465856|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
155282682|NCT03073005|560465857|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
155282683|NCT03073005|560465858|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
155282684|NCT03073005|560465859|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
155282685|NCT03073005|560465856|FG000|Overall Study|Lost to Follow-up|2|||
155282686|NCT03073005|560465857|FG001|Overall Study|Lost to Follow-up|2|||
155282687|NCT03073005|560465858|FG002|Overall Study|Lost to Follow-up|1|||
155282688|NCT03073005|560465859|FG003|Overall Study|Lost to Follow-up|2|||
155282689|NCT03073005|560465856|FG000|Overall Study|Withdrawal by Subject|0|||
155282690|NCT03073005|560465857|FG001|Overall Study|Withdrawal by Subject|4|||
155282691|NCT03073005|560465858|FG002|Overall Study|Withdrawal by Subject|4|||
155282692|NCT03073005|560465859|FG003|Overall Study|Withdrawal by Subject|4|||
155282693|NCT01734811|560465860|FG000|Overall Study|Lost to Follow-up|2|||
155282694|NCT01734811|560465861|FG001|Overall Study|Lost to Follow-up|3|||
155282695|NCT01734811|560465860|FG000|Overall Study|Withdrawal by Subject|2|||
155282696|NCT01734811|560465861|FG001|Overall Study|Withdrawal by Subject|0|||
155282697|NCT02427646|560465862|FG000|Overall Study|Lack of Efficacy|2|||
155282698|NCT02427646|560465863|FG001|Overall Study|Lack of Efficacy|3|||
155282699|NCT02427646|560465862|FG000|Overall Study|Physician Decision|1|||
155282700|NCT02427646|560465863|FG001|Overall Study|Physician Decision|4|||
155282701|NCT02427646|560465862|FG000|Overall Study|Protocol Violation|3|||
155282702|NCT02427646|560465863|FG001|Overall Study|Protocol Violation|3|||
155282703|NCT02427646|560465862|FG000|Overall Study|Bothersome hand weakness|2|||
155282704|NCT02427646|560465863|FG001|Overall Study|Bothersome hand weakness|4|||
155282705|NCT03824236|560465864|FG000|Overall Study|Lost to Follow-up|0|||
155282706|NCT03824236|560465865|FG001|Overall Study|Lost to Follow-up|0|||
155282707|NCT03824236|560465866|FG002|Overall Study|Lost to Follow-up|1|||
155282708|NCT01290094|560465867|FG000|Overall Study|Withdrawal by Subject|1|||
155282709|NCT01290094|560465867|FG000|Overall Study|Lost to Follow-up|5|||
155282710|NCT01101542|560465868|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
155282711|NCT01101542|560465868|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
155282712|NCT01101542|560465868|FG000|Year 4 Surveillance Period|Other|287|||
155282713|NCT01101542|560465868|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
155282714|NCT01101542|560465868|FG000|Year 5 Surveillance Period|Pregnancy|1|||
155282715|NCT01101542|560465868|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
155282716|NCT01101542|560465868|FG000|Year 6 Surveillance Period|Pregnancy|1|||
155282717|NCT01101542|560465868|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
155282718|NCT00814489|560465894|FG000|Overall Study|Other|2|||
155282719|NCT00814489|560465895|FG001|Overall Study|Other|0|||
155282720|NCT00814489|560465896|FG002|Overall Study|Other|1|||
155282721|NCT04880161|560465897|FG000|Overall Study|Withdrawal by Subject|1|||
155282722|NCT04880161|560465898|FG001|Overall Study|Withdrawal by Subject|0|||
155282723|NCT04880161|560465897|FG000|Overall Study|Lack of Compliance|1|||
155282724|NCT04880161|560465898|FG001|Overall Study|Lack of Compliance|1|||
155282725|NCT04880161|560465897|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
155282726|NCT04880161|560465898|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
155282727|NCT04880161|560465897|FG000|Overall Study|Screen Failure|0|||
155282728|NCT04880161|560465898|FG001|Overall Study|Screen Failure|1|||
155282729|NCT01354106|560465899|FG000|Overall Study|Withdrawal by Subject|2|||
155282730|NCT00901485|560465900|FG000|Overall Study|Lack of Efficacy|0|||
155282731|NCT00901485|560465901|FG001|Overall Study|Lack of Efficacy|2|||
155282732|NCT00901485|560465900|FG000|Overall Study|Withdrawal by Subject|1|||
155282733|NCT00901485|560465901|FG001|Overall Study|Withdrawal by Subject|2|||
155282734|NCT01871285|560465902|FG000|First Intervention (1 Day)|Adverse Event|1|||
155282735|NCT01871285|560465903|FG001|First Intervention (1 Day)|Adverse Event|0|||
155282736|NCT01871285|560465904|FG002|First Intervention (1 Day)|Adverse Event|0|||
155282737|NCT01871285|560465905|FG003|First Intervention (1 Day)|Adverse Event|0|||
155282738|NCT01871285|560465902|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
155282739|NCT01871285|560465903|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
155282740|NCT01871285|560465904|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
155282741|NCT01871285|560465905|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
155282742|NCT03015740|560465906|FG000|Overall Study|Adverse Event|1|||
155282743|NCT03015740|560465907|FG001|Overall Study|Adverse Event|0|||
155282744|NCT03015740|560465908|FG002|Overall Study|Adverse Event|0|||
155282745|NCT03015740|560465906|FG000|Overall Study|Death|3|||
155282746|NCT03015740|560465907|FG001|Overall Study|Death|5|||
155282747|NCT03015740|560465908|FG002|Overall Study|Death|0|||
155393168|NCT01968070|560874853|FG000|Period 2|Withdrawal by Subject|0|||
155282748|NCT03015740|560465906|FG000|Overall Study|Withdrawal by Subject|2|||
155393169|NCT01968070|560874854|FG001|Period 2|Withdrawal by Subject|0|||
155393170|NCT01968070|560874855|FG002|Period 2|Withdrawal by Subject|0|||
155393171|NCT01968070|560874856|FG003|Period 2|Withdrawal by Subject|0|||
155393172|NCT01968070|560874857|FG004|Period 2|Withdrawal by Subject|1|||
155393173|NCT01968070|560874858|FG005|Period 2|Withdrawal by Subject|0|||
155393174|NCT01968070|560874859|FG006|Period 2|Withdrawal by Subject|0|||
155393175|NCT01968070|560874860|FG007|Period 2|Withdrawal by Subject|0|||
155393176|NCT01968070|560874861|FG008|Period 2|Withdrawal by Subject|0|||
155393177|NCT01968070|560874862|FG009|Period 2|Withdrawal by Subject|0|||
155393178|NCT01968070|560874863|FG010|Period 2|Withdrawal by Subject|0|||
155393179|NCT01968070|560874864|FG011|Period 2|Withdrawal by Subject|0|||
155393180|NCT01968070|560874865|FG012|Period 2|Withdrawal by Subject|0|||
155393181|NCT01968070|560874866|FG013|Period 2|Withdrawal by Subject|0|||
155393182|NCT01968070|560874867|FG014|Period 2|Withdrawal by Subject|0|||
155393183|NCT01968070|560874868|FG015|Period 2|Withdrawal by Subject|0|||
155393184|NCT01968070|560874869|FG016|Period 2|Withdrawal by Subject|0|||
155393185|NCT01968070|560874870|FG017|Period 2|Withdrawal by Subject|0|||
155393186|NCT00890929|560874873|FG000|Overall Study|Death before treatment|2|||
155393187|NCT00890929|560874873|FG000|Overall Study|Withdrawal by Subject|3|||
155393188|NCT00890929|560874873|FG000|Overall Study|Physician Decision|1|||
155393189|NCT00108069|560874874|FG000|Overall Study|Never rec'd study drug|0|||
155393190|NCT00108069|560874875|FG001|Overall Study|Never rec'd study drug|1|||
155393191|NCT00108069|560874874|FG000|Overall Study|Adverse Event|1|||
155393192|NCT00108069|560874875|FG001|Overall Study|Adverse Event|1|||
155393193|NCT00108069|560874874|FG000|Overall Study|Withdrawal by Subject|1|||
155393194|NCT00108069|560874875|FG001|Overall Study|Withdrawal by Subject|0|||
155393195|NCT00108069|560874874|FG000|Overall Study|Death|1|||
155393196|NCT00108069|560874875|FG001|Overall Study|Death|0|||
155393197|NCT00108069|560874874|FG000|Overall Study|Progessive disease|27|||
155393198|NCT00108069|560874875|FG001|Overall Study|Progessive disease|11|||
155393199|NCT01237340|560874877|FG000|Overall Study|Adverse Event|3|||
155393200|NCT01237340|560874877|FG000|Overall Study|Withdrawal by Subject|1|||
155393201|NCT01237340|560874877|FG000|Overall Study|Early termination of the trial|36|||
155393202|NCT01272947|560874878|FG000|Overall Study|Abnormal Laboratory Value|2|||
155393203|NCT01272947|560874879|FG001|Overall Study|Abnormal Laboratory Value|2|||
155393204|NCT02019420|560874880|FG000|Overall Study|Did not receive study drug|2|||
155393205|NCT02019420|560874881|FG001|Overall Study|Did not receive study drug|2|||
155393206|NCT02019420|560874880|FG000|Overall Study|Withdrawal by Subject|1|||
155393207|NCT02019420|560874881|FG001|Overall Study|Withdrawal by Subject|3|||
155393208|NCT02019420|560874880|FG000|Overall Study|At request of sponsor or investigator|0|||
155393209|NCT02019420|560874881|FG001|Overall Study|At request of sponsor or investigator|1|||
155393210|NCT02019420|560874880|FG000|Overall Study|Death|104|||
155393211|NCT02019420|560874881|FG001|Overall Study|Death|99|||
155393212|NCT02019420|560874880|FG000|Overall Study|Transferred to other care facility|1|||
155393213|NCT02019420|560874881|FG001|Overall Study|Transferred to other care facility|1|||
155393214|NCT02401412|560874882|FG000|Overall Study|Lost to Follow-up|1|||
155393215|NCT02401412|560874883|FG001|Overall Study|Lost to Follow-up|0|||
155393216|NCT02401412|560874882|FG000|Overall Study|Discontinued Intervention|15|||
155393217|NCT02401412|560874883|FG001|Overall Study|Discontinued Intervention|21|||
155393218|NCT02401412|560874882|FG000|Overall Study|Withdrawal by Subject|4|||
155393219|NCT02401412|560874883|FG001|Overall Study|Withdrawal by Subject|4|||
155393220|NCT02401412|560874882|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
155393221|NCT02401412|560874883|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
155393222|NCT02401412|560874882|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
155393223|NCT02401412|560874883|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
155393224|NCT02742766|560874892|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393225|NCT02742766|560874893|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393226|NCT02742766|560874894|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393227|NCT02742766|560874895|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393228|NCT02742766|560874896|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
154949456|NCT00950807|559239583|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
154949457|NCT00950807|559239584|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
154949458|NCT00950807|559239575|FG000|Washout Period 2|Adverse Event|3|||
154949459|NCT00950807|559239576|FG001|Washout Period 2|Adverse Event|0|||
154949460|NCT00950807|559239577|FG002|Washout Period 2|Adverse Event|0|||
154949461|NCT00950807|559239578|FG003|Washout Period 2|Adverse Event|1|||
154949462|NCT00950807|559239579|FG004|Washout Period 2|Adverse Event|0|||
154949463|NCT00950807|559239580|FG005|Washout Period 2|Adverse Event|0|||
154949464|NCT00950807|559239581|FG006|Washout Period 2|Adverse Event|0|||
155393229|NCT02742766|560874897|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155051576|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155393230|NCT02742766|560874898|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393231|NCT02742766|560874899|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
154949465|NCT00950807|559239582|FG007|Washout Period 2|Adverse Event|0|||
155393232|NCT02742766|560874900|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393233|NCT02742766|560874901|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
154949466|NCT00950807|559239583|FG008|Washout Period 2|Adverse Event|0|||
154949467|NCT00950807|559239584|FG009|Washout Period 2|Adverse Event|0|||
154949468|NCT00950807|559239575|FG000|Treatment Period 3|Withdrawal by Subject|0|||
154949469|NCT00950807|559239576|FG001|Treatment Period 3|Withdrawal by Subject|0|||
154949470|NCT00950807|559239577|FG002|Treatment Period 3|Withdrawal by Subject|0|||
154949471|NCT00950807|559239578|FG003|Treatment Period 3|Withdrawal by Subject|0|||
154949472|NCT00950807|559239579|FG004|Treatment Period 3|Withdrawal by Subject|0|||
154949473|NCT00950807|559239580|FG005|Treatment Period 3|Withdrawal by Subject|0|||
155282749|NCT03015740|560465907|FG001|Overall Study|Withdrawal by Subject|0|||
155282750|NCT03015740|560465908|FG002|Overall Study|Withdrawal by Subject|0|||
155282751|NCT03253653|560465909|FG000|Overall Study|Withdrawal by Subject|4|||
155282752|NCT03253653|560465910|FG001|Overall Study|Withdrawal by Subject|1|||
155282753|NCT03253653|560465909|FG000|Overall Study|Protocol Violation|0|||
155282754|NCT03253653|560465910|FG001|Overall Study|Protocol Violation|5|||
155282755|NCT02263885|560468086|FG000|Overall Study|Withdrawal by Subject|7|||
155282756|NCT02263885|560468086|FG000|Overall Study|Alternative Treatment|3|||
155282757|NCT04531540|560468089|FG000|Overall Study|Adverse Event|1|||
155282758|NCT04531540|560468089|FG000|Overall Study|Protocol Violation|3|||
155282759|NCT04531540|560468089|FG000|Overall Study|Withdrawal by Subject|4|||
155282760|NCT04531540|560468089|FG000|Overall Study|Found to be Ineligible|1|||
155282761|NCT00003377|560468090|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
155282762|NCT00003377|560468091|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
155282763|NCT00003377|560468092|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
155282764|NCT00003377|560468093|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
155282765|NCT00003377|560468094|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
155282766|NCT00003377|560468090|FG000|Period II|Ureteral stent complications|0|||
155282767|NCT00003377|560468091|FG001|Period II|Ureteral stent complications|0|||
155282768|NCT00003377|560468092|FG002|Period II|Ureteral stent complications|0|||
155282769|NCT00003377|560468093|FG003|Period II|Ureteral stent complications|0|||
155282770|NCT00003377|560468094|FG004|Period II|Ureteral stent complications|1|||
155282771|NCT00582790|560468097|FG000|Overall Study|Rapid progression of disease|1|||
155282772|NCT00480441|560468102|FG000|Screening|Not Eligible|37|||
155282773|NCT00480441|560468103|FG001|Screening|Not Eligible|0|||
155282774|NCT00480441|560468104|FG002|Screening|Not Eligible|0|||
155282775|NCT00480441|560468102|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
155282776|NCT00480441|560468103|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
155282777|NCT00480441|560468104|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
155282778|NCT00480441|560468102|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
155282779|NCT00480441|560468103|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
155282780|NCT00480441|560468104|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
155282781|NCT00480441|560468102|FG000|Baseline Functional MRI|physical contraindication|4|||
155282782|NCT00480441|560468103|FG001|Baseline Functional MRI|physical contraindication|0|||
155282783|NCT00480441|560468104|FG002|Baseline Functional MRI|physical contraindication|0|||
155282784|NCT00480441|560468102|FG000|Randomization|Lost to Follow-up|0|||
155282785|NCT00480441|560468103|FG001|Randomization|Lost to Follow-up|7|||
155282786|NCT00480441|560468104|FG002|Randomization|Lost to Follow-up|2|||
155282787|NCT02374957|560468105|FG000|Overall Study|Patient did not complete forms correctly|1|||
155282788|NCT02374957|560468106|FG001|Overall Study|Patient did not complete forms correctly|0|||
155282789|NCT00748969|560468107|FG000|Overall Study|Withdrawal by Subject|1|||
155282790|NCT00748969|560468108|FG001|Overall Study|Withdrawal by Subject|0|||
155282791|NCT00748969|560468107|FG000|Overall Study|Withdrawal by Subject|0|||
155282792|NCT00748969|560468108|FG001|Overall Study|Withdrawal by Subject|1|||
155282793|NCT03532178|560468109|FG000|First Period|Withdrawal by Subject|1|||
155282794|NCT03532178|560468110|FG001|First Period|Withdrawal by Subject|3|||
155282795|NCT03532178|560468109|FG000|First Period|technical issues in data collection Technical issues|0|||
155282796|NCT03532178|560468110|FG001|First Period|technical issues in data collection Technical issues|1|||
155282797|NCT03532178|560468109|FG000|Second Period|Withdrawal by Subject|1|||
155282798|NCT03532178|560468110|FG001|Second Period|Withdrawal by Subject|1|||
155282799|NCT03532178|560468109|FG000|Second Period|Technical issues|0|||
155282800|NCT03532178|560468110|FG001|Second Period|Technical issues|1|||
155282801|NCT01113463|560468114|FG000|Overall Study|Physician Decision|5|||
155282802|NCT00578227|560468119|FG000|Overall Study|Lost to Follow-up|0|||
155282803|NCT00578227|560468120|FG001|Overall Study|Lost to Follow-up|1|||
154949474|NCT00950807|559239581|FG006|Treatment Period 3|Withdrawal by Subject|0|||
155282804|NCT00578227|560468121|FG002|Overall Study|Lost to Follow-up|1|||
155282805|NCT00578227|560468119|FG000|Overall Study|Withdrawal by Subject|5|||
155282806|NCT00578227|560468120|FG001|Overall Study|Withdrawal by Subject|1|||
155282807|NCT00578227|560468121|FG002|Overall Study|Withdrawal by Subject|3|||
155282808|NCT00916006|560468130|FG000|Overall Study|Adverse Event|1|||
155282809|NCT00916006|560468131|FG001|Overall Study|Adverse Event|1|||
155282810|NCT00916006|560468130|FG000|Overall Study|Withdrawal by Subject|2|||
155282811|NCT00916006|560468131|FG001|Overall Study|Withdrawal by Subject|5|||
155282812|NCT00916006|560468130|FG000|Overall Study|Protocol Violation|0|||
155282813|NCT00916006|560468131|FG001|Overall Study|Protocol Violation|1|||
155282814|NCT01605136|560468136|FG000|Study Period|Withdrawal by Subject|2|||
155282815|NCT01605136|560468137|FG001|Study Period|Withdrawal by Subject|0|||
155282816|NCT01605136|560468136|FG000|Study Period|Physician Decision|1|||
155282817|NCT01605136|560468137|FG001|Study Period|Physician Decision|1|||
155282818|NCT01605136|560468136|FG000|Study Period|Lost to Follow-up|0|||
155282819|NCT01605136|560468137|FG001|Study Period|Lost to Follow-up|2|||
155282820|NCT01605136|560468136|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
155282821|NCT01605136|560468137|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
155282822|NCT01072929|560468138|FG000|Overall Study|Adverse Event|8|||
155282823|NCT01072929|560468139|FG001|Overall Study|Adverse Event|11|||
155282824|NCT01072929|560468140|FG002|Overall Study|Adverse Event|2|||
155282825|NCT01072929|560468138|FG000|Overall Study|Lack of Efficacy|7|||
155282826|NCT01072929|560468139|FG001|Overall Study|Lack of Efficacy|4|||
155282827|NCT01072929|560468140|FG002|Overall Study|Lack of Efficacy|0|||
155282828|NCT01072929|560468138|FG000|Overall Study|Withdrawal by Subject|7|||
155282829|NCT01072929|560468139|FG001|Overall Study|Withdrawal by Subject|15|||
155282830|NCT01072929|560468140|FG002|Overall Study|Withdrawal by Subject|3|||
155282831|NCT01072929|560468138|FG000|Overall Study|Protocol Violation|13|||
155282832|NCT01072929|560468139|FG001|Overall Study|Protocol Violation|11|||
155282833|NCT01072929|560468140|FG002|Overall Study|Protocol Violation|2|||
155282834|NCT01072929|560468138|FG000|Overall Study|Lost to Follow-up|8|||
155282835|NCT01072929|560468139|FG001|Overall Study|Lost to Follow-up|4|||
155282836|NCT01072929|560468140|FG002|Overall Study|Lost to Follow-up|1|||
155282837|NCT01072929|560468138|FG000|Overall Study|Noncompliance with study medication|0|||
155282838|NCT01072929|560468139|FG001|Overall Study|Noncompliance with study medication|3|||
155282839|NCT01072929|560468140|FG002|Overall Study|Noncompliance with study medication|0|||
155282840|NCT01072929|560468138|FG000|Overall Study|Noncompliance with study procedures|1|||
155282841|NCT01072929|560468139|FG001|Overall Study|Noncompliance with study procedures|0|||
155282842|NCT01072929|560468140|FG002|Overall Study|Noncompliance with study procedures|1|||
155282843|NCT01072929|560468138|FG000|Overall Study|Other|0|||
155282844|NCT01072929|560468139|FG001|Overall Study|Other|3|||
155282845|NCT01072929|560468140|FG002|Overall Study|Other|0|||
155282846|NCT02929108|560468141|FG000|Overall Study|Hospice patient death|100|||
155282847|NCT02929108|560468142|FG001|Overall Study|Hospice patient death|64|||
155282848|NCT02929108|560468143|FG002|Overall Study|Hospice patient death|28|||
155282849|NCT02929108|560468144|FG003|Overall Study|Hospice patient death|46|||
155282850|NCT02929108|560468145|FG004|Overall Study|Hospice patient death|55|||
155282851|NCT02929108|560468146|FG005|Overall Study|Hospice patient death|28|||
155282852|NCT02929108|560468147|FG006|Overall Study|Hospice patient death|78|||
155282853|NCT00052962|560468148|FG000|Overall Study|Not evaluable|0|||
155282854|NCT00052962|560468149|FG001|Overall Study|Not evaluable|2|||
155282855|NCT00052962|560468148|FG000|Overall Study|Not randomized/not evaluable|1|||
155282856|NCT00052962|560468149|FG001|Overall Study|Not randomized/not evaluable|0|||
155282857|NCT01414166|560468150|FG000|Overall Study|Adverse Event|10|||
155282858|NCT01414166|560468151|FG001|Overall Study|Adverse Event|2|||
155282859|NCT01414166|560468150|FG000|Overall Study|Lost to Follow-up|4|||
155282860|NCT01414166|560468151|FG001|Overall Study|Lost to Follow-up|1|||
155282861|NCT01414166|560468150|FG000|Overall Study|Non-compliance with study drug|2|||
155282862|NCT01414166|560468151|FG001|Overall Study|Non-compliance with study drug|0|||
155282863|NCT01414166|560468150|FG000|Overall Study|Physician Decision|2|||
155282864|NCT01414166|560468151|FG001|Overall Study|Physician Decision|0|||
155282865|NCT01414166|560468150|FG000|Overall Study|Protocol Violation|2|||
155282866|NCT01414166|560468151|FG001|Overall Study|Protocol Violation|0|||
155282867|NCT01414166|560468150|FG000|Overall Study|Study terminated by Sponsor|68|||
155282868|NCT01414166|560468151|FG001|Overall Study|Study terminated by Sponsor|75|||
155282869|NCT01414166|560468150|FG000|Overall Study|Withdrawal by Subject|3|||
155282870|NCT01414166|560468151|FG001|Overall Study|Withdrawal by Subject|5|||
155282871|NCT02806336|560468152|FG000|Overall Study|Physician Decision|1|||
155282872|NCT02806336|560468153|FG001|Overall Study|Physician Decision|0|||
155282873|NCT02806336|560468152|FG000|Overall Study|Withdrawal by Subject|2|||
155282874|NCT02806336|560468153|FG001|Overall Study|Withdrawal by Subject|4|||
155282875|NCT02806336|560468152|FG000|Overall Study|COVID-19 research shut down|3|||
155282876|NCT02806336|560468153|FG001|Overall Study|COVID-19 research shut down|4|||
155282877|NCT02806336|560468152|FG000|Overall Study|Lack of Efficacy|0|||
155282878|NCT02806336|560468153|FG001|Overall Study|Lack of Efficacy|1|||
155282879|NCT03682536|560468154|FG000|Randomization|Withdrawal by Subject|0|||
155282880|NCT03682536|560468155|FG001|Randomization|Withdrawal by Subject|2|||
155282881|NCT03682536|560468154|FG000|Treatment|Other Reasons|8|||
155282882|NCT03682536|560468155|FG001|Treatment|Other Reasons|7|||
155282883|NCT03682536|560468154|FG000|Treatment|Physician Decision|5|||
155282884|NCT03682536|560468155|FG001|Treatment|Physician Decision|5|||
155282885|NCT03682536|560468154|FG000|Treatment|Protocol Violation|1|||
155282886|NCT03682536|560468155|FG001|Treatment|Protocol Violation|0|||
155282887|NCT03682536|560468154|FG000|Treatment|Study Terminated by Sponsor|1|||
155282888|NCT03682536|560468155|FG001|Treatment|Study Terminated by Sponsor|2|||
155282889|NCT03682536|560468154|FG000|Treatment|Lost to Follow-up|0|||
155282890|NCT03682536|560468155|FG001|Treatment|Lost to Follow-up|1|||
155282891|NCT03682536|560468154|FG000|Treatment|Withdrawal by Subject|16|||
155282892|NCT03682536|560468155|FG001|Treatment|Withdrawal by Subject|18|||
155282893|NCT03682536|560468154|FG000|Treatment|Lack of Efficacy|41|||
155393234|NCT02742766|560874902|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393235|NCT02742766|560874903|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393236|NCT02742766|560874904|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393237|NCT02742766|560874905|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
155393238|NCT02742766|560874906|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393239|NCT02742766|560874907|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393240|NCT02742766|560874908|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393241|NCT02742766|560874909|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393242|NCT02742766|560874910|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
155393243|NCT02742766|560874892|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393244|NCT02742766|560874893|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393245|NCT02742766|560874894|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393246|NCT02742766|560874895|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393247|NCT02742766|560874896|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393248|NCT02742766|560874897|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393249|NCT02742766|560874898|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393250|NCT02742766|560874899|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393251|NCT02742766|560874900|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393252|NCT02742766|560874901|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393253|NCT02742766|560874902|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393254|NCT02742766|560874903|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393255|NCT02742766|560874904|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
155393256|NCT02742766|560874905|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
155393257|NCT02742766|560874906|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393258|NCT02742766|560874907|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
155393259|NCT02742766|560874908|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393260|NCT02742766|560874909|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393261|NCT02742766|560874910|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
155393262|NCT05118204|560874914|FG000|Overall Study|Lost to Follow-up|3|||
155393263|NCT05118204|560874915|FG001|Overall Study|Lost to Follow-up|2|||
155393264|NCT05118204|560874914|FG000|Overall Study|Withdrawal by Subject|0|||
155393265|NCT05118204|560874915|FG001|Overall Study|Withdrawal by Subject|2|||
155393266|NCT05393037|560874919|FG000|Part A|Death|1|||
155393267|NCT05393037|560874920|FG001|Part A|Death|0|||
155393268|NCT05393037|560874919|FG000|Part A|Lost to Follow-up|1|||
155393269|NCT05393037|560874920|FG001|Part A|Lost to Follow-up|1|||
155393270|NCT05393037|560874919|FG000|Part A|Withdrawal by Subject|2|||
155393271|NCT05393037|560874920|FG001|Part A|Withdrawal by Subject|4|||
155393272|NCT05393037|560874919|FG000|Part B|Lost to Follow-up|1|||
155393273|NCT05393037|560874920|FG001|Part B|Lost to Follow-up|0|||
155393274|NCT02593786|560874921|FG000|Overall Study|Disease progression|12|||
155393275|NCT02593786|560874922|FG001|Overall Study|Disease progression|16|||
155393276|NCT02593786|560874923|FG002|Overall Study|Disease progression|10|||
155393277|NCT02593786|560874924|FG003|Overall Study|Disease progression|7|||
155393278|NCT02593786|560874921|FG000|Overall Study|Study drug toxicity|1|||
155393279|NCT02593786|560874922|FG001|Overall Study|Study drug toxicity|0|||
155393280|NCT02593786|560874923|FG002|Overall Study|Study drug toxicity|0|||
155393281|NCT02593786|560874924|FG003|Overall Study|Study drug toxicity|0|||
155393282|NCT02593786|560874921|FG000|Overall Study|Adverse event unrelated to study drug|1|||
155393283|NCT02593786|560874922|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155393284|NCT02593786|560874923|FG002|Overall Study|Adverse event unrelated to study drug|1|||
155393285|NCT02593786|560874924|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155393286|NCT02593786|560874921|FG000|Overall Study|Participant request to discontinue study therapy|0|||
155393287|NCT02593786|560874922|FG001|Overall Study|Participant request to discontinue study therapy|2|||
155393288|NCT02593786|560874923|FG002|Overall Study|Participant request to discontinue study therapy|0|||
155393289|NCT02593786|560874924|FG003|Overall Study|Participant request to discontinue study therapy|0|||
155393290|NCT02593786|560874921|FG000|Overall Study|Other reasons|1|||
155393291|NCT02593786|560874922|FG001|Overall Study|Other reasons|1|||
155393292|NCT02593786|560874923|FG002|Overall Study|Other reasons|0|||
155393293|NCT02593786|560874924|FG003|Overall Study|Other reasons|5|||
155393294|NCT00708175|560874937|FG000|Overall Study|Adverse Event|4|||
155393295|NCT00708175|560874938|FG001|Overall Study|Adverse Event|5|||
155393296|NCT00708175|560874937|FG000|Overall Study|Protocol Violation|2|||
155393297|NCT00708175|560874938|FG001|Overall Study|Protocol Violation|3|||
155393298|NCT00708175|560874937|FG000|Overall Study|Lost to Follow-up|5|||
155393299|NCT00708175|560874938|FG001|Overall Study|Lost to Follow-up|3|||
155393300|NCT00708175|560874937|FG000|Overall Study|Withdrawal by Subject|5|||
155393301|NCT00708175|560874938|FG001|Overall Study|Withdrawal by Subject|7|||
155393302|NCT00708175|560874937|FG000|Overall Study|BMD loss >7%|2|||
155393303|NCT00708175|560874938|FG001|Overall Study|BMD loss >7%|3|||
155393304|NCT02038920|560874939|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
155393305|NCT02038920|560874940|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
155393306|NCT02038920|560874941|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393307|NCT02038920|560874942|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393308|NCT02038920|560874943|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393309|NCT02038920|560874944|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
155393310|NCT02038920|560874939|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
155393311|NCT02038920|560874940|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393312|NCT02038920|560874941|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393313|NCT02038920|560874942|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393314|NCT02038920|560874943|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393315|NCT02038920|560874944|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
155393316|NCT02038920|560874939|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
155393317|NCT02038920|560874940|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
155393318|NCT02038920|560874941|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393319|NCT02038920|560874942|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393320|NCT02038920|560874943|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393321|NCT02038920|560874944|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
155393322|NCT02038920|560874939|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
155393323|NCT02038920|560874940|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
155393324|NCT02038920|560874941|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
155393325|NCT02038920|560874942|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
155393326|NCT02038920|560874943|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
155393327|NCT02038920|560874944|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
155393328|NCT02038920|560874939|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393329|NCT02038920|560874940|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393330|NCT02038920|560874941|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
155393331|NCT02038920|560874942|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393332|NCT02038920|560874943|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393333|NCT02038920|560874944|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
155393334|NCT02038920|560874939|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
155393335|NCT02038920|560874940|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
155393336|NCT02038920|560874941|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
155393337|NCT02038920|560874942|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
155393338|NCT02038920|560874943|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
155393339|NCT02038920|560874944|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
155393340|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393341|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393342|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393343|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393344|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
155393345|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
155393346|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393347|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393348|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155051577|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051578|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
155051579|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051580|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051581|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051582|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051583|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051584|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051585|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051586|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051587|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051588|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051589|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051590|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
155051591|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051592|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051593|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
155051594|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051595|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051596|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051597|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051598|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051599|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155282894|NCT03682536|560468155|FG001|Treatment|Lack of Efficacy|68|||
155282895|NCT03682536|560468154|FG000|Treatment|Disease Progression|9|||
155282896|NCT03682536|560468155|FG001|Treatment|Disease Progression|7|||
155282897|NCT03682536|560468154|FG000|Treatment|Adverse Event|9|||
155282898|NCT03682536|560468155|FG001|Treatment|Adverse Event|5|||
155282899|NCT03682536|560468154|FG000|Treatment|Death|14|||
155282900|NCT03682536|560468155|FG001|Treatment|Death|13|||
155282901|NCT05489224|560468156|FG000|Treatment Period I|Withdrawal by Subject|6|||
155282902|NCT05489224|560468157|FG001|Treatment Period I|Withdrawal by Subject|5|||
155282903|NCT05489224|560468158|FG002|Treatment Period I|Withdrawal by Subject|0|||
155282904|NCT05489224|560468156|FG000|Treatment Period I|Adverse Event|3|||
155282905|NCT05489224|560468157|FG001|Treatment Period I|Adverse Event|11|||
155282906|NCT05489224|560468158|FG002|Treatment Period I|Adverse Event|0|||
155282907|NCT05489224|560468156|FG000|Treatment Period I|Lost to Follow-up|0|||
155282908|NCT05489224|560468157|FG001|Treatment Period I|Lost to Follow-up|1|||
155282909|NCT05489224|560468158|FG002|Treatment Period I|Lost to Follow-up|0|||
155282910|NCT05489224|560468156|FG000|Treatment Period I|Physician Decision|0|||
155282911|NCT05489224|560468157|FG001|Treatment Period I|Physician Decision|1|||
155282912|NCT05489224|560468158|FG002|Treatment Period I|Physician Decision|0|||
155282913|NCT05489224|560468156|FG000|Treatment Period II up to Week 32|Ongoing|222|||
155282914|NCT05489224|560468157|FG001|Treatment Period II up to Week 32|Ongoing|107|||
155282915|NCT05489224|560468158|FG002|Treatment Period II up to Week 32|Ongoing|107|||
155282916|NCT05489224|560468156|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
155282917|NCT05489224|560468157|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
155282918|NCT05489224|560468158|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
155282919|NCT05489224|560468156|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
155282920|NCT05489224|560468157|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
155282921|NCT05489224|560468158|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
155282922|NCT03008122|560468167|FG000|Overall Study|Physician Decision|3|||
155282923|NCT03008122|560468168|FG001|Overall Study|Physician Decision|2|||
155282924|NCT03008122|560468169|FG002|Overall Study|Physician Decision|0|||
155282925|NCT03008122|560468167|FG000|Overall Study|Withdrawal by Subject|1|||
155282926|NCT03008122|560468168|FG001|Overall Study|Withdrawal by Subject|3|||
155282927|NCT03008122|560468169|FG002|Overall Study|Withdrawal by Subject|0|||
155282928|NCT03008122|560468167|FG000|Overall Study|Lost to Follow-up|4|||
155282929|NCT03008122|560468168|FG001|Overall Study|Lost to Follow-up|8|||
155282930|NCT03008122|560468169|FG002|Overall Study|Lost to Follow-up|3|||
155282931|NCT03008122|560468167|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
155282932|NCT03008122|560468168|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155282933|NCT03008122|560468169|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155282934|NCT03008122|560468167|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
155282935|NCT03008122|560468168|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
155282936|NCT03008122|560468169|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
155282937|NCT03008122|560468167|FG000|Overall Study|Death|0|||
155282938|NCT03008122|560468168|FG001|Overall Study|Death|0|||
155282939|NCT03008122|560468169|FG002|Overall Study|Death|1|||
155282940|NCT01222247|560468171|FG000|Overall Study|Lost to Follow-up|2|||
155282941|NCT01222247|560468172|FG001|Overall Study|Lost to Follow-up|2|||
155282942|NCT02084082|560468173|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
155282943|NCT02084082|560468174|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
155282944|NCT02084082|560468175|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
155282945|NCT02084082|560468176|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
155282946|NCT02084082|560468173|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155282947|NCT02084082|560468174|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155282948|NCT02084082|560468175|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
155282949|NCT02084082|560468176|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
155282950|NCT02223182|560468181|FG000|Double-Blind Period|Adverse Event|0|||
155282951|NCT02223182|560468182|FG001|Double-Blind Period|Adverse Event|2|||
155282952|NCT02223182|560468183|FG002|Double-Blind Period|Adverse Event|1|||
155282953|NCT02223182|560468184|FG003|Double-Blind Period|Adverse Event|0|||
155282954|NCT02223182|560468181|FG000|Double-Blind Period|Withdrawal by Subject|1|||
155282955|NCT02223182|560468182|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155282956|NCT02223182|560468183|FG002|Double-Blind Period|Withdrawal by Subject|1|||
155282957|NCT02223182|560468184|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155282958|NCT02223182|560468181|FG000|Double-Blind Period|Lost to Follow-up|0|||
155282959|NCT02223182|560468182|FG001|Double-Blind Period|Lost to Follow-up|1|||
155282960|NCT02223182|560468183|FG002|Double-Blind Period|Lost to Follow-up|0|||
155282961|NCT02223182|560468184|FG003|Double-Blind Period|Lost to Follow-up|0|||
155282962|NCT02223182|560468181|FG000|Double-Blind Period|Non Compliance|0|||
155282963|NCT02223182|560468182|FG001|Double-Blind Period|Non Compliance|0|||
155282964|NCT02223182|560468183|FG002|Double-Blind Period|Non Compliance|0|||
155282965|NCT02223182|560468184|FG003|Double-Blind Period|Non Compliance|1|||
155282966|NCT02223182|560468181|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
155282967|NCT02223182|560468182|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
155282968|NCT02223182|560468183|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
155282969|NCT02223182|560468184|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
155282970|NCT02223182|560468181|FG000|Open-Label 500 Period|Adverse Event|1|||
155282971|NCT02223182|560468182|FG001|Open-Label 500 Period|Adverse Event|0|||
155282972|NCT02223182|560468183|FG002|Open-Label 500 Period|Adverse Event|2|||
155282973|NCT02223182|560468184|FG003|Open-Label 500 Period|Adverse Event|1|||
155282974|NCT02223182|560468181|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
155282975|NCT02223182|560468182|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
155282976|NCT02223182|560468183|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
155282977|NCT02223182|560468184|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
155282978|NCT02223182|560468181|FG000|Open-Label 500 Period|Physician Decision|0|||
155282979|NCT02223182|560468182|FG001|Open-Label 500 Period|Physician Decision|0|||
155282980|NCT02223182|560468183|FG002|Open-Label 500 Period|Physician Decision|0|||
155282981|NCT02223182|560468184|FG003|Open-Label 500 Period|Physician Decision|1|||
155282982|NCT02223182|560468181|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
155282983|NCT02223182|560468182|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
155282984|NCT02223182|560468183|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
155282985|NCT02223182|560468184|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
155282986|NCT02223182|560468181|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
155282987|NCT02223182|560468182|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
155282988|NCT02223182|560468183|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
155282989|NCT02223182|560468184|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
155282990|NCT02223182|560468181|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
155282991|NCT02223182|560468182|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
155282992|NCT02223182|560468183|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
155282993|NCT02223182|560468184|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
155282994|NCT02223182|560468181|FG000|Open-Label 300 Period|Non Compliance|0|||
155282995|NCT02223182|560468182|FG001|Open-Label 300 Period|Non Compliance|2|||
155282996|NCT02223182|560468183|FG002|Open-Label 300 Period|Non Compliance|1|||
155282997|NCT02223182|560468184|FG003|Open-Label 300 Period|Non Compliance|0|||
155282998|NCT04956692|560468191|FG000|Overall Study|Death|115|||
155282999|NCT04956692|560468192|FG001|Overall Study|Death|47|||
155283000|NCT04956692|560468191|FG000|Overall Study|Lost to Follow-up|0|||
155283001|NCT04956692|560468192|FG001|Overall Study|Lost to Follow-up|1|||
155283002|NCT04956692|560468191|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155283003|NCT04956692|560468192|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155283004|NCT04956692|560468191|FG000|Overall Study|Withdrawal by Subject|5|||
155283005|NCT04956692|560468192|FG001|Overall Study|Withdrawal by Subject|2|||
155283006|NCT04956692|560468191|FG000|Overall Study|Ongoing in Study|236|||
155283007|NCT04956692|560468192|FG001|Overall Study|Ongoing in Study|123|||
155283008|NCT02099539|560468197|FG000|Overall Study|Progressive Disease|3|||
155283009|NCT02099539|560468198|FG001|Overall Study|Progressive Disease|2|||
155283010|NCT02099539|560468199|FG002|Overall Study|Progressive Disease|2|||
155283011|NCT02099539|560468200|FG003|Overall Study|Progressive Disease|1|||
155283012|NCT02099539|560468201|FG004|Overall Study|Progressive Disease|4|||
155283013|NCT02099539|560468202|FG005|Overall Study|Progressive Disease|2|||
155283014|NCT02099539|560468203|FG006|Overall Study|Progressive Disease|0|||
155283015|NCT02099539|560468197|FG000|Overall Study|Adverse Event|0|||
155283016|NCT02099539|560468198|FG001|Overall Study|Adverse Event|0|||
155283017|NCT02099539|560468199|FG002|Overall Study|Adverse Event|1|||
155283018|NCT02099539|560468200|FG003|Overall Study|Adverse Event|1|||
155283019|NCT02099539|560468201|FG004|Overall Study|Adverse Event|0|||
155283020|NCT02099539|560468202|FG005|Overall Study|Adverse Event|0|||
155283021|NCT02099539|560468203|FG006|Overall Study|Adverse Event|0|||
155283022|NCT02099539|560468197|FG000|Overall Study|Physician Decision|0|||
155283023|NCT02099539|560468198|FG001|Overall Study|Physician Decision|0|||
155283024|NCT02099539|560468199|FG002|Overall Study|Physician Decision|0|||
155283025|NCT02099539|560468200|FG003|Overall Study|Physician Decision|0|||
155283026|NCT02099539|560468201|FG004|Overall Study|Physician Decision|0|||
155283027|NCT02099539|560468202|FG005|Overall Study|Physician Decision|1|||
155283028|NCT02099539|560468203|FG006|Overall Study|Physician Decision|0|||
155283029|NCT03473756|560468205|FG000|Overall Study|Withdrawal by Subject|1|||
155283030|NCT03473756|560468206|FG001|Overall Study|Withdrawal by Subject|4|||
155283031|NCT03473756|560468205|FG000|Overall Study|Adverse Event|6|||
155283032|NCT03473756|560468206|FG001|Overall Study|Adverse Event|7|||
155283033|NCT03473756|560468205|FG000|Overall Study|Lack of Efficacy|3|||
155283034|NCT03473756|560468206|FG001|Overall Study|Lack of Efficacy|10|||
155283035|NCT03473756|560468205|FG000|Overall Study|Physician Decision|0|||
155283036|NCT03473756|560468206|FG001|Overall Study|Physician Decision|2|||
155283037|NCT03473756|560468205|FG000|Overall Study|End of study treatment|0|||
155283038|NCT03473756|560468206|FG001|Overall Study|End of study treatment|2|||
155283039|NCT03473756|560468205|FG000|Overall Study|Lost to Follow-up|0|||
155283040|NCT03473756|560468206|FG001|Overall Study|Lost to Follow-up|1|||
155283041|NCT03714022|560468207|FG000|Overall Study|Adverse Event|1|||
155283042|NCT03714022|560468208|FG001|Overall Study|Adverse Event|0|||
155283043|NCT03714022|560468207|FG000|Overall Study|Consent withdrawal|0|||
155283044|NCT03714022|560468208|FG001|Overall Study|Consent withdrawal|1|||
155283045|NCT03714022|560468207|FG000|Overall Study|Lost to Follow-up|3|||
155283046|NCT03714022|560468208|FG001|Overall Study|Lost to Follow-up|2|||
155283047|NCT02148718|560468211|FG000|Overall Study|Protocol Violation|26|||
155283048|NCT02148718|560468211|FG000|Overall Study|Discontinued Study Prematurely|5|||
155283049|NCT02487446|560468215|FG000|Period 1|Physician Decision|0|||
155283050|NCT02487446|560468216|FG001|Period 1|Physician Decision|1|||
155283051|NCT02487446|560468215|FG000|Period 1|Lack of Efficacy|1|||
155283052|NCT02487446|560468216|FG001|Period 1|Lack of Efficacy|0|||
155283053|NCT02487446|560468215|FG000|Period 1|Protocol deviation|3|||
155283054|NCT02487446|560468216|FG001|Period 1|Protocol deviation|2|||
155283055|NCT02487446|560468215|FG000|Period 1|Lost to Follow-up|2|||
155283056|NCT02487446|560468216|FG001|Period 1|Lost to Follow-up|0|||
155283057|NCT02487446|560468215|FG000|Period 1|Withdrawal by Subject|2|||
155283058|NCT02487446|560468216|FG001|Period 1|Withdrawal by Subject|0|||
155283059|NCT02487446|560468215|FG000|Period 1|Adverse Event|5|||
155283060|NCT02487446|560468216|FG001|Period 1|Adverse Event|5|||
155283061|NCT02487446|560468215|FG000|Washout|Lost to Follow-up|0|||
155283062|NCT02487446|560468216|FG001|Washout|Lost to Follow-up|2|||
155283063|NCT02487446|560468215|FG000|Washout|Withdrawal by Subject|1|||
155283064|NCT02487446|560468216|FG001|Washout|Withdrawal by Subject|4|||
155283065|NCT02487446|560468215|FG000|Washout|Adverse Event|2|||
155283066|NCT02487446|560468216|FG001|Washout|Adverse Event|2|||
155283067|NCT02487446|560468215|FG000|Period 2|Protocol deviation|0|||
155283068|NCT02487446|560468216|FG001|Period 2|Protocol deviation|1|||
155283069|NCT02487446|560468215|FG000|Period 2|Lost to Follow-up|1|||
155283070|NCT02487446|560468216|FG001|Period 2|Lost to Follow-up|1|||
155283071|NCT02487446|560468215|FG000|Period 2|Withdrawal by Subject|1|||
155283072|NCT02487446|560468216|FG001|Period 2|Withdrawal by Subject|1|||
155283073|NCT02487446|560468215|FG000|Period 2|Adverse Event|6|||
155283074|NCT02487446|560468216|FG001|Period 2|Adverse Event|2|||
155283075|NCT02234310|560468217|FG000|Overall Study|Physician Decision|1|||
155283076|NCT02234310|560468217|FG000|Overall Study|Adverse Event|1|||
155283077|NCT02234310|560468217|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
155283078|NCT02234310|560468217|FG000|Overall Study|Withdrawal by Subject|2|||
155283079|NCT03289455|560468218|FG000|Overall Study|Death|1|||
155283080|NCT03289455|560468219|FG001|Overall Study|Death|0|||
155283081|NCT03289455|560468220|FG002|Overall Study|Death|0|||
155283082|NCT03289455|560468218|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
155283083|NCT03289455|560468219|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
155283084|NCT03289455|560468220|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
155283085|NCT03289455|560468218|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
155283086|NCT03289455|560468219|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
155283087|NCT03289455|560468220|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
155283088|NCT03289455|560468218|FG000|Overall Study|Progressive disease|3|||
155283089|NCT03289455|560468219|FG001|Overall Study|Progressive disease|4|||
155283090|NCT03289455|560468220|FG002|Overall Study|Progressive disease|5|||
155283091|NCT01822821|560468221|FG000|Overall Study|Eligible surgery cancelled|1|||
155283092|NCT01822821|560468222|FG001|Overall Study|Eligible surgery cancelled|1|||
155283093|NCT01822821|560468221|FG000|Overall Study|Other reasons|1|||
155283094|NCT01822821|560468222|FG001|Overall Study|Other reasons|0|||
155283095|NCT00333788|560468223|FG000|Overall Study|Adverse Event|44|||
155283096|NCT00333788|560468223|FG000|Overall Study|Lack of Efficacy|80|||
155283097|NCT00333788|560468223|FG000|Overall Study|Lost to Follow-up|2|||
155283098|NCT00333788|560468223|FG000|Overall Study|Withdrawal by Subject|24|||
155283099|NCT00333788|560468223|FG000|Overall Study|Other: Non-compliance|2|||
155283100|NCT00333788|560468223|FG000|Overall Study|Other: Moved|2|||
155283101|NCT00333788|560468223|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
155283102|NCT00333788|560468223|FG000|Overall Study|Other: Investigator decision|1|||
155283103|NCT00333788|560468223|FG000|Overall Study|Other: Quality of life concern|1|||
155283104|NCT00333788|560468223|FG000|Overall Study|Other: Sponsor decision|1|||
155283105|NCT00333788|560468223|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
155283106|NCT00333788|560468223|FG000|Overall Study|Other: Medical monitor decision|1|||
155283107|NCT00333788|560468223|FG000|Overall Study|Other: Physician decision|1|||
155283108|NCT00333788|560468223|FG000|Overall Study|Other: Signed consent for another study|1|||
155283109|NCT03251378|560468224|FG000|Overall Study|Death|3|||
155283110|NCT03251378|560468225|FG001|Overall Study|Death|2|||
155283111|NCT03251378|560468226|FG002|Overall Study|Death|3|||
155283112|NCT03251378|560468227|FG003|Overall Study|Death|30|||
155283113|NCT03251378|560468228|FG004|Overall Study|Death|24|||
155283114|NCT03251378|560468229|FG005|Overall Study|Death|12|||
155283115|NCT03251378|560468230|FG006|Overall Study|Death|12|||
155283116|NCT03251378|560468224|FG000|Overall Study|Lost to Follow-up|0|||
155393349|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393350|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
155393351|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
155393352|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393353|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393354|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393355|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393356|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
155393357|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
155393358|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393359|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393360|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393361|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393362|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
155393363|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
155393364|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393365|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393366|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393367|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393368|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
155393369|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
155393370|NCT02038920|560874939|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393371|NCT02038920|560874940|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393372|NCT02038920|560874941|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393373|NCT02038920|560874942|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393374|NCT02038920|560874943|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
155393375|NCT02038920|560874944|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
155393376|NCT02383589|560874945|FG000|Treatment Period|Adverse Event|1|||
155393377|NCT02383589|560874946|FG001|Treatment Period|Adverse Event|3|||
155393378|NCT02383589|560874945|FG000|Treatment Period|Lost to Follow-up|0|||
155393379|NCT02383589|560874946|FG001|Treatment Period|Lost to Follow-up|1|||
155393380|NCT02383589|560874945|FG000|Treatment Period|Withdrawal by Subject|0|||
155393381|NCT02383589|560874946|FG001|Treatment Period|Withdrawal by Subject|5|||
155393382|NCT02383589|560874945|FG000|Treatment Period|Non-compliance with study drug|0|||
155393383|NCT02383589|560874946|FG001|Treatment Period|Non-compliance with study drug|1|||
154949475|NCT00950807|559239582|FG007|Treatment Period 3|Withdrawal by Subject|0|||
154949476|NCT00950807|559239583|FG008|Treatment Period 3|Withdrawal by Subject|0|||
155051600|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051601|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051602|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051603|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051604|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051605|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
155051606|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051607|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051608|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
155051609|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051610|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051611|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051612|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051613|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051614|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051615|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051616|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155092578|NCT01959529|559773634|FG000|Overall Study|Lack of glycaemic control|1|||
154949477|NCT00950807|559239584|FG009|Treatment Period 3|Withdrawal by Subject|1|||
154949478|NCT00950807|559239575|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
154949479|NCT00950807|559239576|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949480|NCT00950807|559239577|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949481|NCT00950807|559239578|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949482|NCT00950807|559239579|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949483|NCT00950807|559239580|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949484|NCT00950807|559239581|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949485|NCT00950807|559239582|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
154949486|NCT00950807|559239583|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155051617|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051618|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051619|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051620|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
155051621|NCT02326272|559621505|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051622|NCT02326272|559621506|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051623|NCT02326272|559621507|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
155051624|NCT02326272|559621508|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051625|NCT02326272|559621509|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051626|NCT02326272|559621510|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051627|NCT02326272|559621511|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051628|NCT02326272|559621512|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051629|NCT02326272|559621513|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051630|NCT02326272|559621514|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051631|NCT02326272|559621515|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051632|NCT02326272|559621516|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051633|NCT02326272|559621517|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051634|NCT02326272|559621518|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051635|NCT02326272|559621519|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
155051636|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051637|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051638|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051639|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051640|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155051641|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
155051642|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
155051643|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155051644|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155051645|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051646|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051647|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051648|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051649|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051650|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155051651|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051652|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051653|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051654|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051655|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051656|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
155051657|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155051658|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051659|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155051660|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155051661|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051662|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051663|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051664|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051665|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155051666|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051667|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051668|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051669|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155393384|NCT02383589|560874945|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
154949487|NCT00950807|559239584|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
154949488|NCT00950807|559239575|FG000|Treatment Period 3|Adverse Event|0|||
154949489|NCT00950807|559239576|FG001|Treatment Period 3|Adverse Event|0|||
154949490|NCT00950807|559239577|FG002|Treatment Period 3|Adverse Event|0|||
154949491|NCT00950807|559239578|FG003|Treatment Period 3|Adverse Event|0|||
154949492|NCT00950807|559239579|FG004|Treatment Period 3|Adverse Event|0|||
154949493|NCT00950807|559239580|FG005|Treatment Period 3|Adverse Event|0|||
154949494|NCT00950807|559239581|FG006|Treatment Period 3|Adverse Event|1|||
154949495|NCT00950807|559239582|FG007|Treatment Period 3|Adverse Event|0|||
155051670|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051671|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
155051672|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051673|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
155051674|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051675|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051676|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051677|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051678|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051679|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051680|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155051681|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051682|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051683|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051684|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155051685|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051686|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
155051687|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155051688|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155051689|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051690|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155051691|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051692|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051693|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051694|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051695|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155051696|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051697|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051698|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
154949496|NCT00950807|559239583|FG008|Treatment Period 3|Adverse Event|0|||
154949497|NCT00950807|559239584|FG009|Treatment Period 3|Adverse Event|0|||
154949498|NCT01492400|559239588|FG000|Overall Study|Miscellaneous Reasons|2|||
154949499|NCT01492400|559239589|FG001|Overall Study|Miscellaneous Reasons|3|||
154949500|NCT01492400|559239588|FG000|Overall Study|Personal Reasons|0|||
154949501|NCT01492400|559239589|FG001|Overall Study|Personal Reasons|5|||
154949502|NCT01492400|559239588|FG000|Overall Study|Lost to Follow-up|3|||
154949503|NCT01492400|559239589|FG001|Overall Study|Lost to Follow-up|1|||
154949504|NCT01492400|559239588|FG000|Overall Study|Pregnancy|0|||
154949505|NCT01492400|559239589|FG001|Overall Study|Pregnancy|1|||
154949506|NCT01492400|559239588|FG000|Overall Study|Lack of Efficacy|1|||
154949507|NCT01492400|559239589|FG001|Overall Study|Lack of Efficacy|1|||
154949508|NCT01492400|559239588|FG000|Overall Study|Adverse Event|10|||
154949509|NCT01492400|559239589|FG001|Overall Study|Adverse Event|5|||
154949510|NCT00659607|559239591|FG000|Overall Study|No blood pressure recorded|147|||
154949511|NCT00659607|559239591|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
154949512|NCT00659607|559239591|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
154949513|NCT00659607|559239591|FG000|Overall Study|No recorded efficacy data|15|||
154949514|NCT00659607|559239591|FG000|Overall Study|Inconsistent BP measuring date|2|||
154949515|NCT06179108|559239592|FG000|Overall Study|Withdrawal by Subject|16|||
154949516|NCT06179108|559239593|FG001|Overall Study|Withdrawal by Subject|19|||
154949517|NCT06179108|559239594|FG002|Overall Study|Withdrawal by Subject|10|||
154949518|NCT06179108|559239595|FG003|Overall Study|Withdrawal by Subject|11|||
154949519|NCT06179108|559239592|FG000|Overall Study|Lost to Follow-up|12|||
154949520|NCT06179108|559239593|FG001|Overall Study|Lost to Follow-up|4|||
154949521|NCT06179108|559239594|FG002|Overall Study|Lost to Follow-up|1|||
154949522|NCT06179108|559239595|FG003|Overall Study|Lost to Follow-up|9|||
154949523|NCT06179108|559239592|FG000|Overall Study|Adverse Event|2|||
154949524|NCT06179108|559239593|FG001|Overall Study|Adverse Event|3|||
154949525|NCT06179108|559239594|FG002|Overall Study|Adverse Event|3|||
154949526|NCT06179108|559239595|FG003|Overall Study|Adverse Event|2|||
154949527|NCT06179108|559239592|FG000|Overall Study|Protocol Violation|0|||
154949528|NCT06179108|559239593|FG001|Overall Study|Protocol Violation|1|||
155051699|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051700|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
154949529|NCT06179108|559239594|FG002|Overall Study|Protocol Violation|0|||
154949530|NCT06179108|559239595|FG003|Overall Study|Protocol Violation|1|||
154949531|NCT06179108|559239592|FG000|Overall Study|Physician Decision|1|||
154949532|NCT06179108|559239593|FG001|Overall Study|Physician Decision|1|||
154949533|NCT06179108|559239594|FG002|Overall Study|Physician Decision|0|||
155051701|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
154949534|NCT06179108|559239595|FG003|Overall Study|Physician Decision|0|||
155051702|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051703|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
155051704|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051705|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051706|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051707|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051708|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051709|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051710|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
155051711|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051712|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051713|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051714|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051715|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051716|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051717|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
155051718|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051719|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051720|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051721|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051722|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051723|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051724|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051725|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155051726|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051727|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051728|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051729|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051730|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051731|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051732|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051733|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051734|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
155051735|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
154949535|NCT06179108|559239592|FG000|Overall Study|Lack of Efficacy|0|||
154949536|NCT06179108|559239593|FG001|Overall Study|Lack of Efficacy|0|||
154949537|NCT06179108|559239594|FG002|Overall Study|Lack of Efficacy|0|||
154949538|NCT06179108|559239595|FG003|Overall Study|Lack of Efficacy|1|||
154949539|NCT06179108|559239592|FG000|Overall Study|Death|0|||
154949540|NCT06179108|559239593|FG001|Overall Study|Death|0|||
154949541|NCT06179108|559239594|FG002|Overall Study|Death|0|||
154949542|NCT06179108|559239595|FG003|Overall Study|Death|1|||
154949543|NCT02364557|559239599|FG000|Overall Study|Protocol Violation|3|||
154949544|NCT02364557|559239600|FG001|Overall Study|Protocol Violation|1|||
154949545|NCT04347239|559239601|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
154949546|NCT04347239|559239602|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
154949547|NCT04347239|559239603|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
154949548|NCT04347239|559239601|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
154949549|NCT04347239|559239602|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
154949550|NCT04347239|559239603|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
154949551|NCT02153736|559239618|FG000|Overall Study|Lost to Follow-up|1|||
154949552|NCT02153736|559239619|FG001|Overall Study|Lost to Follow-up|0|||
154949553|NCT02153736|559239618|FG000|Overall Study|Medical status change made ineligible|1|||
154949554|NCT02153736|559239619|FG001|Overall Study|Medical status change made ineligible|0|||
154949555|NCT02153736|559239618|FG000|Overall Study|Death|0|||
154949556|NCT02153736|559239619|FG001|Overall Study|Death|1|||
154949557|NCT02153736|559239618|FG000|Overall Study|Withdrawal by Subject|0|||
154949558|NCT02153736|559239619|FG001|Overall Study|Withdrawal by Subject|1|||
154949559|NCT02568384|559239620|FG000|Overall Study|Mobile devices incompatible with App|2|||
154949560|NCT00796510|559239621|FG000|Overall Study|Death|1|||
154949561|NCT00796510|559239622|FG001|Overall Study|Death|0|||
154949562|NCT00796510|559239621|FG000|Overall Study|Study Terminated|2|||
154949563|NCT00796510|559239622|FG001|Overall Study|Study Terminated|0|||
154949564|NCT01734772|559239623|FG000|Overall Study|Adverse Event|1|||
154949565|NCT01734772|559239624|FG001|Overall Study|Adverse Event|2|||
154949566|NCT01734772|559239623|FG000|Overall Study|Withdrawal by Subject|0|||
154949567|NCT01734772|559239624|FG001|Overall Study|Withdrawal by Subject|1|||
155051736|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051737|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051738|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051739|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051740|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
155051741|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051742|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051743|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051744|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051745|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051746|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
155051747|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
155051748|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
155051749|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
155051750|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051751|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051752|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051753|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051754|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051755|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155051756|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051757|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051758|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051759|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051760|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051761|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
155051762|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051763|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051764|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051765|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051766|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051767|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051768|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051769|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051770|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
155051771|NCT02326272|559621505|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051772|NCT02326272|559621506|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051773|NCT02326272|559621507|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051774|NCT02326272|559621508|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051775|NCT02326272|559621509|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051776|NCT02326272|559621510|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051777|NCT02326272|559621511|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
155051778|NCT02326272|559621512|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051779|NCT02326272|559621513|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051780|NCT02326272|559621514|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051781|NCT02326272|559621515|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051782|NCT02326272|559621516|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051783|NCT02326272|559621517|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051784|NCT02326272|559621518|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051785|NCT02326272|559621519|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
155051786|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
155051787|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
155051788|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
155051789|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
155051790|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
155051791|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
155051792|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
155051793|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
155051794|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
155051795|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
155393385|NCT02383589|560874946|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
155393386|NCT02383589|560874945|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
155393387|NCT02383589|560874946|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
155393388|NCT02383589|560874945|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
155393389|NCT02383589|560874946|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
155393390|NCT02906787|560874949|FG000|Overall Study|Withdrawal by Subject|12|||
155393391|NCT02906787|560874950|FG001|Overall Study|Withdrawal by Subject|10|||
155393392|NCT02906787|560874949|FG000|Overall Study|Missed|24|||
155393393|NCT02906787|560874950|FG001|Overall Study|Missed|22|||
155393394|NCT03901053|560874955|FG000|Overall Study|Lost to Follow-up|6|||
155393395|NCT03901053|560874956|FG001|Overall Study|Lost to Follow-up|2|||
155393396|NCT03901053|560874955|FG000|Overall Study|Withdrawal by Subject|4|||
155393397|NCT03901053|560874956|FG001|Overall Study|Withdrawal by Subject|3|||
155393398|NCT03901053|560874955|FG000|Overall Study|Unsatisfactory Device|1|||
155393399|NCT03901053|560874956|FG001|Overall Study|Unsatisfactory Device|2|||
155393400|NCT03901053|560874955|FG000|Overall Study|No longer meets study criteria|1|||
155393401|NCT03901053|560874956|FG001|Overall Study|No longer meets study criteria|3|||
155393402|NCT03901053|560874955|FG000|Overall Study|Subject's Medical Status|0|||
155393403|NCT03901053|560874956|FG001|Overall Study|Subject's Medical Status|1|||
155393404|NCT03901053|560874955|FG000|Overall Study|Screening Failure|1|||
155393405|NCT03901053|560874956|FG001|Overall Study|Screening Failure|0|||
155393406|NCT02113579|560876726|FG000|Overall Study|Adverse Event|1|||
155393407|NCT02113579|560876727|FG001|Overall Study|Adverse Event|0|||
155393408|NCT02113579|560876726|FG000|Overall Study|Withdrawal by Subject|3|||
155393409|NCT02113579|560876727|FG001|Overall Study|Withdrawal by Subject|2|||
154949568|NCT01139164|559239625|FG000|Overall Study|Withdrawn prior to study start|0|||
154949569|NCT01139164|559239626|FG001|Overall Study|Withdrawn prior to study start|2|||
154949570|NCT01139164|559239627|FG002|Overall Study|Withdrawn prior to study start|0|||
154949571|NCT01790568|559239628|FG000|Overall Study|Progression prior to transplant|0|||
154949572|NCT01790568|559239629|FG001|Overall Study|Progression prior to transplant|1|||
154949573|NCT03184441|559239630|FG000|Overall Study|Withdrawal by Subject|1|||
154949574|NCT02994056|559239631|FG000|Overall Study|Death|8|||
154949575|NCT02994056|559239631|FG000|Overall Study|Withdrew Consent|1|||
154949576|NCT02742181|559239632|FG000|Overall Study|Physician Decision|1|||
154949577|NCT02742181|559239633|FG001|Overall Study|Physician Decision|0|||
154949578|NCT00979628|559239634|FG000|Overall Study|received regimen < 24 hours|7|||
154949579|NCT00979628|559239635|FG001|Overall Study|received regimen < 24 hours|6|||
154949580|NCT00979628|559239636|FG002|Overall Study|received regimen < 24 hours|5|||
154949581|NCT00979628|559239634|FG000|Overall Study|received steroids|1|||
154949582|NCT00979628|559239635|FG001|Overall Study|received steroids|1|||
154949583|NCT00979628|559239636|FG002|Overall Study|received steroids|0|||
154949584|NCT00979628|559239634|FG000|Overall Study|transferred to ICU|1|||
154949585|NCT00979628|559239635|FG001|Overall Study|transferred to ICU|2|||
154949586|NCT00979628|559239636|FG002|Overall Study|transferred to ICU|1|||
154949587|NCT00911859|559239637|FG000|Treatment Period|Adverse Event|3|||
154949588|NCT00911859|559239638|FG001|Treatment Period|Adverse Event|3|||
154949589|NCT00911859|559239639|FG002|Treatment Period|Adverse Event|7|||
154949590|NCT00911859|559239637|FG000|Treatment Period|Death|1|||
154949591|NCT00911859|559239638|FG001|Treatment Period|Death|3|||
154949592|NCT00911859|559239639|FG002|Treatment Period|Death|5|||
154949593|NCT00911859|559239637|FG000|Treatment Period|Lack of Efficacy|1|||
154949594|NCT00911859|559239638|FG001|Treatment Period|Lack of Efficacy|7|||
154949595|NCT00911859|559239639|FG002|Treatment Period|Lack of Efficacy|5|||
154949596|NCT00911859|559239637|FG000|Treatment Period|Physician Decision|3|||
154949597|NCT00911859|559239638|FG001|Treatment Period|Physician Decision|3|||
154949598|NCT00911859|559239639|FG002|Treatment Period|Physician Decision|3|||
154949599|NCT00911859|559239637|FG000|Treatment Period|Withdrawal by Subject|0|||
154949600|NCT00911859|559239638|FG001|Treatment Period|Withdrawal by Subject|4|||
154949601|NCT00911859|559239639|FG002|Treatment Period|Withdrawal by Subject|5|||
154949602|NCT00911859|559239637|FG000|Treatment Period|Did not receive study treatment|0|||
154949603|NCT00911859|559239638|FG001|Treatment Period|Did not receive study treatment|1|||
154949604|NCT00911859|559239639|FG002|Treatment Period|Did not receive study treatment|0|||
154949605|NCT00911859|559239637|FG000|Maintainance Period|Lack of Efficacy|0|||
154949606|NCT00911859|559239638|FG001|Maintainance Period|Lack of Efficacy|0|||
154949607|NCT00911859|559239639|FG002|Maintainance Period|Lack of Efficacy|9|||
154949608|NCT00911859|559239637|FG000|Maintainance Period|Physician Decision|0|||
154949609|NCT00911859|559239638|FG001|Maintainance Period|Physician Decision|0|||
154949610|NCT00911859|559239639|FG002|Maintainance Period|Physician Decision|9|||
154949611|NCT00911859|559239637|FG000|Maintainance Period|Withdrawal by Subject|0|||
154949612|NCT00911859|559239638|FG001|Maintainance Period|Withdrawal by Subject|0|||
154949613|NCT00911859|559239639|FG002|Maintainance Period|Withdrawal by Subject|3|||
154949614|NCT00911859|559239637|FG000|Follow-up Period|Death|5|||
154949615|NCT00911859|559239638|FG001|Follow-up Period|Death|8|||
154949616|NCT00911859|559239639|FG002|Follow-up Period|Death|10|||
154949617|NCT00911859|559239637|FG000|Follow-up Period|Lost to Follow-up|1|||
155393410|NCT02113579|560876726|FG000|Overall Study|Lost to Follow-up|6|||
155393411|NCT02113579|560876727|FG001|Overall Study|Lost to Follow-up|2|||
155393412|NCT00726622|560876728|FG000|Overall Study|Withdrawal by Subject|16|||
155393413|NCT00726622|560876729|FG001|Overall Study|Withdrawal by Subject|2|||
155393414|NCT00726622|560876728|FG000|Overall Study|Physician Decision|0|||
155393415|NCT00726622|560876729|FG001|Overall Study|Physician Decision|1|||
155393416|NCT00726622|560876728|FG000|Overall Study|Metastasis|2|||
155393417|NCT00726622|560876729|FG001|Overall Study|Metastasis|0|||
155393418|NCT02462928|560876730|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
155393419|NCT02462928|560876731|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
155393420|NCT02462928|560876732|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
155393421|NCT02462928|560876730|FG000|Overall Study|Adverse Event|47|||
155393422|NCT02462928|560876731|FG001|Overall Study|Adverse Event|51|||
155393423|NCT02462928|560876732|FG002|Overall Study|Adverse Event|25|||
155393424|NCT02462928|560876730|FG000|Overall Study|Lack of Efficacy|3|||
155393425|NCT02462928|560876731|FG001|Overall Study|Lack of Efficacy|8|||
155393426|NCT02462928|560876732|FG002|Overall Study|Lack of Efficacy|3|||
155393427|NCT02462928|560876730|FG000|Overall Study|Lost to Follow-up|4|||
155393428|NCT02462928|560876731|FG001|Overall Study|Lost to Follow-up|4|||
155393429|NCT02462928|560876732|FG002|Overall Study|Lost to Follow-up|1|||
155393430|NCT02462928|560876730|FG000|Overall Study|Withdrawal by Patient|31|||
155393431|NCT02462928|560876731|FG001|Overall Study|Withdrawal by Patient|21|||
155393432|NCT02462928|560876732|FG002|Overall Study|Withdrawal by Patient|21|||
155393433|NCT02462928|560876730|FG000|Overall Study|Protocol Violation|0|||
155393434|NCT02462928|560876731|FG001|Overall Study|Protocol Violation|1|||
155393435|NCT02462928|560876732|FG002|Overall Study|Protocol Violation|0|||
155393436|NCT02462928|560876730|FG000|Overall Study|Reason not Specified|4|||
155393437|NCT02462928|560876731|FG001|Overall Study|Reason not Specified|6|||
155393438|NCT02462928|560876732|FG002|Overall Study|Reason not Specified|5|||
155393439|NCT00395863|560876733|FG000|Overall Study|Patients did not complete both exams|2|||
155393440|NCT00395863|560876734|FG001|Overall Study|Patients did not complete both exams|3|||
155393441|NCT03873493|560876735|FG000|Overall Study|Withdrawal by Subject|1|||
155393442|NCT03873493|560876735|FG000|Overall Study|Death|9|||
155393443|NCT03873493|560876735|FG000|Overall Study|Lost to Follow-up|1|||
155393444|NCT03873493|560876735|FG000|Overall Study|Study Terminated by Sponsor|1|||
155393445|NCT03873493|560876735|FG000|Overall Study|Other|2|||
155393446|NCT02973425|560876742|FG000|Overall Study|Lost to Follow-up|49|||
155393447|NCT02973425|560876743|FG001|Overall Study|Lost to Follow-up|53|||
155393448|NCT03503513|560876744|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
155393449|NCT03503513|560876744|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
155393450|NCT03503513|560876744|FG000|Overall Study|Physician Decision|3|||
155393451|NCT03503513|560876744|FG000|Overall Study|Withdrawal by Subject|2|||
155393452|NCT03503513|560876744|FG000|Overall Study|Lost to Follow-up|1|||
155393453|NCT01170039|560876745|FG000|Overall Study|Withdrawal by Subject|5|||
155393454|NCT01170039|560876746|FG001|Overall Study|Withdrawal by Subject|3|||
155393455|NCT01170039|560876745|FG000|Overall Study|Lack of funding, drug not available|3|||
155393456|NCT01170039|560876746|FG001|Overall Study|Lack of funding, drug not available|3|||
155393457|NCT02366728|560876749|FG000|Overall Study|Death|0|||
155393458|NCT02366728|560876750|FG001|Overall Study|Death|0|||
155393459|NCT02366728|560876751|FG002|Overall Study|Death|1|||
155393460|NCT02366728|560876749|FG000|Overall Study|Adverse Event|1|||
155393461|NCT02366728|560876750|FG001|Overall Study|Adverse Event|0|||
155393462|NCT02366728|560876751|FG002|Overall Study|Adverse Event|0|||
155393463|NCT02366728|560876749|FG000|Overall Study|Screen Failure|2|||
155393464|NCT02366728|560876750|FG001|Overall Study|Screen Failure|1|||
155393465|NCT02366728|560876751|FG002|Overall Study|Screen Failure|0|||
155393466|NCT02366728|560876749|FG000|Overall Study|Only yielded 2 vaccines|1|||
155393467|NCT02366728|560876750|FG001|Overall Study|Only yielded 2 vaccines|0|||
155393468|NCT02366728|560876751|FG002|Overall Study|Only yielded 2 vaccines|0|||
155393469|NCT00059839|560876754|FG000|Overall Study|Death|1|||
155393470|NCT00059839|560876755|FG001|Overall Study|Death|1|||
155393471|NCT00059839|560876754|FG000|Overall Study|Lack of Efficacy|6|||
155393472|NCT00059839|560876755|FG001|Overall Study|Lack of Efficacy|5|||
155393473|NCT00059839|560876754|FG000|Overall Study|Lost to Follow-up|2|||
155393474|NCT00059839|560876755|FG001|Overall Study|Lost to Follow-up|0|||
155393475|NCT00059839|560876754|FG000|Overall Study|Physician Decision|1|||
155051796|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
155051797|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
155051798|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
155051799|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
155051800|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
155051801|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051802|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051803|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051804|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155393476|NCT00059839|560876755|FG001|Overall Study|Physician Decision|2|||
155393477|NCT00059839|560876754|FG000|Overall Study|Withdrawal by Subject|1|||
155393478|NCT00059839|560876755|FG001|Overall Study|Withdrawal by Subject|6|||
155393479|NCT00059839|560876754|FG000|Overall Study|Ineligible|1|||
155393480|NCT00059839|560876755|FG001|Overall Study|Ineligible|3|||
155393481|NCT01187550|560876756|FG000|Overall Study|Protocol Violation|3|||
154949618|NCT00911859|559239638|FG001|Follow-up Period|Lost to Follow-up|1|||
154949619|NCT00911859|559239639|FG002|Follow-up Period|Lost to Follow-up|0|||
154949620|NCT00911859|559239637|FG000|Follow-up Period|Withdrawal by Subject|0|||
154949621|NCT00911859|559239638|FG001|Follow-up Period|Withdrawal by Subject|4|||
154949622|NCT00911859|559239639|FG002|Follow-up Period|Withdrawal by Subject|4|||
154949623|NCT00911859|559239637|FG000|Follow-up Period|Study terminated by sponsor|5|||
154949624|NCT00911859|559239638|FG001|Follow-up Period|Study terminated by sponsor|33|||
154949625|NCT00911859|559239639|FG002|Follow-up Period|Study terminated by sponsor|27|||
154949626|NCT03008460|559239642|FG000|Overall Study|Protocol deviation|0|||
154949627|NCT03008460|559239643|FG001|Overall Study|Protocol deviation|2|||
154949628|NCT03008460|559239642|FG000|Overall Study|Study drug not dispensed|0|||
154949629|NCT03008460|559239643|FG001|Overall Study|Study drug not dispensed|1|||
154949630|NCT03008460|559239642|FG000|Overall Study|Adverse Event|0|||
154949631|NCT03008460|559239643|FG001|Overall Study|Adverse Event|1|||
154949632|NCT03008460|559239642|FG000|Overall Study|Withdrawal by Subject|5|||
154949633|NCT03008460|559239643|FG001|Overall Study|Withdrawal by Subject|6|||
154949634|NCT03008460|559239642|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
154949635|NCT03008460|559239643|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
154949636|NCT03008460|559239642|FG000|Overall Study|End of study visit outside permitted time window|0|||
154949637|NCT03008460|559239643|FG001|Overall Study|End of study visit outside permitted time window|1|||
154949638|NCT03008460|559239642|FG000|Overall Study|Lost to Follow-up|1|||
154949639|NCT03008460|559239643|FG001|Overall Study|Lost to Follow-up|3|||
154949640|NCT00767325|559239647|FG000|Overall Study|Lack of Efficacy|2|||
154949641|NCT00767325|559239647|FG000|Overall Study|Adverse Event|7|||
154949642|NCT00767325|559239647|FG000|Overall Study|Lost to Follow-up|3|||
154949643|NCT00767325|559239647|FG000|Overall Study|No longer met study criteria|2|||
154949644|NCT00767325|559239647|FG000|Overall Study|Missed visit due to family reasons|1|||
154949645|NCT03538756|559239648|FG000|Long-Term Follow-up|Adverse Event|0|||
154949646|NCT03538756|559239649|FG001|Long-Term Follow-up|Adverse Event|0|||
154949647|NCT03538756|559239650|FG002|Long-Term Follow-up|Adverse Event|6|||
154949648|NCT03538756|559239648|FG000|Long-Term Follow-up|Death|0|||
154949649|NCT03538756|559239649|FG001|Long-Term Follow-up|Death|0|||
154949650|NCT03538756|559239650|FG002|Long-Term Follow-up|Death|1|||
154949651|NCT03538756|559239648|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
154949652|NCT03538756|559239649|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
154949653|NCT03538756|559239650|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
154949654|NCT03538756|559239648|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
154949655|NCT03538756|559239649|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
154949656|NCT03538756|559239650|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
154949657|NCT03538756|559239648|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
154949658|NCT03538756|559239649|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
154949659|NCT03538756|559239650|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
154949660|NCT00752856|559239651|FG000|Overall Study|randomized but did not do viral kinetics|0|||
154949661|NCT00752856|559239652|FG001|Overall Study|randomized but did not do viral kinetics|1|||
154949662|NCT02688608|559239653|FG000|Overall Study|Lost to Follow-up|1|||
154949663|NCT04529109|559239655|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
154949664|NCT04529109|559239656|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
154949665|NCT01508936|559239658|FG000|Overall Study|Adverse Event|11|||
154949666|NCT01508936|559239659|FG001|Overall Study|Adverse Event|32|||
154949667|NCT01508936|559239658|FG000|Overall Study|Lack of Efficacy|0|||
154949668|NCT01508936|559239659|FG001|Overall Study|Lack of Efficacy|1|||
154949669|NCT01508936|559239658|FG000|Overall Study|Withdrawal by Subject|4|||
154949670|NCT01508936|559239659|FG001|Overall Study|Withdrawal by Subject|18|||
154949671|NCT01508936|559239658|FG000|Overall Study|Protocol Violation|2|||
154949672|NCT01508936|559239659|FG001|Overall Study|Protocol Violation|3|||
154949673|NCT01508936|559239658|FG000|Overall Study|Lost to Follow-up|2|||
154949674|NCT01508936|559239659|FG001|Overall Study|Lost to Follow-up|9|||
154949675|NCT01508936|559239658|FG000|Overall Study|Other|0|||
154949676|NCT01508936|559239659|FG001|Overall Study|Other|5|||
154949677|NCT01508936|559239658|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
154949678|NCT01508936|559239659|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
154949679|NCT00679367|559239660|FG000|Overall Study|Adverse Event|7|||
154949680|NCT00679367|559239660|FG000|Overall Study|inability to swallow oral drugs|1|||
154949681|NCT00679367|559239660|FG000|Overall Study|Lack of Efficacy|3|||
154949682|NCT00679367|559239660|FG000|Overall Study|Withdrawal by Subject|1|||
154949683|NCT03365947|559239661|FG000|Overall Study|Lost to Follow-up|0|||
154949684|NCT03365947|559239662|FG001|Overall Study|Lost to Follow-up|0|||
154949685|NCT03365947|559239663|FG002|Overall Study|Lost to Follow-up|0|||
155051805|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051806|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051807|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051808|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051809|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051810|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051811|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
155051812|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
155051813|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
155051814|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155051815|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
155051816|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051817|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051818|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051819|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051820|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051821|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051822|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051823|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051824|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051825|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051826|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155051827|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051828|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155051829|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051830|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155051831|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051832|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051833|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051834|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051835|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051836|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051837|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051838|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051839|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051840|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051841|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051842|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
155051843|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051844|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051845|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155051846|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051847|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051848|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051849|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051850|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051851|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051852|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051853|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051854|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051855|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051856|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155051857|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051858|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
155051859|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155051860|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
155051861|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051862|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051863|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051864|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051865|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051866|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051867|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051868|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051869|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051870|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051871|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051872|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
155051873|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051874|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155051875|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
155051876|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051877|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051878|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051879|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051880|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051881|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051882|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051883|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051884|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155393482|NCT01187550|560876757|FG001|Overall Study|Protocol Violation|1|||
155393483|NCT01187550|560876756|FG000|Overall Study|Other|3|||
155393484|NCT01187550|560876757|FG001|Overall Study|Other|0|||
155393485|NCT01187550|560876756|FG000|Overall Study|Randomized but not treated|8|||
155393486|NCT01187550|560876757|FG001|Overall Study|Randomized but not treated|0|||
155393487|NCT00733304|560876758|FG000|Overall Study|Adverse Event|3|||
154949686|NCT03365947|559239664|FG003|Overall Study|Lost to Follow-up|0|||
155393488|NCT00733304|560876759|FG001|Overall Study|Adverse Event|0|||
155393489|NCT00733304|560876760|FG002|Overall Study|Adverse Event|0|||
155393490|NCT00733304|560876758|FG000|Overall Study|Lack of Efficacy|0|||
155393491|NCT00733304|560876759|FG001|Overall Study|Lack of Efficacy|0|||
155393492|NCT00733304|560876760|FG002|Overall Study|Lack of Efficacy|2|||
155393493|NCT00733304|560876758|FG000|Overall Study|Lost to Follow-up|0|||
155393494|NCT00733304|560876759|FG001|Overall Study|Lost to Follow-up|1|||
155393495|NCT00733304|560876760|FG002|Overall Study|Lost to Follow-up|0|||
155393496|NCT00733304|560876758|FG000|Overall Study|Physician Decision|3|||
155393497|NCT00733304|560876759|FG001|Overall Study|Physician Decision|1|||
155393498|NCT00733304|560876760|FG002|Overall Study|Physician Decision|3|||
155393499|NCT00733304|560876758|FG000|Overall Study|Withdrawal by Subject|1|||
155393500|NCT00733304|560876759|FG001|Overall Study|Withdrawal by Subject|1|||
155393501|NCT00733304|560876760|FG002|Overall Study|Withdrawal by Subject|0|||
155393502|NCT01330914|560876763|FG000|Overall Study|Withdrawal by Subject|4|||
154949687|NCT03365947|559239665|FG004|Overall Study|Lost to Follow-up|0|||
154949688|NCT03365947|559239666|FG005|Overall Study|Lost to Follow-up|1|||
154949689|NCT03365947|559239667|FG006|Overall Study|Lost to Follow-up|0|||
155051885|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051886|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051887|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
155051888|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
155051889|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155051890|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
155051891|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051892|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051893|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051894|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051895|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051896|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051897|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051898|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051899|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051900|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051901|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
154949690|NCT03365947|559239668|FG007|Overall Study|Lost to Follow-up|0|||
154949691|NCT03365947|559239669|FG008|Overall Study|Lost to Follow-up|0|||
154949692|NCT03365947|559239670|FG009|Overall Study|Lost to Follow-up|0|||
154949693|NCT03365947|559239671|FG010|Overall Study|Lost to Follow-up|0|||
154949694|NCT03365947|559239672|FG011|Overall Study|Lost to Follow-up|0|||
154949695|NCT03365947|559239673|FG012|Overall Study|Lost to Follow-up|0|||
154949696|NCT03365947|559239674|FG013|Overall Study|Lost to Follow-up|0|||
154949697|NCT03365947|559239675|FG014|Overall Study|Lost to Follow-up|0|||
155051902|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
155393503|NCT01330914|560876763|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
155393504|NCT05352048|560876766|FG000|Overall Study|Lost to Follow-up|1|||
154949698|NCT03365947|559239676|FG015|Overall Study|Lost to Follow-up|0|||
154949699|NCT03365947|559239677|FG016|Overall Study|Lost to Follow-up|0|||
155051903|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051904|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051905|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
155051906|NCT02326272|559621505|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051907|NCT02326272|559621506|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051908|NCT02326272|559621507|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051909|NCT02326272|559621508|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051910|NCT02326272|559621509|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155393505|NCT05352048|560876766|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
155051911|NCT02326272|559621510|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051912|NCT02326272|559621511|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155393506|NCT02308007|560876777|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
155393507|NCT02308007|560876778|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
155051913|NCT02326272|559621512|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051914|NCT02326272|559621513|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051915|NCT02326272|559621514|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051916|NCT02326272|559621515|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051917|NCT02326272|559621516|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051918|NCT02326272|559621517|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
155051919|NCT02326272|559621518|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051920|NCT02326272|559621519|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
155051921|NCT00737100|559621520|FG000|Overall Study|Adverse Event|6|||
155051922|NCT00737100|559621521|FG001|Overall Study|Adverse Event|5|||
155051923|NCT00737100|559621522|FG002|Overall Study|Adverse Event|3|||
155051924|NCT00737100|559621520|FG000|Overall Study|Lost to Follow-up|0|||
155051925|NCT00737100|559621521|FG001|Overall Study|Lost to Follow-up|1|||
155051926|NCT00737100|559621522|FG002|Overall Study|Lost to Follow-up|0|||
155051927|NCT00737100|559621520|FG000|Overall Study|Withdrawal by Subject|0|||
155051928|NCT00737100|559621521|FG001|Overall Study|Withdrawal by Subject|0|||
155051929|NCT00737100|559621522|FG002|Overall Study|Withdrawal by Subject|3|||
155051930|NCT00737100|559621520|FG000|Overall Study|Reason discontinued not explained above|1|||
155051931|NCT00737100|559621521|FG001|Overall Study|Reason discontinued not explained above|1|||
155051932|NCT00737100|559621522|FG002|Overall Study|Reason discontinued not explained above|1|||
155051933|NCT00974311|559621523|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
155051934|NCT00974311|559621524|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
155051935|NCT00974311|559621523|FG000|DB Phase (up to 24 Months)|Death|561|||
155051936|NCT00974311|559621524|FG001|DB Phase (up to 24 Months)|Death|298|||
155051937|NCT00974311|559621523|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
155051938|NCT00974311|559621524|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
155051939|NCT00974311|559621523|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
155051940|NCT00974311|559621524|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
155051941|NCT00974311|559621523|FG000|DB Phase (up to 24 Months)|Other|1|||
155051942|NCT00974311|559621524|FG001|DB Phase (up to 24 Months)|Other|0|||
155051943|NCT00974311|559621523|FG000|OLE Phase (up to 77 Months)|Death|14|||
155051944|NCT00974311|559621524|FG001|OLE Phase (up to 77 Months)|Death|21|||
155051945|NCT00974311|559621523|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
155051946|NCT00974311|559621524|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
155051947|NCT00974311|559621523|FG000|OLE Phase (up to 77 Months)|Other|15|||
155051948|NCT00974311|559621524|FG001|OLE Phase (up to 77 Months)|Other|2|||
155051949|NCT00974311|559621523|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
155051950|NCT00974311|559621524|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
155051951|NCT03131167|559621525|FG000|Overall Study|Other (Unspecified)|0|||
155051952|NCT03131167|559621526|FG001|Overall Study|Other (Unspecified)|0|||
155051953|NCT03131167|559621527|FG002|Overall Study|Other (Unspecified)|0|||
155051954|NCT03131167|559621528|FG003|Overall Study|Other (Unspecified)|0|||
155051955|NCT03131167|559621529|FG004|Overall Study|Other (Unspecified)|0|||
155051956|NCT03131167|559621530|FG005|Overall Study|Other (Unspecified)|1|||
155051957|NCT03131167|559621531|FG006|Overall Study|Other (Unspecified)|0|||
155051958|NCT03131167|559621532|FG007|Overall Study|Other (Unspecified)|0|||
155051959|NCT03131167|559621533|FG008|Overall Study|Other (Unspecified)|0|||
155051960|NCT03131167|559621534|FG009|Overall Study|Other (Unspecified)|0|||
155051961|NCT03131167|559621535|FG010|Overall Study|Other (Unspecified)|0|||
155051962|NCT03131167|559621536|FG011|Overall Study|Other (Unspecified)|0|||
155051963|NCT03131167|559621537|FG012|Overall Study|Other (Unspecified)|0|||
155051964|NCT03286218|559621540|FG000|Qualification Phase Period 1|Adverse Event|1|||
155051965|NCT03286218|559621541|FG001|Qualification Phase Period 1|Adverse Event|0|||
155051966|NCT03286218|559621542|FG002|Qualification Phase Period 1|Adverse Event|0|||
155051967|NCT03286218|559621543|FG003|Qualification Phase Period 1|Adverse Event|0|||
155051968|NCT03286218|559621544|FG004|Qualification Phase Period 1|Adverse Event|0|||
155051969|NCT03286218|559621545|FG005|Qualification Phase Period 1|Adverse Event|0|||
155051970|NCT03286218|559621546|FG006|Qualification Phase Period 1|Adverse Event|0|||
155051971|NCT03286218|559621547|FG007|Qualification Phase Period 1|Adverse Event|0|||
155051972|NCT03286218|559621548|FG008|Qualification Phase Period 1|Adverse Event|0|||
154949700|NCT03365947|559239678|FG017|Overall Study|Lost to Follow-up|0|||
154949701|NCT03365947|559239679|FG018|Overall Study|Lost to Follow-up|0|||
154949702|NCT05665595|559241663|FG000|Overall Study|Ongoing|692|||
154949703|NCT05665595|559241664|FG001|Overall Study|Ongoing|698|||
154949704|NCT05665595|559241663|FG000|Overall Study|Withdrawal by Subject|2|||
154949705|NCT05665595|559241664|FG001|Overall Study|Withdrawal by Subject|2|||
154949706|NCT05665595|559241663|FG000|Overall Study|Lost to Follow-up|1|||
154949707|NCT05665595|559241664|FG001|Overall Study|Lost to Follow-up|0|||
154949708|NCT05665595|559241663|FG000|Overall Study|Death|6|||
154949709|NCT05665595|559241664|FG001|Overall Study|Death|1|||
154949710|NCT03815942|559241665|FG000|Overall Study|Withdrawal by Subject|0|||
154949711|NCT03815942|559241666|FG001|Overall Study|Withdrawal by Subject|17|||
154949712|NCT03717064|559241667|FG000|Period 2|Adverse Event|1|||
154949713|NCT00531206|559241668|FG000|Overall Study|Adverse Event related|5|||
154949714|NCT00531206|559241668|FG000|Overall Study|Lack of Efficacy|2|||
154949715|NCT00531206|559241668|FG000|Overall Study|Lost to Follow-up|5|||
154949716|NCT00531206|559241668|FG000|Overall Study|including non-related adverse events|8|||
154949717|NCT00977106|559241670|FG000|Overall Study|Adverse Event|5|||
154949718|NCT00977106|559241671|FG001|Overall Study|Adverse Event|6|||
154949719|NCT00977106|559241670|FG000|Overall Study|Withdrawal by Subject|2|||
154949720|NCT00977106|559241671|FG001|Overall Study|Withdrawal by Subject|2|||
154949721|NCT00977106|559241670|FG000|Overall Study|Lack of Efficacy|2|||
154949722|NCT00977106|559241671|FG001|Overall Study|Lack of Efficacy|2|||
154949723|NCT00977106|559241670|FG000|Overall Study|Protocol Violation|0|||
154949724|NCT00977106|559241671|FG001|Overall Study|Protocol Violation|1|||
154949725|NCT00977106|559241670|FG000|Overall Study|Other|1|||
154949726|NCT00977106|559241671|FG001|Overall Study|Other|0|||
154949727|NCT00436007|559241678|FG000|Overall Study|Withdrawal by Subject|5|||
154949728|NCT00436007|559241679|FG001|Overall Study|Withdrawal by Subject|3|||
154949729|NCT00436007|559241680|FG002|Overall Study|Withdrawal by Subject|4|||
154949730|NCT00436007|559241678|FG000|Overall Study|Lost to Follow-up|14|||
154949731|NCT00436007|559241679|FG001|Overall Study|Lost to Follow-up|10|||
154949732|NCT00436007|559241680|FG002|Overall Study|Lost to Follow-up|13|||
154949733|NCT00436007|559241678|FG000|Overall Study|Physician Decision|0|||
154949734|NCT00436007|559241679|FG001|Overall Study|Physician Decision|0|||
154949735|NCT00436007|559241680|FG002|Overall Study|Physician Decision|2|||
155051973|NCT03286218|559621549|FG009|Qualification Phase Period 1|Adverse Event|0|||
155051974|NCT03286218|559621550|FG010|Qualification Phase Period 1|Adverse Event|0|||
155051975|NCT03286218|559621551|FG011|Qualification Phase Period 1|Adverse Event|0|||
155051976|NCT03286218|559621540|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051977|NCT03286218|559621541|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
155051978|NCT03286218|559621542|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051979|NCT03286218|559621543|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051980|NCT03286218|559621544|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051981|NCT03286218|559621545|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051982|NCT03286218|559621546|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051983|NCT03286218|559621547|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051984|NCT03286218|559621548|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051985|NCT03286218|559621549|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051986|NCT03286218|559621550|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051987|NCT03286218|559621551|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
155051988|NCT03286218|559621540|FG000|Qualification Phase Period 2|Adverse Event|0|||
155051989|NCT03286218|559621541|FG001|Qualification Phase Period 2|Adverse Event|1|||
155051990|NCT03286218|559621542|FG002|Qualification Phase Period 2|Adverse Event|0|||
155051991|NCT03286218|559621543|FG003|Qualification Phase Period 2|Adverse Event|0|||
155051992|NCT03286218|559621544|FG004|Qualification Phase Period 2|Adverse Event|0|||
155051993|NCT03286218|559621545|FG005|Qualification Phase Period 2|Adverse Event|0|||
155051994|NCT03286218|559621546|FG006|Qualification Phase Period 2|Adverse Event|0|||
155051995|NCT03286218|559621547|FG007|Qualification Phase Period 2|Adverse Event|0|||
155051996|NCT03286218|559621548|FG008|Qualification Phase Period 2|Adverse Event|0|||
155051997|NCT03286218|559621549|FG009|Qualification Phase Period 2|Adverse Event|0|||
155051998|NCT03286218|559621550|FG010|Qualification Phase Period 2|Adverse Event|0|||
155051999|NCT03286218|559621551|FG011|Qualification Phase Period 2|Adverse Event|0|||
155052000|NCT03286218|559621540|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
155052001|NCT03286218|559621541|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
155052002|NCT03286218|559621542|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052003|NCT03286218|559621543|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052004|NCT03286218|559621544|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052005|NCT03286218|559621545|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052006|NCT03286218|559621546|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052007|NCT03286218|559621547|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052008|NCT03286218|559621548|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155283117|NCT03251378|560468225|FG001|Overall Study|Lost to Follow-up|0|||
155283118|NCT03251378|560468226|FG002|Overall Study|Lost to Follow-up|1|||
155283119|NCT03251378|560468227|FG003|Overall Study|Lost to Follow-up|3|||
155283120|NCT03251378|560468228|FG004|Overall Study|Lost to Follow-up|0|||
155283121|NCT03251378|560468229|FG005|Overall Study|Lost to Follow-up|0|||
155283122|NCT03251378|560468230|FG006|Overall Study|Lost to Follow-up|0|||
155283123|NCT03251378|560468224|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
155283124|NCT03251378|560468225|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
155283125|NCT03251378|560468226|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
155283126|NCT03251378|560468227|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
155283127|NCT03251378|560468228|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
155283128|NCT03251378|560468229|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
155283129|NCT03251378|560468230|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
155283130|NCT03251378|560468224|FG000|Overall Study|Progressive disease|2|||
155283131|NCT03251378|560468225|FG001|Overall Study|Progressive disease|0|||
155283132|NCT03251378|560468226|FG002|Overall Study|Progressive disease|0|||
155283133|NCT03251378|560468227|FG003|Overall Study|Progressive disease|1|||
155283134|NCT03251378|560468228|FG004|Overall Study|Progressive disease|0|||
155283135|NCT03251378|560468229|FG005|Overall Study|Progressive disease|0|||
155283136|NCT03251378|560468230|FG006|Overall Study|Progressive disease|0|||
155283137|NCT03251378|560468224|FG000|Overall Study|Physician Decision|0|||
154949736|NCT00436007|559241678|FG000|Overall Study|Death|0|||
154949737|NCT00436007|559241679|FG001|Overall Study|Death|1|||
154949738|NCT00436007|559241680|FG002|Overall Study|Death|3|||
154949739|NCT00436007|559241678|FG000|Overall Study|Other|0|||
154949740|NCT00436007|559241679|FG001|Overall Study|Other|0|||
154949741|NCT00436007|559241680|FG002|Overall Study|Other|1|||
154949742|NCT01439165|559241681|FG000|Overall Study|Protocol Violation|3|||
154949743|NCT01439165|559241682|FG001|Overall Study|Protocol Violation|0|||
154949744|NCT01439165|559241681|FG000|Overall Study|Lost to Follow-up|11|||
154949745|NCT01439165|559241682|FG001|Overall Study|Lost to Follow-up|1|||
154949746|NCT01439165|559241681|FG000|Overall Study|Withdrawal by Subject|7|||
154949747|NCT01439165|559241682|FG001|Overall Study|Withdrawal by Subject|1|||
154949748|NCT02419313|559241683|FG000|First Intervention|Lost to Follow-up|2|||
154949749|NCT02419313|559241684|FG001|First Intervention|Lost to Follow-up|0|||
154949750|NCT02419313|559241683|FG000|Second Intervention|Lost to Follow-up|1|||
154949751|NCT02419313|559241684|FG001|Second Intervention|Lost to Follow-up|0|||
154949752|NCT03331042|559241685|FG000|Overall Study|Protocol Violation|1|||
154949753|NCT03331042|559241686|FG001|Overall Study|Protocol Violation|0|||
154949754|NCT03331042|559241687|FG002|Overall Study|Protocol Violation|0|||
154949755|NCT03331042|559241688|FG003|Overall Study|Protocol Violation|0|||
154949756|NCT03331042|559241685|FG000|Overall Study|Physician Decision|0|||
154949757|NCT03331042|559241686|FG001|Overall Study|Physician Decision|0|||
154949758|NCT03331042|559241687|FG002|Overall Study|Physician Decision|1|||
154949759|NCT03331042|559241688|FG003|Overall Study|Physician Decision|0|||
154949760|NCT03331042|559241685|FG000|Overall Study|Lost to Follow-up|0|||
154949761|NCT03331042|559241686|FG001|Overall Study|Lost to Follow-up|0|||
154949762|NCT03331042|559241687|FG002|Overall Study|Lost to Follow-up|0|||
154949763|NCT03331042|559241688|FG003|Overall Study|Lost to Follow-up|1|||
154949764|NCT02433678|559241693|FG000|Overall Study|Lost to Follow-up|1|||
154949765|NCT02433678|559241694|FG001|Overall Study|Lost to Follow-up|2|||
154949766|NCT02236130|559241698|FG000|Overall Study|Lost to Follow-up|7|||
154949767|NCT02236130|559241699|FG001|Overall Study|Lost to Follow-up|12|||
154949768|NCT01400113|559241700|FG000|Overall Study|Withdrawal by Subject|1|||
154949769|NCT01400113|559241701|FG001|Overall Study|Withdrawal by Subject|1|||
154949770|NCT01025037|559241702|FG000|Overall Study|Adverse Event|3|||
154949771|NCT01025037|559241702|FG000|Overall Study|Lost to Follow-up|7|||
154949772|NCT01025037|559241702|FG000|Overall Study|Withdrawal by Subject|1|||
154949773|NCT02660242|559241703|FG000|Glucose Tabs|Lost to Follow-up|1|||
154949774|NCT02660242|559241703|FG000|Glucagon Injection|Lost to Follow-up|1|||
154949775|NCT02796664|559241706|FG000|Overall Study|Withdrawal by Subject|0|||
154949776|NCT02796664|559241707|FG001|Overall Study|Withdrawal by Subject|3|||
154949777|NCT02796664|559241706|FG000|Overall Study|Noncompliance|1|||
154949778|NCT02796664|559241707|FG001|Overall Study|Noncompliance|1|||
154949779|NCT02796664|559241706|FG000|Overall Study|Death|0|||
154949780|NCT02796664|559241707|FG001|Overall Study|Death|1|||
154949781|NCT00927810|559241710|FG000|Overall Study|Withdrawal by Subject|0|||
154949782|NCT00927810|559241711|FG001|Overall Study|Withdrawal by Subject|3|||
154949783|NCT00927810|559241712|FG002|Overall Study|Withdrawal by Subject|0|||
154949784|NCT00927810|559241713|FG003|Overall Study|Withdrawal by Subject|1|||
154949785|NCT00927810|559241710|FG000|Overall Study|Lost to Follow-up|0|||
154949786|NCT00927810|559241711|FG001|Overall Study|Lost to Follow-up|2|||
154949787|NCT00927810|559241712|FG002|Overall Study|Lost to Follow-up|1|||
154949788|NCT00927810|559241713|FG003|Overall Study|Lost to Follow-up|1|||
154949789|NCT00927810|559241710|FG000|Overall Study|Death|0|||
154949790|NCT00927810|559241711|FG001|Overall Study|Death|2|||
154949791|NCT00927810|559241712|FG002|Overall Study|Death|0|||
154949792|NCT00927810|559241713|FG003|Overall Study|Death|0|||
154949793|NCT00927810|559241710|FG000|Overall Study|Abnormal laboratory value(s)|0|||
154949794|NCT00927810|559241711|FG001|Overall Study|Abnormal laboratory value(s)|1|||
154949795|NCT00927810|559241712|FG002|Overall Study|Abnormal laboratory value(s)|0|||
154949796|NCT00927810|559241713|FG003|Overall Study|Abnormal laboratory value(s)|0|||
154949797|NCT00198029|559241716|FG000|Overall Study|Withdrawal by Subject|4|||
154949798|NCT02465567|559241717|FG000|Overall Study|Adverse Event|118|||
154949799|NCT02465567|559241718|FG001|Overall Study|Adverse Event|113|||
154949800|NCT02465567|559241719|FG002|Overall Study|Adverse Event|147|||
154949801|NCT02465567|559241720|FG003|Overall Study|Adverse Event|138|||
154949802|NCT02465567|559241717|FG000|Overall Study|Lack of Efficacy|103|||
154949803|NCT02465567|559241718|FG001|Overall Study|Lack of Efficacy|102|||
154949804|NCT02465567|559241719|FG002|Overall Study|Lack of Efficacy|171|||
154949805|NCT02465567|559241720|FG003|Overall Study|Lack of Efficacy|135|||
154949806|NCT02465567|559241717|FG000|Overall Study|Withdrawal by Subject|104|||
154949807|NCT02465567|559241718|FG001|Overall Study|Withdrawal by Subject|94|||
154949808|NCT02465567|559241719|FG002|Overall Study|Withdrawal by Subject|123|||
154949809|NCT02465567|559241720|FG003|Overall Study|Withdrawal by Subject|130|||
154949810|NCT02465567|559241717|FG000|Overall Study|Physician Decision|23|||
154949811|NCT02465567|559241718|FG001|Overall Study|Physician Decision|33|||
154949812|NCT02465567|559241719|FG002|Overall Study|Physician Decision|38|||
154949813|NCT02465567|559241720|FG003|Overall Study|Physician Decision|28|||
154949814|NCT02465567|559241717|FG000|Overall Study|Major Protocol Deviation|24|||
154949815|NCT02465567|559241718|FG001|Overall Study|Major Protocol Deviation|26|||
154949816|NCT02465567|559241719|FG002|Overall Study|Major Protocol Deviation|22|||
154949817|NCT02465567|559241720|FG003|Overall Study|Major Protocol Deviation|25|||
154949818|NCT02465567|559241717|FG000|Overall Study|Lost to Follow-up|25|||
154949819|NCT02465567|559241718|FG001|Overall Study|Lost to Follow-up|21|||
154949820|NCT02465567|559241719|FG002|Overall Study|Lost to Follow-up|19|||
154949821|NCT02465567|559241720|FG003|Overall Study|Lost to Follow-up|15|||
154949822|NCT02465567|559241717|FG000|Overall Study|Protocol Specified Criteria|20|||
154949823|NCT02465567|559241718|FG001|Overall Study|Protocol Specified Criteria|10|||
154949824|NCT02465567|559241719|FG002|Overall Study|Protocol Specified Criteria|9|||
154949825|NCT02465567|559241720|FG003|Overall Study|Protocol Specified Criteria|12|||
154949826|NCT02465567|559241717|FG000|Overall Study|Administrative Reasons|12|||
154949827|NCT02465567|559241718|FG001|Overall Study|Administrative Reasons|9|||
154949828|NCT02465567|559241719|FG002|Overall Study|Administrative Reasons|11|||
154949829|NCT02465567|559241720|FG003|Overall Study|Administrative Reasons|5|||
154949830|NCT02465567|559241717|FG000|Overall Study|Randomized but not treated|1|||
154949831|NCT02465567|559241718|FG001|Overall Study|Randomized but not treated|5|||
154949832|NCT02465567|559241719|FG002|Overall Study|Randomized but not treated|4|||
154949833|NCT02465567|559241720|FG003|Overall Study|Randomized but not treated|5|||
154949834|NCT02465567|559241717|FG000|Overall Study|enrolled in >1 studies|18|||
154949835|NCT02465567|559241718|FG001|Overall Study|enrolled in >1 studies|11|||
154949836|NCT02465567|559241719|FG002|Overall Study|enrolled in >1 studies|19|||
154949837|NCT02465567|559241720|FG003|Overall Study|enrolled in >1 studies|15|||
154949838|NCT02465567|559241717|FG000|Overall Study|missing PI Signature|1|||
154949839|NCT02465567|559241718|FG001|Overall Study|missing PI Signature|0|||
154949840|NCT02465567|559241719|FG002|Overall Study|missing PI Signature|0|||
154949841|NCT02465567|559241720|FG003|Overall Study|missing PI Signature|0|||
154949842|NCT01626079|559241721|FG000|Overall Study|Death|167|||
154949843|NCT01626079|559241722|FG001|Overall Study|Death|192|||
154949844|NCT01626079|559241723|FG002|Overall Study|Death|39|||
154949845|NCT01626079|559241721|FG000|Overall Study|Withdrawal by Subject|23|||
154949846|NCT01626079|559241722|FG001|Overall Study|Withdrawal by Subject|37|||
154949847|NCT01626079|559241723|FG002|Overall Study|Withdrawal by Subject|5|||
154949848|NCT01626079|559241721|FG000|Overall Study|Lost to Follow-up|7|||
154949849|NCT01626079|559241722|FG001|Overall Study|Lost to Follow-up|4|||
154949850|NCT01626079|559241723|FG002|Overall Study|Lost to Follow-up|2|||
154949851|NCT01626079|559241721|FG000|Overall Study|Missed Visits|1|||
154949852|NCT01626079|559241722|FG001|Overall Study|Missed Visits|4|||
154949853|NCT01626079|559241723|FG002|Overall Study|Missed Visits|6|||
154949854|NCT00337077|559241724|FG000|Overall Study|Progressive disease|25|||
154949855|NCT00337077|559241725|FG001|Overall Study|Progressive disease|37|||
154949856|NCT00337077|559241726|FG002|Overall Study|Progressive disease|19|||
154949857|NCT00337077|559241724|FG000|Overall Study|Adverse Event|7|||
155052009|NCT03286218|559621549|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052010|NCT03286218|559621550|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052011|NCT03286218|559621551|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
155052012|NCT03286218|559621540|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
155052013|NCT03286218|559621541|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
155052014|NCT03286218|559621542|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
155052015|NCT03286218|559621543|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
155052016|NCT03286218|559621544|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
155052017|NCT03286218|559621545|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
155052018|NCT03286218|559621546|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
155052019|NCT03286218|559621547|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
155052020|NCT03286218|559621548|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
155052021|NCT03286218|559621549|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
155052022|NCT03286218|559621550|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
155052023|NCT03286218|559621551|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
155052024|NCT03286218|559621540|FG000|Qualification Phase Period 2|Protocol Violation|2|||
155052025|NCT03286218|559621541|FG001|Qualification Phase Period 2|Protocol Violation|0|||
155052026|NCT03286218|559621542|FG002|Qualification Phase Period 2|Protocol Violation|0|||
155052027|NCT03286218|559621543|FG003|Qualification Phase Period 2|Protocol Violation|0|||
155052028|NCT03286218|559621544|FG004|Qualification Phase Period 2|Protocol Violation|0|||
155052029|NCT03286218|559621545|FG005|Qualification Phase Period 2|Protocol Violation|0|||
155052030|NCT03286218|559621546|FG006|Qualification Phase Period 2|Protocol Violation|0|||
155052031|NCT03286218|559621547|FG007|Qualification Phase Period 2|Protocol Violation|0|||
155052032|NCT03286218|559621548|FG008|Qualification Phase Period 2|Protocol Violation|0|||
155052033|NCT03286218|559621549|FG009|Qualification Phase Period 2|Protocol Violation|0|||
155052034|NCT03286218|559621550|FG010|Qualification Phase Period 2|Protocol Violation|0|||
155052035|NCT03286218|559621551|FG011|Qualification Phase Period 2|Protocol Violation|0|||
155052036|NCT03286218|559621540|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
155052037|NCT03286218|559621541|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
155052038|NCT03286218|559621542|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052039|NCT03286218|559621543|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052040|NCT03286218|559621544|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052041|NCT03286218|559621545|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052042|NCT03286218|559621546|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052043|NCT03286218|559621547|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052044|NCT03286218|559621548|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052045|NCT03286218|559621549|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052046|NCT03286218|559621550|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052047|NCT03286218|559621551|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
155052048|NCT03286218|559621540|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052049|NCT03286218|559621541|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052050|NCT03286218|559621542|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
155052051|NCT03286218|559621543|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
155052052|NCT03286218|559621544|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052053|NCT03286218|559621545|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
155052054|NCT03286218|559621546|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052055|NCT03286218|559621547|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052056|NCT03286218|559621548|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052057|NCT03286218|559621549|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052058|NCT03286218|559621550|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
155052059|NCT03286218|559621551|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
155052060|NCT03286218|559621540|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052061|NCT03286218|559621541|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052062|NCT03286218|559621542|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052063|NCT03286218|559621543|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052064|NCT03286218|559621544|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052065|NCT03286218|559621545|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052066|NCT03286218|559621546|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052067|NCT03286218|559621547|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052068|NCT03286218|559621548|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052069|NCT03286218|559621549|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052070|NCT03286218|559621550|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
155052071|NCT03286218|559621551|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
155052072|NCT00458003|559621552|FG000|Overall Study|Non protocol spinal anesthesia|1|||
155052073|NCT00458003|559621553|FG001|Overall Study|Non protocol spinal anesthesia|1|||
155052074|NCT02346708|559621556|FG000|Overall Study|Adverse Event|2|||
155052075|NCT02346708|559621557|FG001|Overall Study|Adverse Event|0|||
155052076|NCT02346708|559621556|FG000|Overall Study|Protocol Violation|0|||
155052077|NCT02346708|559621557|FG001|Overall Study|Protocol Violation|1|||
155052078|NCT00483652|559621558|FG000|Double-blind Treatment Period|Protocol Violation|2|||
155052079|NCT00483652|559621559|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155052080|NCT00483652|559621558|FG000|Double-blind Treatment Period|Adverse Event|3|||
155052081|NCT00483652|559621559|FG001|Double-blind Treatment Period|Adverse Event|4|||
155052082|NCT00483652|559621558|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
155052083|NCT00483652|559621559|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
155052084|NCT00483652|559621558|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
155052085|NCT00483652|559621559|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
155052086|NCT01781962|559621562|FG000|Overall Study|Other Miscellaneous Reasons|5|||
155052087|NCT00928434|559621563|FG000|Overall Study|Adverse Event|14|||
155052088|NCT00928434|559621564|FG001|Overall Study|Adverse Event|5|||
155052089|NCT00928434|559621565|FG002|Overall Study|Adverse Event|18|||
155052090|NCT00928434|559621563|FG000|Overall Study|Protocol Violation|5|||
155052091|NCT00928434|559621564|FG001|Overall Study|Protocol Violation|0|||
155052092|NCT00928434|559621565|FG002|Overall Study|Protocol Violation|8|||
155052093|NCT00928434|559621563|FG000|Overall Study|Physician Decision|2|||
155052094|NCT00928434|559621564|FG001|Overall Study|Physician Decision|0|||
155052095|NCT00928434|559621565|FG002|Overall Study|Physician Decision|3|||
155052096|NCT00928434|559621563|FG000|Overall Study|Lost to Follow-up|1|||
155052097|NCT00928434|559621564|FG001|Overall Study|Lost to Follow-up|0|||
155052098|NCT00928434|559621565|FG002|Overall Study|Lost to Follow-up|3|||
155052099|NCT00928434|559621563|FG000|Overall Study|Withdrawal by Subject|5|||
155052100|NCT00928434|559621564|FG001|Overall Study|Withdrawal by Subject|3|||
155052101|NCT00928434|559621565|FG002|Overall Study|Withdrawal by Subject|2|||
155052102|NCT00928434|559621563|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
155052103|NCT00928434|559621564|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
155052104|NCT00928434|559621565|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
155052105|NCT00928434|559621563|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
155052106|NCT00928434|559621564|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
155052107|NCT00928434|559621565|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
155052108|NCT00928434|559621563|FG000|Overall Study|Other (not meeting above criteria)|5|||
155052109|NCT00928434|559621564|FG001|Overall Study|Other (not meeting above criteria)|1|||
155052110|NCT00928434|559621565|FG002|Overall Study|Other (not meeting above criteria)|2|||
155052111|NCT02154139|559621572|FG000|Overall Study|Injection not administered|2|||
155052112|NCT02154139|559621572|FG000|Overall Study|Other|2|||
155052113|NCT02154139|559621572|FG000|Overall Study|Investigator transferred|3|||
155052114|NCT05417412|559621576|FG000|Overall Study|Lost to Follow-up|2|||
155052115|NCT04919317|559621580|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
155052116|NCT04919317|559621581|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
155052117|NCT04919317|559621580|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
155052118|NCT04919317|559621581|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
155052119|NCT01443858|559621584|FG000|Overall Study|Withdrawal by Subject|9|||
155052120|NCT01443858|559621585|FG001|Overall Study|Withdrawal by Subject|8|||
155052121|NCT01443858|559621586|FG002|Overall Study|Withdrawal by Subject|5|||
155052122|NCT01443858|559621584|FG000|Overall Study|Lack of Efficacy|1|||
155052123|NCT01443858|559621585|FG001|Overall Study|Lack of Efficacy|0|||
155052124|NCT01443858|559621586|FG002|Overall Study|Lack of Efficacy|0|||
155052125|NCT01443858|559621584|FG000|Overall Study|Lost to Follow-up|5|||
155052126|NCT01443858|559621585|FG001|Overall Study|Lost to Follow-up|5|||
155052127|NCT01443858|559621586|FG002|Overall Study|Lost to Follow-up|2|||
155052128|NCT01272908|559621589|FG000|Initial Treatment Period|Adverse Event|1|||
155052129|NCT01272908|559621589|FG000|Initial Treatment Period|Lack of Efficacy|5|||
155052130|NCT01272908|559621589|FG000|Initial Treatment Period|Protocol Violation|1|||
155052131|NCT01272908|559621589|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
155052132|NCT01272908|559621589|FG000|Re-Treatment Period|Adverse Event|2|||
155052133|NCT01272908|559621589|FG000|Re-Treatment Period|Lack of Efficacy|3|||
155052134|NCT01272908|559621589|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
155052135|NCT02221648|559621590|FG000|Overall Study|Withdrawal by Subject|3|||
155052136|NCT02221648|559621591|FG001|Overall Study|Withdrawal by Subject|3|||
155052137|NCT00810069|559621593|FG000|Lead-in Period I|Adverse Event|43|||
155052138|NCT00810069|559621594|FG001|Lead-in Period I|Adverse Event|0|||
155052139|NCT00810069|559621595|FG002|Lead-in Period I|Adverse Event|0|||
155052140|NCT00810069|559621593|FG000|Lead-in Period I|Lack of Efficacy|1|||
155052141|NCT00810069|559621594|FG001|Lead-in Period I|Lack of Efficacy|0|||
155052142|NCT00810069|559621595|FG002|Lead-in Period I|Lack of Efficacy|0|||
155052143|NCT00810069|559621593|FG000|Lead-in Period I|Lost to Follow-up|19|||
155052144|NCT00810069|559621594|FG001|Lead-in Period I|Lost to Follow-up|0|||
155052145|NCT00810069|559621595|FG002|Lead-in Period I|Lost to Follow-up|0|||
155052146|NCT00810069|559621593|FG000|Lead-in Period I|Physician Decision|1|||
155052147|NCT00810069|559621594|FG001|Lead-in Period I|Physician Decision|0|||
155052148|NCT00810069|559621595|FG002|Lead-in Period I|Physician Decision|0|||
155052149|NCT00810069|559621593|FG000|Lead-in Period I|Protocol Violation|1|||
155052150|NCT00810069|559621594|FG001|Lead-in Period I|Protocol Violation|0|||
155052151|NCT00810069|559621595|FG002|Lead-in Period I|Protocol Violation|0|||
155052152|NCT00810069|559621593|FG000|Lead-in Period I|Withdrawal by Subject|46|||
155052153|NCT00810069|559621594|FG001|Lead-in Period I|Withdrawal by Subject|0|||
155052154|NCT00810069|559621595|FG002|Lead-in Period I|Withdrawal by Subject|0|||
155052155|NCT00810069|559621593|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
155052156|NCT00810069|559621594|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
155052157|NCT00810069|559621595|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
155052158|NCT00810069|559621593|FG000|Lead-in Period I|Randomization criteria not met|158|||
155052159|NCT00810069|559621594|FG001|Lead-in Period I|Randomization criteria not met|0|||
155052160|NCT00810069|559621595|FG002|Lead-in Period I|Randomization criteria not met|0|||
155052161|NCT00810069|559621593|FG000|Double-Blind Period II|Adverse Event|0|||
155052162|NCT00810069|559621594|FG001|Double-Blind Period II|Adverse Event|9|||
155052163|NCT00810069|559621595|FG002|Double-Blind Period II|Adverse Event|8|||
155052164|NCT00810069|559621593|FG000|Double-Blind Period II|Lack of Efficacy|0|||
155052165|NCT00810069|559621594|FG001|Double-Blind Period II|Lack of Efficacy|7|||
155052166|NCT00810069|559621595|FG002|Double-Blind Period II|Lack of Efficacy|12|||
155052167|NCT00810069|559621593|FG000|Double-Blind Period II|Lost to Follow-up|0|||
155052168|NCT00810069|559621594|FG001|Double-Blind Period II|Lost to Follow-up|9|||
155052169|NCT00810069|559621595|FG002|Double-Blind Period II|Lost to Follow-up|9|||
155052170|NCT00810069|559621593|FG000|Double-Blind Period II|Physician Decision|0|||
155052171|NCT00810069|559621594|FG001|Double-Blind Period II|Physician Decision|0|||
155052172|NCT00810069|559621595|FG002|Double-Blind Period II|Physician Decision|1|||
155052173|NCT00810069|559621593|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
155052174|NCT00810069|559621594|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
155052175|NCT00810069|559621595|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
155052176|NCT00810069|559621593|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
155052177|NCT00810069|559621594|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
155052178|NCT00810069|559621595|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
155052179|NCT00810069|559621593|FG000|Double-Blind Period II|Clinical relapse|0|||
155052180|NCT00810069|559621594|FG001|Double-Blind Period II|Clinical relapse|3|||
155052181|NCT00810069|559621595|FG002|Double-Blind Period II|Clinical relapse|0|||
155052182|NCT00810069|559621593|FG000|Double-Blind Period II|Protocol Violation|0|||
155052183|NCT00810069|559621594|FG001|Double-Blind Period II|Protocol Violation|7|||
155052184|NCT00810069|559621595|FG002|Double-Blind Period II|Protocol Violation|6|||
155052185|NCT00905424|559621599|FG000|Overall Study|Lost to Follow-up|3|||
155052186|NCT00905424|559621600|FG001|Overall Study|Lost to Follow-up|3|||
155052187|NCT00905424|559621599|FG000|Overall Study|Withdrawal by Subject|1|||
155052188|NCT00905424|559621600|FG001|Overall Study|Withdrawal by Subject|2|||
155052189|NCT00905424|559621599|FG000|Overall Study|Adverse Event|4|||
155393508|NCT02308007|560876779|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
155393509|NCT02308007|560876777|FG000|Overall Study|Positive for STD at Baseline|7|||
155393510|NCT02308007|560876778|FG001|Overall Study|Positive for STD at Baseline|11|||
155393511|NCT02308007|560876779|FG002|Overall Study|Positive for STD at Baseline|7|||
155052190|NCT00905424|559621600|FG001|Overall Study|Adverse Event|2|||
155393512|NCT02308007|560876777|FG000|Overall Study|Lost to Follow-up|3|||
155052191|NCT00905424|559621599|FG000|Overall Study|Non-compliance with study medication|2|||
155052192|NCT00905424|559621600|FG001|Overall Study|Non-compliance with study medication|0|||
155052193|NCT00905424|559621599|FG000|Overall Study|Sponsor decision|1|||
155052194|NCT00905424|559621600|FG001|Overall Study|Sponsor decision|0|||
155052195|NCT00905424|559621599|FG000|Overall Study|Positive urine drug screen|0|||
155052196|NCT00905424|559621600|FG001|Overall Study|Positive urine drug screen|1|||
155052197|NCT00905424|559621599|FG000|Overall Study|Non-adherence to visit schedule|0|||
155052198|NCT00905424|559621600|FG001|Overall Study|Non-adherence to visit schedule|1|||
155052199|NCT00426764|559621601|FG000|Overall Study|Protocol Violation|1|||
155052200|NCT00426764|559621601|FG000|Overall Study|Withdrawal by Subject|4|||
155052201|NCT00426764|559621601|FG000|Overall Study|Physician Decision|6|||
155052202|NCT00426764|559621601|FG000|Overall Study|Compassionate Use|1|||
155052203|NCT00426764|559621601|FG000|Overall Study|Progressive Disease|83|||
155052204|NCT00426764|559621601|FG000|Overall Study|Adverse Event|24|||
155052205|NCT00426764|559621601|FG000|Overall Study|Other|1|||
155052206|NCT00426764|559621601|FG000|Overall Study|Death|1|||
155052207|NCT00426764|559621601|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
155052208|NCT00379899|559621602|FG000|Overall Study|Adverse Event|7|||
155052209|NCT00379899|559621603|FG001|Overall Study|Adverse Event|3|||
155052210|NCT00379899|559621602|FG000|Overall Study|Death|10|||
155052211|NCT00379899|559621603|FG001|Overall Study|Death|10|||
155052212|NCT00379899|559621602|FG000|Overall Study|Lost to Follow-up|2|||
155052213|NCT00379899|559621603|FG001|Overall Study|Lost to Follow-up|4|||
155052214|NCT00379899|559621602|FG000|Overall Study|Physician Decision|3|||
155052215|NCT00379899|559621603|FG001|Overall Study|Physician Decision|4|||
155052216|NCT00379899|559621602|FG000|Overall Study|Withdrawal by Subject|5|||
155052217|NCT00379899|559621603|FG001|Overall Study|Withdrawal by Subject|5|||
155052218|NCT00379899|559621602|FG000|Overall Study|Ineligibility determined|0|||
155052219|NCT00379899|559621603|FG001|Overall Study|Ineligibility determined|1|||
155052220|NCT00379899|559621602|FG000|Overall Study|Noncompliance|1|||
155052221|NCT00379899|559621603|FG001|Overall Study|Noncompliance|1|||
155052222|NCT00379899|559621602|FG000|Overall Study|Parathyroidectomy|0|||
155052223|NCT00379899|559621603|FG001|Overall Study|Parathyroidectomy|2|||
155052224|NCT00379899|559621602|FG000|Overall Study|Renal transplantation|5|||
155052225|NCT00379899|559621603|FG001|Overall Study|Renal transplantation|4|||
155052226|NCT00379899|559621602|FG000|Overall Study|Coronary artery bypass graft|1|||
155052227|NCT00379899|559621603|FG001|Overall Study|Coronary artery bypass graft|1|||
155052228|NCT00379899|559621602|FG000|Overall Study|Other protocol-specified criteria|3|||
155052229|NCT00379899|559621603|FG001|Overall Study|Other protocol-specified criteria|4|||
155052230|NCT00379899|559621602|FG000|Overall Study|Other|3|||
155052231|NCT00379899|559621603|FG001|Overall Study|Other|1|||
155052232|NCT02417753|559621604|FG000|Overall Study|Death|1|||
155052233|NCT03113968|559621605|FG000|Overall Study|Withdrawal by Subject|31|||
155052234|NCT03113968|559621606|FG001|Overall Study|Withdrawal by Subject|4|||
155052235|NCT04805671|559621607|FG000|Overall Study|Death|2|||
155052236|NCT04805671|559621608|FG001|Overall Study|Death|7|||
155052237|NCT04805671|559621607|FG000|Overall Study|Lost to Follow-up|1|||
155052238|NCT04805671|559621608|FG001|Overall Study|Lost to Follow-up|0|||
155052239|NCT04805671|559621607|FG000|Overall Study|Withdrawal by Subject|9|||
155052240|NCT04805671|559621608|FG001|Overall Study|Withdrawal by Subject|7|||
155052241|NCT04805671|559621607|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
155052242|NCT04805671|559621608|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
155052243|NCT03804268|559621611|FG000|Overall Study|Adverse Event|2|||
155052244|NCT03804268|559621612|FG001|Overall Study|Adverse Event|2|||
155052245|NCT03804268|559621611|FG000|Overall Study|Withdrawal by Subject|2|||
155052246|NCT03804268|559621612|FG001|Overall Study|Withdrawal by Subject|0|||
155052247|NCT03804268|559621611|FG000|Overall Study|Lost to Follow-up|1|||
155052248|NCT03804268|559621612|FG001|Overall Study|Lost to Follow-up|0|||
155052249|NCT03804268|559621611|FG000|Overall Study|Physician Decision|2|||
155052250|NCT03804268|559621612|FG001|Overall Study|Physician Decision|0|||
155052251|NCT02849587|559621613|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
155052252|NCT02849587|559621614|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
155052253|NCT02849587|559621615|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
155052254|NCT02849587|559621613|FG000|Overall Study|Withdrawal by Subject|0|||
155052255|NCT02849587|559621614|FG001|Overall Study|Withdrawal by Subject|1|||
155052256|NCT02849587|559621615|FG002|Overall Study|Withdrawal by Subject|0|||
155052257|NCT03380377|559621618|FG000|Overall Study|Physician Decision|1|||
155052258|NCT03380377|559621618|FG000|Overall Study|Withdrawal by Subject|1|||
155052259|NCT02716779|559621619|FG000|Monotherapy|Adverse Event|0|||
155052260|NCT02716779|559621620|FG001|Monotherapy|Adverse Event|1|||
155052261|NCT02716779|559621621|FG002|Monotherapy|Adverse Event|1|||
155052262|NCT02716779|559621619|FG000|Combination Therapy|Adverse Event|0|||
155052263|NCT02716779|559621620|FG001|Combination Therapy|Adverse Event|2|||
155052264|NCT02716779|559621621|FG002|Combination Therapy|Adverse Event|1|||
155052265|NCT03421379|559621622|FG000|Period 1|Withdrawal by Subject|0|||
155052266|NCT03421379|559621623|FG001|Period 1|Withdrawal by Subject|1|||
155052267|NCT03421379|559621622|FG000|Period 1|Physician Decision|1|||
155052268|NCT03421379|559621623|FG001|Period 1|Physician Decision|1|||
155052269|NCT03421379|559621622|FG000|Period 1|Did not receive treatment|1|||
155052270|NCT03421379|559621623|FG001|Period 1|Did not receive treatment|2|||
155052271|NCT01951417|559621624|FG000|Overall Study|Withdrawal by Subject|1|||
155052272|NCT01951417|559621624|FG000|Overall Study|Protocol Violation|2|||
155052273|NCT01951417|559621624|FG000|Overall Study|Lost to Follow-up|6|||
155052274|NCT04001803|559621625|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
155052275|NCT04001803|559621625|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
155052276|NCT04001803|559621625|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
155052277|NCT04001803|559621625|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
155052278|NCT04001803|559621625|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
155052279|NCT04001803|559621625|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
155052280|NCT04001803|559621625|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
155052281|NCT04001803|559621625|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
155052282|NCT04001803|559621625|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
155052283|NCT04001803|559621625|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
155052284|NCT02329327|559621626|FG000|Overall Study|Death|78|||
155052285|NCT02329327|559621627|FG001|Overall Study|Death|0|||
155052286|NCT02329327|559621626|FG000|Overall Study|Withdrawal by Subject|3|||
155052287|NCT02329327|559621627|FG001|Overall Study|Withdrawal by Subject|0|||
155052288|NCT02329327|559621626|FG000|Overall Study|Lost to Follow-up|4|||
155052289|NCT02329327|559621627|FG001|Overall Study|Lost to Follow-up|0|||
155052290|NCT02493517|559621628|FG000|Overall Study|Protocol Violation|1|||
155052291|NCT02493517|559621629|FG001|Overall Study|Protocol Violation|2|||
155052292|NCT02493517|559621628|FG000|Overall Study|Withdrawal by Subject|1|||
155052293|NCT02493517|559621629|FG001|Overall Study|Withdrawal by Subject|2|||
155052294|NCT02493517|559621628|FG000|Overall Study|Adverse Event|0|||
155052295|NCT02493517|559621629|FG001|Overall Study|Adverse Event|2|||
155052296|NCT02493517|559621628|FG000|Overall Study|Missed study visit|0|||
155052297|NCT02493517|559621629|FG001|Overall Study|Missed study visit|1|||
155052298|NCT01367249|559621630|FG000|Overall Study|Withdrawal by Subject|6|||
155052299|NCT01367249|559621631|FG001|Overall Study|Withdrawal by Subject|6|||
155052300|NCT01367249|559621630|FG000|Overall Study|Other|3|||
155052301|NCT01367249|559621631|FG001|Overall Study|Other|10|||
155052302|NCT03718429|559621632|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
155052303|NCT03718429|559621633|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
155052304|NCT03718429|559621634|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
155052305|NCT03718429|559621635|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
155052306|NCT01683604|559621638|FG000|Overall Study|Adverse Event|2|||
155052307|NCT01683604|559621638|FG000|Overall Study|Lack of Efficacy|1|||
155052308|NCT01683604|559621638|FG000|Overall Study|Other|2|||
155052309|NCT03430856|559621639|FG000|Overall Study|Adverse Event|0|||
155052310|NCT03430856|559621640|FG001|Overall Study|Adverse Event|1|||
155052311|NCT03430856|559621641|FG002|Overall Study|Adverse Event|0|||
155052312|NCT03430856|559621639|FG000|Overall Study|Rescue criteria|1|||
155052313|NCT03430856|559621640|FG001|Overall Study|Rescue criteria|1|||
155052314|NCT03430856|559621641|FG002|Overall Study|Rescue criteria|0|||
155052315|NCT03430856|559621639|FG000|Overall Study|Voluntary withdrawal of consent|1|||
155052316|NCT03430856|559621640|FG001|Overall Study|Voluntary withdrawal of consent|1|||
155052317|NCT03430856|559621641|FG002|Overall Study|Voluntary withdrawal of consent|1|||
155052318|NCT03877224|559621644|FG000|Overall Study|Death|3|||
155052319|NCT03877224|559621645|FG001|Overall Study|Death|2|||
155052320|NCT03877224|559621644|FG000|Overall Study|Withdrawal by Subject|1|||
155052321|NCT03877224|559621645|FG001|Overall Study|Withdrawal by Subject|6|||
155052322|NCT03877224|559621644|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
155052323|NCT03877224|559621645|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
155052324|NCT04152200|559623615|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
155052325|NCT04152200|559623616|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
155052326|NCT04069715|559623617|FG000|Overall Study|Lost to Follow-up|1|||
155052327|NCT04069715|559623618|FG001|Overall Study|Lost to Follow-up|1|||
155052328|NCT04069715|559623617|FG000|Overall Study|Physician Decision|1|||
155052329|NCT04069715|559623618|FG001|Overall Study|Physician Decision|1|||
155052330|NCT04069715|559623617|FG000|Overall Study|Withdrawal by Subject|3|||
155052331|NCT04069715|559623618|FG001|Overall Study|Withdrawal by Subject|3|||
155052332|NCT02723188|559623619|FG000|Overall Study|Withdrawal by Subject|1|||
155052333|NCT02723188|559623620|FG001|Overall Study|Withdrawal by Subject|0|||
155052334|NCT02723188|559623621|FG002|Overall Study|Withdrawal by Subject|0|||
155052335|NCT03110354|559623622|FG000|Overall Study|Death|1|||
155052336|NCT03110354|559623623|FG001|Overall Study|Death|0|||
155052337|NCT03110354|559623624|FG002|Overall Study|Death|0|||
155052338|NCT03110354|559623625|FG003|Overall Study|Death|1|||
155052339|NCT03110354|559623626|FG004|Overall Study|Death|0|||
155052340|NCT03110354|559623622|FG000|Overall Study|Start of new therapy|0|||
155052341|NCT03110354|559623623|FG001|Overall Study|Start of new therapy|0|||
155052342|NCT03110354|559623624|FG002|Overall Study|Start of new therapy|0|||
155052343|NCT03110354|559623625|FG003|Overall Study|Start of new therapy|0|||
155052344|NCT03110354|559623626|FG004|Overall Study|Start of new therapy|1|||
155052345|NCT03110354|559623622|FG000|Overall Study|Failure to achieve response|2|||
155052346|NCT03110354|559623623|FG001|Overall Study|Failure to achieve response|3|||
155052347|NCT03110354|559623624|FG002|Overall Study|Failure to achieve response|0|||
155052348|NCT03110354|559623625|FG003|Overall Study|Failure to achieve response|2|||
155052349|NCT03110354|559623626|FG004|Overall Study|Failure to achieve response|1|||
155052350|NCT03110354|559623622|FG000|Overall Study|Progressive disease|1|||
155052351|NCT03110354|559623623|FG001|Overall Study|Progressive disease|1|||
155052352|NCT03110354|559623624|FG002|Overall Study|Progressive disease|3|||
155052353|NCT03110354|559623625|FG003|Overall Study|Progressive disease|4|||
155052354|NCT03110354|559623626|FG004|Overall Study|Progressive disease|2|||
155052355|NCT03110354|559623622|FG000|Overall Study|Adverse Event|0|||
155052356|NCT03110354|559623623|FG001|Overall Study|Adverse Event|0|||
155052357|NCT03110354|559623624|FG002|Overall Study|Adverse Event|0|||
155052358|NCT03110354|559623625|FG003|Overall Study|Adverse Event|2|||
155052359|NCT03110354|559623626|FG004|Overall Study|Adverse Event|2|||
155052360|NCT03110354|559623622|FG000|Overall Study|Other|0|||
155052361|NCT03110354|559623623|FG001|Overall Study|Other|0|||
155052362|NCT03110354|559623624|FG002|Overall Study|Other|0|||
155052363|NCT03110354|559623625|FG003|Overall Study|Other|1|||
155052364|NCT03110354|559623626|FG004|Overall Study|Other|1|||
155052365|NCT00165503|559623627|FG000|Overall Study|Death|1|||
155052366|NCT00165503|559623627|FG000|Overall Study|Lost to Follow-up|12|||
155052367|NCT00165503|559623627|FG000|Overall Study|Unresectable|3|||
155052368|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Death|20|||
155052369|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Death|26|||
155052370|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
155052371|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
155052372|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
155052373|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
155052374|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
155052375|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
155052376|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
155052377|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
155052378|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
155052379|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
155052380|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
155052381|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
155052382|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
155052383|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
155052384|NCT00643201|559623628|FG000|Randomized, Completed 6 Months of Study|Other|107|||
155052385|NCT00643201|559623629|FG001|Randomized, Completed 6 Months of Study|Other|107|||
155052386|NCT00643201|559623628|FG000|Completed Study Follow Up|Death|28|||
155052387|NCT00643201|559623629|FG001|Completed Study Follow Up|Death|34|||
155052388|NCT00643201|559623628|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
155052389|NCT00643201|559623629|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
155052390|NCT00643201|559623628|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
155052391|NCT00643201|559623629|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
155052392|NCT00643201|559623628|FG000|Completed Study Follow Up|non-specified|1|||
155052393|NCT00643201|559623629|FG001|Completed Study Follow Up|non-specified|0|||
155052394|NCT02976519|559623630|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155052395|NCT02976519|559623631|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
155052396|NCT02976519|559623632|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155052397|NCT02976519|559623633|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155052398|NCT02976519|559623634|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155052399|NCT02976519|559623635|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155052400|NCT02976519|559623636|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
155052401|NCT02976519|559623630|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155052402|NCT02976519|559623631|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155052403|NCT02976519|559623632|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155052404|NCT02976519|559623633|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
154949858|NCT00337077|559241725|FG001|Overall Study|Adverse Event|7|||
154949859|NCT00337077|559241726|FG002|Overall Study|Adverse Event|1|||
154949860|NCT00337077|559241724|FG000|Overall Study|Death|0|||
154949861|NCT00337077|559241725|FG001|Overall Study|Death|1|||
154949862|NCT00337077|559241726|FG002|Overall Study|Death|0|||
154949863|NCT00337077|559241724|FG000|Overall Study|Withdrawal by Subject|7|||
154949864|NCT00337077|559241725|FG001|Overall Study|Withdrawal by Subject|2|||
154949865|NCT00337077|559241726|FG002|Overall Study|Withdrawal by Subject|2|||
154949866|NCT00337077|559241724|FG000|Overall Study|Alternative therapy|1|||
154949867|NCT00337077|559241725|FG001|Overall Study|Alternative therapy|0|||
154949868|NCT00337077|559241726|FG002|Overall Study|Alternative therapy|0|||
154949869|NCT00337077|559241724|FG000|Overall Study|Physician Decision|1|||
154949870|NCT00337077|559241725|FG001|Overall Study|Physician Decision|4|||
154949871|NCT00337077|559241726|FG002|Overall Study|Physician Decision|2|||
154949872|NCT00337077|559241724|FG000|Overall Study|Never started treatment|1|||
154949873|NCT00337077|559241725|FG001|Overall Study|Never started treatment|1|||
154949874|NCT00337077|559241726|FG002|Overall Study|Never started treatment|0|||
154949875|NCT00337077|559241724|FG000|Overall Study|Ineligible|1|||
154949876|NCT00337077|559241725|FG001|Overall Study|Ineligible|1|||
154949877|NCT00337077|559241726|FG002|Overall Study|Ineligible|1|||
154949878|NCT02899338|559241727|FG000|Overall Study|Adverse Event|1|||
154949879|NCT02899338|559241728|FG001|Overall Study|Adverse Event|2|||
154949880|NCT02899338|559241727|FG000|Overall Study|Withdrawal by Subject|2|||
154949881|NCT02899338|559241728|FG001|Overall Study|Withdrawal by Subject|0|||
154949882|NCT01457053|559241729|FG000|Overall Study|Unable to undergo selected treatment|1|||
154949883|NCT01457053|559241730|FG001|Overall Study|Unable to undergo selected treatment|1|||
154949884|NCT00814463|559241731|FG000|Overall Study|Lost to Follow-up|1|||
154949885|NCT01370408|559241732|FG000|Overall Study|treatment failure|9|||
154949886|NCT02073643|559241734|FG000|Overall Study|Lost to Follow-up|24|||
154949887|NCT02430870|559241735|FG000|Part 2|Voluntary Withdrawal|0|||
154949888|NCT02430870|559241736|FG001|Part 2|Voluntary Withdrawal|0|||
154949889|NCT02430870|559241737|FG002|Part 2|Voluntary Withdrawal|0|||
154949890|NCT02430870|559241738|FG003|Part 2|Voluntary Withdrawal|0|||
155052405|NCT02976519|559623634|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155052406|NCT02976519|559623635|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155052407|NCT02976519|559623636|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
155052408|NCT02976519|559623630|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155052409|NCT02976519|559623631|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155052410|NCT02976519|559623632|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155052411|NCT02976519|559623633|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155052412|NCT02976519|559623634|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155052413|NCT02976519|559623635|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
155052414|NCT02976519|559623636|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
155052415|NCT02976519|559623630|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155052416|NCT02976519|559623631|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155052417|NCT02976519|559623632|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155052418|NCT02976519|559623633|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155052419|NCT02976519|559623634|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155052420|NCT02976519|559623635|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
155052421|NCT02976519|559623636|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
155052422|NCT02976519|559623630|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155052423|NCT02976519|559623631|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155052424|NCT02976519|559623632|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155052425|NCT02976519|559623633|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155052426|NCT02976519|559623634|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155052427|NCT02976519|559623635|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
155052428|NCT02976519|559623636|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
155052429|NCT01278342|559623637|FG000|Overall Study|Physician Decision|0|||
155052430|NCT01278342|559623638|FG001|Overall Study|Physician Decision|1|||
155052431|NCT01278342|559623639|FG002|Overall Study|Physician Decision|0|||
155052432|NCT01278342|559623637|FG000|Overall Study|Lost to Follow-up|1|||
155052433|NCT01278342|559623638|FG001|Overall Study|Lost to Follow-up|0|||
155052434|NCT01278342|559623639|FG002|Overall Study|Lost to Follow-up|0|||
155052435|NCT01278342|559623637|FG000|Overall Study|Administrative problems|2|||
155052436|NCT01278342|559623638|FG001|Overall Study|Administrative problems|0|||
155052437|NCT01278342|559623639|FG002|Overall Study|Administrative problems|0|||
155052438|NCT01278342|559623637|FG000|Overall Study|Other|1|||
155052439|NCT01278342|559623638|FG001|Overall Study|Other|0|||
155052440|NCT01278342|559623639|FG002|Overall Study|Other|0|||
155052441|NCT00473655|559623645|FG000|Overall Study|Lost to Follow-up|9|||
155052442|NCT00473655|559623646|FG001|Overall Study|Lost to Follow-up|5|||
155052443|NCT00473655|559623647|FG002|Overall Study|Lost to Follow-up|8|||
155052444|NCT00891813|559623648|FG000|Overall Study|Adverse Event|3|||
155052445|NCT00891813|559623648|FG000|Overall Study|Withdrawal by Subject|1|||
155052446|NCT00891813|559623648|FG000|Overall Study|Patient Noncompliance|6|||
155393513|NCT02308007|560876778|FG001|Overall Study|Lost to Follow-up|0|||
155393514|NCT02308007|560876779|FG002|Overall Study|Lost to Follow-up|1|||
155393515|NCT00528567|560876780|FG000|Overall Study|Death|4|||
155052447|NCT00891813|559623648|FG000|Overall Study|Protocol Violation|2|||
155052448|NCT00243919|559623656|FG000|Overall Study|Death|3|||
155052449|NCT00243919|559623657|FG001|Overall Study|Death|4|||
155052450|NCT00243919|559623658|FG002|Overall Study|Death|6|||
155052451|NCT00243919|559623656|FG000|Overall Study|Withdrawal by Subject|6|||
155052452|NCT00243919|559623657|FG001|Overall Study|Withdrawal by Subject|6|||
155052453|NCT00243919|559623658|FG002|Overall Study|Withdrawal by Subject|2|||
155052454|NCT00243919|559623656|FG000|Overall Study|Lost to Follow-up|6|||
155052455|NCT00243919|559623657|FG001|Overall Study|Lost to Follow-up|7|||
155052456|NCT00243919|559623658|FG002|Overall Study|Lost to Follow-up|3|||
155052457|NCT00243919|559623656|FG000|Overall Study|Administrative Error|1|||
155052458|NCT00243919|559623657|FG001|Overall Study|Administrative Error|0|||
155052459|NCT00243919|559623658|FG002|Overall Study|Administrative Error|0|||
155052460|NCT00243919|559623656|FG000|Overall Study|Physician Decision|1|||
155052461|NCT00243919|559623657|FG001|Overall Study|Physician Decision|1|||
155052462|NCT00243919|559623658|FG002|Overall Study|Physician Decision|0|||
155052463|NCT02513550|559623659|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
155052464|NCT02513550|559623660|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
155052465|NCT02513550|559623661|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
155052466|NCT02513550|559623662|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
155052467|NCT02513550|559623663|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
155052468|NCT02513550|559623664|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
155052469|NCT02513550|559623659|FG000|Double Blind Treatment Period|Adverse Event|5|||
155052470|NCT02513550|559623660|FG001|Double Blind Treatment Period|Adverse Event|13|||
155052471|NCT02513550|559623661|FG002|Double Blind Treatment Period|Adverse Event|17|||
155052472|NCT02513550|559623662|FG003|Double Blind Treatment Period|Adverse Event|0|||
155052473|NCT02513550|559623663|FG004|Double Blind Treatment Period|Adverse Event|1|||
155052474|NCT02513550|559623664|FG005|Double Blind Treatment Period|Adverse Event|0|||
155052475|NCT02513550|559623659|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
155052476|NCT02513550|559623660|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
155393516|NCT00528567|560876781|FG001|Overall Study|Death|5|||
155393517|NCT00528567|560876780|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
155393518|NCT00528567|560876781|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
155052477|NCT02513550|559623661|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
155052478|NCT02513550|559623662|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
155052479|NCT02513550|559623663|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
155052480|NCT02513550|559623664|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
155052481|NCT02513550|559623659|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
155052482|NCT02513550|559623660|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
155052483|NCT02513550|559623661|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
155052484|NCT02513550|559623662|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
155052485|NCT02513550|559623663|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
155052486|NCT02513550|559623664|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
155052487|NCT02513550|559623659|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155393519|NCT00528567|560876780|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
155393520|NCT00528567|560876781|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
155393521|NCT00528567|560876780|FG000|Overall Study|Violation Criteria at Entry|3|||
155393522|NCT00528567|560876781|FG001|Overall Study|Violation Criteria at Entry|17|||
155393523|NCT00528567|560876780|FG000|Overall Study|Withdrew Consent|59|||
155393524|NCT00528567|560876781|FG001|Overall Study|Withdrew Consent|55|||
155393525|NCT00528567|560876780|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
155393526|NCT00528567|560876781|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
155393527|NCT00528567|560876780|FG000|Overall Study|Failure to Return|1|||
155393528|NCT00528567|560876781|FG001|Overall Study|Failure to Return|4|||
155393529|NCT00528567|560876780|FG000|Overall Study|Other Protocol Violation|5|||
155393530|NCT00528567|560876781|FG001|Overall Study|Other Protocol Violation|21|||
155393531|NCT00528567|560876780|FG000|Overall Study|Administrative/Other|22|||
155393532|NCT00528567|560876781|FG001|Overall Study|Administrative/Other|75|||
155393533|NCT03085758|560876782|FG000|Overall Study|Death|26|||
155393534|NCT03085758|560876783|FG001|Overall Study|Death|24|||
155393535|NCT03085758|560876784|FG002|Overall Study|Death|53|||
155393536|NCT03085758|560876782|FG000|Overall Study|Lost to Follow-up|1|||
155393537|NCT03085758|560876783|FG001|Overall Study|Lost to Follow-up|1|||
155393538|NCT03085758|560876784|FG002|Overall Study|Lost to Follow-up|1|||
155393539|NCT03085758|560876782|FG000|Overall Study|Withdrawal by Subject|2|||
155393540|NCT03085758|560876783|FG001|Overall Study|Withdrawal by Subject|2|||
155393541|NCT03085758|560876784|FG002|Overall Study|Withdrawal by Subject|1|||
155393542|NCT03085758|560876782|FG000|Overall Study|Refusal to recall it up to day 90|0|||
155393543|NCT03085758|560876783|FG001|Overall Study|Refusal to recall it up to day 90|0|||
155393544|NCT03085758|560876784|FG002|Overall Study|Refusal to recall it up to day 90|1|||
155393545|NCT03085758|560876782|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
155393546|NCT03085758|560876783|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
155393547|NCT03085758|560876784|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
155393548|NCT01122576|560876785|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
155393549|NCT01122576|560876786|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
155393550|NCT01122576|560876787|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
154949891|NCT02430870|559241739|FG004|Part 2|Voluntary Withdrawal|0|||
155393551|NCT01122576|560876785|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
155393552|NCT01122576|560876786|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
155393553|NCT01122576|560876787|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
155393554|NCT01122576|560876785|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
155393555|NCT01122576|560876786|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
155393556|NCT01122576|560876787|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
155393557|NCT05696236|560876788|FG000|Overall Study|Lost to Follow-up|1|||
155393558|NCT05696236|560876789|FG001|Overall Study|Lost to Follow-up|0|||
155393559|NCT05696236|560876788|FG000|Overall Study|Later determined to not be eligible for participation|0|||
155393560|NCT05696236|560876789|FG001|Overall Study|Later determined to not be eligible for participation|1|||
155393561|NCT05696236|560876788|FG000|Overall Study|Withdrawal by Subject|2|||
155393562|NCT05696236|560876789|FG001|Overall Study|Withdrawal by Subject|2|||
155393563|NCT01829360|560876790|FG000|Overall Study|Protocol Violation|0|||
155393564|NCT01829360|560876791|FG001|Overall Study|Protocol Violation|0|||
155393565|NCT01829360|560876792|FG002|Overall Study|Protocol Violation|1|||
154949892|NCT02430870|559241740|FG005|Part 2|Voluntary Withdrawal|0|||
154949893|NCT02430870|559241741|FG006|Part 2|Voluntary Withdrawal|1|||
154949894|NCT02430870|559241742|FG007|Part 2|Voluntary Withdrawal|0|||
154949895|NCT02430870|559241735|FG000|Part 2|Other Reason Not Specified|0|||
154949896|NCT02430870|559241736|FG001|Part 2|Other Reason Not Specified|0|||
154949897|NCT02430870|559241737|FG002|Part 2|Other Reason Not Specified|0|||
154949898|NCT02430870|559241738|FG003|Part 2|Other Reason Not Specified|0|||
154949899|NCT02430870|559241739|FG004|Part 2|Other Reason Not Specified|0|||
154949900|NCT02430870|559241740|FG005|Part 2|Other Reason Not Specified|0|||
154949901|NCT02430870|559241741|FG006|Part 2|Other Reason Not Specified|0|||
154949902|NCT02430870|559241742|FG007|Part 2|Other Reason Not Specified|1|||
154949903|NCT02780687|559241743|FG000|Overall Study|Adverse Event|1|||
154949904|NCT02780687|559241744|FG001|Overall Study|Adverse Event|1|||
154949905|NCT02780687|559241743|FG000|Overall Study|Withdrawal by Subject|2|||
154949906|NCT02780687|559241744|FG001|Overall Study|Withdrawal by Subject|1|||
154949907|NCT02780687|559241743|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
155393566|NCT01829360|560876793|FG003|Overall Study|Protocol Violation|0|||
155393567|NCT00024167|560876795|FG000|Overall Study|Death|53|||
155393568|NCT00024167|560876796|FG001|Overall Study|Death|47|||
155393569|NCT01132612|560876797|FG000|Overall Study|Death|0|||
155393570|NCT01132612|560876798|FG001|Overall Study|Death|0|||
155393571|NCT01132612|560876799|FG002|Overall Study|Death|1|||
154949908|NCT02780687|559241744|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
154949909|NCT02780687|559241743|FG000|Overall Study|progressive disease|29|||
154949910|NCT02780687|559241744|FG001|Overall Study|progressive disease|6|||
154949911|NCT02353169|559241746|FG000|Overall Study|QTc > 450 msec|1|||
155393572|NCT01132612|560876797|FG000|Overall Study|Protocol deviation|0|||
155393573|NCT01132612|560876798|FG001|Overall Study|Protocol deviation|0|||
155052488|NCT02513550|559623660|FG001|Double Blind Treatment Period|Protocol Violation|1|||
155052489|NCT02513550|559623661|FG002|Double Blind Treatment Period|Protocol Violation|4|||
155052490|NCT02513550|559623662|FG003|Double Blind Treatment Period|Protocol Violation|0|||
155052491|NCT02513550|559623663|FG004|Double Blind Treatment Period|Protocol Violation|0|||
155052492|NCT02513550|559623664|FG005|Double Blind Treatment Period|Protocol Violation|0|||
155052493|NCT02513550|559623659|FG000|Double Blind Treatment Period|Physician Decision|2|||
155052494|NCT02513550|559623660|FG001|Double Blind Treatment Period|Physician Decision|0|||
155052495|NCT02513550|559623661|FG002|Double Blind Treatment Period|Physician Decision|4|||
155052496|NCT02513550|559623662|FG003|Double Blind Treatment Period|Physician Decision|0|||
155052497|NCT02513550|559623663|FG004|Double Blind Treatment Period|Physician Decision|0|||
155052498|NCT02513550|559623664|FG005|Double Blind Treatment Period|Physician Decision|0|||
155052499|NCT02513550|559623659|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
155052500|NCT02513550|559623660|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
155052501|NCT02513550|559623661|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
155052502|NCT02513550|559623662|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
155052503|NCT02513550|559623663|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
155052504|NCT02513550|559623664|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
155052505|NCT02513550|559623659|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155052506|NCT02513550|559623660|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155052507|NCT02513550|559623661|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
155052508|NCT02513550|559623662|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155052509|NCT02513550|559623663|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155052510|NCT02513550|559623664|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
155283138|NCT03251378|560468225|FG001|Overall Study|Physician Decision|2|||
155283139|NCT03251378|560468226|FG002|Overall Study|Physician Decision|0|||
155283140|NCT03251378|560468227|FG003|Overall Study|Physician Decision|0|||
154949912|NCT02353169|559241747|FG001|Overall Study|QTc > 450 msec|1|||
154949913|NCT02353169|559241748|FG002|Overall Study|QTc > 450 msec|1|||
154949914|NCT02353169|559241749|FG003|Overall Study|QTc > 450 msec|1|||
154949915|NCT02353169|559241746|FG000|Overall Study|OR team declined|2|||
155283141|NCT03251378|560468228|FG004|Overall Study|Physician Decision|0|||
155283142|NCT03251378|560468229|FG005|Overall Study|Physician Decision|0|||
155283143|NCT03251378|560468230|FG006|Overall Study|Physician Decision|0|||
154949916|NCT02353169|559241747|FG001|Overall Study|OR team declined|0|||
154949917|NCT02353169|559241748|FG002|Overall Study|OR team declined|0|||
154949918|NCT02353169|559241749|FG003|Overall Study|OR team declined|0|||
155283144|NCT03251378|560468224|FG000|Overall Study|Other|2|||
155283145|NCT03251378|560468225|FG001|Overall Study|Other|3|||
155283146|NCT03251378|560468226|FG002|Overall Study|Other|2|||
155283147|NCT03251378|560468227|FG003|Overall Study|Other|0|||
155283148|NCT03251378|560468228|FG004|Overall Study|Other|1|||
155283149|NCT03251378|560468229|FG005|Overall Study|Other|1|||
155283150|NCT03251378|560468230|FG006|Overall Study|Other|1|||
155283151|NCT03251378|560468224|FG000|Overall Study|Other|0|||
155283152|NCT03251378|560468225|FG001|Overall Study|Other|0|||
155283153|NCT03251378|560468226|FG002|Overall Study|Other|0|||
155283154|NCT03251378|560468227|FG003|Overall Study|Other|4|||
155283155|NCT03251378|560468228|FG004|Overall Study|Other|13|||
155283156|NCT03251378|560468229|FG005|Overall Study|Other|0|||
155283157|NCT03251378|560468230|FG006|Overall Study|Other|0|||
155283158|NCT02956967|560468235|FG000|Overall Study|Adverse Event|3|||
155283159|NCT02956967|560468235|FG000|Overall Study|Reason non-related to neutropenia|10|||
155283160|NCT02956967|560468235|FG000|Overall Study|Lost to Follow-up|5|||
155283161|NCT02956967|560468235|FG000|Overall Study|Missing|1|||
155283162|NCT02956967|560468235|FG000|Overall Study|Termination of Nivestim administration|29|||
155283163|NCT02322775|560468236|FG000|Overall Study|Adverse Event|1|||
155283164|NCT02322775|560468237|FG001|Overall Study|Adverse Event|0|||
155283165|NCT02322775|560468236|FG000|Overall Study|Lost to Follow-up|0|||
155283166|NCT02322775|560468237|FG001|Overall Study|Lost to Follow-up|1|||
155283167|NCT02322775|560468236|FG000|Overall Study|Protocol Violation|1|||
155283168|NCT02322775|560468237|FG001|Overall Study|Protocol Violation|0|||
155283169|NCT02322775|560468236|FG000|Overall Study|Withdrawal by Subject|3|||
155283170|NCT02322775|560468237|FG001|Overall Study|Withdrawal by Subject|4|||
155283171|NCT02322775|560468236|FG000|Overall Study|Not willing to perform all FU visits|0|||
155283172|NCT02322775|560468237|FG001|Overall Study|Not willing to perform all FU visits|1|||
155283173|NCT04739423|560468238|FG000|Overall Study|Protocol Violation|0|||
155283174|NCT04739423|560468239|FG001|Overall Study|Protocol Violation|1|||
155283175|NCT04739423|560468240|FG002|Overall Study|Protocol Violation|0|||
155283176|NCT04739423|560468241|FG003|Overall Study|Protocol Violation|0|||
155283177|NCT04739423|560468242|FG004|Overall Study|Protocol Violation|0|||
155283178|NCT04739423|560468243|FG005|Overall Study|Protocol Violation|0|||
155283179|NCT04739423|560468238|FG000|Overall Study|Adverse Event|0|||
155283180|NCT04739423|560468239|FG001|Overall Study|Adverse Event|0|||
155283181|NCT04739423|560468240|FG002|Overall Study|Adverse Event|1|||
155393574|NCT01132612|560876799|FG002|Overall Study|Protocol deviation|3|||
154949919|NCT02353169|559241746|FG000|Overall Study|Inhalational induction|0|||
154949920|NCT02353169|559241747|FG001|Overall Study|Inhalational induction|2|||
154949921|NCT02353169|559241748|FG002|Overall Study|Inhalational induction|0|||
154949922|NCT02353169|559241749|FG003|Overall Study|Inhalational induction|0|||
154949923|NCT02353169|559241746|FG000|Overall Study|ECG data error|0|||
154949924|NCT02353169|559241747|FG001|Overall Study|ECG data error|3|||
154949925|NCT02353169|559241748|FG002|Overall Study|ECG data error|2|||
154949926|NCT02353169|559241749|FG003|Overall Study|ECG data error|2|||
154949927|NCT02353169|559241746|FG000|Overall Study|Pre-op medication|0|||
154949928|NCT02353169|559241747|FG001|Overall Study|Pre-op medication|0|||
154949929|NCT02353169|559241748|FG002|Overall Study|Pre-op medication|1|||
154949930|NCT02353169|559241749|FG003|Overall Study|Pre-op medication|0|||
154949931|NCT00414765|559241750|FG000|Overall Study|Adverse Event|5|||
154949932|NCT00414765|559241751|FG001|Overall Study|Adverse Event|9|||
154949933|NCT00414765|559241750|FG000|Overall Study|Withdrawal by Subject|1|||
154949934|NCT00414765|559241751|FG001|Overall Study|Withdrawal by Subject|1|||
154949935|NCT00414765|559241750|FG000|Overall Study|Disease Progression|0|||
154949936|NCT00414765|559241751|FG001|Overall Study|Disease Progression|1|||
154949937|NCT05694013|559241752|FG000|Overall Study|Death|6|||
154949938|NCT05694013|559241753|FG001|Overall Study|Death|2|||
154949939|NCT05694013|559241752|FG000|Overall Study|Participant Decision|0|||
154949940|NCT05694013|559241753|FG001|Overall Study|Participant Decision|1|||
154949941|NCT05694013|559241752|FG000|Overall Study|Physician Decision|1|||
154949942|NCT05694013|559241753|FG001|Overall Study|Physician Decision|0|||
154949943|NCT05694013|559241752|FG000|Overall Study|Progressive Disease|0|||
154949944|NCT05694013|559241753|FG001|Overall Study|Progressive Disease|1|||
154949945|NCT05694013|559241752|FG000|Overall Study|Study Terminated by Sponsor|12|||
154949946|NCT05694013|559241753|FG001|Overall Study|Study Terminated by Sponsor|17|||
154949947|NCT05694013|559241752|FG000|Overall Study|Withdrawal by Subject|3|||
154949948|NCT05694013|559241753|FG001|Overall Study|Withdrawal by Subject|0|||
154949949|NCT04817891|559241754|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
154949950|NCT04817891|559241754|FG000|Overall Study|Adverse Event|1|||
154949951|NCT04817891|559241754|FG000|Overall Study|Withdrawal by Subject|1|||
154949952|NCT03982433|559241755|FG000|Overall Study|Lost to Follow-up|1|||
154949953|NCT04981912|559241756|FG000|Overall Study|Physician Decision|2|||
154949954|NCT05049460|559241757|FG000|Overall Study|Withdrawal by Subject|2|||
154949955|NCT05049460|559241758|FG001|Overall Study|Withdrawal by Subject|2|||
154949956|NCT05049460|559241757|FG000|Overall Study|Lost to Follow-up|2|||
154949957|NCT05049460|559241758|FG001|Overall Study|Lost to Follow-up|2|||
154949958|NCT00918567|559241759|FG000|Overall Study|Lack of Efficacy|3|||
154949959|NCT00918567|559241760|FG001|Overall Study|Lack of Efficacy|1|||
154949960|NCT00918567|559241759|FG000|Overall Study|Withdrawal by Subject|1|||
154949961|NCT00918567|559241760|FG001|Overall Study|Withdrawal by Subject|1|||
154949962|NCT00918567|559241759|FG000|Overall Study|Adverse Event|1|||
154949963|NCT00918567|559241760|FG001|Overall Study|Adverse Event|0|||
154949964|NCT05275998|559241761|FG000|Overall Study|Adverse Event|0|||
154949965|NCT05275998|559241762|FG001|Overall Study|Adverse Event|0|||
154949966|NCT05275998|559241763|FG002|Overall Study|Adverse Event|0|||
154949967|NCT05275998|559241764|FG003|Overall Study|Adverse Event|1|||
154949968|NCT05275998|559241761|FG000|Overall Study|Withdrawal by Subject|0|||
154949969|NCT05275998|559241762|FG001|Overall Study|Withdrawal by Subject|0|||
154949970|NCT05275998|559241763|FG002|Overall Study|Withdrawal by Subject|0|||
155052511|NCT02513550|559623659|FG000|Double Blind Treatment Period|Due to personal business|2|||
154949971|NCT05275998|559241764|FG003|Overall Study|Withdrawal by Subject|1|||
154949972|NCT05275998|559241761|FG000|Overall Study|Physician Decision|0|||
154949973|NCT05275998|559241762|FG001|Overall Study|Physician Decision|0|||
154949974|NCT05275998|559241763|FG002|Overall Study|Physician Decision|0|||
154949975|NCT05275998|559241764|FG003|Overall Study|Physician Decision|1|||
154949976|NCT05275998|559241761|FG000|Overall Study|Protocol Violation|0|||
154949977|NCT05275998|559241762|FG001|Overall Study|Protocol Violation|0|||
154949978|NCT05275998|559241763|FG002|Overall Study|Protocol Violation|1|||
155283182|NCT04739423|560468241|FG003|Overall Study|Adverse Event|0|||
154949979|NCT05275998|559241764|FG003|Overall Study|Protocol Violation|0|||
154949980|NCT01867242|559241767|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
154949981|NCT01867242|559241768|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
154949982|NCT01867242|559241769|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
154949983|NCT00661999|559241770|FG000|Overall Study|Adverse Event|11|||
155283183|NCT04739423|560468242|FG004|Overall Study|Adverse Event|1|||
155283184|NCT04739423|560468243|FG005|Overall Study|Adverse Event|0|||
155283185|NCT04739423|560468238|FG000|Overall Study|Withdrawal by Subject|0|||
155283186|NCT04739423|560468239|FG001|Overall Study|Withdrawal by Subject|0|||
155283187|NCT04739423|560468240|FG002|Overall Study|Withdrawal by Subject|0|||
155283188|NCT04739423|560468241|FG003|Overall Study|Withdrawal by Subject|0|||
155283189|NCT04739423|560468242|FG004|Overall Study|Withdrawal by Subject|0|||
155283190|NCT04739423|560468243|FG005|Overall Study|Withdrawal by Subject|1|||
155283191|NCT01007552|560468244|FG000|Overall Study|Withdrawal by Subject|1|||
155283192|NCT00764868|560468249|FG000|Overall Study|Adverse Event|18|||
155052512|NCT02513550|559623660|FG001|Double Blind Treatment Period|Due to personal business|0|||
155052513|NCT02513550|559623661|FG002|Double Blind Treatment Period|Due to personal business|1|||
155052514|NCT02513550|559623662|FG003|Double Blind Treatment Period|Due to personal business|0|||
155052515|NCT02513550|559623663|FG004|Double Blind Treatment Period|Due to personal business|0|||
155052516|NCT02513550|559623664|FG005|Double Blind Treatment Period|Due to personal business|0|||
155052517|NCT02513550|559623659|FG000|Double Blind Treatment Period|Death|1|||
155052518|NCT02513550|559623660|FG001|Double Blind Treatment Period|Death|0|||
155052519|NCT02513550|559623661|FG002|Double Blind Treatment Period|Death|2|||
155052520|NCT02513550|559623662|FG003|Double Blind Treatment Period|Death|0|||
155052521|NCT02513550|559623663|FG004|Double Blind Treatment Period|Death|0|||
155052522|NCT02513550|559623664|FG005|Double Blind Treatment Period|Death|0|||
155052523|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
155052524|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
155052525|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
155052526|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155052527|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155052528|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
155052529|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
155052530|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
155052531|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
155052532|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
155283193|NCT00764868|560468249|FG000|Overall Study|Withdrawal by Subject|31|||
155283194|NCT00764868|560468249|FG000|Overall Study|Non-compliance|16|||
155283195|NCT00764868|560468249|FG000|Overall Study|Lost to Follow-up|25|||
155283196|NCT00764868|560468249|FG000|Overall Study|Lack of Efficacy|5|||
155283197|NCT00764868|560468249|FG000|Overall Study|Subject moved|7|||
155283198|NCT00764868|560468249|FG000|Overall Study|Pregnancy|3|||
155283199|NCT00764868|560468249|FG000|Overall Study|Prohibited medication|1|||
155283200|NCT00764868|560468249|FG000|Overall Study|Out of town|1|||
155283201|NCT00764868|560468249|FG000|Overall Study|Misuse and compliance of study drug|1|||
155283202|NCT00764868|560468249|FG000|Overall Study|Subject sent to boarding school|1|||
155283203|NCT00764868|560468249|FG000|Overall Study|Met an exclusion criteria|1|||
155283204|NCT00764868|560468249|FG000|Overall Study|Positive drug screen|2|||
155283205|NCT00764868|560468249|FG000|Overall Study|Sponsor requested withdrawal|1|||
155283206|NCT00333138|560468259|FG000|Core Study (6 Months)|Adverse Event|4|||
155283207|NCT00333138|560468260|FG001|Core Study (6 Months)|Adverse Event|5|||
155283208|NCT00333138|560468261|FG002|Core Study (6 Months)|Adverse Event|8|||
155283209|NCT00333138|560468259|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
155283210|NCT00333138|560468260|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
155283211|NCT00333138|560468261|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
155283212|NCT00333138|560468259|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
155283213|NCT00333138|560468260|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
155283214|NCT00333138|560468261|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
155283215|NCT00333138|560468259|FG000|Core Study (6 Months)|Protocol Violation|1|||
155283216|NCT00333138|560468260|FG001|Core Study (6 Months)|Protocol Violation|0|||
155283217|NCT00333138|560468261|FG002|Core Study (6 Months)|Protocol Violation|1|||
155283218|NCT00333138|560468259|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
155283219|NCT00333138|560468260|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
155283220|NCT00333138|560468261|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
155283221|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
155283222|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
155283223|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
155283224|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
155283225|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
155283226|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
155283227|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
155283228|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
155283229|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
155283230|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
155283231|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
155283232|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
155283233|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
155283234|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
155283235|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
155283236|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
155283237|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
155283238|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
155283239|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
155052533|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
155052534|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
155052535|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
155052536|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
155052537|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
155052538|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155052539|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155052540|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
155052541|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
155052542|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
155052543|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
155052544|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
155052545|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
155052546|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
155052547|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
155052548|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
155052549|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
155052550|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
155052551|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
155052552|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
155052553|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Death|0|||
155052554|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Death|0|||
155052555|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Death|1|||
155052556|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Death|0|||
155052557|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Death|0|||
155052558|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Death|0|||
155052559|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
155052560|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
155052561|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
155052562|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
155052563|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
155052564|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
155052565|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155052566|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155052567|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
155052568|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155052569|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155052570|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
155052571|NCT02513550|559623659|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
155052572|NCT02513550|559623660|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
155052573|NCT02513550|559623661|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
155052574|NCT02513550|559623662|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
155052575|NCT02513550|559623663|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
155052576|NCT02513550|559623664|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
155052577|NCT04176939|559623669|FG000|Overall Study|Withdrawal by Subject|5|||
155052578|NCT04176939|559623669|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
155052579|NCT04176939|559623669|FG000|Overall Study|Lost to Follow-up|2|||
155052580|NCT04176939|559623669|FG000|Overall Study|Unspecified reason|4|||
155052581|NCT04176939|559623669|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
155052582|NCT02157519|559623670|FG000|Overall Study|Death|3|||
155052583|NCT02157519|559623671|FG001|Overall Study|Death|1|||
155052584|NCT02157519|559623670|FG000|Overall Study|Withdrawal by Subject|7|||
155052585|NCT02157519|559623671|FG001|Overall Study|Withdrawal by Subject|0|||
155052586|NCT02157519|559623670|FG000|Overall Study|Lost to Follow-up|1|||
155052587|NCT02157519|559623671|FG001|Overall Study|Lost to Follow-up|0|||
155052588|NCT01656395|559623672|FG000|Overall Study|Adverse Event|1|||
155052589|NCT01656395|559623673|FG001|Overall Study|Adverse Event|14|||
155052590|NCT01656395|559623674|FG002|Overall Study|Adverse Event|5|||
155052591|NCT01656395|559623675|FG003|Overall Study|Adverse Event|4|||
155052592|NCT01656395|559623676|FG004|Overall Study|Adverse Event|5|||
155052593|NCT01656395|559623677|FG005|Overall Study|Adverse Event|7|||
155052594|NCT01656395|559623678|FG006|Overall Study|Adverse Event|0|||
155052595|NCT01656395|559623679|FG007|Overall Study|Adverse Event|0|||
155052596|NCT01656395|559623672|FG000|Overall Study|Lack of Efficacy|1|||
155052597|NCT01656395|559623673|FG001|Overall Study|Lack of Efficacy|8|||
155052598|NCT01656395|559623674|FG002|Overall Study|Lack of Efficacy|6|||
155052599|NCT01656395|559623675|FG003|Overall Study|Lack of Efficacy|1|||
155052600|NCT01656395|559623676|FG004|Overall Study|Lack of Efficacy|1|||
155052601|NCT01656395|559623677|FG005|Overall Study|Lack of Efficacy|6|||
155052602|NCT01656395|559623678|FG006|Overall Study|Lack of Efficacy|0|||
155052603|NCT01656395|559623679|FG007|Overall Study|Lack of Efficacy|0|||
154949984|NCT00661999|559241771|FG001|Overall Study|Adverse Event|5|||
154949985|NCT00661999|559241772|FG002|Overall Study|Adverse Event|8|||
154949986|NCT00661999|559241770|FG000|Overall Study|Death|8|||
154949987|NCT00661999|559241771|FG001|Overall Study|Death|6|||
154949988|NCT00661999|559241772|FG002|Overall Study|Death|3|||
154949989|NCT00661999|559241770|FG000|Overall Study|Other Reasons|5|||
154949990|NCT00661999|559241771|FG001|Overall Study|Other Reasons|12|||
154949991|NCT00661999|559241772|FG002|Overall Study|Other Reasons|23|||
154949992|NCT00661999|559241770|FG000|Overall Study|Withdrawal by Subject|30|||
154949993|NCT00661999|559241771|FG001|Overall Study|Withdrawal by Subject|23|||
154949994|NCT00661999|559241772|FG002|Overall Study|Withdrawal by Subject|14|||
154949995|NCT00661999|559241770|FG000|Overall Study|Alternative Treatment|1|||
154949996|NCT00661999|559241771|FG001|Overall Study|Alternative Treatment|0|||
154949997|NCT00661999|559241772|FG002|Overall Study|Alternative Treatment|0|||
154949998|NCT00661999|559241770|FG000|Overall Study|Other Medical Problems|4|||
154949999|NCT00661999|559241771|FG001|Overall Study|Other Medical Problems|4|||
154950000|NCT00661999|559241772|FG002|Overall Study|Other Medical Problems|9|||
154950001|NCT03066999|559241773|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
154950002|NCT03066999|559241774|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
154950003|NCT01361126|559241777|FG000|Overall Study|Sponsor decision|0|||
154950004|NCT01361126|559241778|FG001|Overall Study|Sponsor decision|2|||
154950005|NCT00264810|559241779|FG000|Baseline|Withdrawal by Subject|10|||
154950006|NCT00264810|559241780|FG001|Baseline|Withdrawal by Subject|10|||
154950007|NCT00264810|559241779|FG000|Baseline|Physician Decision|7|||
154950008|NCT00264810|559241780|FG001|Baseline|Physician Decision|8|||
154950009|NCT00264810|559241779|FG000|Baseline|Subject Compliance Failure|3|||
154950010|NCT00264810|559241780|FG001|Baseline|Subject Compliance Failure|3|||
154950011|NCT00264810|559241779|FG000|Baseline|Insufficient Seizure Frequency|2|||
154950012|NCT00264810|559241780|FG001|Baseline|Insufficient Seizure Frequency|2|||
154950013|NCT00264810|559241779|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
154950014|NCT00264810|559241780|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
154950015|NCT00264810|559241779|FG000|Baseline|Other|0|||
154950016|NCT00264810|559241780|FG001|Baseline|Other|1|||
154950017|NCT00264810|559241779|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
154950018|NCT00264810|559241780|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
154950019|NCT00264810|559241779|FG000|Stimulation Optimization Period|Death|0|||
154950020|NCT00264810|559241780|FG001|Stimulation Optimization Period|Death|1|||
154950021|NCT00264810|559241779|FG000|Blinded Evaluation Period|Explant due to infection|1|||
154950022|NCT00264810|559241780|FG001|Blinded Evaluation Period|Explant due to infection|1|||
154950023|NCT00264810|559241779|FG000|Open Label Evaluation Period|Explant due to infection|1|||
154950024|NCT00264810|559241780|FG001|Open Label Evaluation Period|Explant due to infection|1|||
154950025|NCT00264810|559241779|FG000|Open Label Evaluation Period|Death|3|||
154950026|NCT00264810|559241780|FG001|Open Label Evaluation Period|Death|2|||
154950027|NCT00264810|559241779|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
154950028|NCT00264810|559241780|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
154950029|NCT00182091|559241784|FG000|Overall Study|Withdrawal by Subject|1|||
154950030|NCT00182091|559241785|FG001|Overall Study|Withdrawal by Subject|0|||
154950031|NCT00182091|559241786|FG002|Overall Study|Withdrawal by Subject|0|||
154950032|NCT00182091|559241787|FG003|Overall Study|Withdrawal by Subject|0|||
154950033|NCT02199509|559241788|FG000|Overall Study|Suicidal Ideation|0|||
154950034|NCT02199509|559241789|FG001|Overall Study|Suicidal Ideation|1|||
154950035|NCT02199509|559241788|FG000|Overall Study|Misunderstood titration schedule|1|||
154950036|NCT02199509|559241789|FG001|Overall Study|Misunderstood titration schedule|0|||
154950037|NCT01658943|559241791|FG000|Overall Study|Adverse Event|6|||
154950038|NCT01658943|559241792|FG001|Overall Study|Adverse Event|13|||
154950039|NCT01658943|559241791|FG000|Overall Study|Withdrawal by Subject|9|||
154950040|NCT01658943|559241792|FG001|Overall Study|Withdrawal by Subject|2|||
154950041|NCT01658943|559241791|FG000|Overall Study|Progression/Relapse|39|||
154950042|NCT01658943|559241792|FG001|Overall Study|Progression/Relapse|40|||
154950043|NCT01658943|559241791|FG000|Overall Study|Death|4|||
154950044|NCT01658943|559241792|FG001|Overall Study|Death|2|||
154950045|NCT01658943|559241791|FG000|Overall Study|not protocol specified|4|||
154950046|NCT01658943|559241792|FG001|Overall Study|not protocol specified|1|||
155052604|NCT01656395|559623672|FG000|Overall Study|Lost to Follow-up|1|||
154950047|NCT01658943|559241791|FG000|Overall Study|Not eligible|7|||
154950048|NCT01658943|559241792|FG001|Overall Study|Not eligible|9|||
154950049|NCT01658943|559241791|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
154950050|NCT01658943|559241792|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
154950051|NCT02576990|559241794|FG000|Overall Study|Death|29|||
154950052|NCT02576990|559241795|FG001|Overall Study|Death|18|||
154950053|NCT02576990|559241794|FG000|Overall Study|Physician Decision|1|||
154950054|NCT02576990|559241795|FG001|Overall Study|Physician Decision|0|||
154950055|NCT02576990|559241794|FG000|Overall Study|Screen failure|2|||
154950056|NCT02576990|559241795|FG001|Overall Study|Screen failure|0|||
154950057|NCT02576990|559241794|FG000|Overall Study|Sponsor's decision|24|||
154950058|NCT02576990|559241795|FG001|Overall Study|Sponsor's decision|4|||
155052605|NCT01656395|559623673|FG001|Overall Study|Lost to Follow-up|0|||
155052606|NCT01656395|559623674|FG002|Overall Study|Lost to Follow-up|0|||
155052607|NCT01656395|559623675|FG003|Overall Study|Lost to Follow-up|0|||
155052608|NCT01656395|559623676|FG004|Overall Study|Lost to Follow-up|0|||
155052609|NCT01656395|559623677|FG005|Overall Study|Lost to Follow-up|0|||
155052610|NCT01656395|559623678|FG006|Overall Study|Lost to Follow-up|0|||
155052611|NCT01656395|559623679|FG007|Overall Study|Lost to Follow-up|0|||
155052612|NCT01656395|559623672|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155052613|NCT01656395|559623673|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155052614|NCT01656395|559623674|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155052615|NCT01656395|559623675|FG003|Overall Study|Non-Compliance with Study Drug|0|||
155052616|NCT01656395|559623676|FG004|Overall Study|Non-Compliance with Study Drug|1|||
155052617|NCT01656395|559623677|FG005|Overall Study|Non-Compliance with Study Drug|1|||
155052618|NCT01656395|559623678|FG006|Overall Study|Non-Compliance with Study Drug|0|||
155052619|NCT01656395|559623679|FG007|Overall Study|Non-Compliance with Study Drug|0|||
155052620|NCT01656395|559623672|FG000|Overall Study|Other|0|||
155052621|NCT01656395|559623673|FG001|Overall Study|Other|0|||
155052622|NCT01656395|559623674|FG002|Overall Study|Other|1|||
155052623|NCT01656395|559623675|FG003|Overall Study|Other|0|||
155052624|NCT01656395|559623676|FG004|Overall Study|Other|0|||
155052625|NCT01656395|559623677|FG005|Overall Study|Other|1|||
155052626|NCT01656395|559623678|FG006|Overall Study|Other|0|||
155052627|NCT01656395|559623679|FG007|Overall Study|Other|0|||
155052628|NCT01656395|559623672|FG000|Overall Study|Physician Decision|2|||
155052629|NCT01656395|559623673|FG001|Overall Study|Physician Decision|3|||
155052630|NCT01656395|559623674|FG002|Overall Study|Physician Decision|3|||
155052631|NCT01656395|559623675|FG003|Overall Study|Physician Decision|2|||
155052632|NCT01656395|559623676|FG004|Overall Study|Physician Decision|3|||
155052633|NCT01656395|559623677|FG005|Overall Study|Physician Decision|3|||
155052634|NCT01656395|559623678|FG006|Overall Study|Physician Decision|0|||
155052635|NCT01656395|559623679|FG007|Overall Study|Physician Decision|0|||
155052636|NCT01656395|559623672|FG000|Overall Study|Pregnancy|0|||
155052637|NCT01656395|559623673|FG001|Overall Study|Pregnancy|0|||
155052638|NCT01656395|559623674|FG002|Overall Study|Pregnancy|1|||
155052639|NCT01656395|559623675|FG003|Overall Study|Pregnancy|0|||
155052640|NCT01656395|559623676|FG004|Overall Study|Pregnancy|0|||
155052641|NCT01656395|559623677|FG005|Overall Study|Pregnancy|0|||
155052642|NCT01656395|559623678|FG006|Overall Study|Pregnancy|0|||
155052643|NCT01656395|559623679|FG007|Overall Study|Pregnancy|0|||
155052644|NCT01656395|559623672|FG000|Overall Study|Progressive Disease|0|||
155052645|NCT01656395|559623673|FG001|Overall Study|Progressive Disease|0|||
155052646|NCT01656395|559623674|FG002|Overall Study|Progressive Disease|0|||
155052647|NCT01656395|559623675|FG003|Overall Study|Progressive Disease|0|||
155052648|NCT01656395|559623676|FG004|Overall Study|Progressive Disease|0|||
155052649|NCT01656395|559623677|FG005|Overall Study|Progressive Disease|1|||
155052650|NCT01656395|559623678|FG006|Overall Study|Progressive Disease|0|||
155052651|NCT01656395|559623679|FG007|Overall Study|Progressive Disease|0|||
155052652|NCT01656395|559623672|FG000|Overall Study|Protocol Violation|6|||
155052653|NCT01656395|559623673|FG001|Overall Study|Protocol Violation|6|||
155052654|NCT01656395|559623674|FG002|Overall Study|Protocol Violation|9|||
155052655|NCT01656395|559623675|FG003|Overall Study|Protocol Violation|2|||
155052656|NCT01656395|559623676|FG004|Overall Study|Protocol Violation|4|||
155052657|NCT01656395|559623677|FG005|Overall Study|Protocol Violation|10|||
155052658|NCT01656395|559623678|FG006|Overall Study|Protocol Violation|0|||
154950059|NCT02576990|559241794|FG000|Overall Study|Withdrawal by Subject|0|||
154950060|NCT02576990|559241795|FG001|Overall Study|Withdrawal by Subject|2|||
154950061|NCT05905783|559241796|FG000|Overall Study|Lost to Follow-up|12|||
154950062|NCT05905783|559241797|FG001|Overall Study|Lost to Follow-up|18|||
154950063|NCT05905783|559241796|FG000|Overall Study|Withdrawal by Subject|29|||
154950064|NCT05905783|559241797|FG001|Overall Study|Withdrawal by Subject|37|||
154950065|NCT05905783|559241796|FG000|Overall Study|Decision by sponsor|69|||
154950066|NCT05905783|559241797|FG001|Overall Study|Decision by sponsor|65|||
154950067|NCT02768298|559241800|FG000|Overall Study|Adverse Event|1|||
154950068|NCT02768298|559241801|FG001|Overall Study|Adverse Event|4|||
154950069|NCT02768298|559241800|FG000|Overall Study|Death|2|||
155052659|NCT01656395|559623679|FG007|Overall Study|Protocol Violation|0|||
155052660|NCT01656395|559623672|FG000|Overall Study|Screen Failure|2|||
155052661|NCT01656395|559623673|FG001|Overall Study|Screen Failure|1|||
155052662|NCT01656395|559623674|FG002|Overall Study|Screen Failure|7|||
155052663|NCT01656395|559623675|FG003|Overall Study|Screen Failure|1|||
155052664|NCT01656395|559623676|FG004|Overall Study|Screen Failure|0|||
155052665|NCT01656395|559623677|FG005|Overall Study|Screen Failure|8|||
155052666|NCT01656395|559623678|FG006|Overall Study|Screen Failure|0|||
155052667|NCT01656395|559623679|FG007|Overall Study|Screen Failure|0|||
155052668|NCT01656395|559623672|FG000|Overall Study|Withdrawal by Subject|3|||
155052669|NCT01656395|559623673|FG001|Overall Study|Withdrawal by Subject|1|||
155052670|NCT01656395|559623674|FG002|Overall Study|Withdrawal by Subject|4|||
155052671|NCT01656395|559623675|FG003|Overall Study|Withdrawal by Subject|2|||
155052672|NCT01656395|559623676|FG004|Overall Study|Withdrawal by Subject|0|||
155052673|NCT01656395|559623677|FG005|Overall Study|Withdrawal by Subject|3|||
155052674|NCT01656395|559623678|FG006|Overall Study|Withdrawal by Subject|0|||
155052675|NCT01656395|559623679|FG007|Overall Study|Withdrawal by Subject|0|||
155052676|NCT00230048|559623684|FG000|Overall Study|Lost to Follow-up|13|||
155052677|NCT00230048|559623685|FG001|Overall Study|Lost to Follow-up|18|||
155052678|NCT00676403|559623686|FG000|Overall Study|Adverse Event|1|||
155052679|NCT00676403|559623687|FG001|Overall Study|Adverse Event|2|||
155052680|NCT00676403|559623688|FG002|Overall Study|Adverse Event|0|||
155052681|NCT00676403|559623689|FG003|Overall Study|Adverse Event|5|||
155052682|NCT00676403|559623690|FG004|Overall Study|Adverse Event|1|||
155052683|NCT00676403|559623691|FG005|Overall Study|Adverse Event|2|||
155052684|NCT00676403|559623686|FG000|Overall Study|Lost to Follow-up|0|||
155052685|NCT00676403|559623687|FG001|Overall Study|Lost to Follow-up|0|||
155052686|NCT00676403|559623688|FG002|Overall Study|Lost to Follow-up|0|||
155052687|NCT00676403|559623689|FG003|Overall Study|Lost to Follow-up|0|||
155052688|NCT00676403|559623690|FG004|Overall Study|Lost to Follow-up|0|||
155052689|NCT00676403|559623691|FG005|Overall Study|Lost to Follow-up|1|||
155052690|NCT00676403|559623686|FG000|Overall Study|Reason Unspecified|1|||
155052691|NCT00676403|559623687|FG001|Overall Study|Reason Unspecified|0|||
155052692|NCT00676403|559623688|FG002|Overall Study|Reason Unspecified|1|||
155052693|NCT00676403|559623689|FG003|Overall Study|Reason Unspecified|0|||
155052694|NCT00676403|559623690|FG004|Overall Study|Reason Unspecified|0|||
155052695|NCT00676403|559623691|FG005|Overall Study|Reason Unspecified|1|||
155052696|NCT00676403|559623686|FG000|Overall Study|Withdrawal by Subject|0|||
155052697|NCT00676403|559623687|FG001|Overall Study|Withdrawal by Subject|0|||
155052698|NCT00676403|559623688|FG002|Overall Study|Withdrawal by Subject|0|||
155052699|NCT00676403|559623689|FG003|Overall Study|Withdrawal by Subject|0|||
155052700|NCT00676403|559623690|FG004|Overall Study|Withdrawal by Subject|0|||
155052701|NCT00676403|559623691|FG005|Overall Study|Withdrawal by Subject|1|||
155052702|NCT03225170|559623692|FG000|Overall Study|Lost to Follow-up|4|||
155052703|NCT03225170|559623693|FG001|Overall Study|Lost to Follow-up|4|||
155052704|NCT03225170|559623694|FG002|Overall Study|Lost to Follow-up|0|||
155052705|NCT03225170|559623692|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
155052706|NCT03225170|559623693|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
155052707|NCT03225170|559623694|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
155052708|NCT00705757|559623697|FG000|Overall Study|Lack of Efficacy|5|||
155052709|NCT00705757|559623698|FG001|Overall Study|Lack of Efficacy|1|||
155052710|NCT00705757|559623699|FG002|Overall Study|Lack of Efficacy|3|||
155052711|NCT00705757|559623697|FG000|Overall Study|Lost to Follow-up|7|||
155052712|NCT00705757|559623698|FG001|Overall Study|Lost to Follow-up|6|||
155052713|NCT00705757|559623699|FG002|Overall Study|Lost to Follow-up|6|||
155052714|NCT00705757|559623697|FG000|Overall Study|Withdrawal by Subject|1|||
155052715|NCT00705757|559623698|FG001|Overall Study|Withdrawal by Subject|1|||
155052716|NCT00705757|559623699|FG002|Overall Study|Withdrawal by Subject|2|||
155052717|NCT04742673|559623700|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
155052718|NCT04742673|559623701|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
155052719|NCT04073303|559623706|FG000|Overall Study|Adverse Event|0|||
155052720|NCT04073303|559623707|FG001|Overall Study|Adverse Event|2|||
155052721|NCT04073303|559623706|FG000|Overall Study|Withdrawal by Subject|16|||
155052722|NCT04073303|559623707|FG001|Overall Study|Withdrawal by Subject|36|||
155052723|NCT04073303|559623706|FG000|Overall Study|Lost to Follow-up|6|||
155052724|NCT04073303|559623707|FG001|Overall Study|Lost to Follow-up|1|||
155052725|NCT04073303|559623706|FG000|Overall Study|Protocol Deviation|0|||
155052726|NCT04073303|559623707|FG001|Overall Study|Protocol Deviation|4|||
155052727|NCT04073303|559623706|FG000|Overall Study|Other|1|||
154950070|NCT02768298|559241801|FG001|Overall Study|Death|1|||
154950071|NCT02768298|559241800|FG000|Overall Study|Non-compliance with study treatment|0|||
154950072|NCT02768298|559241801|FG001|Overall Study|Non-compliance with study treatment|1|||
154950073|NCT02768298|559241800|FG000|Overall Study|Subject/guardian decision|1|||
154950074|NCT02768298|559241801|FG001|Overall Study|Subject/guardian decision|0|||
154950075|NCT02768298|559241800|FG000|Overall Study|Withdrawal of informed consent|0|||
154950076|NCT02768298|559241801|FG001|Overall Study|Withdrawal of informed consent|1|||
154950077|NCT05771428|559243761|FG000|Overall Study|Adverse Event|0|||
154950078|NCT05771428|559243762|FG001|Overall Study|Adverse Event|1|||
154950079|NCT05771428|559243763|FG002|Overall Study|Adverse Event|1|||
154950080|NCT05771428|559243764|FG003|Overall Study|Adverse Event|1|||
154950081|NCT05771428|559243761|FG000|Overall Study|Withdrawal by Subject|3|||
154950082|NCT05771428|559243762|FG001|Overall Study|Withdrawal by Subject|2|||
154950083|NCT05771428|559243763|FG002|Overall Study|Withdrawal by Subject|1|||
154950084|NCT05771428|559243764|FG003|Overall Study|Withdrawal by Subject|4|||
154950085|NCT05771428|559243761|FG000|Overall Study|Other|0|||
154950086|NCT05771428|559243762|FG001|Overall Study|Other|1|||
154950087|NCT05771428|559243763|FG002|Overall Study|Other|2|||
154950088|NCT05771428|559243764|FG003|Overall Study|Other|1|||
154950089|NCT05771428|559243761|FG000|Overall Study|Randomized but Not Treated|0|||
154950090|NCT05771428|559243762|FG001|Overall Study|Randomized but Not Treated|0|||
154950091|NCT05771428|559243763|FG002|Overall Study|Randomized but Not Treated|1|||
154950092|NCT05771428|559243764|FG003|Overall Study|Randomized but Not Treated|0|||
155052728|NCT04073303|559623707|FG001|Overall Study|Other|1|||
155052729|NCT01158261|559623713|FG000|Overall Study|Lost to Follow-up|9|||
155052730|NCT01158261|559623713|FG000|Overall Study|Death|7|||
155052731|NCT01158261|559623713|FG000|Overall Study|Withdrawal by Subject|1|||
155052732|NCT00971867|559623714|FG000|Overall Study|Adverse Event|4|||
155052733|NCT00971867|559623714|FG000|Overall Study|Participant Withdrew Consent|1|||
155052734|NCT00971867|559623714|FG000|Overall Study|Disease Progression|6|||
155052735|NCT01922258|559623717|FG000|Overall Study|Lost to Follow-up|1|||
155052736|NCT01922258|559623718|FG001|Overall Study|Lost to Follow-up|1|||
155052737|NCT01922258|559623717|FG000|Overall Study|Adverse Event|9|||
155052738|NCT01922258|559623718|FG001|Overall Study|Adverse Event|2|||
155052739|NCT01922258|559623717|FG000|Overall Study|Met Withdrawal Criteria|0|||
155052740|NCT01922258|559623718|FG001|Overall Study|Met Withdrawal Criteria|4|||
155052741|NCT01922258|559623717|FG000|Overall Study|Withdrawn by the Investigator|1|||
155052742|NCT01922258|559623718|FG001|Overall Study|Withdrawn by the Investigator|4|||
155052743|NCT01922258|559623717|FG000|Overall Study|Withdrawal by participant|5|||
155052744|NCT01922258|559623718|FG001|Overall Study|Withdrawal by participant|5|||
155052745|NCT00673257|559623719|FG000|Overall Study|Withdrawal by Subject|4|||
155052746|NCT00673257|559623719|FG000|Overall Study|Unable to obtain specimen|1|||
155052747|NCT01166750|559623726|FG000|Overall Study|Lost to Follow-up|1|||
155052748|NCT01166750|559623727|FG001|Overall Study|Lost to Follow-up|0|||
155052749|NCT05225389|559623728|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
155052750|NCT01585246|559623729|FG000|Overall Study|Lost to Follow-up|0|||
155052751|NCT01585246|559623730|FG001|Overall Study|Lost to Follow-up|0|||
155052752|NCT01585246|559623731|FG002|Overall Study|Lost to Follow-up|2|||
155052753|NCT01585246|559623732|FG003|Overall Study|Lost to Follow-up|1|||
155052754|NCT01585246|559623733|FG004|Overall Study|Lost to Follow-up|0|||
155052755|NCT01585246|559623729|FG000|Overall Study|Protocol Violation|0|||
155052756|NCT01585246|559623730|FG001|Overall Study|Protocol Violation|0|||
155052757|NCT01585246|559623731|FG002|Overall Study|Protocol Violation|0|||
155052758|NCT01585246|559623732|FG003|Overall Study|Protocol Violation|0|||
155052759|NCT01585246|559623733|FG004|Overall Study|Protocol Violation|1|||
155052760|NCT01585246|559623729|FG000|Overall Study|Withdrawal by Subject|0|||
155052761|NCT01585246|559623730|FG001|Overall Study|Withdrawal by Subject|0|||
155052762|NCT01585246|559623731|FG002|Overall Study|Withdrawal by Subject|1|||
154950093|NCT04025229|559243765|FG000|Overall Study|Adverse Event|1|||
154950094|NCT04025229|559243766|FG001|Overall Study|Adverse Event|0|||
154950095|NCT04025229|559243765|FG000|Overall Study|Withdrawal by Subject|0|||
154950096|NCT04025229|559243766|FG001|Overall Study|Withdrawal by Subject|2|||
154950097|NCT04025229|559243765|FG000|Overall Study|Death|0|||
154950098|NCT04025229|559243766|FG001|Overall Study|Death|1|||
154950099|NCT04025229|559243765|FG000|Overall Study|Physician Decision|0|||
154950100|NCT04025229|559243766|FG001|Overall Study|Physician Decision|1|||
154950101|NCT00788125|559243767|FG000|Overall Study|Death|6|||
154950102|NCT02180711|559243774|FG000|Overall Study|Death|0|||
154950103|NCT02180711|559243775|FG001|Overall Study|Death|1|||
154950104|NCT02180711|559243776|FG002|Overall Study|Death|0|||
154950105|NCT02180711|559243777|FG003|Overall Study|Death|0|||
154950106|NCT02180711|559243778|FG004|Overall Study|Death|7|||
154950107|NCT02180711|559243779|FG005|Overall Study|Death|0|||
154950108|NCT02180711|559243780|FG006|Overall Study|Death|1|||
154950109|NCT02180711|559243781|FG007|Overall Study|Death|3|||
154950110|NCT02180711|559243774|FG000|Overall Study|Lost to Follow-up|0|||
154950111|NCT02180711|559243775|FG001|Overall Study|Lost to Follow-up|1|||
154950112|NCT02180711|559243776|FG002|Overall Study|Lost to Follow-up|0|||
154950113|NCT02180711|559243777|FG003|Overall Study|Lost to Follow-up|0|||
154950114|NCT02180711|559243778|FG004|Overall Study|Lost to Follow-up|1|||
154950115|NCT02180711|559243779|FG005|Overall Study|Lost to Follow-up|1|||
154950116|NCT02180711|559243780|FG006|Overall Study|Lost to Follow-up|0|||
154950117|NCT02180711|559243781|FG007|Overall Study|Lost to Follow-up|3|||
154950118|NCT02180711|559243774|FG000|Overall Study|Withdrawal by Subject|2|||
154950119|NCT02180711|559243775|FG001|Overall Study|Withdrawal by Subject|1|||
154950120|NCT02180711|559243776|FG002|Overall Study|Withdrawal by Subject|0|||
154950121|NCT02180711|559243777|FG003|Overall Study|Withdrawal by Subject|4|||
154950122|NCT02180711|559243778|FG004|Overall Study|Withdrawal by Subject|3|||
154950123|NCT02180711|559243779|FG005|Overall Study|Withdrawal by Subject|0|||
154950124|NCT02180711|559243780|FG006|Overall Study|Withdrawal by Subject|3|||
154950125|NCT02180711|559243781|FG007|Overall Study|Withdrawal by Subject|2|||
154950126|NCT02180711|559243774|FG000|Overall Study|- Disease Progression|0|||
155052763|NCT01585246|559623732|FG003|Overall Study|Withdrawal by Subject|2|||
155052764|NCT01585246|559623733|FG004|Overall Study|Withdrawal by Subject|1|||
155052765|NCT01585246|559623729|FG000|Overall Study|Other|0|||
155052766|NCT01585246|559623730|FG001|Overall Study|Other|1|||
154950127|NCT02180711|559243775|FG001|Overall Study|- Disease Progression|1|||
154950128|NCT02180711|559243776|FG002|Overall Study|- Disease Progression|0|||
155052767|NCT01585246|559623731|FG002|Overall Study|Other|1|||
155052768|NCT01585246|559623732|FG003|Overall Study|Other|1|||
155052769|NCT01585246|559623733|FG004|Overall Study|Other|0|||
154950129|NCT02180711|559243777|FG003|Overall Study|- Disease Progression|0|||
155052770|NCT04396626|559623734|FG000|Overall Study|Premature termination of study|975|||
155052771|NCT02111174|559623737|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
155052772|NCT02111174|559623738|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
155052773|NCT02111174|559623737|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
155052774|NCT02111174|559623738|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
155052775|NCT02111174|559623737|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
155052776|NCT02111174|559623738|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
155052777|NCT02111174|559623737|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
155052778|NCT02111174|559623738|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
155052779|NCT04552132|559623739|FG000|Overall Study|Lost to Follow-up|4|||
155052780|NCT04552132|559623740|FG001|Overall Study|Lost to Follow-up|3|||
155052781|NCT04552132|559623739|FG000|Overall Study|Protocol Violation|1|||
155052782|NCT04552132|559623740|FG001|Overall Study|Protocol Violation|0|||
155052783|NCT01657162|559623741|FG000|Overall Study|Adverse Event|26|||
155052784|NCT01657162|559623742|FG001|Overall Study|Adverse Event|36|||
155052785|NCT01657162|559623741|FG000|Overall Study|Withdrawal by Subject|13|||
155052786|NCT01657162|559623742|FG001|Overall Study|Withdrawal by Subject|13|||
155052787|NCT01657162|559623741|FG000|Overall Study|Continuing Significant Deterioration|9|||
155052788|NCT01657162|559623742|FG001|Overall Study|Continuing Significant Deterioration|3|||
155052789|NCT01657162|559623741|FG000|Overall Study|Refusal of Treatment|4|||
155052790|NCT01657162|559623742|FG001|Overall Study|Refusal of Treatment|6|||
155052791|NCT01657162|559623741|FG000|Overall Study|Lost to Follow-up|3|||
155052792|NCT01657162|559623742|FG001|Overall Study|Lost to Follow-up|4|||
155052793|NCT01657162|559623741|FG000|Overall Study|Death|2|||
155052794|NCT01657162|559623742|FG001|Overall Study|Death|3|||
155052795|NCT01657162|559623741|FG000|Overall Study|Inability to Complete Study Procedures|1|||
155052796|NCT01657162|559623742|FG001|Overall Study|Inability to Complete Study Procedures|7|||
155052797|NCT01657162|559623741|FG000|Overall Study|Protocol Violation|1|||
155052798|NCT01657162|559623742|FG001|Overall Study|Protocol Violation|0|||
155052799|NCT01657162|559623741|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
155052800|NCT01657162|559623742|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
155052801|NCT01657162|559623741|FG000|Overall Study|Other than Specified|0|||
155052802|NCT01657162|559623742|FG001|Overall Study|Other than Specified|2|||
155052803|NCT00901342|559623743|FG000|Overall Study|Adverse Event|1|||
155052804|NCT00901342|559623743|FG000|Overall Study|Death|4|||
155052805|NCT00901342|559623743|FG000|Overall Study|Disease progression|1|||
155052806|NCT00901342|559623743|FG000|Overall Study|Withdrawal by Subject|9|||
155052807|NCT00792909|559623744|FG000|Overall Study|Withdrawal by Subject|0|||
155052808|NCT00792909|559623745|FG001|Overall Study|Withdrawal by Subject|1|||
155052809|NCT00792909|559623746|FG002|Overall Study|Withdrawal by Subject|0|||
155052810|NCT01261390|559623751|FG000|Overall Study|Significant Concurrent Illness|1|||
155052811|NCT01261390|559623752|FG001|Overall Study|Significant Concurrent Illness|0|||
155052812|NCT01261390|559623753|FG002|Overall Study|Significant Concurrent Illness|1|||
155052813|NCT01261390|559623754|FG003|Overall Study|Significant Concurrent Illness|0|||
155052814|NCT01261390|559623751|FG000|Overall Study|Dissatisfaction with Treatment|2|||
155052815|NCT01261390|559623752|FG001|Overall Study|Dissatisfaction with Treatment|1|||
155052816|NCT01261390|559623753|FG002|Overall Study|Dissatisfaction with Treatment|1|||
155052817|NCT01261390|559623754|FG003|Overall Study|Dissatisfaction with Treatment|2|||
155052818|NCT01261390|559623751|FG000|Overall Study|Relocation|0|||
155052819|NCT01261390|559623752|FG001|Overall Study|Relocation|1|||
155052820|NCT01261390|559623753|FG002|Overall Study|Relocation|0|||
155052821|NCT01261390|559623754|FG003|Overall Study|Relocation|0|||
155052822|NCT01261390|559623751|FG000|Overall Study|Loss of Interest in the Study|3|||
155052823|NCT01261390|559623752|FG001|Overall Study|Loss of Interest in the Study|1|||
155052824|NCT01261390|559623753|FG002|Overall Study|Loss of Interest in the Study|0|||
155052825|NCT01261390|559623754|FG003|Overall Study|Loss of Interest in the Study|0|||
155052826|NCT01261390|559623751|FG000|Overall Study|Lost to Follow-up|1|||
155052827|NCT01261390|559623752|FG001|Overall Study|Lost to Follow-up|6|||
155052828|NCT01261390|559623753|FG002|Overall Study|Lost to Follow-up|5|||
155052829|NCT01261390|559623754|FG003|Overall Study|Lost to Follow-up|6|||
155052830|NCT04010461|559623756|FG000|Overall Study|COVID based withdrawal|5|||
155052831|NCT04010461|559623756|FG000|Overall Study|Withdrawal by Subject|5|||
155052832|NCT04010461|559623756|FG000|Overall Study|Adverse Event|1|||
155052833|NCT04010461|559623756|FG000|Overall Study|No Motor Threshold obtainable|1|||
155052834|NCT04010461|559623756|FG000|Overall Study|Physician Decision|1|||
155052835|NCT00096538|559623758|FG000|Overall Study|Withdrawal by Subject|1|||
155052836|NCT02324361|559623762|FG000|Overall Study|Lost to Follow-up|5|||
155052837|NCT02324361|559623763|FG001|Overall Study|Lost to Follow-up|2|||
155052838|NCT00003471|559623769|FG000|Overall Study|Not evaluable|4|||
155052839|NCT00735007|559623774|FG000|Overall Study|Adverse Event|4|||
155052840|NCT00735007|559623774|FG000|Overall Study|Protocol Violation|1|||
155052841|NCT00715403|559623775|FG000|Overall Study|Progressive disease|0|||
155052842|NCT00715403|559623776|FG001|Overall Study|Progressive disease|1|||
155052843|NCT00715403|559623777|FG002|Overall Study|Progressive disease|3|||
155052844|NCT00715403|559623778|FG003|Overall Study|Progressive disease|9|||
155052845|NCT00715403|559623779|FG004|Overall Study|Progressive disease|5|||
155052846|NCT00715403|559623780|FG005|Overall Study|Progressive disease|14|||
155052847|NCT00715403|559623781|FG006|Overall Study|Progressive disease|1|||
155052848|NCT00715403|559623775|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
155052849|NCT00715403|559623776|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
155052850|NCT00715403|559623777|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
155052851|NCT00715403|559623778|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
155052852|NCT00715403|559623779|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
155052853|NCT00715403|559623780|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
154950130|NCT02180711|559243778|FG004|Overall Study|- Disease Progression|0|||
154950131|NCT02180711|559243779|FG005|Overall Study|- Disease Progression|0|||
154950132|NCT02180711|559243780|FG006|Overall Study|- Disease Progression|0|||
154950133|NCT02180711|559243781|FG007|Overall Study|- Disease Progression|0|||
154950134|NCT02180711|559243774|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
154950135|NCT02180711|559243775|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
154950136|NCT02180711|559243776|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
154950137|NCT02180711|559243777|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
154950138|NCT02180711|559243778|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
154950139|NCT02180711|559243779|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
154950140|NCT02180711|559243780|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
154950141|NCT02180711|559243781|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
154950142|NCT02180711|559243774|FG000|Overall Study|- Study Terminated by Sponsor|2|||
154950143|NCT02180711|559243775|FG001|Overall Study|- Study Terminated by Sponsor|3|||
154950144|NCT02180711|559243776|FG002|Overall Study|- Study Terminated by Sponsor|0|||
154950145|NCT02180711|559243777|FG003|Overall Study|- Study Terminated by Sponsor|5|||
154950146|NCT02180711|559243778|FG004|Overall Study|- Study Terminated by Sponsor|32|||
154950147|NCT02180711|559243779|FG005|Overall Study|- Study Terminated by Sponsor|0|||
154950148|NCT02180711|559243780|FG006|Overall Study|- Study Terminated by Sponsor|4|||
154950149|NCT02180711|559243781|FG007|Overall Study|- Study Terminated by Sponsor|13|||
154950150|NCT02180711|559243774|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
154950151|NCT02180711|559243775|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
154950152|NCT02180711|559243776|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
154950153|NCT02180711|559243777|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
154950154|NCT02180711|559243778|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
154950155|NCT02180711|559243779|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
154950156|NCT02180711|559243780|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
154950157|NCT02180711|559243781|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
154950158|NCT02180711|559243774|FG000|Overall Study|- Other|1|||
154950159|NCT02180711|559243775|FG001|Overall Study|- Other|0|||
154950160|NCT02180711|559243776|FG002|Overall Study|- Other|0|||
154950161|NCT02180711|559243777|FG003|Overall Study|- Other|1|||
154950162|NCT02180711|559243778|FG004|Overall Study|- Other|0|||
154950163|NCT02180711|559243779|FG005|Overall Study|- Other|0|||
154950164|NCT02180711|559243780|FG006|Overall Study|- Other|0|||
154950165|NCT02180711|559243781|FG007|Overall Study|- Other|0|||
154950166|NCT00444145|559243785|FG000|Overall Study|Withdrawal by Subject|2|||
154950167|NCT00444145|559243785|FG000|Overall Study|Lost to Follow-up|1|||
154950168|NCT00444145|559243785|FG000|Overall Study|non-compliant|11|||
154950169|NCT00444145|559243785|FG000|Overall Study|Screen Failures|5|||
154950170|NCT01619800|559243786|FG000|Overall Study|study terminated|2|||
154950171|NCT01619800|559243787|FG001|Overall Study|study terminated|0|||
154950172|NCT00414466|559243789|FG000|Overall Study|Adverse Event|0|||
154950173|NCT00414466|559243790|FG001|Overall Study|Adverse Event|0|||
154950174|NCT00414466|559243791|FG002|Overall Study|Adverse Event|1|||
154950175|NCT00414466|559243792|FG003|Overall Study|Adverse Event|1|||
154950176|NCT00414466|559243789|FG000|Overall Study|Lack of Efficacy|1|||
154950177|NCT00414466|559243790|FG001|Overall Study|Lack of Efficacy|0|||
154950178|NCT00414466|559243791|FG002|Overall Study|Lack of Efficacy|0|||
154950179|NCT00414466|559243792|FG003|Overall Study|Lack of Efficacy|0|||
154950180|NCT00414466|559243789|FG000|Overall Study|Withdrawn by Sponsor|1|||
154950181|NCT00414466|559243790|FG001|Overall Study|Withdrawn by Sponsor|0|||
154950182|NCT00414466|559243791|FG002|Overall Study|Withdrawn by Sponsor|0|||
154950183|NCT00414466|559243792|FG003|Overall Study|Withdrawn by Sponsor|0|||
154950184|NCT04526210|559243793|FG000|Overall Study|Sponsor decision|7|||
154950185|NCT04526210|559243794|FG001|Overall Study|Sponsor decision|5|||
154950186|NCT04526210|559243793|FG000|Overall Study|Withdrawal by Subject|3|||
154950187|NCT04526210|559243794|FG001|Overall Study|Withdrawal by Subject|2|||
154950188|NCT01781637|559243795|FG000|Overall Study|Adverse Event|1|||
154950189|NCT01781637|559243796|FG001|Overall Study|Adverse Event|0|||
154950190|NCT01781637|559243795|FG000|Overall Study|Lack of Efficacy|2|||
154950191|NCT01781637|559243796|FG001|Overall Study|Lack of Efficacy|6|||
155052854|NCT00715403|559623781|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
155052855|NCT00715403|559623775|FG000|Overall Study|Other Adverse Event than DLT|1|||
154950192|NCT01781637|559243795|FG000|Overall Study|Withdrawal by Subject|1|||
155052856|NCT00715403|559623776|FG001|Overall Study|Other Adverse Event than DLT|0|||
155052857|NCT00715403|559623777|FG002|Overall Study|Other Adverse Event than DLT|0|||
155052858|NCT00715403|559623778|FG003|Overall Study|Other Adverse Event than DLT|0|||
155052859|NCT00715403|559623779|FG004|Overall Study|Other Adverse Event than DLT|0|||
155052860|NCT00715403|559623780|FG005|Overall Study|Other Adverse Event than DLT|2|||
155052861|NCT00715403|559623781|FG006|Overall Study|Other Adverse Event than DLT|0|||
155052862|NCT00715403|559623775|FG000|Overall Study|Protocol Violation|0|||
155052863|NCT00715403|559623776|FG001|Overall Study|Protocol Violation|0|||
155052864|NCT00715403|559623777|FG002|Overall Study|Protocol Violation|0|||
155052865|NCT00715403|559623778|FG003|Overall Study|Protocol Violation|0|||
155052866|NCT00715403|559623779|FG004|Overall Study|Protocol Violation|0|||
155052867|NCT00715403|559623780|FG005|Overall Study|Protocol Violation|1|||
155052868|NCT00715403|559623781|FG006|Overall Study|Protocol Violation|0|||
155052869|NCT00715403|559623775|FG000|Overall Study|Other reason not defined above|0|||
155052870|NCT00715403|559623776|FG001|Overall Study|Other reason not defined above|0|||
155052871|NCT00715403|559623777|FG002|Overall Study|Other reason not defined above|1|||
155052872|NCT00715403|559623778|FG003|Overall Study|Other reason not defined above|0|||
155052873|NCT00715403|559623779|FG004|Overall Study|Other reason not defined above|1|||
155052874|NCT00715403|559623780|FG005|Overall Study|Other reason not defined above|1|||
155052875|NCT00715403|559623781|FG006|Overall Study|Other reason not defined above|0|||
155052876|NCT00101868|559623788|FG000|Overall Study|Death|10|||
155052877|NCT00101868|559623789|FG001|Overall Study|Death|10|||
155052878|NCT00101868|559623788|FG000|Overall Study|Withdrawal by Subject|8|||
155052879|NCT00101868|559623789|FG001|Overall Study|Withdrawal by Subject|9|||
155052880|NCT00101868|559623788|FG000|Overall Study|Protocol Violation|3|||
155052881|NCT00101868|559623789|FG001|Overall Study|Protocol Violation|0|||
155052882|NCT00101868|559623788|FG000|Overall Study|Lost to Follow-up|8|||
155052883|NCT00101868|559623789|FG001|Overall Study|Lost to Follow-up|13|||
155052884|NCT03839394|559623790|FG000|Overall Study|Lost to Follow-up|6|||
155052885|NCT03839394|559623791|FG001|Overall Study|Lost to Follow-up|8|||
155052886|NCT03839394|559623790|FG000|Overall Study|Withdrawal by Subject|0|||
155052887|NCT03839394|559623791|FG001|Overall Study|Withdrawal by Subject|2|||
155052888|NCT01931397|559623794|FG000|Overall Study|Physician Decision|2|||
155052889|NCT01931397|559623794|FG000|Overall Study|Withdrawal by Subject|8|||
155052890|NCT01931397|559623794|FG000|Overall Study|moved out of state|1|||
155052891|NCT05404711|559623798|FG000|Completed Study Visit|Withdrawal by Subject|1|||
155052892|NCT05404711|559623798|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
155052893|NCT05404711|559623798|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
155052894|NCT05404711|559623798|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
155052895|NCT05404711|559623798|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
155052896|NCT05404711|559623798|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
155052897|NCT02346877|559623799|FG000|Overall Study|Adverse Event|1|||
155052898|NCT02346877|559623800|FG001|Overall Study|Adverse Event|0|||
155052899|NCT02346877|559623799|FG000|Overall Study|Administrative Decision|1|||
155052900|NCT02346877|559623800|FG001|Overall Study|Administrative Decision|0|||
155052901|NCT02346877|559623799|FG000|Overall Study|Sponsor Decision|12|||
155052902|NCT02346877|559623800|FG001|Overall Study|Sponsor Decision|0|||
155052903|NCT02346877|559623799|FG000|Overall Study|Missing|5|||
155052904|NCT02346877|559623800|FG001|Overall Study|Missing|0|||
155052905|NCT00565604|559623802|FG000|Overall Study|Failure to treat|2|||
155052906|NCT00565604|559623802|FG000|Overall Study|Lost to Follow-up|2|||
155052907|NCT02481050|559625700|FG000|Overall Study|Adverse Event|1|||
155052908|NCT02481050|559625700|FG000|Overall Study|Disease Progression|47|||
155052909|NCT02481050|559625700|FG000|Overall Study|Withdrawal by Subject|7|||
155052910|NCT02481050|559625700|FG000|Overall Study|Other|3|||
155052911|NCT01386606|559625701|FG000|Overall Study|Adverse Event|0|||
155052912|NCT01386606|559625702|FG001|Overall Study|Adverse Event|1|||
155052913|NCT01386606|559625703|FG002|Overall Study|Adverse Event|0|||
155052914|NCT01386606|559625704|FG003|Overall Study|Adverse Event|0|||
155052915|NCT01386606|559625701|FG000|Overall Study|Withdrawal by Subject|0|||
155052916|NCT01386606|559625702|FG001|Overall Study|Withdrawal by Subject|1|||
155052917|NCT01386606|559625703|FG002|Overall Study|Withdrawal by Subject|1|||
155052918|NCT01386606|559625704|FG003|Overall Study|Withdrawal by Subject|0|||
155052919|NCT01386606|559625701|FG000|Overall Study|Protocol Violation|1|||
155052920|NCT01386606|559625702|FG001|Overall Study|Protocol Violation|0|||
155052921|NCT01386606|559625703|FG002|Overall Study|Protocol Violation|1|||
155052922|NCT01386606|559625704|FG003|Overall Study|Protocol Violation|1|||
155052923|NCT01386606|559625701|FG000|Overall Study|Lost to Follow-up|2|||
155052924|NCT01386606|559625702|FG001|Overall Study|Lost to Follow-up|0|||
155052925|NCT01386606|559625703|FG002|Overall Study|Lost to Follow-up|0|||
155052926|NCT01386606|559625704|FG003|Overall Study|Lost to Follow-up|0|||
155052927|NCT01386606|559625701|FG000|Overall Study|Subject incarcerated|0|||
155052928|NCT01386606|559625702|FG001|Overall Study|Subject incarcerated|1|||
155052929|NCT01386606|559625703|FG002|Overall Study|Subject incarcerated|0|||
155052930|NCT01386606|559625704|FG003|Overall Study|Subject incarcerated|0|||
155052931|NCT01386606|559625701|FG000|Overall Study|Unable to draw PK|1|||
155283240|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
155283241|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
155283242|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
155283243|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
155283244|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
155283245|NCT00333138|560468259|FG000|Extension Study (Month6 to End of Study)|Death|0|||
154950193|NCT01781637|559243796|FG001|Overall Study|Withdrawal by Subject|0|||
154950194|NCT02637232|559243797|FG000|Overall Study|Lost to Follow-up|42|||
154950195|NCT02637232|559243797|FG000|Overall Study|Adverse Event|11|||
154950196|NCT02637232|559243797|FG000|Overall Study|patient 's decision|2|||
154950197|NCT02999178|559243798|FG000|Overall Study|Adverse Event|85|||
154950198|NCT02999178|559243799|FG001|Overall Study|Adverse Event|62|||
154950199|NCT02999178|559243798|FG000|Overall Study|Protocol Violation|1|||
154950200|NCT02999178|559243799|FG001|Overall Study|Protocol Violation|2|||
154950201|NCT02999178|559243798|FG000|Overall Study|Lost to Follow-up|0|||
154950202|NCT02999178|559243799|FG001|Overall Study|Lost to Follow-up|2|||
154950203|NCT02999178|559243798|FG000|Overall Study|Withdrawal by Subject|21|||
154950204|NCT02999178|559243799|FG001|Overall Study|Withdrawal by Subject|21|||
154950205|NCT02999178|559243798|FG000|Overall Study|Other reason not defined above|7|||
154950206|NCT02999178|559243799|FG001|Overall Study|Other reason not defined above|13|||
154950207|NCT00090857|559243801|FG000|Overall Study|Lost to Follow-up|0|||
154950208|NCT00090857|559243802|FG001|Overall Study|Lost to Follow-up|1|||
154950209|NCT00090857|559243801|FG000|Overall Study|Withdrawal by Subject|2|||
154950210|NCT00090857|559243802|FG001|Overall Study|Withdrawal by Subject|0|||
154950211|NCT00090857|559243801|FG000|Overall Study|Adverse Event|2|||
154950212|NCT00090857|559243802|FG001|Overall Study|Adverse Event|2|||
154950213|NCT05097326|559243803|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
154950214|NCT05097326|559243804|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
154950215|NCT03480425|559243806|FG000|Overall Study|Force transducer technical failure|1|||
154950216|NCT01244126|559243807|FG000|Overall Study|Protocol Violation|3|||
154950217|NCT01244126|559243808|FG001|Overall Study|Protocol Violation|3|||
154950218|NCT01244126|559243809|FG002|Overall Study|Protocol Violation|9|||
154950219|NCT00863746|559243815|FG000|Treatment|Not treated|4|||
154950220|NCT00863746|559243816|FG001|Treatment|Not treated|2|||
154950221|NCT00863746|559243815|FG000|Treatment|Adverse Event|41|||
154950222|NCT00863746|559243816|FG001|Treatment|Adverse Event|16|||
154950223|NCT00863746|559243815|FG000|Treatment|non-compliant with study medication|4|||
154950224|NCT00863746|559243816|FG001|Treatment|non-compliant with study medication|0|||
154950225|NCT00863746|559243815|FG000|Treatment|Consent withdrawn|15|||
154950226|NCT00863746|559243816|FG001|Treatment|Consent withdrawn|14|||
154950227|NCT00863746|559243815|FG000|Treatment|Lost to Follow-up|1|||
154950228|NCT00863746|559243816|FG001|Treatment|Lost to Follow-up|0|||
154950229|NCT00863746|559243815|FG000|Treatment|Protocol Violation|5|||
154950230|NCT00863746|559243816|FG001|Treatment|Protocol Violation|3|||
154950231|NCT00863746|559243815|FG000|Treatment|Other|1|||
154950232|NCT00863746|559243816|FG001|Treatment|Other|0|||
154950233|NCT00863746|559243815|FG000|Survival Follow up|Death|244|||
154950234|NCT00863746|559243816|FG001|Survival Follow up|Death|271|||
154950235|NCT00863746|559243815|FG000|Survival Follow up|Lost to Follow-up|2|||
154950236|NCT00863746|559243816|FG001|Survival Follow up|Lost to Follow-up|1|||
154950237|NCT00863746|559243815|FG000|Survival Follow up|Consent Withdrawn|7|||
154950238|NCT00863746|559243816|FG001|Survival Follow up|Consent Withdrawn|8|||
154950239|NCT02473640|559243817|FG000|Treatment Period 1|Adverse Event|1|||
154950240|NCT02395822|559243818|FG000|Overall Study|Withdrawal by Subject|1|||
154950241|NCT02395822|559243818|FG000|Overall Study|Death|1|||
154950242|NCT02127281|559243819|FG000|Overall Study|Lost to Follow-up|1|||
154950243|NCT02127281|559243820|FG001|Overall Study|Lost to Follow-up|0|||
154950244|NCT03292653|559243823|FG000|Overall Study|Adverse Event|0|||
154950245|NCT03292653|559243824|FG001|Overall Study|Adverse Event|0|||
154950246|NCT03292653|559243825|FG002|Overall Study|Adverse Event|1|||
154950247|NCT03292653|559243823|FG000|Overall Study|Did not Receive Treatment|1|||
154950248|NCT03292653|559243824|FG001|Overall Study|Did not Receive Treatment|0|||
154950249|NCT03292653|559243825|FG002|Overall Study|Did not Receive Treatment|0|||
154950250|NCT04720664|559243826|FG000|Overall Study|Adverse Event|2|||
154950251|NCT04720664|559243826|FG000|Overall Study|Lack of Efficacy|9|||
154950252|NCT03103100|559243829|FG000|Overall Study|Adverse Event|1|||
154950253|NCT03103100|559243830|FG001|Overall Study|Adverse Event|0|||
154950254|NCT03103100|559243831|FG002|Overall Study|Adverse Event|0|||
154950255|NCT03103100|559243829|FG000|Overall Study|Physician Decision|1|||
154950256|NCT03103100|559243830|FG001|Overall Study|Physician Decision|0|||
154950257|NCT03103100|559243831|FG002|Overall Study|Physician Decision|2|||
154950258|NCT02906709|559243832|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
154950259|NCT02906709|559243833|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
154950260|NCT02906709|559243832|FG000|Phase A (Week 0 to Week 16)|Death|0|||
154950261|NCT02906709|559243833|FG001|Phase A (Week 0 to Week 16)|Death|1|||
154950262|NCT02906709|559243832|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
154950263|NCT02906709|559243833|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
155052932|NCT01386606|559625702|FG001|Overall Study|Unable to draw PK|0|||
155052933|NCT01386606|559625703|FG002|Overall Study|Unable to draw PK|0|||
155052934|NCT01386606|559625704|FG003|Overall Study|Unable to draw PK|0|||
155052935|NCT01386606|559625701|FG000|Overall Study|T levels too high|0|||
155052936|NCT01386606|559625702|FG001|Overall Study|T levels too high|1|||
155052937|NCT01386606|559625703|FG002|Overall Study|T levels too high|1|||
155052938|NCT01386606|559625704|FG003|Overall Study|T levels too high|0|||
155052939|NCT01548599|559625707|FG000|Overall Study|Lost to Follow-up|0|||
155052940|NCT01548599|559625708|FG001|Overall Study|Lost to Follow-up|1|||
155052941|NCT01548599|559625707|FG000|Overall Study|Withdrawal by Subject|4|||
155052942|NCT01548599|559625708|FG001|Overall Study|Withdrawal by Subject|0|||
155052943|NCT01548599|559625707|FG000|Overall Study|Death|2|||
155052944|NCT01548599|559625708|FG001|Overall Study|Death|1|||
155052945|NCT03638128|559625709|FG000|Overall Study|Withdrawal by Subject|1|||
155052946|NCT03638128|559625710|FG001|Overall Study|Withdrawal by Subject|7|||
155052947|NCT03638128|559625711|FG002|Overall Study|Withdrawal by Subject|6|||
155052948|NCT03638128|559625709|FG000|Overall Study|Sponsor Decision|15|||
155052949|NCT03638128|559625710|FG001|Overall Study|Sponsor Decision|12|||
155052950|NCT03638128|559625711|FG002|Overall Study|Sponsor Decision|19|||
155052951|NCT03638128|559625709|FG000|Overall Study|Lost to Follow-up|0|||
155052952|NCT03638128|559625710|FG001|Overall Study|Lost to Follow-up|0|||
155052953|NCT03638128|559625711|FG002|Overall Study|Lost to Follow-up|1|||
155052954|NCT00611806|559625712|FG000|Overall Study|Withdrawal by Subject|8|||
155052955|NCT00611806|559625713|FG001|Overall Study|Withdrawal by Subject|2|||
155052956|NCT00611806|559625712|FG000|Overall Study|Adverse Event|2|||
155052957|NCT00611806|559625713|FG001|Overall Study|Adverse Event|1|||
155052958|NCT00611806|559625712|FG000|Overall Study|Lost to Follow-up|6|||
155052959|NCT00611806|559625713|FG001|Overall Study|Lost to Follow-up|0|||
155052960|NCT00329108|559625715|FG000|Overall Study|Adverse Event|2|||
155052961|NCT00329108|559625716|FG001|Overall Study|Adverse Event|2|||
155052962|NCT00329108|559625715|FG000|Overall Study|Lack of Efficacy|3|||
155052963|NCT00329108|559625716|FG001|Overall Study|Lack of Efficacy|3|||
155052964|NCT00329108|559625715|FG000|Overall Study|Withdrawal by Subject|0|||
155052965|NCT00329108|559625716|FG001|Overall Study|Withdrawal by Subject|2|||
155052966|NCT00329108|559625715|FG000|Overall Study|symptomatic deterioration|1|||
155052967|NCT00329108|559625716|FG001|Overall Study|symptomatic deterioration|1|||
155052968|NCT00329108|559625715|FG000|Overall Study|Subject no longer willing to participate|2|||
155052969|NCT00329108|559625716|FG001|Overall Study|Subject no longer willing to participate|2|||
155052970|NCT00329108|559625715|FG000|Overall Study|study terminated by sponsor|1|||
154950264|NCT02906709|559243832|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
154950265|NCT02906709|559243833|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
154950266|NCT00920140|559243834|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
154950267|NCT00920140|559243835|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
154950268|NCT00920140|559243836|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
154950269|NCT00920140|559243837|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
154950270|NCT00920140|559243838|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
154950271|NCT00920140|559243834|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
154950272|NCT00920140|559243835|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
154950273|NCT00920140|559243836|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
154950274|NCT00920140|559243837|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
154950275|NCT00920140|559243838|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
154950276|NCT00920140|559243834|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
154950277|NCT00920140|559243835|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
154950278|NCT00920140|559243836|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
154950279|NCT00920140|559243837|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
154950280|NCT00920140|559243838|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
154950281|NCT00920140|559243834|FG000|Phase 2|Adverse Event|0|||
154950282|NCT00920140|559243835|FG001|Phase 2|Adverse Event|0|||
154950283|NCT00920140|559243836|FG002|Phase 2|Adverse Event|14|||
154950284|NCT00920140|559243837|FG003|Phase 2|Adverse Event|2|||
154950285|NCT00920140|559243838|FG004|Phase 2|Adverse Event|3|||
154950286|NCT00920140|559243834|FG000|Phase 2|Lack of Efficacy|0|||
154950287|NCT00920140|559243835|FG001|Phase 2|Lack of Efficacy|0|||
155052971|NCT00329108|559625716|FG001|Overall Study|study terminated by sponsor|0|||
155052972|NCT00329108|559625715|FG000|Overall Study|withdrew patient after SAE resolved|1|||
154950288|NCT00920140|559243836|FG002|Phase 2|Lack of Efficacy|29|||
155052973|NCT00329108|559625716|FG001|Overall Study|withdrew patient after SAE resolved|0|||
155052974|NCT00329108|559625715|FG000|Overall Study|Protocol Violation|0|||
155052975|NCT00329108|559625716|FG001|Overall Study|Protocol Violation|2|||
155052976|NCT00754741|559625717|FG000|Overall Study|Died or disenrolled|57|||
155052977|NCT00754741|559625718|FG001|Overall Study|Died or disenrolled|69|||
155052978|NCT00754741|559625719|FG002|Overall Study|Died or disenrolled|54|||
155052979|NCT04969289|559625721|FG000|Overall Study|Lost to Follow-up|13|||
155052980|NCT04969289|559625722|FG001|Overall Study|Lost to Follow-up|9|||
154950289|NCT00920140|559243837|FG003|Phase 2|Lack of Efficacy|14|||
154950290|NCT00920140|559243838|FG004|Phase 2|Lack of Efficacy|5|||
155052981|NCT00593814|559625723|FG000|Overall Study|Death|7|||
155052982|NCT00593814|559625724|FG001|Overall Study|Death|0|||
155052983|NCT00593814|559625723|FG000|Overall Study|Withdrawal by Subject|7|||
155052984|NCT00593814|559625724|FG001|Overall Study|Withdrawal by Subject|0|||
155052985|NCT00593814|559625723|FG000|Overall Study|Lost to Follow-up|7|||
155052986|NCT00593814|559625724|FG001|Overall Study|Lost to Follow-up|0|||
155052987|NCT00593814|559625723|FG000|Overall Study|Physician Decision|3|||
155052988|NCT00593814|559625724|FG001|Overall Study|Physician Decision|0|||
155052989|NCT01921517|559625725|FG000|Overall Study|Lost to Follow-up|5|||
155052990|NCT01921517|559625726|FG001|Overall Study|Lost to Follow-up|0|||
155052991|NCT01921517|559625725|FG000|Overall Study|Newly diagnosed health concern|2|||
155052992|NCT01921517|559625726|FG001|Overall Study|Newly diagnosed health concern|0|||
155052993|NCT01921517|559625725|FG000|Overall Study|Physician Decision|0|||
155052994|NCT01921517|559625726|FG001|Overall Study|Physician Decision|2|||
155052995|NCT01921517|559625725|FG000|Overall Study|Withdrawal by Subject|7|||
155052996|NCT01921517|559625726|FG001|Overall Study|Withdrawal by Subject|3|||
155052997|NCT01921517|559625725|FG000|Overall Study|Subject missed final imaging|1|||
155052998|NCT01921517|559625726|FG001|Overall Study|Subject missed final imaging|4|||
155052999|NCT02486692|559625732|FG000|Overall Study|did not login for randomization|4|||
154950291|NCT00920140|559243834|FG000|Phase 2|Lost to Follow-up|0|||
154950292|NCT00920140|559243835|FG001|Phase 2|Lost to Follow-up|0|||
154950293|NCT00920140|559243836|FG002|Phase 2|Lost to Follow-up|0|||
154950294|NCT00920140|559243837|FG003|Phase 2|Lost to Follow-up|1|||
154950295|NCT00920140|559243838|FG004|Phase 2|Lost to Follow-up|0|||
154950296|NCT00920140|559243834|FG000|Phase 2|Physician Decision|0|||
154950297|NCT00920140|559243835|FG001|Phase 2|Physician Decision|0|||
154950298|NCT00920140|559243836|FG002|Phase 2|Physician Decision|3|||
154950299|NCT00920140|559243837|FG003|Phase 2|Physician Decision|3|||
154950300|NCT00920140|559243838|FG004|Phase 2|Physician Decision|2|||
154950301|NCT00920140|559243834|FG000|Phase 2|Withdrawal by Subject|0|||
154950302|NCT00920140|559243835|FG001|Phase 2|Withdrawal by Subject|0|||
154950303|NCT00920140|559243836|FG002|Phase 2|Withdrawal by Subject|4|||
154950304|NCT00920140|559243837|FG003|Phase 2|Withdrawal by Subject|2|||
154950305|NCT00920140|559243838|FG004|Phase 2|Withdrawal by Subject|1|||
154950306|NCT01124149|559243839|FG000|Acute Phase|Withdrawal by Subject|22|||
154950307|NCT01124149|559243839|FG000|Acute Phase|Adverse Event|21|||
154950308|NCT01124149|559243839|FG000|Acute Phase|Lack of Efficacy|17|||
154950309|NCT01124149|559243839|FG000|Acute Phase|Protocol Violation|14|||
154950310|NCT01124149|559243839|FG000|Acute Phase|Lost to Follow-up|2|||
154950311|NCT01124149|559243839|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
154950312|NCT01124149|559243839|FG000|Acute Phase|Sponsor request|1|||
154950313|NCT01124149|559243839|FG000|Acute Phase|UC symptoms not ameliorated|1|||
154950314|NCT01124149|559243839|FG000|Acute Phase|Non-compliance|1|||
154950315|NCT01124149|559243839|FG000|Acute Phase|Low hemoglobin|1|||
154950316|NCT01124149|559243839|FG000|Acute Phase|Travelling to another country|1|||
154950317|NCT01124149|559243839|FG000|Acute Phase|Sponsor decision|1|||
154950318|NCT01124149|559243839|FG000|Maintenance Phase|Lack of Efficacy|40|||
154950319|NCT01124149|559243839|FG000|Maintenance Phase|Adverse Event|24|||
154950320|NCT01124149|559243839|FG000|Maintenance Phase|Lost to Follow-up|15|||
154950321|NCT01124149|559243839|FG000|Maintenance Phase|Withdrawal by Subject|10|||
154950322|NCT01124149|559243839|FG000|Maintenance Phase|Protocol Violation|5|||
154950323|NCT01124149|559243839|FG000|Maintenance Phase|Coordinator error|1|||
154950324|NCT01124149|559243839|FG000|Maintenance Phase|Non-compliance|1|||
154950325|NCT02460159|559243840|FG000|Overall Study|Adverse Event|4|||
154950326|NCT02460159|559243841|FG001|Overall Study|Adverse Event|1|||
154950327|NCT02460159|559243840|FG000|Overall Study|Withdrawal by Subject|2|||
154950328|NCT02460159|559243841|FG001|Overall Study|Withdrawal by Subject|0|||
154950329|NCT00243932|559243842|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
154950330|NCT00243932|559243843|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
154950331|NCT00243932|559243844|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
154950332|NCT05518487|559243845|FG000|Overall Study|Withdrawal by Subject|3|||
154950333|NCT01458405|559243848|FG000|Phase 1 (up to 12 Months)|Other|0|||
154950334|NCT01458405|559243849|FG001|Phase 1 (up to 12 Months)|Other|1|||
154950335|NCT01458405|559243850|FG002|Phase 1 (up to 12 Months)|Other|0|||
154950336|NCT01458405|559243851|FG003|Phase 1 (up to 12 Months)|Other|0|||
154950337|NCT01458405|559243848|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
154950338|NCT01458405|559243849|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
154950339|NCT01458405|559243850|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
154950340|NCT01458405|559243851|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
155053000|NCT02486692|559625733|FG001|Overall Study|did not login for randomization|7|||
155053001|NCT00116688|559625737|FG000|Overall Study|Protocol deviation|1|||
155053002|NCT00116688|559625738|FG001|Overall Study|Protocol deviation|0|||
155053003|NCT00116688|559625737|FG000|Overall Study|Noncompliance|3|||
154950341|NCT01458405|559243848|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
154950342|NCT01458405|559243849|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
154950343|NCT01458405|559243850|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
154950344|NCT01458405|559243851|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
154950345|NCT01458405|559243848|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
154950346|NCT01458405|559243849|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
155053004|NCT00116688|559625738|FG001|Overall Study|Noncompliance|1|||
155053005|NCT00116688|559625737|FG000|Overall Study|Adverse Event|11|||
155053006|NCT00116688|559625738|FG001|Overall Study|Adverse Event|0|||
155053007|NCT00116688|559625737|FG000|Overall Study|Withdrawal by Subject|26|||
155053008|NCT00116688|559625738|FG001|Overall Study|Withdrawal by Subject|2|||
155053009|NCT00116688|559625737|FG000|Overall Study|Requirement for alternative therapy|11|||
155053010|NCT00116688|559625738|FG001|Overall Study|Requirement for alternative therapy|1|||
155053011|NCT00116688|559625737|FG000|Overall Study|Physician Decision|7|||
155053012|NCT00116688|559625738|FG001|Overall Study|Physician Decision|0|||
155053013|NCT00116688|559625737|FG000|Overall Study|Lost to Follow-up|3|||
155053014|NCT00116688|559625738|FG001|Overall Study|Lost to Follow-up|0|||
155053015|NCT00116688|559625737|FG000|Overall Study|Death|15|||
155053016|NCT00116688|559625738|FG001|Overall Study|Death|0|||
155053017|NCT00116688|559625737|FG000|Overall Study|Protocol-specified criteria|3|||
155053018|NCT00116688|559625738|FG001|Overall Study|Protocol-specified criteria|0|||
155053019|NCT00116688|559625737|FG000|Overall Study|Pregnancy|1|||
155053020|NCT00116688|559625738|FG001|Overall Study|Pregnancy|0|||
155053021|NCT00116688|559625737|FG000|Overall Study|Other|11|||
155053022|NCT00116688|559625738|FG001|Overall Study|Other|0|||
155053023|NCT01775670|559625743|FG000|Overall Study|Lost to Follow-up|1|||
155053024|NCT01775670|559625744|FG001|Overall Study|Lost to Follow-up|1|||
155053025|NCT01298700|559625746|FG000|Overall Study|Adverse Event|50|||
155053026|NCT01298700|559625747|FG001|Overall Study|Adverse Event|51|||
155053027|NCT01298700|559625746|FG000|Overall Study|Lack of Efficacy|9|||
155053028|NCT01298700|559625747|FG001|Overall Study|Lack of Efficacy|14|||
155053029|NCT01298700|559625746|FG000|Overall Study|Lost to Follow-up|5|||
155053030|NCT01298700|559625747|FG001|Overall Study|Lost to Follow-up|2|||
155053031|NCT01298700|559625746|FG000|Overall Study|Withdrawal by Subject|12|||
155053032|NCT01298700|559625747|FG001|Overall Study|Withdrawal by Subject|9|||
155053033|NCT01298700|559625746|FG000|Overall Study|Protocol Violation|6|||
155053034|NCT01298700|559625747|FG001|Overall Study|Protocol Violation|4|||
155053035|NCT01298700|559625746|FG000|Overall Study|Other Miscellaneous Reasons|16|||
155053036|NCT01298700|559625747|FG001|Overall Study|Other Miscellaneous Reasons|15|||
155053037|NCT01298700|559625746|FG000|Overall Study|Did not Receive Study Drug|3|||
155053038|NCT01298700|559625747|FG001|Overall Study|Did not Receive Study Drug|5|||
155053039|NCT04006145|559625748|FG000|Overall Study|Lost to Follow-up|0|||
155053040|NCT04006145|559625749|FG001|Overall Study|Lost to Follow-up|1|||
155053041|NCT04006145|559625748|FG000|Overall Study|Other|1|||
155053042|NCT04006145|559625749|FG001|Overall Study|Other|2|||
154950347|NCT01458405|559243850|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
154950348|NCT01458405|559243851|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
154950349|NCT02497781|559243855|FG000|Overall Study|Withdrawal by Subject|2|||
154950350|NCT02497781|559243856|FG001|Overall Study|Withdrawal by Subject|0|||
154950351|NCT02497781|559243855|FG000|Overall Study|Lack of Efficacy|0|||
154950352|NCT02497781|559243856|FG001|Overall Study|Lack of Efficacy|1|||
154950353|NCT02497781|559243855|FG000|Overall Study|Randomised but not treated|1|||
154950354|NCT02497781|559243856|FG001|Overall Study|Randomised but not treated|1|||
154950355|NCT02497781|559243855|FG000|Overall Study|Lost to Follow-up|1|||
154950356|NCT02497781|559243856|FG001|Overall Study|Lost to Follow-up|1|||
154950357|NCT02674334|559243857|FG000|Overall Study|Lost to Follow-up|5|||
154950358|NCT02674334|559243858|FG001|Overall Study|Lost to Follow-up|3|||
154950359|NCT02674334|559243857|FG000|Overall Study|participant difficulty breathing|1|||
154950360|NCT02674334|559243858|FG001|Overall Study|participant difficulty breathing|0|||
154950361|NCT02674334|559243857|FG000|Overall Study|NIRS not recording|1|||
154950362|NCT02674334|559243858|FG001|Overall Study|NIRS not recording|0|||
154950363|NCT04257929|559243861|FG000|Overall Study|Adverse Event|1|||
154950364|NCT04257929|559243862|FG001|Overall Study|Adverse Event|0|||
154950365|NCT04257929|559243863|FG002|Overall Study|Adverse Event|1|||
154950366|NCT04257929|559243861|FG000|Overall Study|Withdrawal by Subject|1|||
154950367|NCT04257929|559243862|FG001|Overall Study|Withdrawal by Subject|0|||
154950368|NCT04257929|559243863|FG002|Overall Study|Withdrawal by Subject|0|||
154950369|NCT04257929|559243861|FG000|Overall Study|COVID-19|0|||
154950370|NCT04257929|559243862|FG001|Overall Study|COVID-19|1|||
154950371|NCT04257929|559243863|FG002|Overall Study|COVID-19|1|||
154950372|NCT04257929|559243861|FG000|Overall Study|Lost to Follow-up|0|||
154950373|NCT04257929|559243862|FG001|Overall Study|Lost to Follow-up|0|||
155053043|NCT01001429|559625750|FG000|Overall Study|surgery cancelled|0|||
154950374|NCT04257929|559243863|FG002|Overall Study|Lost to Follow-up|1|||
154950375|NCT05630547|559243864|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
155053044|NCT01001429|559625751|FG001|Overall Study|surgery cancelled|1|||
155053045|NCT00010257|559625754|FG000|Overall Study|Withdrawal by Subject|1|||
155053046|NCT00010257|559625755|FG001|Overall Study|Withdrawal by Subject|0|||
154950376|NCT05630547|559243865|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
155053047|NCT02063672|559625759|FG000|Overall Study|Ongoing Follow-up|27|||
155053048|NCT02063672|559625760|FG001|Overall Study|Ongoing Follow-up|14|||
155053049|NCT02063672|559625759|FG000|Overall Study|Death|5|||
155053050|NCT02063672|559625760|FG001|Overall Study|Death|3|||
155053051|NCT02063672|559625759|FG000|Overall Study|Lost to Follow-up|1|||
155053052|NCT02063672|559625760|FG001|Overall Study|Lost to Follow-up|3|||
155053053|NCT02063672|559625759|FG000|Overall Study|Withdrawal by Subject|2|||
155053054|NCT02063672|559625760|FG001|Overall Study|Withdrawal by Subject|2|||
155053055|NCT01307787|559625762|FG000|Overall Study|Withdrawal by Subject|2|||
155053056|NCT01307787|559625763|FG001|Overall Study|Withdrawal by Subject|0|||
155053057|NCT00789321|559625767|FG000|Overall Study|Adverse Event|0|||
155153052|NCT00419393|559998524|FG000|Overall Study|Withdrawal by Subject|7|||
155153053|NCT00419393|559998524|FG000|Overall Study|Other: Sponsor request|3|||
155153054|NCT00419393|559998524|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
155153055|NCT00419393|559998524|FG000|Overall Study|Other: Site closure|1|||
155153056|NCT00419393|559998524|FG000|Overall Study|Other: Other health problems|1|||
155153057|NCT00419393|559998524|FG000|Overall Study|Other: Investigator decision|1|||
155153058|NCT03103542|559998532|FG000|Overall Study|Physician Decision|2|||
155153059|NCT03103542|559998532|FG000|Overall Study|Adverse Event|2|||
155153060|NCT03103542|559998532|FG000|Overall Study|Other|2|||
155153061|NCT03103542|559998532|FG000|Overall Study|Withdrawal by Subject|1|||
155153062|NCT02939287|559998536|FG000|Overall Study|met exclusion criteria|1|||
155153063|NCT02939287|559998537|FG001|Overall Study|met exclusion criteria|1|||
155153064|NCT02939287|559998538|FG002|Overall Study|met exclusion criteria|1|||
155153065|NCT02939287|559998536|FG000|Overall Study|Did not complete survey|2|||
155153066|NCT02939287|559998537|FG001|Overall Study|Did not complete survey|2|||
155153067|NCT02939287|559998538|FG002|Overall Study|Did not complete survey|0|||
155153068|NCT02939287|559998536|FG000|Overall Study|Withdrawal by Subject|1|||
155153069|NCT02939287|559998537|FG001|Overall Study|Withdrawal by Subject|1|||
154950377|NCT05630547|559243866|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
154950378|NCT05630547|559243867|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
154950379|NCT05630547|559243864|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
154950380|NCT05630547|559243865|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
154950381|NCT05630547|559243866|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
154950382|NCT05630547|559243867|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
154950383|NCT05630547|559243864|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
154950384|NCT05630547|559243865|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
154950385|NCT05630547|559243866|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
154950386|NCT05630547|559243867|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
154950387|NCT05630547|559243864|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
154950388|NCT05630547|559243865|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
154950389|NCT05630547|559243866|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
154950390|NCT05630547|559243867|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
154950391|NCT05630547|559243864|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
154950392|NCT05630547|559243865|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
154950393|NCT05630547|559243866|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
154950394|NCT05630547|559243867|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
154950395|NCT05630547|559243864|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
154950396|NCT05630547|559243865|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
154950397|NCT05630547|559243866|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
154950398|NCT05630547|559243867|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
154950399|NCT05630547|559243864|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
154950400|NCT05630547|559243865|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
154950401|NCT05630547|559243866|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
154950402|NCT05630547|559243867|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
154950403|NCT05630547|559243864|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
154950404|NCT05630547|559243865|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
154950405|NCT05630547|559243866|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
154950406|NCT05630547|559243867|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
154950407|NCT05630547|559243864|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
154950408|NCT05630547|559243865|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
154950409|NCT05630547|559243866|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
154950410|NCT05630547|559243867|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
154950411|NCT05630547|559243864|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
154950412|NCT05630547|559243865|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
155053058|NCT00789321|559625768|FG001|Overall Study|Adverse Event|1|||
155153070|NCT02939287|559998538|FG002|Overall Study|Withdrawal by Subject|0|||
155153071|NCT05365217|559998542|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155153072|NCT05365217|559998543|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155153073|NCT03796728|559998547|FG000|Overall Study|Lost to Follow-up|8|||
155153074|NCT03796728|559998547|FG000|Overall Study|Reason not Specified|16|||
155153075|NCT00333775|559998548|FG000|Overall Study|Death|144|||
155153076|NCT00333775|559998549|FG001|Overall Study|Death|149|||
155153077|NCT00333775|559998550|FG002|Overall Study|Death|143|||
155153078|NCT00333775|559998548|FG000|Overall Study|In Follow-up When Study Stopped|87|||
155053059|NCT00104052|559625769|FG000|Overall Study|Adverse Event|1|||
155053060|NCT00104052|559625769|FG000|Overall Study|Lack of Efficacy|26|||
155053061|NCT00104052|559625769|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
155053062|NCT01294423|559625773|FG000|Overall Study|Adverse Event|1|||
155053063|NCT01294423|559625774|FG001|Overall Study|Adverse Event|2|||
155053064|NCT01294423|559625775|FG002|Overall Study|Adverse Event|3|||
155053065|NCT01294423|559625773|FG000|Overall Study|Withdrawal by Subject|1|||
155053066|NCT01294423|559625774|FG001|Overall Study|Withdrawal by Subject|2|||
155053067|NCT01294423|559625775|FG002|Overall Study|Withdrawal by Subject|2|||
155053068|NCT01294423|559625773|FG000|Overall Study|subject no longer meets study criteria|2|||
155053069|NCT01294423|559625774|FG001|Overall Study|subject no longer meets study criteria|5|||
155053070|NCT01294423|559625775|FG002|Overall Study|subject no longer meets study criteria|2|||
155053071|NCT01294423|559625773|FG000|Overall Study|poor/non-compliance|1|||
155053072|NCT01294423|559625774|FG001|Overall Study|poor/non-compliance|0|||
155053073|NCT01294423|559625775|FG002|Overall Study|poor/non-compliance|1|||
155053074|NCT01145482|559625776|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155053075|NCT01145482|559625777|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155053076|NCT01699750|559625782|FG000|Overall Study|Withdrew Consent|0|||
155053077|NCT01699750|559625783|FG001|Overall Study|Withdrew Consent|1|||
155053078|NCT01699750|559625782|FG000|Overall Study|Other|0|||
155053079|NCT01699750|559625783|FG001|Overall Study|Other|2|||
155053080|NCT01484951|559625784|FG000|Overall Study|Adverse Event|3|||
155053081|NCT01484951|559625784|FG000|Overall Study|Personal Reasons|1|||
155053082|NCT01484951|559625784|FG000|Overall Study|Non-Compliance|1|||
155053083|NCT03933449|559625789|FG000|Overall Study|Adverse Event|6|||
155053084|NCT03933449|559625790|FG001|Overall Study|Adverse Event|4|||
155053085|NCT03933449|559625789|FG000|Overall Study|Death|55|||
155053086|NCT03933449|559625790|FG001|Overall Study|Death|57|||
155053087|NCT03933449|559625789|FG000|Overall Study|Sponsor Decision|1|||
155053088|NCT03933449|559625790|FG001|Overall Study|Sponsor Decision|0|||
155053089|NCT02087774|559625791|FG000|Overall Study|Were absent day of data collection|8|||
155053090|NCT02087774|559625792|FG001|Overall Study|Were absent day of data collection|20|||
155053091|NCT01601496|559625795|FG000|Overall Study|Physician Decision|1|||
155053092|NCT01601496|559625795|FG000|Overall Study|Withdrawal by Subject|1|||
155053093|NCT01601496|559625795|FG000|Overall Study|Lost to Follow-up|6|||
155053094|NCT01601496|559625795|FG000|Overall Study|Death|4|||
155053095|NCT01601496|559625795|FG000|Overall Study|Other: patient refusal to continue|3|||
155053096|NCT02689804|559625796|FG000|Overall Study|Withdrawal by Subject|2|||
155053097|NCT02689804|559625797|FG001|Overall Study|Withdrawal by Subject|0|||
155053098|NCT00227539|559625798|FG000|Overall Study|Protocol Violation|1|||
155053099|NCT02600923|559625802|FG000|Overall Study|Death|10|||
155053100|NCT02600923|559625802|FG000|Overall Study|Adverse Event|3|||
155053101|NCT02600923|559625802|FG000|Overall Study|Global deterioration of health status|2|||
155053102|NCT02600923|559625802|FG000|Overall Study|Insufficient clinical response|6|||
155053103|NCT02600923|559625802|FG000|Overall Study|Lost to Follow-up|1|||
155053104|NCT02600923|559625802|FG000|Overall Study|Withdrawal by Subject|5|||
155053105|NCT02600923|559625802|FG000|Overall Study|Objective progression or relapse|50|||
155053106|NCT02600923|559625802|FG000|Overall Study|Study terminated by Sponsor|53|||
155053107|NCT02600923|559625802|FG000|Overall Study|Not treated|1|||
155053108|NCT00385918|559625804|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
155053109|NCT00385918|559625805|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
155053110|NCT00385918|559625806|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
155053111|NCT00385918|559625804|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
155053112|NCT00385918|559625805|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
155053113|NCT00385918|559625806|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
155053114|NCT00385918|559625804|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
155053115|NCT00385918|559625805|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
155053116|NCT00385918|559625806|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
155053117|NCT00385918|559625804|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
155283246|NCT00333138|560468260|FG001|Extension Study (Month6 to End of Study)|Death|1|||
155283247|NCT00333138|560468261|FG002|Extension Study (Month6 to End of Study)|Death|0|||
155283248|NCT03005288|560468262|FG000|Overall Study|Withdrawal by Subject|7|||
155283249|NCT03005288|560468263|FG001|Overall Study|Withdrawal by Subject|5|||
155283250|NCT03005288|560468262|FG000|Overall Study|Lost to Follow-up|0|||
155283251|NCT03005288|560468263|FG001|Overall Study|Lost to Follow-up|1|||
155053118|NCT00385918|559625805|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
155053119|NCT00385918|559625806|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
155053120|NCT00385918|559625804|FG000|Intervention Phase After Randomization|Physician Decision|1|||
155053121|NCT00385918|559625805|FG001|Intervention Phase After Randomization|Physician Decision|0|||
155053122|NCT00385918|559625806|FG002|Intervention Phase After Randomization|Physician Decision|0|||
155053123|NCT00385918|559625804|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
155053124|NCT00385918|559625805|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
155283252|NCT03005288|560468262|FG000|Overall Study|Adverse Event|5|||
155053125|NCT00385918|559625806|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
155053126|NCT00128661|559625807|FG000|Overall Study|Adverse Event|14|||
155053127|NCT00128661|559625808|FG001|Overall Study|Adverse Event|11|||
155053128|NCT00128661|559625807|FG000|Overall Study|Lost to Follow-up|10|||
155053129|NCT00128661|559625808|FG001|Overall Study|Lost to Follow-up|7|||
155053130|NCT00128661|559625807|FG000|Overall Study|Withdrawal by Subject|243|||
155053131|NCT00128661|559625808|FG001|Overall Study|Withdrawal by Subject|232|||
155053132|NCT00128661|559625807|FG000|Overall Study|Other|7|||
155053133|NCT00128661|559625808|FG001|Overall Study|Other|8|||
155053134|NCT02782741|559625809|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
155053135|NCT02782741|559625810|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
155053136|NCT02782741|559625811|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
155053137|NCT02782741|559625809|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
155053138|NCT02782741|559625810|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
155053139|NCT02782741|559625811|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
155053140|NCT02782741|559625809|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
155053141|NCT02782741|559625810|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
155053142|NCT02782741|559625811|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
155053143|NCT02782741|559625809|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
155053144|NCT02782741|559625810|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
155053145|NCT02782741|559625811|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
155053146|NCT02782741|559625809|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
155053147|NCT02782741|559625810|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
155053148|NCT02782741|559625811|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
155053149|NCT04157088|559625812|FG000|Overall Study|Study terminated by sponsor|23|||
155053150|NCT04157088|559625812|FG000|Overall Study|Withdrawal by Subject|4|||
155053151|NCT04157088|559625812|FG000|Overall Study|Lost to Follow-up|2|||
155053152|NCT04157088|559625812|FG000|Overall Study|Death|1|||
155053153|NCT02421419|559625813|FG000|Overall Study|Physician Decision|0|||
155053154|NCT02421419|559625814|FG001|Overall Study|Physician Decision|0|||
155053155|NCT02421419|559625815|FG002|Overall Study|Physician Decision|1|||
155053156|NCT01676701|559625817|FG000|Overall Study|Protocol Violation|1|||
155053157|NCT01676701|559625818|FG001|Overall Study|Protocol Violation|0|||
155053158|NCT01676701|559625817|FG000|Overall Study|Sponsor Decision|3|||
155053159|NCT01676701|559625818|FG001|Overall Study|Sponsor Decision|4|||
155053160|NCT04863872|559625819|FG000|Overall Study|Withdrawal by Subject|4|||
155053161|NCT04863872|559625820|FG001|Overall Study|Withdrawal by Subject|15|||
155053162|NCT04863872|559625819|FG000|Overall Study|Death|5|||
155053163|NCT04863872|559625820|FG001|Overall Study|Death|2|||
155053164|NCT04863872|559625819|FG000|Overall Study|Lost to Follow-up|2|||
155053165|NCT04863872|559625820|FG001|Overall Study|Lost to Follow-up|1|||
155053166|NCT01497067|559625821|FG000|Overall Study|Lost to Follow-up|56|||
155053167|NCT01497067|559625821|FG000|Overall Study|Adverse Event|3|||
155053168|NCT01497067|559625821|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
155053169|NCT01497067|559625821|FG000|Overall Study|Other|13|||
155053170|NCT04058028|559625825|FG000|Overall Study|Withdrawal of Consent from Study|12|||
155053171|NCT04058028|559625826|FG001|Overall Study|Withdrawal of Consent from Study|8|||
155053172|NCT04058028|559625827|FG002|Overall Study|Withdrawal of Consent from Study|6|||
155053173|NCT04058028|559625828|FG003|Overall Study|Withdrawal of Consent from Study|7|||
155053174|NCT04058028|559625825|FG000|Overall Study|Decision by Sponsor|13|||
155053175|NCT04058028|559625826|FG001|Overall Study|Decision by Sponsor|4|||
155053176|NCT04058028|559625827|FG002|Overall Study|Decision by Sponsor|1|||
155053177|NCT04058028|559625828|FG003|Overall Study|Decision by Sponsor|35|||
155283253|NCT03005288|560468263|FG001|Overall Study|Adverse Event|0|||
155283254|NCT03005288|560468262|FG000|Overall Study|Protocol deviation|0|||
155053178|NCT04058028|559625825|FG000|Overall Study|Lost to Follow-up|1|||
155053179|NCT04058028|559625826|FG001|Overall Study|Lost to Follow-up|1|||
155053180|NCT04058028|559625827|FG002|Overall Study|Lost to Follow-up|1|||
155053181|NCT04058028|559625828|FG003|Overall Study|Lost to Follow-up|0|||
155053182|NCT04058028|559625825|FG000|Overall Study|Death|0|||
155053183|NCT04058028|559625826|FG001|Overall Study|Death|1|||
155283255|NCT03005288|560468263|FG001|Overall Study|Protocol deviation|1|||
155283256|NCT03005288|560468262|FG000|Overall Study|Physician Decision|0|||
155283257|NCT03005288|560468263|FG001|Overall Study|Physician Decision|1|||
155283258|NCT04438785|560468264|FG000|Overall Study|change of weight, give up intervention|2|||
155283259|NCT04438785|560468265|FG001|Overall Study|change of weight, give up intervention|10|||
155283260|NCT04011033|560468266|FG000|Overall Study|Physician Decision|2|||
155283261|NCT04011033|560468267|FG001|Overall Study|Physician Decision|3|||
155393575|NCT01132612|560876797|FG000|Overall Study|Lost to Follow-up|2|||
155053184|NCT04058028|559625827|FG002|Overall Study|Death|0|||
155053185|NCT04058028|559625828|FG003|Overall Study|Death|0|||
155053186|NCT02227784|559625829|FG000|Double-Blind Phase|Adverse Event|3|||
155053187|NCT02227784|559625830|FG001|Double-Blind Phase|Adverse Event|2|||
155053188|NCT02227784|559625831|FG002|Double-Blind Phase|Adverse Event|1|||
155053189|NCT02227784|559625832|FG003|Double-Blind Phase|Adverse Event|3|||
155393576|NCT01132612|560876798|FG001|Overall Study|Lost to Follow-up|2|||
155053190|NCT02227784|559625833|FG004|Double-Blind Phase|Adverse Event|0|||
155053191|NCT02227784|559625829|FG000|Double-Blind Phase|Physician Decision|1|||
155053192|NCT02227784|559625830|FG001|Double-Blind Phase|Physician Decision|0|||
155053193|NCT02227784|559625831|FG002|Double-Blind Phase|Physician Decision|0|||
155053194|NCT02227784|559625832|FG003|Double-Blind Phase|Physician Decision|1|||
155053195|NCT02227784|559625833|FG004|Double-Blind Phase|Physician Decision|0|||
155053196|NCT02227784|559625829|FG000|Double-Blind Phase|Protocol Violation|0|||
155053197|NCT02227784|559625830|FG001|Double-Blind Phase|Protocol Violation|0|||
155053198|NCT02227784|559625831|FG002|Double-Blind Phase|Protocol Violation|1|||
155053199|NCT02227784|559625832|FG003|Double-Blind Phase|Protocol Violation|1|||
155053200|NCT02227784|559625833|FG004|Double-Blind Phase|Protocol Violation|0|||
155053201|NCT02227784|559625829|FG000|Double-Blind Phase|Sponsor Decision|34|||
155053202|NCT02227784|559625830|FG001|Double-Blind Phase|Sponsor Decision|15|||
155053203|NCT02227784|559625831|FG002|Double-Blind Phase|Sponsor Decision|14|||
155053204|NCT02227784|559625832|FG003|Double-Blind Phase|Sponsor Decision|32|||
155053205|NCT02227784|559625833|FG004|Double-Blind Phase|Sponsor Decision|0|||
155053206|NCT02227784|559625829|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155053207|NCT02227784|559625830|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
155053208|NCT02227784|559625831|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
155053209|NCT02227784|559625832|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
155053210|NCT02227784|559625833|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155053211|NCT02227784|559625829|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155053212|NCT02227784|559625830|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155053213|NCT02227784|559625831|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155053214|NCT02227784|559625832|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
155053215|NCT02227784|559625833|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
155053216|NCT02227784|559625829|FG000|Open-Label Extension Phase (OLE)|Death|0|||
155053217|NCT02227784|559625830|FG001|Open-Label Extension Phase (OLE)|Death|0|||
155053218|NCT02227784|559625831|FG002|Open-Label Extension Phase (OLE)|Death|0|||
155053219|NCT02227784|559625832|FG003|Open-Label Extension Phase (OLE)|Death|0|||
155053220|NCT02227784|559625833|FG004|Open-Label Extension Phase (OLE)|Death|1|||
155053221|NCT02227784|559625829|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155053222|NCT02227784|559625830|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155053223|NCT02227784|559625831|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155053224|NCT02227784|559625832|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155053225|NCT02227784|559625833|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
155053226|NCT02227784|559625829|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155053227|NCT02227784|559625830|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155053228|NCT02227784|559625831|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155053229|NCT02227784|559625832|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
155053230|NCT02227784|559625833|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
155053231|NCT00102596|559625834|FG000|Part A|Screen failures|6|||
155053232|NCT00102596|559625835|FG001|Part A|Screen failures|0|||
155053233|NCT00102596|559625834|FG000|Part A|Adverse Event|1|||
155053234|NCT00102596|559625835|FG001|Part A|Adverse Event|0|||
155053235|NCT00248651|559625836|FG000|Overall Study|Withdrawal by Subject|28|||
155053236|NCT00248651|559625837|FG001|Overall Study|Withdrawal by Subject|40|||
155053237|NCT00248651|559625838|FG002|Overall Study|Withdrawal by Subject|32|||
155053238|NCT01275144|559625841|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
155053239|NCT01275144|559625842|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
155053240|NCT00828113|559625843|FG000|Overall Study|Withdrawal by Subject|27|||
155053241|NCT00828113|559625844|FG001|Overall Study|Withdrawal by Subject|26|||
155053242|NCT00828113|559625843|FG000|Overall Study|Lost to Follow-up|3|||
155053243|NCT00828113|559625844|FG001|Overall Study|Lost to Follow-up|5|||
155053244|NCT01365130|559625845|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
155053245|NCT05607576|559625846|FG000|Overall Study|immediate sensor error|2|||
155053246|NCT05607576|559625846|FG000|Overall Study|Physician Decision|2|||
155053247|NCT05116202|559625847|FG000|Overall Study|Study Terminated by Sponsor|21|||
155053248|NCT05116202|559625848|FG001|Overall Study|Study Terminated by Sponsor|38|||
155053249|NCT05116202|559625849|FG002|Overall Study|Study Terminated by Sponsor|17|||
155053250|NCT05116202|559625850|FG003|Overall Study|Study Terminated by Sponsor|18|||
155053251|NCT05116202|559625851|FG004|Overall Study|Study Terminated by Sponsor|0|||
155053252|NCT05116202|559625847|FG000|Overall Study|Withdrawal by Subject|0|||
155053253|NCT05116202|559625848|FG001|Overall Study|Withdrawal by Subject|1|||
155053254|NCT05116202|559625849|FG002|Overall Study|Withdrawal by Subject|1|||
155053255|NCT05116202|559625850|FG003|Overall Study|Withdrawal by Subject|1|||
155053256|NCT05116202|559625851|FG004|Overall Study|Withdrawal by Subject|1|||
155053257|NCT05116202|559625847|FG000|Overall Study|Lost to Follow-up|0|||
155053258|NCT05116202|559625848|FG001|Overall Study|Lost to Follow-up|0|||
155053259|NCT05116202|559625849|FG002|Overall Study|Lost to Follow-up|0|||
155053260|NCT05116202|559625850|FG003|Overall Study|Lost to Follow-up|0|||
155053261|NCT05116202|559625851|FG004|Overall Study|Lost to Follow-up|2|||
155053262|NCT05116202|559625847|FG000|Overall Study|Death|1|||
155053263|NCT05116202|559625848|FG001|Overall Study|Death|1|||
155053264|NCT05116202|559625849|FG002|Overall Study|Death|2|||
155053265|NCT05116202|559625850|FG003|Overall Study|Death|1|||
155053266|NCT05116202|559625851|FG004|Overall Study|Death|5|||
155053267|NCT05067972|559625852|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
155053268|NCT05067972|559625853|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
155053269|NCT05067972|559625854|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
155053270|NCT05067972|559625855|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
155053271|NCT05067972|559625856|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
155053272|NCT05067972|559625857|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
155053273|NCT05067972|559625858|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
155053274|NCT05067972|559625852|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
155053275|NCT05067972|559625853|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
155053276|NCT05067972|559625854|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
155053277|NCT05067972|559625855|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
155053278|NCT05067972|559625856|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
155053279|NCT05067972|559625857|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
155053280|NCT05067972|559625858|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
155053281|NCT05067972|559625852|FG000|Part 1: Treatment|Progressive Disease|3|||
155053282|NCT05067972|559625853|FG001|Part 1: Treatment|Progressive Disease|3|||
155053283|NCT05067972|559625854|FG002|Part 1: Treatment|Progressive Disease|4|||
155053284|NCT05067972|559625855|FG003|Part 1: Treatment|Progressive Disease|2|||
155053285|NCT05067972|559625856|FG004|Part 1: Treatment|Progressive Disease|3|||
155053286|NCT05067972|559625857|FG005|Part 1: Treatment|Progressive Disease|0|||
155053287|NCT05067972|559625858|FG006|Part 1: Treatment|Progressive Disease|2|||
155053288|NCT05067972|559625852|FG000|Part 1: Treatment|Physician Decision|0|||
155053289|NCT05067972|559625853|FG001|Part 1: Treatment|Physician Decision|0|||
155053290|NCT05067972|559625854|FG002|Part 1: Treatment|Physician Decision|0|||
155053291|NCT05067972|559625855|FG003|Part 1: Treatment|Physician Decision|1|||
155053292|NCT05067972|559625856|FG004|Part 1: Treatment|Physician Decision|0|||
155053293|NCT05067972|559625857|FG005|Part 1: Treatment|Physician Decision|0|||
155053294|NCT05067972|559625858|FG006|Part 1: Treatment|Physician Decision|0|||
155053295|NCT05067972|559625852|FG000|Part 1: Treatment|Death|0|||
155053296|NCT05067972|559625853|FG001|Part 1: Treatment|Death|0|||
155053297|NCT05067972|559625854|FG002|Part 1: Treatment|Death|0|||
155053298|NCT05067972|559625855|FG003|Part 1: Treatment|Death|2|||
155053299|NCT05067972|559625856|FG004|Part 1: Treatment|Death|0|||
155053300|NCT05067972|559625857|FG005|Part 1: Treatment|Death|0|||
155053301|NCT05067972|559625858|FG006|Part 1: Treatment|Death|0|||
155053302|NCT05067972|559625852|FG000|Part 1: Treatment|Adverse Event|0|||
155053303|NCT05067972|559625853|FG001|Part 1: Treatment|Adverse Event|0|||
155053304|NCT05067972|559625854|FG002|Part 1: Treatment|Adverse Event|0|||
155053305|NCT05067972|559625855|FG003|Part 1: Treatment|Adverse Event|0|||
155053306|NCT05067972|559625856|FG004|Part 1: Treatment|Adverse Event|0|||
155053307|NCT05067972|559625857|FG005|Part 1: Treatment|Adverse Event|2|||
155053308|NCT05067972|559625858|FG006|Part 1: Treatment|Adverse Event|1|||
155053309|NCT05067972|559625852|FG000|Part 1: Follow-up|Adverse Event|0|||
155053310|NCT05067972|559625853|FG001|Part 1: Follow-up|Adverse Event|0|||
155053311|NCT05067972|559625854|FG002|Part 1: Follow-up|Adverse Event|0|||
155053312|NCT05067972|559625855|FG003|Part 1: Follow-up|Adverse Event|0|||
155053313|NCT05067972|559625856|FG004|Part 1: Follow-up|Adverse Event|0|||
155053314|NCT05067972|559625857|FG005|Part 1: Follow-up|Adverse Event|1|||
155053315|NCT05067972|559625858|FG006|Part 1: Follow-up|Adverse Event|0|||
155053316|NCT05067972|559625852|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
155053317|NCT05067972|559625853|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
155053318|NCT05067972|559625854|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
155053319|NCT05067972|559625855|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
155053320|NCT05067972|559625856|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
155053321|NCT05067972|559625857|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
155283262|NCT04011033|560468266|FG000|Overall Study|Withdrawal by Subject|1|||
155283263|NCT04011033|560468267|FG001|Overall Study|Withdrawal by Subject|0|||
155283264|NCT02027935|560468268|FG000|Overall Study|Death|1|||
155283265|NCT02027935|560468268|FG000|Overall Study|Lack of Efficacy|5|||
155283266|NCT02027935|560468268|FG000|Overall Study|Study Closure|1|||
155283267|NCT04873817|560468269|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
155283268|NCT04873817|560468269|FG000|Overall Study|Lost to Follow-up|4|||
155283269|NCT04873817|560468269|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
155283270|NCT04873817|560468269|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
155053322|NCT05067972|559625858|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
155053323|NCT05067972|559625852|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155053324|NCT05067972|559625853|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155053325|NCT05067972|559625854|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155053326|NCT05067972|559625855|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155053327|NCT05067972|559625856|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155053328|NCT05067972|559625857|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
155053329|NCT05067972|559625858|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
155283271|NCT04873817|560468269|FG000|Overall Study|Other Reasons|3|||
155053330|NCT05067972|559625852|FG000|Part 1: Follow-up|Physician Decision|0|||
155053331|NCT05067972|559625853|FG001|Part 1: Follow-up|Physician Decision|0|||
155053332|NCT05067972|559625854|FG002|Part 1: Follow-up|Physician Decision|0|||
155053333|NCT05067972|559625855|FG003|Part 1: Follow-up|Physician Decision|1|||
155053334|NCT05067972|559625856|FG004|Part 1: Follow-up|Physician Decision|0|||
155053335|NCT05067972|559625857|FG005|Part 1: Follow-up|Physician Decision|0|||
155053336|NCT05067972|559625858|FG006|Part 1: Follow-up|Physician Decision|0|||
155053337|NCT05067972|559625852|FG000|Part 1: Follow-up|Death|1|||
155053338|NCT05067972|559625853|FG001|Part 1: Follow-up|Death|2|||
155053339|NCT05067972|559625854|FG002|Part 1: Follow-up|Death|1|||
155053340|NCT05067972|559625855|FG003|Part 1: Follow-up|Death|0|||
155053341|NCT05067972|559625856|FG004|Part 1: Follow-up|Death|1|||
155053342|NCT05067972|559625857|FG005|Part 1: Follow-up|Death|0|||
155053343|NCT05067972|559625858|FG006|Part 1: Follow-up|Death|1|||
155053344|NCT04888494|559625865|FG000|Overall Study|Lost to Follow-up|2|||
155053345|NCT04888494|559625866|FG001|Overall Study|Lost to Follow-up|3|||
155053346|NCT04888494|559625865|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
155053347|NCT04888494|559625866|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
155053348|NCT02357459|559627835|FG000|Overall Study|Adverse Event|0|||
154950413|NCT05630547|559243866|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
154950414|NCT05630547|559243867|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
154950415|NCT03257462|559243870|FG000|Cohort A|Lost to Follow-up|1|||
154950416|NCT03257462|559243871|FG001|Cohort A|Lost to Follow-up|0|||
154950417|NCT03257462|559243872|FG002|Cohort A|Lost to Follow-up|0|||
154950418|NCT03257462|559243873|FG003|Cohort A|Lost to Follow-up|0|||
154950419|NCT03257462|559243870|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
154950420|NCT03257462|559243871|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
154950421|NCT03257462|559243872|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
154950422|NCT03257462|559243873|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
154950423|NCT00796822|559243874|FG000|Overall Study|Lost to Follow-up|2|||
154950424|NCT00796822|559243875|FG001|Overall Study|Lost to Follow-up|0|||
154950425|NCT00796822|559243874|FG000|Overall Study|Adverse Event|1|||
154950426|NCT00796822|559243875|FG001|Overall Study|Adverse Event|0|||
154950427|NCT00368277|559243876|FG000|Overall Study|Adverse Event|33|||
154950428|NCT00368277|559243877|FG001|Overall Study|Adverse Event|49|||
154950429|NCT00368277|559243876|FG000|Overall Study|Death|2|||
154950430|NCT00368277|559243877|FG001|Overall Study|Death|1|||
154950431|NCT00368277|559243876|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
154950432|NCT00368277|559243877|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
154950433|NCT00368277|559243876|FG000|Overall Study|Protocol deviation|7|||
154950434|NCT00368277|559243877|FG001|Overall Study|Protocol deviation|0|||
154950435|NCT00368277|559243876|FG000|Overall Study|Patient withdrew consent|32|||
154950436|NCT00368277|559243877|FG001|Overall Study|Patient withdrew consent|28|||
154950437|NCT00368277|559243876|FG000|Overall Study|Lost to Follow-up|8|||
154950438|NCT00368277|559243877|FG001|Overall Study|Lost to Follow-up|6|||
154950439|NCT03978624|559243878|FG000|Overall Study|Protocol Violation|1|||
154950440|NCT03978624|559243879|FG001|Overall Study|Protocol Violation|0|||
154950441|NCT05097989|559243880|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950442|NCT05097989|559243881|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950443|NCT05097989|559243882|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950444|NCT05097989|559243883|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950445|NCT05097989|559243884|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950446|NCT05097989|559243885|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
154950447|NCT05097989|559243886|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950448|NCT05097989|559243887|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950449|NCT05097989|559243888|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
154950450|NCT05097989|559243880|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
154950451|NCT05097989|559243881|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
154950452|NCT05097989|559243882|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
154950453|NCT05097989|559243883|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
154950454|NCT05097989|559243884|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
154950455|NCT05097989|559243885|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
154950456|NCT05097989|559243886|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
154950457|NCT05097989|559243887|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
154950458|NCT05097989|559243888|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
154950459|NCT05097989|559243880|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
154950460|NCT05097989|559243881|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
154950461|NCT05097989|559243882|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
154950462|NCT05097989|559243883|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
154950463|NCT05097989|559243884|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
155053349|NCT02357459|559627836|FG001|Overall Study|Adverse Event|1|||
154950464|NCT05097989|559243885|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
154950465|NCT05097989|559243886|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
155053350|NCT02357459|559627837|FG002|Overall Study|Adverse Event|1|||
155053351|NCT02357459|559627835|FG000|Overall Study|Withdrawal by Subject|5|||
155283272|NCT00924560|560468273|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
155283273|NCT00924560|560468274|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
155283274|NCT00924560|560468275|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
155283275|NCT00924560|560468273|FG000|Overall Study|Non Compliance with the Protocol|20|||
155283276|NCT00924560|560468274|FG001|Overall Study|Non Compliance with the Protocol|15|||
155283277|NCT00924560|560468275|FG002|Overall Study|Non Compliance with the Protocol|4|||
154950466|NCT05097989|559243887|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
154950467|NCT05097989|559243888|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
154950468|NCT05097989|559243880|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
154950469|NCT05097989|559243881|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
154950470|NCT05097989|559243882|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
154950471|NCT05097989|559243883|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
154950472|NCT05097989|559243884|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
154950473|NCT05097989|559243885|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
154950474|NCT05097989|559243886|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
154950475|NCT05097989|559243887|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
154950476|NCT05097989|559243888|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
154950477|NCT05097989|559243880|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950478|NCT05097989|559243881|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950479|NCT05097989|559243882|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
154950480|NCT05097989|559243883|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950481|NCT05097989|559243884|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950482|NCT05097989|559243885|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950483|NCT05097989|559243886|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950484|NCT05097989|559243887|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950485|NCT05097989|559243888|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
154950486|NCT05097989|559243880|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950487|NCT05097989|559243881|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
154950488|NCT05097989|559243882|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950489|NCT05097989|559243883|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950490|NCT05097989|559243884|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950491|NCT05097989|559243885|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950492|NCT05097989|559243886|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950493|NCT05097989|559243887|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950494|NCT05097989|559243888|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
154950495|NCT05097989|559243880|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950496|NCT05097989|559243881|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950497|NCT05097989|559243882|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950498|NCT05097989|559243883|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950499|NCT05097989|559243884|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154950500|NCT05097989|559243885|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950501|NCT05097989|559243886|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950502|NCT05097989|559243887|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950503|NCT05097989|559243888|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154950504|NCT05097989|559243880|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950505|NCT05097989|559243881|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950506|NCT05097989|559243882|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950507|NCT05097989|559243883|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950508|NCT05097989|559243884|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
155053352|NCT02357459|559627836|FG001|Overall Study|Withdrawal by Subject|3|||
155053353|NCT02357459|559627837|FG002|Overall Study|Withdrawal by Subject|3|||
155053354|NCT02357459|559627835|FG000|Overall Study|Physician Decision|0|||
155053355|NCT02357459|559627836|FG001|Overall Study|Physician Decision|2|||
155283278|NCT00924560|560468273|FG000|Overall Study|Physician Decision|2|||
155283279|NCT00924560|560468274|FG001|Overall Study|Physician Decision|3|||
155283280|NCT00924560|560468275|FG002|Overall Study|Physician Decision|4|||
155283281|NCT00924560|560468273|FG000|Overall Study|Withdrawal by Subject|50|||
155283282|NCT00924560|560468274|FG001|Overall Study|Withdrawal by Subject|44|||
155283283|NCT00924560|560468275|FG002|Overall Study|Withdrawal by Subject|18|||
155283284|NCT00924560|560468273|FG000|Overall Study|Adverse Event|39|||
155283285|NCT00924560|560468274|FG001|Overall Study|Adverse Event|33|||
155053356|NCT02357459|559627837|FG002|Overall Study|Physician Decision|0|||
155053357|NCT02357459|559627835|FG000|Overall Study|Protocol Violation|1|||
155053358|NCT02357459|559627836|FG001|Overall Study|Protocol Violation|1|||
155053359|NCT02357459|559627837|FG002|Overall Study|Protocol Violation|0|||
155053360|NCT02357459|559627835|FG000|Overall Study|Lost to Follow-up|1|||
155053361|NCT02357459|559627836|FG001|Overall Study|Lost to Follow-up|3|||
155053362|NCT02357459|559627837|FG002|Overall Study|Lost to Follow-up|0|||
155053363|NCT02357459|559627835|FG000|Overall Study|Lack of Efficacy|7|||
155053364|NCT02357459|559627836|FG001|Overall Study|Lack of Efficacy|4|||
155053365|NCT02357459|559627837|FG002|Overall Study|Lack of Efficacy|4|||
155053366|NCT02357459|559627835|FG000|Overall Study|Patient Relocated|2|||
155053367|NCT02357459|559627836|FG001|Overall Study|Patient Relocated|0|||
155053368|NCT02357459|559627837|FG002|Overall Study|Patient Relocated|0|||
155053369|NCT02357459|559627835|FG000|Overall Study|Instruction from PCP|1|||
155053370|NCT02357459|559627836|FG001|Overall Study|Instruction from PCP|0|||
155053371|NCT02357459|559627837|FG002|Overall Study|Instruction from PCP|0|||
155053372|NCT02357459|559627835|FG000|Overall Study|Incarceration|0|||
155053373|NCT02357459|559627836|FG001|Overall Study|Incarceration|0|||
155053374|NCT02357459|559627837|FG002|Overall Study|Incarceration|1|||
155053375|NCT02357459|559627835|FG000|Overall Study|Pre-planned Knee surgery|0|||
155053376|NCT02357459|559627836|FG001|Overall Study|Pre-planned Knee surgery|0|||
155053377|NCT02357459|559627837|FG002|Overall Study|Pre-planned Knee surgery|2|||
155053378|NCT02357459|559627835|FG000|Overall Study|Job Commitments|0|||
155053379|NCT02357459|559627836|FG001|Overall Study|Job Commitments|0|||
155053380|NCT02357459|559627837|FG002|Overall Study|Job Commitments|1|||
155053381|NCT03246347|559627838|FG000|Overall Study|On Study|23|||
155053382|NCT02188160|559627839|FG000|Overall Study|Adverse Event|1|||
155053383|NCT02188160|559627840|FG001|Overall Study|Adverse Event|0|||
155053384|NCT02188160|559627839|FG000|Overall Study|Use of an excluded medication|0|||
155053385|NCT02188160|559627840|FG001|Overall Study|Use of an excluded medication|1|||
155053386|NCT04113694|559627841|FG000|Overall Study|Adverse Event|2|||
155053387|NCT04113694|559627841|FG000|Overall Study|Lost to Follow-up|2|||
155053388|NCT04113694|559627841|FG000|Overall Study|Withdrawal by Subject|6|||
155053389|NCT04113694|559627841|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
155053390|NCT00916578|559627844|FG000|Overall Study|Physician Decision|2|||
155053391|NCT00916578|559627844|FG000|Overall Study|Withdrawal by Subject|3|||
155053392|NCT00916578|559627844|FG000|Overall Study|Insurance Denial|2|||
155053393|NCT03163446|559627847|FG000|Overall Study|Unable to return for Day 180 visit|2|||
155053394|NCT03163446|559627848|FG001|Overall Study|Unable to return for Day 180 visit|0|||
155053395|NCT03163446|559627847|FG000|Overall Study|Withdrawal by Subject|2|||
155053396|NCT03163446|559627848|FG001|Overall Study|Withdrawal by Subject|6|||
155053397|NCT03163446|559627847|FG000|Overall Study|Death|16|||
155053398|NCT03163446|559627848|FG001|Overall Study|Death|5|||
155053399|NCT03163446|559627847|FG000|Overall Study|Lost to Follow-up|6|||
155053400|NCT03163446|559627848|FG001|Overall Study|Lost to Follow-up|5|||
155053401|NCT03163446|559627847|FG000|Overall Study|Physician Decision|1|||
155053402|NCT03163446|559627848|FG001|Overall Study|Physician Decision|1|||
155053403|NCT03163446|559627847|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
155053404|NCT03163446|559627848|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
155053405|NCT01094288|559627849|FG000|Overall Study|Adverse Event|0|||
155053406|NCT01094288|559627850|FG001|Overall Study|Adverse Event|3|||
155053407|NCT01094288|559627851|FG002|Overall Study|Adverse Event|1|||
155053408|NCT01094288|559627852|FG003|Overall Study|Adverse Event|1|||
155053409|NCT01094288|559627853|FG004|Overall Study|Adverse Event|0|||
155053410|NCT01094288|559627854|FG005|Overall Study|Adverse Event|0|||
155053411|NCT01094288|559627855|FG006|Overall Study|Adverse Event|0|||
155053412|NCT01094288|559627856|FG007|Overall Study|Adverse Event|0|||
155053413|NCT01094288|559627849|FG000|Overall Study|Withdrawal by Subject|0|||
155053414|NCT01094288|559627850|FG001|Overall Study|Withdrawal by Subject|1|||
155053415|NCT01094288|559627851|FG002|Overall Study|Withdrawal by Subject|2|||
155053416|NCT01094288|559627852|FG003|Overall Study|Withdrawal by Subject|0|||
155053417|NCT01094288|559627853|FG004|Overall Study|Withdrawal by Subject|0|||
155053418|NCT01094288|559627854|FG005|Overall Study|Withdrawal by Subject|0|||
155053419|NCT01094288|559627855|FG006|Overall Study|Withdrawal by Subject|0|||
155053420|NCT01094288|559627856|FG007|Overall Study|Withdrawal by Subject|2|||
155053421|NCT01094288|559627849|FG000|Overall Study|Initiation of Alternative Therapy|0|||
155053422|NCT01094288|559627850|FG001|Overall Study|Initiation of Alternative Therapy|0|||
155053423|NCT01094288|559627851|FG002|Overall Study|Initiation of Alternative Therapy|1|||
155053424|NCT01094288|559627852|FG003|Overall Study|Initiation of Alternative Therapy|0|||
155053425|NCT01094288|559627853|FG004|Overall Study|Initiation of Alternative Therapy|0|||
154950509|NCT05097989|559243885|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950510|NCT05097989|559243886|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950511|NCT05097989|559243887|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
155053426|NCT01094288|559627854|FG005|Overall Study|Initiation of Alternative Therapy|0|||
154950512|NCT05097989|559243888|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
154950513|NCT05097989|559243880|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154950514|NCT05097989|559243881|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
154950515|NCT05097989|559243882|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155053427|NCT01094288|559627855|FG006|Overall Study|Initiation of Alternative Therapy|0|||
155053428|NCT01094288|559627856|FG007|Overall Study|Initiation of Alternative Therapy|0|||
155053429|NCT01094288|559627849|FG000|Overall Study|Reason not Specified|2|||
155053430|NCT01094288|559627850|FG001|Overall Study|Reason not Specified|3|||
155283286|NCT00924560|560468275|FG002|Overall Study|Adverse Event|0|||
155053431|NCT01094288|559627851|FG002|Overall Study|Reason not Specified|0|||
155053432|NCT01094288|559627852|FG003|Overall Study|Reason not Specified|1|||
155053433|NCT01094288|559627853|FG004|Overall Study|Reason not Specified|0|||
155053434|NCT01094288|559627854|FG005|Overall Study|Reason not Specified|0|||
155053435|NCT01094288|559627855|FG006|Overall Study|Reason not Specified|0|||
155053436|NCT01094288|559627856|FG007|Overall Study|Reason not Specified|0|||
155053437|NCT01094288|559627849|FG000|Overall Study|Ongoing Participants|0|||
155053438|NCT01094288|559627850|FG001|Overall Study|Ongoing Participants|3|||
155053439|NCT01094288|559627851|FG002|Overall Study|Ongoing Participants|0|||
155053440|NCT01094288|559627852|FG003|Overall Study|Ongoing Participants|0|||
155053441|NCT01094288|559627853|FG004|Overall Study|Ongoing Participants|0|||
155053442|NCT01094288|559627854|FG005|Overall Study|Ongoing Participants|0|||
155053443|NCT01094288|559627855|FG006|Overall Study|Ongoing Participants|0|||
155053444|NCT01094288|559627856|FG007|Overall Study|Ongoing Participants|0|||
155053445|NCT01228591|559627857|FG000|Baseline|Lack of Efficacy|1|||
155053446|NCT01228591|559627858|FG001|Baseline|Lack of Efficacy|2|||
155053447|NCT02611882|559627859|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
155053448|NCT02611882|559627860|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
155053449|NCT02611882|559627861|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
155053450|NCT01389232|559627862|FG000|Overall Study|Had scaffold removed|15|||
155053451|NCT01389232|559627862|FG000|Overall Study|Personal reasons|2|||
155053452|NCT01389232|559627862|FG000|Overall Study|Adverse Event|1|||
155053453|NCT01389232|559627862|FG000|Overall Study|Death|1|||
155053454|NCT01317940|559627863|FG000|Overall Study|Death|1|||
155053455|NCT01317940|559627864|FG001|Overall Study|Death|0|||
155053456|NCT01317940|559627865|FG002|Overall Study|Death|1|||
155053457|NCT01317940|559627866|FG003|Overall Study|Death|0|||
155053458|NCT01317940|559627867|FG004|Overall Study|Death|0|||
155053459|NCT01317940|559627868|FG005|Overall Study|Death|0|||
155053460|NCT01317940|559627863|FG000|Overall Study|Lost to Follow-up|0|||
155053461|NCT01317940|559627864|FG001|Overall Study|Lost to Follow-up|0|||
155053462|NCT01317940|559627865|FG002|Overall Study|Lost to Follow-up|1|||
155053463|NCT01317940|559627866|FG003|Overall Study|Lost to Follow-up|1|||
155053464|NCT01317940|559627867|FG004|Overall Study|Lost to Follow-up|1|||
155053465|NCT01317940|559627868|FG005|Overall Study|Lost to Follow-up|0|||
155053466|NCT01317940|559627863|FG000|Overall Study|Change in therapy plan|0|||
155053467|NCT01317940|559627864|FG001|Overall Study|Change in therapy plan|0|||
155053468|NCT01317940|559627865|FG002|Overall Study|Change in therapy plan|3|||
155053469|NCT01317940|559627866|FG003|Overall Study|Change in therapy plan|0|||
155053470|NCT01317940|559627867|FG004|Overall Study|Change in therapy plan|0|||
155053471|NCT01317940|559627868|FG005|Overall Study|Change in therapy plan|0|||
155053472|NCT02371616|559627870|FG000|Overall Study|Protocol Violation|2|||
155053473|NCT02371616|559627871|FG001|Overall Study|Protocol Violation|1|||
155053474|NCT02371616|559627870|FG000|Overall Study|Adverse Event|0|||
155053475|NCT02371616|559627871|FG001|Overall Study|Adverse Event|1|||
155053476|NCT02371616|559627870|FG000|Overall Study|Withdrawal of Consent|1|||
155053477|NCT02371616|559627871|FG001|Overall Study|Withdrawal of Consent|0|||
155053478|NCT02371616|559627870|FG000|Overall Study|Other (Not specified)|1|||
155053479|NCT02371616|559627871|FG001|Overall Study|Other (Not specified)|5|||
155053480|NCT02699996|559627874|FG000|Overall Study|Withdrawal by Subject|5|||
155053481|NCT02699996|559627875|FG001|Overall Study|Withdrawal by Subject|2|||
155053482|NCT03205150|559627876|FG000|Overall Study|Protocol deviation|1|||
155053483|NCT03205150|559627877|FG001|Overall Study|Protocol deviation|3|||
155053484|NCT03205150|559627878|FG002|Overall Study|Protocol deviation|0|||
155053485|NCT03205150|559627876|FG000|Overall Study|Patient/guardian decision|0|||
155053486|NCT03205150|559627877|FG001|Overall Study|Patient/guardian decision|3|||
155053487|NCT03205150|559627878|FG002|Overall Study|Patient/guardian decision|0|||
155053488|NCT03205150|559627876|FG000|Overall Study|Adverse Event|1|||
155053489|NCT03205150|559627877|FG001|Overall Study|Adverse Event|1|||
155053490|NCT03205150|559627878|FG002|Overall Study|Adverse Event|1|||
155053491|NCT03205150|559627876|FG000|Overall Study|Lost to Follow-up|0|||
155053492|NCT03205150|559627877|FG001|Overall Study|Lost to Follow-up|0|||
155053493|NCT03205150|559627878|FG002|Overall Study|Lost to Follow-up|1|||
155053494|NCT01095835|559627879|FG000|Overall Study|Adverse Event|8|||
155053495|NCT01095835|559627880|FG001|Overall Study|Adverse Event|6|||
155053496|NCT01095835|559627881|FG002|Overall Study|Adverse Event|6|||
155053497|NCT01095835|559627879|FG000|Overall Study|Lack of Efficacy|0|||
155053498|NCT01095835|559627880|FG001|Overall Study|Lack of Efficacy|1|||
155053499|NCT01095835|559627881|FG002|Overall Study|Lack of Efficacy|0|||
155053500|NCT01095835|559627879|FG000|Overall Study|Physician Decision|0|||
155053501|NCT01095835|559627880|FG001|Overall Study|Physician Decision|0|||
155053502|NCT01095835|559627881|FG002|Overall Study|Physician Decision|1|||
155053503|NCT01095835|559627879|FG000|Overall Study|Withdrawal by Subject|1|||
155053504|NCT01095835|559627880|FG001|Overall Study|Withdrawal by Subject|3|||
155053505|NCT01095835|559627881|FG002|Overall Study|Withdrawal by Subject|0|||
155053506|NCT01095835|559627879|FG000|Overall Study|Non study compliance|0|||
155053507|NCT01095835|559627880|FG001|Overall Study|Non study compliance|0|||
155053508|NCT01095835|559627881|FG002|Overall Study|Non study compliance|1|||
155053509|NCT01095835|559627879|FG000|Overall Study|Protocol Violation|1|||
155053510|NCT01095835|559627880|FG001|Overall Study|Protocol Violation|2|||
155053511|NCT01095835|559627881|FG002|Overall Study|Protocol Violation|0|||
155053512|NCT00643760|559627890|FG000|Overall Study|Adverse Event|11|||
155053513|NCT00643760|559627891|FG001|Overall Study|Adverse Event|5|||
155053514|NCT00643760|559627892|FG002|Overall Study|Adverse Event|12|||
155053515|NCT00643760|559627893|FG003|Overall Study|Adverse Event|21|||
155053516|NCT00643760|559627894|FG004|Overall Study|Adverse Event|6|||
155053517|NCT00643760|559627890|FG000|Overall Study|Lack of Efficacy|3|||
155053518|NCT00643760|559627891|FG001|Overall Study|Lack of Efficacy|1|||
155053519|NCT00643760|559627892|FG002|Overall Study|Lack of Efficacy|0|||
155053520|NCT00643760|559627893|FG003|Overall Study|Lack of Efficacy|4|||
155053521|NCT00643760|559627894|FG004|Overall Study|Lack of Efficacy|3|||
155053522|NCT00643760|559627890|FG000|Overall Study|Protocol Violation|7|||
155053523|NCT00643760|559627891|FG001|Overall Study|Protocol Violation|6|||
155053524|NCT00643760|559627892|FG002|Overall Study|Protocol Violation|4|||
155053525|NCT00643760|559627893|FG003|Overall Study|Protocol Violation|4|||
155053526|NCT00643760|559627894|FG004|Overall Study|Protocol Violation|6|||
155053527|NCT00643760|559627890|FG000|Overall Study|Lost to Follow-up|6|||
155053528|NCT00643760|559627891|FG001|Overall Study|Lost to Follow-up|2|||
155053529|NCT00643760|559627892|FG002|Overall Study|Lost to Follow-up|1|||
155053530|NCT00643760|559627893|FG003|Overall Study|Lost to Follow-up|3|||
155053531|NCT00643760|559627894|FG004|Overall Study|Lost to Follow-up|3|||
155053532|NCT00643760|559627890|FG000|Overall Study|Investigator Discretion|0|||
155053533|NCT00643760|559627891|FG001|Overall Study|Investigator Discretion|0|||
155053534|NCT00643760|559627892|FG002|Overall Study|Investigator Discretion|0|||
155053535|NCT00643760|559627893|FG003|Overall Study|Investigator Discretion|2|||
155053536|NCT00643760|559627894|FG004|Overall Study|Investigator Discretion|0|||
155053537|NCT00643760|559627890|FG000|Overall Study|Withdrawal by Subject|3|||
155053538|NCT00643760|559627891|FG001|Overall Study|Withdrawal by Subject|1|||
155053539|NCT00643760|559627892|FG002|Overall Study|Withdrawal by Subject|2|||
155053540|NCT00643760|559627893|FG003|Overall Study|Withdrawal by Subject|4|||
155053541|NCT00643760|559627894|FG004|Overall Study|Withdrawal by Subject|1|||
155053542|NCT03353792|559627895|FG000|Overall Study|Lost to Follow-up|1|||
155053543|NCT03353792|559627896|FG001|Overall Study|Lost to Follow-up|0|||
155053544|NCT03353792|559627895|FG000|Overall Study|Participant Unable to Manage Device|1|||
155053545|NCT03353792|559627896|FG001|Overall Study|Participant Unable to Manage Device|0|||
155053546|NCT01965327|559627897|FG000|Overall Study|Physician Decision|2|||
155053547|NCT02498678|559627898|FG000|Overall Study|interference from the surgical team|0|||
155053548|NCT02498678|559627899|FG001|Overall Study|interference from the surgical team|2|||
155053549|NCT03652818|559627900|FG000|Overall Study|Adverse Event|1|||
155053550|NCT03652818|559627901|FG001|Overall Study|Adverse Event|0|||
155053551|NCT03652818|559627902|FG002|Overall Study|Adverse Event|0|||
155053552|NCT03652818|559627903|FG003|Overall Study|Adverse Event|0|||
155053553|NCT03652818|559627904|FG004|Overall Study|Adverse Event|0|||
155053554|NCT03652818|559627900|FG000|Overall Study|Physician Decision|1|||
155053555|NCT03652818|559627901|FG001|Overall Study|Physician Decision|0|||
155053556|NCT03652818|559627902|FG002|Overall Study|Physician Decision|0|||
155053557|NCT03652818|559627903|FG003|Overall Study|Physician Decision|0|||
155053558|NCT03652818|559627904|FG004|Overall Study|Physician Decision|0|||
155053559|NCT03652818|559627900|FG000|Overall Study|Lost to Follow-up|0|||
155053560|NCT03652818|559627901|FG001|Overall Study|Lost to Follow-up|1|||
155053561|NCT03652818|559627902|FG002|Overall Study|Lost to Follow-up|2|||
155053562|NCT03652818|559627903|FG003|Overall Study|Lost to Follow-up|1|||
155053563|NCT03652818|559627904|FG004|Overall Study|Lost to Follow-up|1|||
155053564|NCT01241279|559627909|FG000|Overall Study|Lost to Follow-up|0|||
155053565|NCT01241279|559627910|FG001|Overall Study|Lost to Follow-up|1|||
155053566|NCT01405560|559627913|FG000|Overall Study|Physician Decision|1|||
155053567|NCT02452047|559627915|FG000|Overall Study|Adverse Event|0|||
155053568|NCT02452047|559627916|FG001|Overall Study|Adverse Event|1|||
155053569|NCT02452047|559627917|FG002|Overall Study|Adverse Event|1|||
155053570|NCT02452047|559627915|FG000|Overall Study|Death|1|||
155053571|NCT02452047|559627916|FG001|Overall Study|Death|3|||
155053572|NCT02452047|559627917|FG002|Overall Study|Death|1|||
155053573|NCT02452047|559627915|FG000|Overall Study|Physician Decision|1|||
155053574|NCT02452047|559627916|FG001|Overall Study|Physician Decision|0|||
155053575|NCT02452047|559627917|FG002|Overall Study|Physician Decision|0|||
155053576|NCT02452047|559627915|FG000|Overall Study|Lost to Follow-up|1|||
155053577|NCT02452047|559627916|FG001|Overall Study|Lost to Follow-up|1|||
155053578|NCT02452047|559627917|FG002|Overall Study|Lost to Follow-up|0|||
155053579|NCT02452047|559627915|FG000|Overall Study|Withdrawal by Subject|1|||
155053580|NCT02452047|559627916|FG001|Overall Study|Withdrawal by Subject|0|||
155053581|NCT02452047|559627917|FG002|Overall Study|Withdrawal by Subject|0|||
155053582|NCT02169505|559627918|FG000|Overall Study|Withdrawal by Subject|1|||
155053583|NCT00917124|559627922|FG000|Overall Study|Protocol Violation|4|||
155053584|NCT00917124|559627923|FG001|Overall Study|Protocol Violation|6|||
155053585|NCT01529606|559627925|FG000|Overall Study|Lost to Follow-up|21|||
155053586|NCT01529606|559627926|FG001|Overall Study|Lost to Follow-up|18|||
155053587|NCT05209880|559627931|FG000|1-Month Follow-up|Spoke with Doctor|5|||
155053588|NCT05209880|559627932|FG001|1-Month Follow-up|Spoke with Doctor|5|||
155153079|NCT00333775|559998549|FG001|Overall Study|In Follow-up When Study Stopped|92|||
154950516|NCT05097989|559243883|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
154950517|NCT05097989|559243884|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154950518|NCT05097989|559243885|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154950519|NCT05097989|559243886|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154950520|NCT05097989|559243887|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154950521|NCT05097989|559243888|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154950522|NCT05097989|559243880|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
154950523|NCT05097989|559243881|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
154950524|NCT05097989|559243882|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
154950525|NCT05097989|559243883|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
154950526|NCT05097989|559243884|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
154950527|NCT05097989|559243885|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
154950528|NCT05097989|559243886|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
154950529|NCT05097989|559243887|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
154950530|NCT05097989|559243888|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
154950531|NCT05097989|559243880|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
154950532|NCT05097989|559243881|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
154950533|NCT05097989|559243882|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
154950534|NCT05097989|559243883|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
154950535|NCT05097989|559243884|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
154950536|NCT05097989|559243885|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
154950537|NCT05097989|559243886|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
154950538|NCT05097989|559243887|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
154950539|NCT05097989|559243888|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
154950540|NCT05097989|559243880|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950541|NCT05097989|559243881|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950542|NCT05097989|559243882|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950543|NCT05097989|559243883|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950544|NCT05097989|559243884|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
154950545|NCT05097989|559243885|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950546|NCT05097989|559243886|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950547|NCT05097989|559243887|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950548|NCT05097989|559243888|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
154950549|NCT05097989|559243880|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
154950550|NCT05097989|559243881|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
154950551|NCT05097989|559243882|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950552|NCT05097989|559243883|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950553|NCT05097989|559243884|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950554|NCT05097989|559243885|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950555|NCT05097989|559243886|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950556|NCT05097989|559243887|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950557|NCT05097989|559243888|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
154950558|NCT05097989|559243880|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
154950559|NCT05097989|559243881|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
154950560|NCT05097989|559243882|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
154950561|NCT05097989|559243883|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
154950562|NCT05097989|559243884|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
154950563|NCT05097989|559243885|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
154950564|NCT05097989|559243886|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
154950565|NCT05097989|559243887|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
154950566|NCT05097989|559243888|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
154950567|NCT03283709|559243898|FG000|Overall Study|trial terminated|0|||
154950568|NCT03283709|559243899|FG001|Overall Study|trial terminated|1|||
154950569|NCT00117949|559243900|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
154950570|NCT00117949|559243901|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
155053589|NCT05209880|559627931|FG000|1-Month Follow-up|Lost to Follow-up|7|||
155053590|NCT05209880|559627932|FG001|1-Month Follow-up|Lost to Follow-up|9|||
155053591|NCT05209880|559627931|FG000|1-Month Follow-up|Discontinued|0|||
155053592|NCT05209880|559627932|FG001|1-Month Follow-up|Discontinued|1|||
155053593|NCT05209880|559627931|FG000|3-Month Follow-up|Spoke with Doctor|17|||
155053594|NCT05209880|559627932|FG001|3-Month Follow-up|Spoke with Doctor|7|||
155053595|NCT05209880|559627931|FG000|3-Month Follow-up|Lost to Follow-up|8|||
155053596|NCT05209880|559627932|FG001|3-Month Follow-up|Lost to Follow-up|10|||
155053597|NCT05209880|559627931|FG000|3-Month Follow-up|Discontinued|1|||
155053598|NCT05209880|559627932|FG001|3-Month Follow-up|Discontinued|3|||
155053599|NCT05209880|559627931|FG000|6-Month Follow-up|Spoke with Doctor|25|||
155053600|NCT05209880|559627932|FG001|6-Month Follow-up|Spoke with Doctor|14|||
155053601|NCT05209880|559627931|FG000|6-Month Follow-up|Lost to Follow-up|9|||
155053602|NCT05209880|559627932|FG001|6-Month Follow-up|Lost to Follow-up|14|||
155053603|NCT05209880|559627931|FG000|6-Month Follow-up|Discontinued|1|||
155053604|NCT05209880|559627932|FG001|6-Month Follow-up|Discontinued|3|||
155053605|NCT03143101|559627940|FG000|Overall Study|Withdrawal by Subject|0|||
155053606|NCT03143101|559627941|FG001|Overall Study|Withdrawal by Subject|1|||
155053607|NCT03143101|559627942|FG002|Overall Study|Withdrawal by Subject|0|||
155053608|NCT03143101|559627940|FG000|Overall Study|Lost to Follow-up|2|||
155053609|NCT03143101|559627941|FG001|Overall Study|Lost to Follow-up|2|||
155053610|NCT03143101|559627942|FG002|Overall Study|Lost to Follow-up|0|||
155053611|NCT05227118|559627943|FG000|Overall Study|Adverse Event|0|||
155053612|NCT05227118|559627944|FG001|Overall Study|Adverse Event|0|||
155053613|NCT05227118|559627945|FG002|Overall Study|Adverse Event|1|||
154950571|NCT00117949|559243902|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
155053614|NCT05227118|559627946|FG003|Overall Study|Adverse Event|0|||
155053615|NCT05227118|559627943|FG000|Overall Study|Withdrawal by Subject|0|||
155053616|NCT05227118|559627944|FG001|Overall Study|Withdrawal by Subject|0|||
155053617|NCT05227118|559627945|FG002|Overall Study|Withdrawal by Subject|2|||
154950572|NCT00117949|559243903|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
154950573|NCT00117949|559243900|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
154950574|NCT00117949|559243901|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
154950575|NCT00117949|559243902|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
154950576|NCT00117949|559243903|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
154950577|NCT00117949|559243900|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
154950578|NCT00117949|559243901|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
154950579|NCT00117949|559243902|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
154950580|NCT00117949|559243903|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
154950581|NCT00117949|559243900|FG000|Overall Study|PSA increase >=10ng/mL|0|||
154950582|NCT00117949|559243901|FG001|Overall Study|PSA increase >=10ng/mL|1|||
154950583|NCT00117949|559243902|FG002|Overall Study|PSA increase >=10ng/mL|1|||
154950584|NCT00117949|559243903|FG003|Overall Study|PSA increase >=10ng/mL|0|||
154950585|NCT00117949|559243900|FG000|Overall Study|PSA reduction <=50%|0|||
154950586|NCT00117949|559243901|FG001|Overall Study|PSA reduction <=50%|2|||
154950587|NCT00117949|559243902|FG002|Overall Study|PSA reduction <=50%|2|||
154950588|NCT00117949|559243903|FG003|Overall Study|PSA reduction <=50%|4|||
154950589|NCT00117949|559243900|FG000|Overall Study|Hepatic abnormalities|0|||
154950590|NCT00117949|559243901|FG001|Overall Study|Hepatic abnormalities|1|||
154950591|NCT00117949|559243902|FG002|Overall Study|Hepatic abnormalities|0|||
154950592|NCT00117949|559243903|FG003|Overall Study|Hepatic abnormalities|1|||
154950593|NCT00406848|559243906|FG000|Overall Study|Withdrawal by Subject|27|||
154950594|NCT00406848|559243907|FG001|Overall Study|Withdrawal by Subject|22|||
154950595|NCT00406848|559243906|FG000|Overall Study|Adverse Event|38|||
154950596|NCT00406848|559243907|FG001|Overall Study|Adverse Event|7|||
154950597|NCT00406848|559243906|FG000|Overall Study|Lack of Efficacy|9|||
154950598|NCT00406848|559243907|FG001|Overall Study|Lack of Efficacy|14|||
154950599|NCT00406848|559243906|FG000|Overall Study|Protocol Violation|10|||
154950600|NCT00406848|559243907|FG001|Overall Study|Protocol Violation|6|||
154950601|NCT00406848|559243906|FG000|Overall Study|Lost to Follow-up|6|||
154950602|NCT00406848|559243907|FG001|Overall Study|Lost to Follow-up|2|||
154950603|NCT00406848|559243906|FG000|Overall Study|Physician Decision|2|||
154950604|NCT00406848|559243907|FG001|Overall Study|Physician Decision|2|||
154950605|NCT00406848|559243906|FG000|Overall Study|Sponsor Decision|1|||
154950606|NCT00406848|559243907|FG001|Overall Study|Sponsor Decision|1|||
154950607|NCT04803357|559243908|FG000|Overall Study|Withdrawal by Subject|31|||
154950608|NCT04803357|559243909|FG001|Overall Study|Withdrawal by Subject|5|||
154950609|NCT02879643|559243911|FG000|Overall Study|Adverse Event|0|||
154950610|NCT02879643|559243912|FG001|Overall Study|Adverse Event|0|||
154950611|NCT02879643|559243913|FG002|Overall Study|Adverse Event|1|||
154950612|NCT02879643|559243914|FG003|Overall Study|Adverse Event|1|||
154950613|NCT02879643|559243915|FG004|Overall Study|Adverse Event|0|||
154950614|NCT01346410|559243916|FG000|Overall Study|Death|1|||
154950615|NCT00936390|559243917|FG000|Overall Study|Protocol Violation|21|||
154950616|NCT00936390|559243918|FG001|Overall Study|Protocol Violation|25|||
154950617|NCT02093689|559243919|FG000|Overall Study|Physician Decision|4|||
154950618|NCT02093689|559243920|FG001|Overall Study|Physician Decision|0|||
154950619|NCT02093689|559243921|FG002|Overall Study|Physician Decision|0|||
154950620|NCT04947579|559243924|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
154950621|NCT04947579|559243925|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
154950622|NCT04947579|559243926|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
154950623|NCT04947579|559243927|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
155153080|NCT00333775|559998550|FG002|Overall Study|In Follow-up When Study Stopped|96|||
154950624|NCT04947579|559243928|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
155053618|NCT05227118|559627946|FG003|Overall Study|Withdrawal by Subject|0|||
155053619|NCT01435759|559627947|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
155053620|NCT01435759|559627948|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
155053621|NCT01435759|559627949|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
155053622|NCT01435759|559627950|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
155053623|NCT01435759|559627951|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
155053624|NCT01435759|559627952|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
155053625|NCT01435759|559627947|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
155053626|NCT01435759|559627948|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
155053627|NCT01435759|559627949|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
155053628|NCT01435759|559627950|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
155053629|NCT01435759|559627951|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
155053630|NCT01435759|559627952|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
155053631|NCT01435759|559627947|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
155153081|NCT00333775|559998548|FG000|Overall Study|Lost to Follow-up|10|||
155283287|NCT00924560|560468273|FG000|Overall Study|Pregnancy|5|||
155283288|NCT00924560|560468274|FG001|Overall Study|Pregnancy|7|||
154950625|NCT04947579|559243929|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
154950626|NCT04947579|559243924|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
154950627|NCT04947579|559243925|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
154950628|NCT04947579|559243926|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
154950629|NCT04947579|559243927|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
154950630|NCT04947579|559243928|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
154950631|NCT04947579|559243929|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
154950632|NCT04947579|559243924|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
154950633|NCT04947579|559243925|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
154950634|NCT04947579|559243926|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
154950635|NCT04947579|559243927|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
154950636|NCT04947579|559243928|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
154950637|NCT04947579|559243929|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
154950638|NCT04947579|559243924|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
154950639|NCT04947579|559243925|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
154950640|NCT04947579|559243926|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
154950641|NCT04947579|559243927|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
154950642|NCT04947579|559243928|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
154950643|NCT04947579|559243929|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
154950644|NCT04947579|559243924|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
154950645|NCT04947579|559243925|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
154950646|NCT04947579|559243926|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
154950647|NCT04947579|559243927|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
154950648|NCT04947579|559243928|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
154950649|NCT04947579|559243929|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
154950650|NCT04947579|559243924|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
154950651|NCT04947579|559243925|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
154950652|NCT04947579|559243926|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
154950653|NCT04947579|559243927|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
154950654|NCT04947579|559243928|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
154950655|NCT04947579|559243929|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
154950656|NCT04947579|559243924|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
154950657|NCT04947579|559243925|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
154950658|NCT04947579|559243926|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
154950659|NCT04947579|559243927|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
154950660|NCT04947579|559243928|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
154950661|NCT04947579|559243929|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
154950662|NCT04947579|559243924|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
154950663|NCT04947579|559243925|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
154950664|NCT04947579|559243926|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
154950665|NCT04947579|559243927|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
154950666|NCT04947579|559243928|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
154950667|NCT04947579|559243929|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
154950668|NCT04947579|559243924|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
154950669|NCT04947579|559243925|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
154950670|NCT04947579|559243926|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
154950671|NCT04947579|559243927|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
154950672|NCT04947579|559243928|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
154950673|NCT04947579|559243929|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
155053632|NCT01435759|559627948|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155153082|NCT00333775|559998549|FG001|Overall Study|Lost to Follow-up|7|||
155053633|NCT01435759|559627949|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155053634|NCT01435759|559627950|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155053635|NCT01435759|559627951|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155053636|NCT01435759|559627952|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155053637|NCT01435759|559627947|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
155053638|NCT01435759|559627948|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155053639|NCT01435759|559627949|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155053640|NCT01435759|559627950|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155053641|NCT01435759|559627951|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155053642|NCT01435759|559627952|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155053643|NCT01435759|559627947|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
155053644|NCT01435759|559627948|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053645|NCT01435759|559627949|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053646|NCT01435759|559627950|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053647|NCT01435759|559627951|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053648|NCT01435759|559627952|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053649|NCT01435759|559627947|FG000|Antidepressant Lead-in Phase|Other|119|||
155053650|NCT01435759|559627948|FG001|Antidepressant Lead-in Phase|Other|0|||
155053651|NCT01435759|559627949|FG002|Antidepressant Lead-in Phase|Other|0|||
155053652|NCT01435759|559627950|FG003|Antidepressant Lead-in Phase|Other|0|||
155053653|NCT01435759|559627951|FG004|Antidepressant Lead-in Phase|Other|0|||
155053654|NCT01435759|559627952|FG005|Antidepressant Lead-in Phase|Other|0|||
155053655|NCT01435759|559627947|FG000|Double-blind Phase|Adverse Event|7|||
155053656|NCT01435759|559627948|FG001|Double-blind Phase|Adverse Event|0|||
155053657|NCT01435759|559627949|FG002|Double-blind Phase|Adverse Event|1|||
155053658|NCT01435759|559627950|FG003|Double-blind Phase|Adverse Event|1|||
155053659|NCT01435759|559627951|FG004|Double-blind Phase|Adverse Event|1|||
155053660|NCT01435759|559627952|FG005|Double-blind Phase|Adverse Event|3|||
155053661|NCT01435759|559627947|FG000|Double-blind Phase|Protocol Violation|2|||
155053662|NCT01435759|559627948|FG001|Double-blind Phase|Protocol Violation|0|||
155053663|NCT01435759|559627949|FG002|Double-blind Phase|Protocol Violation|1|||
155053664|NCT01435759|559627950|FG003|Double-blind Phase|Protocol Violation|2|||
155053665|NCT01435759|559627951|FG004|Double-blind Phase|Protocol Violation|0|||
155053666|NCT01435759|559627952|FG005|Double-blind Phase|Protocol Violation|1|||
155053667|NCT01435759|559627947|FG000|Double-blind Phase|Withdrawal by Subject|17|||
155053668|NCT01435759|559627948|FG001|Double-blind Phase|Withdrawal by Subject|4|||
155053669|NCT01435759|559627949|FG002|Double-blind Phase|Withdrawal by Subject|3|||
155053670|NCT01435759|559627950|FG003|Double-blind Phase|Withdrawal by Subject|4|||
155053671|NCT01435759|559627951|FG004|Double-blind Phase|Withdrawal by Subject|2|||
155053672|NCT01435759|559627952|FG005|Double-blind Phase|Withdrawal by Subject|2|||
155053673|NCT01435759|559627947|FG000|Double-blind Phase|Lost to Follow-up|31|||
155053674|NCT01435759|559627948|FG001|Double-blind Phase|Lost to Follow-up|1|||
155053675|NCT01435759|559627949|FG002|Double-blind Phase|Lost to Follow-up|2|||
155053676|NCT01435759|559627950|FG003|Double-blind Phase|Lost to Follow-up|0|||
155053677|NCT01435759|559627951|FG004|Double-blind Phase|Lost to Follow-up|3|||
155053678|NCT01435759|559627952|FG005|Double-blind Phase|Lost to Follow-up|3|||
155053679|NCT01435759|559627947|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
155053680|NCT01435759|559627948|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053681|NCT01435759|559627949|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053682|NCT01435759|559627950|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053683|NCT01435759|559627951|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
155053684|NCT01435759|559627952|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
155053685|NCT01435759|559627947|FG000|Double-blind Phase|Other|8|||
155053686|NCT01435759|559627948|FG001|Double-blind Phase|Other|2|||
155053687|NCT01435759|559627949|FG002|Double-blind Phase|Other|0|||
155053688|NCT01435759|559627950|FG003|Double-blind Phase|Other|2|||
155053689|NCT01435759|559627951|FG004|Double-blind Phase|Other|0|||
155053690|NCT01435759|559627952|FG005|Double-blind Phase|Other|0|||
155053691|NCT03727841|559627953|FG000|Overall Study|Physician Decision|3|||
155053692|NCT03727841|559627954|FG001|Overall Study|Physician Decision|1|||
155053693|NCT03126786|559627955|FG000|Overall Study|Adverse Event|3|||
155053694|NCT03126786|559627956|FG001|Overall Study|Adverse Event|0|||
155053695|NCT03126786|559627955|FG000|Overall Study|Lost to Follow-up|0|||
155053696|NCT03126786|559627956|FG001|Overall Study|Lost to Follow-up|1|||
155053697|NCT03126786|559627955|FG000|Overall Study|Withdrawal by Subject|3|||
155053698|NCT03126786|559627956|FG001|Overall Study|Withdrawal by Subject|1|||
155053699|NCT03243305|559627957|FG000|Overall Study|Lost to Follow-up|250|||
155053700|NCT03243305|559627957|FG000|Overall Study|Withdrawal by Subject|170|||
155053701|NCT03243305|559627957|FG000|Overall Study|Pregnancy|104|||
155053702|NCT03243305|559627957|FG000|Overall Study|Non-Compliance with Study Drug|38|||
155053703|NCT03243305|559627957|FG000|Overall Study|Adverse Event|23|||
155053704|NCT03243305|559627957|FG000|Overall Study|No sexually active|26|||
155053705|NCT03243305|559627957|FG000|Overall Study|Physician Decision|22|||
155053706|NCT03243305|559627957|FG000|Overall Study|Protocol Violation|22|||
154950674|NCT04947579|559243924|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
154950675|NCT04947579|559243925|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
154950676|NCT04947579|559243926|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
154950677|NCT04947579|559243927|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
154950678|NCT04947579|559243928|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
154950679|NCT04947579|559243929|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
154950680|NCT04947579|559243924|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
154950681|NCT04947579|559243925|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
154950682|NCT04947579|559243926|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
154950683|NCT04947579|559243927|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
154950684|NCT04947579|559243928|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
154950685|NCT04947579|559243929|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
154950686|NCT00634179|559243930|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
154950687|NCT04272801|559243931|FG000|Overall Study|Withdrawal by Subject|4|||
154950688|NCT04272801|559243931|FG000|Overall Study|Lost to Follow-up|4|||
154950689|NCT04272801|559243931|FG000|Overall Study|Ineligible|1|||
154950690|NCT00475020|559243932|FG000|Overall Study|Physician Decision|3|||
154950691|NCT00475020|559243932|FG000|Overall Study|Insurance Denial|1|||
154950692|NCT00475020|559243932|FG000|Overall Study|Donor not able to donate the last minute|1|||
154950693|NCT01575054|559243933|FG000|Overall Study|Other Reasons|5|||
154950694|NCT01575054|559243934|FG001|Overall Study|Other Reasons|3|||
154950695|NCT01575054|559243933|FG000|Overall Study|Protocol Violation|2|||
154950696|NCT01575054|559243934|FG001|Overall Study|Protocol Violation|1|||
154950697|NCT01575054|559243933|FG000|Overall Study|Personal Reasons|10|||
154950698|NCT01575054|559243934|FG001|Overall Study|Personal Reasons|11|||
154950699|NCT01575054|559243933|FG000|Overall Study|Lost to Follow-up|3|||
154950700|NCT01575054|559243934|FG001|Overall Study|Lost to Follow-up|3|||
154950701|NCT01575054|559243933|FG000|Overall Study|Adverse Event|9|||
154950702|NCT01575054|559243934|FG001|Overall Study|Adverse Event|8|||
154950703|NCT03481309|559243935|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
154950704|NCT03481309|559243936|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
154950705|NCT03481309|559243937|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
154950706|NCT03481309|559243938|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
154950707|NCT03481309|559243939|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
154950708|NCT03481309|559243940|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
154950709|NCT02130466|559243943|FG000|Overall Study|Death|4|||
154950710|NCT02130466|559243944|FG001|Overall Study|Death|1|||
154950711|NCT02130466|559243945|FG002|Overall Study|Death|1|||
154950712|NCT02130466|559243946|FG003|Overall Study|Death|3|||
154950713|NCT02130466|559243947|FG004|Overall Study|Death|2|||
154950714|NCT02130466|559243948|FG005|Overall Study|Death|30|||
154950715|NCT02130466|559243949|FG006|Overall Study|Death|45|||
155053707|NCT03243305|559627957|FG000|Overall Study|Study method no longer primary method|12|||
155053708|NCT03243305|559627957|FG000|Overall Study|Study Terminated by Sponsor|1|||
155053709|NCT03243305|559627957|FG000|Overall Study|Early terminations|267|||
155053710|NCT02115607|559627960|FG000|Overall Study|Withdrawal by Subject|1|||
155053711|NCT00196105|559627964|FG000|Overall Study|Lost to Follow-up|4|||
155053712|NCT00196105|559627965|FG001|Overall Study|Lost to Follow-up|5|||
154950716|NCT02130466|559243950|FG007|Overall Study|Death|2|||
154950717|NCT02130466|559243951|FG008|Overall Study|Death|3|||
154950718|NCT02130466|559243952|FG009|Overall Study|Death|4|||
154950719|NCT02130466|559243953|FG010|Overall Study|Death|5|||
154950720|NCT02130466|559243954|FG011|Overall Study|Death|3|||
154950721|NCT02130466|559243955|FG012|Overall Study|Death|11|||
154950722|NCT02130466|559243956|FG013|Overall Study|Death|7|||
154950723|NCT02130466|559243943|FG000|Overall Study|Lost to Follow-up|1|||
154950724|NCT02130466|559243944|FG001|Overall Study|Lost to Follow-up|0|||
154950725|NCT02130466|559243945|FG002|Overall Study|Lost to Follow-up|0|||
154950726|NCT02130466|559243946|FG003|Overall Study|Lost to Follow-up|0|||
154950727|NCT02130466|559243947|FG004|Overall Study|Lost to Follow-up|0|||
154950728|NCT02130466|559243948|FG005|Overall Study|Lost to Follow-up|1|||
154950729|NCT02130466|559243949|FG006|Overall Study|Lost to Follow-up|0|||
154950730|NCT02130466|559243950|FG007|Overall Study|Lost to Follow-up|0|||
154950731|NCT02130466|559243951|FG008|Overall Study|Lost to Follow-up|0|||
155053713|NCT00196105|559627966|FG002|Overall Study|Lost to Follow-up|7|||
154950732|NCT02130466|559243952|FG009|Overall Study|Lost to Follow-up|0|||
155053714|NCT05616013|559627968|FG000|Overall Study|Adverse Event|6|||
154950733|NCT02130466|559243953|FG010|Overall Study|Lost to Follow-up|0|||
154950734|NCT02130466|559243954|FG011|Overall Study|Lost to Follow-up|0|||
154950735|NCT02130466|559243955|FG012|Overall Study|Lost to Follow-up|1|||
154950736|NCT02130466|559243956|FG013|Overall Study|Lost to Follow-up|0|||
154950737|NCT02130466|559243943|FG000|Overall Study|Physician Decision|0|||
154950738|NCT02130466|559243944|FG001|Overall Study|Physician Decision|0|||
154950739|NCT02130466|559243945|FG002|Overall Study|Physician Decision|0|||
154950740|NCT02130466|559243946|FG003|Overall Study|Physician Decision|0|||
155053715|NCT05616013|559627969|FG001|Overall Study|Adverse Event|12|||
155053716|NCT05616013|559627970|FG002|Overall Study|Adverse Event|8|||
155053717|NCT05616013|559627971|FG003|Overall Study|Adverse Event|4|||
155053718|NCT05616013|559627972|FG004|Overall Study|Adverse Event|6|||
155053719|NCT05616013|559627973|FG005|Overall Study|Adverse Event|8|||
155053720|NCT05616013|559627974|FG006|Overall Study|Adverse Event|3|||
155053721|NCT05616013|559627975|FG007|Overall Study|Adverse Event|6|||
155053722|NCT05616013|559627976|FG008|Overall Study|Adverse Event|1|||
155053723|NCT05616013|559627968|FG000|Overall Study|Lost to Follow-up|5|||
155053724|NCT05616013|559627969|FG001|Overall Study|Lost to Follow-up|4|||
155053725|NCT05616013|559627970|FG002|Overall Study|Lost to Follow-up|3|||
155053726|NCT05616013|559627971|FG003|Overall Study|Lost to Follow-up|2|||
155053727|NCT05616013|559627972|FG004|Overall Study|Lost to Follow-up|0|||
155053728|NCT05616013|559627973|FG005|Overall Study|Lost to Follow-up|5|||
155053729|NCT05616013|559627974|FG006|Overall Study|Lost to Follow-up|2|||
155053730|NCT05616013|559627975|FG007|Overall Study|Lost to Follow-up|1|||
155053731|NCT05616013|559627976|FG008|Overall Study|Lost to Follow-up|2|||
155053732|NCT05616013|559627968|FG000|Overall Study|Non-compliance with study requirements|2|||
155053733|NCT05616013|559627969|FG001|Overall Study|Non-compliance with study requirements|2|||
155053734|NCT05616013|559627970|FG002|Overall Study|Non-compliance with study requirements|2|||
155053735|NCT05616013|559627971|FG003|Overall Study|Non-compliance with study requirements|3|||
155053736|NCT05616013|559627972|FG004|Overall Study|Non-compliance with study requirements|0|||
155053737|NCT05616013|559627973|FG005|Overall Study|Non-compliance with study requirements|2|||
155053738|NCT05616013|559627974|FG006|Overall Study|Non-compliance with study requirements|1|||
155053739|NCT05616013|559627975|FG007|Overall Study|Non-compliance with study requirements|1|||
155053740|NCT05616013|559627976|FG008|Overall Study|Non-compliance with study requirements|4|||
155053741|NCT05616013|559627968|FG000|Overall Study|Withdrawal by Subject|11|||
155053742|NCT05616013|559627969|FG001|Overall Study|Withdrawal by Subject|9|||
155053743|NCT05616013|559627970|FG002|Overall Study|Withdrawal by Subject|8|||
155053744|NCT05616013|559627971|FG003|Overall Study|Withdrawal by Subject|6|||
155053745|NCT05616013|559627972|FG004|Overall Study|Withdrawal by Subject|3|||
155053746|NCT05616013|559627973|FG005|Overall Study|Withdrawal by Subject|4|||
155053747|NCT05616013|559627974|FG006|Overall Study|Withdrawal by Subject|6|||
155053748|NCT05616013|559627975|FG007|Overall Study|Withdrawal by Subject|5|||
155053749|NCT05616013|559627976|FG008|Overall Study|Withdrawal by Subject|4|||
155053750|NCT05616013|559627968|FG000|Overall Study|Physician Decision|0|||
155053751|NCT05616013|559627969|FG001|Overall Study|Physician Decision|0|||
155053752|NCT05616013|559627970|FG002|Overall Study|Physician Decision|1|||
155053753|NCT05616013|559627971|FG003|Overall Study|Physician Decision|0|||
155053754|NCT05616013|559627972|FG004|Overall Study|Physician Decision|0|||
155053755|NCT05616013|559627973|FG005|Overall Study|Physician Decision|1|||
155053756|NCT05616013|559627974|FG006|Overall Study|Physician Decision|3|||
155053757|NCT05616013|559627975|FG007|Overall Study|Physician Decision|0|||
155053758|NCT05616013|559627976|FG008|Overall Study|Physician Decision|0|||
155053759|NCT05616013|559627968|FG000|Overall Study|Protocol Violation|0|||
155053760|NCT05616013|559627969|FG001|Overall Study|Protocol Violation|0|||
155053761|NCT05616013|559627970|FG002|Overall Study|Protocol Violation|0|||
155053762|NCT05616013|559627971|FG003|Overall Study|Protocol Violation|0|||
155053763|NCT05616013|559627972|FG004|Overall Study|Protocol Violation|0|||
155053764|NCT05616013|559627973|FG005|Overall Study|Protocol Violation|0|||
155053765|NCT05616013|559627974|FG006|Overall Study|Protocol Violation|1|||
155053766|NCT05616013|559627975|FG007|Overall Study|Protocol Violation|0|||
155053767|NCT05616013|559627976|FG008|Overall Study|Protocol Violation|2|||
155053768|NCT05616013|559627968|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
155053769|NCT05616013|559627969|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053770|NCT05616013|559627970|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053771|NCT05616013|559627971|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053772|NCT05616013|559627972|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053773|NCT05616013|559627973|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053774|NCT05616013|559627974|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053775|NCT05616013|559627975|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053776|NCT05616013|559627976|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
155053777|NCT05616013|559627968|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
155053778|NCT05616013|559627969|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053779|NCT05616013|559627970|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053780|NCT05616013|559627971|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053781|NCT05616013|559627972|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053782|NCT05616013|559627973|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053783|NCT05616013|559627974|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053784|NCT05616013|559627975|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053785|NCT05616013|559627976|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
155053786|NCT05616013|559627968|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
155053787|NCT05616013|559627969|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155153083|NCT00333775|559998550|FG002|Overall Study|Lost to Follow-up|8|||
154950741|NCT02130466|559243947|FG004|Overall Study|Physician Decision|0|||
154950742|NCT02130466|559243948|FG005|Overall Study|Physician Decision|1|||
154950743|NCT02130466|559243949|FG006|Overall Study|Physician Decision|1|||
154950744|NCT02130466|559243950|FG007|Overall Study|Physician Decision|0|||
154950745|NCT02130466|559243951|FG008|Overall Study|Physician Decision|0|||
154950746|NCT02130466|559243952|FG009|Overall Study|Physician Decision|0|||
154950747|NCT02130466|559243953|FG010|Overall Study|Physician Decision|0|||
154950748|NCT02130466|559243954|FG011|Overall Study|Physician Decision|0|||
154950749|NCT02130466|559243955|FG012|Overall Study|Physician Decision|0|||
154950750|NCT02130466|559243956|FG013|Overall Study|Physician Decision|0|||
154950751|NCT02130466|559243943|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
154950752|NCT02130466|559243944|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
154950753|NCT02130466|559243945|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
154950754|NCT02130466|559243946|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
154950755|NCT02130466|559243947|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
154950756|NCT02130466|559243948|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
154950757|NCT02130466|559243949|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
154950758|NCT02130466|559243950|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
154950759|NCT02130466|559243951|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
154950760|NCT02130466|559243952|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
154950761|NCT02130466|559243953|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
154950762|NCT02130466|559243954|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
154950763|NCT02130466|559243955|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
154950764|NCT02130466|559243956|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
154950765|NCT02130466|559243943|FG000|Overall Study|Withdrawal by Subject|1|||
154950766|NCT02130466|559243944|FG001|Overall Study|Withdrawal by Subject|0|||
154950767|NCT02130466|559243945|FG002|Overall Study|Withdrawal by Subject|0|||
154950768|NCT02130466|559243946|FG003|Overall Study|Withdrawal by Subject|0|||
154950769|NCT02130466|559243947|FG004|Overall Study|Withdrawal by Subject|0|||
154950770|NCT02130466|559243948|FG005|Overall Study|Withdrawal by Subject|1|||
154950771|NCT02130466|559243949|FG006|Overall Study|Withdrawal by Subject|0|||
154950772|NCT02130466|559243950|FG007|Overall Study|Withdrawal by Subject|0|||
154950773|NCT02130466|559243951|FG008|Overall Study|Withdrawal by Subject|1|||
154950774|NCT02130466|559243952|FG009|Overall Study|Withdrawal by Subject|0|||
154950775|NCT02130466|559243953|FG010|Overall Study|Withdrawal by Subject|0|||
154950776|NCT02130466|559243954|FG011|Overall Study|Withdrawal by Subject|0|||
154950777|NCT02130466|559243955|FG012|Overall Study|Withdrawal by Subject|0|||
154950778|NCT02130466|559243956|FG013|Overall Study|Withdrawal by Subject|0|||
154950779|NCT02518685|559243957|FG000|Overall Study|Adverse Event|29|||
154950780|NCT02518685|559243958|FG001|Overall Study|Adverse Event|1|||
154950781|NCT02518685|559243957|FG000|Overall Study|Withdrawal by Subject|10|||
154950782|NCT02518685|559243958|FG001|Overall Study|Withdrawal by Subject|3|||
154950783|NCT02518685|559243957|FG000|Overall Study|relocation, study fatigue|7|||
154950784|NCT02518685|559243958|FG001|Overall Study|relocation, study fatigue|2|||
154950785|NCT02518685|559243957|FG000|Overall Study|Pregnancy|1|||
154950786|NCT02518685|559243958|FG001|Overall Study|Pregnancy|0|||
154950787|NCT02518685|559243957|FG000|Overall Study|Physician Decision|1|||
154950788|NCT02518685|559243958|FG001|Overall Study|Physician Decision|0|||
154950789|NCT02518685|559243957|FG000|Overall Study|Lost to Follow-up|1|||
154950790|NCT02518685|559243958|FG001|Overall Study|Lost to Follow-up|4|||
154950791|NCT00922779|559243959|FG000|Overall Study|Adverse Event|67|||
154950792|NCT00922779|559243959|FG000|Overall Study|Pregnancy|7|||
154950793|NCT00922779|559243959|FG000|Overall Study|Withdrawal by Subject|308|||
154950794|NCT00922779|559243959|FG000|Overall Study|Lost to Follow-up|44|||
154950795|NCT00922779|559243959|FG000|Overall Study|Other|27|||
154950796|NCT00922779|559243959|FG000|Overall Study|Missing|1874|||
154950797|NCT01922349|559243960|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
154950798|NCT01922349|559243961|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
154950799|NCT01922349|559243962|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
154950800|NCT01922349|559243963|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
154950801|NCT01611090|559243964|FG000|Randomized Period|Lost to Follow-up|8|||
154950802|NCT01611090|559243965|FG001|Randomized Period|Lost to Follow-up|3|||
154950803|NCT01611090|559243966|FG002|Randomized Period|Lost to Follow-up|0|||
154950804|NCT01611090|559243964|FG000|Randomized Period|Withdrawal by Subject|22|||
154950805|NCT01611090|559243965|FG001|Randomized Period|Withdrawal by Subject|26|||
154950806|NCT01611090|559243966|FG002|Randomized Period|Withdrawal by Subject|0|||
154950807|NCT01611090|559243964|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
154950808|NCT01611090|559243965|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
154950809|NCT01611090|559243966|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
155053788|NCT05616013|559627970|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155053789|NCT05616013|559627971|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155053790|NCT05616013|559627972|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155153084|NCT02476617|559998551|FG000|Overall Study|Adverse Event|1|||
155053791|NCT05616013|559627973|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155053792|NCT05616013|559627974|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155053793|NCT05616013|559627975|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155053794|NCT05616013|559627976|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
155053795|NCT05616013|559627968|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053796|NCT05616013|559627969|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
155053797|NCT05616013|559627970|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053798|NCT05616013|559627971|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053799|NCT05616013|559627972|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053800|NCT05616013|559627973|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053801|NCT05616013|559627974|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
154950810|NCT01611090|559243964|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
154950811|NCT01611090|559243965|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
154950812|NCT01611090|559243966|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
154950813|NCT05109234|559243967|FG000|Overall Study|Adverse Event|2|||
154950814|NCT05109234|559243968|FG001|Overall Study|Adverse Event|2|||
154950815|NCT05109234|559243967|FG000|Overall Study|Lack of Efficacy|5|||
154950816|NCT05109234|559243968|FG001|Overall Study|Lack of Efficacy|0|||
154950817|NCT05109234|559243967|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
154950818|NCT05109234|559243968|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
154950819|NCT05109234|559243967|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
154950820|NCT05109234|559243968|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
154950821|NCT05109234|559243967|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
154950822|NCT05109234|559243968|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
154950823|NCT05109234|559243967|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
154950824|NCT05109234|559243968|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
154950825|NCT00336024|559243969|FG000|Overall Study|Death|2|||
154950826|NCT00336024|559243970|FG001|Overall Study|Death|1|||
154950827|NCT00336024|559243969|FG000|Overall Study|Physician Decision|4|||
154950828|NCT00336024|559243970|FG001|Overall Study|Physician Decision|1|||
154950829|NCT00336024|559243969|FG000|Overall Study|Protocol Violation|1|||
154950830|NCT00336024|559243970|FG001|Overall Study|Protocol Violation|0|||
154950831|NCT00336024|559243969|FG000|Overall Study|Withdrawal by Subject|1|||
154950832|NCT00336024|559243970|FG001|Overall Study|Withdrawal by Subject|2|||
154950833|NCT00336024|559243969|FG000|Overall Study|Failure to fulfill consolidation|1|||
154950834|NCT00336024|559243970|FG001|Overall Study|Failure to fulfill consolidation|1|||
154950835|NCT00336024|559243969|FG000|Overall Study|Progressive Disease|4|||
154950836|NCT00336024|559243970|FG001|Overall Study|Progressive Disease|7|||
154950837|NCT00336024|559243969|FG000|Overall Study|Ineligible|7|||
154950838|NCT00336024|559243970|FG001|Overall Study|Ineligible|7|||
154950839|NCT03946449|559243971|FG000|Treatment Extension II|Rolled over to another study|0|||
154950840|NCT03946449|559243972|FG001|Treatment Extension II|Rolled over to another study|0|||
154950841|NCT03946449|559243973|FG002|Treatment Extension II|Rolled over to another study|2|||
154950842|NCT03946449|559243971|FG000|Treatment Extension II|Withdrawal by Subject|0|||
154950843|NCT03946449|559243972|FG001|Treatment Extension II|Withdrawal by Subject|0|||
154950844|NCT03946449|559243973|FG002|Treatment Extension II|Withdrawal by Subject|1|||
154950845|NCT05067504|559243975|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
154950846|NCT05067504|559243976|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
154950847|NCT05067504|559243975|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
154950848|NCT05067504|559243976|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
154950849|NCT05067504|559243975|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
154950850|NCT05067504|559243976|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
154950851|NCT00366899|559245788|FG000|Infant Series|Withdrawal by Subject|4|||
154950852|NCT00366899|559245789|FG001|Infant Series|Withdrawal by Subject|7|||
154950853|NCT00366899|559245788|FG000|Infant Series|Protocol Violation|2|||
154950854|NCT00366899|559245789|FG001|Infant Series|Protocol Violation|1|||
154950855|NCT00366899|559245788|FG000|Infant Series|Failed to return|1|||
154950856|NCT00366899|559245789|FG001|Infant Series|Failed to return|1|||
154950857|NCT00366899|559245788|FG000|Infant Series|Lost to Follow-up|0|||
154950858|NCT00366899|559245789|FG001|Infant Series|Lost to Follow-up|2|||
154950859|NCT00366899|559245788|FG000|Infant Series|Adverse Event|0|||
154950860|NCT00366899|559245789|FG001|Infant Series|Adverse Event|1|||
154950861|NCT00366899|559245788|FG000|Infant Series|Physician Decision|1|||
154950862|NCT00366899|559245789|FG001|Infant Series|Physician Decision|0|||
154950863|NCT00366899|559245788|FG000|Infant Series|Randomized but not consented|1|||
154950864|NCT00366899|559245789|FG001|Infant Series|Randomized but not consented|0|||
154950865|NCT00366899|559245788|FG000|After Infant Series|Lost to Follow-up|4|||
154950866|NCT00366899|559245789|FG001|After Infant Series|Lost to Follow-up|3|||
154950867|NCT00366899|559245788|FG000|After Infant Series|Withdrawal by Subject|1|||
154950868|NCT00366899|559245789|FG001|After Infant Series|Withdrawal by Subject|4|||
154950869|NCT00366899|559245788|FG000|After Infant Series|Adverse Event|1|||
154950870|NCT00366899|559245789|FG001|After Infant Series|Adverse Event|2|||
154950871|NCT00366899|559245788|FG000|After Infant Series|Protocol Violation|1|||
154950872|NCT00366899|559245789|FG001|After Infant Series|Protocol Violation|0|||
154950873|NCT00366899|559245788|FG000|Toddler Dose|Withdrawal by Subject|1|||
154950874|NCT00366899|559245789|FG001|Toddler Dose|Withdrawal by Subject|1|||
154950875|NCT00366899|559245788|FG000|Toddler Dose|Protocol Violation|1|||
154950876|NCT00366899|559245789|FG001|Toddler Dose|Protocol Violation|0|||
154950877|NCT02684344|559245795|FG000|Overall Study|Withdrawal by Subject|0|||
154950878|NCT02684344|559245796|FG001|Overall Study|Withdrawal by Subject|1|||
154950879|NCT01451762|559245797|FG000|Overall Study|Lost to Follow-up|3|||
154950880|NCT01451762|559245798|FG001|Overall Study|Lost to Follow-up|6|||
154950881|NCT01451762|559245799|FG002|Overall Study|Lost to Follow-up|6|||
154950882|NCT02424188|559245805|FG000|Overall Study|Death|2|||
154950883|NCT02424188|559245806|FG001|Overall Study|Death|2|||
154950884|NCT02424188|559245805|FG000|Overall Study|Lost to Follow-up|1|||
154950885|NCT02424188|559245806|FG001|Overall Study|Lost to Follow-up|3|||
154950886|NCT02424188|559245805|FG000|Overall Study|Incarceration|1|||
154950887|NCT02424188|559245806|FG001|Overall Study|Incarceration|0|||
154950888|NCT00630305|559245807|FG000|Overall Study|Withdrawal by Subject|1|||
154950889|NCT00630305|559245807|FG000|Overall Study|Inability to insert contact lens|1|||
154950890|NCT01085045|559245808|FG000|Part A|Withdrawal by Subject|4|||
154950891|NCT01085045|559245808|FG000|Part A|Adverse Event|6|||
154950892|NCT01085045|559245808|FG000|Part A|Protocol Violation|1|||
154950893|NCT01085045|559245808|FG000|Part A|Protocol Specified Criteria|7|||
154950894|NCT01085045|559245808|FG000|Part B|Withdrawal by Subject|2|||
154950895|NCT01085045|559245808|FG000|Part B|Protocol Specified Criteria|6|||
154950896|NCT01085045|559245808|FG000|Part B|Lost to Follow-up|1|||
154950897|NCT01085045|559245808|FG000|Part B|Adverse Event|6|||
154950898|NCT01494506|559245815|FG000|Overall Study|Lack of Efficacy|77|||
154950899|NCT01494506|559245816|FG001|Overall Study|Lack of Efficacy|83|||
154950900|NCT01494506|559245817|FG002|Overall Study|Lack of Efficacy|57|||
154950901|NCT01494506|559245815|FG000|Overall Study|Adverse Event|17|||
154950902|NCT01494506|559245816|FG001|Overall Study|Adverse Event|10|||
154950903|NCT01494506|559245817|FG002|Overall Study|Adverse Event|11|||
154950904|NCT01494506|559245815|FG000|Overall Study|Death|9|||
154950905|NCT01494506|559245816|FG001|Overall Study|Death|5|||
154950906|NCT01494506|559245817|FG002|Overall Study|Death|2|||
154950907|NCT01494506|559245815|FG000|Overall Study|Physician Decision|7|||
154950908|NCT01494506|559245816|FG001|Overall Study|Physician Decision|5|||
154950909|NCT01494506|559245817|FG002|Overall Study|Physician Decision|4|||
154950910|NCT01494506|559245815|FG000|Overall Study|Withdrawal by Subject|17|||
154950911|NCT01494506|559245816|FG001|Overall Study|Withdrawal by Subject|20|||
154950912|NCT01494506|559245817|FG002|Overall Study|Withdrawal by Subject|14|||
154950913|NCT01494506|559245815|FG000|Overall Study|Clinical Deterioration|21|||
154950914|NCT01494506|559245816|FG001|Overall Study|Clinical Deterioration|17|||
154950915|NCT01494506|559245817|FG002|Overall Study|Clinical Deterioration|13|||
154950916|NCT01494506|559245815|FG000|Overall Study|Sponsor Decision|0|||
154950917|NCT01494506|559245816|FG001|Overall Study|Sponsor Decision|0|||
154950918|NCT01494506|559245817|FG002|Overall Study|Sponsor Decision|1|||
154950919|NCT01494506|559245815|FG000|Overall Study|Other|0|||
154950920|NCT01494506|559245816|FG001|Overall Study|Other|3|||
154950921|NCT01494506|559245817|FG002|Overall Study|Other|1|||
154950922|NCT02924038|559245818|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
154950923|NCT02924038|559245819|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
154950924|NCT02777528|559245823|FG000|Overall Study|Still in study|24|||
154950925|NCT02777528|559245824|FG001|Overall Study|Still in study|10|||
154950926|NCT02777528|559245825|FG002|Overall Study|Still in study|1|||
154950927|NCT02777528|559245823|FG000|Overall Study|Study Device Explanted|1|||
154950928|NCT02777528|559245824|FG001|Overall Study|Study Device Explanted|0|||
155053802|NCT05616013|559627975|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053803|NCT05616013|559627976|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
155053804|NCT05616013|559627968|FG000|Overall Study|Participant Decision, Time Constraints|0|||
155053805|NCT05616013|559627969|FG001|Overall Study|Participant Decision, Time Constraints|1|||
155053806|NCT05616013|559627970|FG002|Overall Study|Participant Decision, Time Constraints|0|||
155053807|NCT05616013|559627971|FG003|Overall Study|Participant Decision, Time Constraints|0|||
155053808|NCT05616013|559627972|FG004|Overall Study|Participant Decision, Time Constraints|0|||
155053809|NCT05616013|559627973|FG005|Overall Study|Participant Decision, Time Constraints|0|||
155053810|NCT05616013|559627974|FG006|Overall Study|Participant Decision, Time Constraints|0|||
155053811|NCT05616013|559627975|FG007|Overall Study|Participant Decision, Time Constraints|0|||
155053812|NCT05616013|559627976|FG008|Overall Study|Participant Decision, Time Constraints|0|||
155053813|NCT05616013|559627968|FG000|Overall Study|Prohibited Concomitant Medication|0|||
155053814|NCT05616013|559627969|FG001|Overall Study|Prohibited Concomitant Medication|0|||
155053815|NCT05616013|559627970|FG002|Overall Study|Prohibited Concomitant Medication|1|||
155053816|NCT05616013|559627971|FG003|Overall Study|Prohibited Concomitant Medication|0|||
155053817|NCT05616013|559627972|FG004|Overall Study|Prohibited Concomitant Medication|0|||
155153085|NCT02476617|559998551|FG000|Overall Study|Lost to Follow-up|1|||
155053818|NCT05616013|559627973|FG005|Overall Study|Prohibited Concomitant Medication|0|||
155053819|NCT05616013|559627974|FG006|Overall Study|Prohibited Concomitant Medication|0|||
155053820|NCT05616013|559627975|FG007|Overall Study|Prohibited Concomitant Medication|0|||
155053821|NCT05616013|559627976|FG008|Overall Study|Prohibited Concomitant Medication|0|||
155053822|NCT05616013|559627968|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053823|NCT05616013|559627969|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053824|NCT05616013|559627970|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
155053825|NCT05616013|559627971|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053826|NCT05616013|559627972|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053827|NCT05616013|559627973|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053828|NCT05616013|559627974|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053829|NCT05616013|559627975|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053830|NCT05616013|559627976|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
155053831|NCT05616013|559627968|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053832|NCT05616013|559627969|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053833|NCT05616013|559627970|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053834|NCT05616013|559627971|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
155053835|NCT05616013|559627972|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053836|NCT05616013|559627973|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053837|NCT05616013|559627974|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053838|NCT05616013|559627975|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053839|NCT05616013|559627976|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
155053840|NCT05616013|559627968|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053841|NCT05616013|559627969|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053842|NCT05616013|559627970|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053843|NCT05616013|559627971|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053844|NCT05616013|559627972|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053845|NCT05616013|559627973|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053846|NCT05616013|559627974|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
155053847|NCT05616013|559627975|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053848|NCT05616013|559627976|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
155053849|NCT05616013|559627968|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053850|NCT05616013|559627969|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053851|NCT05616013|559627970|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053852|NCT05616013|559627971|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053853|NCT05616013|559627972|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053854|NCT05616013|559627973|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053855|NCT05616013|559627974|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053856|NCT05616013|559627975|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
155053857|NCT05616013|559627976|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
155053858|NCT05616013|559627968|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053859|NCT05616013|559627969|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053860|NCT05616013|559627970|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053861|NCT05616013|559627971|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053862|NCT05616013|559627972|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053863|NCT05616013|559627973|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053864|NCT05616013|559627974|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053865|NCT05616013|559627975|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
155053866|NCT05616013|559627976|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
155053867|NCT04391842|559627977|FG000|Overall Study|Withdrawal by Subject|2|||
155053868|NCT00810199|559627978|FG000|Overall Study|Adverse Event|24|||
155053869|NCT00810199|559627979|FG001|Overall Study|Adverse Event|26|||
155053870|NCT00810199|559627978|FG000|Overall Study|Death|4|||
155053871|NCT00810199|559627979|FG001|Overall Study|Death|6|||
155053872|NCT00810199|559627978|FG000|Overall Study|Withdrew consent|9|||
155053873|NCT00810199|559627979|FG001|Overall Study|Withdrew consent|12|||
155053874|NCT00810199|559627978|FG000|Overall Study|Insufficient therapeutic response|5|||
155393577|NCT01132612|560876799|FG002|Overall Study|Lost to Follow-up|7|||
155053875|NCT00810199|559627979|FG001|Overall Study|Insufficient therapeutic response|14|||
155053876|NCT00810199|559627978|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
155053877|NCT00810199|559627979|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
155053878|NCT00810199|559627978|FG000|Overall Study|Administrative/Other|5|||
155053879|NCT00810199|559627979|FG001|Overall Study|Administrative/Other|6|||
155053880|NCT00810199|559627978|FG000|Overall Study|Protocol Violation|2|||
155053881|NCT00810199|559627979|FG001|Overall Study|Protocol Violation|6|||
155053882|NCT00810199|559627978|FG000|Overall Study|Failure to return|1|||
155053883|NCT00810199|559627979|FG001|Overall Study|Failure to return|4|||
155053884|NCT00810199|559627978|FG000|Overall Study|Did not receive study drug|2|||
155053885|NCT00810199|559627979|FG001|Overall Study|Did not receive study drug|1|||
155053886|NCT00992017|559627981|FG000|Overall Study|Lost to Follow-up|2|||
155053887|NCT00992017|559627981|FG000|Overall Study|Withdrawal by Subject|2|||
155053888|NCT00992017|559627981|FG000|Overall Study|Unable to get to clinic|5|||
155053889|NCT00992017|559627981|FG000|Overall Study|Not adhere to study requirements|1|||
155053890|NCT02864407|559627982|FG000|Overall Study|Protocol Violation|3|||
155053891|NCT02864407|559627982|FG000|Overall Study|Lost to Follow-up|115|||
155053892|NCT02864407|559627982|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
155053893|NCT02864407|559627982|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
155053894|NCT02864407|559627982|FG000|Overall Study|Consent prior to the contract date|1|||
155053895|NCT02686164|559627990|FG000|Overall Study|Adverse Event|1|||
155053896|NCT02686164|559627990|FG000|Overall Study|Withdrawal of consent|1|||
154950929|NCT02777528|559245825|FG002|Overall Study|Study Device Explanted|0|||
154950930|NCT02777528|559245823|FG000|Overall Study|Death|14|||
154950931|NCT02777528|559245824|FG001|Overall Study|Death|7|||
154950932|NCT02777528|559245825|FG002|Overall Study|Death|1|||
154950933|NCT02777528|559245823|FG000|Overall Study|Withdrawal by Subject|2|||
154950934|NCT02777528|559245824|FG001|Overall Study|Withdrawal by Subject|2|||
154950935|NCT02777528|559245825|FG002|Overall Study|Withdrawal by Subject|1|||
154950936|NCT02777528|559245823|FG000|Overall Study|Physician Decision|2|||
154950937|NCT02777528|559245824|FG001|Overall Study|Physician Decision|1|||
154950938|NCT02777528|559245825|FG002|Overall Study|Physician Decision|0|||
154950939|NCT02777528|559245823|FG000|Overall Study|Lost to Follow-up|2|||
154950940|NCT02777528|559245824|FG001|Overall Study|Lost to Follow-up|0|||
154950941|NCT02777528|559245825|FG002|Overall Study|Lost to Follow-up|0|||
154950942|NCT02777528|559245823|FG000|Overall Study|Discontinued due to Other|1|||
154950943|NCT02777528|559245824|FG001|Overall Study|Discontinued due to Other|0|||
154950944|NCT02777528|559245825|FG002|Overall Study|Discontinued due to Other|0|||
154950945|NCT00453362|559245826|FG000|Overall Study|Adverse Event|5|||
154950946|NCT00453362|559245826|FG000|Overall Study|Death|7|||
154950947|NCT00453362|559245826|FG000|Overall Study|Physician Decision|2|||
154950948|NCT00453362|559245826|FG000|Overall Study|Withdrawal by Subject|3|||
154950949|NCT00453362|559245826|FG000|Overall Study|Progression of disease|56|||
154950950|NCT00453362|559245826|FG000|Overall Study|Screening Failure|14|||
154950951|NCT04885296|559245827|FG000|Period 1|Covid-19 Related|1|||
154950952|NCT04885296|559245828|FG001|Period 1|Covid-19 Related|0|||
154950953|NCT04885296|559245827|FG000|Period 1|Adverse Event|0|||
154950954|NCT04885296|559245828|FG001|Period 1|Adverse Event|1|||
154950955|NCT04885296|559245827|FG000|Period 1|Withdrawal by Subject|1|||
154950956|NCT04885296|559245828|FG001|Period 1|Withdrawal by Subject|1|||
154950957|NCT04885296|559245827|FG000|Period 1|Test Article No Longer Available|1|||
154950958|NCT04885296|559245828|FG001|Period 1|Test Article No Longer Available|0|||
154950959|NCT04885296|559245827|FG000|Period 1|Dispensed Study lens in Error|1|||
154950960|NCT04885296|559245828|FG001|Period 1|Dispensed Study lens in Error|0|||
154950961|NCT04885296|559245827|FG000|Period 1|Lost to Follow-up|1|||
154950962|NCT04885296|559245828|FG001|Period 1|Lost to Follow-up|0|||
154950963|NCT04885296|559245827|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
154950964|NCT04885296|559245828|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
154950965|NCT00433147|559245829|FG000|Overall Study|Adverse Event|0|||
154950966|NCT00433147|559245830|FG001|Overall Study|Adverse Event|1|||
154950967|NCT00433147|559245831|FG002|Overall Study|Adverse Event|0|||
154950968|NCT00433147|559245832|FG003|Overall Study|Adverse Event|0|||
154950969|NCT01882647|559245833|FG000|Overall Study|Lost to Follow-up|2|||
154950970|NCT01882647|559245834|FG001|Overall Study|Lost to Follow-up|2|||
154950971|NCT01882647|559245833|FG000|Overall Study|Withdrawal by Subject|0|||
154950972|NCT01882647|559245834|FG001|Overall Study|Withdrawal by Subject|4|||
155053897|NCT02686164|559627990|FG000|Overall Study|Clinical progression|1|||
155053898|NCT01691378|559627991|FG000|Overall Study|Withdrawal by Subject|2|||
155153086|NCT01383928|559998552|FG000|Overall Study|Initiation of ASCT|2|||
154950973|NCT03601637|559245836|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
154950974|NCT03601637|559245837|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
154950975|NCT03601637|559245836|FG000|Overall Study|Adverse Event|1|||
154950976|NCT03601637|559245837|FG001|Overall Study|Adverse Event|1|||
154950977|NCT03601637|559245836|FG000|Overall Study|Other|0|||
154950978|NCT03601637|559245837|FG001|Overall Study|Other|1|||
154950979|NCT05037097|559245838|FG000|Overall Study|Withdrawal by Subject|0|||
154950980|NCT05037097|559245839|FG001|Overall Study|Withdrawal by Subject|1|||
154950981|NCT05037097|559245840|FG002|Overall Study|Withdrawal by Subject|0|||
155053899|NCT01691378|559627992|FG001|Overall Study|Withdrawal by Subject|0|||
155053900|NCT01691378|559627991|FG000|Overall Study|Lost to Follow-up|5|||
155053901|NCT01691378|559627992|FG001|Overall Study|Lost to Follow-up|2|||
155053902|NCT01827592|559627993|FG000|Overall Study|Adverse Event|11|||
155053903|NCT01827592|559627994|FG001|Overall Study|Adverse Event|9|||
155053904|NCT01827592|559627995|FG002|Overall Study|Adverse Event|2|||
155053905|NCT01827592|559627993|FG000|Overall Study|Physician Decision|0|||
155053906|NCT01827592|559627994|FG001|Overall Study|Physician Decision|2|||
155053907|NCT01827592|559627995|FG002|Overall Study|Physician Decision|1|||
155053908|NCT01827592|559627993|FG000|Overall Study|Protocol Violation|2|||
155053909|NCT01827592|559627994|FG001|Overall Study|Protocol Violation|1|||
155053910|NCT01827592|559627995|FG002|Overall Study|Protocol Violation|0|||
155053911|NCT01827592|559627993|FG000|Overall Study|Lost to Follow-up|1|||
155053912|NCT01827592|559627994|FG001|Overall Study|Lost to Follow-up|2|||
155053913|NCT01827592|559627995|FG002|Overall Study|Lost to Follow-up|2|||
155053914|NCT01827592|559627993|FG000|Overall Study|Withdrawal by Subject|12|||
155053915|NCT01827592|559627994|FG001|Overall Study|Withdrawal by Subject|11|||
155053916|NCT01827592|559627995|FG002|Overall Study|Withdrawal by Subject|11|||
155053917|NCT01827592|559627993|FG000|Overall Study|Patient's substantial non-compliance|1|||
155053918|NCT01827592|559627994|FG001|Overall Study|Patient's substantial non-compliance|1|||
155053919|NCT01827592|559627995|FG002|Overall Study|Patient's substantial non-compliance|6|||
155053920|NCT01827592|559627993|FG000|Overall Study|Trial terminated by Sponsor|47|||
155053921|NCT01827592|559627994|FG001|Overall Study|Trial terminated by Sponsor|53|||
155053922|NCT01827592|559627995|FG002|Overall Study|Trial terminated by Sponsor|51|||
155053923|NCT01827592|559627993|FG000|Overall Study|Others|0|||
155053924|NCT01827592|559627994|FG001|Overall Study|Others|1|||
155053925|NCT01827592|559627995|FG002|Overall Study|Others|3|||
155053926|NCT00689338|559627999|FG000|Overall Study|Death|65|||
155053927|NCT00689338|559627999|FG000|Overall Study|Adverse Event|13|||
155053928|NCT00689338|559627999|FG000|Overall Study|Insufficient Clinical Response|1|||
155053929|NCT00689338|559627999|FG000|Overall Study|Lack of Efficacy|6|||
155053930|NCT00689338|559627999|FG000|Overall Study|Other|8|||
155053931|NCT00689338|559627999|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
155053932|NCT00689338|559627999|FG000|Overall Study|Lost to Follow-up|5|||
155053933|NCT00689338|559627999|FG000|Overall Study|Withdrawal by Subject|3|||
155053934|NCT00689338|559627999|FG000|Overall Study|Protocol Violation|15|||
155053935|NCT00808067|559628000|FG000|Overall Study|Major/minor bleed|30|||
155053936|NCT00808067|559628001|FG001|Overall Study|Major/minor bleed|44|||
155053937|NCT00808067|559628000|FG000|Overall Study|Outcome event - other|33|||
155053938|NCT00808067|559628001|FG001|Overall Study|Outcome event - other|25|||
155053939|NCT00808067|559628000|FG000|Overall Study|Adverse Event|111|||
155053940|NCT00808067|559628001|FG001|Overall Study|Adverse Event|121|||
155053941|NCT00808067|559628000|FG000|Overall Study|Hospitalization (not including surgery)|18|||
155053942|NCT00808067|559628001|FG001|Overall Study|Hospitalization (not including surgery)|17|||
155053943|NCT00808067|559628000|FG000|Overall Study|Hospitalization due to surgery|37|||
155053944|NCT00808067|559628001|FG001|Overall Study|Hospitalization due to surgery|40|||
155053945|NCT00808067|559628000|FG000|Overall Study|Reduced creatinine clearance|53|||
155053946|NCT00808067|559628001|FG001|Overall Study|Reduced creatinine clearance|55|||
155053947|NCT00808067|559628000|FG000|Overall Study|Elevated LFT results|7|||
155053948|NCT00808067|559628001|FG001|Overall Study|Elevated LFT results|3|||
155053949|NCT00808067|559628000|FG000|Overall Study|Patient refused to take study medication|65|||
155053950|NCT00808067|559628001|FG001|Overall Study|Patient refused to take study medication|76|||
155053951|NCT00808067|559628000|FG000|Overall Study|Missing|1|||
155053952|NCT00808067|559628001|FG001|Overall Study|Missing|0|||
155053953|NCT00808067|559628000|FG000|Overall Study|Death|1|||
155053954|NCT00808067|559628001|FG001|Overall Study|Death|1|||
155053955|NCT00808067|559628000|FG000|Overall Study|Procedure|6|||
155053956|NCT00808067|559628001|FG001|Overall Study|Procedure|7|||
155053957|NCT00808067|559628000|FG000|Overall Study|Withdrawal by Subject|21|||
155053958|NCT00808067|559628001|FG001|Overall Study|Withdrawal by Subject|25|||
155053959|NCT00808067|559628000|FG000|Overall Study|Site closed|4|||
155053960|NCT00808067|559628001|FG001|Overall Study|Site closed|3|||
155283289|NCT00924560|560468275|FG002|Overall Study|Pregnancy|1|||
155053961|NCT00808067|559628000|FG000|Overall Study|Physician Decision|47|||
155053962|NCT00808067|559628001|FG001|Overall Study|Physician Decision|38|||
155053963|NCT00808067|559628000|FG000|Overall Study|Protocol Violation|3|||
155053964|NCT00808067|559628001|FG001|Overall Study|Protocol Violation|11|||
155053965|NCT00808067|559628000|FG000|Overall Study|Patient elected|7|||
155053966|NCT00808067|559628001|FG001|Overall Study|Patient elected|9|||
155053967|NCT00808067|559628000|FG000|Overall Study|Site closed for cause|19|||
155053968|NCT00808067|559628001|FG001|Overall Study|Site closed for cause|19|||
155053969|NCT00808067|559628000|FG000|Overall Study|Other reason not defined above|5|||
155283290|NCT00924560|560468273|FG000|Overall Study|Lost to Follow-up|78|||
155053970|NCT00808067|559628001|FG001|Overall Study|Other reason not defined above|5|||
155053971|NCT00808067|559628000|FG000|Overall Study|Excluded from analysis|13|||
155053972|NCT00808067|559628001|FG001|Overall Study|Excluded from analysis|19|||
155053973|NCT02104895|559628002|FG000|Overall Study|Withdrawal by Subject|0|||
155053974|NCT02104895|559628003|FG001|Overall Study|Withdrawal by Subject|14|||
155053975|NCT04235504|559628006|FG000|Study Phase|Withdrawal by Subject|5|||
155053976|NCT04235504|559628007|FG001|Study Phase|Withdrawal by Subject|2|||
155053977|NCT04235504|559628008|FG002|Study Phase|Withdrawal by Subject|0|||
155053978|NCT04235504|559628009|FG003|Study Phase|Withdrawal by Subject|0|||
155053979|NCT04235504|559628006|FG000|Continuation Phase|Withdrawal by Subject|0|||
155053980|NCT04235504|559628007|FG001|Continuation Phase|Withdrawal by Subject|4|||
155053981|NCT04235504|559628008|FG002|Continuation Phase|Withdrawal by Subject|0|||
155053982|NCT04235504|559628009|FG003|Continuation Phase|Withdrawal by Subject|0|||
155053983|NCT04235504|559628006|FG000|Continuation Phase|Adverse Event|0|||
155053984|NCT04235504|559628007|FG001|Continuation Phase|Adverse Event|1|||
155053985|NCT04235504|559628008|FG002|Continuation Phase|Adverse Event|0|||
155053986|NCT04235504|559628009|FG003|Continuation Phase|Adverse Event|0|||
155053987|NCT04235504|559628006|FG000|Continuation Phase|Physician Decision|1|||
155053988|NCT04235504|559628007|FG001|Continuation Phase|Physician Decision|2|||
155053989|NCT04235504|559628008|FG002|Continuation Phase|Physician Decision|1|||
155053990|NCT04235504|559628009|FG003|Continuation Phase|Physician Decision|0|||
155053991|NCT02532283|559628011|FG000|Overall Study|Adverse Event|0|||
155053992|NCT02532283|559628012|FG001|Overall Study|Adverse Event|1|||
155053993|NCT02532283|559628011|FG000|Overall Study|Death|1|||
155053994|NCT02532283|559628012|FG001|Overall Study|Death|0|||
155053995|NCT02532283|559628011|FG000|Overall Study|Lost to Follow-up|0|||
155053996|NCT02532283|559628012|FG001|Overall Study|Lost to Follow-up|1|||
155053997|NCT02532283|559628011|FG000|Overall Study|Withdrawal by Subject|8|||
155053998|NCT02532283|559628012|FG001|Overall Study|Withdrawal by Subject|3|||
155053999|NCT01945944|559628015|FG000|Overall Study|Adverse Event|0|||
155054000|NCT01945944|559628016|FG001|Overall Study|Adverse Event|2|||
155054001|NCT01945944|559628015|FG000|Overall Study|Physician Decision|1|||
155054002|NCT01945944|559628016|FG001|Overall Study|Physician Decision|0|||
155054003|NCT01945944|559628015|FG000|Overall Study|Withdrawal by Subject|0|||
155054004|NCT01945944|559628016|FG001|Overall Study|Withdrawal by Subject|1|||
155054005|NCT01817075|559628017|FG000|Overall Study|Adverse Event|7|||
155054006|NCT01817075|559628018|FG001|Overall Study|Adverse Event|5|||
155054007|NCT01817075|559628017|FG000|Overall Study|Physician Decision|9|||
155054008|NCT01817075|559628018|FG001|Overall Study|Physician Decision|12|||
155054009|NCT01817075|559628017|FG000|Overall Study|Withdrawal by Subject|31|||
155054010|NCT01817075|559628018|FG001|Overall Study|Withdrawal by Subject|15|||
155054011|NCT01817075|559628017|FG000|Overall Study|Received Sorafenib after enrollment|0|||
155054012|NCT01817075|559628018|FG001|Overall Study|Received Sorafenib after enrollment|1|||
155054013|NCT01817075|559628017|FG000|Overall Study|Ineligible|0|||
155054014|NCT01817075|559628018|FG001|Overall Study|Ineligible|2|||
155054015|NCT04376515|559628021|FG000|Overall Study|Found to have been vaccinated before study start|6|||
155054016|NCT04376515|559628022|FG001|Overall Study|Found to have been vaccinated before study start|6|||
155054017|NCT03811821|559628023|FG000|Overall Study|Adverse Event|1|||
155054018|NCT03811821|559628024|FG001|Overall Study|Adverse Event|1|||
155054019|NCT03811821|559628023|FG000|Overall Study|Withdrawal by Subject|5|||
155054020|NCT03811821|559628024|FG001|Overall Study|Withdrawal by Subject|4|||
155054021|NCT03811821|559628023|FG000|Overall Study|Lost to Follow-up|2|||
155054022|NCT03811821|559628024|FG001|Overall Study|Lost to Follow-up|2|||
155054023|NCT03811821|559628023|FG000|Overall Study|Contraindication for treatment|0|||
155054024|NCT03811821|559628024|FG001|Overall Study|Contraindication for treatment|1|||
155054025|NCT03811821|559628023|FG000|Overall Study|Tolerability|0|||
155054026|NCT03811821|559628024|FG001|Overall Study|Tolerability|3|||
155054027|NCT03811821|559628023|FG000|Overall Study|Comorbidities|0|||
155054028|NCT03811821|559628024|FG001|Overall Study|Comorbidities|2|||
155054029|NCT01395810|559628027|FG000|Overall Study|Adverse Event|0|||
155054030|NCT01395810|559628028|FG001|Overall Study|Adverse Event|1|||
155054031|NCT01395810|559628029|FG002|Overall Study|Adverse Event|0|||
155054032|NCT01395810|559628030|FG003|Overall Study|Adverse Event|0|||
155054033|NCT01395810|559628027|FG000|Overall Study|Lack of Efficacy|0|||
155054034|NCT01395810|559628028|FG001|Overall Study|Lack of Efficacy|1|||
155054035|NCT01395810|559628029|FG002|Overall Study|Lack of Efficacy|0|||
155054036|NCT01395810|559628030|FG003|Overall Study|Lack of Efficacy|0|||
155054037|NCT01395810|559628027|FG000|Overall Study|Withdrawal criteria|0|||
155054038|NCT01395810|559628028|FG001|Overall Study|Withdrawal criteria|2|||
155054039|NCT01395810|559628029|FG002|Overall Study|Withdrawal criteria|0|||
155054040|NCT01395810|559628030|FG003|Overall Study|Withdrawal criteria|0|||
155054041|NCT01395810|559628027|FG000|Overall Study|Unclassified|2|||
155054042|NCT01395810|559628028|FG001|Overall Study|Unclassified|0|||
155054043|NCT01395810|559628029|FG002|Overall Study|Unclassified|0|||
155054044|NCT01395810|559628030|FG003|Overall Study|Unclassified|0|||
155054045|NCT03964207|559630295|FG000|First Treatment|Withdrawal by Subject|1|||
155054046|NCT03964207|559630296|FG001|First Treatment|Withdrawal by Subject|2|||
155054047|NCT03964207|559630295|FG000|First Treatment|Protocol Violation|1|||
155054048|NCT03964207|559630296|FG001|First Treatment|Protocol Violation|0|||
155054049|NCT03964207|559630295|FG000|First Treatment|Lost to Follow-up|1|||
155054050|NCT03964207|559630296|FG001|First Treatment|Lost to Follow-up|0|||
155054051|NCT03964207|559630295|FG000|Second Treatment|Lost to Follow-up|0|||
155054052|NCT03964207|559630296|FG001|Second Treatment|Lost to Follow-up|1|||
155054053|NCT03964207|559630295|FG000|Second Treatment|Adverse Event|1|||
155054054|NCT03964207|559630296|FG001|Second Treatment|Adverse Event|2|||
155054055|NCT00239720|559630297|FG000|Overall Study|Adverse Event|1|||
154950982|NCT05037097|559245841|FG003|Overall Study|Withdrawal by Subject|1|||
154950983|NCT05037097|559245842|FG004|Overall Study|Withdrawal by Subject|0|||
154950984|NCT05037097|559245843|FG005|Overall Study|Withdrawal by Subject|2|||
154950985|NCT05037097|559245844|FG006|Overall Study|Withdrawal by Subject|0|||
154950986|NCT05037097|559245845|FG007|Overall Study|Withdrawal by Subject|0|||
154950987|NCT05037097|559245838|FG000|Overall Study|Lost to Follow-up|0|||
154950988|NCT05037097|559245839|FG001|Overall Study|Lost to Follow-up|1|||
154950989|NCT05037097|559245840|FG002|Overall Study|Lost to Follow-up|0|||
154950990|NCT05037097|559245841|FG003|Overall Study|Lost to Follow-up|0|||
154950991|NCT05037097|559245842|FG004|Overall Study|Lost to Follow-up|1|||
154950992|NCT05037097|559245843|FG005|Overall Study|Lost to Follow-up|1|||
154950993|NCT05037097|559245844|FG006|Overall Study|Lost to Follow-up|0|||
154950994|NCT05037097|559245845|FG007|Overall Study|Lost to Follow-up|0|||
154950995|NCT02322047|559245846|FG000|Overall Study|Physician Decision|1|||
154950996|NCT02322047|559245847|FG001|Overall Study|Physician Decision|0|||
154950997|NCT02322047|559245848|FG002|Overall Study|Physician Decision|0|||
154950998|NCT02322047|559245849|FG003|Overall Study|Physician Decision|0|||
154950999|NCT02322047|559245846|FG000|Overall Study|Withdrawal by Subject|1|||
154951000|NCT02322047|559245847|FG001|Overall Study|Withdrawal by Subject|0|||
154951001|NCT02322047|559245848|FG002|Overall Study|Withdrawal by Subject|0|||
154951002|NCT02322047|559245849|FG003|Overall Study|Withdrawal by Subject|1|||
154951003|NCT02322047|559245846|FG000|Overall Study|Adverse Event|0|||
154951004|NCT02322047|559245847|FG001|Overall Study|Adverse Event|1|||
154951005|NCT02322047|559245848|FG002|Overall Study|Adverse Event|0|||
154951006|NCT02322047|559245849|FG003|Overall Study|Adverse Event|0|||
154951007|NCT02322047|559245846|FG000|Overall Study|Lost to Follow-up|0|||
154951008|NCT02322047|559245847|FG001|Overall Study|Lost to Follow-up|0|||
154951009|NCT02322047|559245848|FG002|Overall Study|Lost to Follow-up|1|||
154951010|NCT02322047|559245849|FG003|Overall Study|Lost to Follow-up|1|||
154951011|NCT00376220|559245852|FG000|Overall Study|Lost to Follow-up|7|||
154951012|NCT00376220|559245853|FG001|Overall Study|Lost to Follow-up|10|||
154951013|NCT00376220|559245852|FG000|Overall Study|Withdrawal by Subject|3|||
154951014|NCT00376220|559245853|FG001|Overall Study|Withdrawal by Subject|2|||
154951015|NCT02564263|559245856|FG000|Overall Study|Adverse Event|31|||
154951016|NCT02564263|559245857|FG001|Overall Study|Adverse Event|29|||
154951017|NCT02564263|559245856|FG000|Overall Study|Death|270|||
154951018|NCT02564263|559245857|FG001|Overall Study|Death|262|||
154951019|NCT02564263|559245856|FG000|Overall Study|Withdrawal by Subject|4|||
154951020|NCT02564263|559245857|FG001|Overall Study|Withdrawal by Subject|19|||
154951021|NCT02564263|559245856|FG000|Overall Study|Sponsor's decision|9|||
154951022|NCT02564263|559245857|FG001|Overall Study|Sponsor's decision|4|||
154951023|NCT03311646|559245858|FG000|Overall Study|Physician Decision|1|||
154951024|NCT03311646|559245858|FG000|Overall Study|Withdrawal by Subject|5|||
154951025|NCT03311646|559245858|FG000|Overall Study|Lost to Follow-up|5|||
154951026|NCT03311646|559245858|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
154951027|NCT01644500|559245859|FG000|Overall Study|Adverse Event|6|||
154951028|NCT01644500|559245860|FG001|Overall Study|Adverse Event|1|||
154951029|NCT01644500|559245861|FG002|Overall Study|Adverse Event|2|||
154951030|NCT01644500|559245859|FG000|Overall Study|Death|0|||
154951031|NCT01644500|559245860|FG001|Overall Study|Death|1|||
154951032|NCT01644500|559245861|FG002|Overall Study|Death|0|||
154951033|NCT01644500|559245859|FG000|Overall Study|Lost to Follow-up|3|||
154951034|NCT01644500|559245860|FG001|Overall Study|Lost to Follow-up|8|||
154951035|NCT01644500|559245861|FG002|Overall Study|Lost to Follow-up|0|||
154951036|NCT01644500|559245859|FG000|Overall Study|Protocol Violation|1|||
154951037|NCT01644500|559245860|FG001|Overall Study|Protocol Violation|1|||
154951038|NCT01644500|559245861|FG002|Overall Study|Protocol Violation|0|||
154951039|NCT01644500|559245859|FG000|Overall Study|Withdrawal by Subject|11|||
154951040|NCT01644500|559245860|FG001|Overall Study|Withdrawal by Subject|12|||
154951041|NCT01644500|559245861|FG002|Overall Study|Withdrawal by Subject|12|||
154951042|NCT01644500|559245859|FG000|Overall Study|Physician Decision|1|||
154951043|NCT01644500|559245860|FG001|Overall Study|Physician Decision|1|||
155054056|NCT00239720|559630298|FG001|Overall Study|Adverse Event|0|||
154951044|NCT01644500|559245861|FG002|Overall Study|Physician Decision|1|||
154951045|NCT01400425|559245865|FG000|Overall Study|Withdrawal by Subject|10|||
154951046|NCT00688064|559245866|FG000|Overall Study|Protocol Violation|0|||
154951047|NCT00688064|559245867|FG001|Overall Study|Protocol Violation|1|||
154951048|NCT00688064|559245866|FG000|Overall Study|Adverse Event|2|||
154951049|NCT00688064|559245867|FG001|Overall Study|Adverse Event|4|||
154951050|NCT00688064|559245866|FG000|Overall Study|Withdrawal by Subject|7|||
154951051|NCT00688064|559245867|FG001|Overall Study|Withdrawal by Subject|7|||
155054057|NCT00239720|559630297|FG000|Overall Study|Lost to Follow-up|0|||
155054058|NCT00239720|559630298|FG001|Overall Study|Lost to Follow-up|1|||
155054059|NCT01783743|559630303|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
155054060|NCT01783743|559630304|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
155054061|NCT01783743|559630303|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
155054062|NCT01783743|559630304|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
155054063|NCT01783743|559630303|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
155054064|NCT01783743|559630304|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
155054065|NCT02771275|559630305|FG000|Overall Study|Reoperation|3|||
154951052|NCT00688064|559245866|FG000|Overall Study|Lost to Follow-up|10|||
154951053|NCT00688064|559245867|FG001|Overall Study|Lost to Follow-up|10|||
154951054|NCT00688064|559245866|FG000|Overall Study|Lack of Efficacy|0|||
154951055|NCT00688064|559245867|FG001|Overall Study|Lack of Efficacy|1|||
154951056|NCT00688064|559245866|FG000|Overall Study|Pregnancy|1|||
154951057|NCT00688064|559245867|FG001|Overall Study|Pregnancy|0|||
154951058|NCT00688064|559245866|FG000|Overall Study|Any other reasons|1|||
154951059|NCT00688064|559245867|FG001|Overall Study|Any other reasons|3|||
154951060|NCT00720096|559245870|FG000|Overall Study|Withdrawal by Subject|0|||
154951061|NCT00720096|559245871|FG001|Overall Study|Withdrawal by Subject|2|||
154951062|NCT04557124|559245872|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
154951063|NCT04557124|559245873|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
154951064|NCT04557124|559245872|FG000|Mid-point (1 Month)|Missed testing|5|||
154951065|NCT04557124|559245873|FG001|Mid-point (1 Month)|Missed testing|4|||
154951066|NCT04557124|559245872|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
154951067|NCT04557124|559245873|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
154951068|NCT04557124|559245872|FG000|Post-testing (2 Months)|Missed testing|1|||
154951069|NCT04557124|559245873|FG001|Post-testing (2 Months)|Missed testing|5|||
154951070|NCT04557124|559245872|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
154951071|NCT04557124|559245873|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
154951072|NCT04557124|559245872|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
154951073|NCT04557124|559245873|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
154951074|NCT00001849|559245874|FG000|Overall Study|Death|4|||
154951075|NCT00001849|559245874|FG000|Overall Study|Lost to Follow-up|2|||
154951076|NCT00001849|559245874|FG000|Overall Study|Withdrawal by Subject|2|||
154951077|NCT00001849|559245874|FG000|Overall Study|tumor remained occult|6|||
154951078|NCT00442936|559245875|FG000|Overall Study|Protocol Violation|1|||
154951079|NCT00442936|559245876|FG001|Overall Study|Protocol Violation|0|||
154951080|NCT00442936|559245877|FG002|Overall Study|Protocol Violation|1|||
154951081|NCT00442936|559245878|FG003|Overall Study|Protocol Violation|1|||
154951082|NCT00524459|559245883|FG000|Overall Study|Withdrawal by Subject|1|||
154951083|NCT00524459|559245883|FG000|Overall Study|Other|1|||
154951084|NCT02428699|559245884|FG000|Washout Period 1|Screen Failure|1|||
154951085|NCT02428699|559245885|FG001|Washout Period 1|Screen Failure|2|||
154951086|NCT04424407|559245886|FG000|Overall Study|Withdrawal by Subject|2|||
154951087|NCT04424407|559245886|FG000|Overall Study|Lost to Follow-up|1|||
154951088|NCT01574248|559245889|FG000|Overall Study|Withdrawal by Subject|2|||
154951089|NCT01574248|559245890|FG001|Overall Study|Withdrawal by Subject|0|||
154951090|NCT01574248|559245889|FG000|Overall Study|Missing primary endpoint data|1|||
154951091|NCT01574248|559245890|FG001|Overall Study|Missing primary endpoint data|0|||
154951092|NCT01193608|559245891|FG000|Overall Study|Other|0|||
154951093|NCT01193608|559245892|FG001|Overall Study|Other|1|||
154951094|NCT01193608|559245893|FG002|Overall Study|Other|0|||
154951095|NCT01193608|559245894|FG003|Overall Study|Other|0|||
154951096|NCT01193608|559245895|FG004|Overall Study|Other|0|||
154951097|NCT01193608|559245896|FG005|Overall Study|Other|0|||
154951098|NCT01193608|559245891|FG000|Overall Study|Withdrawal by Subject|0|||
154951099|NCT01193608|559245892|FG001|Overall Study|Withdrawal by Subject|1|||
154951100|NCT01193608|559245893|FG002|Overall Study|Withdrawal by Subject|2|||
154951101|NCT01193608|559245894|FG003|Overall Study|Withdrawal by Subject|3|||
154951102|NCT01193608|559245895|FG004|Overall Study|Withdrawal by Subject|3|||
154951103|NCT01193608|559245896|FG005|Overall Study|Withdrawal by Subject|0|||
154951104|NCT01193608|559245891|FG000|Overall Study|Lost to Follow-up|0|||
154951105|NCT01193608|559245892|FG001|Overall Study|Lost to Follow-up|0|||
154951106|NCT01193608|559245893|FG002|Overall Study|Lost to Follow-up|0|||
154951107|NCT01193608|559245894|FG003|Overall Study|Lost to Follow-up|0|||
154951108|NCT01193608|559245895|FG004|Overall Study|Lost to Follow-up|1|||
154951109|NCT01193608|559245896|FG005|Overall Study|Lost to Follow-up|2|||
154951110|NCT01193608|559245891|FG000|Overall Study|Adverse Event|0|||
154951111|NCT01193608|559245892|FG001|Overall Study|Adverse Event|0|||
154951112|NCT01193608|559245893|FG002|Overall Study|Adverse Event|0|||
154951113|NCT01193608|559245894|FG003|Overall Study|Adverse Event|0|||
154951114|NCT01193608|559245895|FG004|Overall Study|Adverse Event|1|||
154951115|NCT01193608|559245896|FG005|Overall Study|Adverse Event|0|||
154951116|NCT00864097|559245897|FG000|Overall Study|Death|0|||
154951117|NCT00864097|559245898|FG001|Overall Study|Death|1|||
154951118|NCT00864097|559245899|FG002|Overall Study|Death|0|||
154951119|NCT00864097|559245900|FG003|Overall Study|Death|0|||
154951120|NCT00864097|559245897|FG000|Overall Study|Adverse Event|6|||
154951121|NCT00864097|559245898|FG001|Overall Study|Adverse Event|8|||
154951122|NCT00864097|559245899|FG002|Overall Study|Adverse Event|11|||
154951123|NCT00864097|559245900|FG003|Overall Study|Adverse Event|9|||
154951124|NCT00864097|559245897|FG000|Overall Study|Lack of Efficacy|9|||
154951125|NCT00864097|559245898|FG001|Overall Study|Lack of Efficacy|3|||
154951126|NCT00864097|559245899|FG002|Overall Study|Lack of Efficacy|7|||
154951127|NCT00864097|559245900|FG003|Overall Study|Lack of Efficacy|2|||
154951128|NCT00864097|559245897|FG000|Overall Study|Lost to Follow-up|0|||
155054066|NCT02771275|559630305|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
155054067|NCT05556148|559630306|FG000|Overall Study|Early Termination|29|||
155054068|NCT05556148|559630306|FG000|Overall Study|Baseline Tasks Expired|4|||
155054069|NCT05556148|559630306|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
155054070|NCT05556148|559630306|FG000|Overall Study|No Longer Wished to Participate|1|||
155054071|NCT05556148|559630306|FG000|Overall Study|Bacterial Conjunctivitis|1|||
155054072|NCT00126594|559630320|FG000|Overall Study|Ineligible|2|||
155054073|NCT00126594|559630321|FG001|Overall Study|Ineligible|0|||
155054074|NCT00126594|559630320|FG000|Overall Study|Withdrawal by Subject|0|||
155054075|NCT00126594|559630321|FG001|Overall Study|Withdrawal by Subject|4|||
155054076|NCT00126594|559630320|FG000|Overall Study|Physician Decision|1|||
155054077|NCT00126594|559630321|FG001|Overall Study|Physician Decision|3|||
155054078|NCT00126594|559630320|FG000|Overall Study|Adverse Event|7|||
155054079|NCT00126594|559630321|FG001|Overall Study|Adverse Event|5|||
155054080|NCT00126594|559630320|FG000|Overall Study|Non-compliance|0|||
155054081|NCT00126594|559630321|FG001|Overall Study|Non-compliance|1|||
155054082|NCT00126594|559630320|FG000|Overall Study|Disease Progression|29|||
155054083|NCT00126594|559630321|FG001|Overall Study|Disease Progression|24|||
155054084|NCT00853762|559630322|FG000|Overall Study|Premature Termination|16|||
155054085|NCT00853762|559630323|FG001|Overall Study|Premature Termination|15|||
155054086|NCT00853762|559630324|FG002|Overall Study|Premature Termination|14|||
155054087|NCT00853762|559630325|FG003|Overall Study|Premature Termination|21|||
155054088|NCT00853762|559630322|FG000|Overall Study|Protocol Violation|0|||
155054089|NCT00853762|559630323|FG001|Overall Study|Protocol Violation|0|||
155054090|NCT00853762|559630324|FG002|Overall Study|Protocol Violation|0|||
155054091|NCT00853762|559630325|FG003|Overall Study|Protocol Violation|1|||
155054092|NCT00853762|559630322|FG000|Overall Study|Withdrawal by Subject|0|||
155054093|NCT00853762|559630323|FG001|Overall Study|Withdrawal by Subject|0|||
155054094|NCT00853762|559630324|FG002|Overall Study|Withdrawal by Subject|1|||
155054095|NCT00853762|559630325|FG003|Overall Study|Withdrawal by Subject|0|||
155054096|NCT00853762|559630322|FG000|Overall Study|Other|0|||
155054097|NCT00853762|559630323|FG001|Overall Study|Other|2|||
155054098|NCT00853762|559630324|FG002|Overall Study|Other|0|||
155054099|NCT00853762|559630325|FG003|Overall Study|Other|0|||
155054100|NCT00853762|559630322|FG000|Overall Study|Randomised but not Treated|0|||
155054101|NCT00853762|559630323|FG001|Overall Study|Randomised but not Treated|2|||
155054102|NCT00853762|559630324|FG002|Overall Study|Randomised but not Treated|2|||
155054103|NCT00853762|559630325|FG003|Overall Study|Randomised but not Treated|0|||
155054104|NCT02000921|559630330|FG000|Overall Study|Withdrawal by Subject|3|||
155054105|NCT02000921|559630331|FG001|Overall Study|Withdrawal by Subject|10|||
155054106|NCT02000921|559630332|FG002|Overall Study|Withdrawal by Subject|5|||
155054107|NCT02000921|559630330|FG000|Overall Study|Lost to Follow-up|2|||
155054108|NCT02000921|559630331|FG001|Overall Study|Lost to Follow-up|4|||
155054109|NCT02000921|559630332|FG002|Overall Study|Lost to Follow-up|5|||
155054110|NCT02000921|559630330|FG000|Overall Study|Physician Decision|0|||
155054111|NCT02000921|559630331|FG001|Overall Study|Physician Decision|2|||
155054112|NCT02000921|559630332|FG002|Overall Study|Physician Decision|0|||
155054113|NCT01290718|559630333|FG000|Overall Study|Early termination of the study|4|||
155054114|NCT02631941|559630336|FG000|Overall Study|Physician Decision|0|||
155054115|NCT02631941|559630337|FG001|Overall Study|Physician Decision|1|||
155054116|NCT02631941|559630338|FG002|Overall Study|Physician Decision|0|||
155054117|NCT02631941|559630339|FG003|Overall Study|Physician Decision|0|||
155054118|NCT02631941|559630340|FG004|Overall Study|Physician Decision|0|||
155054119|NCT02631941|559630341|FG005|Overall Study|Physician Decision|0|||
155054120|NCT02631941|559630342|FG006|Overall Study|Physician Decision|0|||
155054121|NCT02631941|559630343|FG007|Overall Study|Physician Decision|0|||
155054122|NCT02631941|559630344|FG008|Overall Study|Physician Decision|0|||
155054123|NCT02631941|559630345|FG009|Overall Study|Physician Decision|0|||
155054124|NCT02631941|559630336|FG000|Overall Study|Adverse Event|0|||
155054125|NCT02631941|559630337|FG001|Overall Study|Adverse Event|1|||
155054126|NCT02631941|559630338|FG002|Overall Study|Adverse Event|0|||
155054127|NCT02631941|559630339|FG003|Overall Study|Adverse Event|0|||
155054128|NCT02631941|559630340|FG004|Overall Study|Adverse Event|0|||
155054129|NCT02631941|559630341|FG005|Overall Study|Adverse Event|0|||
155054130|NCT02631941|559630342|FG006|Overall Study|Adverse Event|0|||
155054131|NCT02631941|559630343|FG007|Overall Study|Adverse Event|0|||
155054132|NCT02631941|559630344|FG008|Overall Study|Adverse Event|0|||
155054133|NCT02631941|559630345|FG009|Overall Study|Adverse Event|0|||
155054134|NCT02631941|559630336|FG000|Overall Study|Withdrawal by Subject|0|||
155054135|NCT02631941|559630337|FG001|Overall Study|Withdrawal by Subject|0|||
155054136|NCT02631941|559630338|FG002|Overall Study|Withdrawal by Subject|0|||
155054137|NCT02631941|559630339|FG003|Overall Study|Withdrawal by Subject|0|||
155054138|NCT02631941|559630340|FG004|Overall Study|Withdrawal by Subject|1|||
155054139|NCT02631941|559630341|FG005|Overall Study|Withdrawal by Subject|0|||
155054140|NCT02631941|559630342|FG006|Overall Study|Withdrawal by Subject|0|||
155054141|NCT02631941|559630343|FG007|Overall Study|Withdrawal by Subject|1|||
155054142|NCT02631941|559630344|FG008|Overall Study|Withdrawal by Subject|0|||
155054143|NCT02631941|559630345|FG009|Overall Study|Withdrawal by Subject|0|||
155054144|NCT02631941|559630336|FG000|Overall Study|Lost to Follow-up|0|||
155054145|NCT02631941|559630337|FG001|Overall Study|Lost to Follow-up|0|||
155054146|NCT02631941|559630338|FG002|Overall Study|Lost to Follow-up|0|||
155054147|NCT02631941|559630339|FG003|Overall Study|Lost to Follow-up|0|||
155054148|NCT02631941|559630340|FG004|Overall Study|Lost to Follow-up|0|||
155054149|NCT02631941|559630341|FG005|Overall Study|Lost to Follow-up|0|||
155054150|NCT02631941|559630342|FG006|Overall Study|Lost to Follow-up|0|||
155054151|NCT02631941|559630343|FG007|Overall Study|Lost to Follow-up|0|||
155054152|NCT02631941|559630344|FG008|Overall Study|Lost to Follow-up|1|||
155054153|NCT02631941|559630345|FG009|Overall Study|Lost to Follow-up|0|||
155054154|NCT00719901|559630348|FG000|Overall Study|Adverse Event|5|||
155054155|NCT00719901|559630348|FG000|Overall Study|Withdrawal by Subject|1|||
155054156|NCT00719901|559630348|FG000|Overall Study|Alternate Treatment|1|||
155054157|NCT00719901|559630348|FG000|Overall Study|Disease Progression|3|||
155054158|NCT00719901|559630348|FG000|Overall Study|Availability of Study Drug|1|||
155054159|NCT04456686|559630351|FG000|Overall Study|Adverse Event|2|||
155054160|NCT04456686|559630352|FG001|Overall Study|Adverse Event|1|||
155054161|NCT04456686|559630351|FG000|Overall Study|Lack of Efficacy|3|||
155054162|NCT04456686|559630352|FG001|Overall Study|Lack of Efficacy|1|||
155054163|NCT04456686|559630351|FG000|Overall Study|Withdrew consent|3|||
155054164|NCT04456686|559630352|FG001|Overall Study|Withdrew consent|1|||
155054165|NCT04456686|559630351|FG000|Overall Study|Physician Decision|2|||
155054166|NCT04456686|559630352|FG001|Overall Study|Physician Decision|2|||
155054167|NCT04456686|559630351|FG000|Overall Study|Withdrawal by Subject|5|||
155054168|NCT04456686|559630352|FG001|Overall Study|Withdrawal by Subject|1|||
155054169|NCT04456686|559630351|FG000|Overall Study|Protocol Violation|0|||
155054170|NCT04456686|559630352|FG001|Overall Study|Protocol Violation|1|||
155054171|NCT02858401|559630355|FG000|Overall Study|Withdrew Consent|0|||
155054172|NCT02858401|559630356|FG001|Overall Study|Withdrew Consent|0|||
155054173|NCT02858401|559630357|FG002|Overall Study|Withdrew Consent|0|||
155054174|NCT02858401|559630358|FG003|Overall Study|Withdrew Consent|0|||
155054175|NCT02858401|559630359|FG004|Overall Study|Withdrew Consent|0|||
155054176|NCT02858401|559630360|FG005|Overall Study|Withdrew Consent|1|||
155054177|NCT02858401|559630361|FG006|Overall Study|Withdrew Consent|0|||
155054178|NCT02858401|559630355|FG000|Overall Study|Lost to Follow-up|0|||
155054179|NCT02858401|559630356|FG001|Overall Study|Lost to Follow-up|1|||
155054180|NCT02858401|559630357|FG002|Overall Study|Lost to Follow-up|0|||
155054181|NCT02858401|559630358|FG003|Overall Study|Lost to Follow-up|0|||
155054182|NCT02858401|559630359|FG004|Overall Study|Lost to Follow-up|0|||
155054183|NCT02858401|559630360|FG005|Overall Study|Lost to Follow-up|0|||
155054184|NCT02858401|559630361|FG006|Overall Study|Lost to Follow-up|0|||
155054185|NCT02869789|559630367|FG000|Overall Study|Disease progression|184|||
155054186|NCT02869789|559630368|FG001|Overall Study|Disease progression|109|||
155054187|NCT02869789|559630369|FG002|Overall Study|Disease progression|260|||
155054188|NCT02869789|559630370|FG003|Overall Study|Disease progression|19|||
155054189|NCT02869789|559630367|FG000|Overall Study|Study drug toxicity|90|||
155054190|NCT02869789|559630368|FG001|Overall Study|Study drug toxicity|32|||
155054191|NCT02869789|559630369|FG002|Overall Study|Study drug toxicity|55|||
155054192|NCT02869789|559630370|FG003|Overall Study|Study drug toxicity|14|||
155054193|NCT02869789|559630367|FG000|Overall Study|Death|7|||
155054194|NCT02869789|559630368|FG001|Overall Study|Death|3|||
155054195|NCT02869789|559630369|FG002|Overall Study|Death|5|||
155054196|NCT02869789|559630370|FG003|Overall Study|Death|1|||
155054197|NCT02869789|559630367|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
155054198|NCT02869789|559630368|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
155054199|NCT02869789|559630369|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
155054200|NCT02869789|559630370|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
155054201|NCT02869789|559630367|FG000|Overall Study|Participant request to discontinue study treatment|10|||
155054202|NCT02869789|559630368|FG001|Overall Study|Participant request to discontinue study treatment|5|||
155054203|NCT02869789|559630369|FG002|Overall Study|Participant request to discontinue study treatment|5|||
155054204|NCT02869789|559630370|FG003|Overall Study|Participant request to discontinue study treatment|3|||
155054205|NCT02869789|559630367|FG000|Overall Study|Withdrawal by Subject|5|||
155054206|NCT02869789|559630368|FG001|Overall Study|Withdrawal by Subject|2|||
155054207|NCT02869789|559630369|FG002|Overall Study|Withdrawal by Subject|7|||
155054208|NCT02869789|559630370|FG003|Overall Study|Withdrawal by Subject|2|||
155054209|NCT02869789|559630367|FG000|Overall Study|Lost to Follow-up|0|||
155054210|NCT02869789|559630368|FG001|Overall Study|Lost to Follow-up|0|||
155054211|NCT02869789|559630369|FG002|Overall Study|Lost to Follow-up|2|||
155054212|NCT02869789|559630370|FG003|Overall Study|Lost to Follow-up|0|||
155054213|NCT02869789|559630367|FG000|Overall Study|Maximum clinical benefit|5|||
155054214|NCT02869789|559630368|FG001|Overall Study|Maximum clinical benefit|2|||
155054215|NCT02869789|559630369|FG002|Overall Study|Maximum clinical benefit|1|||
155054216|NCT02869789|559630370|FG003|Overall Study|Maximum clinical benefit|0|||
155054217|NCT02869789|559630367|FG000|Overall Study|Poor/Non-compliance|0|||
155054218|NCT02869789|559630368|FG001|Overall Study|Poor/Non-compliance|2|||
155054219|NCT02869789|559630369|FG002|Overall Study|Poor/Non-compliance|1|||
155054220|NCT02869789|559630370|FG003|Overall Study|Poor/Non-compliance|0|||
155054221|NCT02869789|559630367|FG000|Overall Study|Participant no longer meets study criteria|0|||
155054222|NCT02869789|559630368|FG001|Overall Study|Participant no longer meets study criteria|1|||
155054223|NCT02869789|559630369|FG002|Overall Study|Participant no longer meets study criteria|1|||
155054224|NCT02869789|559630370|FG003|Overall Study|Participant no longer meets study criteria|0|||
155054225|NCT02869789|559630367|FG000|Overall Study|Administrative reason by sponsor|0|||
155054226|NCT02869789|559630368|FG001|Overall Study|Administrative reason by sponsor|0|||
155054227|NCT02869789|559630369|FG002|Overall Study|Administrative reason by sponsor|1|||
155054228|NCT02869789|559630370|FG003|Overall Study|Administrative reason by sponsor|0|||
155054229|NCT02869789|559630367|FG000|Overall Study|Other reasons|4|||
155054230|NCT02869789|559630368|FG001|Overall Study|Other reasons|8|||
155054231|NCT02869789|559630369|FG002|Overall Study|Other reasons|6|||
155054232|NCT02869789|559630370|FG003|Overall Study|Other reasons|0|||
155054233|NCT00297648|559630372|FG000|Overall Study|Adverse Event|13|||
155054234|NCT00297648|559630372|FG000|Overall Study|Lack of Efficacy|18|||
155054235|NCT00297648|559630372|FG000|Overall Study|Lost to Follow-up|1|||
155054236|NCT00297648|559630372|FG000|Overall Study|Withdrawal by Subject|3|||
155054237|NCT00297648|559630372|FG000|Overall Study|Other: Incompliance|1|||
155054238|NCT02048722|559630373|FG000|2 Cycles of Treatment|Adverse Event|2|||
155054239|NCT02048722|559630373|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
155054240|NCT02048722|559630373|FG000|2 Cycles of Treatment|Progressive Disease|2|||
155054241|NCT02048722|559630373|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
155054242|NCT02048722|559630373|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
155054243|NCT02048722|559630373|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
155054244|NCT01746862|559630375|FG000|Overall Study|Withdrawal by Subject|1|||
155054245|NCT01746862|559630376|FG001|Overall Study|Withdrawal by Subject|1|||
155054246|NCT01746862|559630375|FG000|Overall Study|Protocol Violation|1|||
155054247|NCT01746862|559630376|FG001|Overall Study|Protocol Violation|0|||
155054248|NCT01746862|559630375|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
155054249|NCT01746862|559630376|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
155054250|NCT01746862|559630375|FG000|Overall Study|Entered puberty during the study|1|||
155054251|NCT01746862|559630376|FG001|Overall Study|Entered puberty during the study|0|||
155054252|NCT00731822|559630383|FG000|Overall Study|Adverse Event|2|||
155054253|NCT00731822|559630384|FG001|Overall Study|Adverse Event|1|||
155054254|NCT00731822|559630383|FG000|Overall Study|Protocol Violation|1|||
155054255|NCT00731822|559630384|FG001|Overall Study|Protocol Violation|0|||
155054256|NCT00731822|559630383|FG000|Overall Study|Lost to Follow-up|1|||
155054257|NCT00731822|559630384|FG001|Overall Study|Lost to Follow-up|0|||
155054258|NCT02127658|559630385|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
155054259|NCT02127658|559630386|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
155054260|NCT02127658|559630385|FG000|Overall Study|Withdrawal by Subject|0|||
155054261|NCT02127658|559630386|FG001|Overall Study|Withdrawal by Subject|2|||
155054262|NCT02127658|559630385|FG000|Overall Study|Physician Decision|0|||
155054263|NCT02127658|559630386|FG001|Overall Study|Physician Decision|1|||
155054264|NCT03834493|559630387|FG000|Overall Study|Participants Ongoing|311|||
155054265|NCT03834493|559630388|FG001|Overall Study|Participants Ongoing|324|||
155054266|NCT03834493|559630387|FG000|Overall Study|Withdrawal by Subject|20|||
155054267|NCT03834493|559630388|FG001|Overall Study|Withdrawal by Subject|17|||
155054268|NCT03834493|559630387|FG000|Overall Study|Physician Decision|1|||
155054269|NCT03834493|559630388|FG001|Overall Study|Physician Decision|0|||
155054270|NCT03834493|559630387|FG000|Overall Study|Death|289|||
155054271|NCT03834493|559630388|FG001|Overall Study|Death|282|||
155054272|NCT04144322|559630392|FG000|Overall Study|Lack of Efficacy|2|||
155054273|NCT04144322|559630393|FG001|Overall Study|Lack of Efficacy|2|||
155054274|NCT02277028|559630394|FG000|Overall Study|Lost to Follow-up|1|||
155054275|NCT02277028|559630395|FG001|Overall Study|Lost to Follow-up|0|||
155054276|NCT02277028|559630394|FG000|Overall Study|Withdrawal by Subject|0|||
155054277|NCT02277028|559630395|FG001|Overall Study|Withdrawal by Subject|1|||
155054278|NCT02718911|559630396|FG000|Overall Study|Adverse Event|0|||
155054279|NCT02718911|559630397|FG001|Overall Study|Adverse Event|0|||
155054280|NCT02718911|559630398|FG002|Overall Study|Adverse Event|0|||
155054281|NCT02718911|559630399|FG003|Overall Study|Adverse Event|0|||
155054282|NCT02718911|559630400|FG004|Overall Study|Adverse Event|0|||
155054283|NCT02718911|559630401|FG005|Overall Study|Adverse Event|0|||
155054284|NCT02718911|559630402|FG006|Overall Study|Adverse Event|0|||
155054285|NCT02718911|559630403|FG007|Overall Study|Adverse Event|0|||
155054286|NCT02718911|559630404|FG008|Overall Study|Adverse Event|0|||
155054287|NCT02718911|559630405|FG009|Overall Study|Adverse Event|2|||
155054288|NCT02718911|559630396|FG000|Overall Study|Death|2|||
155054289|NCT02718911|559630397|FG001|Overall Study|Death|3|||
155054290|NCT02718911|559630398|FG002|Overall Study|Death|1|||
155054291|NCT02718911|559630399|FG003|Overall Study|Death|0|||
155054292|NCT02718911|559630400|FG004|Overall Study|Death|1|||
155054293|NCT02718911|559630401|FG005|Overall Study|Death|3|||
155054294|NCT02718911|559630402|FG006|Overall Study|Death|1|||
155054295|NCT02718911|559630403|FG007|Overall Study|Death|1|||
155054296|NCT02718911|559630404|FG008|Overall Study|Death|4|||
155054297|NCT02718911|559630405|FG009|Overall Study|Death|3|||
155054298|NCT02718911|559630396|FG000|Overall Study|Lost to Follow-up|0|||
155054299|NCT02718911|559630397|FG001|Overall Study|Lost to Follow-up|0|||
155054300|NCT02718911|559630398|FG002|Overall Study|Lost to Follow-up|0|||
155054301|NCT02718911|559630399|FG003|Overall Study|Lost to Follow-up|0|||
155054302|NCT02718911|559630400|FG004|Overall Study|Lost to Follow-up|0|||
155054303|NCT02718911|559630401|FG005|Overall Study|Lost to Follow-up|0|||
155054304|NCT02718911|559630402|FG006|Overall Study|Lost to Follow-up|0|||
155054305|NCT02718911|559630403|FG007|Overall Study|Lost to Follow-up|0|||
155054306|NCT02718911|559630404|FG008|Overall Study|Lost to Follow-up|1|||
155054307|NCT02718911|559630405|FG009|Overall Study|Lost to Follow-up|0|||
155054308|NCT02718911|559630396|FG000|Overall Study|Physician Decision|2|||
155054309|NCT02718911|559630397|FG001|Overall Study|Physician Decision|0|||
155054310|NCT02718911|559630398|FG002|Overall Study|Physician Decision|1|||
155054311|NCT02718911|559630399|FG003|Overall Study|Physician Decision|1|||
155054312|NCT02718911|559630400|FG004|Overall Study|Physician Decision|0|||
155054313|NCT02718911|559630401|FG005|Overall Study|Physician Decision|0|||
155054314|NCT02718911|559630402|FG006|Overall Study|Physician Decision|0|||
155054315|NCT02718911|559630403|FG007|Overall Study|Physician Decision|1|||
155054316|NCT02718911|559630404|FG008|Overall Study|Physician Decision|2|||
155054317|NCT02718911|559630405|FG009|Overall Study|Physician Decision|1|||
155054318|NCT02718911|559630396|FG000|Overall Study|Withdrawal by Subject|0|||
155054319|NCT02718911|559630397|FG001|Overall Study|Withdrawal by Subject|0|||
155054320|NCT02718911|559630398|FG002|Overall Study|Withdrawal by Subject|0|||
155054321|NCT02718911|559630399|FG003|Overall Study|Withdrawal by Subject|0|||
155054322|NCT02718911|559630400|FG004|Overall Study|Withdrawal by Subject|1|||
155054323|NCT02718911|559630401|FG005|Overall Study|Withdrawal by Subject|0|||
155054324|NCT02718911|559630402|FG006|Overall Study|Withdrawal by Subject|0|||
155054325|NCT02718911|559630403|FG007|Overall Study|Withdrawal by Subject|0|||
155054326|NCT02718911|559630404|FG008|Overall Study|Withdrawal by Subject|1|||
155054327|NCT02718911|559630405|FG009|Overall Study|Withdrawal by Subject|4|||
155054328|NCT02718911|559630396|FG000|Overall Study|Reason Not Collected|0|||
155054329|NCT02718911|559630397|FG001|Overall Study|Reason Not Collected|0|||
155054330|NCT02718911|559630398|FG002|Overall Study|Reason Not Collected|1|||
155054331|NCT02718911|559630399|FG003|Overall Study|Reason Not Collected|0|||
155054332|NCT02718911|559630400|FG004|Overall Study|Reason Not Collected|0|||
155054333|NCT02718911|559630401|FG005|Overall Study|Reason Not Collected|0|||
155054334|NCT02718911|559630402|FG006|Overall Study|Reason Not Collected|2|||
155054335|NCT02718911|559630403|FG007|Overall Study|Reason Not Collected|1|||
155054336|NCT02718911|559630404|FG008|Overall Study|Reason Not Collected|4|||
155054337|NCT02718911|559630405|FG009|Overall Study|Reason Not Collected|9|||
155054338|NCT04817332|559630406|FG000|Overall Study|Lost to Follow-up|3|||
155054339|NCT04817332|559630407|FG001|Overall Study|Lost to Follow-up|3|||
155054340|NCT04817332|559630406|FG000|Overall Study|Protocol Violation|2|||
155054341|NCT04817332|559630407|FG001|Overall Study|Protocol Violation|0|||
155054342|NCT01867008|559630408|FG000|Overall Study|Withdrawal by Subject|1|||
155054343|NCT00983372|559630409|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
155054344|NCT00983372|559630409|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
155054345|NCT00983372|559630409|FG000|Diltiazem ER Alone|Adverse Event|1|||
155054346|NCT05635045|559630410|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
155054347|NCT05635045|559630411|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
155054348|NCT05635045|559630412|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
155054349|NCT05635045|559630413|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
155054350|NCT00570401|559630426|FG000|Overall Study|Adverse Event|2|||
155054351|NCT00871234|559630427|FG000|Overall Study|Adverse Event|2|||
155054352|NCT00871234|559630427|FG000|Overall Study|Lost to Follow-up|3|||
155054353|NCT01710020|559630428|FG000|Period 1|Protocol Violation|1|||
155054354|NCT00427908|559630429|FG000|Primary Phase|Lost to Follow-up|4|||
155054355|NCT00427908|559630430|FG001|Primary Phase|Lost to Follow-up|0|||
155054356|NCT00427908|559630431|FG002|Primary Phase|Lost to Follow-up|2|||
155054357|NCT00427908|559630432|FG003|Primary Phase|Lost to Follow-up|0|||
155054358|NCT00427908|559630429|FG000|Primary Phase|Withdrawal by Subject|1|||
155054359|NCT00427908|559630430|FG001|Primary Phase|Withdrawal by Subject|2|||
155054360|NCT00427908|559630431|FG002|Primary Phase|Withdrawal by Subject|1|||
155054361|NCT00427908|559630432|FG003|Primary Phase|Withdrawal by Subject|0|||
155054362|NCT00427908|559630429|FG000|Primary Phase|Adverse Event|0|||
155054363|NCT00427908|559630430|FG001|Primary Phase|Adverse Event|1|||
155054364|NCT00427908|559630431|FG002|Primary Phase|Adverse Event|0|||
155054365|NCT00427908|559630432|FG003|Primary Phase|Adverse Event|0|||
155054366|NCT01764841|559630433|FG000|Overall Study|Logistical Difficulties|0|||
155054367|NCT01764841|559630434|FG001|Overall Study|Logistical Difficulties|1|||
155054368|NCT01764841|559630435|FG002|Overall Study|Logistical Difficulties|0|||
155054369|NCT01764841|559630436|FG003|Overall Study|Logistical Difficulties|0|||
155054370|NCT01764841|559630433|FG000|Overall Study|Death|3|||
155054371|NCT01764841|559630434|FG001|Overall Study|Death|0|||
155054372|NCT01764841|559630435|FG002|Overall Study|Death|1|||
155054373|NCT01764841|559630436|FG003|Overall Study|Death|4|||
155054374|NCT01764841|559630433|FG000|Overall Study|No Follow Up|1|||
155054375|NCT01764841|559630434|FG001|Overall Study|No Follow Up|0|||
155393578|NCT01132612|560876797|FG000|Overall Study|Adverse Event|5|||
155054376|NCT01764841|559630435|FG002|Overall Study|No Follow Up|1|||
155054377|NCT01764841|559630436|FG003|Overall Study|No Follow Up|0|||
155054378|NCT01764841|559630433|FG000|Overall Study|Protocol Violation|0|||
155054379|NCT01764841|559630434|FG001|Overall Study|Protocol Violation|1|||
155054380|NCT01764841|559630435|FG002|Overall Study|Protocol Violation|0|||
155054381|NCT01764841|559630436|FG003|Overall Study|Protocol Violation|0|||
155054382|NCT01764841|559630433|FG000|Overall Study|Withdrawal by Subject|16|||
155054383|NCT01764841|559630434|FG001|Overall Study|Withdrawal by Subject|24|||
155054384|NCT01764841|559630435|FG002|Overall Study|Withdrawal by Subject|11|||
155054385|NCT01764841|559630436|FG003|Overall Study|Withdrawal by Subject|15|||
155054386|NCT01764841|559630433|FG000|Overall Study|Lost to Follow-up|3|||
155054387|NCT01764841|559630434|FG001|Overall Study|Lost to Follow-up|0|||
155054388|NCT01764841|559630435|FG002|Overall Study|Lost to Follow-up|1|||
155054389|NCT01764841|559630436|FG003|Overall Study|Lost to Follow-up|0|||
155054390|NCT01747499|559630437|FG000|Overall Study|Steroid refractory aGvHD|1|||
155054391|NCT01747499|559630438|FG001|Overall Study|Steroid refractory aGvHD|0|||
155054392|NCT01747499|559630439|FG002|Overall Study|Steroid refractory aGvHD|0|||
155054393|NCT01747499|559630440|FG003|Overall Study|Steroid refractory aGvHD|1|||
155054394|NCT01747499|559630441|FG004|Overall Study|Steroid refractory aGvHD|4|||
155054395|NCT01747499|559630437|FG000|Overall Study|Physician Decision|0|||
155054396|NCT01747499|559630438|FG001|Overall Study|Physician Decision|1|||
155054397|NCT01747499|559630439|FG002|Overall Study|Physician Decision|0|||
155054398|NCT01747499|559630440|FG003|Overall Study|Physician Decision|0|||
155054399|NCT01747499|559630441|FG004|Overall Study|Physician Decision|2|||
155054400|NCT01747499|559630437|FG000|Overall Study|Death|0|||
155054401|NCT01747499|559630438|FG001|Overall Study|Death|0|||
155054402|NCT01747499|559630439|FG002|Overall Study|Death|0|||
155054403|NCT01747499|559630440|FG003|Overall Study|Death|1|||
155054404|NCT01747499|559630441|FG004|Overall Study|Death|1|||
155054405|NCT01747499|559630437|FG000|Overall Study|Withdrawal by Subject|0|||
155054406|NCT01747499|559630438|FG001|Overall Study|Withdrawal by Subject|0|||
155054407|NCT01747499|559630439|FG002|Overall Study|Withdrawal by Subject|0|||
155054408|NCT01747499|559630440|FG003|Overall Study|Withdrawal by Subject|0|||
155054409|NCT01747499|559630441|FG004|Overall Study|Withdrawal by Subject|6|||
155054410|NCT01747499|559630437|FG000|Overall Study|Developed AML and death|0|||
155054411|NCT01747499|559630438|FG001|Overall Study|Developed AML and death|0|||
155054412|NCT01747499|559630439|FG002|Overall Study|Developed AML and death|0|||
155054413|NCT01747499|559630440|FG003|Overall Study|Developed AML and death|0|||
155054414|NCT01747499|559630441|FG004|Overall Study|Developed AML and death|1|||
155054415|NCT01747499|559630437|FG000|Overall Study|Determined not to be eligible|0|||
155054416|NCT01747499|559630438|FG001|Overall Study|Determined not to be eligible|0|||
155054417|NCT01747499|559630439|FG002|Overall Study|Determined not to be eligible|0|||
155054418|NCT01747499|559630440|FG003|Overall Study|Determined not to be eligible|0|||
155054419|NCT01747499|559630441|FG004|Overall Study|Determined not to be eligible|1|||
155054420|NCT02573259|559630455|FG000|Overall Study|Death|1|||
155054421|NCT02573259|559630456|FG001|Overall Study|Death|6|||
155054422|NCT02573259|559630457|FG002|Overall Study|Death|5|||
155054423|NCT02573259|559630458|FG003|Overall Study|Death|6|||
155054424|NCT02573259|559630459|FG004|Overall Study|Death|9|||
155054425|NCT02573259|559630460|FG005|Overall Study|Death|32|||
155054426|NCT02573259|559630461|FG006|Overall Study|Death|21|||
155054427|NCT02573259|559630455|FG000|Overall Study|Lost to Follow-up|0|||
155054428|NCT02573259|559630456|FG001|Overall Study|Lost to Follow-up|0|||
155054429|NCT02573259|559630457|FG002|Overall Study|Lost to Follow-up|0|||
155054430|NCT02573259|559630458|FG003|Overall Study|Lost to Follow-up|0|||
155054431|NCT02573259|559630459|FG004|Overall Study|Lost to Follow-up|0|||
155054432|NCT02573259|559630460|FG005|Overall Study|Lost to Follow-up|2|||
155054433|NCT02573259|559630461|FG006|Overall Study|Lost to Follow-up|1|||
155054434|NCT02573259|559630455|FG000|Overall Study|Participant refused further follow-up|0|||
155054435|NCT02573259|559630456|FG001|Overall Study|Participant refused further follow-up|2|||
155054436|NCT02573259|559630457|FG002|Overall Study|Participant refused further follow-up|1|||
155054437|NCT02573259|559630458|FG003|Overall Study|Participant refused further follow-up|0|||
155054438|NCT02573259|559630459|FG004|Overall Study|Participant refused further follow-up|3|||
155054439|NCT02573259|559630460|FG005|Overall Study|Participant refused further follow-up|20|||
155054440|NCT02573259|559630461|FG006|Overall Study|Participant refused further follow-up|7|||
155054441|NCT02573259|559630455|FG000|Overall Study|Other|0|||
155054442|NCT02573259|559630456|FG001|Overall Study|Other|0|||
155054443|NCT02573259|559630457|FG002|Overall Study|Other|0|||
155054444|NCT02573259|559630458|FG003|Overall Study|Other|0|||
155054445|NCT02573259|559630459|FG004|Overall Study|Other|1|||
155153087|NCT01383928|559998553|FG001|Overall Study|Initiation of ASCT|1|||
155054446|NCT02573259|559630460|FG005|Overall Study|Other|4|||
155054447|NCT02573259|559630461|FG006|Overall Study|Other|5|||
155054448|NCT00751140|559630462|FG000|Overall Study|benign angioma excluded from analysis|1|||
155054449|NCT03160716|559630463|FG000|Overall Study|Lost to Follow-up|1|||
155054450|NCT01628848|559630464|FG000|Overall Study|Adverse Event|9|||
155054451|NCT01628848|559630465|FG001|Overall Study|Adverse Event|7|||
155054452|NCT01628848|559630464|FG000|Overall Study|Lack of Efficacy|0|||
154951129|NCT00864097|559245898|FG001|Overall Study|Lost to Follow-up|1|||
154951130|NCT00864097|559245899|FG002|Overall Study|Lost to Follow-up|0|||
154951131|NCT00864097|559245900|FG003|Overall Study|Lost to Follow-up|1|||
154951132|NCT00864097|559245897|FG000|Overall Study|Withdrawal by Subject|15|||
154951133|NCT00864097|559245898|FG001|Overall Study|Withdrawal by Subject|11|||
154951134|NCT00864097|559245899|FG002|Overall Study|Withdrawal by Subject|11|||
154951135|NCT00864097|559245900|FG003|Overall Study|Withdrawal by Subject|12|||
154951136|NCT00864097|559245897|FG000|Overall Study|Protocol Violation|2|||
154951137|NCT00864097|559245898|FG001|Overall Study|Protocol Violation|1|||
154951138|NCT00864097|559245899|FG002|Overall Study|Protocol Violation|0|||
154951139|NCT00864097|559245900|FG003|Overall Study|Protocol Violation|1|||
154951140|NCT00864097|559245897|FG000|Overall Study|Terminated by sponsor|105|||
154951141|NCT00864097|559245898|FG001|Overall Study|Terminated by sponsor|112|||
154951142|NCT00864097|559245899|FG002|Overall Study|Terminated by sponsor|102|||
154951143|NCT00864097|559245900|FG003|Overall Study|Terminated by sponsor|99|||
154951144|NCT00864097|559245897|FG000|Overall Study|Randomized but not treated|2|||
154951145|NCT00864097|559245898|FG001|Overall Study|Randomized but not treated|0|||
154951146|NCT00864097|559245899|FG002|Overall Study|Randomized but not treated|1|||
154951147|NCT00864097|559245900|FG003|Overall Study|Randomized but not treated|0|||
154951148|NCT00864097|559245897|FG000|Overall Study|Other|0|||
154951149|NCT00864097|559245898|FG001|Overall Study|Other|0|||
154951150|NCT00864097|559245899|FG002|Overall Study|Other|0|||
154951151|NCT00864097|559245900|FG003|Overall Study|Other|1|||
154951152|NCT00320112|559245902|FG000|Overall Study|Lost to Follow-up|3|||
154951153|NCT00320112|559245903|FG001|Overall Study|Lost to Follow-up|4|||
154951154|NCT00320112|559245902|FG000|Overall Study|Withdrawal by Subject|3|||
154951155|NCT00320112|559245903|FG001|Overall Study|Withdrawal by Subject|0|||
154951156|NCT00320112|559245902|FG000|Overall Study|Death|2|||
154951157|NCT00320112|559245903|FG001|Overall Study|Death|1|||
154951158|NCT05014412|559245906|FG000|Overall Study|Death|11|||
154951159|NCT05014412|559245907|FG001|Overall Study|Death|7|||
154951160|NCT05014412|559245908|FG002|Overall Study|Death|4|||
154951161|NCT05014412|559245909|FG003|Overall Study|Death|7|||
154951162|NCT05014412|559245906|FG000|Overall Study|Withdrawal by Subject|1|||
154951163|NCT05014412|559245907|FG001|Overall Study|Withdrawal by Subject|1|||
154951164|NCT05014412|559245908|FG002|Overall Study|Withdrawal by Subject|1|||
154951165|NCT05014412|559245909|FG003|Overall Study|Withdrawal by Subject|2|||
154951166|NCT05014412|559245906|FG000|Overall Study|Ongoing|21|||
154951167|NCT05014412|559245907|FG001|Overall Study|Ongoing|4|||
154951168|NCT05014412|559245908|FG002|Overall Study|Ongoing|6|||
154951169|NCT05014412|559245909|FG003|Overall Study|Ongoing|20|||
154951170|NCT00486837|559245911|FG000|Overall Study|Withdrawal by Subject|1|||
154951171|NCT00486837|559245912|FG001|Overall Study|Withdrawal by Subject|0|||
154951172|NCT00486837|559245911|FG000|Overall Study|Adverse Event|1|||
154951173|NCT00486837|559245912|FG001|Overall Study|Adverse Event|1|||
154951174|NCT00486837|559245911|FG000|Overall Study|Protocol Violation|4|||
154951175|NCT00486837|559245912|FG001|Overall Study|Protocol Violation|2|||
154951176|NCT00486837|559245911|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
154951177|NCT00486837|559245912|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
154951178|NCT05295953|559245914|FG000|Overall Study|Withdrawal by Subject|0|||
154951179|NCT05295953|559245915|FG001|Overall Study|Withdrawal by Subject|1|||
154951180|NCT01199861|559245917|FG000|Overall Study|Administrative problems|1|||
154951181|NCT01199861|559245918|FG001|Overall Study|Administrative problems|0|||
154951182|NCT01199861|559245917|FG000|Overall Study|Adverse Event|1|||
154951183|NCT01199861|559245918|FG001|Overall Study|Adverse Event|0|||
154951184|NCT00661505|559245919|FG000|Overall Study|Adverse Event|3|||
154951185|NCT00661505|559245919|FG000|Overall Study|Protocol Violation|14|||
154951186|NCT00661505|559245919|FG000|Overall Study|Withdrawal by Subject|8|||
154951187|NCT00661505|559245919|FG000|Overall Study|Lost to Follow-up|3|||
154951188|NCT00661505|559245919|FG000|Overall Study|Other|2|||
154951189|NCT04534283|559245920|FG000|Overall Study|Physician Decision|2|||
154951190|NCT04534283|559245920|FG000|Overall Study|Withdrawal by Subject|1|||
154951191|NCT04534283|559245920|FG000|Overall Study|Disease Progression|12|||
154951192|NCT04534283|559245920|FG000|Overall Study|Adverse Event|1|||
154951193|NCT00977470|559245923|FG000|Overall Study|Lack of Efficacy|32|||
154951194|NCT00977470|559245924|FG001|Overall Study|Lack of Efficacy|30|||
154951195|NCT00977470|559245923|FG000|Overall Study|Physician Decision|2|||
155283291|NCT00924560|560468274|FG001|Overall Study|Lost to Follow-up|94|||
154951196|NCT00977470|559245924|FG001|Overall Study|Physician Decision|0|||
154951197|NCT00977470|559245923|FG000|Overall Study|Adverse Event|1|||
154951198|NCT00977470|559245924|FG001|Overall Study|Adverse Event|2|||
154951199|NCT00977470|559245923|FG000|Overall Study|Protocol Violation|1|||
154951200|NCT00977470|559245924|FG001|Overall Study|Protocol Violation|0|||
154951201|NCT00977470|559245923|FG000|Overall Study|Withdrawal by Subject|0|||
154951202|NCT00977470|559245924|FG001|Overall Study|Withdrawal by Subject|2|||
154951203|NCT00977470|559245923|FG000|Overall Study|Death|0|||
154951204|NCT00977470|559245924|FG001|Overall Study|Death|2|||
154951205|NCT00977470|559245923|FG000|Overall Study|clinical decline|0|||
154951206|NCT00977470|559245924|FG001|Overall Study|clinical decline|1|||
154951207|NCT00977470|559245923|FG000|Overall Study|prolonged recovery post-surgery|0|||
155054453|NCT01628848|559630465|FG001|Overall Study|Lack of Efficacy|4|||
155054454|NCT01628848|559630464|FG000|Overall Study|Withdrawal by Subject|0|||
155054455|NCT01628848|559630465|FG001|Overall Study|Withdrawal by Subject|2|||
155054456|NCT01628848|559630464|FG000|Overall Study|Physician Decision|3|||
155054457|NCT01628848|559630465|FG001|Overall Study|Physician Decision|1|||
155054458|NCT01939314|559630466|FG000|Overall Study|Withdrawal by Subject|3|||
155054459|NCT01939314|559630467|FG001|Overall Study|Withdrawal by Subject|1|||
155054460|NCT01939314|559630466|FG000|Overall Study|Protocol Violation|1|||
155054461|NCT01939314|559630467|FG001|Overall Study|Protocol Violation|0|||
155054462|NCT01939314|559630466|FG000|Overall Study|Pregnancy|0|||
155054463|NCT01939314|559630467|FG001|Overall Study|Pregnancy|1|||
155054464|NCT01939314|559630466|FG000|Overall Study|Lost to Follow-up|5|||
155054465|NCT01939314|559630467|FG001|Overall Study|Lost to Follow-up|6|||
155054466|NCT00969228|559630470|FG000|Overall Study|Adverse Event|1|||
155054467|NCT00969228|559630471|FG001|Overall Study|Adverse Event|0|||
155054468|NCT00969228|559630470|FG000|Overall Study|Withdrawal by Subject|4|||
155054469|NCT00969228|559630471|FG001|Overall Study|Withdrawal by Subject|0|||
155054470|NCT00969228|559630470|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
155054471|NCT00969228|559630471|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
155054472|NCT01107925|559630478|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
155054473|NCT01107925|559630479|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155054474|NCT01107925|559630480|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155054475|NCT01107925|559630481|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155054476|NCT01107925|559630482|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
155054477|NCT01107925|559630483|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
155054478|NCT01107925|559630478|FG000|Period 2|Withdrawal by Subject|0|||
155054479|NCT01107925|559630479|FG001|Period 2|Withdrawal by Subject|1|||
155054480|NCT01107925|559630480|FG002|Period 2|Withdrawal by Subject|0|||
155054481|NCT01107925|559630481|FG003|Period 2|Withdrawal by Subject|0|||
155054482|NCT01107925|559630482|FG004|Period 2|Withdrawal by Subject|0|||
155054483|NCT01107925|559630483|FG005|Period 2|Withdrawal by Subject|1|||
155054484|NCT03311945|559630484|FG000|Overall Study|Adverse Event|2|||
155054485|NCT03311945|559630484|FG000|Overall Study|Lack of Efficacy|1|||
155054486|NCT04877990|559630485|FG000|Treatment|Other reasons|3|||
155054487|NCT04877990|559630486|FG001|Treatment|Other reasons|1|||
155054488|NCT04877990|559630485|FG000|Treatment|Administrative reasons by sponsor|17|||
155054489|NCT04877990|559630486|FG001|Treatment|Administrative reasons by sponsor|33|||
155054490|NCT04877990|559630485|FG000|Treatment|Withdrawal by Subject|2|||
155054491|NCT04877990|559630486|FG001|Treatment|Withdrawal by Subject|6|||
155054492|NCT04877990|559630485|FG000|Treatment|Adverse Event|2|||
155054493|NCT04877990|559630486|FG001|Treatment|Adverse Event|1|||
155054494|NCT05630196|559631817|FG000|Overall Study|Adverse Event|2|||
155054495|NCT05630196|559631818|FG001|Overall Study|Adverse Event|1|||
155054496|NCT05630196|559631817|FG000|Overall Study|Lost to Follow-up|1|||
155054497|NCT05630196|559631818|FG001|Overall Study|Lost to Follow-up|1|||
155054498|NCT05630196|559631817|FG000|Overall Study|Protocol Violation|2|||
155054499|NCT05630196|559631818|FG001|Overall Study|Protocol Violation|3|||
155054500|NCT05630196|559631817|FG000|Overall Study|Physician Decision|1|||
155054501|NCT05630196|559631818|FG001|Overall Study|Physician Decision|0|||
155054502|NCT05630196|559631817|FG000|Overall Study|Withdrawal by Subject|3|||
155054503|NCT05630196|559631818|FG001|Overall Study|Withdrawal by Subject|4|||
155054504|NCT01022203|559631824|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
155054505|NCT01022203|559631825|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
155054506|NCT01022203|559631824|FG000|Post Treatment Assessment|Physician Decision|2|||
155054507|NCT01022203|559631825|FG001|Post Treatment Assessment|Physician Decision|0|||
155054508|NCT01022203|559631824|FG000|Post Treatment Assessment|Adverse Event|0|||
155054509|NCT01022203|559631825|FG001|Post Treatment Assessment|Adverse Event|2|||
155054510|NCT01022203|559631824|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
155054511|NCT01022203|559631825|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
155054512|NCT00903201|559631826|FG000|Overall Study|Adverse Event|1|||
155054513|NCT00903201|559631827|FG001|Overall Study|Adverse Event|4|||
155054514|NCT00903201|559631828|FG002|Overall Study|Adverse Event|0|||
155054515|NCT00903201|559631826|FG000|Overall Study|Protocol Violation|2|||
155054516|NCT00903201|559631827|FG001|Overall Study|Protocol Violation|1|||
155054517|NCT00903201|559631828|FG002|Overall Study|Protocol Violation|0|||
155054518|NCT00903201|559631826|FG000|Overall Study|Lost to Follow-up|0|||
155054519|NCT00903201|559631827|FG001|Overall Study|Lost to Follow-up|1|||
155054520|NCT00903201|559631828|FG002|Overall Study|Lost to Follow-up|0|||
155054521|NCT00903201|559631826|FG000|Overall Study|Physician Decision|1|||
155054522|NCT00903201|559631827|FG001|Overall Study|Physician Decision|0|||
155054523|NCT00903201|559631828|FG002|Overall Study|Physician Decision|1|||
155054524|NCT00903201|559631826|FG000|Overall Study|Withdrawal by Subject|1|||
155054525|NCT00903201|559631827|FG001|Overall Study|Withdrawal by Subject|0|||
155054526|NCT00903201|559631828|FG002|Overall Study|Withdrawal by Subject|1|||
155054527|NCT00945243|559631831|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
155054528|NCT03256578|559631832|FG000|Overall Study|Excluded Post Randomization|66|||
155054529|NCT03256578|559631833|FG001|Overall Study|Excluded Post Randomization|56|||
155054530|NCT03028142|559631834|FG000|Overall Study|Adverse Event|1|||
155054531|NCT03028142|559631835|FG001|Overall Study|Adverse Event|1|||
155054532|NCT03028142|559631836|FG002|Overall Study|Adverse Event|0|||
155054533|NCT03028142|559631837|FG003|Overall Study|Adverse Event|0|||
155054534|NCT03028142|559631838|FG004|Overall Study|Adverse Event|0|||
155054535|NCT03028142|559631839|FG005|Overall Study|Adverse Event|1|||
155054536|NCT03028142|559631834|FG000|Overall Study|Withdrawal by Subject|0|||
155054537|NCT03028142|559631835|FG001|Overall Study|Withdrawal by Subject|0|||
155054538|NCT03028142|559631836|FG002|Overall Study|Withdrawal by Subject|0|||
155054539|NCT03028142|559631837|FG003|Overall Study|Withdrawal by Subject|0|||
155054540|NCT03028142|559631838|FG004|Overall Study|Withdrawal by Subject|1|||
155054541|NCT03028142|559631839|FG005|Overall Study|Withdrawal by Subject|0|||
155054542|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
155054543|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
155054544|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
155054545|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
155054546|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
155054547|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
155054548|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
155054549|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
155054550|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
155054551|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
155054552|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
155054553|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
155054554|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
155054555|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
155054556|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
155054557|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
155054558|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
155054559|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
155054560|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
155054561|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
155054562|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
155054563|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
155054564|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
155054565|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
155054566|NCT01198002|559631840|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
155054567|NCT01198002|559631841|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
155054568|NCT01198002|559631842|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
155054569|NCT01198002|559631840|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
155054570|NCT01198002|559631841|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
155054571|NCT01198002|559631842|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
155054572|NCT01198002|559631840|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
155054573|NCT01198002|559631841|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
155054574|NCT01198002|559631842|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
155054575|NCT01198002|559631840|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
155054576|NCT01198002|559631841|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
155054577|NCT01198002|559631842|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
155054578|NCT01198002|559631840|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
155054579|NCT01198002|559631841|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
155054580|NCT01198002|559631842|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
155054581|NCT01198002|559631840|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
155054582|NCT01198002|559631841|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
155054583|NCT01198002|559631842|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
155054584|NCT01198002|559631840|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
155054585|NCT01198002|559631841|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
155054586|NCT01198002|559631842|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
155054587|NCT02812186|559631845|FG000|Period 1|Post randomization screen failure|5|||
155054588|NCT02812186|559631846|FG001|Period 1|Post randomization screen failure|9|||
155054589|NCT02812186|559631845|FG000|Period 1|nonevaluable data sets|6|||
155054590|NCT02812186|559631846|FG001|Period 1|nonevaluable data sets|6|||
155054591|NCT01162343|559631847|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
155054592|NCT01162343|559631847|FG000|Overall Study|Refused psychiatrist assessment|12|||
155054593|NCT00830219|559631850|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155054594|NCT00830219|559631851|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
155054595|NCT01130272|559631852|FG000|Overall Study|Adverse Event|2|||
155054596|NCT01130272|559631853|FG001|Overall Study|Adverse Event|5|||
155054597|NCT01130272|559631854|FG002|Overall Study|Adverse Event|6|||
155054598|NCT01130272|559631855|FG003|Overall Study|Adverse Event|22|||
155054599|NCT01130272|559631856|FG004|Overall Study|Adverse Event|7|||
155054600|NCT01130272|559631852|FG000|Overall Study|IVRS-confirmed constipation|0|||
155054601|NCT01130272|559631853|FG001|Overall Study|IVRS-confirmed constipation|1|||
155054602|NCT01130272|559631854|FG002|Overall Study|IVRS-confirmed constipation|1|||
155054603|NCT01130272|559631855|FG003|Overall Study|IVRS-confirmed constipation|2|||
155054604|NCT01130272|559631856|FG004|Overall Study|IVRS-confirmed constipation|0|||
155054605|NCT01130272|559631852|FG000|Overall Study|Rescue medications due to diarrhea|3|||
155054606|NCT01130272|559631853|FG001|Overall Study|Rescue medications due to diarrhea|5|||
155054607|NCT01130272|559631854|FG002|Overall Study|Rescue medications due to diarrhea|8|||
155054608|NCT01130272|559631855|FG003|Overall Study|Rescue medications due to diarrhea|8|||
155054609|NCT01130272|559631856|FG004|Overall Study|Rescue medications due to diarrhea|6|||
155054610|NCT01130272|559631852|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
155054611|NCT01130272|559631853|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
155054612|NCT01130272|559631854|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
155054613|NCT01130272|559631855|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
155054614|NCT01130272|559631856|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
155054615|NCT01130272|559631852|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155054616|NCT01130272|559631853|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155054617|NCT01130272|559631854|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155054618|NCT01130272|559631855|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
155054619|NCT01130272|559631856|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
155054620|NCT01130272|559631852|FG000|Overall Study|Protocol Violation|0|||
155054621|NCT01130272|559631853|FG001|Overall Study|Protocol Violation|0|||
155054622|NCT01130272|559631854|FG002|Overall Study|Protocol Violation|3|||
155054623|NCT01130272|559631855|FG003|Overall Study|Protocol Violation|5|||
155054624|NCT01130272|559631856|FG004|Overall Study|Protocol Violation|5|||
155054625|NCT01130272|559631852|FG000|Overall Study|Lost to Follow-up|4|||
155054626|NCT01130272|559631853|FG001|Overall Study|Lost to Follow-up|3|||
155054627|NCT01130272|559631854|FG002|Overall Study|Lost to Follow-up|4|||
155054628|NCT01130272|559631855|FG003|Overall Study|Lost to Follow-up|7|||
155054629|NCT01130272|559631856|FG004|Overall Study|Lost to Follow-up|6|||
155054630|NCT01130272|559631852|FG000|Overall Study|Withdrawal by Subject|4|||
155054631|NCT01130272|559631853|FG001|Overall Study|Withdrawal by Subject|11|||
155054632|NCT01130272|559631854|FG002|Overall Study|Withdrawal by Subject|10|||
155054633|NCT01130272|559631855|FG003|Overall Study|Withdrawal by Subject|9|||
155054634|NCT01130272|559631856|FG004|Overall Study|Withdrawal by Subject|8|||
155054635|NCT01130272|559631852|FG000|Overall Study|Physician Decision|1|||
155054636|NCT01130272|559631853|FG001|Overall Study|Physician Decision|1|||
155054637|NCT01130272|559631854|FG002|Overall Study|Physician Decision|0|||
155054638|NCT01130272|559631855|FG003|Overall Study|Physician Decision|1|||
155054639|NCT01130272|559631856|FG004|Overall Study|Physician Decision|2|||
155054640|NCT01130272|559631852|FG000|Overall Study|Sponsor decision|6|||
155054641|NCT01130272|559631853|FG001|Overall Study|Sponsor decision|15|||
155054642|NCT01130272|559631854|FG002|Overall Study|Sponsor decision|16|||
155054643|NCT01130272|559631855|FG003|Overall Study|Sponsor decision|13|||
155054644|NCT01130272|559631856|FG004|Overall Study|Sponsor decision|16|||
155054645|NCT01130272|559631852|FG000|Overall Study|Study arm discontinued|38|||
155054646|NCT01130272|559631853|FG001|Overall Study|Study arm discontinued|0|||
155054647|NCT01130272|559631854|FG002|Overall Study|Study arm discontinued|0|||
155054648|NCT01130272|559631855|FG003|Overall Study|Study arm discontinued|0|||
155054649|NCT01130272|559631856|FG004|Overall Study|Study arm discontinued|0|||
155054650|NCT00641056|559631857|FG000|Overall Study|Adverse Event|12|||
155054651|NCT00641056|559631858|FG001|Overall Study|Adverse Event|2|||
155054652|NCT00641056|559631857|FG000|Overall Study|Lost to Follow-up|2|||
155054653|NCT00641056|559631858|FG001|Overall Study|Lost to Follow-up|1|||
155054654|NCT00641056|559631857|FG000|Overall Study|Physician Decision|3|||
155054655|NCT00641056|559631858|FG001|Overall Study|Physician Decision|1|||
155054656|NCT00641056|559631857|FG000|Overall Study|Protocol Violation|2|||
155054657|NCT00641056|559631858|FG001|Overall Study|Protocol Violation|0|||
155054658|NCT00641056|559631857|FG000|Overall Study|Entry Criteria Not Met|3|||
155054659|NCT00641056|559631858|FG001|Overall Study|Entry Criteria Not Met|0|||
155054660|NCT00641056|559631857|FG000|Overall Study|Subject Decision|6|||
155054661|NCT00641056|559631858|FG001|Overall Study|Subject Decision|19|||
155054662|NCT00641056|559631857|FG000|Overall Study|Sponsor Decision|1|||
155054663|NCT00641056|559631858|FG001|Overall Study|Sponsor Decision|2|||
155054664|NCT01811732|559631862|FG000|Overall Study|Lost to Follow-up|24|||
155054665|NCT01811732|559631863|FG001|Overall Study|Lost to Follow-up|30|||
155054666|NCT01811732|559631862|FG000|Overall Study|Withdrawal by Subject|16|||
155054667|NCT01811732|559631863|FG001|Overall Study|Withdrawal by Subject|10|||
155054668|NCT01811732|559631862|FG000|Overall Study|Adverse Event|3|||
155054669|NCT01811732|559631863|FG001|Overall Study|Adverse Event|9|||
155054670|NCT01811732|559631862|FG000|Overall Study|Lack of Efficacy|3|||
155054671|NCT01811732|559631863|FG001|Overall Study|Lack of Efficacy|1|||
155054672|NCT01811732|559631862|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
155054673|NCT01811732|559631863|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
155054674|NCT01811732|559631862|FG000|Overall Study|Physician Decision|2|||
155054675|NCT01811732|559631863|FG001|Overall Study|Physician Decision|0|||
155054676|NCT01811732|559631862|FG000|Overall Study|Death|1|||
155054677|NCT01811732|559631863|FG001|Overall Study|Death|1|||
155054678|NCT01811732|559631862|FG000|Overall Study|Insufficient venous access|0|||
155054679|NCT01811732|559631863|FG001|Overall Study|Insufficient venous access|1|||
155054680|NCT01811732|559631862|FG000|Overall Study|Protocol Violation|0|||
155054681|NCT01811732|559631863|FG001|Overall Study|Protocol Violation|1|||
155054682|NCT01811732|559631862|FG000|Overall Study|Subject incarcerated|1|||
155054683|NCT01811732|559631863|FG001|Overall Study|Subject incarcerated|2|||
155054684|NCT01811732|559631862|FG000|Overall Study|Admitted to another facility|1|||
155054685|NCT01811732|559631863|FG001|Overall Study|Admitted to another facility|0|||
155054686|NCT01811732|559631862|FG000|Overall Study|Correct study drug not available on site|1|||
155054687|NCT01811732|559631863|FG001|Overall Study|Correct study drug not available on site|0|||
155054688|NCT02026141|559631864|FG000|Overall Study|Protocol Violation|0|||
155054689|NCT02026141|559631865|FG001|Overall Study|Protocol Violation|1|||
155054690|NCT01249417|559631866|FG000|Randomised Population|Study treatment not received|0|||
155054691|NCT01249417|559631867|FG001|Randomised Population|Study treatment not received|0|||
155054692|NCT01249417|559631868|FG002|Randomised Population|Study treatment not received|2|||
155054693|NCT01249417|559631866|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
155054694|NCT01249417|559631867|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
155054695|NCT01249417|559631868|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
155054696|NCT01249417|559631866|FG000|Treatment Phase - ITT Population|Other|0|||
155054697|NCT01249417|559631867|FG001|Treatment Phase - ITT Population|Other|0|||
155054698|NCT01249417|559631868|FG002|Treatment Phase - ITT Population|Other|1|||
155054699|NCT01249417|559631866|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
155054700|NCT01249417|559631867|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
155054701|NCT01249417|559631868|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
155054702|NCT01249417|559631866|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
155054703|NCT01249417|559631867|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
155054704|NCT01249417|559631868|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
155054705|NCT01249417|559631866|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
155054706|NCT01249417|559631867|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
155054707|NCT01249417|559631868|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
155054708|NCT01248455|559631869|FG000|Overall Study|switched to alternate treatment|1|||
155054709|NCT02735980|559631870|FG000|Overall Study|Adverse Event|0|||
155054710|NCT02735980|559631871|FG001|Overall Study|Adverse Event|4|||
155054711|NCT02735980|559631872|FG002|Overall Study|Adverse Event|1|||
155054712|NCT02735980|559631870|FG000|Overall Study|Death|5|||
155054713|NCT02735980|559631871|FG001|Overall Study|Death|4|||
155054714|NCT02735980|559631872|FG002|Overall Study|Death|0|||
155054715|NCT02735980|559631870|FG000|Overall Study|Physician Decision|3|||
155054716|NCT02735980|559631871|FG001|Overall Study|Physician Decision|1|||
155054717|NCT02735980|559631872|FG002|Overall Study|Physician Decision|0|||
155054718|NCT02735980|559631870|FG000|Overall Study|Screen failure|1|||
155054719|NCT02735980|559631871|FG001|Overall Study|Screen failure|0|||
155054720|NCT02735980|559631872|FG002|Overall Study|Screen failure|0|||
155054721|NCT02735980|559631870|FG000|Overall Study|Withdrawal by Subject|1|||
155054722|NCT02735980|559631871|FG001|Overall Study|Withdrawal by Subject|2|||
155054723|NCT02735980|559631872|FG002|Overall Study|Withdrawal by Subject|0|||
155054724|NCT01232790|559631873|FG000|Randomization|Withdrawal by Subject|2|||
155054725|NCT01232790|559631874|FG001|Randomization|Withdrawal by Subject|0|||
155054726|NCT01232790|559631873|FG000|Randomization|Protocol Violation|0|||
155054727|NCT01232790|559631874|FG001|Randomization|Protocol Violation|1|||
155054728|NCT01232790|559631873|FG000|Randomization|Physician Decision|0|||
155054729|NCT01232790|559631874|FG001|Randomization|Physician Decision|1|||
155054730|NCT01232790|559631873|FG000|Initial Assessment|Withdrawal by Subject|0|||
155054731|NCT01232790|559631874|FG001|Initial Assessment|Withdrawal by Subject|1|||
155054732|NCT01232790|559631873|FG000|First Crossover|Withdrawal by Subject|1|||
155054733|NCT01232790|559631874|FG001|First Crossover|Withdrawal by Subject|0|||
155054734|NCT01232790|559631873|FG000|Second Crossover|Withdrawal by Subject|1|||
155054735|NCT01232790|559631874|FG001|Second Crossover|Withdrawal by Subject|2|||
155054736|NCT00468585|559631875|FG000|Overall Study|Patient not treated|1|||
155054737|NCT00468585|559631876|FG001|Overall Study|Patient not treated|0|||
155054738|NCT00468585|559631877|FG002|Overall Study|Patient not treated|1|||
155054739|NCT00468585|559631878|FG003|Overall Study|Patient not treated|0|||
155054740|NCT00468585|559631875|FG000|Overall Study|Patient found to be ineligible|0|||
155054741|NCT00468585|559631876|FG001|Overall Study|Patient found to be ineligible|0|||
155054742|NCT00468585|559631877|FG002|Overall Study|Patient found to be ineligible|1|||
155054743|NCT00468585|559631878|FG003|Overall Study|Patient found to be ineligible|0|||
155054744|NCT00468585|559631875|FG000|Overall Study|Adverse Event|0|||
155054745|NCT00468585|559631876|FG001|Overall Study|Adverse Event|0|||
155054746|NCT00468585|559631877|FG002|Overall Study|Adverse Event|1|||
155054747|NCT00468585|559631878|FG003|Overall Study|Adverse Event|0|||
155054748|NCT00468585|559631875|FG000|Overall Study|Withdrawal by Subject|0|||
155054749|NCT00468585|559631876|FG001|Overall Study|Withdrawal by Subject|0|||
155054750|NCT00468585|559631877|FG002|Overall Study|Withdrawal by Subject|2|||
155054751|NCT00468585|559631878|FG003|Overall Study|Withdrawal by Subject|1|||
155054752|NCT03769649|559631879|FG000|Overall Study|Lost to Follow-up|4|||
155054753|NCT03322293|559631880|FG000|Overall Study|Lost to Follow-up|0|||
155054754|NCT03322293|559631881|FG001|Overall Study|Lost to Follow-up|0|||
155054755|NCT03322293|559631882|FG002|Overall Study|Lost to Follow-up|1|||
155054756|NCT00083915|559631885|FG000|Overall Study|Death|6|||
155054757|NCT00083915|559631886|FG001|Overall Study|Death|3|||
155054758|NCT00083915|559631885|FG000|Overall Study|Physician Decision|11|||
155054759|NCT00083915|559631886|FG001|Overall Study|Physician Decision|6|||
155054760|NCT00083915|559631885|FG000|Overall Study|Withdrawal by Subject|8|||
155054761|NCT00083915|559631886|FG001|Overall Study|Withdrawal by Subject|3|||
155054762|NCT00083915|559631885|FG000|Overall Study|disease progression|18|||
155054763|NCT00083915|559631886|FG001|Overall Study|disease progression|23|||
155054764|NCT00083915|559631885|FG000|Overall Study|Failure to collect|3|||
155054765|NCT00083915|559631886|FG001|Overall Study|Failure to collect|0|||
155054766|NCT00083915|559631885|FG000|Overall Study|No response|3|||
155054767|NCT00083915|559631886|FG001|Overall Study|No response|1|||
155054768|NCT00083915|559631885|FG000|Overall Study|Insurance issues|1|||
155054769|NCT00083915|559631886|FG001|Overall Study|Insurance issues|1|||
155054770|NCT01239797|559631887|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
155054771|NCT01239797|559631888|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
155054772|NCT01239797|559631887|FG000|Randomized Participants|Participant withdrew consent|1|||
155054773|NCT01239797|559631888|FG001|Randomized Participants|Participant withdrew consent|7|||
155054774|NCT01239797|559631887|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
155054775|NCT01239797|559631888|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
155054776|NCT01239797|559631887|FG000|Treated Participants|Disease progression|185|||
155054777|NCT01239797|559631888|FG001|Treated Participants|Disease progression|185|||
155054778|NCT01239797|559631887|FG000|Treated Participants|Study drug toxicity|39|||
155054779|NCT01239797|559631888|FG001|Treated Participants|Study drug toxicity|45|||
155054780|NCT01239797|559631887|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
155054781|NCT01239797|559631888|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
155054782|NCT01239797|559631887|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
155054783|NCT01239797|559631888|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
155054784|NCT01239797|559631887|FG000|Treated Participants|Administrative reason by sponsor|13|||
155054785|NCT01239797|559631888|FG001|Treated Participants|Administrative reason by sponsor|4|||
155054786|NCT01239797|559631887|FG000|Treated Participants|Other reasons|14|||
155054787|NCT01239797|559631888|FG001|Treated Participants|Other reasons|14|||
155054788|NCT01239797|559631887|FG000|Treated Participants|Participant withdrew consent|6|||
155054789|NCT01239797|559631888|FG001|Treated Participants|Participant withdrew consent|11|||
155054790|NCT01239797|559631887|FG000|Treated Participants|Death|1|||
155054791|NCT01239797|559631888|FG001|Treated Participants|Death|1|||
155054792|NCT01239797|559631887|FG000|Treated Participants|Participant no longer meets study criteria|1|||
155054793|NCT01239797|559631888|FG001|Treated Participants|Participant no longer meets study criteria|1|||
155054794|NCT01239797|559631887|FG000|Treated Participants|Poor/non-compliance|0|||
155054795|NCT01239797|559631888|FG001|Treated Participants|Poor/non-compliance|1|||
155054796|NCT03722576|559631893|FG000|Overall Study|Withdrawal by Subject|3|||
155054797|NCT03722576|559631893|FG000|Overall Study|Adverse Event|2|||
155054798|NCT03722576|559631893|FG000|Overall Study|Physician Decision|1|||
155054799|NCT03722576|559631893|FG000|Overall Study|Lost to Follow-up|1|||
155054800|NCT01240382|559631894|FG000|Overall Study|Adverse Event|2|||
155054801|NCT01240382|559631895|FG001|Overall Study|Adverse Event|1|||
155054802|NCT01240382|559631894|FG000|Overall Study|Lack of Efficacy|0|||
155054803|NCT01240382|559631895|FG001|Overall Study|Lack of Efficacy|2|||
155054804|NCT01240382|559631894|FG000|Overall Study|Fear of adverse events|0|||
155054805|NCT01240382|559631895|FG001|Overall Study|Fear of adverse events|1|||
155054806|NCT02643693|559631896|FG000|Overall Study|Physician Decision|0|||
155054807|NCT02643693|559631897|FG001|Overall Study|Physician Decision|1|||
155054808|NCT02643693|559631898|FG002|Overall Study|Physician Decision|0|||
155054809|NCT02643693|559631899|FG003|Overall Study|Physician Decision|0|||
155054810|NCT02643693|559631900|FG004|Overall Study|Physician Decision|0|||
155054811|NCT02643693|559631901|FG005|Overall Study|Physician Decision|0|||
155054812|NCT02643693|559631896|FG000|Overall Study|Withdrawal by Subject|0|||
155054813|NCT02643693|559631897|FG001|Overall Study|Withdrawal by Subject|1|||
155054814|NCT02643693|559631898|FG002|Overall Study|Withdrawal by Subject|0|||
155054815|NCT02643693|559631899|FG003|Overall Study|Withdrawal by Subject|0|||
155054816|NCT02643693|559631900|FG004|Overall Study|Withdrawal by Subject|0|||
155054817|NCT02643693|559631901|FG005|Overall Study|Withdrawal by Subject|0|||
155054818|NCT02643693|559631896|FG000|Overall Study|Protocol Adherence Issues|2|||
155054819|NCT02643693|559631897|FG001|Overall Study|Protocol Adherence Issues|0|||
155054820|NCT02643693|559631898|FG002|Overall Study|Protocol Adherence Issues|1|||
155054821|NCT02643693|559631899|FG003|Overall Study|Protocol Adherence Issues|0|||
155054822|NCT02643693|559631900|FG004|Overall Study|Protocol Adherence Issues|0|||
155054823|NCT02643693|559631901|FG005|Overall Study|Protocol Adherence Issues|1|||
155054824|NCT02059239|559631902|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
155054825|NCT02059239|559631903|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
155393579|NCT01132612|560876798|FG001|Overall Study|Adverse Event|2|||
155393580|NCT01132612|560876799|FG002|Overall Study|Adverse Event|15|||
154951208|NCT00977470|559245924|FG001|Overall Study|prolonged recovery post-surgery|1|||
154951209|NCT00977470|559245923|FG000|Overall Study|Still on-study|2|||
154951210|NCT00977470|559245924|FG001|Overall Study|Still on-study|0|||
154951211|NCT01004172|559245925|FG000|Overall Study|Progressive Disease in CNS Only|16|||
154951212|NCT01004172|559245925|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
154951213|NCT01004172|559245925|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
154951214|NCT01004172|559245925|FG000|Overall Study|Adverse Event|1|||
154951215|NCT01004172|559245925|FG000|Overall Study|Physician Decision|1|||
154951216|NCT01004172|559245925|FG000|Overall Study|Symptomatic Deterioration|2|||
154951217|NCT01355081|559245929|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
154951218|NCT01355081|559245930|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
154951219|NCT01355081|559245931|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
154951220|NCT01355081|559245929|FG000|Overall Study|Major Protocol Deviation|0|||
154951221|NCT01355081|559245930|FG001|Overall Study|Major Protocol Deviation|1|||
154951222|NCT01355081|559245931|FG002|Overall Study|Major Protocol Deviation|0|||
154951223|NCT01355081|559245929|FG000|Overall Study|Lost to Follow-up|0|||
154951224|NCT01355081|559245930|FG001|Overall Study|Lost to Follow-up|0|||
154951225|NCT01355081|559245931|FG002|Overall Study|Lost to Follow-up|1|||
154951226|NCT01355081|559245929|FG000|Overall Study|Withdrawal of Consent|2|||
154951227|NCT01355081|559245930|FG001|Overall Study|Withdrawal of Consent|3|||
154951228|NCT01355081|559245931|FG002|Overall Study|Withdrawal of Consent|3|||
154951229|NCT01355081|559245929|FG000|Overall Study|Lack of Efficacy|2|||
154951230|NCT01355081|559245930|FG001|Overall Study|Lack of Efficacy|1|||
154951231|NCT01355081|559245931|FG002|Overall Study|Lack of Efficacy|1|||
154951232|NCT01355081|559245929|FG000|Overall Study|Non Compliance with Study Medication|0|||
154951233|NCT01355081|559245930|FG001|Overall Study|Non Compliance with Study Medication|1|||
154951234|NCT01355081|559245931|FG002|Overall Study|Non Compliance with Study Medication|0|||
154951235|NCT02719522|559245932|FG000|Overall Study|Implant Failure|4|||
154951236|NCT02719522|559245932|FG000|Overall Study|Death|2|||
154951237|NCT02719522|559245932|FG000|Overall Study|Lost to Follow-up|5|||
154951238|NCT02456909|559245933|FG000|Overall Study|Did not receive allocated intervention|24|||
154951239|NCT02456909|559245934|FG001|Overall Study|Did not receive allocated intervention|26|||
154951240|NCT02456909|559245933|FG000|Overall Study|Did not complete the primary outcome|0|||
154951241|NCT02456909|559245934|FG001|Overall Study|Did not complete the primary outcome|1|||
154951242|NCT03309956|559245935|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
154951243|NCT04603937|559245936|FG000|Overall Study|Adverse Event|9|||
154951244|NCT04603937|559245937|FG001|Overall Study|Adverse Event|10|||
154951245|NCT04603937|559245936|FG000|Overall Study|Withdrawal by Subject|7|||
154951246|NCT04603937|559245937|FG001|Overall Study|Withdrawal by Subject|6|||
154951247|NCT04603937|559245936|FG000|Overall Study|Lost to Follow-up|5|||
154951248|NCT04603937|559245937|FG001|Overall Study|Lost to Follow-up|6|||
154951249|NCT04603937|559245936|FG000|Overall Study|Physician Decision|0|||
154951250|NCT04603937|559245937|FG001|Overall Study|Physician Decision|1|||
154951251|NCT04603937|559245936|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
154951252|NCT04603937|559245937|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
154951253|NCT00993616|559245938|FG000|Overall Study|No tumor at entry|1|||
154951254|NCT00993616|559245938|FG000|Overall Study|Never treated|1|||
154951255|NCT01210001|559247401|FG000|Overall Study|Not treated|1|||
154951256|NCT01210001|559247402|FG001|Overall Study|Not treated|0|||
154951257|NCT01210001|559247403|FG002|Overall Study|Not treated|0|||
154951258|NCT01210001|559247401|FG000|Overall Study|Adverse Event|4|||
154951259|NCT01210001|559247402|FG001|Overall Study|Adverse Event|2|||
154951260|NCT01210001|559247403|FG002|Overall Study|Adverse Event|5|||
154951261|NCT01210001|559247401|FG000|Overall Study|Non compliant with protocol|2|||
154951262|NCT01210001|559247402|FG001|Overall Study|Non compliant with protocol|2|||
154951263|NCT01210001|559247403|FG002|Overall Study|Non compliant with protocol|3|||
154951264|NCT01210001|559247401|FG000|Overall Study|Lost to Follow-up|4|||
154951265|NCT01210001|559247402|FG001|Overall Study|Lost to Follow-up|3|||
154951266|NCT01210001|559247403|FG002|Overall Study|Lost to Follow-up|2|||
154951267|NCT01210001|559247401|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
154951268|NCT01210001|559247402|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
154951269|NCT01210001|559247403|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
154951270|NCT01210001|559247401|FG000|Overall Study|Other reason not defined above|2|||
154951271|NCT01210001|559247402|FG001|Overall Study|Other reason not defined above|2|||
154951272|NCT01210001|559247403|FG002|Overall Study|Other reason not defined above|1|||
154951273|NCT01374919|559247404|FG000|Overall Study|Withdrawal by Subject|2|||
154951274|NCT03805438|559247405|FG000|Overall Study|Lack of Efficacy|1|||
154951275|NCT03805438|559247405|FG000|Overall Study|Protocol Violation|1|||
154951276|NCT00419770|559247409|FG000|Overall Study|Withdrawal by Subject|5|||
154951277|NCT00419770|559247410|FG001|Overall Study|Withdrawal by Subject|1|||
154951278|NCT02848326|559247411|FG000|Treatment Period|Adverse Event|5|||
154951279|NCT02848326|559247412|FG001|Treatment Period|Adverse Event|4|||
154951280|NCT02848326|559247413|FG002|Treatment Period|Adverse Event|11|||
154951281|NCT02848326|559247414|FG003|Treatment Period|Adverse Event|6|||
154951282|NCT02848326|559247415|FG004|Treatment Period|Adverse Event|5|||
154951283|NCT02848326|559247416|FG005|Treatment Period|Adverse Event|7|||
154951284|NCT02848326|559247411|FG000|Treatment Period|Withdrawal of Consent|20|||
154951285|NCT02848326|559247412|FG001|Treatment Period|Withdrawal of Consent|6|||
154951286|NCT02848326|559247413|FG002|Treatment Period|Withdrawal of Consent|9|||
154951287|NCT02848326|559247414|FG003|Treatment Period|Withdrawal of Consent|6|||
154951288|NCT02848326|559247415|FG004|Treatment Period|Withdrawal of Consent|9|||
154951289|NCT02848326|559247416|FG005|Treatment Period|Withdrawal of Consent|6|||
154951290|NCT02848326|559247411|FG000|Treatment Period|Lost to Follow-up|5|||
154951291|NCT02848326|559247412|FG001|Treatment Period|Lost to Follow-up|1|||
154951292|NCT02848326|559247413|FG002|Treatment Period|Lost to Follow-up|11|||
154951293|NCT02848326|559247414|FG003|Treatment Period|Lost to Follow-up|7|||
154951294|NCT02848326|559247415|FG004|Treatment Period|Lost to Follow-up|2|||
154951295|NCT02848326|559247416|FG005|Treatment Period|Lost to Follow-up|3|||
154951296|NCT02848326|559247411|FG000|Treatment Period|Pregnancy|0|||
154951297|NCT02848326|559247412|FG001|Treatment Period|Pregnancy|0|||
154951298|NCT02848326|559247413|FG002|Treatment Period|Pregnancy|1|||
154951299|NCT02848326|559247414|FG003|Treatment Period|Pregnancy|1|||
154951300|NCT02848326|559247415|FG004|Treatment Period|Pregnancy|0|||
154951301|NCT02848326|559247416|FG005|Treatment Period|Pregnancy|1|||
154951302|NCT02848326|559247411|FG000|Treatment Period|Protocol Violation|4|||
154951303|NCT02848326|559247412|FG001|Treatment Period|Protocol Violation|3|||
154951304|NCT02848326|559247413|FG002|Treatment Period|Protocol Violation|4|||
154951305|NCT02848326|559247414|FG003|Treatment Period|Protocol Violation|2|||
154951306|NCT02848326|559247415|FG004|Treatment Period|Protocol Violation|3|||
154951307|NCT02848326|559247416|FG005|Treatment Period|Protocol Violation|3|||
154951308|NCT02848326|559247411|FG000|Treatment Period|Non-compliance with Study Drug|4|||
154951309|NCT02848326|559247412|FG001|Treatment Period|Non-compliance with Study Drug|0|||
154951310|NCT02848326|559247413|FG002|Treatment Period|Non-compliance with Study Drug|0|||
154951311|NCT02848326|559247414|FG003|Treatment Period|Non-compliance with Study Drug|1|||
154951312|NCT02848326|559247415|FG004|Treatment Period|Non-compliance with Study Drug|0|||
154951313|NCT02848326|559247416|FG005|Treatment Period|Non-compliance with Study Drug|0|||
154951314|NCT02848326|559247411|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
154951315|NCT02848326|559247412|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
154951316|NCT02848326|559247413|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
154951317|NCT02848326|559247414|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
154951318|NCT02848326|559247415|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
154951319|NCT02848326|559247416|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
154951320|NCT02848326|559247411|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
154951321|NCT02848326|559247412|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
154951322|NCT02848326|559247413|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
154951323|NCT02848326|559247414|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
154951324|NCT02848326|559247415|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
154951325|NCT02848326|559247416|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
154951326|NCT02937701|559247420|FG000|Day 1 to Week 22|Adverse Event|11|||
154951327|NCT02937701|559247421|FG001|Day 1 to Week 22|Adverse Event|14|||
154951328|NCT02937701|559247422|FG002|Day 1 to Week 22|Adverse Event|0|||
154951329|NCT02937701|559247423|FG003|Day 1 to Week 22|Adverse Event|0|||
154951330|NCT02937701|559247424|FG004|Day 1 to Week 22|Adverse Event|0|||
154951331|NCT02937701|559247420|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
154951332|NCT02937701|559247421|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
154951333|NCT02937701|559247422|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
154951334|NCT02937701|559247423|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
154951335|NCT02937701|559247424|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
155054826|NCT02059239|559631902|FG000|Overall Study|Physician Decision|1|||
155054827|NCT02059239|559631903|FG001|Overall Study|Physician Decision|0|||
155054828|NCT01408706|559631905|FG000|Overall Study|Physician Decision|1|||
155054829|NCT01408706|559631906|FG001|Overall Study|Physician Decision|0|||
155054830|NCT01268267|559631907|FG000|Overall Study|Protocol Violation|1|||
155054831|NCT01222104|559631908|FG000|Overall Study|Lost to Follow-up|37|||
155054832|NCT01222104|559631908|FG000|Overall Study|Death|10|||
155054833|NCT00888654|559631910|FG000|Overall Study|Problems swallowing oral meds.|1|||
155054834|NCT00888654|559631910|FG000|Overall Study|Not enough oral meds before surgery|3|||
155054835|NCT00888654|559631910|FG000|Overall Study|Surgery aborted|2|||
155054836|NCT00888654|559631910|FG000|Overall Study|Withdrawal by Subject|1|||
155054837|NCT00888654|559631910|FG000|Overall Study|Inelig. due to contraindication of med|1|||
155054838|NCT00888654|559631910|FG000|Overall Study|Change in surg date|1|||
154951336|NCT02937701|559247420|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
154951337|NCT02937701|559247421|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
154951338|NCT02937701|559247422|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
155054839|NCT00888654|559631910|FG000|Overall Study|Stopped meds due to headaches|1|||
155054840|NCT01418339|559631911|FG000|Overall Study|Adverse Event|5|||
154951339|NCT02937701|559247423|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
154951340|NCT02937701|559247424|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
154951341|NCT02937701|559247420|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
154951342|NCT02937701|559247421|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
154951343|NCT02937701|559247422|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
154951344|NCT02937701|559247423|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
154951345|NCT02937701|559247424|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
154951346|NCT02937701|559247420|FG000|Day 1 to Week 22|Death|1|||
154951347|NCT02937701|559247421|FG001|Day 1 to Week 22|Death|1|||
154951348|NCT02937701|559247422|FG002|Day 1 to Week 22|Death|0|||
154951349|NCT02937701|559247423|FG003|Day 1 to Week 22|Death|0|||
154951350|NCT02937701|559247424|FG004|Day 1 to Week 22|Death|0|||
154951351|NCT02937701|559247420|FG000|Day 1 to Week 22|Protocol Violation|1|||
154951352|NCT02937701|559247421|FG001|Day 1 to Week 22|Protocol Violation|1|||
154951353|NCT02937701|559247422|FG002|Day 1 to Week 22|Protocol Violation|0|||
154951354|NCT02937701|559247423|FG003|Day 1 to Week 22|Protocol Violation|0|||
154951355|NCT02937701|559247424|FG004|Day 1 to Week 22|Protocol Violation|0|||
154951356|NCT02937701|559247420|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
154951357|NCT02937701|559247421|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
154951358|NCT02937701|559247422|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
154951359|NCT02937701|559247423|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
154951360|NCT02937701|559247424|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
154951361|NCT02937701|559247420|FG000|Day 1 to Week 22|Physician Decision|2|||
154951362|NCT02937701|559247421|FG001|Day 1 to Week 22|Physician Decision|0|||
154951363|NCT02937701|559247422|FG002|Day 1 to Week 22|Physician Decision|0|||
154951364|NCT02937701|559247423|FG003|Day 1 to Week 22|Physician Decision|0|||
154951365|NCT02937701|559247424|FG004|Day 1 to Week 22|Physician Decision|0|||
154951366|NCT02937701|559247420|FG000|Day 1 to Week 22|Other|1|||
154951367|NCT02937701|559247421|FG001|Day 1 to Week 22|Other|0|||
154951368|NCT02937701|559247422|FG002|Day 1 to Week 22|Other|0|||
154951369|NCT02937701|559247423|FG003|Day 1 to Week 22|Other|0|||
154951370|NCT02937701|559247424|FG004|Day 1 to Week 22|Other|0|||
154951371|NCT02937701|559247420|FG000|Week 22 to Week 50|Adverse Event|0|||
154951372|NCT02937701|559247421|FG001|Week 22 to Week 50|Adverse Event|0|||
154951373|NCT02937701|559247422|FG002|Week 22 to Week 50|Adverse Event|10|||
154951374|NCT02937701|559247423|FG003|Week 22 to Week 50|Adverse Event|3|||
154951375|NCT02937701|559247424|FG004|Week 22 to Week 50|Adverse Event|3|||
154951376|NCT02937701|559247420|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
154951377|NCT02937701|559247421|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
154951378|NCT02937701|559247422|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
154951379|NCT02937701|559247423|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
154951380|NCT02937701|559247424|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
154951381|NCT02937701|559247420|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
154951382|NCT02937701|559247421|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
154951383|NCT02937701|559247422|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
154951384|NCT02937701|559247423|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
154951385|NCT02937701|559247424|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
154951386|NCT02937701|559247420|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
154951387|NCT02937701|559247421|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
154951388|NCT02937701|559247422|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
154951389|NCT02937701|559247423|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
154951390|NCT02937701|559247424|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
154951391|NCT02937701|559247420|FG000|Week 22 to Week 50|Physician Decision|0|||
154951392|NCT02937701|559247421|FG001|Week 22 to Week 50|Physician Decision|0|||
154951393|NCT02937701|559247422|FG002|Week 22 to Week 50|Physician Decision|2|||
154951394|NCT02937701|559247423|FG003|Week 22 to Week 50|Physician Decision|0|||
154951395|NCT02937701|559247424|FG004|Week 22 to Week 50|Physician Decision|1|||
154951396|NCT02937701|559247420|FG000|Week 22 to Week 50|Other|0|||
154951397|NCT02937701|559247421|FG001|Week 22 to Week 50|Other|0|||
154951398|NCT02937701|559247422|FG002|Week 22 to Week 50|Other|0|||
154951399|NCT02937701|559247423|FG003|Week 22 to Week 50|Other|0|||
154951400|NCT02937701|559247424|FG004|Week 22 to Week 50|Other|1|||
154951401|NCT00416520|559247426|FG000|Open-label Period|Adverse Event|28|||
155283292|NCT00924560|560468275|FG002|Overall Study|Lost to Follow-up|45|||
154951402|NCT00416520|559247427|FG001|Open-label Period|Adverse Event|10|||
154951403|NCT00416520|559247428|FG002|Open-label Period|Adverse Event|0|||
154951404|NCT00416520|559247429|FG003|Open-label Period|Adverse Event|0|||
154951405|NCT00416520|559247426|FG000|Open-label Period|Death|2|||
154951406|NCT00416520|559247427|FG001|Open-label Period|Death|1|||
154951407|NCT00416520|559247428|FG002|Open-label Period|Death|0|||
154951408|NCT00416520|559247429|FG003|Open-label Period|Death|0|||
154951409|NCT00416520|559247426|FG000|Open-label Period|Lack of Efficacy|8|||
154951410|NCT00416520|559247427|FG001|Open-label Period|Lack of Efficacy|1|||
154951411|NCT00416520|559247428|FG002|Open-label Period|Lack of Efficacy|0|||
154951412|NCT00416520|559247429|FG003|Open-label Period|Lack of Efficacy|0|||
154951413|NCT00416520|559247426|FG000|Open-label Period|Protocol Violation|3|||
154951414|NCT00416520|559247427|FG001|Open-label Period|Protocol Violation|3|||
154951415|NCT00416520|559247428|FG002|Open-label Period|Protocol Violation|0|||
154951416|NCT00416520|559247429|FG003|Open-label Period|Protocol Violation|0|||
154951417|NCT00416520|559247426|FG000|Open-label Period|Withdrawal by Subject|16|||
154951418|NCT00416520|559247427|FG001|Open-label Period|Withdrawal by Subject|5|||
154951419|NCT00416520|559247428|FG002|Open-label Period|Withdrawal by Subject|0|||
154951420|NCT00416520|559247429|FG003|Open-label Period|Withdrawal by Subject|0|||
154951421|NCT00416520|559247426|FG000|Open-label Period|Other Reasons|3|||
154951422|NCT00416520|559247427|FG001|Open-label Period|Other Reasons|12|||
154951423|NCT00416520|559247428|FG002|Open-label Period|Other Reasons|0|||
154951424|NCT00416520|559247429|FG003|Open-label Period|Other Reasons|0|||
154951425|NCT00416520|559247426|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
154951426|NCT00416520|559247427|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
154951427|NCT00416520|559247428|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
154951428|NCT00416520|559247429|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
154951429|NCT00416520|559247426|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
154951430|NCT00416520|559247427|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
154951431|NCT00416520|559247428|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
154951432|NCT00416520|559247429|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
154951433|NCT00416520|559247426|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
154951434|NCT00416520|559247427|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
154951435|NCT00416520|559247428|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
154951436|NCT00416520|559247429|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
154951437|NCT01108094|559247430|FG000|Overall Study|Adverse Event|2|||
154951438|NCT01108094|559247431|FG001|Overall Study|Adverse Event|0|||
154951439|NCT01108094|559247432|FG002|Overall Study|Adverse Event|0|||
154951440|NCT01108094|559247433|FG003|Overall Study|Adverse Event|0|||
154951441|NCT01108094|559247430|FG000|Overall Study|Withdrawal by Subject|1|||
154951442|NCT01108094|559247431|FG001|Overall Study|Withdrawal by Subject|0|||
154951443|NCT01108094|559247432|FG002|Overall Study|Withdrawal by Subject|0|||
154951444|NCT01108094|559247433|FG003|Overall Study|Withdrawal by Subject|0|||
154951445|NCT04510857|559247437|FG000|Overall Study|Withdrawal by Subject|1|||
154951446|NCT04510857|559247438|FG001|Overall Study|Withdrawal by Subject|2|||
154951447|NCT00322491|559247439|FG000|Overall Study|Adverse Event|1|||
154951448|NCT00322491|559247440|FG001|Overall Study|Adverse Event|0|||
154951449|NCT00322491|559247439|FG000|Overall Study|Death|1|||
154951450|NCT00322491|559247440|FG001|Overall Study|Death|2|||
154951451|NCT03127137|559247441|FG000|Overall Study|Requested sedation after consent|1|||
154951452|NCT03127137|559247442|FG001|Overall Study|Requested sedation after consent|0|||
154951453|NCT03127137|559247441|FG000|Overall Study|Malfunction in electronic data collection|1|||
154951454|NCT03127137|559247442|FG001|Overall Study|Malfunction in electronic data collection|0|||
154951455|NCT03127137|559247441|FG000|Overall Study|Post procedure testing could not be obtained|0|||
154951456|NCT03127137|559247442|FG001|Overall Study|Post procedure testing could not be obtained|1|||
154951457|NCT02319148|559247445|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
154951458|NCT02319148|559247446|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
154951459|NCT02319148|559247447|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
154951460|NCT02319148|559247448|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
154951461|NCT02319148|559247445|FG000|Second Intervention Period|No longer willing to participate|0|||
154951462|NCT02319148|559247446|FG001|Second Intervention Period|No longer willing to participate|1|||
154951463|NCT02319148|559247447|FG002|Second Intervention Period|No longer willing to participate|0|||
154951464|NCT02319148|559247448|FG003|Second Intervention Period|No longer willing to participate|0|||
154951465|NCT02319148|559247445|FG000|Second Intervention Period|Other|0|||
154951466|NCT02319148|559247446|FG001|Second Intervention Period|Other|0|||
154951467|NCT02319148|559247447|FG002|Second Intervention Period|Other|0|||
154951468|NCT02319148|559247448|FG003|Second Intervention Period|Other|1|||
154951469|NCT00264797|559247451|FG000|Overall Study|Withdrawal by Subject|11|||
154951470|NCT00264797|559247452|FG001|Overall Study|Withdrawal by Subject|11|||
154951471|NCT00264797|559247451|FG000|Overall Study|Lost to Follow-up|9|||
154951472|NCT00264797|559247452|FG001|Overall Study|Lost to Follow-up|17|||
154951473|NCT00264797|559247451|FG000|Overall Study|Moved from area|3|||
154951474|NCT00264797|559247452|FG001|Overall Study|Moved from area|1|||
154951475|NCT00264797|559247451|FG000|Overall Study|Practical Problems|2|||
154951476|NCT00264797|559247452|FG001|Overall Study|Practical Problems|3|||
154951477|NCT00264797|559247451|FG000|Overall Study|Incarceration|4|||
154951478|NCT00264797|559247452|FG001|Overall Study|Incarceration|5|||
154951479|NCT00264797|559247451|FG000|Overall Study|Pressure/advice from Outsiders|1|||
154951480|NCT00264797|559247452|FG001|Overall Study|Pressure/advice from Outsiders|1|||
154951481|NCT00264797|559247451|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
154951482|NCT00264797|559247452|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
154951483|NCT00264797|559247451|FG000|Overall Study|Other|3|||
154951484|NCT00264797|559247452|FG001|Overall Study|Other|4|||
154951485|NCT03992196|559247453|FG000|Enrollment|lost to follow-up prior dosing|1|||
154951486|NCT03992196|559247454|FG001|Enrollment|lost to follow-up prior dosing|0|||
154951487|NCT03992196|559247455|FG002|Enrollment|lost to follow-up prior dosing|0|||
155054841|NCT01418339|559631912|FG001|Overall Study|Adverse Event|2|||
155054842|NCT01418339|559631911|FG000|Overall Study|Subject Withdrew Consent|1|||
155054843|NCT01418339|559631912|FG001|Overall Study|Subject Withdrew Consent|2|||
155054844|NCT01418339|559631911|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
155054845|NCT01418339|559631912|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
155054846|NCT02204917|559631915|FG000|Overall Study|Protocol Violation|1|||
155054847|NCT02219685|559631916|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
155054848|NCT02219685|559631917|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
155054849|NCT02219685|559631916|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
155054850|NCT02219685|559631917|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
155054851|NCT00698815|559631918|FG000|Overall Study|Death|1|||
155054852|NCT00698815|559631919|FG001|Overall Study|Death|2|||
155054853|NCT00698815|559631920|FG002|Overall Study|Death|4|||
155054854|NCT00698815|559631918|FG000|Overall Study|Withdrawal by Subject|6|||
155054855|NCT00698815|559631919|FG001|Overall Study|Withdrawal by Subject|3|||
155054856|NCT00698815|559631920|FG002|Overall Study|Withdrawal by Subject|2|||
155054857|NCT00698815|559631918|FG000|Overall Study|MD discretion|2|||
155054858|NCT00698815|559631919|FG001|Overall Study|MD discretion|7|||
155054859|NCT00698815|559631920|FG002|Overall Study|MD discretion|2|||
155054860|NCT00698815|559631918|FG000|Overall Study|Did not receive protocol treatment|1|||
155054861|NCT00698815|559631919|FG001|Overall Study|Did not receive protocol treatment|2|||
155054862|NCT00698815|559631920|FG002|Overall Study|Did not receive protocol treatment|2|||
155054863|NCT04003103|559631925|FG000|Overall Study|Death|1|||
155054864|NCT04003103|559631926|FG001|Overall Study|Death|0|||
155054865|NCT04003103|559631927|FG002|Overall Study|Death|0|||
155054866|NCT04003103|559631925|FG000|Overall Study|Lost to Follow-up|4|||
155054867|NCT04003103|559631926|FG001|Overall Study|Lost to Follow-up|3|||
155054868|NCT04003103|559631927|FG002|Overall Study|Lost to Follow-up|2|||
155054869|NCT04003103|559631925|FG000|Overall Study|Withdrawal by Subject|10|||
155054870|NCT04003103|559631926|FG001|Overall Study|Withdrawal by Subject|1|||
155054871|NCT04003103|559631927|FG002|Overall Study|Withdrawal by Subject|1|||
155054872|NCT04003103|559631925|FG000|Overall Study|Status not recorded|0|||
155054873|NCT04003103|559631926|FG001|Overall Study|Status not recorded|2|||
155054874|NCT04003103|559631927|FG002|Overall Study|Status not recorded|0|||
155054875|NCT02131064|559631933|FG000|Overall Study|Death|5|||
155054876|NCT02131064|559631934|FG001|Overall Study|Death|6|||
155054877|NCT02131064|559631933|FG000|Overall Study|Lost to Follow-up|4|||
155054878|NCT02131064|559631934|FG001|Overall Study|Lost to Follow-up|8|||
155054879|NCT02131064|559631933|FG000|Overall Study|Withdrawal by Subject|14|||
155054880|NCT02131064|559631934|FG001|Overall Study|Withdrawal by Subject|18|||
155054881|NCT02131064|559631933|FG000|Overall Study|Other|2|||
155054882|NCT02131064|559631934|FG001|Overall Study|Other|2|||
155054883|NCT00593918|559631935|FG000|Overall Study|Withdrawal by Subject|5|||
155054884|NCT00593918|559631936|FG001|Overall Study|Withdrawal by Subject|24|||
155054885|NCT04202497|559631943|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
155054886|NCT04202497|559631944|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
155054887|NCT04202497|559631945|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
155054888|NCT04202497|559631946|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
155054889|NCT05547386|559631947|FG000|Overall Study|Withdrawal by Subject|7|||
155054890|NCT03834506|559631948|FG000|Overall Study|Death|336|||
155054891|NCT03834506|559631949|FG001|Overall Study|Death|326|||
155054892|NCT03834506|559631948|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155054893|NCT03834506|559631949|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155054894|NCT03834506|559631948|FG000|Overall Study|Withdrawal by Subject|10|||
155054895|NCT03834506|559631949|FG001|Overall Study|Withdrawal by Subject|8|||
155054896|NCT03834506|559631948|FG000|Overall Study|Sponsor decision|165|||
155054897|NCT03834506|559631949|FG001|Overall Study|Sponsor decision|178|||
155054898|NCT03834506|559631948|FG000|Overall Study|Physician Decision|3|||
155054899|NCT03834506|559631949|FG001|Overall Study|Physician Decision|1|||
155054900|NCT03834506|559631948|FG000|Overall Study|Lost to Follow-up|0|||
155054901|NCT03834506|559631949|FG001|Overall Study|Lost to Follow-up|1|||
155054902|NCT05502302|559631952|FG000|Overall Study|Lost to Follow-up|6|||
155054903|NCT05502302|559631952|FG000|Overall Study|Death|2|||
155054904|NCT02998151|559631953|FG000|Overall Study|Withdrawal by Subject|3|||
155054905|NCT02998151|559631953|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
155054906|NCT02998151|559631953|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
155054907|NCT02667301|559631954|FG000|Overall Study|Adverse Event|1|||
155054908|NCT02667301|559631954|FG000|Overall Study|Lack of Efficacy|1|||
155054909|NCT01619878|559631955|FG000|6 Week Follow-up Phase|Adverse Event|1|||
155054910|NCT01619878|559631955|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
155054911|NCT01619878|559631955|FG000|Follow-up at 12 Months of Age|Death|2|||
155054912|NCT02895295|559631956|FG000|Overall Study|Survey Non-response|71|||
155054913|NCT02895295|559631957|FG001|Overall Study|Survey Non-response|94|||
155054914|NCT02895295|559631958|FG002|Overall Study|Survey Non-response|92|||
155054915|NCT04414787|559631959|FG000|Overall Study|Patient Death|18|||
155054916|NCT04414787|559631960|FG001|Overall Study|Patient Death|18|||
155054917|NCT04414787|559631961|FG002|Overall Study|Patient Death|15|||
155054918|NCT04414787|559631962|FG003|Overall Study|Patient Death|15|||
155054919|NCT04414787|559631959|FG000|Overall Study|Patient Hospitalization|1|||
155054920|NCT04414787|559631960|FG001|Overall Study|Patient Hospitalization|1|||
155054921|NCT04414787|559631961|FG002|Overall Study|Patient Hospitalization|2|||
155054922|NCT04414787|559631962|FG003|Overall Study|Patient Hospitalization|2|||
155054923|NCT04414787|559631959|FG000|Overall Study|Lost to Follow-up|7|||
155054924|NCT04414787|559631960|FG001|Overall Study|Lost to Follow-up|7|||
155054925|NCT04414787|559631961|FG002|Overall Study|Lost to Follow-up|5|||
155054926|NCT04414787|559631962|FG003|Overall Study|Lost to Follow-up|5|||
155054927|NCT04414787|559631959|FG000|Overall Study|Residence in post-acute care facility|3|||
155054928|NCT04414787|559631960|FG001|Overall Study|Residence in post-acute care facility|3|||
155054929|NCT04414787|559631961|FG002|Overall Study|Residence in post-acute care facility|5|||
155054930|NCT04414787|559631962|FG003|Overall Study|Residence in post-acute care facility|5|||
155054931|NCT01496976|559633652|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
155054932|NCT04579380|559633653|FG000|Overall Study|Death|9|||
155054933|NCT04579380|559633654|FG001|Overall Study|Death|22|||
155054934|NCT04579380|559633655|FG002|Overall Study|Death|22|||
155054935|NCT04579380|559633656|FG003|Overall Study|Death|17|||
155054936|NCT04579380|559633657|FG004|Overall Study|Death|6|||
155054937|NCT04579380|559633658|FG005|Overall Study|Death|21|||
155054938|NCT04579380|559633659|FG006|Overall Study|Death|10|||
155054939|NCT04579380|559633660|FG007|Overall Study|Death|11|||
155054940|NCT04579380|559633661|FG008|Overall Study|Death|25|||
155054941|NCT04579380|559633653|FG000|Overall Study|Withdrawal by Subject|0|||
155054942|NCT04579380|559633654|FG001|Overall Study|Withdrawal by Subject|3|||
155054943|NCT04579380|559633655|FG002|Overall Study|Withdrawal by Subject|4|||
155054944|NCT04579380|559633656|FG003|Overall Study|Withdrawal by Subject|0|||
155054945|NCT04579380|559633657|FG004|Overall Study|Withdrawal by Subject|1|||
155054946|NCT04579380|559633658|FG005|Overall Study|Withdrawal by Subject|2|||
155054947|NCT04579380|559633659|FG006|Overall Study|Withdrawal by Subject|0|||
155054948|NCT04579380|559633660|FG007|Overall Study|Withdrawal by Subject|1|||
155054949|NCT04579380|559633661|FG008|Overall Study|Withdrawal by Subject|2|||
155054950|NCT04579380|559633653|FG000|Overall Study|Ongoing|2|||
155054951|NCT04579380|559633654|FG001|Overall Study|Ongoing|6|||
155054952|NCT04579380|559633655|FG002|Overall Study|Ongoing|4|||
155054953|NCT04579380|559633656|FG003|Overall Study|Ongoing|8|||
155054954|NCT04579380|559633657|FG004|Overall Study|Ongoing|5|||
155054955|NCT04579380|559633658|FG005|Overall Study|Ongoing|8|||
155054956|NCT04579380|559633659|FG006|Overall Study|Ongoing|3|||
155054957|NCT04579380|559633660|FG007|Overall Study|Ongoing|19|||
155054958|NCT04579380|559633661|FG008|Overall Study|Ongoing|6|||
155054959|NCT03973996|559633663|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155054960|NCT03973996|559633664|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155054961|NCT03973996|559633665|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155054962|NCT03973996|559633666|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
155054963|NCT04070989|559633667|FG000|Overall Study|Death|1|||
155054964|NCT04070989|559633668|FG001|Overall Study|Death|0|||
155054965|NCT04070989|559633669|FG002|Overall Study|Death|0|||
155054966|NCT04070989|559633667|FG000|Overall Study|Study Terminated by Sponsor|7|||
155054967|NCT04070989|559633668|FG001|Overall Study|Study Terminated by Sponsor|8|||
155054968|NCT04070989|559633669|FG002|Overall Study|Study Terminated by Sponsor|23|||
155054969|NCT04070989|559633667|FG000|Overall Study|Withdrawal by Subject|0|||
155054970|NCT04070989|559633668|FG001|Overall Study|Withdrawal by Subject|1|||
155054971|NCT04070989|559633669|FG002|Overall Study|Withdrawal by Subject|0|||
155054972|NCT04070989|559633667|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
155054973|NCT04070989|559633668|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
155054974|NCT04070989|559633669|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
155054975|NCT04070989|559633667|FG000|Overall Study|Other|1|||
155054976|NCT04070989|559633668|FG001|Overall Study|Other|1|||
155054977|NCT04070989|559633669|FG002|Overall Study|Other|0|||
155054978|NCT06088784|559633670|FG000|Overall Study|Adverse Event|0|||
155054979|NCT06088784|559633671|FG001|Overall Study|Adverse Event|0|||
155054980|NCT06088784|559633672|FG002|Overall Study|Adverse Event|0|||
155054981|NCT06088784|559633673|FG003|Overall Study|Adverse Event|0|||
155054982|NCT06088784|559633674|FG004|Overall Study|Adverse Event|0|||
155054983|NCT06088784|559633675|FG005|Overall Study|Adverse Event|0|||
155054984|NCT06088784|559633676|FG006|Overall Study|Adverse Event|3|||
155054985|NCT06088784|559633677|FG007|Overall Study|Adverse Event|0|||
155054986|NCT06088784|559633678|FG008|Overall Study|Adverse Event|0|||
155054987|NCT06088784|559633679|FG009|Overall Study|Adverse Event|0|||
155054988|NCT06088784|559633680|FG010|Overall Study|Adverse Event|0|||
155054989|NCT06088784|559633681|FG011|Overall Study|Adverse Event|0|||
155054990|NCT06088784|559633670|FG000|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054991|NCT06088784|559633671|FG001|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054992|NCT06088784|559633672|FG002|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054993|NCT06088784|559633673|FG003|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054994|NCT06088784|559633674|FG004|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054995|NCT06088784|559633675|FG005|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054996|NCT06088784|559633676|FG006|Overall Study|Exclusion criterion: QTcF >450 msec|1|||
155054997|NCT06088784|559633677|FG007|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054998|NCT06088784|559633678|FG008|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155054999|NCT06088784|559633679|FG009|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155055000|NCT06088784|559633680|FG010|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155055001|NCT06088784|559633681|FG011|Overall Study|Exclusion criterion: QTcF >450 msec|0|||
155055002|NCT05556616|559633684|FG000|Overall Study|Withdrawal by Subject|1|||
155055003|NCT05556616|559633685|FG001|Overall Study|Withdrawal by Subject|0|||
155055004|NCT05556616|559633686|FG002|Overall Study|Withdrawal by Subject|0|||
155055005|NCT05556616|559633687|FG003|Overall Study|Withdrawal by Subject|0|||
155055006|NCT05556616|559633688|FG004|Overall Study|Withdrawal by Subject|0|||
155055007|NCT05556616|559633689|FG005|Overall Study|Withdrawal by Subject|0|||
155055008|NCT05556616|559633690|FG006|Overall Study|Withdrawal by Subject|0|||
155055009|NCT05556616|559633684|FG000|Overall Study|Death|0|||
155055010|NCT05556616|559633685|FG001|Overall Study|Death|0|||
155055011|NCT05556616|559633686|FG002|Overall Study|Death|2|||
155055012|NCT05556616|559633687|FG003|Overall Study|Death|1|||
155055013|NCT05556616|559633688|FG004|Overall Study|Death|0|||
155055014|NCT05556616|559633689|FG005|Overall Study|Death|0|||
155055015|NCT05556616|559633690|FG006|Overall Study|Death|0|||
155055016|NCT05556616|559633684|FG000|Overall Study|Study Terminated by Sponsor|0|||
155055017|NCT05556616|559633685|FG001|Overall Study|Study Terminated by Sponsor|3|||
155055018|NCT05556616|559633686|FG002|Overall Study|Study Terminated by Sponsor|0|||
155055019|NCT05556616|559633687|FG003|Overall Study|Study Terminated by Sponsor|0|||
154951488|NCT03992196|559247453|FG000|Treatment|Protocol Violation|0|||
154951489|NCT03992196|559247454|FG001|Treatment|Protocol Violation|0|||
154951490|NCT03992196|559247455|FG002|Treatment|Protocol Violation|1|||
154951491|NCT03992196|559247453|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
154951492|NCT03992196|559247454|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
154951493|NCT03992196|559247455|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
154951494|NCT03992196|559247453|FG000|Treatment|Withdrawal due to non-compliance|0|||
154951495|NCT03992196|559247454|FG001|Treatment|Withdrawal due to non-compliance|0|||
154951496|NCT03992196|559247455|FG002|Treatment|Withdrawal due to non-compliance|1|||
154951497|NCT03992196|559247453|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
154951498|NCT03992196|559247454|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
154951499|NCT03992196|559247455|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
154951500|NCT03992196|559247453|FG000|Treatment|Withdrawal by parent/guardian|0|||
154951501|NCT03992196|559247454|FG001|Treatment|Withdrawal by parent/guardian|0|||
154951502|NCT03992196|559247455|FG002|Treatment|Withdrawal by parent/guardian|2|||
154951503|NCT00048048|559247456|FG000|Core Treatment|Withdrawal by Subject|0|||
154951504|NCT00048048|559247457|FG001|Core Treatment|Withdrawal by Subject|0|||
154951505|NCT00048048|559247458|FG002|Core Treatment|Withdrawal by Subject|1|||
154951506|NCT00048048|559247459|FG003|Core Treatment|Withdrawal by Subject|0|||
154951507|NCT00048048|559247460|FG004|Core Treatment|Withdrawal by Subject|0|||
154951508|NCT00048048|559247461|FG005|Core Treatment|Withdrawal by Subject|0|||
154951509|NCT00048048|559247462|FG006|Core Treatment|Withdrawal by Subject|0|||
154951510|NCT00048048|559247463|FG007|Core Treatment|Withdrawal by Subject|0|||
154951511|NCT00048048|559247464|FG008|Core Treatment|Withdrawal by Subject|0|||
154951512|NCT00048048|559247465|FG009|Core Treatment|Withdrawal by Subject|0|||
154951513|NCT00048048|559247466|FG010|Core Treatment|Withdrawal by Subject|0|||
154951514|NCT00048048|559247467|FG011|Core Treatment|Withdrawal by Subject|0|||
154951515|NCT00048048|559247456|FG000|Core Treatment|Adverse Event|0|||
154951516|NCT00048048|559247457|FG001|Core Treatment|Adverse Event|0|||
154951517|NCT00048048|559247458|FG002|Core Treatment|Adverse Event|0|||
154951518|NCT00048048|559247459|FG003|Core Treatment|Adverse Event|0|||
154951519|NCT00048048|559247460|FG004|Core Treatment|Adverse Event|0|||
154951520|NCT00048048|559247461|FG005|Core Treatment|Adverse Event|0|||
154951521|NCT00048048|559247462|FG006|Core Treatment|Adverse Event|0|||
154951522|NCT00048048|559247463|FG007|Core Treatment|Adverse Event|1|||
154951523|NCT00048048|559247464|FG008|Core Treatment|Adverse Event|0|||
154951524|NCT00048048|559247465|FG009|Core Treatment|Adverse Event|0|||
155055020|NCT05556616|559633688|FG004|Overall Study|Study Terminated by Sponsor|0|||
155055021|NCT05556616|559633689|FG005|Overall Study|Study Terminated by Sponsor|0|||
155393581|NCT01132612|560876797|FG000|Overall Study|Withdrawal by Subject|5|||
155055022|NCT05556616|559633690|FG006|Overall Study|Study Terminated by Sponsor|0|||
154951525|NCT00048048|559247466|FG010|Core Treatment|Adverse Event|0|||
154951526|NCT00048048|559247467|FG011|Core Treatment|Adverse Event|0|||
154951527|NCT00048048|559247456|FG000|Extension Year 1|Early withdrawals|0|||
154951528|NCT00048048|559247457|FG001|Extension Year 1|Early withdrawals|0|||
154951529|NCT00048048|559247458|FG002|Extension Year 1|Early withdrawals|0|||
154951530|NCT00048048|559247459|FG003|Extension Year 1|Early withdrawals|0|||
154951531|NCT00048048|559247460|FG004|Extension Year 1|Early withdrawals|0|||
155055023|NCT05428436|559633691|FG000|Period 1 - 2 washout|Adverse Event|1|||
155055024|NCT05428436|559633692|FG001|Period 1 - 2 washout|Adverse Event|0|||
154951532|NCT00048048|559247461|FG005|Extension Year 1|Early withdrawals|0|||
154951533|NCT00048048|559247462|FG006|Extension Year 1|Early withdrawals|0|||
154951534|NCT00048048|559247463|FG007|Extension Year 1|Early withdrawals|0|||
154951535|NCT00048048|559247464|FG008|Extension Year 1|Early withdrawals|0|||
154951536|NCT00048048|559247465|FG009|Extension Year 1|Early withdrawals|2|||
154951537|NCT00048048|559247466|FG010|Extension Year 1|Early withdrawals|2|||
154951538|NCT00048048|559247467|FG011|Extension Year 1|Early withdrawals|4|||
154951539|NCT00048048|559247456|FG000|Extension Year 2|Early withdrawals|0|||
154951540|NCT00048048|559247457|FG001|Extension Year 2|Early withdrawals|0|||
154951541|NCT00048048|559247458|FG002|Extension Year 2|Early withdrawals|0|||
154951542|NCT00048048|559247459|FG003|Extension Year 2|Early withdrawals|0|||
154951543|NCT00048048|559247460|FG004|Extension Year 2|Early withdrawals|0|||
154951544|NCT00048048|559247461|FG005|Extension Year 2|Early withdrawals|0|||
154951545|NCT00048048|559247462|FG006|Extension Year 2|Early withdrawals|0|||
154951546|NCT00048048|559247463|FG007|Extension Year 2|Early withdrawals|0|||
154951547|NCT00048048|559247464|FG008|Extension Year 2|Early withdrawals|0|||
154951548|NCT00048048|559247465|FG009|Extension Year 2|Early withdrawals|0|||
154951549|NCT00048048|559247466|FG010|Extension Year 2|Early withdrawals|4|||
154951550|NCT00048048|559247467|FG011|Extension Year 2|Early withdrawals|2|||
154951551|NCT00755196|559247471|FG000|Overall Study|Lost to Follow-up|1|||
154951552|NCT00755196|559247471|FG000|Overall Study|Lack of Efficiency|1|||
154951553|NCT02388763|559247472|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
154951554|NCT02388763|559247473|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
154951555|NCT02388763|559247472|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
154951556|NCT02388763|559247473|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
154951557|NCT01604850|559247474|FG000|Overall Study|Enrolled but never treated|0|||
154951558|NCT01604850|559247475|FG001|Overall Study|Enrolled but never treated|1|||
154951559|NCT01604850|559247474|FG000|Overall Study|Efficacy Failure|50|||
154951560|NCT01604850|559247475|FG001|Overall Study|Efficacy Failure|29|||
154951561|NCT01604850|559247474|FG000|Overall Study|Lost to Follow-up|1|||
154951562|NCT01604850|559247475|FG001|Overall Study|Lost to Follow-up|0|||
154951563|NCT01604850|559247474|FG000|Overall Study|Subject withdrew consent|1|||
154951564|NCT01604850|559247475|FG001|Overall Study|Subject withdrew consent|0|||
154951565|NCT01703832|559247476|FG000|Overall Study|Withdrawal by Subject|1|||
154951566|NCT01703832|559247477|FG001|Overall Study|Withdrawal by Subject|0|||
154951567|NCT00543309|559247478|FG000|Overall Study|Physician Decision|0|||
154951568|NCT00543309|559247479|FG001|Overall Study|Physician Decision|1|||
154951569|NCT00543309|559247480|FG002|Overall Study|Physician Decision|0|||
154951570|NCT02194998|559247485|FG000|On-HCV Treatment|Did not pick up study medication|0|||
154951571|NCT02194998|559247486|FG001|On-HCV Treatment|Did not pick up study medication|1|||
154951572|NCT02194998|559247487|FG002|On-HCV Treatment|Did not pick up study medication|0|||
154951573|NCT02194998|559247488|FG003|On-HCV Treatment|Did not pick up study medication|0|||
154951574|NCT02194998|559247485|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
154951575|NCT02194998|559247486|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
154951576|NCT02194998|559247487|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
154951577|NCT02194998|559247488|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
154951578|NCT01249664|559247489|FG000|Overall Study|Withdrawal by Subject|5|||
154951579|NCT01249664|559247490|FG001|Overall Study|Withdrawal by Subject|0|||
154951580|NCT01249664|559247489|FG000|Overall Study|Adverse Event|1|||
154951581|NCT01249664|559247490|FG001|Overall Study|Adverse Event|0|||
154951582|NCT00525590|559247491|FG000|Overall Study|Adverse Event|3|||
154951583|NCT00525590|559247491|FG000|Overall Study|Physician Decision|3|||
154951584|NCT00525590|559247491|FG000|Overall Study|Withdrawal by Subject|16|||
154951585|NCT00525590|559247491|FG000|Overall Study|Lost to Follow-up|1|||
154951586|NCT00525590|559247491|FG000|Overall Study|Death|9|||
154951587|NCT00525590|559247491|FG000|Overall Study|Other|13|||
154951588|NCT00860405|559247502|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
154951589|NCT00860405|559247503|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
154951590|NCT01074554|559247507|FG000|Overall Study|Adverse Event|3|||
154951591|NCT01074554|559247508|FG001|Overall Study|Adverse Event|3|||
154951592|NCT01074554|559247507|FG000|Overall Study|Lost to Follow-up|0|||
154951593|NCT01074554|559247508|FG001|Overall Study|Lost to Follow-up|1|||
154951594|NCT00497796|559247509|FG000|Overall Study|Adverse event (not related)|9|||
154951595|NCT00497796|559247510|FG001|Overall Study|Adverse event (not related)|9|||
154951596|NCT00497796|559247509|FG000|Overall Study|Adverse event (related)|5|||
154951597|NCT00497796|559247510|FG001|Overall Study|Adverse event (related)|4|||
154951598|NCT00497796|559247509|FG000|Overall Study|CMV infection or disease treatment|30|||
154951599|NCT00497796|559247510|FG001|Overall Study|CMV infection or disease treatment|4|||
154951600|NCT00497796|559247509|FG000|Overall Study|Consent withdrawn|10|||
154951601|NCT00497796|559247510|FG001|Overall Study|Consent withdrawn|3|||
154951602|NCT00497796|559247509|FG000|Overall Study|Investigator/sponsor discretion|31|||
154951603|NCT00497796|559247510|FG001|Overall Study|Investigator/sponsor discretion|34|||
154951604|NCT00497796|559247509|FG000|Overall Study|Lost to Follow-up|0|||
154951605|NCT00497796|559247510|FG001|Overall Study|Lost to Follow-up|1|||
154951606|NCT00497796|559247509|FG000|Overall Study|Not applicable (randomized not treated)|0|||
155153088|NCT01383928|559998554|FG002|Overall Study|Initiation of ASCT|18|||
154951607|NCT00497796|559247510|FG001|Overall Study|Not applicable (randomized not treated)|4|||
154951608|NCT00220337|559247512|FG000|Overall Study|Adverse Event|70|||
155055025|NCT05428436|559633693|FG002|Period 1 - 2 washout|Adverse Event|0|||
155055026|NCT00896493|559633694|FG000|Overall Study|Early disease relapse|3|||
155055027|NCT01868646|559633697|FG000|Overall Study|Do not meet inclusion criteria|3|||
155055028|NCT01868646|559633698|FG001|Overall Study|Do not meet inclusion criteria|5|||
155055029|NCT01831427|559633699|FG000|Overall Study|Adverse Event|0|||
155055030|NCT01831427|559633700|FG001|Overall Study|Adverse Event|1|||
155055031|NCT01831427|559633701|FG002|Overall Study|Adverse Event|0|||
155055032|NCT01831427|559633702|FG003|Overall Study|Adverse Event|0|||
155055033|NCT01831427|559633703|FG004|Overall Study|Adverse Event|0|||
155055034|NCT01831427|559633704|FG005|Overall Study|Adverse Event|1|||
155055035|NCT01831427|559633705|FG006|Overall Study|Adverse Event|0|||
155055036|NCT01831427|559633706|FG007|Overall Study|Adverse Event|1|||
155055037|NCT01831427|559633707|FG008|Overall Study|Adverse Event|0|||
155055038|NCT01831427|559633708|FG009|Overall Study|Adverse Event|0|||
155055039|NCT01831427|559633709|FG010|Overall Study|Adverse Event|2|||
155055040|NCT01831427|559633699|FG000|Overall Study|Investigator's Discretion|0|||
155055041|NCT01831427|559633700|FG001|Overall Study|Investigator's Discretion|0|||
155055042|NCT01831427|559633701|FG002|Overall Study|Investigator's Discretion|0|||
155055043|NCT01831427|559633702|FG003|Overall Study|Investigator's Discretion|1|||
155055044|NCT01831427|559633703|FG004|Overall Study|Investigator's Discretion|0|||
155055045|NCT01831427|559633704|FG005|Overall Study|Investigator's Discretion|0|||
155055046|NCT01831427|559633705|FG006|Overall Study|Investigator's Discretion|0|||
155055047|NCT01831427|559633706|FG007|Overall Study|Investigator's Discretion|0|||
155055048|NCT01831427|559633707|FG008|Overall Study|Investigator's Discretion|0|||
155055049|NCT01831427|559633708|FG009|Overall Study|Investigator's Discretion|0|||
155055050|NCT01831427|559633709|FG010|Overall Study|Investigator's Discretion|0|||
154951609|NCT00220337|559247512|FG000|Overall Study|Lack of Efficacy|17|||
154951610|NCT00220337|559247512|FG000|Overall Study|Withdrawal by Subject|68|||
154951611|NCT00220337|559247512|FG000|Overall Study|Protocol Violation|2|||
154951612|NCT00220337|559247512|FG000|Overall Study|Lost to Follow-up|5|||
154951613|NCT00220337|559247512|FG000|Overall Study|Other|12|||
154951614|NCT00220337|559247512|FG000|Overall Study|Unsatisfactory compliance|5|||
154951615|NCT04276883|559247513|FG000|Overall Study|Withdrawal by Subject|2|||
154951616|NCT04276883|559247514|FG001|Overall Study|Withdrawal by Subject|3|||
154951617|NCT04276883|559247515|FG002|Overall Study|Withdrawal by Subject|6|||
154951618|NCT04276883|559247513|FG000|Overall Study|Lost to Follow-up|1|||
154951619|NCT04276883|559247514|FG001|Overall Study|Lost to Follow-up|3|||
154951620|NCT04276883|559247515|FG002|Overall Study|Lost to Follow-up|0|||
154951621|NCT04276883|559247513|FG000|Overall Study|Adverse Event|0|||
154951622|NCT04276883|559247514|FG001|Overall Study|Adverse Event|1|||
154951623|NCT04276883|559247515|FG002|Overall Study|Adverse Event|0|||
154951624|NCT04276883|559247513|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
154951625|NCT04276883|559247514|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
154951626|NCT04276883|559247515|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
154951627|NCT02732210|559247516|FG000|Overall Study|Site Closed|0|||
154951628|NCT02732210|559247517|FG001|Overall Study|Site Closed|11|||
154951629|NCT02732210|559247516|FG000|Overall Study|Study Ended|13|||
154951630|NCT02732210|559247517|FG001|Overall Study|Study Ended|13|||
154951631|NCT02732210|559247516|FG000|Overall Study|Withdrawal by Subject|28|||
154951632|NCT02732210|559247517|FG001|Overall Study|Withdrawal by Subject|87|||
154951633|NCT02732210|559247516|FG000|Overall Study|Lost to Follow-up|5|||
154951634|NCT02732210|559247517|FG001|Overall Study|Lost to Follow-up|57|||
154951635|NCT02732210|559247516|FG000|Overall Study|Death|4|||
154951636|NCT02732210|559247517|FG001|Overall Study|Death|15|||
154951637|NCT02732210|559247516|FG000|Overall Study|Other|35|||
154951638|NCT02732210|559247517|FG001|Overall Study|Other|103|||
154951639|NCT02732210|559247516|FG000|Overall Study|Missing|0|||
154951640|NCT02732210|559247517|FG001|Overall Study|Missing|8|||
154951641|NCT01876706|559247518|FG000|Overall Study|BPH Intervention|9|||
154951642|NCT01876706|559247518|FG000|Overall Study|Lost to Follow-up|7|||
154951643|NCT01876706|559247518|FG000|Overall Study|Withdrawals|6|||
154951644|NCT01876706|559247518|FG000|Overall Study|Death|3|||
154951645|NCT00604500|559247519|FG000|Overall Study|Adverse Event|2|||
154951646|NCT00604500|559247519|FG000|Overall Study|Protocol Violation|2|||
155055051|NCT01831427|559633699|FG000|Overall Study|Withdrew Consent|0|||
155055052|NCT01831427|559633700|FG001|Overall Study|Withdrew Consent|0|||
155055053|NCT01831427|559633701|FG002|Overall Study|Withdrew Consent|0|||
155055054|NCT01831427|559633702|FG003|Overall Study|Withdrew Consent|0|||
155055055|NCT01831427|559633703|FG004|Overall Study|Withdrew Consent|0|||
155055056|NCT01831427|559633704|FG005|Overall Study|Withdrew Consent|0|||
155393582|NCT01132612|560876798|FG001|Overall Study|Withdrawal by Subject|8|||
155393583|NCT01132612|560876799|FG002|Overall Study|Withdrawal by Subject|19|||
154951647|NCT00604500|559247519|FG000|Overall Study|Treatment Failure|1|||
154951648|NCT00604500|559247519|FG000|Overall Study|Withdrawal by Subject|4|||
154951649|NCT00604500|559247519|FG000|Overall Study|Administrative|1|||
154951650|NCT00604500|559247519|FG000|Overall Study|Did not meet protocol eligibility|1|||
155055057|NCT01831427|559633705|FG006|Overall Study|Withdrew Consent|2|||
155055058|NCT01831427|559633706|FG007|Overall Study|Withdrew Consent|0|||
155055059|NCT01831427|559633707|FG008|Overall Study|Withdrew Consent|0|||
155055060|NCT01831427|559633708|FG009|Overall Study|Withdrew Consent|1|||
155055061|NCT01831427|559633709|FG010|Overall Study|Withdrew Consent|1|||
155055062|NCT02035553|559633712|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
155055063|NCT02035553|559633713|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
155055064|NCT02035553|559633712|FG000|Overall Study|Adverse Event|10|||
155055065|NCT02035553|559633713|FG001|Overall Study|Adverse Event|6|||
155055066|NCT02035553|559633712|FG000|Overall Study|Physician Decision|3|||
155055067|NCT02035553|559633713|FG001|Overall Study|Physician Decision|2|||
155055068|NCT02035553|559633712|FG000|Overall Study|Lack of Efficacy|1|||
155055069|NCT02035553|559633713|FG001|Overall Study|Lack of Efficacy|1|||
155055070|NCT02035553|559633712|FG000|Overall Study|Withdrawal by Subject|4|||
155055071|NCT02035553|559633713|FG001|Overall Study|Withdrawal by Subject|7|||
155055072|NCT02035553|559633712|FG000|Overall Study|Non-compliance with Study Drug|0|||
155055073|NCT02035553|559633713|FG001|Overall Study|Non-compliance with Study Drug|1|||
155055074|NCT02035553|559633712|FG000|Overall Study|Lost to Follow-up|0|||
155055075|NCT02035553|559633713|FG001|Overall Study|Lost to Follow-up|1|||
155055076|NCT02035553|559633712|FG000|Overall Study|Other Reason|0|||
155055077|NCT02035553|559633713|FG001|Overall Study|Other Reason|4|||
155055078|NCT04539964|559633714|FG000|Overall Study|device malfunction|1|||
155055079|NCT04539964|559633715|FG001|Overall Study|device malfunction|0|||
155055080|NCT04539964|559633714|FG000|Overall Study|Withdrawal by Subject|1|||
155055081|NCT04539964|559633715|FG001|Overall Study|Withdrawal by Subject|2|||
155055082|NCT04539964|559633714|FG000|Overall Study|Adverse Event|0|||
155055083|NCT04539964|559633715|FG001|Overall Study|Adverse Event|2|||
155055084|NCT01854697|559633716|FG000|Overall Study|Adverse Event|1|||
155055085|NCT01854697|559633717|FG001|Overall Study|Adverse Event|0|||
155055086|NCT01854697|559633718|FG002|Overall Study|Adverse Event|0|||
155055087|NCT01854697|559633719|FG003|Overall Study|Adverse Event|0|||
155055088|NCT01854697|559633720|FG004|Overall Study|Adverse Event|1|||
155055089|NCT01854697|559633716|FG000|Overall Study|Lost to Follow-up|4|||
155055090|NCT01854697|559633717|FG001|Overall Study|Lost to Follow-up|1|||
155055091|NCT01854697|559633718|FG002|Overall Study|Lost to Follow-up|1|||
155055092|NCT01854697|559633719|FG003|Overall Study|Lost to Follow-up|2|||
155055093|NCT01854697|559633720|FG004|Overall Study|Lost to Follow-up|0|||
155055094|NCT01854697|559633716|FG000|Overall Study|To enter another AbbVie study|1|||
155055095|NCT01854697|559633717|FG001|Overall Study|To enter another AbbVie study|0|||
155055096|NCT01854697|559633718|FG002|Overall Study|To enter another AbbVie study|0|||
155393584|NCT01132612|560876797|FG000|Overall Study|Administrative problems|5|||
154951651|NCT03130699|559247525|FG000|Overall Study|Lost to Follow-up|34|||
155055097|NCT01854697|559633719|FG003|Overall Study|To enter another AbbVie study|0|||
155055098|NCT01854697|559633720|FG004|Overall Study|To enter another AbbVie study|1|||
155055099|NCT01854697|559633716|FG000|Overall Study|Withdrew Consent|0|||
154951652|NCT03130699|559247526|FG001|Overall Study|Lost to Follow-up|37|||
154951653|NCT03130699|559247527|FG002|Overall Study|Lost to Follow-up|26|||
154951654|NCT03130699|559247525|FG000|Overall Study|Withdrawal by Subject|5|||
154951655|NCT03130699|559247526|FG001|Overall Study|Withdrawal by Subject|1|||
154951656|NCT03130699|559247527|FG002|Overall Study|Withdrawal by Subject|0|||
154951657|NCT03130699|559247525|FG000|Overall Study|Withdrawal by PI|1|||
154951658|NCT03130699|559247526|FG001|Overall Study|Withdrawal by PI|2|||
154951659|NCT03130699|559247527|FG002|Overall Study|Withdrawal by PI|5|||
154951660|NCT03130699|559247525|FG000|Overall Study|Death|0|||
154951661|NCT03130699|559247526|FG001|Overall Study|Death|0|||
154951662|NCT03130699|559247527|FG002|Overall Study|Death|1|||
154951663|NCT04028843|559247536|FG000|Overall Study|Lost to Follow-up|32|||
154951664|NCT04028843|559247537|FG001|Overall Study|Lost to Follow-up|39|||
154951665|NCT04028843|559247536|FG000|Overall Study|Adverse Event|1|||
154951666|NCT04028843|559247537|FG001|Overall Study|Adverse Event|0|||
154951667|NCT04028843|559247536|FG000|Overall Study|Non-viable Pregnancy|0|||
154951668|NCT04028843|559247537|FG001|Overall Study|Non-viable Pregnancy|1|||
154951669|NCT04028843|559247536|FG000|Overall Study|Withdrawal by Subject|4|||
154951670|NCT04028843|559247537|FG001|Overall Study|Withdrawal by Subject|2|||
154951671|NCT01606306|559247542|FG000|Overall Study|Lack of Efficacy|2|||
154951672|NCT01606306|559247543|FG001|Overall Study|Lack of Efficacy|1|||
154951673|NCT01606306|559247544|FG002|Overall Study|Lack of Efficacy|4|||
155055100|NCT01854697|559633717|FG001|Overall Study|Withdrew Consent|1|||
155055101|NCT01854697|559633718|FG002|Overall Study|Withdrew Consent|0|||
155055102|NCT01854697|559633719|FG003|Overall Study|Withdrew Consent|1|||
155055103|NCT01854697|559633720|FG004|Overall Study|Withdrew Consent|0|||
155055104|NCT01854697|559633716|FG000|Overall Study|Other|0|||
155055105|NCT01854697|559633717|FG001|Overall Study|Other|1|||
155055106|NCT01854697|559633718|FG002|Overall Study|Other|1|||
155055107|NCT01854697|559633719|FG003|Overall Study|Other|0|||
154951674|NCT01606306|559247545|FG003|Overall Study|Lack of Efficacy|4|||
154951675|NCT01606306|559247546|FG004|Overall Study|Lack of Efficacy|1|||
155055108|NCT01854697|559633720|FG004|Overall Study|Other|0|||
155055109|NCT01171898|559633721|FG000|Overall Study|Death|0|||
155055110|NCT01171898|559633722|FG001|Overall Study|Death|0|||
154951676|NCT01606306|559247547|FG005|Overall Study|Lack of Efficacy|2|||
154951677|NCT01606306|559247542|FG000|Overall Study|Adverse Event|1|||
154951678|NCT01606306|559247543|FG001|Overall Study|Adverse Event|0|||
154951679|NCT01606306|559247544|FG002|Overall Study|Adverse Event|1|||
154951680|NCT01606306|559247545|FG003|Overall Study|Adverse Event|1|||
154951681|NCT01606306|559247546|FG004|Overall Study|Adverse Event|2|||
154951682|NCT01606306|559247547|FG005|Overall Study|Adverse Event|0|||
154951683|NCT01606306|559247542|FG000|Overall Study|Lost to Follow-up|7|||
154951684|NCT01606306|559247543|FG001|Overall Study|Lost to Follow-up|4|||
154951685|NCT01606306|559247544|FG002|Overall Study|Lost to Follow-up|5|||
154951686|NCT01606306|559247545|FG003|Overall Study|Lost to Follow-up|4|||
154951687|NCT01606306|559247546|FG004|Overall Study|Lost to Follow-up|3|||
154951688|NCT01606306|559247547|FG005|Overall Study|Lost to Follow-up|5|||
154951689|NCT01606306|559247542|FG000|Overall Study|Withdrawal by Subject|4|||
154951690|NCT01606306|559247543|FG001|Overall Study|Withdrawal by Subject|3|||
154951691|NCT01606306|559247544|FG002|Overall Study|Withdrawal by Subject|4|||
154951692|NCT01606306|559247545|FG003|Overall Study|Withdrawal by Subject|4|||
154951693|NCT01606306|559247546|FG004|Overall Study|Withdrawal by Subject|5|||
154951694|NCT01606306|559247547|FG005|Overall Study|Withdrawal by Subject|4|||
154951695|NCT01606306|559247542|FG000|Overall Study|Physician Decision|1|||
154951696|NCT01606306|559247543|FG001|Overall Study|Physician Decision|2|||
154951697|NCT01606306|559247544|FG002|Overall Study|Physician Decision|0|||
154951698|NCT01606306|559247545|FG003|Overall Study|Physician Decision|0|||
154951699|NCT01606306|559247546|FG004|Overall Study|Physician Decision|0|||
154951700|NCT01606306|559247547|FG005|Overall Study|Physician Decision|0|||
154951701|NCT00950872|559247550|FG000|Overall Study|Withdrawal by Subject|1|||
154951702|NCT00950872|559247550|FG000|Overall Study|Did not have surgery|2|||
154951703|NCT00860028|559247551|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
154951704|NCT00860028|559247552|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
154951705|NCT02585258|559247553|FG000|Overall Study|Adverse Event|28|||
154951706|NCT02585258|559247554|FG001|Overall Study|Adverse Event|29|||
154951707|NCT02585258|559247553|FG000|Overall Study|Death|3|||
154951708|NCT02585258|559247554|FG001|Overall Study|Death|2|||
154951709|NCT02585258|559247553|FG000|Overall Study|Lack of Efficacy|7|||
154951710|NCT02585258|559247554|FG001|Overall Study|Lack of Efficacy|9|||
154951711|NCT02585258|559247553|FG000|Overall Study|includes covid-related access problems|42|||
154951712|NCT02585258|559247554|FG001|Overall Study|includes covid-related access problems|46|||
154951713|NCT02585258|559247553|FG000|Overall Study|Lost to Follow-up|5|||
154951714|NCT02585258|559247554|FG001|Overall Study|Lost to Follow-up|2|||
154951715|NCT05125952|559247555|FG000|Overall Study|Physician Decision|1|||
154951716|NCT02918877|559249079|FG000|Overall Study|Withdrawal by Subject|2|||
154951717|NCT02918877|559249080|FG001|Overall Study|Withdrawal by Subject|2|||
154951718|NCT02918877|559249079|FG000|Overall Study|Surgery cancelled|1|||
154951719|NCT02918877|559249080|FG001|Overall Study|Surgery cancelled|0|||
154951720|NCT02918877|559249079|FG000|Overall Study|Physician Decision|1|||
154951721|NCT02918877|559249080|FG001|Overall Study|Physician Decision|0|||
154951722|NCT02918877|559249079|FG000|Overall Study|Received intraoperative steroids|1|||
154951723|NCT02918877|559249080|FG001|Overall Study|Received intraoperative steroids|0|||
154951724|NCT02918877|559249079|FG000|Overall Study|Unable to obtain lab samples|1|||
154951725|NCT02918877|559249080|FG001|Overall Study|Unable to obtain lab samples|0|||
154951726|NCT02918877|559249079|FG000|Overall Study|Unsafe to perform BAL|0|||
154951727|NCT02918877|559249080|FG001|Overall Study|Unsafe to perform BAL|1|||
154951728|NCT00088829|559249081|FG000|Overall Study|PI left institution and study was close|22|||
154951729|NCT05818137|559249082|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
154951730|NCT05818137|559249082|FG000|Extension Treatment Period|Ongoing participants|44|||
154951731|NCT01367275|559249083|FG000|Overall Study|Ineligible|1|||
154951732|NCT01367275|559249083|FG000|Overall Study|Disease Progression|2|||
154951733|NCT05346055|559249086|FG000|Overall Study|Withdrawal by Subject|1|||
154951734|NCT05346055|559249086|FG000|Overall Study|Protocol Violation|1|||
154951735|NCT05346055|559249086|FG000|Overall Study|Therapist decision|1|||
154951736|NCT00728949|559249094|FG000|Overall Study|Adverse Event|8|||
154951737|NCT00728949|559249095|FG001|Overall Study|Adverse Event|0|||
154951738|NCT00728949|559249094|FG000|Overall Study|Withdrawal by Subject|2|||
154951739|NCT00728949|559249095|FG001|Overall Study|Withdrawal by Subject|2|||
154951740|NCT00728949|559249094|FG000|Overall Study|Abnormal Lab Results|0|||
154951741|NCT00728949|559249095|FG001|Overall Study|Abnormal Lab Results|2|||
154951742|NCT00728949|559249094|FG000|Overall Study|On treatment at cutoff date|1|||
154951743|NCT00728949|559249095|FG001|Overall Study|On treatment at cutoff date|0|||
154951744|NCT01996033|559249097|FG000|Overall Study|Death|1|||
154951745|NCT01996033|559249097|FG000|Overall Study|Physician Decision|1|||
154951746|NCT01996033|559249097|FG000|Overall Study|Withdrawal by Subject|4|||
154951747|NCT01996033|559249097|FG000|Overall Study|Lost to Follow-up|3|||
154951748|NCT02143102|559249109|FG000|Overall Study|Lost to Follow-up|11|||
154951749|NCT02143102|559249110|FG001|Overall Study|Lost to Follow-up|0|||
154951750|NCT01345019|559249113|FG000|Blinded Treatment Phase|Death|147|||
154951751|NCT01345019|559249114|FG001|Blinded Treatment Phase|Death|137|||
154951752|NCT01345019|559249113|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
155055111|NCT01171898|559633723|FG002|Overall Study|Death|2|||
155055112|NCT01171898|559633724|FG003|Overall Study|Death|0|||
155055113|NCT01171898|559633721|FG000|Overall Study|Lost to Follow-up|0|||
155055114|NCT01171898|559633722|FG001|Overall Study|Lost to Follow-up|1|||
155055115|NCT01171898|559633723|FG002|Overall Study|Lost to Follow-up|1|||
155055116|NCT01171898|559633724|FG003|Overall Study|Lost to Follow-up|1|||
155055117|NCT01171898|559633721|FG000|Overall Study|Withdrawal by Subject|1|||
155055118|NCT01171898|559633722|FG001|Overall Study|Withdrawal by Subject|4|||
155055119|NCT01171898|559633723|FG002|Overall Study|Withdrawal by Subject|6|||
155055120|NCT01171898|559633724|FG003|Overall Study|Withdrawal by Subject|3|||
155055121|NCT01171898|559633721|FG000|Overall Study|Terminated by Sponsor|1|||
155055122|NCT01171898|559633722|FG001|Overall Study|Terminated by Sponsor|0|||
155055123|NCT01171898|559633723|FG002|Overall Study|Terminated by Sponsor|0|||
155055124|NCT01171898|559633724|FG003|Overall Study|Terminated by Sponsor|0|||
155055125|NCT01171898|559633721|FG000|Overall Study|Ongoing|1|||
155055126|NCT01171898|559633722|FG001|Overall Study|Ongoing|9|||
155055127|NCT01171898|559633723|FG002|Overall Study|Ongoing|3|||
155055128|NCT01171898|559633724|FG003|Overall Study|Ongoing|0|||
155055129|NCT01171898|559633721|FG000|Overall Study|Other|1|||
155055130|NCT01171898|559633722|FG001|Overall Study|Other|5|||
155055131|NCT01171898|559633723|FG002|Overall Study|Other|0|||
155055132|NCT01171898|559633724|FG003|Overall Study|Other|2|||
155055133|NCT03191799|559633725|FG000|Overall Study|Withdrawal by Subject|4|||
155055134|NCT03191799|559633725|FG000|Overall Study|Physician Decision|2|||
155055135|NCT03191799|559633725|FG000|Overall Study|Lost to Follow-up|1|||
155055136|NCT03191799|559633725|FG000|Overall Study|Death|2|||
155055137|NCT00902577|559633728|FG000|Overall Study|Withdrawal by Subject|6|||
155055138|NCT00902577|559633728|FG000|Overall Study|FMISO production failure|2|||
155055139|NCT01319565|559633731|FG000|Overall Study|Not treated: Rapid disease progression prior to start|0|||
155055140|NCT01319565|559633732|FG001|Overall Study|Not treated: Rapid disease progression prior to start|2|||
155055141|NCT01319565|559633733|FG002|Overall Study|Not treated: Rapid disease progression prior to start|0|||
155055142|NCT05953363|559633734|FG000|Overall Study|Screen Failure|2|||
155055143|NCT05953363|559633734|FG000|Overall Study|Withdrawal by Subject|3|||
155055144|NCT05953363|559633734|FG000|Overall Study|Surgery cancelled|2|||
155055145|NCT05953363|559633734|FG000|Overall Study|Adverse Event|1|||
155055146|NCT05696392|559633736|FG000|Overall Study|Lost to Follow-up|3|||
155055147|NCT05696392|559633736|FG000|Overall Study|Protocol Violation|1|||
155055148|NCT05696392|559633736|FG000|Overall Study|Withdrawal by Subject|1|||
155055149|NCT03904693|559633737|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155055150|NCT03904693|559633738|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155055151|NCT03904693|559633739|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
155055152|NCT03904693|559633740|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155055153|NCT03904693|559633741|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155055154|NCT03904693|559633742|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
155055155|NCT03904693|559633737|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155055156|NCT03904693|559633738|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155055157|NCT03904693|559633739|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
155055158|NCT03904693|559633740|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155055159|NCT03904693|559633741|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155055160|NCT03904693|559633742|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
155055161|NCT03904693|559633737|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155055162|NCT03904693|559633738|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
155055163|NCT03904693|559633739|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
155055164|NCT03904693|559633740|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155055165|NCT03904693|559633741|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155055166|NCT03904693|559633742|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
155055167|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
155055168|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
155055169|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
155055170|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
155055171|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
155055172|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
155055173|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
155055174|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
155055175|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
155055176|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
155055177|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
155055178|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
155055179|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155055180|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155055181|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155055182|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
155055183|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155055184|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
155055185|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155055186|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155055187|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155055188|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
155055189|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155055190|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
155055191|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155055192|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155055193|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155055194|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155055195|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
155055196|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
155055197|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155055198|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155055199|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155055200|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155055201|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
155055202|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
155055203|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155055204|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155055205|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155055206|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155055207|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
155055208|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
155055209|NCT03904693|559633737|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155055210|NCT03904693|559633738|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155055211|NCT03904693|559633739|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155055212|NCT03904693|559633740|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155055213|NCT03904693|559633741|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
155055214|NCT03904693|559633742|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
155055215|NCT03180736|559633743|FG000|Overall Study|Adverse Event|3|||
155055216|NCT03180736|559633744|FG001|Overall Study|Adverse Event|4|||
155055217|NCT03180736|559633743|FG000|Overall Study|Death|10|||
155055218|NCT03180736|559633744|FG001|Overall Study|Death|7|||
155055219|NCT03180736|559633743|FG000|Overall Study|Withdrawal by Subject|5|||
155055220|NCT03180736|559633744|FG001|Overall Study|Withdrawal by Subject|12|||
155055221|NCT03180736|559633743|FG000|Overall Study|Lost to Follow-up|1|||
155055222|NCT03180736|559633744|FG001|Overall Study|Lost to Follow-up|0|||
155055223|NCT03180736|559633743|FG000|Overall Study|Lack of Efficacy|66|||
155055224|NCT03180736|559633744|FG001|Overall Study|Lack of Efficacy|87|||
155055225|NCT03180736|559633743|FG000|Overall Study|Physician Decision|4|||
155055226|NCT03180736|559633744|FG001|Overall Study|Physician Decision|7|||
155055227|NCT03180736|559633743|FG000|Overall Study|randomized but not treated|2|||
155055228|NCT03180736|559633744|FG001|Overall Study|randomized but not treated|3|||
155055229|NCT03258593|559633745|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
155055230|NCT03258593|559633746|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
155055231|NCT03258593|559633747|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
155055232|NCT03258593|559633748|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
155055233|NCT03258593|559633745|FG000|Run-In Maintenance Phase|Disease progression|3|||
155055234|NCT03258593|559633746|FG001|Run-In Maintenance Phase|Disease progression|0|||
155055235|NCT03258593|559633747|FG002|Run-In Maintenance Phase|Disease progression|0|||
155055236|NCT03258593|559633748|FG003|Run-In Maintenance Phase|Disease progression|0|||
155055237|NCT03258593|559633745|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
155055238|NCT03258593|559633746|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
155055239|NCT03258593|559633747|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
155055240|NCT03258593|559633748|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
155055241|NCT03258593|559633745|FG000|Expansion Maintenance Phase|Physician Decision|0|||
155055242|NCT03258593|559633746|FG001|Expansion Maintenance Phase|Physician Decision|1|||
155055243|NCT03258593|559633747|FG002|Expansion Maintenance Phase|Physician Decision|0|||
155055244|NCT03258593|559633748|FG003|Expansion Maintenance Phase|Physician Decision|0|||
155055245|NCT05457257|559633753|FG000|Overall Study|Withdrawal by Subject|0|||
155055246|NCT05457257|559633754|FG001|Overall Study|Withdrawal by Subject|2|||
155055247|NCT05457257|559633753|FG000|Overall Study|Death|10|||
155055248|NCT05457257|559633754|FG001|Overall Study|Death|3|||
155055249|NCT05457257|559633753|FG000|Overall Study|Ongoing|19|||
155055250|NCT05457257|559633754|FG001|Overall Study|Ongoing|9|||
155055251|NCT04464707|559633755|FG000|Overall Study|Adverse Event|1|||
155055252|NCT04464707|559633756|FG001|Overall Study|Adverse Event|0|||
155055253|NCT04464707|559633757|FG002|Overall Study|Adverse Event|0|||
155055254|NCT04464707|559633755|FG000|Overall Study|Withdrawal by Subject|0|||
155055255|NCT04464707|559633756|FG001|Overall Study|Withdrawal by Subject|0|||
155055256|NCT04464707|559633757|FG002|Overall Study|Withdrawal by Subject|2|||
155055257|NCT04464707|559633755|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155055258|NCT04464707|559633756|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155055259|NCT04464707|559633757|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155055260|NCT04464707|559633755|FG000|Overall Study|Protocol Deviation|1|||
155055261|NCT04464707|559633756|FG001|Overall Study|Protocol Deviation|0|||
155055262|NCT04464707|559633757|FG002|Overall Study|Protocol Deviation|0|||
155055263|NCT04464707|559633755|FG000|Overall Study|Lost to Follow-up|2|||
155055264|NCT04464707|559633756|FG001|Overall Study|Lost to Follow-up|0|||
155055265|NCT04464707|559633757|FG002|Overall Study|Lost to Follow-up|1|||
155055266|NCT04831138|559633758|FG000|Overall Study|Lost to Follow-up|2|||
155055267|NCT04831138|559633759|FG001|Overall Study|Lost to Follow-up|0|||
155055268|NCT04344301|559633761|FG000|Overall Study|Withdrawal by Subject|1|||
155055269|NCT04344301|559633762|FG001|Overall Study|Withdrawal by Subject|0|||
155055270|NCT04344301|559633761|FG000|Overall Study|Death|0|||
155055271|NCT04344301|559633762|FG001|Overall Study|Death|1|||
155055272|NCT00072410|559633763|FG000|Overall Study|Progressive disease|0|||
155055273|NCT00072410|559633764|FG001|Overall Study|Progressive disease|3|||
155055274|NCT05590377|559633765|FG000|Overall Study|Death|1|||
155055275|NCT05590377|559633766|FG001|Overall Study|Death|1|||
155055276|NCT05590377|559633767|FG002|Overall Study|Death|2|||
155055277|NCT05590377|559633768|FG003|Overall Study|Death|0|||
155055278|NCT05590377|559633769|FG004|Overall Study|Death|0|||
155055279|NCT05590377|559633765|FG000|Overall Study|Study Terminated by Sponsor|1|||
155055280|NCT05590377|559633766|FG001|Overall Study|Study Terminated by Sponsor|5|||
155055281|NCT05590377|559633767|FG002|Overall Study|Study Terminated by Sponsor|4|||
155055282|NCT05590377|559633768|FG003|Overall Study|Study Terminated by Sponsor|0|||
155055283|NCT05590377|559633769|FG004|Overall Study|Study Terminated by Sponsor|0|||
155055284|NCT05590377|559633765|FG000|Overall Study|Withdrawal by Subject|1|||
155055285|NCT05590377|559633766|FG001|Overall Study|Withdrawal by Subject|0|||
155055286|NCT05590377|559633767|FG002|Overall Study|Withdrawal by Subject|0|||
155055287|NCT05590377|559633768|FG003|Overall Study|Withdrawal by Subject|0|||
155055288|NCT05590377|559633769|FG004|Overall Study|Withdrawal by Subject|0|||
155055289|NCT03389620|559633770|FG000|Overall Study|Lost to Follow-up|5|||
155055290|NCT03389620|559633771|FG001|Overall Study|Lost to Follow-up|1|||
155055291|NCT00549549|559633772|FG000|Overall Study|Adverse Event|5|||
155055292|NCT00549549|559633773|FG001|Overall Study|Adverse Event|3|||
155055293|NCT00549549|559633774|FG002|Overall Study|Adverse Event|1|||
155055294|NCT00549549|559633775|FG003|Overall Study|Adverse Event|9|||
155055295|NCT00549549|559633772|FG000|Overall Study|Lack of Efficacy|9|||
155055296|NCT00549549|559633773|FG001|Overall Study|Lack of Efficacy|6|||
155055297|NCT00549549|559633774|FG002|Overall Study|Lack of Efficacy|4|||
155055298|NCT00549549|559633775|FG003|Overall Study|Lack of Efficacy|2|||
155055299|NCT00549549|559633772|FG000|Overall Study|Lost to Follow-up|1|||
155055300|NCT00549549|559633773|FG001|Overall Study|Lost to Follow-up|0|||
155055301|NCT00549549|559633774|FG002|Overall Study|Lost to Follow-up|1|||
155055302|NCT00549549|559633775|FG003|Overall Study|Lost to Follow-up|2|||
155055303|NCT00549549|559633772|FG000|Overall Study|Withdrawal by Subject|0|||
155055304|NCT00549549|559633773|FG001|Overall Study|Withdrawal by Subject|4|||
155055305|NCT00549549|559633774|FG002|Overall Study|Withdrawal by Subject|1|||
155055306|NCT00549549|559633775|FG003|Overall Study|Withdrawal by Subject|0|||
155055307|NCT00549549|559633772|FG000|Overall Study|Other|9|||
155055308|NCT00549549|559633773|FG001|Overall Study|Other|9|||
155055309|NCT00549549|559633774|FG002|Overall Study|Other|9|||
155055310|NCT00549549|559633775|FG003|Overall Study|Other|11|||
155055311|NCT00549549|559633772|FG000|Overall Study|Randomized but not treated|0|||
155055312|NCT00549549|559633773|FG001|Overall Study|Randomized but not treated|0|||
155055313|NCT00549549|559633774|FG002|Overall Study|Randomized but not treated|1|||
155055314|NCT00549549|559633775|FG003|Overall Study|Randomized but not treated|1|||
155055315|NCT02155699|559633776|FG000|Overall Study|Withdrawal by Subject|0|||
155055316|NCT02155699|559633777|FG001|Overall Study|Withdrawal by Subject|3|||
155055317|NCT02155699|559633778|FG002|Overall Study|Withdrawal by Subject|6|||
155055318|NCT02155699|559633779|FG003|Overall Study|Withdrawal by Subject|1|||
155055319|NCT02155699|559633776|FG000|Overall Study|Lost to Follow-up|0|||
155055320|NCT02155699|559633777|FG001|Overall Study|Lost to Follow-up|0|||
155055321|NCT02155699|559633778|FG002|Overall Study|Lost to Follow-up|0|||
155055322|NCT02155699|559633779|FG003|Overall Study|Lost to Follow-up|3|||
155055323|NCT02155699|559633776|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
155055324|NCT02155699|559633777|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
155055325|NCT02155699|559633778|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
155055326|NCT02155699|559633779|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
155153089|NCT01383928|559998552|FG000|Overall Study|Adverse Event|1|||
154951753|NCT01345019|559249114|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
154951754|NCT01345019|559249113|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
154951755|NCT01345019|559249114|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
154951756|NCT01345019|559249113|FG000|Blinded Treatment Phase|Disease Progression|12|||
154951757|NCT01345019|559249114|FG001|Blinded Treatment Phase|Disease Progression|10|||
154951758|NCT01345019|559249113|FG000|Blinded Treatment Phase|Adverse Event|6|||
154951759|NCT01345019|559249114|FG001|Blinded Treatment Phase|Adverse Event|13|||
154951760|NCT01345019|559249113|FG000|Blinded Treatment Phase|Administrative Decision|10|||
154951761|NCT01345019|559249114|FG001|Blinded Treatment Phase|Administrative Decision|8|||
154951762|NCT01345019|559249113|FG000|Blinded Treatment Phase|Noncompliance|5|||
154951763|NCT01345019|559249114|FG001|Blinded Treatment Phase|Noncompliance|3|||
154951764|NCT01345019|559249113|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
154951765|NCT01345019|559249114|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
154951766|NCT01345019|559249113|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
154951767|NCT01345019|559249114|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
154951768|NCT01345019|559249113|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
154951769|NCT01345019|559249114|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
154951770|NCT01345019|559249113|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
154951771|NCT01345019|559249114|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
154951772|NCT01345019|559249113|FG000|Open Label Treatment Phase|Death|49|||
154951773|NCT01345019|559249114|FG001|Open Label Treatment Phase|Death|48|||
154951774|NCT01345019|559249113|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
154951775|NCT01345019|559249114|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
154951776|NCT01345019|559249113|FG000|Open Label Treatment Phase|Adverse Event|30|||
154951777|NCT01345019|559249114|FG001|Open Label Treatment Phase|Adverse Event|51|||
154951778|NCT01345019|559249113|FG000|Open Label Treatment Phase|Administrative Decision|30|||
154951779|NCT01345019|559249114|FG001|Open Label Treatment Phase|Administrative Decision|15|||
154951780|NCT01345019|559249113|FG000|Open Label Treatment Phase|Disease Progression|17|||
154951781|NCT01345019|559249114|FG001|Open Label Treatment Phase|Disease Progression|18|||
154951782|NCT01345019|559249113|FG000|Open Label Treatment Phase|Noncompliance|5|||
154951783|NCT01345019|559249114|FG001|Open Label Treatment Phase|Noncompliance|4|||
154951784|NCT01345019|559249113|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
154951785|NCT01345019|559249114|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
154951786|NCT01345019|559249113|FG000|Open Label Treatment Phase|Pregnancy|1|||
154951787|NCT01345019|559249114|FG001|Open Label Treatment Phase|Pregnancy|0|||
154951788|NCT01345019|559249113|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
154951789|NCT01345019|559249114|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
154951790|NCT01345019|559249113|FG000|Open Label Treatment Phase|Protocol Violation|0|||
154951791|NCT01345019|559249114|FG001|Open Label Treatment Phase|Protocol Violation|1|||
154951792|NCT02636907|559249115|FG000|Autoinjector Assessment Period|Adverse Event|2|||
154951793|NCT02636907|559249115|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
154951794|NCT02636907|559249115|FG000|Extension Phase|Adverse Event|2|||
154951795|NCT02636907|559249115|FG000|Extension Phase|Withdrawal by Subject|4|||
154951796|NCT02636907|559249115|FG000|Extension Phase|Physician Decision|1|||
154951797|NCT02636907|559249115|FG000|Extension Phase|Lost to Follow-up|2|||
154951798|NCT02636907|559249115|FG000|Extension Phase|Lack of Efficacy|1|||
154951799|NCT00762086|559249116|FG000|Overall Study|Adverse Event|2|||
154951800|NCT00762086|559249117|FG001|Overall Study|Adverse Event|0|||
154951801|NCT00762086|559249116|FG000|Overall Study|Lost to Follow-up|0|||
154951802|NCT00762086|559249117|FG001|Overall Study|Lost to Follow-up|2|||
154951803|NCT00762086|559249116|FG000|Overall Study|Non compliance|1|||
154951804|NCT00762086|559249117|FG001|Overall Study|Non compliance|0|||
154951805|NCT00762086|559249116|FG000|Overall Study|Withdrawal by Subject|2|||
154951806|NCT00762086|559249117|FG001|Overall Study|Withdrawal by Subject|2|||
154951807|NCT00762086|559249116|FG000|Overall Study|Ineligible to participate in the study|1|||
154951808|NCT00762086|559249117|FG001|Overall Study|Ineligible to participate in the study|0|||
154951809|NCT03830164|559249122|FG000|Overall Study|Adverse Event|0|||
154951810|NCT03830164|559249123|FG001|Overall Study|Adverse Event|2|||
154951811|NCT03830164|559249124|FG002|Overall Study|Adverse Event|0|||
154951812|NCT03830164|559249122|FG000|Overall Study|Lack of Efficacy|1|||
154951813|NCT03830164|559249123|FG001|Overall Study|Lack of Efficacy|5|||
154951814|NCT03830164|559249124|FG002|Overall Study|Lack of Efficacy|0|||
154951815|NCT03830164|559249122|FG000|Overall Study|Lost to Follow-up|0|||
154951816|NCT03830164|559249123|FG001|Overall Study|Lost to Follow-up|1|||
154951817|NCT03830164|559249124|FG002|Overall Study|Lost to Follow-up|0|||
154951818|NCT03830164|559249122|FG000|Overall Study|Withdrawal by Subject|1|||
154951819|NCT03830164|559249123|FG001|Overall Study|Withdrawal by Subject|0|||
154951820|NCT03830164|559249124|FG002|Overall Study|Withdrawal by Subject|0|||
154951821|NCT04099888|559249125|FG000|Overall Study|Study terminated by sponsor|9|||
154951822|NCT04099888|559249126|FG001|Overall Study|Study terminated by sponsor|11|||
154951823|NCT04099888|559249125|FG000|Overall Study|Lost to Follow-up|1|||
154951824|NCT04099888|559249126|FG001|Overall Study|Lost to Follow-up|1|||
154951825|NCT04099888|559249125|FG000|Overall Study|Withdrawal by Subject|5|||
154951826|NCT04099888|559249126|FG001|Overall Study|Withdrawal by Subject|6|||
155055327|NCT02287038|559633782|FG000|Overall Study|Stopped attending appointments|3|||
155055328|NCT02287038|559633783|FG001|Overall Study|Stopped attending appointments|2|||
155055329|NCT02287038|559633782|FG000|Overall Study|Anxiety after starting medication|0|||
155055330|NCT02287038|559633783|FG001|Overall Study|Anxiety after starting medication|1|||
155055331|NCT02287038|559633782|FG000|Overall Study|Nausea after starting medication|1|||
155055332|NCT02287038|559633783|FG001|Overall Study|Nausea after starting medication|0|||
155055333|NCT02287038|559633782|FG000|Overall Study|Abnormal ECG after starting medication|1|||
155055334|NCT02287038|559633783|FG001|Overall Study|Abnormal ECG after starting medication|0|||
155055335|NCT05027815|559633792|FG000|Overall Study|Death|2|||
155055336|NCT05027815|559633793|FG001|Overall Study|Death|1|||
155055337|NCT00447902|559633798|FG000|Overall Study|Adverse Event|0|||
155055338|NCT00447902|559633799|FG001|Overall Study|Adverse Event|3|||
155055339|NCT00447902|559633798|FG000|Overall Study|Protocol Violation|1|||
155055340|NCT00447902|559633799|FG001|Overall Study|Protocol Violation|0|||
155055341|NCT00447902|559633798|FG000|Overall Study|Withdrawal by Subject|0|||
155055342|NCT00447902|559633799|FG001|Overall Study|Withdrawal by Subject|1|||
155055343|NCT00447902|559633798|FG000|Overall Study|included patients who discontinued|1|||
155055344|NCT00447902|559633799|FG001|Overall Study|included patients who discontinued|1|||
155055345|NCT00447902|559633798|FG000|Overall Study|Lack of Efficacy|2|||
155055346|NCT00447902|559633799|FG001|Overall Study|Lack of Efficacy|1|||
155055347|NCT00536510|559634856|FG000|Overall Study|Adverse Event|27|||
155055348|NCT00536510|559634857|FG001|Overall Study|Adverse Event|4|||
155055349|NCT00536510|559634856|FG000|Overall Study|Lost to Follow-up|11|||
155055350|NCT00536510|559634857|FG001|Overall Study|Lost to Follow-up|8|||
155055351|NCT00536510|559634856|FG000|Overall Study|Protocol Violation|4|||
155055352|NCT00536510|559634857|FG001|Overall Study|Protocol Violation|5|||
155055353|NCT00536510|559634856|FG000|Overall Study|Withdrawal by Subject|16|||
155055354|NCT00536510|559634857|FG001|Overall Study|Withdrawal by Subject|9|||
155055355|NCT00536510|559634856|FG000|Overall Study|Flushing with Product|20|||
155055356|NCT00536510|559634857|FG001|Overall Study|Flushing with Product|0|||
155055357|NCT00536510|559634856|FG000|Overall Study|Laboratory Adverse Event|2|||
155055358|NCT00536510|559634857|FG001|Overall Study|Laboratory Adverse Event|1|||
155055359|NCT00536510|559634856|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
155055360|NCT00536510|559634857|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
155055361|NCT00960193|559634858|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
155055362|NCT01701674|559634859|FG000|Overall Study|Unable to safely complete treatment|1|||
155055363|NCT05276973|559634860|FG000|Overall Study|Treated and DLT unevaluable|1|||
155055364|NCT05276973|559634861|FG001|Overall Study|Treated and DLT unevaluable|1|||
155055365|NCT05276973|559634862|FG002|Overall Study|Treated and DLT unevaluable|0|||
155055366|NCT01946204|559634865|FG000|Overall Study|Death|38|||
155055367|NCT01946204|559634866|FG001|Overall Study|Death|59|||
155055368|NCT01946204|559634865|FG000|Overall Study|Withdrawal by Subject|37|||
155055369|NCT01946204|559634866|FG001|Overall Study|Withdrawal by Subject|50|||
155055370|NCT01946204|559634865|FG000|Overall Study|Lost to Follow-up|3|||
155055371|NCT01946204|559634866|FG001|Overall Study|Lost to Follow-up|7|||
155055372|NCT01946204|559634865|FG000|Overall Study|Ongoing|316|||
155055373|NCT01946204|559634866|FG001|Overall Study|Ongoing|687|||
155055374|NCT01946204|559634865|FG000|Overall Study|Other|7|||
155055375|NCT01946204|559634866|FG001|Overall Study|Other|3|||
155055376|NCT04782180|559634867|FG000|Overall Study|Withdrawal by Subject|2|||
155055377|NCT04782180|559634867|FG000|Overall Study|Lost to Follow-up|2|||
155055378|NCT05852353|559634868|FG000|Overall Study|Family (dyad with LUTS) who consented but withdrew|2|||
155055379|NCT05852353|559634868|FG000|Overall Study|Family (dyad did not have LUTS) who consented but withdrew|1|||
155055380|NCT05852353|559634868|FG000|Overall Study|Family (dyad) who consented but did not complete intervention|24|||
155055381|NCT05852353|559634868|FG000|Overall Study|Family (dyad) who completed intervention but was lost to follow-up|7|||
155055382|NCT03509467|559634869|FG000|Overall Study|Withdrawal by Subject|5|||
155055383|NCT03509467|559634870|FG001|Overall Study|Withdrawal by Subject|1|||
155055384|NCT03509467|559634871|FG002|Overall Study|Withdrawal by Subject|6|||
155055385|NCT03509467|559634872|FG003|Overall Study|Withdrawal by Subject|7|||
155055386|NCT03509467|559634873|FG004|Overall Study|Withdrawal by Subject|10|||
155055387|NCT03509467|559634874|FG005|Overall Study|Withdrawal by Subject|10|||
155055388|NCT03509467|559634875|FG006|Overall Study|Withdrawal by Subject|10|||
155055389|NCT03509467|559634876|FG007|Overall Study|Withdrawal by Subject|10|||
155055390|NCT03509467|559634869|FG000|Overall Study|Death|0|||
155055391|NCT03509467|559634870|FG001|Overall Study|Death|0|||
155055392|NCT03509467|559634871|FG002|Overall Study|Death|2|||
155055393|NCT03509467|559634872|FG003|Overall Study|Death|2|||
155055394|NCT03509467|559634873|FG004|Overall Study|Death|1|||
155055395|NCT03509467|559634874|FG005|Overall Study|Death|0|||
155055396|NCT03509467|559634875|FG006|Overall Study|Death|1|||
155055397|NCT03509467|559634876|FG007|Overall Study|Death|0|||
155055398|NCT03509467|559634869|FG000|Overall Study|Proxy Withdrawal|0|||
155055399|NCT03509467|559634870|FG001|Overall Study|Proxy Withdrawal|0|||
155055400|NCT03509467|559634871|FG002|Overall Study|Proxy Withdrawal|0|||
155055401|NCT03509467|559634872|FG003|Overall Study|Proxy Withdrawal|0|||
155055402|NCT03509467|559634873|FG004|Overall Study|Proxy Withdrawal|0|||
155055403|NCT03509467|559634874|FG005|Overall Study|Proxy Withdrawal|0|||
155055404|NCT03509467|559634875|FG006|Overall Study|Proxy Withdrawal|0|||
155055405|NCT03509467|559634876|FG007|Overall Study|Proxy Withdrawal|1|||
155055406|NCT01005745|559634877|FG000|Overall Study|No TIL growth|1|||
155055407|NCT01005745|559634877|FG000|Overall Study|Disease progressed during TIL growth|3|||
155055408|NCT01005745|559634877|FG000|Overall Study|Death prior to treatment|1|||
155055409|NCT01005745|559634877|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
155055410|NCT06077773|559634880|FG000|Overall Study|Withdrawal by Subject|1|||
155055411|NCT06077773|559634881|FG001|Overall Study|Withdrawal by Subject|0|||
155055412|NCT06077773|559634882|FG002|Overall Study|Withdrawal by Subject|1|||
155055413|NCT06077773|559634880|FG000|Overall Study|Lost to Follow-up|0|||
155055414|NCT06077773|559634881|FG001|Overall Study|Lost to Follow-up|1|||
155055415|NCT06077773|559634882|FG002|Overall Study|Lost to Follow-up|0|||
155055416|NCT06077773|559634880|FG000|Overall Study|Adverse Event|0|||
155055417|NCT06077773|559634881|FG001|Overall Study|Adverse Event|0|||
155055418|NCT06077773|559634882|FG002|Overall Study|Adverse Event|2|||
155055419|NCT04275973|559634883|FG000|Overall Study|Withdrawal by Subject|2|||
155055420|NCT04275973|559634884|FG001|Overall Study|Withdrawal by Subject|1|||
155055421|NCT06110754|559634885|FG000|Overall Study|Withdrawal by Subject|0|||
155055422|NCT06110754|559634886|FG001|Overall Study|Withdrawal by Subject|0|||
155055423|NCT06110754|559634887|FG002|Overall Study|Withdrawal by Subject|1|||
155055424|NCT06110754|559634888|FG003|Overall Study|Withdrawal by Subject|0|||
155055425|NCT02499146|559634891|FG000|Overall Study|Global deterioration of health status|1|||
155055426|NCT02499146|559634891|FG000|Overall Study|Objective progression or relapse|20|||
155055427|NCT02499146|559634891|FG000|Overall Study|Other|2|||
155055428|NCT02499146|559634891|FG000|Overall Study|Participant refused continued treatment for reason other than adverse event|3|||
155055429|NCT04325828|559634892|FG000|Overall Study|Ongoing|26|||
155055430|NCT05115630|559634893|FG000|Overall Study|Due to COVID19|1|||
155055431|NCT05115630|559634893|FG000|Overall Study|Due to Bacteremia|1|||
155055432|NCT05115630|559634893|FG000|Overall Study|Due to viral infection|1|||
155055433|NCT05093933|559634894|FG000|Overall Study|Death|372|||
155055434|NCT05093933|559634895|FG001|Overall Study|Death|434|||
155055435|NCT05093933|559634894|FG000|Overall Study|Lost to Follow-up|13|||
155055436|NCT05093933|559634895|FG001|Overall Study|Lost to Follow-up|16|||
155055437|NCT05093933|559634894|FG000|Overall Study|Physician Decision|0|||
155055438|NCT05093933|559634895|FG001|Overall Study|Physician Decision|2|||
155055439|NCT05093933|559634894|FG000|Overall Study|Sponsor Decision|1|||
155055440|NCT05093933|559634895|FG001|Overall Study|Sponsor Decision|3|||
155055441|NCT05093933|559634894|FG000|Overall Study|Withdrawal by Guardian|1|||
155055442|NCT05093933|559634895|FG001|Overall Study|Withdrawal by Guardian|1|||
155055443|NCT05093933|559634894|FG000|Overall Study|Withdrawal by Subject|18|||
155055444|NCT05093933|559634895|FG001|Overall Study|Withdrawal by Subject|25|||
155055445|NCT04037358|559634896|FG000|Overall Study|Patient withdrew before intervention|1|||
155055446|NCT04037358|559634897|FG001|Overall Study|Patient withdrew before intervention|0|||
155055447|NCT04157517|559634900|FG000|Overall Study|Death|1|||
155055448|NCT04157517|559634901|FG001|Overall Study|Death|2|||
155055449|NCT04157517|559634902|FG002|Overall Study|Death|2|||
155055450|NCT04157517|559634903|FG003|Overall Study|Death|3|||
155055451|NCT04157517|559634904|FG004|Overall Study|Death|3|||
155055452|NCT04157517|559634905|FG005|Overall Study|Death|4|||
155055453|NCT04157517|559634906|FG006|Overall Study|Death|1|||
155055454|NCT04157517|559634907|FG007|Overall Study|Death|2|||
155055455|NCT04157517|559634908|FG008|Overall Study|Death|4|||
155055456|NCT04157517|559634909|FG009|Overall Study|Death|0|||
155055457|NCT04157517|559634900|FG000|Overall Study|Withdrawal by Subject|1|||
155055458|NCT04157517|559634901|FG001|Overall Study|Withdrawal by Subject|1|||
155055459|NCT04157517|559634902|FG002|Overall Study|Withdrawal by Subject|1|||
155055460|NCT04157517|559634903|FG003|Overall Study|Withdrawal by Subject|0|||
155055461|NCT04157517|559634904|FG004|Overall Study|Withdrawal by Subject|0|||
155055462|NCT04157517|559634905|FG005|Overall Study|Withdrawal by Subject|1|||
155055463|NCT04157517|559634906|FG006|Overall Study|Withdrawal by Subject|0|||
155055464|NCT04157517|559634907|FG007|Overall Study|Withdrawal by Subject|0|||
155055465|NCT04157517|559634908|FG008|Overall Study|Withdrawal by Subject|1|||
155055466|NCT04157517|559634909|FG009|Overall Study|Withdrawal by Subject|0|||
155055467|NCT04157517|559634900|FG000|Overall Study|Other|1|||
155055468|NCT04157517|559634901|FG001|Overall Study|Other|0|||
155055469|NCT04157517|559634902|FG002|Overall Study|Other|0|||
155055470|NCT04157517|559634903|FG003|Overall Study|Other|0|||
155055471|NCT04157517|559634904|FG004|Overall Study|Other|0|||
155055472|NCT04157517|559634905|FG005|Overall Study|Other|1|||
155055473|NCT04157517|559634906|FG006|Overall Study|Other|2|||
155055474|NCT04157517|559634907|FG007|Overall Study|Other|7|||
155055475|NCT04157517|559634908|FG008|Overall Study|Other|7|||
155055476|NCT04157517|559634909|FG009|Overall Study|Other|0|||
155055477|NCT03433898|559634910|FG000|Overall Study|Progressive disease|6|||
155055478|NCT03433898|559634911|FG001|Overall Study|Progressive disease|3|||
155055479|NCT03433898|559634912|FG002|Overall Study|Progressive disease|3|||
155055480|NCT03433898|559634913|FG003|Overall Study|Progressive disease|2|||
155055481|NCT03433898|559634914|FG004|Overall Study|Progressive disease|30|||
155055482|NCT03433898|559634915|FG005|Overall Study|Progressive disease|29|||
155055483|NCT03433898|559634916|FG006|Overall Study|Progressive disease|17|||
155055484|NCT03433898|559634917|FG007|Overall Study|Progressive disease|30|||
155055485|NCT03433898|559634910|FG000|Overall Study|Not treated|1|||
155055486|NCT03433898|559634911|FG001|Overall Study|Not treated|0|||
155055487|NCT03433898|559634912|FG002|Overall Study|Not treated|0|||
155055488|NCT03433898|559634913|FG003|Overall Study|Not treated|0|||
155055489|NCT03433898|559634914|FG004|Overall Study|Not treated|1|||
155055490|NCT03433898|559634915|FG005|Overall Study|Not treated|0|||
155055491|NCT03433898|559634916|FG006|Overall Study|Not treated|0|||
155055492|NCT03433898|559634917|FG007|Overall Study|Not treated|0|||
155055493|NCT03433898|559634910|FG000|Overall Study|Death|0|||
155055494|NCT03433898|559634911|FG001|Overall Study|Death|0|||
155055495|NCT03433898|559634912|FG002|Overall Study|Death|0|||
155055496|NCT03433898|559634913|FG003|Overall Study|Death|0|||
155055497|NCT03433898|559634914|FG004|Overall Study|Death|0|||
155055498|NCT03433898|559634915|FG005|Overall Study|Death|0|||
155055499|NCT03433898|559634916|FG006|Overall Study|Death|1|||
155055500|NCT03433898|559634917|FG007|Overall Study|Death|1|||
155055501|NCT03433898|559634910|FG000|Overall Study|Withdrawal by Subject|0|||
155055502|NCT03433898|559634911|FG001|Overall Study|Withdrawal by Subject|0|||
155055503|NCT03433898|559634912|FG002|Overall Study|Withdrawal by Subject|0|||
155055504|NCT03433898|559634913|FG003|Overall Study|Withdrawal by Subject|0|||
155055505|NCT03433898|559634914|FG004|Overall Study|Withdrawal by Subject|2|||
155055506|NCT03433898|559634915|FG005|Overall Study|Withdrawal by Subject|0|||
155055507|NCT03433898|559634916|FG006|Overall Study|Withdrawal by Subject|0|||
155055508|NCT03433898|559634917|FG007|Overall Study|Withdrawal by Subject|0|||
155055509|NCT03433898|559634910|FG000|Overall Study|Adverse Event|0|||
155055510|NCT03433898|559634911|FG001|Overall Study|Adverse Event|0|||
155055511|NCT03433898|559634912|FG002|Overall Study|Adverse Event|0|||
155055512|NCT03433898|559634913|FG003|Overall Study|Adverse Event|0|||
155055513|NCT03433898|559634914|FG004|Overall Study|Adverse Event|0|||
155055514|NCT03433898|559634915|FG005|Overall Study|Adverse Event|5|||
155055515|NCT03433898|559634916|FG006|Overall Study|Adverse Event|2|||
155055516|NCT03433898|559634917|FG007|Overall Study|Adverse Event|2|||
155055517|NCT03433898|559634910|FG000|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055518|NCT03433898|559634911|FG001|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055519|NCT03433898|559634912|FG002|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055520|NCT03433898|559634913|FG003|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055521|NCT03433898|559634914|FG004|Overall Study|Fatal adverse event: Acute kidney injury|1|||
155055522|NCT03433898|559634915|FG005|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055523|NCT03433898|559634916|FG006|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055524|NCT03433898|559634917|FG007|Overall Study|Fatal adverse event: Acute kidney injury|0|||
155055525|NCT01949142|559634919|FG000|Overall Study|Withdrawal of consent|1|||
155055526|NCT01949142|559634920|FG001|Overall Study|Withdrawal of consent|0|||
155055527|NCT01949142|559634919|FG000|Overall Study|Lost to Follow-up|1|||
155055528|NCT01949142|559634920|FG001|Overall Study|Lost to Follow-up|1|||
155055529|NCT01949142|559634919|FG000|Overall Study|Parent changed their mind|1|||
155055530|NCT01949142|559634920|FG001|Overall Study|Parent changed their mind|0|||
155055531|NCT05069259|559634921|FG000|Overall Study|Withdrawal by Subject|1|||
155055532|NCT05069259|559634921|FG000|Overall Study|Sponsor decision|1|||
155055533|NCT00870727|559635974|FG000|Overall Study|Lost to Follow-up|0|||
155055534|NCT00870727|559635975|FG001|Overall Study|Lost to Follow-up|1|||
155055535|NCT00870727|559635974|FG000|Overall Study|Lack of Efficacy|1|||
155055536|NCT00870727|559635975|FG001|Overall Study|Lack of Efficacy|3|||
155055537|NCT00870727|559635974|FG000|Overall Study|Adverse Event|0|||
155055538|NCT00870727|559635975|FG001|Overall Study|Adverse Event|1|||
155055539|NCT01712516|559635976|FG000|Overall Study|Technical problems|0|||
155055540|NCT01712516|559635977|FG001|Overall Study|Technical problems|0|||
155055541|NCT01712516|559635978|FG002|Overall Study|Technical problems|0|||
155055542|NCT01712516|559635979|FG003|Overall Study|Technical problems|2|||
155055543|NCT01712516|559635976|FG000|Overall Study|Lost to Follow-up|0|||
155055544|NCT01712516|559635977|FG001|Overall Study|Lost to Follow-up|0|||
155055545|NCT01712516|559635978|FG002|Overall Study|Lost to Follow-up|2|||
155055546|NCT01712516|559635979|FG003|Overall Study|Lost to Follow-up|1|||
155055547|NCT01712516|559635976|FG000|Overall Study|Death|0|||
155055548|NCT01712516|559635977|FG001|Overall Study|Death|1|||
155055549|NCT01712516|559635978|FG002|Overall Study|Death|0|||
155055550|NCT01712516|559635979|FG003|Overall Study|Death|0|||
155055551|NCT01712516|559635976|FG000|Overall Study|Protocol deviation|1|||
155055552|NCT01712516|559635977|FG001|Overall Study|Protocol deviation|0|||
155055553|NCT01712516|559635978|FG002|Overall Study|Protocol deviation|1|||
155055554|NCT01712516|559635979|FG003|Overall Study|Protocol deviation|0|||
155055555|NCT01712516|559635976|FG000|Overall Study|Physician Decision|2|||
155055556|NCT01712516|559635977|FG001|Overall Study|Physician Decision|0|||
155055557|NCT01712516|559635978|FG002|Overall Study|Physician Decision|0|||
155055558|NCT01712516|559635979|FG003|Overall Study|Physician Decision|1|||
155055559|NCT01712516|559635976|FG000|Overall Study|Withdrawal by Subject|3|||
155055560|NCT01712516|559635977|FG001|Overall Study|Withdrawal by Subject|9|||
155055561|NCT01712516|559635978|FG002|Overall Study|Withdrawal by Subject|3|||
155055562|NCT01712516|559635979|FG003|Overall Study|Withdrawal by Subject|9|||
155055563|NCT01251952|559635980|FG000|Overall Study|Adverse Event|1|||
155055564|NCT00496769|559635981|FG000|Double Blind|>=1 reason assigned per patient|558|||
155055565|NCT00496769|559635982|FG001|Double Blind|>=1 reason assigned per patient|649|||
155055566|NCT00496769|559635983|FG002|Double Blind|>=1 reason assigned per patient|0|||
155055567|NCT00496769|559635981|FG000|Open Label|>=1 reason assigned per patient|0|||
155055568|NCT00496769|559635982|FG001|Open Label|>=1 reason assigned per patient|0|||
155055569|NCT00496769|559635983|FG002|Open Label|>=1 reason assigned per patient|1011|||
155055570|NCT02224625|559635989|FG000|Irritation|Adverse Event|6|||
155055571|NCT02224625|559635989|FG000|Sensitization|Adverse Event|55|||
155055572|NCT00426270|559635993|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
155055573|NCT00426270|559635993|FG000|Overall Study|Adverse Event|5|||
155055574|NCT01117870|559635994|FG000|Overall Study|Inability to place needle|1|||
155055575|NCT01117870|559635995|FG001|Overall Study|Inability to place needle|0|||
155055576|NCT02062437|559635998|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
155055577|NCT02062437|559635998|FG000|Overall Study|Patient not available for the 2y visit|18|||
155055578|NCT02062437|559635998|FG000|Overall Study|Death|2|||
155055579|NCT02062437|559635998|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
155055580|NCT01674725|559635999|FG000|Overall Study|Adverse Event|1|||
155055581|NCT01674725|559636000|FG001|Overall Study|Adverse Event|0|||
155055582|NCT01674725|559635999|FG000|Overall Study|Did not receive study drug|1|||
155055583|NCT01674725|559636000|FG001|Overall Study|Did not receive study drug|0|||
155055584|NCT01674725|559635999|FG000|Overall Study|Withdrawal by Subject|1|||
155055585|NCT01674725|559636000|FG001|Overall Study|Withdrawal by Subject|0|||
155055586|NCT01674725|559635999|FG000|Overall Study|Lost to Follow-up|0|||
155055587|NCT01674725|559636000|FG001|Overall Study|Lost to Follow-up|1|||
155055588|NCT03102762|559636001|FG000|Overall Study|Lost to Follow-up|1|||
155055589|NCT03102762|559636002|FG001|Overall Study|Lost to Follow-up|0|||
155055590|NCT03074695|559636007|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
155055591|NCT03074695|559636008|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
155055592|NCT03074695|559636007|FG000|Overall Study|Research staff not available|1|||
155055593|NCT03074695|559636008|FG001|Overall Study|Research staff not available|2|||
155055594|NCT03074695|559636007|FG000|Overall Study|Did not receive neuraxial block|2|||
155055595|NCT03074695|559636008|FG001|Overall Study|Did not receive neuraxial block|2|||
155055596|NCT01774981|559636009|FG000|Overall Study|Adverse Event|0|||
155055597|NCT01774981|559636010|FG001|Overall Study|Adverse Event|0|||
155055598|NCT01774981|559636011|FG002|Overall Study|Adverse Event|0|||
155055599|NCT01774981|559636012|FG003|Overall Study|Adverse Event|0|||
155055600|NCT01774981|559636013|FG004|Overall Study|Adverse Event|0|||
155055601|NCT01774981|559636014|FG005|Overall Study|Adverse Event|1|||
155055602|NCT01774981|559636015|FG006|Overall Study|Adverse Event|0|||
155055603|NCT01774981|559636016|FG007|Overall Study|Adverse Event|0|||
155055604|NCT01774981|559636009|FG000|Overall Study|Withdrawal by Subject|0|||
155055605|NCT01774981|559636010|FG001|Overall Study|Withdrawal by Subject|0|||
155055606|NCT01774981|559636011|FG002|Overall Study|Withdrawal by Subject|0|||
155055607|NCT01774981|559636012|FG003|Overall Study|Withdrawal by Subject|0|||
155055608|NCT01774981|559636013|FG004|Overall Study|Withdrawal by Subject|0|||
155055609|NCT01774981|559636014|FG005|Overall Study|Withdrawal by Subject|0|||
155055610|NCT01774981|559636015|FG006|Overall Study|Withdrawal by Subject|0|||
155055611|NCT01774981|559636016|FG007|Overall Study|Withdrawal by Subject|1|||
155055612|NCT01774981|559636009|FG000|Overall Study|Death|0|||
155055613|NCT01774981|559636010|FG001|Overall Study|Death|0|||
155055614|NCT01774981|559636011|FG002|Overall Study|Death|0|||
155055615|NCT01774981|559636012|FG003|Overall Study|Death|0|||
155055616|NCT01774981|559636013|FG004|Overall Study|Death|1|||
155055617|NCT01774981|559636014|FG005|Overall Study|Death|0|||
155055618|NCT01774981|559636015|FG006|Overall Study|Death|0|||
155055619|NCT01774981|559636016|FG007|Overall Study|Death|0|||
155055620|NCT01324102|559636019|FG000|Overall Study|illness|1|||
155055621|NCT01324102|559636020|FG001|Overall Study|illness|6|||
155055622|NCT00728494|559636021|FG000|Overall Study|Adverse Event|7|||
155055623|NCT00728494|559636022|FG001|Overall Study|Adverse Event|0|||
155055624|NCT00728494|559636021|FG000|Overall Study|Withdrawal by Subject|0|||
155055625|NCT00728494|559636022|FG001|Overall Study|Withdrawal by Subject|2|||
155055626|NCT00728494|559636021|FG000|Overall Study|Lack of Efficacy|2|||
155055627|NCT00728494|559636022|FG001|Overall Study|Lack of Efficacy|4|||
155055628|NCT00728494|559636021|FG000|Overall Study|No data available|0|||
155055629|NCT00728494|559636022|FG001|Overall Study|No data available|1|||
155055630|NCT00001566|559636023|FG000|Overall Study|patients' choice to discontinue protocol|3|||
155055631|NCT00001566|559636023|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
155055632|NCT00001566|559636023|FG000|Overall Study|Death|13|||
155055633|NCT00001566|559636023|FG000|Overall Study|Lost to Follow-up|1|||
155055634|NCT00001566|559636023|FG000|Overall Study|unable to complete initial apheresis|1|||
155055635|NCT00433836|559636024|FG000|Overall Study|Adverse Event|7|||
155055636|NCT00433836|559636025|FG001|Overall Study|Adverse Event|0|||
155055637|NCT00433836|559636024|FG000|Overall Study|Lost to Follow-up|3|||
155055638|NCT00433836|559636025|FG001|Overall Study|Lost to Follow-up|0|||
155055639|NCT00433836|559636024|FG000|Overall Study|Withdrawal by Subject|2|||
155055640|NCT00433836|559636025|FG001|Overall Study|Withdrawal by Subject|1|||
155055641|NCT00433836|559636024|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155055642|NCT00433836|559636025|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155055643|NCT00433836|559636024|FG000|Overall Study|Protocol Violation|0|||
155055644|NCT00433836|559636025|FG001|Overall Study|Protocol Violation|2|||
155055645|NCT00433836|559636024|FG000|Overall Study|Condition no longer requires study drug|0|||
155055646|NCT00433836|559636025|FG001|Overall Study|Condition no longer requires study drug|1|||
155055647|NCT00433836|559636024|FG000|Overall Study|Abnormal laboratory values|0|||
155055648|NCT00433836|559636025|FG001|Overall Study|Abnormal laboratory values|1|||
155055649|NCT00748241|559636026|FG000|Overall Study|Implant failure|1|||
155055650|NCT00748241|559636026|FG000|Overall Study|Lost to Follow-up|5|||
155055651|NCT00748241|559636026|FG000|Overall Study|Death|2|||
155055652|NCT02456727|559636027|FG000|Overall Study|Lost to Follow-up|63|||
155055653|NCT02456727|559636028|FG001|Overall Study|Lost to Follow-up|65|||
155055654|NCT02456727|559636027|FG000|Overall Study|Death|2|||
155055655|NCT02456727|559636028|FG001|Overall Study|Death|1|||
155055656|NCT02456727|559636027|FG000|Overall Study|Withdrawal by Subject|1|||
155055657|NCT02456727|559636028|FG001|Overall Study|Withdrawal by Subject|10|||
155055658|NCT02456727|559636027|FG000|Overall Study|Never Initiated Treatment|43|||
155055659|NCT02456727|559636028|FG001|Overall Study|Never Initiated Treatment|30|||
155055660|NCT00492297|559636029|FG000|Treatment|Death|2|||
155055661|NCT00492297|559636029|FG000|Treatment|Study terminated by sponsor|3|||
155055662|NCT00492297|559636029|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
155055663|NCT00492297|559636029|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
155055664|NCT00492297|559636029|FG000|Survival Only Follow-up|Death|46|||
155055665|NCT00492297|559636029|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
155055666|NCT00492297|559636029|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
155055667|NCT00113607|559636030|FG000|Overall Study|Adverse Event|40|||
155055668|NCT00113607|559636031|FG001|Overall Study|Adverse Event|71|||
155055669|NCT00113607|559636030|FG000|Overall Study|Death|8|||
155055670|NCT00113607|559636031|FG001|Overall Study|Death|8|||
155055671|NCT00113607|559636030|FG000|Overall Study|Withdrawal by Subject|50|||
155055672|NCT00113607|559636031|FG001|Overall Study|Withdrawal by Subject|58|||
155055673|NCT00113607|559636030|FG000|Overall Study|Lost to Follow-up|0|||
155055674|NCT00113607|559636031|FG001|Overall Study|Lost to Follow-up|2|||
155055675|NCT00113607|559636030|FG000|Overall Study|Disease Progression|180|||
155055676|NCT00113607|559636031|FG001|Overall Study|Disease Progression|142|||
155055677|NCT00113607|559636030|FG000|Overall Study|Complete Response (Confirmed)|14|||
155055678|NCT00113607|559636031|FG001|Overall Study|Complete Response (Confirmed)|24|||
155055679|NCT00113607|559636030|FG000|Overall Study|Other|43|||
155055680|NCT00113607|559636031|FG001|Overall Study|Other|32|||
155055681|NCT03669549|559636032|FG000|Overall Study|Adverse Event|4|||
155055682|NCT03669549|559636032|FG000|Overall Study|Withdrawal by Subject|1|||
155055683|NCT03669549|559636032|FG000|Overall Study|Study terminated by the Sponsor|1|||
155055684|NCT00909844|559636033|FG000|Overall Study|Adverse Event|1|||
155055685|NCT00909844|559636033|FG000|Overall Study|Withdrawal by Subject|1|||
155055686|NCT00909844|559636033|FG000|Overall Study|Lost to Follow-up|2|||
155055687|NCT02974868|559636035|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
155055688|NCT02974868|559636036|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
155055689|NCT02974868|559636037|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
155055690|NCT02974868|559636038|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
155055691|NCT02974868|559636035|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
155055692|NCT02974868|559636036|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
155055693|NCT02974868|559636037|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
155055694|NCT02974868|559636038|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
155055695|NCT02974868|559636035|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
155055696|NCT02974868|559636036|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
155055697|NCT02974868|559636037|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
155055698|NCT02974868|559636038|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
155055699|NCT02974868|559636035|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
155055700|NCT02974868|559636036|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
155055701|NCT02974868|559636037|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
155055702|NCT02974868|559636038|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
155055703|NCT00706004|559636039|FG000|Overall Study|Did not meet eligibility criteria|2|||
155055704|NCT02674516|559636040|FG000|Overall Study|Lost to Follow-up|3|||
155055705|NCT02674516|559636041|FG001|Overall Study|Lost to Follow-up|0|||
155055706|NCT02674516|559636040|FG000|Overall Study|Protocol Violation|0|||
155055707|NCT02674516|559636041|FG001|Overall Study|Protocol Violation|4|||
155055708|NCT02674516|559636040|FG000|Overall Study|Knowledge of study hypothesis|1|||
155055709|NCT02674516|559636041|FG001|Overall Study|Knowledge of study hypothesis|0|||
155055710|NCT01663402|559636043|FG000|Overall Study|Randomized but not treated|19|||
155055711|NCT01663402|559636044|FG001|Overall Study|Randomized but not treated|11|||
155055712|NCT01663402|559636043|FG000|Overall Study|Adverse Event|347|||
155055713|NCT01663402|559636044|FG001|Overall Study|Adverse Event|362|||
155055714|NCT01663402|559636043|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
155055715|NCT01663402|559636044|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
155055716|NCT01663402|559636043|FG000|Overall Study|Poor compliance to protocol|529|||
155055717|NCT01663402|559636044|FG001|Overall Study|Poor compliance to protocol|454|||
155055718|NCT01663402|559636043|FG000|Overall Study|Physician Decision|77|||
155055719|NCT01663402|559636044|FG001|Overall Study|Physician Decision|62|||
155055720|NCT01663402|559636043|FG000|Overall Study|Site terminated by sponsor|1|||
155055721|NCT01663402|559636044|FG001|Overall Study|Site terminated by sponsor|3|||
155055722|NCT01663402|559636043|FG000|Overall Study|Participant moved|139|||
155055723|NCT01663402|559636044|FG001|Overall Study|Participant moved|104|||
155055724|NCT01663402|559636043|FG000|Overall Study|Withdrawal by Subject|118|||
155055725|NCT01663402|559636044|FG001|Overall Study|Withdrawal by Subject|91|||
155055726|NCT01663402|559636043|FG000|Overall Study|Related to study drug administration|96|||
155055727|NCT01663402|559636044|FG001|Overall Study|Related to study drug administration|105|||
155055728|NCT01663402|559636043|FG000|Overall Study|Lost to Follow-up|17|||
155055729|NCT01663402|559636044|FG001|Overall Study|Lost to Follow-up|15|||
155055730|NCT01663402|559636043|FG000|Overall Study|Other than specified above|172|||
155393585|NCT01132612|560876798|FG001|Overall Study|Administrative problems|1|||
155393586|NCT01132612|560876799|FG002|Overall Study|Administrative problems|52|||
155393587|NCT01132612|560876797|FG000|Overall Study|Lack of Efficacy|23|||
155055731|NCT01663402|559636044|FG001|Overall Study|Other than specified above|147|||
155055732|NCT03575702|559636047|FG000|Overall Study|Withdrawal by Subject|1|||
155055733|NCT03575702|559636048|FG001|Overall Study|Withdrawal by Subject|1|||
155055734|NCT03575702|559636047|FG000|Overall Study|Lost to Follow-up|1|||
155055735|NCT03575702|559636048|FG001|Overall Study|Lost to Follow-up|2|||
155055736|NCT03575702|559636047|FG000|Overall Study|Protocol Violation|0|||
155055737|NCT03575702|559636048|FG001|Overall Study|Protocol Violation|1|||
155055738|NCT03575702|559636047|FG000|Overall Study|Patient non compliance|4|||
155055739|NCT03575702|559636048|FG001|Overall Study|Patient non compliance|0|||
155055740|NCT01825200|559636049|FG000|Overall Study|Lost to Follow-up|5|||
155055741|NCT01825200|559636050|FG001|Overall Study|Lost to Follow-up|6|||
155055742|NCT01825200|559636049|FG000|Overall Study|Withdrawal by Subject|0|||
155055743|NCT01825200|559636050|FG001|Overall Study|Withdrawal by Subject|1|||
155055744|NCT03585270|559636051|FG000|Overall Study|Withdrawal by Subject|2|||
155055745|NCT03585270|559636052|FG001|Overall Study|Withdrawal by Subject|6|||
155055746|NCT03585270|559636051|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
155055747|NCT03585270|559636052|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
155055748|NCT03585270|559636051|FG000|Overall Study|Adverse Event|5|||
155055749|NCT03585270|559636052|FG001|Overall Study|Adverse Event|2|||
155055750|NCT03585270|559636051|FG000|Overall Study|Lost to Follow-up|1|||
155055751|NCT03585270|559636052|FG001|Overall Study|Lost to Follow-up|4|||
155055752|NCT03585270|559636051|FG000|Overall Study|Death|5|||
155055753|NCT03585270|559636052|FG001|Overall Study|Death|3|||
155055754|NCT03585270|559636051|FG000|Overall Study|Other reasons|2|||
155055755|NCT03585270|559636052|FG001|Overall Study|Other reasons|2|||
155055756|NCT05559905|559636053|FG000|Overall Study|Withdrawal by Subject|1|||
155055757|NCT05559905|559636054|FG001|Overall Study|Withdrawal by Subject|0|||
155055758|NCT05559905|559636055|FG002|Overall Study|Withdrawal by Subject|0|||
155055759|NCT05559905|559636053|FG000|Overall Study|Not Reported|1|||
155055760|NCT05559905|559636054|FG001|Overall Study|Not Reported|0|||
155055761|NCT05559905|559636055|FG002|Overall Study|Not Reported|0|||
155055762|NCT04802161|559636069|FG000|Overall Study|Alternate Therapy prior to Day 21|1|||
155055763|NCT04802161|559636070|FG001|Overall Study|Alternate Therapy prior to Day 21|0|||
155055764|NCT04802161|559636071|FG002|Overall Study|Alternate Therapy prior to Day 21|1|||
155055765|NCT04802161|559636072|FG003|Overall Study|Alternate Therapy prior to Day 21|1|||
155055766|NCT04802161|559636069|FG000|Overall Study|Clinical Instability|0|||
155055767|NCT04802161|559636070|FG001|Overall Study|Clinical Instability|0|||
155055768|NCT04802161|559636071|FG002|Overall Study|Clinical Instability|1|||
155055769|NCT04802161|559636072|FG003|Overall Study|Clinical Instability|0|||
155055770|NCT04802161|559636069|FG000|Overall Study|Adverse Event|0|||
155055771|NCT04802161|559636070|FG001|Overall Study|Adverse Event|0|||
155055772|NCT04802161|559636071|FG002|Overall Study|Adverse Event|1|||
155055773|NCT04802161|559636072|FG003|Overall Study|Adverse Event|0|||
155055774|NCT04802161|559636069|FG000|Overall Study|Death|0|||
155055775|NCT04802161|559636070|FG001|Overall Study|Death|0|||
155055776|NCT04802161|559636071|FG002|Overall Study|Death|1|||
155055777|NCT04802161|559636072|FG003|Overall Study|Death|0|||
155055778|NCT07116759|559636078|FG000|Overall Study|Incompatibility with the RHMC device|2|||
155055779|NCT01433159|559637719|FG000|Overall Study|Adverse Event|1|||
155055780|NCT01433159|559637720|FG001|Overall Study|Adverse Event|0|||
155055781|NCT01433159|559637719|FG000|Overall Study|Physician Decision|1|||
155055782|NCT01433159|559637720|FG001|Overall Study|Physician Decision|0|||
155055783|NCT01433159|559637719|FG000|Overall Study|Protocol Violation|0|||
155393588|NCT01132612|560876798|FG001|Overall Study|Lack of Efficacy|22|||
155055784|NCT01433159|559637720|FG001|Overall Study|Protocol Violation|1|||
155055785|NCT01100853|559637721|FG000|Overall Study|Lost to Follow-up|11|||
155393589|NCT01132612|560876799|FG002|Overall Study|Lack of Efficacy|73|||
155393590|NCT02252536|560876801|FG000|Overall Study|Lost to Follow-up|5|||
155393591|NCT02252536|560876802|FG001|Overall Study|Lost to Follow-up|3|||
155393592|NCT01438151|560876803|FG000|Overall Study|study terminated|8|||
155393593|NCT00006392|560876810|FG000|Overall Study|Ineligible|11|||
155393594|NCT00006392|560876811|FG001|Overall Study|Ineligible|3|||
155393595|NCT00006392|560876812|FG002|Overall Study|Ineligible|5|||
155393596|NCT00006392|560876813|FG003|Overall Study|Ineligible|5|||
155393597|NCT00006392|560876810|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
155393598|NCT00006392|560876811|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
155055786|NCT01100853|559637722|FG001|Overall Study|Lost to Follow-up|6|||
155055787|NCT01100853|559637721|FG000|Overall Study|Received <4 study injections|10|||
155055788|NCT01100853|559637722|FG001|Overall Study|Received <4 study injections|13|||
155055789|NCT01100853|559637721|FG000|Overall Study|Withdrawal by Subject|6|||
155055790|NCT01100853|559637722|FG001|Overall Study|Withdrawal by Subject|4|||
155055791|NCT01384877|559637723|FG000|Treatment 2|Lost to Follow-up|2|||
155055792|NCT01384877|559637724|FG001|Treatment 2|Lost to Follow-up|2|||
155055793|NCT01548404|559637725|FG000|Overall Study|Adverse Event|3|||
155055794|NCT01548404|559637726|FG001|Overall Study|Adverse Event|1|||
155055795|NCT01548404|559637725|FG000|Overall Study|Physician Decision|2|||
155055796|NCT01548404|559637726|FG001|Overall Study|Physician Decision|1|||
155055797|NCT01548404|559637725|FG000|Overall Study|Inadequate response to study treatment|23|||
155055798|NCT01548404|559637726|FG001|Overall Study|Inadequate response to study treatment|7|||
155055799|NCT01548404|559637725|FG000|Overall Study|Lost to Follow-up|2|||
155055800|NCT01548404|559637726|FG001|Overall Study|Lost to Follow-up|0|||
155055801|NCT01548404|559637725|FG000|Overall Study|Withdrawal by Subject|0|||
155055802|NCT01548404|559637726|FG001|Overall Study|Withdrawal by Subject|3|||
155055803|NCT01548404|559637725|FG000|Overall Study|Other than specified above|0|||
155055804|NCT01548404|559637726|FG001|Overall Study|Other than specified above|2|||
155055805|NCT01064479|559637727|FG000|Overall Study|Death|10|||
155055806|NCT01064479|559637728|FG001|Overall Study|Death|11|||
155055807|NCT01064479|559637727|FG000|Overall Study|Withdrawal by Subject|2|||
155055808|NCT01064479|559637728|FG001|Overall Study|Withdrawal by Subject|2|||
155055809|NCT01064479|559637727|FG000|Overall Study|Disease progression|1|||
155055810|NCT01064479|559637728|FG001|Overall Study|Disease progression|1|||
155055811|NCT01064479|559637727|FG000|Overall Study|Toxicity|1|||
155055812|NCT01064479|559637728|FG001|Overall Study|Toxicity|1|||
155055813|NCT01064479|559637727|FG000|Overall Study|Other|1|||
155055814|NCT01064479|559637728|FG001|Overall Study|Other|2|||
155055815|NCT00749398|559637729|FG000|Overall Study|Lack of Efficacy|7|||
155055816|NCT00749398|559637729|FG000|Overall Study|Adverse Event|4|||
155055817|NCT00749398|559637729|FG000|Overall Study|Serious adverse event|11|||
155055818|NCT00749398|559637729|FG000|Overall Study|Withdrawal by Subject|17|||
155055819|NCT00749398|559637729|FG000|Overall Study|Lost to Follow-up|11|||
155055820|NCT00749398|559637729|FG000|Overall Study|Reason not specified|2|||
155055821|NCT00749398|559637729|FG000|Overall Study|Unknown reason|1|||
155055822|NCT03903172|559637735|FG000|Overall Study|screen fail|4|||
155055823|NCT03903172|559637736|FG001|Overall Study|screen fail|1|||
155055824|NCT01900444|559637737|FG000|Overall Study|Protocol Violation|2|||
155055825|NCT01900444|559637737|FG000|Overall Study|Lost to Follow-up|1|||
155055826|NCT00072384|559637738|FG000|Overall Study|Physician Decision|1|||
155055827|NCT00072384|559637738|FG000|Overall Study|Ineligible|8|||
155055828|NCT00490035|559637743|FG000|Overall Study|AE, non-serious non-fatal|3|||
155055829|NCT00490035|559637744|FG001|Overall Study|AE, non-serious non-fatal|4|||
155055830|NCT00490035|559637745|FG002|Overall Study|AE, non-serious non-fatal|4|||
155055831|NCT00490035|559637746|FG003|Overall Study|AE, non-serious non-fatal|5|||
155055832|NCT00490035|559637743|FG000|Overall Study|Lost to Follow-up|2|||
155055833|NCT00490035|559637744|FG001|Overall Study|Lost to Follow-up|0|||
155055834|NCT00490035|559637745|FG002|Overall Study|Lost to Follow-up|1|||
155055835|NCT00490035|559637746|FG003|Overall Study|Lost to Follow-up|0|||
155055836|NCT00490035|559637743|FG000|Overall Study|Withdrawal by Subject|2|||
155055837|NCT00490035|559637744|FG001|Overall Study|Withdrawal by Subject|1|||
155055838|NCT00490035|559637745|FG002|Overall Study|Withdrawal by Subject|1|||
155055839|NCT00490035|559637746|FG003|Overall Study|Withdrawal by Subject|0|||
155055840|NCT00490035|559637743|FG000|Overall Study|Other reason|0|||
155055841|NCT00490035|559637744|FG001|Overall Study|Other reason|1|||
155055842|NCT00490035|559637745|FG002|Overall Study|Other reason|3|||
155055843|NCT00490035|559637746|FG003|Overall Study|Other reason|1|||
155055844|NCT00490035|559637743|FG000|Overall Study|AE, serious fatal|1|||
155055845|NCT00490035|559637744|FG001|Overall Study|AE, serious fatal|0|||
155055846|NCT00490035|559637745|FG002|Overall Study|AE, serious fatal|0|||
155055847|NCT00490035|559637746|FG003|Overall Study|AE, serious fatal|0|||
155055848|NCT00490035|559637743|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
155055849|NCT00490035|559637744|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
155055850|NCT00490035|559637745|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
155055851|NCT00490035|559637746|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
155055852|NCT00490035|559637743|FG000|Overall Study|AE of unknown type|0|||
155393599|NCT00006392|560876812|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
155393600|NCT00006392|560876813|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
155055853|NCT00490035|559637744|FG001|Overall Study|AE of unknown type|0|||
155055854|NCT00490035|559637745|FG002|Overall Study|AE of unknown type|2|||
155055855|NCT00490035|559637746|FG003|Overall Study|AE of unknown type|0|||
155055856|NCT06058390|559637747|FG000|Overall Study|Lost to Follow-up|0|||
155055857|NCT06058390|559637748|FG001|Overall Study|Lost to Follow-up|0|||
155393601|NCT02459769|560876815|FG000|Overall Study|Withdrawal by Subject|7|||
155393602|NCT02459769|560876816|FG001|Overall Study|Withdrawal by Subject|4|||
155055858|NCT06058390|559637749|FG002|Overall Study|Lost to Follow-up|2|||
155055859|NCT06058390|559637750|FG003|Overall Study|Lost to Follow-up|1|||
155055860|NCT06058390|559637747|FG000|Overall Study|Physician Decision|0|||
155055861|NCT06058390|559637748|FG001|Overall Study|Physician Decision|0|||
155055862|NCT06058390|559637749|FG002|Overall Study|Physician Decision|0|||
155055863|NCT06058390|559637750|FG003|Overall Study|Physician Decision|1|||
155055864|NCT06058390|559637747|FG000|Overall Study|Participants did not receive any study intervention|0|||
155055865|NCT06058390|559637748|FG001|Overall Study|Participants did not receive any study intervention|0|||
155055866|NCT06058390|559637749|FG002|Overall Study|Participants did not receive any study intervention|0|||
155055867|NCT06058390|559637750|FG003|Overall Study|Participants did not receive any study intervention|1|||
155055868|NCT05002972|559637754|FG000|Overall Study|Withdrawal by Subject|2|||
155055869|NCT01664091|559637755|FG000|Overall Study|Death|1|||
155055870|NCT01664091|559637755|FG000|Overall Study|Disease Progression|2|||
155055871|NCT01664091|559637755|FG000|Overall Study|Lost to Follow-up|2|||
155055872|NCT01664091|559637755|FG000|Overall Study|Withdrawal by Subject|1|||
155055873|NCT01172873|559637759|FG000|Overall Study|Withdrawal by Subject|3|||
155055874|NCT01172873|559637760|FG001|Overall Study|Withdrawal by Subject|2|||
155055875|NCT05518539|559637764|FG000|Overall Study|Lost to Follow-up|6|||
155055876|NCT02053493|559637765|FG000|Overall Study|Withdrawal by Subject|1|||
155055877|NCT02053493|559637766|FG001|Overall Study|Withdrawal by Subject|1|||
155055878|NCT01619865|559637767|FG000|Overall Study|Adverse Event|1|||
155055879|NCT01619865|559637767|FG000|Overall Study|Death|2|||
155055880|NCT01619865|559637767|FG000|Overall Study|subject not able to comply|1|||
155055881|NCT01494818|559637768|FG000|Overall Study|Relocation|1|||
155055882|NCT01494818|559637769|FG001|Overall Study|Relocation|2|||
155055883|NCT01494818|559637768|FG000|Overall Study|Lost to Follow-up|1|||
155055884|NCT01494818|559637769|FG001|Overall Study|Lost to Follow-up|0|||
155055885|NCT01211145|559637770|FG000|Overall Study|Reason not specified|3|||
155055886|NCT01211145|559637771|FG001|Overall Study|Reason not specified|2|||
155055887|NCT01211145|559637772|FG002|Overall Study|Reason not specified|2|||
155055888|NCT01211145|559637773|FG003|Overall Study|Reason not specified|1|||
155055889|NCT01211145|559637770|FG000|Overall Study|Lost to Follow-up|3|||
155055890|NCT01211145|559637771|FG001|Overall Study|Lost to Follow-up|2|||
155055891|NCT01211145|559637772|FG002|Overall Study|Lost to Follow-up|1|||
155055892|NCT01211145|559637773|FG003|Overall Study|Lost to Follow-up|2|||
155055893|NCT01211145|559637770|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155055894|NCT01211145|559637771|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155055895|NCT01211145|559637772|FG002|Overall Study|Study-specific withdrawal criteria|0|||
155055896|NCT01211145|559637773|FG003|Overall Study|Study-specific withdrawal criteria|0|||
155055897|NCT01211145|559637770|FG000|Overall Study|Severe noncompliance to protocol|1|||
155055898|NCT01211145|559637771|FG001|Overall Study|Severe noncompliance to protocol|0|||
155055899|NCT01211145|559637772|FG002|Overall Study|Severe noncompliance to protocol|0|||
155055900|NCT01211145|559637773|FG003|Overall Study|Severe noncompliance to protocol|0|||
155055901|NCT01211145|559637770|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
155055902|NCT01211145|559637771|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
155055903|NCT01211145|559637772|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
155055904|NCT01211145|559637773|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
155055905|NCT01211145|559637770|FG000|Overall Study|Patient decision|2|||
155055906|NCT01211145|559637771|FG001|Overall Study|Patient decision|1|||
155055907|NCT01211145|559637772|FG002|Overall Study|Patient decision|0|||
155055908|NCT01211145|559637773|FG003|Overall Study|Patient decision|2|||
155055909|NCT00791999|559637774|FG000|Overall Study|Protocol planed withdrawal|14|||
155055910|NCT00791999|559637775|FG001|Overall Study|Protocol planed withdrawal|11|||
155055911|NCT00791999|559637776|FG002|Overall Study|Protocol planed withdrawal|11|||
155055912|NCT00791999|559637777|FG003|Overall Study|Protocol planed withdrawal|45|||
155055913|NCT00791999|559637774|FG000|Overall Study|Withdrawal by Subject|0|||
155055914|NCT00791999|559637775|FG001|Overall Study|Withdrawal by Subject|1|||
155055915|NCT00791999|559637776|FG002|Overall Study|Withdrawal by Subject|0|||
155055916|NCT00791999|559637777|FG003|Overall Study|Withdrawal by Subject|2|||
155055917|NCT00791999|559637774|FG000|Overall Study|Protocol Violation|3|||
155055918|NCT00791999|559637775|FG001|Overall Study|Protocol Violation|0|||
155055919|NCT00791999|559637776|FG002|Overall Study|Protocol Violation|1|||
155055920|NCT00791999|559637777|FG003|Overall Study|Protocol Violation|0|||
155055921|NCT00791999|559637774|FG000|Overall Study|Adverse Event|3|||
155055922|NCT00791999|559637775|FG001|Overall Study|Adverse Event|3|||
155055923|NCT00791999|559637776|FG002|Overall Study|Adverse Event|7|||
155055924|NCT00791999|559637777|FG003|Overall Study|Adverse Event|3|||
155055925|NCT00791999|559637774|FG000|Overall Study|Lack of Efficacy|0|||
155055926|NCT00791999|559637775|FG001|Overall Study|Lack of Efficacy|1|||
155055927|NCT00791999|559637776|FG002|Overall Study|Lack of Efficacy|0|||
155055928|NCT00791999|559637777|FG003|Overall Study|Lack of Efficacy|2|||
155055929|NCT00791999|559637774|FG000|Overall Study|Reason other than those above|1|||
155055930|NCT00791999|559637775|FG001|Overall Study|Reason other than those above|0|||
155055931|NCT00791999|559637776|FG002|Overall Study|Reason other than those above|1|||
155055932|NCT00791999|559637777|FG003|Overall Study|Reason other than those above|0|||
155055933|NCT00617357|559637778|FG000|Overall Study|Lost to Follow-up|7|||
155055934|NCT00617357|559637778|FG000|Overall Study|Death|5|||
155055935|NCT00617357|559637778|FG000|Overall Study|insurance concerns|2|||
155055936|NCT00617357|559637778|FG000|Overall Study|Withdrawal by Subject|1|||
155055937|NCT00617357|559637778|FG000|Overall Study|Physician Decision|1|||
155055938|NCT00485069|559637789|FG000|Overall Study|Adverse Event|10|||
155055939|NCT00485069|559637790|FG001|Overall Study|Adverse Event|4|||
155055940|NCT00485069|559637789|FG000|Overall Study|Lack of Efficacy|2|||
155055941|NCT00485069|559637790|FG001|Overall Study|Lack of Efficacy|1|||
155055942|NCT00485069|559637789|FG000|Overall Study|Protocol Violation|0|||
155055943|NCT00485069|559637790|FG001|Overall Study|Protocol Violation|1|||
155055944|NCT00485069|559637789|FG000|Overall Study|Withdrawal by Subject|6|||
155055945|NCT00485069|559637790|FG001|Overall Study|Withdrawal by Subject|6|||
155055946|NCT00086190|559637791|FG000|Overall Study|Adverse Event|6|||
155055947|NCT00086190|559637792|FG001|Overall Study|Adverse Event|2|||
155055948|NCT00086190|559637793|FG002|Overall Study|Adverse Event|2|||
155055949|NCT00086190|559637791|FG000|Overall Study|Withdrawal by Subject|0|||
155055950|NCT00086190|559637792|FG001|Overall Study|Withdrawal by Subject|2|||
155055951|NCT00086190|559637793|FG002|Overall Study|Withdrawal by Subject|2|||
155393603|NCT02459769|560876817|FG002|Overall Study|Withdrawal by Subject|8|||
155393604|NCT02459769|560876818|FG003|Overall Study|Withdrawal by Subject|5|||
155393605|NCT02459769|560876815|FG000|Overall Study|Lost to Follow-up|1|||
155055952|NCT00086190|559637791|FG000|Overall Study|Protocol Violation|1|||
155055953|NCT00086190|559637792|FG001|Overall Study|Protocol Violation|0|||
155055954|NCT00086190|559637793|FG002|Overall Study|Protocol Violation|0|||
155055955|NCT00086190|559637791|FG000|Overall Study|Moved|1|||
155055956|NCT00086190|559637792|FG001|Overall Study|Moved|0|||
155055957|NCT00086190|559637793|FG002|Overall Study|Moved|0|||
155055958|NCT00086190|559637791|FG000|Overall Study|Worsening depression|0|||
155055959|NCT00086190|559637792|FG001|Overall Study|Worsening depression|0|||
155055960|NCT00086190|559637793|FG002|Overall Study|Worsening depression|2|||
155055961|NCT00249834|559637794|FG000|Overall Study|Ovarian stimulation failed|1|||
155055962|NCT00249834|559637795|FG001|Overall Study|Ovarian stimulation failed|0|||
155055963|NCT00249834|559637796|FG002|Overall Study|Ovarian stimulation failed|0|||
155055964|NCT00249834|559637797|FG003|Overall Study|Ovarian stimulation failed|0|||
155055965|NCT00249834|559637798|FG004|Overall Study|Ovarian stimulation failed|0|||
155055966|NCT00249834|559637799|FG005|Overall Study|Ovarian stimulation failed|0|||
155055967|NCT00249834|559637800|FG006|Overall Study|Ovarian stimulation failed|0|||
155055968|NCT00249834|559637801|FG007|Overall Study|Ovarian stimulation failed|0|||
155055969|NCT00249834|559637794|FG000|Overall Study|Failure of down-regulation|0|||
155055970|NCT00249834|559637795|FG001|Overall Study|Failure of down-regulation|0|||
155055971|NCT00249834|559637796|FG002|Overall Study|Failure of down-regulation|0|||
155055972|NCT00249834|559637797|FG003|Overall Study|Failure of down-regulation|0|||
155055973|NCT00249834|559637798|FG004|Overall Study|Failure of down-regulation|0|||
155055974|NCT00249834|559637799|FG005|Overall Study|Failure of down-regulation|0|||
155055975|NCT00249834|559637800|FG006|Overall Study|Failure of down-regulation|1|||
155055976|NCT00249834|559637801|FG007|Overall Study|Failure of down-regulation|0|||
155055977|NCT00249834|559637794|FG000|Overall Study|Protocol Violation|0|||
155055978|NCT00249834|559637795|FG001|Overall Study|Protocol Violation|19|||
155055979|NCT00249834|559637796|FG002|Overall Study|Protocol Violation|14|||
155055980|NCT00249834|559637797|FG003|Overall Study|Protocol Violation|8|||
155055981|NCT00249834|559637798|FG004|Overall Study|Protocol Violation|5|||
155055982|NCT00249834|559637799|FG005|Overall Study|Protocol Violation|2|||
155055983|NCT00249834|559637800|FG006|Overall Study|Protocol Violation|0|||
155055984|NCT00249834|559637801|FG007|Overall Study|Protocol Violation|0|||
155393606|NCT02459769|560876816|FG001|Overall Study|Lost to Follow-up|0|||
155393607|NCT02459769|560876817|FG002|Overall Study|Lost to Follow-up|1|||
155393608|NCT02459769|560876818|FG003|Overall Study|Lost to Follow-up|0|||
155055985|NCT02688933|559637802|FG000|Overall Study|Adverse Event|3|||
155055986|NCT02688933|559637803|FG001|Overall Study|Adverse Event|1|||
155055987|NCT02688933|559637802|FG000|Overall Study|Lack of Efficacy|2|||
155055988|NCT02688933|559637803|FG001|Overall Study|Lack of Efficacy|2|||
155055989|NCT02688933|559637802|FG000|Overall Study|Poor compliance to protocol|7|||
155393609|NCT01186796|560876819|FG000|Overall Study|Adverse Event|3|||
155393610|NCT01186796|560876820|FG001|Overall Study|Adverse Event|0|||
155055990|NCT02688933|559637803|FG001|Overall Study|Poor compliance to protocol|4|||
155055991|NCT02688933|559637802|FG000|Overall Study|Hypoglycemia|2|||
155055992|NCT02688933|559637803|FG001|Overall Study|Hypoglycemia|0|||
155055993|NCT02688933|559637802|FG000|Overall Study|Other than Specified|14|||
155055994|NCT02688933|559637803|FG001|Overall Study|Other than Specified|25|||
155055995|NCT02688933|559637802|FG000|Overall Study|Lost to Follow-up|1|||
155055996|NCT02688933|559637803|FG001|Overall Study|Lost to Follow-up|5|||
155153090|NCT01383928|559998553|FG001|Overall Study|Adverse Event|2|||
154951827|NCT04099888|559249125|FG000|Overall Study|Death|5|||
154951828|NCT04099888|559249126|FG001|Overall Study|Death|2|||
154951829|NCT04099888|559249125|FG000|Overall Study|Other|1|||
154951830|NCT04099888|559249126|FG001|Overall Study|Other|0|||
154951831|NCT01856309|559249134|FG000|Overall Study|Death|4|||
154951832|NCT01856309|559249135|FG001|Overall Study|Death|6|||
154951833|NCT01856309|559249136|FG002|Overall Study|Death|11|||
154951834|NCT01856309|559249137|FG003|Overall Study|Death|6|||
154951835|NCT01856309|559249134|FG000|Overall Study|Lost to Follow-up|6|||
154951836|NCT01856309|559249135|FG001|Overall Study|Lost to Follow-up|2|||
154951837|NCT01856309|559249136|FG002|Overall Study|Lost to Follow-up|4|||
154951838|NCT01856309|559249137|FG003|Overall Study|Lost to Follow-up|8|||
154951839|NCT01856309|559249134|FG000|Overall Study|Withdrawal by Subject|11|||
154951840|NCT01856309|559249135|FG001|Overall Study|Withdrawal by Subject|13|||
154951841|NCT01856309|559249136|FG002|Overall Study|Withdrawal by Subject|28|||
154951842|NCT01856309|559249137|FG003|Overall Study|Withdrawal by Subject|26|||
154951843|NCT01856309|559249134|FG000|Overall Study|Other|227|||
154951844|NCT01856309|559249135|FG001|Overall Study|Other|225|||
154951845|NCT01856309|559249136|FG002|Overall Study|Other|447|||
154951846|NCT01856309|559249137|FG003|Overall Study|Other|469|||
154951847|NCT01856309|559249134|FG000|Overall Study|Lack of Efficacy|14|||
154951848|NCT01856309|559249135|FG001|Overall Study|Lack of Efficacy|9|||
154951849|NCT01856309|559249136|FG002|Overall Study|Lack of Efficacy|40|||
154951850|NCT01856309|559249137|FG003|Overall Study|Lack of Efficacy|25|||
154951851|NCT01856309|559249134|FG000|Overall Study|Adverse Event|31|||
154951852|NCT01856309|559249135|FG001|Overall Study|Adverse Event|31|||
154951853|NCT01856309|559249136|FG002|Overall Study|Adverse Event|55|||
154951854|NCT01856309|559249137|FG003|Overall Study|Adverse Event|65|||
154951855|NCT01856309|559249134|FG000|Overall Study|Pregnancy|0|||
154951856|NCT01856309|559249135|FG001|Overall Study|Pregnancy|0|||
154951857|NCT01856309|559249136|FG002|Overall Study|Pregnancy|0|||
154951858|NCT01856309|559249137|FG003|Overall Study|Pregnancy|1|||
154951859|NCT01856309|559249134|FG000|Overall Study|Physician Decision|6|||
154951860|NCT01856309|559249135|FG001|Overall Study|Physician Decision|1|||
154951861|NCT01856309|559249136|FG002|Overall Study|Physician Decision|6|||
154951862|NCT01856309|559249137|FG003|Overall Study|Physician Decision|8|||
154951863|NCT01856309|559249134|FG000|Overall Study|Noncompliance With Study Drug|0|||
154951864|NCT01856309|559249135|FG001|Overall Study|Noncompliance With Study Drug|1|||
154951865|NCT01856309|559249136|FG002|Overall Study|Noncompliance With Study Drug|4|||
154951866|NCT01856309|559249137|FG003|Overall Study|Noncompliance With Study Drug|1|||
154951867|NCT00832377|559249140|FG000|Overall Study|Protocol Violation|1|||
154951868|NCT01273181|559249141|FG000|Phase I, Dose 1|Study termination|1|||
154951869|NCT01273181|559249142|FG001|Phase I, Dose 1|Study termination|0|||
154951870|NCT01273181|559249143|FG002|Phase I, Dose 1|Study termination|0|||
154951871|NCT01273181|559249144|FG003|Phase I, Dose 1|Study termination|0|||
154951872|NCT01273181|559249141|FG000|Phase I, Dose 2|Death during treatment|0|||
154951873|NCT01273181|559249142|FG001|Phase I, Dose 2|Death during treatment|1|||
154951874|NCT01273181|559249143|FG002|Phase I, Dose 2|Death during treatment|0|||
154951875|NCT01273181|559249144|FG003|Phase I, Dose 2|Death during treatment|0|||
154951876|NCT01273181|559249141|FG000|Phase 2, Dose 1|Study termination|0|||
154951877|NCT01273181|559249142|FG001|Phase 2, Dose 1|Study termination|0|||
154951878|NCT01273181|559249143|FG002|Phase 2, Dose 1|Study termination|1|||
154951879|NCT01273181|559249144|FG003|Phase 2, Dose 1|Study termination|0|||
154951880|NCT01273181|559249141|FG000|Phase 2, Dose 2|Death during treatment|0|||
154951881|NCT01273181|559249142|FG001|Phase 2, Dose 2|Death during treatment|0|||
154951882|NCT01273181|559249143|FG002|Phase 2, Dose 2|Death during treatment|0|||
154951883|NCT01273181|559249144|FG003|Phase 2, Dose 2|Death during treatment|1|||
154951884|NCT00944697|559249145|FG000|Overall Study|Withdrawal by Subject|1|||
154951885|NCT00944697|559249146|FG001|Overall Study|Withdrawal by Subject|1|||
154951886|NCT00944697|559249145|FG000|Overall Study|Adverse Event|0|||
154951887|NCT00944697|559249146|FG001|Overall Study|Adverse Event|3|||
154951888|NCT00944697|559249145|FG000|Overall Study|Administrative|1|||
154951889|NCT00944697|559249146|FG001|Overall Study|Administrative|1|||
154951890|NCT03661528|559249147|FG000|Overall Study|Death|1|||
154951891|NCT03661528|559249148|FG001|Overall Study|Death|0|||
154951892|NCT03661528|559249147|FG000|Overall Study|Physician Decision|3|||
154951893|NCT03661528|559249148|FG001|Overall Study|Physician Decision|1|||
154951894|NCT03661528|559249147|FG000|Overall Study|Other than Specified|5|||
154951895|NCT03661528|559249148|FG001|Overall Study|Other than Specified|2|||
154951896|NCT03661528|559249147|FG000|Overall Study|Withdrawal by Subject|5|||
154951897|NCT03661528|559249148|FG001|Overall Study|Withdrawal by Subject|3|||
154951898|NCT03661528|559249147|FG000|Overall Study|Disease Progression|8|||
154951899|NCT03661528|559249148|FG001|Overall Study|Disease Progression|13|||
154951900|NCT03661528|559249147|FG000|Overall Study|Adverse Event|61|||
154951901|NCT03661528|559249148|FG001|Overall Study|Adverse Event|55|||
154951902|NCT02468778|559249154|FG000|Overall Study|Death|2|||
154951903|NCT02468778|559249155|FG001|Overall Study|Death|1|||
154951904|NCT02468778|559249156|FG002|Overall Study|Death|0|||
154951905|NCT02468778|559249154|FG000|Overall Study|Lost to Follow-up|1|||
154951906|NCT02468778|559249155|FG001|Overall Study|Lost to Follow-up|2|||
154951907|NCT02468778|559249156|FG002|Overall Study|Lost to Follow-up|2|||
154951908|NCT02468778|559249154|FG000|Overall Study|Withdrawal by Subject|0|||
154951909|NCT02468778|559249155|FG001|Overall Study|Withdrawal by Subject|1|||
154951910|NCT02468778|559249156|FG002|Overall Study|Withdrawal by Subject|1|||
154951911|NCT02458469|559249160|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
154951912|NCT02458469|559249161|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
154951913|NCT02458469|559249162|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155055997|NCT04622969|559637807|FG000|Overall Study|Withdrawal by Subject|2|||
155055998|NCT04622969|559637808|FG001|Overall Study|Withdrawal by Subject|3|||
155055999|NCT04467515|559637809|FG000|Overall Study|Lost to Follow-up|1|||
155056000|NCT04467515|559637810|FG001|Overall Study|Lost to Follow-up|0|||
155056001|NCT04467515|559637811|FG002|Overall Study|Lost to Follow-up|0|||
155056002|NCT04467515|559637809|FG000|Overall Study|Withdrawal by Subject|1|||
154951914|NCT02458469|559249163|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
154951915|NCT02458469|559249164|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
154951916|NCT02458469|559249165|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
154951917|NCT02458469|559249160|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
154951918|NCT02458469|559249161|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
154951919|NCT02458469|559249162|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
154951920|NCT02458469|559249163|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
154951921|NCT02458469|559249164|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
154951922|NCT02458469|559249165|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
154951923|NCT02458469|559249160|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
154951924|NCT02458469|559249161|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
154951925|NCT02458469|559249162|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
154951926|NCT02458469|559249163|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
154951927|NCT02458469|559249164|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
154951928|NCT02458469|559249165|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
154951929|NCT03561883|559249167|FG000|Overall Study|Adverse Event|10|||
154951930|NCT03561883|559249168|FG001|Overall Study|Adverse Event|13|||
154951931|NCT03561883|559249167|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154951932|NCT03561883|559249168|FG001|Overall Study|Non-Compliance With Study Drug|2|||
154951933|NCT03561883|559249167|FG000|Overall Study|Protocol Violation|2|||
154951934|NCT03561883|559249168|FG001|Overall Study|Protocol Violation|3|||
154951935|NCT03561883|559249167|FG000|Overall Study|Withdrawal by Subject|14|||
154951936|NCT03561883|559249168|FG001|Overall Study|Withdrawal by Subject|6|||
154951937|NCT03561883|559249167|FG000|Overall Study|Lost to Follow-up|2|||
154951938|NCT03561883|559249168|FG001|Overall Study|Lost to Follow-up|6|||
154951939|NCT03561883|559249167|FG000|Overall Study|Study Terminated by Sponsor|12|||
154951940|NCT03561883|559249168|FG001|Overall Study|Study Terminated by Sponsor|11|||
154951941|NCT03561883|559249167|FG000|Overall Study|Physician Decision|1|||
154951942|NCT03561883|559249168|FG001|Overall Study|Physician Decision|0|||
154951943|NCT03561883|559249167|FG000|Overall Study|Randomized by Mistake|1|||
154951944|NCT03561883|559249168|FG001|Overall Study|Randomized by Mistake|0|||
154951945|NCT03561883|559249167|FG000|Overall Study|Other, Not Specified|3|||
154951946|NCT03561883|559249168|FG001|Overall Study|Other, Not Specified|2|||
154951947|NCT05956665|559249169|FG000|Overall Study|Death|1|||
154951948|NCT05956665|559249169|FG000|Overall Study|Withdrawal by Subject|1|||
154951949|NCT06354270|559249175|FG000|Overall Study|Withdrawal by Subject|1|||
154951950|NCT06354270|559249176|FG001|Overall Study|Withdrawal by Subject|0|||
154951951|NCT02603952|559249185|FG000|Overall Study|Withdrawal by Subject|1|||
154951952|NCT02603952|559249186|FG001|Overall Study|Withdrawal by Subject|0|||
154951953|NCT02603952|559249187|FG002|Overall Study|Withdrawal by Subject|0|||
154951954|NCT02603952|559249188|FG003|Overall Study|Withdrawal by Subject|0|||
154951955|NCT02603952|559249185|FG000|Overall Study|Received oseltamivir by error|0|||
154951956|NCT02603952|559249186|FG001|Overall Study|Received oseltamivir by error|0|||
154951957|NCT02603952|559249187|FG002|Overall Study|Received oseltamivir by error|0|||
154951958|NCT02603952|559249188|FG003|Overall Study|Received oseltamivir by error|1|||
154951959|NCT04646109|559249192|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
154951960|NCT04646109|559249193|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
154951961|NCT01226797|559249194|FG000|Overall Study|Adverse Event|1|||
154951962|NCT01226797|559249195|FG001|Overall Study|Adverse Event|0|||
154951963|NCT01226797|559249194|FG000|Overall Study|No longer willing to participate|1|||
154951964|NCT01226797|559249195|FG001|Overall Study|No longer willing to participate|0|||
155056003|NCT04467515|559637810|FG001|Overall Study|Withdrawal by Subject|0|||
155283293|NCT00924560|560468273|FG000|Overall Study|Miscellaneous Reasons|13|||
155056004|NCT04467515|559637811|FG002|Overall Study|Withdrawal by Subject|1|||
155056005|NCT04467515|559637809|FG000|Overall Study|Progressive Disease|0|||
155283294|NCT00924560|560468274|FG001|Overall Study|Miscellaneous Reasons|10|||
155283295|NCT00924560|560468275|FG002|Overall Study|Miscellaneous Reasons|10|||
155283296|NCT00663962|560468278|FG000|Overall Study|somnolence|1|||
155283297|NCT00663962|560468279|FG001|Overall Study|somnolence|0|||
155283298|NCT04091672|560470701|FG000|Overall Study|Death|6|||
155283299|NCT04091672|560470702|FG001|Overall Study|Death|6|||
155283300|NCT04091672|560470701|FG000|Overall Study|Lost to Follow-up|7|||
155056006|NCT04467515|559637810|FG001|Overall Study|Progressive Disease|1|||
155056007|NCT04467515|559637811|FG002|Overall Study|Progressive Disease|3|||
155056008|NCT04467515|559637809|FG000|Overall Study|Death|0|||
155056009|NCT04467515|559637810|FG001|Overall Study|Death|1|||
155056010|NCT04467515|559637811|FG002|Overall Study|Death|0|||
155056011|NCT02155985|559637821|FG000|Overall Study|Withdrawal by Subject|0|||
155056012|NCT02155985|559637822|FG001|Overall Study|Withdrawal by Subject|0|||
155056013|NCT02155985|559637823|FG002|Overall Study|Withdrawal by Subject|1|||
155056014|NCT02155985|559637821|FG000|Overall Study|Lost to Follow-up|1|||
155056015|NCT02155985|559637822|FG001|Overall Study|Lost to Follow-up|0|||
155056016|NCT02155985|559637823|FG002|Overall Study|Lost to Follow-up|0|||
155056017|NCT04460326|559637824|FG000|Completed at Least 4 Meals|Early discharge|5|||
155056018|NCT04460326|559637825|FG001|Completed at Least 4 Meals|Early discharge|5|||
155056019|NCT04460326|559637824|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
155056020|NCT04460326|559637825|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
155056021|NCT04460326|559637824|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
155056022|NCT04460326|559637825|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
155056023|NCT04460326|559637824|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
155056024|NCT04460326|559637825|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
155056025|NCT04460326|559637824|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
155056026|NCT04460326|559637825|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
155056027|NCT04460326|559637824|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
155056028|NCT04460326|559637825|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
155056029|NCT04794751|559637828|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
155056030|NCT04794751|559637829|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
155056031|NCT04794751|559637828|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
155056032|NCT04794751|559637829|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
155056033|NCT04794751|559637828|FG000|Period 1|Protocol Violation|0|||
155056034|NCT04794751|559637829|FG001|Period 1|Protocol Violation|2|||
155056035|NCT04794751|559637828|FG000|Period 1|Withdrawal by Subject|0|||
155056036|NCT04794751|559637829|FG001|Period 1|Withdrawal by Subject|1|||
155056037|NCT04794751|559637828|FG000|Period 2|Withdrawal by Subject|0|||
155056038|NCT04794751|559637829|FG001|Period 2|Withdrawal by Subject|1|||
155056039|NCT04794751|559637828|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
155056040|NCT04794751|559637829|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
155056041|NCT04794751|559637828|FG000|Period 2|Protocol Violation|1|||
155056042|NCT04794751|559637829|FG001|Period 2|Protocol Violation|0|||
155056043|NCT03528551|559637831|FG000|Overall Study|Lost to Follow-up|0|||
155056044|NCT03528551|559637832|FG001|Overall Study|Lost to Follow-up|1|||
155056045|NCT03528551|559637833|FG002|Overall Study|Lost to Follow-up|0|||
155056046|NCT03528551|559637831|FG000|Overall Study|Transferred to other arm/group|2|||
155056047|NCT03528551|559637832|FG001|Overall Study|Transferred to other arm/group|3|||
155056048|NCT03528551|559637833|FG002|Overall Study|Transferred to other arm/group|0|||
155056049|NCT03528551|559637831|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155056050|NCT03528551|559637832|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155056051|NCT03528551|559637833|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155056052|NCT03528551|559637831|FG000|Overall Study|Protocol Violation|0|||
155056053|NCT03528551|559637832|FG001|Overall Study|Protocol Violation|3|||
155056054|NCT03528551|559637833|FG002|Overall Study|Protocol Violation|0|||
155056055|NCT03528551|559637831|FG000|Overall Study|Withdrawal by Subject|0|||
155056056|NCT03528551|559637832|FG001|Overall Study|Withdrawal by Subject|7|||
155056057|NCT03528551|559637833|FG002|Overall Study|Withdrawal by Subject|0|||
155056058|NCT01789047|559637836|FG000|Overall Study|Adverse Event|3|||
155056059|NCT01789047|559637837|FG001|Overall Study|Adverse Event|2|||
155056060|NCT01789047|559637836|FG000|Overall Study|Withdrawal by Subject|1|||
155056061|NCT01789047|559637837|FG001|Overall Study|Withdrawal by Subject|2|||
155056062|NCT01204671|559637838|FG000|Overall Study|Adverse Event|4|||
155056063|NCT01204671|559637839|FG001|Overall Study|Adverse Event|3|||
155056064|NCT01204671|559637840|FG002|Overall Study|Adverse Event|3|||
155056065|NCT01204671|559637841|FG003|Overall Study|Adverse Event|3|||
155056066|NCT01204671|559637842|FG004|Overall Study|Adverse Event|1|||
155056067|NCT01204671|559637838|FG000|Overall Study|Withdrawal by Subject|2|||
155056068|NCT01204671|559637839|FG001|Overall Study|Withdrawal by Subject|3|||
155056069|NCT01204671|559637840|FG002|Overall Study|Withdrawal by Subject|4|||
155056070|NCT01204671|559637841|FG003|Overall Study|Withdrawal by Subject|5|||
155056071|NCT01204671|559637842|FG004|Overall Study|Withdrawal by Subject|3|||
155056072|NCT01204671|559637838|FG000|Overall Study|Lost to Follow-up|7|||
155056073|NCT01204671|559637839|FG001|Overall Study|Lost to Follow-up|8|||
155056074|NCT01204671|559637840|FG002|Overall Study|Lost to Follow-up|6|||
155056075|NCT01204671|559637841|FG003|Overall Study|Lost to Follow-up|4|||
155056076|NCT01204671|559637842|FG004|Overall Study|Lost to Follow-up|0|||
155056077|NCT01204671|559637838|FG000|Overall Study|Unknown Completion Status|1|||
155056078|NCT01204671|559637839|FG001|Overall Study|Unknown Completion Status|1|||
155056079|NCT01204671|559637840|FG002|Overall Study|Unknown Completion Status|0|||
155056080|NCT01204671|559637841|FG003|Overall Study|Unknown Completion Status|0|||
155056081|NCT01204671|559637842|FG004|Overall Study|Unknown Completion Status|0|||
155056082|NCT01204671|559637838|FG000|Overall Study|Physician Decision|0|||
155056083|NCT01204671|559637839|FG001|Overall Study|Physician Decision|0|||
155056084|NCT01204671|559637840|FG002|Overall Study|Physician Decision|0|||
155056085|NCT01204671|559637841|FG003|Overall Study|Physician Decision|1|||
155056086|NCT01204671|559637842|FG004|Overall Study|Physician Decision|0|||
155393611|NCT01186796|560876819|FG000|Overall Study|Withdrawal by Subject|1|||
155393612|NCT01186796|560876820|FG001|Overall Study|Withdrawal by Subject|1|||
155056087|NCT02700048|559637843|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
155056088|NCT02700048|559637844|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
155056089|NCT02175225|559637845|FG000|Overall Study|Withdrawal by Subject|1|||
155056090|NCT02175225|559637846|FG001|Overall Study|Withdrawal by Subject|2|||
155056091|NCT02175225|559637845|FG000|Overall Study|Lost to Follow-up|6|||
155056092|NCT02175225|559637846|FG001|Overall Study|Lost to Follow-up|7|||
155056093|NCT02175225|559637845|FG000|Overall Study|Study drug not administered|1|||
155056094|NCT02175225|559637846|FG001|Overall Study|Study drug not administered|2|||
155056095|NCT02340000|559637847|FG000|Time Period 1|Withdrawal by Subject|6|||
155056096|NCT02340000|559637848|FG001|Time Period 1|Withdrawal by Subject|8|||
155056097|NCT02340000|559637847|FG000|Time Period 1|Lost to Follow-up|6|||
155056098|NCT02340000|559637848|FG001|Time Period 1|Lost to Follow-up|7|||
154951965|NCT01226797|559249194|FG000|Overall Study|Protocol Violation|0|||
154951966|NCT01226797|559249195|FG001|Overall Study|Protocol Violation|1|||
154951967|NCT00577460|559249198|FG000|Overall Study|Adverse Event|11|||
154951968|NCT00577460|559249199|FG001|Overall Study|Adverse Event|7|||
154951969|NCT00577460|559249200|FG002|Overall Study|Adverse Event|14|||
154951970|NCT00577460|559249198|FG000|Overall Study|Protocol Violation|0|||
154951971|NCT00577460|559249199|FG001|Overall Study|Protocol Violation|1|||
154951972|NCT00577460|559249200|FG002|Overall Study|Protocol Violation|1|||
154951973|NCT00577460|559249198|FG000|Overall Study|Lost to Follow-up|0|||
154951974|NCT00577460|559249199|FG001|Overall Study|Lost to Follow-up|3|||
154951975|NCT00577460|559249200|FG002|Overall Study|Lost to Follow-up|4|||
154951976|NCT00577460|559249198|FG000|Overall Study|Withdrawal by Subject|5|||
154951977|NCT00577460|559249199|FG001|Overall Study|Withdrawal by Subject|5|||
154951978|NCT00577460|559249200|FG002|Overall Study|Withdrawal by Subject|6|||
154951979|NCT00577460|559249198|FG000|Overall Study|Other|0|||
154951980|NCT00577460|559249199|FG001|Overall Study|Other|3|||
154951981|NCT00577460|559249200|FG002|Overall Study|Other|2|||
154951982|NCT00162123|559249201|FG000|Overall Study|Disease progression|27|||
154951983|NCT00162123|559249202|FG001|Overall Study|Disease progression|19|||
154951984|NCT00162123|559249203|FG002|Overall Study|Disease progression|10|||
154951985|NCT00162123|559249204|FG003|Overall Study|Disease progression|4|||
154951986|NCT00162123|559249205|FG004|Overall Study|Disease progression|8|||
154951987|NCT00162123|559249206|FG005|Overall Study|Disease progression|3|||
154951988|NCT00162123|559249207|FG006|Overall Study|Disease progression|1|||
154951989|NCT00162123|559249208|FG007|Overall Study|Disease progression|0|||
154951990|NCT00162123|559249201|FG000|Overall Study|Study drug toxicity|6|||
154951991|NCT00162123|559249202|FG001|Overall Study|Study drug toxicity|1|||
154951992|NCT00162123|559249203|FG002|Overall Study|Study drug toxicity|5|||
154951993|NCT00162123|559249204|FG003|Overall Study|Study drug toxicity|0|||
154951994|NCT00162123|559249205|FG004|Overall Study|Study drug toxicity|4|||
154951995|NCT00162123|559249206|FG005|Overall Study|Study drug toxicity|1|||
154951996|NCT00162123|559249207|FG006|Overall Study|Study drug toxicity|1|||
154951997|NCT00162123|559249208|FG007|Overall Study|Study drug toxicity|0|||
154951998|NCT00162123|559249201|FG000|Overall Study|Death|3|||
154951999|NCT00162123|559249202|FG001|Overall Study|Death|3|||
154952000|NCT00162123|559249203|FG002|Overall Study|Death|1|||
154952001|NCT00162123|559249204|FG003|Overall Study|Death|1|||
154952002|NCT00162123|559249205|FG004|Overall Study|Death|1|||
154952003|NCT00162123|559249206|FG005|Overall Study|Death|1|||
154952004|NCT00162123|559249207|FG006|Overall Study|Death|0|||
154952005|NCT00162123|559249208|FG007|Overall Study|Death|0|||
154952006|NCT00162123|559249201|FG000|Overall Study|Withdrawal by Subject|2|||
154952007|NCT00162123|559249202|FG001|Overall Study|Withdrawal by Subject|0|||
154952008|NCT00162123|559249203|FG002|Overall Study|Withdrawal by Subject|2|||
154952009|NCT00162123|559249204|FG003|Overall Study|Withdrawal by Subject|1|||
154952010|NCT00162123|559249205|FG004|Overall Study|Withdrawal by Subject|1|||
154952011|NCT00162123|559249206|FG005|Overall Study|Withdrawal by Subject|2|||
154952012|NCT00162123|559249207|FG006|Overall Study|Withdrawal by Subject|1|||
154952013|NCT00162123|559249208|FG007|Overall Study|Withdrawal by Subject|0|||
154952014|NCT00162123|559249201|FG000|Overall Study|Deterioration without progression|2|||
154952015|NCT00162123|559249202|FG001|Overall Study|Deterioration without progression|2|||
154952016|NCT00162123|559249203|FG002|Overall Study|Deterioration without progression|3|||
154952017|NCT00162123|559249204|FG003|Overall Study|Deterioration without progression|0|||
154952018|NCT00162123|559249205|FG004|Overall Study|Deterioration without progression|1|||
154952019|NCT00162123|559249206|FG005|Overall Study|Deterioration without progression|0|||
155056099|NCT02340000|559637847|FG000|Time Period 2|Withdrawal by Subject|9|||
155056100|NCT02340000|559637848|FG001|Time Period 2|Withdrawal by Subject|7|||
154952020|NCT00162123|559249207|FG006|Overall Study|Deterioration without progression|0|||
155056101|NCT02340000|559637847|FG000|Time Period 2|Lost to Follow-up|10|||
155056102|NCT02340000|559637848|FG001|Time Period 2|Lost to Follow-up|8|||
155056103|NCT02668640|559637849|FG000|Overall Study|Lost to Follow-up|13|||
155056104|NCT02668640|559637849|FG000|Overall Study|Other, not specified|1|||
155056105|NCT01883895|559637851|FG000|Overall Study|Lost to Follow-up|2|||
155056106|NCT01526785|559637858|FG000|Overall Study|Study Terminated by Sponsor|8|||
155056107|NCT01526785|559637858|FG000|Overall Study|Death|2|||
155056108|NCT01526785|559637858|FG000|Overall Study|Physician Decision|1|||
155056109|NCT01526785|559637858|FG000|Overall Study|Withdrawal by Subject|2|||
155056110|NCT01121263|559637861|FG000|Overall Study|Death|3|||
155056111|NCT01121263|559637862|FG001|Overall Study|Death|2|||
155056112|NCT01121263|559637861|FG000|Overall Study|Lost to Follow-up|22|||
155056113|NCT01121263|559637862|FG001|Overall Study|Lost to Follow-up|12|||
155393613|NCT01186796|560876819|FG000|Overall Study|Protocol Violation|0|||
155393614|NCT01186796|560876820|FG001|Overall Study|Protocol Violation|1|||
155393615|NCT03838198|560876821|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
155393616|NCT03838198|560876822|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
155393617|NCT03838198|560876823|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
155393618|NCT03838198|560876824|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
155393619|NCT03838198|560876821|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
155056114|NCT01121263|559637861|FG000|Overall Study|Withdrawal by Subject|0|||
155056115|NCT01121263|559637862|FG001|Overall Study|Withdrawal by Subject|1|||
155056116|NCT03810456|559637864|FG000|Treatment|Urgent Family Matters|3|||
155056117|NCT03810456|559637865|FG001|Treatment|Urgent Family Matters|0|||
155056118|NCT03810456|559637866|FG002|Treatment|Urgent Family Matters|0|||
155056119|NCT03810456|559637864|FG000|Treatment|Scheduling Conflicts|0|||
155056120|NCT03810456|559637865|FG001|Treatment|Scheduling Conflicts|11|||
155056121|NCT03810456|559637866|FG002|Treatment|Scheduling Conflicts|0|||
155056122|NCT03810456|559637864|FG000|Treatment|No Longer Interested|0|||
155056123|NCT03810456|559637865|FG001|Treatment|No Longer Interested|12|||
155056124|NCT03810456|559637866|FG002|Treatment|No Longer Interested|0|||
155056125|NCT03810456|559637864|FG000|Treatment|Transportation Issues|0|||
155056126|NCT03810456|559637865|FG001|Treatment|Transportation Issues|1|||
155056127|NCT03810456|559637866|FG002|Treatment|Transportation Issues|0|||
155056128|NCT03810456|559637864|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
155056129|NCT03810456|559637865|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
155056130|NCT03810456|559637866|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
155056131|NCT03810456|559637864|FG000|1 Month Follow-Up|Relocated to Different State|1|||
155056132|NCT03810456|559637865|FG001|1 Month Follow-Up|Relocated to Different State|0|||
155056133|NCT03810456|559637866|FG002|1 Month Follow-Up|Relocated to Different State|1|||
155056134|NCT03810456|559637864|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
155056135|NCT03810456|559637865|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
155056136|NCT03810456|559637866|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
155056137|NCT03810456|559637864|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
155056138|NCT03810456|559637865|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
155056139|NCT03810456|559637866|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
155056140|NCT03810456|559637864|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
155056141|NCT03810456|559637865|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
155056142|NCT03810456|559637866|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
155056143|NCT03810456|559637864|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
155056144|NCT03810456|559637865|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
155056145|NCT03810456|559637866|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
155056146|NCT03810456|559637864|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
155056147|NCT03810456|559637865|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
155056148|NCT03810456|559637866|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
155056149|NCT02007720|559637867|FG000|Overall Study|Withdrawal by Subject|9|||
155056150|NCT02007720|559637868|FG001|Overall Study|Withdrawal by Subject|11|||
155056151|NCT02007720|559637867|FG000|Overall Study|study terminated by sponsor|58|||
155056152|NCT02007720|559637868|FG001|Overall Study|study terminated by sponsor|54|||
155056153|NCT02007720|559637867|FG000|Overall Study|technical problem|4|||
155056154|NCT02007720|559637868|FG001|Overall Study|technical problem|2|||
155056155|NCT02007720|559637867|FG000|Overall Study|patient followd less than 165 days|11|||
155056156|NCT02007720|559637868|FG001|Overall Study|patient followd less than 165 days|5|||
155056157|NCT00490919|559637871|FG000|Open-label Run-in Period|Adverse Event|239|||
155056158|NCT00490919|559637872|FG001|Open-label Run-in Period|Adverse Event|0|||
155056159|NCT00490919|559637873|FG002|Open-label Run-in Period|Adverse Event|0|||
155056160|NCT00490919|559637871|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
155056161|NCT00490919|559637872|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
155056162|NCT00490919|559637873|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
155056163|NCT00490919|559637871|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
155056164|NCT00490919|559637872|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
155056165|NCT00490919|559637873|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
155056166|NCT00490919|559637871|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
155056167|NCT00490919|559637872|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
155056168|NCT00490919|559637873|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
155056169|NCT00490919|559637871|FG000|Open-label Run-in Period|Administrative|40|||
155056170|NCT00490919|559637872|FG001|Open-label Run-in Period|Administrative|0|||
155056171|NCT00490919|559637873|FG002|Open-label Run-in Period|Administrative|0|||
154952021|NCT00162123|559249208|FG007|Overall Study|Deterioration without progression|0|||
154952022|NCT00162123|559249201|FG000|Overall Study|Adverse Event|1|||
154952023|NCT00162123|559249202|FG001|Overall Study|Adverse Event|2|||
154952024|NCT00162123|559249203|FG002|Overall Study|Adverse Event|0|||
154952025|NCT00162123|559249204|FG003|Overall Study|Adverse Event|2|||
154952026|NCT00162123|559249205|FG004|Overall Study|Adverse Event|1|||
154952027|NCT00162123|559249206|FG005|Overall Study|Adverse Event|0|||
154952028|NCT00162123|559249207|FG006|Overall Study|Adverse Event|0|||
154952029|NCT00162123|559249208|FG007|Overall Study|Adverse Event|0|||
154952030|NCT00162123|559249201|FG000|Overall Study|Not specified (before treatment)|2|||
154952031|NCT00162123|559249202|FG001|Overall Study|Not specified (before treatment)|0|||
154952032|NCT00162123|559249203|FG002|Overall Study|Not specified (before treatment)|0|||
154952033|NCT00162123|559249204|FG003|Overall Study|Not specified (before treatment)|0|||
154952034|NCT00162123|559249205|FG004|Overall Study|Not specified (before treatment)|12|||
154952035|NCT00162123|559249206|FG005|Overall Study|Not specified (before treatment)|1|||
154952036|NCT00162123|559249207|FG006|Overall Study|Not specified (before treatment)|0|||
154952037|NCT00162123|559249208|FG007|Overall Study|Not specified (before treatment)|0|||
154952038|NCT00162123|559249201|FG000|Overall Study|Not specified (after start of treatment)|0|||
154952039|NCT00162123|559249202|FG001|Overall Study|Not specified (after start of treatment)|0|||
154952040|NCT00162123|559249203|FG002|Overall Study|Not specified (after start of treatment)|0|||
154952041|NCT00162123|559249204|FG003|Overall Study|Not specified (after start of treatment)|0|||
154952042|NCT00162123|559249205|FG004|Overall Study|Not specified (after start of treatment)|3|||
154952043|NCT00162123|559249206|FG005|Overall Study|Not specified (after start of treatment)|0|||
154952044|NCT00162123|559249207|FG006|Overall Study|Not specified (after start of treatment)|0|||
154952045|NCT00162123|559249208|FG007|Overall Study|Not specified (after start of treatment)|0|||
154952046|NCT00162123|559249201|FG000|Overall Study|Physician Decision|1|||
154952047|NCT00162123|559249202|FG001|Overall Study|Physician Decision|2|||
154952048|NCT00162123|559249203|FG002|Overall Study|Physician Decision|0|||
154952049|NCT00162123|559249204|FG003|Overall Study|Physician Decision|0|||
154952050|NCT00162123|559249205|FG004|Overall Study|Physician Decision|0|||
154952051|NCT00162123|559249206|FG005|Overall Study|Physician Decision|1|||
154952052|NCT00162123|559249207|FG006|Overall Study|Physician Decision|1|||
154952053|NCT00162123|559249208|FG007|Overall Study|Physician Decision|0|||
154952054|NCT00162123|559249201|FG000|Overall Study|Tumor assessment only (not treated)|0|||
154952055|NCT00162123|559249202|FG001|Overall Study|Tumor assessment only (not treated)|0|||
154952056|NCT00162123|559249203|FG002|Overall Study|Tumor assessment only (not treated)|0|||
154952057|NCT00162123|559249204|FG003|Overall Study|Tumor assessment only (not treated)|0|||
154952058|NCT00162123|559249205|FG004|Overall Study|Tumor assessment only (not treated)|0|||
154952059|NCT00162123|559249206|FG005|Overall Study|Tumor assessment only (not treated)|0|||
154952060|NCT00162123|559249207|FG006|Overall Study|Tumor assessment only (not treated)|0|||
154952061|NCT00162123|559249208|FG007|Overall Study|Tumor assessment only (not treated)|1|||
154952062|NCT00162123|559249201|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
154952063|NCT00162123|559249202|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
154952064|NCT00162123|559249203|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
154952065|NCT00162123|559249204|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
154952066|NCT00162123|559249205|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
154952067|NCT00162123|559249206|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
154952068|NCT00162123|559249207|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
154952069|NCT00162123|559249208|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
154952070|NCT01318499|559249210|FG000|Overall Study|Adverse Event|16|||
154952071|NCT01318499|559249211|FG001|Overall Study|Adverse Event|11|||
154952072|NCT01318499|559249212|FG002|Overall Study|Adverse Event|6|||
154952073|NCT01318499|559249210|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
154952074|NCT01318499|559249211|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
154952075|NCT01318499|559249212|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
154952076|NCT01318499|559249210|FG000|Overall Study|Noncompliance|2|||
154952077|NCT01318499|559249211|FG001|Overall Study|Noncompliance|3|||
154952078|NCT01318499|559249212|FG002|Overall Study|Noncompliance|0|||
154952079|NCT01318499|559249210|FG000|Overall Study|Treatment Failure|19|||
154952080|NCT01318499|559249211|FG001|Overall Study|Treatment Failure|19|||
154952081|NCT01318499|559249212|FG002|Overall Study|Treatment Failure|101|||
154952082|NCT01318499|559249210|FG000|Overall Study|Protocol Violation|2|||
154952083|NCT01318499|559249211|FG001|Overall Study|Protocol Violation|4|||
154952084|NCT01318499|559249212|FG002|Overall Study|Protocol Violation|2|||
154952085|NCT01318499|559249210|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
154952086|NCT01318499|559249211|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
154952087|NCT01318499|559249212|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
154952088|NCT01318499|559249210|FG000|Overall Study|Other|7|||
154952089|NCT01318499|559249211|FG001|Overall Study|Other|10|||
155056172|NCT00490919|559637871|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
155056173|NCT00490919|559637872|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
155056174|NCT00490919|559637873|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
155056175|NCT00490919|559637871|FG000|Double-blind Phase|Adverse Event|0|||
155056176|NCT00490919|559637872|FG001|Double-blind Phase|Adverse Event|40|||
155056177|NCT00490919|559637873|FG002|Double-blind Phase|Adverse Event|20|||
155056178|NCT00490919|559637871|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155056179|NCT00490919|559637872|FG001|Double-blind Phase|Withdrawal by Subject|10|||
155056180|NCT00490919|559637873|FG002|Double-blind Phase|Withdrawal by Subject|11|||
155056181|NCT00490919|559637871|FG000|Double-blind Phase|Lost to Follow-up|0|||
155056182|NCT00490919|559637872|FG001|Double-blind Phase|Lost to Follow-up|8|||
155056183|NCT00490919|559637873|FG002|Double-blind Phase|Lost to Follow-up|11|||
155056184|NCT00490919|559637871|FG000|Double-blind Phase|Lack of Efficacy|0|||
155056185|NCT00490919|559637872|FG001|Double-blind Phase|Lack of Efficacy|22|||
155056186|NCT00490919|559637873|FG002|Double-blind Phase|Lack of Efficacy|36|||
155056187|NCT00490919|559637871|FG000|Double-blind Phase|Administrative|0|||
155056188|NCT00490919|559637872|FG001|Double-blind Phase|Administrative|6|||
155056189|NCT00490919|559637873|FG002|Double-blind Phase|Administrative|6|||
155056190|NCT04350827|559637876|FG000|Overall Study|Lost to Follow-up|1|||
155056191|NCT04350827|559637877|FG001|Overall Study|Lost to Follow-up|2|||
155056192|NCT01655901|559639958|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155056193|NCT01655901|559639959|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155056194|NCT01655901|559639960|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155056195|NCT01655901|559639961|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
155056196|NCT01655901|559639962|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
155056197|NCT01655901|559639963|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
155056198|NCT00352118|559639964|FG000|Overall Study|Physician Decision|4|||
155056199|NCT02997163|559639965|FG000|Overall Study|Adverse Event|1|||
155056200|NCT02997163|559639966|FG001|Overall Study|Adverse Event|0|||
155056201|NCT02997163|559639967|FG002|Overall Study|Adverse Event|0|||
155056202|NCT02997163|559639968|FG003|Overall Study|Adverse Event|1|||
155056203|NCT00922636|559639969|FG000|Overall Study|Adverse Event|3|||
155056204|NCT00922636|559639970|FG001|Overall Study|Adverse Event|3|||
155056205|NCT00922636|559639971|FG002|Overall Study|Adverse Event|2|||
155056206|NCT00922636|559639972|FG003|Overall Study|Adverse Event|3|||
155056207|NCT00922636|559639973|FG004|Overall Study|Adverse Event|2|||
155056208|NCT00922636|559639969|FG000|Overall Study|Lack of Efficacy|1|||
155056209|NCT00922636|559639970|FG001|Overall Study|Lack of Efficacy|7|||
155056210|NCT00922636|559639971|FG002|Overall Study|Lack of Efficacy|3|||
155056211|NCT00922636|559639972|FG003|Overall Study|Lack of Efficacy|2|||
155056212|NCT00922636|559639973|FG004|Overall Study|Lack of Efficacy|4|||
155056213|NCT00922636|559639969|FG000|Overall Study|Sponsor Decision|0|||
155056214|NCT00922636|559639970|FG001|Overall Study|Sponsor Decision|0|||
155056215|NCT00922636|559639971|FG002|Overall Study|Sponsor Decision|2|||
155056216|NCT00922636|559639972|FG003|Overall Study|Sponsor Decision|0|||
155056217|NCT00922636|559639973|FG004|Overall Study|Sponsor Decision|0|||
155056218|NCT00922636|559639969|FG000|Overall Study|Withdrawal by Subject|0|||
155056219|NCT00922636|559639970|FG001|Overall Study|Withdrawal by Subject|0|||
155056220|NCT00922636|559639971|FG002|Overall Study|Withdrawal by Subject|5|||
155056221|NCT00922636|559639972|FG003|Overall Study|Withdrawal by Subject|2|||
155056222|NCT00922636|559639973|FG004|Overall Study|Withdrawal by Subject|4|||
155056223|NCT00922636|559639969|FG000|Overall Study|Protocol Violation|0|||
155056224|NCT00922636|559639970|FG001|Overall Study|Protocol Violation|0|||
155056225|NCT00922636|559639971|FG002|Overall Study|Protocol Violation|2|||
155056226|NCT00922636|559639972|FG003|Overall Study|Protocol Violation|2|||
155056227|NCT00922636|559639973|FG004|Overall Study|Protocol Violation|0|||
155056228|NCT00922636|559639969|FG000|Overall Study|Entry Criteria Not Met|0|||
155056229|NCT00922636|559639970|FG001|Overall Study|Entry Criteria Not Met|0|||
155056230|NCT00922636|559639971|FG002|Overall Study|Entry Criteria Not Met|1|||
155056231|NCT00922636|559639972|FG003|Overall Study|Entry Criteria Not Met|1|||
155056232|NCT00922636|559639973|FG004|Overall Study|Entry Criteria Not Met|0|||
155056233|NCT00922636|559639969|FG000|Overall Study|Parent/Caregiver Decision|2|||
155056234|NCT00922636|559639970|FG001|Overall Study|Parent/Caregiver Decision|4|||
155056235|NCT00922636|559639971|FG002|Overall Study|Parent/Caregiver Decision|3|||
155056236|NCT00922636|559639972|FG003|Overall Study|Parent/Caregiver Decision|5|||
155056237|NCT00922636|559639973|FG004|Overall Study|Parent/Caregiver Decision|2|||
155056238|NCT00922636|559639969|FG000|Overall Study|Lost to Follow-up|1|||
155056239|NCT00922636|559639970|FG001|Overall Study|Lost to Follow-up|2|||
155056240|NCT00922636|559639971|FG002|Overall Study|Lost to Follow-up|2|||
155056241|NCT00922636|559639972|FG003|Overall Study|Lost to Follow-up|2|||
155056242|NCT00922636|559639973|FG004|Overall Study|Lost to Follow-up|4|||
155056243|NCT02308046|559639974|FG000|Overall Study|Negative yeast culture at Baseline|32|||
155056244|NCT02308046|559639975|FG001|Overall Study|Negative yeast culture at Baseline|33|||
155056245|NCT02308046|559639974|FG000|Overall Study|Positive for STD at Baseline|1|||
155056246|NCT02308046|559639975|FG001|Overall Study|Positive for STD at Baseline|2|||
155056247|NCT02308046|559639974|FG000|Overall Study|Lost to Follow-up|1|||
155056248|NCT02308046|559639975|FG001|Overall Study|Lost to Follow-up|3|||
155056249|NCT01181167|559639976|FG000|Overall Study|Adverse Event|11|||
155056250|NCT01181167|559639977|FG001|Overall Study|Adverse Event|21|||
155056251|NCT01181167|559639976|FG000|Overall Study|Lost to Follow-up|1|||
155056252|NCT01181167|559639977|FG001|Overall Study|Lost to Follow-up|0|||
155056253|NCT01181167|559639976|FG000|Overall Study|Physician Decision|2|||
155056254|NCT01181167|559639977|FG001|Overall Study|Physician Decision|3|||
155056255|NCT01181167|559639976|FG000|Overall Study|Protocol Violation|3|||
155056256|NCT01181167|559639977|FG001|Overall Study|Protocol Violation|0|||
155056257|NCT01181167|559639976|FG000|Overall Study|Withdrawal by Subject|6|||
155056258|NCT01181167|559639977|FG001|Overall Study|Withdrawal by Subject|8|||
155056259|NCT01573000|559639981|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
155056260|NCT01573000|559639982|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
155056261|NCT01573000|559639981|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
155056262|NCT01573000|559639982|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
155056263|NCT01573000|559639981|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
155056264|NCT01573000|559639982|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
155056265|NCT01573000|559639981|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
155056266|NCT01573000|559639982|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
155056267|NCT01573000|559639981|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
155056268|NCT01573000|559639982|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
155056269|NCT01573000|559639981|FG000|Crossover Phase|Lack of Efficacy|0|||
155056270|NCT01573000|559639982|FG001|Crossover Phase|Lack of Efficacy|13|||
155056271|NCT01573000|559639981|FG000|Crossover Phase|Lost to Follow-up|0|||
155056272|NCT01573000|559639982|FG001|Crossover Phase|Lost to Follow-up|2|||
155056273|NCT01573000|559639981|FG000|Crossover Phase|Death|0|||
155056274|NCT01573000|559639982|FG001|Crossover Phase|Death|3|||
155056275|NCT01573000|559639981|FG000|Long-Term Follow-Up|Death|3|||
155056276|NCT01573000|559639982|FG001|Long-Term Follow-Up|Death|0|||
155056277|NCT01573000|559639981|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
155056278|NCT01573000|559639982|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
155056279|NCT03885908|559639985|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
155056280|NCT03885908|559639986|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
155393620|NCT03838198|560876822|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
155056281|NCT03885908|559639985|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
155056282|NCT03885908|559639986|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
155056283|NCT03885908|559639985|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
155056284|NCT03885908|559639986|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
155092579|NCT01959529|559773635|FG001|Overall Study|Lack of glycaemic control|1|||
154952090|NCT01318499|559249212|FG002|Overall Study|Other|22|||
154952091|NCT01347710|559249215|FG000|Overall Study|Withdrawal by Subject|2|||
154952092|NCT01347710|559249215|FG000|Overall Study|Adverse Event|4|||
154952093|NCT01347710|559249215|FG000|Overall Study|Angio or SPECT not completed|18|||
154952094|NCT01347710|559249215|FG000|Overall Study|issue with vitals prior to dosing|1|||
154952095|NCT01347710|559249215|FG000|Overall Study|Lost to Follow-up|1|||
154952096|NCT01347710|559249215|FG000|Overall Study|Physician Decision|2|||
154952097|NCT01347710|559249215|FG000|Overall Study|Other|3|||
154952098|NCT04591626|559249216|FG000|Overall Study|Adverse Event|4|||
154952099|NCT04591626|559249217|FG001|Overall Study|Adverse Event|0|||
154952100|NCT04591626|559249216|FG000|Overall Study|Withdrawal by Subject|5|||
154952101|NCT04591626|559249217|FG001|Overall Study|Withdrawal by Subject|3|||
154952102|NCT04591626|559249216|FG000|Overall Study|Physician Decision|0|||
154952103|NCT04591626|559249217|FG001|Overall Study|Physician Decision|1|||
154952104|NCT04591626|559249216|FG000|Overall Study|Death|0|||
154952105|NCT04591626|559249217|FG001|Overall Study|Death|1|||
154952106|NCT04591626|559249216|FG000|Overall Study|Non-Compliance with Study Drug|1|||
154952107|NCT04591626|559249217|FG001|Overall Study|Non-Compliance with Study Drug|0|||
154952108|NCT02003183|559249218|FG000|Overall Study|Lost to Follow-up|0|||
154952109|NCT02003183|559249219|FG001|Overall Study|Lost to Follow-up|2|||
154952110|NCT01759290|559249222|FG000|Overall Study|Subjects withdrawn consent|5|||
154952111|NCT01759290|559249222|FG000|Overall Study|Physician Decision|2|||
154952112|NCT01759290|559249222|FG000|Overall Study|Death|17|||
154952113|NCT01759290|559249222|FG000|Overall Study|Lost to Follow-up|53|||
154952114|NCT01759290|559249222|FG000|Overall Study|Unknown reason|4|||
154952115|NCT00841100|559249223|FG000|Phase 1 (28 Days)|Adverse Event|1|||
154952116|NCT00841100|559249223|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
154952117|NCT03338972|559249226|FG000|Overall Study|Death|1|||
154952118|NCT03338972|559249227|FG001|Overall Study|Death|1|||
154952119|NCT03338972|559249228|FG002|Overall Study|Death|0|||
154952120|NCT03338972|559249229|FG003|Overall Study|Death|0|||
154952121|NCT03338972|559249226|FG000|Overall Study|Withdrawal by Subject|1|||
154952122|NCT03338972|559249227|FG001|Overall Study|Withdrawal by Subject|0|||
154952123|NCT03338972|559249228|FG002|Overall Study|Withdrawal by Subject|0|||
154952124|NCT03338972|559249229|FG003|Overall Study|Withdrawal by Subject|0|||
155056285|NCT03885908|559639985|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
155056286|NCT03885908|559639986|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
155056287|NCT01545388|559639991|FG000|Overall Study|Adverse Event|2|||
155056288|NCT01545388|559639992|FG001|Overall Study|Adverse Event|4|||
155056289|NCT01545388|559639993|FG002|Overall Study|Adverse Event|1|||
155056290|NCT01545388|559639991|FG000|Overall Study|Lack of Efficacy|3|||
155056291|NCT01545388|559639992|FG001|Overall Study|Lack of Efficacy|2|||
155056292|NCT01545388|559639993|FG002|Overall Study|Lack of Efficacy|5|||
155056293|NCT01545388|559639991|FG000|Overall Study|Participant moved or relocated|1|||
155056294|NCT01545388|559639992|FG001|Overall Study|Participant moved or relocated|0|||
155056295|NCT01545388|559639993|FG002|Overall Study|Participant moved or relocated|0|||
155056296|NCT01545388|559639991|FG000|Overall Study|Withdrawal by Subject|1|||
155056297|NCT01545388|559639992|FG001|Overall Study|Withdrawal by Subject|4|||
155056298|NCT01545388|559639993|FG002|Overall Study|Withdrawal by Subject|2|||
155056299|NCT01545388|559639991|FG000|Overall Study|Other|1|||
155056300|NCT01545388|559639992|FG001|Overall Study|Other|1|||
155056301|NCT01545388|559639993|FG002|Overall Study|Other|0|||
155056302|NCT01474486|559639994|FG000|Overall Study|Death|2|||
155056303|NCT01474486|559639994|FG000|Overall Study|Withdrawal by Subject|4|||
155056304|NCT01474486|559639994|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
155056305|NCT01255163|559639995|FG000|Overall Study|Withdrawal by Subject|1|||
155056306|NCT01255163|559639996|FG001|Overall Study|Withdrawal by Subject|0|||
155056307|NCT01255163|559639995|FG000|Overall Study|Lost to Follow-up|2|||
155056308|NCT01255163|559639996|FG001|Overall Study|Lost to Follow-up|0|||
155056309|NCT01255163|559639995|FG000|Overall Study|Adverse Event|0|||
155056310|NCT01255163|559639996|FG001|Overall Study|Adverse Event|2|||
155056311|NCT01255163|559639995|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
155056312|NCT01255163|559639996|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
155056313|NCT03863353|559639997|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
155056314|NCT03863353|559639998|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
155056315|NCT02495389|559639999|FG000|Overall Study|Withdrawal by Subject|40|||
155056316|NCT04079790|559640000|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
155056317|NCT04079790|559640001|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
155056318|NCT04079790|559640002|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
155056319|NCT04079790|559640003|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
155056320|NCT04079790|559640000|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
155056321|NCT04079790|559640001|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
155056322|NCT04079790|559640002|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
155056323|NCT04079790|559640003|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
155056324|NCT04079790|559640000|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
155056325|NCT04079790|559640001|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
155056326|NCT04079790|559640002|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
155056327|NCT04079790|559640003|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
155056328|NCT05817669|559640005|FG000|Overall Study|Prohibited medication used|1|||
155056329|NCT05817669|559640006|FG001|Overall Study|Prohibited medication used|2|||
155056330|NCT05817669|559640005|FG000|Overall Study|Adverse Event|1|||
155056331|NCT05817669|559640006|FG001|Overall Study|Adverse Event|0|||
155056332|NCT05817669|559640005|FG000|Overall Study|Withdrawal by Subject|1|||
155056333|NCT05817669|559640006|FG001|Overall Study|Withdrawal by Subject|2|||
155056334|NCT01802385|559640009|FG000|Overall Study|Death|106|||
155056335|NCT01802385|559640010|FG001|Overall Study|Death|120|||
155056336|NCT00323063|559640012|FG000|Overall Study|Adverse Event|1|||
155056337|NCT00323063|559640013|FG001|Overall Study|Adverse Event|0|||
155056338|NCT00323063|559640012|FG000|Overall Study|brain mets discovered prior to treatment|1|||
155056339|NCT00323063|559640013|FG001|Overall Study|brain mets discovered prior to treatment|0|||
155056340|NCT03055936|559640016|FG000|Overall Study|Adverse Event|0|||
155056341|NCT03055936|559640017|FG001|Overall Study|Adverse Event|1|||
155056342|NCT03055936|559640018|FG002|Overall Study|Adverse Event|1|||
155056343|NCT03055936|559640019|FG003|Overall Study|Adverse Event|1|||
155056344|NCT03055936|559640016|FG000|Overall Study|Personal reason|2|||
155056345|NCT03055936|559640017|FG001|Overall Study|Personal reason|0|||
155056346|NCT03055936|559640018|FG002|Overall Study|Personal reason|1|||
155056347|NCT03055936|559640019|FG003|Overall Study|Personal reason|0|||
155056348|NCT04613518|559640024|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
155056349|NCT04613518|559640025|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
155056350|NCT04613518|559640026|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
155056351|NCT04613518|559640024|FG000|Double-Blind Treatment Period|Adverse Event|2|||
155056352|NCT04613518|559640025|FG001|Double-Blind Treatment Period|Adverse Event|0|||
155056353|NCT04613518|559640026|FG002|Double-Blind Treatment Period|Adverse Event|1|||
155056354|NCT04613518|559640024|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
155056355|NCT04613518|559640025|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
155092580|NCT02234362|559773636|FG000|Overall Study|Not eligible after first screening visit|17|||
155056356|NCT04613518|559640026|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
155056357|NCT04613518|559640024|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
155056358|NCT04613518|559640025|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
155056359|NCT04613518|559640026|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
155056360|NCT04613518|559640024|FG000|Double-Blind Treatment Period|Other Reasons|2|||
155056361|NCT04613518|559640025|FG001|Double-Blind Treatment Period|Other Reasons|0|||
155056362|NCT04613518|559640026|FG002|Double-Blind Treatment Period|Other Reasons|0|||
155056363|NCT04613518|559640024|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
155393621|NCT03838198|560876823|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
155393622|NCT03838198|560876824|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
155056364|NCT04613518|559640025|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
155056365|NCT04613518|559640026|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155056366|NCT04613518|559640024|FG000|Open-Label Treatment Period|Adverse Event|1|||
155056367|NCT04613518|559640025|FG001|Open-Label Treatment Period|Adverse Event|0|||
155056368|NCT04613518|559640026|FG002|Open-Label Treatment Period|Adverse Event|3|||
155056369|NCT04613518|559640024|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
155056370|NCT04613518|559640025|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
155056371|NCT04613518|559640026|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
155056372|NCT04613518|559640024|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
155056373|NCT04613518|559640025|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
155056374|NCT04613518|559640026|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
155056375|NCT04613518|559640024|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
155056376|NCT04613518|559640025|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
155056377|NCT04613518|559640026|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
155056378|NCT04613518|559640024|FG000|Open-Label Treatment Period|Other reasons|1|||
155056379|NCT04613518|559640025|FG001|Open-Label Treatment Period|Other reasons|0|||
155056380|NCT04613518|559640026|FG002|Open-Label Treatment Period|Other reasons|0|||
155056381|NCT03589807|559640027|FG000|Overall Study|Lost to Follow-up|0|||
155056382|NCT03589807|559640028|FG001|Overall Study|Lost to Follow-up|2|||
155056383|NCT03589807|559640029|FG002|Overall Study|Lost to Follow-up|2|||
155056384|NCT03589807|559640030|FG003|Overall Study|Lost to Follow-up|3|||
155056385|NCT03589807|559640031|FG004|Overall Study|Lost to Follow-up|1|||
155056386|NCT03589807|559640032|FG005|Overall Study|Lost to Follow-up|1|||
155056387|NCT03589807|559640027|FG000|Overall Study|Withdrawal by Subject|0|||
155056388|NCT03589807|559640028|FG001|Overall Study|Withdrawal by Subject|5|||
155056389|NCT03589807|559640029|FG002|Overall Study|Withdrawal by Subject|0|||
155056390|NCT03589807|559640030|FG003|Overall Study|Withdrawal by Subject|0|||
155056391|NCT03589807|559640031|FG004|Overall Study|Withdrawal by Subject|0|||
155056392|NCT03589807|559640032|FG005|Overall Study|Withdrawal by Subject|0|||
155056393|NCT03589807|559640027|FG000|Overall Study|Protocol Violation|0|||
155056394|NCT03589807|559640028|FG001|Overall Study|Protocol Violation|0|||
155056395|NCT03589807|559640029|FG002|Overall Study|Protocol Violation|0|||
155056396|NCT03589807|559640030|FG003|Overall Study|Protocol Violation|1|||
155056397|NCT03589807|559640031|FG004|Overall Study|Protocol Violation|0|||
155056398|NCT03589807|559640032|FG005|Overall Study|Protocol Violation|0|||
155056399|NCT03589807|559640027|FG000|Overall Study|Enrolled but treatment not administered|0|||
155056400|NCT03589807|559640028|FG001|Overall Study|Enrolled but treatment not administered|0|||
155092581|NCT02234362|559773636|FG000|Overall Study|Lost to Follow-up|6|||
155393623|NCT02378220|560876829|FG000|Overall Study|Death|6|||
155393624|NCT02378220|560876830|FG001|Overall Study|Death|1|||
155393625|NCT00578786|560876831|FG000|Overall Study|Adverse Event|27|||
155393626|NCT00578786|560876832|FG001|Overall Study|Adverse Event|37|||
154952125|NCT03831048|559250578|FG000|Overall Study|Protocol Violation|9|||
154952126|NCT03831048|559250579|FG001|Overall Study|Protocol Violation|3|||
154952127|NCT03831048|559250578|FG000|Overall Study|Death|4|||
154952128|NCT03831048|559250579|FG001|Overall Study|Death|9|||
154952129|NCT03831048|559250578|FG000|Overall Study|Re-transplant|0|||
154952130|NCT03831048|559250579|FG001|Overall Study|Re-transplant|2|||
154952131|NCT03831048|559250578|FG000|Overall Study|Protocol violation and death|1|||
154952132|NCT03831048|559250579|FG001|Overall Study|Protocol violation and death|1|||
154952133|NCT01087970|559250580|FG000|Overall Study|Protocol Violation|2|||
154952134|NCT04538170|559250597|FG000|Overall Study|Withdrawal by Subject|104|||
154952135|NCT04538170|559250598|FG001|Overall Study|Withdrawal by Subject|210|||
154952136|NCT01682083|559250600|FG000|Overall Study|Lost to Follow-up|11|||
154952137|NCT01682083|559250601|FG001|Overall Study|Lost to Follow-up|18|||
154952138|NCT01682083|559250600|FG000|Overall Study|Withdrawal by Subject|31|||
154952139|NCT01682083|559250601|FG001|Overall Study|Withdrawal by Subject|40|||
154952140|NCT01682083|559250600|FG000|Overall Study|Death|60|||
154952141|NCT01682083|559250601|FG001|Overall Study|Death|93|||
154952142|NCT01682083|559250600|FG000|Overall Study|Physician Decision|5|||
154952143|NCT01682083|559250601|FG001|Overall Study|Physician Decision|4|||
154952144|NCT01866319|559250602|FG000|Overall Study|Adverse Event|12|||
155393627|NCT00578786|560876833|FG002|Overall Study|Adverse Event|17|||
155393628|NCT00578786|560876831|FG000|Overall Study|Lack of Efficacy|2|||
155393629|NCT00578786|560876832|FG001|Overall Study|Lack of Efficacy|5|||
155393630|NCT00578786|560876833|FG002|Overall Study|Lack of Efficacy|2|||
155393631|NCT00578786|560876831|FG000|Overall Study|Early Escape from Prior Study|2|||
155393632|NCT00578786|560876832|FG001|Overall Study|Early Escape from Prior Study|1|||
155393633|NCT00578786|560876833|FG002|Overall Study|Early Escape from Prior Study|2|||
155393634|NCT00578786|560876831|FG000|Overall Study|Withdrawal by Subject|7|||
155393635|NCT00578786|560876832|FG001|Overall Study|Withdrawal by Subject|8|||
154952145|NCT01866319|559250603|FG001|Overall Study|Adverse Event|5|||
154952146|NCT01866319|559250604|FG002|Overall Study|Adverse Event|9|||
154952147|NCT01866319|559250602|FG000|Overall Study|Clinical progression|3|||
154952148|NCT01866319|559250603|FG001|Overall Study|Clinical progression|2|||
154952149|NCT01866319|559250604|FG002|Overall Study|Clinical progression|2|||
154952150|NCT01866319|559250602|FG000|Overall Study|Death|153|||
154952151|NCT01866319|559250603|FG001|Overall Study|Death|154|||
154952152|NCT01866319|559250604|FG002|Overall Study|Death|147|||
154952153|NCT01866319|559250602|FG000|Overall Study|Lost to Follow-up|6|||
154952154|NCT01866319|559250603|FG001|Overall Study|Lost to Follow-up|3|||
154952155|NCT01866319|559250604|FG002|Overall Study|Lost to Follow-up|8|||
154952156|NCT01866319|559250602|FG000|Overall Study|Physician Decision|1|||
154952157|NCT01866319|559250603|FG001|Overall Study|Physician Decision|0|||
154952158|NCT01866319|559250604|FG002|Overall Study|Physician Decision|1|||
154952159|NCT01866319|559250602|FG000|Overall Study|Protocol Violation|0|||
154952160|NCT01866319|559250603|FG001|Overall Study|Protocol Violation|0|||
154952161|NCT01866319|559250604|FG002|Overall Study|Protocol Violation|1|||
154952162|NCT01866319|559250602|FG000|Overall Study|Withdrawal by Subject|32|||
154952163|NCT01866319|559250603|FG001|Overall Study|Withdrawal by Subject|14|||
154952164|NCT01866319|559250604|FG002|Overall Study|Withdrawal by Subject|12|||
154952165|NCT02731157|559250606|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
154952166|NCT01225146|559250612|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
154952167|NCT01225146|559250613|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
154952168|NCT05150964|559250614|FG000|Overall Study|Lost to Follow-up|2|||
154952169|NCT00623779|559250615|FG000|Overall Study|Adverse Event|1|||
154952170|NCT00623779|559250616|FG001|Overall Study|Adverse Event|3|||
154952171|NCT00623779|559250617|FG002|Overall Study|Adverse Event|0|||
154952172|NCT00623779|559250615|FG000|Overall Study|Criteria from CSR|2|||
154952173|NCT00623779|559250616|FG001|Overall Study|Criteria from CSR|0|||
154952174|NCT00623779|559250617|FG002|Overall Study|Criteria from CSR|1|||
154952175|NCT00958243|559250629|FG000|Overall Study|Withdrawal by Subject|0|||
154952176|NCT00958243|559250630|FG001|Overall Study|Withdrawal by Subject|1|||
154952177|NCT00958243|559250631|FG002|Overall Study|Withdrawal by Subject|3|||
154952178|NCT00958243|559250632|FG003|Overall Study|Withdrawal by Subject|1|||
154952179|NCT00958243|559250633|FG004|Overall Study|Withdrawal by Subject|1|||
154952180|NCT00958243|559250634|FG005|Overall Study|Withdrawal by Subject|5|||
154952181|NCT00958243|559250629|FG000|Overall Study|Lost to Follow-up|2|||
154952182|NCT00958243|559250630|FG001|Overall Study|Lost to Follow-up|5|||
154952183|NCT00958243|559250631|FG002|Overall Study|Lost to Follow-up|11|||
154952184|NCT00958243|559250632|FG003|Overall Study|Lost to Follow-up|2|||
154952185|NCT00958243|559250633|FG004|Overall Study|Lost to Follow-up|8|||
154952186|NCT00958243|559250634|FG005|Overall Study|Lost to Follow-up|5|||
154952187|NCT06176768|559250635|FG000|Overall Study|Adverse Event|1|||
154952188|NCT06176768|559250636|FG001|Overall Study|Adverse Event|0|||
154952189|NCT06176768|559250635|FG000|Overall Study|Assigned treatment by mistake|1|||
154952190|NCT06176768|559250636|FG001|Overall Study|Assigned treatment by mistake|0|||
154952191|NCT06176768|559250635|FG000|Overall Study|Lost to Follow-up|0|||
154952192|NCT06176768|559250636|FG001|Overall Study|Lost to Follow-up|3|||
154952193|NCT06176768|559250635|FG000|Overall Study|Physician Decision|1|||
154952194|NCT06176768|559250636|FG001|Overall Study|Physician Decision|0|||
154952195|NCT06176768|559250635|FG000|Overall Study|Protocol deviation|3|||
154952196|NCT06176768|559250636|FG001|Overall Study|Protocol deviation|1|||
154952197|NCT06176768|559250635|FG000|Overall Study|Other|1|||
154952198|NCT06176768|559250636|FG001|Overall Study|Other|0|||
154952199|NCT06176768|559250635|FG000|Overall Study|Withdrawal by Subject|6|||
154952200|NCT06176768|559250636|FG001|Overall Study|Withdrawal by Subject|9|||
154952201|NCT02016170|559250637|FG000|Overall Study|Adverse Event|1|||
154952202|NCT02016170|559250638|FG001|Overall Study|Adverse Event|1|||
154952203|NCT02016170|559250639|FG002|Overall Study|Adverse Event|0|||
154952204|NCT02016170|559250637|FG000|Overall Study|Protocol Violation|1|||
154952205|NCT02016170|559250638|FG001|Overall Study|Protocol Violation|0|||
154952206|NCT02016170|559250639|FG002|Overall Study|Protocol Violation|0|||
154952207|NCT01936948|559250642|FG000|Overall Study|no 30-day follow-up data|0|||
154952208|NCT01936948|559250643|FG001|Overall Study|no 30-day follow-up data|3|||
154952209|NCT01936948|559250644|FG002|Overall Study|no 30-day follow-up data|3|||
154952210|NCT01936948|559250645|FG003|Overall Study|no 30-day follow-up data|3|||
154952211|NCT02365207|559250646|FG000|Overall Study|Withdrawal by Subject|1|||
154952212|NCT02365207|559250646|FG000|Overall Study|Physician Decision|1|||
154952213|NCT01395030|559250649|FG000|Overall Study|Did not complete FCH PET/CT|7|||
155393636|NCT00578786|560876833|FG002|Overall Study|Withdrawal by Subject|5|||
155393637|NCT00578786|560876831|FG000|Overall Study|Protocol Violation|0|||
155393638|NCT00578786|560876832|FG001|Overall Study|Protocol Violation|3|||
155393639|NCT00578786|560876833|FG002|Overall Study|Protocol Violation|1|||
155393640|NCT00578786|560876831|FG000|Overall Study|Physician Decision|1|||
155393641|NCT00578786|560876832|FG001|Overall Study|Physician Decision|0|||
154952214|NCT01974141|559250653|FG000|Overall Study|Other Reasons|28|||
154952215|NCT01974141|559250654|FG001|Overall Study|Other Reasons|18|||
154952216|NCT01974141|559250653|FG000|Overall Study|Protocol Violation|2|||
154952217|NCT01974141|559250654|FG001|Overall Study|Protocol Violation|6|||
154952218|NCT01974141|559250653|FG000|Overall Study|Personal Reasons|21|||
154952219|NCT01974141|559250654|FG001|Overall Study|Personal Reasons|20|||
154952220|NCT01974141|559250653|FG000|Overall Study|Lost to Follow-up|38|||
154952221|NCT01974141|559250654|FG001|Overall Study|Lost to Follow-up|29|||
154952222|NCT01974141|559250653|FG000|Overall Study|Pregnancy|3|||
154952223|NCT01974141|559250654|FG001|Overall Study|Pregnancy|3|||
154952224|NCT01974141|559250653|FG000|Overall Study|Lack of Efficacy|0|||
154952225|NCT01974141|559250654|FG001|Overall Study|Lack of Efficacy|1|||
154952226|NCT01974141|559250653|FG000|Overall Study|Adverse Event|4|||
154952227|NCT01974141|559250654|FG001|Overall Study|Adverse Event|5|||
154952228|NCT02327130|559250657|FG000|Overall Study|Discharged in less than 5 days|5|||
154952229|NCT02327130|559250657|FG000|Overall Study|Physician Decision|2|||
154952230|NCT02327130|559250657|FG000|Overall Study|Unable to provide breath sample|1|||
154952231|NCT02327130|559250657|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
154952232|NCT02327130|559250657|FG000|Overall Study|Met exclusion criteria|3|||
154952233|NCT04977336|559250658|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
154952234|NCT04977336|559250659|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
154952235|NCT04977336|559250660|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
154952236|NCT04977336|559250661|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
154952237|NCT04977336|559250662|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
154952238|NCT04977336|559250658|FG000|Overall Study|Lost to Follow-up|0|||
154952239|NCT04977336|559250659|FG001|Overall Study|Lost to Follow-up|0|||
154952240|NCT04977336|559250660|FG002|Overall Study|Lost to Follow-up|1|||
154952241|NCT04977336|559250661|FG003|Overall Study|Lost to Follow-up|0|||
154952242|NCT04977336|559250662|FG004|Overall Study|Lost to Follow-up|0|||
154952243|NCT03298451|559250663|FG000|Overall Study|Death|275|||
154952244|NCT03298451|559250664|FG001|Overall Study|Death|260|||
154952245|NCT03298451|559250665|FG002|Overall Study|Death|122|||
154952246|NCT03298451|559250666|FG003|Overall Study|Death|280|||
154952247|NCT03298451|559250663|FG000|Overall Study|Lost to Follow-up|1|||
154952248|NCT03298451|559250664|FG001|Overall Study|Lost to Follow-up|1|||
154952249|NCT03298451|559250665|FG002|Overall Study|Lost to Follow-up|0|||
154952250|NCT03298451|559250666|FG003|Overall Study|Lost to Follow-up|7|||
154952251|NCT03298451|559250663|FG000|Overall Study|Withdrawal by Subject|9|||
154952252|NCT03298451|559250664|FG001|Overall Study|Withdrawal by Subject|7|||
154952253|NCT03298451|559250665|FG002|Overall Study|Withdrawal by Subject|1|||
154952254|NCT03298451|559250666|FG003|Overall Study|Withdrawal by Subject|20|||
154952255|NCT02672553|559250668|FG000|Overall Study|Death|3|||
154952256|NCT02672553|559250669|FG001|Overall Study|Death|5|||
154952257|NCT02672553|559250668|FG000|Overall Study|Valve Explant|1|||
154952258|NCT02672553|559250669|FG001|Overall Study|Valve Explant|0|||
154952259|NCT02672553|559250668|FG000|Overall Study|Conversion to Commercial Valve|3|||
154952260|NCT02672553|559250669|FG001|Overall Study|Conversion to Commercial Valve|0|||
154952261|NCT02672553|559250668|FG000|Overall Study|Withdrawal by Subject|3|||
154952262|NCT02672553|559250669|FG001|Overall Study|Withdrawal by Subject|3|||
154952263|NCT02672553|559250668|FG000|Overall Study|Intraoperative screen failure|2|||
154952264|NCT02672553|559250669|FG001|Overall Study|Intraoperative screen failure|0|||
154952265|NCT00878995|559250672|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
154952266|NCT00878995|559250673|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
154952267|NCT02480764|559250674|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
154952268|NCT02480764|559250675|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
154952269|NCT02480764|559250676|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
154952270|NCT02480764|559250674|FG000|Overall Study|Major Protocol Deviation|1|||
154952271|NCT02480764|559250675|FG001|Overall Study|Major Protocol Deviation|4|||
154952272|NCT02480764|559250676|FG002|Overall Study|Major Protocol Deviation|3|||
154952273|NCT02480764|559250674|FG000|Overall Study|Lost to Follow-up|0|||
154952274|NCT02480764|559250675|FG001|Overall Study|Lost to Follow-up|1|||
154952275|NCT02480764|559250676|FG002|Overall Study|Lost to Follow-up|2|||
155393642|NCT00578786|560876833|FG002|Overall Study|Physician Decision|1|||
154952276|NCT02480764|559250674|FG000|Overall Study|Voluntary Withdrawal|6|||
154952277|NCT02480764|559250675|FG001|Overall Study|Voluntary Withdrawal|5|||
154952278|NCT02480764|559250676|FG002|Overall Study|Voluntary Withdrawal|10|||
154952279|NCT02480764|559250674|FG000|Overall Study|Lack of Efficacy|0|||
154952280|NCT02480764|559250675|FG001|Overall Study|Lack of Efficacy|3|||
154952281|NCT02480764|559250676|FG002|Overall Study|Lack of Efficacy|3|||
154952282|NCT02480764|559250674|FG000|Overall Study|Reason not Specified|0|||
154952283|NCT02480764|559250675|FG001|Overall Study|Reason not Specified|1|||
155056401|NCT03589807|559640029|FG002|Overall Study|Enrolled but treatment not administered|0|||
155056402|NCT03589807|559640030|FG003|Overall Study|Enrolled but treatment not administered|0|||
155056403|NCT03589807|559640031|FG004|Overall Study|Enrolled but treatment not administered|1|||
155056404|NCT03589807|559640032|FG005|Overall Study|Enrolled but treatment not administered|0|||
155056405|NCT01076543|559640033|FG000|Overall Study|Withdrawal by Subject|2|||
155056406|NCT01076543|559640034|FG001|Overall Study|Withdrawal by Subject|0|||
155056407|NCT01076543|559640035|FG002|Overall Study|Withdrawal by Subject|0|||
155056408|NCT01076543|559640036|FG003|Overall Study|Withdrawal by Subject|0|||
155056409|NCT01076543|559640037|FG004|Overall Study|Withdrawal by Subject|0|||
155056410|NCT01076543|559640038|FG005|Overall Study|Withdrawal by Subject|0|||
155056411|NCT00338741|559640039|FG000|Overall Study|Lost to Follow-up|2|||
155056412|NCT00338741|559640040|FG001|Overall Study|Lost to Follow-up|0|||
155056413|NCT01534273|559640041|FG000|Period 1|Physician Decision|0|||
155056414|NCT01534273|559640042|FG001|Period 1|Physician Decision|0|||
155056415|NCT01534273|559640043|FG002|Period 1|Physician Decision|0|||
155056416|NCT01534273|559640044|FG003|Period 1|Physician Decision|1|||
155056417|NCT01534273|559640045|FG004|Period 1|Physician Decision|0|||
155056418|NCT01534273|559640046|FG005|Period 1|Physician Decision|0|||
155056419|NCT01534273|559640047|FG006|Period 1|Physician Decision|0|||
155056420|NCT03586050|559640048|FG000|Overall Study|Death|3|||
155056421|NCT03586050|559640048|FG000|Overall Study|Withdrawal by Subject|2|||
155056422|NCT01791985|559640049|FG000|Overall Study|Adverse Event|7|||
155056423|NCT01791985|559640049|FG000|Overall Study|Withdrawal by Subject|1|||
155393643|NCT00578786|560876831|FG000|Overall Study|Sponsor Decision|0|||
155393644|NCT00578786|560876832|FG001|Overall Study|Sponsor Decision|0|||
155393645|NCT00578786|560876833|FG002|Overall Study|Sponsor Decision|1|||
155393646|NCT00578786|560876831|FG000|Overall Study|Lost to Follow-up|0|||
155393647|NCT00578786|560876832|FG001|Overall Study|Lost to Follow-up|4|||
155393648|NCT00578786|560876833|FG002|Overall Study|Lost to Follow-up|0|||
155393649|NCT00578786|560876831|FG000|Overall Study|Pregnancy|0|||
155393650|NCT00578786|560876832|FG001|Overall Study|Pregnancy|1|||
155056424|NCT03902613|559640056|FG000|Overall Study|Physician Decision|1|||
155056425|NCT01091246|559640057|FG000|Overall Study|Lost to Follow-up|23|||
155056426|NCT01091246|559640058|FG001|Overall Study|Lost to Follow-up|11|||
155056427|NCT01091246|559640059|FG002|Overall Study|Lost to Follow-up|7|||
155056428|NCT01091246|559640057|FG000|Overall Study|Adverse Event|1|||
155056429|NCT01091246|559640058|FG001|Overall Study|Adverse Event|0|||
155056430|NCT01091246|559640059|FG002|Overall Study|Adverse Event|1|||
155056431|NCT01091246|559640057|FG000|Overall Study|Withdrawal by Subject|9|||
155056432|NCT01091246|559640058|FG001|Overall Study|Withdrawal by Subject|5|||
155056433|NCT01091246|559640059|FG002|Overall Study|Withdrawal by Subject|4|||
155393651|NCT00578786|560876833|FG002|Overall Study|Pregnancy|0|||
155393652|NCT00578786|560876831|FG000|Overall Study|Not Otherwise Specified|0|||
155393653|NCT00578786|560876832|FG001|Overall Study|Not Otherwise Specified|4|||
155393654|NCT00578786|560876833|FG002|Overall Study|Not Otherwise Specified|1|||
155393655|NCT00578786|560876831|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
155393656|NCT00578786|560876832|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
155393657|NCT00578786|560876833|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
155393658|NCT00312221|560876834|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
155393659|NCT00312221|560876835|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
155056434|NCT01091246|559640057|FG000|Overall Study|Subject not dosed|2|||
155056435|NCT01091246|559640058|FG001|Overall Study|Subject not dosed|0|||
155056436|NCT01091246|559640059|FG002|Overall Study|Subject not dosed|1|||
155056437|NCT04577794|559640060|FG000|Overall Study|Adverse Event|1|||
155056438|NCT04577794|559640061|FG001|Overall Study|Adverse Event|1|||
155056439|NCT01676012|559640062|FG000|Overall Study|Adverse Event|2|||
155056440|NCT01676012|559640062|FG000|Overall Study|incomplete set of videos|1|||
155056441|NCT03372798|559640069|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
155056442|NCT03372798|559640070|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
155056443|NCT03372798|559640069|FG000|Overall Study|Failure of imaging probe|0|||
155056444|NCT03372798|559640070|FG001|Overall Study|Failure of imaging probe|1|||
155056445|NCT01405898|559640072|FG000|Overall Study|Withdrawal by Subject|2|||
155056446|NCT01405898|559640073|FG001|Overall Study|Withdrawal by Subject|2|||
155056447|NCT02283658|559640074|FG000|Overall Study|Withdrawal by Subject|1|||
155056448|NCT01687218|559640075|FG000|Overall Study|Withdrawal by Subject|2|||
155056449|NCT01687218|559640076|FG001|Overall Study|Withdrawal by Subject|3|||
155056450|NCT01687218|559640077|FG002|Overall Study|Withdrawal by Subject|0|||
155056451|NCT01687218|559640078|FG003|Overall Study|Withdrawal by Subject|1|||
155056452|NCT01687218|559640079|FG004|Overall Study|Withdrawal by Subject|1|||
155056453|NCT01687218|559640080|FG005|Overall Study|Withdrawal by Subject|0|||
155056454|NCT01687218|559640075|FG000|Overall Study|Relocated, no follow-up planned|1|||
155056455|NCT01687218|559640076|FG001|Overall Study|Relocated, no follow-up planned|0|||
155056456|NCT01687218|559640077|FG002|Overall Study|Relocated, no follow-up planned|1|||
155056457|NCT01687218|559640078|FG003|Overall Study|Relocated, no follow-up planned|1|||
155393660|NCT00312221|560876836|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
155393661|NCT00312221|560876837|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
155056458|NCT01687218|559640079|FG004|Overall Study|Relocated, no follow-up planned|0|||
155056459|NCT01687218|559640080|FG005|Overall Study|Relocated, no follow-up planned|0|||
155056460|NCT03608826|559640082|FG000|Overall Study|Death|3|||
155056461|NCT03608826|559640082|FG000|Overall Study|Heart Transplant|3|||
155056462|NCT03608826|559640082|FG000|Overall Study|Physician Decision|4|||
155056463|NCT00846586|559640089|FG000|Overall Study|Adverse Event|20|||
155056464|NCT00846586|559640090|FG001|Overall Study|Adverse Event|10|||
155056465|NCT00846586|559640089|FG000|Overall Study|Subject withdrew consent|8|||
155056466|NCT00846586|559640090|FG001|Overall Study|Subject withdrew consent|10|||
154952284|NCT02480764|559250676|FG002|Overall Study|Reason not Specified|0|||
155056467|NCT00846586|559640089|FG000|Overall Study|Administrative problems|5|||
155056468|NCT00846586|559640090|FG001|Overall Study|Administrative problems|4|||
155056469|NCT00846586|559640089|FG000|Overall Study|Death|2|||
155056470|NCT00846586|559640090|FG001|Overall Study|Death|0|||
155056471|NCT00846586|559640089|FG000|Overall Study|Protocol deviation|2|||
155056472|NCT00846586|559640090|FG001|Overall Study|Protocol deviation|6|||
155056473|NCT00846586|559640089|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155056474|NCT00846586|559640090|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155056475|NCT00846586|559640089|FG000|Overall Study|Lost to Follow-up|1|||
155056476|NCT00846586|559640090|FG001|Overall Study|Lost to Follow-up|4|||
155056477|NCT00846586|559640089|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155056478|NCT00846586|559640090|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155056479|NCT00875810|559640091|FG000|Overall Study|Withdrawal by Subject|1|||
155056480|NCT00875810|559640091|FG000|Overall Study|Physician Decision|3|||
155056481|NCT00875810|559640091|FG000|Overall Study|Lost to Follow-up|39|||
155056482|NCT00875810|559640091|FG000|Overall Study|Patient enroled but not implanted|2|||
155056483|NCT00875810|559640091|FG000|Overall Study|Device explanted|1|||
155056484|NCT00780975|559640092|FG000|Overall Study|Progressive disease|3|||
155056485|NCT00780975|559640092|FG000|Overall Study|Toxicity|5|||
155056486|NCT01061606|559640093|FG000|Overall Study|Adverse Event|1|||
155056487|NCT01061606|559640093|FG000|Overall Study|Death|1|||
155056488|NCT01061606|559640093|FG000|Overall Study|Disease Progression|4|||
154952285|NCT03629249|559250677|FG000|Overall Study|Study terminated by sponsor|197|||
154952286|NCT03629249|559250678|FG001|Overall Study|Study terminated by sponsor|197|||
154952287|NCT03629249|559250679|FG002|Overall Study|Study terminated by sponsor|194|||
154952288|NCT03629249|559250677|FG000|Overall Study|Protocol deviation|0|||
154952289|NCT03629249|559250678|FG001|Overall Study|Protocol deviation|2|||
154952290|NCT03629249|559250679|FG002|Overall Study|Protocol deviation|5|||
154952291|NCT03629249|559250677|FG000|Overall Study|Subject decision|1|||
154952292|NCT03629249|559250678|FG001|Overall Study|Subject decision|1|||
154952293|NCT03629249|559250679|FG002|Overall Study|Subject decision|3|||
154952294|NCT03629249|559250677|FG000|Overall Study|Adverse Event|1|||
154952295|NCT03629249|559250678|FG001|Overall Study|Adverse Event|1|||
154952296|NCT03629249|559250679|FG002|Overall Study|Adverse Event|0|||
154952297|NCT03629249|559250677|FG000|Overall Study|Death|1|||
154952298|NCT03629249|559250678|FG001|Overall Study|Death|0|||
154952299|NCT03629249|559250679|FG002|Overall Study|Death|0|||
154952300|NCT03629249|559250677|FG000|Overall Study|Physician Decision|1|||
154952301|NCT03629249|559250678|FG001|Overall Study|Physician Decision|0|||
154952302|NCT03629249|559250679|FG002|Overall Study|Physician Decision|0|||
154952303|NCT00352690|559250680|FG000|Overall Study|Determined to be ineligible|2|||
154952304|NCT00352690|559250681|FG001|Overall Study|Determined to be ineligible|0|||
154952305|NCT03633721|559250684|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
154952306|NCT03633721|559250685|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
154952307|NCT03633721|559250686|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
154952308|NCT03633721|559250687|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
154952309|NCT01475474|559250691|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
154952310|NCT01475474|559250691|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
154952311|NCT02343120|559250692|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
154952312|NCT02343120|559250693|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
154952313|NCT02343120|559250694|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
154952314|NCT02343120|559250695|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
154952315|NCT02343120|559250696|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
154952316|NCT02343120|559250692|FG000|Part 1: Dose Escalation|Death|1|||
154952317|NCT02343120|559250693|FG001|Part 1: Dose Escalation|Death|2|||
154952318|NCT02343120|559250694|FG002|Part 1: Dose Escalation|Death|2|||
154952319|NCT02343120|559250695|FG003|Part 1: Dose Escalation|Death|2|||
154952320|NCT02343120|559250696|FG004|Part 1: Dose Escalation|Death|1|||
154952321|NCT02343120|559250692|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
154952322|NCT02343120|559250693|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
155056489|NCT01061606|559640093|FG000|Overall Study|alternative therapy|2|||
155056490|NCT03644017|559640094|FG000|Overall Study|Access Abandonment|5|||
155056491|NCT03644017|559640094|FG000|Overall Study|Kidney Transplant|2|||
154952323|NCT02343120|559250694|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
154952324|NCT02343120|559250695|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
154952325|NCT02343120|559250696|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
155056492|NCT01305564|559640095|FG000|Overall Study|Death|21|||
155056493|NCT01305564|559640095|FG000|Overall Study|Lost to Follow-up|12|||
155056494|NCT01305564|559640095|FG000|Overall Study|Withdrawal by Subject|1|||
155056495|NCT01305564|559640095|FG000|Overall Study|Physician Decision|3|||
155056496|NCT02322749|559640097|FG000|Period 2|Adverse Event|0|||
155056497|NCT02322749|559640098|FG001|Period 2|Adverse Event|0|||
155056498|NCT02322749|559640099|FG002|Period 2|Adverse Event|0|||
155056499|NCT02322749|559640100|FG003|Period 2|Adverse Event|1|||
155056500|NCT02322749|559640101|FG004|Period 2|Adverse Event|0|||
155056501|NCT02322749|559640102|FG005|Period 2|Adverse Event|0|||
155056502|NCT02322749|559640097|FG000|Period 2|Withdrawal by Subject|0|||
155056503|NCT02322749|559640098|FG001|Period 2|Withdrawal by Subject|0|||
155056504|NCT02322749|559640099|FG002|Period 2|Withdrawal by Subject|0|||
155056505|NCT02322749|559640100|FG003|Period 2|Withdrawal by Subject|1|||
155056506|NCT02322749|559640101|FG004|Period 2|Withdrawal by Subject|0|||
155056507|NCT02322749|559640102|FG005|Period 2|Withdrawal by Subject|0|||
155056508|NCT02322749|559640097|FG000|Period 3|Withdrawal by Subject|0|||
155056509|NCT02322749|559640098|FG001|Period 3|Withdrawal by Subject|0|||
155056510|NCT02322749|559640099|FG002|Period 3|Withdrawal by Subject|1|||
155056511|NCT02322749|559640100|FG003|Period 3|Withdrawal by Subject|0|||
155056512|NCT02322749|559640101|FG004|Period 3|Withdrawal by Subject|0|||
155393662|NCT00312221|560876834|FG000|Open-label Run-in Period|Adverse Event|74|||
155393663|NCT00312221|560876835|FG001|Open-label Run-in Period|Adverse Event|0|||
155393664|NCT00312221|560876836|FG002|Open-label Run-in Period|Adverse Event|0|||
155393665|NCT00312221|560876837|FG003|Open-label Run-in Period|Adverse Event|0|||
155056513|NCT02322749|559640102|FG005|Period 3|Withdrawal by Subject|0|||
155056514|NCT00073918|559640107|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
155056515|NCT00073918|559640107|FG000|Overall Study|Rapid disease progression|2|||
155056516|NCT00073918|559640107|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
155056517|NCT01190813|559640110|FG000|Overall Study|Lost to Follow-up|1|||
155056518|NCT01190813|559640111|FG001|Overall Study|Lost to Follow-up|2|||
155056519|NCT01190813|559640110|FG000|Overall Study|Withdrawal by Subject|2|||
155056520|NCT01190813|559640111|FG001|Overall Study|Withdrawal by Subject|1|||
155056521|NCT01190813|559640110|FG000|Overall Study|Refused study treatment after randomized|1|||
155056522|NCT01190813|559640111|FG001|Overall Study|Refused study treatment after randomized|0|||
155056523|NCT01190813|559640110|FG000|Overall Study|Adverse Event|0|||
155056524|NCT01190813|559640111|FG001|Overall Study|Adverse Event|1|||
155056525|NCT02033759|559640113|FG000|Overall Study|Withdrawal by Subject|2|||
155056526|NCT02033759|559640114|FG001|Overall Study|Withdrawal by Subject|1|||
155056527|NCT02033759|559640113|FG000|Overall Study|Protocol Violation|1|||
155056528|NCT02033759|559640114|FG001|Overall Study|Protocol Violation|1|||
155056529|NCT00807365|559640118|FG000|Overall Study|Study Terminated|5|||
155056530|NCT04821830|559640121|FG000|Overall Study|Withdrawal by Subject|1|||
155056531|NCT04821830|559640122|FG001|Overall Study|Withdrawal by Subject|0|||
155056532|NCT00919633|559640124|FG000|Overall Study|Adverse Event|1|||
155056533|NCT00919633|559640125|FG001|Overall Study|Adverse Event|9|||
155056534|NCT00919633|559640126|FG002|Overall Study|Adverse Event|12|||
155056535|NCT00919633|559640127|FG003|Overall Study|Adverse Event|10|||
155056536|NCT00919633|559640124|FG000|Overall Study|Death|0|||
155056537|NCT00919633|559640125|FG001|Overall Study|Death|0|||
155056538|NCT00919633|559640126|FG002|Overall Study|Death|2|||
155056539|NCT00919633|559640127|FG003|Overall Study|Death|0|||
155056540|NCT00919633|559640124|FG000|Overall Study|Lack of Efficacy|17|||
155393666|NCT00312221|560876834|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
155393667|NCT00312221|560876835|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
155393668|NCT00312221|560876836|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
155393669|NCT00312221|560876837|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
155056541|NCT00919633|559640125|FG001|Overall Study|Lack of Efficacy|3|||
155056542|NCT00919633|559640126|FG002|Overall Study|Lack of Efficacy|2|||
155056543|NCT00919633|559640127|FG003|Overall Study|Lack of Efficacy|3|||
155056544|NCT00919633|559640124|FG000|Overall Study|Withdrawal by Subject|1|||
155056545|NCT00919633|559640125|FG001|Overall Study|Withdrawal by Subject|2|||
155056546|NCT00919633|559640126|FG002|Overall Study|Withdrawal by Subject|4|||
155056547|NCT00919633|559640127|FG003|Overall Study|Withdrawal by Subject|3|||
155056548|NCT00919633|559640124|FG000|Overall Study|Lost to Follow-up|3|||
155056549|NCT00919633|559640125|FG001|Overall Study|Lost to Follow-up|1|||
155056550|NCT00919633|559640126|FG002|Overall Study|Lost to Follow-up|0|||
155056551|NCT00919633|559640127|FG003|Overall Study|Lost to Follow-up|2|||
155056552|NCT00919633|559640124|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
155056553|NCT00919633|559640125|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
155056554|NCT00919633|559640126|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
155056555|NCT00919633|559640127|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
155056556|NCT00919633|559640124|FG000|Overall Study|Protocol Violation|0|||
155056557|NCT00919633|559640125|FG001|Overall Study|Protocol Violation|0|||
155056558|NCT00919633|559640126|FG002|Overall Study|Protocol Violation|0|||
155056559|NCT00919633|559640127|FG003|Overall Study|Protocol Violation|1|||
155056560|NCT00919633|559640124|FG000|Overall Study|Physician Decision|0|||
155056561|NCT00919633|559640125|FG001|Overall Study|Physician Decision|0|||
155056562|NCT00919633|559640126|FG002|Overall Study|Physician Decision|0|||
155056563|NCT00919633|559640127|FG003|Overall Study|Physician Decision|1|||
155056564|NCT00919633|559640124|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
155056565|NCT00919633|559640125|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
155056566|NCT00919633|559640126|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
155056567|NCT00919633|559640127|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
155056568|NCT00919633|559640124|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
155056569|NCT00919633|559640125|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
155056570|NCT00919633|559640126|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
155056571|NCT00919633|559640127|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
155056572|NCT02100124|559640128|FG000|Overall Study|Lost to Follow-up|5|||
155056573|NCT02100124|559640129|FG001|Overall Study|Lost to Follow-up|11|||
155056574|NCT02100124|559640130|FG002|Overall Study|Lost to Follow-up|3|||
155056575|NCT02100124|559640128|FG000|Overall Study|Withdrawal by Subject|1|||
155056576|NCT02100124|559640129|FG001|Overall Study|Withdrawal by Subject|0|||
155056577|NCT02100124|559640130|FG002|Overall Study|Withdrawal by Subject|0|||
155056578|NCT04265261|559640135|FG000|Overall Study|Adverse Event|2|||
155056579|NCT04265261|559640136|FG001|Overall Study|Adverse Event|0|||
155056580|NCT04265261|559640137|FG002|Overall Study|Adverse Event|0|||
155056581|NCT04265261|559640135|FG000|Overall Study|Death|1|||
155056582|NCT04265261|559640136|FG001|Overall Study|Death|0|||
155056583|NCT04265261|559640137|FG002|Overall Study|Death|0|||
155056584|NCT04265261|559640135|FG000|Overall Study|Lost to Follow-up|4|||
155056585|NCT04265261|559640136|FG001|Overall Study|Lost to Follow-up|1|||
155056586|NCT04265261|559640137|FG002|Overall Study|Lost to Follow-up|3|||
155056587|NCT04265261|559640135|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155056588|NCT04265261|559640136|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155056589|NCT04265261|559640137|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155056590|NCT04265261|559640135|FG000|Overall Study|Physician Decision|0|||
155056591|NCT04265261|559640136|FG001|Overall Study|Physician Decision|0|||
155056592|NCT04265261|559640137|FG002|Overall Study|Physician Decision|1|||
155056593|NCT04265261|559640135|FG000|Overall Study|Protocol Deviation|0|||
155056594|NCT04265261|559640136|FG001|Overall Study|Protocol Deviation|2|||
155056595|NCT04265261|559640137|FG002|Overall Study|Protocol Deviation|0|||
155056596|NCT04265261|559640135|FG000|Overall Study|Withdrawal by Subject|2|||
155056597|NCT04265261|559640136|FG001|Overall Study|Withdrawal by Subject|1|||
155056598|NCT04265261|559640137|FG002|Overall Study|Withdrawal by Subject|4|||
155056599|NCT00557466|559641936|FG000|Overall Study|Adverse Event|3|||
155056600|NCT00557466|559641937|FG001|Overall Study|Adverse Event|1|||
155056601|NCT00557466|559641938|FG002|Overall Study|Adverse Event|4|||
155056602|NCT00557466|559641939|FG003|Overall Study|Adverse Event|1|||
155056603|NCT00557466|559641940|FG004|Overall Study|Adverse Event|2|||
155056604|NCT00557466|559641941|FG005|Overall Study|Adverse Event|4|||
155056605|NCT00557466|559641936|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155056606|NCT00557466|559641937|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155056607|NCT00557466|559641938|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155056608|NCT00557466|559641939|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155056609|NCT00557466|559641940|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155056610|NCT00557466|559641941|FG005|Overall Study|Abnormal laboratory value(s)|0|||
155056611|NCT00557466|559641936|FG000|Overall Study|Protocol deviation|0|||
155056612|NCT00557466|559641937|FG001|Overall Study|Protocol deviation|1|||
155056613|NCT00557466|559641938|FG002|Overall Study|Protocol deviation|0|||
155056614|NCT00557466|559641939|FG003|Overall Study|Protocol deviation|2|||
155056615|NCT00557466|559641940|FG004|Overall Study|Protocol deviation|0|||
155056616|NCT00557466|559641941|FG005|Overall Study|Protocol deviation|0|||
155056617|NCT00557466|559641936|FG000|Overall Study|Subject withdrew consent|0|||
155056618|NCT00557466|559641937|FG001|Overall Study|Subject withdrew consent|0|||
155056619|NCT00557466|559641938|FG002|Overall Study|Subject withdrew consent|0|||
155056620|NCT00557466|559641939|FG003|Overall Study|Subject withdrew consent|0|||
155056621|NCT00557466|559641940|FG004|Overall Study|Subject withdrew consent|1|||
155056622|NCT00557466|559641941|FG005|Overall Study|Subject withdrew consent|2|||
155393670|NCT00312221|560876834|FG000|Open-label Run-in Period|Administrative|42|||
155393671|NCT00312221|560876835|FG001|Open-label Run-in Period|Administrative|0|||
155393672|NCT00312221|560876836|FG002|Open-label Run-in Period|Administrative|0|||
155056623|NCT00557466|559641936|FG000|Overall Study|Administrative problems|0|||
155056624|NCT00557466|559641937|FG001|Overall Study|Administrative problems|1|||
155056625|NCT00557466|559641938|FG002|Overall Study|Administrative problems|1|||
155056626|NCT00557466|559641939|FG003|Overall Study|Administrative problems|0|||
155056627|NCT00557466|559641940|FG004|Overall Study|Administrative problems|0|||
155056628|NCT00557466|559641941|FG005|Overall Study|Administrative problems|0|||
155056629|NCT00557466|559641936|FG000|Overall Study|Abnormal test procedure results|0|||
155056630|NCT00557466|559641937|FG001|Overall Study|Abnormal test procedure results|0|||
155056631|NCT00557466|559641938|FG002|Overall Study|Abnormal test procedure results|1|||
155056632|NCT00557466|559641939|FG003|Overall Study|Abnormal test procedure results|0|||
155056633|NCT00557466|559641940|FG004|Overall Study|Abnormal test procedure results|0|||
155056634|NCT00557466|559641941|FG005|Overall Study|Abnormal test procedure results|0|||
155393673|NCT00312221|560876837|FG003|Open-label Run-in Period|Administrative|0|||
155056635|NCT00557466|559641936|FG000|Overall Study|Lost to Follow-up|0|||
155056636|NCT00557466|559641937|FG001|Overall Study|Lost to Follow-up|0|||
155056637|NCT00557466|559641938|FG002|Overall Study|Lost to Follow-up|0|||
155056638|NCT00557466|559641939|FG003|Overall Study|Lost to Follow-up|1|||
155056639|NCT00557466|559641940|FG004|Overall Study|Lost to Follow-up|0|||
155056640|NCT00557466|559641941|FG005|Overall Study|Lost to Follow-up|0|||
155056641|NCT02810418|559641944|FG000|Arm A Dose Escalation|Adverse Event|2|||
155056642|NCT02810418|559641945|FG001|Arm A Dose Escalation|Adverse Event|1|||
155056643|NCT02810418|559641946|FG002|Arm A Dose Escalation|Adverse Event|0|||
155056644|NCT02810418|559641947|FG003|Arm A Dose Escalation|Adverse Event|0|||
155056645|NCT02810418|559641948|FG004|Arm A Dose Escalation|Adverse Event|0|||
155056646|NCT02810418|559641949|FG005|Arm A Dose Escalation|Adverse Event|0|||
155056647|NCT02810418|559641950|FG006|Arm A Dose Escalation|Adverse Event|0|||
155056648|NCT02810418|559641944|FG000|Dose Expansion|Adverse Event|0|||
155056649|NCT02810418|559641945|FG001|Dose Expansion|Adverse Event|1|||
155056650|NCT02810418|559641946|FG002|Dose Expansion|Adverse Event|1|||
155056651|NCT02810418|559641947|FG003|Dose Expansion|Adverse Event|0|||
155056652|NCT02810418|559641948|FG004|Dose Expansion|Adverse Event|0|||
155056653|NCT02810418|559641949|FG005|Dose Expansion|Adverse Event|0|||
155056654|NCT02810418|559641950|FG006|Dose Expansion|Adverse Event|0|||
155056655|NCT02810418|559641944|FG000|Dose Expansion|Physician Decision|0|||
155056656|NCT02810418|559641945|FG001|Dose Expansion|Physician Decision|0|||
155056657|NCT02810418|559641946|FG002|Dose Expansion|Physician Decision|2|||
155056658|NCT02810418|559641947|FG003|Dose Expansion|Physician Decision|0|||
155056659|NCT02810418|559641948|FG004|Dose Expansion|Physician Decision|0|||
155056660|NCT02810418|559641949|FG005|Dose Expansion|Physician Decision|0|||
155056661|NCT02810418|559641950|FG006|Dose Expansion|Physician Decision|0|||
155056662|NCT02810418|559641944|FG000|Arm B Dose Escalation|Adverse Event|0|||
155056663|NCT02810418|559641945|FG001|Arm B Dose Escalation|Adverse Event|0|||
155056664|NCT02810418|559641946|FG002|Arm B Dose Escalation|Adverse Event|0|||
155056665|NCT02810418|559641947|FG003|Arm B Dose Escalation|Adverse Event|0|||
155056666|NCT02810418|559641948|FG004|Arm B Dose Escalation|Adverse Event|1|||
155056667|NCT02810418|559641949|FG005|Arm B Dose Escalation|Adverse Event|2|||
155056668|NCT02810418|559641950|FG006|Arm B Dose Escalation|Adverse Event|0|||
155056669|NCT04161391|559641953|FG000|Overall Study|Adverse Event|0|||
155056670|NCT04161391|559641954|FG001|Overall Study|Adverse Event|1|||
155056671|NCT04161391|559641955|FG002|Overall Study|Adverse Event|0|||
155056672|NCT04161391|559641956|FG003|Overall Study|Adverse Event|1|||
155056673|NCT04161391|559641957|FG004|Overall Study|Adverse Event|0|||
155056674|NCT04161391|559641958|FG005|Overall Study|Adverse Event|0|||
155056675|NCT04161391|559641959|FG006|Overall Study|Adverse Event|0|||
155056676|NCT04161391|559641960|FG007|Overall Study|Adverse Event|3|||
155056677|NCT04161391|559641961|FG008|Overall Study|Adverse Event|0|||
155056678|NCT04161391|559641953|FG000|Overall Study|Death|0|||
155056679|NCT04161391|559641954|FG001|Overall Study|Death|0|||
155056680|NCT04161391|559641955|FG002|Overall Study|Death|0|||
155056681|NCT04161391|559641956|FG003|Overall Study|Death|0|||
155056682|NCT04161391|559641957|FG004|Overall Study|Death|0|||
155056683|NCT04161391|559641958|FG005|Overall Study|Death|0|||
155056684|NCT04161391|559641959|FG006|Overall Study|Death|0|||
155056685|NCT04161391|559641960|FG007|Overall Study|Death|1|||
155056686|NCT04161391|559641961|FG008|Overall Study|Death|0|||
155056687|NCT04161391|559641953|FG000|Overall Study|Physician Decision|0|||
155056688|NCT04161391|559641954|FG001|Overall Study|Physician Decision|0|||
155056689|NCT04161391|559641955|FG002|Overall Study|Physician Decision|1|||
155056690|NCT04161391|559641956|FG003|Overall Study|Physician Decision|2|||
155056691|NCT04161391|559641957|FG004|Overall Study|Physician Decision|0|||
155056692|NCT04161391|559641958|FG005|Overall Study|Physician Decision|0|||
155056693|NCT04161391|559641959|FG006|Overall Study|Physician Decision|2|||
155056694|NCT04161391|559641960|FG007|Overall Study|Physician Decision|0|||
155056695|NCT04161391|559641961|FG008|Overall Study|Physician Decision|0|||
155056696|NCT04161391|559641953|FG000|Overall Study|Progressive Disease|4|||
155056697|NCT04161391|559641954|FG001|Overall Study|Progressive Disease|3|||
155056698|NCT04161391|559641955|FG002|Overall Study|Progressive Disease|3|||
155056699|NCT04161391|559641956|FG003|Overall Study|Progressive Disease|5|||
155056700|NCT04161391|559641957|FG004|Overall Study|Progressive Disease|3|||
155056701|NCT04161391|559641958|FG005|Overall Study|Progressive Disease|3|||
155056702|NCT04161391|559641959|FG006|Overall Study|Progressive Disease|5|||
155056703|NCT04161391|559641960|FG007|Overall Study|Progressive Disease|2|||
155056704|NCT04161391|559641961|FG008|Overall Study|Progressive Disease|2|||
155056705|NCT02870868|559641962|FG000|Overall Study|Withdrawal by Subject|2|||
155056706|NCT02870868|559641963|FG001|Overall Study|Withdrawal by Subject|1|||
155056707|NCT00883181|559641965|FG000|Overall Study|Hematological Adverse Event|26|||
155056708|NCT00883181|559641965|FG000|Overall Study|Non-hematological Adverse Event|55|||
155283301|NCT04091672|560470702|FG001|Overall Study|Lost to Follow-up|7|||
155056709|NCT00883181|559641965|FG000|Overall Study|Disease Progression|94|||
155056710|NCT00883181|559641965|FG000|Overall Study|Administrative Reason|24|||
155056711|NCT00883181|559641965|FG000|Overall Study|Withdrawal by Subject|4|||
155056712|NCT00883181|559641965|FG000|Overall Study|Death|31|||
155056713|NCT00883181|559641965|FG000|Overall Study|Other|38|||
155056714|NCT00883181|559641965|FG000|Overall Study|Protocol Deviation|3|||
155056715|NCT00883181|559641965|FG000|Overall Study|Noncompliance|3|||
155056716|NCT04040439|559641966|FG000|Overall Study|Invalid registration|11|||
155056717|NCT04040439|559641966|FG000|Overall Study|No IC* on publication of study results|2|||
155056718|NCT02089347|559641969|FG000|Overall Study|Protocol Violation|1|||
155056719|NCT02089347|559641970|FG001|Overall Study|Protocol Violation|0|||
155056720|NCT02914834|559641974|FG000|Overall Study|Study halted due to COVID|1|||
155056721|NCT02914834|559641975|FG001|Overall Study|Study halted due to COVID|1|||
155056722|NCT02914834|559641974|FG000|Overall Study|1 subject withdrew|0|||
155056723|NCT02914834|559641975|FG001|Overall Study|1 subject withdrew|1|||
155056724|NCT00975416|559641982|FG000|Overall Study|early discharge from tx|3|||
155056725|NCT00975416|559641983|FG001|Overall Study|early discharge from tx|5|||
155056726|NCT01249131|559641984|FG000|Washout Period of 10 Days|Adverse Event|0|||
155056727|NCT01249131|559641985|FG001|Washout Period of 10 Days|Adverse Event|0|||
155056728|NCT01249131|559641986|FG002|Washout Period of 10 Days|Adverse Event|0|||
155056729|NCT01249131|559641987|FG003|Washout Period of 10 Days|Adverse Event|0|||
155056730|NCT01249131|559641988|FG004|Washout Period of 10 Days|Adverse Event|1|||
155056731|NCT01249131|559641989|FG005|Washout Period of 10 Days|Adverse Event|0|||
155056732|NCT02915835|559641990|FG000|Overall Study|Physician Decision|1|||
155056733|NCT02915835|559641991|FG001|Overall Study|Physician Decision|0|||
155056734|NCT02915835|559641990|FG000|Overall Study|Withdrawal by Subject|0|||
155056735|NCT02915835|559641991|FG001|Overall Study|Withdrawal by Subject|1|||
155056736|NCT03426345|559641992|FG000|Overall Study|Adverse Event|4|||
155056737|NCT03426345|559641993|FG001|Overall Study|Adverse Event|4|||
155056738|NCT03426345|559641992|FG000|Overall Study|Lack of Efficacy|1|||
155056739|NCT03426345|559641993|FG001|Overall Study|Lack of Efficacy|0|||
155056740|NCT03426345|559641992|FG000|Overall Study|Withdrawal by Subject|5|||
155056741|NCT03426345|559641993|FG001|Overall Study|Withdrawal by Subject|6|||
155056742|NCT03426345|559641992|FG000|Overall Study|Lost to Follow-up|3|||
155056743|NCT03426345|559641993|FG001|Overall Study|Lost to Follow-up|1|||
155056744|NCT03426345|559641992|FG000|Overall Study|Protocol Deviation|3|||
155056745|NCT03426345|559641993|FG001|Overall Study|Protocol Deviation|4|||
155056746|NCT03426345|559641992|FG000|Overall Study|Reason Not Specified|1|||
155056747|NCT03426345|559641993|FG001|Overall Study|Reason Not Specified|2|||
155056748|NCT03426345|559641992|FG000|Overall Study|Missing Completion Status|1|||
155056749|NCT03426345|559641993|FG001|Overall Study|Missing Completion Status|0|||
155056750|NCT02446691|559642000|FG000|Overall Study|Withdrawal by Subject|2|||
155056751|NCT02446691|559642000|FG000|Overall Study|Lost to Follow-up|8|||
155056752|NCT02446691|559642000|FG000|Overall Study|Protocol Violation|1|||
155056753|NCT00192114|559642001|FG000|Overall Study|Objective Tumor Progression|19|||
155056754|NCT00192114|559642001|FG000|Overall Study|Adverse Event|2|||
155056755|NCT00192114|559642001|FG000|Overall Study|Clinical Progression|2|||
155056756|NCT00192114|559642001|FG000|Overall Study|Death|1|||
155056757|NCT02666222|559642009|FG000|Overall Study|Death|2|||
155056758|NCT03504917|559642014|FG000|Blinded Treatment Period|Protocol Violation|1|||
155056759|NCT03504917|559642015|FG001|Blinded Treatment Period|Protocol Violation|0|||
155056760|NCT03504917|559642014|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
155056761|NCT03504917|559642015|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
155056762|NCT03504917|559642014|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
155056763|NCT03504917|559642015|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
155056764|NCT03504917|559642014|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
155056765|NCT03504917|559642015|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
155056766|NCT03504917|559642014|FG000|Blinded Treatment Period|Adverse Event|4|||
155056767|NCT03504917|559642015|FG001|Blinded Treatment Period|Adverse Event|4|||
155056768|NCT03504917|559642014|FG000|Blinded Treatment Period|Physician Decision|1|||
155056769|NCT03504917|559642015|FG001|Blinded Treatment Period|Physician Decision|0|||
155056770|NCT03504917|559642014|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
154952326|NCT02343120|559250692|FG000|Part 2: Expansion|Sponsor decision|0|||
154952327|NCT02343120|559250693|FG001|Part 2: Expansion|Sponsor decision|0|||
154952328|NCT02343120|559250694|FG002|Part 2: Expansion|Sponsor decision|0|||
154952329|NCT02343120|559250695|FG003|Part 2: Expansion|Sponsor decision|165|||
154952330|NCT02343120|559250696|FG004|Part 2: Expansion|Sponsor decision|67|||
154952331|NCT02343120|559250692|FG000|Part 2: Expansion|Death|0|||
154952332|NCT02343120|559250693|FG001|Part 2: Expansion|Death|0|||
154952333|NCT02343120|559250694|FG002|Part 2: Expansion|Death|0|||
154952334|NCT02343120|559250695|FG003|Part 2: Expansion|Death|74|||
154952335|NCT02343120|559250696|FG004|Part 2: Expansion|Death|17|||
154952336|NCT02343120|559250692|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
155056771|NCT03504917|559642015|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
155056772|NCT03504917|559642014|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
155056773|NCT03504917|559642015|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
155056774|NCT03504917|559642014|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
154952337|NCT02343120|559250693|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
154952338|NCT02343120|559250694|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
154952339|NCT02343120|559250695|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
155283302|NCT04091672|560470701|FG000|Overall Study|Withdrawal by Subject|3|||
155283303|NCT04091672|560470702|FG001|Overall Study|Withdrawal by Subject|3|||
155283304|NCT04091672|560470701|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
155283305|NCT04091672|560470702|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
155283306|NCT00359619|560470703|FG000|Overall Study|Adverse Event|0|||
155283307|NCT00359619|560470704|FG001|Overall Study|Adverse Event|0|||
155283308|NCT00359619|560470705|FG002|Overall Study|Adverse Event|1|||
155283309|NCT00359619|560470706|FG003|Overall Study|Adverse Event|0|||
155283310|NCT00359619|560470707|FG004|Overall Study|Adverse Event|0|||
155283311|NCT00359619|560470708|FG005|Overall Study|Adverse Event|0|||
155283312|NCT00359619|560470709|FG006|Overall Study|Adverse Event|1|||
155283313|NCT00359619|560470703|FG000|Overall Study|Withdrawal by Subject|3|||
155283314|NCT00359619|560470704|FG001|Overall Study|Withdrawal by Subject|1|||
155283315|NCT00359619|560470705|FG002|Overall Study|Withdrawal by Subject|4|||
155283316|NCT00359619|560470706|FG003|Overall Study|Withdrawal by Subject|2|||
155283317|NCT00359619|560470707|FG004|Overall Study|Withdrawal by Subject|2|||
155283318|NCT00359619|560470708|FG005|Overall Study|Withdrawal by Subject|0|||
155283319|NCT00359619|560470709|FG006|Overall Study|Withdrawal by Subject|3|||
155283320|NCT00359619|560470703|FG000|Overall Study|Other|1|||
155283321|NCT00359619|560470704|FG001|Overall Study|Other|0|||
155283322|NCT00359619|560470705|FG002|Overall Study|Other|0|||
155283323|NCT00359619|560470706|FG003|Overall Study|Other|0|||
155283324|NCT00359619|560470707|FG004|Overall Study|Other|0|||
155283325|NCT00359619|560470708|FG005|Overall Study|Other|0|||
155056775|NCT03504917|559642015|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
155283326|NCT00359619|560470709|FG006|Overall Study|Other|0|||
155283327|NCT00359619|560470703|FG000|Overall Study|Lost to Follow-up|4|||
155283328|NCT00359619|560470704|FG001|Overall Study|Lost to Follow-up|4|||
155283329|NCT00359619|560470705|FG002|Overall Study|Lost to Follow-up|2|||
155283330|NCT00359619|560470706|FG003|Overall Study|Lost to Follow-up|1|||
155283331|NCT00359619|560470707|FG004|Overall Study|Lost to Follow-up|1|||
155283332|NCT00359619|560470708|FG005|Overall Study|Lost to Follow-up|5|||
155283333|NCT00359619|560470709|FG006|Overall Study|Lost to Follow-up|0|||
155283334|NCT01251614|560470715|FG000|Overall Study|Adverse Event|1|||
155283335|NCT01251614|560470716|FG001|Overall Study|Adverse Event|0|||
155283336|NCT01251614|560470717|FG002|Overall Study|Adverse Event|1|||
155283337|NCT01251614|560470715|FG000|Overall Study|Lack of Efficacy|1|||
155283338|NCT01251614|560470716|FG001|Overall Study|Lack of Efficacy|9|||
155283339|NCT01251614|560470717|FG002|Overall Study|Lack of Efficacy|4|||
155283340|NCT01251614|560470715|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
155283341|NCT01251614|560470716|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
155283342|NCT01251614|560470717|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
155283343|NCT01251614|560470715|FG000|Overall Study|Pregnancy|0|||
155283344|NCT01251614|560470716|FG001|Overall Study|Pregnancy|0|||
155283345|NCT01251614|560470717|FG002|Overall Study|Pregnancy|2|||
155283346|NCT01251614|560470715|FG000|Overall Study|Loss of Disease Control|0|||
155283347|NCT01251614|560470716|FG001|Overall Study|Loss of Disease Control|1|||
155283348|NCT01251614|560470717|FG002|Overall Study|Loss of Disease Control|0|||
155283349|NCT01251614|560470715|FG000|Overall Study|Withdrawal by Subject|0|||
155283350|NCT01251614|560470716|FG001|Overall Study|Withdrawal by Subject|2|||
155283351|NCT01251614|560470717|FG002|Overall Study|Withdrawal by Subject|1|||
155056776|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
155056777|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
155056778|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
155056779|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
155056780|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
155056781|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
155056782|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
155056783|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
155056784|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
155056785|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
155056786|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
155056787|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
155056788|NCT03504917|559642014|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
155056789|NCT03504917|559642015|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
155056790|NCT04219189|559642016|FG000|Overall Study|Withdrawal by Subject|1|||
155056791|NCT04219189|559642017|FG001|Overall Study|Withdrawal by Subject|2|||
155056792|NCT04219189|559642016|FG000|Overall Study|Protocol Violation|0|||
155056793|NCT04219189|559642017|FG001|Overall Study|Protocol Violation|1|||
155056794|NCT04219189|559642016|FG000|Overall Study|Lost to Follow-up|0|||
155056795|NCT04219189|559642017|FG001|Overall Study|Lost to Follow-up|1|||
155056796|NCT04219189|559642016|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
155056797|NCT04219189|559642017|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
155056798|NCT01924533|559642021|FG000|Overall Study|Death|181|||
155056799|NCT01924533|559642022|FG001|Overall Study|Death|200|||
155056800|NCT01924533|559642021|FG000|Overall Study|Lost to Follow-up|0|||
155056801|NCT01924533|559642022|FG001|Overall Study|Lost to Follow-up|1|||
155056802|NCT01924533|559642021|FG000|Overall Study|Withdrawal by Subject|7|||
155056803|NCT01924533|559642022|FG001|Overall Study|Withdrawal by Subject|3|||
155056804|NCT01924533|559642021|FG000|Overall Study|Other Eligibility criteria|1|||
155056805|NCT01924533|559642022|FG001|Overall Study|Other Eligibility criteria|1|||
155056806|NCT04233879|559642023|FG000|Overall Study|Death|2|||
155056807|NCT04233879|559642024|FG001|Overall Study|Death|0|||
155056808|NCT04233879|559642023|FG000|Overall Study|Lost to Follow-up|3|||
155056809|NCT04233879|559642024|FG001|Overall Study|Lost to Follow-up|8|||
155056810|NCT04233879|559642023|FG000|Overall Study|Physician Decision|4|||
155056811|NCT04233879|559642024|FG001|Overall Study|Physician Decision|4|||
155056812|NCT04233879|559642023|FG000|Overall Study|Withdrawal by Subject|7|||
155056813|NCT04233879|559642024|FG001|Overall Study|Withdrawal by Subject|10|||
155056814|NCT04233879|559642023|FG000|Overall Study|Other|281|||
155056815|NCT04233879|559642024|FG001|Overall Study|Other|279|||
155056816|NCT03292016|559642025|FG000|Second Washout|Adverse Event|0|||
155056817|NCT03292016|559642026|FG001|Second Washout|Adverse Event|1|||
155056818|NCT03292016|559642027|FG002|Second Washout|Adverse Event|0|||
155056819|NCT03292016|559642028|FG003|Second Washout|Adverse Event|0|||
155056820|NCT03292016|559642029|FG004|Second Washout|Adverse Event|0|||
155056821|NCT03292016|559642030|FG005|Second Washout|Adverse Event|0|||
155056822|NCT03810183|559642032|FG000|Overall Study|Study terminated by Sponsor|2|||
155056823|NCT03810183|559642033|FG001|Overall Study|Study terminated by Sponsor|1|||
155056824|NCT04275336|559642034|FG000|Overall Study|First venipuncture failed|4|||
155056825|NCT04275336|559642035|FG001|Overall Study|First venipuncture failed|6|||
155056826|NCT04275336|559642036|FG002|Overall Study|First venipuncture failed|5|||
155056827|NCT04275336|559642034|FG000|Overall Study|Unscheduled venipuncture|9|||
155056828|NCT04275336|559642035|FG001|Overall Study|Unscheduled venipuncture|13|||
155056829|NCT04275336|559642036|FG002|Overall Study|Unscheduled venipuncture|7|||
155056830|NCT04275336|559642034|FG000|Overall Study|Failed specimen of saliva|4|||
155056831|NCT04275336|559642035|FG001|Overall Study|Failed specimen of saliva|3|||
155056832|NCT04275336|559642036|FG002|Overall Study|Failed specimen of saliva|4|||
155056833|NCT01909804|559642040|FG000|Overall Study|Randomized but Never Treated|0|||
155056834|NCT01909804|559642041|FG001|Overall Study|Randomized but Never Treated|0|||
155056835|NCT01909804|559642042|FG002|Overall Study|Randomized but Never Treated|0|||
155056836|NCT01909804|559642043|FG003|Overall Study|Randomized but Never Treated|0|||
155056837|NCT01909804|559642044|FG004|Overall Study|Randomized but Never Treated|0|||
155056838|NCT01909804|559642045|FG005|Overall Study|Randomized but Never Treated|0|||
155056839|NCT01909804|559642046|FG006|Overall Study|Randomized but Never Treated|1|||
155056840|NCT01909804|559642047|FG007|Overall Study|Randomized but Never Treated|0|||
155056841|NCT01909804|559642048|FG008|Overall Study|Randomized but Never Treated|0|||
155056842|NCT01909804|559642049|FG009|Overall Study|Randomized but Never Treated|0|||
155056843|NCT01909804|559642050|FG010|Overall Study|Randomized but Never Treated|0|||
155056844|NCT01909804|559642051|FG011|Overall Study|Randomized but Never Treated|1|||
155056845|NCT01909804|559642040|FG000|Overall Study|Death|0|||
155056846|NCT01909804|559642041|FG001|Overall Study|Death|0|||
155056847|NCT01909804|559642042|FG002|Overall Study|Death|0|||
155056848|NCT01909804|559642043|FG003|Overall Study|Death|0|||
155056849|NCT01909804|559642044|FG004|Overall Study|Death|0|||
155056850|NCT01909804|559642045|FG005|Overall Study|Death|0|||
155056851|NCT01909804|559642046|FG006|Overall Study|Death|0|||
155056852|NCT01909804|559642047|FG007|Overall Study|Death|0|||
155056853|NCT01909804|559642048|FG008|Overall Study|Death|0|||
155056854|NCT01909804|559642049|FG009|Overall Study|Death|0|||
155056855|NCT01909804|559642050|FG010|Overall Study|Death|1|||
155056856|NCT01909804|559642051|FG011|Overall Study|Death|0|||
155056857|NCT01909804|559642040|FG000|Overall Study|Lack of Efficacy|4|||
155056858|NCT01909804|559642041|FG001|Overall Study|Lack of Efficacy|1|||
155056859|NCT01909804|559642042|FG002|Overall Study|Lack of Efficacy|0|||
155056860|NCT01909804|559642043|FG003|Overall Study|Lack of Efficacy|0|||
155056861|NCT01909804|559642044|FG004|Overall Study|Lack of Efficacy|7|||
155056862|NCT01909804|559642045|FG005|Overall Study|Lack of Efficacy|3|||
155056863|NCT01909804|559642046|FG006|Overall Study|Lack of Efficacy|1|||
155056864|NCT01909804|559642047|FG007|Overall Study|Lack of Efficacy|1|||
155056865|NCT01909804|559642048|FG008|Overall Study|Lack of Efficacy|0|||
155056866|NCT01909804|559642049|FG009|Overall Study|Lack of Efficacy|1|||
155056867|NCT01909804|559642050|FG010|Overall Study|Lack of Efficacy|0|||
155056868|NCT01909804|559642051|FG011|Overall Study|Lack of Efficacy|1|||
155056869|NCT01909804|559642040|FG000|Overall Study|Withdrew Consent|0|||
155056870|NCT01909804|559642041|FG001|Overall Study|Withdrew Consent|0|||
155056871|NCT01909804|559642042|FG002|Overall Study|Withdrew Consent|0|||
155056872|NCT01909804|559642043|FG003|Overall Study|Withdrew Consent|0|||
155056873|NCT01909804|559642044|FG004|Overall Study|Withdrew Consent|1|||
155056874|NCT01909804|559642045|FG005|Overall Study|Withdrew Consent|1|||
155056875|NCT01909804|559642046|FG006|Overall Study|Withdrew Consent|0|||
155056876|NCT01909804|559642047|FG007|Overall Study|Withdrew Consent|0|||
155056877|NCT01909804|559642048|FG008|Overall Study|Withdrew Consent|0|||
155056878|NCT01909804|559642049|FG009|Overall Study|Withdrew Consent|0|||
155056879|NCT01909804|559642050|FG010|Overall Study|Withdrew Consent|0|||
155056880|NCT01909804|559642051|FG011|Overall Study|Withdrew Consent|0|||
155056881|NCT01909804|559642040|FG000|Overall Study|Protocol Violation|0|||
155056882|NCT01909804|559642041|FG001|Overall Study|Protocol Violation|0|||
155056883|NCT01909804|559642042|FG002|Overall Study|Protocol Violation|0|||
155056884|NCT01909804|559642043|FG003|Overall Study|Protocol Violation|0|||
155056885|NCT01909804|559642044|FG004|Overall Study|Protocol Violation|0|||
155056886|NCT01909804|559642045|FG005|Overall Study|Protocol Violation|0|||
155056887|NCT01909804|559642046|FG006|Overall Study|Protocol Violation|0|||
155056888|NCT01909804|559642047|FG007|Overall Study|Protocol Violation|0|||
155056889|NCT01909804|559642048|FG008|Overall Study|Protocol Violation|0|||
155056890|NCT01909804|559642049|FG009|Overall Study|Protocol Violation|0|||
155056891|NCT01909804|559642050|FG010|Overall Study|Protocol Violation|0|||
155056892|NCT01909804|559642051|FG011|Overall Study|Protocol Violation|1|||
155056893|NCT05222880|559642053|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155056894|NCT05222880|559642053|FG000|Overall Study|Withdrew Consent during Study|1|||
155056895|NCT05222880|559642053|FG000|Overall Study|COVID-19 Related|1|||
155056896|NCT01077323|559642058|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
155056897|NCT01077323|559642059|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
155056898|NCT01077323|559642060|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
155056899|NCT01077323|559642058|FG000|Overall Study|Dispensing of drug in baseline period|0|||
155056900|NCT01077323|559642059|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
155056901|NCT01077323|559642060|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
155056902|NCT01077323|559642058|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
155056903|NCT01077323|559642059|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
155056904|NCT01077323|559642060|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
155056905|NCT02153918|559642063|FG000|Overall Study|Refused further treatment|1|||
155056906|NCT02144701|559642064|FG000|Overall Study|development of relapse, GVHD or death|9|||
155056907|NCT02144701|559642065|FG001|Overall Study|development of relapse, GVHD or death|3|||
155056908|NCT03327324|559642066|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056909|NCT03327324|559642067|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155056910|NCT03327324|559642068|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056911|NCT03327324|559642069|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155056912|NCT03327324|559642070|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056913|NCT03327324|559642071|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
155056914|NCT03327324|559642066|FG000|Baseline (Month 0-Month 3)|Refused|0|||
155056915|NCT03327324|559642067|FG001|Baseline (Month 0-Month 3)|Refused|0|||
155056916|NCT03327324|559642068|FG002|Baseline (Month 0-Month 3)|Refused|0|||
155056917|NCT03327324|559642069|FG003|Baseline (Month 0-Month 3)|Refused|0|||
155056918|NCT03327324|559642070|FG004|Baseline (Month 0-Month 3)|Refused|1|||
155056919|NCT03327324|559642071|FG005|Baseline (Month 0-Month 3)|Refused|0|||
155056920|NCT03327324|559642066|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155056921|NCT03327324|559642067|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
155056922|NCT03327324|559642068|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155056923|NCT03327324|559642069|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155056924|NCT03327324|559642070|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155056925|NCT03327324|559642071|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
155056926|NCT03327324|559642066|FG000|Baseline (Month 0-Month 3)|Death|0|||
155056927|NCT03327324|559642067|FG001|Baseline (Month 0-Month 3)|Death|0|||
155056928|NCT03327324|559642068|FG002|Baseline (Month 0-Month 3)|Death|0|||
155056929|NCT03327324|559642069|FG003|Baseline (Month 0-Month 3)|Death|0|||
155056930|NCT03327324|559642070|FG004|Baseline (Month 0-Month 3)|Death|1|||
155056931|NCT03327324|559642071|FG005|Baseline (Month 0-Month 3)|Death|0|||
155056932|NCT03327324|559642066|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056933|NCT03327324|559642067|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056934|NCT03327324|559642068|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056935|NCT03327324|559642069|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056936|NCT03327324|559642070|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056937|NCT03327324|559642071|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
155056938|NCT03327324|559642066|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056939|NCT03327324|559642067|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056940|NCT03327324|559642068|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155092582|NCT02234362|559773636|FG000|Overall Study|Withdrawal by Subject|3|||
155056941|NCT03327324|559642069|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056942|NCT03327324|559642070|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056943|NCT03327324|559642071|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056944|NCT03327324|559642066|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
155056945|NCT03327324|559642067|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
155056946|NCT03327324|559642068|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
155056947|NCT03327324|559642069|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
155056948|NCT03327324|559642070|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
155056949|NCT03327324|559642071|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
155056950|NCT03327324|559642066|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
155056951|NCT03327324|559642067|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155056952|NCT03327324|559642068|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155056953|NCT03327324|559642069|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155056954|NCT03327324|559642070|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155056955|NCT03327324|559642071|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
155056956|NCT03327324|559642066|FG000|Intervention (Month 3-Month 6)|Death|1|||
155056957|NCT03327324|559642067|FG001|Intervention (Month 3-Month 6)|Death|0|||
155056958|NCT03327324|559642068|FG002|Intervention (Month 3-Month 6)|Death|1|||
155056959|NCT03327324|559642069|FG003|Intervention (Month 3-Month 6)|Death|1|||
155056960|NCT03327324|559642070|FG004|Intervention (Month 3-Month 6)|Death|1|||
155056961|NCT03327324|559642071|FG005|Intervention (Month 3-Month 6)|Death|0|||
155056962|NCT03327324|559642066|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056963|NCT03327324|559642067|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056964|NCT03327324|559642068|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056965|NCT03327324|559642069|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056966|NCT03327324|559642070|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056967|NCT03327324|559642071|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
155056968|NCT03327324|559642066|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
155056969|NCT03327324|559642067|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056970|NCT03327324|559642068|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056971|NCT03327324|559642069|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056972|NCT03327324|559642070|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056973|NCT03327324|559642071|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
155056974|NCT03327324|559642066|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
155056975|NCT03327324|559642067|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
155056976|NCT03327324|559642068|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155056977|NCT03327324|559642069|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155056978|NCT03327324|559642070|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155056979|NCT03327324|559642071|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
155056980|NCT03327324|559642066|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
155056981|NCT03327324|559642067|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
155056982|NCT03327324|559642068|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
155056983|NCT03327324|559642069|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
155056984|NCT03327324|559642070|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
155056985|NCT03327324|559642071|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
155056986|NCT03327324|559642066|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056987|NCT03327324|559642067|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056988|NCT03327324|559642068|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056989|NCT03327324|559642069|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
155056990|NCT03327324|559642070|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
155056991|NCT03327324|559642071|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
155056992|NCT03327324|559642066|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
155056993|NCT03327324|559642067|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155056994|NCT03327324|559642068|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155056995|NCT03327324|559642069|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155056996|NCT03327324|559642070|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155056997|NCT03327324|559642071|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
155056998|NCT03327324|559642066|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
155056999|NCT03327324|559642067|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155057000|NCT03327324|559642068|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155393674|NCT00312221|560876834|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
155393675|NCT00312221|560876835|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
155393676|NCT00312221|560876836|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
155393677|NCT00312221|560876837|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
155393678|NCT00312221|560876834|FG000|Open-label Run-in Period|Did not qualify|5|||
155393679|NCT00312221|560876835|FG001|Open-label Run-in Period|Did not qualify|0|||
155393680|NCT00312221|560876836|FG002|Open-label Run-in Period|Did not qualify|0|||
155393681|NCT00312221|560876837|FG003|Open-label Run-in Period|Did not qualify|0|||
155393682|NCT00312221|560876834|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155393683|NCT00312221|560876835|FG001|Double-blind Phase|Withdrawal by Subject|6|||
155393684|NCT00312221|560876836|FG002|Double-blind Phase|Withdrawal by Subject|8|||
155057001|NCT03327324|559642069|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155057002|NCT03327324|559642070|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155057003|NCT03327324|559642071|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
155057004|NCT03886272|559642073|FG000|Period 1|Withdrawal by Subject|0|||
155057005|NCT03886272|559642074|FG001|Period 1|Withdrawal by Subject|0|||
155057006|NCT03886272|559642075|FG002|Period 1|Withdrawal by Subject|0|||
155057007|NCT03886272|559642076|FG003|Period 1|Withdrawal by Subject|0|||
155057008|NCT03886272|559642077|FG004|Period 1|Withdrawal by Subject|0|||
155057009|NCT03886272|559642078|FG005|Period 1|Withdrawal by Subject|1|||
155057010|NCT03886272|559642079|FG006|Period 1|Withdrawal by Subject|0|||
155057011|NCT03014206|559642080|FG000|Overall Study|Registration Violation|12|||
155057012|NCT03177148|559642081|FG000|Overall Study|Lost to Follow-up|50|||
155057013|NCT03177148|559642082|FG001|Overall Study|Lost to Follow-up|1|||
155057014|NCT03177148|559642081|FG000|Overall Study|Death|1|||
155057015|NCT03177148|559642082|FG001|Overall Study|Death|0|||
155057016|NCT02848664|559642086|FG000|Overall Study|Withdrawal by Subject|2|||
155057017|NCT02848664|559642086|FG000|Overall Study|Adverse Event|1|||
155057018|NCT02848664|559642086|FG000|Overall Study|no assistance for device training|1|||
155057019|NCT02849080|559642087|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
155057020|NCT02849080|559642088|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
155057021|NCT02849080|559642089|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
155057022|NCT02849080|559642090|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
155057023|NCT02849080|559642087|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
155057024|NCT02849080|559642088|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
155057025|NCT02849080|559642089|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
155057026|NCT02849080|559642090|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
155057027|NCT02849080|559642087|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
155057028|NCT02849080|559642088|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
155057029|NCT02849080|559642089|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
155057030|NCT02849080|559642090|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
155057031|NCT02849080|559642087|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
155057032|NCT02849080|559642088|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
155057033|NCT02849080|559642089|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
155057034|NCT02849080|559642090|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
155057035|NCT02849080|559642087|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
155057036|NCT02849080|559642088|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
155057037|NCT02849080|559642089|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
155057038|NCT02849080|559642090|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
155057039|NCT02849080|559642087|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
155057040|NCT02849080|559642088|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
155057041|NCT02849080|559642089|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
155057042|NCT02849080|559642090|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
155057043|NCT01819727|559642093|FG000|Overall Study|Adverse Event|8|||
155057044|NCT01819727|559642094|FG001|Overall Study|Adverse Event|9|||
155057045|NCT01819727|559642093|FG000|Overall Study|Death|1|||
155057046|NCT01819727|559642094|FG001|Overall Study|Death|0|||
155057047|NCT01819727|559642093|FG000|Overall Study|Lost to Follow-up|1|||
155057048|NCT01819727|559642094|FG001|Overall Study|Lost to Follow-up|1|||
155057049|NCT01819727|559642093|FG000|Overall Study|Physician Decision|3|||
155057050|NCT01819727|559642094|FG001|Overall Study|Physician Decision|2|||
155057051|NCT01819727|559642093|FG000|Overall Study|Pregnancy|1|||
155057052|NCT01819727|559642094|FG001|Overall Study|Pregnancy|0|||
155057053|NCT01819727|559642093|FG000|Overall Study|Protocol Violation|0|||
155057054|NCT01819727|559642094|FG001|Overall Study|Protocol Violation|2|||
155057055|NCT01819727|559642093|FG000|Overall Study|Study Terminated by Sponsor|0|||
155057056|NCT01819727|559642094|FG001|Overall Study|Study Terminated by Sponsor|1|||
155057057|NCT01819727|559642093|FG000|Overall Study|Withdrawal by Subject|6|||
155057058|NCT01819727|559642094|FG001|Overall Study|Withdrawal by Subject|11|||
155393685|NCT00312221|560876837|FG003|Double-blind Phase|Withdrawal by Subject|7|||
155057059|NCT01819727|559642093|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
155057060|NCT01819727|559642094|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
155057061|NCT01819727|559642093|FG000|Overall Study|Quit due to lack of health benifits|0|||
155057062|NCT01819727|559642094|FG001|Overall Study|Quit due to lack of health benifits|1|||
155057063|NCT00732069|559642097|FG000|Washout After First Study Drug|Adverse Event|1|||
155057064|NCT00732069|559642098|FG001|Washout After First Study Drug|Adverse Event|0|||
155057065|NCT00732069|559642099|FG002|Washout After First Study Drug|Adverse Event|0|||
155057066|NCT00732069|559642100|FG003|Washout After First Study Drug|Adverse Event|0|||
155057067|NCT00732069|559642101|FG004|Washout After First Study Drug|Adverse Event|0|||
155057068|NCT00732069|559642102|FG005|Washout After First Study Drug|Adverse Event|0|||
155057069|NCT00402727|559642103|FG000|Overall Study|Adverse Event|10|||
155057070|NCT00402727|559642104|FG001|Overall Study|Adverse Event|6|||
155057071|NCT00402727|559642103|FG000|Overall Study|Death|1|||
155057072|NCT00402727|559642104|FG001|Overall Study|Death|0|||
155057073|NCT00402727|559642103|FG000|Overall Study|Lack of Efficacy|1|||
155057074|NCT00402727|559642104|FG001|Overall Study|Lack of Efficacy|3|||
155057075|NCT00402727|559642103|FG000|Overall Study|Lost to Follow-up|24|||
155057076|NCT00402727|559642104|FG001|Overall Study|Lost to Follow-up|11|||
155057077|NCT00402727|559642103|FG000|Overall Study|Physician Decision|1|||
155057078|NCT00402727|559642104|FG001|Overall Study|Physician Decision|1|||
155057079|NCT00402727|559642103|FG000|Overall Study|Protocol Violation|0|||
155057080|NCT00402727|559642104|FG001|Overall Study|Protocol Violation|4|||
155057081|NCT00402727|559642103|FG000|Overall Study|Withdrawal by Subject|3|||
155057082|NCT00402727|559642104|FG001|Overall Study|Withdrawal by Subject|7|||
155057083|NCT00402727|559642103|FG000|Overall Study|supply problems|2|||
155057084|NCT00402727|559642104|FG001|Overall Study|supply problems|1|||
155057085|NCT00402727|559642103|FG000|Overall Study|non-compliance|0|||
155057086|NCT00402727|559642104|FG001|Overall Study|non-compliance|1|||
155057087|NCT00577317|559642105|FG000|Overall Study|Study Terminated|0|||
155057088|NCT00577317|559642106|FG001|Overall Study|Study Terminated|2|||
155057089|NCT02008526|559642118|FG000|Overall Study|Death|0|||
155057090|NCT02008526|559642119|FG001|Overall Study|Death|2|||
155057091|NCT02008526|559642120|FG002|Overall Study|Death|1|||
155057092|NCT02008526|559642118|FG000|Overall Study|Withdrawal by Subject|3|||
155057093|NCT02008526|559642119|FG001|Overall Study|Withdrawal by Subject|3|||
155057094|NCT02008526|559642120|FG002|Overall Study|Withdrawal by Subject|2|||
155057095|NCT02008526|559642118|FG000|Overall Study|Lost to Follow-up|5|||
155057096|NCT02008526|559642119|FG001|Overall Study|Lost to Follow-up|9|||
155057097|NCT02008526|559642120|FG002|Overall Study|Lost to Follow-up|6|||
155057098|NCT00960804|559642125|FG000|Overall Study|Adverse Event|1|||
155057099|NCT00960804|559642126|FG001|Overall Study|Adverse Event|0|||
155057100|NCT00960804|559642127|FG002|Overall Study|Adverse Event|0|||
155057101|NCT00960804|559642125|FG000|Overall Study|Withdrawal by Subject|1|||
155057102|NCT00960804|559642126|FG001|Overall Study|Withdrawal by Subject|0|||
155057103|NCT00960804|559642127|FG002|Overall Study|Withdrawal by Subject|0|||
155057104|NCT00960804|559642125|FG000|Overall Study|Study terminated by the sponsor|5|||
155057105|NCT00960804|559642126|FG001|Overall Study|Study terminated by the sponsor|4|||
155057106|NCT00960804|559642127|FG002|Overall Study|Study terminated by the sponsor|10|||
155057107|NCT02337764|559643991|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
155057108|NCT02337764|559643991|FG000|Overall Study|Voluntary Withdrawal|12|||
155057109|NCT02337764|559643991|FG000|Overall Study|Lack of Efficacy|2|||
155057110|NCT02990000|559643992|FG000|Overall Study|Failed to provide data beyond baseline|36|||
155057111|NCT02990000|559643993|FG001|Overall Study|Failed to provide data beyond baseline|34|||
155057112|NCT00161213|559644008|FG000|Overall Study|Withdrawal by Subject|1|||
155057113|NCT00161213|559644008|FG000|Overall Study|Evaluable for toxicity but not response|1|||
155057114|NCT03103503|559644009|FG000|Overall Study|Death|64|||
155057115|NCT03103503|559644009|FG000|Overall Study|Physician Decision|57|||
155057116|NCT03103503|559644009|FG000|Overall Study|Withdrawal by Subject|10|||
155057117|NCT03103503|559644009|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
155057118|NCT03103503|559644009|FG000|Overall Study|Lost to Follow-up|3|||
155057119|NCT03103503|559644009|FG000|Overall Study|Study Closure|757|||
155057120|NCT03342001|559644013|FG000|Overall Study|Adverse Event|1|||
155057121|NCT03342001|559644013|FG000|Overall Study|Lost to Follow-up|1|||
155057122|NCT02579629|559644030|FG000|Overall Study|Withdrawal by Subject|0|||
155057123|NCT02579629|559644031|FG001|Overall Study|Withdrawal by Subject|1|||
155057124|NCT02579629|559644032|FG002|Overall Study|Withdrawal by Subject|0|||
155057125|NCT02579629|559644030|FG000|Overall Study|Screen Failure|2|||
155057126|NCT02579629|559644031|FG001|Overall Study|Screen Failure|0|||
155057127|NCT02579629|559644032|FG002|Overall Study|Screen Failure|2|||
155057128|NCT01930539|559644033|FG000|Overall Study|Withdrawal by Subject|2|||
155057129|NCT01930539|559644034|FG001|Overall Study|Withdrawal by Subject|2|||
155057130|NCT01450813|559644037|FG000|Overall Study|Physician Decision|1|||
155057131|NCT01450813|559644038|FG001|Overall Study|Physician Decision|1|||
155057132|NCT01450813|559644039|FG002|Overall Study|Physician Decision|0|||
155057133|NCT01450813|559644040|FG003|Overall Study|Physician Decision|3|||
155057134|NCT01309386|559644041|FG000|Overall Study|Other|2|||
155283352|NCT01251614|560470715|FG000|Overall Study|Lost to Follow-up|0|||
155057135|NCT01309386|559644042|FG001|Overall Study|Other|0|||
155057136|NCT01309386|559644041|FG000|Overall Study|Withdrawal by Subject|2|||
155057137|NCT01309386|559644042|FG001|Overall Study|Withdrawal by Subject|0|||
155057138|NCT01309386|559644041|FG000|Overall Study|Progressive disease|9|||
155057139|NCT01309386|559644042|FG001|Overall Study|Progressive disease|11|||
155057140|NCT01309386|559644041|FG000|Overall Study|Physician Decision|1|||
155057141|NCT01309386|559644042|FG001|Overall Study|Physician Decision|1|||
155057142|NCT01309386|559644041|FG000|Overall Study|Lack of Efficacy|3|||
155057143|NCT01309386|559644042|FG001|Overall Study|Lack of Efficacy|1|||
155057144|NCT01309386|559644041|FG000|Overall Study|Adverse Event|5|||
155057145|NCT01309386|559644042|FG001|Overall Study|Adverse Event|8|||
155393686|NCT00312221|560876834|FG000|Double-blind Phase|Adverse Event|0|||
155393687|NCT00312221|560876835|FG001|Double-blind Phase|Adverse Event|10|||
155393688|NCT00312221|560876836|FG002|Double-blind Phase|Adverse Event|19|||
155393689|NCT00312221|560876837|FG003|Double-blind Phase|Adverse Event|18|||
155393690|NCT00312221|560876834|FG000|Double-blind Phase|Lost to Follow-up|0|||
155393691|NCT00312221|560876835|FG001|Double-blind Phase|Lost to Follow-up|0|||
155393692|NCT00312221|560876836|FG002|Double-blind Phase|Lost to Follow-up|2|||
155393693|NCT00312221|560876837|FG003|Double-blind Phase|Lost to Follow-up|2|||
155393694|NCT00312221|560876834|FG000|Double-blind Phase|Administrative|0|||
155393695|NCT00312221|560876835|FG001|Double-blind Phase|Administrative|26|||
155393696|NCT00312221|560876836|FG002|Double-blind Phase|Administrative|37|||
155393697|NCT00312221|560876837|FG003|Double-blind Phase|Administrative|33|||
155393698|NCT00312221|560876834|FG000|Double-blind Phase|Lack of Efficacy|0|||
155393699|NCT00312221|560876835|FG001|Double-blind Phase|Lack of Efficacy|17|||
155393700|NCT00312221|560876836|FG002|Double-blind Phase|Lack of Efficacy|6|||
155393701|NCT00312221|560876837|FG003|Double-blind Phase|Lack of Efficacy|10|||
155393702|NCT02060721|560876838|FG000|Overall Study|Lost to Follow-up|1|||
155393703|NCT02060721|560876838|FG000|Overall Study|Physician Decision|2|||
155393704|NCT02060721|560876838|FG000|Overall Study|Death|14|||
155393705|NCT02060721|560876838|FG000|Overall Study|Withdrawal by Subject|2|||
155393706|NCT02060721|560876838|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
155393707|NCT05105789|560876839|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
155393708|NCT02558231|560876843|FG000|Overall Study|Death|4|||
155393709|NCT02558231|560876844|FG001|Overall Study|Death|12|||
155393710|NCT02558231|560876843|FG000|Overall Study|Lost to Follow-up|7|||
155393711|NCT02558231|560876844|FG001|Overall Study|Lost to Follow-up|4|||
155393712|NCT02558231|560876843|FG000|Overall Study|Withdrawal by Subject|7|||
155393713|NCT02558231|560876844|FG001|Overall Study|Withdrawal by Subject|4|||
155393714|NCT02558231|560876843|FG000|Overall Study|Physician Decision|7|||
155393715|NCT02558231|560876844|FG001|Overall Study|Physician Decision|5|||
155057146|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
155057147|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155393716|NCT02558231|560876843|FG000|Overall Study|Sponsor Decision|0|||
155393717|NCT02558231|560876844|FG001|Overall Study|Sponsor Decision|1|||
155393718|NCT02066051|560876847|FG000|Overall Study|Subject developed active GVHD|1|||
155393719|NCT01294150|560876848|FG000|Overall Study|Physician Decision|2|||
155393720|NCT01294150|560876849|FG001|Overall Study|Physician Decision|2|||
155393721|NCT01093625|560876850|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
155393722|NCT01093625|560876851|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
155393723|NCT01093625|560876850|FG000|2-Week Visit|Withdrawal by Subject|1|||
155393724|NCT01093625|560876851|FG001|2-Week Visit|Withdrawal by Subject|0|||
155393725|NCT01093625|560876850|FG000|1-Month Visit|Lost to Follow-up|2|||
155393726|NCT01093625|560876851|FG001|1-Month Visit|Lost to Follow-up|0|||
155393727|NCT01093625|560876850|FG000|3-Month Visit|Lost to Follow-up|2|||
155393728|NCT01093625|560876851|FG001|3-Month Visit|Lost to Follow-up|0|||
155393729|NCT01093625|560876850|FG000|6-Month Visit|Withdrawal by Subject|6|||
155393730|NCT01093625|560876851|FG001|6-Month Visit|Withdrawal by Subject|7|||
155393731|NCT01093625|560876850|FG000|6-Month Visit|Lost to Follow-up|2|||
155393732|NCT01093625|560876851|FG001|6-Month Visit|Lost to Follow-up|2|||
155393733|NCT01093625|560876850|FG000|1-Year Visit|Lost to Follow-up|5|||
155393734|NCT01093625|560876851|FG001|1-Year Visit|Lost to Follow-up|3|||
155393735|NCT02608879|560876852|FG000|Overall Study|Lost to Follow-up|1|||
155393736|NCT02608879|560876853|FG001|Overall Study|Lost to Follow-up|0|||
155393737|NCT02608879|560876854|FG002|Overall Study|Lost to Follow-up|0|||
155393738|NCT02608879|560876852|FG000|Overall Study|Did not meet continuation criteria|0|||
155393739|NCT02608879|560876853|FG001|Overall Study|Did not meet continuation criteria|0|||
155393740|NCT02608879|560876854|FG002|Overall Study|Did not meet continuation criteria|3|||
155393741|NCT01840605|560876855|FG000|Overall Study|Adverse Event|0|||
155393742|NCT01840605|560876856|FG001|Overall Study|Adverse Event|1|||
155393743|NCT01840605|560876855|FG000|Overall Study|Physician Decision|2|||
155393744|NCT01840605|560876856|FG001|Overall Study|Physician Decision|1|||
155393745|NCT03739437|560876857|FG000|Overall Study|Lost to Follow-up|2|||
155393746|NCT03739437|560876858|FG001|Overall Study|Lost to Follow-up|5|||
155057148|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155393747|NCT03359590|560876859|FG000|First Intervention|Withdrawal by Subject|1|||
155057149|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155393748|NCT03359590|560876860|FG001|First Intervention|Withdrawal by Subject|1|||
155393749|NCT03359590|560876859|FG000|First Intervention|Protocol Violation|0|||
155393750|NCT03359590|560876860|FG001|First Intervention|Protocol Violation|1|||
155393751|NCT01557348|560876861|FG000|Overall Study|Adverse Event|6|||
155393752|NCT01557348|560876862|FG001|Overall Study|Adverse Event|16|||
155393753|NCT01557348|560876861|FG000|Overall Study|Infusion reaction event|5|||
155393754|NCT01557348|560876862|FG001|Overall Study|Infusion reaction event|5|||
155393755|NCT01557348|560876861|FG000|Overall Study|Death|7|||
155393756|NCT01557348|560876862|FG001|Overall Study|Death|4|||
155393757|NCT01557348|560876861|FG000|Overall Study|Insufficient Therapeutic Response|13|||
155393758|NCT01557348|560876862|FG001|Overall Study|Insufficient Therapeutic Response|28|||
155393759|NCT01557348|560876861|FG000|Overall Study|Withdrawal by Subject|5|||
155393760|NCT01557348|560876862|FG001|Overall Study|Withdrawal by Subject|4|||
155057150|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
155057151|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
155057152|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155393761|NCT01557348|560876861|FG000|Overall Study|Lost to Follow-up|26|||
155393762|NCT01557348|560876862|FG001|Overall Study|Lost to Follow-up|22|||
155057153|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155057154|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155057155|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
155057156|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
155057157|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155057158|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155057159|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155057160|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
155057161|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
155393763|NCT01557348|560876861|FG000|Overall Study|Administrative|18|||
155393764|NCT01557348|560876862|FG001|Overall Study|Administrative|11|||
155393765|NCT06132425|560876863|FG000|Overall Study|Withdrawal by Subject|3|||
155393766|NCT06132425|560876864|FG001|Overall Study|Withdrawal by Subject|0|||
155393767|NCT06132425|560876863|FG000|Overall Study|Did not follow study instructions|0|||
155393768|NCT06132425|560876864|FG001|Overall Study|Did not follow study instructions|2|||
155393769|NCT06132425|560876863|FG000|Overall Study|Lost to Follow-up|3|||
155393770|NCT06132425|560876864|FG001|Overall Study|Lost to Follow-up|5|||
155393771|NCT04014361|560876865|FG000|Period 2|Physician Decision|0|||
155393772|NCT04014361|560876866|FG001|Period 2|Physician Decision|0|||
155393773|NCT04014361|560876867|FG002|Period 2|Physician Decision|0|||
155393774|NCT04014361|560876868|FG003|Period 2|Physician Decision|1|||
155393775|NCT04014361|560876869|FG004|Period 2|Physician Decision|0|||
155393776|NCT04014361|560876870|FG005|Period 2|Physician Decision|0|||
155393777|NCT04014361|560876871|FG006|Period 2|Physician Decision|0|||
155393778|NCT04014361|560876872|FG007|Period 2|Physician Decision|0|||
155057162|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155057163|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155057164|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155057165|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
155057166|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
155057167|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155057168|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155057169|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155057170|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
155057171|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
155057172|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155057173|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155057174|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155057175|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
155057176|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
155057177|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155057178|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155057179|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155057180|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
155057181|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
155057182|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155057183|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155057184|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155057185|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
155092583|NCT00560417|559773637|FG000|Overall Study|Adverse Event|3|||
155393779|NCT06308666|560876873|FG000|Overall Study|Withdrawal by Subject|1|||
155393780|NCT06308666|560876873|FG000|Overall Study|Protocol Violation|2|||
155057186|NCT02709746|559644043|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
155057187|NCT02709746|559644044|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155057188|NCT02709746|559644045|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155057189|NCT02709746|559644046|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155057190|NCT02709746|559644047|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
155057191|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
155057192|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
155057193|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
155057194|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
155057195|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
155057196|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
155057197|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
155057198|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
155057199|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
155057200|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
155057201|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
155057202|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
155057203|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
155057204|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
155057205|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
155057206|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
155057207|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
155057208|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
155057209|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
155057210|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
155057211|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
155057212|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
155393781|NCT01130051|560876875|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
155057213|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
155057214|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
155057215|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
155057216|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
155057217|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
155057218|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
155057219|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
155057220|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
155057221|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155057222|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155057223|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
155057224|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155057225|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
155057226|NCT02709746|559644043|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
155057227|NCT02709746|559644044|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
155393782|NCT01130051|560876876|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
155393783|NCT01130051|560876875|FG000|Washout Period of 14 Days|Protocol Violation|1|||
155393784|NCT01130051|560876876|FG001|Washout Period of 14 Days|Protocol Violation|1|||
155393785|NCT04252287|560876878|FG000|Overall Study|Death|5|||
155393786|NCT04252287|560876879|FG001|Overall Study|Death|3|||
155393787|NCT04252287|560876878|FG000|Overall Study|Lost to Follow-up|4|||
155393788|NCT04252287|560876879|FG001|Overall Study|Lost to Follow-up|6|||
155393789|NCT04252287|560876878|FG000|Overall Study|Withdrawal by Subject|19|||
155393790|NCT04252287|560876879|FG001|Overall Study|Withdrawal by Subject|16|||
155393791|NCT04252287|560876878|FG000|Overall Study|Protocol Violation|3|||
155393792|NCT04252287|560876879|FG001|Overall Study|Protocol Violation|4|||
155393793|NCT00835120|560876881|FG000|Overall Study|Lack of Efficacy|1|||
155393794|NCT00835120|560876881|FG000|Overall Study|Lost to Follow-up|3|||
155393795|NCT00835120|560876881|FG000|Overall Study|Adverse Event|2|||
155393796|NCT00835120|560876881|FG000|Overall Study|Withdrawal by Subject|2|||
155393797|NCT02499770|560876882|FG000|Overall Study|Death|17|||
155393798|NCT02499770|560876883|FG001|Overall Study|Death|56|||
155393799|NCT02499770|560876882|FG000|Overall Study|Study completion|1|||
155393800|NCT02499770|560876883|FG001|Overall Study|Study completion|10|||
155393801|NCT02499770|560876882|FG000|Overall Study|Withdrawal by Subject|0|||
155393802|NCT02499770|560876883|FG001|Overall Study|Withdrawal by Subject|7|||
155393803|NCT02499770|560876882|FG000|Overall Study|Lost to Follow-up|0|||
155393804|NCT02499770|560876883|FG001|Overall Study|Lost to Follow-up|2|||
155393805|NCT02499770|560876882|FG000|Overall Study|Subject declined further treatment|1|||
155393806|NCT02499770|560876883|FG001|Overall Study|Subject declined further treatment|0|||
155393807|NCT02499770|560876882|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
155393808|NCT02499770|560876883|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
155393809|NCT02499770|560876882|FG000|Overall Study|Randomized but not enrolled|0|||
155393810|NCT02499770|560876883|FG001|Overall Study|Randomized but not enrolled|1|||
155393811|NCT01019980|560876886|FG000|Overall Study|Drug not available.|2|||
155393812|NCT01019980|560876887|FG001|Overall Study|Drug not available.|0|||
155393813|NCT03610165|560876888|FG000|Overall Study|Device didn't work|0|||
155393814|NCT03610165|560876889|FG001|Overall Study|Device didn't work|1|||
155393815|NCT04600336|560876896|FG000|Initial Treatment|Withdrawal by Subject|1|||
155393816|NCT04600336|560876897|FG001|Initial Treatment|Withdrawal by Subject|2|||
155393817|NCT04600336|560876898|FG002|Initial Treatment|Withdrawal by Subject|0|||
155393818|NCT04600336|560876899|FG003|Initial Treatment|Withdrawal by Subject|0|||
155393819|NCT04600336|560876896|FG000|Initial Treatment|Adverse Event|0|||
155393820|NCT04600336|560876897|FG001|Initial Treatment|Adverse Event|2|||
155393821|NCT04600336|560876898|FG002|Initial Treatment|Adverse Event|0|||
155393822|NCT04600336|560876899|FG003|Initial Treatment|Adverse Event|0|||
155393823|NCT04600336|560876896|FG000|Initial Treatment|Other complicating disease|0|||
155393824|NCT04600336|560876897|FG001|Initial Treatment|Other complicating disease|0|||
155393825|NCT04600336|560876898|FG002|Initial Treatment|Other complicating disease|1|||
155393826|NCT04600336|560876899|FG003|Initial Treatment|Other complicating disease|0|||
155393827|NCT04600336|560876896|FG000|Crossover Treatment|Withdrawal by Subject|0|||
155393828|NCT04600336|560876897|FG001|Crossover Treatment|Withdrawal by Subject|0|||
155393829|NCT04600336|560876898|FG002|Crossover Treatment|Withdrawal by Subject|2|||
155393830|NCT04600336|560876899|FG003|Crossover Treatment|Withdrawal by Subject|1|||
155393831|NCT04600336|560876896|FG000|Crossover Treatment|Adverse Event|0|||
155393832|NCT04600336|560876897|FG001|Crossover Treatment|Adverse Event|0|||
155393833|NCT04600336|560876898|FG002|Crossover Treatment|Adverse Event|1|||
155393834|NCT04600336|560876899|FG003|Crossover Treatment|Adverse Event|1|||
155393835|NCT01310803|560878179|FG000|Overall Study|Subject terminated by Sponsor|1|||
155393836|NCT01310803|560878180|FG001|Overall Study|Subject terminated by Sponsor|0|||
155393837|NCT03047551|560878183|FG000|Overall Study|Did not receive TAS|1|||
155393838|NCT03047551|560878184|FG001|Overall Study|Did not receive TAS|0|||
155393839|NCT03047551|560878183|FG000|Overall Study|Physician Decision|1|||
155393840|NCT03047551|560878184|FG001|Overall Study|Physician Decision|0|||
155393841|NCT03047551|560878183|FG000|Overall Study|Withdrawal by Subject|0|||
155393842|NCT03047551|560878184|FG001|Overall Study|Withdrawal by Subject|1|||
155393843|NCT03047551|560878183|FG000|Overall Study|Probe malfunction|0|||
155393844|NCT03047551|560878184|FG001|Overall Study|Probe malfunction|1|||
155393845|NCT03047551|560878183|FG000|Overall Study|Ineligible|0|||
155393846|NCT03047551|560878184|FG001|Overall Study|Ineligible|1|||
155393847|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
155393848|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
155393849|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
155393850|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
155393851|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
155393852|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
155393853|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
155393854|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
155393855|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
155393856|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
155393857|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
155393858|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
155393859|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
155393860|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
155393861|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
155393862|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
155393863|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
155393864|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
155393865|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Early termination|0|||
155393866|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Early termination|0|||
155393867|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Early termination|34|||
155393868|NCT01493557|560878186|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
155393869|NCT01493557|560878187|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
155393870|NCT01493557|560878188|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
155393871|NCT01493557|560878186|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
155393872|NCT01493557|560878187|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
155393873|NCT01493557|560878188|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
155393874|NCT01493557|560878186|FG000|Randomized to Management Strategies|Other adverse event|8|||
155393875|NCT01493557|560878187|FG001|Randomized to Management Strategies|Other adverse event|5|||
155393876|NCT01493557|560878188|FG002|Randomized to Management Strategies|Other adverse event|0|||
155393877|NCT01493557|560878186|FG000|Randomized to Management Strategies|Protocol Violation|3|||
155393878|NCT01493557|560878187|FG001|Randomized to Management Strategies|Protocol Violation|0|||
155393879|NCT01493557|560878188|FG002|Randomized to Management Strategies|Protocol Violation|0|||
155393880|NCT01493557|560878186|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
155393881|NCT01493557|560878187|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
155393882|NCT01493557|560878188|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
155393883|NCT01493557|560878186|FG000|Randomized to Management Strategies|Other than stated above|1|||
155393884|NCT01493557|560878187|FG001|Randomized to Management Strategies|Other than stated above|3|||
155393885|NCT01493557|560878188|FG002|Randomized to Management Strategies|Other than stated above|0|||
155393886|NCT01493557|560878186|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
155393887|NCT01493557|560878187|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
155393888|NCT01493557|560878188|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
155393889|NCT01493557|560878186|FG000|Adding the Second Strategy|Other adverse event|1|||
155393890|NCT01493557|560878187|FG001|Adding the Second Strategy|Other adverse event|2|||
155393891|NCT01493557|560878188|FG002|Adding the Second Strategy|Other adverse event|0|||
155393892|NCT01493557|560878186|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
155393893|NCT01493557|560878187|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
155393894|NCT01493557|560878188|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
155393895|NCT02012296|560878191|FG000|Overall Study|Lack of Efficacy|0|||
155393896|NCT02012296|560878192|FG001|Overall Study|Lack of Efficacy|0|||
155393897|NCT02012296|560878193|FG002|Overall Study|Lack of Efficacy|15|||
155393898|NCT02012296|560878191|FG000|Overall Study|Adverse Event|0|||
155393899|NCT02012296|560878192|FG001|Overall Study|Adverse Event|0|||
155393900|NCT02012296|560878193|FG002|Overall Study|Adverse Event|2|||
155393901|NCT02012296|560878191|FG000|Overall Study|Early study closure|0|||
155393902|NCT02012296|560878192|FG001|Overall Study|Early study closure|0|||
155393903|NCT02012296|560878193|FG002|Overall Study|Early study closure|5|||
155393904|NCT02012296|560878191|FG000|Overall Study|Protocol Violation|0|||
155393905|NCT02012296|560878192|FG001|Overall Study|Protocol Violation|1|||
155393906|NCT02012296|560878193|FG002|Overall Study|Protocol Violation|0|||
155393907|NCT00727649|560878196|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
155393908|NCT00727649|560878197|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
155393909|NCT00727649|560878196|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
155393910|NCT00727649|560878197|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
155393911|NCT00727649|560878196|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
155393912|NCT00727649|560878197|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
155393913|NCT00727649|560878196|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
155393914|NCT00727649|560878197|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
155393915|NCT00727649|560878196|FG000|Second Intervention (4-weeks)|Death|1|||
155393916|NCT00727649|560878197|FG001|Second Intervention (4-weeks)|Death|0|||
155393917|NCT00727649|560878196|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
155393918|NCT00727649|560878197|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
155393919|NCT00727649|560878196|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
155393920|NCT00727649|560878197|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
155393921|NCT00434421|560878201|FG000|Overall Study|Withdrawal by Subject|1|||
155393922|NCT00434421|560878201|FG000|Overall Study|Non-compliance with study treatment|1|||
155393923|NCT01087957|560878202|FG000|Overall Study|Death|2|||
155393924|NCT01087957|560878203|FG001|Overall Study|Death|2|||
155393925|NCT01087957|560878202|FG000|Overall Study|Lost to Follow-up|3|||
155393926|NCT01087957|560878203|FG001|Overall Study|Lost to Follow-up|4|||
155393927|NCT01087957|560878202|FG000|Overall Study|Protocol Violation|13|||
155393928|NCT01087957|560878203|FG001|Overall Study|Protocol Violation|25|||
155393929|NCT01087957|560878202|FG000|Overall Study|Withdrawal by Subject|18|||
155393930|NCT01087957|560878203|FG001|Overall Study|Withdrawal by Subject|15|||
155393931|NCT01087957|560878202|FG000|Overall Study|Physician Decision|5|||
155393932|NCT01087957|560878203|FG001|Overall Study|Physician Decision|9|||
155393933|NCT03842163|560878204|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
155393934|NCT03842163|560878204|FG000|Overall Study|Scintigraphy was not performed|44|||
155393935|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
155393936|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
155393937|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
155393938|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
155393939|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
155393940|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
155393941|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
155393942|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
155393943|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
155393944|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
155393945|NCT03829241|560878208|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
155283353|NCT01251614|560470716|FG001|Overall Study|Lost to Follow-up|1|||
155283354|NCT01251614|560470717|FG002|Overall Study|Lost to Follow-up|0|||
155283355|NCT01876043|560470719|FG000|Overall Study|Death|1|||
155283356|NCT01876043|560470719|FG000|Overall Study|Withdrawal by Subject|1|||
155283357|NCT00049517|560470720|FG000|Induction|Disease progression|0|||
155283358|NCT00049517|560470721|FG001|Induction|Disease progression|0|||
155283359|NCT00049517|560470722|FG002|Induction|Disease progression|0|||
155283360|NCT00049517|560470723|FG003|Induction|Disease progression|0|||
155283361|NCT00049517|560470724|FG004|Induction|Disease progression|18|||
155283362|NCT00049517|560470725|FG005|Induction|Disease progression|11|||
155283363|NCT00049517|560470720|FG000|Induction|Adverse Event|0|||
155283364|NCT00049517|560470721|FG001|Induction|Adverse Event|0|||
155283365|NCT00049517|560470722|FG002|Induction|Adverse Event|0|||
155283366|NCT00049517|560470723|FG003|Induction|Adverse Event|0|||
155283367|NCT00049517|560470724|FG004|Induction|Adverse Event|5|||
155283368|NCT00049517|560470725|FG005|Induction|Adverse Event|7|||
155283369|NCT00049517|560470720|FG000|Induction|Death|0|||
155283370|NCT00049517|560470721|FG001|Induction|Death|0|||
155283371|NCT00049517|560470722|FG002|Induction|Death|0|||
155283372|NCT00049517|560470723|FG003|Induction|Death|0|||
155283373|NCT00049517|560470724|FG004|Induction|Death|9|||
155283374|NCT00049517|560470725|FG005|Induction|Death|6|||
155283375|NCT00049517|560470720|FG000|Induction|Withdrawal by Subject|0|||
155283376|NCT00049517|560470721|FG001|Induction|Withdrawal by Subject|0|||
155283377|NCT00049517|560470722|FG002|Induction|Withdrawal by Subject|0|||
155283378|NCT00049517|560470723|FG003|Induction|Withdrawal by Subject|0|||
155283379|NCT00049517|560470724|FG004|Induction|Withdrawal by Subject|1|||
155283380|NCT00049517|560470725|FG005|Induction|Withdrawal by Subject|3|||
155283381|NCT00049517|560470720|FG000|Induction|Alternative therapy|0|||
155283382|NCT00049517|560470721|FG001|Induction|Alternative therapy|0|||
155283383|NCT00049517|560470722|FG002|Induction|Alternative therapy|0|||
155283384|NCT00049517|560470723|FG003|Induction|Alternative therapy|0|||
155283385|NCT00049517|560470724|FG004|Induction|Alternative therapy|2|||
155283386|NCT00049517|560470725|FG005|Induction|Alternative therapy|2|||
155283387|NCT00049517|560470720|FG000|Induction|Other complicating disease|0|||
155283388|NCT00049517|560470721|FG001|Induction|Other complicating disease|0|||
155283389|NCT00049517|560470722|FG002|Induction|Other complicating disease|0|||
155283390|NCT00049517|560470723|FG003|Induction|Other complicating disease|0|||
155283391|NCT00049517|560470724|FG004|Induction|Other complicating disease|3|||
155283392|NCT00049517|560470725|FG005|Induction|Other complicating disease|0|||
155283393|NCT00049517|560470720|FG000|Induction|Reasons not reported|0|||
155283394|NCT00049517|560470721|FG001|Induction|Reasons not reported|0|||
155283395|NCT00049517|560470722|FG002|Induction|Reasons not reported|0|||
155283396|NCT00049517|560470723|FG003|Induction|Reasons not reported|0|||
155283397|NCT00049517|560470724|FG004|Induction|Reasons not reported|22|||
155283398|NCT00049517|560470725|FG005|Induction|Reasons not reported|25|||
155283399|NCT00049517|560470720|FG000|Conditioning/Transplant|Disease progression|14|||
155283400|NCT00049517|560470721|FG001|Conditioning/Transplant|Disease progression|6|||
155283401|NCT00049517|560470722|FG002|Conditioning/Transplant|Disease progression|10|||
155283402|NCT00049517|560470723|FG003|Conditioning/Transplant|Disease progression|6|||
155283403|NCT00049517|560470724|FG004|Conditioning/Transplant|Disease progression|0|||
155283404|NCT00049517|560470725|FG005|Conditioning/Transplant|Disease progression|0|||
155283405|NCT00049517|560470720|FG000|Conditioning/Transplant|Adverse Event|2|||
155283406|NCT00049517|560470721|FG001|Conditioning/Transplant|Adverse Event|1|||
155283407|NCT00049517|560470722|FG002|Conditioning/Transplant|Adverse Event|4|||
155283408|NCT00049517|560470723|FG003|Conditioning/Transplant|Adverse Event|8|||
155283409|NCT00049517|560470724|FG004|Conditioning/Transplant|Adverse Event|0|||
155283410|NCT00049517|560470725|FG005|Conditioning/Transplant|Adverse Event|0|||
155283411|NCT00049517|560470720|FG000|Conditioning/Transplant|Death|1|||
155283412|NCT00049517|560470721|FG001|Conditioning/Transplant|Death|0|||
155283413|NCT00049517|560470722|FG002|Conditioning/Transplant|Death|0|||
155283414|NCT00049517|560470723|FG003|Conditioning/Transplant|Death|2|||
155283415|NCT00049517|560470724|FG004|Conditioning/Transplant|Death|0|||
155283416|NCT00049517|560470725|FG005|Conditioning/Transplant|Death|0|||
155283417|NCT00049517|560470720|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
155283418|NCT00049517|560470721|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
155283419|NCT00049517|560470722|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
155283420|NCT00049517|560470723|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
155283421|NCT00049517|560470724|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
155283422|NCT00049517|560470725|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
155283423|NCT00049517|560470720|FG000|Conditioning/Transplant|Alternative therapy|4|||
155283424|NCT00049517|560470721|FG001|Conditioning/Transplant|Alternative therapy|4|||
155283425|NCT00049517|560470722|FG002|Conditioning/Transplant|Alternative therapy|2|||
155283426|NCT00049517|560470723|FG003|Conditioning/Transplant|Alternative therapy|1|||
155283427|NCT00049517|560470724|FG004|Conditioning/Transplant|Alternative therapy|1|||
155283428|NCT00049517|560470725|FG005|Conditioning/Transplant|Alternative therapy|0|||
155057228|NCT02709746|559644045|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
155057229|NCT02709746|559644046|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
155057230|NCT02709746|559644047|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
155057231|NCT00752089|559644048|FG000|Overall Study|Adverse Event|1|||
155057232|NCT00752089|559644048|FG000|Overall Study|Protocol Deviation|2|||
155057233|NCT00752089|559644048|FG000|Overall Study|Could not attend visit 9|1|||
155057234|NCT00752089|559644048|FG000|Overall Study|Not capable of wearing partial denture|1|||
155057235|NCT00752089|559644048|FG000|Overall Study|Cannot continue the study|1|||
155057236|NCT02900352|559644049|FG000|Overall Study|Lost to Follow-up|28|||
155057237|NCT02900352|559644050|FG001|Overall Study|Lost to Follow-up|17|||
155057238|NCT01245101|559644053|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
155057239|NCT01245101|559644054|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
155057240|NCT01245101|559644053|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
155057241|NCT01245101|559644054|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
155057242|NCT01245101|559644053|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
155057243|NCT01245101|559644054|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
155057244|NCT01225549|559644055|FG000|Period 4 - Washout|Disallowed medication|0|||
155057245|NCT01225549|559644056|FG001|Period 4 - Washout|Disallowed medication|1|||
155057246|NCT01225549|559644057|FG002|Period 4 - Washout|Disallowed medication|0|||
155057247|NCT01225549|559644058|FG003|Period 4 - Washout|Disallowed medication|0|||
155057248|NCT01225549|559644059|FG004|Period 4 - Washout|Disallowed medication|0|||
155057249|NCT01225549|559644060|FG005|Period 4 - Washout|Disallowed medication|0|||
155057250|NCT01225549|559644061|FG006|Period 4 - Washout|Disallowed medication|0|||
155057251|NCT01225549|559644062|FG007|Period 4 - Washout|Disallowed medication|0|||
155057252|NCT01225549|559644063|FG008|Period 4 - Washout|Disallowed medication|0|||
155057253|NCT01225549|559644064|FG009|Period 4 - Washout|Disallowed medication|0|||
155057254|NCT01225549|559644055|FG000|Period 6 - Washout|Disallowed medication|0|||
155057255|NCT01225549|559644056|FG001|Period 6 - Washout|Disallowed medication|0|||
155057256|NCT01225549|559644057|FG002|Period 6 - Washout|Disallowed medication|0|||
155057257|NCT01225549|559644058|FG003|Period 6 - Washout|Disallowed medication|1|||
155057258|NCT01225549|559644059|FG004|Period 6 - Washout|Disallowed medication|0|||
155057259|NCT01225549|559644060|FG005|Period 6 - Washout|Disallowed medication|0|||
155057260|NCT01225549|559644061|FG006|Period 6 - Washout|Disallowed medication|0|||
155057261|NCT01225549|559644062|FG007|Period 6 - Washout|Disallowed medication|0|||
155057262|NCT01225549|559644063|FG008|Period 6 - Washout|Disallowed medication|0|||
155057263|NCT01225549|559644064|FG009|Period 6 - Washout|Disallowed medication|0|||
155057264|NCT00473083|559644067|FG000|Overall Study|Adverse Event|1|||
155057265|NCT00473083|559644068|FG001|Overall Study|Adverse Event|0|||
155057266|NCT00473083|559644069|FG002|Overall Study|Adverse Event|0|||
155057267|NCT01184872|559644070|FG000|Overall Study|Adverse Event|3|||
155057268|NCT01184872|559644071|FG001|Overall Study|Adverse Event|4|||
155057269|NCT01184872|559644070|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155057270|NCT01184872|559644071|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155057271|NCT01184872|559644070|FG000|Overall Study|Withdrawal by Subject|2|||
155057272|NCT01184872|559644071|FG001|Overall Study|Withdrawal by Subject|0|||
155057273|NCT01184872|559644070|FG000|Overall Study|Lost to Follow-up|0|||
155057274|NCT01184872|559644071|FG001|Overall Study|Lost to Follow-up|1|||
155057275|NCT01184872|559644070|FG000|Overall Study|Administrative problems|1|||
155057276|NCT01184872|559644071|FG001|Overall Study|Administrative problems|1|||
155057277|NCT01184872|559644070|FG000|Overall Study|Protocol deviation|1|||
155057278|NCT01184872|559644071|FG001|Overall Study|Protocol deviation|0|||
155057279|NCT04210986|559644076|FG000|Overall Study|Lost to Follow-up|5|||
155057280|NCT04210986|559644077|FG001|Overall Study|Lost to Follow-up|2|||
154952340|NCT02343120|559250696|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
154952341|NCT02343120|559250692|FG000|Part 2: Expansion|Lost to Follow-up|0|||
154952342|NCT02343120|559250693|FG001|Part 2: Expansion|Lost to Follow-up|0|||
154952343|NCT02343120|559250694|FG002|Part 2: Expansion|Lost to Follow-up|0|||
154952344|NCT02343120|559250695|FG003|Part 2: Expansion|Lost to Follow-up|5|||
154952345|NCT02343120|559250696|FG004|Part 2: Expansion|Lost to Follow-up|2|||
154952346|NCT02343120|559250692|FG000|Part 2: Expansion|Other|0|||
154952347|NCT02343120|559250693|FG001|Part 2: Expansion|Other|0|||
154952348|NCT02343120|559250694|FG002|Part 2: Expansion|Other|0|||
154952349|NCT02343120|559250695|FG003|Part 2: Expansion|Other|1|||
155057281|NCT04210986|559644076|FG000|Overall Study|Withdrawal by Subject|3|||
155057282|NCT04210986|559644077|FG001|Overall Study|Withdrawal by Subject|1|||
155057283|NCT04210986|559644076|FG000|Overall Study|Protocol Violation|1|||
155057284|NCT04210986|559644077|FG001|Overall Study|Protocol Violation|1|||
155057285|NCT04210986|559644076|FG000|Overall Study|Physician Decision|0|||
155057286|NCT04210986|559644077|FG001|Overall Study|Physician Decision|1|||
155057287|NCT02378662|559644078|FG000|Overall Study|Early Discontinuation|2|||
155057288|NCT02378662|559644079|FG001|Overall Study|Early Discontinuation|0|||
155057289|NCT02295644|559644080|FG000|Overall Study|Did not meet inclusion criterion|0|||
155057290|NCT02295644|559644081|FG001|Overall Study|Did not meet inclusion criterion|0|||
155283429|NCT00049517|560470720|FG000|Conditioning/Transplant|Other complicating disease|2|||
154952350|NCT02343120|559250696|FG004|Part 2: Expansion|Other|5|||
154952351|NCT02343120|559250692|FG000|Part 2: Expansion|Adverse Event|0|||
155057291|NCT02295644|559644082|FG002|Overall Study|Did not meet inclusion criterion|1|||
155057292|NCT02295644|559644083|FG003|Overall Study|Did not meet inclusion criterion|2|||
155057293|NCT03101020|559644084|FG000|Overall Study|Lack of time to participate|1|||
155057294|NCT03101020|559644085|FG001|Overall Study|Lack of time to participate|0|||
155393946|NCT03829241|560878209|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
155393947|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
155393948|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
155393949|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
155393950|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
155393951|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
155393952|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
155393953|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
155393954|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
155393955|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
155057295|NCT03101020|559644084|FG000|Overall Study|Ran over by a car|0|||
155057296|NCT03101020|559644085|FG001|Overall Study|Ran over by a car|1|||
155057297|NCT03101020|559644084|FG000|Overall Study|Withdrawal by Subject|0|||
155057298|NCT03101020|559644085|FG001|Overall Study|Withdrawal by Subject|2|||
155057299|NCT02616783|559644086|FG000|Overall Study|Randomized but Not Treated|1|||
155057300|NCT02616783|559644087|FG001|Overall Study|Randomized but Not Treated|0|||
155057301|NCT02616783|559644086|FG000|Overall Study|Adverse Event|1|||
155057302|NCT02616783|559644087|FG001|Overall Study|Adverse Event|0|||
155057303|NCT02616783|559644086|FG000|Overall Study|Death|1|||
155057304|NCT02616783|559644087|FG001|Overall Study|Death|0|||
155057305|NCT02616783|559644086|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155057306|NCT02616783|559644087|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155057307|NCT02616783|559644086|FG000|Overall Study|Protocol Violation|1|||
155057308|NCT02616783|559644087|FG001|Overall Study|Protocol Violation|1|||
155057309|NCT02616783|559644086|FG000|Overall Study|Withdrew Consent|1|||
155057310|NCT02616783|559644087|FG001|Overall Study|Withdrew Consent|1|||
155057311|NCT01103323|559644088|FG000|Without/Before Drug Switch|Adverse Event|50|||
155057312|NCT01103323|559644089|FG001|Without/Before Drug Switch|Adverse Event|7|||
155057313|NCT01103323|559644088|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
155057314|NCT01103323|559644089|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
155057315|NCT01103323|559644088|FG000|Without/Before Drug Switch|Protocol Violation|2|||
155057316|NCT01103323|559644089|FG001|Without/Before Drug Switch|Protocol Violation|0|||
155057317|NCT01103323|559644088|FG000|Without/Before Drug Switch|Physician Decision|2|||
155057318|NCT01103323|559644089|FG001|Without/Before Drug Switch|Physician Decision|0|||
155057319|NCT01103323|559644088|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
155057320|NCT01103323|559644089|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
155057321|NCT01103323|559644088|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
155057322|NCT01103323|559644089|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
155057323|NCT01103323|559644088|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
155057324|NCT01103323|559644089|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
155057325|NCT00372424|559644090|FG000|Overall Study|Adverse Event|2|||
155057326|NCT00372424|559644090|FG000|Overall Study|Withdrawal by Subject|1|||
155057327|NCT00372424|559644090|FG000|Overall Study|Death|1|||
155057328|NCT00372424|559644090|FG000|Overall Study|Objective Progression or Relapse|14|||
155057329|NCT00372424|559644090|FG000|Overall Study|Other|7|||
155057330|NCT00372424|559644090|FG000|Overall Study|Enrolled, Not Treated|1|||
155057331|NCT05214118|559644099|FG000|Overall Study|Lost to Follow-up|0|||
155057332|NCT05214118|559644100|FG001|Overall Study|Lost to Follow-up|2|||
155057333|NCT05214118|559644099|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
155057334|NCT05214118|559644100|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
155057335|NCT05214118|559644099|FG000|Overall Study|moved|1|||
155057336|NCT05214118|559644100|FG001|Overall Study|moved|0|||
155057337|NCT03797898|559644103|FG000|Overall Study|Lost to Follow-up|60|||
155057338|NCT03797898|559644104|FG001|Overall Study|Lost to Follow-up|69|||
155393956|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
155393957|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
155393958|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
155057339|NCT03797898|559644103|FG000|Overall Study|Withdrawal by Subject|9|||
155057340|NCT03797898|559644104|FG001|Overall Study|Withdrawal by Subject|7|||
155057341|NCT03797898|559644103|FG000|Overall Study|Became ineligible|5|||
155057342|NCT03797898|559644104|FG001|Overall Study|Became ineligible|2|||
155057343|NCT02314728|559644105|FG000|Overall Study|Protocol Violation|1|||
155393959|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
155057344|NCT02314728|559644106|FG001|Overall Study|Protocol Violation|0|||
155057345|NCT02314728|559644105|FG000|Overall Study|Lost to Follow-up|0|||
155057346|NCT02314728|559644106|FG001|Overall Study|Lost to Follow-up|1|||
155057347|NCT03118934|559644107|FG000|Overall Study|Adverse Event|0|||
155057348|NCT03118934|559644108|FG001|Overall Study|Adverse Event|0|||
155057349|NCT03118934|559644109|FG002|Overall Study|Adverse Event|0|||
155393960|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
154952352|NCT02343120|559250693|FG001|Part 2: Expansion|Adverse Event|0|||
154952353|NCT02343120|559250694|FG002|Part 2: Expansion|Adverse Event|0|||
154952354|NCT02343120|559250695|FG003|Part 2: Expansion|Adverse Event|1|||
154952355|NCT02343120|559250696|FG004|Part 2: Expansion|Adverse Event|1|||
154952356|NCT06096168|559250702|FG000|Overall Study|Death|30|||
154952357|NCT06096168|559250702|FG000|Overall Study|Revision|2|||
154952358|NCT01868009|559250703|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
154952359|NCT01868009|559250704|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
154952360|NCT01868009|559250703|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
154952361|NCT01868009|559250704|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
154952362|NCT01868009|559250703|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
154952363|NCT01868009|559250704|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
154952364|NCT01046253|559250707|FG000|Second Intervention|Adverse Event|0|||
154952365|NCT01046253|559250708|FG001|Second Intervention|Adverse Event|1|||
154952366|NCT01046253|559250707|FG000|Second Intervention|Protocol Violation|0|||
154952367|NCT01046253|559250708|FG001|Second Intervention|Protocol Violation|1|||
154952368|NCT02534493|559250709|FG000|Overall Study|Lost to Follow-up|1|||
154952369|NCT02534493|559250709|FG000|Overall Study|Withdrawal by Subject|1|||
154952370|NCT02339909|559250712|FG000|Overall Study|Became ineligible after randomisation|89|||
154952371|NCT02339909|559250713|FG001|Overall Study|Became ineligible after randomisation|63|||
154952372|NCT02339909|559250714|FG002|Overall Study|Became ineligible after randomisation|71|||
154952373|NCT01766778|559250722|FG000|Overall Study|Adverse Event|4|||
154952374|NCT01766778|559250723|FG001|Overall Study|Adverse Event|4|||
154952375|NCT01766778|559250722|FG000|Overall Study|Withdrawal by Subject|1|||
154952376|NCT01766778|559250723|FG001|Overall Study|Withdrawal by Subject|0|||
154952377|NCT01054599|559250724|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
154952378|NCT01054599|559250725|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
154952379|NCT01054599|559250724|FG000|Overall Study|Protocol Violation|1|||
154952380|NCT01054599|559250725|FG001|Overall Study|Protocol Violation|0|||
154952381|NCT01054599|559250724|FG000|Overall Study|Spells/seizure-like episodes|1|||
154952382|NCT01054599|559250725|FG001|Overall Study|Spells/seizure-like episodes|1|||
154952383|NCT01054599|559250724|FG000|Overall Study|Timing/scheduling difficulties|1|||
154952384|NCT01054599|559250725|FG001|Overall Study|Timing/scheduling difficulties|1|||
154952385|NCT01054599|559250724|FG000|Overall Study|Visual impairment, WTAR <80|0|||
154952386|NCT01054599|559250725|FG001|Overall Study|Visual impairment, WTAR <80|1|||
154952387|NCT01054599|559250724|FG000|Overall Study|Lost to Follow-up|0|||
154952388|NCT01054599|559250725|FG001|Overall Study|Lost to Follow-up|2|||
154952389|NCT01054599|559250724|FG000|Overall Study|Adverse Event|0|||
154952390|NCT01054599|559250725|FG001|Overall Study|Adverse Event|1|||
154952391|NCT01054599|559250724|FG000|Overall Study|Withdrawal by Subject|0|||
154952392|NCT01054599|559250725|FG001|Overall Study|Withdrawal by Subject|1|||
154952393|NCT01104662|559250726|FG000|Overall Study|Adverse Event|2|||
154952394|NCT01104662|559250727|FG001|Overall Study|Adverse Event|2|||
154952395|NCT01104662|559250728|FG002|Overall Study|Adverse Event|0|||
154952396|NCT01104662|559250729|FG003|Overall Study|Adverse Event|1|||
154952397|NCT01104662|559250730|FG004|Overall Study|Adverse Event|1|||
154952398|NCT01104662|559250731|FG005|Overall Study|Adverse Event|1|||
154952399|NCT01104662|559250732|FG006|Overall Study|Adverse Event|0|||
154952400|NCT01104662|559250733|FG007|Overall Study|Adverse Event|0|||
154952401|NCT01104662|559250726|FG000|Overall Study|Clinical Failure|1|||
154952402|NCT01104662|559250727|FG001|Overall Study|Clinical Failure|0|||
155393961|NCT03829241|560878208|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
155393962|NCT03829241|560878209|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
155393963|NCT00698451|560878210|FG000|Overall Study|Adverse Event|22|||
155393964|NCT00698451|560878210|FG000|Overall Study|Physician Decision|2|||
155393965|NCT00698451|560878210|FG000|Overall Study|Protocol Violation|6|||
155393966|NCT00698451|560878210|FG000|Overall Study|Withdrawal by Subject|6|||
155393967|NCT00698451|560878210|FG000|Overall Study|Disease progression|3|||
155393968|NCT02224599|560878213|FG000|Overall Study|Physician Decision|1|||
155393969|NCT02224599|560878213|FG000|Overall Study|Progression of Disease|1|||
155393970|NCT00129623|560878215|FG000|Overall Study|Adverse Event|3|||
155393971|NCT00129623|560878216|FG001|Overall Study|Adverse Event|7|||
155393972|NCT00129623|560878215|FG000|Overall Study|Refused Treatment|5|||
155393973|NCT00129623|560878216|FG001|Overall Study|Refused Treatment|3|||
155393974|NCT00129623|560878215|FG000|Overall Study|Failure to Return|1|||
155393975|NCT00129623|560878216|FG001|Overall Study|Failure to Return|1|||
155393976|NCT00129623|560878215|FG000|Overall Study|Relocated job out of state|1|||
155393977|NCT00129623|560878216|FG001|Overall Study|Relocated job out of state|0|||
154952403|NCT01104662|559250728|FG002|Overall Study|Clinical Failure|0|||
154952404|NCT01104662|559250729|FG003|Overall Study|Clinical Failure|0|||
154952405|NCT01104662|559250730|FG004|Overall Study|Clinical Failure|0|||
154952406|NCT01104662|559250731|FG005|Overall Study|Clinical Failure|1|||
154952407|NCT01104662|559250732|FG006|Overall Study|Clinical Failure|0|||
154952408|NCT01104662|559250733|FG007|Overall Study|Clinical Failure|0|||
154952409|NCT01104662|559250726|FG000|Overall Study|Participant left investigator's care|1|||
154952410|NCT01104662|559250727|FG001|Overall Study|Participant left investigator's care|1|||
154952411|NCT01104662|559250728|FG002|Overall Study|Participant left investigator's care|0|||
154952412|NCT01104662|559250729|FG003|Overall Study|Participant left investigator's care|0|||
155283430|NCT00049517|560470721|FG001|Conditioning/Transplant|Other complicating disease|0|||
155283431|NCT00049517|560470722|FG002|Conditioning/Transplant|Other complicating disease|0|||
155283432|NCT00049517|560470723|FG003|Conditioning/Transplant|Other complicating disease|4|||
154952413|NCT01104662|559250730|FG004|Overall Study|Participant left investigator's care|0|||
154952414|NCT01104662|559250731|FG005|Overall Study|Participant left investigator's care|0|||
154952415|NCT01104662|559250732|FG006|Overall Study|Participant left investigator's care|0|||
154952416|NCT01104662|559250733|FG007|Overall Study|Participant left investigator's care|0|||
154952417|NCT01104662|559250726|FG000|Overall Study|Reason not specified|3|||
154952418|NCT01104662|559250727|FG001|Overall Study|Reason not specified|3|||
155057350|NCT03118934|559644110|FG003|Overall Study|Adverse Event|0|||
155283433|NCT00049517|560470724|FG004|Conditioning/Transplant|Other complicating disease|0|||
155283434|NCT00049517|560470725|FG005|Conditioning/Transplant|Other complicating disease|1|||
155283435|NCT00049517|560470720|FG000|Conditioning/Transplant|Reasons not reported|25|||
155283436|NCT00049517|560470721|FG001|Conditioning/Transplant|Reasons not reported|31|||
155283437|NCT00049517|560470722|FG002|Conditioning/Transplant|Reasons not reported|18|||
155283438|NCT00049517|560470723|FG003|Conditioning/Transplant|Reasons not reported|15|||
155283439|NCT00049517|560470724|FG004|Conditioning/Transplant|Reasons not reported|5|||
155283440|NCT00049517|560470725|FG005|Conditioning/Transplant|Reasons not reported|5|||
155283441|NCT00079937|560470726|FG000|Overall Study|Adverse Event|2|||
155283442|NCT00079937|560470727|FG001|Overall Study|Adverse Event|1|||
155283443|NCT00079937|560470726|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155283444|NCT00079937|560470727|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155283445|NCT00079937|560470726|FG000|Overall Study|Subject no longer requires study drug|3|||
155283446|NCT00079937|560470727|FG001|Overall Study|Subject no longer requires study drug|0|||
155283447|NCT00079937|560470726|FG000|Overall Study|Protocol Violation|8|||
155283448|NCT00079937|560470727|FG001|Overall Study|Protocol Violation|6|||
155283449|NCT00079937|560470726|FG000|Overall Study|Withdrawal by Subject|21|||
155283450|NCT00079937|560470727|FG001|Overall Study|Withdrawal by Subject|7|||
155283451|NCT00079937|560470726|FG000|Overall Study|Lost to Follow-up|12|||
155283452|NCT00079937|560470727|FG001|Overall Study|Lost to Follow-up|5|||
155283453|NCT00079937|560470726|FG000|Overall Study|Administrative problems|22|||
155283454|NCT00079937|560470727|FG001|Overall Study|Administrative problems|11|||
155283455|NCT02857283|560470728|FG000|First Exposure|Withdrawal by Subject|1|||
155283456|NCT02857283|560470729|FG001|First Exposure|Withdrawal by Subject|0|||
155283457|NCT00093795|560470730|FG000|Overall Study|No follow up data|20|||
155283458|NCT00093795|560470731|FG001|Overall Study|No follow up data|16|||
155283459|NCT00093795|560470732|FG002|Overall Study|No follow up data|17|||
155283460|NCT00940017|560470733|FG000|Overall Study|did not meet entrance criteria|3|||
155283461|NCT00940017|560470733|FG000|Overall Study|Adverse Event|1|||
155283462|NCT00613301|560470734|FG000|Overall Study|Adverse Event|49|||
155283463|NCT00613301|560470734|FG000|Overall Study|Lost to Follow-up|88|||
155283464|NCT00613301|560470734|FG000|Overall Study|Withdrawal by Subject|5|||
155283465|NCT00613301|560470734|FG000|Overall Study|Death|6|||
155283466|NCT00613301|560470734|FG000|Overall Study|Lack of Efficacy|13|||
155283467|NCT00613301|560470734|FG000|Overall Study|Physician Decision|2|||
155283468|NCT00613301|560470734|FG000|Overall Study|No data was collected|53|||
155283469|NCT00613301|560470734|FG000|Overall Study|Irregularly enrolled patients|12|||
155283470|NCT00569946|560470735|FG000|Overall Study|Adverse Event|16|||
155283471|NCT00569946|560470735|FG000|Overall Study|Objective Progression or Relapse|42|||
155283472|NCT00569946|560470735|FG000|Overall Study|Global Deterioration of Health Status|1|||
155283473|NCT01684046|560470738|FG000|Period 1, First 30 Days|Adverse Event|0|||
155283474|NCT01684046|560470739|FG001|Period 1, First 30 Days|Adverse Event|2|||
155283475|NCT01306331|560470740|FG000|Overall Study|Adverse Event|28|||
155283476|NCT01306331|560470741|FG001|Overall Study|Adverse Event|25|||
155283477|NCT01306331|560470740|FG000|Overall Study|Lost to Follow-up|321|||
155283478|NCT01306331|560470741|FG001|Overall Study|Lost to Follow-up|323|||
155283479|NCT01306331|560470740|FG000|Overall Study|Physician Decision|26|||
155283480|NCT01306331|560470741|FG001|Overall Study|Physician Decision|22|||
155283481|NCT01306331|560470740|FG000|Overall Study|Pregnancy|136|||
155283482|NCT01306331|560470741|FG001|Overall Study|Pregnancy|151|||
155283483|NCT01306331|560470740|FG000|Overall Study|Protocol Violation|154|||
155283484|NCT01306331|560470741|FG001|Overall Study|Protocol Violation|124|||
155283485|NCT01306331|560470740|FG000|Overall Study|Withdrawal by Subject|163|||
155283486|NCT01306331|560470741|FG001|Overall Study|Withdrawal by Subject|152|||
155283487|NCT01306331|560470740|FG000|Overall Study|Not sexually active|29|||
155283488|NCT01306331|560470741|FG001|Overall Study|Not sexually active|28|||
155283489|NCT01306331|560470740|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
155283490|NCT01306331|560470741|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
155283491|NCT01306331|560470740|FG000|Overall Study|Other|34|||
155283492|NCT01306331|560470741|FG001|Overall Study|Other|32|||
155057351|NCT03118934|559644111|FG004|Overall Study|Adverse Event|0|||
155057352|NCT03118934|559644112|FG005|Overall Study|Adverse Event|1|||
155057353|NCT03118934|559644107|FG000|Overall Study|Physician Decision|0|||
155057354|NCT03118934|559644108|FG001|Overall Study|Physician Decision|0|||
155057355|NCT03118934|559644109|FG002|Overall Study|Physician Decision|0|||
155057356|NCT03118934|559644110|FG003|Overall Study|Physician Decision|0|||
155057357|NCT03118934|559644111|FG004|Overall Study|Physician Decision|0|||
155057358|NCT03118934|559644112|FG005|Overall Study|Physician Decision|1|||
155057359|NCT03118934|559644107|FG000|Overall Study|Discontinued prior to exposure|0|||
155057360|NCT03118934|559644108|FG001|Overall Study|Discontinued prior to exposure|1|||
155057361|NCT03118934|559644109|FG002|Overall Study|Discontinued prior to exposure|1|||
155057362|NCT03118934|559644110|FG003|Overall Study|Discontinued prior to exposure|1|||
155057363|NCT03118934|559644111|FG004|Overall Study|Discontinued prior to exposure|2|||
155057364|NCT03118934|559644112|FG005|Overall Study|Discontinued prior to exposure|0|||
155057365|NCT03080935|559644113|FG000|Overall Study|Death|34|||
155057366|NCT03080935|559644114|FG001|Overall Study|Death|50|||
155057367|NCT03080935|559644113|FG000|Overall Study|Lost to Follow-up|5|||
155393978|NCT00129623|560878215|FG000|Overall Study|Uncertainty to return|0|||
155393979|NCT00129623|560878216|FG001|Overall Study|Uncertainty to return|1|||
155393980|NCT00596934|560878217|FG000|Overall Study|Protocol Violation|1|||
155393981|NCT00596934|560878217|FG000|Overall Study|Withdrawal by Subject|1|||
155393982|NCT02315898|560878218|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
155393983|NCT02315898|560878219|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
155393984|NCT02315898|560878220|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
155393985|NCT02315898|560878221|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
155393986|NCT02445755|560878222|FG000|Overall Study|Withdrawal by Subject|2|||
155393987|NCT02445755|560878222|FG000|Overall Study|Protocol Violation|6|||
155393988|NCT02445755|560878222|FG000|Overall Study|Screen Failure|5|||
155393989|NCT01296035|560878224|FG000|Overall Study|Withdrawal by Subject|1|||
155393990|NCT01674712|560878225|FG000|Overall Study|Adverse Event|5|||
155393991|NCT01674712|560878226|FG001|Overall Study|Adverse Event|6|||
155393992|NCT01674712|560878227|FG002|Overall Study|Adverse Event|3|||
155393993|NCT01674712|560878228|FG003|Overall Study|Adverse Event|4|||
155393994|NCT01674712|560878229|FG004|Overall Study|Adverse Event|6|||
155393995|NCT01674712|560878225|FG000|Overall Study|Lost to Follow-up|1|||
155393996|NCT01674712|560878226|FG001|Overall Study|Lost to Follow-up|0|||
155393997|NCT01674712|560878227|FG002|Overall Study|Lost to Follow-up|0|||
155393998|NCT01674712|560878228|FG003|Overall Study|Lost to Follow-up|0|||
155393999|NCT01674712|560878229|FG004|Overall Study|Lost to Follow-up|0|||
155394000|NCT01674712|560878225|FG000|Overall Study|Protocol Violation|2|||
155394001|NCT01674712|560878226|FG001|Overall Study|Protocol Violation|0|||
155394002|NCT01674712|560878227|FG002|Overall Study|Protocol Violation|0|||
155394003|NCT01674712|560878228|FG003|Overall Study|Protocol Violation|0|||
155394004|NCT01674712|560878229|FG004|Overall Study|Protocol Violation|0|||
155394005|NCT01674712|560878225|FG000|Overall Study|Withdrawal by Subject|2|||
155394006|NCT01674712|560878226|FG001|Overall Study|Withdrawal by Subject|2|||
155394007|NCT01674712|560878227|FG002|Overall Study|Withdrawal by Subject|5|||
155394008|NCT01674712|560878228|FG003|Overall Study|Withdrawal by Subject|4|||
155394009|NCT01674712|560878229|FG004|Overall Study|Withdrawal by Subject|3|||
155394010|NCT01674712|560878225|FG000|Overall Study|Administrative|0|||
155394011|NCT01674712|560878226|FG001|Overall Study|Administrative|1|||
155394012|NCT01674712|560878227|FG002|Overall Study|Administrative|0|||
155394013|NCT01674712|560878228|FG003|Overall Study|Administrative|0|||
155394014|NCT01674712|560878229|FG004|Overall Study|Administrative|1|||
155394015|NCT01674712|560878225|FG000|Overall Study|Lack of Efficacy|0|||
155394016|NCT01674712|560878226|FG001|Overall Study|Lack of Efficacy|0|||
155394017|NCT01674712|560878227|FG002|Overall Study|Lack of Efficacy|1|||
155394018|NCT01674712|560878228|FG003|Overall Study|Lack of Efficacy|0|||
155394019|NCT01674712|560878229|FG004|Overall Study|Lack of Efficacy|1|||
155394020|NCT00866723|560878230|FG000|Overall Study|Withdrawal by Subject|1|||
155394021|NCT00866723|560878230|FG000|Overall Study|Disease Progression|4|||
155394022|NCT01271803|560878233|FG000|Overall Study|Progressive disease|0|||
155394023|NCT01271803|560878234|FG001|Overall Study|Progressive disease|0|||
155394024|NCT01271803|560878235|FG002|Overall Study|Progressive disease|2|||
155394025|NCT01271803|560878233|FG000|Overall Study|Death|53|||
155394026|NCT01271803|560878234|FG001|Overall Study|Death|34|||
155394027|NCT01271803|560878235|FG002|Overall Study|Death|0|||
155394028|NCT01271803|560878233|FG000|Overall Study|Withdrawal by Subject|1|||
155394029|NCT01271803|560878234|FG001|Overall Study|Withdrawal by Subject|5|||
155394030|NCT01271803|560878235|FG002|Overall Study|Withdrawal by Subject|0|||
155394031|NCT01271803|560878233|FG000|Overall Study|Lost to Follow-up|1|||
155394032|NCT01271803|560878234|FG001|Overall Study|Lost to Follow-up|0|||
155394033|NCT01271803|560878235|FG002|Overall Study|Lost to Follow-up|0|||
155394034|NCT01975428|560878239|FG000|Overall Study|Lost to Follow-up|17|||
155057368|NCT03080935|559644114|FG001|Overall Study|Lost to Follow-up|4|||
155057369|NCT03080935|559644113|FG000|Overall Study|Withdrawal by Subject|11|||
155394035|NCT01975428|560878240|FG001|Overall Study|Lost to Follow-up|4|||
155394036|NCT01975428|560878239|FG000|Overall Study|Withdrawal by Subject|3|||
155394037|NCT01975428|560878240|FG001|Overall Study|Withdrawal by Subject|10|||
155394038|NCT00995007|560878241|FG000|Overall Study|Withdrew consent|1|||
155394039|NCT00995007|560878242|FG001|Overall Study|Withdrew consent|0|||
155394040|NCT00995007|560878241|FG000|Overall Study|Refused further treatment|8|||
155394041|NCT00995007|560878242|FG001|Overall Study|Refused further treatment|2|||
155394042|NCT00995007|560878241|FG000|Overall Study|Toxicity|8|||
155394043|NCT00995007|560878242|FG001|Overall Study|Toxicity|0|||
155394044|NCT03933397|560878243|FG000|Overall Study|No emergency department visit|65|||
155394045|NCT03933397|560878244|FG001|Overall Study|No emergency department visit|71|||
155394046|NCT03933397|560878243|FG000|Overall Study|Missed emergency department visit|25|||
155394047|NCT03933397|560878244|FG001|Overall Study|Missed emergency department visit|30|||
155394048|NCT03933397|560878243|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
155394049|NCT03933397|560878244|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
155394050|NCT03933397|560878243|FG000|Overall Study|Withdrawal by Subject|1|||
155394051|NCT03933397|560878244|FG001|Overall Study|Withdrawal by Subject|0|||
155057370|NCT03080935|559644114|FG001|Overall Study|Withdrawal by Subject|15|||
155057371|NCT01614470|559644115|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
155057372|NCT01614470|559644116|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155057373|NCT01614470|559644117|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155057374|NCT01614470|559644115|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
155057375|NCT01614470|559644116|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
155057376|NCT01614470|559644117|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
155057377|NCT03217591|559644118|FG000|Overall Study|Adverse Event|1|||
155057378|NCT03217591|559644119|FG001|Overall Study|Adverse Event|2|||
155057379|NCT03217591|559644120|FG002|Overall Study|Adverse Event|6|||
155057380|NCT03217591|559644118|FG000|Overall Study|Withdrawal by Subject|0|||
155057381|NCT03217591|559644119|FG001|Overall Study|Withdrawal by Subject|1|||
155057382|NCT03217591|559644120|FG002|Overall Study|Withdrawal by Subject|3|||
155057383|NCT03217591|559644118|FG000|Overall Study|Lost to Follow-up|1|||
155057384|NCT03217591|559644119|FG001|Overall Study|Lost to Follow-up|0|||
155057385|NCT03217591|559644120|FG002|Overall Study|Lost to Follow-up|0|||
155057386|NCT03217591|559644118|FG000|Overall Study|Protocol Violation|1|||
155057387|NCT03217591|559644119|FG001|Overall Study|Protocol Violation|0|||
155394052|NCT03933397|560878243|FG000|Overall Study|Physician Decision|1|||
155394053|NCT03933397|560878244|FG001|Overall Study|Physician Decision|1|||
155394054|NCT03933397|560878243|FG000|Overall Study|missing pain score|1|||
155394055|NCT03933397|560878244|FG001|Overall Study|missing pain score|1|||
155394056|NCT03933397|560878243|FG000|Overall Study|Confirmed COVID-19|1|||
155394057|NCT03933397|560878244|FG001|Overall Study|Confirmed COVID-19|2|||
155394058|NCT01610687|560878246|FG000|Overall Study|Lack of Efficacy|26|||
155394059|NCT01610687|560878246|FG000|Overall Study|Adverse Event|18|||
155394060|NCT01610687|560878246|FG000|Overall Study|Moved out of area|6|||
155394061|NCT01610687|560878246|FG000|Overall Study|Withdrawal by Subject|7|||
155394062|NCT01610687|560878246|FG000|Overall Study|Lost to Follow-up|4|||
155394063|NCT01610687|560878246|FG000|Overall Study|Symptom control without study medication|2|||
155394064|NCT01610687|560878246|FG000|Overall Study|Unable to make journey|1|||
155057388|NCT03217591|559644120|FG002|Overall Study|Protocol Violation|1|||
155057389|NCT00069264|559644135|FG000|Overall Study|Adverse Event|3|||
155057390|NCT00069264|559644135|FG000|Overall Study|Progressive Disease|23|||
155057391|NCT00069264|559644135|FG000|Overall Study|Withdrawal by Subject|3|||
155057392|NCT00069264|559644135|FG000|Overall Study|Discon Therapy|3|||
155057393|NCT04249427|559644138|FG000|Overall Study|Adverse Event|3|||
155394065|NCT01610687|560878246|FG000|Overall Study|Death|1|||
155394066|NCT01610687|560878246|FG000|Overall Study|Cannabis affecting job|1|||
155394067|NCT01610687|560878246|FG000|Overall Study|Felt more alter without study medication|1|||
155394068|NCT03675776|560878247|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
155394069|NCT03675776|560878248|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
155394070|NCT03675776|560878249|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
155394071|NCT03675776|560878247|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
155394072|NCT03675776|560878248|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155057394|NCT04249427|559644139|FG001|Overall Study|Adverse Event|1|||
155057395|NCT04249427|559644138|FG000|Overall Study|Lack of Efficacy|0|||
155057396|NCT04249427|559644139|FG001|Overall Study|Lack of Efficacy|1|||
155057397|NCT04249427|559644138|FG000|Overall Study|Withdrawal by Subject|1|||
155057398|NCT04249427|559644139|FG001|Overall Study|Withdrawal by Subject|2|||
155057399|NCT02895347|559644142|FG000|Overall Study|Withdrawal by Subject|3|||
155057400|NCT02895347|559644143|FG001|Overall Study|Withdrawal by Subject|1|||
155394073|NCT03675776|560878249|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155394074|NCT00999713|560878250|FG000|Overall Study|Physician Decision|2|||
155394075|NCT00999713|560878251|FG001|Overall Study|Physician Decision|0|||
155057401|NCT01673178|559644147|FG000|Overall Study|Lost to Follow-up|0|||
155057402|NCT01673178|559644148|FG001|Overall Study|Lost to Follow-up|1|||
155394076|NCT01130974|560878252|FG000|Overall Study|Protocol Violation|10|||
155057403|NCT01673178|559644149|FG002|Overall Study|Lost to Follow-up|0|||
155057404|NCT01673178|559644150|FG003|Overall Study|Lost to Follow-up|0|||
155394077|NCT01130974|560878253|FG001|Overall Study|Protocol Violation|10|||
155394078|NCT01130974|560878252|FG000|Overall Study|Withdrawal by Subject|0|||
155394079|NCT01130974|560878253|FG001|Overall Study|Withdrawal by Subject|1|||
155394080|NCT01130974|560878252|FG000|Overall Study|Ineligibility criteria|5|||
155394081|NCT01130974|560878253|FG001|Overall Study|Ineligibility criteria|2|||
155394082|NCT02966223|560878254|FG000|Overall Study|Physician Decision|3|||
155394083|NCT02966223|560878254|FG000|Overall Study|Withdrawal by Subject|11|||
155394084|NCT02966223|560878254|FG000|Overall Study|Lost to Follow-up|1|||
155394085|NCT04409353|560878257|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
155394086|NCT04409353|560878258|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
155394087|NCT04409353|560878259|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
155394088|NCT04409353|560878257|FG000|Overall Study|Lost to Follow-up|6|||
155394089|NCT04409353|560878258|FG001|Overall Study|Lost to Follow-up|8|||
155394090|NCT04409353|560878259|FG002|Overall Study|Lost to Follow-up|7|||
155394091|NCT04409353|560878257|FG000|Overall Study|Major surgery during participation window|4|||
155394092|NCT04409353|560878258|FG001|Overall Study|Major surgery during participation window|3|||
155394093|NCT04409353|560878259|FG002|Overall Study|Major surgery during participation window|3|||
155394094|NCT04409353|560878257|FG000|Overall Study|Life event occurred during participation window|3|||
155394095|NCT04409353|560878258|FG001|Overall Study|Life event occurred during participation window|2|||
155394096|NCT04409353|560878259|FG002|Overall Study|Life event occurred during participation window|4|||
155394097|NCT04409353|560878257|FG000|Overall Study|Lack of Efficacy|4|||
155394098|NCT04409353|560878258|FG001|Overall Study|Lack of Efficacy|1|||
155394099|NCT04409353|560878259|FG002|Overall Study|Lack of Efficacy|3|||
155394100|NCT04409353|560878257|FG000|Overall Study|Adverse Event|2|||
155394101|NCT04409353|560878258|FG001|Overall Study|Adverse Event|1|||
155394102|NCT04409353|560878259|FG002|Overall Study|Adverse Event|1|||
155394103|NCT04409353|560878257|FG000|Overall Study|Disease burden - unable to participate|0|||
155394104|NCT04409353|560878258|FG001|Overall Study|Disease burden - unable to participate|1|||
155394105|NCT04409353|560878259|FG002|Overall Study|Disease burden - unable to participate|1|||
155394106|NCT04409353|560878257|FG000|Overall Study|Intervention too complicated|1|||
155394107|NCT04409353|560878258|FG001|Overall Study|Intervention too complicated|0|||
155394108|NCT04409353|560878259|FG002|Overall Study|Intervention too complicated|1|||
155394109|NCT00671554|560878265|FG000|Overall Study|Disease progression|3|||
155394110|NCT04275297|560878269|FG000|Overall Study|Lost to Follow-up|1|||
155394111|NCT04275297|560878270|FG001|Overall Study|Lost to Follow-up|1|||
155057405|NCT01673178|559644151|FG004|Overall Study|Lost to Follow-up|0|||
155057406|NCT01673178|559644147|FG000|Overall Study|Withdrawal by Subject|0|||
155057407|NCT01673178|559644148|FG001|Overall Study|Withdrawal by Subject|0|||
155057408|NCT01673178|559644149|FG002|Overall Study|Withdrawal by Subject|1|||
155057409|NCT01673178|559644150|FG003|Overall Study|Withdrawal by Subject|4|||
155057410|NCT01673178|559644151|FG004|Overall Study|Withdrawal by Subject|2|||
155057411|NCT01673178|559644147|FG000|Overall Study|Protocol Violation|1|||
155057412|NCT01673178|559644148|FG001|Overall Study|Protocol Violation|1|||
155057413|NCT01673178|559644149|FG002|Overall Study|Protocol Violation|0|||
155057414|NCT01673178|559644150|FG003|Overall Study|Protocol Violation|1|||
155057415|NCT01673178|559644151|FG004|Overall Study|Protocol Violation|0|||
155057416|NCT01673178|559644147|FG000|Overall Study|Adverse Event|1|||
155057417|NCT01673178|559644148|FG001|Overall Study|Adverse Event|0|||
155057418|NCT01673178|559644149|FG002|Overall Study|Adverse Event|0|||
155057419|NCT01673178|559644150|FG003|Overall Study|Adverse Event|2|||
155057420|NCT01673178|559644151|FG004|Overall Study|Adverse Event|0|||
155057421|NCT01673178|559644147|FG000|Overall Study|Other|1|||
155057422|NCT01673178|559644148|FG001|Overall Study|Other|0|||
155057423|NCT01673178|559644149|FG002|Overall Study|Other|2|||
155057424|NCT01673178|559644150|FG003|Overall Study|Other|1|||
155057425|NCT01673178|559644151|FG004|Overall Study|Other|0|||
155057426|NCT02557399|559644152|FG000|Overall Study|Adverse Event|6|||
155057427|NCT02557399|559644153|FG001|Overall Study|Adverse Event|5|||
155057428|NCT02557399|559644152|FG000|Overall Study|Protocol Violation|0|||
155057429|NCT02557399|559644153|FG001|Overall Study|Protocol Violation|1|||
155057430|NCT02557399|559644152|FG000|Overall Study|Protocol-defined stopping criteria|0|||
155057431|NCT02557399|559644153|FG001|Overall Study|Protocol-defined stopping criteria|1|||
155394112|NCT01093326|560878273|FG000|Overall Study|Death|0|||
155394113|NCT01093326|560878274|FG001|Overall Study|Death|1|||
155057432|NCT02557399|559644152|FG000|Overall Study|Withdrawal by Subject|1|||
155057433|NCT02557399|559644153|FG001|Overall Study|Withdrawal by Subject|1|||
155057434|NCT03106077|559644165|FG000|Overall Study|Screen Failure|94|||
155394114|NCT01093326|560878275|FG002|Overall Study|Death|0|||
155394115|NCT01093326|560878273|FG000|Overall Study|Lack of Efficacy|7|||
155394116|NCT01093326|560878274|FG001|Overall Study|Lack of Efficacy|6|||
155057435|NCT03106077|559644166|FG001|Overall Study|Screen Failure|0|||
155057436|NCT00606307|559644167|FG000|Overall Study|Adverse Event|2|||
155394117|NCT01093326|560878275|FG002|Overall Study|Lack of Efficacy|3|||
155394118|NCT01093326|560878273|FG000|Overall Study|Lost to Follow-up|2|||
155394119|NCT01093326|560878274|FG001|Overall Study|Lost to Follow-up|5|||
155394120|NCT01093326|560878275|FG002|Overall Study|Lost to Follow-up|4|||
155394121|NCT01093326|560878273|FG000|Overall Study|Physician Decision|3|||
155394122|NCT01093326|560878274|FG001|Overall Study|Physician Decision|1|||
155394123|NCT01093326|560878275|FG002|Overall Study|Physician Decision|3|||
155394124|NCT01093326|560878273|FG000|Overall Study|Withdrawal by Subject|30|||
155394125|NCT01093326|560878274|FG001|Overall Study|Withdrawal by Subject|27|||
155394126|NCT01093326|560878275|FG002|Overall Study|Withdrawal by Subject|26|||
155394127|NCT01093326|560878273|FG000|Overall Study|Adverse Event|2|||
155394128|NCT01093326|560878274|FG001|Overall Study|Adverse Event|1|||
155394129|NCT01093326|560878275|FG002|Overall Study|Adverse Event|4|||
154952419|NCT01104662|559250728|FG002|Overall Study|Reason not specified|0|||
154952420|NCT01104662|559250729|FG003|Overall Study|Reason not specified|0|||
154952421|NCT01104662|559250730|FG004|Overall Study|Reason not specified|0|||
154952422|NCT01104662|559250731|FG005|Overall Study|Reason not specified|1|||
154952423|NCT01104662|559250732|FG006|Overall Study|Reason not specified|0|||
154952424|NCT01104662|559250733|FG007|Overall Study|Reason not specified|0|||
154952425|NCT01104662|559250726|FG000|Overall Study|Randomized but not treated|3|||
154952426|NCT01104662|559250727|FG001|Overall Study|Randomized but not treated|4|||
154952427|NCT01104662|559250728|FG002|Overall Study|Randomized but not treated|1|||
154952428|NCT01104662|559250729|FG003|Overall Study|Randomized but not treated|0|||
154952429|NCT01104662|559250730|FG004|Overall Study|Randomized but not treated|0|||
154952430|NCT01104662|559250731|FG005|Overall Study|Randomized but not treated|1|||
154952431|NCT01104662|559250732|FG006|Overall Study|Randomized but not treated|0|||
154952432|NCT01104662|559250733|FG007|Overall Study|Randomized but not treated|0|||
154952433|NCT01478620|559250734|FG000|Overall Study|Lost to Follow-up|6|||
154952434|NCT02514174|559250740|FG000|Overall Study|Patient refused to continue medication|1|||
154952435|NCT02514174|559250740|FG000|Overall Study|Adverse Event|2|||
154952436|NCT02514174|559250740|FG000|Overall Study|Study closed by sponsor|9|||
154952437|NCT02514174|559250740|FG000|Overall Study|Progressive disease|11|||
154952438|NCT02514174|559250740|FG000|Overall Study|Treatment change|1|||
154952439|NCT02514174|559250740|FG000|Overall Study|Treated off study with Afatinib.|1|||
154952440|NCT02888171|559250743|FG000|Overall Study|Lost to Follow-up|2|||
154952441|NCT02888171|559250744|FG001|Overall Study|Lost to Follow-up|1|||
154952442|NCT02888171|559250743|FG000|Overall Study|Withdrawal by Subject|3|||
154952443|NCT02888171|559250744|FG001|Overall Study|Withdrawal by Subject|2|||
154952444|NCT02888171|559250743|FG000|Overall Study|Adverse Event|0|||
154952445|NCT02888171|559250744|FG001|Overall Study|Adverse Event|1|||
154952446|NCT04349917|559251958|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
154952447|NCT04349917|559251959|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
154952448|NCT04349917|559251958|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
154952449|NCT04349917|559251959|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
154952450|NCT00441467|559251964|FG000|Overall Study|Adverse Event|6|||
154952451|NCT00441467|559251964|FG000|Overall Study|Withdrawal by Subject|3|||
154952452|NCT00441467|559251964|FG000|Overall Study|Progressive disease|9|||
154952453|NCT02289963|559251965|FG000|Overall Study|Adverse Event|1|||
154952454|NCT02289963|559251966|FG001|Overall Study|Adverse Event|2|||
154952455|NCT02289963|559251965|FG000|Overall Study|Poor compliance to protocol|1|||
154952456|NCT02289963|559251966|FG001|Overall Study|Poor compliance to protocol|0|||
154952457|NCT02289963|559251965|FG000|Overall Study|Withdrawal by Subject|1|||
154952458|NCT02289963|559251966|FG001|Overall Study|Withdrawal by Subject|0|||
154952459|NCT02289963|559251965|FG000|Overall Study|Last injection missed|2|||
154952460|NCT02289963|559251966|FG001|Overall Study|Last injection missed|2|||
154952461|NCT02289963|559251965|FG000|Overall Study|End treatment visit outside visit window|0|||
154952462|NCT02289963|559251966|FG001|Overall Study|End treatment visit outside visit window|4|||
154952463|NCT02289963|559251965|FG000|Overall Study|Other than specified above|0|||
154952464|NCT02289963|559251966|FG001|Overall Study|Other than specified above|2|||
154952465|NCT01042522|559251968|FG000|Overall Study|Adverse Event|1|||
154952466|NCT01042522|559251969|FG001|Overall Study|Adverse Event|2|||
154952467|NCT01042522|559251968|FG000|Overall Study|Disease Progression|5|||
154952468|NCT01042522|559251969|FG001|Overall Study|Disease Progression|0|||
154952469|NCT01042522|559251968|FG000|Overall Study|Death|1|||
154952470|NCT01042522|559251969|FG001|Overall Study|Death|0|||
154952471|NCT01042522|559251968|FG000|Overall Study|Patient Refused|0|||
154952472|NCT01042522|559251969|FG001|Overall Study|Patient Refused|3|||
154952473|NCT01042522|559251968|FG000|Overall Study|Withdrawal by Subject|1|||
154952474|NCT01042522|559251969|FG001|Overall Study|Withdrawal by Subject|1|||
154952475|NCT00745420|559251971|FG000|Overall Study|Ineligible|1|||
154952476|NCT01941095|559251972|FG000|Overall Study|Insufficient therapeutic response|13|||
154952477|NCT01941095|559251972|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
154952478|NCT01941095|559251972|FG000|Overall Study|Adverse Event|11|||
154952479|NCT01941095|559251972|FG000|Overall Study|Physician Decision|3|||
154952480|NCT01941095|559251972|FG000|Overall Study|Withdrawal by Subject|17|||
154952481|NCT01941095|559251972|FG000|Overall Study|Lost to Follow-up|10|||
154952482|NCT01648166|559251982|FG000|Overall Study|inadequate toenail samples|53|||
155394130|NCT01093326|560878273|FG000|Overall Study|Other|0|||
155394131|NCT01093326|560878274|FG001|Overall Study|Other|0|||
154952483|NCT01648166|559251983|FG001|Overall Study|inadequate toenail samples|100|||
155394132|NCT01093326|560878275|FG002|Overall Study|Other|1|||
155394133|NCT04435782|560878276|FG000|Overall Study|Study terminated by sponsor|4|||
155394134|NCT03672461|560878277|FG000|Overall Study|COVID Related|4|||
155394135|NCT03672461|560878278|FG001|Overall Study|COVID Related|2|||
155394136|NCT03672461|560878277|FG000|Overall Study|Adverse Event|2|||
155394137|NCT03672461|560878278|FG001|Overall Study|Adverse Event|0|||
155394138|NCT03672461|560878277|FG000|Overall Study|Serious Adverse Event|0|||
155394139|NCT03672461|560878278|FG001|Overall Study|Serious Adverse Event|1|||
155394140|NCT03672461|560878277|FG000|Overall Study|Too Busy|3|||
155394141|NCT03672461|560878278|FG001|Overall Study|Too Busy|1|||
155394142|NCT03672461|560878277|FG000|Overall Study|Lost to Follow-up|1|||
155394143|NCT03672461|560878278|FG001|Overall Study|Lost to Follow-up|2|||
155394144|NCT03672461|560878277|FG000|Overall Study|Family|2|||
155394145|NCT03672461|560878278|FG001|Overall Study|Family|2|||
155394146|NCT03672461|560878277|FG000|Overall Study|No remote technology access|0|||
155394147|NCT03672461|560878278|FG001|Overall Study|No remote technology access|1|||
155394148|NCT03672461|560878277|FG000|Overall Study|Withdrawal by Subject|1|||
155394149|NCT03672461|560878278|FG001|Overall Study|Withdrawal by Subject|0|||
155394150|NCT03672461|560878277|FG000|Overall Study|Cannot tolerate intervention|1|||
155394151|NCT03672461|560878278|FG001|Overall Study|Cannot tolerate intervention|0|||
155394152|NCT03672461|560878277|FG000|Overall Study|Incomplete outcome data|6|||
155057437|NCT00606307|559644167|FG000|Overall Study|Withdrawal by Subject|2|||
155057438|NCT00606307|559644167|FG000|Overall Study|Disease progression|6|||
155394153|NCT03672461|560878278|FG001|Overall Study|Incomplete outcome data|1|||
155394154|NCT04225806|560878279|FG000|Overall Study|Trial termination|15|||
155394155|NCT00977574|560878282|FG000|Overall Study|Never Treated|4|||
155394156|NCT00977574|560878283|FG001|Overall Study|Never Treated|2|||
155394157|NCT00977574|560878284|FG002|Overall Study|Never Treated|4|||
155394158|NCT04223791|560878285|FG000|Overall Study|Lost to Follow-up|0|||
155394159|NCT04223791|560878286|FG001|Overall Study|Lost to Follow-up|4|||
155394160|NCT04223791|560878285|FG000|Overall Study|Physician Decision|5|||
155394161|NCT04223791|560878286|FG001|Overall Study|Physician Decision|1|||
155394162|NCT04223791|560878285|FG000|Overall Study|Protocol Violation|1|||
155394163|NCT04223791|560878286|FG001|Overall Study|Protocol Violation|1|||
155394164|NCT04223791|560878285|FG000|Overall Study|Withdrawal by Subject|10|||
155394165|NCT04223791|560878286|FG001|Overall Study|Withdrawal by Subject|12|||
155394166|NCT04223791|560878285|FG000|Overall Study|Pregnancy|1|||
155394167|NCT04223791|560878286|FG001|Overall Study|Pregnancy|1|||
155394168|NCT04223791|560878285|FG000|Overall Study|Ongoing in Study|305|||
155394169|NCT04223791|560878286|FG001|Overall Study|Ongoing in Study|302|||
155394170|NCT04667247|560878287|FG000|Overall Study|Withdrawal by Subject|0|||
155394171|NCT04667247|560878288|FG001|Overall Study|Withdrawal by Subject|1|||
155394172|NCT05460273|560878289|FG000|Overall Study|Death|43|||
155394173|NCT05460273|560878290|FG001|Overall Study|Death|9|||
155394174|NCT05460273|560878289|FG000|Overall Study|Lost to Follow-up|7|||
155394175|NCT05460273|560878290|FG001|Overall Study|Lost to Follow-up|0|||
155394176|NCT05460273|560878289|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
155394177|NCT05460273|560878290|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
155394178|NCT04124614|560878291|FG000|Placebo Run-in Period|Not Randomized|34|||
155394179|NCT04124614|560878292|FG001|Placebo Run-in Period|Not Randomized|0|||
155394180|NCT04124614|560878293|FG002|Placebo Run-in Period|Not Randomized|0|||
155394181|NCT04124614|560878291|FG000|Double Blind Treatment Period|Adverse Event|0|||
155394182|NCT04124614|560878292|FG001|Double Blind Treatment Period|Adverse Event|7|||
155394183|NCT04124614|560878293|FG002|Double Blind Treatment Period|Adverse Event|22|||
155057439|NCT00606307|559644167|FG000|Overall Study|QTc prolongation|1|||
155057440|NCT01274533|559644168|FG000|Overall Study|Withdrawal by Subject|1|||
155057441|NCT01274533|559644168|FG000|Overall Study|Non-compliance|1|||
155283493|NCT00172185|560470749|FG000|Overall Study|Adverse Event|0|||
155283494|NCT00172185|560470750|FG001|Overall Study|Adverse Event|1|||
155283495|NCT00172185|560470751|FG002|Overall Study|Adverse Event|3|||
155283496|NCT00172185|560470752|FG003|Overall Study|Adverse Event|4|||
155283497|NCT00172185|560470749|FG000|Overall Study|Physician Decision|0|||
155283498|NCT00172185|560470750|FG001|Overall Study|Physician Decision|0|||
155283499|NCT00172185|560470751|FG002|Overall Study|Physician Decision|1|||
155283500|NCT00172185|560470752|FG003|Overall Study|Physician Decision|0|||
155283501|NCT00172185|560470749|FG000|Overall Study|SPONSOR Decision|0|||
155283502|NCT00172185|560470750|FG001|Overall Study|SPONSOR Decision|1|||
155394184|NCT04124614|560878291|FG000|Double Blind Treatment Period|Death|0|||
155394185|NCT04124614|560878292|FG001|Double Blind Treatment Period|Death|0|||
155057442|NCT01274533|559644168|FG000|Overall Study|Disease progression|2|||
155057443|NCT02563899|559644169|FG000|Overall Study|Protocol Violation|1|||
155283503|NCT00172185|560470751|FG002|Overall Study|SPONSOR Decision|0|||
155283504|NCT00172185|560470752|FG003|Overall Study|SPONSOR Decision|0|||
155394186|NCT04124614|560878293|FG002|Double Blind Treatment Period|Death|1|||
155394187|NCT04124614|560878291|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155394188|NCT04124614|560878292|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
155394189|NCT04124614|560878293|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
155394190|NCT04124614|560878291|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
155057444|NCT02563899|559644170|FG001|Overall Study|Protocol Violation|0|||
155057445|NCT02563899|559644171|FG002|Overall Study|Protocol Violation|0|||
155057446|NCT02563899|559644172|FG003|Overall Study|Protocol Violation|0|||
155057447|NCT02563899|559644169|FG000|Overall Study|Withdrawal by Subject|0|||
155394191|NCT04124614|560878292|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
155394192|NCT04124614|560878293|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
155283505|NCT00172185|560470749|FG000|Overall Study|Withdrawal by Subject|0|||
155283506|NCT00172185|560470750|FG001|Overall Study|Withdrawal by Subject|0|||
155283507|NCT00172185|560470751|FG002|Overall Study|Withdrawal by Subject|1|||
155283508|NCT00172185|560470752|FG003|Overall Study|Withdrawal by Subject|0|||
155283509|NCT04048135|560470753|FG000|Overall Study|Withdrawal by Subject|1|||
155394193|NCT04124614|560878291|FG000|Double Blind Treatment Period|Physician Decision|0|||
155394194|NCT04124614|560878292|FG001|Double Blind Treatment Period|Physician Decision|0|||
155394195|NCT04124614|560878293|FG002|Double Blind Treatment Period|Physician Decision|3|||
155394196|NCT04124614|560878291|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
155394197|NCT04124614|560878292|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
155394198|NCT04124614|560878293|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
155394199|NCT04124614|560878291|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155394200|NCT04124614|560878292|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
155394201|NCT04124614|560878293|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
155394202|NCT04124614|560878291|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
155394203|NCT04124614|560878292|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
155394204|NCT04124614|560878293|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
155394205|NCT05749952|560878294|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
155394206|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Administrative problems|1|||
155394207|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Administrative problems|1|||
155394208|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
155394209|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
155394210|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
155394211|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
155394212|NCT00332839|560880232|FG000|Core (Months 0 - 12)|Adverse Event|5|||
155394213|NCT00332839|560880233|FG001|Core (Months 0 - 12)|Adverse Event|15|||
155394214|NCT00332839|560880232|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
155394215|NCT00332839|560880233|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
155394216|NCT00332839|560880232|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
155394217|NCT00332839|560880233|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
155394218|NCT00332839|560880232|FG000|Follow-up (Months 12 - 60)|Death|1|||
155394219|NCT00332839|560880233|FG001|Follow-up (Months 12 - 60)|Death|1|||
155394220|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
155394221|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
155394222|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
155394223|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
155394224|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
155394225|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
155394226|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
155394227|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
155394228|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
155394229|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
155394230|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
155394231|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
155394232|NCT00594516|560880237|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
155394233|NCT00594516|560880238|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
155394234|NCT00594516|560880239|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
155394235|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
155394236|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
155394237|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
155057448|NCT02563899|559644170|FG001|Overall Study|Withdrawal by Subject|0|||
155057449|NCT02563899|559644171|FG002|Overall Study|Withdrawal by Subject|1|||
155057450|NCT02563899|559644172|FG003|Overall Study|Withdrawal by Subject|0|||
155283510|NCT04048135|560470754|FG001|Overall Study|Withdrawal by Subject|1|||
155283511|NCT04048135|560470755|FG002|Overall Study|Withdrawal by Subject|1|||
155283512|NCT04048135|560470756|FG003|Overall Study|Withdrawal by Subject|2|||
155283513|NCT04048135|560470757|FG004|Overall Study|Withdrawal by Subject|0|||
155283514|NCT04048135|560470758|FG005|Overall Study|Withdrawal by Subject|0|||
155283515|NCT04048135|560470759|FG006|Overall Study|Withdrawal by Subject|1|||
155283516|NCT04048135|560470760|FG007|Overall Study|Withdrawal by Subject|1|||
155283517|NCT04048135|560470753|FG000|Overall Study|Adverse Event|0|||
155394238|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
155394239|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
155394240|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
155394241|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
155394242|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
155394243|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
155394244|NCT00594516|560880237|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
155394245|NCT00594516|560880238|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
155394246|NCT00594516|560880239|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
155394247|NCT01876251|560880242|FG000|Overall Study|Clinical progression|1|||
155394248|NCT01876251|560880243|FG001|Overall Study|Clinical progression|0|||
155394249|NCT01876251|560880244|FG002|Overall Study|Clinical progression|0|||
155394250|NCT01876251|560880242|FG000|Overall Study|Death|2|||
155394251|NCT01876251|560880243|FG001|Overall Study|Death|0|||
155394252|NCT01876251|560880244|FG002|Overall Study|Death|1|||
155394253|NCT01876251|560880242|FG000|Overall Study|Participant started new treatment|1|||
155057451|NCT03669588|559644174|FG000|Overall Study|Adverse Event|1|||
155057452|NCT03669588|559644175|FG001|Overall Study|Adverse Event|0|||
155057453|NCT03669588|559644174|FG000|Overall Study|Physician Decision|0|||
155057454|NCT03669588|559644175|FG001|Overall Study|Physician Decision|1|||
155057455|NCT03669588|559644174|FG000|Overall Study|Protocol Violation|1|||
155057456|NCT03669588|559644175|FG001|Overall Study|Protocol Violation|0|||
155057457|NCT03669588|559644174|FG000|Overall Study|Sponsor Decision|1|||
155057458|NCT03669588|559644175|FG001|Overall Study|Sponsor Decision|1|||
155057459|NCT03669588|559644174|FG000|Overall Study|Withdrawal by Subject|1|||
155057460|NCT03669588|559644175|FG001|Overall Study|Withdrawal by Subject|4|||
155057461|NCT03669588|559644174|FG000|Overall Study|Rescue Therapy Needed|0|||
155057462|NCT03669588|559644175|FG001|Overall Study|Rescue Therapy Needed|1|||
155057463|NCT02949947|559644176|FG000|Overall Study|Non Compliance|0|||
155057464|NCT02949947|559644177|FG001|Overall Study|Non Compliance|1|||
155057465|NCT02949947|559644176|FG000|Overall Study|Insurance change|1|||
155057466|NCT02949947|559644177|FG001|Overall Study|Insurance change|0|||
155057467|NCT01973218|559644178|FG000|Overall Study|Adverse Event|1|||
155057468|NCT01973218|559644179|FG001|Overall Study|Adverse Event|0|||
155057469|NCT01973218|559644178|FG000|Overall Study|Withdrawal by Subject|1|||
155057470|NCT01973218|559644179|FG001|Overall Study|Withdrawal by Subject|0|||
155057471|NCT00492726|559644180|FG000|Overall Study|Adverse Event|10|||
155057472|NCT00492726|559644181|FG001|Overall Study|Adverse Event|6|||
155057473|NCT00492726|559644180|FG000|Overall Study|Death|7|||
155057474|NCT00492726|559644181|FG001|Overall Study|Death|2|||
155057475|NCT00492726|559644180|FG000|Overall Study|Lack of Efficacy|0|||
155057476|NCT00492726|559644181|FG001|Overall Study|Lack of Efficacy|2|||
155057477|NCT00492726|559644180|FG000|Overall Study|Lost to Follow-up|27|||
155057478|NCT00492726|559644181|FG001|Overall Study|Lost to Follow-up|19|||
155057479|NCT00492726|559644180|FG000|Overall Study|Physician Decision|0|||
155057480|NCT00492726|559644181|FG001|Overall Study|Physician Decision|1|||
155057481|NCT00492726|559644180|FG000|Overall Study|Withdrawal by Subject|6|||
155057482|NCT00492726|559644181|FG001|Overall Study|Withdrawal by Subject|3|||
155057483|NCT00492726|559644180|FG000|Overall Study|Non compliant with study medication|0|||
155057484|NCT00492726|559644181|FG001|Overall Study|Non compliant with study medication|3|||
155057485|NCT01100502|559644182|FG000|Overall Study|Withdrawal by Subject|18|||
155057486|NCT01100502|559644183|FG001|Overall Study|Withdrawal by Subject|25|||
155057487|NCT01100502|559644182|FG000|Overall Study|Lost to Follow-up|13|||
155057488|NCT01100502|559644183|FG001|Overall Study|Lost to Follow-up|28|||
155057489|NCT01100502|559644182|FG000|Overall Study|Site request to end participation in study|0|||
155057490|NCT01100502|559644183|FG001|Overall Study|Site request to end participation in study|1|||
155057491|NCT01100502|559644182|FG000|Overall Study|Death|45|||
155057492|NCT01100502|559644183|FG001|Overall Study|Death|40|||
155057493|NCT04386902|559644184|FG000|Overall Study|Withdrawal by Subject|5|||
155057494|NCT04386902|559644184|FG000|Overall Study|Technical problems in the recording|5|||
155057495|NCT01926028|559645714|FG000|Overall Study|Lost to Follow-up|7|||
155057496|NCT01926028|559645715|FG001|Overall Study|Lost to Follow-up|6|||
155394254|NCT01876251|560880243|FG001|Overall Study|Participant started new treatment|0|||
155394255|NCT01876251|560880244|FG002|Overall Study|Participant started new treatment|1|||
155394256|NCT01876251|560880242|FG000|Overall Study|Participant refused further follow-up|0|||
155057497|NCT01926028|559645716|FG002|Overall Study|Lost to Follow-up|0|||
155057498|NCT01926028|559645714|FG000|Overall Study|Physician Decision|1|||
155394257|NCT01876251|560880243|FG001|Overall Study|Participant refused further follow-up|0|||
155057499|NCT01926028|559645715|FG001|Overall Study|Physician Decision|5|||
155057500|NCT01926028|559645716|FG002|Overall Study|Physician Decision|0|||
155057501|NCT01926028|559645714|FG000|Overall Study|Withdrawal by Subject|9|||
155057502|NCT01926028|559645715|FG001|Overall Study|Withdrawal by Subject|9|||
155057503|NCT01926028|559645716|FG002|Overall Study|Withdrawal by Subject|2|||
155394258|NCT01876251|560880244|FG002|Overall Study|Participant refused further follow-up|1|||
155394259|NCT01876251|560880242|FG000|Overall Study|Study terminated|1|||
155057504|NCT01926028|559645714|FG000|Overall Study|Non compliance or other reasons|4|||
155057505|NCT01926028|559645715|FG001|Overall Study|Non compliance or other reasons|2|||
155394260|NCT01876251|560880243|FG001|Overall Study|Study terminated|0|||
155394261|NCT01876251|560880244|FG002|Overall Study|Study terminated|0|||
155394262|NCT01876251|560880242|FG000|Overall Study|Objective progression or relapse|10|||
155057506|NCT01926028|559645716|FG002|Overall Study|Non compliance or other reasons|0|||
155057507|NCT00301834|559645717|FG000|Overall Study|Death|1|||
155057508|NCT00744939|559645718|FG000|Overall Study|Withdrawal by Subject|9|||
155057509|NCT00744939|559645718|FG000|Overall Study|Protocol Violation|13|||
155057510|NCT00744939|559645718|FG000|Overall Study|Death|24|||
155057511|NCT00744939|559645718|FG000|Overall Study|distance|4|||
155057512|NCT00744939|559645718|FG000|Overall Study|Lost to Follow-up|12|||
155057513|NCT00744939|559645718|FG000|Overall Study|Medical history exclusionary|1|||
155057514|NCT00744939|559645718|FG000|Overall Study|Did not receive Magnevist|7|||
155057515|NCT00744939|559645718|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
155057516|NCT00744939|559645718|FG000|Overall Study|coma|1|||
155057517|NCT00744939|559645718|FG000|Overall Study|incorrect race|1|||
155057518|NCT01739335|559645719|FG000|Overall Study|Lost to Follow-up|7|||
155057519|NCT01739335|559645720|FG001|Overall Study|Lost to Follow-up|4|||
155057520|NCT01739335|559645719|FG000|Overall Study|Ineligible patient randomized|0|||
155057521|NCT01739335|559645720|FG001|Overall Study|Ineligible patient randomized|1|||
155057522|NCT00288912|559645721|FG000|Overall Study|Developed exclusion criterion|4|||
155057523|NCT00288912|559645722|FG001|Overall Study|Developed exclusion criterion|6|||
155057524|NCT00288912|559645723|FG002|Overall Study|Developed exclusion criterion|7|||
155057525|NCT00288912|559645721|FG000|Overall Study|Lost to Follow-up|9|||
155057526|NCT00288912|559645722|FG001|Overall Study|Lost to Follow-up|6|||
155057527|NCT00288912|559645723|FG002|Overall Study|Lost to Follow-up|9|||
155057528|NCT00288912|559645721|FG000|Overall Study|Withdrawal by Subject|4|||
155057529|NCT00288912|559645722|FG001|Overall Study|Withdrawal by Subject|5|||
155057530|NCT00288912|559645723|FG002|Overall Study|Withdrawal by Subject|12|||
155057531|NCT00183430|559645726|FG000|Overall Study|Adverse Event|1|||
155057532|NCT00183430|559645727|FG001|Overall Study|Adverse Event|0|||
155057533|NCT00183430|559645726|FG000|Overall Study|Lost to Follow-up|3|||
155057534|NCT00183430|559645727|FG001|Overall Study|Lost to Follow-up|0|||
155057535|NCT00183430|559645726|FG000|Overall Study|did not meet inclusion criteria|1|||
155057536|NCT00183430|559645727|FG001|Overall Study|did not meet inclusion criteria|0|||
155057537|NCT00183430|559645726|FG000|Overall Study|Withdrawal by Subject|1|||
155057538|NCT00183430|559645727|FG001|Overall Study|Withdrawal by Subject|0|||
154952484|NCT00883090|559251984|FG000|Overall Study|Sponsor's decision|1|||
154952485|NCT00883090|559251984|FG000|Overall Study|Withdrawal by Subject|1|||
154952486|NCT03164772|559251988|FG000|Overall Study|Death|4|||
154952487|NCT03164772|559251989|FG001|Overall Study|Death|2|||
154952488|NCT03164772|559251988|FG000|Overall Study|Adverse Event|1|||
154952489|NCT03164772|559251989|FG001|Overall Study|Adverse Event|4|||
154952490|NCT03164772|559251988|FG000|Overall Study|Progressive Disease|11|||
154952491|NCT03164772|559251989|FG001|Overall Study|Progressive Disease|21|||
154952492|NCT03164772|559251988|FG000|Overall Study|Physician Decision|2|||
154952493|NCT03164772|559251989|FG001|Overall Study|Physician Decision|0|||
154952494|NCT03164772|559251988|FG000|Overall Study|Withdrawal by Subject|0|||
154952495|NCT03164772|559251989|FG001|Overall Study|Withdrawal by Subject|4|||
154952496|NCT02932878|559251994|FG000|Overall Study|Due to Lab Results|2|||
154952497|NCT02932878|559251995|FG001|Overall Study|Due to Lab Results|1|||
154952498|NCT00849901|559251996|FG000|Acute Treatment Phase|Adverse Event|9|||
154952499|NCT00849901|559251997|FG001|Acute Treatment Phase|Adverse Event|1|||
154952500|NCT00849901|559251998|FG002|Acute Treatment Phase|Adverse Event|3|||
154952501|NCT00849901|559251996|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
154952502|NCT00849901|559251997|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
154952503|NCT00849901|559251998|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
154952504|NCT00849901|559251996|FG000|Acute Treatment Phase|Protocol Violation|0|||
154952505|NCT00849901|559251997|FG001|Acute Treatment Phase|Protocol Violation|2|||
154952506|NCT00849901|559251998|FG002|Acute Treatment Phase|Protocol Violation|1|||
154952507|NCT00849901|559251996|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
154952508|NCT00849901|559251997|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
154952509|NCT00849901|559251998|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
154952510|NCT00849901|559251996|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
154952511|NCT00849901|559251997|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
154952512|NCT00849901|559251998|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
154952513|NCT00849901|559251996|FG000|Acute Treatment Phase|Physician Decision|1|||
154952514|NCT00849901|559251997|FG001|Acute Treatment Phase|Physician Decision|1|||
154952515|NCT00849901|559251998|FG002|Acute Treatment Phase|Physician Decision|1|||
154952516|NCT00849901|559251996|FG000|Acute Treatment Phase|Sponsor Decision|1|||
154952517|NCT00849901|559251997|FG001|Acute Treatment Phase|Sponsor Decision|0|||
154952518|NCT00849901|559251998|FG002|Acute Treatment Phase|Sponsor Decision|0|||
155057539|NCT01863771|559645736|FG000|Induction Phase|Adverse Event|9|||
154952519|NCT00849901|559251996|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
154952520|NCT00849901|559251997|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
154952521|NCT00849901|559251998|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
154952522|NCT00849901|559251996|FG000|Extension Phase|Adverse Event|2|||
154952523|NCT00849901|559251997|FG001|Extension Phase|Adverse Event|8|||
154952524|NCT00849901|559251998|FG002|Extension Phase|Adverse Event|4|||
154952525|NCT00849901|559251996|FG000|Extension Phase|Lost to Follow-up|3|||
155057540|NCT01863771|559645737|FG001|Induction Phase|Adverse Event|0|||
155394263|NCT01876251|560880243|FG001|Overall Study|Objective progression or relapse|3|||
155394264|NCT01876251|560880244|FG002|Overall Study|Objective progression or relapse|8|||
155394265|NCT02460497|560880249|FG000|Overall Study|Participant Requested Withdrawal|4|||
155394266|NCT02460497|560880249|FG000|Overall Study|Non-Compliance|1|||
155394267|NCT02460497|560880249|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
155394268|NCT02460497|560880249|FG000|Overall Study|Lost to Follow-up|2|||
155394269|NCT02460497|560880249|FG000|Overall Study|Investigator Decision|1|||
155394270|NCT03876171|560880250|FG000|Overall Study|Withdrawal by Subject|3|||
155394271|NCT03876171|560880251|FG001|Overall Study|Withdrawal by Subject|3|||
155283518|NCT04048135|560470754|FG001|Overall Study|Adverse Event|0|||
155394272|NCT03876171|560880250|FG000|Overall Study|Re-arrest|0|||
155394273|NCT03876171|560880251|FG001|Overall Study|Re-arrest|4|||
155394274|NCT02953639|560880252|FG000|Overall Study|Adverse Event|2|||
155394275|NCT02953639|560880253|FG001|Overall Study|Adverse Event|0|||
155394276|NCT02953639|560880254|FG002|Overall Study|Adverse Event|1|||
155394277|NCT02953639|560880252|FG000|Overall Study|Lost to Follow-up|8|||
155394278|NCT02953639|560880253|FG001|Overall Study|Lost to Follow-up|4|||
155394279|NCT02953639|560880254|FG002|Overall Study|Lost to Follow-up|3|||
155394280|NCT02953639|560880252|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155394281|NCT02953639|560880253|FG001|Overall Study|Non-Compliance With Study Drug|2|||
155057541|NCT01863771|559645738|FG002|Induction Phase|Adverse Event|0|||
155057542|NCT01863771|559645739|FG003|Induction Phase|Adverse Event|0|||
155057543|NCT01863771|559645736|FG000|Induction Phase|Lack of Efficacy|10|||
155057544|NCT01863771|559645737|FG001|Induction Phase|Lack of Efficacy|0|||
155057545|NCT01863771|559645738|FG002|Induction Phase|Lack of Efficacy|0|||
155057546|NCT01863771|559645739|FG003|Induction Phase|Lack of Efficacy|0|||
155057547|NCT01863771|559645736|FG000|Induction Phase|Withdrawal by Subject|2|||
155057548|NCT01863771|559645737|FG001|Induction Phase|Withdrawal by Subject|0|||
155057549|NCT01863771|559645738|FG002|Induction Phase|Withdrawal by Subject|0|||
155057550|NCT01863771|559645739|FG003|Induction Phase|Withdrawal by Subject|0|||
155057551|NCT01863771|559645736|FG000|Maintenance Phase|Adverse Event|0|||
155057552|NCT01863771|559645737|FG001|Maintenance Phase|Adverse Event|0|||
155057553|NCT01863771|559645738|FG002|Maintenance Phase|Adverse Event|1|||
155057554|NCT01863771|559645739|FG003|Maintenance Phase|Adverse Event|1|||
155057555|NCT01863771|559645736|FG000|Maintenance Phase|Lack of Efficacy|0|||
155057556|NCT01863771|559645737|FG001|Maintenance Phase|Lack of Efficacy|3|||
155057557|NCT01863771|559645738|FG002|Maintenance Phase|Lack of Efficacy|7|||
155057558|NCT01863771|559645739|FG003|Maintenance Phase|Lack of Efficacy|38|||
155283519|NCT04048135|560470755|FG002|Overall Study|Adverse Event|0|||
155283520|NCT04048135|560470756|FG003|Overall Study|Adverse Event|1|||
155283521|NCT04048135|560470757|FG004|Overall Study|Adverse Event|1|||
155283522|NCT04048135|560470758|FG005|Overall Study|Adverse Event|0|||
155283523|NCT04048135|560470759|FG006|Overall Study|Adverse Event|0|||
155283524|NCT04048135|560470760|FG007|Overall Study|Adverse Event|0|||
155283525|NCT04048135|560470753|FG000|Overall Study|Protocol Violation|0|||
155283526|NCT04048135|560470754|FG001|Overall Study|Protocol Violation|0|||
155283527|NCT04048135|560470755|FG002|Overall Study|Protocol Violation|0|||
155283528|NCT04048135|560470756|FG003|Overall Study|Protocol Violation|0|||
155283529|NCT04048135|560470757|FG004|Overall Study|Protocol Violation|0|||
155283530|NCT04048135|560470758|FG005|Overall Study|Protocol Violation|1|||
155283531|NCT04048135|560470759|FG006|Overall Study|Protocol Violation|0|||
155283532|NCT04048135|560470760|FG007|Overall Study|Protocol Violation|0|||
155283533|NCT02790606|560470763|FG000|Overall Study|Death|27|||
155283534|NCT02790606|560470763|FG000|Overall Study|Lost to Follow-up|4|||
155283535|NCT02790606|560470763|FG000|Overall Study|Physician Decision|3|||
155283536|NCT02790606|560470763|FG000|Overall Study|Withdrawal by Subject|1|||
155283537|NCT02735915|560470764|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
155283538|NCT02735915|560470764|FG000|Overall Study|Withdrawal following SAE|2|||
155283539|NCT02735915|560470764|FG000|Overall Study|Withdrawal by Subject|1|||
155283540|NCT05328973|560470765|FG000|Overall Study|Withdrawal by Subject|0|||
155283541|NCT05328973|560470766|FG001|Overall Study|Withdrawal by Subject|1|||
155283542|NCT00852475|560470772|FG000|Overall Study|Lost to Follow-up|3|||
155283543|NCT00852475|560470773|FG001|Overall Study|Lost to Follow-up|4|||
155283544|NCT00409708|560470774|FG000|Treatment|Abnormal test procedure result(s)|1|||
155283545|NCT00409708|560470775|FG001|Treatment|Abnormal test procedure result(s)|0|||
155283546|NCT00409708|560470774|FG000|Treatment|Lack of Efficacy|0|||
155283547|NCT00409708|560470775|FG001|Treatment|Lack of Efficacy|1|||
155283548|NCT00409708|560470774|FG000|Treatment|Protocol Violation|6|||
155283549|NCT00409708|560470775|FG001|Treatment|Protocol Violation|2|||
155394282|NCT02953639|560880254|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155057559|NCT01863771|559645736|FG000|Maintenance Phase|Physician Decision|0|||
155394283|NCT02953639|560880252|FG000|Overall Study|Multiple Reasons|1|||
155057560|NCT01863771|559645737|FG001|Maintenance Phase|Physician Decision|0|||
155057561|NCT01863771|559645738|FG002|Maintenance Phase|Physician Decision|2|||
155057562|NCT01863771|559645739|FG003|Maintenance Phase|Physician Decision|1|||
155283550|NCT00409708|560470774|FG000|Treatment|Withdrawal by Subject|3|||
155283551|NCT00409708|560470775|FG001|Treatment|Withdrawal by Subject|8|||
155394284|NCT02953639|560880253|FG001|Overall Study|Multiple Reasons|0|||
155057563|NCT01863771|559645736|FG000|Maintenance Phase|Pregnancy|0|||
155057564|NCT01863771|559645737|FG001|Maintenance Phase|Pregnancy|1|||
155394285|NCT02953639|560880254|FG002|Overall Study|Multiple Reasons|1|||
155394286|NCT02953639|560880252|FG000|Overall Study|Physician Decision|1|||
155057565|NCT01863771|559645738|FG002|Maintenance Phase|Pregnancy|0|||
155057566|NCT01863771|559645739|FG003|Maintenance Phase|Pregnancy|0|||
155057567|NCT01863771|559645736|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155394287|NCT02953639|560880253|FG001|Overall Study|Physician Decision|0|||
155394288|NCT02953639|560880254|FG002|Overall Study|Physician Decision|0|||
155394289|NCT02953639|560880252|FG000|Overall Study|Withdrawal by Subject|7|||
155394290|NCT02953639|560880253|FG001|Overall Study|Withdrawal by Subject|8|||
155394291|NCT02953639|560880254|FG002|Overall Study|Withdrawal by Subject|10|||
155394292|NCT02953639|560880252|FG000|Overall Study|Completed or Discontinued information is missing|1|||
155394293|NCT02953639|560880253|FG001|Overall Study|Completed or Discontinued information is missing|0|||
155394294|NCT02953639|560880254|FG002|Overall Study|Completed or Discontinued information is missing|0|||
155394295|NCT01830855|560880255|FG000|Overall Study|Other|7|||
155394296|NCT01830855|560880256|FG001|Overall Study|Other|1|||
155394297|NCT01830855|560880257|FG002|Overall Study|Other|4|||
155394298|NCT01830855|560880258|FG003|Overall Study|Other|4|||
155394299|NCT01830855|560880255|FG000|Overall Study|Medication error without associated AE|1|||
155394300|NCT01830855|560880256|FG001|Overall Study|Medication error without associated AE|0|||
155394301|NCT01830855|560880257|FG002|Overall Study|Medication error without associated AE|0|||
155394302|NCT01830855|560880258|FG003|Overall Study|Medication error without associated AE|1|||
155394303|NCT01830855|560880255|FG000|Overall Study|Pregnancy|3|||
155394304|NCT01830855|560880256|FG001|Overall Study|Pregnancy|1|||
155394305|NCT01830855|560880257|FG002|Overall Study|Pregnancy|2|||
155394306|NCT01830855|560880258|FG003|Overall Study|Pregnancy|1|||
155394307|NCT01830855|560880255|FG000|Overall Study|No longer meets eligibility criteria|11|||
155394308|NCT01830855|560880256|FG001|Overall Study|No longer meets eligibility criteria|2|||
155394309|NCT01830855|560880257|FG002|Overall Study|No longer meets eligibility criteria|3|||
155394310|NCT01830855|560880258|FG003|Overall Study|No longer meets eligibility criteria|5|||
155394311|NCT01830855|560880255|FG000|Overall Study|Adverse Event|11|||
155394312|NCT01830855|560880256|FG001|Overall Study|Adverse Event|5|||
155394313|NCT01830855|560880257|FG002|Overall Study|Adverse Event|6|||
155394314|NCT01830855|560880258|FG003|Overall Study|Adverse Event|3|||
155394315|NCT01830855|560880255|FG000|Overall Study|Protocol deviation|10|||
155394316|NCT01830855|560880256|FG001|Overall Study|Protocol deviation|5|||
155394317|NCT01830855|560880257|FG002|Overall Study|Protocol deviation|6|||
155394318|NCT01830855|560880258|FG003|Overall Study|Protocol deviation|6|||
155394319|NCT01830855|560880255|FG000|Overall Study|Withdrawal by Subject|33|||
155394320|NCT01830855|560880256|FG001|Overall Study|Withdrawal by Subject|14|||
155057568|NCT01863771|559645737|FG001|Maintenance Phase|Withdrawal by Subject|1|||
155057569|NCT01863771|559645738|FG002|Maintenance Phase|Withdrawal by Subject|2|||
155057570|NCT01863771|559645739|FG003|Maintenance Phase|Withdrawal by Subject|3|||
155057571|NCT03636256|559645740|FG000|Overall Study|Lost to Follow-up|3|||
155057572|NCT03636256|559645741|FG001|Overall Study|Lost to Follow-up|0|||
155057573|NCT03636256|559645742|FG002|Overall Study|Lost to Follow-up|2|||
155057574|NCT03636256|559645743|FG003|Overall Study|Lost to Follow-up|1|||
155057575|NCT03636256|559645744|FG004|Overall Study|Lost to Follow-up|0|||
155057576|NCT03636256|559645745|FG005|Overall Study|Lost to Follow-up|4|||
155057577|NCT03636256|559645746|FG006|Overall Study|Lost to Follow-up|2|||
155057578|NCT03636256|559645747|FG007|Overall Study|Lost to Follow-up|0|||
155057579|NCT03636256|559645748|FG008|Overall Study|Lost to Follow-up|4|||
155057580|NCT03636256|559645740|FG000|Overall Study|Withdrawal by Subject|0|||
155057581|NCT03636256|559645741|FG001|Overall Study|Withdrawal by Subject|0|||
155057582|NCT03636256|559645742|FG002|Overall Study|Withdrawal by Subject|0|||
155057583|NCT03636256|559645743|FG003|Overall Study|Withdrawal by Subject|0|||
155057584|NCT03636256|559645744|FG004|Overall Study|Withdrawal by Subject|0|||
155057585|NCT03636256|559645745|FG005|Overall Study|Withdrawal by Subject|0|||
155057586|NCT03636256|559645746|FG006|Overall Study|Withdrawal by Subject|0|||
155057587|NCT03636256|559645747|FG007|Overall Study|Withdrawal by Subject|0|||
155057588|NCT03636256|559645748|FG008|Overall Study|Withdrawal by Subject|1|||
155057589|NCT01218308|559645749|FG000|Overall Study|Adverse Event|1|||
155057590|NCT01218308|559645750|FG001|Overall Study|Adverse Event|2|||
155057591|NCT01218308|559645749|FG000|Overall Study|Protocol Violation|0|||
155057592|NCT01218308|559645750|FG001|Overall Study|Protocol Violation|2|||
155057593|NCT01218308|559645749|FG000|Overall Study|Withdrawal by Subject|61|||
155057594|NCT01218308|559645750|FG001|Overall Study|Withdrawal by Subject|64|||
155057595|NCT01218308|559645749|FG000|Overall Study|Lost to Follow-up|27|||
155057596|NCT01218308|559645750|FG001|Overall Study|Lost to Follow-up|31|||
155394321|NCT01830855|560880257|FG002|Overall Study|Withdrawal by Subject|10|||
155394322|NCT01830855|560880258|FG003|Overall Study|Withdrawal by Subject|12|||
155394323|NCT01830855|560880255|FG000|Overall Study|No longer willing to participate|32|||
155394324|NCT01830855|560880256|FG001|Overall Study|No longer willing to participate|13|||
155394325|NCT01830855|560880257|FG002|Overall Study|No longer willing to participate|12|||
155394326|NCT01830855|560880258|FG003|Overall Study|No longer willing to participate|17|||
155394327|NCT01830855|560880255|FG000|Overall Study|Lost to Follow-up|47|||
155394328|NCT01830855|560880256|FG001|Overall Study|Lost to Follow-up|20|||
155057597|NCT01218308|559645749|FG000|Overall Study|Other|14|||
155057598|NCT01218308|559645750|FG001|Overall Study|Other|21|||
155394329|NCT01830855|560880257|FG002|Overall Study|Lost to Follow-up|23|||
155057599|NCT02426684|559645751|FG000|Overall Study|Physician Decision|1|||
155057600|NCT00723229|559645754|FG000|First Intervention|Lost to Follow-up|7|||
155057601|NCT00723229|559645755|FG001|First Intervention|Lost to Follow-up|3|||
155057602|NCT00977197|559645756|FG000|Overall Study|Withdrawal by Subject|3|||
155057603|NCT00977197|559645757|FG001|Overall Study|Withdrawal by Subject|4|||
155057604|NCT00977197|559645756|FG000|Overall Study|Adverse Event|3|||
155057605|NCT00977197|559645757|FG001|Overall Study|Adverse Event|1|||
155057606|NCT00977197|559645756|FG000|Overall Study|Lack of Efficacy|1|||
155057607|NCT00977197|559645757|FG001|Overall Study|Lack of Efficacy|0|||
155057608|NCT00977197|559645756|FG000|Overall Study|Lost to Follow-up|1|||
155057609|NCT00977197|559645757|FG001|Overall Study|Lost to Follow-up|3|||
155057610|NCT00977197|559645756|FG000|Overall Study|Nonadherence|1|||
155057611|NCT00977197|559645757|FG001|Overall Study|Nonadherence|1|||
155057612|NCT00386334|559645760|FG000|Double Blind Period|Adverse Event|9|||
155057613|NCT00386334|559645761|FG001|Double Blind Period|Adverse Event|14|||
155057614|NCT00386334|559645760|FG000|Double Blind Period|Protocol Violation|1|||
155057615|NCT00386334|559645761|FG001|Double Blind Period|Protocol Violation|1|||
155057616|NCT00386334|559645760|FG000|Double Blind Period|Withdrawal by Subject|9|||
155057617|NCT00386334|559645761|FG001|Double Blind Period|Withdrawal by Subject|13|||
155057618|NCT00386334|559645760|FG000|Double Blind Period|Lack of Efficacy|20|||
155057619|NCT00386334|559645761|FG001|Double Blind Period|Lack of Efficacy|11|||
155057620|NCT00386334|559645760|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
155057621|NCT00386334|559645761|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
155057622|NCT00386334|559645760|FG000|Double Blind Period|Other|3|||
155057623|NCT00386334|559645761|FG001|Double Blind Period|Other|3|||
155057624|NCT00386334|559645760|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
155057625|NCT00386334|559645761|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
155394330|NCT01830855|560880258|FG003|Overall Study|Lost to Follow-up|33|||
155394331|NCT01667081|560880259|FG000|Overall Study|Death|43|||
155394332|NCT01667081|560880260|FG001|Overall Study|Death|3|||
155394333|NCT01667081|560880259|FG000|Overall Study|Lost to Follow-up|99|||
155394334|NCT01667081|560880260|FG001|Overall Study|Lost to Follow-up|48|||
155394335|NCT01667081|560880259|FG000|Overall Study|Physician Decision|16|||
155394336|NCT01667081|560880260|FG001|Overall Study|Physician Decision|2|||
155057626|NCT00785356|559645762|FG000|Overall Study|Study prematurely terminated|8|||
155057627|NCT03238417|559645764|FG000|Overall|non-response|955|||
155057628|NCT03238417|559645765|FG001|Overall|non-response|1920|||
155057629|NCT03238417|559645764|FG000|Overall|partial completion|48|||
155057630|NCT03238417|559645765|FG001|Overall|partial completion|68|||
155057631|NCT03238417|559645764|FG000|Baseline|Partial completion|17|||
155057632|NCT03238417|559645765|FG001|Baseline|Partial completion|48|||
155057633|NCT03238417|559645764|FG000|Baseline|non-response|372|||
155057634|NCT03238417|559645765|FG001|Baseline|non-response|669|||
155057635|NCT03238417|559645764|FG000|12-month|non-response|296|||
155057636|NCT03238417|559645765|FG001|12-month|non-response|669|||
155153091|NCT01383928|559998554|FG002|Overall Study|Adverse Event|8|||
155153092|NCT01383928|559998552|FG000|Overall Study|Other|1|||
155153093|NCT01383928|559998553|FG001|Overall Study|Other|3|||
155153094|NCT01383928|559998554|FG002|Overall Study|Other|4|||
155153095|NCT01383928|559998552|FG000|Overall Study|Progressive Disease|1|||
155153096|NCT01383928|559998553|FG001|Overall Study|Progressive Disease|1|||
155153097|NCT01383928|559998554|FG002|Overall Study|Progressive Disease|5|||
155153098|NCT01383928|559998552|FG000|Overall Study|Withdrawal by Subject|0|||
155153099|NCT01383928|559998553|FG001|Overall Study|Withdrawal by Subject|0|||
155153100|NCT01383928|559998554|FG002|Overall Study|Withdrawal by Subject|4|||
155153101|NCT01383928|559998552|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
155153102|NCT01383928|559998553|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155153103|NCT01383928|559998554|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
155153104|NCT02491684|559998555|FG000|Treatment Phase|Adverse Event|2|||
155153105|NCT02491684|559998556|FG001|Treatment Phase|Adverse Event|2|||
155394337|NCT01667081|560880259|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
155153106|NCT02491684|559998555|FG000|Treatment Phase|Incorrect randomisation|1|||
155153107|NCT02491684|559998556|FG001|Treatment Phase|Incorrect randomisation|0|||
155394338|NCT01667081|560880260|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
155394339|NCT01667081|560880259|FG000|Overall Study|Withdrawal by Subject|90|||
155153108|NCT02491684|559998555|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
155153109|NCT02491684|559998556|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
155153110|NCT01149096|559998557|FG000|Overall Study|Lost to Follow-up|0|||
155153111|NCT01149096|559998558|FG001|Overall Study|Lost to Follow-up|1|||
155153112|NCT04739982|559998560|FG000|Overall Study|Lost to Follow-up|176|||
155153113|NCT04739982|559998561|FG001|Overall Study|Lost to Follow-up|65|||
155153114|NCT04739982|559998560|FG000|Overall Study|Withdrawal by Subject|19|||
155153115|NCT04739982|559998561|FG001|Overall Study|Withdrawal by Subject|0|||
154952526|NCT00849901|559251997|FG001|Extension Phase|Lost to Follow-up|0|||
154952527|NCT00849901|559251998|FG002|Extension Phase|Lost to Follow-up|1|||
154952528|NCT00849901|559251996|FG000|Extension Phase|Protocol Violation|2|||
154952529|NCT00849901|559251997|FG001|Extension Phase|Protocol Violation|2|||
155057637|NCT03238417|559645764|FG000|12-month|partial completion|23|||
155283552|NCT00409708|560470774|FG000|Treatment|Lost to Follow-up|0|||
154952530|NCT00849901|559251998|FG002|Extension Phase|Protocol Violation|4|||
154952531|NCT00849901|559251996|FG000|Extension Phase|Withdrawal by Subject|7|||
154952532|NCT00849901|559251997|FG001|Extension Phase|Withdrawal by Subject|6|||
154952533|NCT00849901|559251998|FG002|Extension Phase|Withdrawal by Subject|3|||
154952534|NCT00849901|559251996|FG000|Extension Phase|Parent or Caregiver Decision|10|||
154952535|NCT00849901|559251997|FG001|Extension Phase|Parent or Caregiver Decision|4|||
154952536|NCT00849901|559251998|FG002|Extension Phase|Parent or Caregiver Decision|4|||
154952537|NCT00849901|559251996|FG000|Extension Phase|Physician Decision|1|||
154952538|NCT00849901|559251997|FG001|Extension Phase|Physician Decision|2|||
154952539|NCT00849901|559251998|FG002|Extension Phase|Physician Decision|0|||
154952540|NCT00849901|559251996|FG000|Extension Phase|Lack of Efficacy|2|||
154952541|NCT00849901|559251997|FG001|Extension Phase|Lack of Efficacy|4|||
154952542|NCT00849901|559251998|FG002|Extension Phase|Lack of Efficacy|1|||
154952543|NCT00262223|559251999|FG000|Treatment Phase|Withdrawal by Subject|3|||
154952544|NCT00262223|559252000|FG001|Treatment Phase|Withdrawal by Subject|6|||
154952545|NCT00262223|559251999|FG000|Treatment Phase|Adverse Event|1|||
154952546|NCT00262223|559252000|FG001|Treatment Phase|Adverse Event|2|||
154952547|NCT00262223|559251999|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
154952548|NCT00262223|559252000|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
154952549|NCT00262223|559251999|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
154952550|NCT00262223|559252000|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
154952551|NCT00262223|559251999|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
154952552|NCT00262223|559252000|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
154952553|NCT00437658|559252003|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
154952554|NCT00437658|559252004|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
154952555|NCT00437658|559252005|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
154952556|NCT00437658|559252003|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
154952557|NCT00437658|559252004|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
154952558|NCT00437658|559252005|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
154952559|NCT00437658|559252003|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
154952560|NCT00437658|559252004|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
154952561|NCT00437658|559252005|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
154952562|NCT00437658|559252003|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
154952563|NCT00437658|559252004|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
154952564|NCT00437658|559252005|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
154952565|NCT00437658|559252003|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
154952566|NCT00437658|559252004|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
154952567|NCT00437658|559252005|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
154952568|NCT00437658|559252003|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
154952569|NCT00437658|559252004|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
154952570|NCT00437658|559252005|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
154952571|NCT00437658|559252003|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
155057638|NCT03238417|559645765|FG001|12-month|partial completion|37|||
155283553|NCT00409708|560470775|FG001|Treatment|Lost to Follow-up|6|||
155283554|NCT00409708|560470774|FG000|Treatment|Administrative problems|5|||
155283555|NCT00409708|560470775|FG001|Treatment|Administrative problems|0|||
155283556|NCT00409708|560470774|FG000|Washout|Lack of Efficacy|9|||
155283557|NCT00409708|560470775|FG001|Washout|Lack of Efficacy|1|||
155283558|NCT00409708|560470774|FG000|Washout|Protocol Violation|0|||
155283559|NCT00409708|560470775|FG001|Washout|Protocol Violation|1|||
155283560|NCT00409708|560470774|FG000|Washout|Withdrawal by Subject|11|||
155283561|NCT00409708|560470775|FG001|Washout|Withdrawal by Subject|5|||
155283562|NCT00409708|560470774|FG000|Washout|Lost to Follow-up|1|||
155283563|NCT00409708|560470775|FG001|Washout|Lost to Follow-up|3|||
155283564|NCT00946114|560470776|FG000|Overall Study|Death|5|||
155283565|NCT00946114|560470777|FG001|Overall Study|Death|2|||
155283566|NCT00946114|560470776|FG000|Overall Study|Other|1|||
155283567|NCT00946114|560470777|FG001|Overall Study|Other|0|||
155283568|NCT00946114|560470776|FG000|Overall Study|Withdrawal by Subject|2|||
155283569|NCT00946114|560470777|FG001|Overall Study|Withdrawal by Subject|0|||
155283570|NCT01175707|560470778|FG000|Overall Study|Adverse Event|4|||
155283571|NCT01175707|560470779|FG001|Overall Study|Adverse Event|6|||
155283572|NCT03085017|560470782|FG000|Overall Study|Death|0|||
155283573|NCT03085017|560470783|FG001|Overall Study|Death|3|||
155283574|NCT00058058|560470784|FG000|Overall Study|Withdrawal by Subject|4|||
155283575|NCT00058058|560470784|FG000|Overall Study|Ineligible|20|||
155283576|NCT00058058|560470784|FG000|Overall Study|Claustrophobic|5|||
155283577|NCT00058058|560470784|FG000|Overall Study|technical issues|6|||
155283578|NCT00058058|560470784|FG000|Overall Study|Poor positioning, illness,pain|3|||
155057639|NCT03238417|559645764|FG000|24-month|non-response|287|||
155057640|NCT03238417|559645765|FG001|24-month|non-response|594|||
155057641|NCT03238417|559645764|FG000|24-month|partial completion|8|||
154952572|NCT00437658|559252004|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
154952573|NCT00437658|559252005|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
154952574|NCT00437658|559252003|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
154952575|NCT00437658|559252004|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
154952576|NCT00437658|559252005|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
154952577|NCT00437658|559252003|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
154952578|NCT00437658|559252004|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
154952579|NCT00437658|559252005|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
154952580|NCT00437658|559252003|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
154952581|NCT00437658|559252004|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
154952582|NCT00437658|559252005|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
154952583|NCT00437658|559252003|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
154952584|NCT00437658|559252004|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
154952585|NCT00437658|559252005|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
154952586|NCT00437658|559252003|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
154952587|NCT00437658|559252004|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
154952588|NCT00437658|559252005|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
154952589|NCT03952143|559252006|FG000|Lead-In Period|Adverse Event|2|||
154952590|NCT03952143|559252007|FG001|Lead-In Period|Adverse Event|0|||
154952591|NCT03952143|559252008|FG002|Lead-In Period|Adverse Event|0|||
154952592|NCT03952143|559252006|FG000|Lead-In Period|Lack of Efficacy|2|||
154952593|NCT03952143|559252007|FG001|Lead-In Period|Lack of Efficacy|0|||
154952594|NCT03952143|559252008|FG002|Lead-In Period|Lack of Efficacy|0|||
154952595|NCT03952143|559252006|FG000|Lead-In Period|Physician Decision|5|||
154952596|NCT03952143|559252007|FG001|Lead-In Period|Physician Decision|0|||
154952597|NCT03952143|559252008|FG002|Lead-In Period|Physician Decision|0|||
154952598|NCT03952143|559252006|FG000|Lead-In Period|Protocol Violation|5|||
154952599|NCT03952143|559252007|FG001|Lead-In Period|Protocol Violation|0|||
154952600|NCT03952143|559252008|FG002|Lead-In Period|Protocol Violation|0|||
154952601|NCT03952143|559252006|FG000|Lead-In Period|Withdrawal by Subject|19|||
155057642|NCT03238417|559645765|FG001|24-month|partial completion|31|||
155394340|NCT01667081|560880260|FG001|Overall Study|Withdrawal by Subject|35|||
155394341|NCT03034460|560880261|FG000|Overall Study|Adverse Event|0|||
155394342|NCT03034460|560880262|FG001|Overall Study|Adverse Event|1|||
155394343|NCT03034460|560880261|FG000|Overall Study|Withdrawal by Subject|2|||
155394344|NCT03034460|560880262|FG001|Overall Study|Withdrawal by Subject|2|||
155394345|NCT03034460|560880261|FG000|Overall Study|Personal Reasons|1|||
155394346|NCT03034460|560880262|FG001|Overall Study|Personal Reasons|0|||
155394347|NCT00295633|560880265|FG000|Overall Study|Lack of Efficacy|19|||
155394348|NCT00295633|560880266|FG001|Overall Study|Lack of Efficacy|7|||
155394349|NCT00295633|560880267|FG002|Overall Study|Lack of Efficacy|16|||
155394350|NCT00295633|560880265|FG000|Overall Study|Withdrawal of consent by subject|16|||
155394351|NCT00295633|560880266|FG001|Overall Study|Withdrawal of consent by subject|16|||
155394352|NCT00295633|560880267|FG002|Overall Study|Withdrawal of consent by subject|26|||
155394353|NCT00295633|560880265|FG000|Overall Study|Adverse Event|9|||
155394354|NCT00295633|560880266|FG001|Overall Study|Adverse Event|17|||
155394355|NCT00295633|560880267|FG002|Overall Study|Adverse Event|9|||
155394356|NCT00295633|560880265|FG000|Overall Study|Lost to Follow-up|6|||
155394357|NCT00295633|560880266|FG001|Overall Study|Lost to Follow-up|11|||
155394358|NCT00295633|560880267|FG002|Overall Study|Lost to Follow-up|7|||
155394359|NCT00295633|560880265|FG000|Overall Study|Physician Decision|9|||
155394360|NCT00295633|560880266|FG001|Overall Study|Physician Decision|10|||
155394361|NCT00295633|560880267|FG002|Overall Study|Physician Decision|8|||
155394362|NCT00295633|560880265|FG000|Overall Study|Poor/Noncompliance|2|||
155394363|NCT00295633|560880266|FG001|Overall Study|Poor/Noncompliance|2|||
155394364|NCT00295633|560880267|FG002|Overall Study|Poor/Noncompliance|6|||
155394365|NCT00295633|560880265|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155394366|NCT00295633|560880266|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
155394367|NCT00295633|560880267|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
155394368|NCT00295633|560880265|FG000|Overall Study|Death|1|||
155394369|NCT00295633|560880266|FG001|Overall Study|Death|1|||
155394370|NCT00295633|560880267|FG002|Overall Study|Death|0|||
155394371|NCT00295633|560880265|FG000|Overall Study|Administrative reason by sponsor|0|||
154952602|NCT03952143|559252007|FG001|Lead-In Period|Withdrawal by Subject|0|||
154952603|NCT03952143|559252008|FG002|Lead-In Period|Withdrawal by Subject|0|||
155394372|NCT00295633|560880266|FG001|Overall Study|Administrative reason by sponsor|0|||
155394373|NCT00295633|560880267|FG002|Overall Study|Administrative reason by sponsor|1|||
155394374|NCT01798992|560880268|FG000|Overall Study|Administrative withdrawal|0|||
155394375|NCT01798992|560880269|FG001|Overall Study|Administrative withdrawal|1|||
155394376|NCT01798992|560880270|FG002|Overall Study|Administrative withdrawal|0|||
155057643|NCT03439137|559645773|FG000|Overall Study|Adverse Event|16|||
155057644|NCT03439137|559645774|FG001|Overall Study|Adverse Event|12|||
155394377|NCT01798992|560880271|FG003|Overall Study|Administrative withdrawal|1|||
155394378|NCT01798992|560880268|FG000|Overall Study|Lost to Follow-up|0|||
155394379|NCT01798992|560880269|FG001|Overall Study|Lost to Follow-up|1|||
155394380|NCT01798992|560880270|FG002|Overall Study|Lost to Follow-up|1|||
155394381|NCT01798992|560880271|FG003|Overall Study|Lost to Follow-up|0|||
155394382|NCT01798992|560880268|FG000|Overall Study|Insufficient biopsy tissue|0|||
155394383|NCT01798992|560880269|FG001|Overall Study|Insufficient biopsy tissue|0|||
155394384|NCT01798992|560880270|FG002|Overall Study|Insufficient biopsy tissue|1|||
155394385|NCT01798992|560880271|FG003|Overall Study|Insufficient biopsy tissue|0|||
155394386|NCT02294682|560880272|FG000|Overall Study|Could not swallow pills|1|||
155394387|NCT02294682|560880273|FG001|Overall Study|Could not swallow pills|0|||
155394388|NCT01516970|560880274|FG000|Overall Study|Lost to Follow-up|7|||
155394389|NCT01516970|560880275|FG001|Overall Study|Lost to Follow-up|8|||
155394390|NCT01516970|560880274|FG000|Overall Study|Adverse Event|1|||
155394391|NCT01516970|560880275|FG001|Overall Study|Adverse Event|5|||
155394392|NCT01516970|560880274|FG000|Overall Study|Withdrawal by Subject|1|||
155394393|NCT01516970|560880275|FG001|Overall Study|Withdrawal by Subject|1|||
155394394|NCT01516970|560880274|FG000|Overall Study|Other|9|||
155394395|NCT01516970|560880275|FG001|Overall Study|Other|7|||
155394396|NCT01205438|560880276|FG000|Overall Study|Adverse Event|19|||
155394397|NCT01205438|560880277|FG001|Overall Study|Adverse Event|17|||
155394398|NCT01205438|560880278|FG002|Overall Study|Adverse Event|24|||
155394399|NCT01205438|560880276|FG000|Overall Study|Death|1|||
155394400|NCT01205438|560880277|FG001|Overall Study|Death|1|||
155394401|NCT01205438|560880278|FG002|Overall Study|Death|3|||
155394402|NCT01205438|560880276|FG000|Overall Study|Entry Criteria Not Met|16|||
155394403|NCT01205438|560880277|FG001|Overall Study|Entry Criteria Not Met|15|||
155394404|NCT01205438|560880278|FG002|Overall Study|Entry Criteria Not Met|13|||
155394405|NCT01205438|560880276|FG000|Overall Study|Lack of Efficacy|14|||
155394406|NCT01205438|560880277|FG001|Overall Study|Lack of Efficacy|11|||
155394407|NCT01205438|560880278|FG002|Overall Study|Lack of Efficacy|14|||
155394408|NCT01205438|560880276|FG000|Overall Study|Lost to Follow-up|6|||
155394409|NCT01205438|560880277|FG001|Overall Study|Lost to Follow-up|7|||
155394410|NCT01205438|560880278|FG002|Overall Study|Lost to Follow-up|8|||
155394411|NCT01205438|560880276|FG000|Overall Study|Withdrawal by Subject|19|||
155394412|NCT01205438|560880277|FG001|Overall Study|Withdrawal by Subject|25|||
155394413|NCT01205438|560880278|FG002|Overall Study|Withdrawal by Subject|19|||
155394414|NCT01205438|560880276|FG000|Overall Study|Physician Decision|0|||
155394415|NCT01205438|560880277|FG001|Overall Study|Physician Decision|3|||
155394416|NCT01205438|560880278|FG002|Overall Study|Physician Decision|2|||
155394417|NCT01205438|560880276|FG000|Overall Study|Protocol Violation|2|||
155394418|NCT01205438|560880277|FG001|Overall Study|Protocol Violation|7|||
155394419|NCT01205438|560880278|FG002|Overall Study|Protocol Violation|4|||
155394420|NCT01205438|560880276|FG000|Overall Study|Sponsor Decision|0|||
155394421|NCT01205438|560880277|FG001|Overall Study|Sponsor Decision|1|||
155283579|NCT04337489|560470785|FG000|Overall Study|Withdrawal by Subject|1|||
155283580|NCT01579578|560470786|FG000|Overall Study|Death|4|||
155283581|NCT01579578|560470787|FG001|Overall Study|Death|1|||
155283582|NCT01579578|560470786|FG000|Overall Study|Lost to Follow-up|1|||
155283583|NCT01579578|560470787|FG001|Overall Study|Lost to Follow-up|1|||
155283584|NCT01579578|560470786|FG000|Overall Study|Withdrawal by Subject|2|||
155283585|NCT01579578|560470787|FG001|Overall Study|Withdrawal by Subject|1|||
155283586|NCT01579578|560470786|FG000|Overall Study|Eligibility criteria|3|||
155283587|NCT01579578|560470787|FG001|Overall Study|Eligibility criteria|9|||
155283588|NCT01579578|560470786|FG000|Overall Study|Ongoing|3|||
155283589|NCT01579578|560470787|FG001|Overall Study|Ongoing|0|||
155283590|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
155283591|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
155283592|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
155283593|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
155283594|NCT00335153|560470788|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
155283595|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
155283596|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
155283597|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
155283598|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
155283599|NCT00335153|560470788|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
155394422|NCT01205438|560880278|FG002|Overall Study|Sponsor Decision|1|||
154952604|NCT03952143|559252006|FG000|Treatment Period|Adverse Event|0|||
155283600|NCT00530777|560470797|FG000|Overall Study|Lost to Follow-up|0|||
155283601|NCT00530777|560470798|FG001|Overall Study|Lost to Follow-up|1|||
155283602|NCT00530777|560470797|FG000|Overall Study|Death|1|||
155283603|NCT00530777|560470798|FG001|Overall Study|Death|2|||
155394423|NCT03823404|560880279|FG000|Overall Study|Lost to Follow-up|1|||
155394424|NCT03823404|560880280|FG001|Overall Study|Lost to Follow-up|2|||
155394425|NCT03823404|560880281|FG002|Overall Study|Lost to Follow-up|3|||
155394426|NCT03823404|560880279|FG000|Overall Study|Protocol Violation|2|||
155394427|NCT03823404|560880280|FG001|Overall Study|Protocol Violation|0|||
155394428|NCT03823404|560880281|FG002|Overall Study|Protocol Violation|2|||
155153116|NCT04739982|559998560|FG000|Overall Study|Protocol Violation|0|||
155153117|NCT04739982|559998561|FG001|Overall Study|Protocol Violation|5|||
155153118|NCT03651765|559998562|FG000|Overall Study|Adverse Event|6|||
155153119|NCT03651765|559998562|FG000|Overall Study|Lack of Efficacy|18|||
155153120|NCT03651765|559998562|FG000|Overall Study|Lost to Follow-up|5|||
155153121|NCT03651765|559998562|FG000|Overall Study|Non-Compliance with Study Drug|4|||
155153122|NCT03651765|559998562|FG000|Overall Study|Physician Decision|6|||
155153123|NCT03651765|559998562|FG000|Overall Study|Pregnancy|1|||
155153124|NCT03651765|559998562|FG000|Overall Study|Discontinued by Sponsor|40|||
155153125|NCT03651765|559998562|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
155153126|NCT03651765|559998562|FG000|Overall Study|Withdrawal by Subject|24|||
155153127|NCT03651765|559998562|FG000|Overall Study|Miscellaneous|6|||
155153128|NCT03267277|559998563|FG000|Overall Study|Withdrawal by Subject|1|||
155153129|NCT01346358|559998564|FG000|Overall Study|Withdrawal by Subject|1|||
155153130|NCT01346358|559998565|FG001|Overall Study|Withdrawal by Subject|0|||
155153131|NCT01346358|559998566|FG002|Overall Study|Withdrawal by Subject|1|||
155153132|NCT01346358|559998567|FG003|Overall Study|Withdrawal by Subject|1|||
155153133|NCT01346358|559998568|FG004|Overall Study|Withdrawal by Subject|0|||
155153134|NCT01346358|559998569|FG005|Overall Study|Withdrawal by Subject|2|||
155153135|NCT01346358|559998570|FG006|Overall Study|Withdrawal by Subject|1|||
155153136|NCT01346358|559998571|FG007|Overall Study|Withdrawal by Subject|1|||
155153137|NCT01346358|559998572|FG008|Overall Study|Withdrawal by Subject|1|||
155153138|NCT01346358|559998564|FG000|Overall Study|Adverse Event|1|||
155153139|NCT01346358|559998565|FG001|Overall Study|Adverse Event|0|||
155153140|NCT01346358|559998566|FG002|Overall Study|Adverse Event|0|||
155153141|NCT01346358|559998567|FG003|Overall Study|Adverse Event|0|||
155153142|NCT01346358|559998568|FG004|Overall Study|Adverse Event|1|||
155153143|NCT01346358|559998569|FG005|Overall Study|Adverse Event|0|||
155153144|NCT01346358|559998570|FG006|Overall Study|Adverse Event|0|||
155153145|NCT01346358|559998571|FG007|Overall Study|Adverse Event|0|||
155153146|NCT01346358|559998572|FG008|Overall Study|Adverse Event|1|||
155153147|NCT01346358|559998564|FG000|Overall Study|Non-Compliance|0|||
155153148|NCT01346358|559998565|FG001|Overall Study|Non-Compliance|0|||
155153149|NCT01346358|559998566|FG002|Overall Study|Non-Compliance|0|||
155153150|NCT01346358|559998567|FG003|Overall Study|Non-Compliance|0|||
155153151|NCT01346358|559998568|FG004|Overall Study|Non-Compliance|0|||
155153152|NCT01346358|559998569|FG005|Overall Study|Non-Compliance|0|||
155153153|NCT01346358|559998570|FG006|Overall Study|Non-Compliance|0|||
155153154|NCT01346358|559998571|FG007|Overall Study|Non-Compliance|2|||
155153155|NCT01346358|559998572|FG008|Overall Study|Non-Compliance|0|||
155153156|NCT01346358|559998564|FG000|Overall Study|Physician Decision|0|||
155153157|NCT01346358|559998565|FG001|Overall Study|Physician Decision|1|||
155153158|NCT01346358|559998566|FG002|Overall Study|Physician Decision|0|||
155153159|NCT01346358|559998567|FG003|Overall Study|Physician Decision|0|||
155153160|NCT01346358|559998568|FG004|Overall Study|Physician Decision|0|||
155153161|NCT01346358|559998569|FG005|Overall Study|Physician Decision|0|||
155153162|NCT01346358|559998570|FG006|Overall Study|Physician Decision|0|||
155153163|NCT01346358|559998571|FG007|Overall Study|Physician Decision|1|||
155153164|NCT01346358|559998572|FG008|Overall Study|Physician Decision|1|||
155153165|NCT03521570|559998577|FG000|Overall Study|Not eligible|11|||
155283604|NCT00530777|560470797|FG000|Overall Study|Physician Decision|1|||
155153166|NCT00322881|559998579|FG000|Overall Study|Death|2|||
155153167|NCT00322881|559998579|FG000|Overall Study|Adverse Event|1|||
155283605|NCT00530777|560470798|FG001|Overall Study|Physician Decision|0|||
155283606|NCT00530777|560470797|FG000|Overall Study|Withdrawal by Subject|0|||
155283607|NCT00530777|560470798|FG001|Overall Study|Withdrawal by Subject|1|||
155283608|NCT00530777|560470797|FG000|Overall Study|Unable to adhere to visit schedule|5|||
155283609|NCT00530777|560470798|FG001|Overall Study|Unable to adhere to visit schedule|1|||
155283610|NCT01582243|560470802|FG000|Overall Study|Withdrawal by Subject|1|||
155283611|NCT01582243|560470802|FG000|Overall Study|Adverse Event|1|||
155283612|NCT01582243|560470802|FG000|Overall Study|Lost to Follow-up|1|||
155283613|NCT02096003|560470806|FG000|Overall Study|Protocol Violation|0|||
155283614|NCT02096003|560470807|FG001|Overall Study|Protocol Violation|2|||
155283615|NCT02096003|560470806|FG000|Overall Study|additional surgery|2|||
155283616|NCT02096003|560470807|FG001|Overall Study|additional surgery|1|||
155283617|NCT01008748|560470810|FG000|Overall Study|Lost to Follow-up|80|||
155283618|NCT01008748|560470810|FG000|Overall Study|Other|1|||
155283619|NCT04833855|560470811|FG000|Overall Study|Decision by sponsor|0|||
155283620|NCT04833855|560470812|FG001|Overall Study|Decision by sponsor|1|||
155283621|NCT04833855|560470813|FG002|Overall Study|Decision by sponsor|0|||
155283622|NCT04833855|560470814|FG003|Overall Study|Decision by sponsor|0|||
155283623|NCT04833855|560470811|FG000|Overall Study|Withdrawal by Subject|4|||
155283624|NCT04833855|560470812|FG001|Overall Study|Withdrawal by Subject|1|||
155283625|NCT04833855|560470813|FG002|Overall Study|Withdrawal by Subject|3|||
155283626|NCT04833855|560470814|FG003|Overall Study|Withdrawal by Subject|1|||
155283627|NCT04833855|560470811|FG000|Overall Study|Lost to Follow-up|1|||
155283628|NCT04833855|560470812|FG001|Overall Study|Lost to Follow-up|0|||
155283629|NCT04833855|560470813|FG002|Overall Study|Lost to Follow-up|2|||
155394429|NCT03823404|560880279|FG000|Overall Study|Adverse Event|35|||
155394430|NCT03823404|560880280|FG001|Overall Study|Adverse Event|38|||
155394431|NCT03823404|560880281|FG002|Overall Study|Adverse Event|8|||
155394432|NCT03823404|560880279|FG000|Overall Study|Withdrawal by Subject|38|||
155394433|NCT03823404|560880280|FG001|Overall Study|Withdrawal by Subject|40|||
155394434|NCT03823404|560880281|FG002|Overall Study|Withdrawal by Subject|35|||
155394435|NCT03823404|560880279|FG000|Overall Study|Death|4|||
155394436|NCT03823404|560880280|FG001|Overall Study|Death|0|||
155394437|NCT03823404|560880281|FG002|Overall Study|Death|0|||
155394438|NCT03823404|560880279|FG000|Overall Study|Other: Various reasons provided|5|||
155394439|NCT03823404|560880280|FG001|Overall Study|Other: Various reasons provided|5|||
155394440|NCT03823404|560880281|FG002|Overall Study|Other: Various reasons provided|6|||
155394441|NCT01446016|560880282|FG000|Overall Study|Lost to Follow-up|3|||
155394442|NCT01446016|560880282|FG000|Overall Study|Withdrawal by Subject|1|||
155394443|NCT01446016|560880282|FG000|Overall Study|Toxicity|3|||
155394444|NCT00404066|560880289|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
155394445|NCT00404066|560880289|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
155394446|NCT01399190|560880292|FG000|Overall Study|Not Eligible for Final Analysis|5|||
155394447|NCT01399190|560880292|FG000|Overall Study|Adverse Event|8|||
155394448|NCT01399190|560880292|FG000|Overall Study|Participant's Request|5|||
155394449|NCT01399190|560880292|FG000|Overall Study|Physician Decision|2|||
155394450|NCT05395104|560880293|FG000|Overall Study|Met Liver Stopping Criteria|1|||
154952605|NCT03952143|559252007|FG001|Treatment Period|Adverse Event|0|||
154952606|NCT03952143|559252008|FG002|Treatment Period|Adverse Event|1|||
154952607|NCT03952143|559252006|FG000|Treatment Period|Lost to Follow-up|0|||
154952608|NCT03952143|559252007|FG001|Treatment Period|Lost to Follow-up|2|||
154952609|NCT03952143|559252008|FG002|Treatment Period|Lost to Follow-up|0|||
154952610|NCT03952143|559252006|FG000|Treatment Period|Physician Decision|0|||
154952611|NCT03952143|559252007|FG001|Treatment Period|Physician Decision|0|||
154952612|NCT03952143|559252008|FG002|Treatment Period|Physician Decision|2|||
154952613|NCT03952143|559252006|FG000|Treatment Period|Protocol Violation|0|||
154952614|NCT03952143|559252007|FG001|Treatment Period|Protocol Violation|0|||
154952615|NCT03952143|559252008|FG002|Treatment Period|Protocol Violation|1|||
154952616|NCT03952143|559252006|FG000|Treatment Period|Withdrawal by Subject|0|||
154952617|NCT03952143|559252007|FG001|Treatment Period|Withdrawal by Subject|5|||
154952618|NCT03952143|559252008|FG002|Treatment Period|Withdrawal by Subject|26|||
154952619|NCT03952143|559252006|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
154952620|NCT03952143|559252007|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
154952621|NCT03952143|559252008|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
154952622|NCT03952143|559252006|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
154952623|NCT03952143|559252007|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
154952624|NCT03952143|559252008|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
154952625|NCT02152566|559252009|FG000|Overall Study|Lost to Follow-up|1|||
154952626|NCT02152566|559252009|FG000|Overall Study|Withdrawal by Subject|2|||
154952627|NCT01328093|559252010|FG000|Double-Blind Phase|Adverse Event|78|||
154952628|NCT01328093|559252011|FG001|Double-Blind Phase|Adverse Event|15|||
154952629|NCT01328093|559252010|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
154952630|NCT01328093|559252011|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
154952631|NCT01328093|559252010|FG000|Double-Blind Phase|Lost to Follow-up|39|||
154952632|NCT01328093|559252011|FG001|Double-Blind Phase|Lost to Follow-up|14|||
154952633|NCT01328093|559252010|FG000|Double-Blind Phase|Protocol Violation|30|||
154952634|NCT01328093|559252011|FG001|Double-Blind Phase|Protocol Violation|10|||
154952635|NCT01328093|559252010|FG000|Double-Blind Phase|Lack of Efficacy|55|||
154952636|NCT01328093|559252011|FG001|Double-Blind Phase|Lack of Efficacy|13|||
154952637|NCT01328093|559252010|FG000|Double-Blind Phase|Sponsor Decision|17|||
154952638|NCT01328093|559252011|FG001|Double-Blind Phase|Sponsor Decision|3|||
154952639|NCT01328093|559252010|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
154952640|NCT01328093|559252011|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
154952641|NCT01328093|559252010|FG000|Double-Blind Phase|Scheduling conflict|8|||
154952642|NCT01328093|559252011|FG001|Double-Blind Phase|Scheduling conflict|3|||
154952643|NCT01328093|559252010|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
154952644|NCT01328093|559252011|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
154952645|NCT01328093|559252010|FG000|Double-Blind Phase|Death|1|||
154952646|NCT01328093|559252011|FG001|Double-Blind Phase|Death|0|||
154952647|NCT01328093|559252010|FG000|Open-Label Phase|Sponsor Decision|98|||
154952648|NCT01328093|559252011|FG001|Open-Label Phase|Sponsor Decision|34|||
154952649|NCT01328093|559252010|FG000|Open-Label Phase|Protocol Violation|8|||
154952650|NCT01328093|559252011|FG001|Open-Label Phase|Protocol Violation|3|||
154952651|NCT01328093|559252010|FG000|Open-Label Phase|Lost to Follow-up|10|||
154952652|NCT01328093|559252011|FG001|Open-Label Phase|Lost to Follow-up|1|||
154952653|NCT01328093|559252010|FG000|Open-Label Phase|Adverse Event|10|||
154952654|NCT01328093|559252011|FG001|Open-Label Phase|Adverse Event|4|||
154952655|NCT01328093|559252010|FG000|Open-Label Phase|Lack of Efficacy|5|||
155394451|NCT05395104|560880293|FG000|Overall Study|Withdrawal by Subject|1|||
155394452|NCT00381563|560880294|FG000|Overall Study|Withdrawal by Subject|5|||
155394453|NCT00381563|560880295|FG001|Overall Study|Withdrawal by Subject|5|||
155394454|NCT00381563|560880294|FG000|Overall Study|Lost to Follow-up|2|||
155394455|NCT00381563|560880295|FG001|Overall Study|Lost to Follow-up|0|||
155394456|NCT00381563|560880294|FG000|Overall Study|Protocol Violation|0|||
155394457|NCT00381563|560880295|FG001|Overall Study|Protocol Violation|1|||
155394458|NCT01287364|560880296|FG000|Overall Study|Adverse Event|0|||
155394459|NCT01287364|560880297|FG001|Overall Study|Adverse Event|3|||
155394460|NCT01287364|560880296|FG000|Overall Study|Protocol Violation|5|||
155394461|NCT01287364|560880297|FG001|Overall Study|Protocol Violation|5|||
155394462|NCT01287364|560880296|FG000|Overall Study|Other Reason|4|||
155394463|NCT01287364|560880297|FG001|Overall Study|Other Reason|2|||
155394464|NCT05372653|560880304|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
155394465|NCT05372653|560880305|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
155394466|NCT05372653|560880304|FG000|Overall Study|Adverse Event|0|||
155394467|NCT05372653|560880305|FG001|Overall Study|Adverse Event|1|||
155394468|NCT00117507|560880306|FG000|Overall Study|Adverse Event|4|||
155394469|NCT00117507|560880306|FG000|Overall Study|Abnormal laboratory values|3|||
155394470|NCT00117507|560880306|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155394471|NCT00117507|560880306|FG000|Overall Study|Patient withdrew consent|4|||
155394472|NCT00117507|560880306|FG000|Overall Study|Death|3|||
155394473|NCT03740997|560880307|FG000|Overall Study|Withdrawal by Subject|1|||
155394474|NCT03740997|560880308|FG001|Overall Study|Withdrawal by Subject|0|||
155394475|NCT03740997|560880307|FG000|Overall Study|Participant was unable to complete study procedures|1|||
155394476|NCT03740997|560880308|FG001|Overall Study|Participant was unable to complete study procedures|0|||
155394477|NCT01003990|560880309|FG000|Overall Study|Adverse Event|8|||
155394478|NCT01003990|560880310|FG001|Overall Study|Adverse Event|5|||
155394479|NCT01003990|560880311|FG002|Overall Study|Adverse Event|11|||
155394480|NCT01003990|560880309|FG000|Overall Study|Death|0|||
155394481|NCT01003990|560880310|FG001|Overall Study|Death|8|||
155394482|NCT01003990|560880311|FG002|Overall Study|Death|1|||
155394483|NCT01003990|560880309|FG000|Overall Study|Lack of Efficacy|10|||
155394484|NCT01003990|560880310|FG001|Overall Study|Lack of Efficacy|2|||
155394485|NCT01003990|560880311|FG002|Overall Study|Lack of Efficacy|3|||
155394486|NCT01003990|560880309|FG000|Overall Study|Lost to Follow-up|30|||
155394487|NCT01003990|560880310|FG001|Overall Study|Lost to Follow-up|12|||
155394488|NCT01003990|560880311|FG002|Overall Study|Lost to Follow-up|7|||
155394489|NCT01003990|560880309|FG000|Overall Study|Reasons Not Identified|14|||
155394490|NCT01003990|560880310|FG001|Overall Study|Reasons Not Identified|13|||
155394491|NCT01003990|560880311|FG002|Overall Study|Reasons Not Identified|8|||
155394492|NCT01003990|560880309|FG000|Overall Study|Poor/Non-compliance|4|||
155394493|NCT01003990|560880310|FG001|Overall Study|Poor/Non-compliance|3|||
155394494|NCT01003990|560880311|FG002|Overall Study|Poor/Non-compliance|2|||
155394495|NCT01003990|560880309|FG000|Overall Study|Pregnancy|10|||
155394496|NCT01003990|560880310|FG001|Overall Study|Pregnancy|2|||
155394497|NCT01003990|560880311|FG002|Overall Study|Pregnancy|4|||
155394498|NCT01003990|560880309|FG000|Overall Study|No Longer Met Study Criteria|4|||
155394499|NCT01003990|560880310|FG001|Overall Study|No Longer Met Study Criteria|1|||
155394500|NCT01003990|560880311|FG002|Overall Study|No Longer Met Study Criteria|0|||
155394501|NCT01003990|560880309|FG000|Overall Study|Subject Withdrew Consent|12|||
155394502|NCT01003990|560880310|FG001|Overall Study|Subject Withdrew Consent|5|||
155394503|NCT01003990|560880311|FG002|Overall Study|Subject Withdrew Consent|7|||
155394504|NCT01829425|560880317|FG000|Overall Study|Withdrawal by Subject|4|||
155394505|NCT01829425|560880318|FG001|Overall Study|Withdrawal by Subject|3|||
155394506|NCT01829425|560880317|FG000|Overall Study|Lost to Follow-up|2|||
155394507|NCT01829425|560880318|FG001|Overall Study|Lost to Follow-up|1|||
155394508|NCT03681951|560880319|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
155394509|NCT03681951|560880320|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394510|NCT03681951|560880321|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394511|NCT03681951|560880322|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394512|NCT03681951|560880323|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394513|NCT03681951|560880324|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394514|NCT03681951|560880325|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394515|NCT03681951|560880326|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
155394516|NCT03681951|560880319|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
155394517|NCT03681951|560880320|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394518|NCT03681951|560880321|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394519|NCT03681951|560880322|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394520|NCT03681951|560880323|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394521|NCT03681951|560880324|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394522|NCT03681951|560880325|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394523|NCT03681951|560880326|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
155394524|NCT03681951|560880319|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
155153168|NCT00322881|559998579|FG000|Overall Study|Disease Progression|2|||
155153169|NCT01667900|559998585|FG000|Part B|Death|0|||
155283630|NCT04833855|560470814|FG003|Overall Study|Lost to Follow-up|2|||
155283631|NCT04833855|560470811|FG000|Overall Study|Protocol specified criteria|0|||
155153170|NCT01667900|559998586|FG001|Part B|Death|0|||
155283632|NCT04833855|560470812|FG001|Overall Study|Protocol specified criteria|0|||
155283633|NCT04833855|560470813|FG002|Overall Study|Protocol specified criteria|2|||
155283634|NCT04833855|560470814|FG003|Overall Study|Protocol specified criteria|1|||
155283635|NCT04824131|560470816|FG000|CAB LA Oral Phase|Adverse Event|1|||
155283636|NCT04824131|560470816|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
155283637|NCT04824131|560470816|FG000|Step 3|Withdrawal by Subject|2|||
155283638|NCT03686384|560470817|FG000|Overall Study|Lack of Efficacy|4|||
155283639|NCT03686384|560470818|FG001|Overall Study|Lack of Efficacy|13|||
155283640|NCT03686384|560470817|FG000|Overall Study|Lost to Follow-up|3|||
155283641|NCT03686384|560470818|FG001|Overall Study|Lost to Follow-up|0|||
155283642|NCT03686384|560470817|FG000|Overall Study|Physician Decision|0|||
155283643|NCT03686384|560470818|FG001|Overall Study|Physician Decision|1|||
155283644|NCT03686384|560470817|FG000|Overall Study|Took prohibited medication|0|||
155283645|NCT03686384|560470818|FG001|Overall Study|Took prohibited medication|1|||
155283646|NCT00783692|560470825|FG000|Induction Phase|Adverse Event|7|||
155283647|NCT00783692|560470826|FG001|Induction Phase|Adverse Event|9|||
155283648|NCT00783692|560470827|FG002|Induction Phase|Adverse Event|24|||
155283649|NCT00783692|560470828|FG003|Induction Phase|Adverse Event|0|||
155283650|NCT00783692|560470829|FG004|Induction Phase|Adverse Event|0|||
155283651|NCT00783692|560470830|FG005|Induction Phase|Adverse Event|0|||
155283652|NCT00783692|560470831|FG006|Induction Phase|Adverse Event|0|||
155283653|NCT00783692|560470825|FG000|Induction Phase|Protocol Violation|0|||
155283654|NCT00783692|560470826|FG001|Induction Phase|Protocol Violation|0|||
155283655|NCT00783692|560470827|FG002|Induction Phase|Protocol Violation|1|||
155283656|NCT00783692|560470828|FG003|Induction Phase|Protocol Violation|0|||
155283657|NCT00783692|560470829|FG004|Induction Phase|Protocol Violation|0|||
155283658|NCT00783692|560470830|FG005|Induction Phase|Protocol Violation|0|||
155283659|NCT00783692|560470831|FG006|Induction Phase|Protocol Violation|0|||
155283660|NCT00783692|560470825|FG000|Induction Phase|Lack of Efficacy|1|||
155283661|NCT00783692|560470826|FG001|Induction Phase|Lack of Efficacy|3|||
155283662|NCT00783692|560470827|FG002|Induction Phase|Lack of Efficacy|28|||
155283663|NCT00783692|560470828|FG003|Induction Phase|Lack of Efficacy|0|||
155283664|NCT00783692|560470829|FG004|Induction Phase|Lack of Efficacy|0|||
155283665|NCT00783692|560470830|FG005|Induction Phase|Lack of Efficacy|0|||
155283666|NCT00783692|560470831|FG006|Induction Phase|Lack of Efficacy|0|||
155283667|NCT00783692|560470825|FG000|Induction Phase|Withdrawal by Subject|3|||
155283668|NCT00783692|560470826|FG001|Induction Phase|Withdrawal by Subject|9|||
155283669|NCT00783692|560470827|FG002|Induction Phase|Withdrawal by Subject|16|||
155283670|NCT00783692|560470828|FG003|Induction Phase|Withdrawal by Subject|0|||
155283671|NCT00783692|560470829|FG004|Induction Phase|Withdrawal by Subject|0|||
155283672|NCT00783692|560470830|FG005|Induction Phase|Withdrawal by Subject|0|||
155283673|NCT00783692|560470831|FG006|Induction Phase|Withdrawal by Subject|0|||
155283674|NCT00783692|560470825|FG000|Induction Phase|Lost to Follow-up|0|||
155283675|NCT00783692|560470826|FG001|Induction Phase|Lost to Follow-up|0|||
155283676|NCT00783692|560470827|FG002|Induction Phase|Lost to Follow-up|3|||
155283677|NCT00783692|560470828|FG003|Induction Phase|Lost to Follow-up|0|||
155283678|NCT00783692|560470829|FG004|Induction Phase|Lost to Follow-up|0|||
155283679|NCT00783692|560470830|FG005|Induction Phase|Lost to Follow-up|0|||
155283680|NCT00783692|560470831|FG006|Induction Phase|Lost to Follow-up|0|||
155283681|NCT00783692|560470825|FG000|Induction Phase|Other|0|||
155283682|NCT00783692|560470826|FG001|Induction Phase|Other|0|||
155283683|NCT00783692|560470827|FG002|Induction Phase|Other|2|||
155283684|NCT00783692|560470828|FG003|Induction Phase|Other|0|||
155283685|NCT00783692|560470829|FG004|Induction Phase|Other|0|||
155283686|NCT00783692|560470830|FG005|Induction Phase|Other|0|||
155283687|NCT00783692|560470831|FG006|Induction Phase|Other|0|||
155283688|NCT00783692|560470825|FG000|Maintenance Phase|Adverse Event|7|||
155283689|NCT00783692|560470826|FG001|Maintenance Phase|Adverse Event|0|||
155283690|NCT00783692|560470827|FG002|Maintenance Phase|Adverse Event|0|||
155283691|NCT00783692|560470828|FG003|Maintenance Phase|Adverse Event|15|||
155283692|NCT00783692|560470829|FG004|Maintenance Phase|Adverse Event|12|||
155283693|NCT00783692|560470830|FG005|Maintenance Phase|Adverse Event|9|||
155283694|NCT00783692|560470831|FG006|Maintenance Phase|Adverse Event|38|||
155283695|NCT00783692|560470825|FG000|Maintenance Phase|Protocol Violation|0|||
155283696|NCT00783692|560470826|FG001|Maintenance Phase|Protocol Violation|0|||
155283697|NCT00783692|560470827|FG002|Maintenance Phase|Protocol Violation|0|||
155283698|NCT00783692|560470828|FG003|Maintenance Phase|Protocol Violation|1|||
155283699|NCT00783692|560470829|FG004|Maintenance Phase|Protocol Violation|2|||
155283700|NCT00783692|560470830|FG005|Maintenance Phase|Protocol Violation|3|||
155283701|NCT00783692|560470831|FG006|Maintenance Phase|Protocol Violation|4|||
155283702|NCT00783692|560470825|FG000|Maintenance Phase|Lack of Efficacy|79|||
155283703|NCT00783692|560470826|FG001|Maintenance Phase|Lack of Efficacy|0|||
155394525|NCT03681951|560880320|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394526|NCT03681951|560880321|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394527|NCT03681951|560880322|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394528|NCT03681951|560880323|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394529|NCT03681951|560880324|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394530|NCT03681951|560880325|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394531|NCT03681951|560880326|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
155394532|NCT02187809|560880327|FG000|Overall Study|The study was terminated|3|||
155394533|NCT01020448|560880328|FG000|Pre-assignment|Adverse Event|6|||
155394534|NCT01020448|560880328|FG000|Pre-assignment|Withdrawal by Subject|5|||
155394535|NCT01020448|560880328|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
155394536|NCT01020448|560880328|FG000|Treatment|Adverse Event|11|||
155394537|NCT01020448|560880328|FG000|Treatment|Consent Withdrawn|3|||
155394538|NCT01020448|560880328|FG000|Treatment|Disease Progression|2|||
155394539|NCT01020448|560880328|FG000|Treatment|Lack of Efficacy|8|||
155394540|NCT01020448|560880328|FG000|Treatment|Lost to Follow-up|2|||
155394541|NCT01230554|560880329|FG000|Overall Study|Lost to Follow-up|2|||
155394542|NCT01230554|560880329|FG000|Overall Study|Inability to maintain visit schedule|1|||
155394543|NCT01505010|560880330|FG000|Overall Study|Protocol Violation|0|||
155394544|NCT01505010|560880331|FG001|Overall Study|Protocol Violation|1|||
155394545|NCT01505010|560880330|FG000|Overall Study|Lost to Follow-up|0|||
155394546|NCT01505010|560880331|FG001|Overall Study|Lost to Follow-up|1|||
155394547|NCT00698932|560880340|FG000|Overall Study|Adverse Event|0|||
155394548|NCT00698932|560880341|FG001|Overall Study|Adverse Event|2|||
155394549|NCT00698932|560880340|FG000|Overall Study|Incorrect enrollment|0|||
155394550|NCT00698932|560880341|FG001|Overall Study|Incorrect enrollment|2|||
155394551|NCT00698932|560880340|FG000|Overall Study|Study specific discontinuation criteria|3|||
155394552|NCT00698932|560880341|FG001|Overall Study|Study specific discontinuation criteria|4|||
155394553|NCT00698932|560880340|FG000|Overall Study|Withdrawal by Subject|11|||
155394554|NCT00698932|560880341|FG001|Overall Study|Withdrawal by Subject|23|||
155394555|NCT00698932|560880340|FG000|Overall Study|Lost to Follow-up|6|||
155394556|NCT00698932|560880341|FG001|Overall Study|Lost to Follow-up|1|||
155394557|NCT00698932|560880340|FG000|Overall Study|Severe non-compliance to protocol|1|||
155394558|NCT00698932|560880341|FG001|Overall Study|Severe non-compliance to protocol|2|||
155394559|NCT00698932|560880340|FG000|Overall Study|Safety reasons|0|||
155394560|NCT00698932|560880341|FG001|Overall Study|Safety reasons|2|||
155394561|NCT00698932|560880340|FG000|Overall Study|Death|1|||
155394562|NCT00698932|560880341|FG001|Overall Study|Death|0|||
155394563|NCT00601705|560880342|FG000|Overall Study|Withdrawal by Subject|1|||
155394564|NCT04513665|560880343|FG000|Overall Study|Adverse Event|2|||
155394565|NCT04513665|560880344|FG001|Overall Study|Adverse Event|0|||
155394566|NCT04513665|560880343|FG000|Overall Study|Lack of Efficacy|14|||
155394567|NCT04513665|560880344|FG001|Overall Study|Lack of Efficacy|0|||
155394568|NCT02146599|560880348|FG000|Overall Study|Failed to meet inclusion criteria|5|||
155394569|NCT04246801|560880349|FG000|Overall Study|Adverse Event|1|||
155394570|NCT04246801|560880350|FG001|Overall Study|Adverse Event|1|||
155394571|NCT04246801|560880349|FG000|Overall Study|Protocol Violation|1|||
155394572|NCT04246801|560880350|FG001|Overall Study|Protocol Violation|1|||
155394573|NCT04246801|560880349|FG000|Overall Study|Lack of Efficacy|0|||
155394574|NCT04246801|560880350|FG001|Overall Study|Lack of Efficacy|2|||
155394575|NCT04246801|560880349|FG000|Overall Study|Lost to Follow-up|1|||
155394576|NCT04246801|560880350|FG001|Overall Study|Lost to Follow-up|1|||
155394577|NCT04246801|560880349|FG000|Overall Study|Withdrawal by Subject|2|||
155394578|NCT04246801|560880350|FG001|Overall Study|Withdrawal by Subject|1|||
155394579|NCT01368042|560880354|FG000|Overall Study|Death|14|||
155394580|NCT01368042|560880354|FG000|Overall Study|Protocol Violation|11|||
155394581|NCT01368042|560880354|FG000|Overall Study|Lost to Follow-up|4|||
154952656|NCT01328093|559252011|FG001|Open-Label Phase|Lack of Efficacy|6|||
154952657|NCT01328093|559252010|FG000|Open-Label Phase|Withdrawal by Subject|4|||
154952658|NCT01328093|559252011|FG001|Open-Label Phase|Withdrawal by Subject|1|||
154952659|NCT01328093|559252010|FG000|Open-Label Phase|Scheduling conflict|2|||
154952660|NCT01328093|559252011|FG001|Open-Label Phase|Scheduling conflict|1|||
154952661|NCT01328093|559252010|FG000|Open-Label Phase|Subject is moving or has moved|2|||
154952662|NCT01328093|559252011|FG001|Open-Label Phase|Subject is moving or has moved|0|||
155394582|NCT01368042|560880354|FG000|Overall Study|Transplanted|1|||
155394583|NCT01621542|560880355|FG000|Overall Study|Adverse Event|0|||
155394584|NCT01621542|560880356|FG001|Overall Study|Adverse Event|0|||
155394585|NCT01621542|560880357|FG002|Overall Study|Adverse Event|1|||
155394586|NCT01621542|560880358|FG003|Overall Study|Adverse Event|3|||
155394587|NCT01621542|560880359|FG004|Overall Study|Adverse Event|0|||
155394588|NCT01621542|560880360|FG005|Overall Study|Adverse Event|0|||
155394589|NCT01621542|560880355|FG000|Overall Study|Death|0|||
155394590|NCT01621542|560880356|FG001|Overall Study|Death|1|||
154952663|NCT01328093|559252010|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
154952664|NCT01328093|559252011|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
155394591|NCT01621542|560880357|FG002|Overall Study|Death|0|||
155394592|NCT01621542|560880358|FG003|Overall Study|Death|0|||
155394593|NCT01621542|560880359|FG004|Overall Study|Death|0|||
155394594|NCT01621542|560880360|FG005|Overall Study|Death|0|||
155394595|NCT01621542|560880355|FG000|Overall Study|Physician Decision|1|||
155394596|NCT01621542|560880356|FG001|Overall Study|Physician Decision|0|||
155394597|NCT01621542|560880357|FG002|Overall Study|Physician Decision|1|||
155394598|NCT01621542|560880358|FG003|Overall Study|Physician Decision|13|||
155394599|NCT01621542|560880359|FG004|Overall Study|Physician Decision|3|||
155394600|NCT01621542|560880360|FG005|Overall Study|Physician Decision|1|||
155394601|NCT01621542|560880355|FG000|Overall Study|Withdrawal by Subject|2|||
155394602|NCT01621542|560880356|FG001|Overall Study|Withdrawal by Subject|0|||
155394603|NCT01621542|560880357|FG002|Overall Study|Withdrawal by Subject|1|||
155394604|NCT01621542|560880358|FG003|Overall Study|Withdrawal by Subject|3|||
155394605|NCT01621542|560880359|FG004|Overall Study|Withdrawal by Subject|3|||
155394606|NCT01621542|560880360|FG005|Overall Study|Withdrawal by Subject|3|||
155394607|NCT01621542|560880355|FG000|Overall Study|progression/treatment failure|2|||
155394608|NCT01621542|560880356|FG001|Overall Study|progression/treatment failure|4|||
155394609|NCT01621542|560880357|FG002|Overall Study|progression/treatment failure|3|||
155394610|NCT01621542|560880358|FG003|Overall Study|progression/treatment failure|7|||
155394611|NCT01621542|560880359|FG004|Overall Study|progression/treatment failure|3|||
155394612|NCT01621542|560880360|FG005|Overall Study|progression/treatment failure|5|||
155394613|NCT01621542|560880355|FG000|Overall Study|Protocol Violation|0|||
155394614|NCT01621542|560880356|FG001|Overall Study|Protocol Violation|0|||
155394615|NCT01621542|560880357|FG002|Overall Study|Protocol Violation|0|||
155394616|NCT01621542|560880358|FG003|Overall Study|Protocol Violation|1|||
155394617|NCT01621542|560880359|FG004|Overall Study|Protocol Violation|0|||
155394618|NCT01621542|560880360|FG005|Overall Study|Protocol Violation|0|||
155394619|NCT01621542|560880355|FG000|Overall Study|study stopped by sponsor|0|||
155394620|NCT01621542|560880356|FG001|Overall Study|study stopped by sponsor|0|||
155394621|NCT01621542|560880357|FG002|Overall Study|study stopped by sponsor|0|||
155394622|NCT01621542|560880358|FG003|Overall Study|study stopped by sponsor|1|||
155394623|NCT01621542|560880359|FG004|Overall Study|study stopped by sponsor|0|||
155394624|NCT01621542|560880360|FG005|Overall Study|study stopped by sponsor|0|||
155394625|NCT00544648|560880365|FG000|Overall Study|Withdrawal by Subject|1|||
155394626|NCT00544648|560880366|FG001|Overall Study|Withdrawal by Subject|0|||
155394627|NCT00544648|560880365|FG000|Overall Study|Adverse Event|1|||
155394628|NCT00544648|560880366|FG001|Overall Study|Adverse Event|1|||
155394629|NCT00544648|560880365|FG000|Overall Study|progression of disease|1|||
155394630|NCT00544648|560880366|FG001|Overall Study|progression of disease|0|||
155394631|NCT02663271|560880367|FG000|Overall Study|Withdrawal by Subject|5|||
155394632|NCT02663271|560880367|FG000|Overall Study|Lack of Efficacy|1|||
155394633|NCT01351623|560880369|FG000|Overall Study|Protocol Violation|2|||
155394634|NCT01351623|560880369|FG000|Overall Study|Adverse Event|4|||
155394635|NCT01351623|560880369|FG000|Overall Study|Withdrawal by Subject|1|||
155394636|NCT01351623|560880369|FG000|Overall Study|Death|2|||
155394637|NCT04399122|560880372|FG000|Overall Study|Lost to Follow-up|2|||
155394638|NCT04399122|560880373|FG001|Overall Study|Lost to Follow-up|0|||
155394639|NCT04399122|560880372|FG000|Overall Study|Withdrawal by Subject|1|||
155394640|NCT04399122|560880373|FG001|Overall Study|Withdrawal by Subject|0|||
155394641|NCT02322229|560880374|FG000|Overall Study|Physician Decision|2|||
155394642|NCT00705432|560880375|FG000|Treatment Period|Adverse Event|45|||
155394643|NCT00705432|560880376|FG001|Treatment Period|Adverse Event|37|||
155394644|NCT00705432|560880377|FG002|Treatment Period|Adverse Event|51|||
155394645|NCT00705432|560880378|FG003|Treatment Period|Adverse Event|12|||
155394646|NCT00705432|560880379|FG004|Treatment Period|Adverse Event|8|||
155394647|NCT00705432|560880380|FG005|Treatment Period|Adverse Event|9|||
155394648|NCT00705432|560880375|FG000|Treatment Period|Treatment failure|92|||
155394649|NCT00705432|560880376|FG001|Treatment Period|Treatment failure|42|||
155394650|NCT00705432|560880377|FG002|Treatment Period|Treatment failure|33|||
155394651|NCT00705432|560880378|FG003|Treatment Period|Treatment failure|25|||
155394652|NCT00705432|560880379|FG004|Treatment Period|Treatment failure|13|||
155394653|NCT00705432|560880380|FG005|Treatment Period|Treatment failure|14|||
155394654|NCT00705432|560880375|FG000|Treatment Period|Non medical reason|26|||
155394655|NCT00705432|560880376|FG001|Treatment Period|Non medical reason|32|||
155394656|NCT00705432|560880377|FG002|Treatment Period|Non medical reason|37|||
155394657|NCT00705432|560880378|FG003|Treatment Period|Non medical reason|4|||
155394658|NCT00705432|560880379|FG004|Treatment Period|Non medical reason|7|||
155394659|NCT00705432|560880380|FG005|Treatment Period|Non medical reason|7|||
155394660|NCT00705432|560880375|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
155394661|NCT00705432|560880376|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
155394662|NCT00705432|560880377|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
155394663|NCT00705432|560880378|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
155394664|NCT00705432|560880379|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
155394665|NCT00705432|560880380|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
155394666|NCT00705432|560880375|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
155394667|NCT00705432|560880376|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
155394668|NCT00705432|560880377|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
155394669|NCT00705432|560880378|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
155394670|NCT00705432|560880379|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
155394671|NCT00705432|560880380|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
155394672|NCT00521053|560880381|FG000|Observation Phase|Disease Progression|55|||
155394673|NCT00521053|560880381|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
155394674|NCT00521053|560880381|FG000|Observation Phase|Death|2|||
155394675|NCT00521053|560880381|FG000|Observation Phase|Adverse Event|1|||
155394676|NCT00521053|560880381|FG000|Observation Phase|Other non-study melanoma treatment|1|||
155394677|NCT00521053|560880381|FG000|Observation Phase|Physician Decision|1|||
155394678|NCT05390580|560880382|FG000|Overall Study|Physician Decision|3|||
155394679|NCT05390580|560880383|FG001|Overall Study|Physician Decision|2|||
155394680|NCT04448756|560880384|FG000|Overall Study|Adverse Event|0|||
155394681|NCT04448756|560880385|FG001|Overall Study|Adverse Event|1|||
155394682|NCT04448756|560880386|FG002|Overall Study|Adverse Event|0|||
155394683|NCT04448756|560880384|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
155394684|NCT04448756|560880385|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
155394685|NCT04448756|560880386|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
155394686|NCT04448756|560880384|FG000|Overall Study|Withdrawal by Subject|0|||
155394687|NCT04448756|560880385|FG001|Overall Study|Withdrawal by Subject|3|||
155394688|NCT04448756|560880386|FG002|Overall Study|Withdrawal by Subject|1|||
155394689|NCT04448756|560880384|FG000|Overall Study|Death|2|||
155394690|NCT04448756|560880385|FG001|Overall Study|Death|1|||
155394691|NCT04448756|560880386|FG002|Overall Study|Death|0|||
155394692|NCT02129205|560880387|FG000|Overall Study|Withdrawal by Subject|0|||
155394693|NCT02129205|560880388|FG001|Overall Study|Withdrawal by Subject|0|||
155394694|NCT02129205|560880389|FG002|Overall Study|Withdrawal by Subject|0|||
155394695|NCT02129205|560880390|FG003|Overall Study|Withdrawal by Subject|0|||
155394696|NCT02129205|560880391|FG004|Overall Study|Withdrawal by Subject|1|||
155394697|NCT02129205|560880392|FG005|Overall Study|Withdrawal by Subject|1|||
155394698|NCT02129205|560880393|FG006|Overall Study|Withdrawal by Subject|1|||
155394699|NCT02129205|560880394|FG007|Overall Study|Withdrawal by Subject|0|||
155394700|NCT02129205|560880395|FG008|Overall Study|Withdrawal by Subject|1|||
155394701|NCT02129205|560880396|FG009|Overall Study|Withdrawal by Subject|0|||
155394702|NCT02129205|560880387|FG000|Overall Study|Other|1|||
155394703|NCT02129205|560880388|FG001|Overall Study|Other|0|||
155394704|NCT02129205|560880389|FG002|Overall Study|Other|0|||
155394705|NCT02129205|560880390|FG003|Overall Study|Other|0|||
155394706|NCT02129205|560880391|FG004|Overall Study|Other|2|||
155394707|NCT02129205|560880392|FG005|Overall Study|Other|3|||
155394708|NCT02129205|560880393|FG006|Overall Study|Other|3|||
155394709|NCT02129205|560880394|FG007|Overall Study|Other|2|||
155394710|NCT02129205|560880395|FG008|Overall Study|Other|1|||
155394711|NCT02129205|560880396|FG009|Overall Study|Other|0|||
155394712|NCT02877927|560880397|FG000|Overall Study|Adverse Event|1|||
155394713|NCT02877927|560880398|FG001|Overall Study|Adverse Event|0|||
155394714|NCT02877927|560880397|FG000|Overall Study|Lost to Follow-up|37|||
155394715|NCT02877927|560880398|FG001|Overall Study|Lost to Follow-up|38|||
155394716|NCT02877927|560880397|FG000|Overall Study|Withdrawal by Subject|11|||
155394717|NCT02877927|560880398|FG001|Overall Study|Withdrawal by Subject|12|||
155394718|NCT02877927|560880397|FG000|Overall Study|Physician Decision|0|||
155394719|NCT02877927|560880398|FG001|Overall Study|Physician Decision|1|||
155394720|NCT02877927|560880397|FG000|Overall Study|Missed EOT/PTE Visit|5|||
155394721|NCT02877927|560880398|FG001|Overall Study|Missed EOT/PTE Visit|6|||
155394722|NCT00601250|560880399|FG000|Overall Study|Adverse Event|3|||
155394723|NCT00601250|560880400|FG001|Overall Study|Adverse Event|9|||
155394724|NCT00601250|560880399|FG000|Overall Study|Protocol Violation|3|||
155394725|NCT00601250|560880400|FG001|Overall Study|Protocol Violation|2|||
155394726|NCT00601250|560880399|FG000|Overall Study|Lost to Follow-up|2|||
155394727|NCT00601250|560880400|FG001|Overall Study|Lost to Follow-up|6|||
155394728|NCT00601250|560880399|FG000|Overall Study|Withdrawal by Subject|4|||
155394729|NCT00601250|560880400|FG001|Overall Study|Withdrawal by Subject|13|||
155394730|NCT00601250|560880399|FG000|Overall Study|Other incl. lack of efficacy|2|||
155394731|NCT00601250|560880400|FG001|Overall Study|Other incl. lack of efficacy|9|||
155394732|NCT04376060|560880401|FG000|Overall Study|Physician Decision|1|||
155394733|NCT01791803|560880402|FG000|Overall Study|Withdrawal by Subject|0|||
155394734|NCT01791803|560880403|FG001|Overall Study|Withdrawal by Subject|0|||
155394735|NCT01791803|560880404|FG002|Overall Study|Withdrawal by Subject|0|||
155394736|NCT01791803|560880405|FG003|Overall Study|Withdrawal by Subject|2|||
155394737|NCT01791803|560880402|FG000|Overall Study|Physician Decision|0|||
155394738|NCT01791803|560880403|FG001|Overall Study|Physician Decision|2|||
155394739|NCT01791803|560880404|FG002|Overall Study|Physician Decision|0|||
155394740|NCT01791803|560880405|FG003|Overall Study|Physician Decision|1|||
155394741|NCT01791803|560880402|FG000|Overall Study|Death|0|||
155394742|NCT01791803|560880403|FG001|Overall Study|Death|0|||
155394743|NCT01791803|560880404|FG002|Overall Study|Death|2|||
155394744|NCT01791803|560880405|FG003|Overall Study|Death|2|||
155394745|NCT00972777|560880406|FG000|Overall Study|Adverse Event|3|||
155394746|NCT00972777|560880407|FG001|Overall Study|Adverse Event|2|||
155394747|NCT00972777|560880406|FG000|Overall Study|Lost to Follow-up|0|||
155394748|NCT00972777|560880407|FG001|Overall Study|Lost to Follow-up|4|||
155394749|NCT00972777|560880406|FG000|Overall Study|Withdrawal by Subject|4|||
155394750|NCT00972777|560880407|FG001|Overall Study|Withdrawal by Subject|5|||
155394751|NCT00972777|560880406|FG000|Overall Study|Physician Decision|4|||
155394752|NCT00972777|560880407|FG001|Overall Study|Physician Decision|0|||
155394753|NCT00972777|560880406|FG000|Overall Study|Protocol Violation|0|||
155394754|NCT00972777|560880407|FG001|Overall Study|Protocol Violation|2|||
155394755|NCT00972777|560880406|FG000|Overall Study|Screening Failure|2|||
155394756|NCT00972777|560880407|FG001|Overall Study|Screening Failure|1|||
155394757|NCT00972777|560880406|FG000|Overall Study|Missed visit|1|||
155394758|NCT00972777|560880407|FG001|Overall Study|Missed visit|0|||
155394759|NCT03426787|560881910|FG000|Overall Study|Withdrawal by Subject|6|||
155394760|NCT03426787|560881910|FG000|Overall Study|Lost to Follow-up|7|||
155394761|NCT03426787|560881910|FG000|Overall Study|Unrelated to intervention death|1|||
155394762|NCT02592551|560881911|FG000|Overall Study|Not evaluable|1|||
155394763|NCT02592551|560881912|FG001|Overall Study|Not evaluable|3|||
155394764|NCT02592551|560881913|FG002|Overall Study|Not evaluable|0|||
155394765|NCT00908583|560881917|FG000|Phase 1|Withdrawal by Subject|1|||
155394766|NCT00908583|560881917|FG000|Phase 1|Adverse Event|4|||
155394767|NCT00908583|560881917|FG000|Phase 2|Physician Decision|1|||
155394768|NCT00908583|560881917|FG000|Phase 2|Adverse Event|1|||
155394769|NCT00908583|560881917|FG000|Phase 3|Adverse Event|2|||
155394770|NCT00908583|560881917|FG000|Phase 4|Adverse Event|1|||
155394771|NCT00908583|560881917|FG000|Phase 4|Physician Decision|1|||
155394772|NCT00908583|560881917|FG000|Phase 5|Adverse Event|3|||
155394773|NCT00993954|560881918|FG000|Overall Study|Protocol Violation|21|||
155394774|NCT00993954|560881919|FG001|Overall Study|Protocol Violation|2|||
155394775|NCT00860951|560881920|FG000|Overall Study|Withdrawal by Subject|2|||
155394776|NCT00860951|560881920|FG000|Overall Study|Lost to Follow-up|5|||
155394777|NCT01950247|560881921|FG000|Overall Study|Withdrawal by Subject|28|||
155394778|NCT01950247|560881922|FG001|Overall Study|Withdrawal by Subject|13|||
155394779|NCT01950247|560881921|FG000|Overall Study|Lost to Follow-up|18|||
155394780|NCT01950247|560881922|FG001|Overall Study|Lost to Follow-up|16|||
155394781|NCT01950247|560881921|FG000|Overall Study|Physician Decision|3|||
155394782|NCT01950247|560881922|FG001|Overall Study|Physician Decision|4|||
155394783|NCT01950247|560881921|FG000|Overall Study|Adverse Event|3|||
155394784|NCT01950247|560881922|FG001|Overall Study|Adverse Event|2|||
155394785|NCT01950247|560881921|FG000|Overall Study|Death|1|||
155394786|NCT01950247|560881922|FG001|Overall Study|Death|1|||
155394787|NCT01950247|560881921|FG000|Overall Study|Not Defined|4|||
155394788|NCT01950247|560881922|FG001|Overall Study|Not Defined|10|||
155394789|NCT01069120|560881925|FG000|Overall Study|Study prematurely terminated|27|||
155394790|NCT00763971|560881926|FG000|Overall Study|Adverse Event|5|||
155394791|NCT00763971|560881927|FG001|Overall Study|Adverse Event|2|||
155394792|NCT00763971|560881928|FG002|Overall Study|Adverse Event|4|||
155394793|NCT00763971|560881926|FG000|Overall Study|Protocol Violation|3|||
155394794|NCT00763971|560881927|FG001|Overall Study|Protocol Violation|3|||
155394795|NCT00763971|560881928|FG002|Overall Study|Protocol Violation|2|||
155394796|NCT00763971|560881926|FG000|Overall Study|Withdrawal by Subject|4|||
155394797|NCT00763971|560881927|FG001|Overall Study|Withdrawal by Subject|5|||
155394798|NCT00763971|560881928|FG002|Overall Study|Withdrawal by Subject|5|||
155394799|NCT00763971|560881926|FG000|Overall Study|Lost to Follow-up|0|||
155394800|NCT00763971|560881927|FG001|Overall Study|Lost to Follow-up|1|||
155394801|NCT00763971|560881928|FG002|Overall Study|Lost to Follow-up|0|||
155394802|NCT00763971|560881926|FG000|Overall Study|Lack of Efficacy|11|||
155394803|NCT00763971|560881927|FG001|Overall Study|Lack of Efficacy|22|||
155394804|NCT00763971|560881928|FG002|Overall Study|Lack of Efficacy|54|||
155394805|NCT00763971|560881926|FG000|Overall Study|Unable to swallow capsule|2|||
155394806|NCT00763971|560881927|FG001|Overall Study|Unable to swallow capsule|1|||
155394807|NCT00763971|560881928|FG002|Overall Study|Unable to swallow capsule|1|||
155394808|NCT00763971|560881926|FG000|Overall Study|Personal reason|3|||
155394809|NCT00763971|560881927|FG001|Overall Study|Personal reason|0|||
155394810|NCT00763971|560881928|FG002|Overall Study|Personal reason|0|||
155394811|NCT00763971|560881926|FG000|Overall Study|Exclusion criteria met|1|||
155394812|NCT00763971|560881927|FG001|Overall Study|Exclusion criteria met|0|||
155394813|NCT00763971|560881928|FG002|Overall Study|Exclusion criteria met|0|||
155394814|NCT00763971|560881926|FG000|Overall Study|Sponsor decision|1|||
155394815|NCT00763971|560881927|FG001|Overall Study|Sponsor decision|0|||
155394816|NCT00763971|560881928|FG002|Overall Study|Sponsor decision|0|||
155394817|NCT00763971|560881926|FG000|Overall Study|Due to holiday season|2|||
155394818|NCT00763971|560881927|FG001|Overall Study|Due to holiday season|0|||
155394819|NCT00763971|560881928|FG002|Overall Study|Due to holiday season|1|||
155394820|NCT00763971|560881926|FG000|Overall Study|Randomization error|0|||
155394821|NCT00763971|560881927|FG001|Overall Study|Randomization error|0|||
155394822|NCT00763971|560881928|FG002|Overall Study|Randomization error|1|||
155394823|NCT00763971|560881926|FG000|Overall Study|Medical monitor decision|0|||
155394824|NCT00763971|560881927|FG001|Overall Study|Medical monitor decision|0|||
155394825|NCT00763971|560881928|FG002|Overall Study|Medical monitor decision|1|||
155394826|NCT00763971|560881926|FG000|Overall Study|Moved to another country|0|||
155283704|NCT00783692|560470827|FG002|Maintenance Phase|Lack of Efficacy|0|||
155283705|NCT00783692|560470828|FG003|Maintenance Phase|Lack of Efficacy|64|||
155283706|NCT00783692|560470829|FG004|Maintenance Phase|Lack of Efficacy|58|||
155283707|NCT00783692|560470830|FG005|Maintenance Phase|Lack of Efficacy|48|||
155283708|NCT00783692|560470831|FG006|Maintenance Phase|Lack of Efficacy|177|||
155283709|NCT00783692|560470825|FG000|Maintenance Phase|Withdrawal by Subject|7|||
155283710|NCT00783692|560470826|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155283711|NCT00783692|560470827|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155283712|NCT00783692|560470828|FG003|Maintenance Phase|Withdrawal by Subject|7|||
155283713|NCT00783692|560470829|FG004|Maintenance Phase|Withdrawal by Subject|6|||
155283714|NCT00783692|560470830|FG005|Maintenance Phase|Withdrawal by Subject|9|||
155283715|NCT00783692|560470831|FG006|Maintenance Phase|Withdrawal by Subject|24|||
155283716|NCT00783692|560470825|FG000|Maintenance Phase|Lost to Follow-up|2|||
155283717|NCT00783692|560470826|FG001|Maintenance Phase|Lost to Follow-up|0|||
155283718|NCT00783692|560470827|FG002|Maintenance Phase|Lost to Follow-up|0|||
155283719|NCT00783692|560470828|FG003|Maintenance Phase|Lost to Follow-up|1|||
155283720|NCT00783692|560470829|FG004|Maintenance Phase|Lost to Follow-up|3|||
155283721|NCT00783692|560470830|FG005|Maintenance Phase|Lost to Follow-up|2|||
155283722|NCT00783692|560470831|FG006|Maintenance Phase|Lost to Follow-up|5|||
155283723|NCT00783692|560470825|FG000|Maintenance Phase|Other|0|||
155283724|NCT00783692|560470826|FG001|Maintenance Phase|Other|0|||
155283725|NCT00783692|560470827|FG002|Maintenance Phase|Other|0|||
155283726|NCT00783692|560470828|FG003|Maintenance Phase|Other|1|||
155283727|NCT00783692|560470829|FG004|Maintenance Phase|Other|0|||
155283728|NCT00783692|560470830|FG005|Maintenance Phase|Other|1|||
155283729|NCT00783692|560470831|FG006|Maintenance Phase|Other|1|||
155283730|NCT00819234|560470838|FG000|Overall Study|Withdrawal by Subject|8|||
155283731|NCT00819234|560470839|FG001|Overall Study|Withdrawal by Subject|13|||
155283732|NCT00819234|560470840|FG002|Overall Study|Withdrawal by Subject|6|||
155283733|NCT00819234|560470841|FG003|Overall Study|Withdrawal by Subject|3|||
155283734|NCT00819234|560470842|FG004|Overall Study|Withdrawal by Subject|0|||
155283735|NCT00819234|560470843|FG005|Overall Study|Withdrawal by Subject|4|||
155283736|NCT00819234|560470844|FG006|Overall Study|Withdrawal by Subject|4|||
155283737|NCT00819234|560470845|FG007|Overall Study|Withdrawal by Subject|8|||
155283738|NCT00819234|560470846|FG008|Overall Study|Withdrawal by Subject|5|||
155283739|NCT00819234|560470847|FG009|Overall Study|Withdrawal by Subject|3|||
155283740|NCT00819234|560470838|FG000|Overall Study|Adverse Event|0|||
155283741|NCT00819234|560470839|FG001|Overall Study|Adverse Event|0|||
155283742|NCT00819234|560470840|FG002|Overall Study|Adverse Event|1|||
155283743|NCT00819234|560470841|FG003|Overall Study|Adverse Event|0|||
155283744|NCT00819234|560470842|FG004|Overall Study|Adverse Event|0|||
155283745|NCT00819234|560470843|FG005|Overall Study|Adverse Event|2|||
155283746|NCT00819234|560470844|FG006|Overall Study|Adverse Event|0|||
155283747|NCT00819234|560470845|FG007|Overall Study|Adverse Event|0|||
155283748|NCT00819234|560470846|FG008|Overall Study|Adverse Event|0|||
155283749|NCT00819234|560470847|FG009|Overall Study|Adverse Event|0|||
155283750|NCT00819234|560470838|FG000|Overall Study|Physician Decision|0|||
155283751|NCT00819234|560470839|FG001|Overall Study|Physician Decision|0|||
155283752|NCT00819234|560470840|FG002|Overall Study|Physician Decision|0|||
155283753|NCT00819234|560470841|FG003|Overall Study|Physician Decision|1|||
155283754|NCT00819234|560470842|FG004|Overall Study|Physician Decision|0|||
155283755|NCT00819234|560470843|FG005|Overall Study|Physician Decision|0|||
155283756|NCT00819234|560470844|FG006|Overall Study|Physician Decision|0|||
155283757|NCT00819234|560470845|FG007|Overall Study|Physician Decision|0|||
155283758|NCT00819234|560470846|FG008|Overall Study|Physician Decision|0|||
155283759|NCT00819234|560470847|FG009|Overall Study|Physician Decision|2|||
155283760|NCT00819234|560470838|FG000|Overall Study|Protocol Violation|0|||
155283761|NCT00819234|560470839|FG001|Overall Study|Protocol Violation|0|||
155283762|NCT00819234|560470840|FG002|Overall Study|Protocol Violation|1|||
155283763|NCT00819234|560470841|FG003|Overall Study|Protocol Violation|0|||
155283764|NCT00819234|560470842|FG004|Overall Study|Protocol Violation|0|||
155283765|NCT00819234|560470843|FG005|Overall Study|Protocol Violation|0|||
155283766|NCT00819234|560470844|FG006|Overall Study|Protocol Violation|0|||
155283767|NCT00819234|560470845|FG007|Overall Study|Protocol Violation|0|||
155283768|NCT00819234|560470846|FG008|Overall Study|Protocol Violation|0|||
155283769|NCT00819234|560470847|FG009|Overall Study|Protocol Violation|0|||
155283770|NCT00819234|560470838|FG000|Overall Study|Lost to Follow-up|2|||
155283771|NCT00819234|560470839|FG001|Overall Study|Lost to Follow-up|2|||
155283772|NCT00819234|560470840|FG002|Overall Study|Lost to Follow-up|0|||
155283773|NCT00819234|560470841|FG003|Overall Study|Lost to Follow-up|2|||
155283774|NCT00819234|560470842|FG004|Overall Study|Lost to Follow-up|1|||
155283775|NCT00819234|560470843|FG005|Overall Study|Lost to Follow-up|1|||
155283776|NCT00819234|560470844|FG006|Overall Study|Lost to Follow-up|1|||
155283777|NCT00819234|560470845|FG007|Overall Study|Lost to Follow-up|1|||
155283778|NCT00819234|560470846|FG008|Overall Study|Lost to Follow-up|1|||
155283779|NCT00819234|560470847|FG009|Overall Study|Lost to Follow-up|2|||
155283780|NCT01823341|560470848|FG000|Overall Study|Failed run-in|7|||
155394827|NCT00763971|560881927|FG001|Overall Study|Moved to another country|1|||
155394828|NCT00763971|560881928|FG002|Overall Study|Moved to another country|0|||
155394829|NCT00763971|560881926|FG000|Overall Study|Subject wanted dose reduction|0|||
155394830|NCT00763971|560881927|FG001|Overall Study|Subject wanted dose reduction|1|||
155394831|NCT00763971|560881928|FG002|Overall Study|Subject wanted dose reduction|0|||
155394832|NCT00763971|560881926|FG000|Overall Study|Lack of availability|0|||
155394833|NCT00763971|560881927|FG001|Overall Study|Lack of availability|1|||
155394834|NCT00763971|560881928|FG002|Overall Study|Lack of availability|0|||
155394835|NCT00763971|560881926|FG000|Overall Study|Performed final visit on phone|0|||
155394836|NCT00763971|560881927|FG001|Overall Study|Performed final visit on phone|1|||
155394837|NCT00763971|560881928|FG002|Overall Study|Performed final visit on phone|0|||
155394838|NCT00763971|560881926|FG000|Overall Study|Participation in 489-326 required|1|||
155394839|NCT00763971|560881927|FG001|Overall Study|Participation in 489-326 required|0|||
155394840|NCT00763971|560881928|FG002|Overall Study|Participation in 489-326 required|0|||
155394841|NCT02713542|560881936|FG000|Overall Study|Use of prohibited medication|14|||
155394842|NCT02713542|560881937|FG001|Overall Study|Use of prohibited medication|5|||
155394843|NCT02713542|560881936|FG000|Overall Study|Withdrawal by Subject|4|||
155394844|NCT02713542|560881937|FG001|Overall Study|Withdrawal by Subject|1|||
155394845|NCT03631667|560881938|FG000|Overall Study|Withdrawal by Subject|3|||
155394846|NCT03383289|560881939|FG000|Overall Study|Death|83|||
155394847|NCT03383289|560881940|FG001|Overall Study|Death|78|||
155394848|NCT03383289|560881939|FG000|Overall Study|discharge from facility|84|||
155394849|NCT03383289|560881940|FG001|Overall Study|discharge from facility|84|||
155394850|NCT03383289|560881939|FG000|Overall Study|Withdrawal by Subject|4|||
155394851|NCT03383289|560881940|FG001|Overall Study|Withdrawal by Subject|1|||
155394852|NCT00884325|560881941|FG000|Overall Study|Lost to Follow-up|1|||
155394853|NCT00884325|560881942|FG001|Overall Study|Lost to Follow-up|2|||
155394854|NCT00884325|560881941|FG000|Overall Study|Lack of Efficacy|0|||
155394855|NCT00884325|560881942|FG001|Overall Study|Lack of Efficacy|1|||
155394856|NCT00884325|560881941|FG000|Overall Study|Withdrawal by Subject|1|||
155394857|NCT00884325|560881942|FG001|Overall Study|Withdrawal by Subject|1|||
155394858|NCT00884325|560881941|FG000|Overall Study|Not provided|1|||
155394859|NCT00884325|560881942|FG001|Overall Study|Not provided|0|||
155394860|NCT01641237|560881943|FG000|Period II|Withdrawal by Subject|1|||
155394861|NCT01641237|560881944|FG001|Period II|Withdrawal by Subject|0|||
155394862|NCT01641237|560881945|FG002|Period II|Withdrawal by Subject|0|||
155394863|NCT01641237|560881946|FG003|Period II|Withdrawal by Subject|0|||
155394864|NCT01641237|560881943|FG000|Period III|Lost to Follow-up|1|||
155394865|NCT01641237|560881944|FG001|Period III|Lost to Follow-up|0|||
155394866|NCT01641237|560881945|FG002|Period III|Lost to Follow-up|0|||
155394867|NCT01641237|560881946|FG003|Period III|Lost to Follow-up|0|||
155394868|NCT00832117|560881958|FG000|Overall Study|Death|1|||
155394869|NCT00832117|560881958|FG000|Overall Study|Disease Progression|11|||
155394870|NCT01301456|560881959|FG000|Stage 1|Withdrawal by Subject|0|||
155394871|NCT01301456|560881960|FG001|Stage 1|Withdrawal by Subject|0|||
155394872|NCT01301456|560881961|FG002|Stage 1|Withdrawal by Subject|1|||
155394873|NCT01301456|560881962|FG003|Stage 1|Withdrawal by Subject|0|||
155394874|NCT01301456|560881963|FG004|Stage 1|Withdrawal by Subject|1|||
155394875|NCT01301456|560881964|FG005|Stage 1|Withdrawal by Subject|0|||
155394876|NCT01301456|560881965|FG006|Stage 1|Withdrawal by Subject|0|||
155394877|NCT01301456|560881966|FG007|Stage 1|Withdrawal by Subject|0|||
155394878|NCT01301456|560881967|FG008|Stage 1|Withdrawal by Subject|0|||
155394879|NCT01301456|560881968|FG009|Stage 1|Withdrawal by Subject|0|||
155394880|NCT01301456|560881969|FG010|Stage 1|Withdrawal by Subject|0|||
154952665|NCT00760266|559252014|FG000|Overall Study|Adverse Event|13|||
154952666|NCT00760266|559252015|FG001|Overall Study|Adverse Event|7|||
154952667|NCT00760266|559252014|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154952668|NCT00760266|559252015|FG001|Overall Study|Abnormal laboratory value(s)|0|||
154952669|NCT00760266|559252014|FG000|Overall Study|Abnormal test procedure result(s)|1|||
154952670|NCT00760266|559252015|FG001|Overall Study|Abnormal test procedure result(s)|0|||
154952671|NCT00760266|559252014|FG000|Overall Study|Lack of Efficacy|2|||
154952672|NCT00760266|559252015|FG001|Overall Study|Lack of Efficacy|2|||
154952673|NCT00760266|559252014|FG000|Overall Study|Protocol deviation|2|||
154952674|NCT00760266|559252015|FG001|Overall Study|Protocol deviation|4|||
154952675|NCT00760266|559252014|FG000|Overall Study|Patient withdrew consent|3|||
154952676|NCT00760266|559252015|FG001|Overall Study|Patient withdrew consent|3|||
154952677|NCT00760266|559252014|FG000|Overall Study|Lost to Follow-up|2|||
154952678|NCT00760266|559252015|FG001|Overall Study|Lost to Follow-up|1|||
154952679|NCT00760266|559252014|FG000|Overall Study|Administrative Problems|0|||
155394881|NCT01301456|560881970|FG011|Stage 1|Withdrawal by Subject|0|||
155394882|NCT01301456|560881959|FG000|Stage 1|Randomized but not treated|0|||
154952680|NCT00760266|559252015|FG001|Overall Study|Administrative Problems|1|||
154952681|NCT03657160|559252016|FG000|Overall Study|Adverse Event|5|||
155394883|NCT01301456|560881960|FG001|Stage 1|Randomized but not treated|0|||
154952682|NCT03657160|559252017|FG001|Overall Study|Adverse Event|6|||
155394884|NCT01301456|560881961|FG002|Stage 1|Randomized but not treated|0|||
155394885|NCT01301456|560881962|FG003|Stage 1|Randomized but not treated|0|||
155394886|NCT01301456|560881963|FG004|Stage 1|Randomized but not treated|0|||
155394887|NCT01301456|560881964|FG005|Stage 1|Randomized but not treated|0|||
155394888|NCT01301456|560881965|FG006|Stage 1|Randomized but not treated|1|||
155394889|NCT01301456|560881966|FG007|Stage 1|Randomized but not treated|0|||
155394890|NCT01301456|560881967|FG008|Stage 1|Randomized but not treated|0|||
155394891|NCT01301456|560881968|FG009|Stage 1|Randomized but not treated|0|||
155394892|NCT01301456|560881969|FG010|Stage 1|Randomized but not treated|0|||
155394893|NCT01301456|560881970|FG011|Stage 1|Randomized but not treated|0|||
155394894|NCT01301456|560881959|FG000|Stage 2|Adverse Event|0|||
155394895|NCT01301456|560881960|FG001|Stage 2|Adverse Event|0|||
155394896|NCT01301456|560881961|FG002|Stage 2|Adverse Event|0|||
155394897|NCT01301456|560881962|FG003|Stage 2|Adverse Event|0|||
155394898|NCT01301456|560881963|FG004|Stage 2|Adverse Event|0|||
155394899|NCT01301456|560881964|FG005|Stage 2|Adverse Event|0|||
155394900|NCT01301456|560881965|FG006|Stage 2|Adverse Event|0|||
155394901|NCT01301456|560881966|FG007|Stage 2|Adverse Event|0|||
155394902|NCT01301456|560881967|FG008|Stage 2|Adverse Event|0|||
155394903|NCT01301456|560881968|FG009|Stage 2|Adverse Event|0|||
155394904|NCT01301456|560881969|FG010|Stage 2|Adverse Event|1|||
155394905|NCT01301456|560881970|FG011|Stage 2|Adverse Event|0|||
155394906|NCT03239483|560881971|FG000|Overall Study|Lost to Follow-up|1|||
155394907|NCT03239483|560881972|FG001|Overall Study|Lost to Follow-up|0|||
155394908|NCT03239483|560881971|FG000|Overall Study|Withdrawal by Subject|1|||
155394909|NCT03239483|560881972|FG001|Overall Study|Withdrawal by Subject|0|||
155394910|NCT03678103|560881973|FG000|Overall Study|Withdrawn prior to completion|4|||
155394911|NCT04422990|560881976|FG000|Overall Study|Withdrawal by Subject|0|||
155394912|NCT04422990|560881977|FG001|Overall Study|Withdrawal by Subject|1|||
155394913|NCT04422990|560881976|FG000|Overall Study|Travel|3|||
155394914|NCT04422990|560881977|FG001|Overall Study|Travel|0|||
155394915|NCT00770770|560881981|FG000|Overall Study|Lost to Follow-up|1|||
155394916|NCT00770770|560881982|FG001|Overall Study|Lost to Follow-up|0|||
155394917|NCT00770770|560881981|FG000|Overall Study|Withdrawal by Subject|1|||
155394918|NCT00770770|560881982|FG001|Overall Study|Withdrawal by Subject|0|||
155394919|NCT00770770|560881981|FG000|Overall Study|Death|0|||
155394920|NCT00770770|560881982|FG001|Overall Study|Death|1|||
155394921|NCT00770770|560881981|FG000|Overall Study|Study Terminated|8|||
155394922|NCT00770770|560881982|FG001|Overall Study|Study Terminated|0|||
155394923|NCT02486653|560881983|FG000|Overall Study|Withdrawal by Subject|1|||
155394924|NCT02486653|560881984|FG001|Overall Study|Withdrawal by Subject|3|||
155394925|NCT02486653|560881983|FG000|Overall Study|Protocol Violation|1|||
155394926|NCT02486653|560881984|FG001|Overall Study|Protocol Violation|0|||
155394927|NCT02486653|560881983|FG000|Overall Study|surgery cancelled|4|||
155394928|NCT02486653|560881984|FG001|Overall Study|surgery cancelled|1|||
155394929|NCT01006265|560881985|FG000|Overall Study|Lost to Follow-up|1|||
155394930|NCT01006265|560881986|FG001|Overall Study|Lost to Follow-up|0|||
155394931|NCT01006265|560881987|FG002|Overall Study|Lost to Follow-up|1|||
155394932|NCT01006265|560881988|FG003|Overall Study|Lost to Follow-up|0|||
155394933|NCT01006265|560881985|FG000|Overall Study|Withdrawal by Subject|4|||
155394934|NCT01006265|560881986|FG001|Overall Study|Withdrawal by Subject|7|||
155394935|NCT01006265|560881987|FG002|Overall Study|Withdrawal by Subject|5|||
155394936|NCT01006265|560881988|FG003|Overall Study|Withdrawal by Subject|5|||
155394937|NCT01006265|560881985|FG000|Overall Study|Administrative reason|1|||
155394938|NCT01006265|560881986|FG001|Overall Study|Administrative reason|2|||
155394939|NCT01006265|560881987|FG002|Overall Study|Administrative reason|3|||
155394940|NCT01006265|560881988|FG003|Overall Study|Administrative reason|0|||
155394941|NCT01245387|560881989|FG000|Overall Study|Lost to Follow-up|106|||
155394942|NCT01245387|560881989|FG000|Overall Study|Lack of Efficacy|195|||
155394943|NCT01245387|560881989|FG000|Overall Study|Adverse Event|9|||
155394944|NCT01245387|560881989|FG000|Overall Study|Death|3|||
155394945|NCT01245387|560881989|FG000|Overall Study|Other|131|||
155394946|NCT01245387|560881989|FG000|Overall Study|Missing discontinuation status|369|||
155394947|NCT02101021|560881990|FG000|Overall Study|Death|4|||
155394948|NCT02101021|560881991|FG001|Overall Study|Death|3|||
155394949|NCT02101021|560881992|FG002|Overall Study|Death|6|||
155394950|NCT02101021|560881993|FG003|Overall Study|Death|0|||
155394951|NCT02101021|560881994|FG004|Overall Study|Death|3|||
155394952|NCT02101021|560881990|FG000|Overall Study|Withdrew Consent from study|1|||
155394953|NCT02101021|560881991|FG001|Overall Study|Withdrew Consent from study|1|||
155394954|NCT02101021|560881992|FG002|Overall Study|Withdrew Consent from study|0|||
154952683|NCT03657160|559252016|FG000|Overall Study|Protocol Deviation|3|||
154952684|NCT03657160|559252017|FG001|Overall Study|Protocol Deviation|0|||
154952685|NCT03657160|559252016|FG000|Overall Study|Withdrawal by Subject|18|||
154952686|NCT03657160|559252017|FG001|Overall Study|Withdrawal by Subject|16|||
154952687|NCT03657160|559252016|FG000|Overall Study|Site Termination|1|||
154952688|NCT03657160|559252017|FG001|Overall Study|Site Termination|0|||
154952689|NCT03657160|559252016|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
154952690|NCT03657160|559252017|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
154952691|NCT03657160|559252016|FG000|Overall Study|Death|33|||
154952692|NCT03657160|559252017|FG001|Overall Study|Death|26|||
154952693|NCT03657160|559252016|FG000|Overall Study|Death (COVID-19-Related)|1|||
155057645|NCT03439137|559645773|FG000|Overall Study|Physician Decision|0|||
155057646|NCT03439137|559645774|FG001|Overall Study|Physician Decision|5|||
155057647|NCT03439137|559645773|FG000|Overall Study|Withdrawal by Subject|14|||
155057648|NCT03439137|559645774|FG001|Overall Study|Withdrawal by Subject|4|||
155057649|NCT03439137|559645773|FG000|Overall Study|Conducting rescue therapy|2|||
155057650|NCT03439137|559645774|FG001|Overall Study|Conducting rescue therapy|1|||
155057651|NCT03439137|559645773|FG000|Overall Study|Difficult to control Hb|10|||
155057652|NCT03439137|559645774|FG001|Overall Study|Difficult to control Hb|2|||
155057653|NCT03439137|559645773|FG000|Overall Study|Initiation of a renal transplant|0|||
155394955|NCT02101021|560881993|FG003|Overall Study|Withdrew Consent from study|2|||
155394956|NCT02101021|560881994|FG004|Overall Study|Withdrew Consent from study|0|||
155394957|NCT02101021|560881990|FG000|Overall Study|Lost to Follow-up|1|||
155394958|NCT02101021|560881991|FG001|Overall Study|Lost to Follow-up|0|||
155394959|NCT02101021|560881992|FG002|Overall Study|Lost to Follow-up|0|||
155394960|NCT02101021|560881993|FG003|Overall Study|Lost to Follow-up|0|||
155394961|NCT02101021|560881994|FG004|Overall Study|Lost to Follow-up|0|||
155394962|NCT02101021|560881990|FG000|Overall Study|Study Terminated by Sponsor|1|||
155394963|NCT02101021|560881991|FG001|Overall Study|Study Terminated by Sponsor|0|||
155394964|NCT02101021|560881992|FG002|Overall Study|Study Terminated by Sponsor|1|||
155394965|NCT02101021|560881993|FG003|Overall Study|Study Terminated by Sponsor|1|||
155394966|NCT02101021|560881994|FG004|Overall Study|Study Terminated by Sponsor|1|||
155394967|NCT02632721|560881997|FG000|Overall Study|Adverse Event|0|||
155394968|NCT02632721|560881998|FG001|Overall Study|Adverse Event|0|||
155394969|NCT02632721|560881999|FG002|Overall Study|Adverse Event|2|||
155394970|NCT02632721|560882000|FG003|Overall Study|Adverse Event|5|||
155394971|NCT02632721|560882001|FG004|Overall Study|Adverse Event|3|||
155394972|NCT02632721|560881997|FG000|Overall Study|Dose limiting toxicity|0|||
155394973|NCT02632721|560881998|FG001|Overall Study|Dose limiting toxicity|0|||
155394974|NCT02632721|560881999|FG002|Overall Study|Dose limiting toxicity|0|||
155394975|NCT02632721|560882000|FG003|Overall Study|Dose limiting toxicity|1|||
155394976|NCT02632721|560882001|FG004|Overall Study|Dose limiting toxicity|0|||
155394977|NCT02632721|560881997|FG000|Overall Study|Progressive disease|3|||
155394978|NCT02632721|560881998|FG001|Overall Study|Progressive disease|0|||
155394979|NCT02632721|560881999|FG002|Overall Study|Progressive disease|4|||
155394980|NCT02632721|560882000|FG003|Overall Study|Progressive disease|6|||
155394981|NCT02632721|560882001|FG004|Overall Study|Progressive disease|5|||
155394982|NCT02632721|560881997|FG000|Overall Study|Refused to continue taking trial medication|0|||
155394983|NCT02632721|560881998|FG001|Overall Study|Refused to continue taking trial medication|1|||
155394984|NCT02632721|560881999|FG002|Overall Study|Refused to continue taking trial medication|1|||
155394985|NCT02632721|560882000|FG003|Overall Study|Refused to continue taking trial medication|1|||
155394986|NCT02632721|560882001|FG004|Overall Study|Refused to continue taking trial medication|2|||
155394987|NCT02632721|560881997|FG000|Overall Study|Inadequate clinical condition|0|||
155394988|NCT02632721|560881998|FG001|Overall Study|Inadequate clinical condition|0|||
155394989|NCT02632721|560881999|FG002|Overall Study|Inadequate clinical condition|0|||
155394990|NCT02632721|560882000|FG003|Overall Study|Inadequate clinical condition|0|||
155394991|NCT02632721|560882001|FG004|Overall Study|Inadequate clinical condition|1|||
155394992|NCT02632721|560881997|FG000|Overall Study|No meet eligibility|0|||
155394993|NCT02632721|560881998|FG001|Overall Study|No meet eligibility|0|||
155394994|NCT02632721|560881999|FG002|Overall Study|No meet eligibility|0|||
155394995|NCT02632721|560882000|FG003|Overall Study|No meet eligibility|0|||
155394996|NCT02632721|560882001|FG004|Overall Study|No meet eligibility|1|||
155394997|NCT02632721|560881997|FG000|Overall Study|Allergic reaction|0|||
155394998|NCT02632721|560881998|FG001|Overall Study|Allergic reaction|0|||
155394999|NCT02632721|560881999|FG002|Overall Study|Allergic reaction|0|||
155395000|NCT02632721|560882000|FG003|Overall Study|Allergic reaction|1|||
155395001|NCT02632721|560882001|FG004|Overall Study|Allergic reaction|0|||
155395002|NCT02632721|560881997|FG000|Overall Study|Receiving Decitabine locally|0|||
155395003|NCT02632721|560881998|FG001|Overall Study|Receiving Decitabine locally|0|||
155395004|NCT02632721|560881999|FG002|Overall Study|Receiving Decitabine locally|1|||
155395005|NCT02632721|560882000|FG003|Overall Study|Receiving Decitabine locally|0|||
155395006|NCT02632721|560882001|FG004|Overall Study|Receiving Decitabine locally|0|||
155395007|NCT02632721|560881997|FG000|Overall Study|No benefit from study treatment|1|||
155395008|NCT02632721|560881998|FG001|Overall Study|No benefit from study treatment|1|||
155395009|NCT02632721|560881999|FG002|Overall Study|No benefit from study treatment|0|||
155395010|NCT02632721|560882000|FG003|Overall Study|No benefit from study treatment|0|||
155395011|NCT02632721|560882001|FG004|Overall Study|No benefit from study treatment|1|||
155057654|NCT03439137|559645774|FG001|Overall Study|Initiation of a renal transplant|2|||
155057655|NCT00106002|559645776|FG000|Overall Study|Did not take any study drug|1|||
155395012|NCT02632721|560881997|FG000|Overall Study|Patient wish for other treatment|0|||
155395013|NCT02632721|560881998|FG001|Overall Study|Patient wish for other treatment|1|||
155395014|NCT02632721|560881999|FG002|Overall Study|Patient wish for other treatment|0|||
155057656|NCT00106002|559645776|FG000|Overall Study|Ineligible after Registration|1|||
155395015|NCT02632721|560882000|FG003|Overall Study|Patient wish for other treatment|0|||
155395016|NCT02632721|560882001|FG004|Overall Study|Patient wish for other treatment|0|||
155395017|NCT02632721|560881997|FG000|Overall Study|Relapsed Pneumonia|0|||
155395018|NCT02632721|560881998|FG001|Overall Study|Relapsed Pneumonia|0|||
155395019|NCT02632721|560881999|FG002|Overall Study|Relapsed Pneumonia|0|||
155395020|NCT02632721|560882000|FG003|Overall Study|Relapsed Pneumonia|0|||
155395021|NCT02632721|560882001|FG004|Overall Study|Relapsed Pneumonia|1|||
155395022|NCT02632721|560881997|FG000|Overall Study|Therapy refractory AML|0|||
155395023|NCT02632721|560881998|FG001|Overall Study|Therapy refractory AML|0|||
155395024|NCT02632721|560881999|FG002|Overall Study|Therapy refractory AML|0|||
155395025|NCT02632721|560882000|FG003|Overall Study|Therapy refractory AML|0|||
155395026|NCT02632721|560882001|FG004|Overall Study|Therapy refractory AML|1|||
155395027|NCT02632721|560881997|FG000|Overall Study|Increase of white blood cell count|0|||
155395028|NCT02632721|560881998|FG001|Overall Study|Increase of white blood cell count|0|||
155395029|NCT02632721|560881999|FG002|Overall Study|Increase of white blood cell count|0|||
155395030|NCT02632721|560882000|FG003|Overall Study|Increase of white blood cell count|0|||
155395031|NCT02632721|560882001|FG004|Overall Study|Increase of white blood cell count|1|||
155395032|NCT02632721|560881997|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395033|NCT02632721|560881998|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395034|NCT02632721|560881999|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
155395035|NCT02632721|560882000|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395036|NCT02632721|560882001|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
155395037|NCT01572675|560882002|FG000|Overall Study|End of prescribed treatment|140|||
155395038|NCT01572675|560882003|FG001|Overall Study|End of prescribed treatment|118|||
155395039|NCT01572675|560882002|FG000|Overall Study|Recovery|16|||
155395040|NCT01572675|560882003|FG001|Overall Study|Recovery|23|||
155395041|NCT01572675|560882002|FG000|Overall Study|Lack of Efficacy|31|||
155395042|NCT01572675|560882003|FG001|Overall Study|Lack of Efficacy|31|||
155395043|NCT01572675|560882002|FG000|Overall Study|Intolerance|6|||
155395044|NCT01572675|560882003|FG001|Overall Study|Intolerance|5|||
155395045|NCT01572675|560882002|FG000|Overall Study|Improved symptoms|8|||
155395046|NCT01572675|560882003|FG001|Overall Study|Improved symptoms|2|||
155395047|NCT01572675|560882002|FG000|Overall Study|Surgical intervention|3|||
155395048|NCT01572675|560882003|FG001|Overall Study|Surgical intervention|6|||
155395049|NCT01572675|560882002|FG000|Overall Study|Withdrawal by Subject|5|||
155395050|NCT01572675|560882003|FG001|Overall Study|Withdrawal by Subject|1|||
155395051|NCT01572675|560882002|FG000|Overall Study|Physician Decision|2|||
155395052|NCT01572675|560882003|FG001|Overall Study|Physician Decision|2|||
155395053|NCT01572675|560882002|FG000|Overall Study|Death unrelated to coxibs|1|||
155395054|NCT01572675|560882003|FG001|Overall Study|Death unrelated to coxibs|1|||
155395055|NCT01572675|560882002|FG000|Overall Study|Other disease detected|1|||
155395056|NCT01572675|560882003|FG001|Overall Study|Other disease detected|1|||
155395057|NCT01572675|560882002|FG000|Overall Study|Unknown reason|1|||
155395058|NCT01572675|560882003|FG001|Overall Study|Unknown reason|1|||
155395059|NCT01572675|560882002|FG000|Overall Study|Rheumatologist new evaluation|0|||
155395060|NCT01572675|560882003|FG001|Overall Study|Rheumatologist new evaluation|1|||
155395061|NCT01572675|560882002|FG000|Overall Study|Missing data|1|||
155395062|NCT01572675|560882003|FG001|Overall Study|Missing data|4|||
155395063|NCT01572675|560882002|FG000|Overall Study|Lost to Follow-up|22|||
155395064|NCT01572675|560882003|FG001|Overall Study|Lost to Follow-up|27|||
155395065|NCT03346057|560882006|FG000|Overall Study|Death|1|||
155395066|NCT03346057|560882007|FG001|Overall Study|Death|2|||
155395067|NCT03346057|560882008|FG002|Overall Study|Death|0|||
155395068|NCT03346057|560882009|FG003|Overall Study|Death|0|||
155395069|NCT03346057|560882006|FG000|Overall Study|Lost to Follow-up|0|||
155395070|NCT03346057|560882007|FG001|Overall Study|Lost to Follow-up|2|||
155395071|NCT03346057|560882008|FG002|Overall Study|Lost to Follow-up|1|||
155395072|NCT03346057|560882009|FG003|Overall Study|Lost to Follow-up|0|||
155395073|NCT03346057|560882006|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
155395074|NCT03346057|560882007|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
155395075|NCT03346057|560882008|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
155395076|NCT03346057|560882009|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
155395077|NCT03346057|560882006|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
155395078|NCT03346057|560882007|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
155395079|NCT03346057|560882008|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
155395080|NCT03346057|560882009|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
155395081|NCT03346057|560882006|FG000|Overall Study|Physician Decision|3|||
155395082|NCT03346057|560882007|FG001|Overall Study|Physician Decision|2|||
155395083|NCT03346057|560882008|FG002|Overall Study|Physician Decision|0|||
154952694|NCT03657160|559252017|FG001|Overall Study|Death (COVID-19-Related)|0|||
154952695|NCT03657160|559252016|FG000|Overall Study|Reason Not Specified|5|||
154952696|NCT03657160|559252017|FG001|Overall Study|Reason Not Specified|5|||
154952697|NCT03657160|559252016|FG000|Overall Study|Other (COVID-19-Related)|0|||
154952698|NCT03657160|559252017|FG001|Overall Study|Other (COVID-19-Related)|1|||
154952699|NCT00686959|559252019|FG000|Overall Study|Participants censored (no death events)|124|||
154952700|NCT00686959|559252020|FG001|Overall Study|Participants censored (no death events)|117|||
155395084|NCT03346057|560882009|FG003|Overall Study|Physician Decision|2|||
155395085|NCT03346057|560882006|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
155395086|NCT03346057|560882007|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
155395087|NCT03346057|560882008|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
155395088|NCT03346057|560882009|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
155395089|NCT03346057|560882006|FG000|Overall Study|Withdrawal by Subject|1|||
155395090|NCT03346057|560882007|FG001|Overall Study|Withdrawal by Subject|0|||
155395091|NCT03346057|560882008|FG002|Overall Study|Withdrawal by Subject|0|||
155395092|NCT03346057|560882009|FG003|Overall Study|Withdrawal by Subject|0|||
155395093|NCT02921269|560882010|FG000|Overall Study|Did not complete DLT period|1|||
155395094|NCT01326728|560882011|FG000|Overall Study|Death|13|||
155395095|NCT01326728|560882012|FG001|Overall Study|Death|0|||
155395096|NCT01326728|560882011|FG000|Overall Study|Early closure of study|34|||
155395097|NCT01326728|560882012|FG001|Overall Study|Early closure of study|9|||
155395098|NCT01184053|560882013|FG000|Overall Study|progression while on treatment|3|||
155395099|NCT02536755|560882017|FG000|Overall Study|Adverse Event|4|||
155395100|NCT02301936|560882018|FG000|Overall Study|Lost to Follow-up|1|||
155395101|NCT02301936|560882019|FG001|Overall Study|Lost to Follow-up|0|||
155395102|NCT03065023|560882020|FG000|Overall Study|Progressive Disease|0|||
155395103|NCT03065023|560882021|FG001|Overall Study|Progressive Disease|1|||
155395104|NCT03065023|560882022|FG002|Overall Study|Progressive Disease|0|||
155395105|NCT03065023|560882023|FG003|Overall Study|Progressive Disease|0|||
155395106|NCT03065023|560882024|FG004|Overall Study|Progressive Disease|0|||
155395107|NCT03065023|560882020|FG000|Overall Study|Death|2|||
155395108|NCT03065023|560882021|FG001|Overall Study|Death|0|||
155395109|NCT03065023|560882022|FG002|Overall Study|Death|1|||
155395110|NCT03065023|560882023|FG003|Overall Study|Death|1|||
155395111|NCT03065023|560882024|FG004|Overall Study|Death|0|||
155395112|NCT03065023|560882020|FG000|Overall Study|Lost to Follow-up|0|||
155395113|NCT03065023|560882021|FG001|Overall Study|Lost to Follow-up|1|||
155395114|NCT03065023|560882022|FG002|Overall Study|Lost to Follow-up|0|||
155395115|NCT03065023|560882023|FG003|Overall Study|Lost to Follow-up|0|||
155395116|NCT03065023|560882024|FG004|Overall Study|Lost to Follow-up|0|||
155395117|NCT03065023|560882020|FG000|Overall Study|Participant Decision|0|||
155395118|NCT03065023|560882021|FG001|Overall Study|Participant Decision|0|||
155395119|NCT03065023|560882022|FG002|Overall Study|Participant Decision|0|||
155395120|NCT03065023|560882023|FG003|Overall Study|Participant Decision|1|||
155395121|NCT03065023|560882024|FG004|Overall Study|Participant Decision|0|||
155395122|NCT03065023|560882020|FG000|Overall Study|Withdrawal by Subject|0|||
155395123|NCT03065023|560882021|FG001|Overall Study|Withdrawal by Subject|0|||
155395124|NCT03065023|560882022|FG002|Overall Study|Withdrawal by Subject|0|||
155395125|NCT03065023|560882023|FG003|Overall Study|Withdrawal by Subject|1|||
155395126|NCT03065023|560882024|FG004|Overall Study|Withdrawal by Subject|0|||
155395127|NCT01102803|560882025|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
155395128|NCT01102803|560882026|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
155395129|NCT01102803|560882025|FG000|Post to Follow-Up|Lost to Follow-up|1|||
155395130|NCT01102803|560882026|FG001|Post to Follow-Up|Lost to Follow-up|3|||
155395131|NCT01667107|560882027|FG000|Overall Study|Adverse Event|4|||
155395132|NCT01667107|560882028|FG001|Overall Study|Adverse Event|3|||
155395133|NCT01667107|560882027|FG000|Overall Study|Tolerability issues|0|||
155395134|NCT01667107|560882028|FG001|Overall Study|Tolerability issues|2|||
155395135|NCT01667107|560882027|FG000|Overall Study|Protocol Violation|0|||
155395136|NCT01667107|560882028|FG001|Overall Study|Protocol Violation|1|||
155395137|NCT01667107|560882027|FG000|Overall Study|Lack of Efficacy|0|||
155395138|NCT01667107|560882028|FG001|Overall Study|Lack of Efficacy|1|||
155395139|NCT03427125|560882029|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
155395140|NCT03427125|560882030|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
155395141|NCT03427125|560882031|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
155395142|NCT02281357|560882032|FG000|Overall Study|Adverse Event|2|||
155057657|NCT01122173|559645781|FG000|Overall Study|Lost to Follow-up|3|||
155057658|NCT01122173|559645781|FG000|Overall Study|Withdrawal by Subject|3|||
155057659|NCT01122173|559645781|FG000|Overall Study|Left study for other reasons|3|||
155395143|NCT02281357|560882033|FG001|Overall Study|Adverse Event|1|||
155395144|NCT02281357|560882032|FG000|Overall Study|Lost to Follow-up|1|||
155395145|NCT02281357|560882033|FG001|Overall Study|Lost to Follow-up|0|||
155395146|NCT02281357|560882032|FG000|Overall Study|Withdrawal by Subject|4|||
155395147|NCT02281357|560882033|FG001|Overall Study|Withdrawal by Subject|3|||
155395148|NCT01162239|560882034|FG000|Treatment Phase|Withdrawal by Subject|1|||
155395149|NCT01162239|560882035|FG001|Treatment Phase|Withdrawal by Subject|3|||
155395150|NCT01162239|560882036|FG002|Treatment Phase|Withdrawal by Subject|2|||
155395151|NCT01162239|560882037|FG003|Treatment Phase|Withdrawal by Subject|3|||
155395152|NCT01162239|560882034|FG000|Treatment Phase|Death|0|||
155395153|NCT01162239|560882035|FG001|Treatment Phase|Death|0|||
155395154|NCT01162239|560882036|FG002|Treatment Phase|Death|0|||
155395155|NCT01162239|560882037|FG003|Treatment Phase|Death|1|||
155395156|NCT01162239|560882034|FG000|Treatment Phase|Lost to Follow-up|5|||
155395157|NCT01162239|560882035|FG001|Treatment Phase|Lost to Follow-up|4|||
155395158|NCT01162239|560882036|FG002|Treatment Phase|Lost to Follow-up|2|||
155395159|NCT01162239|560882037|FG003|Treatment Phase|Lost to Follow-up|1|||
155395160|NCT01162239|560882034|FG000|Extended Follow-up|Lost to Follow-up|8|||
155395161|NCT01162239|560882035|FG001|Extended Follow-up|Lost to Follow-up|13|||
155395162|NCT01162239|560882036|FG002|Extended Follow-up|Lost to Follow-up|8|||
155395163|NCT01162239|560882037|FG003|Extended Follow-up|Lost to Follow-up|6|||
155395164|NCT02733185|560882040|FG000|Overall Study|Withdrawal by Subject|12|||
155395165|NCT02733185|560882041|FG001|Overall Study|Withdrawal by Subject|10|||
155395166|NCT02733185|560882042|FG002|Overall Study|Withdrawal by Subject|17|||
155395167|NCT02733185|560882043|FG003|Overall Study|Withdrawal by Subject|21|||
155395168|NCT02733185|560882040|FG000|Overall Study|Death|46|||
155395169|NCT02733185|560882041|FG001|Overall Study|Death|34|||
155395170|NCT02733185|560882042|FG002|Overall Study|Death|35|||
155395171|NCT02733185|560882043|FG003|Overall Study|Death|43|||
155395172|NCT02733185|560882040|FG000|Overall Study|Lost to Follow-up|17|||
155395173|NCT02733185|560882041|FG001|Overall Study|Lost to Follow-up|18|||
155395174|NCT02733185|560882042|FG002|Overall Study|Lost to Follow-up|16|||
155395175|NCT02733185|560882043|FG003|Overall Study|Lost to Follow-up|11|||
155395176|NCT01810016|560882044|FG000|Overall Study|Progressive disease|1|||
155395177|NCT01810016|560882045|FG001|Overall Study|Progressive disease|1|||
155395178|NCT01810016|560882046|FG002|Overall Study|Progressive disease|0|||
155395179|NCT01810016|560882044|FG000|Overall Study|Death|0|||
155395180|NCT01810016|560882045|FG001|Overall Study|Death|0|||
155395181|NCT01810016|560882046|FG002|Overall Study|Death|1|||
155395182|NCT04572854|560882047|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
155395183|NCT04572854|560882048|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
155395184|NCT04572854|560882049|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
155395185|NCT04572854|560882050|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
155395186|NCT04572854|560882047|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
155395187|NCT04572854|560882048|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
155395188|NCT04572854|560882049|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
155395189|NCT04572854|560882050|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
155395190|NCT07052682|560882053|FG000|Overall Study|Withdrawal by Subject|4|||
155395191|NCT06950879|560882054|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
155395192|NCT02246582|560883397|FG000|Overall Study|Withdrawal by Subject|3|||
155395193|NCT02246582|560883398|FG001|Overall Study|Withdrawal by Subject|4|||
155395194|NCT02229539|560883399|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
155395195|NCT02229539|560883400|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
155395196|NCT02229539|560883401|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
155395197|NCT02229539|560883399|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
155395198|NCT02229539|560883400|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
155395199|NCT02229539|560883401|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
155395200|NCT02229539|560883399|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
155395201|NCT02229539|560883400|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
155395202|NCT02229539|560883401|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
155395203|NCT02229539|560883399|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
155395204|NCT02229539|560883400|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
155395205|NCT02229539|560883401|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
155395206|NCT02229539|560883399|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
155395207|NCT02229539|560883400|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
155395208|NCT02229539|560883401|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
155395209|NCT02229539|560883399|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
155395210|NCT02229539|560883400|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
155395211|NCT02229539|560883401|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
155395212|NCT03441334|560883403|FG000|Overall Study|Withdrawal by Subject|1|||
155395213|NCT03441334|560883404|FG001|Overall Study|Withdrawal by Subject|0|||
155395214|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
155395215|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
155395216|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Adverse Event|14|||
155395217|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Adverse Event|19|||
155395218|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Death|11|||
155395219|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Death|12|||
155395220|NCT00088907|560883405|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
155395221|NCT00088907|560883406|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
155395222|NCT00088907|560883405|FG000|Randomized Study (Step 1)|complicating disease|3|||
155395223|NCT00088907|560883406|FG001|Randomized Study (Step 1)|complicating disease|1|||
155395224|NCT00088907|560883405|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
155395225|NCT00088907|560883406|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
155395226|NCT00088907|560883405|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
155395227|NCT00088907|560883406|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
154952701|NCT02191891|559252021|FG000|Overall Study|Withdrawal by Subject|0|||
154952702|NCT02191891|559252022|FG001|Overall Study|Withdrawal by Subject|1|||
154952703|NCT02191891|559252023|FG002|Overall Study|Withdrawal by Subject|0|||
154952704|NCT02191891|559252024|FG003|Overall Study|Withdrawal by Subject|0|||
155395228|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
155395229|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
155395230|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
155395231|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
155395232|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
155395233|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
155395234|NCT00088907|560883405|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
155395235|NCT00088907|560883406|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
155395236|NCT00682448|560883413|FG000|Overall Study|Adverse Event|1|||
155395237|NCT00682448|560883414|FG001|Overall Study|Adverse Event|2|||
155395238|NCT00682448|560883413|FG000|Overall Study|Lack of Efficacy|1|||
155395239|NCT00682448|560883414|FG001|Overall Study|Lack of Efficacy|0|||
155395240|NCT00682448|560883413|FG000|Overall Study|Lost to Follow-up|1|||
155395241|NCT00682448|560883414|FG001|Overall Study|Lost to Follow-up|3|||
155395242|NCT00682448|560883413|FG000|Overall Study|Pregnancy|0|||
155395243|NCT00682448|560883414|FG001|Overall Study|Pregnancy|1|||
155395244|NCT00682448|560883413|FG000|Overall Study|Withdrawal by Subject|2|||
155395245|NCT00682448|560883414|FG001|Overall Study|Withdrawal by Subject|0|||
155395246|NCT00257166|560883418|FG000|Overall Study|Adverse Event|18|||
155395247|NCT00257166|560883419|FG001|Overall Study|Adverse Event|13|||
155395248|NCT00257166|560883418|FG000|Overall Study|Laboratory abnormality|1|||
155395249|NCT00257166|560883419|FG001|Overall Study|Laboratory abnormality|0|||
155395250|NCT00257166|560883418|FG000|Overall Study|Lost to Follow-up|8|||
155395251|NCT00257166|560883419|FG001|Overall Study|Lost to Follow-up|1|||
155395252|NCT00257166|560883418|FG000|Overall Study|Withdrawal by Subject|9|||
155395253|NCT00257166|560883419|FG001|Overall Study|Withdrawal by Subject|2|||
155395254|NCT00257166|560883418|FG000|Overall Study|Other|16|||
155395255|NCT00257166|560883419|FG001|Overall Study|Other|21|||
155395256|NCT00257166|560883418|FG000|Overall Study|Randomized, but not treated|1|||
155395257|NCT00257166|560883419|FG001|Overall Study|Randomized, but not treated|0|||
155395258|NCT00525044|560883420|FG000|Overall Study|Lost to Follow-up|0|||
155395259|NCT00525044|560883421|FG001|Overall Study|Lost to Follow-up|1|||
155395260|NCT02553265|560883422|FG000|Enrollment|Death|0|||
155395261|NCT02553265|560883423|FG001|Enrollment|Death|0|||
155395262|NCT02553265|560883424|FG002|Enrollment|Death|1|||
155395263|NCT02553265|560883422|FG000|First Intervention (28 Days)|Adverse Event|1|||
155395264|NCT02553265|560883423|FG001|First Intervention (28 Days)|Adverse Event|0|||
155395265|NCT02553265|560883424|FG002|First Intervention (28 Days)|Adverse Event|0|||
155395266|NCT02553265|560883422|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
155395267|NCT02553265|560883423|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
155395268|NCT02553265|560883424|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
155395269|NCT02553265|560883422|FG000|Second Intervention (28 Days)|Adverse Event|1|||
155395270|NCT02553265|560883423|FG001|Second Intervention (28 Days)|Adverse Event|0|||
155395271|NCT02553265|560883424|FG002|Second Intervention (28 Days)|Adverse Event|0|||
155395272|NCT02553265|560883422|FG000|Third Intervention (28 Days)|Adverse Event|1|||
155395273|NCT02553265|560883423|FG001|Third Intervention (28 Days)|Adverse Event|0|||
155395274|NCT02553265|560883424|FG002|Third Intervention (28 Days)|Adverse Event|0|||
155395275|NCT02553265|560883422|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
155395276|NCT02553265|560883423|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
155395277|NCT02553265|560883424|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
155395278|NCT01650285|560883434|FG000|Overall Study|Adverse Event|1|||
155395279|NCT00659529|560883435|FG000|Overall Study|Withdrawal by Subject|4|||
155395280|NCT00659529|560883435|FG000|Overall Study|Protocol Violation|3|||
155395281|NCT00659529|560883435|FG000|Overall Study|Screen failure|9|||
155395282|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
155395283|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395284|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395285|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395286|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
155395287|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
155395288|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395289|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395290|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395291|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
155395292|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
155395293|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395294|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395295|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395296|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
155395297|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
155395298|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395299|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395300|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395301|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
155395302|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
155395303|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395304|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395305|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395306|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
155395307|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
155395308|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395309|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395310|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395311|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
155395312|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
155395313|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395314|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395315|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395316|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
155395317|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
155395318|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395319|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395320|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395321|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
155395322|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
155395323|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395324|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395325|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395326|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
155395327|NCT03627767|560883440|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
155395328|NCT03627767|560883441|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395329|NCT03627767|560883442|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395330|NCT03627767|560883443|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395331|NCT03627767|560883444|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
155395332|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
155395333|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
155395334|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
155395335|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
155395336|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
155395337|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155395338|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155395339|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
155395340|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
155395341|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155395342|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
155395343|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
155395344|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
155395345|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
155395346|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
155395347|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155395348|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
155395349|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
155395350|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
155395351|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155395352|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
154952705|NCT02191891|559252025|FG004|Overall Study|Withdrawal by Subject|1|||
154952706|NCT02191891|559252021|FG000|Overall Study|Adverse Event|0|||
154952707|NCT02191891|559252022|FG001|Overall Study|Adverse Event|1|||
154952708|NCT02191891|559252023|FG002|Overall Study|Adverse Event|0|||
154952709|NCT02191891|559252024|FG003|Overall Study|Adverse Event|0|||
154952710|NCT02191891|559252025|FG004|Overall Study|Adverse Event|2|||
154952711|NCT02191891|559252021|FG000|Overall Study|Disease Progression|4|||
155057660|NCT02265510|559645782|FG000|Overall Study|Withdrawal by Subject|1|||
154952712|NCT02191891|559252022|FG001|Overall Study|Disease Progression|10|||
155395353|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155395354|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
155395355|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155395356|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
155395357|NCT03627767|560883440|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
155395358|NCT03627767|560883441|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
155395359|NCT03627767|560883442|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
155395360|NCT03627767|560883443|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
155395361|NCT03627767|560883444|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
155395362|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395363|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395364|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395365|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
155395366|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
155395367|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395368|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395369|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395370|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
155395371|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
155395372|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395373|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395374|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395375|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
155395376|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
155395377|NCT03627767|560883440|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
155395378|NCT03627767|560883441|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
155395379|NCT03627767|560883442|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
155395380|NCT03627767|560883443|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
155395381|NCT03627767|560883444|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
155395382|NCT00621751|560883445|FG000|Overall Study|Adverse Event|0|||
155395383|NCT00621751|560883446|FG001|Overall Study|Adverse Event|1|||
155395384|NCT04439071|560883451|FG000|Overall Study|Lost to Follow-up|0|||
155395385|NCT04439071|560883452|FG001|Overall Study|Lost to Follow-up|3|||
155395386|NCT04439071|560883451|FG000|Overall Study|Withdrawal by Subject|3|||
155395387|NCT04439071|560883452|FG001|Overall Study|Withdrawal by Subject|8|||
155395388|NCT04439071|560883451|FG000|Overall Study|Death|6|||
155395389|NCT04439071|560883452|FG001|Overall Study|Death|4|||
155395390|NCT04439071|560883451|FG000|Overall Study|Other than specified|3|||
155395391|NCT04439071|560883452|FG001|Overall Study|Other than specified|3|||
155395392|NCT04439071|560883451|FG000|Overall Study|Randomized but not treated|2|||
155395393|NCT04439071|560883452|FG001|Overall Study|Randomized but not treated|0|||
155395394|NCT00892177|560883453|FG000|Phase II|Ineligible|0|||
155395395|NCT00892177|560883454|FG001|Phase II|Ineligible|0|||
155395396|NCT00892177|560883455|FG002|Phase II|Ineligible|0|||
155395397|NCT00892177|560883456|FG003|Phase II|Ineligible|0|||
155395398|NCT00892177|560883457|FG004|Phase II|Ineligible|1|||
155395399|NCT00892177|560883458|FG005|Phase II|Ineligible|1|||
155395400|NCT00892177|560883453|FG000|Phase II|Withdrawal by Subject|0|||
155395401|NCT00892177|560883454|FG001|Phase II|Withdrawal by Subject|0|||
155395402|NCT00892177|560883455|FG002|Phase II|Withdrawal by Subject|0|||
155395403|NCT00892177|560883456|FG003|Phase II|Withdrawal by Subject|0|||
155395404|NCT00892177|560883457|FG004|Phase II|Withdrawal by Subject|4|||
155395405|NCT00892177|560883458|FG005|Phase II|Withdrawal by Subject|1|||
155395406|NCT05097716|560883459|FG000|Period 1|Adverse Event|1|||
155395407|NCT05097716|560883459|FG000|Period 1|Close contact with highly-transmissible infection|1|||
155395408|NCT01949155|560883460|FG000|Overall Study|Lost to Follow-up|1|||
155395409|NCT01949155|560883461|FG001|Overall Study|Lost to Follow-up|0|||
154952713|NCT02191891|559252023|FG002|Overall Study|Disease Progression|4|||
154952714|NCT02191891|559252024|FG003|Overall Study|Disease Progression|2|||
154952715|NCT02191891|559252025|FG004|Overall Study|Disease Progression|7|||
154952716|NCT01448057|559252029|FG000|Overall Study|Protocol Violation|3|||
154952717|NCT01448057|559252030|FG001|Overall Study|Protocol Violation|2|||
154952718|NCT01448057|559252029|FG000|Overall Study|Lost to Follow-up|3|||
154952719|NCT01448057|559252030|FG001|Overall Study|Lost to Follow-up|0|||
154952720|NCT01448057|559252029|FG000|Overall Study|Adverse Event|0|||
154952721|NCT01448057|559252030|FG001|Overall Study|Adverse Event|2|||
154952722|NCT01448057|559252029|FG000|Overall Study|Withdrawal by Subject|2|||
154952723|NCT01448057|559252030|FG001|Overall Study|Withdrawal by Subject|0|||
154952724|NCT03883906|559252033|FG000|Overall Study|Withdrawal by Subject|2|||
154952725|NCT03883906|559252033|FG000|Overall Study|Physician Decision|5|||
154952726|NCT03912337|559252034|FG000|Overall Study|Withdrawal of Consent From Study|1|||
154952727|NCT03912337|559252035|FG001|Overall Study|Withdrawal of Consent From Study|0|||
154952728|NCT03912337|559252034|FG000|Overall Study|Lost to Follow-up|1|||
154952729|NCT03912337|559252035|FG001|Overall Study|Lost to Follow-up|1|||
155395410|NCT01949155|560883460|FG000|Overall Study|Protocol Violation|1|||
155395411|NCT01949155|560883461|FG001|Overall Study|Protocol Violation|0|||
155395412|NCT00800436|560883470|FG000|Overall Study|Withdrawal by Subject|0|||
155395413|NCT00800436|560883471|FG001|Overall Study|Withdrawal by Subject|0|||
155395414|NCT00800436|560883472|FG002|Overall Study|Withdrawal by Subject|1|||
155395415|NCT00800436|560883473|FG003|Overall Study|Withdrawal by Subject|1|||
155395416|NCT00800436|560883474|FG004|Overall Study|Withdrawal by Subject|0|||
155395417|NCT00800436|560883475|FG005|Overall Study|Withdrawal by Subject|0|||
154952730|NCT00680121|559252038|FG000|Overall Study|Lost to Follow-up|27|||
154952731|NCT00680121|559252039|FG001|Overall Study|Lost to Follow-up|23|||
154952732|NCT01939197|559252040|FG000|Overall Study|Withdrawal by Subject|1|||
154952733|NCT01939197|559252041|FG001|Overall Study|Withdrawal by Subject|0|||
154952734|NCT01939197|559252042|FG002|Overall Study|Withdrawal by Subject|0|||
154952735|NCT01939197|559252043|FG003|Overall Study|Withdrawal by Subject|0|||
154952736|NCT01939197|559252044|FG004|Overall Study|Withdrawal by Subject|1|||
154952737|NCT01939197|559252045|FG005|Overall Study|Withdrawal by Subject|0|||
154952738|NCT01939197|559252046|FG006|Overall Study|Withdrawal by Subject|0|||
154952739|NCT01939197|559252040|FG000|Overall Study|Lost to Follow-up|0|||
154952740|NCT01939197|559252041|FG001|Overall Study|Lost to Follow-up|1|||
154952741|NCT01939197|559252042|FG002|Overall Study|Lost to Follow-up|0|||
154952742|NCT01939197|559252043|FG003|Overall Study|Lost to Follow-up|1|||
154952743|NCT01939197|559252044|FG004|Overall Study|Lost to Follow-up|3|||
154952744|NCT01939197|559252045|FG005|Overall Study|Lost to Follow-up|1|||
154952745|NCT01939197|559252046|FG006|Overall Study|Lost to Follow-up|2|||
154952746|NCT02545998|559252049|FG000|Overall Study|Lost to Follow-up|12|||
154952747|NCT02545998|559252050|FG001|Overall Study|Lost to Follow-up|3|||
154952748|NCT02545998|559252049|FG000|Overall Study|Withdrawal by Subject|3|||
154952749|NCT02545998|559252050|FG001|Overall Study|Withdrawal by Subject|2|||
154952750|NCT05214560|559252054|FG000|Overall Study|Screening Failure|1|||
154952751|NCT05214560|559252054|FG000|Overall Study|Physician Decision|4|||
154952752|NCT05214560|559252054|FG000|Overall Study|Withdrawal by Subject|1|||
154952753|NCT05214560|559252054|FG000|Overall Study|Lost to Follow-up|2|||
154952754|NCT05214560|559252054|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
154952755|NCT05214560|559252054|FG000|Overall Study|Study physician not available for the anesthesia|3|||
154952756|NCT05214560|559252054|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
154952757|NCT05214560|559252054|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
154952758|NCT05214560|559252054|FG000|Overall Study|Surgery not performed|3|||
154952759|NCT00970281|559252056|FG000|Overall Study|Lack of Efficacy|1|||
154952760|NCT00970281|559252057|FG001|Overall Study|Lack of Efficacy|14|||
154952761|NCT00970281|559252056|FG000|Overall Study|Withdrawal by Subject|0|||
154952762|NCT00970281|559252057|FG001|Overall Study|Withdrawal by Subject|1|||
154952763|NCT00970281|559252056|FG000|Overall Study|Physician Decision|1|||
154952764|NCT00970281|559252057|FG001|Overall Study|Physician Decision|1|||
154952765|NCT00408902|559252058|FG000|Overall Study|Lack of Efficacy|7|||
154952766|NCT00408902|559252058|FG000|Overall Study|Adverse Event|3|||
154952767|NCT02457832|559252059|FG000|Training|Lost to Follow-up|10|||
154952768|NCT02457832|559252060|FG001|Training|Lost to Follow-up|6|||
154952769|NCT02457832|559252061|FG002|Training|Lost to Follow-up|3|||
154952770|NCT02457832|559252059|FG000|One Month Washout|Lost to Follow-up|0|||
154952771|NCT02457832|559252060|FG001|One Month Washout|Lost to Follow-up|1|||
154952772|NCT02457832|559252061|FG002|One Month Washout|Lost to Follow-up|1|||
154952773|NCT01030965|559252062|FG000|Overall Study|Lack of Efficacy|3|||
154952774|NCT01030965|559252063|FG001|Overall Study|Lack of Efficacy|2|||
154952775|NCT01030965|559252064|FG002|Overall Study|Lack of Efficacy|0|||
154952776|NCT01030965|559252065|FG003|Overall Study|Lack of Efficacy|3|||
154952777|NCT01030965|559252062|FG000|Overall Study|Protocol Violation|1|||
154952778|NCT01030965|559252063|FG001|Overall Study|Protocol Violation|1|||
154952779|NCT01030965|559252064|FG002|Overall Study|Protocol Violation|1|||
154952780|NCT01030965|559252065|FG003|Overall Study|Protocol Violation|1|||
154952781|NCT01030965|559252062|FG000|Overall Study|Adverse Event|0|||
154952782|NCT01030965|559252063|FG001|Overall Study|Adverse Event|1|||
154952783|NCT01030965|559252064|FG002|Overall Study|Adverse Event|2|||
154952784|NCT01030965|559252065|FG003|Overall Study|Adverse Event|1|||
154952785|NCT01030965|559252062|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
154952786|NCT01030965|559252063|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
154952787|NCT01030965|559252064|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
154952788|NCT01030965|559252065|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
154952789|NCT01030965|559252062|FG000|Overall Study|Withdrawal by Subject|0|||
154952790|NCT01030965|559252063|FG001|Overall Study|Withdrawal by Subject|1|||
154952791|NCT01030965|559252064|FG002|Overall Study|Withdrawal by Subject|0|||
154952792|NCT01030965|559252065|FG003|Overall Study|Withdrawal by Subject|2|||
154952793|NCT02097290|559252066|FG000|Overall Study|Death|6|||
154952794|NCT02097290|559252066|FG000|Overall Study|Total Withdrawals|3|||
154952795|NCT02097290|559252066|FG000|Overall Study|Attempt|8|||
155395418|NCT00800436|560883476|FG006|Overall Study|Withdrawal by Subject|0|||
155395419|NCT00711529|560883483|FG000|Overall Study|Protocol Violation|2|||
155395420|NCT00711529|560883484|FG001|Overall Study|Protocol Violation|0|||
154952796|NCT03069937|559252067|FG000|Overall Study|Second primary malignancy noted|1|||
154952797|NCT01691248|559252070|FG000|Overall Study|Protocol Violation|43|||
154952798|NCT01691248|559252071|FG001|Overall Study|Protocol Violation|27|||
154952799|NCT01691248|559252070|FG000|Overall Study|Adverse Event|24|||
154952800|NCT01691248|559252071|FG001|Overall Study|Adverse Event|22|||
154952801|NCT01691248|559252070|FG000|Overall Study|Withdrawal by Subject|20|||
154952802|NCT01691248|559252071|FG001|Overall Study|Withdrawal by Subject|18|||
154952803|NCT01691248|559252070|FG000|Overall Study|Confirmed CDAD|14|||
154952804|NCT01691248|559252071|FG001|Overall Study|Confirmed CDAD|31|||
154952805|NCT01691248|559252070|FG000|Overall Study|Lost to Follow-up|2|||
154952806|NCT01691248|559252071|FG001|Overall Study|Lost to Follow-up|5|||
154952807|NCT01691248|559252070|FG000|Overall Study|Reason not provided|4|||
154952808|NCT01691248|559252071|FG001|Overall Study|Reason not provided|4|||
154952809|NCT01691248|559252070|FG000|Overall Study|Not Treated|4|||
154952810|NCT01691248|559252071|FG001|Overall Study|Not Treated|7|||
154952811|NCT02863575|559252072|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
154952812|NCT02863575|559252073|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
154952813|NCT02863575|559252074|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
154952814|NCT02863575|559252072|FG000|Overall Study|Withdrawal by Subject|0|||
154952815|NCT02863575|559252073|FG001|Overall Study|Withdrawal by Subject|1|||
154952816|NCT02863575|559252074|FG002|Overall Study|Withdrawal by Subject|1|||
154952817|NCT02863575|559252072|FG000|Overall Study|Adverse Event|0|||
154952818|NCT02863575|559252073|FG001|Overall Study|Adverse Event|1|||
154952819|NCT02863575|559252074|FG002|Overall Study|Adverse Event|0|||
154952820|NCT04188106|559254480|FG000|Overall Study|Lost to Follow-up|5|||
154952821|NCT04188106|559254480|FG000|Overall Study|Non-Compliance|1|||
154952822|NCT01746017|559254481|FG000|Period 1|Withdrawal by Subject|0|||
154952823|NCT01746017|559254482|FG001|Period 1|Withdrawal by Subject|0|||
154952824|NCT01746017|559254483|FG002|Period 1|Withdrawal by Subject|0|||
154952825|NCT01746017|559254484|FG003|Period 1|Withdrawal by Subject|0|||
154952826|NCT01746017|559254485|FG004|Period 1|Withdrawal by Subject|0|||
154952827|NCT01746017|559254486|FG005|Period 1|Withdrawal by Subject|0|||
154952828|NCT01746017|559254487|FG006|Period 1|Withdrawal by Subject|1|||
154952829|NCT01746017|559254488|FG007|Period 1|Withdrawal by Subject|0|||
154952830|NCT01746017|559254489|FG008|Period 1|Withdrawal by Subject|0|||
154952831|NCT01746017|559254490|FG009|Period 1|Withdrawal by Subject|0|||
154952832|NCT01746017|559254491|FG010|Period 1|Withdrawal by Subject|0|||
154952833|NCT01746017|559254481|FG000|Period 3|Withdrawal by Subject|0|||
154952834|NCT01746017|559254482|FG001|Period 3|Withdrawal by Subject|0|||
155283781|NCT01823341|560470848|FG000|Overall Study|Withdrawal by Subject|7|||
154952835|NCT01746017|559254483|FG002|Period 3|Withdrawal by Subject|0|||
154952836|NCT01746017|559254484|FG003|Period 3|Withdrawal by Subject|0|||
154952837|NCT01746017|559254485|FG004|Period 3|Withdrawal by Subject|0|||
154952838|NCT01746017|559254486|FG005|Period 3|Withdrawal by Subject|1|||
154952839|NCT01746017|559254487|FG006|Period 3|Withdrawal by Subject|0|||
154952840|NCT01746017|559254488|FG007|Period 3|Withdrawal by Subject|0|||
154952841|NCT01746017|559254489|FG008|Period 3|Withdrawal by Subject|0|||
154952842|NCT01746017|559254490|FG009|Period 3|Withdrawal by Subject|0|||
154952843|NCT01746017|559254491|FG010|Period 3|Withdrawal by Subject|0|||
155283782|NCT01823341|560470848|FG000|Overall Study|Adverse Event|1|||
155283783|NCT00689104|560470850|FG000|Overall Study|Eligibility criterion not met|5|||
155283784|NCT00689104|560470851|FG001|Overall Study|Eligibility criterion not met|8|||
155283785|NCT00689104|560470852|FG002|Overall Study|Eligibility criterion not met|0|||
155283786|NCT00689104|560470853|FG003|Overall Study|Eligibility criterion not met|4|||
155283787|NCT00689104|560470850|FG000|Overall Study|Adverse Event|13|||
155283788|NCT00689104|560470851|FG001|Overall Study|Adverse Event|25|||
155283789|NCT00689104|560470852|FG002|Overall Study|Adverse Event|16|||
155283790|NCT00689104|560470853|FG003|Overall Study|Adverse Event|24|||
155283791|NCT00689104|560470850|FG000|Overall Study|Lack of Efficacy|5|||
155283792|NCT00689104|560470851|FG001|Overall Study|Lack of Efficacy|6|||
155283793|NCT00689104|560470852|FG002|Overall Study|Lack of Efficacy|2|||
155283794|NCT00689104|560470853|FG003|Overall Study|Lack of Efficacy|3|||
155283795|NCT00689104|560470850|FG000|Overall Study|Withdrawal by Subject|12|||
155283796|NCT00689104|560470851|FG001|Overall Study|Withdrawal by Subject|11|||
155283797|NCT00689104|560470852|FG002|Overall Study|Withdrawal by Subject|18|||
155283798|NCT00689104|560470853|FG003|Overall Study|Withdrawal by Subject|11|||
155283799|NCT00689104|560470850|FG000|Overall Study|Lost to Follow-up|4|||
155283800|NCT00689104|560470851|FG001|Overall Study|Lost to Follow-up|3|||
155283801|NCT00689104|560470852|FG002|Overall Study|Lost to Follow-up|2|||
155283802|NCT00689104|560470853|FG003|Overall Study|Lost to Follow-up|5|||
155283803|NCT00689104|560470850|FG000|Overall Study|Protocol Violation|2|||
155283804|NCT00689104|560470851|FG001|Overall Study|Protocol Violation|3|||
155283805|NCT00689104|560470852|FG002|Overall Study|Protocol Violation|5|||
155283806|NCT00689104|560470853|FG003|Overall Study|Protocol Violation|3|||
155283807|NCT00689104|560470850|FG000|Overall Study|Randomized but never received study drug|2|||
155283808|NCT00689104|560470851|FG001|Overall Study|Randomized but never received study drug|1|||
155283809|NCT00689104|560470852|FG002|Overall Study|Randomized but never received study drug|1|||
155395421|NCT00711529|560883483|FG000|Overall Study|Withdrawal by Subject|2|||
155395422|NCT00711529|560883484|FG001|Overall Study|Withdrawal by Subject|6|||
155395423|NCT01177384|560883490|FG000|Overall Study|Adverse Event|6|||
155395424|NCT01177384|560883491|FG001|Overall Study|Adverse Event|4|||
155395425|NCT01177384|560883490|FG000|Overall Study|Lack of Efficacy|0|||
155395426|NCT01177384|560883491|FG001|Overall Study|Lack of Efficacy|1|||
155395427|NCT01177384|560883490|FG000|Overall Study|Lost to Follow-up|3|||
155395428|NCT01177384|560883491|FG001|Overall Study|Lost to Follow-up|4|||
155395429|NCT01177384|560883490|FG000|Overall Study|Physician Decision|0|||
155395430|NCT01177384|560883491|FG001|Overall Study|Physician Decision|3|||
155395431|NCT01177384|560883490|FG000|Overall Study|Protocol Violation|0|||
155395432|NCT01177384|560883491|FG001|Overall Study|Protocol Violation|2|||
155395433|NCT01177384|560883490|FG000|Overall Study|Withdrawal by Subject|5|||
155395434|NCT01177384|560883491|FG001|Overall Study|Withdrawal by Subject|12|||
155395435|NCT03606980|560883492|FG000|Overall Study|Lost to Follow-up|3|||
155395436|NCT03606980|560883493|FG001|Overall Study|Lost to Follow-up|2|||
155395437|NCT03606980|560883494|FG002|Overall Study|Lost to Follow-up|3|||
155395438|NCT03606980|560883492|FG000|Overall Study|Withdrawal by Subject|1|||
155395439|NCT03606980|560883493|FG001|Overall Study|Withdrawal by Subject|0|||
155395440|NCT03606980|560883494|FG002|Overall Study|Withdrawal by Subject|4|||
155395441|NCT01849497|560883495|FG000|Overall Study|Withdrawal by Subject|1|||
155395442|NCT01849497|560883496|FG001|Overall Study|Withdrawal by Subject|2|||
155395443|NCT01849497|560883495|FG000|Overall Study|Sponsor Decision|0|||
155395444|NCT01849497|560883496|FG001|Overall Study|Sponsor Decision|1|||
155395445|NCT01849497|560883495|FG000|Overall Study|Lost to Follow-up|0|||
155395446|NCT01849497|560883496|FG001|Overall Study|Lost to Follow-up|1|||
155395447|NCT03044886|560883497|FG000|Overall Study|Lost to Follow-up|15|||
155395448|NCT03044886|560883498|FG001|Overall Study|Lost to Follow-up|10|||
155395449|NCT03044886|560883499|FG002|Overall Study|Lost to Follow-up|12|||
155395450|NCT01174238|560883502|FG000|Overall Study|Lost to Follow-up|2|||
155395451|NCT00732251|560883506|FG000|Overall Study|Lost to Follow-up|3|||
155395452|NCT00732251|560883506|FG000|Overall Study|Withdrawal by Subject|3|||
155395453|NCT00732251|560883506|FG000|Overall Study|Early Term due to Site Closure|1|||
155395454|NCT02684279|560883509|FG000|Overall Study|Adverse Event|87|||
155395455|NCT02684279|560883509|FG000|Overall Study|Lack of Efficacy|4|||
155395456|NCT02684279|560883509|FG000|Overall Study|Lost to Follow-up|61|||
155395457|NCT02684279|560883509|FG000|Overall Study|Protocol Violation|6|||
155395458|NCT02684279|560883509|FG000|Overall Study|Pregnancy|8|||
155395459|NCT02684279|560883509|FG000|Overall Study|Withdrawal by Subject|92|||
155395460|NCT02684279|560883509|FG000|Overall Study|non-compliance with study drug|9|||
155395461|NCT02684279|560883509|FG000|Overall Study|non compliance with study visits|2|||
155395462|NCT02684279|560883509|FG000|Overall Study|subject to have surgery|1|||
154952844|NCT01507051|559254492|FG000|Overall Study|Withdrawal by Subject|1|||
154952845|NCT01507051|559254493|FG001|Overall Study|Withdrawal by Subject|3|||
154952846|NCT01507051|559254494|FG002|Overall Study|Withdrawal by Subject|1|||
154952847|NCT01507051|559254495|FG003|Overall Study|Withdrawal by Subject|6|||
154952848|NCT01507051|559254492|FG000|Overall Study|Physician Decision|0|||
154952849|NCT01507051|559254493|FG001|Overall Study|Physician Decision|0|||
154952850|NCT01507051|559254494|FG002|Overall Study|Physician Decision|0|||
154952851|NCT01507051|559254495|FG003|Overall Study|Physician Decision|1|||
154952852|NCT01507051|559254492|FG000|Overall Study|Adverse Event|1|||
154952853|NCT01507051|559254493|FG001|Overall Study|Adverse Event|0|||
154952854|NCT01507051|559254494|FG002|Overall Study|Adverse Event|0|||
154952855|NCT01507051|559254495|FG003|Overall Study|Adverse Event|0|||
154952856|NCT02311361|559254496|FG000|Overall Study|Did not receive treatment|0|||
154952857|NCT02311361|559254497|FG001|Overall Study|Did not receive treatment|1|||
154952858|NCT02311361|559254498|FG002|Overall Study|Did not receive treatment|0|||
154952859|NCT02311361|559254499|FG003|Overall Study|Did not receive treatment|1|||
154952860|NCT05628675|559254500|FG000|Overall Study|Lost to Follow-up|2|||
154952861|NCT05628675|559254500|FG000|Overall Study|Withdrawal by Subject|1|||
154952862|NCT04455633|559254501|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
154952863|NCT04455633|559254502|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
155283810|NCT00689104|560470853|FG003|Overall Study|Randomized but never received study drug|0|||
155283811|NCT00689104|560470850|FG000|Overall Study|Physician Decision|1|||
155283812|NCT00689104|560470851|FG001|Overall Study|Physician Decision|0|||
155283813|NCT00689104|560470852|FG002|Overall Study|Physician Decision|0|||
155283814|NCT00689104|560470853|FG003|Overall Study|Physician Decision|0|||
155283815|NCT00689104|560470850|FG000|Overall Study|Non-compliance with study procedures|0|||
155283816|NCT00689104|560470851|FG001|Overall Study|Non-compliance with study procedures|0|||
155283817|NCT00689104|560470852|FG002|Overall Study|Non-compliance with study procedures|1|||
155283818|NCT00689104|560470853|FG003|Overall Study|Non-compliance with study procedures|0|||
155283819|NCT00209274|560470858|FG000|Overall Study|Missed visit|3|||
155283820|NCT00209274|560470859|FG001|Overall Study|Missed visit|2|||
155283821|NCT00209274|560470858|FG000|Overall Study|Death|32|||
155283822|NCT00209274|560470859|FG001|Overall Study|Death|15|||
155283823|NCT00209274|560470858|FG000|Overall Study|Withdrawal by Subject|30|||
155283824|NCT00209274|560470859|FG001|Overall Study|Withdrawal by Subject|15|||
155395463|NCT02684279|560883509|FG000|Overall Study|family emergency|1|||
155395464|NCT02684279|560883509|FG000|Overall Study|Site closures|7|||
155395465|NCT02684279|560883509|FG000|Overall Study|Physician Decision|1|||
155395466|NCT00228566|560883510|FG000|Overall Study|Adverse Event|31|||
155395467|NCT00228566|560883510|FG000|Overall Study|Lack of Efficacy|14|||
155395468|NCT00228566|560883510|FG000|Overall Study|Lost to Follow-up|16|||
155395469|NCT00228566|560883510|FG000|Overall Study|Physician Decision|5|||
155395470|NCT00228566|560883510|FG000|Overall Study|Withdrawal by Subject|4|||
155395471|NCT00228566|560883510|FG000|Overall Study|Miscellaneous|1|||
155395472|NCT05975840|560883511|FG000|Overall Study|Other|1|||
155395473|NCT05975840|560883512|FG001|Overall Study|Other|0|||
155395474|NCT05975840|560883513|FG002|Overall Study|Other|0|||
155395475|NCT05975840|560883514|FG003|Overall Study|Other|0|||
155395476|NCT05975840|560883515|FG004|Overall Study|Other|1|||
155395477|NCT05975840|560883516|FG005|Overall Study|Other|0|||
155395478|NCT05975840|560883517|FG006|Overall Study|Other|0|||
155395479|NCT05975840|560883518|FG007|Overall Study|Other|0|||
155395480|NCT05975840|560883511|FG000|Overall Study|Lost to Follow-up|3|||
155395481|NCT05975840|560883512|FG001|Overall Study|Lost to Follow-up|6|||
155395482|NCT05975840|560883513|FG002|Overall Study|Lost to Follow-up|3|||
155395483|NCT05975840|560883514|FG003|Overall Study|Lost to Follow-up|1|||
155395484|NCT05975840|560883515|FG004|Overall Study|Lost to Follow-up|4|||
155395485|NCT05975840|560883516|FG005|Overall Study|Lost to Follow-up|1|||
155395486|NCT05975840|560883517|FG006|Overall Study|Lost to Follow-up|2|||
155395487|NCT05975840|560883518|FG007|Overall Study|Lost to Follow-up|4|||
155395488|NCT05975840|560883511|FG000|Overall Study|Migrated/moved from the study area|1|||
155395489|NCT05975840|560883512|FG001|Overall Study|Migrated/moved from the study area|0|||
155395490|NCT05975840|560883513|FG002|Overall Study|Migrated/moved from the study area|0|||
155395491|NCT05975840|560883514|FG003|Overall Study|Migrated/moved from the study area|0|||
155395492|NCT05975840|560883515|FG004|Overall Study|Migrated/moved from the study area|0|||
155395493|NCT05975840|560883516|FG005|Overall Study|Migrated/moved from the study area|0|||
155395494|NCT05975840|560883517|FG006|Overall Study|Migrated/moved from the study area|0|||
155395495|NCT05975840|560883518|FG007|Overall Study|Migrated/moved from the study area|0|||
155395496|NCT05975840|560883511|FG000|Overall Study|Withdrawal by Subject|0|||
155395497|NCT05975840|560883512|FG001|Overall Study|Withdrawal by Subject|5|||
155395498|NCT05975840|560883513|FG002|Overall Study|Withdrawal by Subject|2|||
155395499|NCT05975840|560883514|FG003|Overall Study|Withdrawal by Subject|2|||
155395500|NCT05975840|560883515|FG004|Overall Study|Withdrawal by Subject|0|||
155395501|NCT05975840|560883516|FG005|Overall Study|Withdrawal by Subject|2|||
155395502|NCT05975840|560883517|FG006|Overall Study|Withdrawal by Subject|2|||
155395503|NCT05975840|560883518|FG007|Overall Study|Withdrawal by Subject|1|||
155395504|NCT05975840|560883511|FG000|Overall Study|Protocol Violation|0|||
155395505|NCT05975840|560883512|FG001|Overall Study|Protocol Violation|1|||
155395506|NCT05975840|560883513|FG002|Overall Study|Protocol Violation|0|||
155395507|NCT05975840|560883514|FG003|Overall Study|Protocol Violation|0|||
155395508|NCT05975840|560883515|FG004|Overall Study|Protocol Violation|0|||
155395509|NCT05975840|560883516|FG005|Overall Study|Protocol Violation|0|||
155395510|NCT05975840|560883517|FG006|Overall Study|Protocol Violation|0|||
155395511|NCT05975840|560883518|FG007|Overall Study|Protocol Violation|0|||
155395512|NCT05975840|560883511|FG000|Overall Study|Adverse Event|0|||
155395513|NCT05975840|560883512|FG001|Overall Study|Adverse Event|0|||
155395514|NCT05975840|560883513|FG002|Overall Study|Adverse Event|0|||
155395515|NCT05975840|560883514|FG003|Overall Study|Adverse Event|1|||
155395516|NCT05975840|560883515|FG004|Overall Study|Adverse Event|0|||
155395517|NCT05975840|560883516|FG005|Overall Study|Adverse Event|0|||
155395518|NCT05975840|560883517|FG006|Overall Study|Adverse Event|0|||
155395519|NCT05975840|560883518|FG007|Overall Study|Adverse Event|0|||
155395520|NCT05975840|560883511|FG000|Overall Study|Death|0|||
155395521|NCT05975840|560883512|FG001|Overall Study|Death|1|||
155395522|NCT05975840|560883513|FG002|Overall Study|Death|0|||
155395523|NCT05975840|560883514|FG003|Overall Study|Death|0|||
155395524|NCT05975840|560883515|FG004|Overall Study|Death|0|||
155395525|NCT05975840|560883516|FG005|Overall Study|Death|0|||
155395526|NCT05975840|560883517|FG006|Overall Study|Death|0|||
155395527|NCT05975840|560883518|FG007|Overall Study|Death|1|||
155395528|NCT00232141|560883519|FG000|Overall Study|Adverse Event|9|||
155395529|NCT00232141|560883520|FG001|Overall Study|Adverse Event|4|||
155395530|NCT00232141|560883519|FG000|Overall Study|Lack of Efficacy|0|||
155395531|NCT00232141|560883520|FG001|Overall Study|Lack of Efficacy|3|||
155395532|NCT00232141|560883519|FG000|Overall Study|Lost to Follow-up|9|||
155395533|NCT00232141|560883520|FG001|Overall Study|Lost to Follow-up|6|||
155395534|NCT00232141|560883519|FG000|Overall Study|Other|8|||
155395535|NCT00232141|560883520|FG001|Overall Study|Other|10|||
155395536|NCT00232141|560883519|FG000|Overall Study|Withdrawal by Subject|5|||
155395537|NCT00232141|560883520|FG001|Overall Study|Withdrawal by Subject|3|||
155395538|NCT04263896|560883526|FG000|Overall Study|Withdrawal by Subject|2|||
155395539|NCT04263896|560883527|FG001|Overall Study|Withdrawal by Subject|4|||
155395540|NCT04263896|560883526|FG000|Overall Study|converted to open procedure|0|||
155395541|NCT04263896|560883527|FG001|Overall Study|converted to open procedure|1|||
155395542|NCT04263896|560883526|FG000|Overall Study|Lost to Follow-up|9|||
155395543|NCT04263896|560883527|FG001|Overall Study|Lost to Follow-up|11|||
155395544|NCT04263896|560883526|FG000|Overall Study|surveys lost in mail|5|||
155395545|NCT04263896|560883527|FG001|Overall Study|surveys lost in mail|3|||
155395546|NCT04263896|560883526|FG000|Overall Study|excluded from analysis|1|||
155395547|NCT04263896|560883527|FG001|Overall Study|excluded from analysis|0|||
155395548|NCT02060383|560884971|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
155395549|NCT02060383|560884972|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
155395550|NCT02060383|560884973|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
155395551|NCT02060383|560884974|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
155395552|NCT02060383|560884975|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
155057661|NCT02265510|559645783|FG001|Overall Study|Withdrawal by Subject|1|||
155057662|NCT02265510|559645784|FG002|Overall Study|Withdrawal by Subject|2|||
155057663|NCT02265510|559645785|FG003|Overall Study|Withdrawal by Subject|1|||
155057664|NCT02265510|559645786|FG004|Overall Study|Withdrawal by Subject|0|||
155057665|NCT02265510|559645787|FG005|Overall Study|Withdrawal by Subject|2|||
155057666|NCT02265510|559645788|FG006|Overall Study|Withdrawal by Subject|0|||
155057667|NCT02265510|559645789|FG007|Overall Study|Withdrawal by Subject|2|||
155395553|NCT02060383|560884971|FG000|Core Phase|Adverse Event|2|||
155395554|NCT02060383|560884972|FG001|Core Phase|Adverse Event|0|||
155395555|NCT02060383|560884973|FG002|Core Phase|Adverse Event|0|||
155395556|NCT02060383|560884974|FG003|Core Phase|Adverse Event|2|||
155395557|NCT02060383|560884975|FG004|Core Phase|Adverse Event|6|||
154952864|NCT04455633|559254503|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
154952865|NCT04455633|559254501|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
154952866|NCT04455633|559254502|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
154952867|NCT04455633|559254503|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
154952868|NCT04455633|559254501|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
154952869|NCT04455633|559254502|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
154952870|NCT04455633|559254503|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
154952871|NCT04455633|559254501|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
154952872|NCT04455633|559254502|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
154952873|NCT04455633|559254503|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
154952874|NCT02532764|559254504|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952875|NCT02532764|559254505|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952876|NCT02532764|559254506|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952877|NCT02532764|559254507|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952878|NCT02532764|559254508|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952879|NCT02532764|559254509|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952880|NCT02532764|559254510|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
154952881|NCT02532764|559254511|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
154952882|NCT02532764|559254512|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
154952883|NCT02532764|559254513|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
154952884|NCT03527745|559254514|FG000|Overall Study|Lost to Follow-up|3|||
154952885|NCT03527745|559254515|FG001|Overall Study|Lost to Follow-up|6|||
154952886|NCT03527745|559254516|FG002|Overall Study|Lost to Follow-up|7|||
154952887|NCT03527745|559254517|FG003|Overall Study|Lost to Follow-up|9|||
154952888|NCT03527745|559254518|FG004|Overall Study|Lost to Follow-up|0|||
154952889|NCT03527745|559254519|FG005|Overall Study|Lost to Follow-up|2|||
154952890|NCT03527745|559254520|FG006|Overall Study|Lost to Follow-up|3|||
154952891|NCT03527745|559254521|FG007|Overall Study|Lost to Follow-up|2|||
154952892|NCT03527745|559254522|FG008|Overall Study|Lost to Follow-up|3|||
154952893|NCT03527745|559254523|FG009|Overall Study|Lost to Follow-up|2|||
154952894|NCT03527745|559254524|FG010|Overall Study|Lost to Follow-up|1|||
154952895|NCT03527745|559254525|FG011|Overall Study|Lost to Follow-up|1|||
154952896|NCT03527745|559254526|FG012|Overall Study|Lost to Follow-up|0|||
154952897|NCT03527745|559254527|FG013|Overall Study|Lost to Follow-up|0|||
154952898|NCT03527745|559254528|FG014|Overall Study|Lost to Follow-up|0|||
154952899|NCT03527745|559254529|FG015|Overall Study|Lost to Follow-up|0|||
154952900|NCT03527745|559254530|FG016|Overall Study|Lost to Follow-up|1|||
154952901|NCT03527745|559254531|FG017|Overall Study|Lost to Follow-up|0|||
154952902|NCT03527745|559254532|FG018|Overall Study|Lost to Follow-up|0|||
154952903|NCT03527745|559254533|FG019|Overall Study|Lost to Follow-up|1|||
154952904|NCT03527745|559254534|FG020|Overall Study|Lost to Follow-up|1|||
155395558|NCT02060383|560884971|FG000|Core Phase|Administrative problems|0|||
155395559|NCT02060383|560884972|FG001|Core Phase|Administrative problems|1|||
155395560|NCT02060383|560884973|FG002|Core Phase|Administrative problems|0|||
155395561|NCT02060383|560884974|FG003|Core Phase|Administrative problems|0|||
154952905|NCT03527745|559254535|FG021|Overall Study|Lost to Follow-up|5|||
154952906|NCT03527745|559254536|FG022|Overall Study|Lost to Follow-up|6|||
154952907|NCT03527745|559254537|FG023|Overall Study|Lost to Follow-up|8|||
155057668|NCT02265510|559645790|FG008|Overall Study|Withdrawal by Subject|0|||
155395562|NCT02060383|560884975|FG004|Core Phase|Administrative problems|0|||
155395563|NCT02060383|560884971|FG000|Core Phase|Protocol Violation|0|||
155395564|NCT02060383|560884972|FG001|Core Phase|Protocol Violation|0|||
155395565|NCT02060383|560884973|FG002|Core Phase|Protocol Violation|0|||
155395566|NCT02060383|560884974|FG003|Core Phase|Protocol Violation|1|||
155395567|NCT02060383|560884975|FG004|Core Phase|Protocol Violation|0|||
155395568|NCT02060383|560884971|FG000|Core Phase|Withdrawal by Subject|0|||
155395569|NCT02060383|560884972|FG001|Core Phase|Withdrawal by Subject|0|||
155395570|NCT02060383|560884973|FG002|Core Phase|Withdrawal by Subject|0|||
155395571|NCT02060383|560884974|FG003|Core Phase|Withdrawal by Subject|4|||
155395572|NCT02060383|560884975|FG004|Core Phase|Withdrawal by Subject|2|||
155395573|NCT02060383|560884971|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
155395574|NCT02060383|560884972|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
155395575|NCT02060383|560884973|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
155395576|NCT02060383|560884974|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
154952908|NCT03527745|559254538|FG024|Overall Study|Lost to Follow-up|1|||
154952909|NCT03527745|559254539|FG025|Overall Study|Lost to Follow-up|3|||
155395577|NCT02060383|560884975|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
155395578|NCT02060383|560884971|FG000|Extension Phase|Adverse Event|1|||
155395579|NCT02060383|560884972|FG001|Extension Phase|Adverse Event|1|||
155395580|NCT02060383|560884973|FG002|Extension Phase|Adverse Event|2|||
155395581|NCT02060383|560884974|FG003|Extension Phase|Adverse Event|0|||
155395582|NCT02060383|560884975|FG004|Extension Phase|Adverse Event|1|||
155395583|NCT02060383|560884971|FG000|Extension Phase|Withdrawal by Subject|0|||
155395584|NCT02060383|560884972|FG001|Extension Phase|Withdrawal by Subject|1|||
155395585|NCT02060383|560884973|FG002|Extension Phase|Withdrawal by Subject|0|||
155395586|NCT02060383|560884974|FG003|Extension Phase|Withdrawal by Subject|0|||
155395587|NCT02060383|560884975|FG004|Extension Phase|Withdrawal by Subject|2|||
155395588|NCT02060383|560884971|FG000|Extension Phase|Administrative problems|1|||
155395589|NCT02060383|560884972|FG001|Extension Phase|Administrative problems|0|||
155395590|NCT02060383|560884973|FG002|Extension Phase|Administrative problems|0|||
155395591|NCT02060383|560884974|FG003|Extension Phase|Administrative problems|0|||
155395592|NCT02060383|560884975|FG004|Extension Phase|Administrative problems|0|||
155395593|NCT02060383|560884971|FG000|Extension Phase|Death|0|||
155395594|NCT02060383|560884972|FG001|Extension Phase|Death|0|||
155395595|NCT02060383|560884973|FG002|Extension Phase|Death|1|||
155395596|NCT02060383|560884974|FG003|Extension Phase|Death|0|||
155395597|NCT02060383|560884975|FG004|Extension Phase|Death|1|||
155395598|NCT02060383|560884971|FG000|Extension Phase|Protocol Violation|0|||
155395599|NCT02060383|560884972|FG001|Extension Phase|Protocol Violation|0|||
155395600|NCT02060383|560884973|FG002|Extension Phase|Protocol Violation|0|||
155395601|NCT02060383|560884974|FG003|Extension Phase|Protocol Violation|0|||
155395602|NCT02060383|560884975|FG004|Extension Phase|Protocol Violation|1|||
155395603|NCT04050670|560884978|FG000|Period 3|Physician Decision|0|||
155395604|NCT04050670|560884979|FG001|Period 3|Physician Decision|1|||
155395605|NCT04050670|560884980|FG002|Period 3|Physician Decision|0|||
155395606|NCT00761306|560884981|FG000|Overall Study|Adverse Event|5|||
155395607|NCT00761306|560884981|FG000|Overall Study|Lack of Efficacy|4|||
155395608|NCT00761306|560884981|FG000|Overall Study|Protocol Violation|2|||
155395609|NCT00761306|560884981|FG000|Overall Study|Withdrawal of Consent|3|||
155395610|NCT00761306|560884981|FG000|Overall Study|Lost to Follow-up|1|||
155395611|NCT00761306|560884981|FG000|Overall Study|Administrative or Other Reasons|5|||
154952910|NCT01475838|559254540|FG000|Randomized Phase|Randomized but Not Treated|0|||
155395612|NCT00268437|560884982|FG000|Overall Study|Ineligible|1|||
155395613|NCT05162027|560884983|FG000|Overall Study|Adverse Event|1|||
155395614|NCT05162027|560884984|FG001|Overall Study|Adverse Event|0|||
155395615|NCT02982239|560884985|FG000|Overall Study|Lost to Follow-up|3|||
155395616|NCT02982239|560884986|FG001|Overall Study|Lost to Follow-up|2|||
155395617|NCT00907257|560884987|FG000|Overall Study|Adverse Event|0|||
155395618|NCT00907257|560884988|FG001|Overall Study|Adverse Event|4|||
155395619|NCT00907257|560884987|FG000|Overall Study|Protocol Violation|1|||
155395620|NCT00907257|560884988|FG001|Overall Study|Protocol Violation|2|||
155395621|NCT00907257|560884987|FG000|Overall Study|Lost to Follow-up|3|||
155395622|NCT00907257|560884988|FG001|Overall Study|Lost to Follow-up|3|||
155395623|NCT00907257|560884987|FG000|Overall Study|Withdrawal by Subject|1|||
155395624|NCT00907257|560884988|FG001|Overall Study|Withdrawal by Subject|2|||
155395625|NCT00907257|560884987|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
155395626|NCT00907257|560884988|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
155395627|NCT00907257|560884987|FG000|Overall Study|Moved|1|||
155395628|NCT00907257|560884988|FG001|Overall Study|Moved|0|||
154952911|NCT01475838|559254541|FG001|Randomized Phase|Randomized but Not Treated|5|||
155395629|NCT00907257|560884987|FG000|Overall Study|Personal Reasons|6|||
154952912|NCT01475838|559254540|FG000|Randomized Phase|Adverse Event|6|||
155395630|NCT00907257|560884988|FG001|Overall Study|Personal Reasons|1|||
155395631|NCT00880555|560884989|FG000|Overall Study|Physician Decision|0|||
155395632|NCT00880555|560884990|FG001|Overall Study|Physician Decision|8|||
155395633|NCT00880555|560884991|FG002|Overall Study|Physician Decision|0|||
155395634|NCT00880555|560884992|FG003|Overall Study|Physician Decision|2|||
155395635|NCT00880555|560884993|FG004|Overall Study|Physician Decision|1|||
155395636|NCT00880555|560884994|FG005|Overall Study|Physician Decision|0|||
155395637|NCT00880555|560884989|FG000|Overall Study|Withdrawal by Subject|1|||
155395638|NCT00880555|560884990|FG001|Overall Study|Withdrawal by Subject|1|||
155395639|NCT00880555|560884991|FG002|Overall Study|Withdrawal by Subject|0|||
155395640|NCT00880555|560884992|FG003|Overall Study|Withdrawal by Subject|0|||
155395641|NCT00880555|560884993|FG004|Overall Study|Withdrawal by Subject|0|||
155395642|NCT00880555|560884994|FG005|Overall Study|Withdrawal by Subject|0|||
155395643|NCT00880555|560884989|FG000|Overall Study|Lack of resources (hired rater)|9|||
155395644|NCT00880555|560884990|FG001|Overall Study|Lack of resources (hired rater)|7|||
155395645|NCT00880555|560884991|FG002|Overall Study|Lack of resources (hired rater)|5|||
155395646|NCT00880555|560884992|FG003|Overall Study|Lack of resources (hired rater)|0|||
155395647|NCT00880555|560884993|FG004|Overall Study|Lack of resources (hired rater)|0|||
155395648|NCT00880555|560884994|FG005|Overall Study|Lack of resources (hired rater)|0|||
155395649|NCT00880555|560884989|FG000|Overall Study|Death|0|||
155395650|NCT00880555|560884990|FG001|Overall Study|Death|0|||
155395651|NCT00880555|560884991|FG002|Overall Study|Death|0|||
155395652|NCT00880555|560884992|FG003|Overall Study|Death|0|||
155395653|NCT00880555|560884993|FG004|Overall Study|Death|0|||
155395654|NCT00880555|560884994|FG005|Overall Study|Death|1|||
155395655|NCT00880555|560884989|FG000|Overall Study|Lost to Follow-up|0|||
155283825|NCT00209274|560470858|FG000|Overall Study|Randomized not treated (RNT)|6|||
155283826|NCT00209274|560470859|FG001|Overall Study|Randomized not treated (RNT)|15|||
155283827|NCT00604786|560470867|FG000|Overall Study|Lost to Follow-up|2|||
155283828|NCT00604786|560470868|FG001|Overall Study|Lost to Follow-up|0|||
155283829|NCT00062868|560470878|FG000|Dose Level 1|Death|2|||
155283830|NCT00062868|560470879|FG001|Dose Level 1|Death|0|||
155283831|NCT00062868|560470880|FG002|Dose Level 1|Death|0|||
155283832|NCT00062868|560470881|FG003|Dose Level 1|Death|2|||
155283833|NCT00062868|560470882|FG004|Dose Level 1|Death|0|||
155283834|NCT00062868|560470883|FG005|Dose Level 1|Death|0|||
155283835|NCT00062868|560470884|FG006|Dose Level 1|Death|3|||
155283836|NCT00062868|560470885|FG007|Dose Level 1|Death|0|||
155283837|NCT00062868|560470886|FG008|Dose Level 1|Death|0|||
155283838|NCT00062868|560470887|FG009|Dose Level 1|Death|0|||
155283839|NCT00062868|560470888|FG010|Dose Level 1|Death|0|||
155283840|NCT00062868|560470889|FG011|Dose Level 1|Death|0|||
155283841|NCT00062868|560470890|FG012|Dose Level 1|Death|0|||
155283842|NCT00062868|560470891|FG013|Dose Level 1|Death|0|||
155283843|NCT00062868|560470892|FG014|Dose Level 1|Death|0|||
155283844|NCT00062868|560470893|FG015|Dose Level 1|Death|0|||
155283845|NCT00062868|560470894|FG016|Dose Level 1|Death|0|||
155283846|NCT00062868|560470895|FG017|Dose Level 1|Death|0|||
155283847|NCT00062868|560470896|FG018|Dose Level 1|Death|7|||
155283848|NCT00062868|560470897|FG019|Dose Level 1|Death|0|||
155283849|NCT00062868|560470898|FG020|Dose Level 1|Death|1|||
155283850|NCT00062868|560470878|FG000|Dose Level 1|Lost to Follow-up|0|||
155283851|NCT00062868|560470879|FG001|Dose Level 1|Lost to Follow-up|0|||
155283852|NCT00062868|560470880|FG002|Dose Level 1|Lost to Follow-up|0|||
155283853|NCT00062868|560470881|FG003|Dose Level 1|Lost to Follow-up|0|||
155283854|NCT00062868|560470882|FG004|Dose Level 1|Lost to Follow-up|0|||
155283855|NCT00062868|560470883|FG005|Dose Level 1|Lost to Follow-up|0|||
155283856|NCT00062868|560470884|FG006|Dose Level 1|Lost to Follow-up|0|||
155283857|NCT00062868|560470885|FG007|Dose Level 1|Lost to Follow-up|0|||
155283858|NCT00062868|560470886|FG008|Dose Level 1|Lost to Follow-up|0|||
155283859|NCT00062868|560470887|FG009|Dose Level 1|Lost to Follow-up|0|||
155283860|NCT00062868|560470888|FG010|Dose Level 1|Lost to Follow-up|0|||
155283861|NCT00062868|560470889|FG011|Dose Level 1|Lost to Follow-up|0|||
155283862|NCT00062868|560470890|FG012|Dose Level 1|Lost to Follow-up|1|||
155283863|NCT00062868|560470891|FG013|Dose Level 1|Lost to Follow-up|0|||
155283864|NCT00062868|560470892|FG014|Dose Level 1|Lost to Follow-up|0|||
155283865|NCT00062868|560470893|FG015|Dose Level 1|Lost to Follow-up|0|||
155283866|NCT00062868|560470894|FG016|Dose Level 1|Lost to Follow-up|0|||
155283867|NCT00062868|560470895|FG017|Dose Level 1|Lost to Follow-up|0|||
155283868|NCT00062868|560470896|FG018|Dose Level 1|Lost to Follow-up|2|||
155395656|NCT00880555|560884990|FG001|Overall Study|Lost to Follow-up|1|||
155283869|NCT00062868|560470897|FG019|Dose Level 1|Lost to Follow-up|0|||
155283870|NCT00062868|560470898|FG020|Dose Level 1|Lost to Follow-up|1|||
155283871|NCT00062868|560470878|FG000|Dose Level 2|Death|0|||
155283872|NCT00062868|560470879|FG001|Dose Level 2|Death|3|||
155283873|NCT00062868|560470880|FG002|Dose Level 2|Death|0|||
155395657|NCT00880555|560884991|FG002|Overall Study|Lost to Follow-up|0|||
155395658|NCT00880555|560884992|FG003|Overall Study|Lost to Follow-up|0|||
155283874|NCT00062868|560470881|FG003|Dose Level 2|Death|0|||
155283875|NCT00062868|560470882|FG004|Dose Level 2|Death|2|||
155283876|NCT00062868|560470883|FG005|Dose Level 2|Death|0|||
155283877|NCT00062868|560470884|FG006|Dose Level 2|Death|0|||
155283878|NCT00062868|560470885|FG007|Dose Level 2|Death|0|||
155283879|NCT00062868|560470886|FG008|Dose Level 2|Death|0|||
155283880|NCT00062868|560470887|FG009|Dose Level 2|Death|0|||
155283881|NCT00062868|560470888|FG010|Dose Level 2|Death|1|||
155395659|NCT00880555|560884993|FG004|Overall Study|Lost to Follow-up|0|||
155395660|NCT00880555|560884994|FG005|Overall Study|Lost to Follow-up|0|||
155395661|NCT04163900|560884995|FG000|Overall Study|Radiological disease progression|112|||
155283882|NCT00062868|560470889|FG011|Dose Level 2|Death|0|||
155283883|NCT00062868|560470890|FG012|Dose Level 2|Death|0|||
155283884|NCT00062868|560470891|FG013|Dose Level 2|Death|0|||
155283885|NCT00062868|560470892|FG014|Dose Level 2|Death|0|||
155283886|NCT00062868|560470893|FG015|Dose Level 2|Death|0|||
155283887|NCT00062868|560470894|FG016|Dose Level 2|Death|2|||
155283888|NCT00062868|560470895|FG017|Dose Level 2|Death|0|||
155283889|NCT00062868|560470896|FG018|Dose Level 2|Death|0|||
155283890|NCT00062868|560470897|FG019|Dose Level 2|Death|0|||
155283891|NCT00062868|560470898|FG020|Dose Level 2|Death|0|||
155283892|NCT00062868|560470878|FG000|Dose Level 2|Lost to Follow-up|0|||
155283893|NCT00062868|560470879|FG001|Dose Level 2|Lost to Follow-up|0|||
155283894|NCT00062868|560470880|FG002|Dose Level 2|Lost to Follow-up|0|||
155283895|NCT00062868|560470881|FG003|Dose Level 2|Lost to Follow-up|0|||
155283896|NCT00062868|560470882|FG004|Dose Level 2|Lost to Follow-up|0|||
155283897|NCT00062868|560470883|FG005|Dose Level 2|Lost to Follow-up|0|||
155283898|NCT00062868|560470884|FG006|Dose Level 2|Lost to Follow-up|0|||
155283899|NCT00062868|560470885|FG007|Dose Level 2|Lost to Follow-up|0|||
155283900|NCT00062868|560470886|FG008|Dose Level 2|Lost to Follow-up|0|||
155283901|NCT00062868|560470887|FG009|Dose Level 2|Lost to Follow-up|0|||
155283902|NCT00062868|560470888|FG010|Dose Level 2|Lost to Follow-up|0|||
155283903|NCT00062868|560470889|FG011|Dose Level 2|Lost to Follow-up|0|||
155283904|NCT00062868|560470890|FG012|Dose Level 2|Lost to Follow-up|0|||
155283905|NCT00062868|560470891|FG013|Dose Level 2|Lost to Follow-up|1|||
155283906|NCT00062868|560470892|FG014|Dose Level 2|Lost to Follow-up|0|||
155283907|NCT00062868|560470893|FG015|Dose Level 2|Lost to Follow-up|0|||
155283908|NCT00062868|560470894|FG016|Dose Level 2|Lost to Follow-up|1|||
155283909|NCT00062868|560470895|FG017|Dose Level 2|Lost to Follow-up|0|||
155283910|NCT00062868|560470896|FG018|Dose Level 2|Lost to Follow-up|0|||
155283911|NCT00062868|560470897|FG019|Dose Level 2|Lost to Follow-up|0|||
155283912|NCT00062868|560470898|FG020|Dose Level 2|Lost to Follow-up|0|||
155283913|NCT00062868|560470878|FG000|Dose Level 3|Death|0|||
155283914|NCT00062868|560470879|FG001|Dose Level 3|Death|0|||
155283915|NCT00062868|560470880|FG002|Dose Level 3|Death|0|||
155283916|NCT00062868|560470881|FG003|Dose Level 3|Death|0|||
155283917|NCT00062868|560470882|FG004|Dose Level 3|Death|0|||
155283918|NCT00062868|560470883|FG005|Dose Level 3|Death|0|||
155283919|NCT00062868|560470884|FG006|Dose Level 3|Death|0|||
155283920|NCT00062868|560470885|FG007|Dose Level 3|Death|0|||
155283921|NCT00062868|560470886|FG008|Dose Level 3|Death|0|||
155283922|NCT00062868|560470887|FG009|Dose Level 3|Death|0|||
155283923|NCT00062868|560470888|FG010|Dose Level 3|Death|0|||
155283924|NCT00062868|560470889|FG011|Dose Level 3|Death|1|||
155283925|NCT00062868|560470890|FG012|Dose Level 3|Death|0|||
155283926|NCT00062868|560470891|FG013|Dose Level 3|Death|0|||
155283927|NCT00062868|560470892|FG014|Dose Level 3|Death|0|||
155283928|NCT00062868|560470893|FG015|Dose Level 3|Death|0|||
155283929|NCT00062868|560470894|FG016|Dose Level 3|Death|0|||
155283930|NCT00062868|560470895|FG017|Dose Level 3|Death|1|||
155283931|NCT00062868|560470896|FG018|Dose Level 3|Death|0|||
155283932|NCT00062868|560470897|FG019|Dose Level 3|Death|0|||
155283933|NCT00062868|560470898|FG020|Dose Level 3|Death|0|||
155283934|NCT00062868|560470878|FG000|Dose Level 3|Lost to Follow-up|0|||
155283935|NCT00062868|560470879|FG001|Dose Level 3|Lost to Follow-up|0|||
155283936|NCT00062868|560470880|FG002|Dose Level 3|Lost to Follow-up|0|||
155283937|NCT00062868|560470881|FG003|Dose Level 3|Lost to Follow-up|0|||
155283938|NCT00062868|560470882|FG004|Dose Level 3|Lost to Follow-up|0|||
155283939|NCT00062868|560470883|FG005|Dose Level 3|Lost to Follow-up|0|||
155283940|NCT00062868|560470884|FG006|Dose Level 3|Lost to Follow-up|0|||
155283941|NCT00062868|560470885|FG007|Dose Level 3|Lost to Follow-up|0|||
155283942|NCT00062868|560470886|FG008|Dose Level 3|Lost to Follow-up|0|||
155283943|NCT00062868|560470887|FG009|Dose Level 3|Lost to Follow-up|0|||
155283944|NCT00062868|560470888|FG010|Dose Level 3|Lost to Follow-up|0|||
155283945|NCT00062868|560470889|FG011|Dose Level 3|Lost to Follow-up|0|||
155283946|NCT00062868|560470890|FG012|Dose Level 3|Lost to Follow-up|0|||
155283947|NCT00062868|560470891|FG013|Dose Level 3|Lost to Follow-up|0|||
155283948|NCT00062868|560470892|FG014|Dose Level 3|Lost to Follow-up|1|||
155283949|NCT00062868|560470893|FG015|Dose Level 3|Lost to Follow-up|0|||
155283950|NCT00062868|560470894|FG016|Dose Level 3|Lost to Follow-up|0|||
155283951|NCT00062868|560470895|FG017|Dose Level 3|Lost to Follow-up|0|||
155283952|NCT00062868|560470896|FG018|Dose Level 3|Lost to Follow-up|0|||
155283953|NCT00062868|560470897|FG019|Dose Level 3|Lost to Follow-up|0|||
155283954|NCT00062868|560470898|FG020|Dose Level 3|Lost to Follow-up|0|||
155283955|NCT00062868|560470878|FG000|Dose Level 3|Withdrew|0|||
155283956|NCT00062868|560470879|FG001|Dose Level 3|Withdrew|0|||
155283957|NCT00062868|560470880|FG002|Dose Level 3|Withdrew|2|||
155283958|NCT00062868|560470881|FG003|Dose Level 3|Withdrew|0|||
155283959|NCT00062868|560470882|FG004|Dose Level 3|Withdrew|0|||
155283960|NCT00062868|560470883|FG005|Dose Level 3|Withdrew|0|||
155283961|NCT00062868|560470884|FG006|Dose Level 3|Withdrew|0|||
155283962|NCT00062868|560470885|FG007|Dose Level 3|Withdrew|0|||
155395662|NCT04163900|560884996|FG001|Overall Study|Radiological disease progression|127|||
155395663|NCT04163900|560884995|FG000|Overall Study|Study closure|98|||
155395664|NCT04163900|560884996|FG001|Overall Study|Study closure|133|||
155395665|NCT04163900|560884995|FG000|Overall Study|Adverse Event|78|||
155395666|NCT04163900|560884996|FG001|Overall Study|Adverse Event|32|||
155395667|NCT04163900|560884995|FG000|Overall Study|Withdrawal by Subject|37|||
155395668|NCT04163900|560884996|FG001|Overall Study|Withdrawal by Subject|34|||
155395669|NCT04163900|560884995|FG000|Overall Study|Death|29|||
155395670|NCT04163900|560884996|FG001|Overall Study|Death|16|||
155395671|NCT04163900|560884995|FG000|Overall Study|Physician Decision|17|||
155395672|NCT04163900|560884996|FG001|Overall Study|Physician Decision|25|||
155395673|NCT04163900|560884995|FG000|Overall Study|Clinical disease progression|14|||
155395674|NCT04163900|560884996|FG001|Overall Study|Clinical disease progression|13|||
155395675|NCT04163900|560884995|FG000|Overall Study|Protocol Violation|3|||
155395676|NCT04163900|560884996|FG001|Overall Study|Protocol Violation|4|||
155395677|NCT04163900|560884995|FG000|Overall Study|Lost to Follow-up|0|||
155395678|NCT04163900|560884996|FG001|Overall Study|Lost to Follow-up|1|||
155395679|NCT00283049|560884999|FG000|Overall Study|Adverse Event|6|||
155395680|NCT00283049|560885000|FG001|Overall Study|Adverse Event|1|||
155395681|NCT00283049|560885001|FG002|Overall Study|Adverse Event|4|||
155395682|NCT00283049|560884999|FG000|Overall Study|Protocol Violation|3|||
155395683|NCT00283049|560885000|FG001|Overall Study|Protocol Violation|0|||
155395684|NCT00283049|560885001|FG002|Overall Study|Protocol Violation|3|||
155395685|NCT00283049|560884999|FG000|Overall Study|Death|1|||
155395686|NCT00283049|560885000|FG001|Overall Study|Death|1|||
155395687|NCT00283049|560885001|FG002|Overall Study|Death|1|||
155395688|NCT00283049|560884999|FG000|Overall Study|Lack of Efficacy|0|||
155395689|NCT00283049|560885000|FG001|Overall Study|Lack of Efficacy|1|||
155395690|NCT00283049|560885001|FG002|Overall Study|Lack of Efficacy|1|||
155395691|NCT00283049|560884999|FG000|Overall Study|Lost to Follow-up|4|||
155395692|NCT00283049|560885000|FG001|Overall Study|Lost to Follow-up|2|||
155395693|NCT00283049|560885001|FG002|Overall Study|Lost to Follow-up|5|||
155395694|NCT00283049|560884999|FG000|Overall Study|Withdrawal by Subject|26|||
155395695|NCT00283049|560885000|FG001|Overall Study|Withdrawal by Subject|24|||
155395696|NCT00283049|560885001|FG002|Overall Study|Withdrawal by Subject|19|||
155395697|NCT00283049|560884999|FG000|Overall Study|Discontinuation of Study|18|||
155395698|NCT00283049|560885000|FG001|Overall Study|Discontinuation of Study|16|||
155395699|NCT00283049|560885001|FG002|Overall Study|Discontinuation of Study|20|||
155395700|NCT00283049|560884999|FG000|Overall Study|No longer requires study treatment|0|||
155395701|NCT00283049|560885000|FG001|Overall Study|No longer requires study treatment|0|||
155395702|NCT00283049|560885001|FG002|Overall Study|No longer requires study treatment|1|||
155395703|NCT01873417|560885002|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
155395704|NCT01873417|560885002|FG000|Overall Study|Adverse Event|24|||
155395705|NCT01873417|560885002|FG000|Overall Study|Lost to Follow-up|2|||
155395706|NCT01873417|560885002|FG000|Overall Study|Withdrawal by Subject|2|||
155395707|NCT01873417|560885002|FG000|Overall Study|Physician Decision|3|||
155395708|NCT00785044|560885003|FG000|Overall Study|Dosed at non-participating sites|152|||
154952913|NCT01475838|559254541|FG001|Randomized Phase|Adverse Event|1|||
154952914|NCT01475838|559254540|FG000|Randomized Phase|Pregnancy|0|||
154952915|NCT01475838|559254541|FG001|Randomized Phase|Pregnancy|1|||
154952916|NCT01475838|559254540|FG000|Randomized Phase|Investigators Discretion|1|||
154952917|NCT01475838|559254541|FG001|Randomized Phase|Investigators Discretion|2|||
154952918|NCT01475838|559254540|FG000|Randomized Phase|Withdrew Consent|10|||
154952919|NCT01475838|559254541|FG001|Randomized Phase|Withdrew Consent|14|||
154952920|NCT01475838|559254540|FG000|Randomized Phase|Lost to Follow-up|3|||
154952921|NCT01475838|559254541|FG001|Randomized Phase|Lost to Follow-up|4|||
154952922|NCT01475838|559254540|FG000|Randomized Phase|Participant Noncompliance|1|||
154952923|NCT01475838|559254541|FG001|Randomized Phase|Participant Noncompliance|5|||
154952924|NCT01475838|559254540|FG000|Randomized Phase|Protocol Violation|9|||
154952925|NCT01475838|559254541|FG001|Randomized Phase|Protocol Violation|4|||
154952926|NCT01475838|559254540|FG000|Extension Phase|Participant Noncompliance|1|||
154952927|NCT01475838|559254541|FG001|Extension Phase|Participant Noncompliance|0|||
155153171|NCT01667900|559998587|FG002|Part B|Death|0|||
155395709|NCT00785044|560885003|FG000|Overall Study|Death|77|||
155395710|NCT00785044|560885003|FG000|Overall Study|Lost to Follow-up|266|||
155395711|NCT00785044|560885003|FG000|Overall Study|Withdrawal by Subject|1|||
154952928|NCT00048568|559254547|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
154952929|NCT00048568|559254548|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
154952930|NCT00048568|559254549|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
155395712|NCT01628107|560885004|FG000|Overall Study|Withdrawal by Subject|17|||
155395713|NCT01628107|560885004|FG000|Overall Study|Lost to Follow-up|4|||
155395714|NCT01628107|560885004|FG000|Overall Study|Adverse Event|33|||
155395715|NCT01628107|560885004|FG000|Overall Study|Physician Decision|2|||
155395716|NCT01628107|560885004|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
155395717|NCT01628107|560885004|FG000|Overall Study|Non-compliant with Study Procedures|10|||
155395718|NCT01628107|560885004|FG000|Overall Study|Not Treated|8|||
155395719|NCT01628107|560885004|FG000|Overall Study|Sponsor Decision|11|||
155395720|NCT01628107|560885004|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
155395721|NCT01628107|560885004|FG000|Overall Study|Relocated|8|||
155395722|NCT01628107|560885004|FG000|Overall Study|Kidney Transplant|9|||
155395723|NCT01628107|560885004|FG000|Overall Study|Use of Standard of Care|9|||
155395724|NCT01086410|560885005|FG000|Overall Study|Adverse Event|1|||
155395725|NCT01086410|560885006|FG001|Overall Study|Adverse Event|0|||
155395726|NCT01086410|560885007|FG002|Overall Study|Adverse Event|0|||
155395727|NCT01086410|560885008|FG003|Overall Study|Adverse Event|2|||
155395728|NCT01086410|560885005|FG000|Overall Study|Lack of Efficacy|1|||
155395729|NCT01086410|560885006|FG001|Overall Study|Lack of Efficacy|1|||
155395730|NCT01086410|560885007|FG002|Overall Study|Lack of Efficacy|0|||
155395731|NCT01086410|560885008|FG003|Overall Study|Lack of Efficacy|0|||
155395732|NCT01086410|560885005|FG000|Overall Study|Protocol Violation|1|||
155395733|NCT01086410|560885006|FG001|Overall Study|Protocol Violation|1|||
155395734|NCT01086410|560885007|FG002|Overall Study|Protocol Violation|0|||
155395735|NCT01086410|560885008|FG003|Overall Study|Protocol Violation|0|||
155395736|NCT01086410|560885005|FG000|Overall Study|Lost to Follow-up|0|||
155395737|NCT01086410|560885006|FG001|Overall Study|Lost to Follow-up|0|||
155395738|NCT01086410|560885007|FG002|Overall Study|Lost to Follow-up|1|||
155395739|NCT01086410|560885008|FG003|Overall Study|Lost to Follow-up|0|||
155395740|NCT04196803|560885009|FG000|Overall Study|Withdrawal by Subject|1|||
155395741|NCT04196803|560885010|FG001|Overall Study|Withdrawal by Subject|3|||
155395742|NCT04196803|560885009|FG000|Overall Study|Adverse Event|4|||
155395743|NCT04196803|560885010|FG001|Overall Study|Adverse Event|2|||
155395744|NCT04196803|560885009|FG000|Overall Study|Lost to Follow-up|0|||
155395745|NCT04196803|560885010|FG001|Overall Study|Lost to Follow-up|1|||
155395746|NCT01022996|560885011|FG000|Overall Study|Adverse Event|14|||
155395747|NCT01022996|560885011|FG000|Overall Study|Withdrawal by Subject|3|||
155395748|NCT01022996|560885011|FG000|Overall Study|Lost to Follow-up|1|||
155395749|NCT01022996|560885011|FG000|Overall Study|Administrative problems|6|||
155395750|NCT01022996|560885011|FG000|Overall Study|Disease Progression|32|||
155395751|NCT01022996|560885011|FG000|Overall Study|Protocol Violation|1|||
155395752|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Adverse Event|2|||
155395753|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Adverse Event|2|||
155395754|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Adverse Event|4|||
155395755|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Adverse Event|0|||
155395756|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Adverse Event|0|||
155395757|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Progressive disease|0|||
155395758|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Progressive disease|0|||
155395759|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Progressive disease|1|||
155395760|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Progressive disease|0|||
155395761|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Progressive disease|0|||
155395762|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
155395763|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395764|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395765|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395766|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
155395767|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
155395768|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155283963|NCT00062868|560470886|FG008|Dose Level 3|Withdrew|0|||
155283964|NCT00062868|560470887|FG009|Dose Level 3|Withdrew|0|||
155283965|NCT00062868|560470888|FG010|Dose Level 3|Withdrew|0|||
155283966|NCT00062868|560470889|FG011|Dose Level 3|Withdrew|0|||
155283967|NCT00062868|560470890|FG012|Dose Level 3|Withdrew|0|||
155283968|NCT00062868|560470891|FG013|Dose Level 3|Withdrew|0|||
155283969|NCT00062868|560470892|FG014|Dose Level 3|Withdrew|0|||
155283970|NCT00062868|560470893|FG015|Dose Level 3|Withdrew|0|||
155283971|NCT00062868|560470894|FG016|Dose Level 3|Withdrew|0|||
155283972|NCT00062868|560470895|FG017|Dose Level 3|Withdrew|0|||
155283973|NCT00062868|560470896|FG018|Dose Level 3|Withdrew|0|||
155283974|NCT00062868|560470897|FG019|Dose Level 3|Withdrew|0|||
155283975|NCT00062868|560470898|FG020|Dose Level 3|Withdrew|0|||
155283976|NCT01641861|560470899|FG000|Overall Study|Lost to Follow-up|21|||
155283977|NCT01641861|560470900|FG001|Overall Study|Lost to Follow-up|16|||
155283978|NCT01641861|560470899|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
155283979|NCT01641861|560470900|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
155395769|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155395770|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155395771|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
155395772|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
155395773|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
155395774|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
155395775|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
155395776|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
155283980|NCT01641861|560470899|FG000|Overall Study|Died due to drowning|0|||
155395777|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
155283981|NCT01641861|560470900|FG001|Overall Study|Died due to drowning|1|||
155283982|NCT01712685|560470903|FG000|Overall Study|pt declined to participate before trmt|1|||
155283983|NCT01515319|560470904|FG000|Overall Study|Withdrawal by Subject|0|||
155395778|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
155395779|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
155395780|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
155395781|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
155395782|NCT03523728|560885012|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
155395783|NCT03523728|560885013|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
155395784|NCT03523728|560885014|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
155395785|NCT03523728|560885015|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
155395786|NCT03523728|560885016|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
155395787|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Adverse Event|0|||
155395788|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Adverse Event|0|||
155395789|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Adverse Event|0|||
155395790|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Adverse Event|1|||
155395791|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Adverse Event|2|||
155395792|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395793|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395794|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395795|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
155395796|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
155395797|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
155395798|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
155395799|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
155395800|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
155395801|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
155395802|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
155395803|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
155395804|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
155395805|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
155395806|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
155395807|NCT03523728|560885012|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
155395808|NCT03523728|560885013|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
155395809|NCT03523728|560885014|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
155395810|NCT03523728|560885015|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
155395811|NCT03523728|560885016|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
155395812|NCT02230254|560885017|FG000|Overall Study|Lost to Follow-up|3|||
155395813|NCT02023242|560885018|FG000|Overall Study|Lost to Follow-up|3|||
155395814|NCT02023242|560885019|FG001|Overall Study|Lost to Follow-up|1|||
155395815|NCT02023242|560885018|FG000|Overall Study|Death|0|||
155395816|NCT02023242|560885019|FG001|Overall Study|Death|1|||
155395817|NCT00419120|560885021|FG000|Long Term Follow up Period|study ongoing|10|||
155395818|NCT00710879|560885023|FG000|Overall Study|Lost to Follow-up|2|||
155395819|NCT00710879|560885024|FG001|Overall Study|Lost to Follow-up|1|||
155395820|NCT00710879|560885023|FG000|Overall Study|Protocol Violation|0|||
155395821|NCT00710879|560885024|FG001|Overall Study|Protocol Violation|3|||
155395822|NCT01809132|560885025|FG000|Overall Study|Withdrawal by Subject|0|||
155395823|NCT01809132|560885026|FG001|Overall Study|Withdrawal by Subject|0|||
155395824|NCT01809132|560885027|FG002|Overall Study|Withdrawal by Subject|1|||
155395825|NCT04854434|560885028|FG000|Overall Study|Death|1|||
155395826|NCT04854434|560885029|FG001|Overall Study|Death|3|||
155395827|NCT04854434|560885030|FG002|Overall Study|Death|4|||
155395828|NCT04854434|560885028|FG000|Overall Study|Study Terminated by Sponsor|2|||
155395829|NCT04854434|560885029|FG001|Overall Study|Study Terminated by Sponsor|0|||
155395830|NCT04854434|560885030|FG002|Overall Study|Study Terminated by Sponsor|0|||
155395831|NCT04854434|560885028|FG000|Overall Study|Other|1|||
155395832|NCT04854434|560885029|FG001|Overall Study|Other|1|||
155395833|NCT04854434|560885030|FG002|Overall Study|Other|0|||
155395834|NCT03349775|560885031|FG000|Overall Study|Side Effects|1|||
155395835|NCT03349775|560885032|FG001|Overall Study|Side Effects|2|||
155395836|NCT03349775|560885031|FG000|Overall Study|Withdrawal by Subject|1|||
155395837|NCT03349775|560885032|FG001|Overall Study|Withdrawal by Subject|1|||
155395838|NCT03349775|560885031|FG000|Overall Study|No primary outcome measurements|0|||
155395839|NCT03349775|560885032|FG001|Overall Study|No primary outcome measurements|1|||
155395840|NCT01274715|560885037|FG000|Overall Study|Lost to Follow-up|1|||
155395841|NCT01274715|560885037|FG000|Overall Study|After consent, met exclusion criteria.|1|||
155395842|NCT01274715|560885037|FG000|Overall Study|After consent, met exclusion criteria.|1|||
155395843|NCT01274715|560885037|FG000|Overall Study|After consent, met exclusion criteria.|1|||
155395844|NCT03583450|560885038|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
155395845|NCT03583450|560885039|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
155395846|NCT01186939|560885040|FG000|Overall Study|Death|7|||
155395847|NCT01186939|560885040|FG000|Overall Study|Withdrawal by Subject|2|||
155395848|NCT01186939|560885040|FG000|Overall Study|No longer receiving clinical benefit|17|||
155395849|NCT01186939|560885040|FG000|Overall Study|Program closed|5|||
155395850|NCT01186939|560885040|FG000|Overall Study|Sponsor decision|4|||
155395851|NCT01186939|560885040|FG000|Overall Study|Started additional treatment|1|||
155395852|NCT01186939|560885040|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
155395853|NCT01186939|560885040|FG000|Overall Study|Myocardial infarction|1|||
155395854|NCT01186939|560885040|FG000|Overall Study|Bone marrow transplant|1|||
155395855|NCT01186939|560885040|FG000|Overall Study|Transformation to AML|1|||
155395856|NCT03945591|560885045|FG000|Overall Study|Participant not transplanted|1|||
155395857|NCT03945591|560885045|FG000|Overall Study|Change in treatment plan|3|||
155395858|NCT03945591|560885045|FG000|Overall Study|Adverse Event|1|||
155395859|NCT00698204|560885046|FG000|Overall Study|Withdrawal by Subject|1|||
155395860|NCT00698204|560885047|FG001|Overall Study|Withdrawal by Subject|0|||
155395861|NCT01179672|560885048|FG000|Overall Study|Adverse Event|17|||
155395862|NCT01179672|560885049|FG001|Overall Study|Adverse Event|8|||
155395863|NCT01179672|560885048|FG000|Overall Study|Withdrawal by Subject|10|||
155395864|NCT01179672|560885049|FG001|Overall Study|Withdrawal by Subject|12|||
155395865|NCT01179672|560885048|FG000|Overall Study|Entry Criteria Not Met|0|||
155395866|NCT01179672|560885049|FG001|Overall Study|Entry Criteria Not Met|2|||
155395867|NCT01179672|560885048|FG000|Overall Study|Lost to Follow-up|0|||
155395868|NCT01179672|560885049|FG001|Overall Study|Lost to Follow-up|1|||
155395869|NCT01179672|560885048|FG000|Overall Study|Protocol Violation|2|||
155395870|NCT01179672|560885049|FG001|Overall Study|Protocol Violation|2|||
155395871|NCT01179672|560885048|FG000|Overall Study|Physician Decision|1|||
155395872|NCT01179672|560885049|FG001|Overall Study|Physician Decision|1|||
155395873|NCT00210184|560885050|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
155395874|NCT02316340|560885051|FG000|First Progression|Clinical progression|2|||
155395875|NCT02316340|560885052|FG001|First Progression|Clinical progression|1|||
155395876|NCT02316340|560885051|FG000|First Progression|Withdrawal by Subject|1|||
155395877|NCT02316340|560885052|FG001|First Progression|Withdrawal by Subject|0|||
155395878|NCT01835015|560885053|FG000|Overall Study|Adverse Event|0|||
155395879|NCT01835015|560885054|FG001|Overall Study|Adverse Event|0|||
155395880|NCT01835015|560885055|FG002|Overall Study|Adverse Event|1|||
155395881|NCT01835015|560885056|FG003|Overall Study|Adverse Event|0|||
155395882|NCT01835015|560885057|FG004|Overall Study|Adverse Event|0|||
155395883|NCT03781323|560885060|FG000|Overall Study|Withdrawal by Subject|1|||
155395884|NCT00975715|560885064|FG000|Titration Period|Adverse Event|6|||
155395885|NCT00975715|560885065|FG001|Titration Period|Adverse Event|0|||
155395886|NCT00975715|560885064|FG000|Titration Period|Protocol Violation|1|||
155395887|NCT00975715|560885065|FG001|Titration Period|Protocol Violation|0|||
155395888|NCT00975715|560885064|FG000|Maintenance Period|Adverse Event|2|||
155395889|NCT00975715|560885065|FG001|Maintenance Period|Adverse Event|1|||
155395890|NCT01241552|560885066|FG000|Overall Study|Lack of Efficacy|1|||
155395891|NCT01241552|560885067|FG001|Overall Study|Lack of Efficacy|0|||
155395892|NCT01241552|560885068|FG002|Overall Study|Lack of Efficacy|0|||
155395893|NCT01241552|560885069|FG003|Overall Study|Lack of Efficacy|0|||
155395894|NCT01241552|560885066|FG000|Overall Study|Death|26|||
155395895|NCT01241552|560885067|FG001|Overall Study|Death|30|||
155395896|NCT01241552|560885068|FG002|Overall Study|Death|20|||
155395897|NCT01241552|560885069|FG003|Overall Study|Death|25|||
155395898|NCT01241552|560885066|FG000|Overall Study|Adverse Event|1|||
155395899|NCT01241552|560885067|FG001|Overall Study|Adverse Event|1|||
155395900|NCT01241552|560885068|FG002|Overall Study|Adverse Event|0|||
155395901|NCT01241552|560885069|FG003|Overall Study|Adverse Event|0|||
155395902|NCT01241552|560885066|FG000|Overall Study|Technical Problems|2|||
155395903|NCT01241552|560885067|FG001|Overall Study|Technical Problems|0|||
155395904|NCT01241552|560885068|FG002|Overall Study|Technical Problems|2|||
155395905|NCT01241552|560885069|FG003|Overall Study|Technical Problems|2|||
155395906|NCT01241552|560885066|FG000|Overall Study|Progressive Disease|0|||
154952931|NCT00048568|559254547|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
154952932|NCT00048568|559254548|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
154952933|NCT00048568|559254549|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
154952934|NCT00048568|559254547|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
154952935|NCT00048568|559254548|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
154952936|NCT00048568|559254549|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
154952937|NCT00048568|559254547|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
154952938|NCT00048568|559254548|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
154952939|NCT00048568|559254549|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
154952940|NCT00048568|559254547|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
154952941|NCT00048568|559254548|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
154952942|NCT00048568|559254549|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
154952943|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|Death|1|||
154952944|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|Death|1|||
154952945|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|Death|0|||
155395907|NCT01241552|560885067|FG001|Overall Study|Progressive Disease|0|||
155395908|NCT01241552|560885068|FG002|Overall Study|Progressive Disease|1|||
155092584|NCT00560417|559773638|FG001|Overall Study|Adverse Event|2|||
155153172|NCT01667900|559998588|FG003|Part B|Death|0|||
155395909|NCT01241552|560885069|FG003|Overall Study|Progressive Disease|2|||
155395910|NCT01241552|560885066|FG000|Overall Study|Protocol Violation|0|||
155395911|NCT01241552|560885067|FG001|Overall Study|Protocol Violation|2|||
155395912|NCT01241552|560885068|FG002|Overall Study|Protocol Violation|6|||
155395913|NCT01241552|560885069|FG003|Overall Study|Protocol Violation|1|||
155395914|NCT01241552|560885066|FG000|Overall Study|Withdrawal by Subject|7|||
155395915|NCT01241552|560885067|FG001|Overall Study|Withdrawal by Subject|15|||
155395916|NCT01241552|560885068|FG002|Overall Study|Withdrawal by Subject|14|||
155395917|NCT01241552|560885069|FG003|Overall Study|Withdrawal by Subject|15|||
155395918|NCT01241552|560885066|FG000|Overall Study|Physician Decision|2|||
154952946|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
154952947|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
154952948|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
154952949|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
154952950|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
154952951|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
154952952|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
154952953|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
154952954|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
154952955|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
154952956|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
154952957|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
154952958|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
154952959|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
154952960|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
154952961|NCT00048568|559254547|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
154952962|NCT00048568|559254548|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
154952963|NCT00048568|559254549|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
154952964|NCT00048568|559254547|FG000|Open-Label Period|Death|0|||
154952965|NCT00048568|559254548|FG001|Open-Label Period|Death|0|||
154952966|NCT00048568|559254549|FG002|Open-Label Period|Death|13|||
154952967|NCT00048568|559254547|FG000|Open-Label Period|Adverse Event|0|||
154952968|NCT00048568|559254548|FG001|Open-Label Period|Adverse Event|0|||
154952969|NCT00048568|559254549|FG002|Open-Label Period|Adverse Event|49|||
154952970|NCT00048568|559254547|FG000|Open-Label Period|Lack of Efficacy|0|||
154952971|NCT00048568|559254548|FG001|Open-Label Period|Lack of Efficacy|0|||
154952972|NCT00048568|559254549|FG002|Open-Label Period|Lack of Efficacy|32|||
154952973|NCT00048568|559254547|FG000|Open-Label Period|Withdrawal by Subject|0|||
154952974|NCT00048568|559254548|FG001|Open-Label Period|Withdrawal by Subject|0|||
154952975|NCT00048568|559254549|FG002|Open-Label Period|Withdrawal by Subject|26|||
154952976|NCT00048568|559254547|FG000|Open-Label Period|Pregnancy|0|||
154952977|NCT00048568|559254548|FG001|Open-Label Period|Pregnancy|0|||
154952978|NCT00048568|559254549|FG002|Open-Label Period|Pregnancy|5|||
154952979|NCT00048568|559254547|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
154952980|NCT00048568|559254548|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
154952981|NCT00048568|559254549|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
154952982|NCT00048568|559254547|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
154952983|NCT00048568|559254548|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
154952984|NCT00048568|559254549|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
154952985|NCT00048568|559254547|FG000|Open-Label Period|Unknown Reasons|0|||
154952986|NCT00048568|559254548|FG001|Open-Label Period|Unknown Reasons|0|||
154952987|NCT00048568|559254549|FG002|Open-Label Period|Unknown Reasons|25|||
154952988|NCT00048568|559254547|FG000|Open-Label Period|Lost to Follow-up|0|||
154952989|NCT00048568|559254548|FG001|Open-Label Period|Lost to Follow-up|0|||
154952990|NCT00048568|559254549|FG002|Open-Label Period|Lost to Follow-up|7|||
154952991|NCT01717976|559254550|FG000|Overall Study|Protocol Violation|0|||
154952992|NCT01717976|559254551|FG001|Overall Study|Protocol Violation|1|||
154952993|NCT00560235|559254552|FG000|Phase 1|Discontinued|8|||
154952994|NCT00560235|559254553|FG001|Phase 1|Discontinued|0|||
154952995|NCT00560235|559254554|FG002|Phase 1|Discontinued|0|||
154952996|NCT00560235|559254552|FG000|Phase 1B|Discontinued|0|||
154952997|NCT00560235|559254553|FG001|Phase 1B|Discontinued|19|||
154952998|NCT00560235|559254554|FG002|Phase 1B|Discontinued|0|||
154952999|NCT00560235|559254552|FG000|Phase 2|Discontinued|0|||
154953000|NCT00560235|559254553|FG001|Phase 2|Discontinued|0|||
154953001|NCT00560235|559254554|FG002|Phase 2|Discontinued|96|||
154953002|NCT00560235|559254552|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
154953003|NCT00560235|559254553|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
154953004|NCT00560235|559254554|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
154953005|NCT04015232|559254555|FG000|Overall Study|Withdrawal by Subject|7|||
154953006|NCT04015232|559254556|FG001|Overall Study|Withdrawal by Subject|4|||
154953007|NCT04015232|559254555|FG000|Overall Study|Protocol Violation|1|||
154953008|NCT04015232|559254556|FG001|Overall Study|Protocol Violation|0|||
154953009|NCT04015232|559254555|FG000|Overall Study|Medical Grounds|3|||
154953010|NCT04015232|559254556|FG001|Overall Study|Medical Grounds|3|||
155153173|NCT01667900|559998589|FG004|Part B|Death|0|||
154953011|NCT02896361|559254559|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
154953012|NCT02896361|559254560|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
154953013|NCT02896361|559254561|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
154966764|NCT00902538|559301138|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
155153174|NCT01667900|559998590|FG005|Part B|Death|0|||
155395919|NCT01241552|560885067|FG001|Overall Study|Physician Decision|4|||
155395920|NCT01241552|560885068|FG002|Overall Study|Physician Decision|2|||
155395921|NCT01241552|560885069|FG003|Overall Study|Physician Decision|3|||
155395922|NCT01241552|560885066|FG000|Overall Study|Lost to Follow-up|2|||
155395923|NCT01241552|560885067|FG001|Overall Study|Lost to Follow-up|11|||
155395924|NCT01241552|560885068|FG002|Overall Study|Lost to Follow-up|15|||
155395925|NCT01241552|560885069|FG003|Overall Study|Lost to Follow-up|16|||
155395926|NCT04004429|560885070|FG000|Overall Study|Protocol Violation|1|||
155395927|NCT04004429|560885071|FG001|Overall Study|Protocol Violation|0|||
155395928|NCT04004429|560885072|FG002|Overall Study|Protocol Violation|0|||
155395929|NCT04004429|560885070|FG000|Overall Study|Physician Decision|0|||
155395930|NCT04004429|560885071|FG001|Overall Study|Physician Decision|1|||
155395931|NCT04004429|560885072|FG002|Overall Study|Physician Decision|1|||
155395932|NCT04004429|560885070|FG000|Overall Study|Withdrawal by Subject|1|||
155395933|NCT04004429|560885071|FG001|Overall Study|Withdrawal by Subject|1|||
155395934|NCT04004429|560885072|FG002|Overall Study|Withdrawal by Subject|1|||
155395935|NCT02606461|560885073|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395936|NCT02606461|560885074|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395937|NCT02606461|560885075|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
155395938|NCT02606461|560885076|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395939|NCT02606461|560885077|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395940|NCT02606461|560885078|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
155395941|NCT00851682|560885080|FG000|Overall Study|screen failure|5|||
155395942|NCT00851682|560885081|FG001|Overall Study|screen failure|0|||
155395943|NCT01379573|560885087|FG000|Overall Study|Lost to Follow-up|1|||
155395944|NCT01379573|560885087|FG000|Overall Study|Screen Failure|10|||
155395945|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Adverse Event|1|||
155395946|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Adverse Event|1|||
155395947|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Adverse Event|1|||
155395948|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Adverse Event|0|||
155395949|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Adverse Event|0|||
155395950|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Adverse Event|0|||
155395951|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Adverse Event|0|||
155395952|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Adverse Event|0|||
155395953|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
155395954|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
155395955|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395956|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
155395957|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395958|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395959|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395960|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
155395961|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395962|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395963|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
155395964|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395965|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395966|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395967|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395968|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
155395969|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395970|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395971|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
155395972|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395973|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395974|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395975|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395976|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
155395977|NCT02871778|560885089|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395978|NCT02871778|560885090|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
155395979|NCT02871778|560885091|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
154953014|NCT02896361|559254559|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
155395980|NCT02871778|560885092|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395981|NCT02871778|560885093|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395982|NCT02871778|560885094|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395983|NCT02871778|560885095|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
154953015|NCT02896361|559254560|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
154953016|NCT02896361|559254561|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
155395984|NCT02871778|560885096|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
155395985|NCT02871778|560885089|FG000|Part A: Treatment Period 2|Adverse Event|2|||
155395986|NCT02871778|560885090|FG001|Part A: Treatment Period 2|Adverse Event|2|||
155395987|NCT02871778|560885091|FG002|Part A: Treatment Period 2|Adverse Event|0|||
155395988|NCT02871778|560885092|FG003|Part A: Treatment Period 2|Adverse Event|0|||
155395989|NCT02871778|560885093|FG004|Part A: Treatment Period 2|Adverse Event|0|||
155395990|NCT02871778|560885094|FG005|Part A: Treatment Period 2|Adverse Event|0|||
155395991|NCT02871778|560885095|FG006|Part A: Treatment Period 2|Adverse Event|0|||
155395992|NCT02871778|560885096|FG007|Part A: Treatment Period 2|Adverse Event|0|||
155395993|NCT02871778|560885089|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395994|NCT02871778|560885090|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395995|NCT02871778|560885091|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
155057669|NCT02265510|559645791|FG009|Overall Study|Withdrawal by Subject|0|||
155057670|NCT02265510|559645792|FG010|Overall Study|Withdrawal by Subject|0|||
155057671|NCT02265510|559645793|FG011|Overall Study|Withdrawal by Subject|0|||
155057672|NCT02265510|559645794|FG012|Overall Study|Withdrawal by Subject|1|||
155395996|NCT02871778|560885092|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
155395997|NCT02871778|560885093|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395998|NCT02871778|560885094|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
155395999|NCT02871778|560885095|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
155396000|NCT02871778|560885096|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
155396001|NCT02871778|560885089|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
155396002|NCT02871778|560885090|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396003|NCT02871778|560885091|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
155396004|NCT02871778|560885092|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396005|NCT02871778|560885093|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396006|NCT02871778|560885094|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396007|NCT02871778|560885095|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396008|NCT02871778|560885096|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
155396009|NCT02871778|560885089|FG000|Part B: Treatment Period 3|Adverse Event|0|||
155396010|NCT02871778|560885090|FG001|Part B: Treatment Period 3|Adverse Event|0|||
155396011|NCT02871778|560885091|FG002|Part B: Treatment Period 3|Adverse Event|0|||
155396012|NCT02871778|560885092|FG003|Part B: Treatment Period 3|Adverse Event|0|||
155396013|NCT02871778|560885093|FG004|Part B: Treatment Period 3|Adverse Event|1|||
155396014|NCT02871778|560885094|FG005|Part B: Treatment Period 3|Adverse Event|1|||
155396015|NCT02871778|560885095|FG006|Part B: Treatment Period 3|Adverse Event|1|||
155396016|NCT02871778|560885096|FG007|Part B: Treatment Period 3|Adverse Event|0|||
155396017|NCT02653300|560885097|FG000|Overall Study|Withdrawal by Subject|2|||
155396018|NCT02289352|560885106|FG000|Overall Study|Withdrawal by Subject|1|||
155396019|NCT02289352|560885107|FG001|Overall Study|Withdrawal by Subject|1|||
155396020|NCT02289352|560885108|FG002|Overall Study|Withdrawal by Subject|0|||
155396021|NCT01390272|560885109|FG000|Overall Study|Death|3|||
155396022|NCT01390272|560885110|FG001|Overall Study|Death|2|||
155396023|NCT01390272|560885109|FG000|Overall Study|Withdrawal by Subject|9|||
155396024|NCT01390272|560885110|FG001|Overall Study|Withdrawal by Subject|5|||
155396025|NCT01390272|560885109|FG000|Overall Study|Patient moved, no longer eligible|5|||
155396026|NCT01390272|560885110|FG001|Overall Study|Patient moved, no longer eligible|8|||
155396027|NCT00307333|560885111|FG000|Overall Study|Lost to Follow-up|11|||
155396028|NCT00307333|560885112|FG001|Overall Study|Lost to Follow-up|3|||
155396029|NCT04166383|560885113|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
155396030|NCT04166383|560885113|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
155396031|NCT04166383|560885113|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
155396032|NCT00387764|560885114|FG000|Overall Study|Adverse Event|12|||
155396033|NCT00387764|560885114|FG000|Overall Study|Withdrawal by Subject|8|||
155396034|NCT00387764|560885114|FG000|Overall Study|Sponsor Terminated Study|1|||
155396035|NCT00387764|560885114|FG000|Overall Study|Physician Decision|1|||
155396036|NCT00387764|560885114|FG000|Overall Study|Other|2|||
155396037|NCT00387764|560885114|FG000|Overall Study|Death|7|||
155396038|NCT00375219|560885116|FG000|Overall Study|Failure to achieve a response|16|||
155396039|NCT00375219|560885117|FG001|Overall Study|Failure to achieve a response|2|||
155396040|NCT00375219|560885118|FG002|Overall Study|Failure to achieve a response|0|||
155396041|NCT00375219|560885116|FG000|Overall Study|Adverse Event|8|||
155396042|NCT00375219|560885117|FG001|Overall Study|Adverse Event|2|||
155396043|NCT00375219|560885118|FG002|Overall Study|Adverse Event|1|||
155396044|NCT00375219|560885116|FG000|Overall Study|Protocol Violation|1|||
155396045|NCT00375219|560885117|FG001|Overall Study|Protocol Violation|0|||
155396046|NCT00375219|560885118|FG002|Overall Study|Protocol Violation|1|||
155396047|NCT00375219|560885116|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
155396048|NCT00375219|560885117|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
155396049|NCT00375219|560885118|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
155396050|NCT00375219|560885116|FG000|Overall Study|Lost to Follow-up|1|||
155057673|NCT02265510|559645795|FG013|Overall Study|Withdrawal by Subject|0|||
155396051|NCT00375219|560885117|FG001|Overall Study|Lost to Follow-up|1|||
155396052|NCT00375219|560885118|FG002|Overall Study|Lost to Follow-up|0|||
155396053|NCT00375219|560885116|FG000|Overall Study|Disease progression|18|||
155396054|NCT00375219|560885117|FG001|Overall Study|Disease progression|9|||
155396055|NCT00375219|560885118|FG002|Overall Study|Disease progression|12|||
155396056|NCT00375219|560885116|FG000|Overall Study|Death|4|||
155396057|NCT00375219|560885117|FG001|Overall Study|Death|3|||
155396058|NCT00375219|560885118|FG002|Overall Study|Death|7|||
155396059|NCT00375219|560885116|FG000|Overall Study|Hematologic resistance|1|||
155396060|NCT00375219|560885117|FG001|Overall Study|Hematologic resistance|0|||
155396061|NCT00375219|560885118|FG002|Overall Study|Hematologic resistance|0|||
155396062|NCT00375219|560885116|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
155396063|NCT00375219|560885117|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
155396064|NCT00375219|560885118|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
155396065|NCT00375219|560885116|FG000|Overall Study|Allograft|2|||
155396066|NCT00375219|560885117|FG001|Overall Study|Allograft|0|||
155396067|NCT00375219|560885118|FG002|Overall Study|Allograft|0|||
155396068|NCT00375219|560885116|FG000|Overall Study|Cord blood transplantation|1|||
155396069|NCT00375219|560885117|FG001|Overall Study|Cord blood transplantation|0|||
155396070|NCT00375219|560885118|FG002|Overall Study|Cord blood transplantation|0|||
155396071|NCT00375219|560885116|FG000|Overall Study|Withdrawal by Subject|1|||
155396072|NCT00375219|560885117|FG001|Overall Study|Withdrawal by Subject|0|||
155396073|NCT00375219|560885118|FG002|Overall Study|Withdrawal by Subject|0|||
155396074|NCT02767323|560886743|FG000|Overall Study|Withdrawal by Subject|17|||
155396075|NCT02767323|560886744|FG001|Overall Study|Withdrawal by Subject|5|||
155396076|NCT02767323|560886745|FG002|Overall Study|Withdrawal by Subject|13|||
155396077|NCT02767323|560886746|FG003|Overall Study|Withdrawal by Subject|0|||
155396078|NCT02767323|560886743|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
155396079|NCT02767323|560886744|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
155396080|NCT02767323|560886745|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
155396081|NCT02767323|560886746|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
155396082|NCT02667275|560886750|FG000|Overall Study|Protocol Violation|11|||
155396083|NCT02667275|560886751|FG001|Overall Study|Protocol Violation|7|||
155396084|NCT02667275|560886750|FG000|Overall Study|Lost to Follow-up|0|||
155396085|NCT02667275|560886751|FG001|Overall Study|Lost to Follow-up|2|||
155396086|NCT02667275|560886750|FG000|Overall Study|Withdrawal by Subject|0|||
155396087|NCT02667275|560886751|FG001|Overall Study|Withdrawal by Subject|5|||
155396088|NCT02667275|560886750|FG000|Overall Study|Discontinued early without completing|0|||
155396089|NCT02667275|560886751|FG001|Overall Study|Discontinued early without completing|1|||
155396090|NCT01756040|560886752|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
155396091|NCT01756040|560886752|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
155396092|NCT01756040|560886752|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
155396093|NCT04479436|560886753|FG000|Overall Study|Progressive disease|26|||
155396094|NCT04479436|560886754|FG001|Overall Study|Progressive disease|1|||
155396095|NCT04479436|560886753|FG000|Overall Study|Adverse Event|6|||
155396096|NCT04479436|560886754|FG001|Overall Study|Adverse Event|0|||
155396097|NCT04479436|560886753|FG000|Overall Study|Withdrawal by Subject|5|||
155396098|NCT04479436|560886754|FG001|Overall Study|Withdrawal by Subject|0|||
155396099|NCT04479436|560886753|FG000|Overall Study|Clinical progression|1|||
155396100|NCT04479436|560886754|FG001|Overall Study|Clinical progression|0|||
155396101|NCT04479436|560886753|FG000|Overall Study|Physician Decision|1|||
155396102|NCT04479436|560886754|FG001|Overall Study|Physician Decision|0|||
155396103|NCT00791258|560886759|FG000|Overall Study|Adverse Event|87|||
155396104|NCT00791258|560886759|FG000|Overall Study|Lost to Follow-up|18|||
155396105|NCT00791258|560886759|FG000|Overall Study|Protocol Violation|109|||
155396106|NCT00791258|560886759|FG000|Overall Study|Withdrawal by Subject|40|||
155396107|NCT00791258|560886759|FG000|Overall Study|Did not take medication for >3 days|1|||
155396108|NCT00791258|560886759|FG000|Overall Study|subject left area|2|||
155396109|NCT00791258|560886759|FG000|Overall Study|non-compliance|3|||
155396110|NCT00791258|560886759|FG000|Overall Study|Subject incarcerated|1|||
155396111|NCT00791258|560886759|FG000|Overall Study|Subject required restricted medication|1|||
155396112|NCT00791258|560886759|FG000|Overall Study|Lack of Efficacy|1|||
155396113|NCT00436618|560886760|FG000|Overall Study|Withdrawal by Subject|5|||
155396114|NCT00436618|560886761|FG001|Overall Study|Withdrawal by Subject|8|||
155396115|NCT00436618|560886762|FG002|Overall Study|Withdrawal by Subject|11|||
155396116|NCT00436618|560886760|FG000|Overall Study|Adverse Event|8|||
155396117|NCT00436618|560886761|FG001|Overall Study|Adverse Event|8|||
155396118|NCT00436618|560886762|FG002|Overall Study|Adverse Event|9|||
155396119|NCT00436618|560886760|FG000|Overall Study|Alternate Treatment|3|||
155396120|NCT00436618|560886761|FG001|Overall Study|Alternate Treatment|4|||
155396121|NCT00436618|560886762|FG002|Overall Study|Alternate Treatment|12|||
155396122|NCT00436618|560886760|FG000|Overall Study|Other Medical Problems|3|||
155396123|NCT00436618|560886761|FG001|Overall Study|Other Medical Problems|1|||
155396124|NCT00436618|560886762|FG002|Overall Study|Other Medical Problems|7|||
155396125|NCT00436618|560886760|FG000|Overall Study|Death|4|||
155396126|NCT00436618|560886761|FG001|Overall Study|Death|2|||
155396127|NCT00436618|560886762|FG002|Overall Study|Death|3|||
155396128|NCT00436618|560886760|FG000|Overall Study|New Primary or Other Reasons|6|||
155396129|NCT00436618|560886761|FG001|Overall Study|New Primary or Other Reasons|2|||
155396130|NCT00436618|560886762|FG002|Overall Study|New Primary or Other Reasons|12|||
155396131|NCT00436618|560886760|FG000|Overall Study|Still on treatment|1|||
155396132|NCT00436618|560886761|FG001|Overall Study|Still on treatment|2|||
155396133|NCT00436618|560886762|FG002|Overall Study|Still on treatment|7|||
155396134|NCT01994382|560886763|FG000|Overall Study|Informed consent withdrawn|0|||
155396135|NCT01994382|560886764|FG001|Overall Study|Informed consent withdrawn|0|||
155396136|NCT01994382|560886765|FG002|Overall Study|Informed consent withdrawn|0|||
155396137|NCT01994382|560886766|FG003|Overall Study|Informed consent withdrawn|0|||
155396138|NCT01994382|560886767|FG004|Overall Study|Informed consent withdrawn|0|||
155396139|NCT01994382|560886768|FG005|Overall Study|Informed consent withdrawn|0|||
155396140|NCT01994382|560886769|FG006|Overall Study|Informed consent withdrawn|1|||
155396141|NCT01994382|560886770|FG007|Overall Study|Informed consent withdrawn|0|||
155396142|NCT01994382|560886771|FG008|Overall Study|Informed consent withdrawn|0|||
155396143|NCT01994382|560886772|FG009|Overall Study|Informed consent withdrawn|0|||
155396144|NCT01994382|560886773|FG010|Overall Study|Informed consent withdrawn|0|||
155396145|NCT01994382|560886774|FG011|Overall Study|Informed consent withdrawn|0|||
155396146|NCT01994382|560886775|FG012|Overall Study|Informed consent withdrawn|0|||
155396147|NCT01994382|560886776|FG013|Overall Study|Informed consent withdrawn|0|||
155396148|NCT01994382|560886777|FG014|Overall Study|Informed consent withdrawn|0|||
155396149|NCT01994382|560886778|FG015|Overall Study|Informed consent withdrawn|0|||
155396150|NCT01994382|560886779|FG016|Overall Study|Informed consent withdrawn|0|||
155396151|NCT01994382|560886763|FG000|Overall Study|Progressive disease|3|||
155396152|NCT01994382|560886764|FG001|Overall Study|Progressive disease|4|||
155396153|NCT01994382|560886765|FG002|Overall Study|Progressive disease|4|||
155396154|NCT01994382|560886766|FG003|Overall Study|Progressive disease|3|||
155396155|NCT01994382|560886767|FG004|Overall Study|Progressive disease|2|||
155396156|NCT01994382|560886768|FG005|Overall Study|Progressive disease|3|||
155396157|NCT01994382|560886769|FG006|Overall Study|Progressive disease|3|||
155396158|NCT01994382|560886770|FG007|Overall Study|Progressive disease|6|||
155396159|NCT01994382|560886771|FG008|Overall Study|Progressive disease|2|||
155396160|NCT01994382|560886772|FG009|Overall Study|Progressive disease|2|||
155396161|NCT01994382|560886773|FG010|Overall Study|Progressive disease|13|||
155396162|NCT01994382|560886774|FG011|Overall Study|Progressive disease|8|||
155396163|NCT01994382|560886775|FG012|Overall Study|Progressive disease|7|||
155396164|NCT01994382|560886776|FG013|Overall Study|Progressive disease|3|||
155396165|NCT01994382|560886777|FG014|Overall Study|Progressive disease|6|||
155396166|NCT01994382|560886778|FG015|Overall Study|Progressive disease|44|||
155396167|NCT01994382|560886779|FG016|Overall Study|Progressive disease|28|||
155396168|NCT01994382|560886763|FG000|Overall Study|Physician Decision|0|||
155396169|NCT01994382|560886764|FG001|Overall Study|Physician Decision|1|||
155396170|NCT01994382|560886765|FG002|Overall Study|Physician Decision|0|||
155396171|NCT01994382|560886766|FG003|Overall Study|Physician Decision|0|||
155396172|NCT01994382|560886767|FG004|Overall Study|Physician Decision|0|||
155396173|NCT01994382|560886768|FG005|Overall Study|Physician Decision|0|||
155396174|NCT01994382|560886769|FG006|Overall Study|Physician Decision|0|||
155396175|NCT01994382|560886770|FG007|Overall Study|Physician Decision|0|||
155396176|NCT01994382|560886771|FG008|Overall Study|Physician Decision|0|||
155396177|NCT01994382|560886772|FG009|Overall Study|Physician Decision|0|||
155396178|NCT01994382|560886773|FG010|Overall Study|Physician Decision|3|||
155396179|NCT01994382|560886774|FG011|Overall Study|Physician Decision|1|||
155396180|NCT01994382|560886775|FG012|Overall Study|Physician Decision|1|||
155396181|NCT01994382|560886776|FG013|Overall Study|Physician Decision|0|||
155396182|NCT01994382|560886777|FG014|Overall Study|Physician Decision|1|||
155396183|NCT01994382|560886778|FG015|Overall Study|Physician Decision|4|||
155396184|NCT01994382|560886779|FG016|Overall Study|Physician Decision|2|||
155396185|NCT01994382|560886763|FG000|Overall Study|Death|0|||
155396186|NCT01994382|560886764|FG001|Overall Study|Death|0|||
155396187|NCT01994382|560886765|FG002|Overall Study|Death|0|||
155396188|NCT01994382|560886766|FG003|Overall Study|Death|0|||
155396189|NCT01994382|560886767|FG004|Overall Study|Death|1|||
155396190|NCT01994382|560886768|FG005|Overall Study|Death|0|||
155396191|NCT01994382|560886769|FG006|Overall Study|Death|0|||
155396192|NCT01994382|560886770|FG007|Overall Study|Death|0|||
155396193|NCT01994382|560886771|FG008|Overall Study|Death|1|||
155396194|NCT01994382|560886772|FG009|Overall Study|Death|1|||
155396195|NCT01994382|560886773|FG010|Overall Study|Death|0|||
155396196|NCT01994382|560886774|FG011|Overall Study|Death|0|||
155396197|NCT01994382|560886775|FG012|Overall Study|Death|0|||
155396198|NCT01994382|560886776|FG013|Overall Study|Death|0|||
155396199|NCT01994382|560886777|FG014|Overall Study|Death|0|||
155396200|NCT01994382|560886778|FG015|Overall Study|Death|1|||
155396201|NCT01994382|560886779|FG016|Overall Study|Death|0|||
155396202|NCT01994382|560886763|FG000|Overall Study|Adverse Event|0|||
155396203|NCT01994382|560886764|FG001|Overall Study|Adverse Event|1|||
155396204|NCT01994382|560886765|FG002|Overall Study|Adverse Event|2|||
155396205|NCT01994382|560886766|FG003|Overall Study|Adverse Event|0|||
155396206|NCT01994382|560886767|FG004|Overall Study|Adverse Event|0|||
155396207|NCT01994382|560886768|FG005|Overall Study|Adverse Event|0|||
155396208|NCT01994382|560886769|FG006|Overall Study|Adverse Event|0|||
155396209|NCT01994382|560886770|FG007|Overall Study|Adverse Event|0|||
155396210|NCT01994382|560886771|FG008|Overall Study|Adverse Event|0|||
155396211|NCT01994382|560886772|FG009|Overall Study|Adverse Event|0|||
155396212|NCT01994382|560886773|FG010|Overall Study|Adverse Event|15|||
155396213|NCT01994382|560886774|FG011|Overall Study|Adverse Event|2|||
155396214|NCT01994382|560886775|FG012|Overall Study|Adverse Event|7|||
155396215|NCT01994382|560886776|FG013|Overall Study|Adverse Event|3|||
155396216|NCT01994382|560886777|FG014|Overall Study|Adverse Event|17|||
155396217|NCT01994382|560886778|FG015|Overall Study|Adverse Event|6|||
155396218|NCT01994382|560886779|FG016|Overall Study|Adverse Event|3|||
155396219|NCT01994382|560886763|FG000|Overall Study|Other than specified|0|||
155396220|NCT01994382|560886764|FG001|Overall Study|Other than specified|0|||
155396221|NCT01994382|560886765|FG002|Overall Study|Other than specified|0|||
155396222|NCT01994382|560886766|FG003|Overall Study|Other than specified|0|||
155396223|NCT01994382|560886767|FG004|Overall Study|Other than specified|0|||
155396224|NCT01994382|560886768|FG005|Overall Study|Other than specified|0|||
155396225|NCT01994382|560886769|FG006|Overall Study|Other than specified|0|||
155396226|NCT01994382|560886770|FG007|Overall Study|Other than specified|0|||
155396227|NCT01994382|560886771|FG008|Overall Study|Other than specified|0|||
155396228|NCT01994382|560886772|FG009|Overall Study|Other than specified|0|||
155396229|NCT01994382|560886773|FG010|Overall Study|Other than specified|2|||
155396230|NCT01994382|560886774|FG011|Overall Study|Other than specified|0|||
155396231|NCT01994382|560886775|FG012|Overall Study|Other than specified|2|||
155396232|NCT01994382|560886776|FG013|Overall Study|Other than specified|0|||
155396233|NCT01994382|560886777|FG014|Overall Study|Other than specified|0|||
155396234|NCT01994382|560886778|FG015|Overall Study|Other than specified|4|||
155396235|NCT01994382|560886779|FG016|Overall Study|Other than specified|4|||
155396236|NCT01994382|560886763|FG000|Overall Study|Withdrawal by Subject|0|||
155396237|NCT01994382|560886764|FG001|Overall Study|Withdrawal by Subject|0|||
155396238|NCT01994382|560886765|FG002|Overall Study|Withdrawal by Subject|0|||
155396239|NCT01994382|560886766|FG003|Overall Study|Withdrawal by Subject|0|||
155396240|NCT01994382|560886767|FG004|Overall Study|Withdrawal by Subject|0|||
155396241|NCT01994382|560886768|FG005|Overall Study|Withdrawal by Subject|0|||
155396242|NCT01994382|560886769|FG006|Overall Study|Withdrawal by Subject|0|||
155396243|NCT01994382|560886770|FG007|Overall Study|Withdrawal by Subject|0|||
155396244|NCT01994382|560886771|FG008|Overall Study|Withdrawal by Subject|0|||
155396245|NCT01994382|560886772|FG009|Overall Study|Withdrawal by Subject|0|||
155396246|NCT01994382|560886773|FG010|Overall Study|Withdrawal by Subject|6|||
155396247|NCT01994382|560886774|FG011|Overall Study|Withdrawal by Subject|0|||
155396248|NCT01994382|560886775|FG012|Overall Study|Withdrawal by Subject|2|||
155396249|NCT01994382|560886776|FG013|Overall Study|Withdrawal by Subject|0|||
155396250|NCT01994382|560886777|FG014|Overall Study|Withdrawal by Subject|4|||
155396251|NCT01994382|560886778|FG015|Overall Study|Withdrawal by Subject|3|||
155396252|NCT01994382|560886779|FG016|Overall Study|Withdrawal by Subject|0|||
155396253|NCT01994382|560886763|FG000|Overall Study|Lost to Follow-up|0|||
155396254|NCT01994382|560886764|FG001|Overall Study|Lost to Follow-up|0|||
155396255|NCT01994382|560886765|FG002|Overall Study|Lost to Follow-up|0|||
155396256|NCT01994382|560886766|FG003|Overall Study|Lost to Follow-up|0|||
155396257|NCT01994382|560886767|FG004|Overall Study|Lost to Follow-up|0|||
155396258|NCT01994382|560886768|FG005|Overall Study|Lost to Follow-up|0|||
155396259|NCT01994382|560886769|FG006|Overall Study|Lost to Follow-up|0|||
155396260|NCT01994382|560886770|FG007|Overall Study|Lost to Follow-up|0|||
155396261|NCT01994382|560886771|FG008|Overall Study|Lost to Follow-up|0|||
155396262|NCT01994382|560886772|FG009|Overall Study|Lost to Follow-up|0|||
155396263|NCT01994382|560886773|FG010|Overall Study|Lost to Follow-up|1|||
155396264|NCT01994382|560886774|FG011|Overall Study|Lost to Follow-up|0|||
155396265|NCT01994382|560886775|FG012|Overall Study|Lost to Follow-up|0|||
155396266|NCT01994382|560886776|FG013|Overall Study|Lost to Follow-up|0|||
155396267|NCT01994382|560886777|FG014|Overall Study|Lost to Follow-up|0|||
155396268|NCT01994382|560886778|FG015|Overall Study|Lost to Follow-up|0|||
154953017|NCT01029353|559254562|FG000|Overall Study|Lost to Follow-up|4|||
154953018|NCT01029353|559254563|FG001|Overall Study|Lost to Follow-up|5|||
154953019|NCT01029353|559254564|FG002|Overall Study|Lost to Follow-up|5|||
154953020|NCT01029353|559254565|FG003|Overall Study|Lost to Follow-up|4|||
154953021|NCT01029353|559254562|FG000|Overall Study|Consent Withdrawn|2|||
154953022|NCT01029353|559254563|FG001|Overall Study|Consent Withdrawn|0|||
154953023|NCT01029353|559254564|FG002|Overall Study|Consent Withdrawn|0|||
154953024|NCT01029353|559254565|FG003|Overall Study|Consent Withdrawn|0|||
154953025|NCT01029353|559254562|FG000|Overall Study|Primary Outcome Indeterminate|1|||
154953026|NCT01029353|559254563|FG001|Overall Study|Primary Outcome Indeterminate|3|||
154953027|NCT01029353|559254564|FG002|Overall Study|Primary Outcome Indeterminate|2|||
155057674|NCT02265510|559645782|FG000|Overall Study|Disease Progression|0|||
155396269|NCT01994382|560886779|FG016|Overall Study|Lost to Follow-up|0|||
155396270|NCT01994382|560886763|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396271|NCT01994382|560886764|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155057675|NCT02265510|559645783|FG001|Overall Study|Disease Progression|1|||
155396272|NCT01994382|560886765|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396273|NCT01994382|560886766|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396274|NCT01994382|560886767|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396275|NCT01994382|560886768|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396276|NCT01994382|560886769|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396277|NCT01994382|560886770|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396278|NCT01994382|560886771|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396279|NCT01994382|560886772|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396280|NCT01994382|560886773|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
155396281|NCT01994382|560886774|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396282|NCT01994382|560886775|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
155396283|NCT01994382|560886776|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396284|NCT01994382|560886777|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
155396285|NCT01994382|560886778|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
155396286|NCT01994382|560886779|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
155396287|NCT01994382|560886763|FG000|Overall Study|Protocol violation/noncompliance|0|||
155396288|NCT01994382|560886764|FG001|Overall Study|Protocol violation/noncompliance|0|||
155396289|NCT01994382|560886765|FG002|Overall Study|Protocol violation/noncompliance|0|||
155396290|NCT01994382|560886766|FG003|Overall Study|Protocol violation/noncompliance|0|||
155396291|NCT01994382|560886767|FG004|Overall Study|Protocol violation/noncompliance|0|||
155396292|NCT01994382|560886768|FG005|Overall Study|Protocol violation/noncompliance|0|||
155396293|NCT01994382|560886769|FG006|Overall Study|Protocol violation/noncompliance|0|||
155396294|NCT01994382|560886770|FG007|Overall Study|Protocol violation/noncompliance|0|||
155396295|NCT01994382|560886771|FG008|Overall Study|Protocol violation/noncompliance|0|||
155396296|NCT01994382|560886772|FG009|Overall Study|Protocol violation/noncompliance|0|||
155396297|NCT01994382|560886773|FG010|Overall Study|Protocol violation/noncompliance|0|||
155396298|NCT01994382|560886774|FG011|Overall Study|Protocol violation/noncompliance|1|||
155396299|NCT01994382|560886775|FG012|Overall Study|Protocol violation/noncompliance|0|||
155396300|NCT01994382|560886776|FG013|Overall Study|Protocol violation/noncompliance|0|||
155396301|NCT01994382|560886777|FG014|Overall Study|Protocol violation/noncompliance|0|||
155396302|NCT01994382|560886778|FG015|Overall Study|Protocol violation/noncompliance|0|||
155396303|NCT01994382|560886779|FG016|Overall Study|Protocol violation/noncompliance|2|||
155396304|NCT01994382|560886763|FG000|Overall Study|Rolled over to Phase 2a|0|||
155396305|NCT01994382|560886764|FG001|Overall Study|Rolled over to Phase 2a|0|||
155396306|NCT01994382|560886765|FG002|Overall Study|Rolled over to Phase 2a|1|||
155396307|NCT01994382|560886766|FG003|Overall Study|Rolled over to Phase 2a|0|||
155396308|NCT01994382|560886767|FG004|Overall Study|Rolled over to Phase 2a|0|||
155396309|NCT01994382|560886768|FG005|Overall Study|Rolled over to Phase 2a|0|||
155396310|NCT01994382|560886769|FG006|Overall Study|Rolled over to Phase 2a|0|||
155396311|NCT01994382|560886770|FG007|Overall Study|Rolled over to Phase 2a|0|||
155396312|NCT01994382|560886771|FG008|Overall Study|Rolled over to Phase 2a|0|||
155396313|NCT01994382|560886772|FG009|Overall Study|Rolled over to Phase 2a|2|||
155396314|NCT01994382|560886773|FG010|Overall Study|Rolled over to Phase 2a|0|||
155057676|NCT02265510|559645784|FG002|Overall Study|Disease Progression|2|||
155057677|NCT02265510|559645785|FG003|Overall Study|Disease Progression|1|||
155283984|NCT01515319|560470905|FG001|Overall Study|Withdrawal by Subject|0|||
155283985|NCT01515319|560470906|FG002|Overall Study|Withdrawal by Subject|0|||
155396315|NCT01994382|560886774|FG011|Overall Study|Rolled over to Phase 2a|0|||
155396316|NCT01994382|560886775|FG012|Overall Study|Rolled over to Phase 2a|0|||
155396317|NCT01994382|560886776|FG013|Overall Study|Rolled over to Phase 2a|0|||
155396318|NCT01994382|560886777|FG014|Overall Study|Rolled over to Phase 2a|0|||
155396319|NCT01994382|560886778|FG015|Overall Study|Rolled over to Phase 2a|0|||
155396320|NCT01994382|560886779|FG016|Overall Study|Rolled over to Phase 2a|0|||
155396321|NCT00314249|560886780|FG000|Overall Study|Adverse Event|73|||
155396322|NCT00314249|560886781|FG001|Overall Study|Adverse Event|94|||
155396323|NCT00314249|560886780|FG000|Overall Study|Lack of Efficacy|33|||
155396324|NCT00314249|560886781|FG001|Overall Study|Lack of Efficacy|24|||
155396325|NCT00314249|560886780|FG000|Overall Study|Withdrawal by Subject|21|||
155396326|NCT00314249|560886781|FG001|Overall Study|Withdrawal by Subject|28|||
155396327|NCT00314249|560886780|FG000|Overall Study|Lost to Follow-up|15|||
155396328|NCT00314249|560886781|FG001|Overall Study|Lost to Follow-up|9|||
155396329|NCT00314249|560886780|FG000|Overall Study|Physician Decision|1|||
155396330|NCT00314249|560886781|FG001|Overall Study|Physician Decision|1|||
155396331|NCT00314249|560886780|FG000|Overall Study|Withdrawn for other reasons|4|||
155283986|NCT01515319|560470907|FG003|Overall Study|Withdrawal by Subject|0|||
155283987|NCT01515319|560470908|FG004|Overall Study|Withdrawal by Subject|0|||
155283988|NCT01515319|560470909|FG005|Overall Study|Withdrawal by Subject|0|||
155396332|NCT00314249|560886781|FG001|Overall Study|Withdrawn for other reasons|1|||
155396333|NCT00314249|560886780|FG000|Overall Study|Non-Compliant|5|||
155396334|NCT00314249|560886781|FG001|Overall Study|Non-Compliant|6|||
155396335|NCT04667377|560886782|FG000|Dose Escalation Period|Other not specified below|3|||
155396336|NCT04667377|560886783|FG001|Dose Escalation Period|Other not specified below|3|||
155396337|NCT04667377|560886784|FG002|Dose Escalation Period|Other not specified below|2|||
155396338|NCT04667377|560886785|FG003|Dose Escalation Period|Other not specified below|1|||
155396339|NCT04667377|560886786|FG004|Dose Escalation Period|Other not specified below|3|||
155396340|NCT04667377|560886782|FG000|Dose Escalation Period|Protocol Violation|2|||
155396341|NCT04667377|560886783|FG001|Dose Escalation Period|Protocol Violation|2|||
155396342|NCT04667377|560886784|FG002|Dose Escalation Period|Protocol Violation|0|||
155396343|NCT04667377|560886785|FG003|Dose Escalation Period|Protocol Violation|2|||
155396344|NCT04667377|560886786|FG004|Dose Escalation Period|Protocol Violation|1|||
155396345|NCT04667377|560886782|FG000|Dose Escalation Period|Burden of study procedures|2|||
155396346|NCT04667377|560886783|FG001|Dose Escalation Period|Burden of study procedures|1|||
155396347|NCT04667377|560886784|FG002|Dose Escalation Period|Burden of study procedures|1|||
155396348|NCT04667377|560886785|FG003|Dose Escalation Period|Burden of study procedures|1|||
155396349|NCT04667377|560886786|FG004|Dose Escalation Period|Burden of study procedures|5|||
155396350|NCT04667377|560886782|FG000|Dose Escalation Period|Change of residence|0|||
155396351|NCT04667377|560886783|FG001|Dose Escalation Period|Change of residence|0|||
155396352|NCT04667377|560886784|FG002|Dose Escalation Period|Change of residence|1|||
155396353|NCT04667377|560886785|FG003|Dose Escalation Period|Change of residence|0|||
155396354|NCT04667377|560886786|FG004|Dose Escalation Period|Change of residence|0|||
155396355|NCT04667377|560886782|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
155396356|NCT04667377|560886783|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
155396357|NCT04667377|560886784|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
155396358|NCT04667377|560886785|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
155396359|NCT04667377|560886786|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
155396360|NCT04667377|560886782|FG000|Dose Escalation Period|Adverse Event|9|||
155396361|NCT04667377|560886783|FG001|Dose Escalation Period|Adverse Event|10|||
155396362|NCT04667377|560886784|FG002|Dose Escalation Period|Adverse Event|12|||
155396363|NCT04667377|560886785|FG003|Dose Escalation Period|Adverse Event|17|||
155396364|NCT04667377|560886786|FG004|Dose Escalation Period|Adverse Event|3|||
155396365|NCT04667377|560886782|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
155396366|NCT04667377|560886783|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
155396367|NCT04667377|560886784|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
155396368|NCT04667377|560886785|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
155396369|NCT04667377|560886786|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
155396370|NCT04667377|560886782|FG000|Dose Escalation Period|Not treated|1|||
155396371|NCT04667377|560886783|FG001|Dose Escalation Period|Not treated|0|||
155396372|NCT04667377|560886784|FG002|Dose Escalation Period|Not treated|0|||
155396373|NCT04667377|560886785|FG003|Dose Escalation Period|Not treated|0|||
155396374|NCT04667377|560886786|FG004|Dose Escalation Period|Not treated|0|||
155396375|NCT04667377|560886782|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
155396376|NCT04667377|560886783|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
155396377|NCT04667377|560886784|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
155396378|NCT04667377|560886785|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
155396379|NCT04667377|560886786|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
155396380|NCT04667377|560886782|FG000|Dose Escalation Period|Lost to Follow-up|0|||
155396381|NCT04667377|560886783|FG001|Dose Escalation Period|Lost to Follow-up|1|||
155396382|NCT04667377|560886784|FG002|Dose Escalation Period|Lost to Follow-up|0|||
155396383|NCT04667377|560886785|FG003|Dose Escalation Period|Lost to Follow-up|0|||
155396384|NCT04667377|560886786|FG004|Dose Escalation Period|Lost to Follow-up|0|||
155396385|NCT04667377|560886782|FG000|Maintenance Period|Perceived lack of efficacy|0|||
155396386|NCT04667377|560886783|FG001|Maintenance Period|Perceived lack of efficacy|2|||
155396387|NCT04667377|560886784|FG002|Maintenance Period|Perceived lack of efficacy|1|||
155396388|NCT04667377|560886785|FG003|Maintenance Period|Perceived lack of efficacy|0|||
155396389|NCT04667377|560886786|FG004|Maintenance Period|Perceived lack of efficacy|1|||
155396390|NCT04667377|560886782|FG000|Maintenance Period|Adverse Event|2|||
155396391|NCT04667377|560886783|FG001|Maintenance Period|Adverse Event|8|||
155396392|NCT04667377|560886784|FG002|Maintenance Period|Adverse Event|5|||
155396393|NCT04667377|560886785|FG003|Maintenance Period|Adverse Event|4|||
155396394|NCT04667377|560886786|FG004|Maintenance Period|Adverse Event|1|||
155396395|NCT04667377|560886782|FG000|Maintenance Period|Adverse event: COVID infection|0|||
155396396|NCT04667377|560886783|FG001|Maintenance Period|Adverse event: COVID infection|1|||
155396397|NCT04667377|560886784|FG002|Maintenance Period|Adverse event: COVID infection|0|||
155396398|NCT04667377|560886785|FG003|Maintenance Period|Adverse event: COVID infection|0|||
155396399|NCT04667377|560886786|FG004|Maintenance Period|Adverse event: COVID infection|0|||
155396400|NCT04667377|560886782|FG000|Maintenance Period|COVID-related|0|||
155396401|NCT04667377|560886783|FG001|Maintenance Period|COVID-related|0|||
155396402|NCT04667377|560886784|FG002|Maintenance Period|COVID-related|1|||
155396403|NCT04667377|560886785|FG003|Maintenance Period|COVID-related|1|||
155396404|NCT04667377|560886786|FG004|Maintenance Period|COVID-related|0|||
155396405|NCT04667377|560886782|FG000|Maintenance Period|Protocol Violation|1|||
155396406|NCT04667377|560886783|FG001|Maintenance Period|Protocol Violation|0|||
155396407|NCT04667377|560886784|FG002|Maintenance Period|Protocol Violation|0|||
155396408|NCT04667377|560886785|FG003|Maintenance Period|Protocol Violation|0|||
155396409|NCT04667377|560886786|FG004|Maintenance Period|Protocol Violation|1|||
155396410|NCT04667377|560886782|FG000|Maintenance Period|Burden of study procedures|1|||
155396411|NCT04667377|560886783|FG001|Maintenance Period|Burden of study procedures|2|||
155396412|NCT04667377|560886784|FG002|Maintenance Period|Burden of study procedures|0|||
155396413|NCT04667377|560886785|FG003|Maintenance Period|Burden of study procedures|1|||
155396414|NCT04667377|560886786|FG004|Maintenance Period|Burden of study procedures|0|||
155396415|NCT04667377|560886782|FG000|Maintenance Period|Change of residence|0|||
155396416|NCT04667377|560886783|FG001|Maintenance Period|Change of residence|1|||
155396417|NCT04667377|560886784|FG002|Maintenance Period|Change of residence|0|||
155396418|NCT04667377|560886785|FG003|Maintenance Period|Change of residence|0|||
155396419|NCT04667377|560886786|FG004|Maintenance Period|Change of residence|1|||
155396420|NCT04667377|560886782|FG000|Maintenance Period|Missing|1|||
155396421|NCT04667377|560886783|FG001|Maintenance Period|Missing|0|||
155396422|NCT04667377|560886784|FG002|Maintenance Period|Missing|0|||
155396423|NCT04667377|560886785|FG003|Maintenance Period|Missing|0|||
155396424|NCT04667377|560886786|FG004|Maintenance Period|Missing|0|||
155396425|NCT04667377|560886782|FG000|Maintenance Period|Other than listed above|2|||
155396426|NCT04667377|560886783|FG001|Maintenance Period|Other than listed above|0|||
155396427|NCT04667377|560886784|FG002|Maintenance Period|Other than listed above|3|||
155396428|NCT04667377|560886785|FG003|Maintenance Period|Other than listed above|2|||
155396429|NCT04667377|560886786|FG004|Maintenance Period|Other than listed above|6|||
155396430|NCT04667377|560886782|FG000|Maintenance Period|Withdrawal by Subject|0|||
155396431|NCT04667377|560886783|FG001|Maintenance Period|Withdrawal by Subject|1|||
155396432|NCT04667377|560886784|FG002|Maintenance Period|Withdrawal by Subject|0|||
155396433|NCT04667377|560886785|FG003|Maintenance Period|Withdrawal by Subject|0|||
155396434|NCT04667377|560886786|FG004|Maintenance Period|Withdrawal by Subject|0|||
155396435|NCT04667377|560886782|FG000|Maintenance Period|Lost to Follow-up|1|||
155396436|NCT04667377|560886783|FG001|Maintenance Period|Lost to Follow-up|0|||
155396437|NCT04667377|560886784|FG002|Maintenance Period|Lost to Follow-up|1|||
155396438|NCT04667377|560886785|FG003|Maintenance Period|Lost to Follow-up|0|||
155396439|NCT04667377|560886786|FG004|Maintenance Period|Lost to Follow-up|1|||
155396440|NCT02066311|560886787|FG000|Overall Study|Adverse Event|4|||
155396441|NCT02066311|560886787|FG000|Overall Study|Withdrawal by Subject|1|||
155396442|NCT00359021|560886788|FG000|Overall Study|Adverse Event|26|||
155396443|NCT00359021|560886789|FG001|Overall Study|Adverse Event|8|||
155396444|NCT00359021|560886788|FG000|Overall Study|Subject Non-Compliant|1|||
155396445|NCT00359021|560886789|FG001|Overall Study|Subject Non-Compliant|2|||
155396446|NCT00359021|560886788|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
155396447|NCT00359021|560886789|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
155396448|NCT00359021|560886788|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
155396449|NCT00359021|560886789|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
155396450|NCT00359021|560886788|FG000|Overall Study|Withdrawal by Subject|2|||
155396451|NCT00359021|560886789|FG001|Overall Study|Withdrawal by Subject|9|||
155396452|NCT00359021|560886788|FG000|Overall Study|Lost to Follow-up|1|||
155396453|NCT00359021|560886789|FG001|Overall Study|Lost to Follow-up|0|||
155396454|NCT00359021|560886788|FG000|Overall Study|Other|4|||
155396455|NCT00359021|560886789|FG001|Overall Study|Other|1|||
155396456|NCT00359021|560886788|FG000|Overall Study|Pregnancy|1|||
155396457|NCT00359021|560886789|FG001|Overall Study|Pregnancy|0|||
155396458|NCT03861936|560886790|FG000|Overall Study|Withdrawal by Subject|4|||
155396459|NCT03861936|560886791|FG001|Overall Study|Withdrawal by Subject|1|||
155396460|NCT03861936|560886792|FG002|Overall Study|Withdrawal by Subject|3|||
155396461|NCT03861936|560886790|FG000|Overall Study|Lost to Follow-up|5|||
155396462|NCT03861936|560886791|FG001|Overall Study|Lost to Follow-up|3|||
155396463|NCT03861936|560886792|FG002|Overall Study|Lost to Follow-up|3|||
155396464|NCT03861936|560886790|FG000|Overall Study|Physician Decision|0|||
155396465|NCT03861936|560886791|FG001|Overall Study|Physician Decision|1|||
155396466|NCT03861936|560886792|FG002|Overall Study|Physician Decision|0|||
155396467|NCT03861936|560886790|FG000|Overall Study|Protocol Deviation|0|||
155396468|NCT03861936|560886791|FG001|Overall Study|Protocol Deviation|0|||
155396469|NCT03861936|560886792|FG002|Overall Study|Protocol Deviation|1|||
155396470|NCT03861936|560886790|FG000|Overall Study|Reason not Specified|5|||
155396471|NCT03861936|560886791|FG001|Overall Study|Reason not Specified|5|||
155396472|NCT03861936|560886792|FG002|Overall Study|Reason not Specified|3|||
154953028|NCT01029353|559254565|FG003|Overall Study|Primary Outcome Indeterminate|0|||
154953029|NCT00496964|559254570|FG000|Overall Study|Withdrawal by Subject|0|||
154953030|NCT00496964|559254571|FG001|Overall Study|Withdrawal by Subject|1|||
155057678|NCT02265510|559645786|FG004|Overall Study|Disease Progression|1|||
155396473|NCT05418673|560886795|FG000|Overall Study|Study Terminated by Sponsor|2|||
155396474|NCT05418673|560886796|FG001|Overall Study|Study Terminated by Sponsor|4|||
155396475|NCT05418673|560886795|FG000|Overall Study|Lost to Follow-up|1|||
155396476|NCT05418673|560886796|FG001|Overall Study|Lost to Follow-up|0|||
155396477|NCT01986920|560886799|FG000|A- 101 25%|Withdrawal by Subject|1|||
155396478|NCT01986920|560886800|FG001|A- 101 25%|Withdrawal by Subject|0|||
155396479|NCT01986920|560886801|FG002|A- 101 25%|Withdrawal by Subject|0|||
155396480|NCT01986920|560886802|FG003|A- 101 25%|Withdrawal by Subject|0|||
155396481|NCT01986920|560886799|FG000|A-101 32.5%|Withdrawal by Subject|0|||
155396482|NCT01986920|560886800|FG001|A-101 32.5%|Withdrawal by Subject|1|||
155396483|NCT01986920|560886801|FG002|A-101 32.5%|Withdrawal by Subject|0|||
155396484|NCT01986920|560886802|FG003|A-101 32.5%|Withdrawal by Subject|0|||
155396485|NCT01986920|560886799|FG000|A-101 40%|Withdrawal by Subject|0|||
155396486|NCT01986920|560886800|FG001|A-101 40%|Withdrawal by Subject|0|||
155396487|NCT01986920|560886801|FG002|A-101 40%|Withdrawal by Subject|1|||
155396488|NCT01986920|560886802|FG003|A-101 40%|Withdrawal by Subject|0|||
155396489|NCT01986920|560886799|FG000|Placebo|Withdrawal by Subject|0|||
155396490|NCT01986920|560886800|FG001|Placebo|Withdrawal by Subject|0|||
155396491|NCT01986920|560886801|FG002|Placebo|Withdrawal by Subject|0|||
155396492|NCT01986920|560886802|FG003|Placebo|Withdrawal by Subject|1|||
155396493|NCT01338415|560886803|FG000|Core + Extension|Adverse Event|8|||
155396494|NCT01338415|560886804|FG001|Core + Extension|Adverse Event|6|||
155396495|NCT01338415|560886805|FG002|Core + Extension|Adverse Event|0|||
155396496|NCT01338415|560886803|FG000|Core + Extension|Withdrawal by Subject|1|||
155396497|NCT01338415|560886804|FG001|Core + Extension|Withdrawal by Subject|1|||
155396498|NCT01338415|560886805|FG002|Core + Extension|Withdrawal by Subject|0|||
155396499|NCT01338415|560886803|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
155396500|NCT01338415|560886804|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
155396501|NCT01338415|560886805|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
155396502|NCT01338415|560886803|FG000|Core + Extension|Other (administrative reason)|1|||
155396503|NCT01338415|560886804|FG001|Core + Extension|Other (administrative reason)|0|||
155396504|NCT01338415|560886805|FG002|Core + Extension|Other (administrative reason)|0|||
155396505|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
155396506|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
155396507|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
155396508|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
155396509|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
155396510|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
155396511|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
155396512|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
155396513|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
155396514|NCT01338415|560886803|FG000|Exceptional Use Treatment Period|Death|0|||
155396515|NCT01338415|560886804|FG001|Exceptional Use Treatment Period|Death|0|||
155396516|NCT01338415|560886805|FG002|Exceptional Use Treatment Period|Death|1|||
155396517|NCT01118325|560886806|FG000|Overall Study|Adverse Event|1|||
155396518|NCT01118325|560886807|FG001|Overall Study|Adverse Event|0|||
155396519|NCT01118325|560886808|FG002|Overall Study|Adverse Event|1|||
155396520|NCT03334409|560886809|FG000|Overall Study|Did not meet inclusion criteria|1|||
155396521|NCT03334409|560886810|FG001|Overall Study|Did not meet inclusion criteria|0|||
155396522|NCT01526551|560886819|FG000|Overall Study|Lack of returned parental consent form|424|||
155396523|NCT00874770|560886820|FG000|Overall Study|Lack of Efficacy|2|||
155396524|NCT00874770|560886821|FG001|Overall Study|Lack of Efficacy|0|||
155396525|NCT00874770|560886822|FG002|Overall Study|Lack of Efficacy|0|||
155396526|NCT00874770|560886823|FG003|Overall Study|Lack of Efficacy|2|||
155396527|NCT00874770|560886820|FG000|Overall Study|Adverse Event|1|||
155396528|NCT00874770|560886821|FG001|Overall Study|Adverse Event|1|||
155396529|NCT00874770|560886822|FG002|Overall Study|Adverse Event|4|||
155396530|NCT00874770|560886823|FG003|Overall Study|Adverse Event|2|||
155396531|NCT00874770|560886820|FG000|Overall Study|Lost to Follow-up|1|||
155396532|NCT00874770|560886821|FG001|Overall Study|Lost to Follow-up|0|||
155396533|NCT00874770|560886822|FG002|Overall Study|Lost to Follow-up|0|||
155396534|NCT00874770|560886823|FG003|Overall Study|Lost to Follow-up|1|||
155396535|NCT00874770|560886820|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
155396536|NCT00874770|560886821|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
155396537|NCT00874770|560886822|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
155396538|NCT00874770|560886823|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
155396539|NCT05215262|560886824|FG000|Overall Study|Lost to Follow-up|12|||
155396540|NCT05215262|560886825|FG001|Overall Study|Lost to Follow-up|0|||
155396541|NCT00718549|560886827|FG000|Induction Phase|Disease Progression|1|||
155396542|NCT00718549|560886828|FG001|Induction Phase|Disease Progression|0|||
155396543|NCT00718549|560886829|FG002|Induction Phase|Disease Progression|0|||
155396544|NCT00718549|560886827|FG000|Induction Phase|Eligibility Criteria Violation|2|||
155396545|NCT00718549|560886828|FG001|Induction Phase|Eligibility Criteria Violation|0|||
155396546|NCT00718549|560886829|FG002|Induction Phase|Eligibility Criteria Violation|0|||
155396547|NCT00718549|560886827|FG000|Induction Phase|Early Termination - No Additional Info|59|||
155396548|NCT00718549|560886828|FG001|Induction Phase|Early Termination - No Additional Info|0|||
155396549|NCT00718549|560886829|FG002|Induction Phase|Early Termination - No Additional Info|0|||
155396550|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
155396551|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
155396552|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
155396553|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Death|0|||
155396554|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Death|1|||
155396555|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Death|2|||
155396556|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
155396557|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
155396558|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
155396559|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Progression|0|||
155396560|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Progression|5|||
155396561|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Progression|14|||
155396562|NCT00718549|560886827|FG000|Maintenance/ Observation Phase|Relapse|0|||
155396563|NCT00718549|560886828|FG001|Maintenance/ Observation Phase|Relapse|3|||
155396564|NCT00718549|560886829|FG002|Maintenance/ Observation Phase|Relapse|2|||
155396565|NCT01576172|560886830|FG000|Overall Study|Ineligible|2|||
155396566|NCT01576172|560886831|FG001|Overall Study|Ineligible|1|||
155396567|NCT01576172|560886830|FG000|Overall Study|Withdrawal by Subject|2|||
155396568|NCT01576172|560886831|FG001|Overall Study|Withdrawal by Subject|0|||
155396569|NCT01576172|560886830|FG000|Overall Study|Insurance issue|1|||
155396570|NCT01576172|560886831|FG001|Overall Study|Insurance issue|0|||
155396571|NCT02092350|560886836|FG000|Overall Study|Adverse Event|0|||
155396572|NCT02092350|560886837|FG001|Overall Study|Adverse Event|3|||
155396573|NCT02092350|560886836|FG000|Overall Study|Death|2|||
155396574|NCT02092350|560886837|FG001|Overall Study|Death|5|||
155396575|NCT02092350|560886836|FG000|Overall Study|Lost to Follow-up|3|||
155396576|NCT02092350|560886837|FG001|Overall Study|Lost to Follow-up|1|||
155396577|NCT02092350|560886836|FG000|Overall Study|Protocol Violation|1|||
155396578|NCT02092350|560886837|FG001|Overall Study|Protocol Violation|0|||
155396579|NCT02092350|560886836|FG000|Overall Study|Physician Decision|1|||
155396580|NCT02092350|560886837|FG001|Overall Study|Physician Decision|1|||
155396581|NCT02092350|560886836|FG000|Overall Study|Screen Failure|1|||
155396582|NCT02092350|560886837|FG001|Overall Study|Screen Failure|0|||
155396583|NCT02092350|560886836|FG000|Overall Study|Withdrawal by Subject|2|||
155396584|NCT02092350|560886837|FG001|Overall Study|Withdrawal by Subject|2|||
155396585|NCT00239226|560886838|FG000|Overall Study|permAF during stabilization period|0|||
155396586|NCT00239226|560886839|FG001|Overall Study|permAF during stabilization period|0|||
155396587|NCT00239226|560886840|FG002|Overall Study|permAF during stabilization period|0|||
155396588|NCT00239226|560886841|FG003|Overall Study|permAF during stabilization period|3|||
155396589|NCT00239226|560886838|FG000|Overall Study|Lost to Follow-up|1|||
155396590|NCT00239226|560886839|FG001|Overall Study|Lost to Follow-up|0|||
155396591|NCT00239226|560886840|FG002|Overall Study|Lost to Follow-up|1|||
155396592|NCT00239226|560886841|FG003|Overall Study|Lost to Follow-up|0|||
155396593|NCT00646906|560886842|FG000|Crossover Period 1|Withdrawal by Subject|1|||
155396594|NCT00646906|560886843|FG001|Crossover Period 1|Withdrawal by Subject|0|||
155396595|NCT00646906|560886844|FG002|Crossover Period 1|Withdrawal by Subject|0|||
155396596|NCT00646906|560886845|FG003|Crossover Period 1|Withdrawal by Subject|0|||
155396597|NCT00646906|560886846|FG004|Crossover Period 1|Withdrawal by Subject|0|||
155396598|NCT00646906|560886847|FG005|Crossover Period 1|Withdrawal by Subject|1|||
155396599|NCT00646906|560886848|FG006|Crossover Period 1|Withdrawal by Subject|0|||
155396600|NCT00646906|560886842|FG000|Crossover Period 2|Withdrawal by Subject|0|||
155396601|NCT00646906|560886843|FG001|Crossover Period 2|Withdrawal by Subject|1|||
155396602|NCT00646906|560886844|FG002|Crossover Period 2|Withdrawal by Subject|2|||
155396603|NCT00646906|560886845|FG003|Crossover Period 2|Withdrawal by Subject|1|||
155396604|NCT00646906|560886846|FG004|Crossover Period 2|Withdrawal by Subject|0|||
155396605|NCT00646906|560886847|FG005|Crossover Period 2|Withdrawal by Subject|0|||
155396606|NCT00646906|560886848|FG006|Crossover Period 2|Withdrawal by Subject|0|||
155396607|NCT00646906|560886842|FG000|Crossover Period 2|Physician Decision|0|||
155396608|NCT00646906|560886843|FG001|Crossover Period 2|Physician Decision|0|||
155396609|NCT00646906|560886844|FG002|Crossover Period 2|Physician Decision|0|||
155396610|NCT00646906|560886845|FG003|Crossover Period 2|Physician Decision|0|||
155396611|NCT00646906|560886846|FG004|Crossover Period 2|Physician Decision|0|||
154953031|NCT02942264|559254572|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
154953032|NCT02942264|559254573|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
154953033|NCT02942264|559254574|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
154953034|NCT02942264|559254575|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
154953035|NCT02942264|559254576|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
154953036|NCT02942264|559254577|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
154953037|NCT02942264|559254578|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
154953038|NCT02942264|559254579|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155057679|NCT02265510|559645787|FG005|Overall Study|Disease Progression|0|||
155396612|NCT00646906|560886847|FG005|Crossover Period 2|Physician Decision|0|||
155396613|NCT00646906|560886848|FG006|Crossover Period 2|Physician Decision|1|||
155396614|NCT01303965|560886849|FG000|Overall Study|Adverse Event|1|||
155396615|NCT01303965|560886850|FG001|Overall Study|Adverse Event|1|||
155396616|NCT01303965|560886849|FG000|Overall Study|Death|0|||
155396617|NCT01303965|560886850|FG001|Overall Study|Death|3|||
155396618|NCT01303965|560886849|FG000|Overall Study|Withdrawal by Subject|1|||
155396619|NCT01303965|560886850|FG001|Overall Study|Withdrawal by Subject|0|||
155396620|NCT01303965|560886849|FG000|Overall Study|Disease Progression|1|||
155396621|NCT01303965|560886850|FG001|Overall Study|Disease Progression|6|||
155396622|NCT02448225|560886854|FG000|Overall Study|Withdrawal by Subject|1|||
155396623|NCT02448225|560886854|FG000|Overall Study|Did not get FSPG scan|18|||
155396624|NCT02448225|560886854|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
155396625|NCT04060563|560886855|FG000|Overall Study|Lost to Follow-up|1|||
155396626|NCT04060563|560886856|FG001|Overall Study|Lost to Follow-up|1|||
155396627|NCT04060563|560886855|FG000|Overall Study|Physician Decision|0|||
155396628|NCT04060563|560886856|FG001|Overall Study|Physician Decision|1|||
155396629|NCT00962390|560886864|FG000|Overall Study|Adverse Event|0|||
155396630|NCT00962390|560886865|FG001|Overall Study|Adverse Event|0|||
155396631|NCT00962390|560886866|FG002|Overall Study|Adverse Event|3|||
155396632|NCT00962390|560886867|FG003|Overall Study|Adverse Event|1|||
155396633|NCT00962390|560886864|FG000|Overall Study|Lost to Follow-up|2|||
155396634|NCT00962390|560886865|FG001|Overall Study|Lost to Follow-up|2|||
155396635|NCT00962390|560886866|FG002|Overall Study|Lost to Follow-up|0|||
155396636|NCT00962390|560886867|FG003|Overall Study|Lost to Follow-up|0|||
155396637|NCT00962390|560886864|FG000|Overall Study|Protocol Violation|1|||
155396638|NCT00962390|560886865|FG001|Overall Study|Protocol Violation|0|||
155396639|NCT00962390|560886866|FG002|Overall Study|Protocol Violation|0|||
155396640|NCT00962390|560886867|FG003|Overall Study|Protocol Violation|0|||
155396641|NCT00962390|560886864|FG000|Overall Study|Withdrawal by Subject|1|||
155396642|NCT00962390|560886865|FG001|Overall Study|Withdrawal by Subject|1|||
155396643|NCT00962390|560886866|FG002|Overall Study|Withdrawal by Subject|1|||
155396644|NCT00962390|560886867|FG003|Overall Study|Withdrawal by Subject|0|||
155396645|NCT02613884|560886868|FG000|Overall Study|Death|1|||
155396646|NCT02613884|560886868|FG000|Overall Study|Lost to Follow-up|1|||
155396647|NCT00131469|560886874|FG000|Overall Study|Withdrawal by Subject|3|||
155396648|NCT00131469|560886875|FG001|Overall Study|Withdrawal by Subject|4|||
155396649|NCT00131469|560886874|FG000|Overall Study|Protocol Violation|3|||
155396650|NCT00131469|560886875|FG001|Overall Study|Protocol Violation|1|||
155396651|NCT00131469|560886874|FG000|Overall Study|Death|0|||
155396652|NCT00131469|560886875|FG001|Overall Study|Death|1|||
155396653|NCT00131469|560886874|FG000|Overall Study|Lost to Follow-up|0|||
155396654|NCT00131469|560886875|FG001|Overall Study|Lost to Follow-up|1|||
155396655|NCT00131469|560886874|FG000|Overall Study|scan not analyzable|3|||
155396656|NCT00131469|560886875|FG001|Overall Study|scan not analyzable|6|||
155396657|NCT01910116|560886877|FG000|Overall Study|Adverse Event|0|||
155396658|NCT01910116|560886878|FG001|Overall Study|Adverse Event|3|||
155396659|NCT01910116|560886877|FG000|Overall Study|Lack of Efficacy|3|||
155396660|NCT01910116|560886878|FG001|Overall Study|Lack of Efficacy|4|||
155396661|NCT01910116|560886877|FG000|Overall Study|Lost to Follow-up|1|||
155396662|NCT01910116|560886878|FG001|Overall Study|Lost to Follow-up|0|||
155396663|NCT01910116|560886877|FG000|Overall Study|Protocol Violation|1|||
155396664|NCT01910116|560886878|FG001|Overall Study|Protocol Violation|2|||
155396665|NCT01910116|560886877|FG000|Overall Study|Withdrawal by Subject|8|||
155396666|NCT01910116|560886878|FG001|Overall Study|Withdrawal by Subject|3|||
155396667|NCT01910116|560886877|FG000|Overall Study|uncertain allocation|1|||
155396668|NCT01910116|560886878|FG001|Overall Study|uncertain allocation|3|||
155396669|NCT01910116|560886877|FG000|Overall Study|incomplete data|0|||
155396670|NCT01910116|560886878|FG001|Overall Study|incomplete data|1|||
155396671|NCT00911625|560886882|FG000|Overall Study|Lost to Follow-up|7|||
155396672|NCT00911625|560886883|FG001|Overall Study|Lost to Follow-up|0|||
155396673|NCT00590044|560886884|FG000|Overall Study|Withdrawal by Subject|2|||
155396674|NCT00590044|560886885|FG001|Overall Study|Withdrawal by Subject|2|||
155396675|NCT00590044|560886884|FG000|Overall Study|wrong insulin arm assigned|1|||
155396676|NCT00590044|560886885|FG001|Overall Study|wrong insulin arm assigned|0|||
155396677|NCT00590044|560886884|FG000|Overall Study|Protocol Violation|1|||
155396678|NCT00590044|560886885|FG001|Overall Study|Protocol Violation|0|||
155396679|NCT00888381|560886886|FG000|Overall Study|Lost to Follow-up|0|||
155396680|NCT00888381|560886887|FG001|Overall Study|Lost to Follow-up|1|||
155396681|NCT02729740|560886888|FG000|Overall Study|Early Termination|130|||
155396682|NCT02729740|560886888|FG000|Overall Study|Other|1|||
155396683|NCT00757003|560886889|FG000|Overall Study|Death|33|||
155396684|NCT00757003|560886889|FG000|Overall Study|Lost to Follow-up|9|||
155396685|NCT00757003|560886889|FG000|Overall Study|Withdrawal by Subject|4|||
155396686|NCT00757003|560886889|FG000|Overall Study|Surgically explanted|2|||
155396687|NCT00757003|560886889|FG000|Overall Study|Not implanted|1|||
155396688|NCT03044249|560886892|FG000|Overall Study|Adverse Event|4|||
155396689|NCT03044249|560886893|FG001|Overall Study|Adverse Event|9|||
155396690|NCT03044249|560886892|FG000|Overall Study|Lost to Follow-up|1|||
155396691|NCT03044249|560886893|FG001|Overall Study|Lost to Follow-up|0|||
155396692|NCT03044249|560886892|FG000|Overall Study|Non-compliance with Study Drug|1|||
155396693|NCT03044249|560886893|FG001|Overall Study|Non-compliance with Study Drug|0|||
155396694|NCT03044249|560886892|FG000|Overall Study|Study Terminated by Sponsor|2|||
155396695|NCT03044249|560886893|FG001|Overall Study|Study Terminated by Sponsor|0|||
155396696|NCT03044249|560886892|FG000|Overall Study|Withdrawal by Subject|2|||
155396697|NCT03044249|560886893|FG001|Overall Study|Withdrawal by Subject|5|||
155396698|NCT03785678|560886906|FG000|Overall Study|Death|44|||
155396699|NCT03785678|560886907|FG001|Overall Study|Death|42|||
155396700|NCT03785678|560886906|FG000|Overall Study|Lost to Follow-up|4|||
155396701|NCT03785678|560886907|FG001|Overall Study|Lost to Follow-up|2|||
155396702|NCT03785678|560886906|FG000|Overall Study|Physician Decision|0|||
155396703|NCT03785678|560886907|FG001|Overall Study|Physician Decision|2|||
155396704|NCT03785678|560886906|FG000|Overall Study|Withdrawal by Subject|5|||
155396705|NCT03785678|560886907|FG001|Overall Study|Withdrawal by Subject|3|||
155396706|NCT02374021|560886908|FG000|Overall Study|Adverse Event|1|||
155396707|NCT02374021|560886909|FG001|Overall Study|Adverse Event|0|||
155396708|NCT02374021|560886908|FG000|Overall Study|Lost to Follow-up|3|||
155396709|NCT02374021|560886909|FG001|Overall Study|Lost to Follow-up|2|||
155396710|NCT02374021|560886908|FG000|Overall Study|Physician Decision|0|||
155396711|NCT02374021|560886909|FG001|Overall Study|Physician Decision|3|||
155396712|NCT02374021|560886908|FG000|Overall Study|Withdrawal by Subject|6|||
155396713|NCT02374021|560886909|FG001|Overall Study|Withdrawal by Subject|5|||
155396714|NCT02374021|560886908|FG000|Overall Study|Poor Adherence|0|||
155396715|NCT02374021|560886909|FG001|Overall Study|Poor Adherence|1|||
155396716|NCT02374021|560886908|FG000|Overall Study|Scan protocol not followed|0|||
155396717|NCT02374021|560886909|FG001|Overall Study|Scan protocol not followed|1|||
155396718|NCT02374021|560886908|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
155396719|NCT02374021|560886909|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
155396720|NCT03007979|560886910|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
155396721|NCT01624259|560886911|FG000|Overall Study|Adverse Event|18|||
155396722|NCT01624259|560886912|FG001|Overall Study|Adverse Event|18|||
155396723|NCT01624259|560886911|FG000|Overall Study|Protocol Violation|1|||
155396724|NCT01624259|560886912|FG001|Overall Study|Protocol Violation|2|||
155396725|NCT01624259|560886911|FG000|Overall Study|Withdrawal by Subject|5|||
155396726|NCT01624259|560886912|FG001|Overall Study|Withdrawal by Subject|7|||
155396727|NCT01624259|560886911|FG000|Overall Study|Physician Decision|1|||
155396728|NCT01624259|560886912|FG001|Overall Study|Physician Decision|1|||
155396729|NCT01624259|560886911|FG000|Overall Study|Lost to Follow-up|2|||
155396730|NCT01624259|560886912|FG001|Overall Study|Lost to Follow-up|3|||
155396731|NCT01624259|560886911|FG000|Overall Study|Abnormal laboratory measure|3|||
155396732|NCT01624259|560886912|FG001|Overall Study|Abnormal laboratory measure|0|||
155396733|NCT01298518|560886913|FG000|Overall Study|Withdrawal by Subject|0|||
155396734|NCT01298518|560886914|FG001|Overall Study|Withdrawal by Subject|0|||
155396735|NCT01298518|560886915|FG002|Overall Study|Withdrawal by Subject|1|||
155396736|NCT02273726|560886916|FG000|Overall Study|Death|70|||
155396737|NCT02273726|560886917|FG001|Overall Study|Death|62|||
155396738|NCT02273726|560886916|FG000|Overall Study|Withdrawal by Subject|41|||
155396739|NCT02273726|560886917|FG001|Overall Study|Withdrawal by Subject|29|||
155396740|NCT02273726|560886916|FG000|Overall Study|Kidney transplant|31|||
155396741|NCT02273726|560886917|FG001|Overall Study|Kidney transplant|39|||
155396742|NCT02273726|560886916|FG000|Overall Study|Physician Decision|30|||
155396743|NCT02273726|560886917|FG001|Overall Study|Physician Decision|15|||
155396744|NCT02273726|560886916|FG000|Overall Study|Adverse Event|27|||
155396745|NCT02273726|560886917|FG001|Overall Study|Adverse Event|9|||
155396746|NCT02273726|560886916|FG000|Overall Study|Lost to Follow-up|6|||
155396747|NCT02273726|560886917|FG001|Overall Study|Lost to Follow-up|3|||
155396748|NCT02273726|560886916|FG000|Overall Study|Lack of Efficacy|6|||
155396749|NCT02273726|560886917|FG001|Overall Study|Lack of Efficacy|1|||
155396750|NCT02273726|560886916|FG000|Overall Study|Protocol Violation|4|||
155396751|NCT02273726|560886917|FG001|Overall Study|Protocol Violation|0|||
155396752|NCT02273726|560886916|FG000|Overall Study|Other than specified|28|||
155396753|NCT02273726|560886917|FG001|Overall Study|Other than specified|30|||
155396754|NCT01979835|560886918|FG000|Primary Outcome SA Measurment|failed insertion|18|||
155396755|NCT01979835|560886918|FG000|Follow-up|Lost to Follow-up|32|||
155396756|NCT01479829|560886919|FG000|Overall Study|Withdrawal by Subject|8|||
155396757|NCT01479829|560886920|FG001|Overall Study|Withdrawal by Subject|10|||
155396758|NCT01444456|560886925|FG000|Overall Study|Withdrawal by Subject|21|||
155396759|NCT01444456|560886925|FG000|Overall Study|Physician Decision|9|||
155396760|NCT01444456|560886925|FG000|Overall Study|Lost to Follow-up|37|||
155396761|NCT01444456|560886925|FG000|Overall Study|Death|73|||
155396762|NCT01444456|560886925|FG000|Overall Study|Ineligibility determined|23|||
155396763|NCT01444456|560886925|FG000|Overall Study|Other|18|||
155396764|NCT01444456|560886925|FG000|Overall Study|Not treated|104|||
155396765|NCT02142738|560888448|FG000|Overall Study|Adverse Event|13|||
155396766|NCT02142738|560888449|FG001|Overall Study|Adverse Event|9|||
155396767|NCT02142738|560888448|FG000|Overall Study|Death|92|||
155396768|NCT02142738|560888449|FG001|Overall Study|Death|112|||
155396769|NCT02142738|560888448|FG000|Overall Study|Lost to Follow-up|0|||
155396770|NCT02142738|560888449|FG001|Overall Study|Lost to Follow-up|3|||
155396771|NCT02142738|560888448|FG000|Overall Study|Withdrawal by Subject|6|||
155396772|NCT02142738|560888449|FG001|Overall Study|Withdrawal by Subject|7|||
155396773|NCT02142738|560888448|FG000|Overall Study|Follow up ended by sponsor|43|||
155396774|NCT02142738|560888449|FG001|Overall Study|Follow up ended by sponsor|20|||
155396775|NCT01168973|560888451|FG000|Overall Study|Progressive Disease|341|||
155396776|NCT01168973|560888452|FG001|Overall Study|Progressive Disease|429|||
155396777|NCT01168973|560888451|FG000|Overall Study|Adverse Event|94|||
155396778|NCT01168973|560888452|FG001|Overall Study|Adverse Event|55|||
155396779|NCT01168973|560888451|FG000|Overall Study|Withdrawal by Subject|90|||
155396780|NCT01168973|560888452|FG001|Overall Study|Withdrawal by Subject|53|||
155396781|NCT01168973|560888451|FG000|Overall Study|Death|42|||
155396782|NCT01168973|560888452|FG001|Overall Study|Death|45|||
155396783|NCT01168973|560888451|FG000|Overall Study|Physician Decision|37|||
155396784|NCT01168973|560888452|FG001|Overall Study|Physician Decision|19|||
155396785|NCT01168973|560888451|FG000|Overall Study|Sponsor Decision|2|||
155396786|NCT01168973|560888452|FG001|Overall Study|Sponsor Decision|1|||
155396787|NCT01168973|560888451|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
155396788|NCT01168973|560888452|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
155396789|NCT00930722|560888453|FG000|Overall Study|Lost to Follow-up|16|||
155396790|NCT00930722|560888453|FG000|Overall Study|No longer willing to participate|9|||
155396791|NCT00930722|560888453|FG000|Overall Study|Study terminated by sponsor|2|||
155396792|NCT00388505|560888456|FG000|Overall Study|Adverse Event or Death|43|||
155396793|NCT00388505|560888457|FG001|Overall Study|Adverse Event or Death|17|||
155396794|NCT00388505|560888456|FG000|Overall Study|Withdrawal by Subject|24|||
155396795|NCT00388505|560888457|FG001|Overall Study|Withdrawal by Subject|9|||
155396796|NCT00388505|560888456|FG000|Overall Study|Lost to Follow-up|5|||
155396797|NCT00388505|560888457|FG001|Overall Study|Lost to Follow-up|3|||
155396798|NCT00388505|560888456|FG000|Overall Study|Inappropriate Enrollment|0|||
155396799|NCT00388505|560888457|FG001|Overall Study|Inappropriate Enrollment|1|||
155396800|NCT00388505|560888456|FG000|Overall Study|Administrative Reason|1|||
155396801|NCT00388505|560888457|FG001|Overall Study|Administrative Reason|0|||
155396802|NCT00388505|560888456|FG000|Overall Study|Protocol Violation|6|||
155396803|NCT00388505|560888457|FG001|Overall Study|Protocol Violation|5|||
155396804|NCT00388505|560888456|FG000|Overall Study|Unable to classify|4|||
155396805|NCT00388505|560888457|FG001|Overall Study|Unable to classify|3|||
155396806|NCT02285920|560888461|FG000|Overall Study|Kidney transplantation|2|||
155396807|NCT02285920|560888462|FG001|Overall Study|Kidney transplantation|2|||
155396808|NCT02285920|560888463|FG002|Overall Study|Kidney transplantation|2|||
155396809|NCT02285920|560888464|FG003|Overall Study|Kidney transplantation|0|||
155396810|NCT02285920|560888461|FG000|Overall Study|Change to peritoneal dialysis|0|||
155396811|NCT02285920|560888462|FG001|Overall Study|Change to peritoneal dialysis|0|||
155396812|NCT02285920|560888463|FG002|Overall Study|Change to peritoneal dialysis|1|||
155396813|NCT02285920|560888464|FG003|Overall Study|Change to peritoneal dialysis|0|||
155396814|NCT02285920|560888461|FG000|Overall Study|Transfer to non-participating unit|0|||
155396815|NCT02285920|560888462|FG001|Overall Study|Transfer to non-participating unit|1|||
155396816|NCT02285920|560888463|FG002|Overall Study|Transfer to non-participating unit|0|||
155396817|NCT02285920|560888464|FG003|Overall Study|Transfer to non-participating unit|0|||
155396818|NCT02285920|560888461|FG000|Overall Study|Dialysis discontinuation|0|||
155396819|NCT02285920|560888462|FG001|Overall Study|Dialysis discontinuation|1|||
155396820|NCT02285920|560888463|FG002|Overall Study|Dialysis discontinuation|0|||
155396821|NCT02285920|560888464|FG003|Overall Study|Dialysis discontinuation|0|||
155396822|NCT02285920|560888461|FG000|Overall Study|Death|2|||
155396823|NCT02285920|560888462|FG001|Overall Study|Death|0|||
155396824|NCT02285920|560888463|FG002|Overall Study|Death|2|||
155396825|NCT02285920|560888464|FG003|Overall Study|Death|1|||
155396826|NCT01383096|560888469|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
155396827|NCT01383096|560888470|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
155396828|NCT01383096|560888471|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
155396829|NCT01383096|560888469|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
155396830|NCT01383096|560888470|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
155396831|NCT01383096|560888471|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
155396832|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Elevated AST|0|||
155396833|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Elevated AST|1|||
155396834|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Elevated AST|0|||
155396835|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
155396836|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
155396837|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
155396838|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Adverse Event|1|||
155396839|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Adverse Event|0|||
155396840|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Adverse Event|0|||
155396841|NCT01383096|560888469|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
155396842|NCT01383096|560888470|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
155396843|NCT01383096|560888471|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
155396844|NCT01383096|560888469|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
155396845|NCT01383096|560888470|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396846|NCT01383096|560888471|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396847|NCT01383096|560888469|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
155396848|NCT01383096|560888470|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
155396849|NCT01383096|560888471|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
155396850|NCT01383096|560888469|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
155396851|NCT01383096|560888470|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396852|NCT01383096|560888471|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
155396853|NCT01383096|560888469|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
155396854|NCT01383096|560888470|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
155396855|NCT01383096|560888471|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
155396856|NCT01383096|560888469|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
155396857|NCT01383096|560888470|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
155396858|NCT01383096|560888471|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
155396859|NCT00616434|560888476|FG000|Overall Study|Adverse Event|5|||
155396860|NCT00616434|560888477|FG001|Overall Study|Adverse Event|2|||
155396861|NCT00616434|560888476|FG000|Overall Study|Physician Decision|0|||
155396862|NCT00616434|560888477|FG001|Overall Study|Physician Decision|4|||
155396863|NCT00616434|560888476|FG000|Overall Study|Withdrawal by Subject|1|||
155396864|NCT00616434|560888477|FG001|Overall Study|Withdrawal by Subject|1|||
155396865|NCT00616434|560888476|FG000|Overall Study|Protocol deviation|0|||
155396866|NCT00616434|560888477|FG001|Overall Study|Protocol deviation|1|||
155396867|NCT00467779|560888478|FG000|Stage 1|Adverse Event|1|||
155396868|NCT00467779|560888479|FG001|Stage 1|Adverse Event|0|||
155396869|NCT00467779|560888480|FG002|Stage 1|Adverse Event|0|||
155396870|NCT00467779|560888481|FG003|Stage 1|Adverse Event|0|||
155396871|NCT00467779|560888482|FG004|Stage 1|Adverse Event|0|||
155396872|NCT00467779|560888483|FG005|Stage 1|Adverse Event|1|||
155396873|NCT00467779|560888484|FG006|Stage 1|Adverse Event|2|||
155396874|NCT00467779|560888485|FG007|Stage 1|Adverse Event|1|||
155396875|NCT00467779|560888486|FG008|Stage 1|Adverse Event|0|||
155396876|NCT00467779|560888487|FG009|Stage 1|Adverse Event|0|||
155396877|NCT00467779|560888488|FG010|Stage 1|Adverse Event|0|||
155396878|NCT00467779|560888489|FG011|Stage 1|Adverse Event|0|||
155396879|NCT00467779|560888490|FG012|Stage 1|Adverse Event|0|||
155396880|NCT00467779|560888491|FG013|Stage 1|Adverse Event|0|||
155396881|NCT00467779|560888492|FG014|Stage 1|Adverse Event|0|||
155396882|NCT00467779|560888478|FG000|Stage 1|Disease Progression|2|||
155396883|NCT00467779|560888479|FG001|Stage 1|Disease Progression|2|||
155396884|NCT00467779|560888480|FG002|Stage 1|Disease Progression|2|||
155396885|NCT00467779|560888481|FG003|Stage 1|Disease Progression|3|||
155396886|NCT00467779|560888482|FG004|Stage 1|Disease Progression|2|||
155396887|NCT00467779|560888483|FG005|Stage 1|Disease Progression|2|||
155396888|NCT00467779|560888484|FG006|Stage 1|Disease Progression|4|||
155396889|NCT00467779|560888485|FG007|Stage 1|Disease Progression|5|||
155396890|NCT00467779|560888486|FG008|Stage 1|Disease Progression|0|||
155396891|NCT00467779|560888487|FG009|Stage 1|Disease Progression|0|||
155396892|NCT00467779|560888488|FG010|Stage 1|Disease Progression|0|||
155396893|NCT00467779|560888489|FG011|Stage 1|Disease Progression|0|||
155396894|NCT00467779|560888490|FG012|Stage 1|Disease Progression|0|||
155396895|NCT00467779|560888491|FG013|Stage 1|Disease Progression|0|||
155396896|NCT00467779|560888492|FG014|Stage 1|Disease Progression|0|||
155396897|NCT00467779|560888478|FG000|Stage 1|Unspecified Reason|1|||
155396898|NCT00467779|560888479|FG001|Stage 1|Unspecified Reason|0|||
155396899|NCT00467779|560888480|FG002|Stage 1|Unspecified Reason|1|||
155396900|NCT00467779|560888481|FG003|Stage 1|Unspecified Reason|0|||
155396901|NCT00467779|560888482|FG004|Stage 1|Unspecified Reason|1|||
155396902|NCT00467779|560888483|FG005|Stage 1|Unspecified Reason|2|||
155396903|NCT00467779|560888484|FG006|Stage 1|Unspecified Reason|0|||
155396904|NCT00467779|560888485|FG007|Stage 1|Unspecified Reason|0|||
155396905|NCT00467779|560888486|FG008|Stage 1|Unspecified Reason|0|||
155396906|NCT00467779|560888487|FG009|Stage 1|Unspecified Reason|0|||
155396907|NCT00467779|560888488|FG010|Stage 1|Unspecified Reason|0|||
155396908|NCT00467779|560888489|FG011|Stage 1|Unspecified Reason|0|||
155396909|NCT00467779|560888490|FG012|Stage 1|Unspecified Reason|0|||
155396910|NCT00467779|560888491|FG013|Stage 1|Unspecified Reason|0|||
155396911|NCT00467779|560888492|FG014|Stage 1|Unspecified Reason|0|||
155396912|NCT00467779|560888478|FG000|Stage 1|Physician Decision|0|||
155396913|NCT00467779|560888479|FG001|Stage 1|Physician Decision|1|||
155153175|NCT01667900|559998591|FG006|Part B|Death|0|||
155396914|NCT00467779|560888480|FG002|Stage 1|Physician Decision|0|||
155153176|NCT01667900|559998592|FG007|Part B|Death|0|||
155153177|NCT01667900|559998593|FG008|Part B|Death|0|||
155153178|NCT01667900|559998594|FG009|Part B|Death|0|||
155153179|NCT01667900|559998595|FG010|Part B|Death|0|||
155153180|NCT01667900|559998596|FG011|Part B|Death|0|||
155153181|NCT01667900|559998597|FG012|Part B|Death|0|||
155153182|NCT01667900|559998598|FG013|Part B|Death|0|||
155153183|NCT01667900|559998599|FG014|Part B|Death|0|||
155153184|NCT01667900|559998600|FG015|Part B|Death|0|||
155153185|NCT01667900|559998601|FG016|Part B|Death|1|||
155153186|NCT01667900|559998602|FG017|Part B|Death|0|||
155396915|NCT00467779|560888481|FG003|Stage 1|Physician Decision|0|||
155396916|NCT00467779|560888482|FG004|Stage 1|Physician Decision|0|||
155396917|NCT00467779|560888483|FG005|Stage 1|Physician Decision|0|||
155396918|NCT00467779|560888484|FG006|Stage 1|Physician Decision|0|||
155153187|NCT01667900|559998603|FG018|Part B|Death|0|||
155153188|NCT01667900|559998604|FG019|Part B|Death|0|||
155153189|NCT00468169|559998607|FG000|Overall Study|Withdrawal by Subject|1|||
155153190|NCT00468169|559998608|FG001|Overall Study|Withdrawal by Subject|0|||
155153191|NCT00537394|559998609|FG000|First Year of Follow-up|Death|7|||
155153192|NCT00537394|559998610|FG001|First Year of Follow-up|Death|0|||
155153193|NCT00537394|559998611|FG002|First Year of Follow-up|Death|0|||
155153194|NCT00537394|559998609|FG000|First Year of Follow-up|Severe debilitation|1|||
155153195|NCT00537394|559998610|FG001|First Year of Follow-up|Severe debilitation|0|||
155153196|NCT00537394|559998611|FG002|First Year of Follow-up|Severe debilitation|1|||
155153197|NCT00537394|559998609|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
155153198|NCT00537394|559998610|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
155153199|NCT00537394|559998611|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
155153200|NCT00537394|559998609|FG000|First Year of Follow-up|Lost to Follow-up|1|||
155153201|NCT00537394|559998610|FG001|First Year of Follow-up|Lost to Follow-up|5|||
155153202|NCT00537394|559998611|FG002|First Year of Follow-up|Lost to Follow-up|1|||
155153203|NCT00537394|559998609|FG000|2nd Year of Follow-up|Death|4|||
155153204|NCT00537394|559998610|FG001|2nd Year of Follow-up|Death|1|||
155153205|NCT00537394|559998611|FG002|2nd Year of Follow-up|Death|2|||
155153206|NCT00537394|559998609|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
155396919|NCT00467779|560888485|FG007|Stage 1|Physician Decision|0|||
155396920|NCT00467779|560888486|FG008|Stage 1|Physician Decision|0|||
155396921|NCT00467779|560888487|FG009|Stage 1|Physician Decision|0|||
155396922|NCT00467779|560888488|FG010|Stage 1|Physician Decision|0|||
155396923|NCT00467779|560888489|FG011|Stage 1|Physician Decision|0|||
155396924|NCT00467779|560888490|FG012|Stage 1|Physician Decision|0|||
155396925|NCT00467779|560888491|FG013|Stage 1|Physician Decision|0|||
155396926|NCT00467779|560888492|FG014|Stage 1|Physician Decision|0|||
155396927|NCT00467779|560888478|FG000|Stage 1|Withdrawal by Subject|0|||
155396928|NCT00467779|560888479|FG001|Stage 1|Withdrawal by Subject|0|||
155396929|NCT00467779|560888480|FG002|Stage 1|Withdrawal by Subject|0|||
155396930|NCT00467779|560888481|FG003|Stage 1|Withdrawal by Subject|0|||
155396931|NCT00467779|560888482|FG004|Stage 1|Withdrawal by Subject|0|||
155396932|NCT00467779|560888483|FG005|Stage 1|Withdrawal by Subject|0|||
155396933|NCT00467779|560888484|FG006|Stage 1|Withdrawal by Subject|1|||
155396934|NCT00467779|560888485|FG007|Stage 1|Withdrawal by Subject|1|||
155396935|NCT00467779|560888486|FG008|Stage 1|Withdrawal by Subject|0|||
155396936|NCT00467779|560888487|FG009|Stage 1|Withdrawal by Subject|0|||
155396937|NCT00467779|560888488|FG010|Stage 1|Withdrawal by Subject|0|||
155396938|NCT00467779|560888489|FG011|Stage 1|Withdrawal by Subject|0|||
155396939|NCT00467779|560888490|FG012|Stage 1|Withdrawal by Subject|0|||
155396940|NCT00467779|560888491|FG013|Stage 1|Withdrawal by Subject|0|||
155396941|NCT00467779|560888492|FG014|Stage 1|Withdrawal by Subject|0|||
155396942|NCT00467779|560888478|FG000|Stage 1A|Adverse Event|0|||
155396943|NCT00467779|560888479|FG001|Stage 1A|Adverse Event|0|||
155396944|NCT00467779|560888480|FG002|Stage 1A|Adverse Event|0|||
155396945|NCT00467779|560888481|FG003|Stage 1A|Adverse Event|0|||
155396946|NCT00467779|560888482|FG004|Stage 1A|Adverse Event|0|||
155396947|NCT00467779|560888483|FG005|Stage 1A|Adverse Event|0|||
155396948|NCT00467779|560888484|FG006|Stage 1A|Adverse Event|0|||
155153207|NCT00537394|559998610|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
155153208|NCT00537394|559998611|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
155153209|NCT00537394|559998609|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
155153210|NCT00537394|559998610|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
155153211|NCT00537394|559998611|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
155153212|NCT00537394|559998609|FG000|2nd Year of Follow-up|Clinic site closure|1|||
155153213|NCT00537394|559998610|FG001|2nd Year of Follow-up|Clinic site closure|0|||
155153214|NCT00537394|559998611|FG002|2nd Year of Follow-up|Clinic site closure|0|||
155153215|NCT02183675|559998612|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
155153216|NCT02183675|559998613|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
155153217|NCT02183675|559998614|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
155396949|NCT00467779|560888485|FG007|Stage 1A|Adverse Event|0|||
155396950|NCT00467779|560888486|FG008|Stage 1A|Adverse Event|0|||
155396951|NCT00467779|560888487|FG009|Stage 1A|Adverse Event|0|||
155153218|NCT02183675|559998615|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
155153219|NCT02183675|559998616|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
155153220|NCT02183675|559998617|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
155153221|NCT01521117|559998618|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
155396952|NCT00467779|560888488|FG010|Stage 1A|Adverse Event|0|||
155396953|NCT00467779|560888489|FG011|Stage 1A|Adverse Event|0|||
155396954|NCT00467779|560888490|FG012|Stage 1A|Adverse Event|1|||
155396955|NCT00467779|560888491|FG013|Stage 1A|Adverse Event|0|||
155396956|NCT00467779|560888492|FG014|Stage 1A|Adverse Event|0|||
155396957|NCT00467779|560888478|FG000|Stage 1A|Death|0|||
155396958|NCT00467779|560888479|FG001|Stage 1A|Death|0|||
155396959|NCT00467779|560888480|FG002|Stage 1A|Death|0|||
155396960|NCT00467779|560888481|FG003|Stage 1A|Death|0|||
155396961|NCT00467779|560888482|FG004|Stage 1A|Death|0|||
155396962|NCT00467779|560888483|FG005|Stage 1A|Death|0|||
155396963|NCT00467779|560888484|FG006|Stage 1A|Death|0|||
155396964|NCT00467779|560888485|FG007|Stage 1A|Death|0|||
155153222|NCT01521117|559998619|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155153223|NCT01521117|559998618|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
155153224|NCT01521117|559998619|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
155153225|NCT01521117|559998618|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155153226|NCT01521117|559998619|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
155153227|NCT01056822|559998620|FG000|Overall Study|Adverse Event|0|||
155153228|NCT01056822|559998621|FG001|Overall Study|Adverse Event|1|||
155153229|NCT01056822|559998620|FG000|Overall Study|Protocol Violation|6|||
155153230|NCT01056822|559998621|FG001|Overall Study|Protocol Violation|5|||
155153231|NCT01056822|559998620|FG000|Overall Study|Withdrawal by Subject|1|||
155153232|NCT01056822|559998621|FG001|Overall Study|Withdrawal by Subject|1|||
155153233|NCT01056822|559998620|FG000|Overall Study|Lost to Follow-up|1|||
155153234|NCT01056822|559998621|FG001|Overall Study|Lost to Follow-up|0|||
155153235|NCT00784563|559998622|FG000|Years 1 & 2|Withdrawal by Subject|3|||
155153236|NCT00784563|559998623|FG001|Years 1 & 2|Withdrawal by Subject|2|||
155153237|NCT00784563|559998624|FG002|Years 1 & 2|Withdrawal by Subject|0|||
155153238|NCT00784563|559998622|FG000|Years 1 & 2|Adverse Event|0|||
155153239|NCT00784563|559998623|FG001|Years 1 & 2|Adverse Event|3|||
155153240|NCT00784563|559998624|FG002|Years 1 & 2|Adverse Event|0|||
155153241|NCT00784563|559998622|FG000|Year 3|Withdrawal by Subject|0|||
155153242|NCT00784563|559998623|FG001|Year 3|Withdrawal by Subject|0|||
155153243|NCT00784563|559998624|FG002|Year 3|Withdrawal by Subject|2|||
155153244|NCT00784563|559998622|FG000|Year 3|Adverse Event|0|||
155153245|NCT00784563|559998623|FG001|Year 3|Adverse Event|0|||
155153246|NCT00784563|559998624|FG002|Year 3|Adverse Event|1|||
155153247|NCT00321789|559998625|FG000|Overall Study|Lost to Follow-up|4|||
155153248|NCT00321789|559998626|FG001|Overall Study|Lost to Follow-up|7|||
155153249|NCT00321789|559998625|FG000|Overall Study|Withdrawal by Subject|6|||
155153250|NCT00321789|559998626|FG001|Overall Study|Withdrawal by Subject|6|||
155153251|NCT00321789|559998625|FG000|Overall Study|Protocol Violation|5|||
155153252|NCT00321789|559998626|FG001|Overall Study|Protocol Violation|3|||
155153253|NCT01576341|559998627|FG000|Overall Study|Withdrawal by Subject|24|||
155153254|NCT01576341|559998627|FG000|Overall Study|Adverse Event|10|||
155153255|NCT01576341|559998627|FG000|Overall Study|Death|21|||
155153256|NCT01576341|559998627|FG000|Overall Study|Physician Decision|2|||
155153257|NCT01576341|559998627|FG000|Overall Study|Lost to Follow-up|2|||
155153258|NCT01576341|559998627|FG000|Overall Study|Kidney transplantation|10|||
155153259|NCT01576341|559998627|FG000|Overall Study|Protocol Violation|12|||
155153260|NCT01576341|559998627|FG000|Overall Study|Other|12|||
155153261|NCT00617734|559998628|FG000|Overall Study|Withdrew Consent|2|||
155153262|NCT00617734|559998629|FG001|Overall Study|Withdrew Consent|0|||
155153263|NCT00617734|559998628|FG000|Overall Study|Adverse Event|4|||
155153264|NCT00617734|559998629|FG001|Overall Study|Adverse Event|1|||
155153265|NCT00617734|559998628|FG000|Overall Study|Protocol Violation|1|||
155153266|NCT00617734|559998629|FG001|Overall Study|Protocol Violation|0|||
155153267|NCT00617734|559998628|FG000|Overall Study|Found Ineligible After Randomization|1|||
155153268|NCT00617734|559998629|FG001|Overall Study|Found Ineligible After Randomization|4|||
155153269|NCT00617734|559998628|FG000|Overall Study|Lost to Follow-up|0|||
155153270|NCT00617734|559998629|FG001|Overall Study|Lost to Follow-up|1|||
155153271|NCT00556075|559998630|FG000|Overall Study|Lost to Follow-up|3|||
155153272|NCT00556075|559998631|FG001|Overall Study|Lost to Follow-up|0|||
155153273|NCT00556075|559998632|FG002|Overall Study|Lost to Follow-up|3|||
155153274|NCT00556075|559998630|FG000|Overall Study|Withdrawal by Subject|3|||
155153275|NCT00556075|559998631|FG001|Overall Study|Withdrawal by Subject|3|||
155153276|NCT00556075|559998632|FG002|Overall Study|Withdrawal by Subject|0|||
155396965|NCT00467779|560888486|FG008|Stage 1A|Death|0|||
155153277|NCT00556075|559998630|FG000|Overall Study|Protocol Violation|1|||
155153278|NCT00556075|559998631|FG001|Overall Study|Protocol Violation|1|||
155153279|NCT00556075|559998632|FG002|Overall Study|Protocol Violation|3|||
155153280|NCT00556075|559998630|FG000|Overall Study|Not eligible|1|||
155153281|NCT00556075|559998631|FG001|Overall Study|Not eligible|1|||
155153282|NCT00556075|559998632|FG002|Overall Study|Not eligible|2|||
155153283|NCT00556075|559998630|FG000|Overall Study|Adverse Event|1|||
155153284|NCT00556075|559998631|FG001|Overall Study|Adverse Event|2|||
155153285|NCT00556075|559998632|FG002|Overall Study|Adverse Event|0|||
155153286|NCT00556075|559998630|FG000|Overall Study|Personal issues|4|||
155153287|NCT00556075|559998631|FG001|Overall Study|Personal issues|1|||
155153288|NCT00556075|559998632|FG002|Overall Study|Personal issues|0|||
155153289|NCT00556075|559998630|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
155153290|NCT00556075|559998631|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
155153291|NCT00556075|559998632|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
155153292|NCT02485691|559998633|FG000|Overall Study|Adverse Event|25|||
155153293|NCT02485691|559998634|FG001|Overall Study|Adverse Event|11|||
155153294|NCT02485691|559998633|FG000|Overall Study|Poor compliance to protocol|0|||
155153295|NCT02485691|559998634|FG001|Overall Study|Poor compliance to protocol|1|||
154953039|NCT02942264|559254580|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
155153296|NCT02485691|559998633|FG000|Overall Study|Disease progression|57|||
155153297|NCT02485691|559998634|FG001|Overall Study|Disease progression|92|||
155153298|NCT02485691|559998633|FG000|Overall Study|Investigator's decision|23|||
155396966|NCT00467779|560888487|FG009|Stage 1A|Death|0|||
155396967|NCT00467779|560888488|FG010|Stage 1A|Death|0|||
155396968|NCT00467779|560888489|FG011|Stage 1A|Death|1|||
155396969|NCT00467779|560888490|FG012|Stage 1A|Death|1|||
155396970|NCT00467779|560888491|FG013|Stage 1A|Death|0|||
155396971|NCT00467779|560888492|FG014|Stage 1A|Death|0|||
155396972|NCT00467779|560888478|FG000|Stage 1A|Disease Progression|0|||
155396973|NCT00467779|560888479|FG001|Stage 1A|Disease Progression|0|||
155396974|NCT00467779|560888480|FG002|Stage 1A|Disease Progression|0|||
155396975|NCT00467779|560888481|FG003|Stage 1A|Disease Progression|0|||
155396976|NCT00467779|560888482|FG004|Stage 1A|Disease Progression|0|||
155396977|NCT00467779|560888483|FG005|Stage 1A|Disease Progression|0|||
155396978|NCT00467779|560888484|FG006|Stage 1A|Disease Progression|0|||
155396979|NCT00467779|560888485|FG007|Stage 1A|Disease Progression|0|||
155396980|NCT00467779|560888486|FG008|Stage 1A|Disease Progression|0|||
155396981|NCT00467779|560888487|FG009|Stage 1A|Disease Progression|2|||
155396982|NCT00467779|560888488|FG010|Stage 1A|Disease Progression|2|||
155396983|NCT00467779|560888489|FG011|Stage 1A|Disease Progression|5|||
155396984|NCT00467779|560888490|FG012|Stage 1A|Disease Progression|2|||
155396985|NCT00467779|560888491|FG013|Stage 1A|Disease Progression|0|||
155396986|NCT00467779|560888492|FG014|Stage 1A|Disease Progression|0|||
155396987|NCT00467779|560888478|FG000|Stage 1A|Physician Decision|0|||
155396988|NCT00467779|560888479|FG001|Stage 1A|Physician Decision|0|||
155396989|NCT00467779|560888480|FG002|Stage 1A|Physician Decision|0|||
155396990|NCT00467779|560888481|FG003|Stage 1A|Physician Decision|0|||
155283989|NCT01515319|560470910|FG006|Overall Study|Withdrawal by Subject|1|||
155396991|NCT00467779|560888482|FG004|Stage 1A|Physician Decision|0|||
155396992|NCT00467779|560888483|FG005|Stage 1A|Physician Decision|0|||
155396993|NCT00467779|560888484|FG006|Stage 1A|Physician Decision|0|||
155396994|NCT00467779|560888485|FG007|Stage 1A|Physician Decision|0|||
155396995|NCT00467779|560888486|FG008|Stage 1A|Physician Decision|0|||
155396996|NCT00467779|560888487|FG009|Stage 1A|Physician Decision|1|||
155396997|NCT00467779|560888488|FG010|Stage 1A|Physician Decision|0|||
155396998|NCT00467779|560888489|FG011|Stage 1A|Physician Decision|0|||
155396999|NCT00467779|560888490|FG012|Stage 1A|Physician Decision|0|||
155397000|NCT00467779|560888491|FG013|Stage 1A|Physician Decision|0|||
155397001|NCT00467779|560888492|FG014|Stage 1A|Physician Decision|0|||
155397002|NCT00467779|560888478|FG000|Stage 1A|Withdrawal by Subject|0|||
155397003|NCT00467779|560888479|FG001|Stage 1A|Withdrawal by Subject|0|||
155397004|NCT00467779|560888480|FG002|Stage 1A|Withdrawal by Subject|0|||
155397005|NCT00467779|560888481|FG003|Stage 1A|Withdrawal by Subject|0|||
155397006|NCT00467779|560888482|FG004|Stage 1A|Withdrawal by Subject|0|||
155397007|NCT00467779|560888483|FG005|Stage 1A|Withdrawal by Subject|0|||
155397008|NCT00467779|560888484|FG006|Stage 1A|Withdrawal by Subject|0|||
155397009|NCT00467779|560888485|FG007|Stage 1A|Withdrawal by Subject|0|||
155397010|NCT00467779|560888486|FG008|Stage 1A|Withdrawal by Subject|0|||
155397011|NCT00467779|560888487|FG009|Stage 1A|Withdrawal by Subject|0|||
155397012|NCT00467779|560888488|FG010|Stage 1A|Withdrawal by Subject|1|||
155397013|NCT00467779|560888489|FG011|Stage 1A|Withdrawal by Subject|1|||
155397014|NCT00467779|560888490|FG012|Stage 1A|Withdrawal by Subject|1|||
155397015|NCT00467779|560888491|FG013|Stage 1A|Withdrawal by Subject|0|||
155397016|NCT00467779|560888492|FG014|Stage 1A|Withdrawal by Subject|0|||
155397017|NCT00467779|560888478|FG000|Stage 1A|Unspecified Reason|0|||
155397018|NCT00467779|560888479|FG001|Stage 1A|Unspecified Reason|0|||
155397019|NCT00467779|560888480|FG002|Stage 1A|Unspecified Reason|0|||
155397020|NCT00467779|560888481|FG003|Stage 1A|Unspecified Reason|0|||
155397021|NCT00467779|560888482|FG004|Stage 1A|Unspecified Reason|0|||
155397022|NCT00467779|560888483|FG005|Stage 1A|Unspecified Reason|0|||
155397023|NCT00467779|560888484|FG006|Stage 1A|Unspecified Reason|0|||
155397024|NCT00467779|560888485|FG007|Stage 1A|Unspecified Reason|0|||
155057680|NCT02265510|559645788|FG006|Overall Study|Disease Progression|0|||
155057681|NCT02265510|559645789|FG007|Overall Study|Disease Progression|0|||
155057682|NCT02265510|559645790|FG008|Overall Study|Disease Progression|0|||
155057683|NCT02265510|559645791|FG009|Overall Study|Disease Progression|0|||
155057684|NCT02265510|559645792|FG010|Overall Study|Disease Progression|0|||
155057685|NCT02265510|559645793|FG011|Overall Study|Disease Progression|0|||
155057686|NCT02265510|559645794|FG012|Overall Study|Disease Progression|0|||
155057687|NCT02265510|559645795|FG013|Overall Study|Disease Progression|0|||
155057688|NCT02265510|559645782|FG000|Overall Study|Death|2|||
155057689|NCT02265510|559645783|FG001|Overall Study|Death|0|||
155057690|NCT02265510|559645784|FG002|Overall Study|Death|2|||
155057691|NCT02265510|559645785|FG003|Overall Study|Death|2|||
155057692|NCT02265510|559645786|FG004|Overall Study|Death|1|||
155057693|NCT02265510|559645787|FG005|Overall Study|Death|3|||
155057694|NCT02265510|559645788|FG006|Overall Study|Death|2|||
155057695|NCT02265510|559645789|FG007|Overall Study|Death|1|||
155057696|NCT02265510|559645790|FG008|Overall Study|Death|3|||
155397025|NCT00467779|560888486|FG008|Stage 1A|Unspecified Reason|0|||
155397026|NCT00467779|560888487|FG009|Stage 1A|Unspecified Reason|0|||
155397027|NCT00467779|560888488|FG010|Stage 1A|Unspecified Reason|0|||
155397028|NCT00467779|560888489|FG011|Stage 1A|Unspecified Reason|1|||
155397029|NCT00467779|560888490|FG012|Stage 1A|Unspecified Reason|1|||
155397030|NCT00467779|560888491|FG013|Stage 1A|Unspecified Reason|0|||
155397031|NCT00467779|560888492|FG014|Stage 1A|Unspecified Reason|0|||
155397032|NCT00467779|560888478|FG000|Stage 2|Adverse Event|0|||
155397033|NCT00467779|560888479|FG001|Stage 2|Adverse Event|0|||
155397034|NCT00467779|560888480|FG002|Stage 2|Adverse Event|0|||
155397035|NCT00467779|560888481|FG003|Stage 2|Adverse Event|0|||
155397036|NCT00467779|560888482|FG004|Stage 2|Adverse Event|0|||
155397037|NCT00467779|560888483|FG005|Stage 2|Adverse Event|0|||
155397038|NCT00467779|560888484|FG006|Stage 2|Adverse Event|0|||
155397039|NCT00467779|560888485|FG007|Stage 2|Adverse Event|0|||
155397040|NCT00467779|560888486|FG008|Stage 2|Adverse Event|1|||
155397041|NCT00467779|560888487|FG009|Stage 2|Adverse Event|0|||
155397042|NCT00467779|560888488|FG010|Stage 2|Adverse Event|0|||
155397043|NCT00467779|560888489|FG011|Stage 2|Adverse Event|0|||
155397044|NCT00467779|560888490|FG012|Stage 2|Adverse Event|0|||
155397045|NCT00467779|560888491|FG013|Stage 2|Adverse Event|0|||
155397046|NCT00467779|560888492|FG014|Stage 2|Adverse Event|0|||
155397047|NCT00467779|560888478|FG000|Stage 2|Death|0|||
155397048|NCT00467779|560888479|FG001|Stage 2|Death|0|||
155397049|NCT00467779|560888480|FG002|Stage 2|Death|0|||
155397050|NCT00467779|560888481|FG003|Stage 2|Death|0|||
155397051|NCT00467779|560888482|FG004|Stage 2|Death|0|||
155397052|NCT00467779|560888483|FG005|Stage 2|Death|0|||
155397053|NCT00467779|560888484|FG006|Stage 2|Death|0|||
155397054|NCT00467779|560888485|FG007|Stage 2|Death|0|||
155397055|NCT00467779|560888486|FG008|Stage 2|Death|1|||
155397056|NCT00467779|560888487|FG009|Stage 2|Death|0|||
155397057|NCT00467779|560888488|FG010|Stage 2|Death|0|||
155397058|NCT00467779|560888489|FG011|Stage 2|Death|0|||
155397059|NCT00467779|560888490|FG012|Stage 2|Death|0|||
155397060|NCT00467779|560888491|FG013|Stage 2|Death|0|||
155397061|NCT00467779|560888492|FG014|Stage 2|Death|0|||
155397062|NCT00467779|560888478|FG000|Stage 2|Disease Progression|0|||
155397063|NCT00467779|560888479|FG001|Stage 2|Disease Progression|0|||
155397064|NCT00467779|560888480|FG002|Stage 2|Disease Progression|0|||
155397065|NCT00467779|560888481|FG003|Stage 2|Disease Progression|0|||
155397066|NCT00467779|560888482|FG004|Stage 2|Disease Progression|0|||
155397067|NCT00467779|560888483|FG005|Stage 2|Disease Progression|0|||
155397068|NCT00467779|560888484|FG006|Stage 2|Disease Progression|0|||
155397069|NCT00467779|560888485|FG007|Stage 2|Disease Progression|0|||
155397070|NCT00467779|560888486|FG008|Stage 2|Disease Progression|16|||
155397071|NCT00467779|560888487|FG009|Stage 2|Disease Progression|0|||
155397072|NCT00467779|560888488|FG010|Stage 2|Disease Progression|0|||
155397073|NCT00467779|560888489|FG011|Stage 2|Disease Progression|0|||
155397074|NCT00467779|560888490|FG012|Stage 2|Disease Progression|0|||
155397075|NCT00467779|560888491|FG013|Stage 2|Disease Progression|0|||
155397076|NCT00467779|560888492|FG014|Stage 2|Disease Progression|0|||
155397077|NCT00467779|560888478|FG000|Stage 2|Unspecified Reason|0|||
155397078|NCT00467779|560888479|FG001|Stage 2|Unspecified Reason|0|||
155397079|NCT00467779|560888480|FG002|Stage 2|Unspecified Reason|0|||
155397080|NCT00467779|560888481|FG003|Stage 2|Unspecified Reason|0|||
155397081|NCT00467779|560888482|FG004|Stage 2|Unspecified Reason|0|||
155397082|NCT00467779|560888483|FG005|Stage 2|Unspecified Reason|0|||
155397083|NCT00467779|560888484|FG006|Stage 2|Unspecified Reason|0|||
155397084|NCT00467779|560888485|FG007|Stage 2|Unspecified Reason|0|||
155397085|NCT00467779|560888486|FG008|Stage 2|Unspecified Reason|3|||
155397086|NCT00467779|560888487|FG009|Stage 2|Unspecified Reason|0|||
155397087|NCT00467779|560888488|FG010|Stage 2|Unspecified Reason|0|||
155397088|NCT00467779|560888489|FG011|Stage 2|Unspecified Reason|0|||
155397089|NCT00467779|560888490|FG012|Stage 2|Unspecified Reason|0|||
155397090|NCT00467779|560888491|FG013|Stage 2|Unspecified Reason|0|||
155397091|NCT00467779|560888492|FG014|Stage 2|Unspecified Reason|0|||
155397092|NCT00467779|560888478|FG000|Stage 2A|Adverse Event|0|||
155397093|NCT00467779|560888479|FG001|Stage 2A|Adverse Event|0|||
155397094|NCT00467779|560888480|FG002|Stage 2A|Adverse Event|0|||
155397095|NCT00467779|560888481|FG003|Stage 2A|Adverse Event|0|||
155397096|NCT00467779|560888482|FG004|Stage 2A|Adverse Event|0|||
155397097|NCT00467779|560888483|FG005|Stage 2A|Adverse Event|0|||
155397098|NCT00467779|560888484|FG006|Stage 2A|Adverse Event|0|||
155397099|NCT00467779|560888485|FG007|Stage 2A|Adverse Event|0|||
155397100|NCT00467779|560888486|FG008|Stage 2A|Adverse Event|0|||
155397101|NCT00467779|560888487|FG009|Stage 2A|Adverse Event|0|||
155397102|NCT00467779|560888488|FG010|Stage 2A|Adverse Event|0|||
155397103|NCT00467779|560888489|FG011|Stage 2A|Adverse Event|0|||
155397104|NCT00467779|560888490|FG012|Stage 2A|Adverse Event|0|||
155397105|NCT00467779|560888491|FG013|Stage 2A|Adverse Event|2|||
155397106|NCT00467779|560888492|FG014|Stage 2A|Adverse Event|0|||
155397107|NCT00467779|560888478|FG000|Stage 2A|Death|0|||
155397108|NCT00467779|560888479|FG001|Stage 2A|Death|0|||
155397109|NCT00467779|560888480|FG002|Stage 2A|Death|0|||
155397110|NCT00467779|560888481|FG003|Stage 2A|Death|0|||
155397111|NCT00467779|560888482|FG004|Stage 2A|Death|0|||
155397112|NCT00467779|560888483|FG005|Stage 2A|Death|0|||
155397113|NCT00467779|560888484|FG006|Stage 2A|Death|0|||
155397114|NCT00467779|560888485|FG007|Stage 2A|Death|0|||
155397115|NCT00467779|560888486|FG008|Stage 2A|Death|0|||
155397116|NCT00467779|560888487|FG009|Stage 2A|Death|0|||
155397117|NCT00467779|560888488|FG010|Stage 2A|Death|0|||
155397118|NCT00467779|560888489|FG011|Stage 2A|Death|0|||
155397119|NCT00467779|560888490|FG012|Stage 2A|Death|0|||
155397120|NCT00467779|560888491|FG013|Stage 2A|Death|1|||
155397121|NCT00467779|560888492|FG014|Stage 2A|Death|0|||
155397122|NCT00467779|560888478|FG000|Stage 2A|Disease Progression|0|||
155397123|NCT00467779|560888479|FG001|Stage 2A|Disease Progression|0|||
155397124|NCT00467779|560888480|FG002|Stage 2A|Disease Progression|0|||
155397125|NCT00467779|560888481|FG003|Stage 2A|Disease Progression|0|||
155397126|NCT00467779|560888482|FG004|Stage 2A|Disease Progression|0|||
155397127|NCT00467779|560888483|FG005|Stage 2A|Disease Progression|0|||
155397128|NCT00467779|560888484|FG006|Stage 2A|Disease Progression|0|||
155397129|NCT00467779|560888485|FG007|Stage 2A|Disease Progression|0|||
155397130|NCT00467779|560888486|FG008|Stage 2A|Disease Progression|0|||
155397131|NCT00467779|560888487|FG009|Stage 2A|Disease Progression|0|||
155397132|NCT00467779|560888488|FG010|Stage 2A|Disease Progression|0|||
155397133|NCT00467779|560888489|FG011|Stage 2A|Disease Progression|0|||
155397134|NCT00467779|560888490|FG012|Stage 2A|Disease Progression|0|||
155397135|NCT00467779|560888491|FG013|Stage 2A|Disease Progression|10|||
155397136|NCT00467779|560888492|FG014|Stage 2A|Disease Progression|0|||
155397137|NCT00467779|560888478|FG000|Stage 2A|Unspecified Reason|0|||
155397138|NCT00467779|560888479|FG001|Stage 2A|Unspecified Reason|0|||
155397139|NCT00467779|560888480|FG002|Stage 2A|Unspecified Reason|0|||
155397140|NCT00467779|560888481|FG003|Stage 2A|Unspecified Reason|0|||
155397141|NCT00467779|560888482|FG004|Stage 2A|Unspecified Reason|0|||
155397142|NCT00467779|560888483|FG005|Stage 2A|Unspecified Reason|0|||
155397143|NCT00467779|560888484|FG006|Stage 2A|Unspecified Reason|0|||
155397144|NCT00467779|560888485|FG007|Stage 2A|Unspecified Reason|0|||
155397145|NCT00467779|560888486|FG008|Stage 2A|Unspecified Reason|0|||
155397146|NCT00467779|560888487|FG009|Stage 2A|Unspecified Reason|0|||
155397147|NCT00467779|560888488|FG010|Stage 2A|Unspecified Reason|0|||
155397148|NCT00467779|560888489|FG011|Stage 2A|Unspecified Reason|0|||
155397149|NCT00467779|560888490|FG012|Stage 2A|Unspecified Reason|0|||
155397150|NCT00467779|560888491|FG013|Stage 2A|Unspecified Reason|7|||
155397151|NCT00467779|560888492|FG014|Stage 2A|Unspecified Reason|0|||
155397152|NCT00467779|560888478|FG000|Stage 2A|Withdrawal by Subject|0|||
155397153|NCT00467779|560888479|FG001|Stage 2A|Withdrawal by Subject|0|||
155397154|NCT00467779|560888480|FG002|Stage 2A|Withdrawal by Subject|0|||
155397155|NCT00467779|560888481|FG003|Stage 2A|Withdrawal by Subject|0|||
155397156|NCT00467779|560888482|FG004|Stage 2A|Withdrawal by Subject|0|||
155397157|NCT00467779|560888483|FG005|Stage 2A|Withdrawal by Subject|0|||
155397158|NCT00467779|560888484|FG006|Stage 2A|Withdrawal by Subject|0|||
155397159|NCT00467779|560888485|FG007|Stage 2A|Withdrawal by Subject|0|||
155397160|NCT00467779|560888486|FG008|Stage 2A|Withdrawal by Subject|0|||
155397161|NCT00467779|560888487|FG009|Stage 2A|Withdrawal by Subject|0|||
155397162|NCT00467779|560888488|FG010|Stage 2A|Withdrawal by Subject|0|||
155397163|NCT00467779|560888489|FG011|Stage 2A|Withdrawal by Subject|0|||
155397164|NCT00467779|560888490|FG012|Stage 2A|Withdrawal by Subject|0|||
155397165|NCT00467779|560888491|FG013|Stage 2A|Withdrawal by Subject|1|||
155397166|NCT00467779|560888492|FG014|Stage 2A|Withdrawal by Subject|0|||
155397167|NCT00467779|560888478|FG000|Stage 3|Adverse Event|0|||
155397168|NCT00467779|560888479|FG001|Stage 3|Adverse Event|0|||
155397169|NCT00467779|560888480|FG002|Stage 3|Adverse Event|0|||
155397170|NCT00467779|560888481|FG003|Stage 3|Adverse Event|0|||
155397171|NCT00467779|560888482|FG004|Stage 3|Adverse Event|0|||
155397172|NCT00467779|560888483|FG005|Stage 3|Adverse Event|0|||
155397173|NCT00467779|560888484|FG006|Stage 3|Adverse Event|0|||
155397174|NCT00467779|560888485|FG007|Stage 3|Adverse Event|0|||
155397175|NCT00467779|560888486|FG008|Stage 3|Adverse Event|0|||
155397176|NCT00467779|560888487|FG009|Stage 3|Adverse Event|0|||
155397177|NCT00467779|560888488|FG010|Stage 3|Adverse Event|0|||
155397178|NCT00467779|560888489|FG011|Stage 3|Adverse Event|0|||
155397179|NCT00467779|560888490|FG012|Stage 3|Adverse Event|0|||
155397180|NCT00467779|560888491|FG013|Stage 3|Adverse Event|0|||
155397181|NCT00467779|560888492|FG014|Stage 3|Adverse Event|2|||
155397182|NCT00467779|560888478|FG000|Stage 3|Death|0|||
155397183|NCT00467779|560888479|FG001|Stage 3|Death|0|||
155397184|NCT00467779|560888480|FG002|Stage 3|Death|0|||
155397185|NCT00467779|560888481|FG003|Stage 3|Death|0|||
155397186|NCT00467779|560888482|FG004|Stage 3|Death|0|||
155397187|NCT00467779|560888483|FG005|Stage 3|Death|0|||
155397188|NCT00467779|560888484|FG006|Stage 3|Death|0|||
155397189|NCT00467779|560888485|FG007|Stage 3|Death|0|||
155397190|NCT00467779|560888486|FG008|Stage 3|Death|0|||
155397191|NCT00467779|560888487|FG009|Stage 3|Death|0|||
155397192|NCT00467779|560888488|FG010|Stage 3|Death|0|||
155397193|NCT00467779|560888489|FG011|Stage 3|Death|0|||
155397194|NCT00467779|560888490|FG012|Stage 3|Death|0|||
155397195|NCT00467779|560888491|FG013|Stage 3|Death|0|||
155397196|NCT00467779|560888492|FG014|Stage 3|Death|1|||
155397197|NCT00467779|560888478|FG000|Stage 3|Disease Progression|0|||
155397198|NCT00467779|560888479|FG001|Stage 3|Disease Progression|0|||
155397199|NCT00467779|560888480|FG002|Stage 3|Disease Progression|0|||
155397200|NCT00467779|560888481|FG003|Stage 3|Disease Progression|0|||
155397201|NCT00467779|560888482|FG004|Stage 3|Disease Progression|0|||
155397202|NCT00467779|560888483|FG005|Stage 3|Disease Progression|0|||
155397203|NCT00467779|560888484|FG006|Stage 3|Disease Progression|0|||
155397204|NCT00467779|560888485|FG007|Stage 3|Disease Progression|0|||
155397205|NCT00467779|560888486|FG008|Stage 3|Disease Progression|0|||
155397206|NCT00467779|560888487|FG009|Stage 3|Disease Progression|0|||
155397207|NCT00467779|560888488|FG010|Stage 3|Disease Progression|0|||
155397208|NCT00467779|560888489|FG011|Stage 3|Disease Progression|0|||
155397209|NCT00467779|560888490|FG012|Stage 3|Disease Progression|0|||
155397210|NCT00467779|560888491|FG013|Stage 3|Disease Progression|0|||
155397211|NCT00467779|560888492|FG014|Stage 3|Disease Progression|9|||
155397212|NCT00467779|560888478|FG000|Stage 3|Unspecified Reason|0|||
155397213|NCT00467779|560888479|FG001|Stage 3|Unspecified Reason|0|||
155397214|NCT00467779|560888480|FG002|Stage 3|Unspecified Reason|0|||
155397215|NCT00467779|560888481|FG003|Stage 3|Unspecified Reason|0|||
155397216|NCT00467779|560888482|FG004|Stage 3|Unspecified Reason|0|||
155397217|NCT00467779|560888483|FG005|Stage 3|Unspecified Reason|0|||
155397218|NCT00467779|560888484|FG006|Stage 3|Unspecified Reason|0|||
155397219|NCT00467779|560888485|FG007|Stage 3|Unspecified Reason|0|||
155397220|NCT00467779|560888486|FG008|Stage 3|Unspecified Reason|0|||
155397221|NCT00467779|560888487|FG009|Stage 3|Unspecified Reason|0|||
155397222|NCT00467779|560888488|FG010|Stage 3|Unspecified Reason|0|||
155397223|NCT00467779|560888489|FG011|Stage 3|Unspecified Reason|0|||
155397224|NCT00467779|560888490|FG012|Stage 3|Unspecified Reason|0|||
155397225|NCT00467779|560888491|FG013|Stage 3|Unspecified Reason|0|||
155397226|NCT00467779|560888492|FG014|Stage 3|Unspecified Reason|5|||
155397227|NCT01509079|560888493|FG000|Overall Study|Lack of Efficacy|0|||
155397228|NCT01509079|560888494|FG001|Overall Study|Lack of Efficacy|2|||
155397229|NCT01509079|560888493|FG000|Overall Study|started an excluded medication|0|||
155397230|NCT01509079|560888494|FG001|Overall Study|started an excluded medication|1|||
155397231|NCT04912245|560888495|FG000|Overall Study|Withdrawal by Subject|21|||
155397232|NCT04912245|560888496|FG001|Overall Study|Withdrawal by Subject|4|||
155397233|NCT04912245|560888495|FG000|Overall Study|Lost to Follow-up|5|||
155397234|NCT04912245|560888496|FG001|Overall Study|Lost to Follow-up|11|||
155397235|NCT01205230|560888497|FG000|Overall Study|Adverse Event|4|||
155397236|NCT01205230|560888498|FG001|Overall Study|Adverse Event|0|||
155397237|NCT01205230|560888497|FG000|Overall Study|Physician Decision|1|||
155397238|NCT01205230|560888498|FG001|Overall Study|Physician Decision|0|||
155397239|NCT00041080|560888499|FG000|Overall Study|Adverse Event|21|||
155397240|NCT00041080|560888500|FG001|Overall Study|Adverse Event|1|||
155397241|NCT00041080|560888499|FG000|Overall Study|Withdrawal by Subject|6|||
155397242|NCT00041080|560888500|FG001|Overall Study|Withdrawal by Subject|6|||
155397243|NCT00041080|560888499|FG000|Overall Study|Concommitant Illness/Other|1|||
155397244|NCT00041080|560888500|FG001|Overall Study|Concommitant Illness/Other|2|||
155397245|NCT00041080|560888499|FG000|Overall Study|Did not start therapy|1|||
155397246|NCT00041080|560888500|FG001|Overall Study|Did not start therapy|1|||
155397247|NCT00041080|560888499|FG000|Overall Study|Ineligible|1|||
155397248|NCT00041080|560888500|FG001|Overall Study|Ineligible|0|||
155397249|NCT00058552|560888501|FG000|Overall Study|Died prior to receiving treatment|4|||
155397250|NCT00058552|560888502|FG001|Overall Study|Died prior to receiving treatment|2|||
155397251|NCT00058552|560888501|FG000|Overall Study|Disease progression|52|||
155397252|NCT00058552|560888502|FG001|Overall Study|Disease progression|44|||
155397253|NCT00058552|560888501|FG000|Overall Study|Adverse Event|4|||
155397254|NCT00058552|560888502|FG001|Overall Study|Adverse Event|2|||
155397255|NCT00058552|560888501|FG000|Overall Study|Withdrawal by Subject|3|||
155397256|NCT00058552|560888502|FG001|Overall Study|Withdrawal by Subject|5|||
155397257|NCT00058552|560888501|FG000|Overall Study|Physician Decision|2|||
155397258|NCT00058552|560888502|FG001|Overall Study|Physician Decision|5|||
155397259|NCT00058552|560888501|FG000|Overall Study|Clinical disease progression|0|||
155397260|NCT00058552|560888502|FG001|Overall Study|Clinical disease progression|4|||
155397261|NCT02428855|560888503|FG000|Overall Study|Withdrawal by Subject|2|||
155397262|NCT01372150|560888506|FG000|Overall Study|Lack of Efficacy|3|||
155397263|NCT01372150|560888507|FG001|Overall Study|Lack of Efficacy|0|||
155397264|NCT01372150|560888508|FG002|Overall Study|Lack of Efficacy|1|||
155397265|NCT01372150|560888506|FG000|Overall Study|Lost to Follow-up|4|||
155397266|NCT01372150|560888507|FG001|Overall Study|Lost to Follow-up|5|||
155397267|NCT01372150|560888508|FG002|Overall Study|Lost to Follow-up|6|||
155397268|NCT01372150|560888506|FG000|Overall Study|Protocol Violation|1|||
155397269|NCT01372150|560888507|FG001|Overall Study|Protocol Violation|0|||
155397270|NCT01372150|560888508|FG002|Overall Study|Protocol Violation|3|||
155397271|NCT01372150|560888506|FG000|Overall Study|Withdrawal by Subject|2|||
155397272|NCT01372150|560888507|FG001|Overall Study|Withdrawal by Subject|7|||
155397273|NCT01372150|560888508|FG002|Overall Study|Withdrawal by Subject|2|||
155397274|NCT01372150|560888506|FG000|Overall Study|Other|1|||
155397275|NCT01372150|560888507|FG001|Overall Study|Other|0|||
155397276|NCT01372150|560888508|FG002|Overall Study|Other|2|||
155397277|NCT01372150|560888506|FG000|Overall Study|Adverse Event|2|||
155397278|NCT01372150|560888507|FG001|Overall Study|Adverse Event|1|||
155397279|NCT01372150|560888508|FG002|Overall Study|Adverse Event|2|||
155397280|NCT01372150|560888506|FG000|Overall Study|Randomized but not treated|0|||
155397281|NCT01372150|560888507|FG001|Overall Study|Randomized but not treated|1|||
155397282|NCT01372150|560888508|FG002|Overall Study|Randomized but not treated|0|||
155153299|NCT02485691|559998634|FG001|Overall Study|Investigator's decision|5|||
155153300|NCT02485691|559998633|FG000|Overall Study|Participant's request|13|||
155153301|NCT02485691|559998634|FG001|Overall Study|Participant's request|6|||
155153302|NCT02485691|559998633|FG000|Overall Study|Other reason|8|||
155153303|NCT02485691|559998634|FG001|Overall Study|Other reason|9|||
155153304|NCT02485691|559998633|FG000|Overall Study|Randomized and not treated|3|||
155153305|NCT02485691|559998634|FG001|Overall Study|Randomized and not treated|2|||
155153306|NCT01420861|559998643|FG000|Overall Study|Adverse Event|2|||
155153307|NCT01420861|559998643|FG000|Overall Study|Study terminated by Sponsor|7|||
155153308|NCT01420861|559998643|FG000|Overall Study|Screen failure|7|||
155397283|NCT03198520|560888509|FG000|Overall Study|Physician Decision|2|||
155397284|NCT03198520|560888509|FG000|Overall Study|Protocol Violation|2|||
155397285|NCT03198520|560888509|FG000|Overall Study|Withdrawal by Subject|1|||
155397286|NCT03198520|560888509|FG000|Overall Study|Study Ended|1|||
155397287|NCT01670539|560888510|FG000|Overall Study|Death|3|||
155397288|NCT01670539|560888511|FG001|Overall Study|Death|5|||
155397289|NCT01670539|560888510|FG000|Overall Study|Withdrawal by Subject|3|||
155397290|NCT01670539|560888511|FG001|Overall Study|Withdrawal by Subject|0|||
155397291|NCT04353596|560888512|FG000|Overall Study|Protocol Violation|4|||
155397292|NCT04353596|560888513|FG001|Overall Study|Protocol Violation|4|||
155397293|NCT04353596|560888512|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
155397294|NCT04353596|560888513|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
155397295|NCT02665052|560888514|FG000|Overall Study|Lost to Follow-up|1|||
155397296|NCT02665052|560888515|FG001|Overall Study|Lost to Follow-up|0|||
155397297|NCT02665052|560888516|FG002|Overall Study|Lost to Follow-up|0|||
155153309|NCT01420861|559998643|FG000|Overall Study|Randomized not Treated|2|||
155153310|NCT00791934|559998644|FG000|Overall Study|Withdrawal by Subject|2|||
155153311|NCT00791934|559998644|FG000|Overall Study|Did not consent for extended follow-up|13|||
155153312|NCT03413891|559998646|FG000|Overall Study|Lost to Follow-up|2|||
155153313|NCT03413891|559998647|FG001|Overall Study|Lost to Follow-up|1|||
155153314|NCT03413891|559998646|FG000|Overall Study|Protocol Violation|0|||
155153315|NCT03413891|559998647|FG001|Overall Study|Protocol Violation|1|||
155153316|NCT04905134|559998648|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
155153317|NCT04905134|559998648|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
155153318|NCT03137992|559998649|FG000|Washout Period 1|Adverse Event|1|||
155153319|NCT03137992|559998650|FG001|Washout Period 1|Adverse Event|1|||
155153320|NCT03137992|559998651|FG002|Washout Period 1|Adverse Event|0|||
155153321|NCT03137992|559998652|FG003|Washout Period 1|Adverse Event|0|||
155153322|NCT03137992|559998653|FG004|Washout Period 1|Adverse Event|0|||
155153323|NCT03137992|559998654|FG005|Washout Period 1|Adverse Event|1|||
155153324|NCT03137992|559998649|FG000|Washout Period 1|Withdrawal by Subject|0|||
155153325|NCT03137992|559998650|FG001|Washout Period 1|Withdrawal by Subject|1|||
155153326|NCT03137992|559998651|FG002|Washout Period 1|Withdrawal by Subject|1|||
155153327|NCT03137992|559998652|FG003|Washout Period 1|Withdrawal by Subject|0|||
155153328|NCT03137992|559998653|FG004|Washout Period 1|Withdrawal by Subject|0|||
155153329|NCT03137992|559998654|FG005|Washout Period 1|Withdrawal by Subject|0|||
155153330|NCT03137992|559998649|FG000|Washout Period 1|Principal Investigator Discretion|0|||
155153331|NCT03137992|559998650|FG001|Washout Period 1|Principal Investigator Discretion|1|||
155153332|NCT03137992|559998651|FG002|Washout Period 1|Principal Investigator Discretion|0|||
155153333|NCT03137992|559998652|FG003|Washout Period 1|Principal Investigator Discretion|0|||
155153334|NCT03137992|559998653|FG004|Washout Period 1|Principal Investigator Discretion|0|||
155153335|NCT03137992|559998654|FG005|Washout Period 1|Principal Investigator Discretion|0|||
155153336|NCT03137992|559998649|FG000|Washout Period 1|COPD Exacerbation|1|||
155153337|NCT03137992|559998650|FG001|Washout Period 1|COPD Exacerbation|1|||
155153338|NCT03137992|559998651|FG002|Washout Period 1|COPD Exacerbation|1|||
155153339|NCT03137992|559998652|FG003|Washout Period 1|COPD Exacerbation|0|||
155153340|NCT03137992|559998653|FG004|Washout Period 1|COPD Exacerbation|1|||
155153341|NCT03137992|559998654|FG005|Washout Period 1|COPD Exacerbation|1|||
155153342|NCT03137992|559998649|FG000|Washout Period 1|Subject Noncompliance|1|||
155153343|NCT03137992|559998650|FG001|Washout Period 1|Subject Noncompliance|0|||
155153344|NCT03137992|559998651|FG002|Washout Period 1|Subject Noncompliance|0|||
155153345|NCT03137992|559998652|FG003|Washout Period 1|Subject Noncompliance|0|||
155397298|NCT02665052|560888517|FG003|Overall Study|Lost to Follow-up|0|||
155397299|NCT02665052|560888514|FG000|Overall Study|Withdrawal by Subject|1|||
155397300|NCT02665052|560888515|FG001|Overall Study|Withdrawal by Subject|1|||
155153346|NCT03137992|559998653|FG004|Washout Period 1|Subject Noncompliance|1|||
155153347|NCT03137992|559998654|FG005|Washout Period 1|Subject Noncompliance|0|||
155153348|NCT03137992|559998649|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
155153349|NCT03137992|559998650|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
155153350|NCT03137992|559998651|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
155153351|NCT03137992|559998652|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
155153352|NCT03137992|559998653|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
155153353|NCT03137992|559998654|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
155153354|NCT03137992|559998649|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
155397301|NCT02665052|560888516|FG002|Overall Study|Withdrawal by Subject|0|||
155397302|NCT02665052|560888517|FG003|Overall Study|Withdrawal by Subject|5|||
155397303|NCT02665052|560888514|FG000|Overall Study|Adverse Event|1|||
155397304|NCT02665052|560888515|FG001|Overall Study|Adverse Event|1|||
155397305|NCT02665052|560888516|FG002|Overall Study|Adverse Event|0|||
155397306|NCT02665052|560888517|FG003|Overall Study|Adverse Event|0|||
155397307|NCT02234284|560888518|FG000|Overall Study|Death|4|||
155397308|NCT02234284|560888519|FG001|Overall Study|Death|2|||
155397309|NCT02234284|560888518|FG000|Overall Study|Withdrawal by Subject|1|||
155397310|NCT02234284|560888519|FG001|Overall Study|Withdrawal by Subject|0|||
155397311|NCT02234284|560888518|FG000|Overall Study|Lost to Follow-up|20|||
155397312|NCT02234284|560888519|FG001|Overall Study|Lost to Follow-up|7|||
155397313|NCT03023059|560888520|FG000|Overall Study|Withdrawal by Subject|5|||
155397314|NCT00536809|560888521|FG000|Phase II|Adverse Event|1|||
155397315|NCT00536809|560888521|FG000|Phase II|Referred for surgical resection|1|||
155397316|NCT00233363|560888522|FG000|Overall Study|Adverse Event|1|||
155397317|NCT00233363|560888523|FG001|Overall Study|Adverse Event|2|||
155397318|NCT00233363|560888522|FG000|Overall Study|Lack of Efficacy|0|||
155397319|NCT00233363|560888523|FG001|Overall Study|Lack of Efficacy|2|||
155397320|NCT00233363|560888522|FG000|Overall Study|Withdrawal by Subject|1|||
155397321|NCT00233363|560888523|FG001|Overall Study|Withdrawal by Subject|1|||
155397322|NCT00233363|560888522|FG000|Overall Study|Aggravation of complication|1|||
155397323|NCT00233363|560888523|FG001|Overall Study|Aggravation of complication|0|||
155397324|NCT04880447|560888527|FG000|Overall Study|No vaccination information|1|||
155397325|NCT04880447|560888527|FG000|Overall Study|No adverse event information (missing information)|1|||
155397326|NCT04880447|560888527|FG000|Overall Study|Disease not covered in this study|35|||
155397327|NCT01353508|560888532|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
155397328|NCT01353508|560888533|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
155397329|NCT01353508|560888534|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
155397330|NCT01353508|560888535|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
155397331|NCT01353508|560888532|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
155397332|NCT01353508|560888533|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
155397333|NCT01353508|560888534|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
155397334|NCT01353508|560888535|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
155397335|NCT00433914|560888541|FG000|Overall Study|Withdrawal by Subject|0|||
155397336|NCT00433914|560888542|FG001|Overall Study|Withdrawal by Subject|2|||
155397337|NCT00433914|560888541|FG000|Overall Study|Lost to Follow-up|0|||
155397338|NCT00433914|560888542|FG001|Overall Study|Lost to Follow-up|1|||
155397339|NCT02844920|560888543|FG000|Overall Study|Lost to Follow-up|2|||
155397340|NCT04534491|560888544|FG000|Overall Study|Not completed end-of-study interview|24|||
155397341|NCT04534491|560888544|FG000|Overall Study|Non-users|70|||
155397342|NCT04534491|560888544|FG000|Overall Study|Non-verifiable users|58|||
155397343|NCT00766090|560888547|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397344|NCT00766090|560888548|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397345|NCT00766090|560888549|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397346|NCT00766090|560888550|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397347|NCT00766090|560888551|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397348|NCT00766090|560888552|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397349|NCT00766090|560888553|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397350|NCT00766090|560888554|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397351|NCT00766090|560888555|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
155397352|NCT00766090|560888556|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397353|NCT00766090|560888557|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397354|NCT00766090|560888558|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155397355|NCT00766090|560888547|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
155397356|NCT00766090|560888548|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397357|NCT00766090|560888549|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155153355|NCT03137992|559998650|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
155397358|NCT00766090|560888550|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397359|NCT00766090|560888551|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397360|NCT00766090|560888552|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397361|NCT00766090|560888553|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397362|NCT00766090|560888554|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397363|NCT00766090|560888555|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397364|NCT00766090|560888556|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397365|NCT00766090|560888557|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155397366|NCT00766090|560888558|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
155153356|NCT03137992|559998651|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
155153357|NCT03137992|559998652|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
155153358|NCT03137992|559998653|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
155153359|NCT03137992|559998654|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
155397367|NCT00766090|560888547|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155397368|NCT00766090|560888548|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397369|NCT00766090|560888549|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397370|NCT00766090|560888550|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155397371|NCT00766090|560888551|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397372|NCT00766090|560888552|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397373|NCT00766090|560888553|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397374|NCT00766090|560888554|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397375|NCT00766090|560888555|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397376|NCT00766090|560888556|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397377|NCT00766090|560888557|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397378|NCT00766090|560888558|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155397379|NCT00766090|560888547|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397380|NCT00766090|560888548|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397381|NCT00766090|560888549|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
155397382|NCT00766090|560888550|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397383|NCT00766090|560888551|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397384|NCT00766090|560888552|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397385|NCT00766090|560888553|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397386|NCT00766090|560888554|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397387|NCT00766090|560888555|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397388|NCT00766090|560888556|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397389|NCT00766090|560888557|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397390|NCT00766090|560888558|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
155397391|NCT00766090|560888547|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397392|NCT00766090|560888548|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397393|NCT00766090|560888549|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397394|NCT00766090|560888550|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397395|NCT00766090|560888551|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
155397396|NCT00766090|560888552|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397397|NCT00766090|560888553|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397398|NCT00766090|560888554|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397399|NCT00766090|560888555|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397400|NCT00766090|560888556|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397401|NCT00766090|560888557|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397402|NCT00766090|560888558|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155397403|NCT00766090|560888547|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397404|NCT00766090|560888548|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397405|NCT00766090|560888549|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
155397406|NCT00766090|560888550|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397407|NCT00766090|560888551|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397408|NCT00766090|560888552|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397409|NCT00766090|560888553|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397410|NCT00766090|560888554|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397411|NCT00766090|560888555|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397412|NCT00766090|560888556|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397413|NCT00766090|560888557|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397414|NCT00766090|560888558|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
155397415|NCT00766090|560888547|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
155397416|NCT00766090|560888548|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
155397417|NCT00766090|560888549|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
155397418|NCT00766090|560888550|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
155397419|NCT00766090|560888551|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
155397420|NCT00766090|560888552|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
155397421|NCT00766090|560888553|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
155397422|NCT00766090|560888554|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
155397423|NCT00766090|560888555|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
155397424|NCT00766090|560888556|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
155397425|NCT00766090|560888557|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
155397426|NCT00766090|560888558|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
155397427|NCT00766090|560888547|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397428|NCT00766090|560888548|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397429|NCT00766090|560888549|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397430|NCT00766090|560888550|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397431|NCT00766090|560888551|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397432|NCT00766090|560888552|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
155397433|NCT00766090|560888553|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397434|NCT00766090|560888554|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397435|NCT00766090|560888555|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397436|NCT00766090|560888556|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397437|NCT00766090|560888557|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155153360|NCT03137992|559998649|FG000|Period 2 (Visit 3)|Adverse Event|0|||
154953040|NCT02942264|559254572|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953041|NCT02942264|559254573|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953042|NCT02942264|559254574|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953043|NCT02942264|559254575|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953044|NCT02942264|559254576|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953045|NCT02942264|559254577|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953046|NCT02942264|559254578|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953047|NCT02942264|559254579|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
154953048|NCT02942264|559254580|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
154953049|NCT03980483|559254581|FG000|Overall Study|Adverse Event|13|||
154953050|NCT03980483|559254582|FG001|Overall Study|Adverse Event|29|||
154953051|NCT03980483|559254583|FG002|Overall Study|Adverse Event|11|||
154953052|NCT03980483|559254584|FG003|Overall Study|Adverse Event|2|||
154953053|NCT03980483|559254585|FG004|Overall Study|Adverse Event|2|||
154953054|NCT03980483|559254586|FG005|Overall Study|Adverse Event|2|||
154953055|NCT03980483|559254581|FG000|Overall Study|Lack of Efficacy|7|||
154953056|NCT03980483|559254582|FG001|Overall Study|Lack of Efficacy|6|||
154953057|NCT03980483|559254583|FG002|Overall Study|Lack of Efficacy|0|||
154953058|NCT03980483|559254584|FG003|Overall Study|Lack of Efficacy|3|||
154953059|NCT03980483|559254585|FG004|Overall Study|Lack of Efficacy|1|||
154953060|NCT03980483|559254586|FG005|Overall Study|Lack of Efficacy|1|||
154953061|NCT03980483|559254581|FG000|Overall Study|Lost to Follow-up|2|||
154953062|NCT03980483|559254582|FG001|Overall Study|Lost to Follow-up|4|||
154953063|NCT03980483|559254583|FG002|Overall Study|Lost to Follow-up|2|||
154953064|NCT03980483|559254584|FG003|Overall Study|Lost to Follow-up|1|||
154953065|NCT03980483|559254585|FG004|Overall Study|Lost to Follow-up|2|||
154953066|NCT03980483|559254586|FG005|Overall Study|Lost to Follow-up|0|||
154953067|NCT03980483|559254581|FG000|Overall Study|Protocol Violation|4|||
154953068|NCT03980483|559254582|FG001|Overall Study|Protocol Violation|2|||
154953069|NCT03980483|559254583|FG002|Overall Study|Protocol Violation|1|||
154953070|NCT03980483|559254584|FG003|Overall Study|Protocol Violation|1|||
154953071|NCT03980483|559254585|FG004|Overall Study|Protocol Violation|0|||
154953072|NCT03980483|559254586|FG005|Overall Study|Protocol Violation|0|||
154953073|NCT03980483|559254581|FG000|Overall Study|Physician Decision|14|||
154953074|NCT03980483|559254582|FG001|Overall Study|Physician Decision|10|||
154953075|NCT03980483|559254583|FG002|Overall Study|Physician Decision|7|||
154953076|NCT03980483|559254584|FG003|Overall Study|Physician Decision|4|||
154953077|NCT03980483|559254585|FG004|Overall Study|Physician Decision|4|||
154953078|NCT03980483|559254586|FG005|Overall Study|Physician Decision|2|||
154953079|NCT03980483|559254581|FG000|Overall Study|Withdrawal by Subject|38|||
154953080|NCT03980483|559254582|FG001|Overall Study|Withdrawal by Subject|21|||
154953081|NCT03980483|559254583|FG002|Overall Study|Withdrawal by Subject|15|||
154953082|NCT03980483|559254584|FG003|Overall Study|Withdrawal by Subject|5|||
154953083|NCT03980483|559254585|FG004|Overall Study|Withdrawal by Subject|3|||
154953084|NCT03980483|559254586|FG005|Overall Study|Withdrawal by Subject|4|||
154953085|NCT03980483|559254581|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
154953086|NCT03980483|559254582|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
154953087|NCT03980483|559254583|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
154953088|NCT03980483|559254584|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
154953089|NCT03980483|559254585|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
154953090|NCT03980483|559254586|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
154953091|NCT03980483|559254581|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
154953092|NCT03980483|559254582|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
154953093|NCT03980483|559254583|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
154953094|NCT03980483|559254584|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
154953095|NCT03980483|559254585|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
154953096|NCT03980483|559254586|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
154953097|NCT03980483|559254581|FG000|Overall Study|Other|0|||
154953098|NCT03980483|559254582|FG001|Overall Study|Other|1|||
154953099|NCT03980483|559254583|FG002|Overall Study|Other|0|||
154953100|NCT03980483|559254584|FG003|Overall Study|Other|0|||
154953101|NCT03980483|559254585|FG004|Overall Study|Other|0|||
154953102|NCT03980483|559254586|FG005|Overall Study|Other|0|||
154953103|NCT01062256|559254587|FG000|Overall Study|Adverse Event|1|||
154953104|NCT01062256|559254588|FG001|Overall Study|Adverse Event|0|||
154953105|NCT01062256|559254589|FG002|Overall Study|Adverse Event|0|||
154953106|NCT01062256|559254587|FG000|Overall Study|Withdrawal by Subject|1|||
154953107|NCT01062256|559254588|FG001|Overall Study|Withdrawal by Subject|1|||
154953108|NCT01062256|559254589|FG002|Overall Study|Withdrawal by Subject|1|||
154953109|NCT01062256|559254587|FG000|Overall Study|Ineligible|1|||
154953110|NCT01062256|559254588|FG001|Overall Study|Ineligible|4|||
154953111|NCT01062256|559254589|FG002|Overall Study|Ineligible|3|||
154953112|NCT01062256|559254587|FG000|Overall Study|Administrative|0|||
154953113|NCT01062256|559254588|FG001|Overall Study|Administrative|2|||
154953114|NCT01062256|559254589|FG002|Overall Study|Administrative|0|||
154953115|NCT03049488|559254590|FG000|Overall Study|Lost to Follow-up|1|||
155397438|NCT00766090|560888558|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
155397439|NCT00766090|560888547|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397440|NCT00766090|560888548|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
155397441|NCT00766090|560888549|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397442|NCT00766090|560888550|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
155397443|NCT00766090|560888551|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397444|NCT00766090|560888552|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397445|NCT00766090|560888553|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397446|NCT00766090|560888554|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397447|NCT00766090|560888555|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397448|NCT00766090|560888556|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397449|NCT00766090|560888557|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
155397450|NCT00766090|560888558|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
155397451|NCT00766090|560888547|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397452|NCT00766090|560888548|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397453|NCT00766090|560888549|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397454|NCT00766090|560888550|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397455|NCT00766090|560888551|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
155397456|NCT00766090|560888552|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155153361|NCT03137992|559998650|FG001|Period 2 (Visit 3)|Adverse Event|1|||
155153362|NCT03137992|559998651|FG002|Period 2 (Visit 3)|Adverse Event|0|||
155153363|NCT03137992|559998652|FG003|Period 2 (Visit 3)|Adverse Event|0|||
155153364|NCT03137992|559998653|FG004|Period 2 (Visit 3)|Adverse Event|0|||
155153365|NCT03137992|559998654|FG005|Period 2 (Visit 3)|Adverse Event|0|||
155153366|NCT03137992|559998649|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
155153367|NCT03137992|559998650|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
155153368|NCT03137992|559998651|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
155153369|NCT03137992|559998652|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
155153370|NCT03137992|559998653|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
155153371|NCT03137992|559998654|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
155153372|NCT03137992|559998649|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155153373|NCT03137992|559998650|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
155153374|NCT03137992|559998651|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155153375|NCT03137992|559998652|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155153376|NCT03137992|559998653|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
155153377|NCT03137992|559998654|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
155153378|NCT03137992|559998649|FG000|Washout Period 2|COPD Exacerbation|1|||
155153379|NCT03137992|559998650|FG001|Washout Period 2|COPD Exacerbation|1|||
155153380|NCT03137992|559998651|FG002|Washout Period 2|COPD Exacerbation|0|||
155153381|NCT03137992|559998652|FG003|Washout Period 2|COPD Exacerbation|0|||
155153382|NCT03137992|559998653|FG004|Washout Period 2|COPD Exacerbation|1|||
155153383|NCT03137992|559998654|FG005|Washout Period 2|COPD Exacerbation|0|||
155153384|NCT03137992|559998649|FG000|Washout Period 2|Subject Non-compliance|0|||
155153385|NCT03137992|559998650|FG001|Washout Period 2|Subject Non-compliance|1|||
155153386|NCT03137992|559998651|FG002|Washout Period 2|Subject Non-compliance|0|||
155153387|NCT03137992|559998652|FG003|Washout Period 2|Subject Non-compliance|0|||
155153388|NCT03137992|559998653|FG004|Washout Period 2|Subject Non-compliance|0|||
155153389|NCT03137992|559998654|FG005|Washout Period 2|Subject Non-compliance|0|||
155153390|NCT03137992|559998649|FG000|Washout Period 2|Adverse Event|0|||
155153391|NCT03137992|559998650|FG001|Washout Period 2|Adverse Event|0|||
155153392|NCT03137992|559998651|FG002|Washout Period 2|Adverse Event|0|||
155153393|NCT03137992|559998652|FG003|Washout Period 2|Adverse Event|1|||
155153394|NCT03137992|559998653|FG004|Washout Period 2|Adverse Event|1|||
155153395|NCT03137992|559998654|FG005|Washout Period 2|Adverse Event|0|||
155153396|NCT03137992|559998649|FG000|Washout Period 2|Withdrawal by Subject|1|||
155153397|NCT03137992|559998650|FG001|Washout Period 2|Withdrawal by Subject|0|||
155153398|NCT03137992|559998651|FG002|Washout Period 2|Withdrawal by Subject|0|||
155153399|NCT03137992|559998652|FG003|Washout Period 2|Withdrawal by Subject|0|||
155153400|NCT03137992|559998653|FG004|Washout Period 2|Withdrawal by Subject|1|||
155153401|NCT03137992|559998654|FG005|Washout Period 2|Withdrawal by Subject|0|||
155153402|NCT03137992|559998649|FG000|Washout Period 2|Sponsor Decision|0|||
155397457|NCT00766090|560888553|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397458|NCT00766090|560888554|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397459|NCT00766090|560888555|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155153403|NCT03137992|559998650|FG001|Washout Period 2|Sponsor Decision|0|||
155153404|NCT03137992|559998651|FG002|Washout Period 2|Sponsor Decision|0|||
155153405|NCT03137992|559998652|FG003|Washout Period 2|Sponsor Decision|0|||
155153406|NCT03137992|559998653|FG004|Washout Period 2|Sponsor Decision|0|||
155153407|NCT03137992|559998654|FG005|Washout Period 2|Sponsor Decision|1|||
155397460|NCT00766090|560888556|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397461|NCT00766090|560888557|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155397462|NCT00766090|560888558|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
155153408|NCT03137992|559998649|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
155153409|NCT03137992|559998650|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
155153410|NCT03137992|559998651|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
155153411|NCT03137992|559998652|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
155153412|NCT03137992|559998653|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
155153413|NCT03137992|559998654|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
155153414|NCT03137992|559998649|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
155153415|NCT03137992|559998650|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
155153416|NCT03137992|559998651|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
155153417|NCT03137992|559998652|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
155153418|NCT03137992|559998653|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
155153419|NCT03137992|559998654|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
155153420|NCT03137992|559998649|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
155153421|NCT03137992|559998650|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155153422|NCT03137992|559998651|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
155153423|NCT03137992|559998652|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155153424|NCT03137992|559998653|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155153425|NCT03137992|559998654|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
155153426|NCT03137992|559998649|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155153427|NCT03137992|559998650|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155153428|NCT03137992|559998651|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155153429|NCT03137992|559998652|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
155153430|NCT03137992|559998653|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155153431|NCT03137992|559998654|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
155153432|NCT03137992|559998649|FG000|Part 2 (Open-label Extension)|Per study team|1|||
155153433|NCT03137992|559998650|FG001|Part 2 (Open-label Extension)|Per study team|0|||
155153434|NCT03137992|559998651|FG002|Part 2 (Open-label Extension)|Per study team|0|||
155153435|NCT03137992|559998652|FG003|Part 2 (Open-label Extension)|Per study team|0|||
155153436|NCT03137992|559998653|FG004|Part 2 (Open-label Extension)|Per study team|0|||
155153437|NCT03137992|559998654|FG005|Part 2 (Open-label Extension)|Per study team|0|||
155153438|NCT03137992|559998649|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155153439|NCT03137992|559998650|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155153440|NCT03137992|559998651|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155153441|NCT03137992|559998652|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155153442|NCT03137992|559998653|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
155153443|NCT03137992|559998654|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
155153444|NCT03221556|559998657|FG000|Allocation|post-randomization exclusion|0|||
155153445|NCT03221556|559998658|FG001|Allocation|post-randomization exclusion|1|||
155153446|NCT03221556|559998657|FG000|Follow-Up|Withdrawal by Subject|0|||
155153447|NCT03221556|559998658|FG001|Follow-Up|Withdrawal by Subject|1|||
155153448|NCT01486966|559998661|FG000|Overall Study|Adverse Event|0|||
155397463|NCT03024970|560888559|FG000|First Intervention|Adverse Event|1|||
155397464|NCT03024970|560888560|FG001|First Intervention|Adverse Event|0|||
155397465|NCT03024970|560888559|FG000|Second Intervention|Lost to Follow-up|1|||
155397466|NCT03024970|560888560|FG001|Second Intervention|Lost to Follow-up|0|||
155397467|NCT00574288|560888561|FG000|Overall Study|Adverse Event|2|||
155397468|NCT00574288|560888562|FG001|Overall Study|Adverse Event|0|||
155397469|NCT00574288|560888563|FG002|Overall Study|Adverse Event|0|||
155397470|NCT00574288|560888564|FG003|Overall Study|Adverse Event|0|||
155397471|NCT00574288|560888565|FG004|Overall Study|Adverse Event|1|||
155397472|NCT00574288|560888566|FG005|Overall Study|Adverse Event|0|||
155397473|NCT00574288|560888567|FG006|Overall Study|Adverse Event|0|||
155397474|NCT00574288|560888561|FG000|Overall Study|Death|0|||
155397475|NCT00574288|560888562|FG001|Overall Study|Death|0|||
155397476|NCT00574288|560888563|FG002|Overall Study|Death|0|||
155397477|NCT00574288|560888564|FG003|Overall Study|Death|0|||
155397478|NCT00574288|560888565|FG004|Overall Study|Death|0|||
155397479|NCT00574288|560888566|FG005|Overall Study|Death|25|||
155397480|NCT00574288|560888567|FG006|Overall Study|Death|21|||
155397481|NCT00574288|560888561|FG000|Overall Study|Lost to Follow-up|0|||
155153449|NCT01486966|559998662|FG001|Overall Study|Adverse Event|1|||
155153450|NCT01486966|559998661|FG000|Overall Study|Withdrawal by Subject|0|||
155153451|NCT01486966|559998662|FG001|Overall Study|Withdrawal by Subject|1|||
155153452|NCT00506350|559998666|FG000|Overall Study|Serious Adverse Event|1|||
155153453|NCT00506350|559998667|FG001|Overall Study|Serious Adverse Event|0|||
155153454|NCT00506350|559998668|FG002|Overall Study|Serious Adverse Event|0|||
155153455|NCT00506350|559998669|FG003|Overall Study|Serious Adverse Event|0|||
155153456|NCT00506350|559998670|FG004|Overall Study|Serious Adverse Event|0|||
155153457|NCT00506350|559998671|FG005|Overall Study|Serious Adverse Event|0|||
155153458|NCT00506350|559998672|FG006|Overall Study|Serious Adverse Event|0|||
155153459|NCT00506350|559998673|FG007|Overall Study|Serious Adverse Event|0|||
155153460|NCT00506350|559998674|FG008|Overall Study|Serious Adverse Event|0|||
155397482|NCT00574288|560888562|FG001|Overall Study|Lost to Follow-up|0|||
155397483|NCT00574288|560888563|FG002|Overall Study|Lost to Follow-up|0|||
155397484|NCT00574288|560888564|FG003|Overall Study|Lost to Follow-up|0|||
155397485|NCT00574288|560888565|FG004|Overall Study|Lost to Follow-up|0|||
155397486|NCT00574288|560888566|FG005|Overall Study|Lost to Follow-up|1|||
155397487|NCT00574288|560888567|FG006|Overall Study|Lost to Follow-up|2|||
155397488|NCT00574288|560888561|FG000|Overall Study|Study Terminated By Sponsor|0|||
155397489|NCT00574288|560888562|FG001|Overall Study|Study Terminated By Sponsor|0|||
155397490|NCT00574288|560888563|FG002|Overall Study|Study Terminated By Sponsor|0|||
155397491|NCT00574288|560888564|FG003|Overall Study|Study Terminated By Sponsor|0|||
155397492|NCT00574288|560888565|FG004|Overall Study|Study Terminated By Sponsor|0|||
155397493|NCT00574288|560888566|FG005|Overall Study|Study Terminated By Sponsor|0|||
155397494|NCT00574288|560888567|FG006|Overall Study|Study Terminated By Sponsor|5|||
155397495|NCT00574288|560888561|FG000|Overall Study|Progressive Disease|17|||
155397496|NCT00574288|560888562|FG001|Overall Study|Progressive Disease|2|||
155153461|NCT00506350|559998666|FG000|Overall Study|Adverse Event|0|||
155153462|NCT00506350|559998667|FG001|Overall Study|Adverse Event|0|||
155153463|NCT00506350|559998668|FG002|Overall Study|Adverse Event|0|||
155153464|NCT00506350|559998669|FG003|Overall Study|Adverse Event|0|||
155153465|NCT00506350|559998670|FG004|Overall Study|Adverse Event|0|||
155153466|NCT00506350|559998671|FG005|Overall Study|Adverse Event|0|||
155153467|NCT00506350|559998672|FG006|Overall Study|Adverse Event|0|||
155153468|NCT00506350|559998673|FG007|Overall Study|Adverse Event|1|||
155153469|NCT00506350|559998674|FG008|Overall Study|Adverse Event|1|||
155397497|NCT00574288|560888563|FG002|Overall Study|Progressive Disease|3|||
155153470|NCT00506350|559998666|FG000|Overall Study|Protocol Violation|0|||
155153471|NCT00506350|559998667|FG001|Overall Study|Protocol Violation|0|||
155153472|NCT00506350|559998668|FG002|Overall Study|Protocol Violation|1|||
155153473|NCT00506350|559998669|FG003|Overall Study|Protocol Violation|0|||
155153474|NCT00506350|559998670|FG004|Overall Study|Protocol Violation|0|||
155153475|NCT00506350|559998671|FG005|Overall Study|Protocol Violation|0|||
155153476|NCT00506350|559998672|FG006|Overall Study|Protocol Violation|1|||
155153477|NCT00506350|559998673|FG007|Overall Study|Protocol Violation|0|||
155153478|NCT00506350|559998674|FG008|Overall Study|Protocol Violation|0|||
155153479|NCT00506350|559998666|FG000|Overall Study|Withdrawal by Subject|0|||
155153480|NCT00506350|559998667|FG001|Overall Study|Withdrawal by Subject|1|||
155153481|NCT00506350|559998668|FG002|Overall Study|Withdrawal by Subject|1|||
155153482|NCT00506350|559998669|FG003|Overall Study|Withdrawal by Subject|1|||
155153483|NCT00506350|559998670|FG004|Overall Study|Withdrawal by Subject|4|||
155153484|NCT00506350|559998671|FG005|Overall Study|Withdrawal by Subject|1|||
155153485|NCT00506350|559998672|FG006|Overall Study|Withdrawal by Subject|1|||
155153486|NCT00506350|559998673|FG007|Overall Study|Withdrawal by Subject|2|||
155153487|NCT00506350|559998674|FG008|Overall Study|Withdrawal by Subject|0|||
155153488|NCT00506350|559998666|FG000|Overall Study|Lost to Follow-up|1|||
155153489|NCT00506350|559998667|FG001|Overall Study|Lost to Follow-up|1|||
155153490|NCT00506350|559998668|FG002|Overall Study|Lost to Follow-up|1|||
155153491|NCT00506350|559998669|FG003|Overall Study|Lost to Follow-up|1|||
155153492|NCT00506350|559998670|FG004|Overall Study|Lost to Follow-up|2|||
155153493|NCT00506350|559998671|FG005|Overall Study|Lost to Follow-up|1|||
155153494|NCT00506350|559998672|FG006|Overall Study|Lost to Follow-up|0|||
155153495|NCT00506350|559998673|FG007|Overall Study|Lost to Follow-up|0|||
155153496|NCT00506350|559998674|FG008|Overall Study|Lost to Follow-up|2|||
155153497|NCT00506350|559998666|FG000|Overall Study|Medical Reason|0|||
155153498|NCT00506350|559998667|FG001|Overall Study|Medical Reason|0|||
155153499|NCT00506350|559998668|FG002|Overall Study|Medical Reason|0|||
155153500|NCT00506350|559998669|FG003|Overall Study|Medical Reason|0|||
155153501|NCT00506350|559998670|FG004|Overall Study|Medical Reason|1|||
155153502|NCT00506350|559998671|FG005|Overall Study|Medical Reason|0|||
155153503|NCT00506350|559998672|FG006|Overall Study|Medical Reason|0|||
155397498|NCT00574288|560888564|FG003|Overall Study|Progressive Disease|2|||
155397499|NCT00574288|560888565|FG004|Overall Study|Progressive Disease|1|||
155397500|NCT00574288|560888566|FG005|Overall Study|Progressive Disease|0|||
155397501|NCT00574288|560888567|FG006|Overall Study|Progressive Disease|0|||
155397502|NCT00574288|560888561|FG000|Overall Study|Other|1|||
155397503|NCT00574288|560888562|FG001|Overall Study|Other|1|||
155397504|NCT00574288|560888563|FG002|Overall Study|Other|0|||
155397505|NCT00574288|560888564|FG003|Overall Study|Other|0|||
155153504|NCT00506350|559998673|FG007|Overall Study|Medical Reason|0|||
155153505|NCT00506350|559998674|FG008|Overall Study|Medical Reason|0|||
155153506|NCT00506350|559998666|FG000|Overall Study|Other|1|||
155153507|NCT00506350|559998667|FG001|Overall Study|Other|1|||
155153508|NCT00506350|559998668|FG002|Overall Study|Other|3|||
155153509|NCT00506350|559998669|FG003|Overall Study|Other|0|||
155397506|NCT00574288|560888565|FG004|Overall Study|Other|0|||
155397507|NCT00574288|560888566|FG005|Overall Study|Other|0|||
155397508|NCT00574288|560888567|FG006|Overall Study|Other|0|||
155397509|NCT01106027|560888568|FG000|Overall Study|Lost graft early, discontinued|1|||
155153510|NCT00506350|559998670|FG004|Overall Study|Other|3|||
155153511|NCT00506350|559998671|FG005|Overall Study|Other|0|||
155153512|NCT00506350|559998672|FG006|Overall Study|Other|0|||
155153513|NCT00506350|559998673|FG007|Overall Study|Other|2|||
155153514|NCT00506350|559998674|FG008|Overall Study|Other|2|||
155153515|NCT01607957|559998675|FG000|Overall Study|Not treated|1|||
155153516|NCT01607957|559998676|FG001|Overall Study|Not treated|1|||
155397510|NCT00356889|560888569|FG000|Overall Study|Protocol Violation|2|||
155397511|NCT00356889|560888569|FG000|Overall Study|Adverse Event|1|||
155397512|NCT02678416|560888570|FG000|Part 1|Withdrawal by Subject|1|||
155397513|NCT02678416|560888570|FG000|Part 2|Adverse Event|2|||
155397514|NCT02678416|560888570|FG000|Part 2|Withdrawal by Subject|1|||
155397515|NCT00736034|560888575|FG000|Overall Study|Adverse Event|2|||
155397516|NCT01514136|560888579|FG000|Test Period 1; Test A|Protocol Violation|1|||
155397517|NCT01514136|560888580|FG001|Test Period 1; Test A|Protocol Violation|0|||
155397518|NCT01514136|560888581|FG002|Test Period 1; Test A|Protocol Violation|0|||
155397519|NCT01514136|560888582|FG003|Test Period 1; Test A|Protocol Violation|0|||
155397520|NCT01514136|560888583|FG004|Test Period 1; Test A|Protocol Violation|0|||
155397521|NCT01514136|560888584|FG005|Test Period 1; Test A|Protocol Violation|0|||
155397522|NCT01514136|560888585|FG006|Test Period 1; Test A|Protocol Violation|0|||
155397523|NCT01514136|560888586|FG007|Test Period 1; Test A|Protocol Violation|0|||
155397524|NCT01514136|560888579|FG000|Test Period 1; Test A|Break from study holiday|2|||
155397525|NCT01514136|560888580|FG001|Test Period 1; Test A|Break from study holiday|0|||
155397526|NCT01514136|560888581|FG002|Test Period 1; Test A|Break from study holiday|0|||
155397527|NCT01514136|560888582|FG003|Test Period 1; Test A|Break from study holiday|0|||
155397528|NCT01514136|560888583|FG004|Test Period 1; Test A|Break from study holiday|0|||
155397529|NCT01514136|560888584|FG005|Test Period 1; Test A|Break from study holiday|0|||
155397530|NCT01514136|560888585|FG006|Test Period 1; Test A|Break from study holiday|0|||
155397531|NCT01514136|560888586|FG007|Test Period 1; Test A|Break from study holiday|0|||
155397532|NCT01514136|560888579|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
155397533|NCT01514136|560888580|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
155397534|NCT01514136|560888581|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
155397535|NCT01514136|560888582|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
155397536|NCT01514136|560888583|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
155397537|NCT01514136|560888584|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
155397538|NCT01514136|560888585|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
155397539|NCT01514136|560888586|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
155397540|NCT01514136|560888579|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397541|NCT01514136|560888580|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397542|NCT01514136|560888581|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397543|NCT01514136|560888582|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
155397544|NCT01514136|560888583|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397545|NCT01514136|560888584|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397546|NCT01514136|560888585|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397547|NCT01514136|560888586|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
155397548|NCT01514136|560888579|FG000|Test Period 2; Test A*|Adverse Event|0|||
155397549|NCT01514136|560888580|FG001|Test Period 2; Test A*|Adverse Event|0|||
155397550|NCT01514136|560888581|FG002|Test Period 2; Test A*|Adverse Event|0|||
155397551|NCT01514136|560888582|FG003|Test Period 2; Test A*|Adverse Event|0|||
155397552|NCT01514136|560888583|FG004|Test Period 2; Test A*|Adverse Event|1|||
155397553|NCT01514136|560888584|FG005|Test Period 2; Test A*|Adverse Event|0|||
155397554|NCT01514136|560888585|FG006|Test Period 2; Test A*|Adverse Event|0|||
155397555|NCT01514136|560888586|FG007|Test Period 2; Test A*|Adverse Event|0|||
155397556|NCT01514136|560888579|FG000|Test Period 2; Test A*|Holiday|0|||
155397557|NCT01514136|560888580|FG001|Test Period 2; Test A*|Holiday|0|||
155397558|NCT01514136|560888581|FG002|Test Period 2; Test A*|Holiday|0|||
155397559|NCT01514136|560888582|FG003|Test Period 2; Test A*|Holiday|0|||
155397560|NCT01514136|560888583|FG004|Test Period 2; Test A*|Holiday|1|||
155397561|NCT01514136|560888584|FG005|Test Period 2; Test A*|Holiday|0|||
155397562|NCT01514136|560888585|FG006|Test Period 2; Test A*|Holiday|0|||
155397563|NCT01514136|560888586|FG007|Test Period 2; Test A*|Holiday|0|||
155397564|NCT01514136|560888579|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397565|NCT01514136|560888580|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397566|NCT01514136|560888581|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397567|NCT01514136|560888582|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
155153517|NCT01607957|559998675|FG000|Overall Study|Death|367|||
155153518|NCT01607957|559998676|FG001|Overall Study|Death|211|||
155153519|NCT01607957|559998675|FG000|Overall Study|Lost to Follow-up|3|||
155153520|NCT01607957|559998676|FG001|Overall Study|Lost to Follow-up|3|||
155153521|NCT01607957|559998675|FG000|Overall Study|Participant refusal|1|||
155153522|NCT01607957|559998676|FG001|Overall Study|Participant refusal|0|||
155397568|NCT01514136|560888583|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
155153523|NCT01691794|559998677|FG000|Overall Study|Poor/Non-Compliance|1|||
155153524|NCT01691794|559998678|FG001|Overall Study|Poor/Non-Compliance|4|||
155153525|NCT01691794|559998679|FG002|Overall Study|Poor/Non-Compliance|1|||
155397569|NCT01514136|560888584|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
155397570|NCT01514136|560888585|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397571|NCT01514136|560888586|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
155397572|NCT01514136|560888579|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
155153526|NCT01691794|559998677|FG000|Overall Study|Death|0|||
155153527|NCT01691794|559998678|FG001|Overall Study|Death|0|||
155153528|NCT01691794|559998679|FG002|Overall Study|Death|1|||
155397573|NCT01514136|560888580|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397574|NCT01514136|560888581|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397575|NCT01514136|560888582|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397576|NCT01514136|560888583|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397577|NCT01514136|560888584|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397578|NCT01514136|560888585|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
155397579|NCT01514136|560888586|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
155397580|NCT01514136|560888579|FG000|Test Period 2; Test C*|holiday|0|||
155397581|NCT01514136|560888580|FG001|Test Period 2; Test C*|holiday|0|||
155397582|NCT01514136|560888581|FG002|Test Period 2; Test C*|holiday|0|||
155397583|NCT01514136|560888582|FG003|Test Period 2; Test C*|holiday|0|||
155397584|NCT01514136|560888583|FG004|Test Period 2; Test C*|holiday|0|||
155397585|NCT01514136|560888584|FG005|Test Period 2; Test C*|holiday|0|||
155397586|NCT01514136|560888585|FG006|Test Period 2; Test C*|holiday|1|||
155397587|NCT01514136|560888586|FG007|Test Period 2; Test C*|holiday|0|||
155397588|NCT01514136|560888579|FG000|Test Period 2; Test C*|Protocol Violation|0|||
155397589|NCT01514136|560888580|FG001|Test Period 2; Test C*|Protocol Violation|0|||
155397590|NCT01514136|560888581|FG002|Test Period 2; Test C*|Protocol Violation|0|||
155397591|NCT01514136|560888582|FG003|Test Period 2; Test C*|Protocol Violation|0|||
155397592|NCT01514136|560888583|FG004|Test Period 2; Test C*|Protocol Violation|0|||
155397593|NCT01514136|560888584|FG005|Test Period 2; Test C*|Protocol Violation|0|||
155397594|NCT01514136|560888585|FG006|Test Period 2; Test C*|Protocol Violation|1|||
155397595|NCT01514136|560888586|FG007|Test Period 2; Test C*|Protocol Violation|0|||
155397596|NCT00955279|560888596|FG000|Overall Study|Other|0|||
155397597|NCT00955279|560888597|FG001|Overall Study|Other|0|||
155397598|NCT00955279|560888598|FG002|Overall Study|Other|3|||
155153529|NCT01691794|559998677|FG000|Overall Study|Lack of Efficacy|0|||
155153530|NCT01691794|559998678|FG001|Overall Study|Lack of Efficacy|7|||
155153531|NCT01691794|559998679|FG002|Overall Study|Lack of Efficacy|1|||
155153532|NCT01691794|559998677|FG000|Overall Study|Participant request to discontinue|0|||
155153533|NCT01691794|559998678|FG001|Overall Study|Participant request to discontinue|1|||
155153534|NCT01691794|559998679|FG002|Overall Study|Participant request to discontinue|0|||
155153535|NCT01691794|559998677|FG000|Overall Study|Adverse Event|0|||
155153536|NCT01691794|559998678|FG001|Overall Study|Adverse Event|1|||
155153537|NCT01691794|559998679|FG002|Overall Study|Adverse Event|1|||
155153538|NCT01691794|559998677|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
155153539|NCT01691794|559998678|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
155153540|NCT01691794|559998679|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
155153541|NCT01691794|559998677|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
155153542|NCT01691794|559998678|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
155153543|NCT01691794|559998679|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
155153544|NCT04972786|559998680|FG000|First Intervention (1 Day)|Adverse Event|1|||
155153545|NCT04972786|559998681|FG001|First Intervention (1 Day)|Adverse Event|0|||
155153546|NCT00844844|559998682|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
155153547|NCT00844844|559998682|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
155153548|NCT00844844|559998682|FG000|Extension Treatment Period|Adverse Event|2|||
155153549|NCT00844844|559998682|FG000|Post Treatment Period|Withdrawal by Subject|1|||
155153550|NCT03905096|559998683|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
155153551|NCT03905096|559998684|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
155153552|NCT02016781|559998686|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
155153553|NCT02016781|559998687|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
155153554|NCT02016781|559998686|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
155153555|NCT02016781|559998687|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
155153556|NCT02016781|559998686|FG000|Final Database Lock|Withdrawal by Subject|2|||
155153557|NCT02016781|559998687|FG001|Final Database Lock|Withdrawal by Subject|1|||
155153558|NCT02016781|559998686|FG000|Final Database Lock|Lost to Follow-up|11|||
155153559|NCT02016781|559998687|FG001|Final Database Lock|Lost to Follow-up|4|||
155153560|NCT02016781|559998686|FG000|Final Database Lock|Missing data|0|||
155153561|NCT02016781|559998687|FG001|Final Database Lock|Missing data|3|||
155153562|NCT00781768|560000357|FG000|Overall Study|Not transplanted.|0|||
155153563|NCT00781768|560000358|FG001|Overall Study|Not transplanted.|2|||
155153564|NCT02458313|560000361|FG000|Overall Study|Withdrawal by Subject|6|||
155153565|NCT02458313|560000362|FG001|Overall Study|Withdrawal by Subject|8|||
155153566|NCT02458313|560000361|FG000|Overall Study|Excluded for motion during MRI|1|||
155153567|NCT02458313|560000362|FG001|Overall Study|Excluded for motion during MRI|2|||
155153568|NCT00751296|560000363|FG000|Overall Study|Adverse Event|2|||
155153569|NCT01702311|560000366|FG000|Overall Study|Withdrawal by Subject|3|||
155153570|NCT01702311|560000367|FG001|Overall Study|Withdrawal by Subject|2|||
155397599|NCT00955279|560888596|FG000|Overall Study|Death|1|||
155397600|NCT00955279|560888597|FG001|Overall Study|Death|1|||
155397601|NCT00955279|560888598|FG002|Overall Study|Death|1|||
155397602|NCT00955279|560888596|FG000|Overall Study|Lost to Follow-up|0|||
155397603|NCT00955279|560888597|FG001|Overall Study|Lost to Follow-up|3|||
155397604|NCT00955279|560888598|FG002|Overall Study|Lost to Follow-up|1|||
155397605|NCT00955279|560888596|FG000|Overall Study|Withdrawal by Subject|2|||
155397606|NCT00955279|560888597|FG001|Overall Study|Withdrawal by Subject|0|||
155397607|NCT00955279|560888598|FG002|Overall Study|Withdrawal by Subject|3|||
155397608|NCT01159912|560888599|FG000|Overall Study|Adverse Event|2|||
155397609|NCT01159912|560888600|FG001|Overall Study|Adverse Event|2|||
155397610|NCT01159912|560888601|FG002|Overall Study|Adverse Event|3|||
155397611|NCT01159912|560888599|FG000|Overall Study|Lack of Efficacy|23|||
155397612|NCT01159912|560888600|FG001|Overall Study|Lack of Efficacy|15|||
155397613|NCT01159912|560888601|FG002|Overall Study|Lack of Efficacy|14|||
155153571|NCT01702311|560000366|FG000|Overall Study|Discharge less than 24 hours|10|||
155153572|NCT01702311|560000367|FG001|Overall Study|Discharge less than 24 hours|7|||
155153573|NCT01702311|560000366|FG000|Overall Study|Physician Decision|3|||
155153574|NCT01702311|560000367|FG001|Overall Study|Physician Decision|4|||
155153575|NCT03714672|560000368|FG000|Overall Study|Adverse Event|0|||
155153576|NCT03714672|560000369|FG001|Overall Study|Adverse Event|0|||
155153577|NCT03714672|560000370|FG002|Overall Study|Adverse Event|3|||
155153578|NCT03714672|560000371|FG003|Overall Study|Adverse Event|0|||
155153579|NCT03714672|560000368|FG000|Overall Study|Physician Decision|0|||
155153580|NCT03714672|560000369|FG001|Overall Study|Physician Decision|1|||
155153581|NCT03714672|560000370|FG002|Overall Study|Physician Decision|0|||
155153582|NCT03714672|560000371|FG003|Overall Study|Physician Decision|0|||
155153583|NCT03714672|560000368|FG000|Overall Study|Other Reason|1|||
155153584|NCT03714672|560000369|FG001|Overall Study|Other Reason|2|||
155397614|NCT01159912|560888599|FG000|Overall Study|Protocol Violation|1|||
155397615|NCT01159912|560888600|FG001|Overall Study|Protocol Violation|2|||
155397616|NCT01159912|560888601|FG002|Overall Study|Protocol Violation|3|||
155397617|NCT01159912|560888599|FG000|Overall Study|Lost to Follow-up|4|||
155397618|NCT01159912|560888600|FG001|Overall Study|Lost to Follow-up|0|||
155397619|NCT01159912|560888601|FG002|Overall Study|Lost to Follow-up|0|||
155397620|NCT01159912|560888599|FG000|Overall Study|Physician Decision|0|||
155397621|NCT01159912|560888600|FG001|Overall Study|Physician Decision|0|||
155397622|NCT01159912|560888601|FG002|Overall Study|Physician Decision|3|||
155397623|NCT01159912|560888599|FG000|Overall Study|Withdrawal by Subject|10|||
155397624|NCT01159912|560888600|FG001|Overall Study|Withdrawal by Subject|3|||
155397625|NCT01159912|560888601|FG002|Overall Study|Withdrawal by Subject|3|||
155397626|NCT03734016|560888608|FG000|Overall Study|Sponsor Ended Study|225|||
155397627|NCT03734016|560888609|FG001|Overall Study|Sponsor Ended Study|200|||
155397628|NCT03734016|560888608|FG000|Overall Study|Death|69|||
155397629|NCT03734016|560888609|FG001|Overall Study|Death|83|||
155397630|NCT03734016|560888608|FG000|Overall Study|Withdrawal by Subject|21|||
155397631|NCT03734016|560888609|FG001|Overall Study|Withdrawal by Subject|27|||
155397632|NCT03734016|560888608|FG000|Overall Study|Physician Decision|1|||
155397633|NCT03734016|560888609|FG001|Overall Study|Physician Decision|12|||
155397634|NCT03734016|560888608|FG000|Overall Study|Lost to Follow-up|6|||
155397635|NCT03734016|560888609|FG001|Overall Study|Lost to Follow-up|2|||
155397636|NCT03734016|560888608|FG000|Overall Study|Miscellaneous|5|||
155397637|NCT03734016|560888609|FG001|Overall Study|Miscellaneous|1|||
155397638|NCT02737852|560890402|FG000|Overall Study|Withdrawal by Subject|2|||
155397639|NCT03688880|560890403|FG000|Overall Study|Withdrawal by Subject|0|||
155397640|NCT03688880|560890404|FG001|Overall Study|Withdrawal by Subject|2|||
155397641|NCT03688880|560890403|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
155397642|NCT03688880|560890404|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
155397643|NCT03688880|560890403|FG000|Overall Study|Lost to Follow-up|4|||
155397644|NCT03688880|560890404|FG001|Overall Study|Lost to Follow-up|7|||
155397645|NCT03688880|560890403|FG000|Overall Study|Adverse Event|0|||
155397646|NCT03688880|560890404|FG001|Overall Study|Adverse Event|2|||
155397647|NCT03688880|560890403|FG000|Overall Study|Device deficiencies|0|||
155397648|NCT03688880|560890404|FG001|Overall Study|Device deficiencies|2|||
155397649|NCT03688880|560890403|FG000|Overall Study|Other|10|||
155397650|NCT03688880|560890404|FG001|Overall Study|Other|16|||
155397651|NCT01704287|560890406|FG000|Initial Treatment Period|Death|139|||
155397652|NCT01704287|560890407|FG001|Initial Treatment Period|Death|129|||
155397653|NCT01704287|560890408|FG002|Initial Treatment Period|Death|71|||
155397654|NCT01704287|560890409|FG003|Initial Treatment Period|Death|0|||
155397655|NCT01704287|560890410|FG004|Initial Treatment Period|Death|0|||
155397656|NCT01704287|560890406|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
155397657|NCT01704287|560890407|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
155397658|NCT01704287|560890408|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
155397659|NCT01704287|560890409|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
155153585|NCT03714672|560000370|FG002|Overall Study|Other Reason|1|||
155153586|NCT03714672|560000371|FG003|Overall Study|Other Reason|1|||
155153587|NCT03714672|560000368|FG000|Overall Study|Lost to Follow-up|1|||
155153588|NCT03714672|560000369|FG001|Overall Study|Lost to Follow-up|1|||
155397660|NCT01704287|560890410|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
155397661|NCT01704287|560890406|FG000|Initial Treatment Period|Lost to Follow-up|5|||
155397662|NCT01704287|560890407|FG001|Initial Treatment Period|Lost to Follow-up|3|||
155397663|NCT01704287|560890408|FG002|Initial Treatment Period|Lost to Follow-up|0|||
155397664|NCT01704287|560890409|FG003|Initial Treatment Period|Lost to Follow-up|0|||
155153589|NCT03714672|560000370|FG002|Overall Study|Lost to Follow-up|0|||
155153590|NCT03714672|560000371|FG003|Overall Study|Lost to Follow-up|0|||
155153591|NCT00804908|560000376|FG000|Overall Study|Other|115|||
155153592|NCT00804908|560000377|FG001|Overall Study|Other|116|||
155153593|NCT00804908|560000378|FG002|Overall Study|Other|114|||
155153594|NCT01428258|560000379|FG000|Intervention 1|Withdrawal by Subject|2|||
155153595|NCT01428258|560000380|FG001|Intervention 1|Withdrawal by Subject|0|||
155397665|NCT01704287|560890410|FG004|Initial Treatment Period|Lost to Follow-up|0|||
155397666|NCT01704287|560890406|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397667|NCT01704287|560890407|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397668|NCT01704287|560890408|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
155153596|NCT01074502|560000385|FG000|Overall Study|Withdrawal by Subject|1|||
155153597|NCT00674817|560000386|FG000|Period 1|Withdrawal by Subject|2|||
155153598|NCT00674817|560000386|FG000|Period 1|Protocol Violation|1|||
155153599|NCT00674817|560000386|FG000|Period 3|Adverse Event|1|||
155153600|NCT00674817|560000386|FG000|Period 3|Protocol Violation|1|||
155153601|NCT00674817|560000386|FG000|Period 4|Adverse Event|1|||
155153602|NCT00726063|560000387|FG000|Overall Study|Adverse Event|9|||
155153603|NCT00726063|560000388|FG001|Overall Study|Adverse Event|7|||
155153604|NCT01231984|560000389|FG000|Study Period 1|Withdrawal by Subject|0|||
155153605|NCT01231984|560000390|FG001|Study Period 1|Withdrawal by Subject|0|||
155153606|NCT01231984|560000391|FG002|Study Period 1|Withdrawal by Subject|0|||
155153607|NCT01231984|560000392|FG003|Study Period 1|Withdrawal by Subject|1|||
155153608|NCT01231984|560000389|FG000|Study Period 1|Lost to Follow-up|1|||
155153609|NCT01231984|560000390|FG001|Study Period 1|Lost to Follow-up|1|||
155153610|NCT01231984|560000391|FG002|Study Period 1|Lost to Follow-up|1|||
155153611|NCT01231984|560000392|FG003|Study Period 1|Lost to Follow-up|0|||
155397669|NCT01704287|560890409|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397670|NCT01704287|560890410|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
155397671|NCT01704287|560890406|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
155397672|NCT01704287|560890407|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
155397673|NCT01704287|560890408|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
155397674|NCT01704287|560890409|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
155153612|NCT01231984|560000389|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
155153613|NCT01231984|560000390|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
155153614|NCT01231984|560000391|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
155153615|NCT01231984|560000392|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
155153616|NCT01231984|560000389|FG000|Study Period 1|Screen Failure|0|||
155153617|NCT01231984|560000390|FG001|Study Period 1|Screen Failure|0|||
155153618|NCT01231984|560000391|FG002|Study Period 1|Screen Failure|0|||
155153619|NCT01231984|560000392|FG003|Study Period 1|Screen Failure|1|||
155397675|NCT01704287|560890410|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
155397676|NCT01704287|560890406|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
154953116|NCT03049488|559254591|FG001|Overall Study|Lost to Follow-up|1|||
154953117|NCT03049488|559254592|FG002|Overall Study|Lost to Follow-up|0|||
154953118|NCT03049488|559254593|FG003|Overall Study|Lost to Follow-up|0|||
154953119|NCT03049488|559254594|FG004|Overall Study|Lost to Follow-up|0|||
154953120|NCT03049488|559254595|FG005|Overall Study|Lost to Follow-up|0|||
154953121|NCT03049488|559254590|FG000|Overall Study|Moved from Area|1|||
154953122|NCT03049488|559254591|FG001|Overall Study|Moved from Area|0|||
154953123|NCT03049488|559254592|FG002|Overall Study|Moved from Area|0|||
154953124|NCT03049488|559254593|FG003|Overall Study|Moved from Area|1|||
154953125|NCT03049488|559254594|FG004|Overall Study|Moved from Area|1|||
154953126|NCT03049488|559254595|FG005|Overall Study|Moved from Area|0|||
154953127|NCT03049488|559254590|FG000|Overall Study|Physician Decision|0|||
154953128|NCT03049488|559254591|FG001|Overall Study|Physician Decision|1|||
154953129|NCT03049488|559254592|FG002|Overall Study|Physician Decision|0|||
154953130|NCT03049488|559254593|FG003|Overall Study|Physician Decision|0|||
154953131|NCT03049488|559254594|FG004|Overall Study|Physician Decision|0|||
154953132|NCT03049488|559254595|FG005|Overall Study|Physician Decision|0|||
154953133|NCT03049488|559254590|FG000|Overall Study|Withdrawal by Subject|0|||
154953134|NCT03049488|559254591|FG001|Overall Study|Withdrawal by Subject|0|||
154953135|NCT03049488|559254592|FG002|Overall Study|Withdrawal by Subject|0|||
154953136|NCT03049488|559254593|FG003|Overall Study|Withdrawal by Subject|1|||
154953137|NCT03049488|559254594|FG004|Overall Study|Withdrawal by Subject|1|||
154953138|NCT03049488|559254595|FG005|Overall Study|Withdrawal by Subject|0|||
154953139|NCT03099538|559254597|FG000|Overall Study|Lack of Efficacy|3|||
155153620|NCT01231984|560000389|FG000|Study Period 1|Non-compliance with study requirements|5|||
155153621|NCT01231984|560000390|FG001|Study Period 1|Non-compliance with study requirements|0|||
154953140|NCT00891293|559254598|FG000|Overall Study|Adverse Event|2|||
154953141|NCT00891293|559254598|FG000|Overall Study|Protocol Violation|2|||
154953142|NCT00891293|559254598|FG000|Overall Study|Laboratory abnormality|4|||
154953143|NCT00891293|559254598|FG000|Overall Study|Lost to Follow-up|7|||
154953144|NCT00891293|559254598|FG000|Overall Study|Subject withdrew consent|7|||
155153622|NCT01231984|560000391|FG002|Study Period 1|Non-compliance with study requirements|2|||
154953145|NCT00891293|559254598|FG000|Overall Study|Sponsor termination|62|||
154953146|NCT00440557|559254599|FG000|Overall Study|Withdrawal by Subject|10|||
154953147|NCT00440557|559254600|FG001|Overall Study|Withdrawal by Subject|5|||
154953148|NCT00440557|559254601|FG002|Overall Study|Withdrawal by Subject|11|||
154953149|NCT00440557|559254599|FG000|Overall Study|Lost to Follow-up|1|||
154953150|NCT00440557|559254600|FG001|Overall Study|Lost to Follow-up|2|||
154953151|NCT00440557|559254601|FG002|Overall Study|Lost to Follow-up|6|||
154953152|NCT00440557|559254599|FG000|Overall Study|Adverse Event|3|||
154953153|NCT00440557|559254600|FG001|Overall Study|Adverse Event|3|||
154953154|NCT00440557|559254601|FG002|Overall Study|Adverse Event|5|||
154953155|NCT00440557|559254599|FG000|Overall Study|Death|2|||
154953156|NCT00440557|559254600|FG001|Overall Study|Death|6|||
154953157|NCT00440557|559254601|FG002|Overall Study|Death|3|||
154953158|NCT00440557|559254599|FG000|Overall Study|Began Dialysis|4|||
154953159|NCT00440557|559254600|FG001|Overall Study|Began Dialysis|1|||
154953160|NCT00440557|559254601|FG002|Overall Study|Began Dialysis|4|||
154953161|NCT00440557|559254599|FG000|Overall Study|Principal Investigator decision|0|||
154953162|NCT00440557|559254600|FG001|Overall Study|Principal Investigator decision|3|||
154953163|NCT00440557|559254601|FG002|Overall Study|Principal Investigator decision|1|||
154953164|NCT00440557|559254599|FG000|Overall Study|Patient moved|1|||
154953165|NCT00440557|559254600|FG001|Overall Study|Patient moved|2|||
154953166|NCT00440557|559254601|FG002|Overall Study|Patient moved|1|||
154953167|NCT00440557|559254599|FG000|Overall Study|Principal Investigator's office closed|3|||
154953168|NCT00440557|559254600|FG001|Overall Study|Principal Investigator's office closed|6|||
154953169|NCT00440557|559254601|FG002|Overall Study|Principal Investigator's office closed|4|||
154953170|NCT00440557|559254599|FG000|Overall Study|Patient transferred to nursing home|0|||
154953171|NCT00440557|559254600|FG001|Overall Study|Patient transferred to nursing home|1|||
154953172|NCT00440557|559254601|FG002|Overall Study|Patient transferred to nursing home|0|||
154953173|NCT00440557|559254599|FG000|Overall Study|Patient had surgery|1|||
154953174|NCT00440557|559254600|FG001|Overall Study|Patient had surgery|0|||
154953175|NCT00440557|559254601|FG002|Overall Study|Patient had surgery|0|||
154953176|NCT01572948|559254602|FG000|Overall Study|Lost to Follow-up|1|||
154953177|NCT01572948|559254603|FG001|Overall Study|Lost to Follow-up|0|||
154953178|NCT01572948|559254602|FG000|Overall Study|unable to contact|0|||
154953179|NCT01572948|559254603|FG001|Overall Study|unable to contact|1|||
154953180|NCT01126736|559254610|FG000|Overall Study|Death|2|||
154953181|NCT01126736|559254611|FG001|Overall Study|Death|2|||
154953182|NCT01126736|559254612|FG002|Overall Study|Death|1|||
154953183|NCT01126736|559254613|FG003|Overall Study|Death|19|||
154953184|NCT01126736|559254614|FG004|Overall Study|Death|19|||
154953185|NCT01126736|559254610|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
154953186|NCT01126736|559254611|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
154953187|NCT01126736|559254612|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
154953188|NCT01126736|559254613|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
154953189|NCT01126736|559254614|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
154953190|NCT01126736|559254610|FG000|Overall Study|Lost to Follow-up|0|||
154953191|NCT01126736|559254611|FG001|Overall Study|Lost to Follow-up|0|||
154953192|NCT01126736|559254612|FG002|Overall Study|Lost to Follow-up|0|||
154953193|NCT01126736|559254613|FG003|Overall Study|Lost to Follow-up|1|||
154953194|NCT01126736|559254614|FG004|Overall Study|Lost to Follow-up|1|||
154953195|NCT01126736|559254610|FG000|Overall Study|Administrative reasons|0|||
154953196|NCT01126736|559254611|FG001|Overall Study|Administrative reasons|0|||
154953197|NCT01126736|559254612|FG002|Overall Study|Administrative reasons|0|||
154953198|NCT01126736|559254613|FG003|Overall Study|Administrative reasons|0|||
154953199|NCT01126736|559254614|FG004|Overall Study|Administrative reasons|1|||
154953200|NCT01126736|559254610|FG000|Overall Study|Progressive disease|0|||
154953201|NCT01126736|559254611|FG001|Overall Study|Progressive disease|0|||
154953202|NCT01126736|559254612|FG002|Overall Study|Progressive disease|0|||
154953203|NCT01126736|559254613|FG003|Overall Study|Progressive disease|2|||
154953204|NCT01126736|559254614|FG004|Overall Study|Progressive disease|1|||
154953205|NCT01126736|559254610|FG000|Overall Study|Withdrawal by Subject|0|||
154953206|NCT01126736|559254611|FG001|Overall Study|Withdrawal by Subject|0|||
154953207|NCT01126736|559254612|FG002|Overall Study|Withdrawal by Subject|0|||
154953208|NCT01126736|559254613|FG003|Overall Study|Withdrawal by Subject|1|||
154953209|NCT01126736|559254614|FG004|Overall Study|Withdrawal by Subject|1|||
154953210|NCT01126736|559254610|FG000|Overall Study|Other|2|||
154953211|NCT01126736|559254611|FG001|Overall Study|Other|4|||
154953212|NCT01126736|559254612|FG002|Overall Study|Other|4|||
154953213|NCT01126736|559254613|FG003|Overall Study|Other|16|||
154953214|NCT01126736|559254614|FG004|Overall Study|Other|15|||
154953215|NCT00874237|559254615|FG000|Overall Study|Physician Decision|0|||
154953216|NCT00874237|559254616|FG001|Overall Study|Physician Decision|1|||
154953217|NCT00874237|559254617|FG002|Overall Study|Physician Decision|0|||
154953218|NCT00874237|559254618|FG003|Overall Study|Physician Decision|0|||
154953219|NCT00874237|559254619|FG004|Overall Study|Physician Decision|0|||
154953220|NCT00874237|559254620|FG005|Overall Study|Physician Decision|0|||
154953221|NCT00874237|559254615|FG000|Overall Study|Withdrawal by Subject|0|||
154953222|NCT00874237|559254616|FG001|Overall Study|Withdrawal by Subject|0|||
154953223|NCT00874237|559254617|FG002|Overall Study|Withdrawal by Subject|1|||
155397677|NCT01704287|560890407|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
155397678|NCT01704287|560890408|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
155397679|NCT01704287|560890409|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
155397680|NCT01704287|560890410|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
155397681|NCT01704287|560890406|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397682|NCT01704287|560890407|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397683|NCT01704287|560890408|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397684|NCT01704287|560890409|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
155397685|NCT01704287|560890410|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
155397686|NCT04042740|560890411|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
155397687|NCT04042740|560890411|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
155397688|NCT03713034|560890412|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
155397689|NCT03713034|560890413|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
155397690|NCT02615470|560890414|FG000|Overall Study|Lost to Follow-up|21|||
155397691|NCT02615470|560890415|FG001|Overall Study|Lost to Follow-up|32|||
155397692|NCT01717287|560890419|FG000|Overall Study|Lost to Follow-up|0|||
155397693|NCT01717287|560890420|FG001|Overall Study|Lost to Follow-up|2|||
155397694|NCT01717287|560890419|FG000|Overall Study|Protocol Violation|0|||
155397695|NCT01717287|560890420|FG001|Overall Study|Protocol Violation|1|||
155397696|NCT04024228|560890421|FG000|Overall Study|Adverse Event|1|||
155397697|NCT04024228|560890422|FG001|Overall Study|Adverse Event|0|||
155397698|NCT04024228|560890421|FG000|Overall Study|Protocol Deviation|0|||
155397699|NCT04024228|560890422|FG001|Overall Study|Protocol Deviation|2|||
155397700|NCT04024228|560890421|FG000|Overall Study|Withdrawal by Subject|3|||
155397701|NCT04024228|560890422|FG001|Overall Study|Withdrawal by Subject|4|||
155397702|NCT02982590|560890423|FG000|Overall Study|Lost to Follow-up|0|||
155397703|NCT02982590|560890424|FG001|Overall Study|Lost to Follow-up|1|||
155397704|NCT02982590|560890423|FG000|Overall Study|Death|4|||
155397705|NCT02982590|560890424|FG001|Overall Study|Death|0|||
155397706|NCT02163187|560890428|FG000|Overall Study|Device removed|1|||
155397707|NCT02163187|560890429|FG001|Overall Study|Device removed|0|||
155397708|NCT02163187|560890428|FG000|Overall Study|Progressive disease|1|||
155397709|NCT02163187|560890429|FG001|Overall Study|Progressive disease|0|||
155397710|NCT03281668|560890431|FG000|Overall Study|Physician Decision|1|||
155397711|NCT03281668|560890431|FG000|Overall Study|scheduling conflict, family circumstance|2|||
155397712|NCT03281668|560890431|FG000|Overall Study|Withdrawal by Subject|4|||
155397713|NCT03281668|560890431|FG000|Overall Study|Lost to Follow-up|1|||
155397714|NCT02234479|560890433|FG000|Overall Study|Withdrawal by Subject|1|||
155397715|NCT02234479|560890434|FG001|Overall Study|Withdrawal by Subject|3|||
155397716|NCT00677820|560890437|FG000|Overall Study|Lost to Follow-up|1|||
155397717|NCT00677820|560890438|FG001|Overall Study|Lost to Follow-up|0|||
155397718|NCT02357134|560890442|FG000|Overall Study|Lost to Follow-up|1|||
155397719|NCT02357134|560890443|FG001|Overall Study|Lost to Follow-up|0|||
155397720|NCT02357134|560890444|FG002|Overall Study|Lost to Follow-up|0|||
155397721|NCT02357134|560890445|FG003|Overall Study|Lost to Follow-up|0|||
155397722|NCT02716675|560890446|FG000|Overall Study|Death|2|||
155397723|NCT02716675|560890447|FG001|Overall Study|Death|3|||
155397724|NCT02716675|560890448|FG002|Overall Study|Death|0|||
155397725|NCT02716675|560890446|FG000|Overall Study|Physician Decision|2|||
155397726|NCT02716675|560890447|FG001|Overall Study|Physician Decision|1|||
155397727|NCT02716675|560890448|FG002|Overall Study|Physician Decision|1|||
155397728|NCT02716675|560890446|FG000|Overall Study|Lost to Follow-up|100|||
155397729|NCT02716675|560890447|FG001|Overall Study|Lost to Follow-up|87|||
155397730|NCT02716675|560890448|FG002|Overall Study|Lost to Follow-up|99|||
155397731|NCT02716675|560890446|FG000|Overall Study|Withdrawal by Subject|22|||
155397732|NCT02716675|560890447|FG001|Overall Study|Withdrawal by Subject|25|||
155397733|NCT02716675|560890448|FG002|Overall Study|Withdrawal by Subject|20|||
155397734|NCT02716675|560890446|FG000|Overall Study|Protocol Violation|0|||
155397735|NCT02716675|560890447|FG001|Overall Study|Protocol Violation|3|||
155397736|NCT02716675|560890448|FG002|Overall Study|Protocol Violation|1|||
155397737|NCT02716675|560890446|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
155397738|NCT02716675|560890447|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
155397739|NCT02716675|560890448|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
155397740|NCT02716675|560890446|FG000|Overall Study|Other|38|||
155397741|NCT02716675|560890447|FG001|Overall Study|Other|47|||
155397742|NCT02716675|560890448|FG002|Overall Study|Other|48|||
155397743|NCT00290290|560890453|FG000|Overall Study|Death|3|||
155397744|NCT00290290|560890454|FG001|Overall Study|Death|4|||
155397745|NCT00290290|560890453|FG000|Overall Study|Withdrawal by Subject|2|||
155397746|NCT00290290|560890454|FG001|Overall Study|Withdrawal by Subject|2|||
155397747|NCT00290290|560890453|FG000|Overall Study|Underwent clean surgical procedure|13|||
155397748|NCT00290290|560890454|FG001|Overall Study|Underwent clean surgical procedure|12|||
155397749|NCT03374995|560890455|FG000|Overall Study|Withdrawal by Subject|0|||
155397750|NCT03374995|560890456|FG001|Overall Study|Withdrawal by Subject|1|||
155397751|NCT01211535|560890459|FG000|Overall Study|Adverse Event|0|||
155397752|NCT01211535|560890460|FG001|Overall Study|Adverse Event|1|||
155397753|NCT05111041|560890468|FG000|Overall Study|Lost to Follow-up|6|||
155397754|NCT05111041|560890469|FG001|Overall Study|Lost to Follow-up|7|||
155397755|NCT05111041|560890468|FG000|Overall Study|Withdrawal by Subject|1|||
155397756|NCT05111041|560890469|FG001|Overall Study|Withdrawal by Subject|0|||
155397757|NCT01011439|560890470|FG000|Overall Study|Death|37|||
155397758|NCT01011439|560890470|FG000|Overall Study|Lost to Follow-up|4|||
155397759|NCT01011439|560890470|FG000|Overall Study|Withdrawal by Subject|1|||
155397760|NCT01011439|560890470|FG000|Overall Study|Sponsor's decision|15|||
155397761|NCT02361944|560890475|FG000|Overall Study|surgery cancellation|0|||
155397762|NCT02361944|560890476|FG001|Overall Study|surgery cancellation|1|||
155397763|NCT03123250|560890477|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
155397764|NCT00773136|560890504|FG000|Overall Study|Physician Decision|2|||
155397765|NCT02463071|560890511|FG000|Overall Study|Adverse Event|3|||
155397766|NCT02463071|560890512|FG001|Overall Study|Adverse Event|5|||
155397767|NCT02463071|560890513|FG002|Overall Study|Adverse Event|1|||
155397768|NCT02463071|560890511|FG000|Overall Study|Death|1|||
155397769|NCT02463071|560890512|FG001|Overall Study|Death|0|||
155397770|NCT02463071|560890513|FG002|Overall Study|Death|0|||
155397771|NCT02463071|560890511|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
155397772|NCT02463071|560890512|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155397773|NCT02463071|560890513|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155397774|NCT02463071|560890511|FG000|Overall Study|Reason not specified|7|||
155397775|NCT02463071|560890512|FG001|Overall Study|Reason not specified|9|||
155397776|NCT02463071|560890513|FG002|Overall Study|Reason not specified|4|||
155397777|NCT02463071|560890511|FG000|Overall Study|Protocol Violation|0|||
155397778|NCT02463071|560890512|FG001|Overall Study|Protocol Violation|2|||
155397779|NCT02463071|560890513|FG002|Overall Study|Protocol Violation|0|||
155397780|NCT02463071|560890511|FG000|Overall Study|Lost to Follow-up|0|||
155397781|NCT02463071|560890512|FG001|Overall Study|Lost to Follow-up|0|||
155397782|NCT02463071|560890513|FG002|Overall Study|Lost to Follow-up|1|||
155397783|NCT00175877|560890529|FG000|Overall Study|Adverse Event|136|||
155397784|NCT00175877|560890529|FG000|Overall Study|Withdrawal by Subject|141|||
155397785|NCT00175877|560890529|FG000|Overall Study|Lost to Follow-up|9|||
155397786|NCT00175877|560890529|FG000|Overall Study|Lack of Efficacy|26|||
155397787|NCT00175877|560890529|FG000|Overall Study|Protocol Violation|15|||
155397788|NCT00175877|560890529|FG000|Overall Study|Other Reason|20|||
155397789|NCT00175877|560890529|FG000|Overall Study|AE & Other|1|||
155397790|NCT00175877|560890529|FG000|Overall Study|Withdrawal by subject & Other|1|||
155397791|NCT03061175|560890533|FG000|Baseline|Participant was deemed ineligible|1|||
155397792|NCT03061175|560890534|FG001|Baseline|Participant was deemed ineligible|0|||
155397793|NCT03061175|560890533|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
155397794|NCT03061175|560890534|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
155397795|NCT03061175|560890533|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
155397796|NCT03061175|560890534|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
155397797|NCT03061175|560890533|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
155397798|NCT03061175|560890534|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
155397799|NCT00760669|560890535|FG000|Overall Study|Not assessed for overall improvement|18|||
155397800|NCT00760669|560890535|FG000|Overall Study|Participants missing efficacy assessment|6|||
155397801|NCT00760669|560890535|FG000|Overall Study|Participants with overlapping cases|1|||
155397802|NCT00760669|560890535|FG000|Overall Study|Took drug before entering in contract|5|||
155397803|NCT02003014|560890536|FG000|Overall Study|Case report forms uncollected|9|||
155397804|NCT02003014|560890536|FG000|Overall Study|Treatment started after contract period|1|||
155397805|NCT02003014|560890536|FG000|Overall Study|Patient did not visit the study site|5|||
155397806|NCT02003014|560890536|FG000|Overall Study|Investigator's transfer|4|||
155397807|NCT02456662|560890539|FG000|Overall Study|Lost to Follow-up|2|||
155397808|NCT02456662|560890540|FG001|Overall Study|Lost to Follow-up|1|||
155397809|NCT00504153|560890545|FG000|Overall Study|Withdrawal by Subject|1|||
155397810|NCT00504153|560890545|FG000|Overall Study|Adverse Event|4|||
155397811|NCT00504153|560890545|FG000|Overall Study|Death|1|||
155397812|NCT00074581|560890546|FG000|Overall Study|Death|15|||
155397813|NCT00074581|560890547|FG001|Overall Study|Death|16|||
155397814|NCT00074581|560890546|FG000|Overall Study|Withdrawal by Subject|50|||
155397815|NCT00074581|560890547|FG001|Overall Study|Withdrawal by Subject|49|||
155397816|NCT00074581|560890546|FG000|Overall Study|Unable to adhere to visit schedule|13|||
155397817|NCT00074581|560890547|FG001|Overall Study|Unable to adhere to visit schedule|14|||
155397818|NCT00074581|560890546|FG000|Overall Study|Relocated|14|||
155397819|NCT00074581|560890547|FG001|Overall Study|Relocated|9|||
155397820|NCT00074581|560890546|FG000|Overall Study|Were withdrawn by investigator|5|||
155397821|NCT00074581|560890547|FG001|Overall Study|Were withdrawn by investigator|2|||
155397822|NCT00074581|560890546|FG000|Overall Study|Lost to Follow-up|16|||
155397823|NCT00074581|560890547|FG001|Overall Study|Lost to Follow-up|11|||
155397824|NCT00074581|560890546|FG000|Overall Study|Ended relationship w. index participant|117|||
155397825|NCT00074581|560890547|FG001|Overall Study|Ended relationship w. index participant|106|||
155397826|NCT00074581|560890546|FG000|Overall Study|Other|14|||
155397827|NCT00074581|560890547|FG001|Overall Study|Other|19|||
155397828|NCT00617604|560890548|FG000|Overall Study|Death|2|||
155397829|NCT00617604|560890549|FG001|Overall Study|Death|1|||
155397830|NCT00617604|560890548|FG000|Overall Study|Lost to Follow-up|1|||
155397831|NCT00617604|560890549|FG001|Overall Study|Lost to Follow-up|0|||
155397832|NCT00617604|560890548|FG000|Overall Study|Miscellaneous Reasons|8|||
155397833|NCT00617604|560890549|FG001|Overall Study|Miscellaneous Reasons|10|||
155397834|NCT00617604|560890548|FG000|Overall Study|Withdrawal by Subject|4|||
155397835|NCT00617604|560890549|FG001|Overall Study|Withdrawal by Subject|6|||
155397836|NCT00617604|560890548|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
155397837|NCT00617604|560890549|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
155397838|NCT01708291|560890550|FG000|Overall Study|fighting|2|||
155397839|NCT01708291|560890551|FG001|Overall Study|fighting|1|||
155397840|NCT00805025|560890553|FG000|Overall Study|Screened but not enrolled/treated|42|||
155397841|NCT00805025|560890553|FG000|Overall Study|Adverse Event|4|||
155397842|NCT00805025|560890553|FG000|Overall Study|Withdrawal by Subject|2|||
155397843|NCT00805025|560890553|FG000|Overall Study|Physician Decision|1|||
155397844|NCT04029961|560890554|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
155397845|NCT04029961|560890555|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
155397846|NCT04029961|560890554|FG000|Overall Study|Change in Treatment Course|0|||
155397847|NCT04029961|560890555|FG001|Overall Study|Change in Treatment Course|1|||
155397848|NCT00688155|560890556|FG000|Overall Study|Withdrawal by Subject|2|||
155397849|NCT00688155|560890557|FG001|Overall Study|Withdrawal by Subject|2|||
155397850|NCT00688155|560890558|FG002|Overall Study|Withdrawal by Subject|1|||
155397851|NCT00688155|560890559|FG003|Overall Study|Withdrawal by Subject|1|||
155397852|NCT00382720|560892014|FG000|Overall Study|Adverse Event|21|||
155397853|NCT00382720|560892015|FG001|Overall Study|Adverse Event|23|||
155397854|NCT00382720|560892016|FG002|Overall Study|Adverse Event|15|||
155397855|NCT00382720|560892014|FG000|Overall Study|Protocol Violation|2|||
155397856|NCT00382720|560892015|FG001|Overall Study|Protocol Violation|5|||
155397857|NCT00382720|560892016|FG002|Overall Study|Protocol Violation|1|||
155397858|NCT00382720|560892014|FG000|Overall Study|Death|0|||
155397859|NCT00382720|560892015|FG001|Overall Study|Death|1|||
155397860|NCT00382720|560892016|FG002|Overall Study|Death|2|||
155397861|NCT00382720|560892014|FG000|Overall Study|Progressive disease|37|||
155397862|NCT00382720|560892015|FG001|Overall Study|Progressive disease|28|||
155397863|NCT00382720|560892016|FG002|Overall Study|Progressive disease|38|||
155397864|NCT00382720|560892014|FG000|Overall Study|Withdrew consent|1|||
155397865|NCT00382720|560892015|FG001|Overall Study|Withdrew consent|1|||
155397866|NCT00382720|560892016|FG002|Overall Study|Withdrew consent|2|||
155397867|NCT00382720|560892014|FG000|Overall Study|Withdrawal by Subject|11|||
155397868|NCT00382720|560892015|FG001|Overall Study|Withdrawal by Subject|20|||
155397869|NCT00382720|560892016|FG002|Overall Study|Withdrawal by Subject|12|||
155397870|NCT00382720|560892014|FG000|Overall Study|Surgery|1|||
155397871|NCT00382720|560892015|FG001|Overall Study|Surgery|1|||
155397872|NCT00382720|560892016|FG002|Overall Study|Surgery|4|||
155397873|NCT00382720|560892014|FG000|Overall Study|Patient did not receive study medication|1|||
155397874|NCT00382720|560892015|FG001|Overall Study|Patient did not receive study medication|1|||
155397875|NCT00382720|560892016|FG002|Overall Study|Patient did not receive study medication|4|||
155397876|NCT00382720|560892014|FG000|Overall Study|Clinically progressive disease|0|||
155397877|NCT00382720|560892015|FG001|Overall Study|Clinically progressive disease|1|||
155397878|NCT00382720|560892016|FG002|Overall Study|Clinically progressive disease|0|||
155397879|NCT00382720|560892014|FG000|Overall Study|Good prognosis|0|||
155397880|NCT00382720|560892015|FG001|Overall Study|Good prognosis|1|||
155397881|NCT00382720|560892016|FG002|Overall Study|Good prognosis|0|||
155397882|NCT00382720|560892014|FG000|Overall Study|Investigator/Clinical decision|5|||
155397883|NCT00382720|560892015|FG001|Overall Study|Investigator/Clinical decision|6|||
155397884|NCT00382720|560892016|FG002|Overall Study|Investigator/Clinical decision|6|||
155397885|NCT00382720|560892014|FG000|Overall Study|Discontinued at end of study|0|||
155397886|NCT00382720|560892015|FG001|Overall Study|Discontinued at end of study|1|||
155397887|NCT00382720|560892016|FG002|Overall Study|Discontinued at end of study|2|||
155397888|NCT01858532|560892019|FG000|Overall Study|Adverse Event|58|||
155397889|NCT01858532|560892020|FG001|Overall Study|Adverse Event|50|||
155397890|NCT01858532|560892021|FG002|Overall Study|Adverse Event|23|||
155397891|NCT01858532|560892022|FG003|Overall Study|Adverse Event|28|||
155397892|NCT01858532|560892019|FG000|Overall Study|Withdrew consent|71|||
155397893|NCT01858532|560892020|FG001|Overall Study|Withdrew consent|93|||
155153623|NCT01231984|560000392|FG003|Study Period 1|Non-compliance with study requirements|1|||
155397894|NCT01858532|560892021|FG002|Overall Study|Withdrew consent|46|||
155397895|NCT01858532|560892022|FG003|Overall Study|Withdrew consent|27|||
155397896|NCT01858532|560892019|FG000|Overall Study|Lost to Follow-up|17|||
155397897|NCT01858532|560892020|FG001|Overall Study|Lost to Follow-up|26|||
155397898|NCT01858532|560892021|FG002|Overall Study|Lost to Follow-up|11|||
155397899|NCT01858532|560892022|FG003|Overall Study|Lost to Follow-up|14|||
155397900|NCT01858532|560892019|FG000|Overall Study|Deterioration of medical status|3|||
155397901|NCT01858532|560892020|FG001|Overall Study|Deterioration of medical status|4|||
155397902|NCT01858532|560892021|FG002|Overall Study|Deterioration of medical status|3|||
155397903|NCT01858532|560892022|FG003|Overall Study|Deterioration of medical status|7|||
155397904|NCT01858532|560892019|FG000|Overall Study|Investigator request|3|||
155397905|NCT01858532|560892020|FG001|Overall Study|Investigator request|4|||
155397906|NCT01858532|560892021|FG002|Overall Study|Investigator request|2|||
155397907|NCT01858532|560892022|FG003|Overall Study|Investigator request|6|||
155397908|NCT01858532|560892019|FG000|Overall Study|Other, not specified|29|||
155397909|NCT01858532|560892020|FG001|Overall Study|Other, not specified|15|||
155397910|NCT01858532|560892021|FG002|Overall Study|Other, not specified|13|||
155397911|NCT01858532|560892022|FG003|Overall Study|Other, not specified|11|||
155397912|NCT00514514|560892023|FG000|Pre-phase|Death|10|||
155397913|NCT00514514|560892024|FG001|Pre-phase|Death|0|||
155397914|NCT00514514|560892025|FG002|Pre-phase|Death|0|||
155397915|NCT00514514|560892023|FG000|Pre-phase|administrative problems|2|||
155397916|NCT00514514|560892024|FG001|Pre-phase|administrative problems|0|||
155397917|NCT00514514|560892025|FG002|Pre-phase|administrative problems|0|||
155397918|NCT00514514|560892023|FG000|Pre-phase|Protocol Violation|6|||
155397919|NCT00514514|560892024|FG001|Pre-phase|Protocol Violation|0|||
155397920|NCT00514514|560892025|FG002|Pre-phase|Protocol Violation|0|||
155397921|NCT00514514|560892023|FG000|Pre-phase|condition no longer requires study drug|7|||
155397922|NCT00514514|560892024|FG001|Pre-phase|condition no longer requires study drug|0|||
155397923|NCT00514514|560892025|FG002|Pre-phase|condition no longer requires study drug|0|||
155397924|NCT00514514|560892023|FG000|Pre-phase|abnormal test procedure results|15|||
155397925|NCT00514514|560892024|FG001|Pre-phase|abnormal test procedure results|0|||
155153624|NCT01231984|560000389|FG000|Study Period 1|Protocol Violation|3|||
155153625|NCT01231984|560000390|FG001|Study Period 1|Protocol Violation|4|||
155153626|NCT01231984|560000391|FG002|Study Period 1|Protocol Violation|2|||
155153627|NCT01231984|560000392|FG003|Study Period 1|Protocol Violation|3|||
155153628|NCT01231984|560000389|FG000|Study Period 1|Adverse Event|1|||
155153629|NCT01231984|560000390|FG001|Study Period 1|Adverse Event|0|||
155153630|NCT01231984|560000391|FG002|Study Period 1|Adverse Event|0|||
155153631|NCT01231984|560000392|FG003|Study Period 1|Adverse Event|0|||
155153632|NCT01231984|560000389|FG000|Study Period 1|Other|0|||
155153633|NCT01231984|560000390|FG001|Study Period 1|Other|0|||
155153634|NCT01231984|560000391|FG002|Study Period 1|Other|0|||
155153635|NCT01231984|560000392|FG003|Study Period 1|Other|1|||
155153636|NCT01231984|560000389|FG000|Study Period 2|Withdrawal by Subject|1|||
155153637|NCT01231984|560000390|FG001|Study Period 2|Withdrawal by Subject|1|||
155153638|NCT01231984|560000391|FG002|Study Period 2|Withdrawal by Subject|0|||
155153639|NCT01231984|560000392|FG003|Study Period 2|Withdrawal by Subject|0|||
155153640|NCT01231984|560000389|FG000|Study Period 2|Lost to Follow-up|1|||
155153641|NCT01231984|560000390|FG001|Study Period 2|Lost to Follow-up|0|||
155153642|NCT01231984|560000391|FG002|Study Period 2|Lost to Follow-up|0|||
155153643|NCT01231984|560000392|FG003|Study Period 2|Lost to Follow-up|3|||
155153644|NCT01231984|560000389|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
155153645|NCT01231984|560000390|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
155153646|NCT01231984|560000391|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
155153647|NCT01231984|560000392|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
155153648|NCT02182895|560000395|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
155153649|NCT02182895|560000396|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
155153650|NCT03566511|560000397|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
155153651|NCT03566511|560000398|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
155153652|NCT00981656|560000399|FG000|Overall Study|Protocol Violation|1|||
155153653|NCT00981656|560000399|FG000|Overall Study|Did not start protocol treatment|2|||
155153654|NCT00687596|560000400|FG000|Overall Study|Adverse Event (AE)|10|||
155153655|NCT00687596|560000401|FG001|Overall Study|Adverse Event (AE)|3|||
155153656|NCT00687596|560000400|FG000|Overall Study|Radiological Disease Progression|6|||
155153657|NCT00687596|560000401|FG001|Overall Study|Radiological Disease Progression|2|||
155153658|NCT00687596|560000400|FG000|Overall Study|Clinical Disease Progression|1|||
154953224|NCT00874237|559254618|FG003|Overall Study|Withdrawal by Subject|0|||
154953225|NCT00874237|559254619|FG004|Overall Study|Withdrawal by Subject|0|||
154953226|NCT00874237|559254620|FG005|Overall Study|Withdrawal by Subject|0|||
154953227|NCT02107092|559254630|FG000|Overall Study|Miscellaneous|3|||
154953228|NCT02107092|559254630|FG000|Overall Study|Subject compliance|3|||
154953229|NCT02107092|559254630|FG000|Overall Study|Hypo-or hyperkalemia|2|||
154953230|NCT02107092|559254630|FG000|Overall Study|Met ECG withdrawal criteria|3|||
155153659|NCT00687596|560000401|FG001|Overall Study|Clinical Disease Progression|3|||
155153660|NCT00687596|560000400|FG000|Overall Study|Investigator Discretion|3|||
155397926|NCT00514514|560892025|FG002|Pre-phase|abnormal test procedure results|0|||
155397927|NCT00514514|560892023|FG000|Pre-phase|Lost to Follow-up|2|||
155397928|NCT00514514|560892024|FG001|Pre-phase|Lost to Follow-up|0|||
155397929|NCT00514514|560892025|FG002|Pre-phase|Lost to Follow-up|0|||
155397930|NCT00514514|560892023|FG000|Pre-phase|abnormal lab values|23|||
154953231|NCT02107092|559254630|FG000|Overall Study|Physician Decision|3|||
154953232|NCT02107092|559254630|FG000|Overall Study|Lost to Follow-up|2|||
155153661|NCT00687596|560000401|FG001|Overall Study|Investigator Discretion|1|||
155283990|NCT01515319|560470911|FG007|Overall Study|Withdrawal by Subject|0|||
155397931|NCT00514514|560892024|FG001|Pre-phase|abnormal lab values|0|||
155153662|NCT00687596|560000400|FG000|Overall Study|Sponsor Terminated Study|6|||
155153663|NCT00687596|560000401|FG001|Overall Study|Sponsor Terminated Study|17|||
155153664|NCT02903771|560000402|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
155397932|NCT00514514|560892025|FG002|Pre-phase|abnormal lab values|0|||
155397933|NCT00514514|560892023|FG000|Pre-phase|Lack of Efficacy|35|||
155397934|NCT00514514|560892024|FG001|Pre-phase|Lack of Efficacy|0|||
155397935|NCT00514514|560892025|FG002|Pre-phase|Lack of Efficacy|0|||
155397936|NCT00514514|560892023|FG000|Pre-phase|Adverse Event|137|||
155397937|NCT00514514|560892024|FG001|Pre-phase|Adverse Event|0|||
155153665|NCT02903771|560000403|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
155153666|NCT02903771|560000404|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
155153667|NCT02903771|560000405|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
155153668|NCT02903771|560000406|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
155153669|NCT02903771|560000407|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
155153670|NCT02903771|560000408|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
155153671|NCT02903771|560000402|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
155153672|NCT02903771|560000403|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
155153673|NCT02903771|560000404|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
155153674|NCT02903771|560000405|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
155153675|NCT02903771|560000406|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
155153676|NCT02903771|560000407|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
155153677|NCT02903771|560000408|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
155153678|NCT02903771|560000402|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155153679|NCT02903771|560000403|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155153680|NCT02903771|560000404|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
155153681|NCT02903771|560000405|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155153682|NCT02903771|560000406|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155153683|NCT02903771|560000407|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
155153684|NCT02903771|560000408|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
155153685|NCT02903771|560000402|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155153686|NCT02903771|560000403|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155153687|NCT02903771|560000404|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155153688|NCT02903771|560000405|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155153689|NCT02903771|560000406|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
155153690|NCT02903771|560000407|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155153691|NCT02903771|560000408|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
155153692|NCT02903771|560000402|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
155153693|NCT02903771|560000403|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
155397938|NCT00514514|560892025|FG002|Pre-phase|Adverse Event|0|||
155397939|NCT00514514|560892023|FG000|Pre-phase|Withdrawal by Subject|66|||
155153694|NCT02903771|560000404|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
155153695|NCT02903771|560000405|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
155153696|NCT02903771|560000406|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
155153697|NCT02903771|560000407|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
155153698|NCT02903771|560000408|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
155153699|NCT02903771|560000402|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155153700|NCT02903771|560000403|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155153701|NCT02903771|560000404|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155397940|NCT00514514|560892024|FG001|Pre-phase|Withdrawal by Subject|0|||
155397941|NCT00514514|560892025|FG002|Pre-phase|Withdrawal by Subject|0|||
155397942|NCT00514514|560892023|FG000|Randomized - 9 Month|Death|3|||
155397943|NCT00514514|560892024|FG001|Randomized - 9 Month|Death|2|||
155397944|NCT00514514|560892025|FG002|Randomized - 9 Month|Death|2|||
155397945|NCT00514514|560892023|FG000|Randomized - 9 Month|Administrative problems|1|||
155397946|NCT00514514|560892024|FG001|Randomized - 9 Month|Administrative problems|1|||
155397947|NCT00514514|560892025|FG002|Randomized - 9 Month|Administrative problems|2|||
155397948|NCT00514514|560892023|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
155397949|NCT00514514|560892024|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
155397950|NCT00514514|560892025|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
155397951|NCT00514514|560892023|FG000|Randomized - 9 Month|Protocol Violation|1|||
155397952|NCT00514514|560892024|FG001|Randomized - 9 Month|Protocol Violation|1|||
155397953|NCT00514514|560892025|FG002|Randomized - 9 Month|Protocol Violation|0|||
155397954|NCT00514514|560892023|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
155153702|NCT02903771|560000405|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155153703|NCT02903771|560000406|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
155397955|NCT00514514|560892024|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
155397956|NCT00514514|560892025|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
155153704|NCT02903771|560000407|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155153705|NCT02903771|560000408|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
155397957|NCT00514514|560892023|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
155397958|NCT00514514|560892024|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
155397959|NCT00514514|560892025|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
155397960|NCT00514514|560892023|FG000|Randomized - 9 Month|Adverse Event|25|||
155397961|NCT00514514|560892024|FG001|Randomized - 9 Month|Adverse Event|44|||
155397962|NCT00514514|560892025|FG002|Randomized - 9 Month|Adverse Event|27|||
155397963|NCT00514514|560892023|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
155397964|NCT00514514|560892024|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
155397965|NCT00514514|560892025|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
155397966|NCT00514514|560892023|FG000|Extension - 4 Years|Lost to Follow-up|12|||
155397967|NCT00514514|560892024|FG001|Extension - 4 Years|Lost to Follow-up|10|||
155397968|NCT00514514|560892025|FG002|Extension - 4 Years|Lost to Follow-up|9|||
155397969|NCT00514514|560892023|FG000|Extension - 4 Years|Administrative problems|3|||
155397970|NCT00514514|560892024|FG001|Extension - 4 Years|Administrative problems|1|||
155397971|NCT00514514|560892025|FG002|Extension - 4 Years|Administrative problems|1|||
155397972|NCT00514514|560892023|FG000|Extension - 4 Years|Death|8|||
155397973|NCT00514514|560892024|FG001|Extension - 4 Years|Death|3|||
155397974|NCT00514514|560892025|FG002|Extension - 4 Years|Death|6|||
155397975|NCT00514514|560892023|FG000|Extension - 4 Years|Adverse Event|9|||
155397976|NCT00514514|560892024|FG001|Extension - 4 Years|Adverse Event|6|||
155397977|NCT00514514|560892025|FG002|Extension - 4 Years|Adverse Event|3|||
155397978|NCT00762892|560892031|FG000|Overall Study|Lost to Follow-up|2|||
155397979|NCT00762892|560892032|FG001|Overall Study|Lost to Follow-up|5|||
155397980|NCT00762892|560892031|FG000|Overall Study|Withdrawal by Subject|0|||
155397981|NCT00762892|560892032|FG001|Overall Study|Withdrawal by Subject|1|||
155397982|NCT00762892|560892031|FG000|Overall Study|Death|1|||
155397983|NCT00762892|560892032|FG001|Overall Study|Death|0|||
155397984|NCT00762892|560892031|FG000|Overall Study|Pregnancy|1|||
155397985|NCT00762892|560892032|FG001|Overall Study|Pregnancy|0|||
155397986|NCT00762892|560892031|FG000|Overall Study|Incarceration|1|||
155397987|NCT00762892|560892032|FG001|Overall Study|Incarceration|0|||
155397988|NCT01848288|560892035|FG000|Overall Study|Death|1|||
155397989|NCT01848288|560892035|FG000|Overall Study|Protocol Violation|1|||
155397990|NCT01848288|560892035|FG000|Overall Study|Withdrawal by Subject|1|||
155283991|NCT01515319|560470912|FG008|Overall Study|Withdrawal by Subject|0|||
155283992|NCT01515319|560470913|FG009|Overall Study|Withdrawal by Subject|0|||
155283993|NCT01515319|560470904|FG000|Overall Study|Adverse Event|0|||
155283994|NCT01515319|560470905|FG001|Overall Study|Adverse Event|0|||
155153706|NCT02903771|560000402|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155153707|NCT02903771|560000403|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155153708|NCT02903771|560000404|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155153709|NCT02903771|560000405|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155153710|NCT02903771|560000406|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
155153711|NCT02903771|560000407|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155153712|NCT02903771|560000408|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
155153713|NCT02903771|560000402|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155283995|NCT01515319|560470906|FG002|Overall Study|Adverse Event|0|||
155283996|NCT01515319|560470907|FG003|Overall Study|Adverse Event|0|||
155397991|NCT01841749|560892037|FG000|Overall Study|Protocol Violation|1|||
155397992|NCT01480284|560892045|FG000|Overall Study|Withdrawal by Subject|2|||
155283997|NCT01515319|560470908|FG004|Overall Study|Adverse Event|0|||
155283998|NCT01515319|560470909|FG005|Overall Study|Adverse Event|0|||
155283999|NCT01515319|560470910|FG006|Overall Study|Adverse Event|0|||
155284000|NCT01515319|560470911|FG007|Overall Study|Adverse Event|0|||
155284001|NCT01515319|560470912|FG008|Overall Study|Adverse Event|3|||
155284002|NCT01515319|560470913|FG009|Overall Study|Adverse Event|0|||
155284003|NCT01515319|560470904|FG000|Overall Study|Protocol Violation|0|||
155284004|NCT01515319|560470905|FG001|Overall Study|Protocol Violation|0|||
155284005|NCT01515319|560470906|FG002|Overall Study|Protocol Violation|0|||
155284006|NCT01515319|560470907|FG003|Overall Study|Protocol Violation|0|||
155284007|NCT01515319|560470908|FG004|Overall Study|Protocol Violation|0|||
155284008|NCT01515319|560470909|FG005|Overall Study|Protocol Violation|0|||
155284009|NCT01515319|560470910|FG006|Overall Study|Protocol Violation|0|||
155397993|NCT01480284|560892046|FG001|Overall Study|Withdrawal by Subject|0|||
155397994|NCT01480284|560892045|FG000|Overall Study|Adverse Event|1|||
155397995|NCT01480284|560892046|FG001|Overall Study|Adverse Event|0|||
155284010|NCT01515319|560470911|FG007|Overall Study|Protocol Violation|0|||
155284011|NCT01515319|560470912|FG008|Overall Study|Protocol Violation|2|||
155397996|NCT01480284|560892045|FG000|Overall Study|Study closed/terminated|3|||
155397997|NCT01480284|560892046|FG001|Overall Study|Study closed/terminated|0|||
155397998|NCT01480284|560892045|FG000|Overall Study|Lost to Follow-up|1|||
155397999|NCT01480284|560892046|FG001|Overall Study|Lost to Follow-up|0|||
155398000|NCT01480284|560892045|FG000|Overall Study|Physician Decision|1|||
155284012|NCT01515319|560470913|FG009|Overall Study|Protocol Violation|0|||
155284013|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Adverse Event|5|||
155284014|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Adverse Event|13|||
155398001|NCT01480284|560892046|FG001|Overall Study|Physician Decision|0|||
155398002|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
155398003|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
155398004|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
155398005|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
155398006|NCT00066742|560892047|FG000|Induction Chemoradiotherapy|Ineligible|3|||
155398007|NCT00066742|560892047|FG000|Consolidation Chemotherapy|not protocol specified|1|||
155398008|NCT00066742|560892047|FG000|Consolidation Chemotherapy|Ineligible|2|||
155398009|NCT03593850|560892052|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
155398010|NCT03593850|560892053|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
155398011|NCT00003895|560892054|FG000|Overall Study|Adverse Event|4|||
155398012|NCT00003895|560892055|FG001|Overall Study|Adverse Event|0|||
155398013|NCT00003895|560892054|FG000|Overall Study|Lack of Efficacy|1|||
155398014|NCT00003895|560892055|FG001|Overall Study|Lack of Efficacy|1|||
155398015|NCT00003895|560892054|FG000|Overall Study|Patient Vacation|2|||
155398016|NCT00003895|560892055|FG001|Overall Study|Patient Vacation|0|||
155398017|NCT00003895|560892054|FG000|Overall Study|Withdrawal by Subject|0|||
155398018|NCT00003895|560892055|FG001|Overall Study|Withdrawal by Subject|3|||
155398019|NCT01380730|560892056|FG000|Overall Study|Death|0|||
155398020|NCT01380730|560892057|FG001|Overall Study|Death|0|||
155398021|NCT01380730|560892058|FG002|Overall Study|Death|0|||
155398022|NCT01380730|560892059|FG003|Overall Study|Death|0|||
155398023|NCT01380730|560892060|FG004|Overall Study|Death|1|||
155398024|NCT01380730|560892061|FG005|Overall Study|Death|0|||
155398025|NCT01380730|560892062|FG006|Overall Study|Death|0|||
155398026|NCT01380730|560892063|FG007|Overall Study|Death|0|||
155398027|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
155398028|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
155398029|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
155398030|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
155398031|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
155398032|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
155398033|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
155398034|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
155398035|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
155398036|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
155398037|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
155398038|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
155398039|NCT02490475|560892064|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
155398040|NCT02490475|560892065|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
155398041|NCT02490475|560892066|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
155398042|NCT02490475|560892067|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
155398043|NCT02490475|560892064|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
155398044|NCT02490475|560892065|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
155398045|NCT02490475|560892066|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
155398046|NCT02490475|560892067|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
155398047|NCT02490475|560892064|FG000|Period 2: Extension Phase|Refused Treatment|0|||
155398048|NCT02490475|560892065|FG001|Period 2: Extension Phase|Refused Treatment|0|||
155398049|NCT02490475|560892066|FG002|Period 2: Extension Phase|Refused Treatment|0|||
155398050|NCT02490475|560892067|FG003|Period 2: Extension Phase|Refused Treatment|1|||
155398051|NCT02490475|560892064|FG000|Period 2: Extension Phase|Adverse Event|0|||
155398052|NCT02490475|560892065|FG001|Period 2: Extension Phase|Adverse Event|0|||
155398053|NCT02490475|560892066|FG002|Period 2: Extension Phase|Adverse Event|1|||
155398054|NCT02490475|560892067|FG003|Period 2: Extension Phase|Adverse Event|0|||
155398055|NCT01195090|560892069|FG000|Overall Study|Adverse Event|1|||
155398056|NCT01195090|560892070|FG001|Overall Study|Adverse Event|2|||
155398057|NCT01195090|560892069|FG000|Overall Study|Lost to Follow-up|2|||
155398058|NCT01195090|560892070|FG001|Overall Study|Lost to Follow-up|2|||
155398059|NCT01195090|560892069|FG000|Overall Study|Protocol Violation|3|||
155398060|NCT01195090|560892070|FG001|Overall Study|Protocol Violation|4|||
155398061|NCT04784897|560892071|FG000|Overall Study|Death|4|||
155398062|NCT04784897|560892072|FG001|Overall Study|Death|2|||
155284015|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Adverse Event|0|||
155398063|NCT04784897|560892073|FG002|Overall Study|Death|1|||
155398064|NCT04784897|560892071|FG000|Overall Study|Withdrawal by Subject|0|||
155398065|NCT04784897|560892072|FG001|Overall Study|Withdrawal by Subject|0|||
155398066|NCT04784897|560892073|FG002|Overall Study|Withdrawal by Subject|1|||
155398067|NCT01236573|560892074|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398068|NCT01236573|560892075|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398069|NCT01236573|560892076|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398070|NCT01236573|560892077|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398071|NCT01236573|560892078|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398072|NCT01236573|560892079|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398073|NCT01236573|560892080|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
155398074|NCT01236573|560892081|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398075|NCT01236573|560892082|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
155398076|NCT01236573|560892083|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
155398077|NCT01236573|560892084|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
155398078|NCT01236573|560892074|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398079|NCT01236573|560892075|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398080|NCT01236573|560892076|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398081|NCT01236573|560892077|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398082|NCT01236573|560892078|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398083|NCT01236573|560892079|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398084|NCT01236573|560892080|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398085|NCT01236573|560892081|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398086|NCT01236573|560892082|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
155398087|NCT01236573|560892083|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398088|NCT01236573|560892084|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
155398089|NCT01236573|560892074|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398090|NCT01236573|560892075|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398091|NCT01236573|560892076|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398092|NCT01236573|560892077|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398093|NCT01236573|560892078|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398094|NCT01236573|560892079|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398095|NCT01236573|560892080|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398096|NCT01236573|560892081|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398097|NCT01236573|560892082|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398098|NCT01236573|560892083|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
155398099|NCT01236573|560892084|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
155398100|NCT00823823|560892087|FG000|Overall Study|Lost to Follow-up|3|||
155398101|NCT00823823|560892088|FG001|Overall Study|Lost to Follow-up|1|||
155398102|NCT00823823|560892087|FG000|Overall Study|Protocol Violation|5|||
155398103|NCT00823823|560892088|FG001|Overall Study|Protocol Violation|5|||
155398104|NCT04754802|560892089|FG000|Overall Study|Lost to Follow-up|0|||
155398105|NCT04754802|560892090|FG001|Overall Study|Lost to Follow-up|2|||
155398106|NCT04754802|560892089|FG000|Overall Study|Withdrawal by Subject|2|||
155398107|NCT04754802|560892090|FG001|Overall Study|Withdrawal by Subject|0|||
155398108|NCT04569032|560892091|FG000|Overall Study|Death|10|||
155398109|NCT04569032|560892092|FG001|Overall Study|Death|13|||
155398110|NCT04569032|560892091|FG000|Overall Study|Withdrawal by Subject|2|||
155398111|NCT04569032|560892092|FG001|Overall Study|Withdrawal by Subject|0|||
155398112|NCT04569032|560892091|FG000|Overall Study|Lost to Follow-up|0|||
155398113|NCT04569032|560892092|FG001|Overall Study|Lost to Follow-up|1|||
155398114|NCT04569032|560892091|FG000|Overall Study|In long term follow up|22|||
155398115|NCT04569032|560892092|FG001|Overall Study|In long term follow up|34|||
155398116|NCT01490814|560892109|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
155153714|NCT02903771|560000403|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155153715|NCT02903771|560000404|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155153716|NCT02903771|560000405|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155153717|NCT02903771|560000406|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
155153718|NCT02903771|560000407|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155153719|NCT02903771|560000408|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
155153720|NCT02903771|560000402|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155153721|NCT02903771|560000403|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155153722|NCT02903771|560000404|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155153723|NCT02903771|560000405|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155153724|NCT02903771|560000406|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
155153725|NCT02903771|560000407|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155398117|NCT01490814|560892110|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
155398118|NCT01490814|560892109|FG000|Overall Study|Physician Decision|1|||
155398119|NCT01490814|560892110|FG001|Overall Study|Physician Decision|0|||
155398120|NCT01490814|560892109|FG000|Overall Study|Withdrawal by Subject|0|||
155398121|NCT01490814|560892110|FG001|Overall Study|Withdrawal by Subject|5|||
155398122|NCT00496730|560892111|FG000|Overall Study|Lost to Follow-up|4|||
154953233|NCT02107092|559254630|FG000|Overall Study|Withdrawal by Subject|9|||
154953234|NCT02107092|559254630|FG000|Overall Study|Adverse Event|7|||
154953235|NCT02107092|559254630|FG000|Overall Study|Expected progression of CKD|12|||
154953236|NCT00537030|559254631|FG000|Overall Study|Physician Decision|2|||
154953237|NCT00537030|559254631|FG000|Overall Study|Withdrawal by Subject|2|||
154953238|NCT00537030|559254631|FG000|Overall Study|≥ Grade 2 allergy|7|||
154953239|NCT00537030|559254631|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
154953240|NCT00537030|559254631|FG000|Overall Study|Ineligible|2|||
154953241|NCT00537030|559254631|FG000|Overall Study|Inevaluable|2|||
154953242|NCT01496183|559254633|FG000|Overall Study|Physician Decision|3|||
154953243|NCT01496183|559254634|FG001|Overall Study|Physician Decision|1|||
155398123|NCT00496730|560892112|FG001|Overall Study|Lost to Follow-up|3|||
155398124|NCT00496730|560892111|FG000|Overall Study|Withdrawal by Subject|2|||
155398125|NCT00496730|560892112|FG001|Overall Study|Withdrawal by Subject|2|||
155398126|NCT02170779|560892116|FG000|Overall Study|Withdrawal by Subject|1|||
155398127|NCT02170779|560892117|FG001|Overall Study|Withdrawal by Subject|0|||
155398128|NCT02170779|560892116|FG000|Overall Study|Lost to Follow-up|0|||
155153726|NCT02903771|560000408|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
155153727|NCT02903771|560000402|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155153728|NCT02903771|560000403|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155153729|NCT02903771|560000404|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155153730|NCT02903771|560000405|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155153731|NCT02903771|560000406|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
155153732|NCT02903771|560000407|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155153733|NCT02903771|560000408|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
155153734|NCT02903771|560000402|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155153735|NCT02903771|560000403|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155153736|NCT02903771|560000404|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155153737|NCT02903771|560000405|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155153738|NCT02903771|560000406|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
155153739|NCT02903771|560000407|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155153740|NCT02903771|560000408|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
155153741|NCT01680341|560000411|FG000|Overall Study|Adverse Event|3|||
155153742|NCT01680341|560000412|FG001|Overall Study|Adverse Event|2|||
155153743|NCT01680341|560000411|FG000|Overall Study|Unclassified|18|||
155153744|NCT01680341|560000412|FG001|Overall Study|Unclassified|15|||
155153745|NCT00499486|560000414|FG000|Overall Study|Withdrawal by Subject|16|||
155153746|NCT01867671|560000418|FG000|Overall Study|Adverse Event|5|||
155153747|NCT01867671|560000419|FG001|Overall Study|Adverse Event|3|||
155153748|NCT01867671|560000418|FG000|Overall Study|Anaphylaxis|0|||
155153749|NCT01867671|560000419|FG001|Overall Study|Anaphylaxis|1|||
155153750|NCT01867671|560000418|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
155153751|NCT01867671|560000419|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
155153752|NCT01867671|560000418|FG000|Overall Study|Lost to Follow-up|0|||
155398129|NCT02170779|560892117|FG001|Overall Study|Lost to Follow-up|1|||
155398130|NCT00369785|560892118|FG000|Overall Study|Physician Decision|3|||
155398131|NCT00369785|560892119|FG001|Overall Study|Physician Decision|2|||
155398132|NCT00369785|560892118|FG000|Overall Study|Death|1|||
155398133|NCT00369785|560892119|FG001|Overall Study|Death|2|||
155398134|NCT00369785|560892118|FG000|Overall Study|Withdrawal by Subject|7|||
155153753|NCT01867671|560000419|FG001|Overall Study|Lost to Follow-up|1|||
155153754|NCT01867671|560000418|FG000|Overall Study|Non-compliance with Study Drug|1|||
155153755|NCT01867671|560000419|FG001|Overall Study|Non-compliance with Study Drug|2|||
155153756|NCT01867671|560000418|FG000|Overall Study|Withdrawal by Subject|21|||
155153757|NCT01867671|560000419|FG001|Overall Study|Withdrawal by Subject|21|||
155153758|NCT04914364|560000424|FG000|Overall Study|No longer eligible for study|1|||
155153759|NCT04914364|560000424|FG000|Overall Study|Lost to Follow-up|2|||
155153760|NCT01263769|560000427|FG000|Overall Study|Non-Compliant with treatment|1|||
155153761|NCT05058365|560000430|FG000|Overall Study|Migration|1|||
155153762|NCT05058365|560000431|FG001|Overall Study|Migration|1|||
155153763|NCT00702702|560000432|FG000|Overall Study|Study prematurely terminated|56|||
155153764|NCT04819945|560000433|FG000|Overall Study|Lost to Follow-up|1|||
155153765|NCT00551759|560000434|FG000|Overall Study|Adverse Event|7|||
155153766|NCT00551759|560000434|FG000|Overall Study|Death|5|||
155153767|NCT00551759|560000434|FG000|Overall Study|Ineligible|1|||
155153768|NCT04531176|560000435|FG000|Overall Study|Study was stopped early|24|||
155153769|NCT04531176|560000436|FG001|Overall Study|Study was stopped early|26|||
155153770|NCT04531176|560000437|FG002|Overall Study|Study was stopped early|24|||
155153771|NCT00561652|560000438|FG000|Overall Study|Withdrawal by Subject|0|||
155153772|NCT00561652|560000439|FG001|Overall Study|Withdrawal by Subject|1|||
155153773|NCT00774046|560000445|FG000|Screening|Not eligible|56|||
155153774|NCT00774046|560000445|FG000|Enrollment|Desired other therapy/refused|28|||
155153775|NCT00774046|560000445|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
155153776|NCT00762164|560000446|FG000|Overall Study|Lost to Follow-up|1|||
155153777|NCT00762164|560000447|FG001|Overall Study|Lost to Follow-up|1|||
155153778|NCT00762164|560000446|FG000|Overall Study|Discontinued medication|2|||
155153779|NCT00762164|560000447|FG001|Overall Study|Discontinued medication|0|||
155153780|NCT00762164|560000446|FG000|Overall Study|Withdrawal by Subject|0|||
155153781|NCT00762164|560000447|FG001|Overall Study|Withdrawal by Subject|1|||
155153782|NCT02946580|560000451|FG000|Overall Study|Withdrawal by Subject|1|||
155153783|NCT02946580|560000452|FG001|Overall Study|Withdrawal by Subject|2|||
155153784|NCT02946580|560000451|FG000|Overall Study|Adverse Event|0|||
155398135|NCT00369785|560892119|FG001|Overall Study|Withdrawal by Subject|6|||
155398136|NCT00369785|560892118|FG000|Overall Study|Toxicity|6|||
155398137|NCT00369785|560892119|FG001|Overall Study|Toxicity|4|||
155398138|NCT00369785|560892118|FG000|Overall Study|Never started|0|||
155398139|NCT00369785|560892119|FG001|Overall Study|Never started|2|||
155398140|NCT00369785|560892118|FG000|Overall Study|Progression|4|||
155398141|NCT00369785|560892119|FG001|Overall Study|Progression|4|||
155398142|NCT00369785|560892118|FG000|Overall Study|Multiple reasons|6|||
155398143|NCT00369785|560892119|FG001|Overall Study|Multiple reasons|5|||
155398144|NCT00800683|560892120|FG000|Overall Study|Adverse Event|11|||
155398145|NCT00800683|560892121|FG001|Overall Study|Adverse Event|8|||
155398146|NCT00800683|560892120|FG000|Overall Study|Lost to Follow-up|3|||
155398147|NCT00800683|560892121|FG001|Overall Study|Lost to Follow-up|1|||
155398148|NCT00800683|560892120|FG000|Overall Study|Withdrawal by Subject|1|||
155398149|NCT00800683|560892121|FG001|Overall Study|Withdrawal by Subject|7|||
155398150|NCT00800683|560892120|FG000|Overall Study|Lack of Efficacy|1|||
155398151|NCT00800683|560892121|FG001|Overall Study|Lack of Efficacy|1|||
155398152|NCT00800683|560892120|FG000|Overall Study|Other|1|||
155398153|NCT00800683|560892121|FG001|Overall Study|Other|2|||
155398154|NCT02247960|560892122|FG000|Patient Consent and Randomization|Physician Decision|2|||
155398155|NCT02247960|560892123|FG001|Patient Consent and Randomization|Physician Decision|2|||
155398156|NCT02247960|560892122|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
155398157|NCT02247960|560892123|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
155398158|NCT02247960|560892122|FG000|Catheter Removed|Lost to Follow-up|7|||
155398159|NCT02247960|560892123|FG001|Catheter Removed|Lost to Follow-up|10|||
155398160|NCT01848353|560892126|FG000|Phase 1|Withdrawal by Subject|3|||
155398161|NCT01848353|560892127|FG001|Phase 1|Withdrawal by Subject|1|||
155398162|NCT01848353|560892128|FG002|Phase 1|Withdrawal by Subject|0|||
155398163|NCT01848353|560892129|FG003|Phase 1|Withdrawal by Subject|0|||
155398164|NCT01848353|560892126|FG000|Phase 2|Withdrawal by Subject|3|||
155398165|NCT01848353|560892127|FG001|Phase 2|Withdrawal by Subject|2|||
155398166|NCT01848353|560892128|FG002|Phase 2|Withdrawal by Subject|0|||
155398167|NCT01848353|560892129|FG003|Phase 2|Withdrawal by Subject|0|||
155398168|NCT01848353|560892126|FG000|Phase 3|Withdrawal by Subject|1|||
155398169|NCT01848353|560892127|FG001|Phase 3|Withdrawal by Subject|1|||
155398170|NCT01848353|560892128|FG002|Phase 3|Withdrawal by Subject|0|||
155398171|NCT01848353|560892129|FG003|Phase 3|Withdrawal by Subject|0|||
155398172|NCT00935272|560892132|FG000|Overall Study|Lost to Follow-up|10|||
155398173|NCT00935272|560892133|FG001|Overall Study|Lost to Follow-up|3|||
155398174|NCT00935272|560892132|FG000|Overall Study|Withdrawal by Subject|8|||
155398175|NCT00935272|560892133|FG001|Overall Study|Withdrawal by Subject|2|||
155398176|NCT00935272|560892132|FG000|Overall Study|Physician Decision|1|||
155398177|NCT00935272|560892133|FG001|Overall Study|Physician Decision|0|||
155398178|NCT00935272|560892132|FG000|Overall Study|Protocol Violation|0|||
155398179|NCT00935272|560892133|FG001|Overall Study|Protocol Violation|1|||
155398180|NCT03492554|560892137|FG000|Overall Study|Protocol Violation|0|||
155398181|NCT03492554|560892138|FG001|Overall Study|Protocol Violation|14|||
155398182|NCT04340557|560892142|FG000|Overall Study|Transferred to ICU and/or death|1|||
155398183|NCT04340557|560892143|FG001|Overall Study|Transferred to ICU and/or death|2|||
155398184|NCT00529451|560892144|FG000|Overall Study|Subject withdrew consent|16|||
155398185|NCT00529451|560892145|FG001|Overall Study|Subject withdrew consent|21|||
155398186|NCT00529451|560892146|FG002|Overall Study|Subject withdrew consent|13|||
155398187|NCT00529451|560892147|FG003|Overall Study|Subject withdrew consent|12|||
155398188|NCT00529451|560892144|FG000|Overall Study|Adverse Event|9|||
155398189|NCT00529451|560892145|FG001|Overall Study|Adverse Event|16|||
155398190|NCT00529451|560892146|FG002|Overall Study|Adverse Event|14|||
155153785|NCT02946580|560000452|FG001|Overall Study|Adverse Event|2|||
155398191|NCT00529451|560892147|FG003|Overall Study|Adverse Event|8|||
155398192|NCT00529451|560892144|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
155398193|NCT00529451|560892145|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
155398194|NCT00529451|560892146|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
155398195|NCT00529451|560892147|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
155398196|NCT00529451|560892144|FG000|Overall Study|Lost to Follow-up|4|||
155398197|NCT00529451|560892145|FG001|Overall Study|Lost to Follow-up|7|||
155153786|NCT02946580|560000451|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
155398198|NCT00529451|560892146|FG002|Overall Study|Lost to Follow-up|4|||
155398199|NCT00529451|560892147|FG003|Overall Study|Lost to Follow-up|4|||
155398200|NCT00529451|560892144|FG000|Overall Study|Protocol deviation|1|||
155398201|NCT00529451|560892145|FG001|Overall Study|Protocol deviation|1|||
155398202|NCT00529451|560892146|FG002|Overall Study|Protocol deviation|4|||
155398203|NCT00529451|560892147|FG003|Overall Study|Protocol deviation|1|||
155398204|NCT00529451|560892144|FG000|Overall Study|Administrative problems|1|||
155398205|NCT00529451|560892145|FG001|Overall Study|Administrative problems|1|||
155398206|NCT00529451|560892146|FG002|Overall Study|Administrative problems|0|||
155398207|NCT00529451|560892147|FG003|Overall Study|Administrative problems|2|||
155398208|NCT04305275|560892148|FG000|Overall Study|Adverse Event|4|||
155398209|NCT04305275|560892149|FG001|Overall Study|Adverse Event|0|||
155398210|NCT04305275|560892148|FG000|Overall Study|Lost to Follow-up|1|||
155398211|NCT04305275|560892149|FG001|Overall Study|Lost to Follow-up|1|||
155398212|NCT04305275|560892148|FG000|Overall Study|Withdrawal by Participant|8|||
155398213|NCT04305275|560892149|FG001|Overall Study|Withdrawal by Participant|1|||
155398214|NCT00199836|560892150|FG000|Overall Study|Progressive Disease|5|||
155398215|NCT00199836|560892150|FG000|Overall Study|Death|1|||
155398216|NCT01235793|560892151|FG000|Overall Study|Death|6|||
155398217|NCT02303704|560892154|FG000|Overall Study|Protocol Violation|5|||
155398218|NCT02303704|560892155|FG001|Overall Study|Protocol Violation|9|||
155398219|NCT04411628|560892156|FG000|Overall Study|Withdrawal by Subject|1|||
155153787|NCT02946580|560000452|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
155153788|NCT00685165|560000453|FG000|Washout Period of 14 Days|Adverse Event|1|||
155153789|NCT00685165|560000454|FG001|Washout Period of 14 Days|Adverse Event|0|||
155153790|NCT03050801|560000455|FG000|Experiment 1|Lost to Follow-up|0|||
155153791|NCT03050801|560000456|FG001|Experiment 1|Lost to Follow-up|1|||
155153792|NCT03050801|560000457|FG002|Experiment 1|Lost to Follow-up|0|||
155153793|NCT03050801|560000458|FG003|Experiment 1|Lost to Follow-up|0|||
155153794|NCT03050801|560000459|FG004|Experiment 1|Lost to Follow-up|0|||
155153795|NCT03050801|560000460|FG005|Experiment 1|Lost to Follow-up|0|||
155153796|NCT03050801|560000455|FG000|Experiment 1|Physician Decision|0|||
155153797|NCT03050801|560000456|FG001|Experiment 1|Physician Decision|3|||
155153798|NCT03050801|560000457|FG002|Experiment 1|Physician Decision|0|||
155153799|NCT03050801|560000458|FG003|Experiment 1|Physician Decision|0|||
155153800|NCT03050801|560000459|FG004|Experiment 1|Physician Decision|0|||
155153801|NCT03050801|560000460|FG005|Experiment 1|Physician Decision|0|||
155153802|NCT03050801|560000455|FG000|Experiment 1|Change of experimental design|0|||
155153803|NCT03050801|560000456|FG001|Experiment 1|Change of experimental design|3|||
155153804|NCT03050801|560000457|FG002|Experiment 1|Change of experimental design|0|||
155153805|NCT03050801|560000458|FG003|Experiment 1|Change of experimental design|0|||
155153806|NCT03050801|560000459|FG004|Experiment 1|Change of experimental design|0|||
155153807|NCT03050801|560000460|FG005|Experiment 1|Change of experimental design|0|||
155153808|NCT03050801|560000455|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
155153809|NCT03050801|560000456|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
155153810|NCT03050801|560000457|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
155153811|NCT03050801|560000458|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
155153812|NCT03050801|560000459|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
155153813|NCT03050801|560000460|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
155153814|NCT03050801|560000455|FG000|Experiment 2|Lost to Follow-up|0|||
155153815|NCT03050801|560000456|FG001|Experiment 2|Lost to Follow-up|0|||
155153816|NCT03050801|560000457|FG002|Experiment 2|Lost to Follow-up|0|||
155153817|NCT03050801|560000458|FG003|Experiment 2|Lost to Follow-up|1|||
155153818|NCT03050801|560000459|FG004|Experiment 2|Lost to Follow-up|1|||
155153819|NCT03050801|560000460|FG005|Experiment 2|Lost to Follow-up|0|||
155153820|NCT03050801|560000455|FG000|Experiment 2|Physician Decision|0|||
155153821|NCT03050801|560000456|FG001|Experiment 2|Physician Decision|0|||
155153822|NCT03050801|560000457|FG002|Experiment 2|Physician Decision|0|||
155153823|NCT03050801|560000458|FG003|Experiment 2|Physician Decision|0|||
155153824|NCT03050801|560000459|FG004|Experiment 2|Physician Decision|1|||
155153825|NCT03050801|560000460|FG005|Experiment 2|Physician Decision|0|||
155153826|NCT03050801|560000455|FG000|Experiment 2|Pregnancy|0|||
155153827|NCT03050801|560000456|FG001|Experiment 2|Pregnancy|0|||
155153828|NCT03050801|560000457|FG002|Experiment 2|Pregnancy|0|||
155153829|NCT03050801|560000458|FG003|Experiment 2|Pregnancy|0|||
155153830|NCT03050801|560000459|FG004|Experiment 2|Pregnancy|1|||
155153831|NCT03050801|560000460|FG005|Experiment 2|Pregnancy|0|||
155153832|NCT03050801|560000455|FG000|Experiment 2|Withdrawal by Subject|0|||
155153833|NCT03050801|560000456|FG001|Experiment 2|Withdrawal by Subject|0|||
155153834|NCT03050801|560000457|FG002|Experiment 2|Withdrawal by Subject|0|||
155153835|NCT03050801|560000458|FG003|Experiment 2|Withdrawal by Subject|1|||
155153836|NCT03050801|560000459|FG004|Experiment 2|Withdrawal by Subject|0|||
155153837|NCT03050801|560000460|FG005|Experiment 2|Withdrawal by Subject|0|||
155153838|NCT03050801|560000455|FG000|Experiment 2|Poor data quality|0|||
155153839|NCT03050801|560000456|FG001|Experiment 2|Poor data quality|0|||
155153840|NCT03050801|560000457|FG002|Experiment 2|Poor data quality|0|||
155153841|NCT03050801|560000458|FG003|Experiment 2|Poor data quality|4|||
155153842|NCT03050801|560000459|FG004|Experiment 2|Poor data quality|1|||
155153843|NCT03050801|560000460|FG005|Experiment 2|Poor data quality|0|||
155153844|NCT03050801|560000455|FG000|Experiment 2|Discomfort during stimulation|0|||
155153845|NCT03050801|560000456|FG001|Experiment 2|Discomfort during stimulation|0|||
155153846|NCT03050801|560000457|FG002|Experiment 2|Discomfort during stimulation|0|||
155398220|NCT04411628|560892157|FG001|Overall Study|Withdrawal by Subject|1|||
155398221|NCT04411628|560892158|FG002|Overall Study|Withdrawal by Subject|2|||
155398222|NCT04411628|560892159|FG003|Overall Study|Withdrawal by Subject|0|||
155398223|NCT04411628|560892156|FG000|Overall Study|Lost to Follow-up|0|||
155153847|NCT03050801|560000458|FG003|Experiment 2|Discomfort during stimulation|0|||
155153848|NCT03050801|560000459|FG004|Experiment 2|Discomfort during stimulation|0|||
155153849|NCT03050801|560000460|FG005|Experiment 2|Discomfort during stimulation|2|||
155398224|NCT04411628|560892157|FG001|Overall Study|Lost to Follow-up|1|||
155153850|NCT01844765|560000461|FG000|Overall Study|Adverse Event|6|||
155398225|NCT04411628|560892158|FG002|Overall Study|Lost to Follow-up|0|||
155398226|NCT04411628|560892159|FG003|Overall Study|Lost to Follow-up|0|||
155398227|NCT01034540|560892160|FG000|Overall Study|Adverse Event|0|||
155398228|NCT01034540|560892161|FG001|Overall Study|Adverse Event|1|||
155398229|NCT05293743|560892167|FG000|Overall Study|Withdrawal by Subject|1|||
155398230|NCT05293743|560892168|FG001|Overall Study|Withdrawal by Subject|0|||
155398231|NCT01200238|560892170|FG000|Overall Study|Adverse Event|2|||
155398232|NCT01200238|560892171|FG001|Overall Study|Adverse Event|1|||
155398233|NCT01200238|560892170|FG000|Overall Study|Progressive Disease|5|||
155398234|NCT01200238|560892171|FG001|Overall Study|Progressive Disease|8|||
155398235|NCT01200238|560892170|FG000|Overall Study|Withdrawal by Subject|0|||
155398236|NCT01200238|560892171|FG001|Overall Study|Withdrawal by Subject|1|||
155398237|NCT00482703|560892172|FG000|Overall Study|Poor compliance|1|||
155398238|NCT00482703|560892173|FG001|Overall Study|Poor compliance|0|||
155398239|NCT01428661|560892177|FG000|Double-Masked Phase|Protocol Violation|9|||
155398240|NCT01428661|560892178|FG001|Double-Masked Phase|Protocol Violation|4|||
155398241|NCT01428661|560892179|FG002|Double-Masked Phase|Protocol Violation|0|||
155398242|NCT01428661|560892177|FG000|Double-Masked Phase|Adverse Event|13|||
155398243|NCT01428661|560892178|FG001|Double-Masked Phase|Adverse Event|4|||
155398244|NCT01428661|560892179|FG002|Double-Masked Phase|Adverse Event|0|||
155398245|NCT01428661|560892177|FG000|Double-Masked Phase|Lost to Follow-up|14|||
155398246|NCT01428661|560892178|FG001|Double-Masked Phase|Lost to Follow-up|14|||
155398247|NCT01428661|560892179|FG002|Double-Masked Phase|Lost to Follow-up|0|||
155398248|NCT01428661|560892177|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
155398249|NCT01428661|560892178|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
155398250|NCT01428661|560892179|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
155398251|NCT01428661|560892177|FG000|Double-Masked Phase|Lack of Efficacy|2|||
155398252|NCT01428661|560892178|FG001|Double-Masked Phase|Lack of Efficacy|1|||
155398253|NCT01428661|560892179|FG002|Double-Masked Phase|Lack of Efficacy|0|||
155398254|NCT01428661|560892177|FG000|Double-Masked Phase|*Various|1|||
155398255|NCT01428661|560892178|FG001|Double-Masked Phase|*Various|6|||
155398256|NCT01428661|560892179|FG002|Double-Masked Phase|*Various|0|||
155398257|NCT01428661|560892177|FG000|Open Label Extension|Protocol Violation|0|||
155398258|NCT01428661|560892178|FG001|Open Label Extension|Protocol Violation|0|||
155398259|NCT01428661|560892179|FG002|Open Label Extension|Protocol Violation|9|||
155398260|NCT01428661|560892177|FG000|Open Label Extension|Adverse Event|0|||
155398261|NCT01428661|560892178|FG001|Open Label Extension|Adverse Event|0|||
155398262|NCT01428661|560892179|FG002|Open Label Extension|Adverse Event|15|||
155398263|NCT01428661|560892177|FG000|Open Label Extension|Lost to Follow-up|0|||
155398264|NCT01428661|560892178|FG001|Open Label Extension|Lost to Follow-up|0|||
155398265|NCT01428661|560892179|FG002|Open Label Extension|Lost to Follow-up|38|||
155398266|NCT01428661|560892177|FG000|Open Label Extension|Withdrawal by Subject|0|||
155398267|NCT01428661|560892178|FG001|Open Label Extension|Withdrawal by Subject|0|||
155284016|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
155284017|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
155284018|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
155284019|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
155284020|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
155284021|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
155284022|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
155284023|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
155284024|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
155284025|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
155284026|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
155284027|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
155284028|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
155284029|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
155284030|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
155284031|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Physician Decision|2|||
155284032|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Physician Decision|3|||
155284033|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Physician Decision|0|||
155284034|NCT01449929|560470914|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
155284035|NCT01449929|560470915|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
155284036|NCT01449929|560470916|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
155284037|NCT01449929|560470914|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
155284038|NCT01449929|560470915|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
155284039|NCT01449929|560470916|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
155284040|NCT01449929|560470914|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
155284041|NCT01449929|560470915|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
155398268|NCT01428661|560892179|FG002|Open Label Extension|Withdrawal by Subject|49|||
155398269|NCT01428661|560892177|FG000|Open Label Extension|Lack of Efficacy|0|||
155398270|NCT01428661|560892178|FG001|Open Label Extension|Lack of Efficacy|0|||
155398271|NCT01428661|560892179|FG002|Open Label Extension|Lack of Efficacy|24|||
155398272|NCT01428661|560892177|FG000|Open Label Extension|**Various|0|||
155398273|NCT01428661|560892178|FG001|Open Label Extension|**Various|0|||
155398274|NCT01428661|560892179|FG002|Open Label Extension|**Various|185|||
155398275|NCT02322125|560893933|FG000|Overall Study|Withdrawal by Subject|2|||
155398276|NCT01183143|560893934|FG000|Overall Study|Protocol Violation|115|||
155398277|NCT01183143|560893934|FG000|Overall Study|Withdrawal by Subject|19|||
155398278|NCT01183143|560893934|FG000|Overall Study|Subject Questionnaires not returned|5|||
155398279|NCT01183143|560893934|FG000|Overall Study|Subjects enrolled, but not treated|11|||
155398280|NCT04096274|560893935|FG000|Phase I|Lost to Follow-up|5|||
155398281|NCT04096274|560893936|FG001|Phase I|Lost to Follow-up|5|||
155398282|NCT04096274|560893935|FG000|Phase II|Lost to Follow-up|11|||
155398283|NCT04096274|560893936|FG001|Phase II|Lost to Follow-up|11|||
155398284|NCT04490395|560893937|FG000|Overall Study|Lost to Follow-up|0|||
155398285|NCT04490395|560893938|FG001|Overall Study|Lost to Follow-up|1|||
155398286|NCT05092919|560893940|FG000|Overall Study|Lost to Follow-up|7|||
155153851|NCT01844765|560000462|FG001|Overall Study|Adverse Event|8|||
155153852|NCT01844765|560000461|FG000|Overall Study|Withdrawal by Subject|2|||
155153853|NCT01844765|560000462|FG001|Overall Study|Withdrawal by Subject|3|||
155153854|NCT01844765|560000461|FG000|Overall Study|Disease progression|1|||
155153855|NCT01844765|560000462|FG001|Overall Study|Disease progression|0|||
155153856|NCT01844765|560000461|FG000|Overall Study|Administrative problems|3|||
155153857|NCT01844765|560000462|FG001|Overall Study|Administrative problems|4|||
155153858|NCT01844765|560000461|FG000|Overall Study|Protocol deviation|2|||
155153859|NCT01844765|560000462|FG001|Overall Study|Protocol deviation|0|||
155153860|NCT01844765|560000461|FG000|Overall Study|Untreated|1|||
155153861|NCT01844765|560000462|FG001|Overall Study|Untreated|0|||
155153862|NCT04292535|560000463|FG000|Overall Study|Withdrawal by Subject|0|||
155153863|NCT04292535|560000464|FG001|Overall Study|Withdrawal by Subject|0|||
155153864|NCT04292535|560000465|FG002|Overall Study|Withdrawal by Subject|0|||
155153865|NCT04292535|560000466|FG003|Overall Study|Withdrawal by Subject|0|||
155153866|NCT04292535|560000467|FG004|Overall Study|Withdrawal by Subject|0|||
155153867|NCT04292535|560000468|FG005|Overall Study|Withdrawal by Subject|0|||
155153868|NCT04292535|560000469|FG006|Overall Study|Withdrawal by Subject|0|||
155153869|NCT04292535|560000470|FG007|Overall Study|Withdrawal by Subject|1|||
155153870|NCT04292535|560000471|FG008|Overall Study|Withdrawal by Subject|0|||
155153871|NCT04292535|560000472|FG009|Overall Study|Withdrawal by Subject|0|||
155153872|NCT04292535|560000473|FG010|Overall Study|Withdrawal by Subject|0|||
155153873|NCT04292535|560000474|FG011|Overall Study|Withdrawal by Subject|0|||
155153874|NCT04292535|560000475|FG012|Overall Study|Withdrawal by Subject|0|||
155153875|NCT04292535|560000476|FG013|Overall Study|Withdrawal by Subject|0|||
155153876|NCT04292535|560000463|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153877|NCT04292535|560000464|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153878|NCT04292535|560000465|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153879|NCT04292535|560000466|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153880|NCT04292535|560000467|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153881|NCT04292535|560000468|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153882|NCT04292535|560000469|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153883|NCT04292535|560000470|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
155153884|NCT04292535|560000471|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153885|NCT04292535|560000472|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153886|NCT04292535|560000473|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153887|NCT04292535|560000474|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
155153888|NCT04292535|560000475|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
155153889|NCT04292535|560000476|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
155153890|NCT04292535|560000463|FG000|Overall Study|Report of Dizziness|0|||
155153891|NCT04292535|560000464|FG001|Overall Study|Report of Dizziness|0|||
155153892|NCT04292535|560000465|FG002|Overall Study|Report of Dizziness|0|||
155153893|NCT04292535|560000466|FG003|Overall Study|Report of Dizziness|0|||
155153894|NCT04292535|560000467|FG004|Overall Study|Report of Dizziness|0|||
155153895|NCT04292535|560000468|FG005|Overall Study|Report of Dizziness|0|||
155153896|NCT04292535|560000469|FG006|Overall Study|Report of Dizziness|0|||
155153897|NCT04292535|560000470|FG007|Overall Study|Report of Dizziness|0|||
155153898|NCT04292535|560000471|FG008|Overall Study|Report of Dizziness|0|||
155153899|NCT04292535|560000472|FG009|Overall Study|Report of Dizziness|0|||
155153900|NCT04292535|560000473|FG010|Overall Study|Report of Dizziness|0|||
155153901|NCT04292535|560000474|FG011|Overall Study|Report of Dizziness|0|||
155153902|NCT04292535|560000475|FG012|Overall Study|Report of Dizziness|0|||
155153903|NCT04292535|560000476|FG013|Overall Study|Report of Dizziness|1|||
155153904|NCT04292535|560000463|FG000|Overall Study|Equipment Failure|0|||
155153905|NCT04292535|560000464|FG001|Overall Study|Equipment Failure|0|||
155153906|NCT04292535|560000465|FG002|Overall Study|Equipment Failure|0|||
155153907|NCT04292535|560000466|FG003|Overall Study|Equipment Failure|0|||
155153908|NCT04292535|560000467|FG004|Overall Study|Equipment Failure|0|||
155153909|NCT04292535|560000468|FG005|Overall Study|Equipment Failure|0|||
155398287|NCT05092919|560893940|FG000|Overall Study|Withdrawal by Subject|2|||
155398288|NCT01942148|560893944|FG000|Overall Study|Adverse Event|4|||
155398289|NCT01942148|560893944|FG000|Overall Study|Lack of Efficacy|2|||
155153910|NCT04292535|560000469|FG006|Overall Study|Equipment Failure|0|||
155153911|NCT04292535|560000470|FG007|Overall Study|Equipment Failure|0|||
155153912|NCT04292535|560000471|FG008|Overall Study|Equipment Failure|0|||
155153913|NCT04292535|560000472|FG009|Overall Study|Equipment Failure|0|||
155153914|NCT04292535|560000473|FG010|Overall Study|Equipment Failure|0|||
155153915|NCT04292535|560000474|FG011|Overall Study|Equipment Failure|1|||
155153916|NCT04292535|560000475|FG012|Overall Study|Equipment Failure|0|||
155153917|NCT04292535|560000476|FG013|Overall Study|Equipment Failure|0|||
155153918|NCT03914417|560000477|FG000|Overall Study|Withdrawal by Subject|2|||
155153919|NCT03836625|560000478|FG000|Overall Study|Lost to Follow-up|9|||
155153920|NCT03836625|560000479|FG001|Overall Study|Lost to Follow-up|9|||
155153921|NCT03836625|560000478|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
155153922|NCT03836625|560000479|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
155153923|NCT03836625|560000478|FG000|Overall Study|Death|0|||
155153924|NCT03836625|560000479|FG001|Overall Study|Death|1|||
155153925|NCT03836625|560000478|FG000|Overall Study|Refused follow-up|0|||
155153926|NCT03836625|560000479|FG001|Overall Study|Refused follow-up|1|||
155153927|NCT04609319|560000480|FG000|Overall Study|Death|64|||
155153928|NCT04609319|560000481|FG001|Overall Study|Death|49|||
155153929|NCT04609319|560000482|FG002|Overall Study|Death|1|||
155153930|NCT04609319|560000480|FG000|Overall Study|Withdrawal of consent|15|||
155153931|NCT04609319|560000481|FG001|Overall Study|Withdrawal of consent|3|||
155153932|NCT04609319|560000482|FG002|Overall Study|Withdrawal of consent|0|||
155153933|NCT04609319|560000480|FG000|Overall Study|Lost to Follow-up|20|||
155153934|NCT04609319|560000481|FG001|Overall Study|Lost to Follow-up|33|||
155153935|NCT04609319|560000482|FG002|Overall Study|Lost to Follow-up|0|||
155153936|NCT04609319|560000480|FG000|Overall Study|Alive until end of follow-up|60|||
155153937|NCT04609319|560000481|FG001|Overall Study|Alive until end of follow-up|53|||
155153938|NCT04609319|560000482|FG002|Overall Study|Alive until end of follow-up|1|||
155153939|NCT01247324|560000483|FG000|Overall Study|Death|6|||
155153940|NCT01247324|560000484|FG001|Overall Study|Death|10|||
155153941|NCT01247324|560000483|FG000|Overall Study|Physician Decision|2|||
155153942|NCT01247324|560000484|FG001|Overall Study|Physician Decision|3|||
155153943|NCT01247324|560000483|FG000|Overall Study|Non-compliance with study drug|3|||
155153944|NCT01247324|560000484|FG001|Overall Study|Non-compliance with study drug|0|||
155153945|NCT01247324|560000483|FG000|Overall Study|Lack of Efficacy|24|||
155153946|NCT01247324|560000484|FG001|Overall Study|Lack of Efficacy|14|||
155153947|NCT01247324|560000483|FG000|Overall Study|Non-compliance|3|||
155153948|NCT01247324|560000484|FG001|Overall Study|Non-compliance|2|||
155153949|NCT01247324|560000483|FG000|Overall Study|Pregnancy|5|||
155153950|NCT01247324|560000484|FG001|Overall Study|Pregnancy|10|||
155153951|NCT01247324|560000483|FG000|Overall Study|Protocol Violation|1|||
155153952|NCT01247324|560000484|FG001|Overall Study|Protocol Violation|1|||
155153953|NCT01247324|560000483|FG000|Overall Study|Reason not specified|42|||
155153954|NCT01247324|560000484|FG001|Overall Study|Reason not specified|32|||
155153955|NCT01247324|560000483|FG000|Overall Study|Consent withdrawn by participant|41|||
155153956|NCT01247324|560000484|FG001|Overall Study|Consent withdrawn by participant|56|||
155153957|NCT01247324|560000483|FG000|Overall Study|Adverse Event|49|||
155153958|NCT01247324|560000484|FG001|Overall Study|Adverse Event|35|||
155153959|NCT01247324|560000483|FG000|Overall Study|Lost to Follow-up|3|||
155153960|NCT01247324|560000484|FG001|Overall Study|Lost to Follow-up|6|||
155153961|NCT01247324|560000483|FG000|Overall Study|Study Terminated by Sponsor|4|||
155153962|NCT01247324|560000484|FG001|Overall Study|Study Terminated by Sponsor|1|||
155153963|NCT01247324|560000483|FG000|Overall Study|Missing|2|||
155153964|NCT01247324|560000484|FG001|Overall Study|Missing|1|||
155153965|NCT00301808|560000485|FG000|Overall Study|Adverse Event|5|||
155153966|NCT00301808|560000485|FG000|Overall Study|Death|3|||
154953244|NCT01496183|559254633|FG000|Overall Study|Withdrawal by Subject|0|||
154953245|NCT01496183|559254634|FG001|Overall Study|Withdrawal by Subject|1|||
154953246|NCT00669864|559254637|FG000|Overall Study|Lost to Follow-up|2|||
154953247|NCT00669864|559254637|FG000|Overall Study|Protocol Violation|2|||
154953248|NCT00669864|559254637|FG000|Overall Study|Withdrawal by Subject|3|||
154953249|NCT00669864|559254637|FG000|Overall Study|Other|2|||
154953250|NCT01629381|559254638|FG000|Overall Study|Withdrawal by Subject|2|||
154953251|NCT01629381|559254639|FG001|Overall Study|Withdrawal by Subject|5|||
155153967|NCT00301808|560000485|FG000|Overall Study|Lack of Efficacy|4|||
155153968|NCT03518086|560000490|FG000|Overall Study|Adverse Event|23|||
155153969|NCT03518086|560000491|FG001|Overall Study|Adverse Event|15|||
155153970|NCT03518086|560000492|FG002|Overall Study|Adverse Event|3|||
155153971|NCT03518086|560000493|FG003|Overall Study|Adverse Event|2|||
155153972|NCT03518086|560000490|FG000|Overall Study|Withdrawal by Subject|8|||
155153973|NCT03518086|560000491|FG001|Overall Study|Withdrawal by Subject|5|||
155153974|NCT03518086|560000492|FG002|Overall Study|Withdrawal by Subject|1|||
155153975|NCT03518086|560000493|FG003|Overall Study|Withdrawal by Subject|0|||
155153976|NCT03518086|560000490|FG000|Overall Study|Lack of Efficacy|5|||
155153977|NCT03518086|560000491|FG001|Overall Study|Lack of Efficacy|5|||
154953252|NCT00906347|559254642|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
155153978|NCT03518086|560000492|FG002|Overall Study|Lack of Efficacy|0|||
155153979|NCT03518086|560000493|FG003|Overall Study|Lack of Efficacy|2|||
155398290|NCT01942148|560893944|FG000|Overall Study|Physician Decision|11|||
155398291|NCT01942148|560893944|FG000|Overall Study|Protocol Violation|1|||
155398292|NCT01942148|560893944|FG000|Overall Study|Withdrawal by Subject|8|||
155153980|NCT03518086|560000490|FG000|Overall Study|Protocol Violation|1|||
155153981|NCT03518086|560000491|FG001|Overall Study|Protocol Violation|5|||
155153982|NCT03518086|560000492|FG002|Overall Study|Protocol Violation|1|||
155153983|NCT03518086|560000493|FG003|Overall Study|Protocol Violation|3|||
155153984|NCT03518086|560000490|FG000|Overall Study|Lost to Follow-up|0|||
155153985|NCT03518086|560000491|FG001|Overall Study|Lost to Follow-up|3|||
155153986|NCT03518086|560000492|FG002|Overall Study|Lost to Follow-up|0|||
155153987|NCT03518086|560000493|FG003|Overall Study|Lost to Follow-up|0|||
155153988|NCT03518086|560000490|FG000|Overall Study|Insufficient Diary Data|0|||
155153989|NCT03518086|560000491|FG001|Overall Study|Insufficient Diary Data|2|||
155153990|NCT03518086|560000492|FG002|Overall Study|Insufficient Diary Data|0|||
155153991|NCT03518086|560000493|FG003|Overall Study|Insufficient Diary Data|0|||
155153992|NCT03518086|560000490|FG000|Overall Study|Non- compliance to Protocol|0|||
155153993|NCT03518086|560000491|FG001|Overall Study|Non- compliance to Protocol|1|||
155153994|NCT03518086|560000492|FG002|Overall Study|Non- compliance to Protocol|0|||
155153995|NCT03518086|560000493|FG003|Overall Study|Non- compliance to Protocol|0|||
155153996|NCT03518086|560000490|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
155153997|NCT03518086|560000491|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
155153998|NCT03518086|560000492|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
155153999|NCT03518086|560000493|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
155154000|NCT03518086|560000490|FG000|Overall Study|Site Terminated by Sponsor|0|||
155154001|NCT03518086|560000491|FG001|Overall Study|Site Terminated by Sponsor|1|||
155154002|NCT03518086|560000492|FG002|Overall Study|Site Terminated by Sponsor|0|||
155154003|NCT03518086|560000493|FG003|Overall Study|Site Terminated by Sponsor|0|||
155154004|NCT03518086|560000490|FG000|Overall Study|Pregnancy|0|||
155154005|NCT03518086|560000491|FG001|Overall Study|Pregnancy|0|||
155154006|NCT03518086|560000492|FG002|Overall Study|Pregnancy|0|||
155154007|NCT03518086|560000493|FG003|Overall Study|Pregnancy|2|||
155154008|NCT00668148|560000499|FG000|Overall Study|Adverse Event|5|||
155154009|NCT00668148|560000499|FG000|Overall Study|Subject Non-compliance|1|||
155154010|NCT00668148|560000499|FG000|Overall Study|Progressive Disease Before Treatment|2|||
155154011|NCT00668148|560000499|FG000|Overall Study|Withdrawal of Consent|2|||
155154012|NCT02702492|560000500|FG000|Overall Study|Disease progression|3|||
155154013|NCT02702492|560000501|FG001|Overall Study|Disease progression|3|||
155154014|NCT02702492|560000502|FG002|Overall Study|Disease progression|2|||
155154015|NCT02702492|560000503|FG003|Overall Study|Disease progression|4|||
155154016|NCT02702492|560000504|FG004|Overall Study|Disease progression|4|||
155154017|NCT02702492|560000505|FG005|Overall Study|Disease progression|1|||
155154018|NCT02702492|560000506|FG006|Overall Study|Disease progression|2|||
155154019|NCT02702492|560000507|FG007|Overall Study|Disease progression|8|||
155154020|NCT02702492|560000508|FG008|Overall Study|Disease progression|5|||
155154021|NCT02702492|560000509|FG009|Overall Study|Disease progression|1|||
155154022|NCT02702492|560000510|FG010|Overall Study|Disease progression|0|||
155154023|NCT02702492|560000511|FG011|Overall Study|Disease progression|3|||
155154024|NCT02702492|560000512|FG012|Overall Study|Disease progression|2|||
155154025|NCT02702492|560000500|FG000|Overall Study|Clinical progression|0|||
155154026|NCT02702492|560000501|FG001|Overall Study|Clinical progression|0|||
155154027|NCT02702492|560000502|FG002|Overall Study|Clinical progression|2|||
155154028|NCT02702492|560000503|FG003|Overall Study|Clinical progression|1|||
155154029|NCT02702492|560000504|FG004|Overall Study|Clinical progression|0|||
155154030|NCT02702492|560000505|FG005|Overall Study|Clinical progression|2|||
155154031|NCT02702492|560000506|FG006|Overall Study|Clinical progression|1|||
155154032|NCT02702492|560000507|FG007|Overall Study|Clinical progression|4|||
155154033|NCT02702492|560000508|FG008|Overall Study|Clinical progression|0|||
155154034|NCT02702492|560000509|FG009|Overall Study|Clinical progression|0|||
155154035|NCT02702492|560000510|FG010|Overall Study|Clinical progression|1|||
155154036|NCT02702492|560000511|FG011|Overall Study|Clinical progression|2|||
155154037|NCT02702492|560000512|FG012|Overall Study|Clinical progression|0|||
155398293|NCT01942148|560893944|FG000|Overall Study|Use of the prohibition medicine|1|||
155398294|NCT02248259|560893945|FG000|Treatment Period 1|Adverse Event|0|||
155398295|NCT02248259|560893946|FG001|Treatment Period 1|Adverse Event|0|||
155398296|NCT02248259|560893947|FG002|Treatment Period 1|Adverse Event|1|||
155154038|NCT02702492|560000500|FG000|Overall Study|Adverse Event|0|||
155154039|NCT02702492|560000501|FG001|Overall Study|Adverse Event|0|||
155154040|NCT02702492|560000502|FG002|Overall Study|Adverse Event|1|||
155154041|NCT02702492|560000503|FG003|Overall Study|Adverse Event|2|||
155154042|NCT02702492|560000504|FG004|Overall Study|Adverse Event|1|||
155398297|NCT02248259|560893948|FG003|Treatment Period 1|Adverse Event|0|||
155398298|NCT02807480|560893953|FG000|Overall Study|Withdrawal by Subject|14|||
155398299|NCT02807480|560893954|FG001|Overall Study|Withdrawal by Subject|10|||
155398300|NCT02369848|560893955|FG000|Overall Study|Death|1|||
155154043|NCT02702492|560000505|FG005|Overall Study|Adverse Event|0|||
155154044|NCT02702492|560000506|FG006|Overall Study|Adverse Event|1|||
155154045|NCT02702492|560000507|FG007|Overall Study|Adverse Event|0|||
155154046|NCT02702492|560000508|FG008|Overall Study|Adverse Event|2|||
155398301|NCT02369848|560893955|FG000|Overall Study|Withdrawal by Subject|2|||
155398302|NCT02369848|560893955|FG000|Overall Study|Lost to Follow-up|1|||
155398303|NCT00096785|560893959|FG000|Overall Study|Lost to Follow-up|1|||
155398304|NCT00096785|560893960|FG001|Overall Study|Lost to Follow-up|0|||
155398305|NCT00096785|560893959|FG000|Overall Study|Withdrawal by Subject|0|||
155398306|NCT00096785|560893960|FG001|Overall Study|Withdrawal by Subject|1|||
155398307|NCT00096785|560893959|FG000|Overall Study|Relocated|1|||
155398308|NCT00096785|560893960|FG001|Overall Study|Relocated|0|||
155398309|NCT01838616|560893961|FG000|Titration Period|Adverse Event|18|||
155398310|NCT01838616|560893962|FG001|Titration Period|Adverse Event|48|||
155398311|NCT01838616|560893961|FG000|Titration Period|Lack of Efficacy|5|||
155398312|NCT01838616|560893962|FG001|Titration Period|Lack of Efficacy|12|||
155398313|NCT01838616|560893961|FG000|Titration Period|Withdrawal by Subject|5|||
155398314|NCT01838616|560893962|FG001|Titration Period|Withdrawal by Subject|5|||
155398315|NCT01838616|560893961|FG000|Titration Period|Technical problems|1|||
155398316|NCT01838616|560893962|FG001|Titration Period|Technical problems|0|||
155398317|NCT01838616|560893961|FG000|Titration Period|Other|1|||
155398318|NCT01838616|560893962|FG001|Titration Period|Other|0|||
155398319|NCT01838616|560893961|FG000|Titration Period|Protocol Violation|0|||
155398320|NCT01838616|560893962|FG001|Titration Period|Protocol Violation|1|||
155398321|NCT01838616|560893961|FG000|Continuation Period|Lack of Efficacy|3|||
155398322|NCT01838616|560893962|FG001|Continuation Period|Lack of Efficacy|5|||
155398323|NCT01838616|560893961|FG000|Continuation Period|Adverse Event|8|||
155398324|NCT01838616|560893962|FG001|Continuation Period|Adverse Event|4|||
155398325|NCT01838616|560893961|FG000|Continuation Period|Protocol Violation|2|||
155398326|NCT01838616|560893962|FG001|Continuation Period|Protocol Violation|0|||
155398327|NCT01838616|560893961|FG000|Continuation Period|Lost to Follow-up|1|||
155398328|NCT01838616|560893962|FG001|Continuation Period|Lost to Follow-up|0|||
155398329|NCT01838616|560893961|FG000|Continuation Period|Withdrawal by Subject|0|||
155398330|NCT01838616|560893962|FG001|Continuation Period|Withdrawal by Subject|4|||
155398331|NCT01838616|560893961|FG000|Continuation Period|Technical problems|0|||
155398332|NCT01838616|560893962|FG001|Continuation Period|Technical problems|1|||
155398333|NCT01838616|560893961|FG000|Pick-up Arm|Lack of Efficacy|4|||
155398334|NCT01838616|560893962|FG001|Pick-up Arm|Lack of Efficacy|0|||
155398335|NCT01838616|560893961|FG000|Pick-up Arm|Adverse Event|9|||
155398336|NCT01838616|560893962|FG001|Pick-up Arm|Adverse Event|0|||
155398337|NCT01838616|560893961|FG000|Pick-up Arm|Withdrawal by Subject|1|||
155398338|NCT01838616|560893962|FG001|Pick-up Arm|Withdrawal by Subject|0|||
155398339|NCT01838616|560893961|FG000|Pick-up Arm|Technical problems|1|||
155398340|NCT01838616|560893962|FG001|Pick-up Arm|Technical problems|0|||
155398341|NCT00257725|560893963|FG000|Overall Study|Adverse Event|3|||
155398342|NCT02573870|560893964|FG000|Overall Study|Adverse Event|0|||
155398343|NCT02573870|560893965|FG001|Overall Study|Adverse Event|2|||
155398344|NCT02573870|560893964|FG000|Overall Study|Lack of Efficacy|0|||
155398345|NCT02573870|560893965|FG001|Overall Study|Lack of Efficacy|1|||
155398346|NCT02573870|560893964|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
155398347|NCT02573870|560893965|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
155398348|NCT02573870|560893964|FG000|Overall Study|Lost to Follow-up|0|||
155398349|NCT02573870|560893965|FG001|Overall Study|Lost to Follow-up|1|||
155398350|NCT02573870|560893964|FG000|Overall Study|Other: Fail to Meet Visit|0|||
155398351|NCT02573870|560893965|FG001|Overall Study|Other: Fail to Meet Visit|2|||
155398352|NCT02081534|560893967|FG000|Overall Study|Adverse Event|5|||
155398353|NCT02081534|560893968|FG001|Overall Study|Adverse Event|4|||
155398354|NCT02081534|560893969|FG002|Overall Study|Adverse Event|3|||
155398355|NCT02081534|560893970|FG003|Overall Study|Adverse Event|10|||
155398356|NCT02081534|560893971|FG004|Overall Study|Adverse Event|2|||
155398357|NCT02081534|560893972|FG005|Overall Study|Adverse Event|8|||
155398358|NCT02081534|560893973|FG006|Overall Study|Adverse Event|2|||
155398359|NCT02081534|560893967|FG000|Overall Study|Withdrawal by Subject|0|||
155398360|NCT02081534|560893968|FG001|Overall Study|Withdrawal by Subject|1|||
155398361|NCT02081534|560893969|FG002|Overall Study|Withdrawal by Subject|1|||
155398362|NCT02081534|560893970|FG003|Overall Study|Withdrawal by Subject|1|||
155398363|NCT02081534|560893971|FG004|Overall Study|Withdrawal by Subject|1|||
155398364|NCT02081534|560893972|FG005|Overall Study|Withdrawal by Subject|0|||
155398365|NCT02081534|560893973|FG006|Overall Study|Withdrawal by Subject|1|||
155398366|NCT02081534|560893967|FG000|Overall Study|Protocol Violation|0|||
155398367|NCT02081534|560893968|FG001|Overall Study|Protocol Violation|3|||
155398368|NCT02081534|560893969|FG002|Overall Study|Protocol Violation|0|||
155398369|NCT02081534|560893970|FG003|Overall Study|Protocol Violation|0|||
155398370|NCT02081534|560893971|FG004|Overall Study|Protocol Violation|0|||
155398371|NCT02081534|560893972|FG005|Overall Study|Protocol Violation|0|||
155398372|NCT02081534|560893973|FG006|Overall Study|Protocol Violation|1|||
155154047|NCT02702492|560000509|FG009|Overall Study|Adverse Event|0|||
155398373|NCT02081534|560893967|FG000|Overall Study|Lost to Follow-up|0|||
155398374|NCT02081534|560893968|FG001|Overall Study|Lost to Follow-up|0|||
155398375|NCT02081534|560893969|FG002|Overall Study|Lost to Follow-up|0|||
155398376|NCT02081534|560893970|FG003|Overall Study|Lost to Follow-up|2|||
155398377|NCT02081534|560893971|FG004|Overall Study|Lost to Follow-up|1|||
155398378|NCT02081534|560893972|FG005|Overall Study|Lost to Follow-up|1|||
155398379|NCT02081534|560893973|FG006|Overall Study|Lost to Follow-up|0|||
155398380|NCT01007032|560893974|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
155284042|NCT01449929|560470916|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
155284043|NCT01449929|560470914|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
155284044|NCT01449929|560470915|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
155284045|NCT01449929|560470916|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
155154048|NCT02702492|560000510|FG010|Overall Study|Adverse Event|0|||
155154049|NCT02702492|560000511|FG011|Overall Study|Adverse Event|0|||
155154050|NCT02702492|560000512|FG012|Overall Study|Adverse Event|1|||
155154051|NCT02702492|560000500|FG000|Overall Study|Other|0|||
155154052|NCT02702492|560000501|FG001|Overall Study|Other|0|||
155154053|NCT02702492|560000502|FG002|Overall Study|Other|0|||
155154054|NCT02702492|560000503|FG003|Overall Study|Other|0|||
155154055|NCT02702492|560000504|FG004|Overall Study|Other|0|||
155154056|NCT02702492|560000505|FG005|Overall Study|Other|0|||
155154057|NCT02702492|560000506|FG006|Overall Study|Other|0|||
155154058|NCT02702492|560000507|FG007|Overall Study|Other|0|||
155154059|NCT02702492|560000508|FG008|Overall Study|Other|0|||
155154060|NCT02702492|560000509|FG009|Overall Study|Other|0|||
155154061|NCT02702492|560000510|FG010|Overall Study|Other|0|||
155154062|NCT02702492|560000511|FG011|Overall Study|Other|0|||
155154063|NCT02702492|560000512|FG012|Overall Study|Other|1|||
155154064|NCT05472090|560000513|FG000|Overall Study|Adverse Event|2|||
155154065|NCT05472090|560000514|FG001|Overall Study|Adverse Event|3|||
155154066|NCT05472090|560000513|FG000|Overall Study|Lack of Efficacy|1|||
155154067|NCT05472090|560000514|FG001|Overall Study|Lack of Efficacy|0|||
155154068|NCT05472090|560000513|FG000|Overall Study|Physician Decision|1|||
155154069|NCT05472090|560000514|FG001|Overall Study|Physician Decision|0|||
155154070|NCT05472090|560000513|FG000|Overall Study|Withdrawal by Subject|2|||
155398381|NCT01007032|560893975|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
155398382|NCT01007032|560893976|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
155398383|NCT01007032|560893977|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
155398384|NCT01007032|560893974|FG000|Overall Study|Withdrawal by Subject|0|||
155398385|NCT01007032|560893975|FG001|Overall Study|Withdrawal by Subject|0|||
155398386|NCT01007032|560893976|FG002|Overall Study|Withdrawal by Subject|0|||
155398387|NCT01007032|560893977|FG003|Overall Study|Withdrawal by Subject|1|||
155398388|NCT00709111|560893978|FG000|Overall Study|Withdrawal by Subject|1|||
155154071|NCT05472090|560000514|FG001|Overall Study|Withdrawal by Subject|0|||
155154072|NCT05472090|560000513|FG000|Overall Study|Lost to Follow-up|0|||
155154073|NCT05472090|560000514|FG001|Overall Study|Lost to Follow-up|3|||
155154074|NCT00199381|560002195|FG000|Overall Study|Withdrawal by Subject|38|||
155154075|NCT00199381|560002195|FG000|Overall Study|Adverse Event|73|||
155154076|NCT00199381|560002195|FG000|Overall Study|Protocol Violation|6|||
155154077|NCT00199381|560002195|FG000|Overall Study|Lack of Efficacy|27|||
155154078|NCT00199381|560002195|FG000|Overall Study|Not including due to early termination|37|||
155154079|NCT00199381|560002195|FG000|Overall Study|Study termination by Sponsor|323|||
155154080|NCT02892344|560002196|FG000|Overall Study|Protocol deviation|3|||
155154081|NCT02892344|560002197|FG001|Overall Study|Protocol deviation|4|||
155154082|NCT02892344|560002196|FG000|Overall Study|Adverse Event|1|||
155398389|NCT00709111|560893978|FG000|Overall Study|Unable to attend clinic visits|1|||
155154083|NCT02892344|560002197|FG001|Overall Study|Adverse Event|8|||
155154084|NCT02892344|560002196|FG000|Overall Study|Lost to Follow-up|0|||
155154085|NCT02892344|560002197|FG001|Overall Study|Lost to Follow-up|1|||
155398390|NCT00915772|560893979|FG000|Overall Study|Adverse Event|12|||
155398391|NCT00915772|560893980|FG001|Overall Study|Adverse Event|13|||
155154086|NCT02892344|560002196|FG000|Overall Study|Non-compliance with study treatment|0|||
155398392|NCT00915772|560893981|FG002|Overall Study|Adverse Event|11|||
155398393|NCT00915772|560893979|FG000|Overall Study|Protocol Violation|4|||
155398394|NCT00915772|560893980|FG001|Overall Study|Protocol Violation|1|||
155154087|NCT02892344|560002197|FG001|Overall Study|Non-compliance with study treatment|1|||
155398395|NCT00915772|560893981|FG002|Overall Study|Protocol Violation|2|||
155284046|NCT01919619|560470917|FG000|Overall Study|Physician Decision|1|||
155154088|NCT02892344|560002196|FG000|Overall Study|Physician Decision|0|||
155154089|NCT02892344|560002197|FG001|Overall Study|Physician Decision|2|||
155284047|NCT01919619|560470918|FG001|Overall Study|Physician Decision|1|||
155284048|NCT02268396|560472656|FG000|Overall Study|Adverse Event|3|||
155398396|NCT00915772|560893979|FG000|Overall Study|Lost to Follow-up|1|||
155398397|NCT00915772|560893980|FG001|Overall Study|Lost to Follow-up|2|||
155398398|NCT00915772|560893981|FG002|Overall Study|Lost to Follow-up|2|||
155398399|NCT00915772|560893979|FG000|Overall Study|Lack of Efficacy|9|||
155154090|NCT02892344|560002196|FG000|Overall Study|Subject/guardian decision|0|||
155154091|NCT02892344|560002197|FG001|Overall Study|Subject/guardian decision|4|||
155154092|NCT02892344|560002196|FG000|Overall Study|Technical problems|0|||
155154093|NCT02892344|560002197|FG001|Overall Study|Technical problems|1|||
155154094|NCT02318706|560002198|FG000|Double-blind Phase|Adverse Event|7|||
155154095|NCT02318706|560002199|FG001|Double-blind Phase|Adverse Event|4|||
155154096|NCT02318706|560002200|FG002|Double-blind Phase|Adverse Event|3|||
155154097|NCT02318706|560002201|FG003|Double-blind Phase|Adverse Event|10|||
155154098|NCT02318706|560002202|FG004|Double-blind Phase|Adverse Event|0|||
155398400|NCT00915772|560893980|FG001|Overall Study|Lack of Efficacy|15|||
155398401|NCT00915772|560893981|FG002|Overall Study|Lack of Efficacy|3|||
155398402|NCT00915772|560893979|FG000|Overall Study|Refused to continue trial medication|6|||
155398403|NCT00915772|560893980|FG001|Overall Study|Refused to continue trial medication|8|||
155398404|NCT00915772|560893981|FG002|Overall Study|Refused to continue trial medication|4|||
155398405|NCT00915772|560893979|FG000|Overall Study|Any other reason|4|||
155398406|NCT00915772|560893980|FG001|Overall Study|Any other reason|7|||
155398407|NCT00915772|560893981|FG002|Overall Study|Any other reason|7|||
155398408|NCT00549939|560893985|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
155398409|NCT00549939|560893986|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
155398410|NCT00549939|560893987|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
155398411|NCT00549939|560893985|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
155398412|NCT00549939|560893986|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
155398413|NCT00549939|560893987|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
155398414|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
155398415|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
155154099|NCT02318706|560002198|FG000|Double-blind Phase|Lost to Follow-up|1|||
155154100|NCT02318706|560002199|FG001|Double-blind Phase|Lost to Follow-up|0|||
155154101|NCT02318706|560002200|FG002|Double-blind Phase|Lost to Follow-up|0|||
155154102|NCT02318706|560002201|FG003|Double-blind Phase|Lost to Follow-up|0|||
155154103|NCT02318706|560002202|FG004|Double-blind Phase|Lost to Follow-up|0|||
155154104|NCT02318706|560002198|FG000|Double-blind Phase|Protocol Violation|4|||
155154105|NCT02318706|560002199|FG001|Double-blind Phase|Protocol Violation|2|||
155154106|NCT02318706|560002200|FG002|Double-blind Phase|Protocol Violation|4|||
155154107|NCT02318706|560002201|FG003|Double-blind Phase|Protocol Violation|3|||
155154108|NCT02318706|560002202|FG004|Double-blind Phase|Protocol Violation|0|||
155154109|NCT02318706|560002198|FG000|Double-blind Phase|Withdrawal by Subject|9|||
155154110|NCT02318706|560002199|FG001|Double-blind Phase|Withdrawal by Subject|5|||
155154111|NCT02318706|560002200|FG002|Double-blind Phase|Withdrawal by Subject|7|||
155154112|NCT02318706|560002201|FG003|Double-blind Phase|Withdrawal by Subject|10|||
155154113|NCT02318706|560002202|FG004|Double-blind Phase|Withdrawal by Subject|0|||
155154114|NCT02318706|560002198|FG000|Double-blind Phase|Other|4|||
155154115|NCT02318706|560002199|FG001|Double-blind Phase|Other|1|||
155154116|NCT02318706|560002200|FG002|Double-blind Phase|Other|2|||
155154117|NCT02318706|560002201|FG003|Double-blind Phase|Other|1|||
155154118|NCT02318706|560002202|FG004|Double-blind Phase|Other|0|||
155154119|NCT02318706|560002198|FG000|Double-blind Phase|Death|0|||
155154120|NCT02318706|560002199|FG001|Double-blind Phase|Death|0|||
155154121|NCT02318706|560002200|FG002|Double-blind Phase|Death|2|||
155154122|NCT02318706|560002201|FG003|Double-blind Phase|Death|0|||
155154123|NCT02318706|560002202|FG004|Double-blind Phase|Death|0|||
155154124|NCT02318706|560002198|FG000|Open-label Extension Phase|Adverse Event|0|||
155154125|NCT02318706|560002199|FG001|Open-label Extension Phase|Adverse Event|0|||
155154126|NCT02318706|560002200|FG002|Open-label Extension Phase|Adverse Event|0|||
155154127|NCT02318706|560002201|FG003|Open-label Extension Phase|Adverse Event|0|||
155154128|NCT02318706|560002202|FG004|Open-label Extension Phase|Adverse Event|21|||
155154129|NCT02318706|560002198|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
155154130|NCT02318706|560002199|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
155154131|NCT02318706|560002200|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
155398416|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
155398417|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
155154132|NCT02318706|560002201|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
155154133|NCT02318706|560002202|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
155154134|NCT02318706|560002198|FG000|Open-label Extension Phase|Death|0|||
155154135|NCT02318706|560002199|FG001|Open-label Extension Phase|Death|0|||
155154136|NCT02318706|560002200|FG002|Open-label Extension Phase|Death|0|||
155154137|NCT02318706|560002201|FG003|Open-label Extension Phase|Death|0|||
155398418|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
155398419|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
155398420|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
155398421|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
155398422|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
155398423|NCT00549939|560893985|FG000|40-week Open Label Treatment Period|Other|0|||
155154138|NCT02318706|560002202|FG004|Open-label Extension Phase|Death|1|||
155154139|NCT02318706|560002198|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
155154140|NCT02318706|560002199|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
155154141|NCT02318706|560002200|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
155154142|NCT02318706|560002201|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
155154143|NCT02318706|560002202|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
155154144|NCT04328077|560002203|FG000|Overall Study|Lost to Follow-up|0|||
155154145|NCT04328077|560002204|FG001|Overall Study|Lost to Follow-up|1|||
155154146|NCT04328077|560002205|FG002|Overall Study|Lost to Follow-up|0|||
155154147|NCT04328077|560002206|FG003|Overall Study|Lost to Follow-up|0|||
155154148|NCT04328077|560002203|FG000|Overall Study|Withdrawal by Subject|0|||
155398424|NCT00549939|560893986|FG001|40-week Open Label Treatment Period|Other|1|||
155398425|NCT00549939|560893987|FG002|40-week Open Label Treatment Period|Other|4|||
155398426|NCT01735279|560893988|FG000|Overall Study|Lost to Follow-up|11|||
155398427|NCT01735279|560893989|FG001|Overall Study|Lost to Follow-up|8|||
155398428|NCT00806195|560893990|FG000|Overall Study|Death|6|||
155398429|NCT00806195|560893991|FG001|Overall Study|Death|0|||
155398430|NCT00806195|560893992|FG002|Overall Study|Death|1|||
155398431|NCT00806195|560893993|FG003|Overall Study|Death|0|||
155398432|NCT00806195|560893990|FG000|Overall Study|Adverse Event|25|||
155398433|NCT00806195|560893991|FG001|Overall Study|Adverse Event|5|||
155398434|NCT00806195|560893992|FG002|Overall Study|Adverse Event|11|||
155398435|NCT00806195|560893993|FG003|Overall Study|Adverse Event|2|||
155398436|NCT00806195|560893990|FG000|Overall Study|Withdrawal by Subject|119|||
155398437|NCT00806195|560893991|FG001|Overall Study|Withdrawal by Subject|31|||
155398438|NCT00806195|560893992|FG002|Overall Study|Withdrawal by Subject|76|||
155398439|NCT00806195|560893993|FG003|Overall Study|Withdrawal by Subject|35|||
155398440|NCT00806195|560893990|FG000|Overall Study|Lost to Follow-up|217|||
155398441|NCT00806195|560893991|FG001|Overall Study|Lost to Follow-up|66|||
155398442|NCT00806195|560893992|FG002|Overall Study|Lost to Follow-up|90|||
155398443|NCT00806195|560893993|FG003|Overall Study|Lost to Follow-up|34|||
155398444|NCT00806195|560893990|FG000|Overall Study|Inappropriate Enrollment|0|||
155398445|NCT00806195|560893991|FG001|Overall Study|Inappropriate Enrollment|1|||
155398446|NCT00806195|560893992|FG002|Overall Study|Inappropriate Enrollment|0|||
155398447|NCT00806195|560893993|FG003|Overall Study|Inappropriate Enrollment|0|||
155398448|NCT00806195|560893990|FG000|Overall Study|Administrative Reason|113|||
155398449|NCT00806195|560893991|FG001|Overall Study|Administrative Reason|35|||
155398450|NCT00806195|560893992|FG002|Overall Study|Administrative Reason|66|||
155398451|NCT00806195|560893993|FG003|Overall Study|Administrative Reason|26|||
155398452|NCT00806195|560893990|FG000|Overall Study|Protocol Violation|34|||
155398453|NCT00806195|560893991|FG001|Overall Study|Protocol Violation|24|||
155398454|NCT00806195|560893992|FG002|Overall Study|Protocol Violation|26|||
155398455|NCT00806195|560893993|FG003|Overall Study|Protocol Violation|9|||
155398456|NCT02319668|560893994|FG000|Overall Study|Other (Not specified)|0|||
155398457|NCT02319668|560893995|FG001|Overall Study|Other (Not specified)|2|||
155398458|NCT01161043|560893996|FG000|Overall Study|Withdrawal by Subject|3|||
155398459|NCT02164929|560893997|FG000|Overall Study|Converted to open procedure|1|||
155398460|NCT02164929|560893998|FG001|Overall Study|Converted to open procedure|0|||
155398461|NCT02164929|560893999|FG002|Overall Study|Converted to open procedure|0|||
155398462|NCT02164929|560894000|FG003|Overall Study|Converted to open procedure|2|||
155398463|NCT02164929|560893997|FG000|Overall Study|Failed regional block|0|||
155398464|NCT02164929|560893998|FG001|Overall Study|Failed regional block|0|||
155398465|NCT02164929|560893999|FG002|Overall Study|Failed regional block|1|||
155398466|NCT02164929|560894000|FG003|Overall Study|Failed regional block|0|||
155398467|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Adverse Event|84|||
155398468|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Adverse Event|0|||
155154149|NCT04328077|560002204|FG001|Overall Study|Withdrawal by Subject|1|||
155154150|NCT04328077|560002205|FG002|Overall Study|Withdrawal by Subject|1|||
155154151|NCT04328077|560002206|FG003|Overall Study|Withdrawal by Subject|3|||
155154152|NCT04106557|560002213|FG000|Overall Study|Physician Decision|0|||
155154153|NCT04106557|560002214|FG001|Overall Study|Physician Decision|1|||
155154154|NCT04106557|560002215|FG002|Overall Study|Physician Decision|0|||
155154155|NCT04106557|560002213|FG000|Overall Study|Protocol Violation|0|||
155154156|NCT04106557|560002214|FG001|Overall Study|Protocol Violation|1|||
155154157|NCT04106557|560002215|FG002|Overall Study|Protocol Violation|0|||
155154158|NCT02326155|560002216|FG000|Overall Study|Adverse Event|21|||
155154159|NCT02326155|560002217|FG001|Overall Study|Adverse Event|5|||
155154160|NCT02326155|560002216|FG000|Overall Study|Death|3|||
155154161|NCT02326155|560002217|FG001|Overall Study|Death|0|||
155154162|NCT02326155|560002216|FG000|Overall Study|Lack of Efficacy|49|||
155154163|NCT02326155|560002217|FG001|Overall Study|Lack of Efficacy|5|||
155154164|NCT02326155|560002216|FG000|Overall Study|Lost to Follow-up|14|||
155154165|NCT02326155|560002217|FG001|Overall Study|Lost to Follow-up|3|||
155154166|NCT02326155|560002216|FG000|Overall Study|Protocol Violation|2|||
155398469|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Non-compliance|3|||
155398470|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Non-compliance|0|||
155398471|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
155154167|NCT02326155|560002217|FG001|Overall Study|Protocol Violation|0|||
155398472|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
155398473|NCT00365456|560894004|FG000|Trial Period I (12 Months)|Other|11|||
155398474|NCT00365456|560894005|FG001|Trial Period I (12 Months)|Other|0|||
155398475|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Adverse Event|0|||
155154168|NCT02326155|560002216|FG000|Overall Study|Withdrawal by Subject|34|||
155154169|NCT02326155|560002217|FG001|Overall Study|Withdrawal by Subject|11|||
155154170|NCT02326155|560002216|FG000|Overall Study|Disease progression|37|||
155154171|NCT02326155|560002217|FG001|Overall Study|Disease progression|4|||
155398476|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Adverse Event|6|||
155398477|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Non-compliance|0|||
155398478|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Non-compliance|2|||
155398479|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
155398480|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
155398481|NCT00365456|560894004|FG000|Trial Period II (12 Months)|Other|0|||
155398482|NCT00365456|560894005|FG001|Trial Period II (12 Months)|Other|1|||
155398483|NCT00365456|560894004|FG000|Trial Period III (12 Months)|Adverse Event|13|||
155398484|NCT00365456|560894005|FG001|Trial Period III (12 Months)|Adverse Event|3|||
155398485|NCT00365456|560894004|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
155398486|NCT00365456|560894005|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
155398487|NCT00365456|560894004|FG000|Trial Period III (12 Months)|Other|1|||
155398488|NCT00365456|560894005|FG001|Trial Period III (12 Months)|Other|1|||
155398489|NCT00701090|560894008|FG000|Overall Study|Adverse Event|11|||
155398490|NCT00701090|560894009|FG001|Overall Study|Adverse Event|2|||
155398491|NCT00701090|560894008|FG000|Overall Study|Death|0|||
155398492|NCT00701090|560894009|FG001|Overall Study|Death|1|||
155398493|NCT00701090|560894008|FG000|Overall Study|Lack of Efficacy|5|||
155398494|NCT00701090|560894009|FG001|Overall Study|Lack of Efficacy|4|||
155398495|NCT00701090|560894008|FG000|Overall Study|Lost to Follow-up|9|||
155398496|NCT00701090|560894009|FG001|Overall Study|Lost to Follow-up|9|||
155398497|NCT00701090|560894008|FG000|Overall Study|Physician Decision|3|||
155398498|NCT00701090|560894009|FG001|Overall Study|Physician Decision|4|||
155398499|NCT00701090|560894008|FG000|Overall Study|Protocol Violation|2|||
155398500|NCT00701090|560894009|FG001|Overall Study|Protocol Violation|3|||
155398501|NCT00701090|560894008|FG000|Overall Study|Withdrawal by Subject|11|||
155398502|NCT00701090|560894009|FG001|Overall Study|Withdrawal by Subject|16|||
155154172|NCT02326155|560002216|FG000|Overall Study|Study close|188|||
155154173|NCT02326155|560002217|FG001|Overall Study|Study close|21|||
155398503|NCT00701090|560894008|FG000|Overall Study|Other|7|||
155398504|NCT00701090|560894009|FG001|Overall Study|Other|12|||
155398505|NCT00873366|560894010|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
155398506|NCT00873366|560894010|FG000|Overall Study|Off tamoxifen due to side effects|2|||
155398507|NCT00873366|560894010|FG000|Overall Study|Refused to continue DM-BT testing|3|||
155398508|NCT01537198|560894011|FG000|Overall Study|RSV infection|2|||
155398509|NCT01537198|560894011|FG000|Overall Study|Adverse Event|4|||
155398510|NCT01537198|560894011|FG000|Overall Study|No Further Visits to the Clinic|37|||
155398511|NCT01537198|560894011|FG000|Overall Study|Other|111|||
155398512|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
155398513|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
155398514|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
155398515|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
155398516|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
155398517|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
155398518|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
155398519|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
155398520|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
155398521|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
155398522|NCT01299376|560894018|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
155398523|NCT01299376|560894019|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
155398524|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
155398525|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
155398526|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
155398527|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
155398528|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
155398529|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
155398530|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
155398531|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
155398532|NCT01299376|560894018|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
155398533|NCT01299376|560894019|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
155398534|NCT00113074|560894022|FG000|Overall Study|Lost to Follow-up|10|||
155398535|NCT00113074|560894023|FG001|Overall Study|Lost to Follow-up|10|||
155398536|NCT00113074|560894024|FG002|Overall Study|Lost to Follow-up|14|||
155398537|NCT03680911|560894025|FG000|At Home Treatment|Study Termination|3|||
155398538|NCT03680911|560894026|FG001|At Home Treatment|Study Termination|0|||
155398539|NCT03680911|560894025|FG000|At Home Treatment|Lost to Follow-up|0|||
155398540|NCT03680911|560894026|FG001|At Home Treatment|Lost to Follow-up|1|||
155398541|NCT03680911|560894025|FG000|At Home Treatment|Withdrawal by Subject|0|||
155398542|NCT03680911|560894026|FG001|At Home Treatment|Withdrawal by Subject|2|||
155398543|NCT03680911|560894025|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
155398544|NCT03680911|560894026|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
155398545|NCT03962738|560894027|FG000|Overall Study|Protocol Deviation|3|||
155398546|NCT03962738|560894028|FG001|Overall Study|Protocol Deviation|0|||
155398547|NCT03962738|560894029|FG002|Overall Study|Protocol Deviation|1|||
155154174|NCT02326155|560002216|FG000|Overall Study|except for study close|46|||
155154175|NCT02326155|560002217|FG001|Overall Study|except for study close|13|||
155398548|NCT03962738|560894030|FG003|Overall Study|Protocol Deviation|1|||
155398549|NCT03962738|560894027|FG000|Overall Study|Withdrawal by Subject|4|||
155398550|NCT03962738|560894028|FG001|Overall Study|Withdrawal by Subject|0|||
155398551|NCT03962738|560894029|FG002|Overall Study|Withdrawal by Subject|0|||
155398552|NCT03962738|560894030|FG003|Overall Study|Withdrawal by Subject|0|||
155398553|NCT03962738|560894027|FG000|Overall Study|Lost to Follow-up|0|||
155398554|NCT03962738|560894028|FG001|Overall Study|Lost to Follow-up|0|||
155398555|NCT03962738|560894029|FG002|Overall Study|Lost to Follow-up|1|||
155398556|NCT03962738|560894030|FG003|Overall Study|Lost to Follow-up|0|||
155398557|NCT01478360|560894031|FG000|Overall Study|Lost to Follow-up|1|||
155398558|NCT01478360|560894032|FG001|Overall Study|Lost to Follow-up|0|||
155398559|NCT01478360|560894031|FG000|Overall Study|Adverse Event|0|||
155398560|NCT01478360|560894032|FG001|Overall Study|Adverse Event|1|||
155398561|NCT01478360|560894031|FG000|Overall Study|Administrative problems|1|||
155398562|NCT01478360|560894032|FG001|Overall Study|Administrative problems|2|||
155398563|NCT01221727|560894033|FG000|Overall Study|Physician Decision|2|||
155398564|NCT01221727|560894034|FG001|Overall Study|Physician Decision|0|||
155398565|NCT01221727|560894033|FG000|Overall Study|Withdrawal by Subject|1|||
155398566|NCT01221727|560894034|FG001|Overall Study|Withdrawal by Subject|1|||
155398567|NCT02566577|560894035|FG000|Overall Study|Withdrawal by Subject|1|||
155398568|NCT02566577|560894036|FG001|Overall Study|Withdrawal by Subject|1|||
155398569|NCT02566577|560894035|FG000|Overall Study|Equipment failure|1|||
155398570|NCT02566577|560894036|FG001|Overall Study|Equipment failure|1|||
155398571|NCT02566577|560894035|FG000|Overall Study|Physical limitation|1|||
155398572|NCT02566577|560894036|FG001|Overall Study|Physical limitation|0|||
155398573|NCT01289821|560894037|FG000|Treatment Period|Withdrawal by Subject|1|||
155398574|NCT01289821|560894037|FG000|Treatment Period|Physician Decision|3|||
155398575|NCT01289821|560894037|FG000|Treatment Period|Adverse Event|4|||
155398576|NCT01289821|560894037|FG000|Treatment Period|Radiological Progression|43|||
155398577|NCT01289821|560894037|FG000|Treatment Period|Clinical Progression|2|||
155398578|NCT01289821|560894037|FG000|Treatment Period|Therapeutic procedure required|1|||
155398579|NCT01289821|560894037|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
155398580|NCT01289821|560894037|FG000|Safety Follow-up Period|Protocol Violation|3|||
155398581|NCT01289821|560894037|FG000|Safety Follow-up Period|Unspecified reason|1|||
155398582|NCT01289821|560894037|FG000|Survival Follow-up Period|Protocol Violation|1|||
155398583|NCT01289821|560894037|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
155398584|NCT01289821|560894037|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
155398585|NCT02941926|560894038|FG000|Core Phase|Progressive disease|1109|||
155398586|NCT02941926|560894038|FG000|Core Phase|Adverse Event|504|||
155398587|NCT02941926|560894038|FG000|Core Phase|Subject/guardian decision|127|||
155398588|NCT02941926|560894038|FG000|Core Phase|Physician Decision|112|||
155398589|NCT02941926|560894038|FG000|Core Phase|Death|46|||
155398590|NCT02941926|560894038|FG000|Core Phase|Protocol deviation|34|||
155398591|NCT02941926|560894038|FG000|Core Phase|Lost to Follow-up|8|||
155398592|NCT02941926|560894038|FG000|Core Phase|Technical problems|5|||
155398593|NCT02941926|560894038|FG000|Extension Phase|Physician Decision|155|||
155398594|NCT02941926|560894038|FG000|Extension Phase|Progressive disease|115|||
155398595|NCT02941926|560894038|FG000|Extension Phase|Adverse Event|13|||
155398596|NCT02941926|560894038|FG000|Extension Phase|Subject/Guardian decision|12|||
155398597|NCT02941926|560894038|FG000|Extension Phase|Death|6|||
155398598|NCT00097773|560894039|FG000|Overall Study|Lost to Follow-up|2|||
155398599|NCT00097773|560894040|FG001|Overall Study|Lost to Follow-up|2|||
155398600|NCT00097773|560894041|FG002|Overall Study|Lost to Follow-up|0|||
155398601|NCT00097773|560894042|FG003|Overall Study|Lost to Follow-up|1|||
155398602|NCT00097773|560894039|FG000|Overall Study|Physician Decision|2|||
155398603|NCT00097773|560894040|FG001|Overall Study|Physician Decision|2|||
155398604|NCT00097773|560894041|FG002|Overall Study|Physician Decision|3|||
155398605|NCT00097773|560894042|FG003|Overall Study|Physician Decision|1|||
155398606|NCT00097773|560894039|FG000|Overall Study|Withdrawal by Subject|3|||
155398607|NCT00097773|560894040|FG001|Overall Study|Withdrawal by Subject|3|||
155398608|NCT00097773|560894041|FG002|Overall Study|Withdrawal by Subject|3|||
155398609|NCT00097773|560894042|FG003|Overall Study|Withdrawal by Subject|1|||
155398610|NCT00097773|560894039|FG000|Overall Study|Adverse Event|0|||
155398611|NCT00097773|560894040|FG001|Overall Study|Adverse Event|1|||
155398612|NCT00097773|560894041|FG002|Overall Study|Adverse Event|0|||
155398613|NCT00097773|560894042|FG003|Overall Study|Adverse Event|0|||
155398614|NCT00097773|560894039|FG000|Overall Study|Other|1|||
155398615|NCT00097773|560894040|FG001|Overall Study|Other|0|||
155398616|NCT00097773|560894041|FG002|Overall Study|Other|2|||
155398617|NCT00097773|560894042|FG003|Overall Study|Other|0|||
155398618|NCT01009034|560894043|FG000|Overall Study|Lost to Follow-up|2|||
155398619|NCT01009034|560894043|FG000|Overall Study|Withdrawal by Subject|2|||
155398620|NCT00474708|560894044|FG000|Overall Study|Lack of Efficacy|11|||
155398621|NCT00474708|560894045|FG001|Overall Study|Lack of Efficacy|5|||
155398622|NCT00474708|560894044|FG000|Overall Study|Suicide ideation/behavior|0|||
155398623|NCT00474708|560894045|FG001|Overall Study|Suicide ideation/behavior|1|||
155398624|NCT00474708|560894044|FG000|Overall Study|Withdrawal by Subject|7|||
155398625|NCT00474708|560894045|FG001|Overall Study|Withdrawal by Subject|0|||
155057697|NCT02265510|559645791|FG009|Overall Study|Death|3|||
155398626|NCT00474708|560894044|FG000|Overall Study|Lack of compliance|12|||
155398627|NCT00474708|560894045|FG001|Overall Study|Lack of compliance|4|||
155398628|NCT00474708|560894044|FG000|Overall Study|Lost to Follow-up|18|||
155398629|NCT00474708|560894045|FG001|Overall Study|Lost to Follow-up|9|||
155398630|NCT00474708|560894044|FG000|Overall Study|Physician Decision|9|||
155398631|NCT00474708|560894045|FG001|Overall Study|Physician Decision|6|||
155398632|NCT03700320|560894046|FG000|Overall Study|Adverse Event|5|||
155398633|NCT03700320|560894047|FG001|Overall Study|Adverse Event|31|||
155398634|NCT03700320|560894046|FG000|Overall Study|Lack of Efficacy|2|||
155398635|NCT03700320|560894047|FG001|Overall Study|Lack of Efficacy|5|||
155398636|NCT03700320|560894046|FG000|Overall Study|Withdrawal by Subject|29|||
155398637|NCT03700320|560894047|FG001|Overall Study|Withdrawal by Subject|75|||
155398638|NCT03700320|560894046|FG000|Overall Study|Lost to Follow-up|16|||
155398639|NCT03700320|560894047|FG001|Overall Study|Lost to Follow-up|23|||
155398640|NCT03700320|560894046|FG000|Overall Study|Pregnancy|2|||
155398641|NCT03700320|560894047|FG001|Overall Study|Pregnancy|4|||
155398642|NCT03700320|560894046|FG000|Overall Study|Protocol Deviation|7|||
155398643|NCT03700320|560894047|FG001|Overall Study|Protocol Deviation|31|||
155398644|NCT03700320|560894046|FG000|Overall Study|Non-compliance with Study Drug|1|||
155398645|NCT03700320|560894047|FG001|Overall Study|Non-compliance with Study Drug|3|||
155398646|NCT03700320|560894046|FG000|Overall Study|Reason not Specified|0|||
155398647|NCT03700320|560894047|FG001|Overall Study|Reason not Specified|1|||
155398648|NCT02243865|560894051|FG000|Overall Study|Protocol Violation|1|||
155398649|NCT02243865|560894052|FG001|Overall Study|Protocol Violation|3|||
155398650|NCT02243865|560894051|FG000|Overall Study|Lost to Follow-up|1|||
155398651|NCT02243865|560894052|FG001|Overall Study|Lost to Follow-up|1|||
155398652|NCT02243865|560894051|FG000|Overall Study|Withdrawal by Subject|1|||
155398653|NCT02243865|560894052|FG001|Overall Study|Withdrawal by Subject|0|||
155398654|NCT02243865|560894051|FG000|Overall Study|Adverse Event|1|||
155398655|NCT02243865|560894052|FG001|Overall Study|Adverse Event|1|||
155398656|NCT02054325|560894058|FG000|Overall Study|Lost to Follow-up|8|||
155398657|NCT02054325|560894059|FG001|Overall Study|Lost to Follow-up|5|||
155398658|NCT05093322|560894060|FG000|Overall Study|Death|6|||
155398659|NCT05093322|560894061|FG001|Overall Study|Death|2|||
155398660|NCT05093322|560894060|FG000|Overall Study|Other|4|||
155398661|NCT05093322|560894061|FG001|Overall Study|Other|1|||
155398662|NCT00898443|560894062|FG000|Overall Study|Withdrawal by Subject|1|||
155398663|NCT00898443|560894063|FG001|Overall Study|Withdrawal by Subject|0|||
155398664|NCT01843972|560894065|FG000|Overall Study|Withdrawal by Subject|0|||
155398665|NCT01843972|560894066|FG001|Overall Study|Withdrawal by Subject|0|||
155398666|NCT01843972|560894067|FG002|Overall Study|Withdrawal by Subject|0|||
155398667|NCT01843972|560894068|FG003|Overall Study|Withdrawal by Subject|0|||
155398668|NCT01843972|560894069|FG004|Overall Study|Withdrawal by Subject|1|||
155398669|NCT01843972|560894070|FG005|Overall Study|Withdrawal by Subject|0|||
155398670|NCT01843972|560894071|FG006|Overall Study|Withdrawal by Subject|0|||
155398671|NCT01843972|560894072|FG007|Overall Study|Withdrawal by Subject|0|||
155398672|NCT01843972|560894073|FG008|Overall Study|Withdrawal by Subject|0|||
155398673|NCT01843972|560894074|FG009|Overall Study|Withdrawal by Subject|0|||
155398674|NCT00932425|560894077|FG000|Overall Study|Lost to Follow-up|0|||
155398675|NCT00932425|560894078|FG001|Overall Study|Lost to Follow-up|1|||
155398676|NCT00932425|560894077|FG000|Overall Study|Withdrawal by Subject|0|||
155398677|NCT00932425|560894078|FG001|Overall Study|Withdrawal by Subject|1|||
155398678|NCT00916279|560894081|FG000|Overall Study|Death|2|||
155398679|NCT00916279|560894081|FG000|Overall Study|Lost to Follow-up|2|||
155398680|NCT00310804|560894082|FG000|Overall Study|Lost to Follow-up|2|||
155398681|NCT00310804|560894083|FG001|Overall Study|Lost to Follow-up|0|||
155398682|NCT00310804|560894082|FG000|Overall Study|Withdrawal by Subject|3|||
155398683|NCT00310804|560894083|FG001|Overall Study|Withdrawal by Subject|0|||
155398684|NCT02717754|560894086|FG000|Overall Study|Incorrect Infusion Duration|0|||
155398685|NCT02717754|560894087|FG001|Overall Study|Incorrect Infusion Duration|0|||
155398686|NCT02717754|560894088|FG002|Overall Study|Incorrect Infusion Duration|0|||
155398687|NCT02717754|560894089|FG003|Overall Study|Incorrect Infusion Duration|10|||
155398688|NCT02717754|560894090|FG004|Overall Study|Incorrect Infusion Duration|20|||
155154176|NCT00939393|560002218|FG000|Overall Study|Withdrawal by Subject|1|||
155154177|NCT00939393|560002219|FG001|Overall Study|Withdrawal by Subject|0|||
155284049|NCT02268396|560472656|FG000|Overall Study|Administrative|2|||
155398689|NCT02717754|560894091|FG005|Overall Study|Incorrect Infusion Duration|20|||
155398690|NCT00667823|560894092|FG000|Overall Study|Lost to Follow-up|5|||
155398691|NCT00667823|560894092|FG000|Overall Study|Adverse Event|7|||
155398692|NCT00667823|560894092|FG000|Overall Study|Death|182|||
155398693|NCT00667823|560894092|FG000|Overall Study|Withdrawal by Subject|12|||
155398694|NCT00667823|560894092|FG000|Overall Study|Other|8|||
155398695|NCT00667823|560894092|FG000|Overall Study|Missing (completion page missing)|2|||
155398696|NCT03828292|560894093|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398697|NCT03828292|560894094|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
155398698|NCT03828292|560894095|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398699|NCT03828292|560894096|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398700|NCT03828292|560894097|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398701|NCT03828292|560894098|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
155398702|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398703|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398704|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
155398705|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398706|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398707|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
155398708|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398709|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398710|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398711|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
155398712|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398713|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
155398714|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398715|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398716|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398717|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
155398718|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398719|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
155398720|NCT03828292|560894093|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398721|NCT03828292|560894094|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398722|NCT03828292|560894095|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
155398723|NCT03828292|560894096|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
155398724|NCT03828292|560894097|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398725|NCT03828292|560894098|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
155398726|NCT04376827|560894099|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
155284050|NCT02268396|560472656|FG000|Overall Study|Withdrawal by Subject|1|||
155284051|NCT02268396|560472656|FG000|Overall Study|Lost to Follow-up|2|||
155284052|NCT02268396|560472656|FG000|Overall Study|Protocol-Specified Criteria|2|||
155284053|NCT02268396|560472656|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
155284054|NCT01304706|560472659|FG000|Overall Study|Adverse Event|2|||
155284055|NCT01304706|560472659|FG000|Overall Study|Lack of Efficacy|1|||
155284056|NCT01304706|560472659|FG000|Overall Study|Death|3|||
155284057|NCT01304706|560472659|FG000|Overall Study|Withdrawal by Subject|3|||
155284058|NCT01304706|560472659|FG000|Overall Study|Lost to Follow-up|7|||
155284059|NCT01304706|560472659|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
155398727|NCT04376827|560894100|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
155398728|NCT04376827|560894099|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
155398729|NCT04376827|560894100|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
155398730|NCT04376827|560894099|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
155398731|NCT04376827|560894100|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
155398732|NCT04376827|560894099|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
155398733|NCT04376827|560894100|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
155398734|NCT04376827|560894099|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
155284060|NCT04978363|560472660|FG000|Overall Study|Other medical issues unrelated to the study|0|||
155284061|NCT04978363|560472661|FG001|Overall Study|Other medical issues unrelated to the study|0|||
155398735|NCT04376827|560894100|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
155154178|NCT00939393|560002218|FG000|Overall Study|Lost to Follow-up|3|||
155154179|NCT00939393|560002219|FG001|Overall Study|Lost to Follow-up|0|||
155398736|NCT03697720|560895782|FG000|Overall Study|Lost to Follow-up|7|||
155398737|NCT03496012|560895783|FG000|Overall Study|Withdrawal by Subject|2|||
155398738|NCT03496012|560895784|FG001|Overall Study|Withdrawal by Subject|0|||
155398739|NCT03496012|560895785|FG002|Overall Study|Withdrawal by Subject|2|||
155398740|NCT03496012|560895783|FG000|Overall Study|Adverse Event|0|||
155398741|NCT03496012|560895784|FG001|Overall Study|Adverse Event|0|||
155398742|NCT03496012|560895785|FG002|Overall Study|Adverse Event|1|||
155398743|NCT03496012|560895783|FG000|Overall Study|Reason Not Specified|2|||
155398744|NCT03496012|560895784|FG001|Overall Study|Reason Not Specified|0|||
155398745|NCT03496012|560895785|FG002|Overall Study|Reason Not Specified|1|||
155398746|NCT02053168|560895788|FG000|Overall Study|Withdrawal by Subject|1|||
155398747|NCT02053168|560895788|FG000|Overall Study|Physician Decision|1|||
155398748|NCT02053168|560895788|FG000|Overall Study|Lost to Follow-up|1|||
155154180|NCT00313014|560002220|FG000|Overall Study|Withdrawal by Subject|11|||
155284062|NCT04978363|560472662|FG002|Overall Study|Other medical issues unrelated to the study|0|||
155284063|NCT04978363|560472663|FG003|Overall Study|Other medical issues unrelated to the study|0|||
155284064|NCT04978363|560472664|FG004|Overall Study|Other medical issues unrelated to the study|1|||
155398749|NCT03785925|560895789|FG000|Overall Study|Withdrawal by Subject|15|||
155154181|NCT00313014|560002221|FG001|Overall Study|Withdrawal by Subject|7|||
155398750|NCT03785925|560895789|FG000|Overall Study|Lost to Follow-up|1|||
155398751|NCT00957528|560895793|FG000|Overall Study|Protocol Violation|0|||
155398752|NCT00957528|560895794|FG001|Overall Study|Protocol Violation|1|||
155398753|NCT00957528|560895795|FG002|Overall Study|Protocol Violation|0|||
155398754|NCT00957528|560895793|FG000|Overall Study|Withdrawal by Subject|0|||
155398755|NCT00957528|560895794|FG001|Overall Study|Withdrawal by Subject|0|||
155398756|NCT00957528|560895795|FG002|Overall Study|Withdrawal by Subject|1|||
155398757|NCT01101438|560895797|FG000|Overall Study|Withdrawal by Subject|8|||
155398758|NCT01101438|560895798|FG001|Overall Study|Withdrawal by Subject|9|||
155398759|NCT03677596|560895814|FG000|Overall Study|Adverse Event|0|||
155398760|NCT03677596|560895815|FG001|Overall Study|Adverse Event|1|||
155398761|NCT03677596|560895814|FG000|Overall Study|Death|10|||
155398762|NCT03677596|560895815|FG001|Overall Study|Death|6|||
155398763|NCT03677596|560895814|FG000|Overall Study|Lost to Follow-up|0|||
155398764|NCT03677596|560895815|FG001|Overall Study|Lost to Follow-up|1|||
155398765|NCT03677596|560895814|FG000|Overall Study|Progressive Disease|8|||
155398766|NCT03677596|560895815|FG001|Overall Study|Progressive Disease|8|||
155398767|NCT03677596|560895814|FG000|Overall Study|Withdrawal by Subject|3|||
155398768|NCT03677596|560895815|FG001|Overall Study|Withdrawal by Subject|0|||
155398769|NCT03677596|560895814|FG000|Overall Study|Disease Relapse|2|||
155398770|NCT03677596|560895815|FG001|Overall Study|Disease Relapse|2|||
155398771|NCT03677596|560895814|FG000|Overall Study|Other|0|||
155398772|NCT03677596|560895815|FG001|Overall Study|Other|1|||
155398773|NCT00922480|560895822|FG000|Main Study|Protocol Violation|3|||
155398774|NCT00922480|560895823|FG001|Main Study|Protocol Violation|6|||
155398775|NCT00922480|560895822|FG000|Main Study|Adverse Event|6|||
155398776|NCT00922480|560895823|FG001|Main Study|Adverse Event|7|||
155398777|NCT00922480|560895822|FG000|Main Study|Lack of Efficacy|3|||
155398778|NCT00922480|560895823|FG001|Main Study|Lack of Efficacy|0|||
155398779|NCT00922480|560895822|FG000|Main Study|Withdrawal by Subject|20|||
155398780|NCT00922480|560895823|FG001|Main Study|Withdrawal by Subject|15|||
155398781|NCT00922480|560895822|FG000|Main Study|Lost to Follow-up|5|||
155398782|NCT00922480|560895823|FG001|Main Study|Lost to Follow-up|0|||
155398783|NCT00922480|560895822|FG000|Main Study|Physician Decision|0|||
155398784|NCT00922480|560895823|FG001|Main Study|Physician Decision|1|||
155398785|NCT00922480|560895822|FG000|Extension Study|Protocol Violation|3|||
155398786|NCT00922480|560895823|FG001|Extension Study|Protocol Violation|0|||
155398787|NCT00922480|560895822|FG000|Extension Study|Adverse Event|1|||
155398788|NCT00922480|560895823|FG001|Extension Study|Adverse Event|1|||
155398789|NCT00922480|560895822|FG000|Extension Study|Withdrawal by Subject|1|||
155398790|NCT00922480|560895823|FG001|Extension Study|Withdrawal by Subject|1|||
155398791|NCT00922480|560895822|FG000|Extension Study|Others|0|||
155398792|NCT00922480|560895823|FG001|Extension Study|Others|1|||
155398793|NCT03716050|560895829|FG000|Overall Study|Lost to Follow-up|0|||
155398794|NCT03716050|560895830|FG001|Overall Study|Lost to Follow-up|0|||
155398795|NCT03716050|560895831|FG002|Overall Study|Lost to Follow-up|1|||
155398796|NCT03716050|560895832|FG003|Overall Study|Lost to Follow-up|0|||
155398797|NCT03716050|560895833|FG004|Overall Study|Lost to Follow-up|0|||
155398798|NCT03716050|560895834|FG005|Overall Study|Lost to Follow-up|0|||
155398799|NCT03716050|560895835|FG006|Overall Study|Lost to Follow-up|0|||
155398800|NCT03716050|560895836|FG007|Overall Study|Lost to Follow-up|0|||
155398801|NCT03716050|560895829|FG000|Overall Study|Physician Decision|0|||
155398802|NCT03716050|560895830|FG001|Overall Study|Physician Decision|0|||
155398803|NCT03716050|560895831|FG002|Overall Study|Physician Decision|0|||
155398804|NCT03716050|560895832|FG003|Overall Study|Physician Decision|1|||
155398805|NCT03716050|560895833|FG004|Overall Study|Physician Decision|0|||
155398806|NCT03716050|560895834|FG005|Overall Study|Physician Decision|0|||
155398807|NCT03716050|560895835|FG006|Overall Study|Physician Decision|0|||
155398808|NCT03716050|560895836|FG007|Overall Study|Physician Decision|0|||
155398809|NCT03716050|560895829|FG000|Overall Study|Protocol Violation|0|||
155398810|NCT03716050|560895830|FG001|Overall Study|Protocol Violation|0|||
155398811|NCT03716050|560895831|FG002|Overall Study|Protocol Violation|0|||
155398812|NCT03716050|560895832|FG003|Overall Study|Protocol Violation|1|||
155398813|NCT03716050|560895833|FG004|Overall Study|Protocol Violation|0|||
155398814|NCT03716050|560895834|FG005|Overall Study|Protocol Violation|0|||
155398815|NCT03716050|560895835|FG006|Overall Study|Protocol Violation|0|||
155398816|NCT03716050|560895836|FG007|Overall Study|Protocol Violation|2|||
155398817|NCT01010633|560895839|FG000|Overall Study|Adverse Event|1|||
155398818|NCT01010633|560895840|FG001|Overall Study|Adverse Event|1|||
155398819|NCT01010633|560895839|FG000|Overall Study|Protocol Violation|1|||
155398820|NCT01010633|560895840|FG001|Overall Study|Protocol Violation|2|||
155398821|NCT01010633|560895839|FG000|Overall Study|Withdrawal by Subject|2|||
155398822|NCT01010633|560895840|FG001|Overall Study|Withdrawal by Subject|1|||
155398823|NCT01010633|560895839|FG000|Overall Study|Investigator decision|0|||
155398824|NCT01010633|560895840|FG001|Overall Study|Investigator decision|1|||
155398825|NCT00073528|560895841|FG000|Overall Study|Death|488|||
155398826|NCT00073528|560895842|FG001|Overall Study|Death|473|||
155398827|NCT00073528|560895841|FG000|Overall Study|Lost to Follow-up|52|||
155398828|NCT00073528|560895842|FG001|Overall Study|Lost to Follow-up|45|||
155398829|NCT00073528|560895841|FG000|Overall Study|Withdrawal by Subject|50|||
155398830|NCT00073528|560895842|FG001|Overall Study|Withdrawal by Subject|45|||
155398831|NCT00073528|560895841|FG000|Overall Study|Study terminated by Sponsor|10|||
155398832|NCT00073528|560895842|FG001|Overall Study|Study terminated by Sponsor|29|||
155398833|NCT00073528|560895841|FG000|Overall Study|Other|18|||
155398834|NCT00073528|560895842|FG001|Overall Study|Other|19|||
155398835|NCT00073528|560895841|FG000|Overall Study|Other|9|||
155398836|NCT00073528|560895842|FG001|Overall Study|Other|12|||
155398837|NCT00073528|560895841|FG000|Overall Study|Protocol Violation|3|||
155398838|NCT00073528|560895842|FG001|Overall Study|Protocol Violation|5|||
155398839|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
155398840|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
155398841|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
155398842|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
155398843|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
155398844|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
155398845|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
155398846|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
155398847|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
155398848|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
155398849|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
155398850|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
155398851|NCT03086057|560895843|FG000|Stage 1: PrEP Uptake|Death|1|||
155398852|NCT03086057|560895844|FG001|Stage 1: PrEP Uptake|Death|0|||
155398853|NCT03086057|560895845|FG002|Stage 1: PrEP Uptake|Death|0|||
155398854|NCT03086057|560895846|FG003|Stage 1: PrEP Uptake|Death|0|||
155398855|NCT03086057|560895843|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
155398856|NCT03086057|560895844|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
155398857|NCT03086057|560895845|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
155398858|NCT03086057|560895846|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
155398859|NCT03086057|560895843|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
155398860|NCT03086057|560895844|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
155398861|NCT03086057|560895845|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
155398862|NCT03086057|560895846|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
155398863|NCT03086057|560895843|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
155398864|NCT03086057|560895844|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
155398865|NCT03086057|560895845|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
155398866|NCT03086057|560895846|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
155398867|NCT01494350|560895851|FG000|Overall Study|Worsening of lesion|1|||
155398868|NCT01786603|560895852|FG000|Overall Study|Death|5|||
155398869|NCT01786603|560895853|FG001|Overall Study|Death|1|||
155398870|NCT01786603|560895852|FG000|Overall Study|Adverse Event|6|||
155398871|NCT01786603|560895853|FG001|Overall Study|Adverse Event|2|||
155398872|NCT01786603|560895852|FG000|Overall Study|Physician decision to withdraw|6|||
155398873|NCT01786603|560895853|FG001|Overall Study|Physician decision to withdraw|7|||
155398874|NCT01786603|560895852|FG000|Overall Study|Lost to Follow-up|1|||
155398875|NCT01786603|560895853|FG001|Overall Study|Lost to Follow-up|2|||
155398876|NCT03654976|560895863|FG000|Overall Study|Withdrawal by Subject|12|||
155398877|NCT03654976|560895864|FG001|Overall Study|Withdrawal by Subject|11|||
155398878|NCT03654976|560895863|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
155398879|NCT03654976|560895864|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
155398880|NCT03654976|560895863|FG000|Overall Study|Adverse Event|5|||
155398881|NCT03654976|560895864|FG001|Overall Study|Adverse Event|0|||
155398882|NCT03654976|560895863|FG000|Overall Study|Lost to Follow-up|2|||
155154182|NCT00313014|560002222|FG002|Overall Study|Withdrawal by Subject|5|||
155154183|NCT00313014|560002220|FG000|Overall Study|Adverse Event|14|||
155154184|NCT00313014|560002221|FG001|Overall Study|Adverse Event|29|||
155154185|NCT00313014|560002222|FG002|Overall Study|Adverse Event|16|||
155154186|NCT00313014|560002220|FG000|Overall Study|Lost to Follow-up|7|||
155154187|NCT00313014|560002221|FG001|Overall Study|Lost to Follow-up|6|||
155154188|NCT00313014|560002222|FG002|Overall Study|Lost to Follow-up|10|||
155154189|NCT00313014|560002220|FG000|Overall Study|Administrative|9|||
155154190|NCT00313014|560002221|FG001|Overall Study|Administrative|6|||
155154191|NCT00313014|560002222|FG002|Overall Study|Administrative|14|||
155154192|NCT00313014|560002220|FG000|Overall Study|Lack of Efficacy|52|||
155154193|NCT00313014|560002221|FG001|Overall Study|Lack of Efficacy|25|||
155398883|NCT03654976|560895864|FG001|Overall Study|Lost to Follow-up|0|||
155398884|NCT03654976|560895863|FG000|Overall Study|Lack of Efficacy|0|||
155398885|NCT03654976|560895864|FG001|Overall Study|Lack of Efficacy|1|||
155398886|NCT03098836|560895865|FG000|Overall Study|Adverse Event|1|||
155398887|NCT03098836|560895866|FG001|Overall Study|Adverse Event|3|||
155398888|NCT03098836|560895865|FG000|Overall Study|Lack of Efficacy|30|||
155398889|NCT03098836|560895866|FG001|Overall Study|Lack of Efficacy|15|||
155398890|NCT03098836|560895865|FG000|Overall Study|Physician Decision|2|||
155398891|NCT03098836|560895866|FG001|Overall Study|Physician Decision|1|||
155398892|NCT03098836|560895865|FG000|Overall Study|Withdrawal by Subject|3|||
155398893|NCT03098836|560895866|FG001|Overall Study|Withdrawal by Subject|2|||
155398894|NCT03986866|560895867|FG000|Overall Study|Withdrawal by Subject|0|||
155398895|NCT03986866|560895868|FG001|Overall Study|Withdrawal by Subject|3|||
154953253|NCT00906347|559254643|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
154953254|NCT00906347|559254642|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
154953255|NCT00906347|559254643|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
154953256|NCT00906347|559254642|FG000|Received Study Drug|Refused study drug|1|||
154953257|NCT00906347|559254643|FG001|Received Study Drug|Refused study drug|0|||
154953258|NCT00906347|559254642|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
154953259|NCT00906347|559254643|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
154953260|NCT02849652|559254651|FG000|Overall Study|Lost to Follow-up|104|||
154953261|NCT02849652|559254652|FG001|Overall Study|Lost to Follow-up|35|||
154953262|NCT02849652|559254653|FG002|Overall Study|Lost to Follow-up|116|||
155154194|NCT00313014|560002222|FG002|Overall Study|Lack of Efficacy|16|||
155154195|NCT01280903|560002223|FG000|Overall Study|Lost to Follow-up|23|||
155154196|NCT01280903|560002224|FG001|Overall Study|Lost to Follow-up|16|||
155154197|NCT03453164|560002225|FG000|Overall Study|Lack of Efficacy|16|||
155154198|NCT03453164|560002225|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
155154199|NCT03829228|560002226|FG000|Overall Study|Protocol Violation|1|||
155154200|NCT02177695|560002227|FG000|ITT Analysis|Ineligible|5|||
155154201|NCT02177695|560002228|FG001|ITT Analysis|Ineligible|5|||
155154202|NCT02177695|560002227|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
155154203|NCT02177695|560002228|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
155154204|NCT02177695|560002227|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
155154205|NCT02177695|560002228|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
155154206|NCT02177695|560002227|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
155154207|NCT02177695|560002228|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
155154208|NCT03085095|560002231|FG000|Overall Study|Adverse Event|23|||
155154209|NCT03085095|560002232|FG001|Overall Study|Adverse Event|8|||
154953263|NCT02849652|559254654|FG003|Overall Study|Lost to Follow-up|22|||
154953264|NCT02849652|559254651|FG000|Overall Study|Withdrawal by Subject|10|||
154953265|NCT02849652|559254652|FG001|Overall Study|Withdrawal by Subject|2|||
154953266|NCT02849652|559254653|FG002|Overall Study|Withdrawal by Subject|8|||
154953267|NCT02849652|559254654|FG003|Overall Study|Withdrawal by Subject|4|||
154953268|NCT00472290|559254655|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
154953269|NCT00472290|559254655|FG000|Overall Study|Protocol Specified Criteria|7|||
154953270|NCT00472290|559254655|FG000|Overall Study|Administrative Decision|37|||
154953271|NCT00472290|559254655|FG000|Overall Study|Death|3|||
154953272|NCT00472290|559254655|FG000|Overall Study|Lost to Follow-up|1|||
154953273|NCT00472290|559254655|FG000|Overall Study|Lack of Efficacy|1|||
154953274|NCT00472290|559254655|FG000|Overall Study|Disease Progression|4|||
154953275|NCT00472290|559254655|FG000|Overall Study|Withdrawal by Subject|5|||
155154210|NCT03085095|560002231|FG000|Overall Study|Protocol Violation|0|||
155154211|NCT03085095|560002232|FG001|Overall Study|Protocol Violation|1|||
155154212|NCT03085095|560002231|FG000|Overall Study|Lost to Follow-up|2|||
155154213|NCT03085095|560002232|FG001|Overall Study|Lost to Follow-up|1|||
155284065|NCT04978363|560472665|FG005|Overall Study|Other medical issues unrelated to the study|0|||
155398896|NCT03986866|560895867|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
155398897|NCT03986866|560895868|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
155398898|NCT00545064|560895871|FG000|Overall Study|Lost to Follow-up|3|||
155398899|NCT00545064|560895871|FG000|Overall Study|Withdrawal by Subject|2|||
155398900|NCT00545064|560895871|FG000|Overall Study|did not complete course of treatment|1|||
155398901|NCT00545064|560895871|FG000|Overall Study|cancel all appointments, no rebooking|1|||
155398902|NCT00545064|560895871|FG000|Overall Study|inclement weather|1|||
155398903|NCT01660451|560895874|FG000|Overall Study|Protocol Violation|0|||
155398904|NCT01660451|560895875|FG001|Overall Study|Protocol Violation|1|||
155398905|NCT01660451|560895876|FG002|Overall Study|Protocol Violation|1|||
155398906|NCT01660451|560895874|FG000|Overall Study|AE not associated with clinical disease progression|13|||
155398907|NCT01660451|560895875|FG001|Overall Study|AE not associated with clinical disease progression|10|||
155398908|NCT01660451|560895876|FG002|Overall Study|AE not associated with clinical disease progression|40|||
155398909|NCT01660451|560895874|FG000|Overall Study|AE associated with clinical disease progression|1|||
155398910|NCT01660451|560895875|FG001|Overall Study|AE associated with clinical disease progression|3|||
155398911|NCT01660451|560895876|FG002|Overall Study|AE associated with clinical disease progression|11|||
155398912|NCT01660451|560895874|FG000|Overall Study|Sponsor Decision|0|||
155398913|NCT01660451|560895875|FG001|Overall Study|Sponsor Decision|0|||
155398914|NCT01660451|560895876|FG002|Overall Study|Sponsor Decision|1|||
155398915|NCT01660451|560895874|FG000|Overall Study|Protocol Deviation|0|||
155398916|NCT01660451|560895875|FG001|Overall Study|Protocol Deviation|0|||
155398917|NCT01660451|560895876|FG002|Overall Study|Protocol Deviation|1|||
155398918|NCT01660451|560895874|FG000|Overall Study|Physician Decision|1|||
155398919|NCT01660451|560895875|FG001|Overall Study|Physician Decision|2|||
155398920|NCT01660451|560895876|FG002|Overall Study|Physician Decision|5|||
155398921|NCT01660451|560895874|FG000|Overall Study|Withdrawal by Subject|1|||
155398922|NCT01660451|560895875|FG001|Overall Study|Withdrawal by Subject|1|||
155398923|NCT01660451|560895876|FG002|Overall Study|Withdrawal by Subject|20|||
155398924|NCT01660451|560895874|FG000|Overall Study|Trial closure.|0|||
155154214|NCT03085095|560002231|FG000|Overall Study|Withdrawal by Subject|17|||
155154215|NCT03085095|560002232|FG001|Overall Study|Withdrawal by Subject|6|||
155154216|NCT03085095|560002231|FG000|Overall Study|Physician Decision|9|||
155154217|NCT03085095|560002232|FG001|Overall Study|Physician Decision|3|||
155154218|NCT03085095|560002231|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
155154219|NCT03085095|560002232|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
155154220|NCT03085095|560002231|FG000|Overall Study|Did not Receive Study Drug|2|||
155154221|NCT03085095|560002232|FG001|Overall Study|Did not Receive Study Drug|2|||
155154222|NCT03085095|560002231|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
155154223|NCT03085095|560002232|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
155154224|NCT03459079|560002234|FG000|Overall Study|Adverse Event|4|||
155154225|NCT03459079|560002235|FG001|Overall Study|Adverse Event|2|||
155154226|NCT03459079|560002236|FG002|Overall Study|Adverse Event|0|||
155154227|NCT03459079|560002234|FG000|Overall Study|Withdrawal by Subject|2|||
155154228|NCT03459079|560002235|FG001|Overall Study|Withdrawal by Subject|2|||
155154229|NCT03459079|560002236|FG002|Overall Study|Withdrawal by Subject|0|||
155154230|NCT05101122|560002238|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
155154231|NCT05101122|560002238|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
155154232|NCT05101122|560002238|FG000|AD313 80/5|Withdrawal by Subject|1|||
155154233|NCT05101122|560002238|FG000|AD313 80/10|Physician Decision|1|||
155154234|NCT04945733|560002242|FG000|Overall Study|Physician Decision|1|||
155154235|NCT04945733|560002243|FG001|Overall Study|Physician Decision|3|||
155154236|NCT04945733|560002244|FG002|Overall Study|Physician Decision|0|||
155154237|NCT04945733|560002242|FG000|Overall Study|Withdrawal by Subject|3|||
155154238|NCT04945733|560002243|FG001|Overall Study|Withdrawal by Subject|3|||
155154239|NCT04945733|560002244|FG002|Overall Study|Withdrawal by Subject|0|||
155398925|NCT01660451|560895875|FG001|Overall Study|Trial closure.|0|||
155398926|NCT01660451|560895876|FG002|Overall Study|Trial closure.|1|||
155398927|NCT01660451|560895874|FG000|Overall Study|Switching to other therapy|0|||
155398928|NCT01660451|560895875|FG001|Overall Study|Switching to other therapy|1|||
155398929|NCT01660451|560895876|FG002|Overall Study|Switching to other therapy|1|||
155398930|NCT01660451|560895874|FG000|Overall Study|Progressive disease - clinical progression|4|||
155398931|NCT01660451|560895875|FG001|Overall Study|Progressive disease - clinical progression|10|||
155398932|NCT01660451|560895876|FG002|Overall Study|Progressive disease - clinical progression|9|||
155398933|NCT01660451|560895874|FG000|Overall Study|Progressive disease - radiological progression|12|||
155398934|NCT01660451|560895875|FG001|Overall Study|Progressive disease - radiological progression|23|||
155398935|NCT01660451|560895876|FG002|Overall Study|Progressive disease - radiological progression|50|||
155398936|NCT01660451|560895874|FG000|Overall Study|Death|1|||
155398937|NCT01660451|560895875|FG001|Overall Study|Death|0|||
155398938|NCT01660451|560895876|FG002|Overall Study|Death|1|||
155398939|NCT01660451|560895874|FG000|Overall Study|Other|0|||
155398940|NCT01660451|560895875|FG001|Overall Study|Other|0|||
155398941|NCT01660451|560895876|FG002|Overall Study|Other|1|||
155398942|NCT04688775|560895877|FG000|Placebo-controlled Period|Randomized, not treated|1|||
155398943|NCT04688775|560895878|FG001|Placebo-controlled Period|Randomized, not treated|1|||
155398944|NCT04688775|560895879|FG002|Placebo-controlled Period|Randomized, not treated|0|||
155398945|NCT04688775|560895880|FG003|Placebo-controlled Period|Randomized, not treated|0|||
155398946|NCT04688775|560895877|FG000|Placebo-controlled Period|Adverse Event|2|||
155398947|NCT04688775|560895878|FG001|Placebo-controlled Period|Adverse Event|0|||
155398948|NCT04688775|560895879|FG002|Placebo-controlled Period|Adverse Event|0|||
155398949|NCT04688775|560895880|FG003|Placebo-controlled Period|Adverse Event|0|||
155398950|NCT04688775|560895877|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
155398951|NCT04688775|560895878|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
155398952|NCT04688775|560895879|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
155398953|NCT04688775|560895880|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
155398954|NCT04688775|560895877|FG000|Placebo-controlled Period|Protocol Violation|0|||
155398955|NCT04688775|560895878|FG001|Placebo-controlled Period|Protocol Violation|1|||
155398956|NCT04688775|560895879|FG002|Placebo-controlled Period|Protocol Violation|0|||
155398957|NCT04688775|560895880|FG003|Placebo-controlled Period|Protocol Violation|0|||
155398958|NCT04688775|560895877|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
155398959|NCT04688775|560895878|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
155398960|NCT04688775|560895879|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
155398961|NCT04688775|560895880|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
155398962|NCT04688775|560895877|FG000|Placebo-controlled Period|Other reasons|0|||
155398963|NCT04688775|560895878|FG001|Placebo-controlled Period|Other reasons|1|||
155398964|NCT04688775|560895879|FG002|Placebo-controlled Period|Other reasons|0|||
155398965|NCT04688775|560895880|FG003|Placebo-controlled Period|Other reasons|0|||
155398966|NCT04688775|560895877|FG000|Delayed Start Period|Adverse Event|0|||
155398967|NCT04688775|560895878|FG001|Delayed Start Period|Adverse Event|0|||
155398968|NCT04688775|560895879|FG002|Delayed Start Period|Adverse Event|1|||
155398969|NCT04688775|560895880|FG003|Delayed Start Period|Adverse Event|0|||
155398970|NCT04688775|560895877|FG000|Delayed Start Period|Lack of Efficacy|0|||
155398971|NCT04688775|560895878|FG001|Delayed Start Period|Lack of Efficacy|0|||
155398972|NCT04688775|560895879|FG002|Delayed Start Period|Lack of Efficacy|0|||
155398973|NCT04688775|560895880|FG003|Delayed Start Period|Lack of Efficacy|3|||
155398974|NCT04688775|560895877|FG000|Delayed Start Period|Withdrawal by Subject|0|||
155398975|NCT04688775|560895878|FG001|Delayed Start Period|Withdrawal by Subject|0|||
155398976|NCT04688775|560895879|FG002|Delayed Start Period|Withdrawal by Subject|2|||
155398977|NCT04688775|560895880|FG003|Delayed Start Period|Withdrawal by Subject|4|||
155398978|NCT04688775|560895877|FG000|Delayed Start Period|Lost to Follow-up|0|||
155398979|NCT04688775|560895878|FG001|Delayed Start Period|Lost to Follow-up|0|||
155398980|NCT04688775|560895879|FG002|Delayed Start Period|Lost to Follow-up|2|||
155398981|NCT04688775|560895880|FG003|Delayed Start Period|Lost to Follow-up|1|||
155398982|NCT04688775|560895877|FG000|Delayed Start Period|other reasons|0|||
155398983|NCT04688775|560895878|FG001|Delayed Start Period|other reasons|0|||
155398984|NCT04688775|560895879|FG002|Delayed Start Period|other reasons|1|||
155398985|NCT04688775|560895880|FG003|Delayed Start Period|other reasons|0|||
155398986|NCT01770912|560895883|FG000|Overall Study|Lost to Follow-up|2|||
155398987|NCT01770912|560895884|FG001|Overall Study|Lost to Follow-up|0|||
155398988|NCT03250832|560895885|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
155398989|NCT03250832|560895886|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
155398990|NCT03250832|560895887|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
155398991|NCT03250832|560895888|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
155398992|NCT03250832|560895889|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
155398993|NCT03250832|560895890|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
155398994|NCT03250832|560895891|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
155398995|NCT03250832|560895892|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398996|NCT03250832|560895893|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398997|NCT03250832|560895894|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398998|NCT03250832|560895895|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
155398999|NCT03250832|560895896|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
155399000|NCT03250832|560895885|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
155399001|NCT03250832|560895886|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
155399002|NCT03250832|560895887|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
155154240|NCT02007096|560002245|FG000|Overall Study|medication not available|2|||
155154241|NCT02007096|560002246|FG001|Overall Study|medication not available|0|||
155399003|NCT03250832|560895888|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
155399004|NCT03250832|560895889|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
155399005|NCT03250832|560895890|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
155399006|NCT03250832|560895891|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
155399007|NCT03250832|560895892|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399008|NCT03250832|560895893|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399009|NCT03250832|560895894|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399010|NCT03250832|560895895|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155154242|NCT02007096|560002245|FG000|Overall Study|did not inject saline|0|||
155154243|NCT02007096|560002246|FG001|Overall Study|did not inject saline|3|||
155154244|NCT02007096|560002245|FG000|Overall Study|did not follow postoperative protocol|8|||
155154245|NCT02007096|560002246|FG001|Overall Study|did not follow postoperative protocol|11|||
155399011|NCT03250832|560895896|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
155399012|NCT03250832|560895885|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399013|NCT03250832|560895886|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399014|NCT03250832|560895887|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
155399015|NCT03250832|560895888|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399016|NCT03250832|560895889|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399017|NCT03250832|560895890|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399018|NCT03250832|560895891|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399019|NCT03250832|560895892|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399020|NCT03250832|560895893|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399021|NCT03250832|560895894|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399022|NCT03250832|560895895|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399023|NCT03250832|560895896|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
155399024|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399025|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
155154246|NCT02007096|560002245|FG000|Overall Study|converted to open surgery|1|||
155154247|NCT02007096|560002246|FG001|Overall Study|converted to open surgery|1|||
155399026|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
155284066|NCT04978363|560472666|FG006|Overall Study|Other medical issues unrelated to the study|0|||
155154248|NCT02007096|560002245|FG000|Overall Study|no mesh placed|0|||
155154249|NCT02007096|560002246|FG001|Overall Study|no mesh placed|1|||
155154250|NCT05660577|560002247|FG000|Overall Study|Discontinued|9|||
155154251|NCT03363841|560002253|FG000|Overall Study|Adverse Event|1|||
155154252|NCT03363841|560002253|FG000|Overall Study|Withdrawal by Subject|1|||
155284067|NCT04978363|560472667|FG007|Overall Study|Other medical issues unrelated to the study|0|||
155154253|NCT03363841|560002253|FG000|Overall Study|Death|7|||
155154254|NCT03363841|560002253|FG000|Overall Study|Physician Decision|1|||
155154255|NCT02156076|560002256|FG000|Treatment Period|no longer meets study criteria|0|||
155154256|NCT02156076|560002257|FG001|Treatment Period|no longer meets study criteria|0|||
155399027|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399028|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399029|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399030|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399031|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
155399032|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399033|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399034|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399035|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
155399036|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399037|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399038|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399039|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399040|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155154257|NCT02156076|560002258|FG002|Treatment Period|no longer meets study criteria|1|||
155399041|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399042|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399043|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
155399044|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399045|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399046|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399047|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
155399048|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399049|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399050|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399051|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399052|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399053|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399054|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399055|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
155399056|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399057|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399058|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399059|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
155399060|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399061|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399062|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399063|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399064|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399065|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399066|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399067|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
155399068|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399069|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399070|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399071|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
155399072|NCT03250832|560895885|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399073|NCT03250832|560895886|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399074|NCT03250832|560895887|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399075|NCT03250832|560895888|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399076|NCT03250832|560895889|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399077|NCT03250832|560895890|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399078|NCT03250832|560895891|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399079|NCT03250832|560895892|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
155399080|NCT03250832|560895893|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399081|NCT03250832|560895894|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399082|NCT03250832|560895895|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399083|NCT03250832|560895896|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
155399084|NCT03250832|560895885|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399085|NCT03250832|560895886|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399086|NCT03250832|560895887|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
155154258|NCT02156076|560002259|FG003|Treatment Period|no longer meets study criteria|0|||
154953276|NCT00472290|559254655|FG000|Overall Study|Adverse Event|6|||
155399087|NCT03250832|560895888|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399088|NCT03250832|560895889|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399089|NCT03250832|560895890|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399090|NCT03250832|560895891|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399091|NCT03250832|560895892|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399092|NCT03250832|560895893|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
155399093|NCT03250832|560895894|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
155399094|NCT03250832|560895895|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399095|NCT03250832|560895896|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
155399096|NCT03250832|560895885|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399097|NCT03250832|560895886|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399098|NCT03250832|560895887|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399099|NCT03250832|560895888|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399100|NCT03250832|560895889|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399101|NCT03250832|560895890|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399102|NCT03250832|560895891|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399103|NCT03250832|560895892|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399104|NCT03250832|560895893|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
155399105|NCT03250832|560895894|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
155399106|NCT03250832|560895895|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399107|NCT03250832|560895896|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
155399108|NCT03250832|560895885|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399109|NCT03250832|560895886|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399110|NCT03250832|560895887|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399111|NCT03250832|560895888|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399112|NCT03250832|560895889|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399113|NCT03250832|560895890|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399114|NCT03250832|560895891|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399115|NCT03250832|560895892|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399116|NCT03250832|560895893|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
155399117|NCT03250832|560895894|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
155399118|NCT03250832|560895895|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399119|NCT03250832|560895896|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
155399120|NCT03250832|560895885|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399121|NCT03250832|560895886|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399122|NCT03250832|560895887|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399123|NCT03250832|560895888|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399124|NCT03250832|560895889|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399125|NCT03250832|560895890|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399126|NCT03250832|560895891|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399127|NCT03250832|560895892|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399128|NCT03250832|560895893|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399129|NCT03250832|560895894|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399130|NCT03250832|560895895|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
155399131|NCT03250832|560895896|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
155399132|NCT01536951|560895899|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399133|NCT01536951|560895900|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399134|NCT01536951|560895901|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
155399135|NCT01536951|560895902|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399136|NCT01536951|560895903|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399137|NCT01536951|560895904|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399138|NCT01536951|560895905|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399139|NCT01536951|560895906|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399140|NCT01536951|560895907|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
155399141|NCT01536951|560895899|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
155399142|NCT01536951|560895900|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
155399143|NCT01536951|560895901|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
155399144|NCT01536951|560895902|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
155154259|NCT02156076|560002256|FG000|Treatment Period|Poor/non-compliance|0|||
155154260|NCT02156076|560002257|FG001|Treatment Period|Poor/non-compliance|1|||
155399145|NCT01536951|560895903|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
155399146|NCT01536951|560895904|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
155399147|NCT01536951|560895905|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
155399148|NCT01536951|560895906|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
155154261|NCT02156076|560002258|FG002|Treatment Period|Poor/non-compliance|0|||
155154262|NCT02156076|560002259|FG003|Treatment Period|Poor/non-compliance|0|||
155154263|NCT02156076|560002256|FG000|Treatment Period|Lost to Follow-up|0|||
155154264|NCT02156076|560002257|FG001|Treatment Period|Lost to Follow-up|0|||
155154265|NCT02156076|560002258|FG002|Treatment Period|Lost to Follow-up|0|||
155154266|NCT02156076|560002259|FG003|Treatment Period|Lost to Follow-up|1|||
155154267|NCT02156076|560002256|FG000|Treatment Period|Withdrawal by Subject|0|||
155154268|NCT02156076|560002257|FG001|Treatment Period|Withdrawal by Subject|0|||
155284068|NCT04978363|560472668|FG008|Overall Study|Other medical issues unrelated to the study|0|||
155284069|NCT04978363|560472669|FG009|Overall Study|Other medical issues unrelated to the study|0|||
155284070|NCT04978363|560472670|FG010|Overall Study|Other medical issues unrelated to the study|0|||
155284071|NCT04978363|560472660|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
155284072|NCT04978363|560472661|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
155284073|NCT04978363|560472662|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
155284074|NCT04978363|560472663|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
155284075|NCT04978363|560472664|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
155284076|NCT04978363|560472665|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
155284077|NCT04978363|560472666|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
155284078|NCT04978363|560472667|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
155284079|NCT04978363|560472668|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
155284080|NCT04978363|560472669|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
155284081|NCT04978363|560472670|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
155284082|NCT04978363|560472660|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284083|NCT04978363|560472661|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
155284084|NCT04978363|560472662|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284085|NCT04978363|560472663|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284086|NCT04978363|560472664|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284087|NCT04978363|560472665|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284088|NCT04978363|560472666|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284089|NCT04978363|560472667|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284090|NCT04978363|560472668|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284091|NCT04978363|560472669|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284092|NCT04978363|560472670|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
155284093|NCT00723294|560472676|FG000|Overall Study|Lobular histology|2|||
155284094|NCT00723294|560472676|FG000|Overall Study|>25% intraductal component|1|||
155284095|NCT00723294|560472676|FG000|Overall Study|No MRI tumor enhancement|1|||
155284096|NCT00723294|560472676|FG000|Overall Study|1.0-Tesla MRI|1|||
155284097|NCT00723294|560472676|FG000|Overall Study|No cryoabalation|2|||
155284098|NCT00723294|560472676|FG000|Overall Study|Did not undergo surgery|1|||
155284099|NCT00723294|560472676|FG000|Overall Study|Treated prior to registration|1|||
155284100|NCT00723294|560472676|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
155284101|NCT00723294|560472676|FG000|Overall Study|Benign lesion|1|||
155284102|NCT00723294|560472676|FG000|Overall Study|Withdrawal by Subject|1|||
155284103|NCT00723294|560472676|FG000|Overall Study|No treatment due to probe failure|1|||
155284104|NCT01211665|560472677|FG000|Overall Study|Withdrawal by Subject|1|||
155284105|NCT01211665|560472678|FG001|Overall Study|Withdrawal by Subject|0|||
155284106|NCT01211665|560472677|FG000|Overall Study|Death|1|||
154953277|NCT00472290|559254655|FG000|Overall Study|Requirement for alternative therapy|7|||
154953278|NCT00777829|559254656|FG000|Overall Study|Withdrawal by Subject|0|||
154953279|NCT00777829|559254657|FG001|Overall Study|Withdrawal by Subject|2|||
154953280|NCT00745095|559254658|FG000|Overall Study|Declined to participate|1|||
154953281|NCT00745095|559254659|FG001|Overall Study|Declined to participate|0|||
154953282|NCT00745095|559254660|FG002|Overall Study|Declined to participate|0|||
154953283|NCT00745095|559254661|FG003|Overall Study|Declined to participate|0|||
154953284|NCT00745095|559254662|FG004|Overall Study|Declined to participate|92|||
154953285|NCT00745095|559254663|FG005|Overall Study|Declined to participate|95|||
154953286|NCT00745095|559254658|FG000|Overall Study|Ineligible due to GFR criteria|0|||
154953287|NCT00745095|559254659|FG001|Overall Study|Ineligible due to GFR criteria|2|||
154953288|NCT00745095|559254660|FG002|Overall Study|Ineligible due to GFR criteria|3|||
154953289|NCT00745095|559254661|FG003|Overall Study|Ineligible due to GFR criteria|3|||
154953290|NCT00745095|559254662|FG004|Overall Study|Ineligible due to GFR criteria|30|||
154953291|NCT00745095|559254663|FG005|Overall Study|Ineligible due to GFR criteria|28|||
154953292|NCT05277389|559254670|FG000|Overall Study|Lost to Follow-up|1|||
154953293|NCT05277389|559254671|FG001|Overall Study|Lost to Follow-up|4|||
154953294|NCT03144687|559254675|FG000|Overall Study|Death|0|||
154953295|NCT03144687|559254676|FG001|Overall Study|Death|2|||
154953296|NCT03144687|559254675|FG000|Overall Study|Lost to Follow-up|0|||
154953297|NCT03144687|559254676|FG001|Overall Study|Lost to Follow-up|1|||
154953298|NCT03144687|559254675|FG000|Overall Study|Physician Decision|0|||
155284107|NCT01211665|560472678|FG001|Overall Study|Death|0|||
155284108|NCT00498186|560472681|FG000|Overall Study|Protocol Violation|10|||
155284109|NCT00498186|560472681|FG000|Overall Study|Lack of Efficacy|31|||
155284110|NCT00498186|560472681|FG000|Overall Study|Adverse Event|89|||
155284111|NCT00498186|560472681|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
155284112|NCT00498186|560472681|FG000|Overall Study|Withdrawal by Subject|18|||
155284113|NCT00498186|560472681|FG000|Overall Study|Lost to Follow-up|3|||
155284114|NCT00498186|560472681|FG000|Overall Study|Other|10|||
155284115|NCT04454567|560472682|FG000|Overall Study|Study Terminated by Sponsor|1|||
155284116|NCT04454567|560472683|FG001|Overall Study|Study Terminated by Sponsor|1|||
155284117|NCT02757885|560472684|FG000|Overall Study|Screen Failures|4|||
155284118|NCT01456780|560472685|FG000|Overall Study|Lost to Follow-up|3|||
155284119|NCT01456780|560472686|FG001|Overall Study|Lost to Follow-up|3|||
155284120|NCT01456780|560472687|FG002|Overall Study|Lost to Follow-up|0|||
155284121|NCT02688621|560472692|FG000|Overall Study|Pregnancy|1|||
155284122|NCT02688621|560472693|FG001|Overall Study|Pregnancy|3|||
155284123|NCT02688621|560472692|FG000|Overall Study|Lost to Follow-up|38|||
155284124|NCT02688621|560472693|FG001|Overall Study|Lost to Follow-up|15|||
155284125|NCT02688621|560472692|FG000|Overall Study|Withdrawal by Subject|1|||
155284126|NCT02688621|560472693|FG001|Overall Study|Withdrawal by Subject|0|||
155284127|NCT04565249|560472698|FG000|Overall Study|Death|0|||
155284128|NCT04565249|560472699|FG001|Overall Study|Death|0|||
155284129|NCT04565249|560472700|FG002|Overall Study|Death|0|||
155284130|NCT04565249|560472701|FG003|Overall Study|Death|1|||
155284131|NCT05349864|560472706|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
155284132|NCT05349864|560472707|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
155284133|NCT02333630|560472708|FG000|Overall Study|Lost to Follow-up|5|||
155284134|NCT02333630|560472709|FG001|Overall Study|Lost to Follow-up|2|||
155284135|NCT00984282|560472710|FG000|Double Blind Treatment|Adverse Event|40|||
155284136|NCT00984282|560472711|FG001|Double Blind Treatment|Adverse Event|6|||
155284137|NCT00984282|560472710|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
155284138|NCT00984282|560472711|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
155284139|NCT00984282|560472710|FG000|Double Blind Treatment|Physician Decision|1|||
155284140|NCT00984282|560472711|FG001|Double Blind Treatment|Physician Decision|2|||
155284141|NCT00984282|560472710|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
155284142|NCT00984282|560472711|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
155284143|NCT00984282|560472710|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
155284144|NCT00984282|560472711|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
155284145|NCT00984282|560472710|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
155284146|NCT00984282|560472711|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
155284147|NCT00984282|560472710|FG000|Double Blind Treatment|Lost to Follow-up|3|||
155284148|NCT00984282|560472711|FG001|Double Blind Treatment|Lost to Follow-up|0|||
155284149|NCT00984282|560472710|FG000|Double Blind Treatment|Death|8|||
155284150|NCT00984282|560472711|FG001|Double Blind Treatment|Death|4|||
155284151|NCT00984282|560472710|FG000|Double Blind Treatment|Not treated|0|||
155284152|NCT00984282|560472711|FG001|Double Blind Treatment|Not treated|1|||
155284153|NCT00984282|560472710|FG000|Double Blind Treatment|Switched to commercial drug|6|||
155284154|NCT00984282|560472711|FG001|Double Blind Treatment|Switched to commercial drug|1|||
155284155|NCT00984282|560472710|FG000|Double Blind Treatment|protocol driven decision point|1|||
155284156|NCT00984282|560472711|FG001|Double Blind Treatment|protocol driven decision point|1|||
155284157|NCT00984282|560472710|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
155284158|NCT00984282|560472711|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
155284159|NCT00984282|560472710|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
155284160|NCT00984282|560472711|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
155284161|NCT00984282|560472710|FG000|Open-label Treatment|Adverse Event|20|||
155284162|NCT00984282|560472711|FG001|Open-label Treatment|Adverse Event|30|||
155284163|NCT00984282|560472710|FG000|Open-label Treatment|Withdrawal by Subject|6|||
155284164|NCT00984282|560472711|FG001|Open-label Treatment|Withdrawal by Subject|21|||
155284165|NCT00984282|560472710|FG000|Open-label Treatment|Death|7|||
155284166|NCT00984282|560472711|FG001|Open-label Treatment|Death|15|||
155284167|NCT00984282|560472710|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
155284168|NCT00984282|560472711|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
155284169|NCT00984282|560472710|FG000|Open-label Treatment|Lost to Follow-up|1|||
155284170|NCT00984282|560472711|FG001|Open-label Treatment|Lost to Follow-up|1|||
155399149|NCT01536951|560895907|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
155284171|NCT00984282|560472710|FG000|Open-label Treatment|Patient convenience|1|||
155284172|NCT00984282|560472711|FG001|Open-label Treatment|Patient convenience|0|||
155284173|NCT00984282|560472710|FG000|Open-label Treatment|Non-compliant with study medication|1|||
155284174|NCT00984282|560472711|FG001|Open-label Treatment|Non-compliant with study medication|0|||
155284175|NCT00984282|560472710|FG000|Open-label Treatment|Target lesion removed|0|||
155284176|NCT00984282|560472711|FG001|Open-label Treatment|Target lesion removed|1|||
155284177|NCT00984282|560472710|FG000|Open-label Treatment|Protocol driven decision point|1|||
155154269|NCT02156076|560002258|FG002|Treatment Period|Withdrawal by Subject|1|||
155154270|NCT02156076|560002259|FG003|Treatment Period|Withdrawal by Subject|0|||
155154271|NCT02156076|560002256|FG000|Treatment Period|Subject request to discontinue treatment|0|||
155154272|NCT02156076|560002257|FG001|Treatment Period|Subject request to discontinue treatment|1|||
155154273|NCT02156076|560002258|FG002|Treatment Period|Subject request to discontinue treatment|0|||
155154274|NCT02156076|560002259|FG003|Treatment Period|Subject request to discontinue treatment|0|||
155399150|NCT00545402|560895910|FG000|Overall Study|Discontinuation of treatment|17|||
155399151|NCT00545402|560895911|FG001|Overall Study|Discontinuation of treatment|9|||
155399152|NCT00545402|560895910|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
155399153|NCT00545402|560895911|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
155399154|NCT00545402|560895910|FG000|Overall Study|Death|5|||
155399155|NCT00545402|560895911|FG001|Overall Study|Death|7|||
155399156|NCT00545402|560895910|FG000|Overall Study|Graft loss|2|||
155399157|NCT00545402|560895911|FG001|Overall Study|Graft loss|4|||
155399158|NCT00545402|560895910|FG000|Overall Study|Withdrawal by Subject|0|||
155399159|NCT00545402|560895911|FG001|Overall Study|Withdrawal by Subject|1|||
155399160|NCT00545402|560895910|FG000|Overall Study|Protocol Violation|1|||
155399161|NCT00545402|560895911|FG001|Overall Study|Protocol Violation|0|||
155399162|NCT00545402|560895910|FG000|Overall Study|Reason not specified|1|||
155399163|NCT00545402|560895911|FG001|Overall Study|Reason not specified|1|||
155399164|NCT01721876|560895912|FG000|Overall Study|Not treated|1|||
155154275|NCT02156076|560002256|FG000|Treatment Period|Adverse Event|0|||
155399165|NCT01721876|560895913|FG001|Overall Study|Not treated|4|||
155399166|NCT01721876|560895912|FG000|Overall Study|Disease progression / relapse|123|||
155399167|NCT01721876|560895913|FG001|Overall Study|Disease progression / relapse|156|||
155399168|NCT01721876|560895912|FG000|Overall Study|Death|6|||
155399169|NCT01721876|560895913|FG001|Overall Study|Death|13|||
155399170|NCT01721876|560895912|FG000|Overall Study|Adverse Event|41|||
155399171|NCT01721876|560895913|FG001|Overall Study|Adverse Event|165|||
155399172|NCT01721876|560895912|FG000|Overall Study|Protocol Violation|2|||
155399173|NCT01721876|560895913|FG001|Overall Study|Protocol Violation|1|||
155399174|NCT01721876|560895912|FG000|Overall Study|Withdrawal by Subject|15|||
155399175|NCT01721876|560895913|FG001|Overall Study|Withdrawal by Subject|38|||
155399176|NCT01721876|560895912|FG000|Overall Study|Reason not listed|34|||
155399177|NCT01721876|560895913|FG001|Overall Study|Reason not listed|63|||
155399178|NCT01721876|560895912|FG000|Overall Study|Sponsor terminated trial|0|||
155399179|NCT01721876|560895913|FG001|Overall Study|Sponsor terminated trial|4|||
155399180|NCT01252810|560895914|FG000|Overall Study|Withdrawal by Subject|4|||
155399181|NCT01252810|560895915|FG001|Overall Study|Withdrawal by Subject|1|||
155399182|NCT01252810|560895914|FG000|Overall Study|Lost to Follow-up|0|||
155399183|NCT01252810|560895915|FG001|Overall Study|Lost to Follow-up|1|||
155399184|NCT01252810|560895914|FG000|Overall Study|Physician Decision|2|||
155399185|NCT01252810|560895915|FG001|Overall Study|Physician Decision|1|||
155399186|NCT01252810|560895914|FG000|Overall Study|Various reasons|8|||
155399187|NCT01252810|560895915|FG001|Overall Study|Various reasons|0|||
155399188|NCT03805750|560895916|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
155399189|NCT03805750|560895917|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
155399190|NCT01984164|560895918|FG000|Overall Study|Withdrawal by Subject|4|||
155399191|NCT01984164|560895919|FG001|Overall Study|Withdrawal by Subject|3|||
155399192|NCT01984164|560895918|FG000|Overall Study|Adverse Event|5|||
155399193|NCT01984164|560895919|FG001|Overall Study|Adverse Event|19|||
155399194|NCT01984164|560895918|FG000|Overall Study|Lost to Follow-up|1|||
155399195|NCT01984164|560895919|FG001|Overall Study|Lost to Follow-up|3|||
155399196|NCT02811549|560895920|FG000|Overall Study|Lost to Follow-up|1|||
155399197|NCT02811549|560895920|FG000|Overall Study|Withdrawal by Subject|3|||
155399198|NCT02811549|560895920|FG000|Overall Study|Subject screen failed|4|||
155399199|NCT02811549|560895920|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
155399200|NCT05082376|560895921|FG000|Overall Study|Lost to Follow-up|2|||
155399201|NCT00493220|560895922|FG000|Third Intervention|Withdrawal by Subject|1|||
155399202|NCT00493220|560895923|FG001|Third Intervention|Withdrawal by Subject|0|||
155399203|NCT00493220|560895924|FG002|Third Intervention|Withdrawal by Subject|0|||
155399204|NCT00493220|560895925|FG003|Third Intervention|Withdrawal by Subject|0|||
155399205|NCT00493220|560895926|FG004|Third Intervention|Withdrawal by Subject|0|||
155399206|NCT00493220|560895927|FG005|Third Intervention|Withdrawal by Subject|0|||
155154276|NCT02156076|560002257|FG001|Treatment Period|Adverse Event|0|||
155154277|NCT02156076|560002258|FG002|Treatment Period|Adverse Event|0|||
155399207|NCT03184077|560895933|FG000|Overall Study|Lost to Follow-up|21|||
155399208|NCT03184077|560895934|FG001|Overall Study|Lost to Follow-up|21|||
155399209|NCT01889238|560895936|FG000|Overall Study|Death|1|||
155154278|NCT02156076|560002259|FG003|Treatment Period|Adverse Event|1|||
155154279|NCT02156076|560002256|FG000|Follow-up Period|Withdrawal by Subject|1|||
155399210|NCT01889238|560895936|FG000|Overall Study|Withdrawal by Subject|1|||
155399211|NCT01889238|560895936|FG000|Overall Study|Adverse Event|6|||
155399212|NCT01889238|560895936|FG000|Overall Study|Disease Progression|104|||
155399213|NCT01889238|560895936|FG000|Overall Study|Other|6|||
155399214|NCT04136184|560895937|FG000|Overall Study|Lost to Follow-up|0|||
155399215|NCT04136184|560895938|FG001|Overall Study|Lost to Follow-up|3|||
155399216|NCT04136184|560895937|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
155284178|NCT00984282|560472711|FG001|Open-label Treatment|Protocol driven decision point|1|||
155284179|NCT00984282|560472710|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
155284180|NCT00984282|560472711|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
155284181|NCT00984282|560472710|FG000|Open-label Treatment|Switched to commercial drug|6|||
155284182|NCT00984282|560472711|FG001|Open-label Treatment|Switched to commercial drug|7|||
155399217|NCT04136184|560895938|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
155399218|NCT03318978|560895942|FG000|Overall Study|Withdrawal by Subject|1|||
155399219|NCT02844816|560895943|FG000|Overall Study|No protocol treatment received|5|||
155399220|NCT02844816|560895944|FG001|Overall Study|No protocol treatment received|1|||
155399221|NCT02844816|560895943|FG000|Overall Study|Ineligible|22|||
155399222|NCT02844816|560895944|FG001|Overall Study|Ineligible|15|||
155399223|NCT02844816|560895943|FG000|Overall Study|Participant refusal|5|||
155399224|NCT02844816|560895944|FG001|Overall Study|Participant refusal|5|||
155399225|NCT02844816|560895943|FG000|Overall Study|Adverse Event|5|||
155399226|NCT02844816|560895944|FG001|Overall Study|Adverse Event|4|||
155399227|NCT02844816|560895943|FG000|Overall Study|Death|0|||
155399228|NCT02844816|560895944|FG001|Overall Study|Death|1|||
155399229|NCT02844816|560895943|FG000|Overall Study|Disease progression/recurrence|50|||
155399230|NCT02844816|560895944|FG001|Overall Study|Disease progression/recurrence|24|||
155399231|NCT02844816|560895943|FG000|Overall Study|Physician Decision|1|||
155399232|NCT02844816|560895944|FG001|Overall Study|Physician Decision|1|||
155399233|NCT02592018|560895948|FG000|Overall Study|Adverse Event|1|||
155399234|NCT02592018|560895948|FG000|Overall Study|Lost to Follow-up|1|||
155399235|NCT06156215|560895951|FG000|Overall Study|Withdrawal by Subject|2|||
155399236|NCT06156215|560895952|FG001|Overall Study|Withdrawal by Subject|4|||
155399237|NCT06156215|560895953|FG002|Overall Study|Withdrawal by Subject|4|||
155399238|NCT06156215|560895954|FG003|Overall Study|Withdrawal by Subject|0|||
155399239|NCT06156215|560895955|FG004|Overall Study|Withdrawal by Subject|2|||
155399240|NCT06156215|560895956|FG005|Overall Study|Withdrawal by Subject|2|||
155399241|NCT06156215|560895951|FG000|Overall Study|Left ED without completing study|9|||
155399242|NCT06156215|560895952|FG001|Overall Study|Left ED without completing study|3|||
155399243|NCT06156215|560895953|FG002|Overall Study|Left ED without completing study|9|||
155399244|NCT06156215|560895954|FG003|Overall Study|Left ED without completing study|0|||
155399245|NCT06156215|560895955|FG004|Overall Study|Left ED without completing study|8|||
155399246|NCT06156215|560895956|FG005|Overall Study|Left ED without completing study|16|||
155399247|NCT06156215|560895951|FG000|Overall Study|Physician Decision|1|||
155399248|NCT06156215|560895952|FG001|Overall Study|Physician Decision|0|||
155399249|NCT06156215|560895953|FG002|Overall Study|Physician Decision|0|||
155399250|NCT06156215|560895954|FG003|Overall Study|Physician Decision|0|||
155399251|NCT06156215|560895955|FG004|Overall Study|Physician Decision|0|||
155399252|NCT06156215|560895956|FG005|Overall Study|Physician Decision|0|||
155399253|NCT06156215|560895951|FG000|Overall Study|Became or found ineligible|2|||
155399254|NCT06156215|560895952|FG001|Overall Study|Became or found ineligible|0|||
155399255|NCT06156215|560895953|FG002|Overall Study|Became or found ineligible|2|||
155399256|NCT06156215|560895954|FG003|Overall Study|Became or found ineligible|0|||
155399257|NCT06156215|560895955|FG004|Overall Study|Became or found ineligible|1|||
155399258|NCT06156215|560895956|FG005|Overall Study|Became or found ineligible|2|||
155399259|NCT04360551|560897442|FG000|Overall Study|Withdrawal by Subject|1|||
155399260|NCT04360551|560897443|FG001|Overall Study|Withdrawal by Subject|0|||
155399261|NCT01524198|560897455|FG000|Overall Study|Protocol Violation|8|||
155399262|NCT01524198|560897456|FG001|Overall Study|Protocol Violation|6|||
155399263|NCT01524198|560897455|FG000|Overall Study|Withdrawal by Subject|15|||
155399264|NCT01524198|560897456|FG001|Overall Study|Withdrawal by Subject|10|||
155399265|NCT02232802|560897457|FG000|Period 1|Sponsor request|1|||
155399266|NCT02232802|560897458|FG001|Period 1|Sponsor request|0|||
155399267|NCT02232802|560897457|FG000|Period 1|Adverse Event|1|||
155399268|NCT02232802|560897458|FG001|Period 1|Adverse Event|1|||
155399269|NCT00885703|560897463|FG000|Overall Study|Death|9|||
155399270|NCT00885703|560897464|FG001|Overall Study|Death|7|||
155399271|NCT00885703|560897465|FG002|Overall Study|Death|8|||
155399272|NCT00885703|560897466|FG003|Overall Study|Death|7|||
155399273|NCT00885703|560897467|FG004|Overall Study|Death|7|||
155399274|NCT00885703|560897468|FG005|Overall Study|Death|8|||
155399275|NCT00885703|560897469|FG006|Overall Study|Death|4|||
155399276|NCT00885703|560897463|FG000|Overall Study|Lost to Follow-up|0|||
155399277|NCT00885703|560897464|FG001|Overall Study|Lost to Follow-up|0|||
155399278|NCT00885703|560897465|FG002|Overall Study|Lost to Follow-up|1|||
155399279|NCT00885703|560897466|FG003|Overall Study|Lost to Follow-up|0|||
155399280|NCT00885703|560897467|FG004|Overall Study|Lost to Follow-up|0|||
155399281|NCT00885703|560897468|FG005|Overall Study|Lost to Follow-up|1|||
155399282|NCT00885703|560897469|FG006|Overall Study|Lost to Follow-up|0|||
155399283|NCT00885703|560897463|FG000|Overall Study|Withdrawal by Subject|0|||
155399284|NCT00885703|560897464|FG001|Overall Study|Withdrawal by Subject|0|||
155399285|NCT00885703|560897465|FG002|Overall Study|Withdrawal by Subject|0|||
155154280|NCT02156076|560002257|FG001|Follow-up Period|Withdrawal by Subject|0|||
155399286|NCT00885703|560897466|FG003|Overall Study|Withdrawal by Subject|1|||
155399287|NCT00885703|560897467|FG004|Overall Study|Withdrawal by Subject|3|||
155399288|NCT00885703|560897468|FG005|Overall Study|Withdrawal by Subject|1|||
155399289|NCT00885703|560897469|FG006|Overall Study|Withdrawal by Subject|1|||
155399290|NCT00885703|560897463|FG000|Overall Study|Ineligible (no CM)|1|||
155399291|NCT00885703|560897464|FG001|Overall Study|Ineligible (no CM)|3|||
155399292|NCT00885703|560897465|FG002|Overall Study|Ineligible (no CM)|2|||
155399293|NCT00885703|560897466|FG003|Overall Study|Ineligible (no CM)|1|||
155399294|NCT00885703|560897467|FG004|Overall Study|Ineligible (no CM)|2|||
155399295|NCT00885703|560897468|FG005|Overall Study|Ineligible (no CM)|3|||
155399296|NCT00885703|560897469|FG006|Overall Study|Ineligible (no CM)|1|||
155399297|NCT01490450|560897470|FG000|Period 1|Lack of Efficacy|2|||
155399298|NCT01490450|560897471|FG001|Period 1|Lack of Efficacy|0|||
155399299|NCT01490450|560897472|FG002|Period 1|Lack of Efficacy|3|||
155399300|NCT01490450|560897473|FG003|Period 1|Lack of Efficacy|0|||
155399301|NCT01490450|560897470|FG000|Period 1|Adverse Event|0|||
155399302|NCT01490450|560897471|FG001|Period 1|Adverse Event|0|||
155399303|NCT01490450|560897472|FG002|Period 1|Adverse Event|0|||
155399304|NCT01490450|560897473|FG003|Period 1|Adverse Event|5|||
155399305|NCT01490450|560897470|FG000|Period 1|Request to discontinue treatment|1|||
155399306|NCT01490450|560897471|FG001|Period 1|Request to discontinue treatment|0|||
155399307|NCT01490450|560897472|FG002|Period 1|Request to discontinue treatment|0|||
155399308|NCT01490450|560897473|FG003|Period 1|Request to discontinue treatment|0|||
155399309|NCT01490450|560897470|FG000|Period 1|Withdrawal by Subject|0|||
155399310|NCT01490450|560897471|FG001|Period 1|Withdrawal by Subject|0|||
155399311|NCT01490450|560897472|FG002|Period 1|Withdrawal by Subject|0|||
155399312|NCT01490450|560897473|FG003|Period 1|Withdrawal by Subject|3|||
155399313|NCT01490450|560897470|FG000|Period 1|No longer met study criteria|0|||
155399314|NCT01490450|560897471|FG001|Period 1|No longer met study criteria|1|||
155399315|NCT01490450|560897472|FG002|Period 1|No longer met study criteria|1|||
155399316|NCT01490450|560897473|FG003|Period 1|No longer met study criteria|0|||
155399317|NCT01490450|560897470|FG000|Period 2|Lack of Efficacy|0|||
155399318|NCT01490450|560897471|FG001|Period 2|Lack of Efficacy|0|||
155399319|NCT01490450|560897472|FG002|Period 2|Lack of Efficacy|0|||
155399320|NCT01490450|560897473|FG003|Period 2|Lack of Efficacy|1|||
155399321|NCT01490450|560897470|FG000|Period 2|Adverse Event|1|||
155399322|NCT01490450|560897471|FG001|Period 2|Adverse Event|1|||
155399323|NCT01490450|560897472|FG002|Period 2|Adverse Event|0|||
155399324|NCT01490450|560897473|FG003|Period 2|Adverse Event|1|||
155399325|NCT01490450|560897470|FG000|Period 2|Withdrawal by Subject|1|||
155399326|NCT01490450|560897471|FG001|Period 2|Withdrawal by Subject|0|||
155399327|NCT01490450|560897472|FG002|Period 2|Withdrawal by Subject|0|||
155399328|NCT01490450|560897473|FG003|Period 2|Withdrawal by Subject|0|||
155399329|NCT01490450|560897470|FG000|Period 2|Lost to Follow-up|0|||
155399330|NCT01490450|560897471|FG001|Period 2|Lost to Follow-up|0|||
155399331|NCT01490450|560897472|FG002|Period 2|Lost to Follow-up|0|||
155399332|NCT01490450|560897473|FG003|Period 2|Lost to Follow-up|2|||
155399333|NCT00404820|560897474|FG000|Overall Study|Adverse Event|4|||
155399334|NCT00404820|560897475|FG001|Overall Study|Adverse Event|16|||
155399335|NCT00404820|560897474|FG000|Overall Study|Withdrawal by Subject|5|||
155399336|NCT00404820|560897475|FG001|Overall Study|Withdrawal by Subject|3|||
154953299|NCT03144687|559254676|FG001|Overall Study|Physician Decision|1|||
154953300|NCT03144687|559254675|FG000|Overall Study|Withdrawal by Subject|1|||
154953301|NCT03144687|559254676|FG001|Overall Study|Withdrawal by Subject|3|||
154953302|NCT03144687|559254675|FG000|Overall Study|Not Reported|2|||
154953303|NCT03144687|559254676|FG001|Overall Study|Not Reported|0|||
154953304|NCT00683293|559254679|FG000|Overall Study|Withdrawal by Subject|2|||
154953305|NCT00683293|559254680|FG001|Overall Study|Withdrawal by Subject|3|||
154953306|NCT00743197|559254683|FG000|Overall Study|Study terminated due to departure of PI.|1|||
154953307|NCT00743197|559254684|FG001|Overall Study|Study terminated due to departure of PI.|2|||
154953308|NCT00824265|559254685|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
154953309|NCT00824265|559254686|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
154953310|NCT00824265|559254685|FG000|Treatment Phase|Protocol Violation|1|||
154953311|NCT00824265|559254686|FG001|Treatment Phase|Protocol Violation|0|||
154953312|NCT00824265|559254685|FG000|Treatment Phase|Lost to Follow-up|1|||
154953313|NCT00824265|559254686|FG001|Treatment Phase|Lost to Follow-up|1|||
155399337|NCT00404820|560897474|FG000|Overall Study|Lost to Follow-up|7|||
155399338|NCT00404820|560897475|FG001|Overall Study|Lost to Follow-up|3|||
155399339|NCT00404820|560897474|FG000|Overall Study|Administrative problems|2|||
155399340|NCT00404820|560897475|FG001|Overall Study|Administrative problems|0|||
155399341|NCT00404820|560897474|FG000|Overall Study|Death|1|||
155399342|NCT00404820|560897475|FG001|Overall Study|Death|0|||
154953314|NCT00824265|559254685|FG000|Treatment Phase|Physician Decision|6|||
155399343|NCT00404820|560897474|FG000|Overall Study|Other|0|||
155399344|NCT00404820|560897475|FG001|Overall Study|Other|2|||
155399345|NCT00938717|560897476|FG000|Overall Study|Adverse Event|10|||
155399346|NCT00938717|560897477|FG001|Overall Study|Adverse Event|41|||
155399347|NCT00938717|560897476|FG000|Overall Study|Protocol Violation|11|||
154953315|NCT00824265|559254686|FG001|Treatment Phase|Physician Decision|12|||
154953316|NCT00824265|559254685|FG000|Treatment Phase|Withdrawal by Subject|6|||
155057698|NCT02265510|559645792|FG010|Overall Study|Death|4|||
155057699|NCT02265510|559645793|FG011|Overall Study|Death|12|||
155284183|NCT00984282|560472710|FG000|Open-label Treatment|Physician Decision|1|||
155284184|NCT00984282|560472711|FG001|Open-label Treatment|Physician Decision|0|||
154953317|NCT00824265|559254686|FG001|Treatment Phase|Withdrawal by Subject|15|||
154953318|NCT00824265|559254685|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
154953319|NCT00824265|559254686|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
154953320|NCT00824265|559254685|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
154953321|NCT00824265|559254686|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
154953322|NCT01411332|559254689|FG000|Enrollment|Protocol Violation|0|||
154953323|NCT01411332|559254690|FG001|Enrollment|Protocol Violation|1|||
154953324|NCT01411332|559254689|FG000|Enrollment|Withdrawal by Subject|0|||
154953325|NCT01411332|559254690|FG001|Enrollment|Withdrawal by Subject|1|||
154953326|NCT01411332|559254689|FG000|Treatment|Lost to Follow-up|1|||
154953327|NCT01411332|559254690|FG001|Treatment|Lost to Follow-up|0|||
154953328|NCT02170688|559254691|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
154953329|NCT02170688|559254692|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
154953330|NCT02170688|559254693|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
154953331|NCT02170688|559254694|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
154953332|NCT02170688|559254695|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
154953333|NCT02170688|559254691|FG000|Overall Study|Full dose not received|0|||
154953334|NCT02170688|559254692|FG001|Overall Study|Full dose not received|1|||
154953335|NCT02170688|559254693|FG002|Overall Study|Full dose not received|0|||
154953336|NCT02170688|559254694|FG003|Overall Study|Full dose not received|0|||
154953337|NCT02170688|559254695|FG004|Overall Study|Full dose not received|0|||
154953338|NCT02170688|559254691|FG000|Overall Study|Physician Decision|0|||
154953339|NCT02170688|559254692|FG001|Overall Study|Physician Decision|0|||
154953340|NCT02170688|559254693|FG002|Overall Study|Physician Decision|1|||
154953341|NCT02170688|559254694|FG003|Overall Study|Physician Decision|0|||
154953342|NCT02170688|559254695|FG004|Overall Study|Physician Decision|0|||
154953343|NCT02079532|559254698|FG000|Overall Study|Adverse Event|7|||
154953344|NCT02079532|559254698|FG000|Overall Study|Additional or changed therapy|2|||
154953345|NCT02079532|559254698|FG000|Overall Study|Lack of Efficacy|9|||
154953346|NCT02079532|559254698|FG000|Overall Study|Protocol Violation|3|||
154953347|NCT02079532|559254698|FG000|Overall Study|Withdrawal by Subject|1|||
154953348|NCT02079532|559254698|FG000|Overall Study|Administrative problems|1|||
154953349|NCT02079532|559254698|FG000|Overall Study|Inclusion into ReFIRST|3|||
154953350|NCT02079532|559254698|FG000|Overall Study|Other|3|||
154953351|NCT02920996|559254699|FG000|Overall Study|Adverse Event|8|||
154953352|NCT02920996|559254700|FG001|Overall Study|Adverse Event|0|||
154953353|NCT02920996|559254699|FG000|Overall Study|Physician Decision|1|||
154953354|NCT02920996|559254700|FG001|Overall Study|Physician Decision|0|||
154953355|NCT02920996|559254699|FG000|Overall Study|Death|1|||
154953356|NCT02920996|559254700|FG001|Overall Study|Death|0|||
154953357|NCT02920996|559254699|FG000|Overall Study|Missing|1|||
154953358|NCT02920996|559254700|FG001|Overall Study|Missing|0|||
154953359|NCT02920996|559254699|FG000|Overall Study|Subject Non-Compliance|1|||
154953360|NCT02920996|559254700|FG001|Overall Study|Subject Non-Compliance|0|||
154953361|NCT01402947|559254701|FG000|First Intervention|Adverse Event|0|||
154953362|NCT01402947|559254702|FG001|First Intervention|Adverse Event|1|||
154953363|NCT00591630|559254703|FG000|Overall Study|Death|0|||
154953364|NCT00591630|559254704|FG001|Overall Study|Death|0|||
154953365|NCT00591630|559254705|FG002|Overall Study|Death|1|||
154953366|NCT00591630|559254706|FG003|Overall Study|Death|0|||
154953367|NCT01471522|559254708|FG000|Overall Study|Withdrawal by Subject|28|||
154953368|NCT01471522|559254709|FG001|Overall Study|Withdrawal by Subject|22|||
154953369|NCT01471522|559254708|FG000|Overall Study|Lost to Follow-up|36|||
154953370|NCT01471522|559254709|FG001|Overall Study|Lost to Follow-up|26|||
154966765|NCT00902538|559301139|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
154966766|NCT00902538|559301140|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
154966767|NCT00902538|559301141|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
154966768|NCT00902538|559301136|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
154966769|NCT00902538|559301137|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
154966770|NCT00902538|559301138|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
154966771|NCT00902538|559301139|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
154966772|NCT00902538|559301140|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
154966773|NCT00902538|559301141|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
154966774|NCT00902538|559301136|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
154966775|NCT00902538|559301137|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
154966776|NCT00902538|559301138|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
154966777|NCT00902538|559301139|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
154966778|NCT00902538|559301140|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
154966779|NCT00902538|559301141|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
154966780|NCT00902538|559301136|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
154966781|NCT00902538|559301137|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
155284185|NCT00984282|560472710|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
155284186|NCT00984282|560472711|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
155284187|NCT00984282|560472710|FG000|Long Term Follow-up|Death|27|||
155284188|NCT00984282|560472711|FG001|Long Term Follow-up|Death|68|||
155284189|NCT00984282|560472710|FG000|Long Term Follow-up|Lost to Follow-up|3|||
155284190|NCT00984282|560472711|FG001|Long Term Follow-up|Lost to Follow-up|6|||
155284191|NCT00984282|560472710|FG000|Long Term Follow-up|Protocol driven decision point|25|||
155284192|NCT00984282|560472711|FG001|Long Term Follow-up|Protocol driven decision point|26|||
155284193|NCT00984282|560472710|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
155284194|NCT00984282|560472711|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
155284195|NCT00984282|560472710|FG000|Long Term Follow-up|Switched to commercial drug|4|||
155284196|NCT00984282|560472711|FG001|Long Term Follow-up|Switched to commercial drug|2|||
155284197|NCT00984282|560472710|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
155284198|NCT00984282|560472711|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
155284199|NCT02223793|560472712|FG000|Overall Study|Lost to Follow-up|10|||
155284200|NCT02223793|560472713|FG001|Overall Study|Lost to Follow-up|1|||
155284201|NCT02223793|560472714|FG002|Overall Study|Lost to Follow-up|2|||
155284202|NCT02223793|560472712|FG000|Overall Study|Withdrawal by Subject|3|||
155284203|NCT02223793|560472713|FG001|Overall Study|Withdrawal by Subject|2|||
155284204|NCT02223793|560472714|FG002|Overall Study|Withdrawal by Subject|3|||
155284205|NCT02223793|560472712|FG000|Overall Study|Moved/studycenter unable to participate|4|||
155284206|NCT02223793|560472713|FG001|Overall Study|Moved/studycenter unable to participate|6|||
155284207|NCT02223793|560472714|FG002|Overall Study|Moved/studycenter unable to participate|8|||
155284208|NCT00315055|560472715|FG000|Overall Study|Protocol Violation|2|||
155284209|NCT00315055|560472716|FG001|Overall Study|Protocol Violation|4|||
155284210|NCT00315055|560472715|FG000|Overall Study|Lost to Follow-up|1|||
155284211|NCT00315055|560472716|FG001|Overall Study|Lost to Follow-up|1|||
155284212|NCT02321540|560472718|FG000|Overall Study|Death|0|||
155284213|NCT02321540|560472719|FG001|Overall Study|Death|1|||
155284214|NCT02321540|560472718|FG000|Overall Study|Progression|3|||
155284215|NCT02321540|560472719|FG001|Overall Study|Progression|9|||
155284216|NCT03606460|560472720|FG000|Overall Study|Lost to Follow-up|1|||
155284217|NCT03606460|560472721|FG001|Overall Study|Lost to Follow-up|8|||
155284218|NCT04541186|560472725|FG000|Main Study|Adverse Event|0|||
155284219|NCT04541186|560472726|FG001|Main Study|Adverse Event|0|||
155284220|NCT04541186|560472727|FG002|Main Study|Adverse Event|4|||
155284221|NCT04541186|560472728|FG003|Main Study|Adverse Event|0|||
155284222|NCT04541186|560472729|FG004|Main Study|Adverse Event|0|||
155284223|NCT04541186|560472725|FG000|Main Study|Investigator Decision|0|||
155284224|NCT04541186|560472726|FG001|Main Study|Investigator Decision|0|||
155284225|NCT04541186|560472727|FG002|Main Study|Investigator Decision|1|||
155284226|NCT04541186|560472728|FG003|Main Study|Investigator Decision|1|||
155284227|NCT04541186|560472729|FG004|Main Study|Investigator Decision|0|||
155284228|NCT04541186|560472725|FG000|Main Study|Withdrawal by Subject|1|||
155284229|NCT04541186|560472726|FG001|Main Study|Withdrawal by Subject|1|||
155284230|NCT04541186|560472727|FG002|Main Study|Withdrawal by Subject|0|||
155284231|NCT04541186|560472728|FG003|Main Study|Withdrawal by Subject|0|||
155284232|NCT04541186|560472729|FG004|Main Study|Withdrawal by Subject|0|||
155284233|NCT04541186|560472725|FG000|Main Study|COVID-19-related Dose Interruption|0|||
155284234|NCT04541186|560472726|FG001|Main Study|COVID-19-related Dose Interruption|0|||
155284235|NCT04541186|560472727|FG002|Main Study|COVID-19-related Dose Interruption|0|||
154953371|NCT01387737|559256247|FG000|Overall Study|Adverse Event|20|||
154953372|NCT01387737|559256248|FG001|Overall Study|Adverse Event|30|||
154953373|NCT01387737|559256247|FG000|Overall Study|Lack of Efficacy|1|||
154953374|NCT01387737|559256248|FG001|Overall Study|Lack of Efficacy|0|||
154953375|NCT01387737|559256247|FG000|Overall Study|Physician Decision|3|||
154953376|NCT01387737|559256248|FG001|Overall Study|Physician Decision|10|||
154953377|NCT01387737|559256247|FG000|Overall Study|Withdrawal by Subject|27|||
154953378|NCT01387737|559256248|FG001|Overall Study|Withdrawal by Subject|31|||
154953379|NCT01387737|559256247|FG000|Overall Study|Clearly not eligible for the study|1|||
154953380|NCT01387737|559256248|FG001|Overall Study|Clearly not eligible for the study|3|||
155284236|NCT04541186|560472728|FG003|Main Study|COVID-19-related Dose Interruption|0|||
155399348|NCT00938717|560897477|FG001|Overall Study|Protocol Violation|8|||
155399349|NCT00938717|560897476|FG000|Overall Study|Withdrawal by Subject|26|||
155284237|NCT04541186|560472729|FG004|Main Study|COVID-19-related Dose Interruption|1|||
155284238|NCT04541186|560472725|FG000|Main Study|Randomized in Error Not Treated|0|||
155284239|NCT04541186|560472726|FG001|Main Study|Randomized in Error Not Treated|0|||
155399350|NCT00938717|560897477|FG001|Overall Study|Withdrawal by Subject|24|||
155399351|NCT00938717|560897476|FG000|Overall Study|Lost to Follow-up|13|||
155399352|NCT00938717|560897477|FG001|Overall Study|Lost to Follow-up|18|||
155399353|NCT00938717|560897476|FG000|Overall Study|Lack of Efficacy|33|||
154953381|NCT01248247|559256250|FG000|Overall Study|Adverse Event|2|||
155284240|NCT04541186|560472727|FG002|Main Study|Randomized in Error Not Treated|1|||
155284241|NCT04541186|560472728|FG003|Main Study|Randomized in Error Not Treated|0|||
155284242|NCT04541186|560472729|FG004|Main Study|Randomized in Error Not Treated|0|||
155399354|NCT00938717|560897477|FG001|Overall Study|Lack of Efficacy|15|||
155399355|NCT00938717|560897476|FG000|Overall Study|Other reason|5|||
155154281|NCT02156076|560002258|FG002|Follow-up Period|Withdrawal by Subject|0|||
155154282|NCT02156076|560002259|FG003|Follow-up Period|Withdrawal by Subject|0|||
155154283|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
155154284|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
155154285|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155154286|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
155154287|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
155154288|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
155154289|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155154290|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
155154291|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
155154292|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155399356|NCT00938717|560897477|FG001|Overall Study|Other reason|2|||
155399357|NCT01462435|560897479|FG000|Overall Study|Lack of Efficacy|1|||
155399358|NCT01462435|560897480|FG001|Overall Study|Lack of Efficacy|0|||
155399359|NCT01462435|560897481|FG002|Overall Study|Lack of Efficacy|0|||
155399360|NCT01462435|560897482|FG003|Overall Study|Lack of Efficacy|3|||
155399361|NCT01462435|560897479|FG000|Overall Study|Physician Decision|0|||
155399362|NCT01462435|560897480|FG001|Overall Study|Physician Decision|0|||
155399363|NCT01462435|560897481|FG002|Overall Study|Physician Decision|1|||
155399364|NCT01462435|560897482|FG003|Overall Study|Physician Decision|0|||
155399365|NCT01462435|560897479|FG000|Overall Study|Withdrawal by Subject|0|||
155399366|NCT01462435|560897480|FG001|Overall Study|Withdrawal by Subject|0|||
155399367|NCT01462435|560897481|FG002|Overall Study|Withdrawal by Subject|0|||
155399368|NCT01462435|560897482|FG003|Overall Study|Withdrawal by Subject|1|||
155399369|NCT01462435|560897479|FG000|Overall Study|Lost to Follow-up|0|||
155399370|NCT01462435|560897480|FG001|Overall Study|Lost to Follow-up|0|||
155399371|NCT01462435|560897481|FG002|Overall Study|Lost to Follow-up|0|||
155399372|NCT01462435|560897482|FG003|Overall Study|Lost to Follow-up|1|||
155399373|NCT01543152|560897485|FG000|Overall Study|Withdrawal by Subject|0|||
155399374|NCT01543152|560897486|FG001|Overall Study|Withdrawal by Subject|2|||
155399375|NCT01543152|560897487|FG002|Overall Study|Withdrawal by Subject|0|||
155399376|NCT01543152|560897488|FG003|Overall Study|Withdrawal by Subject|0|||
155399377|NCT01543152|560897489|FG004|Overall Study|Withdrawal by Subject|0|||
155399378|NCT00636675|560897492|FG000|Overall Study|Lost to Follow-up|121|||
155399379|NCT00636675|560897493|FG001|Overall Study|Lost to Follow-up|31|||
155399380|NCT00636675|560897492|FG000|Overall Study|Withdrawal by Subject|19|||
155399381|NCT00636675|560897493|FG001|Overall Study|Withdrawal by Subject|10|||
155399382|NCT02687542|560897495|FG000|Overall Study|Medication error without associated AEs|0|||
155399383|NCT02687542|560897496|FG001|Overall Study|Medication error without associated AEs|0|||
155399384|NCT02687542|560897497|FG002|Overall Study|Medication error without associated AEs|0|||
155399385|NCT02687542|560897498|FG003|Overall Study|Medication error without associated AEs|0|||
155399386|NCT02687542|560897499|FG004|Overall Study|Medication error without associated AEs|1|||
155399387|NCT02687542|560897495|FG000|Overall Study|Lost to Follow-up|0|||
155399388|NCT02687542|560897496|FG001|Overall Study|Lost to Follow-up|0|||
155399389|NCT02687542|560897497|FG002|Overall Study|Lost to Follow-up|0|||
155399390|NCT02687542|560897498|FG003|Overall Study|Lost to Follow-up|0|||
155399391|NCT02687542|560897499|FG004|Overall Study|Lost to Follow-up|1|||
155399392|NCT02687542|560897495|FG000|Overall Study|Protocol Violation|0|||
155399393|NCT02687542|560897496|FG001|Overall Study|Protocol Violation|1|||
155399394|NCT02687542|560897497|FG002|Overall Study|Protocol Violation|0|||
155399395|NCT02687542|560897498|FG003|Overall Study|Protocol Violation|0|||
155399396|NCT02687542|560897499|FG004|Overall Study|Protocol Violation|0|||
155399397|NCT02687542|560897495|FG000|Overall Study|Other|5|||
155399398|NCT02687542|560897496|FG001|Overall Study|Other|9|||
155399399|NCT02687542|560897497|FG002|Overall Study|Other|10|||
155399400|NCT02687542|560897498|FG003|Overall Study|Other|6|||
155399401|NCT02687542|560897499|FG004|Overall Study|Other|5|||
155399402|NCT02687542|560897495|FG000|Overall Study|Adverse Event|3|||
155399403|NCT02687542|560897496|FG001|Overall Study|Adverse Event|1|||
155399404|NCT02687542|560897497|FG002|Overall Study|Adverse Event|3|||
155399405|NCT02687542|560897498|FG003|Overall Study|Adverse Event|2|||
155399406|NCT02687542|560897499|FG004|Overall Study|Adverse Event|9|||
155399407|NCT02687542|560897495|FG000|Overall Study|Withdrawal by Subject|0|||
155399408|NCT02687542|560897496|FG001|Overall Study|Withdrawal by Subject|1|||
155399409|NCT02687542|560897497|FG002|Overall Study|Withdrawal by Subject|1|||
155399410|NCT02687542|560897498|FG003|Overall Study|Withdrawal by Subject|2|||
155399411|NCT02687542|560897499|FG004|Overall Study|Withdrawal by Subject|4|||
155399412|NCT01227187|560897500|FG000|Overall Study|Physician Decision|0|||
155399413|NCT01227187|560897501|FG001|Overall Study|Physician Decision|0|||
155399414|NCT01227187|560897502|FG002|Overall Study|Physician Decision|0|||
155399415|NCT01227187|560897503|FG003|Overall Study|Physician Decision|1|||
155399416|NCT00914927|560897505|FG000|Overall Study|Adverse Event|0|||
155399417|NCT00914927|560897506|FG001|Overall Study|Adverse Event|0|||
155399418|NCT00914927|560897507|FG002|Overall Study|Adverse Event|0|||
155399419|NCT00914927|560897508|FG003|Overall Study|Adverse Event|0|||
155399420|NCT00914927|560897509|FG004|Overall Study|Adverse Event|1|||
155399421|NCT00914927|560897510|FG005|Overall Study|Adverse Event|0|||
155399422|NCT00914927|560897511|FG006|Overall Study|Adverse Event|0|||
155399423|NCT00914927|560897505|FG000|Overall Study|Withdrawal by Subject|0|||
155399424|NCT00914927|560897506|FG001|Overall Study|Withdrawal by Subject|1|||
155399425|NCT00914927|560897507|FG002|Overall Study|Withdrawal by Subject|0|||
155399426|NCT00914927|560897508|FG003|Overall Study|Withdrawal by Subject|1|||
155399427|NCT00914927|560897509|FG004|Overall Study|Withdrawal by Subject|0|||
155399428|NCT00914927|560897510|FG005|Overall Study|Withdrawal by Subject|0|||
155399429|NCT00914927|560897511|FG006|Overall Study|Withdrawal by Subject|0|||
155399430|NCT00914927|560897505|FG000|Overall Study|Lost to Follow-up|0|||
155399431|NCT00914927|560897506|FG001|Overall Study|Lost to Follow-up|0|||
155399432|NCT00914927|560897507|FG002|Overall Study|Lost to Follow-up|0|||
155399433|NCT00914927|560897508|FG003|Overall Study|Lost to Follow-up|1|||
155399434|NCT00914927|560897509|FG004|Overall Study|Lost to Follow-up|0|||
155399435|NCT00914927|560897510|FG005|Overall Study|Lost to Follow-up|0|||
155399436|NCT00914927|560897511|FG006|Overall Study|Lost to Follow-up|0|||
155399437|NCT00914927|560897505|FG000|Overall Study|Administrative/Other|2|||
155399438|NCT00914927|560897506|FG001|Overall Study|Administrative/Other|1|||
155399439|NCT00914927|560897507|FG002|Overall Study|Administrative/Other|0|||
155399440|NCT00914927|560897508|FG003|Overall Study|Administrative/Other|0|||
155399441|NCT00914927|560897509|FG004|Overall Study|Administrative/Other|1|||
155399442|NCT00914927|560897510|FG005|Overall Study|Administrative/Other|0|||
155399443|NCT00914927|560897511|FG006|Overall Study|Administrative/Other|0|||
155399444|NCT01519934|560897512|FG000|Overall Study|Lost to Follow-up|3|||
155399445|NCT04109222|560897517|FG000|Overall Study|Adverse Event|1|||
155399446|NCT04109222|560897518|FG001|Overall Study|Adverse Event|0|||
155399447|NCT04109222|560897519|FG002|Overall Study|Adverse Event|0|||
155399448|NCT02577406|560897520|FG000|Randomized Period|Death|1|||
155399449|NCT02577406|560897521|FG001|Randomized Period|Death|0|||
155399450|NCT02577406|560897520|FG000|Randomized Period|Other reasons|0|||
155284243|NCT04541186|560472725|FG000|Fibrate Expansion Study|Other than Specified|0|||
155284244|NCT04541186|560472726|FG001|Fibrate Expansion Study|Other than Specified|0|||
155284245|NCT04541186|560472727|FG002|Fibrate Expansion Study|Other than Specified|0|||
155399451|NCT02577406|560897521|FG001|Randomized Period|Other reasons|20|||
155399452|NCT02577406|560897520|FG000|Treatment Period|Death|38|||
155399453|NCT02577406|560897521|FG001|Treatment Period|Death|23|||
155399454|NCT02577406|560897520|FG000|Treatment Period|Adverse Event|17|||
155399455|NCT02577406|560897521|FG001|Treatment Period|Adverse Event|12|||
155399456|NCT02577406|560897520|FG000|Treatment Period|Progressive Disease|53|||
155399457|NCT02577406|560897521|FG001|Treatment Period|Progressive Disease|37|||
155399458|NCT02577406|560897520|FG000|Treatment Period|Withdrawal by Subject|10|||
155399459|NCT02577406|560897521|FG001|Treatment Period|Withdrawal by Subject|24|||
155399460|NCT02577406|560897520|FG000|Treatment Period|Lost to Follow-up|0|||
155399461|NCT02577406|560897521|FG001|Treatment Period|Lost to Follow-up|1|||
155399462|NCT02577406|560897520|FG000|Treatment Period|Transition to commercially available treatment|1|||
155399463|NCT02577406|560897521|FG001|Treatment Period|Transition to commercially available treatment|1|||
155399464|NCT02577406|560897520|FG000|Treatment Period|Physician Decision|1|||
155399465|NCT02577406|560897521|FG001|Treatment Period|Physician Decision|0|||
155399466|NCT02577406|560897520|FG000|Treatment Period|Disease Relapse|28|||
155399467|NCT02577406|560897521|FG001|Treatment Period|Disease Relapse|1|||
155399468|NCT02577406|560897520|FG000|Treatment Period|Protocol Violation|0|||
155399469|NCT02577406|560897521|FG001|Treatment Period|Protocol Violation|1|||
155399470|NCT02577406|560897520|FG000|Treatment Period|Other Reasons|3|||
155399471|NCT02577406|560897521|FG001|Treatment Period|Other Reasons|39|||
155399472|NCT02577406|560897520|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
155399473|NCT02577406|560897521|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
155399474|NCT02138617|560897522|FG000|Overall Study|Death|1|||
155399475|NCT02138617|560897523|FG001|Overall Study|Death|2|||
155399476|NCT02138617|560897524|FG002|Overall Study|Death|2|||
155399477|NCT02138617|560897522|FG000|Overall Study|Adverse Event|8|||
155399478|NCT02138617|560897523|FG001|Overall Study|Adverse Event|5|||
155399479|NCT02138617|560897524|FG002|Overall Study|Adverse Event|2|||
155399480|NCT02138617|560897522|FG000|Overall Study|Disease Progression|20|||
155399481|NCT02138617|560897523|FG001|Overall Study|Disease Progression|13|||
155284246|NCT04541186|560472728|FG003|Fibrate Expansion Study|Other than Specified|0|||
155284247|NCT04541186|560472729|FG004|Fibrate Expansion Study|Other than Specified|1|||
155284248|NCT02347943|560472730|FG000|Overall Study|Study was cancelled|140|||
155399482|NCT02138617|560897524|FG002|Overall Study|Disease Progression|4|||
155399483|NCT02138617|560897522|FG000|Overall Study|Withdrawal by Subject|7|||
155399484|NCT02138617|560897523|FG001|Overall Study|Withdrawal by Subject|10|||
155399485|NCT02138617|560897524|FG002|Overall Study|Withdrawal by Subject|2|||
155399486|NCT02138617|560897522|FG000|Overall Study|other complicating disease|0|||
155399487|NCT02138617|560897523|FG001|Overall Study|other complicating disease|2|||
155399488|NCT02138617|560897524|FG002|Overall Study|other complicating disease|0|||
155284249|NCT02347943|560472731|FG001|Overall Study|Study was cancelled|67|||
155284250|NCT02347943|560472732|FG002|Overall Study|Study was cancelled|45|||
155284251|NCT00303303|560472734|FG000|Overall Study|Withdrawal by Subject|0|||
155284252|NCT00303303|560472735|FG001|Overall Study|Withdrawal by Subject|0|||
155284253|NCT00303303|560472736|FG002|Overall Study|Withdrawal by Subject|1|||
155284254|NCT00691028|560472737|FG000|Open-label Period|Adverse Event|0|||
155284255|NCT00691028|560472738|FG001|Open-label Period|Adverse Event|0|||
155284256|NCT00691028|560472739|FG002|Open-label Period|Adverse Event|0|||
155284257|NCT00691028|560472740|FG003|Open-label Period|Adverse Event|16|||
155284258|NCT00691028|560472737|FG000|Open-label Period|Withdrawal by Subject|0|||
155284259|NCT00691028|560472738|FG001|Open-label Period|Withdrawal by Subject|0|||
155284260|NCT00691028|560472739|FG002|Open-label Period|Withdrawal by Subject|0|||
155284261|NCT00691028|560472740|FG003|Open-label Period|Withdrawal by Subject|3|||
155284262|NCT00691028|560472737|FG000|Open-label Period|not come to a hospital|0|||
155284263|NCT00691028|560472738|FG001|Open-label Period|not come to a hospital|0|||
155284264|NCT00691028|560472739|FG002|Open-label Period|not come to a hospital|0|||
155284265|NCT00691028|560472740|FG003|Open-label Period|not come to a hospital|1|||
155284266|NCT00691028|560472737|FG000|Double-blind Period|Adverse Event|8|||
155154293|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155399489|NCT02138617|560897522|FG000|Overall Study|Protocol Violation|1|||
155399490|NCT02138617|560897523|FG001|Overall Study|Protocol Violation|0|||
155399491|NCT02138617|560897524|FG002|Overall Study|Protocol Violation|0|||
155399492|NCT02138617|560897522|FG000|Overall Study|Physician Decision|7|||
155399493|NCT02138617|560897523|FG001|Overall Study|Physician Decision|6|||
155399494|NCT02138617|560897524|FG002|Overall Study|Physician Decision|0|||
155399495|NCT02138617|560897522|FG000|Overall Study|financial reason|0|||
155399496|NCT02138617|560897523|FG001|Overall Study|financial reason|1|||
155399497|NCT02138617|560897524|FG002|Overall Study|financial reason|0|||
155399498|NCT02138617|560897522|FG000|Overall Study|other therapy|3|||
155399499|NCT02138617|560897523|FG001|Overall Study|other therapy|4|||
155399500|NCT02138617|560897524|FG002|Overall Study|other therapy|0|||
155399501|NCT01970488|560897526|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
155399502|NCT01970488|560897527|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
155399503|NCT01970488|560897528|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
155399504|NCT01970488|560897529|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
155399505|NCT01970488|560897530|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
155399506|NCT01970488|560897526|FG000|Part 1: Through Week 16|Protocol Violation|1|||
155399507|NCT01970488|560897527|FG001|Part 1: Through Week 16|Protocol Violation|2|||
155399508|NCT01970488|560897528|FG002|Part 1: Through Week 16|Protocol Violation|0|||
155399509|NCT01970488|560897529|FG003|Part 1: Through Week 16|Protocol Violation|0|||
155399510|NCT01970488|560897530|FG004|Part 1: Through Week 16|Protocol Violation|0|||
155399511|NCT01970488|560897526|FG000|Part 1: Through Week 16|Adverse Event|6|||
155399512|NCT01970488|560897527|FG001|Part 1: Through Week 16|Adverse Event|5|||
155399513|NCT01970488|560897528|FG002|Part 1: Through Week 16|Adverse Event|0|||
155399514|NCT01970488|560897529|FG003|Part 1: Through Week 16|Adverse Event|0|||
155399515|NCT01970488|560897530|FG004|Part 1: Through Week 16|Adverse Event|0|||
155399516|NCT01970488|560897526|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
155399517|NCT01970488|560897527|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
155399518|NCT01970488|560897528|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
155399519|NCT01970488|560897529|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
155399520|NCT01970488|560897530|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
155399521|NCT01970488|560897526|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
155399522|NCT01970488|560897527|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
155399523|NCT01970488|560897528|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
155399524|NCT01970488|560897529|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
155399525|NCT01970488|560897530|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
155399526|NCT01970488|560897526|FG000|Part 2: Post Week 16|Physician Decision|0|||
155399527|NCT01970488|560897527|FG001|Part 2: Post Week 16|Physician Decision|0|||
155399528|NCT01970488|560897528|FG002|Part 2: Post Week 16|Physician Decision|0|||
155399529|NCT01970488|560897529|FG003|Part 2: Post Week 16|Physician Decision|0|||
155399530|NCT01970488|560897530|FG004|Part 2: Post Week 16|Physician Decision|1|||
155399531|NCT01970488|560897526|FG000|Part 2: Post Week 16|Non-compliance|0|||
155154294|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155284267|NCT00691028|560472738|FG001|Double-blind Period|Adverse Event|9|||
155284268|NCT00691028|560472739|FG002|Double-blind Period|Adverse Event|6|||
155284269|NCT00691028|560472740|FG003|Double-blind Period|Adverse Event|0|||
155284270|NCT00691028|560472737|FG000|Double-blind Period|Lack of Efficacy|4|||
155284271|NCT00691028|560472738|FG001|Double-blind Period|Lack of Efficacy|3|||
155284272|NCT00691028|560472739|FG002|Double-blind Period|Lack of Efficacy|2|||
155284273|NCT00691028|560472740|FG003|Double-blind Period|Lack of Efficacy|0|||
155284274|NCT00691028|560472737|FG000|Double-blind Period|Withdrawal by Subject|1|||
155284275|NCT00691028|560472738|FG001|Double-blind Period|Withdrawal by Subject|0|||
155284276|NCT00691028|560472739|FG002|Double-blind Period|Withdrawal by Subject|1|||
155399532|NCT01970488|560897527|FG001|Part 2: Post Week 16|Non-compliance|0|||
155399533|NCT01970488|560897528|FG002|Part 2: Post Week 16|Non-compliance|1|||
155284277|NCT00691028|560472740|FG003|Double-blind Period|Withdrawal by Subject|0|||
155284278|NCT00691028|560472737|FG000|Double-blind Period|not come to a hospital.|0|||
155284279|NCT00691028|560472738|FG001|Double-blind Period|not come to a hospital.|1|||
155284280|NCT00691028|560472739|FG002|Double-blind Period|not come to a hospital.|0|||
155399534|NCT01970488|560897529|FG003|Part 2: Post Week 16|Non-compliance|0|||
155399535|NCT01970488|560897530|FG004|Part 2: Post Week 16|Non-compliance|0|||
155399536|NCT01970488|560897526|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
155399537|NCT01970488|560897527|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
155399538|NCT01970488|560897528|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
155399539|NCT01970488|560897529|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
155399540|NCT01970488|560897530|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
155399541|NCT01970488|560897526|FG000|Part 2: Post Week 16|Adverse Event|0|||
155284281|NCT00691028|560472740|FG003|Double-blind Period|not come to a hospital.|0|||
155284282|NCT02680756|560472747|FG000|Overall Study|Adverse Event|10|||
155284283|NCT02680756|560472748|FG001|Overall Study|Adverse Event|2|||
155284284|NCT02680756|560472747|FG000|Overall Study|Lost to Follow-up|7|||
155284285|NCT02680756|560472748|FG001|Overall Study|Lost to Follow-up|6|||
155284286|NCT02680756|560472747|FG000|Overall Study|Withdrawal by Subject|5|||
155284287|NCT02680756|560472748|FG001|Overall Study|Withdrawal by Subject|5|||
155284288|NCT02680756|560472747|FG000|Overall Study|Physician Decision|4|||
155284289|NCT02680756|560472748|FG001|Overall Study|Physician Decision|1|||
155284290|NCT02680756|560472747|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
155284291|NCT02680756|560472748|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
155399542|NCT01970488|560897527|FG001|Part 2: Post Week 16|Adverse Event|0|||
155399543|NCT01970488|560897528|FG002|Part 2: Post Week 16|Adverse Event|5|||
155399544|NCT01970488|560897529|FG003|Part 2: Post Week 16|Adverse Event|1|||
155399545|NCT01970488|560897530|FG004|Part 2: Post Week 16|Adverse Event|1|||
155399546|NCT01970488|560897526|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
155399547|NCT01970488|560897527|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
155399548|NCT01970488|560897528|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
155399549|NCT01970488|560897529|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
155399550|NCT01970488|560897530|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
155399551|NCT01970488|560897526|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
155399552|NCT01970488|560897527|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
155399553|NCT01970488|560897528|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
155399554|NCT01970488|560897529|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
155284292|NCT02680756|560472747|FG000|Overall Study|Blood transfusion for any reason|0|||
155284293|NCT02680756|560472748|FG001|Overall Study|Blood transfusion for any reason|1|||
155284294|NCT02680756|560472747|FG000|Overall Study|Death|1|||
155284295|NCT02680756|560472748|FG001|Overall Study|Death|0|||
155284296|NCT02680756|560472747|FG000|Overall Study|Protocol Violation|1|||
155284297|NCT02680756|560472748|FG001|Overall Study|Protocol Violation|0|||
155284298|NCT02680756|560472747|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
155284299|NCT02680756|560472748|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
155284300|NCT02680756|560472747|FG000|Overall Study|None of above or not recorded|3|||
155284301|NCT02680756|560472748|FG001|Overall Study|None of above or not recorded|2|||
155284302|NCT03681691|560472749|FG000|Overall Study|COVID|1|||
155284303|NCT03681691|560472750|FG001|Overall Study|COVID|0|||
155284304|NCT03681691|560472749|FG000|Overall Study|prolonged bleeding|1|||
155284305|NCT03681691|560472750|FG001|Overall Study|prolonged bleeding|0|||
155284306|NCT03681691|560472749|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
155284307|NCT03681691|560472750|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
155284308|NCT02334306|560472751|FG000|Double-blind Period|Adverse Event|0|||
155284309|NCT02334306|560472752|FG001|Double-blind Period|Adverse Event|1|||
155284310|NCT02334306|560472751|FG000|Double-blind Period|Withdrawal by Subject|1|||
155399555|NCT01970488|560897530|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
155399556|NCT01816061|560897531|FG000|Overall Study|Lost to Follow-up|13|||
155399557|NCT01816061|560897532|FG001|Overall Study|Lost to Follow-up|24|||
155399558|NCT01671111|560897533|FG000|Overall Study|Adverse Event|2|||
155399559|NCT01671111|560897533|FG000|Overall Study|Lack of Efficacy|1|||
155399560|NCT01671111|560897533|FG000|Overall Study|Withdrawal by Subject|2|||
155399561|NCT01671111|560897533|FG000|Overall Study|Physician Decision|1|||
155284311|NCT02334306|560472752|FG001|Double-blind Period|Withdrawal by Subject|1|||
155284312|NCT01687270|560472753|FG000|Overall Study|Lack of Efficacy|11|||
155284313|NCT01687270|560472753|FG000|Overall Study|Lost to Follow-up|1|||
155284314|NCT00465985|560472754|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
155284315|NCT00465985|560472755|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
155399562|NCT01671111|560897533|FG000|Overall Study|Other|24|||
155399563|NCT01231659|560897534|FG000|Overall Study|Adverse Event|9|||
155284316|NCT00465985|560472754|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
155284317|NCT00465985|560472755|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
155284318|NCT00465985|560472754|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
155284319|NCT00465985|560472755|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
155284320|NCT00465985|560472754|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
155284321|NCT00465985|560472755|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
155284322|NCT03302156|560472756|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
155284323|NCT03302156|560472757|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
155284324|NCT03302156|560472758|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
155284325|NCT02390557|560472759|FG000|Wave 2|Survey non-respondent|72|||
155284326|NCT02390557|560472760|FG001|Wave 2|Survey non-respondent|41|||
155284327|NCT02390557|560472761|FG002|Wave 2|Survey non-respondent|23|||
155284328|NCT03635112|560472763|FG000|Overall Study|Adverse Event|5|||
155284329|NCT03635112|560472764|FG001|Overall Study|Adverse Event|9|||
155284330|NCT03635112|560472765|FG002|Overall Study|Adverse Event|14|||
155284331|NCT03635112|560472763|FG000|Overall Study|Lost to Follow-up|1|||
155284332|NCT03635112|560472764|FG001|Overall Study|Lost to Follow-up|0|||
155284333|NCT03635112|560472765|FG002|Overall Study|Lost to Follow-up|1|||
155284334|NCT03635112|560472763|FG000|Overall Study|Physician Decision|5|||
155284335|NCT03635112|560472764|FG001|Overall Study|Physician Decision|7|||
155284336|NCT03635112|560472765|FG002|Overall Study|Physician Decision|5|||
155284337|NCT03635112|560472763|FG000|Overall Study|Protocol Violation|0|||
155284338|NCT03635112|560472764|FG001|Overall Study|Protocol Violation|0|||
155284339|NCT03635112|560472765|FG002|Overall Study|Protocol Violation|1|||
155284340|NCT03635112|560472763|FG000|Overall Study|Study Terminated by Sponsor|11|||
155284341|NCT03635112|560472764|FG001|Overall Study|Study Terminated by Sponsor|17|||
155284342|NCT03635112|560472765|FG002|Overall Study|Study Terminated by Sponsor|21|||
155284343|NCT03635112|560472763|FG000|Overall Study|Withdrawal by Subject|4|||
155284344|NCT03635112|560472764|FG001|Overall Study|Withdrawal by Subject|9|||
155284345|NCT03635112|560472765|FG002|Overall Study|Withdrawal by Subject|7|||
155284346|NCT03635112|560472763|FG000|Overall Study|Miscellaneous|0|||
155284347|NCT03635112|560472764|FG001|Overall Study|Miscellaneous|0|||
155284348|NCT03635112|560472765|FG002|Overall Study|Miscellaneous|1|||
155399564|NCT01231659|560897534|FG000|Overall Study|Disease Progression|48|||
155399565|NCT01231659|560897534|FG000|Overall Study|Death|2|||
155399566|NCT01231659|560897534|FG000|Overall Study|Patient refused to complete study visit|1|||
155399567|NCT01231659|560897534|FG000|Overall Study|Other protocol defined criteria|12|||
155399568|NCT00509067|560897535|FG000|Overall Study|Lost to Follow-up|1|||
155399569|NCT00509067|560897536|FG001|Overall Study|Lost to Follow-up|1|||
155399570|NCT00509067|560897535|FG000|Overall Study|Adverse Event|3|||
155399571|NCT00509067|560897536|FG001|Overall Study|Adverse Event|1|||
155399572|NCT00509067|560897535|FG000|Overall Study|Protocol Violation|0|||
155399573|NCT00509067|560897536|FG001|Overall Study|Protocol Violation|3|||
155399574|NCT00702325|560897550|FG000|Overall Study|Adverse Event|1|||
155399575|NCT00702325|560897551|FG001|Overall Study|Adverse Event|0|||
155399576|NCT00702325|560897550|FG000|Overall Study|Withdrawal by Subject|7|||
155399577|NCT00702325|560897551|FG001|Overall Study|Withdrawal by Subject|7|||
155399578|NCT00702325|560897550|FG000|Overall Study|Lost to Follow-up|3|||
155399579|NCT00702325|560897551|FG001|Overall Study|Lost to Follow-up|4|||
155399580|NCT00702325|560897550|FG000|Overall Study|Incorrect enrollment|5|||
155399581|NCT00702325|560897551|FG001|Overall Study|Incorrect enrollment|7|||
155399582|NCT00702325|560897550|FG000|Overall Study|Developed study discontinuation criteria|18|||
155399583|NCT00702325|560897551|FG001|Overall Study|Developed study discontinuation criteria|28|||
155399584|NCT00702325|560897550|FG000|Overall Study|Severe noncompliance to protocol|3|||
155399585|NCT00702325|560897551|FG001|Overall Study|Severe noncompliance to protocol|3|||
155399586|NCT00702325|560897550|FG000|Overall Study|Termination due to lab results|1|||
155399587|NCT00702325|560897551|FG001|Overall Study|Termination due to lab results|0|||
155399588|NCT00702325|560897550|FG000|Overall Study|Didn't follow study medication dosage|0|||
155399589|NCT00702325|560897551|FG001|Overall Study|Didn't follow study medication dosage|2|||
155399590|NCT00702325|560897550|FG000|Overall Study|Withdrew consent|0|||
155399591|NCT00702325|560897551|FG001|Overall Study|Withdrew consent|1|||
155399592|NCT00702325|560897550|FG000|Overall Study|Incorrectly Discontinued|0|||
155399593|NCT00702325|560897551|FG001|Overall Study|Incorrectly Discontinued|1|||
155399594|NCT04556136|560897555|FG000|Overall Study|Lost to Follow-up|6|||
155399595|NCT04556136|560897556|FG001|Overall Study|Lost to Follow-up|6|||
155399596|NCT04556136|560897555|FG000|Overall Study|Physician Decision|2|||
155399597|NCT04556136|560897556|FG001|Overall Study|Physician Decision|1|||
155399598|NCT04556136|560897555|FG000|Overall Study|Withdrawal by Subject|2|||
155399599|NCT04556136|560897556|FG001|Overall Study|Withdrawal by Subject|1|||
155399600|NCT01022502|560897559|FG000|Overall Study|Adverse Event|1|||
155399601|NCT01022502|560897559|FG000|Overall Study|employment related reasons|1|||
155399602|NCT01022502|560897559|FG000|Overall Study|Withdrawal by Subject|1|||
155399603|NCT03199040|560897567|FG000|Overall Study|Lack of Efficacy|2|||
155399604|NCT03199040|560897568|FG001|Overall Study|Lack of Efficacy|0|||
155399605|NCT03199040|560897567|FG000|Overall Study|Withdrawal by Subject|2|||
155399606|NCT03199040|560897568|FG001|Overall Study|Withdrawal by Subject|0|||
155399607|NCT03199040|560897567|FG000|Overall Study|Adverse Event|0|||
155399608|NCT03199040|560897568|FG001|Overall Study|Adverse Event|1|||
155284349|NCT00463151|560472770|FG000|Overall Study|Adverse Event|0|||
155284350|NCT00463151|560472771|FG001|Overall Study|Adverse Event|0|||
155284351|NCT00463151|560472772|FG002|Overall Study|Adverse Event|1|||
155284352|NCT00463151|560472773|FG003|Overall Study|Adverse Event|0|||
155399609|NCT03199040|560897567|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
155399610|NCT03199040|560897568|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
155399611|NCT01226459|560897569|FG000|Overall Study|Adverse Event|2|||
155399612|NCT01226459|560897570|FG001|Overall Study|Adverse Event|8|||
155399613|NCT01226459|560897569|FG000|Overall Study|Protocol Violation|4|||
155399614|NCT01226459|560897570|FG001|Overall Study|Protocol Violation|3|||
155399615|NCT01226459|560897569|FG000|Overall Study|Withdrawal by Subject|10|||
155399616|NCT01226459|560897570|FG001|Overall Study|Withdrawal by Subject|13|||
155399617|NCT01226459|560897569|FG000|Overall Study|Lost to Follow-up|4|||
155399618|NCT01226459|560897570|FG001|Overall Study|Lost to Follow-up|8|||
155399619|NCT01226459|560897569|FG000|Overall Study|Pregnancy|1|||
155399620|NCT01226459|560897570|FG001|Overall Study|Pregnancy|0|||
155399621|NCT01092143|560897571|FG000|Overall Study|Adverse Event|10|||
155399622|NCT01092143|560897572|FG001|Overall Study|Adverse Event|5|||
155399623|NCT01092143|560897573|FG002|Overall Study|Adverse Event|1|||
155399624|NCT01092143|560897574|FG003|Overall Study|Adverse Event|4|||
155399625|NCT01092143|560897575|FG004|Overall Study|Adverse Event|3|||
155399626|NCT01092143|560897571|FG000|Overall Study|Lost to Follow-up|1|||
155399627|NCT01092143|560897572|FG001|Overall Study|Lost to Follow-up|0|||
155399628|NCT01092143|560897573|FG002|Overall Study|Lost to Follow-up|1|||
155399629|NCT01092143|560897574|FG003|Overall Study|Lost to Follow-up|0|||
155399630|NCT01092143|560897575|FG004|Overall Study|Lost to Follow-up|0|||
155399631|NCT01092143|560897571|FG000|Overall Study|Consent withdrawn|2|||
155399632|NCT01092143|560897572|FG001|Overall Study|Consent withdrawn|1|||
155399633|NCT01092143|560897573|FG002|Overall Study|Consent withdrawn|0|||
155399634|NCT01092143|560897574|FG003|Overall Study|Consent withdrawn|1|||
155399635|NCT01092143|560897575|FG004|Overall Study|Consent withdrawn|3|||
155399636|NCT01092143|560897571|FG000|Overall Study|Not treated|0|||
155399637|NCT01092143|560897572|FG001|Overall Study|Not treated|0|||
155399638|NCT01092143|560897573|FG002|Overall Study|Not treated|1|||
155399639|NCT01092143|560897574|FG003|Overall Study|Not treated|0|||
155399640|NCT01092143|560897575|FG004|Overall Study|Not treated|0|||
155399641|NCT01092143|560897571|FG000|Overall Study|did not reversibility criteria|0|||
155399642|NCT01092143|560897572|FG001|Overall Study|did not reversibility criteria|0|||
155399643|NCT01092143|560897573|FG002|Overall Study|did not reversibility criteria|1|||
155399644|NCT01092143|560897574|FG003|Overall Study|did not reversibility criteria|0|||
155399645|NCT01092143|560897575|FG004|Overall Study|did not reversibility criteria|0|||
155399646|NCT01092143|560897571|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
155399647|NCT01092143|560897572|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
155399648|NCT01092143|560897573|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
155399649|NCT01092143|560897574|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
155399650|NCT01092143|560897575|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
155399651|NCT01092143|560897571|FG000|Overall Study|Ineligible patient|1|||
155399652|NCT01092143|560897572|FG001|Overall Study|Ineligible patient|0|||
155399653|NCT01092143|560897573|FG002|Overall Study|Ineligible patient|0|||
155399654|NCT01092143|560897574|FG003|Overall Study|Ineligible patient|0|||
155399655|NCT01092143|560897575|FG004|Overall Study|Ineligible patient|0|||
155399656|NCT01092143|560897571|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
155399657|NCT01092143|560897572|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
155399658|NCT01092143|560897573|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
155399659|NCT01092143|560897574|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
155399660|NCT01092143|560897575|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
155399661|NCT01092143|560897571|FG000|Overall Study|Patient travel|0|||
155399662|NCT01092143|560897572|FG001|Overall Study|Patient travel|0|||
155399663|NCT01092143|560897573|FG002|Overall Study|Patient travel|0|||
155399664|NCT01092143|560897574|FG003|Overall Study|Patient travel|0|||
155399665|NCT01092143|560897575|FG004|Overall Study|Patient travel|1|||
155399666|NCT01092143|560897571|FG000|Overall Study|Non compliance with study medication|0|||
155399667|NCT01092143|560897572|FG001|Overall Study|Non compliance with study medication|0|||
155399668|NCT01092143|560897573|FG002|Overall Study|Non compliance with study medication|0|||
155399669|NCT01092143|560897574|FG003|Overall Study|Non compliance with study medication|0|||
155399670|NCT01092143|560897575|FG004|Overall Study|Non compliance with study medication|1|||
155399671|NCT01092143|560897571|FG000|Overall Study|Randomized by mistake|0|||
155399672|NCT01092143|560897572|FG001|Overall Study|Randomized by mistake|0|||
155399673|NCT01092143|560897573|FG002|Overall Study|Randomized by mistake|0|||
155399674|NCT01092143|560897574|FG003|Overall Study|Randomized by mistake|1|||
155399675|NCT01092143|560897575|FG004|Overall Study|Randomized by mistake|0|||
155399676|NCT01092143|560897571|FG000|Overall Study|Pregnancy|0|||
155399677|NCT01092143|560897572|FG001|Overall Study|Pregnancy|0|||
155399678|NCT01092143|560897573|FG002|Overall Study|Pregnancy|0|||
155399679|NCT01092143|560897574|FG003|Overall Study|Pregnancy|1|||
155399680|NCT01092143|560897575|FG004|Overall Study|Pregnancy|0|||
155399681|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Death|40|||
155399682|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Death|41|||
155399683|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Death|37|||
155399684|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Death|0|||
155399685|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Death|0|||
155399686|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
155284353|NCT00463151|560472770|FG000|Overall Study|Lack of Efficacy|2|||
155284354|NCT00463151|560472771|FG001|Overall Study|Lack of Efficacy|5|||
155284355|NCT00463151|560472772|FG002|Overall Study|Lack of Efficacy|2|||
155284356|NCT00463151|560472773|FG003|Overall Study|Lack of Efficacy|5|||
155284357|NCT00463151|560472770|FG000|Overall Study|Protocol Violation|0|||
155284358|NCT00463151|560472771|FG001|Overall Study|Protocol Violation|0|||
155284359|NCT00463151|560472772|FG002|Overall Study|Protocol Violation|0|||
155284360|NCT00463151|560472773|FG003|Overall Study|Protocol Violation|1|||
155284361|NCT00463151|560472770|FG000|Overall Study|Withdrawal by Subject|0|||
155284362|NCT00463151|560472771|FG001|Overall Study|Withdrawal by Subject|0|||
155284363|NCT00463151|560472772|FG002|Overall Study|Withdrawal by Subject|0|||
155284364|NCT00463151|560472773|FG003|Overall Study|Withdrawal by Subject|1|||
155284365|NCT05349084|560472774|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
155284366|NCT00972543|560472775|FG000|Overall Study|Adverse Event|1|||
155284367|NCT00972543|560472776|FG001|Overall Study|Adverse Event|0|||
155284368|NCT00972543|560472775|FG000|Overall Study|Early study termination by sponsor|4|||
155284369|NCT00972543|560472776|FG001|Overall Study|Early study termination by sponsor|1|||
155284370|NCT00688688|560472777|FG000|Overall Study|Eligibility criterion not met|7|||
155284371|NCT00688688|560472778|FG001|Overall Study|Eligibility criterion not met|7|||
155284372|NCT00688688|560472779|FG002|Overall Study|Eligibility criterion not met|10|||
155284373|NCT00688688|560472777|FG000|Overall Study|Adverse Event|52|||
155284374|NCT00688688|560472778|FG001|Overall Study|Adverse Event|51|||
155284375|NCT00688688|560472779|FG002|Overall Study|Adverse Event|50|||
155284376|NCT00688688|560472777|FG000|Overall Study|Lack of Efficacy|34|||
155284377|NCT00688688|560472778|FG001|Overall Study|Lack of Efficacy|25|||
155284378|NCT00688688|560472779|FG002|Overall Study|Lack of Efficacy|45|||
154953382|NCT01248247|559256251|FG001|Overall Study|Adverse Event|4|||
155284379|NCT00688688|560472777|FG000|Overall Study|Withdrawal by Subject|66|||
155284380|NCT00688688|560472778|FG001|Overall Study|Withdrawal by Subject|75|||
155284381|NCT00688688|560472779|FG002|Overall Study|Withdrawal by Subject|65|||
155399687|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
155399688|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
154953383|NCT01248247|559256252|FG002|Overall Study|Adverse Event|4|||
154953384|NCT01248247|559256253|FG003|Overall Study|Adverse Event|2|||
154953385|NCT01248247|559256250|FG000|Overall Study|Death|0|||
154953386|NCT01248247|559256251|FG001|Overall Study|Death|1|||
154953387|NCT01248247|559256252|FG002|Overall Study|Death|4|||
154953388|NCT01248247|559256253|FG003|Overall Study|Death|7|||
154953389|NCT01248247|559256250|FG000|Overall Study|Lost to Follow-up|0|||
154953390|NCT01248247|559256251|FG001|Overall Study|Lost to Follow-up|1|||
154953391|NCT01248247|559256252|FG002|Overall Study|Lost to Follow-up|1|||
154953392|NCT01248247|559256253|FG003|Overall Study|Lost to Follow-up|0|||
154953393|NCT01248247|559256250|FG000|Overall Study|Alternative treatment|0|||
154953394|NCT01248247|559256251|FG001|Overall Study|Alternative treatment|1|||
154953395|NCT01248247|559256252|FG002|Overall Study|Alternative treatment|0|||
154953396|NCT01248247|559256253|FG003|Overall Study|Alternative treatment|0|||
154953397|NCT01248247|559256250|FG000|Overall Study|Other|2|||
154953398|NCT01248247|559256251|FG001|Overall Study|Other|8|||
154953399|NCT01248247|559256252|FG002|Overall Study|Other|8|||
154953400|NCT01248247|559256253|FG003|Overall Study|Other|5|||
154953401|NCT01248247|559256250|FG000|Overall Study|Progression|18|||
154953402|NCT01248247|559256251|FG001|Overall Study|Progression|27|||
154953403|NCT01248247|559256252|FG002|Overall Study|Progression|56|||
154953404|NCT01248247|559256253|FG003|Overall Study|Progression|44|||
154953405|NCT01248247|559256250|FG000|Overall Study|Refuse further treatment|0|||
154953406|NCT01248247|559256251|FG001|Overall Study|Refuse further treatment|0|||
154953407|NCT01248247|559256252|FG002|Overall Study|Refuse further treatment|1|||
154953408|NCT01248247|559256253|FG003|Overall Study|Refuse further treatment|2|||
154953409|NCT01248247|559256250|FG000|Overall Study|Complicating disease|0|||
154953410|NCT01248247|559256251|FG001|Overall Study|Complicating disease|0|||
154953411|NCT01248247|559256252|FG002|Overall Study|Complicating disease|1|||
154953412|NCT01248247|559256253|FG003|Overall Study|Complicating disease|1|||
154953413|NCT02817841|559256254|FG000|Overall Study|Lost to Follow-up|287|||
154953414|NCT02817841|559256254|FG000|Overall Study|Withdrawal by Subject|183|||
154953415|NCT02817841|559256254|FG000|Overall Study|Adverse event not related to bleeding|131|||
155399689|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
155399690|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
155399691|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
155399692|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
154953416|NCT02817841|559256254|FG000|Overall Study|Adverse event related to bleeding|51|||
154953417|NCT02817841|559256254|FG000|Overall Study|Pregnancy|32|||
154953418|NCT02817841|559256254|FG000|Overall Study|Pregnancy wish|17|||
154953419|NCT02817841|559256254|FG000|Overall Study|Other reasons|53|||
154953420|NCT02817841|559256254|FG000|Overall Study|Protocol Violation|94|||
154953421|NCT00705536|559256255|FG000|Start Period 1|Withdrawal by Subject|0|||
154953422|NCT00705536|559256256|FG001|Start Period 1|Withdrawal by Subject|0|||
154953423|NCT00705536|559256257|FG002|Start Period 1|Withdrawal by Subject|0|||
155284382|NCT00688688|560472777|FG000|Overall Study|Lost to Follow-up|14|||
155284383|NCT00688688|560472778|FG001|Overall Study|Lost to Follow-up|7|||
155284384|NCT00688688|560472779|FG002|Overall Study|Lost to Follow-up|7|||
155284385|NCT00688688|560472777|FG000|Overall Study|Protocol Violation|6|||
155284386|NCT00688688|560472778|FG001|Overall Study|Protocol Violation|9|||
155284387|NCT00688688|560472779|FG002|Overall Study|Protocol Violation|11|||
155284388|NCT00688688|560472777|FG000|Overall Study|Randomized but never received study drug|1|||
155284389|NCT00688688|560472778|FG001|Overall Study|Randomized but never received study drug|0|||
155284390|NCT00688688|560472779|FG002|Overall Study|Randomized but never received study drug|0|||
155284391|NCT00688688|560472777|FG000|Overall Study|Non-compliance with study procedures|5|||
155284392|NCT00688688|560472778|FG001|Overall Study|Non-compliance with study procedures|3|||
155284393|NCT00688688|560472779|FG002|Overall Study|Non-compliance with study procedures|4|||
155284394|NCT00688688|560472777|FG000|Overall Study|Taking exclusionary medications|1|||
155284395|NCT00688688|560472778|FG001|Overall Study|Taking exclusionary medications|0|||
155284396|NCT00688688|560472779|FG002|Overall Study|Taking exclusionary medications|0|||
155284397|NCT00688688|560472777|FG000|Overall Study|Site closure|0|||
155284398|NCT00688688|560472778|FG001|Overall Study|Site closure|1|||
155284399|NCT00688688|560472779|FG002|Overall Study|Site closure|0|||
155284400|NCT00688688|560472777|FG000|Overall Study|Violation of exclusion criterion|0|||
155284401|NCT00688688|560472778|FG001|Overall Study|Violation of exclusion criterion|1|||
155284402|NCT00688688|560472779|FG002|Overall Study|Violation of exclusion criterion|0|||
155284403|NCT03283553|560472783|FG000|Patient Participant Flow|Death|5|||
155284404|NCT03283553|560472784|FG001|Patient Participant Flow|Death|10|||
155284405|NCT03283553|560472783|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
155284406|NCT03283553|560472784|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
155284407|NCT03283553|560472783|FG000|Patient Participant Flow|Lost to Follow-up|1|||
155284408|NCT03283553|560472784|FG001|Patient Participant Flow|Lost to Follow-up|1|||
155284409|NCT03283553|560472783|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
155284410|NCT03283553|560472784|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
155284411|NCT03283553|560472783|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
155284412|NCT03283553|560472784|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
155284413|NCT03283553|560472783|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
155284414|NCT03283553|560472784|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
155284415|NCT03686683|560472785|FG000|Overall Study|Withdrawal by Subject|52|||
155284416|NCT03686683|560472786|FG001|Overall Study|Withdrawal by Subject|32|||
155284417|NCT03686683|560472785|FG000|Overall Study|Lost to Follow-up|23|||
155284418|NCT03686683|560472786|FG001|Overall Study|Lost to Follow-up|19|||
155284419|NCT03686683|560472785|FG000|Overall Study|Adverse Event|1|||
155284420|NCT03686683|560472786|FG001|Overall Study|Adverse Event|0|||
155284421|NCT03686683|560472785|FG000|Overall Study|Death|10|||
155284422|NCT03686683|560472786|FG001|Overall Study|Death|5|||
155284423|NCT03686683|560472785|FG000|Overall Study|Progressive Disease|1|||
155284424|NCT03686683|560472786|FG001|Overall Study|Progressive Disease|1|||
155284425|NCT03686683|560472785|FG000|Overall Study|Noncompliance|1|||
155284426|NCT03686683|560472786|FG001|Overall Study|Noncompliance|0|||
155284427|NCT03686683|560472785|FG000|Overall Study|Physician Decision|1|||
155284428|NCT03686683|560472786|FG001|Overall Study|Physician Decision|1|||
155284429|NCT03686683|560472785|FG000|Overall Study|Screen fail post-randomization|1|||
155284430|NCT03686683|560472786|FG001|Overall Study|Screen fail post-randomization|0|||
155284431|NCT03686683|560472785|FG000|Overall Study|Protocol Violation|3|||
155284432|NCT03686683|560472786|FG001|Overall Study|Protocol Violation|0|||
155284433|NCT03686683|560472785|FG000|Overall Study|No data available|1|||
155284434|NCT03686683|560472786|FG001|Overall Study|No data available|0|||
155284435|NCT04296942|560472787|FG000|Overall Study|Study closure by sponsor|1|||
155284436|NCT04296942|560472788|FG001|Overall Study|Study closure by sponsor|0|||
155284437|NCT04296942|560472789|FG002|Overall Study|Study closure by sponsor|0|||
154953424|NCT00705536|559256258|FG003|Start Period 1|Withdrawal by Subject|1|||
155284438|NCT03255941|560472790|FG000|Overall Study|Not eligible or refused injection|37|||
155284439|NCT03255941|560472791|FG001|Overall Study|Not eligible or refused injection|44|||
155284440|NCT03255941|560472792|FG002|Overall Study|Not eligible or refused injection|5|||
155284441|NCT03255941|560472793|FG003|Overall Study|Not eligible or refused injection|6|||
155284442|NCT03255941|560472790|FG000|Overall Study|Did not complete exit interview|1|||
154953425|NCT01675622|559256266|FG000|Overall Study|Withdrawal by Subject|2|||
154953426|NCT01675622|559256267|FG001|Overall Study|Withdrawal by Subject|2|||
154953427|NCT01675622|559256266|FG000|Overall Study|Adverse Event|12|||
154953428|NCT01675622|559256267|FG001|Overall Study|Adverse Event|10|||
154953429|NCT01675622|559256266|FG000|Overall Study|Protocol Violation|4|||
154953430|NCT01675622|559256267|FG001|Overall Study|Protocol Violation|1|||
154953431|NCT01675622|559256266|FG000|Overall Study|Lack of Efficacy|2|||
154953432|NCT01675622|559256267|FG001|Overall Study|Lack of Efficacy|4|||
154953433|NCT01675622|559256266|FG000|Overall Study|Lost to Follow-up|1|||
154953434|NCT01675622|559256267|FG001|Overall Study|Lost to Follow-up|3|||
155284443|NCT03255941|560472791|FG001|Overall Study|Did not complete exit interview|2|||
155284444|NCT03255941|560472792|FG002|Overall Study|Did not complete exit interview|0|||
154953435|NCT01675622|559256266|FG000|Overall Study|Other|5|||
155154295|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
155154296|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
155154297|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
155154298|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
155154299|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
155154300|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
155284445|NCT03255941|560472793|FG003|Overall Study|Did not complete exit interview|0|||
155284446|NCT01770860|560472805|FG000|Overall Study|Withdrawal by Subject|4|||
155399693|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
155399694|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
155399695|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
155399696|NCT00117598|560897576|FG000|Prior to Treatment Cross Over|Other|15|||
155399697|NCT00117598|560897577|FG001|Prior to Treatment Cross Over|Other|9|||
155399698|NCT00117598|560897578|FG002|Prior to Treatment Cross Over|Other|9|||
155399699|NCT00117598|560897579|FG003|Prior to Treatment Cross Over|Other|0|||
155399700|NCT00117598|560897580|FG004|Prior to Treatment Cross Over|Other|0|||
155399701|NCT00117598|560897576|FG000|After Treament Cross Over|Death|0|||
155399702|NCT00117598|560897577|FG001|After Treament Cross Over|Death|0|||
155399703|NCT00117598|560897578|FG002|After Treament Cross Over|Death|0|||
155399704|NCT00117598|560897579|FG003|After Treament Cross Over|Death|1|||
155399705|NCT00117598|560897580|FG004|After Treament Cross Over|Death|2|||
155399706|NCT00117598|560897576|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
155399707|NCT00117598|560897577|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
155399708|NCT00117598|560897578|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
155399709|NCT00117598|560897579|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
155399710|NCT00117598|560897580|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
155399711|NCT00117598|560897576|FG000|After Treament Cross Over|Other|0|||
155399712|NCT00117598|560897577|FG001|After Treament Cross Over|Other|0|||
155399713|NCT00117598|560897578|FG002|After Treament Cross Over|Other|0|||
155399714|NCT00117598|560897579|FG003|After Treament Cross Over|Other|1|||
155399715|NCT00117598|560897580|FG004|After Treament Cross Over|Other|2|||
155399716|NCT00382018|560897581|FG000|Overall Study|Progression|0|||
155399717|NCT00382018|560897582|FG001|Overall Study|Progression|136|||
155399718|NCT00382018|560897583|FG002|Overall Study|Progression|51|||
155399719|NCT00382018|560897584|FG003|Overall Study|Progression|43|||
155399720|NCT00382018|560897581|FG000|Overall Study|Death|0|||
155399721|NCT00382018|560897582|FG001|Overall Study|Death|9|||
155399722|NCT00382018|560897583|FG002|Overall Study|Death|7|||
155399723|NCT00382018|560897584|FG003|Overall Study|Death|11|||
155399724|NCT00382018|560897581|FG000|Overall Study|Withdrawal by Subject|0|||
155399725|NCT00382018|560897582|FG001|Overall Study|Withdrawal by Subject|4|||
155399726|NCT00382018|560897583|FG002|Overall Study|Withdrawal by Subject|3|||
155399727|NCT00382018|560897584|FG003|Overall Study|Withdrawal by Subject|4|||
155399728|NCT00382018|560897581|FG000|Overall Study|Other, not protocol specified|0|||
155399729|NCT00382018|560897582|FG001|Overall Study|Other, not protocol specified|16|||
155399730|NCT00382018|560897583|FG002|Overall Study|Other, not protocol specified|3|||
155399731|NCT00382018|560897584|FG003|Overall Study|Other, not protocol specified|1|||
155399732|NCT00427349|560897590|FG000|Overall Study|Lack of Efficacy|23|||
155399733|NCT00427349|560897590|FG000|Overall Study|Adverse Event|14|||
155399734|NCT00427349|560897590|FG000|Overall Study|Death|1|||
155399735|NCT00427349|560897590|FG000|Overall Study|Withdrawal by Subject|3|||
155399736|NCT00427349|560897590|FG000|Overall Study|Alternative therapy|1|||
155399737|NCT00427349|560897590|FG000|Overall Study|Other|2|||
155399738|NCT00427349|560897590|FG000|Overall Study|Ineligible|1|||
155399739|NCT00427349|560897590|FG000|Overall Study|Never started therapy|1|||
155399740|NCT02064920|560897595|FG000|Overall Study|Adverse Event|0|||
155399741|NCT02064920|560897596|FG001|Overall Study|Adverse Event|4|||
155399742|NCT02064920|560897595|FG000|Overall Study|Physician Decision|0|||
155399743|NCT02064920|560897596|FG001|Overall Study|Physician Decision|1|||
155399744|NCT02064920|560897595|FG000|Overall Study|Technical Problems|0|||
155399745|NCT02064920|560897596|FG001|Overall Study|Technical Problems|1|||
155399746|NCT02064920|560897595|FG000|Overall Study|Withdrawal by Subject|1|||
155399747|NCT02064920|560897596|FG001|Overall Study|Withdrawal by Subject|3|||
155399748|NCT02109562|560897597|FG000|Overall Study|Insufficient clinical response|2|||
155399749|NCT02109562|560897598|FG001|Overall Study|Insufficient clinical response|0|||
155399750|NCT02109562|560897599|FG002|Overall Study|Insufficient clinical response|4|||
155399751|NCT02109562|560897597|FG000|Overall Study|Adverse Event|0|||
155399752|NCT02109562|560897598|FG001|Overall Study|Adverse Event|2|||
155399753|NCT02109562|560897599|FG002|Overall Study|Adverse Event|3|||
155399754|NCT02109562|560897597|FG000|Overall Study|Lost to Follow-up|1|||
155399755|NCT02109562|560897598|FG001|Overall Study|Lost to Follow-up|0|||
155399756|NCT02109562|560897599|FG002|Overall Study|Lost to Follow-up|1|||
155399757|NCT02109562|560897597|FG000|Overall Study|Protocol Violation|0|||
155399758|NCT02109562|560897598|FG001|Overall Study|Protocol Violation|3|||
155399759|NCT02109562|560897599|FG002|Overall Study|Protocol Violation|1|||
155399760|NCT02109562|560897597|FG000|Overall Study|Withdrawal by Subject|20|||
155399761|NCT02109562|560897598|FG001|Overall Study|Withdrawal by Subject|25|||
154953436|NCT01675622|559256267|FG001|Overall Study|Other|4|||
154953437|NCT04032977|559256268|FG000|Overall Study|Withdrawal by Subject|6|||
154953438|NCT04032977|559256269|FG001|Overall Study|Withdrawal by Subject|1|||
154953439|NCT04032977|559256268|FG000|Overall Study|Lost to Follow-up|2|||
154953440|NCT04032977|559256269|FG001|Overall Study|Lost to Follow-up|7|||
154953441|NCT04032977|559256268|FG000|Overall Study|Pregnancy|1|||
154953442|NCT04032977|559256269|FG001|Overall Study|Pregnancy|0|||
154953443|NCT01101022|559256270|FG000|Overall Study|Adverse Event|6|||
154953444|NCT01101022|559256271|FG001|Overall Study|Adverse Event|2|||
154953445|NCT01101022|559256270|FG000|Overall Study|Protocol Violation|4|||
154953446|NCT01101022|559256271|FG001|Overall Study|Protocol Violation|3|||
154953447|NCT01101022|559256270|FG000|Overall Study|Withdrawal by Subject|3|||
154953448|NCT01101022|559256271|FG001|Overall Study|Withdrawal by Subject|8|||
154953449|NCT01101022|559256270|FG000|Overall Study|Lost to Follow-up|1|||
154953450|NCT01101022|559256271|FG001|Overall Study|Lost to Follow-up|4|||
154953451|NCT01101022|559256270|FG000|Overall Study|Lack of Efficacy|0|||
154953452|NCT01101022|559256271|FG001|Overall Study|Lack of Efficacy|7|||
154953453|NCT01101022|559256270|FG000|Overall Study|Sponsor decision|1|||
154953454|NCT01101022|559256271|FG001|Overall Study|Sponsor decision|1|||
154953455|NCT01101022|559256270|FG000|Overall Study|Non-compliance|1|||
154953456|NCT01101022|559256271|FG001|Overall Study|Non-compliance|0|||
154953457|NCT01101022|559256270|FG000|Overall Study|Work schedule|1|||
154953458|NCT01101022|559256271|FG001|Overall Study|Work schedule|1|||
154953459|NCT01101022|559256270|FG000|Overall Study|Vacation|0|||
154953460|NCT01101022|559256271|FG001|Overall Study|Vacation|1|||
154953461|NCT01519661|559256272|FG000|Overall Study|Protocol deviation|6|||
154953462|NCT01519661|559256272|FG000|Overall Study|Lost to Follow-up|3|||
154953463|NCT01519661|559256272|FG000|Overall Study|Withdrawal by Subject|17|||
154953464|NCT01519661|559256272|FG000|Overall Study|Lack of Efficacy|6|||
154953465|NCT01519661|559256272|FG000|Overall Study|Adverse Event|29|||
154953466|NCT03075761|559256273|FG000|Overall Study|Lost to Follow-up|1|||
154953467|NCT03075761|559256274|FG001|Overall Study|Lost to Follow-up|6|||
154953468|NCT01139047|559256275|FG000|Overall Study|Withdrawal by Subject|1|||
154953469|NCT00420303|559256281|FG000|Overall Study|Serious Adverse Event|1|||
154953470|NCT00420303|559256282|FG001|Overall Study|Serious Adverse Event|0|||
154953471|NCT00420303|559256281|FG000|Overall Study|Lack of Efficacy|0|||
154953472|NCT00420303|559256282|FG001|Overall Study|Lack of Efficacy|3|||
154953473|NCT00420303|559256281|FG000|Overall Study|Physician Decision|0|||
154953474|NCT00420303|559256282|FG001|Overall Study|Physician Decision|1|||
154953475|NCT00840632|559256283|FG000|First Intervention|Withdrawal by Subject|0|||
154953476|NCT00840632|559256284|FG001|First Intervention|Withdrawal by Subject|1|||
154953477|NCT00840632|559256283|FG000|Washout|Withdrawal by Subject|1|||
154953478|NCT00840632|559256284|FG001|Washout|Withdrawal by Subject|1|||
154953479|NCT00485472|559256285|FG000|Overall Study|Adverse Event|8|||
154953480|NCT00485472|559256286|FG001|Overall Study|Adverse Event|5|||
154953481|NCT00485472|559256285|FG000|Overall Study|Lack of Efficacy|5|||
154953482|NCT00485472|559256286|FG001|Overall Study|Lack of Efficacy|4|||
154953483|NCT00485472|559256285|FG000|Overall Study|Withdrawal by Subject|1|||
154953484|NCT00485472|559256286|FG001|Overall Study|Withdrawal by Subject|0|||
154953485|NCT00485472|559256285|FG000|Overall Study|Protocol Violation|0|||
154953486|NCT00485472|559256286|FG001|Overall Study|Protocol Violation|1|||
154953487|NCT00485472|559256285|FG000|Overall Study|Other|2|||
154953488|NCT00485472|559256286|FG001|Overall Study|Other|1|||
154953489|NCT00485472|559256285|FG000|Overall Study|Lost to Follow-up|0|||
154953490|NCT00485472|559256286|FG001|Overall Study|Lost to Follow-up|1|||
154953491|NCT01492361|559256287|FG000|Overall Study|Withdrawal by Subject|281|||
154953492|NCT01492361|559256288|FG001|Overall Study|Withdrawal by Subject|297|||
154953493|NCT01492361|559256287|FG000|Overall Study|Physician Decision|12|||
155399762|NCT02109562|560897599|FG002|Overall Study|Withdrawal by Subject|21|||
155399763|NCT02109562|560897597|FG000|Overall Study|Physician Decision|3|||
155399764|NCT02109562|560897598|FG001|Overall Study|Physician Decision|4|||
155399765|NCT02109562|560897599|FG002|Overall Study|Physician Decision|5|||
154953494|NCT01492361|559256288|FG001|Overall Study|Physician Decision|12|||
154953495|NCT01492361|559256287|FG000|Overall Study|Lost to Follow-up|6|||
154953496|NCT01492361|559256288|FG001|Overall Study|Lost to Follow-up|13|||
155399766|NCT00445224|560897609|FG000|Specific Exercises|Withdrawal by Subject|3|||
155399767|NCT00445224|560897610|FG001|Specific Exercises|Withdrawal by Subject|3|||
155399768|NCT00445224|560897609|FG000|Specific Exercises|Withdrawal by Subject|1|||
155399769|NCT00445224|560897610|FG001|Specific Exercises|Withdrawal by Subject|0|||
155399770|NCT00176605|560899403|FG000|Overall Study|Withdrawal by Subject|2|||
155399771|NCT01566773|560899406|FG000|Overall Study|Protocol specified criteria|4|||
155399772|NCT01566773|560899406|FG000|Overall Study|Protocol Violation|4|||
155399773|NCT01566773|560899406|FG000|Overall Study|Withdrawal by Subject|9|||
155399774|NCT01566773|560899406|FG000|Overall Study|Administrative reason|1|||
155399775|NCT01566773|560899406|FG000|Overall Study|Adverse Event|10|||
155399776|NCT01566773|560899406|FG000|Overall Study|Physician Decision|2|||
155399777|NCT01033734|560899407|FG000|Overall Study|Withdrawal by Subject|1|||
155399778|NCT00139776|560899410|FG000|Period I|Did not enter Period II|575|||
155399779|NCT00139776|560899411|FG001|Period I|Did not enter Period II|0|||
155284447|NCT01770860|560472805|FG000|Overall Study|Lost to Follow-up|1|||
155284448|NCT01770860|560472805|FG000|Overall Study|Administrative decision made by the PI|1|||
155284449|NCT05124899|560472806|FG000|Overall Study|Lost to Follow-up|3|||
155284450|NCT03432533|560472813|FG000|Overall Study|Lost to Follow-up|1|||
155284451|NCT03432533|560472814|FG001|Overall Study|Lost to Follow-up|2|||
155284452|NCT03432533|560472813|FG000|Overall Study|Withdrawal by Subject|14|||
155284453|NCT03432533|560472814|FG001|Overall Study|Withdrawal by Subject|9|||
155399780|NCT00139776|560899412|FG002|Period I|Did not enter Period II|0|||
155399781|NCT00139776|560899413|FG003|Period I|Did not enter Period II|0|||
155399782|NCT00139776|560899410|FG000|Period II|Not Randomized into Period III|0|||
155399783|NCT00139776|560899411|FG001|Period II|Not Randomized into Period III|322|||
155399784|NCT00139776|560899412|FG002|Period II|Not Randomized into Period III|0|||
155399785|NCT00139776|560899413|FG003|Period II|Not Randomized into Period III|0|||
155399786|NCT00139776|560899410|FG000|Period III|Adverse Event|0|||
155399787|NCT00139776|560899411|FG001|Period III|Adverse Event|0|||
155399788|NCT00139776|560899412|FG002|Period III|Adverse Event|22|||
155399789|NCT00139776|560899413|FG003|Period III|Adverse Event|23|||
155399790|NCT00139776|560899410|FG000|Period III|Other|0|||
155399791|NCT00139776|560899411|FG001|Period III|Other|0|||
155399792|NCT00139776|560899412|FG002|Period III|Other|23|||
155284454|NCT01648283|560472815|FG000|Overall Study|Withdrawal by Subject|14|||
155284455|NCT00821236|560472816|FG000|Overall Study|Lost to Follow-up|3|||
155284456|NCT03382821|560472821|FG000|Overall Study|Did not receive allocated intervention.|0|||
155284457|NCT03382821|560472822|FG001|Overall Study|Did not receive allocated intervention.|3|||
155284458|NCT00797225|560472823|FG000|Weeks 1 to 12|Adverse Event|0|||
155284459|NCT00797225|560472824|FG001|Weeks 1 to 12|Adverse Event|0|||
155284460|NCT00797225|560472825|FG002|Weeks 1 to 12|Adverse Event|1|||
155284461|NCT00797225|560472826|FG003|Weeks 1 to 12|Adverse Event|0|||
155284462|NCT00797225|560472827|FG004|Weeks 1 to 12|Adverse Event|0|||
155284463|NCT00797225|560472828|FG005|Weeks 1 to 12|Adverse Event|0|||
155284464|NCT00797225|560472829|FG006|Weeks 1 to 12|Adverse Event|0|||
155284465|NCT00797225|560472830|FG007|Weeks 1 to 12|Adverse Event|0|||
155284466|NCT00797225|560472823|FG000|Weeks 1 to 12|Non-compliance|0|||
155284467|NCT00797225|560472824|FG001|Weeks 1 to 12|Non-compliance|1|||
155284468|NCT00797225|560472825|FG002|Weeks 1 to 12|Non-compliance|0|||
155284469|NCT00797225|560472826|FG003|Weeks 1 to 12|Non-compliance|0|||
155284470|NCT00797225|560472827|FG004|Weeks 1 to 12|Non-compliance|0|||
155284471|NCT00797225|560472828|FG005|Weeks 1 to 12|Non-compliance|0|||
155284472|NCT00797225|560472829|FG006|Weeks 1 to 12|Non-compliance|0|||
155284473|NCT00797225|560472830|FG007|Weeks 1 to 12|Non-compliance|0|||
155284474|NCT00797225|560472823|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
155284475|NCT00797225|560472824|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
155284476|NCT00797225|560472825|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
155284477|NCT00797225|560472826|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
155284478|NCT00797225|560472827|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
154953497|NCT01492361|559256287|FG000|Overall Study|Other than specified above|106|||
154953498|NCT01492361|559256288|FG001|Overall Study|Other than specified above|138|||
154953499|NCT03227445|559256293|FG000|Period 1 (28 Days)|Adverse Event|1|||
154953500|NCT03227445|559256294|FG001|Period 1 (28 Days)|Adverse Event|2|||
154953501|NCT03227445|559256295|FG002|Period 1 (28 Days)|Adverse Event|0|||
154953502|NCT03227445|559256296|FG003|Period 1 (28 Days)|Adverse Event|1|||
154953503|NCT03227445|559256293|FG000|Period 1 (28 Days)|Protocol Violation|1|||
154953504|NCT03227445|559256294|FG001|Period 1 (28 Days)|Protocol Violation|0|||
154953505|NCT03227445|559256295|FG002|Period 1 (28 Days)|Protocol Violation|0|||
154953506|NCT03227445|559256296|FG003|Period 1 (28 Days)|Protocol Violation|0|||
154953507|NCT03227445|559256293|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
154953508|NCT03227445|559256294|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
154953509|NCT03227445|559256295|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
154953510|NCT03227445|559256296|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
154953511|NCT03227445|559256293|FG000|Period 2 (28 Days)|Adverse Event|1|||
154953512|NCT03227445|559256294|FG001|Period 2 (28 Days)|Adverse Event|0|||
154953513|NCT03227445|559256295|FG002|Period 2 (28 Days)|Adverse Event|2|||
154953514|NCT03227445|559256296|FG003|Period 2 (28 Days)|Adverse Event|1|||
154953515|NCT03227445|559256293|FG000|Period 2 (28 Days)|Protocol Violation|0|||
154953516|NCT03227445|559256294|FG001|Period 2 (28 Days)|Protocol Violation|0|||
154953517|NCT03227445|559256295|FG002|Period 2 (28 Days)|Protocol Violation|0|||
154953518|NCT03227445|559256296|FG003|Period 2 (28 Days)|Protocol Violation|1|||
155284479|NCT00797225|560472828|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
155284480|NCT00797225|560472829|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
155399793|NCT00139776|560899413|FG003|Period III|Other|34|||
155399794|NCT00139776|560899410|FG000|Period III|Lack of Efficacy|0|||
154953519|NCT03227445|559256293|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
154953520|NCT03227445|559256294|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
155154301|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
155284481|NCT00797225|560472830|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
155284482|NCT00797225|560472823|FG000|Weeks 1 to 12|Sponsor Decision|1|||
155284483|NCT00797225|560472824|FG001|Weeks 1 to 12|Sponsor Decision|0|||
155399795|NCT00139776|560899411|FG001|Period III|Lack of Efficacy|0|||
155399796|NCT00139776|560899412|FG002|Period III|Lack of Efficacy|10|||
155399797|NCT00139776|560899413|FG003|Period III|Lack of Efficacy|24|||
155399798|NCT00139776|560899410|FG000|Period III|Lost to Follow-up|0|||
155399799|NCT00139776|560899411|FG001|Period III|Lost to Follow-up|0|||
155399800|NCT00139776|560899412|FG002|Period III|Lost to Follow-up|5|||
155399801|NCT00139776|560899413|FG003|Period III|Lost to Follow-up|4|||
155399802|NCT00139776|560899410|FG000|Period III|Withdrawal by Subject|0|||
155399803|NCT00139776|560899411|FG001|Period III|Withdrawal by Subject|0|||
155399804|NCT00139776|560899412|FG002|Period III|Withdrawal by Subject|16|||
155399805|NCT00139776|560899413|FG003|Period III|Withdrawal by Subject|21|||
155399806|NCT00187096|560899414|FG000|Overall Study|unacceptable toxicity|0|||
155399807|NCT00187096|560899415|FG001|Overall Study|unacceptable toxicity|0|||
155399808|NCT00187096|560899416|FG002|Overall Study|unacceptable toxicity|1|||
155399809|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
155399810|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
155399811|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
155399812|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
155399813|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
155399814|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
155399815|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
155399816|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
155399817|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
155399818|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
155399819|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
155399820|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
155399821|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
155399822|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
155399823|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
155399824|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
155399825|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
155399826|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
155399827|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
155399828|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
155399829|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
155399830|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
155399831|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
155399832|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
155154302|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
155154303|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
155154304|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
155154305|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155154306|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155154307|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
155154308|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
155154309|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
155154310|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
155154311|NCT04026113|560002262|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155154312|NCT04026113|560002263|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
155154313|NCT04026113|560002264|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155154314|NCT04026113|560002265|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155154315|NCT04026113|560002262|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
155154316|NCT04026113|560002263|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
154953521|NCT03227445|559256295|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
155284484|NCT00797225|560472825|FG002|Weeks 1 to 12|Sponsor Decision|0|||
155399833|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
155399834|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155399835|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155399836|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
155399837|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
155399838|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
154953522|NCT03227445|559256296|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
154953523|NCT00365300|559256299|FG000|Open-label Phase|Adverse Event|4|||
154953524|NCT00365300|559256300|FG001|Open-label Phase|Adverse Event|0|||
154953525|NCT00365300|559256299|FG000|Open-label Phase|Failed to Return|1|||
154953526|NCT00365300|559256300|FG001|Open-label Phase|Failed to Return|0|||
154953527|NCT00365300|559256299|FG000|Open-label Phase|Physician Decision|1|||
154953528|NCT00365300|559256300|FG001|Open-label Phase|Physician Decision|0|||
154953529|NCT00365300|559256299|FG000|Open-label Phase|Noncompliance|9|||
154953530|NCT00365300|559256300|FG001|Open-label Phase|Noncompliance|0|||
154953531|NCT00365300|559256299|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
154953532|NCT00365300|559256300|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
155284485|NCT00797225|560472826|FG003|Weeks 1 to 12|Sponsor Decision|0|||
155284486|NCT00797225|560472827|FG004|Weeks 1 to 12|Sponsor Decision|0|||
155284487|NCT00797225|560472828|FG005|Weeks 1 to 12|Sponsor Decision|0|||
155284488|NCT00797225|560472829|FG006|Weeks 1 to 12|Sponsor Decision|0|||
155284489|NCT00797225|560472830|FG007|Weeks 1 to 12|Sponsor Decision|0|||
155284490|NCT00797225|560472823|FG000|Weeks 13 to 24|Non-compliance|0|||
155284491|NCT00797225|560472824|FG001|Weeks 13 to 24|Non-compliance|2|||
155284492|NCT00797225|560472825|FG002|Weeks 13 to 24|Non-compliance|0|||
155284493|NCT00797225|560472826|FG003|Weeks 13 to 24|Non-compliance|0|||
155284494|NCT00797225|560472827|FG004|Weeks 13 to 24|Non-compliance|0|||
155284495|NCT00797225|560472828|FG005|Weeks 13 to 24|Non-compliance|0|||
155284496|NCT00797225|560472829|FG006|Weeks 13 to 24|Non-compliance|0|||
155284497|NCT00797225|560472830|FG007|Weeks 13 to 24|Non-compliance|0|||
155284498|NCT00797225|560472823|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
155284499|NCT00797225|560472824|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
155284500|NCT00797225|560472825|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
155284501|NCT00797225|560472826|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
155284502|NCT00797225|560472827|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
155284503|NCT00797225|560472828|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
155284504|NCT00797225|560472829|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
155284505|NCT00797225|560472830|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
155284506|NCT00797225|560472823|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
155399839|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399840|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399841|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399842|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399843|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399844|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399845|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
155399846|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
155399847|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
155399848|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
155399849|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
155399850|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
155399851|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
155399852|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
155284507|NCT00797225|560472824|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
155284508|NCT00797225|560472825|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
155284509|NCT00797225|560472826|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
155284510|NCT00797225|560472827|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
155284511|NCT00797225|560472828|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
155284512|NCT00797225|560472829|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
155284513|NCT00797225|560472830|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
155284514|NCT00797225|560472823|FG000|Weeks 13 to 24|Adverse Event|0|||
155284515|NCT00797225|560472824|FG001|Weeks 13 to 24|Adverse Event|1|||
155284516|NCT00797225|560472825|FG002|Weeks 13 to 24|Adverse Event|0|||
155284517|NCT00797225|560472826|FG003|Weeks 13 to 24|Adverse Event|0|||
155284518|NCT00797225|560472827|FG004|Weeks 13 to 24|Adverse Event|0|||
155284519|NCT00797225|560472828|FG005|Weeks 13 to 24|Adverse Event|0|||
155284520|NCT00797225|560472829|FG006|Weeks 13 to 24|Adverse Event|1|||
155284521|NCT00797225|560472830|FG007|Weeks 13 to 24|Adverse Event|0|||
155284522|NCT00797225|560472823|FG000|Weeks 13 to 24|Sponsor Decision|0|||
155284523|NCT00797225|560472824|FG001|Weeks 13 to 24|Sponsor Decision|0|||
155284524|NCT00797225|560472825|FG002|Weeks 13 to 24|Sponsor Decision|0|||
155284525|NCT00797225|560472826|FG003|Weeks 13 to 24|Sponsor Decision|0|||
155399853|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155399854|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155399855|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155284526|NCT00797225|560472827|FG004|Weeks 13 to 24|Sponsor Decision|0|||
155284527|NCT00797225|560472828|FG005|Weeks 13 to 24|Sponsor Decision|0|||
155284528|NCT00797225|560472829|FG006|Weeks 13 to 24|Sponsor Decision|1|||
155284529|NCT00797225|560472830|FG007|Weeks 13 to 24|Sponsor Decision|0|||
155284530|NCT05174065|560472831|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
155284531|NCT05174065|560472832|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
155399856|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
155284532|NCT05174065|560472833|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
155284533|NCT05174065|560472831|FG000|Placebo-controlled Period|Other|0|||
155284534|NCT05174065|560472832|FG001|Placebo-controlled Period|Other|1|||
155284535|NCT05174065|560472833|FG002|Placebo-controlled Period|Other|0|||
155284536|NCT05174065|560472831|FG000|Placebo-controlled Period|Adverse Event|1|||
155284537|NCT05174065|560472832|FG001|Placebo-controlled Period|Adverse Event|1|||
155284538|NCT05174065|560472833|FG002|Placebo-controlled Period|Adverse Event|0|||
155057700|NCT02265510|559645794|FG012|Overall Study|Death|7|||
155284539|NCT05174065|560472831|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
155154317|NCT04026113|560002264|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
155154318|NCT04026113|560002265|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
155154319|NCT01527149|560002267|FG000|Overall Study|Death|2|||
155399857|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
155154320|NCT02992288|560002268|FG000|Overall Study|Adverse Event|8|||
155154321|NCT02992288|560002269|FG001|Overall Study|Adverse Event|2|||
155154322|NCT02992288|560002270|FG002|Overall Study|Adverse Event|2|||
155154323|NCT02992288|560002271|FG003|Overall Study|Adverse Event|2|||
155154324|NCT02992288|560002272|FG004|Overall Study|Adverse Event|2|||
155154325|NCT02992288|560002273|FG005|Overall Study|Adverse Event|7|||
155399858|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399859|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399860|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399861|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399862|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
155399863|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155154326|NCT02992288|560002268|FG000|Overall Study|Non-compliance with study drug|0|||
155154327|NCT02992288|560002269|FG001|Overall Study|Non-compliance with study drug|1|||
155154328|NCT02992288|560002270|FG002|Overall Study|Non-compliance with study drug|1|||
155154329|NCT02992288|560002271|FG003|Overall Study|Non-compliance with study drug|0|||
155154330|NCT02992288|560002272|FG004|Overall Study|Non-compliance with study drug|1|||
155154331|NCT02992288|560002273|FG005|Overall Study|Non-compliance with study drug|0|||
155154332|NCT02992288|560002268|FG000|Overall Study|Physician Decision|3|||
155154333|NCT02992288|560002269|FG001|Overall Study|Physician Decision|0|||
155154334|NCT02992288|560002270|FG002|Overall Study|Physician Decision|1|||
155154335|NCT02992288|560002271|FG003|Overall Study|Physician Decision|0|||
155154336|NCT02992288|560002272|FG004|Overall Study|Physician Decision|0|||
155154337|NCT02992288|560002273|FG005|Overall Study|Physician Decision|1|||
155154338|NCT02992288|560002268|FG000|Overall Study|Death|2|||
155154339|NCT02992288|560002269|FG001|Overall Study|Death|0|||
155154340|NCT02992288|560002270|FG002|Overall Study|Death|2|||
155154341|NCT02992288|560002271|FG003|Overall Study|Death|1|||
155154342|NCT02992288|560002272|FG004|Overall Study|Death|2|||
155154343|NCT02992288|560002273|FG005|Overall Study|Death|0|||
155154344|NCT02992288|560002268|FG000|Overall Study|Lost to Follow-up|0|||
155154345|NCT02992288|560002269|FG001|Overall Study|Lost to Follow-up|0|||
155154346|NCT02992288|560002270|FG002|Overall Study|Lost to Follow-up|0|||
155154347|NCT02992288|560002271|FG003|Overall Study|Lost to Follow-up|1|||
155154348|NCT02992288|560002272|FG004|Overall Study|Lost to Follow-up|0|||
155154349|NCT02992288|560002273|FG005|Overall Study|Lost to Follow-up|0|||
155154350|NCT02992288|560002268|FG000|Overall Study|Protocol Violation|0|||
155154351|NCT02992288|560002269|FG001|Overall Study|Protocol Violation|0|||
155154352|NCT02992288|560002270|FG002|Overall Study|Protocol Violation|0|||
155154353|NCT02992288|560002271|FG003|Overall Study|Protocol Violation|0|||
155154354|NCT02992288|560002272|FG004|Overall Study|Protocol Violation|0|||
155154355|NCT02992288|560002273|FG005|Overall Study|Protocol Violation|1|||
155154356|NCT02992288|560002268|FG000|Overall Study|Withdrawal by Subject|4|||
155154357|NCT02992288|560002269|FG001|Overall Study|Withdrawal by Subject|2|||
155154358|NCT02992288|560002270|FG002|Overall Study|Withdrawal by Subject|1|||
155154359|NCT02992288|560002271|FG003|Overall Study|Withdrawal by Subject|5|||
155154360|NCT02992288|560002272|FG004|Overall Study|Withdrawal by Subject|3|||
155154361|NCT02992288|560002273|FG005|Overall Study|Withdrawal by Subject|4|||
155154362|NCT00656513|560002274|FG000|Overall Study|Protocol Violation|1|||
155154363|NCT00656513|560002275|FG001|Overall Study|Protocol Violation|0|||
155154364|NCT00656513|560002276|FG002|Overall Study|Protocol Violation|2|||
155154365|NCT00656513|560002274|FG000|Overall Study|Withdrawal by Subject|0|||
155154366|NCT00656513|560002275|FG001|Overall Study|Withdrawal by Subject|11|||
155154367|NCT00656513|560002276|FG002|Overall Study|Withdrawal by Subject|4|||
155154368|NCT00656513|560002274|FG000|Overall Study|Death|0|||
155154369|NCT00656513|560002275|FG001|Overall Study|Death|0|||
155154370|NCT00656513|560002276|FG002|Overall Study|Death|1|||
155154371|NCT00656513|560002274|FG000|Overall Study|Missing data|0|||
155154372|NCT00656513|560002275|FG001|Overall Study|Missing data|11|||
155154373|NCT00656513|560002276|FG002|Overall Study|Missing data|9|||
155154374|NCT00656513|560002274|FG000|Overall Study|Incomplete treatment|3|||
155154375|NCT00656513|560002275|FG001|Overall Study|Incomplete treatment|0|||
155154376|NCT00656513|560002276|FG002|Overall Study|Incomplete treatment|0|||
155154377|NCT00656513|560002274|FG000|Overall Study|Treatment completed outside of timeframe|0|||
155154378|NCT00656513|560002275|FG001|Overall Study|Treatment completed outside of timeframe|3|||
155154379|NCT00656513|560002276|FG002|Overall Study|Treatment completed outside of timeframe|1|||
155154380|NCT00656513|560002274|FG000|Overall Study|Missing baseline form|0|||
155154381|NCT00656513|560002275|FG001|Overall Study|Missing baseline form|5|||
155154382|NCT00656513|560002276|FG002|Overall Study|Missing baseline form|5|||
155154383|NCT03962491|560002281|FG000|Overall Study|Lost to Follow-up|4|||
155154384|NCT03962491|560002282|FG001|Overall Study|Lost to Follow-up|5|||
155399864|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
155399865|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399866|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399867|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399868|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
155399869|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399870|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
155399871|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399872|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399873|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399874|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
155399875|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399876|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
155399877|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399878|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399879|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399880|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
155399881|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399882|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
155399883|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399884|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399885|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399886|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
155399887|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399888|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399889|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399890|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
155399891|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399892|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
155399893|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399894|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399895|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399896|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
155399897|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399898|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
155399899|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399900|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399901|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399902|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399903|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
155399904|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
155399905|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399906|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399907|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399908|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399909|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
155399910|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
155399911|NCT00111800|560899423|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399912|NCT00111800|560899424|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399913|NCT00111800|560899425|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399914|NCT00111800|560899426|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399915|NCT00111800|560899427|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
155399916|NCT00111800|560899428|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
155399917|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
155399918|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
155399919|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
155399920|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
155399921|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
155399922|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
155399923|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155399924|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
155284540|NCT05174065|560472832|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
155284541|NCT05174065|560472833|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
155284542|NCT05174065|560472831|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
155284543|NCT05174065|560472832|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
155284544|NCT05174065|560472833|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
155284545|NCT05174065|560472831|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
155284546|NCT05174065|560472832|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
155284547|NCT05174065|560472833|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
155284548|NCT01419717|560474349|FG000|Overall Study|Protocol-specified Criteria|62|||
155284549|NCT01419717|560474349|FG000|Overall Study|Adverse Event|19|||
155284550|NCT01419717|560474349|FG000|Overall Study|Death|17|||
155284551|NCT01419717|560474349|FG000|Overall Study|Withdrawal by Subject|10|||
155284552|NCT01419717|560474349|FG000|Overall Study|Disease Progression|9|||
155284553|NCT01419717|560474349|FG000|Overall Study|Other|4|||
155284554|NCT01419717|560474349|FG000|Overall Study|Lost to Follow-up|2|||
155284555|NCT01419717|560474349|FG000|Overall Study|Administrative Decision|1|||
155284556|NCT01419717|560474349|FG000|Overall Study|Noncompliance|1|||
155284557|NCT00587288|560474350|FG000|Overall Study|Adverse Event|0|||
155154385|NCT00106704|560002283|FG000|Overall Study|Adverse Event|10|||
155154386|NCT00106704|560002284|FG001|Overall Study|Adverse Event|7|||
155154387|NCT00106704|560002283|FG000|Overall Study|Death|2|||
155154388|NCT00106704|560002284|FG001|Overall Study|Death|1|||
155154389|NCT00106704|560002283|FG000|Overall Study|Lack of Efficacy|67|||
155154390|NCT00106704|560002284|FG001|Overall Study|Lack of Efficacy|69|||
155154391|NCT00106704|560002283|FG000|Overall Study|Lost to Follow-up|7|||
155154392|NCT00106704|560002284|FG001|Overall Study|Lost to Follow-up|3|||
155154393|NCT00106704|560002283|FG000|Overall Study|Pregnancy|1|||
155154394|NCT00106704|560002284|FG001|Overall Study|Pregnancy|0|||
155154395|NCT00106704|560002283|FG000|Overall Study|Protocol Violation|4|||
155154396|NCT00106704|560002284|FG001|Overall Study|Protocol Violation|7|||
155154397|NCT00106704|560002283|FG000|Overall Study|Withdrawal by Subject|14|||
155154398|NCT00106704|560002284|FG001|Overall Study|Withdrawal by Subject|21|||
155154399|NCT00106704|560002283|FG000|Overall Study|Patient moved|1|||
154953533|NCT00365300|559256299|FG000|Open-label Phase|Protocol Violation|1|||
154953534|NCT00365300|559256300|FG001|Open-label Phase|Protocol Violation|0|||
154953535|NCT00365300|559256299|FG000|Open-label Phase|Lack of Efficacy|1|||
154953536|NCT00365300|559256300|FG001|Open-label Phase|Lack of Efficacy|0|||
154953537|NCT00365300|559256299|FG000|Open-label Phase|Patient skipped open label phase|1|||
154953538|NCT00365300|559256300|FG001|Open-label Phase|Patient skipped open label phase|0|||
154953539|NCT00365300|559256299|FG000|Double-blind Phase|Failed to return|1|||
154953540|NCT00365300|559256300|FG001|Double-blind Phase|Failed to return|0|||
154953541|NCT00365300|559256299|FG000|Double-blind Phase|Noncompliance|1|||
154953542|NCT00365300|559256300|FG001|Double-blind Phase|Noncompliance|1|||
154953543|NCT00365300|559256299|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155154400|NCT00106704|560002284|FG001|Overall Study|Patient moved|0|||
155154401|NCT00106704|560002283|FG000|Overall Study|Site terminated|0|||
155399925|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
155399926|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155399927|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155399928|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
155154402|NCT00106704|560002284|FG001|Overall Study|Site terminated|1|||
155284558|NCT00587288|560474351|FG001|Overall Study|Adverse Event|1|||
155399929|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
155399930|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
155399931|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
155399932|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
155399933|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
155399934|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
155399935|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399936|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
155399937|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399938|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399939|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
155399940|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
155399941|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399942|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399943|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
155399944|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
154953544|NCT00365300|559256300|FG001|Double-blind Phase|Withdrawal by Subject|1|||
155284559|NCT00587288|560474350|FG000|Overall Study|Lack of Efficacy|2|||
155154403|NCT00106704|560002283|FG000|Overall Study|Planned major surgery|1|||
155154404|NCT00106704|560002284|FG001|Overall Study|Planned major surgery|0|||
155399945|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399946|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
155399947|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399948|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
155399949|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399950|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399951|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399952|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
155399953|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155399954|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155284560|NCT00587288|560474351|FG001|Overall Study|Lack of Efficacy|8|||
155284561|NCT00587288|560474350|FG000|Overall Study|Protocol Violation|1|||
155284562|NCT00587288|560474351|FG001|Overall Study|Protocol Violation|0|||
155284563|NCT00797862|560474352|FG000|Overall Study|Adverse Event|86|||
155284564|NCT00797862|560474353|FG001|Overall Study|Adverse Event|44|||
155284565|NCT00797862|560474354|FG002|Overall Study|Adverse Event|58|||
155284566|NCT00797862|560474352|FG000|Overall Study|Abnormal Test Procedure Result|0|||
155154405|NCT00106704|560002283|FG000|Overall Study|Patient Received Glycemic Medication|22|||
155284567|NCT00797862|560474353|FG001|Overall Study|Abnormal Test Procedure Result|1|||
155284568|NCT00797862|560474354|FG002|Overall Study|Abnormal Test Procedure Result|1|||
155284569|NCT00797862|560474352|FG000|Overall Study|Lack of Efficacy|1|||
155284570|NCT00797862|560474353|FG001|Overall Study|Lack of Efficacy|7|||
155284571|NCT00797862|560474354|FG002|Overall Study|Lack of Efficacy|6|||
155284572|NCT00797862|560474352|FG000|Overall Study|No longer required study medication|1|||
155284573|NCT00797862|560474353|FG001|Overall Study|No longer required study medication|0|||
155284574|NCT00797862|560474354|FG002|Overall Study|No longer required study medication|0|||
155284575|NCT00797862|560474352|FG000|Overall Study|Withdrawal by Subject|14|||
155284576|NCT00797862|560474353|FG001|Overall Study|Withdrawal by Subject|7|||
155284577|NCT00797862|560474354|FG002|Overall Study|Withdrawal by Subject|7|||
155284578|NCT00797862|560474352|FG000|Overall Study|Lost to Follow-up|11|||
155284579|NCT00797862|560474353|FG001|Overall Study|Lost to Follow-up|0|||
155284580|NCT00797862|560474354|FG002|Overall Study|Lost to Follow-up|5|||
155284581|NCT00797862|560474352|FG000|Overall Study|Administrative Problem|4|||
155284582|NCT00797862|560474353|FG001|Overall Study|Administrative Problem|0|||
155284583|NCT00797862|560474354|FG002|Overall Study|Administrative Problem|0|||
155284584|NCT00797862|560474352|FG000|Overall Study|Protocol Violation|4|||
155284585|NCT00797862|560474353|FG001|Overall Study|Protocol Violation|6|||
155284586|NCT00797862|560474354|FG002|Overall Study|Protocol Violation|8|||
155284587|NCT00797862|560474352|FG000|Overall Study|Mis-randomized|3|||
155284588|NCT00797862|560474353|FG001|Overall Study|Mis-randomized|3|||
155284589|NCT00797862|560474354|FG002|Overall Study|Mis-randomized|1|||
155284590|NCT05074498|560474357|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284591|NCT05074498|560474358|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284592|NCT05074498|560474359|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284593|NCT05074498|560474360|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
155284594|NCT05074498|560474361|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284595|NCT05074498|560474362|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
155284596|NCT05074498|560474357|FG000|Part 1 (Upto Day 104)|Other|1|||
155284597|NCT05074498|560474358|FG001|Part 1 (Upto Day 104)|Other|0|||
155399955|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
155399956|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155399957|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155399958|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
155284598|NCT05074498|560474359|FG002|Part 1 (Upto Day 104)|Other|0|||
155284599|NCT05074498|560474360|FG003|Part 1 (Upto Day 104)|Other|0|||
155284600|NCT05074498|560474361|FG004|Part 1 (Upto Day 104)|Other|0|||
155284601|NCT05074498|560474362|FG005|Part 1 (Upto Day 104)|Other|0|||
155284602|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155284603|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155284604|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155399959|NCT00111800|560899423|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
154953545|NCT00365300|559256299|FG000|Double-blind Phase|Protocol Violation|3|||
154953546|NCT00365300|559256300|FG001|Double-blind Phase|Protocol Violation|1|||
155284605|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155284606|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
155399960|NCT00111800|560899424|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
154953547|NCT00365300|559256299|FG000|Double-blind Phase|Lack of Efficacy|6|||
154953548|NCT00365300|559256300|FG001|Double-blind Phase|Lack of Efficacy|6|||
154953549|NCT01991470|559256301|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
154953550|NCT01991470|559256301|FG000|Enlite 1 Period|Adverse Event|1|||
154953551|NCT01991470|559256301|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
154953552|NCT01991470|559256301|FG000|Enlite 3 Period|Lost to Follow-up|1|||
154953553|NCT01991470|559256301|FG000|Enlite 3 Period|Physician Decision|2|||
154953554|NCT01991470|559256301|FG000|Enlite 3 Period|Physician Decision|8|||
154953555|NCT01991470|559256301|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
154953556|NCT00324168|559256302|FG000|Overall Study|Lost to Follow-up|19|||
154953557|NCT00324168|559256303|FG001|Overall Study|Lost to Follow-up|18|||
154953558|NCT00324168|559256302|FG000|Overall Study|Death|3|||
155284607|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
155399961|NCT00111800|560899425|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
155399962|NCT00111800|560899426|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
154953559|NCT00324168|559256303|FG001|Overall Study|Death|3|||
154953560|NCT00324168|559256302|FG000|Overall Study|Patient did not visit in f/u window|6|||
155284608|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Death|0|||
155284609|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Death|0|||
155284610|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Death|0|||
155399963|NCT00111800|560899427|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155399964|NCT00111800|560899428|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
155399965|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
155399966|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
155399967|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
155284611|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Death|0|||
155284612|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Death|1|||
155284613|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Death|0|||
155284614|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284615|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284616|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284617|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
155284618|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
155284619|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
154953561|NCT00324168|559256303|FG001|Overall Study|Patient did not visit in f/u window|9|||
154953562|NCT01203878|559256304|FG000|Overall Study|Withdrawal by Subject|0|||
154953563|NCT01203878|559256305|FG001|Overall Study|Withdrawal by Subject|0|||
154953564|NCT01203878|559256306|FG002|Overall Study|Withdrawal by Subject|1|||
154953565|NCT01203878|559256304|FG000|Overall Study|Adverse Event|0|||
154953566|NCT01203878|559256305|FG001|Overall Study|Adverse Event|0|||
154953567|NCT01203878|559256306|FG002|Overall Study|Adverse Event|2|||
154953568|NCT00528606|559256307|FG000|Overall Study|Withdrew consent|4|||
155284620|NCT05074498|560474357|FG000|Part 2 (Upto Day 104)|Other|0|||
155284621|NCT05074498|560474358|FG001|Part 2 (Upto Day 104)|Other|0|||
155284622|NCT05074498|560474359|FG002|Part 2 (Upto Day 104)|Other|0|||
155284623|NCT05074498|560474360|FG003|Part 2 (Upto Day 104)|Other|0|||
154953569|NCT00528606|559256308|FG001|Overall Study|Withdrew consent|3|||
154953570|NCT00528606|559256307|FG000|Overall Study|Lost to Follow-up|4|||
154953571|NCT00528606|559256308|FG001|Overall Study|Lost to Follow-up|1|||
154953572|NCT00528606|559256307|FG000|Overall Study|Adverse Event|3|||
154953573|NCT00528606|559256308|FG001|Overall Study|Adverse Event|0|||
154953574|NCT00528606|559256307|FG000|Overall Study|Other|2|||
154953575|NCT00528606|559256308|FG001|Overall Study|Other|0|||
154953576|NCT02475954|559256309|FG000|Overall Study|Withdrawal by Subject|2|||
155284624|NCT05074498|560474361|FG004|Part 2 (Upto Day 104)|Other|1|||
155284625|NCT05074498|560474362|FG005|Part 2 (Upto Day 104)|Other|0|||
155284626|NCT01257503|560474363|FG000|Overall Study|Lost to Follow-up|7|||
155284627|NCT01257503|560474364|FG001|Overall Study|Lost to Follow-up|10|||
155284628|NCT01257503|560474363|FG000|Overall Study|Over 5 years old at enrollment|0|||
155284629|NCT01257503|560474364|FG001|Overall Study|Over 5 years old at enrollment|1|||
155284630|NCT01257503|560474363|FG000|Overall Study|strep culture positive at enrollment|1|||
155284631|NCT01257503|560474364|FG001|Overall Study|strep culture positive at enrollment|0|||
155284632|NCT00367237|560474365|FG000|Overall Study|Adverse Event|7|||
155284633|NCT00367237|560474366|FG001|Overall Study|Adverse Event|2|||
155284634|NCT00367237|560474365|FG000|Overall Study|Lost to Follow-up|1|||
155284635|NCT00367237|560474366|FG001|Overall Study|Lost to Follow-up|0|||
155284636|NCT00367237|560474365|FG000|Overall Study|Withdrawal by Subject|0|||
155284637|NCT00367237|560474366|FG001|Overall Study|Withdrawal by Subject|4|||
155284638|NCT00367237|560474365|FG000|Overall Study|Protocol Violation|2|||
155284639|NCT00367237|560474366|FG001|Overall Study|Protocol Violation|5|||
155284640|NCT02359435|560474367|FG000|Overall Study|Lost to Follow-up|4|||
155284641|NCT02359435|560474368|FG001|Overall Study|Lost to Follow-up|4|||
155284642|NCT01528709|560474374|FG000|Overall Study|Death|2|||
155284643|NCT01528709|560474375|FG001|Overall Study|Death|0|||
155284644|NCT01528709|560474374|FG000|Overall Study|Withdrawal by Subject|10|||
155284645|NCT01528709|560474375|FG001|Overall Study|Withdrawal by Subject|15|||
155284646|NCT01528709|560474374|FG000|Overall Study|allergy|1|||
155284647|NCT01528709|560474375|FG001|Overall Study|allergy|0|||
155284648|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
155284649|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
155284650|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
155284651|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
155284652|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
155284653|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
155284654|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
155284655|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
155284656|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
155284657|NCT01237678|560474376|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
155284658|NCT01237678|560474377|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
155284659|NCT01237678|560474378|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
155284660|NCT01237678|560474376|FG000|Phase II|Adverse Event|0|||
155284661|NCT01237678|560474377|FG001|Phase II|Adverse Event|39|||
155284662|NCT01237678|560474378|FG002|Phase II|Adverse Event|9|||
155284663|NCT01237678|560474376|FG000|Phase II|Death|0|||
155284664|NCT01237678|560474377|FG001|Phase II|Death|0|||
155284665|NCT01237678|560474378|FG002|Phase II|Death|2|||
155284666|NCT01237678|560474376|FG000|Phase II|Lack of Efficacy|0|||
155284667|NCT01237678|560474377|FG001|Phase II|Lack of Efficacy|25|||
155284668|NCT01237678|560474378|FG002|Phase II|Lack of Efficacy|3|||
155284669|NCT01237678|560474376|FG000|Phase II|Withdrawal by Subject|0|||
155284670|NCT01237678|560474377|FG001|Phase II|Withdrawal by Subject|1|||
155284671|NCT01237678|560474378|FG002|Phase II|Withdrawal by Subject|5|||
155399968|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
155399969|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
155399970|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
155399971|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
155399972|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
155399973|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
155399974|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
155399975|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
155399976|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
155399977|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
155399978|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
155399979|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
155399980|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
155399981|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
155399982|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
154953577|NCT02475954|559256310|FG001|Overall Study|Withdrawal by Subject|2|||
154953578|NCT02475954|559256309|FG000|Overall Study|Lost to Follow-up|11|||
154953579|NCT02475954|559256310|FG001|Overall Study|Lost to Follow-up|9|||
154953580|NCT02475954|559256309|FG000|Overall Study|Death|1|||
154953581|NCT02475954|559256310|FG001|Overall Study|Death|1|||
154953582|NCT01918397|559256312|FG000|Overall Study|Never started treatment|2|||
154953583|NCT01918397|559256313|FG001|Overall Study|Never started treatment|1|||
154953584|NCT01918397|559256314|FG002|Overall Study|Never started treatment|0|||
154953585|NCT01918397|559256315|FG003|Overall Study|Never started treatment|0|||
154953586|NCT01918397|559256312|FG000|Overall Study|Adverse Event|1|||
154953587|NCT01918397|559256313|FG001|Overall Study|Adverse Event|1|||
154953588|NCT01918397|559256314|FG002|Overall Study|Adverse Event|1|||
154953589|NCT01918397|559256315|FG003|Overall Study|Adverse Event|0|||
154953590|NCT01918397|559256312|FG000|Overall Study|Lack of compliance|2|||
154953591|NCT01918397|559256313|FG001|Overall Study|Lack of compliance|2|||
154953592|NCT01918397|559256314|FG002|Overall Study|Lack of compliance|3|||
154953593|NCT01918397|559256315|FG003|Overall Study|Lack of compliance|0|||
154953594|NCT01918397|559256312|FG000|Overall Study|Pregnancy|0|||
154953595|NCT01918397|559256313|FG001|Overall Study|Pregnancy|1|||
154953596|NCT01918397|559256314|FG002|Overall Study|Pregnancy|0|||
154953597|NCT01918397|559256315|FG003|Overall Study|Pregnancy|0|||
154953598|NCT01918397|559256312|FG000|Overall Study|Rifampin susceptible|0|||
154953599|NCT01918397|559256313|FG001|Overall Study|Rifampin susceptible|0|||
154953600|NCT01918397|559256314|FG002|Overall Study|Rifampin susceptible|0|||
154953601|NCT01918397|559256315|FG003|Overall Study|Rifampin susceptible|2|||
154953602|NCT01918397|559256312|FG000|Overall Study|Treatment failure|0|||
154953603|NCT01918397|559256313|FG001|Overall Study|Treatment failure|0|||
154953604|NCT01918397|559256314|FG002|Overall Study|Treatment failure|0|||
154953605|NCT01918397|559256315|FG003|Overall Study|Treatment failure|1|||
154953606|NCT01918397|559256312|FG000|Overall Study|Withdrawal by Subject|3|||
154953607|NCT01918397|559256313|FG001|Overall Study|Withdrawal by Subject|2|||
154953608|NCT01918397|559256314|FG002|Overall Study|Withdrawal by Subject|1|||
154953609|NCT01918397|559256315|FG003|Overall Study|Withdrawal by Subject|1|||
154953610|NCT01918397|559256312|FG000|Overall Study|XDR at baseline|0|||
154953611|NCT01918397|559256313|FG001|Overall Study|XDR at baseline|0|||
154953612|NCT01918397|559256314|FG002|Overall Study|XDR at baseline|1|||
154953613|NCT01918397|559256315|FG003|Overall Study|XDR at baseline|0|||
154953614|NCT01918397|559256312|FG000|Overall Study|Lost to Follow-up|2|||
154953615|NCT01918397|559256313|FG001|Overall Study|Lost to Follow-up|1|||
154953616|NCT01918397|559256314|FG002|Overall Study|Lost to Follow-up|1|||
154953617|NCT01918397|559256315|FG003|Overall Study|Lost to Follow-up|1|||
154953618|NCT01918397|559256312|FG000|Overall Study|Increased QTc|1|||
154953619|NCT01918397|559256313|FG001|Overall Study|Increased QTc|0|||
154953620|NCT01918397|559256314|FG002|Overall Study|Increased QTc|0|||
154953621|NCT01918397|559256315|FG003|Overall Study|Increased QTc|1|||
154953622|NCT01918397|559256312|FG000|Overall Study|Death|0|||
154953623|NCT01918397|559256313|FG001|Overall Study|Death|0|||
154953624|NCT01918397|559256314|FG002|Overall Study|Death|1|||
154953625|NCT01918397|559256315|FG003|Overall Study|Death|0|||
154953626|NCT01918397|559256312|FG000|Overall Study|Involved in another investigative trial|0|||
154953627|NCT01918397|559256313|FG001|Overall Study|Involved in another investigative trial|0|||
155057701|NCT02265510|559645795|FG013|Overall Study|Death|6|||
154953628|NCT01918397|559256314|FG002|Overall Study|Involved in another investigative trial|0|||
154953629|NCT01918397|559256315|FG003|Overall Study|Involved in another investigative trial|1|||
154953630|NCT01239121|559256319|FG000|Overall Study|Withdrawal by Subject|2|||
154953631|NCT01239121|559256320|FG001|Overall Study|Withdrawal by Subject|4|||
154953632|NCT01239121|559256321|FG002|Overall Study|Withdrawal by Subject|0|||
154953633|NCT01434693|559256325|FG000|Overall Study|Adverse Event|1|||
154953634|NCT01434693|559256326|FG001|Overall Study|Adverse Event|0|||
155057702|NCT02265510|559645782|FG000|Overall Study|Lost to Follow-up|0|||
155284672|NCT01237678|560474376|FG000|Phase II|Completed Cycles 4-6|0|||
155284673|NCT01237678|560474377|FG001|Phase II|Completed Cycles 4-6|11|||
155284674|NCT01237678|560474378|FG002|Phase II|Completed Cycles 4-6|21|||
155284675|NCT01237678|560474376|FG000|Phase II|Sponsor Decision/Study Closed|0|||
155284676|NCT01237678|560474377|FG001|Phase II|Sponsor Decision/Study Closed|18|||
155284677|NCT01237678|560474378|FG002|Phase II|Sponsor Decision/Study Closed|7|||
155284678|NCT01237678|560474376|FG000|Phase II|Randomized but were not treated|0|||
155284679|NCT01237678|560474377|FG001|Phase II|Randomized but were not treated|4|||
155284680|NCT01237678|560474378|FG002|Phase II|Randomized but were not treated|3|||
155284681|NCT03398356|560474379|FG000|Before Treatment|Lost to Follow-up|1|||
155284682|NCT03398356|560474380|FG001|Before Treatment|Lost to Follow-up|2|||
155284683|NCT03398356|560474381|FG002|Before Treatment|Lost to Follow-up|0|||
155284684|NCT03398356|560474379|FG000|Before Treatment|drug intolerance|2|||
155399983|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
155399984|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
155399985|NCT02752035|560899429|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
155399986|NCT02752035|560899430|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
155399987|NCT02752035|560899431|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
155399988|NCT02752035|560899432|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
155399989|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
155399990|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
155399991|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
155399992|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
155399993|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
155399994|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
155399995|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
155399996|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
155399997|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
155399998|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
155399999|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
155400000|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
155400001|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
155400002|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
155400003|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
155400004|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
155284685|NCT03398356|560474380|FG001|Before Treatment|drug intolerance|1|||
155284686|NCT03398356|560474381|FG002|Before Treatment|drug intolerance|0|||
155284687|NCT03398356|560474379|FG000|Before Treatment|Withdrawal by Subject|0|||
155284688|NCT03398356|560474380|FG001|Before Treatment|Withdrawal by Subject|5|||
155284689|NCT03398356|560474381|FG002|Before Treatment|Withdrawal by Subject|0|||
155284690|NCT03398356|560474379|FG000|Before Treatment|Physician Decision|0|||
155284691|NCT03398356|560474380|FG001|Before Treatment|Physician Decision|0|||
155284692|NCT03398356|560474381|FG002|Before Treatment|Physician Decision|11|||
155284693|NCT03398356|560474379|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
155284694|NCT03398356|560474380|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
155284695|NCT03398356|560474381|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
155284696|NCT01982760|560474382|FG000|Overall Study|Physician Decision|1|||
155284697|NCT01982760|560474383|FG001|Overall Study|Physician Decision|0|||
155284698|NCT00282438|560474384|FG000|Overall Study|Lack of Efficacy|1|||
155284699|NCT00282438|560474385|FG001|Overall Study|Lack of Efficacy|0|||
155284700|NCT00282438|560474384|FG000|Overall Study|Death|0|||
155284701|NCT00282438|560474385|FG001|Overall Study|Death|1|||
155284702|NCT02397889|560474386|FG000|Overall Study|Physician Decision|1|||
155284703|NCT02397889|560474387|FG001|Overall Study|Physician Decision|0|||
155284704|NCT02954055|560474392|FG000|Overall Study|Did not initiate therapy|6|||
155284705|NCT02954055|560474393|FG001|Overall Study|Did not initiate therapy|1|||
155284706|NCT01119703|560474398|FG000|Overall Study|Adverse Event|0|||
155284707|NCT01119703|560474399|FG001|Overall Study|Adverse Event|1|||
155284708|NCT01511250|560474400|FG000|Overall Study|Withdrawal of Consent|1|||
155284709|NCT01511250|560474401|FG001|Overall Study|Withdrawal of Consent|0|||
155284710|NCT01511250|560474402|FG002|Overall Study|Withdrawal of Consent|0|||
155284711|NCT01511250|560474403|FG003|Overall Study|Withdrawal of Consent|0|||
155400005|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
155284712|NCT01511250|560474404|FG004|Overall Study|Withdrawal of Consent|0|||
155284713|NCT01511250|560474405|FG005|Overall Study|Withdrawal of Consent|0|||
155284714|NCT01511250|560474406|FG006|Overall Study|Withdrawal of Consent|0|||
155284715|NCT01511250|560474407|FG007|Overall Study|Withdrawal of Consent|1|||
155284716|NCT01511250|560474408|FG008|Overall Study|Withdrawal of Consent|1|||
155284717|NCT01511250|560474409|FG009|Overall Study|Withdrawal of Consent|0|||
155284718|NCT01511250|560474400|FG000|Overall Study|Sponsor/Investigator Decision|1|||
155284719|NCT01511250|560474401|FG001|Overall Study|Sponsor/Investigator Decision|0|||
155284720|NCT01511250|560474402|FG002|Overall Study|Sponsor/Investigator Decision|0|||
155154406|NCT00106704|560002284|FG001|Overall Study|Patient Received Glycemic Medication|41|||
155400006|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
155400007|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
155400008|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
155400009|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Death|0|||
155400010|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Death|25|||
155400011|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Death|13|||
155400012|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Death|4|||
155400013|NCT02752035|560899429|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
155400014|NCT02752035|560899430|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
155400015|NCT02752035|560899431|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
155400016|NCT02752035|560899432|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
155400017|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
155400018|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
155400019|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
155400020|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
155400021|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
154953635|NCT01434693|559256327|FG002|Overall Study|Adverse Event|0|||
154953636|NCT01434693|559256328|FG003|Overall Study|Adverse Event|0|||
154953637|NCT01434693|559256325|FG000|Overall Study|Withdrawal by Subject|1|||
154953638|NCT01434693|559256326|FG001|Overall Study|Withdrawal by Subject|0|||
154953639|NCT01434693|559256327|FG002|Overall Study|Withdrawal by Subject|1|||
154953640|NCT01434693|559256328|FG003|Overall Study|Withdrawal by Subject|1|||
154953641|NCT01434693|559256325|FG000|Overall Study|Lost to Follow-up|1|||
154953642|NCT01434693|559256326|FG001|Overall Study|Lost to Follow-up|0|||
154953643|NCT01434693|559256327|FG002|Overall Study|Lost to Follow-up|0|||
154953644|NCT01434693|559256328|FG003|Overall Study|Lost to Follow-up|0|||
154953645|NCT04006171|559256329|FG000|Overall Study|Withdrawal by Subject|8|||
154953646|NCT04006171|559256330|FG001|Overall Study|Withdrawal by Subject|7|||
154953647|NCT04006171|559256329|FG000|Overall Study|missing serum samples|2|||
154953648|NCT04006171|559256330|FG001|Overall Study|missing serum samples|2|||
154953649|NCT04006171|559256329|FG000|Overall Study|insufficient sample volume|2|||
154953650|NCT04006171|559256330|FG001|Overall Study|insufficient sample volume|3|||
154953651|NCT00912288|559256331|FG000|Overall Study|Death|0|||
154953652|NCT00912288|559256332|FG001|Overall Study|Death|1|||
154953653|NCT00912288|559256331|FG000|Overall Study|Adverse Event|1|||
154953654|NCT00912288|559256332|FG001|Overall Study|Adverse Event|1|||
154953655|NCT00912288|559256331|FG000|Overall Study|Lost to Follow-up|1|||
154953656|NCT00912288|559256332|FG001|Overall Study|Lost to Follow-up|0|||
154953657|NCT00912288|559256331|FG000|Overall Study|Protocol Violation|1|||
154953658|NCT00912288|559256332|FG001|Overall Study|Protocol Violation|0|||
154953659|NCT00912288|559256331|FG000|Overall Study|Withdrawal by Subject|3|||
154953660|NCT00912288|559256332|FG001|Overall Study|Withdrawal by Subject|3|||
154953661|NCT00912288|559256331|FG000|Overall Study|Study terminated by sponsor|34|||
154953662|NCT00912288|559256332|FG001|Overall Study|Study terminated by sponsor|35|||
154953663|NCT00912288|559256331|FG000|Overall Study|Other|1|||
154953664|NCT00912288|559256332|FG001|Overall Study|Other|0|||
154953665|NCT02087904|559256335|FG000|Overall Study|Did Not Receive Study Drug|0|||
154953666|NCT02087904|559256336|FG001|Overall Study|Did Not Receive Study Drug|0|||
154953667|NCT02087904|559256337|FG002|Overall Study|Did Not Receive Study Drug|2|||
154953668|NCT02087904|559256338|FG003|Overall Study|Did Not Receive Study Drug|1|||
154953669|NCT02087904|559256335|FG000|Overall Study|Adverse Event|8|||
154953670|NCT02087904|559256336|FG001|Overall Study|Adverse Event|4|||
154953671|NCT02087904|559256337|FG002|Overall Study|Adverse Event|4|||
154953672|NCT02087904|559256338|FG003|Overall Study|Adverse Event|12|||
154953673|NCT02087904|559256335|FG000|Overall Study|Lack of Efficacy|3|||
154953674|NCT02087904|559256336|FG001|Overall Study|Lack of Efficacy|6|||
154953675|NCT02087904|559256337|FG002|Overall Study|Lack of Efficacy|3|||
154953676|NCT02087904|559256338|FG003|Overall Study|Lack of Efficacy|2|||
154953677|NCT02087904|559256335|FG000|Overall Study|Other|6|||
154953678|NCT02087904|559256336|FG001|Overall Study|Other|2|||
154953679|NCT02087904|559256337|FG002|Overall Study|Other|4|||
154953680|NCT02087904|559256338|FG003|Overall Study|Other|4|||
154953681|NCT02087904|559256335|FG000|Overall Study|Withdrawal by Subject|8|||
154953682|NCT02087904|559256336|FG001|Overall Study|Withdrawal by Subject|3|||
154953683|NCT02087904|559256337|FG002|Overall Study|Withdrawal by Subject|7|||
154953684|NCT02087904|559256338|FG003|Overall Study|Withdrawal by Subject|4|||
154953685|NCT02087904|559256335|FG000|Overall Study|Lost to Follow-up|0|||
154953686|NCT02087904|559256336|FG001|Overall Study|Lost to Follow-up|4|||
154953687|NCT02087904|559256337|FG002|Overall Study|Lost to Follow-up|2|||
154953688|NCT02087904|559256338|FG003|Overall Study|Lost to Follow-up|2|||
154953689|NCT02178722|559256339|FG000|Overall Study|Withdrawal by Subject|0|||
154953690|NCT02178722|559256340|FG001|Overall Study|Withdrawal by Subject|0|||
154953691|NCT02178722|559256341|FG002|Overall Study|Withdrawal by Subject|0|||
154953692|NCT02178722|559256342|FG003|Overall Study|Withdrawal by Subject|2|||
155057703|NCT02265510|559645783|FG001|Overall Study|Lost to Follow-up|0|||
154953693|NCT02178722|559256343|FG004|Overall Study|Withdrawal by Subject|33|||
154953694|NCT02178722|559256339|FG000|Overall Study|Death|2|||
154953695|NCT02178722|559256340|FG001|Overall Study|Death|13|||
154953696|NCT02178722|559256341|FG002|Overall Study|Death|12|||
155400022|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
155400023|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
155400024|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
155400025|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
155400026|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
155400027|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
155400028|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
155400029|NCT02752035|560899429|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
155400030|NCT02752035|560899430|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
155400031|NCT02752035|560899431|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
155400032|NCT02752035|560899432|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
155400033|NCT00971178|560899443|FG000|Overall Study|Lost to Follow-up|2|||
155400034|NCT00971178|560899444|FG001|Overall Study|Lost to Follow-up|2|||
155400035|NCT00971178|560899445|FG002|Overall Study|Lost to Follow-up|2|||
155400036|NCT02161575|560899446|FG000|Overall Study|Protocol Violation|8|||
155400037|NCT02161575|560899446|FG000|Overall Study|Lack of Efficacy|1|||
155400038|NCT02161575|560899446|FG000|Overall Study|Adverse Event|2|||
155400039|NCT00326209|560899447|FG000|Overall Study|Adverse Event|28|||
155400040|NCT00326209|560899447|FG000|Overall Study|Withdrawal by Subject|22|||
155400041|NCT00326209|560899447|FG000|Overall Study|Lack of Efficacy|31|||
155400042|NCT00326209|560899447|FG000|Overall Study|Lost to Follow-up|18|||
155400043|NCT00326209|560899447|FG000|Overall Study|Participant non-compliant|6|||
155400044|NCT00326209|560899447|FG000|Overall Study|Sponsor closed study|173|||
155400045|NCT00326209|560899447|FG000|Overall Study|Prohibited medication use|1|||
155400046|NCT00326209|560899447|FG000|Overall Study|Violation of entry criteria|1|||
155400047|NCT00326209|560899447|FG000|Overall Study|Withdrawn in error|1|||
155400048|NCT00326209|560899447|FG000|Overall Study|Pregnancy|1|||
155400049|NCT00714285|560899448|FG000|Overall Study|Lost to Follow-up|0|||
155400050|NCT00714285|560899449|FG001|Overall Study|Lost to Follow-up|2|||
155400051|NCT00714285|560899450|FG002|Overall Study|Lost to Follow-up|0|||
155400052|NCT00714285|560899451|FG003|Overall Study|Lost to Follow-up|1|||
155400053|NCT00714285|560899448|FG000|Overall Study|Migrated/moved from study area|0|||
155154407|NCT00106704|560002283|FG000|Overall Study|Unable to re-enter US|1|||
155154408|NCT00106704|560002284|FG001|Overall Study|Unable to re-enter US|0|||
155400054|NCT00714285|560899449|FG001|Overall Study|Migrated/moved from study area|1|||
155284721|NCT01511250|560474403|FG003|Overall Study|Sponsor/Investigator Decision|0|||
155284722|NCT01511250|560474404|FG004|Overall Study|Sponsor/Investigator Decision|0|||
155284723|NCT01511250|560474405|FG005|Overall Study|Sponsor/Investigator Decision|0|||
155284724|NCT01511250|560474406|FG006|Overall Study|Sponsor/Investigator Decision|0|||
155284725|NCT01511250|560474407|FG007|Overall Study|Sponsor/Investigator Decision|0|||
155284726|NCT01511250|560474408|FG008|Overall Study|Sponsor/Investigator Decision|0|||
155284727|NCT01511250|560474409|FG009|Overall Study|Sponsor/Investigator Decision|0|||
155284728|NCT01511250|560474400|FG000|Overall Study|Lost to Follow-up|7|||
155284729|NCT01511250|560474401|FG001|Overall Study|Lost to Follow-up|3|||
155284730|NCT01511250|560474402|FG002|Overall Study|Lost to Follow-up|3|||
155284731|NCT01511250|560474403|FG003|Overall Study|Lost to Follow-up|3|||
155284732|NCT01511250|560474404|FG004|Overall Study|Lost to Follow-up|0|||
155284733|NCT01511250|560474405|FG005|Overall Study|Lost to Follow-up|0|||
155284734|NCT01511250|560474406|FG006|Overall Study|Lost to Follow-up|2|||
155284735|NCT01511250|560474407|FG007|Overall Study|Lost to Follow-up|3|||
155284736|NCT01511250|560474408|FG008|Overall Study|Lost to Follow-up|13|||
155284737|NCT01511250|560474409|FG009|Overall Study|Lost to Follow-up|5|||
155284738|NCT01511250|560474400|FG000|Overall Study|Protocol Violation|0|||
155284739|NCT01511250|560474401|FG001|Overall Study|Protocol Violation|2|||
155284740|NCT01511250|560474402|FG002|Overall Study|Protocol Violation|1|||
155284741|NCT01511250|560474403|FG003|Overall Study|Protocol Violation|0|||
155284742|NCT01511250|560474404|FG004|Overall Study|Protocol Violation|0|||
155284743|NCT01511250|560474405|FG005|Overall Study|Protocol Violation|0|||
155284744|NCT01511250|560474406|FG006|Overall Study|Protocol Violation|0|||
155284745|NCT01511250|560474407|FG007|Overall Study|Protocol Violation|0|||
155284746|NCT01511250|560474408|FG008|Overall Study|Protocol Violation|0|||
155284747|NCT01511250|560474409|FG009|Overall Study|Protocol Violation|0|||
155284748|NCT01763047|560474410|FG000|Period 1|Test Article Not Available|4|||
154953697|NCT02178722|559256342|FG003|Overall Study|Death|12|||
154953698|NCT02178722|559256343|FG004|Overall Study|Death|205|||
154953699|NCT02178722|559256339|FG000|Overall Study|Lost to Follow-up|0|||
154953700|NCT02178722|559256340|FG001|Overall Study|Lost to Follow-up|0|||
154953701|NCT02178722|559256341|FG002|Overall Study|Lost to Follow-up|0|||
154953702|NCT02178722|559256342|FG003|Overall Study|Lost to Follow-up|2|||
154953703|NCT02178722|559256343|FG004|Overall Study|Lost to Follow-up|11|||
154953704|NCT02178722|559256339|FG000|Overall Study|Study terminated by Sponsor|2|||
154953705|NCT02178722|559256340|FG001|Overall Study|Study terminated by Sponsor|7|||
154953706|NCT02178722|559256341|FG002|Overall Study|Study terminated by Sponsor|6|||
154953707|NCT02178722|559256342|FG003|Overall Study|Study terminated by Sponsor|4|||
154953708|NCT02178722|559256343|FG004|Overall Study|Study terminated by Sponsor|128|||
154953709|NCT02178722|559256339|FG000|Overall Study|Physician Decision|0|||
154953710|NCT02178722|559256340|FG001|Overall Study|Physician Decision|0|||
154953711|NCT02178722|559256341|FG002|Overall Study|Physician Decision|0|||
154953712|NCT02178722|559256342|FG003|Overall Study|Physician Decision|0|||
154953713|NCT02178722|559256343|FG004|Overall Study|Physician Decision|3|||
154953714|NCT02178722|559256339|FG000|Overall Study|Other|0|||
154953715|NCT02178722|559256340|FG001|Overall Study|Other|0|||
154953716|NCT02178722|559256341|FG002|Overall Study|Other|0|||
154953717|NCT02178722|559256342|FG003|Overall Study|Other|0|||
154953718|NCT02178722|559256343|FG004|Overall Study|Other|2|||
154953719|NCT03752528|559256344|FG000|Part A|Lost to Follow-up|1|||
154953720|NCT03752528|559256344|FG000|Part A|Protocol Violation|1|||
154953721|NCT03752528|559256344|FG000|Part B|Protocol Violation|1|||
154953722|NCT03752528|559256344|FG000|Part B|Study terminated by sponsor|3|||
154953723|NCT01044732|559256351|FG000|Overall Study|Lost to Follow-up|2|||
154953724|NCT01044732|559256352|FG001|Overall Study|Lost to Follow-up|1|||
154953725|NCT01044732|559256351|FG000|Overall Study|Physician Decision|5|||
154953726|NCT01044732|559256352|FG001|Overall Study|Physician Decision|3|||
154953727|NCT01044732|559256351|FG000|Overall Study|Protocol Violation|11|||
154953728|NCT01044732|559256352|FG001|Overall Study|Protocol Violation|12|||
154953729|NCT01044732|559256351|FG000|Overall Study|Withdrawal by Subject|0|||
154953730|NCT01044732|559256352|FG001|Overall Study|Withdrawal by Subject|1|||
154953731|NCT01044732|559256351|FG000|Overall Study|Inadequate bowel preparation|11|||
154953732|NCT01044732|559256352|FG001|Overall Study|Inadequate bowel preparation|17|||
154953733|NCT01044732|559256351|FG000|Overall Study|Inability to reach cecum|5|||
154953734|NCT01044732|559256352|FG001|Overall Study|Inability to reach cecum|2|||
154953735|NCT01044732|559256351|FG000|Overall Study|Technical error or malfunction|15|||
154953736|NCT01044732|559256352|FG001|Overall Study|Technical error or malfunction|14|||
154953737|NCT03991494|559256357|FG000|Overall Study|Progressive Disease|4|||
154953738|NCT02507375|559256362|FG000|Overall Study|Progressive Disease|4|||
154953739|NCT02507375|559256363|FG001|Overall Study|Progressive Disease|5|||
154953740|NCT02507375|559256362|FG000|Overall Study|Death|0|||
154953741|NCT02507375|559256363|FG001|Overall Study|Death|1|||
154953742|NCT02507375|559256362|FG000|Overall Study|Refused treatment|0|||
154953743|NCT02507375|559256363|FG001|Overall Study|Refused treatment|1|||
154953744|NCT02507375|559256362|FG000|Overall Study|Adverse Event|0|||
154953745|NCT02507375|559256363|FG001|Overall Study|Adverse Event|1|||
154953746|NCT01432171|559256364|FG000|Overall Study|Death|1|||
155284749|NCT01763047|560474411|FG001|Period 1|Test Article Not Available|1|||
155284750|NCT01763047|560474410|FG000|Period 1|Protocol Violation|4|||
155284751|NCT01763047|560474411|FG001|Period 1|Protocol Violation|4|||
155284752|NCT01763047|560474410|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
155284753|NCT01763047|560474411|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
155284754|NCT01763047|560474410|FG000|Period 1|Adverse Event|0|||
155284755|NCT01763047|560474411|FG001|Period 1|Adverse Event|1|||
155284756|NCT01763047|560474410|FG000|Period 1|Unsatisfactory Visual Response|0|||
155284757|NCT01763047|560474411|FG001|Period 1|Unsatisfactory Visual Response|3|||
155284758|NCT01763047|560474410|FG000|Period 1|Lens Power Not Available|0|||
155284759|NCT01763047|560474411|FG001|Period 1|Lens Power Not Available|1|||
155284760|NCT01763047|560474410|FG000|Period 1|Study Site office Closed|0|||
155284761|NCT01763047|560474411|FG001|Period 1|Study Site office Closed|1|||
155284762|NCT01763047|560474410|FG000|Period 2|Lens Discomfort|1|||
155284763|NCT01763047|560474411|FG001|Period 2|Lens Discomfort|0|||
155284764|NCT01763047|560474410|FG000|Period 2|No longer meets Eligibility Criteria|1|||
155284765|NCT01763047|560474411|FG001|Period 2|No longer meets Eligibility Criteria|0|||
155284766|NCT01763047|560474410|FG000|Period 2|Study Site office Closed|1|||
155284767|NCT01763047|560474411|FG001|Period 2|Study Site office Closed|1|||
155284768|NCT01763047|560474410|FG000|Period 2|Unsatisfactory Visual Response|1|||
155284769|NCT01763047|560474411|FG001|Period 2|Unsatisfactory Visual Response|1|||
155284770|NCT01763047|560474410|FG000|Period 2|Protocol Violation|0|||
155284771|NCT01763047|560474411|FG001|Period 2|Protocol Violation|2|||
155284772|NCT01763047|560474410|FG000|Period 2|Unsatisfactory lens Fitting|0|||
155284773|NCT01763047|560474411|FG001|Period 2|Unsatisfactory lens Fitting|1|||
155400055|NCT00714285|560899450|FG002|Overall Study|Migrated/moved from study area|0|||
155400056|NCT00714285|560899451|FG003|Overall Study|Migrated/moved from study area|0|||
155400057|NCT01131676|560899456|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
155400058|NCT01131676|560899457|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
155400059|NCT01131676|560899458|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
155400060|NCT01131676|560899456|FG000|Discontinuation From Treatment|Not treated|4|||
155400061|NCT01131676|560899457|FG001|Discontinuation From Treatment|Not treated|2|||
155400062|NCT01131676|560899458|FG002|Discontinuation From Treatment|Not treated|2|||
154953747|NCT01432171|559256365|FG001|Overall Study|Death|2|||
154953748|NCT01432171|559256364|FG000|Overall Study|Lost to Follow-up|6|||
154953749|NCT01432171|559256365|FG001|Overall Study|Lost to Follow-up|5|||
154953750|NCT01432171|559256364|FG000|Overall Study|Withdrawal by Subject|3|||
154953751|NCT01432171|559256365|FG001|Overall Study|Withdrawal by Subject|1|||
154953752|NCT01432171|559256364|FG000|Overall Study|Noncompliance|2|||
154953753|NCT01432171|559256365|FG001|Overall Study|Noncompliance|3|||
154953754|NCT01432171|559256364|FG000|Overall Study|Insurance denial trial coverage|1|||
154953755|NCT01432171|559256365|FG001|Overall Study|Insurance denial trial coverage|0|||
154953756|NCT01432171|559256364|FG000|Overall Study|Patient moved to palliative care|1|||
154953757|NCT01432171|559256365|FG001|Overall Study|Patient moved to palliative care|0|||
154953758|NCT01706926|559256366|FG000|Overall Study|Lost to Follow-up|0|||
154953759|NCT01706926|559256367|FG001|Overall Study|Lost to Follow-up|0|||
154953760|NCT01706926|559256368|FG002|Overall Study|Lost to Follow-up|1|||
154953761|NCT01706926|559256369|FG003|Overall Study|Lost to Follow-up|0|||
154953762|NCT01706926|559256366|FG000|Overall Study|Withdrawal by Subject|2|||
154953763|NCT01706926|559256367|FG001|Overall Study|Withdrawal by Subject|0|||
154953764|NCT01706926|559256368|FG002|Overall Study|Withdrawal by Subject|1|||
154953765|NCT01706926|559256369|FG003|Overall Study|Withdrawal by Subject|2|||
154953766|NCT01706926|559256366|FG000|Overall Study|Other|4|||
154953767|NCT01706926|559256367|FG001|Overall Study|Other|4|||
154953768|NCT01706926|559256368|FG002|Overall Study|Other|4|||
154953769|NCT01706926|559256369|FG003|Overall Study|Other|3|||
154953770|NCT00397488|559257346|FG000|Overall Study|Withdrawal by Subject|3|||
154953771|NCT00397488|559257346|FG000|Overall Study|Adverse Event|3|||
154953772|NCT00397488|559257346|FG000|Overall Study|Death|1|||
154953773|NCT02943447|559257348|FG000|Blinded Study Phase|Withdrew Consent|1|||
154953774|NCT02943447|559257349|FG001|Blinded Study Phase|Withdrew Consent|2|||
154953775|NCT02943447|559257350|FG002|Blinded Study Phase|Withdrew Consent|1|||
154953776|NCT02943447|559257348|FG000|Blinded Study Phase|Adverse Event|3|||
154953777|NCT02943447|559257349|FG001|Blinded Study Phase|Adverse Event|0|||
154953778|NCT02943447|559257350|FG002|Blinded Study Phase|Adverse Event|0|||
154953779|NCT02943447|559257348|FG000|Blinded Study Phase|Investigator's discretion|1|||
154953780|NCT02943447|559257349|FG001|Blinded Study Phase|Investigator's discretion|0|||
154953781|NCT02943447|559257350|FG002|Blinded Study Phase|Investigator's discretion|0|||
155284774|NCT01941316|560474417|FG000|Overall Study|Adverse Event|0|||
155284775|NCT01941316|560474418|FG001|Overall Study|Adverse Event|1|||
155284776|NCT01941316|560474419|FG002|Overall Study|Adverse Event|0|||
155284777|NCT01941316|560474420|FG003|Overall Study|Adverse Event|7|||
154953782|NCT02943447|559257348|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
154953783|NCT02943447|559257349|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
154953784|NCT02943447|559257350|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
154953785|NCT02943447|559257348|FG000|Open-Label Extension Phase|Adverse Event|4|||
155400063|NCT01131676|560899456|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
155400064|NCT01131676|560899457|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
155400065|NCT01131676|560899458|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
155400066|NCT01131676|560899456|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
155400067|NCT01131676|560899457|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
155400068|NCT01131676|560899458|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
155400069|NCT01131676|560899456|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
155400070|NCT01131676|560899457|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
155400071|NCT01131676|560899458|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
155400072|NCT01131676|560899456|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
155400073|NCT01131676|560899457|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
155400074|NCT01131676|560899458|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
155400075|NCT01131676|560899456|FG000|Discontinuation From Treatment|Other than those specified|162|||
155400076|NCT01131676|560899457|FG001|Discontinuation From Treatment|Other than those specified|142|||
155400077|NCT01131676|560899458|FG002|Discontinuation From Treatment|Other than those specified|125|||
155400078|NCT01131676|560899456|FG000|Discontinuation From Treatment|Adverse Event|303|||
155400079|NCT01131676|560899457|FG001|Discontinuation From Treatment|Adverse Event|267|||
155400080|NCT01131676|560899458|FG002|Discontinuation From Treatment|Adverse Event|273|||
155400081|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
155400082|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
155400083|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
155400084|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
155400085|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
155400086|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
155400087|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
155400088|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
155400089|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
155400090|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
155400091|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
155400092|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
155400093|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
155400094|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
155400095|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
155400096|NCT01131676|560899456|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
155400097|NCT01131676|560899457|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
155400098|NCT01131676|560899458|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
155400099|NCT01111851|560899459|FG000|Overall Study|All planned PET scans were not obtained.|2|||
155400100|NCT01111851|560899460|FG001|Overall Study|All planned PET scans were not obtained.|0|||
155400101|NCT01961349|560899461|FG000|Overall Study|Withdrawal by Subject|1|||
155400102|NCT01961349|560899462|FG001|Overall Study|Withdrawal by Subject|4|||
155400103|NCT01961349|560899463|FG002|Overall Study|Withdrawal by Subject|0|||
155400104|NCT01961349|560899461|FG000|Overall Study|Adverse Event|0|||
155400105|NCT01961349|560899462|FG001|Overall Study|Adverse Event|0|||
155400106|NCT01961349|560899463|FG002|Overall Study|Adverse Event|1|||
155400107|NCT01961349|560899461|FG000|Overall Study|registration error, personal reason etc|2|||
155400108|NCT01961349|560899462|FG001|Overall Study|registration error, personal reason etc|2|||
155400109|NCT01961349|560899463|FG002|Overall Study|registration error, personal reason etc|1|||
155400110|NCT05525689|560899465|FG000|Overall Study|Lost to Follow-up|1|||
154953786|NCT02943447|559257349|FG001|Open-Label Extension Phase|Adverse Event|7|||
154953787|NCT02943447|559257350|FG002|Open-Label Extension Phase|Adverse Event|3|||
154953788|NCT02943447|559257348|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
154953789|NCT02943447|559257349|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
154953790|NCT02943447|559257350|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
154953791|NCT02943447|559257348|FG000|Open-Label Extension Phase|Withdrew consent|1|||
154953792|NCT02943447|559257349|FG001|Open-Label Extension Phase|Withdrew consent|1|||
154953793|NCT02943447|559257350|FG002|Open-Label Extension Phase|Withdrew consent|1|||
154953794|NCT02943447|559257348|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
154953795|NCT02943447|559257349|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
154953796|NCT02943447|559257350|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
154953797|NCT05017480|559257356|FG000|Stage 1 Study|Withdrawal by Subject|8|||
154953798|NCT05017480|559257357|FG001|Stage 1 Study|Withdrawal by Subject|6|||
154953799|NCT05017480|559257358|FG002|Stage 1 Study|Withdrawal by Subject|0|||
154953800|NCT05017480|559257359|FG003|Stage 1 Study|Withdrawal by Subject|0|||
155154409|NCT00106704|560002283|FG000|Overall Study|Laboratory test|1|||
155154410|NCT00106704|560002284|FG001|Overall Study|Laboratory test|1|||
155154411|NCT05236270|560002287|FG000|Overall Study|Lost to Follow-up|3|||
155400111|NCT05525689|560899466|FG001|Overall Study|Lost to Follow-up|0|||
155400112|NCT01075412|560899475|FG000|Overall Study|Withdrawal by Subject|0|||
155400113|NCT01075412|560899476|FG001|Overall Study|Withdrawal by Subject|1|||
155400114|NCT01854645|560899483|FG000|Overall Study|Protocol-Specified Criteria|13|||
155400115|NCT01854645|560899484|FG001|Overall Study|Protocol-Specified Criteria|10|||
155400116|NCT01854645|560899485|FG002|Overall Study|Protocol-Specified Criteria|8|||
155400117|NCT01854645|560899486|FG003|Overall Study|Protocol-Specified Criteria|5|||
155400118|NCT01854645|560899487|FG004|Overall Study|Protocol-Specified Criteria|7|||
155400119|NCT01854645|560899483|FG000|Overall Study|Administrative Reasons / Missing|0|||
155400120|NCT01854645|560899484|FG001|Overall Study|Administrative Reasons / Missing|0|||
155400121|NCT01854645|560899485|FG002|Overall Study|Administrative Reasons / Missing|0|||
155400122|NCT01854645|560899486|FG003|Overall Study|Administrative Reasons / Missing|1|||
155400123|NCT01854645|560899487|FG004|Overall Study|Administrative Reasons / Missing|1|||
155400124|NCT01854645|560899483|FG000|Overall Study|Protocol Violation|3|||
155400125|NCT01854645|560899484|FG001|Overall Study|Protocol Violation|0|||
155400126|NCT01854645|560899485|FG002|Overall Study|Protocol Violation|5|||
155400127|NCT01854645|560899486|FG003|Overall Study|Protocol Violation|4|||
155400128|NCT01854645|560899487|FG004|Overall Study|Protocol Violation|1|||
155400129|NCT01854645|560899483|FG000|Overall Study|Lost to Follow-up|10|||
155400130|NCT01854645|560899484|FG001|Overall Study|Lost to Follow-up|7|||
155400131|NCT01854645|560899485|FG002|Overall Study|Lost to Follow-up|8|||
155400132|NCT01854645|560899486|FG003|Overall Study|Lost to Follow-up|5|||
155400133|NCT01854645|560899487|FG004|Overall Study|Lost to Follow-up|0|||
155400134|NCT01854645|560899483|FG000|Overall Study|Physician Decision|1|||
155400135|NCT01854645|560899484|FG001|Overall Study|Physician Decision|5|||
155400136|NCT01854645|560899485|FG002|Overall Study|Physician Decision|3|||
155400137|NCT01854645|560899486|FG003|Overall Study|Physician Decision|3|||
155400138|NCT01854645|560899487|FG004|Overall Study|Physician Decision|7|||
155400139|NCT01854645|560899483|FG000|Overall Study|Withdrawal by Subject|31|||
155400140|NCT01854645|560899484|FG001|Overall Study|Withdrawal by Subject|41|||
155400141|NCT01854645|560899485|FG002|Overall Study|Withdrawal by Subject|30|||
155400142|NCT01854645|560899486|FG003|Overall Study|Withdrawal by Subject|21|||
155400143|NCT01854645|560899487|FG004|Overall Study|Withdrawal by Subject|24|||
155400144|NCT01854645|560899483|FG000|Overall Study|Lack of Efficacy|7|||
155400145|NCT01854645|560899484|FG001|Overall Study|Lack of Efficacy|12|||
155057704|NCT02265510|559645784|FG002|Overall Study|Lost to Follow-up|0|||
155400146|NCT01854645|560899485|FG002|Overall Study|Lack of Efficacy|9|||
155400147|NCT01854645|560899486|FG003|Overall Study|Lack of Efficacy|3|||
155400148|NCT01854645|560899487|FG004|Overall Study|Lack of Efficacy|9|||
155400149|NCT01854645|560899483|FG000|Overall Study|Adverse Event|33|||
155400150|NCT01854645|560899484|FG001|Overall Study|Adverse Event|31|||
155400151|NCT01854645|560899485|FG002|Overall Study|Adverse Event|19|||
155400152|NCT01854645|560899486|FG003|Overall Study|Adverse Event|20|||
155400153|NCT01854645|560899487|FG004|Overall Study|Adverse Event|11|||
155400154|NCT01817751|560899493|FG000|Overall Study|Physician Decision|1|||
155400155|NCT00555477|560899494|FG000|Overall Study|Adverse Event|0|||
154953801|NCT05017480|559257360|FG004|Stage 1 Study|Withdrawal by Subject|0|||
154953802|NCT05017480|559257356|FG000|Stage 1 Study|Adverse Event|1|||
154953803|NCT05017480|559257357|FG001|Stage 1 Study|Adverse Event|1|||
154953804|NCT05017480|559257358|FG002|Stage 1 Study|Adverse Event|0|||
154953805|NCT05017480|559257359|FG003|Stage 1 Study|Adverse Event|0|||
154953806|NCT05017480|559257360|FG004|Stage 1 Study|Adverse Event|0|||
154953807|NCT05017480|559257356|FG000|Stage 1 Study|Poor Compliance|1|||
154953808|NCT05017480|559257357|FG001|Stage 1 Study|Poor Compliance|1|||
154953809|NCT05017480|559257358|FG002|Stage 1 Study|Poor Compliance|0|||
154953810|NCT05017480|559257359|FG003|Stage 1 Study|Poor Compliance|0|||
154953811|NCT05017480|559257360|FG004|Stage 1 Study|Poor Compliance|0|||
154953812|NCT05017480|559257356|FG000|Stage 1 Study|Physician Decision|0|||
154953813|NCT05017480|559257357|FG001|Stage 1 Study|Physician Decision|1|||
154953814|NCT05017480|559257358|FG002|Stage 1 Study|Physician Decision|0|||
154953815|NCT05017480|559257359|FG003|Stage 1 Study|Physician Decision|0|||
154953816|NCT05017480|559257360|FG004|Stage 1 Study|Physician Decision|0|||
154953817|NCT05017480|559257356|FG000|Stage 2 Study|Withdrawal by Subject|0|||
154953818|NCT05017480|559257357|FG001|Stage 2 Study|Withdrawal by Subject|0|||
154953819|NCT05017480|559257358|FG002|Stage 2 Study|Withdrawal by Subject|6|||
154953820|NCT05017480|559257359|FG003|Stage 2 Study|Withdrawal by Subject|9|||
154953821|NCT05017480|559257360|FG004|Stage 2 Study|Withdrawal by Subject|11|||
154953822|NCT05017480|559257356|FG000|Stage 2 Study|Lost to Follow-up|0|||
154953823|NCT05017480|559257357|FG001|Stage 2 Study|Lost to Follow-up|0|||
154953824|NCT05017480|559257358|FG002|Stage 2 Study|Lost to Follow-up|0|||
154953825|NCT05017480|559257359|FG003|Stage 2 Study|Lost to Follow-up|2|||
154953826|NCT05017480|559257360|FG004|Stage 2 Study|Lost to Follow-up|1|||
154953827|NCT05017480|559257356|FG000|Stage 2 Study|Adverse Event|0|||
154953828|NCT05017480|559257357|FG001|Stage 2 Study|Adverse Event|0|||
154953829|NCT05017480|559257358|FG002|Stage 2 Study|Adverse Event|0|||
154953830|NCT05017480|559257359|FG003|Stage 2 Study|Adverse Event|1|||
154953831|NCT05017480|559257360|FG004|Stage 2 Study|Adverse Event|0|||
154953832|NCT05017480|559257356|FG000|Stage 2 Study|COVID-19|0|||
154953833|NCT05017480|559257357|FG001|Stage 2 Study|COVID-19|0|||
154953834|NCT05017480|559257358|FG002|Stage 2 Study|COVID-19|0|||
154953835|NCT05017480|559257359|FG003|Stage 2 Study|COVID-19|1|||
154953836|NCT05017480|559257360|FG004|Stage 2 Study|COVID-19|0|||
154953837|NCT05017480|559257356|FG000|Stage 2 Study|Pregnancy|0|||
154953838|NCT05017480|559257357|FG001|Stage 2 Study|Pregnancy|0|||
154953839|NCT05017480|559257358|FG002|Stage 2 Study|Pregnancy|0|||
154953840|NCT05017480|559257359|FG003|Stage 2 Study|Pregnancy|0|||
154953841|NCT05017480|559257360|FG004|Stage 2 Study|Pregnancy|1|||
154953842|NCT02653664|559257361|FG000|Post-Treatment|Withdrawal by Subject|6|||
154953843|NCT02653664|559257362|FG001|Post-Treatment|Withdrawal by Subject|5|||
154953844|NCT02653664|559257363|FG002|Post-Treatment|Withdrawal by Subject|7|||
154953845|NCT02653664|559257361|FG000|Post-Treatment|Lost to Follow-up|8|||
154953846|NCT02653664|559257362|FG001|Post-Treatment|Lost to Follow-up|1|||
154953847|NCT02653664|559257363|FG002|Post-Treatment|Lost to Follow-up|7|||
154953848|NCT02653664|559257361|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
154953849|NCT02653664|559257362|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
154953850|NCT02653664|559257363|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
154953851|NCT02653664|559257361|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
154953852|NCT02653664|559257362|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
154953853|NCT02653664|559257363|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
154953854|NCT02653664|559257361|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
154953855|NCT02653664|559257362|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
154953856|NCT02653664|559257363|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
154953857|NCT02653664|559257361|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
154953858|NCT02653664|559257362|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
154953859|NCT02653664|559257363|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
154953860|NCT02653664|559257361|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
154953861|NCT02653664|559257362|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
154953862|NCT02653664|559257363|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
154953863|NCT02653664|559257361|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
154953864|NCT02653664|559257362|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
155400156|NCT00555477|560899495|FG001|Overall Study|Adverse Event|9|||
155400157|NCT00555477|560899494|FG000|Overall Study|Withdrawal by Subject|1|||
155400158|NCT00555477|560899495|FG001|Overall Study|Withdrawal by Subject|2|||
154953865|NCT02653664|559257363|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
155400159|NCT00555477|560899494|FG000|Overall Study|Physician Decision|1|||
154953866|NCT02653664|559257361|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
154953867|NCT02653664|559257362|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
154953868|NCT02653664|559257363|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
154953869|NCT02653664|559257361|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
154953870|NCT02653664|559257362|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
154953871|NCT02653664|559257363|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
154953872|NCT01315249|559257364|FG000|Overall Study|Adverse Event|22|||
154953873|NCT01315249|559257365|FG001|Overall Study|Adverse Event|26|||
154953874|NCT01315249|559257364|FG000|Overall Study|Withdrawal by Subject|11|||
154953875|NCT01315249|559257365|FG001|Overall Study|Withdrawal by Subject|10|||
154953876|NCT01315249|559257364|FG000|Overall Study|Protocol Violation|8|||
154953877|NCT01315249|559257365|FG001|Overall Study|Protocol Violation|5|||
154953878|NCT01315249|559257364|FG000|Overall Study|Abnormal test results|1|||
154953879|NCT01315249|559257365|FG001|Overall Study|Abnormal test results|2|||
154953880|NCT01315249|559257364|FG000|Overall Study|Administrative problems|1|||
154953881|NCT01315249|559257365|FG001|Overall Study|Administrative problems|0|||
154953882|NCT01315249|559257364|FG000|Overall Study|inability to use device|1|||
154953883|NCT01315249|559257365|FG001|Overall Study|inability to use device|0|||
154953884|NCT01315249|559257364|FG000|Overall Study|Lack of Efficacy|0|||
154953885|NCT01315249|559257365|FG001|Overall Study|Lack of Efficacy|1|||
154953886|NCT01315249|559257364|FG000|Overall Study|Lost to Follow-up|0|||
154953887|NCT01315249|559257365|FG001|Overall Study|Lost to Follow-up|2|||
154953888|NCT01315249|559257364|FG000|Overall Study|Death|0|||
154953889|NCT01315249|559257365|FG001|Overall Study|Death|1|||
154953890|NCT01287013|559257369|FG000|Overall Study|Non-evaluable|3|||
154953891|NCT01287013|559257370|FG001|Overall Study|Non-evaluable|5|||
154953892|NCT01287013|559257371|FG002|Overall Study|Non-evaluable|21|||
154953893|NCT03247556|559257372|FG000|Overall Study|Adverse Event|1|||
154953894|NCT03247556|559257373|FG001|Overall Study|Adverse Event|4|||
154953895|NCT03247556|559257374|FG002|Overall Study|Adverse Event|5|||
154953896|NCT03247556|559257372|FG000|Overall Study|Lost to Follow-up|5|||
154953897|NCT03247556|559257373|FG001|Overall Study|Lost to Follow-up|5|||
154953898|NCT03247556|559257374|FG002|Overall Study|Lost to Follow-up|4|||
154953899|NCT03247556|559257372|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
154953900|NCT03247556|559257373|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
154953901|NCT03247556|559257374|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
154953902|NCT03247556|559257372|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
154953903|NCT03247556|559257373|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
154953904|NCT03247556|559257374|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
154953905|NCT03247556|559257372|FG000|Overall Study|Protocol Violation|2|||
154953906|NCT03247556|559257373|FG001|Overall Study|Protocol Violation|0|||
154953907|NCT03247556|559257374|FG002|Overall Study|Protocol Violation|1|||
154953908|NCT03247556|559257372|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
154953909|NCT03247556|559257373|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
154953910|NCT03247556|559257374|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
154953911|NCT01179048|559257376|FG000|Overall Study|Withdrawn - does not allow contact|4|||
154953912|NCT01179048|559257377|FG001|Overall Study|Withdrawn - does not allow contact|8|||
154953913|NCT01179048|559257376|FG000|Overall Study|Lost to Follow-up|8|||
154953914|NCT01179048|559257377|FG001|Overall Study|Lost to Follow-up|9|||
154953915|NCT01179048|559257376|FG000|Overall Study|Alive|127|||
154953916|NCT01179048|559257377|FG001|Overall Study|Alive|142|||
154953917|NCT00051025|559257378|FG000|Overall Study|Progressive Disease|1|||
154953918|NCT00051025|559257379|FG001|Overall Study|Progressive Disease|1|||
154953919|NCT00051025|559257378|FG000|Overall Study|Adverse Event|1|||
154953920|NCT00051025|559257379|FG001|Overall Study|Adverse Event|1|||
154953921|NCT00051025|559257378|FG000|Overall Study|Withdrawal by Subject|0|||
154953922|NCT00051025|559257379|FG001|Overall Study|Withdrawal by Subject|1|||
154953923|NCT00051025|559257378|FG000|Overall Study|Death|0|||
154953924|NCT00051025|559257379|FG001|Overall Study|Death|1|||
154953925|NCT01900730|559257380|FG000|Overall Study|Withdrawal by Subject|1|||
154953926|NCT01900730|559257381|FG001|Overall Study|Withdrawal by Subject|0|||
154953927|NCT01900730|559257380|FG000|Overall Study|Screen Failure|1|||
154953928|NCT01900730|559257381|FG001|Overall Study|Screen Failure|0|||
154953929|NCT02109042|559257382|FG000|Overall Study|Sponsor Decision|15|||
154953930|NCT03203447|559257383|FG000|Overall Study|Withdrawal by Subject|2|||
154953931|NCT03203447|559257384|FG001|Overall Study|Withdrawal by Subject|1|||
154953932|NCT03203447|559257383|FG000|Overall Study|Lost to Follow-up|1|||
154953933|NCT03203447|559257384|FG001|Overall Study|Lost to Follow-up|10|||
154953934|NCT03203447|559257383|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
154953935|NCT03203447|559257384|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
154953936|NCT00274937|559257389|FG000|Overall Study|Physician Decision|10|||
154953937|NCT00274937|559257389|FG000|Overall Study|Withdrawal by Subject|6|||
154953938|NCT00274937|559257389|FG000|Overall Study|Progressive Disease|4|||
154953939|NCT00445003|559257390|FG000|Overall Study|Death|1|||
154953940|NCT00445003|559257391|FG001|Overall Study|Death|2|||
154953941|NCT00445003|559257392|FG002|Overall Study|Death|1|||
154953942|NCT00445003|559257390|FG000|Overall Study|Missed Visit|3|||
155400160|NCT00555477|560899495|FG001|Overall Study|Physician Decision|2|||
155400161|NCT00397033|560899496|FG000|Overall Study|Adverse Event|7|||
155400162|NCT00397033|560899497|FG001|Overall Study|Adverse Event|10|||
155400163|NCT00397033|560899498|FG002|Overall Study|Adverse Event|4|||
155400164|NCT00397033|560899496|FG000|Overall Study|Lack of Efficacy|22|||
155400165|NCT00397033|560899497|FG001|Overall Study|Lack of Efficacy|12|||
155400166|NCT00397033|560899498|FG002|Overall Study|Lack of Efficacy|9|||
155400167|NCT00397033|560899496|FG000|Overall Study|Lost to Follow-up|3|||
155400168|NCT00397033|560899497|FG001|Overall Study|Lost to Follow-up|3|||
155400169|NCT00397033|560899498|FG002|Overall Study|Lost to Follow-up|3|||
155400170|NCT00397033|560899496|FG000|Overall Study|Withdrawal by Subject|12|||
155400171|NCT00397033|560899497|FG001|Overall Study|Withdrawal by Subject|7|||
155400172|NCT00397033|560899498|FG002|Overall Study|Withdrawal by Subject|5|||
155400173|NCT00397033|560899496|FG000|Overall Study|Other|0|||
155400174|NCT00397033|560899497|FG001|Overall Study|Other|5|||
155400175|NCT00397033|560899498|FG002|Overall Study|Other|2|||
155400176|NCT03519867|560899499|FG000|Overall Study|Adverse Event|1|||
155400177|NCT03519867|560899500|FG001|Overall Study|Adverse Event|1|||
155400178|NCT03519867|560899501|FG002|Overall Study|Adverse Event|0|||
155400179|NCT03519867|560899502|FG003|Overall Study|Adverse Event|0|||
155400180|NCT03519867|560899503|FG004|Overall Study|Adverse Event|0|||
155400181|NCT03519867|560899504|FG005|Overall Study|Adverse Event|0|||
155400182|NCT03519867|560899505|FG006|Overall Study|Adverse Event|0|||
155400183|NCT03519867|560899506|FG007|Overall Study|Adverse Event|0|||
155400184|NCT03519867|560899507|FG008|Overall Study|Adverse Event|0|||
155400185|NCT03519867|560899508|FG009|Overall Study|Adverse Event|0|||
155400186|NCT03519867|560899499|FG000|Overall Study|Protocol Violation|0|||
155400187|NCT03519867|560899500|FG001|Overall Study|Protocol Violation|0|||
155400188|NCT03519867|560899501|FG002|Overall Study|Protocol Violation|0|||
155400189|NCT03519867|560899502|FG003|Overall Study|Protocol Violation|0|||
155400190|NCT03519867|560899503|FG004|Overall Study|Protocol Violation|0|||
155400191|NCT03519867|560899504|FG005|Overall Study|Protocol Violation|1|||
155400192|NCT03519867|560899505|FG006|Overall Study|Protocol Violation|0|||
155400193|NCT03519867|560899506|FG007|Overall Study|Protocol Violation|0|||
155400194|NCT03519867|560899507|FG008|Overall Study|Protocol Violation|0|||
155400195|NCT03519867|560899508|FG009|Overall Study|Protocol Violation|0|||
155400196|NCT03519867|560899499|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400197|NCT03519867|560899500|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400198|NCT03519867|560899501|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400199|NCT03519867|560899502|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400200|NCT03519867|560899503|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400201|NCT03519867|560899504|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400202|NCT03519867|560899505|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
155400203|NCT03519867|560899506|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400204|NCT03519867|560899507|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400205|NCT03519867|560899508|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
155400206|NCT03519867|560899499|FG000|Overall Study|Admin. of other reversal agent|1|||
155400207|NCT03519867|560899500|FG001|Overall Study|Admin. of other reversal agent|1|||
155400208|NCT03519867|560899501|FG002|Overall Study|Admin. of other reversal agent|0|||
155400209|NCT03519867|560899502|FG003|Overall Study|Admin. of other reversal agent|0|||
155400210|NCT03519867|560899503|FG004|Overall Study|Admin. of other reversal agent|0|||
154953943|NCT00445003|559257391|FG001|Overall Study|Missed Visit|5|||
154953944|NCT00445003|559257392|FG002|Overall Study|Missed Visit|1|||
154953945|NCT00445003|559257390|FG000|Overall Study|Dropped|1|||
154953946|NCT00445003|559257391|FG001|Overall Study|Dropped|3|||
154953947|NCT00445003|559257392|FG002|Overall Study|Dropped|2|||
154953948|NCT00880568|559257396|FG000|Overall Study|Disease progression|3|||
154953949|NCT00880568|559257397|FG001|Overall Study|Disease progression|3|||
154953950|NCT00880568|559257398|FG002|Overall Study|Disease progression|3|||
154953951|NCT00880568|559257399|FG003|Overall Study|Disease progression|1|||
154953952|NCT00880568|559257400|FG004|Overall Study|Disease progression|3|||
155400211|NCT03519867|560899504|FG005|Overall Study|Admin. of other reversal agent|1|||
155400212|NCT03519867|560899505|FG006|Overall Study|Admin. of other reversal agent|0|||
155400213|NCT03519867|560899506|FG007|Overall Study|Admin. of other reversal agent|0|||
155400214|NCT03519867|560899507|FG008|Overall Study|Admin. of other reversal agent|0|||
155400215|NCT03519867|560899508|FG009|Overall Study|Admin. of other reversal agent|0|||
155400216|NCT03519867|560899499|FG000|Overall Study|Reason not provided|1|||
155400217|NCT03519867|560899500|FG001|Overall Study|Reason not provided|1|||
155400218|NCT03519867|560899501|FG002|Overall Study|Reason not provided|1|||
155400219|NCT03519867|560899502|FG003|Overall Study|Reason not provided|1|||
155400220|NCT03519867|560899503|FG004|Overall Study|Reason not provided|0|||
155400221|NCT03519867|560899504|FG005|Overall Study|Reason not provided|1|||
154953953|NCT00880568|559257401|FG005|Overall Study|Disease progression|3|||
154953954|NCT00880568|559257402|FG006|Overall Study|Disease progression|5|||
154953955|NCT00880568|559257403|FG007|Overall Study|Disease progression|0|||
155400222|NCT03519867|560899505|FG006|Overall Study|Reason not provided|0|||
155400223|NCT03519867|560899506|FG007|Overall Study|Reason not provided|1|||
155400224|NCT03519867|560899507|FG008|Overall Study|Reason not provided|1|||
155400225|NCT03519867|560899508|FG009|Overall Study|Reason not provided|0|||
155400226|NCT01846624|560899509|FG000|Overall Study|Died during induction, no midostaurin|1|||
155400227|NCT01721057|560899510|FG000|Treatment Period|Withdrawal by Subject|11|||
155400228|NCT01721057|560899511|FG001|Treatment Period|Withdrawal by Subject|5|||
155400229|NCT01721057|560899512|FG002|Treatment Period|Withdrawal by Subject|8|||
155400230|NCT01721057|560899513|FG003|Treatment Period|Withdrawal by Subject|0|||
155400231|NCT01721057|560899514|FG004|Treatment Period|Withdrawal by Subject|0|||
155400232|NCT01721057|560899515|FG005|Treatment Period|Withdrawal by Subject|0|||
155400233|NCT01721057|560899516|FG006|Treatment Period|Withdrawal by Subject|0|||
155400234|NCT01721057|560899510|FG000|Treatment Period|Adverse Event|7|||
155400235|NCT01721057|560899511|FG001|Treatment Period|Adverse Event|10|||
155400236|NCT01721057|560899512|FG002|Treatment Period|Adverse Event|12|||
155400237|NCT01721057|560899513|FG003|Treatment Period|Adverse Event|0|||
155400238|NCT01721057|560899514|FG004|Treatment Period|Adverse Event|0|||
155400239|NCT01721057|560899515|FG005|Treatment Period|Adverse Event|0|||
155400240|NCT01721057|560899516|FG006|Treatment Period|Adverse Event|0|||
155400241|NCT01721057|560899510|FG000|Treatment Period|Lack of Efficacy|7|||
155400242|NCT01721057|560899511|FG001|Treatment Period|Lack of Efficacy|3|||
155400243|NCT01721057|560899512|FG002|Treatment Period|Lack of Efficacy|0|||
155400244|NCT01721057|560899513|FG003|Treatment Period|Lack of Efficacy|0|||
155400245|NCT01721057|560899514|FG004|Treatment Period|Lack of Efficacy|0|||
155400246|NCT01721057|560899515|FG005|Treatment Period|Lack of Efficacy|0|||
155400247|NCT01721057|560899516|FG006|Treatment Period|Lack of Efficacy|0|||
155400248|NCT01721057|560899510|FG000|Treatment Period|Lost to Follow-up|1|||
155400249|NCT01721057|560899511|FG001|Treatment Period|Lost to Follow-up|0|||
155400250|NCT01721057|560899512|FG002|Treatment Period|Lost to Follow-up|0|||
155400251|NCT01721057|560899513|FG003|Treatment Period|Lost to Follow-up|0|||
155400252|NCT01721057|560899514|FG004|Treatment Period|Lost to Follow-up|0|||
155400253|NCT01721057|560899515|FG005|Treatment Period|Lost to Follow-up|0|||
155400254|NCT01721057|560899516|FG006|Treatment Period|Lost to Follow-up|0|||
155400255|NCT01721057|560899510|FG000|Treatment Period|Physician Decision|0|||
155400256|NCT01721057|560899511|FG001|Treatment Period|Physician Decision|1|||
155400257|NCT01721057|560899512|FG002|Treatment Period|Physician Decision|3|||
155400258|NCT01721057|560899513|FG003|Treatment Period|Physician Decision|0|||
155400259|NCT01721057|560899514|FG004|Treatment Period|Physician Decision|0|||
155400260|NCT01721057|560899515|FG005|Treatment Period|Physician Decision|0|||
155400261|NCT01721057|560899516|FG006|Treatment Period|Physician Decision|0|||
155400262|NCT01721057|560899510|FG000|Treatment Period|Death|2|||
155400263|NCT01721057|560899511|FG001|Treatment Period|Death|0|||
155400264|NCT01721057|560899512|FG002|Treatment Period|Death|0|||
155400265|NCT01721057|560899513|FG003|Treatment Period|Death|0|||
155400266|NCT01721057|560899514|FG004|Treatment Period|Death|0|||
155400267|NCT01721057|560899515|FG005|Treatment Period|Death|0|||
155400268|NCT01721057|560899516|FG006|Treatment Period|Death|0|||
155400269|NCT01721057|560899510|FG000|Rescue Period|Adverse Event|0|||
155400270|NCT01721057|560899511|FG001|Rescue Period|Adverse Event|0|||
155400271|NCT01721057|560899512|FG002|Rescue Period|Adverse Event|0|||
155400272|NCT01721057|560899513|FG003|Rescue Period|Adverse Event|1|||
155400273|NCT01721057|560899514|FG004|Rescue Period|Adverse Event|0|||
155400274|NCT01721057|560899515|FG005|Rescue Period|Adverse Event|0|||
155400275|NCT01721057|560899516|FG006|Rescue Period|Adverse Event|0|||
155400276|NCT01721057|560899510|FG000|Rescue Period|Lack of Efficacy|0|||
155400277|NCT01721057|560899511|FG001|Rescue Period|Lack of Efficacy|0|||
155400278|NCT01721057|560899512|FG002|Rescue Period|Lack of Efficacy|0|||
155400279|NCT01721057|560899513|FG003|Rescue Period|Lack of Efficacy|2|||
155400280|NCT01721057|560899514|FG004|Rescue Period|Lack of Efficacy|0|||
155400281|NCT01721057|560899515|FG005|Rescue Period|Lack of Efficacy|0|||
155400282|NCT01721057|560899516|FG006|Rescue Period|Lack of Efficacy|0|||
155400283|NCT01202279|560899517|FG000|Overall Study|Adverse Event|8|||
155400284|NCT01202279|560899518|FG001|Overall Study|Adverse Event|6|||
155400285|NCT01202279|560899517|FG000|Overall Study|Withdrawal by Subject|13|||
155400286|NCT01202279|560899518|FG001|Overall Study|Withdrawal by Subject|10|||
155400287|NCT01202279|560899517|FG000|Overall Study|Physician Decision|0|||
155400288|NCT01202279|560899518|FG001|Overall Study|Physician Decision|1|||
155400289|NCT01202279|560899517|FG000|Overall Study|Lost to Follow-up|10|||
155400290|NCT01202279|560899518|FG001|Overall Study|Lost to Follow-up|7|||
155400291|NCT01202279|560899517|FG000|Overall Study|Protocol Violation|1|||
155400292|NCT01202279|560899518|FG001|Overall Study|Protocol Violation|1|||
155400293|NCT01202279|560899517|FG000|Overall Study|study compliance|5|||
155400294|NCT01202279|560899518|FG001|Overall Study|study compliance|2|||
155400295|NCT03574753|560899519|FG000|Overall Study|Adverse Event|3|||
155400296|NCT03574753|560899519|FG000|Overall Study|Progression/relapse|19|||
155400297|NCT03574753|560899519|FG000|Overall Study|Death|1|||
155400298|NCT01177683|560899520|FG000|Study Treatment|Disease Progressions during treatment|2|||
154953956|NCT00880568|559257404|FG008|Overall Study|Disease progression|3|||
155400299|NCT01177683|560899521|FG001|Study Treatment|Disease Progressions during treatment|0|||
155400300|NCT01177683|560899522|FG002|Study Treatment|Disease Progressions during treatment|3|||
155400301|NCT01177683|560899520|FG000|Study Treatment|Adverse Event|0|||
155400302|NCT01177683|560899521|FG001|Study Treatment|Adverse Event|1|||
155400303|NCT01177683|560899522|FG002|Study Treatment|Adverse Event|12|||
155400304|NCT01177683|560899520|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
155400305|NCT01177683|560899521|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
155400306|NCT01177683|560899522|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
155400307|NCT01177683|560899520|FG000|Study Treatment|Alternative therapy|0|||
155400308|NCT01177683|560899521|FG001|Study Treatment|Alternative therapy|0|||
155400309|NCT01177683|560899522|FG002|Study Treatment|Alternative therapy|4|||
155400310|NCT01177683|560899520|FG000|Study Treatment|Physician Decision|1|||
155400311|NCT01177683|560899521|FG001|Study Treatment|Physician Decision|0|||
155400312|NCT01177683|560899522|FG002|Study Treatment|Physician Decision|1|||
155400313|NCT01177683|560899520|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
155400314|NCT01177683|560899521|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
155400315|NCT01177683|560899522|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
155400316|NCT01177683|560899520|FG000|Study Treatment|Symptomatic Deterioration|0|||
155400317|NCT01177683|560899521|FG001|Study Treatment|Symptomatic Deterioration|0|||
155400318|NCT01177683|560899522|FG002|Study Treatment|Symptomatic Deterioration|1|||
155400319|NCT01177683|560899520|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
155400320|NCT01177683|560899521|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
155400321|NCT01177683|560899522|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
155400322|NCT01177683|560899520|FG000|Follow up|Patient lost to follow up|0|||
155400323|NCT01177683|560899521|FG001|Follow up|Patient lost to follow up|0|||
155400324|NCT01177683|560899522|FG002|Follow up|Patient lost to follow up|2|||
155400325|NCT01177683|560899520|FG000|Follow up|Death|2|||
155400326|NCT01177683|560899521|FG001|Follow up|Death|1|||
155400327|NCT01177683|560899522|FG002|Follow up|Death|7|||
155400328|NCT01177683|560899520|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
155400329|NCT01177683|560899521|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
155400330|NCT01177683|560899522|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
155400331|NCT02546765|560899525|FG000|Overall Study|Withdrawal by Subject|0|||
155400332|NCT02546765|560899526|FG001|Overall Study|Withdrawal by Subject|1|||
155400333|NCT02546765|560899527|FG002|Overall Study|Withdrawal by Subject|0|||
155400334|NCT02546765|560899528|FG003|Overall Study|Withdrawal by Subject|0|||
155400335|NCT01977820|560899529|FG000|Overall Study|Sponsor terminated the study|1|||
155400336|NCT01977820|560899530|FG001|Overall Study|Sponsor terminated the study|1|||
155400337|NCT00698997|560899531|FG000|Overall Study|Lost to Follow-up|3|||
155400338|NCT00698997|560899532|FG001|Overall Study|Lost to Follow-up|0|||
155400339|NCT00698997|560899531|FG000|Overall Study|Withdrawal by Subject|7|||
155400340|NCT00698997|560899532|FG001|Overall Study|Withdrawal by Subject|27|||
155400341|NCT00475722|560899533|FG000|Overall Study|Withdrawal by Subject|12|||
155400342|NCT00475722|560899534|FG001|Overall Study|Withdrawal by Subject|12|||
155400343|NCT00475722|560899533|FG000|Overall Study|Protocol Violation|3|||
155400344|NCT00475722|560899534|FG001|Overall Study|Protocol Violation|0|||
155400345|NCT02568475|560899535|FG000|Overall Study|Lost to Follow-up|40|||
155400346|NCT02568475|560899536|FG001|Overall Study|Lost to Follow-up|39|||
155400347|NCT02568475|560899535|FG000|Overall Study|Withdrawal by Subject|2|||
155400348|NCT02568475|560899536|FG001|Overall Study|Withdrawal by Subject|0|||
155400349|NCT02568475|560899535|FG000|Overall Study|Discharged home|4|||
155400350|NCT02568475|560899536|FG001|Overall Study|Discharged home|4|||
155400351|NCT02568475|560899535|FG000|Overall Study|Short-term: Discharge location unknown|4|||
155400352|NCT02568475|560899536|FG001|Overall Study|Short-term: Discharge location unknown|0|||
155400353|NCT02568475|560899535|FG000|Overall Study|Transferred to another facility|1|||
155400354|NCT02568475|560899536|FG001|Overall Study|Transferred to another facility|0|||
155400355|NCT02625233|560899537|FG000|Overall Study|Adverse Event|2|||
155400356|NCT02625233|560899538|FG001|Overall Study|Adverse Event|0|||
155400357|NCT04425720|560899539|FG000|Overall Study|Withdrawal by Subject|0|||
155400358|NCT04425720|560899540|FG001|Overall Study|Withdrawal by Subject|20|||
155400359|NCT00290186|560899541|FG000|Overall Study|Adverse Event|1|||
155400360|NCT00290186|560899542|FG001|Overall Study|Adverse Event|1|||
155400361|NCT00290186|560899541|FG000|Overall Study|Lost to Follow-up|3|||
155400362|NCT00290186|560899542|FG001|Overall Study|Lost to Follow-up|2|||
155154412|NCT05236270|560002288|FG001|Overall Study|Lost to Follow-up|2|||
155400363|NCT00290186|560899541|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
155400364|NCT00290186|560899542|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
155400365|NCT00290186|560899541|FG000|Overall Study|Withdrawal by Subject|0|||
155400366|NCT00290186|560899542|FG001|Overall Study|Withdrawal by Subject|1|||
155400367|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
155400368|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
155400369|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
155400370|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
155400371|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
155400372|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
155400373|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
155400374|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
155400375|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
155400376|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
155400377|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
155400378|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
155400379|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
155400380|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
155400381|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
155400382|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
155057705|NCT02265510|559645785|FG003|Overall Study|Lost to Follow-up|0|||
155057706|NCT02265510|559645786|FG004|Overall Study|Lost to Follow-up|1|||
155057707|NCT02265510|559645787|FG005|Overall Study|Lost to Follow-up|0|||
155057708|NCT02265510|559645788|FG006|Overall Study|Lost to Follow-up|0|||
155057709|NCT02265510|559645789|FG007|Overall Study|Lost to Follow-up|0|||
155057710|NCT02265510|559645790|FG008|Overall Study|Lost to Follow-up|0|||
155057711|NCT02265510|559645791|FG009|Overall Study|Lost to Follow-up|2|||
155057712|NCT02265510|559645792|FG010|Overall Study|Lost to Follow-up|0|||
155400383|NCT00262522|560899545|FG000|Study Start Through 8 Weeks|Death|1|||
155400384|NCT00262522|560899546|FG001|Study Start Through 8 Weeks|Death|0|||
155400385|NCT00262522|560899547|FG002|Study Start Through 8 Weeks|Death|0|||
155400386|NCT00262522|560899548|FG003|Study Start Through 8 Weeks|Death|0|||
155400387|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
155400388|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
155400389|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
155400390|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
155400391|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
155400392|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
155400393|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
155400394|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
155400395|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
155400396|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
155400397|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
155400398|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
155400399|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
155400400|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
155400401|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
155400402|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
155400403|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Death|2|||
155400404|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Death|0|||
155400405|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Death|1|||
155400406|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Death|0|||
155400407|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
155400408|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
155400409|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
155400410|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
155057713|NCT02265510|559645793|FG011|Overall Study|Lost to Follow-up|0|||
155057714|NCT02265510|559645794|FG012|Overall Study|Lost to Follow-up|0|||
155057715|NCT02265510|559645795|FG013|Overall Study|Lost to Follow-up|2|||
155057716|NCT02265510|559645782|FG000|Overall Study|Other|0|||
155057717|NCT02265510|559645783|FG001|Overall Study|Other|1|||
155057718|NCT02265510|559645784|FG002|Overall Study|Other|0|||
155057719|NCT02265510|559645785|FG003|Overall Study|Other|0|||
155057720|NCT02265510|559645786|FG004|Overall Study|Other|0|||
155057721|NCT02265510|559645787|FG005|Overall Study|Other|0|||
155400411|NCT00262522|560899545|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
155057722|NCT02265510|559645788|FG006|Overall Study|Other|0|||
155057723|NCT02265510|559645789|FG007|Overall Study|Other|0|||
155057724|NCT02265510|559645790|FG008|Overall Study|Other|0|||
155057725|NCT02265510|559645791|FG009|Overall Study|Other|0|||
155057726|NCT02265510|559645792|FG010|Overall Study|Other|0|||
155057727|NCT02265510|559645793|FG011|Overall Study|Other|0|||
155057728|NCT02265510|559645794|FG012|Overall Study|Other|0|||
155057729|NCT02265510|559645795|FG013|Overall Study|Other|0|||
155057730|NCT02265510|559645782|FG000|Overall Study|Study Terminated by Sponsor|0|||
155057731|NCT02265510|559645783|FG001|Overall Study|Study Terminated by Sponsor|0|||
155057732|NCT02265510|559645784|FG002|Overall Study|Study Terminated by Sponsor|0|||
155057733|NCT02265510|559645785|FG003|Overall Study|Study Terminated by Sponsor|0|||
155057734|NCT02265510|559645786|FG004|Overall Study|Study Terminated by Sponsor|0|||
155057735|NCT02265510|559645787|FG005|Overall Study|Study Terminated by Sponsor|1|||
155057736|NCT02265510|559645788|FG006|Overall Study|Study Terminated by Sponsor|1|||
155057737|NCT02265510|559645789|FG007|Overall Study|Study Terminated by Sponsor|1|||
155057738|NCT02265510|559645790|FG008|Overall Study|Study Terminated by Sponsor|1|||
155057739|NCT02265510|559645791|FG009|Overall Study|Study Terminated by Sponsor|2|||
155057740|NCT02265510|559645792|FG010|Overall Study|Study Terminated by Sponsor|1|||
155057741|NCT02265510|559645793|FG011|Overall Study|Study Terminated by Sponsor|4|||
155057742|NCT02265510|559645794|FG012|Overall Study|Study Terminated by Sponsor|1|||
155057743|NCT02265510|559645795|FG013|Overall Study|Study Terminated by Sponsor|2|||
155057744|NCT02530385|559645796|FG000|Overall Study|Withdrawal by Subject|0|||
155057745|NCT02530385|559645797|FG001|Overall Study|Withdrawal by Subject|1|||
155057746|NCT00116142|559645802|FG000|Overall Study|Adverse Event|8|||
155057747|NCT00116142|559645803|FG001|Overall Study|Adverse Event|7|||
155057748|NCT00116142|559645802|FG000|Overall Study|Protocol Violation|2|||
155057749|NCT00116142|559645803|FG001|Overall Study|Protocol Violation|1|||
155057750|NCT00116142|559645802|FG000|Overall Study|Withdrawal by Subject|5|||
155057751|NCT00116142|559645803|FG001|Overall Study|Withdrawal by Subject|5|||
155057752|NCT00116142|559645802|FG000|Overall Study|Physician Decision|3|||
155057753|NCT00116142|559645803|FG001|Overall Study|Physician Decision|1|||
155057754|NCT00116142|559645802|FG000|Overall Study|Delayed Radiation Therapy|1|||
155057755|NCT00116142|559645803|FG001|Overall Study|Delayed Radiation Therapy|0|||
155057756|NCT00116142|559645802|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
155057757|NCT00116142|559645803|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
155057758|NCT00116142|559645802|FG000|Overall Study|Patient stopped due to depression|0|||
155057759|NCT00116142|559645803|FG001|Overall Study|Patient stopped due to depression|1|||
155057760|NCT00116142|559645802|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
155057761|NCT00116142|559645803|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
155057762|NCT00116142|559645802|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
155057763|NCT00116142|559645803|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
155057764|NCT00116142|559645802|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
155057765|NCT00116142|559645803|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
155057766|NCT00644059|559645804|FG000|Overall Study|Lost to Follow-up|37|||
155057767|NCT00644059|559645805|FG001|Overall Study|Lost to Follow-up|34|||
155057768|NCT00644059|559645806|FG002|Overall Study|Lost to Follow-up|16|||
155057769|NCT00644059|559645804|FG000|Overall Study|Withdrawal by Subject|52|||
155057770|NCT00644059|559645805|FG001|Overall Study|Withdrawal by Subject|60|||
155057771|NCT00644059|559645806|FG002|Overall Study|Withdrawal by Subject|30|||
155057772|NCT00644059|559645804|FG000|Overall Study|Adverse Event|8|||
155057773|NCT00644059|559645805|FG001|Overall Study|Adverse Event|5|||
155057774|NCT00644059|559645806|FG002|Overall Study|Adverse Event|1|||
155057775|NCT00644059|559645804|FG000|Overall Study|Inappropriate Enrollment|1|||
155057776|NCT00644059|559645805|FG001|Overall Study|Inappropriate Enrollment|3|||
155057777|NCT00644059|559645806|FG002|Overall Study|Inappropriate Enrollment|0|||
155057778|NCT00644059|559645804|FG000|Overall Study|Protocol Deviation/violation|20|||
155057779|NCT00644059|559645805|FG001|Overall Study|Protocol Deviation/violation|19|||
155057780|NCT00644059|559645806|FG002|Overall Study|Protocol Deviation/violation|15|||
155057781|NCT00644059|559645804|FG000|Overall Study|Unable to classify|6|||
155057782|NCT00644059|559645805|FG001|Overall Study|Unable to classify|2|||
155057783|NCT00644059|559645806|FG002|Overall Study|Unable to classify|3|||
155057784|NCT02133508|559645807|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
155057785|NCT02133508|559645807|FG000|Overall Study|Death|12|||
155057786|NCT02133508|559645807|FG000|Overall Study|Lost to Follow-up|2|||
155057787|NCT01026493|559645809|FG000|Overall Study|Protocol Violation|0|||
155057788|NCT01026493|559645810|FG001|Overall Study|Protocol Violation|1|||
155057789|NCT01026493|559645811|FG002|Overall Study|Protocol Violation|0|||
155057790|NCT01026493|559645812|FG003|Overall Study|Protocol Violation|0|||
155057791|NCT01026493|559645813|FG004|Overall Study|Protocol Violation|2|||
155057792|NCT01026493|559645814|FG005|Overall Study|Protocol Violation|3|||
155057793|NCT01026493|559645815|FG006|Overall Study|Protocol Violation|4|||
155057794|NCT01026493|559645816|FG007|Overall Study|Protocol Violation|1|||
155057795|NCT01038687|559645824|FG000|Overall Study|Adverse Event|0|||
155057796|NCT01038687|559645825|FG001|Overall Study|Adverse Event|2|||
155057797|NCT01038687|559645826|FG002|Overall Study|Adverse Event|1|||
155057798|NCT05401565|559645827|FG000|Overall Study|Lost to Follow-up|1|||
155057799|NCT05401565|559645828|FG001|Overall Study|Lost to Follow-up|0|||
155400412|NCT00262522|560899546|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
155400413|NCT00262522|560899547|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
155400414|NCT00262522|560899548|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
155400415|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
155400416|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
155400417|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
155400418|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
155400419|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
155400420|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
155400421|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
155400422|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
155400423|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
155400424|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
155400425|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
155400426|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
155400427|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
155400428|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
155400429|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
155400430|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
155400431|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Death|2|||
155400432|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Death|0|||
155400433|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Death|2|||
155400434|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Death|0|||
155400435|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
155400436|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
155400437|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
155400438|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
155400439|NCT00262522|560899545|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
155400440|NCT00262522|560899546|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
155400441|NCT00262522|560899547|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
155400442|NCT00262522|560899548|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
155400443|NCT05314517|560899560|FG000|Double-blind Period|Adverse Event|4|||
155400444|NCT05314517|560899561|FG001|Double-blind Period|Adverse Event|0|||
155400445|NCT05314517|560899562|FG002|Double-blind Period|Adverse Event|0|||
155400446|NCT05314517|560899563|FG003|Double-blind Period|Adverse Event|0|||
155400447|NCT05314517|560899560|FG000|Double-blind Period|Noncompliance|0|||
155400448|NCT05314517|560899561|FG001|Double-blind Period|Noncompliance|1|||
155400449|NCT05314517|560899562|FG002|Double-blind Period|Noncompliance|0|||
155400450|NCT05314517|560899563|FG003|Double-blind Period|Noncompliance|0|||
155400451|NCT05314517|560899560|FG000|Double-blind Period|Randomized, not treated|1|||
155400452|NCT05314517|560899561|FG001|Double-blind Period|Randomized, not treated|0|||
155400453|NCT05314517|560899562|FG002|Double-blind Period|Randomized, not treated|0|||
155400454|NCT05314517|560899563|FG003|Double-blind Period|Randomized, not treated|0|||
155400455|NCT05314517|560899560|FG000|Open-label Extension|Adverse Event|0|||
155400456|NCT05314517|560899561|FG001|Open-label Extension|Adverse Event|0|||
155400457|NCT05314517|560899562|FG002|Open-label Extension|Adverse Event|1|||
155400458|NCT05314517|560899563|FG003|Open-label Extension|Adverse Event|2|||
155400459|NCT05314517|560899560|FG000|Open-label Extension|Investigator decision|0|||
155400460|NCT05314517|560899561|FG001|Open-label Extension|Investigator decision|0|||
155400461|NCT05314517|560899562|FG002|Open-label Extension|Investigator decision|1|||
155400462|NCT05314517|560899563|FG003|Open-label Extension|Investigator decision|0|||
155400463|NCT05314517|560899560|FG000|Open-label Extension|Lost to Follow-up|0|||
155400464|NCT05314517|560899561|FG001|Open-label Extension|Lost to Follow-up|0|||
155400465|NCT05314517|560899562|FG002|Open-label Extension|Lost to Follow-up|0|||
155400466|NCT05314517|560899563|FG003|Open-label Extension|Lost to Follow-up|1|||
155400467|NCT05314517|560899560|FG000|Open-label Extension|Withdrawal by Subject|0|||
155400468|NCT05314517|560899561|FG001|Open-label Extension|Withdrawal by Subject|0|||
155400469|NCT05314517|560899562|FG002|Open-label Extension|Withdrawal by Subject|1|||
155400470|NCT05314517|560899563|FG003|Open-label Extension|Withdrawal by Subject|2|||
155057800|NCT05401565|559645827|FG000|Overall Study|Adverse Event|2|||
155057801|NCT05401565|559645828|FG001|Overall Study|Adverse Event|0|||
155057802|NCT02984982|559645829|FG000|Overall Study|Adverse Event|2|||
155057803|NCT02984982|559645830|FG001|Overall Study|Adverse Event|5|||
155057804|NCT02984982|559645829|FG000|Overall Study|Poor Compliance to Protocol|4|||
155057805|NCT02984982|559645830|FG001|Overall Study|Poor Compliance to Protocol|4|||
155400471|NCT05314517|560899560|FG000|Open-label Extension|Use of prohibited medication|0|||
155400472|NCT05314517|560899561|FG001|Open-label Extension|Use of prohibited medication|0|||
155057806|NCT02984982|559645829|FG000|Overall Study|Withdrawal by Subject|2|||
155057807|NCT02984982|559645830|FG001|Overall Study|Withdrawal by Subject|0|||
155057808|NCT02984982|559645829|FG000|Overall Study|Randomized but not treated|0|||
155057809|NCT02984982|559645830|FG001|Overall Study|Randomized but not treated|1|||
155057810|NCT03139552|559645844|FG000|Overall Study|unable to attend tasting due to schedule|3|||
155057811|NCT03122171|559645846|FG000|Overall Study|Withdrawal by Subject|1|||
155057812|NCT03234465|559645847|FG000|Overall Study|Adverse Event|4|||
155057813|NCT03234465|559645848|FG001|Overall Study|Adverse Event|2|||
155057814|NCT03234465|559645847|FG000|Overall Study|Death|0|||
155057815|NCT03234465|559645848|FG001|Overall Study|Death|1|||
155057816|NCT03234465|559645847|FG000|Overall Study|Lost to Follow-up|1|||
155057817|NCT03234465|559645848|FG001|Overall Study|Lost to Follow-up|1|||
155057818|NCT03234465|559645847|FG000|Overall Study|Withdrawal by Subject|12|||
155057819|NCT03234465|559645848|FG001|Overall Study|Withdrawal by Subject|27|||
155057820|NCT03234465|559645847|FG000|Overall Study|Symptomatic deterioration|0|||
155057821|NCT03234465|559645848|FG001|Overall Study|Symptomatic deterioration|1|||
155057822|NCT03234465|559645847|FG000|Overall Study|Non-compliance|2|||
155057823|NCT03234465|559645848|FG001|Overall Study|Non-compliance|0|||
155057824|NCT03234465|559645847|FG000|Overall Study|Other|14|||
155057825|NCT03234465|559645848|FG001|Overall Study|Other|8|||
155057826|NCT03368807|559645849|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
155057827|NCT03368807|559645849|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
155057828|NCT03368807|559645849|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
155057829|NCT03368807|559645849|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
155057830|NCT00369343|559645862|FG000|Double-blind Phase|Adverse Event|19|||
155057831|NCT00369343|559645863|FG001|Double-blind Phase|Adverse Event|4|||
155057832|NCT00369343|559645862|FG000|Double-blind Phase|Failed to return|2|||
155057833|NCT00369343|559645863|FG001|Double-blind Phase|Failed to return|0|||
155057834|NCT00369343|559645862|FG000|Double-blind Phase|Lost to Follow-up|9|||
155057835|NCT00369343|559645863|FG001|Double-blind Phase|Lost to Follow-up|2|||
155057836|NCT00369343|559645862|FG000|Double-blind Phase|Protocol Violation|2|||
155057837|NCT00369343|559645863|FG001|Double-blind Phase|Protocol Violation|0|||
155057838|NCT00369343|559645862|FG000|Double-blind Phase|Withdrawal by Subject|8|||
155057839|NCT00369343|559645863|FG001|Double-blind Phase|Withdrawal by Subject|6|||
155057840|NCT00369343|559645862|FG000|Double-blind Phase|Lack of Efficacy|0|||
155057841|NCT00369343|559645863|FG001|Double-blind Phase|Lack of Efficacy|4|||
155057842|NCT00369343|559645862|FG000|Double-blind Phase|Protocol deviation|4|||
155057843|NCT00369343|559645863|FG001|Double-blind Phase|Protocol deviation|0|||
155057844|NCT00369343|559645862|FG000|Open-label Phase|Adverse Event|19|||
155057845|NCT00369343|559645863|FG001|Open-label Phase|Adverse Event|7|||
155057846|NCT00369343|559645862|FG000|Open-label Phase|Failed to return|4|||
155400473|NCT05314517|560899562|FG002|Open-label Extension|Use of prohibited medication|1|||
155400474|NCT05314517|560899563|FG003|Open-label Extension|Use of prohibited medication|0|||
155400475|NCT05314517|560899560|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
155057847|NCT00369343|559645863|FG001|Open-label Phase|Failed to return|0|||
155057848|NCT00369343|559645862|FG000|Open-label Phase|Physician Decision|2|||
155057849|NCT00369343|559645863|FG001|Open-label Phase|Physician Decision|0|||
155057850|NCT00369343|559645862|FG000|Open-label Phase|Lost to Follow-up|5|||
155057851|NCT00369343|559645863|FG001|Open-label Phase|Lost to Follow-up|3|||
155057852|NCT00369343|559645862|FG000|Open-label Phase|inadvertently reported study completers|3|||
155057853|NCT00369343|559645863|FG001|Open-label Phase|inadvertently reported study completers|2|||
155057854|NCT00369343|559645862|FG000|Open-label Phase|Protocol Violation|1|||
155057855|NCT00369343|559645863|FG001|Open-label Phase|Protocol Violation|3|||
155057856|NCT00369343|559645862|FG000|Open-label Phase|Withdrawal by Subject|15|||
155057857|NCT00369343|559645863|FG001|Open-label Phase|Withdrawal by Subject|6|||
155057858|NCT00369343|559645862|FG000|Open-label Phase|Lack of Efficacy|4|||
155057859|NCT00369343|559645863|FG001|Open-label Phase|Lack of Efficacy|3|||
155057860|NCT00369343|559645862|FG000|Open-label Phase|Lack of continuance tolerability|3|||
155057861|NCT00369343|559645863|FG001|Open-label Phase|Lack of continuance tolerability|4|||
155057862|NCT00369343|559645862|FG000|Open-label Phase|did not take study drug|1|||
155057863|NCT00369343|559645863|FG001|Open-label Phase|did not take study drug|2|||
155057864|NCT02247466|559645864|FG000|Overall Study|Procedure changed to open surgery|0|||
155057865|NCT02247466|559645865|FG001|Overall Study|Procedure changed to open surgery|3|||
155057866|NCT04356937|559645866|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
155057867|NCT04356937|559645867|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
155057868|NCT00617279|559645868|FG000|Overall Study|Study terminated by Sponsor|10|||
155057869|NCT00617279|559645869|FG001|Overall Study|Study terminated by Sponsor|15|||
155057870|NCT00617279|559645868|FG000|Overall Study|Graft abandonment|2|||
155057871|NCT00617279|559645869|FG001|Overall Study|Graft abandonment|0|||
155057872|NCT00617279|559645868|FG000|Overall Study|Lost to Follow-up|1|||
155057873|NCT00617279|559645869|FG001|Overall Study|Lost to Follow-up|0|||
155057874|NCT00617279|559645868|FG000|Overall Study|Death|1|||
155057875|NCT00617279|559645869|FG001|Overall Study|Death|2|||
155057876|NCT01190891|559648497|FG000|Overall Study|Protocol Violation|1|||
155057877|NCT01190891|559648498|FG001|Overall Study|Protocol Violation|0|||
155057878|NCT01190891|559648497|FG000|Overall Study|Withdrawal by Subject|5|||
155057879|NCT01190891|559648498|FG001|Overall Study|Withdrawal by Subject|0|||
155400476|NCT05314517|560899561|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
155057880|NCT00737048|559648499|FG000|Overall Study|Physician Decision|0|||
155057881|NCT00737048|559648500|FG001|Overall Study|Physician Decision|0|||
155400477|NCT05314517|560899562|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
155400478|NCT05314517|560899563|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
155400479|NCT02710136|560899566|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
155400480|NCT02710136|560899567|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
155400481|NCT02269787|560899568|FG000|Overall Study|Lost to Follow-up|20|||
155400482|NCT02269787|560899569|FG001|Overall Study|Lost to Follow-up|6|||
155400483|NCT02269787|560899568|FG000|Overall Study|Death|2|||
155400484|NCT02269787|560899569|FG001|Overall Study|Death|3|||
155400485|NCT02269787|560899568|FG000|Overall Study|Incapacitated|0|||
155400486|NCT02269787|560899569|FG001|Overall Study|Incapacitated|1|||
155400487|NCT00798135|560899570|FG000|Overall Study|Disease progression, relapse|11|||
155400488|NCT00798135|560899570|FG000|Overall Study|Disease progression, refractory|1|||
155400489|NCT00798135|560899570|FG000|Overall Study|Physician Decision|1|||
155400490|NCT03337542|560899571|FG000|Overall Study|Withdrew Consent|17|||
155400491|NCT03337542|560899571|FG000|Overall Study|Allergic Adverse Event|1|||
155400492|NCT03337542|560899571|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
155400493|NCT03337542|560899571|FG000|Overall Study|Lost to Follow-up|1|||
155400494|NCT03337542|560899571|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
155400495|NCT01401842|560899572|FG000|Overall Study|Withdrawal by Subject|3|||
155400496|NCT01401842|560899573|FG001|Overall Study|Withdrawal by Subject|2|||
155400497|NCT01401842|560899572|FG000|Overall Study|academic reason|4|||
155400498|NCT01401842|560899573|FG001|Overall Study|academic reason|1|||
155400499|NCT01401842|560899572|FG000|Overall Study|changed companies|20|||
155400500|NCT01401842|560899573|FG001|Overall Study|changed companies|34|||
155400501|NCT01401842|560899572|FG000|Overall Study|discharged from US Army|3|||
155400502|NCT01401842|560899573|FG001|Overall Study|discharged from US Army|4|||
155400503|NCT01401842|560899572|FG000|Overall Study|invalid follow-up strength data|1|||
155400504|NCT01401842|560899573|FG001|Overall Study|invalid follow-up strength data|4|||
155400505|NCT01401842|560899572|FG000|Overall Study|on profile|9|||
155400506|NCT01401842|560899573|FG001|Overall Study|on profile|5|||
155400507|NCT01401842|560899572|FG000|Overall Study|other/unknown|28|||
155400508|NCT01401842|560899573|FG001|Overall Study|other/unknown|17|||
155400509|NCT00282295|560899574|FG000|Overall Study|Adverse Event|0|||
155400510|NCT00282295|560899575|FG001|Overall Study|Adverse Event|1|||
155400511|NCT00282295|560899576|FG002|Overall Study|Adverse Event|0|||
154953957|NCT00880568|559257396|FG000|Overall Study|Adverse Event|0|||
154953958|NCT00880568|559257397|FG001|Overall Study|Adverse Event|0|||
154953959|NCT00880568|559257398|FG002|Overall Study|Adverse Event|0|||
154953960|NCT00880568|559257399|FG003|Overall Study|Adverse Event|0|||
154953961|NCT00880568|559257400|FG004|Overall Study|Adverse Event|0|||
154953962|NCT00880568|559257401|FG005|Overall Study|Adverse Event|0|||
154953963|NCT00880568|559257402|FG006|Overall Study|Adverse Event|1|||
154953964|NCT00880568|559257403|FG007|Overall Study|Adverse Event|1|||
154953965|NCT00880568|559257404|FG008|Overall Study|Adverse Event|0|||
154953966|NCT00880568|559257396|FG000|Overall Study|Withdrawal by Subject|0|||
154953967|NCT00880568|559257397|FG001|Overall Study|Withdrawal by Subject|0|||
154953968|NCT00880568|559257398|FG002|Overall Study|Withdrawal by Subject|0|||
154953969|NCT00880568|559257399|FG003|Overall Study|Withdrawal by Subject|0|||
154953970|NCT00880568|559257400|FG004|Overall Study|Withdrawal by Subject|0|||
154953971|NCT00880568|559257401|FG005|Overall Study|Withdrawal by Subject|0|||
154953972|NCT00880568|559257402|FG006|Overall Study|Withdrawal by Subject|0|||
154953973|NCT00880568|559257403|FG007|Overall Study|Withdrawal by Subject|1|||
154953974|NCT00880568|559257404|FG008|Overall Study|Withdrawal by Subject|0|||
154953975|NCT00620022|559257405|FG000|Treatment Period 1|Adverse Event|4|||
154953976|NCT00620022|559257406|FG001|Treatment Period 1|Adverse Event|6|||
154953977|NCT00620022|559257405|FG000|Treatment Period 1|Subject withdrew consent|1|||
154953978|NCT00620022|559257406|FG001|Treatment Period 1|Subject withdrew consent|0|||
154953979|NCT00620022|559257405|FG000|Treatment Period 2|Adverse Event|2|||
154953980|NCT00620022|559257406|FG001|Treatment Period 2|Adverse Event|2|||
154953981|NCT03478397|559257412|FG000|Overall Study|Refused to participate|31|||
154953982|NCT03478397|559257413|FG001|Overall Study|Refused to participate|7|||
154953983|NCT01617668|559257414|FG000|Overall Study|Adverse Event|7|||
154953984|NCT01617668|559257415|FG001|Overall Study|Adverse Event|0|||
154953985|NCT01617668|559257416|FG002|Overall Study|Adverse Event|12|||
154953986|NCT01617668|559257417|FG003|Overall Study|Adverse Event|5|||
154953987|NCT01617668|559257414|FG000|Overall Study|Physician Decision|1|||
154953988|NCT01617668|559257415|FG001|Overall Study|Physician Decision|2|||
154953989|NCT01617668|559257416|FG002|Overall Study|Physician Decision|3|||
154953990|NCT01617668|559257417|FG003|Overall Study|Physician Decision|0|||
154953991|NCT01617668|559257414|FG000|Overall Study|Progressive Disease|4|||
154953992|NCT01617668|559257415|FG001|Overall Study|Progressive Disease|4|||
154953993|NCT01617668|559257416|FG002|Overall Study|Progressive Disease|6|||
154953994|NCT01617668|559257417|FG003|Overall Study|Progressive Disease|9|||
154953995|NCT01617668|559257414|FG000|Overall Study|Subject/guardian decision|1|||
155057882|NCT00737048|559648501|FG002|Overall Study|Physician Decision|1|||
155400512|NCT00282295|560899574|FG000|Overall Study|Serious Adverse Events|0|||
155400513|NCT00282295|560899575|FG001|Overall Study|Serious Adverse Events|0|||
155057883|NCT00737048|559648499|FG000|Overall Study|Adverse Event|0|||
155057884|NCT00737048|559648500|FG001|Overall Study|Adverse Event|1|||
155057885|NCT00737048|559648501|FG002|Overall Study|Adverse Event|0|||
155057886|NCT00737048|559648499|FG000|Overall Study|Worsening of the symptoms|3|||
155057887|NCT00737048|559648500|FG001|Overall Study|Worsening of the symptoms|5|||
155057888|NCT00737048|559648501|FG002|Overall Study|Worsening of the symptoms|3|||
155057889|NCT04635839|559648502|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
155057890|NCT04635839|559648503|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
155057891|NCT02737358|559648504|FG000|Overall Study|Withdrawal by Subject|7|||
155057892|NCT02737358|559648505|FG001|Overall Study|Withdrawal by Subject|12|||
155057893|NCT02737358|559648504|FG000|Overall Study|Lost to Follow-up|2|||
155057894|NCT02737358|559648505|FG001|Overall Study|Lost to Follow-up|3|||
155057895|NCT03312738|559648508|FG000|Overall Study|Progressive disease|58|||
155057896|NCT03312738|559648509|FG001|Overall Study|Progressive disease|67|||
155057897|NCT03312738|559648508|FG000|Overall Study|Patient/guardian decision|13|||
155057898|NCT03312738|559648509|FG001|Overall Study|Patient/guardian decision|5|||
155057899|NCT03312738|559648508|FG000|Overall Study|Adverse Event|5|||
155057900|NCT03312738|559648509|FG001|Overall Study|Adverse Event|3|||
155057901|NCT03312738|559648508|FG000|Overall Study|Protocol deviation|2|||
155057902|NCT03312738|559648509|FG001|Overall Study|Protocol deviation|0|||
155057903|NCT03312738|559648508|FG000|Overall Study|Technical problems|0|||
155057904|NCT03312738|559648509|FG001|Overall Study|Technical problems|1|||
155057905|NCT03312738|559648508|FG000|Overall Study|Physician Decision|2|||
155057906|NCT03312738|559648509|FG001|Overall Study|Physician Decision|3|||
155057907|NCT04745351|559648517|FG000|Overall Study|Death|51|||
155057908|NCT04745351|559648518|FG001|Overall Study|Death|25|||
155057909|NCT04745351|559648517|FG000|Overall Study|Lost to Follow-up|9|||
155057910|NCT04745351|559648518|FG001|Overall Study|Lost to Follow-up|3|||
155057911|NCT04745351|559648517|FG000|Overall Study|Randomized but Never Treated|3|||
155057912|NCT04745351|559648518|FG001|Overall Study|Randomized but Never Treated|3|||
155057913|NCT04745351|559648517|FG000|Overall Study|Adverse Event|4|||
155057914|NCT04745351|559648518|FG001|Overall Study|Adverse Event|0|||
155057915|NCT04745351|559648517|FG000|Overall Study|Withdrew Consent|1|||
155057916|NCT04745351|559648518|FG001|Overall Study|Withdrew Consent|2|||
155057917|NCT04745351|559648517|FG000|Overall Study|Investigator's Discretion|2|||
155057918|NCT04745351|559648518|FG001|Overall Study|Investigator's Discretion|0|||
155057919|NCT04745351|559648517|FG000|Overall Study|Protocol Violation|1|||
155057920|NCT04745351|559648518|FG001|Overall Study|Protocol Violation|0|||
155057921|NCT02014272|559648522|FG000|Intervention Period 1|Withdrawal by Subject|1|||
155057922|NCT02014272|559648523|FG001|Intervention Period 1|Withdrawal by Subject|0|||
155057923|NCT02014272|559648522|FG000|Intervention Period 1|Adverse Event|0|||
155057924|NCT02014272|559648523|FG001|Intervention Period 1|Adverse Event|1|||
155057925|NCT00547339|559648524|FG000|Overall Study|Physician Decision|0|||
155057926|NCT00547339|559648525|FG001|Overall Study|Physician Decision|0|||
155057927|NCT00547339|559648526|FG002|Overall Study|Physician Decision|1|||
155057928|NCT00547339|559648527|FG003|Overall Study|Physician Decision|0|||
155057929|NCT02369653|559648528|FG000|Overall Study|Lost to Follow-up|0|||
155057930|NCT02369653|559648529|FG001|Overall Study|Lost to Follow-up|1|||
155057931|NCT02369653|559648528|FG000|Overall Study|Administrative reason by sponsor|0|||
155057932|NCT02369653|559648529|FG001|Overall Study|Administrative reason by sponsor|1|||
155057933|NCT02369653|559648528|FG000|Overall Study|Death|1|||
155057934|NCT02369653|559648529|FG001|Overall Study|Death|2|||
155057935|NCT02369653|559648528|FG000|Overall Study|Participant withdrew consent|13|||
155057936|NCT02369653|559648529|FG001|Overall Study|Participant withdrew consent|3|||
155057937|NCT03587636|559648530|FG000|Overall Study|Lost to Follow-up|2|||
155057938|NCT03587636|559648531|FG001|Overall Study|Lost to Follow-up|5|||
155057939|NCT01587885|559648532|FG000|Treatment Period 1|Failure to Return|0|||
155057940|NCT01587885|559648533|FG001|Treatment Period 1|Failure to Return|1|||
155057941|NCT01587885|559648532|FG000|Treatment Period 1|Protocol Violation|0|||
155057942|NCT01587885|559648533|FG001|Treatment Period 1|Protocol Violation|2|||
155057943|NCT01458587|559648534|FG000|Overall Study|Withdrawal by Subject|1|||
155400514|NCT00282295|560899576|FG002|Overall Study|Serious Adverse Events|1|||
155400515|NCT00282295|560899574|FG000|Overall Study|Protocol Violation|0|||
155400516|NCT00282295|560899575|FG001|Overall Study|Protocol Violation|2|||
155400517|NCT00282295|560899576|FG002|Overall Study|Protocol Violation|1|||
155057944|NCT01458587|559648535|FG001|Overall Study|Withdrawal by Subject|0|||
155057945|NCT01603602|559648536|FG000|Overall Study|Adverse Event|1|||
155057946|NCT01603602|559648537|FG001|Overall Study|Adverse Event|0|||
155057947|NCT01603602|559648538|FG002|Overall Study|Adverse Event|0|||
155057948|NCT01603602|559648536|FG000|Overall Study|Personal Reasons|1|||
155057949|NCT01603602|559648537|FG001|Overall Study|Personal Reasons|0|||
155057950|NCT01603602|559648538|FG002|Overall Study|Personal Reasons|1|||
155057951|NCT04748718|559648540|FG000|Overall Study|Lost to Follow-up|50|||
155057952|NCT00316004|559648541|FG000|Overall Study|Subject was not given study fluid.|14|||
155057953|NCT00316004|559648542|FG001|Overall Study|Subject was not given study fluid.|14|||
155057954|NCT00316004|559648543|FG002|Overall Study|Subject was not given study fluid.|21|||
155057955|NCT01118299|559648544|FG000|Overall Study|Death|7|||
155400518|NCT00282295|560899574|FG000|Overall Study|Withdrawal by Subject|2|||
155400519|NCT00282295|560899575|FG001|Overall Study|Withdrawal by Subject|6|||
155400520|NCT00282295|560899576|FG002|Overall Study|Withdrawal by Subject|4|||
155400521|NCT00282295|560899574|FG000|Overall Study|Lost to Follow-up|1|||
155400522|NCT00282295|560899575|FG001|Overall Study|Lost to Follow-up|7|||
155400523|NCT00282295|560899576|FG002|Overall Study|Lost to Follow-up|2|||
155400524|NCT00282295|560899574|FG000|Overall Study|Other|0|||
155400525|NCT00282295|560899575|FG001|Overall Study|Other|1|||
155400526|NCT00282295|560899576|FG002|Overall Study|Other|0|||
155400527|NCT00430482|560899577|FG000|Completed Treatment|Insufficient Treatment|7|||
155400528|NCT00430482|560899578|FG001|Completed Treatment|Insufficient Treatment|11|||
155400529|NCT00574145|560901176|FG000|Overall Study|Withdrawal by Subject|2|||
155400530|NCT00574145|560901177|FG001|Overall Study|Withdrawal by Subject|1|||
155400531|NCT03227471|560901178|FG000|Overall Study|Withdrawal by Subject|0|||
155400532|NCT03227471|560901179|FG001|Overall Study|Withdrawal by Subject|0|||
155400533|NCT03227471|560901180|FG002|Overall Study|Withdrawal by Subject|0|||
155400534|NCT03227471|560901181|FG003|Overall Study|Withdrawal by Subject|0|||
155400535|NCT03227471|560901182|FG004|Overall Study|Withdrawal by Subject|1|||
155400536|NCT03227471|560901183|FG005|Overall Study|Withdrawal by Subject|0|||
155400537|NCT03227471|560901184|FG006|Overall Study|Withdrawal by Subject|0|||
155400538|NCT03227471|560901185|FG007|Overall Study|Withdrawal by Subject|0|||
155400539|NCT03227471|560901186|FG008|Overall Study|Withdrawal by Subject|0|||
155400540|NCT03227471|560901187|FG009|Overall Study|Withdrawal by Subject|0|||
155400541|NCT03227471|560901188|FG010|Overall Study|Withdrawal by Subject|0|||
155400542|NCT03227471|560901189|FG011|Overall Study|Withdrawal by Subject|0|||
155400543|NCT03227471|560901190|FG012|Overall Study|Withdrawal by Subject|1|||
155400544|NCT03227471|560901191|FG013|Overall Study|Withdrawal by Subject|0|||
155400545|NCT03227471|560901192|FG014|Overall Study|Withdrawal by Subject|0|||
155400546|NCT03227471|560901178|FG000|Overall Study|Randomized, Never Dosed|0|||
155400547|NCT03227471|560901179|FG001|Overall Study|Randomized, Never Dosed|0|||
155400548|NCT03227471|560901180|FG002|Overall Study|Randomized, Never Dosed|0|||
155400549|NCT03227471|560901181|FG003|Overall Study|Randomized, Never Dosed|0|||
155400550|NCT03227471|560901182|FG004|Overall Study|Randomized, Never Dosed|0|||
155400551|NCT03227471|560901183|FG005|Overall Study|Randomized, Never Dosed|0|||
155400552|NCT03227471|560901184|FG006|Overall Study|Randomized, Never Dosed|0|||
155400553|NCT03227471|560901185|FG007|Overall Study|Randomized, Never Dosed|0|||
155400554|NCT03227471|560901186|FG008|Overall Study|Randomized, Never Dosed|0|||
155400555|NCT03227471|560901187|FG009|Overall Study|Randomized, Never Dosed|0|||
155400556|NCT03227471|560901188|FG010|Overall Study|Randomized, Never Dosed|0|||
155400557|NCT03227471|560901189|FG011|Overall Study|Randomized, Never Dosed|0|||
155400558|NCT03227471|560901190|FG012|Overall Study|Randomized, Never Dosed|0|||
155400559|NCT03227471|560901191|FG013|Overall Study|Randomized, Never Dosed|0|||
155400560|NCT03227471|560901192|FG014|Overall Study|Randomized, Never Dosed|1|||
155400561|NCT00766038|560901195|FG000|Overall Study|Lost to Follow-up|15|||
154953996|NCT01617668|559257415|FG001|Overall Study|Subject/guardian decision|3|||
154953997|NCT01617668|559257416|FG002|Overall Study|Subject/guardian decision|2|||
154953998|NCT01617668|559257417|FG003|Overall Study|Subject/guardian decision|1|||
155400562|NCT00766038|560901196|FG001|Overall Study|Lost to Follow-up|14|||
155400563|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
155400564|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
154953999|NCT00925769|559257418|FG000|Overall Study|Major toxicity|1|||
154954000|NCT00925769|559257419|FG001|Overall Study|Major toxicity|0|||
154954001|NCT00925769|559257420|FG002|Overall Study|Major toxicity|1|||
154954002|NCT00925769|559257421|FG003|Overall Study|Major toxicity|1|||
154954003|NCT00925769|559257422|FG004|Overall Study|Major toxicity|0|||
154954004|NCT00925769|559257423|FG005|Overall Study|Major toxicity|0|||
154954005|NCT00925769|559257418|FG000|Overall Study|Disease progression|4|||
154954006|NCT00925769|559257419|FG001|Overall Study|Disease progression|5|||
154954007|NCT00925769|559257420|FG002|Overall Study|Disease progression|3|||
154954008|NCT00925769|559257421|FG003|Overall Study|Disease progression|4|||
154954009|NCT00925769|559257422|FG004|Overall Study|Disease progression|2|||
154954010|NCT00925769|559257423|FG005|Overall Study|Disease progression|3|||
154954011|NCT00925769|559257418|FG000|Overall Study|Death|0|||
154954012|NCT00925769|559257419|FG001|Overall Study|Death|0|||
154954013|NCT00925769|559257420|FG002|Overall Study|Death|1|||
154954014|NCT00925769|559257421|FG003|Overall Study|Death|0|||
154954015|NCT00925769|559257422|FG004|Overall Study|Death|0|||
154954016|NCT00925769|559257423|FG005|Overall Study|Death|0|||
154954017|NCT00925769|559257418|FG000|Overall Study|Physician Decision|1|||
154954018|NCT00925769|559257419|FG001|Overall Study|Physician Decision|0|||
154954019|NCT00925769|559257420|FG002|Overall Study|Physician Decision|0|||
154954020|NCT00925769|559257421|FG003|Overall Study|Physician Decision|0|||
154954021|NCT00925769|559257422|FG004|Overall Study|Physician Decision|0|||
154954022|NCT00925769|559257423|FG005|Overall Study|Physician Decision|0|||
155057956|NCT01118299|559648545|FG001|Overall Study|Death|5|||
155400565|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
155400566|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
155400567|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
155284778|NCT01941316|560474417|FG000|Overall Study|Progressive Disease|3|||
155400568|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
155400569|NCT00449670|560901197|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
155400570|NCT00449670|560901198|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
155400571|NCT00449670|560901197|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
155400572|NCT00449670|560901198|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
155400573|NCT00449670|560901197|FG000|Booster Phase (Study no.109873)|Other|0|||
155400574|NCT00449670|560901198|FG001|Booster Phase (Study no.109873)|Other|2|||
155400575|NCT00847145|560901202|FG000|Overall Study|AE or Death|0|||
155400576|NCT00847145|560901203|FG001|Overall Study|AE or Death|1|||
155400577|NCT00847145|560901204|FG002|Overall Study|AE or Death|1|||
155400578|NCT00847145|560901205|FG003|Overall Study|AE or Death|0|||
155400579|NCT00847145|560901206|FG004|Overall Study|AE or Death|0|||
155400580|NCT00847145|560901207|FG005|Overall Study|AE or Death|0|||
155400581|NCT00847145|560901208|FG006|Overall Study|AE or Death|0|||
155400582|NCT00847145|560901209|FG007|Overall Study|AE or Death|0|||
155400583|NCT00847145|560901202|FG000|Overall Study|Withdrawal by Subject|3|||
155400584|NCT00847145|560901203|FG001|Overall Study|Withdrawal by Subject|4|||
155400585|NCT00847145|560901204|FG002|Overall Study|Withdrawal by Subject|6|||
154954023|NCT00925769|559257418|FG000|Overall Study|Missing documentation|0|||
154954024|NCT00925769|559257419|FG001|Overall Study|Missing documentation|1|||
154954025|NCT00925769|559257420|FG002|Overall Study|Missing documentation|0|||
154954026|NCT00925769|559257421|FG003|Overall Study|Missing documentation|0|||
154954027|NCT00925769|559257422|FG004|Overall Study|Missing documentation|0|||
154954028|NCT00925769|559257423|FG005|Overall Study|Missing documentation|0|||
154954029|NCT00925769|559257418|FG000|Overall Study|End of study visit not done|0|||
154954030|NCT00925769|559257419|FG001|Overall Study|End of study visit not done|0|||
154954031|NCT00925769|559257420|FG002|Overall Study|End of study visit not done|1|||
154954032|NCT00925769|559257421|FG003|Overall Study|End of study visit not done|0|||
154954033|NCT00925769|559257422|FG004|Overall Study|End of study visit not done|0|||
154954034|NCT00925769|559257423|FG005|Overall Study|End of study visit not done|0|||
154954035|NCT00925769|559257418|FG000|Overall Study|Participant is unable to swallow drug|0|||
154954036|NCT00925769|559257419|FG001|Overall Study|Participant is unable to swallow drug|0|||
154954037|NCT00925769|559257420|FG002|Overall Study|Participant is unable to swallow drug|0|||
154954038|NCT00925769|559257421|FG003|Overall Study|Participant is unable to swallow drug|1|||
154954039|NCT00925769|559257422|FG004|Overall Study|Participant is unable to swallow drug|0|||
154954040|NCT00925769|559257423|FG005|Overall Study|Participant is unable to swallow drug|0|||
154954041|NCT00925769|559257418|FG000|Overall Study|Adverse Event|0|||
154954042|NCT00925769|559257419|FG001|Overall Study|Adverse Event|0|||
154954043|NCT00925769|559257420|FG002|Overall Study|Adverse Event|0|||
154954044|NCT00925769|559257421|FG003|Overall Study|Adverse Event|0|||
154954045|NCT00925769|559257422|FG004|Overall Study|Adverse Event|1|||
154954046|NCT00925769|559257423|FG005|Overall Study|Adverse Event|0|||
154954047|NCT01735630|559257425|FG000|Overall Study|Adverse Event|8|||
154954048|NCT01735630|559257426|FG001|Overall Study|Adverse Event|7|||
154954049|NCT01735630|559257425|FG000|Overall Study|Lost to Follow-up|1|||
154954050|NCT01735630|559257426|FG001|Overall Study|Lost to Follow-up|0|||
154954051|NCT01735630|559257425|FG000|Overall Study|Physician Decision|0|||
154954052|NCT01735630|559257426|FG001|Overall Study|Physician Decision|1|||
154954053|NCT01735630|559257425|FG000|Overall Study|Sponsor Decision|2|||
154954054|NCT01735630|559257426|FG001|Overall Study|Sponsor Decision|1|||
154954055|NCT01735630|559257425|FG000|Overall Study|Withdrawal by Subject|7|||
154954056|NCT01735630|559257426|FG001|Overall Study|Withdrawal by Subject|9|||
154954057|NCT01720264|559257428|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
154954058|NCT01720264|559257428|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
154954059|NCT01720264|559257428|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
154954060|NCT00669942|559257431|FG000|Parts 2 and 3|Adverse Event|0|||
154954061|NCT00669942|559257432|FG001|Parts 2 and 3|Adverse Event|0|||
154954062|NCT00669942|559257433|FG002|Parts 2 and 3|Adverse Event|0|||
154954063|NCT00669942|559257434|FG003|Parts 2 and 3|Adverse Event|0|||
154954064|NCT00669942|559257435|FG004|Parts 2 and 3|Adverse Event|0|||
155284779|NCT01941316|560474418|FG001|Overall Study|Progressive Disease|6|||
155400586|NCT00847145|560901205|FG003|Overall Study|Withdrawal by Subject|1|||
154954065|NCT00669942|559257436|FG005|Parts 2 and 3|Adverse Event|0|||
154954066|NCT00669942|559257437|FG006|Parts 2 and 3|Adverse Event|0|||
154954067|NCT00669942|559257438|FG007|Parts 2 and 3|Adverse Event|2|||
154954068|NCT00669942|559257439|FG008|Parts 2 and 3|Adverse Event|1|||
154954069|NCT00669942|559257440|FG009|Parts 2 and 3|Adverse Event|0|||
154954070|NCT00669942|559257441|FG010|Parts 2 and 3|Adverse Event|0|||
154954071|NCT00669942|559257442|FG011|Parts 2 and 3|Adverse Event|0|||
154954072|NCT00669942|559257431|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
154954073|NCT00669942|559257432|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
154954074|NCT00669942|559257433|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
155400587|NCT00847145|560901206|FG004|Overall Study|Withdrawal by Subject|0|||
155400588|NCT00847145|560901207|FG005|Overall Study|Withdrawal by Subject|0|||
155400589|NCT00847145|560901208|FG006|Overall Study|Withdrawal by Subject|1|||
155057957|NCT01118299|559648544|FG000|Overall Study|Withdrawal by Subject|8|||
155057958|NCT01118299|559648545|FG001|Overall Study|Withdrawal by Subject|8|||
155057959|NCT01118299|559648544|FG000|Overall Study|Lost to Follow-up|2|||
155057960|NCT01118299|559648545|FG001|Overall Study|Lost to Follow-up|1|||
155057961|NCT01118299|559648544|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
155057962|NCT01118299|559648545|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
155057963|NCT01935089|559648547|FG000|Overall Study|Adverse Event|2|||
155057964|NCT01935089|559648547|FG000|Overall Study|Withdrawal by Subject|1|||
155057965|NCT02932943|559648548|FG000|Overall Study|Lost to Follow-up|0|||
155057966|NCT02932943|559648549|FG001|Overall Study|Lost to Follow-up|2|||
155057967|NCT02932943|559648548|FG000|Overall Study|Adverse Event|2|||
155057968|NCT02932943|559648549|FG001|Overall Study|Adverse Event|2|||
155057969|NCT02932943|559648548|FG000|Overall Study|Withdrawal by Subject|3|||
155057970|NCT02932943|559648549|FG001|Overall Study|Withdrawal by Subject|3|||
155057971|NCT02337491|559648553|FG000|Overall Study|Death|1|||
155057972|NCT02337491|559648554|FG001|Overall Study|Death|1|||
155057973|NCT02337491|559648553|FG000|Overall Study|Adverse Event|0|||
155057974|NCT02337491|559648554|FG001|Overall Study|Adverse Event|1|||
155057975|NCT02337491|559648553|FG000|Overall Study|Withdrawal by Subject|3|||
155057976|NCT02337491|559648554|FG001|Overall Study|Withdrawal by Subject|0|||
155057977|NCT02337491|559648553|FG000|Overall Study|Progressive Disease|44|||
155057978|NCT02337491|559648554|FG001|Overall Study|Progressive Disease|28|||
155057979|NCT02337491|559648553|FG000|Overall Study|On Treatment|2|||
155057980|NCT02337491|559648554|FG001|Overall Study|On Treatment|0|||
155057981|NCT01432951|559648555|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
155057982|NCT01079780|559648559|FG000|Overall Study|Disease progression|43|||
155057983|NCT01079780|559648560|FG001|Overall Study|Disease progression|7|||
155057984|NCT01079780|559648561|FG002|Overall Study|Disease progression|31|||
155057985|NCT01079780|559648559|FG000|Overall Study|Adverse Event|13|||
155057986|NCT01079780|559648560|FG001|Overall Study|Adverse Event|5|||
155057987|NCT01079780|559648561|FG002|Overall Study|Adverse Event|7|||
155057988|NCT01079780|559648559|FG000|Overall Study|Death|2|||
155057989|NCT01079780|559648560|FG001|Overall Study|Death|0|||
155154413|NCT05236270|560002289|FG002|Overall Study|Lost to Follow-up|0|||
155284780|NCT01941316|560474419|FG002|Overall Study|Progressive Disease|2|||
155400590|NCT00847145|560901209|FG007|Overall Study|Withdrawal by Subject|1|||
155400591|NCT00847145|560901202|FG000|Overall Study|Lost to Follow-up|3|||
155400592|NCT00847145|560901203|FG001|Overall Study|Lost to Follow-up|1|||
155400593|NCT00847145|560901204|FG002|Overall Study|Lost to Follow-up|1|||
155400594|NCT00847145|560901205|FG003|Overall Study|Lost to Follow-up|0|||
155400595|NCT00847145|560901206|FG004|Overall Study|Lost to Follow-up|4|||
155400596|NCT00847145|560901207|FG005|Overall Study|Lost to Follow-up|4|||
155400597|NCT00847145|560901208|FG006|Overall Study|Lost to Follow-up|8|||
155400598|NCT00847145|560901209|FG007|Overall Study|Lost to Follow-up|2|||
155400599|NCT00847145|560901202|FG000|Overall Study|Inappropriate enrollment|0|||
155400600|NCT00847145|560901203|FG001|Overall Study|Inappropriate enrollment|0|||
155400601|NCT00847145|560901204|FG002|Overall Study|Inappropriate enrollment|0|||
155400602|NCT00847145|560901205|FG003|Overall Study|Inappropriate enrollment|0|||
155400603|NCT00847145|560901206|FG004|Overall Study|Inappropriate enrollment|1|||
155400604|NCT00847145|560901207|FG005|Overall Study|Inappropriate enrollment|0|||
155400605|NCT00847145|560901208|FG006|Overall Study|Inappropriate enrollment|0|||
155400606|NCT00847145|560901209|FG007|Overall Study|Inappropriate enrollment|0|||
155400607|NCT00847145|560901202|FG000|Overall Study|Protocol Violation|0|||
155400608|NCT00847145|560901203|FG001|Overall Study|Protocol Violation|0|||
155400609|NCT00847145|560901204|FG002|Overall Study|Protocol Violation|3|||
155400610|NCT00847145|560901205|FG003|Overall Study|Protocol Violation|0|||
155400611|NCT00847145|560901206|FG004|Overall Study|Protocol Violation|1|||
155400612|NCT00847145|560901207|FG005|Overall Study|Protocol Violation|0|||
155400613|NCT00847145|560901208|FG006|Overall Study|Protocol Violation|0|||
155057990|NCT01079780|559648561|FG002|Overall Study|Death|2|||
155057991|NCT01079780|559648559|FG000|Overall Study|Withdrawal by Subject|6|||
155057992|NCT01079780|559648560|FG001|Overall Study|Withdrawal by Subject|4|||
155057993|NCT01079780|559648561|FG002|Overall Study|Withdrawal by Subject|4|||
155057994|NCT01079780|559648559|FG000|Overall Study|Alternative therapy|2|||
155057995|NCT01079780|559648560|FG001|Overall Study|Alternative therapy|0|||
155154414|NCT05236270|560002290|FG003|Overall Study|Lost to Follow-up|0|||
155400614|NCT00847145|560901209|FG007|Overall Study|Protocol Violation|1|||
155400615|NCT02833974|560901210|FG000|Overall Study|Lost to Follow-up|1|||
155400616|NCT02833974|560901211|FG001|Overall Study|Lost to Follow-up|0|||
155400617|NCT02833974|560901210|FG000|Overall Study|Adverse Event|0|||
155057996|NCT01079780|559648561|FG002|Overall Study|Alternative therapy|2|||
155400618|NCT02833974|560901211|FG001|Overall Study|Adverse Event|3|||
155400619|NCT00833053|560901215|FG000|Overall Study|Adverse Event|4|||
155057997|NCT01079780|559648559|FG000|Overall Study|Physician Decision|1|||
155400620|NCT00833053|560901216|FG001|Overall Study|Adverse Event|0|||
155400621|NCT00833053|560901215|FG000|Overall Study|Treatment Failure|3|||
155400622|NCT00833053|560901216|FG001|Overall Study|Treatment Failure|1|||
155057998|NCT01079780|559648560|FG001|Overall Study|Physician Decision|0|||
155057999|NCT01079780|559648561|FG002|Overall Study|Physician Decision|1|||
155058000|NCT01079780|559648559|FG000|Overall Study|Error made in lesion measurement|1|||
155058001|NCT01079780|559648560|FG001|Overall Study|Error made in lesion measurement|0|||
155058002|NCT01079780|559648561|FG002|Overall Study|Error made in lesion measurement|0|||
155058003|NCT01079780|559648559|FG000|Overall Study|Patient had surgery|1|||
155058004|NCT01079780|559648560|FG001|Overall Study|Patient had surgery|0|||
155058005|NCT01079780|559648561|FG002|Overall Study|Patient had surgery|0|||
155058006|NCT01079780|559648559|FG000|Overall Study|Treatment cycle delay|0|||
155058007|NCT01079780|559648560|FG001|Overall Study|Treatment cycle delay|0|||
155058008|NCT01079780|559648561|FG002|Overall Study|Treatment cycle delay|1|||
155058009|NCT01079780|559648559|FG000|Overall Study|Never started treatment|1|||
155058010|NCT01079780|559648560|FG001|Overall Study|Never started treatment|0|||
155058011|NCT01079780|559648561|FG002|Overall Study|Never started treatment|2|||
155058012|NCT02783066|559648562|FG000|Overall Study|Withdrawal by Subject|13|||
155058013|NCT03712280|559648563|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
155058014|NCT03712280|559648564|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
155058015|NCT03712280|559648565|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
155058016|NCT03712280|559648566|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
155400623|NCT00833053|560901215|FG000|Overall Study|Withdrawal by Subject|0|||
155400624|NCT00833053|560901216|FG001|Overall Study|Withdrawal by Subject|1|||
155400625|NCT00833053|560901215|FG000|Overall Study|Protocol Violation|2|||
155400626|NCT00833053|560901216|FG001|Overall Study|Protocol Violation|1|||
155400627|NCT02187471|560901217|FG000|Overall Study|Protocol Violation|4|||
155400628|NCT02187471|560901218|FG001|Overall Study|Protocol Violation|5|||
155400629|NCT02187471|560901219|FG002|Overall Study|Protocol Violation|4|||
155400630|NCT02187471|560901220|FG003|Overall Study|Protocol Violation|4|||
155400631|NCT02187471|560901217|FG000|Overall Study|Missing|0|||
155400632|NCT02187471|560901218|FG001|Overall Study|Missing|0|||
155400633|NCT02187471|560901219|FG002|Overall Study|Missing|0|||
155400634|NCT02187471|560901220|FG003|Overall Study|Missing|1|||
155400635|NCT02187471|560901217|FG000|Overall Study|Lack of Efficacy|18|||
155058017|NCT03712280|559648563|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
155058018|NCT03712280|559648564|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
155058019|NCT03712280|559648565|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
155058020|NCT03712280|559648566|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
155058021|NCT03712280|559648563|FG000|Overall Study|Adverse Event|0|||
155058022|NCT03712280|559648564|FG001|Overall Study|Adverse Event|0|||
155058023|NCT03712280|559648565|FG002|Overall Study|Adverse Event|1|||
155058024|NCT03712280|559648566|FG003|Overall Study|Adverse Event|0|||
155058025|NCT00551369|559648567|FG000|Overall Study|Protocol Violation|5|||
155058026|NCT00551369|559648567|FG000|Overall Study|Withdrawal by Subject|1|||
155058027|NCT00551369|559648567|FG000|Overall Study|Not treated per protocol and re|1|||
155058028|NCT01663623|559648568|FG000|Overall Study|Adverse Event|3|||
155058029|NCT01663623|559648569|FG001|Overall Study|Adverse Event|7|||
155058030|NCT01663623|559648568|FG000|Overall Study|Lack of Efficacy|5|||
155058031|NCT01663623|559648569|FG001|Overall Study|Lack of Efficacy|6|||
155058032|NCT01663623|559648568|FG000|Overall Study|Protocol Violation|0|||
155058033|NCT01663623|559648569|FG001|Overall Study|Protocol Violation|1|||
155058034|NCT01663623|559648568|FG000|Overall Study|Other-Study closed/terminated|1|||
155058035|NCT01663623|559648569|FG001|Overall Study|Other-Study closed/terminated|1|||
155058036|NCT01663623|559648568|FG000|Overall Study|Physician Decision|1|||
155058037|NCT01663623|559648569|FG001|Overall Study|Physician Decision|4|||
155058038|NCT01663623|559648568|FG000|Overall Study|Withdrawal by Subject|2|||
155058039|NCT01663623|559648569|FG001|Overall Study|Withdrawal by Subject|1|||
155058040|NCT01004614|559648570|FG000|Washout|Withdrawal by Subject|0|||
155058041|NCT01004614|559648571|FG001|Washout|Withdrawal by Subject|1|||
155058042|NCT01004614|559648572|FG002|Washout|Withdrawal by Subject|0|||
155058043|NCT01004614|559648573|FG003|Washout|Withdrawal by Subject|0|||
155058044|NCT01302899|559648574|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
155058045|NCT01302899|559648575|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
155058046|NCT01302899|559648574|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
155058047|NCT01302899|559648575|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
155058048|NCT03093181|559648576|FG000|Overall Study|Withdrawal by Subject|2|||
155058049|NCT03093181|559648577|FG001|Overall Study|Withdrawal by Subject|1|||
155058050|NCT03093181|559648578|FG002|Overall Study|Withdrawal by Subject|2|||
155400636|NCT02187471|560901218|FG001|Overall Study|Lack of Efficacy|9|||
155400637|NCT02187471|560901219|FG002|Overall Study|Lack of Efficacy|13|||
155400638|NCT02187471|560901220|FG003|Overall Study|Lack of Efficacy|11|||
155058051|NCT03093181|559648576|FG000|Overall Study|Other (Not specified)|1|||
155400639|NCT02187471|560901217|FG000|Overall Study|Adverse Event|24|||
155400640|NCT02187471|560901218|FG001|Overall Study|Adverse Event|34|||
155058052|NCT03093181|559648577|FG001|Overall Study|Other (Not specified)|0|||
155058053|NCT03093181|559648578|FG002|Overall Study|Other (Not specified)|0|||
155400641|NCT02187471|560901219|FG002|Overall Study|Adverse Event|44|||
155400642|NCT02187471|560901220|FG003|Overall Study|Adverse Event|36|||
155400643|NCT02187471|560901217|FG000|Overall Study|Withdrawal by Subject|23|||
155400644|NCT02187471|560901218|FG001|Overall Study|Withdrawal by Subject|29|||
155400645|NCT02187471|560901219|FG002|Overall Study|Withdrawal by Subject|22|||
155400646|NCT02187471|560901220|FG003|Overall Study|Withdrawal by Subject|24|||
155400647|NCT02187471|560901217|FG000|Overall Study|Other|7|||
155400648|NCT02187471|560901218|FG001|Overall Study|Other|5|||
155400649|NCT02187471|560901219|FG002|Overall Study|Other|3|||
155400650|NCT02187471|560901220|FG003|Overall Study|Other|4|||
155400651|NCT02318667|560901221|FG000|Overall Study|Adverse Event|1|||
155400652|NCT02318667|560901221|FG000|Overall Study|Lack of Efficacy|6|||
155400653|NCT02318667|560901221|FG000|Overall Study|Protocol Violation|2|||
155400654|NCT02289742|560901222|FG000|First Wear Period|Adverse event prior to treatment|0|||
155400655|NCT02289742|560901223|FG001|First Wear Period|Adverse event prior to treatment|1|||
155400656|NCT02289742|560901224|FG002|First Wear Period|Adverse event prior to treatment|0|||
155400657|NCT02289742|560901225|FG003|First Wear Period|Adverse event prior to treatment|0|||
155400658|NCT02289742|560901222|FG000|First Wear Period|Adverse Event|0|||
155400659|NCT02289742|560901223|FG001|First Wear Period|Adverse Event|0|||
155400660|NCT02289742|560901224|FG002|First Wear Period|Adverse Event|1|||
155400661|NCT02289742|560901225|FG003|First Wear Period|Adverse Event|0|||
155400662|NCT02289742|560901222|FG000|First Wear Period|Other prior to treatment|0|||
155400663|NCT02289742|560901223|FG001|First Wear Period|Other prior to treatment|0|||
155400664|NCT02289742|560901224|FG002|First Wear Period|Other prior to treatment|0|||
155400665|NCT02289742|560901225|FG003|First Wear Period|Other prior to treatment|1|||
155400666|NCT02289742|560901222|FG000|Third Wear Period|Adverse Event|0|||
155400667|NCT02289742|560901223|FG001|Third Wear Period|Adverse Event|1|||
155400668|NCT02289742|560901224|FG002|Third Wear Period|Adverse Event|0|||
155400669|NCT02289742|560901225|FG003|Third Wear Period|Adverse Event|0|||
155400670|NCT02289742|560901222|FG000|Third Wear Period|Reason not given|0|||
155400671|NCT02289742|560901223|FG001|Third Wear Period|Reason not given|0|||
155400672|NCT02289742|560901224|FG002|Third Wear Period|Reason not given|0|||
155400673|NCT02289742|560901225|FG003|Third Wear Period|Reason not given|1|||
155400674|NCT02865018|560901226|FG000|Overall Study|Withdrawal by Subject|1|||
155400675|NCT01365039|560901227|FG000|Overall Study|Study related symptoms and complaints|1|||
155400676|NCT01365039|560901228|FG001|Overall Study|Study related symptoms and complaints|0|||
155400677|NCT00294060|560901231|FG000|Overall Study|Death|225|||
155400678|NCT00294060|560901231|FG000|Overall Study|Other|59|||
155400679|NCT00294060|560901231|FG000|Overall Study|Lost to Follow-up|55|||
155400680|NCT00294060|560901231|FG000|Overall Study|Withdrawal by Subject|11|||
155400681|NCT00294060|560901231|FG000|Overall Study|Physician Decision|797|||
155400682|NCT00294060|560901231|FG000|Overall Study|Medical condition|3|||
155400683|NCT00294060|560901231|FG000|Overall Study|Device explanted/not replaced|23|||
155400684|NCT01360554|560901232|FG000|Overall Study|Death|359|||
155400685|NCT01360554|560901233|FG001|Overall Study|Death|371|||
155400686|NCT01360554|560901232|FG000|Overall Study|Lost to Follow-up|4|||
155400687|NCT01360554|560901233|FG001|Overall Study|Lost to Follow-up|4|||
155400688|NCT01360554|560901232|FG000|Overall Study|Withdrawal by Subject|23|||
155400689|NCT01360554|560901233|FG001|Overall Study|Withdrawal by Subject|24|||
155400690|NCT01360554|560901232|FG000|Overall Study|Study terminated by sponsor|49|||
155400691|NCT01360554|560901233|FG001|Overall Study|Study terminated by sponsor|37|||
155400692|NCT01360554|560901232|FG000|Overall Study|Other, not specified|1|||
155400693|NCT01360554|560901233|FG001|Overall Study|Other, not specified|0|||
155058054|NCT03093181|559648576|FG000|Overall Study|Adverse Event|0|||
155400694|NCT01360554|560901232|FG000|Overall Study|Randomized but not treated.|3|||
155400695|NCT01360554|560901233|FG001|Overall Study|Randomized but not treated.|3|||
155400696|NCT03668600|560901234|FG000|Overall Study|Study Terminated by the Sponsor|157|||
155400697|NCT03668600|560901234|FG000|Overall Study|Protocol Violation|1|||
155058055|NCT03093181|559648577|FG001|Overall Study|Adverse Event|1|||
155058056|NCT03093181|559648578|FG002|Overall Study|Adverse Event|0|||
155058057|NCT03093181|559648576|FG000|Overall Study|Other (Protocol violation)|0|||
155400698|NCT03668600|560901234|FG000|Overall Study|Pregnancy|1|||
155058058|NCT03093181|559648577|FG001|Overall Study|Other (Protocol violation)|0|||
155058059|NCT03093181|559648578|FG002|Overall Study|Other (Protocol violation)|1|||
155058060|NCT03154086|559648579|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058061|NCT03154086|559648580|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058062|NCT03154086|559648581|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155400699|NCT03668600|560901234|FG000|Overall Study|Lost to Follow-up|7|||
155400700|NCT03668600|560901234|FG000|Overall Study|Withdrawal by Subject|56|||
155058063|NCT03154086|559648582|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
155058064|NCT03154086|559648583|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058065|NCT03154086|559648584|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155400701|NCT03668600|560901234|FG000|Overall Study|Lack of Efficacy|7|||
155400702|NCT03668600|560901234|FG000|Overall Study|Adverse Event|1|||
155400703|NCT00424749|560901236|FG000|Overall Study|Withdrawal by Subject|1|||
155400704|NCT01263483|560901237|FG000|Overall Study|Adverse Event|4|||
155400705|NCT01263483|560901238|FG001|Overall Study|Adverse Event|0|||
155400706|NCT01263483|560901239|FG002|Overall Study|Adverse Event|3|||
155400707|NCT01263483|560901237|FG000|Overall Study|Withdrawal by Subject|1|||
155400708|NCT01263483|560901238|FG001|Overall Study|Withdrawal by Subject|0|||
155400709|NCT01263483|560901239|FG002|Overall Study|Withdrawal by Subject|0|||
155400710|NCT01263483|560901237|FG000|Overall Study|Lack of Efficacy|2|||
155400711|NCT01263483|560901238|FG001|Overall Study|Lack of Efficacy|0|||
155400712|NCT01263483|560901239|FG002|Overall Study|Lack of Efficacy|0|||
155400713|NCT01263483|560901237|FG000|Overall Study|Protocol Violation|0|||
155400714|NCT01263483|560901238|FG001|Overall Study|Protocol Violation|1|||
155400715|NCT01263483|560901239|FG002|Overall Study|Protocol Violation|1|||
155400716|NCT01263483|560901237|FG000|Overall Study|Participant Unavailability|0|||
155400717|NCT01263483|560901238|FG001|Overall Study|Participant Unavailability|1|||
155400718|NCT01263483|560901239|FG002|Overall Study|Participant Unavailability|1|||
155400719|NCT05500274|560901245|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
155400720|NCT05500274|560901246|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
155400721|NCT05500274|560901245|FG000|Overall Study|Lost to Follow-up|76|||
155400722|NCT05500274|560901246|FG001|Overall Study|Lost to Follow-up|51|||
155400723|NCT05807464|560901249|FG000|Overall Study|Adverse Event|1|||
155400724|NCT01555151|560901250|FG000|Overall Study|Withdrawal by Subject|6|||
155400725|NCT01555151|560901251|FG001|Overall Study|Withdrawal by Subject|2|||
155400726|NCT01555151|560901252|FG002|Overall Study|Withdrawal by Subject|0|||
155284781|NCT01941316|560474420|FG003|Overall Study|Progressive Disease|29|||
154954075|NCT00669942|559257434|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
154954076|NCT00669942|559257435|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
154954077|NCT00669942|559257436|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
154954078|NCT00669942|559257437|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
154954079|NCT00669942|559257438|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
154954080|NCT00669942|559257439|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
154954081|NCT00669942|559257440|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
154954082|NCT00669942|559257441|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
154954083|NCT00669942|559257442|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
154954084|NCT00669942|559257431|FG000|Parts 2 and 3|Protocol Violation|0|||
154954085|NCT00669942|559257432|FG001|Parts 2 and 3|Protocol Violation|0|||
154954086|NCT00669942|559257433|FG002|Parts 2 and 3|Protocol Violation|0|||
154954087|NCT00669942|559257434|FG003|Parts 2 and 3|Protocol Violation|0|||
154954088|NCT00669942|559257435|FG004|Parts 2 and 3|Protocol Violation|0|||
154954089|NCT00669942|559257436|FG005|Parts 2 and 3|Protocol Violation|1|||
154954090|NCT00669942|559257437|FG006|Parts 2 and 3|Protocol Violation|0|||
154954091|NCT00669942|559257438|FG007|Parts 2 and 3|Protocol Violation|0|||
154954092|NCT00669942|559257439|FG008|Parts 2 and 3|Protocol Violation|0|||
154954093|NCT00669942|559257440|FG009|Parts 2 and 3|Protocol Violation|0|||
154954094|NCT00669942|559257441|FG010|Parts 2 and 3|Protocol Violation|0|||
154954095|NCT00669942|559257442|FG011|Parts 2 and 3|Protocol Violation|0|||
154954096|NCT04213326|559257446|FG000|Overall Study|Consent withdrawn|51|||
154954097|NCT04213326|559257447|FG001|Overall Study|Consent withdrawn|241|||
154954098|NCT04213326|559257446|FG000|Overall Study|Lost to Follow-up|50|||
154954099|NCT04213326|559257447|FG001|Overall Study|Lost to Follow-up|902|||
154954100|NCT04213326|559257446|FG000|Overall Study|Protocol Violation|3|||
154954101|NCT04213326|559257447|FG001|Overall Study|Protocol Violation|25|||
154954102|NCT04213326|559257446|FG000|Overall Study|Participant eligibility changed|106|||
154954103|NCT04213326|559257447|FG001|Overall Study|Participant eligibility changed|19|||
154954104|NCT04213326|559257446|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
154954105|NCT04213326|559257447|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
154954106|NCT04213326|559257446|FG000|Overall Study|Incomplete study visit|0|||
154954107|NCT04213326|559257447|FG001|Overall Study|Incomplete study visit|367|||
154954108|NCT02549092|559257448|FG000|Treatment Period|Adverse Event|2|||
154954109|NCT02549092|559257449|FG001|Treatment Period|Adverse Event|2|||
154954110|NCT02549092|559257448|FG000|Treatment Period|Withdrawal by Subject|1|||
154954111|NCT02549092|559257449|FG001|Treatment Period|Withdrawal by Subject|3|||
154954112|NCT02549092|559257448|FG000|Treatment Period|Lack of Efficacy|0|||
154954113|NCT02549092|559257449|FG001|Treatment Period|Lack of Efficacy|2|||
154954114|NCT02549092|559257448|FG000|Extension/Transition Period|Adverse Event|1|||
154954115|NCT02549092|559257449|FG001|Extension/Transition Period|Adverse Event|1|||
154954116|NCT02549092|559257448|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
154954117|NCT02549092|559257449|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
154954118|NCT02549092|559257448|FG000|Extension/Transition Period|Other, Not Specified|4|||
154954119|NCT02549092|559257449|FG001|Extension/Transition Period|Other, Not Specified|2|||
154954120|NCT03002077|559257455|FG000|Overall Study|Non-compliance with Study Drug|4|||
154954121|NCT03002077|559257455|FG000|Overall Study|Non-compliance w/Background ADT|1|||
154954122|NCT03002077|559257455|FG000|Overall Study|Study Terminated by Sponsor|257|||
154954123|NCT03002077|559257455|FG000|Overall Study|Site Terminated by Sponsor|5|||
154954124|NCT03002077|559257455|FG000|Overall Study|Miscellaneous Reasons|10|||
154954125|NCT03002077|559257455|FG000|Overall Study|Adverse Event|23|||
155058066|NCT03154086|559648585|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
154954126|NCT03002077|559257455|FG000|Overall Study|Lack of Efficacy|20|||
155400727|NCT01555151|560901253|FG003|Overall Study|Withdrawal by Subject|2|||
155400728|NCT01555151|560901250|FG000|Overall Study|Administrative|3|||
155400729|NCT01555151|560901251|FG001|Overall Study|Administrative|1|||
155400730|NCT01555151|560901252|FG002|Overall Study|Administrative|2|||
155400731|NCT01555151|560901253|FG003|Overall Study|Administrative|0|||
155400732|NCT01555151|560901250|FG000|Overall Study|Protocol Violation|3|||
155400733|NCT01555151|560901251|FG001|Overall Study|Protocol Violation|3|||
155400734|NCT01555151|560901252|FG002|Overall Study|Protocol Violation|3|||
155400735|NCT01555151|560901253|FG003|Overall Study|Protocol Violation|5|||
155400736|NCT01555151|560901250|FG000|Overall Study|Adverse Event|1|||
155400737|NCT01555151|560901251|FG001|Overall Study|Adverse Event|2|||
155400738|NCT01555151|560901252|FG002|Overall Study|Adverse Event|1|||
155400739|NCT01555151|560901253|FG003|Overall Study|Adverse Event|2|||
155400740|NCT01555151|560901250|FG000|Overall Study|Lost to Follow-up|0|||
155400741|NCT01555151|560901251|FG001|Overall Study|Lost to Follow-up|0|||
155400742|NCT01555151|560901252|FG002|Overall Study|Lost to Follow-up|0|||
155400743|NCT01555151|560901253|FG003|Overall Study|Lost to Follow-up|1|||
155400744|NCT03596866|560901254|FG000|Overall Study|Site terminated by Sponsor|64|||
155400745|NCT03596866|560901255|FG001|Overall Study|Site terminated by Sponsor|65|||
155400746|NCT03596866|560901254|FG000|Overall Study|Death|37|||
155400747|NCT03596866|560901255|FG001|Overall Study|Death|24|||
155400748|NCT03596866|560901254|FG000|Overall Study|Withdrawal by Subject|4|||
155400749|NCT03596866|560901255|FG001|Overall Study|Withdrawal by Subject|6|||
155400750|NCT03596866|560901254|FG000|Overall Study|Missing|0|||
155400751|NCT03596866|560901255|FG001|Overall Study|Missing|6|||
155400752|NCT03596866|560901254|FG000|Overall Study|Lost to Follow-up|2|||
155400753|NCT03596866|560901255|FG001|Overall Study|Lost to Follow-up|3|||
155400754|NCT03596866|560901254|FG000|Overall Study|Protocol Violation|1|||
155400755|NCT03596866|560901255|FG001|Overall Study|Protocol Violation|0|||
155400756|NCT03596866|560901254|FG000|Overall Study|Reason Not Specified|14|||
155400757|NCT03596866|560901255|FG001|Overall Study|Reason Not Specified|13|||
155400758|NCT02343159|560901257|FG000|Overall Study|Early Study Termination|16|||
155400759|NCT02343159|560901258|FG001|Overall Study|Early Study Termination|19|||
155400760|NCT02343159|560901259|FG002|Overall Study|Early Study Termination|23|||
155400761|NCT02343159|560901257|FG000|Overall Study|Physician Decision|2|||
155400762|NCT02343159|560901258|FG001|Overall Study|Physician Decision|0|||
155400763|NCT02343159|560901259|FG002|Overall Study|Physician Decision|1|||
155400764|NCT02343159|560901257|FG000|Overall Study|Withdrawal by Subject|3|||
155400765|NCT02343159|560901258|FG001|Overall Study|Withdrawal by Subject|0|||
155400766|NCT02343159|560901259|FG002|Overall Study|Withdrawal by Subject|2|||
155400767|NCT02343159|560901257|FG000|Overall Study|Lost to Follow-up|0|||
155400768|NCT02343159|560901258|FG001|Overall Study|Lost to Follow-up|2|||
155400769|NCT02343159|560901259|FG002|Overall Study|Lost to Follow-up|2|||
155400770|NCT02343159|560901257|FG000|Overall Study|Adverse Event|4|||
155400771|NCT02343159|560901258|FG001|Overall Study|Adverse Event|4|||
155400772|NCT02343159|560901259|FG002|Overall Study|Adverse Event|2|||
155400773|NCT02343159|560901257|FG000|Overall Study|Sponsor Decision|0|||
155400774|NCT02343159|560901258|FG001|Overall Study|Sponsor Decision|1|||
155400775|NCT02343159|560901259|FG002|Overall Study|Sponsor Decision|0|||
155400776|NCT02343159|560901257|FG000|Overall Study|Enrollment Error|1|||
155400777|NCT02343159|560901258|FG001|Overall Study|Enrollment Error|0|||
155400778|NCT02343159|560901259|FG002|Overall Study|Enrollment Error|0|||
155400779|NCT02114268|560901262|FG000|Overall Study|Lost to Follow-up|4|||
155400780|NCT02114268|560901263|FG001|Overall Study|Lost to Follow-up|1|||
155400781|NCT02114268|560901264|FG002|Overall Study|Lost to Follow-up|1|||
155400782|NCT02114268|560901265|FG003|Overall Study|Lost to Follow-up|0|||
155400783|NCT02114268|560901266|FG004|Overall Study|Lost to Follow-up|0|||
155400784|NCT02114268|560901267|FG005|Overall Study|Lost to Follow-up|2|||
155400785|NCT02114268|560901262|FG000|Overall Study|Withdrawal by Subject|1|||
155400786|NCT02114268|560901263|FG001|Overall Study|Withdrawal by Subject|0|||
155400787|NCT02114268|560901264|FG002|Overall Study|Withdrawal by Subject|0|||
155400788|NCT02114268|560901265|FG003|Overall Study|Withdrawal by Subject|0|||
155400789|NCT02114268|560901266|FG004|Overall Study|Withdrawal by Subject|0|||
155400790|NCT02114268|560901267|FG005|Overall Study|Withdrawal by Subject|1|||
155400791|NCT02114268|560901262|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
155400792|NCT02114268|560901263|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
155400793|NCT02114268|560901264|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
155400794|NCT02114268|560901265|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
155058067|NCT03154086|559648586|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058068|NCT03154086|559648587|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155400795|NCT02114268|560901266|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
155058069|NCT03154086|559648588|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058070|NCT03154086|559648589|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155400796|NCT02114268|560901267|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
155400797|NCT01431274|560901272|FG000|Overall Study|Adverse Event|51|||
155400798|NCT01431274|560901273|FG001|Overall Study|Adverse Event|37|||
155400799|NCT01431274|560901274|FG002|Overall Study|Adverse Event|43|||
155400800|NCT01431274|560901275|FG003|Overall Study|Adverse Event|30|||
155400801|NCT01431274|560901276|FG004|Overall Study|Adverse Event|37|||
155400802|NCT01431274|560901272|FG000|Overall Study|Consent withdrawn not due to AE|29|||
155400803|NCT01431274|560901273|FG001|Overall Study|Consent withdrawn not due to AE|20|||
155400804|NCT01431274|560901274|FG002|Overall Study|Consent withdrawn not due to AE|17|||
155400805|NCT01431274|560901275|FG003|Overall Study|Consent withdrawn not due to AE|20|||
155400806|NCT01431274|560901276|FG004|Overall Study|Consent withdrawn not due to AE|11|||
155400807|NCT01431274|560901272|FG000|Overall Study|Non compliant with protocol|5|||
155400808|NCT01431274|560901273|FG001|Overall Study|Non compliant with protocol|8|||
155400809|NCT01431274|560901274|FG002|Overall Study|Non compliant with protocol|4|||
155400810|NCT01431274|560901275|FG003|Overall Study|Non compliant with protocol|4|||
155400811|NCT01431274|560901276|FG004|Overall Study|Non compliant with protocol|4|||
155400812|NCT01431274|560901272|FG000|Overall Study|Lost to Follow-up|6|||
155400813|NCT01431274|560901273|FG001|Overall Study|Lost to Follow-up|7|||
155400814|NCT01431274|560901274|FG002|Overall Study|Lost to Follow-up|1|||
155400815|NCT01431274|560901275|FG003|Overall Study|Lost to Follow-up|4|||
155400816|NCT01431274|560901276|FG004|Overall Study|Lost to Follow-up|0|||
155400817|NCT01431274|560901272|FG000|Overall Study|Other reason not stated above|6|||
155400818|NCT01431274|560901273|FG001|Overall Study|Other reason not stated above|5|||
155400819|NCT01431274|560901274|FG002|Overall Study|Other reason not stated above|7|||
155058071|NCT03154086|559648590|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058072|NCT03154086|559648591|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058073|NCT03154086|559648592|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155400820|NCT01431274|560901275|FG003|Overall Study|Other reason not stated above|2|||
155400821|NCT01431274|560901276|FG004|Overall Study|Other reason not stated above|4|||
155400822|NCT00003702|560901277|FG000|Overall Study|Ineligible cell types|2|||
155400823|NCT00003702|560901278|FG001|Overall Study|Ineligible cell types|2|||
155400824|NCT00003702|560901277|FG000|Overall Study|Did not meet criteria for persistence|8|||
155400825|NCT00003702|560901278|FG001|Overall Study|Did not meet criteria for persistence|5|||
155400826|NCT00003702|560901277|FG000|Overall Study|WHO score > 6|2|||
155400827|NCT00003702|560901278|FG001|Overall Study|WHO score > 6|1|||
155400828|NCT00003702|560901277|FG000|Overall Study|Inadequate documentation of disease|1|||
155400829|NCT00003702|560901278|FG001|Overall Study|Inadequate documentation of disease|3|||
155400830|NCT02790138|560901279|FG000|Overall Study|Adverse Event|5|||
155400831|NCT02790138|560901280|FG001|Overall Study|Adverse Event|2|||
155400832|NCT02790138|560901279|FG000|Overall Study|Significant Protocol Deviation|0|||
155400833|NCT02790138|560901280|FG001|Overall Study|Significant Protocol Deviation|1|||
155400834|NCT02790138|560901279|FG000|Overall Study|Lost to Follow-up|1|||
155400835|NCT02790138|560901280|FG001|Overall Study|Lost to Follow-up|0|||
155400836|NCT02790138|560901279|FG000|Overall Study|Voluntary Withdrawal|8|||
155400837|NCT02790138|560901280|FG001|Overall Study|Voluntary Withdrawal|9|||
155400838|NCT02790138|560901279|FG000|Overall Study|Lack of Efficacy|6|||
155400839|NCT02790138|560901280|FG001|Overall Study|Lack of Efficacy|7|||
155400840|NCT02790138|560901279|FG000|Overall Study|Reason not Specified|1|||
155400841|NCT02790138|560901280|FG001|Overall Study|Reason not Specified|0|||
155400842|NCT04037748|560901281|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155400843|NCT04037748|560901282|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155400844|NCT04037748|560901281|FG000|Treatment Period 1|Adverse Event|1|||
155400845|NCT04037748|560901282|FG001|Treatment Period 1|Adverse Event|1|||
155400846|NCT04037748|560901281|FG000|Treatment Period 1|Protocol Violation|4|||
155400847|NCT04037748|560901282|FG001|Treatment Period 1|Protocol Violation|5|||
155400848|NCT04037748|560901281|FG000|Treatment Period 2|Adverse Event|0|||
155400849|NCT04037748|560901282|FG001|Treatment Period 2|Adverse Event|1|||
155400850|NCT04037748|560901281|FG000|Treatment Period 2|Protocol Violation|2|||
155400851|NCT04037748|560901282|FG001|Treatment Period 2|Protocol Violation|0|||
155400852|NCT04702737|560901283|FG000|Overall Study|Decision by Sponsor|1|||
155400853|NCT04702737|560901283|FG000|Overall Study|Withdrawal of Consent from Study|3|||
155400854|NCT04702737|560901283|FG000|Overall Study|Lost to Follow-up|1|||
155400855|NCT04702737|560901283|FG000|Overall Study|Death|35|||
155058074|NCT03154086|559648593|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
155058075|NCT03154086|559648579|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058076|NCT03154086|559648580|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
155058077|NCT03154086|559648581|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155154415|NCT05236270|560002291|FG004|Overall Study|Lost to Follow-up|2|||
155400856|NCT02047253|560901284|FG000|Overall Study|Lost to Follow-up|8|||
155400857|NCT03472924|560901286|FG000|Overall Study|Adverse Event|1|||
155400858|NCT03472924|560901287|FG001|Overall Study|Adverse Event|0|||
155400859|NCT05318937|560901294|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155400860|NCT05318937|560901295|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155400861|NCT05318937|560901294|FG000|Overall Study|Lost to Follow-up|0|||
155400862|NCT05318937|560901295|FG001|Overall Study|Lost to Follow-up|1|||
155400863|NCT05318937|560901294|FG000|Overall Study|Withdrawal by Subject|0|||
155400864|NCT05318937|560901295|FG001|Overall Study|Withdrawal by Subject|2|||
155400865|NCT05318937|560901294|FG000|Overall Study|Protocol Violation|0|||
155400866|NCT05318937|560901295|FG001|Overall Study|Protocol Violation|1|||
155400867|NCT01877915|560901296|FG000|Overall Study|Lost to Follow-up|10|||
155400868|NCT01877915|560901297|FG001|Overall Study|Lost to Follow-up|9|||
155400869|NCT01877915|560901296|FG000|Overall Study|Withdrawal by Subject|42|||
155058078|NCT03154086|559648582|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155400870|NCT01877915|560901297|FG001|Overall Study|Withdrawal by Subject|55|||
155400871|NCT01877915|560901296|FG000|Overall Study|Other|2|||
155400872|NCT01877915|560901297|FG001|Overall Study|Other|4|||
155400873|NCT01045798|560901298|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
154954127|NCT03002077|559257455|FG000|Overall Study|Withdrawal by Subject|72|||
154954128|NCT03002077|559257455|FG000|Overall Study|Lost to Follow-up|21|||
154954129|NCT03002077|559257455|FG000|Overall Study|Pregnancy|4|||
154954130|NCT03002077|559257455|FG000|Overall Study|Protocol Violation|21|||
154954131|NCT04625114|559257460|FG000|Overall Study|Adverse Event|3|||
154954132|NCT04625114|559257461|FG001|Overall Study|Adverse Event|1|||
154954133|NCT04625114|559257460|FG000|Overall Study|Withdrawal by Subject|2|||
154954134|NCT04625114|559257461|FG001|Overall Study|Withdrawal by Subject|0|||
154954135|NCT00854308|559257469|FG000|Overall Study|Disease progression|42|||
154954136|NCT00854308|559257470|FG001|Overall Study|Disease progression|50|||
154954137|NCT00854308|559257469|FG000|Overall Study|Adverse Event|8|||
154954138|NCT00854308|559257470|FG001|Overall Study|Adverse Event|3|||
154954139|NCT00854308|559257469|FG000|Overall Study|Death|2|||
154954140|NCT00854308|559257470|FG001|Overall Study|Death|5|||
154954141|NCT00854308|559257469|FG000|Overall Study|Physician Decision|6|||
154954142|NCT00854308|559257470|FG001|Overall Study|Physician Decision|6|||
154954143|NCT00854308|559257469|FG000|Overall Study|Withdrawal by Subject|4|||
154954144|NCT00854308|559257470|FG001|Overall Study|Withdrawal by Subject|2|||
154954145|NCT00854308|559257469|FG000|Overall Study|Sponsor's decision to terminate study|0|||
154954146|NCT00854308|559257470|FG001|Overall Study|Sponsor's decision to terminate study|1|||
154954147|NCT01390844|559257471|FG000|Treatment Phase|Adverse Event|12|||
154954148|NCT01390844|559257472|FG001|Treatment Phase|Adverse Event|2|||
154954149|NCT01390844|559257473|FG002|Treatment Phase|Adverse Event|3|||
154954150|NCT01390844|559257474|FG003|Treatment Phase|Adverse Event|2|||
154954151|NCT01390844|559257471|FG000|Treatment Phase|Treatment Failure|23|||
154954152|NCT01390844|559257472|FG001|Treatment Phase|Treatment Failure|25|||
154954153|NCT01390844|559257473|FG002|Treatment Phase|Treatment Failure|10|||
154954154|NCT01390844|559257474|FG003|Treatment Phase|Treatment Failure|13|||
154954155|NCT01390844|559257471|FG000|Treatment Phase|Non-Medical Reasons|5|||
154954156|NCT01390844|559257472|FG001|Treatment Phase|Non-Medical Reasons|1|||
154954157|NCT01390844|559257473|FG002|Treatment Phase|Non-Medical Reasons|8|||
154954158|NCT01390844|559257474|FG003|Treatment Phase|Non-Medical Reasons|1|||
154954159|NCT01390844|559257471|FG000|Treatment Phase|Non-GCP Compliant|0|||
154954160|NCT01390844|559257472|FG001|Treatment Phase|Non-GCP Compliant|0|||
154954161|NCT01390844|559257473|FG002|Treatment Phase|Non-GCP Compliant|10|||
154954162|NCT01390844|559257474|FG003|Treatment Phase|Non-GCP Compliant|3|||
154954163|NCT01390844|559257471|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
154954164|NCT01390844|559257472|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
154954165|NCT01390844|559257473|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
154954166|NCT01390844|559257474|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
154954167|NCT03048500|559257477|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
154954168|NCT03048500|559257477|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
154954169|NCT03048500|559257477|FG000|Reached 1st Response/Continued Treatment|Death|1|||
154954170|NCT03048500|559257477|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
154954171|NCT03048500|559257477|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
154954172|NCT03048500|559257477|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
154954173|NCT03048500|559257477|FG000|Follow up for 3 Years|Death|12|||
154954174|NCT02079766|559257480|FG000|Overall Study|Physician Decision|1|||
154954175|NCT02079766|559257481|FG001|Overall Study|Physician Decision|0|||
154954176|NCT02079766|559257480|FG000|Overall Study|Withdrawal by Subject|1|||
154954177|NCT02079766|559257481|FG001|Overall Study|Withdrawal by Subject|0|||
154954178|NCT02781727|559257483|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
154954179|NCT02781727|559257484|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
154954180|NCT02781727|559257483|FG000|Treatment Period|Withdrawal by Subject|1|||
154954181|NCT02781727|559257484|FG001|Treatment Period|Withdrawal by Subject|0|||
154954182|NCT02781727|559257483|FG000|Treatment Period|Lost to Follow-up|0|||
154954183|NCT02781727|559257484|FG001|Treatment Period|Lost to Follow-up|1|||
154954184|NCT03018249|559257485|FG000|Overall Study|Withdrawal by Subject|2|||
154954185|NCT03018249|559257486|FG001|Overall Study|Withdrawal by Subject|2|||
154954186|NCT02158936|559257489|FG000|Overall Study|Study closed/ terminated|57|||
154954187|NCT02158936|559257490|FG001|Overall Study|Study closed/ terminated|77|||
154954188|NCT02158936|559257489|FG000|Overall Study|Azacitidine tx discontinued|53|||
155058079|NCT03154086|559648583|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155154416|NCT05236270|560002292|FG005|Overall Study|Lost to Follow-up|0|||
154954189|NCT02158936|559257490|FG001|Overall Study|Azacitidine tx discontinued|46|||
154954190|NCT02158936|559257489|FG000|Overall Study|Adverse Event|39|||
154954191|NCT02158936|559257490|FG001|Overall Study|Adverse Event|24|||
154954192|NCT02158936|559257489|FG000|Overall Study|Withdrawal by Subject|15|||
154954193|NCT02158936|559257490|FG001|Overall Study|Withdrawal by Subject|16|||
154954194|NCT02158936|559257489|FG000|Overall Study|Physician Decision|15|||
154954195|NCT02158936|559257490|FG001|Overall Study|Physician Decision|13|||
155400874|NCT01045798|560901299|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
155400875|NCT01045798|560901298|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
155400876|NCT01045798|560901299|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
155400877|NCT01045798|560901298|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
155400878|NCT01045798|560901299|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
155400879|NCT01045798|560901298|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
155400880|NCT01045798|560901299|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
155400881|NCT01449461|560901300|FG000|Overall Study|Adverse Event|0|||
155400882|NCT01449461|560901301|FG001|Overall Study|Adverse Event|3|||
155400883|NCT01449461|560901302|FG002|Overall Study|Adverse Event|2|||
155400884|NCT01449461|560901303|FG003|Overall Study|Adverse Event|3|||
155400885|NCT01449461|560901304|FG004|Overall Study|Adverse Event|4|||
155400886|NCT01449461|560901305|FG005|Overall Study|Adverse Event|4|||
155400887|NCT01449461|560901300|FG000|Overall Study|Death|0|||
155400888|NCT01449461|560901301|FG001|Overall Study|Death|2|||
155400889|NCT01449461|560901302|FG002|Overall Study|Death|0|||
155400890|NCT01449461|560901303|FG003|Overall Study|Death|0|||
155400891|NCT01449461|560901304|FG004|Overall Study|Death|7|||
155400892|NCT01449461|560901305|FG005|Overall Study|Death|1|||
155400893|NCT01449461|560901300|FG000|Overall Study|Physician Decision|0|||
155400894|NCT01449461|560901301|FG001|Overall Study|Physician Decision|1|||
155400895|NCT01449461|560901302|FG002|Overall Study|Physician Decision|0|||
155400896|NCT01449461|560901303|FG003|Overall Study|Physician Decision|4|||
155400897|NCT01449461|560901304|FG004|Overall Study|Physician Decision|1|||
155400898|NCT01449461|560901305|FG005|Overall Study|Physician Decision|0|||
155400899|NCT01449461|560901300|FG000|Overall Study|Documented Progressive Disease|4|||
155400900|NCT01449461|560901301|FG001|Overall Study|Documented Progressive Disease|7|||
155400901|NCT01449461|560901302|FG002|Overall Study|Documented Progressive Disease|14|||
155400902|NCT01449461|560901303|FG003|Overall Study|Documented Progressive Disease|15|||
155400903|NCT01449461|560901304|FG004|Overall Study|Documented Progressive Disease|24|||
155400904|NCT01449461|560901305|FG005|Overall Study|Documented Progressive Disease|5|||
155400905|NCT01449461|560901300|FG000|Overall Study|Clinical Progressive Disease|2|||
155400906|NCT01449461|560901301|FG001|Overall Study|Clinical Progressive Disease|2|||
155400907|NCT01449461|560901302|FG002|Overall Study|Clinical Progressive Disease|0|||
155400908|NCT01449461|560901303|FG003|Overall Study|Clinical Progressive Disease|3|||
155400909|NCT01449461|560901304|FG004|Overall Study|Clinical Progressive Disease|4|||
155400910|NCT01449461|560901305|FG005|Overall Study|Clinical Progressive Disease|2|||
155400911|NCT01449461|560901300|FG000|Overall Study|Protocol Violation|0|||
155400912|NCT01449461|560901301|FG001|Overall Study|Protocol Violation|0|||
155400913|NCT01449461|560901302|FG002|Overall Study|Protocol Violation|0|||
155400914|NCT01449461|560901303|FG003|Overall Study|Protocol Violation|1|||
155400915|NCT01449461|560901304|FG004|Overall Study|Protocol Violation|0|||
155400916|NCT01449461|560901305|FG005|Overall Study|Protocol Violation|0|||
155400917|NCT01449461|560901300|FG000|Overall Study|Site Terminated by Sponsor|0|||
155400918|NCT01449461|560901301|FG001|Overall Study|Site Terminated by Sponsor|1|||
155400919|NCT01449461|560901302|FG002|Overall Study|Site Terminated by Sponsor|2|||
155400920|NCT01449461|560901303|FG003|Overall Study|Site Terminated by Sponsor|3|||
155400921|NCT01449461|560901304|FG004|Overall Study|Site Terminated by Sponsor|4|||
155400922|NCT01449461|560901305|FG005|Overall Study|Site Terminated by Sponsor|1|||
155400923|NCT01449461|560901300|FG000|Overall Study|Withdrawal by Subject|0|||
155400924|NCT01449461|560901301|FG001|Overall Study|Withdrawal by Subject|1|||
155400925|NCT01449461|560901302|FG002|Overall Study|Withdrawal by Subject|0|||
155400926|NCT01449461|560901303|FG003|Overall Study|Withdrawal by Subject|0|||
155400927|NCT01449461|560901304|FG004|Overall Study|Withdrawal by Subject|2|||
155400928|NCT01449461|560901305|FG005|Overall Study|Withdrawal by Subject|1|||
155400929|NCT01449461|560901300|FG000|Overall Study|Reason not Specified|0|||
155400930|NCT01449461|560901301|FG001|Overall Study|Reason not Specified|1|||
155400931|NCT01449461|560901302|FG002|Overall Study|Reason not Specified|0|||
155400932|NCT01449461|560901303|FG003|Overall Study|Reason not Specified|3|||
155400933|NCT01449461|560901304|FG004|Overall Study|Reason not Specified|2|||
155400934|NCT01449461|560901305|FG005|Overall Study|Reason not Specified|1|||
155400935|NCT02228720|560901307|FG000|Open Label - Day 30|Lost to Follow-up|1|||
155400936|NCT00583024|560901314|FG000|Overall Study|Lost to Follow-up|4|||
155058080|NCT03154086|559648584|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155400937|NCT04198623|560902473|FG000|Overall Study|1 patient was taken off due to covid-19 pandemic shut down|1|||
155400938|NCT05050318|560902481|FG000|Overall Study|Protocol Deviation|1|||
155400939|NCT05050318|560902482|FG001|Overall Study|Protocol Deviation|0|||
155400940|NCT05050318|560902483|FG002|Overall Study|Protocol Deviation|0|||
155400941|NCT04259411|560902484|FG000|Overall Study|Death|1|||
155400942|NCT04259411|560902484|FG000|Overall Study|Missed visit|2|||
155400943|NCT00736255|560902485|FG000|Overall Study|Adverse Event|1|||
155400944|NCT00736255|560902486|FG001|Overall Study|Adverse Event|0|||
155400945|NCT00736255|560902485|FG000|Overall Study|Physician Decision|1|||
155400946|NCT00736255|560902486|FG001|Overall Study|Physician Decision|0|||
155400947|NCT00736255|560902485|FG000|Overall Study|Non-compliance|1|||
155400948|NCT00736255|560902486|FG001|Overall Study|Non-compliance|1|||
155400949|NCT04183790|560902489|FG000|Overall Study|Participants did not rollover to Part B|12|||
155400950|NCT04183790|560902490|FG001|Overall Study|Participants did not rollover to Part B|0|||
155400951|NCT04183790|560902489|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
155400952|NCT04183790|560902490|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155400953|NCT04183790|560902489|FG000|Overall Study|Commercial drug is available for participant|6|||
155058081|NCT03154086|559648585|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058082|NCT03154086|559648586|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058083|NCT03154086|559648587|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058084|NCT03154086|559648588|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058085|NCT03154086|559648589|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058086|NCT03154086|559648590|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058087|NCT03154086|559648591|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058088|NCT03154086|559648592|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058089|NCT03154086|559648593|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
155058090|NCT03154086|559648579|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058091|NCT03154086|559648580|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058092|NCT03154086|559648581|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
155058093|NCT03154086|559648582|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058094|NCT03154086|559648583|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058095|NCT03154086|559648584|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058096|NCT03154086|559648585|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058097|NCT03154086|559648586|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058098|NCT03154086|559648587|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058099|NCT03154086|559648588|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058100|NCT03154086|559648589|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058101|NCT03154086|559648590|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058102|NCT03154086|559648591|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058103|NCT03154086|559648592|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058104|NCT03154086|559648593|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
155058105|NCT03154086|559648579|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
155058106|NCT03154086|559648580|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058107|NCT03154086|559648581|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058108|NCT03154086|559648582|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058109|NCT03154086|559648583|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058110|NCT03154086|559648584|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058111|NCT03154086|559648585|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058112|NCT03154086|559648586|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058113|NCT03154086|559648587|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058114|NCT03154086|559648588|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058115|NCT03154086|559648589|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058116|NCT03154086|559648590|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058117|NCT03154086|559648591|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058118|NCT03154086|559648592|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058119|NCT03154086|559648593|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
155058120|NCT03154086|559648579|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058121|NCT03154086|559648580|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058122|NCT03154086|559648581|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058123|NCT03154086|559648582|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058124|NCT03154086|559648583|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058125|NCT03154086|559648584|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058126|NCT03154086|559648585|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058127|NCT03154086|559648586|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058128|NCT03154086|559648587|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
155058129|NCT03154086|559648588|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058130|NCT03154086|559648589|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058131|NCT03154086|559648590|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058132|NCT03154086|559648591|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058133|NCT03154086|559648592|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058134|NCT03154086|559648593|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
155058135|NCT03154086|559648579|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058136|NCT03154086|559648580|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058137|NCT03154086|559648581|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058138|NCT03154086|559648582|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058139|NCT03154086|559648583|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155400954|NCT04183790|560902490|FG001|Overall Study|Commercial drug is available for participant|0|||
155058140|NCT03154086|559648584|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058141|NCT03154086|559648585|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058142|NCT03154086|559648586|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
155400955|NCT04183790|560902489|FG000|Overall Study|Adverse Event|1|||
155400956|NCT04183790|560902490|FG001|Overall Study|Adverse Event|0|||
155400957|NCT04183790|560902489|FG000|Overall Study|Not enrolled in 107 study|0|||
155400958|NCT04183790|560902490|FG001|Overall Study|Not enrolled in 107 study|2|||
155400959|NCT01251653|560902491|FG000|Overall Study|Progressive Disease|1|||
155400960|NCT01251653|560902492|FG001|Overall Study|Progressive Disease|7|||
155400961|NCT01251653|560902493|FG002|Overall Study|Progressive Disease|16|||
155400962|NCT01251653|560902494|FG003|Overall Study|Progressive Disease|4|||
155400963|NCT01251653|560902495|FG004|Overall Study|Progressive Disease|0|||
155400964|NCT01251653|560902496|FG005|Overall Study|Progressive Disease|17|||
155400965|NCT01251653|560902497|FG006|Overall Study|Progressive Disease|14|||
155400966|NCT01251653|560902498|FG007|Overall Study|Progressive Disease|7|||
155400967|NCT01251653|560902499|FG008|Overall Study|Progressive Disease|5|||
155400968|NCT01251653|560902491|FG000|Overall Study|Dose-limiting toxicity|0|||
155400969|NCT01251653|560902492|FG001|Overall Study|Dose-limiting toxicity|1|||
155400970|NCT01251653|560902493|FG002|Overall Study|Dose-limiting toxicity|1|||
155400971|NCT01251653|560902494|FG003|Overall Study|Dose-limiting toxicity|1|||
155400972|NCT01251653|560902495|FG004|Overall Study|Dose-limiting toxicity|0|||
155400973|NCT01251653|560902496|FG005|Overall Study|Dose-limiting toxicity|0|||
155400974|NCT01251653|560902497|FG006|Overall Study|Dose-limiting toxicity|2|||
155400975|NCT01251653|560902498|FG007|Overall Study|Dose-limiting toxicity|0|||
155400976|NCT01251653|560902499|FG008|Overall Study|Dose-limiting toxicity|0|||
155400977|NCT01251653|560902491|FG000|Overall Study|Adverse Event|1|||
155400978|NCT01251653|560902492|FG001|Overall Study|Adverse Event|0|||
155400979|NCT01251653|560902493|FG002|Overall Study|Adverse Event|2|||
155400980|NCT01251653|560902494|FG003|Overall Study|Adverse Event|1|||
155400981|NCT01251653|560902495|FG004|Overall Study|Adverse Event|1|||
155400982|NCT01251653|560902496|FG005|Overall Study|Adverse Event|0|||
155400983|NCT01251653|560902497|FG006|Overall Study|Adverse Event|2|||
155400984|NCT01251653|560902498|FG007|Overall Study|Adverse Event|2|||
155400985|NCT01251653|560902499|FG008|Overall Study|Adverse Event|1|||
155400986|NCT01251653|560902491|FG000|Overall Study|Withdrawal by Subject|1|||
155400987|NCT01251653|560902492|FG001|Overall Study|Withdrawal by Subject|0|||
155400988|NCT01251653|560902493|FG002|Overall Study|Withdrawal by Subject|1|||
155400989|NCT01251653|560902494|FG003|Overall Study|Withdrawal by Subject|0|||
155400990|NCT01251653|560902495|FG004|Overall Study|Withdrawal by Subject|1|||
155400991|NCT01251653|560902496|FG005|Overall Study|Withdrawal by Subject|1|||
155400992|NCT01251653|560902497|FG006|Overall Study|Withdrawal by Subject|0|||
155400993|NCT01251653|560902498|FG007|Overall Study|Withdrawal by Subject|1|||
155400994|NCT01251653|560902499|FG008|Overall Study|Withdrawal by Subject|0|||
155400995|NCT01251653|560902491|FG000|Overall Study|Other reason not mentioned above|0|||
155400996|NCT01251653|560902492|FG001|Overall Study|Other reason not mentioned above|0|||
155400997|NCT01251653|560902493|FG002|Overall Study|Other reason not mentioned above|0|||
155400998|NCT01251653|560902494|FG003|Overall Study|Other reason not mentioned above|0|||
155400999|NCT01251653|560902495|FG004|Overall Study|Other reason not mentioned above|0|||
155401000|NCT01251653|560902496|FG005|Overall Study|Other reason not mentioned above|0|||
155401001|NCT01251653|560902497|FG006|Overall Study|Other reason not mentioned above|0|||
155058143|NCT03154086|559648587|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058144|NCT03154086|559648588|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058145|NCT03154086|559648589|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058146|NCT03154086|559648590|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058147|NCT03154086|559648591|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058148|NCT03154086|559648592|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155058149|NCT03154086|559648593|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
155401002|NCT01251653|560902498|FG007|Overall Study|Other reason not mentioned above|2|||
155058150|NCT03154086|559648579|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
155284782|NCT01941316|560474417|FG000|Overall Study|Withdrawal by Subject|0|||
155401003|NCT01251653|560902499|FG008|Overall Study|Other reason not mentioned above|0|||
155401004|NCT01502709|560902501|FG000|Overall Study|Lost to Follow-up|4|||
155058151|NCT03154086|559648580|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
155401005|NCT01502709|560902502|FG001|Overall Study|Lost to Follow-up|0|||
155401006|NCT00346073|560902504|FG000|Overall Study|Serious Adverse Event|2|||
155401007|NCT00346073|560902505|FG001|Overall Study|Serious Adverse Event|0|||
155058152|NCT03154086|559648581|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
155058153|NCT03154086|559648582|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
155401008|NCT00346073|560902504|FG000|Overall Study|Lost to Follow-up|39|||
155401009|NCT00346073|560902505|FG001|Overall Study|Lost to Follow-up|24|||
155401010|NCT00457015|560902507|FG000|Overall Study|Left study site against medical advice|0|||
155401011|NCT00457015|560902508|FG001|Overall Study|Left study site against medical advice|1|||
155058154|NCT03154086|559648583|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
155058155|NCT03154086|559648584|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
155058156|NCT03154086|559648585|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
155058157|NCT03154086|559648586|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
155058158|NCT03154086|559648587|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
155058159|NCT03154086|559648588|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
155058160|NCT03154086|559648589|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
155058161|NCT03154086|559648590|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
155058162|NCT03154086|559648591|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
155058163|NCT03154086|559648592|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
155058164|NCT03154086|559648593|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
155058165|NCT04076917|559648594|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
155058166|NCT04076917|559648594|FG000|Overall Study|Study closure|13|||
155058167|NCT04076917|559648594|FG000|Overall Study|Physician Decision|3|||
155058168|NCT04076917|559648594|FG000|Overall Study|Death|1|||
155058169|NCT04076917|559648594|FG000|Overall Study|Lost to Follow-up|1|||
155058170|NCT04076917|559648594|FG000|Overall Study|Withdrawal by Subject|1|||
155058171|NCT04076917|559648594|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
155058172|NCT01774591|559648597|FG000|Overall Study|Physician Decision|1|||
155058173|NCT01774591|559648598|FG001|Overall Study|Physician Decision|1|||
155058174|NCT01774591|559648597|FG000|Overall Study|Withdrawal by Subject|0|||
155058175|NCT01774591|559648598|FG001|Overall Study|Withdrawal by Subject|1|||
155058176|NCT01774591|559648597|FG000|Overall Study|Adverse Event|0|||
155058177|NCT01774591|559648598|FG001|Overall Study|Adverse Event|2|||
155058178|NCT01701245|559648599|FG000|Overall Study|Protocol Violation|1|||
155058179|NCT01701245|559648600|FG001|Overall Study|Protocol Violation|3|||
155058180|NCT01701245|559648599|FG000|Overall Study|Did not complete the open label period|11|||
155058181|NCT01701245|559648600|FG001|Overall Study|Did not complete the open label period|12|||
155058182|NCT01159574|559648601|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
155058183|NCT01159574|559648601|FG000|Treatment Phase|Adverse Event|3|||
155058184|NCT01159574|559648601|FG000|Treatment Phase|Death|6|||
155058185|NCT01159574|559648601|FG000|Treatment Phase|Physician Decision|2|||
155058186|NCT01159574|559648601|FG000|Treatment Phase|Withdrawal by Subject|7|||
155058187|NCT01159574|559648601|FG000|Treatment Phase|still on treatment|2|||
155058188|NCT01159574|559648601|FG000|Follow Up Phase|Lost to Follow-up|2|||
155058189|NCT01159574|559648601|FG000|Follow Up Phase|still being followed for overall surviva|18|||
155058190|NCT01787552|559648604|FG000|Overall Study|Withdrawal by Subject|2|||
155058191|NCT01787552|559648605|FG001|Overall Study|Withdrawal by Subject|0|||
155058192|NCT01787552|559648606|FG002|Overall Study|Withdrawal by Subject|0|||
155058193|NCT01787552|559648607|FG003|Overall Study|Withdrawal by Subject|4|||
155058194|NCT01787552|559648604|FG000|Overall Study|Physician Decision|2|||
155058195|NCT01787552|559648605|FG001|Overall Study|Physician Decision|2|||
155058196|NCT01787552|559648606|FG002|Overall Study|Physician Decision|1|||
155058197|NCT01787552|559648607|FG003|Overall Study|Physician Decision|2|||
155058198|NCT01787552|559648604|FG000|Overall Study|Death|0|||
155058199|NCT01787552|559648605|FG001|Overall Study|Death|0|||
155058200|NCT01787552|559648606|FG002|Overall Study|Death|0|||
155058201|NCT01787552|559648607|FG003|Overall Study|Death|1|||
155058202|NCT01787552|559648604|FG000|Overall Study|Adverse Event|2|||
155058203|NCT01787552|559648605|FG001|Overall Study|Adverse Event|5|||
155058204|NCT01787552|559648606|FG002|Overall Study|Adverse Event|2|||
155058205|NCT01787552|559648607|FG003|Overall Study|Adverse Event|16|||
155058206|NCT01787552|559648604|FG000|Overall Study|Study terminated by Sponsor|0|||
155058207|NCT01787552|559648605|FG001|Overall Study|Study terminated by Sponsor|0|||
155058208|NCT01787552|559648606|FG002|Overall Study|Study terminated by Sponsor|1|||
155058209|NCT01787552|559648607|FG003|Overall Study|Study terminated by Sponsor|3|||
155058210|NCT01787552|559648604|FG000|Overall Study|Progressive Disease|2|||
155058211|NCT01787552|559648605|FG001|Overall Study|Progressive Disease|2|||
155058212|NCT01787552|559648606|FG002|Overall Study|Progressive Disease|1|||
155058213|NCT01787552|559648607|FG003|Overall Study|Progressive Disease|1|||
155058214|NCT00630916|559648608|FG000|Overall Study|Death|110|||
155058215|NCT00630916|559648608|FG000|Overall Study|Explant|8|||
155058216|NCT00630916|559648608|FG000|Overall Study|Lost to Follow-up|5|||
155284783|NCT01941316|560474418|FG001|Overall Study|Withdrawal by Subject|2|||
155284784|NCT01941316|560474419|FG002|Overall Study|Withdrawal by Subject|1|||
155284785|NCT01941316|560474420|FG003|Overall Study|Withdrawal by Subject|8|||
155401012|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
155401013|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
155058217|NCT00630916|559648608|FG000|Overall Study|Withdrawal by Subject|30|||
155058218|NCT00630916|559648608|FG000|Overall Study|Protocol Violation|7|||
155058219|NCT00630916|559648608|FG000|Overall Study|Physician Decision|47|||
155058220|NCT00630916|559648608|FG000|Overall Study|Lack of Efficacy|3|||
155284786|NCT01941316|560474417|FG000|Overall Study|Death|0|||
155284787|NCT01941316|560474418|FG001|Overall Study|Death|0|||
155058221|NCT02147626|559648609|FG000|Overall Study|Lost to Follow-up|4|||
155058222|NCT02147626|559648610|FG001|Overall Study|Lost to Follow-up|4|||
155058223|NCT02147626|559648609|FG000|Overall Study|Pregnancy|1|||
155058224|NCT02147626|559648610|FG001|Overall Study|Pregnancy|2|||
155058225|NCT02147626|559648609|FG000|Overall Study|Withdrawal by Subject|0|||
155058226|NCT02147626|559648610|FG001|Overall Study|Withdrawal by Subject|1|||
155058227|NCT00572832|559648611|FG000|Overall Study|Lost to Follow-up|0|||
155058228|NCT00572832|559648612|FG001|Overall Study|Lost to Follow-up|11|||
155058229|NCT00572832|559648611|FG000|Overall Study|Pregnancy|0|||
155058230|NCT00572832|559648612|FG001|Overall Study|Pregnancy|1|||
155058231|NCT00324155|559648613|FG000|Enrolled and Randomized|No longer met study criteria|3|||
155058232|NCT00324155|559648614|FG001|Enrolled and Randomized|No longer met study criteria|0|||
155058233|NCT00324155|559648613|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
155058234|NCT00324155|559648614|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
155058235|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
155058236|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
155058237|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
155058238|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
155058239|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Death|8|||
155058240|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Death|15|||
155058241|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
155058242|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
155058243|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
155058244|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
155058245|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
155058246|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
155058247|NCT00324155|559648613|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
155058248|NCT00324155|559648614|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
155058249|NCT00324155|559648613|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
155058250|NCT00324155|559648614|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
155058251|NCT00324155|559648613|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
155058252|NCT00324155|559648614|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
155058253|NCT00324155|559648613|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
155058254|NCT00324155|559648614|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
155058255|NCT00324155|559648613|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
155058256|NCT00324155|559648614|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
155058257|NCT00324155|559648613|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
155058258|NCT00324155|559648614|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
155058259|NCT00324155|559648613|FG000|Follow-up Phase|On-going participants still on drug|11|||
155058260|NCT00324155|559648614|FG001|Follow-up Phase|On-going participants still on drug|6|||
155058261|NCT00390689|559648615|FG000|Overall Study|Adverse Event|2|||
155058262|NCT00390689|559648616|FG001|Overall Study|Adverse Event|5|||
155058263|NCT00390689|559648617|FG002|Overall Study|Adverse Event|2|||
155058264|NCT00390689|559648615|FG000|Overall Study|Lack of Efficacy|0|||
155058265|NCT00390689|559648616|FG001|Overall Study|Lack of Efficacy|0|||
155058266|NCT00390689|559648617|FG002|Overall Study|Lack of Efficacy|1|||
155058267|NCT00390689|559648615|FG000|Overall Study|Protocol Violation|1|||
155058268|NCT00390689|559648616|FG001|Overall Study|Protocol Violation|0|||
155058269|NCT00390689|559648617|FG002|Overall Study|Protocol Violation|0|||
155058270|NCT00390689|559648615|FG000|Overall Study|Investigator's judgement|2|||
155058271|NCT00390689|559648616|FG001|Overall Study|Investigator's judgement|0|||
155058272|NCT00390689|559648617|FG002|Overall Study|Investigator's judgement|0|||
155058273|NCT01253161|559648618|FG000|Overall Study|Adverse Event|1|||
155058274|NCT03167242|559648619|FG000|Overall Study|Patient/Guardian Decision|0|||
155058275|NCT03167242|559648620|FG001|Overall Study|Patient/Guardian Decision|1|||
155058276|NCT03167242|559648621|FG002|Overall Study|Patient/Guardian Decision|2|||
155058277|NCT03167242|559648622|FG003|Overall Study|Patient/Guardian Decision|1|||
155058278|NCT03167242|559648623|FG004|Overall Study|Patient/Guardian Decision|1|||
155058279|NCT03167242|559648624|FG005|Overall Study|Patient/Guardian Decision|1|||
155058280|NCT03167242|559648625|FG006|Overall Study|Patient/Guardian Decision|0|||
155058281|NCT03167242|559648626|FG007|Overall Study|Patient/Guardian Decision|0|||
155058282|NCT03167242|559648627|FG008|Overall Study|Patient/Guardian Decision|0|||
155058283|NCT03167242|559648628|FG009|Overall Study|Patient/Guardian Decision|0|||
155058284|NCT03167242|559648629|FG010|Overall Study|Patient/Guardian Decision|1|||
155058285|NCT03167242|559648630|FG011|Overall Study|Patient/Guardian Decision|0|||
155058286|NCT03167242|559648619|FG000|Overall Study|Lost to Follow-up|0|||
155058287|NCT03167242|559648620|FG001|Overall Study|Lost to Follow-up|0|||
155058288|NCT03167242|559648621|FG002|Overall Study|Lost to Follow-up|1|||
155058289|NCT03167242|559648622|FG003|Overall Study|Lost to Follow-up|0|||
155058290|NCT03167242|559648623|FG004|Overall Study|Lost to Follow-up|0|||
155058291|NCT03167242|559648624|FG005|Overall Study|Lost to Follow-up|1|||
155058292|NCT03167242|559648625|FG006|Overall Study|Lost to Follow-up|2|||
155058293|NCT03167242|559648626|FG007|Overall Study|Lost to Follow-up|1|||
155058294|NCT03167242|559648627|FG008|Overall Study|Lost to Follow-up|0|||
155284788|NCT01941316|560474419|FG002|Overall Study|Death|0|||
155401014|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
155401015|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
155401016|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
155401017|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
155401018|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
155401019|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
155401020|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
155401021|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
155401022|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
155401023|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
155401024|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
155401025|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
155401026|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
155401027|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
155401028|NCT03670953|560902509|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
155401029|NCT03670953|560902510|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
155401030|NCT03670953|560902511|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
155401031|NCT03670953|560902512|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
155401032|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
155401033|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
155401034|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
155401035|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
155401036|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
155401037|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
155401038|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
155401039|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
155401040|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
155401041|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
155401042|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
155401043|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
155401044|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
155401045|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
155401046|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
155401047|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
155401048|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
155401049|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
155401050|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
155401051|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
155401052|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
155401053|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
155401054|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
155401055|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
155401056|NCT03670953|560902509|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
155401057|NCT03670953|560902510|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
155401058|NCT03670953|560902511|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
155401059|NCT03670953|560902512|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
154954196|NCT02158936|559257489|FG000|Overall Study|Lost to Follow-up|0|||
154954197|NCT02158936|559257490|FG001|Overall Study|Lost to Follow-up|1|||
154954198|NCT00522457|559257491|FG000|Overall Study|Due to disease progression|16|||
154954199|NCT00522457|559257491|FG000|Overall Study|Adverse Event|2|||
154954200|NCT00549718|559259496|FG000|Overall Study|Insufficient clinical response|20|||
154954201|NCT00549718|559259497|FG001|Overall Study|Insufficient clinical response|7|||
154954202|NCT00549718|559259498|FG002|Overall Study|Insufficient clinical response|18|||
154954203|NCT00549718|559259499|FG003|Overall Study|Insufficient clinical response|32|||
154954204|NCT00549718|559259496|FG000|Overall Study|Adverse Event|6|||
154954205|NCT00549718|559259497|FG001|Overall Study|Adverse Event|8|||
154954206|NCT00549718|559259498|FG002|Overall Study|Adverse Event|7|||
154954207|NCT00549718|559259499|FG003|Overall Study|Adverse Event|3|||
154954208|NCT00549718|559259496|FG000|Overall Study|Lost to Follow-up|4|||
154954209|NCT00549718|559259497|FG001|Overall Study|Lost to Follow-up|2|||
154954210|NCT00549718|559259498|FG002|Overall Study|Lost to Follow-up|0|||
154954211|NCT00549718|559259499|FG003|Overall Study|Lost to Follow-up|6|||
154954212|NCT00549718|559259496|FG000|Overall Study|Withdrawal by Subject|9|||
154954213|NCT00549718|559259497|FG001|Overall Study|Withdrawal by Subject|18|||
154954214|NCT00549718|559259498|FG002|Overall Study|Withdrawal by Subject|12|||
154954215|NCT00549718|559259499|FG003|Overall Study|Withdrawal by Subject|13|||
154954216|NCT00549718|559259496|FG000|Overall Study|Administrative|2|||
154954217|NCT00549718|559259497|FG001|Overall Study|Administrative|2|||
155284789|NCT01941316|560474420|FG003|Overall Study|Death|3|||
154954218|NCT00549718|559259498|FG002|Overall Study|Administrative|2|||
154954219|NCT00549718|559259499|FG003|Overall Study|Administrative|1|||
155058295|NCT03167242|559648628|FG009|Overall Study|Lost to Follow-up|0|||
155058296|NCT03167242|559648629|FG010|Overall Study|Lost to Follow-up|1|||
155058297|NCT03167242|559648630|FG011|Overall Study|Lost to Follow-up|1|||
155401060|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
155401061|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
155401062|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
155401063|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
155401064|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
155401065|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
155401066|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
155401067|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
155401068|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
155401069|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
155401070|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
155401071|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
155401072|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
155401073|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
155401074|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
155401075|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
155401076|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
155401077|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
155401078|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
155401079|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
155401080|NCT03670953|560902509|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
155401081|NCT03670953|560902510|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
155401082|NCT03670953|560902511|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
155401083|NCT03670953|560902512|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
155401084|NCT04179734|560902513|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
155401085|NCT04179734|560902514|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
155401086|NCT04179734|560902513|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
155401087|NCT04179734|560902514|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
155401088|NCT00937937|560902516|FG000|Overall Study|Adverse Event|6|||
155401089|NCT00937937|560902516|FG000|Overall Study|Withdrawal by Subject|2|||
155401090|NCT00937937|560902516|FG000|Overall Study|Progression/relapse|61|||
155401091|NCT00937937|560902516|FG000|Overall Study|Death|1|||
155401092|NCT00937937|560902516|FG000|Overall Study|Other|2|||
155401093|NCT03197493|560902518|FG000|Overall Study|Withdrawal by Subject|5|||
155401094|NCT00054704|560902519|FG000|Overall Study|Lack of Efficacy|2|||
155401095|NCT00054704|560902520|FG001|Overall Study|Lack of Efficacy|3|||
155401096|NCT00054704|560902519|FG000|Overall Study|Adverse Event|3|||
155401097|NCT00054704|560902520|FG001|Overall Study|Adverse Event|1|||
155401098|NCT00054704|560902519|FG000|Overall Study|Lost to Follow-up|0|||
155401099|NCT00054704|560902520|FG001|Overall Study|Lost to Follow-up|1|||
155401100|NCT00362414|560902523|FG000|Overall Study|Death|2|||
155401101|NCT00362414|560902523|FG000|Overall Study|Adverse Event|1|||
155401102|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
155401103|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
155401104|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
155401105|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
155401106|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
155401107|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
155401108|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Death|2|||
155401109|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Death|0|||
155401110|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
155401111|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
155401112|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
155401113|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
155401114|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
155401115|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155401116|NCT02603120|560902524|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
155401117|NCT02603120|560902525|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
155401118|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
155401119|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
155401120|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
155401121|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
155401122|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
155401123|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
155058298|NCT03167242|559648619|FG000|Overall Study|Reason not provided|0|||
155401124|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
155401125|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
155401126|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
155401127|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
155401128|NCT02603120|560902524|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
155401129|NCT02603120|560902525|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
155401130|NCT01469182|560902526|FG000|Overall Study|Adverse Event|21|||
155401131|NCT01469182|560902527|FG001|Overall Study|Adverse Event|3|||
155401132|NCT01469182|560902526|FG000|Overall Study|Lost to Follow-up|3|||
155401133|NCT01469182|560902527|FG001|Overall Study|Lost to Follow-up|0|||
155401134|NCT01469182|560902526|FG000|Overall Study|Withdrawal by Subject|4|||
155401135|NCT01469182|560902527|FG001|Overall Study|Withdrawal by Subject|1|||
155401136|NCT01469182|560902526|FG000|Overall Study|Protocol Violation|4|||
155401137|NCT01469182|560902527|FG001|Overall Study|Protocol Violation|2|||
155401138|NCT01469182|560902526|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
155401139|NCT01469182|560902527|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
155401140|NCT02236520|560902529|FG000|Overall Study|Physician Decision|0|||
155401141|NCT02236520|560902530|FG001|Overall Study|Physician Decision|5|||
155401142|NCT02236520|560902531|FG002|Overall Study|Physician Decision|0|||
155401143|NCT02236520|560902532|FG003|Overall Study|Physician Decision|0|||
155401144|NCT02236520|560902529|FG000|Overall Study|Withdrawal by Subject|1|||
155401145|NCT02236520|560902530|FG001|Overall Study|Withdrawal by Subject|0|||
155401146|NCT02236520|560902531|FG002|Overall Study|Withdrawal by Subject|0|||
155401147|NCT02236520|560902532|FG003|Overall Study|Withdrawal by Subject|1|||
155401148|NCT02236520|560902529|FG000|Overall Study|Pregnancy|1|||
155401149|NCT02236520|560902530|FG001|Overall Study|Pregnancy|0|||
155401150|NCT02236520|560902531|FG002|Overall Study|Pregnancy|0|||
155401151|NCT02236520|560902532|FG003|Overall Study|Pregnancy|0|||
155401152|NCT01785160|560902533|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
155401153|NCT01785160|560902533|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
155401154|NCT03807349|560902534|FG000|Overall Study|Early Study Termination|9|||
155401155|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
155401156|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
155401157|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
155401158|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
155401159|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
155401160|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
155401161|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
155401162|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
155401163|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
155401164|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
155401165|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
155401166|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
155401167|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
155401168|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
155401169|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
155401170|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
155401171|NCT00094770|560902535|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
155401172|NCT00094770|560902536|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
155401173|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
155401174|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
155401175|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
155401176|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
155401177|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
155401178|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
155401179|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
155401180|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
155401181|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
155401182|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
155401183|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
155401184|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
155401185|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
155401186|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
155401187|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
155401188|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
155401189|NCT00094770|560902535|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
155401190|NCT00094770|560902536|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
154954220|NCT02424097|559259500|FG000|Overall Study|Lost to Follow-up|1|||
155401191|NCT00253643|560902537|FG000|Overall Study|Withdrawal by Subject|0|||
155401192|NCT00253643|560902538|FG001|Overall Study|Withdrawal by Subject|0|||
155401193|NCT00253643|560902539|FG002|Overall Study|Withdrawal by Subject|1|||
155401194|NCT00253643|560902540|FG003|Overall Study|Withdrawal by Subject|1|||
155401195|NCT00253643|560902537|FG000|Overall Study|Non-Compliance|0|||
155401196|NCT00253643|560902538|FG001|Overall Study|Non-Compliance|0|||
155401197|NCT00253643|560902539|FG002|Overall Study|Non-Compliance|0|||
155401198|NCT00253643|560902540|FG003|Overall Study|Non-Compliance|2|||
155401199|NCT01368536|560902544|FG000|Overall Study|Adverse Event|5|||
155401200|NCT01368536|560902545|FG001|Overall Study|Adverse Event|6|||
155401201|NCT01368536|560902546|FG002|Overall Study|Adverse Event|8|||
155401202|NCT01368536|560902544|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155401203|NCT01368536|560902545|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155401204|NCT01368536|560902546|FG002|Overall Study|Abnormal laboratory value(s)|2|||
155401205|NCT01368536|560902544|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155401206|NCT01368536|560902545|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155401207|NCT01368536|560902546|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155401208|NCT01368536|560902544|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
155401209|NCT01368536|560902545|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155401210|NCT01368536|560902546|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155401211|NCT01368536|560902544|FG000|Overall Study|No longer required study medication|0|||
155401212|NCT01368536|560902545|FG001|Overall Study|No longer required study medication|0|||
155401213|NCT01368536|560902546|FG002|Overall Study|No longer required study medication|1|||
155401214|NCT01368536|560902544|FG000|Overall Study|Withdrawal by Subject|2|||
155401215|NCT01368536|560902545|FG001|Overall Study|Withdrawal by Subject|5|||
155401216|NCT01368536|560902546|FG002|Overall Study|Withdrawal by Subject|4|||
155401217|NCT01368536|560902544|FG000|Overall Study|Lost to Follow-up|3|||
155401218|NCT01368536|560902545|FG001|Overall Study|Lost to Follow-up|3|||
155401219|NCT01368536|560902546|FG002|Overall Study|Lost to Follow-up|5|||
155401220|NCT01368536|560902544|FG000|Overall Study|Administrative problems|34|||
155401221|NCT01368536|560902545|FG001|Overall Study|Administrative problems|39|||
155401222|NCT01368536|560902546|FG002|Overall Study|Administrative problems|35|||
155401223|NCT01368536|560902544|FG000|Overall Study|Protocol deviation|0|||
155401224|NCT01368536|560902545|FG001|Overall Study|Protocol deviation|3|||
155401225|NCT01368536|560902546|FG002|Overall Study|Protocol deviation|1|||
155401226|NCT02636582|560902549|FG000|Overall Study|Surgical Pathology|1|||
155401227|NCT02636582|560902550|FG001|Overall Study|Surgical Pathology|0|||
155401228|NCT04451161|560902551|FG000|Overall Study|Lost to Follow-up|28|||
155401229|NCT04451161|560902552|FG001|Overall Study|Lost to Follow-up|37|||
155401230|NCT04451161|560902553|FG002|Overall Study|Lost to Follow-up|22|||
155401231|NCT04451161|560902554|FG003|Overall Study|Lost to Follow-up|13|||
155401232|NCT04451161|560902555|FG004|Overall Study|Lost to Follow-up|11|||
155401233|NCT04451161|560902556|FG005|Overall Study|Lost to Follow-up|14|||
155401234|NCT04451161|560902551|FG000|Overall Study|Withdrawal by Subject|3|||
155401235|NCT04451161|560902552|FG001|Overall Study|Withdrawal by Subject|0|||
155401236|NCT04451161|560902553|FG002|Overall Study|Withdrawal by Subject|0|||
155401237|NCT04451161|560902554|FG003|Overall Study|Withdrawal by Subject|0|||
155401238|NCT04451161|560902555|FG004|Overall Study|Withdrawal by Subject|2|||
155401239|NCT04451161|560902556|FG005|Overall Study|Withdrawal by Subject|4|||
155401240|NCT00454857|560902557|FG000|Overall Study|Withdrawal by Subject|15|||
155401241|NCT00454857|560902557|FG000|Overall Study|Lost to Follow-up|16|||
155401242|NCT00454857|560902557|FG000|Overall Study|Noncompliance|6|||
155401243|NCT00454857|560902557|FG000|Overall Study|Death|5|||
155401244|NCT00454857|560902557|FG000|Overall Study|Other|11|||
155401245|NCT00454857|560902557|FG000|Overall Study|Reason unknown|1|||
155401246|NCT00596947|560902558|FG000|Overall Study|study halted due to low enrollment|5|||
155401247|NCT00596947|560902559|FG001|Overall Study|study halted due to low enrollment|3|||
155401248|NCT00596947|560902558|FG000|Overall Study|Lost to Follow-up|1|||
155401249|NCT00596947|560902559|FG001|Overall Study|Lost to Follow-up|0|||
155401250|NCT00829179|560902560|FG000|Overall Study|Withdrawal by Subject|1|||
155401251|NCT03000179|560902561|FG000|Overall Study|Lost to Follow-up|2|||
155401252|NCT00827606|560902563|FG000|Overall Study|Protocol Violation|4|||
155401253|NCT00827606|560902564|FG001|Overall Study|Protocol Violation|3|||
155401254|NCT00827606|560902563|FG000|Overall Study|Lost to Follow-up|3|||
155401255|NCT00827606|560902564|FG001|Overall Study|Lost to Follow-up|1|||
155401256|NCT00827606|560902563|FG000|Overall Study|Withdrawal by Subject|7|||
155401257|NCT00827606|560902564|FG001|Overall Study|Withdrawal by Subject|6|||
155401258|NCT00827606|560902563|FG000|Overall Study|Pregnancy|0|||
155401259|NCT00827606|560902564|FG001|Overall Study|Pregnancy|1|||
155058299|NCT03167242|559648620|FG001|Overall Study|Reason not provided|0|||
155058300|NCT03167242|559648621|FG002|Overall Study|Reason not provided|0|||
155401260|NCT00827606|560902563|FG000|Overall Study|Other|5|||
155401261|NCT00827606|560902564|FG001|Overall Study|Other|13|||
155401262|NCT00827606|560902563|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
155401263|NCT00827606|560902564|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
155401264|NCT00827606|560902563|FG000|Overall Study|Adverse Event|4|||
155401265|NCT00827606|560902564|FG001|Overall Study|Adverse Event|2|||
155401266|NCT00243386|560902569|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
155401267|NCT00243386|560902570|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
155401268|NCT00243386|560902571|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
155401269|NCT00243386|560902569|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
155401270|NCT00243386|560902570|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
155401271|NCT00243386|560902571|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
155401272|NCT00243386|560902569|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
155401273|NCT00243386|560902570|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
155401274|NCT00243386|560902571|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
155401275|NCT00243386|560902569|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
155401276|NCT00243386|560902570|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
155401277|NCT00243386|560902571|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
155401278|NCT00243386|560902569|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
155401279|NCT00243386|560902570|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
155401280|NCT00243386|560902571|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
155401281|NCT00243386|560902569|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
155401282|NCT00243386|560902570|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
155401283|NCT00243386|560902571|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
155401284|NCT00243386|560902569|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
155401285|NCT00243386|560902570|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
155401286|NCT00243386|560902571|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
155401287|NCT00243386|560902569|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
155401288|NCT00243386|560902570|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
155401289|NCT00243386|560902571|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
155401290|NCT04995055|560902572|FG000|Period 1|COVID-19 Related|1|||
155401291|NCT04995055|560902573|FG001|Period 1|COVID-19 Related|0|||
155401292|NCT04995055|560902572|FG000|Period 1|Withdrawal by Subject|0|||
155401293|NCT04995055|560902573|FG001|Period 1|Withdrawal by Subject|1|||
155401294|NCT04995055|560902572|FG000|Period 1|Subject discontinued due to timing|4|||
155401295|NCT04995055|560902573|FG001|Period 1|Subject discontinued due to timing|4|||
155401296|NCT01358760|560902575|FG000|Overall Study|Adverse Event|3|||
155401297|NCT01358760|560902576|FG001|Overall Study|Adverse Event|4|||
155401298|NCT01358760|560902577|FG002|Overall Study|Adverse Event|3|||
155401299|NCT01358760|560902575|FG000|Overall Study|Lost to Follow-up|1|||
155401300|NCT01358760|560902576|FG001|Overall Study|Lost to Follow-up|1|||
155401301|NCT01358760|560902577|FG002|Overall Study|Lost to Follow-up|3|||
155401302|NCT01358760|560902575|FG000|Overall Study|Withdrawal by Subject|5|||
155401303|NCT01358760|560902576|FG001|Overall Study|Withdrawal by Subject|3|||
155401304|NCT01358760|560902577|FG002|Overall Study|Withdrawal by Subject|2|||
155401305|NCT01358760|560902575|FG000|Overall Study|Physician Decision|1|||
155401306|NCT01358760|560902576|FG001|Overall Study|Physician Decision|0|||
155401307|NCT01358760|560902577|FG002|Overall Study|Physician Decision|1|||
155401308|NCT01358760|560902575|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
155401309|NCT01358760|560902576|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
155401310|NCT01358760|560902577|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
155401311|NCT04695392|560902578|FG000|Overall Study|Withdrawn by parent/guardian|0|||
155401312|NCT04695392|560902579|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155401313|NCT04695392|560902578|FG000|Overall Study|Withdrawn by physician|0|||
155401314|NCT04695392|560902579|FG001|Overall Study|Withdrawn by physician|1|||
155401315|NCT01506960|560902580|FG000|Overall Study|Did not meet angiographic criteria|47|||
155401316|NCT01987960|560902582|FG000|Period 1|Adverse Event|24|||
155401317|NCT01987960|560902583|FG001|Period 1|Adverse Event|0|||
155401318|NCT01987960|560902584|FG002|Period 1|Adverse Event|0|||
155401319|NCT01987960|560902585|FG003|Period 1|Adverse Event|0|||
155401320|NCT01987960|560902582|FG000|Period 1|Lack of Efficacy|4|||
155401321|NCT01987960|560902583|FG001|Period 1|Lack of Efficacy|0|||
155401322|NCT01987960|560902584|FG002|Period 1|Lack of Efficacy|0|||
155401323|NCT01987960|560902585|FG003|Period 1|Lack of Efficacy|0|||
155401324|NCT01987960|560902582|FG000|Period 1|Non-compliance with IMP|6|||
155401325|NCT01987960|560902583|FG001|Period 1|Non-compliance with IMP|0|||
154954221|NCT02424097|559259501|FG001|Overall Study|Lost to Follow-up|2|||
154954222|NCT02880761|559259502|FG000|Overall Study|Death|6|||
154954223|NCT02880761|559259503|FG001|Overall Study|Death|8|||
154954224|NCT02880761|559259502|FG000|Overall Study|Withdrawal by Subject|3|||
154954225|NCT02880761|559259503|FG001|Overall Study|Withdrawal by Subject|6|||
154954226|NCT02880761|559259502|FG000|Overall Study|Protocol Violation|4|||
154954227|NCT02880761|559259503|FG001|Overall Study|Protocol Violation|3|||
154954228|NCT02880761|559259502|FG000|Overall Study|Lost to Follow-up|3|||
154954229|NCT02880761|559259503|FG001|Overall Study|Lost to Follow-up|4|||
154954230|NCT03597256|559259504|FG000|Overall Study|Lost to Follow-up|3|||
154954231|NCT03597256|559259505|FG001|Overall Study|Lost to Follow-up|1|||
155154417|NCT05236270|560002293|FG006|Overall Study|Lost to Follow-up|1|||
155154418|NCT05236270|560002294|FG007|Overall Study|Lost to Follow-up|3|||
155154419|NCT03486912|560002295|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
155401326|NCT01987960|560902584|FG002|Period 1|Non-compliance with IMP|0|||
155401327|NCT01987960|560902585|FG003|Period 1|Non-compliance with IMP|0|||
155401328|NCT01987960|560902582|FG000|Period 1|Protocol Violation|12|||
155401329|NCT01987960|560902583|FG001|Period 1|Protocol Violation|0|||
155401330|NCT01987960|560902584|FG002|Period 1|Protocol Violation|0|||
155401331|NCT01987960|560902585|FG003|Period 1|Protocol Violation|0|||
154954232|NCT03597256|559259504|FG000|Overall Study|Withdrawal by Subject|0|||
155401332|NCT01987960|560902582|FG000|Period 1|Withdrawal by Subject|21|||
155401333|NCT01987960|560902583|FG001|Period 1|Withdrawal by Subject|0|||
155401334|NCT01987960|560902584|FG002|Period 1|Withdrawal by Subject|0|||
155401335|NCT01987960|560902585|FG003|Period 1|Withdrawal by Subject|0|||
155401336|NCT01987960|560902582|FG000|Period 1|Lost to Follow-up|40|||
155401337|NCT01987960|560902583|FG001|Period 1|Lost to Follow-up|0|||
155401338|NCT01987960|560902584|FG002|Period 1|Lost to Follow-up|0|||
155401339|NCT01987960|560902585|FG003|Period 1|Lost to Follow-up|0|||
155401340|NCT01987960|560902582|FG000|Period 1|administrative or other reason|75|||
155401341|NCT01987960|560902583|FG001|Period 1|administrative or other reason|0|||
155401342|NCT01987960|560902584|FG002|Period 1|administrative or other reason|0|||
155401343|NCT01987960|560902585|FG003|Period 1|administrative or other reason|0|||
155401344|NCT01987960|560902582|FG000|Period 1|Withdrawal of consent before treatment|4|||
155401345|NCT01987960|560902583|FG001|Period 1|Withdrawal of consent before treatment|0|||
155401346|NCT01987960|560902584|FG002|Period 1|Withdrawal of consent before treatment|0|||
155401347|NCT01987960|560902585|FG003|Period 1|Withdrawal of consent before treatment|0|||
155401348|NCT01987960|560902582|FG000|Period 2|Adverse Event|0|||
155401349|NCT01987960|560902583|FG001|Period 2|Adverse Event|0|||
155401350|NCT01987960|560902584|FG002|Period 2|Adverse Event|1|||
155401351|NCT01987960|560902585|FG003|Period 2|Adverse Event|0|||
155401352|NCT01987960|560902582|FG000|Period 2|Withdrawal by Subject|0|||
155401353|NCT01987960|560902583|FG001|Period 2|Withdrawal by Subject|0|||
155401354|NCT01987960|560902584|FG002|Period 2|Withdrawal by Subject|1|||
155401355|NCT01987960|560902585|FG003|Period 2|Withdrawal by Subject|0|||
155401356|NCT01987960|560902582|FG000|Period 2|Administrative or other reason|0|||
155401357|NCT01987960|560902583|FG001|Period 2|Administrative or other reason|5|||
155401358|NCT01987960|560902584|FG002|Period 2|Administrative or other reason|7|||
155401359|NCT01987960|560902585|FG003|Period 2|Administrative or other reason|0|||
155401360|NCT01987960|560902582|FG000|Period 3|Adverse Event|0|||
155401361|NCT01987960|560902583|FG001|Period 3|Adverse Event|0|||
155401362|NCT01987960|560902584|FG002|Period 3|Adverse Event|0|||
155401363|NCT01987960|560902585|FG003|Period 3|Adverse Event|7|||
155401364|NCT01987960|560902582|FG000|Period 3|Non-compliance with IMP|0|||
155401365|NCT01987960|560902583|FG001|Period 3|Non-compliance with IMP|0|||
155401366|NCT01987960|560902584|FG002|Period 3|Non-compliance with IMP|0|||
155401367|NCT01987960|560902585|FG003|Period 3|Non-compliance with IMP|1|||
155401368|NCT01987960|560902582|FG000|Period 3|Protocol Violation|0|||
155401369|NCT01987960|560902583|FG001|Period 3|Protocol Violation|0|||
155401370|NCT01987960|560902584|FG002|Period 3|Protocol Violation|0|||
155401371|NCT01987960|560902585|FG003|Period 3|Protocol Violation|6|||
155401372|NCT01987960|560902582|FG000|Period 3|Withdrawal by Subject|0|||
155401373|NCT01987960|560902583|FG001|Period 3|Withdrawal by Subject|0|||
155401374|NCT01987960|560902584|FG002|Period 3|Withdrawal by Subject|0|||
155401375|NCT01987960|560902585|FG003|Period 3|Withdrawal by Subject|9|||
155401376|NCT01987960|560902582|FG000|Period 3|Lost to Follow-up|0|||
155401377|NCT01987960|560902583|FG001|Period 3|Lost to Follow-up|0|||
155401378|NCT01987960|560902584|FG002|Period 3|Lost to Follow-up|0|||
155401379|NCT01987960|560902585|FG003|Period 3|Lost to Follow-up|5|||
155401380|NCT01987960|560902582|FG000|Period 3|Administrative or other reason|0|||
155401381|NCT01987960|560902583|FG001|Period 3|Administrative or other reason|0|||
155401382|NCT01987960|560902584|FG002|Period 3|Administrative or other reason|0|||
155401383|NCT01987960|560902585|FG003|Period 3|Administrative or other reason|43|||
155401384|NCT00807742|560902588|FG000|Overall Study|Death|9|||
155401385|NCT00807742|560902589|FG001|Overall Study|Death|2|||
155401386|NCT00807742|560902588|FG000|Overall Study|Withdrawal by Subject|2|||
154954233|NCT03597256|559259505|FG001|Overall Study|Withdrawal by Subject|1|||
154954234|NCT03597256|559259504|FG000|Overall Study|Could not return for treatment|0|||
154954235|NCT03597256|559259505|FG001|Overall Study|Could not return for treatment|1|||
154954236|NCT03597256|559259504|FG000|Overall Study|Moved from location|0|||
154954237|NCT03597256|559259505|FG001|Overall Study|Moved from location|1|||
154954238|NCT03597256|559259504|FG000|Overall Study|Not accepted the treatment|0|||
154954239|NCT03597256|559259505|FG001|Overall Study|Not accepted the treatment|1|||
154954240|NCT02106156|559259506|FG000|Overall Study|Patient Died|19|||
154954241|NCT02106156|559259507|FG001|Overall Study|Patient Died|0|||
154954242|NCT02106156|559259508|FG002|Overall Study|Patient Died|0|||
155154420|NCT03486912|560002296|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
155154421|NCT03486912|560002297|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
155401387|NCT00807742|560902589|FG001|Overall Study|Withdrawal by Subject|1|||
155401388|NCT00807742|560902588|FG000|Overall Study|Lost to Follow-up|35|||
155401389|NCT00807742|560902589|FG001|Overall Study|Lost to Follow-up|51|||
155401390|NCT04814823|560902591|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
155401391|NCT05678257|560902596|FG000|Overall Study|Withdrawal by Subject|2|||
155401392|NCT05678257|560902597|FG001|Overall Study|Withdrawal by Subject|0|||
155401393|NCT05678257|560902598|FG002|Overall Study|Withdrawal by Subject|5|||
155401394|NCT05678257|560902596|FG000|Overall Study|Physician Decision|1|||
155401395|NCT05678257|560902597|FG001|Overall Study|Physician Decision|0|||
155401396|NCT05678257|560902598|FG002|Overall Study|Physician Decision|1|||
155401397|NCT05678257|560902596|FG000|Overall Study|Adverse Event|1|||
155401398|NCT05678257|560902597|FG001|Overall Study|Adverse Event|3|||
155401399|NCT05678257|560902598|FG002|Overall Study|Adverse Event|1|||
155401400|NCT05678257|560902596|FG000|Overall Study|Progressive disease|11|||
155401401|NCT05678257|560902597|FG001|Overall Study|Progressive disease|18|||
155401402|NCT05678257|560902598|FG002|Overall Study|Progressive disease|7|||
155401403|NCT05678257|560902596|FG000|Overall Study|No longer clinically benefitting|2|||
155401404|NCT05678257|560902597|FG001|Overall Study|No longer clinically benefitting|1|||
155401405|NCT05678257|560902598|FG002|Overall Study|No longer clinically benefitting|0|||
155401406|NCT05678257|560902596|FG000|Overall Study|Sponsor decision|5|||
155401407|NCT05678257|560902597|FG001|Overall Study|Sponsor decision|9|||
155401408|NCT05678257|560902598|FG002|Overall Study|Sponsor decision|8|||
155401409|NCT05678257|560902596|FG000|Overall Study|Protocol Violation|0|||
155401410|NCT05678257|560902597|FG001|Overall Study|Protocol Violation|0|||
155401411|NCT05678257|560902598|FG002|Overall Study|Protocol Violation|1|||
155401412|NCT05678257|560902596|FG000|Overall Study|Patient non-compliance|0|||
155401413|NCT05678257|560902597|FG001|Overall Study|Patient non-compliance|0|||
155401414|NCT05678257|560902598|FG002|Overall Study|Patient non-compliance|3|||
155401415|NCT03520959|560902599|FG000|Overall Study|Study terminated by Sponsor|0|||
155401416|NCT03520959|560902600|FG001|Overall Study|Study terminated by Sponsor|1|||
155401417|NCT01357577|560902601|FG000|Overall Study|Lost to Follow-up|20|||
155401418|NCT01357577|560902602|FG001|Overall Study|Lost to Follow-up|16|||
155401419|NCT01357577|560902601|FG000|Overall Study|Withdrawal by Subject|16|||
155401420|NCT01357577|560902602|FG001|Overall Study|Withdrawal by Subject|8|||
155401421|NCT01357577|560902601|FG000|Overall Study|look at data in database?|1|||
155401422|NCT01357577|560902602|FG001|Overall Study|look at data in database?|2|||
155401423|NCT04419610|560903712|FG000|Overall Study|Withdrawal by Subject|3|||
155401424|NCT04419610|560903713|FG001|Overall Study|Withdrawal by Subject|1|||
155401425|NCT04419610|560903712|FG000|Overall Study|Adverse Event|1|||
155401426|NCT04419610|560903713|FG001|Overall Study|Adverse Event|0|||
155401427|NCT04419610|560903712|FG000|Overall Study|discharged early|1|||
155401428|NCT04419610|560903713|FG001|Overall Study|discharged early|1|||
155401429|NCT01439282|560903714|FG000|Overall Study|Adverse Event|5|||
155401430|NCT01439282|560903715|FG001|Overall Study|Adverse Event|0|||
155401431|NCT01439282|560903714|FG000|Overall Study|Withdrawal by Subject|2|||
155401432|NCT01439282|560903715|FG001|Overall Study|Withdrawal by Subject|0|||
155401433|NCT01439282|560903714|FG000|Overall Study|Other|1|||
155401434|NCT01439282|560903715|FG001|Overall Study|Other|1|||
155401435|NCT00307151|560903718|FG000|Overall Study|Death|4|||
155401436|NCT00307151|560903719|FG001|Overall Study|Death|3|||
155401437|NCT00307151|560903720|FG002|Overall Study|Death|10|||
155401438|NCT00307151|560903721|FG003|Overall Study|Death|3|||
155401439|NCT00307151|560903718|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155401440|NCT00307151|560903719|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155401441|NCT00307151|560903720|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155401442|NCT00307151|560903721|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155401443|NCT00307151|560903718|FG000|Overall Study|Subject unable to get to clinic|1|||
155401444|NCT00307151|560903719|FG001|Overall Study|Subject unable to get to clinic|0|||
155401445|NCT00307151|560903720|FG002|Overall Study|Subject unable to get to clinic|6|||
155401446|NCT00307151|560903721|FG003|Overall Study|Subject unable to get to clinic|2|||
155401447|NCT00307151|560903718|FG000|Overall Study|Withdrew consent|0|||
155401448|NCT00307151|560903719|FG001|Overall Study|Withdrew consent|1|||
155401449|NCT00307151|560903720|FG002|Overall Study|Withdrew consent|1|||
155401450|NCT00307151|560903721|FG003|Overall Study|Withdrew consent|3|||
155401451|NCT00307151|560903718|FG000|Overall Study|Not willing to adhere to study reqs|2|||
155401452|NCT00307151|560903719|FG001|Overall Study|Not willing to adhere to study reqs|0|||
155401453|NCT00307151|560903720|FG002|Overall Study|Not willing to adhere to study reqs|2|||
155401454|NCT00307151|560903721|FG003|Overall Study|Not willing to adhere to study reqs|2|||
155401455|NCT00307151|560903718|FG000|Overall Study|Clinic unable to contact subject|3|||
155401456|NCT00307151|560903719|FG001|Overall Study|Clinic unable to contact subject|3|||
155401457|NCT00307151|560903720|FG002|Overall Study|Clinic unable to contact subject|1|||
155401458|NCT00307151|560903721|FG003|Overall Study|Clinic unable to contact subject|1|||
155401459|NCT00980200|560903723|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
155401460|NCT00980200|560903724|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
155401461|NCT00980200|560903725|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
155401462|NCT00980200|560903726|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
155401463|NCT00980200|560903727|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
155058301|NCT03167242|559648622|FG003|Overall Study|Reason not provided|0|||
155058302|NCT03167242|559648623|FG004|Overall Study|Reason not provided|0|||
155401464|NCT00980200|560903723|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
155401465|NCT00980200|560903724|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
155401466|NCT00980200|560903725|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
155401467|NCT00980200|560903726|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
155401468|NCT00980200|560903727|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
155058303|NCT03167242|559648624|FG005|Overall Study|Reason not provided|0|||
155058304|NCT03167242|559648625|FG006|Overall Study|Reason not provided|0|||
155401469|NCT01617460|560903728|FG000|Overall Study|Adverse Event|10|||
155401470|NCT01617460|560903728|FG000|Overall Study|Physician Decision|16|||
155058305|NCT03167242|559648626|FG007|Overall Study|Reason not provided|0|||
155058306|NCT03167242|559648627|FG008|Overall Study|Reason not provided|1|||
155058307|NCT03167242|559648628|FG009|Overall Study|Reason not provided|0|||
155058308|NCT03167242|559648629|FG010|Overall Study|Reason not provided|0|||
155058309|NCT03167242|559648630|FG011|Overall Study|Reason not provided|0|||
155058310|NCT03786380|559648631|FG000|Overall Study|Adverse Event|1|||
155058311|NCT03786380|559648632|FG001|Overall Study|Adverse Event|0|||
155058312|NCT03786380|559648633|FG002|Overall Study|Adverse Event|0|||
155058313|NCT03786380|559648634|FG003|Overall Study|Adverse Event|3|||
155058314|NCT03786380|559648635|FG004|Overall Study|Adverse Event|1|||
155058315|NCT03786380|559648631|FG000|Overall Study|Lack of Efficacy|0|||
155058316|NCT03786380|559648632|FG001|Overall Study|Lack of Efficacy|0|||
155058317|NCT03786380|559648633|FG002|Overall Study|Lack of Efficacy|0|||
155058318|NCT03786380|559648634|FG003|Overall Study|Lack of Efficacy|0|||
155058319|NCT03786380|559648635|FG004|Overall Study|Lack of Efficacy|1|||
155058320|NCT03786380|559648631|FG000|Overall Study|Withdrawal by Subject|1|||
155058321|NCT03786380|559648632|FG001|Overall Study|Withdrawal by Subject|2|||
155058322|NCT03786380|559648633|FG002|Overall Study|Withdrawal by Subject|2|||
155058323|NCT03786380|559648634|FG003|Overall Study|Withdrawal by Subject|1|||
155058324|NCT03786380|559648635|FG004|Overall Study|Withdrawal by Subject|2|||
155058325|NCT03786380|559648631|FG000|Overall Study|Lost to Follow-up|3|||
155058326|NCT03786380|559648632|FG001|Overall Study|Lost to Follow-up|0|||
155058327|NCT03786380|559648633|FG002|Overall Study|Lost to Follow-up|1|||
155058328|NCT03786380|559648634|FG003|Overall Study|Lost to Follow-up|2|||
155058329|NCT03786380|559648635|FG004|Overall Study|Lost to Follow-up|0|||
155058330|NCT03786380|559648631|FG000|Overall Study|Physician Decision|0|||
155058331|NCT03786380|559648632|FG001|Overall Study|Physician Decision|0|||
155058332|NCT03786380|559648633|FG002|Overall Study|Physician Decision|1|||
155058333|NCT03786380|559648634|FG003|Overall Study|Physician Decision|0|||
155058334|NCT03786380|559648635|FG004|Overall Study|Physician Decision|0|||
155058335|NCT03786380|559648631|FG000|Overall Study|Study Terminated by the Sponsor|30|||
155058336|NCT03786380|559648632|FG001|Overall Study|Study Terminated by the Sponsor|20|||
155058337|NCT03786380|559648633|FG002|Overall Study|Study Terminated by the Sponsor|50|||
155058338|NCT03786380|559648634|FG003|Overall Study|Study Terminated by the Sponsor|57|||
155058339|NCT03786380|559648635|FG004|Overall Study|Study Terminated by the Sponsor|23|||
155058340|NCT03786380|559648631|FG000|Overall Study|Reason Not Specified|0|||
155058341|NCT03786380|559648632|FG001|Overall Study|Reason Not Specified|0|||
155058342|NCT03786380|559648633|FG002|Overall Study|Reason Not Specified|0|||
155058343|NCT03786380|559648634|FG003|Overall Study|Reason Not Specified|0|||
155058344|NCT03786380|559648635|FG004|Overall Study|Reason Not Specified|1|||
155058345|NCT02175121|559648638|FG000|Overall Study|Lack of Efficacy|1|||
155058346|NCT02175121|559648639|FG001|Overall Study|Lack of Efficacy|0|||
155058347|NCT02175121|559648640|FG002|Overall Study|Lack of Efficacy|0|||
155058348|NCT02175121|559648641|FG003|Overall Study|Lack of Efficacy|0|||
155058349|NCT02175121|559648642|FG004|Overall Study|Lack of Efficacy|0|||
155058350|NCT02175121|559648638|FG000|Overall Study|Lost to Follow-up|0|||
155058351|NCT02175121|559648639|FG001|Overall Study|Lost to Follow-up|1|||
155401471|NCT01617460|560903728|FG000|Overall Study|Protocol Violation|5|||
155401472|NCT01617460|560903728|FG000|Overall Study|Withdrawal by Subject|9|||
155401473|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
155401474|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
155401475|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Death|0|||
155401476|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Death|1|||
155058352|NCT02175121|559648640|FG002|Overall Study|Lost to Follow-up|0|||
155058353|NCT02175121|559648641|FG003|Overall Study|Lost to Follow-up|1|||
155058354|NCT02175121|559648642|FG004|Overall Study|Lost to Follow-up|0|||
155058355|NCT02175121|559648638|FG000|Overall Study|Personal emergency|0|||
155058356|NCT02175121|559648639|FG001|Overall Study|Personal emergency|0|||
155058357|NCT02175121|559648640|FG002|Overall Study|Personal emergency|0|||
155058358|NCT02175121|559648641|FG003|Overall Study|Personal emergency|0|||
155058359|NCT02175121|559648642|FG004|Overall Study|Personal emergency|1|||
155401477|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
155401478|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
155058360|NCT02175121|559648638|FG000|Overall Study|Schedule conflict|0|||
155058361|NCT02175121|559648639|FG001|Overall Study|Schedule conflict|0|||
155058362|NCT02175121|559648640|FG002|Overall Study|Schedule conflict|1|||
155058363|NCT02175121|559648641|FG003|Overall Study|Schedule conflict|0|||
155058364|NCT02175121|559648642|FG004|Overall Study|Schedule conflict|0|||
155058365|NCT02175121|559648638|FG000|Overall Study|Time issues|0|||
155058366|NCT02175121|559648639|FG001|Overall Study|Time issues|0|||
155058367|NCT02175121|559648640|FG002|Overall Study|Time issues|1|||
155058368|NCT02175121|559648641|FG003|Overall Study|Time issues|0|||
155154422|NCT03486912|560002298|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
155058369|NCT02175121|559648642|FG004|Overall Study|Time issues|0|||
155058370|NCT00931632|559648643|FG000|Overall Study|Withdrawal by Subject|2|||
155058371|NCT00931632|559648644|FG001|Overall Study|Withdrawal by Subject|3|||
155058372|NCT00931632|559648643|FG000|Overall Study|Adverse Event|19|||
155058373|NCT00931632|559648644|FG001|Overall Study|Adverse Event|15|||
155058374|NCT01419314|559648645|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
155058375|NCT01419314|559648646|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
155058376|NCT01419314|559648645|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
155058377|NCT01419314|559648646|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
155401479|NCT02966509|560903734|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
155401480|NCT02966509|560903735|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
155401481|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Death|22|||
155401482|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Death|25|||
155401483|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
155401484|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
155401485|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
155401486|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
155401487|NCT02966509|560903734|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
155401488|NCT02966509|560903735|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
155401489|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Death|36|||
155401490|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Death|33|||
155401491|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
155401492|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
155401493|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
155401494|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
155401495|NCT02966509|560903734|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
155401496|NCT02966509|560903735|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
155401497|NCT02966509|560903734|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
155401498|NCT02966509|560903735|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
155401499|NCT02966509|560903734|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
155401500|NCT02966509|560903735|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
155401501|NCT03332498|560903736|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
155401502|NCT03332498|560903737|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
155401503|NCT03332498|560903738|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
155401504|NCT00916357|560903739|FG000|Period 1|Withdrawal by Subject|1|||
155401505|NCT00916357|560903740|FG001|Period 1|Withdrawal by Subject|0|||
155401506|NCT00916357|560903741|FG002|Period 1|Withdrawal by Subject|0|||
155401507|NCT00916357|560903742|FG003|Period 1|Withdrawal by Subject|0|||
155401508|NCT00916357|560903743|FG004|Period 1|Withdrawal by Subject|0|||
155401509|NCT00916357|560903744|FG005|Period 1|Withdrawal by Subject|0|||
155401510|NCT00916357|560903739|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401511|NCT00916357|560903740|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401512|NCT00916357|560903741|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401513|NCT00916357|560903742|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
155401514|NCT00916357|560903743|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401515|NCT00916357|560903744|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
155401516|NCT05611671|560903748|FG000|Overall Study|Adverse Event|1|||
155401517|NCT05611671|560903749|FG001|Overall Study|Adverse Event|1|||
155401518|NCT05611671|560903750|FG002|Overall Study|Adverse Event|0|||
155401519|NCT05611671|560903751|FG003|Overall Study|Adverse Event|1|||
155401520|NCT05611671|560903748|FG000|Overall Study|Lack of Efficacy|1|||
155401521|NCT05611671|560903749|FG001|Overall Study|Lack of Efficacy|0|||
155401522|NCT05611671|560903750|FG002|Overall Study|Lack of Efficacy|1|||
155401523|NCT05611671|560903751|FG003|Overall Study|Lack of Efficacy|2|||
155401524|NCT05611671|560903748|FG000|Overall Study|Lost to Follow-up|0|||
155401525|NCT05611671|560903749|FG001|Overall Study|Lost to Follow-up|0|||
155401526|NCT05611671|560903750|FG002|Overall Study|Lost to Follow-up|0|||
155401527|NCT05611671|560903751|FG003|Overall Study|Lost to Follow-up|1|||
155401528|NCT05611671|560903748|FG000|Overall Study|Protocol Violation|0|||
155401529|NCT05611671|560903749|FG001|Overall Study|Protocol Violation|1|||
155401530|NCT05611671|560903750|FG002|Overall Study|Protocol Violation|0|||
155401531|NCT05611671|560903751|FG003|Overall Study|Protocol Violation|0|||
155401532|NCT05611671|560903748|FG000|Overall Study|Withdrawal by Subject|2|||
155401533|NCT05611671|560903749|FG001|Overall Study|Withdrawal by Subject|1|||
155401534|NCT05611671|560903750|FG002|Overall Study|Withdrawal by Subject|2|||
155058378|NCT01419314|559648645|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
155058379|NCT01419314|559648646|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
155058380|NCT00887484|559648654|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
155284790|NCT01941316|560474417|FG000|Overall Study|Physician Decision|0|||
155401535|NCT05611671|560903751|FG003|Overall Study|Withdrawal by Subject|1|||
155401536|NCT01911442|560903752|FG000|Overall Study|Adverse Event|2|||
155401537|NCT01911442|560903753|FG001|Overall Study|Adverse Event|2|||
155401538|NCT01911442|560903754|FG002|Overall Study|Adverse Event|4|||
155401539|NCT01911442|560903752|FG000|Overall Study|Lack of Efficacy|1|||
155401540|NCT01911442|560903753|FG001|Overall Study|Lack of Efficacy|1|||
155401541|NCT01911442|560903754|FG002|Overall Study|Lack of Efficacy|1|||
155401542|NCT01911442|560903752|FG000|Overall Study|Lost to Follow-up|2|||
155401543|NCT01911442|560903753|FG001|Overall Study|Lost to Follow-up|0|||
155401544|NCT01911442|560903754|FG002|Overall Study|Lost to Follow-up|1|||
155401545|NCT01911442|560903752|FG000|Overall Study|Withdrawal by Subject|1|||
155401546|NCT01911442|560903753|FG001|Overall Study|Withdrawal by Subject|0|||
155401547|NCT01911442|560903754|FG002|Overall Study|Withdrawal by Subject|6|||
155401548|NCT01911442|560903752|FG000|Overall Study|Mother's Work Schedule|0|||
155401549|NCT01911442|560903753|FG001|Overall Study|Mother's Work Schedule|1|||
155401550|NCT01911442|560903754|FG002|Overall Study|Mother's Work Schedule|0|||
155401551|NCT01648790|560903755|FG000|Treatment 3|Withdrawal by Subject|0|||
155401552|NCT01648790|560903756|FG001|Treatment 3|Withdrawal by Subject|0|||
155401553|NCT01648790|560903757|FG002|Treatment 3|Withdrawal by Subject|0|||
155401554|NCT01648790|560903758|FG003|Treatment 3|Withdrawal by Subject|1|||
155401555|NCT01648790|560903759|FG004|Treatment 3|Withdrawal by Subject|0|||
155058381|NCT00887484|559648654|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
155058382|NCT00887484|559648654|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
155058383|NCT03044314|559648656|FG000|Overall Study|Physician Decision|2|||
155058384|NCT03044314|559648656|FG000|Overall Study|Withdrawal by Subject|1|||
155401556|NCT01486927|560903760|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
155401557|NCT01486927|560903760|FG000|Overall Study|Physician Decision|1|||
155401558|NCT01486927|560903760|FG000|Overall Study|50 Exposure days not reached|2|||
155401559|NCT01486927|560903760|FG000|Overall Study|Withdrawal by Subject|8|||
155401560|NCT01486927|560903760|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
155401561|NCT02159729|560903761|FG000|Overall Study|Adverse Event|0|||
155401562|NCT02159729|560903762|FG001|Overall Study|Adverse Event|1|||
155401563|NCT02159729|560903761|FG000|Overall Study|Subject's Request|13|||
155401564|NCT02159729|560903762|FG001|Overall Study|Subject's Request|10|||
155401565|NCT02159729|560903761|FG000|Overall Study|Lost to Follow-up|24|||
155401566|NCT02159729|560903762|FG001|Overall Study|Lost to Follow-up|9|||
155401567|NCT02159729|560903761|FG000|Overall Study|Non compliance|2|||
155401568|NCT02159729|560903762|FG001|Overall Study|Non compliance|0|||
155401569|NCT02159729|560903761|FG000|Overall Study|Other Unspecified|3|||
155401570|NCT02159729|560903762|FG001|Overall Study|Other Unspecified|1|||
155401571|NCT00573430|560903763|FG000|Overall Study|Incorrect enrollment of randomization|0|||
155401572|NCT00573430|560903764|FG001|Overall Study|Incorrect enrollment of randomization|4|||
155401573|NCT00573430|560903765|FG002|Overall Study|Incorrect enrollment of randomization|3|||
155401574|NCT00573430|560903763|FG000|Overall Study|Adverse Event|0|||
155401575|NCT00573430|560903764|FG001|Overall Study|Adverse Event|0|||
155401576|NCT00573430|560903765|FG002|Overall Study|Adverse Event|2|||
155401577|NCT00573430|560903763|FG000|Overall Study|Withdrawal by Subject|1|||
155401578|NCT00573430|560903764|FG001|Overall Study|Withdrawal by Subject|0|||
155401579|NCT00573430|560903765|FG002|Overall Study|Withdrawal by Subject|1|||
155401580|NCT00573430|560903763|FG000|Overall Study|Protocol Violation|0|||
155401581|NCT00573430|560903764|FG001|Overall Study|Protocol Violation|1|||
155401582|NCT00573430|560903765|FG002|Overall Study|Protocol Violation|1|||
155401583|NCT00573430|560903763|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155401584|NCT00573430|560903764|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155401585|NCT00573430|560903765|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
155401586|NCT02953340|560903769|FG000|Overall Study|Death|0|||
155401587|NCT02953340|560903770|FG001|Overall Study|Death|1|||
155401588|NCT02953340|560903769|FG000|Overall Study|Investigator Decision|3|||
155401589|NCT02953340|560903770|FG001|Overall Study|Investigator Decision|3|||
155401590|NCT02953340|560903769|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
155401591|NCT02953340|560903770|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
155401592|NCT02953340|560903769|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
155401593|NCT02953340|560903770|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
155401594|NCT02953340|560903769|FG000|Overall Study|Withdrawal by Subject|9|||
155401595|NCT02953340|560903770|FG001|Overall Study|Withdrawal by Subject|9|||
155401596|NCT02953340|560903769|FG000|Overall Study|Sponsor decision|0|||
155401597|NCT02953340|560903770|FG001|Overall Study|Sponsor decision|2|||
155401598|NCT02953340|560903769|FG000|Overall Study|Lost to Follow-up|3|||
155401599|NCT02953340|560903770|FG001|Overall Study|Lost to Follow-up|2|||
155401600|NCT02953340|560903769|FG000|Overall Study|Reason not specified|2|||
155401601|NCT02953340|560903770|FG001|Overall Study|Reason not specified|2|||
155401602|NCT04232553|560903771|FG000|Overall Study|Adverse Event|3|||
155401603|NCT04232553|560903772|FG001|Overall Study|Adverse Event|2|||
155401604|NCT04232553|560903773|FG002|Overall Study|Adverse Event|1|||
155401605|NCT04232553|560903774|FG003|Overall Study|Adverse Event|2|||
155401606|NCT04232553|560903775|FG004|Overall Study|Adverse Event|1|||
155401607|NCT04232553|560903776|FG005|Overall Study|Adverse Event|1|||
155401608|NCT04232553|560903777|FG006|Overall Study|Adverse Event|0|||
155401609|NCT04232553|560903778|FG007|Overall Study|Adverse Event|0|||
155401610|NCT04232553|560903779|FG008|Overall Study|Adverse Event|0|||
155401611|NCT04232553|560903771|FG000|Overall Study|Death|0|||
155058385|NCT03044314|559648656|FG000|Overall Study|Connector tubing not available|1|||
155058386|NCT00264147|559648657|FG000|Treatment I Period|Adverse Event|3|||
155058387|NCT00264147|559648658|FG001|Treatment I Period|Adverse Event|6|||
155401612|NCT04232553|560903772|FG001|Overall Study|Death|1|||
155401613|NCT04232553|560903773|FG002|Overall Study|Death|0|||
155401614|NCT04232553|560903774|FG003|Overall Study|Death|1|||
155058388|NCT00264147|559648659|FG002|Treatment I Period|Adverse Event|3|||
155058389|NCT00264147|559648660|FG003|Treatment I Period|Adverse Event|5|||
155058390|NCT00264147|559648661|FG004|Treatment I Period|Adverse Event|7|||
155058391|NCT00264147|559648662|FG005|Treatment I Period|Adverse Event|0|||
155058392|NCT00264147|559648657|FG000|Treatment I Period|Laboratory Adverse Event|0|||
155058393|NCT00264147|559648658|FG001|Treatment I Period|Laboratory Adverse Event|0|||
155058394|NCT00264147|559648659|FG002|Treatment I Period|Laboratory Adverse Event|0|||
155058395|NCT00264147|559648660|FG003|Treatment I Period|Laboratory Adverse Event|1|||
155058396|NCT00264147|559648661|FG004|Treatment I Period|Laboratory Adverse Event|0|||
155058397|NCT00264147|559648662|FG005|Treatment I Period|Laboratory Adverse Event|0|||
155058398|NCT00264147|559648657|FG000|Treatment I Period|Lack of Efficacy|6|||
155058399|NCT00264147|559648658|FG001|Treatment I Period|Lack of Efficacy|2|||
155058400|NCT00264147|559648659|FG002|Treatment I Period|Lack of Efficacy|8|||
155058401|NCT00264147|559648660|FG003|Treatment I Period|Lack of Efficacy|0|||
155058402|NCT00264147|559648661|FG004|Treatment I Period|Lack of Efficacy|1|||
155058403|NCT00264147|559648662|FG005|Treatment I Period|Lack of Efficacy|0|||
155058404|NCT00264147|559648657|FG000|Treatment I Period|Lost to Follow-up|1|||
155058405|NCT00264147|559648658|FG001|Treatment I Period|Lost to Follow-up|0|||
155058406|NCT00264147|559648659|FG002|Treatment I Period|Lost to Follow-up|0|||
155058407|NCT00264147|559648660|FG003|Treatment I Period|Lost to Follow-up|1|||
155058408|NCT00264147|559648661|FG004|Treatment I Period|Lost to Follow-up|1|||
155058409|NCT00264147|559648662|FG005|Treatment I Period|Lost to Follow-up|0|||
155058410|NCT00264147|559648657|FG000|Treatment I Period|Protocol Violation|2|||
155058411|NCT00264147|559648658|FG001|Treatment I Period|Protocol Violation|2|||
155058412|NCT00264147|559648659|FG002|Treatment I Period|Protocol Violation|0|||
155058413|NCT00264147|559648660|FG003|Treatment I Period|Protocol Violation|0|||
155058414|NCT00264147|559648661|FG004|Treatment I Period|Protocol Violation|0|||
155058415|NCT00264147|559648662|FG005|Treatment I Period|Protocol Violation|0|||
155058416|NCT00264147|559648657|FG000|Treatment I Period|Withdrawal by Subject|2|||
155058417|NCT00264147|559648658|FG001|Treatment I Period|Withdrawal by Subject|0|||
155058418|NCT00264147|559648659|FG002|Treatment I Period|Withdrawal by Subject|0|||
155058419|NCT00264147|559648660|FG003|Treatment I Period|Withdrawal by Subject|2|||
155058420|NCT00264147|559648661|FG004|Treatment I Period|Withdrawal by Subject|2|||
155058421|NCT00264147|559648662|FG005|Treatment I Period|Withdrawal by Subject|0|||
155058422|NCT00264147|559648657|FG000|Treatment I Period|Patient out of town for an extended time|0|||
155058423|NCT00264147|559648658|FG001|Treatment I Period|Patient out of town for an extended time|1|||
155401615|NCT04232553|560903775|FG004|Overall Study|Death|0|||
155401616|NCT04232553|560903776|FG005|Overall Study|Death|0|||
155401617|NCT04232553|560903777|FG006|Overall Study|Death|0|||
155401618|NCT04232553|560903778|FG007|Overall Study|Death|0|||
155401619|NCT04232553|560903779|FG008|Overall Study|Death|0|||
155401620|NCT04232553|560903771|FG000|Overall Study|Lack of Efficacy|0|||
155401621|NCT04232553|560903772|FG001|Overall Study|Lack of Efficacy|2|||
155401622|NCT04232553|560903773|FG002|Overall Study|Lack of Efficacy|0|||
155401623|NCT04232553|560903774|FG003|Overall Study|Lack of Efficacy|0|||
155401624|NCT04232553|560903775|FG004|Overall Study|Lack of Efficacy|0|||
155401625|NCT04232553|560903776|FG005|Overall Study|Lack of Efficacy|0|||
155401626|NCT04232553|560903777|FG006|Overall Study|Lack of Efficacy|0|||
155401627|NCT04232553|560903778|FG007|Overall Study|Lack of Efficacy|0|||
155401628|NCT04232553|560903779|FG008|Overall Study|Lack of Efficacy|1|||
155401629|NCT04232553|560903771|FG000|Overall Study|Lost to Follow-up|0|||
155401630|NCT04232553|560903772|FG001|Overall Study|Lost to Follow-up|1|||
155401631|NCT04232553|560903773|FG002|Overall Study|Lost to Follow-up|0|||
155401632|NCT04232553|560903774|FG003|Overall Study|Lost to Follow-up|0|||
155401633|NCT04232553|560903775|FG004|Overall Study|Lost to Follow-up|1|||
155401634|NCT04232553|560903776|FG005|Overall Study|Lost to Follow-up|0|||
155401635|NCT04232553|560903777|FG006|Overall Study|Lost to Follow-up|0|||
155401636|NCT04232553|560903778|FG007|Overall Study|Lost to Follow-up|0|||
155401637|NCT04232553|560903779|FG008|Overall Study|Lost to Follow-up|1|||
155058424|NCT00264147|559648659|FG002|Treatment I Period|Patient out of town for an extended time|0|||
155058425|NCT00264147|559648660|FG003|Treatment I Period|Patient out of town for an extended time|0|||
155058426|NCT00264147|559648661|FG004|Treatment I Period|Patient out of town for an extended time|0|||
155058427|NCT00264147|559648662|FG005|Treatment I Period|Patient out of town for an extended time|0|||
155058428|NCT00264147|559648657|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155058429|NCT00264147|559648658|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155058430|NCT00264147|559648659|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
155154423|NCT03486912|560002295|FG000|Treatment Period|Withdrawal by Subject|3|||
155401638|NCT04232553|560903771|FG000|Overall Study|Other - As reported by the investigator|0|||
155401639|NCT04232553|560903772|FG001|Overall Study|Other - As reported by the investigator|1|||
155401640|NCT04232553|560903773|FG002|Overall Study|Other - As reported by the investigator|0|||
155401641|NCT04232553|560903774|FG003|Overall Study|Other - As reported by the investigator|0|||
155401642|NCT04232553|560903775|FG004|Overall Study|Other - As reported by the investigator|0|||
155401643|NCT04232553|560903776|FG005|Overall Study|Other - As reported by the investigator|0|||
155401644|NCT04232553|560903777|FG006|Overall Study|Other - As reported by the investigator|0|||
155058431|NCT00264147|559648660|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155284791|NCT01941316|560474418|FG001|Overall Study|Physician Decision|0|||
155401645|NCT04232553|560903778|FG007|Overall Study|Other - As reported by the investigator|0|||
155401646|NCT04232553|560903779|FG008|Overall Study|Other - As reported by the investigator|0|||
155401647|NCT04232553|560903771|FG000|Overall Study|Physician Decision|1|||
155401648|NCT04232553|560903772|FG001|Overall Study|Physician Decision|1|||
155401649|NCT04232553|560903773|FG002|Overall Study|Physician Decision|0|||
155401650|NCT04232553|560903774|FG003|Overall Study|Physician Decision|0|||
155401651|NCT04232553|560903775|FG004|Overall Study|Physician Decision|1|||
155401652|NCT04232553|560903776|FG005|Overall Study|Physician Decision|0|||
155401653|NCT04232553|560903777|FG006|Overall Study|Physician Decision|0|||
155401654|NCT04232553|560903778|FG007|Overall Study|Physician Decision|0|||
155401655|NCT04232553|560903779|FG008|Overall Study|Physician Decision|0|||
155401656|NCT04232553|560903771|FG000|Overall Study|Pregnancy|1|||
155401657|NCT04232553|560903772|FG001|Overall Study|Pregnancy|0|||
155401658|NCT04232553|560903773|FG002|Overall Study|Pregnancy|0|||
155401659|NCT04232553|560903774|FG003|Overall Study|Pregnancy|0|||
155401660|NCT04232553|560903775|FG004|Overall Study|Pregnancy|0|||
155401661|NCT04232553|560903776|FG005|Overall Study|Pregnancy|0|||
155401662|NCT04232553|560903777|FG006|Overall Study|Pregnancy|0|||
155401663|NCT04232553|560903778|FG007|Overall Study|Pregnancy|0|||
155401664|NCT04232553|560903779|FG008|Overall Study|Pregnancy|0|||
155401665|NCT04232553|560903771|FG000|Overall Study|Withdrawal by Subject|7|||
155401666|NCT04232553|560903772|FG001|Overall Study|Withdrawal by Subject|5|||
155401667|NCT04232553|560903773|FG002|Overall Study|Withdrawal by Subject|0|||
155401668|NCT04232553|560903774|FG003|Overall Study|Withdrawal by Subject|0|||
155401669|NCT04232553|560903775|FG004|Overall Study|Withdrawal by Subject|2|||
155401670|NCT04232553|560903776|FG005|Overall Study|Withdrawal by Subject|2|||
155401671|NCT04232553|560903777|FG006|Overall Study|Withdrawal by Subject|0|||
155401672|NCT04232553|560903778|FG007|Overall Study|Withdrawal by Subject|2|||
155401673|NCT04232553|560903779|FG008|Overall Study|Withdrawal by Subject|0|||
155401674|NCT02969915|560903780|FG000|Overall Study|Death|104|||
155401675|NCT02969915|560903781|FG001|Overall Study|Death|125|||
155401676|NCT02969915|560903780|FG000|Overall Study|Lost to Follow-up|108|||
155401677|NCT02969915|560903781|FG001|Overall Study|Lost to Follow-up|112|||
155401678|NCT02969915|560903780|FG000|Overall Study|Censored due to COVID-19|481|||
155401679|NCT02969915|560903781|FG001|Overall Study|Censored due to COVID-19|471|||
155401680|NCT01378858|560903784|FG000|Overall Study|Withdrawal by Subject|4|||
155401681|NCT01378858|560903785|FG001|Overall Study|Withdrawal by Subject|4|||
155401682|NCT02664272|560903786|FG000|Overall Study|Fluoroscopic images not made available|2|||
155401683|NCT03073980|560903787|FG000|Overall Study|Lost to Follow-up|10|||
155401684|NCT03073980|560903788|FG001|Overall Study|Lost to Follow-up|2|||
155401685|NCT03073980|560903789|FG002|Overall Study|Lost to Follow-up|9|||
155401686|NCT03073980|560903787|FG000|Overall Study|No post-procedure data|0|||
155401687|NCT03073980|560903788|FG001|Overall Study|No post-procedure data|0|||
155401688|NCT03073980|560903789|FG002|Overall Study|No post-procedure data|2|||
155401689|NCT04810689|560903790|FG000|Overall Study|Withdrawal by Subject|0|||
155401690|NCT04810689|560903791|FG001|Overall Study|Withdrawal by Subject|1|||
155401691|NCT00450723|560903793|FG000|Overall Study|Physician Decision|5|||
155401692|NCT00789880|560903796|FG000|Overall Study|Adverse Event|0|||
155401693|NCT00789880|560903797|FG001|Overall Study|Adverse Event|0|||
155401694|NCT00789880|560903798|FG002|Overall Study|Adverse Event|0|||
155401695|NCT00789880|560903799|FG003|Overall Study|Adverse Event|0|||
155401696|NCT00789880|560903800|FG004|Overall Study|Adverse Event|1|||
155401697|NCT00789880|560903801|FG005|Overall Study|Adverse Event|0|||
155401698|NCT00789880|560903796|FG000|Overall Study|Protocol Violation|0|||
155401699|NCT00789880|560903797|FG001|Overall Study|Protocol Violation|1|||
155401700|NCT00789880|560903798|FG002|Overall Study|Protocol Violation|0|||
155401701|NCT00789880|560903799|FG003|Overall Study|Protocol Violation|1|||
155401702|NCT00789880|560903800|FG004|Overall Study|Protocol Violation|0|||
155401703|NCT00789880|560903801|FG005|Overall Study|Protocol Violation|0|||
155401704|NCT00789880|560903796|FG000|Overall Study|Withdrawal by Subject|1|||
155401705|NCT00789880|560903797|FG001|Overall Study|Withdrawal by Subject|0|||
155401706|NCT00789880|560903798|FG002|Overall Study|Withdrawal by Subject|0|||
155401707|NCT00789880|560903799|FG003|Overall Study|Withdrawal by Subject|0|||
155401708|NCT00789880|560903800|FG004|Overall Study|Withdrawal by Subject|2|||
155401709|NCT00789880|560903801|FG005|Overall Study|Withdrawal by Subject|0|||
155401710|NCT06347731|560903802|FG000|Overall Study|Death|1|||
155401711|NCT06347731|560903802|FG000|Overall Study|Protocol Violation|1|||
155401712|NCT06347731|560903802|FG000|Overall Study|Withdrawal by Subject|2|||
155401713|NCT00609986|560903803|FG000|Overall Study|Did not receive transplant or treatment|8|||
155401714|NCT00609986|560903804|FG001|Overall Study|Did not receive transplant or treatment|3|||
155401715|NCT03159091|560903805|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
155401716|NCT03159091|560903806|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
155401717|NCT03159091|560903805|FG000|Overall Study|Patient has taken no dose of study drug|0|||
155284792|NCT01941316|560474419|FG002|Overall Study|Physician Decision|0|||
155401718|NCT03159091|560903806|FG001|Overall Study|Patient has taken no dose of study drug|1|||
155401719|NCT02044133|560903810|FG000|Overall Study|Lost to Follow-up|1|||
155401720|NCT02044133|560903811|FG001|Overall Study|Lost to Follow-up|1|||
155401721|NCT02044133|560903810|FG000|Overall Study|Death|1|||
155401722|NCT02044133|560903811|FG001|Overall Study|Death|0|||
155401723|NCT02044133|560903810|FG000|Overall Study|Release|3|||
155401724|NCT02044133|560903811|FG001|Overall Study|Release|4|||
155401725|NCT02044133|560903810|FG000|Overall Study|Transfer|1|||
155401726|NCT02044133|560903811|FG001|Overall Study|Transfer|0|||
155401727|NCT02044133|560903810|FG000|Overall Study|refusal of blood sampling|0|||
155401728|NCT02044133|560903811|FG001|Overall Study|refusal of blood sampling|1|||
155401729|NCT04722042|560903812|FG000|Overall Study|Withdrawal by Subject|2|||
155401730|NCT04722042|560903813|FG001|Overall Study|Withdrawal by Subject|1|||
155401731|NCT04722042|560903814|FG002|Overall Study|Withdrawal by Subject|0|||
155401732|NCT02046096|560903815|FG000|Overall Study|Death|28|||
155401733|NCT02046096|560903816|FG001|Overall Study|Death|45|||
155401734|NCT02046096|560903815|FG000|Overall Study|Lost to Follow-up|9|||
155401735|NCT02046096|560903816|FG001|Overall Study|Lost to Follow-up|20|||
155401736|NCT02046096|560903815|FG000|Overall Study|Withdrawal by Subject|5|||
155401737|NCT02046096|560903816|FG001|Overall Study|Withdrawal by Subject|17|||
155401738|NCT02046096|560903815|FG000|Overall Study|Other endpoint|2|||
155401739|NCT02046096|560903816|FG001|Overall Study|Other endpoint|19|||
155401740|NCT04969276|560903818|FG000|Overall Study|Protocol Deviation|0|||
155401741|NCT04969276|560903819|FG001|Overall Study|Protocol Deviation|1|||
155401742|NCT04969276|560903820|FG002|Overall Study|Protocol Deviation|0|||
155401743|NCT04969276|560903818|FG000|Overall Study|Withdrawal by Subject|1|||
155401744|NCT04969276|560903819|FG001|Overall Study|Withdrawal by Subject|10|||
155401745|NCT04969276|560903820|FG002|Overall Study|Withdrawal by Subject|0|||
155401746|NCT04969276|560903818|FG000|Overall Study|Lost to Follow-up|0|||
155401747|NCT04969276|560903819|FG001|Overall Study|Lost to Follow-up|1|||
155401748|NCT04969276|560903820|FG002|Overall Study|Lost to Follow-up|0|||
155401749|NCT03834519|560903821|FG000|Overall Study|Lost to Follow-up|2|||
155401750|NCT03834519|560903822|FG001|Overall Study|Lost to Follow-up|1|||
155401751|NCT03834519|560903821|FG000|Overall Study|Withdrawal by Subject|5|||
155401752|NCT03834519|560903822|FG001|Overall Study|Withdrawal by Subject|8|||
155401753|NCT03834519|560903821|FG000|Overall Study|Death|368|||
155401754|NCT03834519|560903822|FG001|Overall Study|Death|174|||
155401755|NCT03834519|560903821|FG000|Overall Study|Physician Decision|5|||
155401756|NCT03834519|560903822|FG001|Overall Study|Physician Decision|1|||
155401757|NCT03834519|560903821|FG000|Overall Study|Sponsor decision|149|||
155401758|NCT03834519|560903822|FG001|Overall Study|Sponsor decision|80|||
155401759|NCT04655144|560903826|FG000|Overall Study|Consumed THC|1|||
155401760|NCT04655144|560903827|FG001|Overall Study|Consumed THC|0|||
155401761|NCT04655144|560903826|FG000|Overall Study|Unilateral embolization|0|||
155401762|NCT04655144|560903827|FG001|Overall Study|Unilateral embolization|1|||
155401763|NCT00943579|560903830|FG000|Overall Study|Adverse Event|4|||
155401764|NCT00943579|560903831|FG001|Overall Study|Adverse Event|3|||
155401765|NCT00943579|560903830|FG000|Overall Study|Lack of Efficacy|2|||
155401766|NCT00943579|560903831|FG001|Overall Study|Lack of Efficacy|2|||
155401767|NCT00418665|560903834|FG000|Treatment Period|Ineligibility determined|1|||
155401768|NCT00418665|560903835|FG001|Treatment Period|Ineligibility determined|1|||
155401769|NCT00418665|560903836|FG002|Treatment Period|Ineligibility determined|0|||
155401770|NCT00418665|560903834|FG000|Treatment Period|Adverse Event|2|||
155401771|NCT00418665|560903835|FG001|Treatment Period|Adverse Event|2|||
155401772|NCT00418665|560903836|FG002|Treatment Period|Adverse Event|0|||
155401773|NCT00418665|560903834|FG000|Treatment Period|Withdrawal by Subject|0|||
155401774|NCT00418665|560903835|FG001|Treatment Period|Withdrawal by Subject|3|||
155401775|NCT00418665|560903836|FG002|Treatment Period|Withdrawal by Subject|1|||
155401776|NCT00418665|560903834|FG000|Treatment Period|Requirement for alternative therapy|1|||
155401777|NCT00418665|560903835|FG001|Treatment Period|Requirement for alternative therapy|0|||
155401778|NCT00418665|560903836|FG002|Treatment Period|Requirement for alternative therapy|0|||
155401779|NCT00418665|560903834|FG000|Treatment Period|Physician Decision|1|||
155401780|NCT00418665|560903835|FG001|Treatment Period|Physician Decision|0|||
155401781|NCT00418665|560903836|FG002|Treatment Period|Physician Decision|3|||
155401782|NCT00418665|560903834|FG000|Treatment Extension|Adverse Event|1|||
155401783|NCT00418665|560903835|FG001|Treatment Extension|Adverse Event|0|||
155401784|NCT00418665|560903836|FG002|Treatment Extension|Adverse Event|0|||
155401785|NCT00418665|560903834|FG000|Treatment Extension|Withdrawal by Subject|1|||
155401786|NCT00418665|560903835|FG001|Treatment Extension|Withdrawal by Subject|0|||
155401787|NCT00418665|560903836|FG002|Treatment Extension|Withdrawal by Subject|0|||
155401788|NCT00418665|560903834|FG000|Treatment Extension|Requirement for alternative therapy|2|||
155401789|NCT00418665|560903835|FG001|Treatment Extension|Requirement for alternative therapy|2|||
155401790|NCT00418665|560903836|FG002|Treatment Extension|Requirement for alternative therapy|0|||
155401791|NCT00418665|560903834|FG000|Treatment Extension|Physician Decision|2|||
155401792|NCT00418665|560903835|FG001|Treatment Extension|Physician Decision|2|||
155401793|NCT00418665|560903836|FG002|Treatment Extension|Physician Decision|1|||
155401794|NCT00418665|560903834|FG000|Treatment Extension|Death|0|||
155401795|NCT00418665|560903835|FG001|Treatment Extension|Death|0|||
155401796|NCT00418665|560903836|FG002|Treatment Extension|Death|1|||
155401797|NCT00853749|560903837|FG000|Overall Study|Lost to Follow-up|0|||
155401798|NCT00853749|560903838|FG001|Overall Study|Lost to Follow-up|1|||
155401799|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
155401800|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
155401801|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
155401802|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
155401803|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
155401804|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
155401805|NCT01129921|560903843|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
155401806|NCT01129921|560903844|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
155401807|NCT00687440|560903845|FG000|Overall Study|Adverse Event|3|||
155401808|NCT00687440|560903845|FG000|Overall Study|Lost to Follow-up|3|||
155401809|NCT00687440|560903845|FG000|Overall Study|Lack of Efficacy|2|||
155401810|NCT00687440|560903845|FG000|Overall Study|Death|2|||
155401811|NCT00687440|560903845|FG000|Overall Study|Other|1|||
155401812|NCT00687440|560903845|FG000|Overall Study|Missing|1|||
155401813|NCT05937165|560903854|FG000|Overall Study|Withdrawal by Subject|0|||
155401814|NCT05937165|560903855|FG001|Overall Study|Withdrawal by Subject|1|||
155401815|NCT01538628|560903856|FG000|Overall Study|Withdrawal by Subject|1|||
155401816|NCT01538628|560903857|FG001|Overall Study|Withdrawal by Subject|1|||
155401817|NCT01538628|560903856|FG000|Overall Study|Lost to Follow-up|0|||
155401818|NCT01538628|560903857|FG001|Overall Study|Lost to Follow-up|1|||
155401819|NCT03703882|560904646|FG000|Overall Study|Adverse Event|1|||
155401820|NCT03703882|560904647|FG001|Overall Study|Adverse Event|0|||
155401821|NCT03703882|560904646|FG000|Overall Study|Lost to Follow-up|0|||
155401822|NCT03703882|560904647|FG001|Overall Study|Lost to Follow-up|2|||
155401823|NCT03703882|560904646|FG000|Overall Study|Non-compliance with study drug|0|||
155401824|NCT03703882|560904647|FG001|Overall Study|Non-compliance with study drug|1|||
155401825|NCT03703882|560904646|FG000|Overall Study|Physician Decision|0|||
155401826|NCT03703882|560904647|FG001|Overall Study|Physician Decision|1|||
155401827|NCT03703882|560904646|FG000|Overall Study|Progressive disease|1|||
155401828|NCT03703882|560904647|FG001|Overall Study|Progressive disease|0|||
155401829|NCT03703882|560904646|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155401830|NCT03703882|560904647|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155401831|NCT03703882|560904646|FG000|Overall Study|Starting another treatment|0|||
155401832|NCT03703882|560904647|FG001|Overall Study|Starting another treatment|1|||
155401833|NCT03703882|560904646|FG000|Overall Study|noncompliance with study procedures|0|||
155401834|NCT03703882|560904647|FG001|Overall Study|noncompliance with study procedures|1|||
155401835|NCT01321710|560904648|FG000|Overall Study|Lost to Follow-up|4|||
155401836|NCT01321710|560904649|FG001|Overall Study|Lost to Follow-up|5|||
155401837|NCT01321710|560904650|FG002|Overall Study|Lost to Follow-up|0|||
155401838|NCT01761292|560904652|FG000|Part 1|Adverse Event|1|||
155401839|NCT01761292|560904652|FG000|Part 1|not receiving treatment in Part 1|1|||
155401840|NCT01761292|560904652|FG000|Extension 1|Withdrawal by Subject|1|||
155401841|NCT00840086|560904653|FG000|Overall Study|Adverse Event|1|||
155401842|NCT00840086|560904653|FG000|Overall Study|Protocol Violation|2|||
155401843|NCT00840086|560904653|FG000|Overall Study|Lost to Follow-up|1|||
155401844|NCT03577730|560904654|FG000|Overall Study|Physician Decision|3|||
155401845|NCT03577730|560904655|FG001|Overall Study|Physician Decision|1|||
155401846|NCT03577730|560904654|FG000|Overall Study|Did not receive allocated intervention|1|||
155401847|NCT03577730|560904655|FG001|Overall Study|Did not receive allocated intervention|0|||
155401848|NCT03810781|560904656|FG000|Overall Study|COVID shut down|2|||
155401849|NCT02181816|560904657|FG000|Overall Study|Case Report Forms Uncollected|38|||
155401850|NCT02181816|560904657|FG000|Overall Study|Protocol Deviation|21|||
155401851|NCT00909181|560904658|FG000|Overall Study|Lost to Follow-up|39|||
155401852|NCT00909181|560904659|FG001|Overall Study|Lost to Follow-up|18|||
155401853|NCT00909181|560904660|FG002|Overall Study|Lost to Follow-up|33|||
155401854|NCT02349048|560904663|FG000|Overall Study|Withdrawal by Subject|4|||
155401855|NCT02349048|560904664|FG001|Overall Study|Withdrawal by Subject|0|||
155401856|NCT02349048|560904663|FG000|Overall Study|Lost to Follow-up|1|||
155401857|NCT02349048|560904664|FG001|Overall Study|Lost to Follow-up|0|||
155401858|NCT00383084|560904673|FG000|Overall Study|Withdrawal by Subject|12|||
155401859|NCT00383084|560904674|FG001|Overall Study|Withdrawal by Subject|10|||
155401860|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Adverse Event|1|||
155401861|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Adverse Event|0|||
155401862|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Adverse Event|0|||
155401863|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Adverse Event|0|||
155401864|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
155401865|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
155401866|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
155401867|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
155401868|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
155401869|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
155401870|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
155401871|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
155401872|NCT02113436|560904675|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
155401873|NCT02113436|560904676|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
155284793|NCT01941316|560474420|FG003|Overall Study|Physician Decision|3|||
155401874|NCT02113436|560904677|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
155401875|NCT02113436|560904678|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
155401876|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Adverse Event|0|||
155401877|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Adverse Event|0|||
155401878|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Adverse Event|4|||
155401879|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Adverse Event|5|||
155401880|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
155401881|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
155401882|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
155401883|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
155401884|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Physician Decision|0|||
155401885|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Physician Decision|0|||
155401886|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Physician Decision|2|||
155401887|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Physician Decision|0|||
155401888|NCT02113436|560904675|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
155401889|NCT02113436|560904676|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
155401890|NCT02113436|560904677|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
155401891|NCT02113436|560904678|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
155401892|NCT05895552|560904682|FG000|Overall Study|Adverse Event|2|||
155401893|NCT05895552|560904683|FG001|Overall Study|Adverse Event|2|||
155401894|NCT05895552|560904684|FG002|Overall Study|Adverse Event|1|||
155401895|NCT05895552|560904682|FG000|Overall Study|Lost to Follow-up|0|||
155401896|NCT05895552|560904683|FG001|Overall Study|Lost to Follow-up|1|||
155401897|NCT05895552|560904684|FG002|Overall Study|Lost to Follow-up|0|||
155401898|NCT05895552|560904682|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155401899|NCT05895552|560904683|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155401900|NCT05895552|560904684|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155401901|NCT05895552|560904682|FG000|Overall Study|Protocol Deviation|0|||
155401902|NCT05895552|560904683|FG001|Overall Study|Protocol Deviation|0|||
155401903|NCT05895552|560904684|FG002|Overall Study|Protocol Deviation|2|||
155401904|NCT05895552|560904682|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155401905|NCT05895552|560904683|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
155401906|NCT05895552|560904684|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
155401907|NCT05895552|560904682|FG000|Overall Study|Withdrawal by Subject|2|||
155401908|NCT05895552|560904683|FG001|Overall Study|Withdrawal by Subject|2|||
155401909|NCT05895552|560904684|FG002|Overall Study|Withdrawal by Subject|4|||
155401910|NCT03810911|560904685|FG000|Overall Study|Death|1|||
155401911|NCT03810911|560904686|FG001|Overall Study|Death|1|||
155401912|NCT03810911|560904685|FG000|Overall Study|Withdrawal by Subject|1|||
155401913|NCT03810911|560904686|FG001|Overall Study|Withdrawal by Subject|1|||
155401914|NCT04770532|560904687|FG000|Overall Study|Withdrawal by Subject|0|||
155401915|NCT04770532|560904688|FG001|Overall Study|Withdrawal by Subject|3|||
155401916|NCT04770532|560904687|FG000|Overall Study|Physician Decision|1|||
155401917|NCT04770532|560904688|FG001|Overall Study|Physician Decision|0|||
155401918|NCT04770532|560904687|FG000|Overall Study|Death|2|||
155401919|NCT04770532|560904688|FG001|Overall Study|Death|2|||
155401920|NCT04707157|560904692|FG000|Overall Study|Adverse Event|12|||
155401921|NCT04707157|560904693|FG001|Overall Study|Adverse Event|3|||
155401922|NCT04707157|560904692|FG000|Overall Study|Lost to Follow-up|2|||
155401923|NCT04707157|560904693|FG001|Overall Study|Lost to Follow-up|0|||
155401924|NCT04707157|560904692|FG000|Overall Study|Sponsor's decision|1|||
155401925|NCT04707157|560904693|FG001|Overall Study|Sponsor's decision|0|||
155401926|NCT04707157|560904692|FG000|Overall Study|Physician Decision|8|||
155401927|NCT04707157|560904693|FG001|Overall Study|Physician Decision|5|||
155401928|NCT04707157|560904692|FG000|Overall Study|Protocol Deviation|1|||
155401929|NCT04707157|560904693|FG001|Overall Study|Protocol Deviation|0|||
155401930|NCT04707157|560904692|FG000|Overall Study|Withdrawal by Subject|1|||
155401931|NCT04707157|560904693|FG001|Overall Study|Withdrawal by Subject|1|||
155401932|NCT00133991|560904696|FG000|Overall Study|Death|4|||
155401933|NCT05998148|560904699|FG000|Allocation|Did not attend any appointments|1|||
155401934|NCT05998148|560904700|FG001|Allocation|Did not attend any appointments|4|||
155284794|NCT01941316|560474417|FG000|Overall Study|Protocol Violation|0|||
155284795|NCT01941316|560474418|FG001|Overall Study|Protocol Violation|0|||
155284796|NCT01941316|560474419|FG002|Overall Study|Protocol Violation|0|||
155284797|NCT01941316|560474420|FG003|Overall Study|Protocol Violation|3|||
155401935|NCT05998148|560904699|FG000|Follow-Up|Lost to Follow-up|1|||
155401936|NCT05998148|560904700|FG001|Follow-Up|Lost to Follow-up|2|||
155401937|NCT05998148|560904699|FG000|Follow-Up|Change in insurance|1|||
155401938|NCT05998148|560904700|FG001|Follow-Up|Change in insurance|1|||
155401939|NCT04085523|560904701|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401940|NCT04085523|560904702|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401941|NCT04085523|560904703|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401942|NCT04085523|560904704|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401943|NCT04085523|560904705|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
155401944|NCT04085523|560904706|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
155401945|NCT03977974|560904716|FG000|Period 2|Adverse Event|0|||
155401946|NCT03977974|560904717|FG001|Period 2|Adverse Event|0|||
155401947|NCT03977974|560904718|FG002|Period 2|Adverse Event|0|||
155401948|NCT03977974|560904719|FG003|Period 2|Adverse Event|0|||
155401949|NCT03977974|560904720|FG004|Period 2|Adverse Event|1|||
155401950|NCT03977974|560904721|FG005|Period 2|Adverse Event|0|||
155401951|NCT03977974|560904722|FG006|Period 2|Adverse Event|0|||
155401952|NCT03977974|560904723|FG007|Period 2|Adverse Event|0|||
155401953|NCT03977974|560904724|FG008|Period 2|Adverse Event|0|||
155401954|NCT03977974|560904725|FG009|Period 2|Adverse Event|0|||
155401955|NCT03977974|560904726|FG010|Period 2|Adverse Event|0|||
155401956|NCT03977974|560904727|FG011|Period 2|Adverse Event|0|||
155401957|NCT03977974|560904728|FG012|Period 2|Adverse Event|0|||
155401958|NCT04526899|560904730|FG000|Overall Study|Withdrawal by Subject|3|||
155401959|NCT04526899|560904731|FG001|Overall Study|Withdrawal by Subject|2|||
155401960|NCT04526899|560904732|FG002|Overall Study|Withdrawal by Subject|2|||
155401961|NCT04526899|560904730|FG000|Overall Study|Lost to Follow-up|3|||
155401962|NCT04526899|560904731|FG001|Overall Study|Lost to Follow-up|3|||
155401963|NCT04526899|560904732|FG002|Overall Study|Lost to Follow-up|1|||
155401964|NCT04526899|560904730|FG000|Overall Study|Investigator's decision|1|||
155401965|NCT04526899|560904731|FG001|Overall Study|Investigator's decision|0|||
155401966|NCT04526899|560904732|FG002|Overall Study|Investigator's decision|0|||
155401967|NCT04526899|560904730|FG000|Overall Study|Death|33|||
155401968|NCT04526899|560904731|FG001|Overall Study|Death|17|||
155401969|NCT04526899|560904732|FG002|Overall Study|Death|13|||
155401970|NCT04526899|560904730|FG000|Overall Study|Other|1|||
155401971|NCT04526899|560904731|FG001|Overall Study|Other|0|||
155401972|NCT04526899|560904732|FG002|Overall Study|Other|0|||
155401973|NCT04526899|560904730|FG000|Overall Study|On-Treatment|19|||
155401974|NCT04526899|560904731|FG001|Overall Study|On-Treatment|10|||
155401975|NCT04526899|560904732|FG002|Overall Study|On-Treatment|12|||
155401976|NCT04526899|560904730|FG000|Overall Study|Survival Follow-up|34|||
155401977|NCT04526899|560904731|FG001|Overall Study|Survival Follow-up|14|||
155401978|NCT04526899|560904732|FG002|Overall Study|Survival Follow-up|16|||
155401979|NCT00516048|560905593|FG000|Overall Study|Death|0|||
155401980|NCT00516048|560905594|FG001|Overall Study|Death|0|||
155401981|NCT00516048|560905595|FG002|Overall Study|Death|1|||
155401982|NCT00516048|560905593|FG000|Overall Study|Subject Decision|0|||
155401983|NCT00516048|560905594|FG001|Overall Study|Subject Decision|2|||
155401984|NCT00516048|560905595|FG002|Overall Study|Subject Decision|0|||
155401985|NCT02263079|560905596|FG000|Overall Study|Physician Decision|1|||
155401986|NCT02263079|560905597|FG001|Overall Study|Physician Decision|0|||
155401987|NCT02263079|560905598|FG002|Overall Study|Physician Decision|0|||
155401988|NCT02263079|560905596|FG000|Overall Study|Withdrawal by Subject|2|||
155401989|NCT02263079|560905597|FG001|Overall Study|Withdrawal by Subject|8|||
155401990|NCT02263079|560905598|FG002|Overall Study|Withdrawal by Subject|0|||
155401991|NCT02554019|560905604|FG000|Overall Study|Withdrawal by Subject|1|||
155401992|NCT02554019|560905605|FG001|Overall Study|Withdrawal by Subject|0|||
155401993|NCT02554019|560905606|FG002|Overall Study|Withdrawal by Subject|2|||
155401994|NCT02554019|560905604|FG000|Overall Study|Adverse Event|1|||
155401995|NCT02554019|560905605|FG001|Overall Study|Adverse Event|0|||
155401996|NCT02554019|560905606|FG002|Overall Study|Adverse Event|0|||
155401997|NCT02463409|560905607|FG000|Overall Study|Withdrawal by Subject|1|||
155401998|NCT02463409|560905607|FG000|Overall Study|Screen failure|1|||
155401999|NCT00003535|560905609|FG000|Overall Study|Not evaluable|5|||
155402000|NCT01278745|560905615|FG000|Overall Study|Death|2|||
155402001|NCT01278745|560905616|FG001|Overall Study|Death|5|||
155402002|NCT01278745|560905617|FG002|Overall Study|Death|7|||
155402003|NCT01278745|560905618|FG003|Overall Study|Death|0|||
155402004|NCT01278745|560905615|FG000|Overall Study|Physician Decision|1|||
155402005|NCT01278745|560905616|FG001|Overall Study|Physician Decision|0|||
155402006|NCT01278745|560905617|FG002|Overall Study|Physician Decision|0|||
155402007|NCT01278745|560905618|FG003|Overall Study|Physician Decision|9|||
155402008|NCT01278745|560905615|FG000|Overall Study|Withdrawal by Subject|1|||
155402009|NCT01278745|560905616|FG001|Overall Study|Withdrawal by Subject|1|||
155402010|NCT01278745|560905617|FG002|Overall Study|Withdrawal by Subject|5|||
155402011|NCT01278745|560905618|FG003|Overall Study|Withdrawal by Subject|1|||
155402012|NCT01278745|560905615|FG000|Overall Study|Sponsor Decision|1|||
155402013|NCT01278745|560905616|FG001|Overall Study|Sponsor Decision|0|||
155402014|NCT01278745|560905617|FG002|Overall Study|Sponsor Decision|62|||
155402015|NCT01278745|560905618|FG003|Overall Study|Sponsor Decision|6|||
155402016|NCT01278745|560905615|FG000|Overall Study|Ineligible|0|||
155402017|NCT01278745|560905616|FG001|Overall Study|Ineligible|0|||
155402018|NCT01278745|560905617|FG002|Overall Study|Ineligible|42|||
155402019|NCT01278745|560905618|FG003|Overall Study|Ineligible|61|||
155402020|NCT01278745|560905615|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
155402021|NCT01278745|560905616|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
155402022|NCT01278745|560905617|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
155402023|NCT01278745|560905618|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
155402024|NCT01148537|560905619|FG000|Overall Study|Withdrawal by Subject|1|||
155402025|NCT01148537|560905620|FG001|Overall Study|Withdrawal by Subject|0|||
155402026|NCT01148537|560905621|FG002|Overall Study|Withdrawal by Subject|2|||
155402027|NCT01148537|560905619|FG000|Overall Study|Adverse Event|2|||
155402028|NCT01148537|560905620|FG001|Overall Study|Adverse Event|0|||
155402029|NCT01148537|560905621|FG002|Overall Study|Adverse Event|1|||
155402030|NCT05630001|560905622|FG000|Overall Study|Adverse Event|1|||
155402031|NCT05374525|560905624|FG000|Overall Study|Adverse Event|5|||
155402032|NCT05374525|560905625|FG001|Overall Study|Adverse Event|6|||
155402033|NCT05374525|560905624|FG000|Overall Study|Lost to Follow-up|3|||
155402034|NCT05374525|560905625|FG001|Overall Study|Lost to Follow-up|3|||
155402035|NCT05374525|560905624|FG000|Overall Study|Physician Decision|2|||
155402036|NCT05374525|560905625|FG001|Overall Study|Physician Decision|2|||
155402037|NCT05374525|560905624|FG000|Overall Study|Withdrawal by Subject|26|||
155402038|NCT05374525|560905625|FG001|Overall Study|Withdrawal by Subject|8|||
155402039|NCT01349101|560905628|FG000|Overall Study|Disease Progression|1|||
155402040|NCT01349101|560905629|FG001|Overall Study|Disease Progression|1|||
155402041|NCT01349101|560905628|FG000|Overall Study|Death|3|||
155402042|NCT01349101|560905629|FG001|Overall Study|Death|8|||
155402043|NCT00632099|560905630|FG000|Overall Study|Lost to Follow-up|3|||
155402044|NCT00632099|560905631|FG001|Overall Study|Lost to Follow-up|3|||
155402045|NCT01517893|560905634|FG000|Overall Study|Withdrawal by Subject|3|||
155402046|NCT01517893|560905635|FG001|Overall Study|Withdrawal by Subject|0|||
155402047|NCT00865904|560905639|FG000|Overall Study|Randomized but not Treated|2|||
155402048|NCT00865904|560905640|FG001|Overall Study|Randomized but not Treated|0|||
155402049|NCT00865904|560905641|FG002|Overall Study|Randomized but not Treated|0|||
155402050|NCT00865904|560905642|FG003|Overall Study|Randomized but not Treated|1|||
155402051|NCT00865904|560905643|FG004|Overall Study|Randomized but not Treated|1|||
155402052|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
155402053|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
155402054|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Death|0|||
155402055|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Death|1|||
155402056|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
155402057|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
155402058|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
155402059|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
155402060|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
155402061|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
155402062|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
155402063|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
155402064|NCT00843518|560905647|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
155402065|NCT00843518|560905648|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
155402066|NCT00589420|560905649|FG000|Overall Study|screen failure|1|||
155402067|NCT01131520|560905655|FG000|Overall Study|Computer problem|1|||
155402068|NCT01131520|560905656|FG001|Overall Study|Computer problem|0|||
155402069|NCT01131520|560905655|FG000|Overall Study|Counselor not available|0|||
155402070|NCT01131520|560905656|FG001|Overall Study|Counselor not available|3|||
155402071|NCT01131520|560905655|FG000|Overall Study|Subject changed history after enrollment|0|||
155402072|NCT01131520|560905656|FG001|Overall Study|Subject changed history after enrollment|1|||
155402073|NCT04857996|560905659|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
155402074|NCT04857996|560905660|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
155402075|NCT04857996|560905659|FG000|Overall Study|Lost to Follow-up|1|||
155402076|NCT04857996|560905660|FG001|Overall Study|Lost to Follow-up|3|||
155402077|NCT04857996|560905659|FG000|Overall Study|Site Closure|1|||
155402078|NCT04857996|560905660|FG001|Overall Study|Site Closure|0|||
155402079|NCT04857996|560905659|FG000|Overall Study|Withdrawal by Subject|1|||
155402080|NCT04857996|560905660|FG001|Overall Study|Withdrawal by Subject|0|||
155402081|NCT02988661|560905661|FG000|Overall Study|Death|2|||
155402082|NCT02988661|560905662|FG001|Overall Study|Death|18|||
155402083|NCT02988661|560905661|FG000|Overall Study|Lost to Follow-up|0|||
155402084|NCT02988661|560905662|FG001|Overall Study|Lost to Follow-up|33|||
155402085|NCT02988661|560905661|FG000|Overall Study|Withdrawal by Subject|0|||
155402086|NCT02988661|560905662|FG001|Overall Study|Withdrawal by Subject|6|||
155402087|NCT02988661|560905661|FG000|Overall Study|Unable to complete the 18-month survey|1|||
155402088|NCT02988661|560905662|FG001|Overall Study|Unable to complete the 18-month survey|27|||
155402089|NCT01392677|560905663|FG000|Overall Study|Adverse Event|3|||
155402090|NCT01392677|560905664|FG001|Overall Study|Adverse Event|1|||
155402091|NCT01392677|560905663|FG000|Overall Study|Withdrawal by Subject|0|||
155402092|NCT01392677|560905664|FG001|Overall Study|Withdrawal by Subject|2|||
155402093|NCT01392677|560905663|FG000|Overall Study|Incorrect enrollment|2|||
155402094|NCT01392677|560905664|FG001|Overall Study|Incorrect enrollment|3|||
155402095|NCT01392677|560905663|FG000|Overall Study|Other reason|3|||
155402096|NCT01392677|560905664|FG001|Overall Study|Other reason|2|||
155402097|NCT01380379|560905665|FG000|Overall Study|Pregnancy|1|||
155402098|NCT05493280|560905668|FG000|Part 2 intervention (7 months)|Withdrawal by Subject|1|||
154954243|NCT02106156|559259506|FG000|Overall Study|Lack of Tolerability|305|||
155402099|NCT05493280|560905669|FG001|Part 2 intervention (7 months)|Withdrawal by Subject|0|||
155402100|NCT06608368|560905670|FG000|Overall Study|Family Emergency|0|||
155402101|NCT06608368|560905671|FG001|Overall Study|Family Emergency|1|||
155402102|NCT06608368|560905672|FG002|Overall Study|Family Emergency|0|||
155402103|NCT06608368|560905670|FG000|Overall Study|Scheduling Issues|0|||
155402104|NCT06608368|560905671|FG001|Overall Study|Scheduling Issues|1|||
155402105|NCT06608368|560905672|FG002|Overall Study|Scheduling Issues|0|||
155402106|NCT02982954|560907142|FG000|Overall Study|Death|55|||
155402107|NCT02982954|560907143|FG001|Overall Study|Death|29|||
155402108|NCT02982954|560907144|FG002|Overall Study|Death|15|||
155402109|NCT02982954|560907145|FG003|Overall Study|Death|20|||
155402110|NCT02982954|560907142|FG000|Overall Study|Lost to Follow-up|2|||
155402111|NCT02982954|560907143|FG001|Overall Study|Lost to Follow-up|1|||
155402112|NCT02982954|560907144|FG002|Overall Study|Lost to Follow-up|0|||
155284798|NCT01941316|560474417|FG000|Overall Study|Intercurrent illness|0|||
155402113|NCT02982954|560907145|FG003|Overall Study|Lost to Follow-up|0|||
155402114|NCT02982954|560907142|FG000|Overall Study|Participant withdrew consent|7|||
155402115|NCT02982954|560907143|FG001|Overall Study|Participant withdrew consent|5|||
155402116|NCT02982954|560907144|FG002|Overall Study|Participant withdrew consent|1|||
154954244|NCT02106156|559259507|FG001|Overall Study|Lack of Tolerability|3|||
155284799|NCT01941316|560474418|FG001|Overall Study|Intercurrent illness|0|||
155284800|NCT01941316|560474419|FG002|Overall Study|Intercurrent illness|0|||
155284801|NCT01941316|560474420|FG003|Overall Study|Intercurrent illness|1|||
155284802|NCT01941316|560474417|FG000|Overall Study|Other, not specified|0|||
155284803|NCT01941316|560474418|FG001|Overall Study|Other, not specified|0|||
155284804|NCT01941316|560474419|FG002|Overall Study|Other, not specified|0|||
155284805|NCT01941316|560474420|FG003|Overall Study|Other, not specified|1|||
155284806|NCT02775435|560474421|FG000|Overall Study|Adverse Event|32|||
155284807|NCT02775435|560474422|FG001|Overall Study|Adverse Event|27|||
155284808|NCT02775435|560474421|FG000|Overall Study|Lost to Follow-up|2|||
155284809|NCT02775435|560474422|FG001|Overall Study|Lost to Follow-up|2|||
155284810|NCT02775435|560474421|FG000|Overall Study|Sponsor decision|44|||
155284811|NCT02775435|560474422|FG001|Overall Study|Sponsor decision|19|||
155284812|NCT02775435|560474421|FG000|Overall Study|Withdrawal by Subject|4|||
155284813|NCT02775435|560474422|FG001|Overall Study|Withdrawal by Subject|9|||
155284814|NCT02775435|560474421|FG000|Overall Study|Death|196|||
155284815|NCT02775435|560474422|FG001|Overall Study|Death|224|||
155284816|NCT02282527|560474423|FG000|Overall Study|Lost to Follow-up|0|||
155284817|NCT02282527|560474424|FG001|Overall Study|Lost to Follow-up|1|||
155284818|NCT02282527|560474423|FG000|Overall Study|Lack of home health aid|1|||
155284819|NCT02282527|560474424|FG001|Overall Study|Lack of home health aid|0|||
155284820|NCT00941031|560474425|FG000|Induction Period|Lack of Efficacy|2|||
155284821|NCT00941031|560474426|FG001|Induction Period|Lack of Efficacy|1|||
155284822|NCT00941031|560474427|FG002|Induction Period|Lack of Efficacy|0|||
155284823|NCT00941031|560474428|FG003|Induction Period|Lack of Efficacy|5|||
155284824|NCT00941031|560474429|FG004|Induction Period|Lack of Efficacy|0|||
155284825|NCT00941031|560474430|FG005|Induction Period|Lack of Efficacy|0|||
155284826|NCT00941031|560474431|FG006|Induction Period|Lack of Efficacy|0|||
155284827|NCT00941031|560474425|FG000|Induction Period|Withdrawal by Subject|1|||
155284828|NCT00941031|560474426|FG001|Induction Period|Withdrawal by Subject|2|||
155284829|NCT00941031|560474427|FG002|Induction Period|Withdrawal by Subject|2|||
155284830|NCT00941031|560474428|FG003|Induction Period|Withdrawal by Subject|2|||
155284831|NCT00941031|560474429|FG004|Induction Period|Withdrawal by Subject|0|||
155284832|NCT00941031|560474430|FG005|Induction Period|Withdrawal by Subject|0|||
155284833|NCT00941031|560474431|FG006|Induction Period|Withdrawal by Subject|0|||
155284834|NCT00941031|560474425|FG000|Induction Period|Adminstative Problems|1|||
155284835|NCT00941031|560474426|FG001|Induction Period|Adminstative Problems|1|||
155284836|NCT00941031|560474427|FG002|Induction Period|Adminstative Problems|1|||
155284837|NCT00941031|560474428|FG003|Induction Period|Adminstative Problems|0|||
155284838|NCT00941031|560474429|FG004|Induction Period|Adminstative Problems|0|||
155284839|NCT00941031|560474430|FG005|Induction Period|Adminstative Problems|0|||
155284840|NCT00941031|560474431|FG006|Induction Period|Adminstative Problems|0|||
155284841|NCT00941031|560474425|FG000|Induction Period|Adverse Event|1|||
155402117|NCT02982954|560907145|FG003|Overall Study|Participant withdrew consent|1|||
154954245|NCT02106156|559259508|FG002|Overall Study|Lack of Tolerability|0|||
155284842|NCT00941031|560474426|FG001|Induction Period|Adverse Event|0|||
155284843|NCT00941031|560474427|FG002|Induction Period|Adverse Event|3|||
155284844|NCT00941031|560474428|FG003|Induction Period|Adverse Event|2|||
155284845|NCT00941031|560474429|FG004|Induction Period|Adverse Event|0|||
155284846|NCT00941031|560474430|FG005|Induction Period|Adverse Event|0|||
154954246|NCT02106156|559259506|FG000|Overall Study|Lack of Virological Response|1044|||
155284847|NCT00941031|560474431|FG006|Induction Period|Adverse Event|0|||
155284848|NCT00941031|560474425|FG000|Maintenance Period|Withdrawal by Subject|0|||
155284849|NCT00941031|560474426|FG001|Maintenance Period|Withdrawal by Subject|0|||
155402118|NCT02982954|560907142|FG000|Overall Study|Other reasons|42|||
155402119|NCT02982954|560907143|FG001|Overall Study|Other reasons|17|||
155402120|NCT02982954|560907144|FG002|Overall Study|Other reasons|12|||
154954247|NCT02106156|559259507|FG001|Overall Study|Lack of Virological Response|8|||
155284850|NCT00941031|560474427|FG002|Maintenance Period|Withdrawal by Subject|0|||
155402121|NCT02982954|560907145|FG003|Overall Study|Other reasons|3|||
155402122|NCT02982954|560907142|FG000|Overall Study|Premature site closure|0|||
155402123|NCT02982954|560907143|FG001|Overall Study|Premature site closure|0|||
155402124|NCT02982954|560907144|FG002|Overall Study|Premature site closure|0|||
155402125|NCT02982954|560907145|FG003|Overall Study|Premature site closure|1|||
155402126|NCT02634151|560907146|FG000|Overall Study|Withdrawal by Subject|1|||
155402127|NCT02634151|560907147|FG001|Overall Study|Withdrawal by Subject|0|||
155402128|NCT02634151|560907146|FG000|Overall Study|Non-Compliance|0|||
155402129|NCT02634151|560907147|FG001|Overall Study|Non-Compliance|1|||
155402130|NCT02634151|560907146|FG000|Overall Study|Other|0|||
155402131|NCT02634151|560907147|FG001|Overall Study|Other|1|||
155402132|NCT02347098|560907148|FG000|Overall Study|Death|1|||
155402133|NCT02347098|560907149|FG001|Overall Study|Death|0|||
155402134|NCT02347098|560907148|FG000|Overall Study|Withdrawal by Subject|1|||
155402135|NCT02347098|560907149|FG001|Overall Study|Withdrawal by Subject|0|||
155402136|NCT02347098|560907148|FG000|Overall Study|Lost to Follow-up|2|||
155402137|NCT02347098|560907149|FG001|Overall Study|Lost to Follow-up|2|||
155402138|NCT02347098|560907148|FG000|Overall Study|Refuse Follow-up Visit|1|||
155402139|NCT02347098|560907149|FG001|Overall Study|Refuse Follow-up Visit|5|||
155402140|NCT02347098|560907148|FG000|Overall Study|no visit due to illness|2|||
155402141|NCT02347098|560907149|FG001|Overall Study|no visit due to illness|1|||
155402142|NCT01444742|560907150|FG000|Overall Study|Death|1|||
155402143|NCT02830880|560907151|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
155402144|NCT02830880|560907151|FG000|Overall Study|Death|1|||
155402145|NCT02830880|560907151|FG000|Overall Study|Physician Decision|1|||
155402146|NCT01843842|560907156|FG000|Overall Study|Do not meet inclusion criteria|1|||
155402147|NCT01843842|560907157|FG001|Overall Study|Do not meet inclusion criteria|1|||
155402148|NCT01376778|560907158|FG000|Overall Study|Lost to Follow-up|3|||
155402149|NCT01376778|560907159|FG001|Overall Study|Lost to Follow-up|2|||
155402150|NCT03462576|560907160|FG000|Overall Study|Protocol Violation|5|||
155402151|NCT03462576|560907161|FG001|Overall Study|Protocol Violation|11|||
155402152|NCT03462576|560907162|FG002|Overall Study|Protocol Violation|7|||
155402153|NCT03462576|560907160|FG000|Overall Study|Device Malfunction|0|||
155402154|NCT03462576|560907161|FG001|Overall Study|Device Malfunction|0|||
155402155|NCT03462576|560907162|FG002|Overall Study|Device Malfunction|1|||
155402156|NCT00271596|560907163|FG000|Overall Study|Protocol Violation|1|||
155402157|NCT00271596|560907164|FG001|Overall Study|Protocol Violation|0|||
155402158|NCT00271596|560907163|FG000|Overall Study|Withdrawal by Subject|0|||
155402159|NCT00271596|560907164|FG001|Overall Study|Withdrawal by Subject|1|||
155402160|NCT04206605|560907171|FG000|Overall Study|Adverse Event|0|||
155402161|NCT04206605|560907172|FG001|Overall Study|Adverse Event|1|||
155402162|NCT04206605|560907171|FG000|Overall Study|Withdrawal by Subject|1|||
155402163|NCT04206605|560907172|FG001|Overall Study|Withdrawal by Subject|0|||
155402164|NCT05879107|560907173|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
155402165|NCT05879107|560907174|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
155402166|NCT05879107|560907173|FG000|Overall Study|Migrated / moved from the study area|1|||
155402167|NCT05879107|560907174|FG001|Overall Study|Migrated / moved from the study area|1|||
155402168|NCT05879107|560907173|FG000|Overall Study|Lost to Follow-up|8|||
155402169|NCT05879107|560907174|FG001|Overall Study|Lost to Follow-up|13|||
155402170|NCT05879107|560907173|FG000|Overall Study|Death|0|||
155402171|NCT05879107|560907174|FG001|Overall Study|Death|2|||
155402172|NCT05879107|560907173|FG000|Overall Study|Other|0|||
155402173|NCT05879107|560907174|FG001|Overall Study|Other|3|||
155402174|NCT03418129|560907179|FG000|Overall Study|Lost to Follow-up|11|||
155402175|NCT03418129|560907180|FG001|Overall Study|Lost to Follow-up|20|||
155402176|NCT03418129|560907181|FG002|Overall Study|Lost to Follow-up|15|||
155402177|NCT03418129|560907179|FG000|Overall Study|Withdrawal by Subject|3|||
155402178|NCT03418129|560907180|FG001|Overall Study|Withdrawal by Subject|6|||
155402179|NCT03418129|560907181|FG002|Overall Study|Withdrawal by Subject|4|||
155402180|NCT00942175|560907184|FG000|Overall Study|Adverse Event|2|||
155402181|NCT00942175|560907185|FG001|Overall Study|Adverse Event|1|||
155402182|NCT00942175|560907186|FG002|Overall Study|Adverse Event|0|||
155402183|NCT00942175|560907187|FG003|Overall Study|Adverse Event|0|||
155402184|NCT00942175|560907184|FG000|Overall Study|Protocol Violation|0|||
155402185|NCT00942175|560907185|FG001|Overall Study|Protocol Violation|1|||
155402186|NCT00942175|560907186|FG002|Overall Study|Protocol Violation|2|||
155402187|NCT00942175|560907187|FG003|Overall Study|Protocol Violation|0|||
155402188|NCT00942175|560907184|FG000|Overall Study|Pregnancy|0|||
155402189|NCT00942175|560907185|FG001|Overall Study|Pregnancy|0|||
155402190|NCT00942175|560907186|FG002|Overall Study|Pregnancy|0|||
155402191|NCT00942175|560907187|FG003|Overall Study|Pregnancy|1|||
155284851|NCT00941031|560474428|FG003|Maintenance Period|Withdrawal by Subject|0|||
155402192|NCT00942175|560907184|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
154954248|NCT02106156|559259508|FG002|Overall Study|Lack of Virological Response|0|||
155402193|NCT00942175|560907185|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
155402194|NCT00942175|560907186|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
155402195|NCT00942175|560907187|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
155402196|NCT00942175|560907184|FG000|Overall Study|Low Platelet Count|0|||
155402197|NCT00942175|560907185|FG001|Overall Study|Low Platelet Count|2|||
155402198|NCT00942175|560907186|FG002|Overall Study|Low Platelet Count|0|||
155402199|NCT00942175|560907187|FG003|Overall Study|Low Platelet Count|0|||
155402200|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
155402201|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
155402202|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
155402203|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
155402204|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
155402205|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
155402206|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155402207|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155402208|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
155402209|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
155402210|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
155402211|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
155402212|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
155402213|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
155402214|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
155402215|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
155402216|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
155402217|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
155402218|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
155402219|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
155402220|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
155402221|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
155402222|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
155402223|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
155402224|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Death|2|||
155402225|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Death|1|||
155402226|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Death|0|||
155402227|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Death|0|||
155402228|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
155402229|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
155402230|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155402231|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155402232|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
155402233|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
155402234|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
155402235|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
155402236|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
155402237|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
155402238|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155402239|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
155402240|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
155402241|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
155402242|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
155402243|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
155402244|NCT01940471|560907188|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
155402245|NCT01940471|560907189|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
155402246|NCT01940471|560907190|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
155402247|NCT01940471|560907191|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
155402248|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
155402249|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
155402250|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
155402251|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
155402252|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155402253|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155402254|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
155402255|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
155402256|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
155402257|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
155402258|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
155402259|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
155402260|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
155402261|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
155402262|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
155402263|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
155402264|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155402265|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
155402266|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
155402267|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
155402268|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155402269|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
155402270|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
155402271|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
155402272|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155402273|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155402274|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
155402275|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
155402276|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
155402277|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
155402278|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
155402279|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
155402280|NCT01940471|560907188|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155402281|NCT01940471|560907189|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155402282|NCT01940471|560907190|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
155402283|NCT01940471|560907191|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
155402284|NCT02973087|560907192|FG000|Overall Study|Withdrawal by Subject|2|||
155402285|NCT02973087|560907193|FG001|Overall Study|Withdrawal by Subject|1|||
155402286|NCT02973087|560907192|FG000|Overall Study|Adverse Event|1|||
155402287|NCT02973087|560907193|FG001|Overall Study|Adverse Event|0|||
155402288|NCT02973087|560907192|FG000|Overall Study|other|1|||
155402289|NCT02973087|560907193|FG001|Overall Study|other|1|||
155402290|NCT03710486|560907194|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
155402291|NCT03710486|560907195|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
155402292|NCT03710486|560907194|FG000|Overall Study|Missing|0|||
155402293|NCT03710486|560907195|FG001|Overall Study|Missing|2|||
155402294|NCT01279850|560907200|FG000|Overall Study|Protocol Violation|50|||
155402295|NCT01279850|560907200|FG000|Overall Study|No Drug Administration Information|7|||
155402296|NCT01279850|560907200|FG000|Overall Study|No Visit After Treatment|34|||
155402297|NCT01147744|560907201|FG000|Overall Study|Protocol Violation|1|||
155402298|NCT01147744|560907202|FG001|Overall Study|Protocol Violation|0|||
155402299|NCT01147744|560907203|FG002|Overall Study|Protocol Violation|1|||
155402300|NCT01147744|560907204|FG003|Overall Study|Protocol Violation|0|||
155402301|NCT01147744|560907205|FG004|Overall Study|Protocol Violation|1|||
155402302|NCT01147744|560907206|FG005|Overall Study|Protocol Violation|3|||
155402303|NCT01147744|560907207|FG006|Overall Study|Protocol Violation|1|||
155402304|NCT01147744|560907201|FG000|Overall Study|Physician Decision|0|||
155402305|NCT01147744|560907202|FG001|Overall Study|Physician Decision|1|||
155402306|NCT01147744|560907203|FG002|Overall Study|Physician Decision|1|||
155402307|NCT01147744|560907204|FG003|Overall Study|Physician Decision|0|||
155402308|NCT01147744|560907205|FG004|Overall Study|Physician Decision|0|||
155402309|NCT01147744|560907206|FG005|Overall Study|Physician Decision|0|||
155402310|NCT01147744|560907207|FG006|Overall Study|Physician Decision|1|||
155402311|NCT01147744|560907201|FG000|Overall Study|Lack of Efficacy|11|||
155402312|NCT01147744|560907202|FG001|Overall Study|Lack of Efficacy|11|||
155402313|NCT01147744|560907203|FG002|Overall Study|Lack of Efficacy|9|||
155402314|NCT01147744|560907204|FG003|Overall Study|Lack of Efficacy|11|||
155402315|NCT01147744|560907205|FG004|Overall Study|Lack of Efficacy|13|||
155402316|NCT01147744|560907206|FG005|Overall Study|Lack of Efficacy|8|||
155402317|NCT01147744|560907207|FG006|Overall Study|Lack of Efficacy|7|||
155402318|NCT01147744|560907201|FG000|Overall Study|Adverse Event|1|||
155402319|NCT01147744|560907202|FG001|Overall Study|Adverse Event|2|||
155402320|NCT01147744|560907203|FG002|Overall Study|Adverse Event|3|||
155402321|NCT01147744|560907204|FG003|Overall Study|Adverse Event|0|||
155402322|NCT01147744|560907205|FG004|Overall Study|Adverse Event|2|||
155402323|NCT01147744|560907206|FG005|Overall Study|Adverse Event|1|||
155402324|NCT01147744|560907207|FG006|Overall Study|Adverse Event|2|||
155402325|NCT01147744|560907201|FG000|Overall Study|Withdrawal by Subject|8|||
155402326|NCT01147744|560907202|FG001|Overall Study|Withdrawal by Subject|4|||
155402327|NCT01147744|560907203|FG002|Overall Study|Withdrawal by Subject|2|||
155402328|NCT01147744|560907204|FG003|Overall Study|Withdrawal by Subject|2|||
155402329|NCT01147744|560907205|FG004|Overall Study|Withdrawal by Subject|2|||
155402330|NCT01147744|560907206|FG005|Overall Study|Withdrawal by Subject|5|||
155402331|NCT01147744|560907207|FG006|Overall Study|Withdrawal by Subject|2|||
155402332|NCT01147744|560907201|FG000|Overall Study|Lost to Follow-up|0|||
155402333|NCT01147744|560907202|FG001|Overall Study|Lost to Follow-up|1|||
155402334|NCT01147744|560907203|FG002|Overall Study|Lost to Follow-up|0|||
155402335|NCT01147744|560907204|FG003|Overall Study|Lost to Follow-up|0|||
155402336|NCT01147744|560907205|FG004|Overall Study|Lost to Follow-up|0|||
155402337|NCT01147744|560907206|FG005|Overall Study|Lost to Follow-up|0|||
155402338|NCT01147744|560907207|FG006|Overall Study|Lost to Follow-up|0|||
155402339|NCT01147744|560907201|FG000|Overall Study|Sponsor decision to amend protocol|7|||
155402340|NCT01147744|560907202|FG001|Overall Study|Sponsor decision to amend protocol|4|||
155402341|NCT01147744|560907203|FG002|Overall Study|Sponsor decision to amend protocol|2|||
155402342|NCT01147744|560907204|FG003|Overall Study|Sponsor decision to amend protocol|5|||
155402343|NCT01147744|560907205|FG004|Overall Study|Sponsor decision to amend protocol|7|||
155402344|NCT01147744|560907206|FG005|Overall Study|Sponsor decision to amend protocol|2|||
155402345|NCT01147744|560907207|FG006|Overall Study|Sponsor decision to amend protocol|6|||
155402346|NCT01147744|560907201|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155402347|NCT01147744|560907202|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402348|NCT01147744|560907203|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402349|NCT01147744|560907204|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402350|NCT01147744|560907205|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402351|NCT01147744|560907206|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155402352|NCT01147744|560907207|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155402353|NCT01342484|560907212|FG000|Overall Study|Other Reasons|1|||
155402354|NCT01342484|560907213|FG001|Overall Study|Other Reasons|0|||
155402355|NCT01342484|560907214|FG002|Overall Study|Other Reasons|0|||
155402356|NCT01342484|560907212|FG000|Overall Study|Protocol Violation|0|||
155402357|NCT01342484|560907213|FG001|Overall Study|Protocol Violation|0|||
155402358|NCT01342484|560907214|FG002|Overall Study|Protocol Violation|1|||
155402359|NCT01342484|560907212|FG000|Overall Study|Withdrawal by Subject|1|||
155402360|NCT01342484|560907213|FG001|Overall Study|Withdrawal by Subject|0|||
155402361|NCT01342484|560907214|FG002|Overall Study|Withdrawal by Subject|0|||
155402362|NCT01840579|560907215|FG000|Overall Study|Status not recorded|0|||
155402363|NCT01840579|560907216|FG001|Overall Study|Status not recorded|0|||
155402364|NCT01840579|560907217|FG002|Overall Study|Status not recorded|2|||
155402365|NCT01840579|560907218|FG003|Overall Study|Status not recorded|3|||
155402366|NCT01840579|560907219|FG004|Overall Study|Status not recorded|4|||
155402367|NCT01840579|560907220|FG005|Overall Study|Status not recorded|3|||
155402368|NCT01840579|560907221|FG006|Overall Study|Status not recorded|0|||
155402369|NCT01840579|560907222|FG007|Overall Study|Status not recorded|3|||
155402370|NCT01840579|560907223|FG008|Overall Study|Status not recorded|3|||
155402371|NCT01840579|560907224|FG009|Overall Study|Status not recorded|3|||
155402372|NCT01840579|560907215|FG000|Overall Study|Progressive disease|3|||
155402373|NCT01840579|560907216|FG001|Overall Study|Progressive disease|5|||
155402374|NCT01840579|560907217|FG002|Overall Study|Progressive disease|0|||
155402375|NCT01840579|560907218|FG003|Overall Study|Progressive disease|0|||
155402376|NCT01840579|560907219|FG004|Overall Study|Progressive disease|0|||
155402377|NCT01840579|560907220|FG005|Overall Study|Progressive disease|0|||
155402378|NCT01840579|560907221|FG006|Overall Study|Progressive disease|0|||
155402379|NCT01840579|560907222|FG007|Overall Study|Progressive disease|0|||
155402380|NCT01840579|560907223|FG008|Overall Study|Progressive disease|0|||
155402381|NCT01840579|560907224|FG009|Overall Study|Progressive disease|0|||
155402382|NCT01840579|560907215|FG000|Overall Study|Ongoing in study|0|||
155402383|NCT01840579|560907216|FG001|Overall Study|Ongoing in study|1|||
155402384|NCT01840579|560907217|FG002|Overall Study|Ongoing in study|0|||
155402385|NCT01840579|560907218|FG003|Overall Study|Ongoing in study|0|||
155402386|NCT01840579|560907219|FG004|Overall Study|Ongoing in study|0|||
155402387|NCT01840579|560907220|FG005|Overall Study|Ongoing in study|0|||
155402388|NCT01840579|560907221|FG006|Overall Study|Ongoing in study|0|||
155402389|NCT01840579|560907222|FG007|Overall Study|Ongoing in study|0|||
155402390|NCT01840579|560907223|FG008|Overall Study|Ongoing in study|0|||
155402391|NCT01840579|560907224|FG009|Overall Study|Ongoing in study|0|||
155402392|NCT01840579|560907215|FG000|Overall Study|Death|0|||
155402393|NCT01840579|560907216|FG001|Overall Study|Death|0|||
155402394|NCT01840579|560907217|FG002|Overall Study|Death|0|||
155402395|NCT01840579|560907218|FG003|Overall Study|Death|0|||
155402396|NCT01840579|560907219|FG004|Overall Study|Death|0|||
155402397|NCT01840579|560907220|FG005|Overall Study|Death|1|||
155402398|NCT01840579|560907221|FG006|Overall Study|Death|0|||
155402399|NCT01840579|560907222|FG007|Overall Study|Death|0|||
155402400|NCT01840579|560907223|FG008|Overall Study|Death|0|||
155402401|NCT01840579|560907224|FG009|Overall Study|Death|0|||
155402402|NCT01840579|560907215|FG000|Overall Study|Adverse Event|0|||
155284852|NCT00941031|560474429|FG004|Maintenance Period|Withdrawal by Subject|6|||
155284853|NCT00941031|560474430|FG005|Maintenance Period|Withdrawal by Subject|2|||
155402403|NCT01840579|560907216|FG001|Overall Study|Adverse Event|1|||
155402404|NCT01840579|560907217|FG002|Overall Study|Adverse Event|0|||
155402405|NCT01840579|560907218|FG003|Overall Study|Adverse Event|0|||
155402406|NCT01840579|560907219|FG004|Overall Study|Adverse Event|0|||
155402407|NCT01840579|560907220|FG005|Overall Study|Adverse Event|0|||
155402408|NCT01840579|560907221|FG006|Overall Study|Adverse Event|0|||
155402409|NCT01840579|560907222|FG007|Overall Study|Adverse Event|0|||
155402410|NCT01840579|560907223|FG008|Overall Study|Adverse Event|0|||
155402411|NCT01840579|560907224|FG009|Overall Study|Adverse Event|0|||
155402412|NCT01840579|560907215|FG000|Overall Study|Follow-up ended by Sponsor|0|||
155402413|NCT01840579|560907216|FG001|Overall Study|Follow-up ended by Sponsor|0|||
155402414|NCT01840579|560907217|FG002|Overall Study|Follow-up ended by Sponsor|0|||
155402415|NCT01840579|560907218|FG003|Overall Study|Follow-up ended by Sponsor|0|||
155402416|NCT01840579|560907219|FG004|Overall Study|Follow-up ended by Sponsor|0|||
155402417|NCT01840579|560907220|FG005|Overall Study|Follow-up ended by Sponsor|0|||
155402418|NCT01840579|560907221|FG006|Overall Study|Follow-up ended by Sponsor|2|||
155402419|NCT01840579|560907222|FG007|Overall Study|Follow-up ended by Sponsor|0|||
155402420|NCT01840579|560907223|FG008|Overall Study|Follow-up ended by Sponsor|0|||
155402421|NCT01840579|560907224|FG009|Overall Study|Follow-up ended by Sponsor|0|||
155402422|NCT03302975|560907226|FG000|Overall Study|Lost to Follow-up|4|||
155402423|NCT01436084|560907227|FG000|Overall Study|Disease Progression|2|||
155402424|NCT01436084|560907227|FG000|Overall Study|Withdrawal by Subject|1|||
155402425|NCT01436084|560907227|FG000|Overall Study|Early Closure of Study|1|||
155402426|NCT02090413|560907230|FG000|Overall Study|Adverse Event|11|||
155402427|NCT02090413|560907231|FG001|Overall Study|Adverse Event|15|||
155402428|NCT02090413|560907232|FG002|Overall Study|Adverse Event|20|||
155402429|NCT02090413|560907230|FG000|Overall Study|Flushing event|2|||
155402430|NCT02090413|560907231|FG001|Overall Study|Flushing event|0|||
155402431|NCT02090413|560907232|FG002|Overall Study|Flushing event|1|||
155402432|NCT02090413|560907230|FG000|Overall Study|Withdrawal by Subject|2|||
155402433|NCT02090413|560907231|FG001|Overall Study|Withdrawal by Subject|2|||
155402434|NCT02090413|560907232|FG002|Overall Study|Withdrawal by Subject|2|||
155402435|NCT02090413|560907230|FG000|Overall Study|Investigator Decision|1|||
155402436|NCT02090413|560907231|FG001|Overall Study|Investigator Decision|1|||
155402437|NCT02090413|560907232|FG002|Overall Study|Investigator Decision|0|||
155402438|NCT02090413|560907230|FG000|Overall Study|Other|2|||
155402439|NCT02090413|560907231|FG001|Overall Study|Other|1|||
155402440|NCT02090413|560907232|FG002|Overall Study|Other|0|||
155402441|NCT02090413|560907230|FG000|Overall Study|Lost to Follow-up|1|||
155402442|NCT02090413|560907231|FG001|Overall Study|Lost to Follow-up|1|||
155402443|NCT02090413|560907232|FG002|Overall Study|Lost to Follow-up|0|||
155402444|NCT05419128|560907233|FG000|Overall Study|Withdrawal by Subject|1|||
155402445|NCT05419128|560907234|FG001|Overall Study|Withdrawal by Subject|1|||
155402446|NCT05419128|560907235|FG002|Overall Study|Withdrawal by Subject|0|||
155402447|NCT05419128|560907236|FG003|Overall Study|Withdrawal by Subject|1|||
155402448|NCT05419128|560907237|FG004|Overall Study|Withdrawal by Subject|1|||
155402449|NCT05419128|560907238|FG005|Overall Study|Withdrawal by Subject|0|||
155402450|NCT05419128|560907233|FG000|Overall Study|Lost to Follow-up|0|||
155402451|NCT05419128|560907234|FG001|Overall Study|Lost to Follow-up|0|||
155402452|NCT05419128|560907235|FG002|Overall Study|Lost to Follow-up|1|||
155402453|NCT05419128|560907236|FG003|Overall Study|Lost to Follow-up|0|||
155402454|NCT05419128|560907237|FG004|Overall Study|Lost to Follow-up|0|||
155402455|NCT05419128|560907238|FG005|Overall Study|Lost to Follow-up|1|||
155402456|NCT05248295|560907239|FG000|Overall Study|found ineligible|4|||
155402457|NCT05248295|560907240|FG001|Overall Study|found ineligible|1|||
155058432|NCT00264147|559648661|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155402458|NCT05248295|560907239|FG000|Overall Study|Withdrawal by Subject|0|||
155402459|NCT05248295|560907240|FG001|Overall Study|Withdrawal by Subject|1|||
155402460|NCT05248295|560907239|FG000|Overall Study|Data loss: audio recording error|1|||
155402461|NCT05248295|560907240|FG001|Overall Study|Data loss: audio recording error|1|||
155402462|NCT04066491|560907241|FG000|Overall Study|Randomized, not treated|0|||
155402463|NCT04066491|560907242|FG001|Overall Study|Randomized, not treated|0|||
155402464|NCT04066491|560907243|FG002|Overall Study|Randomized, not treated|2|||
155402465|NCT04506086|560907244|FG000|Overall Study|Withdrawal by Subject|2|||
155402466|NCT04490018|560907245|FG000|Overall Study|Protocol Violation|0|||
155402467|NCT04490018|560907246|FG001|Overall Study|Protocol Violation|2|||
155402468|NCT04490018|560907247|FG002|Overall Study|Protocol Violation|1|||
155402469|NCT04490018|560907245|FG000|Overall Study|Lost to Follow-up|2|||
155402470|NCT04490018|560907246|FG001|Overall Study|Lost to Follow-up|2|||
155402471|NCT04490018|560907247|FG002|Overall Study|Lost to Follow-up|0|||
155402472|NCT04490018|560907245|FG000|Overall Study|Withdrawal by Subject|2|||
155402473|NCT04490018|560907246|FG001|Overall Study|Withdrawal by Subject|1|||
155402474|NCT04490018|560907247|FG002|Overall Study|Withdrawal by Subject|0|||
155402475|NCT04490018|560907245|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155402476|NCT04490018|560907246|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155402477|NCT04490018|560907247|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155402478|NCT02321930|560907250|FG000|Overall Study|Lost to Follow-up|1|||
155402479|NCT01484977|560907251|FG000|Overall Study|Adverse Event|8|||
155402480|NCT01484977|560907251|FG000|Overall Study|Lack of Efficacy|4|||
155402481|NCT01484977|560907251|FG000|Overall Study|Protocol Violation|6|||
155402482|NCT01484977|560907251|FG000|Overall Study|Lost to Follow-up|1|||
155402483|NCT01484977|560907251|FG000|Overall Study|Withdrawal by Subject|4|||
155402484|NCT01484977|560907251|FG000|Overall Study|Subject Protocol Non-compliant|1|||
155402485|NCT01484977|560907251|FG000|Overall Study|Moving Overseas|1|||
155402486|NCT01484977|560907251|FG000|Overall Study|Low White Blood Cell Count|1|||
155058433|NCT00264147|559648662|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
155402487|NCT01484977|560907251|FG000|Overall Study|Lack of Compliance|1|||
155058434|NCT00264147|559648657|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
155402488|NCT01133379|560907252|FG000|Overall Study|Withdrawal by Subject|0|||
155402489|NCT01133379|560907253|FG001|Overall Study|Withdrawal by Subject|1|||
155402490|NCT01133379|560907254|FG002|Overall Study|Withdrawal by Subject|1|||
155402491|NCT01133379|560907252|FG000|Overall Study|Lost to Follow-up|1|||
155402492|NCT01133379|560907253|FG001|Overall Study|Lost to Follow-up|1|||
155402493|NCT01133379|560907254|FG002|Overall Study|Lost to Follow-up|1|||
155284854|NCT00941031|560474431|FG006|Maintenance Period|Withdrawal by Subject|13|||
155284855|NCT00941031|560474425|FG000|Maintenance Period|Administrative Problems|0|||
155284856|NCT00941031|560474426|FG001|Maintenance Period|Administrative Problems|0|||
155284857|NCT00941031|560474427|FG002|Maintenance Period|Administrative Problems|0|||
155284858|NCT00941031|560474428|FG003|Maintenance Period|Administrative Problems|0|||
155402494|NCT00591214|560907255|FG000|Overall Study|Physician Decision|7|||
155402495|NCT00591214|560907255|FG000|Overall Study|Withdrawal by Subject|1|||
155402496|NCT00597753|560907258|FG000|Overall Study|Adverse Event|6|||
155402497|NCT00597753|560907259|FG001|Overall Study|Adverse Event|2|||
155402498|NCT00597753|560907258|FG000|Overall Study|Death|55|||
155402499|NCT00597753|560907259|FG001|Overall Study|Death|29|||
155402500|NCT00597753|560907258|FG000|Overall Study|Lack of Efficacy|2|||
155402501|NCT00597753|560907259|FG001|Overall Study|Lack of Efficacy|0|||
155402502|NCT00597753|560907258|FG000|Overall Study|Lost to Follow-up|10|||
155402503|NCT00597753|560907259|FG001|Overall Study|Lost to Follow-up|3|||
155402504|NCT00597753|560907258|FG000|Overall Study|Physician Decision|5|||
155402505|NCT00597753|560907259|FG001|Overall Study|Physician Decision|1|||
155402506|NCT00597753|560907258|FG000|Overall Study|Pregnancy|1|||
155402507|NCT00597753|560907259|FG001|Overall Study|Pregnancy|0|||
155402508|NCT00597753|560907258|FG000|Overall Study|Withdrawal by Subject|35|||
155402509|NCT00597753|560907259|FG001|Overall Study|Withdrawal by Subject|12|||
155402510|NCT00597753|560907258|FG000|Overall Study|Discontinued Dialysis|0|||
155402511|NCT00597753|560907259|FG001|Overall Study|Discontinued Dialysis|1|||
155402512|NCT00597753|560907258|FG000|Overall Study|Never dosed|2|||
155402513|NCT00597753|560907259|FG001|Overall Study|Never dosed|0|||
155402514|NCT00597753|560907258|FG000|Overall Study|Noncompliance|2|||
155402515|NCT00597753|560907259|FG001|Overall Study|Noncompliance|1|||
155402516|NCT00597753|560907258|FG000|Overall Study|Relocation|17|||
155402517|NCT00597753|560907259|FG001|Overall Study|Relocation|6|||
155402518|NCT00597753|560907258|FG000|Overall Study|Renal transplant|10|||
155402519|NCT00597753|560907259|FG001|Overall Study|Renal transplant|3|||
155402520|NCT00597753|560907258|FG000|Overall Study|Site closed by sponsor|19|||
155402521|NCT00597753|560907259|FG001|Overall Study|Site closed by sponsor|7|||
155402522|NCT00597753|560907258|FG000|Overall Study|Site elected to close|2|||
155402523|NCT00597753|560907259|FG001|Overall Study|Site elected to close|4|||
155402524|NCT03080883|560907260|FG000|Overall Study|Withdrawal by Subject|11|||
155402525|NCT03080883|560907261|FG001|Overall Study|Withdrawal by Subject|15|||
155402526|NCT03080883|560907260|FG000|Overall Study|Adverse Event|22|||
155402527|NCT03080883|560907261|FG001|Overall Study|Adverse Event|22|||
155402528|NCT03080883|560907260|FG000|Overall Study|Alternative Therapy|0|||
155402529|NCT03080883|560907261|FG001|Overall Study|Alternative Therapy|3|||
155402530|NCT03080883|560907260|FG000|Overall Study|Other Complicating Disease|9|||
155402531|NCT03080883|560907261|FG001|Overall Study|Other Complicating Disease|5|||
155402532|NCT03080883|560907260|FG000|Overall Study|Death|21|||
155402533|NCT03080883|560907261|FG001|Overall Study|Death|16|||
155402534|NCT03080883|560907260|FG000|Overall Study|Physician Decision|2|||
155402535|NCT03080883|560907261|FG001|Overall Study|Physician Decision|2|||
155402536|NCT03080883|560907260|FG000|Overall Study|Disease Progression|2|||
155402537|NCT03080883|560907261|FG001|Overall Study|Disease Progression|8|||
155402538|NCT03080883|560907260|FG000|Overall Study|Lost to Follow-up|1|||
155402539|NCT03080883|560907261|FG001|Overall Study|Lost to Follow-up|1|||
155402540|NCT05091567|560907977|FG000|Enrollment Phase|Death|37|||
155402541|NCT05091567|560907978|FG001|Enrollment Phase|Death|0|||
155402542|NCT05091567|560907979|FG002|Enrollment Phase|Death|0|||
155402543|NCT05091567|560907977|FG000|Enrollment Phase|Adverse Event|21|||
155402544|NCT05091567|560907978|FG001|Enrollment Phase|Adverse Event|0|||
155402545|NCT05091567|560907979|FG002|Enrollment Phase|Adverse Event|0|||
155402546|NCT05091567|560907977|FG000|Enrollment Phase|Progressive Disease|10|||
155402547|NCT05091567|560907978|FG001|Enrollment Phase|Progressive Disease|0|||
155402548|NCT05091567|560907979|FG002|Enrollment Phase|Progressive Disease|0|||
155402549|NCT05091567|560907977|FG000|Enrollment Phase|Withdrawal by Subject|8|||
155402550|NCT05091567|560907978|FG001|Enrollment Phase|Withdrawal by Subject|0|||
155402551|NCT05091567|560907979|FG002|Enrollment Phase|Withdrawal by Subject|0|||
155402552|NCT05091567|560907977|FG000|Enrollment Phase|Symptomatic Deterioration|7|||
154954249|NCT02106156|559259506|FG000|Overall Study|Concomitant Disease|74|||
155284859|NCT00941031|560474429|FG004|Maintenance Period|Administrative Problems|1|||
155402553|NCT05091567|560907978|FG001|Enrollment Phase|Symptomatic Deterioration|0|||
155402554|NCT05091567|560907979|FG002|Enrollment Phase|Symptomatic Deterioration|0|||
155402555|NCT05091567|560907977|FG000|Enrollment Phase|Physician Decision|3|||
155402556|NCT05091567|560907978|FG001|Enrollment Phase|Physician Decision|0|||
155402557|NCT05091567|560907979|FG002|Enrollment Phase|Physician Decision|0|||
155402558|NCT05091567|560907977|FG000|Enrollment Phase|Protocol Violation|2|||
155402559|NCT05091567|560907978|FG001|Enrollment Phase|Protocol Violation|0|||
155402560|NCT05091567|560907979|FG002|Enrollment Phase|Protocol Violation|0|||
155402561|NCT05091567|560907977|FG000|Enrollment Phase|Reason not Specified|1|||
155402562|NCT05091567|560907978|FG001|Enrollment Phase|Reason not Specified|0|||
155402563|NCT05091567|560907979|FG002|Enrollment Phase|Reason not Specified|0|||
155402564|NCT05091567|560907977|FG000|Randomized Phase|Death|0|||
155402565|NCT05091567|560907978|FG001|Randomized Phase|Death|135|||
155402566|NCT05091567|560907979|FG002|Randomized Phase|Death|112|||
155402567|NCT05091567|560907977|FG000|Randomized Phase|Progressive Disease|0|||
155402568|NCT05091567|560907978|FG001|Randomized Phase|Progressive Disease|2|||
155402569|NCT05091567|560907979|FG002|Randomized Phase|Progressive Disease|0|||
155402570|NCT05091567|560907977|FG000|Randomized Phase|Withdrawal by Subject|0|||
155402571|NCT05091567|560907978|FG001|Randomized Phase|Withdrawal by Subject|1|||
155402572|NCT05091567|560907979|FG002|Randomized Phase|Withdrawal by Subject|3|||
155402573|NCT05091567|560907977|FG000|Randomized Phase|Lost to Follow-up|0|||
155402574|NCT05091567|560907978|FG001|Randomized Phase|Lost to Follow-up|1|||
155402575|NCT05091567|560907979|FG002|Randomized Phase|Lost to Follow-up|1|||
155402576|NCT05091567|560907977|FG000|Randomized Phase|Ongoing in Study|0|||
155402577|NCT05091567|560907978|FG001|Randomized Phase|Ongoing in Study|102|||
155402578|NCT05091567|560907979|FG002|Randomized Phase|Ongoing in Study|126|||
155402579|NCT04369053|560907980|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
155402580|NCT04369053|560907980|FG000|Overall Study|Withdrawal by Subject|773|||
155402581|NCT04369053|560907980|FG000|Overall Study|Lost to Follow-up|182|||
155402582|NCT04369053|560907980|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
155402583|NCT01695005|560907981|FG000|Overall Study|Lost to Follow-up|0|||
155402584|NCT01695005|560907982|FG001|Overall Study|Lost to Follow-up|1|||
155402585|NCT01695005|560907983|FG002|Overall Study|Lost to Follow-up|1|||
155402586|NCT01695005|560907984|FG003|Overall Study|Lost to Follow-up|0|||
155402587|NCT01695005|560907985|FG004|Overall Study|Lost to Follow-up|0|||
155402588|NCT01695005|560907986|FG005|Overall Study|Lost to Follow-up|1|||
155402589|NCT01695005|560907987|FG006|Overall Study|Lost to Follow-up|1|||
155402590|NCT01695005|560907988|FG007|Overall Study|Lost to Follow-up|1|||
155402591|NCT01695005|560907989|FG008|Overall Study|Lost to Follow-up|3|||
155402592|NCT01695005|560907990|FG009|Overall Study|Lost to Follow-up|3|||
155402593|NCT01695005|560907991|FG010|Overall Study|Lost to Follow-up|8|||
155402594|NCT01695005|560907992|FG011|Overall Study|Lost to Follow-up|5|||
155402595|NCT01695005|560907993|FG012|Overall Study|Lost to Follow-up|2|||
155402596|NCT01695005|560907994|FG013|Overall Study|Lost to Follow-up|5|||
155402597|NCT01695005|560907995|FG014|Overall Study|Lost to Follow-up|0|||
155402598|NCT01695005|560907996|FG015|Overall Study|Lost to Follow-up|4|||
155402599|NCT01695005|560907997|FG016|Overall Study|Lost to Follow-up|0|||
155402600|NCT01695005|560907998|FG017|Overall Study|Lost to Follow-up|0|||
155402601|NCT01695005|560907999|FG018|Overall Study|Lost to Follow-up|0|||
155402602|NCT01695005|560908000|FG019|Overall Study|Lost to Follow-up|1|||
155402603|NCT01695005|560908001|FG020|Overall Study|Lost to Follow-up|1|||
155402604|NCT01695005|560908002|FG021|Overall Study|Lost to Follow-up|0|||
155402605|NCT01695005|560908003|FG022|Overall Study|Lost to Follow-up|2|||
155402606|NCT01695005|560908004|FG023|Overall Study|Lost to Follow-up|4|||
155402607|NCT01695005|560908005|FG024|Overall Study|Lost to Follow-up|2|||
155402608|NCT01695005|560908006|FG025|Overall Study|Lost to Follow-up|0|||
155402609|NCT01695005|560908007|FG026|Overall Study|Lost to Follow-up|0|||
155402610|NCT01695005|560908008|FG027|Overall Study|Lost to Follow-up|0|||
155402611|NCT01695005|560908009|FG028|Overall Study|Lost to Follow-up|1|||
155402612|NCT01695005|560907981|FG000|Overall Study|Withdrawal by Subject|0|||
155402613|NCT01695005|560907982|FG001|Overall Study|Withdrawal by Subject|0|||
155402614|NCT01695005|560907983|FG002|Overall Study|Withdrawal by Subject|0|||
155402615|NCT01695005|560907984|FG003|Overall Study|Withdrawal by Subject|2|||
155402616|NCT01695005|560907985|FG004|Overall Study|Withdrawal by Subject|0|||
154954250|NCT02106156|559259507|FG001|Overall Study|Concomitant Disease|2|||
155402617|NCT01695005|560907986|FG005|Overall Study|Withdrawal by Subject|1|||
155402618|NCT01695005|560907987|FG006|Overall Study|Withdrawal by Subject|0|||
155402619|NCT01695005|560907988|FG007|Overall Study|Withdrawal by Subject|1|||
154954251|NCT02106156|559259508|FG002|Overall Study|Concomitant Disease|0|||
155402620|NCT01695005|560907989|FG008|Overall Study|Withdrawal by Subject|0|||
155402621|NCT01695005|560907990|FG009|Overall Study|Withdrawal by Subject|1|||
155402622|NCT01695005|560907991|FG010|Overall Study|Withdrawal by Subject|2|||
155402623|NCT01695005|560907992|FG011|Overall Study|Withdrawal by Subject|1|||
155402624|NCT01695005|560907993|FG012|Overall Study|Withdrawal by Subject|1|||
155402625|NCT01695005|560907994|FG013|Overall Study|Withdrawal by Subject|0|||
155402626|NCT01695005|560907995|FG014|Overall Study|Withdrawal by Subject|0|||
155402627|NCT01695005|560907996|FG015|Overall Study|Withdrawal by Subject|0|||
155402628|NCT01695005|560907997|FG016|Overall Study|Withdrawal by Subject|0|||
155402629|NCT01695005|560907998|FG017|Overall Study|Withdrawal by Subject|0|||
155402630|NCT01695005|560907999|FG018|Overall Study|Withdrawal by Subject|2|||
155402631|NCT01695005|560908000|FG019|Overall Study|Withdrawal by Subject|0|||
155402632|NCT01695005|560908001|FG020|Overall Study|Withdrawal by Subject|1|||
155402633|NCT01695005|560908002|FG021|Overall Study|Withdrawal by Subject|0|||
155402634|NCT01695005|560908003|FG022|Overall Study|Withdrawal by Subject|0|||
155402635|NCT01695005|560908004|FG023|Overall Study|Withdrawal by Subject|0|||
155402636|NCT01695005|560908005|FG024|Overall Study|Withdrawal by Subject|1|||
155402637|NCT01695005|560908006|FG025|Overall Study|Withdrawal by Subject|0|||
155402638|NCT01695005|560908007|FG026|Overall Study|Withdrawal by Subject|0|||
155402639|NCT01695005|560908008|FG027|Overall Study|Withdrawal by Subject|1|||
155402640|NCT01695005|560908009|FG028|Overall Study|Withdrawal by Subject|0|||
155402641|NCT03760731|560908010|FG000|Pre-Treatment and Randomization|Withdrawal by Subject|1|||
155402642|NCT03760731|560908011|FG001|Pre-Treatment and Randomization|Withdrawal by Subject|0|||
155402643|NCT03760731|560908010|FG000|Treatment|Attended less than 70% of sessions|10|||
155402644|NCT03760731|560908011|FG001|Treatment|Attended less than 70% of sessions|15|||
155402645|NCT01970358|560908012|FG000|Overall Study|Unable to make NeoVax or NeoVax not viable|3|||
155402646|NCT01970358|560908012|FG000|Overall Study|Ineligible at time of second consent|4|||
155402647|NCT03869216|560908013|FG000|Overall Study|prostate removed during the study|1|||
155402648|NCT03869216|560908014|FG001|Overall Study|prostate removed during the study|1|||
155402649|NCT03869216|560908013|FG000|Overall Study|Withdrawal by Subject|0|||
155402650|NCT03869216|560908014|FG001|Overall Study|Withdrawal by Subject|1|||
155402651|NCT03869216|560908013|FG000|Overall Study|Lost to Follow-up|3|||
155402652|NCT03869216|560908014|FG001|Overall Study|Lost to Follow-up|12|||
155402653|NCT03869216|560908013|FG000|Overall Study|Changed clinical site or moved out of city|5|||
155402654|NCT03869216|560908014|FG001|Overall Study|Changed clinical site or moved out of city|9|||
155402655|NCT03869216|560908013|FG000|Overall Study|No primary care appointment scheduled|10|||
155402656|NCT03869216|560908014|FG001|Overall Study|No primary care appointment scheduled|4|||
155402657|NCT03869216|560908013|FG000|Overall Study|Death|1|||
155402658|NCT03869216|560908014|FG001|Overall Study|Death|1|||
155402659|NCT04148911|560908017|FG000|Overall Study|Death|104|||
155402660|NCT04148911|560908017|FG000|Overall Study|Lost to Follow-up|5|||
155402661|NCT04148911|560908017|FG000|Overall Study|Withdrawal by Subject|17|||
155402662|NCT04148911|560908017|FG000|Overall Study|Study Ended by Sponsor|56|||
155402663|NCT04927364|560908022|FG000|Overall Study|Withdrawal by Subject|3|||
155402664|NCT04927364|560908022|FG000|Overall Study|Unable to complete preassessment MRI|1|||
155402665|NCT05101317|560908025|FG000|Week1-13|Adverse Event|0|||
155402666|NCT05101317|560908026|FG001|Week1-13|Adverse Event|1|||
155402667|NCT05101317|560908027|FG002|Week1-13|Adverse Event|0|||
155402668|NCT05101317|560908028|FG003|Week1-13|Adverse Event|0|||
155402669|NCT05101317|560908025|FG000|Week1-13|Withdrawal by Subject|0|||
155402670|NCT05101317|560908026|FG001|Week1-13|Withdrawal by Subject|2|||
155402671|NCT05101317|560908027|FG002|Week1-13|Withdrawal by Subject|0|||
155402672|NCT05101317|560908028|FG003|Week1-13|Withdrawal by Subject|0|||
155402673|NCT05101317|560908025|FG000|Week1-13|Early Withdrawl|0|||
155402674|NCT05101317|560908026|FG001|Week1-13|Early Withdrawl|0|||
155402675|NCT05101317|560908027|FG002|Week1-13|Early Withdrawl|0|||
155402676|NCT05101317|560908028|FG003|Week1-13|Early Withdrawl|1|||
155402677|NCT05101317|560908025|FG000|Week 13-25|Lost to Follow-up|0|||
155402678|NCT05101317|560908026|FG001|Week 13-25|Lost to Follow-up|0|||
155402679|NCT05101317|560908027|FG002|Week 13-25|Lost to Follow-up|1|||
155402680|NCT05101317|560908028|FG003|Week 13-25|Lost to Follow-up|0|||
155402681|NCT05101317|560908025|FG000|Week 13-25|Withdrawal by Subject|1|||
155402682|NCT05101317|560908026|FG001|Week 13-25|Withdrawal by Subject|1|||
155402683|NCT05101317|560908027|FG002|Week 13-25|Withdrawal by Subject|0|||
155402684|NCT05101317|560908028|FG003|Week 13-25|Withdrawal by Subject|0|||
155402685|NCT05101317|560908025|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
155402686|NCT05101317|560908026|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
155402687|NCT05101317|560908027|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
155402688|NCT05101317|560908028|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
155402689|NCT05764265|560908029|FG000|Overall Study|Adverse Event|1|||
155402690|NCT05764265|560908030|FG001|Overall Study|Adverse Event|0|||
155402691|NCT05764265|560908029|FG000|Overall Study|Physician Decision|1|||
155402692|NCT05764265|560908030|FG001|Overall Study|Physician Decision|8|||
155402693|NCT05764265|560908029|FG000|Overall Study|Study Terminated By Sponsor|20|||
154954252|NCT02106156|559259506|FG000|Overall Study|Lack of Compliance|211|||
154954253|NCT02106156|559259507|FG001|Overall Study|Lack of Compliance|7|||
155402694|NCT05764265|560908030|FG001|Overall Study|Study Terminated By Sponsor|0|||
155402695|NCT05764265|560908029|FG000|Overall Study|Participant Decision|1|||
155402696|NCT05764265|560908030|FG001|Overall Study|Participant Decision|0|||
155402697|NCT05422638|560908033|FG000|Overall Study|Withdrawal by Subject|8|||
155402698|NCT05422638|560908034|FG001|Overall Study|Withdrawal by Subject|2|||
155402699|NCT04777331|560908035|FG000|DBT Period|Death|2|||
155402700|NCT04777331|560908036|FG001|DBT Period|Death|1|||
155402701|NCT04777331|560908037|FG002|DBT Period|Death|0|||
155402702|NCT04777331|560908035|FG000|DBT Period|Reason not Specified|1|||
155402703|NCT04777331|560908036|FG001|DBT Period|Reason not Specified|1|||
155402704|NCT04777331|560908037|FG002|DBT Period|Reason not Specified|0|||
155402705|NCT04777331|560908035|FG000|DBT Period|Physician Decision|4|||
155402706|NCT04777331|560908036|FG001|DBT Period|Physician Decision|0|||
155402707|NCT04777331|560908037|FG002|DBT Period|Physician Decision|0|||
155402708|NCT04777331|560908035|FG000|DBT Period|Withdrawal by Subject|12|||
155402709|NCT04777331|560908036|FG001|DBT Period|Withdrawal by Subject|11|||
155402710|NCT04777331|560908037|FG002|DBT Period|Withdrawal by Subject|0|||
155402711|NCT04777331|560908035|FG000|DBT Period|Randomized but not Treated|1|||
155402712|NCT04777331|560908036|FG001|DBT Period|Randomized but not Treated|3|||
155402713|NCT04777331|560908037|FG002|DBT Period|Randomized but not Treated|0|||
155402714|NCT04777331|560908035|FG000|OLE Period|Ongoing in OLE|0|||
155402715|NCT04777331|560908036|FG001|OLE Period|Ongoing in OLE|0|||
155402716|NCT04777331|560908037|FG002|OLE Period|Ongoing in OLE|534|||
155402717|NCT01827956|560908038|FG000|Overall Study|Protocol Violation|3|||
155402718|NCT03993379|560908039|FG000|Overall Study|The study was terminated early due to business decision.|0|||
155402719|NCT03993379|560908040|FG001|Overall Study|The study was terminated early due to business decision.|2|||
155402720|NCT03993379|560908041|FG002|Overall Study|The study was terminated early due to business decision.|0|||
155402721|NCT03993379|560908042|FG003|Overall Study|The study was terminated early due to business decision.|0|||
155402722|NCT03993379|560908039|FG000|Overall Study|Withdrawal by Subject|0|||
155402723|NCT03993379|560908040|FG001|Overall Study|Withdrawal by Subject|1|||
155402724|NCT03993379|560908041|FG002|Overall Study|Withdrawal by Subject|0|||
155402725|NCT03993379|560908042|FG003|Overall Study|Withdrawal by Subject|0|||
155402726|NCT06374394|560908043|FG000|Overall Study|Adverse Event|0|||
155402727|NCT06374394|560908044|FG001|Overall Study|Adverse Event|2|||
155402728|NCT06374394|560908043|FG000|Overall Study|Lost to Follow-up|6|||
155402729|NCT06374394|560908044|FG001|Overall Study|Lost to Follow-up|9|||
155402730|NCT06374394|560908043|FG000|Overall Study|Withdrawal by Subject|1|||
155402731|NCT06374394|560908044|FG001|Overall Study|Withdrawal by Subject|7|||
155402732|NCT06374394|560908043|FG000|Overall Study|Other|1|||
155402733|NCT06374394|560908044|FG001|Overall Study|Other|0|||
155402734|NCT02483429|560908356|FG000|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|8|||
155402735|NCT02483429|560908357|FG001|Overall Study|Incomplete 1-week follow-up (excluded from primary analysis)|9|||
155402736|NCT04090957|560908358|FG000|Overall Study|Lost to Follow-up|22|||
155402737|NCT04090957|560908359|FG001|Overall Study|Lost to Follow-up|25|||
155402738|NCT04090957|560908360|FG002|Overall Study|Lost to Follow-up|25|||
155402739|NCT04090957|560908361|FG003|Overall Study|Lost to Follow-up|36|||
155402740|NCT04090957|560908358|FG000|Overall Study|Withdrawal of Consent for Another Reason|15|||
155402741|NCT04090957|560908359|FG001|Overall Study|Withdrawal of Consent for Another Reason|17|||
155402742|NCT04090957|560908360|FG002|Overall Study|Withdrawal of Consent for Another Reason|21|||
155402743|NCT04090957|560908361|FG003|Overall Study|Withdrawal of Consent for Another Reason|39|||
155402744|NCT04090957|560908358|FG000|Overall Study|Adverse Event|19|||
155402745|NCT04090957|560908359|FG001|Overall Study|Adverse Event|25|||
155402746|NCT04090957|560908360|FG002|Overall Study|Adverse Event|8|||
155402747|NCT04090957|560908361|FG003|Overall Study|Adverse Event|104|||
155402748|NCT04090957|560908358|FG000|Overall Study|Other|10|||
155402749|NCT04090957|560908359|FG001|Overall Study|Other|6|||
155402750|NCT04090957|560908360|FG002|Overall Study|Other|5|||
155402751|NCT04090957|560908361|FG003|Overall Study|Other|12|||
155402752|NCT04090957|560908358|FG000|Overall Study|Serious Adverse Event|7|||
155402753|NCT04090957|560908359|FG001|Overall Study|Serious Adverse Event|11|||
155402754|NCT04090957|560908360|FG002|Overall Study|Serious Adverse Event|1|||
155058435|NCT00264147|559648658|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
155402755|NCT04090957|560908361|FG003|Overall Study|Serious Adverse Event|32|||
155402756|NCT04090957|560908358|FG000|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|7|||
155402757|NCT04090957|560908359|FG001|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|9|||
155402758|NCT04090957|560908360|FG002|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|1|||
155402759|NCT04090957|560908361|FG003|Overall Study|Endometrial Biopsy Showing Proliferative Disorder|26|||
155402760|NCT04090957|560908358|FG000|Overall Study|Lack of Efficacy|1|||
155402761|NCT04090957|560908359|FG001|Overall Study|Lack of Efficacy|1|||
155402762|NCT04090957|560908360|FG002|Overall Study|Lack of Efficacy|9|||
155402763|NCT04090957|560908361|FG003|Overall Study|Lack of Efficacy|0|||
155402764|NCT04090957|560908358|FG000|Overall Study|Protocol Violation|3|||
155402765|NCT04090957|560908359|FG001|Overall Study|Protocol Violation|5|||
155402766|NCT04090957|560908360|FG002|Overall Study|Protocol Violation|2|||
155402767|NCT04090957|560908361|FG003|Overall Study|Protocol Violation|1|||
155402768|NCT04090957|560908358|FG000|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
155402769|NCT04090957|560908359|FG001|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|2|||
155402770|NCT04090957|560908360|FG002|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|6|||
155402771|NCT04090957|560908361|FG003|Overall Study|Withdrawal of Consent Due to Lack of Efficacy|3|||
155402772|NCT04090957|560908358|FG000|Overall Study|COVID-19|2|||
155402773|NCT04090957|560908359|FG001|Overall Study|COVID-19|2|||
155402774|NCT04090957|560908360|FG002|Overall Study|COVID-19|3|||
155402775|NCT04090957|560908361|FG003|Overall Study|COVID-19|7|||
155402776|NCT04090957|560908358|FG000|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
155402777|NCT04090957|560908359|FG001|Overall Study|Non-Compliance with Trial Protocol: Other|2|||
155402778|NCT04090957|560908360|FG002|Overall Study|Non-Compliance with Trial Protocol: Other|1|||
155402779|NCT04090957|560908361|FG003|Overall Study|Non-Compliance with Trial Protocol: Other|4|||
155402780|NCT04090957|560908358|FG000|Overall Study|Physician Decision|2|||
155402781|NCT04090957|560908359|FG001|Overall Study|Physician Decision|1|||
155402782|NCT04090957|560908360|FG002|Overall Study|Physician Decision|1|||
155402783|NCT04090957|560908361|FG003|Overall Study|Physician Decision|5|||
155402784|NCT04090957|560908358|FG000|Overall Study|Sponsor Decision|1|||
155402785|NCT04090957|560908359|FG001|Overall Study|Sponsor Decision|1|||
155402786|NCT04090957|560908360|FG002|Overall Study|Sponsor Decision|1|||
155402787|NCT04090957|560908361|FG003|Overall Study|Sponsor Decision|3|||
155402788|NCT04090957|560908358|FG000|Overall Study|Endometrial Findings - Physician Decision|1|||
155402789|NCT04090957|560908359|FG001|Overall Study|Endometrial Findings - Physician Decision|1|||
155402790|NCT04090957|560908360|FG002|Overall Study|Endometrial Findings - Physician Decision|0|||
155402791|NCT04090957|560908361|FG003|Overall Study|Endometrial Findings - Physician Decision|5|||
155402792|NCT04090957|560908358|FG000|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
155402793|NCT04090957|560908359|FG001|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|0|||
155402794|NCT04090957|560908360|FG002|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|1|||
155402795|NCT04090957|560908361|FG003|Overall Study|Non-Compliance to Trial Protocol: Study Drug Intake Compliance|4|||
155402796|NCT04090957|560908358|FG000|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
155402797|NCT04090957|560908359|FG001|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
155402798|NCT04090957|560908360|FG002|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|1|||
155402799|NCT04090957|560908361|FG003|Overall Study|Non-Compliance to Trial Protocol: VMS Count Compliance|0|||
155402800|NCT04090957|560908358|FG000|Overall Study|Death|1|||
155402801|NCT04090957|560908359|FG001|Overall Study|Death|0|||
155402802|NCT04090957|560908360|FG002|Overall Study|Death|0|||
155402803|NCT04090957|560908361|FG003|Overall Study|Death|0|||
155402804|NCT04090957|560908358|FG000|Overall Study|No Treatment Administered|2|||
155402805|NCT04090957|560908359|FG001|Overall Study|No Treatment Administered|1|||
155402806|NCT04090957|560908360|FG002|Overall Study|No Treatment Administered|2|||
155402807|NCT04090957|560908361|FG003|Overall Study|No Treatment Administered|1|||
155402808|NCT06173063|560908362|FG000|Overall Study|Withdrawal by Subject|2|||
155154424|NCT03486912|560002296|FG001|Treatment Period|Withdrawal by Subject|3|||
155154425|NCT03486912|560002297|FG002|Treatment Period|Withdrawal by Subject|3|||
155154426|NCT03486912|560002298|FG003|Treatment Period|Withdrawal by Subject|2|||
155154427|NCT03486912|560002295|FG000|Treatment Period|Other Reasons|0|||
155154428|NCT03486912|560002296|FG001|Treatment Period|Other Reasons|2|||
155154429|NCT03486912|560002297|FG002|Treatment Period|Other Reasons|1|||
155154430|NCT03486912|560002298|FG003|Treatment Period|Other Reasons|1|||
155154431|NCT03486912|560002295|FG000|Treatment Period|Adverse Event|0|||
155154432|NCT03486912|560002296|FG001|Treatment Period|Adverse Event|1|||
155154433|NCT03486912|560002297|FG002|Treatment Period|Adverse Event|1|||
155154434|NCT03486912|560002298|FG003|Treatment Period|Adverse Event|0|||
155154435|NCT03486912|560002295|FG000|Treatment Period|Lost to Follow-up|1|||
155154436|NCT03486912|560002296|FG001|Treatment Period|Lost to Follow-up|0|||
155154437|NCT03486912|560002297|FG002|Treatment Period|Lost to Follow-up|0|||
155154438|NCT03486912|560002298|FG003|Treatment Period|Lost to Follow-up|2|||
155154439|NCT01499940|560002299|FG000|Overall Study|Study was withdrawn before completion.|9|||
155154440|NCT04484961|560002305|FG000|Overall Study|Lost to Follow-up|9|||
155154441|NCT04484961|560002306|FG001|Overall Study|Lost to Follow-up|9|||
155154442|NCT00388349|560002307|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
155154443|NCT00388349|560002308|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
155154444|NCT01345240|560002310|FG000|Overall Study|Adverse Event|3|||
155154445|NCT01345240|560002311|FG001|Overall Study|Adverse Event|5|||
155154446|NCT01345240|560002312|FG002|Overall Study|Adverse Event|4|||
155154447|NCT01345240|560002313|FG003|Overall Study|Adverse Event|2|||
155154448|NCT01345240|560002314|FG004|Overall Study|Adverse Event|1|||
155154449|NCT01345240|560002310|FG000|Overall Study|Lost to Follow-up|8|||
155154450|NCT01345240|560002311|FG001|Overall Study|Lost to Follow-up|9|||
155154451|NCT01345240|560002312|FG002|Overall Study|Lost to Follow-up|14|||
155154452|NCT01345240|560002313|FG003|Overall Study|Lost to Follow-up|7|||
155154453|NCT01345240|560002314|FG004|Overall Study|Lost to Follow-up|9|||
155154454|NCT01339832|560002316|FG000|Overall Study|Lost to Follow-up|3|||
155154455|NCT01339832|560002316|FG000|Overall Study|Death|11|||
155154456|NCT02954536|560002321|FG000|Overall Study|Adverse Event|2|||
155154457|NCT02954536|560002321|FG000|Overall Study|Death|12|||
155154458|NCT03600909|560002322|FG000|Overall Study|Not treated|0|||
155154459|NCT03600909|560002323|FG001|Overall Study|Not treated|3|||
155154460|NCT03600909|560002324|FG002|Overall Study|Not treated|0|||
155154461|NCT02234843|560002325|FG000|Overall Study|Death|1|||
155154462|NCT02234843|560002326|FG001|Overall Study|Death|0|||
155154463|NCT02234843|560002327|FG002|Overall Study|Death|0|||
155154464|NCT02234843|560002328|FG003|Overall Study|Death|0|||
155154465|NCT02234843|560002329|FG004|Overall Study|Death|0|||
155154466|NCT02234843|560002330|FG005|Overall Study|Death|0|||
155154467|NCT02234843|560002331|FG006|Overall Study|Death|0|||
155154468|NCT02234843|560002332|FG007|Overall Study|Death|0|||
155154469|NCT02234843|560002333|FG008|Overall Study|Death|0|||
155154470|NCT02234843|560002334|FG009|Overall Study|Death|0|||
155154471|NCT02234843|560002325|FG000|Overall Study|Protocol Violation|1|||
155154472|NCT02234843|560002326|FG001|Overall Study|Protocol Violation|0|||
155154473|NCT02234843|560002327|FG002|Overall Study|Protocol Violation|1|||
155154474|NCT02234843|560002328|FG003|Overall Study|Protocol Violation|0|||
155154475|NCT02234843|560002329|FG004|Overall Study|Protocol Violation|0|||
155154476|NCT02234843|560002330|FG005|Overall Study|Protocol Violation|0|||
155154477|NCT02234843|560002331|FG006|Overall Study|Protocol Violation|0|||
155154478|NCT02234843|560002332|FG007|Overall Study|Protocol Violation|0|||
155154479|NCT02234843|560002333|FG008|Overall Study|Protocol Violation|0|||
155154480|NCT02234843|560002334|FG009|Overall Study|Protocol Violation|0|||
155154481|NCT02234843|560002325|FG000|Overall Study|Efficacy outcome reached|2|||
155154482|NCT02234843|560002326|FG001|Overall Study|Efficacy outcome reached|0|||
155154483|NCT02234843|560002327|FG002|Overall Study|Efficacy outcome reached|0|||
155154484|NCT02234843|560002328|FG003|Overall Study|Efficacy outcome reached|0|||
155154485|NCT02234843|560002329|FG004|Overall Study|Efficacy outcome reached|0|||
155154486|NCT02234843|560002330|FG005|Overall Study|Efficacy outcome reached|2|||
155154487|NCT02234843|560002331|FG006|Overall Study|Efficacy outcome reached|0|||
155154488|NCT02234843|560002332|FG007|Overall Study|Efficacy outcome reached|0|||
155154489|NCT02234843|560002333|FG008|Overall Study|Efficacy outcome reached|0|||
155154490|NCT02234843|560002334|FG009|Overall Study|Efficacy outcome reached|0|||
155154491|NCT02234843|560002325|FG000|Overall Study|Patient convenience|2|||
155154492|NCT02234843|560002326|FG001|Overall Study|Patient convenience|0|||
155154493|NCT02234843|560002327|FG002|Overall Study|Patient convenience|0|||
155154494|NCT02234843|560002328|FG003|Overall Study|Patient convenience|0|||
155154495|NCT02234843|560002329|FG004|Overall Study|Patient convenience|0|||
155154496|NCT02234843|560002330|FG005|Overall Study|Patient convenience|1|||
155154497|NCT02234843|560002331|FG006|Overall Study|Patient convenience|0|||
155154498|NCT02234843|560002332|FG007|Overall Study|Patient convenience|0|||
155154499|NCT02234843|560002333|FG008|Overall Study|Patient convenience|0|||
155154500|NCT02234843|560002334|FG009|Overall Study|Patient convenience|0|||
155154501|NCT02234843|560002325|FG000|Overall Study|Withdrawal by Subject|5|||
155154502|NCT02234843|560002326|FG001|Overall Study|Withdrawal by Subject|1|||
155154503|NCT02234843|560002327|FG002|Overall Study|Withdrawal by Subject|1|||
155154504|NCT02234843|560002328|FG003|Overall Study|Withdrawal by Subject|0|||
155154505|NCT02234843|560002329|FG004|Overall Study|Withdrawal by Subject|0|||
155154506|NCT02234843|560002330|FG005|Overall Study|Withdrawal by Subject|7|||
155154507|NCT02234843|560002331|FG006|Overall Study|Withdrawal by Subject|0|||
155154508|NCT02234843|560002332|FG007|Overall Study|Withdrawal by Subject|0|||
155154509|NCT02234843|560002333|FG008|Overall Study|Withdrawal by Subject|0|||
155154510|NCT02234843|560002334|FG009|Overall Study|Withdrawal by Subject|0|||
155154511|NCT02234843|560002325|FG000|Overall Study|Recovery|1|||
155154512|NCT02234843|560002326|FG001|Overall Study|Recovery|0|||
155154513|NCT02234843|560002327|FG002|Overall Study|Recovery|0|||
155154514|NCT02234843|560002328|FG003|Overall Study|Recovery|0|||
155154515|NCT02234843|560002329|FG004|Overall Study|Recovery|0|||
155154516|NCT02234843|560002330|FG005|Overall Study|Recovery|0|||
155154517|NCT02234843|560002331|FG006|Overall Study|Recovery|0|||
155154518|NCT02234843|560002332|FG007|Overall Study|Recovery|0|||
155154519|NCT02234843|560002333|FG008|Overall Study|Recovery|0|||
155154520|NCT02234843|560002334|FG009|Overall Study|Recovery|0|||
155154521|NCT02234843|560002325|FG000|Overall Study|Other|0|||
155154522|NCT02234843|560002326|FG001|Overall Study|Other|2|||
155154523|NCT02234843|560002327|FG002|Overall Study|Other|0|||
155154524|NCT02234843|560002328|FG003|Overall Study|Other|1|||
155154525|NCT02234843|560002329|FG004|Overall Study|Other|0|||
155154526|NCT02234843|560002330|FG005|Overall Study|Other|1|||
155154527|NCT02234843|560002331|FG006|Overall Study|Other|0|||
155154528|NCT02234843|560002332|FG007|Overall Study|Other|1|||
155154529|NCT02234843|560002333|FG008|Overall Study|Other|0|||
155154530|NCT02234843|560002334|FG009|Overall Study|Other|0|||
155154531|NCT02234843|560002325|FG000|Overall Study|Physician Decision|4|||
155154532|NCT02234843|560002326|FG001|Overall Study|Physician Decision|1|||
155154533|NCT02234843|560002327|FG002|Overall Study|Physician Decision|0|||
155154534|NCT02234843|560002328|FG003|Overall Study|Physician Decision|1|||
155154535|NCT02234843|560002329|FG004|Overall Study|Physician Decision|0|||
155154536|NCT02234843|560002330|FG005|Overall Study|Physician Decision|0|||
155154537|NCT02234843|560002331|FG006|Overall Study|Physician Decision|0|||
155154538|NCT02234843|560002332|FG007|Overall Study|Physician Decision|1|||
155154539|NCT02234843|560002333|FG008|Overall Study|Physician Decision|0|||
155154540|NCT02234843|560002334|FG009|Overall Study|Physician Decision|0|||
155154541|NCT02234843|560002325|FG000|Overall Study|Adverse Event|5|||
155154542|NCT02234843|560002326|FG001|Overall Study|Adverse Event|1|||
155154543|NCT02234843|560002327|FG002|Overall Study|Adverse Event|1|||
155154544|NCT02234843|560002328|FG003|Overall Study|Adverse Event|3|||
155154545|NCT02234843|560002329|FG004|Overall Study|Adverse Event|2|||
155154546|NCT02234843|560002330|FG005|Overall Study|Adverse Event|1|||
155154547|NCT02234843|560002331|FG006|Overall Study|Adverse Event|0|||
155154548|NCT02234843|560002332|FG007|Overall Study|Adverse Event|0|||
155154549|NCT02234843|560002333|FG008|Overall Study|Adverse Event|1|||
155154550|NCT02234843|560002334|FG009|Overall Study|Adverse Event|0|||
155154551|NCT02234843|560002325|FG000|Overall Study|Non-compliance with study drug|1|||
155154552|NCT02234843|560002326|FG001|Overall Study|Non-compliance with study drug|0|||
155154553|NCT02234843|560002327|FG002|Overall Study|Non-compliance with study drug|0|||
155154554|NCT02234843|560002328|FG003|Overall Study|Non-compliance with study drug|0|||
155154555|NCT02234843|560002329|FG004|Overall Study|Non-compliance with study drug|0|||
155154556|NCT02234843|560002330|FG005|Overall Study|Non-compliance with study drug|1|||
155154557|NCT02234843|560002331|FG006|Overall Study|Non-compliance with study drug|1|||
155154558|NCT02234843|560002332|FG007|Overall Study|Non-compliance with study drug|0|||
155154559|NCT02234843|560002333|FG008|Overall Study|Non-compliance with study drug|0|||
155154560|NCT02234843|560002334|FG009|Overall Study|Non-compliance with study drug|0|||
155154561|NCT02234843|560002325|FG000|Overall Study|Lost to Follow-up|0|||
155154562|NCT02234843|560002326|FG001|Overall Study|Lost to Follow-up|1|||
155154563|NCT02234843|560002327|FG002|Overall Study|Lost to Follow-up|0|||
155154564|NCT02234843|560002328|FG003|Overall Study|Lost to Follow-up|0|||
155154565|NCT02234843|560002329|FG004|Overall Study|Lost to Follow-up|0|||
155154566|NCT02234843|560002330|FG005|Overall Study|Lost to Follow-up|0|||
155154567|NCT02234843|560002331|FG006|Overall Study|Lost to Follow-up|1|||
155154568|NCT02234843|560002332|FG007|Overall Study|Lost to Follow-up|0|||
155154569|NCT02234843|560002333|FG008|Overall Study|Lost to Follow-up|0|||
155154570|NCT02234843|560002334|FG009|Overall Study|Lost to Follow-up|0|||
155154571|NCT02336282|560002338|FG000|Overall Study|Unrelated illness|1|||
155154572|NCT02336282|560002338|FG000|Overall Study|Uncomfortable with technology|1|||
155154573|NCT02336282|560002338|FG000|Overall Study|Lost to Follow-up|1|||
155154574|NCT02336282|560002338|FG000|Overall Study|Not enough time to complete sessions|2|||
155154575|NCT01456039|560004320|FG000|Phase 1 (First Step)|Disease Progression|1|||
155154576|NCT01456039|560004321|FG001|Phase 1 (First Step)|Disease Progression|1|||
155154577|NCT01456039|560004322|FG002|Phase 1 (First Step)|Disease Progression|0|||
155154578|NCT01456039|560004320|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
155154579|NCT01456039|560004321|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
155154580|NCT01456039|560004322|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
155154581|NCT01456039|560004320|FG000|Phase 1 (First Step)|Adverse Event|0|||
155154582|NCT01456039|560004321|FG001|Phase 1 (First Step)|Adverse Event|3|||
155154583|NCT01456039|560004322|FG002|Phase 1 (First Step)|Adverse Event|0|||
155154584|NCT01456039|560004320|FG000|Phase 1 (First Step)|Other|0|||
155154585|NCT01456039|560004321|FG001|Phase 1 (First Step)|Other|1|||
155154586|NCT01456039|560004322|FG002|Phase 1 (First Step)|Other|0|||
155154587|NCT01456039|560004320|FG000|Phase 2 (Second Step)|Disease Progression|0|||
155154588|NCT01456039|560004321|FG001|Phase 2 (Second Step)|Disease Progression|0|||
155154589|NCT01456039|560004322|FG002|Phase 2 (Second Step)|Disease Progression|17|||
155154590|NCT01456039|560004320|FG000|Phase 2 (Second Step)|Adverse Event|0|||
155154591|NCT01456039|560004321|FG001|Phase 2 (Second Step)|Adverse Event|0|||
155154592|NCT01456039|560004322|FG002|Phase 2 (Second Step)|Adverse Event|10|||
155154593|NCT01456039|560004320|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
155154594|NCT01456039|560004321|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
155154595|NCT01456039|560004322|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
155154596|NCT01456039|560004320|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
155154597|NCT01456039|560004321|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
155154598|NCT01456039|560004322|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
155154599|NCT01456039|560004320|FG000|Phase 2 (Second Step)|Other|0|||
155154600|NCT01456039|560004321|FG001|Phase 2 (Second Step)|Other|0|||
155154601|NCT01456039|560004322|FG002|Phase 2 (Second Step)|Other|1|||
155154602|NCT00335777|560004325|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
155154603|NCT00335777|560004325|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
155154604|NCT00335777|560004325|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
155154605|NCT00335777|560004325|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
155154606|NCT00335777|560004325|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
155154607|NCT05024032|560004326|FG000|Overall Study|Withdrawal by Subject|0|||
155154608|NCT05024032|560004327|FG001|Overall Study|Withdrawal by Subject|3|||
155154609|NCT05024032|560004328|FG002|Overall Study|Withdrawal by Subject|4|||
155154610|NCT05024032|560004326|FG000|Overall Study|Adverse Event|0|||
155154611|NCT05024032|560004327|FG001|Overall Study|Adverse Event|1|||
155154612|NCT05024032|560004328|FG002|Overall Study|Adverse Event|0|||
155154613|NCT05024032|560004326|FG000|Overall Study|Protocol Deviation|1|||
155154614|NCT05024032|560004327|FG001|Overall Study|Protocol Deviation|0|||
155154615|NCT05024032|560004328|FG002|Overall Study|Protocol Deviation|0|||
155154616|NCT01209689|560004331|FG000|Overall Study|Insufficient Therapeutic Response|7|||
155154617|NCT01209689|560004332|FG001|Overall Study|Insufficient Therapeutic Response|2|||
155154618|NCT01209689|560004331|FG000|Overall Study|Refused Treatment|8|||
155154619|NCT01209689|560004332|FG001|Overall Study|Refused Treatment|3|||
155154620|NCT01209689|560004331|FG000|Overall Study|Adverse Event|4|||
155154621|NCT01209689|560004332|FG001|Overall Study|Adverse Event|0|||
155154622|NCT01209689|560004331|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155154623|NCT01209689|560004332|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155154624|NCT01209689|560004331|FG000|Overall Study|Failure to Return|3|||
155154625|NCT01209689|560004332|FG001|Overall Study|Failure to Return|0|||
155154626|NCT01209689|560004331|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
155154627|NCT01209689|560004332|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
155154628|NCT03780244|560004333|FG000|Overall Study|Lost to Follow-up|1|||
155154629|NCT03780244|560004334|FG001|Overall Study|Lost to Follow-up|0|||
155154630|NCT02345070|560004335|FG000|Overall Study|Adverse Event|12|||
155154631|NCT02345070|560004336|FG001|Overall Study|Adverse Event|8|||
155154632|NCT02345070|560004337|FG002|Overall Study|Adverse Event|16|||
155154633|NCT02345070|560004335|FG000|Overall Study|Poor compliance to protocol|2|||
155154634|NCT02345070|560004336|FG001|Overall Study|Poor compliance to protocol|0|||
155154635|NCT02345070|560004337|FG002|Overall Study|Poor compliance to protocol|0|||
155154636|NCT02345070|560004335|FG000|Overall Study|Other than specified above|6|||
155154637|NCT02345070|560004336|FG001|Overall Study|Other than specified above|3|||
155154638|NCT02345070|560004337|FG002|Overall Study|Other than specified above|7|||
155154639|NCT01054885|560004338|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
155154640|NCT01054885|560004339|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155154641|NCT01054885|560004340|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155154642|NCT01054885|560004341|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155154643|NCT01054885|560004342|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155154644|NCT01054885|560004343|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155154645|NCT01054885|560004344|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155154646|NCT01054885|560004338|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
155154647|NCT01054885|560004339|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
155154648|NCT01054885|560004340|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
155154649|NCT01054885|560004341|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
155154650|NCT01054885|560004342|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
155154651|NCT01054885|560004343|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
155154652|NCT01054885|560004344|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
155154653|NCT01054885|560004338|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
155154654|NCT01054885|560004339|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155154655|NCT01054885|560004340|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155154656|NCT01054885|560004341|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155154657|NCT01054885|560004342|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155154658|NCT01054885|560004343|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155154659|NCT01054885|560004344|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155154660|NCT01054885|560004338|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
155154661|NCT01054885|560004339|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155154662|NCT01054885|560004340|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155154663|NCT01054885|560004341|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155154664|NCT01054885|560004342|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155154665|NCT01054885|560004343|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155154666|NCT01054885|560004344|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155154667|NCT01054885|560004338|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
155154668|NCT01054885|560004339|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
155154669|NCT01054885|560004340|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
155154670|NCT01054885|560004341|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
155154671|NCT01054885|560004342|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
155154672|NCT01054885|560004343|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
155154673|NCT01054885|560004344|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
155154674|NCT01054885|560004338|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
155154675|NCT01054885|560004339|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155154676|NCT01054885|560004340|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155154677|NCT01054885|560004341|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155154678|NCT01054885|560004342|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155154679|NCT01054885|560004343|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155154680|NCT01054885|560004344|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155154681|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155154682|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
155154683|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
155154684|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
155154685|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
155154686|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
155154687|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
155170023|NCT00830869|560062414|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
155284860|NCT00941031|560474430|FG005|Maintenance Period|Administrative Problems|0|||
155284861|NCT00941031|560474431|FG006|Maintenance Period|Administrative Problems|1|||
155284862|NCT00941031|560474425|FG000|Maintenance Period|Protocol Violation|0|||
155284863|NCT00941031|560474426|FG001|Maintenance Period|Protocol Violation|0|||
155284864|NCT00941031|560474427|FG002|Maintenance Period|Protocol Violation|0|||
155284865|NCT00941031|560474428|FG003|Maintenance Period|Protocol Violation|0|||
155284866|NCT00941031|560474429|FG004|Maintenance Period|Protocol Violation|0|||
155284867|NCT00941031|560474430|FG005|Maintenance Period|Protocol Violation|0|||
155284868|NCT00941031|560474431|FG006|Maintenance Period|Protocol Violation|1|||
155284869|NCT00941031|560474425|FG000|Maintenance Period|Adverse Event|0|||
155284870|NCT00941031|560474426|FG001|Maintenance Period|Adverse Event|0|||
155284871|NCT00941031|560474427|FG002|Maintenance Period|Adverse Event|0|||
155284872|NCT00941031|560474428|FG003|Maintenance Period|Adverse Event|0|||
155284873|NCT00941031|560474429|FG004|Maintenance Period|Adverse Event|0|||
155284874|NCT00941031|560474430|FG005|Maintenance Period|Adverse Event|2|||
155154688|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155154689|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155154690|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
155154691|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
155154692|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155154693|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
155154694|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155154695|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
155154696|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
155154697|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
155154698|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
155154699|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
155154700|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
155154701|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
155154702|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155154703|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
155154704|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
155154705|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
155154706|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
155154707|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
155154708|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155154709|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
155154710|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
155154711|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
155154712|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
155154713|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
155154714|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
155154715|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
155154716|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155154717|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155154718|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
155154719|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155154720|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155154721|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
155154722|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
155154723|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155154724|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
155284875|NCT00941031|560474431|FG006|Maintenance Period|Adverse Event|8|||
155058436|NCT00264147|559648659|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
155058437|NCT00264147|559648660|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
155058438|NCT00264147|559648661|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
155058439|NCT00264147|559648662|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
155058440|NCT00264147|559648657|FG000|Treatment II Period|Adverse Event|0|||
155058441|NCT00264147|559648658|FG001|Treatment II Period|Adverse Event|0|||
155284876|NCT00941031|560474425|FG000|Maintenance Period|Lost to Follow-up|0|||
155284877|NCT00941031|560474426|FG001|Maintenance Period|Lost to Follow-up|0|||
155284878|NCT00941031|560474427|FG002|Maintenance Period|Lost to Follow-up|0|||
155284879|NCT00941031|560474428|FG003|Maintenance Period|Lost to Follow-up|0|||
155284880|NCT00941031|560474429|FG004|Maintenance Period|Lost to Follow-up|2|||
155284881|NCT00941031|560474430|FG005|Maintenance Period|Lost to Follow-up|2|||
155154725|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155154726|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155154727|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155154728|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155154729|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155154730|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
155058442|NCT00264147|559648659|FG002|Treatment II Period|Adverse Event|0|||
155154731|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
155154732|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
155058443|NCT00264147|559648660|FG003|Treatment II Period|Adverse Event|0|||
155058444|NCT00264147|559648661|FG004|Treatment II Period|Adverse Event|9|||
155058445|NCT00264147|559648662|FG005|Treatment II Period|Adverse Event|9|||
155058446|NCT00264147|559648657|FG000|Treatment II Period|Laboratory Adverse Event|0|||
155058447|NCT00264147|559648658|FG001|Treatment II Period|Laboratory Adverse Event|0|||
155058448|NCT00264147|559648659|FG002|Treatment II Period|Laboratory Adverse Event|0|||
155058449|NCT00264147|559648660|FG003|Treatment II Period|Laboratory Adverse Event|0|||
155058450|NCT00264147|559648661|FG004|Treatment II Period|Laboratory Adverse Event|0|||
155058451|NCT00264147|559648662|FG005|Treatment II Period|Laboratory Adverse Event|1|||
155058452|NCT00264147|559648657|FG000|Treatment II Period|Lack of Efficacy|0|||
155058453|NCT00264147|559648658|FG001|Treatment II Period|Lack of Efficacy|0|||
155058454|NCT00264147|559648659|FG002|Treatment II Period|Lack of Efficacy|0|||
155058455|NCT00264147|559648660|FG003|Treatment II Period|Lack of Efficacy|0|||
155058456|NCT00264147|559648661|FG004|Treatment II Period|Lack of Efficacy|20|||
155058457|NCT00264147|559648662|FG005|Treatment II Period|Lack of Efficacy|19|||
155058458|NCT00264147|559648657|FG000|Treatment II Period|Lost to Follow-up|0|||
155058459|NCT00264147|559648658|FG001|Treatment II Period|Lost to Follow-up|0|||
155058460|NCT00264147|559648659|FG002|Treatment II Period|Lost to Follow-up|0|||
155058461|NCT00264147|559648660|FG003|Treatment II Period|Lost to Follow-up|0|||
155058462|NCT00264147|559648661|FG004|Treatment II Period|Lost to Follow-up|1|||
155058463|NCT00264147|559648662|FG005|Treatment II Period|Lost to Follow-up|1|||
155058464|NCT00264147|559648657|FG000|Treatment II Period|Withdrawal by Subject|0|||
155058465|NCT00264147|559648658|FG001|Treatment II Period|Withdrawal by Subject|0|||
155058466|NCT00264147|559648659|FG002|Treatment II Period|Withdrawal by Subject|0|||
155058467|NCT00264147|559648660|FG003|Treatment II Period|Withdrawal by Subject|0|||
155058468|NCT00264147|559648661|FG004|Treatment II Period|Withdrawal by Subject|3|||
155058469|NCT00264147|559648662|FG005|Treatment II Period|Withdrawal by Subject|2|||
155058470|NCT00264147|559648657|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
155058471|NCT00264147|559648658|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
155058472|NCT00264147|559648659|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
155058473|NCT00264147|559648660|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
155058474|NCT00264147|559648661|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
155058475|NCT00264147|559648662|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
155058476|NCT01316224|559648663|FG000|Overall Study|Protocol Violation|3|||
155058477|NCT01316224|559648663|FG000|Overall Study|Adverse Event|3|||
155058478|NCT01316224|559648663|FG000|Overall Study|Lack of Efficacy|1|||
155058479|NCT01316224|559648663|FG000|Overall Study|Withdrawal by Subject|1|||
155058480|NCT01316224|559648663|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
155058481|NCT01316224|559648663|FG000|Overall Study|Other|1|||
155058482|NCT00449163|559648666|FG000|Overall Study|Physician Decision|3|||
155058483|NCT00843492|559648682|FG000|Overall Study|Adverse Event|0|||
155058484|NCT00843492|559648683|FG001|Overall Study|Adverse Event|3|||
155058485|NCT00843492|559648682|FG000|Overall Study|Lost to Follow-up|4|||
155058486|NCT00843492|559648683|FG001|Overall Study|Lost to Follow-up|4|||
155058487|NCT00843492|559648682|FG000|Overall Study|Withdrawal by Subject|0|||
155058488|NCT00843492|559648683|FG001|Overall Study|Withdrawal by Subject|4|||
155058489|NCT00843492|559648682|FG000|Overall Study|Immobilization Stopped|1|||
155058490|NCT00843492|559648683|FG001|Overall Study|Immobilization Stopped|0|||
155058491|NCT00843492|559648682|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
155058492|NCT00843492|559648683|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
155058493|NCT00843492|559648682|FG000|Overall Study|Orthopedic Surgery|0|||
155154733|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
155058494|NCT00843492|559648683|FG001|Overall Study|Orthopedic Surgery|2|||
155154734|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
155154735|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
155058495|NCT00843492|559648682|FG000|Overall Study|Visit Not Performed|1|||
155058496|NCT00843492|559648683|FG001|Overall Study|Visit Not Performed|0|||
155154736|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
155058497|NCT00843492|559648682|FG000|Overall Study|Deep-vein Thrombosis|1|||
155058498|NCT00843492|559648683|FG001|Overall Study|Deep-vein Thrombosis|0|||
155058499|NCT00720499|559648684|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
155058500|NCT00720499|559648685|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
155058501|NCT00720499|559648684|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
155058502|NCT00720499|559648685|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
155058503|NCT00720499|559648684|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
155058504|NCT00720499|559648685|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
155058505|NCT00828711|559648686|FG000|Overall Study|Lost to Follow-up|1|||
155058506|NCT00828711|559648687|FG001|Overall Study|Lost to Follow-up|0|||
155058507|NCT00828711|559648688|FG002|Overall Study|Lost to Follow-up|0|||
155058508|NCT01618968|559648689|FG000|Overall Study|Adverse Event|1|||
155058509|NCT01618968|559648690|FG001|Overall Study|Adverse Event|0|||
155058510|NCT01618968|559648691|FG002|Overall Study|Adverse Event|0|||
155058511|NCT01618968|559648692|FG003|Overall Study|Adverse Event|0|||
155058512|NCT01618968|559648689|FG000|Overall Study|Death|0|||
155058513|NCT01618968|559648690|FG001|Overall Study|Death|0|||
155058514|NCT01618968|559648691|FG002|Overall Study|Death|0|||
155058515|NCT01618968|559648692|FG003|Overall Study|Death|1|||
155058516|NCT00721799|559648698|FG000|Overall Study|Withdrawal by Subject|7|||
155058517|NCT00721799|559648698|FG000|Overall Study|withdraw by subject after scan 1|1|||
155058518|NCT01441973|559648699|FG000|Overall Study|Disease progression|8|||
155058519|NCT01441973|559648700|FG001|Overall Study|Disease progression|6|||
155058520|NCT01441973|559648699|FG000|Overall Study|Adverse event unrelated to study drug|3|||
155058521|NCT01441973|559648700|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155058522|NCT01441973|559648699|FG000|Overall Study|Participant request to discontinue|1|||
155058523|NCT01441973|559648700|FG001|Overall Study|Participant request to discontinue|1|||
155058524|NCT01441973|559648699|FG000|Overall Study|Poor compliance/noncompliance|0|||
155058525|NCT01441973|559648700|FG001|Overall Study|Poor compliance/noncompliance|1|||
155058526|NCT01441973|559648699|FG000|Overall Study|Administrative reason by sponsor|3|||
155058527|NCT01441973|559648700|FG001|Overall Study|Administrative reason by sponsor|5|||
155058528|NCT01441973|559648699|FG000|Overall Study|Participant withdrew consent|0|||
155058529|NCT01441973|559648700|FG001|Overall Study|Participant withdrew consent|1|||
155058530|NCT00350545|559650216|FG000|Overall Study|Withdrawal by Subject|2|||
155058531|NCT00750269|559650226|FG000|Overall Study|Protocol Violation|0|||
155058532|NCT00750269|559650227|FG001|Overall Study|Protocol Violation|1|||
155058533|NCT00750269|559650228|FG002|Overall Study|Protocol Violation|1|||
155058534|NCT00750269|559650229|FG003|Overall Study|Protocol Violation|2|||
155058535|NCT00750269|559650230|FG004|Overall Study|Protocol Violation|4|||
155058536|NCT00750269|559650226|FG000|Overall Study|Withdrawal by Subject|0|||
155058537|NCT00750269|559650227|FG001|Overall Study|Withdrawal by Subject|0|||
155058538|NCT00750269|559650228|FG002|Overall Study|Withdrawal by Subject|2|||
155058539|NCT00750269|559650229|FG003|Overall Study|Withdrawal by Subject|2|||
155058540|NCT00750269|559650230|FG004|Overall Study|Withdrawal by Subject|2|||
155058541|NCT00750269|559650226|FG000|Overall Study|Physician Decision|0|||
155058542|NCT00750269|559650227|FG001|Overall Study|Physician Decision|0|||
155058543|NCT00750269|559650228|FG002|Overall Study|Physician Decision|0|||
155058544|NCT00750269|559650229|FG003|Overall Study|Physician Decision|0|||
155058545|NCT00750269|559650230|FG004|Overall Study|Physician Decision|2|||
155058546|NCT00750269|559650226|FG000|Overall Study|Patient too large for positioning|0|||
155058547|NCT00750269|559650227|FG001|Overall Study|Patient too large for positioning|0|||
155058548|NCT00750269|559650228|FG002|Overall Study|Patient too large for positioning|1|||
155058549|NCT00750269|559650229|FG003|Overall Study|Patient too large for positioning|0|||
155058550|NCT00750269|559650230|FG004|Overall Study|Patient too large for positioning|0|||
155058551|NCT00750269|559650226|FG000|Overall Study|Site error|0|||
155058552|NCT00750269|559650227|FG001|Overall Study|Site error|0|||
155058553|NCT00750269|559650228|FG002|Overall Study|Site error|0|||
155058554|NCT00750269|559650229|FG003|Overall Study|Site error|1|||
155058555|NCT00750269|559650230|FG004|Overall Study|Site error|0|||
155058556|NCT00750269|559650226|FG000|Overall Study|SBRT plan could not be drawn|0|||
155058557|NCT00750269|559650227|FG001|Overall Study|SBRT plan could not be drawn|0|||
155058558|NCT00750269|559650228|FG002|Overall Study|SBRT plan could not be drawn|0|||
155058559|NCT00750269|559650229|FG003|Overall Study|SBRT plan could not be drawn|0|||
155058560|NCT00750269|559650230|FG004|Overall Study|SBRT plan could not be drawn|1|||
155058561|NCT00750269|559650226|FG000|Overall Study|Fiducials could not be placed|0|||
155058562|NCT00750269|559650227|FG001|Overall Study|Fiducials could not be placed|0|||
155058563|NCT00750269|559650228|FG002|Overall Study|Fiducials could not be placed|0|||
155058564|NCT00750269|559650229|FG003|Overall Study|Fiducials could not be placed|0|||
155058565|NCT00750269|559650230|FG004|Overall Study|Fiducials could not be placed|1|||
155058566|NCT03630393|559650232|FG000|Overall Study|Death|1|||
155058567|NCT03630393|559650233|FG001|Overall Study|Death|0|||
155058568|NCT00408499|559650234|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155058569|NCT00408499|559650235|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155058570|NCT00408499|559650236|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
155058571|NCT00408499|559650237|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155058572|NCT00408499|559650238|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
155058573|NCT00408499|559650234|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
155058574|NCT00408499|559650235|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
155058575|NCT00408499|559650236|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
155058576|NCT00408499|559650237|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
155058577|NCT00408499|559650238|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
155154737|NCT01054885|560004338|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155154738|NCT01054885|560004339|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
155154739|NCT01054885|560004340|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155154740|NCT01054885|560004341|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
155154741|NCT01054885|560004342|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
155154742|NCT01054885|560004343|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155154743|NCT01054885|560004344|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
155154744|NCT02443688|560004345|FG000|Overall Study|Adverse Event|2|||
155154745|NCT02443688|560004346|FG001|Overall Study|Adverse Event|3|||
155154746|NCT02443688|560004347|FG002|Overall Study|Adverse Event|2|||
155154747|NCT02443688|560004345|FG000|Overall Study|Lost to Follow-up|1|||
155154748|NCT02443688|560004346|FG001|Overall Study|Lost to Follow-up|0|||
155154749|NCT02443688|560004347|FG002|Overall Study|Lost to Follow-up|0|||
155154750|NCT02443688|560004345|FG000|Overall Study|Physician Decision|3|||
155154751|NCT02443688|560004346|FG001|Overall Study|Physician Decision|0|||
155154752|NCT02443688|560004347|FG002|Overall Study|Physician Decision|1|||
155154753|NCT02443688|560004345|FG000|Overall Study|Pregnancy|0|||
155154754|NCT02443688|560004346|FG001|Overall Study|Pregnancy|0|||
155154755|NCT02443688|560004347|FG002|Overall Study|Pregnancy|1|||
155154756|NCT02443688|560004345|FG000|Overall Study|Withdrawal by Subject|3|||
155154757|NCT02443688|560004346|FG001|Overall Study|Withdrawal by Subject|3|||
155154758|NCT02443688|560004347|FG002|Overall Study|Withdrawal by Subject|4|||
155154759|NCT02443688|560004345|FG000|Overall Study|Non-compliance with study drug|1|||
155154760|NCT02443688|560004346|FG001|Overall Study|Non-compliance with study drug|2|||
155154761|NCT02443688|560004347|FG002|Overall Study|Non-compliance with study drug|4|||
155154762|NCT02443688|560004345|FG000|Overall Study|Sponsor Request|2|||
155154763|NCT02443688|560004346|FG001|Overall Study|Sponsor Request|1|||
155154764|NCT02443688|560004347|FG002|Overall Study|Sponsor Request|0|||
155154765|NCT02379728|560004348|FG000|Overall Study|Lost to Follow-up|1|||
155154766|NCT02379728|560004349|FG001|Overall Study|Lost to Follow-up|0|||
155154767|NCT02379728|560004350|FG002|Overall Study|Lost to Follow-up|3|||
155154768|NCT02379728|560004351|FG003|Overall Study|Lost to Follow-up|0|||
155154769|NCT02379728|560004348|FG000|Overall Study|Withdrawal by Subject|5|||
155154770|NCT02379728|560004349|FG001|Overall Study|Withdrawal by Subject|0|||
155154771|NCT02379728|560004350|FG002|Overall Study|Withdrawal by Subject|5|||
155154772|NCT02379728|560004351|FG003|Overall Study|Withdrawal by Subject|3|||
155154773|NCT02379728|560004348|FG000|Overall Study|Protocol Violation|0|||
155154774|NCT02379728|560004349|FG001|Overall Study|Protocol Violation|0|||
155154775|NCT02379728|560004350|FG002|Overall Study|Protocol Violation|2|||
155154776|NCT02379728|560004351|FG003|Overall Study|Protocol Violation|0|||
155154777|NCT01112917|560004352|FG000|Overall Study|Death|2|||
155154778|NCT01112917|560004353|FG001|Overall Study|Death|11|||
155154779|NCT01112917|560004352|FG000|Overall Study|Lost to Follow-up|1|||
155154780|NCT01112917|560004353|FG001|Overall Study|Lost to Follow-up|1|||
155154781|NCT01112917|560004352|FG000|Overall Study|Withdrawal by Subject|1|||
155154782|NCT01112917|560004353|FG001|Overall Study|Withdrawal by Subject|3|||
155154783|NCT01112917|560004352|FG000|Overall Study|Unable to Convert Filter|3|||
155154784|NCT01112917|560004353|FG001|Overall Study|Unable to Convert Filter|0|||
155154785|NCT00837434|560004365|FG000|Overall Study|Physician Decision|3|||
155154786|NCT00837434|560004366|FG001|Overall Study|Physician Decision|0|||
155154787|NCT00837434|560004365|FG000|Overall Study|Lost to Follow-up|1|||
155154788|NCT00837434|560004366|FG001|Overall Study|Lost to Follow-up|1|||
155154789|NCT00837434|560004365|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
155154790|NCT00837434|560004366|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
155154791|NCT00837434|560004365|FG000|Overall Study|Noncompliant|2|||
154954254|NCT02106156|559259508|FG002|Overall Study|Lack of Compliance|0|||
154954255|NCT02106156|559259506|FG000|Overall Study|Patients Request|307|||
154954256|NCT02106156|559259507|FG001|Overall Study|Patients Request|9|||
154954257|NCT02106156|559259508|FG002|Overall Study|Patients Request|0|||
154954258|NCT02106156|559259506|FG000|Overall Study|Lost to Follow-up|451|||
154954259|NCT02106156|559259507|FG001|Overall Study|Lost to Follow-up|8|||
154954260|NCT02106156|559259508|FG002|Overall Study|Lost to Follow-up|0|||
154954261|NCT02106156|559259506|FG000|Overall Study|Unplanned Event|82|||
154954262|NCT02106156|559259507|FG001|Overall Study|Unplanned Event|2|||
154954263|NCT02106156|559259508|FG002|Overall Study|Unplanned Event|0|||
154954264|NCT02106156|559259506|FG000|Overall Study|Change of Laboratory Parameter|10|||
155154792|NCT00837434|560004366|FG001|Overall Study|Noncompliant|0|||
154954265|NCT02106156|559259507|FG001|Overall Study|Change of Laboratory Parameter|0|||
154954266|NCT02106156|559259508|FG002|Overall Study|Change of Laboratory Parameter|0|||
155154793|NCT00837434|560004365|FG000|Overall Study|Baseline assessments not done in time|1|||
154954267|NCT02106156|559259506|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
154954268|NCT02106156|559259507|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
154954269|NCT02106156|559259508|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
155154794|NCT00837434|560004366|FG001|Overall Study|Baseline assessments not done in time|0|||
155154795|NCT00837434|560004365|FG000|Overall Study|Unable to obtain study drug|1|||
155154796|NCT00837434|560004366|FG001|Overall Study|Unable to obtain study drug|0|||
155154797|NCT01709721|560004367|FG000|Open Label Phase|Withdrawal by Subject|0|||
155154798|NCT01709721|560004368|FG001|Open Label Phase|Withdrawal by Subject|0|||
155154799|NCT01709721|560004369|FG002|Open Label Phase|Withdrawal by Subject|5|||
155154800|NCT01709721|560004367|FG000|Open Label Phase|Adverse Event|0|||
155154801|NCT01709721|560004368|FG001|Open Label Phase|Adverse Event|0|||
155154802|NCT01709721|560004369|FG002|Open Label Phase|Adverse Event|8|||
155154803|NCT01709721|560004367|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
155154804|NCT01709721|560004368|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
155154805|NCT01709721|560004369|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
155154806|NCT01709721|560004367|FG000|Open Label Phase|Investigator Decision|0|||
155154807|NCT01709721|560004368|FG001|Open Label Phase|Investigator Decision|0|||
155154808|NCT01709721|560004369|FG002|Open Label Phase|Investigator Decision|1|||
155154809|NCT01709721|560004367|FG000|Open Label Phase|Sponsor Decision|0|||
155154810|NCT01709721|560004368|FG001|Open Label Phase|Sponsor Decision|0|||
155154811|NCT01709721|560004369|FG002|Open Label Phase|Sponsor Decision|2|||
155154812|NCT01709721|560004367|FG000|Open Label Phase|Protocol Violation|0|||
155154813|NCT01709721|560004368|FG001|Open Label Phase|Protocol Violation|0|||
155154814|NCT01709721|560004369|FG002|Open Label Phase|Protocol Violation|1|||
155154815|NCT01709721|560004367|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
155154816|NCT01709721|560004368|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
155154817|NCT01709721|560004369|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
155284882|NCT00941031|560474431|FG006|Maintenance Period|Lost to Follow-up|7|||
155154818|NCT01709721|560004367|FG000|Open Label Phase|Inadequate Pain Control|0|||
155154819|NCT01709721|560004368|FG001|Open Label Phase|Inadequate Pain Control|0|||
155154820|NCT01709721|560004369|FG002|Open Label Phase|Inadequate Pain Control|37|||
155284883|NCT00941031|560474425|FG000|Maintenance Period|Lack of Efficacy|0|||
155284884|NCT00941031|560474426|FG001|Maintenance Period|Lack of Efficacy|0|||
155284885|NCT00941031|560474427|FG002|Maintenance Period|Lack of Efficacy|0|||
155284886|NCT00941031|560474428|FG003|Maintenance Period|Lack of Efficacy|0|||
155284887|NCT00941031|560474429|FG004|Maintenance Period|Lack of Efficacy|0|||
155284888|NCT00941031|560474430|FG005|Maintenance Period|Lack of Efficacy|0|||
155284889|NCT00941031|560474431|FG006|Maintenance Period|Lack of Efficacy|13|||
155284890|NCT04555044|560474434|FG000|Overall Study|Adverse Event|0|||
155284891|NCT04555044|560474435|FG001|Overall Study|Adverse Event|1|||
155284892|NCT00631917|560474437|FG000|Overall Study|Adverse Event|34|||
155284893|NCT00631917|560474438|FG001|Overall Study|Adverse Event|45|||
155284894|NCT00631917|560474437|FG000|Overall Study|Abnormal laboratory value(s)|2|||
155284895|NCT00631917|560474438|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155284896|NCT00631917|560474437|FG000|Overall Study|Abnormal test procedure result(s)|3|||
155284897|NCT00631917|560474438|FG001|Overall Study|Abnormal test procedure result(s)|2|||
155284898|NCT00631917|560474437|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
155284899|NCT00631917|560474438|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
155284900|NCT00631917|560474437|FG000|Overall Study|No longer required study drug|0|||
155284901|NCT00631917|560474438|FG001|Overall Study|No longer required study drug|1|||
155284902|NCT00631917|560474437|FG000|Overall Study|Protocol deviation|6|||
155284903|NCT00631917|560474438|FG001|Overall Study|Protocol deviation|5|||
155284904|NCT00631917|560474437|FG000|Overall Study|Subject withdrew consent|25|||
155284905|NCT00631917|560474438|FG001|Overall Study|Subject withdrew consent|33|||
155284906|NCT00631917|560474437|FG000|Overall Study|Lost to Follow-up|7|||
155284907|NCT00631917|560474438|FG001|Overall Study|Lost to Follow-up|7|||
155284908|NCT00631917|560474437|FG000|Overall Study|Administrative problems|2|||
155284909|NCT00631917|560474438|FG001|Overall Study|Administrative problems|0|||
155284910|NCT00631917|560474437|FG000|Overall Study|Death|1|||
155284911|NCT00631917|560474438|FG001|Overall Study|Death|0|||
155284912|NCT01767909|560474441|FG000|Overall Study|Withdrawal by Subject|4|||
155284913|NCT01767909|560474442|FG001|Overall Study|Withdrawal by Subject|7|||
155284914|NCT01767909|560474441|FG000|Overall Study|Adverse Event|3|||
155284915|NCT01767909|560474442|FG001|Overall Study|Adverse Event|1|||
155284916|NCT01767909|560474441|FG000|Overall Study|Withdrawal by Study Partner|3|||
155284917|NCT01767909|560474442|FG001|Overall Study|Withdrawal by Study Partner|1|||
155284918|NCT01767909|560474441|FG000|Overall Study|Non-Compliance|2|||
155284919|NCT01767909|560474442|FG001|Overall Study|Non-Compliance|0|||
155284920|NCT01767909|560474441|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155284921|NCT01767909|560474442|FG001|Overall Study|Perceived Lack of Efficacy|0|||
155284922|NCT01767909|560474441|FG000|Overall Study|Investigator Recommendation|0|||
155284923|NCT01767909|560474442|FG001|Overall Study|Investigator Recommendation|1|||
155284924|NCT01767909|560474441|FG000|Overall Study|Lost to Follow-up|0|||
155284925|NCT01767909|560474442|FG001|Overall Study|Lost to Follow-up|1|||
155284926|NCT01767909|560474441|FG000|Overall Study|LP uncessessful|0|||
155154821|NCT01709721|560004367|FG000|Open Label Phase|Other, Specify in text field in database|0|||
155154822|NCT01709721|560004368|FG001|Open Label Phase|Other, Specify in text field in database|0|||
155284927|NCT01767909|560474442|FG001|Overall Study|LP uncessessful|1|||
155284928|NCT02696785|560474451|FG000|Blinded Treatment Period|Adverse Event|0|||
155284929|NCT02696785|560474452|FG001|Blinded Treatment Period|Adverse Event|1|||
155154823|NCT01709721|560004369|FG002|Open Label Phase|Other, Specify in text field in database|14|||
155154824|NCT01709721|560004367|FG000|Randomized Phase|Adverse Event|0|||
155154825|NCT01709721|560004368|FG001|Randomized Phase|Adverse Event|1|||
155154826|NCT01709721|560004369|FG002|Randomized Phase|Adverse Event|0|||
155154827|NCT01709721|560004367|FG000|Randomized Phase|Lost to Follow-up|1|||
155154828|NCT01709721|560004368|FG001|Randomized Phase|Lost to Follow-up|0|||
155154829|NCT01709721|560004369|FG002|Randomized Phase|Lost to Follow-up|0|||
155154830|NCT01709721|560004367|FG000|Randomized Phase|Inadequate Pain Control|1|||
155154831|NCT01709721|560004368|FG001|Randomized Phase|Inadequate Pain Control|2|||
155154832|NCT01709721|560004369|FG002|Randomized Phase|Inadequate Pain Control|0|||
155154833|NCT01709721|560004367|FG000|Randomized Phase|Other, Specify text field in database|1|||
155154834|NCT01709721|560004368|FG001|Randomized Phase|Other, Specify text field in database|3|||
155154835|NCT01709721|560004369|FG002|Randomized Phase|Other, Specify text field in database|0|||
155154836|NCT02230410|560004370|FG000|Overall Study|Screen Failure|3|||
155154837|NCT02558894|560004376|FG000|Overall Study|Death; any cause, entire study duration|28|||
155154838|NCT02558894|560004377|FG001|Overall Study|Death; any cause, entire study duration|31|||
155154839|NCT02558894|560004376|FG000|Overall Study|Withdrawal by Subject|2|||
155154840|NCT02558894|560004377|FG001|Overall Study|Withdrawal by Subject|1|||
155154841|NCT02558894|560004376|FG000|Overall Study|Closure of Part A|2|||
155154842|NCT02558894|560004377|FG001|Overall Study|Closure of Part A|1|||
155154843|NCT04558125|560004378|FG000|Overall Study|Death|1|||
155154844|NCT01748292|560004379|FG000|Overall Study|Adverse Event|2|||
155154845|NCT01748292|560004380|FG001|Overall Study|Adverse Event|4|||
155154846|NCT01748292|560004379|FG000|Overall Study|Lost to Follow-up|0|||
155154847|NCT01748292|560004380|FG001|Overall Study|Lost to Follow-up|3|||
155154848|NCT01748292|560004379|FG000|Overall Study|Death|0|||
155154849|NCT01748292|560004380|FG001|Overall Study|Death|3|||
155154850|NCT01748292|560004379|FG000|Overall Study|Withdrawal by Subject|0|||
155154851|NCT01748292|560004380|FG001|Overall Study|Withdrawal by Subject|2|||
155154852|NCT03199976|560004381|FG000|Overall Study|Lack of Efficacy|3|||
155154853|NCT03199976|560004382|FG001|Overall Study|Lack of Efficacy|6|||
155154854|NCT03199976|560004383|FG002|Overall Study|Lack of Efficacy|13|||
155154855|NCT03199976|560004381|FG000|Overall Study|Withdrawal by Subject|1|||
155154856|NCT03199976|560004382|FG001|Overall Study|Withdrawal by Subject|0|||
155154857|NCT03199976|560004383|FG002|Overall Study|Withdrawal by Subject|0|||
154954270|NCT02106156|559259506|FG000|Overall Study|Relocation/Change of Physician|40|||
154954271|NCT02106156|559259507|FG001|Overall Study|Relocation/Change of Physician|1|||
155154858|NCT03199976|560004381|FG000|Overall Study|Lost to Follow-up|0|||
155154859|NCT03199976|560004382|FG001|Overall Study|Lost to Follow-up|1|||
155154860|NCT03199976|560004383|FG002|Overall Study|Lost to Follow-up|1|||
155154861|NCT01761877|560004384|FG000|Overall Study|Adverse Event|7|||
155154862|NCT01761877|560004385|FG001|Overall Study|Adverse Event|0|||
155154863|NCT01761877|560004384|FG000|Overall Study|Withdrawal by Subject|6|||
155154864|NCT01761877|560004385|FG001|Overall Study|Withdrawal by Subject|4|||
155154865|NCT01761877|560004384|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
155154866|NCT01761877|560004385|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
155284930|NCT02696785|560474453|FG002|Blinded Treatment Period|Adverse Event|3|||
154954272|NCT02106156|559259508|FG002|Overall Study|Relocation/Change of Physician|0|||
154954273|NCT01136382|559259511|FG000|Overall Study|Other|8|||
154954274|NCT01136382|559259512|FG001|Overall Study|Other|3|||
155154867|NCT01761877|560004384|FG000|Overall Study|Death|0|||
155154868|NCT01761877|560004385|FG001|Overall Study|Death|1|||
155284931|NCT02696785|560474454|FG003|Blinded Treatment Period|Adverse Event|0|||
155284932|NCT02696785|560474451|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
155284933|NCT02696785|560474452|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
155284934|NCT02696785|560474453|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
155284935|NCT02696785|560474454|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
155284936|NCT02696785|560474451|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
155284937|NCT02696785|560474452|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
155284938|NCT02696785|560474453|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
155284939|NCT02696785|560474454|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
155284940|NCT02696785|560474451|FG000|Blinded Treatment Period|Screen Failure|1|||
155284941|NCT02696785|560474452|FG001|Blinded Treatment Period|Screen Failure|0|||
155284942|NCT02696785|560474453|FG002|Blinded Treatment Period|Screen Failure|0|||
155284943|NCT02696785|560474454|FG003|Blinded Treatment Period|Screen Failure|0|||
155284944|NCT02696785|560474451|FG000|Washout Period|Withdrawal by Subject|0|||
155284945|NCT02696785|560474452|FG001|Washout Period|Withdrawal by Subject|1|||
155284946|NCT02696785|560474453|FG002|Washout Period|Withdrawal by Subject|0|||
155284947|NCT02696785|560474454|FG003|Washout Period|Withdrawal by Subject|0|||
155284948|NCT02696785|560474451|FG000|Washout Period|Lack of Efficacy|0|||
155284949|NCT02696785|560474452|FG001|Washout Period|Lack of Efficacy|1|||
155284950|NCT02696785|560474453|FG002|Washout Period|Lack of Efficacy|0|||
155284951|NCT02696785|560474454|FG003|Washout Period|Lack of Efficacy|0|||
155284952|NCT02696785|560474451|FG000|Extended Treatment Period|Adverse Event|2|||
154954275|NCT01136382|559259511|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
155284953|NCT02696785|560474452|FG001|Extended Treatment Period|Adverse Event|3|||
155284954|NCT02696785|560474453|FG002|Extended Treatment Period|Adverse Event|2|||
155284955|NCT02696785|560474454|FG003|Extended Treatment Period|Adverse Event|1|||
155154869|NCT01761877|560004384|FG000|Overall Study|MRI intolerant|1|||
155284956|NCT02696785|560474451|FG000|Extended Treatment Period|Lack of Efficacy|0|||
155154870|NCT01761877|560004385|FG001|Overall Study|MRI intolerant|6|||
155154871|NCT00003475|560004386|FG000|Overall Study|Not evaluable|13|||
155154872|NCT03697252|560004393|FG000|Overall Study|Adverse Event|3|||
155154873|NCT03697252|560004394|FG001|Overall Study|Adverse Event|2|||
155154874|NCT03697252|560004393|FG000|Overall Study|Withdrawal by Subject|14|||
155154875|NCT03697252|560004394|FG001|Overall Study|Withdrawal by Subject|14|||
154954276|NCT01136382|559259512|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
154954277|NCT01136382|559259511|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
154954278|NCT01136382|559259512|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
155284957|NCT02696785|560474452|FG001|Extended Treatment Period|Lack of Efficacy|1|||
155284958|NCT02696785|560474453|FG002|Extended Treatment Period|Lack of Efficacy|0|||
155284959|NCT02696785|560474454|FG003|Extended Treatment Period|Lack of Efficacy|0|||
155284960|NCT02696785|560474451|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
155284961|NCT02696785|560474452|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
155284962|NCT02696785|560474453|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
155284963|NCT02696785|560474454|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
155284964|NCT02696785|560474451|FG000|Follow-up Period|Adverse Event|0|||
155284965|NCT02696785|560474452|FG001|Follow-up Period|Adverse Event|0|||
155284966|NCT02696785|560474453|FG002|Follow-up Period|Adverse Event|8|||
155284967|NCT02696785|560474454|FG003|Follow-up Period|Adverse Event|2|||
155284968|NCT02696785|560474451|FG000|Follow-up Period|Lost to Follow-up|0|||
155284969|NCT02696785|560474452|FG001|Follow-up Period|Lost to Follow-up|0|||
155284970|NCT02696785|560474453|FG002|Follow-up Period|Lost to Follow-up|0|||
155284971|NCT02696785|560474454|FG003|Follow-up Period|Lost to Follow-up|1|||
155284972|NCT02696785|560474451|FG000|Follow-up Period|Lack of Efficacy|0|||
155284973|NCT02696785|560474452|FG001|Follow-up Period|Lack of Efficacy|0|||
155284974|NCT02696785|560474453|FG002|Follow-up Period|Lack of Efficacy|0|||
155284975|NCT02696785|560474454|FG003|Follow-up Period|Lack of Efficacy|1|||
155284976|NCT02696785|560474451|FG000|Follow-up Period|Withdrawal by Subject|1|||
155284977|NCT02696785|560474452|FG001|Follow-up Period|Withdrawal by Subject|0|||
155284978|NCT02696785|560474453|FG002|Follow-up Period|Withdrawal by Subject|5|||
155284979|NCT02696785|560474454|FG003|Follow-up Period|Withdrawal by Subject|4|||
155284980|NCT04863898|560474458|FG000|Overall Study|Away from study clinic during intervention training period|2|||
155284981|NCT04863898|560474458|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
155284982|NCT04863898|560474458|FG000|Overall Study|Lost to Follow-up|3|||
155284983|NCT04863898|560474458|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
155284984|NCT04863898|560474458|FG000|Overall Study|No longer employed at clinic|3|||
155284985|NCT00614744|560474459|FG000|Overall Study|Lost to Follow-up|5|||
155284986|NCT00614744|560474460|FG001|Overall Study|Lost to Follow-up|4|||
155284987|NCT00614744|560474459|FG000|Overall Study|Incomplete for Behavior Issues|0|||
155284988|NCT00614744|560474460|FG001|Overall Study|Incomplete for Behavior Issues|2|||
155284989|NCT02431533|560474461|FG000|Overall Study|Withdrawal by Subject|1|||
155284990|NCT02431533|560474462|FG001|Overall Study|Withdrawal by Subject|3|||
155284991|NCT02431533|560474461|FG000|Overall Study|Developed Exclusionary criteria|1|||
155154876|NCT03697252|560004393|FG000|Overall Study|Lost to Follow-up|0|||
155154877|NCT03697252|560004394|FG001|Overall Study|Lost to Follow-up|1|||
155154878|NCT03697252|560004393|FG000|Overall Study|Physician Decision|1|||
155154879|NCT03697252|560004394|FG001|Overall Study|Physician Decision|1|||
155154880|NCT03697252|560004393|FG000|Overall Study|Other|0|||
155154881|NCT03697252|560004394|FG001|Overall Study|Other|1|||
155154882|NCT01780506|560004395|FG000|Double-Blind Phase|Randomized but not Treated|3|||
155154883|NCT01780506|560004396|FG001|Double-Blind Phase|Randomized but not Treated|2|||
154954279|NCT01136382|559259511|FG000|Overall Study|Withdrawal by Subject|4|||
155154884|NCT01780506|560004395|FG000|Double-Blind Phase|Adverse Event|4|||
155154885|NCT01780506|560004396|FG001|Double-Blind Phase|Adverse Event|14|||
155154886|NCT01780506|560004395|FG000|Double-Blind Phase|Death|1|||
154954280|NCT01136382|559259512|FG001|Overall Study|Withdrawal by Subject|1|||
155154887|NCT01780506|560004396|FG001|Double-Blind Phase|Death|2|||
155154888|NCT01780506|560004395|FG000|Double-Blind Phase|Pregnancy|2|||
155154889|NCT01780506|560004396|FG001|Double-Blind Phase|Pregnancy|1|||
155154890|NCT01780506|560004395|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155154891|NCT01780506|560004396|FG001|Double-Blind Phase|Lack of Efficacy|1|||
155154892|NCT01780506|560004395|FG000|Double-Blind Phase|Investigator's Discretion|5|||
155154893|NCT01780506|560004396|FG001|Double-Blind Phase|Investigator's Discretion|2|||
155154894|NCT01780506|560004395|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
155154895|NCT01780506|560004396|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
155154896|NCT01780506|560004395|FG000|Double-Blind Phase|Protocol Violation|4|||
155154897|NCT01780506|560004396|FG001|Double-Blind Phase|Protocol Violation|3|||
155154898|NCT01780506|560004395|FG000|Double-Blind Phase|Withdrew Consent|23|||
155154899|NCT01780506|560004396|FG001|Double-Blind Phase|Withdrew Consent|24|||
155154900|NCT01780506|560004395|FG000|Double-Blind Phase|Lost to Follow-up|23|||
155154901|NCT01780506|560004396|FG001|Double-Blind Phase|Lost to Follow-up|26|||
155154902|NCT01780506|560004395|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
154954281|NCT01725529|559259520|FG000|Overall Study|Adverse Event|1|||
155154903|NCT01780506|560004396|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
155154904|NCT00412984|560004401|FG000|Overall Study|Death|331|||
155154905|NCT00412984|560004402|FG001|Overall Study|Death|349|||
154954282|NCT01725529|559259521|FG001|Overall Study|Adverse Event|0|||
154954283|NCT01725529|559259522|FG002|Overall Study|Adverse Event|0|||
154954284|NCT01725529|559259520|FG000|Overall Study|Lost to Follow-up|2|||
154954285|NCT01725529|559259521|FG001|Overall Study|Lost to Follow-up|1|||
154954286|NCT01725529|559259522|FG002|Overall Study|Lost to Follow-up|1|||
154954287|NCT01725529|559259520|FG000|Overall Study|Protocol Violation|0|||
154954288|NCT01725529|559259521|FG001|Overall Study|Protocol Violation|1|||
155154906|NCT00412984|560004401|FG000|Overall Study|Adverse Event|679|||
155154907|NCT00412984|560004402|FG001|Overall Study|Adverse Event|738|||
155154908|NCT00412984|560004401|FG000|Overall Study|Withdrawal by Subject|921|||
155154909|NCT00412984|560004402|FG001|Overall Study|Withdrawal by Subject|989|||
155154910|NCT00412984|560004401|FG000|Overall Study|Lost to Follow-up|51|||
155154911|NCT00412984|560004402|FG001|Overall Study|Lost to Follow-up|39|||
155154912|NCT00412984|560004401|FG000|Overall Study|Poor/Noncompliance|57|||
155154913|NCT00412984|560004402|FG001|Overall Study|Poor/Noncompliance|77|||
155154914|NCT00412984|560004401|FG000|Overall Study|Pregnancy|1|||
155154915|NCT00412984|560004402|FG001|Overall Study|Pregnancy|0|||
155154916|NCT00412984|560004401|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
155154917|NCT00412984|560004402|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
155154918|NCT00412984|560004401|FG000|Overall Study|Administrative Reason by Sponsor|11|||
155154919|NCT00412984|560004402|FG001|Overall Study|Administrative Reason by Sponsor|8|||
155154920|NCT00412984|560004401|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
155154921|NCT00412984|560004402|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
155154922|NCT00412984|560004401|FG000|Overall Study|Other Reason|80|||
155154923|NCT00412984|560004402|FG001|Overall Study|Other Reason|92|||
155154924|NCT00412984|560004401|FG000|Overall Study|Not Reported|11|||
155154925|NCT00412984|560004402|FG001|Overall Study|Not Reported|12|||
155154926|NCT04097678|560004404|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
155154927|NCT04097678|560004405|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
155154928|NCT03694678|560004406|FG000|Overall Study|Withdrawal by Subject|2|||
155154929|NCT03694678|560004407|FG001|Overall Study|Withdrawal by Subject|0|||
155154930|NCT03694678|560004406|FG000|Overall Study|Lost to Follow-up|2|||
155154931|NCT03694678|560004407|FG001|Overall Study|Lost to Follow-up|3|||
155154932|NCT02435212|560004408|FG000|Core Phase|Adverse Event|8|||
155154933|NCT02435212|560004409|FG001|Core Phase|Adverse Event|5|||
155154934|NCT02435212|560004408|FG000|Core Phase|Withdrawal by Subject|3|||
155154935|NCT02435212|560004409|FG001|Core Phase|Withdrawal by Subject|0|||
155154936|NCT02435212|560004408|FG000|Core Phase|Withdrawal by parent/guardian|9|||
155154937|NCT02435212|560004409|FG001|Core Phase|Withdrawal by parent/guardian|4|||
155154938|NCT02435212|560004408|FG000|Core Phase|Protocol Violation|1|||
155154939|NCT02435212|560004409|FG001|Core Phase|Protocol Violation|2|||
155154940|NCT02435212|560004408|FG000|Core Phase|Physician Decision|3|||
155154941|NCT02435212|560004409|FG001|Core Phase|Physician Decision|0|||
155154942|NCT02435212|560004408|FG000|Core Phase|Lost to Follow-up|0|||
155154943|NCT02435212|560004409|FG001|Core Phase|Lost to Follow-up|1|||
155154944|NCT02435212|560004408|FG000|Core Phase|Lack of Efficacy|0|||
155154945|NCT02435212|560004409|FG001|Core Phase|Lack of Efficacy|1|||
155154946|NCT02435212|560004408|FG000|Core Phase|Recovery|1|||
154954289|NCT01725529|559259522|FG002|Overall Study|Protocol Violation|1|||
154954290|NCT01725529|559259520|FG000|Overall Study|Withdrawal by Subject|12|||
154954291|NCT01725529|559259521|FG001|Overall Study|Withdrawal by Subject|14|||
154954292|NCT01725529|559259522|FG002|Overall Study|Withdrawal by Subject|8|||
155284992|NCT02431533|560474462|FG001|Overall Study|Developed Exclusionary criteria|0|||
155284993|NCT00235495|560474465|FG000|Overall Study|Death|52|||
154954293|NCT00746798|559259528|FG000|Overall Study|Protocol Violation|0|||
154954294|NCT00746798|559259529|FG001|Overall Study|Protocol Violation|1|||
154954295|NCT00746798|559259530|FG002|Overall Study|Protocol Violation|0|||
154954296|NCT00746798|559259531|FG003|Overall Study|Protocol Violation|0|||
154954297|NCT00746798|559259528|FG000|Overall Study|Withdrawal by Subject|0|||
154954298|NCT00746798|559259529|FG001|Overall Study|Withdrawal by Subject|1|||
154954299|NCT00746798|559259530|FG002|Overall Study|Withdrawal by Subject|1|||
154954300|NCT00746798|559259531|FG003|Overall Study|Withdrawal by Subject|0|||
154954301|NCT00746798|559259528|FG000|Overall Study|Death|0|||
154954302|NCT00746798|559259529|FG001|Overall Study|Death|0|||
154954303|NCT00746798|559259530|FG002|Overall Study|Death|2|||
154954304|NCT00746798|559259531|FG003|Overall Study|Death|0|||
154954305|NCT00746798|559259528|FG000|Overall Study|Participant unable to return for visit|1|||
154954306|NCT00746798|559259529|FG001|Overall Study|Participant unable to return for visit|0|||
154954307|NCT00746798|559259530|FG002|Overall Study|Participant unable to return for visit|0|||
154954308|NCT00746798|559259531|FG003|Overall Study|Participant unable to return for visit|0|||
154954309|NCT00633594|559259534|FG000|Overall Study|Adverse Event|0|||
154954310|NCT00633594|559259535|FG001|Overall Study|Adverse Event|4|||
154954311|NCT00633594|559259536|FG002|Overall Study|Adverse Event|7|||
154954312|NCT00633594|559259534|FG000|Overall Study|Death|0|||
154954313|NCT00633594|559259535|FG001|Overall Study|Death|1|||
154954314|NCT00633594|559259536|FG002|Overall Study|Death|2|||
154954315|NCT00633594|559259534|FG000|Overall Study|Disease Progression|0|||
154954316|NCT00633594|559259535|FG001|Overall Study|Disease Progression|0|||
154954317|NCT00633594|559259536|FG002|Overall Study|Disease Progression|1|||
154954318|NCT02028715|559259540|FG000|Overall Study|Adverse Event|2|||
154954319|NCT02028715|559259541|FG001|Overall Study|Adverse Event|2|||
154954320|NCT02028715|559259540|FG000|Overall Study|Physician Decision|1|||
154954321|NCT02028715|559259541|FG001|Overall Study|Physician Decision|0|||
154954322|NCT02028715|559259540|FG000|Overall Study|Did not complete satisfaction surveys|2|||
154954323|NCT02028715|559259541|FG001|Overall Study|Did not complete satisfaction surveys|2|||
154954324|NCT04915755|559259542|FG000|Overall Study|Physician Decision|3|||
154954325|NCT04915755|559259543|FG001|Overall Study|Physician Decision|2|||
154954326|NCT04915755|559259542|FG000|Overall Study|Withdrawal by Subject|1|||
154954327|NCT04915755|559259543|FG001|Overall Study|Withdrawal by Subject|1|||
154954328|NCT04915755|559259542|FG000|Overall Study|Ongoing for PACT|3|||
154954329|NCT04915755|559259543|FG001|Overall Study|Ongoing for PACT|2|||
154954330|NCT04915755|559259542|FG000|Overall Study|Other|7|||
154954331|NCT04915755|559259543|FG001|Overall Study|Other|11|||
154954332|NCT03655106|559259545|FG000|Overall Study|Withdrawal by Subject|3|||
154954333|NCT03655106|559259546|FG001|Overall Study|Withdrawal by Subject|2|||
154954334|NCT03655106|559259545|FG000|Overall Study|Lost to Follow-up|2|||
154954335|NCT03655106|559259546|FG001|Overall Study|Lost to Follow-up|1|||
154954336|NCT03655106|559259545|FG000|Overall Study|Duplicate Enrollment|1|||
154954337|NCT03655106|559259546|FG001|Overall Study|Duplicate Enrollment|1|||
155154947|NCT02435212|560004409|FG001|Core Phase|Recovery|0|||
155154948|NCT02435212|560004408|FG000|Optional Extension Phase|Adverse Event|3|||
155154949|NCT02435212|560004409|FG001|Optional Extension Phase|Adverse Event|9|||
155154950|NCT02435212|560004408|FG000|Optional Extension Phase|Physician Decision|6|||
155284994|NCT00235495|560474466|FG001|Overall Study|Death|42|||
155154951|NCT02435212|560004409|FG001|Optional Extension Phase|Physician Decision|8|||
154954338|NCT03655106|559259545|FG000|Overall Study|Protocol Violation|3|||
154954339|NCT03655106|559259546|FG001|Overall Study|Protocol Violation|0|||
154954340|NCT00727571|559259550|FG000|Overall Study|Ineligibility determined|1|||
155154952|NCT02435212|560004408|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
155154953|NCT02435212|560004409|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
155284995|NCT00235495|560474465|FG000|Overall Study|Withdrawal by Subject|5|||
155154954|NCT02435212|560004408|FG000|Optional Extension Phase|Lack of Efficacy|2|||
155154955|NCT02435212|560004409|FG001|Optional Extension Phase|Lack of Efficacy|3|||
155154956|NCT02435212|560004408|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
155154957|NCT02435212|560004409|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
155154958|NCT02435212|560004408|FG000|Optional Extension Phase|Protocol Violation|0|||
155154959|NCT02435212|560004409|FG001|Optional Extension Phase|Protocol Violation|1|||
155154960|NCT02435212|560004408|FG000|Optional Extension Phase|Recovery|1|||
155154961|NCT02435212|560004409|FG001|Optional Extension Phase|Recovery|1|||
155154962|NCT02435212|560004408|FG000|Optional Extension Phase|Death|1|||
155154963|NCT02435212|560004409|FG001|Optional Extension Phase|Death|0|||
155154964|NCT02435212|560004408|FG000|Optional Extension Phase|Technical problems|2|||
155154965|NCT02435212|560004409|FG001|Optional Extension Phase|Technical problems|0|||
155154966|NCT04852302|560004410|FG000|Overall Study|Withdrawal by Subject|2|||
155154967|NCT04852302|560004410|FG000|Overall Study|Did not complete CALM therapy.|2|||
155154968|NCT04711850|560004411|FG000|Overall Study|Graft loss|2|||
155154969|NCT04711850|560004412|FG001|Overall Study|Graft loss|1|||
155154970|NCT04711850|560004411|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
155154971|NCT04711850|560004412|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
155154972|NCT04711850|560004411|FG000|Overall Study|Study terminated by sponsor|5|||
155154973|NCT04711850|560004412|FG001|Overall Study|Study terminated by sponsor|3|||
155154974|NCT04711850|560004411|FG000|Overall Study|Sponsor decision|0|||
155154975|NCT04711850|560004412|FG001|Overall Study|Sponsor decision|2|||
155154976|NCT05249582|560004413|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
155154977|NCT05249582|560004414|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
155154978|NCT05249582|560004413|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
155154979|NCT05249582|560004414|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
155154980|NCT05249582|560004413|FG000|Overall Study|Declined to use virtual reality headset|1|||
155154981|NCT05249582|560004414|FG001|Overall Study|Declined to use virtual reality headset|0|||
155154982|NCT03279081|560004432|FG000|Overall Study|Withdrawal by Subject|12|||
155154983|NCT03279081|560004433|FG001|Overall Study|Withdrawal by Subject|20|||
155154984|NCT03279081|560004432|FG000|Overall Study|Physician Decision|4|||
155154985|NCT03279081|560004433|FG001|Overall Study|Physician Decision|1|||
155154986|NCT03279081|560004432|FG000|Overall Study|Lost to Follow-up|8|||
155154987|NCT03279081|560004433|FG001|Overall Study|Lost to Follow-up|8|||
155154988|NCT03279081|560004432|FG000|Overall Study|Death|0|||
155154989|NCT03279081|560004433|FG001|Overall Study|Death|1|||
155154990|NCT03279081|560004432|FG000|Overall Study|Adverse Event|1|||
155154991|NCT03279081|560004433|FG001|Overall Study|Adverse Event|0|||
155154992|NCT03279081|560004432|FG000|Overall Study|Reason not Specified|14|||
155154993|NCT03279081|560004433|FG001|Overall Study|Reason not Specified|4|||
155154994|NCT00771914|560004436|FG000|Overall Study|Physician Decision|0|||
155154995|NCT00771914|560004437|FG001|Overall Study|Physician Decision|0|||
155154996|NCT00771914|560004438|FG002|Overall Study|Physician Decision|0|||
155154997|NCT00771914|560004439|FG003|Overall Study|Physician Decision|1|||
155154998|NCT00771914|560004436|FG000|Overall Study|Lost to Follow-up|0|||
155154999|NCT00771914|560004437|FG001|Overall Study|Lost to Follow-up|0|||
155155000|NCT00771914|560004438|FG002|Overall Study|Lost to Follow-up|0|||
155155001|NCT00771914|560004439|FG003|Overall Study|Lost to Follow-up|1|||
155155002|NCT04842747|560004440|FG000|Overall Study|Withdrawal by Subject|6|||
155155003|NCT04842747|560004441|FG001|Overall Study|Withdrawal by Subject|2|||
155155004|NCT04842747|560004440|FG000|Overall Study|Lost to Follow-up|1|||
155155005|NCT04842747|560004441|FG001|Overall Study|Lost to Follow-up|2|||
155155006|NCT04842747|560004440|FG000|Overall Study|Physician Decision|1|||
155155007|NCT04842747|560004441|FG001|Overall Study|Physician Decision|0|||
155155008|NCT04842747|560004440|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
155155009|NCT04842747|560004441|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
155155010|NCT01743469|560004442|FG000|Active Treatment Phase|Adverse Event|10|||
155155011|NCT01743469|560004443|FG001|Active Treatment Phase|Adverse Event|5|||
155155012|NCT01743469|560004444|FG002|Active Treatment Phase|Adverse Event|8|||
155284996|NCT00235495|560474466|FG001|Overall Study|Withdrawal by Subject|3|||
155155013|NCT01743469|560004445|FG003|Active Treatment Phase|Adverse Event|1|||
155155014|NCT01743469|560004442|FG000|Active Treatment Phase|Disease Progression|40|||
155155015|NCT01743469|560004443|FG001|Active Treatment Phase|Disease Progression|47|||
155155016|NCT01743469|560004444|FG002|Active Treatment Phase|Disease Progression|30|||
155155017|NCT01743469|560004445|FG003|Active Treatment Phase|Disease Progression|20|||
155155018|NCT01743469|560004442|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
155155019|NCT01743469|560004443|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
155155020|NCT01743469|560004444|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
155155021|NCT01743469|560004445|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
155155022|NCT01743469|560004442|FG000|Active Treatment Phase|Missing|1|||
155155023|NCT01743469|560004443|FG001|Active Treatment Phase|Missing|0|||
155155024|NCT01743469|560004444|FG002|Active Treatment Phase|Missing|0|||
155155025|NCT01743469|560004445|FG003|Active Treatment Phase|Missing|0|||
155155026|NCT01743469|560004442|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
155155027|NCT01743469|560004443|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
155155028|NCT01743469|560004444|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
155155029|NCT01743469|560004445|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
155155030|NCT01743469|560004442|FG000|Follow-up Period - Post-Treatment|Death|43|||
155155031|NCT01743469|560004443|FG001|Follow-up Period - Post-Treatment|Death|47|||
155155032|NCT01743469|560004444|FG002|Follow-up Period - Post-Treatment|Death|22|||
155155033|NCT01743469|560004445|FG003|Follow-up Period - Post-Treatment|Death|16|||
155155034|NCT01743469|560004442|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
155155035|NCT01743469|560004443|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
155284997|NCT00235495|560474465|FG000|Overall Study|Lost to Follow-up|11|||
155155036|NCT01743469|560004444|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
155155037|NCT01743469|560004445|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
155155038|NCT00317473|560004446|FG000|Overall Study|Withdrawal by Subject|2|||
155155039|NCT00317473|560004447|FG001|Overall Study|Withdrawal by Subject|1|||
155155040|NCT00317473|560004448|FG002|Overall Study|Withdrawal by Subject|2|||
155155041|NCT00317473|560004449|FG003|Overall Study|Withdrawal by Subject|1|||
155155042|NCT00317473|560004450|FG004|Overall Study|Withdrawal by Subject|3|||
155155043|NCT00317473|560004451|FG005|Overall Study|Withdrawal by Subject|1|||
155155044|NCT00317473|560004446|FG000|Overall Study|Relocation|1|||
155155045|NCT00317473|560004447|FG001|Overall Study|Relocation|0|||
155155046|NCT00317473|560004448|FG002|Overall Study|Relocation|1|||
155155047|NCT00317473|560004449|FG003|Overall Study|Relocation|1|||
155155048|NCT00317473|560004450|FG004|Overall Study|Relocation|5|||
155155049|NCT00317473|560004451|FG005|Overall Study|Relocation|2|||
155155050|NCT00317473|560004446|FG000|Overall Study|Death|1|||
155155051|NCT00317473|560004447|FG001|Overall Study|Death|0|||
155155052|NCT00317473|560004448|FG002|Overall Study|Death|0|||
155155053|NCT00317473|560004449|FG003|Overall Study|Death|0|||
155155054|NCT00317473|560004450|FG004|Overall Study|Death|0|||
155155055|NCT00317473|560004451|FG005|Overall Study|Death|0|||
155155056|NCT00317473|560004446|FG000|Overall Study|Other|0|||
155155057|NCT00317473|560004447|FG001|Overall Study|Other|2|||
155155058|NCT00317473|560004448|FG002|Overall Study|Other|0|||
155155059|NCT00317473|560004449|FG003|Overall Study|Other|0|||
155155060|NCT00317473|560004450|FG004|Overall Study|Other|0|||
155155061|NCT00317473|560004451|FG005|Overall Study|Other|0|||
155155062|NCT02285855|560004452|FG000|Overall Study|Withdrawal by Subject|2|||
155155063|NCT02285855|560004453|FG001|Overall Study|Withdrawal by Subject|1|||
155155064|NCT01451606|560004458|FG000|Overall Study|Withdrawal by Subject|4|||
155155065|NCT01451606|560004459|FG001|Overall Study|Withdrawal by Subject|3|||
155155066|NCT02718898|560004460|FG000|Blinded Treatment Period|Adverse Event|5|||
155155067|NCT02718898|560004461|FG001|Blinded Treatment Period|Adverse Event|1|||
155155068|NCT02718898|560004462|FG002|Blinded Treatment Period|Adverse Event|0|||
155155069|NCT02718898|560004463|FG003|Blinded Treatment Period|Adverse Event|0|||
155155070|NCT02718898|560004464|FG004|Blinded Treatment Period|Adverse Event|0|||
155284998|NCT00235495|560474466|FG001|Overall Study|Lost to Follow-up|13|||
155155071|NCT02718898|560004465|FG005|Blinded Treatment Period|Adverse Event|0|||
155155072|NCT02718898|560004466|FG006|Blinded Treatment Period|Adverse Event|0|||
155155073|NCT02718898|560004460|FG000|Blinded Treatment Period|Physician Decision|1|||
155155074|NCT02718898|560004461|FG001|Blinded Treatment Period|Physician Decision|0|||
155155075|NCT02718898|560004462|FG002|Blinded Treatment Period|Physician Decision|0|||
155155076|NCT02718898|560004463|FG003|Blinded Treatment Period|Physician Decision|0|||
155155077|NCT02718898|560004464|FG004|Blinded Treatment Period|Physician Decision|0|||
155155078|NCT02718898|560004465|FG005|Blinded Treatment Period|Physician Decision|0|||
155155079|NCT02718898|560004466|FG006|Blinded Treatment Period|Physician Decision|0|||
155155080|NCT02718898|560004460|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
155155081|NCT02718898|560004461|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
155155082|NCT02718898|560004462|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
155155083|NCT02718898|560004463|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
155155084|NCT02718898|560004464|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
155155085|NCT02718898|560004465|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
155155086|NCT02718898|560004466|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
155155087|NCT02718898|560004460|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
155155088|NCT02718898|560004461|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
155155089|NCT02718898|560004462|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
155155090|NCT02718898|560004463|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
155155091|NCT02718898|560004464|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
155155092|NCT02718898|560004465|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
155155093|NCT02718898|560004466|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
155155094|NCT02718898|560004460|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155155095|NCT02718898|560004461|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155155096|NCT02718898|560004462|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
155155097|NCT02718898|560004463|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
155155098|NCT02718898|560004464|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155155099|NCT02718898|560004465|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155155100|NCT02718898|560004466|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
155155101|NCT02718898|560004460|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155155102|NCT02718898|560004461|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155155103|NCT02718898|560004462|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155155104|NCT02718898|560004463|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
155155105|NCT02718898|560004464|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155155106|NCT02718898|560004465|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155155107|NCT02718898|560004466|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
155155108|NCT02718898|560004460|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155109|NCT02718898|560004461|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155110|NCT02718898|560004462|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
155155111|NCT02718898|560004463|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
155155112|NCT02718898|560004464|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155113|NCT02718898|560004465|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155114|NCT02718898|560004466|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155115|NCT02718898|560004460|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155155116|NCT02718898|560004461|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155155117|NCT02718898|560004462|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
155155118|NCT02718898|560004463|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
155155119|NCT02718898|560004464|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155155120|NCT02718898|560004465|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155155121|NCT02718898|560004466|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
155155122|NCT02718898|560004460|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155155123|NCT02718898|560004461|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155155124|NCT02718898|560004462|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155155125|NCT02718898|560004463|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
155155126|NCT02718898|560004464|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155155127|NCT02718898|560004465|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155155128|NCT02718898|560004466|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
155155129|NCT02718898|560004460|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155155130|NCT02718898|560004461|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155155131|NCT02718898|560004462|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155155132|NCT02718898|560004463|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
155155133|NCT02718898|560004464|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155155134|NCT02718898|560004465|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155155135|NCT02718898|560004466|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
155155136|NCT02718898|560004460|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
155155137|NCT02718898|560004461|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
155155138|NCT02718898|560004462|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
155155139|NCT02718898|560004463|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
155155140|NCT02718898|560004464|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
155155141|NCT02718898|560004465|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
155155142|NCT02718898|560004466|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
155155143|NCT02718898|560004460|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155155144|NCT02718898|560004461|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155155145|NCT02718898|560004462|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155155146|NCT02718898|560004463|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
155058578|NCT00408499|559650234|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
155058579|NCT00408499|559650235|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
155058580|NCT00408499|559650236|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
155058581|NCT00408499|559650237|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
155058582|NCT00408499|559650238|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
155155147|NCT02718898|560004464|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
155155148|NCT02718898|560004465|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
155155149|NCT02718898|560004466|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
155155150|NCT02718898|560004460|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155155151|NCT02718898|560004461|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155155152|NCT02718898|560004462|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155155153|NCT02718898|560004463|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155155154|NCT02718898|560004464|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
155155155|NCT02718898|560004465|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
155155156|NCT02718898|560004466|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
155155157|NCT02163538|560004469|FG000|Overall Study|Protocol Violation|1|||
155155158|NCT02163538|560004470|FG001|Overall Study|Protocol Violation|0|||
155155159|NCT02163538|560004469|FG000|Overall Study|Physician Decision|0|||
155155160|NCT02163538|560004470|FG001|Overall Study|Physician Decision|1|||
155155161|NCT04011540|560004471|FG000|Overall Study|Lost to Follow-up|9|||
155155162|NCT04011540|560004472|FG001|Overall Study|Lost to Follow-up|6|||
155155163|NCT01126749|560004474|FG000|Phase 1b|Other|0|||
155155164|NCT01126749|560004475|FG001|Phase 1b|Other|1|||
155155165|NCT01126749|560004476|FG002|Phase 1b|Other|0|||
155155166|NCT01126749|560004477|FG003|Phase 1b|Other|0|||
155155167|NCT01126749|560004474|FG000|Phase 1b|Withdrawal by Subject|0|||
155155168|NCT01126749|560004475|FG001|Phase 1b|Withdrawal by Subject|1|||
155155169|NCT01126749|560004476|FG002|Phase 1b|Withdrawal by Subject|0|||
155155170|NCT01126749|560004477|FG003|Phase 1b|Withdrawal by Subject|0|||
155155171|NCT01126749|560004474|FG000|Phase 1b|Death|3|||
154954341|NCT00727571|559259551|FG001|Overall Study|Ineligibility determined|1|||
154954342|NCT00727571|559259552|FG002|Overall Study|Ineligibility determined|1|||
155155172|NCT01126749|560004475|FG001|Phase 1b|Death|4|||
155058583|NCT00408499|559650234|FG000|Phase II- MTD Expansion|Adverse Event|0|||
155155173|NCT01126749|560004476|FG002|Phase 1b|Death|0|||
155155174|NCT01126749|560004477|FG003|Phase 1b|Death|0|||
155155175|NCT01126749|560004474|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
155155176|NCT01126749|560004475|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
155155177|NCT01126749|560004476|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
155155178|NCT01126749|560004477|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
155155179|NCT01126749|560004474|FG000|Phase 2|Study Termination by Sponsor|0|||
155155180|NCT01126749|560004475|FG001|Phase 2|Study Termination by Sponsor|0|||
155155181|NCT01126749|560004476|FG002|Phase 2|Study Termination by Sponsor|12|||
155155182|NCT01126749|560004477|FG003|Phase 2|Study Termination by Sponsor|6|||
155155183|NCT01126749|560004474|FG000|Phase 2|Other|0|||
155155184|NCT01126749|560004475|FG001|Phase 2|Other|0|||
155155185|NCT01126749|560004476|FG002|Phase 2|Other|4|||
155155186|NCT01126749|560004477|FG003|Phase 2|Other|2|||
155155187|NCT01126749|560004474|FG000|Phase 2|Withdrawal by Subject|0|||
155155188|NCT01126749|560004475|FG001|Phase 2|Withdrawal by Subject|0|||
155155189|NCT01126749|560004476|FG002|Phase 2|Withdrawal by Subject|0|||
155155190|NCT01126749|560004477|FG003|Phase 2|Withdrawal by Subject|2|||
155155191|NCT01126749|560004474|FG000|Phase 2|Lost to Follow-up|0|||
155155192|NCT01126749|560004475|FG001|Phase 2|Lost to Follow-up|0|||
155155193|NCT01126749|560004476|FG002|Phase 2|Lost to Follow-up|0|||
155155194|NCT01126749|560004477|FG003|Phase 2|Lost to Follow-up|1|||
155155195|NCT01126749|560004474|FG000|Phase 2|Death|0|||
155155196|NCT01126749|560004475|FG001|Phase 2|Death|0|||
155155197|NCT01126749|560004476|FG002|Phase 2|Death|22|||
155155198|NCT01126749|560004477|FG003|Phase 2|Death|22|||
155155199|NCT01126749|560004474|FG000|Phase 2|Adverse Event|0|||
155155200|NCT01126749|560004475|FG001|Phase 2|Adverse Event|0|||
155155201|NCT01126749|560004476|FG002|Phase 2|Adverse Event|0|||
155155202|NCT01126749|560004477|FG003|Phase 2|Adverse Event|1|||
155155203|NCT00976274|560004479|FG000|Overall Study|Lost to Follow-up|5|||
155155204|NCT00976274|560004480|FG001|Overall Study|Lost to Follow-up|5|||
155155205|NCT00976274|560004479|FG000|Overall Study|Withdrawal by Subject|1|||
155155206|NCT00976274|560004480|FG001|Overall Study|Withdrawal by Subject|1|||
155155207|NCT00976274|560004479|FG000|Overall Study|Physician Decision|1|||
155155208|NCT00976274|560004480|FG001|Overall Study|Physician Decision|2|||
155155209|NCT00627393|560004481|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
155155210|NCT00627393|560004482|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
155155211|NCT00627393|560004481|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
155155212|NCT00627393|560004482|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
155155213|NCT00627393|560004481|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
155155214|NCT00627393|560004482|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
155155215|NCT00627393|560004481|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
155155216|NCT00627393|560004482|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
155155217|NCT01614249|560004486|FG000|Overall Study|Lost to Follow-up|11|||
155155218|NCT01614249|560004487|FG001|Overall Study|Lost to Follow-up|23|||
155155219|NCT05498649|560004488|FG000|Overall Study|Lost to Follow-up|1|||
155155220|NCT03094416|560004500|FG000|Run-in|Screening failure|8|||
155155221|NCT03094416|560004500|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
155155222|NCT03094416|560004500|FG000|Run-in|Withdrawal by Subject|3|||
155155223|NCT03094416|560004500|FG000|Treatment Period|Withdrawal by Subject|2|||
155155224|NCT02158442|560004503|FG000|Overall Study|Withdrawal by Subject|1|||
155155225|NCT02158442|560004504|FG001|Overall Study|Withdrawal by Subject|0|||
155155226|NCT02158442|560004503|FG000|Overall Study|Perfusion staff not available|1|||
155155227|NCT02158442|560004504|FG001|Overall Study|Perfusion staff not available|0|||
155155228|NCT01668784|560004505|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
155155229|NCT01668784|560004506|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
155155230|NCT01668784|560004505|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
155155231|NCT01668784|560004506|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
155155232|NCT01668784|560004505|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
155155233|NCT01668784|560004506|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
155155234|NCT01668784|560004505|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
155155235|NCT01668784|560004506|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
155155236|NCT01668784|560004505|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
155155237|NCT01668784|560004506|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
155155238|NCT01668784|560004505|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
155155239|NCT01668784|560004506|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
155155240|NCT01668784|560004505|FG000|Treatment Period|Disease Progression|316|||
155155241|NCT01668784|560004506|FG001|Treatment Period|Disease Progression|293|||
155155242|NCT01668784|560004505|FG000|Treatment Period|Study Drug Toxicity|46|||
155155243|NCT01668784|560004506|FG001|Treatment Period|Study Drug Toxicity|53|||
155155244|NCT01668784|560004505|FG000|Treatment Period|Death|1|||
155155245|NCT01668784|560004506|FG001|Treatment Period|Death|1|||
155155246|NCT01668784|560004505|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
155155247|NCT01668784|560004506|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
155155248|NCT01668784|560004505|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
155155249|NCT01668784|560004506|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
155155250|NCT01668784|560004505|FG000|Treatment Period|Withdrawal by Subject|5|||
155155251|NCT01668784|560004506|FG001|Treatment Period|Withdrawal by Subject|3|||
155155252|NCT01668784|560004505|FG000|Treatment Period|Maximal Clinical Benefit|3|||
155155253|NCT01668784|560004506|FG001|Treatment Period|Maximal Clinical Benefit|3|||
155155254|NCT01668784|560004505|FG000|Treatment Period|Other|2|||
155155255|NCT01668784|560004506|FG001|Treatment Period|Other|8|||
155155256|NCT01668784|560004505|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
155155257|NCT01668784|560004506|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
155155258|NCT02761330|560004507|FG000|Treatment Week 1|Withdrawal by Subject|0|||
155155259|NCT02761330|560004508|FG001|Treatment Week 1|Withdrawal by Subject|0|||
155155260|NCT02761330|560004509|FG002|Treatment Week 1|Withdrawal by Subject|0|||
155155261|NCT02761330|560004510|FG003|Treatment Week 1|Withdrawal by Subject|1|||
155155262|NCT02761330|560004511|FG004|Treatment Week 1|Withdrawal by Subject|0|||
155155263|NCT02761330|560004512|FG005|Treatment Week 1|Withdrawal by Subject|1|||
155155264|NCT05386329|560004513|FG000|Overall Study|Lost to Follow-up|3|||
155155265|NCT02657889|560004518|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
155155266|NCT02657889|560004519|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
155155267|NCT02657889|560004520|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
155155268|NCT02657889|560004521|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
155155269|NCT02657889|560004518|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
155155270|NCT02657889|560004519|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
154954343|NCT00727571|559259553|FG003|Overall Study|Ineligibility determined|0|||
154954344|NCT00727571|559259550|FG000|Overall Study|Death|0|||
154954345|NCT00727571|559259551|FG001|Overall Study|Death|19|||
154954346|NCT00727571|559259552|FG002|Overall Study|Death|5|||
154954347|NCT00727571|559259553|FG003|Overall Study|Death|1|||
154954348|NCT00727571|559259550|FG000|Overall Study|Physician Decision|0|||
154954349|NCT00727571|559259551|FG001|Overall Study|Physician Decision|5|||
154954350|NCT00727571|559259552|FG002|Overall Study|Physician Decision|0|||
154954351|NCT00727571|559259553|FG003|Overall Study|Physician Decision|0|||
154954352|NCT00727571|559259550|FG000|Overall Study|Withdrawal by Subject|0|||
154954353|NCT00727571|559259551|FG001|Overall Study|Withdrawal by Subject|10|||
154954354|NCT00727571|559259552|FG002|Overall Study|Withdrawal by Subject|11|||
154954355|NCT00727571|559259553|FG003|Overall Study|Withdrawal by Subject|0|||
154954356|NCT00727571|559259550|FG000|Overall Study|Subject Non Compliance|0|||
154954357|NCT00727571|559259551|FG001|Overall Study|Subject Non Compliance|6|||
154954358|NCT00727571|559259552|FG002|Overall Study|Subject Non Compliance|0|||
154954359|NCT00727571|559259553|FG003|Overall Study|Subject Non Compliance|4|||
154954360|NCT00727571|559259550|FG000|Overall Study|Dismissed from nursing home|0|||
154954361|NCT00727571|559259551|FG001|Overall Study|Dismissed from nursing home|9|||
154954362|NCT00727571|559259552|FG002|Overall Study|Dismissed from nursing home|5|||
154954363|NCT00727571|559259553|FG003|Overall Study|Dismissed from nursing home|0|||
154954364|NCT00727571|559259550|FG000|Overall Study|Hospitalization|0|||
154954365|NCT00727571|559259551|FG001|Overall Study|Hospitalization|1|||
154954366|NCT00727571|559259552|FG002|Overall Study|Hospitalization|0|||
154954367|NCT00727571|559259553|FG003|Overall Study|Hospitalization|1|||
154954368|NCT00727571|559259550|FG000|Overall Study|AE not leading to hospitalization|0|||
154954369|NCT00727571|559259551|FG001|Overall Study|AE not leading to hospitalization|0|||
154954370|NCT00727571|559259552|FG002|Overall Study|AE not leading to hospitalization|2|||
154954371|NCT00727571|559259553|FG003|Overall Study|AE not leading to hospitalization|0|||
155058584|NCT00408499|559650235|FG001|Phase II- MTD Expansion|Adverse Event|0|||
155058585|NCT00408499|559650236|FG002|Phase II- MTD Expansion|Adverse Event|0|||
155284999|NCT00235495|560474465|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
155155271|NCT02657889|560004520|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
154954372|NCT00727571|559259550|FG000|Overall Study|Other|0|||
154954373|NCT00727571|559259551|FG001|Overall Study|Other|4|||
155155272|NCT02657889|560004521|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
154954374|NCT00727571|559259552|FG002|Overall Study|Other|6|||
155058586|NCT00408499|559650237|FG003|Phase II- MTD Expansion|Adverse Event|0|||
155058587|NCT00408499|559650238|FG004|Phase II- MTD Expansion|Adverse Event|9|||
155058588|NCT00408499|559650234|FG000|Phase II- MTD Expansion|Death|0|||
155058589|NCT00408499|559650235|FG001|Phase II- MTD Expansion|Death|0|||
155058590|NCT00408499|559650236|FG002|Phase II- MTD Expansion|Death|0|||
155058591|NCT00408499|559650237|FG003|Phase II- MTD Expansion|Death|0|||
155058592|NCT00408499|559650238|FG004|Phase II- MTD Expansion|Death|2|||
155058593|NCT00408499|559650234|FG000|Phase II- MTD Expansion|Physician Decision|0|||
155058594|NCT00408499|559650235|FG001|Phase II- MTD Expansion|Physician Decision|0|||
155058595|NCT00408499|559650236|FG002|Phase II- MTD Expansion|Physician Decision|0|||
155058596|NCT00408499|559650237|FG003|Phase II- MTD Expansion|Physician Decision|0|||
155058597|NCT00408499|559650238|FG004|Phase II- MTD Expansion|Physician Decision|1|||
155058598|NCT00408499|559650234|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155058599|NCT00408499|559650235|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155058600|NCT00408499|559650236|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155058601|NCT00408499|559650237|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
155058602|NCT00408499|559650238|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
155058603|NCT00408499|559650234|FG000|Phase II- MTD Expansion|treatment delay|0|||
155058604|NCT00408499|559650235|FG001|Phase II- MTD Expansion|treatment delay|0|||
155058605|NCT00408499|559650236|FG002|Phase II- MTD Expansion|treatment delay|0|||
155058606|NCT00408499|559650237|FG003|Phase II- MTD Expansion|treatment delay|0|||
155058607|NCT00408499|559650238|FG004|Phase II- MTD Expansion|treatment delay|3|||
155058608|NCT01586195|559650240|FG000|Overall Study|Death|11|||
155058609|NCT01586195|559650240|FG000|Overall Study|Withdrawal of Consent|5|||
155155273|NCT02657889|560004518|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
155155274|NCT02657889|560004519|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
154954375|NCT00727571|559259553|FG003|Overall Study|Other|0|||
154954376|NCT02189941|559259554|FG000|Overall Study|Non-compliance|0|||
154954377|NCT02189941|559259555|FG001|Overall Study|Non-compliance|0|||
154954378|NCT02189941|559259556|FG002|Overall Study|Non-compliance|1|||
154954379|NCT00358449|559259557|FG000|Overall Study|Adverse Event|1|||
154954380|NCT00358449|559259558|FG001|Overall Study|Adverse Event|0|||
154954381|NCT00358449|559259559|FG002|Overall Study|Adverse Event|1|||
154954382|NCT00358449|559259557|FG000|Overall Study|Lost to Follow-up|1|||
155285000|NCT00235495|560474466|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
155285001|NCT02320253|560474467|FG000|Overall Study|Withdrawal by Subject|3|||
155285002|NCT02320253|560474468|FG001|Overall Study|Withdrawal by Subject|0|||
155285003|NCT02320253|560474469|FG002|Overall Study|Withdrawal by Subject|0|||
155285004|NCT02320253|560474467|FG000|Overall Study|Lost to Follow-up|2|||
155285005|NCT02320253|560474468|FG001|Overall Study|Lost to Follow-up|2|||
155058610|NCT01586195|559650240|FG000|Overall Study|Started new anti-melanoma therapy|1|||
155058611|NCT01586195|559650240|FG000|Overall Study|Reason not specified|9|||
155058612|NCT00997334|559650241|FG000|Overall Study|still on therapy|12|||
154954383|NCT00358449|559259558|FG001|Overall Study|Lost to Follow-up|0|||
154954384|NCT00358449|559259559|FG002|Overall Study|Lost to Follow-up|0|||
154954385|NCT00358449|559259557|FG000|Overall Study|Withdrawal by Subject|2|||
154954386|NCT00358449|559259558|FG001|Overall Study|Withdrawal by Subject|0|||
155285006|NCT02320253|560474469|FG002|Overall Study|Lost to Follow-up|1|||
155285007|NCT02320253|560474467|FG000|Overall Study|Death|1|||
155285008|NCT02320253|560474468|FG001|Overall Study|Death|0|||
155285009|NCT02320253|560474469|FG002|Overall Study|Death|1|||
155285010|NCT05780047|560474471|FG000|Overall Study|Did not submit baseline urine test kit|226|||
155285011|NCT05780047|560474471|FG000|Overall Study|Lost to Follow-up|34|||
155285012|NCT05780047|560474471|FG000|Overall Study|Did not submit second urine test kit|124|||
155285013|NCT03115346|560474480|FG000|Overall Study|Did not have AAA surgery|28|||
155285014|NCT03115346|560474481|FG001|Overall Study|Did not have AAA surgery|15|||
155285015|NCT03115346|560474480|FG000|Overall Study|Death|3|||
155285016|NCT03115346|560474481|FG001|Overall Study|Death|1|||
155285017|NCT03115346|560474480|FG000|Overall Study|Withdrawal by Subject|0|||
155285018|NCT03115346|560474481|FG001|Overall Study|Withdrawal by Subject|3|||
155285019|NCT03115346|560474480|FG000|Overall Study|Lost to Follow-up|0|||
155285020|NCT03115346|560474481|FG001|Overall Study|Lost to Follow-up|3|||
155285021|NCT01737268|560474483|FG000|Overall Study|Adverse Event|6|||
155285022|NCT01737268|560474483|FG000|Overall Study|Worsening of Target Disease|2|||
155285023|NCT01737268|560474483|FG000|Overall Study|In consideration of the patient's safety|1|||
155285024|NCT02753530|560474484|FG000|Overall Study|Adverse Event|7|||
155285025|NCT02753530|560474485|FG001|Overall Study|Adverse Event|1|||
155285026|NCT02753530|560474484|FG000|Overall Study|Death|0|||
155285027|NCT02753530|560474485|FG001|Overall Study|Death|1|||
155285028|NCT02753530|560474484|FG000|Overall Study|Physician Decision|0|||
155285029|NCT02753530|560474485|FG001|Overall Study|Physician Decision|1|||
155285030|NCT02753530|560474484|FG000|Overall Study|Protocol Violation|1|||
155285031|NCT02753530|560474485|FG001|Overall Study|Protocol Violation|0|||
155285032|NCT02753530|560474484|FG000|Overall Study|Withdrawal by Subject|4|||
155285033|NCT02753530|560474485|FG001|Overall Study|Withdrawal by Subject|3|||
155285034|NCT01221181|560474486|FG000|Overall Study|Lost to Follow-up|1|||
155285035|NCT03369951|560474487|FG000|Overall Study|Withdrawal by Subject|3|||
155285036|NCT03369951|560474487|FG000|Overall Study|Death|1|||
155285037|NCT03369951|560474487|FG000|Overall Study|Lost to Follow-up|1|||
155285038|NCT03369951|560474487|FG000|Overall Study|Protocol Violation|1|||
155285039|NCT04580407|560474493|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
155285040|NCT04949399|560474494|FG000|Overall Study|Lost to Follow-up|11|||
155285041|NCT04949399|560474495|FG001|Overall Study|Lost to Follow-up|6|||
155285042|NCT04949399|560474494|FG000|Overall Study|Withdrawal by Subject|2|||
155285043|NCT04949399|560474495|FG001|Overall Study|Withdrawal by Subject|3|||
155285044|NCT00670540|560474496|FG000|Overall Study|ineligible|17|||
155285045|NCT00670540|560474496|FG000|Overall Study|not living in France|348|||
155285046|NCT00670540|560474496|FG000|Overall Study|refused to participate|189|||
155285047|NCT00670540|560474496|FG000|Overall Study|controls randomised for no follow up|2770|||
155285048|NCT00670540|560474496|FG000|Overall Study|missing information inclusion criteria|1|||
155285049|NCT01866917|560474497|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
155285050|NCT01866917|560474498|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
155285051|NCT01311648|560476235|FG000|Main Study|Protocol Violation|0|||
155285052|NCT01311648|560476236|FG001|Main Study|Protocol Violation|1|||
155285053|NCT01311648|560476235|FG000|Main Study|Adverse Event|0|||
155285054|NCT01311648|560476236|FG001|Main Study|Adverse Event|1|||
155285055|NCT01311648|560476235|FG000|Main Study|Inhibitor management|0|||
155285056|NCT01311648|560476236|FG001|Main Study|Inhibitor management|17|||
155285057|NCT01311648|560476235|FG000|Main Study|Withdrawal by Subject|0|||
155285058|NCT01311648|560476236|FG001|Main Study|Withdrawal by Subject|2|||
155285059|NCT01311648|560476235|FG000|Extension Study|Physician Decision|0|||
155285060|NCT01311648|560476236|FG001|Extension Study|Physician Decision|1|||
155285061|NCT01311648|560476235|FG000|Extension Study|ITI therapy with marketed product|0|||
155285062|NCT01311648|560476236|FG001|Extension Study|ITI therapy with marketed product|1|||
155285063|NCT01311648|560476235|FG000|Extension Study|Incorrect visit planning|0|||
155285064|NCT01311648|560476236|FG001|Extension Study|Incorrect visit planning|1|||
155285065|NCT01311648|560476235|FG000|Extension Study|Family's decision|0|||
155285066|NCT01311648|560476236|FG001|Extension Study|Family's decision|1|||
155285067|NCT01311648|560476235|FG000|Extension Study|Failure of ITI therapy|0|||
155285068|NCT01311648|560476236|FG001|Extension Study|Failure of ITI therapy|3|||
155285069|NCT01311648|560476235|FG000|Extension Study|Long travel|0|||
155285070|NCT01311648|560476236|FG001|Extension Study|Long travel|1|||
155285071|NCT01311648|560476235|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
155285072|NCT01311648|560476236|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
155285073|NCT01311648|560476235|FG000|Extension Study|Withdrawal by Subject|0|||
155285074|NCT01311648|560476236|FG001|Extension Study|Withdrawal by Subject|1|||
155285075|NCT01311648|560476235|FG000|Extension Study|Inhibitor management|0|||
155285076|NCT01311648|560476236|FG001|Extension Study|Inhibitor management|2|||
155285077|NCT01645111|560476237|FG000|Overall Study|Did not require Clevidipine|15|||
155285078|NCT05526911|560476238|FG000|Overall Study|Adverse Event|2|||
155285079|NCT05025449|560476239|FG000|Overall Study|Withdrawal by Subject|1|||
155285080|NCT05025449|560476239|FG000|Overall Study|Patient emergently taken to operating room|1|||
155285081|NCT00762463|560476241|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
155155275|NCT02657889|560004520|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
155285082|NCT00762463|560476242|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
155058613|NCT00997334|559650241|FG000|Overall Study|Adverse Event|3|||
155058614|NCT00997334|559650241|FG000|Overall Study|Patient non-compliance|1|||
155058615|NCT00997334|559650241|FG000|Overall Study|Withdrawal by Subject|3|||
155058616|NCT00997334|559650241|FG000|Overall Study|Death|2|||
155058617|NCT00997334|559650241|FG000|Overall Study|Urgent Palliative Care|2|||
155058618|NCT00997334|559650241|FG000|Overall Study|No lesion amenable|1|||
155058619|NCT00997334|559650241|FG000|Overall Study|Ineligible|1|||
155058620|NCT01855958|559650242|FG000|Overall Study|Withdrawal by Subject|1|||
155058621|NCT01855958|559650243|FG001|Overall Study|Withdrawal by Subject|0|||
155058622|NCT02351934|559650247|FG000|Allocation|POD weight<pre-op weight|3|||
155058623|NCT02351934|559650248|FG001|Allocation|POD weight<pre-op weight|0|||
155058624|NCT02351934|559650247|FG000|Allocation|Hypotension preventing administration|2|||
155058625|NCT02351934|559650248|FG001|Allocation|Hypotension preventing administration|0|||
155058626|NCT02351934|559650247|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
155058627|NCT02351934|559650248|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
155058628|NCT02351934|559650247|FG000|Follow-Up|POD weight<pre-op weight|3|||
155058629|NCT02351934|559650248|FG001|Follow-Up|POD weight<pre-op weight|0|||
155058630|NCT02351934|559650247|FG000|Follow-Up|Acute Kidney Injury|1|||
155058631|NCT02351934|559650248|FG001|Follow-Up|Acute Kidney Injury|0|||
155058632|NCT02351934|559650247|FG000|Follow-Up|Early dismissal|3|||
155058633|NCT02351934|559650248|FG001|Follow-Up|Early dismissal|0|||
155058634|NCT02351934|559650247|FG000|Follow-Up|Hypotension|3|||
155058635|NCT02351934|559650248|FG001|Follow-Up|Hypotension|0|||
155058636|NCT02351934|559650247|FG000|Follow-Up|No documentation|2|||
155058637|NCT02351934|559650248|FG001|Follow-Up|No documentation|0|||
155058638|NCT02351934|559650247|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
155058639|NCT02351934|559650248|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
155058640|NCT02351934|559650247|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
155058641|NCT02351934|559650248|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
155058642|NCT02683109|559650249|FG000|Overall Study|Adverse Event|1|||
155058643|NCT02683109|559650250|FG001|Overall Study|Adverse Event|0|||
155058644|NCT02669849|559650251|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155058645|NCT02669849|559650252|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
155058646|NCT02669849|559650253|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
155058647|NCT02669849|559650251|FG000|Overall Study|Lost to Follow-up|1|||
155058648|NCT02669849|559650252|FG001|Overall Study|Lost to Follow-up|0|||
155058649|NCT02669849|559650253|FG002|Overall Study|Lost to Follow-up|3|||
155058650|NCT02669849|559650251|FG000|Overall Study|Death|1|||
155058651|NCT02669849|559650252|FG001|Overall Study|Death|1|||
155058652|NCT02669849|559650253|FG002|Overall Study|Death|2|||
155058653|NCT02669849|559650251|FG000|Overall Study|Study terminated by sponsor|16|||
155058654|NCT02669849|559650252|FG001|Overall Study|Study terminated by sponsor|1|||
155058655|NCT02669849|559650253|FG002|Overall Study|Study terminated by sponsor|14|||
155058656|NCT02669849|559650251|FG000|Overall Study|Other|0|||
155058657|NCT02669849|559650252|FG001|Overall Study|Other|0|||
155058658|NCT02669849|559650253|FG002|Overall Study|Other|2|||
155058659|NCT03408899|559650254|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
155058660|NCT00606008|559650255|FG000|Overall Study|Adverse Event|1|||
155058661|NCT00606008|559650255|FG000|Overall Study|Withdrawal by Subject|4|||
155058662|NCT03499795|559650256|FG000|Overall Study|Adverse Event|1|||
155058663|NCT03499795|559650256|FG000|Overall Study|Lost to Follow-up|1|||
155058664|NCT03736967|559650257|FG000|Overall Study|Withdrawal by Subject|26|||
155058665|NCT03736967|559650258|FG001|Overall Study|Withdrawal by Subject|25|||
155058666|NCT03736967|559650259|FG002|Overall Study|Withdrawal by Subject|23|||
155058667|NCT03736967|559650260|FG003|Overall Study|Withdrawal by Subject|26|||
155058668|NCT03736967|559650257|FG000|Overall Study|Lost to Follow-up|3|||
155058669|NCT03736967|559650258|FG001|Overall Study|Lost to Follow-up|2|||
155058670|NCT03736967|559650259|FG002|Overall Study|Lost to Follow-up|1|||
155058671|NCT03736967|559650260|FG003|Overall Study|Lost to Follow-up|1|||
155058672|NCT03736967|559650257|FG000|Overall Study|Physician Decision|1|||
155058673|NCT03736967|559650258|FG001|Overall Study|Physician Decision|0|||
155058674|NCT03736967|559650259|FG002|Overall Study|Physician Decision|0|||
155058675|NCT03736967|559650260|FG003|Overall Study|Physician Decision|1|||
155058676|NCT03736967|559650257|FG000|Overall Study|Adverse Event|0|||
155058677|NCT03736967|559650258|FG001|Overall Study|Adverse Event|1|||
155058678|NCT03736967|559650259|FG002|Overall Study|Adverse Event|0|||
155058679|NCT03736967|559650260|FG003|Overall Study|Adverse Event|1|||
155058680|NCT03736967|559650257|FG000|Overall Study|Death|0|||
155058681|NCT03736967|559650258|FG001|Overall Study|Death|0|||
155058682|NCT03736967|559650259|FG002|Overall Study|Death|0|||
155058683|NCT03736967|559650260|FG003|Overall Study|Death|1|||
155058684|NCT03736967|559650257|FG000|Overall Study|Randomized but never treated|1|||
155058685|NCT03736967|559650258|FG001|Overall Study|Randomized but never treated|0|||
155058686|NCT03736967|559650259|FG002|Overall Study|Randomized but never treated|0|||
155058687|NCT03736967|559650260|FG003|Overall Study|Randomized but never treated|0|||
155058688|NCT02665117|559650265|FG000|Overall Study|Physician Decision|1|||
155058689|NCT02665117|559650266|FG001|Overall Study|Physician Decision|0|||
155058690|NCT02251275|559650267|FG000|Overall Study|Adverse Event|23|||
155058691|NCT02251275|559650268|FG001|Overall Study|Adverse Event|60|||
155058692|NCT02251275|559650269|FG002|Overall Study|Adverse Event|28|||
155058693|NCT02251275|559650270|FG003|Overall Study|Adverse Event|0|||
155058694|NCT02251275|559650271|FG004|Overall Study|Adverse Event|0|||
155058695|NCT02251275|559650267|FG000|Overall Study|Lost to Follow-up|5|||
155058696|NCT02251275|559650268|FG001|Overall Study|Lost to Follow-up|6|||
155058697|NCT02251275|559650269|FG002|Overall Study|Lost to Follow-up|4|||
155058698|NCT02251275|559650270|FG003|Overall Study|Lost to Follow-up|0|||
155058699|NCT02251275|559650271|FG004|Overall Study|Lost to Follow-up|0|||
155058700|NCT02251275|559650267|FG000|Overall Study|Physician Decision|19|||
155058701|NCT02251275|559650268|FG001|Overall Study|Physician Decision|30|||
155058702|NCT02251275|559650269|FG002|Overall Study|Physician Decision|26|||
155058703|NCT02251275|559650270|FG003|Overall Study|Physician Decision|0|||
155058704|NCT02251275|559650271|FG004|Overall Study|Physician Decision|1|||
155058705|NCT02251275|559650267|FG000|Overall Study|Protocol Deviation|0|||
155058706|NCT02251275|559650268|FG001|Overall Study|Protocol Deviation|0|||
155058707|NCT02251275|559650269|FG002|Overall Study|Protocol Deviation|1|||
155058708|NCT02251275|559650270|FG003|Overall Study|Protocol Deviation|0|||
155058709|NCT02251275|559650271|FG004|Overall Study|Protocol Deviation|0|||
155058710|NCT02251275|559650267|FG000|Overall Study|Withdrawal by Subject|25|||
155058711|NCT02251275|559650268|FG001|Overall Study|Withdrawal by Subject|51|||
155058712|NCT02251275|559650269|FG002|Overall Study|Withdrawal by Subject|35|||
155058713|NCT02251275|559650270|FG003|Overall Study|Withdrawal by Subject|1|||
155058714|NCT02251275|559650271|FG004|Overall Study|Withdrawal by Subject|0|||
155058715|NCT01569022|559650274|FG000|First Intervention|Lost to Follow-up|2|||
155058716|NCT01569022|559650275|FG001|First Intervention|Lost to Follow-up|1|||
155058717|NCT01569022|559650274|FG000|Second Intervention|Lost to Follow-up|2|||
154954387|NCT00358449|559259559|FG002|Overall Study|Withdrawal by Subject|0|||
154954388|NCT00358449|559259557|FG000|Overall Study|Lack of Efficacy|0|||
154954389|NCT00358449|559259558|FG001|Overall Study|Lack of Efficacy|1|||
154954390|NCT00358449|559259559|FG002|Overall Study|Lack of Efficacy|0|||
154954391|NCT00358449|559259557|FG000|Overall Study|Steriod Inhaler was Increased|0|||
154954392|NCT00358449|559259558|FG001|Overall Study|Steriod Inhaler was Increased|0|||
154954393|NCT00358449|559259559|FG002|Overall Study|Steriod Inhaler was Increased|1|||
154954394|NCT01804270|559259560|FG000|Overall Study|Withdrawal by Subject|1|||
154954395|NCT01804270|559259561|FG001|Overall Study|Withdrawal by Subject|1|||
154954396|NCT02188303|559259562|FG000|Overall Study|Adverse Event|0|||
154954397|NCT02188303|559259563|FG001|Overall Study|Adverse Event|0|||
154954398|NCT02188303|559259564|FG002|Overall Study|Adverse Event|0|||
154954399|NCT02188303|559259565|FG003|Overall Study|Adverse Event|0|||
154954400|NCT02188303|559259566|FG004|Overall Study|Adverse Event|0|||
154954401|NCT02188303|559259567|FG005|Overall Study|Adverse Event|2|||
154954402|NCT02188303|559259568|FG006|Overall Study|Adverse Event|0|||
154954403|NCT02188303|559259569|FG007|Overall Study|Adverse Event|2|||
154954404|NCT02188303|559259562|FG000|Overall Study|Dose Termination Criteria Met|0|||
154954405|NCT02188303|559259563|FG001|Overall Study|Dose Termination Criteria Met|0|||
154954406|NCT02188303|559259564|FG002|Overall Study|Dose Termination Criteria Met|0|||
154954407|NCT02188303|559259565|FG003|Overall Study|Dose Termination Criteria Met|0|||
154954408|NCT02188303|559259566|FG004|Overall Study|Dose Termination Criteria Met|0|||
154954409|NCT02188303|559259567|FG005|Overall Study|Dose Termination Criteria Met|0|||
154954410|NCT02188303|559259568|FG006|Overall Study|Dose Termination Criteria Met|2|||
154954411|NCT02188303|559259569|FG007|Overall Study|Dose Termination Criteria Met|4|||
154954412|NCT04206332|559259571|FG000|Part A|Lost to Follow-up|0|||
154954413|NCT04206332|559259572|FG001|Part A|Lost to Follow-up|1|||
154954414|NCT04206332|559259573|FG002|Part A|Lost to Follow-up|0|||
154954415|NCT04206332|559259574|FG003|Part A|Lost to Follow-up|0|||
155058718|NCT01569022|559650275|FG001|Second Intervention|Lost to Follow-up|2|||
155058719|NCT02111083|559650276|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
155155276|NCT02657889|560004521|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
154954416|NCT04206332|559259575|FG004|Part A|Lost to Follow-up|0|||
154954417|NCT04206332|559259576|FG005|Part A|Lost to Follow-up|0|||
154954418|NCT04206332|559259577|FG006|Part A|Lost to Follow-up|0|||
154954419|NCT04206332|559259578|FG007|Part A|Lost to Follow-up|0|||
155058720|NCT02111083|559650277|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
155058721|NCT02152007|559650278|FG000|Overall Study|Withdrawal by Subject|1|||
155058722|NCT02834975|559650283|FG000|Overall Study|Physician Decision|2|||
155058723|NCT02834975|559650283|FG000|Overall Study|Adverse Event|1|||
155058724|NCT02834975|559650283|FG000|Overall Study|Withdrawal by Subject|1|||
155058725|NCT02834975|559650283|FG000|Overall Study|Lack of Efficacy|1|||
155058726|NCT03482024|559650285|FG000|Overall Study|Physician Decision|1|||
155058727|NCT03482024|559650286|FG001|Overall Study|Physician Decision|0|||
155058728|NCT03482024|559650287|FG002|Overall Study|Physician Decision|0|||
155058729|NCT03482024|559650288|FG003|Overall Study|Physician Decision|0|||
155058730|NCT03482024|559650289|FG004|Overall Study|Physician Decision|0|||
155058731|NCT02497469|559650290|FG000|Overall Study|Randomized but not Treated|0|||
155058732|NCT02497469|559650291|FG001|Overall Study|Randomized but not Treated|2|||
155058733|NCT02497469|559650290|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
155058734|NCT02497469|559650291|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
155058735|NCT02497469|559650290|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
155058736|NCT02497469|559650291|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
155058737|NCT02497469|559650290|FG000|Overall Study|Significant Protocol Deviation|4|||
155058738|NCT02497469|559650291|FG001|Overall Study|Significant Protocol Deviation|5|||
155058739|NCT02497469|559650290|FG000|Overall Study|Lost to Follow-up|14|||
155058740|NCT02497469|559650291|FG001|Overall Study|Lost to Follow-up|4|||
155058741|NCT02497469|559650290|FG000|Overall Study|Voluntary Withdrawal|39|||
155058742|NCT02497469|559650291|FG001|Overall Study|Voluntary Withdrawal|41|||
155058743|NCT02497469|559650290|FG000|Overall Study|Pregnancy|1|||
155058744|NCT02497469|559650291|FG001|Overall Study|Pregnancy|1|||
155058745|NCT02497469|559650290|FG000|Overall Study|Lack of Efficacy|86|||
155058746|NCT02497469|559650291|FG001|Overall Study|Lack of Efficacy|40|||
155058747|NCT02497469|559650290|FG000|Overall Study|Reason not Specified|6|||
155058748|NCT02497469|559650291|FG001|Overall Study|Reason not Specified|6|||
155058749|NCT03558516|559650292|FG000|Overall Study|Protocol Violation|2|||
155058750|NCT03558516|559650293|FG001|Overall Study|Protocol Violation|2|||
155058751|NCT00472420|559650294|FG000|Induction Treatment Period|Physician Decision|9|||
155058752|NCT00472420|559650294|FG000|Induction Treatment Period|Adverse Event|3|||
155058753|NCT00472420|559650294|FG000|Induction Treatment Period|Non-compliance|1|||
155058754|NCT00472420|559650294|FG000|Induction Treatment Period|Death|3|||
155058755|NCT00472420|559650294|FG000|Follow-up Period|Death|5|||
155058756|NCT00472420|559650294|FG000|Follow-up Period|Physician Decision|9|||
155058757|NCT00472420|559650294|FG000|Follow-up Period|Lost to Follow-up|2|||
155058758|NCT00472420|559650294|FG000|Follow-up Period|Protocol Violation|1|||
155058759|NCT00686972|559650296|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
155058760|NCT01901185|559650297|FG000|Overall Study|Withdrawal by Subject|2|||
155058761|NCT02065557|559650300|FG000|Induction Period|Withdrawal by Subject|2|||
155058762|NCT02065557|559650301|FG001|Induction Period|Withdrawal by Subject|1|||
155058763|NCT02065557|559650302|FG002|Induction Period|Withdrawal by Subject|0|||
155058764|NCT02065557|559650303|FG003|Induction Period|Withdrawal by Subject|0|||
155058765|NCT02065557|559650304|FG004|Induction Period|Withdrawal by Subject|0|||
155058766|NCT02065557|559650305|FG005|Induction Period|Withdrawal by Subject|0|||
155058767|NCT02065557|559650300|FG000|Induction Period|Lack of Efficacy|2|||
155058768|NCT02065557|559650301|FG001|Induction Period|Lack of Efficacy|1|||
155058769|NCT02065557|559650302|FG002|Induction Period|Lack of Efficacy|1|||
155058770|NCT02065557|559650303|FG003|Induction Period|Lack of Efficacy|0|||
155058771|NCT02065557|559650304|FG004|Induction Period|Lack of Efficacy|0|||
155058772|NCT02065557|559650305|FG005|Induction Period|Lack of Efficacy|0|||
155058773|NCT02065557|559650300|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
155058774|NCT02065557|559650301|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
155058775|NCT02065557|559650302|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
155058776|NCT02065557|559650303|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
155058777|NCT02065557|559650304|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
155058778|NCT02065557|559650305|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
155058779|NCT02065557|559650300|FG000|Induction Period|Non-Responder at Week 8|4|||
155058780|NCT02065557|559650301|FG001|Induction Period|Non-Responder at Week 8|4|||
155058781|NCT02065557|559650302|FG002|Induction Period|Non-Responder at Week 8|0|||
155058782|NCT02065557|559650303|FG003|Induction Period|Non-Responder at Week 8|0|||
155058783|NCT02065557|559650304|FG004|Induction Period|Non-Responder at Week 8|0|||
155058784|NCT02065557|559650305|FG005|Induction Period|Non-Responder at Week 8|0|||
155058785|NCT02065557|559650300|FG000|Induction Period|Adverse Event|1|||
155058786|NCT02065557|559650301|FG001|Induction Period|Adverse Event|1|||
155058787|NCT02065557|559650302|FG002|Induction Period|Adverse Event|0|||
155058788|NCT02065557|559650303|FG003|Induction Period|Adverse Event|0|||
155058789|NCT02065557|559650304|FG004|Induction Period|Adverse Event|0|||
155058790|NCT02065557|559650305|FG005|Induction Period|Adverse Event|0|||
155058791|NCT02065557|559650300|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155058792|NCT02065557|559650301|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155058793|NCT02065557|559650302|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155285083|NCT00762463|560476243|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
155285084|NCT00762463|560476244|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
155285085|NCT00762463|560476241|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
155285086|NCT00762463|560476242|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
155285087|NCT00762463|560476243|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
155285088|NCT00762463|560476244|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
155285089|NCT00762463|560476241|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
155285090|NCT00762463|560476242|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
155285091|NCT00762463|560476243|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
155285092|NCT00762463|560476244|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
155285093|NCT00762463|560476241|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
155285094|NCT00762463|560476242|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
155285095|NCT00762463|560476243|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
155285096|NCT00762463|560476244|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
155285097|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
155058794|NCT02065557|559650303|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
155058795|NCT02065557|559650304|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
155058796|NCT02065557|559650305|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
155285098|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
155285099|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
155285100|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
155155277|NCT02657889|560004518|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
155155278|NCT02657889|560004519|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
155155279|NCT02657889|560004520|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
155155280|NCT02657889|560004521|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
155155281|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
155285101|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
155285102|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
155155282|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
155155283|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
155155284|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
155155285|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
155155286|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
155155287|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
155155288|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
155155289|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
155155290|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
155155291|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
154954420|NCT04206332|559259579|FG008|Part A|Lost to Follow-up|0|||
154954421|NCT04206332|559259580|FG009|Part A|Lost to Follow-up|0|||
154954422|NCT04206332|559259581|FG010|Part A|Lost to Follow-up|0|||
154954423|NCT04206332|559259582|FG011|Part A|Lost to Follow-up|0|||
154954424|NCT04206332|559259583|FG012|Part A|Lost to Follow-up|0|||
154954425|NCT04206332|559259584|FG013|Part A|Lost to Follow-up|0|||
154954426|NCT04206332|559259585|FG014|Part A|Lost to Follow-up|0|||
154954427|NCT04206332|559259586|FG015|Part A|Lost to Follow-up|0|||
154954428|NCT04206332|559259587|FG016|Part A|Lost to Follow-up|0|||
154954429|NCT04206332|559259571|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954430|NCT04206332|559259572|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954431|NCT04206332|559259573|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954432|NCT04206332|559259574|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954433|NCT04206332|559259575|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954434|NCT04206332|559259576|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
154954435|NCT04206332|559259577|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954436|NCT04206332|559259578|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954437|NCT04206332|559259579|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954438|NCT04206332|559259580|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954439|NCT04206332|559259581|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954440|NCT04206332|559259582|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954441|NCT04206332|559259583|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954442|NCT04206332|559259584|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954443|NCT04206332|559259585|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954444|NCT04206332|559259586|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954445|NCT04206332|559259587|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
154954446|NCT04206332|559259571|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954447|NCT04206332|559259572|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954448|NCT04206332|559259573|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954449|NCT04206332|559259574|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954450|NCT04206332|559259575|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954451|NCT04206332|559259576|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954452|NCT04206332|559259577|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954453|NCT04206332|559259578|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
154954454|NCT04206332|559259579|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954455|NCT04206332|559259580|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954456|NCT04206332|559259581|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
154954457|NCT04206332|559259582|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155155292|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
154954458|NCT04206332|559259583|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954459|NCT04206332|559259584|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954460|NCT04206332|559259585|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954461|NCT04206332|559259586|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954462|NCT04206332|559259587|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954463|NCT04206332|559259571|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954464|NCT04206332|559259572|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954465|NCT04206332|559259573|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954466|NCT04206332|559259574|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954467|NCT04206332|559259575|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954468|NCT04206332|559259576|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954469|NCT04206332|559259577|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954470|NCT04206332|559259578|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954471|NCT04206332|559259579|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954472|NCT04206332|559259580|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954473|NCT04206332|559259581|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155285103|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
155285104|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
155285105|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
155285106|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
155285107|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
155285108|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
155285109|NCT00762463|560476241|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
155285110|NCT00762463|560476242|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
155285111|NCT00762463|560476243|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
155285112|NCT00762463|560476244|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
155285113|NCT00531479|560476245|FG000|Overall Study|Death|68|||
155285114|NCT00531479|560476246|FG001|Overall Study|Death|71|||
155285115|NCT00531479|560476245|FG000|Overall Study|Lost to Follow-up|0|||
155285116|NCT00531479|560476246|FG001|Overall Study|Lost to Follow-up|2|||
155285117|NCT00531479|560476245|FG000|Overall Study|Other|0|||
155285118|NCT00531479|560476246|FG001|Overall Study|Other|1|||
155285119|NCT00531479|560476245|FG000|Overall Study|Withdrawal by Subject|6|||
155285120|NCT00531479|560476246|FG001|Overall Study|Withdrawal by Subject|6|||
155285121|NCT00531479|560476245|FG000|Overall Study|Did not receive treatment|2|||
155285122|NCT00531479|560476246|FG001|Overall Study|Did not receive treatment|3|||
155285123|NCT01240356|560476247|FG000|Overall Study|Withdrawal by Subject|2|||
155285124|NCT01240356|560476248|FG001|Overall Study|Withdrawal by Subject|0|||
155285125|NCT01240356|560476247|FG000|Overall Study|MRI contraindication|1|||
155285126|NCT01240356|560476248|FG001|Overall Study|MRI contraindication|0|||
155285127|NCT01677936|560476249|FG000|Overall Study|Lost to Follow-up|4|||
155285128|NCT01677936|560476250|FG001|Overall Study|Lost to Follow-up|1|||
155285129|NCT01677936|560476249|FG000|Overall Study|Protocol Violation|3|||
155285130|NCT01677936|560476250|FG001|Overall Study|Protocol Violation|0|||
155285131|NCT01677936|560476249|FG000|Overall Study|Adverse Event|1|||
155285132|NCT01677936|560476250|FG001|Overall Study|Adverse Event|0|||
155285133|NCT01677936|560476249|FG000|Overall Study|Lost to Follow-up|1|||
155285134|NCT01677936|560476250|FG001|Overall Study|Lost to Follow-up|0|||
155285135|NCT01677936|560476249|FG000|Overall Study|Protocol Violation|0|||
155285136|NCT01677936|560476250|FG001|Overall Study|Protocol Violation|4|||
155285137|NCT03837028|560476254|FG000|Overall Study|Lost to Follow-up|4|||
155285138|NCT03837028|560476255|FG001|Overall Study|Lost to Follow-up|0|||
155285139|NCT03837028|560476256|FG002|Overall Study|Lost to Follow-up|2|||
155285140|NCT03837028|560476257|FG003|Overall Study|Lost to Follow-up|0|||
155285141|NCT03837028|560476254|FG000|Overall Study|Withdrawal by Subject|12|||
155285142|NCT03837028|560476255|FG001|Overall Study|Withdrawal by Subject|11|||
155285143|NCT03837028|560476256|FG002|Overall Study|Withdrawal by Subject|11|||
155285144|NCT03837028|560476257|FG003|Overall Study|Withdrawal by Subject|7|||
155285145|NCT00157014|560476258|FG000|Overall Study|Death|4|||
155285146|NCT00157014|560476259|FG001|Overall Study|Death|2|||
155285147|NCT00157014|560476260|FG002|Overall Study|Death|1|||
155058797|NCT02065557|559650300|FG000|Maintenance Period|Withdrawal by Subject|0|||
155058798|NCT02065557|559650301|FG001|Maintenance Period|Withdrawal by Subject|0|||
155058799|NCT02065557|559650302|FG002|Maintenance Period|Withdrawal by Subject|0|||
155058800|NCT02065557|559650303|FG003|Maintenance Period|Withdrawal by Subject|0|||
155058801|NCT02065557|559650304|FG004|Maintenance Period|Withdrawal by Subject|2|||
155058802|NCT02065557|559650305|FG005|Maintenance Period|Withdrawal by Subject|1|||
155058803|NCT02065557|559650300|FG000|Maintenance Period|Lack of Efficacy|0|||
155058804|NCT02065557|559650301|FG001|Maintenance Period|Lack of Efficacy|0|||
155058805|NCT02065557|559650302|FG002|Maintenance Period|Lack of Efficacy|0|||
155058806|NCT02065557|559650303|FG003|Maintenance Period|Lack of Efficacy|0|||
155058807|NCT02065557|559650304|FG004|Maintenance Period|Lack of Efficacy|5|||
155058808|NCT02065557|559650305|FG005|Maintenance Period|Lack of Efficacy|2|||
155058809|NCT02065557|559650300|FG000|Maintenance Period|Subject Non-Compliance|0|||
155058810|NCT02065557|559650301|FG001|Maintenance Period|Subject Non-Compliance|0|||
155058811|NCT02065557|559650302|FG002|Maintenance Period|Subject Non-Compliance|0|||
155058812|NCT02065557|559650303|FG003|Maintenance Period|Subject Non-Compliance|0|||
155058813|NCT02065557|559650304|FG004|Maintenance Period|Subject Non-Compliance|0|||
155058814|NCT02065557|559650305|FG005|Maintenance Period|Subject Non-Compliance|1|||
155058815|NCT01462942|559650308|FG000|Overall Study|Adverse Event|7|||
155058816|NCT01462942|559650309|FG001|Overall Study|Adverse Event|12|||
155058817|NCT01462942|559650310|FG002|Overall Study|Adverse Event|10|||
155058818|NCT01462942|559650311|FG003|Overall Study|Adverse Event|11|||
155285148|NCT00157014|560476261|FG003|Overall Study|Death|1|||
155285149|NCT00157014|560476258|FG000|Overall Study|Physician Decision|0|||
155058819|NCT01462942|559650312|FG004|Overall Study|Adverse Event|11|||
155285150|NCT00157014|560476259|FG001|Overall Study|Physician Decision|1|||
155285151|NCT00157014|560476260|FG002|Overall Study|Physician Decision|0|||
155285152|NCT00157014|560476261|FG003|Overall Study|Physician Decision|0|||
155285153|NCT00157014|560476258|FG000|Overall Study|Medications withdrawn on family request|0|||
155285154|NCT00157014|560476259|FG001|Overall Study|Medications withdrawn on family request|1|||
155285155|NCT00157014|560476260|FG002|Overall Study|Medications withdrawn on family request|0|||
155285156|NCT00157014|560476261|FG003|Overall Study|Medications withdrawn on family request|0|||
155285157|NCT00157014|560476258|FG000|Overall Study|Patient withdrawn by investigator|1|||
155285158|NCT00157014|560476259|FG001|Overall Study|Patient withdrawn by investigator|0|||
155285159|NCT00157014|560476260|FG002|Overall Study|Patient withdrawn by investigator|0|||
155285160|NCT00157014|560476261|FG003|Overall Study|Patient withdrawn by investigator|0|||
155285161|NCT00157014|560476258|FG000|Overall Study|Patient unable to return in nursing home|1|||
155285162|NCT00157014|560476259|FG001|Overall Study|Patient unable to return in nursing home|0|||
155285163|NCT00157014|560476260|FG002|Overall Study|Patient unable to return in nursing home|0|||
155285164|NCT00157014|560476261|FG003|Overall Study|Patient unable to return in nursing home|0|||
155285165|NCT00157014|560476258|FG000|Overall Study|Patient would not receive transplant|0|||
155285166|NCT00157014|560476259|FG001|Overall Study|Patient would not receive transplant|1|||
155285167|NCT00157014|560476260|FG002|Overall Study|Patient would not receive transplant|0|||
155285168|NCT00157014|560476261|FG003|Overall Study|Patient would not receive transplant|0|||
155285169|NCT00157014|560476258|FG000|Overall Study|Withdrawal by Subject|1|||
155285170|NCT00157014|560476259|FG001|Overall Study|Withdrawal by Subject|0|||
155285171|NCT00157014|560476260|FG002|Overall Study|Withdrawal by Subject|0|||
155285172|NCT00157014|560476261|FG003|Overall Study|Withdrawal by Subject|0|||
155285173|NCT01362491|560476262|FG000|Overall Study|Ineligible|1|||
155285174|NCT01362491|560476263|FG001|Overall Study|Ineligible|0|||
155285175|NCT01362491|560476264|FG002|Overall Study|Ineligible|0|||
155285176|NCT04867902|560476265|FG000|Overall Study|Lost to Follow-up|1|||
155285177|NCT04867902|560476265|FG000|Overall Study|Withdrawal by Subject|2|||
155285178|NCT04867902|560476265|FG000|Overall Study|Protocol Violation|1|||
155285179|NCT00088465|560476268|FG000|Overall Study|Withdrawal by Subject|290|||
155285180|NCT00088465|560476268|FG000|Overall Study|Adverse Event|77|||
155285181|NCT00088465|560476268|FG000|Overall Study|Lost to Follow-up|57|||
155285182|NCT00088465|560476268|FG000|Overall Study|Physician Decision|45|||
155285183|NCT00088465|560476268|FG000|Overall Study|Sponsor Decision|37|||
155285184|NCT00088465|560476268|FG000|Overall Study|Lack of Efficacy|27|||
155285185|NCT00088465|560476268|FG000|Overall Study|Protocol Violation|17|||
155285186|NCT00088465|560476268|FG000|Overall Study|Death|11|||
155285187|NCT00448864|560476269|FG000|Overall Study|Death|1|||
155285188|NCT00448864|560476270|FG001|Overall Study|Death|0|||
155058820|NCT01462942|559650308|FG000|Overall Study|Other, including COPD exacerbation|3|||
155058821|NCT01462942|559650309|FG001|Overall Study|Other, including COPD exacerbation|5|||
155058822|NCT01462942|559650310|FG002|Overall Study|Other, including COPD exacerbation|2|||
155058823|NCT01462942|559650311|FG003|Overall Study|Other, including COPD exacerbation|8|||
155058824|NCT01462942|559650312|FG004|Overall Study|Other, including COPD exacerbation|5|||
155058825|NCT01462942|559650308|FG000|Overall Study|Withdrawal by Subject|14|||
155058826|NCT01462942|559650309|FG001|Overall Study|Withdrawal by Subject|10|||
155058827|NCT01462942|559650310|FG002|Overall Study|Withdrawal by Subject|14|||
155058828|NCT01462942|559650311|FG003|Overall Study|Withdrawal by Subject|16|||
155058829|NCT01462942|559650312|FG004|Overall Study|Withdrawal by Subject|19|||
155058830|NCT01462942|559650308|FG000|Overall Study|Lack of Efficacy|6|||
155058831|NCT01462942|559650309|FG001|Overall Study|Lack of Efficacy|0|||
155058832|NCT01462942|559650310|FG002|Overall Study|Lack of Efficacy|4|||
155058833|NCT01462942|559650311|FG003|Overall Study|Lack of Efficacy|5|||
155058834|NCT01462942|559650312|FG004|Overall Study|Lack of Efficacy|3|||
155058835|NCT01462942|559650308|FG000|Overall Study|Lost to Follow-up|0|||
155058836|NCT01462942|559650309|FG001|Overall Study|Lost to Follow-up|1|||
155058837|NCT01462942|559650310|FG002|Overall Study|Lost to Follow-up|1|||
155058838|NCT01462942|559650311|FG003|Overall Study|Lost to Follow-up|1|||
155058839|NCT01462942|559650312|FG004|Overall Study|Lost to Follow-up|1|||
155058840|NCT01462942|559650308|FG000|Overall Study|Protocol Violation|4|||
155058841|NCT01462942|559650309|FG001|Overall Study|Protocol Violation|6|||
155058842|NCT01462942|559650310|FG002|Overall Study|Protocol Violation|9|||
155058843|NCT01462942|559650311|FG003|Overall Study|Protocol Violation|9|||
155058844|NCT01462942|559650312|FG004|Overall Study|Protocol Violation|6|||
155058845|NCT02737722|559650315|FG000|Overall Study|Physician Decision|0|||
155058846|NCT02737722|559650316|FG001|Overall Study|Physician Decision|0|||
155058847|NCT02737722|559650317|FG002|Overall Study|Physician Decision|1|||
155058848|NCT02737722|559650318|FG003|Overall Study|Physician Decision|0|||
155058849|NCT02662569|559650319|FG000|Overall Study|Withdrawal by Subject|6|||
155155293|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
155285189|NCT00448864|560476271|FG002|Overall Study|Death|0|||
155285190|NCT00448864|560476269|FG000|Overall Study|Lost to Follow-up|3|||
155285191|NCT00448864|560476270|FG001|Overall Study|Lost to Follow-up|1|||
155285192|NCT00448864|560476271|FG002|Overall Study|Lost to Follow-up|0|||
155285193|NCT00448864|560476269|FG000|Overall Study|Physician Decision|1|||
155285194|NCT00448864|560476270|FG001|Overall Study|Physician Decision|0|||
155058850|NCT02662569|559650320|FG001|Overall Study|Withdrawal by Subject|1|||
155058851|NCT02662569|559650321|FG002|Overall Study|Withdrawal by Subject|6|||
155058852|NCT02662569|559650322|FG003|Overall Study|Withdrawal by Subject|4|||
155155294|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
155155295|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
155155296|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
155155297|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
155155298|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
155155299|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
155155300|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
155155301|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
155155302|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
155155303|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
155155304|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
155155305|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
155155306|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
155155307|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
155155308|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
155155309|NCT02657889|560004518|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
155155310|NCT02657889|560004519|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
155285195|NCT00448864|560476271|FG002|Overall Study|Physician Decision|1|||
155058853|NCT02662569|559650319|FG000|Overall Study|Lost to Follow-up|1|||
155058854|NCT02662569|559650320|FG001|Overall Study|Lost to Follow-up|0|||
155058855|NCT02662569|559650321|FG002|Overall Study|Lost to Follow-up|0|||
155058856|NCT02662569|559650322|FG003|Overall Study|Lost to Follow-up|0|||
155058857|NCT03555149|559650330|FG000|Overall Study|Death|18|||
155058858|NCT03555149|559650331|FG001|Overall Study|Death|15|||
155058859|NCT03555149|559650332|FG002|Overall Study|Death|15|||
155058860|NCT03555149|559650333|FG003|Overall Study|Death|4|||
155058861|NCT03555149|559650334|FG004|Overall Study|Death|4|||
155058862|NCT03555149|559650335|FG005|Overall Study|Death|11|||
155058863|NCT03555149|559650336|FG006|Overall Study|Death|12|||
155058864|NCT03555149|559650337|FG007|Overall Study|Death|1|||
155058865|NCT03555149|559650330|FG000|Overall Study|Lost to Follow-up|1|||
155058866|NCT03555149|559650331|FG001|Overall Study|Lost to Follow-up|0|||
155058867|NCT03555149|559650332|FG002|Overall Study|Lost to Follow-up|0|||
155058868|NCT03555149|559650333|FG003|Overall Study|Lost to Follow-up|0|||
155058869|NCT03555149|559650334|FG004|Overall Study|Lost to Follow-up|0|||
155058870|NCT03555149|559650335|FG005|Overall Study|Lost to Follow-up|1|||
155058871|NCT03555149|559650336|FG006|Overall Study|Lost to Follow-up|0|||
155058872|NCT03555149|559650337|FG007|Overall Study|Lost to Follow-up|0|||
155058873|NCT03555149|559650330|FG000|Overall Study|Physician Decision|1|||
155058874|NCT03555149|559650331|FG001|Overall Study|Physician Decision|0|||
155058875|NCT03555149|559650332|FG002|Overall Study|Physician Decision|0|||
155058876|NCT03555149|559650333|FG003|Overall Study|Physician Decision|0|||
155058877|NCT03555149|559650334|FG004|Overall Study|Physician Decision|0|||
155058878|NCT03555149|559650335|FG005|Overall Study|Physician Decision|0|||
155058879|NCT03555149|559650336|FG006|Overall Study|Physician Decision|0|||
155058880|NCT03555149|559650337|FG007|Overall Study|Physician Decision|0|||
155058881|NCT03555149|559650330|FG000|Overall Study|Study Terminated By Sponsor|1|||
155058882|NCT03555149|559650331|FG001|Overall Study|Study Terminated By Sponsor|0|||
155058883|NCT03555149|559650332|FG002|Overall Study|Study Terminated By Sponsor|0|||
155058884|NCT03555149|559650333|FG003|Overall Study|Study Terminated By Sponsor|0|||
155058885|NCT03555149|559650334|FG004|Overall Study|Study Terminated By Sponsor|0|||
155058886|NCT03555149|559650335|FG005|Overall Study|Study Terminated By Sponsor|2|||
155058887|NCT03555149|559650336|FG006|Overall Study|Study Terminated By Sponsor|3|||
155058888|NCT03555149|559650337|FG007|Overall Study|Study Terminated By Sponsor|1|||
155058889|NCT03555149|559650330|FG000|Overall Study|Withdrawal by Subject|3|||
155058890|NCT03555149|559650331|FG001|Overall Study|Withdrawal by Subject|0|||
155058891|NCT03555149|559650332|FG002|Overall Study|Withdrawal by Subject|0|||
155058892|NCT03555149|559650333|FG003|Overall Study|Withdrawal by Subject|2|||
155058893|NCT03555149|559650334|FG004|Overall Study|Withdrawal by Subject|0|||
155285196|NCT00448864|560476269|FG000|Overall Study|Withdrawal by Subject|0|||
155058894|NCT03555149|559650335|FG005|Overall Study|Withdrawal by Subject|1|||
155058895|NCT03555149|559650336|FG006|Overall Study|Withdrawal by Subject|0|||
155058896|NCT03555149|559650337|FG007|Overall Study|Withdrawal by Subject|0|||
155058897|NCT02785939|559650351|FG000|Overall Study|Progression|25|||
155058898|NCT02785939|559650352|FG001|Overall Study|Progression|8|||
155058899|NCT02785939|559650351|FG000|Overall Study|Adverse Event|3|||
155058900|NCT02785939|559650352|FG001|Overall Study|Adverse Event|1|||
155058901|NCT02785939|559650351|FG000|Overall Study|Death|1|||
155058902|NCT02785939|559650352|FG001|Overall Study|Death|0|||
155058903|NCT02785939|559650351|FG000|Overall Study|Refusal|1|||
155058904|NCT02785939|559650352|FG001|Overall Study|Refusal|0|||
155058905|NCT02785939|559650351|FG000|Overall Study|Deteriorating health|1|||
155058906|NCT02785939|559650352|FG001|Overall Study|Deteriorating health|0|||
155058907|NCT02785939|559650351|FG000|Overall Study|Not protocol specified|0|||
155058908|NCT02785939|559650352|FG001|Overall Study|Not protocol specified|1|||
155058909|NCT01299584|559650356|FG000|Overall Study|Protocol Violation|9|||
155058910|NCT01118052|559650361|FG000|Overall Study|Never treated|2|||
155058911|NCT01677741|559650363|FG000|Overall Study|Death|0|||
155285197|NCT00448864|560476270|FG001|Overall Study|Withdrawal by Subject|2|||
155285198|NCT00448864|560476271|FG002|Overall Study|Withdrawal by Subject|0|||
155285199|NCT00448864|560476269|FG000|Overall Study|Protocol Violation|0|||
155285200|NCT00448864|560476270|FG001|Overall Study|Protocol Violation|2|||
155285201|NCT00448864|560476271|FG002|Overall Study|Protocol Violation|0|||
155285202|NCT01390857|560476272|FG000|Overall Study|Protocol Violation|2|||
155285203|NCT01390857|560476272|FG000|Overall Study|Lost to Follow-up|1|||
155285204|NCT01390857|560476272|FG000|Overall Study|No Visit after the First Visit|7|||
155285205|NCT01474538|560476274|FG000|Treatment Period 1|Death|1|||
155285206|NCT01474538|560476275|FG001|Treatment Period 1|Death|0|||
155285207|NCT01474538|560476274|FG000|Treatment Period 1|Physician Decision|1|||
155285208|NCT01474538|560476275|FG001|Treatment Period 1|Physician Decision|0|||
155285209|NCT01474538|560476274|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155285210|NCT01474538|560476275|FG001|Treatment Period 1|Withdrawal by Subject|3|||
155285211|NCT01474538|560476274|FG000|Treatment Period 1|Protocol Violation|0|||
155285212|NCT01474538|560476275|FG001|Treatment Period 1|Protocol Violation|1|||
155285213|NCT01474538|560476274|FG000|Treatment Period 2|Death|1|||
155285214|NCT01474538|560476275|FG001|Treatment Period 2|Death|0|||
155285215|NCT01474538|560476274|FG000|Treatment Period 2|Adverse Event|1|||
155285216|NCT01474538|560476275|FG001|Treatment Period 2|Adverse Event|1|||
155285217|NCT01474538|560476274|FG000|Treatment Period 2|Withdrawal by Subject|2|||
155285218|NCT01474538|560476275|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155285219|NCT01474538|560476274|FG000|Treatment Period 2|Sponsor decision|1|||
155285220|NCT01474538|560476275|FG001|Treatment Period 2|Sponsor decision|0|||
155285221|NCT01474538|560476274|FG000|Treatment Period 2|Physician Decision|0|||
155285222|NCT01474538|560476275|FG001|Treatment Period 2|Physician Decision|1|||
155285223|NCT01474538|560476274|FG000|Treatment Period 2|Protocol Violation|1|||
155285224|NCT01474538|560476275|FG001|Treatment Period 2|Protocol Violation|0|||
155285225|NCT02501629|560476276|FG000|Overall Study|Death|0|||
155285226|NCT02501629|560476277|FG001|Overall Study|Death|1|||
155285227|NCT02501629|560476276|FG000|Overall Study|Withdrawn from study by sponsor|1|||
155285228|NCT02501629|560476277|FG001|Overall Study|Withdrawn from study by sponsor|0|||
155285229|NCT02501629|560476276|FG000|Overall Study|Early termination by sponsor|1|||
155285230|NCT02501629|560476277|FG001|Overall Study|Early termination by sponsor|0|||
155285231|NCT02501629|560476276|FG000|Overall Study|Withdrawal by Subject|3|||
155285232|NCT02501629|560476277|FG001|Overall Study|Withdrawal by Subject|5|||
155285233|NCT02501629|560476276|FG000|Overall Study|Subject did not return to site|0|||
155285234|NCT02501629|560476277|FG001|Overall Study|Subject did not return to site|1|||
155285235|NCT03120676|560476280|FG000|Overall Study|Not treated|1|||
155285236|NCT00886613|560476285|FG000|Overall Study|Protocol deviation (Part B)|1|||
155285237|NCT00886613|560476286|FG001|Overall Study|Protocol deviation (Part B)|0|||
155285238|NCT00886613|560476287|FG002|Overall Study|Protocol deviation (Part B)|0|||
155285239|NCT00886613|560476285|FG000|Overall Study|Lost to follow-up (Part B)|1|||
155285240|NCT00886613|560476286|FG001|Overall Study|Lost to follow-up (Part B)|0|||
155285241|NCT00886613|560476287|FG002|Overall Study|Lost to follow-up (Part B)|1|||
155285242|NCT00886613|560476285|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
155285243|NCT00886613|560476286|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
155285244|NCT00886613|560476287|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
155285245|NCT01289119|560476291|FG000|Overall Study|Adverse Event|2|||
155285246|NCT01289119|560476292|FG001|Overall Study|Adverse Event|1|||
155285247|NCT01289119|560476293|FG002|Overall Study|Adverse Event|0|||
155285248|NCT01289119|560476294|FG003|Overall Study|Adverse Event|2|||
155285249|NCT01289119|560476295|FG004|Overall Study|Adverse Event|1|||
155285250|NCT01289119|560476296|FG005|Overall Study|Adverse Event|0|||
155285251|NCT01289119|560476291|FG000|Overall Study|Major Protocol Deviation|2|||
155285252|NCT01289119|560476292|FG001|Overall Study|Major Protocol Deviation|1|||
155285253|NCT01289119|560476293|FG002|Overall Study|Major Protocol Deviation|3|||
155285254|NCT01289119|560476294|FG003|Overall Study|Major Protocol Deviation|0|||
155285255|NCT01289119|560476295|FG004|Overall Study|Major Protocol Deviation|2|||
155285256|NCT01289119|560476296|FG005|Overall Study|Major Protocol Deviation|1|||
155285257|NCT01289119|560476291|FG000|Overall Study|Lost to Follow-up|0|||
155285258|NCT01289119|560476292|FG001|Overall Study|Lost to Follow-up|3|||
155058912|NCT01677741|559650364|FG001|Overall Study|Death|0|||
155058913|NCT01677741|559650365|FG002|Overall Study|Death|0|||
155285259|NCT01289119|560476293|FG002|Overall Study|Lost to Follow-up|0|||
155285260|NCT01289119|560476294|FG003|Overall Study|Lost to Follow-up|0|||
155285261|NCT01289119|560476295|FG004|Overall Study|Lost to Follow-up|0|||
155285262|NCT01289119|560476296|FG005|Overall Study|Lost to Follow-up|1|||
155285263|NCT01289119|560476291|FG000|Overall Study|Withdrawal by Subject|4|||
155285264|NCT01289119|560476292|FG001|Overall Study|Withdrawal by Subject|2|||
155285265|NCT01289119|560476293|FG002|Overall Study|Withdrawal by Subject|4|||
155285266|NCT01289119|560476294|FG003|Overall Study|Withdrawal by Subject|3|||
155285267|NCT01289119|560476295|FG004|Overall Study|Withdrawal by Subject|1|||
155285268|NCT01289119|560476296|FG005|Overall Study|Withdrawal by Subject|1|||
154954474|NCT04206332|559259582|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954475|NCT04206332|559259583|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954476|NCT04206332|559259584|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954477|NCT04206332|559259585|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
155285269|NCT01289119|560476291|FG000|Overall Study|Pregnancy|0|||
154954478|NCT04206332|559259586|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
154954479|NCT04206332|559259587|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
154954480|NCT04206332|559259571|FG000|Part C|Withdrawal by Subject|0|||
154954481|NCT04206332|559259572|FG001|Part C|Withdrawal by Subject|0|||
154954482|NCT04206332|559259573|FG002|Part C|Withdrawal by Subject|0|||
154954483|NCT04206332|559259574|FG003|Part C|Withdrawal by Subject|0|||
154954484|NCT04206332|559259575|FG004|Part C|Withdrawal by Subject|0|||
154954485|NCT04206332|559259576|FG005|Part C|Withdrawal by Subject|0|||
154954486|NCT04206332|559259577|FG006|Part C|Withdrawal by Subject|0|||
154954487|NCT04206332|559259578|FG007|Part C|Withdrawal by Subject|0|||
154954488|NCT04206332|559259579|FG008|Part C|Withdrawal by Subject|0|||
154954489|NCT04206332|559259580|FG009|Part C|Withdrawal by Subject|0|||
154954490|NCT04206332|559259581|FG010|Part C|Withdrawal by Subject|0|||
154954491|NCT04206332|559259582|FG011|Part C|Withdrawal by Subject|0|||
154954492|NCT04206332|559259583|FG012|Part C|Withdrawal by Subject|0|||
154954493|NCT04206332|559259584|FG013|Part C|Withdrawal by Subject|0|||
154954494|NCT04206332|559259585|FG014|Part C|Withdrawal by Subject|2|||
154954495|NCT04206332|559259586|FG015|Part C|Withdrawal by Subject|0|||
154954496|NCT04206332|559259587|FG016|Part C|Withdrawal by Subject|0|||
154954497|NCT02334722|559259588|FG000|Overall Study|Lost to Follow-up|4|||
154954498|NCT02334722|559259589|FG001|Overall Study|Lost to Follow-up|0|||
154954499|NCT02334722|559259588|FG000|Overall Study|6 week questionnaire not completed|2|||
154954500|NCT02334722|559259589|FG001|Overall Study|6 week questionnaire not completed|0|||
154954501|NCT02334722|559259588|FG000|Overall Study|Unable to obtain medication|1|||
154954502|NCT02334722|559259589|FG001|Overall Study|Unable to obtain medication|1|||
154954503|NCT02334722|559259588|FG000|Overall Study|Withdrawal by Subject|0|||
154954504|NCT02334722|559259589|FG001|Overall Study|Withdrawal by Subject|3|||
154954505|NCT02334722|559259588|FG000|Overall Study|Adverse Event|0|||
154954506|NCT02334722|559259589|FG001|Overall Study|Adverse Event|2|||
154954507|NCT02334722|559259588|FG000|Overall Study|Physician Decision|0|||
154954508|NCT02334722|559259589|FG001|Overall Study|Physician Decision|1|||
154954509|NCT03988803|559259591|FG000|Period 2|Prematurely discontinued from medication|2|||
154954510|NCT03988803|559259591|FG000|Period 2|Adverse Event|1|||
154954511|NCT00856388|559259594|FG000|Overall Study|Other|1|||
154954512|NCT02017964|559259598|FG000|Overall Study|Patient deemed ineligible|1|||
154954513|NCT01038856|559259601|FG000|Overall Study|Adverse Event|2|||
154954514|NCT02300103|559259604|FG000|Overall Study|Lack of Efficacy|3|||
154954515|NCT02300103|559259604|FG000|Overall Study|Protocol Violation|1|||
154954516|NCT02300103|559259604|FG000|Overall Study|Withdrew Consent|2|||
154954517|NCT04091971|559259605|FG000|Overall Study|Withdrawal by Subject|1|||
154954518|NCT04091971|559259605|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
154954519|NCT04091971|559259605|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
154954520|NCT00150462|559259606|FG000|Overall Study|Disease Progression or Relapse|3|||
154954521|NCT00150462|559259607|FG001|Overall Study|Disease Progression or Relapse|1|||
154954522|NCT00150462|559259608|FG002|Overall Study|Disease Progression or Relapse|2|||
154954523|NCT00150462|559259609|FG003|Overall Study|Disease Progression or Relapse|1|||
154954524|NCT00150462|559259610|FG004|Overall Study|Disease Progression or Relapse|2|||
154954525|NCT00150462|559259611|FG005|Overall Study|Disease Progression or Relapse|2|||
154954526|NCT00150462|559259612|FG006|Overall Study|Disease Progression or Relapse|3|||
154954527|NCT00150462|559259613|FG007|Overall Study|Disease Progression or Relapse|5|||
154954528|NCT00150462|559259614|FG008|Overall Study|Disease Progression or Relapse|5|||
154954529|NCT00150462|559259615|FG009|Overall Study|Disease Progression or Relapse|3|||
154954530|NCT00150462|559259616|FG010|Overall Study|Disease Progression or Relapse|2|||
154954531|NCT00150462|559259606|FG000|Overall Study|Withdrawal by Subject|0|||
154954532|NCT00150462|559259607|FG001|Overall Study|Withdrawal by Subject|1|||
154954533|NCT00150462|559259608|FG002|Overall Study|Withdrawal by Subject|1|||
154954534|NCT00150462|559259609|FG003|Overall Study|Withdrawal by Subject|0|||
155285270|NCT01289119|560476292|FG001|Overall Study|Pregnancy|1|||
155285271|NCT01289119|560476293|FG002|Overall Study|Pregnancy|0|||
155285272|NCT01289119|560476294|FG003|Overall Study|Pregnancy|0|||
155285273|NCT01289119|560476295|FG004|Overall Study|Pregnancy|0|||
155285274|NCT01289119|560476296|FG005|Overall Study|Pregnancy|0|||
155285275|NCT01289119|560476291|FG000|Overall Study|Lack of Efficacy|0|||
155285276|NCT01289119|560476292|FG001|Overall Study|Lack of Efficacy|1|||
155285277|NCT01289119|560476293|FG002|Overall Study|Lack of Efficacy|1|||
155285278|NCT01289119|560476294|FG003|Overall Study|Lack of Efficacy|1|||
155285279|NCT01289119|560476295|FG004|Overall Study|Lack of Efficacy|1|||
155285280|NCT01289119|560476296|FG005|Overall Study|Lack of Efficacy|1|||
155285281|NCT01289119|560476291|FG000|Overall Study|Other|1|||
155285282|NCT01289119|560476292|FG001|Overall Study|Other|0|||
155285283|NCT01289119|560476293|FG002|Overall Study|Other|1|||
155285284|NCT01289119|560476294|FG003|Overall Study|Other|0|||
155058914|NCT01677741|559650366|FG003|Overall Study|Death|1|||
155058915|NCT01677741|559650367|FG004|Overall Study|Death|0|||
155058916|NCT01677741|559650368|FG005|Overall Study|Death|1|||
155058917|NCT01677741|559650369|FG006|Overall Study|Death|0|||
155058918|NCT01677741|559650370|FG007|Overall Study|Death|0|||
155058919|NCT01677741|559650363|FG000|Overall Study|Withdrawal by Subject|2|||
155058920|NCT01677741|559650364|FG001|Overall Study|Withdrawal by Subject|7|||
155058921|NCT01677741|559650365|FG002|Overall Study|Withdrawal by Subject|5|||
155058922|NCT01677741|559650366|FG003|Overall Study|Withdrawal by Subject|4|||
155058923|NCT01677741|559650367|FG004|Overall Study|Withdrawal by Subject|11|||
155058924|NCT01677741|559650368|FG005|Overall Study|Withdrawal by Subject|20|||
155058925|NCT01677741|559650369|FG006|Overall Study|Withdrawal by Subject|4|||
155058926|NCT01677741|559650370|FG007|Overall Study|Withdrawal by Subject|2|||
155058927|NCT01677741|559650363|FG000|Overall Study|Enrolled in a rollover study|0|||
155058928|NCT01677741|559650364|FG001|Overall Study|Enrolled in a rollover study|3|||
155058929|NCT01677741|559650365|FG002|Overall Study|Enrolled in a rollover study|2|||
155058930|NCT01677741|559650366|FG003|Overall Study|Enrolled in a rollover study|1|||
155058931|NCT01677741|559650367|FG004|Overall Study|Enrolled in a rollover study|6|||
155058932|NCT01677741|559650368|FG005|Overall Study|Enrolled in a rollover study|6|||
155058933|NCT01677741|559650369|FG006|Overall Study|Enrolled in a rollover study|7|||
155058934|NCT01677741|559650370|FG007|Overall Study|Enrolled in a rollover study|0|||
155058935|NCT01677741|559650363|FG000|Overall Study|Progressive disease|1|||
155285285|NCT01289119|560476295|FG004|Overall Study|Other|0|||
155285286|NCT01289119|560476296|FG005|Overall Study|Other|0|||
155285287|NCT01704846|560476297|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155285288|NCT01704846|560476298|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155285289|NCT00530335|560476301|FG000|Overall Study|Adverse Event|3|||
155285290|NCT00530335|560476301|FG000|Overall Study|Protocol Violation|1|||
155285291|NCT00530335|560476301|FG000|Overall Study|Withdrawal by Subject|1|||
155285292|NCT00530335|560476301|FG000|Overall Study|Physician Decision|1|||
155285293|NCT01244984|560476302|FG000|Overall Study|Adverse Event|2|||
155285294|NCT01244984|560476303|FG001|Overall Study|Adverse Event|11|||
155285295|NCT01244984|560476304|FG002|Overall Study|Adverse Event|2|||
155285296|NCT01244984|560476302|FG000|Overall Study|Protocol Violation|1|||
155285297|NCT01244984|560476303|FG001|Overall Study|Protocol Violation|0|||
155285298|NCT01244984|560476304|FG002|Overall Study|Protocol Violation|0|||
155285299|NCT01244984|560476302|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
155285300|NCT01244984|560476303|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
155285301|NCT01244984|560476304|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
155058936|NCT01677741|559650364|FG001|Overall Study|Progressive disease|0|||
155058937|NCT01677741|559650365|FG002|Overall Study|Progressive disease|1|||
155058938|NCT01677741|559650366|FG003|Overall Study|Progressive disease|0|||
155155311|NCT02657889|560004520|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
155155312|NCT02657889|560004521|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
155155313|NCT03341299|560004524|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
155155314|NCT03341299|560004525|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
155155315|NCT03341299|560004526|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
155155316|NCT03341299|560004527|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
155285302|NCT01244984|560476302|FG000|Overall Study|Withdrawal by Subject|1|||
155285303|NCT01244984|560476303|FG001|Overall Study|Withdrawal by Subject|2|||
155285304|NCT01244984|560476304|FG002|Overall Study|Withdrawal by Subject|2|||
155285305|NCT04577183|560476306|FG000|Overall Study|Death|1|||
155285306|NCT04577183|560476306|FG000|Overall Study|Withdrawal by Subject|3|||
155285307|NCT04577183|560476306|FG000|Overall Study|Early termination|2|||
155285308|NCT00672256|560476307|FG000|Overall Study|PI dropped, bad data|44|||
155285309|NCT01360840|560476310|FG000|Overall Study|Ongoing at data cut-off|10|||
155285310|NCT01360840|560476311|FG001|Overall Study|Ongoing at data cut-off|10|||
155285311|NCT01360840|560476312|FG002|Overall Study|Ongoing at data cut-off|9|||
155285312|NCT00920686|560476314|FG000|Overall Study|Lost to Follow-up|2|||
155285313|NCT00920686|560476315|FG001|Overall Study|Lost to Follow-up|3|||
155285314|NCT00920686|560476316|FG002|Overall Study|Lost to Follow-up|1|||
155285315|NCT00920686|560476314|FG000|Overall Study|Study drug dosing criteria not met|17|||
155058939|NCT01677741|559650367|FG004|Overall Study|Progressive disease|0|||
155058940|NCT01677741|559650368|FG005|Overall Study|Progressive disease|1|||
155058941|NCT01677741|559650369|FG006|Overall Study|Progressive disease|0|||
155058942|NCT01677741|559650370|FG007|Overall Study|Progressive disease|0|||
155058943|NCT00794664|559650371|FG000|Treatment Period|Withdrawal by Subject|0|||
155058944|NCT00794664|559650372|FG001|Treatment Period|Withdrawal by Subject|2|||
155058945|NCT00794664|559650371|FG000|Treatment Period|Protocol non-compliance|0|||
155058946|NCT00794664|559650372|FG001|Treatment Period|Protocol non-compliance|1|||
155058947|NCT00794664|559650371|FG000|Treatment Period|Other|0|||
155058948|NCT00794664|559650372|FG001|Treatment Period|Other|1|||
155058949|NCT00794664|559650371|FG000|Treatment Period|Adverse Event|1|||
155058950|NCT00794664|559650372|FG001|Treatment Period|Adverse Event|8|||
155058951|NCT00794664|559650371|FG000|Follow-up Period|Other|1|||
155058952|NCT00794664|559650372|FG001|Follow-up Period|Other|2|||
155058953|NCT00794664|559650371|FG000|Follow-up Period|Withdrawal by Subject|0|||
155058954|NCT00794664|559650372|FG001|Follow-up Period|Withdrawal by Subject|2|||
155058955|NCT00794664|559650371|FG000|Follow-up Period|Protocol non-compliance|0|||
155058956|NCT00794664|559650372|FG001|Follow-up Period|Protocol non-compliance|1|||
155058957|NCT02230891|559650375|FG000|Baseline|Did not meet inclusion|0|||
155058958|NCT02230891|559650376|FG001|Baseline|Did not meet inclusion|1|||
155058959|NCT02230891|559650377|FG002|Baseline|Did not meet inclusion|1|||
155058960|NCT02230891|559650375|FG000|2 Week|Withdrawal by Subject|2|||
155058961|NCT02230891|559650376|FG001|2 Week|Withdrawal by Subject|2|||
155058962|NCT02230891|559650377|FG002|2 Week|Withdrawal by Subject|0|||
155058963|NCT02230891|559650375|FG000|2 Week|Consent withdrawn|1|||
155058964|NCT02230891|559650376|FG001|2 Week|Consent withdrawn|0|||
155058965|NCT02230891|559650377|FG002|2 Week|Consent withdrawn|0|||
155058966|NCT02230891|559650375|FG000|6 Month|Withdrawal by Subject|1|||
155058967|NCT02230891|559650376|FG001|6 Month|Withdrawal by Subject|1|||
155058968|NCT02230891|559650377|FG002|6 Month|Withdrawal by Subject|1|||
155058969|NCT02230891|559650375|FG000|6 Month|Physician Decision|0|||
155058970|NCT02230891|559650376|FG001|6 Month|Physician Decision|2|||
154954535|NCT00150462|559259610|FG004|Overall Study|Withdrawal by Subject|1|||
154954536|NCT00150462|559259611|FG005|Overall Study|Withdrawal by Subject|2|||
154954537|NCT00150462|559259612|FG006|Overall Study|Withdrawal by Subject|0|||
154954538|NCT00150462|559259613|FG007|Overall Study|Withdrawal by Subject|1|||
154954539|NCT00150462|559259614|FG008|Overall Study|Withdrawal by Subject|0|||
154954540|NCT00150462|559259615|FG009|Overall Study|Withdrawal by Subject|1|||
154954541|NCT00150462|559259616|FG010|Overall Study|Withdrawal by Subject|0|||
154954542|NCT00150462|559259606|FG000|Overall Study|Death|0|||
154954543|NCT00150462|559259607|FG001|Overall Study|Death|1|||
154954544|NCT00150462|559259608|FG002|Overall Study|Death|0|||
154954545|NCT00150462|559259609|FG003|Overall Study|Death|0|||
154954546|NCT00150462|559259610|FG004|Overall Study|Death|0|||
154954547|NCT00150462|559259611|FG005|Overall Study|Death|0|||
154954548|NCT00150462|559259612|FG006|Overall Study|Death|0|||
154954549|NCT00150462|559259613|FG007|Overall Study|Death|0|||
154954550|NCT00150462|559259614|FG008|Overall Study|Death|1|||
154954551|NCT00150462|559259615|FG009|Overall Study|Death|0|||
154954552|NCT00150462|559259616|FG010|Overall Study|Death|0|||
154954553|NCT00150462|559259606|FG000|Overall Study|Adverse Event|0|||
154954554|NCT00150462|559259607|FG001|Overall Study|Adverse Event|0|||
154954555|NCT00150462|559259608|FG002|Overall Study|Adverse Event|0|||
154954556|NCT00150462|559259609|FG003|Overall Study|Adverse Event|1|||
154954557|NCT00150462|559259610|FG004|Overall Study|Adverse Event|0|||
154954558|NCT00150462|559259611|FG005|Overall Study|Adverse Event|0|||
154954559|NCT00150462|559259612|FG006|Overall Study|Adverse Event|0|||
154954560|NCT00150462|559259613|FG007|Overall Study|Adverse Event|2|||
154954561|NCT00150462|559259614|FG008|Overall Study|Adverse Event|0|||
154954562|NCT00150462|559259615|FG009|Overall Study|Adverse Event|1|||
154954563|NCT00150462|559259616|FG010|Overall Study|Adverse Event|0|||
154954564|NCT00150462|559259606|FG000|Overall Study|Physician Decision|0|||
154954565|NCT00150462|559259607|FG001|Overall Study|Physician Decision|0|||
154954566|NCT00150462|559259608|FG002|Overall Study|Physician Decision|1|||
154954567|NCT00150462|559259609|FG003|Overall Study|Physician Decision|1|||
154954568|NCT00150462|559259610|FG004|Overall Study|Physician Decision|0|||
154954569|NCT00150462|559259611|FG005|Overall Study|Physician Decision|0|||
154954570|NCT00150462|559259612|FG006|Overall Study|Physician Decision|0|||
154954571|NCT00150462|559259613|FG007|Overall Study|Physician Decision|0|||
154954572|NCT00150462|559259614|FG008|Overall Study|Physician Decision|0|||
154954573|NCT00150462|559259615|FG009|Overall Study|Physician Decision|0|||
154954574|NCT00150462|559259616|FG010|Overall Study|Physician Decision|0|||
155058971|NCT02230891|559650377|FG002|6 Month|Physician Decision|0|||
155058972|NCT02230891|559650375|FG000|12 Month|Death|1|||
155058973|NCT02230891|559650376|FG001|12 Month|Death|0|||
154954575|NCT00150462|559259606|FG000|Overall Study|Other|0|||
154954576|NCT00150462|559259607|FG001|Overall Study|Other|0|||
155058974|NCT02230891|559650377|FG002|12 Month|Death|0|||
155285316|NCT00920686|560476315|FG001|Overall Study|Study drug dosing criteria not met|19|||
154954577|NCT00150462|559259608|FG002|Overall Study|Other|0|||
155285317|NCT00920686|560476316|FG002|Overall Study|Study drug dosing criteria not met|12|||
154954578|NCT00150462|559259609|FG003|Overall Study|Other|0|||
154954579|NCT00150462|559259610|FG004|Overall Study|Other|0|||
154954580|NCT00150462|559259611|FG005|Overall Study|Other|0|||
154954581|NCT00150462|559259612|FG006|Overall Study|Other|0|||
154954582|NCT00150462|559259613|FG007|Overall Study|Other|0|||
154954583|NCT00150462|559259614|FG008|Overall Study|Other|0|||
154954584|NCT00150462|559259615|FG009|Overall Study|Other|1|||
154954585|NCT00150462|559259616|FG010|Overall Study|Other|1|||
154954586|NCT01666730|559259619|FG000|Overall Study|Adverse Event|16|||
154954587|NCT01666730|559259619|FG000|Overall Study|Death|2|||
154954588|NCT01666730|559259619|FG000|Overall Study|Physician Decision|5|||
154954589|NCT01666730|559259619|FG000|Overall Study|Withdrawal by Subject|9|||
154954590|NCT01666730|559259619|FG000|Overall Study|Disease progression/relapse|18|||
154954591|NCT04638153|559259620|FG000|Overall Study|Withdrawal by parent/guardian|0|||
154954592|NCT04638153|559259621|FG001|Overall Study|Withdrawal by parent/guardian|0|||
154954593|NCT04638153|559259622|FG002|Overall Study|Withdrawal by parent/guardian|1|||
154954594|NCT04638153|559259620|FG000|Overall Study|Study terminated by sponsor|4|||
154954595|NCT04638153|559259621|FG001|Overall Study|Study terminated by sponsor|2|||
154954596|NCT04638153|559259622|FG002|Overall Study|Study terminated by sponsor|14|||
154954597|NCT01440283|559259625|FG000|Overall Study|Death|3|||
154954598|NCT01440283|559259625|FG000|Overall Study|Withdrawal by Subject|4|||
154954599|NCT01440283|559259625|FG000|Overall Study|Physician Decision|3|||
154954600|NCT01449630|559259626|FG000|Period 1|Physician Decision|1|||
154954601|NCT01449630|559259627|FG001|Period 1|Physician Decision|0|||
154954602|NCT01449630|559259628|FG002|Period 1|Physician Decision|0|||
154954603|NCT01449630|559259629|FG003|Period 1|Physician Decision|1|||
154954604|NCT01449630|559259630|FG004|Period 1|Physician Decision|0|||
154954605|NCT01449630|559259631|FG005|Period 1|Physician Decision|0|||
154954606|NCT01449630|559259632|FG006|Period 1|Physician Decision|0|||
154954607|NCT01449630|559259633|FG007|Period 1|Physician Decision|0|||
154954608|NCT01449630|559259634|FG008|Period 1|Physician Decision|0|||
154954609|NCT01449630|559259626|FG000|Period 1|Sponsor Decision|0|||
154954610|NCT01449630|559259627|FG001|Period 1|Sponsor Decision|0|||
154954611|NCT01449630|559259628|FG002|Period 1|Sponsor Decision|0|||
154954612|NCT01449630|559259629|FG003|Period 1|Sponsor Decision|0|||
154954613|NCT01449630|559259630|FG004|Period 1|Sponsor Decision|0|||
154954614|NCT01449630|559259631|FG005|Period 1|Sponsor Decision|1|||
154954615|NCT01449630|559259632|FG006|Period 1|Sponsor Decision|0|||
154954616|NCT01449630|559259633|FG007|Period 1|Sponsor Decision|0|||
154954617|NCT01449630|559259634|FG008|Period 1|Sponsor Decision|0|||
154954618|NCT01449630|559259626|FG000|Period 2|Sponsor Decision|0|||
154954619|NCT01449630|559259627|FG001|Period 2|Sponsor Decision|0|||
154954620|NCT01449630|559259628|FG002|Period 2|Sponsor Decision|0|||
154954621|NCT01449630|559259629|FG003|Period 2|Sponsor Decision|0|||
154954622|NCT01449630|559259630|FG004|Period 2|Sponsor Decision|0|||
154954623|NCT01449630|559259631|FG005|Period 2|Sponsor Decision|0|||
154954624|NCT01449630|559259632|FG006|Period 2|Sponsor Decision|1|||
154954625|NCT01449630|559259633|FG007|Period 2|Sponsor Decision|0|||
154954626|NCT01449630|559259634|FG008|Period 2|Sponsor Decision|0|||
154954627|NCT03340727|559259635|FG000|Overall Study|Death|1|||
154954628|NCT03340727|559259636|FG001|Overall Study|Death|0|||
154954629|NCT03340727|559259635|FG000|Overall Study|Lost to Follow-up|31|||
154954630|NCT03340727|559259636|FG001|Overall Study|Lost to Follow-up|35|||
154954631|NCT03340727|559259635|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
154954632|NCT03340727|559259636|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
154954633|NCT03340727|559259635|FG000|Overall Study|Transferred to another facility|10|||
155285318|NCT03006341|560476317|FG000|Overall Study|Not linked in the EMR|25069|||
155285319|NCT03006341|560476318|FG001|Overall Study|Not linked in the EMR|67505|||
155285320|NCT03006341|560476319|FG002|Overall Study|Not linked in the EMR|30993|||
155285321|NCT03006341|560476320|FG003|Overall Study|Not linked in the EMR|10685|||
155285322|NCT00293462|560476321|FG000|Overall Study|Withdrawal by Subject|4|||
155285323|NCT00293462|560476322|FG001|Overall Study|Withdrawal by Subject|3|||
155285324|NCT00293462|560476323|FG002|Overall Study|Withdrawal by Subject|8|||
155285325|NCT00293462|560476321|FG000|Overall Study|Death|1|||
155285326|NCT00293462|560476322|FG001|Overall Study|Death|0|||
155285327|NCT00293462|560476323|FG002|Overall Study|Death|0|||
155285328|NCT00293462|560476321|FG000|Overall Study|Lost to Follow-up|0|||
155285329|NCT00293462|560476322|FG001|Overall Study|Lost to Follow-up|1|||
155285330|NCT00293462|560476323|FG002|Overall Study|Lost to Follow-up|0|||
155285331|NCT00293462|560476321|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
155285332|NCT00293462|560476322|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
155285333|NCT00293462|560476323|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
155285334|NCT00293462|560476321|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
155285335|NCT00293462|560476322|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
155285336|NCT00293462|560476323|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
155285337|NCT00293462|560476321|FG000|Overall Study|Refuse Radiation Treatment|1|||
155285338|NCT00293462|560476322|FG001|Overall Study|Refuse Radiation Treatment|0|||
155285339|NCT00293462|560476323|FG002|Overall Study|Refuse Radiation Treatment|0|||
155285340|NCT00293462|560476321|FG000|Overall Study|No Show|0|||
155285341|NCT00293462|560476322|FG001|Overall Study|No Show|0|||
155285342|NCT00293462|560476323|FG002|Overall Study|No Show|1|||
155285343|NCT00293462|560476321|FG000|Overall Study|Went back to his home country|0|||
155285344|NCT00293462|560476322|FG001|Overall Study|Went back to his home country|0|||
155285345|NCT00293462|560476323|FG002|Overall Study|Went back to his home country|1|||
155285346|NCT00293462|560476321|FG000|Overall Study|Blood clot after chemotherapy|0|||
155285347|NCT00293462|560476322|FG001|Overall Study|Blood clot after chemotherapy|0|||
155285348|NCT00293462|560476323|FG002|Overall Study|Blood clot after chemotherapy|1|||
155285349|NCT00293462|560476321|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
155285350|NCT00293462|560476322|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
155285351|NCT00293462|560476323|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
155285352|NCT00293462|560476321|FG000|Overall Study|Possible Tracheostomy leakage|0|||
155285353|NCT00293462|560476322|FG001|Overall Study|Possible Tracheostomy leakage|1|||
155285354|NCT00293462|560476323|FG002|Overall Study|Possible Tracheostomy leakage|0|||
155285355|NCT00293462|560476321|FG000|Overall Study|Low radiation dose in oral cavity|0|||
155285356|NCT00293462|560476322|FG001|Overall Study|Low radiation dose in oral cavity|1|||
155285357|NCT00293462|560476323|FG002|Overall Study|Low radiation dose in oral cavity|0|||
155285358|NCT00293462|560476321|FG000|Overall Study|Physician Decision|0|||
155285359|NCT00293462|560476322|FG001|Overall Study|Physician Decision|1|||
155285360|NCT00293462|560476323|FG002|Overall Study|Physician Decision|0|||
155285361|NCT02950545|560476324|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285362|NCT02950545|560476325|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285363|NCT02950545|560476326|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285364|NCT02950545|560476327|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285365|NCT02950545|560476328|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
155285366|NCT02950545|560476329|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
155285367|NCT02950545|560476324|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
155285368|NCT02950545|560476325|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
154954634|NCT03340727|559259636|FG001|Overall Study|Transferred to another facility|7|||
154954635|NCT03340727|559259635|FG000|Overall Study|Withdrawal by Subject|28|||
154954636|NCT03340727|559259636|FG001|Overall Study|Withdrawal by Subject|17|||
154954637|NCT03553823|559259637|FG000|Overall Study|Physician Decision|0|||
154954638|NCT03553823|559259638|FG001|Overall Study|Physician Decision|1|||
154954639|NCT01389102|559259639|FG000|Overall Study|Adverse Event|1|||
154954640|NCT01389102|559259640|FG001|Overall Study|Adverse Event|3|||
155285369|NCT02950545|560476326|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
155285370|NCT02950545|560476327|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
155285371|NCT02950545|560476328|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
155285372|NCT02950545|560476329|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
155285373|NCT02950545|560476324|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285374|NCT02950545|560476325|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285375|NCT02950545|560476326|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285376|NCT02950545|560476327|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285377|NCT02950545|560476328|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
155285378|NCT02950545|560476329|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
155285379|NCT02950545|560476324|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
155285380|NCT02950545|560476325|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285381|NCT02950545|560476326|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285382|NCT02950545|560476327|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285383|NCT02950545|560476328|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285384|NCT02950545|560476329|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
155285385|NCT02950545|560476324|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285386|NCT02950545|560476325|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285387|NCT02950545|560476326|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285388|NCT02950545|560476327|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285389|NCT02950545|560476328|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
155285390|NCT02950545|560476329|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
155285391|NCT00372060|560476330|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
155285392|NCT00372060|560476331|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
155285393|NCT00372060|560476330|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
155285394|NCT00372060|560476331|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
155285395|NCT00372060|560476330|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
155285396|NCT00372060|560476331|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
155285397|NCT00372060|560476330|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
155285398|NCT00372060|560476331|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
155285399|NCT00372060|560476330|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
155285400|NCT00372060|560476331|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
155285401|NCT00372060|560476330|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
155285402|NCT00372060|560476331|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
155285403|NCT01004263|560476332|FG000|Overall Study|Adverse Event|15|||
155285404|NCT01004263|560476332|FG000|Overall Study|Withdrawal by Subject|58|||
155285405|NCT01004263|560476332|FG000|Overall Study|Protocol Violation|10|||
155285406|NCT01004263|560476332|FG000|Overall Study|Lost to Follow-up|64|||
155285407|NCT01004263|560476332|FG000|Overall Study|Lack of Efficacy|13|||
155285408|NCT01004263|560476332|FG000|Overall Study|Pregnancy|2|||
155285409|NCT01004263|560476332|FG000|Overall Study|Physician Decision|15|||
155285410|NCT01004263|560476332|FG000|Overall Study|Lack of Qualifying Event|2|||
155285411|NCT01516892|560476343|FG000|Overall Study|Adverse Event|25|||
155285412|NCT01516892|560476343|FG000|Overall Study|Lack of Efficacy|35|||
155285413|NCT01516892|560476343|FG000|Overall Study|Pregnancy|5|||
155285414|NCT01516892|560476343|FG000|Overall Study|Lost to Follow-up|82|||
155285415|NCT01516892|560476343|FG000|Overall Study|Subject Withdrew Consent|92|||
155285416|NCT01516892|560476343|FG000|Overall Study|Protocol Violation|60|||
155285417|NCT01516892|560476343|FG000|Overall Study|Other Miscellaneous Reasons|43|||
155285418|NCT01516892|560476343|FG000|Overall Study|Missing|1|||
155285419|NCT04794179|560476344|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
155285420|NCT04794179|560476345|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
155285421|NCT01096056|560476346|FG000|Overall Study|Lost to Follow-up|0|||
155285422|NCT01096056|560476347|FG001|Overall Study|Lost to Follow-up|1|||
155285423|NCT03568162|560476348|FG000|Overall Study|Adverse Event|0|||
155285424|NCT03568162|560476349|FG001|Overall Study|Adverse Event|1|||
155285425|NCT03568162|560476350|FG002|Overall Study|Adverse Event|2|||
155285426|NCT03568162|560476351|FG003|Overall Study|Adverse Event|0|||
155285427|NCT03568162|560476352|FG004|Overall Study|Adverse Event|0|||
155285428|NCT03568162|560476353|FG005|Overall Study|Adverse Event|1|||
155285429|NCT03568162|560476348|FG000|Overall Study|Death|0|||
155285430|NCT03568162|560476349|FG001|Overall Study|Death|0|||
155285431|NCT03568162|560476350|FG002|Overall Study|Death|0|||
155285432|NCT03568162|560476351|FG003|Overall Study|Death|0|||
155285433|NCT03568162|560476352|FG004|Overall Study|Death|1|||
155285434|NCT03568162|560476353|FG005|Overall Study|Death|0|||
155285435|NCT03568162|560476348|FG000|Overall Study|Lost to Follow-up|3|||
155285436|NCT03568162|560476349|FG001|Overall Study|Lost to Follow-up|2|||
155285437|NCT03568162|560476350|FG002|Overall Study|Lost to Follow-up|4|||
155285438|NCT03568162|560476351|FG003|Overall Study|Lost to Follow-up|2|||
155285439|NCT03568162|560476352|FG004|Overall Study|Lost to Follow-up|3|||
155285440|NCT03568162|560476353|FG005|Overall Study|Lost to Follow-up|2|||
155285441|NCT03568162|560476348|FG000|Overall Study|Physician Decision|0|||
155285442|NCT03568162|560476349|FG001|Overall Study|Physician Decision|1|||
155285443|NCT03568162|560476350|FG002|Overall Study|Physician Decision|1|||
155285444|NCT03568162|560476351|FG003|Overall Study|Physician Decision|0|||
155285445|NCT03568162|560476352|FG004|Overall Study|Physician Decision|1|||
155285446|NCT03568162|560476353|FG005|Overall Study|Physician Decision|0|||
155285447|NCT03568162|560476348|FG000|Overall Study|Pregnancy|0|||
155285448|NCT03568162|560476349|FG001|Overall Study|Pregnancy|0|||
155285449|NCT03568162|560476350|FG002|Overall Study|Pregnancy|0|||
155285450|NCT03568162|560476351|FG003|Overall Study|Pregnancy|1|||
155285451|NCT03568162|560476352|FG004|Overall Study|Pregnancy|0|||
155285452|NCT03568162|560476353|FG005|Overall Study|Pregnancy|0|||
155285453|NCT03568162|560476348|FG000|Overall Study|Protocol Violation|1|||
155285454|NCT03568162|560476349|FG001|Overall Study|Protocol Violation|0|||
155285455|NCT03568162|560476350|FG002|Overall Study|Protocol Violation|1|||
155285456|NCT03568162|560476351|FG003|Overall Study|Protocol Violation|1|||
155285457|NCT03568162|560476352|FG004|Overall Study|Protocol Violation|1|||
155285458|NCT03568162|560476353|FG005|Overall Study|Protocol Violation|1|||
155285459|NCT03568162|560476348|FG000|Overall Study|Withdrawal by Subject|15|||
155285460|NCT03568162|560476349|FG001|Overall Study|Withdrawal by Subject|15|||
155285461|NCT03568162|560476350|FG002|Overall Study|Withdrawal by Subject|26|||
155285462|NCT03568162|560476351|FG003|Overall Study|Withdrawal by Subject|22|||
155285463|NCT03568162|560476352|FG004|Overall Study|Withdrawal by Subject|6|||
155285464|NCT03568162|560476353|FG005|Overall Study|Withdrawal by Subject|9|||
155285465|NCT03568162|560476348|FG000|Overall Study|Others|3|||
155285466|NCT03568162|560476349|FG001|Overall Study|Others|4|||
155285467|NCT03568162|560476350|FG002|Overall Study|Others|1|||
155285468|NCT03568162|560476351|FG003|Overall Study|Others|4|||
155285469|NCT03568162|560476352|FG004|Overall Study|Others|2|||
155285470|NCT03568162|560476353|FG005|Overall Study|Others|1|||
155285471|NCT00768066|560476355|FG000|Overall Study|Did not receive study product injection.|3|||
155285472|NCT00768066|560476356|FG001|Overall Study|Did not receive study product injection.|3|||
155285473|NCT00768066|560476357|FG002|Overall Study|Did not receive study product injection.|0|||
155285474|NCT04831775|560476358|FG000|Overall Study|Lost to Follow-up|11|||
155285475|NCT04831775|560476359|FG001|Overall Study|Lost to Follow-up|13|||
155285476|NCT00337818|560476360|FG000|Overall Study|Lost to Follow-up|289|||
155285477|NCT00337818|560476361|FG001|Overall Study|Lost to Follow-up|91|||
155285478|NCT00337818|560476362|FG002|Overall Study|Lost to Follow-up|107|||
155285479|NCT03590743|560476363|FG000|Overall Study|Withdrawal by Subject|0|||
155285480|NCT03590743|560476364|FG001|Overall Study|Withdrawal by Subject|1|||
155285481|NCT02696226|560476365|FG000|Overall Study|Study terminated - lack of enrollment|1|||
155285482|NCT02696226|560476366|FG001|Overall Study|Study terminated - lack of enrollment|0|||
155285483|NCT02696226|560476367|FG002|Overall Study|Study terminated - lack of enrollment|2|||
155285484|NCT02696226|560476368|FG003|Overall Study|Study terminated - lack of enrollment|0|||
155285485|NCT01190176|560476369|FG000|Overall Study|Withdrawal by Subject|1|||
155285486|NCT01190176|560476369|FG000|Overall Study|Lost to Follow-up|1|||
155285487|NCT02909101|560476370|FG000|Overall Study|Lost to Follow-up|1|||
155285488|NCT02909101|560476371|FG001|Overall Study|Lost to Follow-up|1|||
155285489|NCT02189863|560476372|FG000|First 2 Weeks|Motion Sickness|4|||
155285490|NCT02189863|560476373|FG001|First 2 Weeks|Motion Sickness|2|||
155285491|NCT03697460|560476374|FG000|Overall Study|Withdrawal by Subject|3|||
155285492|NCT00429793|560476375|FG000|Overall Study|Improper pre-protocol treatment|3|||
155285493|NCT00429793|560476375|FG000|Overall Study|Required test not done|1|||
155285494|NCT00429793|560476375|FG000|Overall Study|Never treated|1|||
155285495|NCT00429793|560476375|FG000|Overall Study|Non-measurable|1|||
155285496|NCT02414828|560476379|FG000|Overall Study|Lost to Follow-up|0|||
155285497|NCT02414828|560476380|FG001|Overall Study|Lost to Follow-up|1|||
155285498|NCT02414828|560476381|FG002|Overall Study|Lost to Follow-up|1|||
155285499|NCT02414828|560476382|FG003|Overall Study|Lost to Follow-up|2|||
155285500|NCT00389519|560476386|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
155285501|NCT00389519|560476387|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
155285502|NCT00389519|560476388|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
155285503|NCT00389519|560476389|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
155285504|NCT00389519|560476386|FG000|Placebo Run-In|Withdrawal by Subject|19|||
155058975|NCT02230891|559650375|FG000|12 Month|Lost to Follow-up|0|||
155058976|NCT02230891|559650376|FG001|12 Month|Lost to Follow-up|1|||
155058977|NCT02230891|559650377|FG002|12 Month|Lost to Follow-up|0|||
155058978|NCT02230891|559650375|FG000|12 Month|Withdrawal by Subject|0|||
155058979|NCT02230891|559650376|FG001|12 Month|Withdrawal by Subject|2|||
155058980|NCT02230891|559650377|FG002|12 Month|Withdrawal by Subject|0|||
155058981|NCT02230891|559650375|FG000|18 Month End of Study|Death|0|||
155058982|NCT02230891|559650376|FG001|18 Month End of Study|Death|0|||
155058983|NCT02230891|559650377|FG002|18 Month End of Study|Death|1|||
155058984|NCT02230891|559650375|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
155058985|NCT02230891|559650376|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
155285505|NCT00389519|560476387|FG001|Placebo Run-In|Withdrawal by Subject|0|||
155285506|NCT00389519|560476388|FG002|Placebo Run-In|Withdrawal by Subject|0|||
155285507|NCT00389519|560476389|FG003|Placebo Run-In|Withdrawal by Subject|0|||
155285508|NCT00389519|560476386|FG000|Placebo Run-In|Reason not specified|40|||
155285509|NCT00389519|560476387|FG001|Placebo Run-In|Reason not specified|0|||
155285510|NCT00389519|560476388|FG002|Placebo Run-In|Reason not specified|0|||
155285511|NCT00389519|560476389|FG003|Placebo Run-In|Reason not specified|0|||
155285512|NCT00389519|560476386|FG000|Randomized|Did not receive study drug|2|||
155285513|NCT00389519|560476387|FG001|Randomized|Did not receive study drug|0|||
155285514|NCT00389519|560476388|FG002|Randomized|Did not receive study drug|0|||
155285515|NCT00389519|560476389|FG003|Randomized|Did not receive study drug|0|||
155285516|NCT00389519|560476386|FG000|Treated|Adverse Event|1|||
155285517|NCT00389519|560476387|FG001|Treated|Adverse Event|0|||
155285518|NCT00389519|560476388|FG002|Treated|Adverse Event|0|||
155285519|NCT00389519|560476389|FG003|Treated|Adverse Event|2|||
155285520|NCT00389519|560476386|FG000|Treated|Reason not specified|1|||
155285521|NCT00389519|560476387|FG001|Treated|Reason not specified|1|||
155285522|NCT00389519|560476388|FG002|Treated|Reason not specified|0|||
155285523|NCT00389519|560476389|FG003|Treated|Reason not specified|2|||
155285524|NCT01140347|560476390|FG000|Overall Study|Lost to Follow-up|5|||
155285525|NCT01140347|560476391|FG001|Overall Study|Lost to Follow-up|6|||
155285526|NCT01140347|560476390|FG000|Overall Study|Withdrawal by Subject|13|||
155285527|NCT01140347|560476391|FG001|Overall Study|Withdrawal by Subject|8|||
155285528|NCT01959880|560476392|FG000|Overall Study|Withdrawal by Subject|11|||
155285529|NCT01959880|560476393|FG001|Overall Study|Withdrawal by Subject|13|||
155285530|NCT01959880|560476394|FG002|Overall Study|Withdrawal by Subject|8|||
155285531|NCT01959880|560476395|FG003|Overall Study|Withdrawal by Subject|7|||
155285532|NCT01959880|560476392|FG000|Overall Study|Death|1|||
155285533|NCT01959880|560476393|FG001|Overall Study|Death|10|||
155285534|NCT01959880|560476394|FG002|Overall Study|Death|1|||
155285535|NCT01959880|560476395|FG003|Overall Study|Death|2|||
155285536|NCT01959880|560476392|FG000|Overall Study|Lost to Follow-up|95|||
155285537|NCT01959880|560476393|FG001|Overall Study|Lost to Follow-up|18|||
155285538|NCT01959880|560476394|FG002|Overall Study|Lost to Follow-up|15|||
155285539|NCT01959880|560476395|FG003|Overall Study|Lost to Follow-up|8|||
155285540|NCT01959880|560476392|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
155285541|NCT01959880|560476393|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
155285542|NCT01959880|560476394|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
155285543|NCT01959880|560476395|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
155285544|NCT01959880|560476392|FG000|Overall Study|Study completed early-FDA approved|1003|||
155285545|NCT01959880|560476393|FG001|Overall Study|Study completed early-FDA approved|311|||
155285546|NCT01959880|560476394|FG002|Overall Study|Study completed early-FDA approved|179|||
155285547|NCT01959880|560476395|FG003|Overall Study|Study completed early-FDA approved|152|||
155285548|NCT04155424|560476396|FG000|Overall Study|Other than specified|3|||
155285549|NCT04155424|560476396|FG000|Overall Study|Withdrawal by Subject|1|||
155285550|NCT04155424|560476396|FG000|Overall Study|Adverse Event|1|||
155285551|NCT01801930|560478285|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
155285552|NCT01801930|560478286|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
155285553|NCT01801930|560478287|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
155285554|NCT01801930|560478288|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
155285555|NCT01801930|560478285|FG000|Overall Study|DLT occurs|0|||
155285556|NCT01801930|560478286|FG001|Overall Study|DLT occurs|1|||
155285557|NCT01801930|560478287|FG002|Overall Study|DLT occurs|0|||
155285558|NCT01801930|560478288|FG003|Overall Study|DLT occurs|0|||
155285559|NCT02072226|560478289|FG000|Overall Study|Lost to Follow-up|11|||
155285560|NCT02072226|560478290|FG001|Overall Study|Lost to Follow-up|7|||
155285561|NCT02072226|560478289|FG000|Overall Study|Patient Non-compliance|2|||
155285562|NCT02072226|560478290|FG001|Overall Study|Patient Non-compliance|3|||
155285563|NCT02072226|560478289|FG000|Overall Study|Death|1|||
154954641|NCT01389102|559259641|FG002|Overall Study|Adverse Event|2|||
154954642|NCT01389102|559259642|FG003|Overall Study|Adverse Event|2|||
154954643|NCT01389102|559259643|FG004|Overall Study|Adverse Event|2|||
154954644|NCT01389102|559259644|FG005|Overall Study|Adverse Event|2|||
154954645|NCT01389102|559259639|FG000|Overall Study|Hurricane Katrina|4|||
154954646|NCT01389102|559259640|FG001|Overall Study|Hurricane Katrina|2|||
154954647|NCT01389102|559259641|FG002|Overall Study|Hurricane Katrina|3|||
154954648|NCT01389102|559259642|FG003|Overall Study|Hurricane Katrina|0|||
154954649|NCT01389102|559259643|FG004|Overall Study|Hurricane Katrina|3|||
154954650|NCT01389102|559259644|FG005|Overall Study|Hurricane Katrina|1|||
154954651|NCT01389102|559259639|FG000|Overall Study|Lost to Follow-up|4|||
154954652|NCT01389102|559259640|FG001|Overall Study|Lost to Follow-up|1|||
154954653|NCT01389102|559259641|FG002|Overall Study|Lost to Follow-up|1|||
154954654|NCT01389102|559259642|FG003|Overall Study|Lost to Follow-up|2|||
154954655|NCT01389102|559259643|FG004|Overall Study|Lost to Follow-up|4|||
154954656|NCT01389102|559259644|FG005|Overall Study|Lost to Follow-up|1|||
154954657|NCT01389102|559259639|FG000|Overall Study|Protocol Violation|0|||
155285564|NCT02072226|560478290|FG001|Overall Study|Death|0|||
155285565|NCT02072226|560478289|FG000|Overall Study|Patient Withdrawal of Consent|1|||
155285566|NCT02072226|560478290|FG001|Overall Study|Patient Withdrawal of Consent|0|||
155285567|NCT03255018|560478292|FG000|Overall Study|Death on study|0|||
155285568|NCT03255018|560478293|FG001|Overall Study|Death on study|5|||
155285569|NCT03255018|560478292|FG000|Overall Study|Withdrawal by Subject|0|||
155285570|NCT03255018|560478293|FG001|Overall Study|Withdrawal by Subject|2|||
155285571|NCT01720043|560478295|FG000|Overall Study|Withdrawal by Subject|1|||
155285572|NCT01688973|560478296|FG000|Overall Study|Ineligible|2|||
155285573|NCT01688973|560478297|FG001|Overall Study|Ineligible|3|||
155285574|NCT01124162|560478298|FG000|First Intervention|Adverse Event|2|||
155285575|NCT01124162|560478299|FG001|First Intervention|Adverse Event|0|||
155285576|NCT01124162|560478298|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155285577|NCT01124162|560478299|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155285578|NCT03613129|560478305|FG000|Pre-treatment Assessment|Protocol Violation|2|||
155285579|NCT03613129|560478306|FG001|Pre-treatment Assessment|Protocol Violation|0|||
155285580|NCT03613129|560478307|FG002|Pre-treatment Assessment|Protocol Violation|0|||
155285581|NCT03613129|560478308|FG003|Pre-treatment Assessment|Protocol Violation|0|||
155285582|NCT03613129|560478309|FG004|Pre-treatment Assessment|Protocol Violation|0|||
155285583|NCT03613129|560478305|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
155285584|NCT03613129|560478306|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285585|NCT03613129|560478307|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285586|NCT03613129|560478308|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285587|NCT03613129|560478309|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
155285588|NCT02534896|560478310|FG000|Overall Study|Adverse Event|2|||
155285589|NCT02534896|560478311|FG001|Overall Study|Adverse Event|1|||
155285590|NCT02534896|560478312|FG002|Overall Study|Adverse Event|1|||
155285591|NCT02534896|560478310|FG000|Overall Study|Insufficient therapeutic response|2|||
155285592|NCT02534896|560478311|FG001|Overall Study|Insufficient therapeutic response|0|||
155285593|NCT02534896|560478312|FG002|Overall Study|Insufficient therapeutic response|0|||
155285594|NCT00711646|560478315|FG000|Overall Study|Adverse Event|6|||
155285595|NCT00711646|560478316|FG001|Overall Study|Adverse Event|1|||
155285596|NCT00711646|560478315|FG000|Overall Study|Withdrawal by Subject|4|||
155285597|NCT00711646|560478316|FG001|Overall Study|Withdrawal by Subject|0|||
155285598|NCT00711646|560478315|FG000|Overall Study|Protocol Violation|0|||
155285599|NCT00711646|560478316|FG001|Overall Study|Protocol Violation|1|||
155285600|NCT00711646|560478315|FG000|Overall Study|Lost to Follow-up|1|||
155285601|NCT00711646|560478316|FG001|Overall Study|Lost to Follow-up|0|||
155285602|NCT00711646|560478315|FG000|Overall Study|administrative decision|0|||
155285603|NCT00711646|560478316|FG001|Overall Study|administrative decision|1|||
155285604|NCT00711646|560478315|FG000|Overall Study|patient non-compliance|1|||
155285605|NCT00711646|560478316|FG001|Overall Study|patient non-compliance|0|||
155285606|NCT03441360|560478317|FG000|Overall Study|Radiological disease progression|5|||
155285607|NCT03441360|560478318|FG001|Overall Study|Radiological disease progression|6|||
155285608|NCT03441360|560478319|FG002|Overall Study|Radiological disease progression|4|||
155285609|NCT03441360|560478317|FG000|Overall Study|Clinical disease progression|2|||
155285610|NCT03441360|560478318|FG001|Overall Study|Clinical disease progression|2|||
155285611|NCT03441360|560478319|FG002|Overall Study|Clinical disease progression|0|||
155285612|NCT03441360|560478317|FG000|Overall Study|Adverse Event|1|||
155285613|NCT03441360|560478318|FG001|Overall Study|Adverse Event|0|||
155285614|NCT03441360|560478319|FG002|Overall Study|Adverse Event|1|||
155285615|NCT00269399|560478320|FG000|Overall Study|Lack of Efficacy|27|||
155285616|NCT00269399|560478321|FG001|Overall Study|Lack of Efficacy|10|||
155285617|NCT00269399|560478320|FG000|Overall Study|Adverse Event|10|||
155285618|NCT00269399|560478321|FG001|Overall Study|Adverse Event|4|||
155285619|NCT00269399|560478320|FG000|Overall Study|Withdrawal by Subject|2|||
155285620|NCT00269399|560478321|FG001|Overall Study|Withdrawal by Subject|5|||
155285621|NCT00269399|560478320|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
155285622|NCT00269399|560478321|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
155285623|NCT00269399|560478320|FG000|Overall Study|Other|0|||
155285624|NCT00269399|560478321|FG001|Overall Study|Other|4|||
155285625|NCT00269399|560478320|FG000|Overall Study|Development of exclusion criteria|0|||
155285626|NCT00269399|560478321|FG001|Overall Study|Development of exclusion criteria|1|||
155285627|NCT03439124|560478322|FG000|Overall Study|Adverse Event|2|||
155285628|NCT03439124|560478323|FG001|Overall Study|Adverse Event|0|||
155285629|NCT03439124|560478322|FG000|Overall Study|Lost to Follow-up|1|||
155285630|NCT03439124|560478323|FG001|Overall Study|Lost to Follow-up|0|||
155285631|NCT03439124|560478322|FG000|Overall Study|Other reasons|1|||
155285632|NCT03439124|560478323|FG001|Overall Study|Other reasons|0|||
155285633|NCT04353037|560478324|FG000|Overall Study|Lost to Follow-up|0|||
155285634|NCT04353037|560478325|FG001|Overall Study|Lost to Follow-up|1|||
155285635|NCT04353037|560478326|FG002|Overall Study|Lost to Follow-up|2|||
155285636|NCT04353037|560478327|FG003|Overall Study|Lost to Follow-up|3|||
155285637|NCT04353037|560478324|FG000|Overall Study|Withdrawal by Subject|0|||
155285638|NCT04353037|560478325|FG001|Overall Study|Withdrawal by Subject|2|||
155285639|NCT04353037|560478326|FG002|Overall Study|Withdrawal by Subject|3|||
155285640|NCT04353037|560478327|FG003|Overall Study|Withdrawal by Subject|5|||
155285641|NCT04353037|560478324|FG000|Overall Study|Adverse Event|0|||
154954658|NCT01389102|559259640|FG001|Overall Study|Protocol Violation|0|||
155285642|NCT04353037|560478325|FG001|Overall Study|Adverse Event|0|||
155285643|NCT04353037|560478326|FG002|Overall Study|Adverse Event|2|||
155285644|NCT04353037|560478327|FG003|Overall Study|Adverse Event|0|||
155285645|NCT04353037|560478324|FG000|Overall Study|Exposure Change|0|||
155285646|NCT04353037|560478325|FG001|Overall Study|Exposure Change|0|||
155285647|NCT04353037|560478326|FG002|Overall Study|Exposure Change|0|||
155285648|NCT04353037|560478327|FG003|Overall Study|Exposure Change|2|||
155285649|NCT03101592|560478329|FG000|Overall Study|participant files could not be located|111|||
155285650|NCT03101592|560478330|FG001|Overall Study|participant files could not be located|170|||
155285651|NCT03101592|560478331|FG002|Overall Study|participant files could not be located|118|||
155285652|NCT00647348|560478332|FG000|Overall Study|Lost to Follow-up|3|||
155285653|NCT00647348|560478333|FG001|Overall Study|Lost to Follow-up|6|||
155285654|NCT02219490|560478339|FG000|Overall Study|Adverse Event|24|||
155285655|NCT02219490|560478339|FG000|Overall Study|Withdrew consent|96|||
155285656|NCT02219490|560478339|FG000|Overall Study|Lost to Follow-up|126|||
155285657|NCT02219490|560478339|FG000|Overall Study|COVID-19 infection|2|||
155285658|NCT02219490|560478339|FG000|Overall Study|COVID-19 logistical restrictions|33|||
155285659|NCT02219490|560478339|FG000|Overall Study|Other, not specified|57|||
155285660|NCT01928940|560478343|FG000|Overall Study|Adverse Event|0|||
155285661|NCT01928940|560478344|FG001|Overall Study|Adverse Event|1|||
155285662|NCT01352507|560478347|FG000|Treatment Period 1|Adverse Event|3|||
155285663|NCT01352507|560478348|FG001|Treatment Period 1|Adverse Event|0|||
155285664|NCT01352507|560478347|FG000|Treatment Period 1|Lost to Follow-up|3|||
155285665|NCT01352507|560478348|FG001|Treatment Period 1|Lost to Follow-up|4|||
155285666|NCT01352507|560478347|FG000|Treatment Period 1|Withdrawal by Subject|7|||
155285667|NCT01352507|560478348|FG001|Treatment Period 1|Withdrawal by Subject|5|||
155285668|NCT01352507|560478347|FG000|Treatment Period 1|Physician Decision|1|||
155285669|NCT01352507|560478348|FG001|Treatment Period 1|Physician Decision|0|||
155285670|NCT01352507|560478347|FG000|Washout Period|Withdrawal by Subject|0|||
155285671|NCT01352507|560478348|FG001|Washout Period|Withdrawal by Subject|1|||
155285672|NCT01352507|560478347|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
155285673|NCT01352507|560478348|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
155285674|NCT01352507|560478347|FG000|Treatment Period 2|Withdrawal by Subject|4|||
155285675|NCT01352507|560478348|FG001|Treatment Period 2|Withdrawal by Subject|3|||
155285676|NCT01352507|560478347|FG000|Treatment Period 2|Lack of Efficacy|1|||
155285677|NCT01352507|560478348|FG001|Treatment Period 2|Lack of Efficacy|0|||
155285678|NCT03178201|560478349|FG000|Overall Study|Off study|5|||
155285679|NCT04668144|560478350|FG000|Overall Study|Protocol Violation|0|||
155285680|NCT04668144|560478351|FG001|Overall Study|Protocol Violation|1|||
155285681|NCT04668144|560478352|FG002|Overall Study|Protocol Violation|2|||
155285682|NCT02095158|560478356|FG000|Overall Study|Adverse Event|14|||
155285683|NCT02095158|560478356|FG000|Overall Study|Lack of Efficacy|3|||
155285684|NCT02095158|560478356|FG000|Overall Study|Pregnancy|1|||
155285685|NCT02095158|560478356|FG000|Overall Study|Lost to Follow-up|20|||
155285686|NCT02095158|560478356|FG000|Overall Study|Personal Reasons|35|||
155285687|NCT02095158|560478356|FG000|Overall Study|Protocol Violation|1|||
155285688|NCT02095158|560478356|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155285689|NCT00320489|560478357|FG000|Overall Study|Adverse Event|26|||
155285690|NCT00320489|560478358|FG001|Overall Study|Adverse Event|25|||
155285691|NCT00320489|560478357|FG000|Overall Study|Clinical Relapse|26|||
155285692|NCT00320489|560478358|FG001|Overall Study|Clinical Relapse|20|||
155285693|NCT00320489|560478357|FG000|Overall Study|Death|0|||
155285694|NCT00320489|560478358|FG001|Overall Study|Death|2|||
155285695|NCT00320489|560478357|FG000|Overall Study|Entry Criteria Exclusion|2|||
155285696|NCT00320489|560478358|FG001|Overall Study|Entry Criteria Exclusion|4|||
155285697|NCT00320489|560478357|FG000|Overall Study|Lack of Efficacy|16|||
155285698|NCT00320489|560478358|FG001|Overall Study|Lack of Efficacy|7|||
155285699|NCT00320489|560478357|FG000|Overall Study|Lost to Follow-up|21|||
155285700|NCT00320489|560478358|FG001|Overall Study|Lost to Follow-up|22|||
155285701|NCT00320489|560478357|FG000|Overall Study|Physician Decision|8|||
155285702|NCT00320489|560478358|FG001|Overall Study|Physician Decision|8|||
155285703|NCT00320489|560478357|FG000|Overall Study|Protocol Violation|4|||
155285704|NCT00320489|560478358|FG001|Overall Study|Protocol Violation|4|||
155285705|NCT00320489|560478357|FG000|Overall Study|Sponsor Decision|3|||
155285706|NCT00320489|560478358|FG001|Overall Study|Sponsor Decision|3|||
155285707|NCT00320489|560478357|FG000|Overall Study|Withdrawal by Subject|39|||
155285708|NCT00320489|560478358|FG001|Overall Study|Withdrawal by Subject|41|||
155285709|NCT01872611|560478360|FG000|Overall Study|Adverse Event|3|||
154954659|NCT01389102|559259641|FG002|Overall Study|Protocol Violation|3|||
155155317|NCT00079417|560006350|FG000|Overall Study|Physician Decision|2|||
155155318|NCT00079417|560006350|FG000|Overall Study|Ineligible|7|||
155285710|NCT01872611|560478361|FG001|Overall Study|Adverse Event|1|||
155285711|NCT01872611|560478360|FG000|Overall Study|Adverse Event, prior to treatment|0|||
155285712|NCT01872611|560478361|FG001|Overall Study|Adverse Event, prior to treatment|1|||
155285713|NCT01872611|560478360|FG000|Overall Study|Death|0|||
155285714|NCT01872611|560478361|FG001|Overall Study|Death|1|||
155285715|NCT01872611|560478360|FG000|Overall Study|Death, prior to treatment|0|||
155285716|NCT01872611|560478361|FG001|Overall Study|Death, prior to treatment|1|||
155285717|NCT01872611|560478360|FG000|Overall Study|Lost to Follow-up|8|||
155285718|NCT01872611|560478361|FG001|Overall Study|Lost to Follow-up|1|||
155285719|NCT01872611|560478360|FG000|Overall Study|Physician Decision|1|||
155285720|NCT01872611|560478361|FG001|Overall Study|Physician Decision|0|||
155285721|NCT01872611|560478360|FG000|Overall Study|Withdrawal by Subject|6|||
155285722|NCT01872611|560478361|FG001|Overall Study|Withdrawal by Subject|1|||
155285723|NCT01872611|560478360|FG000|Overall Study|Reason not provided|6|||
155285724|NCT01872611|560478361|FG001|Overall Study|Reason not provided|6|||
155285725|NCT03441984|560478362|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285726|NCT03441984|560478363|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285727|NCT03441984|560478364|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
155285728|NCT03441984|560478365|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285729|NCT03441984|560478366|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285730|NCT03441984|560478367|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285731|NCT03441984|560478368|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285732|NCT03441984|560478369|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285733|NCT03441984|560478370|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285734|NCT03441984|560478371|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285735|NCT03441984|560478372|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285736|NCT03441984|560478373|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
155285737|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
155285738|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
155285739|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
155285740|NCT03537651|560478378|FG000|Part A (Up to 96 Weeks)|Other|1|||
155285741|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
155285742|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
155285743|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
155285744|NCT03537651|560478378|FG000|Part B (Up to 192 Weeks)|Other|1|||
155285745|NCT01835899|560478379|FG000|Overall Study|Adverse Event|0|||
155285746|NCT01835899|560478380|FG001|Overall Study|Adverse Event|0|||
155285747|NCT01835899|560478381|FG002|Overall Study|Adverse Event|1|||
155285748|NCT01835899|560478379|FG000|Overall Study|Other than stated above|0|||
155285749|NCT01835899|560478380|FG001|Overall Study|Other than stated above|1|||
155285750|NCT01835899|560478381|FG002|Overall Study|Other than stated above|0|||
155285751|NCT04939428|560478384|FG000|Overall Study|Death|0|||
155285752|NCT04939428|560478385|FG001|Overall Study|Death|1|||
155285753|NCT04939428|560478386|FG002|Overall Study|Death|0|||
155285754|NCT04939428|560478384|FG000|Overall Study|Lost to Follow-up|0|||
155285755|NCT04939428|560478385|FG001|Overall Study|Lost to Follow-up|5|||
155285756|NCT04939428|560478386|FG002|Overall Study|Lost to Follow-up|0|||
155285757|NCT04939428|560478384|FG000|Overall Study|Physician Decision|1|||
155285758|NCT04939428|560478385|FG001|Overall Study|Physician Decision|0|||
155285759|NCT04939428|560478386|FG002|Overall Study|Physician Decision|0|||
155285760|NCT04939428|560478384|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155285761|NCT04939428|560478385|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155285762|NCT04939428|560478386|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155285763|NCT04939428|560478384|FG000|Overall Study|Withdrawal by Subject|10|||
155285764|NCT04939428|560478385|FG001|Overall Study|Withdrawal by Subject|11|||
155285765|NCT04939428|560478386|FG002|Overall Study|Withdrawal by Subject|0|||
155285766|NCT04939428|560478384|FG000|Overall Study|Unkown|6|||
155285767|NCT04939428|560478385|FG001|Overall Study|Unkown|3|||
155285768|NCT04939428|560478386|FG002|Overall Study|Unkown|0|||
155285769|NCT04939428|560478384|FG000|Overall Study|Discotinued per protocol|0|||
155285770|NCT04939428|560478385|FG001|Overall Study|Discotinued per protocol|0|||
155285771|NCT04939428|560478386|FG002|Overall Study|Discotinued per protocol|902|||
155285772|NCT04319094|560478387|FG000|Baseline|Lost to Follow-up|4|||
155285773|NCT04319094|560478388|FG001|Baseline|Lost to Follow-up|5|||
155285774|NCT04319094|560478387|FG000|Baseline|Protocol Violation|0|||
155285775|NCT04319094|560478388|FG001|Baseline|Protocol Violation|3|||
155285776|NCT04319094|560478387|FG000|Baseline|Withdrawal by Subject|2|||
155285777|NCT04319094|560478388|FG001|Baseline|Withdrawal by Subject|1|||
155285778|NCT04319094|560478387|FG000|Post-Intervention|Death|0|||
155285779|NCT04319094|560478388|FG001|Post-Intervention|Death|1|||
155285780|NCT04319094|560478387|FG000|Post-Intervention|Lost to Follow-up|4|||
154954660|NCT01389102|559259642|FG003|Overall Study|Protocol Violation|0|||
155285781|NCT04319094|560478388|FG001|Post-Intervention|Lost to Follow-up|4|||
154954661|NCT01389102|559259643|FG004|Overall Study|Protocol Violation|1|||
154954662|NCT01389102|559259644|FG005|Overall Study|Protocol Violation|1|||
154954663|NCT01389102|559259639|FG000|Overall Study|Withdrawal by Subject|7|||
154954664|NCT01389102|559259640|FG001|Overall Study|Withdrawal by Subject|4|||
154954665|NCT01389102|559259641|FG002|Overall Study|Withdrawal by Subject|9|||
154954666|NCT01389102|559259642|FG003|Overall Study|Withdrawal by Subject|2|||
154954667|NCT01389102|559259643|FG004|Overall Study|Withdrawal by Subject|3|||
154954668|NCT01389102|559259644|FG005|Overall Study|Withdrawal by Subject|3|||
154954669|NCT01389102|559259639|FG000|Overall Study|Subject Traveling Out of Country|0|||
154954670|NCT01389102|559259640|FG001|Overall Study|Subject Traveling Out of Country|0|||
154954671|NCT01389102|559259641|FG002|Overall Study|Subject Traveling Out of Country|0|||
154954672|NCT01389102|559259642|FG003|Overall Study|Subject Traveling Out of Country|1|||
154954673|NCT01389102|559259643|FG004|Overall Study|Subject Traveling Out of Country|0|||
155155319|NCT01615939|560006351|FG000|Overall Study|Lost to Follow-up|5|||
155155320|NCT01615939|560006352|FG001|Overall Study|Lost to Follow-up|0|||
155155321|NCT01586364|560006356|FG000|Overall Study|Withdrawal by Subject|40|||
155155322|NCT01586364|560006356|FG000|Overall Study|Adverse Event|37|||
155155323|NCT01586364|560006356|FG000|Overall Study|Lost to Follow-up|17|||
155155324|NCT01586364|560006356|FG000|Overall Study|Protocol Violation|16|||
155155325|NCT01586364|560006356|FG000|Overall Study|Lack of Efficacy|1|||
155155326|NCT01586364|560006356|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
155155327|NCT01586364|560006356|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
155155328|NCT01586364|560006356|FG000|Overall Study|Other-Site closure due to PI illness|1|||
155155329|NCT01586364|560006356|FG000|Overall Study|Other-PI discretion, site closing|2|||
155155330|NCT01586364|560006356|FG000|Overall Study|Other-Not specified|1|||
155155331|NCT02121535|560006357|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
155155332|NCT02121535|560006358|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
155155333|NCT02121535|560006357|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
155155334|NCT02121535|560006358|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
155155335|NCT04944992|560006359|FG000|Overall Study|Lost to Follow-up|1|||
155155336|NCT04944992|560006360|FG001|Overall Study|Lost to Follow-up|1|||
155155337|NCT04944992|560006359|FG000|Overall Study|Physician Decision|1|||
155155338|NCT04944992|560006360|FG001|Overall Study|Physician Decision|0|||
155155339|NCT04944992|560006359|FG000|Overall Study|Withdrawal by Subject|6|||
155155340|NCT04944992|560006360|FG001|Overall Study|Withdrawal by Subject|1|||
155155341|NCT00091949|560006361|FG000|Overall Study|Withdrawal by Subject|117|||
155155342|NCT00091949|560006362|FG001|Overall Study|Withdrawal by Subject|110|||
155155343|NCT00091949|560006361|FG000|Overall Study|Lost to Follow-up|58|||
155155344|NCT00091949|560006362|FG001|Overall Study|Lost to Follow-up|41|||
155155345|NCT00303069|560006363|FG000|Overall Study|Lost to Follow-up|1|||
155155346|NCT00303069|560006364|FG001|Overall Study|Lost to Follow-up|0|||
155155347|NCT00303069|560006365|FG002|Overall Study|Lost to Follow-up|0|||
155155348|NCT00303069|560006366|FG003|Overall Study|Lost to Follow-up|2|||
155155349|NCT00303069|560006363|FG000|Overall Study|subject moved|1|||
155155350|NCT00303069|560006364|FG001|Overall Study|subject moved|0|||
155155351|NCT00303069|560006365|FG002|Overall Study|subject moved|0|||
155155352|NCT00303069|560006366|FG003|Overall Study|subject moved|0|||
155155353|NCT00303069|560006363|FG000|Overall Study|Recruitment into Army Reserves|0|||
155155354|NCT00303069|560006364|FG001|Overall Study|Recruitment into Army Reserves|0|||
155155355|NCT00303069|560006365|FG002|Overall Study|Recruitment into Army Reserves|1|||
155155356|NCT00303069|560006366|FG003|Overall Study|Recruitment into Army Reserves|0|||
155155357|NCT01520506|560006367|FG000|Overall Study|Missed Visit|4|||
155155358|NCT01520506|560006367|FG000|Overall Study|Lost to Follow-up|1|||
155155359|NCT01520506|560006367|FG000|Overall Study|Withdrawal by Subject|1|||
155155360|NCT01256788|560006372|FG000|Overall Study|Lost to Follow-up|5|||
155155361|NCT01256788|560006373|FG001|Overall Study|Lost to Follow-up|8|||
155155362|NCT01256788|560006374|FG002|Overall Study|Lost to Follow-up|3|||
155155363|NCT01972217|560006375|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
155155364|NCT01972217|560006376|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
155155365|NCT01972217|560006377|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
155155366|NCT01972217|560006378|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
155155367|NCT01972217|560006375|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
155155368|NCT01972217|560006376|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
155155369|NCT01972217|560006377|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
155155370|NCT01972217|560006378|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
155155371|NCT01972217|560006375|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
155155372|NCT01972217|560006376|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
155155373|NCT01972217|560006377|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
155155374|NCT01972217|560006378|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
155155375|NCT01972217|560006375|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
155155376|NCT01972217|560006376|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
155155377|NCT01972217|560006377|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
155155378|NCT01972217|560006378|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
155155379|NCT01972217|560006375|FG000|Part B Double-blind, Randomised Period|Death|0|||
155155380|NCT01972217|560006376|FG001|Part B Double-blind, Randomised Period|Death|0|||
155155381|NCT01972217|560006377|FG002|Part B Double-blind, Randomised Period|Death|43|||
155155382|NCT01972217|560006378|FG003|Part B Double-blind, Randomised Period|Death|44|||
155155383|NCT01972217|560006375|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
155155384|NCT01972217|560006376|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
155155385|NCT01972217|560006377|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
155155386|NCT01972217|560006378|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
155155387|NCT01972217|560006375|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
155155388|NCT01972217|560006376|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
155155389|NCT01972217|560006377|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
155285782|NCT04319094|560478387|FG000|Post-Intervention|Withdrawal by Subject|8|||
155285783|NCT04319094|560478388|FG001|Post-Intervention|Withdrawal by Subject|5|||
155285784|NCT04319094|560478387|FG000|Post-Intervention|Incomplete Data Collection|1|||
155285785|NCT04319094|560478388|FG001|Post-Intervention|Incomplete Data Collection|3|||
155285786|NCT04319094|560478387|FG000|3-month|Death|1|||
155285787|NCT04319094|560478388|FG001|3-month|Death|0|||
155285788|NCT04319094|560478387|FG000|3-month|Lost to Follow-up|2|||
155285789|NCT04319094|560478388|FG001|3-month|Lost to Follow-up|2|||
155285790|NCT04319094|560478387|FG000|3-month|Withdrawal by Subject|0|||
155285791|NCT04319094|560478388|FG001|3-month|Withdrawal by Subject|3|||
155285792|NCT04319094|560478387|FG000|3-month|Incomplete data collection|9|||
155285793|NCT04319094|560478388|FG001|3-month|Incomplete data collection|7|||
155285794|NCT04319094|560478387|FG000|6-month|Lost to Follow-up|1|||
155285795|NCT04319094|560478388|FG001|6-month|Lost to Follow-up|1|||
155285796|NCT04319094|560478387|FG000|6-month|Withdrawal by Subject|0|||
155285797|NCT04319094|560478388|FG001|6-month|Withdrawal by Subject|3|||
155285798|NCT04319094|560478387|FG000|6-month|Incomplete data collection|14|||
155285799|NCT04319094|560478388|FG001|6-month|Incomplete data collection|9|||
155285800|NCT04319094|560478387|FG000|9-month|Lost to Follow-up|8|||
155285801|NCT04319094|560478388|FG001|9-month|Lost to Follow-up|4|||
155285802|NCT04319094|560478387|FG000|9-month|Withdrawal by Subject|0|||
155285803|NCT04319094|560478388|FG001|9-month|Withdrawal by Subject|1|||
155285804|NCT04319094|560478387|FG000|9-month|Incomplete data collection|8|||
155285805|NCT04319094|560478388|FG001|9-month|Incomplete data collection|5|||
155285806|NCT04319094|560478387|FG000|12-month|Lost to Follow-up|11|||
155285807|NCT04319094|560478388|FG001|12-month|Lost to Follow-up|8|||
155285808|NCT00877851|560478389|FG000|Overall Study|Lost to Follow-up|5|||
155285809|NCT00877851|560478390|FG001|Overall Study|Lost to Follow-up|5|||
155285810|NCT00877851|560478389|FG000|Overall Study|computer problem|3|||
155285811|NCT00877851|560478390|FG001|Overall Study|computer problem|0|||
155285812|NCT00877851|560478389|FG000|Overall Study|no longer interested in participating|1|||
155285813|NCT00877851|560478390|FG001|Overall Study|no longer interested in participating|0|||
155285814|NCT03285711|560478391|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
155285815|NCT03285711|560478392|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
155285816|NCT03285711|560478393|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
155285817|NCT03285711|560478394|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
155285818|NCT03285711|560478391|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
155285819|NCT03285711|560478392|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
155285820|NCT03285711|560478393|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
155285821|NCT03285711|560478394|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
155285822|NCT03285711|560478391|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
155285823|NCT03285711|560478392|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
155285824|NCT03285711|560478393|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
155285825|NCT03285711|560478394|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
155285826|NCT03285711|560478391|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
155285827|NCT03285711|560478392|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
155285828|NCT03285711|560478393|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
155285829|NCT03285711|560478394|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
155285830|NCT03424239|560478395|FG000|Overall Study|Withdrawal by Subject|2|||
155285831|NCT00770211|560478396|FG000|Overall Study|Lost to Follow-up|1|||
155285832|NCT00770211|560478397|FG001|Overall Study|Lost to Follow-up|0|||
155285833|NCT00770211|560478396|FG000|Overall Study|Withdrawal by Subject|0|||
155285834|NCT00770211|560478397|FG001|Overall Study|Withdrawal by Subject|2|||
155285835|NCT00318656|560478399|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
155058986|NCT02230891|559650377|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
155058987|NCT03087058|559650379|FG000|Overall Study|Withdrawal by Subject|2|||
155058988|NCT03087058|559650380|FG001|Overall Study|Withdrawal by Subject|0|||
155058989|NCT03087058|559650381|FG002|Overall Study|Withdrawal by Subject|0|||
155058990|NCT05158140|559650382|FG000|Overall Study|Death|0|||
155285836|NCT00318656|560478400|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
155285837|NCT00318656|560478399|FG000|Overall Study|Did not receive any treatment|0|||
155285838|NCT00318656|560478400|FG001|Overall Study|Did not receive any treatment|1|||
155285839|NCT01446003|560478401|FG000|Period 1|Protocol Violation|2|||
155285840|NCT01446003|560478402|FG001|Period 1|Protocol Violation|0|||
155285841|NCT01446003|560478401|FG000|Period 2|Adverse Event|1|||
155285842|NCT01446003|560478402|FG001|Period 2|Adverse Event|0|||
155285843|NCT03905135|560478403|FG000|Dose Escalation|Adverse Event|1|||
155285844|NCT03905135|560478404|FG001|Dose Escalation|Adverse Event|1|||
155285845|NCT03905135|560478403|FG000|Dose Escalation|Progressive disease|3|||
155285846|NCT03905135|560478404|FG001|Dose Escalation|Progressive disease|1|||
155285847|NCT03905135|560478403|FG000|Dose Escalation|Intercurrent illness|1|||
155285848|NCT03905135|560478404|FG001|Dose Escalation|Intercurrent illness|0|||
155285849|NCT01740557|560478405|FG000|Overall Study|Ineligible|1|||
155285850|NCT01740557|560478405|FG000|Overall Study|Screen failure|1|||
155285851|NCT00490555|560478406|FG000|Overall Study|noncompliant with drug administration|0|||
155285852|NCT00490555|560478407|FG001|Overall Study|noncompliant with drug administration|0|||
155285853|NCT00490555|560478408|FG002|Overall Study|noncompliant with drug administration|2|||
155285854|NCT00490555|560478409|FG003|Overall Study|noncompliant with drug administration|0|||
155285855|NCT02042443|560478410|FG000|Overall Study|Adverse Event|2|||
155285856|NCT02042443|560478411|FG001|Overall Study|Adverse Event|1|||
155285857|NCT02042443|560478410|FG000|Overall Study|Withdrawal by Subject|0|||
155285858|NCT02042443|560478411|FG001|Overall Study|Withdrawal by Subject|1|||
155285859|NCT02042443|560478410|FG000|Overall Study|Progression|21|||
155285860|NCT02042443|560478411|FG001|Overall Study|Progression|17|||
155155390|NCT01972217|560006378|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
155155391|NCT01972217|560006375|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
155155392|NCT01972217|560006376|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
155155393|NCT01972217|560006377|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
155155394|NCT01972217|560006378|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
155155395|NCT01972217|560006375|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
155155396|NCT01972217|560006376|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
155155397|NCT01972217|560006377|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
155155398|NCT01972217|560006378|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
155155399|NCT05366738|560006379|FG000|Overall Study|Adverse Event|0|||
155155400|NCT05366738|560006380|FG001|Overall Study|Adverse Event|1|||
155155401|NCT05366738|560006381|FG002|Overall Study|Adverse Event|0|||
155155402|NCT04639245|560006388|FG000|Overall Study|Death|1|||
155155403|NCT00535496|560006389|FG000|Overall Study|Lost to Follow-up|0|||
155155404|NCT00535496|560006390|FG001|Overall Study|Lost to Follow-up|1|||
155155405|NCT00535496|560006391|FG002|Overall Study|Lost to Follow-up|0|||
155155406|NCT00535496|560006392|FG003|Overall Study|Lost to Follow-up|0|||
155155407|NCT00535496|560006389|FG000|Overall Study|Not treated with sugammadex|0|||
155155408|NCT00535496|560006390|FG001|Overall Study|Not treated with sugammadex|1|||
155155409|NCT00535496|560006391|FG002|Overall Study|Not treated with sugammadex|0|||
155155410|NCT00535496|560006392|FG003|Overall Study|Not treated with sugammadex|0|||
155155411|NCT03175367|560006394|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155155412|NCT03175367|560006395|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155155413|NCT03175367|560006396|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
155155414|NCT03175367|560006397|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
155155415|NCT03175367|560006398|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155155416|NCT03175367|560006399|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
155155417|NCT03175367|560006400|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
155155418|NCT03175367|560006394|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155155419|NCT03175367|560006395|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155155420|NCT03175367|560006396|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155155421|NCT03175367|560006397|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155155422|NCT03175367|560006398|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
155155423|NCT03175367|560006399|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155155424|NCT03175367|560006400|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
155155425|NCT03175367|560006394|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155155426|NCT03175367|560006395|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155155427|NCT03175367|560006396|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
155155428|NCT03175367|560006397|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
155155429|NCT03175367|560006398|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155155430|NCT03175367|560006399|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155155431|NCT03175367|560006400|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155285861|NCT02042443|560478410|FG000|Overall Study|not protocol specified|1|||
155285862|NCT02042443|560478411|FG001|Overall Study|not protocol specified|1|||
155285863|NCT02042443|560478410|FG000|Overall Study|Not eligible/not analyzable|3|||
155155432|NCT03175367|560006394|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
155155433|NCT03175367|560006395|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
155155434|NCT03175367|560006396|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
155155435|NCT03175367|560006397|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
155155436|NCT03175367|560006398|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155155437|NCT03175367|560006399|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155155438|NCT03175367|560006400|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155155439|NCT03175367|560006394|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155155440|NCT03175367|560006395|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155155441|NCT03175367|560006396|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
155155442|NCT03175367|560006397|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155155443|NCT03175367|560006398|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
155285864|NCT02042443|560478411|FG001|Overall Study|Not eligible/not analyzable|6|||
155285865|NCT01007149|560478414|FG000|Overall Study|Administrative problems|0|||
154954674|NCT01389102|559259644|FG005|Overall Study|Subject Traveling Out of Country|0|||
154954675|NCT01389102|559259639|FG000|Overall Study|Subject Moved|2|||
154954676|NCT01389102|559259640|FG001|Overall Study|Subject Moved|0|||
154954677|NCT01389102|559259641|FG002|Overall Study|Subject Moved|1|||
154954678|NCT01389102|559259642|FG003|Overall Study|Subject Moved|0|||
154954679|NCT01389102|559259643|FG004|Overall Study|Subject Moved|0|||
154954680|NCT01389102|559259644|FG005|Overall Study|Subject Moved|0|||
154954681|NCT01389102|559259639|FG000|Overall Study|Unavailable due to husband's illness|0|||
154954682|NCT01389102|559259640|FG001|Overall Study|Unavailable due to husband's illness|1|||
154954683|NCT01389102|559259641|FG002|Overall Study|Unavailable due to husband's illness|0|||
155058991|NCT05158140|559650383|FG001|Overall Study|Death|0|||
155058992|NCT05158140|559650384|FG002|Overall Study|Death|0|||
155058993|NCT05158140|559650385|FG003|Overall Study|Death|1|||
155058994|NCT05158140|559650382|FG000|Overall Study|Lost to Follow-up|3|||
155058995|NCT05158140|559650383|FG001|Overall Study|Lost to Follow-up|6|||
155058996|NCT05158140|559650384|FG002|Overall Study|Lost to Follow-up|4|||
155058997|NCT05158140|559650385|FG003|Overall Study|Lost to Follow-up|3|||
155058998|NCT05158140|559650382|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155058999|NCT05158140|559650383|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155059000|NCT05158140|559650384|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
155059001|NCT05158140|559650385|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155059002|NCT05158140|559650382|FG000|Overall Study|Withdrawal by Subject|3|||
155059003|NCT05158140|559650383|FG001|Overall Study|Withdrawal by Subject|7|||
155059004|NCT05158140|559650384|FG002|Overall Study|Withdrawal by Subject|3|||
155059005|NCT05158140|559650385|FG003|Overall Study|Withdrawal by Subject|7|||
155059006|NCT00921024|559650386|FG000|Overall Study|Lost to Follow-up|2|||
155059007|NCT00921024|559650387|FG001|Overall Study|Lost to Follow-up|0|||
155059008|NCT00921024|559650386|FG000|Overall Study|Received concomittant therapy|2|||
155059009|NCT00921024|559650387|FG001|Overall Study|Received concomittant therapy|0|||
155059010|NCT00921024|559650386|FG000|Overall Study|Withdrawal by Subject|0|||
155059011|NCT00921024|559650387|FG001|Overall Study|Withdrawal by Subject|3|||
155059012|NCT02873689|559651786|FG000|Overall Study|Lack of Efficacy|1|||
155059013|NCT02873689|559651787|FG001|Overall Study|Lack of Efficacy|0|||
155059014|NCT02873689|559651786|FG000|Overall Study|Withdrawal by Subject|2|||
155059015|NCT02873689|559651787|FG001|Overall Study|Withdrawal by Subject|2|||
155059016|NCT02873689|559651786|FG000|Overall Study|Protocol Violation|1|||
155059017|NCT02873689|559651787|FG001|Overall Study|Protocol Violation|0|||
155059018|NCT02873689|559651786|FG000|Overall Study|Adverse Event|2|||
155059019|NCT02873689|559651787|FG001|Overall Study|Adverse Event|2|||
155059020|NCT02873689|559651786|FG000|Overall Study|Randomized but not Treated|1|||
155059021|NCT02873689|559651787|FG001|Overall Study|Randomized but not Treated|1|||
155059022|NCT00434252|559651788|FG000|Overall Study|Lack of Efficacy|50|||
155059023|NCT00434252|559651789|FG001|Overall Study|Lack of Efficacy|100|||
155059024|NCT00434252|559651788|FG000|Overall Study|Adverse Event|6|||
155059025|NCT00434252|559651789|FG001|Overall Study|Adverse Event|13|||
155059026|NCT00434252|559651788|FG000|Overall Study|Death|1|||
155059027|NCT00434252|559651789|FG001|Overall Study|Death|2|||
155059028|NCT00434252|559651788|FG000|Overall Study|Lost to Follow-up|0|||
155059029|NCT00434252|559651789|FG001|Overall Study|Lost to Follow-up|1|||
155059030|NCT00434252|559651788|FG000|Overall Study|Physician Decision|4|||
155059031|NCT00434252|559651789|FG001|Overall Study|Physician Decision|8|||
155059032|NCT00434252|559651788|FG000|Overall Study|Withdrawal by Subject|3|||
155059033|NCT00434252|559651789|FG001|Overall Study|Withdrawal by Subject|7|||
155059034|NCT01898078|559651799|FG000|Overall Study|Progressive Disease|1|||
155059035|NCT01898078|559651800|FG001|Overall Study|Progressive Disease|5|||
155059036|NCT01898078|559651799|FG000|Overall Study|Adverse Event|2|||
155059037|NCT01898078|559651800|FG001|Overall Study|Adverse Event|1|||
155059038|NCT01898078|559651799|FG000|Overall Study|Withdrawal by Subject|1|||
155059039|NCT01898078|559651800|FG001|Overall Study|Withdrawal by Subject|1|||
155059040|NCT01898078|559651799|FG000|Overall Study|Symptomatic Deterioration|2|||
155059041|NCT01898078|559651800|FG001|Overall Study|Symptomatic Deterioration|0|||
155285866|NCT01007149|560478415|FG001|Overall Study|Administrative problems|1|||
155285867|NCT02784704|560478416|FG000|Overall Study|Adverse Event|4|||
155285868|NCT02784704|560478417|FG001|Overall Study|Adverse Event|2|||
155285869|NCT02784704|560478416|FG000|Overall Study|Lost to Follow-up|6|||
155285870|NCT02784704|560478417|FG001|Overall Study|Lost to Follow-up|4|||
155285871|NCT02784704|560478416|FG000|Overall Study|Withdrawal by Subject|1|||
155285872|NCT02784704|560478417|FG001|Overall Study|Withdrawal by Subject|3|||
155285873|NCT02784704|560478416|FG000|Overall Study|Subject Non Compliance|2|||
155285874|NCT02784704|560478417|FG001|Overall Study|Subject Non Compliance|0|||
155285875|NCT01913340|560478418|FG000|Overall Study|Death|2|||
155285876|NCT01913340|560478419|FG001|Overall Study|Death|5|||
155285877|NCT01913340|560478418|FG000|Overall Study|Lost to Follow-up|1|||
155285878|NCT01913340|560478419|FG001|Overall Study|Lost to Follow-up|1|||
155285879|NCT00603538|560478420|FG000|Overall Study|Adverse Event|0|||
155285880|NCT00603538|560478421|FG001|Overall Study|Adverse Event|4|||
155285881|NCT00603538|560478422|FG002|Overall Study|Adverse Event|2|||
155285882|NCT00603538|560478420|FG000|Overall Study|Objective progression or relapse|3|||
155285883|NCT00603538|560478421|FG001|Overall Study|Objective progression or relapse|0|||
155285884|NCT00603538|560478422|FG002|Overall Study|Objective progression or relapse|0|||
155285885|NCT05750745|560478424|FG000|Overall Study|Adverse Event|1|||
155285886|NCT05750745|560478425|FG001|Overall Study|Adverse Event|0|||
155285887|NCT05750745|560478426|FG002|Overall Study|Adverse Event|0|||
155285888|NCT05750745|560478424|FG000|Overall Study|Protocol Violation|1|||
155285889|NCT05750745|560478425|FG001|Overall Study|Protocol Violation|0|||
155285890|NCT05750745|560478426|FG002|Overall Study|Protocol Violation|0|||
155285891|NCT05750745|560478424|FG000|Overall Study|Withdrawal by Subject|0|||
155285892|NCT05750745|560478425|FG001|Overall Study|Withdrawal by Subject|1|||
155285893|NCT05750745|560478426|FG002|Overall Study|Withdrawal by Subject|0|||
155285894|NCT00938340|560478427|FG000|Overall Study|Withdrawal by Subject|3|||
155285895|NCT00938340|560478427|FG000|Overall Study|Protocol Violation|1|||
155285896|NCT00938340|560478427|FG000|Overall Study|Adverse Event|1|||
155285897|NCT03677375|560478431|FG000|Overall Study|Incomplete procedure|8|||
155285898|NCT03677375|560478431|FG000|Overall Study|Adverse Event|3|||
155285899|NCT03677375|560478431|FG000|Overall Study|Physician Decision|1|||
155285900|NCT00725010|560478432|FG000|Overall Study|Toxicity|9|||
155285901|NCT00725010|560478432|FG000|Overall Study|Tumor Progression|7|||
155285902|NCT00725010|560478432|FG000|Overall Study|Withdrawal by Subject|2|||
155285903|NCT00725010|560478432|FG000|Overall Study|Death|1|||
155285904|NCT00725010|560478432|FG000|Overall Study|Lost to Follow-up|1|||
155285905|NCT00725010|560478432|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
155285906|NCT00725010|560478432|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
155285907|NCT00725010|560478432|FG000|Overall Study|No further documentation|1|||
155285908|NCT00725010|560478432|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
155285909|NCT03425539|560478433|FG000|Overall Study|Randomized but not treated|0|||
155285910|NCT03425539|560478434|FG001|Overall Study|Randomized but not treated|1|||
155285911|NCT03425539|560478433|FG000|Overall Study|Adverse Event|2|||
155285912|NCT03425539|560478434|FG001|Overall Study|Adverse Event|2|||
155285913|NCT03425539|560478433|FG000|Overall Study|Withdrawal by Subject|3|||
155285914|NCT03425539|560478434|FG001|Overall Study|Withdrawal by Subject|0|||
155285915|NCT03425539|560478433|FG000|Overall Study|Lost to Follow-up|0|||
155285916|NCT03425539|560478434|FG001|Overall Study|Lost to Follow-up|1|||
155285917|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
155285918|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
155285919|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
155285920|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
155285921|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
155285922|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
155285923|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
155285924|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
155285925|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Death|1|||
155285926|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Death|0|||
155285927|NCT01080131|560478435|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
155285928|NCT01080131|560478436|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
155285929|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
155285930|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
155285931|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
155285932|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
155285933|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
155285934|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
155285935|NCT01080131|560478435|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
155285936|NCT01080131|560478436|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
155285937|NCT01080131|560478435|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
155285938|NCT01080131|560478436|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
155285939|NCT01080131|560478435|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
155285940|NCT01080131|560478436|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
155285941|NCT01080131|560478435|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
155285942|NCT01080131|560478436|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
155285943|NCT00299702|560478437|FG000|Overall Study|Death|1|||
155285944|NCT00299702|560478438|FG001|Overall Study|Death|0|||
155285945|NCT00299702|560478437|FG000|Overall Study|Adverse Event|0|||
155285946|NCT00299702|560478438|FG001|Overall Study|Adverse Event|4|||
155285947|NCT00299702|560478437|FG000|Overall Study|Lost to Follow-up|18|||
155285948|NCT00299702|560478438|FG001|Overall Study|Lost to Follow-up|10|||
155285949|NCT00299702|560478437|FG000|Overall Study|Withdrawal by Subject|25|||
155285950|NCT00299702|560478438|FG001|Overall Study|Withdrawal by Subject|23|||
155285951|NCT00299702|560478437|FG000|Overall Study|Pregnancy|0|||
155285952|NCT00299702|560478438|FG001|Overall Study|Pregnancy|1|||
155285953|NCT00299702|560478437|FG000|Overall Study|Insufficient Response|4|||
155285954|NCT00299702|560478438|FG001|Overall Study|Insufficient Response|3|||
155285955|NCT00299702|560478437|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
155285956|NCT00299702|560478438|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
155285957|NCT01560949|560478439|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
155285958|NCT01560949|560478439|FG000|Surgery Phase|Physician Decision|3|||
155285959|NCT00751036|560478440|FG000|Overall Study|Disease Progression|28|||
155285960|NCT00751036|560478441|FG001|Overall Study|Disease Progression|29|||
155285961|NCT00751036|560478440|FG000|Overall Study|Adverse Event|6|||
155285962|NCT00751036|560478441|FG001|Overall Study|Adverse Event|4|||
155285963|NCT00751036|560478440|FG000|Overall Study|Administrative Problems|3|||
155285964|NCT00751036|560478441|FG001|Overall Study|Administrative Problems|4|||
155285965|NCT00751036|560478440|FG000|Overall Study|Withdrawal by Subject|5|||
155285966|NCT00751036|560478441|FG001|Overall Study|Withdrawal by Subject|2|||
155285967|NCT00751036|560478440|FG000|Overall Study|Death|3|||
155285968|NCT00751036|560478441|FG001|Overall Study|Death|3|||
155285969|NCT00751036|560478440|FG000|Overall Study|Lost to Follow-up|0|||
155285970|NCT00751036|560478441|FG001|Overall Study|Lost to Follow-up|1|||
155285971|NCT00751036|560478440|FG000|Overall Study|Protocol Violation|1|||
155285972|NCT00751036|560478441|FG001|Overall Study|Protocol Violation|0|||
155285973|NCT00751036|560478440|FG000|Overall Study|Missing end of Treatment Page|2|||
155285974|NCT00751036|560478441|FG001|Overall Study|Missing end of Treatment Page|3|||
155285975|NCT02738840|560480390|FG000|Overall Study|MRI Scan not Performed|5|||
155285976|NCT02738840|560480390|FG000|Overall Study|Lost to Follow-up|1|||
155285977|NCT02738840|560480390|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
155285978|NCT02738840|560480390|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
155285979|NCT00256308|560480396|FG000|Overall Study|Death|2|||
155285980|NCT01537133|560480397|FG000|Overall Study|Withdrawal by Subject|2|||
155285981|NCT01537133|560480398|FG001|Overall Study|Withdrawal by Subject|0|||
155285982|NCT01537133|560480399|FG002|Overall Study|Withdrawal by Subject|0|||
155285983|NCT01537133|560480400|FG003|Overall Study|Withdrawal by Subject|0|||
155285984|NCT01537133|560480397|FG000|Overall Study|Lost to Follow-up|1|||
155285985|NCT01537133|560480398|FG001|Overall Study|Lost to Follow-up|0|||
155285986|NCT01537133|560480399|FG002|Overall Study|Lost to Follow-up|0|||
155285987|NCT01537133|560480400|FG003|Overall Study|Lost to Follow-up|0|||
155285988|NCT02466516|560480403|FG000|Overall Study|Adverse Event|1|||
155285989|NCT02466516|560480404|FG001|Overall Study|Adverse Event|1|||
155285990|NCT02466516|560480405|FG002|Overall Study|Adverse Event|0|||
155285991|NCT02466516|560480406|FG003|Overall Study|Adverse Event|0|||
155285992|NCT02466516|560480407|FG004|Overall Study|Adverse Event|0|||
155285993|NCT02466516|560480403|FG000|Overall Study|Withdrew Consent|1|||
155285994|NCT02466516|560480404|FG001|Overall Study|Withdrew Consent|0|||
155285995|NCT02466516|560480405|FG002|Overall Study|Withdrew Consent|0|||
155285996|NCT02466516|560480406|FG003|Overall Study|Withdrew Consent|0|||
155285997|NCT02466516|560480407|FG004|Overall Study|Withdrew Consent|0|||
155285998|NCT02466516|560480403|FG000|Overall Study|Lost to Follow-up|2|||
155285999|NCT02466516|560480404|FG001|Overall Study|Lost to Follow-up|0|||
155286000|NCT02466516|560480405|FG002|Overall Study|Lost to Follow-up|1|||
155286001|NCT02466516|560480406|FG003|Overall Study|Lost to Follow-up|0|||
155286002|NCT02466516|560480407|FG004|Overall Study|Lost to Follow-up|0|||
155286003|NCT04358549|560480408|FG000|Overall Study|Adverse Event|0|||
155286004|NCT04358549|560480409|FG001|Overall Study|Adverse Event|1|||
155286005|NCT04358549|560480408|FG000|Overall Study|Death|1|||
155286006|NCT04358549|560480409|FG001|Overall Study|Death|0|||
155286007|NCT04358549|560480408|FG000|Overall Study|Lost to Follow-up|2|||
155286008|NCT04358549|560480409|FG001|Overall Study|Lost to Follow-up|1|||
155286009|NCT04358549|560480408|FG000|Overall Study|Withdrawal by Subject|6|||
155286010|NCT04358549|560480409|FG001|Overall Study|Withdrawal by Subject|6|||
155286011|NCT04358549|560480408|FG000|Overall Study|Start remdesivir|1|||
155286012|NCT04358549|560480409|FG001|Overall Study|Start remdesivir|0|||
155286013|NCT03712930|560480410|FG000|Overall Study|Death|7|||
155286014|NCT03712930|560480410|FG000|Overall Study|Physician Decision|1|||
155286015|NCT03712930|560480410|FG000|Overall Study|Study Terminated by Sponsor|3|||
155286016|NCT03712930|560480410|FG000|Overall Study|Progressive Disease|2|||
155286017|NCT01062126|560480414|FG000|Overall Study|Death|209|||
155286018|NCT01062126|560480414|FG000|Overall Study|All Withdrawals|324|||
155286019|NCT00646451|560480415|FG000|Overall Study|Adverse Event|3|||
155286020|NCT00646451|560480416|FG001|Overall Study|Adverse Event|0|||
154954684|NCT01389102|559259642|FG003|Overall Study|Unavailable due to husband's illness|0|||
154954685|NCT01389102|559259643|FG004|Overall Study|Unavailable due to husband's illness|0|||
154954686|NCT01389102|559259644|FG005|Overall Study|Unavailable due to husband's illness|0|||
154954687|NCT01389102|559259639|FG000|Overall Study|Investigator Judgement|0|||
154954688|NCT01389102|559259640|FG001|Overall Study|Investigator Judgement|1|||
154954689|NCT01389102|559259641|FG002|Overall Study|Investigator Judgement|0|||
154954690|NCT01389102|559259642|FG003|Overall Study|Investigator Judgement|0|||
154954691|NCT01389102|559259643|FG004|Overall Study|Investigator Judgement|0|||
154954692|NCT01389102|559259644|FG005|Overall Study|Investigator Judgement|0|||
154954693|NCT01661686|559259647|FG000|Overall Study|Lost to Follow-up|2|||
154954694|NCT01661686|559259648|FG001|Overall Study|Lost to Follow-up|1|||
154954695|NCT01661686|559259647|FG000|Overall Study|did not receive allocated intervention|0|||
154954696|NCT01661686|559259648|FG001|Overall Study|did not receive allocated intervention|1|||
154954697|NCT04869787|559259655|FG000|Screening|Physician Decision|1|||
154954698|NCT04869787|559259655|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
154954699|NCT00877032|559259656|FG000|Overall Study|Did not meet entrance criteria|0|||
154954700|NCT00877032|559259657|FG001|Overall Study|Did not meet entrance criteria|0|||
154954701|NCT00877032|559259658|FG002|Overall Study|Did not meet entrance criteria|0|||
154954702|NCT00877032|559259659|FG003|Overall Study|Did not meet entrance criteria|1|||
154954703|NCT00877032|559259660|FG004|Overall Study|Did not meet entrance criteria|0|||
154954704|NCT00877032|559259661|FG005|Overall Study|Did not meet entrance criteria|0|||
154954705|NCT00877032|559259662|FG006|Overall Study|Did not meet entrance criteria|2|||
154954706|NCT00813293|559259663|FG000|Overall Study|Intercurrent illness|1|||
155286021|NCT00646451|560480415|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
155286022|NCT00646451|560480416|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
155286023|NCT03784963|560480417|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
155286024|NCT03784963|560480418|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
155286025|NCT03784963|560480419|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
155286026|NCT03784963|560480420|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
155286027|NCT05355116|560480421|FG000|Overall Study|Withdrawal by Subject|2|||
155286028|NCT00868231|560480422|FG000|Treatment Period 1|Adverse Event|0|||
155286029|NCT00868231|560480423|FG001|Treatment Period 1|Adverse Event|0|||
155286030|NCT00868231|560480424|FG002|Treatment Period 1|Adverse Event|0|||
155286031|NCT00868231|560480425|FG003|Treatment Period 1|Adverse Event|0|||
155286032|NCT00868231|560480426|FG004|Treatment Period 1|Adverse Event|1|||
155286033|NCT00868231|560480427|FG005|Treatment Period 1|Adverse Event|0|||
155286034|NCT00868231|560480422|FG000|Treatment Period 2|Adverse Event|1|||
155286035|NCT00868231|560480423|FG001|Treatment Period 2|Adverse Event|0|||
155286036|NCT00868231|560480424|FG002|Treatment Period 2|Adverse Event|0|||
155286037|NCT00868231|560480425|FG003|Treatment Period 2|Adverse Event|0|||
155286038|NCT00868231|560480426|FG004|Treatment Period 2|Adverse Event|0|||
155286039|NCT00868231|560480427|FG005|Treatment Period 2|Adverse Event|0|||
155286040|NCT00868231|560480422|FG000|Treatment Period 3|Adverse Event|0|||
155286041|NCT00868231|560480423|FG001|Treatment Period 3|Adverse Event|0|||
155286042|NCT00868231|560480424|FG002|Treatment Period 3|Adverse Event|1|||
155286043|NCT00868231|560480425|FG003|Treatment Period 3|Adverse Event|0|||
155286044|NCT00868231|560480426|FG004|Treatment Period 3|Adverse Event|0|||
155286045|NCT00868231|560480427|FG005|Treatment Period 3|Adverse Event|0|||
155286046|NCT01168401|560480431|FG000|Overall Study|Lost to Follow-up|1|||
155286047|NCT01168401|560480432|FG001|Overall Study|Lost to Follow-up|1|||
155286048|NCT01168401|560480433|FG002|Overall Study|Lost to Follow-up|2|||
155286049|NCT01168401|560480434|FG003|Overall Study|Lost to Follow-up|1|||
155286050|NCT01168401|560480435|FG004|Overall Study|Lost to Follow-up|0|||
155286051|NCT01168401|560480436|FG005|Overall Study|Lost to Follow-up|0|||
155286052|NCT01168401|560480437|FG006|Overall Study|Lost to Follow-up|0|||
155286053|NCT01168401|560480438|FG007|Overall Study|Lost to Follow-up|0|||
155286054|NCT01168401|560480439|FG008|Overall Study|Lost to Follow-up|0|||
155286055|NCT01168401|560480440|FG009|Overall Study|Lost to Follow-up|0|||
155286056|NCT01168401|560480441|FG010|Overall Study|Lost to Follow-up|0|||
155286057|NCT01168401|560480431|FG000|Overall Study|Withdrawal by Subject|0|||
155286058|NCT01168401|560480432|FG001|Overall Study|Withdrawal by Subject|0|||
155286059|NCT01168401|560480433|FG002|Overall Study|Withdrawal by Subject|0|||
155286060|NCT01168401|560480434|FG003|Overall Study|Withdrawal by Subject|1|||
155286061|NCT01168401|560480435|FG004|Overall Study|Withdrawal by Subject|0|||
155286062|NCT01168401|560480436|FG005|Overall Study|Withdrawal by Subject|0|||
155286063|NCT01168401|560480437|FG006|Overall Study|Withdrawal by Subject|0|||
155286064|NCT01168401|560480438|FG007|Overall Study|Withdrawal by Subject|0|||
155286065|NCT01168401|560480439|FG008|Overall Study|Withdrawal by Subject|0|||
155286066|NCT01168401|560480440|FG009|Overall Study|Withdrawal by Subject|0|||
155286067|NCT01168401|560480441|FG010|Overall Study|Withdrawal by Subject|0|||
155286068|NCT03396835|560480446|FG000|Overall Study|Withdrawn prior to completion|1|||
155286069|NCT03396835|560480446|FG000|Overall Study|Did not meet criteria for data analysis|1|||
155286070|NCT01451814|560480447|FG000|Overall Study|Withdrawal by Subject|1|||
155286071|NCT01451814|560480448|FG001|Overall Study|Withdrawal by Subject|1|||
155286072|NCT01451814|560480447|FG000|Overall Study|Lost to Follow-up|5|||
155286073|NCT01451814|560480448|FG001|Overall Study|Lost to Follow-up|4|||
155286074|NCT02049866|560480449|FG000|Overall Study|Withdrawal by Subject|1|||
155286075|NCT03710564|560480451|FG000|Overall Study|Study Terminated by Sponsor|104|||
155286076|NCT03710564|560480452|FG001|Overall Study|Study Terminated by Sponsor|55|||
155286077|NCT03710564|560480451|FG000|Overall Study|Withdrawal by Subject|57|||
155286078|NCT03710564|560480452|FG001|Overall Study|Withdrawal by Subject|25|||
155286079|NCT03710564|560480451|FG000|Overall Study|Death|10|||
155286080|NCT03710564|560480452|FG001|Overall Study|Death|4|||
155286081|NCT03710564|560480451|FG000|Overall Study|Lost to Follow-up|5|||
155286082|NCT03710564|560480452|FG001|Overall Study|Lost to Follow-up|4|||
155286083|NCT03710564|560480451|FG000|Overall Study|Protocol Violation|3|||
155286084|NCT03710564|560480452|FG001|Overall Study|Protocol Violation|2|||
155286085|NCT03710564|560480451|FG000|Overall Study|Adverse Event|3|||
155286086|NCT03710564|560480452|FG001|Overall Study|Adverse Event|0|||
155286087|NCT03710564|560480451|FG000|Overall Study|Physician Decision|2|||
155286088|NCT03710564|560480452|FG001|Overall Study|Physician Decision|3|||
155286089|NCT02993471|560480453|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
155286090|NCT02993471|560480453|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
155286091|NCT00619151|560480454|FG000|Overall Study|Study terminated prior to followup|1|||
155286092|NCT00619151|560480455|FG001|Overall Study|Study terminated prior to followup|0|||
155286093|NCT04088188|560480456|FG000|Overall Study|Withdrawal by Subject|2|||
155286094|NCT04088188|560480457|FG001|Overall Study|Withdrawal by Subject|0|||
155286095|NCT04088188|560480456|FG000|Overall Study|Adverse Event|2|||
155286096|NCT04088188|560480457|FG001|Overall Study|Adverse Event|0|||
155286097|NCT02524288|560480458|FG000|Overall Study|Adverse Event|115|||
155286098|NCT02524288|560480458|FG000|Overall Study|Lost to Follow-up|216|||
155286099|NCT02524288|560480458|FG000|Overall Study|Non-Compliance With Protocol|32|||
155286100|NCT02524288|560480458|FG000|Overall Study|Non-Compliance With Study Drug|14|||
155286101|NCT02524288|560480458|FG000|Overall Study|Pregnancy Wish|6|||
155286102|NCT02524288|560480458|FG000|Overall Study|Protocol Violation|6|||
155286103|NCT02524288|560480458|FG000|Overall Study|Screen Failure|2|||
155286104|NCT02524288|560480458|FG000|Overall Study|Site Discontinued Study Participation|1|||
155286105|NCT02524288|560480458|FG000|Overall Study|Study Terminated By Sponsor|1417|||
155286106|NCT02524288|560480458|FG000|Overall Study|Subject Moved|32|||
155286107|NCT02524288|560480458|FG000|Overall Study|Withdrawal by Subject|76|||
155286108|NCT02524288|560480458|FG000|Overall Study|Pregnancy|22|||
155286109|NCT02524288|560480458|FG000|Overall Study|Physician Decision|2|||
155286110|NCT02616263|560480460|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
155286111|NCT02616263|560480461|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
155286112|NCT02616263|560480460|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
155286113|NCT02616263|560480461|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
155286114|NCT02616263|560480460|FG000|6 Month to 1.5 Year|Death|1|||
155286115|NCT02616263|560480461|FG001|6 Month to 1.5 Year|Death|0|||
155286116|NCT02616263|560480460|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
155286117|NCT02616263|560480461|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
155286118|NCT02616263|560480460|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
155286119|NCT02616263|560480461|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
155286120|NCT02616263|560480460|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
155286121|NCT02616263|560480461|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
155286122|NCT02939183|560480465|FG000|Overall Study|Death|0|||
155286123|NCT02939183|560480466|FG001|Overall Study|Death|0|||
155286124|NCT02939183|560480467|FG002|Overall Study|Death|1|||
155286125|NCT02939183|560480468|FG003|Overall Study|Death|0|||
155286126|NCT02939183|560480469|FG004|Overall Study|Death|0|||
155286127|NCT02939183|560480470|FG005|Overall Study|Death|2|||
155155444|NCT03175367|560006399|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155155445|NCT03175367|560006400|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155155446|NCT03175367|560006394|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155155447|NCT03175367|560006395|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155155448|NCT03175367|560006396|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155155449|NCT03175367|560006397|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155155450|NCT03175367|560006398|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155155451|NCT03175367|560006399|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
155155452|NCT03175367|560006400|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
155155453|NCT03175367|560006394|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155454|NCT03175367|560006395|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155455|NCT03175367|560006396|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155456|NCT03175367|560006397|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155457|NCT03175367|560006398|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155155458|NCT03175367|560006399|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
155155459|NCT03175367|560006400|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
155155460|NCT02851615|560006401|FG000|Overall Study|Cognitive Issue|1|||
155155461|NCT02851615|560006402|FG001|Overall Study|Cognitive Issue|0|||
155155462|NCT02851615|560006401|FG000|Overall Study|Lost to Follow-up|0|||
155155463|NCT02851615|560006402|FG001|Overall Study|Lost to Follow-up|4|||
155155464|NCT00371150|560006404|FG000|Overall Study|Lost to Follow-up|3|||
155155465|NCT00371150|560006405|FG001|Overall Study|Lost to Follow-up|2|||
155155466|NCT03337477|560006406|FG000|Overall Study|not categorized into the listed ones|11|||
155155467|NCT03337477|560006407|FG001|Overall Study|not categorized into the listed ones|9|||
155155468|NCT03337477|560006406|FG000|Overall Study|Withdrawal by Subject|0|||
155155469|NCT03337477|560006407|FG001|Overall Study|Withdrawal by Subject|1|||
155155470|NCT03337477|560006406|FG000|Overall Study|Death|0|||
155155471|NCT03337477|560006407|FG001|Overall Study|Death|1|||
155286128|NCT02939183|560480471|FG006|Overall Study|Death|1|||
155286129|NCT02939183|560480472|FG007|Overall Study|Death|0|||
155286130|NCT02939183|560480473|FG008|Overall Study|Death|0|||
155286131|NCT02939183|560480465|FG000|Overall Study|Sponsor decision|0|||
155286132|NCT02939183|560480466|FG001|Overall Study|Sponsor decision|1|||
155286133|NCT02939183|560480467|FG002|Overall Study|Sponsor decision|0|||
155286134|NCT02939183|560480468|FG003|Overall Study|Sponsor decision|1|||
155155472|NCT03337477|560006406|FG000|Overall Study|Lost to Follow-up|0|||
155155473|NCT03337477|560006407|FG001|Overall Study|Lost to Follow-up|2|||
155155474|NCT03304626|560006408|FG000|Overall Study|Adverse Event|1|||
155155475|NCT03304626|560006409|FG001|Overall Study|Adverse Event|0|||
155155476|NCT03304626|560006408|FG000|Overall Study|Lack of Efficacy|1|||
155155477|NCT03304626|560006409|FG001|Overall Study|Lack of Efficacy|1|||
155155478|NCT00744497|560006410|FG000|Overall Study|Withdrawal by Subject|21|||
155286135|NCT02939183|560480469|FG004|Overall Study|Sponsor decision|2|||
155286136|NCT02939183|560480470|FG005|Overall Study|Sponsor decision|0|||
155286137|NCT02939183|560480471|FG006|Overall Study|Sponsor decision|3|||
155286138|NCT02939183|560480472|FG007|Overall Study|Sponsor decision|1|||
155286139|NCT02939183|560480473|FG008|Overall Study|Sponsor decision|4|||
155286140|NCT02939183|560480465|FG000|Overall Study|Withdrawal by Subject|0|||
155286141|NCT02939183|560480466|FG001|Overall Study|Withdrawal by Subject|2|||
155286142|NCT02939183|560480467|FG002|Overall Study|Withdrawal by Subject|0|||
155286143|NCT02939183|560480468|FG003|Overall Study|Withdrawal by Subject|1|||
155286144|NCT02939183|560480469|FG004|Overall Study|Withdrawal by Subject|0|||
155286145|NCT02939183|560480470|FG005|Overall Study|Withdrawal by Subject|0|||
155286146|NCT02939183|560480471|FG006|Overall Study|Withdrawal by Subject|2|||
155286147|NCT02939183|560480472|FG007|Overall Study|Withdrawal by Subject|2|||
155286148|NCT02939183|560480473|FG008|Overall Study|Withdrawal by Subject|2|||
155286149|NCT02939183|560480465|FG000|Overall Study|Not treated due to adverse event|0|||
155286150|NCT02939183|560480466|FG001|Overall Study|Not treated due to adverse event|0|||
155286151|NCT02939183|560480467|FG002|Overall Study|Not treated due to adverse event|0|||
155286152|NCT02939183|560480468|FG003|Overall Study|Not treated due to adverse event|1|||
155286153|NCT02939183|560480469|FG004|Overall Study|Not treated due to adverse event|0|||
155286154|NCT02939183|560480470|FG005|Overall Study|Not treated due to adverse event|0|||
155286155|NCT02939183|560480471|FG006|Overall Study|Not treated due to adverse event|1|||
155286156|NCT02939183|560480472|FG007|Overall Study|Not treated due to adverse event|0|||
155286157|NCT02939183|560480473|FG008|Overall Study|Not treated due to adverse event|0|||
155286158|NCT05015478|560480474|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
155286159|NCT05015478|560480475|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
155286160|NCT05015478|560480476|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
155286161|NCT05015478|560480477|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
155286162|NCT04927975|560480480|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
155286163|NCT04927975|560480481|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
155286164|NCT04927975|560480482|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
155286165|NCT04927975|560480483|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
155286166|NCT04927975|560480484|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
155286167|NCT04927975|560480485|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
155286168|NCT04927975|560480480|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286169|NCT04927975|560480481|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286170|NCT04927975|560480482|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286171|NCT04927975|560480483|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
155286172|NCT04927975|560480484|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
155286173|NCT04927975|560480485|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
155286174|NCT04927975|560480480|FG000|Period 1 (Baseline-Week 24)|Death|0|||
155286175|NCT04927975|560480481|FG001|Period 1 (Baseline-Week 24)|Death|0|||
155286176|NCT04927975|560480482|FG002|Period 1 (Baseline-Week 24)|Death|0|||
155286177|NCT04927975|560480483|FG003|Period 1 (Baseline-Week 24)|Death|0|||
155286178|NCT04927975|560480484|FG004|Period 1 (Baseline-Week 24)|Death|0|||
155286179|NCT04927975|560480485|FG005|Period 1 (Baseline-Week 24)|Death|1|||
155286180|NCT04927975|560480480|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
155286181|NCT04927975|560480481|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
155286182|NCT04927975|560480482|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
155286183|NCT04927975|560480483|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
155286184|NCT04927975|560480484|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
155286185|NCT04927975|560480485|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
155286186|NCT04927975|560480480|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
155286187|NCT04927975|560480481|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155286188|NCT04927975|560480482|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155286189|NCT04927975|560480483|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
155286190|NCT04927975|560480484|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
155286191|NCT04927975|560480485|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
154954707|NCT00813293|559259664|FG001|Overall Study|Intercurrent illness|0|||
154954708|NCT00813293|559259663|FG000|Overall Study|Adverse Event|0|||
154954709|NCT00813293|559259664|FG001|Overall Study|Adverse Event|1|||
154954710|NCT00533273|559259665|FG000|Double-blind|Withdrew consent|0|||
154954711|NCT00533273|559259666|FG001|Double-blind|Withdrew consent|2|||
154954712|NCT00533273|559259665|FG000|Open-label|Withdrawal by Subject|6|||
154954713|NCT00533273|559259666|FG001|Open-label|Withdrawal by Subject|0|||
154954714|NCT02794974|559259667|FG000|Overall Study|Physician Decision|0|||
154954715|NCT02794974|559259668|FG001|Overall Study|Physician Decision|1|||
154954716|NCT02202850|559259670|FG000|Overall Study|Other|2|||
154954717|NCT02202850|559259671|FG001|Overall Study|Other|2|||
154954718|NCT02202850|559259670|FG000|Overall Study|Enbrel treatment discontinued|15|||
154954719|NCT02202850|559259671|FG001|Overall Study|Enbrel treatment discontinued|3|||
154954720|NCT02202850|559259670|FG000|Overall Study|Lost to Follow-up|7|||
154954721|NCT02202850|559259671|FG001|Overall Study|Lost to Follow-up|1|||
154954722|NCT01873586|559259672|FG000|Overall Study|Lost to Follow-up|3|||
155286192|NCT03781804|560480486|FG000|Overall Study|Adverse Event|2|||
155286193|NCT03781804|560480487|FG001|Overall Study|Adverse Event|2|||
155286194|NCT03781804|560480488|FG002|Overall Study|Adverse Event|3|||
154954723|NCT00615069|559259673|FG000|Overall Study|Death|10|||
155286195|NCT03781804|560480486|FG000|Overall Study|Lost to Follow-up|1|||
155286196|NCT03781804|560480487|FG001|Overall Study|Lost to Follow-up|1|||
155286197|NCT03781804|560480488|FG002|Overall Study|Lost to Follow-up|2|||
155059042|NCT01898078|559651799|FG000|Overall Study|Reason not Specified|0|||
155059043|NCT01898078|559651800|FG001|Overall Study|Reason not Specified|1|||
155059044|NCT00720278|559651807|FG000|Overall Study|Adverse Event|5|||
155059045|NCT00720278|559651808|FG001|Overall Study|Adverse Event|3|||
155059046|NCT00720278|559651809|FG002|Overall Study|Adverse Event|4|||
155059047|NCT00720278|559651807|FG000|Overall Study|Withdrawal by Subject|0|||
155059048|NCT00720278|559651808|FG001|Overall Study|Withdrawal by Subject|1|||
155059049|NCT00720278|559651809|FG002|Overall Study|Withdrawal by Subject|0|||
155059050|NCT00720278|559651807|FG000|Overall Study|Lost to Follow-up|0|||
155059051|NCT00720278|559651808|FG001|Overall Study|Lost to Follow-up|0|||
155059052|NCT00720278|559651809|FG002|Overall Study|Lost to Follow-up|1|||
155059053|NCT00720278|559651807|FG000|Overall Study|Non-compliance|1|||
155059054|NCT00720278|559651808|FG001|Overall Study|Non-compliance|0|||
155059055|NCT00720278|559651809|FG002|Overall Study|Non-compliance|0|||
155059056|NCT00720278|559651807|FG000|Overall Study|eligibility criteria violation|1|||
155059057|NCT00720278|559651808|FG001|Overall Study|eligibility criteria violation|0|||
155059058|NCT00720278|559651809|FG002|Overall Study|eligibility criteria violation|1|||
155059059|NCT00266708|559651812|FG000|Overall Study|No renal function|1|||
155059060|NCT00266708|559651813|FG001|Overall Study|No renal function|1|||
155059061|NCT00266708|559651812|FG000|Overall Study|Refused biopsy|3|||
155059062|NCT00266708|559651813|FG001|Overall Study|Refused biopsy|6|||
155059063|NCT00266708|559651812|FG000|Overall Study|Asthma|0|||
155059064|NCT00266708|559651813|FG001|Overall Study|Asthma|2|||
155155479|NCT00744497|560006411|FG001|Overall Study|Withdrawal by Subject|18|||
155155480|NCT00744497|560006410|FG000|Overall Study|Death|11|||
155155481|NCT00744497|560006411|FG001|Overall Study|Death|9|||
155155482|NCT00744497|560006410|FG000|Overall Study|Lost to Follow-up|4|||
155155483|NCT00744497|560006411|FG001|Overall Study|Lost to Follow-up|2|||
155155484|NCT00744497|560006410|FG000|Overall Study|Poor compliance/noncompliance|9|||
155155485|NCT00744497|560006411|FG001|Overall Study|Poor compliance/noncompliance|5|||
155155486|NCT00744497|560006410|FG000|Overall Study|No longer meets study criteria|7|||
155155487|NCT00744497|560006411|FG001|Overall Study|No longer meets study criteria|3|||
155155488|NCT00744497|560006410|FG000|Overall Study|Administrative Reason By Sponsor|25|||
155155489|NCT00744497|560006411|FG001|Overall Study|Administrative Reason By Sponsor|8|||
155155490|NCT00744497|560006410|FG000|Overall Study|Disease progression|312|||
155155491|NCT00744497|560006411|FG001|Overall Study|Disease progression|219|||
155155492|NCT00744497|560006410|FG000|Overall Study|Study drug toxicity|68|||
155155493|NCT00744497|560006411|FG001|Overall Study|Study drug toxicity|141|||
155155494|NCT00744497|560006410|FG000|Overall Study|Adverse event unrelated to study drug|78|||
155155495|NCT00744497|560006411|FG001|Overall Study|Adverse event unrelated to study drug|122|||
155155496|NCT00744497|560006410|FG000|Overall Study|Patient requested to stop study drug|65|||
155155497|NCT00744497|560006411|FG001|Overall Study|Patient requested to stop study drug|80|||
155155498|NCT00744497|560006410|FG000|Overall Study|Maximum clinical benefit|141|||
155155499|NCT00744497|560006411|FG001|Overall Study|Maximum clinical benefit|142|||
155155500|NCT00744497|560006410|FG000|Overall Study|Not defined|19|||
155155501|NCT00744497|560006411|FG001|Overall Study|Not defined|13|||
155155502|NCT03182374|560006412|FG000|Overall Study|Lost to Follow-up|3|||
155155503|NCT03182374|560006413|FG001|Overall Study|Lost to Follow-up|2|||
155155504|NCT03182374|560006412|FG000|Overall Study|Lack of Efficacy|8|||
155155505|NCT03182374|560006413|FG001|Overall Study|Lack of Efficacy|14|||
155155506|NCT03182374|560006412|FG000|Overall Study|Withdrawal by Subject|1|||
155155507|NCT03182374|560006413|FG001|Overall Study|Withdrawal by Subject|1|||
155155508|NCT03182374|560006412|FG000|Overall Study|exit for non-compliance|1|||
155155509|NCT03182374|560006413|FG001|Overall Study|exit for non-compliance|1|||
155155510|NCT03182374|560006412|FG000|Overall Study|one subject was randomized but not treated|1|||
155155511|NCT03182374|560006413|FG001|Overall Study|one subject was randomized but not treated|0|||
155155512|NCT03182374|560006412|FG000|Overall Study|Other reasons|0|||
155155513|NCT03182374|560006413|FG001|Overall Study|Other reasons|3|||
155155514|NCT06271993|560006415|FG000|Overall Study|Not reactive to histamine|5|||
155155515|NCT06271993|560006416|FG001|Overall Study|Not reactive to histamine|5|||
155286198|NCT03781804|560480486|FG000|Overall Study|Lack of Efficacy|4|||
155059065|NCT02791269|559651814|FG000|Overall Study|Lost to Follow-up|0|||
155059066|NCT02791269|559651815|FG001|Overall Study|Lost to Follow-up|1|||
155059067|NCT00368251|559651816|FG000|Overall Study|SAE, non-fatal|1|||
155155516|NCT06271993|560006417|FG002|Overall Study|Not reactive to histamine|5|||
155155517|NCT04613362|560006418|FG000|3 Month Follow-up|Lost to Follow-up|1|||
155155518|NCT04613362|560006419|FG001|3 Month Follow-up|Lost to Follow-up|2|||
155059068|NCT00368251|559651817|FG001|Overall Study|SAE, non-fatal|0|||
155059069|NCT00368251|559651818|FG002|Overall Study|SAE, non-fatal|0|||
155059070|NCT00368251|559651816|FG000|Overall Study|AE, non-serious non-fatal|0|||
155155519|NCT04613362|560006418|FG000|6 Month Follow-up|Lost to Follow-up|0|||
155155520|NCT04613362|560006419|FG001|6 Month Follow-up|Lost to Follow-up|1|||
155286199|NCT03781804|560480487|FG001|Overall Study|Lack of Efficacy|2|||
155286200|NCT03781804|560480488|FG002|Overall Study|Lack of Efficacy|9|||
155286201|NCT03781804|560480486|FG000|Overall Study|Protocol Violation|0|||
155286202|NCT03781804|560480487|FG001|Overall Study|Protocol Violation|0|||
155286203|NCT03781804|560480488|FG002|Overall Study|Protocol Violation|1|||
155286204|NCT03781804|560480486|FG000|Overall Study|Withdrawal by Subject|0|||
155286205|NCT03781804|560480487|FG001|Overall Study|Withdrawal by Subject|1|||
155286206|NCT03781804|560480488|FG002|Overall Study|Withdrawal by Subject|1|||
155286207|NCT03781804|560480486|FG000|Overall Study|Reason not provided|2|||
155286208|NCT03781804|560480487|FG001|Overall Study|Reason not provided|2|||
155286209|NCT03781804|560480488|FG002|Overall Study|Reason not provided|0|||
155286210|NCT03717194|560480489|FG000|Overall Study|Withdrawal by Subject|2|||
155286211|NCT03717194|560480490|FG001|Overall Study|Withdrawal by Subject|4|||
155286212|NCT03717194|560480489|FG000|Overall Study|Adverse Event|1|||
155286213|NCT03717194|560480490|FG001|Overall Study|Adverse Event|1|||
155286214|NCT03499600|560480493|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
155286215|NCT03499600|560480494|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
155286216|NCT00561574|560480495|FG000|Overall Study|Adverse Event|21|||
155286217|NCT00561574|560480496|FG001|Overall Study|Adverse Event|24|||
155286218|NCT00561574|560480495|FG000|Overall Study|Lack of Efficacy|11|||
155286219|NCT00561574|560480496|FG001|Overall Study|Lack of Efficacy|21|||
155286220|NCT00561574|560480495|FG000|Overall Study|Withdrawal by Subject|4|||
155286221|NCT00561574|560480496|FG001|Overall Study|Withdrawal by Subject|4|||
155286222|NCT00561574|560480495|FG000|Overall Study|Reason Unrelated to Trial|6|||
155286223|NCT00561574|560480496|FG001|Overall Study|Reason Unrelated to Trial|2|||
155286224|NCT00561574|560480495|FG000|Overall Study|Lost to Follow-up|1|||
155286225|NCT00561574|560480496|FG001|Overall Study|Lost to Follow-up|0|||
155286226|NCT00561574|560480495|FG000|Overall Study|Other|5|||
155286227|NCT00561574|560480496|FG001|Overall Study|Other|7|||
155286228|NCT03971357|560480497|FG000|Overall Study|Lack of Efficacy|0|||
155286229|NCT03971357|560480498|FG001|Overall Study|Lack of Efficacy|1|||
155286230|NCT00445692|560480499|FG000|Overall Study|Adverse Event|11|||
155286231|NCT00445692|560480499|FG000|Overall Study|Lack of Efficacy|5|||
155286232|NCT00630864|560480506|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
155286233|NCT00630864|560480506|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
155286234|NCT00430677|560480507|FG000|Short-term Period|Death|1|||
155286235|NCT00430677|560480508|FG001|Short-term Period|Death|1|||
155286236|NCT00430677|560480509|FG002|Short-term Period|Death|5|||
155286237|NCT00430677|560480507|FG000|Short-term Period|Adverse Event|15|||
155286238|NCT00430677|560480508|FG001|Short-term Period|Adverse Event|13|||
155286239|NCT00430677|560480509|FG002|Short-term Period|Adverse Event|9|||
155286240|NCT00430677|560480507|FG000|Short-term Period|Lack of Efficacy|5|||
155286241|NCT00430677|560480508|FG001|Short-term Period|Lack of Efficacy|6|||
155286242|NCT00430677|560480509|FG002|Short-term Period|Lack of Efficacy|4|||
155286243|NCT00430677|560480507|FG000|Short-term Period|Withdrawal by Subject|1|||
155286244|NCT00430677|560480508|FG001|Short-term Period|Withdrawal by Subject|1|||
155286245|NCT00430677|560480509|FG002|Short-term Period|Withdrawal by Subject|2|||
155286246|NCT00430677|560480507|FG000|Short-term Period|Participant no longer met study criteria|1|||
155286247|NCT00430677|560480508|FG001|Short-term Period|Participant no longer met study criteria|1|||
155286248|NCT00430677|560480509|FG002|Short-term Period|Participant no longer met study criteria|2|||
155286249|NCT00430677|560480507|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
155286250|NCT00430677|560480508|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
155286251|NCT00430677|560480509|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
155286252|NCT00430677|560480507|FG000|Short-term Period|Pregnancy|0|||
155286253|NCT00430677|560480508|FG001|Short-term Period|Pregnancy|2|||
155286254|NCT00430677|560480509|FG002|Short-term Period|Pregnancy|0|||
154954724|NCT00615069|559259673|FG000|Overall Study|Physician Decision|2|||
154954725|NCT00615069|559259673|FG000|Overall Study|Withdrawal by Subject|4|||
154954726|NCT00454909|559259674|FG000|Overall Study|Withdrawal by Subject|1|||
154954727|NCT00454909|559259675|FG001|Overall Study|Withdrawal by Subject|0|||
154954728|NCT00454909|559259676|FG002|Overall Study|Withdrawal by Subject|0|||
154954729|NCT00454909|559259674|FG000|Overall Study|Migrated/moved from study area|0|||
154954730|NCT00454909|559259675|FG001|Overall Study|Migrated/moved from study area|0|||
154954731|NCT00454909|559259676|FG002|Overall Study|Migrated/moved from study area|1|||
154954732|NCT00454909|559259674|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
155286255|NCT00430677|560480507|FG000|Long-term Extension Period|Death|1|||
155286256|NCT00430677|560480508|FG001|Long-term Extension Period|Death|0|||
155286257|NCT00430677|560480509|FG002|Long-term Extension Period|Death|0|||
155286258|NCT00430677|560480507|FG000|Long-term Extension Period|Adverse Event|3|||
155286259|NCT00430677|560480508|FG001|Long-term Extension Period|Adverse Event|2|||
155286260|NCT00430677|560480509|FG002|Long-term Extension Period|Adverse Event|5|||
155286261|NCT00430677|560480507|FG000|Long-term Extension Period|Lack of Efficacy|5|||
155286262|NCT00430677|560480508|FG001|Long-term Extension Period|Lack of Efficacy|3|||
155286263|NCT00430677|560480509|FG002|Long-term Extension Period|Lack of Efficacy|8|||
155286264|NCT00430677|560480507|FG000|Long-term Extension Period|Lost to Follow-up|1|||
155286265|NCT00430677|560480508|FG001|Long-term Extension Period|Lost to Follow-up|1|||
155286266|NCT00430677|560480509|FG002|Long-term Extension Period|Lost to Follow-up|1|||
155286267|NCT00430677|560480507|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
155286268|NCT00430677|560480508|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
155286269|NCT00430677|560480509|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
155286270|NCT00430677|560480507|FG000|Long-term Extension Period|Pregnancy|1|||
155286271|NCT00430677|560480508|FG001|Long-term Extension Period|Pregnancy|1|||
155286272|NCT00430677|560480509|FG002|Long-term Extension Period|Pregnancy|0|||
155286273|NCT00430677|560480507|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
155286274|NCT00430677|560480508|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
155286275|NCT00430677|560480509|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
155286276|NCT00430677|560480507|FG000|Long-term Extension Period|Other|2|||
155286277|NCT00430677|560480508|FG001|Long-term Extension Period|Other|1|||
155286278|NCT00430677|560480509|FG002|Long-term Extension Period|Other|1|||
155286279|NCT00430677|560480507|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
155286280|NCT00430677|560480508|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
155286281|NCT00430677|560480509|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
155286282|NCT01555762|560480510|FG000|Overall Study|No information on Bevacizumab intake|11|||
155286283|NCT01555762|560480510|FG000|Overall Study|Missing start date of infusion|8|||
155286284|NCT01555762|560480510|FG000|Overall Study|75 years old or more ticked No|1|||
155286285|NCT01555762|560480510|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
155286286|NCT01555762|560480510|FG000|Overall Study|Death linked to progression of disease|165|||
155286287|NCT01555762|560480510|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
155286288|NCT01555762|560480510|FG000|Overall Study|Investigator's decision|10|||
155286289|NCT01555762|560480510|FG000|Overall Study|Participant not wishing to continue|5|||
155155521|NCT03331315|560006421|FG000|Overall Study|Physician Decision|18|||
155155522|NCT03331315|560006422|FG001|Overall Study|Physician Decision|14|||
155155523|NCT00481832|560006423|FG000|Enrollment|Physician Decision|8|||
155155524|NCT00481832|560006423|FG000|Enrollment|Unable to collect enough stem cells|2|||
155155525|NCT00481832|560006423|FG000|Inter-transplant Period|Adverse Event|4|||
155155526|NCT00481832|560006423|FG000|Inter-transplant Period|Death|3|||
155155527|NCT00481832|560006423|FG000|Inter-transplant Period|Physician Decision|4|||
155155528|NCT00481832|560006423|FG000|Inter-transplant Period|Disease relapse|11|||
155155529|NCT00481832|560006423|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
155155530|NCT00456846|560006424|FG000|Overall Study|Adverse Event|2|||
155155531|NCT00456846|560006425|FG001|Overall Study|Adverse Event|15|||
155155532|NCT00456846|560006424|FG000|Overall Study|Physician Decision|11|||
155155533|NCT00456846|560006425|FG001|Overall Study|Physician Decision|6|||
155155534|NCT00456846|560006424|FG000|Overall Study|Protocol Deviation|2|||
155155535|NCT00456846|560006425|FG001|Overall Study|Protocol Deviation|0|||
155155536|NCT00456846|560006424|FG000|Overall Study|Participant Discretion|1|||
155155537|NCT00456846|560006425|FG001|Overall Study|Participant Discretion|5|||
155155538|NCT00456846|560006424|FG000|Overall Study|Other|0|||
155155539|NCT00456846|560006425|FG001|Overall Study|Other|2|||
155155540|NCT00581308|560006426|FG000|Pre Discharge|Lost to Follow-up|1|||
155155541|NCT00581308|560006426|FG000|Pre Discharge|Device Removed|1|||
155155542|NCT00581308|560006426|FG000|Month 1|Lost to Follow-up|3|||
155155543|NCT00581308|560006426|FG000|Month 1|Withdrawal by Subject|2|||
155155544|NCT00581308|560006426|FG000|Month 1|Device Removed|2|||
155155545|NCT00581308|560006426|FG000|Month 1|Uknown|1|||
155155546|NCT00581308|560006426|FG000|Month 6|Lost to Follow-up|1|||
155155547|NCT00581308|560006426|FG000|Month 6|Withdrawal by Subject|2|||
155155548|NCT00581308|560006426|FG000|Month 12|Death|1|||
155155549|NCT00581308|560006426|FG000|Month 12|Lost to Follow-up|14|||
155155550|NCT00581308|560006426|FG000|Month 12|Withdrawal by Subject|3|||
155155551|NCT00581308|560006426|FG000|Month 12|Device Removed|1|||
155155552|NCT00581308|560006426|FG000|Month 12|Other|1|||
155155553|NCT03137381|560006430|FG000|Overall Study|Adverse Event|3|||
155155554|NCT03137381|560006431|FG001|Overall Study|Adverse Event|0|||
155155555|NCT03137381|560006432|FG002|Overall Study|Adverse Event|2|||
155155556|NCT03137381|560006433|FG003|Overall Study|Adverse Event|0|||
155286290|NCT01555762|560480510|FG000|Overall Study|Missing data|1|||
155155557|NCT03137381|560006430|FG000|Overall Study|Lost to Follow-up|2|||
155155558|NCT03137381|560006431|FG001|Overall Study|Lost to Follow-up|1|||
155155559|NCT03137381|560006432|FG002|Overall Study|Lost to Follow-up|1|||
155155560|NCT03137381|560006433|FG003|Overall Study|Lost to Follow-up|0|||
155286291|NCT01555762|560480510|FG000|Overall Study|Death linked to an adverse event|14|||
155286292|NCT00819910|560480511|FG000|Overall Study|Adverse Event|0|||
155286293|NCT00819910|560480512|FG001|Overall Study|Adverse Event|0|||
155286294|NCT00819910|560480513|FG002|Overall Study|Adverse Event|2|||
155286295|NCT00819910|560480514|FG003|Overall Study|Adverse Event|1|||
155286296|NCT00819910|560480511|FG000|Overall Study|Withdrawal by Subject|1|||
155286297|NCT00819910|560480512|FG001|Overall Study|Withdrawal by Subject|1|||
155286298|NCT00819910|560480513|FG002|Overall Study|Withdrawal by Subject|1|||
155286299|NCT00819910|560480514|FG003|Overall Study|Withdrawal by Subject|0|||
155286300|NCT00819910|560480511|FG000|Overall Study|Lost to Follow-up|1|||
155286301|NCT00819910|560480512|FG001|Overall Study|Lost to Follow-up|0|||
155286302|NCT00819910|560480513|FG002|Overall Study|Lost to Follow-up|0|||
155286303|NCT00819910|560480514|FG003|Overall Study|Lost to Follow-up|0|||
155286304|NCT02040844|560480519|FG000|Overall Study|Adverse Event|0|||
155286305|NCT02040844|560480520|FG001|Overall Study|Adverse Event|0|||
155286306|NCT02040844|560480521|FG002|Overall Study|Adverse Event|1|||
155286307|NCT02040844|560480519|FG000|Overall Study|Withdrawal by Subject|16|||
155286308|NCT02040844|560480520|FG001|Overall Study|Withdrawal by Subject|22|||
155286309|NCT02040844|560480521|FG002|Overall Study|Withdrawal by Subject|25|||
155286310|NCT02040844|560480519|FG000|Overall Study|Lost to Follow-up|12|||
155286311|NCT02040844|560480520|FG001|Overall Study|Lost to Follow-up|9|||
155286312|NCT02040844|560480521|FG002|Overall Study|Lost to Follow-up|13|||
155286313|NCT02040844|560480519|FG000|Overall Study|Missing|13|||
155286314|NCT02040844|560480520|FG001|Overall Study|Missing|3|||
155286315|NCT02040844|560480521|FG002|Overall Study|Missing|2|||
155286316|NCT02040844|560480519|FG000|Overall Study|Non-specified|8|||
155286317|NCT02040844|560480520|FG001|Overall Study|Non-specified|2|||
155286318|NCT02040844|560480521|FG002|Overall Study|Non-specified|5|||
155286319|NCT02040844|560480519|FG000|Overall Study|Concomitant medication|1|||
155286320|NCT02040844|560480520|FG001|Overall Study|Concomitant medication|3|||
155286321|NCT02040844|560480521|FG002|Overall Study|Concomitant medication|1|||
155286322|NCT00946192|560480522|FG000|Overall Study|Lost to Follow-up|6|||
155286323|NCT00946192|560480523|FG001|Overall Study|Lost to Follow-up|11|||
155286324|NCT00946192|560480524|FG002|Overall Study|Lost to Follow-up|9|||
155286325|NCT00946192|560480522|FG000|Overall Study|Withdrawal by Subject|10|||
155286326|NCT00946192|560480523|FG001|Overall Study|Withdrawal by Subject|7|||
155286327|NCT00946192|560480524|FG002|Overall Study|Withdrawal by Subject|3|||
155286328|NCT00946192|560480522|FG000|Overall Study|Did not start medication|2|||
155286329|NCT00946192|560480523|FG001|Overall Study|Did not start medication|0|||
155286330|NCT00946192|560480524|FG002|Overall Study|Did not start medication|0|||
155286331|NCT05460663|560480527|FG000|Overall Study|Withdrawal by Subject|2|||
155286332|NCT05460663|560480528|FG001|Overall Study|Withdrawal by Subject|5|||
155286333|NCT02068885|560480529|FG000|Overall Study|Withdrew|3|||
155286334|NCT02068885|560480530|FG001|Overall Study|Withdrew|5|||
155286335|NCT02068885|560480531|FG002|Overall Study|Withdrew|8|||
155286336|NCT00681811|560480532|FG000|Overall Study|Adverse Event|1|||
155286337|NCT00681811|560480533|FG001|Overall Study|Adverse Event|1|||
155286338|NCT00681811|560480532|FG000|Overall Study|Withdrawal by Subject|2|||
154954733|NCT00454909|559259675|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
154954734|NCT00454909|559259676|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
154954735|NCT00454909|559259674|FG000|Overall Study|Others|1|||
154954736|NCT00454909|559259675|FG001|Overall Study|Others|0|||
154954737|NCT00454909|559259676|FG002|Overall Study|Others|0|||
154954738|NCT02996682|559259677|FG000|Overall Study|Death|0|||
154954739|NCT02996682|559259678|FG001|Overall Study|Death|3|||
154954740|NCT01981720|559259679|FG000|Overall Study|Adverse Event|1|||
154954741|NCT01981720|559259679|FG000|Overall Study|Withdrawal by Subject|3|||
154954742|NCT01981720|559259679|FG000|Overall Study|Pregnancy|1|||
154954743|NCT00282048|559259680|FG000|Overall Study|Lack of Efficacy|30|||
154954744|NCT00282048|559259680|FG000|Overall Study|Adverse Event|22|||
154954745|NCT00282048|559259680|FG000|Overall Study|Withdrawal by Subject|1|||
154954746|NCT00282048|559259680|FG000|Overall Study|Other|8|||
154954747|NCT00282048|559259680|FG000|Overall Study|Ongoing|1|||
155286339|NCT00681811|560480533|FG001|Overall Study|Withdrawal by Subject|2|||
154954748|NCT00259012|559259682|FG000|Overall Study|Adverse Event|0|||
154954749|NCT00259012|559259683|FG001|Overall Study|Adverse Event|1|||
154954750|NCT00259012|559259682|FG000|Overall Study|Withdrawal by Subject|1|||
154954751|NCT00259012|559259683|FG001|Overall Study|Withdrawal by Subject|0|||
154954752|NCT00259012|559259682|FG000|Overall Study|Physician Decision|0|||
154954753|NCT00259012|559259683|FG001|Overall Study|Physician Decision|1|||
154954754|NCT00259012|559259682|FG000|Overall Study|Lost to Follow-up|0|||
155286340|NCT00681811|560480532|FG000|Overall Study|Non-compliance|0|||
155286341|NCT00681811|560480533|FG001|Overall Study|Non-compliance|1|||
155286342|NCT00828919|560480534|FG000|Overall Study|Death|0|||
155286343|NCT00828919|560480535|FG001|Overall Study|Death|1|||
154954755|NCT00259012|559259683|FG001|Overall Study|Lost to Follow-up|1|||
154954756|NCT00259012|559259682|FG000|Overall Study|Protocol Violation|1|||
154954757|NCT00259012|559259683|FG001|Overall Study|Protocol Violation|1|||
154954758|NCT03522675|559259684|FG000|Overall Study|Screen fail|1|||
155286344|NCT00828919|560480536|FG002|Overall Study|Death|2|||
155155561|NCT03137381|560006430|FG000|Overall Study|Protocol deviation|1|||
155155562|NCT03137381|560006431|FG001|Overall Study|Protocol deviation|1|||
155155563|NCT03137381|560006432|FG002|Overall Study|Protocol deviation|0|||
155155564|NCT03137381|560006433|FG003|Overall Study|Protocol deviation|1|||
155155565|NCT03137381|560006430|FG000|Overall Study|Withdrawal by Investigator|0|||
155155566|NCT03137381|560006431|FG001|Overall Study|Withdrawal by Investigator|1|||
155155567|NCT03137381|560006432|FG002|Overall Study|Withdrawal by Investigator|1|||
155155568|NCT03137381|560006433|FG003|Overall Study|Withdrawal by Investigator|0|||
155155569|NCT03137381|560006430|FG000|Overall Study|Withdrawal by Subject|3|||
155155570|NCT03137381|560006431|FG001|Overall Study|Withdrawal by Subject|4|||
155155571|NCT03137381|560006432|FG002|Overall Study|Withdrawal by Subject|3|||
155155572|NCT03137381|560006433|FG003|Overall Study|Withdrawal by Subject|0|||
155155573|NCT03137381|560006430|FG000|Overall Study|Pregnancy|0|||
155155574|NCT03137381|560006431|FG001|Overall Study|Pregnancy|0|||
155155575|NCT03137381|560006432|FG002|Overall Study|Pregnancy|1|||
155155576|NCT03137381|560006433|FG003|Overall Study|Pregnancy|0|||
155155577|NCT01980017|560006434|FG000|Overall Study|Lost to Follow-up|30|||
155155578|NCT01980017|560006435|FG001|Overall Study|Lost to Follow-up|21|||
155155579|NCT01980017|560006434|FG000|Overall Study|Death|0|||
155155580|NCT01980017|560006435|FG001|Overall Study|Death|1|||
155155581|NCT03379818|560006436|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
155155582|NCT03379818|560006437|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
155155583|NCT03379818|560006436|FG000|Overall Study|Withdrawal by Subject|2|||
155155584|NCT03379818|560006437|FG001|Overall Study|Withdrawal by Subject|3|||
155155585|NCT03379818|560006436|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
155155586|NCT03379818|560006437|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
155155587|NCT01310777|560006438|FG000|Overall Study|Adverse Event|23|||
155155588|NCT01310777|560006439|FG001|Overall Study|Adverse Event|1|||
155155589|NCT01310777|560006440|FG002|Overall Study|Adverse Event|15|||
155155590|NCT01310777|560006438|FG000|Overall Study|Lost to Follow-up|0|||
155155591|NCT01310777|560006439|FG001|Overall Study|Lost to Follow-up|4|||
155155592|NCT01310777|560006440|FG002|Overall Study|Lost to Follow-up|1|||
155155593|NCT01310777|560006438|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
155155594|NCT01310777|560006439|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
155155595|NCT01310777|560006440|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
155155596|NCT01310777|560006438|FG000|Overall Study|Inadequate Control of IOP|5|||
155155597|NCT01310777|560006439|FG001|Overall Study|Inadequate Control of IOP|7|||
155155598|NCT01310777|560006440|FG002|Overall Study|Inadequate Control of IOP|10|||
155155599|NCT01310777|560006438|FG000|Overall Study|Other|4|||
155155600|NCT01310777|560006439|FG001|Overall Study|Other|1|||
155155601|NCT01310777|560006440|FG002|Overall Study|Other|2|||
155155602|NCT00888134|560006450|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
155155603|NCT00888134|560006450|FG000|Follow-up|being followed for long-term survival|1|||
155155604|NCT03043313|560006451|FG000|Overall Study|Withdrawal by Subject|5|||
155155605|NCT03043313|560006452|FG001|Overall Study|Withdrawal by Subject|1|||
155155606|NCT03043313|560006453|FG002|Overall Study|Withdrawal by Subject|1|||
155155607|NCT03043313|560006451|FG000|Overall Study|Lost to Follow-up|1|||
155155608|NCT03043313|560006452|FG001|Overall Study|Lost to Follow-up|1|||
155155609|NCT03043313|560006453|FG002|Overall Study|Lost to Follow-up|0|||
155155610|NCT03043313|560006451|FG000|Overall Study|Death|28|||
155155611|NCT03043313|560006452|FG001|Overall Study|Death|26|||
155155612|NCT03043313|560006453|FG002|Overall Study|Death|17|||
155155613|NCT03043313|560006451|FG000|Overall Study|Participation terminated by sponsor|11|||
155155614|NCT03043313|560006452|FG001|Overall Study|Participation terminated by sponsor|13|||
155155615|NCT03043313|560006453|FG002|Overall Study|Participation terminated by sponsor|13|||
155155616|NCT00795535|560006454|FG000|Overall Study|incomplete data and technical problems|20|||
155155617|NCT00374140|560006457|FG000|Overall Study|Lost to Follow-up|1|||
155155618|NCT00374140|560006457|FG000|Overall Study|Protocol Violation|1|||
155155619|NCT02651675|560006458|FG000|Overall Study|Death|0|||
155155620|NCT02651675|560006459|FG001|Overall Study|Death|0|||
155155621|NCT02651675|560006460|FG002|Overall Study|Death|1|||
155155622|NCT01506596|560006461|FG000|Overall Study|ineligible pathology|1|||
155155623|NCT01488890|560006462|FG000|Overall Study|Serious adverse event|2|||
155155624|NCT01488890|560006463|FG001|Overall Study|Serious adverse event|0|||
155155625|NCT01488890|560006464|FG002|Overall Study|Serious adverse event|0|||
155155626|NCT01488890|560006465|FG003|Overall Study|Serious adverse event|0|||
155155627|NCT01488890|560006462|FG000|Overall Study|Protocol Violation|3|||
155286345|NCT00828919|560480537|FG003|Overall Study|Death|0|||
155286346|NCT00828919|560480538|FG004|Overall Study|Death|0|||
155286347|NCT00828919|560480534|FG000|Overall Study|Adverse Event|2|||
155286348|NCT00828919|560480535|FG001|Overall Study|Adverse Event|2|||
155286349|NCT00828919|560480536|FG002|Overall Study|Adverse Event|2|||
155286350|NCT00828919|560480537|FG003|Overall Study|Adverse Event|1|||
155286351|NCT00828919|560480538|FG004|Overall Study|Adverse Event|3|||
155286352|NCT00828919|560480534|FG000|Overall Study|Objective progression or relapse|4|||
155286353|NCT00828919|560480535|FG001|Overall Study|Objective progression or relapse|4|||
155286354|NCT00828919|560480536|FG002|Overall Study|Objective progression or relapse|11|||
155286355|NCT00828919|560480537|FG003|Overall Study|Objective progression or relapse|0|||
155286356|NCT00828919|560480538|FG004|Overall Study|Objective progression or relapse|5|||
155059071|NCT00368251|559651817|FG001|Overall Study|AE, non-serious non-fatal|0|||
155059072|NCT00368251|559651818|FG002|Overall Study|AE, non-serious non-fatal|1|||
155059073|NCT00499122|559651819|FG000|Overall Study|Withdrawal by Subject|2|||
155059074|NCT04539275|559651825|FG000|Overall Study|Death|2|||
155059075|NCT04539275|559651826|FG001|Overall Study|Death|4|||
155059076|NCT04539275|559651825|FG000|Overall Study|Lost to Follow-up|1|||
155059077|NCT04539275|559651826|FG001|Overall Study|Lost to Follow-up|1|||
155059078|NCT04539275|559651825|FG000|Overall Study|Withdrawal by Subject|3|||
155059079|NCT04539275|559651826|FG001|Overall Study|Withdrawal by Subject|0|||
155059080|NCT02466399|559651827|FG000|Overall Study|Adverse Event|1|||
155059081|NCT02466399|559651828|FG001|Overall Study|Adverse Event|0|||
155059082|NCT02466399|559651827|FG000|Overall Study|Early exit due to family emergency|1|||
155059083|NCT02466399|559651828|FG001|Overall Study|Early exit due to family emergency|0|||
155059084|NCT00095979|559651831|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
155059085|NCT01483118|559651832|FG000|Overall Study|Lost to Follow-up|12|||
155059086|NCT01483118|559651833|FG001|Overall Study|Lost to Follow-up|16|||
155059087|NCT01829347|559651834|FG000|VTI-210|Death|5|||
155059088|NCT01829347|559651835|FG001|VTI-210|Death|3|||
155059089|NCT01829347|559651834|FG000|VTI-210|Withdrawal by Subject|1|||
155059090|NCT01829347|559651835|FG001|VTI-210|Withdrawal by Subject|0|||
155059091|NCT01829347|559651834|FG000|VTI-210E|Death|2|||
155059092|NCT01829347|559651835|FG001|VTI-210E|Death|1|||
155059093|NCT01829347|559651834|FG000|VTI-210E|Study terminated prematurely|1|||
155059094|NCT01829347|559651835|FG001|VTI-210E|Study terminated prematurely|5|||
155059095|NCT01178294|559651836|FG000|Overall Study|Adverse Event|4|||
155059096|NCT01178294|559651836|FG000|Overall Study|Lost to Follow-up|2|||
155059097|NCT01178294|559651836|FG000|Overall Study|Lack of Efficacy|1|||
155059098|NCT01178294|559651836|FG000|Overall Study|Death|1|||
155059099|NCT01178294|559651836|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
155059100|NCT01178294|559651836|FG000|Overall Study|Subject status is terminal|1|||
155059101|NCT01178294|559651836|FG000|Overall Study|Completion status could not be verified|1|||
155059102|NCT02051296|559651841|FG000|Overall Study|Lost to Follow-up|1|||
155059103|NCT02051296|559651842|FG001|Overall Study|Lost to Follow-up|2|||
155059104|NCT02051296|559651841|FG000|Overall Study|withdraw prior to treatment|7|||
155059105|NCT02051296|559651842|FG001|Overall Study|withdraw prior to treatment|7|||
155059106|NCT05379920|559651843|FG000|Overall Study|Lost to Follow-up|0|||
155059107|NCT05379920|559651844|FG001|Overall Study|Lost to Follow-up|5|||
155059108|NCT05379920|559651845|FG002|Overall Study|Lost to Follow-up|0|||
155059109|NCT05379920|559651846|FG003|Overall Study|Lost to Follow-up|0|||
155059110|NCT03176771|559651849|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
155059111|NCT03176771|559651850|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
155059112|NCT03176771|559651851|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
155059113|NCT03176771|559651852|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
155286357|NCT00828919|560480534|FG000|Overall Study|No longer willing to participate in study|0|||
155286358|NCT00828919|560480535|FG001|Overall Study|No longer willing to participate in study|0|||
155286359|NCT00828919|560480536|FG002|Overall Study|No longer willing to participate in study|2|||
155286360|NCT00828919|560480537|FG003|Overall Study|No longer willing to participate in study|0|||
155059114|NCT03176771|559651853|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
155059115|NCT03176771|559651849|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155059116|NCT03176771|559651850|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
155059117|NCT03176771|559651851|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155059118|NCT03176771|559651852|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155059119|NCT03176771|559651853|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
155059120|NCT03176771|559651849|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
155059121|NCT03176771|559651850|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
155059122|NCT03176771|559651851|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
155059123|NCT03176771|559651852|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
155059124|NCT03176771|559651853|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
155059125|NCT03176771|559651849|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155059126|NCT03176771|559651850|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155059127|NCT03176771|559651851|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
155286361|NCT00828919|560480538|FG004|Overall Study|No longer willing to participate in study|0|||
155286362|NCT00828919|560480534|FG000|Overall Study|Insufficient Clinical Response|0|||
155286363|NCT00828919|560480535|FG001|Overall Study|Insufficient Clinical Response|1|||
155286364|NCT00828919|560480536|FG002|Overall Study|Insufficient Clinical Response|2|||
155286365|NCT00828919|560480537|FG003|Overall Study|Insufficient Clinical Response|0|||
155286366|NCT00828919|560480538|FG004|Overall Study|Insufficient Clinical Response|0|||
155286367|NCT00828919|560480534|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286368|NCT00828919|560480535|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286369|NCT00828919|560480536|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286370|NCT00828919|560480537|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
155286371|NCT00828919|560480538|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
155286372|NCT00828919|560480534|FG000|Overall Study|Other|1|||
155286373|NCT00828919|560480535|FG001|Overall Study|Other|0|||
155286374|NCT00828919|560480536|FG002|Overall Study|Other|1|||
155286375|NCT00828919|560480537|FG003|Overall Study|Other|1|||
155286376|NCT00828919|560480538|FG004|Overall Study|Other|0|||
155286377|NCT00828919|560480534|FG000|Overall Study|Lost to Follow-up|0|||
155286378|NCT00828919|560480535|FG001|Overall Study|Lost to Follow-up|1|||
155286379|NCT00828919|560480536|FG002|Overall Study|Lost to Follow-up|0|||
155286380|NCT00828919|560480537|FG003|Overall Study|Lost to Follow-up|0|||
155286381|NCT00828919|560480538|FG004|Overall Study|Lost to Follow-up|0|||
155286382|NCT01562743|560480539|FG000|Overall Study|Adverse Event|29|||
155286383|NCT01562743|560480539|FG000|Overall Study|Lack of Efficacy|3|||
155286384|NCT01562743|560480539|FG000|Overall Study|Withdrawal by Subject|13|||
155286385|NCT01562743|560480539|FG000|Overall Study|Protocol Violation|1|||
155286386|NCT01562743|560480539|FG000|Overall Study|Discontinuation criteria|2|||
155286387|NCT01562743|560480539|FG000|Overall Study|Lost to Follow-up|2|||
155286388|NCT01562743|560480539|FG000|Overall Study|Physician Decision|2|||
155286389|NCT05567159|560480540|FG000|Overall Study|Adverse Event|4|||
155286390|NCT05567159|560480540|FG000|Overall Study|Physician Decision|3|||
155286391|NCT05567159|560480540|FG000|Overall Study|Protocol deviation|1|||
155286392|NCT02449044|560480543|FG000|Overall Study|Lost to Follow-up|2|||
155286393|NCT02449044|560480543|FG000|Overall Study|Withdrawal by Subject|13|||
155286394|NCT02449044|560480543|FG000|Overall Study|Adverse Event|30|||
155286395|NCT02449044|560480543|FG000|Overall Study|Met Withdrawal Criteria|7|||
155286396|NCT02449044|560480543|FG000|Overall Study|Physician Decision|9|||
155286397|NCT02449044|560480543|FG000|Overall Study|Sponsor Discontinued Trial|3|||
155286398|NCT00349908|560482249|FG000|Overall Study|Withdrawal by Subject|0|||
155286399|NCT00349908|560482250|FG001|Overall Study|Withdrawal by Subject|4|||
155286400|NCT04381494|560482257|FG000|Overall Study|Early termination of trial|19|||
155286401|NCT04381494|560482257|FG000|Overall Study|Investigator's discretion|1|||
155286402|NCT04381494|560482257|FG000|Overall Study|Withdrawal by Subject|9|||
155286403|NCT04381494|560482257|FG000|Overall Study|NSCLC disease progression|4|||
155286404|NCT04381494|560482257|FG000|Overall Study|Device-Related Adverse Event|2|||
155286405|NCT04310579|560482258|FG000|Overall Study|Adverse Event|0|||
155286406|NCT04310579|560482259|FG001|Overall Study|Adverse Event|0|||
155286407|NCT04310579|560482260|FG002|Overall Study|Adverse Event|0|||
155286408|NCT04310579|560482261|FG003|Overall Study|Adverse Event|0|||
155286409|NCT04310579|560482262|FG004|Overall Study|Adverse Event|0|||
155286410|NCT04310579|560482263|FG005|Overall Study|Adverse Event|0|||
155286411|NCT04310579|560482264|FG006|Overall Study|Adverse Event|2|||
155286412|NCT04310579|560482265|FG007|Overall Study|Adverse Event|0|||
155286413|NCT04310579|560482266|FG008|Overall Study|Adverse Event|1|||
155286414|NCT04310579|560482267|FG009|Overall Study|Adverse Event|1|||
155286415|NCT04310579|560482268|FG010|Overall Study|Adverse Event|0|||
155286416|NCT04310579|560482258|FG000|Overall Study|Withdrawal by Subject|0|||
155286417|NCT04310579|560482259|FG001|Overall Study|Withdrawal by Subject|0|||
155286418|NCT04310579|560482260|FG002|Overall Study|Withdrawal by Subject|0|||
154954759|NCT03522675|559259684|FG000|Overall Study|Non-reactive to histamine|1|||
155286419|NCT04310579|560482261|FG003|Overall Study|Withdrawal by Subject|0|||
155286420|NCT04310579|560482262|FG004|Overall Study|Withdrawal by Subject|0|||
154954760|NCT00707161|559259685|FG000|Overall Study|Physician Decision|6|||
154954761|NCT02674477|559259686|FG000|Overall Study|Protocol Violation|8|||
154954762|NCT02674477|559259687|FG001|Overall Study|Protocol Violation|2|||
155286421|NCT04310579|560482263|FG005|Overall Study|Withdrawal by Subject|1|||
155286422|NCT04310579|560482264|FG006|Overall Study|Withdrawal by Subject|0|||
155286423|NCT04310579|560482265|FG007|Overall Study|Withdrawal by Subject|0|||
155286424|NCT04310579|560482266|FG008|Overall Study|Withdrawal by Subject|0|||
155286425|NCT04310579|560482267|FG009|Overall Study|Withdrawal by Subject|0|||
155286426|NCT04310579|560482268|FG010|Overall Study|Withdrawal by Subject|0|||
155286427|NCT04310579|560482258|FG000|Overall Study|Positive COVID-19 test|0|||
155286428|NCT04310579|560482259|FG001|Overall Study|Positive COVID-19 test|0|||
155286429|NCT04310579|560482260|FG002|Overall Study|Positive COVID-19 test|0|||
154954763|NCT01173692|559259691|FG000|Overall Study|Adverse Event|1|||
154954764|NCT01173692|559259692|FG001|Overall Study|Adverse Event|2|||
155286430|NCT04310579|560482261|FG003|Overall Study|Positive COVID-19 test|0|||
155286431|NCT04310579|560482262|FG004|Overall Study|Positive COVID-19 test|0|||
155286432|NCT04310579|560482263|FG005|Overall Study|Positive COVID-19 test|0|||
155286433|NCT04310579|560482264|FG006|Overall Study|Positive COVID-19 test|0|||
155286434|NCT04310579|560482265|FG007|Overall Study|Positive COVID-19 test|0|||
155286435|NCT04310579|560482266|FG008|Overall Study|Positive COVID-19 test|0|||
155286436|NCT04310579|560482267|FG009|Overall Study|Positive COVID-19 test|0|||
155286437|NCT04310579|560482268|FG010|Overall Study|Positive COVID-19 test|1|||
155286438|NCT03467724|560482269|FG000|Overall Study|Lost to Follow-up|5|||
155286439|NCT03467724|560482269|FG000|Overall Study|Withdrawal by Subject|1|||
155286440|NCT03467724|560482269|FG000|Overall Study|Protocol Violation|1|||
155286441|NCT03467724|560482269|FG000|Overall Study|Adverse Event|1|||
155286442|NCT02236559|560482273|FG000|Overall Study|Met Exclusion|3|||
155286443|NCT02236559|560482274|FG001|Overall Study|Met Exclusion|6|||
155286444|NCT02236559|560482273|FG000|Overall Study|Did not Meet Inclusion|3|||
155286445|NCT02236559|560482274|FG001|Overall Study|Did not Meet Inclusion|3|||
155155628|NCT01488890|560006463|FG001|Overall Study|Protocol Violation|0|||
155155629|NCT01488890|560006464|FG002|Overall Study|Protocol Violation|4|||
155155630|NCT01488890|560006465|FG003|Overall Study|Protocol Violation|0|||
155155631|NCT01488890|560006462|FG000|Overall Study|Lost to Follow-up|13|||
155155632|NCT01488890|560006463|FG001|Overall Study|Lost to Follow-up|10|||
155155633|NCT01488890|560006464|FG002|Overall Study|Lost to Follow-up|20|||
155155634|NCT01488890|560006465|FG003|Overall Study|Lost to Follow-up|3|||
155155635|NCT01488890|560006462|FG000|Overall Study|Withdrawal by Subject|14|||
155155636|NCT01488890|560006463|FG001|Overall Study|Withdrawal by Subject|10|||
155155637|NCT01488890|560006464|FG002|Overall Study|Withdrawal by Subject|11|||
155155638|NCT01488890|560006465|FG003|Overall Study|Withdrawal by Subject|2|||
155155639|NCT05712460|560006466|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155640|NCT05712460|560006467|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155641|NCT05712460|560006468|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155642|NCT05712460|560006469|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155643|NCT05712460|560006470|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155644|NCT05712460|560006471|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155645|NCT05712460|560006472|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155646|NCT05712460|560006473|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
155155647|NCT05712460|560006474|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155648|NCT05712460|560006475|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155649|NCT05712460|560006476|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155650|NCT05712460|560006477|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
155155651|NCT05082857|560006480|FG000|Overall Study|participants relocated and could not continue|2|||
155155652|NCT05082857|560006481|FG001|Overall Study|participants relocated and could not continue|1|||
155155653|NCT05082857|560006480|FG000|Overall Study|Lost to Follow-up|1|||
155155654|NCT05082857|560006481|FG001|Overall Study|Lost to Follow-up|3|||
155155655|NCT04363320|560006482|FG000|Overall Study|Lost to Follow-up|43|||
155155656|NCT04363320|560006483|FG001|Overall Study|Lost to Follow-up|42|||
155155657|NCT04363320|560006484|FG002|Overall Study|Lost to Follow-up|24|||
155155658|NCT04363320|560006485|FG003|Overall Study|Lost to Follow-up|29|||
155155659|NCT04363320|560006482|FG000|Overall Study|Death|0|||
155155660|NCT04363320|560006483|FG001|Overall Study|Death|0|||
155155661|NCT04363320|560006484|FG002|Overall Study|Death|1|||
155155662|NCT04363320|560006485|FG003|Overall Study|Death|0|||
155155663|NCT00604565|560006486|FG000|Overall Study|Study terminated|0|||
155155664|NCT00604565|560006487|FG001|Overall Study|Study terminated|3|||
155155665|NCT02260934|560006489|FG000|Overall Study|Lost to Follow-up|2|||
155155666|NCT02260934|560006490|FG001|Overall Study|Lost to Follow-up|1|||
155155667|NCT02260934|560006489|FG000|Overall Study|Withdrawal by Subject|0|||
155155668|NCT02260934|560006490|FG001|Overall Study|Withdrawal by Subject|2|||
155286446|NCT02236559|560482273|FG000|Overall Study|Subject Did Not Consent|4|||
155286447|NCT02236559|560482274|FG001|Overall Study|Subject Did Not Consent|2|||
155286448|NCT02236559|560482273|FG000|Overall Study|Physician Decision|1|||
155286449|NCT02236559|560482274|FG001|Overall Study|Physician Decision|1|||
155286450|NCT02236559|560482273|FG000|Overall Study|Withdrawal by Subject|1|||
155286451|NCT02236559|560482274|FG001|Overall Study|Withdrawal by Subject|0|||
155286452|NCT03721016|560482275|FG000|Overall Study|Adverse Event|0|||
155286453|NCT03721016|560482276|FG001|Overall Study|Adverse Event|1|||
155155669|NCT02260934|560006489|FG000|Overall Study|Participant Relocated|1|||
155155670|NCT02260934|560006490|FG001|Overall Study|Participant Relocated|0|||
155155671|NCT02260934|560006489|FG000|Overall Study|Site error|0|||
155155672|NCT02260934|560006490|FG001|Overall Study|Site error|1|||
155155673|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
155286454|NCT03721016|560482277|FG002|Overall Study|Adverse Event|1|||
155286455|NCT03721016|560482275|FG000|Overall Study|Withdrawal by Subject|8|||
155286456|NCT03721016|560482276|FG001|Overall Study|Withdrawal by Subject|16|||
155286457|NCT03721016|560482277|FG002|Overall Study|Withdrawal by Subject|13|||
155286458|NCT03721016|560482275|FG000|Overall Study|Lost to Follow-up|4|||
155286459|NCT03721016|560482276|FG001|Overall Study|Lost to Follow-up|6|||
155286460|NCT03721016|560482277|FG002|Overall Study|Lost to Follow-up|5|||
154954765|NCT01173692|559259691|FG000|Overall Study|Withdrawal by Subject|1|||
154954766|NCT01173692|559259692|FG001|Overall Study|Withdrawal by Subject|3|||
154954767|NCT01479439|559259699|FG000|Overall Study|Adverse Event|1|||
154954768|NCT01479439|559259700|FG001|Overall Study|Adverse Event|0|||
154954769|NCT01479439|559259701|FG002|Overall Study|Adverse Event|0|||
154954770|NCT01479439|559259699|FG000|Overall Study|Lost to Follow-up|0|||
155286461|NCT03721016|560482275|FG000|Overall Study|Physician Decision|0|||
155286462|NCT03721016|560482276|FG001|Overall Study|Physician Decision|1|||
155286463|NCT03721016|560482277|FG002|Overall Study|Physician Decision|2|||
155286464|NCT03721016|560482275|FG000|Overall Study|Protocol Violation|0|||
155286465|NCT03721016|560482276|FG001|Overall Study|Protocol Violation|1|||
155286466|NCT03721016|560482277|FG002|Overall Study|Protocol Violation|0|||
154954771|NCT01479439|559259700|FG001|Overall Study|Lost to Follow-up|1|||
155059128|NCT03176771|559651852|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
154954772|NCT01479439|559259701|FG002|Overall Study|Lost to Follow-up|0|||
154954773|NCT01479439|559259699|FG000|Overall Study|Protocol Violation|0|||
155286467|NCT03721016|560482275|FG000|Overall Study|Site terminated by sponsor|3|||
155286468|NCT03721016|560482276|FG001|Overall Study|Site terminated by sponsor|7|||
155286469|NCT03721016|560482277|FG002|Overall Study|Site terminated by sponsor|6|||
155286470|NCT03721016|560482275|FG000|Overall Study|Subject exited early due to COVID-19|1|||
155286471|NCT03721016|560482276|FG001|Overall Study|Subject exited early due to COVID-19|0|||
155286472|NCT03721016|560482277|FG002|Overall Study|Subject exited early due to COVID-19|0|||
155286473|NCT01149681|560482279|FG000|Overall Study|Withdrawal by Subject|7|||
155286474|NCT01149681|560482279|FG000|Overall Study|Progressive disease|1|||
155286475|NCT01149681|560482279|FG000|Overall Study|Physician Decision|2|||
155286476|NCT01149681|560482279|FG000|Overall Study|adverse events nonrelated study drug|2|||
155286477|NCT03107611|560482280|FG000|Overall Study|Adverse Event|1|||
155286478|NCT03107611|560482281|FG001|Overall Study|Adverse Event|0|||
155286479|NCT03107611|560482282|FG002|Overall Study|Adverse Event|2|||
155286480|NCT03107611|560482280|FG000|Overall Study|Lost to Follow-up|3|||
155286481|NCT03107611|560482281|FG001|Overall Study|Lost to Follow-up|3|||
155286482|NCT03107611|560482282|FG002|Overall Study|Lost to Follow-up|3|||
155286483|NCT03107611|560482280|FG000|Overall Study|Protocol Violation|0|||
155286484|NCT03107611|560482281|FG001|Overall Study|Protocol Violation|0|||
155286485|NCT03107611|560482282|FG002|Overall Study|Protocol Violation|1|||
155286486|NCT03107611|560482280|FG000|Overall Study|Withdrawal by Subject|1|||
155286487|NCT03107611|560482281|FG001|Overall Study|Withdrawal by Subject|0|||
155286488|NCT03107611|560482282|FG002|Overall Study|Withdrawal by Subject|1|||
155286489|NCT03107611|560482280|FG000|Overall Study|Worsening signs/symptoms|2|||
155286490|NCT03107611|560482281|FG001|Overall Study|Worsening signs/symptoms|1|||
155286491|NCT03107611|560482282|FG002|Overall Study|Worsening signs/symptoms|2|||
155286492|NCT01020838|560482283|FG000|Overall Study|Death|90|||
155286493|NCT01020838|560482283|FG000|Overall Study|Adverse Event|1|||
155286494|NCT01020838|560482283|FG000|Overall Study|Withdrawal by Subject|9|||
155286495|NCT01020838|560482283|FG000|Overall Study|Lost to Follow-up|6|||
155155674|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
155286496|NCT01020838|560482283|FG000|Overall Study|Most common: Study ended by sponsor|77|||
155286497|NCT00763282|560482288|FG000|Overall Study|Withdrawal by Subject|6|||
155286498|NCT00763282|560482289|FG001|Overall Study|Withdrawal by Subject|5|||
155286499|NCT00763282|560482288|FG000|Overall Study|Death|4|||
155286500|NCT00763282|560482289|FG001|Overall Study|Death|3|||
155286501|NCT00763282|560482288|FG000|Overall Study|Lost to Follow-up|22|||
155286502|NCT00763282|560482289|FG001|Overall Study|Lost to Follow-up|26|||
155286503|NCT00742274|560482290|FG000|Overall Study|Death|1|||
155286504|NCT00742274|560482291|FG001|Overall Study|Death|0|||
155286505|NCT00742274|560482290|FG000|Overall Study|Withdrawal by Subject|1|||
155286506|NCT00742274|560482291|FG001|Overall Study|Withdrawal by Subject|2|||
155286507|NCT00742274|560482290|FG000|Overall Study|Removed for medical reasons|1|||
155286508|NCT00742274|560482291|FG001|Overall Study|Removed for medical reasons|1|||
155286509|NCT00335556|560482296|FG000|Overall Study|Death|0|||
155286510|NCT00335556|560482297|FG001|Overall Study|Death|5|||
155286511|NCT00335556|560482298|FG002|Overall Study|Death|0|||
155286512|NCT00335556|560482299|FG003|Overall Study|Death|0|||
155286513|NCT00335556|560482300|FG004|Overall Study|Death|1|||
155286514|NCT00335556|560482301|FG005|Overall Study|Death|0|||
155286515|NCT00335556|560482296|FG000|Overall Study|Lack of Efficacy|0|||
155286516|NCT00335556|560482297|FG001|Overall Study|Lack of Efficacy|19|||
155286517|NCT00335556|560482298|FG002|Overall Study|Lack of Efficacy|3|||
155286518|NCT00335556|560482299|FG003|Overall Study|Lack of Efficacy|3|||
155286519|NCT00335556|560482300|FG004|Overall Study|Lack of Efficacy|0|||
155286520|NCT00335556|560482301|FG005|Overall Study|Lack of Efficacy|1|||
155286521|NCT00335556|560482296|FG000|Overall Study|Physician Decision|0|||
155155675|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
155155676|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
155286522|NCT00335556|560482297|FG001|Overall Study|Physician Decision|6|||
155286523|NCT00335556|560482298|FG002|Overall Study|Physician Decision|2|||
155286524|NCT00335556|560482299|FG003|Overall Study|Physician Decision|1|||
155286525|NCT00335556|560482300|FG004|Overall Study|Physician Decision|0|||
155286526|NCT00335556|560482301|FG005|Overall Study|Physician Decision|0|||
155286527|NCT00335556|560482296|FG000|Overall Study|Ineligible|2|||
155286528|NCT00335556|560482297|FG001|Overall Study|Ineligible|0|||
155155677|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
155286529|NCT00335556|560482298|FG002|Overall Study|Ineligible|0|||
155286530|NCT00335556|560482299|FG003|Overall Study|Ineligible|0|||
155286531|NCT00335556|560482300|FG004|Overall Study|Ineligible|0|||
155286532|NCT00335556|560482301|FG005|Overall Study|Ineligible|0|||
155286533|NCT00335556|560482296|FG000|Overall Study|Refusal of further protocol therapy|0|||
155286534|NCT00335556|560482297|FG001|Overall Study|Refusal of further protocol therapy|4|||
155286535|NCT00335556|560482298|FG002|Overall Study|Refusal of further protocol therapy|0|||
155286536|NCT00335556|560482299|FG003|Overall Study|Refusal of further protocol therapy|1|||
155286537|NCT00335556|560482300|FG004|Overall Study|Refusal of further protocol therapy|0|||
155286538|NCT00335556|560482301|FG005|Overall Study|Refusal of further protocol therapy|0|||
155286539|NCT02365298|560482302|FG000|Period 2|incorrect Rx dispensed|1|||
155286540|NCT02365298|560482303|FG001|Period 2|incorrect Rx dispensed|0|||
155286541|NCT02365298|560482302|FG000|Period 2|Discontinued at request of Sponsor|1|||
155286542|NCT02365298|560482303|FG001|Period 2|Discontinued at request of Sponsor|0|||
155286543|NCT02365298|560482302|FG000|Period 2|Test Article longer available|0|||
155286544|NCT02365298|560482303|FG001|Period 2|Test Article longer available|1|||
155286545|NCT02365298|560482302|FG000|Period 2|Protocol Violation|0|||
155286546|NCT02365298|560482303|FG001|Period 2|Protocol Violation|1|||
155286547|NCT03124108|560482306|FG000|Overall Study|Adverse Event|0|||
155286548|NCT03124108|560482307|FG001|Overall Study|Adverse Event|1|||
155286549|NCT03124108|560482308|FG002|Overall Study|Adverse Event|0|||
155286550|NCT01670019|560482313|FG000|Overall Study|Adverse Event|3|||
155286551|NCT01670019|560482314|FG001|Overall Study|Adverse Event|0|||
155286552|NCT01670019|560482313|FG000|Overall Study|Withdrawal by Subject|6|||
155286553|NCT01670019|560482314|FG001|Overall Study|Withdrawal by Subject|0|||
155286554|NCT05487703|560482315|FG000|Overall Study|Other|19|||
155286555|NCT05487703|560482315|FG000|Overall Study|Participant not well|5|||
155286556|NCT05487703|560482315|FG000|Overall Study|Insurance Reasons|6|||
155286557|NCT05487703|560482315|FG000|Overall Study|Physician Decision|19|||
155286558|NCT05487703|560482315|FG000|Overall Study|Lack of Efficacy|60|||
155286559|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
155286560|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
155286561|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
155286562|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Death|3|||
155286563|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Death|0|||
155286564|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Death|0|||
155286565|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
155286566|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155286567|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
155286568|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
155286569|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
155286570|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
155286571|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
155286572|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
155286573|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
155286574|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
155286575|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
155286576|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
155286577|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
155286578|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
155286579|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
155286580|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Other|1|||
155286581|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Other|0|||
155286582|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Other|0|||
155286583|NCT02403323|560482316|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
155286584|NCT02403323|560482317|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155286585|NCT02403323|560482318|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
155286586|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155286587|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
155286588|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
155286589|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
155286590|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
155286591|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
155286592|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
155286593|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
155286594|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
155286595|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155286596|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
155286597|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
155286598|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
155059129|NCT03176771|559651853|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
155059130|NCT03176771|559651849|FG000|Double-Blind Extension Period|Adverse Event|0|||
155059131|NCT03176771|559651850|FG001|Double-Blind Extension Period|Adverse Event|0|||
155059132|NCT03176771|559651851|FG002|Double-Blind Extension Period|Adverse Event|0|||
155059133|NCT03176771|559651852|FG003|Double-Blind Extension Period|Adverse Event|15|||
155286599|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
155286600|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
155286601|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
155286602|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
155286603|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
154954774|NCT01479439|559259700|FG001|Overall Study|Protocol Violation|0|||
154954775|NCT01479439|559259701|FG002|Overall Study|Protocol Violation|2|||
154954776|NCT01215981|559261714|FG000|Overall Study|Physician Decision|0|||
154954777|NCT01215981|559261715|FG001|Overall Study|Physician Decision|1|||
154954778|NCT01215981|559261714|FG000|Overall Study|Protocol Violation|1|||
154954779|NCT01215981|559261715|FG001|Overall Study|Protocol Violation|0|||
154954780|NCT01215981|559261714|FG000|Overall Study|Withdrawal by Subject|1|||
154954781|NCT01215981|559261715|FG001|Overall Study|Withdrawal by Subject|0|||
154954782|NCT04657770|559261716|FG000|Overall Study|Withdrawal by Subject|3|||
154954783|NCT04657770|559261716|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
154954784|NCT03497897|559261717|FG000|Overall Study|Adverse Event|1|||
155155678|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
155155679|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
155155680|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
155155681|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
155155682|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
155155683|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
155155684|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
155155685|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
155155686|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
155155687|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
155155688|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
155155689|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
155155690|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
155155691|NCT03605667|560006493|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
155155692|NCT03605667|560006494|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
155155693|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
155155694|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
155155695|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Other|6|||
155155696|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Other|8|||
155155697|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
155155698|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
155155699|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
155155700|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
155155701|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
155155702|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
155155703|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
155155704|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
155155705|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
155155706|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
155155707|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
155155708|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
155155709|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Death|0|||
155155710|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Death|2|||
155155711|NCT03605667|560006493|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
155155712|NCT03605667|560006494|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
155155713|NCT05632211|560006495|FG000|Overall Study|Withdrawal by Subject|2|||
155155714|NCT05632211|560006496|FG001|Overall Study|Withdrawal by Subject|0|||
155155715|NCT05632211|560006497|FG002|Overall Study|Withdrawal by Subject|2|||
155155716|NCT05632211|560006495|FG000|Overall Study|Other reasons|1|||
155155717|NCT05632211|560006496|FG001|Overall Study|Other reasons|1|||
155155718|NCT05632211|560006497|FG002|Overall Study|Other reasons|1|||
155155719|NCT05194124|560006498|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155720|NCT05194124|560006499|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155721|NCT05194124|560006500|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155722|NCT05194124|560006501|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
155155723|NCT05194124|560006502|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155724|NCT05194124|560006503|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
155155725|NCT05194124|560006504|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155726|NCT05194124|560006505|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155727|NCT05194124|560006506|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155728|NCT05194124|560006507|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
155155729|NCT05194124|560006498|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155730|NCT05194124|560006499|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
154954785|NCT03497897|559261718|FG001|Overall Study|Adverse Event|1|||
154954786|NCT03497897|559261719|FG002|Overall Study|Adverse Event|1|||
155286604|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
155286605|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
155286606|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
155286607|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
155286608|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
155286609|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
155286610|NCT02403323|560482316|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
155286611|NCT02403323|560482317|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
155286612|NCT02403323|560482318|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
155286613|NCT00197236|560482322|FG000|Overall Study|Adverse Event|1|||
155286614|NCT00197236|560482323|FG001|Overall Study|Adverse Event|0|||
155286615|NCT00197236|560482324|FG002|Overall Study|Adverse Event|1|||
155286616|NCT00197236|560482322|FG000|Overall Study|Lost to Follow-up|5|||
155286617|NCT00197236|560482323|FG001|Overall Study|Lost to Follow-up|14|||
155286618|NCT00197236|560482324|FG002|Overall Study|Lost to Follow-up|6|||
155286619|NCT00197236|560482322|FG000|Overall Study|Protocol Violation|0|||
155286620|NCT00197236|560482323|FG001|Overall Study|Protocol Violation|0|||
155286621|NCT00197236|560482324|FG002|Overall Study|Protocol Violation|1|||
155286622|NCT00197236|560482322|FG000|Overall Study|Withdrawal by Subject|7|||
155286623|NCT00197236|560482323|FG001|Overall Study|Withdrawal by Subject|3|||
155286624|NCT00197236|560482324|FG002|Overall Study|Withdrawal by Subject|11|||
155286625|NCT00197236|560482322|FG000|Overall Study|Study drug/medication expiration|1|||
155286626|NCT00197236|560482323|FG001|Overall Study|Study drug/medication expiration|0|||
155286627|NCT00197236|560482324|FG002|Overall Study|Study drug/medication expiration|3|||
155286628|NCT00197236|560482322|FG000|Overall Study|Returned out of specified time window|0|||
155286629|NCT00197236|560482323|FG001|Overall Study|Returned out of specified time window|0|||
155286630|NCT00197236|560482324|FG002|Overall Study|Returned out of specified time window|1|||
155286631|NCT03885596|560482325|FG000|Overall Study|Withdrawal by Subject|2|||
155286632|NCT03885596|560482326|FG001|Overall Study|Withdrawal by Subject|1|||
155286633|NCT03885596|560482327|FG002|Overall Study|Withdrawal by Subject|0|||
155286634|NCT03885596|560482328|FG003|Overall Study|Withdrawal by Subject|0|||
155286635|NCT00746330|560482329|FG000|Period 1|Abnormal test procedure result|0|||
155286636|NCT00746330|560482330|FG001|Period 1|Abnormal test procedure result|0|||
155286637|NCT00746330|560482331|FG002|Period 1|Abnormal test procedure result|1|||
155286638|NCT00746330|560482332|FG003|Period 1|Abnormal test procedure result|0|||
155286639|NCT01076335|560482333|FG000|Overall Study|Withdrawal by Subject|3|||
155286640|NCT01076335|560482333|FG000|Overall Study|Withdrawal without treatment|1|||
155286641|NCT00517933|560482335|FG000|Period 1|Death|2|||
155286642|NCT00517933|560482336|FG001|Period 1|Death|1|||
155286643|NCT00517933|560482335|FG000|Period 1|Adverse Event|4|||
155286644|NCT00517933|560482336|FG001|Period 1|Adverse Event|4|||
155286645|NCT00517933|560482335|FG000|Period 1|Lost to Follow-up|2|||
155286646|NCT00517933|560482336|FG001|Period 1|Lost to Follow-up|0|||
155286647|NCT00517933|560482335|FG000|Period 1|Underwent lung transplant|0|||
155286648|NCT00517933|560482336|FG001|Period 1|Underwent lung transplant|1|||
155286649|NCT00517933|560482335|FG000|Period 2|Death|2|||
155286650|NCT00517933|560482336|FG001|Period 2|Death|4|||
155286651|NCT00517933|560482335|FG000|Period 2|Adverse Event|2|||
155286652|NCT00517933|560482336|FG001|Period 2|Adverse Event|4|||
155286653|NCT00517933|560482335|FG000|Period 2|Physician Decision|1|||
155286654|NCT00517933|560482336|FG001|Period 2|Physician Decision|0|||
155286655|NCT00517933|560482335|FG000|Period 2|Withdrawal by Subject|1|||
155286656|NCT00517933|560482336|FG001|Period 2|Withdrawal by Subject|3|||
155286657|NCT00517933|560482335|FG000|Period 2|Underwent lung transplant|0|||
155286658|NCT00517933|560482336|FG001|Period 2|Underwent lung transplant|2|||
155286659|NCT04639947|560482339|FG000|Overall Study|Screen fail|1|||
155286660|NCT01018511|560482340|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
155286661|NCT01018511|560482341|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
155286662|NCT01018511|560482342|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
155286663|NCT01018511|560482343|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
155286664|NCT01018511|560482340|FG000|Overall Study|Adverse Event|5|||
155286665|NCT01018511|560482341|FG001|Overall Study|Adverse Event|9|||
155286666|NCT01018511|560482342|FG002|Overall Study|Adverse Event|13|||
155286667|NCT01018511|560482343|FG003|Overall Study|Adverse Event|10|||
155286668|NCT01018511|560482340|FG000|Overall Study|Lack of Efficacy|4|||
155286669|NCT01018511|560482341|FG001|Overall Study|Lack of Efficacy|1|||
155286670|NCT01018511|560482342|FG002|Overall Study|Lack of Efficacy|1|||
155286671|NCT01018511|560482343|FG003|Overall Study|Lack of Efficacy|2|||
155286672|NCT01018511|560482340|FG000|Overall Study|Withdrawal by Subject|6|||
155286673|NCT01018511|560482341|FG001|Overall Study|Withdrawal by Subject|5|||
155286674|NCT01018511|560482342|FG002|Overall Study|Withdrawal by Subject|11|||
155286675|NCT01018511|560482343|FG003|Overall Study|Withdrawal by Subject|9|||
155286676|NCT01018511|560482340|FG000|Overall Study|Lost to Follow-up|0|||
155286677|NCT01018511|560482341|FG001|Overall Study|Lost to Follow-up|0|||
155286678|NCT01018511|560482342|FG002|Overall Study|Lost to Follow-up|1|||
155286679|NCT01018511|560482343|FG003|Overall Study|Lost to Follow-up|0|||
155059134|NCT03176771|559651853|FG004|Double-Blind Extension Period|Adverse Event|18|||
155059135|NCT03176771|559651849|FG000|Double-Blind Extension Period|Death|0|||
155059136|NCT03176771|559651850|FG001|Double-Blind Extension Period|Death|0|||
155059137|NCT03176771|559651851|FG002|Double-Blind Extension Period|Death|0|||
155059138|NCT03176771|559651852|FG003|Double-Blind Extension Period|Death|3|||
155059139|NCT03176771|559651853|FG004|Double-Blind Extension Period|Death|4|||
155059140|NCT03176771|559651849|FG000|Double-Blind Extension Period|Physician Decision|0|||
155059141|NCT03176771|559651850|FG001|Double-Blind Extension Period|Physician Decision|0|||
155059142|NCT03176771|559651851|FG002|Double-Blind Extension Period|Physician Decision|0|||
155059143|NCT03176771|559651852|FG003|Double-Blind Extension Period|Physician Decision|3|||
155155731|NCT05194124|560006500|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155732|NCT05194124|560006501|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155733|NCT05194124|560006502|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155734|NCT05194124|560006503|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155735|NCT05194124|560006504|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155736|NCT05194124|560006505|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155737|NCT05194124|560006506|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
155155738|NCT05194124|560006507|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
155155739|NCT03642873|560006510|FG000|Third Intervention (1 Day)|Screen failure|0|||
155155740|NCT03642873|560006511|FG001|Third Intervention (1 Day)|Screen failure|0|||
155155741|NCT03642873|560006512|FG002|Third Intervention (1 Day)|Screen failure|0|||
155155742|NCT03642873|560006513|FG003|Third Intervention (1 Day)|Screen failure|0|||
155059144|NCT03176771|559651853|FG004|Double-Blind Extension Period|Physician Decision|1|||
155059145|NCT03176771|559651849|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
155059146|NCT03176771|559651850|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
155059147|NCT03176771|559651851|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
155059148|NCT03176771|559651852|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
155059149|NCT03176771|559651853|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
155059150|NCT03530293|559651854|FG000|Pre-randomization|Adverse Event|12|||
155059151|NCT03530293|559651855|FG001|Pre-randomization|Adverse Event|0|||
155059152|NCT03530293|559651856|FG002|Pre-randomization|Adverse Event|0|||
155059153|NCT03530293|559651854|FG000|Pre-randomization|Protocol Violation|2|||
155059154|NCT03530293|559651855|FG001|Pre-randomization|Protocol Violation|0|||
155059155|NCT03530293|559651856|FG002|Pre-randomization|Protocol Violation|0|||
155059156|NCT03530293|559651854|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
155059157|NCT03530293|559651855|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
155059158|NCT03530293|559651856|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
155059159|NCT03530293|559651854|FG000|Pre-randomization|Withdrawal by Subject|5|||
155059160|NCT03530293|559651855|FG001|Pre-randomization|Withdrawal by Subject|0|||
155059161|NCT03530293|559651856|FG002|Pre-randomization|Withdrawal by Subject|0|||
155059162|NCT03530293|559651854|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
155059163|NCT03530293|559651855|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
155059164|NCT03530293|559651856|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
155059165|NCT03530293|559651854|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
155059166|NCT03530293|559651855|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
155059167|NCT03530293|559651856|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
155059168|NCT03530293|559651854|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
155059169|NCT03530293|559651855|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
155059170|NCT03530293|559651856|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
155286680|NCT01018511|560482340|FG000|Overall Study|Protocol Violation|5|||
154954787|NCT03497897|559261717|FG000|Overall Study|Lost to Follow-up|2|||
154954788|NCT03497897|559261718|FG001|Overall Study|Lost to Follow-up|0|||
154954789|NCT03497897|559261719|FG002|Overall Study|Lost to Follow-up|2|||
154954790|NCT03497897|559261717|FG000|Overall Study|Physician Decision|1|||
154954791|NCT03497897|559261718|FG001|Overall Study|Physician Decision|0|||
154954792|NCT03497897|559261719|FG002|Overall Study|Physician Decision|0|||
154954793|NCT03497897|559261717|FG000|Overall Study|Subject/Guardian Decision|2|||
154954794|NCT03497897|559261718|FG001|Overall Study|Subject/Guardian Decision|1|||
154954795|NCT03497897|559261719|FG002|Overall Study|Subject/Guardian Decision|3|||
154954796|NCT01471093|559261722|FG000|Overall Study|Adverse Event|1|||
154954797|NCT01471093|559261723|FG001|Overall Study|Adverse Event|0|||
154954798|NCT01471093|559261724|FG002|Overall Study|Adverse Event|0|||
154954799|NCT01471093|559261725|FG003|Overall Study|Adverse Event|0|||
154954800|NCT01710657|559261726|FG000|Overall Study|Lost to Follow-up|2|||
154954801|NCT01710657|559261727|FG001|Overall Study|Lost to Follow-up|0|||
154954802|NCT01710657|559261728|FG002|Overall Study|Lost to Follow-up|1|||
154954803|NCT01710657|559261726|FG000|Overall Study|Protocol Violation|2|||
154954804|NCT01710657|559261727|FG001|Overall Study|Protocol Violation|2|||
154954805|NCT01710657|559261728|FG002|Overall Study|Protocol Violation|0|||
154954806|NCT01710657|559261726|FG000|Overall Study|Adverse Event|14|||
154954807|NCT01710657|559261727|FG001|Overall Study|Adverse Event|8|||
154954808|NCT01710657|559261728|FG002|Overall Study|Adverse Event|28|||
154954809|NCT01710657|559261726|FG000|Overall Study|Withdrawal by Subject|0|||
154954810|NCT01710657|559261727|FG001|Overall Study|Withdrawal by Subject|1|||
154954811|NCT01710657|559261728|FG002|Overall Study|Withdrawal by Subject|2|||
154954812|NCT01710657|559261726|FG000|Overall Study|Lack of Efficacy|0|||
154954813|NCT01710657|559261727|FG001|Overall Study|Lack of Efficacy|1|||
154954814|NCT01710657|559261728|FG002|Overall Study|Lack of Efficacy|1|||
154954815|NCT02495857|559261737|FG000|Overall Study|Adverse Event|5|||
154954816|NCT02495857|559261738|FG001|Overall Study|Adverse Event|0|||
154954817|NCT02495857|559261739|FG002|Overall Study|Adverse Event|1|||
154954818|NCT02495857|559261737|FG000|Overall Study|Withdrawal by Subject|9|||
154954819|NCT02495857|559261738|FG001|Overall Study|Withdrawal by Subject|6|||
154954820|NCT02495857|559261739|FG002|Overall Study|Withdrawal by Subject|10|||
154954821|NCT02495857|559261737|FG000|Overall Study|Physician Decision|0|||
154954822|NCT02495857|559261738|FG001|Overall Study|Physician Decision|1|||
154954823|NCT02495857|559261739|FG002|Overall Study|Physician Decision|0|||
154954824|NCT02495857|559261737|FG000|Overall Study|Protocol Violation|1|||
154954825|NCT02495857|559261738|FG001|Overall Study|Protocol Violation|1|||
154954826|NCT02495857|559261739|FG002|Overall Study|Protocol Violation|2|||
154954827|NCT02495857|559261737|FG000|Overall Study|Lost to Follow-up|4|||
154954828|NCT02495857|559261738|FG001|Overall Study|Lost to Follow-up|5|||
154954829|NCT02495857|559261739|FG002|Overall Study|Lost to Follow-up|3|||
154954830|NCT02495857|559261737|FG000|Overall Study|Other|3|||
155286681|NCT01018511|560482341|FG001|Overall Study|Protocol Violation|8|||
155286682|NCT01018511|560482342|FG002|Overall Study|Protocol Violation|7|||
155286683|NCT01018511|560482343|FG003|Overall Study|Protocol Violation|9|||
155286684|NCT01018511|560482340|FG000|Overall Study|Miscellaneous|0|||
155286685|NCT01018511|560482341|FG001|Overall Study|Miscellaneous|2|||
155286686|NCT01018511|560482342|FG002|Overall Study|Miscellaneous|0|||
155286687|NCT01018511|560482343|FG003|Overall Study|Miscellaneous|0|||
155286688|NCT00654238|560482344|FG000|Overall Study|Screen Failures|4|||
155286689|NCT04523181|560482346|FG000|Overall Study|Withdrawal by Subject|4|||
155286690|NCT04523181|560482347|FG001|Overall Study|Withdrawal by Subject|5|||
155286691|NCT04523181|560482346|FG000|Overall Study|Lost to Follow-up|2|||
155286692|NCT04523181|560482347|FG001|Overall Study|Lost to Follow-up|3|||
155286693|NCT04523181|560482346|FG000|Overall Study|Physician Decision|1|||
155286694|NCT04523181|560482347|FG001|Overall Study|Physician Decision|0|||
155286695|NCT04523181|560482346|FG000|Overall Study|Transferred to external facility.|1|||
155286696|NCT04523181|560482347|FG001|Overall Study|Transferred to external facility.|1|||
155286697|NCT01559090|560482352|FG000|Stage I|Withdrawal by Subject|2|||
155286698|NCT01559090|560482353|FG001|Stage I|Withdrawal by Subject|2|||
155286699|NCT01559090|560482354|FG002|Stage I|Withdrawal by Subject|3|||
155286700|NCT01559090|560482352|FG000|Stage II|Withdrawal by Subject|1|||
155286701|NCT01559090|560482353|FG001|Stage II|Withdrawal by Subject|0|||
155286702|NCT01559090|560482354|FG002|Stage II|Withdrawal by Subject|0|||
155286703|NCT01729871|560482357|FG000|Overall Study|Adverse Event|7|||
155286704|NCT01729871|560482358|FG001|Overall Study|Adverse Event|7|||
155286705|NCT01729871|560482357|FG000|Overall Study|Death|0|||
155286706|NCT01729871|560482358|FG001|Overall Study|Death|1|||
155286707|NCT01729871|560482357|FG000|Overall Study|Lack of Efficacy|0|||
155286708|NCT01729871|560482358|FG001|Overall Study|Lack of Efficacy|1|||
155286709|NCT01729871|560482357|FG000|Overall Study|Physician Decision|0|||
155286710|NCT01729871|560482358|FG001|Overall Study|Physician Decision|2|||
155286711|NCT01729871|560482357|FG000|Overall Study|Protocol Violation|1|||
155286712|NCT01729871|560482358|FG001|Overall Study|Protocol Violation|0|||
155286713|NCT01729871|560482357|FG000|Overall Study|Withdrawal by Subject|0|||
155286714|NCT01729871|560482358|FG001|Overall Study|Withdrawal by Subject|3|||
155286715|NCT01729871|560482357|FG000|Overall Study|Other|4|||
155286716|NCT01729871|560482358|FG001|Overall Study|Other|9|||
155286717|NCT01143077|560482359|FG000|Overall Study|Lack of Efficacy|0|||
155286718|NCT01143077|560482360|FG001|Overall Study|Lack of Efficacy|2|||
155286719|NCT01143077|560482361|FG002|Overall Study|Lack of Efficacy|1|||
155286720|NCT01143077|560482359|FG000|Overall Study|Adverse Event|5|||
155286721|NCT01143077|560482360|FG001|Overall Study|Adverse Event|6|||
155286722|NCT01143077|560482361|FG002|Overall Study|Adverse Event|5|||
155286723|NCT01143077|560482359|FG000|Overall Study|Lost to Follow-up|2|||
155286724|NCT01143077|560482360|FG001|Overall Study|Lost to Follow-up|3|||
155286725|NCT01143077|560482361|FG002|Overall Study|Lost to Follow-up|4|||
155286726|NCT01143077|560482359|FG000|Overall Study|Protocol Violation|2|||
155286727|NCT01143077|560482360|FG001|Overall Study|Protocol Violation|0|||
155059171|NCT03530293|559651854|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
155059172|NCT03530293|559651855|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
155059173|NCT03530293|559651856|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
155059174|NCT03530293|559651854|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
155059175|NCT03530293|559651855|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
155286728|NCT01143077|560482361|FG002|Overall Study|Protocol Violation|0|||
155286729|NCT01143077|560482359|FG000|Overall Study|Withdrawal by Subject|4|||
155286730|NCT01143077|560482360|FG001|Overall Study|Withdrawal by Subject|3|||
155286731|NCT01143077|560482361|FG002|Overall Study|Withdrawal by Subject|3|||
155286732|NCT01143077|560482359|FG000|Overall Study|Non-compliance with study drug|0|||
155286733|NCT01143077|560482360|FG001|Overall Study|Non-compliance with study drug|1|||
155286734|NCT01143077|560482361|FG002|Overall Study|Non-compliance with study drug|1|||
155286735|NCT01143077|560482359|FG000|Overall Study|Administrative|1|||
155286736|NCT01143077|560482360|FG001|Overall Study|Administrative|0|||
155286737|NCT01143077|560482361|FG002|Overall Study|Administrative|0|||
155286738|NCT01143077|560482359|FG000|Overall Study|Principal Investigator Decision|2|||
155286739|NCT01143077|560482360|FG001|Overall Study|Principal Investigator Decision|0|||
155286740|NCT01143077|560482361|FG002|Overall Study|Principal Investigator Decision|1|||
155286741|NCT00836810|560482362|FG000|Overall Study|New diagnosis|1|||
155286742|NCT00836810|560482363|FG001|Overall Study|New diagnosis|0|||
155286743|NCT01772719|560482365|FG000|Overall Study|Withdrawal by Subject|3|||
155286744|NCT01772719|560482365|FG000|Overall Study|Adverse Event|2|||
155286745|NCT01772719|560482365|FG000|Overall Study|Protocol Violation|1|||
155286746|NCT01772719|560482365|FG000|Overall Study|Lost to Follow-up|1|||
155286747|NCT02014558|560482370|FG000|Overall Study|Never Received Study Drug|0|||
155286748|NCT02014558|560482371|FG001|Overall Study|Never Received Study Drug|0|||
155286749|NCT02014558|560482372|FG002|Overall Study|Never Received Study Drug|0|||
155286750|NCT02014558|560482373|FG003|Overall Study|Never Received Study Drug|0|||
155286751|NCT02014558|560482374|FG004|Overall Study|Never Received Study Drug|1|||
155286752|NCT02014558|560482375|FG005|Overall Study|Never Received Study Drug|0|||
155286753|NCT02014558|560482376|FG006|Overall Study|Never Received Study Drug|1|||
155286754|NCT02014558|560482377|FG007|Overall Study|Never Received Study Drug|0|||
155286755|NCT02014558|560482378|FG008|Overall Study|Never Received Study Drug|2|||
155286756|NCT02014558|560482379|FG009|Overall Study|Never Received Study Drug|0|||
155286757|NCT02014558|560482380|FG010|Overall Study|Never Received Study Drug|2|||
155286758|NCT02014558|560482381|FG011|Overall Study|Never Received Study Drug|2|||
155286759|NCT02014558|560482382|FG012|Overall Study|Never Received Study Drug|0|||
155286760|NCT02014558|560482370|FG000|Overall Study|Adverse Event|0|||
155286761|NCT02014558|560482371|FG001|Overall Study|Adverse Event|0|||
155286762|NCT02014558|560482372|FG002|Overall Study|Adverse Event|0|||
155286763|NCT02014558|560482373|FG003|Overall Study|Adverse Event|0|||
155286764|NCT02014558|560482374|FG004|Overall Study|Adverse Event|1|||
155286765|NCT02014558|560482375|FG005|Overall Study|Adverse Event|0|||
155286766|NCT02014558|560482376|FG006|Overall Study|Adverse Event|0|||
155286767|NCT02014558|560482377|FG007|Overall Study|Adverse Event|0|||
155286768|NCT02014558|560482378|FG008|Overall Study|Adverse Event|2|||
155286769|NCT02014558|560482379|FG009|Overall Study|Adverse Event|2|||
155286770|NCT02014558|560482380|FG010|Overall Study|Adverse Event|5|||
155286771|NCT02014558|560482381|FG011|Overall Study|Adverse Event|21|||
155286772|NCT02014558|560482382|FG012|Overall Study|Adverse Event|3|||
155286773|NCT02014558|560482370|FG000|Overall Study|Death|1|||
155286774|NCT02014558|560482371|FG001|Overall Study|Death|0|||
155286775|NCT02014558|560482372|FG002|Overall Study|Death|0|||
155286776|NCT02014558|560482373|FG003|Overall Study|Death|0|||
155286777|NCT02014558|560482374|FG004|Overall Study|Death|0|||
155286778|NCT02014558|560482375|FG005|Overall Study|Death|0|||
155286779|NCT02014558|560482376|FG006|Overall Study|Death|1|||
155286780|NCT02014558|560482377|FG007|Overall Study|Death|1|||
155286781|NCT02014558|560482378|FG008|Overall Study|Death|2|||
155286782|NCT02014558|560482379|FG009|Overall Study|Death|5|||
155286783|NCT02014558|560482380|FG010|Overall Study|Death|5|||
155286784|NCT02014558|560482381|FG011|Overall Study|Death|19|||
155286785|NCT02014558|560482382|FG012|Overall Study|Death|2|||
155286786|NCT02014558|560482370|FG000|Overall Study|Lack of Efficacy|1|||
155286787|NCT02014558|560482371|FG001|Overall Study|Lack of Efficacy|2|||
155286788|NCT02014558|560482372|FG002|Overall Study|Lack of Efficacy|1|||
155286789|NCT02014558|560482373|FG003|Overall Study|Lack of Efficacy|1|||
155286790|NCT02014558|560482374|FG004|Overall Study|Lack of Efficacy|0|||
155286791|NCT02014558|560482375|FG005|Overall Study|Lack of Efficacy|0|||
155286792|NCT02014558|560482376|FG006|Overall Study|Lack of Efficacy|1|||
155286793|NCT02014558|560482377|FG007|Overall Study|Lack of Efficacy|3|||
155286794|NCT02014558|560482378|FG008|Overall Study|Lack of Efficacy|3|||
155286795|NCT02014558|560482379|FG009|Overall Study|Lack of Efficacy|3|||
155286796|NCT02014558|560482380|FG010|Overall Study|Lack of Efficacy|16|||
155286797|NCT02014558|560482381|FG011|Overall Study|Lack of Efficacy|8|||
155286798|NCT02014558|560482382|FG012|Overall Study|Lack of Efficacy|5|||
155286799|NCT02014558|560482370|FG000|Overall Study|Lost to Follow-up|0|||
155286800|NCT02014558|560482371|FG001|Overall Study|Lost to Follow-up|0|||
155286801|NCT02014558|560482372|FG002|Overall Study|Lost to Follow-up|0|||
155286802|NCT02014558|560482373|FG003|Overall Study|Lost to Follow-up|0|||
155286803|NCT02014558|560482374|FG004|Overall Study|Lost to Follow-up|0|||
155286804|NCT02014558|560482375|FG005|Overall Study|Lost to Follow-up|0|||
155286805|NCT02014558|560482376|FG006|Overall Study|Lost to Follow-up|0|||
155286806|NCT02014558|560482377|FG007|Overall Study|Lost to Follow-up|0|||
155286807|NCT02014558|560482378|FG008|Overall Study|Lost to Follow-up|0|||
155286808|NCT02014558|560482379|FG009|Overall Study|Lost to Follow-up|0|||
155286809|NCT02014558|560482380|FG010|Overall Study|Lost to Follow-up|1|||
155286810|NCT02014558|560482381|FG011|Overall Study|Lost to Follow-up|0|||
155286811|NCT02014558|560482382|FG012|Overall Study|Lost to Follow-up|0|||
155286812|NCT02014558|560482370|FG000|Overall Study|Progressive Disease|1|||
155286813|NCT02014558|560482371|FG001|Overall Study|Progressive Disease|0|||
154954831|NCT02495857|559261738|FG001|Overall Study|Other|3|||
154954832|NCT02495857|559261739|FG002|Overall Study|Other|2|||
155286814|NCT02014558|560482372|FG002|Overall Study|Progressive Disease|1|||
155286815|NCT02014558|560482373|FG003|Overall Study|Progressive Disease|1|||
155286816|NCT02014558|560482374|FG004|Overall Study|Progressive Disease|1|||
154954833|NCT01367457|559261740|FG000|Overall Study|Death|2|||
155286817|NCT02014558|560482375|FG005|Overall Study|Progressive Disease|2|||
155286818|NCT02014558|560482376|FG006|Overall Study|Progressive Disease|1|||
155286819|NCT02014558|560482377|FG007|Overall Study|Progressive Disease|6|||
155286820|NCT02014558|560482378|FG008|Overall Study|Progressive Disease|5|||
154954834|NCT01367457|559261741|FG001|Overall Study|Death|0|||
155286821|NCT02014558|560482379|FG009|Overall Study|Progressive Disease|6|||
155286822|NCT02014558|560482380|FG010|Overall Study|Progressive Disease|22|||
155286823|NCT02014558|560482381|FG011|Overall Study|Progressive Disease|31|||
155286824|NCT02014558|560482382|FG012|Overall Study|Progressive Disease|6|||
155286825|NCT02014558|560482370|FG000|Overall Study|Withdrawal by Subject|0|||
155286826|NCT02014558|560482371|FG001|Overall Study|Withdrawal by Subject|0|||
155286827|NCT02014558|560482372|FG002|Overall Study|Withdrawal by Subject|0|||
155286828|NCT02014558|560482373|FG003|Overall Study|Withdrawal by Subject|0|||
155286829|NCT02014558|560482374|FG004|Overall Study|Withdrawal by Subject|1|||
155286830|NCT02014558|560482375|FG005|Overall Study|Withdrawal by Subject|0|||
155286831|NCT02014558|560482376|FG006|Overall Study|Withdrawal by Subject|0|||
155286832|NCT02014558|560482377|FG007|Overall Study|Withdrawal by Subject|0|||
155286833|NCT02014558|560482378|FG008|Overall Study|Withdrawal by Subject|0|||
155286834|NCT02014558|560482379|FG009|Overall Study|Withdrawal by Subject|2|||
155286835|NCT02014558|560482380|FG010|Overall Study|Withdrawal by Subject|6|||
155286836|NCT02014558|560482381|FG011|Overall Study|Withdrawal by Subject|10|||
155286837|NCT02014558|560482382|FG012|Overall Study|Withdrawal by Subject|0|||
155286838|NCT02014558|560482370|FG000|Overall Study|Miscellaneous|2|||
155286839|NCT02014558|560482371|FG001|Overall Study|Miscellaneous|1|||
155286840|NCT02014558|560482372|FG002|Overall Study|Miscellaneous|1|||
155286841|NCT02014558|560482373|FG003|Overall Study|Miscellaneous|1|||
155286842|NCT02014558|560482374|FG004|Overall Study|Miscellaneous|0|||
155286843|NCT02014558|560482375|FG005|Overall Study|Miscellaneous|1|||
155286844|NCT02014558|560482376|FG006|Overall Study|Miscellaneous|0|||
155286845|NCT02014558|560482377|FG007|Overall Study|Miscellaneous|1|||
155286846|NCT02014558|560482378|FG008|Overall Study|Miscellaneous|1|||
155286847|NCT02014558|560482379|FG009|Overall Study|Miscellaneous|3|||
155286848|NCT02014558|560482380|FG010|Overall Study|Miscellaneous|12|||
155286849|NCT02014558|560482381|FG011|Overall Study|Miscellaneous|11|||
155286850|NCT02014558|560482382|FG012|Overall Study|Miscellaneous|1|||
155286851|NCT02931396|560482385|FG000|Overall Study|Lost to Follow-up|3|||
155286852|NCT02931396|560482386|FG001|Overall Study|Lost to Follow-up|0|||
155286853|NCT02931396|560482385|FG000|Overall Study|Withdrawal by Subject|2|||
155286854|NCT02931396|560482386|FG001|Overall Study|Withdrawal by Subject|0|||
155286855|NCT05273801|560482387|FG000|Overall Study|Physician Decision|1|||
155286856|NCT04159506|560482388|FG000|Overall Study|Lost to Follow-up|2|||
155286857|NCT04159506|560482389|FG001|Overall Study|Lost to Follow-up|5|||
155286858|NCT03227757|560484190|FG000|Overall Study|Death|25|||
155286859|NCT03227757|560484190|FG000|Overall Study|Withdrawal|10|||
155286860|NCT03227757|560484190|FG000|Overall Study|Missed visits|1|||
155286861|NCT03227757|560484190|FG000|Overall Study|Lost to Follow-up|2|||
155286862|NCT01144468|560484191|FG000|Overall Study|Lost to Follow-up|4|||
155286863|NCT01144468|560484192|FG001|Overall Study|Lost to Follow-up|7|||
155286864|NCT01144468|560484191|FG000|Overall Study|Adverse Event|3|||
155286865|NCT01144468|560484192|FG001|Overall Study|Adverse Event|2|||
155286866|NCT01144468|560484191|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
155286867|NCT01144468|560484192|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
155286868|NCT02960659|560484193|FG000|Overall Study|Withdrawal by Subject|1|||
155286869|NCT02960659|560484194|FG001|Overall Study|Withdrawal by Subject|0|||
155286870|NCT02960659|560484193|FG000|Overall Study|Poor compliance|0|||
155286871|NCT02960659|560484194|FG001|Overall Study|Poor compliance|1|||
155286872|NCT04199728|560484198|FG000|Overall Study|Adverse Event|1|||
155286873|NCT04199728|560484199|FG001|Overall Study|Adverse Event|0|||
155286874|NCT04199728|560484198|FG000|Overall Study|Withdrawal by Subject|8|||
155286875|NCT04199728|560484199|FG001|Overall Study|Withdrawal by Subject|3|||
155286876|NCT04199728|560484198|FG000|Overall Study|Screen fail after consent|0|||
155286877|NCT04199728|560484199|FG001|Overall Study|Screen fail after consent|1|||
155286878|NCT04199728|560484198|FG000|Overall Study|Early withdraw criteria met|0|||
155286879|NCT04199728|560484199|FG001|Overall Study|Early withdraw criteria met|1|||
155286880|NCT04199728|560484198|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
155286881|NCT04199728|560484199|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
155286882|NCT03068468|560484200|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
155286883|NCT03068468|560484201|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
155286884|NCT03068468|560484202|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
155286885|NCT03068468|560484203|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
155286886|NCT03068468|560484200|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
155286887|NCT03068468|560484201|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
155286888|NCT03068468|560484202|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
155286889|NCT03068468|560484203|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
155286890|NCT03068468|560484200|FG000|Placebo-Controlled Period|Adverse Event|16|||
155286891|NCT03068468|560484201|FG001|Placebo-Controlled Period|Adverse Event|21|||
155286892|NCT03068468|560484202|FG002|Placebo-Controlled Period|Adverse Event|0|||
155286893|NCT03068468|560484203|FG003|Placebo-Controlled Period|Adverse Event|0|||
155286894|NCT03068468|560484200|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
155286895|NCT03068468|560484201|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
155286896|NCT03068468|560484202|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
155286897|NCT03068468|560484203|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
155286898|NCT03068468|560484200|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155286899|NCT03068468|560484201|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
155286900|NCT03068468|560484202|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
154954835|NCT01367457|559261742|FG002|Overall Study|Death|0|||
154954836|NCT01367457|559261740|FG000|Overall Study|Investigator's decision|2|||
155286901|NCT03068468|560484203|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155286902|NCT03068468|560484200|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
155286903|NCT03068468|560484201|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
155286904|NCT03068468|560484202|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
155286905|NCT03068468|560484203|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
155286906|NCT03068468|560484200|FG000|Placebo-Controlled Period|Death|0|||
155286907|NCT03068468|560484201|FG001|Placebo-Controlled Period|Death|1|||
155286908|NCT03068468|560484202|FG002|Placebo-Controlled Period|Death|0|||
155286909|NCT03068468|560484203|FG003|Placebo-Controlled Period|Death|0|||
155286910|NCT03068468|560484200|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
155286911|NCT03068468|560484201|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
155286912|NCT03068468|560484202|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
155286913|NCT03068468|560484203|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
155286914|NCT03068468|560484200|FG000|Open-Label Extension Period|Adverse Event|0|||
155286915|NCT03068468|560484201|FG001|Open-Label Extension Period|Adverse Event|0|||
155286916|NCT03068468|560484202|FG002|Open-Label Extension Period|Adverse Event|13|||
155286917|NCT03068468|560484203|FG003|Open-Label Extension Period|Adverse Event|17|||
155286918|NCT03068468|560484200|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
155286919|NCT03068468|560484201|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
155286920|NCT03068468|560484202|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
155286921|NCT03068468|560484203|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
155286922|NCT03068468|560484200|FG000|Open-Label Extension Period|Death|0|||
155286923|NCT03068468|560484201|FG001|Open-Label Extension Period|Death|0|||
155286924|NCT03068468|560484202|FG002|Open-Label Extension Period|Death|0|||
155286925|NCT03068468|560484203|FG003|Open-Label Extension Period|Death|1|||
155286926|NCT03068468|560484200|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
155286927|NCT03068468|560484201|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
155286928|NCT03068468|560484202|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
155286929|NCT03068468|560484203|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
155286930|NCT03068468|560484200|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
155286931|NCT03068468|560484201|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
155286932|NCT03068468|560484202|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
155286933|NCT03068468|560484203|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
155286934|NCT03068468|560484200|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
155286935|NCT03068468|560484201|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
155286936|NCT03068468|560484202|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
155286937|NCT03068468|560484203|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
155286938|NCT03068468|560484200|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
155286939|NCT03068468|560484201|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
155286940|NCT03068468|560484202|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
155286941|NCT03068468|560484203|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
155286942|NCT03068468|560484200|FG000|Open-Label Extension Period|Reason not Specified|0|||
155286943|NCT03068468|560484201|FG001|Open-Label Extension Period|Reason not Specified|0|||
155286944|NCT03068468|560484202|FG002|Open-Label Extension Period|Reason not Specified|1|||
155286945|NCT03068468|560484203|FG003|Open-Label Extension Period|Reason not Specified|4|||
155286946|NCT03181958|560484205|FG000|Overall Study|Lost to Follow-up|17|||
155286947|NCT03181958|560484206|FG001|Overall Study|Lost to Follow-up|21|||
155286948|NCT03181958|560484207|FG002|Overall Study|Lost to Follow-up|15|||
155286949|NCT01268891|560484213|FG000|Overall Study|Adverse Event|3|||
155286950|NCT01268891|560484214|FG001|Overall Study|Adverse Event|7|||
155286951|NCT01268891|560484213|FG000|Overall Study|Lack of Efficacy|1|||
155286952|NCT01268891|560484214|FG001|Overall Study|Lack of Efficacy|0|||
155286953|NCT01268891|560484213|FG000|Overall Study|Withdrawal of Consent|3|||
155155743|NCT03642873|560006514|FG004|Third Intervention (1 Day)|Screen failure|1|||
155155744|NCT03642873|560006515|FG005|Third Intervention (1 Day)|Screen failure|0|||
155155745|NCT03694353|560006519|FG000|Overall Study|Withdrawal by Subject|1|||
155155746|NCT03694353|560006519|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
155286954|NCT01268891|560484214|FG001|Overall Study|Withdrawal of Consent|1|||
155286955|NCT01268891|560484213|FG000|Overall Study|Administrative or other reason(s)|1|||
155286956|NCT01268891|560484214|FG001|Overall Study|Administrative or other reason(s)|0|||
155286957|NCT00991276|560484216|FG000|First Intervention Period|Adverse Event|0|||
155286958|NCT00991276|560484217|FG001|First Intervention Period|Adverse Event|1|||
155286959|NCT00991276|560484218|FG002|First Intervention Period|Adverse Event|0|||
155286960|NCT00991276|560484219|FG003|First Intervention Period|Adverse Event|1|||
155286961|NCT00991276|560484220|FG004|First Intervention Period|Adverse Event|0|||
155286962|NCT00991276|560484221|FG005|First Intervention Period|Adverse Event|0|||
155286963|NCT00991276|560484216|FG000|First Intervention Period|Protocol Violation|0|||
155286964|NCT00991276|560484217|FG001|First Intervention Period|Protocol Violation|0|||
155155747|NCT03804528|560006520|FG000|Overall Study|Time Commitment|18|||
155286965|NCT00991276|560484218|FG002|First Intervention Period|Protocol Violation|0|||
155286966|NCT00991276|560484219|FG003|First Intervention Period|Protocol Violation|0|||
155286967|NCT00991276|560484220|FG004|First Intervention Period|Protocol Violation|2|||
155286968|NCT00991276|560484221|FG005|First Intervention Period|Protocol Violation|0|||
155286969|NCT00991276|560484216|FG000|First Intervention Period|Insufficient clinical response|0|||
155286970|NCT00991276|560484217|FG001|First Intervention Period|Insufficient clinical response|0|||
155286971|NCT00991276|560484218|FG002|First Intervention Period|Insufficient clinical response|0|||
155286972|NCT00991276|560484219|FG003|First Intervention Period|Insufficient clinical response|0|||
155286973|NCT00991276|560484220|FG004|First Intervention Period|Insufficient clinical response|1|||
155286974|NCT00991276|560484221|FG005|First Intervention Period|Insufficient clinical response|0|||
155286975|NCT00991276|560484216|FG000|First Intervention Period|Other|0|||
155286976|NCT00991276|560484217|FG001|First Intervention Period|Other|0|||
155286977|NCT00991276|560484218|FG002|First Intervention Period|Other|0|||
155286978|NCT00991276|560484219|FG003|First Intervention Period|Other|1|||
155286979|NCT00991276|560484220|FG004|First Intervention Period|Other|1|||
155286980|NCT00991276|560484221|FG005|First Intervention Period|Other|0|||
155286981|NCT00991276|560484216|FG000|First Intervention Period|Withdrawal by Subject|0|||
155286982|NCT00991276|560484217|FG001|First Intervention Period|Withdrawal by Subject|1|||
155286983|NCT00991276|560484218|FG002|First Intervention Period|Withdrawal by Subject|0|||
155286984|NCT00991276|560484219|FG003|First Intervention Period|Withdrawal by Subject|1|||
155286985|NCT00991276|560484220|FG004|First Intervention Period|Withdrawal by Subject|0|||
155286986|NCT00991276|560484221|FG005|First Intervention Period|Withdrawal by Subject|1|||
155286987|NCT00991276|560484216|FG000|First Intervention Period|Lost to Follow-up|0|||
155286988|NCT00991276|560484217|FG001|First Intervention Period|Lost to Follow-up|1|||
155286989|NCT00991276|560484218|FG002|First Intervention Period|Lost to Follow-up|0|||
155286990|NCT00991276|560484219|FG003|First Intervention Period|Lost to Follow-up|1|||
155286991|NCT00991276|560484220|FG004|First Intervention Period|Lost to Follow-up|0|||
155286992|NCT00991276|560484221|FG005|First Intervention Period|Lost to Follow-up|0|||
155286993|NCT00991276|560484216|FG000|Second Intervention Period|Adverse Event|0|||
155286994|NCT00991276|560484217|FG001|Second Intervention Period|Adverse Event|2|||
155286995|NCT00991276|560484218|FG002|Second Intervention Period|Adverse Event|0|||
155286996|NCT00991276|560484219|FG003|Second Intervention Period|Adverse Event|1|||
155286997|NCT00991276|560484220|FG004|Second Intervention Period|Adverse Event|1|||
155286998|NCT00991276|560484221|FG005|Second Intervention Period|Adverse Event|0|||
155286999|NCT00991276|560484216|FG000|Second Intervention Period|Protocol Violation|1|||
155287000|NCT00991276|560484217|FG001|Second Intervention Period|Protocol Violation|0|||
155287001|NCT00991276|560484218|FG002|Second Intervention Period|Protocol Violation|0|||
155287002|NCT00991276|560484219|FG003|Second Intervention Period|Protocol Violation|0|||
155287003|NCT00991276|560484220|FG004|Second Intervention Period|Protocol Violation|0|||
155287004|NCT00991276|560484221|FG005|Second Intervention Period|Protocol Violation|0|||
155287005|NCT00991276|560484216|FG000|Second Intervention Period|Other|0|||
155287006|NCT00991276|560484217|FG001|Second Intervention Period|Other|0|||
155287007|NCT00991276|560484218|FG002|Second Intervention Period|Other|0|||
155287008|NCT00991276|560484219|FG003|Second Intervention Period|Other|1|||
155287009|NCT00991276|560484220|FG004|Second Intervention Period|Other|0|||
155287010|NCT00991276|560484221|FG005|Second Intervention Period|Other|1|||
155155748|NCT03804528|560006520|FG000|Overall Study|Health Reasons|5|||
155287011|NCT00991276|560484216|FG000|Third Intervention Period|Protocol Violation|1|||
155287012|NCT00991276|560484217|FG001|Third Intervention Period|Protocol Violation|0|||
155287013|NCT00991276|560484218|FG002|Third Intervention Period|Protocol Violation|0|||
155287014|NCT00991276|560484219|FG003|Third Intervention Period|Protocol Violation|0|||
155287015|NCT00991276|560484220|FG004|Third Intervention Period|Protocol Violation|0|||
155287016|NCT00991276|560484221|FG005|Third Intervention Period|Protocol Violation|0|||
155287017|NCT00991276|560484216|FG000|Third Intervention Period|Other|0|||
155287018|NCT00991276|560484217|FG001|Third Intervention Period|Other|0|||
155287019|NCT00991276|560484218|FG002|Third Intervention Period|Other|0|||
155287020|NCT00991276|560484219|FG003|Third Intervention Period|Other|0|||
155287021|NCT00991276|560484220|FG004|Third Intervention Period|Other|0|||
155287022|NCT00991276|560484221|FG005|Third Intervention Period|Other|1|||
155287023|NCT00991276|560484216|FG000|Third Intervention Period|Adverse Event|0|||
155287024|NCT00991276|560484217|FG001|Third Intervention Period|Adverse Event|0|||
155287025|NCT00991276|560484218|FG002|Third Intervention Period|Adverse Event|1|||
155287026|NCT00991276|560484219|FG003|Third Intervention Period|Adverse Event|0|||
155287027|NCT00991276|560484220|FG004|Third Intervention Period|Adverse Event|0|||
155287028|NCT00991276|560484221|FG005|Third Intervention Period|Adverse Event|0|||
155287029|NCT00991276|560484216|FG000|Third Intervention Period|Withdrawal by Subject|0|||
155287030|NCT00991276|560484217|FG001|Third Intervention Period|Withdrawal by Subject|0|||
155287031|NCT00991276|560484218|FG002|Third Intervention Period|Withdrawal by Subject|0|||
155287032|NCT00991276|560484219|FG003|Third Intervention Period|Withdrawal by Subject|1|||
155287033|NCT00991276|560484220|FG004|Third Intervention Period|Withdrawal by Subject|0|||
155287034|NCT00991276|560484221|FG005|Third Intervention Period|Withdrawal by Subject|0|||
155287035|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
155287036|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
155287037|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
155287038|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
155287039|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Adverse Event|198|||
155287040|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Adverse Event|0|||
155287041|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Adverse Event|0|||
155287042|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Adverse Event|0|||
155287043|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Death|62|||
155287044|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Death|0|||
155287045|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Death|0|||
155287046|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Death|0|||
155287047|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
155287048|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
155287049|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
155287050|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
155287051|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Complicating disease|13|||
155287052|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Complicating disease|0|||
155287053|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Complicating disease|0|||
155287054|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Complicating disease|0|||
155287055|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
155287056|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
155287057|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
155287058|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
155287059|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
155287060|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
155287061|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
155287062|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
155287063|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Non-compliance|4|||
155287064|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Non-compliance|0|||
155287065|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Non-compliance|0|||
155287066|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Non-compliance|0|||
155287067|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Pain|4|||
155287068|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Pain|0|||
155287069|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Pain|0|||
155287070|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Pain|0|||
155287071|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
155287072|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
155287073|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
155287074|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
155287075|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Hospice care|1|||
155287076|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Hospice care|0|||
155287077|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Hospice care|0|||
155059176|NCT03530293|559651856|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
155059177|NCT02714153|559651857|FG000|Overall Study|Death|1|||
155059178|NCT04465422|559651858|FG000|Overall Study|Lost to Follow-up|0|||
155059179|NCT04465422|559651859|FG001|Overall Study|Lost to Follow-up|2|||
155287078|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Hospice care|0|||
155287079|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Physician Decision|1|||
155287080|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Physician Decision|0|||
155287081|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Physician Decision|0|||
155287082|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Physician Decision|0|||
155287083|NCT01107626|560484223|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
155287084|NCT01107626|560484224|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
155287085|NCT01107626|560484225|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
155287086|NCT01107626|560484226|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
155287087|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
155287088|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
155287089|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
155287090|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
155287091|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
155287092|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
155287093|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
155287094|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
155287095|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Death|0|||
155287096|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Death|8|||
155287097|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Death|2|||
155287098|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Death|13|||
155287099|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
155287100|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
155287101|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
155287102|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
155287103|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
155287104|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
155287105|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
155287106|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
155287107|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
155287108|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
155287109|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
155287110|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
155287111|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
155287112|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
155287113|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
155287114|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
155287115|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
155287116|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
155287117|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
155287118|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
155287119|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
155287120|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
155287121|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
154954837|NCT01367457|559261741|FG001|Overall Study|Investigator's decision|0|||
154954838|NCT01367457|559261742|FG002|Overall Study|Investigator's decision|0|||
154954839|NCT01367457|559261740|FG000|Overall Study|Clinical decline (CD)|2|||
154954840|NCT01367457|559261741|FG001|Overall Study|Clinical decline (CD)|0|||
154954841|NCT01367457|559261742|FG002|Overall Study|Clinical decline (CD)|0|||
154954842|NCT01367457|559261740|FG000|Overall Study|Progression and death|8|||
154954843|NCT01367457|559261741|FG001|Overall Study|Progression and death|0|||
154954844|NCT01367457|559261742|FG002|Overall Study|Progression and death|0|||
154954845|NCT01367457|559261740|FG000|Overall Study|Toxicity|16|||
155287122|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
155287123|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
155287124|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
155287125|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
155287126|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
155287127|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
155287128|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
155287129|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
155287130|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
155287131|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
155287132|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
155287133|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
155287134|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
155287135|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
155287136|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
155287137|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
155287138|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
155287139|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Pain|0|||
155287140|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Pain|0|||
155287141|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Pain|0|||
155287142|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Pain|1|||
155287143|NCT01107626|560484223|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
155287144|NCT01107626|560484224|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
155287145|NCT01107626|560484225|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
155287146|NCT01107626|560484226|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
155287147|NCT00817635|560484229|FG000|Overall Study|Adverse Event|1|||
155287148|NCT00817635|560484230|FG001|Overall Study|Adverse Event|0|||
155287149|NCT00817635|560484231|FG002|Overall Study|Adverse Event|0|||
155287150|NCT00817635|560484232|FG003|Overall Study|Adverse Event|1|||
155287151|NCT00817635|560484233|FG004|Overall Study|Adverse Event|1|||
155287152|NCT00817635|560484229|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155287153|NCT00817635|560484230|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
155287154|NCT00817635|560484231|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155287155|NCT00817635|560484232|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
155287156|NCT00817635|560484233|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
155287157|NCT00817635|560484229|FG000|Overall Study|Withdrawal by Subject|2|||
155287158|NCT00817635|560484230|FG001|Overall Study|Withdrawal by Subject|1|||
155287159|NCT00817635|560484231|FG002|Overall Study|Withdrawal by Subject|0|||
155287160|NCT00817635|560484232|FG003|Overall Study|Withdrawal by Subject|1|||
155287161|NCT00817635|560484233|FG004|Overall Study|Withdrawal by Subject|2|||
155287162|NCT00817635|560484229|FG000|Overall Study|Lost to Follow-up|0|||
155287163|NCT00817635|560484230|FG001|Overall Study|Lost to Follow-up|1|||
155287164|NCT00817635|560484231|FG002|Overall Study|Lost to Follow-up|0|||
155287165|NCT00817635|560484232|FG003|Overall Study|Lost to Follow-up|1|||
155287166|NCT00817635|560484233|FG004|Overall Study|Lost to Follow-up|0|||
155287167|NCT00817635|560484229|FG000|Overall Study|Administrative Problems|0|||
155287168|NCT00817635|560484230|FG001|Overall Study|Administrative Problems|0|||
155287169|NCT00817635|560484231|FG002|Overall Study|Administrative Problems|0|||
155287170|NCT00817635|560484232|FG003|Overall Study|Administrative Problems|0|||
155287171|NCT00817635|560484233|FG004|Overall Study|Administrative Problems|1|||
155287172|NCT00817635|560484229|FG000|Overall Study|Protocol Violation|5|||
155287173|NCT00817635|560484230|FG001|Overall Study|Protocol Violation|1|||
155287174|NCT00817635|560484231|FG002|Overall Study|Protocol Violation|3|||
155287175|NCT00817635|560484232|FG003|Overall Study|Protocol Violation|2|||
155287176|NCT00817635|560484233|FG004|Overall Study|Protocol Violation|3|||
155287177|NCT00918957|560484234|FG000|Overall Study|Adverse Event|2|||
155287178|NCT00918957|560484235|FG001|Overall Study|Adverse Event|0|||
155287179|NCT00918957|560484234|FG000|Overall Study|Withdrawal by Subject|1|||
155287180|NCT00918957|560484235|FG001|Overall Study|Withdrawal by Subject|0|||
155287181|NCT01720446|560484238|FG000|Overall Study|Lost to Follow-up|12|||
155287182|NCT01720446|560484239|FG001|Overall Study|Lost to Follow-up|6|||
155287183|NCT01720446|560484240|FG002|Overall Study|Lost to Follow-up|16|||
155287184|NCT01720446|560484241|FG003|Overall Study|Lost to Follow-up|16|||
154954846|NCT01367457|559261741|FG001|Overall Study|Toxicity|0|||
155287185|NCT01720446|560484238|FG000|Overall Study|Withdrawal by Subject|2|||
155287186|NCT01720446|560484239|FG001|Overall Study|Withdrawal by Subject|5|||
155287187|NCT01720446|560484240|FG002|Overall Study|Withdrawal by Subject|4|||
154954847|NCT01367457|559261742|FG002|Overall Study|Toxicity|0|||
155287188|NCT01720446|560484241|FG003|Overall Study|Withdrawal by Subject|4|||
155287189|NCT01167426|560484242|FG000|Overall Study|Lost to Follow-up|6|||
155287190|NCT01167426|560484242|FG000|Overall Study|Protocol Violation|1|||
155287191|NCT01167426|560484242|FG000|Overall Study|Withdrawal by Subject|2|||
155287192|NCT01167426|560484242|FG000|Overall Study|Sponsor Decision|1|||
155287193|NCT01908634|560484243|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
155287194|NCT01908634|560484243|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
155287195|NCT04176458|560484245|FG000|Overall Study|Covid 19|4|||
155287196|NCT02131324|560484246|FG000|Overall Study|Withdrawal by Subject|1|||
155287197|NCT02131324|560484247|FG001|Overall Study|Withdrawal by Subject|2|||
155287198|NCT02131324|560484246|FG000|Overall Study|Lost to Follow-up|1|||
155287199|NCT02131324|560484247|FG001|Overall Study|Lost to Follow-up|1|||
155287200|NCT00891618|560484248|FG000|Overall Study|Withdrawal by Subject|1|||
155287201|NCT04582877|560484251|FG000|Overall Study|Did not use device measurement|5|||
155287202|NCT04582877|560484251|FG000|Overall Study|No fractional flow reserve test results|2|||
155287203|NCT04582877|560484251|FG000|Overall Study|Protocol Violation|1|||
155287204|NCT00003656|560484252|FG000|Overall Study|Adverse Event|0|||
155287205|NCT00003656|560484253|FG001|Overall Study|Adverse Event|1|||
155287206|NCT01268566|560484257|FG000|Overall Study|Lost to Follow-up|1|||
155287207|NCT01268566|560484257|FG000|Overall Study|Withdrawal by Subject|12|||
155287208|NCT01268566|560484257|FG000|Overall Study|Death|30|||
155287209|NCT01649427|560484262|FG000|Overall Study|Adverse Event|1|||
155287210|NCT01649427|560484263|FG001|Overall Study|Adverse Event|1|||
155287211|NCT01649427|560484262|FG000|Overall Study|Withdrawal by Subject|8|||
155287212|NCT01649427|560484263|FG001|Overall Study|Withdrawal by Subject|7|||
154954848|NCT01367457|559261740|FG000|Overall Study|Progression|137|||
155287213|NCT01649427|560484262|FG000|Overall Study|Lost to Follow-up|0|||
155287214|NCT01649427|560484263|FG001|Overall Study|Lost to Follow-up|1|||
154954849|NCT01367457|559261741|FG001|Overall Study|Progression|0|||
154954850|NCT01367457|559261742|FG002|Overall Study|Progression|0|||
154954851|NCT01367457|559261740|FG000|Overall Study|Patient asks for rest + slow progression|1|||
154954852|NCT01367457|559261741|FG001|Overall Study|Patient asks for rest + slow progression|0|||
154954853|NCT01367457|559261742|FG002|Overall Study|Patient asks for rest + slow progression|0|||
154954854|NCT01367457|559261740|FG000|Overall Study|Investigator's opinion, stable disease|1|||
155287215|NCT01649427|560484262|FG000|Overall Study|Graft loss|0|||
155287216|NCT01649427|560484263|FG001|Overall Study|Graft loss|1|||
155287217|NCT01649427|560484262|FG000|Overall Study|Surgical problems during nephrectomy|2|||
155287218|NCT01649427|560484263|FG001|Overall Study|Surgical problems during nephrectomy|2|||
155287219|NCT02138916|560484264|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
155287220|NCT02138916|560484265|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
155287221|NCT02138916|560484266|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
155287222|NCT02138916|560484264|FG000|Overall Study|Death|14|||
155287223|NCT02138916|560484265|FG001|Overall Study|Death|11|||
155287224|NCT02138916|560484266|FG002|Overall Study|Death|12|||
155287225|NCT02138916|560484264|FG000|Overall Study|Withdrawal by Subject|27|||
155287226|NCT02138916|560484265|FG001|Overall Study|Withdrawal by Subject|31|||
155287227|NCT02138916|560484266|FG002|Overall Study|Withdrawal by Subject|32|||
155287228|NCT02138916|560484264|FG000|Overall Study|Study specific withdrawal criteria|0|||
155287229|NCT02138916|560484265|FG001|Overall Study|Study specific withdrawal criteria|0|||
155287230|NCT02138916|560484266|FG002|Overall Study|Study specific withdrawal criteria|1|||
155287231|NCT02138916|560484264|FG000|Overall Study|incorrect enrolment|1|||
155287232|NCT02138916|560484265|FG001|Overall Study|incorrect enrolment|1|||
155287233|NCT02138916|560484266|FG002|Overall Study|incorrect enrolment|0|||
155287234|NCT02138916|560484264|FG000|Overall Study|Severe non-compliance|1|||
155287235|NCT02138916|560484265|FG001|Overall Study|Severe non-compliance|2|||
155287236|NCT02138916|560484266|FG002|Overall Study|Severe non-compliance|1|||
155287237|NCT02138916|560484264|FG000|Overall Study|Lost to Follow-up|4|||
155287238|NCT02138916|560484265|FG001|Overall Study|Lost to Follow-up|2|||
155287239|NCT02138916|560484266|FG002|Overall Study|Lost to Follow-up|3|||
155287240|NCT02138916|560484264|FG000|Overall Study|Adverse Event|4|||
155287241|NCT02138916|560484265|FG001|Overall Study|Adverse Event|4|||
155287242|NCT02138916|560484266|FG002|Overall Study|Adverse Event|3|||
155287243|NCT05096884|560484268|FG000|Overall Study|Excluded based on negative tilt table test|4|||
155287244|NCT02482233|560484273|FG000|Overall Study|Lost to Follow-up|1|||
155287245|NCT02482233|560484274|FG001|Overall Study|Lost to Follow-up|1|||
155287246|NCT04888585|560484275|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
155287247|NCT04888585|560484276|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
155287248|NCT04888585|560484277|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
155287249|NCT04888585|560484278|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
155287250|NCT04888585|560484279|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
155287251|NCT04888585|560484280|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287252|NCT04888585|560484281|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287253|NCT04888585|560484282|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287254|NCT04888585|560484283|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287255|NCT04888585|560484284|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287256|NCT04888585|560484285|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
155287257|NCT04888585|560484275|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287258|NCT04888585|560484276|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
155287259|NCT04888585|560484277|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
154954855|NCT01367457|559261741|FG001|Overall Study|Investigator's opinion, stable disease|0|||
154954856|NCT01367457|559261742|FG002|Overall Study|Investigator's opinion, stable disease|0|||
155287260|NCT04888585|560484278|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
155287261|NCT04888585|560484279|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
154954857|NCT01367457|559261740|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
154954858|NCT01367457|559261741|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
154954859|NCT01367457|559261742|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
155287262|NCT04888585|560484280|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287263|NCT04888585|560484281|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287264|NCT04888585|560484282|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287265|NCT04888585|560484283|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287266|NCT04888585|560484284|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287267|NCT04888585|560484285|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
155287268|NCT04888585|560484275|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287269|NCT04888585|560484276|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287270|NCT04888585|560484277|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
155287271|NCT04888585|560484278|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287272|NCT04888585|560484279|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
155287273|NCT04888585|560484280|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287274|NCT04888585|560484281|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287275|NCT04888585|560484282|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287276|NCT04888585|560484283|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287277|NCT04888585|560484284|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287278|NCT04888585|560484285|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
155287279|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287280|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287281|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287282|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287283|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287284|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287285|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287286|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
155287287|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287288|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
155287289|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
155287290|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287291|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287292|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287293|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287294|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
155287295|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
155287296|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
155287297|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
155287298|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
155287299|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
155287300|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
155287301|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155287302|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155059180|NCT05412134|559651862|FG000|Overall Study|Lost to Follow-up|2|||
155059181|NCT05412134|559651863|FG001|Overall Study|Lost to Follow-up|0|||
155059182|NCT03444584|559651866|FG000|Overall Study|Withdrawal by Subject|0|||
155059183|NCT03444584|559651867|FG001|Overall Study|Withdrawal by Subject|1|||
155059184|NCT03444584|559651866|FG000|Overall Study|Other|0|||
155059185|NCT03444584|559651867|FG001|Overall Study|Other|1|||
155059186|NCT00423046|559651868|FG000|Overall Study|Other|340|||
155059187|NCT00423046|559651869|FG001|Overall Study|Other|345|||
155059188|NCT01604785|559651870|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
155059189|NCT01604785|559651871|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
155059190|NCT02783911|559651878|FG000|Overall Study|Lost to Follow-up|3|||
155059191|NCT02783911|559651879|FG001|Overall Study|Lost to Follow-up|32|||
155059192|NCT00467519|559651880|FG000|Overall Study|Protocol Violation|8|||
155059193|NCT00467519|559651881|FG001|Overall Study|Protocol Violation|4|||
155059194|NCT00467519|559651880|FG000|Overall Study|Lost to Follow-up|2|||
155059195|NCT00467519|559651881|FG001|Overall Study|Lost to Follow-up|9|||
155287303|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155059196|NCT00467519|559651880|FG000|Overall Study|Withdrawal by Subject|4|||
155059197|NCT00467519|559651881|FG001|Overall Study|Withdrawal by Subject|10|||
155059198|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
155059199|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155059200|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155059201|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155059202|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155059203|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155059204|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
155155749|NCT05138653|560006523|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
155059205|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
155059206|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155059207|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155059208|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155059209|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155059210|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155059211|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
155059212|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155059213|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
155059214|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155059215|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155059216|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155059217|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155059218|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
155059219|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155059220|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155059221|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
155059222|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155059223|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155059224|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155059225|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
155059226|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155155750|NCT05138653|560006524|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155751|NCT05138653|560006525|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155752|NCT05138653|560006526|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155753|NCT05138653|560006527|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155754|NCT05138653|560006528|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155755|NCT05138653|560006529|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155756|NCT05138653|560006530|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155757|NCT05138653|560006531|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155758|NCT05138653|560006532|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155759|NCT05138653|560006533|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155760|NCT05138653|560006534|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155761|NCT05138653|560006535|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155762|NCT05138653|560006536|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155763|NCT05138653|560006537|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155764|NCT05138653|560006538|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
155155765|NCT05138653|560006523|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155766|NCT05138653|560006524|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
155155767|NCT05138653|560006525|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155768|NCT05138653|560006526|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155769|NCT05138653|560006527|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155770|NCT05138653|560006528|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155771|NCT05138653|560006529|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155772|NCT05138653|560006530|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155773|NCT05138653|560006531|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
155155774|NCT05138653|560006532|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155775|NCT05138653|560006533|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155776|NCT05138653|560006534|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155777|NCT05138653|560006535|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155778|NCT05138653|560006536|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155779|NCT05138653|560006537|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155780|NCT05138653|560006538|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
155155781|NCT05138653|560006523|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155782|NCT05138653|560006524|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
155155783|NCT05138653|560006525|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155784|NCT05138653|560006526|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155785|NCT05138653|560006527|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
155155786|NCT05138653|560006528|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155787|NCT05138653|560006529|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155788|NCT05138653|560006530|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155789|NCT05138653|560006531|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155790|NCT05138653|560006532|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155791|NCT05138653|560006533|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155792|NCT05138653|560006534|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155793|NCT05138653|560006535|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155794|NCT05138653|560006536|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155795|NCT05138653|560006537|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155796|NCT05138653|560006538|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
155155797|NCT05138653|560006523|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155798|NCT05138653|560006524|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155799|NCT05138653|560006525|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155800|NCT05138653|560006526|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155801|NCT05138653|560006527|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155802|NCT05138653|560006528|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155803|NCT05138653|560006529|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
155155804|NCT05138653|560006530|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155805|NCT05138653|560006531|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155806|NCT05138653|560006532|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155807|NCT05138653|560006533|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155808|NCT05138653|560006534|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155809|NCT05138653|560006535|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155810|NCT05138653|560006536|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155811|NCT05138653|560006537|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155812|NCT05138653|560006538|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
155155813|NCT05138653|560006523|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155814|NCT05138653|560006524|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155815|NCT05138653|560006525|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155816|NCT05138653|560006526|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155817|NCT05138653|560006527|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155818|NCT05138653|560006528|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155819|NCT05138653|560006529|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155820|NCT05138653|560006530|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155821|NCT05138653|560006531|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155822|NCT05138653|560006532|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155823|NCT05138653|560006533|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
155155824|NCT05138653|560006534|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155825|NCT05138653|560006535|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
155155826|NCT05138653|560006536|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155827|NCT05138653|560006537|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
155155828|NCT05138653|560006538|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
155155829|NCT05138653|560006523|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155830|NCT05138653|560006524|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155831|NCT05138653|560006525|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155832|NCT05138653|560006526|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155833|NCT05138653|560006527|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155834|NCT05138653|560006528|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155835|NCT05138653|560006529|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155836|NCT05138653|560006530|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155837|NCT05138653|560006531|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155838|NCT05138653|560006532|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155839|NCT05138653|560006533|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155840|NCT05138653|560006534|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155841|NCT05138653|560006535|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155842|NCT05138653|560006536|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155843|NCT05138653|560006537|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
155155844|NCT05138653|560006538|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
155155845|NCT05138653|560006523|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155846|NCT05138653|560006524|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155847|NCT05138653|560006525|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155848|NCT05138653|560006526|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155849|NCT05138653|560006527|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155850|NCT05138653|560006528|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155851|NCT05138653|560006529|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155852|NCT05138653|560006530|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155853|NCT05138653|560006531|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155854|NCT05138653|560006532|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155855|NCT05138653|560006533|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155856|NCT05138653|560006534|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155857|NCT05138653|560006535|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
154954860|NCT01367457|559261740|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
155155858|NCT05138653|560006536|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
155155859|NCT05138653|560006537|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155860|NCT05138653|560006538|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
155155861|NCT04607005|560006539|FG000|Overall Study|Adverse Event|0|||
155155862|NCT04607005|560006540|FG001|Overall Study|Adverse Event|1|||
155155863|NCT04607005|560006539|FG000|Overall Study|Lack of Efficacy|1|||
155155864|NCT04607005|560006540|FG001|Overall Study|Lack of Efficacy|6|||
155155865|NCT04607005|560006539|FG000|Overall Study|Withdrawal by Subject|4|||
155155866|NCT04607005|560006540|FG001|Overall Study|Withdrawal by Subject|9|||
155059227|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155059228|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
155059229|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155059230|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155059231|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155059232|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
155059233|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155059234|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155059235|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
155059236|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155059237|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155059238|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155059239|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
155059240|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155059241|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155059242|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155059243|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
155059244|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155155867|NCT04607005|560006539|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
155155868|NCT04607005|560006540|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
155155869|NCT02331134|560006541|FG000|Overall Study|Withdrawal by Subject|1|||
155155870|NCT04825574|560006542|FG000|Overall Study|Commercial treatment became available|1|||
155155871|NCT04825574|560006542|FG000|Overall Study|Disease progression|1|||
155155872|NCT05967260|560006543|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
155155873|NCT05967260|560006544|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
155155874|NCT05565742|560006545|FG000|Overall Study|Withdrawal by Subject|0|||
155155875|NCT05565742|560006546|FG001|Overall Study|Withdrawal by Subject|0|||
155155876|NCT05565742|560006547|FG002|Overall Study|Withdrawal by Subject|2|||
155155877|NCT05565742|560006548|FG003|Overall Study|Withdrawal by Subject|2|||
155155878|NCT05565742|560006549|FG004|Overall Study|Withdrawal by Subject|2|||
155155879|NCT05565742|560006545|FG000|Overall Study|Death|1|||
155155880|NCT05565742|560006546|FG001|Overall Study|Death|0|||
155155881|NCT05565742|560006547|FG002|Overall Study|Death|0|||
155155882|NCT05565742|560006548|FG003|Overall Study|Death|0|||
155155883|NCT05565742|560006549|FG004|Overall Study|Death|0|||
155155884|NCT05565742|560006545|FG000|Overall Study|Participant Travelled Abroad|0|||
155155885|NCT05565742|560006546|FG001|Overall Study|Participant Travelled Abroad|0|||
155155886|NCT05565742|560006547|FG002|Overall Study|Participant Travelled Abroad|0|||
155155887|NCT05565742|560006548|FG003|Overall Study|Participant Travelled Abroad|0|||
155155888|NCT05565742|560006549|FG004|Overall Study|Participant Travelled Abroad|1|||
155155889|NCT04163341|560006550|FG000|Overall Study|Withdrawal by Subject|2|||
155155890|NCT04163341|560006551|FG001|Overall Study|Withdrawal by Subject|0|||
155155891|NCT04163341|560006550|FG000|Overall Study|Lost to Follow-up|3|||
155155892|NCT04163341|560006551|FG001|Overall Study|Lost to Follow-up|4|||
155155893|NCT00092417|560008128|FG000|Overall Study|Lost to Follow-up|2|||
155155894|NCT00092417|560008129|FG001|Overall Study|Lost to Follow-up|0|||
155155895|NCT00092417|560008128|FG000|Overall Study|Withdrawal by Subject|2|||
155155896|NCT00092417|560008129|FG001|Overall Study|Withdrawal by Subject|1|||
155155897|NCT00092417|560008128|FG000|Overall Study|Other|1|||
155155898|NCT00092417|560008129|FG001|Overall Study|Other|0|||
155155899|NCT00425269|560008130|FG000|Overall Study|Pregnancy|5|||
155155900|NCT00425269|560008131|FG001|Overall Study|Pregnancy|7|||
155155901|NCT00425269|560008130|FG000|Overall Study|Lost to Follow-up|9|||
155155902|NCT00425269|560008131|FG001|Overall Study|Lost to Follow-up|9|||
155155903|NCT00425269|560008130|FG000|Overall Study|moved or medical reason|5|||
155155904|NCT00425269|560008131|FG001|Overall Study|moved or medical reason|4|||
155155905|NCT01084655|560008132|FG000|Overall Study|Radiographic disease progression|3|||
155155906|NCT01084655|560008133|FG001|Overall Study|Radiographic disease progression|2|||
155155907|NCT01084655|560008134|FG002|Overall Study|Radiographic disease progression|8|||
155155908|NCT01084655|560008132|FG000|Overall Study|Withdrawal by Subject|1|||
155155909|NCT01084655|560008133|FG001|Overall Study|Withdrawal by Subject|0|||
155155910|NCT01084655|560008134|FG002|Overall Study|Withdrawal by Subject|4|||
155155911|NCT01084655|560008132|FG000|Overall Study|Adverse Event|2|||
155059245|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155155912|NCT01084655|560008133|FG001|Overall Study|Adverse Event|1|||
155155913|NCT01084655|560008134|FG002|Overall Study|Adverse Event|2|||
155155914|NCT01084655|560008132|FG000|Overall Study|Other|0|||
155155915|NCT01084655|560008133|FG001|Overall Study|Other|3|||
155155916|NCT01084655|560008134|FG002|Overall Study|Other|2|||
155155917|NCT01084655|560008132|FG000|Overall Study|Symptomatic deterioration|0|||
155155918|NCT01084655|560008133|FG001|Overall Study|Symptomatic deterioration|0|||
154954861|NCT01367457|559261741|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
154954862|NCT01367457|559261742|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
154954863|NCT01367457|559261740|FG000|Overall Study|low grade toxicities + stable disease|1|||
154954864|NCT01367457|559261741|FG001|Overall Study|low grade toxicities + stable disease|0|||
155059246|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
155059247|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155059248|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155059249|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155059250|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
155059251|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155059252|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155059253|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
155059254|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155059255|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155059256|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155059257|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155059258|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
155059259|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155059260|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
155059261|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155059262|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155059263|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155059264|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155059265|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
155059266|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155059267|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
155059268|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155059269|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155059270|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155059271|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155059272|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
155059273|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155059274|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
155059275|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155059276|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155059277|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155059278|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155059279|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
155059280|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155059281|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
155059282|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155059283|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155059284|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155059285|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155059286|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155059287|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
155059288|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
155059289|NCT01791595|559651885|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155059290|NCT01791595|559651886|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155059291|NCT01791595|559651887|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155059292|NCT01791595|559651888|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155059293|NCT01791595|559651889|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155059294|NCT01791595|559651890|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
155059295|NCT01791595|559651891|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
155059296|NCT01791595|559651885|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155059297|NCT01791595|559651886|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155059298|NCT01791595|559651887|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155059299|NCT01791595|559651888|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155059300|NCT01791595|559651889|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155059301|NCT01791595|559651890|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
155059302|NCT01791595|559651891|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
155059303|NCT01791595|559651885|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155059304|NCT01791595|559651886|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155059305|NCT01791595|559651887|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155155919|NCT01084655|560008134|FG002|Overall Study|Symptomatic deterioration|2|||
155155920|NCT01084655|560008132|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
155155921|NCT01084655|560008133|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
155155922|NCT01084655|560008134|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
155059306|NCT01791595|559651888|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155059307|NCT01791595|559651889|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155059308|NCT01791595|559651890|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
155059309|NCT01791595|559651891|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
155059310|NCT01791595|559651885|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155059311|NCT01791595|559651886|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155059312|NCT01791595|559651887|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155059313|NCT01791595|559651888|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155059314|NCT01791595|559651889|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155059315|NCT01791595|559651890|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
155059316|NCT01791595|559651891|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
154954865|NCT01367457|559261742|FG002|Overall Study|low grade toxicities + stable disease|0|||
154954866|NCT01367457|559261740|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
154954867|NCT01367457|559261741|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
154954868|NCT01367457|559261742|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
154954869|NCT01367457|559261740|FG000|Overall Study|Withdrawal by Subject|1|||
155155923|NCT00696072|560008135|FG000|Overall Study|continuing active treatment|10|||
155155924|NCT00696072|560008136|FG001|Overall Study|continuing active treatment|13|||
155155925|NCT00696072|560008135|FG000|Overall Study|Adverse Event|10|||
155155926|NCT00696072|560008136|FG001|Overall Study|Adverse Event|6|||
155155927|NCT00696072|560008135|FG000|Overall Study|Patient Request|3|||
155155928|NCT00696072|560008136|FG001|Overall Study|Patient Request|7|||
155155929|NCT00696072|560008135|FG000|Overall Study|Investigator Request|1|||
155155930|NCT00696072|560008136|FG001|Overall Study|Investigator Request|4|||
155155931|NCT00696072|560008135|FG000|Overall Study|Sponsor Request|0|||
155155932|NCT00696072|560008136|FG001|Overall Study|Sponsor Request|1|||
155155933|NCT00696072|560008135|FG000|Overall Study|Disease Progression|32|||
155155934|NCT00696072|560008136|FG001|Overall Study|Disease Progression|30|||
155155935|NCT00696072|560008135|FG000|Overall Study|Non-specified|1|||
155155936|NCT00696072|560008136|FG001|Overall Study|Non-specified|2|||
155155937|NCT01597596|560008137|FG000|Overall Study|Study terminated by sponsor|1|||
155155938|NCT01597596|560008138|FG001|Overall Study|Study terminated by sponsor|0|||
155155939|NCT01597596|560008137|FG000|Overall Study|Physician Decision|0|||
155155940|NCT01597596|560008138|FG001|Overall Study|Physician Decision|1|||
155155941|NCT00992108|560008145|FG000|Overall Study|Lost to Follow-up|0|||
155155942|NCT00992108|560008146|FG001|Overall Study|Lost to Follow-up|1|||
155155943|NCT02419001|560008149|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
155155944|NCT02419001|560008150|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
155155945|NCT02151058|560008152|FG000|Overall Study|Withdrawal by Subject|1|||
155155946|NCT02151058|560008153|FG001|Overall Study|Withdrawal by Subject|1|||
155155947|NCT02151058|560008154|FG002|Overall Study|Withdrawal by Subject|3|||
155155948|NCT02151058|560008152|FG000|Overall Study|Lost to Follow-up|1|||
155155949|NCT02151058|560008153|FG001|Overall Study|Lost to Follow-up|0|||
155155950|NCT02151058|560008154|FG002|Overall Study|Lost to Follow-up|2|||
155155951|NCT02006472|560008157|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
155155952|NCT02006472|560008158|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
155155953|NCT02006472|560008159|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
155155954|NCT02006472|560008160|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
155155955|NCT02006472|560008161|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
155155956|NCT02006472|560008157|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155155957|NCT02006472|560008158|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155155958|NCT02006472|560008159|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
155155959|NCT02006472|560008160|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155155960|NCT02006472|560008161|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
155155961|NCT02006472|560008157|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
155155962|NCT02006472|560008158|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
155155963|NCT02006472|560008159|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
155155964|NCT02006472|560008160|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
155155965|NCT02006472|560008161|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
155155966|NCT02006472|560008157|FG000|Period 1 (Through Week 26)|Other|1|||
155155967|NCT02006472|560008158|FG001|Period 1 (Through Week 26)|Other|5|||
155155968|NCT02006472|560008159|FG002|Period 1 (Through Week 26)|Other|0|||
155155969|NCT02006472|560008160|FG003|Period 1 (Through Week 26)|Other|2|||
155155970|NCT02006472|560008161|FG004|Period 1 (Through Week 26)|Other|3|||
155155971|NCT02006472|560008157|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
155155972|NCT02006472|560008158|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
155155973|NCT02006472|560008159|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
155155974|NCT02006472|560008160|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
155155975|NCT02006472|560008161|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
155155976|NCT02006472|560008157|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
155155977|NCT02006472|560008158|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
155155978|NCT02006472|560008159|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
155155979|NCT02006472|560008160|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
155155980|NCT02006472|560008161|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
155155981|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
155155982|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
155155983|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
155155984|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
155155985|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
155155986|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
155155987|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
155155988|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
155155989|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
155059317|NCT01791595|559651885|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155287304|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155059318|NCT01791595|559651886|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155059319|NCT01791595|559651887|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155059320|NCT01791595|559651888|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155059321|NCT01791595|559651889|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155059322|NCT01791595|559651890|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
155059323|NCT01791595|559651891|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
155059324|NCT01776554|559651892|FG000|Overall Study|Adverse Event|1|||
155059325|NCT01776554|559651893|FG001|Overall Study|Adverse Event|0|||
155059326|NCT01776554|559651892|FG000|Overall Study|Withdrawal by Subject|3|||
155059327|NCT01776554|559651893|FG001|Overall Study|Withdrawal by Subject|8|||
155059328|NCT01776554|559651892|FG000|Overall Study|Lost to Follow-up|6|||
155059329|NCT01776554|559651893|FG001|Overall Study|Lost to Follow-up|9|||
155059330|NCT01776554|559651892|FG000|Overall Study|Administrative Reason|2|||
155059331|NCT01776554|559651893|FG001|Overall Study|Administrative Reason|5|||
155059332|NCT01776554|559651892|FG000|Overall Study|Protocol Violation|1|||
155059333|NCT01776554|559651893|FG001|Overall Study|Protocol Violation|0|||
155059334|NCT01776554|559651892|FG000|Overall Study|Unclassified|4|||
155059335|NCT01776554|559651893|FG001|Overall Study|Unclassified|1|||
155287305|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
155287306|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
155287307|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
155287308|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
155287309|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
155287310|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
155287311|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
155287312|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287313|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287314|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287315|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287316|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
155287317|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
155287318|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
155287319|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
155287320|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
155287321|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
155287322|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
155287323|NCT04888585|560484275|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287324|NCT04888585|560484276|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287325|NCT04888585|560484277|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287326|NCT04888585|560484278|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287327|NCT04888585|560484279|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287328|NCT04888585|560484280|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287329|NCT04888585|560484281|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
155287330|NCT04888585|560484282|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
155287331|NCT04888585|560484283|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
155287332|NCT04888585|560484284|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
155287333|NCT04888585|560484285|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
155287334|NCT04678830|560484292|FG000|Overall Study|Lack of Efficacy|2|||
155287335|NCT04678830|560484293|FG001|Overall Study|Lack of Efficacy|0|||
155287336|NCT04678830|560484292|FG000|Overall Study|Withdrawal by Subject|0|||
155287337|NCT04678830|560484293|FG001|Overall Study|Withdrawal by Subject|1|||
155287338|NCT05550337|560484294|FG000|Overall Study|Lack of Efficacy|0|||
155287339|NCT05550337|560484295|FG001|Overall Study|Lack of Efficacy|0|||
155287340|NCT05550337|560484296|FG002|Overall Study|Lack of Efficacy|1|||
155287341|NCT05550337|560484294|FG000|Overall Study|Adverse Event|1|||
155287342|NCT05550337|560484295|FG001|Overall Study|Adverse Event|5|||
155287343|NCT05550337|560484296|FG002|Overall Study|Adverse Event|0|||
155287344|NCT05550337|560484294|FG000|Overall Study|Withdrawal by Subject|8|||
155287345|NCT05550337|560484295|FG001|Overall Study|Withdrawal by Subject|14|||
155059336|NCT01041859|559651894|FG000|Open-Label Titration|Adverse Event|69|||
155059337|NCT01041859|559651895|FG001|Open-Label Titration|Adverse Event|0|||
155059338|NCT01041859|559651896|FG002|Open-Label Titration|Adverse Event|0|||
155059339|NCT01041859|559651894|FG000|Open-Label Titration|Lack of Efficacy|3|||
155059340|NCT01041859|559651895|FG001|Open-Label Titration|Lack of Efficacy|0|||
155059341|NCT01041859|559651896|FG002|Open-Label Titration|Lack of Efficacy|0|||
155059342|NCT01041859|559651894|FG000|Open-Label Titration|Lost to Follow-up|1|||
155059343|NCT01041859|559651895|FG001|Open-Label Titration|Lost to Follow-up|0|||
155059344|NCT01041859|559651896|FG002|Open-Label Titration|Lost to Follow-up|0|||
155287346|NCT05550337|560484296|FG002|Overall Study|Withdrawal by Subject|10|||
155287347|NCT05550337|560484294|FG000|Overall Study|Pregnancy|0|||
155287348|NCT05550337|560484295|FG001|Overall Study|Pregnancy|0|||
155287349|NCT05550337|560484296|FG002|Overall Study|Pregnancy|1|||
155287350|NCT05550337|560484294|FG000|Overall Study|Protocol Violation|1|||
155287351|NCT05550337|560484295|FG001|Overall Study|Protocol Violation|3|||
155287352|NCT05550337|560484296|FG002|Overall Study|Protocol Violation|4|||
155059345|NCT01041859|559651894|FG000|Open-Label Titration|Physician Decision|1|||
155059346|NCT01041859|559651895|FG001|Open-Label Titration|Physician Decision|0|||
155059347|NCT01041859|559651896|FG002|Open-Label Titration|Physician Decision|0|||
155059348|NCT01041859|559651894|FG000|Open-Label Titration|Protocol Violation|1|||
155059349|NCT01041859|559651895|FG001|Open-Label Titration|Protocol Violation|0|||
155059350|NCT01041859|559651896|FG002|Open-Label Titration|Protocol Violation|0|||
155059351|NCT01041859|559651894|FG000|Open-Label Titration|Other|7|||
155059352|NCT01041859|559651895|FG001|Open-Label Titration|Other|0|||
155059353|NCT01041859|559651896|FG002|Open-Label Titration|Other|0|||
155059354|NCT01041859|559651894|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
155059355|NCT01041859|559651895|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
155059356|NCT01041859|559651896|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
155059357|NCT01041859|559651894|FG000|Open-Label Titration|Withdrawal by Subject|11|||
155059358|NCT01041859|559651895|FG001|Open-Label Titration|Withdrawal by Subject|0|||
155059359|NCT01041859|559651896|FG002|Open-Label Titration|Withdrawal by Subject|0|||
155059360|NCT01041859|559651894|FG000|Double-Blind Maintenance|Adverse Event|0|||
155059361|NCT01041859|559651895|FG001|Double-Blind Maintenance|Adverse Event|23|||
155059362|NCT01041859|559651896|FG002|Double-Blind Maintenance|Adverse Event|13|||
155059363|NCT01041859|559651894|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
155059364|NCT01041859|559651895|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
155059365|NCT01041859|559651896|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
155059366|NCT01041859|559651894|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
155059367|NCT01041859|559651895|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
155059368|NCT01041859|559651896|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
155059369|NCT01041859|559651894|FG000|Double-Blind Maintenance|Physician Decision|0|||
155059370|NCT01041859|559651895|FG001|Double-Blind Maintenance|Physician Decision|2|||
155059371|NCT01041859|559651896|FG002|Double-Blind Maintenance|Physician Decision|1|||
155059372|NCT01041859|559651894|FG000|Double-Blind Maintenance|Protocol Violation|0|||
155059373|NCT01041859|559651895|FG001|Double-Blind Maintenance|Protocol Violation|1|||
155059374|NCT01041859|559651896|FG002|Double-Blind Maintenance|Protocol Violation|3|||
155059375|NCT01041859|559651894|FG000|Double-Blind Maintenance|Other|0|||
155059376|NCT01041859|559651895|FG001|Double-Blind Maintenance|Other|6|||
155059377|NCT01041859|559651896|FG002|Double-Blind Maintenance|Other|2|||
155059378|NCT01041859|559651894|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
155059379|NCT01041859|559651895|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
155059380|NCT01041859|559651896|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
155059381|NCT01041859|559651894|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
155059382|NCT01041859|559651895|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
155059383|NCT01041859|559651896|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
155059384|NCT03329885|559651897|FG000|Overall Study|Sponsor discontinued the study early|0|||
155287353|NCT05550337|560484294|FG000|Overall Study|Physician Decision|2|||
155287354|NCT05550337|560484295|FG001|Overall Study|Physician Decision|1|||
155059385|NCT03329885|559651898|FG001|Overall Study|Sponsor discontinued the study early|0|||
155059386|NCT03329885|559651899|FG002|Overall Study|Sponsor discontinued the study early|0|||
155059387|NCT03329885|559651900|FG003|Overall Study|Sponsor discontinued the study early|0|||
155059388|NCT03329885|559651901|FG004|Overall Study|Sponsor discontinued the study early|0|||
155059389|NCT03329885|559651902|FG005|Overall Study|Sponsor discontinued the study early|0|||
155059390|NCT03329885|559651903|FG006|Overall Study|Sponsor discontinued the study early|1|||
155287355|NCT05550337|560484296|FG002|Overall Study|Physician Decision|1|||
155059391|NCT03329885|559651904|FG007|Overall Study|Sponsor discontinued the study early|1|||
155059392|NCT03329885|559651905|FG008|Overall Study|Sponsor discontinued the study early|0|||
155059393|NCT01991795|559651906|FG000|Overall Study|Lost to Follow-up|6|||
155059394|NCT01991795|559651907|FG001|Overall Study|Lost to Follow-up|4|||
155059395|NCT01991795|559651906|FG000|Overall Study|Withdrawal by Subject|117|||
155059396|NCT01991795|559651907|FG001|Overall Study|Withdrawal by Subject|94|||
155059397|NCT01991795|559651906|FG000|Overall Study|Site prematurely closed by sponsor|26|||
155059398|NCT01991795|559651907|FG001|Overall Study|Site prematurely closed by sponsor|25|||
155059399|NCT02027025|559651908|FG000|Overall Study|Adverse Event|0|||
155059400|NCT02027025|559651909|FG001|Overall Study|Adverse Event|1|||
155287356|NCT05550337|560484294|FG000|Overall Study|Lost to Follow-up|16|||
155059401|NCT02027025|559651910|FG002|Overall Study|Adverse Event|1|||
155059402|NCT02027025|559651908|FG000|Overall Study|Protocol Violation|1|||
155059403|NCT02027025|559651909|FG001|Overall Study|Protocol Violation|0|||
155287357|NCT05550337|560484295|FG001|Overall Study|Lost to Follow-up|11|||
155059404|NCT02027025|559651910|FG002|Overall Study|Protocol Violation|0|||
155059405|NCT02027025|559651908|FG000|Overall Study|Lost to Follow-up|0|||
155059406|NCT02027025|559651909|FG001|Overall Study|Lost to Follow-up|2|||
155059407|NCT02027025|559651910|FG002|Overall Study|Lost to Follow-up|0|||
155059408|NCT02027025|559651908|FG000|Overall Study|Withdrawal by Subject|0|||
155059409|NCT02027025|559651909|FG001|Overall Study|Withdrawal by Subject|1|||
155059410|NCT02027025|559651910|FG002|Overall Study|Withdrawal by Subject|0|||
155059411|NCT02027025|559651908|FG000|Overall Study|Sponsor's decision|0|||
155059412|NCT02027025|559651909|FG001|Overall Study|Sponsor's decision|1|||
155059413|NCT02027025|559651910|FG002|Overall Study|Sponsor's decision|0|||
155059414|NCT03883386|559651912|FG000|First Assignment|Lost to Follow-up|1|||
155059415|NCT03883386|559651913|FG001|First Assignment|Lost to Follow-up|0|||
155059416|NCT03883386|559651912|FG000|First Assignment|Withdrawal by Subject|1|||
155059417|NCT03883386|559651913|FG001|First Assignment|Withdrawal by Subject|1|||
155059418|NCT01326871|559651914|FG000|Overall Study|Major surgery|0|||
155059419|NCT01326871|559651915|FG001|Overall Study|Major surgery|1|||
155059420|NCT01326871|559651916|FG002|Overall Study|Major surgery|0|||
155059421|NCT01326871|559651914|FG000|Overall Study|SAE and death|0|||
155059422|NCT01326871|559651915|FG001|Overall Study|SAE and death|2|||
155059423|NCT01326871|559651916|FG002|Overall Study|SAE and death|0|||
155059424|NCT01326871|559651914|FG000|Overall Study|Physician decision and decreased performance status|0|||
155059425|NCT01326871|559651915|FG001|Overall Study|Physician decision and decreased performance status|1|||
155059426|NCT01326871|559651916|FG002|Overall Study|Physician decision and decreased performance status|0|||
155059427|NCT01326871|559651914|FG000|Overall Study|Disease progression|0|||
155059428|NCT01326871|559651915|FG001|Overall Study|Disease progression|11|||
155059429|NCT01326871|559651916|FG002|Overall Study|Disease progression|5|||
155059430|NCT01326871|559651914|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
155059431|NCT01326871|559651915|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
155059432|NCT01326871|559651916|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
155059433|NCT01326871|559651914|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
155059434|NCT01326871|559651915|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
155059435|NCT01326871|559651916|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
155059436|NCT01326871|559651914|FG000|Overall Study|Withdrawal by Subject|0|||
155059437|NCT01326871|559651915|FG001|Overall Study|Withdrawal by Subject|1|||
155059438|NCT01326871|559651916|FG002|Overall Study|Withdrawal by Subject|0|||
155059439|NCT01326871|559651914|FG000|Overall Study|DLT|0|||
155059440|NCT01326871|559651915|FG001|Overall Study|DLT|2|||
155059441|NCT01326871|559651916|FG002|Overall Study|DLT|0|||
155059442|NCT01326871|559651914|FG000|Overall Study|SAE, disease progression and subject decision|0|||
155059443|NCT01326871|559651915|FG001|Overall Study|SAE, disease progression and subject decision|1|||
155059444|NCT01326871|559651916|FG002|Overall Study|SAE, disease progression and subject decision|0|||
155059445|NCT01326871|559651914|FG000|Overall Study|Death|0|||
155059446|NCT01326871|559651915|FG001|Overall Study|Death|1|||
155059447|NCT01326871|559651916|FG002|Overall Study|Death|0|||
155059448|NCT01326871|559651914|FG000|Overall Study|Other|0|||
155059449|NCT01326871|559651915|FG001|Overall Study|Other|3|||
155059450|NCT01326871|559651916|FG002|Overall Study|Other|0|||
155059451|NCT01326871|559651914|FG000|Overall Study|SAE and disease progression|0|||
155155990|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
155155991|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
155155992|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
155155993|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
155155994|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
155155995|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
155155996|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Other|0|||
155155997|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Other|1|||
155155998|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Other|0|||
155155999|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Other|1|||
155156000|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Other|0|||
155156001|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Not treated|0|||
155156002|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Not treated|0|||
155156003|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Not treated|2|||
155156004|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Not treated|0|||
155156005|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Not treated|0|||
155156006|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
155156007|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
155156008|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
155156009|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
155156010|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
155156011|NCT02006472|560008157|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
155156012|NCT02006472|560008158|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
155156013|NCT02006472|560008159|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
155156014|NCT02006472|560008160|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
155156015|NCT02006472|560008161|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
155156016|NCT00459316|560008162|FG000|Steps 1 & 2|Other eligibility failure|1|||
155156017|NCT00459316|560008163|FG001|Steps 1 & 2|Other eligibility failure|1|||
155156018|NCT00459316|560008164|FG002|Steps 1 & 2|Other eligibility failure|0|||
155156019|NCT00459316|560008162|FG000|Steps 1 & 2|Death|1|||
155156020|NCT00459316|560008163|FG001|Steps 1 & 2|Death|1|||
155156021|NCT00459316|560008164|FG002|Steps 1 & 2|Death|0|||
155156022|NCT00459316|560008162|FG000|Steps 1 & 2|Not able to get to clinic|7|||
155156023|NCT00459316|560008163|FG001|Steps 1 & 2|Not able to get to clinic|4|||
155156024|NCT00459316|560008164|FG002|Steps 1 & 2|Not able to get to clinic|0|||
155156025|NCT00459316|560008162|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
155156026|NCT00459316|560008163|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
155156027|NCT00459316|560008164|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
155156028|NCT00459316|560008162|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
155156029|NCT00459316|560008163|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
155156030|NCT00459316|560008164|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
155156031|NCT00459316|560008162|FG000|Steps 1 & 2|Lost to Follow-up|5|||
155156032|NCT00459316|560008163|FG001|Steps 1 & 2|Lost to Follow-up|0|||
155156033|NCT00459316|560008164|FG002|Steps 1 & 2|Lost to Follow-up|2|||
155156034|NCT00459316|560008162|FG000|Step 3|Withdrawal by Subject|3|||
155156035|NCT00459316|560008163|FG001|Step 3|Withdrawal by Subject|0|||
155156036|NCT00459316|560008164|FG002|Step 3|Withdrawal by Subject|1|||
155156037|NCT03044106|560008166|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
155156038|NCT03044106|560008167|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
155156039|NCT01207414|560008168|FG000|Overall Study|Adverse Event|25|||
155156040|NCT01207414|560008169|FG001|Overall Study|Adverse Event|39|||
155156041|NCT01207414|560008168|FG000|Overall Study|Abnormal test procedure results|0|||
155156042|NCT01207414|560008169|FG001|Overall Study|Abnormal test procedure results|1|||
155156043|NCT01207414|560008168|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155156044|NCT01207414|560008169|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155156045|NCT01207414|560008168|FG000|Overall Study|Patient withdrew consent|14|||
155156046|NCT01207414|560008169|FG001|Overall Study|Patient withdrew consent|11|||
155156047|NCT01207414|560008168|FG000|Overall Study|Lost to Follow-up|15|||
154954870|NCT01367457|559261741|FG001|Overall Study|Withdrawal by Subject|0|||
154954871|NCT01367457|559261742|FG002|Overall Study|Withdrawal by Subject|0|||
155156048|NCT01207414|560008169|FG001|Overall Study|Lost to Follow-up|17|||
155156049|NCT01207414|560008168|FG000|Overall Study|Administrative problems|1|||
155156050|NCT01207414|560008169|FG001|Overall Study|Administrative problems|1|||
155156051|NCT01207414|560008168|FG000|Overall Study|Protocol deviation|12|||
155156052|NCT01207414|560008169|FG001|Overall Study|Protocol deviation|9|||
155156053|NCT01207414|560008168|FG000|Overall Study|Randomized in error|1|||
155156054|NCT01207414|560008169|FG001|Overall Study|Randomized in error|0|||
155156055|NCT02057250|560008170|FG000|AID Assessment Phase|Adverse Event|3|||
155156056|NCT02057250|560008171|FG001|AID Assessment Phase|Adverse Event|2|||
155156057|NCT02057250|560008172|FG002|AID Assessment Phase|Adverse Event|6|||
155156058|NCT02057250|560008173|FG003|AID Assessment Phase|Adverse Event|1|||
155156059|NCT02057250|560008174|FG004|AID Assessment Phase|Adverse Event|0|||
155156060|NCT02057250|560008170|FG000|AID Assessment Phase|Other than specified above|1|||
155156061|NCT02057250|560008171|FG001|AID Assessment Phase|Other than specified above|1|||
155156062|NCT02057250|560008172|FG002|AID Assessment Phase|Other than specified above|1|||
155156063|NCT02057250|560008173|FG003|AID Assessment Phase|Other than specified above|1|||
155059452|NCT01326871|559651915|FG001|Overall Study|SAE and disease progression|0|||
155059453|NCT01326871|559651916|FG002|Overall Study|SAE and disease progression|1|||
155059454|NCT01326871|559651914|FG000|Overall Study|SAE and physician decision|0|||
155059455|NCT01326871|559651915|FG001|Overall Study|SAE and physician decision|0|||
155059456|NCT01326871|559651916|FG002|Overall Study|SAE and physician decision|1|||
155059457|NCT01326871|559651914|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
155059458|NCT01326871|559651915|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
155059459|NCT01326871|559651916|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
155059460|NCT01326871|559651914|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
155059461|NCT01326871|559651915|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
155059462|NCT01326871|559651916|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
155059463|NCT01326871|559651914|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
155059464|NCT01326871|559651915|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
155059465|NCT01326871|559651916|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
155059466|NCT01326871|559651914|FG000|Overall Study|Physician Decision|0|||
155059467|NCT01326871|559651915|FG001|Overall Study|Physician Decision|0|||
155059468|NCT01326871|559651916|FG002|Overall Study|Physician Decision|1|||
155059469|NCT01326871|559651914|FG000|Overall Study|SAE|0|||
155059470|NCT01326871|559651915|FG001|Overall Study|SAE|0|||
155059471|NCT01326871|559651916|FG002|Overall Study|SAE|1|||
155059472|NCT01326871|559651914|FG000|Overall Study|Disease progression and death|0|||
155059473|NCT01326871|559651915|FG001|Overall Study|Disease progression and death|0|||
155059474|NCT01326871|559651916|FG002|Overall Study|Disease progression and death|1|||
155059475|NCT01326871|559651914|FG000|Overall Study|Subject decision|0|||
155059476|NCT01326871|559651915|FG001|Overall Study|Subject decision|0|||
155287358|NCT05550337|560484296|FG002|Overall Study|Lost to Follow-up|11|||
155059477|NCT01326871|559651916|FG002|Overall Study|Subject decision|1|||
155059478|NCT01387269|559651918|FG000|Overall Study|Death|38|||
155059479|NCT01387269|559651919|FG001|Overall Study|Death|20|||
155059480|NCT01387269|559651918|FG000|Overall Study|Other|8|||
155059481|NCT01387269|559651919|FG001|Overall Study|Other|7|||
155059482|NCT01387269|559651918|FG000|Overall Study|Unrelated AE|12|||
155059483|NCT01387269|559651919|FG001|Overall Study|Unrelated AE|3|||
155059484|NCT01387269|559651918|FG000|Overall Study|Withdrawal by patient|32|||
154954872|NCT01367457|559261740|FG000|Overall Study|CD, associated leukaemia|1|||
154954873|NCT01367457|559261741|FG001|Overall Study|CD, associated leukaemia|0|||
155287359|NCT01836458|560484299|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155287360|NCT01836458|560484300|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155287361|NCT01836458|560484301|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
155287362|NCT01836458|560484302|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
155287363|NCT02081391|560484303|FG000|12-hour Treatment|Withdrawal by Subject|3|||
155287364|NCT02081391|560484304|FG001|12-hour Treatment|Withdrawal by Subject|2|||
155287365|NCT02081391|560484305|FG002|12-hour Treatment|Withdrawal by Subject|0|||
155287366|NCT02081391|560484306|FG003|12-hour Treatment|Withdrawal by Subject|0|||
155287367|NCT02081391|560484303|FG000|12-hour Treatment|Physician Decision|4|||
155287368|NCT02081391|560484304|FG001|12-hour Treatment|Physician Decision|1|||
155287369|NCT02081391|560484305|FG002|12-hour Treatment|Physician Decision|0|||
155287370|NCT02081391|560484306|FG003|12-hour Treatment|Physician Decision|0|||
155287371|NCT02081391|560484303|FG000|12-hour Treatment|Lack of Efficacy|3|||
155287372|NCT02081391|560484304|FG001|12-hour Treatment|Lack of Efficacy|0|||
155287373|NCT02081391|560484305|FG002|12-hour Treatment|Lack of Efficacy|0|||
155287374|NCT02081391|560484306|FG003|12-hour Treatment|Lack of Efficacy|0|||
155287375|NCT02081391|560484303|FG000|12-hour Treatment|Adverse Event|4|||
155287376|NCT02081391|560484304|FG001|12-hour Treatment|Adverse Event|2|||
155287377|NCT02081391|560484305|FG002|12-hour Treatment|Adverse Event|0|||
155287378|NCT02081391|560484306|FG003|12-hour Treatment|Adverse Event|0|||
155287379|NCT02081391|560484303|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
155287380|NCT02081391|560484304|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
155287381|NCT02081391|560484305|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
155287382|NCT02081391|560484306|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
155287383|NCT02081391|560484303|FG000|12-hour Treatment|Further reasons|2|||
155287384|NCT02081391|560484304|FG001|12-hour Treatment|Further reasons|1|||
155287385|NCT02081391|560484305|FG002|12-hour Treatment|Further reasons|0|||
155287386|NCT02081391|560484306|FG003|12-hour Treatment|Further reasons|0|||
155287387|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
155287388|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
155287389|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
155287390|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
155287391|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
155287392|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
155287393|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
155287394|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
155287395|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
155287396|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
155287397|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
155287398|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
155287399|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
155287400|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
155287401|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
155287402|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
155287403|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
155287404|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
155287405|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
155287406|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
155287407|NCT02081391|560484303|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
155287408|NCT02081391|560484304|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
155287409|NCT02081391|560484305|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
155287410|NCT02081391|560484306|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
155287411|NCT00813488|560484308|FG000|Titration Period 1|Adverse Event|6|||
155287412|NCT00813488|560484309|FG001|Titration Period 1|Adverse Event|1|||
155287413|NCT00813488|560484308|FG000|Titration Period 1|Lack of Efficacy|9|||
155287414|NCT00813488|560484309|FG001|Titration Period 1|Lack of Efficacy|7|||
155287415|NCT00813488|560484308|FG000|Titration Period 1|Withdrawal by Subject|2|||
155287416|NCT00813488|560484309|FG001|Titration Period 1|Withdrawal by Subject|2|||
155287417|NCT00813488|560484308|FG000|Titration Period 1|Protocol Violation|4|||
155287418|NCT00813488|560484309|FG001|Titration Period 1|Protocol Violation|3|||
155287419|NCT00813488|560484308|FG000|Titration Period 1|Non-compliance to study medication|4|||
155287420|NCT00813488|560484309|FG001|Titration Period 1|Non-compliance to study medication|1|||
155287421|NCT00813488|560484308|FG000|Titration Period 1|Non-compliance to study procedures|2|||
155287422|NCT00813488|560484309|FG001|Titration Period 1|Non-compliance to study procedures|2|||
155287423|NCT00813488|560484308|FG000|Titration Period 1|Technical Difficulties|0|||
155287424|NCT00813488|560484309|FG001|Titration Period 1|Technical Difficulties|1|||
155287425|NCT00813488|560484308|FG000|Titration Period 2|Adverse Event|2|||
155287426|NCT00813488|560484309|FG001|Titration Period 2|Adverse Event|3|||
155287427|NCT00813488|560484308|FG000|Titration Period 2|Lack of Efficacy|8|||
155287428|NCT00813488|560484309|FG001|Titration Period 2|Lack of Efficacy|4|||
155287429|NCT00813488|560484308|FG000|Titration Period 2|Protocol Violation|3|||
155287430|NCT00813488|560484309|FG001|Titration Period 2|Protocol Violation|2|||
155287431|NCT00813488|560484308|FG000|Titration Period 2|Lost to Follow-up|1|||
155287432|NCT00813488|560484309|FG001|Titration Period 2|Lost to Follow-up|0|||
155287433|NCT00813488|560484308|FG000|Titration Period 2|Non-compliance with study procedures|2|||
155287434|NCT00813488|560484309|FG001|Titration Period 2|Non-compliance with study procedures|1|||
155287435|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
155287436|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
155287437|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
155287438|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
155287439|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
155287440|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
155287441|NCT00813488|560484308|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
155287442|NCT00813488|560484309|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
155287443|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
155287444|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
155287445|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
155287446|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
155287447|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
155287448|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
155287449|NCT00813488|560484308|FG000|Double-blind Treatment Period 2|Other|1|||
155287450|NCT00813488|560484309|FG001|Double-blind Treatment Period 2|Other|0|||
155287451|NCT00813488|560484308|FG000|Open-label Extension|Adverse Event|1|||
155287452|NCT00813488|560484309|FG001|Open-label Extension|Adverse Event|2|||
155287453|NCT00813488|560484308|FG000|Open-label Extension|Lack of Efficacy|3|||
155287454|NCT00813488|560484309|FG001|Open-label Extension|Lack of Efficacy|0|||
155287455|NCT00813488|560484308|FG000|Open-label Extension|Withdrawal by Subject|0|||
155287456|NCT00813488|560484309|FG001|Open-label Extension|Withdrawal by Subject|2|||
155287457|NCT00813488|560484308|FG000|Open-label Extension|Protocol Violation|1|||
155287458|NCT00813488|560484309|FG001|Open-label Extension|Protocol Violation|2|||
155287459|NCT00813488|560484308|FG000|Open-label Extension|Non-compliance study medication|4|||
155287460|NCT00813488|560484309|FG001|Open-label Extension|Non-compliance study medication|0|||
155287461|NCT00813488|560484308|FG000|Open-label Extension|Non-compliance study procedures|2|||
155287462|NCT00813488|560484309|FG001|Open-label Extension|Non-compliance study procedures|1|||
155287463|NCT00813488|560484308|FG000|Open-label Extension|Other|1|||
155287464|NCT00813488|560484309|FG001|Open-label Extension|Other|0|||
155287465|NCT02926937|560484310|FG000|Overall Study|Adverse Event|0|||
155287466|NCT02926937|560484311|FG001|Overall Study|Adverse Event|1|||
155287467|NCT02926937|560484312|FG002|Overall Study|Adverse Event|1|||
155287468|NCT02926937|560484310|FG000|Overall Study|Poor Compliance to Protocol|1|||
155287469|NCT02926937|560484311|FG001|Overall Study|Poor Compliance to Protocol|0|||
155287470|NCT02926937|560484312|FG002|Overall Study|Poor Compliance to Protocol|0|||
155287471|NCT02926937|560484310|FG000|Overall Study|Lost to Follow-up|4|||
155287472|NCT02926937|560484311|FG001|Overall Study|Lost to Follow-up|5|||
155287473|NCT02926937|560484312|FG002|Overall Study|Lost to Follow-up|0|||
155287474|NCT02926937|560484310|FG000|Overall Study|At the Participant's own Request|11|||
155287475|NCT02926937|560484311|FG001|Overall Study|At the Participant's own Request|5|||
155287476|NCT02926937|560484312|FG002|Overall Study|At the Participant's own Request|8|||
155287477|NCT02926937|560484310|FG000|Overall Study|Reason not Specified|3|||
155287478|NCT02926937|560484311|FG001|Overall Study|Reason not Specified|4|||
155287479|NCT02926937|560484312|FG002|Overall Study|Reason not Specified|2|||
155287480|NCT01333514|560484314|FG000|Overall Study|Withdrawal by Subject|1|||
155287481|NCT01333514|560484315|FG001|Overall Study|Withdrawal by Subject|0|||
155287482|NCT00477412|560484316|FG000|Overall Study|Death|0|||
155287483|NCT00477412|560484317|FG001|Overall Study|Death|0|||
155287484|NCT00477412|560484318|FG002|Overall Study|Death|0|||
155287485|NCT00477412|560484319|FG003|Overall Study|Death|4|||
155287486|NCT00477412|560484316|FG000|Overall Study|Lost to Follow-up|0|||
155287487|NCT00477412|560484317|FG001|Overall Study|Lost to Follow-up|0|||
155287488|NCT00477412|560484318|FG002|Overall Study|Lost to Follow-up|0|||
155287489|NCT00477412|560484319|FG003|Overall Study|Lost to Follow-up|1|||
155287490|NCT00477412|560484316|FG000|Overall Study|Withdrawal by Subject|0|||
155287491|NCT00477412|560484317|FG001|Overall Study|Withdrawal by Subject|0|||
155287492|NCT00477412|560484318|FG002|Overall Study|Withdrawal by Subject|0|||
155287493|NCT00477412|560484319|FG003|Overall Study|Withdrawal by Subject|2|||
155287494|NCT00477412|560484316|FG000|Overall Study|Second Malignancy|0|||
155287495|NCT00477412|560484317|FG001|Overall Study|Second Malignancy|0|||
155287496|NCT00477412|560484318|FG002|Overall Study|Second Malignancy|0|||
155287497|NCT00477412|560484319|FG003|Overall Study|Second Malignancy|1|||
155287498|NCT00477412|560484316|FG000|Overall Study|Adverse Event|1|||
155287499|NCT00477412|560484317|FG001|Overall Study|Adverse Event|0|||
155287500|NCT00477412|560484318|FG002|Overall Study|Adverse Event|1|||
155287501|NCT00477412|560484319|FG003|Overall Study|Adverse Event|0|||
155287502|NCT02501811|560484321|FG000|Overall Study|Death|1|||
155287503|NCT02501811|560484322|FG001|Overall Study|Death|3|||
155287504|NCT02501811|560484323|FG002|Overall Study|Death|2|||
155287505|NCT02501811|560484324|FG003|Overall Study|Death|3|||
155287506|NCT02501811|560484321|FG000|Overall Study|Withdrawal by Subject|3|||
155287507|NCT02501811|560484322|FG001|Overall Study|Withdrawal by Subject|3|||
155287508|NCT02501811|560484323|FG002|Overall Study|Withdrawal by Subject|2|||
155287509|NCT02501811|560484324|FG003|Overall Study|Withdrawal by Subject|3|||
155287510|NCT02501811|560484321|FG000|Overall Study|Lost to Follow-up|0|||
155287511|NCT02501811|560484322|FG001|Overall Study|Lost to Follow-up|0|||
155287512|NCT02501811|560484323|FG002|Overall Study|Lost to Follow-up|2|||
155287513|NCT02501811|560484324|FG003|Overall Study|Lost to Follow-up|1|||
155287514|NCT00662909|560484325|FG000|Overall Study|Adverse Event|17|||
155287515|NCT00662909|560484326|FG001|Overall Study|Adverse Event|18|||
155287516|NCT00662909|560484327|FG002|Overall Study|Adverse Event|19|||
155287517|NCT00662909|560484325|FG000|Overall Study|Lack of Efficacy|9|||
155287518|NCT00662909|560484326|FG001|Overall Study|Lack of Efficacy|1|||
155059485|NCT01387269|559651919|FG001|Overall Study|Withdrawal by patient|10|||
155059486|NCT01387269|559651918|FG000|Overall Study|Study drug-related AE|1|||
155059487|NCT01387269|559651919|FG001|Overall Study|Study drug-related AE|0|||
155287519|NCT00662909|560484327|FG002|Overall Study|Lack of Efficacy|5|||
155287520|NCT00662909|560484325|FG000|Overall Study|Withdrawal by Subject|29|||
155287521|NCT00662909|560484326|FG001|Overall Study|Withdrawal by Subject|22|||
155287522|NCT00662909|560484327|FG002|Overall Study|Withdrawal by Subject|16|||
155287523|NCT00662909|560484325|FG000|Overall Study|Lost to Follow-up|2|||
155059488|NCT01387269|559651918|FG000|Overall Study|Lost to Follow-up|1|||
155287524|NCT00662909|560484326|FG001|Overall Study|Lost to Follow-up|9|||
155287525|NCT00662909|560484327|FG002|Overall Study|Lost to Follow-up|3|||
155287526|NCT00662909|560484325|FG000|Overall Study|Protocol Violation|7|||
155287527|NCT00662909|560484326|FG001|Overall Study|Protocol Violation|4|||
155287528|NCT00662909|560484327|FG002|Overall Study|Protocol Violation|5|||
155287529|NCT00662909|560484325|FG000|Overall Study|Randomized- never received study drug|1|||
155287530|NCT00662909|560484326|FG001|Overall Study|Randomized- never received study drug|0|||
155287531|NCT00662909|560484327|FG002|Overall Study|Randomized- never received study drug|0|||
155287532|NCT00662909|560484325|FG000|Overall Study|Non-compliance with study procedures|3|||
155287533|NCT00662909|560484326|FG001|Overall Study|Non-compliance with study procedures|3|||
155287534|NCT00662909|560484327|FG002|Overall Study|Non-compliance with study procedures|2|||
155287535|NCT00662909|560484325|FG000|Overall Study|Physician Decision|1|||
155287536|NCT00662909|560484326|FG001|Overall Study|Physician Decision|1|||
155287537|NCT00662909|560484327|FG002|Overall Study|Physician Decision|2|||
155287538|NCT00662909|560484325|FG000|Overall Study|Eligibility criterion not met|0|||
155287539|NCT00662909|560484326|FG001|Overall Study|Eligibility criterion not met|1|||
155287540|NCT00662909|560484327|FG002|Overall Study|Eligibility criterion not met|1|||
155287541|NCT04257058|560486069|FG000|Overall Study|Lost to Follow-up|31|||
155287542|NCT04057196|560486072|FG000|Overall Study|Withdrawal by Subject|3|||
155287543|NCT04057196|560486072|FG000|Overall Study|Death|3|||
155287544|NCT03895034|560486073|FG000|Overall Study|Lost to Follow-up|2|||
155287545|NCT01118377|560486078|FG000|Overall Study|Did Not Receive Study Medication|1|||
155287546|NCT01118377|560486078|FG000|Overall Study|Death|38|||
155287547|NCT01118377|560486078|FG000|Overall Study|Failure to Return|3|||
155287548|NCT00739102|560486079|FG000|Overall Study|Death|5|||
155287549|NCT00739102|560486079|FG000|Overall Study|Withdrawal by Subject|10|||
155287550|NCT01331824|560486081|FG000|Overall Study|Adverse Event|2|||
155287551|NCT01331824|560486081|FG000|Overall Study|Death|1|||
155287552|NCT01331824|560486081|FG000|Overall Study|Disease Progression|9|||
155287553|NCT01331824|560486081|FG000|Overall Study|Withdrawal by Subject|1|||
155287554|NCT01091454|560486084|FG000|Overall Study|Ineligible|1|||
155287555|NCT01510912|560486085|FG000|Overall Study|Adverse Event|99|||
155287556|NCT01510912|560486085|FG000|Overall Study|Lack of Efficacy|12|||
155287557|NCT01510912|560486085|FG000|Overall Study|Non-compliance with trial drug|23|||
155287558|NCT01510912|560486085|FG000|Overall Study|Withdrawal by Subject|49|||
155287559|NCT01510912|560486085|FG000|Overall Study|Physician Decision|1|||
155287560|NCT01510912|560486085|FG000|Overall Study|Protocol Violation|27|||
155287561|NCT01510912|560486085|FG000|Overall Study|Lost to Follow-up|26|||
155287562|NCT01510912|560486085|FG000|Overall Study|Other, including joint replacement|5|||
155287563|NCT02001623|560486097|FG000|Overall Study|Disease Progression|2|||
155287564|NCT02001623|560486098|FG001|Overall Study|Disease Progression|2|||
155287565|NCT02001623|560486099|FG002|Overall Study|Disease Progression|3|||
155287566|NCT02001623|560486100|FG003|Overall Study|Disease Progression|2|||
155287567|NCT02001623|560486101|FG004|Overall Study|Disease Progression|3|||
155287568|NCT02001623|560486102|FG005|Overall Study|Disease Progression|2|||
155287569|NCT02001623|560486103|FG006|Overall Study|Disease Progression|3|||
155287570|NCT02001623|560486104|FG007|Overall Study|Disease Progression|3|||
155287571|NCT02001623|560486105|FG008|Overall Study|Disease Progression|7|||
155287572|NCT02001623|560486106|FG009|Overall Study|Disease Progression|40|||
155287573|NCT02001623|560486107|FG010|Overall Study|Disease Progression|5|||
155287574|NCT02001623|560486108|FG011|Overall Study|Disease Progression|9|||
155287575|NCT02001623|560486109|FG012|Overall Study|Disease Progression|9|||
155287576|NCT02001623|560486110|FG013|Overall Study|Disease Progression|20|||
155287577|NCT02001623|560486111|FG014|Overall Study|Disease Progression|9|||
155287578|NCT02001623|560486097|FG000|Overall Study|Physician Decision|0|||
155287579|NCT02001623|560486098|FG001|Overall Study|Physician Decision|0|||
155287580|NCT02001623|560486099|FG002|Overall Study|Physician Decision|0|||
155287581|NCT02001623|560486100|FG003|Overall Study|Physician Decision|0|||
155287582|NCT02001623|560486101|FG004|Overall Study|Physician Decision|0|||
155287583|NCT02001623|560486102|FG005|Overall Study|Physician Decision|0|||
155287584|NCT02001623|560486103|FG006|Overall Study|Physician Decision|0|||
155287585|NCT02001623|560486104|FG007|Overall Study|Physician Decision|0|||
155287586|NCT02001623|560486105|FG008|Overall Study|Physician Decision|3|||
155287587|NCT02001623|560486106|FG009|Overall Study|Physician Decision|2|||
155287588|NCT02001623|560486107|FG010|Overall Study|Physician Decision|3|||
155287589|NCT02001623|560486108|FG011|Overall Study|Physician Decision|3|||
155287590|NCT02001623|560486109|FG012|Overall Study|Physician Decision|1|||
155287591|NCT02001623|560486110|FG013|Overall Study|Physician Decision|2|||
155287592|NCT02001623|560486111|FG014|Overall Study|Physician Decision|1|||
155287593|NCT02001623|560486097|FG000|Overall Study|Death|0|||
155287594|NCT02001623|560486098|FG001|Overall Study|Death|1|||
155287595|NCT02001623|560486099|FG002|Overall Study|Death|0|||
155287596|NCT02001623|560486100|FG003|Overall Study|Death|0|||
155287597|NCT02001623|560486101|FG004|Overall Study|Death|0|||
155287598|NCT02001623|560486102|FG005|Overall Study|Death|0|||
155287599|NCT02001623|560486103|FG006|Overall Study|Death|0|||
155287600|NCT02001623|560486104|FG007|Overall Study|Death|0|||
155287601|NCT02001623|560486105|FG008|Overall Study|Death|0|||
155287602|NCT02001623|560486106|FG009|Overall Study|Death|0|||
155287603|NCT02001623|560486107|FG010|Overall Study|Death|0|||
155287604|NCT02001623|560486108|FG011|Overall Study|Death|0|||
155287605|NCT02001623|560486109|FG012|Overall Study|Death|0|||
155287606|NCT02001623|560486110|FG013|Overall Study|Death|0|||
155287607|NCT02001623|560486111|FG014|Overall Study|Death|0|||
155287608|NCT02001623|560486097|FG000|Overall Study|Adverse Event|0|||
155287609|NCT02001623|560486098|FG001|Overall Study|Adverse Event|0|||
155287610|NCT02001623|560486099|FG002|Overall Study|Adverse Event|0|||
155287611|NCT02001623|560486100|FG003|Overall Study|Adverse Event|0|||
155287612|NCT02001623|560486101|FG004|Overall Study|Adverse Event|0|||
154954874|NCT01367457|559261742|FG002|Overall Study|CD, associated leukaemia|0|||
154954875|NCT01367457|559261740|FG000|Overall Study|Uncontrolled pain|1|||
155287613|NCT02001623|560486102|FG005|Overall Study|Adverse Event|1|||
155287614|NCT02001623|560486103|FG006|Overall Study|Adverse Event|0|||
155287615|NCT02001623|560486104|FG007|Overall Study|Adverse Event|3|||
155287616|NCT02001623|560486105|FG008|Overall Study|Adverse Event|4|||
155287617|NCT02001623|560486106|FG009|Overall Study|Adverse Event|6|||
155287618|NCT02001623|560486107|FG010|Overall Study|Adverse Event|4|||
155287619|NCT02001623|560486108|FG011|Overall Study|Adverse Event|0|||
155287620|NCT02001623|560486109|FG012|Overall Study|Adverse Event|3|||
155287621|NCT02001623|560486110|FG013|Overall Study|Adverse Event|5|||
155287622|NCT02001623|560486111|FG014|Overall Study|Adverse Event|6|||
155287623|NCT02001623|560486097|FG000|Overall Study|Other - Miscellaneous|0|||
155287624|NCT02001623|560486098|FG001|Overall Study|Other - Miscellaneous|0|||
155287625|NCT02001623|560486099|FG002|Overall Study|Other - Miscellaneous|0|||
155287626|NCT02001623|560486100|FG003|Overall Study|Other - Miscellaneous|0|||
155287627|NCT02001623|560486101|FG004|Overall Study|Other - Miscellaneous|0|||
155287628|NCT02001623|560486102|FG005|Overall Study|Other - Miscellaneous|0|||
155287629|NCT02001623|560486103|FG006|Overall Study|Other - Miscellaneous|0|||
155287630|NCT02001623|560486104|FG007|Overall Study|Other - Miscellaneous|0|||
155287631|NCT02001623|560486105|FG008|Overall Study|Other - Miscellaneous|0|||
155287632|NCT02001623|560486106|FG009|Overall Study|Other - Miscellaneous|1|||
155287633|NCT02001623|560486107|FG010|Overall Study|Other - Miscellaneous|0|||
155287634|NCT02001623|560486108|FG011|Overall Study|Other - Miscellaneous|0|||
155287635|NCT02001623|560486109|FG012|Overall Study|Other - Miscellaneous|0|||
155287636|NCT02001623|560486110|FG013|Overall Study|Other - Miscellaneous|1|||
155287637|NCT02001623|560486111|FG014|Overall Study|Other - Miscellaneous|0|||
155287638|NCT02001623|560486097|FG000|Overall Study|Withdrawal by Subject|1|||
155287639|NCT02001623|560486098|FG001|Overall Study|Withdrawal by Subject|0|||
155287640|NCT02001623|560486099|FG002|Overall Study|Withdrawal by Subject|0|||
155287641|NCT02001623|560486100|FG003|Overall Study|Withdrawal by Subject|0|||
155287642|NCT02001623|560486101|FG004|Overall Study|Withdrawal by Subject|0|||
155287643|NCT02001623|560486102|FG005|Overall Study|Withdrawal by Subject|0|||
155287644|NCT02001623|560486103|FG006|Overall Study|Withdrawal by Subject|0|||
155287645|NCT02001623|560486104|FG007|Overall Study|Withdrawal by Subject|0|||
155287646|NCT02001623|560486105|FG008|Overall Study|Withdrawal by Subject|1|||
155287647|NCT02001623|560486106|FG009|Overall Study|Withdrawal by Subject|3|||
155287648|NCT02001623|560486107|FG010|Overall Study|Withdrawal by Subject|2|||
155287649|NCT02001623|560486108|FG011|Overall Study|Withdrawal by Subject|2|||
155287650|NCT02001623|560486109|FG012|Overall Study|Withdrawal by Subject|1|||
155287651|NCT02001623|560486110|FG013|Overall Study|Withdrawal by Subject|5|||
155287652|NCT02001623|560486111|FG014|Overall Study|Withdrawal by Subject|2|||
155287653|NCT02001623|560486097|FG000|Overall Study|Lost to Follow-up|0|||
155287654|NCT02001623|560486098|FG001|Overall Study|Lost to Follow-up|0|||
155287655|NCT02001623|560486099|FG002|Overall Study|Lost to Follow-up|0|||
155287656|NCT02001623|560486100|FG003|Overall Study|Lost to Follow-up|0|||
155287657|NCT02001623|560486101|FG004|Overall Study|Lost to Follow-up|0|||
155287658|NCT02001623|560486102|FG005|Overall Study|Lost to Follow-up|0|||
155287659|NCT02001623|560486103|FG006|Overall Study|Lost to Follow-up|0|||
155287660|NCT02001623|560486104|FG007|Overall Study|Lost to Follow-up|0|||
155287661|NCT02001623|560486105|FG008|Overall Study|Lost to Follow-up|0|||
155287662|NCT02001623|560486106|FG009|Overall Study|Lost to Follow-up|1|||
155287663|NCT02001623|560486107|FG010|Overall Study|Lost to Follow-up|0|||
155287664|NCT02001623|560486108|FG011|Overall Study|Lost to Follow-up|0|||
155287665|NCT02001623|560486109|FG012|Overall Study|Lost to Follow-up|0|||
155287666|NCT02001623|560486110|FG013|Overall Study|Lost to Follow-up|0|||
155287667|NCT02001623|560486111|FG014|Overall Study|Lost to Follow-up|0|||
155287668|NCT02001623|560486097|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
155287669|NCT02001623|560486098|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
155287670|NCT02001623|560486099|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
155287671|NCT02001623|560486100|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
155287672|NCT02001623|560486101|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
155287673|NCT02001623|560486102|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
155287674|NCT02001623|560486103|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
155287675|NCT02001623|560486104|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
155287676|NCT02001623|560486105|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
155287677|NCT02001623|560486106|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
155287678|NCT02001623|560486107|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
155287679|NCT02001623|560486108|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
155287680|NCT02001623|560486109|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
155287681|NCT02001623|560486110|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
155287682|NCT02001623|560486111|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
155287683|NCT02001623|560486097|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
155287684|NCT02001623|560486098|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
155287685|NCT02001623|560486099|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
155287686|NCT02001623|560486100|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
155287687|NCT02001623|560486101|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
155287688|NCT02001623|560486102|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
155287689|NCT02001623|560486103|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
154954876|NCT01367457|559261741|FG001|Overall Study|Uncontrolled pain|0|||
155287690|NCT02001623|560486104|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
155287691|NCT02001623|560486105|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
155287692|NCT02001623|560486106|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
155287693|NCT02001623|560486107|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
155287694|NCT02001623|560486108|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
155287695|NCT02001623|560486109|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
155287696|NCT02001623|560486110|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
155287697|NCT02001623|560486111|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
155287698|NCT00109967|560486118|FG000|Overall Study|Cancel Prior to Treatment|2|||
155287699|NCT00109967|560486119|FG001|Overall Study|Cancel Prior to Treatment|0|||
155287700|NCT00109967|560486118|FG000|Overall Study|Adverse Event|12|||
155287701|NCT00109967|560486119|FG001|Overall Study|Adverse Event|1|||
155287702|NCT00109967|560486118|FG000|Overall Study|Withdrawal by Subject|5|||
155287703|NCT00109967|560486119|FG001|Overall Study|Withdrawal by Subject|0|||
155287704|NCT00109967|560486118|FG000|Overall Study|Physician Decision|1|||
155287705|NCT00109967|560486119|FG001|Overall Study|Physician Decision|3|||
155287706|NCT00109967|560486118|FG000|Overall Study|Death|0|||
155287707|NCT00109967|560486119|FG001|Overall Study|Death|2|||
155287708|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Adverse Event|1|||
155287709|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
155287710|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
155287711|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
155287712|NCT01063036|560486124|FG000|Participants Treated With Study Drug|Pregnancy|1|||
155287713|NCT01063036|560486124|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
155287714|NCT01063036|560486124|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
155287715|NCT01063036|560486124|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
155287716|NCT01977612|560486127|FG000|Overall Study|Lost to Follow-up|1|||
155287717|NCT01977612|560486128|FG001|Overall Study|Lost to Follow-up|1|||
155287718|NCT02715258|560486130|FG000|Overall Study|Withdrawal by Subject|6|||
155287719|NCT02715258|560486131|FG001|Overall Study|Withdrawal by Subject|1|||
155287720|NCT02715258|560486130|FG000|Overall Study|Lost to Follow-up|7|||
155287721|NCT02715258|560486131|FG001|Overall Study|Lost to Follow-up|1|||
155287722|NCT02715258|560486130|FG000|Overall Study|Terminated by Sponsor|0|||
155287723|NCT02715258|560486131|FG001|Overall Study|Terminated by Sponsor|1|||
155287724|NCT02715258|560486130|FG000|Overall Study|Death|0|||
155287725|NCT02715258|560486131|FG001|Overall Study|Death|1|||
155287726|NCT02715258|560486130|FG000|Overall Study|Subject non-compliant|1|||
155287727|NCT02715258|560486131|FG001|Overall Study|Subject non-compliant|1|||
155287728|NCT02715258|560486130|FG000|Overall Study|GCP violation|2|||
155287729|NCT02715258|560486131|FG001|Overall Study|GCP violation|1|||
155287730|NCT02263508|560486139|FG000|Overall Study|Withdrawal by Subject|1|||
155287731|NCT02263508|560486140|FG001|Overall Study|Withdrawal by Subject|23|||
155287732|NCT02263508|560486141|FG002|Overall Study|Withdrawal by Subject|17|||
155287733|NCT02263508|560486139|FG000|Overall Study|Sponsor Decision|12|||
155287734|NCT02263508|560486140|FG001|Overall Study|Sponsor Decision|165|||
155287735|NCT02263508|560486141|FG002|Overall Study|Sponsor Decision|182|||
155287736|NCT02263508|560486139|FG000|Overall Study|Lost to Follow-up|2|||
155287737|NCT02263508|560486140|FG001|Overall Study|Lost to Follow-up|7|||
155287738|NCT02263508|560486141|FG002|Overall Study|Lost to Follow-up|7|||
155287739|NCT02263508|560486139|FG000|Overall Study|Death|6|||
155287740|NCT02263508|560486140|FG001|Overall Study|Death|151|||
155287741|NCT02263508|560486141|FG002|Overall Study|Death|140|||
155287742|NCT01117480|560486142|FG000|Overall Study|Protocol Violation|8|||
155287743|NCT01117480|560486142|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
155287744|NCT01280591|560486143|FG000|Overall Study|Withdrawal by Subject|0|||
155287745|NCT01280591|560486144|FG001|Overall Study|Withdrawal by Subject|0|||
155287746|NCT01280591|560486145|FG002|Overall Study|Withdrawal by Subject|0|||
155287747|NCT01280591|560486146|FG003|Overall Study|Withdrawal by Subject|2|||
155287748|NCT01280591|560486143|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
155287749|NCT01280591|560486144|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
155287750|NCT01280591|560486145|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
155287751|NCT01280591|560486146|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
155287752|NCT02955069|560486147|FG000|Overall Study|Adverse Event|7|||
155287753|NCT02955069|560486148|FG001|Overall Study|Adverse Event|2|||
155287754|NCT02955069|560486147|FG000|Overall Study|Death|7|||
155287755|NCT02955069|560486148|FG001|Overall Study|Death|3|||
155287756|NCT02955069|560486147|FG000|Overall Study|Physician Decision|10|||
155287757|NCT02955069|560486148|FG001|Overall Study|Physician Decision|2|||
155287758|NCT02955069|560486147|FG000|Overall Study|Progressive disease|64|||
155287759|NCT02955069|560486148|FG001|Overall Study|Progressive disease|13|||
155287760|NCT02955069|560486147|FG000|Overall Study|Study terminated by sponsor|4|||
155287761|NCT02955069|560486148|FG001|Overall Study|Study terminated by sponsor|0|||
155287762|NCT02955069|560486147|FG000|Overall Study|Subject/Guardian decision|3|||
155287763|NCT02955069|560486148|FG001|Overall Study|Subject/Guardian decision|1|||
155287764|NCT00943605|560486149|FG000|Overall Study|Study termination|30|||
155287765|NCT00943605|560486150|FG001|Overall Study|Study termination|30|||
155287766|NCT04148937|560486151|FG000|Overall Study|Withdrawal by Subject|0|||
155287767|NCT04148937|560486152|FG001|Overall Study|Withdrawal by Subject|0|||
155287768|NCT04148937|560486153|FG002|Overall Study|Withdrawal by Subject|0|||
155287769|NCT04148937|560486154|FG003|Overall Study|Withdrawal by Subject|1|||
155287770|NCT04148937|560486155|FG004|Overall Study|Withdrawal by Subject|0|||
155287771|NCT04148937|560486156|FG005|Overall Study|Withdrawal by Subject|1|||
155287772|NCT04148937|560486157|FG006|Overall Study|Withdrawal by Subject|1|||
155287773|NCT04148937|560486158|FG007|Overall Study|Withdrawal by Subject|0|||
155287774|NCT04148937|560486151|FG000|Overall Study|Lost to Follow-up|0|||
155287775|NCT04148937|560486152|FG001|Overall Study|Lost to Follow-up|0|||
155287776|NCT04148937|560486153|FG002|Overall Study|Lost to Follow-up|1|||
155287777|NCT04148937|560486154|FG003|Overall Study|Lost to Follow-up|0|||
155287778|NCT04148937|560486155|FG004|Overall Study|Lost to Follow-up|0|||
155287779|NCT04148937|560486156|FG005|Overall Study|Lost to Follow-up|2|||
155287780|NCT04148937|560486157|FG006|Overall Study|Lost to Follow-up|0|||
155287781|NCT04148937|560486158|FG007|Overall Study|Lost to Follow-up|0|||
155287782|NCT03999554|560486159|FG000|Overall Study|Lost to Follow-up|4|||
155287783|NCT03999554|560486160|FG001|Overall Study|Lost to Follow-up|5|||
155287784|NCT03999554|560486161|FG002|Overall Study|Lost to Follow-up|4|||
155287785|NCT03999554|560486162|FG003|Overall Study|Lost to Follow-up|5|||
155287786|NCT03999554|560486163|FG004|Overall Study|Lost to Follow-up|8|||
155287787|NCT03999554|560486159|FG000|Overall Study|Protocol Violation|0|||
155287788|NCT03999554|560486160|FG001|Overall Study|Protocol Violation|0|||
155287789|NCT03999554|560486161|FG002|Overall Study|Protocol Violation|5|||
155287790|NCT03999554|560486162|FG003|Overall Study|Protocol Violation|0|||
155287791|NCT03999554|560486163|FG004|Overall Study|Protocol Violation|0|||
155287792|NCT03999554|560486159|FG000|Overall Study|Pregnancy|0|||
155287793|NCT03999554|560486160|FG001|Overall Study|Pregnancy|0|||
155287794|NCT03999554|560486161|FG002|Overall Study|Pregnancy|1|||
155287795|NCT03999554|560486162|FG003|Overall Study|Pregnancy|0|||
155287796|NCT03999554|560486163|FG004|Overall Study|Pregnancy|0|||
155287797|NCT03999554|560486159|FG000|Overall Study|Withdrawal by Subject|2|||
155287798|NCT03999554|560486160|FG001|Overall Study|Withdrawal by Subject|2|||
155287799|NCT03999554|560486161|FG002|Overall Study|Withdrawal by Subject|2|||
155287800|NCT03999554|560486162|FG003|Overall Study|Withdrawal by Subject|1|||
155287801|NCT03999554|560486163|FG004|Overall Study|Withdrawal by Subject|1|||
155287802|NCT03999554|560486159|FG000|Overall Study|failure to comply with protocol requirements|0|||
155287803|NCT03999554|560486160|FG001|Overall Study|failure to comply with protocol requirements|0|||
155287804|NCT03999554|560486161|FG002|Overall Study|failure to comply with protocol requirements|0|||
155287805|NCT03999554|560486162|FG003|Overall Study|failure to comply with protocol requirements|1|||
155287806|NCT03999554|560486163|FG004|Overall Study|failure to comply with protocol requirements|0|||
155287807|NCT02082158|560486164|FG000|Overall Study|Withdrawal by Subject|0|||
155287808|NCT02082158|560486165|FG001|Overall Study|Withdrawal by Subject|0|||
155287809|NCT02082158|560486166|FG002|Overall Study|Withdrawal by Subject|0|||
155287810|NCT02082158|560486167|FG003|Overall Study|Withdrawal by Subject|0|||
155287811|NCT02082158|560486168|FG004|Overall Study|Withdrawal by Subject|1|||
155287812|NCT02082158|560486169|FG005|Overall Study|Withdrawal by Subject|0|||
155287813|NCT02082158|560486164|FG000|Overall Study|Failed Fit-testing|8|||
155287814|NCT02082158|560486165|FG001|Overall Study|Failed Fit-testing|8|||
155287815|NCT02082158|560486166|FG002|Overall Study|Failed Fit-testing|14|||
155287816|NCT02082158|560486167|FG003|Overall Study|Failed Fit-testing|4|||
155287817|NCT02082158|560486168|FG004|Overall Study|Failed Fit-testing|3|||
155287818|NCT02082158|560486169|FG005|Overall Study|Failed Fit-testing|7|||
155287819|NCT04012853|560486170|FG000|Overall Study|Withdrawal by Subject|1|||
155287820|NCT04012853|560486171|FG001|Overall Study|Withdrawal by Subject|1|||
155287821|NCT04012853|560486170|FG000|Overall Study|Protocol Violation|1|||
155287822|NCT04012853|560486171|FG001|Overall Study|Protocol Violation|0|||
155287823|NCT04012853|560486170|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
155287824|NCT04012853|560486171|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
155287825|NCT04304534|560486172|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
155287826|NCT04304534|560486173|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
155287827|NCT04304534|560486174|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
155287828|NCT04304534|560486175|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
155287829|NCT04304534|560486172|FG000|Overall Study|Non-Compliance with study drug|0|||
155287830|NCT04304534|560486173|FG001|Overall Study|Non-Compliance with study drug|1|||
155287831|NCT04304534|560486174|FG002|Overall Study|Non-Compliance with study drug|1|||
155287832|NCT04304534|560486175|FG003|Overall Study|Non-Compliance with study drug|1|||
155287833|NCT04304534|560486172|FG000|Overall Study|Lost to Follow-up|0|||
155287834|NCT04304534|560486173|FG001|Overall Study|Lost to Follow-up|1|||
155287835|NCT04304534|560486174|FG002|Overall Study|Lost to Follow-up|2|||
155287836|NCT04304534|560486175|FG003|Overall Study|Lost to Follow-up|3|||
155287837|NCT04304534|560486172|FG000|Overall Study|Unspecific|4|||
155287838|NCT04304534|560486173|FG001|Overall Study|Unspecific|2|||
155287839|NCT04304534|560486174|FG002|Overall Study|Unspecific|2|||
155287840|NCT04304534|560486175|FG003|Overall Study|Unspecific|2|||
155287841|NCT04304534|560486172|FG000|Overall Study|Technical Problems|2|||
155287842|NCT04304534|560486173|FG001|Overall Study|Technical Problems|2|||
155287843|NCT04304534|560486174|FG002|Overall Study|Technical Problems|3|||
155287844|NCT04304534|560486175|FG003|Overall Study|Technical Problems|4|||
155287845|NCT04304534|560486172|FG000|Overall Study|Death|7|||
155287846|NCT04304534|560486173|FG001|Overall Study|Death|2|||
155287847|NCT04304534|560486174|FG002|Overall Study|Death|4|||
155287848|NCT04304534|560486175|FG003|Overall Study|Death|3|||
155287849|NCT04304534|560486172|FG000|Overall Study|Withdrawal by Subject|7|||
155287850|NCT04304534|560486173|FG001|Overall Study|Withdrawal by Subject|2|||
155287851|NCT04304534|560486174|FG002|Overall Study|Withdrawal by Subject|7|||
155287852|NCT04304534|560486175|FG003|Overall Study|Withdrawal by Subject|4|||
155287853|NCT04304534|560486172|FG000|Overall Study|Physician Decision|4|||
155287854|NCT04304534|560486173|FG001|Overall Study|Physician Decision|9|||
155287855|NCT04304534|560486174|FG002|Overall Study|Physician Decision|9|||
155287856|NCT04304534|560486175|FG003|Overall Study|Physician Decision|5|||
155287857|NCT04304534|560486172|FG000|Overall Study|Subject Decision|34|||
155287858|NCT04304534|560486173|FG001|Overall Study|Subject Decision|25|||
155287859|NCT04304534|560486174|FG002|Overall Study|Subject Decision|25|||
155287860|NCT04304534|560486175|FG003|Overall Study|Subject Decision|26|||
155287861|NCT04304534|560486172|FG000|Overall Study|Adverse Event|35|||
155287862|NCT04304534|560486173|FG001|Overall Study|Adverse Event|40|||
155287863|NCT04304534|560486174|FG002|Overall Study|Adverse Event|39|||
155287864|NCT04304534|560486175|FG003|Overall Study|Adverse Event|44|||
155287865|NCT01695317|560486176|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
155287866|NCT01695317|560486177|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
155287867|NCT01695317|560486176|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
155287868|NCT01695317|560486177|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
155287869|NCT00464672|560486178|FG000|Overall Study|withdrawal of consent|0|||
155287870|NCT00464672|560486179|FG001|Overall Study|withdrawal of consent|0|||
155287871|NCT00464672|560486180|FG002|Overall Study|withdrawal of consent|0|||
155287872|NCT00464672|560486181|FG003|Overall Study|withdrawal of consent|1|||
155287873|NCT00464672|560486182|FG004|Overall Study|withdrawal of consent|9|||
155287874|NCT00464672|560486183|FG005|Overall Study|withdrawal of consent|4|||
155287875|NCT00464672|560486178|FG000|Overall Study|Lost to Follow-up|25|||
155287876|NCT00464672|560486179|FG001|Overall Study|Lost to Follow-up|10|||
155287877|NCT00464672|560486180|FG002|Overall Study|Lost to Follow-up|0|||
155287878|NCT00464672|560486181|FG003|Overall Study|Lost to Follow-up|0|||
155287879|NCT00464672|560486182|FG004|Overall Study|Lost to Follow-up|1|||
155287880|NCT00464672|560486183|FG005|Overall Study|Lost to Follow-up|0|||
155287881|NCT03055767|560486184|FG000|Open-Label Period|Lost to Follow-up|0|||
155287882|NCT03055767|560486185|FG001|Open-Label Period|Lost to Follow-up|0|||
155287883|NCT03055767|560486186|FG002|Open-Label Period|Lost to Follow-up|2|||
155287884|NCT03055767|560486187|FG003|Open-Label Period|Lost to Follow-up|0|||
155287885|NCT03055767|560486184|FG000|Open-Label Period|Withdrawal by Subject|0|||
155287886|NCT03055767|560486185|FG001|Open-Label Period|Withdrawal by Subject|0|||
155287887|NCT03055767|560486186|FG002|Open-Label Period|Withdrawal by Subject|0|||
155287888|NCT03055767|560486187|FG003|Open-Label Period|Withdrawal by Subject|1|||
155287889|NCT02759731|560486188|FG000|Overall Study|Did not complete treatment.|8|||
155287890|NCT01101165|560486189|FG000|Period 1|Adverse Event|1|||
155287891|NCT01101165|560486190|FG001|Period 1|Adverse Event|2|||
155287892|NCT01101165|560486189|FG000|Period 1|Withdrawal by Subject|0|||
155287893|NCT01101165|560486190|FG001|Period 1|Withdrawal by Subject|2|||
155287894|NCT01101165|560486189|FG000|Period 1|Positive Drug Screen|0|||
155287895|NCT01101165|560486190|FG001|Period 1|Positive Drug Screen|1|||
155287896|NCT01101165|560486189|FG000|Period 1|Lost to Follow-up|1|||
155287897|NCT01101165|560486190|FG001|Period 1|Lost to Follow-up|0|||
155287898|NCT01101165|560486189|FG000|Period 2|Withdrawal by Subject|3|||
155287899|NCT01101165|560486190|FG001|Period 2|Withdrawal by Subject|1|||
155287900|NCT01101165|560486189|FG000|Period 2|Adverse Event|1|||
155287901|NCT01101165|560486190|FG001|Period 2|Adverse Event|0|||
155287902|NCT00015457|560486193|FG000|First Intervention|Adverse Event|0|||
155287903|NCT00015457|560486194|FG001|First Intervention|Adverse Event|2|||
155287904|NCT00015457|560486193|FG000|First Intervention|Lack of Efficacy|0|||
155287905|NCT00015457|560486194|FG001|First Intervention|Lack of Efficacy|1|||
155287906|NCT00015457|560486193|FG000|Second Intervention|Withdrawal by Subject|1|||
154954877|NCT01367457|559261742|FG002|Overall Study|Uncontrolled pain|0|||
155287907|NCT00015457|560486194|FG001|Second Intervention|Withdrawal by Subject|0|||
155287908|NCT01456936|560486199|FG000|Overall Study|Other reason|41|||
155287909|NCT01456936|560486200|FG001|Overall Study|Other reason|30|||
155287910|NCT01456936|560486201|FG002|Overall Study|Other reason|36|||
155287911|NCT01456936|560486202|FG003|Overall Study|Other reason|33|||
155287912|NCT01456936|560486199|FG000|Overall Study|No longer meets eligibility criteria|4|||
154954878|NCT01367457|559261740|FG000|Overall Study|Overall status worsens to grade 4|1|||
155287913|NCT01456936|560486200|FG001|Overall Study|No longer meets eligibility criteria|8|||
155287914|NCT01456936|560486201|FG002|Overall Study|No longer meets eligibility criteria|6|||
155287915|NCT01456936|560486202|FG003|Overall Study|No longer meets eligibility criteria|5|||
155287916|NCT01456936|560486199|FG000|Overall Study|Protocol Violation|4|||
155287917|NCT01456936|560486200|FG001|Overall Study|Protocol Violation|2|||
155287918|NCT01456936|560486201|FG002|Overall Study|Protocol Violation|5|||
155287919|NCT01456936|560486202|FG003|Overall Study|Protocol Violation|5|||
155287920|NCT01456936|560486199|FG000|Overall Study|Pregnancy|1|||
155287921|NCT01456936|560486200|FG001|Overall Study|Pregnancy|0|||
155287922|NCT01456936|560486201|FG002|Overall Study|Pregnancy|0|||
155287923|NCT01456936|560486202|FG003|Overall Study|Pregnancy|1|||
155287924|NCT01456936|560486199|FG000|Overall Study|Insufficient clinical response|4|||
155287925|NCT01456936|560486200|FG001|Overall Study|Insufficient clinical response|4|||
155287926|NCT01456936|560486201|FG002|Overall Study|Insufficient clinical response|14|||
155287927|NCT01456936|560486202|FG003|Overall Study|Insufficient clinical response|13|||
155287928|NCT01456936|560486199|FG000|Overall Study|No longer willing to participate|195|||
155287929|NCT01456936|560486200|FG001|Overall Study|No longer willing to participate|218|||
155287930|NCT01456936|560486201|FG002|Overall Study|No longer willing to participate|224|||
155287931|NCT01456936|560486202|FG003|Overall Study|No longer willing to participate|248|||
155287932|NCT01456936|560486199|FG000|Overall Study|Lost to Follow-up|135|||
155287933|NCT01456936|560486200|FG001|Overall Study|Lost to Follow-up|126|||
155287934|NCT01456936|560486201|FG002|Overall Study|Lost to Follow-up|144|||
155287935|NCT01456936|560486202|FG003|Overall Study|Lost to Follow-up|127|||
155287936|NCT01456936|560486199|FG000|Overall Study|Medication error|0|||
155287937|NCT01456936|560486200|FG001|Overall Study|Medication error|1|||
155287938|NCT01456936|560486201|FG002|Overall Study|Medication error|0|||
155287939|NCT01456936|560486202|FG003|Overall Study|Medication error|1|||
155287940|NCT01456936|560486199|FG000|Overall Study|Adverse event (study drug)|25|||
155287941|NCT01456936|560486200|FG001|Overall Study|Adverse event (study drug)|21|||
155287942|NCT01456936|560486201|FG002|Overall Study|Adverse event (study drug)|26|||
155287943|NCT01456936|560486202|FG003|Overall Study|Adverse event (study drug)|17|||
155287944|NCT01456936|560486199|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
155287945|NCT01456936|560486200|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
155287946|NCT01456936|560486201|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
155287947|NCT01456936|560486202|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
155287948|NCT01456936|560486199|FG000|Overall Study|Death|0|||
155287949|NCT01456936|560486200|FG001|Overall Study|Death|3|||
155287950|NCT01456936|560486201|FG002|Overall Study|Death|1|||
155287951|NCT01456936|560486202|FG003|Overall Study|Death|3|||
155287952|NCT01456936|560486199|FG000|Overall Study|Randomized but not treated|21|||
155287953|NCT01456936|560486200|FG001|Overall Study|Randomized but not treated|28|||
155287954|NCT01456936|560486201|FG002|Overall Study|Randomized but not treated|16|||
155287955|NCT01456936|560486202|FG003|Overall Study|Randomized but not treated|21|||
155287956|NCT02317705|560486203|FG000|Overall Study|Withdrawal by Subject|3|||
155287957|NCT02317705|560486203|FG000|Overall Study|Physician Decision|1|||
155287958|NCT02317705|560486203|FG000|Overall Study|Drug not usable|1|||
155287959|NCT03095508|560486204|FG000|Overall Study|Adverse Event|0|||
155287960|NCT03095508|560486205|FG001|Overall Study|Adverse Event|1|||
155287961|NCT01674569|560486206|FG000|Overall Study|Adverse Event|0|||
155287962|NCT01674569|560486207|FG001|Overall Study|Adverse Event|2|||
155287963|NCT01674569|560486208|FG002|Overall Study|Adverse Event|0|||
155287964|NCT01674569|560486209|FG003|Overall Study|Adverse Event|1|||
155287965|NCT01674569|560486210|FG004|Overall Study|Adverse Event|2|||
155287966|NCT01674569|560486211|FG005|Overall Study|Adverse Event|2|||
155287967|NCT01674569|560486206|FG000|Overall Study|Protocol Violation|0|||
155287968|NCT01674569|560486207|FG001|Overall Study|Protocol Violation|1|||
155287969|NCT01674569|560486208|FG002|Overall Study|Protocol Violation|1|||
155287970|NCT01674569|560486209|FG003|Overall Study|Protocol Violation|0|||
155287971|NCT01674569|560486210|FG004|Overall Study|Protocol Violation|0|||
155287972|NCT01674569|560486211|FG005|Overall Study|Protocol Violation|0|||
155287973|NCT01674569|560486206|FG000|Overall Study|Withdrawal by Subject|0|||
155287974|NCT01674569|560486207|FG001|Overall Study|Withdrawal by Subject|0|||
155287975|NCT01674569|560486208|FG002|Overall Study|Withdrawal by Subject|1|||
155287976|NCT01674569|560486209|FG003|Overall Study|Withdrawal by Subject|0|||
155287977|NCT01674569|560486210|FG004|Overall Study|Withdrawal by Subject|0|||
155287978|NCT01674569|560486211|FG005|Overall Study|Withdrawal by Subject|0|||
155287979|NCT01599325|560486212|FG000|Primary Parent Phase|Adverse Event|5|||
155287980|NCT01599325|560486212|FG000|Primary Parent Phase|Disease Progression|7|||
155287981|NCT01599325|560486212|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
155287982|NCT01599325|560486212|FG000|Primary Parent Phase|Death|13|||
155287983|NCT01599325|560486212|FG000|Primary Parent Phase|Protocol Violation|1|||
155287984|NCT01599325|560486212|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
155287985|NCT01599325|560486212|FG000|Primary Parent Phase|Other|2|||
155287986|NCT01599325|560486212|FG000|Extension Phase|Study Closure|1|||
155287987|NCT01599325|560486212|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
155287988|NCT01599325|560486212|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
155287989|NCT01599325|560486212|FG000|Extension Phase|Disease Progression|1|||
155287990|NCT01599325|560486212|FG000|Extension Phase|Withdrawal by Subject|8|||
155287991|NCT01710514|560486214|FG000|Overall Study|Adverse Event|6|||
155287992|NCT01710514|560486215|FG001|Overall Study|Adverse Event|7|||
155287993|NCT01710514|560486214|FG000|Overall Study|Withdrawal by Subject|1|||
155287994|NCT01710514|560486215|FG001|Overall Study|Withdrawal by Subject|0|||
155287995|NCT03404843|560486218|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
155287996|NCT03404843|560486219|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
155287997|NCT04044664|560486220|FG000|Stage 1|Adverse Event|3|||
155287998|NCT04044664|560486221|FG001|Stage 1|Adverse Event|3|||
155287999|NCT04044664|560486222|FG002|Stage 1|Adverse Event|1|||
155288000|NCT04044664|560486220|FG000|Stage 1|Lost to Follow-up|3|||
155288001|NCT04044664|560486221|FG001|Stage 1|Lost to Follow-up|2|||
155288002|NCT04044664|560486222|FG002|Stage 1|Lost to Follow-up|2|||
155288003|NCT04044664|560486220|FG000|Stage 1|Withdrawal by Subject|9|||
155288004|NCT04044664|560486221|FG001|Stage 1|Withdrawal by Subject|1|||
155288005|NCT04044664|560486222|FG002|Stage 1|Withdrawal by Subject|0|||
155288006|NCT04044664|560486220|FG000|Stage 1|noncompliance, personal reason|2|||
155288007|NCT04044664|560486221|FG001|Stage 1|noncompliance, personal reason|0|||
155288008|NCT04044664|560486222|FG002|Stage 1|noncompliance, personal reason|0|||
155288009|NCT04044664|560486220|FG000|Stage 1|randomization error|0|||
155288010|NCT04044664|560486221|FG001|Stage 1|randomization error|1|||
155288011|NCT04044664|560486222|FG002|Stage 1|randomization error|0|||
155288012|NCT04044664|560486220|FG000|Stage 2|Adverse Event|2|||
155288013|NCT04044664|560486221|FG001|Stage 2|Adverse Event|0|||
155288014|NCT04044664|560486222|FG002|Stage 2|Adverse Event|0|||
155288015|NCT04044664|560486220|FG000|Stage 2|Lost to Follow-up|3|||
155288016|NCT04044664|560486221|FG001|Stage 2|Lost to Follow-up|2|||
155288017|NCT04044664|560486222|FG002|Stage 2|Lost to Follow-up|1|||
155288018|NCT04044664|560486220|FG000|Stage 2|Withdrawal by Subject|3|||
155288019|NCT04044664|560486221|FG001|Stage 2|Withdrawal by Subject|0|||
155288020|NCT04044664|560486222|FG002|Stage 2|Withdrawal by Subject|0|||
155288021|NCT04044664|560486220|FG000|Stage 2|protocol deviation|1|||
155288022|NCT04044664|560486221|FG001|Stage 2|protocol deviation|0|||
155288023|NCT04044664|560486222|FG002|Stage 2|protocol deviation|0|||
155288024|NCT03822351|560486234|FG000|Overall Study|Death|27|||
155288025|NCT03822351|560486235|FG001|Overall Study|Death|23|||
155288026|NCT03822351|560486236|FG002|Overall Study|Death|24|||
155288027|NCT03822351|560486234|FG000|Overall Study|Lost to Follow-up|6|||
155288028|NCT03822351|560486235|FG001|Overall Study|Lost to Follow-up|2|||
155288029|NCT03822351|560486236|FG002|Overall Study|Lost to Follow-up|1|||
155288030|NCT03822351|560486234|FG000|Overall Study|Withdrawal by Subject|10|||
155288031|NCT03822351|560486235|FG001|Overall Study|Withdrawal by Subject|4|||
155288032|NCT03822351|560486236|FG002|Overall Study|Withdrawal by Subject|6|||
155288033|NCT03822351|560486234|FG000|Overall Study|Progressive Disease|2|||
155288034|NCT03822351|560486235|FG001|Overall Study|Progressive Disease|1|||
155288035|NCT03822351|560486236|FG002|Overall Study|Progressive Disease|0|||
155288036|NCT03822351|560486234|FG000|Overall Study|Not Treated|1|||
155288037|NCT03822351|560486235|FG001|Overall Study|Not Treated|1|||
155288038|NCT03822351|560486236|FG002|Overall Study|Not Treated|1|||
155288039|NCT01458275|560486237|FG000|Overall Study|Adverse Event|3|||
155288040|NCT01458275|560486238|FG001|Overall Study|Adverse Event|4|||
155288041|NCT01458275|560486239|FG002|Overall Study|Adverse Event|1|||
155288042|NCT01458275|560486237|FG000|Overall Study|Lost to Follow-up|3|||
155288043|NCT01458275|560486238|FG001|Overall Study|Lost to Follow-up|2|||
155288044|NCT01458275|560486239|FG002|Overall Study|Lost to Follow-up|5|||
155288045|NCT01458275|560486237|FG000|Overall Study|Protocol Violation|5|||
155288046|NCT01458275|560486238|FG001|Overall Study|Protocol Violation|5|||
155288047|NCT01458275|560486239|FG002|Overall Study|Protocol Violation|2|||
155288048|NCT01458275|560486237|FG000|Overall Study|Withdrawal by Subject|3|||
155288049|NCT01458275|560486238|FG001|Overall Study|Withdrawal by Subject|2|||
155288050|NCT01458275|560486239|FG002|Overall Study|Withdrawal by Subject|1|||
155288051|NCT00871429|560486240|FG000|Overall Study|Lost to Follow-up|6|||
155288052|NCT00871429|560486240|FG000|Overall Study|Withdrawal by Subject|17|||
155288053|NCT00871429|560486240|FG000|Overall Study|Questionnaire not completed|1|||
155288054|NCT03102242|560486241|FG000|Overall Study|Adverse Event|2|||
155288055|NCT01875250|560488425|FG000|Overall Study|Adverse Event|2|||
155288056|NCT01875250|560488426|FG001|Overall Study|Adverse Event|0|||
155288057|NCT00661778|560488429|FG000|Overall Study|Disease Progression|23|||
155288058|NCT00661778|560488429|FG000|Overall Study|Adverse Event|18|||
155288059|NCT00661778|560488429|FG000|Overall Study|Reason not Specified|6|||
155288060|NCT00661778|560488429|FG000|Overall Study|Protocol Violation|2|||
155288061|NCT00661778|560488429|FG000|Overall Study|Withdrawal of Consent|1|||
155288062|NCT05298111|560488430|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
155288063|NCT05298111|560488431|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
155288064|NCT02232178|560488432|FG000|Overall Study|Lost to Follow-up|0|||
155288065|NCT02232178|560488433|FG001|Overall Study|Lost to Follow-up|1|||
155288066|NCT02232178|560488434|FG002|Overall Study|Lost to Follow-up|0|||
155288067|NCT02232178|560488432|FG000|Overall Study|ineligibility|0|||
155288068|NCT02232178|560488433|FG001|Overall Study|ineligibility|0|||
155288069|NCT02232178|560488434|FG002|Overall Study|ineligibility|1|||
155288070|NCT02232178|560488432|FG000|Overall Study|surgical complication|1|||
155288071|NCT02232178|560488433|FG001|Overall Study|surgical complication|0|||
155288072|NCT02232178|560488434|FG002|Overall Study|surgical complication|0|||
155288073|NCT01259102|560488435|FG000|Overall Study|Adverse Event|1|||
155288074|NCT01259102|560488436|FG001|Overall Study|Adverse Event|0|||
155288075|NCT01259102|560488437|FG002|Overall Study|Adverse Event|1|||
155288076|NCT01259102|560488438|FG003|Overall Study|Adverse Event|1|||
155288077|NCT01259102|560488439|FG004|Overall Study|Adverse Event|0|||
155288078|NCT01259102|560488435|FG000|Overall Study|Other|0|||
155288079|NCT01259102|560488436|FG001|Overall Study|Other|0|||
155288080|NCT01259102|560488437|FG002|Overall Study|Other|1|||
155288081|NCT01259102|560488438|FG003|Overall Study|Other|1|||
155288082|NCT01259102|560488439|FG004|Overall Study|Other|1|||
155288083|NCT00686517|560488441|FG000|Treatment|Serious Adverse Event|1|||
155288084|NCT00686517|560488442|FG001|Treatment|Serious Adverse Event|2|||
155288085|NCT00686517|560488443|FG002|Treatment|Serious Adverse Event|1|||
155288086|NCT00686517|560488441|FG000|Treatment|Adverse Event|2|||
155288087|NCT00686517|560488442|FG001|Treatment|Adverse Event|0|||
155288088|NCT00686517|560488443|FG002|Treatment|Adverse Event|0|||
155288089|NCT00686517|560488441|FG000|Treatment|Poor Protocol Compliance|1|||
155288090|NCT00686517|560488442|FG001|Treatment|Poor Protocol Compliance|0|||
155288091|NCT00686517|560488443|FG002|Treatment|Poor Protocol Compliance|0|||
155288092|NCT00686517|560488441|FG000|Treatment|Protocol Violation|2|||
155288093|NCT00686517|560488442|FG001|Treatment|Protocol Violation|1|||
155288094|NCT00686517|560488443|FG002|Treatment|Protocol Violation|0|||
155288095|NCT01803646|560488444|FG000|Overall Study|Protocol Violation|1|||
155288096|NCT01803646|560488445|FG001|Overall Study|Protocol Violation|0|||
155288097|NCT01803646|560488444|FG000|Overall Study|Adverse Event|1|||
155288098|NCT01803646|560488445|FG001|Overall Study|Adverse Event|1|||
155288099|NCT01803646|560488444|FG000|Overall Study|Withdrawal by Subject|9|||
155288100|NCT01803646|560488445|FG001|Overall Study|Withdrawal by Subject|6|||
155288101|NCT01803646|560488444|FG000|Overall Study|Randomization error|1|||
155288102|NCT01803646|560488445|FG001|Overall Study|Randomization error|2|||
155288103|NCT01803646|560488444|FG000|Overall Study|Lost to Follow-up|5|||
155288104|NCT01803646|560488445|FG001|Overall Study|Lost to Follow-up|1|||
155288105|NCT01072357|560488448|FG000|Overall Study|Lost to Follow-up|0|||
155288106|NCT01072357|560488449|FG001|Overall Study|Lost to Follow-up|1|||
155288107|NCT01876511|560488450|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
155288108|NCT01876511|560488451|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
155288109|NCT01876511|560488452|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
155288110|NCT01876511|560488450|FG000|Overall Study|Death (unrelated)|3|||
155288111|NCT01876511|560488451|FG001|Overall Study|Death (unrelated)|0|||
155288112|NCT01876511|560488452|FG002|Overall Study|Death (unrelated)|2|||
155288113|NCT01876511|560488450|FG000|Overall Study|Drug-related Toxicity|5|||
155288114|NCT01876511|560488451|FG001|Overall Study|Drug-related Toxicity|1|||
155288115|NCT01876511|560488452|FG002|Overall Study|Drug-related Toxicity|6|||
155288116|NCT01876511|560488450|FG000|Overall Study|Patient Decision|3|||
155288117|NCT01876511|560488451|FG001|Overall Study|Patient Decision|0|||
155288118|NCT01876511|560488452|FG002|Overall Study|Patient Decision|6|||
155288119|NCT01876511|560488450|FG000|Overall Study|Physician Decision|1|||
155288120|NCT01876511|560488451|FG001|Overall Study|Physician Decision|0|||
155288121|NCT01876511|560488452|FG002|Overall Study|Physician Decision|1|||
155288122|NCT01048788|560488453|FG000|Overall Study|Adverse Event|5|||
155288123|NCT01048788|560488454|FG001|Overall Study|Adverse Event|1|||
155288124|NCT01048788|560488455|FG002|Overall Study|Adverse Event|1|||
155288125|NCT01048788|560488453|FG000|Overall Study|Lack of Efficacy|0|||
155288126|NCT01048788|560488454|FG001|Overall Study|Lack of Efficacy|0|||
155288127|NCT01048788|560488455|FG002|Overall Study|Lack of Efficacy|1|||
155288128|NCT01048788|560488453|FG000|Overall Study|Withdrawal by Subject|0|||
155288129|NCT01048788|560488454|FG001|Overall Study|Withdrawal by Subject|1|||
155288130|NCT01048788|560488455|FG002|Overall Study|Withdrawal by Subject|0|||
155288131|NCT02145182|560488456|FG000|Overall Study|Adverse Event|4|||
155288132|NCT02145182|560488457|FG001|Overall Study|Adverse Event|1|||
155288133|NCT02145182|560488456|FG000|Overall Study|Death|7|||
155288134|NCT02145182|560488457|FG001|Overall Study|Death|7|||
155288135|NCT02145182|560488456|FG000|Overall Study|Lost to Follow-up|2|||
155288136|NCT02145182|560488457|FG001|Overall Study|Lost to Follow-up|2|||
155288137|NCT02145182|560488456|FG000|Overall Study|Pre-transplant Withdrawal|0|||
155288138|NCT02145182|560488457|FG001|Overall Study|Pre-transplant Withdrawal|2|||
155288139|NCT02145182|560488456|FG000|Overall Study|Withdrawal by Subject|5|||
155288140|NCT02145182|560488457|FG001|Overall Study|Withdrawal by Subject|4|||
155288141|NCT01196988|560488458|FG000|Overall Study|Adverse Event|1|||
155288142|NCT01196988|560488459|FG001|Overall Study|Adverse Event|2|||
155288143|NCT01196988|560488460|FG002|Overall Study|Adverse Event|0|||
155288144|NCT01196988|560488461|FG003|Overall Study|Adverse Event|0|||
155288145|NCT01196988|560488458|FG000|Overall Study|Withdrawal by Subject|5|||
155288146|NCT01196988|560488459|FG001|Overall Study|Withdrawal by Subject|1|||
155288147|NCT01196988|560488460|FG002|Overall Study|Withdrawal by Subject|4|||
155288148|NCT01196988|560488461|FG003|Overall Study|Withdrawal by Subject|0|||
155059489|NCT01387269|559651919|FG001|Overall Study|Lost to Follow-up|0|||
155059490|NCT01200329|559651922|FG000|Overall Study|Lack of financial coverage|2|||
155059491|NCT01200329|559651922|FG000|Overall Study|Progressive disease|1|||
155288149|NCT01196988|560488458|FG000|Overall Study|Lost to Follow-up|16|||
155288150|NCT01196988|560488459|FG001|Overall Study|Lost to Follow-up|29|||
155288151|NCT01196988|560488460|FG002|Overall Study|Lost to Follow-up|21|||
155288152|NCT01196988|560488461|FG003|Overall Study|Lost to Follow-up|1|||
155288153|NCT01196988|560488458|FG000|Overall Study|Other|2|||
155288154|NCT01196988|560488459|FG001|Overall Study|Other|0|||
155288155|NCT01196988|560488460|FG002|Overall Study|Other|0|||
155288156|NCT01196988|560488461|FG003|Overall Study|Other|0|||
155288157|NCT01233050|560488462|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
155288158|NCT01233050|560488463|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
155288159|NCT01466881|560488466|FG000|Overall Study|Ineligible|5|||
155288160|NCT01466881|560488466|FG000|Overall Study|Adverse Event|6|||
155288161|NCT01466881|560488466|FG000|Overall Study|Progression/relapse|20|||
155288162|NCT01466881|560488466|FG000|Overall Study|Death|4|||
155288163|NCT01466881|560488466|FG000|Overall Study|Other reason not protocol specified|5|||
155288164|NCT00957229|560488467|FG000|Study Start|Adverse Event|0|||
155288165|NCT00957229|560488468|FG001|Study Start|Adverse Event|3|||
155288166|NCT00957229|560488467|FG000|Study Start|Disease Progression|1|||
155288167|NCT00957229|560488468|FG001|Study Start|Disease Progression|0|||
155288168|NCT00957229|560488467|FG000|Reallocated to or Continued Vismodegib|Death|1|||
155288169|NCT00957229|560488468|FG001|Reallocated to or Continued Vismodegib|Death|1|||
155288170|NCT00957229|560488467|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
155288171|NCT00957229|560488468|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
155288172|NCT00606580|560488469|FG000|Overall Study|Lost to Follow-up|1|||
155288173|NCT00606580|560488470|FG001|Overall Study|Lost to Follow-up|1|||
155288174|NCT00606580|560488471|FG002|Overall Study|Lost to Follow-up|4|||
155288175|NCT00606580|560488469|FG000|Overall Study|Clinical failures|1|||
155288176|NCT00606580|560488470|FG001|Overall Study|Clinical failures|0|||
155288177|NCT00606580|560488471|FG002|Overall Study|Clinical failures|12|||
155288178|NCT00606580|560488469|FG000|Overall Study|Withdrawal by investigator|0|||
155288179|NCT00606580|560488470|FG001|Overall Study|Withdrawal by investigator|1|||
155288180|NCT00606580|560488471|FG002|Overall Study|Withdrawal by investigator|6|||
155288181|NCT00606580|560488469|FG000|Overall Study|Withdrawal by Subject|0|||
155288182|NCT00606580|560488470|FG001|Overall Study|Withdrawal by Subject|1|||
155288183|NCT00606580|560488471|FG002|Overall Study|Withdrawal by Subject|0|||
155288184|NCT04580303|560488472|FG000|Overall Study|Adverse Event|0|||
155288185|NCT04580303|560488473|FG001|Overall Study|Adverse Event|1|||
155288186|NCT04580303|560488474|FG002|Overall Study|Adverse Event|0|||
155288187|NCT04580303|560488475|FG003|Overall Study|Adverse Event|0|||
155288188|NCT04580303|560488472|FG000|Overall Study|Withdrawal by Subject|0|||
155288189|NCT04580303|560488473|FG001|Overall Study|Withdrawal by Subject|0|||
155288190|NCT04580303|560488474|FG002|Overall Study|Withdrawal by Subject|1|||
155288191|NCT04580303|560488475|FG003|Overall Study|Withdrawal by Subject|0|||
155288192|NCT01833065|560488477|FG000|Overall Study|Adverse Event|6|||
155288193|NCT01833065|560488478|FG001|Overall Study|Adverse Event|1|||
155288194|NCT01833065|560488479|FG002|Overall Study|Adverse Event|0|||
155288195|NCT01833065|560488480|FG003|Overall Study|Adverse Event|2|||
155288196|NCT01833065|560488481|FG004|Overall Study|Adverse Event|3|||
155288197|NCT01833065|560488477|FG000|Overall Study|Protocol Violation|1|||
155288198|NCT01833065|560488478|FG001|Overall Study|Protocol Violation|0|||
155288199|NCT01833065|560488479|FG002|Overall Study|Protocol Violation|0|||
155288200|NCT01833065|560488480|FG003|Overall Study|Protocol Violation|0|||
155288201|NCT01833065|560488481|FG004|Overall Study|Protocol Violation|2|||
155288202|NCT01833065|560488477|FG000|Overall Study|Lost to Follow-up|1|||
155288203|NCT01833065|560488478|FG001|Overall Study|Lost to Follow-up|0|||
155288204|NCT01833065|560488479|FG002|Overall Study|Lost to Follow-up|0|||
155288205|NCT01833065|560488480|FG003|Overall Study|Lost to Follow-up|0|||
155288206|NCT01833065|560488481|FG004|Overall Study|Lost to Follow-up|3|||
155288207|NCT01833065|560488477|FG000|Overall Study|Withdrawal by Subject|6|||
155288208|NCT01833065|560488478|FG001|Overall Study|Withdrawal by Subject|2|||
155288209|NCT01833065|560488479|FG002|Overall Study|Withdrawal by Subject|4|||
155288210|NCT01833065|560488480|FG003|Overall Study|Withdrawal by Subject|3|||
155288211|NCT01833065|560488481|FG004|Overall Study|Withdrawal by Subject|11|||
155288212|NCT01833065|560488477|FG000|Overall Study|Subject's substantial non-compliance|0|||
155288213|NCT01833065|560488478|FG001|Overall Study|Subject's substantial non-compliance|1|||
155288214|NCT01833065|560488479|FG002|Overall Study|Subject's substantial non-compliance|0|||
155288215|NCT01833065|560488480|FG003|Overall Study|Subject's substantial non-compliance|0|||
155288216|NCT01833065|560488481|FG004|Overall Study|Subject's substantial non-compliance|0|||
155288217|NCT01833065|560488477|FG000|Overall Study|Trial terminated by sponsor|8|||
155288218|NCT01833065|560488478|FG001|Overall Study|Trial terminated by sponsor|8|||
155288219|NCT01833065|560488479|FG002|Overall Study|Trial terminated by sponsor|7|||
155288220|NCT01833065|560488480|FG003|Overall Study|Trial terminated by sponsor|3|||
155288221|NCT01833065|560488481|FG004|Overall Study|Trial terminated by sponsor|13|||
155288222|NCT01833065|560488477|FG000|Overall Study|Others|2|||
155288223|NCT01833065|560488478|FG001|Overall Study|Others|1|||
155288224|NCT01833065|560488479|FG002|Overall Study|Others|1|||
155288225|NCT01833065|560488480|FG003|Overall Study|Others|1|||
155288226|NCT01833065|560488481|FG004|Overall Study|Others|4|||
155288227|NCT00927823|560488484|FG000|Continuous Dosing Period|Death|0|||
155288228|NCT00927823|560488485|FG001|Continuous Dosing Period|Death|0|||
155288229|NCT00927823|560488486|FG002|Continuous Dosing Period|Death|6|||
155288230|NCT00927823|560488487|FG003|Continuous Dosing Period|Death|0|||
155288231|NCT00927823|560488484|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
155288232|NCT00927823|560488485|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
155288233|NCT00927823|560488486|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
155288234|NCT00927823|560488487|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
155288235|NCT00927823|560488484|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
155288236|NCT00927823|560488485|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
155288237|NCT00927823|560488486|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
154954879|NCT01367457|559261741|FG001|Overall Study|Overall status worsens to grade 4|0|||
154954880|NCT01367457|559261742|FG002|Overall Study|Overall status worsens to grade 4|0|||
155288238|NCT00927823|560488487|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
155288239|NCT00927823|560488484|FG000|Continuous Dosing Period|Other|1|||
155288240|NCT00927823|560488485|FG001|Continuous Dosing Period|Other|2|||
155288241|NCT00927823|560488486|FG002|Continuous Dosing Period|Other|9|||
155288242|NCT00927823|560488487|FG003|Continuous Dosing Period|Other|3|||
155288243|NCT00828672|560488488|FG000|Study Treatment|Lost to Follow-up|1|||
155288244|NCT00828672|560488489|FG001|Study Treatment|Lost to Follow-up|0|||
155288245|NCT00828672|560488488|FG000|Study Treatment|Adverse Event|0|||
155288246|NCT00828672|560488489|FG001|Study Treatment|Adverse Event|1|||
155288247|NCT00828672|560488488|FG000|Study Treatment|Complete response, no surgery|1|||
155288248|NCT00828672|560488489|FG001|Study Treatment|Complete response, no surgery|1|||
155288249|NCT00828672|560488488|FG000|Post-surgery (<30 Days)|No central review materials|0|||
155288250|NCT00828672|560488489|FG001|Post-surgery (<30 Days)|No central review materials|1|||
155288251|NCT00601640|560488490|FG000|Overall Study|Withdrawal by Subject|3|||
155288252|NCT00601640|560488491|FG001|Overall Study|Withdrawal by Subject|0|||
155288253|NCT00601640|560488492|FG002|Overall Study|Withdrawal by Subject|7|||
155288254|NCT00601640|560488490|FG000|Overall Study|Death|1|||
155288255|NCT00601640|560488491|FG001|Overall Study|Death|0|||
155288256|NCT00601640|560488492|FG002|Overall Study|Death|0|||
155288257|NCT00601640|560488490|FG000|Overall Study|Adverse Event|0|||
155288258|NCT00601640|560488491|FG001|Overall Study|Adverse Event|4|||
155288259|NCT00601640|560488492|FG002|Overall Study|Adverse Event|2|||
155288260|NCT00601640|560488490|FG000|Overall Study|intercurrent illness|1|||
155288261|NCT00601640|560488491|FG001|Overall Study|intercurrent illness|0|||
155288262|NCT00601640|560488492|FG002|Overall Study|intercurrent illness|0|||
155288263|NCT00601640|560488490|FG000|Overall Study|change in eligibility status|0|||
155288264|NCT00601640|560488491|FG001|Overall Study|change in eligibility status|1|||
155288265|NCT00601640|560488492|FG002|Overall Study|change in eligibility status|1|||
155288266|NCT01878890|560488498|FG000|Overall Study|Protocol Violation|0|||
155288267|NCT01878890|560488499|FG001|Overall Study|Protocol Violation|1|||
155288268|NCT01878890|560488500|FG002|Overall Study|Protocol Violation|0|||
155288269|NCT01878890|560488501|FG003|Overall Study|Protocol Violation|0|||
155288270|NCT00831792|560488507|FG000|Overall Study|Not Eligible|3|||
155288271|NCT00831792|560488507|FG000|Overall Study|Adverse Event|1|||
155288272|NCT00831792|560488507|FG000|Overall Study|Death|1|||
155288273|NCT00831792|560488507|FG000|Overall Study|Lack of Efficacy|1|||
155288274|NCT03736785|560488508|FG000|Overall Study|Adverse Event|1|||
154954881|NCT01367457|559261740|FG000|Overall Study|Stabilisation + frequent infections|1|||
154954882|NCT01367457|559261741|FG001|Overall Study|Stabilisation + frequent infections|0|||
154954883|NCT01367457|559261742|FG002|Overall Study|Stabilisation + frequent infections|0|||
154954884|NCT01367457|559261740|FG000|Overall Study|No clinical benefit|1|||
155288275|NCT03736785|560488509|FG001|Overall Study|Adverse Event|1|||
155288276|NCT03736785|560488510|FG002|Overall Study|Adverse Event|1|||
155288277|NCT03736785|560488508|FG000|Overall Study|Death|1|||
155288278|NCT03736785|560488509|FG001|Overall Study|Death|0|||
155288279|NCT03736785|560488510|FG002|Overall Study|Death|1|||
155288280|NCT03736785|560488508|FG000|Overall Study|Lost to Follow-up|0|||
155288281|NCT03736785|560488509|FG001|Overall Study|Lost to Follow-up|2|||
155288282|NCT03736785|560488510|FG002|Overall Study|Lost to Follow-up|3|||
155288283|NCT03736785|560488508|FG000|Overall Study|Non compliance with study drug|1|||
155288284|NCT03736785|560488509|FG001|Overall Study|Non compliance with study drug|1|||
155288285|NCT03736785|560488510|FG002|Overall Study|Non compliance with study drug|0|||
155288286|NCT03736785|560488508|FG000|Overall Study|Physician Decision|0|||
155288287|NCT03736785|560488509|FG001|Overall Study|Physician Decision|1|||
155288288|NCT03736785|560488510|FG002|Overall Study|Physician Decision|1|||
155288289|NCT03736785|560488508|FG000|Overall Study|Protocol Violation|1|||
155288290|NCT03736785|560488509|FG001|Overall Study|Protocol Violation|4|||
155288291|NCT03736785|560488510|FG002|Overall Study|Protocol Violation|3|||
155288292|NCT03736785|560488508|FG000|Overall Study|Sponsor Decision|1|||
155288293|NCT03736785|560488509|FG001|Overall Study|Sponsor Decision|0|||
155288294|NCT03736785|560488510|FG002|Overall Study|Sponsor Decision|0|||
155288295|NCT03736785|560488508|FG000|Overall Study|Unknown/Missing data|3|||
155288296|NCT03736785|560488509|FG001|Overall Study|Unknown/Missing data|2|||
155288297|NCT03736785|560488510|FG002|Overall Study|Unknown/Missing data|1|||
155288298|NCT03736785|560488508|FG000|Overall Study|Withdrawal by Subject|9|||
155288299|NCT03736785|560488509|FG001|Overall Study|Withdrawal by Subject|6|||
155156064|NCT02057250|560008174|FG004|AID Assessment Phase|Other than specified above|0|||
155156065|NCT02057250|560008170|FG000|Extension Phase|Adverse Event|0|||
155156066|NCT02057250|560008171|FG001|Extension Phase|Adverse Event|0|||
155156067|NCT02057250|560008172|FG002|Extension Phase|Adverse Event|0|||
155156068|NCT02057250|560008173|FG003|Extension Phase|Adverse Event|0|||
155156069|NCT02057250|560008174|FG004|Extension Phase|Adverse Event|15|||
155156070|NCT02057250|560008170|FG000|Extension Phase|Lack of Efficacy|0|||
155156071|NCT02057250|560008171|FG001|Extension Phase|Lack of Efficacy|0|||
155156072|NCT02057250|560008172|FG002|Extension Phase|Lack of Efficacy|0|||
155156073|NCT02057250|560008173|FG003|Extension Phase|Lack of Efficacy|0|||
155156074|NCT02057250|560008174|FG004|Extension Phase|Lack of Efficacy|10|||
155156075|NCT02057250|560008170|FG000|Extension Phase|Entered in this period but not treated|0|||
155156076|NCT02057250|560008171|FG001|Extension Phase|Entered in this period but not treated|0|||
155156077|NCT02057250|560008172|FG002|Extension Phase|Entered in this period but not treated|0|||
155156078|NCT02057250|560008173|FG003|Extension Phase|Entered in this period but not treated|0|||
155156079|NCT02057250|560008174|FG004|Extension Phase|Entered in this period but not treated|4|||
155156080|NCT02057250|560008170|FG000|Extension Phase|Other than specified above|0|||
154954885|NCT01367457|559261741|FG001|Overall Study|No clinical benefit|0|||
154954886|NCT01367457|559261742|FG002|Overall Study|No clinical benefit|0|||
154954887|NCT01367457|559261740|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
154954888|NCT01367457|559261741|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
154954889|NCT01367457|559261742|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
154954890|NCT01367457|559261740|FG000|Overall Study|Overall decline|1|||
154954891|NCT01367457|559261741|FG001|Overall Study|Overall decline|0|||
154954892|NCT01367457|559261742|FG002|Overall Study|Overall decline|0|||
154954893|NCT01367457|559261740|FG000|Overall Study|Rejection of treatment|1|||
154954894|NCT01367457|559261741|FG001|Overall Study|Rejection of treatment|0|||
155288300|NCT03736785|560488510|FG002|Overall Study|Withdrawal by Subject|4|||
155288301|NCT02974010|560488512|FG000|Overall Study|Lost to Follow-up|3|||
155288302|NCT02974010|560488513|FG001|Overall Study|Lost to Follow-up|1|||
155288303|NCT02974010|560488514|FG002|Overall Study|Lost to Follow-up|0|||
155288304|NCT02974010|560488515|FG003|Overall Study|Lost to Follow-up|0|||
155288305|NCT02974010|560488512|FG000|Overall Study|Withdrawal by Subject|2|||
155288306|NCT02974010|560488513|FG001|Overall Study|Withdrawal by Subject|1|||
155288307|NCT02974010|560488514|FG002|Overall Study|Withdrawal by Subject|0|||
155288308|NCT02974010|560488515|FG003|Overall Study|Withdrawal by Subject|0|||
155288309|NCT02974010|560488512|FG000|Overall Study|Adverse Event|0|||
155288310|NCT02974010|560488513|FG001|Overall Study|Adverse Event|1|||
155288311|NCT02974010|560488514|FG002|Overall Study|Adverse Event|0|||
155288312|NCT02974010|560488515|FG003|Overall Study|Adverse Event|0|||
155288313|NCT02974010|560488512|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
155288314|NCT02974010|560488513|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
155288315|NCT02974010|560488514|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
155288316|NCT02974010|560488515|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
155288317|NCT02974010|560488512|FG000|Overall Study|Lack of Efficacy|0|||
155288318|NCT02974010|560488513|FG001|Overall Study|Lack of Efficacy|0|||
155288319|NCT02974010|560488514|FG002|Overall Study|Lack of Efficacy|1|||
155288320|NCT02974010|560488515|FG003|Overall Study|Lack of Efficacy|0|||
155288321|NCT02595398|560488526|FG000|Overall Study|Non-compliance|1|||
155288322|NCT02595398|560488527|FG001|Overall Study|Non-compliance|0|||
155288323|NCT02595398|560488526|FG000|Overall Study|Withdrawal by Subject|2|||
155288324|NCT02595398|560488527|FG001|Overall Study|Withdrawal by Subject|1|||
155288325|NCT02595398|560488526|FG000|Overall Study|Lost to Follow-up|1|||
155288326|NCT02595398|560488527|FG001|Overall Study|Lost to Follow-up|0|||
155288327|NCT00502593|560488528|FG000|Overall Study|Withdrawn unspecified reason|1|||
155288328|NCT00502593|560488529|FG001|Overall Study|Withdrawn unspecified reason|1|||
155288329|NCT00502593|560488530|FG002|Overall Study|Withdrawn unspecified reason|3|||
155288330|NCT00502593|560488531|FG003|Overall Study|Withdrawn unspecified reason|1|||
155288331|NCT00502593|560488532|FG004|Overall Study|Withdrawn unspecified reason|2|||
155288332|NCT00502593|560488533|FG005|Overall Study|Withdrawn unspecified reason|0|||
155288333|NCT00502593|560488534|FG006|Overall Study|Withdrawn unspecified reason|2|||
155288334|NCT00502593|560488535|FG007|Overall Study|Withdrawn unspecified reason|0|||
155288335|NCT00502593|560488536|FG008|Overall Study|Withdrawn unspecified reason|0|||
155288336|NCT00502593|560488537|FG009|Overall Study|Withdrawn unspecified reason|0|||
155288337|NCT00502593|560488538|FG010|Overall Study|Withdrawn unspecified reason|0|||
155288338|NCT00502593|560488539|FG011|Overall Study|Withdrawn unspecified reason|0|||
155288339|NCT00502593|560488528|FG000|Overall Study|Withdrawal by Subject|0|||
155288340|NCT00502593|560488529|FG001|Overall Study|Withdrawal by Subject|0|||
155288341|NCT00502593|560488530|FG002|Overall Study|Withdrawal by Subject|6|||
155288342|NCT00502593|560488531|FG003|Overall Study|Withdrawal by Subject|2|||
155288343|NCT00502593|560488532|FG004|Overall Study|Withdrawal by Subject|2|||
155288344|NCT00502593|560488533|FG005|Overall Study|Withdrawal by Subject|0|||
155288345|NCT00502593|560488534|FG006|Overall Study|Withdrawal by Subject|3|||
155288346|NCT00502593|560488535|FG007|Overall Study|Withdrawal by Subject|0|||
155288347|NCT00502593|560488536|FG008|Overall Study|Withdrawal by Subject|3|||
155288348|NCT00502593|560488537|FG009|Overall Study|Withdrawal by Subject|0|||
155288349|NCT00502593|560488538|FG010|Overall Study|Withdrawal by Subject|1|||
155288350|NCT00502593|560488539|FG011|Overall Study|Withdrawal by Subject|0|||
155288351|NCT00502593|560488528|FG000|Overall Study|Lost to Follow-up|2|||
155288352|NCT00502593|560488529|FG001|Overall Study|Lost to Follow-up|1|||
155288353|NCT00502593|560488530|FG002|Overall Study|Lost to Follow-up|1|||
155288354|NCT00502593|560488531|FG003|Overall Study|Lost to Follow-up|1|||
155288355|NCT00502593|560488532|FG004|Overall Study|Lost to Follow-up|0|||
155288356|NCT00502593|560488533|FG005|Overall Study|Lost to Follow-up|0|||
155288357|NCT00502593|560488534|FG006|Overall Study|Lost to Follow-up|0|||
155288358|NCT00502593|560488535|FG007|Overall Study|Lost to Follow-up|0|||
154954895|NCT01367457|559261742|FG002|Overall Study|Rejection of treatment|0|||
155288359|NCT00502593|560488536|FG008|Overall Study|Lost to Follow-up|3|||
155288360|NCT00502593|560488537|FG009|Overall Study|Lost to Follow-up|0|||
155288361|NCT00502593|560488538|FG010|Overall Study|Lost to Follow-up|1|||
155288362|NCT00502593|560488539|FG011|Overall Study|Lost to Follow-up|0|||
155288363|NCT00880906|560488540|FG000|Overall Study|Lost to Follow-up|0|||
155288364|NCT00880906|560488541|FG001|Overall Study|Lost to Follow-up|1|||
155288365|NCT00880906|560488540|FG000|Overall Study|Did not meet criteria following patholog|12|||
155288366|NCT00880906|560488541|FG001|Overall Study|Did not meet criteria following patholog|6|||
155288367|NCT00544440|560488542|FG000|Overall Study|Other|1|||
155288368|NCT00544440|560488542|FG000|Overall Study|Adverse Event|1|||
155288369|NCT00544440|560488542|FG000|Overall Study|Withdrawal by Subject|2|||
155288370|NCT00544440|560488542|FG000|Overall Study|Subject Non-compliance|1|||
155288371|NCT00544440|560488542|FG000|Overall Study|Progressive Disease|47|||
155288372|NCT00544440|560488542|FG000|Overall Study|Other|5|||
155288373|NCT03601507|560488543|FG000|Overall Study|Adverse Event|1|||
155288374|NCT05650333|560488544|FG000|Treatment Period (7 Days)|Adverse Event|1|||
155288375|NCT01460342|560488547|FG000|Overall Study|Adverse Event|5|||
155288376|NCT01460342|560488548|FG001|Overall Study|Adverse Event|4|||
155288377|NCT01460342|560488547|FG000|Overall Study|Lost to Follow-up|1|||
155288378|NCT01460342|560488548|FG001|Overall Study|Lost to Follow-up|2|||
155288379|NCT01460342|560488547|FG000|Overall Study|Protocol Violation|0|||
155288380|NCT01460342|560488548|FG001|Overall Study|Protocol Violation|1|||
155288381|NCT01460342|560488547|FG000|Overall Study|Withdrawal by Subject|3|||
155288382|NCT01460342|560488548|FG001|Overall Study|Withdrawal by Subject|4|||
155288383|NCT01460342|560488547|FG000|Overall Study|Physician Decision|1|||
155288384|NCT01460342|560488548|FG001|Overall Study|Physician Decision|3|||
155288385|NCT01460342|560488547|FG000|Overall Study|Lack of Efficacy|1|||
155288386|NCT01460342|560488548|FG001|Overall Study|Lack of Efficacy|0|||
155288387|NCT02107014|560488550|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
155288388|NCT00591838|560488551|FG000|Overall Study|Withdrawal by Subject|0|||
155156081|NCT02057250|560008171|FG001|Extension Phase|Other than specified above|0|||
155156082|NCT02057250|560008172|FG002|Extension Phase|Other than specified above|0|||
155156083|NCT02057250|560008173|FG003|Extension Phase|Other than specified above|0|||
155156084|NCT02057250|560008174|FG004|Extension Phase|Other than specified above|7|||
155156085|NCT03367793|560008177|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155156086|NCT03367793|560008178|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155156087|NCT03367793|560008179|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
155156088|NCT03367793|560008180|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155156089|NCT03367793|560008181|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155156090|NCT03367793|560008182|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
155156091|NCT00423579|560008183|FG000|Overall Study|Lost to Follow-up|3|||
155156092|NCT00423579|560008184|FG001|Overall Study|Lost to Follow-up|0|||
155156093|NCT00423579|560008183|FG000|Overall Study|Protocol Violation|1|||
155156094|NCT00423579|560008184|FG001|Overall Study|Protocol Violation|3|||
155156095|NCT00423579|560008183|FG000|Overall Study|Diagnosis of diabetes|0|||
155156096|NCT00423579|560008184|FG001|Overall Study|Diagnosis of diabetes|1|||
155156097|NCT00260533|560008185|FG000|Overall Study|Other|3|||
155156098|NCT00260533|560008186|FG001|Overall Study|Other|3|||
155156099|NCT02383576|560008187|FG000|Overall Study|Death|53|||
155156100|NCT02383576|560008188|FG001|Overall Study|Death|33|||
155156101|NCT02383576|560008187|FG000|Overall Study|Lost to Follow-up|7|||
155156102|NCT02383576|560008188|FG001|Overall Study|Lost to Follow-up|1|||
155156103|NCT02383576|560008187|FG000|Overall Study|Withdrew Consent|1|||
155156104|NCT02383576|560008188|FG001|Overall Study|Withdrew Consent|6|||
155156105|NCT02383576|560008187|FG000|Overall Study|Investigator's Decision|0|||
155156106|NCT02383576|560008188|FG001|Overall Study|Investigator's Decision|1|||
155156107|NCT02383576|560008187|FG000|Overall Study|Administrative/Other|2|||
155156108|NCT02383576|560008188|FG001|Overall Study|Administrative/Other|4|||
155156109|NCT04218240|560008189|FG000|Overall Study|Withdrawal by Subject|6|||
155156110|NCT04218240|560008190|FG001|Overall Study|Withdrawal by Subject|0|||
155156111|NCT04218240|560008189|FG000|Overall Study|Lack of Efficacy|24|||
155156112|NCT04218240|560008190|FG001|Overall Study|Lack of Efficacy|19|||
155156113|NCT04218240|560008189|FG000|Overall Study|Physician Decision|0|||
155156114|NCT04218240|560008190|FG001|Overall Study|Physician Decision|1|||
155156115|NCT04218240|560008189|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
155156116|NCT04218240|560008190|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
155156117|NCT02738801|560008191|FG000|Overall Study|Adverse Event|1|||
155156118|NCT02738801|560008192|FG001|Overall Study|Adverse Event|1|||
155156119|NCT02738801|560008191|FG000|Overall Study|Withdrawal by Subject|0|||
155156120|NCT02738801|560008192|FG001|Overall Study|Withdrawal by Subject|1|||
155156121|NCT00231816|560008196|FG000|Overall Study|Adverse Event|1|||
155156122|NCT00231816|560008197|FG001|Overall Study|Adverse Event|0|||
155156123|NCT00231816|560008196|FG000|Overall Study|Lost to Follow-up|8|||
155156124|NCT00231816|560008197|FG001|Overall Study|Lost to Follow-up|5|||
155156125|NCT00231816|560008196|FG000|Overall Study|Protocol Violation|2|||
155156126|NCT00231816|560008197|FG001|Overall Study|Protocol Violation|3|||
155288389|NCT00591838|560488552|FG001|Overall Study|Withdrawal by Subject|0|||
155288390|NCT00591838|560488553|FG002|Overall Study|Withdrawal by Subject|0|||
155288391|NCT00591838|560488554|FG003|Overall Study|Withdrawal by Subject|1|||
155288392|NCT00591838|560488555|FG004|Overall Study|Withdrawal by Subject|0|||
155288393|NCT03586167|560488556|FG000|Overall Study|Other|1|||
155156127|NCT00231816|560008196|FG000|Overall Study|Withdrawal by Subject|3|||
155156128|NCT00231816|560008197|FG001|Overall Study|Withdrawal by Subject|3|||
155288394|NCT03586167|560488557|FG001|Overall Study|Other|0|||
155288395|NCT03761784|560488558|FG000|Overall Study|Adverse Event|4|||
154954896|NCT01367457|559261740|FG000|Overall Study|Lost to Follow-up|1|||
154954897|NCT01367457|559261741|FG001|Overall Study|Lost to Follow-up|0|||
155288396|NCT03761784|560488559|FG001|Overall Study|Adverse Event|0|||
155288397|NCT03761784|560488558|FG000|Overall Study|Lost to Follow-up|10|||
155288398|NCT03761784|560488559|FG001|Overall Study|Lost to Follow-up|7|||
155288399|NCT03761784|560488558|FG000|Overall Study|Pregnancy|1|||
155288400|NCT03761784|560488559|FG001|Overall Study|Pregnancy|0|||
155288401|NCT03761784|560488558|FG000|Overall Study|Protocol Violation|2|||
155288402|NCT03761784|560488559|FG001|Overall Study|Protocol Violation|0|||
155288403|NCT03761784|560488558|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
155288404|NCT03761784|560488559|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
155288405|NCT03761784|560488558|FG000|Overall Study|Withdrawal by Subject|9|||
155288406|NCT03761784|560488559|FG001|Overall Study|Withdrawal by Subject|4|||
155288407|NCT03761784|560488558|FG000|Overall Study|Physician Decision|1|||
155288408|NCT03761784|560488559|FG001|Overall Study|Physician Decision|0|||
155288409|NCT03761784|560488558|FG000|Overall Study|Other Than Specified|1|||
155288410|NCT03761784|560488559|FG001|Overall Study|Other Than Specified|0|||
155288411|NCT00586339|560488562|FG000|Overall Study|Withdrawal by Subject|1|||
155288412|NCT00586339|560488563|FG001|Overall Study|Withdrawal by Subject|3|||
155288413|NCT00586339|560488564|FG002|Overall Study|Withdrawal by Subject|1|||
155288414|NCT00586339|560488562|FG000|Overall Study|Migrated/moved from study area|3|||
155288415|NCT00586339|560488563|FG001|Overall Study|Migrated/moved from study area|2|||
155288416|NCT00586339|560488564|FG002|Overall Study|Migrated/moved from study area|4|||
155288417|NCT00586339|560488562|FG000|Overall Study|Lost to Follow-up|3|||
155288418|NCT00586339|560488563|FG001|Overall Study|Lost to Follow-up|2|||
155288419|NCT00586339|560488564|FG002|Overall Study|Lost to Follow-up|1|||
155288420|NCT04163458|560488567|FG000|Overall Study|Protocol Deviation|7|||
155288421|NCT04163458|560488568|FG001|Overall Study|Protocol Deviation|13|||
155288422|NCT04163458|560488567|FG000|Overall Study|Adverse Event|5|||
155288423|NCT04163458|560488568|FG001|Overall Study|Adverse Event|8|||
155288424|NCT04163458|560488567|FG000|Overall Study|Due to COVID-19 pandemic|4|||
155288425|NCT04163458|560488568|FG001|Overall Study|Due to COVID-19 pandemic|2|||
155288426|NCT04163458|560488567|FG000|Overall Study|Participant withdrew consent|2|||
155288427|NCT04163458|560488568|FG001|Overall Study|Participant withdrew consent|3|||
155156129|NCT00231816|560008196|FG000|Overall Study|Other|2|||
155288428|NCT04163458|560488567|FG000|Overall Study|Randomization failure|2|||
154954898|NCT01367457|559261742|FG002|Overall Study|Lost to Follow-up|0|||
155288429|NCT04163458|560488568|FG001|Overall Study|Randomization failure|2|||
155288430|NCT04163458|560488567|FG000|Overall Study|Other|4|||
155156130|NCT00231816|560008197|FG001|Overall Study|Other|1|||
155288431|NCT04163458|560488568|FG001|Overall Study|Other|2|||
155288432|NCT03852433|560488570|FG000|Overall Study|Withdrawal of consent|5|||
155288433|NCT03852433|560488571|FG001|Overall Study|Withdrawal of consent|8|||
155288434|NCT03852433|560488572|FG002|Overall Study|Withdrawal of consent|1|||
155288435|NCT03852433|560488573|FG003|Overall Study|Withdrawal of consent|1|||
155288436|NCT03852433|560488570|FG000|Overall Study|Adverse Event|1|||
155288437|NCT03852433|560488571|FG001|Overall Study|Adverse Event|1|||
155288438|NCT03852433|560488572|FG002|Overall Study|Adverse Event|1|||
155288439|NCT03852433|560488573|FG003|Overall Study|Adverse Event|1|||
155288440|NCT03852433|560488570|FG000|Overall Study|Lost to Follow-up|0|||
155288441|NCT03852433|560488571|FG001|Overall Study|Lost to Follow-up|1|||
155288442|NCT03852433|560488572|FG002|Overall Study|Lost to Follow-up|0|||
155288443|NCT03852433|560488573|FG003|Overall Study|Lost to Follow-up|1|||
155288444|NCT03852433|560488570|FG000|Overall Study|Pregnancy|0|||
155288445|NCT03852433|560488571|FG001|Overall Study|Pregnancy|1|||
155288446|NCT03852433|560488572|FG002|Overall Study|Pregnancy|1|||
155288447|NCT03852433|560488573|FG003|Overall Study|Pregnancy|0|||
155288448|NCT03852433|560488570|FG000|Overall Study|Protocol Violation|0|||
155288449|NCT03852433|560488571|FG001|Overall Study|Protocol Violation|0|||
155288450|NCT03852433|560488572|FG002|Overall Study|Protocol Violation|1|||
155288451|NCT03852433|560488573|FG003|Overall Study|Protocol Violation|1|||
155288452|NCT03852433|560488570|FG000|Overall Study|Death|0|||
154954899|NCT01367457|559261740|FG000|Overall Study|Death from septic shock|1|||
155288453|NCT03852433|560488571|FG001|Overall Study|Death|0|||
155288454|NCT03852433|560488572|FG002|Overall Study|Death|1|||
155288455|NCT03852433|560488573|FG003|Overall Study|Death|0|||
155288456|NCT03852433|560488570|FG000|Overall Study|Lack of Efficacy|0|||
155288457|NCT03852433|560488571|FG001|Overall Study|Lack of Efficacy|1|||
155288458|NCT03852433|560488572|FG002|Overall Study|Lack of Efficacy|0|||
155288459|NCT03852433|560488573|FG003|Overall Study|Lack of Efficacy|0|||
155288460|NCT03852433|560488570|FG000|Overall Study|Non-compliance with study drug|0|||
155288461|NCT03852433|560488571|FG001|Overall Study|Non-compliance with study drug|0|||
155288462|NCT03852433|560488572|FG002|Overall Study|Non-compliance with study drug|0|||
155288463|NCT03852433|560488573|FG003|Overall Study|Non-compliance with study drug|1|||
155288464|NCT03852433|560488570|FG000|Overall Study|Physician Decision|1|||
155288465|NCT03852433|560488571|FG001|Overall Study|Physician Decision|0|||
155288466|NCT03852433|560488572|FG002|Overall Study|Physician Decision|0|||
155288467|NCT03852433|560488573|FG003|Overall Study|Physician Decision|0|||
155288468|NCT03852433|560488570|FG000|Overall Study|Randomized but never treated|1|||
155288469|NCT03852433|560488571|FG001|Overall Study|Randomized but never treated|0|||
155288470|NCT03852433|560488572|FG002|Overall Study|Randomized but never treated|0|||
155288471|NCT03852433|560488573|FG003|Overall Study|Randomized but never treated|0|||
155288472|NCT01981850|560488574|FG000|Main Phase Stage 1|Death|2|||
155288473|NCT01981850|560488575|FG001|Main Phase Stage 1|Death|0|||
155288474|NCT01981850|560488576|FG002|Main Phase Stage 1|Death|0|||
155288475|NCT01981850|560488577|FG003|Main Phase Stage 1|Death|0|||
155288476|NCT01981850|560488578|FG004|Main Phase Stage 1|Death|0|||
155288477|NCT01981850|560488579|FG005|Main Phase Stage 1|Death|0|||
155288478|NCT01981850|560488580|FG006|Main Phase Stage 1|Death|0|||
155288479|NCT01981850|560488581|FG007|Main Phase Stage 1|Death|0|||
155288480|NCT01981850|560488582|FG008|Main Phase Stage 1|Death|0|||
155288481|NCT01981850|560488583|FG009|Main Phase Stage 1|Death|0|||
155288482|NCT01981850|560488574|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
155288483|NCT01981850|560488575|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288484|NCT01981850|560488576|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288485|NCT01981850|560488577|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288486|NCT01981850|560488578|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288487|NCT01981850|560488579|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288488|NCT01981850|560488580|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288489|NCT01981850|560488581|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288490|NCT01981850|560488582|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288491|NCT01981850|560488583|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
155288492|NCT01981850|560488574|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
155288493|NCT01981850|560488575|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
155288494|NCT01981850|560488576|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
155288495|NCT01981850|560488577|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
155288496|NCT01981850|560488578|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
155288497|NCT01981850|560488579|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
155288498|NCT01981850|560488580|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
155288499|NCT01981850|560488581|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
155288500|NCT01981850|560488582|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
155288501|NCT01981850|560488583|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
155288502|NCT01981850|560488574|FG000|Main Phase Stage 1|Various reasons|0|||
155288503|NCT01981850|560488575|FG001|Main Phase Stage 1|Various reasons|0|||
155288504|NCT01981850|560488576|FG002|Main Phase Stage 1|Various reasons|2|||
155288505|NCT01981850|560488577|FG003|Main Phase Stage 1|Various reasons|0|||
155288506|NCT01981850|560488578|FG004|Main Phase Stage 1|Various reasons|0|||
155288507|NCT01981850|560488579|FG005|Main Phase Stage 1|Various reasons|0|||
155288508|NCT01981850|560488580|FG006|Main Phase Stage 1|Various reasons|0|||
155288509|NCT01981850|560488581|FG007|Main Phase Stage 1|Various reasons|0|||
155288510|NCT01981850|560488582|FG008|Main Phase Stage 1|Various reasons|0|||
155288511|NCT01981850|560488583|FG009|Main Phase Stage 1|Various reasons|0|||
155288512|NCT01981850|560488574|FG000|Main Phase Stage 2|Adverse Event|0|||
155288513|NCT01981850|560488575|FG001|Main Phase Stage 2|Adverse Event|0|||
155288514|NCT01981850|560488576|FG002|Main Phase Stage 2|Adverse Event|0|||
155288515|NCT01981850|560488577|FG003|Main Phase Stage 2|Adverse Event|0|||
155288516|NCT01981850|560488578|FG004|Main Phase Stage 2|Adverse Event|6|||
155288517|NCT01981850|560488579|FG005|Main Phase Stage 2|Adverse Event|5|||
155288518|NCT01981850|560488580|FG006|Main Phase Stage 2|Adverse Event|7|||
155288519|NCT01981850|560488581|FG007|Main Phase Stage 2|Adverse Event|0|||
155288520|NCT01981850|560488582|FG008|Main Phase Stage 2|Adverse Event|0|||
155288521|NCT01981850|560488583|FG009|Main Phase Stage 2|Adverse Event|0|||
155288522|NCT01981850|560488574|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288523|NCT01981850|560488575|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288524|NCT01981850|560488576|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288525|NCT01981850|560488577|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288526|NCT01981850|560488578|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
155288527|NCT01981850|560488579|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
155288528|NCT01981850|560488580|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
155288529|NCT01981850|560488581|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288530|NCT01981850|560488582|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288531|NCT01981850|560488583|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
155288532|NCT01981850|560488574|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
155288533|NCT01981850|560488575|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
155288534|NCT01981850|560488576|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
155288535|NCT01981850|560488577|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
155288536|NCT01981850|560488578|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
155288537|NCT01981850|560488579|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
155288538|NCT01981850|560488580|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
155288539|NCT01981850|560488581|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
155288540|NCT01981850|560488582|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
155288541|NCT01981850|560488583|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
155288542|NCT01981850|560488574|FG000|Main Phase Stage 2|Various reasons|0|||
155288543|NCT01981850|560488575|FG001|Main Phase Stage 2|Various reasons|0|||
155288544|NCT01981850|560488576|FG002|Main Phase Stage 2|Various reasons|0|||
155288545|NCT01981850|560488577|FG003|Main Phase Stage 2|Various reasons|0|||
155288546|NCT01981850|560488578|FG004|Main Phase Stage 2|Various reasons|2|||
155288547|NCT01981850|560488579|FG005|Main Phase Stage 2|Various reasons|0|||
155288548|NCT01981850|560488580|FG006|Main Phase Stage 2|Various reasons|1|||
155288549|NCT01981850|560488581|FG007|Main Phase Stage 2|Various reasons|0|||
155288550|NCT01981850|560488582|FG008|Main Phase Stage 2|Various reasons|0|||
155288551|NCT01981850|560488583|FG009|Main Phase Stage 2|Various reasons|0|||
155288552|NCT01981850|560488574|FG000|Main Phase Stage 2|Progressive Disease|0|||
155288553|NCT01981850|560488575|FG001|Main Phase Stage 2|Progressive Disease|0|||
155288554|NCT01981850|560488576|FG002|Main Phase Stage 2|Progressive Disease|0|||
155288555|NCT01981850|560488577|FG003|Main Phase Stage 2|Progressive Disease|0|||
155288556|NCT01981850|560488578|FG004|Main Phase Stage 2|Progressive Disease|0|||
155059492|NCT04158219|559651935|FG000|Overall Study|Lost to Follow-up|1|||
155288557|NCT01981850|560488579|FG005|Main Phase Stage 2|Progressive Disease|6|||
155288558|NCT01981850|560488580|FG006|Main Phase Stage 2|Progressive Disease|6|||
155288559|NCT01981850|560488581|FG007|Main Phase Stage 2|Progressive Disease|0|||
155288560|NCT01981850|560488582|FG008|Main Phase Stage 2|Progressive Disease|0|||
155288561|NCT01981850|560488583|FG009|Main Phase Stage 2|Progressive Disease|0|||
155288562|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Adverse Event|0|||
155288563|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Adverse Event|0|||
155288564|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Adverse Event|0|||
155288565|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Adverse Event|0|||
155288566|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Adverse Event|0|||
155288567|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Adverse Event|0|||
155288568|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Adverse Event|0|||
155288569|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Adverse Event|2|||
155288570|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Adverse Event|1|||
155288571|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Adverse Event|8|||
155288572|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288573|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288574|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288575|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288576|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288577|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288578|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
155288579|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
155288580|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
155288581|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
155288582|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Various reasons|0|||
155288583|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Various reasons|0|||
155288584|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Various reasons|0|||
155288585|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Various reasons|0|||
155288586|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Various reasons|0|||
155288587|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Various reasons|0|||
155288588|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Various reasons|0|||
155288589|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Various reasons|3|||
155288590|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Various reasons|1|||
155288591|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Various reasons|3|||
155288592|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
155288593|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
155288594|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
155288595|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
155288596|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
155288597|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
155288598|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
155288599|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
155288600|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
155288601|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
155288602|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288603|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288604|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288605|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288606|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288607|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288608|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288609|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288610|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
155288611|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
155288612|NCT01981850|560488574|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288613|NCT01981850|560488575|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288614|NCT01981850|560488576|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288615|NCT01981850|560488577|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288616|NCT01981850|560488578|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288617|NCT01981850|560488579|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288618|NCT01981850|560488580|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288619|NCT01981850|560488581|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
155288620|NCT01981850|560488582|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
154954900|NCT01367457|559261741|FG001|Overall Study|Death from septic shock|0|||
154954901|NCT01367457|559261742|FG002|Overall Study|Death from septic shock|0|||
154954902|NCT01367457|559261740|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
154954903|NCT01367457|559261741|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
155288621|NCT01981850|560488583|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
155288622|NCT01467700|560488584|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
155288623|NCT01467700|560488585|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
155288624|NCT01467700|560488586|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
155288625|NCT01467700|560488587|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
155288626|NCT01467700|560488584|FG000|Overall Study|Major Protocol Deviation|3|||
155288627|NCT01467700|560488585|FG001|Overall Study|Major Protocol Deviation|3|||
155288628|NCT01467700|560488586|FG002|Overall Study|Major Protocol Deviation|2|||
155288629|NCT01467700|560488587|FG003|Overall Study|Major Protocol Deviation|3|||
155288630|NCT01467700|560488584|FG000|Overall Study|Lost to Follow-up|6|||
155288631|NCT01467700|560488585|FG001|Overall Study|Lost to Follow-up|5|||
155288632|NCT01467700|560488586|FG002|Overall Study|Lost to Follow-up|2|||
155288633|NCT01467700|560488587|FG003|Overall Study|Lost to Follow-up|3|||
155288634|NCT01467700|560488584|FG000|Overall Study|Voluntary Withdrawal|5|||
155288635|NCT01467700|560488585|FG001|Overall Study|Voluntary Withdrawal|7|||
155288636|NCT01467700|560488586|FG002|Overall Study|Voluntary Withdrawal|6|||
155288637|NCT01467700|560488587|FG003|Overall Study|Voluntary Withdrawal|2|||
155288638|NCT01467700|560488584|FG000|Overall Study|Study Termination|6|||
155288639|NCT01467700|560488585|FG001|Overall Study|Study Termination|5|||
155288640|NCT01467700|560488586|FG002|Overall Study|Study Termination|10|||
155288641|NCT01467700|560488587|FG003|Overall Study|Study Termination|7|||
155288642|NCT01467700|560488584|FG000|Overall Study|Pregnancy|0|||
155288643|NCT01467700|560488585|FG001|Overall Study|Pregnancy|1|||
155288644|NCT01467700|560488586|FG002|Overall Study|Pregnancy|1|||
155288645|NCT01467700|560488587|FG003|Overall Study|Pregnancy|0|||
155288646|NCT01467700|560488584|FG000|Overall Study|Lack of Efficacy|2|||
155288647|NCT01467700|560488585|FG001|Overall Study|Lack of Efficacy|0|||
155288648|NCT01467700|560488586|FG002|Overall Study|Lack of Efficacy|2|||
155288649|NCT01467700|560488587|FG003|Overall Study|Lack of Efficacy|1|||
155288650|NCT01467700|560488584|FG000|Overall Study|Reason not Specified|1|||
155288651|NCT01467700|560488585|FG001|Overall Study|Reason not Specified|3|||
155288652|NCT01467700|560488586|FG002|Overall Study|Reason not Specified|2|||
155288653|NCT01467700|560488587|FG003|Overall Study|Reason not Specified|8|||
155288654|NCT03168438|560488588|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
155288655|NCT03168438|560488589|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
155288656|NCT04109118|560488592|FG000|Overall Study|Lost to Follow-up|3|||
155288657|NCT03235349|560488593|FG000|Overall Study|Adverse Event|1|||
155288658|NCT03235349|560488593|FG000|Overall Study|Other|1|||
155288659|NCT03394027|560488594|FG000|Overall Study|Ineligible|3|||
155288660|NCT03394027|560488595|FG001|Overall Study|Ineligible|1|||
155288661|NCT03394027|560488596|FG002|Overall Study|Ineligible|3|||
155288662|NCT03394027|560488594|FG000|Overall Study|Participant declined to participate before treatment started|0|||
155288663|NCT03394027|560488595|FG001|Overall Study|Participant declined to participate before treatment started|0|||
155288664|NCT03394027|560488596|FG002|Overall Study|Participant declined to participate before treatment started|1|||
155288665|NCT04305912|560488600|FG000|First Intervention|COVID-19 Suspension|2|||
155288666|NCT04305912|560488601|FG001|First Intervention|COVID-19 Suspension|0|||
155288667|NCT04305912|560488600|FG000|First Intervention|Withdrawal by Subject|0|||
155288668|NCT04305912|560488601|FG001|First Intervention|Withdrawal by Subject|1|||
155288669|NCT04305912|560488600|FG000|Second Intervention|Adverse Event|0|||
155288670|NCT04305912|560488601|FG001|Second Intervention|Adverse Event|1|||
155288671|NCT01348087|560488603|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
155288672|NCT01348087|560488603|FG000|Overall Study|Administrative problems|79|||
155288673|NCT01348087|560488603|FG000|Overall Study|protocol deviation|1|||
155288674|NCT01348087|560488603|FG000|Overall Study|Lost to Follow-up|1|||
155288675|NCT01348087|560488603|FG000|Overall Study|Subject withdrew consent|7|||
155288676|NCT01348087|560488603|FG000|Overall Study|Adverse Event|25|||
155288677|NCT03140176|560490285|FG000|Overall Study|Reason missing|23|||
155288678|NCT03140176|560490285|FG000|Overall Study|Death|33|||
155288679|NCT03140176|560490285|FG000|Overall Study|Disease progression|1|||
154954904|NCT01367457|559261742|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
154954905|NCT01367457|559261740|FG000|Overall Study|Patient's Wish|1|||
155288680|NCT03140176|560490285|FG000|Overall Study|Physician Decision|1|||
155288681|NCT03140176|560490285|FG000|Overall Study|Withdrawal by Subject|1|||
155288682|NCT03140176|560490285|FG000|Overall Study|Lost to Follow-up|15|||
155288683|NCT03179787|560490291|FG000|Overall Study|Lost to Follow-up|15|||
155288684|NCT03179787|560490291|FG000|Overall Study|Case report failures|2|||
154954906|NCT01367457|559261741|FG001|Overall Study|Patient's Wish|0|||
154954907|NCT01367457|559261742|FG002|Overall Study|Patient's Wish|0|||
155288685|NCT03179787|560490291|FG000|Overall Study|Treatment not administered|1|||
155288686|NCT02030028|560490292|FG000|Overall Study|Withdrawal by Subject|4|||
155288687|NCT02030028|560490292|FG000|Overall Study|lack of transportation|1|||
155288688|NCT00149630|560490293|FG000|Overall Study|Incarceration|2|||
155288689|NCT00149630|560490294|FG001|Overall Study|Incarceration|0|||
155288690|NCT00149630|560490293|FG000|Overall Study|Treatment Programs|4|||
155288691|NCT00149630|560490294|FG001|Overall Study|Treatment Programs|5|||
155288692|NCT00149630|560490293|FG000|Overall Study|Adverse Event|2|||
155288693|NCT00149630|560490294|FG001|Overall Study|Adverse Event|0|||
155288694|NCT03357341|560490303|FG000|Overall Study|Withdrawal by Subject|3|||
155288695|NCT03357341|560490304|FG001|Overall Study|Withdrawal by Subject|6|||
155288696|NCT03357341|560490303|FG000|Overall Study|Lost to Follow-up|4|||
155288697|NCT03357341|560490304|FG001|Overall Study|Lost to Follow-up|5|||
155288698|NCT03357341|560490303|FG000|Overall Study|Death|0|||
155288699|NCT03357341|560490304|FG001|Overall Study|Death|1|||
155288700|NCT01956669|560490307|FG000|Overall Study|Disease Progression|12|||
155288701|NCT01956669|560490308|FG001|Overall Study|Disease Progression|7|||
155288702|NCT01956669|560490309|FG002|Overall Study|Disease Progression|7|||
155288703|NCT01956669|560490310|FG003|Overall Study|Disease Progression|8|||
155288704|NCT01956669|560490311|FG004|Overall Study|Disease Progression|4|||
155288705|NCT01956669|560490312|FG005|Overall Study|Disease Progression|3|||
155288706|NCT01956669|560490313|FG006|Overall Study|Disease Progression|5|||
155288707|NCT01956669|560490307|FG000|Overall Study|Adverse Event|0|||
155288708|NCT01956669|560490308|FG001|Overall Study|Adverse Event|2|||
155288709|NCT01956669|560490309|FG002|Overall Study|Adverse Event|2|||
155288710|NCT01956669|560490310|FG003|Overall Study|Adverse Event|1|||
155288711|NCT01956669|560490311|FG004|Overall Study|Adverse Event|0|||
155288712|NCT01956669|560490312|FG005|Overall Study|Adverse Event|0|||
155288713|NCT01956669|560490313|FG006|Overall Study|Adverse Event|0|||
155288714|NCT01956669|560490307|FG000|Overall Study|Physician Decision|0|||
155288715|NCT01956669|560490308|FG001|Overall Study|Physician Decision|2|||
155288716|NCT01956669|560490309|FG002|Overall Study|Physician Decision|0|||
155288717|NCT01956669|560490310|FG003|Overall Study|Physician Decision|0|||
155288718|NCT01956669|560490311|FG004|Overall Study|Physician Decision|0|||
155288719|NCT01956669|560490312|FG005|Overall Study|Physician Decision|1|||
155288720|NCT01956669|560490313|FG006|Overall Study|Physician Decision|0|||
155288721|NCT01956669|560490307|FG000|Overall Study|Withdrawal by Subject|0|||
155288722|NCT01956669|560490308|FG001|Overall Study|Withdrawal by Subject|0|||
155288723|NCT01956669|560490309|FG002|Overall Study|Withdrawal by Subject|1|||
155288724|NCT01956669|560490310|FG003|Overall Study|Withdrawal by Subject|1|||
155288725|NCT01956669|560490311|FG004|Overall Study|Withdrawal by Subject|0|||
155288726|NCT01956669|560490312|FG005|Overall Study|Withdrawal by Subject|0|||
155288727|NCT01956669|560490313|FG006|Overall Study|Withdrawal by Subject|1|||
155288728|NCT01570751|560490314|FG000|Period A (16 Weeks)|Protocol Violation|1|||
155288729|NCT01570751|560490315|FG001|Period A (16 Weeks)|Protocol Violation|1|||
155288730|NCT01570751|560490314|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
155288731|NCT01570751|560490315|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
155288732|NCT01570751|560490314|FG000|Period A (16 Weeks)|Unclassified|2|||
155288733|NCT01570751|560490315|FG001|Period A (16 Weeks)|Unclassified|3|||
155288734|NCT01570751|560490314|FG000|Period B (16 Weeks)|Adverse Event|1|||
155288735|NCT01570751|560490315|FG001|Period B (16 Weeks)|Adverse Event|0|||
155288736|NCT01570751|560490314|FG000|Period B (16 Weeks)|Protocol Violation|0|||
155288737|NCT01570751|560490315|FG001|Period B (16 Weeks)|Protocol Violation|1|||
155288738|NCT00930813|560490316|FG000|Overall Study|Death|4|||
155288739|NCT00930813|560490317|FG001|Overall Study|Death|5|||
155288740|NCT00930813|560490316|FG000|Overall Study|Withdrawal by Subject|2|||
155288741|NCT00930813|560490317|FG001|Overall Study|Withdrawal by Subject|5|||
155288742|NCT00930813|560490316|FG000|Overall Study|Lost to Follow-up|2|||
155288743|NCT00930813|560490317|FG001|Overall Study|Lost to Follow-up|4|||
155288744|NCT05790408|560490322|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
155288745|NCT01693614|560490323|FG000|Overall Study|Adverse Event|7|||
155288746|NCT01693614|560490324|FG001|Overall Study|Adverse Event|11|||
155288747|NCT01693614|560490325|FG002|Overall Study|Adverse Event|5|||
155288748|NCT01693614|560490323|FG000|Overall Study|Disease progression|11|||
155288749|NCT01693614|560490324|FG001|Overall Study|Disease progression|8|||
155288750|NCT01693614|560490325|FG002|Overall Study|Disease progression|7|||
155288751|NCT01693614|560490323|FG000|Overall Study|Protocol Violation|5|||
155288752|NCT01693614|560490324|FG001|Overall Study|Protocol Violation|2|||
155288753|NCT01693614|560490325|FG002|Overall Study|Protocol Violation|1|||
155288754|NCT01693614|560490323|FG000|Overall Study|Death|1|||
155288755|NCT01693614|560490324|FG001|Overall Study|Death|0|||
155288756|NCT01693614|560490325|FG002|Overall Study|Death|0|||
155288757|NCT01693614|560490323|FG000|Overall Study|Physician Decision|1|||
155288758|NCT01693614|560490324|FG001|Overall Study|Physician Decision|1|||
155288759|NCT01693614|560490325|FG002|Overall Study|Physician Decision|4|||
155288760|NCT01693614|560490323|FG000|Overall Study|Withdrawal by subject/guardian|0|||
155288761|NCT01693614|560490324|FG001|Overall Study|Withdrawal by subject/guardian|0|||
155288762|NCT01693614|560490325|FG002|Overall Study|Withdrawal by subject/guardian|2|||
155288763|NCT01693614|560490323|FG000|Overall Study|Withdrawal by Subject|1|||
155288764|NCT01693614|560490324|FG001|Overall Study|Withdrawal by Subject|0|||
155288765|NCT01693614|560490325|FG002|Overall Study|Withdrawal by Subject|5|||
155288766|NCT01131494|560490326|FG000|Overall Study|Withdrawal by Subject|2|||
155288767|NCT05419557|560490327|FG000|Overall Study|Lost to Follow-up|11|||
155288768|NCT05419557|560490328|FG001|Overall Study|Lost to Follow-up|4|||
155288769|NCT00588666|560490330|FG000|Overall Study|Adverse Event|4|||
155288770|NCT02281318|560490331|FG000|Overall Study|Adverse Event|2|||
155288771|NCT02281318|560490332|FG001|Overall Study|Adverse Event|2|||
155288772|NCT02281318|560490331|FG000|Overall Study|Lack of Efficacy|2|||
155288773|NCT02281318|560490332|FG001|Overall Study|Lack of Efficacy|0|||
155288774|NCT02281318|560490331|FG000|Overall Study|Lost to Follow-up|2|||
155288775|NCT02281318|560490332|FG001|Overall Study|Lost to Follow-up|1|||
155288776|NCT02281318|560490331|FG000|Overall Study|Physician Decision|2|||
155288777|NCT02281318|560490332|FG001|Overall Study|Physician Decision|0|||
155059493|NCT01814007|559651936|FG000|Overall Study|Withdrawal by Subject|1|||
155059494|NCT01324947|559651938|FG000|Overall Study|Adverse Event|7|||
155059495|NCT01324947|559651938|FG000|Overall Study|Death|10|||
155059496|NCT01324947|559651938|FG000|Overall Study|Other|3|||
155059497|NCT01324947|559651938|FG000|Overall Study|Progressive Disease|50|||
155059498|NCT01324947|559651938|FG000|Overall Study|Withdrawal by Subject|3|||
155059499|NCT01324947|559651938|FG000|Overall Study|1 discontinued before starting drug|1|||
155059500|NCT01296412|559651939|FG000|Overall Study|Adverse Event|8|||
155059501|NCT01296412|559651940|FG001|Overall Study|Adverse Event|29|||
155059502|NCT01296412|559651939|FG000|Overall Study|Lack of Efficacy|1|||
155059503|NCT01296412|559651940|FG001|Overall Study|Lack of Efficacy|0|||
155059504|NCT01296412|559651939|FG000|Overall Study|Lost to Follow-up|10|||
155059505|NCT01296412|559651940|FG001|Overall Study|Lost to Follow-up|7|||
155059506|NCT01296412|559651939|FG000|Overall Study|Non-compliance with study drug|1|||
155059507|NCT01296412|559651940|FG001|Overall Study|Non-compliance with study drug|2|||
155059508|NCT01296412|559651939|FG000|Overall Study|Other reason not specified|20|||
155059509|NCT01296412|559651940|FG001|Overall Study|Other reason not specified|15|||
155059510|NCT01296412|559651939|FG000|Overall Study|Physician Decision|1|||
155059511|NCT01296412|559651940|FG001|Overall Study|Physician Decision|3|||
155059512|NCT01296412|559651939|FG000|Overall Study|Pregnancy|0|||
155059513|NCT01296412|559651940|FG001|Overall Study|Pregnancy|1|||
155059514|NCT01296412|559651939|FG000|Overall Study|Withdrawal by Subject|10|||
155059515|NCT01296412|559651940|FG001|Overall Study|Withdrawal by Subject|13|||
155059516|NCT02160626|559651941|FG000|Overall Study|Adverse Event|1|||
155059517|NCT02160626|559651942|FG001|Overall Study|Adverse Event|0|||
155059518|NCT02160626|559651943|FG002|Overall Study|Adverse Event|0|||
155059519|NCT02160626|559651941|FG000|Overall Study|Schedule not conducive to study visits|0|||
155059520|NCT02160626|559651942|FG001|Overall Study|Schedule not conducive to study visits|0|||
155059521|NCT02160626|559651943|FG002|Overall Study|Schedule not conducive to study visits|1|||
155059522|NCT02160626|559651941|FG000|Overall Study|Withdrawal by Subject|0|||
155059523|NCT02160626|559651942|FG001|Overall Study|Withdrawal by Subject|1|||
155059524|NCT02160626|559651943|FG002|Overall Study|Withdrawal by Subject|0|||
155059525|NCT01113749|559653762|FG000|Overall Study|Lost to Follow-up|1|||
155059526|NCT01113749|559653763|FG001|Overall Study|Lost to Follow-up|2|||
155059527|NCT02034006|559653764|FG000|Overall Study|Withdrawal by Subject|7|||
155059528|NCT02034006|559653764|FG000|Overall Study|Lost to Follow-up|5|||
155059529|NCT02034006|559653764|FG000|Overall Study|Death|1|||
155059530|NCT02034006|559653764|FG000|Overall Study|Pregnancy|1|||
155059531|NCT02934178|559653765|FG000|Received Vaccination 2|Death|0|||
155059532|NCT02934178|559653766|FG001|Received Vaccination 2|Death|1|||
155059533|NCT02934178|559653765|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
155059534|NCT02934178|559653766|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
155059535|NCT01075048|559653769|FG000|Overall Study|Death|4|||
155059536|NCT01075048|559653770|FG001|Overall Study|Death|17|||
155059537|NCT01075048|559653771|FG002|Overall Study|Death|12|||
155059538|NCT01075048|559653769|FG000|Overall Study|Start of other or new therapy|4|||
155059539|NCT01075048|559653770|FG001|Overall Study|Start of other or new therapy|36|||
155059540|NCT01075048|559653771|FG002|Overall Study|Start of other or new therapy|46|||
155059541|NCT01075048|559653769|FG000|Overall Study|Withdrawal by Subject|1|||
155059542|NCT01075048|559653770|FG001|Overall Study|Withdrawal by Subject|6|||
155059543|NCT01075048|559653771|FG002|Overall Study|Withdrawal by Subject|3|||
155059544|NCT01075048|559653769|FG000|Overall Study|Lost to Follow-up|0|||
155059545|NCT01075048|559653770|FG001|Overall Study|Lost to Follow-up|1|||
155059546|NCT01075048|559653771|FG002|Overall Study|Lost to Follow-up|1|||
155059547|NCT03944616|559653772|FG000|Overall Study|Lost to Follow-up|0|||
155059548|NCT03944616|559653773|FG001|Overall Study|Lost to Follow-up|2|||
155059549|NCT01287936|559653778|FG000|Overall Study|Lost to Follow-up|0|||
155059550|NCT01287936|559653779|FG001|Overall Study|Lost to Follow-up|1|||
155059551|NCT01287936|559653780|FG002|Overall Study|Lost to Follow-up|1|||
155059552|NCT00296244|559653781|FG000|Overall Study|Underwent retransplant|0|||
155059553|NCT00296244|559653782|FG001|Overall Study|Underwent retransplant|1|||
155059554|NCT00761319|559653783|FG000|Overall Study|Protocol Violation|21|||
155059555|NCT00761319|559653784|FG001|Overall Study|Protocol Violation|14|||
155059556|NCT00761319|559653783|FG000|Overall Study|Adverse Event|11|||
155059557|NCT00761319|559653784|FG001|Overall Study|Adverse Event|7|||
155059558|NCT00761319|559653783|FG000|Overall Study|Withdrawal by Subject|8|||
155059559|NCT00761319|559653784|FG001|Overall Study|Withdrawal by Subject|7|||
155059560|NCT00761319|559653783|FG000|Overall Study|Noncompliance|4|||
155059561|NCT00761319|559653784|FG001|Overall Study|Noncompliance|3|||
155059562|NCT00761319|559653783|FG000|Overall Study|Lost to Follow-up|1|||
155059563|NCT00761319|559653784|FG001|Overall Study|Lost to Follow-up|1|||
155059564|NCT00761319|559653783|FG000|Overall Study|Nonspecified|2|||
155059565|NCT00761319|559653784|FG001|Overall Study|Nonspecified|2|||
155059566|NCT00761319|559653783|FG000|Overall Study|Missing|1|||
155059567|NCT00761319|559653784|FG001|Overall Study|Missing|0|||
155059568|NCT00607893|559653785|FG000|Overall Study|Lost to Follow-up|4|||
155059569|NCT00607893|559653786|FG001|Overall Study|Lost to Follow-up|0|||
155288778|NCT02281318|560490331|FG000|Overall Study|Withdrawal by Subject|6|||
155288779|NCT02281318|560490332|FG001|Overall Study|Withdrawal by Subject|2|||
155288780|NCT05257798|560490333|FG000|Follow-up Phase|Lost to Follow-up|1|||
155288781|NCT05257798|560490334|FG001|Follow-up Phase|Lost to Follow-up|0|||
155288782|NCT00703911|560490337|FG000|Overall Study|Death|1|||
155288783|NCT00703911|560490337|FG000|Overall Study|Physician Decision|6|||
155288784|NCT00703911|560490337|FG000|Overall Study|Lost to Follow-up|1|||
155288785|NCT00703911|560490337|FG000|Overall Study|Withdrawal by Subject|2|||
155288786|NCT01064817|560490338|FG000|Study Completion|Physician Decision|1|||
155288787|NCT01064817|560490339|FG001|Study Completion|Physician Decision|0|||
155288788|NCT01064817|560490338|FG000|Study Completion|Withdrawal by Subject|1|||
155288789|NCT01064817|560490339|FG001|Study Completion|Withdrawal by Subject|0|||
155288790|NCT03102710|560490340|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
155288791|NCT03102710|560490341|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
155288792|NCT03102710|560490342|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
155288793|NCT03102710|560490340|FG000|Overall Study|Technical issues during final MRI scan|0|||
155288794|NCT03102710|560490341|FG001|Overall Study|Technical issues during final MRI scan|1|||
155288795|NCT03102710|560490342|FG002|Overall Study|Technical issues during final MRI scan|0|||
155288796|NCT03102710|560490340|FG000|Overall Study|Nausea during MRI scan|0|||
155288797|NCT03102710|560490341|FG001|Overall Study|Nausea during MRI scan|1|||
155288798|NCT03102710|560490342|FG002|Overall Study|Nausea during MRI scan|0|||
155288799|NCT03102710|560490340|FG000|Overall Study|Subject unable to attend final session|0|||
155288800|NCT03102710|560490341|FG001|Overall Study|Subject unable to attend final session|1|||
155288801|NCT03102710|560490342|FG002|Overall Study|Subject unable to attend final session|0|||
155288802|NCT01368406|560490343|FG000|Overall Study|Lost to Follow-up|8|||
155288803|NCT01368406|560490344|FG001|Overall Study|Lost to Follow-up|4|||
155288804|NCT01368406|560490343|FG000|Overall Study|Withdrawal by Subject|8|||
155288805|NCT01368406|560490344|FG001|Overall Study|Withdrawal by Subject|4|||
155288806|NCT01368406|560490343|FG000|Overall Study|relapse of the disease|3|||
155288807|NCT01368406|560490344|FG001|Overall Study|relapse of the disease|2|||
155288808|NCT01368406|560490343|FG000|Overall Study|started working|2|||
155288809|NCT01368406|560490344|FG001|Overall Study|started working|3|||
155288810|NCT02299635|560490350|FG000|Overall Study|Adverse Event|2|||
155288811|NCT02299635|560490350|FG000|Overall Study|Death|1|||
155288812|NCT02299635|560490350|FG000|Overall Study|Global deterioration of health status|1|||
155288813|NCT02299635|560490350|FG000|Overall Study|Objective progression or relapse|10|||
155288814|NCT02299635|560490350|FG000|Overall Study|Withdrawal by Subject|2|||
155288815|NCT02299635|560490350|FG000|Overall Study|Other|3|||
155288816|NCT00543725|560490351|FG000|Overall Study|Adverse Event|18|||
155288817|NCT00543725|560490352|FG001|Overall Study|Adverse Event|27|||
155288818|NCT00543725|560490351|FG000|Overall Study|Sponsor's Decision|0|||
155288819|NCT00543725|560490352|FG001|Overall Study|Sponsor's Decision|1|||
155288820|NCT00543725|560490351|FG000|Overall Study|Subject Non-Compliant|4|||
155288821|NCT00543725|560490352|FG001|Overall Study|Subject Non-Compliant|4|||
155288822|NCT00543725|560490351|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
155288823|NCT00543725|560490352|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
155288824|NCT00543725|560490351|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
155288825|NCT00543725|560490352|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
155288826|NCT00543725|560490351|FG000|Overall Study|Protocol Violation|0|||
155288827|NCT00543725|560490352|FG001|Overall Study|Protocol Violation|1|||
155288828|NCT00543725|560490351|FG000|Overall Study|Withdrawal by Subject|4|||
155288829|NCT00543725|560490352|FG001|Overall Study|Withdrawal by Subject|13|||
155288830|NCT00543725|560490351|FG000|Overall Study|Lost to Follow-up|15|||
155288831|NCT00543725|560490352|FG001|Overall Study|Lost to Follow-up|11|||
155288832|NCT00543725|560490351|FG000|Overall Study|Other|3|||
155288833|NCT00543725|560490352|FG001|Overall Study|Other|3|||
155288834|NCT00906698|560490353|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288835|NCT00906698|560490354|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
155288836|NCT00906698|560490355|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288837|NCT00906698|560490356|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288838|NCT00906698|560490357|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
155288839|NCT00906698|560490358|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
155288840|NCT00906698|560490353|FG000|Overall Study|Adverse Event|0|||
155288841|NCT00906698|560490354|FG001|Overall Study|Adverse Event|0|||
155288842|NCT00906698|560490355|FG002|Overall Study|Adverse Event|2|||
155288843|NCT00906698|560490356|FG003|Overall Study|Adverse Event|0|||
155288844|NCT00906698|560490357|FG004|Overall Study|Adverse Event|4|||
155288845|NCT00906698|560490358|FG005|Overall Study|Adverse Event|1|||
155288846|NCT00906698|560490353|FG000|Overall Study|Disease progression|3|||
155288847|NCT00906698|560490354|FG001|Overall Study|Disease progression|12|||
155288848|NCT00906698|560490355|FG002|Overall Study|Disease progression|4|||
155288849|NCT00906698|560490356|FG003|Overall Study|Disease progression|4|||
155288850|NCT00906698|560490357|FG004|Overall Study|Disease progression|12|||
155288851|NCT00906698|560490358|FG005|Overall Study|Disease progression|4|||
155288852|NCT00906698|560490353|FG000|Overall Study|Withdrawal by Subject|0|||
154954908|NCT01367457|559261740|FG000|Overall Study|Palliative. Overall decline|1|||
154954909|NCT01367457|559261741|FG001|Overall Study|Palliative. Overall decline|0|||
154954910|NCT01367457|559261742|FG002|Overall Study|Palliative. Overall decline|0|||
154954911|NCT01367457|559261740|FG000|Overall Study|Suspected DP/suspected active infection|1|||
154954912|NCT01367457|559261741|FG001|Overall Study|Suspected DP/suspected active infection|0|||
155288853|NCT00906698|560490354|FG001|Overall Study|Withdrawal by Subject|0|||
155288854|NCT00906698|560490355|FG002|Overall Study|Withdrawal by Subject|0|||
155288855|NCT00906698|560490356|FG003|Overall Study|Withdrawal by Subject|0|||
155288856|NCT00906698|560490357|FG004|Overall Study|Withdrawal by Subject|1|||
155288857|NCT00906698|560490358|FG005|Overall Study|Withdrawal by Subject|0|||
155288858|NCT00906698|560490353|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
155288859|NCT00906698|560490354|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
155288860|NCT00906698|560490355|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
155288861|NCT00906698|560490356|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
155288862|NCT00906698|560490357|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
155288863|NCT00906698|560490358|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
155288864|NCT01250002|560490359|FG000|Overall Study|Change to open surgical procedure|4|||
155288865|NCT01250002|560490360|FG001|Overall Study|Change to open surgical procedure|3|||
155288866|NCT00567164|560490374|FG000|Overall Study|Withdrawal by Subject|171|||
155288867|NCT00567164|560490375|FG001|Overall Study|Withdrawal by Subject|21|||
155288868|NCT00567164|560490376|FG002|Overall Study|Withdrawal by Subject|17|||
155288869|NCT00567164|560490374|FG000|Overall Study|Protocol Violation|23|||
155288870|NCT00567164|560490375|FG001|Overall Study|Protocol Violation|4|||
155288871|NCT00567164|560490376|FG002|Overall Study|Protocol Violation|2|||
155288872|NCT00567164|560490374|FG000|Overall Study|Adverse Event|92|||
155288873|NCT00567164|560490375|FG001|Overall Study|Adverse Event|13|||
155288874|NCT00567164|560490376|FG002|Overall Study|Adverse Event|9|||
155288875|NCT00567164|560490374|FG000|Overall Study|Death|0|||
155288876|NCT00567164|560490375|FG001|Overall Study|Death|0|||
155288877|NCT00567164|560490376|FG002|Overall Study|Death|1|||
155288878|NCT00567164|560490374|FG000|Overall Study|Lost to Follow-up|202|||
155288879|NCT00567164|560490375|FG001|Overall Study|Lost to Follow-up|23|||
155288880|NCT00567164|560490376|FG002|Overall Study|Lost to Follow-up|21|||
155288881|NCT00567164|560490374|FG000|Overall Study|Pregnancy|20|||
155288882|NCT00567164|560490375|FG001|Overall Study|Pregnancy|4|||
155288883|NCT00567164|560490376|FG002|Overall Study|Pregnancy|6|||
155288884|NCT00567164|560490374|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
155288885|NCT00567164|560490375|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
155288886|NCT00567164|560490376|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
155288887|NCT00567164|560490374|FG000|Overall Study|Missing|1|||
155288888|NCT00567164|560490375|FG001|Overall Study|Missing|0|||
155288889|NCT00567164|560490376|FG002|Overall Study|Missing|0|||
155288890|NCT00001575|560490377|FG000|Overall Study|Screening failures-Ph I portion|22|||
155288891|NCT00001575|560490377|FG000|Overall Study|Withdrawn/deaths|23|||
155288892|NCT03256344|560490378|FG000|Overall Study|Death|6|||
155288893|NCT03256344|560490379|FG001|Overall Study|Death|22|||
155288894|NCT03256344|560490378|FG000|Overall Study|Withdrawal by Subject|3|||
155288895|NCT03256344|560490379|FG001|Overall Study|Withdrawal by Subject|3|||
155288896|NCT03256344|560490378|FG000|Overall Study|Sponsor Decision|1|||
155288897|NCT03256344|560490379|FG001|Overall Study|Sponsor Decision|0|||
155288898|NCT00404079|560490380|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
155288899|NCT00404079|560490381|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
155288900|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Other|4|||
155288901|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Other|0|||
155288902|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
155288903|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
155288904|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
155288905|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
155288906|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
155156131|NCT01075243|560008201|FG000|Overall Study|Lost to Follow-up|5|||
155288907|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
155288908|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
155288909|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
155288910|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
155288911|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
155288912|NCT00853827|560490382|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
155156132|NCT01075243|560008202|FG001|Overall Study|Lost to Follow-up|2|||
154954913|NCT01367457|559261742|FG002|Overall Study|Suspected DP/suspected active infection|0|||
154954914|NCT04407806|559261743|FG000|Overall Study|Withdrawal by Subject|1|||
154954915|NCT04407806|559261744|FG001|Overall Study|Withdrawal by Subject|2|||
154954916|NCT03447262|559261745|FG000|Overall Study|Adverse Event|7|||
154954917|NCT03447262|559261745|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
154954918|NCT03447262|559261745|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
154954919|NCT03447262|559261745|FG000|Overall Study|Death|2|||
154954920|NCT03447262|559261745|FG000|Overall Study|Study Termination by Sponsor|455|||
154954921|NCT03447262|559261745|FG000|Overall Study|Other|4|||
154954922|NCT02058498|559261746|FG000|Overall Study|Withdrawal by Subject|4|||
154954923|NCT05327491|559261747|FG000|Periods 1 & 2|Miscellaneous|0|||
154954924|NCT05327491|559261748|FG001|Periods 1 & 2|Miscellaneous|1|||
154954925|NCT05327491|559261749|FG002|Periods 1 & 2|Miscellaneous|0|||
154954926|NCT05327491|559261750|FG003|Periods 1 & 2|Miscellaneous|0|||
154954927|NCT05327491|559261747|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
154954928|NCT05327491|559261748|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
155288913|NCT00853827|560490383|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
155288914|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
155288915|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
155288916|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
155288917|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
155288918|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
155288919|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
155288920|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
155288921|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
155288922|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
155288923|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
155288924|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
155288925|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
155288926|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
155288927|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
155288928|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
155288929|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
155288930|NCT00853827|560490382|FG000|Double Blind Period (103 Weeks)|Death|1|||
155288931|NCT00853827|560490383|FG001|Double Blind Period (103 Weeks)|Death|6|||
155288932|NCT00580801|560490394|FG000|Overall Study|Physician Decision|1|||
155288933|NCT00580801|560490395|FG001|Overall Study|Physician Decision|0|||
155288934|NCT00580801|560490396|FG002|Overall Study|Physician Decision|0|||
155288935|NCT00580801|560490394|FG000|Overall Study|Adverse Event|2|||
155288936|NCT00580801|560490395|FG001|Overall Study|Adverse Event|0|||
155288937|NCT00580801|560490396|FG002|Overall Study|Adverse Event|0|||
155288938|NCT00580801|560490394|FG000|Overall Study|Lost to Follow-up|2|||
155288939|NCT00580801|560490395|FG001|Overall Study|Lost to Follow-up|0|||
155288940|NCT00580801|560490396|FG002|Overall Study|Lost to Follow-up|0|||
155288941|NCT00580801|560490394|FG000|Overall Study|Reached a virologic endpoint|0|||
155288942|NCT00580801|560490395|FG001|Overall Study|Reached a virologic endpoint|1|||
155288943|NCT00580801|560490396|FG002|Overall Study|Reached a virologic endpoint|2|||
155288944|NCT00580801|560490394|FG000|Overall Study|Participant non-compliant|0|||
155288945|NCT00580801|560490395|FG001|Overall Study|Participant non-compliant|0|||
155288946|NCT00580801|560490396|FG002|Overall Study|Participant non-compliant|1|||
155288947|NCT00580801|560490394|FG000|Overall Study|Travel|1|||
155288948|NCT00580801|560490395|FG001|Overall Study|Travel|0|||
155288949|NCT00580801|560490396|FG002|Overall Study|Travel|0|||
155288950|NCT01664104|560490397|FG000|Overall Study|Adverse Event|6|||
155288951|NCT01664104|560490397|FG000|Overall Study|Lack of Efficacy|2|||
155288952|NCT01664104|560490397|FG000|Overall Study|Withdrawal by Subject|1|||
155288953|NCT01664104|560490397|FG000|Overall Study|Lost to Follow-up|4|||
155288954|NCT01664104|560490397|FG000|Overall Study|Other|1|||
155288955|NCT01664104|560490397|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
155288956|NCT00559949|560490398|FG000|Overall Study|Progressive Disease during cycle 1|1|||
155288957|NCT00559949|560490398|FG000|Overall Study|Adverse Event|1|||
155288958|NCT00559949|560490398|FG000|Overall Study|Withdrawal by Subject|4|||
155288959|NCT00559949|560490398|FG000|Overall Study|No disease evaluation per protocol|1|||
155288960|NCT02512042|560490399|FG000|Overall Study|Adverse Event|0|||
155156133|NCT01075243|560008203|FG002|Overall Study|Lost to Follow-up|0|||
155288961|NCT02512042|560490400|FG001|Overall Study|Adverse Event|4|||
155288962|NCT02512042|560490399|FG000|Overall Study|Withdrawal by Subject|6|||
155288963|NCT02512042|560490400|FG001|Overall Study|Withdrawal by Subject|6|||
155288964|NCT02512042|560490399|FG000|Overall Study|Non-compliance with study drug|1|||
155288965|NCT02512042|560490400|FG001|Overall Study|Non-compliance with study drug|2|||
155288966|NCT02512042|560490399|FG000|Overall Study|Lost to Follow-up|5|||
155059570|NCT00607893|559653785|FG000|Overall Study|withdrew due to loss of interest|0|||
155059571|NCT00607893|559653786|FG001|Overall Study|withdrew due to loss of interest|1|||
155288967|NCT02512042|560490400|FG001|Overall Study|Lost to Follow-up|2|||
155288968|NCT02512042|560490399|FG000|Overall Study|Other|11|||
155288969|NCT02512042|560490400|FG001|Overall Study|Other|11|||
155288970|NCT01194258|560490406|FG000|Titration Period|Withdrawal by Subject|6|||
155288971|NCT01194258|560490407|FG001|Titration Period|Withdrawal by Subject|0|||
155288972|NCT01194258|560490408|FG002|Titration Period|Withdrawal by Subject|0|||
155288973|NCT01194258|560490409|FG003|Titration Period|Withdrawal by Subject|0|||
155288974|NCT01194258|560490410|FG004|Titration Period|Withdrawal by Subject|0|||
155059572|NCT00607893|559653785|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
155059573|NCT00607893|559653786|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
155059574|NCT00607893|559653785|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
155059575|NCT00607893|559653786|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
155059576|NCT00607893|559653785|FG000|Overall Study|Declined to be treated|1|||
155059577|NCT00607893|559653786|FG001|Overall Study|Declined to be treated|0|||
155288975|NCT01194258|560490406|FG000|Titration Period|Lost to Follow-up|2|||
155288976|NCT01194258|560490407|FG001|Titration Period|Lost to Follow-up|0|||
155288977|NCT01194258|560490408|FG002|Titration Period|Lost to Follow-up|0|||
155288978|NCT01194258|560490409|FG003|Titration Period|Lost to Follow-up|0|||
155288979|NCT01194258|560490410|FG004|Titration Period|Lost to Follow-up|0|||
155288980|NCT01194258|560490406|FG000|Titration Period|Titration failure|3|||
155288981|NCT01194258|560490407|FG001|Titration Period|Titration failure|0|||
155288982|NCT01194258|560490408|FG002|Titration Period|Titration failure|0|||
155288983|NCT01194258|560490409|FG003|Titration Period|Titration failure|0|||
155288984|NCT01194258|560490410|FG004|Titration Period|Titration failure|0|||
155288985|NCT01194258|560490406|FG000|Period 1 (12 Weeks)|Death|0|||
155288986|NCT01194258|560490407|FG001|Period 1 (12 Weeks)|Death|0|||
155288987|NCT01194258|560490408|FG002|Period 1 (12 Weeks)|Death|0|||
155288988|NCT01194258|560490409|FG003|Period 1 (12 Weeks)|Death|0|||
155288989|NCT01194258|560490410|FG004|Period 1 (12 Weeks)|Death|1|||
155288990|NCT01194258|560490406|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155288991|NCT01194258|560490407|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155288992|NCT01194258|560490408|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155288993|NCT01194258|560490409|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
155288994|NCT01194258|560490410|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
155288995|NCT01194258|560490406|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
155288996|NCT01194258|560490407|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
155288997|NCT01194258|560490408|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
155288998|NCT01194258|560490409|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
155288999|NCT01194258|560490410|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
155289000|NCT01194258|560490406|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155289001|NCT01194258|560490407|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155289002|NCT01194258|560490408|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155289003|NCT01194258|560490409|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155289004|NCT01194258|560490410|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155289005|NCT00121199|560490418|FG000|Overall Study|Adverse Event|11|||
155289006|NCT00121199|560490418|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155289007|NCT00121199|560490418|FG000|Overall Study|Progression/Relapse|1|||
155289008|NCT00121199|560490418|FG000|Overall Study|Death|3|||
155289009|NCT00121199|560490418|FG000|Overall Study|Other - Not Protocol Specified|3|||
155289010|NCT00121199|560490418|FG000|Overall Study|Ineligible|9|||
155289011|NCT02824432|560490422|FG000|Overall Study|Major Protocol Deviation|1|||
155289012|NCT02824432|560490423|FG001|Overall Study|Major Protocol Deviation|0|||
155289013|NCT00117988|560490427|FG000|Overall Study|Death|3|||
155289014|NCT00117988|560490427|FG000|Overall Study|Adverse Event|1|||
155289015|NCT03563053|560490428|FG000|Overall Study|Withdrawal by Subject|17|||
155289016|NCT03563053|560490428|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
155289017|NCT03563053|560490428|FG000|Overall Study|Adverse Event|3|||
155289018|NCT03563053|560490428|FG000|Overall Study|Physician Decision|1|||
155289019|NCT03563053|560490428|FG000|Overall Study|study terminated by sponsor|71|||
155289020|NCT00124982|560490429|FG000|Short-term Period|Death|1|||
155289021|NCT00124982|560490430|FG001|Short-term Period|Death|1|||
155289022|NCT00124982|560490431|FG002|Short-term Period|Death|0|||
155289023|NCT00124982|560490429|FG000|Short-term Period|Adverse Event|17|||
155289024|NCT00124982|560490430|FG001|Short-term Period|Adverse Event|22|||
155289025|NCT00124982|560490431|FG002|Short-term Period|Adverse Event|0|||
155289026|NCT00124982|560490429|FG000|Short-term Period|Lack of Efficacy|32|||
155289027|NCT00124982|560490430|FG001|Short-term Period|Lack of Efficacy|73|||
155289028|NCT00124982|560490431|FG002|Short-term Period|Lack of Efficacy|0|||
155289029|NCT00124982|560490429|FG000|Short-term Period|Lost to Follow-up|8|||
155289030|NCT00124982|560490430|FG001|Short-term Period|Lost to Follow-up|5|||
155289031|NCT00124982|560490431|FG002|Short-term Period|Lost to Follow-up|0|||
155289032|NCT00124982|560490429|FG000|Short-term Period|Withdrawal of Consent|7|||
155289033|NCT00124982|560490430|FG001|Short-term Period|Withdrawal of Consent|9|||
155289034|NCT00124982|560490431|FG002|Short-term Period|Withdrawal of Consent|0|||
155289035|NCT00124982|560490429|FG000|Short-term Period|Poor/Non-compliance|3|||
155289036|NCT00124982|560490430|FG001|Short-term Period|Poor/Non-compliance|1|||
155289037|NCT00124982|560490431|FG002|Short-term Period|Poor/Non-compliance|0|||
155289038|NCT00124982|560490429|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
155289039|NCT00124982|560490430|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
155289040|NCT00124982|560490431|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
155289041|NCT00124982|560490429|FG000|Short-term Period|Participant Decision|1|||
155289042|NCT00124982|560490430|FG001|Short-term Period|Participant Decision|0|||
155289043|NCT00124982|560490431|FG002|Short-term Period|Participant Decision|0|||
155289044|NCT00124982|560490429|FG000|Short-term Period|Participant Chose Own Doctor|0|||
155289045|NCT00124982|560490430|FG001|Short-term Period|Participant Chose Own Doctor|1|||
155289046|NCT00124982|560490431|FG002|Short-term Period|Participant Chose Own Doctor|0|||
155289047|NCT00124982|560490429|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
155289048|NCT00124982|560490430|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
155289049|NCT00124982|560490431|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
155289050|NCT00124982|560490429|FG000|Short-term Period|Participant Had Lymphopenia|1|||
155289051|NCT00124982|560490430|FG001|Short-term Period|Participant Had Lymphopenia|0|||
155289052|NCT00124982|560490431|FG002|Short-term Period|Participant Had Lymphopenia|0|||
155289053|NCT00124982|560490429|FG000|Long-term Period|Death|0|||
155289054|NCT00124982|560490430|FG001|Long-term Period|Death|0|||
155289055|NCT00124982|560490431|FG002|Long-term Period|Death|1|||
155289056|NCT00124982|560490429|FG000|Long-term Period|Adverse Event|0|||
155289057|NCT00124982|560490430|FG001|Long-term Period|Adverse Event|0|||
155289058|NCT00124982|560490431|FG002|Long-term Period|Adverse Event|17|||
155289059|NCT00124982|560490429|FG000|Long-term Period|Lack of Efficacy|0|||
155289060|NCT00124982|560490430|FG001|Long-term Period|Lack of Efficacy|0|||
155289061|NCT00124982|560490431|FG002|Long-term Period|Lack of Efficacy|46|||
155289062|NCT00124982|560490429|FG000|Long-term Period|Lost to Follow-up|0|||
155289063|NCT00124982|560490430|FG001|Long-term Period|Lost to Follow-up|0|||
155289064|NCT00124982|560490431|FG002|Long-term Period|Lost to Follow-up|4|||
155289065|NCT00124982|560490429|FG000|Long-term Period|Withdrawal by Subject|0|||
155289066|NCT00124982|560490430|FG001|Long-term Period|Withdrawal by Subject|0|||
155289067|NCT00124982|560490431|FG002|Long-term Period|Withdrawal by Subject|16|||
155289068|NCT00124982|560490429|FG000|Long-term Period|Pregnancy|0|||
155289069|NCT00124982|560490430|FG001|Long-term Period|Pregnancy|0|||
155289070|NCT00124982|560490431|FG002|Long-term Period|Pregnancy|1|||
155289071|NCT00124982|560490429|FG000|Long-term Period|Poor/Non-compliance|0|||
155289072|NCT00124982|560490430|FG001|Long-term Period|Poor/Non-compliance|0|||
155289073|NCT00124982|560490431|FG002|Long-term Period|Poor/Non-compliance|2|||
155059578|NCT00607893|559653785|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
155289074|NCT00124982|560490429|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
155289075|NCT00124982|560490430|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
155289076|NCT00124982|560490431|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
155289077|NCT00124982|560490429|FG000|Long-term Period|Neurologist Recommendation|0|||
155289078|NCT00124982|560490430|FG001|Long-term Period|Neurologist Recommendation|0|||
155289079|NCT00124982|560490431|FG002|Long-term Period|Neurologist Recommendation|1|||
155289080|NCT01137292|560490432|FG000|Overall Study|Death|30|||
155289081|NCT01137292|560490432|FG000|Overall Study|Adverse Event|3|||
155289082|NCT01137292|560490432|FG000|Overall Study|Lack of Efficacy|13|||
155289083|NCT01137292|560490432|FG000|Overall Study|Lost to Follow-up|1|||
155289084|NCT01137292|560490432|FG000|Overall Study|Other|7|||
155289085|NCT01311713|560490435|FG000|Overall Study|Death|0|||
155289086|NCT01311713|560490436|FG001|Overall Study|Death|0|||
155289087|NCT01311713|560490437|FG002|Overall Study|Death|1|||
155289088|NCT01311713|560490438|FG003|Overall Study|Death|1|||
155289089|NCT01311713|560490439|FG004|Overall Study|Death|0|||
155289090|NCT01311713|560490440|FG005|Overall Study|Death|1|||
155289091|NCT01311713|560490441|FG006|Overall Study|Death|0|||
155289092|NCT01311713|560490435|FG000|Overall Study|Adverse Event|0|||
155289093|NCT01311713|560490436|FG001|Overall Study|Adverse Event|1|||
155289094|NCT01311713|560490437|FG002|Overall Study|Adverse Event|0|||
155289095|NCT01311713|560490438|FG003|Overall Study|Adverse Event|2|||
155289096|NCT01311713|560490439|FG004|Overall Study|Adverse Event|0|||
155289097|NCT01311713|560490440|FG005|Overall Study|Adverse Event|0|||
155289098|NCT01311713|560490441|FG006|Overall Study|Adverse Event|2|||
155289099|NCT01311713|560490435|FG000|Overall Study|Withdrawal by Subject|0|||
155289100|NCT01311713|560490436|FG001|Overall Study|Withdrawal by Subject|1|||
155289101|NCT01311713|560490437|FG002|Overall Study|Withdrawal by Subject|1|||
155289102|NCT01311713|560490438|FG003|Overall Study|Withdrawal by Subject|0|||
155289103|NCT01311713|560490439|FG004|Overall Study|Withdrawal by Subject|0|||
155289104|NCT01311713|560490440|FG005|Overall Study|Withdrawal by Subject|1|||
155289105|NCT01311713|560490441|FG006|Overall Study|Withdrawal by Subject|2|||
155289106|NCT01311713|560490435|FG000|Overall Study|Disease progression|3|||
155289107|NCT01311713|560490436|FG001|Overall Study|Disease progression|4|||
155289108|NCT01311713|560490437|FG002|Overall Study|Disease progression|3|||
155289109|NCT01311713|560490438|FG003|Overall Study|Disease progression|2|||
155289110|NCT01311713|560490439|FG004|Overall Study|Disease progression|4|||
155289111|NCT01311713|560490440|FG005|Overall Study|Disease progression|4|||
155289112|NCT01311713|560490441|FG006|Overall Study|Disease progression|5|||
155289113|NCT01311713|560490435|FG000|Overall Study|Lost to Follow-up|0|||
155289114|NCT01311713|560490436|FG001|Overall Study|Lost to Follow-up|0|||
155289115|NCT01311713|560490437|FG002|Overall Study|Lost to Follow-up|1|||
155289116|NCT01311713|560490438|FG003|Overall Study|Lost to Follow-up|0|||
155289117|NCT01311713|560490439|FG004|Overall Study|Lost to Follow-up|0|||
155289118|NCT01311713|560490440|FG005|Overall Study|Lost to Follow-up|0|||
155289119|NCT01311713|560490441|FG006|Overall Study|Lost to Follow-up|0|||
155289120|NCT01311713|560490435|FG000|Overall Study|Stopped taking study medication|0|||
155289121|NCT01311713|560490436|FG001|Overall Study|Stopped taking study medication|0|||
155289122|NCT01311713|560490437|FG002|Overall Study|Stopped taking study medication|0|||
155289123|NCT01311713|560490438|FG003|Overall Study|Stopped taking study medication|1|||
155289124|NCT01311713|560490439|FG004|Overall Study|Stopped taking study medication|1|||
155289125|NCT01311713|560490440|FG005|Overall Study|Stopped taking study medication|0|||
155289126|NCT01311713|560490441|FG006|Overall Study|Stopped taking study medication|0|||
155289127|NCT01311713|560490435|FG000|Overall Study|Enrolled but not treated|0|||
155289128|NCT01311713|560490436|FG001|Overall Study|Enrolled but not treated|0|||
155289129|NCT01311713|560490437|FG002|Overall Study|Enrolled but not treated|1|||
155289130|NCT01311713|560490438|FG003|Overall Study|Enrolled but not treated|0|||
155289131|NCT01311713|560490439|FG004|Overall Study|Enrolled but not treated|0|||
155289132|NCT01311713|560490440|FG005|Overall Study|Enrolled but not treated|0|||
155289133|NCT01311713|560490441|FG006|Overall Study|Enrolled but not treated|0|||
155289134|NCT01311713|560490435|FG000|Overall Study|Other than specified|0|||
155289135|NCT01311713|560490436|FG001|Overall Study|Other than specified|1|||
155289136|NCT01311713|560490437|FG002|Overall Study|Other than specified|2|||
155289137|NCT01311713|560490438|FG003|Overall Study|Other than specified|0|||
155289138|NCT01311713|560490439|FG004|Overall Study|Other than specified|0|||
155289139|NCT01311713|560490440|FG005|Overall Study|Other than specified|0|||
155289140|NCT01311713|560490441|FG006|Overall Study|Other than specified|0|||
155289141|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
155289142|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
155289143|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
155059579|NCT00607893|559653786|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
155289144|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
155289145|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
155289146|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
155289147|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
155289148|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
155289149|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
155289150|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
155289151|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
155289152|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
155289153|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289154|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289155|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289156|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
155289157|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289158|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
155289159|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
155289160|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
155289161|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
155289162|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289163|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289164|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289165|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289166|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289167|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
155289168|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
155289169|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
155289170|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
155289171|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289172|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289173|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289174|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289175|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289176|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
155289177|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
155289178|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
155289179|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
155289180|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289181|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289182|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289183|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
155289184|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289185|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
155289186|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
155059580|NCT01373164|559653787|FG000|Overall Study|Lost to Follow-up|0|||
155289187|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289188|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289189|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289190|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289191|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289192|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289193|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289194|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
155289195|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289196|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
155289197|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289198|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289199|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289200|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289201|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289202|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289203|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289204|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289205|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289206|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
155289207|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289208|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289209|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289210|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289211|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289212|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
155289213|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
155289214|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289215|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289216|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289217|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289218|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289219|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289220|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289221|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
155289222|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
155289223|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289224|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289225|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289226|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289227|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289228|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289229|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289230|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
155289231|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
155289232|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289233|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289234|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289235|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289236|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289237|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289238|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289239|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
155289240|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289241|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
155289242|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
155289243|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155059581|NCT01373164|559653788|FG001|Overall Study|Lost to Follow-up|0|||
155059582|NCT01373164|559653789|FG002|Overall Study|Lost to Follow-up|1|||
155059583|NCT01373164|559653790|FG003|Overall Study|Lost to Follow-up|2|||
155059584|NCT01373164|559653791|FG004|Overall Study|Lost to Follow-up|0|||
155289244|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289245|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289246|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289247|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289248|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
155289249|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
155289250|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
155289251|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289252|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289253|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289254|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289255|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289256|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289257|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
155289258|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289259|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
155289260|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289261|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289262|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289263|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289264|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289265|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289266|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
155289267|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289268|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
155289269|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289270|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289271|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289272|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289273|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289274|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289275|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
155289276|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289277|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289278|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
155289279|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289280|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289281|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289282|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289283|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289284|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
155289285|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289286|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289287|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
155289288|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289289|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289290|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289291|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289292|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289293|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
155289294|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289295|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289296|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
155289297|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289298|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289299|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289300|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155059585|NCT01373164|559653787|FG000|Overall Study|Withdrawal by Subject|0|||
155059586|NCT01373164|559653788|FG001|Overall Study|Withdrawal by Subject|1|||
155059587|NCT01373164|559653789|FG002|Overall Study|Withdrawal by Subject|0|||
155289301|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289302|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
155289303|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289304|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289305|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289306|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289307|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289308|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289309|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
155289310|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289311|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
155289312|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
155289313|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
155289314|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289315|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289316|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289317|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289318|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289319|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289320|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
155289321|NCT03598790|560492260|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155059588|NCT01373164|559653790|FG003|Overall Study|Withdrawal by Subject|10|||
155059589|NCT01373164|559653791|FG004|Overall Study|Withdrawal by Subject|2|||
155059590|NCT01799941|559653792|FG000|Overall Study|Adverse Event|34|||
155059591|NCT01799941|559653792|FG000|Overall Study|Withdrawal by Subject|21|||
155059592|NCT01799941|559653792|FG000|Overall Study|Death|2|||
155059593|NCT01799941|559653792|FG000|Overall Study|Investigator Decision|4|||
155059594|NCT01799941|559653792|FG000|Overall Study|Lack of Efficacy|3|||
155059595|NCT01799941|559653792|FG000|Overall Study|Lost to Follow-up|17|||
155059596|NCT01799941|559653792|FG000|Overall Study|Other|15|||
155059597|NCT01715831|559653806|FG000|Overall Study|Adverse Event|1|||
155059598|NCT00900562|559653809|FG000|Overall Study|Progressive disease|9|||
155289322|NCT03598790|560492261|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289323|NCT03598790|560492262|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
155289324|NCT03598790|560492263|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289325|NCT03598790|560492264|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289326|NCT03598790|560492265|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289327|NCT03598790|560492266|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155059599|NCT00900562|559653810|FG001|Overall Study|Progressive disease|5|||
155059600|NCT00900562|559653809|FG000|Overall Study|Toxicity|1|||
155059601|NCT00900562|559653810|FG001|Overall Study|Toxicity|0|||
155059602|NCT00900562|559653809|FG000|Overall Study|Death|1|||
155059603|NCT00900562|559653810|FG001|Overall Study|Death|1|||
155059604|NCT00900562|559653809|FG000|Overall Study|Withdrawal by Subject|0|||
155059605|NCT00900562|559653810|FG001|Overall Study|Withdrawal by Subject|1|||
155059606|NCT00900562|559653809|FG000|Overall Study|Unrelated adverse event|1|||
155059607|NCT00900562|559653810|FG001|Overall Study|Unrelated adverse event|0|||
155059608|NCT01516216|559653811|FG000|Overall Study|Adverse Event|2|||
155059609|NCT01516216|559653812|FG001|Overall Study|Adverse Event|4|||
155059610|NCT01516216|559653811|FG000|Overall Study|Disease Progression|38|||
155059611|NCT01516216|559653812|FG001|Overall Study|Disease Progression|34|||
155059612|NCT01516216|559653811|FG000|Overall Study|Withdrawal by Subject|9|||
155059613|NCT01516216|559653812|FG001|Overall Study|Withdrawal by Subject|11|||
155059614|NCT01516216|559653811|FG000|Overall Study|Potentially Curative Resection|6|||
155059615|NCT01516216|559653812|FG001|Overall Study|Potentially Curative Resection|12|||
155059616|NCT01516216|559653811|FG000|Overall Study|Nonadherence|2|||
155059617|NCT01516216|559653812|FG001|Overall Study|Nonadherence|3|||
155059618|NCT01516216|559653811|FG000|Overall Study|Physician Decision|6|||
155059619|NCT01516216|559653812|FG001|Overall Study|Physician Decision|3|||
155059620|NCT01516216|559653811|FG000|Overall Study|Prolonged Treatment Delay|5|||
155059621|NCT01516216|559653812|FG001|Overall Study|Prolonged Treatment Delay|1|||
155289328|NCT03598790|560492267|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289329|NCT03598790|560492268|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
155289330|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289331|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289332|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289333|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
155289334|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
155289335|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
155289336|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289337|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289338|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155289339|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289340|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289341|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289342|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
155289343|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289344|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289345|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289346|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289347|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
155289348|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289349|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289350|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289351|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
155289352|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289353|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289354|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289355|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289356|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155289357|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289358|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289359|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289360|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
155289361|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
155289362|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289363|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289364|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289365|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
155289366|NCT03598790|560492260|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289367|NCT03598790|560492261|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289368|NCT03598790|560492262|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289369|NCT03598790|560492263|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
155289370|NCT03598790|560492264|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289371|NCT03598790|560492265|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289372|NCT03598790|560492266|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289373|NCT03598790|560492267|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289374|NCT03598790|560492268|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
155289375|NCT05570006|560492269|FG000|Overall Study|Lost to Follow-up|2|||
155289376|NCT05570006|560492269|FG000|Overall Study|Withdrawal by Subject|5|||
155289377|NCT05570006|560492269|FG000|Overall Study|Other than Specified|5|||
155289378|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289379|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
155289380|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289381|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289382|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289383|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289384|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289385|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289386|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289387|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289388|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
155289389|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
155289390|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
155289391|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289392|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289393|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289394|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289395|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289396|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289397|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289398|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289399|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
155289400|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
155289401|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
155289402|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289403|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289404|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289405|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289406|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289407|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289408|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289409|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289410|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
155289411|NCT03410992|560492277|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
155289412|NCT03410992|560492278|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289413|NCT03410992|560492279|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289414|NCT03410992|560492280|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289415|NCT03410992|560492281|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289416|NCT03410992|560492282|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289417|NCT03410992|560492283|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289418|NCT03410992|560492284|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289419|NCT03410992|560492285|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289420|NCT03410992|560492286|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289421|NCT03410992|560492287|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
155289422|NCT03410992|560492277|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
155289423|NCT03410992|560492278|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
155289424|NCT03410992|560492279|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289425|NCT03410992|560492280|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289426|NCT03410992|560492281|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289427|NCT03410992|560492282|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289428|NCT03410992|560492283|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289429|NCT03410992|560492284|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289430|NCT03410992|560492285|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289431|NCT03410992|560492286|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289432|NCT03410992|560492287|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
155289433|NCT03410992|560492277|FG000|Week 16 Assessment|Incorrect escapers|0|||
155289434|NCT03410992|560492278|FG001|Week 16 Assessment|Incorrect escapers|6|||
155289435|NCT03410992|560492279|FG002|Week 16 Assessment|Incorrect escapers|0|||
155289436|NCT03410992|560492280|FG003|Week 16 Assessment|Incorrect escapers|0|||
155289437|NCT03410992|560492281|FG004|Week 16 Assessment|Incorrect escapers|0|||
155289438|NCT03410992|560492282|FG005|Week 16 Assessment|Incorrect escapers|0|||
155289439|NCT03410992|560492283|FG006|Week 16 Assessment|Incorrect escapers|0|||
155289440|NCT03410992|560492284|FG007|Week 16 Assessment|Incorrect escapers|0|||
155289441|NCT03410992|560492285|FG008|Week 16 Assessment|Incorrect escapers|0|||
155289442|NCT03410992|560492286|FG009|Week 16 Assessment|Incorrect escapers|0|||
155289443|NCT03410992|560492287|FG010|Week 16 Assessment|Incorrect escapers|0|||
155289444|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289445|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289446|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289447|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
155289448|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
155289449|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289450|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289451|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289452|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289453|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289454|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
155289455|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289456|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289457|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289458|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
155289459|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
155289460|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
155289461|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289462|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289463|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289464|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289465|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
155289466|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289467|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289468|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289469|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289470|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289471|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
155289472|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289473|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155059622|NCT01516216|559653811|FG000|Overall Study|Intercurrent Illness|1|||
155059623|NCT01516216|559653812|FG001|Overall Study|Intercurrent Illness|0|||
155059624|NCT01516216|559653811|FG000|Overall Study|Death|1|||
155059625|NCT01516216|559653812|FG001|Overall Study|Death|1|||
155059626|NCT03098979|559653813|FG000|Overall Study|Adverse Event|1|||
155059627|NCT03098979|559653814|FG001|Overall Study|Adverse Event|0|||
155289474|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289475|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289476|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
155289477|NCT03410992|560492277|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289478|NCT03410992|560492278|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289479|NCT03410992|560492279|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289480|NCT03410992|560492280|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
155289481|NCT03410992|560492281|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
155289482|NCT03410992|560492282|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
155289483|NCT03410992|560492283|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289484|NCT03410992|560492284|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289485|NCT03410992|560492285|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289486|NCT03410992|560492286|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289487|NCT03410992|560492287|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
155289488|NCT03410992|560492277|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289489|NCT03410992|560492278|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289490|NCT03410992|560492279|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289491|NCT03410992|560492280|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289492|NCT03410992|560492281|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289493|NCT03410992|560492282|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289494|NCT03410992|560492283|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289495|NCT03410992|560492284|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
155289496|NCT03410992|560492285|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289497|NCT03410992|560492286|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289498|NCT03410992|560492287|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
155289499|NCT03410992|560492277|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289500|NCT03410992|560492278|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155059628|NCT03098979|559653815|FG002|Overall Study|Adverse Event|1|||
155059629|NCT03098979|559653816|FG003|Overall Study|Adverse Event|4|||
155289501|NCT03410992|560492279|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289502|NCT03410992|560492280|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289503|NCT03410992|560492281|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289504|NCT03410992|560492282|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289505|NCT03410992|560492283|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289506|NCT03410992|560492284|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289507|NCT03410992|560492285|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
155289508|NCT03410992|560492286|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289509|NCT03410992|560492287|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
155289510|NCT04804605|560492288|FG000|Overall Study|Withdrawal by Subject|46|||
155289511|NCT04804605|560492289|FG001|Overall Study|Withdrawal by Subject|26|||
155289512|NCT04804605|560492290|FG002|Overall Study|Withdrawal by Subject|37|||
155289513|NCT04804605|560492291|FG003|Overall Study|Withdrawal by Subject|21|||
155289514|NCT04804605|560492288|FG000|Overall Study|Lost to Follow-up|47|||
155059630|NCT03098979|559653817|FG004|Overall Study|Adverse Event|6|||
155059631|NCT03098979|559653818|FG005|Overall Study|Adverse Event|1|||
155059632|NCT03098979|559653813|FG000|Overall Study|Withdrawal by Subject|2|||
155059633|NCT03098979|559653814|FG001|Overall Study|Withdrawal by Subject|1|||
155059634|NCT03098979|559653815|FG002|Overall Study|Withdrawal by Subject|1|||
155059635|NCT03098979|559653816|FG003|Overall Study|Withdrawal by Subject|1|||
155059636|NCT03098979|559653817|FG004|Overall Study|Withdrawal by Subject|2|||
155059637|NCT03098979|559653818|FG005|Overall Study|Withdrawal by Subject|1|||
155059638|NCT03098979|559653813|FG000|Overall Study|Death|1|||
155059639|NCT03098979|559653814|FG001|Overall Study|Death|0|||
155059640|NCT03098979|559653815|FG002|Overall Study|Death|2|||
155059641|NCT03098979|559653816|FG003|Overall Study|Death|0|||
155059642|NCT03098979|559653817|FG004|Overall Study|Death|1|||
155059643|NCT03098979|559653818|FG005|Overall Study|Death|0|||
155059644|NCT03098979|559653813|FG000|Overall Study|Physician Decision|2|||
155059645|NCT03098979|559653814|FG001|Overall Study|Physician Decision|1|||
155059646|NCT03098979|559653815|FG002|Overall Study|Physician Decision|0|||
155059647|NCT03098979|559653816|FG003|Overall Study|Physician Decision|0|||
155059648|NCT03098979|559653817|FG004|Overall Study|Physician Decision|0|||
155059649|NCT03098979|559653818|FG005|Overall Study|Physician Decision|0|||
155059650|NCT03098979|559653813|FG000|Overall Study|Non-compliance|0|||
155059651|NCT03098979|559653814|FG001|Overall Study|Non-compliance|0|||
155059652|NCT03098979|559653815|FG002|Overall Study|Non-compliance|0|||
155059653|NCT03098979|559653816|FG003|Overall Study|Non-compliance|0|||
155059654|NCT03098979|559653817|FG004|Overall Study|Non-compliance|0|||
155059655|NCT03098979|559653818|FG005|Overall Study|Non-compliance|1|||
155059656|NCT03098979|559653813|FG000|Overall Study|Protocol Violation|0|||
155059657|NCT03098979|559653814|FG001|Overall Study|Protocol Violation|0|||
155059658|NCT03098979|559653815|FG002|Overall Study|Protocol Violation|0|||
155059659|NCT03098979|559653816|FG003|Overall Study|Protocol Violation|0|||
155059660|NCT03098979|559653817|FG004|Overall Study|Protocol Violation|0|||
155059661|NCT03098979|559653818|FG005|Overall Study|Protocol Violation|1|||
155059662|NCT02419807|559653819|FG000|Overall Study|Withdrawal by Subject|4|||
155059663|NCT02419807|559653819|FG000|Overall Study|Physician Decision|1|||
155289515|NCT04804605|560492289|FG001|Overall Study|Lost to Follow-up|21|||
155289516|NCT04804605|560492290|FG002|Overall Study|Lost to Follow-up|30|||
155289517|NCT04804605|560492291|FG003|Overall Study|Lost to Follow-up|17|||
155289518|NCT04804605|560492288|FG000|Overall Study|Lack of Efficacy|28|||
155289519|NCT04804605|560492289|FG001|Overall Study|Lack of Efficacy|11|||
155289520|NCT04804605|560492290|FG002|Overall Study|Lack of Efficacy|37|||
155289521|NCT04804605|560492291|FG003|Overall Study|Lack of Efficacy|8|||
155289522|NCT04804605|560492288|FG000|Overall Study|Adverse Event|10|||
155059664|NCT02419807|559653819|FG000|Overall Study|Protocol Violation|5|||
155059665|NCT01006629|559653820|FG000|Overall Study|Adverse Event|1|||
155059666|NCT01006629|559653820|FG000|Overall Study|Parent refused to continue participation|1|||
155059667|NCT01006629|559653820|FG000|Overall Study|Parent unable to perform site visit|4|||
155289523|NCT04804605|560492289|FG001|Overall Study|Adverse Event|10|||
155289524|NCT04804605|560492290|FG002|Overall Study|Adverse Event|10|||
155289525|NCT04804605|560492291|FG003|Overall Study|Adverse Event|7|||
155289526|NCT04804605|560492288|FG000|Overall Study|Non-compliance|8|||
155289527|NCT04804605|560492289|FG001|Overall Study|Non-compliance|3|||
155289528|NCT04804605|560492290|FG002|Overall Study|Non-compliance|5|||
155059668|NCT01065818|559653821|FG000|Overall Study|Withdrawal by Subject|1|||
155059669|NCT01065818|559653821|FG000|Overall Study|Not a candidate for surgery|1|||
155289529|NCT04804605|560492291|FG003|Overall Study|Non-compliance|1|||
155289530|NCT04804605|560492288|FG000|Overall Study|Physician Decision|3|||
155059670|NCT04459338|559653824|FG000|Overall Study|Loss of IV during study|1|||
155059671|NCT04459338|559653825|FG001|Overall Study|Loss of IV during study|0|||
155059672|NCT03157089|559653826|FG000|Overall Study|Treated only with pembrolizumab|1|||
155289531|NCT04804605|560492289|FG001|Overall Study|Physician Decision|0|||
155289532|NCT04804605|560492290|FG002|Overall Study|Physician Decision|5|||
155289533|NCT04804605|560492291|FG003|Overall Study|Physician Decision|0|||
155289534|NCT04804605|560492288|FG000|Overall Study|Protocol Violation|1|||
155289535|NCT04804605|560492289|FG001|Overall Study|Protocol Violation|0|||
155289536|NCT04804605|560492290|FG002|Overall Study|Protocol Violation|0|||
155289537|NCT04804605|560492291|FG003|Overall Study|Protocol Violation|1|||
155289538|NCT04804605|560492288|FG000|Overall Study|Miscellaneous|7|||
155289539|NCT04804605|560492289|FG001|Overall Study|Miscellaneous|3|||
155289540|NCT04804605|560492290|FG002|Overall Study|Miscellaneous|4|||
155289541|NCT04804605|560492291|FG003|Overall Study|Miscellaneous|2|||
155289542|NCT04018066|560492294|FG000|Overall Study|participants started taking medications during the study period|3|||
155289543|NCT04018066|560492294|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
155289544|NCT03568318|560492295|FG000|Overall Study|Adverse Event|3|||
155289545|NCT03568318|560492296|FG001|Overall Study|Adverse Event|1|||
155289546|NCT03568318|560492297|FG002|Overall Study|Adverse Event|1|||
155289547|NCT03568318|560492298|FG003|Overall Study|Adverse Event|0|||
155289548|NCT03568318|560492299|FG004|Overall Study|Adverse Event|1|||
155289549|NCT03568318|560492300|FG005|Overall Study|Adverse Event|0|||
155289550|NCT03568318|560492295|FG000|Overall Study|Withdrawal by Subject|6|||
155289551|NCT03568318|560492296|FG001|Overall Study|Withdrawal by Subject|5|||
155289552|NCT03568318|560492297|FG002|Overall Study|Withdrawal by Subject|2|||
155289553|NCT03568318|560492298|FG003|Overall Study|Withdrawal by Subject|1|||
155289554|NCT03568318|560492299|FG004|Overall Study|Withdrawal by Subject|0|||
155289555|NCT03568318|560492300|FG005|Overall Study|Withdrawal by Subject|0|||
155289556|NCT03568318|560492295|FG000|Overall Study|Lost to Follow-up|3|||
155289557|NCT03568318|560492296|FG001|Overall Study|Lost to Follow-up|2|||
155289558|NCT03568318|560492297|FG002|Overall Study|Lost to Follow-up|2|||
155289559|NCT03568318|560492298|FG003|Overall Study|Lost to Follow-up|2|||
155289560|NCT03568318|560492299|FG004|Overall Study|Lost to Follow-up|1|||
155289561|NCT03568318|560492300|FG005|Overall Study|Lost to Follow-up|0|||
155289562|NCT03568318|560492295|FG000|Overall Study|Other|3|||
155289563|NCT03568318|560492296|FG001|Overall Study|Other|1|||
155289564|NCT03568318|560492297|FG002|Overall Study|Other|3|||
155289565|NCT03568318|560492298|FG003|Overall Study|Other|0|||
155289566|NCT03568318|560492299|FG004|Overall Study|Other|0|||
155289567|NCT03568318|560492300|FG005|Overall Study|Other|0|||
155289568|NCT03568318|560492295|FG000|Overall Study|Ongoing at Time of Analysis|5|||
155289569|NCT03568318|560492296|FG001|Overall Study|Ongoing at Time of Analysis|3|||
155289570|NCT03568318|560492297|FG002|Overall Study|Ongoing at Time of Analysis|2|||
155289571|NCT03568318|560492298|FG003|Overall Study|Ongoing at Time of Analysis|1|||
155289572|NCT03568318|560492299|FG004|Overall Study|Ongoing at Time of Analysis|0|||
155289573|NCT03568318|560492300|FG005|Overall Study|Ongoing at Time of Analysis|0|||
155289574|NCT04988295|560492304|FG000|Overall Study|Withdrawal by Subject|9|||
155289575|NCT04988295|560492305|FG001|Overall Study|Withdrawal by Subject|29|||
155289576|NCT04988295|560492306|FG002|Overall Study|Withdrawal by Subject|6|||
155289577|NCT04988295|560492307|FG003|Overall Study|Withdrawal by Subject|0|||
155289578|NCT04988295|560492304|FG000|Overall Study|Lost to Follow-up|1|||
155289579|NCT04988295|560492305|FG001|Overall Study|Lost to Follow-up|0|||
155289580|NCT04988295|560492306|FG002|Overall Study|Lost to Follow-up|0|||
155289581|NCT04988295|560492307|FG003|Overall Study|Lost to Follow-up|0|||
155289582|NCT04988295|560492304|FG000|Overall Study|Study participation ongoing|186|||
155289583|NCT04988295|560492305|FG001|Overall Study|Study participation ongoing|169|||
155289584|NCT04988295|560492306|FG002|Overall Study|Study participation ongoing|99|||
155289585|NCT04988295|560492307|FG003|Overall Study|Study participation ongoing|119|||
155289586|NCT04083976|560492310|FG000|Overall Study|Lost to Follow-up|3|||
155289587|NCT04083976|560492311|FG001|Overall Study|Lost to Follow-up|0|||
155289588|NCT04083976|560492312|FG002|Overall Study|Lost to Follow-up|0|||
155289589|NCT04083976|560492313|FG003|Overall Study|Lost to Follow-up|1|||
155289590|NCT04083976|560492310|FG000|Overall Study|Withdrawal by Subject|16|||
155289591|NCT04083976|560492311|FG001|Overall Study|Withdrawal by Subject|1|||
155289592|NCT04083976|560492312|FG002|Overall Study|Withdrawal by Subject|9|||
155289593|NCT04083976|560492313|FG003|Overall Study|Withdrawal by Subject|0|||
155289594|NCT04083976|560492310|FG000|Overall Study|Sponsor Decision|14|||
155289595|NCT04083976|560492311|FG001|Overall Study|Sponsor Decision|0|||
155289596|NCT04083976|560492312|FG002|Overall Study|Sponsor Decision|0|||
155289597|NCT04083976|560492313|FG003|Overall Study|Sponsor Decision|7|||
155289598|NCT04083976|560492310|FG000|Overall Study|Other|1|||
155289599|NCT04083976|560492311|FG001|Overall Study|Other|0|||
155289600|NCT04083976|560492312|FG002|Overall Study|Other|1|||
155289601|NCT04083976|560492313|FG003|Overall Study|Other|0|||
155289602|NCT04618471|560492314|FG000|Overall Study|Screen Failure|62|||
155289603|NCT04618471|560492314|FG000|Overall Study|Withdrawal by Subject|6|||
155289604|NCT04618471|560492314|FG000|Overall Study|Physician Decision|2|||
155289605|NCT04618471|560492314|FG000|Overall Study|Lost to Follow-up|1|||
155289606|NCT04618471|560492314|FG000|Overall Study|Various other reasons|2|||
155289607|NCT04618471|560492314|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
155289608|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289609|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Adverse Event|1|||
155289610|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289611|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289612|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289613|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289614|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289615|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289616|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289617|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289618|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289619|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289620|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Adverse Event|0|||
155289621|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Death|0|||
155289622|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Death|0|||
155289623|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Death|0|||
155289624|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Death|1|||
155289625|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Death|0|||
155289626|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Death|0|||
155289627|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Death|0|||
155289628|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Death|0|||
155289629|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Death|0|||
155289630|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Death|0|||
155289631|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Death|0|||
155289632|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Death|0|||
155289633|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Death|0|||
155289634|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289635|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
155289636|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
155289637|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Lost to Follow-up|2|||
155289638|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Lost to Follow-up|1|||
155289639|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289640|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289641|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289642|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289643|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289644|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289645|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289646|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Lost to Follow-up|0|||
155289647|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289648|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Physician Decision|1|||
155289649|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289650|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289651|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289652|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289653|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289654|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289655|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289656|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289657|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289658|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Physician Decision|0|||
154954929|NCT05327491|559261749|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
154954930|NCT05327491|559261750|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
154954931|NCT05612724|559261751|FG000|Overall Study|Lost to Follow-up|4|||
154954932|NCT04000815|559261758|FG000|Overall Study|Lost to Follow-up|9|||
154954933|NCT04000815|559261759|FG001|Overall Study|Lost to Follow-up|2|||
154954934|NCT04000815|559261760|FG002|Overall Study|Lost to Follow-up|3|||
154954935|NCT04000815|559261758|FG000|Overall Study|Withdrawal by Subject|4|||
155289659|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Physician Decision|0|||
155289660|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289661|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289662|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Protocol Deviation|1|||
155289663|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289664|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289665|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289666|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289667|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289668|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289669|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289670|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289671|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289672|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Protocol Deviation|0|||
155289673|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
155289674|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|5|||
155289675|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|1|||
155289676|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|2|||
155289677|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|3|||
155289678|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289679|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289680|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289681|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289682|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289683|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289684|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
154954936|NCT04000815|559261759|FG001|Overall Study|Withdrawal by Subject|3|||
154954937|NCT04000815|559261760|FG002|Overall Study|Withdrawal by Subject|2|||
155289685|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Subject Stopped Participation in the Study|0|||
155289686|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289687|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289688|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289689|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289690|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Reason Unknown|1|||
155289691|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289692|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289693|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289694|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289695|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289696|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289697|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289698|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Reason Unknown|0|||
155289699|NCT04936035|560492315|FG000|6-Month Placebo-controlled DB Period|Withdrawal by Subject|1|||
155289700|NCT04936035|560492316|FG001|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289701|NCT04936035|560492317|FG002|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289702|NCT04936035|560492318|FG003|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289703|NCT04936035|560492319|FG004|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289704|NCT04936035|560492320|FG005|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289705|NCT04936035|560492321|FG006|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289706|NCT04936035|560492322|FG007|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289707|NCT04936035|560492323|FG008|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289708|NCT04936035|560492324|FG009|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289709|NCT04936035|560492325|FG010|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289710|NCT04936035|560492326|FG011|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289711|NCT04936035|560492327|FG012|6-Month Placebo-controlled DB Period|Withdrawal by Subject|0|||
155289712|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289713|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289714|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289715|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289716|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289717|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
155289718|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|1|||
155289719|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289720|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|0|||
155289721|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|2|||
155289722|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|7|||
155289723|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|5|||
155289724|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Participant Stopped Participation in the Study|3|||
155289725|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289726|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289727|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289728|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289729|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289730|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289731|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289732|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289733|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Lost to Follow-up|0|||
155289734|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Lost to Follow-up|3|||
155289735|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289736|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Lost to Follow-up|1|||
155289737|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Lost to Follow-up|4|||
155289738|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289739|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289740|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289741|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289742|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289743|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289744|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289745|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289746|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289747|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Physician Decision|2|||
155289748|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289749|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Physician Decision|1|||
155289750|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Physician Decision|0|||
155289751|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289752|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289753|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289754|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289755|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289756|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Adverse Event|1|||
155289757|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289758|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Adverse Event|1|||
155289759|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289760|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289761|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289762|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289763|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Adverse Event|0|||
155289764|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Death|0|||
155289765|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Death|0|||
155289766|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Death|0|||
155289767|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Death|0|||
155289768|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Death|0|||
155289769|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Death|0|||
155289770|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Death|0|||
155289771|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Death|0|||
155289772|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Death|0|||
155289773|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Death|1|||
155289774|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Death|0|||
155289775|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Death|0|||
155289776|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Death|0|||
155289777|NCT04936035|560492315|FG000|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289778|NCT04936035|560492316|FG001|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
154954938|NCT04000815|559261758|FG000|Overall Study|Right ovarian cyst occured|1|||
154954939|NCT04000815|559261759|FG001|Overall Study|Right ovarian cyst occured|0|||
155289779|NCT04936035|560492317|FG002|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289780|NCT04936035|560492318|FG003|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
154954940|NCT04000815|559261760|FG002|Overall Study|Right ovarian cyst occured|0|||
155289781|NCT04936035|560492319|FG004|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289782|NCT04936035|560492320|FG005|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
155289783|NCT04936035|560492321|FG006|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289784|NCT04936035|560492322|FG007|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289785|NCT04936035|560492323|FG008|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289786|NCT04936035|560492324|FG009|Post-6-Month DB Period (30months)|Reason Not Specified|1|||
155289787|NCT04936035|560492325|FG010|Post-6-Month DB Period (30months)|Reason Not Specified|2|||
155289788|NCT04936035|560492326|FG011|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289789|NCT04936035|560492327|FG012|Post-6-Month DB Period (30months)|Reason Not Specified|0|||
155289790|NCT01313182|560492328|FG000|Overall Study|Protocol Violation|66|||
155289791|NCT01313182|560492329|FG001|Overall Study|Protocol Violation|92|||
155289792|NCT03673124|560492330|FG000|Overall Study|Eligible with no protocol therapy|2|||
155289793|NCT05827926|560492333|FG000|Overall Study|Lost to Follow-up|1|||
155289794|NCT05827926|560492334|FG001|Overall Study|Lost to Follow-up|0|||
155289795|NCT05827926|560492335|FG002|Overall Study|Lost to Follow-up|0|||
155289796|NCT05827926|560492336|FG003|Overall Study|Lost to Follow-up|0|||
155289797|NCT05827926|560492337|FG004|Overall Study|Lost to Follow-up|0|||
155289798|NCT05827926|560492338|FG005|Overall Study|Lost to Follow-up|1|||
155289799|NCT05827926|560492339|FG006|Overall Study|Lost to Follow-up|0|||
155289800|NCT05827926|560492340|FG007|Overall Study|Lost to Follow-up|0|||
155289801|NCT05827926|560492341|FG008|Overall Study|Lost to Follow-up|0|||
155289802|NCT05827926|560492342|FG009|Overall Study|Lost to Follow-up|0|||
155289803|NCT05827926|560492343|FG010|Overall Study|Lost to Follow-up|0|||
155289804|NCT05827926|560492344|FG011|Overall Study|Lost to Follow-up|0|||
155289805|NCT05827926|560492345|FG012|Overall Study|Lost to Follow-up|1|||
155289806|NCT05827926|560492346|FG013|Overall Study|Lost to Follow-up|1|||
155289807|NCT05827926|560492347|FG014|Overall Study|Lost to Follow-up|0|||
155289808|NCT05827926|560492348|FG015|Overall Study|Lost to Follow-up|1|||
155289809|NCT05827926|560492349|FG016|Overall Study|Lost to Follow-up|2|||
155289810|NCT05827926|560492350|FG017|Overall Study|Lost to Follow-up|0|||
155289811|NCT05827926|560492351|FG018|Overall Study|Lost to Follow-up|0|||
155289812|NCT05827926|560492352|FG019|Overall Study|Lost to Follow-up|0|||
155289813|NCT05827926|560492353|FG020|Overall Study|Lost to Follow-up|1|||
155289814|NCT05827926|560492354|FG021|Overall Study|Lost to Follow-up|2|||
155289815|NCT05827926|560492355|FG022|Overall Study|Lost to Follow-up|1|||
155289816|NCT05827926|560492356|FG023|Overall Study|Lost to Follow-up|1|||
155289817|NCT05827926|560492357|FG024|Overall Study|Lost to Follow-up|2|||
155289818|NCT05827926|560492358|FG025|Overall Study|Lost to Follow-up|1|||
154954941|NCT04000815|559261758|FG000|Overall Study|Hypertension occured on follow up|0|||
154954942|NCT04000815|559261759|FG001|Overall Study|Hypertension occured on follow up|0|||
154954943|NCT04000815|559261760|FG002|Overall Study|Hypertension occured on follow up|2|||
154954944|NCT00239577|559261761|FG000|Primary Phase|Adverse Event|0|||
154954945|NCT00239577|559261762|FG001|Primary Phase|Adverse Event|0|||
154954946|NCT00239577|559261763|FG002|Primary Phase|Adverse Event|1|||
154954947|NCT00239577|559261764|FG003|Primary Phase|Adverse Event|0|||
154954948|NCT00239577|559261761|FG000|Primary Phase|Other|5|||
154954949|NCT00239577|559261762|FG001|Primary Phase|Other|3|||
154954950|NCT00239577|559261763|FG002|Primary Phase|Other|2|||
154954951|NCT00239577|559261764|FG003|Primary Phase|Other|0|||
154954952|NCT02422264|559261767|FG000|Overall Study|Serious Adverse Event|1|||
154954953|NCT02422264|559261768|FG001|Overall Study|Serious Adverse Event|0|||
154954954|NCT02422264|559261767|FG000|Overall Study|Withdrawal by Subject|1|||
154954955|NCT02422264|559261768|FG001|Overall Study|Withdrawal by Subject|2|||
154954956|NCT02422264|559261767|FG000|Overall Study|Migrated/moved from study area|3|||
154954957|NCT02422264|559261768|FG001|Overall Study|Migrated/moved from study area|1|||
154954958|NCT02422264|559261767|FG000|Overall Study|Subject vaccinated outside of the study|0|||
154954959|NCT02422264|559261768|FG001|Overall Study|Subject vaccinated outside of the study|1|||
154954960|NCT03021018|559261770|FG000|Overall Study|Adverse Event|1|||
154954961|NCT03021018|559261771|FG001|Overall Study|Adverse Event|0|||
154954962|NCT03021018|559261772|FG002|Overall Study|Adverse Event|0|||
154954963|NCT03021018|559261770|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
154954964|NCT03021018|559261771|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
154954965|NCT03021018|559261772|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
154954966|NCT01391793|559261781|FG000|Overall Study|Ineligible|3|||
154954967|NCT01391793|559261782|FG001|Overall Study|Ineligible|0|||
154954968|NCT01391793|559261781|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
154954969|NCT01391793|559261782|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
154954970|NCT01391793|559261781|FG000|Overall Study|No DMSA|73|||
154954971|NCT01391793|559261782|FG001|Overall Study|No DMSA|57|||
154954972|NCT00050778|559261787|FG000|Overall Study|Adverse Event|13|||
154954973|NCT00050778|559261788|FG001|Overall Study|Adverse Event|3|||
154954974|NCT00050778|559261789|FG002|Overall Study|Adverse Event|2|||
154954975|NCT00050778|559261787|FG000|Overall Study|Death|0|||
154954976|NCT00050778|559261788|FG001|Overall Study|Death|1|||
155289819|NCT05827926|560492359|FG026|Overall Study|Lost to Follow-up|4|||
155289820|NCT05827926|560492360|FG027|Overall Study|Lost to Follow-up|1|||
155289821|NCT05827926|560492361|FG028|Overall Study|Lost to Follow-up|2|||
155289822|NCT05827926|560492362|FG029|Overall Study|Lost to Follow-up|1|||
155289823|NCT05827926|560492363|FG030|Overall Study|Lost to Follow-up|5|||
155289824|NCT05827926|560492364|FG031|Overall Study|Lost to Follow-up|0|||
155289825|NCT05827926|560492365|FG032|Overall Study|Lost to Follow-up|3|||
155289826|NCT05827926|560492366|FG033|Overall Study|Lost to Follow-up|2|||
155289827|NCT05827926|560492367|FG034|Overall Study|Lost to Follow-up|1|||
155289828|NCT05827926|560492368|FG035|Overall Study|Lost to Follow-up|3|||
155289829|NCT05827926|560492369|FG036|Overall Study|Lost to Follow-up|4|||
155289830|NCT05827926|560492333|FG000|Overall Study|Withdrawal by Subject|1|||
155289831|NCT05827926|560492334|FG001|Overall Study|Withdrawal by Subject|0|||
155289832|NCT05827926|560492335|FG002|Overall Study|Withdrawal by Subject|1|||
155289833|NCT05827926|560492336|FG003|Overall Study|Withdrawal by Subject|1|||
155289834|NCT05827926|560492337|FG004|Overall Study|Withdrawal by Subject|0|||
155289835|NCT05827926|560492338|FG005|Overall Study|Withdrawal by Subject|0|||
155289836|NCT05827926|560492339|FG006|Overall Study|Withdrawal by Subject|0|||
155289837|NCT05827926|560492340|FG007|Overall Study|Withdrawal by Subject|0|||
155289838|NCT05827926|560492341|FG008|Overall Study|Withdrawal by Subject|0|||
155289839|NCT05827926|560492342|FG009|Overall Study|Withdrawal by Subject|0|||
155289840|NCT05827926|560492343|FG010|Overall Study|Withdrawal by Subject|0|||
155289841|NCT05827926|560492344|FG011|Overall Study|Withdrawal by Subject|0|||
155289842|NCT05827926|560492345|FG012|Overall Study|Withdrawal by Subject|1|||
155289843|NCT05827926|560492346|FG013|Overall Study|Withdrawal by Subject|1|||
155289844|NCT05827926|560492347|FG014|Overall Study|Withdrawal by Subject|1|||
155289845|NCT05827926|560492348|FG015|Overall Study|Withdrawal by Subject|2|||
155289846|NCT05827926|560492349|FG016|Overall Study|Withdrawal by Subject|1|||
155289847|NCT05827926|560492350|FG017|Overall Study|Withdrawal by Subject|1|||
155289848|NCT05827926|560492351|FG018|Overall Study|Withdrawal by Subject|0|||
155289849|NCT05827926|560492352|FG019|Overall Study|Withdrawal by Subject|0|||
155289850|NCT05827926|560492353|FG020|Overall Study|Withdrawal by Subject|1|||
155289851|NCT05827926|560492354|FG021|Overall Study|Withdrawal by Subject|0|||
155289852|NCT05827926|560492355|FG022|Overall Study|Withdrawal by Subject|0|||
155289853|NCT05827926|560492356|FG023|Overall Study|Withdrawal by Subject|2|||
155289854|NCT05827926|560492357|FG024|Overall Study|Withdrawal by Subject|1|||
155289855|NCT05827926|560492358|FG025|Overall Study|Withdrawal by Subject|0|||
155289856|NCT05827926|560492359|FG026|Overall Study|Withdrawal by Subject|0|||
155289857|NCT05827926|560492360|FG027|Overall Study|Withdrawal by Subject|1|||
155289858|NCT05827926|560492361|FG028|Overall Study|Withdrawal by Subject|0|||
155289859|NCT05827926|560492362|FG029|Overall Study|Withdrawal by Subject|0|||
155289860|NCT05827926|560492363|FG030|Overall Study|Withdrawal by Subject|0|||
155289861|NCT05827926|560492364|FG031|Overall Study|Withdrawal by Subject|2|||
155289862|NCT05827926|560492365|FG032|Overall Study|Withdrawal by Subject|0|||
155289863|NCT05827926|560492366|FG033|Overall Study|Withdrawal by Subject|0|||
155289864|NCT05827926|560492367|FG034|Overall Study|Withdrawal by Subject|0|||
155289865|NCT05827926|560492368|FG035|Overall Study|Withdrawal by Subject|0|||
155289866|NCT05827926|560492369|FG036|Overall Study|Withdrawal by Subject|1|||
155289867|NCT05827926|560492333|FG000|Overall Study|Other Than Specified|0|||
155289868|NCT05827926|560492334|FG001|Overall Study|Other Than Specified|0|||
155289869|NCT05827926|560492335|FG002|Overall Study|Other Than Specified|0|||
155289870|NCT05827926|560492336|FG003|Overall Study|Other Than Specified|1|||
155289871|NCT05827926|560492337|FG004|Overall Study|Other Than Specified|0|||
155289872|NCT05827926|560492338|FG005|Overall Study|Other Than Specified|0|||
155289873|NCT05827926|560492339|FG006|Overall Study|Other Than Specified|1|||
155289874|NCT05827926|560492340|FG007|Overall Study|Other Than Specified|0|||
155289875|NCT05827926|560492341|FG008|Overall Study|Other Than Specified|0|||
155289876|NCT05827926|560492342|FG009|Overall Study|Other Than Specified|0|||
155289877|NCT05827926|560492343|FG010|Overall Study|Other Than Specified|0|||
155289878|NCT05827926|560492344|FG011|Overall Study|Other Than Specified|0|||
155289879|NCT05827926|560492345|FG012|Overall Study|Other Than Specified|0|||
155289880|NCT05827926|560492346|FG013|Overall Study|Other Than Specified|1|||
155289881|NCT05827926|560492347|FG014|Overall Study|Other Than Specified|0|||
155289882|NCT05827926|560492348|FG015|Overall Study|Other Than Specified|1|||
155289883|NCT05827926|560492349|FG016|Overall Study|Other Than Specified|0|||
155289884|NCT05827926|560492350|FG017|Overall Study|Other Than Specified|0|||
155289885|NCT05827926|560492351|FG018|Overall Study|Other Than Specified|0|||
155289886|NCT05827926|560492352|FG019|Overall Study|Other Than Specified|0|||
155289887|NCT05827926|560492353|FG020|Overall Study|Other Than Specified|0|||
155289888|NCT05827926|560492354|FG021|Overall Study|Other Than Specified|1|||
155289889|NCT05827926|560492355|FG022|Overall Study|Other Than Specified|1|||
155289890|NCT05827926|560492356|FG023|Overall Study|Other Than Specified|0|||
155289891|NCT05827926|560492357|FG024|Overall Study|Other Than Specified|0|||
155289892|NCT05827926|560492358|FG025|Overall Study|Other Than Specified|1|||
155289893|NCT05827926|560492359|FG026|Overall Study|Other Than Specified|0|||
155289894|NCT05827926|560492360|FG027|Overall Study|Other Than Specified|0|||
155289895|NCT05827926|560492361|FG028|Overall Study|Other Than Specified|0|||
155289896|NCT05827926|560492362|FG029|Overall Study|Other Than Specified|0|||
155289897|NCT05827926|560492363|FG030|Overall Study|Other Than Specified|0|||
155289898|NCT05827926|560492364|FG031|Overall Study|Other Than Specified|1|||
155289899|NCT05827926|560492365|FG032|Overall Study|Other Than Specified|0|||
155289900|NCT05827926|560492366|FG033|Overall Study|Other Than Specified|0|||
155289901|NCT05827926|560492367|FG034|Overall Study|Other Than Specified|0|||
155289902|NCT05827926|560492368|FG035|Overall Study|Other Than Specified|0|||
155289903|NCT05827926|560492369|FG036|Overall Study|Other Than Specified|0|||
155289904|NCT05827926|560492333|FG000|Overall Study|Physician Decision|0|||
155289905|NCT05827926|560492334|FG001|Overall Study|Physician Decision|0|||
155289906|NCT05827926|560492335|FG002|Overall Study|Physician Decision|0|||
155289907|NCT05827926|560492336|FG003|Overall Study|Physician Decision|0|||
155289908|NCT05827926|560492337|FG004|Overall Study|Physician Decision|0|||
155289909|NCT05827926|560492338|FG005|Overall Study|Physician Decision|0|||
155289910|NCT05827926|560492339|FG006|Overall Study|Physician Decision|0|||
155289911|NCT05827926|560492340|FG007|Overall Study|Physician Decision|0|||
155289912|NCT05827926|560492341|FG008|Overall Study|Physician Decision|0|||
155289913|NCT05827926|560492342|FG009|Overall Study|Physician Decision|0|||
155289914|NCT05827926|560492343|FG010|Overall Study|Physician Decision|0|||
155289915|NCT05827926|560492344|FG011|Overall Study|Physician Decision|0|||
155289916|NCT05827926|560492345|FG012|Overall Study|Physician Decision|0|||
155289917|NCT05827926|560492346|FG013|Overall Study|Physician Decision|0|||
155289918|NCT05827926|560492347|FG014|Overall Study|Physician Decision|0|||
155289919|NCT05827926|560492348|FG015|Overall Study|Physician Decision|0|||
155289920|NCT05827926|560492349|FG016|Overall Study|Physician Decision|0|||
155289921|NCT05827926|560492350|FG017|Overall Study|Physician Decision|0|||
155289922|NCT05827926|560492351|FG018|Overall Study|Physician Decision|1|||
155289923|NCT05827926|560492352|FG019|Overall Study|Physician Decision|0|||
155289924|NCT05827926|560492353|FG020|Overall Study|Physician Decision|0|||
155289925|NCT05827926|560492354|FG021|Overall Study|Physician Decision|0|||
155289926|NCT05827926|560492355|FG022|Overall Study|Physician Decision|0|||
155289927|NCT05827926|560492356|FG023|Overall Study|Physician Decision|0|||
155289928|NCT05827926|560492357|FG024|Overall Study|Physician Decision|0|||
155289929|NCT05827926|560492358|FG025|Overall Study|Physician Decision|0|||
155289930|NCT05827926|560492359|FG026|Overall Study|Physician Decision|0|||
155289931|NCT05827926|560492360|FG027|Overall Study|Physician Decision|0|||
155289932|NCT05827926|560492361|FG028|Overall Study|Physician Decision|0|||
155289933|NCT05827926|560492362|FG029|Overall Study|Physician Decision|0|||
155289934|NCT05827926|560492363|FG030|Overall Study|Physician Decision|0|||
155289935|NCT05827926|560492364|FG031|Overall Study|Physician Decision|0|||
155289936|NCT05827926|560492365|FG032|Overall Study|Physician Decision|0|||
155289937|NCT05827926|560492366|FG033|Overall Study|Physician Decision|0|||
155289938|NCT05827926|560492367|FG034|Overall Study|Physician Decision|0|||
155289939|NCT05827926|560492368|FG035|Overall Study|Physician Decision|0|||
155289940|NCT05827926|560492369|FG036|Overall Study|Physician Decision|0|||
155289941|NCT05197049|560492370|FG000|Overall Study|Death|0|||
155289942|NCT05197049|560492371|FG001|Overall Study|Death|1|||
155289943|NCT05197049|560492372|FG002|Overall Study|Death|0|||
155289944|NCT05197049|560492370|FG000|Overall Study|Lost to Follow-up|3|||
155289945|NCT05197049|560492371|FG001|Overall Study|Lost to Follow-up|1|||
155289946|NCT05197049|560492372|FG002|Overall Study|Lost to Follow-up|0|||
155289947|NCT05197049|560492370|FG000|Overall Study|Withdrawal by Subject|15|||
155289948|NCT05197049|560492371|FG001|Overall Study|Withdrawal by Subject|3|||
155289949|NCT05197049|560492372|FG002|Overall Study|Withdrawal by Subject|1|||
155289950|NCT05197049|560492370|FG000|Overall Study|GCP non-compliance|1|||
155289951|NCT05197049|560492371|FG001|Overall Study|GCP non-compliance|2|||
155289952|NCT05197049|560492372|FG002|Overall Study|GCP non-compliance|0|||
155289953|NCT04889118|560492373|FG000|Overall Study|Death|49|||
155289954|NCT04889118|560492374|FG001|Overall Study|Death|47|||
154954977|NCT00050778|559261789|FG002|Overall Study|Death|1|||
155289955|NCT04889118|560492373|FG000|Overall Study|Sponsor Decision|15|||
155289956|NCT04889118|560492374|FG001|Overall Study|Sponsor Decision|20|||
155289957|NCT02846415|560492379|FG000|Overall Study|Lost to Follow-up|2|||
155289958|NCT02846415|560492380|FG001|Overall Study|Lost to Follow-up|0|||
155289959|NCT02846415|560492379|FG000|Overall Study|Withdrawal by Subject|1|||
155289960|NCT02846415|560492380|FG001|Overall Study|Withdrawal by Subject|1|||
155289961|NCT05576051|560492381|FG000|Overall Study|Lack of Efficacy|543|||
155289962|NCT05576051|560492382|FG001|Overall Study|Lack of Efficacy|343|||
155289963|NCT05576051|560492383|FG002|Overall Study|Lack of Efficacy|108|||
155289964|NCT05576051|560492384|FG003|Overall Study|Lack of Efficacy|72|||
155289965|NCT05576051|560492385|FG004|Overall Study|Lack of Efficacy|28|||
155289966|NCT05576051|560492386|FG005|Overall Study|Lack of Efficacy|50|||
155289967|NCT05576051|560492381|FG000|Overall Study|Safety|78|||
155289968|NCT05576051|560492382|FG001|Overall Study|Safety|74|||
155289969|NCT05576051|560492383|FG002|Overall Study|Safety|16|||
155289970|NCT05576051|560492384|FG003|Overall Study|Safety|14|||
155289971|NCT05576051|560492385|FG004|Overall Study|Safety|4|||
155289972|NCT05576051|560492386|FG005|Overall Study|Safety|5|||
155289973|NCT05576051|560492381|FG000|Overall Study|Efficacy + Safety|10|||
155289974|NCT05576051|560492382|FG001|Overall Study|Efficacy + Safety|7|||
155289975|NCT05576051|560492383|FG002|Overall Study|Efficacy + Safety|3|||
155289976|NCT05576051|560492384|FG003|Overall Study|Efficacy + Safety|0|||
155289977|NCT05576051|560492385|FG004|Overall Study|Efficacy + Safety|0|||
155289978|NCT05576051|560492386|FG005|Overall Study|Efficacy + Safety|0|||
155289979|NCT05576051|560492381|FG000|Overall Study|Other|231|||
155289980|NCT05576051|560492382|FG001|Overall Study|Other|127|||
155289981|NCT05576051|560492383|FG002|Overall Study|Other|35|||
155289982|NCT05576051|560492384|FG003|Overall Study|Other|14|||
155289983|NCT05576051|560492385|FG004|Overall Study|Other|6|||
155289984|NCT05576051|560492386|FG005|Overall Study|Other|0|||
155289985|NCT04154943|560492387|FG000|Overall Study|Study Ongoing|68|||
155289986|NCT04154943|560492387|FG000|Overall Study|Lost to Follow-up|1|||
155289987|NCT04154943|560492387|FG000|Overall Study|Decision by the Investigator|1|||
155289988|NCT04154943|560492387|FG000|Overall Study|Death|5|||
155289989|NCT04154943|560492387|FG000|Overall Study|Withdrawal by Subject|4|||
155289990|NCT03381274|560492390|FG000|Overall Study|Death|2|||
155289991|NCT03381274|560492391|FG001|Overall Study|Death|9|||
155289992|NCT03381274|560492392|FG002|Overall Study|Death|3|||
155289993|NCT03381274|560492393|FG003|Overall Study|Death|2|||
155289994|NCT03381274|560492394|FG004|Overall Study|Death|3|||
155289995|NCT03381274|560492390|FG000|Overall Study|Lost to Follow-up|0|||
155289996|NCT03381274|560492391|FG001|Overall Study|Lost to Follow-up|0|||
155289997|NCT03381274|560492392|FG002|Overall Study|Lost to Follow-up|0|||
155289998|NCT03381274|560492393|FG003|Overall Study|Lost to Follow-up|1|||
155289999|NCT03381274|560492394|FG004|Overall Study|Lost to Follow-up|0|||
155290000|NCT03381274|560492390|FG000|Overall Study|Withdrawal by Subject|2|||
155290001|NCT03381274|560492391|FG001|Overall Study|Withdrawal by Subject|1|||
155290002|NCT03381274|560492392|FG002|Overall Study|Withdrawal by Subject|3|||
155290003|NCT03381274|560492393|FG003|Overall Study|Withdrawal by Subject|1|||
155290004|NCT03381274|560492394|FG004|Overall Study|Withdrawal by Subject|0|||
155290005|NCT03381274|560492390|FG000|Overall Study|Other|1|||
155290006|NCT03381274|560492391|FG001|Overall Study|Other|11|||
155290007|NCT03381274|560492392|FG002|Overall Study|Other|0|||
155290008|NCT03381274|560492393|FG003|Overall Study|Other|2|||
155290009|NCT03381274|560492394|FG004|Overall Study|Other|2|||
155290010|NCT05916170|560492395|FG000|No Warning Control|Lost to Follow-up|12|||
155290011|NCT05916170|560492395|FG000|No Warning Control|Withdrawal by Subject|15|||
155290012|NCT05916170|560492395|FG000|No Warning Control|Noncompliance with protocol|1|||
155290013|NCT05916170|560492395|FG000|Health Warning Intervention|Lost to Follow-up|15|||
155290014|NCT05916170|560492395|FG000|Health Warning Intervention|Withdrawal by Subject|10|||
155290015|NCT05916170|560492395|FG000|Health Warning Intervention|Noncompliance with protocol|14|||
155290016|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
155290017|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
155290018|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
155290019|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
155290020|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
155290021|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
155290022|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
155290023|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
155290024|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
155290025|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
155290026|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
155290027|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
155290028|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
155290029|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
155290030|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
155290031|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
155290032|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
155290033|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
155290034|NCT03412747|560492396|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
155290035|NCT03412747|560492397|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
155290036|NCT03412747|560492398|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
155290037|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
155290038|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
155290039|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
155290040|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
155290041|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
155290042|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
155290043|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
155290044|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
155290045|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
155290046|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
155290047|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
155290048|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
155290049|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
155290050|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
155290051|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
155290052|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
155290053|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
155290054|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
155290055|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
155290056|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
155290057|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
155290058|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
155290059|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
155290060|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
155290061|NCT03412747|560492396|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
155290062|NCT03412747|560492397|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
155290063|NCT03412747|560492398|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
155290064|NCT04075266|560492399|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
155290065|NCT04075266|560492400|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
155290066|NCT04075266|560492399|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
155290067|NCT04075266|560492400|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
155290068|NCT03473743|560492403|FG000|Overall Study|Withdrawal by Subject|0|||
155290069|NCT03473743|560492404|FG001|Overall Study|Withdrawal by Subject|0|||
155290070|NCT03473743|560492405|FG002|Overall Study|Withdrawal by Subject|0|||
155290071|NCT03473743|560492406|FG003|Overall Study|Withdrawal by Subject|0|||
155290072|NCT03473743|560492407|FG004|Overall Study|Withdrawal by Subject|0|||
155290073|NCT03473743|560492408|FG005|Overall Study|Withdrawal by Subject|0|||
155290074|NCT03473743|560492409|FG006|Overall Study|Withdrawal by Subject|0|||
155290075|NCT03473743|560492410|FG007|Overall Study|Withdrawal by Subject|3|||
155290076|NCT03473743|560492403|FG000|Overall Study|Other|0|||
155290077|NCT03473743|560492404|FG001|Overall Study|Other|0|||
155290078|NCT03473743|560492405|FG002|Overall Study|Other|0|||
155290079|NCT03473743|560492406|FG003|Overall Study|Other|1|||
155290080|NCT03473743|560492407|FG004|Overall Study|Other|0|||
155290081|NCT03473743|560492408|FG005|Overall Study|Other|0|||
155290082|NCT03473743|560492409|FG006|Overall Study|Other|0|||
155290083|NCT03473743|560492410|FG007|Overall Study|Other|0|||
155290084|NCT03473743|560492403|FG000|Overall Study|Ongoing|0|||
155290085|NCT03473743|560492404|FG001|Overall Study|Ongoing|0|||
155290086|NCT03473743|560492405|FG002|Overall Study|Ongoing|6|||
155290087|NCT03473743|560492406|FG003|Overall Study|Ongoing|8|||
155290088|NCT03473743|560492407|FG004|Overall Study|Ongoing|1|||
155290089|NCT03473743|560492408|FG005|Overall Study|Ongoing|1|||
155290090|NCT03473743|560492409|FG006|Overall Study|Ongoing|22|||
155290091|NCT03473743|560492410|FG007|Overall Study|Ongoing|24|||
155290092|NCT03473743|560492403|FG000|Overall Study|Randomized but not treated|0|||
155290093|NCT03473743|560492404|FG001|Overall Study|Randomized but not treated|0|||
155290094|NCT03473743|560492405|FG002|Overall Study|Randomized but not treated|0|||
155290095|NCT03473743|560492406|FG003|Overall Study|Randomized but not treated|0|||
155290096|NCT03473743|560492407|FG004|Overall Study|Randomized but not treated|0|||
155290097|NCT03473743|560492408|FG005|Overall Study|Randomized but not treated|0|||
155290098|NCT03473743|560492409|FG006|Overall Study|Randomized but not treated|1|||
155290099|NCT03473743|560492410|FG007|Overall Study|Randomized but not treated|1|||
155290100|NCT02864992|560492415|FG000|Overall Study|still on treatment|15|||
155290101|NCT02864992|560492416|FG001|Overall Study|still on treatment|1|||
155290102|NCT02864992|560492417|FG002|Overall Study|still on treatment|33|||
155290103|NCT04982575|560492418|FG000|Overall Study|Withdrawal by Subject|2|||
155290104|NCT04982575|560492419|FG001|Overall Study|Withdrawal by Subject|0|||
155290105|NCT04982575|560492420|FG002|Overall Study|Withdrawal by Subject|2|||
155290106|NCT04948333|560492423|FG000|Overall Study|Adverse Event|6|||
155290107|NCT04948333|560492424|FG001|Overall Study|Adverse Event|4|||
155290108|NCT04948333|560492425|FG002|Overall Study|Adverse Event|0|||
155290109|NCT04948333|560492426|FG003|Overall Study|Adverse Event|2|||
155290110|NCT04948333|560492423|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155290111|NCT04948333|560492424|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155290112|NCT04948333|560492425|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155290113|NCT04948333|560492426|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155290114|NCT04948333|560492423|FG000|Overall Study|Progressive Disease|1|||
155290115|NCT04948333|560492424|FG001|Overall Study|Progressive Disease|5|||
155290116|NCT04948333|560492425|FG002|Overall Study|Progressive Disease|0|||
155290117|NCT04948333|560492426|FG003|Overall Study|Progressive Disease|0|||
155290118|NCT04948333|560492423|FG000|Overall Study|Physician Decision|2|||
155290119|NCT04948333|560492424|FG001|Overall Study|Physician Decision|2|||
155290120|NCT04948333|560492425|FG002|Overall Study|Physician Decision|0|||
155290121|NCT04948333|560492426|FG003|Overall Study|Physician Decision|0|||
155290122|NCT04948333|560492423|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
155290123|NCT04948333|560492424|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
155290124|NCT04948333|560492425|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
155290125|NCT04948333|560492426|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
155290126|NCT04948333|560492423|FG000|Overall Study|Withdrawal by Subject|2|||
155290127|NCT04948333|560492424|FG001|Overall Study|Withdrawal by Subject|0|||
155290128|NCT04948333|560492425|FG002|Overall Study|Withdrawal by Subject|0|||
155290129|NCT04948333|560492426|FG003|Overall Study|Withdrawal by Subject|1|||
155290130|NCT04948333|560492423|FG000|Overall Study|Protocol Violation|0|||
155290131|NCT04948333|560492424|FG001|Overall Study|Protocol Violation|1|||
155290132|NCT04948333|560492425|FG002|Overall Study|Protocol Violation|0|||
155290133|NCT04948333|560492426|FG003|Overall Study|Protocol Violation|0|||
155290134|NCT04948333|560492423|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
155290135|NCT04948333|560492424|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
155290136|NCT04948333|560492425|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
155290137|NCT04948333|560492426|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
155290138|NCT03038022|560492427|FG000|Overall Study|Withdrawal by Subject|2|||
155290139|NCT03038022|560492428|FG001|Overall Study|Withdrawal by Subject|0|||
155290140|NCT03038022|560492427|FG000|Overall Study|Adverse Event|4|||
155290141|NCT03038022|560492428|FG001|Overall Study|Adverse Event|2|||
155290142|NCT03887936|560492429|FG000|Overall Study|Relocation|2|||
155290143|NCT03887936|560492430|FG001|Overall Study|Relocation|2|||
155290144|NCT03887936|560492429|FG000|Overall Study|Physician Decision|0|||
155290145|NCT03887936|560492430|FG001|Overall Study|Physician Decision|1|||
155290146|NCT03887936|560492429|FG000|Overall Study|Withdrawal by Subject|0|||
155290147|NCT03887936|560492430|FG001|Overall Study|Withdrawal by Subject|1|||
155290148|NCT00539591|560492431|FG000|Overall Study|Toxicity|3|||
155290149|NCT00539591|560492432|FG001|Overall Study|Toxicity|0|||
155290150|NCT00539591|560492433|FG002|Overall Study|Toxicity|0|||
155290151|NCT00539591|560492431|FG000|Overall Study|Disease progression|2|||
155290152|NCT00539591|560492432|FG001|Overall Study|Disease progression|2|||
155290153|NCT00539591|560492433|FG002|Overall Study|Disease progression|3|||
155290154|NCT06269367|560492434|FG000|Phase I|Unable to perform study procedures|0|||
155290155|NCT06269367|560492435|FG001|Phase I|Unable to perform study procedures|1|||
155290156|NCT06269367|560492434|FG000|Phase I|Could not continue study for personal reasons.|1|||
155290157|NCT06269367|560492435|FG001|Phase I|Could not continue study for personal reasons.|0|||
155290158|NCT03331250|560492436|FG000|Overall Study|Withdrawal by Subject|1|||
155290159|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
155290160|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
155290161|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
155290162|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
155290163|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
155290164|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
155290165|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
155290166|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
155290167|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
155290168|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
155290169|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
155290170|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
155290171|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
155290172|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
155290173|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
155290174|NCT02137850|560492440|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
155290175|NCT02137850|560492441|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
155290176|NCT02137850|560492442|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
155290177|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290178|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
155290179|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290180|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
155290181|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
155290182|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
155290183|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
155290184|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
155290185|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
155290186|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
155290187|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
155290188|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
155290189|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Other|0|||
155290190|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Other|1|||
155290191|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Other|0|||
155290192|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
155290193|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
155290194|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
155290195|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Early site closure|0|||
155290196|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Early site closure|2|||
155290197|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Early site closure|0|||
155290198|NCT02137850|560492440|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
155290199|NCT02137850|560492441|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
155290200|NCT02137850|560492442|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
155290201|NCT02137850|560492440|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
155290202|NCT02137850|560492441|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
155290203|NCT02137850|560492442|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
155290204|NCT02137850|560492440|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
155290205|NCT02137850|560492441|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
155290206|NCT02137850|560492442|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
155290207|NCT02137850|560492440|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
155290208|NCT02137850|560492441|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
155290209|NCT02137850|560492442|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
155290210|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
155290211|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
155290212|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
155290213|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
155290214|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
155290215|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
155290216|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290217|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
155290218|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
155290219|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Other|0|||
155290220|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Other|1|||
155290221|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Other|0|||
155290222|NCT02137850|560492440|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
155290223|NCT02137850|560492441|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
155290224|NCT02137850|560492442|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
155290225|NCT02912260|560492443|FG000|Main Study|Lost to Follow-up|5|||
155290226|NCT02912260|560492444|FG001|Main Study|Lost to Follow-up|4|||
155290227|NCT02912260|560492443|FG000|Main Study|Withdrawal by Subject|2|||
155290228|NCT02912260|560492444|FG001|Main Study|Withdrawal by Subject|2|||
155290229|NCT02912260|560492443|FG000|Main Study|Adverse Event|3|||
155290230|NCT02912260|560492444|FG001|Main Study|Adverse Event|0|||
155290231|NCT02912260|560492443|FG000|Main Study|Physician Decision|0|||
155290232|NCT02912260|560492444|FG001|Main Study|Physician Decision|1|||
155290233|NCT02912260|560492443|FG000|Extension Study|Withdrawal by Subject|1|||
155290234|NCT02912260|560492444|FG001|Extension Study|Withdrawal by Subject|1|||
155290235|NCT00980538|560492446|FG000|Overall Study|Lost to Follow-up|20|||
155290236|NCT00980538|560492446|FG000|Overall Study|Sponsor's Decision|4|||
155290237|NCT00980538|560492446|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
155290238|NCT00980538|560492446|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
155290239|NCT00980538|560492446|FG000|Overall Study|Switch to Commercially Available Medication|25|||
155290240|NCT00980538|560492446|FG000|Overall Study|Participant Non-Compliant|9|||
154954978|NCT00050778|559261787|FG000|Overall Study|Lack of Efficacy|16|||
154954979|NCT00050778|559261788|FG001|Overall Study|Lack of Efficacy|2|||
154954980|NCT00050778|559261789|FG002|Overall Study|Lack of Efficacy|2|||
154954981|NCT00050778|559261787|FG000|Overall Study|Lost to Follow-up|0|||
154954982|NCT00050778|559261788|FG001|Overall Study|Lost to Follow-up|2|||
154954983|NCT00050778|559261789|FG002|Overall Study|Lost to Follow-up|4|||
154954984|NCT00050778|559261787|FG000|Overall Study|Physician Decision|3|||
154954985|NCT00050778|559261788|FG001|Overall Study|Physician Decision|0|||
154954986|NCT00050778|559261789|FG002|Overall Study|Physician Decision|2|||
154954987|NCT00050778|559261787|FG000|Overall Study|Protocol Violation|2|||
154954988|NCT00050778|559261788|FG001|Overall Study|Protocol Violation|0|||
154954989|NCT00050778|559261789|FG002|Overall Study|Protocol Violation|1|||
154954990|NCT00050778|559261787|FG000|Overall Study|Withdrawal by Subject|6|||
154954991|NCT00050778|559261788|FG001|Overall Study|Withdrawal by Subject|8|||
154954992|NCT00050778|559261789|FG002|Overall Study|Withdrawal by Subject|4|||
154954993|NCT00050778|559261787|FG000|Overall Study|Randomized but not treated|4|||
154954994|NCT00050778|559261788|FG001|Overall Study|Randomized but not treated|5|||
154954995|NCT00050778|559261789|FG002|Overall Study|Randomized but not treated|2|||
154954996|NCT00050778|559261787|FG000|Overall Study|Familial and personal reasons|1|||
154954997|NCT00050778|559261788|FG001|Overall Study|Familial and personal reasons|0|||
154954998|NCT00050778|559261789|FG002|Overall Study|Familial and personal reasons|0|||
154954999|NCT02511782|559261790|FG000|Overall Study|Withdrawal by Subject|1|||
154955000|NCT02511782|559261791|FG001|Overall Study|Withdrawal by Subject|0|||
154955001|NCT02511782|559261792|FG002|Overall Study|Withdrawal by Subject|0|||
154955002|NCT00579670|559261793|FG000|Overall Study|Death|1|||
154955003|NCT00579670|559261794|FG001|Overall Study|Death|0|||
154955004|NCT00579670|559261795|FG002|Overall Study|Death|0|||
154955005|NCT00579670|559261796|FG003|Overall Study|Death|0|||
154955006|NCT00579670|559261797|FG004|Overall Study|Death|0|||
154955007|NCT00579670|559261793|FG000|Overall Study|Adverse Event|1|||
154955008|NCT00579670|559261794|FG001|Overall Study|Adverse Event|0|||
154955009|NCT00579670|559261795|FG002|Overall Study|Adverse Event|1|||
154955010|NCT00579670|559261796|FG003|Overall Study|Adverse Event|2|||
154955011|NCT00579670|559261797|FG004|Overall Study|Adverse Event|0|||
154955012|NCT00579670|559261793|FG000|Overall Study|Lack of Efficacy|0|||
154955013|NCT00579670|559261794|FG001|Overall Study|Lack of Efficacy|0|||
154955014|NCT00579670|559261795|FG002|Overall Study|Lack of Efficacy|1|||
155290241|NCT00980538|560492446|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
155290242|NCT00980538|560492446|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
155290243|NCT00980538|560492446|FG000|Overall Study|Other|60|||
155290244|NCT00980538|560492446|FG000|Overall Study|Other|1|||
155290245|NCT03878446|560492447|FG000|Overall Study|Withdrawn by parent or guardian|1|||
155290246|NCT03878446|560492448|FG001|Overall Study|Withdrawn by parent or guardian|0|||
155290247|NCT03878446|560492449|FG002|Overall Study|Withdrawn by parent or guardian|0|||
155290248|NCT03878446|560492450|FG003|Overall Study|Withdrawn by parent or guardian|0|||
155290249|NCT03878446|560492451|FG004|Overall Study|Withdrawn by parent or guardian|0|||
155290250|NCT05663866|560492452|FG000|Overall Study|Adverse Event|0|||
155290251|NCT05663866|560492453|FG001|Overall Study|Adverse Event|0|||
155290252|NCT05663866|560492454|FG002|Overall Study|Adverse Event|1|||
155290253|NCT05663866|560492455|FG003|Overall Study|Adverse Event|0|||
155290254|NCT05663866|560492452|FG000|Overall Study|Physician Decision|0|||
155290255|NCT05663866|560492453|FG001|Overall Study|Physician Decision|0|||
155290256|NCT05663866|560492454|FG002|Overall Study|Physician Decision|0|||
155290257|NCT05663866|560492455|FG003|Overall Study|Physician Decision|1|||
155290258|NCT05663866|560492452|FG000|Overall Study|Withdrawal by Subject|0|||
155290259|NCT05663866|560492453|FG001|Overall Study|Withdrawal by Subject|2|||
155290260|NCT05663866|560492454|FG002|Overall Study|Withdrawal by Subject|1|||
155059673|NCT03157089|559653827|FG001|Overall Study|Treated only with pembrolizumab|0|||
155059674|NCT03157089|559653826|FG000|Overall Study|Adverse Event|5|||
155059675|NCT03157089|559653827|FG001|Overall Study|Adverse Event|4|||
155059676|NCT03157089|559653826|FG000|Overall Study|Progressive disease|6|||
155059677|NCT03157089|559653827|FG001|Overall Study|Progressive disease|8|||
155059678|NCT00958074|559653828|FG000|Overall Study|Withdrawal by Subject|0|||
155059679|NCT00958074|559653829|FG001|Overall Study|Withdrawal by Subject|1|||
155059680|NCT00784875|559653830|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
155059681|NCT00784875|559653831|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
155059682|NCT00784875|559653832|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
155059683|NCT00784875|559653833|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
155059684|NCT00784875|559653830|FG000|Period A - Baseline|Adverse Event|0|||
155059685|NCT00784875|559653831|FG001|Period A - Baseline|Adverse Event|0|||
155059686|NCT00784875|559653832|FG002|Period A - Baseline|Adverse Event|0|||
155059687|NCT00784875|559653833|FG003|Period A - Baseline|Adverse Event|8|||
155059688|NCT00784875|559653830|FG000|Period A - Baseline|Protocol Violation|0|||
155059689|NCT00784875|559653831|FG001|Period A - Baseline|Protocol Violation|0|||
155059690|NCT00784875|559653832|FG002|Period A - Baseline|Protocol Violation|0|||
155059691|NCT00784875|559653833|FG003|Period A - Baseline|Protocol Violation|25|||
155059692|NCT00784875|559653830|FG000|Period A - Baseline|Withdrawal by Subject|0|||
155059693|NCT00784875|559653831|FG001|Period A - Baseline|Withdrawal by Subject|0|||
155059694|NCT00784875|559653832|FG002|Period A - Baseline|Withdrawal by Subject|0|||
155059695|NCT00784875|559653833|FG003|Period A - Baseline|Withdrawal by Subject|27|||
155059696|NCT00784875|559653830|FG000|Period A - Baseline|Physician Decision|0|||
155059697|NCT00784875|559653831|FG001|Period A - Baseline|Physician Decision|0|||
155059698|NCT00784875|559653832|FG002|Period A - Baseline|Physician Decision|0|||
155059699|NCT00784875|559653833|FG003|Period A - Baseline|Physician Decision|2|||
155059700|NCT00784875|559653830|FG000|Period A - Baseline|Sponsor Decision|0|||
155059701|NCT00784875|559653831|FG001|Period A - Baseline|Sponsor Decision|0|||
155059702|NCT00784875|559653832|FG002|Period A - Baseline|Sponsor Decision|0|||
155059703|NCT00784875|559653833|FG003|Period A - Baseline|Sponsor Decision|113|||
155059704|NCT00784875|559653830|FG000|Period A - Baseline|Lost to Follow-up|0|||
155059705|NCT00784875|559653831|FG001|Period A - Baseline|Lost to Follow-up|0|||
155059706|NCT00784875|559653832|FG002|Period A - Baseline|Lost to Follow-up|0|||
155290261|NCT05663866|560492455|FG003|Overall Study|Withdrawal by Subject|2|||
155290262|NCT05663866|560492452|FG000|Overall Study|Progressive disease|4|||
155290263|NCT05663866|560492453|FG001|Overall Study|Progressive disease|8|||
155290264|NCT05663866|560492454|FG002|Overall Study|Progressive disease|5|||
155059707|NCT00784875|559653833|FG003|Period A - Baseline|Lost to Follow-up|2|||
155059708|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
155059709|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
155059710|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
155059711|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
155290265|NCT05663866|560492455|FG003|Overall Study|Progressive disease|2|||
155290266|NCT05663866|560492452|FG000|Overall Study|Other|1|||
155059712|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
155059713|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
155059714|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
155290267|NCT05663866|560492453|FG001|Overall Study|Other|0|||
155290268|NCT05663866|560492454|FG002|Overall Study|Other|0|||
155059715|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
155059716|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
155059717|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
155290269|NCT05663866|560492455|FG003|Overall Study|Other|0|||
155290270|NCT05663866|560492452|FG000|Overall Study|Ongoing|1|||
155290271|NCT05663866|560492453|FG001|Overall Study|Ongoing|27|||
155290272|NCT05663866|560492454|FG002|Overall Study|Ongoing|6|||
155290273|NCT05663866|560492455|FG003|Overall Study|Ongoing|1|||
155290274|NCT01467427|560493310|FG000|Overall Study|Withdrawal by Subject|1|||
155290275|NCT01467427|560493311|FG001|Overall Study|Withdrawal by Subject|0|||
155290276|NCT01467427|560493310|FG000|Overall Study|Not continuing in extension phase|0|||
155290277|NCT01467427|560493311|FG001|Overall Study|Not continuing in extension phase|2|||
155290278|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
155290279|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
155290280|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
155290281|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
155290282|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
155290283|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
155290284|NCT01467427|560493310|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
155290285|NCT01467427|560493311|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
155290286|NCT03805295|560493312|FG000|Overall Study|Lost to Follow-up|17|||
155290287|NCT03805295|560493313|FG001|Overall Study|Lost to Follow-up|43|||
155290288|NCT04925752|560493314|FG000|Overall Study|Still on Study|1826|||
154955015|NCT00579670|559261796|FG003|Overall Study|Lack of Efficacy|14|||
155290289|NCT04925752|560493315|FG001|Overall Study|Still on Study|926|||
155290290|NCT04925752|560493314|FG000|Overall Study|Withdrew Consent|128|||
154955016|NCT00579670|559261797|FG004|Overall Study|Lack of Efficacy|0|||
154955017|NCT00579670|559261793|FG000|Overall Study|Lost to Follow-up|0|||
154955018|NCT00579670|559261794|FG001|Overall Study|Lost to Follow-up|1|||
154955019|NCT00579670|559261795|FG002|Overall Study|Lost to Follow-up|0|||
154955020|NCT00579670|559261796|FG003|Overall Study|Lost to Follow-up|4|||
154955021|NCT00579670|559261797|FG004|Overall Study|Lost to Follow-up|0|||
154955022|NCT00579670|559261793|FG000|Overall Study|Other|0|||
154955023|NCT00579670|559261794|FG001|Overall Study|Other|0|||
154955024|NCT00579670|559261795|FG002|Overall Study|Other|1|||
154955025|NCT00579670|559261796|FG003|Overall Study|Other|2|||
154955026|NCT00579670|559261797|FG004|Overall Study|Other|0|||
154955027|NCT00579670|559261793|FG000|Overall Study|Withdrawal by Subject|0|||
154955028|NCT00579670|559261794|FG001|Overall Study|Withdrawal by Subject|0|||
154955029|NCT00579670|559261795|FG002|Overall Study|Withdrawal by Subject|1|||
154955030|NCT00579670|559261796|FG003|Overall Study|Withdrawal by Subject|0|||
154955031|NCT00579670|559261797|FG004|Overall Study|Withdrawal by Subject|0|||
154955032|NCT00986245|559261798|FG000|First Intervention|Poor compliance|8|||
154955033|NCT00986245|559261799|FG001|First Intervention|Poor compliance|4|||
154955034|NCT00986245|559261798|FG000|First Intervention|Lack of Efficacy|1|||
154955035|NCT00986245|559261799|FG001|First Intervention|Lack of Efficacy|2|||
154955036|NCT00986245|559261798|FG000|First Intervention|Withdrawal by Subject|0|||
154955037|NCT00986245|559261799|FG001|First Intervention|Withdrawal by Subject|1|||
154955038|NCT00986245|559261798|FG000|First Intervention|Protocol Violation|0|||
154955039|NCT00986245|559261799|FG001|First Intervention|Protocol Violation|1|||
154955040|NCT00986245|559261798|FG000|First Intervention|Out of indication|1|||
155290291|NCT04925752|560493315|FG001|Overall Study|Withdrew Consent|59|||
155290292|NCT04925752|560493314|FG000|Overall Study|Lost to Follow-up|73|||
155290293|NCT04925752|560493315|FG001|Overall Study|Lost to Follow-up|47|||
155290294|NCT04925752|560493314|FG000|Overall Study|Randomized but Never Treated|12|||
155290295|NCT04925752|560493315|FG001|Overall Study|Randomized but Never Treated|9|||
155290296|NCT04925752|560493314|FG000|Overall Study|Hiv-1 Infection|6|||
155290297|NCT04925752|560493315|FG001|Overall Study|Hiv-1 Infection|7|||
155290298|NCT04925752|560493314|FG000|Overall Study|Investigator's discretion|8|||
155290299|NCT04925752|560493315|FG001|Overall Study|Investigator's discretion|5|||
155290300|NCT04925752|560493314|FG000|Overall Study|Non-compliance with Study Drug|8|||
155290301|NCT04925752|560493315|FG001|Overall Study|Non-compliance with Study Drug|5|||
155290302|NCT04925752|560493314|FG000|Overall Study|Adverse Event|5|||
155290303|NCT04925752|560493315|FG001|Overall Study|Adverse Event|2|||
155290304|NCT04925752|560493314|FG000|Overall Study|Death|4|||
155290305|NCT04925752|560493315|FG001|Overall Study|Death|2|||
155290306|NCT04925752|560493314|FG000|Overall Study|Protocol Violation|1|||
155290307|NCT04925752|560493315|FG001|Overall Study|Protocol Violation|3|||
155290308|NCT04925752|560493314|FG000|Overall Study|Withdrew Assent|1|||
155290309|NCT04925752|560493315|FG001|Overall Study|Withdrew Assent|0|||
155290310|NCT04269200|560493316|FG000|Global Cohort|Death|72|||
155290311|NCT04269200|560493317|FG001|Global Cohort|Death|54|||
155290312|NCT04269200|560493318|FG002|Global Cohort|Death|49|||
155290313|NCT04269200|560493316|FG000|Global Cohort|Lost to Follow-up|0|||
155290314|NCT04269200|560493317|FG001|Global Cohort|Lost to Follow-up|0|||
155290315|NCT04269200|560493318|FG002|Global Cohort|Lost to Follow-up|2|||
155290316|NCT04269200|560493316|FG000|Global Cohort|Withdrawal by Subject|22|||
155290317|NCT04269200|560493317|FG001|Global Cohort|Withdrawal by Subject|25|||
154955041|NCT00986245|559261799|FG001|First Intervention|Out of indication|0|||
155290318|NCT04269200|560493318|FG002|Global Cohort|Withdrawal by Subject|18|||
155290319|NCT04269200|560493316|FG000|China Cohort|Death|12|||
155290320|NCT04269200|560493317|FG001|China Cohort|Death|11|||
155290321|NCT04269200|560493318|FG002|China Cohort|Death|13|||
155290322|NCT04269200|560493316|FG000|China Cohort|Lost to Follow-up|0|||
155290323|NCT04269200|560493317|FG001|China Cohort|Lost to Follow-up|1|||
155290324|NCT04269200|560493318|FG002|China Cohort|Lost to Follow-up|1|||
155290325|NCT04269200|560493316|FG000|China Cohort|Withdrawal by Subject|2|||
155290326|NCT04269200|560493317|FG001|China Cohort|Withdrawal by Subject|2|||
155290327|NCT04269200|560493318|FG002|China Cohort|Withdrawal by Subject|4|||
155290328|NCT04181827|560493319|FG000|Overall Study|Ongoing|124|||
155290329|NCT04181827|560493320|FG001|Overall Study|Ongoing|157|||
155290330|NCT04181827|560493319|FG000|Overall Study|Death|82|||
155290331|NCT04181827|560493320|FG001|Overall Study|Death|50|||
155290332|NCT04181827|560493319|FG000|Overall Study|Lost to Follow-up|0|||
155290333|NCT04181827|560493320|FG001|Overall Study|Lost to Follow-up|1|||
155290334|NCT04181827|560493319|FG000|Overall Study|Withdrawal by Subject|5|||
155059718|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
155059719|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
155059720|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
155059721|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
155059722|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
155059723|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
155059724|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
155059725|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
155059726|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
155059727|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
155059728|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
155059729|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
155059730|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
155059731|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
155059732|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
155059733|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
155059734|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
155059735|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
155059736|NCT00784875|559653830|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
155059737|NCT00784875|559653831|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
155059738|NCT00784875|559653832|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
155059739|NCT00784875|559653833|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
155059740|NCT00784875|559653830|FG000|Period C|Adverse Event|1|||
155059741|NCT00784875|559653831|FG001|Period C|Adverse Event|0|||
155059742|NCT00784875|559653832|FG002|Period C|Adverse Event|4|||
155059743|NCT00784875|559653833|FG003|Period C|Adverse Event|2|||
155059744|NCT00784875|559653830|FG000|Period C|Protocol Violation|0|||
155059745|NCT00784875|559653831|FG001|Period C|Protocol Violation|0|||
155059746|NCT00784875|559653832|FG002|Period C|Protocol Violation|1|||
155059747|NCT00784875|559653833|FG003|Period C|Protocol Violation|2|||
155059748|NCT00784875|559653830|FG000|Period C|Lack of Efficacy|0|||
155059749|NCT00784875|559653831|FG001|Period C|Lack of Efficacy|0|||
155059750|NCT00784875|559653832|FG002|Period C|Lack of Efficacy|1|||
155059751|NCT00784875|559653833|FG003|Period C|Lack of Efficacy|0|||
155059752|NCT00784875|559653830|FG000|Period C|Withdrawal by Subject|1|||
155059753|NCT00784875|559653831|FG001|Period C|Withdrawal by Subject|1|||
155059754|NCT00784875|559653832|FG002|Period C|Withdrawal by Subject|2|||
155059755|NCT00784875|559653833|FG003|Period C|Withdrawal by Subject|0|||
155059756|NCT00784875|559653830|FG000|Period C|Physician Decision|0|||
155059757|NCT00784875|559653831|FG001|Period C|Physician Decision|0|||
155290335|NCT04181827|560493320|FG001|Overall Study|Withdrawal by Subject|0|||
155059758|NCT00784875|559653832|FG002|Period C|Physician Decision|1|||
155059759|NCT00784875|559653833|FG003|Period C|Physician Decision|1|||
155059760|NCT00784875|559653830|FG000|Period C|Sponsor Decision|5|||
155059761|NCT00784875|559653831|FG001|Period C|Sponsor Decision|5|||
155059762|NCT00784875|559653832|FG002|Period C|Sponsor Decision|4|||
155059763|NCT00784875|559653833|FG003|Period C|Sponsor Decision|2|||
155059764|NCT00784875|559653830|FG000|Period D|Adverse Event|0|||
155059765|NCT00784875|559653831|FG001|Period D|Adverse Event|2|||
155059766|NCT00784875|559653832|FG002|Period D|Adverse Event|2|||
155059767|NCT00784875|559653833|FG003|Period D|Adverse Event|0|||
155059768|NCT00784875|559653830|FG000|Period D|Protocol Violation|1|||
155059769|NCT00784875|559653831|FG001|Period D|Protocol Violation|0|||
155290336|NCT04538664|560493321|FG000|Overall Study|Withdrawal by Subject|5|||
155059770|NCT00784875|559653832|FG002|Period D|Protocol Violation|0|||
155059771|NCT00784875|559653833|FG003|Period D|Protocol Violation|0|||
155059772|NCT00784875|559653830|FG000|Period D|Withdrawal by Subject|2|||
155059773|NCT00784875|559653831|FG001|Period D|Withdrawal by Subject|0|||
155059774|NCT00784875|559653832|FG002|Period D|Withdrawal by Subject|2|||
155059775|NCT00784875|559653833|FG003|Period D|Withdrawal by Subject|0|||
155290337|NCT04538664|560493322|FG001|Overall Study|Withdrawal by Subject|9|||
155290338|NCT04538664|560493321|FG000|Overall Study|Lost to Follow-up|2|||
155290339|NCT04538664|560493322|FG001|Overall Study|Lost to Follow-up|1|||
155290340|NCT04538664|560493321|FG000|Overall Study|Ongoing|106|||
155290341|NCT04538664|560493322|FG001|Overall Study|Ongoing|115|||
155290342|NCT03681678|560493323|FG000|Overall Study|Lost to Follow-up|20|||
155290343|NCT03431350|560493324|FG000|Overall Study|ONGOING|0|||
155290344|NCT03431350|560493325|FG001|Overall Study|ONGOING|0|||
155290345|NCT03431350|560493326|FG002|Overall Study|ONGOING|2|||
155290346|NCT03431350|560493327|FG003|Overall Study|ONGOING|0|||
155290347|NCT03431350|560493328|FG004|Overall Study|ONGOING|1|||
155290348|NCT03431350|560493329|FG005|Overall Study|ONGOING|3|||
155290349|NCT03431350|560493330|FG006|Overall Study|ONGOING|0|||
155290350|NCT03431350|560493331|FG007|Overall Study|ONGOING|1|||
155290351|NCT03431350|560493332|FG008|Overall Study|ONGOING|3|||
155290352|NCT03431350|560493333|FG009|Overall Study|ONGOING|4|||
155290353|NCT03431350|560493334|FG010|Overall Study|ONGOING|2|||
155290354|NCT03431350|560493335|FG011|Overall Study|ONGOING|1|||
155290355|NCT03431350|560493324|FG000|Overall Study|Death|6|||
155290356|NCT03431350|560493325|FG001|Overall Study|Death|5|||
155290357|NCT03431350|560493326|FG002|Overall Study|Death|18|||
155290358|NCT03431350|560493327|FG003|Overall Study|Death|7|||
155290359|NCT03431350|560493328|FG004|Overall Study|Death|4|||
155290360|NCT03431350|560493329|FG005|Overall Study|Death|3|||
155290361|NCT03431350|560493330|FG006|Overall Study|Death|2|||
155290362|NCT03431350|560493331|FG007|Overall Study|Death|0|||
155290363|NCT03431350|560493332|FG008|Overall Study|Death|0|||
155290364|NCT03431350|560493333|FG009|Overall Study|Death|0|||
155290365|NCT03431350|560493334|FG010|Overall Study|Death|4|||
155290366|NCT03431350|560493335|FG011|Overall Study|Death|0|||
155290367|NCT03431350|560493324|FG000|Overall Study|Lost to Follow-up|0|||
155290368|NCT03431350|560493325|FG001|Overall Study|Lost to Follow-up|1|||
155290369|NCT03431350|560493326|FG002|Overall Study|Lost to Follow-up|0|||
155290370|NCT03431350|560493327|FG003|Overall Study|Lost to Follow-up|0|||
155290371|NCT03431350|560493328|FG004|Overall Study|Lost to Follow-up|0|||
155290372|NCT03431350|560493329|FG005|Overall Study|Lost to Follow-up|0|||
155290373|NCT03431350|560493330|FG006|Overall Study|Lost to Follow-up|0|||
155290374|NCT03431350|560493331|FG007|Overall Study|Lost to Follow-up|0|||
155059776|NCT00784875|559653830|FG000|Period D|Physician Decision|0|||
155059777|NCT00784875|559653831|FG001|Period D|Physician Decision|1|||
155059778|NCT00784875|559653832|FG002|Period D|Physician Decision|0|||
155059779|NCT00784875|559653833|FG003|Period D|Physician Decision|0|||
155059780|NCT00784875|559653830|FG000|Period D|Sponsor Decision|1|||
155059781|NCT00784875|559653831|FG001|Period D|Sponsor Decision|1|||
155059782|NCT00784875|559653832|FG002|Period D|Sponsor Decision|1|||
155059783|NCT00784875|559653833|FG003|Period D|Sponsor Decision|0|||
155059784|NCT00784875|559653830|FG000|Period D|Lost to Follow-up|1|||
155059785|NCT00784875|559653831|FG001|Period D|Lost to Follow-up|0|||
155059786|NCT00784875|559653832|FG002|Period D|Lost to Follow-up|1|||
155059787|NCT00784875|559653833|FG003|Period D|Lost to Follow-up|1|||
155059788|NCT00853385|559653834|FG000|Overall Study|Death|0|||
155059789|NCT00853385|559653835|FG001|Overall Study|Death|0|||
155059790|NCT00853385|559653836|FG002|Overall Study|Death|0|||
155059791|NCT00853385|559653837|FG003|Overall Study|Death|0|||
155059792|NCT00853385|559653838|FG004|Overall Study|Death|1|||
155290375|NCT03431350|560493332|FG008|Overall Study|Lost to Follow-up|0|||
155290376|NCT03431350|560493333|FG009|Overall Study|Lost to Follow-up|0|||
155290377|NCT03431350|560493334|FG010|Overall Study|Lost to Follow-up|0|||
155290378|NCT03431350|560493335|FG011|Overall Study|Lost to Follow-up|0|||
155290379|NCT03431350|560493324|FG000|Overall Study|Withdrawal by Subject|0|||
155290380|NCT03431350|560493325|FG001|Overall Study|Withdrawal by Subject|0|||
155290381|NCT03431350|560493326|FG002|Overall Study|Withdrawal by Subject|0|||
155290382|NCT03431350|560493327|FG003|Overall Study|Withdrawal by Subject|1|||
155059793|NCT00853385|559653834|FG000|Overall Study|Adverse Event|24|||
155059794|NCT00853385|559653835|FG001|Overall Study|Adverse Event|24|||
155290383|NCT03431350|560493328|FG004|Overall Study|Withdrawal by Subject|1|||
155059795|NCT00853385|559653836|FG002|Overall Study|Adverse Event|2|||
155290384|NCT03431350|560493329|FG005|Overall Study|Withdrawal by Subject|1|||
155290385|NCT03431350|560493330|FG006|Overall Study|Withdrawal by Subject|0|||
155059796|NCT00853385|559653837|FG003|Overall Study|Adverse Event|5|||
155059797|NCT00853385|559653838|FG004|Overall Study|Adverse Event|22|||
155059798|NCT00853385|559653834|FG000|Overall Study|Lack of Efficacy|6|||
155059799|NCT00853385|559653835|FG001|Overall Study|Lack of Efficacy|7|||
155059800|NCT00853385|559653836|FG002|Overall Study|Lack of Efficacy|3|||
155059801|NCT00853385|559653837|FG003|Overall Study|Lack of Efficacy|3|||
155059802|NCT00853385|559653838|FG004|Overall Study|Lack of Efficacy|6|||
155290386|NCT03431350|560493331|FG007|Overall Study|Withdrawal by Subject|0|||
155290387|NCT03431350|560493332|FG008|Overall Study|Withdrawal by Subject|0|||
155290388|NCT03431350|560493333|FG009|Overall Study|Withdrawal by Subject|2|||
155290389|NCT03431350|560493334|FG010|Overall Study|Withdrawal by Subject|0|||
155290390|NCT03431350|560493335|FG011|Overall Study|Withdrawal by Subject|1|||
155290391|NCT03431350|560493324|FG000|Overall Study|Other|0|||
155290392|NCT03431350|560493325|FG001|Overall Study|Other|0|||
155290393|NCT03431350|560493326|FG002|Overall Study|Other|1|||
155290394|NCT03431350|560493327|FG003|Overall Study|Other|3|||
155290395|NCT03431350|560493328|FG004|Overall Study|Other|2|||
155290396|NCT03431350|560493329|FG005|Overall Study|Other|2|||
155290397|NCT03431350|560493330|FG006|Overall Study|Other|4|||
155290398|NCT03431350|560493331|FG007|Overall Study|Other|0|||
155290399|NCT03431350|560493332|FG008|Overall Study|Other|14|||
155290400|NCT03431350|560493333|FG009|Overall Study|Other|11|||
155290401|NCT03431350|560493334|FG010|Overall Study|Other|11|||
155290402|NCT03431350|560493335|FG011|Overall Study|Other|15|||
155290403|NCT02141074|560493338|FG000|Pre-prophylaxis|Adverse Event|3|||
155290404|NCT02141074|560493339|FG001|Pre-prophylaxis|Adverse Event|0|||
155290405|NCT02141074|560493338|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
155290406|NCT02141074|560493339|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
155290407|NCT02141074|560493338|FG000|Prophylaxis|Adverse Event|0|||
155290408|NCT02141074|560493339|FG001|Prophylaxis|Adverse Event|4|||
155290409|NCT02141074|560493338|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
155290410|NCT02141074|560493339|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
155290411|NCT02141074|560493338|FG000|Prophylaxis|Withdrawal by Subject|0|||
155290412|NCT02141074|560493339|FG001|Prophylaxis|Withdrawal by Subject|1|||
155290413|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
155290414|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
155290415|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290416|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290417|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290418|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290419|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290420|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290421|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290422|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290423|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290424|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
155290425|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290426|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
155290427|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290428|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290429|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290430|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290431|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290432|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290433|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155059803|NCT00853385|559653834|FG000|Overall Study|Lost to Follow-up|2|||
155290434|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290435|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290436|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
155290437|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
155290438|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
155290439|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290440|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290441|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290442|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290443|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290444|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290445|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290446|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290447|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290448|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
155290449|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290450|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
155290451|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290452|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290453|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290454|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290455|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290456|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155059804|NCT00853385|559653835|FG001|Overall Study|Lost to Follow-up|1|||
155290457|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290458|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290459|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290460|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
155290461|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290462|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
155290463|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290464|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290465|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290466|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290467|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290468|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290469|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290470|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290471|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290472|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
155290473|NCT03536884|560493340|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290474|NCT03536884|560493341|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
155290475|NCT03536884|560493342|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290476|NCT03536884|560493343|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290477|NCT03536884|560493344|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290478|NCT03536884|560493345|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290479|NCT03536884|560493346|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290480|NCT03536884|560493347|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290481|NCT03536884|560493348|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290482|NCT03536884|560493349|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290483|NCT03536884|560493350|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290484|NCT03536884|560493351|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
155290485|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290486|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290487|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
155290488|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290489|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
155290490|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290491|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290492|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290493|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290494|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290495|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290496|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
155290497|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290498|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290499|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
155290500|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
155290501|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
155290502|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290503|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290504|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290505|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290506|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290507|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290508|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
155290509|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290510|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290511|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290512|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
155290513|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
155290514|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290515|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290516|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290517|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
154955042|NCT00986245|559261798|FG000|Second Intervention|Poor compliance|1|||
154955043|NCT00986245|559261799|FG001|Second Intervention|Poor compliance|0|||
154955044|NCT00986245|559261798|FG000|Second Intervention|Lost to Follow-up|1|||
154955045|NCT00986245|559261799|FG001|Second Intervention|Lost to Follow-up|0|||
154955046|NCT00986245|559261798|FG000|Second Intervention|Protocol Violation|0|||
155059805|NCT00853385|559653836|FG002|Overall Study|Lost to Follow-up|0|||
155059806|NCT00853385|559653837|FG003|Overall Study|Lost to Follow-up|0|||
155059807|NCT00853385|559653838|FG004|Overall Study|Lost to Follow-up|0|||
155059808|NCT00853385|559653834|FG000|Overall Study|Withdrawal by Subject|4|||
155059809|NCT00853385|559653835|FG001|Overall Study|Withdrawal by Subject|2|||
155059810|NCT00853385|559653836|FG002|Overall Study|Withdrawal by Subject|0|||
155059811|NCT00853385|559653837|FG003|Overall Study|Withdrawal by Subject|1|||
155059812|NCT00853385|559653838|FG004|Overall Study|Withdrawal by Subject|1|||
155059813|NCT00853385|559653834|FG000|Overall Study|Other|18|||
155059814|NCT00853385|559653835|FG001|Overall Study|Other|9|||
155059815|NCT00853385|559653836|FG002|Overall Study|Other|4|||
155059816|NCT00853385|559653837|FG003|Overall Study|Other|4|||
155059817|NCT00853385|559653838|FG004|Overall Study|Other|12|||
155059818|NCT00941928|559653843|FG000|Overall Study|Withdrawal by Subject|1|||
155059819|NCT00941928|559653843|FG000|Overall Study|Disease Progression|1|||
155059820|NCT02300610|559653846|FG000|Overall Study|Withdrawal by Subject|1|||
155059821|NCT02300610|559653847|FG001|Overall Study|Withdrawal by Subject|0|||
155059822|NCT02300610|559653848|FG002|Overall Study|Withdrawal by Subject|1|||
155059823|NCT02515227|559653851|FG000|Overall Study|Adverse Event|0|||
155059824|NCT02515227|559653852|FG001|Overall Study|Adverse Event|2|||
155059825|NCT02515227|559653851|FG000|Overall Study|Progressive disease|2|||
155059826|NCT02515227|559653852|FG001|Overall Study|Progressive disease|9|||
155059827|NCT03451071|559653859|FG000|First Vaccine|Withdrawal by Subject|1|||
155059828|NCT03451071|559653859|FG000|Second Vaccine|Lost to Follow-up|19|||
155059829|NCT03451071|559653859|FG000|Third Vaccine|Lost to Follow-up|22|||
155059830|NCT03451071|559653859|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
155059831|NCT03363906|559653864|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
155059832|NCT03363906|559653865|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
155059833|NCT03363906|559653864|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
155059834|NCT03363906|559653865|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
155059835|NCT03363906|559653864|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
155059836|NCT03363906|559653865|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
155059837|NCT03363906|559653864|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
155059838|NCT03363906|559653865|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
155059839|NCT00676143|559653866|FG000|Overall Study|Adverse Event|34|||
155059840|NCT00676143|559653867|FG001|Overall Study|Adverse Event|60|||
155059841|NCT00676143|559653866|FG000|Overall Study|Death|4|||
155059842|NCT00676143|559653867|FG001|Overall Study|Death|4|||
155059843|NCT00676143|559653866|FG000|Overall Study|Lack of Efficacy|0|||
155059844|NCT00676143|559653867|FG001|Overall Study|Lack of Efficacy|6|||
155059845|NCT00676143|559653866|FG000|Overall Study|Lost to Follow-up|0|||
155059846|NCT00676143|559653867|FG001|Overall Study|Lost to Follow-up|13|||
155059847|NCT00676143|559653866|FG000|Overall Study|Physician Decision|5|||
155059848|NCT00676143|559653867|FG001|Overall Study|Physician Decision|8|||
154955047|NCT00986245|559261799|FG001|Second Intervention|Protocol Violation|1|||
154955048|NCT01941030|559261801|FG000|Overall Study|Death|3|||
154955049|NCT01941030|559261802|FG001|Overall Study|Death|2|||
155059849|NCT00676143|559653866|FG000|Overall Study|Protocol Violation|4|||
155059850|NCT00676143|559653867|FG001|Overall Study|Protocol Violation|8|||
155059851|NCT00676143|559653866|FG000|Overall Study|Withdrawal by Subject|24|||
155059852|NCT00676143|559653867|FG001|Overall Study|Withdrawal by Subject|42|||
155059853|NCT00676143|559653866|FG000|Overall Study|Discontinuation of study by sponsor|65|||
155059854|NCT00676143|559653867|FG001|Overall Study|Discontinuation of study by sponsor|88|||
155059855|NCT00676143|559653866|FG000|Overall Study|Failed to return|2|||
155059856|NCT00676143|559653867|FG001|Overall Study|Failed to return|1|||
155059857|NCT00676143|559653866|FG000|Overall Study|Loss of caregiver|5|||
155059858|NCT00676143|559653867|FG001|Overall Study|Loss of caregiver|3|||
155059859|NCT00676143|559653866|FG000|Overall Study|Other|11|||
155059860|NCT00676143|559653867|FG001|Overall Study|Other|20|||
155059861|NCT00676143|559653866|FG000|Overall Study|Participant participation unknown|1|||
155059862|NCT00676143|559653867|FG001|Overall Study|Participant participation unknown|4|||
155059863|NCT00676143|559653866|FG000|Overall Study|Vasogenic edema recurrence|1|||
155156134|NCT01075243|560008201|FG000|Overall Study|Withdrawal by Subject|1|||
154955050|NCT01941030|559261801|FG000|Overall Study|Lost to Follow-up|6|||
154955051|NCT01941030|559261802|FG001|Overall Study|Lost to Follow-up|5|||
155156135|NCT01075243|560008202|FG001|Overall Study|Withdrawal by Subject|1|||
154955052|NCT01941030|559261801|FG000|Overall Study|Withdrawal by Subject|4|||
155059864|NCT00676143|559653867|FG001|Overall Study|Vasogenic edema recurrence|3|||
155059865|NCT00929669|559653868|FG000|Overall Study|elevated glucose levels|1|||
155059866|NCT00250588|559653869|FG000|Overall Study|Withdrawal by Subject|3|||
155059867|NCT00250588|559653870|FG001|Overall Study|Withdrawal by Subject|6|||
155059868|NCT00250588|559653871|FG002|Overall Study|Withdrawal by Subject|0|||
155059869|NCT00250588|559653869|FG000|Overall Study|Lost to Follow-up|6|||
155059870|NCT00250588|559653870|FG001|Overall Study|Lost to Follow-up|13|||
155059871|NCT00250588|559653871|FG002|Overall Study|Lost to Follow-up|13|||
155059872|NCT00706797|559653874|FG000|Overall Study|Lack of Efficacy|3|||
155059873|NCT00706797|559653875|FG001|Overall Study|Lack of Efficacy|0|||
155059874|NCT00706797|559653874|FG000|Overall Study|Adverse Event|0|||
155059875|NCT00706797|559653875|FG001|Overall Study|Adverse Event|3|||
155059876|NCT00706797|559653874|FG000|Overall Study|Withdrawal by Subject|8|||
155059877|NCT00706797|559653875|FG001|Overall Study|Withdrawal by Subject|1|||
155059878|NCT00706797|559653874|FG000|Overall Study|Death|1|||
155059879|NCT00706797|559653875|FG001|Overall Study|Death|0|||
155059880|NCT00706797|559653874|FG000|Overall Study|Discontinuation of study by sponsor|52|||
155059881|NCT00706797|559653875|FG001|Overall Study|Discontinuation of study by sponsor|63|||
155290518|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290519|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290520|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
155290521|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290522|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290523|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
155290524|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
155290525|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
155290526|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290527|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290528|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290529|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290530|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290531|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290532|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
155290533|NCT03536884|560493340|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290534|NCT03536884|560493341|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290535|NCT03536884|560493342|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
155290536|NCT03536884|560493343|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
155290537|NCT03536884|560493344|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
155290538|NCT03536884|560493345|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290539|NCT03536884|560493346|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290540|NCT03536884|560493347|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290541|NCT03536884|560493348|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290542|NCT03536884|560493349|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290543|NCT03536884|560493350|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290544|NCT03536884|560493351|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
155290545|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290546|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290547|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290548|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290549|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290550|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
155290551|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
155290552|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
155290553|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
155290554|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290555|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290556|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
155290557|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290558|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290559|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290560|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290561|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290562|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
155290563|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
155290564|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
155290565|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
155290566|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155059882|NCT00706797|559653874|FG000|Overall Study|Protocol Violation|3|||
155059883|NCT00706797|559653875|FG001|Overall Study|Protocol Violation|2|||
155156136|NCT01075243|560008203|FG002|Overall Study|Withdrawal by Subject|0|||
155059884|NCT00706797|559653874|FG000|Overall Study|Lost to Follow-up|1|||
155059885|NCT00706797|559653875|FG001|Overall Study|Lost to Follow-up|2|||
155059886|NCT00706797|559653874|FG000|Overall Study|Other|1|||
155059887|NCT00706797|559653875|FG001|Overall Study|Other|0|||
155059888|NCT03502798|559653876|FG000|Overall Study|equipment failure|0|||
155059889|NCT03502798|559653877|FG001|Overall Study|equipment failure|7|||
154955053|NCT01941030|559261802|FG001|Overall Study|Withdrawal by Subject|6|||
154955054|NCT01722877|559261806|FG000|Overall Study|Death|1|||
154955055|NCT01722877|559261806|FG000|Overall Study|Lost to Follow-up|1|||
154955056|NCT03693430|559261807|FG000|Overall Study|Lost to Follow-up|3|||
154955057|NCT03693430|559261808|FG001|Overall Study|Lost to Follow-up|14|||
154955058|NCT03693430|559261807|FG000|Overall Study|Death|1|||
155290567|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290568|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
155290569|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290570|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290571|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290572|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290573|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290574|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
155290575|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290576|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
155290577|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290578|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290579|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290580|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
155290581|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290582|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
154955059|NCT03693430|559261808|FG001|Overall Study|Death|0|||
154955060|NCT03693430|559261807|FG000|Overall Study|Withdrawal by Subject|0|||
154955061|NCT03693430|559261808|FG001|Overall Study|Withdrawal by Subject|4|||
154955062|NCT00585689|559261809|FG000|Overall Study|Received different ABI-007 schedule|3|||
154955063|NCT00585689|559261809|FG000|Overall Study|Adverse Event|1|||
154955064|NCT00585689|559261809|FG000|Overall Study|Patient Declined Surgery|1|||
154955065|NCT00585689|559261809|FG000|Overall Study|Patient had unresectable disease|1|||
154955066|NCT00585689|559261809|FG000|Overall Study|Death|1|||
154955067|NCT02930005|559261810|FG000|Overall Study|Lost to Follow-up|1|||
154955068|NCT02930005|559261811|FG001|Overall Study|Lost to Follow-up|5|||
154955069|NCT02373098|559261813|FG000|Overall Study|Lost to Follow-up|1|||
154955070|NCT02373098|559261814|FG001|Overall Study|Lost to Follow-up|0|||
154955071|NCT02373098|559261813|FG000|Overall Study|Protocol Violation|3|||
154955072|NCT02373098|559261814|FG001|Overall Study|Protocol Violation|0|||
154955073|NCT02373098|559261813|FG000|Overall Study|Withdrawal by Subject|5|||
154955074|NCT02373098|559261814|FG001|Overall Study|Withdrawal by Subject|0|||
154955075|NCT02373098|559261813|FG000|Overall Study|Adverse Event|3|||
154955076|NCT02373098|559261814|FG001|Overall Study|Adverse Event|0|||
154955077|NCT05067647|559261815|FG000|Overall Study|Lost to Follow-up|1|||
154955078|NCT00870870|559261819|FG000|Overall Study|Withdrawal by Subject|0|||
154955079|NCT00870870|559261820|FG001|Overall Study|Withdrawal by Subject|1|||
154955080|NCT00870870|559261821|FG002|Overall Study|Withdrawal by Subject|1|||
154955081|NCT00870870|559261822|FG003|Overall Study|Withdrawal by Subject|3|||
154955082|NCT00870870|559261819|FG000|Overall Study|Adverse Event|0|||
154955083|NCT00870870|559261820|FG001|Overall Study|Adverse Event|0|||
154955084|NCT00870870|559261821|FG002|Overall Study|Adverse Event|2|||
154955085|NCT00870870|559261822|FG003|Overall Study|Adverse Event|2|||
154955086|NCT00855738|559261833|FG000|Overall Study|Lost to Follow-up|2|||
154955087|NCT00855738|559261833|FG000|Overall Study|Adverse Event|1|||
154955088|NCT00855738|559261833|FG000|Overall Study|Subject Defaulted|1|||
155290583|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290584|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290585|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290586|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
155290587|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290588|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
155290589|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
155290590|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290591|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290592|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
155290593|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290594|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290595|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290596|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290597|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290598|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
155290599|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
155290600|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
155290601|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
155290602|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290603|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290604|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
155290605|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290606|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290607|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290608|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290609|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290610|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
155290611|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290612|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290613|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290614|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290615|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290616|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
155290617|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290618|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290619|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290620|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290621|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290622|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290623|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
155290624|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290625|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290626|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290627|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290628|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
155290629|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290630|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290631|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155059890|NCT01027845|559653879|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
155290632|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290633|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290634|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290635|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
155290636|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290637|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290638|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290639|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290640|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
155290641|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290642|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290643|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290644|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290645|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290646|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
155290647|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290648|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290649|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290650|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290651|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290652|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
155290653|NCT03536884|560493340|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290654|NCT03536884|560493341|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290655|NCT03536884|560493342|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290656|NCT03536884|560493343|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290657|NCT03536884|560493344|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290658|NCT03536884|560493345|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290659|NCT03536884|560493346|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290660|NCT03536884|560493347|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290661|NCT03536884|560493348|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
155290662|NCT03536884|560493349|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290663|NCT03536884|560493350|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290664|NCT03536884|560493351|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
155290665|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290666|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290667|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290668|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290669|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290670|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290671|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290672|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290673|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
155290674|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
155290675|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
155290676|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
155290677|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290678|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290679|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290680|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290681|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290682|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290683|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290684|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290685|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
155290686|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
155290687|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
155290688|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
155290689|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155059891|NCT01027845|559653880|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
155290690|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290691|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290692|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290693|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290694|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290695|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290696|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290697|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290698|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290699|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
155290700|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
155290701|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290702|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290703|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290704|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290705|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290706|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290707|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290708|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290709|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290710|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290711|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
155290712|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
155290713|NCT03536884|560493340|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155059892|NCT01027845|559653881|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
155059893|NCT01027845|559653882|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
155059894|NCT01027845|559653879|FG000|Primary Vaccination Phase|Adverse Event|1|||
155059895|NCT01027845|559653880|FG001|Primary Vaccination Phase|Adverse Event|0|||
155059896|NCT01027845|559653881|FG002|Primary Vaccination Phase|Adverse Event|0|||
155059897|NCT01027845|559653882|FG003|Primary Vaccination Phase|Adverse Event|0|||
155059898|NCT01027845|559653879|FG000|Primary Vaccination Phase|Protocol Violation|1|||
155059899|NCT01027845|559653880|FG001|Primary Vaccination Phase|Protocol Violation|0|||
155059900|NCT01027845|559653881|FG002|Primary Vaccination Phase|Protocol Violation|0|||
155059901|NCT01027845|559653882|FG003|Primary Vaccination Phase|Protocol Violation|0|||
155059902|NCT01027845|559653879|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
155059903|NCT01027845|559653880|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
155059904|NCT01027845|559653881|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
155059905|NCT01027845|559653882|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
155059906|NCT01027845|559653879|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
155059907|NCT01027845|559653880|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155290714|NCT03536884|560493341|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290715|NCT03536884|560493342|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290716|NCT03536884|560493343|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290717|NCT03536884|560493344|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290718|NCT03536884|560493345|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290719|NCT03536884|560493346|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290720|NCT03536884|560493347|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290721|NCT03536884|560493348|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290722|NCT03536884|560493349|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290723|NCT03536884|560493350|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
155290724|NCT03536884|560493351|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
155290725|NCT03301220|560493352|FG000|Overall Study|Death|26|||
155290726|NCT03301220|560493353|FG001|Overall Study|Death|15|||
155290727|NCT03301220|560493352|FG000|Overall Study|Withdrawal by Subject|23|||
155059908|NCT01027845|559653881|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
155059909|NCT01027845|559653882|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
155156137|NCT00551642|560008206|FG000|Treatment Period|Protocol Deviation|6|||
155156138|NCT00551642|560008207|FG001|Treatment Period|Protocol Deviation|11|||
155059910|NCT01027845|559653879|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
155059911|NCT01027845|559653880|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
155059912|NCT01027845|559653881|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
155059913|NCT01027845|559653882|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
155059914|NCT01670292|559653883|FG000|Overall Study|Lost to Follow-up|14|||
155290728|NCT03301220|560493353|FG001|Overall Study|Withdrawal by Subject|12|||
155290729|NCT03301220|560493352|FG000|Overall Study|Lost to Follow-up|1|||
155290730|NCT03301220|560493353|FG001|Overall Study|Lost to Follow-up|1|||
155290731|NCT03301220|560493352|FG000|Overall Study|Randomized in error|1|||
155290732|NCT03301220|560493353|FG001|Overall Study|Randomized in error|1|||
155290733|NCT03301220|560493352|FG000|Overall Study|Randomized but not treated|0|||
155290734|NCT03301220|560493353|FG001|Overall Study|Randomized but not treated|1|||
155290735|NCT03301220|560493352|FG000|Overall Study|Ongoing followup|145|||
155290736|NCT03301220|560493353|FG001|Overall Study|Ongoing followup|163|||
155290737|NCT03301220|560493352|FG000|Overall Study|Principal Investigator and participant decision|0|||
155290738|NCT03301220|560493353|FG001|Overall Study|Principal Investigator and participant decision|1|||
155290739|NCT04845620|560493354|FG000|Overall Study|Withdrawal by Subject|11|||
155290740|NCT04845620|560493355|FG001|Overall Study|Withdrawal by Subject|10|||
155290741|NCT04845620|560493354|FG000|Overall Study|Adverse Event|5|||
155290742|NCT04845620|560493355|FG001|Overall Study|Adverse Event|4|||
155290743|NCT04845620|560493354|FG000|Overall Study|Lost to Follow-up|5|||
155290744|NCT04845620|560493355|FG001|Overall Study|Lost to Follow-up|4|||
155290745|NCT04845620|560493354|FG000|Overall Study|Lack of Efficacy|4|||
155290746|NCT04845620|560493355|FG001|Overall Study|Lack of Efficacy|4|||
155059915|NCT01603277|559653887|FG000|Overall Study|Adverse Event|1|||
155059916|NCT01603277|559653888|FG001|Overall Study|Adverse Event|2|||
155059917|NCT01603277|559653887|FG000|Overall Study|Physician Decision|0|||
155059918|NCT01603277|559653888|FG001|Overall Study|Physician Decision|1|||
155059919|NCT01603277|559653887|FG000|Overall Study|Protocol Violation|6|||
155059920|NCT01603277|559653888|FG001|Overall Study|Protocol Violation|10|||
155059921|NCT01603277|559653887|FG000|Overall Study|Withdrawal by Subject|5|||
155059922|NCT01603277|559653888|FG001|Overall Study|Withdrawal by Subject|4|||
155059923|NCT01603277|559653887|FG000|Overall Study|Non-Compliance|2|||
155059924|NCT01603277|559653888|FG001|Overall Study|Non-Compliance|1|||
155059925|NCT00087178|559653889|FG000|Overall Study|No follow up data|5|||
155059926|NCT00087178|559653890|FG001|Overall Study|No follow up data|15|||
155059927|NCT00087178|559653889|FG000|Overall Study|No clinical assessment|1|||
155059928|NCT00087178|559653890|FG001|Overall Study|No clinical assessment|2|||
155059929|NCT00087178|559653889|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
155059930|NCT00087178|559653890|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
155059931|NCT01692119|559653893|FG000|Overall Study|Protocol Violation|3|||
155059932|NCT01692119|559653894|FG001|Overall Study|Protocol Violation|1|||
155059933|NCT01692119|559653893|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
155059934|NCT01692119|559653894|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
155059935|NCT01192815|559653904|FG000|Overall Study|Withdrawal by Subject|1|||
155059936|NCT01192815|559653904|FG000|Overall Study|Lack of Efficacy|1|||
155059937|NCT03451045|559653905|FG000|Overall Study|Lack of Efficacy|3|||
155059938|NCT03451045|559653906|FG001|Overall Study|Lack of Efficacy|2|||
155059939|NCT03451045|559653907|FG002|Overall Study|Lack of Efficacy|2|||
155059940|NCT03451045|559653905|FG000|Overall Study|Physician Decision|1|||
155059941|NCT03451045|559653906|FG001|Overall Study|Physician Decision|1|||
155059942|NCT03451045|559653907|FG002|Overall Study|Physician Decision|1|||
155059943|NCT03451045|559653905|FG000|Overall Study|Withdrawal by Subject|4|||
155059944|NCT03451045|559653906|FG001|Overall Study|Withdrawal by Subject|0|||
155059945|NCT03451045|559653907|FG002|Overall Study|Withdrawal by Subject|5|||
155059946|NCT03451045|559653905|FG000|Overall Study|Pregnancy|0|||
155059947|NCT03451045|559653906|FG001|Overall Study|Pregnancy|0|||
155059948|NCT03451045|559653907|FG002|Overall Study|Pregnancy|2|||
155290747|NCT04845620|560493354|FG000|Overall Study|Physician Decision|2|||
155290748|NCT04845620|560493355|FG001|Overall Study|Physician Decision|1|||
155059949|NCT03451045|559653905|FG000|Overall Study|Adverse Event|7|||
155059950|NCT03451045|559653906|FG001|Overall Study|Adverse Event|1|||
155059951|NCT03451045|559653907|FG002|Overall Study|Adverse Event|3|||
155059952|NCT03451045|559653905|FG000|Overall Study|Non-compliance with study|2|||
155059953|NCT03451045|559653906|FG001|Overall Study|Non-compliance with study|0|||
155059954|NCT03451045|559653907|FG002|Overall Study|Non-compliance with study|1|||
155059955|NCT03451045|559653905|FG000|Overall Study|any other reason|10|||
155059956|NCT03451045|559653906|FG001|Overall Study|any other reason|2|||
155290749|NCT05803720|560493356|FG000|Overall Study|Lost to Follow-up|3|||
155290750|NCT05803720|560493357|FG001|Overall Study|Lost to Follow-up|4|||
155059957|NCT03451045|559653907|FG002|Overall Study|any other reason|13|||
155059958|NCT04142242|559653908|FG000|Stage I|Non-compliance with the protocol|1|||
155290751|NCT05803720|560493356|FG000|Overall Study|Family leave/emergency|1|||
155290752|NCT05803720|560493357|FG001|Overall Study|Family leave/emergency|1|||
155290753|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
155059959|NCT04142242|559653909|FG001|Stage I|Non-compliance with the protocol|0|||
155059960|NCT04142242|559653910|FG002|Stage I|Non-compliance with the protocol|0|||
155059961|NCT04142242|559653911|FG003|Stage I|Non-compliance with the protocol|0|||
155059962|NCT04142242|559653912|FG004|Stage I|Non-compliance with the protocol|0|||
155059963|NCT04142242|559653913|FG005|Stage I|Non-compliance with the protocol|1|||
155059964|NCT04142242|559653908|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155059965|NCT04142242|559653909|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
155059966|NCT04142242|559653910|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155059967|NCT04142242|559653911|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155059968|NCT04142242|559653912|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155290754|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
155290755|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
155290756|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
155290757|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
155290758|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
155290759|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Death|1|||
155290760|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Death|1|||
155290761|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Death|1|||
155290762|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Death|0|||
155290763|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Death|0|||
155290764|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Death|0|||
155290765|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
155290766|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
155290767|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290768|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290769|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290770|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
155290771|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290772|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290773|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
155290774|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290775|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290776|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
155290777|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290778|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
155290779|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290780|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290781|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290782|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
155290783|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
155290784|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
155290785|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
155290786|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
155290787|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
155290788|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
155290789|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290790|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
155290791|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290792|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290793|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290794|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
155290795|NCT03370133|560493358|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
155290796|NCT03370133|560493359|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
155290797|NCT03370133|560493360|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
155290798|NCT03370133|560493361|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
155290799|NCT03370133|560493362|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
155290800|NCT03370133|560493363|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
155290801|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
155290802|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
155290803|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
155290804|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
155290805|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
155290806|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
155290807|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290808|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290809|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290810|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
155290811|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
155290812|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
155290813|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290814|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290815|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290816|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
155290817|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
155290818|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
155290819|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290820|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290821|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290822|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
155290823|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
155290824|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
155290825|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
155290826|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
155290827|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
155290828|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
155290829|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
155290830|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
155290831|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290832|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290833|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290834|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290835|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
155290836|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
155290837|NCT03370133|560493358|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290838|NCT03370133|560493359|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290839|NCT03370133|560493360|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290840|NCT03370133|560493361|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290841|NCT03370133|560493362|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
155290842|NCT03370133|560493363|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
155290843|NCT06688370|560493364|FG000|Overall Study|Discontinued the treatment|1|||
155290844|NCT06688370|560493364|FG000|Overall Study|Prohibited treatment taken|4|||
155290845|NCT04540835|560493365|FG000|Week 1|Lost to Follow-up|1|||
155290846|NCT04540835|560493365|FG000|Week 6|Pregnancy|1|||
155290847|NCT04540835|560493365|FG000|Week 6|Lack of Efficacy|1|||
155290848|NCT04487080|560493366|FG000|Overall Study|Withdrawal by Subject|19|||
155290849|NCT04487080|560493367|FG001|Overall Study|Withdrawal by Subject|18|||
155290850|NCT04487080|560493368|FG002|Overall Study|Withdrawal by Subject|13|||
155290851|NCT04487080|560493366|FG000|Overall Study|Lost to Follow-up|3|||
155290852|NCT04487080|560493367|FG001|Overall Study|Lost to Follow-up|1|||
155290853|NCT04487080|560493368|FG002|Overall Study|Lost to Follow-up|0|||
155290854|NCT04487080|560493366|FG000|Overall Study|Ongoing|313|||
155290855|NCT04487080|560493367|FG001|Overall Study|Ongoing|297|||
155290856|NCT04487080|560493368|FG002|Overall Study|Ongoing|149|||
155290857|NCT03105336|560493369|FG000|Overall Study|Rollover to Longterm Follow-up Study Criteria|61|||
155290858|NCT03105336|560493370|FG001|Overall Study|Rollover to Longterm Follow-up Study Criteria|15|||
155290859|NCT03105336|560493369|FG000|Overall Study|Death|40|||
155290860|NCT03105336|560493370|FG001|Overall Study|Death|8|||
155290861|NCT03105336|560493369|FG000|Overall Study|Lost to Follow-up|13|||
155290862|NCT03105336|560493370|FG001|Overall Study|Lost to Follow-up|2|||
155290863|NCT03105336|560493369|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|7|||
155290864|NCT03105336|560493370|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
155290865|NCT03105336|560493369|FG000|Overall Study|Reason Not Specified|3|||
155290866|NCT03105336|560493370|FG001|Overall Study|Reason Not Specified|3|||
155290867|NCT03105336|560493369|FG000|Overall Study|Investigator Decision|3|||
155156139|NCT00551642|560008206|FG000|Treatment Period|Delivery device failure|1|||
155156140|NCT00551642|560008207|FG001|Treatment Period|Delivery device failure|3|||
155290868|NCT03105336|560493370|FG001|Overall Study|Investigator Decision|0|||
155290869|NCT03451851|560493371|FG000|PCP: Week 0 -16|Adverse Event|1|||
155290870|NCT03451851|560493372|FG001|PCP: Week 0 -16|Adverse Event|0|||
155290871|NCT03451851|560493373|FG002|PCP: Week 0 -16|Adverse Event|0|||
155290872|NCT03451851|560493374|FG003|PCP: Week 0 -16|Adverse Event|0|||
155290873|NCT03451851|560493375|FG004|PCP: Week 0 -16|Adverse Event|0|||
155290874|NCT03451851|560493376|FG005|PCP: Week 0 -16|Adverse Event|0|||
155290875|NCT03451851|560493377|FG006|PCP: Week 0 -16|Adverse Event|1|||
155290876|NCT03451851|560493378|FG007|PCP: Week 0 -16|Adverse Event|0|||
155290877|NCT03451851|560493371|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290878|NCT03451851|560493372|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290879|NCT03451851|560493373|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
155290880|NCT03451851|560493374|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290881|NCT03451851|560493375|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290882|NCT03451851|560493376|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290883|NCT03451851|560493377|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290884|NCT03451851|560493378|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
155290885|NCT03451851|560493371|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290886|NCT03451851|560493372|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290887|NCT03451851|560493373|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
155290888|NCT03451851|560493374|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290889|NCT03451851|560493375|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290890|NCT03451851|560493376|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290891|NCT03451851|560493377|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290892|NCT03451851|560493378|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
155290893|NCT03451851|560493371|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290894|NCT03451851|560493372|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290895|NCT03451851|560493373|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290896|NCT03451851|560493374|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290897|NCT03451851|560493375|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
155290898|NCT03451851|560493376|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
155290899|NCT03451851|560493377|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290900|NCT03451851|560493378|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
155290901|NCT03451851|560493371|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290902|NCT03451851|560493372|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290903|NCT03451851|560493373|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290904|NCT03451851|560493374|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290905|NCT03451851|560493375|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
155290906|NCT03451851|560493376|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290907|NCT03451851|560493377|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290908|NCT03451851|560493378|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
155290909|NCT03451851|560493371|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290910|NCT03451851|560493372|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290911|NCT03451851|560493373|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290912|NCT03451851|560493374|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290913|NCT03451851|560493375|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
155290914|NCT03451851|560493376|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290915|NCT03451851|560493377|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290916|NCT03451851|560493378|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
155290917|NCT07214922|560493381|FG000|Overall Study|Adverse Event|0|||
155290918|NCT07214922|560493382|FG001|Overall Study|Adverse Event|0|||
155290919|NCT07214922|560493383|FG002|Overall Study|Adverse Event|1|||
155290920|NCT07214922|560493384|FG003|Overall Study|Adverse Event|0|||
155290921|NCT07214922|560493381|FG000|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
155290922|NCT07214922|560493382|FG001|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|1|||
155290923|NCT07214922|560493383|FG002|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
155290924|NCT07214922|560493384|FG003|Overall Study|DROPPED OUT ON DAY 5; PRIVATE REASONS|0|||
155290925|NCT03944512|560493385|FG000|Overall Study|Death|0|||
155290926|NCT03944512|560493386|FG001|Overall Study|Death|0|||
155290927|NCT03944512|560493387|FG002|Overall Study|Death|1|||
155290928|NCT03944512|560493388|FG003|Overall Study|Death|2|||
155290929|NCT03944512|560493385|FG000|Overall Study|Lost to Follow-up|0|||
155290930|NCT03944512|560493386|FG001|Overall Study|Lost to Follow-up|0|||
155290931|NCT03944512|560493387|FG002|Overall Study|Lost to Follow-up|4|||
155290932|NCT03944512|560493388|FG003|Overall Study|Lost to Follow-up|4|||
155290933|NCT03944512|560493385|FG000|Overall Study|refused follow-up|0|||
155290934|NCT03944512|560493386|FG001|Overall Study|refused follow-up|0|||
155290935|NCT03944512|560493387|FG002|Overall Study|refused follow-up|2|||
155290936|NCT03944512|560493388|FG003|Overall Study|refused follow-up|2|||
155290937|NCT00567879|560494154|FG000|Overall Study|Adverse Event|2|||
155290938|NCT00567879|560494155|FG001|Overall Study|Adverse Event|0|||
155290939|NCT00567879|560494156|FG002|Overall Study|Adverse Event|1|||
155290940|NCT00567879|560494157|FG003|Overall Study|Adverse Event|0|||
155290941|NCT00567879|560494158|FG004|Overall Study|Adverse Event|1|||
155290942|NCT00567879|560494159|FG005|Overall Study|Adverse Event|0|||
155290943|NCT00567879|560494154|FG000|Overall Study|Abnormal test procedure(s)|0|||
155290944|NCT00567879|560494155|FG001|Overall Study|Abnormal test procedure(s)|0|||
155290945|NCT00567879|560494156|FG002|Overall Study|Abnormal test procedure(s)|1|||
155290946|NCT00567879|560494157|FG003|Overall Study|Abnormal test procedure(s)|0|||
155290947|NCT00567879|560494158|FG004|Overall Study|Abnormal test procedure(s)|0|||
155290948|NCT00567879|560494159|FG005|Overall Study|Abnormal test procedure(s)|0|||
155290949|NCT00567879|560494154|FG000|Overall Study|Withdrawal by Subject|0|||
155290950|NCT00567879|560494155|FG001|Overall Study|Withdrawal by Subject|0|||
155290951|NCT00567879|560494156|FG002|Overall Study|Withdrawal by Subject|3|||
155290952|NCT00567879|560494157|FG003|Overall Study|Withdrawal by Subject|1|||
155290953|NCT00567879|560494158|FG004|Overall Study|Withdrawal by Subject|0|||
155290954|NCT00567879|560494159|FG005|Overall Study|Withdrawal by Subject|0|||
155290955|NCT00567879|560494154|FG000|Overall Study|New cancer therapy|0|||
155290956|NCT00567879|560494155|FG001|Overall Study|New cancer therapy|0|||
155290957|NCT00567879|560494156|FG002|Overall Study|New cancer therapy|1|||
155290958|NCT00567879|560494157|FG003|Overall Study|New cancer therapy|0|||
155290959|NCT00567879|560494158|FG004|Overall Study|New cancer therapy|0|||
155290960|NCT00567879|560494159|FG005|Overall Study|New cancer therapy|0|||
155290961|NCT00567879|560494154|FG000|Overall Study|Disease progression|5|||
155290962|NCT00567879|560494155|FG001|Overall Study|Disease progression|7|||
155290963|NCT00567879|560494156|FG002|Overall Study|Disease progression|15|||
155290964|NCT00567879|560494157|FG003|Overall Study|Disease progression|5|||
155290965|NCT00567879|560494158|FG004|Overall Study|Disease progression|11|||
155290966|NCT00567879|560494159|FG005|Overall Study|Disease progression|3|||
155290967|NCT00151996|560494160|FG000|Overall Study|Adverse Event|3|||
155290968|NCT00151996|560494161|FG001|Overall Study|Adverse Event|2|||
155290969|NCT00151996|560494160|FG000|Overall Study|Withdrawal by Subject|1|||
155290970|NCT00151996|560494161|FG001|Overall Study|Withdrawal by Subject|1|||
155290971|NCT00151996|560494160|FG000|Overall Study|Protocol Violation|1|||
155290972|NCT00151996|560494161|FG001|Overall Study|Protocol Violation|2|||
155290973|NCT00151996|560494160|FG000|Overall Study|Sponsor's decision|0|||
155290974|NCT00151996|560494161|FG001|Overall Study|Sponsor's decision|2|||
155290975|NCT01281813|560494164|FG000|Overall Study|Adverse Event|0|||
155290976|NCT01281813|560494165|FG001|Overall Study|Adverse Event|0|||
155290977|NCT01281813|560494166|FG002|Overall Study|Adverse Event|10|||
155290978|NCT01281813|560494164|FG000|Overall Study|Lost to Follow-up|0|||
155290979|NCT01281813|560494165|FG001|Overall Study|Lost to Follow-up|0|||
155290980|NCT01281813|560494166|FG002|Overall Study|Lost to Follow-up|31|||
155290981|NCT01281813|560494164|FG000|Overall Study|Withdrawal by Subject|0|||
155156141|NCT00551642|560008206|FG000|Treatment Period|Physician Decision|0|||
155156142|NCT00551642|560008207|FG001|Treatment Period|Physician Decision|1|||
155156143|NCT00551642|560008206|FG000|Treatment Period|Death|33|||
155156144|NCT00551642|560008207|FG001|Treatment Period|Death|31|||
155156145|NCT00551642|560008206|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
155156146|NCT00551642|560008207|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
155156147|NCT00551642|560008206|FG000|Treatment Period|Adverse Event|15|||
155156148|NCT00551642|560008207|FG001|Treatment Period|Adverse Event|12|||
155156149|NCT00551642|560008206|FG000|Treatment Period|Withdrawal by Subject|2|||
155156150|NCT00551642|560008207|FG001|Treatment Period|Withdrawal by Subject|1|||
155156151|NCT03337308|560008208|FG000|Overall Study|Adverse Event|2|||
155156152|NCT03337308|560008209|FG001|Overall Study|Adverse Event|3|||
155156153|NCT03337308|560008210|FG002|Overall Study|Adverse Event|3|||
155156154|NCT03337308|560008211|FG003|Overall Study|Adverse Event|1|||
155156155|NCT03337308|560008208|FG000|Overall Study|Lost to Follow-up|1|||
155156156|NCT03337308|560008209|FG001|Overall Study|Lost to Follow-up|2|||
155290982|NCT01281813|560494165|FG001|Overall Study|Withdrawal by Subject|0|||
155290983|NCT01281813|560494166|FG002|Overall Study|Withdrawal by Subject|13|||
155290984|NCT01281813|560494164|FG000|Overall Study|Subject Non-Compliant|0|||
155290985|NCT01281813|560494165|FG001|Overall Study|Subject Non-Compliant|0|||
155290986|NCT01281813|560494166|FG002|Overall Study|Subject Non-Compliant|6|||
155290987|NCT01281813|560494164|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
155290988|NCT01281813|560494165|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
155290989|NCT01281813|560494166|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
155290990|NCT01281813|560494164|FG000|Overall Study|Sponsor's Decision|4|||
155290991|NCT01281813|560494165|FG001|Overall Study|Sponsor's Decision|3|||
155290992|NCT01281813|560494166|FG002|Overall Study|Sponsor's Decision|7|||
155290993|NCT01281813|560494164|FG000|Overall Study|Switched to Commercially Available Medication|0|||
155290994|NCT01281813|560494165|FG001|Overall Study|Switched to Commercially Available Medication|0|||
155290995|NCT01281813|560494166|FG002|Overall Study|Switched to Commercially Available Medication|26|||
155290996|NCT01281813|560494164|FG000|Overall Study|Other|0|||
155290997|NCT01281813|560494165|FG001|Overall Study|Other|1|||
155290998|NCT01281813|560494166|FG002|Overall Study|Other|39|||
155290999|NCT02274493|560494167|FG000|Overall Study|Withdrawal by Subject|1|||
155291000|NCT01744691|560494176|FG000|Overall Study|Progressive Disease|18|||
155291001|NCT01744691|560494176|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
155291002|NCT01744691|560494176|FG000|Overall Study|Withdrawal of consent for treatment|3|||
155291003|NCT01744691|560494176|FG000|Overall Study|Physician Decision|4|||
155291004|NCT02701361|560494178|FG000|Overall Study|Lost to Follow-up|5|||
155291005|NCT02701361|560494179|FG001|Overall Study|Lost to Follow-up|2|||
155291006|NCT02701361|560494180|FG002|Overall Study|Lost to Follow-up|1|||
155291007|NCT02701361|560494178|FG000|Overall Study|Withdrawal by Subject|4|||
155291008|NCT02701361|560494179|FG001|Overall Study|Withdrawal by Subject|0|||
155291009|NCT02701361|560494180|FG002|Overall Study|Withdrawal by Subject|0|||
155291010|NCT02701361|560494178|FG000|Overall Study|timed out in rehab center|0|||
155291011|NCT02701361|560494179|FG001|Overall Study|timed out in rehab center|1|||
155291012|NCT02701361|560494180|FG002|Overall Study|timed out in rehab center|0|||
155291013|NCT02701361|560494178|FG000|Overall Study|incarceration|0|||
155291014|NCT02701361|560494179|FG001|Overall Study|incarceration|0|||
155291015|NCT02701361|560494180|FG002|Overall Study|incarceration|1|||
155291016|NCT04588480|560494181|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
155291017|NCT04588480|560494182|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
155291018|NCT04588480|560494183|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
155291019|NCT04588480|560494181|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
155291020|NCT04588480|560494182|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
155291021|NCT04588480|560494183|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
155291022|NCT01242085|560494184|FG000|Overall Study|Withdrawal by Subject|4|||
155291023|NCT01242085|560494185|FG001|Overall Study|Withdrawal by Subject|2|||
155291024|NCT01242085|560494186|FG002|Overall Study|Withdrawal by Subject|0|||
155291025|NCT01242085|560494184|FG000|Overall Study|medically unable to have surgery|4|||
155291026|NCT01242085|560494185|FG001|Overall Study|medically unable to have surgery|5|||
155291027|NCT01242085|560494186|FG002|Overall Study|medically unable to have surgery|0|||
155291028|NCT01178762|560494187|FG000|Overall Study|Lost to Follow-up|15|||
155291029|NCT02322216|560494190|FG000|Overall Study|Adverse Event|1|||
155291030|NCT02322216|560494191|FG001|Overall Study|Adverse Event|0|||
155291031|NCT02322216|560494190|FG000|Overall Study|Withdrawal by Subject|1|||
155291032|NCT02322216|560494191|FG001|Overall Study|Withdrawal by Subject|4|||
155291033|NCT02430532|560494193|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
155291034|NCT02430532|560494194|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
155291035|NCT02430532|560494193|FG000|Overall Study|Consent Withdrawn|0|||
155291036|NCT02430532|560494194|FG001|Overall Study|Consent Withdrawn|2|||
155291037|NCT02430532|560494193|FG000|Overall Study|Adverse Event|0|||
155291038|NCT02430532|560494194|FG001|Overall Study|Adverse Event|1|||
155291039|NCT01190150|560494195|FG000|First Treatment|Withdrawal by Subject|1|||
155291040|NCT01190150|560494196|FG001|First Treatment|Withdrawal by Subject|0|||
155291041|NCT01190150|560494195|FG000|Washout|Withdrawal by Subject|0|||
155291042|NCT01190150|560494196|FG001|Washout|Withdrawal by Subject|1|||
155291043|NCT01190150|560494195|FG000|Washout|Difficulty in adherence|0|||
155291044|NCT01190150|560494196|FG001|Washout|Difficulty in adherence|1|||
155291045|NCT01549652|560494204|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
155291046|NCT01549652|560494205|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
155291047|NCT01549652|560494206|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
155291048|NCT01549652|560494207|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
155291049|NCT01549652|560494204|FG000|Overall Study|Study Drug Titration Failure|5|||
155059969|NCT04142242|559653913|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
155059970|NCT04142242|559653908|FG000|Stage II|Non-compliance with the protocol|0|||
155059971|NCT04142242|559653909|FG001|Stage II|Non-compliance with the protocol|0|||
155059972|NCT04142242|559653910|FG002|Stage II|Non-compliance with the protocol|0|||
155059973|NCT04142242|559653911|FG003|Stage II|Non-compliance with the protocol|2|||
155291050|NCT01549652|560494205|FG001|Overall Study|Study Drug Titration Failure|6|||
155291051|NCT01549652|560494206|FG002|Overall Study|Study Drug Titration Failure|0|||
155291052|NCT01549652|560494207|FG003|Overall Study|Study Drug Titration Failure|0|||
155291053|NCT01549652|560494204|FG000|Overall Study|Withdrawal Effect|0|||
155291054|NCT01549652|560494205|FG001|Overall Study|Withdrawal Effect|2|||
155291055|NCT01549652|560494206|FG002|Overall Study|Withdrawal Effect|0|||
155291056|NCT01549652|560494207|FG003|Overall Study|Withdrawal Effect|0|||
155291057|NCT01549652|560494204|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
155291058|NCT01549652|560494205|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
155291059|NCT01549652|560494206|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
155291060|NCT01549652|560494207|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
155291061|NCT01549652|560494204|FG000|Overall Study|Problem with Infusion|1|||
155291062|NCT01549652|560494205|FG001|Overall Study|Problem with Infusion|0|||
155291063|NCT01549652|560494206|FG002|Overall Study|Problem with Infusion|0|||
155291064|NCT01549652|560494207|FG003|Overall Study|Problem with Infusion|0|||
154955089|NCT00855738|559261833|FG000|Overall Study|Death|1|||
154955090|NCT00304083|559261837|FG000|Overall Study|Withdrawal by Subject|4|||
154955091|NCT00304083|559261838|FG001|Overall Study|Withdrawal by Subject|2|||
154955092|NCT00304083|559261837|FG000|Overall Study|Physician Decision|8|||
154955093|NCT00304083|559261838|FG001|Overall Study|Physician Decision|3|||
154955094|NCT00304083|559261837|FG000|Overall Study|Disease Progression|5|||
154955095|NCT00304083|559261838|FG001|Overall Study|Disease Progression|1|||
154955096|NCT00304083|559261837|FG000|Overall Study|Other|5|||
154955097|NCT00304083|559261838|FG001|Overall Study|Other|2|||
154955098|NCT03929393|559261839|FG000|Overall Study|Death|1|||
154955099|NCT03929393|559261840|FG001|Overall Study|Death|0|||
154955100|NCT03929393|559261839|FG000|Overall Study|Time Commitment|2|||
154955101|NCT03929393|559261840|FG001|Overall Study|Time Commitment|5|||
154955102|NCT03929393|559261839|FG000|Overall Study|Motor Vehicle Accident|0|||
154955103|NCT03929393|559261840|FG001|Overall Study|Motor Vehicle Accident|1|||
154955104|NCT03929393|559261839|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
154955105|NCT03929393|559261840|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
154955106|NCT03929393|559261839|FG000|Overall Study|Other|1|||
154955107|NCT03929393|559261840|FG001|Overall Study|Other|3|||
155291065|NCT01549652|560494204|FG000|Overall Study|Titration Non-Compliance|1|||
155291066|NCT01549652|560494205|FG001|Overall Study|Titration Non-Compliance|3|||
155291067|NCT01549652|560494206|FG002|Overall Study|Titration Non-Compliance|4|||
155291068|NCT01549652|560494207|FG003|Overall Study|Titration Non-Compliance|5|||
155291069|NCT01549652|560494204|FG000|Overall Study|Titration Side Effects|0|||
155291070|NCT01549652|560494205|FG001|Overall Study|Titration Side Effects|0|||
155291071|NCT01549652|560494206|FG002|Overall Study|Titration Side Effects|6|||
155291072|NCT01549652|560494207|FG003|Overall Study|Titration Side Effects|3|||
155291073|NCT01549652|560494204|FG000|Overall Study|Withdrawal by Subject|0|||
155291074|NCT01549652|560494205|FG001|Overall Study|Withdrawal by Subject|0|||
155291075|NCT01549652|560494206|FG002|Overall Study|Withdrawal by Subject|5|||
155291076|NCT01549652|560494207|FG003|Overall Study|Withdrawal by Subject|3|||
155291077|NCT02873754|560494213|FG000|Overall Study|Lost to Follow-up|5|||
155291078|NCT02873754|560494213|FG000|Overall Study|Couldn't complete study procedures|1|||
155291079|NCT03523962|560494214|FG000|Closed Fractures|Death|86|||
155291080|NCT03523962|560494215|FG001|Closed Fractures|Death|71|||
155291081|NCT03523962|560494216|FG002|Closed Fractures|Death|0|||
155291082|NCT03523962|560494217|FG003|Closed Fractures|Death|0|||
155291083|NCT03523962|560494214|FG000|Closed Fractures|Lost to Follow-up|62|||
155291084|NCT03523962|560494215|FG001|Closed Fractures|Lost to Follow-up|36|||
155291085|NCT03523962|560494216|FG002|Closed Fractures|Lost to Follow-up|0|||
155291086|NCT03523962|560494217|FG003|Closed Fractures|Lost to Follow-up|0|||
155291087|NCT03523962|560494214|FG000|Closed Fractures|Withdrawal by Subject|19|||
155291088|NCT03523962|560494215|FG001|Closed Fractures|Withdrawal by Subject|29|||
155291089|NCT03523962|560494216|FG002|Closed Fractures|Withdrawal by Subject|0|||
155291090|NCT03523962|560494217|FG003|Closed Fractures|Withdrawal by Subject|0|||
155291091|NCT03523962|560494214|FG000|Closed Fractures|Incarceration|1|||
155291092|NCT03523962|560494215|FG001|Closed Fractures|Incarceration|4|||
155291093|NCT03523962|560494216|FG002|Closed Fractures|Incarceration|0|||
155291094|NCT03523962|560494217|FG003|Closed Fractures|Incarceration|0|||
155291095|NCT03523962|560494214|FG000|Open Fractures|Death|0|||
155291096|NCT03523962|560494215|FG001|Open Fractures|Death|0|||
155291097|NCT03523962|560494216|FG002|Open Fractures|Death|11|||
155291098|NCT03523962|560494217|FG003|Open Fractures|Death|6|||
155291099|NCT03523962|560494214|FG000|Open Fractures|Lost to Follow-up|0|||
155291100|NCT03523962|560494215|FG001|Open Fractures|Lost to Follow-up|0|||
155291101|NCT03523962|560494216|FG002|Open Fractures|Lost to Follow-up|15|||
155291102|NCT03523962|560494217|FG003|Open Fractures|Lost to Follow-up|8|||
155291103|NCT03523962|560494214|FG000|Open Fractures|Withdrawal by Subject|0|||
155291104|NCT03523962|560494215|FG001|Open Fractures|Withdrawal by Subject|0|||
155291105|NCT03523962|560494216|FG002|Open Fractures|Withdrawal by Subject|6|||
155291106|NCT03523962|560494217|FG003|Open Fractures|Withdrawal by Subject|2|||
155291107|NCT03523962|560494214|FG000|Open Fractures|Incarceration|0|||
155291108|NCT03523962|560494215|FG001|Open Fractures|Incarceration|0|||
155291109|NCT03523962|560494216|FG002|Open Fractures|Incarceration|1|||
155291110|NCT03523962|560494217|FG003|Open Fractures|Incarceration|0|||
155291111|NCT01081145|560494221|FG000|Open-Label Phase|Lack of Efficacy|56|||
155291112|NCT01081145|560494222|FG001|Open-Label Phase|Lack of Efficacy|0|||
155291113|NCT01081145|560494221|FG000|Open-Label Phase|Response criteria not met|46|||
155291114|NCT01081145|560494222|FG001|Open-Label Phase|Response criteria not met|0|||
155291115|NCT01081145|560494221|FG000|Open-Label Phase|Adverse Event|42|||
155291116|NCT01081145|560494222|FG001|Open-Label Phase|Adverse Event|0|||
155291117|NCT01081145|560494221|FG000|Open-Label Phase|Withdrawal by Subject|41|||
155291118|NCT01081145|560494222|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155291119|NCT01081145|560494221|FG000|Open-Label Phase|Other|12|||
155291120|NCT01081145|560494222|FG001|Open-Label Phase|Other|0|||
155291121|NCT01081145|560494221|FG000|Open-Label Phase|Lost to Follow-up|11|||
155291122|NCT01081145|560494222|FG001|Open-Label Phase|Lost to Follow-up|0|||
155291123|NCT01081145|560494221|FG000|Open-Label Phase|Protocol Violation|4|||
155291124|NCT01081145|560494222|FG001|Open-Label Phase|Protocol Violation|0|||
155291125|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
155291126|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
155291127|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
155291128|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
155291129|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
155291130|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
155291131|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
155291132|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
155291133|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
155291134|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
155291135|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
155291136|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
155291137|NCT01081145|560494221|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
155291138|NCT01081145|560494222|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
155291139|NCT01582945|560494224|FG000|Overall Study|Intolerable side-effects|1|||
155291140|NCT01582945|560494224|FG000|Overall Study|Scheduling conflicts|1|||
155291141|NCT01726023|560494225|FG000|Overall Study|Death|1|||
155291142|NCT01726023|560494226|FG001|Overall Study|Death|1|||
155291143|NCT01726023|560494225|FG000|Overall Study|Lost to Follow-up|5|||
155291144|NCT01726023|560494226|FG001|Overall Study|Lost to Follow-up|10|||
155291145|NCT01726023|560494225|FG000|Overall Study|Other Eligibility criteria|7|||
155291146|NCT01726023|560494226|FG001|Overall Study|Other Eligibility criteria|7|||
155291147|NCT01726023|560494225|FG000|Overall Study|Withdrawal by Subject|16|||
155291148|NCT01726023|560494226|FG001|Overall Study|Withdrawal by Subject|8|||
155291149|NCT03643211|560494229|FG000|Overall Study|Contract violation/deficiency|12|||
155291150|NCT03643211|560494229|FG000|Overall Study|Invalid registration|3|||
155291151|NCT03643211|560494229|FG000|Overall Study|No treatment information|2|||
155291152|NCT03643211|560494229|FG000|Overall Study|No adverse event information - No revisit|4|||
155291153|NCT04858425|560494230|FG000|Overall Study|Adverse Event|2|||
155291154|NCT04858425|560494231|FG001|Overall Study|Adverse Event|2|||
155291155|NCT04858425|560494230|FG000|Overall Study|Withdrawal by Subject|3|||
155291156|NCT04858425|560494231|FG001|Overall Study|Withdrawal by Subject|1|||
155291157|NCT04858425|560494230|FG000|Overall Study|Lost to Follow-up|4|||
155291158|NCT04858425|560494231|FG001|Overall Study|Lost to Follow-up|2|||
155291159|NCT04858425|560494230|FG000|Overall Study|Lost to Follow-up|1|||
155291160|NCT04858425|560494231|FG001|Overall Study|Lost to Follow-up|0|||
155291161|NCT04536077|560494233|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
155291162|NCT04536077|560494234|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
155291163|NCT04536077|560494233|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
155291164|NCT04536077|560494234|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
155291165|NCT01155869|560494244|FG000|Overall Study|Lost to Follow-up|3|||
155291166|NCT01155869|560494245|FG001|Overall Study|Lost to Follow-up|1|||
155291167|NCT00881335|560494247|FG000|Overall Study|Lost to Follow-up|3|||
155291168|NCT00881335|560494248|FG001|Overall Study|Lost to Follow-up|2|||
155291169|NCT05824351|560494249|FG000|Overall Study|Adverse Event|6|||
155291170|NCT03722446|560494250|FG000|Overall Study|Protocol Violation|15|||
155291171|NCT03722446|560494251|FG001|Overall Study|Protocol Violation|2|||
155291172|NCT00470626|560495457|FG000|Overall Study|Lost to Follow-up|10|||
155291173|NCT00470626|560495457|FG000|Overall Study|Withdrawal by Subject|7|||
155291174|NCT01249092|560495459|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
155291175|NCT01249092|560495459|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
155291176|NCT02380742|560495460|FG000|Overall Study|Withdrawal by Subject|1|||
155291177|NCT02380742|560495461|FG001|Overall Study|Withdrawal by Subject|0|||
155291178|NCT03518112|560495464|FG000|Overall Study|Withdrawal by Subject|1|||
155291179|NCT01546155|560495465|FG000|Overall Study|could not tolerate long scan duration|3|||
155291180|NCT02930343|560495466|FG000|Overall Study|Lost to Follow-up|9|||
155291181|NCT02930343|560495467|FG001|Overall Study|Lost to Follow-up|7|||
155291182|NCT01729819|560495471|FG000|Overall Study|Adverse Event|2|||
155291183|NCT01729819|560495472|FG001|Overall Study|Adverse Event|4|||
155291184|NCT01729819|560495471|FG000|Overall Study|Lack of Efficacy|1|||
155291185|NCT01729819|560495472|FG001|Overall Study|Lack of Efficacy|0|||
155291186|NCT01729819|560495471|FG000|Overall Study|Lost to Follow-up|2|||
155291187|NCT01729819|560495472|FG001|Overall Study|Lost to Follow-up|0|||
155291188|NCT01729819|560495471|FG000|Overall Study|Other reason|1|||
155291189|NCT01729819|560495472|FG001|Overall Study|Other reason|0|||
155291190|NCT01729819|560495471|FG000|Overall Study|Protocol Violation|0|||
155291191|NCT01729819|560495472|FG001|Overall Study|Protocol Violation|1|||
155291192|NCT01729819|560495471|FG000|Overall Study|Withdrawal by Subject|0|||
155291193|NCT01729819|560495472|FG001|Overall Study|Withdrawal by Subject|2|||
155291194|NCT01025843|560495473|FG000|Washout 4|Withdrawal by Subject|0|||
155291195|NCT01025843|560495474|FG001|Washout 4|Withdrawal by Subject|0|||
155291196|NCT01025843|560495475|FG002|Washout 4|Withdrawal by Subject|1|||
155291197|NCT01025843|560495476|FG003|Washout 4|Withdrawal by Subject|1|||
155291198|NCT01025843|560495477|FG004|Washout 4|Withdrawal by Subject|0|||
155291199|NCT01025843|560495478|FG005|Washout 4|Withdrawal by Subject|0|||
155291200|NCT01025843|560495479|FG006|Washout 4|Withdrawal by Subject|0|||
155291201|NCT01025843|560495480|FG007|Washout 4|Withdrawal by Subject|0|||
155291202|NCT01025843|560495481|FG008|Washout 4|Withdrawal by Subject|0|||
155291203|NCT01025843|560495482|FG009|Washout 4|Withdrawal by Subject|0|||
155291204|NCT01649791|560495483|FG000|Overall Study|Disease Progression|2|||
155291205|NCT01649791|560495483|FG000|Overall Study|Adverse Event|1|||
155291206|NCT00364286|560495484|FG000|Overall Study|Withdrawal by Subject|1|||
155291207|NCT00364286|560495484|FG000|Overall Study|Adverse Event|2|||
155291208|NCT02814643|560495485|FG000|Overall Study|Lost to Follow-up|0|||
155291209|NCT02814643|560495486|FG001|Overall Study|Lost to Follow-up|1|||
155291210|NCT02814643|560495485|FG000|Overall Study|Withdrawal by Subject|1|||
155291211|NCT02814643|560495486|FG001|Overall Study|Withdrawal by Subject|2|||
155291212|NCT01227278|560495489|FG000|Overall Study|Withdrawal by Subject|4|||
155291213|NCT01227278|560495490|FG001|Overall Study|Withdrawal by Subject|4|||
155291214|NCT01227278|560495489|FG000|Overall Study|Death|0|||
155291215|NCT01227278|560495490|FG001|Overall Study|Death|2|||
155291216|NCT01227278|560495489|FG000|Overall Study|Other|1|||
155291217|NCT01227278|560495490|FG001|Overall Study|Other|2|||
155291218|NCT00420316|560495491|FG000|Overall Study|Withdrawal by Subject|0|||
155291219|NCT00420316|560495492|FG001|Overall Study|Withdrawal by Subject|1|||
155291220|NCT00420316|560495491|FG000|Overall Study|Lost to Follow-up|12|||
155291221|NCT00420316|560495492|FG001|Overall Study|Lost to Follow-up|8|||
155291222|NCT03546907|560495501|FG000|Overall Study|Lack of Efficacy|1|||
155291223|NCT03546907|560495502|FG001|Overall Study|Lack of Efficacy|1|||
155291224|NCT03546907|560495501|FG000|Overall Study|Withdrawal by Subject|8|||
155291225|NCT03546907|560495502|FG001|Overall Study|Withdrawal by Subject|9|||
155291226|NCT03546907|560495501|FG000|Overall Study|Adverse events (AEs)|7|||
155291227|NCT03546907|560495502|FG001|Overall Study|Adverse events (AEs)|10|||
155291228|NCT03546907|560495501|FG000|Overall Study|Other-unspecified|1|||
155291229|NCT03546907|560495502|FG001|Overall Study|Other-unspecified|1|||
155291230|NCT03720210|560495509|FG000|Overall Study|Lost to Follow-up|1|||
155291231|NCT04033432|560495510|FG000|Overall Study|Progressive Disease|8|||
155291232|NCT04033432|560495510|FG000|Overall Study|Adverse Event|4|||
155291233|NCT04033432|560495510|FG000|Overall Study|Death|1|||
155291234|NCT00558363|560495516|FG000|Overall Study|Physician Decision|18|||
155291235|NCT00558363|560495517|FG001|Overall Study|Physician Decision|4|||
155291236|NCT00558363|560495516|FG000|Overall Study|Withdrawal by Subject|11|||
155291237|NCT00558363|560495517|FG001|Overall Study|Withdrawal by Subject|4|||
155291238|NCT00558363|560495516|FG000|Overall Study|Adverse Event|5|||
155291239|NCT00558363|560495517|FG001|Overall Study|Adverse Event|5|||
155291240|NCT00558363|560495516|FG000|Overall Study|Lack of Efficacy|2|||
155291241|NCT00558363|560495517|FG001|Overall Study|Lack of Efficacy|2|||
155291242|NCT00558363|560495516|FG000|Overall Study|Protocol Violation|2|||
155291243|NCT00558363|560495517|FG001|Overall Study|Protocol Violation|1|||
155291244|NCT00558363|560495516|FG000|Overall Study|Lost to Follow-up|0|||
155291245|NCT00558363|560495517|FG001|Overall Study|Lost to Follow-up|1|||
155291246|NCT00558363|560495516|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
155291247|NCT00558363|560495517|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
155291248|NCT00558363|560495516|FG000|Overall Study|Randomized in Error|1|||
155291249|NCT00558363|560495517|FG001|Overall Study|Randomized in Error|2|||
155291250|NCT00558363|560495516|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
155291251|NCT00558363|560495517|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
155291252|NCT02174562|560495518|FG000|Overall Study|Withdrawal by Subject|7|||
155291253|NCT02174562|560495519|FG001|Overall Study|Withdrawal by Subject|2|||
155291254|NCT02174562|560495518|FG000|Overall Study|Death|2|||
155291255|NCT02174562|560495519|FG001|Overall Study|Death|0|||
155291256|NCT02174562|560495518|FG000|Overall Study|Lost to Follow-up|0|||
155291257|NCT02174562|560495519|FG001|Overall Study|Lost to Follow-up|3|||
155291258|NCT03201809|560495520|FG000|Overall Study|Lost to Follow-up|2|||
155291259|NCT03201809|560495521|FG001|Overall Study|Lost to Follow-up|0|||
155291260|NCT01651949|560495525|FG000|Overall Study|Unknown status|4|||
155291261|NCT01651949|560495526|FG001|Overall Study|Unknown status|4|||
155291262|NCT01651949|560495527|FG002|Overall Study|Unknown status|0|||
155291263|NCT01651949|560495525|FG000|Overall Study|Lost to Follow-up|30|||
155291264|NCT01651949|560495526|FG001|Overall Study|Lost to Follow-up|56|||
155291265|NCT01651949|560495527|FG002|Overall Study|Lost to Follow-up|20|||
155291266|NCT01651949|560495525|FG000|Overall Study|Protocol Violation|0|||
155291267|NCT01651949|560495526|FG001|Overall Study|Protocol Violation|2|||
155291268|NCT01651949|560495527|FG002|Overall Study|Protocol Violation|1|||
155291269|NCT01651949|560495525|FG000|Overall Study|Physician Decision|0|||
155291270|NCT01651949|560495526|FG001|Overall Study|Physician Decision|2|||
155291271|NCT01651949|560495527|FG002|Overall Study|Physician Decision|0|||
155291272|NCT01651949|560495525|FG000|Overall Study|Adverse Event|0|||
154955108|NCT00694551|559261851|FG000|Overall Study|Disease Progression|1|||
154955109|NCT00694551|559261852|FG001|Overall Study|Disease Progression|0|||
154955110|NCT00694551|559261853|FG002|Overall Study|Disease Progression|1|||
154955111|NCT01569152|559261865|FG000|Phase IIa, Period 1|Early Escape|5|||
154955112|NCT01569152|559261866|FG001|Phase IIa, Period 1|Early Escape|22|||
154955113|NCT01569152|559261867|FG002|Phase IIa, Period 1|Early Escape|0|||
154955114|NCT01569152|559261865|FG000|Phase IIa, Period 1|Adverse Event|4|||
154955115|NCT01569152|559261866|FG001|Phase IIa, Period 1|Adverse Event|0|||
155291273|NCT01651949|560495526|FG001|Overall Study|Adverse Event|2|||
155291274|NCT01651949|560495527|FG002|Overall Study|Adverse Event|1|||
155291275|NCT01651949|560495525|FG000|Overall Study|Screen failure|2|||
155291276|NCT01651949|560495526|FG001|Overall Study|Screen failure|2|||
155291277|NCT01651949|560495527|FG002|Overall Study|Screen failure|0|||
155291278|NCT01651949|560495525|FG000|Overall Study|Withdrawal by Subject|17|||
155291279|NCT01651949|560495526|FG001|Overall Study|Withdrawal by Subject|18|||
155291280|NCT01651949|560495527|FG002|Overall Study|Withdrawal by Subject|9|||
155291281|NCT02155829|560495528|FG000|Overall Study|Adverse Event|1|||
154955116|NCT01569152|559261867|FG002|Phase IIa, Period 1|Adverse Event|0|||
154955117|NCT01569152|559261865|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
155156157|NCT03337308|560008210|FG002|Overall Study|Lost to Follow-up|0|||
155156158|NCT03337308|560008211|FG003|Overall Study|Lost to Follow-up|0|||
155291282|NCT02155829|560495529|FG001|Overall Study|Adverse Event|0|||
155291283|NCT02155829|560495528|FG000|Overall Study|Withdrawal by Subject|3|||
155291284|NCT02155829|560495529|FG001|Overall Study|Withdrawal by Subject|3|||
155291285|NCT02155829|560495528|FG000|Overall Study|Protocol Violation|2|||
155291286|NCT02155829|560495529|FG001|Overall Study|Protocol Violation|0|||
155291287|NCT00771849|560495530|FG000|Overall Study|Lost to Follow-up|1|||
155291288|NCT00771849|560495531|FG001|Overall Study|Lost to Follow-up|2|||
155291289|NCT00771849|560495530|FG000|Overall Study|Withdrawal by Subject|1|||
155291290|NCT00771849|560495531|FG001|Overall Study|Withdrawal by Subject|1|||
155291291|NCT00771849|560495530|FG000|Overall Study|Not vaccinated|0|||
155291292|NCT00771849|560495531|FG001|Overall Study|Not vaccinated|1|||
155291293|NCT03058991|560495532|FG000|Overall Study|Lost to Follow-up|17|||
155291294|NCT03058991|560495533|FG001|Overall Study|Lost to Follow-up|12|||
155291295|NCT03058991|560495534|FG002|Overall Study|Lost to Follow-up|12|||
155291296|NCT03058991|560495532|FG000|Overall Study|Withdrawal by Subject|1|||
155291297|NCT03058991|560495533|FG001|Overall Study|Withdrawal by Subject|0|||
155291298|NCT03058991|560495534|FG002|Overall Study|Withdrawal by Subject|0|||
155291299|NCT01689519|560495535|FG000|Intent to Treat|Death|157|||
155291300|NCT01689519|560495536|FG001|Intent to Treat|Death|167|||
155291301|NCT01689519|560495535|FG000|Intent to Treat|Lost to Follow-up|4|||
155291302|NCT01689519|560495536|FG001|Intent to Treat|Lost to Follow-up|8|||
155291303|NCT01689519|560495535|FG000|Intent to Treat|Other|2|||
155291304|NCT01689519|560495536|FG001|Intent to Treat|Other|4|||
155291305|NCT01689519|560495535|FG000|Intent to Treat|Physician Decision|4|||
155291306|NCT01689519|560495536|FG001|Intent to Treat|Physician Decision|1|||
155291307|NCT01689519|560495535|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
155291308|NCT01689519|560495536|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
155291309|NCT01689519|560495535|FG000|Intent to Treat|Withdrawal by Subject|21|||
155291310|NCT01689519|560495536|FG001|Intent to Treat|Withdrawal by Subject|20|||
155291311|NCT01689519|560495535|FG000|Safety Population|Death|158|||
155291312|NCT01689519|560495536|FG001|Safety Population|Death|165|||
155291313|NCT01689519|560495535|FG000|Safety Population|Lost to Follow-up|4|||
155291314|NCT01689519|560495536|FG001|Safety Population|Lost to Follow-up|8|||
155291315|NCT01689519|560495535|FG000|Safety Population|Other|2|||
155291316|NCT01689519|560495536|FG001|Safety Population|Other|4|||
155291317|NCT01689519|560495535|FG000|Safety Population|Physician Decision|4|||
155291318|NCT01689519|560495536|FG001|Safety Population|Physician Decision|1|||
155291319|NCT01689519|560495535|FG000|Safety Population|Study Terminated By Sponsor|60|||
155291320|NCT01689519|560495536|FG001|Safety Population|Study Terminated By Sponsor|47|||
155291321|NCT01689519|560495535|FG000|Safety Population|Withdrawal by Subject|20|||
155291322|NCT01689519|560495536|FG001|Safety Population|Withdrawal by Subject|20|||
155291323|NCT02982213|560495541|FG000|Overall Study|Did not complete follow up questionnaire|5|||
155291324|NCT02982213|560495542|FG001|Overall Study|Did not complete follow up questionnaire|1|||
155291325|NCT02596035|560495545|FG000|Overall Study|Disease Progression|64|||
155291326|NCT02596035|560495546|FG001|Overall Study|Disease Progression|32|||
155291327|NCT02596035|560495547|FG002|Overall Study|Disease Progression|1|||
155291328|NCT02596035|560495545|FG000|Overall Study|study drug toxicity|12|||
155291329|NCT02596035|560495546|FG001|Overall Study|study drug toxicity|3|||
155291330|NCT02596035|560495547|FG002|Overall Study|study drug toxicity|0|||
155291331|NCT02596035|560495545|FG000|Overall Study|AE unrelated to study drug|5|||
155291332|NCT02596035|560495546|FG001|Overall Study|AE unrelated to study drug|2|||
155291333|NCT02596035|560495547|FG002|Overall Study|AE unrelated to study drug|0|||
155291334|NCT02596035|560495545|FG000|Overall Study|participant request to discontinue study treatment|2|||
155291335|NCT02596035|560495546|FG001|Overall Study|participant request to discontinue study treatment|0|||
155291336|NCT02596035|560495547|FG002|Overall Study|participant request to discontinue study treatment|0|||
155291337|NCT02596035|560495545|FG000|Overall Study|participant withdrew consent|2|||
155291338|NCT02596035|560495546|FG001|Overall Study|participant withdrew consent|2|||
155291339|NCT02596035|560495547|FG002|Overall Study|participant withdrew consent|0|||
155291340|NCT02596035|560495545|FG000|Overall Study|Poor/Non Comlpiance|0|||
155291341|NCT02596035|560495546|FG001|Overall Study|Poor/Non Comlpiance|1|||
155059974|NCT04142242|559653912|FG004|Stage II|Non-compliance with the protocol|0|||
155291342|NCT02596035|560495547|FG002|Overall Study|Poor/Non Comlpiance|0|||
155291343|NCT02596035|560495545|FG000|Overall Study|participant no longer meets study criteria|1|||
155291344|NCT02596035|560495546|FG001|Overall Study|participant no longer meets study criteria|0|||
155291345|NCT02596035|560495547|FG002|Overall Study|participant no longer meets study criteria|0|||
155059975|NCT04142242|559653913|FG005|Stage II|Non-compliance with the protocol|0|||
155291346|NCT02596035|560495545|FG000|Overall Study|other reasons|11|||
155291347|NCT02596035|560495546|FG001|Overall Study|other reasons|4|||
155291348|NCT02596035|560495547|FG002|Overall Study|other reasons|0|||
155291349|NCT00835380|560495550|FG000|Overall Study|Withdrawal by Subject|2|||
155291350|NCT03247543|560495551|FG000|Overall Study|Adverse Event|3|||
155291351|NCT03247543|560495552|FG001|Overall Study|Adverse Event|6|||
155291352|NCT03247543|560495553|FG002|Overall Study|Adverse Event|4|||
155291353|NCT03247543|560495551|FG000|Overall Study|Lost to Follow-up|10|||
155291354|NCT03247543|560495552|FG001|Overall Study|Lost to Follow-up|7|||
155291355|NCT03247543|560495553|FG002|Overall Study|Lost to Follow-up|8|||
155291356|NCT03247543|560495551|FG000|Overall Study|Consent withdrawn by caregiver|2|||
155156159|NCT03337308|560008208|FG000|Overall Study|Withdrawal by Subject|2|||
155156160|NCT03337308|560008209|FG001|Overall Study|Withdrawal by Subject|1|||
155156161|NCT03337308|560008210|FG002|Overall Study|Withdrawal by Subject|2|||
155156162|NCT03337308|560008211|FG003|Overall Study|Withdrawal by Subject|1|||
155156163|NCT03337308|560008208|FG000|Overall Study|Protocol Violation|0|||
155156164|NCT03337308|560008209|FG001|Overall Study|Protocol Violation|1|||
155156165|NCT03337308|560008210|FG002|Overall Study|Protocol Violation|0|||
155156166|NCT03337308|560008211|FG003|Overall Study|Protocol Violation|0|||
155156167|NCT02246530|560008215|FG000|Overall Study|Lost to Follow-up|4|||
155156168|NCT02246530|560008216|FG001|Overall Study|Lost to Follow-up|0|||
155156169|NCT05135767|560008221|FG000|Baseline|Lost to Follow-up|1|||
155156170|NCT05135767|560008222|FG001|Baseline|Lost to Follow-up|1|||
155156171|NCT05135767|560008221|FG000|Baseline|Withdrawal by Subject|0|||
155156172|NCT05135767|560008222|FG001|Baseline|Withdrawal by Subject|2|||
155156173|NCT05135767|560008221|FG000|Active Study Phase|Lost to Follow-up|2|||
155156174|NCT05135767|560008222|FG001|Active Study Phase|Lost to Follow-up|0|||
155156175|NCT02694185|560008223|FG000|Overall Study|Withdrawal by Subject|45|||
155156176|NCT02694185|560008224|FG001|Overall Study|Withdrawal by Subject|0|||
155156177|NCT04366349|560008234|FG000|Overall Study|Withdrawal by Subject|1|||
155156178|NCT04366349|560008235|FG001|Overall Study|Withdrawal by Subject|0|||
155156179|NCT04366349|560008236|FG002|Overall Study|Withdrawal by Subject|0|||
155156180|NCT04366349|560008237|FG003|Overall Study|Withdrawal by Subject|0|||
155156181|NCT04366349|560008238|FG004|Overall Study|Withdrawal by Subject|0|||
155156182|NCT04366349|560008239|FG005|Overall Study|Withdrawal by Subject|0|||
155156183|NCT02532517|560008248|FG000|Overall Study|Did not complete 24-Month visit|4|||
155156184|NCT02532517|560008248|FG000|Overall Study|Failed Angiographic eligibility|1|||
155156185|NCT02532517|560008248|FG000|Overall Study|Lost to Follow-up|4|||
155156186|NCT02532517|560008248|FG000|Overall Study|Withdrawal by Subject|4|||
155156187|NCT02532517|560008248|FG000|Overall Study|Death|4|||
155156188|NCT03312231|560008249|FG000|Overall Study|Lost to Follow-up|2|||
155156189|NCT03312231|560008250|FG001|Overall Study|Lost to Follow-up|6|||
155156190|NCT03312231|560008251|FG002|Overall Study|Lost to Follow-up|1|||
155156191|NCT03312231|560008252|FG003|Overall Study|Lost to Follow-up|3|||
155156192|NCT03312231|560008253|FG004|Overall Study|Lost to Follow-up|1|||
155156193|NCT03312231|560008249|FG000|Overall Study|Withdrawal by Subject|0|||
155156194|NCT03312231|560008250|FG001|Overall Study|Withdrawal by Subject|3|||
155156195|NCT03312231|560008251|FG002|Overall Study|Withdrawal by Subject|1|||
155156196|NCT03312231|560008252|FG003|Overall Study|Withdrawal by Subject|0|||
155156197|NCT03312231|560008253|FG004|Overall Study|Withdrawal by Subject|0|||
155156198|NCT03312231|560008249|FG000|Overall Study|Death|0|||
155156199|NCT03312231|560008250|FG001|Overall Study|Death|1|||
155156200|NCT03312231|560008251|FG002|Overall Study|Death|1|||
154955118|NCT01569152|559261866|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
154955119|NCT01569152|559261867|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
154955120|NCT01569152|559261865|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
154955121|NCT01569152|559261866|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
154955122|NCT01569152|559261867|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
154955123|NCT01569152|559261865|FG000|Phase IIa, Period 1|Protocol Violation|0|||
154955124|NCT01569152|559261866|FG001|Phase IIa, Period 1|Protocol Violation|1|||
154955125|NCT01569152|559261867|FG002|Phase IIa, Period 1|Protocol Violation|0|||
154955126|NCT01569152|559261865|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
154955127|NCT01569152|559261866|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
154955128|NCT01569152|559261867|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
154955129|NCT01569152|559261865|FG000|Safety Extension, Period 3|Adverse Event|0|||
154955130|NCT01569152|559261866|FG001|Safety Extension, Period 3|Adverse Event|0|||
154955131|NCT01569152|559261867|FG002|Safety Extension, Period 3|Adverse Event|4|||
154955132|NCT01569152|559261865|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
154955133|NCT01569152|559261866|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
154955134|NCT01569152|559261867|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
154955135|NCT01569152|559261865|FG000|Safety Extension, Period 3|Physician Decision|0|||
154955136|NCT01569152|559261866|FG001|Safety Extension, Period 3|Physician Decision|0|||
154955137|NCT01569152|559261867|FG002|Safety Extension, Period 3|Physician Decision|2|||
154955138|NCT01569152|559261865|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
154955139|NCT01569152|559261866|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
154955140|NCT01569152|559261867|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
154955141|NCT03262012|559261868|FG000|Overall Study|Withdrawal by Subject|15|||
154955142|NCT03262012|559261869|FG001|Overall Study|Withdrawal by Subject|13|||
154955143|NCT03262012|559261870|FG002|Overall Study|Withdrawal by Subject|8|||
154955144|NCT03262012|559261871|FG003|Overall Study|Withdrawal by Subject|7|||
154955145|NCT03262012|559261868|FG000|Overall Study|Adverse Event|10|||
154955146|NCT03262012|559261869|FG001|Overall Study|Adverse Event|12|||
154955147|NCT03262012|559261870|FG002|Overall Study|Adverse Event|4|||
154955148|NCT03262012|559261871|FG003|Overall Study|Adverse Event|6|||
154955149|NCT03262012|559261868|FG000|Overall Study|Physician Decision|2|||
154955150|NCT03262012|559261869|FG001|Overall Study|Physician Decision|5|||
154955151|NCT03262012|559261870|FG002|Overall Study|Physician Decision|1|||
154955152|NCT03262012|559261871|FG003|Overall Study|Physician Decision|0|||
154955153|NCT03262012|559261868|FG000|Overall Study|Lack of Efficacy|0|||
154955154|NCT03262012|559261869|FG001|Overall Study|Lack of Efficacy|5|||
155156201|NCT03312231|560008252|FG003|Overall Study|Death|0|||
155156202|NCT03312231|560008253|FG004|Overall Study|Death|0|||
155156203|NCT03312231|560008249|FG000|Overall Study|Study Vaccination not Received|1|||
155156204|NCT03312231|560008250|FG001|Overall Study|Study Vaccination not Received|1|||
155156205|NCT03312231|560008251|FG002|Overall Study|Study Vaccination not Received|1|||
155156206|NCT03312231|560008252|FG003|Overall Study|Study Vaccination not Received|0|||
155156207|NCT03312231|560008253|FG004|Overall Study|Study Vaccination not Received|0|||
155156208|NCT03157830|560008254|FG000|Overall Study|Lost to Follow-up|1|||
155156209|NCT03157830|560008254|FG000|Overall Study|Withdrawal by Subject|1|||
155156210|NCT03472885|560008255|FG000|24-Week Treatment Period|Adverse Event|1|||
155156211|NCT05417438|560008256|FG000|Overall Study|Withdrawal by Subject|3|||
155156212|NCT03253393|560008263|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
155156213|NCT03253393|560008264|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
155156214|NCT03253393|560008265|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
155156215|NCT03204188|560008266|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
155156216|NCT03204188|560008266|FG000|Immunotherapy Phase (1 Year)|Death|1|||
155156217|NCT03204188|560008266|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
155156218|NCT03204188|560008266|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
155156219|NCT00906204|560010572|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
155156220|NCT00906204|560010573|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
155156221|NCT00906204|560010572|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
155156222|NCT00906204|560010573|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
155156223|NCT00906204|560010572|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
155156224|NCT00906204|560010573|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
155156225|NCT00906204|560010572|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
155156226|NCT00906204|560010573|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
155156227|NCT00906204|560010572|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
154955155|NCT03262012|559261870|FG002|Overall Study|Lack of Efficacy|1|||
154955156|NCT03262012|559261871|FG003|Overall Study|Lack of Efficacy|2|||
154955157|NCT03262012|559261868|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
154955158|NCT03262012|559261869|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
155156228|NCT00906204|560010573|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
155156229|NCT01462370|560010581|FG000|Overall Study|Lack of Qualifying Event|1|||
155156230|NCT01462370|560010582|FG001|Overall Study|Lack of Qualifying Event|1|||
155156231|NCT01462370|560010581|FG000|Overall Study|Physician Decision|0|||
155291357|NCT03247543|560495552|FG001|Overall Study|Consent withdrawn by caregiver|2|||
155291358|NCT03247543|560495553|FG002|Overall Study|Consent withdrawn by caregiver|9|||
155291359|NCT03247543|560495551|FG000|Overall Study|Withdrawal by Subject|0|||
155291360|NCT03247543|560495552|FG001|Overall Study|Withdrawal by Subject|0|||
155291361|NCT03247543|560495553|FG002|Overall Study|Withdrawal by Subject|1|||
155291362|NCT03247543|560495551|FG000|Overall Study|Failure to Follow study procedures|1|||
155291363|NCT03247543|560495552|FG001|Overall Study|Failure to Follow study procedures|3|||
155291364|NCT03247543|560495553|FG002|Overall Study|Failure to Follow study procedures|1|||
155291365|NCT03247543|560495551|FG000|Overall Study|Lack of Efficacy|1|||
155291366|NCT03247543|560495552|FG001|Overall Study|Lack of Efficacy|0|||
155291367|NCT03247543|560495553|FG002|Overall Study|Lack of Efficacy|0|||
155291368|NCT03247543|560495551|FG000|Overall Study|Non-compliance with study visits|0|||
155291369|NCT03247543|560495552|FG001|Overall Study|Non-compliance with study visits|1|||
155291370|NCT03247543|560495553|FG002|Overall Study|Non-compliance with study visits|0|||
155291371|NCT02059980|560495560|FG000|Overall Study|Lost to Follow-up|2|||
155291372|NCT02059980|560495561|FG001|Overall Study|Lost to Follow-up|1|||
155291373|NCT01321606|560495562|FG000|Overall Study|Lost to Follow-up|0|||
155291374|NCT01321606|560495563|FG001|Overall Study|Lost to Follow-up|0|||
155291375|NCT01321606|560495564|FG002|Overall Study|Lost to Follow-up|0|||
155291376|NCT01321606|560495565|FG003|Overall Study|Lost to Follow-up|1|||
155291377|NCT01253226|560495566|FG000|Overall Study|Adverse Event|0|||
155291378|NCT01253226|560495567|FG001|Overall Study|Adverse Event|0|||
155291379|NCT01253226|560495568|FG002|Overall Study|Adverse Event|1|||
155291380|NCT01253226|560495569|FG003|Overall Study|Adverse Event|0|||
155291381|NCT01253226|560495570|FG004|Overall Study|Adverse Event|0|||
155291382|NCT01253226|560495566|FG000|Overall Study|Death|0|||
155291383|NCT01253226|560495567|FG001|Overall Study|Death|1|||
155291384|NCT01253226|560495568|FG002|Overall Study|Death|0|||
155291385|NCT01253226|560495569|FG003|Overall Study|Death|0|||
155291386|NCT01253226|560495570|FG004|Overall Study|Death|0|||
155291387|NCT01253226|560495566|FG000|Overall Study|Physician Decision|0|||
155291388|NCT01253226|560495567|FG001|Overall Study|Physician Decision|0|||
155291389|NCT01253226|560495568|FG002|Overall Study|Physician Decision|0|||
155291390|NCT01253226|560495569|FG003|Overall Study|Physician Decision|0|||
155291391|NCT01253226|560495570|FG004|Overall Study|Physician Decision|2|||
155291392|NCT01253226|560495566|FG000|Overall Study|Withdrawal by Subject|0|||
155291393|NCT01253226|560495567|FG001|Overall Study|Withdrawal by Subject|0|||
154955159|NCT03262012|559261870|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
154955160|NCT03262012|559261871|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
154955161|NCT01015625|559263276|FG000|Overall Study|Lost to Follow-up|3|||
154955162|NCT01015625|559263277|FG001|Overall Study|Lost to Follow-up|1|||
155291394|NCT01253226|560495568|FG002|Overall Study|Withdrawal by Subject|0|||
155291395|NCT01253226|560495569|FG003|Overall Study|Withdrawal by Subject|1|||
155291396|NCT01253226|560495570|FG004|Overall Study|Withdrawal by Subject|0|||
155291397|NCT04550039|560495576|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
155291398|NCT04550039|560495577|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
155291399|NCT04550039|560495576|FG000|Overall Study|patient self-withdrew from study|0|||
155291400|NCT04550039|560495577|FG001|Overall Study|patient self-withdrew from study|1|||
155291401|NCT00554801|560495580|FG000|Overall Study|left area before completion|5|||
155291402|NCT00554801|560495581|FG001|Overall Study|left area before completion|0|||
155291403|NCT00554801|560495580|FG000|Overall Study|Withdrawal by Subject|14|||
155291404|NCT00554801|560495581|FG001|Overall Study|Withdrawal by Subject|0|||
155291405|NCT05196737|560495582|FG000|Non-intervention Week|Lost to Follow-up|2|||
155291406|NCT05196737|560495582|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
155291407|NCT00828945|560495585|FG000|Overall Study|Death|4|||
155291408|NCT00828945|560495585|FG000|Overall Study|Participant was missing|1|||
155291409|NCT00828945|560495585|FG000|Overall Study|Other|36|||
155291410|NCT04222959|560495586|FG000|Overall Study|Lost to Follow-up|76|||
155291411|NCT04222959|560495587|FG001|Overall Study|Lost to Follow-up|28|||
155291412|NCT00603447|560495598|FG000|Overall Study|Adverse Event|0|||
155291413|NCT00603447|560495599|FG001|Overall Study|Adverse Event|1|||
155291414|NCT00603447|560495600|FG002|Overall Study|Adverse Event|1|||
155291415|NCT00603447|560495601|FG003|Overall Study|Adverse Event|2|||
155291416|NCT00603447|560495602|FG004|Overall Study|Adverse Event|1|||
155291417|NCT00603447|560495603|FG005|Overall Study|Adverse Event|2|||
155291418|NCT00603447|560495604|FG006|Overall Study|Adverse Event|10|||
155291419|NCT00603447|560495598|FG000|Overall Study|Other|0|||
155291420|NCT00603447|560495599|FG001|Overall Study|Other|0|||
155059976|NCT04142242|559653908|FG000|Stage II|Lost to Follow-up|0|||
155059977|NCT04142242|559653909|FG001|Stage II|Lost to Follow-up|0|||
155291421|NCT00603447|560495600|FG002|Overall Study|Other|1|||
155291422|NCT00603447|560495601|FG003|Overall Study|Other|0|||
155291423|NCT00603447|560495602|FG004|Overall Study|Other|3|||
155291424|NCT00603447|560495603|FG005|Overall Study|Other|0|||
155291425|NCT00603447|560495604|FG006|Overall Study|Other|13|||
155291426|NCT00603447|560495598|FG000|Overall Study|Withdrew Consent|0|||
155291427|NCT00603447|560495599|FG001|Overall Study|Withdrew Consent|2|||
155291428|NCT00603447|560495600|FG002|Overall Study|Withdrew Consent|0|||
155291429|NCT00603447|560495601|FG003|Overall Study|Withdrew Consent|0|||
155291430|NCT00603447|560495602|FG004|Overall Study|Withdrew Consent|1|||
155291431|NCT00603447|560495603|FG005|Overall Study|Withdrew Consent|0|||
155291432|NCT00603447|560495604|FG006|Overall Study|Withdrew Consent|1|||
155291433|NCT04133363|560495607|FG000|Overall Study|Lost to Follow-up|2|||
155291434|NCT04133363|560495608|FG001|Overall Study|Lost to Follow-up|1|||
155291435|NCT04133363|560495609|FG002|Overall Study|Lost to Follow-up|4|||
155291436|NCT00482729|560497498|FG000|Overall Study|Adverse Event|29|||
155291437|NCT00482729|560497499|FG001|Overall Study|Adverse Event|33|||
155291438|NCT00482729|560497498|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
155291439|NCT00482729|560497499|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
155291440|NCT00482729|560497498|FG000|Overall Study|Hyperglycemia Criteria|7|||
155291441|NCT00482729|560497499|FG001|Overall Study|Hyperglycemia Criteria|5|||
155291442|NCT00482729|560497498|FG000|Overall Study|Lack of Efficacy|4|||
155291443|NCT00482729|560497499|FG001|Overall Study|Lack of Efficacy|16|||
155291444|NCT00482729|560497498|FG000|Overall Study|Lost to Follow-up|86|||
155291445|NCT00482729|560497499|FG001|Overall Study|Lost to Follow-up|66|||
155291446|NCT00482729|560497498|FG000|Overall Study|Physician Decision|10|||
155291447|NCT00482729|560497499|FG001|Overall Study|Physician Decision|7|||
155291448|NCT00482729|560497498|FG000|Overall Study|Pregnancy|4|||
155291449|NCT00482729|560497499|FG001|Overall Study|Pregnancy|2|||
155291450|NCT00482729|560497498|FG000|Overall Study|Protocol Violation|10|||
155291451|NCT00482729|560497499|FG001|Overall Study|Protocol Violation|18|||
155291452|NCT00482729|560497498|FG000|Overall Study|Withdrawal by Subject|67|||
155291453|NCT00482729|560497499|FG001|Overall Study|Withdrawal by Subject|69|||
155291456|NCT01090024|560497505|FG000|Period 1|Met exclusion criteria|0|||
155291457|NCT01090024|560497506|FG001|Period 1|Met exclusion criteria|0|||
155291458|NCT01090024|560497507|FG002|Period 1|Met exclusion criteria|0|||
155291459|NCT01090024|560497508|FG003|Period 1|Met exclusion criteria|0|||
155291460|NCT01090024|560497509|FG004|Period 1|Met exclusion criteria|0|||
155291461|NCT01090024|560497510|FG005|Period 1|Met exclusion criteria|0|||
155291462|NCT01090024|560497511|FG006|Period 1|Met exclusion criteria|0|||
155059978|NCT04142242|559653910|FG002|Stage II|Lost to Follow-up|1|||
155291463|NCT01090024|560497512|FG007|Period 1|Met exclusion criteria|0|||
155291464|NCT01090024|560497513|FG008|Period 1|Met exclusion criteria|0|||
155059979|NCT04142242|559653911|FG003|Stage II|Lost to Follow-up|2|||
155059980|NCT04142242|559653912|FG004|Stage II|Lost to Follow-up|0|||
155291465|NCT01090024|560497514|FG009|Period 1|Met exclusion criteria|0|||
155059981|NCT04142242|559653913|FG005|Stage II|Lost to Follow-up|0|||
155291466|NCT01090024|560497515|FG010|Period 1|Met exclusion criteria|0|||
155291467|NCT01090024|560497516|FG011|Period 1|Met exclusion criteria|0|||
155291468|NCT01090024|560497517|FG012|Period 1|Met exclusion criteria|0|||
155291469|NCT01090024|560497518|FG013|Period 1|Met exclusion criteria|0|||
155291470|NCT01090024|560497519|FG014|Period 1|Met exclusion criteria|1|||
155291471|NCT01090024|560497520|FG015|Period 1|Met exclusion criteria|0|||
155291472|NCT01090024|560497521|FG016|Period 1|Met exclusion criteria|0|||
155291473|NCT01090024|560497522|FG017|Period 1|Met exclusion criteria|0|||
155291474|NCT01090024|560497505|FG000|Period 1|Adverse Event|0|||
155291475|NCT01090024|560497506|FG001|Period 1|Adverse Event|0|||
155291476|NCT01090024|560497507|FG002|Period 1|Adverse Event|0|||
155291477|NCT01090024|560497508|FG003|Period 1|Adverse Event|0|||
155291478|NCT01090024|560497509|FG004|Period 1|Adverse Event|0|||
155291479|NCT01090024|560497510|FG005|Period 1|Adverse Event|0|||
155291480|NCT01090024|560497511|FG006|Period 1|Adverse Event|0|||
155291481|NCT01090024|560497512|FG007|Period 1|Adverse Event|0|||
155291482|NCT01090024|560497513|FG008|Period 1|Adverse Event|0|||
155291483|NCT01090024|560497514|FG009|Period 1|Adverse Event|1|||
155291484|NCT01090024|560497515|FG010|Period 1|Adverse Event|0|||
155291485|NCT01090024|560497516|FG011|Period 1|Adverse Event|1|||
155291486|NCT01090024|560497517|FG012|Period 1|Adverse Event|0|||
155291487|NCT01090024|560497518|FG013|Period 1|Adverse Event|0|||
155291488|NCT01090024|560497519|FG014|Period 1|Adverse Event|0|||
155291489|NCT01090024|560497520|FG015|Period 1|Adverse Event|0|||
155291490|NCT01090024|560497521|FG016|Period 1|Adverse Event|0|||
155291491|NCT01090024|560497522|FG017|Period 1|Adverse Event|1|||
155291492|NCT01090024|560497505|FG000|Period 1|Withdrawal by Subject|0|||
155291493|NCT01090024|560497506|FG001|Period 1|Withdrawal by Subject|0|||
155291494|NCT01090024|560497507|FG002|Period 1|Withdrawal by Subject|0|||
155291495|NCT01090024|560497508|FG003|Period 1|Withdrawal by Subject|1|||
155291496|NCT01090024|560497509|FG004|Period 1|Withdrawal by Subject|0|||
155059982|NCT04142242|559653908|FG000|Stage II|Withdrawal by Subject|0|||
155059983|NCT04142242|559653909|FG001|Stage II|Withdrawal by Subject|0|||
155059984|NCT04142242|559653910|FG002|Stage II|Withdrawal by Subject|5|||
155059985|NCT04142242|559653911|FG003|Stage II|Withdrawal by Subject|9|||
155059986|NCT04142242|559653912|FG004|Stage II|Withdrawal by Subject|0|||
155059987|NCT04142242|559653913|FG005|Stage II|Withdrawal by Subject|0|||
155059988|NCT01274351|559653921|FG000|Overall Study|Lost to Follow-up|1|||
155059989|NCT01274351|559653921|FG000|Overall Study|patient not compliant with the protocol|1|||
155059990|NCT01274351|559653921|FG000|Overall Study|Pregnancy|1|||
155059991|NCT01274351|559653921|FG000|Overall Study|Death|2|||
155059992|NCT01274351|559653921|FG000|Overall Study|Withdrawal by Subject|3|||
155059993|NCT01274351|559653921|FG000|Overall Study|Adverse Event|8|||
155059994|NCT01274351|559653921|FG000|Overall Study|progression of disease|3|||
155059995|NCT01274351|559653921|FG000|Overall Study|hospitalization|1|||
155059996|NCT04194814|559653929|FG000|Overall Study|Physician Decision|3|||
155059997|NCT04194814|559653930|FG001|Overall Study|Physician Decision|0|||
155059998|NCT04194814|559653929|FG000|Overall Study|Withdrawal by Subject|0|||
155059999|NCT04194814|559653930|FG001|Overall Study|Withdrawal by Subject|2|||
155060000|NCT00959751|559655500|FG000|Overall Study|Lost to Follow-up|2|||
155060001|NCT00959751|559655501|FG001|Overall Study|Lost to Follow-up|3|||
155060002|NCT00959751|559655500|FG000|Overall Study|Consent Withdrawn|0|||
155291497|NCT01090024|560497510|FG005|Period 1|Withdrawal by Subject|0|||
155291498|NCT01090024|560497511|FG006|Period 1|Withdrawal by Subject|0|||
155291499|NCT01090024|560497512|FG007|Period 1|Withdrawal by Subject|0|||
155060003|NCT00959751|559655501|FG001|Overall Study|Consent Withdrawn|1|||
155060004|NCT00959751|559655500|FG000|Overall Study|Non-compliance to Study Procedures|0|||
155060005|NCT00959751|559655501|FG001|Overall Study|Non-compliance to Study Procedures|1|||
155060006|NCT00959751|559655500|FG000|Overall Study|No migraine headache without aura|7|||
155060007|NCT00959751|559655501|FG001|Overall Study|No migraine headache without aura|7|||
155060008|NCT03861039|559655504|FG000|Overall Study|Adverse Event|2|||
155291500|NCT01090024|560497513|FG008|Period 1|Withdrawal by Subject|0|||
155291501|NCT01090024|560497514|FG009|Period 1|Withdrawal by Subject|0|||
155291502|NCT01090024|560497515|FG010|Period 1|Withdrawal by Subject|0|||
155291503|NCT01090024|560497516|FG011|Period 1|Withdrawal by Subject|0|||
155291504|NCT01090024|560497517|FG012|Period 1|Withdrawal by Subject|0|||
155060009|NCT03861039|559655505|FG001|Overall Study|Adverse Event|5|||
155291505|NCT01090024|560497518|FG013|Period 1|Withdrawal by Subject|0|||
155291506|NCT01090024|560497519|FG014|Period 1|Withdrawal by Subject|0|||
155291507|NCT01090024|560497520|FG015|Period 1|Withdrawal by Subject|0|||
155291508|NCT01090024|560497521|FG016|Period 1|Withdrawal by Subject|0|||
155291509|NCT01090024|560497522|FG017|Period 1|Withdrawal by Subject|0|||
155291510|NCT01090024|560497505|FG000|Period 1|Lost to Follow-up|0|||
155291511|NCT01090024|560497506|FG001|Period 1|Lost to Follow-up|1|||
155291512|NCT01090024|560497507|FG002|Period 1|Lost to Follow-up|0|||
155060010|NCT03861039|559655506|FG002|Overall Study|Adverse Event|11|||
155291513|NCT01090024|560497508|FG003|Period 1|Lost to Follow-up|0|||
155291514|NCT01090024|560497509|FG004|Period 1|Lost to Follow-up|0|||
155291515|NCT01090024|560497510|FG005|Period 1|Lost to Follow-up|0|||
155060011|NCT03861039|559655504|FG000|Overall Study|Withdrawal by Subject|1|||
155060012|NCT03861039|559655505|FG001|Overall Study|Withdrawal by Subject|3|||
155060013|NCT03861039|559655506|FG002|Overall Study|Withdrawal by Subject|4|||
155291516|NCT01090024|560497511|FG006|Period 1|Lost to Follow-up|0|||
155291517|NCT01090024|560497512|FG007|Period 1|Lost to Follow-up|0|||
155291518|NCT01090024|560497513|FG008|Period 1|Lost to Follow-up|0|||
155291519|NCT01090024|560497514|FG009|Period 1|Lost to Follow-up|0|||
155291520|NCT01090024|560497515|FG010|Period 1|Lost to Follow-up|0|||
155291521|NCT01090024|560497516|FG011|Period 1|Lost to Follow-up|0|||
155291522|NCT01090024|560497517|FG012|Period 1|Lost to Follow-up|0|||
155291523|NCT01090024|560497518|FG013|Period 1|Lost to Follow-up|0|||
155291524|NCT01090024|560497519|FG014|Period 1|Lost to Follow-up|0|||
155291525|NCT01090024|560497520|FG015|Period 1|Lost to Follow-up|0|||
155291526|NCT01090024|560497521|FG016|Period 1|Lost to Follow-up|0|||
155291527|NCT01090024|560497522|FG017|Period 1|Lost to Follow-up|0|||
155291528|NCT01090024|560497505|FG000|Period 2|Lost to Follow-up|0|||
155291529|NCT01090024|560497506|FG001|Period 2|Lost to Follow-up|0|||
155291530|NCT01090024|560497507|FG002|Period 2|Lost to Follow-up|0|||
155291531|NCT01090024|560497508|FG003|Period 2|Lost to Follow-up|1|||
155291532|NCT01090024|560497509|FG004|Period 2|Lost to Follow-up|0|||
155291533|NCT01090024|560497510|FG005|Period 2|Lost to Follow-up|0|||
155291534|NCT01090024|560497511|FG006|Period 2|Lost to Follow-up|0|||
155291535|NCT01090024|560497512|FG007|Period 2|Lost to Follow-up|0|||
155291536|NCT01090024|560497513|FG008|Period 2|Lost to Follow-up|0|||
155291537|NCT01090024|560497514|FG009|Period 2|Lost to Follow-up|0|||
155291538|NCT01090024|560497515|FG010|Period 2|Lost to Follow-up|0|||
155060014|NCT03427892|559655507|FG000|Overall Study|Lost to Follow-up|2|||
155060015|NCT03255187|559655508|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
155060016|NCT03255187|559655509|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
155060017|NCT03255187|559655508|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
155060018|NCT03255187|559655509|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
155060019|NCT03617588|559655514|FG000|Overall Study|Withdrawal by Subject|1|||
155060020|NCT03617588|559655515|FG001|Overall Study|Withdrawal by Subject|0|||
155060021|NCT01499511|559655516|FG000|Overall Study|Death|1|||
155060022|NCT01499511|559655517|FG001|Overall Study|Death|0|||
155060023|NCT00296335|559655524|FG000|Overall Study|Recurrence|3|||
155060024|NCT00296335|559655525|FG001|Overall Study|Recurrence|51|||
155060025|NCT00296335|559655524|FG000|Overall Study|Adverse Event|17|||
155060026|NCT00296335|559655525|FG001|Overall Study|Adverse Event|27|||
155060027|NCT00296335|559655524|FG000|Overall Study|Lost to Follow-up|7|||
155060028|NCT00296335|559655525|FG001|Overall Study|Lost to Follow-up|33|||
155060029|NCT00296335|559655524|FG000|Overall Study|Physician Decision|3|||
155060030|NCT00296335|559655525|FG001|Overall Study|Physician Decision|11|||
155060031|NCT01142336|559655526|FG000|Overall Study|Adverse Event|1|||
155060032|NCT01142336|559655527|FG001|Overall Study|Adverse Event|1|||
155060033|NCT01142336|559655526|FG000|Overall Study|Lost to Follow-up|0|||
155060034|NCT01142336|559655527|FG001|Overall Study|Lost to Follow-up|1|||
155060035|NCT01704261|559655528|FG000|Overall Study|Withdrawal by Subject|12|||
155060036|NCT01704261|559655529|FG001|Overall Study|Withdrawal by Subject|15|||
155060037|NCT01704261|559655528|FG000|Overall Study|Lost to Follow-up|1|||
155060038|NCT01704261|559655529|FG001|Overall Study|Lost to Follow-up|0|||
155060039|NCT02722967|559655530|FG000|Overall Study|Adverse Event|1|||
155060040|NCT02722967|559655531|FG001|Overall Study|Adverse Event|0|||
155060041|NCT02722967|559655532|FG002|Overall Study|Adverse Event|0|||
155060042|NCT02722967|559655530|FG000|Overall Study|Lost to Follow-up|0|||
155060043|NCT02722967|559655531|FG001|Overall Study|Lost to Follow-up|1|||
155060044|NCT02722967|559655532|FG002|Overall Study|Lost to Follow-up|0|||
155060045|NCT02722967|559655530|FG000|Overall Study|Non-compliance with patch wearing|2|||
155060046|NCT02722967|559655531|FG001|Overall Study|Non-compliance with patch wearing|1|||
155060047|NCT02722967|559655532|FG002|Overall Study|Non-compliance with patch wearing|1|||
155060048|NCT02722967|559655530|FG000|Overall Study|Withdrawal by Subject|1|||
155060049|NCT02722967|559655531|FG001|Overall Study|Withdrawal by Subject|0|||
155060050|NCT02722967|559655532|FG002|Overall Study|Withdrawal by Subject|1|||
155291539|NCT01090024|560497516|FG011|Period 2|Lost to Follow-up|0|||
155291540|NCT01090024|560497517|FG012|Period 2|Lost to Follow-up|0|||
155291541|NCT01090024|560497518|FG013|Period 2|Lost to Follow-up|0|||
155291542|NCT01090024|560497519|FG014|Period 2|Lost to Follow-up|0|||
155291543|NCT01090024|560497520|FG015|Period 2|Lost to Follow-up|0|||
155291544|NCT01090024|560497521|FG016|Period 2|Lost to Follow-up|0|||
155291545|NCT01090024|560497522|FG017|Period 2|Lost to Follow-up|0|||
155291546|NCT01090024|560497505|FG000|Period 2|Adverse Event|1|||
155291547|NCT01090024|560497506|FG001|Period 2|Adverse Event|0|||
155291548|NCT01090024|560497507|FG002|Period 2|Adverse Event|0|||
155291549|NCT01090024|560497508|FG003|Period 2|Adverse Event|0|||
155291550|NCT01090024|560497509|FG004|Period 2|Adverse Event|0|||
155060051|NCT02722967|559655530|FG000|Overall Study|Physician Decision|1|||
155060052|NCT02722967|559655531|FG001|Overall Study|Physician Decision|0|||
155291551|NCT01090024|560497510|FG005|Period 2|Adverse Event|0|||
155291552|NCT01090024|560497511|FG006|Period 2|Adverse Event|0|||
155291553|NCT01090024|560497512|FG007|Period 2|Adverse Event|0|||
155291554|NCT01090024|560497513|FG008|Period 2|Adverse Event|0|||
155291555|NCT01090024|560497514|FG009|Period 2|Adverse Event|0|||
155291556|NCT01090024|560497515|FG010|Period 2|Adverse Event|0|||
155291557|NCT01090024|560497516|FG011|Period 2|Adverse Event|0|||
155291558|NCT01090024|560497517|FG012|Period 2|Adverse Event|0|||
155060053|NCT02722967|559655532|FG002|Overall Study|Physician Decision|0|||
155060054|NCT02722967|559655530|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
155060055|NCT02722967|559655531|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
155060056|NCT02722967|559655532|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
155060057|NCT02391337|559655533|FG000|6 Months Follow-up|Death|5|||
155060058|NCT02391337|559655534|FG001|6 Months Follow-up|Death|4|||
155060059|NCT02391337|559655533|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
155060060|NCT02391337|559655534|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
155060061|NCT02391337|559655533|FG000|12 Months Follow-up|Death|2|||
155060062|NCT02391337|559655534|FG001|12 Months Follow-up|Death|0|||
155060063|NCT02391337|559655533|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
155060064|NCT02391337|559655534|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
155060065|NCT02391337|559655533|FG000|12 Months Follow-up|Lost to Follow-up|0|||
155060066|NCT02391337|559655534|FG001|12 Months Follow-up|Lost to Follow-up|2|||
155060067|NCT00830128|559655538|FG000|Overall Study|Adverse Event|5|||
155060068|NCT00830128|559655538|FG000|Overall Study|Lack of Efficacy|7|||
155060069|NCT00830128|559655538|FG000|Overall Study|Protocol Violation|1|||
155060070|NCT00830128|559655538|FG000|Overall Study|Withdrawal by Subject|2|||
155060071|NCT00830128|559655538|FG000|Overall Study|Family obligation|1|||
155060072|NCT00830128|559655538|FG000|Overall Study|Relocation|1|||
155060073|NCT00830128|559655538|FG000|Overall Study|Work obligation|1|||
155060074|NCT00830128|559655538|FG000|Overall Study|Operating a vehicle|1|||
155060075|NCT00846053|559655541|FG000|Overall Study|Physician Decision|3|||
155060076|NCT00846053|559655542|FG001|Overall Study|Physician Decision|0|||
155060077|NCT05063448|559655546|FG000|Overall Study|Withdrawal by Subject|1|||
155060078|NCT02475369|559655547|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
155060079|NCT02475369|559655548|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
155060080|NCT04798027|559655554|FG000|Overall Study|Protocol Violation|0|||
155060081|NCT04798027|559655555|FG001|Overall Study|Protocol Violation|0|||
155060082|NCT04798027|559655556|FG002|Overall Study|Protocol Violation|0|||
155060083|NCT04798027|559655557|FG003|Overall Study|Protocol Violation|0|||
155060084|NCT04798027|559655558|FG004|Overall Study|Protocol Violation|1|||
155060085|NCT04798027|559655559|FG005|Overall Study|Protocol Violation|0|||
155060086|NCT04798027|559655560|FG006|Overall Study|Protocol Violation|0|||
155060087|NCT04798027|559655561|FG007|Overall Study|Protocol Violation|1|||
155060088|NCT04798027|559655562|FG008|Overall Study|Protocol Violation|0|||
155060089|NCT04798027|559655554|FG000|Overall Study|Withdrawal by Subject|1|||
155060090|NCT04798027|559655555|FG001|Overall Study|Withdrawal by Subject|0|||
155060091|NCT04798027|559655556|FG002|Overall Study|Withdrawal by Subject|1|||
155060092|NCT04798027|559655557|FG003|Overall Study|Withdrawal by Subject|1|||
155060093|NCT04798027|559655558|FG004|Overall Study|Withdrawal by Subject|1|||
155060094|NCT04798027|559655559|FG005|Overall Study|Withdrawal by Subject|1|||
155060095|NCT04798027|559655560|FG006|Overall Study|Withdrawal by Subject|3|||
155060096|NCT04798027|559655561|FG007|Overall Study|Withdrawal by Subject|2|||
155060097|NCT04798027|559655562|FG008|Overall Study|Withdrawal by Subject|2|||
155060098|NCT04798027|559655554|FG000|Overall Study|Lost to Follow-up|1|||
155060099|NCT04798027|559655555|FG001|Overall Study|Lost to Follow-up|3|||
155060100|NCT04798027|559655556|FG002|Overall Study|Lost to Follow-up|0|||
155060101|NCT04798027|559655557|FG003|Overall Study|Lost to Follow-up|0|||
155060102|NCT04798027|559655558|FG004|Overall Study|Lost to Follow-up|0|||
155060103|NCT04798027|559655559|FG005|Overall Study|Lost to Follow-up|1|||
155060104|NCT04798027|559655560|FG006|Overall Study|Lost to Follow-up|0|||
155060105|NCT04798027|559655561|FG007|Overall Study|Lost to Follow-up|0|||
155060106|NCT04798027|559655562|FG008|Overall Study|Lost to Follow-up|1|||
155060107|NCT04798027|559655554|FG000|Overall Study|Withdrawal by Sponsor|8|||
155060108|NCT04798027|559655555|FG001|Overall Study|Withdrawal by Sponsor|22|||
155060109|NCT04798027|559655556|FG002|Overall Study|Withdrawal by Sponsor|9|||
155060110|NCT04798027|559655557|FG003|Overall Study|Withdrawal by Sponsor|26|||
155060111|NCT04798027|559655558|FG004|Overall Study|Withdrawal by Sponsor|24|||
155060112|NCT04798027|559655559|FG005|Overall Study|Withdrawal by Sponsor|11|||
155060113|NCT04798027|559655560|FG006|Overall Study|Withdrawal by Sponsor|25|||
155060114|NCT04798027|559655561|FG007|Overall Study|Withdrawal by Sponsor|26|||
155060115|NCT04798027|559655562|FG008|Overall Study|Withdrawal by Sponsor|11|||
155060116|NCT03210714|559655563|FG000|Overall Study|Adverse Event|6|||
155060117|NCT03210714|559655563|FG000|Overall Study|Physician Decision|1|||
155060118|NCT03210714|559655563|FG000|Overall Study|Progressive disease|11|||
155060119|NCT03210714|559655563|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
155060120|NCT00803179|559655564|FG000|Overall Study|Lost to Follow-up|3|||
155060121|NCT04158648|559655565|FG000|Overall Study|Ongoing in the Study|69|||
155060122|NCT04158648|559655565|FG000|Overall Study|Withdrawal by Subject|4|||
155060123|NCT02121210|559655566|FG000|Overall Study|Adverse Event|5|||
155060124|NCT02121210|559655567|FG001|Overall Study|Adverse Event|7|||
155060125|NCT02121210|559655566|FG000|Overall Study|Lack of Efficacy|2|||
155060126|NCT02121210|559655567|FG001|Overall Study|Lack of Efficacy|0|||
155060127|NCT02121210|559655566|FG000|Overall Study|Other than specified above|0|||
155060128|NCT02121210|559655567|FG001|Overall Study|Other than specified above|2|||
155060129|NCT04609514|559655568|FG000|Overall Study|Lost to Follow-up|5|||
155060130|NCT04609514|559655569|FG001|Overall Study|Lost to Follow-up|4|||
155060131|NCT04609514|559655568|FG000|Overall Study|Withdrawal by PI|0|||
155060132|NCT04609514|559655569|FG001|Overall Study|Withdrawal by PI|2|||
155060133|NCT00251758|559655571|FG000|Overall Study|Adverse Event|7|||
155291559|NCT01090024|560497518|FG013|Period 2|Adverse Event|0|||
155291560|NCT01090024|560497519|FG014|Period 2|Adverse Event|0|||
155291561|NCT01090024|560497520|FG015|Period 2|Adverse Event|0|||
155291562|NCT01090024|560497521|FG016|Period 2|Adverse Event|0|||
155291563|NCT01090024|560497522|FG017|Period 2|Adverse Event|0|||
155291564|NCT01090024|560497505|FG000|Period 3|Withdrawal by Subject|0|||
155291565|NCT01090024|560497506|FG001|Period 3|Withdrawal by Subject|0|||
155291566|NCT01090024|560497507|FG002|Period 3|Withdrawal by Subject|0|||
155291567|NCT01090024|560497508|FG003|Period 3|Withdrawal by Subject|0|||
155291568|NCT01090024|560497509|FG004|Period 3|Withdrawal by Subject|0|||
155291569|NCT01090024|560497510|FG005|Period 3|Withdrawal by Subject|0|||
155291570|NCT01090024|560497511|FG006|Period 3|Withdrawal by Subject|0|||
155291571|NCT01090024|560497512|FG007|Period 3|Withdrawal by Subject|0|||
155291572|NCT01090024|560497513|FG008|Period 3|Withdrawal by Subject|0|||
155291573|NCT01090024|560497514|FG009|Period 3|Withdrawal by Subject|0|||
155291574|NCT01090024|560497515|FG010|Period 3|Withdrawal by Subject|0|||
155291575|NCT01090024|560497516|FG011|Period 3|Withdrawal by Subject|0|||
155291576|NCT01090024|560497517|FG012|Period 3|Withdrawal by Subject|0|||
155291577|NCT01090024|560497518|FG013|Period 3|Withdrawal by Subject|0|||
155291578|NCT01090024|560497519|FG014|Period 3|Withdrawal by Subject|0|||
155291579|NCT01090024|560497520|FG015|Period 3|Withdrawal by Subject|1|||
155291580|NCT01090024|560497521|FG016|Period 3|Withdrawal by Subject|0|||
155291581|NCT01090024|560497522|FG017|Period 3|Withdrawal by Subject|0|||
155291582|NCT01090024|560497505|FG000|Period 3|Protocol Violation|0|||
155291583|NCT01090024|560497506|FG001|Period 3|Protocol Violation|0|||
155291584|NCT01090024|560497507|FG002|Period 3|Protocol Violation|0|||
155291585|NCT01090024|560497508|FG003|Period 3|Protocol Violation|0|||
155291586|NCT01090024|560497509|FG004|Period 3|Protocol Violation|0|||
155291587|NCT01090024|560497510|FG005|Period 3|Protocol Violation|0|||
155291588|NCT01090024|560497511|FG006|Period 3|Protocol Violation|0|||
155060134|NCT00251758|559655572|FG001|Overall Study|Adverse Event|9|||
155291589|NCT01090024|560497512|FG007|Period 3|Protocol Violation|0|||
155291590|NCT01090024|560497513|FG008|Period 3|Protocol Violation|1|||
155291591|NCT01090024|560497514|FG009|Period 3|Protocol Violation|0|||
155060135|NCT00251758|559655573|FG002|Overall Study|Adverse Event|11|||
155060136|NCT00251758|559655571|FG000|Overall Study|Lost to Follow-up|4|||
155291592|NCT01090024|560497515|FG010|Period 3|Protocol Violation|0|||
155291593|NCT01090024|560497516|FG011|Period 3|Protocol Violation|0|||
155291594|NCT01090024|560497517|FG012|Period 3|Protocol Violation|0|||
155060137|NCT00251758|559655572|FG001|Overall Study|Lost to Follow-up|2|||
155060138|NCT00251758|559655573|FG002|Overall Study|Lost to Follow-up|5|||
155291595|NCT01090024|560497518|FG013|Period 3|Protocol Violation|0|||
155291596|NCT01090024|560497519|FG014|Period 3|Protocol Violation|0|||
155291597|NCT01090024|560497520|FG015|Period 3|Protocol Violation|0|||
155291598|NCT01090024|560497521|FG016|Period 3|Protocol Violation|0|||
155291599|NCT01090024|560497522|FG017|Period 3|Protocol Violation|0|||
155291600|NCT01090024|560497505|FG000|Period 3|Adverse Event|0|||
155291601|NCT01090024|560497506|FG001|Period 3|Adverse Event|0|||
155291602|NCT01090024|560497507|FG002|Period 3|Adverse Event|0|||
155291603|NCT01090024|560497508|FG003|Period 3|Adverse Event|0|||
155156232|NCT01462370|560010582|FG001|Overall Study|Physician Decision|1|||
155156233|NCT01462370|560010581|FG000|Overall Study|Withdrawal by Subject|0|||
155156234|NCT01462370|560010582|FG001|Overall Study|Withdrawal by Subject|3|||
155156235|NCT03198715|560010585|FG000|Overall Study|Death|0|||
155156236|NCT03198715|560010586|FG001|Overall Study|Death|0|||
155156237|NCT03198715|560010587|FG002|Overall Study|Death|1|||
155156238|NCT03198715|560010588|FG003|Overall Study|Death|0|||
155156239|NCT03198715|560010589|FG004|Overall Study|Death|2|||
155156240|NCT03198715|560010585|FG000|Overall Study|Other|0|||
155156241|NCT03198715|560010586|FG001|Overall Study|Other|1|||
155156242|NCT03198715|560010587|FG002|Overall Study|Other|1|||
155156243|NCT03198715|560010588|FG003|Overall Study|Other|0|||
155156244|NCT03198715|560010589|FG004|Overall Study|Other|0|||
155156245|NCT00473564|560010590|FG000|Overall Study|robot surgery aborted in OR|23|||
155156246|NCT00914316|560010591|FG000|Phase 1|Physician Decision|4|||
155156247|NCT00914316|560010592|FG001|Phase 1|Physician Decision|0|||
155156248|NCT00914316|560010593|FG002|Phase 1|Physician Decision|1|||
155156249|NCT00914316|560010594|FG003|Phase 1|Physician Decision|2|||
155156250|NCT00914316|560010591|FG000|Phase 1|Withdrawal by Subject|0|||
155156251|NCT00914316|560010592|FG001|Phase 1|Withdrawal by Subject|2|||
155156252|NCT00914316|560010593|FG002|Phase 1|Withdrawal by Subject|4|||
155156253|NCT00914316|560010594|FG003|Phase 1|Withdrawal by Subject|0|||
155156254|NCT00914316|560010591|FG000|Phase 1|Adverse Event|1|||
155156255|NCT00914316|560010592|FG001|Phase 1|Adverse Event|0|||
155156256|NCT00914316|560010593|FG002|Phase 1|Adverse Event|0|||
155156257|NCT00914316|560010594|FG003|Phase 1|Adverse Event|0|||
155156258|NCT00914316|560010591|FG000|Phase 2|Withdrawal by Subject|1|||
155156259|NCT00914316|560010592|FG001|Phase 2|Withdrawal by Subject|0|||
155156260|NCT00914316|560010593|FG002|Phase 2|Withdrawal by Subject|1|||
155156261|NCT00914316|560010594|FG003|Phase 2|Withdrawal by Subject|0|||
155156262|NCT03131219|560010595|FG000|Initial Evaluation Period|Adverse Event|2|||
155156263|NCT03131219|560010596|FG001|Initial Evaluation Period|Adverse Event|0|||
155156264|NCT03131219|560010595|FG000|Initial Evaluation Period|Protocol Violation|1|||
155156265|NCT03131219|560010596|FG001|Initial Evaluation Period|Protocol Violation|0|||
155156266|NCT03131219|560010595|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
155156267|NCT03131219|560010596|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
155156268|NCT03131219|560010595|FG000|Initial Evaluation Period|Physician Decision|1|||
155156269|NCT03131219|560010596|FG001|Initial Evaluation Period|Physician Decision|0|||
155156270|NCT03131219|560010595|FG000|Extension Period|Physician Decision|1|||
155156271|NCT03131219|560010596|FG001|Extension Period|Physician Decision|0|||
155156272|NCT00616759|560010598|FG000|Overall Study|Physician Decision|2|||
155156273|NCT00616759|560010599|FG001|Overall Study|Physician Decision|0|||
155156274|NCT00616759|560010598|FG000|Overall Study|Withdrawal by Subject|1|||
155156275|NCT00616759|560010599|FG001|Overall Study|Withdrawal by Subject|2|||
155156276|NCT02399163|560010602|FG000|Overall Study|Adverse Event|2|||
155156277|NCT02399163|560010602|FG000|Overall Study|Protocol Deviation|2|||
155156278|NCT02399163|560010602|FG000|Overall Study|Withdrawal by Participant|5|||
155156279|NCT04225897|560010606|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156280|NCT04225897|560010607|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
155156281|NCT04225897|560010608|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156282|NCT04225897|560010609|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156283|NCT04225897|560010610|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156284|NCT04225897|560010611|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156285|NCT04225897|560010612|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156286|NCT04225897|560010613|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156287|NCT04225897|560010614|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156288|NCT04225897|560010615|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156289|NCT04225897|560010616|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156290|NCT04225897|560010617|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
155156291|NCT04225897|560010606|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156292|NCT04225897|560010607|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156293|NCT04225897|560010608|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
155156294|NCT04225897|560010609|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156295|NCT04225897|560010610|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156296|NCT04225897|560010611|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156297|NCT04225897|560010612|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156298|NCT04225897|560010613|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156299|NCT04225897|560010614|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156300|NCT04225897|560010615|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156301|NCT04225897|560010616|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156302|NCT04225897|560010617|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
155156303|NCT04225897|560010606|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156304|NCT04225897|560010607|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155291604|NCT01090024|560497509|FG004|Period 3|Adverse Event|0|||
155156305|NCT04225897|560010608|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
155156306|NCT04225897|560010609|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156307|NCT04225897|560010610|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156308|NCT04225897|560010611|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156309|NCT04225897|560010612|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156310|NCT04225897|560010613|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156311|NCT04225897|560010614|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156312|NCT04225897|560010615|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156313|NCT04225897|560010616|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156314|NCT04225897|560010617|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
155156315|NCT04225897|560010606|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156316|NCT04225897|560010607|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156317|NCT04225897|560010608|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156318|NCT04225897|560010609|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156319|NCT04225897|560010610|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156320|NCT04225897|560010611|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156321|NCT04225897|560010612|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156322|NCT04225897|560010613|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
155156323|NCT04225897|560010614|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156324|NCT04225897|560010615|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156325|NCT04225897|560010616|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156326|NCT04225897|560010617|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
155156327|NCT00074711|560010618|FG000|Overall Study|Withdrawal by Subject|1|||
155156328|NCT00074711|560010619|FG001|Overall Study|Withdrawal by Subject|1|||
155156329|NCT00074711|560010618|FG000|Overall Study|Lost to Follow-up|10|||
155156330|NCT00074711|560010619|FG001|Overall Study|Lost to Follow-up|8|||
155156331|NCT00074711|560010618|FG000|Overall Study|Participant stopped study drug|4|||
155156332|NCT00074711|560010619|FG001|Overall Study|Participant stopped study drug|6|||
155156333|NCT03466658|560010620|FG000|Overall Study|Withdrawal by Subject|3|||
155156334|NCT00360230|560010625|FG000|Overall Study|Withdrawal by Subject|1|||
155156335|NCT00360230|560010626|FG001|Overall Study|Withdrawal by Subject|1|||
155156336|NCT00360230|560010627|FG002|Overall Study|Withdrawal by Subject|0|||
155156337|NCT00360230|560010628|FG003|Overall Study|Withdrawal by Subject|1|||
155156338|NCT00360230|560010629|FG004|Overall Study|Withdrawal by Subject|1|||
155156339|NCT00360230|560010630|FG005|Overall Study|Withdrawal by Subject|1|||
155156340|NCT00360230|560010631|FG006|Overall Study|Withdrawal by Subject|0|||
155156341|NCT00360230|560010625|FG000|Overall Study|Migrated|4|||
155156342|NCT00360230|560010626|FG001|Overall Study|Migrated|1|||
155156343|NCT00360230|560010627|FG002|Overall Study|Migrated|3|||
155156344|NCT00360230|560010628|FG003|Overall Study|Migrated|1|||
155156345|NCT00360230|560010629|FG004|Overall Study|Migrated|4|||
155156346|NCT00360230|560010630|FG005|Overall Study|Migrated|1|||
155156347|NCT00360230|560010631|FG006|Overall Study|Migrated|1|||
155156348|NCT00360230|560010625|FG000|Overall Study|Other|1|||
155156349|NCT00360230|560010626|FG001|Overall Study|Other|0|||
155156350|NCT00360230|560010627|FG002|Overall Study|Other|0|||
155156351|NCT00360230|560010628|FG003|Overall Study|Other|0|||
155156352|NCT00360230|560010629|FG004|Overall Study|Other|0|||
155156353|NCT00360230|560010630|FG005|Overall Study|Other|0|||
155156354|NCT00360230|560010631|FG006|Overall Study|Other|0|||
155156355|NCT00360230|560010625|FG000|Overall Study|Protocol Violation|0|||
155156356|NCT00360230|560010626|FG001|Overall Study|Protocol Violation|0|||
155156357|NCT00360230|560010627|FG002|Overall Study|Protocol Violation|0|||
155156358|NCT00360230|560010628|FG003|Overall Study|Protocol Violation|0|||
155156359|NCT00360230|560010629|FG004|Overall Study|Protocol Violation|0|||
155156360|NCT00360230|560010630|FG005|Overall Study|Protocol Violation|1|||
155156361|NCT00360230|560010631|FG006|Overall Study|Protocol Violation|0|||
155156362|NCT00360230|560010625|FG000|Overall Study|Death|0|||
155156363|NCT00360230|560010626|FG001|Overall Study|Death|1|||
155156364|NCT00360230|560010627|FG002|Overall Study|Death|0|||
155156365|NCT00360230|560010628|FG003|Overall Study|Death|0|||
155156366|NCT00360230|560010629|FG004|Overall Study|Death|0|||
155156367|NCT00360230|560010630|FG005|Overall Study|Death|1|||
155156368|NCT00360230|560010631|FG006|Overall Study|Death|1|||
155156369|NCT02703597|560010632|FG000|Assignment to Baseline|Lost to Follow-up|17|||
155156370|NCT02703597|560010633|FG001|Assignment to Baseline|Lost to Follow-up|16|||
155156371|NCT02703597|560010632|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
155156372|NCT02703597|560010633|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
155156373|NCT02703597|560010632|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
155156374|NCT02703597|560010633|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
155156375|NCT02703597|560010632|FG000|First Post-test to First Follow-up|Site drop out|0|||
155156376|NCT02703597|560010633|FG001|First Post-test to First Follow-up|Site drop out|58|||
155156377|NCT02703597|560010632|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
155060139|NCT00251758|559655571|FG000|Overall Study|Withdrawal by Subject|13|||
155060140|NCT00251758|559655572|FG001|Overall Study|Withdrawal by Subject|7|||
155060141|NCT00251758|559655573|FG002|Overall Study|Withdrawal by Subject|3|||
155291605|NCT01090024|560497510|FG005|Period 3|Adverse Event|1|||
155291606|NCT01090024|560497511|FG006|Period 3|Adverse Event|0|||
155291607|NCT01090024|560497512|FG007|Period 3|Adverse Event|0|||
155291608|NCT01090024|560497513|FG008|Period 3|Adverse Event|0|||
155291609|NCT01090024|560497514|FG009|Period 3|Adverse Event|0|||
155291610|NCT01090024|560497515|FG010|Period 3|Adverse Event|0|||
155291611|NCT01090024|560497516|FG011|Period 3|Adverse Event|0|||
155291612|NCT01090024|560497517|FG012|Period 3|Adverse Event|0|||
155291613|NCT01090024|560497518|FG013|Period 3|Adverse Event|0|||
155291614|NCT01090024|560497519|FG014|Period 3|Adverse Event|0|||
155291615|NCT01090024|560497520|FG015|Period 3|Adverse Event|0|||
155291616|NCT01090024|560497521|FG016|Period 3|Adverse Event|0|||
155291617|NCT01090024|560497522|FG017|Period 3|Adverse Event|0|||
155291618|NCT00771667|560497523|FG000|Induction Phase|Adverse Event|5|||
155291619|NCT00771667|560497524|FG001|Induction Phase|Adverse Event|2|||
155291620|NCT00771667|560497525|FG002|Induction Phase|Adverse Event|4|||
155291621|NCT00771667|560497526|FG003|Induction Phase|Adverse Event|1|||
155291622|NCT00771667|560497527|FG004|Induction Phase|Adverse Event|0|||
155291623|NCT00771667|560497528|FG005|Induction Phase|Adverse Event|0|||
155291624|NCT00771667|560497529|FG006|Induction Phase|Adverse Event|0|||
155291625|NCT00771667|560497530|FG007|Induction Phase|Adverse Event|0|||
155291626|NCT00771667|560497531|FG008|Induction Phase|Adverse Event|0|||
155291627|NCT00771667|560497532|FG009|Induction Phase|Adverse Event|0|||
155291628|NCT00771667|560497523|FG000|Induction Phase|Lack of Efficacy|9|||
155291629|NCT00771667|560497524|FG001|Induction Phase|Lack of Efficacy|2|||
155291630|NCT00771667|560497525|FG002|Induction Phase|Lack of Efficacy|4|||
155291631|NCT00771667|560497526|FG003|Induction Phase|Lack of Efficacy|3|||
155291632|NCT00771667|560497527|FG004|Induction Phase|Lack of Efficacy|0|||
155291633|NCT00771667|560497528|FG005|Induction Phase|Lack of Efficacy|0|||
155291634|NCT00771667|560497529|FG006|Induction Phase|Lack of Efficacy|0|||
155291635|NCT00771667|560497530|FG007|Induction Phase|Lack of Efficacy|0|||
155291636|NCT00771667|560497531|FG008|Induction Phase|Lack of Efficacy|0|||
155291637|NCT00771667|560497532|FG009|Induction Phase|Lack of Efficacy|0|||
155291638|NCT00771667|560497523|FG000|Induction Phase|Lost to Follow-up|1|||
155291639|NCT00771667|560497524|FG001|Induction Phase|Lost to Follow-up|0|||
155291640|NCT00771667|560497525|FG002|Induction Phase|Lost to Follow-up|1|||
155291641|NCT00771667|560497526|FG003|Induction Phase|Lost to Follow-up|0|||
155291642|NCT00771667|560497527|FG004|Induction Phase|Lost to Follow-up|0|||
155291643|NCT00771667|560497528|FG005|Induction Phase|Lost to Follow-up|0|||
155291644|NCT00771667|560497529|FG006|Induction Phase|Lost to Follow-up|0|||
155291645|NCT00771667|560497530|FG007|Induction Phase|Lost to Follow-up|0|||
155291646|NCT00771667|560497531|FG008|Induction Phase|Lost to Follow-up|0|||
155291647|NCT00771667|560497532|FG009|Induction Phase|Lost to Follow-up|0|||
155291648|NCT00771667|560497523|FG000|Induction Phase|Other|4|||
155291649|NCT00771667|560497524|FG001|Induction Phase|Other|6|||
155291650|NCT00771667|560497525|FG002|Induction Phase|Other|3|||
155291651|NCT00771667|560497526|FG003|Induction Phase|Other|4|||
155291652|NCT00771667|560497527|FG004|Induction Phase|Other|0|||
155291653|NCT00771667|560497528|FG005|Induction Phase|Other|0|||
155291654|NCT00771667|560497529|FG006|Induction Phase|Other|0|||
155291655|NCT00771667|560497530|FG007|Induction Phase|Other|0|||
155291656|NCT00771667|560497531|FG008|Induction Phase|Other|0|||
155291657|NCT00771667|560497532|FG009|Induction Phase|Other|0|||
155291658|NCT00771667|560497523|FG000|Maintenance Phase|Adverse Event|0|||
155291659|NCT00771667|560497524|FG001|Maintenance Phase|Adverse Event|0|||
155291660|NCT00771667|560497525|FG002|Maintenance Phase|Adverse Event|0|||
155291661|NCT00771667|560497526|FG003|Maintenance Phase|Adverse Event|0|||
155291662|NCT00771667|560497527|FG004|Maintenance Phase|Adverse Event|1|||
155291663|NCT00771667|560497528|FG005|Maintenance Phase|Adverse Event|3|||
155291664|NCT00771667|560497529|FG006|Maintenance Phase|Adverse Event|5|||
155291665|NCT00771667|560497530|FG007|Maintenance Phase|Adverse Event|1|||
155291666|NCT00771667|560497531|FG008|Maintenance Phase|Adverse Event|8|||
155060142|NCT00251758|559655571|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
155291667|NCT00771667|560497532|FG009|Maintenance Phase|Adverse Event|7|||
155291668|NCT00771667|560497523|FG000|Maintenance Phase|Lack of Efficacy|0|||
155291669|NCT00771667|560497524|FG001|Maintenance Phase|Lack of Efficacy|0|||
155291670|NCT00771667|560497525|FG002|Maintenance Phase|Lack of Efficacy|0|||
155291671|NCT00771667|560497526|FG003|Maintenance Phase|Lack of Efficacy|0|||
155060143|NCT00251758|559655572|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
155291672|NCT00771667|560497527|FG004|Maintenance Phase|Lack of Efficacy|1|||
155291673|NCT00771667|560497528|FG005|Maintenance Phase|Lack of Efficacy|3|||
155291674|NCT00771667|560497529|FG006|Maintenance Phase|Lack of Efficacy|3|||
155291675|NCT00771667|560497530|FG007|Maintenance Phase|Lack of Efficacy|2|||
155291676|NCT00771667|560497531|FG008|Maintenance Phase|Lack of Efficacy|11|||
155291677|NCT00771667|560497532|FG009|Maintenance Phase|Lack of Efficacy|7|||
155291678|NCT00771667|560497523|FG000|Maintenance Phase|Other|0|||
155291679|NCT00771667|560497524|FG001|Maintenance Phase|Other|0|||
155291680|NCT00771667|560497525|FG002|Maintenance Phase|Other|0|||
155291681|NCT00771667|560497526|FG003|Maintenance Phase|Other|0|||
155291682|NCT00771667|560497527|FG004|Maintenance Phase|Other|0|||
155291683|NCT00771667|560497528|FG005|Maintenance Phase|Other|1|||
155291684|NCT00771667|560497529|FG006|Maintenance Phase|Other|2|||
155291685|NCT00771667|560497530|FG007|Maintenance Phase|Other|2|||
155291686|NCT00771667|560497531|FG008|Maintenance Phase|Other|3|||
155291687|NCT00771667|560497532|FG009|Maintenance Phase|Other|3|||
155291688|NCT01897233|560497533|FG000|Part B (24 Weeks)|Adverse Event|1|||
155291689|NCT01897233|560497533|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
155291690|NCT01897233|560497533|FG000|Part B (24 Weeks)|Physician Decision|1|||
155291691|NCT00628862|560497538|FG000|Overall Study|Adverse Event|6|||
155291692|NCT00628862|560497539|FG001|Overall Study|Adverse Event|8|||
155291693|NCT00628862|560497540|FG002|Overall Study|Adverse Event|10|||
155291694|NCT00628862|560497538|FG000|Overall Study|Withdrawal by Subject|4|||
155291695|NCT00628862|560497539|FG001|Overall Study|Withdrawal by Subject|6|||
155291696|NCT00628862|560497540|FG002|Overall Study|Withdrawal by Subject|11|||
155291697|NCT00628862|560497538|FG000|Overall Study|Lost to Follow-up|0|||
155291698|NCT00628862|560497539|FG001|Overall Study|Lost to Follow-up|2|||
155291699|NCT00628862|560497540|FG002|Overall Study|Lost to Follow-up|1|||
155291700|NCT00628862|560497538|FG000|Overall Study|Protocol Violation|1|||
155291701|NCT00628862|560497539|FG001|Overall Study|Protocol Violation|0|||
155291702|NCT00628862|560497540|FG002|Overall Study|Protocol Violation|0|||
155291703|NCT00628862|560497538|FG000|Overall Study|COPD Exacerbation|0|||
155291704|NCT00628862|560497539|FG001|Overall Study|COPD Exacerbation|1|||
155291705|NCT00628862|560497540|FG002|Overall Study|COPD Exacerbation|0|||
155291706|NCT01883492|560497541|FG000|Overall Study|Lost to Follow-up|3|||
155291707|NCT01883492|560497542|FG001|Overall Study|Lost to Follow-up|4|||
155291708|NCT01883492|560497541|FG000|Overall Study|Surgery on contra-lateral hip|0|||
155291709|NCT01883492|560497542|FG001|Overall Study|Surgery on contra-lateral hip|1|||
155291710|NCT01883492|560497541|FG000|Overall Study|Poor X-ray quality|7|||
155291711|NCT01883492|560497542|FG001|Overall Study|Poor X-ray quality|4|||
155291712|NCT01883492|560497541|FG000|Overall Study|Withdrawal by Subject|1|||
155291713|NCT01883492|560497542|FG001|Overall Study|Withdrawal by Subject|0|||
155291714|NCT01883492|560497541|FG000|Overall Study|inappropriate implant used|1|||
155291715|NCT01883492|560497542|FG001|Overall Study|inappropriate implant used|1|||
155291716|NCT01883492|560497541|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
155291717|NCT01883492|560497542|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
155291718|NCT03265210|560497543|FG000|Overall Study|Withdrawal by Subject|7|||
155291719|NCT03265210|560497544|FG001|Overall Study|Withdrawal by Subject|9|||
155291720|NCT03265210|560497543|FG000|Overall Study|Lost to Follow-up|2|||
155291721|NCT03265210|560497544|FG001|Overall Study|Lost to Follow-up|0|||
155291722|NCT03265210|560497543|FG000|Overall Study|Physician Decision|2|||
155291723|NCT03265210|560497544|FG001|Overall Study|Physician Decision|0|||
155291724|NCT03265210|560497543|FG000|Overall Study|Adverse Event|1|||
155291725|NCT03265210|560497544|FG001|Overall Study|Adverse Event|0|||
155291726|NCT00549848|560497548|FG000|Overall Study|Death|1|||
155291727|NCT00549848|560497549|FG001|Overall Study|Death|4|||
155060144|NCT00251758|559655573|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
155060145|NCT00251758|559655571|FG000|Overall Study|Lack of Efficacy|3|||
155291728|NCT00549848|560497550|FG002|Overall Study|Death|13|||
155291729|NCT00549848|560497548|FG000|Overall Study|Physician Decision|0|||
155291730|NCT00549848|560497549|FG001|Overall Study|Physician Decision|0|||
155291731|NCT00549848|560497550|FG002|Overall Study|Physician Decision|4|||
155291732|NCT00549848|560497548|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
155291733|NCT00549848|560497549|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
155291734|NCT00549848|560497550|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
155060146|NCT00251758|559655572|FG001|Overall Study|Lack of Efficacy|0|||
155291735|NCT00549848|560497548|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
155291736|NCT00549848|560497549|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
155291737|NCT00549848|560497550|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
155291738|NCT00549848|560497548|FG000|Overall Study|Participant/Family Withdraw|2|||
155291739|NCT00549848|560497549|FG001|Overall Study|Participant/Family Withdraw|3|||
155291740|NCT00549848|560497550|FG002|Overall Study|Participant/Family Withdraw|5|||
155291741|NCT00549848|560497548|FG000|Overall Study|Second Malignancy|1|||
155291742|NCT00549848|560497549|FG001|Overall Study|Second Malignancy|0|||
155291743|NCT00549848|560497550|FG002|Overall Study|Second Malignancy|0|||
155291744|NCT00549848|560497548|FG000|Overall Study|Transplant|3|||
155291745|NCT00549848|560497549|FG001|Overall Study|Transplant|3|||
155291746|NCT00549848|560497550|FG002|Overall Study|Transplant|18|||
155291747|NCT00549848|560497548|FG000|Overall Study|Unacceptable Toxicity|1|||
155291748|NCT00549848|560497549|FG001|Overall Study|Unacceptable Toxicity|6|||
155291749|NCT00549848|560497550|FG002|Overall Study|Unacceptable Toxicity|6|||
155291750|NCT00868192|560497551|FG000|Overall Study|Ineligible|4|||
155291751|NCT00798096|560497554|FG000|Overall Study|Ongoing|2|||
155291752|NCT03670602|560497555|FG000|Overall Study|Lost to Follow-up|1|||
155291753|NCT03670602|560497556|FG001|Overall Study|Lost to Follow-up|0|||
155291754|NCT03670602|560497555|FG000|Overall Study|Withdrawal by Subject|0|||
155291755|NCT03670602|560497556|FG001|Overall Study|Withdrawal by Subject|3|||
155291756|NCT03383887|560497557|FG000|Overall Study|Lost to Follow-up|0|||
155291757|NCT03383887|560497558|FG001|Overall Study|Lost to Follow-up|1|||
155291758|NCT00975806|560497565|FG000|Overall Study|Adverse Event|2|||
155291759|NCT00975806|560497566|FG001|Overall Study|Adverse Event|1|||
155291760|NCT00975806|560497567|FG002|Overall Study|Adverse Event|2|||
155291761|NCT00975806|560497565|FG000|Overall Study|Disease Progression|1|||
155291762|NCT00975806|560497566|FG001|Overall Study|Disease Progression|5|||
155291763|NCT00975806|560497567|FG002|Overall Study|Disease Progression|1|||
155291764|NCT00975806|560497565|FG000|Overall Study|Withdrawal by Subject|1|||
155291765|NCT00975806|560497566|FG001|Overall Study|Withdrawal by Subject|0|||
155291766|NCT00975806|560497567|FG002|Overall Study|Withdrawal by Subject|0|||
155291767|NCT00975806|560497565|FG000|Overall Study|Death|0|||
155291768|NCT00975806|560497566|FG001|Overall Study|Death|1|||
155291769|NCT00975806|560497567|FG002|Overall Study|Death|0|||
155291770|NCT00975806|560497565|FG000|Overall Study|Physician decision and disease related|1|||
155291771|NCT00975806|560497566|FG001|Overall Study|Physician decision and disease related|0|||
155060147|NCT00251758|559655573|FG002|Overall Study|Lack of Efficacy|0|||
155060148|NCT00251758|559655571|FG000|Overall Study|Noncompliant|0|||
155291772|NCT00975806|560497567|FG002|Overall Study|Physician decision and disease related|1|||
155060149|NCT00251758|559655572|FG001|Overall Study|Noncompliant|2|||
155060150|NCT00251758|559655573|FG002|Overall Study|Noncompliant|2|||
155060151|NCT00251758|559655571|FG000|Overall Study|Pregnancy|0|||
155060152|NCT00251758|559655572|FG001|Overall Study|Pregnancy|1|||
155060153|NCT00251758|559655573|FG002|Overall Study|Pregnancy|0|||
155060154|NCT00251758|559655571|FG000|Overall Study|Per Subject Request|0|||
155060155|NCT00251758|559655572|FG001|Overall Study|Per Subject Request|0|||
155060156|NCT00251758|559655573|FG002|Overall Study|Per Subject Request|1|||
155060157|NCT00251758|559655571|FG000|Overall Study|Per Investigator Request|1|||
155060158|NCT00251758|559655572|FG001|Overall Study|Per Investigator Request|0|||
155060159|NCT00251758|559655573|FG002|Overall Study|Per Investigator Request|0|||
155060160|NCT02404545|559655576|FG000|Overall Study|Sponsor Termination|6|||
155060161|NCT02404545|559655577|FG001|Overall Study|Sponsor Termination|6|||
155060162|NCT03641508|559655578|FG000|First Injection|Lost to Follow-up|2|||
155060163|NCT03641508|559655579|FG001|First Injection|Lost to Follow-up|0|||
155060164|NCT03642990|559655580|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
155060165|NCT03642990|559655580|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
155060166|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
155060167|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
155060168|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
155060169|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
155291773|NCT00246012|560497568|FG000|Overall Study|Adverse Event|0|||
155060170|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
155060171|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
155291774|NCT00246012|560497569|FG001|Overall Study|Adverse Event|0|||
155291775|NCT00246012|560497570|FG002|Overall Study|Adverse Event|0|||
155291776|NCT00246012|560497571|FG003|Overall Study|Adverse Event|0|||
155291777|NCT00246012|560497572|FG004|Overall Study|Adverse Event|0|||
155291778|NCT00246012|560497573|FG005|Overall Study|Adverse Event|1|||
155060172|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
155060173|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155291779|NCT00246012|560497574|FG006|Overall Study|Adverse Event|0|||
155291780|NCT00246012|560497575|FG007|Overall Study|Adverse Event|0|||
155291781|NCT00246012|560497576|FG008|Overall Study|Adverse Event|2|||
155291782|NCT00246012|560497568|FG000|Overall Study|Withdrawal by Subject|0|||
155291783|NCT00246012|560497569|FG001|Overall Study|Withdrawal by Subject|0|||
155291784|NCT00246012|560497570|FG002|Overall Study|Withdrawal by Subject|0|||
155291785|NCT00246012|560497571|FG003|Overall Study|Withdrawal by Subject|0|||
155291786|NCT00246012|560497572|FG004|Overall Study|Withdrawal by Subject|0|||
155291787|NCT00246012|560497573|FG005|Overall Study|Withdrawal by Subject|1|||
155291788|NCT00246012|560497574|FG006|Overall Study|Withdrawal by Subject|0|||
155291789|NCT00246012|560497575|FG007|Overall Study|Withdrawal by Subject|0|||
155291790|NCT00246012|560497576|FG008|Overall Study|Withdrawal by Subject|0|||
155291791|NCT00246012|560497568|FG000|Overall Study|Disease progression|3|||
155291792|NCT00246012|560497569|FG001|Overall Study|Disease progression|1|||
155291793|NCT00246012|560497570|FG002|Overall Study|Disease progression|2|||
155291794|NCT00246012|560497571|FG003|Overall Study|Disease progression|3|||
155291795|NCT00246012|560497572|FG004|Overall Study|Disease progression|3|||
155291796|NCT00246012|560497573|FG005|Overall Study|Disease progression|25|||
155291797|NCT00246012|560497574|FG006|Overall Study|Disease progression|30|||
155291798|NCT00246012|560497575|FG007|Overall Study|Disease progression|27|||
155291799|NCT00246012|560497576|FG008|Overall Study|Disease progression|26|||
155291800|NCT00246012|560497568|FG000|Overall Study|Other|0|||
155291801|NCT00246012|560497569|FG001|Overall Study|Other|0|||
155291802|NCT00246012|560497570|FG002|Overall Study|Other|0|||
155291803|NCT00246012|560497571|FG003|Overall Study|Other|0|||
155291804|NCT00246012|560497572|FG004|Overall Study|Other|0|||
155291805|NCT00246012|560497573|FG005|Overall Study|Other|0|||
155291806|NCT00246012|560497574|FG006|Overall Study|Other|0|||
155291807|NCT00246012|560497575|FG007|Overall Study|Other|1|||
155291808|NCT00246012|560497576|FG008|Overall Study|Other|0|||
155291809|NCT00246012|560497568|FG000|Overall Study|Randomly assigned but not treated|0|||
155291810|NCT00246012|560497569|FG001|Overall Study|Randomly assigned but not treated|0|||
155291811|NCT00246012|560497570|FG002|Overall Study|Randomly assigned but not treated|0|||
155291812|NCT00246012|560497571|FG003|Overall Study|Randomly assigned but not treated|0|||
155291813|NCT00246012|560497572|FG004|Overall Study|Randomly assigned but not treated|0|||
155291814|NCT00246012|560497573|FG005|Overall Study|Randomly assigned but not treated|1|||
155291815|NCT00246012|560497574|FG006|Overall Study|Randomly assigned but not treated|1|||
155291816|NCT00246012|560497575|FG007|Overall Study|Randomly assigned but not treated|0|||
155291817|NCT00246012|560497576|FG008|Overall Study|Randomly assigned but not treated|0|||
155291818|NCT02377362|560497577|FG000|Part A Second Treatment|Protocol Violation|0|||
155291819|NCT02377362|560497578|FG001|Part A Second Treatment|Protocol Violation|0|||
155291820|NCT02377362|560497579|FG002|Part A Second Treatment|Protocol Violation|0|||
155291821|NCT02377362|560497580|FG003|Part A Second Treatment|Protocol Violation|0|||
155291822|NCT02377362|560497581|FG004|Part A Second Treatment|Protocol Violation|1|||
155291823|NCT02377362|560497582|FG005|Part A Second Treatment|Protocol Violation|0|||
155291824|NCT02377362|560497583|FG006|Part A Second Treatment|Protocol Violation|0|||
155291825|NCT02377362|560497584|FG007|Part A Second Treatment|Protocol Violation|0|||
155291826|NCT02377362|560497585|FG008|Part A Second Treatment|Protocol Violation|0|||
155291827|NCT02377362|560497586|FG009|Part A Second Treatment|Protocol Violation|0|||
155291828|NCT02377362|560497587|FG010|Part A Second Treatment|Protocol Violation|0|||
155291829|NCT02377362|560497588|FG011|Part A Second Treatment|Protocol Violation|0|||
155291830|NCT02377362|560497589|FG012|Part A Second Treatment|Protocol Violation|0|||
155291831|NCT02377362|560497577|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291832|NCT02377362|560497578|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291833|NCT02377362|560497579|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291834|NCT02377362|560497580|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
154955163|NCT01015625|559263276|FG000|Overall Study|Withdrawal by Subject|2|||
155291835|NCT02377362|560497581|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
155291836|NCT02377362|560497582|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
155291837|NCT02377362|560497583|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
154955164|NCT01015625|559263277|FG001|Overall Study|Withdrawal by Subject|3|||
155291838|NCT02377362|560497584|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291839|NCT02377362|560497585|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291840|NCT02377362|560497586|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291841|NCT02377362|560497587|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291842|NCT02377362|560497588|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291843|NCT02377362|560497589|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
155291844|NCT02377362|560497577|FG000|Part B Overall|Protocol Violation|0|||
155291845|NCT02377362|560497578|FG001|Part B Overall|Protocol Violation|0|||
155291846|NCT02377362|560497579|FG002|Part B Overall|Protocol Violation|0|||
155291847|NCT02377362|560497580|FG003|Part B Overall|Protocol Violation|0|||
155291848|NCT02377362|560497581|FG004|Part B Overall|Protocol Violation|0|||
155291849|NCT02377362|560497582|FG005|Part B Overall|Protocol Violation|0|||
155291850|NCT02377362|560497583|FG006|Part B Overall|Protocol Violation|0|||
155291851|NCT02377362|560497584|FG007|Part B Overall|Protocol Violation|0|||
155291852|NCT02377362|560497585|FG008|Part B Overall|Protocol Violation|0|||
155291853|NCT02377362|560497586|FG009|Part B Overall|Protocol Violation|1|||
155291854|NCT02377362|560497587|FG010|Part B Overall|Protocol Violation|0|||
155291855|NCT02377362|560497588|FG011|Part B Overall|Protocol Violation|0|||
155291856|NCT02377362|560497589|FG012|Part B Overall|Protocol Violation|0|||
155291857|NCT02377362|560497577|FG000|Part B Overall|Adverse Event|0|||
155291858|NCT02377362|560497578|FG001|Part B Overall|Adverse Event|0|||
155291859|NCT02377362|560497579|FG002|Part B Overall|Adverse Event|0|||
155291860|NCT02377362|560497580|FG003|Part B Overall|Adverse Event|0|||
155291861|NCT02377362|560497581|FG004|Part B Overall|Adverse Event|0|||
155291862|NCT02377362|560497582|FG005|Part B Overall|Adverse Event|0|||
155291863|NCT02377362|560497583|FG006|Part B Overall|Adverse Event|1|||
155291864|NCT02377362|560497584|FG007|Part B Overall|Adverse Event|1|||
155291865|NCT02377362|560497585|FG008|Part B Overall|Adverse Event|0|||
155291866|NCT02377362|560497586|FG009|Part B Overall|Adverse Event|0|||
155291867|NCT02377362|560497587|FG010|Part B Overall|Adverse Event|0|||
155291868|NCT02377362|560497588|FG011|Part B Overall|Adverse Event|0|||
155291869|NCT02377362|560497589|FG012|Part B Overall|Adverse Event|0|||
155291870|NCT02377362|560497577|FG000|Part B Overall|Withdrawal by Subject|0|||
155291871|NCT02377362|560497578|FG001|Part B Overall|Withdrawal by Subject|0|||
155291872|NCT02377362|560497579|FG002|Part B Overall|Withdrawal by Subject|0|||
155291873|NCT02377362|560497580|FG003|Part B Overall|Withdrawal by Subject|0|||
155291874|NCT02377362|560497581|FG004|Part B Overall|Withdrawal by Subject|0|||
155291875|NCT02377362|560497582|FG005|Part B Overall|Withdrawal by Subject|0|||
155291876|NCT02377362|560497583|FG006|Part B Overall|Withdrawal by Subject|1|||
155291877|NCT02377362|560497584|FG007|Part B Overall|Withdrawal by Subject|0|||
155291878|NCT02377362|560497585|FG008|Part B Overall|Withdrawal by Subject|0|||
155291879|NCT02377362|560497586|FG009|Part B Overall|Withdrawal by Subject|0|||
155291880|NCT02377362|560497587|FG010|Part B Overall|Withdrawal by Subject|0|||
155291881|NCT02377362|560497588|FG011|Part B Overall|Withdrawal by Subject|1|||
155291882|NCT02377362|560497589|FG012|Part B Overall|Withdrawal by Subject|0|||
155291883|NCT01806714|560497592|FG000|Overall Study|No functioning phone number|200|||
155291884|NCT01806714|560497593|FG001|Overall Study|No functioning phone number|170|||
155291885|NCT01585038|560497594|FG000|Overall Study|Adverse Event|2|||
155291886|NCT01585038|560497595|FG001|Overall Study|Adverse Event|2|||
155291887|NCT00678795|560497596|FG000|Overall Study|Adverse Event|7|||
155291888|NCT00678795|560497597|FG001|Overall Study|Adverse Event|3|||
155291889|NCT00678795|560497596|FG000|Overall Study|Withdrawal by Subject|3|||
154955165|NCT01015625|559263276|FG000|Overall Study|Physician Decision|2|||
154955166|NCT01015625|559263277|FG001|Overall Study|Physician Decision|0|||
155291890|NCT00678795|560497597|FG001|Overall Study|Withdrawal by Subject|0|||
155291891|NCT00678795|560497596|FG000|Overall Study|Protocol Violation|0|||
155291892|NCT00678795|560497597|FG001|Overall Study|Protocol Violation|1|||
155291893|NCT00678795|560497596|FG000|Overall Study|Lost to Follow-up|0|||
155291894|NCT00678795|560497597|FG001|Overall Study|Lost to Follow-up|1|||
155291895|NCT00678795|560497596|FG000|Overall Study|Lack of Efficacy|1|||
154955167|NCT01015625|559263276|FG000|Overall Study|Death|30|||
154955168|NCT01015625|559263277|FG001|Overall Study|Death|22|||
154955169|NCT00569374|559263278|FG000|Overall Study|Withdrawal by Subject|4|||
154955170|NCT01196052|559263281|FG000|Overall Study|Adverse Event|9|||
154955171|NCT01196052|559263281|FG000|Overall Study|Lost to Follow-up|1|||
154955172|NCT01196052|559263281|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
154955173|NCT01196052|559263281|FG000|Overall Study|Reason not Specified|5|||
154955174|NCT01196052|559263281|FG000|Overall Study|Withdrawal by Subject|6|||
155291896|NCT00678795|560497597|FG001|Overall Study|Lack of Efficacy|1|||
155291897|NCT04107805|560497600|FG000|Overall Study|Adverse Event|0|||
155291898|NCT04107805|560497601|FG001|Overall Study|Adverse Event|0|||
155291899|NCT04107805|560497602|FG002|Overall Study|Adverse Event|0|||
155291900|NCT04107805|560497603|FG003|Overall Study|Adverse Event|1|||
155291901|NCT04107805|560497604|FG004|Overall Study|Adverse Event|0|||
155291902|NCT04107805|560497605|FG005|Overall Study|Adverse Event|1|||
155291903|NCT04107805|560497606|FG006|Overall Study|Adverse Event|0|||
155291904|NCT04107805|560497607|FG007|Overall Study|Adverse Event|0|||
155291905|NCT04107805|560497608|FG008|Overall Study|Adverse Event|1|||
155291906|NCT02750709|560497609|FG000|Treatment Period 1|Adverse Event|0|||
155291907|NCT02750709|560497610|FG001|Treatment Period 1|Adverse Event|0|||
155291908|NCT02750709|560497611|FG002|Treatment Period 1|Adverse Event|0|||
155291909|NCT02750709|560497612|FG003|Treatment Period 1|Adverse Event|0|||
155291910|NCT02750709|560497613|FG004|Treatment Period 1|Adverse Event|0|||
155291911|NCT02750709|560497614|FG005|Treatment Period 1|Adverse Event|1|||
155291912|NCT01120275|560497617|FG000|Overall Study|Adverse Event|3|||
155291913|NCT01120275|560497617|FG000|Overall Study|Progression|27|||
155291914|NCT01120275|560497617|FG000|Overall Study|Ineligible|3|||
155291915|NCT01120275|560497617|FG000|Overall Study|Withdrawal by Subject|1|||
155291916|NCT01120275|560497617|FG000|Overall Study|Refusal|1|||
155291917|NCT01120275|560497617|FG000|Overall Study|Not specific|1|||
155291918|NCT01191086|560497619|FG000|Overall Study|Adverse Event|20|||
155291919|NCT01191086|560497619|FG000|Overall Study|Lack of Efficacy|10|||
155291920|NCT01191086|560497619|FG000|Overall Study|Lost to Follow-up|4|||
155291921|NCT01191086|560497619|FG000|Overall Study|Physician Decision|2|||
155291922|NCT01191086|560497619|FG000|Overall Study|Withdrawal by Subject|24|||
154955175|NCT03603314|559263282|FG000|Overall Study|Lost to Follow-up|0|||
154955176|NCT03603314|559263283|FG001|Overall Study|Lost to Follow-up|3|||
154955177|NCT03603314|559263284|FG002|Overall Study|Lost to Follow-up|0|||
154955178|NCT03603314|559263282|FG000|Overall Study|Protocol Violation|0|||
154955179|NCT03603314|559263283|FG001|Overall Study|Protocol Violation|1|||
154955180|NCT03603314|559263284|FG002|Overall Study|Protocol Violation|0|||
154955181|NCT03603314|559263282|FG000|Overall Study|Adverse Event|2|||
154955182|NCT03603314|559263283|FG001|Overall Study|Adverse Event|0|||
154955183|NCT03603314|559263284|FG002|Overall Study|Adverse Event|0|||
154955184|NCT03603314|559263282|FG000|Overall Study|Physician Decision|1|||
154955185|NCT03603314|559263283|FG001|Overall Study|Physician Decision|1|||
154955186|NCT03603314|559263284|FG002|Overall Study|Physician Decision|0|||
154955187|NCT03603314|559263282|FG000|Overall Study|Withdrawal by Subject|4|||
154955188|NCT03603314|559263283|FG001|Overall Study|Withdrawal by Subject|5|||
154955189|NCT03603314|559263284|FG002|Overall Study|Withdrawal by Subject|3|||
154955190|NCT03603314|559263282|FG000|Overall Study|Other|0|||
154955191|NCT03603314|559263283|FG001|Overall Study|Other|1|||
154955192|NCT03603314|559263284|FG002|Overall Study|Other|0|||
154955193|NCT03450070|559263285|FG000|Overall Study|Withdrawal by Subject|8|||
154955194|NCT02910037|559263286|FG000|Overall Study|Withdrawal by Subject|4|||
154955195|NCT02910037|559263286|FG000|Overall Study|Lost to Follow-up|6|||
154955196|NCT01035060|559263287|FG000|Overall Study|Lost to Follow-up|0|||
154955197|NCT01035060|559263288|FG001|Overall Study|Lost to Follow-up|7|||
154955198|NCT01035060|559263287|FG000|Overall Study|Did not quality after 2nd screening|14|||
154955199|NCT01035060|559263288|FG001|Overall Study|Did not quality after 2nd screening|1|||
154955200|NCT01035060|559263287|FG000|Overall Study|Withdrawal by Subject|8|||
154955201|NCT01035060|559263288|FG001|Overall Study|Withdrawal by Subject|6|||
154955202|NCT01035060|559263287|FG000|Overall Study|Physician Decision|2|||
154955203|NCT01035060|559263288|FG001|Overall Study|Physician Decision|0|||
154955204|NCT02015390|559263289|FG000|Overall Study|Lost to Follow-up|1|||
154955205|NCT02015390|559263290|FG001|Overall Study|Lost to Follow-up|0|||
154955206|NCT02015390|559263289|FG000|Overall Study|Adverse Event|0|||
154955207|NCT02015390|559263290|FG001|Overall Study|Adverse Event|3|||
154955208|NCT02015390|559263289|FG000|Overall Study|Physician Decision|0|||
154955209|NCT02015390|559263290|FG001|Overall Study|Physician Decision|1|||
154955210|NCT00064753|559263293|FG000|Overall Study|Death|251|||
154955211|NCT00064753|559263294|FG001|Overall Study|Death|242|||
154955212|NCT00064753|559263293|FG000|Overall Study|Withdrawal by Subject|198|||
154955213|NCT00064753|559263294|FG001|Overall Study|Withdrawal by Subject|171|||
154955214|NCT00064753|559263293|FG000|Overall Study|Lost to Follow-up|225|||
154955215|NCT00064753|559263294|FG001|Overall Study|Lost to Follow-up|235|||
154955216|NCT02193880|559263295|FG000|Overall Study|patients did not collect enough HPC|3|||
154955217|NCT02914600|559263299|FG000|Overall Study|Adverse Event|298|||
154955218|NCT02914600|559263300|FG001|Overall Study|Adverse Event|35|||
154955219|NCT02914600|559263301|FG002|Overall Study|Adverse Event|25|||
154955220|NCT02914600|559263299|FG000|Overall Study|Sponsors decision|287|||
154955221|NCT02914600|559263300|FG001|Overall Study|Sponsors decision|41|||
154955222|NCT02914600|559263301|FG002|Overall Study|Sponsors decision|12|||
154955223|NCT02914600|559263299|FG000|Overall Study|Withdrawal by Subject|158|||
154955224|NCT02914600|559263300|FG001|Overall Study|Withdrawal by Subject|20|||
154955225|NCT02914600|559263301|FG002|Overall Study|Withdrawal by Subject|18|||
154955226|NCT02914600|559263299|FG000|Overall Study|Investigators discretion|169|||
154955227|NCT02914600|559263300|FG001|Overall Study|Investigators discretion|14|||
154955228|NCT02914600|559263301|FG002|Overall Study|Investigators discretion|13|||
154955229|NCT02914600|559263299|FG000|Overall Study|Lost to Follow-up|10|||
154955230|NCT02914600|559263300|FG001|Overall Study|Lost to Follow-up|4|||
154955231|NCT02914600|559263301|FG002|Overall Study|Lost to Follow-up|0|||
154955232|NCT02914600|559263299|FG000|Overall Study|Pregnancy|8|||
154955233|NCT02914600|559263300|FG001|Overall Study|Pregnancy|0|||
155060174|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
154955234|NCT02914600|559263301|FG002|Overall Study|Pregnancy|0|||
155291923|NCT01191086|560497619|FG000|Overall Study|Discontinuation criterion met|1|||
155291924|NCT01191086|560497619|FG000|Overall Study|Other|1|||
155291925|NCT00290732|560497621|FG000|Overall Study|Inability to instill drug intraductally.|0|||
154955235|NCT02914600|559263299|FG000|Overall Study|Protocol Violation|5|||
155291926|NCT00290732|560497622|FG001|Overall Study|Inability to instill drug intraductally.|1|||
155291927|NCT00290732|560497623|FG002|Overall Study|Inability to instill drug intraductally.|1|||
155291928|NCT00290732|560497624|FG003|Overall Study|Inability to instill drug intraductally.|0|||
155291929|NCT00290732|560497625|FG004|Overall Study|Inability to instill drug intraductally.|0|||
155291930|NCT02736799|560497626|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
155291931|NCT02736799|560497627|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
155291932|NCT02736799|560497628|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
155291933|NCT02736799|560497629|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
155291934|NCT01833832|560497630|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
155291935|NCT01156116|560497631|FG000|Overall Study|Withdrawal by Subject|3|||
155291936|NCT01156116|560497632|FG001|Overall Study|Withdrawal by Subject|1|||
155291937|NCT01156116|560497631|FG000|Overall Study|CPAP intolerance|2|||
155291938|NCT01156116|560497632|FG001|Overall Study|CPAP intolerance|0|||
155291939|NCT00843193|560497633|FG000|Overall Study|Adverse Event|2|||
155291940|NCT00843193|560497634|FG001|Overall Study|Adverse Event|4|||
155291941|NCT00843193|560497633|FG000|Overall Study|Lack of Efficacy|1|||
155291942|NCT00843193|560497634|FG001|Overall Study|Lack of Efficacy|1|||
155291943|NCT00843193|560497633|FG000|Overall Study|Protocol Violation|1|||
155291944|NCT00843193|560497634|FG001|Overall Study|Protocol Violation|2|||
155291945|NCT00843193|560497633|FG000|Overall Study|Lost to Follow-up|1|||
155291946|NCT00843193|560497634|FG001|Overall Study|Lost to Follow-up|0|||
155291947|NCT00843193|560497633|FG000|Overall Study|Physician Decision|0|||
155291948|NCT00843193|560497634|FG001|Overall Study|Physician Decision|1|||
155291949|NCT00843193|560497633|FG000|Overall Study|Withdrawal by Subject|3|||
155291950|NCT00843193|560497634|FG001|Overall Study|Withdrawal by Subject|3|||
155291951|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
155291952|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
155291953|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
155291954|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
155291955|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
155291956|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
155291957|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
155291958|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
155291959|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
155291960|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
155291961|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
155291962|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
155291963|NCT02057718|560497635|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
155291964|NCT02057718|560497636|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
155291965|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
155291966|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
155291967|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
155291968|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
155291969|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
155291970|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
155291971|NCT02057718|560497635|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
155291972|NCT02057718|560497636|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
155291973|NCT00542386|560497637|FG000|Overall Study|Adverse Event|1|||
155291974|NCT00542386|560497638|FG001|Overall Study|Adverse Event|7|||
155291975|NCT00542386|560497639|FG002|Overall Study|Adverse Event|7|||
155291976|NCT00542386|560497640|FG003|Overall Study|Adverse Event|8|||
155291977|NCT00542386|560497641|FG004|Overall Study|Adverse Event|13|||
154955236|NCT02914600|559263300|FG001|Overall Study|Protocol Violation|3|||
155060175|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
155060176|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
155060177|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
155060178|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
155060179|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
155060180|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
155060181|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
155060182|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
155060183|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155060184|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155060185|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
155060186|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
155060187|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
155060188|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155060189|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155060190|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
155060191|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
155060192|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
155060193|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
155060194|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
155060195|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
155060196|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
155060197|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
155060198|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
155060199|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
155060200|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
155060201|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
155060202|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
155060203|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
155060204|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
155060205|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
155060206|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
155060207|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155060208|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155060209|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155060210|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
155060211|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
155060212|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
155060213|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
155060214|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
155060215|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
155060216|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
155060217|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
155060218|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
155060219|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
155060220|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
155060221|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
155060222|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155060223|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155060224|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155060225|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
155060226|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
155060227|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155291978|NCT00542386|560497642|FG005|Overall Study|Adverse Event|4|||
155291979|NCT00542386|560497637|FG000|Overall Study|Death|0|||
155291980|NCT00542386|560497638|FG001|Overall Study|Death|0|||
155291981|NCT00542386|560497639|FG002|Overall Study|Death|1|||
155291982|NCT00542386|560497640|FG003|Overall Study|Death|2|||
155291983|NCT00542386|560497641|FG004|Overall Study|Death|1|||
155291984|NCT00542386|560497642|FG005|Overall Study|Death|2|||
155291985|NCT00542386|560497637|FG000|Overall Study|Lack of Efficacy|32|||
155291986|NCT00542386|560497638|FG001|Overall Study|Lack of Efficacy|12|||
155291987|NCT00542386|560497639|FG002|Overall Study|Lack of Efficacy|10|||
155291988|NCT00542386|560497640|FG003|Overall Study|Lack of Efficacy|13|||
155291989|NCT00542386|560497641|FG004|Overall Study|Lack of Efficacy|7|||
155291990|NCT00542386|560497642|FG005|Overall Study|Lack of Efficacy|31|||
155291991|NCT00542386|560497637|FG000|Overall Study|Physician Decision|1|||
155291992|NCT00542386|560497638|FG001|Overall Study|Physician Decision|0|||
155291993|NCT00542386|560497639|FG002|Overall Study|Physician Decision|0|||
155291994|NCT00542386|560497640|FG003|Overall Study|Physician Decision|1|||
155291995|NCT00542386|560497641|FG004|Overall Study|Physician Decision|0|||
155291996|NCT00542386|560497642|FG005|Overall Study|Physician Decision|0|||
155291997|NCT00542386|560497637|FG000|Overall Study|Protocol Violation|0|||
155291998|NCT00542386|560497638|FG001|Overall Study|Protocol Violation|0|||
155291999|NCT00542386|560497639|FG002|Overall Study|Protocol Violation|1|||
155292000|NCT00542386|560497640|FG003|Overall Study|Protocol Violation|0|||
155292001|NCT00542386|560497641|FG004|Overall Study|Protocol Violation|0|||
155292002|NCT00542386|560497642|FG005|Overall Study|Protocol Violation|4|||
155292003|NCT00542386|560497637|FG000|Overall Study|Withdrawal by Subject|5|||
155292004|NCT00542386|560497638|FG001|Overall Study|Withdrawal by Subject|8|||
155292005|NCT00542386|560497639|FG002|Overall Study|Withdrawal by Subject|10|||
155292006|NCT00542386|560497640|FG003|Overall Study|Withdrawal by Subject|11|||
155292007|NCT00542386|560497641|FG004|Overall Study|Withdrawal by Subject|15|||
155292008|NCT00542386|560497642|FG005|Overall Study|Withdrawal by Subject|7|||
155292009|NCT00542386|560497637|FG000|Overall Study|Other Reasons|4|||
155292010|NCT00542386|560497638|FG001|Overall Study|Other Reasons|1|||
155292011|NCT00542386|560497639|FG002|Overall Study|Other Reasons|4|||
155292012|NCT00542386|560497640|FG003|Overall Study|Other Reasons|3|||
155292013|NCT00542386|560497641|FG004|Overall Study|Other Reasons|4|||
155292014|NCT00542386|560497642|FG005|Overall Study|Other Reasons|2|||
155292015|NCT00197015|560497643|FG000|Overall Study|Adverse Event|3|||
155292016|NCT00197015|560497644|FG001|Overall Study|Adverse Event|0|||
155292017|NCT00197015|560497645|FG002|Overall Study|Adverse Event|1|||
155292018|NCT00197015|560497643|FG000|Overall Study|Protocol Violation|0|||
155292019|NCT00197015|560497644|FG001|Overall Study|Protocol Violation|3|||
155292020|NCT00197015|560497645|FG002|Overall Study|Protocol Violation|3|||
155292021|NCT00197015|560497643|FG000|Overall Study|Withdrawal by Subject|17|||
155292022|NCT00197015|560497644|FG001|Overall Study|Withdrawal by Subject|37|||
155292023|NCT00197015|560497645|FG002|Overall Study|Withdrawal by Subject|34|||
155292024|NCT00197015|560497643|FG000|Overall Study|Lost to Follow-up|28|||
155292025|NCT00197015|560497644|FG001|Overall Study|Lost to Follow-up|46|||
155292026|NCT00197015|560497645|FG002|Overall Study|Lost to Follow-up|37|||
155292027|NCT00197015|560497643|FG000|Overall Study|Other|2|||
155292028|NCT00197015|560497644|FG001|Overall Study|Other|3|||
155292029|NCT00197015|560497645|FG002|Overall Study|Other|2|||
155292030|NCT04511650|560497648|FG000|Overall Study|Lost to Follow-up|1|||
155292031|NCT04511650|560497649|FG001|Overall Study|Lost to Follow-up|0|||
155292032|NCT04511650|560497650|FG002|Overall Study|Lost to Follow-up|0|||
155292033|NCT04511650|560497648|FG000|Overall Study|Withdrawal by Subject|1|||
155292034|NCT04511650|560497649|FG001|Overall Study|Withdrawal by Subject|0|||
155292035|NCT04511650|560497650|FG002|Overall Study|Withdrawal by Subject|0|||
155292036|NCT04511650|560497648|FG000|Overall Study|reason not provided|0|||
155292037|NCT04511650|560497649|FG001|Overall Study|reason not provided|0|||
155292038|NCT04511650|560497650|FG002|Overall Study|reason not provided|1|||
155292039|NCT04511650|560497648|FG000|Overall Study|Death|1|||
155292040|NCT04511650|560497649|FG001|Overall Study|Death|1|||
155292041|NCT04511650|560497650|FG002|Overall Study|Death|1|||
155292042|NCT00608907|560497654|FG000|Overall Study|Adverse Event|6|||
155292043|NCT00608907|560497655|FG001|Overall Study|Adverse Event|0|||
155292044|NCT00608907|560497656|FG002|Overall Study|Adverse Event|1|||
155292045|NCT00608907|560497654|FG000|Overall Study|Death|1|||
155292046|NCT00608907|560497655|FG001|Overall Study|Death|0|||
155292047|NCT00608907|560497656|FG002|Overall Study|Death|0|||
155292048|NCT00608907|560497654|FG000|Overall Study|Withdrawal by Subject|4|||
155292049|NCT00608907|560497655|FG001|Overall Study|Withdrawal by Subject|0|||
155292050|NCT00608907|560497656|FG002|Overall Study|Withdrawal by Subject|0|||
155292051|NCT00608907|560497654|FG000|Overall Study|Progressive Disease|1|||
155292052|NCT00608907|560497655|FG001|Overall Study|Progressive Disease|0|||
155292053|NCT00608907|560497656|FG002|Overall Study|Progressive Disease|0|||
155292054|NCT01186848|560497659|FG000|Overall Study|Lost to Follow-up|4|||
155292055|NCT01186848|560497659|FG000|Overall Study|Withdrawal by Subject|2|||
155292056|NCT01186848|560497659|FG000|Overall Study|Adverse Event|2|||
155292057|NCT01104415|560497660|FG000|Core Phase|Consent withdrawn by subjects|1|||
155292058|NCT01104415|560497661|FG001|Core Phase|Consent withdrawn by subjects|0|||
155292059|NCT01104415|560497660|FG000|Extension Period|Progressive disease|0|||
155292060|NCT01104415|560497661|FG001|Extension Period|Progressive disease|4|||
155292061|NCT01104415|560497660|FG000|Extension Period|Death|0|||
155292062|NCT01104415|560497661|FG001|Extension Period|Death|1|||
155292063|NCT01104415|560497660|FG000|Extension Period|Physician Decision|0|||
155292064|NCT01104415|560497661|FG001|Extension Period|Physician Decision|1|||
155292065|NCT01104415|560497660|FG000|Extension Period|Transition to Study LX1606.302|0|||
155292066|NCT01104415|560497661|FG001|Extension Period|Transition to Study LX1606.302|4|||
155292067|NCT01104415|560497660|FG000|Extension Period|Heart surgery/feeling miserable|0|||
155292068|NCT01104415|560497661|FG001|Extension Period|Heart surgery/feeling miserable|1|||
155292069|NCT03593070|560497663|FG000|Overall Study|administrative withdrawal|1|||
155292070|NCT03593070|560497664|FG001|Overall Study|administrative withdrawal|1|||
155292071|NCT03612804|560497665|FG000|Overall Study|Death|0|||
155292072|NCT03612804|560497666|FG001|Overall Study|Death|7|||
155292073|NCT03612804|560497667|FG002|Overall Study|Death|0|||
155292074|NCT03612804|560497668|FG003|Overall Study|Death|8|||
155292075|NCT03612804|560497665|FG000|Overall Study|Medication copay coverage issues|0|||
155292076|NCT03612804|560497666|FG001|Overall Study|Medication copay coverage issues|0|||
155292077|NCT03612804|560497667|FG002|Overall Study|Medication copay coverage issues|0|||
155292078|NCT03612804|560497668|FG003|Overall Study|Medication copay coverage issues|17|||
155292079|NCT03612804|560497665|FG000|Overall Study|Not current smoker at time of screening|0|||
155292080|NCT03612804|560497666|FG001|Overall Study|Not current smoker at time of screening|1|||
155292081|NCT03612804|560497667|FG002|Overall Study|Not current smoker at time of screening|0|||
155292082|NCT03612804|560497668|FG003|Overall Study|Not current smoker at time of screening|3|||
155292083|NCT03612804|560497665|FG000|Overall Study|Non-veteran status|0|||
155292084|NCT03612804|560497666|FG001|Overall Study|Non-veteran status|1|||
155292085|NCT03612804|560497667|FG002|Overall Study|Non-veteran status|0|||
155292086|NCT03612804|560497668|FG003|Overall Study|Non-veteran status|0|||
155292087|NCT03612804|560497665|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
155292088|NCT03612804|560497666|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
155292089|NCT03612804|560497667|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
155292090|NCT03612804|560497668|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
155292091|NCT03612804|560497665|FG000|Overall Study|Provider retired from VA|0|||
155292092|NCT03612804|560497666|FG001|Overall Study|Provider retired from VA|0|||
155292093|NCT03612804|560497667|FG002|Overall Study|Provider retired from VA|2|||
155292094|NCT03612804|560497668|FG003|Overall Study|Provider retired from VA|0|||
155292095|NCT03612804|560497665|FG000|Overall Study|Withdrawal by Subject|0|||
155292096|NCT03612804|560497666|FG001|Overall Study|Withdrawal by Subject|0|||
155292097|NCT03612804|560497667|FG002|Overall Study|Withdrawal by Subject|7|||
155292098|NCT03612804|560497668|FG003|Overall Study|Withdrawal by Subject|0|||
155292099|NCT03612804|560497665|FG000|Overall Study|Provider involved with study activities|1|||
155292100|NCT03612804|560497666|FG001|Overall Study|Provider involved with study activities|0|||
155292101|NCT03612804|560497667|FG002|Overall Study|Provider involved with study activities|0|||
155292102|NCT03612804|560497668|FG003|Overall Study|Provider involved with study activities|0|||
155292103|NCT02104765|560497669|FG000|Overall Study|Lost to Follow-up|0|||
155292104|NCT02104765|560497670|FG001|Overall Study|Lost to Follow-up|0|||
155292105|NCT02104765|560497671|FG002|Overall Study|Lost to Follow-up|1|||
155292106|NCT02104765|560497672|FG003|Overall Study|Lost to Follow-up|0|||
155292107|NCT02104765|560497673|FG004|Overall Study|Lost to Follow-up|0|||
155292108|NCT02104765|560497674|FG005|Overall Study|Lost to Follow-up|0|||
155292109|NCT02104765|560497675|FG006|Overall Study|Lost to Follow-up|0|||
155292110|NCT02104765|560497669|FG000|Overall Study|Withdrawal by Subject|0|||
155292111|NCT02104765|560497670|FG001|Overall Study|Withdrawal by Subject|0|||
155292112|NCT02104765|560497671|FG002|Overall Study|Withdrawal by Subject|0|||
155292113|NCT02104765|560497672|FG003|Overall Study|Withdrawal by Subject|1|||
155292114|NCT02104765|560497673|FG004|Overall Study|Withdrawal by Subject|1|||
155292115|NCT02104765|560497674|FG005|Overall Study|Withdrawal by Subject|0|||
155292116|NCT02104765|560497675|FG006|Overall Study|Withdrawal by Subject|1|||
155292117|NCT04771273|560497676|FG000|Dose Escalation Period|Not treated with trial medication|0|||
155292118|NCT04771273|560497677|FG001|Dose Escalation Period|Not treated with trial medication|1|||
155292119|NCT04771273|560497678|FG002|Dose Escalation Period|Not treated with trial medication|1|||
155292120|NCT04771273|560497679|FG003|Dose Escalation Period|Not treated with trial medication|0|||
155292121|NCT04771273|560497676|FG000|Dose Escalation Period|Other reasons than listed|2|||
155292122|NCT04771273|560497677|FG001|Dose Escalation Period|Other reasons than listed|0|||
155292123|NCT04771273|560497678|FG002|Dose Escalation Period|Other reasons than listed|2|||
155292124|NCT04771273|560497679|FG003|Dose Escalation Period|Other reasons than listed|1|||
155292125|NCT04771273|560497676|FG000|Dose Escalation Period|Protocol Violation|0|||
155292126|NCT04771273|560497677|FG001|Dose Escalation Period|Protocol Violation|0|||
155292127|NCT04771273|560497678|FG002|Dose Escalation Period|Protocol Violation|3|||
155292128|NCT04771273|560497679|FG003|Dose Escalation Period|Protocol Violation|1|||
155292129|NCT04771273|560497676|FG000|Dose Escalation Period|Burden of study procedures|1|||
155292130|NCT04771273|560497677|FG001|Dose Escalation Period|Burden of study procedures|0|||
155292131|NCT04771273|560497678|FG002|Dose Escalation Period|Burden of study procedures|0|||
155292132|NCT04771273|560497679|FG003|Dose Escalation Period|Burden of study procedures|0|||
155292133|NCT04771273|560497676|FG000|Dose Escalation Period|Change of residence|0|||
155292134|NCT04771273|560497677|FG001|Dose Escalation Period|Change of residence|0|||
155292135|NCT04771273|560497678|FG002|Dose Escalation Period|Change of residence|0|||
155292136|NCT04771273|560497679|FG003|Dose Escalation Period|Change of residence|1|||
155292137|NCT04771273|560497676|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
155292138|NCT04771273|560497677|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
155292139|NCT04771273|560497678|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
155292140|NCT04771273|560497679|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
155292141|NCT04771273|560497676|FG000|Dose Escalation Period|Adverse Event|8|||
155292142|NCT04771273|560497677|FG001|Dose Escalation Period|Adverse Event|9|||
155292143|NCT04771273|560497678|FG002|Dose Escalation Period|Adverse Event|12|||
155292144|NCT04771273|560497679|FG003|Dose Escalation Period|Adverse Event|2|||
155292145|NCT04771273|560497676|FG000|Maintenance Period|Other than listed|4|||
155292146|NCT04771273|560497677|FG001|Maintenance Period|Other than listed|2|||
155292147|NCT04771273|560497678|FG002|Maintenance Period|Other than listed|0|||
155292148|NCT04771273|560497679|FG003|Maintenance Period|Other than listed|3|||
155292149|NCT04771273|560497676|FG000|Maintenance Period|Burden of study procedures|1|||
155292150|NCT04771273|560497677|FG001|Maintenance Period|Burden of study procedures|0|||
155292151|NCT04771273|560497678|FG002|Maintenance Period|Burden of study procedures|0|||
155292152|NCT04771273|560497679|FG003|Maintenance Period|Burden of study procedures|0|||
155292153|NCT04771273|560497676|FG000|Maintenance Period|Change of residence|0|||
155292154|NCT04771273|560497677|FG001|Maintenance Period|Change of residence|1|||
155292155|NCT04771273|560497678|FG002|Maintenance Period|Change of residence|3|||
155292156|NCT04771273|560497679|FG003|Maintenance Period|Change of residence|0|||
155292157|NCT04771273|560497676|FG000|Maintenance Period|Perceived lack of efficacy|0|||
155292158|NCT04771273|560497677|FG001|Maintenance Period|Perceived lack of efficacy|0|||
155292159|NCT04771273|560497678|FG002|Maintenance Period|Perceived lack of efficacy|0|||
155292160|NCT04771273|560497679|FG003|Maintenance Period|Perceived lack of efficacy|1|||
155292161|NCT04771273|560497676|FG000|Maintenance Period|Adverse Event|4|||
155292162|NCT04771273|560497677|FG001|Maintenance Period|Adverse Event|5|||
155292163|NCT04771273|560497678|FG002|Maintenance Period|Adverse Event|5|||
155292164|NCT04771273|560497679|FG003|Maintenance Period|Adverse Event|0|||
155292165|NCT02357784|560497680|FG000|Overall Study|Withdrawal by Subject|1|||
155060228|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155060229|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155292166|NCT00995709|560497681|FG000|Overall Study|Adverse Event|4|||
155292167|NCT00995709|560497682|FG001|Overall Study|Adverse Event|2|||
155292168|NCT00995709|560497683|FG002|Overall Study|Adverse Event|0|||
155292169|NCT00995709|560497681|FG000|Overall Study|Lack of Efficacy|0|||
155292170|NCT00995709|560497682|FG001|Overall Study|Lack of Efficacy|1|||
155292171|NCT00995709|560497683|FG002|Overall Study|Lack of Efficacy|4|||
155292172|NCT00995709|560497681|FG000|Overall Study|Withdrawal by Subject|0|||
155292173|NCT00995709|560497682|FG001|Overall Study|Withdrawal by Subject|4|||
155292174|NCT00995709|560497683|FG002|Overall Study|Withdrawal by Subject|1|||
155292175|NCT00995709|560497681|FG000|Overall Study|Lost to Follow-up|1|||
155292176|NCT00995709|560497682|FG001|Overall Study|Lost to Follow-up|0|||
155292177|NCT00995709|560497683|FG002|Overall Study|Lost to Follow-up|0|||
155292178|NCT00995709|560497681|FG000|Overall Study|Death|0|||
155292179|NCT00995709|560497682|FG001|Overall Study|Death|1|||
155292180|NCT00995709|560497683|FG002|Overall Study|Death|0|||
155292181|NCT00995709|560497681|FG000|Overall Study|Protocol Violation|2|||
155292182|NCT00995709|560497682|FG001|Overall Study|Protocol Violation|1|||
155292183|NCT00995709|560497683|FG002|Overall Study|Protocol Violation|0|||
155292184|NCT03395353|560497691|FG000|Overall Study|Adverse Event|20|||
155292185|NCT03395353|560497691|FG000|Overall Study|Protocol Violation|1|||
155292186|NCT03395353|560497691|FG000|Overall Study|Lack of Efficacy|3|||
155292187|NCT03395353|560497691|FG000|Overall Study|Withdrawal by Subject|24|||
155292188|NCT03395353|560497691|FG000|Overall Study|Discontinued visit|1|||
155292189|NCT03395353|560497691|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
155292190|NCT03395353|560497691|FG000|Overall Study|Physician Decision|4|||
155292191|NCT03395353|560497691|FG000|Overall Study|Early termination of overall study|33|||
155292192|NCT02685033|560497692|FG000|Overall Study|Withdrawal of Consent|0|||
155292193|NCT02685033|560497693|FG001|Overall Study|Withdrawal of Consent|1|||
155292194|NCT02685033|560497692|FG000|Overall Study|Lost to Follow-up|2|||
155292195|NCT02685033|560497693|FG001|Overall Study|Lost to Follow-up|1|||
155292196|NCT02685033|560497692|FG000|Overall Study|Adverse Event|1|||
155292197|NCT02685033|560497693|FG001|Overall Study|Adverse Event|0|||
155292198|NCT00708097|560497694|FG000|Period 1|Protocol Violation|0|||
155292199|NCT00708097|560497695|FG001|Period 1|Protocol Violation|1|||
155292200|NCT00708097|560497696|FG002|Period 1|Protocol Violation|0|||
155292201|NCT00708097|560497697|FG003|Period 1|Protocol Violation|2|||
155292202|NCT00708097|560497698|FG004|Period 1|Protocol Violation|0|||
155292203|NCT00708097|560497694|FG000|Period 1|Other Reason|0|||
155292204|NCT00708097|560497695|FG001|Period 1|Other Reason|0|||
155292205|NCT00708097|560497696|FG002|Period 1|Other Reason|0|||
155292206|NCT00708097|560497697|FG003|Period 1|Other Reason|0|||
155292207|NCT00708097|560497698|FG004|Period 1|Other Reason|1|||
155292208|NCT00708097|560497694|FG000|Period 2|Protocol Violation|0|||
155292209|NCT00708097|560497695|FG001|Period 2|Protocol Violation|1|||
155292210|NCT00708097|560497696|FG002|Period 2|Protocol Violation|1|||
155292211|NCT00708097|560497697|FG003|Period 2|Protocol Violation|1|||
155292212|NCT00708097|560497698|FG004|Period 2|Protocol Violation|0|||
155292213|NCT03425643|560497699|FG000|Overall Study|Withdrawal by Subject|10|||
155292214|NCT03425643|560497700|FG001|Overall Study|Withdrawal by Subject|12|||
155292215|NCT03425643|560497699|FG000|Overall Study|Lost to Follow-up|2|||
155292216|NCT03425643|560497700|FG001|Overall Study|Lost to Follow-up|0|||
155292217|NCT03425643|560497699|FG000|Overall Study|Death|109|||
155292218|NCT03425643|560497700|FG001|Overall Study|Death|141|||
155292219|NCT03425643|560497699|FG000|Overall Study|Ongoing in study|276|||
155292220|NCT03425643|560497700|FG001|Overall Study|Ongoing in study|247|||
155292221|NCT01838200|560497701|FG000|Overall Study|Adverse Event|0|||
155292222|NCT01838200|560497702|FG001|Overall Study|Adverse Event|2|||
155292223|NCT01838200|560497701|FG000|Overall Study|Progressive disease|3|||
155292224|NCT01838200|560497702|FG001|Overall Study|Progressive disease|0|||
155292225|NCT03354390|560497706|FG000|Level 1|Death|2|||
155292226|NCT03354390|560497707|FG001|Level 1|Death|0|||
155060230|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
155060231|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155060232|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
155060233|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155060234|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155060235|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
155060236|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
155060237|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
155060238|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
155060239|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
155060240|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
155060241|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155060242|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
155060243|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155060244|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155060245|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
155292227|NCT03354390|560497708|FG002|Level 1|Death|0|||
155292228|NCT03354390|560497709|FG003|Level 1|Death|0|||
155292229|NCT03354390|560497706|FG000|Level 1|Physician Decision|1|||
155292230|NCT03354390|560497707|FG001|Level 1|Physician Decision|0|||
155292231|NCT03354390|560497708|FG002|Level 1|Physician Decision|0|||
155292232|NCT03354390|560497709|FG003|Level 1|Physician Decision|0|||
155292233|NCT03354390|560497706|FG000|Level 2|Physician Decision|0|||
155292234|NCT03354390|560497707|FG001|Level 2|Physician Decision|2|||
155292235|NCT03354390|560497708|FG002|Level 2|Physician Decision|0|||
155292236|NCT03354390|560497709|FG003|Level 2|Physician Decision|0|||
155292237|NCT03354390|560497706|FG000|Level 2|Lack of Efficacy|0|||
155292238|NCT03354390|560497707|FG001|Level 2|Lack of Efficacy|1|||
155292239|NCT03354390|560497708|FG002|Level 2|Lack of Efficacy|0|||
155292240|NCT03354390|560497709|FG003|Level 2|Lack of Efficacy|0|||
155292241|NCT03354390|560497706|FG000|Level 2|Lost to Follow-up|0|||
155292242|NCT03354390|560497707|FG001|Level 2|Lost to Follow-up|1|||
155292243|NCT03354390|560497708|FG002|Level 2|Lost to Follow-up|0|||
155292244|NCT03354390|560497709|FG003|Level 2|Lost to Follow-up|0|||
155292245|NCT03354390|560497706|FG000|Level 3|Death|0|||
155292246|NCT03354390|560497707|FG001|Level 3|Death|0|||
155292247|NCT03354390|560497708|FG002|Level 3|Death|1|||
155292248|NCT03354390|560497709|FG003|Level 3|Death|0|||
155292249|NCT03354390|560497706|FG000|Level 3|Physician Decision|0|||
155292250|NCT03354390|560497707|FG001|Level 3|Physician Decision|0|||
155292251|NCT03354390|560497708|FG002|Level 3|Physician Decision|2|||
155292252|NCT03354390|560497709|FG003|Level 3|Physician Decision|0|||
155292253|NCT03354390|560497706|FG000|Level 4|Death|0|||
155292254|NCT03354390|560497707|FG001|Level 4|Death|0|||
155292255|NCT03354390|560497708|FG002|Level 4|Death|0|||
155292256|NCT03354390|560497709|FG003|Level 4|Death|3|||
155292257|NCT00777556|560499016|FG000|Overall Study|Inappropriate self-selection|34|||
155292258|NCT00777556|560499016|FG000|Overall Study|Dispensed but did not use product|12|||
155292259|NCT00777556|560499016|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
155292260|NCT02689349|560499017|FG000|Overall Study|Not implanted|4|||
155292261|NCT02689349|560499018|FG001|Overall Study|Not implanted|0|||
155292262|NCT02689349|560499017|FG000|Overall Study|Withdrawal by Subject|9|||
155292263|NCT02689349|560499018|FG001|Overall Study|Withdrawal by Subject|0|||
155292264|NCT00486759|560499027|FG000|Treatment|Adverse event/intercurrent illness|86|||
155292265|NCT00486759|560499028|FG001|Treatment|Adverse event/intercurrent illness|39|||
155292266|NCT00486759|560499027|FG000|Treatment|Insufficient therapeutic response|37|||
155292267|NCT00486759|560499028|FG001|Treatment|Insufficient therapeutic response|39|||
155292268|NCT00486759|560499027|FG000|Treatment|Death|17|||
155292269|NCT00486759|560499028|FG001|Treatment|Death|10|||
155292270|NCT00486759|560499027|FG000|Treatment|Withdrew consent|15|||
155292271|NCT00486759|560499028|FG001|Treatment|Withdrew consent|12|||
155292272|NCT00486759|560499027|FG000|Treatment|Administrative/reason not specified|17|||
155292273|NCT00486759|560499028|FG001|Treatment|Administrative/reason not specified|21|||
155292274|NCT00486759|560499027|FG000|Treatment|Refused treatment|10|||
155292275|NCT00486759|560499028|FG001|Treatment|Refused treatment|7|||
155292276|NCT00486759|560499027|FG000|Treatment|Violation of selection criteria at entry|3|||
155292277|NCT00486759|560499028|FG001|Treatment|Violation of selection criteria at entry|3|||
155292278|NCT00486759|560499027|FG000|Treatment|Other protocol violation|1|||
155292279|NCT00486759|560499028|FG001|Treatment|Other protocol violation|5|||
155292280|NCT00486759|560499027|FG000|Treatment|Failure to return|1|||
155292281|NCT00486759|560499028|FG001|Treatment|Failure to return|1|||
155292282|NCT00486759|560499027|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
155292283|NCT00486759|560499028|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
155292284|NCT00486759|560499027|FG000|Safety Follow-up|Death|40|||
155292285|NCT00486759|560499028|FG001|Safety Follow-up|Death|29|||
155292286|NCT00486759|560499027|FG000|Safety Follow-up|Withdrew consent|32|||
155292287|NCT00486759|560499028|FG001|Safety Follow-up|Withdrew consent|23|||
155060246|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
155060247|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155060248|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155060249|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155060250|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
155060251|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155060252|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
155060253|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155060254|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155060255|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
155060256|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
155060257|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155060258|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155292288|NCT00486759|560499027|FG000|Safety Follow-up|Failure to return|9|||
155292289|NCT00486759|560499028|FG001|Safety Follow-up|Failure to return|6|||
155292290|NCT00486759|560499027|FG000|Safety Follow-up|Administrative/not specified|8|||
155292291|NCT00486759|560499028|FG001|Safety Follow-up|Administrative/not specified|6|||
155292292|NCT00486759|560499027|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
155292293|NCT00486759|560499028|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
155292294|NCT00486759|560499027|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
155292295|NCT00486759|560499028|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
155292296|NCT01185522|560499029|FG000|Overall Study|Lack of Efficacy|28|||
155292297|NCT01185522|560499029|FG000|Overall Study|Lost to Follow-up|19|||
155292298|NCT01185522|560499029|FG000|Overall Study|Withdrawal by Subject|10|||
155292299|NCT01185522|560499029|FG000|Overall Study|Poor tolerance|39|||
155292300|NCT01185522|560499029|FG000|Overall Study|Other reasons|12|||
155292301|NCT02987543|560499030|FG000|Overall Study|Ongoing study at data cut off|49|||
155292302|NCT02987543|560499031|FG001|Overall Study|Ongoing study at data cut off|21|||
155292303|NCT02987543|560499032|FG002|Overall Study|Ongoing study at data cut off|19|||
155292304|NCT02987543|560499033|FG003|Overall Study|Ongoing study at data cut off|12|||
155292305|NCT02987543|560499030|FG000|Overall Study|Death|88|||
155292306|NCT02987543|560499031|FG001|Overall Study|Death|54|||
155292307|NCT02987543|560499032|FG002|Overall Study|Death|67|||
155292308|NCT02987543|560499033|FG003|Overall Study|Death|28|||
155292309|NCT02987543|560499030|FG000|Overall Study|Lost to Follow-up|3|||
155292310|NCT02987543|560499031|FG001|Overall Study|Lost to Follow-up|0|||
155292311|NCT02987543|560499032|FG002|Overall Study|Lost to Follow-up|1|||
155292312|NCT02987543|560499033|FG003|Overall Study|Lost to Follow-up|0|||
155292313|NCT02987543|560499030|FG000|Overall Study|Screen failure|0|||
155292314|NCT02987543|560499031|FG001|Overall Study|Screen failure|0|||
155292315|NCT02987543|560499032|FG002|Overall Study|Screen failure|0|||
155292316|NCT02987543|560499033|FG003|Overall Study|Screen failure|1|||
155292317|NCT02987543|560499030|FG000|Overall Study|Withdrawal by Subject|21|||
155292318|NCT02987543|560499031|FG001|Overall Study|Withdrawal by Subject|7|||
155292319|NCT02987543|560499032|FG002|Overall Study|Withdrawal by Subject|7|||
155292320|NCT02987543|560499033|FG003|Overall Study|Withdrawal by Subject|6|||
155292321|NCT02987543|560499030|FG000|Overall Study|Study terminated by sponsor|1|||
155292322|NCT02987543|560499031|FG001|Overall Study|Study terminated by sponsor|0|||
155292323|NCT02987543|560499032|FG002|Overall Study|Study terminated by sponsor|0|||
155292324|NCT02987543|560499033|FG003|Overall Study|Study terminated by sponsor|0|||
155292325|NCT02987543|560499030|FG000|Overall Study|Investigator decision|0|||
155292326|NCT02987543|560499031|FG001|Overall Study|Investigator decision|1|||
155292327|NCT02987543|560499032|FG002|Overall Study|Investigator decision|0|||
155292328|NCT02987543|560499033|FG003|Overall Study|Investigator decision|0|||
155292329|NCT02987543|560499030|FG000|Overall Study|Disease progression|0|||
155292330|NCT02987543|560499031|FG001|Overall Study|Disease progression|0|||
155292331|NCT02987543|560499032|FG002|Overall Study|Disease progression|0|||
155292332|NCT02987543|560499033|FG003|Overall Study|Disease progression|1|||
155292333|NCT03646669|560499036|FG000|Overall Study|Withdrawal by Subject|5|||
155292334|NCT03646669|560499037|FG001|Overall Study|Withdrawal by Subject|0|||
155292335|NCT00377455|560499038|FG000|Overall Study|Withdrawal by Subject|1|||
155292336|NCT00309452|560499039|FG000|Overall Study|Withdrawal by Subject|3|||
155292337|NCT00309452|560499040|FG001|Overall Study|Withdrawal by Subject|0|||
155292338|NCT02962674|560499041|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
155292339|NCT05193318|560499044|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
155292340|NCT05193318|560499044|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
155292341|NCT02046616|560499045|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
155292342|NCT02046616|560499045|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
155292343|NCT02046616|560499045|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
155292344|NCT02046616|560499045|FG000|24-Week Treatment Period|Physician Decision|3|||
155292345|NCT02046616|560499045|FG000|24-Week Treatment Period|Other|1|||
155292346|NCT02046616|560499045|FG000|8-Week FU Period|Lost to Follow-up|1|||
155292347|NCT00344019|560499049|FG000|Overall Study|did not meet final inclusion criteria|0|||
155292348|NCT00344019|560499050|FG001|Overall Study|did not meet final inclusion criteria|0|||
155292349|NCT00344019|560499051|FG002|Overall Study|did not meet final inclusion criteria|74|||
155292350|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Death|1|||
155292351|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Death|1|||
155292352|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Death|0|||
155292353|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Death|0|||
155292354|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Death|0|||
155292355|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
155292356|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
155292357|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
155292358|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
155292359|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
155292360|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Physician Decision|0|||
155292361|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Physician Decision|0|||
155292362|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Physician Decision|0|||
155292363|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Physician Decision|0|||
155292364|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Physician Decision|1|||
155292365|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
155292366|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
155292367|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
155292368|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
155292369|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
155292370|NCT02503202|560499052|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
155292371|NCT02503202|560499053|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
155292372|NCT02503202|560499054|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
155292373|NCT02503202|560499055|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
155292374|NCT02503202|560499056|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
155292375|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
155292376|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
155292377|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
155292378|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
155292379|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
155292380|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Death|1|||
155292381|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Death|0|||
155292382|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Death|0|||
155292383|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Death|0|||
155292384|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Death|0|||
155292385|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
155292386|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
155292387|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
155292388|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
155292389|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
155292390|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Physician Decision|1|||
155292391|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Physician Decision|0|||
155292392|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Physician Decision|1|||
155292393|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Physician Decision|3|||
155292394|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Physician Decision|0|||
155292395|NCT02503202|560499052|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
155292396|NCT02503202|560499053|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
155060259|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155292397|NCT02503202|560499054|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
155292398|NCT02503202|560499055|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
155292399|NCT02503202|560499056|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
155292400|NCT00906035|560499057|FG000|Overall Study|Withdrawal by Subject|2|||
155292401|NCT00906035|560499058|FG001|Overall Study|Withdrawal by Subject|3|||
155292402|NCT00906035|560499059|FG002|Overall Study|Withdrawal by Subject|0|||
155292403|NCT00139737|560499060|FG000|Overall Study|Withdrawal by Subject|190|||
155292404|NCT00139737|560499060|FG000|Overall Study|Adverse Event|58|||
155292405|NCT00139737|560499060|FG000|Overall Study|Lack of Efficacy|40|||
155292406|NCT00139737|560499060|FG000|Overall Study|Lost to Follow-up|8|||
155292407|NCT00139737|560499060|FG000|Overall Study|Death|3|||
155292408|NCT00139737|560499060|FG000|Overall Study|Laboratory Abnormality|2|||
155292409|NCT00139737|560499060|FG000|Overall Study|Protocol Violation|18|||
155292410|NCT00139737|560499060|FG000|Overall Study|Withdrew During Screening Phase|8|||
155292411|NCT00139737|560499060|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155292412|NCT00139737|560499060|FG000|Overall Study|Screened, Not Treated|13|||
155292413|NCT00217672|560499067|FG000|Allocation|Ineligible|2|||
155292414|NCT00217672|560499068|FG001|Allocation|Ineligible|0|||
155292415|NCT00217672|560499067|FG000|Treatment|disease progression|33|||
155292416|NCT00217672|560499068|FG001|Treatment|disease progression|4|||
155292417|NCT00217672|560499067|FG000|Treatment|Adverse Event|18|||
155292418|NCT00217672|560499068|FG001|Treatment|Adverse Event|2|||
155292419|NCT00217672|560499067|FG000|Treatment|reqd treatment not permitted by protocol|6|||
155292420|NCT00217672|560499068|FG001|Treatment|reqd treatment not permitted by protocol|0|||
155292421|NCT00217672|560499067|FG000|Treatment|Physician Decision|6|||
155292422|NCT00217672|560499068|FG001|Treatment|Physician Decision|0|||
155292423|NCT00217672|560499067|FG000|Treatment|insurance issues|1|||
155292424|NCT00217672|560499068|FG001|Treatment|insurance issues|1|||
155292425|NCT00217672|560499067|FG000|Treatment|Death|2|||
155292426|NCT00217672|560499068|FG001|Treatment|Death|0|||
155292427|NCT00217672|560499067|FG000|Treatment|secondary malignancy|1|||
155292428|NCT00217672|560499068|FG001|Treatment|secondary malignancy|0|||
155292429|NCT00217672|560499067|FG000|Follow-up|Withdrawal by Subject|4|||
155292430|NCT00217672|560499068|FG001|Follow-up|Withdrawal by Subject|0|||
155292431|NCT00217672|560499067|FG000|Follow-up|Lost to Follow-up|1|||
155292432|NCT00217672|560499068|FG001|Follow-up|Lost to Follow-up|0|||
155292433|NCT01591616|560499069|FG000|Overall Study|Withdrawal by Subject|1|||
155292434|NCT03525119|560499070|FG000|Overall Study|Adverse Event|0|||
155292435|NCT03525119|560499071|FG001|Overall Study|Adverse Event|1|||
155292436|NCT03525119|560499072|FG002|Overall Study|Adverse Event|0|||
155292437|NCT03525119|560499070|FG000|Overall Study|Lost to Follow-up|32|||
155292438|NCT03525119|560499071|FG001|Overall Study|Lost to Follow-up|33|||
155292439|NCT03525119|560499072|FG002|Overall Study|Lost to Follow-up|37|||
155292440|NCT03525119|560499070|FG000|Overall Study|Withdrawal by Subject|5|||
155292441|NCT03525119|560499071|FG001|Overall Study|Withdrawal by Subject|4|||
155292442|NCT03525119|560499072|FG002|Overall Study|Withdrawal by Subject|2|||
155292443|NCT03525119|560499070|FG000|Overall Study|Reason not Specified|2|||
155292444|NCT03525119|560499071|FG001|Overall Study|Reason not Specified|1|||
155292445|NCT03525119|560499072|FG002|Overall Study|Reason not Specified|2|||
155292446|NCT03525119|560499070|FG000|Overall Study|Randomized but not Vaccinated|1|||
155292447|NCT03525119|560499071|FG001|Overall Study|Randomized but not Vaccinated|0|||
155292448|NCT03525119|560499072|FG002|Overall Study|Randomized but not Vaccinated|2|||
155292449|NCT03781336|560499073|FG000|Overall Study|Withdrawal by Subject|2|||
155292450|NCT03781336|560499074|FG001|Overall Study|Withdrawal by Subject|2|||
155292451|NCT00158054|560499079|FG000|Overall Study|Refused to continue|3|||
155292452|NCT00158054|560499080|FG001|Overall Study|Refused to continue|0|||
155292453|NCT00158054|560499079|FG000|Overall Study|Unavailable for follow up|7|||
155292454|NCT00158054|560499080|FG001|Overall Study|Unavailable for follow up|3|||
155292455|NCT00414648|560499081|FG000|Overall Study|Adverse Event|5|||
155292456|NCT00414648|560499082|FG001|Overall Study|Adverse Event|5|||
155292457|NCT00414648|560499081|FG000|Overall Study|Death|0|||
155292458|NCT00414648|560499082|FG001|Overall Study|Death|1|||
155292459|NCT00414648|560499081|FG000|Overall Study|Lack of Efficacy|0|||
155292460|NCT00414648|560499082|FG001|Overall Study|Lack of Efficacy|2|||
155292461|NCT00414648|560499081|FG000|Overall Study|Withdrawal by Subject|0|||
155292462|NCT00414648|560499082|FG001|Overall Study|Withdrawal by Subject|1|||
155292463|NCT00988637|560499083|FG000|Overall Study|Lost to Follow-up|2|||
155292464|NCT00988637|560499084|FG001|Overall Study|Lost to Follow-up|1|||
155292465|NCT00988637|560499083|FG000|Overall Study|Withdrawal by Subject|1|||
155292466|NCT00988637|560499084|FG001|Overall Study|Withdrawal by Subject|1|||
155292467|NCT00988637|560499083|FG000|Overall Study|non-compliance with study drug|0|||
155292468|NCT00988637|560499084|FG001|Overall Study|non-compliance with study drug|1|||
155292469|NCT03098030|560499087|FG000|Overall Study|Death|10|||
155292470|NCT03098030|560499088|FG001|Overall Study|Death|156|||
155292471|NCT03098030|560499089|FG002|Overall Study|Death|156|||
155292472|NCT03098030|560499090|FG003|Overall Study|Death|82|||
155292473|NCT03098030|560499087|FG000|Overall Study|Withdrawal by Subject|0|||
155292474|NCT03098030|560499088|FG001|Overall Study|Withdrawal by Subject|7|||
155292475|NCT03098030|560499089|FG002|Overall Study|Withdrawal by Subject|8|||
155292476|NCT03098030|560499090|FG003|Overall Study|Withdrawal by Subject|2|||
155292477|NCT03098030|560499087|FG000|Overall Study|Lost to Follow-up|0|||
155292478|NCT03098030|560499088|FG001|Overall Study|Lost to Follow-up|0|||
155292479|NCT03098030|560499089|FG002|Overall Study|Lost to Follow-up|2|||
155292480|NCT03098030|560499090|FG003|Overall Study|Lost to Follow-up|1|||
155292481|NCT05484726|560499091|FG000|Overall Study|Protocol Violation|3|||
155292482|NCT05484726|560499092|FG001|Overall Study|Protocol Violation|3|||
155292483|NCT05484726|560499091|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
155292484|NCT05484726|560499092|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
155292485|NCT05484726|560499091|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
155292486|NCT05484726|560499092|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
155292487|NCT05484726|560499091|FG000|Overall Study|continued need of mechanical ventilation|2|||
155292488|NCT05484726|560499092|FG001|Overall Study|continued need of mechanical ventilation|3|||
155292489|NCT05484726|560499091|FG000|Overall Study|Withdrawal by Subject|2|||
155292490|NCT05484726|560499092|FG001|Overall Study|Withdrawal by Subject|3|||
155292491|NCT05484726|560499091|FG000|Overall Study|IVH (G III & IV)|2|||
155292492|NCT05484726|560499092|FG001|Overall Study|IVH (G III & IV)|1|||
155292493|NCT05484726|560499091|FG000|Overall Study|NEC (stage II & III)|2|||
155292494|NCT05484726|560499092|FG001|Overall Study|NEC (stage II & III)|3|||
155292495|NCT04391309|560499093|FG000|Overall Study|Death|1|||
155292496|NCT04391309|560499094|FG001|Overall Study|Death|1|||
155292497|NCT04391309|560499093|FG000|Overall Study|Lost to Follow-up|3|||
155292498|NCT04391309|560499094|FG001|Overall Study|Lost to Follow-up|2|||
155292499|NCT04391309|560499093|FG000|Overall Study|Withdrawal by Subject|2|||
155292500|NCT04391309|560499094|FG001|Overall Study|Withdrawal by Subject|2|||
155292501|NCT00768651|560499097|FG000|Overall Study|Withdrawal by Subject|1|||
155292502|NCT00462943|560499098|FG000|Overall Study|Failure to achieve a response|5|||
155292503|NCT00462943|560499099|FG001|Overall Study|Failure to achieve a response|5|||
155292504|NCT00462943|560499100|FG002|Overall Study|Failure to achieve a response|1|||
155292505|NCT00462943|560499098|FG000|Overall Study|Adverse Event|6|||
155292506|NCT00462943|560499099|FG001|Overall Study|Adverse Event|4|||
155292507|NCT00462943|560499100|FG002|Overall Study|Adverse Event|1|||
155292508|NCT00462943|560499098|FG000|Overall Study|Protocol Violation|1|||
155292509|NCT00462943|560499099|FG001|Overall Study|Protocol Violation|0|||
155292510|NCT00462943|560499100|FG002|Overall Study|Protocol Violation|0|||
155292511|NCT00462943|560499098|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
155292512|NCT00462943|560499099|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
155292513|NCT00462943|560499100|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
155292514|NCT00462943|560499098|FG000|Overall Study|Disease Progression|15|||
155292515|NCT00462943|560499099|FG001|Overall Study|Disease Progression|15|||
155292516|NCT00462943|560499100|FG002|Overall Study|Disease Progression|9|||
155292517|NCT00462943|560499098|FG000|Overall Study|Death|5|||
155292518|NCT00462943|560499099|FG001|Overall Study|Death|2|||
155292519|NCT00462943|560499100|FG002|Overall Study|Death|7|||
155292520|NCT00462943|560499098|FG000|Overall Study|Stem Cell Transplant|1|||
155292521|NCT00462943|560499099|FG001|Overall Study|Stem Cell Transplant|1|||
155292522|NCT00462943|560499100|FG002|Overall Study|Stem Cell Transplant|0|||
155292523|NCT00462943|560499098|FG000|Overall Study|Bone Marrow Transplant|1|||
155292524|NCT00462943|560499099|FG001|Overall Study|Bone Marrow Transplant|0|||
155292525|NCT00462943|560499100|FG002|Overall Study|Bone Marrow Transplant|0|||
154955237|NCT02914600|559263301|FG002|Overall Study|Protocol Violation|0|||
154955238|NCT02914600|559263299|FG000|Overall Study|Non-compliance with study drug|6|||
154955239|NCT02914600|559263300|FG001|Overall Study|Non-compliance with study drug|1|||
154955240|NCT02914600|559263301|FG002|Overall Study|Non-compliance with study drug|0|||
154955241|NCT02914600|559263299|FG000|Overall Study|Death|3|||
154955242|NCT02914600|559263300|FG001|Overall Study|Death|1|||
154955243|NCT02914600|559263301|FG002|Overall Study|Death|1|||
154955244|NCT02914600|559263299|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
154955245|NCT02914600|559263300|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
154955246|NCT02914600|559263301|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
154955247|NCT02914600|559263299|FG000|Overall Study|Enrolled but not treated|1|||
154955248|NCT02914600|559263300|FG001|Overall Study|Enrolled but not treated|0|||
154955249|NCT02914600|559263301|FG002|Overall Study|Enrolled but not treated|0|||
155060260|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
155060261|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155060262|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
155060263|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155060264|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155060265|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
155060266|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
155060267|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155060268|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155060269|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155060270|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
155060271|NCT02717195|559655581|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
155060272|NCT02717195|559655582|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155060273|NCT02717195|559655583|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155060274|NCT02717195|559655584|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155060275|NCT02717195|559655585|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
155060276|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
155060277|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
155060278|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
155060279|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
155060280|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
155060281|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
155060282|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
155060283|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
155060284|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
155060285|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
155060286|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
155060287|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
155060288|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
155060289|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
155060290|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
155060291|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
155060292|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
155060293|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
155060294|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
155060295|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
155060296|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155060297|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
155060298|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
155060299|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
155060300|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
155060301|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
155060302|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
155060303|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
155060304|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
155060305|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
155060306|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155060307|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155060308|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
154955250|NCT02457520|559263302|FG000|Active Treatment Phase|Adverse Event|10|||
154955251|NCT02457520|559263302|FG000|Active Treatment Phase|Lost to Follow-up|8|||
154955252|NCT02457520|559263302|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
154955253|NCT02457520|559263302|FG000|Active Treatment Phase|other|4|||
155292526|NCT00462943|560499098|FG000|Overall Study|Required Lymphocyte Infusion|1|||
155292527|NCT00462943|560499099|FG001|Overall Study|Required Lymphocyte Infusion|0|||
155292528|NCT00462943|560499100|FG002|Overall Study|Required Lymphocyte Infusion|0|||
155292529|NCT00462943|560499098|FG000|Overall Study|Transplant - not specified|1|||
155292530|NCT00462943|560499099|FG001|Overall Study|Transplant - not specified|0|||
155292531|NCT00462943|560499100|FG002|Overall Study|Transplant - not specified|1|||
155292532|NCT00462943|560499098|FG000|Overall Study|Physician Decision|1|||
155292533|NCT00462943|560499099|FG001|Overall Study|Physician Decision|0|||
155292534|NCT00462943|560499100|FG002|Overall Study|Physician Decision|0|||
155292535|NCT00462943|560499098|FG000|Overall Study|Withdrawal by Subject|0|||
155292536|NCT00462943|560499099|FG001|Overall Study|Withdrawal by Subject|1|||
155292537|NCT00462943|560499100|FG002|Overall Study|Withdrawal by Subject|0|||
155292538|NCT01697319|560499101|FG000|Primary Phase|Withdrawal by Subject|1|||
155292539|NCT01697319|560499101|FG000|Extension Phase|Terminated by Sponsor|15|||
155292540|NCT02698241|560499104|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
155292541|NCT02698241|560499104|FG000|Overall Study|Screening not met|7|||
155292542|NCT02698241|560499104|FG000|Overall Study|Withdrawal by Subject|7|||
155292543|NCT02698241|560499104|FG000|Overall Study|Physician Decision|2|||
155292544|NCT02698241|560499104|FG000|Overall Study|Subject underwent system modification|2|||
155292545|NCT02698241|560499104|FG000|Overall Study|Lost to Follow-up|3|||
155292546|NCT02698241|560499104|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
155292547|NCT02698241|560499104|FG000|Overall Study|geographic and licensing issue|1|||
155292548|NCT02698241|560499104|FG000|Overall Study|Death|2|||
155292549|NCT01543685|560499109|FG000|Overall Study|Lack of Efficacy|1|||
155292550|NCT01543685|560499110|FG001|Overall Study|Lack of Efficacy|2|||
155292551|NCT01543685|560499111|FG002|Overall Study|Lack of Efficacy|2|||
155292552|NCT01543685|560499112|FG003|Overall Study|Lack of Efficacy|0|||
155292553|NCT01543685|560499113|FG004|Overall Study|Lack of Efficacy|2|||
155292554|NCT01543685|560499109|FG000|Overall Study|Adverse Event|2|||
155292555|NCT01543685|560499110|FG001|Overall Study|Adverse Event|1|||
155292556|NCT01543685|560499111|FG002|Overall Study|Adverse Event|0|||
155292557|NCT01543685|560499112|FG003|Overall Study|Adverse Event|0|||
155292558|NCT01543685|560499113|FG004|Overall Study|Adverse Event|2|||
155292559|NCT00604721|560499114|FG000|Overall Study|Physician Decision|1|||
155292560|NCT00604721|560499114|FG000|Overall Study|Withdrawal by Subject|1|||
155292561|NCT04776213|560499115|FG000|Overall Study|Other|1|||
155292562|NCT04776213|560499115|FG000|Overall Study|Withdrawal by Subject|7|||
155292563|NCT04776213|560499115|FG000|Overall Study|Protocol Violation|1|||
155292564|NCT04776213|560499115|FG000|Overall Study|Lost to Follow-up|2|||
155292565|NCT01838551|560499119|FG000|Overall Study|Adverse Event|16|||
155292566|NCT01838551|560499119|FG000|Overall Study|Death|1|||
155292567|NCT01838551|560499119|FG000|Overall Study|Lack of Efficacy|10|||
155292568|NCT01838551|560499119|FG000|Overall Study|Physician Decision|4|||
155292569|NCT01838551|560499119|FG000|Overall Study|Withdrawal by Subject|10|||
155292570|NCT01838551|560499119|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
155292571|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
155292572|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
155292573|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Progressive disease|6|||
155292574|NCT00906282|560499120|FG000|Preoperative Chemotherapy|Toxicity|1|||
155292575|NCT02908464|560499121|FG000|Overall Study|Withdrawal by Subject|2|||
155292576|NCT02908464|560499122|FG001|Overall Study|Withdrawal by Subject|1|||
155292577|NCT02908464|560499121|FG000|Overall Study|Found ineligible after randomization|0|||
155292578|NCT02908464|560499122|FG001|Overall Study|Found ineligible after randomization|2|||
155292579|NCT02163915|560499127|FG000|Overall Study|Withdrawal by Subject|2|||
155292580|NCT02163915|560499128|FG001|Overall Study|Withdrawal by Subject|0|||
155292581|NCT02163915|560499129|FG002|Overall Study|Withdrawal by Subject|2|||
155292582|NCT02163915|560499130|FG003|Overall Study|Withdrawal by Subject|2|||
155292583|NCT02163915|560499131|FG004|Overall Study|Withdrawal by Subject|2|||
155292584|NCT02163915|560499127|FG000|Overall Study|Study termination|1|||
155292585|NCT02163915|560499128|FG001|Overall Study|Study termination|0|||
155292586|NCT02163915|560499129|FG002|Overall Study|Study termination|0|||
155292587|NCT02163915|560499130|FG003|Overall Study|Study termination|0|||
155292588|NCT02163915|560499131|FG004|Overall Study|Study termination|2|||
155292589|NCT02163915|560499127|FG000|Overall Study|Physician Decision|0|||
155292590|NCT02163915|560499128|FG001|Overall Study|Physician Decision|0|||
154955254|NCT02457520|559263302|FG000|Active Treatment Phase|Physician Decision|1|||
155292591|NCT02163915|560499129|FG002|Overall Study|Physician Decision|0|||
155292592|NCT02163915|560499130|FG003|Overall Study|Physician Decision|1|||
155292593|NCT02163915|560499131|FG004|Overall Study|Physician Decision|0|||
155292594|NCT01751724|560499132|FG000|Overall Study|extubated bef.start assigned treatment|1|||
155292595|NCT01751724|560499133|FG001|Overall Study|extubated bef.start assigned treatment|0|||
155292596|NCT01751724|560499132|FG000|Overall Study|withdrawn by parent|0|||
154955255|NCT02457520|559263302|FG000|Active Treatment Phase|Protocol Violation|1|||
155292597|NCT01751724|560499133|FG001|Overall Study|withdrawn by parent|2|||
155292598|NCT02013037|560499134|FG000|Overall Study|Death|6|||
155292599|NCT02013037|560499134|FG000|Overall Study|Withdrawal by Subject|1|||
155292600|NCT02013037|560499134|FG000|Overall Study|Awaiting Transplantation|7|||
155292601|NCT02013037|560499134|FG000|Overall Study|Transplanted without DSA|2|||
155292602|NCT01278862|560499135|FG000|Overall Study|Lost to Follow-up|1|||
155292603|NCT01278862|560499136|FG001|Overall Study|Lost to Follow-up|1|||
155292604|NCT00589667|560500600|FG000|Overall Study|Adverse Event|2|||
155292605|NCT00589667|560500600|FG000|Overall Study|Withdrawal by Subject|1|||
155292606|NCT03538041|560500603|FG000|12-Week Treatment Period|Adverse Event|1|||
155292607|NCT03538041|560500604|FG001|12-Week Treatment Period|Adverse Event|1|||
155292608|NCT03538041|560500603|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
154955256|NCT02457520|559263302|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
154955257|NCT02457520|559263302|FG000|Post-treatment Period|Other: Retreatment Required|7|||
154955258|NCT02457520|559263302|FG000|Post-treatment Period|Lost to Follow-up|23|||
154955259|NCT02457520|559263302|FG000|Post-treatment Period|Other|3|||
154955260|NCT02457520|559263302|FG000|Post-treatment Period|Physician Decision|1|||
154955261|NCT02457520|559263302|FG000|Post-treatment Period|Withdrawal by Subject|14|||
155060309|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155060310|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
155060311|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
155060312|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
155060313|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
155060314|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
155060315|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
154955262|NCT01772537|559263303|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
154955263|NCT01772537|559263304|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
155292609|NCT03538041|560500604|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
155292610|NCT03538041|560500603|FG000|Treatment Extension Period|Adverse Event|4|||
155292611|NCT03538041|560500604|FG001|Treatment Extension Period|Adverse Event|1|||
155292612|NCT03538041|560500603|FG000|Treatment Extension Period|Physician Decision|1|||
155292613|NCT03538041|560500604|FG001|Treatment Extension Period|Physician Decision|1|||
155292614|NCT03538041|560500603|FG000|Treatment Extension Period|Lack of Efficacy|1|||
155292615|NCT03538041|560500604|FG001|Treatment Extension Period|Lack of Efficacy|4|||
155292616|NCT03538041|560500603|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
155292617|NCT03538041|560500604|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
155292618|NCT03538041|560500603|FG000|Treatment Extension Period|Death|0|||
155292619|NCT03538041|560500604|FG001|Treatment Extension Period|Death|1|||
155292620|NCT01049503|560500605|FG000|Overall Study|Lost to Follow-up|11|||
155292621|NCT01049503|560500606|FG001|Overall Study|Lost to Follow-up|12|||
155292622|NCT01049503|560500607|FG002|Overall Study|Lost to Follow-up|24|||
155292623|NCT01049503|560500608|FG003|Overall Study|Lost to Follow-up|26|||
155292624|NCT01049503|560500609|FG004|Overall Study|Lost to Follow-up|27|||
155292625|NCT01049503|560500610|FG005|Overall Study|Lost to Follow-up|8|||
155292626|NCT00726596|560500611|FG000|Overall Study|Adverse Event|2|||
155292627|NCT00726596|560500612|FG001|Overall Study|Adverse Event|1|||
155292628|NCT00726596|560500611|FG000|Overall Study|Withdrawal by Subject|3|||
155292629|NCT00726596|560500612|FG001|Overall Study|Withdrawal by Subject|3|||
155292630|NCT00954707|560500614|FG000|Overall Study|Death|34|||
155292631|NCT00954707|560500614|FG000|Overall Study|Withdrawal by Subject|100|||
155292632|NCT00954707|560500614|FG000|Overall Study|Lost to Follow-up|33|||
155292633|NCT00357396|560500621|FG000|Overall Study|Adverse Event|1|||
155292634|NCT00357396|560500622|FG001|Overall Study|Adverse Event|0|||
155292635|NCT00487578|560500624|FG000|Overall Study|Adverse Event|1|||
155292636|NCT00487578|560500625|FG001|Overall Study|Adverse Event|2|||
155292637|NCT00487578|560500624|FG000|Overall Study|Lack of Efficacy|0|||
155292638|NCT00487578|560500625|FG001|Overall Study|Lack of Efficacy|1|||
155292639|NCT00487578|560500624|FG000|Overall Study|Lost to Follow-up|0|||
155292640|NCT00487578|560500625|FG001|Overall Study|Lost to Follow-up|1|||
155292641|NCT00726999|560500630|FG000|Overall Study|Physician Decision|0|||
155292642|NCT00726999|560500631|FG001|Overall Study|Physician Decision|1|||
155292643|NCT00726999|560500630|FG000|Overall Study|Withdrawal by Subject|2|||
155292644|NCT00726999|560500631|FG001|Overall Study|Withdrawal by Subject|0|||
155292645|NCT00726999|560500630|FG000|Overall Study|Protocol Violation|1|||
155292646|NCT00726999|560500631|FG001|Overall Study|Protocol Violation|0|||
155292647|NCT02488980|560500632|FG000|Overall Study|Protocol Violation|2|||
155292648|NCT02488980|560500633|FG001|Overall Study|Protocol Violation|2|||
155292649|NCT02488980|560500634|FG002|Overall Study|Protocol Violation|2|||
155292650|NCT02614560|560500639|FG000|Overall Study|Death|6|||
155292651|NCT02614560|560500640|FG001|Overall Study|Death|2|||
155292652|NCT02192606|560500641|FG000|Overall Study|surgery type was changed|1|||
155292653|NCT02192606|560500642|FG001|Overall Study|surgery type was changed|1|||
155292654|NCT02192606|560500641|FG000|Overall Study|Physician Decision|1|||
155292655|NCT02192606|560500642|FG001|Overall Study|Physician Decision|2|||
155292656|NCT02192606|560500641|FG000|Overall Study|3D equipment rep unable to join|0|||
155292657|NCT02192606|560500642|FG001|Overall Study|3D equipment rep unable to join|1|||
155292658|NCT00738699|560500643|FG000|Overall Study|Withdrawal by Subject|5|||
155292659|NCT00738699|560500644|FG001|Overall Study|Withdrawal by Subject|0|||
155292660|NCT00738699|560500643|FG000|Overall Study|Lost to Follow-up|1|||
155292661|NCT00738699|560500644|FG001|Overall Study|Lost to Follow-up|0|||
155292662|NCT00738699|560500643|FG000|Overall Study|Death|144|||
155292663|NCT00738699|560500644|FG001|Overall Study|Death|68|||
155292664|NCT00738699|560500643|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
155292665|NCT00738699|560500644|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
155292666|NCT00738699|560500643|FG000|Overall Study|Other|2|||
155292667|NCT00738699|560500644|FG001|Overall Study|Other|0|||
155292668|NCT05174013|560500646|FG000|Overall Study|Lost to Follow-up|0|||
155292669|NCT05174013|560500647|FG001|Overall Study|Lost to Follow-up|0|||
155292670|NCT05174013|560500648|FG002|Overall Study|Lost to Follow-up|0|||
155292671|NCT05174013|560500649|FG003|Overall Study|Lost to Follow-up|1|||
155292672|NCT05174013|560500650|FG004|Overall Study|Lost to Follow-up|0|||
155292673|NCT05174013|560500651|FG005|Overall Study|Lost to Follow-up|0|||
155292674|NCT05174013|560500646|FG000|Overall Study|Withdrawal by Subject|0|||
155292675|NCT05174013|560500647|FG001|Overall Study|Withdrawal by Subject|0|||
155292676|NCT05174013|560500648|FG002|Overall Study|Withdrawal by Subject|1|||
155292677|NCT05174013|560500649|FG003|Overall Study|Withdrawal by Subject|0|||
155292678|NCT05174013|560500650|FG004|Overall Study|Withdrawal by Subject|0|||
155292679|NCT05174013|560500651|FG005|Overall Study|Withdrawal by Subject|0|||
155292680|NCT02034916|560500652|FG000|Overall Study|Death|39|||
155292681|NCT02034916|560500653|FG001|Overall Study|Death|28|||
155292682|NCT02034916|560500652|FG000|Overall Study|Withdrawal by Subject|2|||
155292683|NCT02034916|560500653|FG001|Overall Study|Withdrawal by Subject|1|||
155292684|NCT02034916|560500652|FG000|Overall Study|Lost to Follow-up|4|||
155292685|NCT02034916|560500653|FG001|Overall Study|Lost to Follow-up|1|||
155292686|NCT02034916|560500652|FG000|Overall Study|Study terminated by sponsor|4|||
155156378|NCT02703597|560010633|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
155170024|NCT00830869|560062415|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
154955264|NCT01772537|559263305|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
154955265|NCT00450190|559263306|FG000|Overall Study|Withdrawal by Subject|2|||
154955266|NCT01536574|559263307|FG000|Overall Study|Adverse Event|4|||
154955267|NCT01536574|559263308|FG001|Overall Study|Adverse Event|5|||
154955268|NCT01536574|559263307|FG000|Overall Study|Withdrawal by Subject|1|||
154955269|NCT01536574|559263308|FG001|Overall Study|Withdrawal by Subject|2|||
154955270|NCT01536574|559263307|FG000|Overall Study|Lack of Efficacy|1|||
154955271|NCT01536574|559263308|FG001|Overall Study|Lack of Efficacy|0|||
154955272|NCT01376167|559263309|FG000|Overall Study|Lost to Follow-up|2|||
154955273|NCT01376167|559263310|FG001|Overall Study|Lost to Follow-up|4|||
154955274|NCT01376167|559263311|FG002|Overall Study|Lost to Follow-up|2|||
154955275|NCT01376167|559263309|FG000|Overall Study|Physician Decision|1|||
154955276|NCT01376167|559263310|FG001|Overall Study|Physician Decision|1|||
154955277|NCT01376167|559263311|FG002|Overall Study|Physician Decision|0|||
154955278|NCT01376167|559263309|FG000|Overall Study|Withdrawal by Subject|1|||
154955279|NCT01376167|559263310|FG001|Overall Study|Withdrawal by Subject|5|||
154955280|NCT01376167|559263311|FG002|Overall Study|Withdrawal by Subject|4|||
154955281|NCT00834756|559263312|FG000|First Intervention|Adverse Event|1|||
155292687|NCT02034916|560500653|FG001|Overall Study|Study terminated by sponsor|5|||
155292688|NCT00753012|560500654|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
155292689|NCT00753012|560500655|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
155292690|NCT00753012|560500654|FG000|Overall Study|Adverse Event|2|||
155292691|NCT00753012|560500655|FG001|Overall Study|Adverse Event|0|||
155292692|NCT00753012|560500654|FG000|Overall Study|Withdrawal by Subject|0|||
155292693|NCT00753012|560500655|FG001|Overall Study|Withdrawal by Subject|1|||
155292694|NCT00753012|560500654|FG000|Overall Study|Lost to Follow-up|4|||
155292695|NCT00753012|560500655|FG001|Overall Study|Lost to Follow-up|0|||
155292696|NCT00753012|560500654|FG000|Overall Study|Confounded endpoint data|1|||
155292697|NCT00753012|560500655|FG001|Overall Study|Confounded endpoint data|0|||
155292698|NCT00864682|560500656|FG000|Overall Study|Protocol Violation|2|||
155292699|NCT00864682|560500657|FG001|Overall Study|Protocol Violation|1|||
155292700|NCT00864682|560500658|FG002|Overall Study|Protocol Violation|2|||
155292701|NCT00957658|560500659|FG000|Overall Study|Death|1|||
155292702|NCT00957658|560500659|FG000|Overall Study|Lost to Follow-up|4|||
155292703|NCT00957658|560500659|FG000|Overall Study|Withdrawal by Subject|12|||
155292704|NCT00957658|560500659|FG000|Overall Study|Revision|1|||
155292705|NCT00957658|560500659|FG000|Overall Study|Incomplete 2 yr data|28|||
155292706|NCT00957658|560500659|FG000|Overall Study|Site termination|10|||
155292707|NCT00957658|560500659|FG000|Overall Study|unwilling/unable to return|2|||
155292708|NCT00957658|560500659|FG000|Overall Study|surgery cancelled|2|||
155292709|NCT00957658|560500659|FG000|Overall Study|Protocol Violation|5|||
155292710|NCT04889664|560500660|FG000|Screen|Lost to Follow-up|1|||
155292711|NCT04889664|560500660|FG000|Screen|Failed to meet screening criteria|1|||
155292712|NCT04889664|560500660|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
155292713|NCT00130637|560500666|FG000|Overall Study|Adverse Event|2|||
155292714|NCT00130637|560500666|FG000|Overall Study|Withdrawal by Subject|1|||
155292715|NCT01972152|560500667|FG000|First Treatment Visit|Lost to Follow-up|0|||
155292716|NCT01972152|560500668|FG001|First Treatment Visit|Lost to Follow-up|1|||
155292717|NCT01972152|560500669|FG002|First Treatment Visit|Lost to Follow-up|0|||
155292718|NCT01972152|560500670|FG003|First Treatment Visit|Lost to Follow-up|0|||
155292719|NCT01972152|560500671|FG004|First Treatment Visit|Lost to Follow-up|0|||
155292720|NCT01972152|560500672|FG005|First Treatment Visit|Lost to Follow-up|0|||
155292721|NCT01972152|560500667|FG000|Second Treatment Visit|Protocol Violation|0|||
155292722|NCT01972152|560500668|FG001|Second Treatment Visit|Protocol Violation|1|||
155292723|NCT01972152|560500669|FG002|Second Treatment Visit|Protocol Violation|0|||
155292724|NCT01972152|560500670|FG003|Second Treatment Visit|Protocol Violation|0|||
155292725|NCT01972152|560500671|FG004|Second Treatment Visit|Protocol Violation|0|||
155292726|NCT01972152|560500672|FG005|Second Treatment Visit|Protocol Violation|0|||
155292727|NCT01959412|560500673|FG000|Overall Study|Protocol deviation|1|||
155292728|NCT01959412|560500674|FG001|Overall Study|Protocol deviation|1|||
155292729|NCT01959412|560500675|FG002|Overall Study|Protocol deviation|0|||
155292730|NCT01959412|560500676|FG003|Overall Study|Protocol deviation|1|||
155292731|NCT01959412|560500677|FG004|Overall Study|Protocol deviation|3|||
155292732|NCT01959412|560500678|FG005|Overall Study|Protocol deviation|0|||
155292733|NCT01959412|560500673|FG000|Overall Study|Adverse Event|0|||
155292734|NCT01959412|560500674|FG001|Overall Study|Adverse Event|0|||
155292735|NCT01959412|560500675|FG002|Overall Study|Adverse Event|0|||
155292736|NCT01959412|560500676|FG003|Overall Study|Adverse Event|1|||
155292737|NCT01959412|560500677|FG004|Overall Study|Adverse Event|0|||
155292738|NCT01959412|560500678|FG005|Overall Study|Adverse Event|0|||
155292739|NCT04379713|560500679|FG000|Overall Study|Adverse Event|2|||
155292740|NCT04379713|560500680|FG001|Overall Study|Adverse Event|0|||
155292741|NCT04379713|560500679|FG000|Overall Study|Physician Decision|2|||
155292742|NCT04379713|560500680|FG001|Overall Study|Physician Decision|1|||
155292743|NCT04379713|560500679|FG000|Overall Study|Protocol Violation|11|||
155292744|NCT04379713|560500680|FG001|Overall Study|Protocol Violation|6|||
155292745|NCT04379713|560500679|FG000|Overall Study|No longer met eligibility criteria|14|||
155292746|NCT04379713|560500680|FG001|Overall Study|No longer met eligibility criteria|11|||
155292747|NCT04379713|560500679|FG000|Overall Study|Withdrawal by parent/guardian|36|||
155292748|NCT04379713|560500680|FG001|Overall Study|Withdrawal by parent/guardian|15|||
155292749|NCT04379713|560500679|FG000|Overall Study|Lost to Follow-up|31|||
155292750|NCT04379713|560500680|FG001|Overall Study|Lost to Follow-up|21|||
155292751|NCT04567888|560500681|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
155292752|NCT04567888|560500682|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
155292753|NCT04567888|560500681|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
155292754|NCT04567888|560500682|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
155292755|NCT04567888|560500681|FG000|Overall Study|Reported Unusual Birth Year|2|||
155292756|NCT04567888|560500682|FG001|Overall Study|Reported Unusual Birth Year|3|||
155292757|NCT04567888|560500681|FG000|Overall Study|Duplicate Responses|0|||
155292758|NCT04567888|560500682|FG001|Overall Study|Duplicate Responses|1|||
155292759|NCT00509769|560500683|FG000|Overall Study|Progressive disease|77|||
154955282|NCT00834756|559263313|FG001|First Intervention|Adverse Event|0|||
154955283|NCT00834756|559263312|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
154955284|NCT00834756|559263313|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
154955285|NCT02193165|559263316|FG000|4 Week Product Use|Lost to Follow-up|1|||
154955286|NCT02193165|559263317|FG001|4 Week Product Use|Lost to Follow-up|1|||
154955287|NCT02193165|559263318|FG002|4 Week Product Use|Lost to Follow-up|1|||
154955288|NCT02193165|559263316|FG000|6 Week Product Use|Lost to Follow-up|0|||
154955289|NCT02193165|559263317|FG001|6 Week Product Use|Lost to Follow-up|1|||
154955290|NCT02193165|559263318|FG002|6 Week Product Use|Lost to Follow-up|0|||
154955291|NCT00296647|559263322|FG000|Overall Study|Death|4|||
154955292|NCT00296647|559263323|FG001|Overall Study|Death|1|||
154955293|NCT00296647|559263324|FG002|Overall Study|Death|2|||
154955294|NCT00296647|559263325|FG003|Overall Study|Death|1|||
154955295|NCT00296647|559263326|FG004|Overall Study|Death|1|||
154955296|NCT00296647|559263322|FG000|Overall Study|Withdrawal by Subject|28|||
154955297|NCT00296647|559263323|FG001|Overall Study|Withdrawal by Subject|27|||
154955298|NCT00296647|559263324|FG002|Overall Study|Withdrawal by Subject|32|||
154955299|NCT00296647|559263325|FG003|Overall Study|Withdrawal by Subject|16|||
154955300|NCT00296647|559263326|FG004|Overall Study|Withdrawal by Subject|19|||
154955301|NCT01863745|559263327|FG000|Overall Study|Disease Progression|9|||
154955302|NCT01863745|559263327|FG000|Overall Study|Adverse Event|2|||
154955303|NCT01863745|559263327|FG000|Overall Study|Death|1|||
154955304|NCT01863745|559263327|FG000|Overall Study|Withdrawal by Subject|1|||
154955305|NCT00610363|559263330|FG000|Overall Study|Non-compliance with protocol|0|||
154955306|NCT00610363|559263331|FG001|Overall Study|Non-compliance with protocol|1|||
154955307|NCT00610363|559263330|FG000|Overall Study|Adverse Event|3|||
154955308|NCT00610363|559263331|FG001|Overall Study|Adverse Event|1|||
154955309|NCT00610363|559263330|FG000|Overall Study|Lack of Efficacy|2|||
154955310|NCT00610363|559263331|FG001|Overall Study|Lack of Efficacy|0|||
154955311|NCT00610363|559263330|FG000|Overall Study|Lost to Follow-up|4|||
154955312|NCT00610363|559263331|FG001|Overall Study|Lost to Follow-up|0|||
154955313|NCT00610363|559263330|FG000|Overall Study|Withdrawal by Subject|1|||
154955314|NCT00610363|559263331|FG001|Overall Study|Withdrawal by Subject|0|||
154955315|NCT00610363|559263330|FG000|Overall Study|Other than specified above|1|||
154955316|NCT00610363|559263331|FG001|Overall Study|Other than specified above|1|||
154955317|NCT05093205|559263332|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
154955318|NCT05093205|559263333|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
154955319|NCT05093205|559263334|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
154955320|NCT05093205|559263335|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
154955321|NCT05093205|559263336|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
154955322|NCT05093205|559263337|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
154955323|NCT05093205|559263338|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
154955324|NCT05093205|559263339|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
154955325|NCT05093205|559263340|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
154955326|NCT05093205|559263341|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
154955327|NCT05093205|559263342|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
154955328|NCT05093205|559263343|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
154955329|NCT05093205|559263344|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
154955330|NCT05093205|559263332|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955331|NCT05093205|559263333|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955332|NCT05093205|559263334|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
155292760|NCT00509769|560500683|FG000|Overall Study|Adverse Event|4|||
155292761|NCT00509769|560500683|FG000|Overall Study|Patient's decision|1|||
155292762|NCT00509769|560500683|FG000|Overall Study|Physician Decision|8|||
155292763|NCT00509769|560500683|FG000|Overall Study|Use of prohibited therapies during study|1|||
155292764|NCT02371746|560500684|FG000|Overall Study|Consent withdrawn|0|||
155292765|NCT02371746|560500685|FG001|Overall Study|Consent withdrawn|0|||
155292766|NCT02371746|560500686|FG002|Overall Study|Consent withdrawn|0|||
155292767|NCT02371746|560500687|FG003|Overall Study|Consent withdrawn|0|||
155292768|NCT02371746|560500688|FG004|Overall Study|Consent withdrawn|0|||
155292769|NCT02371746|560500689|FG005|Overall Study|Consent withdrawn|0|||
155292770|NCT02371746|560500690|FG006|Overall Study|Consent withdrawn|1|||
155292771|NCT00754936|560500691|FG000|Overall Study|Lost to Follow-up|3|||
155292772|NCT00754936|560500691|FG000|Overall Study|Physician Decision|1|||
155292773|NCT00754936|560500691|FG000|Overall Study|Withdrawal by Subject|2|||
155292774|NCT00754936|560500691|FG000|Overall Study|Side Effects|3|||
155292775|NCT00754936|560500691|FG000|Overall Study|Inter-current medical events|3|||
155292776|NCT00619645|560500692|FG000|Overall Study|Adverse Event|1|||
155292777|NCT01157182|560500693|FG000|Washout of 28 Days|Adverse Event|2|||
155292778|NCT01157182|560500694|FG001|Washout of 28 Days|Adverse Event|0|||
155292779|NCT01490580|560500695|FG000|Overall Study|Parents withdrew consent|0|||
155292780|NCT01490580|560500696|FG001|Overall Study|Parents withdrew consent|2|||
155292781|NCT00878722|560500697|FG000|Overall Study|Progressive disease|3|||
155292782|NCT00878722|560500698|FG001|Overall Study|Progressive disease|3|||
155292783|NCT00878722|560500699|FG002|Overall Study|Progressive disease|3|||
155292784|NCT00878722|560500700|FG003|Overall Study|Progressive disease|7|||
155292785|NCT00878722|560500701|FG004|Overall Study|Progressive disease|7|||
155292786|NCT00878722|560500702|FG005|Overall Study|Progressive disease|1|||
155292787|NCT00878722|560500703|FG006|Overall Study|Progressive disease|4|||
155292788|NCT00878722|560500704|FG007|Overall Study|Progressive disease|3|||
155292789|NCT00878722|560500697|FG000|Overall Study|Death|0|||
155292790|NCT00878722|560500698|FG001|Overall Study|Death|0|||
155292791|NCT00878722|560500699|FG002|Overall Study|Death|0|||
155292792|NCT00878722|560500700|FG003|Overall Study|Death|1|||
155292793|NCT00878722|560500701|FG004|Overall Study|Death|0|||
155292794|NCT00878722|560500702|FG005|Overall Study|Death|1|||
155292795|NCT00878722|560500703|FG006|Overall Study|Death|0|||
155292796|NCT00878722|560500704|FG007|Overall Study|Death|2|||
155292797|NCT00878722|560500697|FG000|Overall Study|Adverse Event|0|||
155292798|NCT00878722|560500698|FG001|Overall Study|Adverse Event|0|||
155292799|NCT00878722|560500699|FG002|Overall Study|Adverse Event|0|||
155292800|NCT00878722|560500700|FG003|Overall Study|Adverse Event|0|||
155292801|NCT00878722|560500701|FG004|Overall Study|Adverse Event|0|||
155292802|NCT00878722|560500702|FG005|Overall Study|Adverse Event|0|||
155292803|NCT00878722|560500703|FG006|Overall Study|Adverse Event|2|||
155292804|NCT00878722|560500704|FG007|Overall Study|Adverse Event|0|||
155292805|NCT00878722|560500697|FG000|Overall Study|Withdrawal by Subject|0|||
155292806|NCT00878722|560500698|FG001|Overall Study|Withdrawal by Subject|0|||
155292807|NCT00878722|560500699|FG002|Overall Study|Withdrawal by Subject|0|||
155292808|NCT00878722|560500700|FG003|Overall Study|Withdrawal by Subject|0|||
155292809|NCT00878722|560500701|FG004|Overall Study|Withdrawal by Subject|0|||
155292810|NCT00878722|560500702|FG005|Overall Study|Withdrawal by Subject|0|||
155292811|NCT00878722|560500703|FG006|Overall Study|Withdrawal by Subject|0|||
155292812|NCT00878722|560500704|FG007|Overall Study|Withdrawal by Subject|2|||
155292813|NCT00878722|560500697|FG000|Overall Study|Relapse|0|||
155292814|NCT00878722|560500698|FG001|Overall Study|Relapse|0|||
155292815|NCT00878722|560500699|FG002|Overall Study|Relapse|0|||
155292816|NCT00878722|560500700|FG003|Overall Study|Relapse|1|||
155292817|NCT00878722|560500701|FG004|Overall Study|Relapse|0|||
155292818|NCT00878722|560500702|FG005|Overall Study|Relapse|0|||
155292819|NCT00878722|560500703|FG006|Overall Study|Relapse|0|||
155292820|NCT00878722|560500704|FG007|Overall Study|Relapse|0|||
155292821|NCT00383188|560500705|FG000|Overall Study|Adverse Event|4|||
155292822|NCT00383188|560500706|FG001|Overall Study|Adverse Event|7|||
155292823|NCT00383188|560500707|FG002|Overall Study|Adverse Event|9|||
155292824|NCT00383188|560500708|FG003|Overall Study|Adverse Event|8|||
155292825|NCT00383188|560500709|FG004|Overall Study|Adverse Event|8|||
155292826|NCT00383188|560500705|FG000|Overall Study|Lack of Efficacy|9|||
155292827|NCT00383188|560500706|FG001|Overall Study|Lack of Efficacy|3|||
155292828|NCT00383188|560500707|FG002|Overall Study|Lack of Efficacy|3|||
155292829|NCT00383188|560500708|FG003|Overall Study|Lack of Efficacy|2|||
155292830|NCT00383188|560500709|FG004|Overall Study|Lack of Efficacy|6|||
155292831|NCT00383188|560500705|FG000|Overall Study|Other|3|||
155292832|NCT00383188|560500706|FG001|Overall Study|Other|1|||
155292833|NCT00383188|560500707|FG002|Overall Study|Other|0|||
155292834|NCT00383188|560500708|FG003|Overall Study|Other|2|||
155292835|NCT00383188|560500709|FG004|Overall Study|Other|6|||
155292836|NCT00383188|560500705|FG000|Overall Study|No longer willing to participate|1|||
155292837|NCT00383188|560500706|FG001|Overall Study|No longer willing to participate|0|||
155292838|NCT00383188|560500707|FG002|Overall Study|No longer willing to participate|1|||
155292839|NCT00383188|560500708|FG003|Overall Study|No longer willing to participate|0|||
155292840|NCT00383188|560500709|FG004|Overall Study|No longer willing to participate|2|||
155292841|NCT00383188|560500705|FG000|Overall Study|Lost to Follow-up|0|||
155292842|NCT00383188|560500706|FG001|Overall Study|Lost to Follow-up|0|||
155292843|NCT00383188|560500707|FG002|Overall Study|Lost to Follow-up|0|||
155292844|NCT00383188|560500708|FG003|Overall Study|Lost to Follow-up|0|||
155292845|NCT00383188|560500709|FG004|Overall Study|Lost to Follow-up|1|||
155292846|NCT01839877|560500715|FG000|Overall Study|Protocol Violation|1|||
155292847|NCT00597519|560500716|FG000|Overall Study|Death|1|||
155292848|NCT02781584|560500717|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
155292849|NCT02781584|560500718|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
155292850|NCT02781584|560500719|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
155292851|NCT02781584|560500720|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
155292852|NCT02781584|560500721|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
155292853|NCT02781584|560500722|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
155292854|NCT02781584|560500723|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
155292855|NCT02781584|560500724|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
155292856|NCT02781584|560500725|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
155292857|NCT02781584|560500726|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
155292858|NCT02781584|560500727|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
155292859|NCT02781584|560500728|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
155292860|NCT02781584|560500729|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
155292861|NCT02781584|560500717|FG000|Pre-treatment Phase|Adverse Event|0|||
155292862|NCT02781584|560500718|FG001|Pre-treatment Phase|Adverse Event|0|||
155292863|NCT02781584|560500719|FG002|Pre-treatment Phase|Adverse Event|0|||
155292864|NCT02781584|560500720|FG003|Pre-treatment Phase|Adverse Event|0|||
155292865|NCT02781584|560500721|FG004|Pre-treatment Phase|Adverse Event|0|||
155292866|NCT02781584|560500722|FG005|Pre-treatment Phase|Adverse Event|0|||
155292867|NCT02781584|560500723|FG006|Pre-treatment Phase|Adverse Event|0|||
155292868|NCT02781584|560500724|FG007|Pre-treatment Phase|Adverse Event|0|||
155292869|NCT02781584|560500725|FG008|Pre-treatment Phase|Adverse Event|0|||
155292870|NCT02781584|560500726|FG009|Pre-treatment Phase|Adverse Event|0|||
155292871|NCT02781584|560500727|FG010|Pre-treatment Phase|Adverse Event|0|||
155292872|NCT02781584|560500728|FG011|Pre-treatment Phase|Adverse Event|1|||
155292873|NCT02781584|560500729|FG012|Pre-treatment Phase|Adverse Event|0|||
155292874|NCT02781584|560500717|FG000|Treatment Phase|Withdrew Consent|0|||
155292875|NCT02781584|560500718|FG001|Treatment Phase|Withdrew Consent|0|||
155292876|NCT02781584|560500719|FG002|Treatment Phase|Withdrew Consent|0|||
155292877|NCT02781584|560500720|FG003|Treatment Phase|Withdrew Consent|0|||
155292878|NCT02781584|560500721|FG004|Treatment Phase|Withdrew Consent|0|||
155292879|NCT02781584|560500722|FG005|Treatment Phase|Withdrew Consent|1|||
155292880|NCT02781584|560500723|FG006|Treatment Phase|Withdrew Consent|0|||
155292881|NCT02781584|560500724|FG007|Treatment Phase|Withdrew Consent|0|||
155292882|NCT02781584|560500725|FG008|Treatment Phase|Withdrew Consent|0|||
155292883|NCT02781584|560500726|FG009|Treatment Phase|Withdrew Consent|0|||
155292884|NCT02781584|560500727|FG010|Treatment Phase|Withdrew Consent|1|||
155292885|NCT02781584|560500728|FG011|Treatment Phase|Withdrew Consent|2|||
155292886|NCT02781584|560500729|FG012|Treatment Phase|Withdrew Consent|0|||
155292887|NCT02781584|560500717|FG000|Treatment Phase|Adverse Event|0|||
155292888|NCT02781584|560500718|FG001|Treatment Phase|Adverse Event|0|||
154955333|NCT05093205|559263335|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955334|NCT05093205|559263336|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
155292889|NCT02781584|560500719|FG002|Treatment Phase|Adverse Event|0|||
155292890|NCT02781584|560500720|FG003|Treatment Phase|Adverse Event|0|||
155292891|NCT02781584|560500721|FG004|Treatment Phase|Adverse Event|0|||
155292892|NCT02781584|560500722|FG005|Treatment Phase|Adverse Event|0|||
155292893|NCT02781584|560500723|FG006|Treatment Phase|Adverse Event|0|||
155292894|NCT02781584|560500724|FG007|Treatment Phase|Adverse Event|1|||
155292895|NCT02781584|560500725|FG008|Treatment Phase|Adverse Event|0|||
155292896|NCT02781584|560500726|FG009|Treatment Phase|Adverse Event|0|||
155292897|NCT02781584|560500727|FG010|Treatment Phase|Adverse Event|0|||
155292898|NCT02781584|560500728|FG011|Treatment Phase|Adverse Event|0|||
155292899|NCT02781584|560500729|FG012|Treatment Phase|Adverse Event|0|||
155292900|NCT03396913|560500730|FG000|Overall Study|Lost to Follow-up|0|||
155292901|NCT03396913|560500731|FG001|Overall Study|Lost to Follow-up|6|||
155292902|NCT05826431|560500732|FG000|Overall Study|Withdrawal by Subject|1|||
155292903|NCT01981356|560500743|FG000|Overall Study|Lost to Follow-up|4|||
155292904|NCT01981356|560500744|FG001|Overall Study|Lost to Follow-up|1|||
155292905|NCT01981356|560500743|FG000|Overall Study|Withdrawal by Subject|1|||
155292906|NCT01981356|560500744|FG001|Overall Study|Withdrawal by Subject|1|||
155292907|NCT01981356|560500743|FG000|Overall Study|Protocol Violation|2|||
155292908|NCT01981356|560500744|FG001|Overall Study|Protocol Violation|0|||
155292909|NCT02317016|560500745|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
155292910|NCT02317016|560500745|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
155292911|NCT02317016|560500745|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
155292912|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
155292913|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
155292914|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
155292915|NCT02317016|560500745|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
155292916|NCT02465359|560500748|FG000|Overall Study|Lack of Efficacy|1|||
155292917|NCT02465359|560500748|FG000|Overall Study|Withdrawal by Subject|1|||
155292918|NCT02465359|560500748|FG000|Overall Study|Adverse Event|1|||
155292919|NCT02952261|560500749|FG000|Overall Study|Withdrawal by Subject|4|||
155292920|NCT02952261|560500750|FG001|Overall Study|Withdrawal by Subject|5|||
155292921|NCT02952261|560500749|FG000|Overall Study|Protocol Violation|1|||
155292922|NCT02952261|560500750|FG001|Overall Study|Protocol Violation|0|||
155292923|NCT00798265|560500751|FG000|Overall Study|Lost to Follow-up|1|||
155292924|NCT00798265|560500752|FG001|Overall Study|Lost to Follow-up|10|||
155292925|NCT00798265|560500751|FG000|Overall Study|Study closing|7|||
155292926|NCT00798265|560500752|FG001|Overall Study|Study closing|6|||
155292927|NCT00798265|560500751|FG000|Overall Study|Withdrawal by Subject|0|||
155292928|NCT00798265|560500752|FG001|Overall Study|Withdrawal by Subject|1|||
155292929|NCT00798265|560500751|FG000|Overall Study|Screen failure|0|||
155292930|NCT00798265|560500752|FG001|Overall Study|Screen failure|1|||
155292931|NCT03141788|560500753|FG000|Overall Study|Lost to Follow-up|1|||
155292932|NCT03141788|560500753|FG000|Overall Study|Protocol Violation|3|||
155292933|NCT03141788|560500753|FG000|Overall Study|Withdrawal by Subject|4|||
155292934|NCT02810080|560502676|FG000|Overall Study|Adverse Event|3|||
155292935|NCT02810080|560502677|FG001|Overall Study|Adverse Event|0|||
155292936|NCT02810080|560502676|FG000|Overall Study|Death|0|||
155292937|NCT02810080|560502677|FG001|Overall Study|Death|2|||
155292938|NCT02810080|560502676|FG000|Overall Study|Physician Decision|4|||
155292939|NCT02810080|560502677|FG001|Overall Study|Physician Decision|0|||
155292940|NCT02810080|560502676|FG000|Overall Study|Withdrawal by Subject|0|||
155292941|NCT02810080|560502677|FG001|Overall Study|Withdrawal by Subject|2|||
155292942|NCT00094809|560502689|FG000|Overall Study|Protocol deviation|2|||
155292943|NCT00094809|560502690|FG001|Overall Study|Protocol deviation|2|||
155292944|NCT00094809|560502689|FG000|Overall Study|Noncompliance|1|||
155292945|NCT00094809|560502690|FG001|Overall Study|Noncompliance|0|||
155292946|NCT00094809|560502689|FG000|Overall Study|Adverse Event|3|||
155292947|NCT00094809|560502690|FG001|Overall Study|Adverse Event|1|||
155292948|NCT00094809|560502689|FG000|Overall Study|Withdrawal by Subject|8|||
155292949|NCT00094809|560502690|FG001|Overall Study|Withdrawal by Subject|9|||
155292950|NCT00094809|560502689|FG000|Overall Study|Disease progression|3|||
155292951|NCT00094809|560502690|FG001|Overall Study|Disease progression|3|||
155292952|NCT00094809|560502689|FG000|Overall Study|Physician Decision|3|||
155292953|NCT00094809|560502690|FG001|Overall Study|Physician Decision|5|||
155292954|NCT00094809|560502689|FG000|Overall Study|Lost to Follow-up|6|||
155292955|NCT00094809|560502690|FG001|Overall Study|Lost to Follow-up|6|||
155292956|NCT00094809|560502689|FG000|Overall Study|Death|19|||
155292957|NCT00094809|560502690|FG001|Overall Study|Death|25|||
155292958|NCT00094809|560502689|FG000|Overall Study|Protocol-specified criteria|1|||
155292959|NCT00094809|560502690|FG001|Overall Study|Protocol-specified criteria|1|||
155292960|NCT00094809|560502689|FG000|Overall Study|Other|2|||
155292961|NCT00094809|560502690|FG001|Overall Study|Other|4|||
155292962|NCT00094809|560502689|FG000|Overall Study|Informed consent signed after treatment|1|||
155292963|NCT00094809|560502690|FG001|Overall Study|Informed consent signed after treatment|0|||
155292964|NCT00094809|560502689|FG000|Overall Study|Study drug not received|2|||
155292965|NCT00094809|560502690|FG001|Overall Study|Study drug not received|8|||
155292966|NCT00094809|560502689|FG000|Overall Study|Other|1|||
155292967|NCT00094809|560502690|FG001|Overall Study|Other|1|||
155292968|NCT02469064|560502696|FG000|Overall Study|Request not to receive intervention.|1|||
155292969|NCT02469064|560502697|FG001|Overall Study|Request not to receive intervention.|3|||
155292970|NCT02506257|560502698|FG000|Overall Study|Adverse Event|0|||
155292971|NCT02506257|560502699|FG001|Overall Study|Adverse Event|2|||
155292972|NCT02506257|560502700|FG002|Overall Study|Adverse Event|3|||
155292973|NCT02506257|560502701|FG003|Overall Study|Adverse Event|0|||
155292974|NCT02506257|560502698|FG000|Overall Study|Protocol Violation|0|||
155292975|NCT02506257|560502699|FG001|Overall Study|Protocol Violation|0|||
155292976|NCT02506257|560502700|FG002|Overall Study|Protocol Violation|1|||
155292977|NCT02506257|560502701|FG003|Overall Study|Protocol Violation|0|||
155292978|NCT00964366|560502702|FG000|Overall Study|Did not qualify at Day 1|1|||
155292979|NCT00964366|560502703|FG001|Overall Study|Did not qualify at Day 1|0|||
155292980|NCT00964366|560502702|FG000|Overall Study|Withdrawal by Subject|0|||
155292981|NCT00964366|560502703|FG001|Overall Study|Withdrawal by Subject|1|||
155292982|NCT02957539|560502707|FG000|Baseline to Week 16|Lost to Follow-up|8|||
155292983|NCT02957539|560502708|FG001|Baseline to Week 16|Lost to Follow-up|10|||
155292984|NCT02957539|560502709|FG002|Baseline to Week 16|Lost to Follow-up|16|||
155292985|NCT02957539|560502707|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
155292986|NCT02957539|560502708|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
155292987|NCT02957539|560502709|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
155292988|NCT02957539|560502707|FG000|Week 16 to 32|Withdrawal by Subject|3|||
155292989|NCT02957539|560502708|FG001|Week 16 to 32|Withdrawal by Subject|3|||
155292990|NCT02957539|560502709|FG002|Week 16 to 32|Withdrawal by Subject|1|||
155292991|NCT02957539|560502707|FG000|Week 16 to 32|Lost to Follow-up|8|||
155292992|NCT02957539|560502708|FG001|Week 16 to 32|Lost to Follow-up|7|||
155292993|NCT02957539|560502709|FG002|Week 16 to 32|Lost to Follow-up|5|||
155292994|NCT02957539|560502707|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
155292995|NCT02957539|560502708|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
155292996|NCT02957539|560502709|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
155292997|NCT02957539|560502707|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
155292998|NCT02957539|560502708|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
155292999|NCT02957539|560502709|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
155293000|NCT04842604|560502711|FG000|Overall Study|Death|1|||
155293001|NCT04842604|560502712|FG001|Overall Study|Death|0|||
155293002|NCT04842604|560502711|FG000|Overall Study|Other|4|||
155293003|NCT04842604|560502712|FG001|Overall Study|Other|4|||
155293004|NCT04842604|560502711|FG000|Overall Study|Randomized but not treated|1|||
155293005|NCT04842604|560502712|FG001|Overall Study|Randomized but not treated|0|||
155293006|NCT01193153|560502714|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
155293007|NCT01193153|560502715|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
155293008|NCT01193153|560502714|FG000|Open-label Lead in Period|Pregnancy|1|||
155293009|NCT01193153|560502715|FG001|Open-label Lead in Period|Pregnancy|0|||
155293010|NCT01193153|560502714|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
155293011|NCT01193153|560502715|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
155293012|NCT01193153|560502714|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
155293013|NCT01193153|560502715|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
155293014|NCT01193153|560502714|FG000|Open-label Lead in Period|Other|14|||
155293015|NCT01193153|560502715|FG001|Open-label Lead in Period|Other|0|||
155293016|NCT01193153|560502714|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
155293017|NCT01193153|560502715|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
155293018|NCT01193153|560502714|FG000|Open-label Lead in Period|Adverse Event|41|||
155293019|NCT01193153|560502715|FG001|Open-label Lead in Period|Adverse Event|0|||
155293020|NCT01193153|560502714|FG000|Open-label Lead in Period|Death|1|||
155293021|NCT01193153|560502715|FG001|Open-label Lead in Period|Death|0|||
155293022|NCT01193153|560502714|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
155293023|NCT01193153|560502715|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
155293024|NCT01193153|560502714|FG000|Open-label Stabilization Period|Adverse Event|9|||
155293025|NCT01193153|560502715|FG001|Open-label Stabilization Period|Adverse Event|0|||
155293026|NCT01193153|560502714|FG000|Open-label Stabilization Period|Death|2|||
155293027|NCT01193153|560502715|FG001|Open-label Stabilization Period|Death|0|||
155293028|NCT01193153|560502714|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
155293029|NCT01193153|560502715|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
155293030|NCT01193153|560502714|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
155293031|NCT01193153|560502715|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
155293032|NCT01193153|560502714|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
155293033|NCT01193153|560502715|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
155293034|NCT01193153|560502714|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
155293035|NCT01193153|560502715|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
155293036|NCT01193153|560502714|FG000|Open-label Stabilization Period|Other|8|||
155293037|NCT01193153|560502715|FG001|Open-label Stabilization Period|Other|0|||
155293038|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Other|2|||
155293039|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Other|3|||
155293040|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
155293041|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
155293042|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Death|2|||
155293043|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Death|0|||
155293044|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
155293045|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
155293046|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
155293047|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
155293048|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
154955335|NCT05093205|559263337|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955336|NCT05093205|559263338|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955337|NCT05093205|559263339|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955338|NCT05093205|559263340|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955339|NCT05093205|559263341|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955340|NCT05093205|559263342|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955341|NCT05093205|559263343|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955342|NCT05093205|559263344|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
154955343|NCT05093205|559263332|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
155293049|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
155293050|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
155293051|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
154955344|NCT05093205|559263333|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
154955345|NCT05093205|559263334|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
154955346|NCT05093205|559263335|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
155293052|NCT01193153|560502714|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
155293053|NCT01193153|560502715|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
155293054|NCT01563354|560502718|FG000|Core Phase|Adverse Event|5|||
155293055|NCT01563354|560502719|FG001|Core Phase|Adverse Event|15|||
155293056|NCT01563354|560502720|FG002|Core Phase|Adverse Event|13|||
155293057|NCT01563354|560502718|FG000|Core Phase|Withdrawal by Subject|1|||
155293058|NCT01563354|560502719|FG001|Core Phase|Withdrawal by Subject|0|||
155293059|NCT01563354|560502720|FG002|Core Phase|Withdrawal by Subject|3|||
155293060|NCT01563354|560502718|FG000|Core Phase|Lost to Follow-up|1|||
155293061|NCT01563354|560502719|FG001|Core Phase|Lost to Follow-up|0|||
155293062|NCT01563354|560502720|FG002|Core Phase|Lost to Follow-up|0|||
155293063|NCT01563354|560502718|FG000|Core Phase|Death|1|||
155293064|NCT01563354|560502719|FG001|Core Phase|Death|5|||
155293065|NCT01563354|560502720|FG002|Core Phase|Death|2|||
155293066|NCT01563354|560502718|FG000|Core Phase|Diseasse progression|18|||
155293067|NCT01563354|560502719|FG001|Core Phase|Diseasse progression|7|||
155293068|NCT01563354|560502720|FG002|Core Phase|Diseasse progression|8|||
155293069|NCT01563354|560502718|FG000|Core Phase|Protocol deviation|2|||
155293070|NCT01563354|560502719|FG001|Core Phase|Protocol deviation|0|||
155293071|NCT01563354|560502720|FG002|Core Phase|Protocol deviation|0|||
155293072|NCT01563354|560502718|FG000|Core Phase|PI decision - did not enter extension|0|||
155293073|NCT01563354|560502719|FG001|Core Phase|PI decision - did not enter extension|1|||
155293074|NCT01563354|560502720|FG002|Core Phase|PI decision - did not enter extension|0|||
155293075|NCT01563354|560502718|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
155293076|NCT01563354|560502719|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
155293077|NCT01563354|560502720|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
155293078|NCT01563354|560502718|FG000|Extension Phase|Adverse Event|0|||
155293079|NCT01563354|560502719|FG001|Extension Phase|Adverse Event|3|||
155293080|NCT01563354|560502720|FG002|Extension Phase|Adverse Event|2|||
155293081|NCT01563354|560502718|FG000|Extension Phase|Withdrawal by Subject|0|||
155293082|NCT01563354|560502719|FG001|Extension Phase|Withdrawal by Subject|1|||
155293083|NCT01563354|560502720|FG002|Extension Phase|Withdrawal by Subject|0|||
155293084|NCT01563354|560502718|FG000|Extension Phase|Administration problems|3|||
155293085|NCT01563354|560502719|FG001|Extension Phase|Administration problems|2|||
155293086|NCT01563354|560502720|FG002|Extension Phase|Administration problems|3|||
155293087|NCT01563354|560502718|FG000|Extension Phase|Disease progression|9|||
155293088|NCT01563354|560502719|FG001|Extension Phase|Disease progression|8|||
155293089|NCT01563354|560502720|FG002|Extension Phase|Disease progression|10|||
155293090|NCT00079183|560502754|FG000|Overall Study|Withdrawal by Subject|4|||
155293091|NCT00079183|560502754|FG000|Overall Study|Study medication non-compliance|2|||
155293092|NCT00079183|560502754|FG000|Overall Study|Specimen collection non-compliance|1|||
155293093|NCT00770965|560502755|FG000|Safety Set|Withdrawal by Subject|0|||
155293094|NCT00770965|560502756|FG001|Safety Set|Withdrawal by Subject|0|||
154955347|NCT05093205|559263336|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
154955348|NCT05093205|559263337|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
154955349|NCT05093205|559263338|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
154955350|NCT05093205|559263339|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
154955351|NCT05093205|559263340|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
154955352|NCT05093205|559263341|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
154955353|NCT05093205|559263342|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
154955354|NCT05093205|559263343|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
154955355|NCT05093205|559263344|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
154955356|NCT05093205|559263332|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
154955357|NCT05093205|559263333|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
154955358|NCT05093205|559263334|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
154955359|NCT05093205|559263335|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
154955360|NCT05093205|559263336|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
154955361|NCT05093205|559263337|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
154955362|NCT05093205|559263338|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
154955363|NCT05093205|559263339|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
154955364|NCT05093205|559263340|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
155293095|NCT00770965|560502757|FG002|Safety Set|Withdrawal by Subject|0|||
155293096|NCT00770965|560502758|FG003|Safety Set|Withdrawal by Subject|1|||
155293097|NCT00770965|560502755|FG000|Safety Set|Protocol deviation|0|||
155293098|NCT00770965|560502756|FG001|Safety Set|Protocol deviation|0|||
155293099|NCT00770965|560502757|FG002|Safety Set|Protocol deviation|1|||
155293100|NCT00770965|560502758|FG003|Safety Set|Protocol deviation|0|||
154955365|NCT05093205|559263341|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
154955366|NCT05093205|559263342|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
154955367|NCT05093205|559263343|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
155293101|NCT00770965|560502755|FG000|Excluded Set|Administrative problems|14|||
155293102|NCT00770965|560502756|FG001|Excluded Set|Administrative problems|12|||
155293103|NCT00770965|560502757|FG002|Excluded Set|Administrative problems|12|||
155293104|NCT00770965|560502758|FG003|Excluded Set|Administrative problems|10|||
155156379|NCT02703597|560010632|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
155156380|NCT02703597|560010633|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
155156381|NCT02703597|560010632|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
155156382|NCT02703597|560010633|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
155156383|NCT00886379|560010634|FG000|Overall Study|Transferred Schools|0|||
155156384|NCT00886379|560010635|FG001|Overall Study|Transferred Schools|0|||
155156385|NCT00886379|560010636|FG002|Overall Study|Transferred Schools|2|||
155156386|NCT00886379|560010637|FG003|Overall Study|Transferred Schools|1|||
155156387|NCT00886379|560010638|FG004|Overall Study|Transferred Schools|1|||
155156388|NCT00886379|560010634|FG000|Overall Study|Final blood draw not obtained|3|||
155156389|NCT00886379|560010635|FG001|Overall Study|Final blood draw not obtained|3|||
155156390|NCT00886379|560010636|FG002|Overall Study|Final blood draw not obtained|4|||
155156391|NCT00886379|560010637|FG003|Overall Study|Final blood draw not obtained|2|||
155156392|NCT00886379|560010638|FG004|Overall Study|Final blood draw not obtained|2|||
155156393|NCT03219723|560010639|FG000|Overall Study|Case Report Forms Uncollected|6|||
155156394|NCT03219723|560010639|FG000|Overall Study|Protocol Deviation|4|||
155156395|NCT01614886|560010644|FG000|Overall Study|Adverse Event|15|||
155156396|NCT01614886|560010645|FG001|Overall Study|Adverse Event|20|||
155156397|NCT01614886|560010644|FG000|Overall Study|Withdrawal by Subject|4|||
155156398|NCT01614886|560010645|FG001|Overall Study|Withdrawal by Subject|4|||
155156399|NCT01614886|560010644|FG000|Overall Study|Death|1|||
155156400|NCT01614886|560010645|FG001|Overall Study|Death|0|||
155156401|NCT01614886|560010644|FG000|Overall Study|Protocol deviation|0|||
155156402|NCT01614886|560010645|FG001|Overall Study|Protocol deviation|2|||
155156403|NCT01435382|560010646|FG000|Overall Study|Lost to Follow-up|1|||
155156404|NCT01435382|560010647|FG001|Overall Study|Lost to Follow-up|0|||
155156405|NCT01435382|560010648|FG002|Overall Study|Lost to Follow-up|1|||
155156406|NCT01435382|560010649|FG003|Overall Study|Lost to Follow-up|0|||
155156407|NCT01435382|560010646|FG000|Overall Study|Withdrawal by Subject|0|||
155156408|NCT01435382|560010647|FG001|Overall Study|Withdrawal by Subject|2|||
155156409|NCT01435382|560010648|FG002|Overall Study|Withdrawal by Subject|0|||
155156410|NCT01435382|560010649|FG003|Overall Study|Withdrawal by Subject|1|||
155156411|NCT00910650|560010650|FG000|Overall Study|Death|2|||
155156412|NCT04004988|560010652|FG000|Period 1|Physician Decision|2|||
155156413|NCT04004988|560010653|FG001|Period 1|Physician Decision|0|||
155156414|NCT04004988|560010652|FG000|Period 1|Withdrawal by Subject|0|||
155156415|NCT04004988|560010653|FG001|Period 1|Withdrawal by Subject|1|||
155156416|NCT04004988|560010652|FG000|Period 1|Adverse Event|1|||
155156417|NCT04004988|560010653|FG001|Period 1|Adverse Event|2|||
155156418|NCT03873116|560010654|FG000|Part 1|Study drug discontinuation due to rash|0|||
155156419|NCT03873116|560010655|FG001|Part 1|Study drug discontinuation due to rash|0|||
155156420|NCT03873116|560010656|FG002|Part 1|Study drug discontinuation due to rash|0|||
155156421|NCT03873116|560010657|FG003|Part 1|Study drug discontinuation due to rash|0|||
155156422|NCT03873116|560010658|FG004|Part 1|Study drug discontinuation due to rash|0|||
155156423|NCT03873116|560010659|FG005|Part 1|Study drug discontinuation due to rash|1|||
155156424|NCT03873116|560010654|FG000|Part 2|Withdrawal by Subject|0|||
154955368|NCT05093205|559263344|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
154955369|NCT05093205|559263332|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
154955370|NCT05093205|559263333|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
154955371|NCT05093205|559263334|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
154955372|NCT05093205|559263335|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
154955373|NCT05093205|559263336|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
154955374|NCT05093205|559263337|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
154955375|NCT05093205|559263338|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
154955376|NCT05093205|559263339|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
154955377|NCT05093205|559263340|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
154955378|NCT05093205|559263341|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
154955379|NCT05093205|559263342|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
154955380|NCT05093205|559263343|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
154955381|NCT05093205|559263344|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
154955382|NCT05093205|559263332|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
154955383|NCT05093205|559263333|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
154955384|NCT05093205|559263334|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
154955385|NCT05093205|559263335|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
154955386|NCT05093205|559263336|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
154955387|NCT05093205|559263337|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
154955388|NCT05093205|559263338|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
154955389|NCT05093205|559263339|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
154955390|NCT05093205|559263340|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
154955391|NCT05093205|559263341|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
154955392|NCT05093205|559263342|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
154955393|NCT05093205|559263343|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
154955394|NCT05093205|559263344|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
154955395|NCT05093205|559263332|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
154955396|NCT05093205|559263333|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
155293105|NCT00770965|560502755|FG000|Excluded Set|Withdrawal by Subject|1|||
155293106|NCT00770965|560502756|FG001|Excluded Set|Withdrawal by Subject|1|||
155293107|NCT00770965|560502757|FG002|Excluded Set|Withdrawal by Subject|2|||
155293108|NCT00770965|560502758|FG003|Excluded Set|Withdrawal by Subject|3|||
155293109|NCT02613364|560502759|FG000|Overall Study|Other|19|||
155293110|NCT02613364|560502760|FG001|Overall Study|Other|29|||
155293111|NCT02613364|560502761|FG002|Overall Study|Other|17|||
155293112|NCT02613364|560502759|FG000|Overall Study|Too time consuming|21|||
155293113|NCT02613364|560502760|FG001|Overall Study|Too time consuming|26|||
155293114|NCT02613364|560502761|FG002|Overall Study|Too time consuming|26|||
155293115|NCT02613364|560502759|FG000|Overall Study|Withdrawal by Subject|13|||
155293116|NCT02613364|560502760|FG001|Overall Study|Withdrawal by Subject|18|||
155293117|NCT02613364|560502761|FG002|Overall Study|Withdrawal by Subject|17|||
155293118|NCT02613364|560502759|FG000|Overall Study|Medical|12|||
155293119|NCT02613364|560502760|FG001|Overall Study|Medical|13|||
155293120|NCT02613364|560502761|FG002|Overall Study|Medical|9|||
155293121|NCT02613364|560502759|FG000|Overall Study|Disliked Study Procedure|1|||
155293122|NCT02613364|560502760|FG001|Overall Study|Disliked Study Procedure|1|||
155293123|NCT02613364|560502761|FG002|Overall Study|Disliked Study Procedure|4|||
155293124|NCT02613364|560502759|FG000|Overall Study|Disliked Intervention|0|||
155293125|NCT02613364|560502760|FG001|Overall Study|Disliked Intervention|3|||
155293126|NCT02613364|560502761|FG002|Overall Study|Disliked Intervention|3|||
155293127|NCT01235949|560502762|FG000|Primary Phase|Migrated/moved from study area|1|||
155293128|NCT01235949|560502763|FG001|Primary Phase|Migrated/moved from study area|1|||
155293129|NCT01235949|560502764|FG002|Primary Phase|Migrated/moved from study area|0|||
155293130|NCT01235949|560502765|FG003|Primary Phase|Migrated/moved from study area|0|||
155293131|NCT01235949|560502766|FG004|Primary Phase|Migrated/moved from study area|1|||
155293132|NCT01235949|560502767|FG005|Primary Phase|Migrated/moved from study area|2|||
155293133|NCT01235949|560502768|FG006|Primary Phase|Migrated/moved from study area|0|||
155293134|NCT01235949|560502769|FG007|Primary Phase|Migrated/moved from study area|0|||
155293135|NCT01235949|560502770|FG008|Primary Phase|Migrated/moved from study area|0|||
155293136|NCT01235949|560502771|FG009|Primary Phase|Migrated/moved from study area|0|||
155293137|NCT01235949|560502772|FG010|Primary Phase|Migrated/moved from study area|0|||
155293138|NCT01235949|560502773|FG011|Primary Phase|Migrated/moved from study area|0|||
155293139|NCT01235949|560502774|FG012|Primary Phase|Migrated/moved from study area|0|||
155293140|NCT01235949|560502775|FG013|Primary Phase|Migrated/moved from study area|0|||
155293141|NCT01235949|560502776|FG014|Primary Phase|Migrated/moved from study area|0|||
155293142|NCT01235949|560502777|FG015|Primary Phase|Migrated/moved from study area|0|||
155293143|NCT01235949|560502778|FG016|Primary Phase|Migrated/moved from study area|0|||
155293144|NCT01235949|560502779|FG017|Primary Phase|Migrated/moved from study area|0|||
155293145|NCT01235949|560502762|FG000|Primary Phase|Adverse Event|0|||
155293146|NCT01235949|560502763|FG001|Primary Phase|Adverse Event|0|||
155293147|NCT01235949|560502764|FG002|Primary Phase|Adverse Event|0|||
155293148|NCT01235949|560502765|FG003|Primary Phase|Adverse Event|1|||
155293149|NCT01235949|560502766|FG004|Primary Phase|Adverse Event|0|||
155293150|NCT01235949|560502767|FG005|Primary Phase|Adverse Event|0|||
155293151|NCT01235949|560502768|FG006|Primary Phase|Adverse Event|0|||
155293152|NCT01235949|560502769|FG007|Primary Phase|Adverse Event|0|||
155293153|NCT01235949|560502770|FG008|Primary Phase|Adverse Event|0|||
155293154|NCT01235949|560502771|FG009|Primary Phase|Adverse Event|0|||
155293155|NCT01235949|560502772|FG010|Primary Phase|Adverse Event|0|||
155293156|NCT01235949|560502773|FG011|Primary Phase|Adverse Event|0|||
155293157|NCT01235949|560502774|FG012|Primary Phase|Adverse Event|0|||
155293158|NCT01235949|560502775|FG013|Primary Phase|Adverse Event|0|||
155293159|NCT01235949|560502776|FG014|Primary Phase|Adverse Event|0|||
155293160|NCT01235949|560502777|FG015|Primary Phase|Adverse Event|0|||
155293161|NCT01235949|560502778|FG016|Primary Phase|Adverse Event|0|||
155293162|NCT01235949|560502779|FG017|Primary Phase|Adverse Event|0|||
155293163|NCT01235949|560502762|FG000|Primary Phase|Withdrawal by Subject|3|||
154955397|NCT05093205|559263334|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
154955398|NCT05093205|559263335|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
154955399|NCT05093205|559263336|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
154955400|NCT05093205|559263337|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
154955401|NCT05093205|559263338|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
155293164|NCT01235949|560502763|FG001|Primary Phase|Withdrawal by Subject|2|||
155293165|NCT01235949|560502764|FG002|Primary Phase|Withdrawal by Subject|2|||
155293166|NCT01235949|560502765|FG003|Primary Phase|Withdrawal by Subject|0|||
155293167|NCT01235949|560502766|FG004|Primary Phase|Withdrawal by Subject|0|||
155293168|NCT01235949|560502767|FG005|Primary Phase|Withdrawal by Subject|3|||
155293169|NCT01235949|560502768|FG006|Primary Phase|Withdrawal by Subject|0|||
155293170|NCT01235949|560502769|FG007|Primary Phase|Withdrawal by Subject|0|||
154955402|NCT05093205|559263339|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
155293171|NCT01235949|560502770|FG008|Primary Phase|Withdrawal by Subject|0|||
155293172|NCT01235949|560502771|FG009|Primary Phase|Withdrawal by Subject|0|||
155293173|NCT01235949|560502772|FG010|Primary Phase|Withdrawal by Subject|0|||
155293174|NCT01235949|560502773|FG011|Primary Phase|Withdrawal by Subject|0|||
155293175|NCT01235949|560502774|FG012|Primary Phase|Withdrawal by Subject|0|||
155293176|NCT01235949|560502775|FG013|Primary Phase|Withdrawal by Subject|0|||
155293177|NCT01235949|560502776|FG014|Primary Phase|Withdrawal by Subject|0|||
155293178|NCT01235949|560502777|FG015|Primary Phase|Withdrawal by Subject|0|||
155293179|NCT01235949|560502778|FG016|Primary Phase|Withdrawal by Subject|0|||
155293180|NCT01235949|560502779|FG017|Primary Phase|Withdrawal by Subject|0|||
155293181|NCT01235949|560502762|FG000|Primary Phase|Lost to Follow-up|0|||
155293182|NCT01235949|560502763|FG001|Primary Phase|Lost to Follow-up|0|||
155293183|NCT01235949|560502764|FG002|Primary Phase|Lost to Follow-up|1|||
155293184|NCT01235949|560502765|FG003|Primary Phase|Lost to Follow-up|1|||
155293185|NCT01235949|560502766|FG004|Primary Phase|Lost to Follow-up|0|||
155293186|NCT01235949|560502767|FG005|Primary Phase|Lost to Follow-up|2|||
155293187|NCT01235949|560502768|FG006|Primary Phase|Lost to Follow-up|0|||
155293188|NCT01235949|560502769|FG007|Primary Phase|Lost to Follow-up|0|||
155293189|NCT01235949|560502770|FG008|Primary Phase|Lost to Follow-up|0|||
155293190|NCT01235949|560502771|FG009|Primary Phase|Lost to Follow-up|0|||
155293191|NCT01235949|560502772|FG010|Primary Phase|Lost to Follow-up|0|||
155293192|NCT01235949|560502773|FG011|Primary Phase|Lost to Follow-up|0|||
155293193|NCT01235949|560502774|FG012|Primary Phase|Lost to Follow-up|0|||
155293194|NCT01235949|560502775|FG013|Primary Phase|Lost to Follow-up|0|||
155293195|NCT01235949|560502776|FG014|Primary Phase|Lost to Follow-up|0|||
155293196|NCT01235949|560502777|FG015|Primary Phase|Lost to Follow-up|0|||
155293197|NCT01235949|560502778|FG016|Primary Phase|Lost to Follow-up|0|||
155293198|NCT01235949|560502779|FG017|Primary Phase|Lost to Follow-up|0|||
155293199|NCT01235949|560502762|FG000|Booster Phase|Migrated/moved from study area|0|||
155293200|NCT01235949|560502763|FG001|Booster Phase|Migrated/moved from study area|0|||
155293201|NCT01235949|560502764|FG002|Booster Phase|Migrated/moved from study area|0|||
155293202|NCT01235949|560502765|FG003|Booster Phase|Migrated/moved from study area|0|||
155293203|NCT01235949|560502766|FG004|Booster Phase|Migrated/moved from study area|0|||
155293204|NCT01235949|560502767|FG005|Booster Phase|Migrated/moved from study area|0|||
155293205|NCT01235949|560502768|FG006|Booster Phase|Migrated/moved from study area|0|||
155293206|NCT01235949|560502769|FG007|Booster Phase|Migrated/moved from study area|0|||
155293207|NCT01235949|560502770|FG008|Booster Phase|Migrated/moved from study area|0|||
155293208|NCT01235949|560502771|FG009|Booster Phase|Migrated/moved from study area|0|||
155293209|NCT01235949|560502772|FG010|Booster Phase|Migrated/moved from study area|0|||
155293210|NCT01235949|560502773|FG011|Booster Phase|Migrated/moved from study area|1|||
155293211|NCT01235949|560502774|FG012|Booster Phase|Migrated/moved from study area|1|||
155293212|NCT01235949|560502775|FG013|Booster Phase|Migrated/moved from study area|0|||
155293213|NCT01235949|560502776|FG014|Booster Phase|Migrated/moved from study area|0|||
155293214|NCT01235949|560502777|FG015|Booster Phase|Migrated/moved from study area|0|||
155293215|NCT01235949|560502778|FG016|Booster Phase|Migrated/moved from study area|0|||
155293216|NCT01235949|560502779|FG017|Booster Phase|Migrated/moved from study area|1|||
155293217|NCT01235949|560502762|FG000|Booster Phase|Adverse Event|0|||
155293218|NCT01235949|560502763|FG001|Booster Phase|Adverse Event|0|||
155293219|NCT01235949|560502764|FG002|Booster Phase|Adverse Event|0|||
155293220|NCT01235949|560502765|FG003|Booster Phase|Adverse Event|0|||
155293221|NCT01235949|560502766|FG004|Booster Phase|Adverse Event|0|||
155293222|NCT01235949|560502767|FG005|Booster Phase|Adverse Event|0|||
155293223|NCT01235949|560502768|FG006|Booster Phase|Adverse Event|0|||
155293224|NCT01235949|560502769|FG007|Booster Phase|Adverse Event|0|||
155293225|NCT01235949|560502770|FG008|Booster Phase|Adverse Event|0|||
155293226|NCT01235949|560502771|FG009|Booster Phase|Adverse Event|0|||
155293227|NCT01235949|560502772|FG010|Booster Phase|Adverse Event|0|||
155293228|NCT01235949|560502773|FG011|Booster Phase|Adverse Event|0|||
155293229|NCT01235949|560502774|FG012|Booster Phase|Adverse Event|0|||
155293230|NCT01235949|560502775|FG013|Booster Phase|Adverse Event|0|||
155293231|NCT01235949|560502776|FG014|Booster Phase|Adverse Event|0|||
155293232|NCT01235949|560502777|FG015|Booster Phase|Adverse Event|1|||
155293233|NCT01235949|560502778|FG016|Booster Phase|Adverse Event|0|||
155293234|NCT01235949|560502779|FG017|Booster Phase|Adverse Event|0|||
155293235|NCT01235949|560502762|FG000|Booster Phase|Withdrawal by Subject|0|||
155293236|NCT01235949|560502763|FG001|Booster Phase|Withdrawal by Subject|0|||
155293237|NCT01235949|560502764|FG002|Booster Phase|Withdrawal by Subject|0|||
155293238|NCT01235949|560502765|FG003|Booster Phase|Withdrawal by Subject|0|||
155293239|NCT01235949|560502766|FG004|Booster Phase|Withdrawal by Subject|0|||
155293240|NCT01235949|560502767|FG005|Booster Phase|Withdrawal by Subject|0|||
155293241|NCT01235949|560502768|FG006|Booster Phase|Withdrawal by Subject|0|||
155293242|NCT01235949|560502769|FG007|Booster Phase|Withdrawal by Subject|1|||
155293243|NCT01235949|560502770|FG008|Booster Phase|Withdrawal by Subject|1|||
155293244|NCT01235949|560502771|FG009|Booster Phase|Withdrawal by Subject|0|||
155293245|NCT01235949|560502772|FG010|Booster Phase|Withdrawal by Subject|1|||
155293246|NCT01235949|560502773|FG011|Booster Phase|Withdrawal by Subject|1|||
155293247|NCT01235949|560502774|FG012|Booster Phase|Withdrawal by Subject|2|||
155293248|NCT01235949|560502775|FG013|Booster Phase|Withdrawal by Subject|0|||
155293249|NCT01235949|560502776|FG014|Booster Phase|Withdrawal by Subject|2|||
155293250|NCT01235949|560502777|FG015|Booster Phase|Withdrawal by Subject|0|||
155293251|NCT01235949|560502778|FG016|Booster Phase|Withdrawal by Subject|0|||
155293252|NCT01235949|560502779|FG017|Booster Phase|Withdrawal by Subject|0|||
155293253|NCT01235949|560502762|FG000|Booster Phase|Lost to Follow-up|0|||
155293254|NCT01235949|560502763|FG001|Booster Phase|Lost to Follow-up|0|||
155293255|NCT01235949|560502764|FG002|Booster Phase|Lost to Follow-up|0|||
155293256|NCT01235949|560502765|FG003|Booster Phase|Lost to Follow-up|0|||
155293257|NCT01235949|560502766|FG004|Booster Phase|Lost to Follow-up|0|||
155293258|NCT01235949|560502767|FG005|Booster Phase|Lost to Follow-up|0|||
155293259|NCT01235949|560502768|FG006|Booster Phase|Lost to Follow-up|0|||
155293260|NCT01235949|560502769|FG007|Booster Phase|Lost to Follow-up|0|||
155293261|NCT01235949|560502770|FG008|Booster Phase|Lost to Follow-up|1|||
155293262|NCT01235949|560502771|FG009|Booster Phase|Lost to Follow-up|1|||
155293263|NCT01235949|560502772|FG010|Booster Phase|Lost to Follow-up|1|||
155293264|NCT01235949|560502773|FG011|Booster Phase|Lost to Follow-up|1|||
155293265|NCT01235949|560502774|FG012|Booster Phase|Lost to Follow-up|0|||
155293266|NCT01235949|560502775|FG013|Booster Phase|Lost to Follow-up|0|||
154955403|NCT05093205|559263340|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
154955404|NCT05093205|559263341|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
154955405|NCT05093205|559263342|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
154955406|NCT05093205|559263343|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
154955407|NCT05093205|559263344|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
155293267|NCT01235949|560502776|FG014|Booster Phase|Lost to Follow-up|0|||
155293268|NCT01235949|560502777|FG015|Booster Phase|Lost to Follow-up|0|||
155293269|NCT01235949|560502778|FG016|Booster Phase|Lost to Follow-up|0|||
155293270|NCT01235949|560502779|FG017|Booster Phase|Lost to Follow-up|1|||
155293271|NCT00371566|560502780|FG000|Treatment Phase|Withdrawal by Subject|0|||
155293272|NCT00371566|560502781|FG001|Treatment Phase|Withdrawal by Subject|1|||
155293273|NCT00371566|560502780|FG000|Treatment Phase|Adverse Event|0|||
155293274|NCT00371566|560502781|FG001|Treatment Phase|Adverse Event|1|||
155293275|NCT00371566|560502780|FG000|Treatment Phase|Protocol Violation|0|||
155293276|NCT00371566|560502781|FG001|Treatment Phase|Protocol Violation|1|||
155293277|NCT00371566|560502780|FG000|Chemoradiation Phase|Physician Decision|2|||
155293278|NCT00371566|560502781|FG001|Chemoradiation Phase|Physician Decision|0|||
155293279|NCT00371566|560502780|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
155293280|NCT00371566|560502781|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
155293281|NCT00371566|560502780|FG000|Chemoradiation Phase|Non compliant|0|||
155293282|NCT00371566|560502781|FG001|Chemoradiation Phase|Non compliant|1|||
155293283|NCT00371566|560502780|FG000|Chemoradiation Phase|Progressive Disease|1|||
155293284|NCT00371566|560502781|FG001|Chemoradiation Phase|Progressive Disease|1|||
155293285|NCT00371566|560502780|FG000|Chemoradiation Phase|Death|2|||
155293286|NCT00371566|560502781|FG001|Chemoradiation Phase|Death|0|||
155293287|NCT00371566|560502780|FG000|Follow Up Phase|Death|0|||
155293288|NCT00371566|560502781|FG001|Follow Up Phase|Death|5|||
155293289|NCT00371566|560502780|FG000|Follow Up Phase|Disease progression|1|||
155293290|NCT00371566|560502781|FG001|Follow Up Phase|Disease progression|0|||
155293291|NCT00371566|560502780|FG000|Follow Up Phase|Withdrawal by Subject|0|||
155293292|NCT00371566|560502781|FG001|Follow Up Phase|Withdrawal by Subject|1|||
155293293|NCT00371566|560502780|FG000|Follow Up Phase|Physician Decision|1|||
155293294|NCT00371566|560502781|FG001|Follow Up Phase|Physician Decision|1|||
155293295|NCT00371566|560502780|FG000|Follow Up Phase|Lost to Follow-up|1|||
155293296|NCT00371566|560502781|FG001|Follow Up Phase|Lost to Follow-up|0|||
155293297|NCT02534350|560502782|FG000|Overall Study|Randomized But Not Treated|1|||
155293298|NCT02534350|560502783|FG001|Overall Study|Randomized But Not Treated|0|||
155293299|NCT02534350|560502782|FG000|Overall Study|Protocol Violation|1|||
155293300|NCT02534350|560502783|FG001|Overall Study|Protocol Violation|0|||
155293301|NCT02534350|560502782|FG000|Overall Study|Withdrew Consent|2|||
155293302|NCT02534350|560502783|FG001|Overall Study|Withdrew Consent|0|||
155293303|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
155293304|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
155293305|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
155293306|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
155293307|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
155293308|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
155293309|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
155293310|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
155293311|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
155293312|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
155293313|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
155293314|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
155293315|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Death|7|||
155293316|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Death|4|||
155293317|NCT00410124|560502784|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
155293318|NCT00410124|560502785|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
155293319|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
155060316|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
155060317|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
155060318|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
155293320|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
155293321|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
155293322|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
155293323|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
155293324|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
155293325|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
155293326|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
155293327|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
155293328|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
155293329|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
155293330|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
155293331|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
155293332|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
155293333|NCT00410124|560502784|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
155293334|NCT00410124|560502785|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
155293335|NCT00319436|560502786|FG000|Overall Study|Withdrawal by Subject|6|||
155293336|NCT00319436|560502787|FG001|Overall Study|Withdrawal by Subject|7|||
155293337|NCT02341625|560502794|FG000|Overall Study|Disease Progression|2|||
155293338|NCT02341625|560502795|FG001|Overall Study|Disease Progression|2|||
155293339|NCT02341625|560502796|FG002|Overall Study|Disease Progression|3|||
155293340|NCT02341625|560502797|FG003|Overall Study|Disease Progression|6|||
155293341|NCT02341625|560502798|FG004|Overall Study|Disease Progression|7|||
155293342|NCT02341625|560502799|FG005|Overall Study|Disease Progression|7|||
155293343|NCT02341625|560502800|FG006|Overall Study|Disease Progression|28|||
155293344|NCT02341625|560502801|FG007|Overall Study|Disease Progression|5|||
155293345|NCT02341625|560502802|FG008|Overall Study|Disease Progression|4|||
155293346|NCT02341625|560502803|FG009|Overall Study|Disease Progression|19|||
155293347|NCT02341625|560502794|FG000|Overall Study|Study Drug Toxicity|0|||
155293348|NCT02341625|560502795|FG001|Overall Study|Study Drug Toxicity|0|||
155293349|NCT02341625|560502796|FG002|Overall Study|Study Drug Toxicity|0|||
155293350|NCT02341625|560502797|FG003|Overall Study|Study Drug Toxicity|1|||
155293351|NCT02341625|560502798|FG004|Overall Study|Study Drug Toxicity|0|||
155293352|NCT02341625|560502799|FG005|Overall Study|Study Drug Toxicity|3|||
155293353|NCT02341625|560502800|FG006|Overall Study|Study Drug Toxicity|10|||
155293354|NCT02341625|560502801|FG007|Overall Study|Study Drug Toxicity|0|||
155293355|NCT02341625|560502802|FG008|Overall Study|Study Drug Toxicity|0|||
155293356|NCT02341625|560502803|FG009|Overall Study|Study Drug Toxicity|3|||
155293357|NCT02341625|560502794|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293358|NCT02341625|560502795|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293359|NCT02341625|560502796|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293360|NCT02341625|560502797|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293361|NCT02341625|560502798|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293362|NCT02341625|560502799|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293363|NCT02341625|560502800|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155293364|NCT02341625|560502801|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155293365|NCT02341625|560502802|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155293366|NCT02341625|560502803|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155293367|NCT02341625|560502794|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293368|NCT02341625|560502795|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293369|NCT02341625|560502796|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293370|NCT02341625|560502797|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293371|NCT02341625|560502798|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293372|NCT02341625|560502799|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293373|NCT02341625|560502800|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
155293374|NCT02341625|560502801|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
155293375|NCT02341625|560502802|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293376|NCT02341625|560502803|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
155293377|NCT02341625|560502794|FG000|Overall Study|Participant Withdrew Consent|0|||
155293378|NCT02341625|560502795|FG001|Overall Study|Participant Withdrew Consent|0|||
155293379|NCT02341625|560502796|FG002|Overall Study|Participant Withdrew Consent|0|||
155293380|NCT02341625|560502797|FG003|Overall Study|Participant Withdrew Consent|1|||
155293381|NCT02341625|560502798|FG004|Overall Study|Participant Withdrew Consent|0|||
155293382|NCT02341625|560502799|FG005|Overall Study|Participant Withdrew Consent|0|||
155293383|NCT02341625|560502800|FG006|Overall Study|Participant Withdrew Consent|0|||
155293384|NCT02341625|560502801|FG007|Overall Study|Participant Withdrew Consent|0|||
155293385|NCT02341625|560502802|FG008|Overall Study|Participant Withdrew Consent|0|||
155293386|NCT02341625|560502803|FG009|Overall Study|Participant Withdrew Consent|0|||
155293387|NCT02341625|560502794|FG000|Overall Study|Completed Treatment as per Protocol|0|||
155293388|NCT02341625|560502795|FG001|Overall Study|Completed Treatment as per Protocol|0|||
155293389|NCT02341625|560502796|FG002|Overall Study|Completed Treatment as per Protocol|0|||
155293390|NCT02341625|560502797|FG003|Overall Study|Completed Treatment as per Protocol|0|||
155293391|NCT02341625|560502798|FG004|Overall Study|Completed Treatment as per Protocol|0|||
155293392|NCT02341625|560502799|FG005|Overall Study|Completed Treatment as per Protocol|0|||
155293393|NCT02341625|560502800|FG006|Overall Study|Completed Treatment as per Protocol|0|||
155293394|NCT02341625|560502801|FG007|Overall Study|Completed Treatment as per Protocol|0|||
155293395|NCT02341625|560502802|FG008|Overall Study|Completed Treatment as per Protocol|0|||
155293396|NCT02341625|560502803|FG009|Overall Study|Completed Treatment as per Protocol|1|||
155293397|NCT02341625|560502794|FG000|Overall Study|Other Reasons|0|||
155293398|NCT02341625|560502795|FG001|Overall Study|Other Reasons|0|||
155293399|NCT02341625|560502796|FG002|Overall Study|Other Reasons|0|||
155293400|NCT02341625|560502797|FG003|Overall Study|Other Reasons|0|||
155293401|NCT02341625|560502798|FG004|Overall Study|Other Reasons|1|||
155293402|NCT02341625|560502799|FG005|Overall Study|Other Reasons|0|||
155293403|NCT02341625|560502800|FG006|Overall Study|Other Reasons|5|||
155293404|NCT02341625|560502801|FG007|Overall Study|Other Reasons|0|||
155293405|NCT02341625|560502802|FG008|Overall Study|Other Reasons|0|||
155293406|NCT02341625|560502803|FG009|Overall Study|Other Reasons|2|||
155293407|NCT02341625|560502794|FG000|Overall Study|Not Reported|0|||
155293408|NCT02341625|560502795|FG001|Overall Study|Not Reported|0|||
155293409|NCT02341625|560502796|FG002|Overall Study|Not Reported|0|||
155293410|NCT02341625|560502797|FG003|Overall Study|Not Reported|0|||
155293411|NCT02341625|560502798|FG004|Overall Study|Not Reported|0|||
155293412|NCT02341625|560502799|FG005|Overall Study|Not Reported|0|||
155293413|NCT02341625|560502800|FG006|Overall Study|Not Reported|0|||
155293414|NCT02341625|560502801|FG007|Overall Study|Not Reported|0|||
155293415|NCT02341625|560502802|FG008|Overall Study|Not Reported|0|||
155293416|NCT02341625|560502803|FG009|Overall Study|Not Reported|3|||
155293417|NCT01161498|560502804|FG000|Overall Study|Disease Progression|0|||
155293418|NCT01161498|560502805|FG001|Overall Study|Disease Progression|1|||
155293419|NCT03310983|560502809|FG000|Overall Study|Lost to Follow-up|15|||
155293420|NCT03310983|560502810|FG001|Overall Study|Lost to Follow-up|17|||
155293421|NCT03368001|560502811|FG000|Allocation|Lost to Pretest|16|||
155293422|NCT03368001|560502812|FG001|Allocation|Lost to Pretest|25|||
155293423|NCT03368001|560502811|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
155293424|NCT03368001|560502812|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
155293425|NCT03368001|560502811|FG000|Posttest|Lost to Posttest|7|||
155293426|NCT03368001|560502812|FG001|Posttest|Lost to Posttest|11|||
155293427|NCT03368001|560502811|FG000|Posttest|Discontinued Intervention|6|||
155293428|NCT03368001|560502812|FG001|Posttest|Discontinued Intervention|19|||
155293429|NCT03368001|560502811|FG000|Follow-up|Lost to Follow-up|6|||
155293430|NCT03368001|560502812|FG001|Follow-up|Lost to Follow-up|3|||
155293431|NCT01656304|560502813|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
155293432|NCT01093534|560502814|FG000|Overall Study|Adverse Event|2|||
155293433|NCT01093534|560502815|FG001|Overall Study|Adverse Event|5|||
155293434|NCT01093534|560502816|FG002|Overall Study|Adverse Event|2|||
155293435|NCT01093534|560502814|FG000|Overall Study|Lack of Efficacy|2|||
155293436|NCT01093534|560502815|FG001|Overall Study|Lack of Efficacy|1|||
155293437|NCT01093534|560502816|FG002|Overall Study|Lack of Efficacy|1|||
155293438|NCT01093534|560502814|FG000|Overall Study|Withdrawal by Subject|5|||
155293439|NCT01093534|560502815|FG001|Overall Study|Withdrawal by Subject|7|||
155293440|NCT01093534|560502816|FG002|Overall Study|Withdrawal by Subject|2|||
155293441|NCT01093534|560502814|FG000|Overall Study|Other|1|||
155293442|NCT01093534|560502815|FG001|Overall Study|Other|3|||
155293443|NCT01093534|560502816|FG002|Overall Study|Other|4|||
155293444|NCT04436120|560502817|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293445|NCT04436120|560502818|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293446|NCT04436120|560502819|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293447|NCT04436120|560502820|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
155293448|NCT04436120|560502821|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293449|NCT04436120|560502822|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
155293450|NCT04436120|560502823|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
155293451|NCT01769391|560502830|FG000|Overall Study|Death|10|||
155293452|NCT01769391|560502831|FG001|Overall Study|Death|1|||
155293453|NCT01769391|560502830|FG000|Overall Study|Adverse Event|0|||
155293454|NCT01769391|560502831|FG001|Overall Study|Adverse Event|3|||
155293455|NCT01769391|560502830|FG000|Overall Study|Progressive Disease|1|||
155293456|NCT01769391|560502831|FG001|Overall Study|Progressive Disease|2|||
155293457|NCT01769391|560502830|FG000|Overall Study|Withdrawal by Subject|4|||
155293458|NCT01769391|560502831|FG001|Overall Study|Withdrawal by Subject|3|||
155293459|NCT01769391|560502830|FG000|Overall Study|Investigator Decision|2|||
155293460|NCT01769391|560502831|FG001|Overall Study|Investigator Decision|0|||
155293461|NCT00038103|560502835|FG000|Overall Study|Adverse Event|5|||
155293462|NCT00038103|560502836|FG001|Overall Study|Adverse Event|6|||
155293463|NCT00038103|560502835|FG000|Overall Study|Lack of Efficacy|48|||
155293464|NCT00038103|560502836|FG001|Overall Study|Lack of Efficacy|41|||
155293465|NCT00038103|560502835|FG000|Overall Study|Withdrawal by Subject|0|||
155293466|NCT00038103|560502836|FG001|Overall Study|Withdrawal by Subject|3|||
155293467|NCT00038103|560502835|FG000|Overall Study|Lost to Follow-up|0|||
155293468|NCT00038103|560502836|FG001|Overall Study|Lost to Follow-up|3|||
155293469|NCT00038103|560502835|FG000|Overall Study|Protocol Violation|0|||
155293470|NCT00038103|560502836|FG001|Overall Study|Protocol Violation|2|||
155293471|NCT00038103|560502835|FG000|Overall Study|Sponsor Decision|0|||
155293472|NCT00038103|560502836|FG001|Overall Study|Sponsor Decision|1|||
155293473|NCT00038103|560502835|FG000|Overall Study|Randomized/never treated|2|||
155293474|NCT00038103|560502836|FG001|Overall Study|Randomized/never treated|0|||
155293475|NCT01144182|560502837|FG000|Overall Study|Death|5|||
155293476|NCT01144182|560502838|FG001|Overall Study|Death|6|||
155293477|NCT01144182|560502837|FG000|Overall Study|Withdrawal by Subject|3|||
155293478|NCT01144182|560502838|FG001|Overall Study|Withdrawal by Subject|6|||
155293479|NCT01144182|560502837|FG000|Overall Study|Lost to Follow-up|9|||
154955408|NCT05093205|559263332|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
154955409|NCT05093205|559263333|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
155293480|NCT01144182|560502838|FG001|Overall Study|Lost to Follow-up|9|||
155293481|NCT03254394|560502843|FG000|Overall Study|Withdrawal by Subject|0|||
155293482|NCT03254394|560502844|FG001|Overall Study|Withdrawal by Subject|2|||
155293483|NCT03545984|560502845|FG000|Overall Study|CSF cases not present during rotation|11|||
155293484|NCT03545984|560502846|FG001|Overall Study|CSF cases not present during rotation|9|||
155293485|NCT00387465|560502847|FG000|Overall Study|Withdrawal by Subject|0|||
155293486|NCT00387465|560502848|FG001|Overall Study|Withdrawal by Subject|1|||
155293487|NCT00387465|560502849|FG002|Overall Study|Withdrawal by Subject|0|||
155293488|NCT01768676|560502851|FG000|Overall Study|Adverse Event|3|||
155293489|NCT01768676|560502852|FG001|Overall Study|Adverse Event|3|||
155293490|NCT01768676|560502851|FG000|Overall Study|Lost to Follow-up|13|||
155293491|NCT01768676|560502852|FG001|Overall Study|Lost to Follow-up|16|||
155293492|NCT01768676|560502851|FG000|Overall Study|Protocol Violation|1|||
155293493|NCT01768676|560502852|FG001|Overall Study|Protocol Violation|1|||
155293494|NCT01768676|560502851|FG000|Overall Study|Physician Decision|4|||
155293495|NCT01768676|560502852|FG001|Overall Study|Physician Decision|1|||
155293496|NCT01768676|560502851|FG000|Overall Study|Withdrawal by Subject|3|||
155293497|NCT01768676|560502852|FG001|Overall Study|Withdrawal by Subject|10|||
155293498|NCT01867580|560502858|FG000|Overall Study|Withdrawal by Subject|2|||
155293499|NCT01867580|560502859|FG001|Overall Study|Withdrawal by Subject|3|||
155293500|NCT01867580|560502858|FG000|Overall Study|Physician Decision|17|||
154955410|NCT05093205|559263334|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
154955411|NCT05093205|559263335|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
154955412|NCT05093205|559263336|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
154955413|NCT05093205|559263337|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
154955414|NCT05093205|559263338|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
155156425|NCT03873116|560010655|FG001|Part 2|Withdrawal by Subject|0|||
155293501|NCT01867580|560502859|FG001|Overall Study|Physician Decision|12|||
155293502|NCT01867580|560502858|FG000|Overall Study|Lost to Follow-up|3|||
155293503|NCT01867580|560502859|FG001|Overall Study|Lost to Follow-up|5|||
155293504|NCT01867580|560502858|FG000|Overall Study|Sponsor terminated study|1|||
155293505|NCT01867580|560502859|FG001|Overall Study|Sponsor terminated study|0|||
155293506|NCT01867580|560502858|FG000|Overall Study|Missed follow-up assessment|2|||
155293507|NCT01867580|560502859|FG001|Overall Study|Missed follow-up assessment|1|||
155293508|NCT01867580|560502858|FG000|Overall Study|Interruption to therapy|3|||
155293509|NCT01867580|560502859|FG001|Overall Study|Interruption to therapy|0|||
155293510|NCT01867580|560502858|FG000|Overall Study|Osteomyelitis|0|||
155293511|NCT01867580|560502859|FG001|Overall Study|Osteomyelitis|1|||
155293512|NCT01867580|560502858|FG000|Overall Study|Continuation of therapy|0|||
155293513|NCT01867580|560502859|FG001|Overall Study|Continuation of therapy|1|||
155293514|NCT01867580|560502858|FG000|Overall Study|Wound recurrence|0|||
155293515|NCT01867580|560502859|FG001|Overall Study|Wound recurrence|1|||
155293516|NCT01304147|560502860|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
155293517|NCT01304147|560502861|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
155293518|NCT01244828|560502862|FG000|Overall Study|Adverse Event|37|||
155293519|NCT01244828|560502862|FG000|Overall Study|Withdrawal by Subject|31|||
155293520|NCT01244828|560502862|FG000|Overall Study|Lack of Efficacy|7|||
155293521|NCT01244828|560502862|FG000|Overall Study|Lost to Follow-up|2|||
155293522|NCT01244828|560502862|FG000|Overall Study|Other reason (not specified)|1|||
155293523|NCT05233085|560502864|FG000|Overall Study|Adverse Event|1|||
155293524|NCT05233085|560502865|FG001|Overall Study|Adverse Event|0|||
155293525|NCT05233085|560502866|FG002|Overall Study|Adverse Event|0|||
155293526|NCT05233085|560502867|FG003|Overall Study|Adverse Event|0|||
155293527|NCT02812966|560502870|FG000|Overall Study|Death|1|||
155293528|NCT02812966|560502871|FG001|Overall Study|Death|0|||
155293529|NCT01066923|560502872|FG000|Overall Study|Withdrawal by Subject|3|||
155293530|NCT01066923|560502873|FG001|Overall Study|Withdrawal by Subject|3|||
155293531|NCT01066923|560502874|FG002|Overall Study|Withdrawal by Subject|8|||
154955415|NCT05093205|559263339|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
155293532|NCT01066923|560502875|FG003|Overall Study|Withdrawal by Subject|8|||
155293533|NCT02577523|560504898|FG000|Overall Study|Adverse Event|1|||
155293534|NCT02577523|560504899|FG001|Overall Study|Adverse Event|1|||
155293535|NCT02577523|560504898|FG000|Overall Study|Lack of Efficacy|1|||
155293536|NCT02577523|560504899|FG001|Overall Study|Lack of Efficacy|1|||
155293537|NCT02577523|560504898|FG000|Overall Study|Withdrawal by Subject|1|||
155293538|NCT02577523|560504899|FG001|Overall Study|Withdrawal by Subject|0|||
155293539|NCT02525796|560504900|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
155293540|NCT02525796|560504901|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
155060319|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
155060320|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
155060321|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155060322|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155060323|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155060324|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
155060325|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
155060326|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
155060327|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
155060328|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
155060329|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
155060330|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
155060331|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155060332|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155060333|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155060334|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
155060335|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
155060336|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155060337|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155060338|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
155060339|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155060340|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
155060341|NCT02717195|559655581|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
155060342|NCT02717195|559655582|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
155060343|NCT02717195|559655583|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
155060344|NCT02717195|559655584|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
155060345|NCT02717195|559655585|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
155060346|NCT02577029|559655588|FG000|Overall Study|Adverse Event|1|||
155060347|NCT02577029|559655589|FG001|Overall Study|Adverse Event|0|||
155060348|NCT02577029|559655590|FG002|Overall Study|Adverse Event|2|||
155060349|NCT02577029|559655591|FG003|Overall Study|Adverse Event|0|||
155060350|NCT02577029|559655592|FG004|Overall Study|Adverse Event|1|||
155060351|NCT02577029|559655593|FG005|Overall Study|Adverse Event|0|||
155060352|NCT02577029|559655594|FG006|Overall Study|Adverse Event|0|||
155060353|NCT02577029|559655595|FG007|Overall Study|Adverse Event|0|||
155060354|NCT02577029|559655588|FG000|Overall Study|Withdrawal by Subject|0|||
155060355|NCT02577029|559655589|FG001|Overall Study|Withdrawal by Subject|0|||
155293541|NCT02525796|560504902|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
155293542|NCT02525796|560504900|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
155293543|NCT02525796|560504901|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
155293544|NCT02525796|560504902|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
155293545|NCT02525796|560504900|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
155293546|NCT02525796|560504901|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
155293547|NCT02525796|560504902|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
155293548|NCT02525796|560504900|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
155293549|NCT02525796|560504901|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
155293550|NCT02525796|560504902|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
155293551|NCT02525796|560504900|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
155293552|NCT02525796|560504901|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
155293553|NCT02525796|560504902|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
154955416|NCT05093205|559263340|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
154955417|NCT05093205|559263341|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
154955418|NCT05093205|559263342|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
154955419|NCT05093205|559263343|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
155293554|NCT00955825|560504905|FG000|Overall Study|Adverse Event|15|||
155060356|NCT02577029|559655590|FG002|Overall Study|Withdrawal by Subject|0|||
155060357|NCT02577029|559655591|FG003|Overall Study|Withdrawal by Subject|0|||
155060358|NCT02577029|559655592|FG004|Overall Study|Withdrawal by Subject|0|||
155060359|NCT02577029|559655593|FG005|Overall Study|Withdrawal by Subject|1|||
155060360|NCT02577029|559655594|FG006|Overall Study|Withdrawal by Subject|0|||
155060361|NCT02577029|559655595|FG007|Overall Study|Withdrawal by Subject|0|||
155060362|NCT02577029|559655588|FG000|Overall Study|Sponsor Termination of the Study|9|||
155060363|NCT02577029|559655589|FG001|Overall Study|Sponsor Termination of the Study|2|||
155060364|NCT02577029|559655590|FG002|Overall Study|Sponsor Termination of the Study|5|||
155060365|NCT02577029|559655591|FG003|Overall Study|Sponsor Termination of the Study|12|||
155060366|NCT02577029|559655592|FG004|Overall Study|Sponsor Termination of the Study|10|||
155060367|NCT02577029|559655593|FG005|Overall Study|Sponsor Termination of the Study|12|||
155060368|NCT02577029|559655594|FG006|Overall Study|Sponsor Termination of the Study|12|||
155060369|NCT02577029|559655595|FG007|Overall Study|Sponsor Termination of the Study|12|||
155060370|NCT02078817|559655596|FG000|Overall Study|Withdrawal by Subject|1|||
155293555|NCT00955825|560504906|FG001|Overall Study|Adverse Event|2|||
155293556|NCT00955825|560504905|FG000|Overall Study|Withdrawal by Subject|4|||
155293557|NCT00955825|560504906|FG001|Overall Study|Withdrawal by Subject|6|||
155060371|NCT00855218|559655597|FG000|Overall Study|Adverse Event|43|||
155060372|NCT00855218|559655598|FG001|Overall Study|Adverse Event|27|||
155293558|NCT00955825|560504905|FG000|Overall Study|Any other reason not above-mentioned|7|||
155060373|NCT00855218|559655597|FG000|Overall Study|Withdrawal by Subject|10|||
155293559|NCT00955825|560504906|FG001|Overall Study|Any other reason not above-mentioned|9|||
155293560|NCT01198275|560504907|FG000|Overall Study|Adverse Event|2|||
155293561|NCT01198275|560504908|FG001|Overall Study|Adverse Event|3|||
155293562|NCT01198275|560504907|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
155293563|NCT01198275|560504908|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
155293564|NCT00391846|560504909|FG000|Overall Study|Adverse Event|4|||
155293565|NCT00391846|560504910|FG001|Overall Study|Adverse Event|1|||
155293566|NCT00391846|560504909|FG000|Overall Study|Did not meet the required elig. crit|2|||
155293567|NCT00391846|560504910|FG001|Overall Study|Did not meet the required elig. crit|2|||
155060374|NCT00855218|559655598|FG001|Overall Study|Withdrawal by Subject|6|||
155060375|NCT00855218|559655597|FG000|Overall Study|Physician Decision|18|||
155060376|NCT00855218|559655598|FG001|Overall Study|Physician Decision|11|||
155060377|NCT00855218|559655597|FG000|Overall Study|Lost to Follow-up|0|||
155060378|NCT00855218|559655598|FG001|Overall Study|Lost to Follow-up|1|||
155293568|NCT00391846|560504909|FG000|Overall Study|Withdrawal by Subject|2|||
155293569|NCT00391846|560504910|FG001|Overall Study|Withdrawal by Subject|3|||
155293570|NCT00391846|560504909|FG000|Overall Study|Developed study specific DC criteria|0|||
155293571|NCT00391846|560504910|FG001|Overall Study|Developed study specific DC criteria|1|||
155293572|NCT02385669|560504913|FG000|Overall Study|Adverse Event|2|||
155293573|NCT02477670|560504914|FG000|Stage 1|Adverse Event|2|||
155293574|NCT02477670|560504915|FG001|Stage 1|Adverse Event|7|||
155293575|NCT02477670|560504916|FG002|Stage 1|Adverse Event|0|||
155293576|NCT02477670|560504917|FG003|Stage 1|Adverse Event|0|||
155293577|NCT02477670|560504918|FG004|Stage 1|Adverse Event|0|||
155293578|NCT02477670|560504919|FG005|Stage 1|Adverse Event|0|||
155293579|NCT02477670|560504920|FG006|Stage 1|Adverse Event|0|||
155293580|NCT02477670|560504914|FG000|Stage 1|Lost to Follow-up|0|||
155293581|NCT02477670|560504915|FG001|Stage 1|Lost to Follow-up|2|||
155293582|NCT02477670|560504916|FG002|Stage 1|Lost to Follow-up|0|||
155293583|NCT02477670|560504917|FG003|Stage 1|Lost to Follow-up|0|||
155293584|NCT02477670|560504918|FG004|Stage 1|Lost to Follow-up|0|||
155293585|NCT02477670|560504919|FG005|Stage 1|Lost to Follow-up|0|||
155293586|NCT02477670|560504920|FG006|Stage 1|Lost to Follow-up|0|||
155293587|NCT02477670|560504914|FG000|Stage 1|Withdrawal by Subject|1|||
155293588|NCT02477670|560504915|FG001|Stage 1|Withdrawal by Subject|2|||
155293589|NCT02477670|560504916|FG002|Stage 1|Withdrawal by Subject|0|||
155293590|NCT02477670|560504917|FG003|Stage 1|Withdrawal by Subject|0|||
155293591|NCT02477670|560504918|FG004|Stage 1|Withdrawal by Subject|0|||
155293592|NCT02477670|560504919|FG005|Stage 1|Withdrawal by Subject|0|||
155293593|NCT02477670|560504920|FG006|Stage 1|Withdrawal by Subject|0|||
155293594|NCT02477670|560504914|FG000|Stage 1|Non-compliance with Study Drug|1|||
155293595|NCT02477670|560504915|FG001|Stage 1|Non-compliance with Study Drug|2|||
154955420|NCT05093205|559263344|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
154955421|NCT05093205|559263332|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955422|NCT05093205|559263333|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
155293596|NCT02477670|560504916|FG002|Stage 1|Non-compliance with Study Drug|0|||
155293597|NCT02477670|560504917|FG003|Stage 1|Non-compliance with Study Drug|0|||
155293598|NCT02477670|560504918|FG004|Stage 1|Non-compliance with Study Drug|0|||
155293599|NCT02477670|560504919|FG005|Stage 1|Non-compliance with Study Drug|0|||
155293600|NCT02477670|560504920|FG006|Stage 1|Non-compliance with Study Drug|0|||
155060379|NCT00855218|559655597|FG000|Overall Study|Protocol Violation|5|||
155293601|NCT02477670|560504914|FG000|Stage 2|Adverse Event|0|||
155293602|NCT02477670|560504915|FG001|Stage 2|Adverse Event|0|||
155060380|NCT00855218|559655598|FG001|Overall Study|Protocol Violation|9|||
155060381|NCT00855218|559655597|FG000|Overall Study|non-compliant with study drug|3|||
155060382|NCT00855218|559655598|FG001|Overall Study|non-compliant with study drug|1|||
155060383|NCT00855218|559655597|FG000|Overall Study|patient convenience|2|||
155060384|NCT00855218|559655598|FG001|Overall Study|patient convenience|0|||
155060385|NCT00855218|559655597|FG000|Overall Study|technical problems|2|||
155293603|NCT02477670|560504916|FG002|Stage 2|Adverse Event|1|||
155293604|NCT02477670|560504917|FG003|Stage 2|Adverse Event|0|||
155293605|NCT02477670|560504918|FG004|Stage 2|Adverse Event|0|||
155293606|NCT02477670|560504919|FG005|Stage 2|Adverse Event|0|||
155293607|NCT02477670|560504920|FG006|Stage 2|Adverse Event|0|||
155293608|NCT02477670|560504914|FG000|Stage 2|Antipsychotic Medication Changed|0|||
155293609|NCT02477670|560504915|FG001|Stage 2|Antipsychotic Medication Changed|0|||
155293610|NCT02477670|560504916|FG002|Stage 2|Antipsychotic Medication Changed|1|||
155293611|NCT02477670|560504917|FG003|Stage 2|Antipsychotic Medication Changed|0|||
155293612|NCT02477670|560504918|FG004|Stage 2|Antipsychotic Medication Changed|0|||
155293613|NCT02477670|560504919|FG005|Stage 2|Antipsychotic Medication Changed|0|||
155293614|NCT02477670|560504920|FG006|Stage 2|Antipsychotic Medication Changed|0|||
155293615|NCT02477670|560504914|FG000|Stage 2|Withdrawal by Subject|0|||
155293616|NCT02477670|560504915|FG001|Stage 2|Withdrawal by Subject|0|||
155293617|NCT02477670|560504916|FG002|Stage 2|Withdrawal by Subject|0|||
155293618|NCT02477670|560504917|FG003|Stage 2|Withdrawal by Subject|1|||
155293619|NCT02477670|560504918|FG004|Stage 2|Withdrawal by Subject|0|||
155293620|NCT02477670|560504919|FG005|Stage 2|Withdrawal by Subject|0|||
155293621|NCT02477670|560504920|FG006|Stage 2|Withdrawal by Subject|0|||
155293622|NCT00970307|560504921|FG000|Overall Study|Serious Adverse Event|1|||
155293623|NCT00970307|560504922|FG001|Overall Study|Serious Adverse Event|0|||
155293624|NCT00970307|560504923|FG002|Overall Study|Serious Adverse Event|0|||
155293625|NCT00970307|560504921|FG000|Overall Study|Withdrawal by Subject|2|||
155293626|NCT00970307|560504922|FG001|Overall Study|Withdrawal by Subject|3|||
155293627|NCT00970307|560504923|FG002|Overall Study|Withdrawal by Subject|2|||
155293628|NCT02937831|560504924|FG000|Overall Study|Protocol Violation|4|||
155293629|NCT01370694|560504940|FG000|Overall Study|Switched to rituximab|4|||
155293630|NCT01370694|560504940|FG000|Overall Study|Progressive disease|2|||
155293631|NCT01119950|560504941|FG000|Overall Study|Adverse Event|25|||
155293632|NCT01119950|560504941|FG000|Overall Study|Withdrawal by Subject|9|||
155293633|NCT01119950|560504941|FG000|Overall Study|Protocol Violation|5|||
155293634|NCT01119950|560504941|FG000|Overall Study|Lost to Follow-up|4|||
155293635|NCT01119950|560504941|FG000|Overall Study|Administrative|2|||
155293636|NCT01119950|560504941|FG000|Overall Study|Abnormal lab value|1|||
155293637|NCT01119950|560504941|FG000|Overall Study|Death|1|||
155293638|NCT01988233|560504942|FG000|Overall Study|Lost to Follow-up|64|||
155293639|NCT01988233|560504943|FG001|Overall Study|Lost to Follow-up|51|||
155293640|NCT03621761|560504945|FG000|Overall Study|Lost to Follow-up|1|||
155293641|NCT03621761|560504946|FG001|Overall Study|Lost to Follow-up|1|||
155293642|NCT03621761|560504947|FG002|Overall Study|Lost to Follow-up|2|||
155293643|NCT03621761|560504945|FG000|Overall Study|Withdrawal by Subject|2|||
155293644|NCT03621761|560504946|FG001|Overall Study|Withdrawal by Subject|1|||
155293645|NCT03621761|560504947|FG002|Overall Study|Withdrawal by Subject|1|||
155293646|NCT03621761|560504945|FG000|Overall Study|Became Ineligible|0|||
155293647|NCT03621761|560504946|FG001|Overall Study|Became Ineligible|2|||
155293648|NCT03621761|560504947|FG002|Overall Study|Became Ineligible|0|||
155293649|NCT01191788|560504952|FG000|Overall Study|Lost to Follow-up|21|||
155293650|NCT01191788|560504953|FG001|Overall Study|Lost to Follow-up|22|||
155293651|NCT01050569|560504955|FG000|Overall Study|Lost to Follow-up|20|||
155293652|NCT01050569|560504956|FG001|Overall Study|Lost to Follow-up|14|||
155293653|NCT01050569|560504957|FG002|Overall Study|Lost to Follow-up|16|||
155293654|NCT01050569|560504955|FG000|Overall Study|Withdrawal by Subject|9|||
155293655|NCT01050569|560504956|FG001|Overall Study|Withdrawal by Subject|3|||
155293656|NCT01050569|560504957|FG002|Overall Study|Withdrawal by Subject|11|||
155293657|NCT01050569|560504955|FG000|Overall Study|Lack of Efficacy|5|||
155293658|NCT01050569|560504956|FG001|Overall Study|Lack of Efficacy|4|||
155293659|NCT01050569|560504957|FG002|Overall Study|Lack of Efficacy|3|||
155293660|NCT01050569|560504955|FG000|Overall Study|Adverse Event|1|||
155293661|NCT01050569|560504956|FG001|Overall Study|Adverse Event|0|||
155293662|NCT01050569|560504957|FG002|Overall Study|Adverse Event|0|||
155293663|NCT01050569|560504955|FG000|Overall Study|Physician Decision|3|||
155293664|NCT01050569|560504956|FG001|Overall Study|Physician Decision|3|||
155293665|NCT01050569|560504957|FG002|Overall Study|Physician Decision|3|||
155293666|NCT03939819|560504959|FG000|Overall Study|Death|2|||
155293667|NCT03939819|560504960|FG001|Overall Study|Death|0|||
155293668|NCT02148133|560504964|FG000|Overall Study|Investigator discretion|1|||
155293669|NCT02148133|560504964|FG000|Overall Study|Lack of Efficacy|1|||
155293670|NCT02148133|560504964|FG000|Overall Study|Protocol deviation|1|||
155293671|NCT02148133|560504964|FG000|Overall Study|Protocol-defined stopping criteria|2|||
155293672|NCT03808883|560504965|FG000|Overall Study|Withdrawal by Subject|2|||
155293673|NCT03808883|560504966|FG001|Overall Study|Withdrawal by Subject|0|||
155293674|NCT03808883|560504965|FG000|Overall Study|Did not complete pre test or post test survey|4|||
155293675|NCT03808883|560504966|FG001|Overall Study|Did not complete pre test or post test survey|3|||
155293676|NCT01909336|560504967|FG000|Overall Study|Lost to Follow-up|4|||
155293677|NCT01909336|560504968|FG001|Overall Study|Lost to Follow-up|2|||
155293678|NCT01909336|560504969|FG002|Overall Study|Lost to Follow-up|2|||
155293679|NCT01909336|560504967|FG000|Overall Study|Physician Decision|0|||
155293680|NCT01909336|560504968|FG001|Overall Study|Physician Decision|1|||
155293681|NCT01909336|560504969|FG002|Overall Study|Physician Decision|1|||
155293682|NCT00436644|560504970|FG000|Overall Study|Adverse Event|2|||
155060386|NCT00855218|559655598|FG001|Overall Study|technical problems|1|||
155293683|NCT00436644|560504970|FG000|Overall Study|Death|1|||
155293684|NCT04364269|560504975|FG000|Overall Study|Adverse Event|1|||
155293685|NCT04364269|560504976|FG001|Overall Study|Adverse Event|0|||
155293686|NCT04364269|560504977|FG002|Overall Study|Adverse Event|0|||
155293687|NCT04364269|560504975|FG000|Overall Study|Withdrawal by Subject|0|||
155293688|NCT04364269|560504976|FG001|Overall Study|Withdrawal by Subject|1|||
155293689|NCT04364269|560504977|FG002|Overall Study|Withdrawal by Subject|0|||
155293690|NCT04173572|560504978|FG000|Overall Study|Withdrawal by Subject|1|||
155293691|NCT04173572|560504979|FG001|Overall Study|Withdrawal by Subject|5|||
155293692|NCT04173572|560504978|FG000|Overall Study|Lost to Follow-up|3|||
155293693|NCT04173572|560504979|FG001|Overall Study|Lost to Follow-up|1|||
155293694|NCT02026258|560504982|FG000|Randomized|Did not start treatment|2|||
155293695|NCT02026258|560504983|FG001|Randomized|Did not start treatment|1|||
155293696|NCT02026258|560504982|FG000|Randomized|Change in treatment plan|1|||
155293697|NCT02026258|560504983|FG001|Randomized|Change in treatment plan|0|||
155293698|NCT02026258|560504982|FG000|Randomized|Presence of periodontal disease|1|||
155293699|NCT02026258|560504983|FG001|Randomized|Presence of periodontal disease|1|||
155293700|NCT02026258|560504982|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
155293701|NCT02026258|560504983|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
155293702|NCT02026258|560504982|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
155293703|NCT02026258|560504983|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
155293704|NCT04246762|560504984|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
155293705|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
155293706|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
155293707|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
155293708|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
155293709|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
155293710|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
155293711|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
155293712|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
155060387|NCT00855218|559655597|FG000|Overall Study|Still treated with study medication|0|||
154955423|NCT05093205|559263334|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955424|NCT05093205|559263335|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955425|NCT05093205|559263336|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955426|NCT05093205|559263337|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955427|NCT05093205|559263338|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955428|NCT05093205|559263339|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955429|NCT05093205|559263340|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955430|NCT05093205|559263341|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
154955431|NCT05093205|559263342|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955432|NCT05093205|559263343|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955433|NCT05093205|559263344|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
154955434|NCT05093205|559263332|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
154955435|NCT05093205|559263333|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
154955436|NCT05093205|559263334|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
154955437|NCT05093205|559263335|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
154955438|NCT05093205|559263336|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
154955439|NCT05093205|559263337|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
154955440|NCT05093205|559263338|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
154955441|NCT05093205|559263339|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
154955442|NCT05093205|559263340|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
155060388|NCT00855218|559655598|FG001|Overall Study|Still treated with study medication|1|||
155293713|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
155293714|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
155293715|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
155293716|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
155293717|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
155293718|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
155293719|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
155293720|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
155293721|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
155293722|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
154955443|NCT05093205|559263341|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
154955444|NCT05093205|559263342|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
155060389|NCT00855218|559655597|FG000|Overall Study|Untreatable disease progression|54|||
155060390|NCT00855218|559655598|FG001|Overall Study|Untreatable disease progression|67|||
155060391|NCT00855218|559655597|FG000|Overall Study|Second malignancy|0|||
155060392|NCT00855218|559655598|FG001|Overall Study|Second malignancy|1|||
155060393|NCT00855218|559655597|FG000|Overall Study|Progression measurement proven|7|||
155060394|NCT00855218|559655598|FG001|Overall Study|Progression measurement proven|15|||
155060395|NCT00855218|559655597|FG000|Overall Study|Clinical endpoint reached|10|||
155060396|NCT00855218|559655598|FG001|Overall Study|Clinical endpoint reached|13|||
155060397|NCT00769561|559655600|FG000|Overall Study|Withdrawal by Subject|2|||
155060398|NCT00769561|559655601|FG001|Overall Study|Withdrawal by Subject|2|||
155060399|NCT00769561|559655600|FG000|Overall Study|Lost to Follow-up|1|||
155060400|NCT00769561|559655601|FG001|Overall Study|Lost to Follow-up|3|||
155060401|NCT03191552|559655607|FG000|Overall Study|Lost to Follow-up|1|||
155060402|NCT03191552|559655608|FG001|Overall Study|Lost to Follow-up|0|||
155060403|NCT03191552|559655609|FG002|Overall Study|Lost to Follow-up|0|||
155293723|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293724|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293725|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293726|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
155293727|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
155293728|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
155293729|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
155293730|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
155293731|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
155293732|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
155293733|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
155293734|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
155293735|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
155293736|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
155293737|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
155293738|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293739|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
155293740|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
155293741|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
155293742|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293743|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293744|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293745|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293746|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155156426|NCT03873116|560010656|FG002|Part 2|Withdrawal by Subject|1|||
155156427|NCT03873116|560010657|FG003|Part 2|Withdrawal by Subject|0|||
155156428|NCT03873116|560010658|FG004|Part 2|Withdrawal by Subject|0|||
155156429|NCT03873116|560010659|FG005|Part 2|Withdrawal by Subject|0|||
155156430|NCT03873116|560010654|FG000|Part 2|Lab abnormality or AE|0|||
155156431|NCT03873116|560010655|FG001|Part 2|Lab abnormality or AE|0|||
155156432|NCT03873116|560010656|FG002|Part 2|Lab abnormality or AE|0|||
155156433|NCT03873116|560010657|FG003|Part 2|Lab abnormality or AE|0|||
155156434|NCT03873116|560010658|FG004|Part 2|Lab abnormality or AE|1|||
155156435|NCT03873116|560010659|FG005|Part 2|Lab abnormality or AE|0|||
155156436|NCT03873116|560010654|FG000|Part 3|Withdrawal by Subject|0|||
155156437|NCT03873116|560010655|FG001|Part 3|Withdrawal by Subject|0|||
155156438|NCT03873116|560010656|FG002|Part 3|Withdrawal by Subject|0|||
155156439|NCT03873116|560010657|FG003|Part 3|Withdrawal by Subject|0|||
155156440|NCT03873116|560010658|FG004|Part 3|Withdrawal by Subject|1|||
155156441|NCT03873116|560010659|FG005|Part 3|Withdrawal by Subject|0|||
155293747|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293748|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
155293749|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293750|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293751|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293752|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293753|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
155293754|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293755|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293756|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293757|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293758|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293759|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
155293760|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
155293761|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293762|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293763|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293764|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293765|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293766|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293767|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293768|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293769|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293770|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
155293771|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
155293772|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
155293773|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
155293774|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
155293775|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
155156442|NCT04682366|560010660|FG000|Overall Study|Lost to Follow-up|1|||
155156443|NCT04682366|560010661|FG001|Overall Study|Lost to Follow-up|1|||
155156444|NCT02461758|560010662|FG000|Overall Study|Lost to Follow-up|0|||
155156445|NCT02461758|560010663|FG001|Overall Study|Lost to Follow-up|1|||
155156446|NCT02461758|560010664|FG002|Overall Study|Lost to Follow-up|1|||
155156447|NCT02461758|560010665|FG003|Overall Study|Lost to Follow-up|0|||
155156448|NCT00929695|560010666|FG000|Overall Study|Death|2|||
155156449|NCT00929695|560010667|FG001|Overall Study|Death|1|||
155156450|NCT00929695|560010666|FG000|Overall Study|Withdrawal by Subject|0|||
155156451|NCT00929695|560010667|FG001|Overall Study|Withdrawal by Subject|2|||
155156452|NCT00929695|560010666|FG000|Overall Study|discharge home|4|||
155156453|NCT00929695|560010667|FG001|Overall Study|discharge home|3|||
155156454|NCT00929695|560010666|FG000|Overall Study|incorrect stratification|2|||
155156455|NCT00929695|560010667|FG001|Overall Study|incorrect stratification|0|||
155156456|NCT00528112|560010674|FG000|Treatment up to 3 Years|Adverse Event|313|||
155156457|NCT00528112|560010675|FG001|Treatment up to 3 Years|Adverse Event|278|||
155156458|NCT00528112|560010674|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
155156459|NCT00528112|560010675|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
155156460|NCT00528112|560010674|FG000|Treatment up to 3 Years|Protocol Violation|16|||
155156461|NCT00528112|560010675|FG001|Treatment up to 3 Years|Protocol Violation|16|||
155156462|NCT00528112|560010674|FG000|Treatment up to 3 Years|Death|0|||
155156463|NCT00528112|560010675|FG001|Treatment up to 3 Years|Death|1|||
155156464|NCT00528112|560010674|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
155156465|NCT00528112|560010675|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
155156466|NCT00528112|560010674|FG000|Treatment up to 3 Years|Pregnancy|9|||
155156467|NCT00528112|560010675|FG001|Treatment up to 3 Years|Pregnancy|10|||
155156468|NCT00528112|560010674|FG000|Treatment up to 3 Years|Other reasons|186|||
155156469|NCT00528112|560010675|FG001|Treatment up to 3 Years|Other reasons|186|||
155156470|NCT00528112|560010674|FG000|Extension Phase|Withdrawal by Subject|0|||
155156471|NCT00528112|560010675|FG001|Extension Phase|Withdrawal by Subject|3|||
155156472|NCT00528112|560010674|FG000|Extension Phase|Other reasons|0|||
155156473|NCT00528112|560010675|FG001|Extension Phase|Other reasons|100|||
155156474|NCT00528112|560010674|FG000|Extension Phase|Pregnancy|0|||
155156475|NCT00528112|560010675|FG001|Extension Phase|Pregnancy|3|||
155156476|NCT00528112|560010674|FG000|Extension Phase|Lost to Follow-up|0|||
155156477|NCT00528112|560010675|FG001|Extension Phase|Lost to Follow-up|12|||
155156478|NCT00528112|560010674|FG000|Extension Phase|Death|0|||
155156479|NCT00528112|560010675|FG001|Extension Phase|Death|1|||
155156480|NCT00528112|560010674|FG000|Extension Phase|Adverse Event|0|||
155156481|NCT00528112|560010675|FG001|Extension Phase|Adverse Event|36|||
155156482|NCT00528112|560010674|FG000|Extension Phase|Protocol Violation|0|||
155156483|NCT00528112|560010675|FG001|Extension Phase|Protocol Violation|2|||
155156484|NCT02559622|560010676|FG000|Overall Study|Progressive disease|0|||
155156485|NCT02559622|560010677|FG001|Overall Study|Progressive disease|1|||
155156486|NCT02559622|560010678|FG002|Overall Study|Progressive disease|0|||
155156487|NCT02559622|560010679|FG003|Overall Study|Progressive disease|0|||
155156488|NCT02559622|560010676|FG000|Overall Study|Adverse Event|0|||
155156489|NCT02559622|560010677|FG001|Overall Study|Adverse Event|2|||
155156490|NCT02559622|560010678|FG002|Overall Study|Adverse Event|2|||
155156491|NCT02559622|560010679|FG003|Overall Study|Adverse Event|2|||
155156492|NCT02559622|560010676|FG000|Overall Study|Patient/guardian decision|1|||
155156493|NCT02559622|560010677|FG001|Overall Study|Patient/guardian decision|2|||
155156494|NCT02559622|560010678|FG002|Overall Study|Patient/guardian decision|0|||
155156495|NCT02559622|560010679|FG003|Overall Study|Patient/guardian decision|1|||
155156496|NCT00449696|560010680|FG000|Overall Study|Other Treatment Required|6|||
155156497|NCT00449696|560010681|FG001|Overall Study|Other Treatment Required|1|||
155156498|NCT00449696|560010680|FG000|Overall Study|Withdrawal by Subject|5|||
155156499|NCT00449696|560010681|FG001|Overall Study|Withdrawal by Subject|5|||
155156500|NCT00449696|560010680|FG000|Overall Study|Lost to Follow-up|2|||
155156501|NCT00449696|560010681|FG001|Overall Study|Lost to Follow-up|3|||
155156502|NCT00449696|560010680|FG000|Overall Study|Others|7|||
155293776|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
155293777|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
155293778|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
155293779|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
155293780|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
155293781|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
155293782|NCT02914522|560504985|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293783|NCT02914522|560504986|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
155293784|NCT02914522|560504987|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293785|NCT02914522|560504988|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293786|NCT02914522|560504989|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
155293787|NCT02914522|560504990|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
155293788|NCT02914522|560504991|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293789|NCT02914522|560504992|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293790|NCT02914522|560504993|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293791|NCT02914522|560504994|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293792|NCT02914522|560504995|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
155293793|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293794|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293795|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293796|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293797|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293798|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
155293799|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
155293800|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
155293801|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
155293802|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
155293803|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
155293804|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293805|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293806|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293807|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293808|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293809|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
155293810|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
155293811|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
155293812|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
155293813|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
155293814|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
155293815|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293816|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293817|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293818|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293819|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293820|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293821|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
155156503|NCT00449696|560010681|FG001|Overall Study|Others|0|||
155156504|NCT01033019|560010682|FG000|Overall Study|Withdrawal by Subject|1|||
155156505|NCT01033019|560010683|FG001|Overall Study|Withdrawal by Subject|0|||
155156506|NCT01052493|560010686|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
155156507|NCT01052493|560010687|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
155156508|NCT01052493|560010688|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
155293822|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
155293823|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
155293824|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
155293825|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
155293826|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293827|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293828|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293829|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293830|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293831|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
155293832|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
155293833|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
155293834|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
155293835|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
155293836|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
155293837|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
155293838|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
155293839|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
155293840|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
155293841|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
155293842|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
155293843|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
155293844|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
155293845|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
155293846|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
155293847|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
155293848|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293849|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293850|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293851|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293852|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293853|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293854|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293855|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
155293856|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
155293857|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293858|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
155293859|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293860|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293861|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293862|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293863|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293864|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293865|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293866|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293867|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
155293868|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
155293869|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
155293870|NCT02914522|560504985|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293871|NCT02914522|560504986|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293872|NCT02914522|560504987|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293873|NCT02914522|560504988|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293874|NCT02914522|560504989|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293875|NCT02914522|560504990|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293876|NCT02914522|560504991|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293877|NCT02914522|560504992|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293878|NCT02914522|560504993|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293879|NCT02914522|560504994|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
155293880|NCT02914522|560504995|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
155293881|NCT00177216|560504996|FG000|Overall Study|Withdrawal by Subject|6|||
155293882|NCT00177216|560504997|FG001|Overall Study|Withdrawal by Subject|3|||
155293883|NCT00177216|560504998|FG002|Overall Study|Withdrawal by Subject|1|||
155293884|NCT00639002|560505001|FG000|Overall Study|Death|1|||
155293885|NCT00639002|560505001|FG000|Overall Study|Adverse Event|1|||
155293886|NCT00639002|560505001|FG000|Overall Study|Protocol Violation|1|||
155293887|NCT00639002|560505001|FG000|Overall Study|Disease progression|3|||
155293888|NCT00639002|560505001|FG000|Overall Study|Physician Decision|6|||
155293889|NCT00639002|560505001|FG000|Overall Study|Lack of Efficacy|1|||
155293890|NCT02807493|560505006|FG000|Overall Study|Adverse Event|5|||
155293891|NCT02807493|560505007|FG001|Overall Study|Adverse Event|2|||
155293892|NCT02807493|560505006|FG000|Overall Study|Lost to Follow-up|6|||
155293893|NCT02807493|560505007|FG001|Overall Study|Lost to Follow-up|0|||
155293894|NCT02807493|560505006|FG000|Overall Study|Physician Decision|4|||
155293895|NCT02807493|560505007|FG001|Overall Study|Physician Decision|1|||
155293896|NCT02807493|560505006|FG000|Overall Study|Protocol Violation|7|||
155293897|NCT02807493|560505007|FG001|Overall Study|Protocol Violation|0|||
155293898|NCT02807493|560505006|FG000|Overall Study|Withdrawal by Subject|17|||
155293899|NCT02807493|560505007|FG001|Overall Study|Withdrawal by Subject|10|||
155293900|NCT02807493|560505006|FG000|Overall Study|Other withdrawal|17|||
155293901|NCT02807493|560505007|FG001|Overall Study|Other withdrawal|0|||
155293902|NCT02807493|560505006|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
155293903|NCT02807493|560505007|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
155293904|NCT01227707|560505008|FG000|Overall Study|Adverse Event|10|||
155293905|NCT01227707|560505008|FG000|Overall Study|Progression of disease|3|||
155293906|NCT01227707|560505008|FG000|Overall Study|Withdrawal by Subject|1|||
155293907|NCT01227707|560505008|FG000|Overall Study|Patient non-compliance|3|||
155293908|NCT01227707|560505008|FG000|Overall Study|Medical decision|6|||
155293909|NCT01227707|560505008|FG000|Overall Study|Death|1|||
155293910|NCT00823979|560505021|FG000|Overall Study|Lack of Efficacy|13|||
155293911|NCT00823979|560505022|FG001|Overall Study|Lack of Efficacy|16|||
155293912|NCT00823979|560505023|FG002|Overall Study|Lack of Efficacy|9|||
155293913|NCT00823979|560505021|FG000|Overall Study|Lost to Follow-up|2|||
155293914|NCT00823979|560505022|FG001|Overall Study|Lost to Follow-up|1|||
155293915|NCT00823979|560505023|FG002|Overall Study|Lost to Follow-up|0|||
155293916|NCT00823979|560505021|FG000|Overall Study|Withdrawal by Subject|2|||
155293917|NCT00823979|560505022|FG001|Overall Study|Withdrawal by Subject|3|||
155293918|NCT00823979|560505023|FG002|Overall Study|Withdrawal by Subject|2|||
155293919|NCT00823979|560505021|FG000|Overall Study|Protocol Violation|1|||
155293920|NCT00823979|560505022|FG001|Overall Study|Protocol Violation|1|||
155293921|NCT00823979|560505023|FG002|Overall Study|Protocol Violation|0|||
155293922|NCT00823979|560505021|FG000|Overall Study|Pregnancy|0|||
155293923|NCT00823979|560505022|FG001|Overall Study|Pregnancy|1|||
155293924|NCT00823979|560505023|FG002|Overall Study|Pregnancy|0|||
155293925|NCT00823979|560505021|FG000|Overall Study|Adverse Event|0|||
155293926|NCT00823979|560505022|FG001|Overall Study|Adverse Event|2|||
155293927|NCT00823979|560505023|FG002|Overall Study|Adverse Event|4|||
155293928|NCT00823979|560505021|FG000|Overall Study|Other|2|||
155293929|NCT00823979|560505022|FG001|Overall Study|Other|0|||
155293930|NCT00823979|560505023|FG002|Overall Study|Other|1|||
155293931|NCT00823979|560505021|FG000|Overall Study|Randomized but not Treated|4|||
155293932|NCT00823979|560505022|FG001|Overall Study|Randomized but not Treated|3|||
155293933|NCT00823979|560505023|FG002|Overall Study|Randomized but not Treated|1|||
155293934|NCT00823979|560505021|FG000|Overall Study|Study Terminated by Sponsor|5|||
155293935|NCT00823979|560505022|FG001|Overall Study|Study Terminated by Sponsor|5|||
155293936|NCT00823979|560505023|FG002|Overall Study|Study Terminated by Sponsor|7|||
155293937|NCT03523091|560505024|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
155293938|NCT03523091|560505025|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
155293939|NCT03523091|560505024|FG000|Overall Study|Withdrawal by Subject|0|||
155293940|NCT03523091|560505025|FG001|Overall Study|Withdrawal by Subject|3|||
155293941|NCT03523091|560505024|FG000|Overall Study|Increase Botox dose|0|||
155293942|NCT03523091|560505025|FG001|Overall Study|Increase Botox dose|1|||
155293943|NCT00741988|560505026|FG000|Overall Study|Adverse Event|2|||
155293944|NCT00741988|560505027|FG001|Overall Study|Adverse Event|4|||
155293945|NCT00741988|560505026|FG000|Overall Study|Lack of Efficacy|2|||
155293946|NCT00741988|560505027|FG001|Overall Study|Lack of Efficacy|0|||
155293947|NCT00811057|560505028|FG000|Overall Study|Protocol Violation|5|||
155293948|NCT00811057|560505029|FG001|Overall Study|Protocol Violation|10|||
155293949|NCT00811057|560505030|FG002|Overall Study|Protocol Violation|10|||
155293950|NCT03008915|560505033|FG000|Treatment 1|Withdrawal by Subject|0|||
155293951|NCT03008915|560505034|FG001|Treatment 1|Withdrawal by Subject|1|||
155293952|NCT00712166|560505037|FG000|Overall Study|Noncompliance|0|||
155293953|NCT00712166|560505038|FG001|Overall Study|Noncompliance|1|||
155293954|NCT01773122|560505039|FG000|Overall Study|Due to amended age eligibility criteria|3|||
155293955|NCT01773122|560505040|FG001|Overall Study|Due to amended age eligibility criteria|1|||
155293956|NCT01773122|560505041|FG002|Overall Study|Due to amended age eligibility criteria|0|||
155293957|NCT01773122|560505042|FG003|Overall Study|Due to amended age eligibility criteria|1|||
155293958|NCT02289560|560505045|FG000|Overall Study|Lost to Follow-up|6|||
155293959|NCT02289560|560505045|FG000|Overall Study|Alternative Treatment|4|||
155293960|NCT02289560|560505045|FG000|Overall Study|Inadequate Treatment|2|||
155293961|NCT02289560|560505045|FG000|Overall Study|Withdrawal by Subject|23|||
155293962|NCT02540213|560505046|FG000|Overall Study|Death/adverse event|18|||
155293963|NCT02540213|560505046|FG000|Overall Study|Administrative reasons|3|||
155293964|NCT02540213|560505046|FG000|Overall Study|Kidney transplant|3|||
155293965|NCT02540213|560505046|FG000|Overall Study|Lack of Efficacy|6|||
155293966|NCT02540213|560505046|FG000|Overall Study|Consent withdrawn|7|||
155293967|NCT02540213|560505046|FG000|Overall Study|Enrolled but not treated|2|||
155293968|NCT01264718|560505047|FG000|Overall Study|Lost to Follow-up|3|||
155293969|NCT01264718|560505048|FG001|Overall Study|Lost to Follow-up|2|||
155293970|NCT01264718|560505047|FG000|Overall Study|Withdrawal by Subject|9|||
155293971|NCT01264718|560505048|FG001|Overall Study|Withdrawal by Subject|15|||
155293972|NCT01264718|560505047|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
155293973|NCT01264718|560505048|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
155293974|NCT03386929|560505049|FG000|Overall Study|Death|0|||
155293975|NCT03386929|560505050|FG001|Overall Study|Death|0|||
155293976|NCT03386929|560505051|FG002|Overall Study|Death|1|||
155293977|NCT03386929|560505049|FG000|Overall Study|Withdrawal by Subject|0|||
155293978|NCT03386929|560505050|FG001|Overall Study|Withdrawal by Subject|1|||
155293979|NCT03386929|560505051|FG002|Overall Study|Withdrawal by Subject|0|||
155293980|NCT03386929|560505049|FG000|Overall Study|Physician Decision|0|||
155293981|NCT03386929|560505050|FG001|Overall Study|Physician Decision|0|||
155293982|NCT03386929|560505051|FG002|Overall Study|Physician Decision|1|||
155293983|NCT03386929|560505049|FG000|Overall Study|Progression|4|||
155293984|NCT03386929|560505050|FG001|Overall Study|Progression|4|||
155293985|NCT03386929|560505051|FG002|Overall Study|Progression|0|||
155293986|NCT03386929|560505049|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
155293987|NCT03386929|560505050|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
155293988|NCT03386929|560505051|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
155293989|NCT03386929|560505049|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
155293990|NCT03386929|560505050|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
155293991|NCT03386929|560505051|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
155293992|NCT00536380|560505052|FG000|Overall Study|Adverse Event|0|||
155293993|NCT00536380|560505053|FG001|Overall Study|Adverse Event|2|||
155293994|NCT00536380|560505054|FG002|Overall Study|Adverse Event|2|||
155293995|NCT00536380|560505052|FG000|Overall Study|Lost to Follow-up|0|||
155293996|NCT00536380|560505053|FG001|Overall Study|Lost to Follow-up|0|||
155293997|NCT00536380|560505054|FG002|Overall Study|Lost to Follow-up|1|||
155293998|NCT00536380|560505052|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
155293999|NCT00536380|560505053|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
155294000|NCT00536380|560505054|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
155294001|NCT00536380|560505052|FG000|Overall Study|Withdrawal related to study drug|7|||
155294002|NCT00536380|560505053|FG001|Overall Study|Withdrawal related to study drug|5|||
155294003|NCT00536380|560505054|FG002|Overall Study|Withdrawal related to study drug|2|||
155294004|NCT00536380|560505052|FG000|Overall Study|Noncompliance with protocol|3|||
155294005|NCT00536380|560505053|FG001|Overall Study|Noncompliance with protocol|2|||
155294006|NCT00536380|560505054|FG002|Overall Study|Noncompliance with protocol|2|||
155294007|NCT00536380|560505052|FG000|Overall Study|Did not meet protocol eligibility|0|||
155294008|NCT00536380|560505053|FG001|Overall Study|Did not meet protocol eligibility|0|||
155294009|NCT00536380|560505054|FG002|Overall Study|Did not meet protocol eligibility|1|||
155294010|NCT00536380|560505052|FG000|Overall Study|Administrative|0|||
155294011|NCT00536380|560505053|FG001|Overall Study|Administrative|0|||
155294012|NCT00536380|560505054|FG002|Overall Study|Administrative|1|||
155294013|NCT03418324|560505055|FG000|Overall Study|Death|0|||
155294014|NCT03418324|560505056|FG001|Overall Study|Death|1|||
155294015|NCT03418324|560505055|FG000|Overall Study|Physician Decision|1|||
155294016|NCT03418324|560505056|FG001|Overall Study|Physician Decision|1|||
155294017|NCT03121950|560505058|FG000|Overall Study|Withdrawal by Subject|11|||
155294018|NCT03121950|560505059|FG001|Overall Study|Withdrawal by Subject|2|||
155294019|NCT04248829|560505062|FG000|Overall Study|Disease progression|44|||
155294020|NCT04248829|560505063|FG001|Overall Study|Disease progression|109|||
155294021|NCT04248829|560505062|FG000|Overall Study|Adverse Event|19|||
155294022|NCT04248829|560505063|FG001|Overall Study|Adverse Event|18|||
155294023|NCT04248829|560505062|FG000|Overall Study|Withdrawal by Subject|11|||
155294024|NCT04248829|560505063|FG001|Overall Study|Withdrawal by Subject|2|||
155294025|NCT04248829|560505062|FG000|Overall Study|Lost to Follow-up|0|||
155294026|NCT04248829|560505063|FG001|Overall Study|Lost to Follow-up|1|||
155294027|NCT04248829|560505062|FG000|Overall Study|Death|12|||
155294028|NCT04248829|560505063|FG001|Overall Study|Death|14|||
155294029|NCT04248829|560505062|FG000|Overall Study|Physician Decision|2|||
155156509|NCT01294553|560010697|FG000|Overall Study|Duplicated Participants|1|||
155294030|NCT04248829|560505063|FG001|Overall Study|Physician Decision|4|||
155294031|NCT04248829|560505062|FG000|Overall Study|Any reason not specifically recorded|0|||
155294032|NCT04248829|560505063|FG001|Overall Study|Any reason not specifically recorded|2|||
155294033|NCT02132702|560505064|FG000|Overall Study|Protocol Violation|2|||
155294034|NCT02132702|560505064|FG000|Overall Study|Adverse Event|3|||
155294035|NCT02132702|560505064|FG000|Overall Study|Withdrawal by Subject|3|||
155294036|NCT02299336|560505065|FG000|Overall Study|Withdrawal by Subject|11|||
155294037|NCT02299336|560505065|FG000|Overall Study|Adverse Event|1|||
155294038|NCT02299336|560505065|FG000|Overall Study|Death|1|||
155294039|NCT02299336|560505065|FG000|Overall Study|Lost to Follow-up|1|||
155294040|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
155294041|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
155294042|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
155294043|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294044|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294045|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294046|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294047|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294048|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155294049|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
155294050|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
155294051|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
155294052|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294053|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294054|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294055|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294056|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294057|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155294058|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
155294059|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
155294060|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
155294061|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294062|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294063|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294064|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294065|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294066|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155294067|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
155294068|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294069|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
155294070|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294071|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294072|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294073|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294074|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294075|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
155294076|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155294077|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155294078|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
155294079|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294080|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155156510|NCT01294553|560010697|FG000|Overall Study|Protocol Violation|268|||
155156511|NCT00453206|560010699|FG000|Overall Study|Death|1|||
155156512|NCT00577889|560010700|FG000|Overall Study|Withdrawal by Subject|1|||
155156513|NCT00577889|560010701|FG001|Overall Study|Withdrawal by Subject|0|||
155294081|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294082|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294083|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294084|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155294085|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294086|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155294087|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155294088|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294089|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155156514|NCT00577889|560010702|FG002|Overall Study|Withdrawal by Subject|0|||
155156515|NCT03041181|560010704|FG000|Overall Study|Disease Progression|1|||
155156516|NCT03041181|560010705|FG001|Overall Study|Disease Progression|2|||
155156517|NCT01903460|560010708|FG000|Overall Study|Adverse Event|0|||
155156518|NCT01903460|560010709|FG001|Overall Study|Adverse Event|0|||
155156519|NCT01903460|560010710|FG002|Overall Study|Adverse Event|0|||
155156520|NCT01903460|560010711|FG003|Overall Study|Adverse Event|1|||
155294090|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294091|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294092|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294093|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155294094|NCT01212757|560505068|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
155294095|NCT01212757|560505069|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
155294096|NCT01212757|560505070|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294097|NCT01212757|560505071|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294098|NCT01212757|560505072|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294099|NCT01212757|560505073|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294100|NCT01212757|560505074|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294101|NCT01212757|560505075|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294102|NCT01212757|560505076|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
155294103|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294104|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
155294105|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
155294106|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
155294107|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294108|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
155294109|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294110|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294111|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
155294112|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294113|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
155294114|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
155294115|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
155294116|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294117|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
155294118|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294119|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294120|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
155294121|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294122|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294123|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
155294124|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294125|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294126|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294127|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294128|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294129|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
155294130|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294131|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
155294132|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
155294133|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
155294134|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
155294135|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
155294136|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294137|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294138|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155294139|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155156521|NCT03104868|560010712|FG000|6 Week Follow up|Lost to Follow-up|5|||
155156522|NCT03104868|560010713|FG001|6 Week Follow up|Lost to Follow-up|8|||
155156523|NCT03104868|560010712|FG000|6 Week Follow up|Death|1|||
155156524|NCT03104868|560010713|FG001|6 Week Follow up|Death|1|||
155156525|NCT03104868|560010712|FG000|6 Week Follow up|Withdrawal by Subject|7|||
155156526|NCT03104868|560010713|FG001|6 Week Follow up|Withdrawal by Subject|6|||
155156527|NCT03104868|560010712|FG000|6 Week Follow up|Completed Later Timepoint|24|||
155156528|NCT03104868|560010713|FG001|6 Week Follow up|Completed Later Timepoint|22|||
155156529|NCT03104868|560010712|FG000|6 Month Follow up|Lost to Follow-up|2|||
155156530|NCT03104868|560010713|FG001|6 Month Follow up|Lost to Follow-up|2|||
155156531|NCT03104868|560010712|FG000|6 Month Follow up|Death|0|||
155156532|NCT03104868|560010713|FG001|6 Month Follow up|Death|1|||
155156533|NCT03104868|560010712|FG000|6 Month Follow up|Completed Later Timepoint|22|||
155156534|NCT03104868|560010713|FG001|6 Month Follow up|Completed Later Timepoint|32|||
155156535|NCT03104868|560010712|FG000|12 Month Follow up|Lost to Follow-up|1|||
155156536|NCT03104868|560010713|FG001|12 Month Follow up|Lost to Follow-up|2|||
155294140|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
155294141|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294142|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294143|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
155294144|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294145|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294146|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294147|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155294148|NCT01212757|560505068|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294149|NCT01212757|560505069|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
155294150|NCT01212757|560505070|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
155294151|NCT01212757|560505071|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294152|NCT01212757|560505072|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294153|NCT01212757|560505073|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294154|NCT01212757|560505074|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294155|NCT01212757|560505075|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294156|NCT01212757|560505076|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
155294157|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294158|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294159|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294160|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294161|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294162|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294163|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294164|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
155294165|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
155294166|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294167|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
155294168|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
155294169|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294170|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294171|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294172|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
155294173|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
155294174|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
155294175|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294176|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
155294177|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
155294178|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294179|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294180|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294181|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294182|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
155294183|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
155294184|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294185|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
155294186|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
155294187|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294188|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294189|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155294190|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155156537|NCT03104868|560010712|FG000|12 Month Follow up|Death|0|||
155156538|NCT03104868|560010713|FG001|12 Month Follow up|Death|1|||
155156539|NCT03104868|560010712|FG000|12 Month Follow up|Withdrawal by Subject|0|||
155156540|NCT03104868|560010713|FG001|12 Month Follow up|Withdrawal by Subject|3|||
155156541|NCT03104868|560010712|FG000|12 Month Follow up|Completed Later Timepoint|32|||
155156542|NCT03104868|560010713|FG001|12 Month Follow up|Completed Later Timepoint|29|||
155156543|NCT03104868|560010712|FG000|18 Month Follow up|Lost to Follow-up|7|||
155156544|NCT03104868|560010713|FG001|18 Month Follow up|Lost to Follow-up|11|||
155156545|NCT03104868|560010712|FG000|18 Month Follow up|Death|2|||
155294191|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
155294192|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
155294193|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294194|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155156546|NCT03104868|560010713|FG001|18 Month Follow up|Death|1|||
155156547|NCT03104868|560010712|FG000|18 Month Follow up|Withdrawal by Subject|1|||
155156548|NCT03104868|560010713|FG001|18 Month Follow up|Withdrawal by Subject|2|||
155294195|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
155294196|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294197|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294198|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294199|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294200|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294201|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
155294202|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294203|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
155294204|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
155294205|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294206|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294207|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294208|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294209|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
155294210|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
155294211|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294212|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
155294213|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
155294214|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294215|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294216|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294217|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
155294218|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
155294219|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
155294220|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294221|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294222|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
155294223|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294224|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294225|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294226|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294227|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294228|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
155294229|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294230|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
155294231|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155294232|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294233|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294234|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294235|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155294236|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155294237|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155294238|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294239|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294240|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294241|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294242|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294243|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294244|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294245|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
155294246|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
155294247|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294248|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
155294249|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294250|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294251|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155156549|NCT03104868|560010712|FG000|18 Month Follow up|Graft Loss|1|||
154955445|NCT05093205|559263343|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
154955446|NCT05093205|559263344|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
154955447|NCT05093205|559263332|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955448|NCT05093205|559263333|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955449|NCT05093205|559263334|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955450|NCT05093205|559263335|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955451|NCT05093205|559263336|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955452|NCT05093205|559263337|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155294252|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
154955453|NCT05093205|559263338|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955454|NCT05093205|559263339|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
155156550|NCT03104868|560010713|FG001|18 Month Follow up|Graft Loss|1|||
155294253|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294254|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294255|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
155294256|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294257|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294258|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
155294259|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294260|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294261|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294262|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294263|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
155294264|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
155294265|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294266|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
155294267|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294268|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294269|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294270|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294271|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294272|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
155294273|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
155294274|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294275|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
155294276|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
155294277|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294278|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294279|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294280|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
155294281|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
155294282|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
155294283|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294284|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
155294285|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
155294286|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294287|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294288|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294289|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
155294290|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
155294291|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
155294292|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294293|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
155294294|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
155294295|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294296|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294297|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294298|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155294299|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
155294300|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
155294301|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
155294302|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
155294303|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
155294304|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
155294305|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
155294306|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
155294307|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
155294308|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
155156551|NCT03104868|560010712|FG000|18 Month Follow up|Completed Later Timepoint|19|||
155156552|NCT03104868|560010713|FG001|18 Month Follow up|Completed Later Timepoint|20|||
155156553|NCT03104868|560010712|FG000|24 Month Follow up|Lost to Follow-up|15|||
155156554|NCT03104868|560010713|FG001|24 Month Follow up|Lost to Follow-up|16|||
155156555|NCT03104868|560010712|FG000|24 Month Follow up|Death|3|||
155156556|NCT03104868|560010713|FG001|24 Month Follow up|Death|2|||
155294309|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
155294310|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294311|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155156557|NCT03104868|560010712|FG000|24 Month Follow up|Withdrawal by Subject|1|||
155156558|NCT03104868|560010713|FG001|24 Month Follow up|Withdrawal by Subject|0|||
155156559|NCT03104868|560010712|FG000|24 Month Follow up|Graft Loss|2|||
155156560|NCT03104868|560010713|FG001|24 Month Follow up|Graft Loss|0|||
155156561|NCT00005780|560010714|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
155156562|NCT04973449|560010715|FG000|Overall Study|Withdrawal by Subject|3|||
155156563|NCT04973449|560010716|FG001|Overall Study|Withdrawal by Subject|3|||
155156564|NCT04973449|560010717|FG002|Overall Study|Withdrawal by Subject|2|||
155156565|NCT04973449|560010718|FG003|Overall Study|Withdrawal by Subject|5|||
155156566|NCT04973449|560010719|FG004|Overall Study|Withdrawal by Subject|5|||
155156567|NCT04973449|560010720|FG005|Overall Study|Withdrawal by Subject|4|||
155156568|NCT04973449|560010721|FG006|Overall Study|Withdrawal by Subject|7|||
155156569|NCT04973449|560010722|FG007|Overall Study|Withdrawal by Subject|5|||
155156570|NCT04973449|560010715|FG000|Overall Study|Lost to Follow-up|15|||
155156571|NCT04973449|560010716|FG001|Overall Study|Lost to Follow-up|16|||
155156572|NCT04973449|560010717|FG002|Overall Study|Lost to Follow-up|16|||
155156573|NCT04973449|560010718|FG003|Overall Study|Lost to Follow-up|13|||
155156574|NCT04973449|560010719|FG004|Overall Study|Lost to Follow-up|5|||
155060404|NCT03191552|559655607|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
155060405|NCT03191552|559655608|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
155060406|NCT03191552|559655609|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
155060407|NCT02370511|559655612|FG000|Overall Study|Death|10|||
155060408|NCT02370511|559655613|FG001|Overall Study|Death|7|||
155060409|NCT02370511|559655614|FG002|Overall Study|Death|1|||
155060410|NCT02370511|559655612|FG000|Overall Study|Withdrawal by Subject|2|||
155060411|NCT02370511|559655613|FG001|Overall Study|Withdrawal by Subject|0|||
155060412|NCT02370511|559655614|FG002|Overall Study|Withdrawal by Subject|0|||
155060413|NCT02370511|559655612|FG000|Overall Study|Lost to Follow-up|0|||
155060414|NCT02370511|559655613|FG001|Overall Study|Lost to Follow-up|4|||
155060415|NCT02370511|559655614|FG002|Overall Study|Lost to Follow-up|0|||
155060416|NCT01149655|559655615|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
155060417|NCT01149655|559655616|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
155060418|NCT01149655|559655617|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
155060419|NCT01149655|559655618|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
155060420|NCT01149655|559655615|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
155060421|NCT01149655|559655616|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
155060422|NCT01149655|559655617|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
155060423|NCT01149655|559655618|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
155060424|NCT01149655|559655615|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
155060425|NCT01149655|559655616|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155060426|NCT01149655|559655617|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155060427|NCT01149655|559655618|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
155060428|NCT01149655|559655615|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
155156575|NCT04973449|560010720|FG005|Overall Study|Lost to Follow-up|6|||
155156576|NCT04973449|560010721|FG006|Overall Study|Lost to Follow-up|10|||
155156577|NCT04973449|560010722|FG007|Overall Study|Lost to Follow-up|6|||
155156578|NCT04973449|560010715|FG000|Overall Study|Death|1|||
155156579|NCT04973449|560010716|FG001|Overall Study|Death|0|||
155156580|NCT04973449|560010717|FG002|Overall Study|Death|0|||
155156581|NCT04973449|560010718|FG003|Overall Study|Death|0|||
155156582|NCT04973449|560010719|FG004|Overall Study|Death|0|||
155156583|NCT04973449|560010720|FG005|Overall Study|Death|1|||
155156584|NCT04973449|560010721|FG006|Overall Study|Death|0|||
155156585|NCT04973449|560010722|FG007|Overall Study|Death|0|||
155156586|NCT04973449|560010715|FG000|Overall Study|Other|1|||
155156587|NCT04973449|560010716|FG001|Overall Study|Other|1|||
155156588|NCT04973449|560010717|FG002|Overall Study|Other|2|||
155156589|NCT04973449|560010718|FG003|Overall Study|Other|1|||
155156590|NCT04973449|560010719|FG004|Overall Study|Other|4|||
155156591|NCT04973449|560010720|FG005|Overall Study|Other|0|||
155156592|NCT04973449|560010721|FG006|Overall Study|Other|2|||
155156593|NCT04973449|560010722|FG007|Overall Study|Other|2|||
155156594|NCT00521079|560010723|FG000|Overall Study|Adverse Event|7|||
155156595|NCT00521079|560010724|FG001|Overall Study|Adverse Event|1|||
155156596|NCT00521079|560010723|FG000|Overall Study|Lost to Follow-up|2|||
155294312|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294313|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294314|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294315|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
154955455|NCT05093205|559263340|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955456|NCT05093205|559263341|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955457|NCT05093205|559263342|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
154955458|NCT05093205|559263343|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955459|NCT05093205|559263344|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
154955460|NCT05093205|559263332|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955461|NCT05093205|559263333|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955462|NCT05093205|559263334|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955463|NCT05093205|559263335|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955464|NCT05093205|559263336|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955465|NCT05093205|559263337|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955466|NCT05093205|559263338|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955467|NCT05093205|559263339|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955468|NCT05093205|559263340|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955469|NCT05093205|559263341|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955470|NCT05093205|559263342|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955471|NCT05093205|559263343|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
154955472|NCT05093205|559263344|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
154955473|NCT05093205|559263332|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
154955474|NCT05093205|559263333|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
154955475|NCT05093205|559263334|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
154955476|NCT05093205|559263335|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
154955477|NCT05093205|559263336|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
154955478|NCT05093205|559263337|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
154955479|NCT05093205|559263338|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
154955480|NCT05093205|559263339|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
154955481|NCT05093205|559263340|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
154955482|NCT05093205|559263341|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
154955483|NCT05093205|559263342|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
154955484|NCT05093205|559263343|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
154955485|NCT05093205|559263344|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
154955486|NCT05093205|559263332|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955487|NCT05093205|559263333|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955488|NCT05093205|559263334|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955489|NCT05093205|559263335|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955490|NCT05093205|559263336|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955491|NCT05093205|559263337|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955492|NCT05093205|559263338|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955493|NCT05093205|559263339|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955494|NCT05093205|559263340|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955495|NCT05093205|559263341|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955496|NCT05093205|559263342|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955497|NCT05093205|559263343|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
154955498|NCT05093205|559263344|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
154955499|NCT03361228|559263354|FG000|Overall Study|Other|1|||
154955500|NCT03361228|559263355|FG001|Overall Study|Other|1|||
154955501|NCT03361228|559263354|FG000|Overall Study|Death|3|||
154955502|NCT03361228|559263355|FG001|Overall Study|Death|0|||
154955503|NCT02979353|559263359|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
154955504|NCT02979353|559263360|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
154955505|NCT02979353|559263359|FG000|Overall Study|Withdrawal by Subject|16|||
154955506|NCT02979353|559263360|FG001|Overall Study|Withdrawal by Subject|12|||
154955507|NCT02979353|559263359|FG000|Overall Study|Death|10|||
154955508|NCT02979353|559263360|FG001|Overall Study|Death|11|||
154955509|NCT02979353|559263359|FG000|Overall Study|Transfer to Hospice Care|19|||
154955510|NCT02979353|559263360|FG001|Overall Study|Transfer to Hospice Care|14|||
154955511|NCT02979353|559263359|FG000|Overall Study|Lost to Follow-up|1|||
154955512|NCT02979353|559263360|FG001|Overall Study|Lost to Follow-up|5|||
154955513|NCT03639311|559263363|FG000|Maintenance Phase|Lost to Follow-up|1|||
154955514|NCT03639311|559263364|FG001|Maintenance Phase|Lost to Follow-up|0|||
154955515|NCT03639311|559263365|FG002|Maintenance Phase|Lost to Follow-up|0|||
154955516|NCT03639311|559263363|FG000|Maintenance Phase|Adverse Event|1|||
155294316|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294317|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
154955517|NCT03639311|559263364|FG001|Maintenance Phase|Adverse Event|0|||
154955518|NCT03639311|559263365|FG002|Maintenance Phase|Adverse Event|0|||
154955519|NCT03639311|559263363|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
154955520|NCT03639311|559263364|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
154955521|NCT03639311|559263365|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
154955522|NCT03639311|559263363|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
154955523|NCT03639311|559263364|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
154955524|NCT03639311|559263365|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
154955525|NCT03639311|559263363|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
154955526|NCT03639311|559263364|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
154955527|NCT03639311|559263365|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
154955528|NCT03639311|559263363|FG000|Maintenance Phase|Lack of Efficacy|1|||
154955529|NCT03639311|559263364|FG001|Maintenance Phase|Lack of Efficacy|0|||
154955530|NCT03639311|559263365|FG002|Maintenance Phase|Lack of Efficacy|0|||
154955531|NCT00822926|559263368|FG000|Second Injection Visit|Lost to Follow-up|1|||
154955532|NCT00822926|559263369|FG001|Second Injection Visit|Lost to Follow-up|0|||
154955533|NCT00822926|559263368|FG000|Second Injection Visit|Withdrawal by Subject|0|||
154955534|NCT00822926|559263369|FG001|Second Injection Visit|Withdrawal by Subject|1|||
154955535|NCT01378975|559263370|FG000|Overall Study|Death|77|||
154955536|NCT01378975|559263371|FG001|Overall Study|Death|46|||
154955537|NCT01378975|559263370|FG000|Overall Study|Investigator Request|1|||
154955538|NCT01378975|559263371|FG001|Overall Study|Investigator Request|0|||
154955539|NCT01378975|559263370|FG000|Overall Study|Lost to Follow-up|4|||
154955540|NCT01378975|559263371|FG001|Overall Study|Lost to Follow-up|1|||
154955541|NCT01378975|559263370|FG000|Overall Study|Withdrew Consent|4|||
154955542|NCT01378975|559263371|FG001|Overall Study|Withdrew Consent|3|||
154955543|NCT03125200|559263378|FG000|Overall Study|Study Termination|0|||
154955544|NCT03125200|559263379|FG001|Overall Study|Study Termination|0|||
154955545|NCT03125200|559263380|FG002|Overall Study|Study Termination|0|||
154955546|NCT03125200|559263381|FG003|Overall Study|Study Termination|1|||
154955547|NCT03125200|559263382|FG004|Overall Study|Study Termination|1|||
154955548|NCT03125200|559263383|FG005|Overall Study|Study Termination|2|||
154955549|NCT03125200|559263384|FG006|Overall Study|Study Termination|1|||
154955550|NCT03125200|559263378|FG000|Overall Study|Clinical Progression|0|||
154955551|NCT03125200|559263379|FG001|Overall Study|Clinical Progression|0|||
154955552|NCT03125200|559263380|FG002|Overall Study|Clinical Progression|0|||
154955553|NCT03125200|559263381|FG003|Overall Study|Clinical Progression|1|||
154955554|NCT03125200|559263382|FG004|Overall Study|Clinical Progression|0|||
154955555|NCT03125200|559263383|FG005|Overall Study|Clinical Progression|1|||
154955556|NCT03125200|559263384|FG006|Overall Study|Clinical Progression|0|||
154955557|NCT03125200|559263378|FG000|Overall Study|Progressive Disease|2|||
154955558|NCT03125200|559263379|FG001|Overall Study|Progressive Disease|1|||
154955559|NCT03125200|559263380|FG002|Overall Study|Progressive Disease|2|||
154955560|NCT03125200|559263381|FG003|Overall Study|Progressive Disease|1|||
154955561|NCT03125200|559263382|FG004|Overall Study|Progressive Disease|2|||
154955562|NCT03125200|559263383|FG005|Overall Study|Progressive Disease|0|||
154955563|NCT03125200|559263384|FG006|Overall Study|Progressive Disease|1|||
154955564|NCT03125200|559263378|FG000|Overall Study|Lack of Efficacy|0|||
154955565|NCT03125200|559263379|FG001|Overall Study|Lack of Efficacy|0|||
154955566|NCT03125200|559263380|FG002|Overall Study|Lack of Efficacy|0|||
154955567|NCT03125200|559263381|FG003|Overall Study|Lack of Efficacy|1|||
154955568|NCT03125200|559263382|FG004|Overall Study|Lack of Efficacy|0|||
154955569|NCT03125200|559263383|FG005|Overall Study|Lack of Efficacy|0|||
154955570|NCT03125200|559263384|FG006|Overall Study|Lack of Efficacy|0|||
154955571|NCT03125200|559263378|FG000|Overall Study|Toxicity|0|||
154955572|NCT03125200|559263379|FG001|Overall Study|Toxicity|0|||
154955573|NCT03125200|559263380|FG002|Overall Study|Toxicity|0|||
154955574|NCT03125200|559263381|FG003|Overall Study|Toxicity|1|||
154955575|NCT03125200|559263382|FG004|Overall Study|Toxicity|0|||
154955576|NCT03125200|559263383|FG005|Overall Study|Toxicity|0|||
154955577|NCT03125200|559263384|FG006|Overall Study|Toxicity|0|||
154955578|NCT03125200|559263378|FG000|Overall Study|Consent Withdrawn by Subject|0|||
154955579|NCT03125200|559263379|FG001|Overall Study|Consent Withdrawn by Subject|1|||
155156597|NCT00521079|560010724|FG001|Overall Study|Lost to Follow-up|1|||
154955580|NCT03125200|559263380|FG002|Overall Study|Consent Withdrawn by Subject|0|||
154955581|NCT03125200|559263381|FG003|Overall Study|Consent Withdrawn by Subject|0|||
154955582|NCT03125200|559263382|FG004|Overall Study|Consent Withdrawn by Subject|1|||
155156598|NCT00521079|560010723|FG000|Overall Study|Withdrawal by Subject|5|||
154955583|NCT03125200|559263383|FG005|Overall Study|Consent Withdrawn by Subject|0|||
155156599|NCT00521079|560010724|FG001|Overall Study|Withdrawal by Subject|3|||
154955584|NCT03125200|559263384|FG006|Overall Study|Consent Withdrawn by Subject|1|||
154955585|NCT00119379|559263385|FG000|Overall Study|Adverse Event|4|||
154955586|NCT00119379|559263386|FG001|Overall Study|Adverse Event|1|||
154955587|NCT01937390|559263396|FG000|Overall Study|Death|2|||
154955588|NCT01937390|559263396|FG000|Overall Study|Lost to Follow-up|7|||
154955589|NCT01937390|559263396|FG000|Overall Study|Withdrawal by Subject|5|||
154955590|NCT01937390|559263396|FG000|Overall Study|Fail to return|21|||
154955591|NCT03544138|559263397|FG000|Overall Study|Lost to Follow-up|29|||
155156600|NCT00888173|560010725|FG000|Overall Study|Wrong Primary|1|||
155156601|NCT00888173|560010725|FG000|Overall Study|Ineligible: required test not done|1|||
155156602|NCT04408989|560010733|FG000|Overall Study|Lost to Follow-up|0|||
155156603|NCT04408989|560010734|FG001|Overall Study|Lost to Follow-up|0|||
155156604|NCT04408989|560010735|FG002|Overall Study|Lost to Follow-up|1|||
155156605|NCT04408989|560010733|FG000|Overall Study|Withdrawal by Subject|0|||
155156606|NCT04408989|560010734|FG001|Overall Study|Withdrawal by Subject|0|||
155156607|NCT04408989|560010735|FG002|Overall Study|Withdrawal by Subject|2|||
155156608|NCT02628873|560010736|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
155156609|NCT02628873|560010737|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
155156610|NCT02628873|560010736|FG000|Second Test (1 Hour)|Physician Decision|1|||
155156611|NCT02628873|560010737|FG001|Second Test (1 Hour)|Physician Decision|0|||
155294318|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
155294319|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294320|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
155294321|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
154955592|NCT01706536|559263398|FG000|Overall Study|Withdrawal by Subject|1|||
154955593|NCT01706536|559263399|FG001|Overall Study|Withdrawal by Subject|0|||
154955594|NCT01706536|559263400|FG002|Overall Study|Withdrawal by Subject|1|||
154955595|NCT01706536|559263401|FG003|Overall Study|Withdrawal by Subject|0|||
154955596|NCT01706536|559263402|FG004|Overall Study|Withdrawal by Subject|0|||
154955597|NCT01706536|559263398|FG000|Overall Study|Adverse Event|2|||
154955598|NCT01706536|559263399|FG001|Overall Study|Adverse Event|3|||
154955599|NCT01706536|559263400|FG002|Overall Study|Adverse Event|4|||
154955600|NCT01706536|559263401|FG003|Overall Study|Adverse Event|3|||
154955601|NCT01706536|559263402|FG004|Overall Study|Adverse Event|2|||
154955602|NCT01706536|559263398|FG000|Overall Study|Lack of Efficacy|1|||
154955603|NCT01706536|559263399|FG001|Overall Study|Lack of Efficacy|0|||
154955604|NCT01706536|559263400|FG002|Overall Study|Lack of Efficacy|0|||
154955605|NCT01706536|559263401|FG003|Overall Study|Lack of Efficacy|1|||
154955606|NCT01706536|559263402|FG004|Overall Study|Lack of Efficacy|0|||
154955607|NCT01706536|559263398|FG000|Overall Study|non compliance|0|||
154955608|NCT01706536|559263399|FG001|Overall Study|non compliance|1|||
154955609|NCT01706536|559263400|FG002|Overall Study|non compliance|0|||
154955610|NCT01706536|559263401|FG003|Overall Study|non compliance|0|||
154955611|NCT01706536|559263402|FG004|Overall Study|non compliance|0|||
155294322|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294323|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294324|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294325|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155294326|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
154955612|NCT00154102|559263411|FG000|Overall Study|investigational study phase ongoing|7|||
154955613|NCT00154102|559263412|FG001|Overall Study|investigational study phase ongoing|2|||
154955614|NCT00463606|559263413|FG000|Overall Study|Adverse Event|21|||
154955615|NCT00463606|559263414|FG001|Overall Study|Adverse Event|18|||
154955616|NCT00463606|559263415|FG002|Overall Study|Adverse Event|11|||
154955617|NCT00463606|559263413|FG000|Overall Study|Withdrawal by Subject|11|||
154955618|NCT00463606|559263414|FG001|Overall Study|Withdrawal by Subject|11|||
154955619|NCT00463606|559263415|FG002|Overall Study|Withdrawal by Subject|5|||
154955620|NCT00463606|559263413|FG000|Overall Study|Lost to Follow-up|2|||
154955621|NCT00463606|559263414|FG001|Overall Study|Lost to Follow-up|2|||
154955622|NCT00463606|559263415|FG002|Overall Study|Lost to Follow-up|3|||
154955623|NCT00463606|559263413|FG000|Overall Study|Subject noncompliance|1|||
154955624|NCT00463606|559263414|FG001|Overall Study|Subject noncompliance|1|||
154955625|NCT00463606|559263415|FG002|Overall Study|Subject noncompliance|0|||
154955626|NCT00463606|559263413|FG000|Overall Study|Subject moved out of town|1|||
155156612|NCT04672239|560010738|FG000|Week 2 Survey|Failed survey check items|1|||
154955627|NCT00463606|559263414|FG001|Overall Study|Subject moved out of town|0|||
155294327|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155294328|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155294329|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
155294330|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
155294331|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155294332|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
155294333|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
154955628|NCT00463606|559263415|FG002|Overall Study|Subject moved out of town|0|||
154955629|NCT00463606|559263413|FG000|Overall Study|Physician Decision|0|||
154955630|NCT00463606|559263414|FG001|Overall Study|Physician Decision|1|||
154955631|NCT00463606|559263415|FG002|Overall Study|Physician Decision|0|||
154955632|NCT00463606|559263413|FG000|Overall Study|Sponsor request|0|||
154955633|NCT00463606|559263414|FG001|Overall Study|Sponsor request|1|||
154955634|NCT00463606|559263415|FG002|Overall Study|Sponsor request|0|||
154955635|NCT00463606|559263413|FG000|Overall Study|Exclusion criteria violation|2|||
154955636|NCT00463606|559263414|FG001|Overall Study|Exclusion criteria violation|0|||
154955637|NCT00463606|559263415|FG002|Overall Study|Exclusion criteria violation|0|||
154955638|NCT00463606|559263413|FG000|Overall Study|Coordinator error|1|||
154955639|NCT00463606|559263414|FG001|Overall Study|Coordinator error|0|||
154955640|NCT00463606|559263415|FG002|Overall Study|Coordinator error|0|||
154955641|NCT00463606|559263413|FG000|Overall Study|Patient randomized in error|1|||
154955642|NCT00463606|559263414|FG001|Overall Study|Patient randomized in error|0|||
154955643|NCT00463606|559263415|FG002|Overall Study|Patient randomized in error|0|||
154955644|NCT00463606|559263413|FG000|Overall Study|Participation in another ABT-335 trial|1|||
154955645|NCT00463606|559263414|FG001|Overall Study|Participation in another ABT-335 trial|0|||
154955646|NCT00463606|559263415|FG002|Overall Study|Participation in another ABT-335 trial|0|||
154955647|NCT00463606|559263413|FG000|Overall Study|Protocol Violation|0|||
154955648|NCT00463606|559263414|FG001|Overall Study|Protocol Violation|0|||
154955649|NCT00463606|559263415|FG002|Overall Study|Protocol Violation|1|||
154955650|NCT02682602|559263417|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
154955651|NCT02682602|559263418|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
154955652|NCT02682602|559263417|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
154955653|NCT02682602|559263418|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
154955654|NCT03567174|559263419|FG000|Overall Study|Death|24|||
154955655|NCT03567174|559263420|FG001|Overall Study|Death|31|||
154955656|NCT03567174|559263419|FG000|Overall Study|Lost to Follow-up|165|||
154955657|NCT03567174|559263420|FG001|Overall Study|Lost to Follow-up|174|||
154955658|NCT02140060|559263421|FG000|Overall Study|Adverse Event|0|||
154955659|NCT02140060|559263422|FG001|Overall Study|Adverse Event|0|||
154955660|NCT02140060|559263423|FG002|Overall Study|Adverse Event|0|||
154955661|NCT02140060|559263424|FG003|Overall Study|Adverse Event|1|||
154955662|NCT02140060|559263425|FG004|Overall Study|Adverse Event|1|||
154955663|NCT02140060|559263426|FG005|Overall Study|Adverse Event|1|||
154955664|NCT02140060|559263421|FG000|Overall Study|Lack of Efficacy|0|||
154955665|NCT02140060|559263422|FG001|Overall Study|Lack of Efficacy|0|||
154955666|NCT02140060|559263423|FG002|Overall Study|Lack of Efficacy|0|||
154955667|NCT02140060|559263424|FG003|Overall Study|Lack of Efficacy|1|||
154955668|NCT02140060|559263425|FG004|Overall Study|Lack of Efficacy|0|||
154955669|NCT02140060|559263426|FG005|Overall Study|Lack of Efficacy|0|||
154955670|NCT00723528|559264919|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
154955671|NCT00723528|559264920|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
154955672|NCT00723528|559264921|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
154955673|NCT00723528|559264922|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
154955674|NCT00723528|559264923|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
154955675|NCT00723528|559264924|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
154955676|NCT00723528|559264925|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
154955677|NCT00723528|559264919|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
154955678|NCT00723528|559264920|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
154955679|NCT00723528|559264921|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
154955680|NCT00723528|559264922|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
154955681|NCT00723528|559264923|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
154955682|NCT00723528|559264924|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
155294334|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
154955683|NCT00723528|559264925|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
154955684|NCT00723528|559264919|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
154955685|NCT00723528|559264920|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
154955686|NCT00723528|559264921|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
154955687|NCT00723528|559264922|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
154955688|NCT00723528|559264923|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
154955689|NCT00723528|559264924|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
154955690|NCT00723528|559264925|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
155156613|NCT04672239|560010739|FG001|Week 2 Survey|Failed survey check items|2|||
155156614|NCT04672239|560010740|FG002|Week 2 Survey|Failed survey check items|3|||
155156615|NCT04672239|560010738|FG000|Week 2 Survey|Partially completed survey|7|||
155156616|NCT04672239|560010739|FG001|Week 2 Survey|Partially completed survey|1|||
155156617|NCT04672239|560010740|FG002|Week 2 Survey|Partially completed survey|4|||
155156618|NCT04672239|560010738|FG000|Week 2 Survey|Withdrawal by Subject|0|||
155156619|NCT04672239|560010739|FG001|Week 2 Survey|Withdrawal by Subject|1|||
155156620|NCT04672239|560010740|FG002|Week 2 Survey|Withdrawal by Subject|0|||
155156621|NCT04672239|560010738|FG000|Week 2 Survey|Lost to Follow-up|3|||
155156622|NCT04672239|560010739|FG001|Week 2 Survey|Lost to Follow-up|2|||
155156623|NCT04672239|560010740|FG002|Week 2 Survey|Lost to Follow-up|5|||
155156624|NCT04672239|560010738|FG000|Week 6 Survey|Failed survey check items|2|||
155156625|NCT04672239|560010739|FG001|Week 6 Survey|Failed survey check items|2|||
155156626|NCT04672239|560010740|FG002|Week 6 Survey|Failed survey check items|2|||
155156627|NCT04672239|560010738|FG000|Week 6 Survey|Partially completed survey|3|||
155156628|NCT04672239|560010739|FG001|Week 6 Survey|Partially completed survey|3|||
155156629|NCT04672239|560010740|FG002|Week 6 Survey|Partially completed survey|2|||
155156630|NCT04672239|560010738|FG000|Week 6 Survey|Withdrawal by Subject|1|||
155156631|NCT04672239|560010739|FG001|Week 6 Survey|Withdrawal by Subject|1|||
155156632|NCT04672239|560010740|FG002|Week 6 Survey|Withdrawal by Subject|1|||
155156633|NCT04672239|560010738|FG000|Week 6 Survey|Withdrawn by PI|0|||
155156634|NCT04672239|560010739|FG001|Week 6 Survey|Withdrawn by PI|1|||
155156635|NCT04672239|560010740|FG002|Week 6 Survey|Withdrawn by PI|0|||
155156636|NCT04672239|560010738|FG000|Week 6 Survey|Lost to Follow-up|12|||
155156637|NCT04672239|560010739|FG001|Week 6 Survey|Lost to Follow-up|2|||
155156638|NCT04672239|560010740|FG002|Week 6 Survey|Lost to Follow-up|5|||
155156639|NCT04672239|560010738|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
155156640|NCT04672239|560010739|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
155156641|NCT04672239|560010740|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
155156642|NCT04672239|560010738|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
155156643|NCT04672239|560010739|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
155156644|NCT04672239|560010740|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
154955691|NCT00723528|559264919|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
154955692|NCT00723528|559264920|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
154955693|NCT00723528|559264921|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
154955694|NCT00723528|559264922|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
154955695|NCT00723528|559264923|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
154955696|NCT00723528|559264924|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155294335|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
155294336|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
154955697|NCT00723528|559264925|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
155156645|NCT04672239|560010738|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
155156646|NCT04672239|560010739|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
155156647|NCT04672239|560010740|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
155156648|NCT04672239|560010738|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
155156649|NCT04672239|560010739|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
155156650|NCT04672239|560010740|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
155156651|NCT04672239|560010738|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
155156652|NCT04672239|560010739|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
155156653|NCT04672239|560010740|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
155156654|NCT04672239|560010738|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
155156655|NCT04672239|560010739|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
154955698|NCT00723528|559264919|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
154955699|NCT00723528|559264920|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
154955700|NCT00723528|559264921|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
154955701|NCT00723528|559264922|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
154955702|NCT00723528|559264923|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
154955703|NCT00723528|559264924|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
155156656|NCT04672239|560010740|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
155156657|NCT04672239|560010738|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
155156658|NCT04672239|560010739|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
155156659|NCT04672239|560010740|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
155156660|NCT03597347|560010741|FG000|Overall Study|Withdrawal by Subject|1|||
155156661|NCT03597347|560010742|FG001|Overall Study|Withdrawal by Subject|1|||
155156662|NCT03597347|560010743|FG002|Overall Study|Withdrawal by Subject|0|||
155156663|NCT03597347|560010741|FG000|Overall Study|Withdrawal due to Covid-19|3|||
155294337|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294338|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
154955704|NCT00723528|559264925|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
154955705|NCT00723528|559264919|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
154955706|NCT00723528|559264920|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
154955707|NCT00723528|559264921|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
154955708|NCT00723528|559264922|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
154955709|NCT00723528|559264923|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
154955710|NCT00723528|559264924|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
154955711|NCT00723528|559264925|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
154955712|NCT00723528|559264919|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
154955713|NCT00723528|559264920|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155294339|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
155294340|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294341|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294342|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155294343|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
155156664|NCT03597347|560010742|FG001|Overall Study|Withdrawal due to Covid-19|0|||
155156665|NCT03597347|560010743|FG002|Overall Study|Withdrawal due to Covid-19|0|||
155156666|NCT03597347|560010741|FG000|Overall Study|Sponsor decision to terminate study|3|||
155156667|NCT03597347|560010742|FG001|Overall Study|Sponsor decision to terminate study|2|||
155156668|NCT03597347|560010743|FG002|Overall Study|Sponsor decision to terminate study|4|||
155156669|NCT00107653|560010744|FG000|Overall Study|Adverse Event|24|||
155156670|NCT00107653|560010745|FG001|Overall Study|Adverse Event|43|||
155156671|NCT00107653|560010744|FG000|Overall Study|Insufficient Therapeutic Response|25|||
155156672|NCT00107653|560010745|FG001|Overall Study|Insufficient Therapeutic Response|11|||
155156673|NCT00107653|560010744|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155156674|NCT00107653|560010745|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155156675|NCT00107653|560010744|FG000|Overall Study|Protocol Violation|1|||
155156676|NCT00107653|560010745|FG001|Overall Study|Protocol Violation|0|||
155156677|NCT00107653|560010744|FG000|Overall Study|Withdrawal by Subject|12|||
155156678|NCT00107653|560010745|FG001|Overall Study|Withdrawal by Subject|13|||
155156679|NCT00107653|560010744|FG000|Overall Study|Lost to Follow-up|13|||
155156680|NCT00107653|560010745|FG001|Overall Study|Lost to Follow-up|5|||
155156681|NCT00107653|560010744|FG000|Overall Study|Administrative Reasons|3|||
155156682|NCT00107653|560010745|FG001|Overall Study|Administrative Reasons|3|||
155156683|NCT00541658|560010746|FG000|Overall Study|Adverse Event|28|||
155156684|NCT00541658|560010747|FG001|Overall Study|Adverse Event|37|||
155156685|NCT00541658|560010748|FG002|Overall Study|Adverse Event|25|||
155156686|NCT00541658|560010746|FG000|Overall Study|Physician Decision|0|||
155156687|NCT00541658|560010747|FG001|Overall Study|Physician Decision|0|||
155156688|NCT00541658|560010748|FG002|Overall Study|Physician Decision|4|||
154955714|NCT00723528|559264921|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
154955715|NCT00723528|559264922|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
154955716|NCT00723528|559264923|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
154955717|NCT00723528|559264924|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
154955718|NCT00723528|559264925|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
155156689|NCT00541658|560010746|FG000|Overall Study|Lost to Follow-up|3|||
154955719|NCT00723528|559264919|FG000|Period 2: After Controlled Period|Other|0|||
154955720|NCT00723528|559264920|FG001|Period 2: After Controlled Period|Other|0|||
154955721|NCT00723528|559264921|FG002|Period 2: After Controlled Period|Other|0|||
155156690|NCT00541658|560010747|FG001|Overall Study|Lost to Follow-up|3|||
155156691|NCT00541658|560010748|FG002|Overall Study|Lost to Follow-up|6|||
155156692|NCT00541658|560010746|FG000|Overall Study|Protocol Violation|0|||
155156693|NCT00541658|560010747|FG001|Overall Study|Protocol Violation|1|||
155156694|NCT00541658|560010748|FG002|Overall Study|Protocol Violation|1|||
155156695|NCT00541658|560010746|FG000|Overall Study|Withdrawal by Subject|28|||
155156696|NCT00541658|560010747|FG001|Overall Study|Withdrawal by Subject|32|||
155156697|NCT00541658|560010748|FG002|Overall Study|Withdrawal by Subject|32|||
155060429|NCT01149655|559655616|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
155060430|NCT01149655|559655617|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
155060431|NCT01149655|559655618|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
155060432|NCT01149655|559655615|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
155060433|NCT01149655|559655616|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155060434|NCT01149655|559655617|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155060435|NCT01149655|559655618|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
155060436|NCT01149655|559655615|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
155060437|NCT01149655|559655616|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
155060438|NCT01149655|559655617|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
155060439|NCT01149655|559655618|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
155060440|NCT01149655|559655615|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
155060441|NCT01149655|559655616|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
155060442|NCT01149655|559655617|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
155060443|NCT01149655|559655618|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
155060444|NCT01149655|559655615|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
155060445|NCT01149655|559655616|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
155060446|NCT01149655|559655617|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
155060447|NCT01149655|559655618|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
155156698|NCT00541658|560010746|FG000|Overall Study|Took No Study Drug|1|||
155156699|NCT00541658|560010747|FG001|Overall Study|Took No Study Drug|0|||
155156700|NCT00541658|560010748|FG002|Overall Study|Took No Study Drug|0|||
155156701|NCT01099267|560010749|FG000|MDS-003 Study|Adverse Event|37|||
155156702|NCT01099267|560010749|FG000|MDS-003 Study|Lack of Efficacy|52|||
155156703|NCT01099267|560010749|FG000|MDS-003 Study|Withdrawal by Subject|8|||
155156704|NCT01099267|560010749|FG000|MDS-003 Study|Lost to Follow-up|1|||
155156705|NCT01099267|560010749|FG000|MDS-003 Study|Death|11|||
155156706|NCT01099267|560010749|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
155156707|NCT01099267|560010749|FG000|MDS-003 Study|Disease Progression|7|||
155156708|NCT01099267|560010749|FG000|MDS-003 Study|Investigator Decision|2|||
154955722|NCT00723528|559264922|FG003|Period 2: After Controlled Period|Other|0|||
154955723|NCT00723528|559264923|FG004|Period 2: After Controlled Period|Other|1|||
154955724|NCT00723528|559264924|FG005|Period 2: After Controlled Period|Other|4|||
154955725|NCT00723528|559264925|FG006|Period 2: After Controlled Period|Other|0|||
154955726|NCT00723528|559264919|FG000|Period 2: After Controlled Period|Adverse Event|0|||
154955727|NCT00723528|559264920|FG001|Period 2: After Controlled Period|Adverse Event|0|||
154955728|NCT00723528|559264921|FG002|Period 2: After Controlled Period|Adverse Event|0|||
154955729|NCT00723528|559264922|FG003|Period 2: After Controlled Period|Adverse Event|0|||
154955730|NCT00723528|559264923|FG004|Period 2: After Controlled Period|Adverse Event|1|||
154955731|NCT00723528|559264924|FG005|Period 2: After Controlled Period|Adverse Event|0|||
154955732|NCT00723528|559264925|FG006|Period 2: After Controlled Period|Adverse Event|1|||
154955733|NCT00723528|559264919|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
154955734|NCT00723528|559264920|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
154955735|NCT00723528|559264921|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
154955736|NCT00723528|559264922|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
154955737|NCT00723528|559264923|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
154955738|NCT00723528|559264924|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
154955739|NCT00723528|559264925|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
154955740|NCT00723528|559264919|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
154955741|NCT00723528|559264920|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
154955742|NCT00723528|559264921|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
154955743|NCT00723528|559264922|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
154955744|NCT00723528|559264923|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
154955745|NCT00723528|559264924|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
154955746|NCT00723528|559264925|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
154955747|NCT00667862|559264928|FG000|Overall Study|Adverse Event|9|||
154955748|NCT00667862|559264928|FG000|Overall Study|Death|1|||
154955749|NCT00667862|559264928|FG000|Overall Study|Disease Progression|22|||
154955750|NCT00667862|559264928|FG000|Overall Study|Withdrawal by Subject|3|||
154955751|NCT00667095|559264934|FG000|Overall Study|Withdrawal by Subject|0|||
154955752|NCT00667095|559264935|FG001|Overall Study|Withdrawal by Subject|1|||
154955753|NCT01435265|559264940|FG000|Overall Study|Lost to Follow-up|0|||
154955754|NCT01435265|559264941|FG001|Overall Study|Lost to Follow-up|1|||
154955755|NCT04605094|559264942|FG000|Overall Study|Adverse Event|2|||
154955756|NCT04605094|559264943|FG001|Overall Study|Adverse Event|2|||
154955757|NCT04605094|559264942|FG000|Overall Study|Lost to Follow-up|1|||
154955758|NCT04605094|559264943|FG001|Overall Study|Lost to Follow-up|4|||
154955759|NCT04605094|559264942|FG000|Overall Study|Physician Decision|2|||
154955760|NCT04605094|559264943|FG001|Overall Study|Physician Decision|2|||
154955761|NCT04605094|559264942|FG000|Overall Study|Study terminated by Sponsor|31|||
154955762|NCT04605094|559264943|FG001|Overall Study|Study terminated by Sponsor|33|||
154955763|NCT04605094|559264942|FG000|Overall Study|Withdrawal by Subject|22|||
154955764|NCT04605094|559264943|FG001|Overall Study|Withdrawal by Subject|19|||
154955765|NCT04605094|559264942|FG000|Overall Study|Other|1|||
154955766|NCT04605094|559264943|FG001|Overall Study|Other|1|||
154955767|NCT02724462|559264944|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
154955768|NCT02724462|559264945|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
154955769|NCT02724462|559264944|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
154955770|NCT02724462|559264945|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
154955771|NCT02724462|559264944|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
154955772|NCT02724462|559264945|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
154955773|NCT02724462|559264944|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
154955774|NCT02724462|559264945|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
155156709|NCT01099267|560010749|FG000|MDS-003 Study|Non-Compliance|2|||
155156710|NCT01099267|560010749|FG000|MDS-003 Study|Loss of Response|1|||
155156711|NCT01099267|560010749|FG000|MDS-003 Study|Secondary Malign Disease|1|||
155156712|NCT04986904|560010750|FG000|Overall Study|Lost to Follow-up|11|||
155156713|NCT04986904|560010750|FG000|Overall Study|Withdrawal by Subject|1|||
155156714|NCT02023086|560010759|FG000|Overall Study|Withdrawal by Subject|2|||
155156715|NCT02023086|560010760|FG001|Overall Study|Withdrawal by Subject|0|||
155156716|NCT04272242|560010765|FG000|Overall Study|Withdrawal by Subject|3|||
155156717|NCT04272242|560010765|FG000|Overall Study|Lost to Follow-up|1|||
155156718|NCT04272242|560010765|FG000|Overall Study|Adverse Event|1|||
155156719|NCT02681523|560010768|FG000|Overall Study|Adverse Event|1|||
155156720|NCT02681523|560010768|FG000|Overall Study|Patient Non-compliance|1|||
155156721|NCT01350999|560010769|FG000|Overall Study|Adverse Event|4|||
155156722|NCT01350999|560010770|FG001|Overall Study|Adverse Event|9|||
155156723|NCT01350999|560010771|FG002|Overall Study|Adverse Event|10|||
155156724|NCT01350999|560010769|FG000|Overall Study|Voluntary withdrawal|3|||
155156725|NCT01350999|560010770|FG001|Overall Study|Voluntary withdrawal|4|||
155156726|NCT01350999|560010771|FG002|Overall Study|Voluntary withdrawal|6|||
155156727|NCT01350999|560010769|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
155156728|NCT01350999|560010770|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
155156729|NCT01350999|560010771|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
155156730|NCT01083771|560012696|FG000|Overall Study|non-compliant|2|||
155156731|NCT01083771|560012696|FG000|Overall Study|Withdrawal by Subject|3|||
155156732|NCT00124943|560012705|FG000|Phase II|Adverse Event|0|||
155156733|NCT00124943|560012706|FG001|Phase II|Adverse Event|2|||
155156734|NCT00124943|560012707|FG002|Phase II|Adverse Event|0|||
155156735|NCT00124943|560012708|FG003|Phase II|Adverse Event|1|||
155156736|NCT00124943|560012705|FG000|Phase II|Protocol Violation|0|||
155156737|NCT00124943|560012706|FG001|Phase II|Protocol Violation|0|||
155156738|NCT00124943|560012707|FG002|Phase II|Protocol Violation|0|||
155156739|NCT00124943|560012708|FG003|Phase II|Protocol Violation|1|||
155156740|NCT00124943|560012705|FG000|Phase II|Lost to Follow-up|0|||
155156741|NCT00124943|560012706|FG001|Phase II|Lost to Follow-up|0|||
155156742|NCT00124943|560012707|FG002|Phase II|Lost to Follow-up|0|||
155156743|NCT00124943|560012708|FG003|Phase II|Lost to Follow-up|1|||
155156744|NCT00124943|560012705|FG000|Phase II|Withdrawal by Subject|0|||
155156745|NCT00124943|560012706|FG001|Phase II|Withdrawal by Subject|0|||
155156746|NCT00124943|560012707|FG002|Phase II|Withdrawal by Subject|0|||
155156747|NCT00124943|560012708|FG003|Phase II|Withdrawal by Subject|2|||
155156748|NCT00321620|560012709|FG000|Overall Study|Death|269|||
155156749|NCT00321620|560012710|FG001|Overall Study|Death|294|||
155156750|NCT00321620|560012709|FG000|Overall Study|Withdrawal by Subject|164|||
155156751|NCT00321620|560012710|FG001|Overall Study|Withdrawal by Subject|147|||
155156752|NCT00321620|560012709|FG000|Overall Study|Disease progression|113|||
155156753|NCT00321620|560012710|FG001|Overall Study|Disease progression|117|||
155156754|NCT00321620|560012709|FG000|Overall Study|Adverse Event|43|||
155156755|NCT00321620|560012710|FG001|Overall Study|Adverse Event|56|||
155156756|NCT00321620|560012709|FG000|Overall Study|Lost to Follow-up|13|||
155156757|NCT00321620|560012710|FG001|Overall Study|Lost to Follow-up|9|||
155156758|NCT00321620|560012709|FG000|Overall Study|Physician Decision|4|||
155156759|NCT00321620|560012710|FG001|Overall Study|Physician Decision|1|||
155156760|NCT00321620|560012709|FG000|Overall Study|Noncompliance|14|||
155156761|NCT00321620|560012710|FG001|Overall Study|Noncompliance|7|||
155156762|NCT00321620|560012709|FG000|Overall Study|Protocol deviation|4|||
155156763|NCT00321620|560012710|FG001|Overall Study|Protocol deviation|3|||
155156764|NCT00321620|560012709|FG000|Overall Study|Ineligibility determined|2|||
155156765|NCT00321620|560012710|FG001|Overall Study|Ineligibility determined|3|||
155156766|NCT00321620|560012709|FG000|Overall Study|Participant request|75|||
155156767|NCT00321620|560012710|FG001|Overall Study|Participant request|52|||
155156768|NCT00321620|560012709|FG000|Overall Study|Other|42|||
154955775|NCT02724462|559264944|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
154955776|NCT02724462|559264945|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
154955777|NCT02724462|559264944|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
154955778|NCT02724462|559264945|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
154955779|NCT00469417|559264948|FG000|Overall Study|Treatment failure all lesions|18|||
154955780|NCT00469417|559264949|FG001|Overall Study|Treatment failure all lesions|11|||
154955781|NCT00469417|559264948|FG000|Overall Study|Consent withdrawn|1|||
154955782|NCT00469417|559264949|FG001|Overall Study|Consent withdrawn|1|||
154955783|NCT00469417|559264948|FG000|Overall Study|Adverse Event|8|||
154955784|NCT00469417|559264949|FG001|Overall Study|Adverse Event|2|||
154955785|NCT00469417|559264948|FG000|Overall Study|Lost to Follow-up|1|||
154955786|NCT00469417|559264949|FG001|Overall Study|Lost to Follow-up|2|||
154955787|NCT00469417|559264948|FG000|Overall Study|Intercurrent disease|0|||
154955788|NCT00469417|559264949|FG001|Overall Study|Intercurrent disease|1|||
154955789|NCT00469417|559264948|FG000|Overall Study|Randomized but not treated|2|||
154955790|NCT00469417|559264949|FG001|Overall Study|Randomized but not treated|0|||
154955791|NCT05038293|559264952|FG000|Overall Study|device was not operating properly for one subject.|1|||
154955792|NCT05038293|559264953|FG001|Overall Study|device was not operating properly for one subject.|0|||
154955793|NCT05038293|559264952|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
154955794|NCT05038293|559264953|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
154955795|NCT01171989|559264955|FG000|Overall Study|Lost to Follow-up|0|||
154955796|NCT01171989|559264956|FG001|Overall Study|Lost to Follow-up|0|||
154955797|NCT01171989|559264957|FG002|Overall Study|Lost to Follow-up|1|||
154955798|NCT01247701|559264959|FG000|Overall Study|Death|2|||
154955799|NCT01247701|559264959|FG000|Overall Study|Relapsed|8|||
154955800|NCT01034358|559264960|FG000|Overall Study|Withdrawal by Subject|1|||
154955801|NCT01034358|559264960|FG000|Overall Study|Protocol Violation|1|||
154955802|NCT01838941|559264961|FG000|Overall Study|Adverse Event|1|||
154955803|NCT01838941|559264961|FG000|Overall Study|Withdrawal by Subject|1|||
154955804|NCT02822235|559264962|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
154955805|NCT02822235|559264963|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
154955806|NCT02822235|559264962|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
154955807|NCT02822235|559264963|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
154955808|NCT02822235|559264962|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
154955809|NCT02822235|559264963|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
154955810|NCT02822235|559264962|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
154955811|NCT02822235|559264963|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
154955812|NCT02822235|559264962|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
154955813|NCT02822235|559264963|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
154955814|NCT02822235|559264962|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
154955815|NCT02822235|559264963|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
154955816|NCT00377260|559264968|FG000|Overall Study|Lost to Follow-up|0|||
154955817|NCT00377260|559264969|FG001|Overall Study|Lost to Follow-up|1|||
154955818|NCT00377260|559264968|FG000|Overall Study|Withdrawal by Subject|2|||
154955819|NCT00377260|559264969|FG001|Overall Study|Withdrawal by Subject|4|||
154955820|NCT00829530|559264970|FG000|First Intervention|Adverse Event|0|||
154955821|NCT00829530|559264971|FG001|First Intervention|Adverse Event|1|||
154955822|NCT00829530|559264970|FG000|First Intervention|Intolerance to Venopuncture|0|||
154955823|NCT00829530|559264971|FG001|First Intervention|Intolerance to Venopuncture|1|||
154955824|NCT00829530|559264970|FG000|Second Intervention|Intolerance to Venopuncture|1|||
154955825|NCT00829530|559264971|FG001|Second Intervention|Intolerance to Venopuncture|0|||
154955826|NCT04466111|559264974|FG000|Prior to Trial Phase|Physician Decision|1|||
154955827|NCT00105196|559264975|FG000|Overall Study|Lack of Efficacy|2|||
154955828|NCT00105196|559264976|FG001|Overall Study|Lack of Efficacy|3|||
154955829|NCT00105196|559264975|FG000|Overall Study|Adverse Event|11|||
154955830|NCT00105196|559264976|FG001|Overall Study|Adverse Event|3|||
154955831|NCT00105196|559264975|FG000|Overall Study|Withdrawal by Subject|6|||
154955832|NCT00105196|559264976|FG001|Overall Study|Withdrawal by Subject|6|||
154955833|NCT00105196|559264975|FG000|Overall Study|Lost to Follow-up|3|||
154955834|NCT00105196|559264976|FG001|Overall Study|Lost to Follow-up|2|||
154955835|NCT00105196|559264975|FG000|Overall Study|Poor/noncompliance|3|||
154955836|NCT00105196|559264976|FG001|Overall Study|Poor/noncompliance|4|||
154955837|NCT00105196|559264975|FG000|Overall Study|Protocol Violation|5|||
154955838|NCT00105196|559264976|FG001|Overall Study|Protocol Violation|2|||
154955839|NCT00105196|559264975|FG000|Overall Study|pending surgery|0|||
154955840|NCT00105196|559264976|FG001|Overall Study|pending surgery|1|||
154955841|NCT00105196|559264975|FG000|Overall Study|marijuana use|0|||
154955842|NCT00105196|559264976|FG001|Overall Study|marijuana use|1|||
154955843|NCT00105196|559264975|FG000|Overall Study|Subject became unblinded|0|||
154955844|NCT00105196|559264976|FG001|Overall Study|Subject became unblinded|1|||
154955845|NCT00893464|559264977|FG000|Overall Study|Did not complete therapy/experience PD|0|||
154955846|NCT00893464|559264978|FG001|Overall Study|Did not complete therapy/experience PD|0|||
155060448|NCT01149655|559655615|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
155060449|NCT01149655|559655616|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
155060450|NCT01149655|559655617|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
155060451|NCT01149655|559655618|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
155060452|NCT01149655|559655615|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
155060453|NCT01149655|559655616|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
155060454|NCT01149655|559655617|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
155060455|NCT01149655|559655618|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
155060456|NCT01149655|559655615|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
155060457|NCT01149655|559655616|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
155060458|NCT01149655|559655617|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
155060459|NCT01149655|559655618|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
155060460|NCT01149655|559655615|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
155156769|NCT00321620|560012710|FG001|Overall Study|Other|33|||
155156770|NCT03181932|560012711|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
155156771|NCT03181932|560012712|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
155156772|NCT03181932|560012711|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
155156773|NCT03181932|560012712|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
155156774|NCT03181932|560012711|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
155156775|NCT03181932|560012712|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
155156776|NCT03181932|560012711|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
155156777|NCT03181932|560012712|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
155156778|NCT03181932|560012711|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
155156779|NCT03181932|560012712|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
155156780|NCT03181932|560012711|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
155156781|NCT03181932|560012712|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
155156782|NCT03181932|560012711|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
155156783|NCT03181932|560012712|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
155156784|NCT03181932|560012711|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
155156785|NCT03181932|560012712|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
155156786|NCT03181932|560012711|FG000|Period 2 (Open-label Period)|Reason missing|2|||
155156787|NCT03181932|560012712|FG001|Period 2 (Open-label Period)|Reason missing|0|||
155156788|NCT00408317|560012717|FG000|First Intervention Period|Adverse Event|0|||
155156789|NCT00408317|560012718|FG001|First Intervention Period|Adverse Event|1|||
155156790|NCT00408317|560012717|FG000|Second Intervention Period|Adverse Event|2|||
155156791|NCT00408317|560012718|FG001|Second Intervention Period|Adverse Event|0|||
155156792|NCT00408317|560012717|FG000|Second Intervention Period|Protocol Violation|0|||
155156793|NCT00408317|560012718|FG001|Second Intervention Period|Protocol Violation|1|||
155156794|NCT00408317|560012717|FG000|Second Intervention Period|Withdrawal of consent|0|||
155156795|NCT00408317|560012718|FG001|Second Intervention Period|Withdrawal of consent|1|||
155156796|NCT01747876|560012719|FG000|Overall Study|Adverse Event|1|||
155156797|NCT01747876|560012720|FG001|Overall Study|Adverse Event|0|||
155156798|NCT01747876|560012721|FG002|Overall Study|Adverse Event|2|||
155156799|NCT01747876|560012719|FG000|Overall Study|Withdrawal by Subject|0|||
155156800|NCT01747876|560012720|FG001|Overall Study|Withdrawal by Subject|1|||
155156801|NCT01747876|560012721|FG002|Overall Study|Withdrawal by Subject|1|||
155156802|NCT01747876|560012719|FG000|Overall Study|Disease progression|4|||
155156803|NCT01747876|560012720|FG001|Overall Study|Disease progression|13|||
155156804|NCT01747876|560012721|FG002|Overall Study|Disease progression|8|||
155156805|NCT01747876|560012719|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
155156806|NCT01747876|560012720|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
155156807|NCT01747876|560012721|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
155156808|NCT00853307|560012722|FG000|Overall Study|Adverse Event|1|||
155156809|NCT00853307|560012723|FG001|Overall Study|Adverse Event|2|||
155156810|NCT00853307|560012722|FG000|Overall Study|Withdrawal by Subject|1|||
155156811|NCT00853307|560012723|FG001|Overall Study|Withdrawal by Subject|2|||
155156812|NCT00853307|560012722|FG000|Overall Study|Reason Not Specified|0|||
155156813|NCT00853307|560012723|FG001|Overall Study|Reason Not Specified|1|||
155156814|NCT02177123|560012728|FG000|Overall Study|Lost to Follow-up|6|||
155156815|NCT02177123|560012728|FG000|Overall Study|Withdrawal by Subject|4|||
155156816|NCT02177123|560012728|FG000|Overall Study|Adverse Event|4|||
155156817|NCT02177123|560012728|FG000|Overall Study|Physician Decision|3|||
155156818|NCT02177123|560012728|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
155156819|NCT02177123|560012728|FG000|Overall Study|Excluded for medical reasons|2|||
155156820|NCT02177123|560012728|FG000|Overall Study|Death|1|||
155156821|NCT02177123|560012728|FG000|Overall Study|Other|1|||
155156822|NCT02177123|560012728|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
155156823|NCT01391546|560012729|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
155156824|NCT01391546|560012730|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
155156825|NCT01921205|560012736|FG000|Overall Study|Adverse Event|12|||
155156826|NCT01921205|560012737|FG001|Overall Study|Adverse Event|7|||
154955847|NCT00893464|559264979|FG002|Overall Study|Did not complete therapy/experience PD|0|||
154955848|NCT00893464|559264980|FG003|Overall Study|Did not complete therapy/experience PD|0|||
154955849|NCT00893464|559264981|FG004|Overall Study|Did not complete therapy/experience PD|0|||
154955850|NCT00893464|559264982|FG005|Overall Study|Did not complete therapy/experience PD|0|||
154955851|NCT00893464|559264983|FG006|Overall Study|Did not complete therapy/experience PD|2|||
154955852|NCT00893464|559264984|FG007|Overall Study|Did not complete therapy/experience PD|2|||
154955853|NCT02661295|559264996|FG000|Overall Study|Death|1|||
154955854|NCT02661295|559264996|FG000|Overall Study|Transferred Out|1|||
154955855|NCT02661295|559264996|FG000|Overall Study|Kidney Transplant|1|||
154955856|NCT02661295|559264996|FG000|Overall Study|Withdrawn due to side effects|8|||
154955857|NCT02661295|559264996|FG000|Overall Study|Withdrawn due to access type|1|||
154955858|NCT02661295|559264996|FG000|Overall Study|Withdrawn due to allergies|1|||
154955859|NCT02661295|559264996|FG000|Overall Study|Withdrawn due to non-compliance|1|||
154955860|NCT02661295|559264996|FG000|Overall Study|Withdrawal by Subject|3|||
154955861|NCT02661295|559264996|FG000|Overall Study|Failed screening|2|||
154955862|NCT02336165|559264997|FG000|Overall Study|Death|3|||
154955863|NCT02336165|559264998|FG001|Overall Study|Death|0|||
154955864|NCT02336165|559264999|FG002|Overall Study|Death|0|||
154955865|NCT02336165|559265000|FG003|Overall Study|Death|0|||
154955866|NCT02336165|559265001|FG004|Overall Study|Death|1|||
155156827|NCT01921205|560012736|FG000|Overall Study|Lack of Efficacy|1|||
155156828|NCT01921205|560012737|FG001|Overall Study|Lack of Efficacy|0|||
155156829|NCT01921205|560012736|FG000|Overall Study|Protocol Violation|1|||
155156830|NCT01921205|560012737|FG001|Overall Study|Protocol Violation|3|||
155156831|NCT01921205|560012736|FG000|Overall Study|Lost to Follow-up|1|||
155156832|NCT01921205|560012737|FG001|Overall Study|Lost to Follow-up|1|||
155156833|NCT01921205|560012736|FG000|Overall Study|Withdrawal by Subject|6|||
155156834|NCT01921205|560012737|FG001|Overall Study|Withdrawal by Subject|5|||
155156835|NCT01921205|560012736|FG000|Overall Study|Use Of Prohibited Medication|0|||
155156836|NCT01921205|560012737|FG001|Overall Study|Use Of Prohibited Medication|1|||
155156837|NCT01921205|560012736|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
155156838|NCT01921205|560012737|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
155156839|NCT01921205|560012736|FG000|Overall Study|Non Compliance Of The Parent|0|||
155156840|NCT01921205|560012737|FG001|Overall Study|Non Compliance Of The Parent|1|||
155156841|NCT01921205|560012736|FG000|Overall Study|Non Compliance Of Child|0|||
155156842|NCT01921205|560012737|FG001|Overall Study|Non Compliance Of Child|1|||
155156843|NCT03125395|560012759|FG000|Overall Study|Adverse Event|2|||
155156844|NCT03125395|560012759|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155156845|NCT03125395|560012759|FG000|Overall Study|Physician Decision|2|||
155156846|NCT03125395|560012759|FG000|Overall Study|Commercial drug is available|5|||
155156847|NCT02531802|560012760|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
155156848|NCT02531802|560012761|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
155156849|NCT02531802|560012762|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
155156850|NCT02531802|560012763|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
155156851|NCT02531802|560012764|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
155156852|NCT02531802|560012765|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
155156853|NCT02531802|560012766|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
155156854|NCT02531802|560012767|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
155156855|NCT02531802|560012768|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
155156856|NCT02531802|560012769|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
155156857|NCT02531802|560012770|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
155156858|NCT02531802|560012771|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
155156859|NCT02531802|560012772|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
155156860|NCT02531802|560012773|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
155156861|NCT02531802|560012774|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
155156862|NCT02531802|560012775|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
155156863|NCT02531802|560012776|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
155156864|NCT02531802|560012777|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
155156865|NCT02531802|560012778|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
155156866|NCT02531802|560012779|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
155156867|NCT02531802|560012780|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
155156868|NCT02531802|560012760|FG000|Received Vaccination 2|Physician Decision|0|||
155156869|NCT02531802|560012761|FG001|Received Vaccination 2|Physician Decision|0|||
155156870|NCT02531802|560012762|FG002|Received Vaccination 2|Physician Decision|0|||
155156871|NCT02531802|560012763|FG003|Received Vaccination 2|Physician Decision|0|||
155156872|NCT02531802|560012764|FG004|Received Vaccination 2|Physician Decision|0|||
155156873|NCT02531802|560012765|FG005|Received Vaccination 2|Physician Decision|1|||
155156874|NCT02531802|560012766|FG006|Received Vaccination 2|Physician Decision|0|||
155156875|NCT02531802|560012767|FG007|Received Vaccination 2|Physician Decision|0|||
155156876|NCT02531802|560012768|FG008|Received Vaccination 2|Physician Decision|0|||
155156877|NCT02531802|560012769|FG009|Received Vaccination 2|Physician Decision|2|||
155156878|NCT02531802|560012770|FG010|Received Vaccination 2|Physician Decision|0|||
155156879|NCT02531802|560012771|FG011|Received Vaccination 2|Physician Decision|0|||
155156880|NCT02531802|560012772|FG012|Received Vaccination 2|Physician Decision|0|||
155156881|NCT02531802|560012773|FG013|Received Vaccination 2|Physician Decision|1|||
155156882|NCT02531802|560012774|FG014|Received Vaccination 2|Physician Decision|0|||
155156883|NCT02531802|560012775|FG015|Received Vaccination 2|Physician Decision|0|||
155156884|NCT02531802|560012776|FG016|Received Vaccination 2|Physician Decision|0|||
155156885|NCT02531802|560012777|FG017|Received Vaccination 2|Physician Decision|1|||
155156886|NCT02531802|560012778|FG018|Received Vaccination 2|Physician Decision|0|||
155156887|NCT02531802|560012779|FG019|Received Vaccination 2|Physician Decision|0|||
155156888|NCT02531802|560012780|FG020|Received Vaccination 2|Physician Decision|0|||
155156889|NCT02531802|560012760|FG000|Received Vaccination 2|Adverse Event|0|||
155156890|NCT02531802|560012761|FG001|Received Vaccination 2|Adverse Event|0|||
155156891|NCT02531802|560012762|FG002|Received Vaccination 2|Adverse Event|0|||
155156892|NCT02531802|560012763|FG003|Received Vaccination 2|Adverse Event|0|||
155156893|NCT02531802|560012764|FG004|Received Vaccination 2|Adverse Event|0|||
155156894|NCT02531802|560012765|FG005|Received Vaccination 2|Adverse Event|2|||
155156895|NCT02531802|560012766|FG006|Received Vaccination 2|Adverse Event|0|||
155156896|NCT02531802|560012767|FG007|Received Vaccination 2|Adverse Event|0|||
155156897|NCT02531802|560012768|FG008|Received Vaccination 2|Adverse Event|0|||
155156898|NCT02531802|560012769|FG009|Received Vaccination 2|Adverse Event|0|||
155156899|NCT02531802|560012770|FG010|Received Vaccination 2|Adverse Event|0|||
155156900|NCT02531802|560012771|FG011|Received Vaccination 2|Adverse Event|0|||
155156901|NCT02531802|560012772|FG012|Received Vaccination 2|Adverse Event|0|||
155156902|NCT02531802|560012773|FG013|Received Vaccination 2|Adverse Event|0|||
155156903|NCT02531802|560012774|FG014|Received Vaccination 2|Adverse Event|0|||
155156904|NCT02531802|560012775|FG015|Received Vaccination 2|Adverse Event|0|||
155156905|NCT02531802|560012776|FG016|Received Vaccination 2|Adverse Event|0|||
155156906|NCT02531802|560012777|FG017|Received Vaccination 2|Adverse Event|2|||
155156907|NCT02531802|560012778|FG018|Received Vaccination 2|Adverse Event|1|||
155156908|NCT02531802|560012779|FG019|Received Vaccination 2|Adverse Event|0|||
155156909|NCT02531802|560012780|FG020|Received Vaccination 2|Adverse Event|1|||
155156910|NCT02531802|560012760|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
155156911|NCT02531802|560012761|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
155156912|NCT02531802|560012762|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
155156913|NCT02531802|560012763|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
155156914|NCT02531802|560012764|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
155156915|NCT02531802|560012765|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
154955867|NCT02336165|559264997|FG000|Overall Study|Physician Decision|2|||
154955868|NCT02336165|559264998|FG001|Overall Study|Physician Decision|2|||
154955869|NCT02336165|559264999|FG002|Overall Study|Physician Decision|1|||
154955870|NCT02336165|559265000|FG003|Overall Study|Physician Decision|1|||
154955871|NCT02336165|559265001|FG004|Overall Study|Physician Decision|0|||
154955872|NCT02336165|559264997|FG000|Overall Study|Withdrawal by Subject|0|||
154955873|NCT02336165|559264998|FG001|Overall Study|Withdrawal by Subject|0|||
154955874|NCT02336165|559264999|FG002|Overall Study|Withdrawal by Subject|1|||
154955875|NCT02336165|559265000|FG003|Overall Study|Withdrawal by Subject|0|||
154955876|NCT02336165|559265001|FG004|Overall Study|Withdrawal by Subject|1|||
154955877|NCT02336165|559264997|FG000|Overall Study|Adverse Event|4|||
154955878|NCT02336165|559264998|FG001|Overall Study|Adverse Event|1|||
154955879|NCT02336165|559264999|FG002|Overall Study|Adverse Event|2|||
154955880|NCT02336165|559265000|FG003|Overall Study|Adverse Event|4|||
154955881|NCT02336165|559265001|FG004|Overall Study|Adverse Event|1|||
154955882|NCT02336165|559264997|FG000|Overall Study|Progressive disease|23|||
154955883|NCT02336165|559264998|FG001|Overall Study|Progressive disease|22|||
154955884|NCT02336165|559264999|FG002|Overall Study|Progressive disease|27|||
154955885|NCT02336165|559265000|FG003|Overall Study|Progressive disease|24|||
154955886|NCT02336165|559265001|FG004|Overall Study|Progressive disease|19|||
154955887|NCT02336165|559264997|FG000|Overall Study|Non-compliance|1|||
154955888|NCT02336165|559264998|FG001|Overall Study|Non-compliance|0|||
154955889|NCT02336165|559264999|FG002|Overall Study|Non-compliance|0|||
154955890|NCT02336165|559265000|FG003|Overall Study|Non-compliance|1|||
154955891|NCT02336165|559265001|FG004|Overall Study|Non-compliance|0|||
154955892|NCT02336165|559264997|FG000|Overall Study|Other|1|||
154955893|NCT02336165|559264998|FG001|Overall Study|Other|0|||
154955894|NCT02336165|559264999|FG002|Overall Study|Other|0|||
154955895|NCT02336165|559265000|FG003|Overall Study|Other|1|||
154955896|NCT02336165|559265001|FG004|Overall Study|Other|0|||
154955897|NCT00910663|559265004|FG000|Period 1|Withdrawal by Subject|0|||
154955898|NCT00910663|559265005|FG001|Period 1|Withdrawal by Subject|1|||
154955899|NCT02726581|559265006|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
154955900|NCT02726581|559265007|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
154955901|NCT02726581|559265008|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
154955902|NCT02726581|559265006|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
154955903|NCT02726581|559265007|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
154955904|NCT02726581|559265008|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
154955905|NCT02726581|559265006|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
154955906|NCT02726581|559265007|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154955907|NCT02726581|559265008|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154955908|NCT02726581|559265006|FG000|Treatment Period|Disease progression|47|||
154955909|NCT02726581|559265007|FG001|Treatment Period|Disease progression|50|||
154955910|NCT02726581|559265008|FG002|Treatment Period|Disease progression|16|||
154955911|NCT02726581|559265006|FG000|Treatment Period|Other reasons|9|||
155156916|NCT02531802|560012766|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
154955912|NCT02726581|559265007|FG001|Treatment Period|Other reasons|8|||
154955913|NCT02726581|559265008|FG002|Treatment Period|Other reasons|2|||
154955914|NCT02726581|559265006|FG000|Treatment Period|Study drug toxicity|6|||
154955915|NCT02726581|559265007|FG001|Treatment Period|Study drug toxicity|3|||
154955916|NCT02726581|559265008|FG002|Treatment Period|Study drug toxicity|2|||
155156917|NCT02531802|560012767|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
154955917|NCT02726581|559265006|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
154955918|NCT02726581|559265007|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
154955919|NCT02726581|559265008|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
155156918|NCT02531802|560012768|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
155060461|NCT01149655|559655616|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
155060462|NCT01149655|559655617|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
155060463|NCT01149655|559655618|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
155060464|NCT01149655|559655615|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
155060465|NCT01149655|559655616|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
155060466|NCT01149655|559655617|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
155294344|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
155294345|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
155294346|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155060467|NCT01149655|559655618|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
155060468|NCT01149655|559655615|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
155060469|NCT01149655|559655616|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
155060470|NCT01149655|559655617|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
155060471|NCT01149655|559655618|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
155156919|NCT02531802|560012769|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
155156920|NCT02531802|560012770|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
155156921|NCT02531802|560012771|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
155156922|NCT02531802|560012772|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
155156923|NCT02531802|560012773|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
155156924|NCT02531802|560012774|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
155156925|NCT02531802|560012775|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
155156926|NCT02531802|560012776|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
155156927|NCT02531802|560012777|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
155156928|NCT02531802|560012778|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
155156929|NCT02531802|560012779|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
155156930|NCT02531802|560012780|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
155156931|NCT04030143|560012782|FG000|Overall Study|Adverse Event|5|||
155156932|NCT04030143|560012783|FG001|Overall Study|Adverse Event|10|||
155156933|NCT04030143|560012782|FG000|Overall Study|Lost to Follow-up|3|||
155156934|NCT04030143|560012783|FG001|Overall Study|Lost to Follow-up|7|||
155156935|NCT04030143|560012782|FG000|Overall Study|Protocol Deviation|2|||
155156936|NCT04030143|560012783|FG001|Overall Study|Protocol Deviation|2|||
155156937|NCT04030143|560012782|FG000|Overall Study|Withdrawal by Subject|16|||
155156938|NCT04030143|560012783|FG001|Overall Study|Withdrawal by Subject|18|||
155156939|NCT04030143|560012782|FG000|Overall Study|Physician Decision|1|||
155156940|NCT04030143|560012783|FG001|Overall Study|Physician Decision|1|||
155156941|NCT04030143|560012782|FG000|Overall Study|Due to Covid-19|2|||
155156942|NCT04030143|560012783|FG001|Overall Study|Due to Covid-19|3|||
155156943|NCT04030143|560012782|FG000|Overall Study|Not Due to Covid-19|1|||
155156944|NCT04030143|560012783|FG001|Overall Study|Not Due to Covid-19|1|||
155156945|NCT01352715|560012784|FG000|Overall Study|Death|3|||
155156946|NCT01352715|560012785|FG001|Overall Study|Death|3|||
155156947|NCT01352715|560012784|FG000|Overall Study|Lost to Follow-up|5|||
155156948|NCT01352715|560012785|FG001|Overall Study|Lost to Follow-up|7|||
155156949|NCT01352715|560012784|FG000|Overall Study|Withdrawal by Subject|4|||
155156950|NCT01352715|560012785|FG001|Overall Study|Withdrawal by Subject|8|||
155156951|NCT01352715|560012784|FG000|Overall Study|site closure|16|||
155156952|NCT01352715|560012785|FG001|Overall Study|site closure|15|||
155156953|NCT01352715|560012784|FG000|Overall Study|no final visit in closeout period|15|||
155156954|NCT01352715|560012785|FG001|Overall Study|no final visit in closeout period|12|||
155156955|NCT01352715|560012784|FG000|Overall Study|major ineligibility|2|||
155156956|NCT01352715|560012785|FG001|Overall Study|major ineligibility|1|||
155156957|NCT02000440|560012787|FG000|Overall Study|Adverse Event|3|||
155294347|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
155156958|NCT02000440|560012787|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
155156959|NCT05966142|560012788|FG000|Overall Study|Death|3|||
155156960|NCT05966142|560012789|FG001|Overall Study|Death|3|||
155156961|NCT05966142|560012788|FG000|Overall Study|Lost to Follow-up|55|||
155156962|NCT05966142|560012789|FG001|Overall Study|Lost to Follow-up|52|||
155156963|NCT05966142|560012788|FG000|Overall Study|Physician Decision|1|||
155156964|NCT05966142|560012789|FG001|Overall Study|Physician Decision|0|||
155156965|NCT05966142|560012788|FG000|Overall Study|Withdrawal by Subject|9|||
155156966|NCT05966142|560012789|FG001|Overall Study|Withdrawal by Subject|8|||
155156967|NCT05966142|560012788|FG000|Overall Study|Duplicate Enrollment|1|||
155156968|NCT05966142|560012789|FG001|Overall Study|Duplicate Enrollment|0|||
155156969|NCT05966142|560012788|FG000|Overall Study|Study Logistical Reason|1|||
155156970|NCT05966142|560012789|FG001|Overall Study|Study Logistical Reason|0|||
155156971|NCT05966142|560012788|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
155156972|NCT05966142|560012789|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
155156973|NCT04849364|560012790|FG000|Overall Study|Eligibility criteria not meet|0|||
155156974|NCT04849364|560012791|FG001|Overall Study|Eligibility criteria not meet|1|||
155156975|NCT04849364|560012792|FG002|Overall Study|Eligibility criteria not meet|0|||
155156976|NCT01643668|560012793|FG000|Overall Study|Death|1|||
155156977|NCT03253796|560012796|FG000|Period 1: Run-In|Adverse Event|4|||
155156978|NCT03253796|560012797|FG001|Period 1: Run-In|Adverse Event|0|||
155156979|NCT03253796|560012798|FG002|Period 1: Run-In|Adverse Event|0|||
155156980|NCT03253796|560012799|FG003|Period 1: Run-In|Adverse Event|0|||
155156981|NCT03253796|560012800|FG004|Period 1: Run-In|Adverse Event|0|||
155156982|NCT03253796|560012796|FG000|Period 1: Run-In|Lack of Efficacy|1|||
155156983|NCT03253796|560012797|FG001|Period 1: Run-In|Lack of Efficacy|0|||
155156984|NCT03253796|560012798|FG002|Period 1: Run-In|Lack of Efficacy|0|||
155156985|NCT03253796|560012799|FG003|Period 1: Run-In|Lack of Efficacy|0|||
155156986|NCT03253796|560012800|FG004|Period 1: Run-In|Lack of Efficacy|0|||
155156987|NCT03253796|560012796|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
155156988|NCT03253796|560012797|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
155156989|NCT03253796|560012798|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
155156990|NCT03253796|560012799|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
155156991|NCT03253796|560012800|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
155156992|NCT03253796|560012796|FG000|Period 1: Run-In|Protocol Violation|5|||
155156993|NCT03253796|560012797|FG001|Period 1: Run-In|Protocol Violation|0|||
155156994|NCT03253796|560012798|FG002|Period 1: Run-In|Protocol Violation|0|||
155156995|NCT03253796|560012799|FG003|Period 1: Run-In|Protocol Violation|0|||
155294348|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294349|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155156996|NCT03253796|560012800|FG004|Period 1: Run-In|Protocol Violation|0|||
155156997|NCT03253796|560012796|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
155156998|NCT03253796|560012797|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
155156999|NCT03253796|560012798|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
155157000|NCT03253796|560012799|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
155157001|NCT03253796|560012800|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
155157002|NCT03253796|560012796|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155157003|NCT03253796|560012797|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155157004|NCT03253796|560012798|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
155157005|NCT03253796|560012799|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155157006|NCT03253796|560012800|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
155157007|NCT03253796|560012796|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155157008|NCT03253796|560012797|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155157009|NCT03253796|560012798|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
155157010|NCT03253796|560012799|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155157011|NCT03253796|560012800|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
155157012|NCT03253796|560012796|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
155157013|NCT03253796|560012797|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
155157014|NCT03253796|560012798|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
155157015|NCT03253796|560012799|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
155157016|NCT03253796|560012800|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
155157017|NCT03253796|560012796|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155157018|NCT03253796|560012797|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155157019|NCT03253796|560012798|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
155157020|NCT03253796|560012799|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155157021|NCT03253796|560012800|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
155157022|NCT03253796|560012796|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
155294350|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155157023|NCT03253796|560012797|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
155170025|NCT00830869|560062416|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
155157024|NCT03253796|560012798|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
155157025|NCT03253796|560012799|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
155157026|NCT03253796|560012800|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
155157027|NCT03253796|560012796|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155157028|NCT03253796|560012797|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155157029|NCT03253796|560012798|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155157030|NCT03253796|560012799|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
155157031|NCT03253796|560012800|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
155157032|NCT00894803|560012801|FG000|Overall Study|Death|20|||
155157033|NCT00894803|560012802|FG001|Overall Study|Death|4|||
155157034|NCT00894803|560012801|FG000|Overall Study|Lost to Follow-up|0|||
155157035|NCT00894803|560012802|FG001|Overall Study|Lost to Follow-up|1|||
155157036|NCT03944577|560012806|FG000|Overall Study|Adverse Event|3|||
155157037|NCT03011099|560012807|FG000|Overall Study|Withdrawal by Subject|0|||
155157038|NCT03011099|560012808|FG001|Overall Study|Withdrawal by Subject|2|||
155157039|NCT00283296|560012811|FG000|Overall Study|in-home trial not completed|5|||
155157040|NCT03558737|560012812|FG000|Overall Study|Death|1|||
155157041|NCT03558737|560012813|FG001|Overall Study|Death|1|||
155157042|NCT01409707|560012814|FG000|Overall Study|Withdrawal by Subject|5|||
155157043|NCT01409707|560012815|FG001|Overall Study|Withdrawal by Subject|17|||
155157044|NCT01409707|560012816|FG002|Overall Study|Withdrawal by Subject|16|||
155157045|NCT01217229|560012817|FG000|Overall Study|Adverse Event|1|||
155157046|NCT01217229|560012817|FG000|Overall Study|Disease progression, deterioration|2|||
155157047|NCT01217229|560012817|FG000|Overall Study|Disease progression, Cheson criteria|14|||
155157048|NCT01217229|560012817|FG000|Overall Study|Protocol Violation|1|||
155157049|NCT01217229|560012817|FG000|Overall Study|Disease progression not confirmed|2|||
155157050|NCT03058146|560012818|FG000|Overall Study|Withdrawal by Subject|4|||
154955920|NCT02726581|559265006|FG000|Treatment Period|Participant withdrew consent|3|||
154955921|NCT02726581|559265007|FG001|Treatment Period|Participant withdrew consent|1|||
154955922|NCT02726581|559265008|FG002|Treatment Period|Participant withdrew consent|1|||
154955923|NCT02726581|559265006|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
154955924|NCT02726581|559265007|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
154955925|NCT02726581|559265008|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
154955926|NCT02726581|559265006|FG000|Treatment Period|Maximum clinical benefit|0|||
154955927|NCT02726581|559265007|FG001|Treatment Period|Maximum clinical benefit|2|||
154955928|NCT02726581|559265008|FG002|Treatment Period|Maximum clinical benefit|0|||
154955929|NCT02726581|559265006|FG000|Treatment Period|Death|1|||
154955930|NCT02726581|559265007|FG001|Treatment Period|Death|0|||
154955931|NCT02726581|559265008|FG002|Treatment Period|Death|0|||
154955932|NCT02726581|559265006|FG000|Treatment Period|Poor/non-compliance|1|||
154955933|NCT02726581|559265007|FG001|Treatment Period|Poor/non-compliance|0|||
154955934|NCT02726581|559265008|FG002|Treatment Period|Poor/non-compliance|0|||
154955935|NCT02726581|559265006|FG000|Treatment Period|Participant no longer meets study criteria|0|||
154955936|NCT02726581|559265007|FG001|Treatment Period|Participant no longer meets study criteria|1|||
154955937|NCT02726581|559265008|FG002|Treatment Period|Participant no longer meets study criteria|0|||
154955938|NCT01844375|559265012|FG000|Overall Study|Protocol Violation|1|||
154955939|NCT01844375|559265013|FG001|Overall Study|Protocol Violation|1|||
154955940|NCT04239872|559265014|FG000|Overall Study|Lost to Follow-up|0|||
154955941|NCT04239872|559265015|FG001|Overall Study|Lost to Follow-up|1|||
154955942|NCT01498120|559265019|FG000|Overall Study|Lost to Follow-up|1|||
154955943|NCT01498120|559265019|FG000|Overall Study|Withdrawal by Subject|5|||
154955944|NCT01498120|559265019|FG000|Overall Study|AE, non-serious non-fatal|3|||
154955945|NCT01498120|559265019|FG000|Overall Study|Other|4|||
154955946|NCT01472341|559265020|FG000|Overall Study|Started insulin therapy|55|||
154955947|NCT01472341|559265020|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
154955948|NCT01472341|559265020|FG000|Overall Study|Withdrawal by Subject|39|||
154955949|NCT01472341|559265020|FG000|Overall Study|Lost to Follow-up|52|||
154955950|NCT01472341|559265020|FG000|Overall Study|Laboratory parameters unavailable|25|||
154955951|NCT01472341|559265020|FG000|Overall Study|Death|9|||
154955952|NCT00112463|559265021|FG000|Overall Study|Physician Decision|1|||
154955953|NCT00112463|559265021|FG000|Overall Study|Progression|30|||
154955954|NCT00112463|559265021|FG000|Overall Study|Second Primary|1|||
154955955|NCT00112463|559265021|FG000|Overall Study|Toxicity|3|||
154955956|NCT00112463|559265021|FG000|Overall Study|Withdrawal by Subject|2|||
154955957|NCT00112463|559265021|FG000|Overall Study|Never started treatment|2|||
154955958|NCT04060147|559265023|FG000|Overall Study|Withdrew consent|1|||
154955959|NCT00565448|559265024|FG000|Overall Study|Adverse Event|1|||
154955960|NCT00565448|559265025|FG001|Overall Study|Adverse Event|2|||
154955961|NCT00565448|559265024|FG000|Overall Study|Disease progression|1|||
154955962|NCT00565448|559265025|FG001|Overall Study|Disease progression|0|||
155157051|NCT03058146|560012819|FG001|Overall Study|Withdrawal by Subject|1|||
155157052|NCT03058146|560012818|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
155157053|NCT03058146|560012819|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
155294351|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294352|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155157054|NCT00632229|560012820|FG000|Overall Study|Adverse Event|6|||
155157055|NCT00632229|560012821|FG001|Overall Study|Adverse Event|0|||
155157056|NCT00632229|560012820|FG000|Overall Study|Lost to Follow-up|0|||
155157057|NCT00632229|560012821|FG001|Overall Study|Lost to Follow-up|3|||
155157058|NCT00632229|560012820|FG000|Overall Study|Lack of Efficacy|0|||
155157059|NCT00632229|560012821|FG001|Overall Study|Lack of Efficacy|2|||
155157060|NCT00632229|560012820|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
155157061|NCT00632229|560012821|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
155157062|NCT03224819|560012824|FG000|Overall Study|Withdrawal by Subject|0|||
155157063|NCT03224819|560012825|FG001|Overall Study|Withdrawal by Subject|0|||
155157064|NCT03224819|560012826|FG002|Overall Study|Withdrawal by Subject|0|||
155157065|NCT03224819|560012827|FG003|Overall Study|Withdrawal by Subject|0|||
155157066|NCT03224819|560012828|FG004|Overall Study|Withdrawal by Subject|0|||
155157067|NCT03224819|560012829|FG005|Overall Study|Withdrawal by Subject|0|||
155157068|NCT03224819|560012830|FG006|Overall Study|Withdrawal by Subject|0|||
155157069|NCT03224819|560012831|FG007|Overall Study|Withdrawal by Subject|0|||
155157070|NCT03224819|560012832|FG008|Overall Study|Withdrawal by Subject|0|||
155157071|NCT03224819|560012833|FG009|Overall Study|Withdrawal by Subject|0|||
155157072|NCT03224819|560012834|FG010|Overall Study|Withdrawal by Subject|0|||
155157073|NCT03224819|560012835|FG011|Overall Study|Withdrawal by Subject|0|||
155157074|NCT03224819|560012836|FG012|Overall Study|Withdrawal by Subject|1|||
155157075|NCT03224819|560012837|FG013|Overall Study|Withdrawal by Subject|0|||
155157076|NCT03224819|560012824|FG000|Overall Study|Sponsor Decision|0|||
155157077|NCT03224819|560012825|FG001|Overall Study|Sponsor Decision|0|||
155157078|NCT03224819|560012826|FG002|Overall Study|Sponsor Decision|0|||
155157079|NCT03224819|560012827|FG003|Overall Study|Sponsor Decision|1|||
155157080|NCT03224819|560012828|FG004|Overall Study|Sponsor Decision|1|||
155157081|NCT03224819|560012829|FG005|Overall Study|Sponsor Decision|2|||
155157082|NCT03224819|560012830|FG006|Overall Study|Sponsor Decision|1|||
155157083|NCT03224819|560012831|FG007|Overall Study|Sponsor Decision|1|||
155157084|NCT03224819|560012832|FG008|Overall Study|Sponsor Decision|1|||
155157085|NCT03224819|560012833|FG009|Overall Study|Sponsor Decision|2|||
155157086|NCT03224819|560012834|FG010|Overall Study|Sponsor Decision|1|||
155157087|NCT03224819|560012835|FG011|Overall Study|Sponsor Decision|1|||
155157088|NCT03224819|560012836|FG012|Overall Study|Sponsor Decision|1|||
155157089|NCT03224819|560012837|FG013|Overall Study|Sponsor Decision|0|||
155157090|NCT03224819|560012824|FG000|Overall Study|Lost to Follow-up|0|||
155157091|NCT03224819|560012825|FG001|Overall Study|Lost to Follow-up|0|||
155157092|NCT03224819|560012826|FG002|Overall Study|Lost to Follow-up|0|||
154955963|NCT00565448|559265024|FG000|Overall Study|Withdrawal by Subject|1|||
154955964|NCT00565448|559265025|FG001|Overall Study|Withdrawal by Subject|0|||
154955965|NCT00193609|559265026|FG000|Overall Study|Lack of Efficacy|2|||
154955966|NCT00193609|559265026|FG000|Overall Study|Adverse Event|2|||
154955967|NCT00735904|559265027|FG000|Overall Study|Adverse Event|3|||
154955968|NCT00735904|559265027|FG000|Overall Study|Death|20|||
154955969|NCT00735904|559265027|FG000|Overall Study|Protocol Violation|1|||
154955970|NCT00735904|559265027|FG000|Overall Study|Withdrawal by Subject|1|||
154955971|NCT00735904|559265027|FG000|Overall Study|Study Terminated by Sponsor|5|||
154955972|NCT00735904|559265027|FG000|Overall Study|Other|8|||
154955973|NCT03204539|559265028|FG000|Overall Study|Loss of funding|0|||
154955974|NCT03204539|559265029|FG001|Overall Study|Loss of funding|1|||
154955975|NCT02008565|559265036|FG000|Overall Study|Protocol Violation|1|||
154955976|NCT02008565|559265037|FG001|Overall Study|Protocol Violation|1|||
154955977|NCT02008565|559265038|FG002|Overall Study|Protocol Violation|2|||
154955978|NCT02008565|559265039|FG003|Overall Study|Protocol Violation|0|||
154955979|NCT00268905|559265040|FG000|Overall Study|Adverse Event|3|||
154955980|NCT00268905|559265041|FG001|Overall Study|Adverse Event|0|||
154955981|NCT00268905|559265042|FG002|Overall Study|Adverse Event|4|||
154955982|NCT00268905|559265040|FG000|Overall Study|Lost to Follow-up|0|||
154955983|NCT00268905|559265041|FG001|Overall Study|Lost to Follow-up|1|||
154955984|NCT00268905|559265042|FG002|Overall Study|Lost to Follow-up|0|||
154955985|NCT00268905|559265040|FG000|Overall Study|Withdrawal by Subject|0|||
154955986|NCT00268905|559265041|FG001|Overall Study|Withdrawal by Subject|0|||
154955987|NCT00268905|559265042|FG002|Overall Study|Withdrawal by Subject|3|||
154955988|NCT00268905|559265040|FG000|Overall Study|Progressive Disease|28|||
154955989|NCT00268905|559265041|FG001|Overall Study|Progressive Disease|4|||
154955990|NCT00268905|559265042|FG002|Overall Study|Progressive Disease|3|||
154955991|NCT00268905|559265040|FG000|Overall Study|Physician Decision|3|||
154955992|NCT00268905|559265041|FG001|Overall Study|Physician Decision|0|||
154955993|NCT00268905|559265042|FG002|Overall Study|Physician Decision|1|||
154955994|NCT00268905|559265040|FG000|Overall Study|Clinical Progression|9|||
154955995|NCT00268905|559265041|FG001|Overall Study|Clinical Progression|4|||
154955996|NCT00268905|559265042|FG002|Overall Study|Clinical Progression|1|||
154955997|NCT02193178|559265043|FG000|Overall Study|Lost to Follow-up|1|||
154955998|NCT02193178|559265043|FG000|Overall Study|Dry eyes|1|||
154955999|NCT04510285|559265044|FG000|Overall Study|Death|1|||
154956000|NCT03897088|559265045|FG000|Overall Study|Withdrawal by Subject|12|||
154956001|NCT03897088|559265046|FG001|Overall Study|Withdrawal by Subject|12|||
154956002|NCT03897088|559265045|FG000|Overall Study|Lost to Follow-up|7|||
154956003|NCT03897088|559265046|FG001|Overall Study|Lost to Follow-up|15|||
154956004|NCT03897088|559265045|FG000|Overall Study|Sponsor Decision|1|||
155157093|NCT03224819|560012827|FG003|Overall Study|Lost to Follow-up|0|||
154956005|NCT03897088|559265046|FG001|Overall Study|Sponsor Decision|2|||
154956006|NCT03897088|559265045|FG000|Overall Study|COVID-19|2|||
155157094|NCT03224819|560012828|FG004|Overall Study|Lost to Follow-up|0|||
155157095|NCT03224819|560012829|FG005|Overall Study|Lost to Follow-up|0|||
155157096|NCT03224819|560012830|FG006|Overall Study|Lost to Follow-up|0|||
155157097|NCT03224819|560012831|FG007|Overall Study|Lost to Follow-up|0|||
155157098|NCT03224819|560012832|FG008|Overall Study|Lost to Follow-up|1|||
155157099|NCT03224819|560012833|FG009|Overall Study|Lost to Follow-up|0|||
155157100|NCT03224819|560012834|FG010|Overall Study|Lost to Follow-up|0|||
155157101|NCT03224819|560012835|FG011|Overall Study|Lost to Follow-up|0|||
155157102|NCT03224819|560012836|FG012|Overall Study|Lost to Follow-up|0|||
155157103|NCT03224819|560012837|FG013|Overall Study|Lost to Follow-up|0|||
155157104|NCT03224819|560012824|FG000|Overall Study|Death|0|||
155157105|NCT03224819|560012825|FG001|Overall Study|Death|1|||
155157106|NCT03224819|560012826|FG002|Overall Study|Death|0|||
155157107|NCT03224819|560012827|FG003|Overall Study|Death|0|||
155157108|NCT03224819|560012828|FG004|Overall Study|Death|0|||
155157109|NCT03224819|560012829|FG005|Overall Study|Death|0|||
155294353|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294354|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
155294355|NCT01212757|560505068|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294356|NCT01212757|560505069|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
155157110|NCT03224819|560012830|FG006|Overall Study|Death|0|||
154956007|NCT03897088|559265046|FG001|Overall Study|COVID-19|0|||
154956008|NCT03897088|559265045|FG000|Overall Study|Other|3|||
154956009|NCT03897088|559265046|FG001|Overall Study|Other|0|||
154956010|NCT03897088|559265045|FG000|Overall Study|Non-compliance with Study Drug|1|||
154956011|NCT03897088|559265046|FG001|Overall Study|Non-compliance with Study Drug|1|||
154956012|NCT03897088|559265045|FG000|Overall Study|Pregnancy|0|||
154956013|NCT03897088|559265046|FG001|Overall Study|Pregnancy|1|||
154956014|NCT00319735|559265055|FG000|Overall Study|Death|2|||
154956015|NCT02216071|559265056|FG000|Overall Study|Withdrawal by Subject|7|||
154956016|NCT02216071|559265057|FG001|Overall Study|Withdrawal by Subject|2|||
154956017|NCT02216071|559265056|FG000|Overall Study|Lost to Follow-up|3|||
154956018|NCT02216071|559265057|FG001|Overall Study|Lost to Follow-up|3|||
154956019|NCT02216071|559265056|FG000|Overall Study|Protocol Violation|3|||
154956020|NCT02216071|559265057|FG001|Overall Study|Protocol Violation|5|||
154956021|NCT02216071|559265056|FG000|Overall Study|Other|2|||
154956022|NCT02216071|559265057|FG001|Overall Study|Other|2|||
154956023|NCT01469546|559265058|FG000|Received 5 mg Dose|Adverse Event|13|||
154956024|NCT01469546|559265058|FG000|Received 5 mg Dose|Death|2|||
154956025|NCT01469546|559265058|FG000|Received 5 mg Dose|Protocol Violation|2|||
154956026|NCT01469546|559265058|FG000|Received 5 mg Dose|Progressive Disease|3|||
154956027|NCT01469546|559265058|FG000|Received 5 mg Dose|Physician Decision|3|||
154956028|NCT04753437|559265059|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
154956029|NCT04753437|559265060|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
154956030|NCT04753437|559265059|FG000|Overall Study|Liver Function Test Abnormalities|2|||
154956031|NCT04753437|559265060|FG001|Overall Study|Liver Function Test Abnormalities|4|||
154956032|NCT00385684|559265061|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
154956033|NCT00385684|559265062|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
154956034|NCT00385684|559265061|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
154956035|NCT00385684|559265062|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
154956036|NCT00385684|559265061|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
154956037|NCT00385684|559265062|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
154956038|NCT01066143|559267109|FG000|Overall Study|ineligible for the study|8|||
154956039|NCT01294787|559267110|FG000|Period 1|Adverse Event|0|||
154956040|NCT01294787|559267111|FG001|Period 1|Adverse Event|0|||
154956041|NCT01294787|559267112|FG002|Period 1|Adverse Event|0|||
154956042|NCT01294787|559267113|FG003|Period 1|Adverse Event|0|||
154956043|NCT01294787|559267114|FG004|Period 1|Adverse Event|1|||
154956044|NCT01294787|559267115|FG005|Period 1|Adverse Event|0|||
154956045|NCT01294787|559267110|FG000|Period 1|Withdrawal by Subject|0|||
154956046|NCT01294787|559267111|FG001|Period 1|Withdrawal by Subject|0|||
154956047|NCT01294787|559267112|FG002|Period 1|Withdrawal by Subject|0|||
154956048|NCT01294787|559267113|FG003|Period 1|Withdrawal by Subject|1|||
154956049|NCT01294787|559267114|FG004|Period 1|Withdrawal by Subject|1|||
154956050|NCT01294787|559267115|FG005|Period 1|Withdrawal by Subject|1|||
154956051|NCT01294787|559267110|FG000|Period 1|Administrative problem|0|||
154956052|NCT01294787|559267111|FG001|Period 1|Administrative problem|0|||
154956053|NCT01294787|559267112|FG002|Period 1|Administrative problem|1|||
154956054|NCT01294787|559267113|FG003|Period 1|Administrative problem|0|||
154956055|NCT01294787|559267114|FG004|Period 1|Administrative problem|0|||
154956056|NCT01294787|559267115|FG005|Period 1|Administrative problem|1|||
154956057|NCT01294787|559267110|FG000|Period 2|Adverse Event|0|||
154956058|NCT01294787|559267111|FG001|Period 2|Adverse Event|3|||
154956059|NCT01294787|559267112|FG002|Period 2|Adverse Event|0|||
155157111|NCT03224819|560012831|FG007|Overall Study|Death|1|||
155157112|NCT03224819|560012832|FG008|Overall Study|Death|0|||
155157113|NCT03224819|560012833|FG009|Overall Study|Death|0|||
155157114|NCT03224819|560012834|FG010|Overall Study|Death|0|||
154956060|NCT01294787|559267113|FG003|Period 2|Adverse Event|1|||
154956061|NCT01294787|559267114|FG004|Period 2|Adverse Event|0|||
154956062|NCT01294787|559267115|FG005|Period 2|Adverse Event|0|||
154956063|NCT01294787|559267110|FG000|Period 2|No longer needs study drug|0|||
154956064|NCT01294787|559267111|FG001|Period 2|No longer needs study drug|0|||
155157115|NCT03224819|560012835|FG011|Overall Study|Death|1|||
155157116|NCT03224819|560012836|FG012|Overall Study|Death|0|||
155294357|NCT01212757|560505070|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
155294358|NCT01212757|560505071|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294359|NCT01212757|560505072|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294360|NCT01212757|560505073|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294361|NCT01212757|560505074|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294362|NCT01212757|560505075|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294363|NCT01212757|560505076|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
155294364|NCT00573833|560505077|FG000|Overall Study|Not Treated|2|||
155157117|NCT03224819|560012837|FG013|Overall Study|Death|0|||
155157118|NCT00737672|560012838|FG000|Overall Study|Graft Abandonment|48|||
155157119|NCT00737672|560012839|FG001|Overall Study|Graft Abandonment|56|||
155294365|NCT05052983|560505078|FG000|Overall Study|Lack of Efficacy|3|||
155294366|NCT05052983|560505079|FG001|Overall Study|Lack of Efficacy|12|||
155294367|NCT05052983|560505078|FG000|Overall Study|Adverse Event|1|||
155294368|NCT05052983|560505079|FG001|Overall Study|Adverse Event|0|||
155157120|NCT00737672|560012838|FG000|Overall Study|Death|23|||
155294369|NCT01070888|560507320|FG000|First Intervention (14 Days)|Adverse Event|0|||
155294370|NCT01070888|560507321|FG001|First Intervention (14 Days)|Adverse Event|1|||
155157121|NCT00737672|560012839|FG001|Overall Study|Death|22|||
155157122|NCT00737672|560012838|FG000|Overall Study|Withdrawal by Subject|1|||
155157123|NCT00737672|560012839|FG001|Overall Study|Withdrawal by Subject|2|||
155157124|NCT00737672|560012838|FG000|Overall Study|Lost to Follow-up|1|||
155157125|NCT00737672|560012839|FG001|Overall Study|Lost to Follow-up|0|||
155157126|NCT00737672|560012838|FG000|Overall Study|Miscellaneous|7|||
155157127|NCT00737672|560012839|FG001|Overall Study|Miscellaneous|1|||
155157128|NCT00737672|560012838|FG000|Overall Study|Physician Decision|0|||
155157129|NCT00737672|560012839|FG001|Overall Study|Physician Decision|2|||
155157130|NCT00829426|560012843|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155157131|NCT00829426|560012844|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155157132|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
155157133|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
155157134|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
155157135|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
155157136|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Adverse Event|2|||
155157137|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Adverse Event|5|||
155157138|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Adverse Event|1|||
155157139|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Adverse Event|2|||
155157140|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Death|13|||
155157141|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Death|17|||
155157142|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Death|1|||
155157143|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Death|0|||
155157144|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
155157145|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
155157146|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
155157147|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
155157148|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Disease Progression|2|||
155157149|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Disease Progression|0|||
155157150|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Disease Progression|0|||
155157151|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Disease Progression|0|||
155157152|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
155157153|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
155157154|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
155157155|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
155157156|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
155157157|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
155157158|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
155157159|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
155157160|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
155157161|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
155157162|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
155157163|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
155157164|NCT03955146|560012845|FG000|DB Period (48 Weeks)|Participant Decision|9|||
155157165|NCT03955146|560012846|FG001|DB Period (48 Weeks)|Participant Decision|12|||
155157166|NCT03955146|560012847|FG002|DB Period (48 Weeks)|Participant Decision|1|||
155157167|NCT03955146|560012848|FG003|DB Period (48 Weeks)|Participant Decision|1|||
155157168|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
155157169|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
155157170|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
155157171|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
155157172|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
155157173|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
155157174|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
155157175|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
155157176|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
155157177|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
154956065|NCT01294787|559267112|FG002|Period 2|No longer needs study drug|0|||
154956066|NCT01294787|559267113|FG003|Period 2|No longer needs study drug|1|||
154956067|NCT01294787|559267114|FG004|Period 2|No longer needs study drug|0|||
154956068|NCT01294787|559267115|FG005|Period 2|No longer needs study drug|0|||
154956069|NCT01294787|559267110|FG000|Period 3|Adverse Event|0|||
154956070|NCT01294787|559267111|FG001|Period 3|Adverse Event|0|||
154956071|NCT01294787|559267112|FG002|Period 3|Adverse Event|0|||
154956072|NCT01294787|559267113|FG003|Period 3|Adverse Event|0|||
154956073|NCT01294787|559267114|FG004|Period 3|Adverse Event|1|||
154956074|NCT01294787|559267115|FG005|Period 3|Adverse Event|0|||
154956075|NCT05376319|559267116|FG000|Overall Study|Funding termination|2|||
154956076|NCT05376319|559267117|FG001|Overall Study|Funding termination|4|||
154956077|NCT01124175|559267118|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
155157178|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
155157179|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
155157180|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
155157181|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
155157182|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
155157183|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
155157184|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
155157185|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
155157186|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
155157187|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
155157188|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
155157189|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
155157190|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
155157191|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
155157192|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
155157193|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
155157194|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
155157195|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
155157196|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
155157197|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
155157198|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
155157199|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
155157200|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
155157201|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
155157202|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
155157203|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
155157204|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
155157205|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
155157206|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
155157207|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
155294371|NCT01070888|560507320|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
155294372|NCT01070888|560507321|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
155157208|NCT03955146|560012845|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
155294373|NCT01070888|560507320|FG000|Washout (14 Days)|Physician Decision|1|||
155157209|NCT03955146|560012846|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
155157210|NCT03955146|560012847|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
155157211|NCT03955146|560012848|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
155157212|NCT02002598|560012853|FG000|Dose Level 1|Withdrawal by Subject|1|||
155157213|NCT02002598|560012854|FG001|Dose Level 1|Withdrawal by Subject|0|||
155157214|NCT02002598|560012855|FG002|Dose Level 1|Withdrawal by Subject|0|||
155157215|NCT02002598|560012856|FG003|Dose Level 1|Withdrawal by Subject|0|||
155157216|NCT02002598|560012857|FG004|Dose Level 1|Withdrawal by Subject|0|||
155157217|NCT04606134|560012861|FG000|Overall Study|Adverse Event|0|||
155157218|NCT04606134|560012862|FG001|Overall Study|Adverse Event|1|||
155157219|NCT02018562|560012870|FG000|Overall Study|Withdrawal by Subject|2|||
155157220|NCT02018562|560012871|FG001|Overall Study|Withdrawal by Subject|0|||
155157221|NCT02018562|560012870|FG000|Overall Study|Discharged prior to study completion|1|||
155157222|NCT02018562|560012871|FG001|Overall Study|Discharged prior to study completion|0|||
155157223|NCT01253291|560012872|FG000|Overall Study|Withdrawal by Subject|1|||
155157224|NCT01253291|560012873|FG001|Overall Study|Withdrawal by Subject|1|||
155157225|NCT01253291|560012874|FG002|Overall Study|Withdrawal by Subject|0|||
155157226|NCT01253291|560012875|FG003|Overall Study|Withdrawal by Subject|0|||
155157227|NCT01253291|560012876|FG004|Overall Study|Withdrawal by Subject|0|||
155157228|NCT01253291|560012872|FG000|Overall Study|Adverse Event|0|||
155157229|NCT01253291|560012873|FG001|Overall Study|Adverse Event|1|||
155157230|NCT01253291|560012874|FG002|Overall Study|Adverse Event|0|||
155157231|NCT01253291|560012875|FG003|Overall Study|Adverse Event|0|||
155157232|NCT01253291|560012876|FG004|Overall Study|Adverse Event|0|||
155157233|NCT01253291|560012872|FG000|Overall Study|Lack of Efficacy|1|||
155157234|NCT01253291|560012873|FG001|Overall Study|Lack of Efficacy|0|||
155157235|NCT01253291|560012874|FG002|Overall Study|Lack of Efficacy|0|||
155157236|NCT01253291|560012875|FG003|Overall Study|Lack of Efficacy|0|||
155157237|NCT01253291|560012876|FG004|Overall Study|Lack of Efficacy|0|||
155157238|NCT01253291|560012872|FG000|Overall Study|Physician Decision|2|||
155157239|NCT01253291|560012873|FG001|Overall Study|Physician Decision|0|||
155157240|NCT01253291|560012874|FG002|Overall Study|Physician Decision|0|||
155157241|NCT01253291|560012875|FG003|Overall Study|Physician Decision|0|||
155157242|NCT01253291|560012876|FG004|Overall Study|Physician Decision|2|||
155157243|NCT01838395|560012877|FG000|Overall Study|Withdrawal by Subject|0|||
155157244|NCT01838395|560012878|FG001|Overall Study|Withdrawal by Subject|0|||
155294374|NCT01070888|560507321|FG001|Washout (14 Days)|Physician Decision|0|||
155060472|NCT01149655|559655615|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
155060473|NCT01149655|559655616|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
155060474|NCT01149655|559655617|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
155060475|NCT01149655|559655618|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
155294375|NCT02631148|560507322|FG000|Overall Study|8 were ineligible|8|||
155060476|NCT01149655|559655615|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
155060477|NCT01149655|559655616|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
155060478|NCT01149655|559655617|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
155060479|NCT01149655|559655618|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
155060480|NCT01265498|559655621|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
155060481|NCT01265498|559655622|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
155060482|NCT03882918|559655626|FG000|Overall Study|Study terminated by sponsor|98|||
155060483|NCT03882918|559655626|FG000|Overall Study|Protocol Violation|1|||
155060484|NCT03882918|559655626|FG000|Overall Study|Other|9|||
155060485|NCT03882918|559655626|FG000|Overall Study|Lack of Efficacy|14|||
155060486|NCT03882918|559655626|FG000|Overall Study|Adverse Event|13|||
155060487|NCT03882918|559655626|FG000|Overall Study|Withdrawal by Subject|5|||
155060488|NCT06996301|559655627|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
155060489|NCT06996301|559655628|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
155060490|NCT06996301|559655627|FG000|Overall Study|Patients with discordant diagnostic results|107|||
155060491|NCT06996301|559655628|FG001|Overall Study|Patients with discordant diagnostic results|90|||
155060492|NCT06996301|559655627|FG000|Overall Study|Lost to Follow-up|31|||
155060493|NCT06996301|559655628|FG001|Overall Study|Lost to Follow-up|56|||
155060494|NCT06996301|559655627|FG000|Overall Study|Withdrawal by Subject|12|||
155060495|NCT06996301|559655628|FG001|Overall Study|Withdrawal by Subject|7|||
155157245|NCT01838395|560012879|FG002|Overall Study|Withdrawal by Subject|0|||
155157246|NCT01838395|560012880|FG003|Overall Study|Withdrawal by Subject|0|||
155157247|NCT01838395|560012881|FG004|Overall Study|Withdrawal by Subject|1|||
155157248|NCT01838395|560012882|FG005|Overall Study|Withdrawal by Subject|0|||
155157249|NCT01838395|560012877|FG000|Overall Study|Death|0|||
155157250|NCT01838395|560012878|FG001|Overall Study|Death|0|||
155157251|NCT01838395|560012879|FG002|Overall Study|Death|1|||
155157252|NCT01838395|560012880|FG003|Overall Study|Death|0|||
155157253|NCT01838395|560012881|FG004|Overall Study|Death|0|||
155157254|NCT01838395|560012882|FG005|Overall Study|Death|0|||
155157255|NCT01838395|560012877|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155157256|NCT01838395|560012878|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
155157257|NCT01838395|560012879|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155060496|NCT04030598|559655629|FG000|Overall Study|Voluntary Withdrawal|0|||
155060497|NCT04030598|559655630|FG001|Overall Study|Voluntary Withdrawal|1|||
155060498|NCT04030598|559655631|FG002|Overall Study|Voluntary Withdrawal|0|||
155060499|NCT05117060|559655632|FG000|Overall Study|Adverse Event|3|||
155060500|NCT05117060|559655633|FG001|Overall Study|Adverse Event|5|||
155060501|NCT05117060|559655634|FG002|Overall Study|Adverse Event|6|||
155060502|NCT05117060|559655635|FG003|Overall Study|Adverse Event|1|||
155170026|NCT00830869|560062405|FG000|Period 2: Part 2|Adverse Event|0|||
155060503|NCT05117060|559655632|FG000|Overall Study|Lost to Follow-up|0|||
155060504|NCT05117060|559655633|FG001|Overall Study|Lost to Follow-up|0|||
155060505|NCT05117060|559655634|FG002|Overall Study|Lost to Follow-up|0|||
155060506|NCT05117060|559655635|FG003|Overall Study|Lost to Follow-up|1|||
155060507|NCT05117060|559655632|FG000|Overall Study|Lack of Efficacy|4|||
155060508|NCT05117060|559655633|FG001|Overall Study|Lack of Efficacy|5|||
155060509|NCT05117060|559655634|FG002|Overall Study|Lack of Efficacy|2|||
155060510|NCT05117060|559655635|FG003|Overall Study|Lack of Efficacy|6|||
155060511|NCT05117060|559655632|FG000|Overall Study|Withdrawal by Subject|8|||
155060512|NCT05117060|559655633|FG001|Overall Study|Withdrawal by Subject|5|||
155060513|NCT05117060|559655634|FG002|Overall Study|Withdrawal by Subject|5|||
155060514|NCT05117060|559655635|FG003|Overall Study|Withdrawal by Subject|6|||
155060515|NCT05117060|559655632|FG000|Overall Study|Other|2|||
155060516|NCT05117060|559655633|FG001|Overall Study|Other|1|||
155060517|NCT05117060|559655634|FG002|Overall Study|Other|3|||
155060518|NCT05117060|559655635|FG003|Overall Study|Other|1|||
155060519|NCT03141359|559655636|FG000|Overall Study|Death|32|||
155060520|NCT03141359|559655636|FG000|Overall Study|Still On Study (in follow up)|29|||
155060521|NCT01081626|559655637|FG000|Overall Study|Dosing error|1|||
155060522|NCT01081626|559655638|FG001|Overall Study|Dosing error|1|||
155060523|NCT01081626|559655637|FG000|Overall Study|Missing Estradiol|25|||
155060524|NCT01081626|559655638|FG001|Overall Study|Missing Estradiol|28|||
155060525|NCT01081626|559655637|FG000|Overall Study|Low antral follicle count|1|||
155060526|NCT01081626|559655638|FG001|Overall Study|Low antral follicle count|0|||
155060527|NCT01081626|559655637|FG000|Overall Study|Overstimulation|0|||
155060528|NCT01081626|559655638|FG001|Overall Study|Overstimulation|1|||
155060529|NCT01081626|559655637|FG000|Overall Study|Lost to Follow-up|0|||
155060530|NCT01081626|559655638|FG001|Overall Study|Lost to Follow-up|1|||
155060531|NCT01081626|559655637|FG000|Overall Study|Other|33|||
155060532|NCT01081626|559655638|FG001|Overall Study|Other|30|||
155060533|NCT02003144|559655639|FG000|Open Label Maintenance Phase|Other than specified|2|||
155060534|NCT02003144|559655640|FG001|Open Label Maintenance Phase|Other than specified|4|||
155060535|NCT02003144|559655639|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
155060536|NCT02003144|559655640|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
155060537|NCT02003144|559655639|FG000|Open Label Maintenance Phase|Pregnancy|0|||
155060538|NCT02003144|559655640|FG001|Open Label Maintenance Phase|Pregnancy|2|||
155060539|NCT02003144|559655639|FG000|Open Label Maintenance Phase|Physician Decision|1|||
155060540|NCT02003144|559655640|FG001|Open Label Maintenance Phase|Physician Decision|1|||
155060541|NCT02003144|559655639|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
155060542|NCT02003144|559655640|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
155060543|NCT02003144|559655639|FG000|Open Label Maintenance Phase|Adverse Event|2|||
155060544|NCT02003144|559655640|FG001|Open Label Maintenance Phase|Adverse Event|1|||
155060545|NCT05965752|559655648|FG000|Overall Study|Adverse Event|0|||
155060546|NCT05965752|559655649|FG001|Overall Study|Adverse Event|1|||
155060547|NCT05965752|559655650|FG002|Overall Study|Adverse Event|0|||
155060548|NCT05965752|559655651|FG003|Overall Study|Adverse Event|1|||
155060549|NCT05965752|559655652|FG004|Overall Study|Adverse Event|3|||
155060550|NCT05965752|559655648|FG000|Overall Study|Lost to Follow-up|2|||
155060551|NCT05965752|559655649|FG001|Overall Study|Lost to Follow-up|0|||
155060552|NCT05965752|559655650|FG002|Overall Study|Lost to Follow-up|1|||
155060553|NCT05965752|559655651|FG003|Overall Study|Lost to Follow-up|1|||
155060554|NCT05965752|559655652|FG004|Overall Study|Lost to Follow-up|1|||
155060555|NCT05965752|559655648|FG000|Overall Study|Withdrawal by Subject|2|||
155060556|NCT05965752|559655649|FG001|Overall Study|Withdrawal by Subject|2|||
155060557|NCT05965752|559655650|FG002|Overall Study|Withdrawal by Subject|1|||
155060558|NCT05965752|559655651|FG003|Overall Study|Withdrawal by Subject|5|||
155060559|NCT05965752|559655652|FG004|Overall Study|Withdrawal by Subject|0|||
155060560|NCT05965752|559655648|FG000|Overall Study|Disease Relapse|1|||
155060561|NCT05965752|559655649|FG001|Overall Study|Disease Relapse|0|||
155060562|NCT05965752|559655650|FG002|Overall Study|Disease Relapse|1|||
155060563|NCT05965752|559655651|FG003|Overall Study|Disease Relapse|0|||
155060564|NCT05965752|559655652|FG004|Overall Study|Disease Relapse|0|||
155060565|NCT05965752|559655648|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155157258|NCT01838395|560012880|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155157259|NCT01838395|560012881|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155294376|NCT02631148|560507323|FG001|Overall Study|8 were ineligible|0|||
155294377|NCT02631148|560507322|FG000|Overall Study|Withdrawal by Subject|1|||
155060566|NCT05965752|559655649|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
155060567|NCT05965752|559655650|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155060568|NCT05965752|559655651|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
155060569|NCT05965752|559655652|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
155060570|NCT05965752|559655648|FG000|Overall Study|Unable to Return for Study Visits|0|||
155060571|NCT05965752|559655649|FG001|Overall Study|Unable to Return for Study Visits|1|||
155060572|NCT05965752|559655650|FG002|Overall Study|Unable to Return for Study Visits|0|||
155060573|NCT05965752|559655651|FG003|Overall Study|Unable to Return for Study Visits|3|||
155060574|NCT05965752|559655652|FG004|Overall Study|Unable to Return for Study Visits|1|||
155060575|NCT05965752|559655648|FG000|Overall Study|Early Termination|0|||
155060576|NCT05965752|559655649|FG001|Overall Study|Early Termination|0|||
155060577|NCT05965752|559655650|FG002|Overall Study|Early Termination|1|||
155060578|NCT05965752|559655651|FG003|Overall Study|Early Termination|0|||
155060579|NCT05965752|559655652|FG004|Overall Study|Early Termination|0|||
155060580|NCT05965752|559655648|FG000|Overall Study|Reported Unwanted Symptoms|0|||
155060581|NCT05965752|559655649|FG001|Overall Study|Reported Unwanted Symptoms|0|||
155060582|NCT05965752|559655650|FG002|Overall Study|Reported Unwanted Symptoms|0|||
155060583|NCT05965752|559655651|FG003|Overall Study|Reported Unwanted Symptoms|0|||
155060584|NCT05965752|559655652|FG004|Overall Study|Reported Unwanted Symptoms|1|||
155060585|NCT05965752|559655648|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155060586|NCT05965752|559655649|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155060587|NCT05965752|559655650|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155060588|NCT05965752|559655651|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
155060589|NCT05965752|559655652|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
155060590|NCT03737994|559657603|FG000|Overall Study|Withdrawal by Subject|0|||
155060591|NCT03737994|559657604|FG001|Overall Study|Withdrawal by Subject|0|||
155060592|NCT03737994|559657605|FG002|Overall Study|Withdrawal by Subject|0|||
155060593|NCT03737994|559657606|FG003|Overall Study|Withdrawal by Subject|0|||
155060594|NCT03737994|559657607|FG004|Overall Study|Withdrawal by Subject|0|||
155060595|NCT03737994|559657608|FG005|Overall Study|Withdrawal by Subject|0|||
155060596|NCT03737994|559657609|FG006|Overall Study|Withdrawal by Subject|1|||
155060597|NCT00703534|559657610|FG000|Overall Study|Adverse Event|14|||
155060598|NCT00703534|559657611|FG001|Overall Study|Adverse Event|3|||
155060599|NCT00703534|559657610|FG000|Overall Study|Withdrawal by Subject|8|||
155060600|NCT00703534|559657611|FG001|Overall Study|Withdrawal by Subject|7|||
155060601|NCT00703534|559657610|FG000|Overall Study|Incorrect Enrollment|6|||
155060602|NCT00703534|559657611|FG001|Overall Study|Incorrect Enrollment|6|||
155060603|NCT00703534|559657610|FG000|Overall Study|Lost to Follow-up|1|||
155060604|NCT00703534|559657611|FG001|Overall Study|Lost to Follow-up|4|||
155060605|NCT00703534|559657610|FG000|Overall Study|Severe Non Compliance|1|||
155060606|NCT00703534|559657611|FG001|Overall Study|Severe Non Compliance|5|||
155060607|NCT00427934|559657612|FG000|Overall Study|Adverse Event|1|||
155060608|NCT00427934|559657613|FG001|Overall Study|Adverse Event|0|||
155060609|NCT00427934|559657614|FG002|Overall Study|Adverse Event|5|||
155060610|NCT00427934|559657615|FG003|Overall Study|Adverse Event|4|||
155060611|NCT00427934|559657612|FG000|Overall Study|Lack of Efficacy|0|||
155060612|NCT00427934|559657613|FG001|Overall Study|Lack of Efficacy|0|||
155060613|NCT00427934|559657614|FG002|Overall Study|Lack of Efficacy|5|||
155060614|NCT00427934|559657615|FG003|Overall Study|Lack of Efficacy|2|||
155060615|NCT00427934|559657612|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
155060616|NCT00427934|559657613|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
155060617|NCT00427934|559657614|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
155060618|NCT00427934|559657615|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
155060619|NCT00427934|559657612|FG000|Overall Study|Other|0|||
155060620|NCT00427934|559657613|FG001|Overall Study|Other|0|||
155060621|NCT00427934|559657614|FG002|Overall Study|Other|11|||
155060622|NCT00427934|559657615|FG003|Overall Study|Other|5|||
155060623|NCT00427934|559657612|FG000|Overall Study|Withdrawal by Subject|0|||
155060624|NCT00427934|559657613|FG001|Overall Study|Withdrawal by Subject|0|||
155060625|NCT00427934|559657614|FG002|Overall Study|Withdrawal by Subject|1|||
155060626|NCT00427934|559657615|FG003|Overall Study|Withdrawal by Subject|3|||
155060627|NCT03261401|559657618|FG000|Overall Study|Withdrawal by Subject|0|||
155060628|NCT03261401|559657619|FG001|Overall Study|Withdrawal by Subject|0|||
155060629|NCT03261401|559657620|FG002|Overall Study|Withdrawal by Subject|0|||
155060630|NCT03261401|559657621|FG003|Overall Study|Withdrawal by Subject|0|||
155060631|NCT03261401|559657622|FG004|Overall Study|Withdrawal by Subject|0|||
155060632|NCT03261401|559657623|FG005|Overall Study|Withdrawal by Subject|1|||
155060633|NCT03261401|559657624|FG006|Overall Study|Withdrawal by Subject|0|||
155060634|NCT03261401|559657625|FG007|Overall Study|Withdrawal by Subject|0|||
155060635|NCT03261401|559657626|FG008|Overall Study|Withdrawal by Subject|0|||
155060636|NCT03261401|559657627|FG009|Overall Study|Withdrawal by Subject|0|||
155060637|NCT03261401|559657628|FG010|Overall Study|Withdrawal by Subject|0|||
155060638|NCT03261401|559657629|FG011|Overall Study|Withdrawal by Subject|0|||
155060639|NCT03261401|559657630|FG012|Overall Study|Withdrawal by Subject|0|||
155060640|NCT03261401|559657618|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
155060641|NCT03261401|559657619|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
155060642|NCT03261401|559657620|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
155060643|NCT03261401|559657621|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
155060644|NCT03261401|559657622|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
155060645|NCT03261401|559657623|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
155060646|NCT03261401|559657624|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
155060647|NCT03261401|559657625|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
155060648|NCT03261401|559657626|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
155060649|NCT03261401|559657627|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
155060650|NCT03261401|559657628|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
155060651|NCT03261401|559657629|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
155060652|NCT03261401|559657630|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
155060653|NCT02058095|559657631|FG000|Overall Study|Adverse Event|1|||
155060654|NCT02058095|559657632|FG001|Overall Study|Adverse Event|0|||
155060655|NCT00998946|559657635|FG000|Overall Study|Lost to Follow-up|1|||
155060656|NCT00998946|559657635|FG000|Overall Study|Withdrawal by Subject|1|||
155060657|NCT00998946|559657635|FG000|Overall Study|Death|2|||
155060658|NCT00998946|559657635|FG000|Overall Study|Reason Unspecified|3|||
155060659|NCT00998946|559657635|FG000|Overall Study|Enrolled but not Dosed|2|||
155060660|NCT00915525|559657641|FG000|Overall Study|Protocol Violation|9|||
155060661|NCT00915525|559657642|FG001|Overall Study|Protocol Violation|4|||
155060662|NCT00915525|559657641|FG000|Overall Study|Withdrawal by Subject|59|||
155060663|NCT00915525|559657642|FG001|Overall Study|Withdrawal by Subject|21|||
155060664|NCT00915525|559657641|FG000|Overall Study|Lost to Follow-up|27|||
155060665|NCT00915525|559657642|FG001|Overall Study|Lost to Follow-up|16|||
155060666|NCT00915525|559657641|FG000|Overall Study|Pregnancy|2|||
155060667|NCT00915525|559657642|FG001|Overall Study|Pregnancy|0|||
155060668|NCT00915525|559657641|FG000|Overall Study|Lack of Efficacy|15|||
155060669|NCT00915525|559657642|FG001|Overall Study|Lack of Efficacy|32|||
155060670|NCT00915525|559657641|FG000|Overall Study|Adverse Event|29|||
155060671|NCT00915525|559657642|FG001|Overall Study|Adverse Event|13|||
155060672|NCT00915525|559657641|FG000|Overall Study|Missing|12|||
155060673|NCT00915525|559657642|FG001|Overall Study|Missing|1|||
155060674|NCT00915525|559657641|FG000|Overall Study|Other Reason|35|||
155060675|NCT00915525|559657642|FG001|Overall Study|Other Reason|12|||
155060676|NCT00915525|559657641|FG000|Overall Study|Site Closed|27|||
155060677|NCT00915525|559657642|FG001|Overall Study|Site Closed|9|||
155060678|NCT00915525|559657641|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
155060679|NCT00915525|559657642|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
155060680|NCT00915525|559657641|FG000|Overall Study|Study Burden|28|||
155060681|NCT00915525|559657642|FG001|Overall Study|Study Burden|12|||
155060682|NCT00915525|559657641|FG000|Overall Study|Non-Compliance|3|||
155060683|NCT00915525|559657642|FG001|Overall Study|Non-Compliance|1|||
155060684|NCT00915525|559657641|FG000|Overall Study|Patient Moved|15|||
155060685|NCT00915525|559657642|FG001|Overall Study|Patient Moved|9|||
155060686|NCT00577408|559657643|FG000|Overall Study|Stopped attending study visits|9|||
155060687|NCT00577408|559657644|FG001|Overall Study|Stopped attending study visits|11|||
155060688|NCT00577408|559657643|FG000|Overall Study|Continued opioid use|3|||
155060689|NCT00577408|559657644|FG001|Overall Study|Continued opioid use|2|||
155060690|NCT00577408|559657643|FG000|Overall Study|Non-compliance with study meds|0|||
155060691|NCT00577408|559657644|FG001|Overall Study|Non-compliance with study meds|3|||
155060692|NCT00577408|559657643|FG000|Overall Study|Refused Oral Naltrexone|0|||
155060693|NCT00577408|559657644|FG001|Overall Study|Refused Oral Naltrexone|1|||
155060694|NCT00577408|559657643|FG000|Overall Study|Moved out of state|0|||
155060695|NCT00577408|559657644|FG001|Overall Study|Moved out of state|1|||
155060696|NCT00577408|559657643|FG000|Overall Study|Scheduling Issues|0|||
155060697|NCT00577408|559657644|FG001|Overall Study|Scheduling Issues|3|||
155060698|NCT00577408|559657643|FG000|Overall Study|Death|0|||
155060699|NCT00577408|559657644|FG001|Overall Study|Death|1|||
155060700|NCT00577408|559657643|FG000|Overall Study|Psychiatric hospitalization|0|||
155060701|NCT00577408|559657644|FG001|Overall Study|Psychiatric hospitalization|1|||
155060702|NCT02765035|559657646|FG000|First Intervention (90 Days)|Adverse Event|1|||
155060703|NCT02765035|559657647|FG001|First Intervention (90 Days)|Adverse Event|1|||
155060704|NCT02765035|559657646|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
155060705|NCT02765035|559657647|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
155060706|NCT02732639|559657648|FG000|Overall Study|Lost to Follow-up|1|||
155060707|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
155060708|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
155157260|NCT01838395|560012882|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
155157261|NCT00400179|560012884|FG000|Overall Study|Adverse Event|2|||
155060709|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
155060710|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
155157262|NCT00400179|560012885|FG001|Overall Study|Adverse Event|2|||
155157263|NCT00400179|560012884|FG000|Overall Study|Death|1|||
155060711|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
155060712|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
155060713|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
155060714|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
155060715|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
155060716|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
155060717|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
155060718|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
155060719|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
155157264|NCT00400179|560012885|FG001|Overall Study|Death|2|||
154956078|NCT01124175|559267119|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
154956079|NCT00942968|559267120|FG000|Overall Study|Adverse Event|60|||
154956080|NCT00942968|559267120|FG000|Overall Study|Death|76|||
154956081|NCT00942968|559267120|FG000|Overall Study|Protocol Violation|9|||
154956082|NCT00942968|559267120|FG000|Overall Study|Lost to Follow-up|4|||
154956083|NCT00942968|559267120|FG000|Overall Study|Withdrawal by Subject|44|||
154956084|NCT00942968|559267120|FG000|Overall Study|Sponsor request|5|||
154956085|NCT00942968|559267120|FG000|Overall Study|Physician Decision|11|||
154956086|NCT00942968|559267120|FG000|Overall Study|Progression of disease|12|||
154956087|NCT00942968|559267120|FG000|Overall Study|Inferior vena cava filter placement|4|||
155060720|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
155060721|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
155060722|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
155060723|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
155060724|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
155060725|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
155060726|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
155060727|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
155060728|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
155060729|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
155060730|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
155060731|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
155060732|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
155060733|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
155060734|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
155060735|NCT01668797|559657649|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
155060736|NCT01668797|559657650|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
155060737|NCT01668797|559657651|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
155060738|NCT01668797|559657652|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
155060739|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
155060740|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
155060741|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
155060742|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
155060743|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
155157265|NCT00400179|560012884|FG000|Overall Study|Withdrew Consent|1|||
155157266|NCT00400179|560012885|FG001|Overall Study|Withdrew Consent|5|||
155157267|NCT00400179|560012884|FG000|Overall Study|Disease progression|1|||
155157268|NCT00400179|560012885|FG001|Overall Study|Disease progression|1|||
155157269|NCT00400179|560012884|FG000|Overall Study|Intercurrent illness|0|||
154956088|NCT00942968|559267120|FG000|Overall Study|Pulmonary embolism (PE)|1|||
154956089|NCT00942968|559267120|FG000|Overall Study|Participant required pancreatic biopsy|1|||
154956090|NCT00942968|559267120|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
154956091|NCT01948258|559267121|FG000|Overall Study|Pregnancy|41|||
154956092|NCT01948258|559267121|FG000|Overall Study|Did not complete by cut-off date|35|||
154956093|NCT01948258|559267121|FG000|Overall Study|Lost to Follow-up|27|||
154956094|NCT01948258|559267121|FG000|Overall Study|Withdrawal by SPD|8|||
154956095|NCT01948258|559267121|FG000|Overall Study|Withdrawal by Subject|6|||
154956096|NCT01948258|559267121|FG000|Overall Study|Health Care Professional|43|||
154956097|NCT01948258|559267121|FG000|Overall Study|Removed from statistical analysis|2|||
154956098|NCT01340495|559267128|FG000|Overall Study|Withdrawal by Subject|1|||
154956099|NCT01811953|559267129|FG000|Overall Study|Adverse Event|0|||
154956100|NCT01811953|559267130|FG001|Overall Study|Adverse Event|0|||
154956101|NCT01811953|559267131|FG002|Overall Study|Adverse Event|0|||
154956102|NCT01811953|559267132|FG003|Overall Study|Adverse Event|1|||
154956103|NCT01811953|559267133|FG004|Overall Study|Adverse Event|0|||
154956104|NCT01811953|559267134|FG005|Overall Study|Adverse Event|1|||
154956105|NCT01811953|559267129|FG000|Overall Study|Protocol Violation|0|||
154956106|NCT01811953|559267130|FG001|Overall Study|Protocol Violation|0|||
154956107|NCT01811953|559267131|FG002|Overall Study|Protocol Violation|0|||
154956108|NCT01811953|559267132|FG003|Overall Study|Protocol Violation|0|||
154956109|NCT01811953|559267133|FG004|Overall Study|Protocol Violation|1|||
154956110|NCT01811953|559267134|FG005|Overall Study|Protocol Violation|0|||
154956111|NCT00070291|559267136|FG000|Step 1|Withdrawal by Subject|1|||
154956112|NCT00070291|559267136|FG000|Step 1|Adverse Event|1|||
154956113|NCT00070291|559267136|FG000|Step 2|Adverse Event|1|||
154956114|NCT00520130|559267137|FG000|Overall Study|Disease progression on study|4|||
154956115|NCT00520130|559267138|FG001|Overall Study|Disease progression on study|0|||
154956116|NCT00520130|559267137|FG000|Overall Study|Physician Decision|1|||
154956117|NCT00520130|559267138|FG001|Overall Study|Physician Decision|1|||
154956118|NCT02533258|559267139|FG000|Overall Study|Adverse Event|1|||
154956119|NCT02533258|559267139|FG000|Overall Study|Death|2|||
155060744|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
155060745|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
155157270|NCT00400179|560012885|FG001|Overall Study|Intercurrent illness|1|||
155060746|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
155060747|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
155060748|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
155060749|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
155060750|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
155060751|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
155060752|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
155060753|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
155060754|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
155060755|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
155060756|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
155060757|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
155060758|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
155060759|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
154956120|NCT02533258|559267139|FG000|Overall Study|Other|1|||
154956121|NCT02533258|559267139|FG000|Overall Study|Economic factor|1|||
154956122|NCT02533258|559267139|FG000|Overall Study|Progression of pleural effusion|1|||
154956123|NCT02533258|559267139|FG000|Overall Study|Lack of Efficacy|2|||
154956124|NCT01520909|559267147|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
154956125|NCT01520909|559267148|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
154956126|NCT01520909|559267149|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
154956127|NCT01520909|559267147|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
154956128|NCT01520909|559267148|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
154956129|NCT01520909|559267149|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
154956130|NCT01520909|559267147|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
154956131|NCT01520909|559267148|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
154956132|NCT01520909|559267149|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
154956133|NCT01520909|559267147|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
154956134|NCT01520909|559267148|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
154956135|NCT01520909|559267149|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
154956136|NCT01882257|559267150|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
154956137|NCT01882257|559267151|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
154956138|NCT01882257|559267152|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
154956139|NCT01882257|559267150|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
154956140|NCT01882257|559267151|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
154956141|NCT01882257|559267152|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
154956142|NCT00830206|559267153|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
154956143|NCT00830206|559267154|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
154956144|NCT03351335|559267157|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
154956145|NCT03351335|559267158|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
154956146|NCT03351335|559267159|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
154956147|NCT01900691|559267160|FG000|Overall Study|Death|7|||
154956148|NCT01900691|559267160|FG000|Overall Study|Lost to Follow-up|4|||
154956149|NCT01900691|559267160|FG000|Overall Study|Study Device Not Placed|3|||
154956150|NCT01900691|559267160|FG000|Overall Study|Non study stent placed|2|||
154956151|NCT01900691|559267160|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
154956152|NCT01900691|559267160|FG000|Overall Study|Complete stent migration through digestive tract|1|||
154956153|NCT01149473|559267161|FG000|First Intervention|Adverse Event|1|||
154956154|NCT01149473|559267162|FG001|First Intervention|Adverse Event|1|||
154956155|NCT01149473|559267161|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
154956156|NCT01149473|559267162|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
154956157|NCT01954394|559267163|FG000|Overall Study|Enrolled but not treated|1|||
154956158|NCT01954394|559267164|FG001|Overall Study|Enrolled but not treated|0|||
154956159|NCT01954394|559267163|FG000|Overall Study|Adverse Event|10|||
154956160|NCT01954394|559267164|FG001|Overall Study|Adverse Event|23|||
154956161|NCT01954394|559267163|FG000|Overall Study|Poor compliance to protocol|7|||
154956162|NCT01954394|559267164|FG001|Overall Study|Poor compliance to protocol|7|||
154956163|NCT01954394|559267163|FG000|Overall Study|Participant Moved|0|||
154956164|NCT01954394|559267164|FG001|Overall Study|Participant Moved|4|||
154956165|NCT01954394|559267163|FG000|Overall Study|Related to Study Drug administration|2|||
154956166|NCT01954394|559267164|FG001|Overall Study|Related to Study Drug administration|2|||
154956167|NCT01954394|559267163|FG000|Overall Study|Other than specified above|10|||
154956168|NCT01954394|559267164|FG001|Overall Study|Other than specified above|21|||
154956169|NCT02128997|559267165|FG000|Overall Study|Lost to Follow-up|6|||
154956170|NCT02128997|559267166|FG001|Overall Study|Lost to Follow-up|11|||
154956171|NCT04123548|559267167|FG000|Overall Study|Withdrawal by Subject|1|||
154956172|NCT04123548|559267167|FG000|Overall Study|Lost to Follow-up|8|||
154956173|NCT04123548|559267167|FG000|Overall Study|Death|4|||
154956174|NCT04123548|559267167|FG000|Overall Study|Reason Not Specified|1|||
154956175|NCT04166630|559267169|FG000|Overall Study|Withdrawal by Subject|0|||
155060760|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
154956176|NCT04166630|559267170|FG001|Overall Study|Withdrawal by Subject|1|||
154956177|NCT04088760|559267171|FG000|Overall Study|Physician Decision|1|||
154956178|NCT00436553|559267172|FG000|Overall Study|Adverse Event|4|||
154956179|NCT00436553|559267173|FG001|Overall Study|Adverse Event|3|||
154956180|NCT00436553|559267174|FG002|Overall Study|Adverse Event|4|||
154956181|NCT00436553|559267172|FG000|Overall Study|Death|3|||
154956182|NCT00436553|559267173|FG001|Overall Study|Death|1|||
154956183|NCT00436553|559267174|FG002|Overall Study|Death|3|||
154956184|NCT00436553|559267172|FG000|Overall Study|Lost to Follow-up|0|||
154956185|NCT00436553|559267173|FG001|Overall Study|Lost to Follow-up|2|||
154956186|NCT00436553|559267174|FG002|Overall Study|Lost to Follow-up|0|||
154956187|NCT00436553|559267172|FG000|Overall Study|Protocol Violation|1|||
154956188|NCT00436553|559267173|FG001|Overall Study|Protocol Violation|0|||
154956189|NCT00436553|559267174|FG002|Overall Study|Protocol Violation|0|||
154956190|NCT00436553|559267172|FG000|Overall Study|Withdrawal by Subject|5|||
154956191|NCT00436553|559267173|FG001|Overall Study|Withdrawal by Subject|6|||
154956192|NCT00436553|559267174|FG002|Overall Study|Withdrawal by Subject|3|||
154956193|NCT00625443|559267179|FG000|Overall Study|Adverse Event|1|||
154956194|NCT00625443|559267180|FG001|Overall Study|Adverse Event|4|||
154956195|NCT00625443|559267181|FG002|Overall Study|Adverse Event|0|||
154956196|NCT00625443|559267179|FG000|Overall Study|Non-compliance with protocol|0|||
154956197|NCT00625443|559267180|FG001|Overall Study|Non-compliance with protocol|1|||
154956198|NCT00625443|559267181|FG002|Overall Study|Non-compliance with protocol|0|||
154956199|NCT00625443|559267179|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
154956200|NCT00625443|559267180|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
154956201|NCT00625443|559267181|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
154956202|NCT00625443|559267179|FG000|Overall Study|Withdrawal by Subject|0|||
154956203|NCT00625443|559267180|FG001|Overall Study|Withdrawal by Subject|1|||
154956204|NCT00625443|559267181|FG002|Overall Study|Withdrawal by Subject|2|||
154956205|NCT00625443|559267179|FG000|Overall Study|Physician Decision|0|||
154956206|NCT00625443|559267180|FG001|Overall Study|Physician Decision|4|||
154956207|NCT00625443|559267181|FG002|Overall Study|Physician Decision|2|||
154956208|NCT00625443|559267179|FG000|Overall Study|Other|0|||
154956209|NCT00625443|559267180|FG001|Overall Study|Other|1|||
154956210|NCT00625443|559267181|FG002|Overall Study|Other|1|||
154956211|NCT02728102|559267182|FG000|Overall Study|Death|3|||
154956212|NCT02728102|559267183|FG001|Overall Study|Death|0|||
154956213|NCT02728102|559267184|FG002|Overall Study|Death|1|||
154956214|NCT02728102|559267182|FG000|Overall Study|Withdrawal by Subject|0|||
154956215|NCT02728102|559267183|FG001|Overall Study|Withdrawal by Subject|2|||
154956216|NCT02728102|559267184|FG002|Overall Study|Withdrawal by Subject|3|||
154956217|NCT02728102|559267182|FG000|Overall Study|Physician Decision|1|||
154956218|NCT02728102|559267183|FG001|Overall Study|Physician Decision|1|||
154956219|NCT02728102|559267184|FG002|Overall Study|Physician Decision|0|||
154956220|NCT02728102|559267182|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
154956221|NCT02728102|559267183|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
154956222|NCT02728102|559267184|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
154956223|NCT02728102|559267182|FG000|Overall Study|Covid|0|||
154956224|NCT02728102|559267183|FG001|Overall Study|Covid|0|||
154956225|NCT02728102|559267184|FG002|Overall Study|Covid|1|||
154956226|NCT02419937|559267189|FG000|Overall Study|Lost to Follow-up|1|||
154956227|NCT02419937|559267190|FG001|Overall Study|Lost to Follow-up|0|||
154956228|NCT00553280|559267191|FG000|Overall Study|Adverse Event|19|||
154956229|NCT00553280|559267191|FG000|Overall Study|Lack of Efficacy|3|||
154956230|NCT00553280|559267191|FG000|Overall Study|Withdrawal by Subject|3|||
154956231|NCT00553280|559267191|FG000|Overall Study|Physician Decision|1|||
154956232|NCT01182415|559267192|FG000|Overall Study|Lost to Follow-up|1|||
154956233|NCT01544127|559267193|FG000|Overall Study|Lost to Follow-up|4|||
154956234|NCT01544127|559267194|FG001|Overall Study|Lost to Follow-up|2|||
154956235|NCT01544127|559267195|FG002|Overall Study|Lost to Follow-up|9|||
154956236|NCT01544127|559267193|FG000|Overall Study|Withdrawal by Subject|2|||
154956237|NCT01544127|559267194|FG001|Overall Study|Withdrawal by Subject|2|||
154956238|NCT01544127|559267195|FG002|Overall Study|Withdrawal by Subject|1|||
154956239|NCT01544127|559267193|FG000|Overall Study|Discharged out of catchment area|1|||
155060761|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
155060762|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
154956240|NCT01544127|559267194|FG001|Overall Study|Discharged out of catchment area|1|||
154956241|NCT01544127|559267195|FG002|Overall Study|Discharged out of catchment area|1|||
154956242|NCT01544127|559267193|FG000|Overall Study|Death|1|||
154956243|NCT01544127|559267194|FG001|Overall Study|Death|0|||
154956244|NCT01544127|559267195|FG002|Overall Study|Death|0|||
154956245|NCT01544127|559267193|FG000|Overall Study|Jail or Prison|1|||
154956246|NCT01544127|559267194|FG001|Overall Study|Jail or Prison|1|||
154956247|NCT01544127|559267195|FG002|Overall Study|Jail or Prison|2|||
154956248|NCT01544127|559267193|FG000|Overall Study|Became Psychotic|1|||
154956249|NCT01544127|559267194|FG001|Overall Study|Became Psychotic|0|||
155060763|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
155092585|NCT00560417|559773637|FG000|Overall Study|Entry Criteria Not Met|1|||
155060764|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
155060765|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
155060766|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
155060767|NCT01668797|559657649|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
155060768|NCT01668797|559657650|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
155294378|NCT02631148|560507323|FG001|Overall Study|Withdrawal by Subject|0|||
155294379|NCT02631148|560507322|FG000|Overall Study|PAH not available to study participant|1|||
155060769|NCT01668797|559657651|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
155060770|NCT01668797|559657652|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
155060771|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
155060772|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
155060773|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
155060774|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
155060775|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
155060776|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
155060777|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
155060778|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
155060779|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
155060780|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
155060781|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
155060782|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
155060783|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
155060784|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
155060785|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
155060786|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
155060787|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
155060788|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
155060789|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
155060790|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
155060791|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
155060792|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
155060793|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
155060794|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
155060795|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
155060796|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
155060797|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
155060798|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
155060799|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
155060800|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
155060801|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
155060802|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
155060803|NCT01668797|559657649|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
155060804|NCT01668797|559657650|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
155060805|NCT01668797|559657651|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
155060806|NCT01668797|559657652|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
155060807|NCT04494646|559657660|FG000|Overall Study|Adverse Event|0|||
155060808|NCT04494646|559657661|FG001|Overall Study|Adverse Event|1|||
155060809|NCT04494646|559657660|FG000|Overall Study|Withdrawal by Subject|0|||
155060810|NCT04494646|559657661|FG001|Overall Study|Withdrawal by Subject|1|||
155060811|NCT05569174|559657662|FG000|Overall Study|Adverse Event|0|||
155060812|NCT05569174|559657663|FG001|Overall Study|Adverse Event|1|||
155060813|NCT05569174|559657662|FG000|Overall Study|Lack of compliance|0|||
155060814|NCT05569174|559657663|FG001|Overall Study|Lack of compliance|1|||
155060815|NCT05569174|559657662|FG000|Overall Study|Withdrawal of consent|0|||
155060816|NCT05569174|559657663|FG001|Overall Study|Withdrawal of consent|1|||
155060817|NCT05569174|559657662|FG000|Overall Study|Participant wish|0|||
155060818|NCT05569174|559657663|FG001|Overall Study|Participant wish|1|||
155060819|NCT05569174|559657662|FG000|Overall Study|Lost to Follow-up|0|||
155060820|NCT05569174|559657663|FG001|Overall Study|Lost to Follow-up|1|||
155294380|NCT02631148|560507323|FG001|Overall Study|PAH not available to study participant|0|||
155170027|NCT00830869|560062406|FG001|Period 2: Part 2|Adverse Event|0|||
155060821|NCT00112957|559657664|FG000|Overall Study|Progressive disease|18|||
155294381|NCT00150176|560507325|FG000|Overall Study|Adverse Event|16|||
155060822|NCT00112957|559657664|FG000|Overall Study|Physician Decision|1|||
155060823|NCT00961415|559657665|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
155157271|NCT00400179|560012884|FG000|Overall Study|Investigator judgment|0|||
155060824|NCT00961415|559657666|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
155060825|NCT00961415|559657667|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
155060826|NCT00961415|559657665|FG000|Induction Treatment Phase|Death|77|||
155060827|NCT00961415|559657666|FG001|Induction Treatment Phase|Death|0|||
155060828|NCT00961415|559657667|FG002|Induction Treatment Phase|Death|0|||
155060829|NCT00961415|559657665|FG000|Induction Treatment Phase|Protocol Violation|1|||
155060830|NCT00961415|559657666|FG001|Induction Treatment Phase|Protocol Violation|0|||
155060831|NCT00961415|559657667|FG002|Induction Treatment Phase|Protocol Violation|0|||
155060832|NCT00961415|559657665|FG000|Induction Treatment Phase|Physician Decision|2|||
155060833|NCT00961415|559657666|FG001|Induction Treatment Phase|Physician Decision|0|||
155060834|NCT00961415|559657667|FG002|Induction Treatment Phase|Physician Decision|0|||
155157272|NCT00400179|560012885|FG001|Overall Study|Investigator judgment|1|||
155294382|NCT00150176|560507326|FG001|Overall Study|Adverse Event|53|||
155294383|NCT00150176|560507325|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
155157273|NCT00400179|560012884|FG000|Overall Study|Randomization error/patient ineligible|1|||
155157274|NCT00400179|560012885|FG001|Overall Study|Randomization error/patient ineligible|6|||
155157275|NCT03589859|560012886|FG000|Overall Study|Withdrawal by Subject|0|||
155157276|NCT03589859|560012887|FG001|Overall Study|Withdrawal by Subject|6|||
155157277|NCT00626106|560012889|FG000|Overall Study|Withdrawal by Subject|2|||
155157278|NCT00626106|560012890|FG001|Overall Study|Withdrawal by Subject|1|||
155157279|NCT00626106|560012889|FG000|Overall Study|Lost to Follow-up|1|||
155157280|NCT00626106|560012890|FG001|Overall Study|Lost to Follow-up|4|||
155157281|NCT00626106|560012889|FG000|Overall Study|Death|64|||
155157282|NCT00626106|560012890|FG001|Overall Study|Death|19|||
155157283|NCT02201953|560012891|FG000|Overall Study|Randomized but Never Treated|1|||
155157284|NCT02201953|560012892|FG001|Overall Study|Randomized but Never Treated|5|||
155157285|NCT02201953|560012891|FG000|Overall Study|Lack of Efficacy|9|||
155157286|NCT02201953|560012892|FG001|Overall Study|Lack of Efficacy|30|||
155157287|NCT02201953|560012891|FG000|Overall Study|Lost to Follow-up|8|||
155157288|NCT02201953|560012892|FG001|Overall Study|Lost to Follow-up|8|||
155157289|NCT02201953|560012891|FG000|Overall Study|Withdrew Consent|2|||
155157290|NCT02201953|560012892|FG001|Overall Study|Withdrew Consent|5|||
155157291|NCT02201953|560012891|FG000|Overall Study|Adverse Event|0|||
155157292|NCT02201953|560012892|FG001|Overall Study|Adverse Event|5|||
155157293|NCT02201953|560012891|FG000|Overall Study|Death|0|||
155157294|NCT02201953|560012892|FG001|Overall Study|Death|3|||
155157295|NCT03591406|560014788|FG000|Overall Study|Adverse Event|5|||
155157296|NCT03591406|560014789|FG001|Overall Study|Adverse Event|3|||
155157297|NCT03591406|560014788|FG000|Overall Study|Protocol Violation|2|||
155157298|NCT03591406|560014789|FG001|Overall Study|Protocol Violation|1|||
155157299|NCT03591406|560014788|FG000|Overall Study|Withdrawal by Subject|0|||
155157300|NCT03591406|560014789|FG001|Overall Study|Withdrawal by Subject|5|||
155157301|NCT02144610|560014790|FG000|Overall Study|Physician Decision|1|||
155157302|NCT02144610|560014791|FG001|Overall Study|Physician Decision|0|||
155157303|NCT02144610|560014790|FG000|Overall Study|Withdrawal by Subject|1|||
155157304|NCT02144610|560014791|FG001|Overall Study|Withdrawal by Subject|5|||
155157305|NCT02144610|560014790|FG000|Overall Study|Death|2|||
155157306|NCT02144610|560014791|FG001|Overall Study|Death|2|||
155157307|NCT02144610|560014790|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
155157308|NCT02144610|560014791|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
155157309|NCT02144610|560014790|FG000|Overall Study|Other|0|||
155157310|NCT02144610|560014791|FG001|Overall Study|Other|1|||
155157311|NCT02796170|560014795|FG000|Overall Study|Lost to Follow-up|3|||
155157312|NCT02796170|560014796|FG001|Overall Study|Lost to Follow-up|0|||
155157313|NCT01527370|560014797|FG000|Overall Study|Withdrawal by Subject|4|||
155157314|NCT01527370|560014797|FG000|Overall Study|Physician Decision|1|||
155157315|NCT01527370|560014797|FG000|Overall Study|Death|1|||
155157316|NCT00482053|560014803|FG000|Inter-treatment Period|Disease progression|1|||
155157317|NCT02224560|560014806|FG000|Overall Study|Protocol Deviation|1|||
155157318|NCT02224560|560014807|FG001|Overall Study|Protocol Deviation|0|||
155157319|NCT02224560|560014808|FG002|Overall Study|Protocol Deviation|0|||
155157320|NCT02224560|560014806|FG000|Overall Study|Withdrawal by Subject|2|||
155157321|NCT02224560|560014807|FG001|Overall Study|Withdrawal by Subject|0|||
155157322|NCT02224560|560014808|FG002|Overall Study|Withdrawal by Subject|1|||
155157323|NCT02224560|560014806|FG000|Overall Study|Met Withdrawal Criteria|1|||
155157324|NCT02224560|560014807|FG001|Overall Study|Met Withdrawal Criteria|0|||
155157325|NCT02224560|560014808|FG002|Overall Study|Met Withdrawal Criteria|0|||
155157326|NCT02224560|560014806|FG000|Overall Study|Adverse Event|4|||
155157327|NCT02224560|560014807|FG001|Overall Study|Adverse Event|1|||
155060835|NCT00961415|559657665|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
155157328|NCT02224560|560014808|FG002|Overall Study|Adverse Event|1|||
155157329|NCT02224560|560014806|FG000|Overall Study|Withdrawn by Investigator|1|||
155157330|NCT02224560|560014807|FG001|Overall Study|Withdrawn by Investigator|1|||
155157331|NCT02224560|560014808|FG002|Overall Study|Withdrawn by Investigator|0|||
155157332|NCT00728689|560014809|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
155157333|NCT00728689|560014810|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
155060836|NCT00961415|559657666|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
155060837|NCT00961415|559657667|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
155060838|NCT00961415|559657665|FG000|Induction Treatment Phase|Other Reason|5|||
155060839|NCT00961415|559657666|FG001|Induction Treatment Phase|Other Reason|0|||
155060840|NCT00961415|559657667|FG002|Induction Treatment Phase|Other Reason|0|||
155060841|NCT00961415|559657665|FG000|Maintenance Treatment Phase|Death|0|||
155060842|NCT00961415|559657666|FG001|Maintenance Treatment Phase|Death|42|||
155060843|NCT00961415|559657667|FG002|Maintenance Treatment Phase|Death|34|||
155060844|NCT00961415|559657665|FG000|Maintenance Treatment Phase|Investigators decision|0|||
155060845|NCT00961415|559657666|FG001|Maintenance Treatment Phase|Investigators decision|2|||
155060846|NCT00961415|559657667|FG002|Maintenance Treatment Phase|Investigators decision|0|||
155060847|NCT00961415|559657665|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155060848|NCT00961415|559657666|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
155060849|NCT00961415|559657667|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
155060850|NCT00961415|559657665|FG000|Maintenance Treatment Phase|Other reason|0|||
155060851|NCT00961415|559657666|FG001|Maintenance Treatment Phase|Other reason|1|||
155060852|NCT00961415|559657667|FG002|Maintenance Treatment Phase|Other reason|3|||
155060853|NCT02309359|559657668|FG000|Overall Study|Adverse Event|4|||
155060854|NCT02309359|559657669|FG001|Overall Study|Adverse Event|5|||
155060855|NCT02309359|559657670|FG002|Overall Study|Adverse Event|5|||
155060856|NCT02309359|559657671|FG003|Overall Study|Adverse Event|4|||
155060857|NCT02309359|559657672|FG004|Overall Study|Adverse Event|4|||
155060858|NCT02309359|559657668|FG000|Overall Study|Death|1|||
155060859|NCT02309359|559657669|FG001|Overall Study|Death|0|||
155060860|NCT02309359|559657670|FG002|Overall Study|Death|0|||
155060861|NCT02309359|559657671|FG003|Overall Study|Death|0|||
155060862|NCT02309359|559657672|FG004|Overall Study|Death|0|||
155060863|NCT02309359|559657668|FG000|Overall Study|Withdrawal by Subject|2|||
155060864|NCT02309359|559657669|FG001|Overall Study|Withdrawal by Subject|2|||
155060865|NCT02309359|559657670|FG002|Overall Study|Withdrawal by Subject|4|||
155060866|NCT02309359|559657671|FG003|Overall Study|Withdrawal by Subject|4|||
155060867|NCT02309359|559657672|FG004|Overall Study|Withdrawal by Subject|0|||
155060868|NCT02309359|559657668|FG000|Overall Study|Lack of Efficacy|3|||
155060869|NCT02309359|559657669|FG001|Overall Study|Lack of Efficacy|1|||
155060870|NCT02309359|559657670|FG002|Overall Study|Lack of Efficacy|0|||
155060871|NCT02309359|559657671|FG003|Overall Study|Lack of Efficacy|0|||
155060872|NCT02309359|559657672|FG004|Overall Study|Lack of Efficacy|3|||
155060873|NCT02309359|559657668|FG000|Overall Study|Lost to Follow-up|0|||
155060874|NCT02309359|559657669|FG001|Overall Study|Lost to Follow-up|0|||
155060875|NCT02309359|559657670|FG002|Overall Study|Lost to Follow-up|0|||
155060876|NCT02309359|559657671|FG003|Overall Study|Lost to Follow-up|1|||
155060877|NCT02309359|559657672|FG004|Overall Study|Lost to Follow-up|0|||
155060878|NCT02309359|559657668|FG000|Overall Study|Other|2|||
155060879|NCT02309359|559657669|FG001|Overall Study|Other|0|||
155060880|NCT02309359|559657670|FG002|Overall Study|Other|2|||
155060881|NCT02309359|559657671|FG003|Overall Study|Other|3|||
155157334|NCT01523366|560014811|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155060882|NCT02309359|559657672|FG004|Overall Study|Other|2|||
155060883|NCT03307174|559657674|FG000|Overall Study|Unplanned ICU Administrion|5|||
155060884|NCT03307174|559657675|FG001|Overall Study|Unplanned ICU Administrion|3|||
155060885|NCT03307174|559657674|FG000|Overall Study|Aborted Surgery|1|||
155060886|NCT03307174|559657675|FG001|Overall Study|Aborted Surgery|2|||
155060887|NCT03307174|559657674|FG000|Overall Study|Hypotension|6|||
155060888|NCT03307174|559657675|FG001|Overall Study|Hypotension|0|||
155060889|NCT03307174|559657674|FG000|Overall Study|Nonfunctional epidural|1|||
155060890|NCT03307174|559657675|FG001|Overall Study|Nonfunctional epidural|1|||
155060891|NCT03307174|559657674|FG000|Overall Study|Planned epidural removal|1|||
155060892|NCT03307174|559657675|FG001|Overall Study|Planned epidural removal|0|||
155060893|NCT03307174|559657674|FG000|Overall Study|Intrathecal catheter placement|0|||
155060894|NCT03307174|559657675|FG001|Overall Study|Intrathecal catheter placement|1|||
155060895|NCT00863707|559657676|FG000|Overall Study|Randomized, but drug not received|4|||
155060896|NCT00863707|559657677|FG001|Overall Study|Randomized, but drug not received|3|||
155060897|NCT03704064|559657678|FG000|Overall Study|Lost to Follow-up|8|||
155060898|NCT03704064|559657679|FG001|Overall Study|Lost to Follow-up|4|||
155060899|NCT03704064|559657678|FG000|Overall Study|Withdrawal by Subject|1|||
155060900|NCT03704064|559657679|FG001|Overall Study|Withdrawal by Subject|1|||
155157335|NCT01523366|560014812|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154956250|NCT01544127|559267195|FG002|Overall Study|Became Psychotic|0|||
154956251|NCT01544127|559267193|FG000|Overall Study|Researcher withdrew|1|||
154956252|NCT01544127|559267194|FG001|Overall Study|Researcher withdrew|0|||
154956253|NCT01544127|559267195|FG002|Overall Study|Researcher withdrew|0|||
154956254|NCT01544127|559267193|FG000|Overall Study|Went active duty|0|||
154956255|NCT01544127|559267194|FG001|Overall Study|Went active duty|0|||
154956256|NCT01544127|559267195|FG002|Overall Study|Went active duty|1|||
154956257|NCT01256684|559267198|FG000|Overall Study|Adverse Event|1|||
154956258|NCT01256684|559267199|FG001|Overall Study|Adverse Event|4|||
154956259|NCT01256684|559267200|FG002|Overall Study|Adverse Event|2|||
154956260|NCT01256684|559267198|FG000|Overall Study|Withdrawal by Subject|4|||
154956261|NCT01256684|559267199|FG001|Overall Study|Withdrawal by Subject|0|||
154956262|NCT01256684|559267200|FG002|Overall Study|Withdrawal by Subject|2|||
154956263|NCT01256684|559267198|FG000|Overall Study|Physician Decision|0|||
154956264|NCT01256684|559267199|FG001|Overall Study|Physician Decision|1|||
154956265|NCT01256684|559267200|FG002|Overall Study|Physician Decision|0|||
154956266|NCT01256684|559267198|FG000|Overall Study|Lack of Efficacy|0|||
154956267|NCT01256684|559267199|FG001|Overall Study|Lack of Efficacy|1|||
154956268|NCT01256684|559267200|FG002|Overall Study|Lack of Efficacy|1|||
154956269|NCT01256684|559267198|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
154956270|NCT01256684|559267199|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
154956271|NCT01256684|559267200|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
154956272|NCT00184600|559267202|FG000|Overall Study|Adverse Event|9|||
154956273|NCT00184600|559267203|FG001|Overall Study|Adverse Event|0|||
154956274|NCT00184600|559267204|FG002|Overall Study|Adverse Event|5|||
154956275|NCT00184600|559267202|FG000|Overall Study|Death|3|||
154956276|NCT00184600|559267203|FG001|Overall Study|Death|9|||
154956277|NCT00184600|559267204|FG002|Overall Study|Death|7|||
154956278|NCT00184600|559267202|FG000|Overall Study|Lack of Efficacy|3|||
154956279|NCT00184600|559267203|FG001|Overall Study|Lack of Efficacy|1|||
154956280|NCT00184600|559267204|FG002|Overall Study|Lack of Efficacy|3|||
154956281|NCT00184600|559267202|FG000|Overall Study|Lost to Follow-up|4|||
154956282|NCT00184600|559267203|FG001|Overall Study|Lost to Follow-up|6|||
154956283|NCT00184600|559267204|FG002|Overall Study|Lost to Follow-up|1|||
154956284|NCT00184600|559267202|FG000|Overall Study|Protocol Violation|2|||
154956285|NCT00184600|559267203|FG001|Overall Study|Protocol Violation|2|||
154956286|NCT00184600|559267204|FG002|Overall Study|Protocol Violation|3|||
154956287|NCT00184600|559267202|FG000|Overall Study|Withdrawal by Subject|20|||
154956288|NCT00184600|559267203|FG001|Overall Study|Withdrawal by Subject|28|||
154956289|NCT00184600|559267204|FG002|Overall Study|Withdrawal by Subject|12|||
154956290|NCT00184600|559267202|FG000|Overall Study|Unclassified|4|||
154956291|NCT00184600|559267203|FG001|Overall Study|Unclassified|5|||
154956292|NCT00184600|559267204|FG002|Overall Study|Unclassified|3|||
154956293|NCT00624065|559267207|FG000|Overall Study|Adverse Event|5|||
154956294|NCT00624065|559267208|FG001|Overall Study|Adverse Event|6|||
154956295|NCT00624065|559267207|FG000|Overall Study|Lost to Follow-up|4|||
154956296|NCT00624065|559267208|FG001|Overall Study|Lost to Follow-up|1|||
154956297|NCT00624065|559267207|FG000|Overall Study|Consent withdrawn|6|||
154956298|NCT00624065|559267208|FG001|Overall Study|Consent withdrawn|5|||
154956299|NCT00624065|559267207|FG000|Overall Study|Lack of Efficacy|0|||
154956300|NCT00624065|559267208|FG001|Overall Study|Lack of Efficacy|3|||
154956301|NCT00624065|559267207|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
154956302|NCT00624065|559267208|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
154956303|NCT00696020|559267209|FG000|Overall Study|Adverse Event|3|||
154956304|NCT00696020|559267210|FG001|Overall Study|Adverse Event|1|||
154956305|NCT00696020|559267211|FG002|Overall Study|Adverse Event|2|||
154956306|NCT00696020|559267212|FG003|Overall Study|Adverse Event|1|||
154956307|NCT00696020|559267209|FG000|Overall Study|Lack of Efficacy|1|||
154956308|NCT00696020|559267210|FG001|Overall Study|Lack of Efficacy|0|||
154956309|NCT00696020|559267211|FG002|Overall Study|Lack of Efficacy|0|||
154956310|NCT00696020|559267212|FG003|Overall Study|Lack of Efficacy|0|||
154956311|NCT00696020|559267209|FG000|Overall Study|Protocol Violation|0|||
154956312|NCT00696020|559267210|FG001|Overall Study|Protocol Violation|0|||
154956313|NCT00696020|559267211|FG002|Overall Study|Protocol Violation|0|||
154956314|NCT00696020|559267212|FG003|Overall Study|Protocol Violation|1|||
154956315|NCT00696020|559267209|FG000|Overall Study|Withdrawal by Subject|0|||
154956316|NCT00696020|559267210|FG001|Overall Study|Withdrawal by Subject|1|||
154956317|NCT00696020|559267211|FG002|Overall Study|Withdrawal by Subject|0|||
154956318|NCT00696020|559267212|FG003|Overall Study|Withdrawal by Subject|1|||
154956319|NCT00696020|559267209|FG000|Overall Study|Other not stated above|0|||
154956320|NCT00696020|559267210|FG001|Overall Study|Other not stated above|0|||
155060901|NCT03704064|559657678|FG000|Overall Study|No longer available for study visits|0|||
154956321|NCT00696020|559267211|FG002|Overall Study|Other not stated above|1|||
154956322|NCT00696020|559267212|FG003|Overall Study|Other not stated above|1|||
154956323|NCT03627091|559267215|FG000|Overall Study|Adverse Event|0|||
154956324|NCT03627091|559267216|FG001|Overall Study|Adverse Event|0|||
154956325|NCT03627091|559267217|FG002|Overall Study|Adverse Event|2|||
154956326|NCT03627091|559267215|FG000|Overall Study|Withdrawal by Subject|2|||
154956327|NCT03627091|559267216|FG001|Overall Study|Withdrawal by Subject|0|||
155060902|NCT03704064|559657679|FG001|Overall Study|No longer available for study visits|1|||
155060903|NCT03704064|559657678|FG000|Overall Study|Censoring event|1|||
155060904|NCT03704064|559657679|FG001|Overall Study|Censoring event|0|||
155060905|NCT01286129|559657680|FG000|Overall Study|Withdrawal by Subject|4|||
155060906|NCT01286129|559657681|FG001|Overall Study|Withdrawal by Subject|1|||
155060907|NCT01286129|559657680|FG000|Overall Study|Could not comply with study requirements|4|||
155060908|NCT01286129|559657681|FG001|Overall Study|Could not comply with study requirements|4|||
155060909|NCT03040726|559657688|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
155060910|NCT03040726|559657689|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
155060911|NCT03040726|559657688|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
155060912|NCT03040726|559657689|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
155060913|NCT03040726|559657688|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
155060914|NCT03040726|559657689|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
155060915|NCT03040726|559657688|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
155060916|NCT03040726|559657689|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
155060917|NCT03040726|559657688|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
155060918|NCT03040726|559657689|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
155060919|NCT03025035|559657690|FG000|Overall Study|Death|2|||
155060920|NCT03025035|559657690|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
155060921|NCT01218802|559657693|FG000|Overall Study|Lost to Follow-up|5|||
155060922|NCT01218802|559657694|FG001|Overall Study|Lost to Follow-up|6|||
155060923|NCT01218802|559657693|FG000|Overall Study|Withdrawal by Subject|3|||
155060924|NCT01218802|559657694|FG001|Overall Study|Withdrawal by Subject|10|||
155060925|NCT01218802|559657693|FG000|Overall Study|Adverse Event|0|||
155060926|NCT01218802|559657694|FG001|Overall Study|Adverse Event|2|||
155060927|NCT01218802|559657693|FG000|Overall Study|Incarcerated|2|||
155060928|NCT01218802|559657694|FG001|Overall Study|Incarcerated|0|||
155060929|NCT01123655|559657697|FG000|Overall Study|Medication for RA had to be changed|1|||
155060930|NCT01123655|559657698|FG001|Overall Study|Medication for RA had to be changed|0|||
155060931|NCT01123655|559657699|FG002|Overall Study|Medication for RA had to be changed|0|||
155060932|NCT01123655|559657697|FG000|Overall Study|new illness|0|||
155060933|NCT01123655|559657698|FG001|Overall Study|new illness|1|||
155060934|NCT01123655|559657699|FG002|Overall Study|new illness|0|||
155060935|NCT01123655|559657697|FG000|Overall Study|began prohibitive drug|0|||
155060936|NCT01123655|559657698|FG001|Overall Study|began prohibitive drug|0|||
155060937|NCT01123655|559657699|FG002|Overall Study|began prohibitive drug|1|||
155060938|NCT00062166|559657700|FG000|Overall Study|Withdrawal by Subject|6|||
155060939|NCT00885118|559657705|FG000|Overall Study|Adverse Event|1|||
155060940|NCT00885118|559657706|FG001|Overall Study|Adverse Event|0|||
155060941|NCT00885118|559657707|FG002|Overall Study|Adverse Event|0|||
155060942|NCT00885118|559657708|FG003|Overall Study|Adverse Event|0|||
155060943|NCT00885118|559657709|FG004|Overall Study|Adverse Event|0|||
155060944|NCT00885118|559657705|FG000|Overall Study|Withdrawal by Subject|0|||
155060945|NCT00885118|559657706|FG001|Overall Study|Withdrawal by Subject|0|||
155060946|NCT00885118|559657707|FG002|Overall Study|Withdrawal by Subject|0|||
155060947|NCT00885118|559657708|FG003|Overall Study|Withdrawal by Subject|0|||
155157336|NCT01523366|560014811|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
155060948|NCT00885118|559657709|FG004|Overall Study|Withdrawal by Subject|1|||
155060949|NCT00885118|559657705|FG000|Overall Study|Other reason not defined above|0|||
155060950|NCT00885118|559657706|FG001|Overall Study|Other reason not defined above|0|||
155060951|NCT00885118|559657707|FG002|Overall Study|Other reason not defined above|1|||
155060952|NCT00885118|559657708|FG003|Overall Study|Other reason not defined above|0|||
155060953|NCT00885118|559657709|FG004|Overall Study|Other reason not defined above|0|||
155060954|NCT01981616|559657715|FG000|Overall Study|Adverse Event|0|||
155060955|NCT01981616|559657716|FG001|Overall Study|Adverse Event|1|||
155060956|NCT01981616|559657715|FG000|Overall Study|Protocol Violation|1|||
155060957|NCT01981616|559657716|FG001|Overall Study|Protocol Violation|0|||
155060958|NCT00094445|559657717|FG000|Overall Study|Withdrawal by Subject|3|||
155060959|NCT00094445|559657717|FG000|Overall Study|Lost to Follow-up|1|||
155060960|NCT00094445|559657717|FG000|Overall Study|Progressive Disease|2|||
155060961|NCT03092752|559657724|FG000|Overall Study|Aged <40 years|14209|||
155060962|NCT03092752|559657724|FG000|Overall Study|At least one claim with T2DM|61299|||
155060963|NCT03092752|559657724|FG000|Overall Study|Having no claim of study drugs|29282|||
155060964|NCT03092752|559657724|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
155060965|NCT03092752|559657724|FG000|Overall Study|<6 month history|245900|||
155060966|NCT05079321|559657727|FG000|Overall Study|Withdrawal by Subject|2|||
155060967|NCT05079321|559657728|FG001|Overall Study|Withdrawal by Subject|2|||
155060968|NCT05079321|559657727|FG000|Overall Study|Lost to Follow-up|0|||
155060969|NCT05079321|559657728|FG001|Overall Study|Lost to Follow-up|1|||
155060970|NCT01884597|559657729|FG000|Overall Study|Adverse Event|0|||
155060971|NCT01884597|559657730|FG001|Overall Study|Adverse Event|0|||
155060972|NCT01884597|559657731|FG002|Overall Study|Adverse Event|1|||
155060973|NCT01884597|559657729|FG000|Overall Study|Lack of Efficacy|1|||
155060974|NCT01884597|559657730|FG001|Overall Study|Lack of Efficacy|0|||
155060975|NCT01884597|559657731|FG002|Overall Study|Lack of Efficacy|0|||
155060976|NCT01884597|559657729|FG000|Overall Study|Death|0|||
155060977|NCT01884597|559657730|FG001|Overall Study|Death|1|||
155060978|NCT01884597|559657731|FG002|Overall Study|Death|0|||
155060979|NCT02097823|559657732|FG000|Overall Study|Withdrawal by Subject|1|||
155060980|NCT02097823|559657733|FG001|Overall Study|Withdrawal by Subject|1|||
155060981|NCT01419535|559657734|FG000|Overall Study|could not maintain iv line|1|||
155060982|NCT01419535|559657735|FG001|Overall Study|could not maintain iv line|1|||
155060983|NCT01419535|559657734|FG000|Overall Study|Withdrawal by Subject|0|||
155060984|NCT01419535|559657735|FG001|Overall Study|Withdrawal by Subject|1|||
155060985|NCT02074514|559657737|FG000|Overall Study|Lack of Efficacy|3|||
155060986|NCT02074514|559657738|FG001|Overall Study|Lack of Efficacy|2|||
155060987|NCT02074514|559657737|FG000|Overall Study|Lost to Follow-up|0|||
155060988|NCT02074514|559657738|FG001|Overall Study|Lost to Follow-up|1|||
155060989|NCT02074514|559657737|FG000|Overall Study|Withdrew Consent|0|||
155060990|NCT02074514|559657738|FG001|Overall Study|Withdrew Consent|1|||
155060991|NCT04239924|559657741|FG000|Overall Study|Lost to Follow-up|2|||
155060992|NCT00666237|559657742|FG000|Overall Study|Death|5|||
155060993|NCT00666237|559657743|FG001|Overall Study|Death|5|||
155060994|NCT00666237|559657742|FG000|Overall Study|Lost to Follow-up|29|||
155060995|NCT00666237|559657743|FG001|Overall Study|Lost to Follow-up|25|||
155060996|NCT02839707|559657745|FG000|Phase I|Not eligible for analysis|9|||
155060997|NCT02839707|559657746|FG001|Phase I|Not eligible for analysis|0|||
155060998|NCT02839707|559657747|FG002|Phase I|Not eligible for analysis|0|||
155060999|NCT02839707|559657745|FG000|Phase II|Not treated according to protocol|4|||
155061000|NCT02839707|559657746|FG001|Phase II|Not treated according to protocol|0|||
155061001|NCT02839707|559657747|FG002|Phase II|Not treated according to protocol|2|||
155061002|NCT02839707|559657745|FG000|Phase III|Not treated according to protocol|0|||
155061003|NCT02839707|559657746|FG001|Phase III|Not treated according to protocol|0|||
155061004|NCT02839707|559657747|FG002|Phase III|Not treated according to protocol|4|||
155061005|NCT03759379|559659215|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
155061006|NCT03759379|559659216|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
155061007|NCT03759379|559659215|FG000|Treatment Period|Death|2|||
155061008|NCT03759379|559659216|FG001|Treatment Period|Death|3|||
155061009|NCT03759379|559659215|FG000|Treatment Period|Lost to Follow-up|1|||
155061010|NCT03759379|559659216|FG001|Treatment Period|Lost to Follow-up|0|||
155061011|NCT03759379|559659215|FG000|Treatment Period|Physician Decision|0|||
155061012|NCT03759379|559659216|FG001|Treatment Period|Physician Decision|1|||
155061013|NCT05399680|559659217|FG000|Overall Study|Lost to Follow-up|1|||
155061014|NCT05399680|559659218|FG001|Overall Study|Lost to Follow-up|0|||
155061015|NCT05399680|559659217|FG000|Overall Study|Death|0|||
155061016|NCT05399680|559659218|FG001|Overall Study|Death|1|||
155157337|NCT01523366|560014812|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
155061017|NCT02659865|559659219|FG000|Period 1|Withdrawal by Subject|1|||
155061018|NCT02659865|559659220|FG001|Period 1|Withdrawal by Subject|0|||
155061019|NCT02659865|559659221|FG002|Period 1|Withdrawal by Subject|0|||
155061020|NCT02659865|559659222|FG003|Period 1|Withdrawal by Subject|0|||
155061021|NCT02659865|559659223|FG004|Period 1|Withdrawal by Subject|0|||
155061022|NCT02659865|559659219|FG000|Period 1|Adverse Event|0|||
155061023|NCT02659865|559659220|FG001|Period 1|Adverse Event|0|||
155061024|NCT02659865|559659221|FG002|Period 1|Adverse Event|0|||
155061025|NCT02659865|559659222|FG003|Period 1|Adverse Event|0|||
155061026|NCT02659865|559659223|FG004|Period 1|Adverse Event|1|||
155061027|NCT03675308|559659224|FG000|Overall Study|Adverse Event|3|||
155061028|NCT03675308|559659225|FG001|Overall Study|Adverse Event|2|||
155061029|NCT03675308|559659224|FG000|Overall Study|Withdrawal by Subject|6|||
155061030|NCT03675308|559659225|FG001|Overall Study|Withdrawal by Subject|4|||
155061031|NCT03675308|559659224|FG000|Overall Study|Lost to Follow-up|3|||
155061032|NCT03675308|559659225|FG001|Overall Study|Lost to Follow-up|0|||
155061033|NCT03675308|559659224|FG000|Overall Study|Lack of Efficacy|1|||
155061034|NCT03675308|559659225|FG001|Overall Study|Lack of Efficacy|1|||
155061035|NCT03675308|559659224|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
155061036|NCT03675308|559659225|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
155061037|NCT03675308|559659224|FG000|Overall Study|Other|0|||
155061038|NCT03675308|559659225|FG001|Overall Study|Other|1|||
155061039|NCT02325414|559659226|FG000|Overall Study|Withdrawal by Subject|3|||
155061040|NCT02325414|559659227|FG001|Overall Study|Withdrawal by Subject|1|||
155061041|NCT02325414|559659226|FG000|Overall Study|Lost to Follow-up|5|||
155061042|NCT02325414|559659227|FG001|Overall Study|Lost to Follow-up|5|||
155061043|NCT05722522|559659228|FG000|Overall Study|Adverse Event|0|||
155061044|NCT05722522|559659229|FG001|Overall Study|Adverse Event|1|||
155061045|NCT02775851|559659231|FG000|Overall Study|Adverse Event|1|||
155061046|NCT02775851|559659232|FG001|Overall Study|Adverse Event|10|||
155061047|NCT02775851|559659231|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
155061048|NCT02775851|559659232|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
155061049|NCT02775851|559659231|FG000|Overall Study|Progression/Relapse|0|||
155061050|NCT02775851|559659232|FG001|Overall Study|Progression/Relapse|4|||
155061051|NCT02775851|559659231|FG000|Overall Study|Other - Not Protocol Specified|0|||
155061052|NCT02775851|559659232|FG001|Overall Study|Other - Not Protocol Specified|7|||
155061053|NCT02775851|559659231|FG000|Overall Study|Withdrawal by Subject|1|||
155061054|NCT02775851|559659232|FG001|Overall Study|Withdrawal by Subject|0|||
155061055|NCT02194465|559659233|FG000|Overall Study|Adverse Event|6|||
155061056|NCT02194465|559659234|FG001|Overall Study|Adverse Event|1|||
155061057|NCT02194465|559659235|FG002|Overall Study|Adverse Event|4|||
155061058|NCT02194465|559659236|FG003|Overall Study|Adverse Event|4|||
155061059|NCT02194465|559659237|FG004|Overall Study|Adverse Event|4|||
155061060|NCT02194465|559659238|FG005|Overall Study|Adverse Event|2|||
155061061|NCT02194465|559659239|FG006|Overall Study|Adverse Event|0|||
155061062|NCT02194465|559659233|FG000|Overall Study|Lost to Follow-up|0|||
155061063|NCT02194465|559659234|FG001|Overall Study|Lost to Follow-up|0|||
155061064|NCT02194465|559659235|FG002|Overall Study|Lost to Follow-up|0|||
155061065|NCT02194465|559659236|FG003|Overall Study|Lost to Follow-up|1|||
155061066|NCT02194465|559659237|FG004|Overall Study|Lost to Follow-up|0|||
155061067|NCT02194465|559659238|FG005|Overall Study|Lost to Follow-up|1|||
155061068|NCT02194465|559659239|FG006|Overall Study|Lost to Follow-up|0|||
155061069|NCT02194465|559659233|FG000|Overall Study|Physician Decision|1|||
155061070|NCT02194465|559659234|FG001|Overall Study|Physician Decision|0|||
155061071|NCT02194465|559659235|FG002|Overall Study|Physician Decision|0|||
155061072|NCT02194465|559659236|FG003|Overall Study|Physician Decision|0|||
155294384|NCT00150176|560507326|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
155061073|NCT02194465|559659237|FG004|Overall Study|Physician Decision|0|||
155061074|NCT02194465|559659238|FG005|Overall Study|Physician Decision|0|||
155061075|NCT02194465|559659239|FG006|Overall Study|Physician Decision|0|||
155061076|NCT02194465|559659233|FG000|Overall Study|Protocol Violation|1|||
155061077|NCT02194465|559659234|FG001|Overall Study|Protocol Violation|1|||
155061078|NCT02194465|559659235|FG002|Overall Study|Protocol Violation|2|||
155157338|NCT04543279|560014814|FG000|Overall Study|Withdrawal by Subject|1|||
155294385|NCT00150176|560507325|FG000|Overall Study|Withdrawal by Subject|19|||
155294386|NCT00150176|560507326|FG001|Overall Study|Withdrawal by Subject|12|||
155061079|NCT02194465|559659236|FG003|Overall Study|Protocol Violation|1|||
155157339|NCT04543279|560014815|FG001|Overall Study|Withdrawal by Subject|0|||
154956328|NCT03627091|559267217|FG002|Overall Study|Withdrawal by Subject|2|||
154956329|NCT03627091|559267215|FG000|Overall Study|Physician Decision|2|||
154956330|NCT03627091|559267216|FG001|Overall Study|Physician Decision|0|||
154956331|NCT03627091|559267217|FG002|Overall Study|Physician Decision|0|||
154956332|NCT03627091|559267215|FG000|Overall Study|Site terminated by sponsor|0|||
154956333|NCT03627091|559267216|FG001|Overall Study|Site terminated by sponsor|1|||
154956334|NCT03627091|559267217|FG002|Overall Study|Site terminated by sponsor|0|||
154956335|NCT03627091|559267215|FG000|Overall Study|Disease relapse|7|||
154956336|NCT03627091|559267216|FG001|Overall Study|Disease relapse|5|||
154956337|NCT03627091|559267217|FG002|Overall Study|Disease relapse|1|||
154956338|NCT03627091|559267215|FG000|Overall Study|Other|1|||
154956339|NCT03627091|559267216|FG001|Overall Study|Other|0|||
154956340|NCT03627091|559267217|FG002|Overall Study|Other|0|||
154956341|NCT00102440|559267218|FG000|Overall Study|Lost to Follow-up|25|||
154956342|NCT00102440|559267219|FG001|Overall Study|Lost to Follow-up|18|||
154956343|NCT00102440|559267220|FG002|Overall Study|Lost to Follow-up|21|||
154956344|NCT00102440|559267218|FG000|Overall Study|Adverse Event|16|||
154956345|NCT00102440|559267219|FG001|Overall Study|Adverse Event|23|||
154956346|NCT00102440|559267220|FG002|Overall Study|Adverse Event|8|||
154956347|NCT00102440|559267218|FG000|Overall Study|Gout Flare|10|||
154956348|NCT00102440|559267219|FG001|Overall Study|Gout Flare|28|||
154956349|NCT00102440|559267220|FG002|Overall Study|Gout Flare|9|||
154956350|NCT00102440|559267218|FG000|Overall Study|Personal Reason(s)|19|||
154956351|NCT00102440|559267219|FG001|Overall Study|Personal Reason(s)|13|||
154956352|NCT00102440|559267220|FG002|Overall Study|Personal Reason(s)|13|||
154956353|NCT00102440|559267218|FG000|Overall Study|Other|11|||
154956354|NCT00102440|559267219|FG001|Overall Study|Other|14|||
154956355|NCT00102440|559267220|FG002|Overall Study|Other|14|||
154956356|NCT00102440|559267218|FG000|Overall Study|Protocol Violation|7|||
154956357|NCT00102440|559267219|FG001|Overall Study|Protocol Violation|2|||
154956358|NCT00102440|559267220|FG002|Overall Study|Protocol Violation|1|||
154956359|NCT01010542|559267222|FG000|Overall Study|Adverse Event|0|||
154956360|NCT01010542|559267223|FG001|Overall Study|Adverse Event|1|||
154956361|NCT01010542|559267224|FG002|Overall Study|Adverse Event|0|||
154956362|NCT01010542|559267222|FG000|Overall Study|Lost to Follow-up|0|||
154956363|NCT01010542|559267223|FG001|Overall Study|Lost to Follow-up|1|||
154956364|NCT01010542|559267224|FG002|Overall Study|Lost to Follow-up|0|||
154956365|NCT01010542|559267222|FG000|Overall Study|Withdrawal by Subject|0|||
154956366|NCT01010542|559267223|FG001|Overall Study|Withdrawal by Subject|3|||
154956367|NCT01010542|559267224|FG002|Overall Study|Withdrawal by Subject|2|||
154956368|NCT00678639|559267227|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
154956369|NCT00678639|559267228|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
154956370|NCT01546545|559267230|FG000|Overall Study|Withdrawal by Subject|1|||
154956371|NCT01214850|559267231|FG000|Overall Study|Withdrawal by Subject|38|||
154956372|NCT01214850|559267232|FG001|Overall Study|Withdrawal by Subject|31|||
154956373|NCT01214850|559267233|FG002|Overall Study|Withdrawal by Subject|28|||
154956374|NCT01214850|559267231|FG000|Overall Study|Lost to Follow-up|124|||
154956375|NCT01214850|559267232|FG001|Overall Study|Lost to Follow-up|98|||
154956376|NCT01214850|559267233|FG002|Overall Study|Lost to Follow-up|123|||
154956377|NCT01214850|559267231|FG000|Overall Study|Protocol Violation|5|||
154956378|NCT01214850|559267232|FG001|Overall Study|Protocol Violation|5|||
154956379|NCT01214850|559267233|FG002|Overall Study|Protocol Violation|6|||
154956380|NCT01214850|559267231|FG000|Overall Study|Adverse event or death|11|||
154956381|NCT01214850|559267232|FG001|Overall Study|Adverse event or death|8|||
154956382|NCT01214850|559267233|FG002|Overall Study|Adverse event or death|3|||
155061080|NCT02194465|559659237|FG004|Overall Study|Protocol Violation|1|||
155061081|NCT02194465|559659238|FG005|Overall Study|Protocol Violation|0|||
155061082|NCT02194465|559659239|FG006|Overall Study|Protocol Violation|0|||
155061083|NCT02194465|559659233|FG000|Overall Study|Withdrawal by Subject|1|||
155061084|NCT02194465|559659234|FG001|Overall Study|Withdrawal by Subject|3|||
155061085|NCT02194465|559659235|FG002|Overall Study|Withdrawal by Subject|1|||
155061086|NCT02194465|559659236|FG003|Overall Study|Withdrawal by Subject|2|||
155061087|NCT02194465|559659237|FG004|Overall Study|Withdrawal by Subject|2|||
155061088|NCT02194465|559659238|FG005|Overall Study|Withdrawal by Subject|1|||
155061089|NCT02194465|559659239|FG006|Overall Study|Withdrawal by Subject|2|||
155061090|NCT02194465|559659233|FG000|Overall Study|Discontinued follow-up period|0|||
155061091|NCT02194465|559659234|FG001|Overall Study|Discontinued follow-up period|2|||
155061092|NCT02194465|559659235|FG002|Overall Study|Discontinued follow-up period|1|||
155061093|NCT02194465|559659236|FG003|Overall Study|Discontinued follow-up period|0|||
155061094|NCT02194465|559659237|FG004|Overall Study|Discontinued follow-up period|2|||
155061095|NCT02194465|559659238|FG005|Overall Study|Discontinued follow-up period|0|||
155061096|NCT02194465|559659239|FG006|Overall Study|Discontinued follow-up period|0|||
155061097|NCT01125930|559659240|FG000|Overall Study|Adverse Event|0|||
155061098|NCT01125930|559659241|FG001|Overall Study|Adverse Event|1|||
155061099|NCT01125930|559659240|FG000|Overall Study|Withdrawal by Subject|1|||
155061100|NCT01125930|559659241|FG001|Overall Study|Withdrawal by Subject|6|||
155061101|NCT01125930|559659240|FG000|Overall Study|Protocol Violation|0|||
155061102|NCT01125930|559659241|FG001|Overall Study|Protocol Violation|1|||
155061103|NCT01125930|559659240|FG000|Overall Study|Lost to Follow-up|0|||
155294387|NCT00150176|560507325|FG000|Overall Study|Lost to Follow-up|3|||
155294388|NCT00150176|560507326|FG001|Overall Study|Lost to Follow-up|3|||
155294389|NCT00150176|560507325|FG000|Overall Study|OTHER|11|||
155294390|NCT00150176|560507326|FG001|Overall Study|OTHER|13|||
155157340|NCT04543279|560014814|FG000|Overall Study|Adverse Event|1|||
155157341|NCT04543279|560014815|FG001|Overall Study|Adverse Event|0|||
155157342|NCT04543279|560014814|FG000|Overall Study|Physician Decision|1|||
155157343|NCT04543279|560014815|FG001|Overall Study|Physician Decision|0|||
155157344|NCT03216226|560014818|FG000|Overall Study|Adverse Event|3|||
155157345|NCT03216226|560014819|FG001|Overall Study|Adverse Event|0|||
155157346|NCT03216226|560014818|FG000|Overall Study|Protocol Violation|1|||
155157347|NCT03216226|560014819|FG001|Overall Study|Protocol Violation|3|||
155157348|NCT03216226|560014818|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
155157349|NCT03216226|560014819|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
155157350|NCT03216226|560014818|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
155157351|NCT03216226|560014819|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
155157352|NCT03216226|560014818|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
155157353|NCT03216226|560014819|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
155157354|NCT00887809|560014821|FG000|Overall Study|Patient Not Treated|3|||
155157355|NCT00887809|560014822|FG001|Overall Study|Patient Not Treated|0|||
155157356|NCT00887809|560014821|FG000|Overall Study|Death|1|||
155157357|NCT00887809|560014822|FG001|Overall Study|Death|0|||
155157358|NCT03131570|560014823|FG000|Overall Study|Adverse Event|1|||
155157359|NCT03131570|560014824|FG001|Overall Study|Adverse Event|0|||
155157360|NCT04596267|560014825|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
155157361|NCT04596267|560014826|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
155157362|NCT04596267|560014825|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
155157363|NCT04596267|560014826|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
155157364|NCT00071058|560014827|FG000|Overall Study|brain tumor-removed from study|1|||
155157365|NCT00871975|560014832|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
155157366|NCT00871975|560014832|FG000|Overall Study|Catheters could not be inserted|1|||
155157367|NCT00871975|560014832|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
155157368|NCT00871975|560014832|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
155157369|NCT01436149|560014836|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
155157370|NCT01436149|560014837|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
155157371|NCT01436149|560014838|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
155157372|NCT01436149|560014836|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
155157373|NCT01436149|560014837|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
155157374|NCT01436149|560014838|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
155157375|NCT01436149|560014836|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
155157376|NCT01436149|560014837|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155157377|NCT01436149|560014838|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
155157378|NCT01436149|560014836|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
155157379|NCT01436149|560014837|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155157380|NCT01436149|560014838|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
155157381|NCT01436149|560014836|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
155157382|NCT01436149|560014837|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
155157383|NCT01436149|560014838|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
155157384|NCT01436149|560014836|FG000|Antidepressant Lead-in Phase|Other|119|||
155157385|NCT01436149|560014837|FG001|Antidepressant Lead-in Phase|Other|0|||
155157386|NCT01436149|560014838|FG002|Antidepressant Lead-in Phase|Other|0|||
155157387|NCT01436149|560014836|FG000|Randomized Phase|Adverse Event|9|||
155157388|NCT01436149|560014837|FG001|Randomized Phase|Adverse Event|10|||
155157389|NCT01436149|560014838|FG002|Randomized Phase|Adverse Event|11|||
155157390|NCT01436149|560014836|FG000|Randomized Phase|Protocol Violation|4|||
155157391|NCT01436149|560014837|FG001|Randomized Phase|Protocol Violation|5|||
155157392|NCT01436149|560014838|FG002|Randomized Phase|Protocol Violation|0|||
155157393|NCT01436149|560014836|FG000|Randomized Phase|Withdrawal by Subject|16|||
155157394|NCT01436149|560014837|FG001|Randomized Phase|Withdrawal by Subject|10|||
155157395|NCT01436149|560014838|FG002|Randomized Phase|Withdrawal by Subject|10|||
155157396|NCT01436149|560014836|FG000|Randomized Phase|Lost to Follow-up|34|||
155157397|NCT01436149|560014837|FG001|Randomized Phase|Lost to Follow-up|5|||
155157398|NCT01436149|560014838|FG002|Randomized Phase|Lost to Follow-up|6|||
155157399|NCT01436149|560014836|FG000|Randomized Phase|Lack of Efficacy|0|||
155157400|NCT01436149|560014837|FG001|Randomized Phase|Lack of Efficacy|0|||
155157401|NCT01436149|560014838|FG002|Randomized Phase|Lack of Efficacy|1|||
155157402|NCT01436149|560014836|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
155157403|NCT01436149|560014837|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
155170028|NCT00830869|560062407|FG002|Period 2: Part 2|Adverse Event|0|||
154956383|NCT01214850|559267231|FG000|Overall Study|Inappropriate enrollment|2|||
154956384|NCT01214850|559267232|FG001|Overall Study|Inappropriate enrollment|1|||
155061104|NCT01125930|559659241|FG001|Overall Study|Lost to Follow-up|2|||
155061105|NCT01715298|559659242|FG000|Overall Study|Lost to Follow-up|0|||
155061106|NCT01715298|559659243|FG001|Overall Study|Lost to Follow-up|2|||
155061107|NCT01715298|559659242|FG000|Overall Study|Patient/guardian decision|7|||
155061108|NCT01715298|559659243|FG001|Overall Study|Patient/guardian decision|9|||
155061109|NCT02842866|559659244|FG000|Overall Study|Serious Adverse Event|0|||
155061110|NCT02842866|559659245|FG001|Overall Study|Serious Adverse Event|1|||
155061111|NCT02842866|559659244|FG000|Overall Study|Protocol Violation|4|||
155061112|NCT02842866|559659245|FG001|Overall Study|Protocol Violation|2|||
155061113|NCT02842866|559659244|FG000|Overall Study|Lost to Follow-up|2|||
155061114|NCT02842866|559659245|FG001|Overall Study|Lost to Follow-up|0|||
155061115|NCT02842866|559659244|FG000|Overall Study|Withdrawal by Subject|1|||
155061116|NCT02842866|559659245|FG001|Overall Study|Withdrawal by Subject|0|||
155061117|NCT01432327|559659246|FG000|Posttest 3 Months|depression|3|||
155061118|NCT01432327|559659247|FG001|Posttest 3 Months|depression|0|||
155061119|NCT01432327|559659248|FG002|Posttest 3 Months|depression|0|||
155061120|NCT01432327|559659249|FG003|Posttest 3 Months|depression|0|||
155061121|NCT01432327|559659246|FG000|Posttest 3 Months|Lost to Follow-up|1|||
155061122|NCT01432327|559659247|FG001|Posttest 3 Months|Lost to Follow-up|0|||
155061123|NCT01432327|559659248|FG002|Posttest 3 Months|Lost to Follow-up|2|||
155157404|NCT01436149|560014838|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
155157405|NCT01436149|560014836|FG000|Randomized Phase|Other|12|||
154956385|NCT01214850|559267233|FG002|Overall Study|Inappropriate enrollment|0|||
154956386|NCT01214850|559267231|FG000|Overall Study|Administrative reason|1|||
154956387|NCT01214850|559267232|FG001|Overall Study|Administrative reason|0|||
154956388|NCT01214850|559267233|FG002|Overall Study|Administrative reason|0|||
154956389|NCT01214850|559267231|FG000|Overall Study|Unable to classify|2|||
154956390|NCT01214850|559267232|FG001|Overall Study|Unable to classify|1|||
154956391|NCT01214850|559267233|FG002|Overall Study|Unable to classify|1|||
155061124|NCT01432327|559659249|FG003|Posttest 3 Months|Lost to Follow-up|1|||
155061125|NCT01432327|559659246|FG000|Posttest 3 Months|Allergic reaction|0|||
155061126|NCT01432327|559659247|FG001|Posttest 3 Months|Allergic reaction|2|||
155061127|NCT01432327|559659248|FG002|Posttest 3 Months|Allergic reaction|0|||
155061128|NCT01432327|559659249|FG003|Posttest 3 Months|Allergic reaction|0|||
155061129|NCT01432327|559659246|FG000|Posttest 6 Months|Lost to Follow-up|0|||
155061130|NCT01432327|559659247|FG001|Posttest 6 Months|Lost to Follow-up|0|||
155061131|NCT01432327|559659248|FG002|Posttest 6 Months|Lost to Follow-up|3|||
154956392|NCT01171963|559267237|FG000|Overall Study|Adverse Event|10|||
155294391|NCT04035668|560507327|FG000|Overall Study|Adverse Event|3|||
155294392|NCT04035668|560507328|FG001|Overall Study|Adverse Event|4|||
155294393|NCT04035668|560507329|FG002|Overall Study|Adverse Event|2|||
155294394|NCT04035668|560507327|FG000|Overall Study|Lost to Follow-up|0|||
155294395|NCT04035668|560507328|FG001|Overall Study|Lost to Follow-up|1|||
155294396|NCT04035668|560507329|FG002|Overall Study|Lost to Follow-up|0|||
155294397|NCT04035668|560507327|FG000|Overall Study|Physician Decision|2|||
155294398|NCT04035668|560507328|FG001|Overall Study|Physician Decision|1|||
155294399|NCT04035668|560507329|FG002|Overall Study|Physician Decision|1|||
155294400|NCT04035668|560507327|FG000|Overall Study|Subject Decision|2|||
155294401|NCT04035668|560507328|FG001|Overall Study|Subject Decision|2|||
155294402|NCT04035668|560507329|FG002|Overall Study|Subject Decision|0|||
155294403|NCT00004124|560507330|FG000|Overall Study|Received no protocol therapy|12|||
155294404|NCT00004124|560507331|FG001|Overall Study|Received no protocol therapy|20|||
155294405|NCT02224924|560507336|FG000|Overall Study|Withdrawal by Subject|7|||
155294406|NCT02224924|560507337|FG001|Overall Study|Withdrawal by Subject|6|||
155294407|NCT02224924|560507336|FG000|Overall Study|Biopsy cancelled|20|||
155294408|NCT02224924|560507337|FG001|Overall Study|Biopsy cancelled|14|||
155294409|NCT02224924|560507336|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
155294410|NCT02224924|560507337|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
155294411|NCT02224924|560507336|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
155294412|NCT02224924|560507337|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
155294413|NCT01458210|560507338|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
155294414|NCT01458210|560507338|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
155294415|NCT01458210|560507338|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
155294416|NCT01458210|560507338|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
155294417|NCT03923491|560507339|FG000|Overall Study|Lost to Follow-up|5|||
155294418|NCT03923491|560507340|FG001|Overall Study|Lost to Follow-up|8|||
155294419|NCT03923491|560507339|FG000|Overall Study|Withdrawal by Subject|4|||
155294420|NCT03923491|560507340|FG001|Overall Study|Withdrawal by Subject|6|||
155294421|NCT03823300|560507345|FG000|Overall Study|Withdrawal by Subject|16|||
155294422|NCT03823300|560507346|FG001|Overall Study|Withdrawal by Subject|22|||
155294423|NCT03823300|560507345|FG000|Overall Study|Death|10|||
155294424|NCT03823300|560507346|FG001|Overall Study|Death|14|||
155294425|NCT03823300|560507345|FG000|Overall Study|Adverse Event|3|||
155294426|NCT03823300|560507346|FG001|Overall Study|Adverse Event|5|||
155294427|NCT03823300|560507345|FG000|Overall Study|Physician Decision|1|||
155294428|NCT03823300|560507346|FG001|Overall Study|Physician Decision|7|||
155294429|NCT03823300|560507345|FG000|Overall Study|Lost to Follow-up|1|||
155294430|NCT03823300|560507346|FG001|Overall Study|Lost to Follow-up|3|||
155294431|NCT03823300|560507345|FG000|Overall Study|Protocol Violation|1|||
155294432|NCT03823300|560507346|FG001|Overall Study|Protocol Violation|1|||
155294433|NCT03823300|560507345|FG000|Overall Study|Lack of Efficacy|1|||
155294434|NCT03823300|560507346|FG001|Overall Study|Lack of Efficacy|1|||
155294435|NCT03823300|560507345|FG000|Overall Study|Not Eligible|0|||
155294436|NCT03823300|560507346|FG001|Overall Study|Not Eligible|1|||
154956393|NCT01171963|559267238|FG001|Overall Study|Adverse Event|15|||
154956394|NCT01171963|559267237|FG000|Overall Study|Lost to Follow-up|23|||
154956395|NCT01171963|559267238|FG001|Overall Study|Lost to Follow-up|24|||
154956396|NCT01171963|559267237|FG000|Overall Study|Other - diarrhoea|1|||
154956397|NCT01171963|559267238|FG001|Overall Study|Other - diarrhoea|0|||
154956398|NCT01171963|559267237|FG000|Overall Study|Withdrawal by Subject|114|||
154956399|NCT01171963|559267238|FG001|Overall Study|Withdrawal by Subject|129|||
154956400|NCT00302952|559267241|FG000|Overall Study|Physician Decision|1|||
154956401|NCT00302952|559267242|FG001|Overall Study|Physician Decision|1|||
154956402|NCT00302952|559267241|FG000|Overall Study|Withdrawal by Subject|2|||
154956403|NCT00302952|559267242|FG001|Overall Study|Withdrawal by Subject|3|||
154956404|NCT00302952|559267241|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
154956405|NCT00302952|559267242|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
154956406|NCT00336479|559267243|FG000|Overall Study|Adverse Event|8|||
154956407|NCT00336479|559267244|FG001|Overall Study|Adverse Event|11|||
154956408|NCT00336479|559267245|FG002|Overall Study|Adverse Event|18|||
154956409|NCT00336479|559267246|FG003|Overall Study|Adverse Event|4|||
154956410|NCT00336479|559267243|FG000|Overall Study|Noncompliant|1|||
154956411|NCT00336479|559267244|FG001|Overall Study|Noncompliant|7|||
154956412|NCT00336479|559267245|FG002|Overall Study|Noncompliant|3|||
154956413|NCT00336479|559267246|FG003|Overall Study|Noncompliant|0|||
154956414|NCT00336479|559267243|FG000|Overall Study|Physician Decision|2|||
154956415|NCT00336479|559267244|FG001|Overall Study|Physician Decision|3|||
154956416|NCT00336479|559267245|FG002|Overall Study|Physician Decision|1|||
154956417|NCT00336479|559267246|FG003|Overall Study|Physician Decision|0|||
154956418|NCT00336479|559267243|FG000|Overall Study|Lost to Follow-up|3|||
155157406|NCT01436149|560014837|FG001|Randomized Phase|Other|5|||
155157407|NCT01436149|560014838|FG002|Randomized Phase|Other|11|||
155157408|NCT01690143|560014839|FG000|Overall Study|Withdrawal by Subject|1|||
155157409|NCT01710345|560014858|FG000|Overall Study|Adverse Event|0|||
155157410|NCT01710345|560014859|FG001|Overall Study|Adverse Event|2|||
155157411|NCT01710345|560014860|FG002|Overall Study|Adverse Event|0|||
155157412|NCT01710345|560014858|FG000|Overall Study|Lack of Efficacy|2|||
155157413|NCT01710345|560014859|FG001|Overall Study|Lack of Efficacy|3|||
155157414|NCT01710345|560014860|FG002|Overall Study|Lack of Efficacy|1|||
155157415|NCT01710345|560014858|FG000|Overall Study|Drug Dosing Error|1|||
155157416|NCT01710345|560014859|FG001|Overall Study|Drug Dosing Error|0|||
155157417|NCT01710345|560014860|FG002|Overall Study|Drug Dosing Error|0|||
155157418|NCT01502293|560014862|FG000|Overall Study|Progressive Disease|20|||
155157419|NCT01502293|560014863|FG001|Overall Study|Progressive Disease|12|||
155157420|NCT01502293|560014864|FG002|Overall Study|Progressive Disease|2|||
155157421|NCT01502293|560014862|FG000|Overall Study|Withdrawal by Subject|3|||
155157422|NCT01502293|560014863|FG001|Overall Study|Withdrawal by Subject|3|||
155157423|NCT01502293|560014864|FG002|Overall Study|Withdrawal by Subject|1|||
155157424|NCT01502293|560014862|FG000|Overall Study|Adverse Event|0|||
155157425|NCT01502293|560014863|FG001|Overall Study|Adverse Event|2|||
155157426|NCT01502293|560014864|FG002|Overall Study|Adverse Event|0|||
155157427|NCT01502293|560014862|FG000|Overall Study|Reason Not Specified|2|||
155157428|NCT01502293|560014863|FG001|Overall Study|Reason Not Specified|0|||
155157429|NCT01502293|560014864|FG002|Overall Study|Reason Not Specified|0|||
155157430|NCT01502293|560014862|FG000|Overall Study|Physician Decision|0|||
155157431|NCT01502293|560014863|FG001|Overall Study|Physician Decision|0|||
155157432|NCT01502293|560014864|FG002|Overall Study|Physician Decision|1|||
155157433|NCT00307801|560014865|FG000|Overall Study|Adverse Event|12|||
155157434|NCT00307801|560014866|FG001|Overall Study|Adverse Event|4|||
155157435|NCT00307801|560014865|FG000|Overall Study|Withdrawal by Subject|9|||
155157436|NCT00307801|560014866|FG001|Overall Study|Withdrawal by Subject|4|||
155157437|NCT00307801|560014865|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
155157438|NCT00307801|560014866|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
155157439|NCT00307801|560014865|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
155157440|NCT00307801|560014866|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
155157441|NCT00307801|560014865|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
155157442|NCT00307801|560014866|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
155157443|NCT00307801|560014865|FG000|Overall Study|Wrong Randomization|1|||
155157444|NCT00307801|560014866|FG001|Overall Study|Wrong Randomization|0|||
155157445|NCT00307801|560014865|FG000|Overall Study|Lack of Efficacy|0|||
155157446|NCT00307801|560014866|FG001|Overall Study|Lack of Efficacy|2|||
155157447|NCT00307801|560014865|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
155157448|NCT00307801|560014866|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
155157449|NCT00307801|560014865|FG000|Overall Study|Frustration with e-diary|1|||
155157450|NCT00307801|560014866|FG001|Overall Study|Frustration with e-diary|0|||
155157451|NCT00307801|560014865|FG000|Overall Study|Protocol Violation|3|||
155157452|NCT00307801|560014866|FG001|Overall Study|Protocol Violation|2|||
155157453|NCT00307801|560014865|FG000|Overall Study|No reason specified|2|||
155157454|NCT00307801|560014866|FG001|Overall Study|No reason specified|0|||
155157455|NCT00307801|560014865|FG000|Overall Study|Pregnancy|0|||
155157456|NCT00307801|560014866|FG001|Overall Study|Pregnancy|1|||
155294437|NCT03823300|560507345|FG000|Overall Study|Other|1|||
155294438|NCT03823300|560507346|FG001|Overall Study|Other|0|||
155294439|NCT03622580|560507347|FG000|Overall Study|Death|16|||
155294440|NCT03622580|560507348|FG001|Overall Study|Death|21|||
155294441|NCT03622580|560507349|FG002|Overall Study|Death|13|||
155294442|NCT03622580|560507347|FG000|Overall Study|Adverse Event|6|||
155294443|NCT03622580|560507348|FG001|Overall Study|Adverse Event|6|||
155294444|NCT03622580|560507349|FG002|Overall Study|Adverse Event|5|||
155294445|NCT03622580|560507347|FG000|Overall Study|Withdrawal by Subject|12|||
155294446|NCT03622580|560507348|FG001|Overall Study|Withdrawal by Subject|7|||
155294447|NCT03622580|560507349|FG002|Overall Study|Withdrawal by Subject|19|||
155294448|NCT03622580|560507347|FG000|Overall Study|Lost to Follow-up|12|||
155294449|NCT03622580|560507348|FG001|Overall Study|Lost to Follow-up|9|||
155294450|NCT03622580|560507349|FG002|Overall Study|Lost to Follow-up|9|||
155294451|NCT03622580|560507347|FG000|Overall Study|Protocol Violation|1|||
155294452|NCT03622580|560507348|FG001|Overall Study|Protocol Violation|0|||
155294453|NCT03622580|560507349|FG002|Overall Study|Protocol Violation|1|||
155294454|NCT03622580|560507347|FG000|Overall Study|Physician Decision|3|||
155294455|NCT03622580|560507348|FG001|Overall Study|Physician Decision|0|||
155294456|NCT03622580|560507349|FG002|Overall Study|Physician Decision|1|||
155294457|NCT03622580|560507347|FG000|Overall Study|Pregnancy|0|||
155294458|NCT03622580|560507348|FG001|Overall Study|Pregnancy|1|||
155294459|NCT03622580|560507349|FG002|Overall Study|Pregnancy|0|||
155294460|NCT03622580|560507347|FG000|Overall Study|Lack of Efficacy|0|||
155294461|NCT03622580|560507348|FG001|Overall Study|Lack of Efficacy|0|||
155294462|NCT03622580|560507349|FG002|Overall Study|Lack of Efficacy|1|||
155294463|NCT03622580|560507347|FG000|Overall Study|Other|2|||
155294464|NCT03622580|560507348|FG001|Overall Study|Other|0|||
155294465|NCT03622580|560507349|FG002|Overall Study|Other|3|||
155294466|NCT01930045|560507354|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294467|NCT01930045|560507355|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294468|NCT01930045|560507356|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294469|NCT01930045|560507357|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294470|NCT01930045|560507358|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
155294471|NCT01930045|560507359|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
155294472|NCT01930045|560507354|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
155157457|NCT01498068|560014867|FG000|Overall Study|Withdrawal by Subject|1|||
154956419|NCT00336479|559267244|FG001|Overall Study|Lost to Follow-up|2|||
154956420|NCT00336479|559267245|FG002|Overall Study|Lost to Follow-up|0|||
154956421|NCT00336479|559267246|FG003|Overall Study|Lost to Follow-up|0|||
154956422|NCT00336479|559267243|FG000|Overall Study|Withdrawal by Subject|3|||
155157458|NCT01498068|560014868|FG001|Overall Study|Withdrawal by Subject|1|||
155157459|NCT00391586|560014870|FG000|Overall Study|Progressive disease|13|||
155157460|NCT00391586|560014870|FG000|Overall Study|Adverse Event|5|||
155157461|NCT00391586|560014870|FG000|Overall Study|Physician Decision|2|||
155157462|NCT00391586|560014870|FG000|Overall Study|Death|4|||
155157463|NCT00198822|560014871|FG000|Overall Study|Lost to Follow-up|14|||
155157464|NCT00198822|560014872|FG001|Overall Study|Lost to Follow-up|20|||
155157465|NCT00198822|560014873|FG002|Overall Study|Lost to Follow-up|21|||
155157466|NCT01353898|560014874|FG000|Overall Study|Study site terminated|0|||
155157467|NCT01353898|560014875|FG001|Overall Study|Study site terminated|0|||
155157468|NCT01353898|560014876|FG002|Overall Study|Study site terminated|0|||
155157469|NCT01353898|560014877|FG003|Overall Study|Study site terminated|0|||
155157470|NCT01353898|560014878|FG004|Overall Study|Study site terminated|0|||
155157471|NCT01353898|560014879|FG005|Overall Study|Study site terminated|1|||
155157472|NCT02668653|560014880|FG000|Overall Study|Refractory disease|41|||
155157473|NCT02668653|560014881|FG001|Overall Study|Refractory disease|70|||
155157474|NCT02668653|560014880|FG000|Overall Study|Relapse|44|||
155157475|NCT02668653|560014881|FG001|Overall Study|Relapse|65|||
155294473|NCT01930045|560507355|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
154956423|NCT00336479|559267244|FG001|Overall Study|Withdrawal by Subject|2|||
154956424|NCT00336479|559267245|FG002|Overall Study|Withdrawal by Subject|3|||
154956425|NCT00336479|559267246|FG003|Overall Study|Withdrawal by Subject|0|||
154956426|NCT00336479|559267243|FG000|Overall Study|Other|0|||
154956427|NCT00336479|559267244|FG001|Overall Study|Other|0|||
154956428|NCT00336479|559267245|FG002|Overall Study|Other|1|||
154956429|NCT00336479|559267246|FG003|Overall Study|Other|0|||
154956430|NCT00336479|559267243|FG000|Overall Study|Virologic Stopping Rule|20|||
155157476|NCT02668653|560014880|FG000|Overall Study|Adverse Event|58|||
155157477|NCT02668653|560014881|FG001|Overall Study|Adverse Event|23|||
155294474|NCT01930045|560507356|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
155294475|NCT01930045|560507357|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
155294476|NCT01930045|560507358|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
155294477|NCT01930045|560507359|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
155294478|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
155294479|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
154956431|NCT00336479|559267244|FG001|Overall Study|Virologic Stopping Rule|0|||
154956432|NCT00336479|559267245|FG002|Overall Study|Virologic Stopping Rule|0|||
155157478|NCT02668653|560014880|FG000|Overall Study|Subject decision to stop study drug|25|||
155157479|NCT02668653|560014881|FG001|Overall Study|Subject decision to stop study drug|23|||
155294480|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
155294481|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
155294482|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
155294483|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
155294484|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
155294485|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
155294486|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
155294487|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
155294488|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
155294489|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
155294490|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
155294491|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
155294492|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
155294493|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
155294494|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
155294495|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
155294496|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
155294497|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
155294498|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
155294499|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
155294500|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
155294501|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
155294502|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
155294503|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
155294504|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
155294505|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
155294506|NCT00241644|560507360|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
155294507|NCT00241644|560507361|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
155294508|NCT00241644|560507362|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
155294509|NCT00241644|560507363|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
155294510|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
155294511|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
155294512|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
155294513|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
155294514|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
155294515|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
155294516|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
155294517|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
155294518|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
155294519|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
155294520|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
155061132|NCT01432327|559659249|FG003|Posttest 6 Months|Lost to Follow-up|2|||
155061133|NCT01432327|559659246|FG000|Posttest 6 Months|Allergic reaction|0|||
155061134|NCT01432327|559659247|FG001|Posttest 6 Months|Allergic reaction|0|||
155061135|NCT01432327|559659248|FG002|Posttest 6 Months|Allergic reaction|1|||
155061136|NCT01432327|559659249|FG003|Posttest 6 Months|Allergic reaction|0|||
155061137|NCT01432327|559659246|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
155061138|NCT01432327|559659247|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
155061139|NCT01432327|559659248|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
155061140|NCT01432327|559659249|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
155294521|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
155294522|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
155294523|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
155294524|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
155294525|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
155294526|NCT00241644|560507360|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
155294527|NCT00241644|560507361|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
155294528|NCT00241644|560507362|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
155294529|NCT00241644|560507363|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
155294530|NCT03959241|560507364|FG000|Overall Study|Withdrawal by Subject|7|||
155294531|NCT03959241|560507365|FG001|Overall Study|Withdrawal by Subject|8|||
155294532|NCT03959241|560507364|FG000|Overall Study|Lost to Follow-up|1|||
155294533|NCT03959241|560507365|FG001|Overall Study|Lost to Follow-up|0|||
155294534|NCT03959241|560507364|FG000|Overall Study|Move to Hospice Care|1|||
155294535|NCT03959241|560507365|FG001|Overall Study|Move to Hospice Care|0|||
155294536|NCT03959241|560507364|FG000|Overall Study|Screen Failure|1|||
155294537|NCT03959241|560507365|FG001|Overall Study|Screen Failure|0|||
155294538|NCT03959241|560507364|FG000|Overall Study|Disease Relapse|0|||
155294539|NCT03959241|560507365|FG001|Overall Study|Disease Relapse|1|||
155294540|NCT03959241|560507364|FG000|Overall Study|Off Study|1|||
155294541|NCT03959241|560507365|FG001|Overall Study|Off Study|0|||
155294542|NCT01713530|560507370|FG000|Overall Study|Adverse Event|0|||
155294543|NCT01713530|560507371|FG001|Overall Study|Adverse Event|5|||
155294544|NCT01713530|560507370|FG000|Overall Study|Withdrawal criteria|21|||
155294545|NCT01713530|560507371|FG001|Overall Study|Withdrawal criteria|12|||
155294546|NCT01713530|560507370|FG000|Overall Study|Unclassified|4|||
155294547|NCT01713530|560507371|FG001|Overall Study|Unclassified|2|||
155294548|NCT00758602|560507372|FG000|Overall Study|Adverse Event|11|||
155294549|NCT00758602|560507373|FG001|Overall Study|Adverse Event|10|||
155294550|NCT00758602|560507372|FG000|Overall Study|Lost to Follow-up|4|||
155294551|NCT00758602|560507373|FG001|Overall Study|Lost to Follow-up|3|||
155294552|NCT00758602|560507372|FG000|Overall Study|Withdrawal by Subject|1|||
155294553|NCT00758602|560507373|FG001|Overall Study|Withdrawal by Subject|3|||
155294554|NCT00758602|560507372|FG000|Overall Study|Protocol Violation|0|||
155294555|NCT00758602|560507373|FG001|Overall Study|Protocol Violation|2|||
155294556|NCT00758602|560507372|FG000|Overall Study|Death|0|||
155294557|NCT00758602|560507373|FG001|Overall Study|Death|1|||
155294558|NCT00758602|560507372|FG000|Overall Study|Reason not specified|3|||
155294559|NCT00758602|560507373|FG001|Overall Study|Reason not specified|3|||
155294560|NCT05046132|560507374|FG000|Overall Study|Adverse Event|4|||
155294561|NCT05046132|560507375|FG001|Overall Study|Adverse Event|0|||
155294562|NCT05046132|560507376|FG002|Overall Study|Adverse Event|0|||
155294563|NCT05046132|560507374|FG000|Overall Study|Withdrawal by Subject|3|||
155294564|NCT05046132|560507375|FG001|Overall Study|Withdrawal by Subject|0|||
155294565|NCT05046132|560507376|FG002|Overall Study|Withdrawal by Subject|0|||
155294566|NCT05046132|560507374|FG000|Overall Study|Positive Covid19 Result.|0|||
155294567|NCT05046132|560507375|FG001|Overall Study|Positive Covid19 Result.|1|||
155294568|NCT05046132|560507376|FG002|Overall Study|Positive Covid19 Result.|0|||
155294569|NCT02441036|560507377|FG000|Overall Study|No tissue resected|0|||
155294570|NCT02441036|560507378|FG001|Overall Study|No tissue resected|1|||
155294571|NCT02441036|560507379|FG002|Overall Study|No tissue resected|0|||
155294572|NCT02441036|560507380|FG003|Overall Study|No tissue resected|1|||
155294573|NCT02441036|560507381|FG004|Overall Study|No tissue resected|0|||
155294574|NCT01183780|560507385|FG000|Overall Study|Withdrawal by Subject|25|||
155294575|NCT01183780|560507386|FG001|Overall Study|Withdrawal by Subject|14|||
155294576|NCT01183780|560507385|FG000|Overall Study|Lost to Follow-up|6|||
155294577|NCT01183780|560507386|FG001|Overall Study|Lost to Follow-up|11|||
155294578|NCT00855465|560507388|FG000|Treatment Period|Adverse Event|4|||
155294579|NCT00855465|560507389|FG001|Treatment Period|Adverse Event|2|||
155157480|NCT02668653|560014880|FG000|Overall Study|Other reasons not specified|16|||
155157481|NCT02668653|560014881|FG001|Overall Study|Other reasons not specified|11|||
155157482|NCT02668653|560014880|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
155157483|NCT02668653|560014881|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
155157484|NCT02668653|560014880|FG000|Overall Study|Investigator decision|10|||
155157485|NCT02668653|560014881|FG001|Overall Study|Investigator decision|7|||
155157486|NCT02668653|560014880|FG000|Overall Study|Failure to meet continuation criteria|5|||
155157487|NCT02668653|560014881|FG001|Overall Study|Failure to meet continuation criteria|12|||
155157488|NCT02668653|560014880|FG000|Overall Study|Lost to Follow-up|1|||
155157489|NCT02668653|560014881|FG001|Overall Study|Lost to Follow-up|0|||
155157490|NCT02668653|560014880|FG000|Overall Study|Pregnancy|0|||
155157491|NCT02668653|560014881|FG001|Overall Study|Pregnancy|1|||
155157492|NCT02668653|560014880|FG000|Overall Study|Death|0|||
155157493|NCT02668653|560014881|FG001|Overall Study|Death|1|||
155157494|NCT01467960|560014882|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
155157495|NCT01467960|560014883|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
155157496|NCT01467960|560014884|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
155157497|NCT01467960|560014885|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
155157498|NCT01467960|560014886|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
155157499|NCT01467960|560014887|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
155157500|NCT00474812|560014888|FG000|Overall Study|Withdrawal by Subject|5|||
155157501|NCT00474812|560014888|FG000|Overall Study|No Initiation of treatment|2|||
155157502|NCT02059278|560014891|FG000|Overall Study|Adverse Event|1|||
155157503|NCT02059278|560014892|FG001|Overall Study|Adverse Event|1|||
155157504|NCT02059278|560014891|FG000|Overall Study|Lost to Follow-up|1|||
155157505|NCT02059278|560014892|FG001|Overall Study|Lost to Follow-up|0|||
155157506|NCT02059278|560014891|FG000|Overall Study|Withdrawal by Subject|0|||
155157507|NCT02059278|560014892|FG001|Overall Study|Withdrawal by Subject|3|||
155157508|NCT02059278|560014891|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
155157509|NCT02059278|560014892|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
155157510|NCT04123470|560014897|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
155157511|NCT04123470|560014898|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
155294580|NCT00855465|560507388|FG000|Treatment Period|Death|2|||
155294581|NCT00855465|560507389|FG001|Treatment Period|Death|2|||
155294582|NCT00855465|560507388|FG000|Treatment Period|Lack of Efficacy|2|||
155294583|NCT00855465|560507389|FG001|Treatment Period|Lack of Efficacy|1|||
155294584|NCT00855465|560507388|FG000|Treatment Period|Non-compliance|1|||
155294585|NCT00855465|560507389|FG001|Treatment Period|Non-compliance|0|||
155294586|NCT00855465|560507388|FG000|Treatment Period|Protocol Violation|2|||
155294587|NCT00855465|560507389|FG001|Treatment Period|Protocol Violation|0|||
155294588|NCT00855465|560507388|FG000|Treatment Period|Withdrawal by Subject|2|||
155294589|NCT00855465|560507389|FG001|Treatment Period|Withdrawal by Subject|0|||
155294590|NCT00855465|560507388|FG000|Treatment Period|Not treated|1|||
155294591|NCT00855465|560507389|FG001|Treatment Period|Not treated|0|||
155294592|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Adverse Event|0|||
155294593|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Adverse Event|1|||
155294594|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Death|0|||
155294595|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Death|1|||
155294596|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
155294597|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
155294598|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
155294599|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
155294600|NCT00855465|560507388|FG000|Follow-up Period (FUP)|Missing|1|||
155294601|NCT00855465|560507389|FG001|Follow-up Period (FUP)|Missing|0|||
155294602|NCT03743246|560507392|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
155294603|NCT03743246|560507393|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
155294604|NCT03743246|560507394|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
155294605|NCT03743246|560507395|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
155294606|NCT03743246|560507392|FG000|Pre-Treatment Period|Death|0|||
155294607|NCT03743246|560507393|FG001|Pre-Treatment Period|Death|1|||
155294608|NCT03743246|560507394|FG002|Pre-Treatment Period|Death|0|||
155294609|NCT03743246|560507395|FG003|Pre-Treatment Period|Death|1|||
155294610|NCT03743246|560507392|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
155294611|NCT03743246|560507393|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
155294612|NCT03743246|560507394|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
155294613|NCT03743246|560507395|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
155294614|NCT03743246|560507392|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
155294615|NCT03743246|560507393|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
155294616|NCT03743246|560507394|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
154956433|NCT00336479|559267246|FG003|Overall Study|Virologic Stopping Rule|0|||
154956434|NCT00550537|559267250|FG000|Overall Study|Death|18|||
154956435|NCT00550537|559267250|FG000|Overall Study|Adverse Event|20|||
154956436|NCT00550537|559267250|FG000|Overall Study|Disease progression before|46|||
154956437|NCT00550537|559267250|FG000|Overall Study|Withdrawal by Subject|7|||
154956438|NCT00550537|559267250|FG000|Overall Study|Change in treatment plan|4|||
154956439|NCT00550537|559267250|FG000|Overall Study|Other complicating ilness|3|||
154956440|NCT00550537|559267250|FG000|Overall Study|Declining performance status|2|||
154956441|NCT00550537|559267250|FG000|Overall Study|Treated closer to home|4|||
154956442|NCT00617305|559267251|FG000|Overall Study|Adverse Event|4|||
154956443|NCT00617305|559267252|FG001|Overall Study|Adverse Event|0|||
154956444|NCT00617305|559267253|FG002|Overall Study|Adverse Event|0|||
154956445|NCT00617305|559267251|FG000|Overall Study|Death|1|||
154956446|NCT00617305|559267252|FG001|Overall Study|Death|0|||
154956447|NCT00617305|559267253|FG002|Overall Study|Death|0|||
154956448|NCT00617305|559267251|FG000|Overall Study|Physician Decision|1|||
154956449|NCT00617305|559267252|FG001|Overall Study|Physician Decision|0|||
154956450|NCT00617305|559267253|FG002|Overall Study|Physician Decision|0|||
154956451|NCT00617305|559267251|FG000|Overall Study|Protocol Violation|1|||
154956452|NCT00617305|559267252|FG001|Overall Study|Protocol Violation|0|||
154956453|NCT00617305|559267253|FG002|Overall Study|Protocol Violation|1|||
154956454|NCT00617305|559267251|FG000|Overall Study|Withdrawal by Subject|1|||
154956455|NCT00617305|559267252|FG001|Overall Study|Withdrawal by Subject|0|||
154956456|NCT00617305|559267253|FG002|Overall Study|Withdrawal by Subject|0|||
154956457|NCT00857623|559267254|FG000|Overall Study|Adverse Event|5|||
154956458|NCT00857623|559267255|FG001|Overall Study|Adverse Event|2|||
154956459|NCT00857623|559267254|FG000|Overall Study|Study-specific discontinuation criteria|5|||
154956460|NCT00857623|559267255|FG001|Overall Study|Study-specific discontinuation criteria|3|||
154956461|NCT00857623|559267254|FG000|Overall Study|Withdrawal by Subject|2|||
154956462|NCT00857623|559267255|FG001|Overall Study|Withdrawal by Subject|1|||
154956463|NCT00857623|559267254|FG000|Overall Study|Lack of Efficacy|1|||
154956464|NCT00857623|559267255|FG001|Overall Study|Lack of Efficacy|1|||
154956465|NCT00857623|559267254|FG000|Overall Study|Severe non-compliance to protocol|1|||
154956466|NCT00857623|559267255|FG001|Overall Study|Severe non-compliance to protocol|1|||
154956467|NCT00857623|559267254|FG000|Overall Study|Intake of prohibited medication|0|||
154956468|NCT00857623|559267255|FG001|Overall Study|Intake of prohibited medication|1|||
154956469|NCT00857623|559267254|FG000|Overall Study|Positive for HEP C|0|||
154956470|NCT00857623|559267255|FG001|Overall Study|Positive for HEP C|1|||
154956471|NCT04185909|559267256|FG000|Overall Study|Lost to Follow-up|1|||
154956472|NCT03435081|559267257|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
155294617|NCT03743246|560507395|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
155294618|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
155157512|NCT04123470|560014897|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
155157513|NCT04123470|560014898|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
155157514|NCT04123470|560014897|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
155061141|NCT01432327|559659246|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
155061142|NCT01432327|559659247|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
155061143|NCT01432327|559659248|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
155061144|NCT01432327|559659249|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
155061145|NCT01432327|559659246|FG000|Posttest 1 Year|Lost to Follow-up|0|||
155061146|NCT01432327|559659247|FG001|Posttest 1 Year|Lost to Follow-up|0|||
155061147|NCT01432327|559659248|FG002|Posttest 1 Year|Lost to Follow-up|4|||
155061148|NCT01432327|559659249|FG003|Posttest 1 Year|Lost to Follow-up|2|||
155061149|NCT01432327|559659246|FG000|Posttest 1 Year|Allergic reaction|0|||
155061150|NCT01432327|559659247|FG001|Posttest 1 Year|Allergic reaction|0|||
155061151|NCT01432327|559659248|FG002|Posttest 1 Year|Allergic reaction|1|||
155061152|NCT01432327|559659249|FG003|Posttest 1 Year|Allergic reaction|1|||
155061153|NCT03248037|559659250|FG000|Overall Study|Withdrawal by Subject|6|||
155061154|NCT03248037|559659251|FG001|Overall Study|Withdrawal by Subject|9|||
155061155|NCT03248037|559659250|FG000|Overall Study|Adverse Event|15|||
155061156|NCT03248037|559659251|FG001|Overall Study|Adverse Event|0|||
155061157|NCT02897349|559659255|FG000|Overall Study|Lost to Follow-up|2|||
155061158|NCT02897349|559659256|FG001|Overall Study|Lost to Follow-up|2|||
155157515|NCT04123470|560014898|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
155157516|NCT04123470|560014897|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
155157517|NCT04123470|560014898|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
155157518|NCT05408429|560014908|FG000|Overall Study|Lost to Follow-up|1|||
155157519|NCT05408429|560014909|FG001|Overall Study|Lost to Follow-up|1|||
155157520|NCT05408429|560014910|FG002|Overall Study|Lost to Follow-up|0|||
155157521|NCT05408429|560014908|FG000|Overall Study|Withdrawal by Subject|5|||
155157522|NCT05408429|560014909|FG001|Overall Study|Withdrawal by Subject|0|||
155157523|NCT05408429|560014910|FG002|Overall Study|Withdrawal by Subject|1|||
155157524|NCT03435211|560014911|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
155157525|NCT05972993|560014912|FG000|Overall Study|Lost to Follow-up|2|||
155157526|NCT05972993|560014913|FG001|Overall Study|Lost to Follow-up|0|||
155157527|NCT05972993|560014914|FG002|Overall Study|Lost to Follow-up|1|||
155157528|NCT05972993|560014915|FG003|Overall Study|Lost to Follow-up|0|||
155157529|NCT05972993|560014916|FG004|Overall Study|Lost to Follow-up|0|||
155157530|NCT05972993|560014917|FG005|Overall Study|Lost to Follow-up|0|||
155157531|NCT05972993|560014918|FG006|Overall Study|Lost to Follow-up|0|||
155157532|NCT05972993|560014919|FG007|Overall Study|Lost to Follow-up|2|||
155157533|NCT05972993|560014920|FG008|Overall Study|Lost to Follow-up|0|||
155157534|NCT03866577|560014923|FG000|Overall Study|Protocol Violation|0|||
155157535|NCT03866577|560014924|FG001|Overall Study|Protocol Violation|0|||
155157536|NCT03866577|560014925|FG002|Overall Study|Protocol Violation|0|||
155157537|NCT03866577|560014926|FG003|Overall Study|Protocol Violation|0|||
155157538|NCT03866577|560014927|FG004|Overall Study|Protocol Violation|0|||
155157539|NCT03866577|560014928|FG005|Overall Study|Protocol Violation|0|||
155157540|NCT03866577|560014929|FG006|Overall Study|Protocol Violation|0|||
155157541|NCT03866577|560014930|FG007|Overall Study|Protocol Violation|0|||
155157542|NCT03866577|560014931|FG008|Overall Study|Protocol Violation|0|||
155157543|NCT03866577|560014932|FG009|Overall Study|Protocol Violation|0|||
155157544|NCT03866577|560014933|FG010|Overall Study|Protocol Violation|0|||
155157545|NCT03866577|560014934|FG011|Overall Study|Protocol Violation|1|||
155157546|NCT03866577|560014935|FG012|Overall Study|Protocol Violation|0|||
155157547|NCT03866577|560014923|FG000|Overall Study|Withdrawal by Subject|0|||
155157548|NCT03866577|560014924|FG001|Overall Study|Withdrawal by Subject|0|||
155157549|NCT03866577|560014925|FG002|Overall Study|Withdrawal by Subject|0|||
155157550|NCT03866577|560014926|FG003|Overall Study|Withdrawal by Subject|0|||
155157551|NCT03866577|560014927|FG004|Overall Study|Withdrawal by Subject|0|||
155157552|NCT03866577|560014928|FG005|Overall Study|Withdrawal by Subject|0|||
155157553|NCT03866577|560014929|FG006|Overall Study|Withdrawal by Subject|0|||
155157554|NCT03866577|560014930|FG007|Overall Study|Withdrawal by Subject|0|||
155157555|NCT03866577|560014931|FG008|Overall Study|Withdrawal by Subject|1|||
155157556|NCT03866577|560014932|FG009|Overall Study|Withdrawal by Subject|1|||
155157557|NCT03866577|560014933|FG010|Overall Study|Withdrawal by Subject|0|||
155157558|NCT03866577|560014934|FG011|Overall Study|Withdrawal by Subject|0|||
155157559|NCT03866577|560014935|FG012|Overall Study|Withdrawal by Subject|0|||
155157560|NCT03866577|560014923|FG000|Overall Study|Not qualified for IVIg infusion|0|||
155157561|NCT03866577|560014924|FG001|Overall Study|Not qualified for IVIg infusion|0|||
155157562|NCT03866577|560014925|FG002|Overall Study|Not qualified for IVIg infusion|0|||
155157563|NCT03866577|560014926|FG003|Overall Study|Not qualified for IVIg infusion|0|||
155157564|NCT03866577|560014927|FG004|Overall Study|Not qualified for IVIg infusion|0|||
155157565|NCT03866577|560014928|FG005|Overall Study|Not qualified for IVIg infusion|0|||
155157566|NCT03866577|560014929|FG006|Overall Study|Not qualified for IVIg infusion|0|||
155157567|NCT03866577|560014930|FG007|Overall Study|Not qualified for IVIg infusion|0|||
155157568|NCT03866577|560014931|FG008|Overall Study|Not qualified for IVIg infusion|0|||
155157569|NCT03866577|560014932|FG009|Overall Study|Not qualified for IVIg infusion|1|||
155157570|NCT03866577|560014933|FG010|Overall Study|Not qualified for IVIg infusion|0|||
155157571|NCT03866577|560014934|FG011|Overall Study|Not qualified for IVIg infusion|0|||
155157572|NCT03866577|560014935|FG012|Overall Study|Not qualified for IVIg infusion|0|||
155157573|NCT05530252|560014937|FG000|Overall Study|Lost to Follow-up|1|||
155157574|NCT05530252|560014938|FG001|Overall Study|Lost to Follow-up|1|||
155157575|NCT05530252|560014939|FG002|Overall Study|Lost to Follow-up|1|||
155157576|NCT02195518|560014940|FG000|Overall Study|Adverse Event|1|||
155157577|NCT02195518|560014940|FG000|Overall Study|Protocol Violation|4|||
155157578|NCT02195518|560014940|FG000|Overall Study|Pregnancy|2|||
155157579|NCT02195518|560014940|FG000|Overall Study|Withdrawal by Subject|1|||
155157580|NCT02195518|560014940|FG000|Overall Study|Lost to Follow-up|1|||
155157581|NCT04825678|560014941|FG000|Overall Study|Decision by Sponsor|2|||
155157582|NCT04825678|560014942|FG001|Overall Study|Decision by Sponsor|3|||
155157583|NCT04825678|560014941|FG000|Overall Study|Withdrawal of Consent From Study|7|||
155157584|NCT04825678|560014942|FG001|Overall Study|Withdrawal of Consent From Study|9|||
155157585|NCT04825678|560014941|FG000|Overall Study|Lost to Follow-up|3|||
155157586|NCT04825678|560014942|FG001|Overall Study|Lost to Follow-up|4|||
155157587|NCT04825678|560014941|FG000|Overall Study|Never Received Investigational Product|1|||
155157588|NCT04825678|560014942|FG001|Overall Study|Never Received Investigational Product|1|||
155157589|NCT03818256|560014943|FG000|Overall Study|Withdrawal by Subject|2|||
155294619|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
155294620|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
155294621|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
155294622|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
155294623|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
155294624|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
155294625|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
155294626|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
155294627|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
155294628|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
155294629|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
155294630|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
155294631|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
155294632|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
155294633|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
155294634|NCT03743246|560507392|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
155294635|NCT03743246|560507393|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
155294636|NCT03743246|560507394|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
155294637|NCT03743246|560507395|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
155294638|NCT01596504|560507396|FG000|Overall Study|Participant's Private Reason|0|||
155294639|NCT01596504|560507397|FG001|Overall Study|Participant's Private Reason|1|||
155157590|NCT03818256|560014944|FG001|Overall Study|Withdrawal by Subject|2|||
155157591|NCT03818256|560014943|FG000|Overall Study|Adverse Event|3|||
155157592|NCT03818256|560014944|FG001|Overall Study|Adverse Event|1|||
155157593|NCT03818256|560014943|FG000|Overall Study|Lost to Follow-up|0|||
155157594|NCT03818256|560014944|FG001|Overall Study|Lost to Follow-up|5|||
155157595|NCT03818256|560014943|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
155157596|NCT03818256|560014944|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
155157597|NCT03818256|560014943|FG000|Overall Study|Not reporting for scheduled visits|1|||
155157598|NCT03818256|560014944|FG001|Overall Study|Not reporting for scheduled visits|0|||
155157599|NCT03818256|560014943|FG000|Overall Study|Non-compliant with investigational product|1|||
155157600|NCT03818256|560014944|FG001|Overall Study|Non-compliant with investigational product|0|||
155157601|NCT00651742|560014952|FG000|Overall Study|Objective Disease Progression|22|||
155157602|NCT00651742|560014952|FG000|Overall Study|Toxicity|3|||
155157603|NCT00651742|560014952|FG000|Overall Study|Investigator Judgment|1|||
155157604|NCT00651742|560014952|FG000|Overall Study|Withdrawal of Consent|1|||
155157605|NCT00651742|560014952|FG000|Overall Study|Enrolled but not treated|1|||
155157606|NCT05720897|560014953|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
155157607|NCT05720897|560014954|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
155157608|NCT04780061|560014955|FG000|Overall Study|Withdrawal by Subject|5|||
155157609|NCT04780061|560014956|FG001|Overall Study|Withdrawal by Subject|8|||
155157610|NCT04780061|560014955|FG000|Overall Study|Adverse Event|2|||
155157611|NCT04780061|560014956|FG001|Overall Study|Adverse Event|2|||
154956473|NCT03435081|559267258|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
154956474|NCT03435081|559267259|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
155157612|NCT04780061|560014955|FG000|Overall Study|Lost to Follow-up|1|||
155157613|NCT04780061|560014956|FG001|Overall Study|Lost to Follow-up|5|||
155157614|NCT04050553|560014958|FG000|Period 1|Physician Decision|2|||
155157615|NCT04050553|560014959|FG001|Period 1|Physician Decision|2|||
155157616|NCT04050553|560014958|FG000|Period 1|Adverse Event|1|||
155157617|NCT04050553|560014959|FG001|Period 1|Adverse Event|1|||
155157618|NCT04050553|560014958|FG000|Period 1|Withdrawal by Subject|0|||
155157619|NCT04050553|560014959|FG001|Period 1|Withdrawal by Subject|1|||
155157620|NCT04050553|560014958|FG000|Wash-out|Adverse Event|0|||
155157621|NCT04050553|560014959|FG001|Wash-out|Adverse Event|1|||
155157622|NCT04050553|560014958|FG000|Wash-out|Withdrawal by Subject|0|||
155157623|NCT04050553|560014959|FG001|Wash-out|Withdrawal by Subject|1|||
155157624|NCT01535040|560014960|FG000|Overall Study|Physician Decision|0|||
155157625|NCT01535040|560014961|FG001|Overall Study|Physician Decision|1|||
154956475|NCT03435081|559267257|FG000|Week 0 to Week 16|Adverse Event|2|||
154956476|NCT03435081|559267258|FG001|Week 0 to Week 16|Adverse Event|2|||
154956477|NCT03435081|559267259|FG002|Week 0 to Week 16|Adverse Event|2|||
154956478|NCT03435081|559267257|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
154956479|NCT03435081|559267258|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
154956480|NCT03435081|559267259|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
154956481|NCT03435081|559267257|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
154956482|NCT03435081|559267258|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
154956483|NCT03435081|559267259|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
155157626|NCT01535040|560014960|FG000|Overall Study|Withdrawal by Subject|13|||
155157627|NCT01535040|560014961|FG001|Overall Study|Withdrawal by Subject|10|||
155294640|NCT01596504|560507398|FG002|Overall Study|Participant's Private Reason|0|||
154956484|NCT03435081|559267257|FG000|Week 0 to Week 16|Pregnancy|1|||
155061159|NCT02897349|559659255|FG000|Overall Study|Adverse Event|3|||
155061160|NCT02897349|559659256|FG001|Overall Study|Adverse Event|3|||
155061161|NCT02897349|559659255|FG000|Overall Study|Other than listed above|0|||
155157628|NCT01535040|560014960|FG000|Overall Study|Never Started|9|||
155157629|NCT01535040|560014961|FG001|Overall Study|Never Started|4|||
155157630|NCT01535040|560014960|FG000|Overall Study|Toxicity|7|||
155157631|NCT01535040|560014961|FG001|Overall Study|Toxicity|5|||
155157632|NCT01535040|560014960|FG000|Overall Study|Multiple Reasons|1|||
155157633|NCT01535040|560014961|FG001|Overall Study|Multiple Reasons|1|||
155157634|NCT01074970|560014962|FG000|Overall Study|Never Treated|0|||
155157635|NCT01074970|560014963|FG001|Overall Study|Never Treated|0|||
155157636|NCT01074970|560014964|FG002|Overall Study|Never Treated|8|||
155157637|NCT01074970|560014965|FG003|Overall Study|Never Treated|1|||
155157638|NCT01074970|560014962|FG000|Overall Study|Adverse Event|1|||
155157639|NCT01074970|560014963|FG001|Overall Study|Adverse Event|0|||
155294641|NCT01596504|560507396|FG000|Overall Study|Adverse Event|1|||
155157640|NCT01074970|560014964|FG002|Overall Study|Adverse Event|4|||
155061162|NCT02897349|559659256|FG001|Overall Study|Other than listed above|1|||
155061163|NCT03055013|559659258|FG000|Overall Study|Adverse Event|78|||
155061164|NCT03055013|559659259|FG001|Overall Study|Adverse Event|0|||
155061165|NCT03055013|559659258|FG000|Overall Study|Death|6|||
155061166|NCT03055013|559659259|FG001|Overall Study|Death|0|||
155061167|NCT03055013|559659258|FG000|Overall Study|Disease relapse|33|||
155157641|NCT01074970|560014965|FG003|Overall Study|Adverse Event|3|||
155294642|NCT01596504|560507397|FG001|Overall Study|Adverse Event|2|||
155294643|NCT01596504|560507398|FG002|Overall Study|Adverse Event|1|||
155294644|NCT01596504|560507396|FG000|Overall Study|Withdrawal by Subject|1|||
155294645|NCT01596504|560507397|FG001|Overall Study|Withdrawal by Subject|0|||
155294646|NCT01596504|560507398|FG002|Overall Study|Withdrawal by Subject|0|||
155294647|NCT00395018|560507399|FG000|On-Treatment|Death|4|||
155294648|NCT00395018|560507399|FG000|On-Treatment|Other Reason|2|||
155294649|NCT00395018|560507399|FG000|On-Treatment|Poor/non-compliance|2|||
155294650|NCT00395018|560507399|FG000|On-Treatment|Subject no longer meets study criteria|2|||
155294651|NCT00395018|560507399|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
155294652|NCT00395018|560507399|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
155294653|NCT00395018|560507399|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
155294654|NCT04439799|560507400|FG000|Overall Study|Lost to Follow-up|6|||
155294655|NCT04439799|560507401|FG001|Overall Study|Lost to Follow-up|6|||
155294656|NCT04439799|560507400|FG000|Overall Study|Withdrawal by Subject|2|||
155294657|NCT04439799|560507401|FG001|Overall Study|Withdrawal by Subject|6|||
155294658|NCT04439799|560507400|FG000|Overall Study|Adverse Event|2|||
155294659|NCT04439799|560507401|FG001|Overall Study|Adverse Event|5|||
155294660|NCT00530842|560507405|FG000|Overall Study|Adverse Event|10|||
155294661|NCT00530842|560507406|FG001|Overall Study|Adverse Event|6|||
155294662|NCT00530842|560507405|FG000|Overall Study|Lack of Efficacy|2|||
155294663|NCT00530842|560507406|FG001|Overall Study|Lack of Efficacy|1|||
155294664|NCT00530842|560507405|FG000|Overall Study|Lost to Follow-up|0|||
155294665|NCT00530842|560507406|FG001|Overall Study|Lost to Follow-up|4|||
155294666|NCT00530842|560507405|FG000|Overall Study|Protocol Violation|3|||
155294667|NCT00530842|560507406|FG001|Overall Study|Protocol Violation|2|||
155294668|NCT00530842|560507405|FG000|Overall Study|Withdrawal by Subject|4|||
155294669|NCT00530842|560507406|FG001|Overall Study|Withdrawal by Subject|5|||
155294670|NCT00530842|560507405|FG000|Overall Study|Individual different reasons|4|||
155294671|NCT00530842|560507406|FG001|Overall Study|Individual different reasons|3|||
155294672|NCT00530842|560507405|FG000|Period 1|Adverse Event|7|||
155294673|NCT00530842|560507406|FG001|Period 1|Adverse Event|3|||
155294674|NCT00530842|560507405|FG000|Period 1|Lack of Efficacy|1|||
155294675|NCT00530842|560507406|FG001|Period 1|Lack of Efficacy|1|||
155294676|NCT00530842|560507405|FG000|Period 1|Protocol Violation|2|||
155294677|NCT00530842|560507406|FG001|Period 1|Protocol Violation|1|||
155294678|NCT00530842|560507405|FG000|Period 1|Withdrawal by Subject|2|||
155294679|NCT00530842|560507406|FG001|Period 1|Withdrawal by Subject|3|||
155294680|NCT00530842|560507405|FG000|Period 1|Individual different reasons|2|||
155294681|NCT00530842|560507406|FG001|Period 1|Individual different reasons|3|||
155294682|NCT00530842|560507405|FG000|Period 2|Adverse Event|3|||
155294683|NCT00530842|560507406|FG001|Period 2|Adverse Event|3|||
155294684|NCT00530842|560507405|FG000|Period 2|Lack of Efficacy|1|||
155294685|NCT00530842|560507406|FG001|Period 2|Lack of Efficacy|0|||
155294686|NCT00530842|560507405|FG000|Period 2|Lost to Follow-up|0|||
155294687|NCT00530842|560507406|FG001|Period 2|Lost to Follow-up|4|||
155294688|NCT00530842|560507405|FG000|Period 2|Protocol Violation|1|||
155294689|NCT00530842|560507406|FG001|Period 2|Protocol Violation|0|||
155294690|NCT00530842|560507405|FG000|Period 2|Withdrawal by Subject|1|||
155294691|NCT00530842|560507406|FG001|Period 2|Withdrawal by Subject|2|||
155294692|NCT00530842|560507405|FG000|Period 2|Individual different reasons|2|||
155294693|NCT00530842|560507406|FG001|Period 2|Individual different reasons|0|||
155294694|NCT00972504|560507419|FG000|Overall Study|Adverse Event|2|||
155294695|NCT00972504|560507419|FG000|Overall Study|Investigator discretion|1|||
155294696|NCT03478696|560507423|FG000|Overall Study|Adverse Event|1|||
155294697|NCT03478696|560507424|FG001|Overall Study|Adverse Event|5|||
155294698|NCT03478696|560507423|FG000|Overall Study|Lost to Follow-up|1|||
155294699|NCT03478696|560507424|FG001|Overall Study|Lost to Follow-up|0|||
155294700|NCT03478696|560507423|FG000|Overall Study|Physician Decision|6|||
155294701|NCT03478696|560507424|FG001|Overall Study|Physician Decision|3|||
155294702|NCT03478696|560507423|FG000|Overall Study|Withdrawal by Subject|9|||
155294703|NCT03478696|560507424|FG001|Overall Study|Withdrawal by Subject|4|||
155294704|NCT03257813|560507425|FG000|Overall Study|Protocol Violation|6|||
154956485|NCT03435081|559267258|FG001|Week 0 to Week 16|Pregnancy|0|||
155294705|NCT03257813|560507426|FG001|Overall Study|Protocol Violation|3|||
155294706|NCT02878330|560507427|FG000|Overall Study|Death|3|||
155294707|NCT02878330|560507428|FG001|Overall Study|Death|2|||
154956486|NCT03435081|559267259|FG002|Week 0 to Week 16|Pregnancy|0|||
155294708|NCT02878330|560507427|FG000|Overall Study|Lost to Follow-up|11|||
155294709|NCT02878330|560507428|FG001|Overall Study|Lost to Follow-up|26|||
155294710|NCT02878330|560507427|FG000|Overall Study|Withdrawal by Subject|11|||
155294711|NCT02878330|560507428|FG001|Overall Study|Withdrawal by Subject|21|||
155294712|NCT02878330|560507427|FG000|Overall Study|Other|4|||
155294713|NCT02878330|560507428|FG001|Overall Study|Other|7|||
155294714|NCT03615924|560507433|FG000|Overall Study|Withdrawal by Subject|2|||
155294715|NCT03615924|560507434|FG001|Overall Study|Withdrawal by Subject|5|||
155294716|NCT03615924|560507433|FG000|Overall Study|Death|3|||
155294717|NCT03615924|560507434|FG001|Overall Study|Death|1|||
155294718|NCT03615924|560507433|FG000|Overall Study|Lost to Follow-up|1|||
155294719|NCT03615924|560507434|FG001|Overall Study|Lost to Follow-up|0|||
155157642|NCT01074970|560014962|FG000|Overall Study|Disease progression during treatment|3|||
155157643|NCT01074970|560014963|FG001|Overall Study|Disease progression during treatment|1|||
154956487|NCT03435081|559267257|FG000|Week 0 to Week 16|Non-compliance|1|||
154956488|NCT03435081|559267258|FG001|Week 0 to Week 16|Non-compliance|0|||
154956489|NCT03435081|559267259|FG002|Week 0 to Week 16|Non-compliance|2|||
154956490|NCT03435081|559267257|FG000|Week 0 to Week 16|Inadequate Response|0|||
154956491|NCT03435081|559267258|FG001|Week 0 to Week 16|Inadequate Response|1|||
154956492|NCT03435081|559267259|FG002|Week 0 to Week 16|Inadequate Response|0|||
154956493|NCT03435081|559267257|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
154956494|NCT03435081|559267258|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
154956495|NCT03435081|559267259|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
154956496|NCT03435081|559267257|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
154956497|NCT03435081|559267258|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
154956498|NCT03435081|559267259|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
154956499|NCT03435081|559267257|FG000|Week 16 to Week 104|Adverse Event|1|||
154956500|NCT03435081|559267258|FG001|Week 16 to Week 104|Adverse Event|0|||
154956501|NCT03435081|559267259|FG002|Week 16 to Week 104|Adverse Event|2|||
154956502|NCT03435081|559267257|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
154956503|NCT03435081|559267258|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
154956504|NCT03435081|559267259|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
154956505|NCT03435081|559267257|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
154956506|NCT03435081|559267258|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
154956507|NCT03435081|559267259|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
154956508|NCT03435081|559267257|FG000|Week 16 to Week 104|Non--Compliance|0|||
154956509|NCT03435081|559267258|FG001|Week 16 to Week 104|Non--Compliance|0|||
154956510|NCT03435081|559267259|FG002|Week 16 to Week 104|Non--Compliance|1|||
154956511|NCT02601560|559267260|FG000|Overall Study|Other|0|||
154956512|NCT02601560|559267261|FG001|Overall Study|Other|0|||
154956513|NCT02601560|559267262|FG002|Overall Study|Other|0|||
154956514|NCT02601560|559267263|FG003|Overall Study|Other|0|||
154956515|NCT02601560|559267264|FG004|Overall Study|Other|0|||
154956516|NCT02601560|559267265|FG005|Overall Study|Other|0|||
154956517|NCT02601560|559267266|FG006|Overall Study|Other|1|||
154956518|NCT02601560|559267267|FG007|Overall Study|Other|0|||
154956519|NCT00048581|559267268|FG000|Double-Blind Period|Adverse Event|9|||
154956520|NCT00048581|559267269|FG001|Double-Blind Period|Adverse Event|5|||
154956521|NCT00048581|559267270|FG002|Double-Blind Period|Adverse Event|0|||
154956522|NCT00048581|559267268|FG000|Double-Blind Period|Lack of Efficacy|14|||
154956523|NCT00048581|559267269|FG001|Double-Blind Period|Lack of Efficacy|27|||
154956524|NCT00048581|559267270|FG002|Double-Blind Period|Lack of Efficacy|0|||
154956525|NCT00048581|559267268|FG000|Double-Blind Period|Lost to Follow-up|5|||
154956526|NCT00048581|559267269|FG001|Double-Blind Period|Lost to Follow-up|0|||
154956527|NCT00048581|559267270|FG002|Double-Blind Period|Lost to Follow-up|0|||
154956528|NCT00048581|559267268|FG000|Double-Blind Period|Withdrawal by Subject|5|||
154956529|NCT00048581|559267269|FG001|Double-Blind Period|Withdrawal by Subject|2|||
154956530|NCT00048581|559267270|FG002|Double-Blind Period|Withdrawal by Subject|0|||
154956531|NCT00048581|559267268|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
154956532|NCT00048581|559267269|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
154956533|NCT00048581|559267270|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
154956534|NCT00048581|559267268|FG000|Double-Blind Period|Investigator Decision|1|||
154956535|NCT00048581|559267269|FG001|Double-Blind Period|Investigator Decision|0|||
154956536|NCT00048581|559267270|FG002|Double-Blind Period|Investigator Decision|0|||
154956537|NCT00048581|559267268|FG000|Open-Label Period|Death|0|||
154956538|NCT00048581|559267269|FG001|Open-Label Period|Death|0|||
154956539|NCT00048581|559267270|FG002|Open-Label Period|Death|4|||
154956540|NCT00048581|559267268|FG000|Open-Label Period|Adverse Event|0|||
154956541|NCT00048581|559267269|FG001|Open-Label Period|Adverse Event|0|||
154956542|NCT00048581|559267270|FG002|Open-Label Period|Adverse Event|37|||
154956543|NCT00048581|559267268|FG000|Open-Label Period|Lack of Efficacy|0|||
154956544|NCT00048581|559267269|FG001|Open-Label Period|Lack of Efficacy|0|||
154956545|NCT00048581|559267270|FG002|Open-Label Period|Lack of Efficacy|69|||
154956546|NCT00048581|559267268|FG000|Open-Label Period|Lost to Follow-up|0|||
154956547|NCT00048581|559267269|FG001|Open-Label Period|Lost to Follow-up|0|||
154956548|NCT00048581|559267270|FG002|Open-Label Period|Lost to Follow-up|14|||
154956549|NCT00048581|559267268|FG000|Open-Label Period|Withdrawal by Subject|0|||
154956550|NCT00048581|559267269|FG001|Open-Label Period|Withdrawal by Subject|0|||
154956551|NCT00048581|559267270|FG002|Open-Label Period|Withdrawal by Subject|20|||
154956552|NCT00048581|559267268|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
154956553|NCT00048581|559267269|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
154956554|NCT00048581|559267270|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
154956555|NCT00048581|559267268|FG000|Open-Label Period|Poor/Non-compliance|0|||
154956556|NCT00048581|559267269|FG001|Open-Label Period|Poor/Non-compliance|0|||
154956557|NCT00048581|559267270|FG002|Open-Label Period|Poor/Non-compliance|5|||
154956558|NCT00048581|559267268|FG000|Open-Label Period|Pregnancy|0|||
154956559|NCT00048581|559267269|FG001|Open-Label Period|Pregnancy|0|||
154956560|NCT00048581|559267270|FG002|Open-Label Period|Pregnancy|7|||
155294720|NCT03615924|560507433|FG000|Overall Study|Randomized in error|1|||
155294721|NCT03615924|560507434|FG001|Overall Study|Randomized in error|0|||
155294722|NCT03615924|560507433|FG000|Overall Study|Study termination by Sponsor|94|||
155294723|NCT03615924|560507434|FG001|Overall Study|Study termination by Sponsor|86|||
155294724|NCT00716144|560507435|FG000|Overall Study|Withdrawal by Subject|4|||
155294725|NCT00716144|560507436|FG001|Overall Study|Withdrawal by Subject|2|||
155294726|NCT00716144|560507437|FG002|Overall Study|Withdrawal by Subject|6|||
155294727|NCT00716144|560507438|FG003|Overall Study|Withdrawal by Subject|6|||
155294728|NCT00716144|560507435|FG000|Overall Study|Lost to Follow-up|2|||
155294729|NCT00716144|560507436|FG001|Overall Study|Lost to Follow-up|2|||
155294730|NCT00716144|560507437|FG002|Overall Study|Lost to Follow-up|1|||
155294731|NCT00716144|560507438|FG003|Overall Study|Lost to Follow-up|2|||
155294732|NCT00716144|560507435|FG000|Overall Study|Adverse Event|0|||
155294733|NCT00716144|560507436|FG001|Overall Study|Adverse Event|0|||
155294734|NCT00716144|560507437|FG002|Overall Study|Adverse Event|0|||
155294735|NCT00716144|560507438|FG003|Overall Study|Adverse Event|2|||
155294736|NCT00716144|560507435|FG000|Overall Study|Non-compliance|1|||
155294737|NCT00716144|560507436|FG001|Overall Study|Non-compliance|0|||
155294738|NCT00716144|560507437|FG002|Overall Study|Non-compliance|0|||
155294739|NCT00716144|560507438|FG003|Overall Study|Non-compliance|0|||
155294740|NCT00716144|560507435|FG000|Overall Study|Protocol Violation|2|||
155294741|NCT00716144|560507436|FG001|Overall Study|Protocol Violation|0|||
155294742|NCT00716144|560507437|FG002|Overall Study|Protocol Violation|1|||
155294743|NCT00716144|560507438|FG003|Overall Study|Protocol Violation|0|||
155294744|NCT00716144|560507435|FG000|Overall Study|Physician Decision|0|||
155294745|NCT00716144|560507436|FG001|Overall Study|Physician Decision|1|||
155294746|NCT00716144|560507437|FG002|Overall Study|Physician Decision|2|||
155294747|NCT00716144|560507438|FG003|Overall Study|Physician Decision|2|||
155294748|NCT00716144|560507435|FG000|Overall Study|Intercurrent illness|0|||
155294749|NCT00716144|560507436|FG001|Overall Study|Intercurrent illness|0|||
155294750|NCT00716144|560507437|FG002|Overall Study|Intercurrent illness|1|||
155294751|NCT00716144|560507438|FG003|Overall Study|Intercurrent illness|0|||
155294752|NCT00716144|560507435|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
155294753|NCT00716144|560507436|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
155294754|NCT00716144|560507437|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
155294755|NCT00716144|560507438|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
155294756|NCT00716144|560507435|FG000|Overall Study|Adverse event: left foot pain|0|||
155294757|NCT00716144|560507436|FG001|Overall Study|Adverse event: left foot pain|1|||
155294758|NCT00716144|560507437|FG002|Overall Study|Adverse event: left foot pain|0|||
155294759|NCT00716144|560507438|FG003|Overall Study|Adverse event: left foot pain|0|||
155294760|NCT00716144|560507435|FG000|Overall Study|Clinical Depression|0|||
155294761|NCT00716144|560507436|FG001|Overall Study|Clinical Depression|1|||
155294762|NCT00716144|560507437|FG002|Overall Study|Clinical Depression|0|||
155294763|NCT00716144|560507438|FG003|Overall Study|Clinical Depression|0|||
155294764|NCT00880048|560507442|FG000|Overall Study|Adverse Event|2|||
155294765|NCT00880048|560507443|FG001|Overall Study|Adverse Event|3|||
155294766|NCT00880048|560507444|FG002|Overall Study|Adverse Event|5|||
155294767|NCT00880048|560507442|FG000|Overall Study|Lack of Efficacy|1|||
155294768|NCT00880048|560507443|FG001|Overall Study|Lack of Efficacy|2|||
155294769|NCT00880048|560507444|FG002|Overall Study|Lack of Efficacy|2|||
155294770|NCT00880048|560507442|FG000|Overall Study|Protocol Violation|4|||
155294771|NCT00880048|560507443|FG001|Overall Study|Protocol Violation|6|||
155294772|NCT00880048|560507444|FG002|Overall Study|Protocol Violation|5|||
155294773|NCT00880048|560507442|FG000|Overall Study|Lost to Follow-up|6|||
155294774|NCT00880048|560507443|FG001|Overall Study|Lost to Follow-up|6|||
155294775|NCT00880048|560507444|FG002|Overall Study|Lost to Follow-up|5|||
155294776|NCT00880048|560507442|FG000|Overall Study|Physician Decision|1|||
155294777|NCT00880048|560507443|FG001|Overall Study|Physician Decision|1|||
155061168|NCT03055013|559659259|FG001|Overall Study|Disease relapse|0|||
155061169|NCT03055013|559659258|FG000|Overall Study|Withdrawal by Subject|28|||
155061170|NCT03055013|559659259|FG001|Overall Study|Withdrawal by Subject|0|||
155061171|NCT03055013|559659258|FG000|Overall Study|Other complicating disease|5|||
155294778|NCT00880048|560507444|FG002|Overall Study|Physician Decision|7|||
155294779|NCT00880048|560507442|FG000|Overall Study|Withdrawal by Subject|5|||
155294780|NCT00880048|560507443|FG001|Overall Study|Withdrawal by Subject|8|||
155294781|NCT00880048|560507444|FG002|Overall Study|Withdrawal by Subject|5|||
155294782|NCT00880048|560507442|FG000|Overall Study|Study closed/terminated|9|||
155294783|NCT00880048|560507443|FG001|Overall Study|Study closed/terminated|7|||
155061172|NCT03055013|559659259|FG001|Overall Study|Other complicating disease|0|||
155061173|NCT03055013|559659258|FG000|Overall Study|Physician Decision|1|||
155294784|NCT00880048|560507444|FG002|Overall Study|Study closed/terminated|6|||
155294785|NCT01069341|560507445|FG000|Overall Study|Lost to Follow-up|1|||
155294786|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
155294787|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
155294788|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
155294789|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
155294790|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
155294791|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
155294792|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
155294793|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
155294794|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
155294795|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
155294796|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
155294797|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
155294798|NCT00790790|560507453|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
155294799|NCT00790790|560507454|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
155294800|NCT00790790|560507455|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
155294801|NCT02808338|560507457|FG000|Screening|Screen Failure|10|||
155294802|NCT02808338|560507457|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
155294803|NCT02808338|560507457|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
155294804|NCT00756730|560507460|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
155294805|NCT00756730|560507461|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
155294806|NCT00756730|560507460|FG000|Overall Study|persistent low-level viremmia|0|||
155294807|NCT00756730|560507461|FG001|Overall Study|persistent low-level viremmia|1|||
155294808|NCT05382104|560507465|FG000|Period 2 (2 Days)|Adverse Event|0|||
155294809|NCT05382104|560507466|FG001|Period 2 (2 Days)|Adverse Event|1|||
155294810|NCT05382104|560507467|FG002|Period 2 (2 Days)|Adverse Event|0|||
155294811|NCT05382104|560507468|FG003|Period 2 (2 Days)|Adverse Event|0|||
155294812|NCT05382104|560507469|FG004|Period 2 (2 Days)|Adverse Event|0|||
155294813|NCT05382104|560507470|FG005|Period 2 (2 Days)|Adverse Event|0|||
155294814|NCT01493778|560507472|FG000|Overall Study|Withdrawal by Subject|8|||
155294815|NCT04210180|560507473|FG000|Overall Study|Withdrawal by Subject|2|||
155294816|NCT05190419|560507474|FG000|Overall Study|Lack of Efficacy|8|||
155294817|NCT05190419|560507475|FG001|Overall Study|Lack of Efficacy|0|||
155294818|NCT05190419|560507476|FG002|Overall Study|Lack of Efficacy|1|||
155294819|NCT05190419|560507477|FG003|Overall Study|Lack of Efficacy|0|||
155294820|NCT05190419|560507474|FG000|Overall Study|Withdrawal by Subject|7|||
155294821|NCT05190419|560507475|FG001|Overall Study|Withdrawal by Subject|1|||
155294822|NCT05190419|560507476|FG002|Overall Study|Withdrawal by Subject|2|||
155294823|NCT05190419|560507477|FG003|Overall Study|Withdrawal by Subject|2|||
155294824|NCT05190419|560507474|FG000|Overall Study|Adverse Event|2|||
155294825|NCT05190419|560507475|FG001|Overall Study|Adverse Event|10|||
155294826|NCT05190419|560507476|FG002|Overall Study|Adverse Event|11|||
155294827|NCT05190419|560507477|FG003|Overall Study|Adverse Event|21|||
155294828|NCT05190419|560507474|FG000|Overall Study|Lost to Follow-up|1|||
155294829|NCT05190419|560507475|FG001|Overall Study|Lost to Follow-up|2|||
155294830|NCT05190419|560507476|FG002|Overall Study|Lost to Follow-up|3|||
155294831|NCT05190419|560507477|FG003|Overall Study|Lost to Follow-up|1|||
155294832|NCT05190419|560507474|FG000|Overall Study|Other|1|||
155294833|NCT05190419|560507475|FG001|Overall Study|Other|1|||
155294834|NCT05190419|560507476|FG002|Overall Study|Other|0|||
155294835|NCT05190419|560507477|FG003|Overall Study|Other|3|||
155294836|NCT03538054|560507478|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
155294837|NCT03538054|560507478|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
155294838|NCT03538054|560507478|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
155294839|NCT00208767|560507479|FG000|Overall Study|Adverse Event|9|||
155294840|NCT00208767|560507480|FG001|Overall Study|Adverse Event|1|||
155294841|NCT00208767|560507479|FG000|Overall Study|Withdrawal by Subject|14|||
155294842|NCT00208767|560507480|FG001|Overall Study|Withdrawal by Subject|3|||
155294843|NCT00208767|560507479|FG000|Overall Study|Death|1|||
155294844|NCT00208767|560507480|FG001|Overall Study|Death|0|||
155294845|NCT00208767|560507479|FG000|Overall Study|Lost to Follow-up|3|||
155294846|NCT00208767|560507480|FG001|Overall Study|Lost to Follow-up|3|||
155294847|NCT02754479|560507481|FG000|Overall Study|Lost to Follow-up|1|||
155294848|NCT03183518|560507482|FG000|Overall Study|Other (Not specified)|2|||
155294849|NCT03183518|560507482|FG000|Overall Study|Other (Withdrawal of consent)|1|||
155294850|NCT04493242|560507485|FG000|Overall Study|Death|10|||
155294851|NCT04493242|560507486|FG001|Overall Study|Death|14|||
155294852|NCT04493242|560507487|FG002|Overall Study|Death|16|||
155294853|NCT04493242|560507485|FG000|Overall Study|Lost to Follow-up|1|||
155294854|NCT04493242|560507486|FG001|Overall Study|Lost to Follow-up|1|||
155294855|NCT04493242|560507487|FG002|Overall Study|Lost to Follow-up|0|||
155294856|NCT04493242|560507485|FG000|Overall Study|Withdrawal by Subject|1|||
155294857|NCT04493242|560507486|FG001|Overall Study|Withdrawal by Subject|0|||
155294858|NCT04493242|560507487|FG002|Overall Study|Withdrawal by Subject|0|||
155294859|NCT04493242|560507485|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
155294860|NCT04493242|560507486|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
155294861|NCT04493242|560507487|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
155294862|NCT04493242|560507485|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
155294863|NCT04493242|560507486|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
155294864|NCT04493242|560507487|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
155294865|NCT00849147|560507488|FG000|Overall Study|Withdrawal by Subject|1|||
155294866|NCT00849147|560507488|FG000|Overall Study|Protocol Violation|2|||
155294867|NCT00849147|560507488|FG000|Overall Study|Disease Relapse/Progression|2|||
155294868|NCT03544515|560509061|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
155294869|NCT03544515|560509062|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
155294870|NCT03544515|560509061|FG000|Overall Study|Lost to Follow-up|2|||
155294871|NCT03544515|560509062|FG001|Overall Study|Lost to Follow-up|0|||
155294872|NCT03169244|560509063|FG000|Overall Study|Lost to Follow-up|1|||
155294873|NCT03169244|560509064|FG001|Overall Study|Lost to Follow-up|2|||
155294874|NCT03169244|560509063|FG000|Overall Study|Adverse Event|1|||
155294875|NCT03169244|560509064|FG001|Overall Study|Adverse Event|0|||
155294876|NCT03169244|560509063|FG000|Overall Study|Withdrawal by Subject|2|||
155294877|NCT03169244|560509064|FG001|Overall Study|Withdrawal by Subject|2|||
155294878|NCT03169244|560509063|FG000|Overall Study|Physician Decision|1|||
155294879|NCT03169244|560509064|FG001|Overall Study|Physician Decision|0|||
155294880|NCT00178399|560509065|FG000|Overall Study|Physician Decision|4|||
155294881|NCT00178399|560509065|FG000|Overall Study|Withdrawal by Subject|8|||
155294882|NCT00178399|560509065|FG000|Overall Study|Lost to Follow-up|1|||
155294883|NCT02027558|560509066|FG000|Overall Study|Death|0|||
155157644|NCT01074970|560014964|FG002|Overall Study|Disease progression during treatment|2|||
155157645|NCT01074970|560014965|FG003|Overall Study|Disease progression during treatment|9|||
155157646|NCT01074970|560014962|FG000|Overall Study|Lost to Follow-up|0|||
155157647|NCT01074970|560014963|FG001|Overall Study|Lost to Follow-up|0|||
155157648|NCT01074970|560014964|FG002|Overall Study|Lost to Follow-up|1|||
155157649|NCT01074970|560014965|FG003|Overall Study|Lost to Follow-up|0|||
155157650|NCT01074970|560014962|FG000|Overall Study|Withdrawal by Subject|0|||
155157651|NCT01074970|560014963|FG001|Overall Study|Withdrawal by Subject|0|||
155157652|NCT01074970|560014964|FG002|Overall Study|Withdrawal by Subject|6|||
155157653|NCT01074970|560014965|FG003|Overall Study|Withdrawal by Subject|4|||
155157654|NCT00734149|560014967|FG000|Overall Study|Withdrawal by Subject|1|||
155157655|NCT05430854|560014968|FG000|Overall Study|Trial terminated by Sponsor|39|||
155157656|NCT05430854|560014969|FG001|Overall Study|Trial terminated by Sponsor|50|||
155294884|NCT02027558|560509067|FG001|Overall Study|Death|1|||
155294885|NCT02027558|560509066|FG000|Overall Study|Withdrawal by Subject|2|||
155157657|NCT05430854|560014970|FG002|Overall Study|Trial terminated by Sponsor|46|||
155157658|NCT05430854|560014968|FG000|Overall Study|Withdrawal by Subject|0|||
155294886|NCT02027558|560509067|FG001|Overall Study|Withdrawal by Subject|0|||
155157659|NCT05430854|560014969|FG001|Overall Study|Withdrawal by Subject|3|||
155157660|NCT05430854|560014970|FG002|Overall Study|Withdrawal by Subject|0|||
155157661|NCT04314284|560014971|FG000|Overall Study|Withdrawal by Subject|4|||
154956561|NCT00048581|559267268|FG000|Open-Label Period|Study Site Closure|0|||
154956562|NCT00048581|559267269|FG001|Open-Label Period|Study Site Closure|0|||
154956563|NCT00048581|559267270|FG002|Open-Label Period|Study Site Closure|2|||
154956564|NCT00048581|559267268|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
154956565|NCT00048581|559267269|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
154956566|NCT00048581|559267270|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
154956567|NCT00048581|559267268|FG000|Open-Label Period|Problem With Transportation To Site|0|||
154956568|NCT00048581|559267269|FG001|Open-Label Period|Problem With Transportation To Site|0|||
154956569|NCT00048581|559267270|FG002|Open-Label Period|Problem With Transportation To Site|1|||
154956570|NCT00048581|559267268|FG000|Open-Label Period|Primary Investigator Retired|0|||
154956571|NCT00048581|559267269|FG001|Open-Label Period|Primary Investigator Retired|0|||
154956572|NCT00048581|559267270|FG002|Open-Label Period|Primary Investigator Retired|2|||
154956573|NCT00048581|559267268|FG000|Open-Label Period|Study Ended By Sponsor|0|||
154956574|NCT00048581|559267269|FG001|Open-Label Period|Study Ended By Sponsor|0|||
154956575|NCT00048581|559267270|FG002|Open-Label Period|Study Ended By Sponsor|1|||
154956576|NCT01406795|559267271|FG000|Overall Study|Withdrawal by Subject|1|||
154956577|NCT04320849|559267272|FG000|Overall Study|Withdrawal by Subject|4|||
154956578|NCT04320849|559267272|FG000|Overall Study|Imaging data unavailable|2|||
154956579|NCT04320849|559267272|FG000|Overall Study|Incomplete imaging|2|||
154956580|NCT02421952|559267273|FG000|Overall Study|Diary Not Returned|93|||
154956581|NCT02421952|559267273|FG000|Overall Study|Failed seriation task|13|||
154956582|NCT02421952|559267273|FG000|Overall Study|Subject uncooperative for baseline test|2|||
154956583|NCT02421952|559267273|FG000|Overall Study|Surgery cancelled|1|||
154956584|NCT02801877|559267277|FG000|Overall Study|Lost to Follow-up|1|||
154956585|NCT02801877|559267278|FG001|Overall Study|Lost to Follow-up|1|||
154956586|NCT02801877|559267279|FG002|Overall Study|Lost to Follow-up|2|||
154956587|NCT02801877|559267280|FG003|Overall Study|Lost to Follow-up|0|||
154956588|NCT02801877|559267277|FG000|Overall Study|Never Started Treatment|2|||
154956589|NCT02801877|559267278|FG001|Overall Study|Never Started Treatment|0|||
154956590|NCT02801877|559267279|FG002|Overall Study|Never Started Treatment|4|||
154956591|NCT02801877|559267280|FG003|Overall Study|Never Started Treatment|0|||
154956592|NCT04934722|559268749|FG000|Overall Study|Death|4|||
154956593|NCT04934722|559268750|FG001|Overall Study|Death|3|||
154956594|NCT04934722|559268749|FG000|Overall Study|Participants Ongoing|88|||
154956595|NCT04934722|559268750|FG001|Overall Study|Participants Ongoing|91|||
154956596|NCT06358820|559268751|FG000|Overall Study|Adverse Event|11|||
154956597|NCT06358820|559268751|FG000|Overall Study|kidney transplantation|3|||
154956598|NCT06358820|559268751|FG000|Overall Study|patient voluntary withdrawal|6|||
154956599|NCT06358820|559268751|FG000|Overall Study|Physician Decision|1|||
154956600|NCT01045096|559268754|FG000|Overall Study|Withdrawal by Subject|2|||
154956601|NCT01045096|559268755|FG001|Overall Study|Withdrawal by Subject|0|||
154956602|NCT01045096|559268756|FG002|Overall Study|Withdrawal by Subject|0|||
154956603|NCT01045096|559268754|FG000|Overall Study|Other|1|||
154956604|NCT01045096|559268755|FG001|Overall Study|Other|0|||
154956605|NCT01045096|559268756|FG002|Overall Study|Other|0|||
154956606|NCT01511939|559268758|FG000|Overall Study|Withdrawal by Subject|2|||
154956607|NCT01511939|559268759|FG001|Overall Study|Withdrawal by Subject|1|||
154956608|NCT01511939|559268760|FG002|Overall Study|Withdrawal by Subject|0|||
154956609|NCT03785548|559268766|FG000|Overall Study|age > 80|1|||
154956610|NCT03785548|559268767|FG001|Overall Study|age > 80|0|||
154956611|NCT03785548|559268766|FG000|Overall Study|no Postop queries|1|||
154956612|NCT03785548|559268767|FG001|Overall Study|no Postop queries|0|||
154956613|NCT01993030|559268768|FG000|Overall Study|Adverse Event|0|||
154956614|NCT01993030|559268769|FG001|Overall Study|Adverse Event|4|||
154956615|NCT01591785|559268771|FG000|Overall Study|worsening condition|1|||
154956616|NCT01591785|559268772|FG001|Overall Study|worsening condition|2|||
154956617|NCT01591785|559268771|FG000|Overall Study|Protocol Violation|2|||
154956618|NCT01591785|559268772|FG001|Overall Study|Protocol Violation|0|||
154956619|NCT01591785|559268771|FG000|Overall Study|Lost to Follow-up|1|||
154956620|NCT01591785|559268772|FG001|Overall Study|Lost to Follow-up|0|||
154956621|NCT00396279|559268774|FG000|Overall Study|Ongoing in study|26|||
154956622|NCT00396279|559268774|FG000|Overall Study|Disease progression|2|||
155294887|NCT02027558|560509066|FG000|Overall Study|Lost to Follow-up|4|||
155294888|NCT02027558|560509067|FG001|Overall Study|Lost to Follow-up|1|||
155294889|NCT02027558|560509066|FG000|Overall Study|Refused assessment|3|||
155294890|NCT02027558|560509067|FG001|Overall Study|Refused assessment|0|||
155294891|NCT00114244|560509068|FG000|Overall Study|Adverse Event|2|||
155294892|NCT00114244|560509069|FG001|Overall Study|Adverse Event|5|||
155294893|NCT00114244|560509068|FG000|Overall Study|Withdrawal by Subject|0|||
155294894|NCT00114244|560509069|FG001|Overall Study|Withdrawal by Subject|2|||
155294895|NCT00393848|560509070|FG000|Overall Study|Surgical schedule|0|||
155294896|NCT00393848|560509071|FG001|Overall Study|Surgical schedule|0|||
155294897|NCT00393848|560509072|FG002|Overall Study|Surgical schedule|0|||
155294898|NCT00393848|560509073|FG003|Overall Study|Surgical schedule|1|||
155294899|NCT00393848|560509070|FG000|Overall Study|Personal reasons|0|||
155294900|NCT00393848|560509071|FG001|Overall Study|Personal reasons|0|||
155294901|NCT00393848|560509072|FG002|Overall Study|Personal reasons|2|||
155294902|NCT00393848|560509073|FG003|Overall Study|Personal reasons|0|||
155294903|NCT02694978|560509080|FG000|Overall Study|Adverse Event|10|||
155294904|NCT02694978|560509081|FG001|Overall Study|Adverse Event|9|||
155294905|NCT02694978|560509080|FG000|Overall Study|Withdrawal by Subject|22|||
155294906|NCT02694978|560509081|FG001|Overall Study|Withdrawal by Subject|19|||
155294907|NCT02694978|560509080|FG000|Overall Study|Lost to Follow-up|14|||
155294908|NCT02694978|560509081|FG001|Overall Study|Lost to Follow-up|17|||
155294909|NCT02694978|560509080|FG000|Overall Study|Death|4|||
155294910|NCT02694978|560509081|FG001|Overall Study|Death|1|||
155294911|NCT02694978|560509080|FG000|Overall Study|Other-Decision of Participant|6|||
155294912|NCT02694978|560509081|FG001|Overall Study|Other-Decision of Participant|1|||
155294913|NCT02694978|560509080|FG000|Overall Study|Other-Investigator's decision|1|||
155294914|NCT02694978|560509081|FG001|Overall Study|Other-Investigator's decision|0|||
155294915|NCT02694978|560509080|FG000|Overall Study|Other-Unable to be reached|0|||
155294916|NCT02694978|560509081|FG001|Overall Study|Other-Unable to be reached|1|||
155294917|NCT02694978|560509080|FG000|Overall Study|Other-Protocol noncompliant|2|||
155294918|NCT02694978|560509081|FG001|Overall Study|Other-Protocol noncompliant|1|||
155294919|NCT02694978|560509080|FG000|Overall Study|Other-Personal reasons|3|||
155294920|NCT02694978|560509081|FG001|Overall Study|Other-Personal reasons|3|||
155294921|NCT02694978|560509080|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
155294922|NCT02694978|560509081|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
155294923|NCT01613716|560509082|FG000|Overall Study|screen failures|3|||
155294924|NCT01613716|560509082|FG000|Overall Study|Lost to Follow-up|4|||
155294925|NCT01376089|560509090|FG000|Overall Study|Patient received no contrast media|3|||
155294926|NCT01376089|560509091|FG001|Overall Study|Patient received no contrast media|4|||
155294927|NCT00419094|560509094|FG000|Overall Study|Adverse Event|3|||
155294928|NCT00419094|560509095|FG001|Overall Study|Adverse Event|7|||
155294929|NCT00419094|560509094|FG000|Overall Study|Lack of Efficacy|1|||
155294930|NCT00419094|560509095|FG001|Overall Study|Lack of Efficacy|0|||
155294931|NCT00419094|560509094|FG000|Overall Study|Lost to Follow-up|0|||
155294932|NCT00419094|560509095|FG001|Overall Study|Lost to Follow-up|2|||
155294933|NCT00419094|560509094|FG000|Overall Study|Protocol Violation|1|||
155294934|NCT00419094|560509095|FG001|Overall Study|Protocol Violation|14|||
155294935|NCT00419094|560509094|FG000|Overall Study|Withdrawal of consent|1|||
155294936|NCT00419094|560509095|FG001|Overall Study|Withdrawal of consent|5|||
155294937|NCT00419094|560509094|FG000|Overall Study|Other: Error determining exit criteria|1|||
155294938|NCT00419094|560509095|FG001|Overall Study|Other: Error determining exit criteria|0|||
155294939|NCT00419094|560509094|FG000|Overall Study|Other: Patient non-compliant|0|||
155294940|NCT00419094|560509095|FG001|Overall Study|Other: Patient non-compliant|1|||
155294941|NCT00419094|560509094|FG000|Overall Study|Other: No contact for extended period|0|||
155294942|NCT00419094|560509095|FG001|Overall Study|Other: No contact for extended period|1|||
155294943|NCT01811706|560509096|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
155294944|NCT01811706|560509097|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
155294945|NCT02567656|560509101|FG000|Overall Study|Premature discontinuation due to PD|1|||
155294946|NCT02567656|560509102|FG001|Overall Study|Premature discontinuation due to PD|1|||
155294947|NCT02567656|560509103|FG002|Overall Study|Premature discontinuation due to PD|2|||
155294948|NCT02567656|560509104|FG003|Overall Study|Premature discontinuation due to PD|0|||
155294949|NCT02567656|560509105|FG004|Overall Study|Premature discontinuation due to PD|0|||
155294950|NCT02567656|560509106|FG005|Overall Study|Premature discontinuation due to PD|0|||
155294951|NCT03287622|560509108|FG000|Overall Study|Withdrawal by Subject|1|||
155294952|NCT03287622|560509109|FG001|Overall Study|Withdrawal by Subject|0|||
155294953|NCT03287622|560509108|FG000|Overall Study|Lost to Follow-up|27|||
155294954|NCT03287622|560509109|FG001|Overall Study|Lost to Follow-up|15|||
155294955|NCT03287622|560509108|FG000|Overall Study|No prescripion after surgery|28|||
155294956|NCT03287622|560509109|FG001|Overall Study|No prescripion after surgery|31|||
155294957|NCT03287622|560509108|FG000|Overall Study|prolonged Length of stay|2|||
155294958|NCT03287622|560509109|FG001|Overall Study|prolonged Length of stay|0|||
155294959|NCT03287622|560509108|FG000|Overall Study|surgery related|0|||
155294960|NCT03287622|560509109|FG001|Overall Study|surgery related|2|||
155294961|NCT01616654|560509113|FG000|Overall Study|Lack of Efficacy|1|||
155294962|NCT01616654|560509114|FG001|Overall Study|Lack of Efficacy|0|||
155294963|NCT01616654|560509115|FG002|Overall Study|Lack of Efficacy|0|||
155294964|NCT01616654|560509116|FG003|Overall Study|Lack of Efficacy|0|||
155294965|NCT01616654|560509117|FG004|Overall Study|Lack of Efficacy|1|||
155294966|NCT01616654|560509113|FG000|Overall Study|Adverse Event|0|||
155294967|NCT01616654|560509114|FG001|Overall Study|Adverse Event|1|||
155294968|NCT01616654|560509115|FG002|Overall Study|Adverse Event|2|||
155294969|NCT01616654|560509116|FG003|Overall Study|Adverse Event|1|||
155294970|NCT01616654|560509117|FG004|Overall Study|Adverse Event|0|||
155294971|NCT01616654|560509113|FG000|Overall Study|Withdrawal by Subject|2|||
155294972|NCT01616654|560509114|FG001|Overall Study|Withdrawal by Subject|2|||
155294973|NCT01616654|560509115|FG002|Overall Study|Withdrawal by Subject|3|||
155294974|NCT01616654|560509116|FG003|Overall Study|Withdrawal by Subject|1|||
155294975|NCT01616654|560509117|FG004|Overall Study|Withdrawal by Subject|5|||
155294976|NCT01616654|560509113|FG000|Overall Study|Protocol Violation|0|||
155294977|NCT01616654|560509114|FG001|Overall Study|Protocol Violation|5|||
155294978|NCT01616654|560509115|FG002|Overall Study|Protocol Violation|2|||
155294979|NCT01616654|560509116|FG003|Overall Study|Protocol Violation|4|||
155294980|NCT01616654|560509117|FG004|Overall Study|Protocol Violation|4|||
155294981|NCT01616654|560509113|FG000|Overall Study|Lost to Follow-up|1|||
155294982|NCT01616654|560509114|FG001|Overall Study|Lost to Follow-up|0|||
155294983|NCT01616654|560509115|FG002|Overall Study|Lost to Follow-up|3|||
155294984|NCT01616654|560509116|FG003|Overall Study|Lost to Follow-up|2|||
155294985|NCT01616654|560509117|FG004|Overall Study|Lost to Follow-up|1|||
155294986|NCT01616654|560509113|FG000|Overall Study|Pregnancy|1|||
155294987|NCT01616654|560509114|FG001|Overall Study|Pregnancy|0|||
155294988|NCT01616654|560509115|FG002|Overall Study|Pregnancy|0|||
155294989|NCT01616654|560509116|FG003|Overall Study|Pregnancy|0|||
155294990|NCT01616654|560509117|FG004|Overall Study|Pregnancy|1|||
155294991|NCT02057692|560509121|FG000|Overall Study|Adverse Event|1|||
155294992|NCT02057692|560509122|FG001|Overall Study|Adverse Event|0|||
155294993|NCT02057692|560509123|FG002|Overall Study|Adverse Event|0|||
155294994|NCT02057692|560509124|FG003|Overall Study|Adverse Event|0|||
155294995|NCT02057692|560509121|FG000|Overall Study|Lost to Follow-up|0|||
155294996|NCT02057692|560509122|FG001|Overall Study|Lost to Follow-up|0|||
155294997|NCT02057692|560509123|FG002|Overall Study|Lost to Follow-up|0|||
155294998|NCT02057692|560509124|FG003|Overall Study|Lost to Follow-up|1|||
155294999|NCT00943735|560509125|FG000|Overall Study|Adverse Event|12|||
155295000|NCT00943735|560509125|FG000|Overall Study|Withdrawal by Subject|8|||
155295001|NCT00943735|560509125|FG000|Overall Study|Death|1|||
155295002|NCT00943735|560509125|FG000|Overall Study|Other|8|||
155295003|NCT00943735|560509125|FG000|Overall Study|Other|3|||
155295004|NCT00486330|560509126|FG000|Overall Study|Adverse Event|2|||
155295005|NCT01027286|560509127|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
155295006|NCT01027286|560509128|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
155295007|NCT01027286|560509127|FG000|Overall Study|Lost to Follow-up|0|||
155295008|NCT01027286|560509128|FG001|Overall Study|Lost to Follow-up|1|||
155295009|NCT03804918|560509129|FG000|Overall Study|Participant did not use the app|1|||
155295010|NCT00545844|560509130|FG000|Overall Study|Lost to Follow-up|9|||
155295011|NCT00545844|560509130|FG000|Overall Study|Protocol Violation|1|||
155295012|NCT00545844|560509130|FG000|Overall Study|Withdrawal by Subject|2|||
155295013|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
155295014|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
155295015|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
155295016|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
155061174|NCT03055013|559659259|FG001|Overall Study|Physician Decision|0|||
155295017|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
155295018|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
155061175|NCT03055013|559659258|FG000|Overall Study|Benign mass/non-RCC|4|||
155295019|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
155295020|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
155295021|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
155295022|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
155295023|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
155295024|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
155295025|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
155295026|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
155295027|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
155295028|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
155295029|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
155295030|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
155295031|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
155295032|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
155295033|NCT01087762|560509131|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
155295034|NCT01087762|560509132|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
155295035|NCT01087762|560509133|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
155295036|NCT01087762|560509134|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
155295037|NCT01087762|560509135|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
155295038|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
155295039|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
155295040|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
155295041|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
155295042|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
155295043|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
155295044|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
155295045|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
155295046|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
155295047|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
155295048|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
155295049|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
155295050|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
155295051|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
155295052|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
155295053|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
155295054|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
155295055|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
155295056|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
155295057|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
155295058|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
155295059|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
155295060|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
155295061|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
155295062|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
155295063|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
155295064|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
155295065|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
155295066|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
155295067|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
155295068|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
155295069|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
155295070|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
155295071|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
155295072|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
155295073|NCT01087762|560509131|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
155295074|NCT01087762|560509132|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
155295075|NCT01087762|560509133|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
155295076|NCT01087762|560509134|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
155295077|NCT01087762|560509135|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
155295078|NCT01329328|560509136|FG000|Overall Study|Withdrawal by Subject|2|||
155295079|NCT01329328|560509137|FG001|Overall Study|Withdrawal by Subject|4|||
155295080|NCT01329328|560509138|FG002|Overall Study|Withdrawal by Subject|3|||
155295081|NCT01565928|560509139|FG000|Overall Study|Adverse Event|3|||
155295082|NCT01565928|560509139|FG000|Overall Study|Other|3|||
155295083|NCT01565928|560509139|FG000|Overall Study|Progressive Disease|13|||
155295084|NCT01565928|560509139|FG000|Overall Study|Withdrawal by Subject|1|||
155295085|NCT01565928|560509139|FG000|Overall Study|Death|2|||
155295086|NCT00612586|560509141|FG000|Overall Study|Adverse Event|6|||
155295087|NCT00612586|560509142|FG001|Overall Study|Adverse Event|2|||
155295088|NCT00612586|560509141|FG000|Overall Study|Death|1|||
155295089|NCT00612586|560509142|FG001|Overall Study|Death|0|||
155295090|NCT00612586|560509141|FG000|Overall Study|Entry Criteria Not Met|0|||
155295091|NCT00612586|560509142|FG001|Overall Study|Entry Criteria Not Met|2|||
155295092|NCT00612586|560509141|FG000|Overall Study|Withdrawal by Subject|7|||
155295093|NCT00612586|560509142|FG001|Overall Study|Withdrawal by Subject|9|||
155295094|NCT00612586|560509141|FG000|Overall Study|Physician Decision|1|||
155295095|NCT00612586|560509142|FG001|Overall Study|Physician Decision|2|||
155295096|NCT00612586|560509141|FG000|Overall Study|Sponsor Decision|1|||
155295097|NCT00612586|560509142|FG001|Overall Study|Sponsor Decision|1|||
155295098|NCT00612586|560509141|FG000|Overall Study|Progressive Disease|26|||
155295099|NCT00612586|560509142|FG001|Overall Study|Progressive Disease|24|||
155295100|NCT00612586|560509141|FG000|Overall Study|Randomized and Not Treated|1|||
155295101|NCT00612586|560509142|FG001|Overall Study|Randomized and Not Treated|1|||
155295102|NCT00762606|560509143|FG000|Overall Study|Lost to Follow-up|18|||
155295103|NCT00762606|560509144|FG001|Overall Study|Lost to Follow-up|13|||
155295104|NCT00949975|560509146|FG000|Overall Study|Voluntary discontinuation|6|||
155295105|NCT00949975|560509147|FG001|Overall Study|Voluntary discontinuation|5|||
155157662|NCT04314284|560014972|FG001|Overall Study|Withdrawal by Subject|7|||
155157663|NCT04314284|560014971|FG000|Overall Study|Consented but did not complete survey|0|||
155157664|NCT04314284|560014972|FG001|Overall Study|Consented but did not complete survey|6|||
155157665|NCT01652235|560014978|FG000|Overall Study|Death|9|||
155157666|NCT01652235|560014978|FG000|Overall Study|Lost to Follow-up|5|||
155295106|NCT00949975|560509148|FG002|Overall Study|Voluntary discontinuation|3|||
155295107|NCT00949975|560509149|FG003|Overall Study|Voluntary discontinuation|6|||
155295108|NCT00949975|560509146|FG000|Overall Study|Adverse Event|11|||
155295109|NCT00949975|560509147|FG001|Overall Study|Adverse Event|11|||
155295110|NCT00949975|560509148|FG002|Overall Study|Adverse Event|10|||
155295111|NCT00949975|560509149|FG003|Overall Study|Adverse Event|10|||
155295112|NCT00949975|560509146|FG000|Overall Study|Safety reason|0|||
155295113|NCT00949975|560509147|FG001|Overall Study|Safety reason|1|||
155295114|NCT00949975|560509148|FG002|Overall Study|Safety reason|0|||
155295115|NCT00949975|560509149|FG003|Overall Study|Safety reason|0|||
155157667|NCT01652235|560014978|FG000|Overall Study|Withdrawal by Subject|2|||
155157668|NCT05291520|560016505|FG000|Overall Study|Lost to Follow-up|0|||
155157669|NCT05291520|560016506|FG001|Overall Study|Lost to Follow-up|0|||
155157670|NCT05291520|560016507|FG002|Overall Study|Lost to Follow-up|1|||
155157671|NCT01347112|560016508|FG000|Overall Study|Withdrawal by Subject|1|||
155157672|NCT01347112|560016509|FG001|Overall Study|Withdrawal by Subject|7|||
155157673|NCT01347112|560016508|FG000|Overall Study|Lost to Follow-up|3|||
155157674|NCT01347112|560016509|FG001|Overall Study|Lost to Follow-up|5|||
155157675|NCT00836693|560016512|FG000|Overall Study|Adverse Event|4|||
155157676|NCT00836693|560016513|FG001|Overall Study|Adverse Event|1|||
155157677|NCT00836693|560016512|FG000|Overall Study|Sponsor Decision|0|||
155157678|NCT00836693|560016513|FG001|Overall Study|Sponsor Decision|1|||
155295116|NCT00949975|560509146|FG000|Overall Study|Study-specific criteria|0|||
155295117|NCT00949975|560509147|FG001|Overall Study|Study-specific criteria|1|||
155295118|NCT00949975|560509148|FG002|Overall Study|Study-specific criteria|1|||
155295119|NCT00949975|560509149|FG003|Overall Study|Study-specific criteria|0|||
155295120|NCT00949975|560509146|FG000|Overall Study|Incorrect enrolment|5|||
155295121|NCT00949975|560509147|FG001|Overall Study|Incorrect enrolment|10|||
155295122|NCT00949975|560509148|FG002|Overall Study|Incorrect enrolment|4|||
155295123|NCT00949975|560509149|FG003|Overall Study|Incorrect enrolment|7|||
155295124|NCT00949975|560509146|FG000|Overall Study|Severe non-compliance|3|||
155295125|NCT00949975|560509147|FG001|Overall Study|Severe non-compliance|1|||
155295126|NCT00949975|560509148|FG002|Overall Study|Severe non-compliance|0|||
155295127|NCT00949975|560509149|FG003|Overall Study|Severe non-compliance|2|||
155295128|NCT00949975|560509146|FG000|Overall Study|Lost to Follow-up|1|||
155295129|NCT00949975|560509147|FG001|Overall Study|Lost to Follow-up|0|||
155295130|NCT00949975|560509148|FG002|Overall Study|Lost to Follow-up|1|||
155295131|NCT00949975|560509149|FG003|Overall Study|Lost to Follow-up|3|||
155295132|NCT00949975|560509146|FG000|Overall Study|Other|1|||
155295133|NCT00949975|560509147|FG001|Overall Study|Other|0|||
155295134|NCT00949975|560509148|FG002|Overall Study|Other|0|||
155295135|NCT00949975|560509149|FG003|Overall Study|Other|0|||
155295136|NCT02954848|560509160|FG000|Overall Study|Randomized but Not Treated|0|||
155295137|NCT02954848|560509161|FG001|Overall Study|Randomized but Not Treated|1|||
155295138|NCT02954848|560509160|FG000|Overall Study|Adverse Event|2|||
155295139|NCT02954848|560509161|FG001|Overall Study|Adverse Event|3|||
155295140|NCT02954848|560509160|FG000|Overall Study|Withdrawal by Participant|0|||
155295141|NCT02954848|560509161|FG001|Overall Study|Withdrawal by Participant|1|||
155295142|NCT01802632|560509162|FG000|Overall Study|Death|28|||
155295143|NCT01802632|560509163|FG001|Overall Study|Death|1|||
155295144|NCT01802632|560509164|FG002|Overall Study|Death|38|||
155295145|NCT01802632|560509165|FG003|Overall Study|Death|0|||
155295146|NCT01802632|560509166|FG004|Overall Study|Death|2|||
155295147|NCT01802632|560509167|FG005|Overall Study|Death|0|||
155295148|NCT01802632|560509162|FG000|Overall Study|Withdrawal by Subject|4|||
155295149|NCT01802632|560509163|FG001|Overall Study|Withdrawal by Subject|2|||
155295150|NCT01802632|560509164|FG002|Overall Study|Withdrawal by Subject|7|||
155295151|NCT01802632|560509165|FG003|Overall Study|Withdrawal by Subject|3|||
155295152|NCT01802632|560509166|FG004|Overall Study|Withdrawal by Subject|0|||
155295153|NCT01802632|560509167|FG005|Overall Study|Withdrawal by Subject|1|||
155295154|NCT01802632|560509162|FG000|Overall Study|Objective Disease Progression|1|||
155295155|NCT01802632|560509163|FG001|Overall Study|Objective Disease Progression|12|||
155295156|NCT01802632|560509164|FG002|Overall Study|Objective Disease Progression|104|||
155295157|NCT01802632|560509165|FG003|Overall Study|Objective Disease Progression|6|||
155295158|NCT01802632|560509166|FG004|Overall Study|Objective Disease Progression|4|||
155295159|NCT01802632|560509167|FG005|Overall Study|Objective Disease Progression|4|||
155295160|NCT01802632|560509162|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
155295161|NCT01802632|560509163|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
155295162|NCT01802632|560509164|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
155295163|NCT01802632|560509165|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
155157679|NCT00836693|560016512|FG000|Overall Study|Physician Decision|2|||
155157680|NCT00836693|560016513|FG001|Overall Study|Physician Decision|0|||
155157681|NCT00836693|560016512|FG000|Overall Study|Withdrawal by Subject|9|||
155157682|NCT00836693|560016513|FG001|Overall Study|Withdrawal by Subject|4|||
155157683|NCT00836693|560016512|FG000|Overall Study|Protocol Violation|1|||
155157684|NCT00836693|560016513|FG001|Overall Study|Protocol Violation|0|||
155157685|NCT00836693|560016512|FG000|Overall Study|Lost to Follow-up|1|||
155157686|NCT00836693|560016513|FG001|Overall Study|Lost to Follow-up|0|||
154956623|NCT00396279|559268774|FG000|Overall Study|Withdrawal by Subject|1|||
154956624|NCT00396279|559268774|FG000|Overall Study|Physician Decision|1|||
154956625|NCT02883452|559268775|FG000|Overall Study|Withdrawal by Subject|1|||
154956626|NCT02883452|559268776|FG001|Overall Study|Withdrawal by Subject|1|||
154956627|NCT02883452|559268777|FG002|Overall Study|Withdrawal by Subject|3|||
155157687|NCT01213472|560016514|FG000|Overall Study|Recurrence/Progressive disease|25|||
155295164|NCT01802632|560509166|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
155295165|NCT01802632|560509167|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
155295166|NCT01802632|560509162|FG000|Overall Study|Other (not specified)|0|||
155295167|NCT01802632|560509163|FG001|Overall Study|Other (not specified)|0|||
155295168|NCT01802632|560509164|FG002|Overall Study|Other (not specified)|7|||
155295169|NCT01802632|560509165|FG003|Overall Study|Other (not specified)|1|||
155295170|NCT01802632|560509166|FG004|Overall Study|Other (not specified)|0|||
155295171|NCT01802632|560509167|FG005|Overall Study|Other (not specified)|1|||
155295172|NCT03299816|560509168|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
155157688|NCT01213472|560016514|FG000|Overall Study|Withdrawal by Subject|1|||
155295173|NCT03299816|560509169|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
155295174|NCT03299816|560509168|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
155295175|NCT03299816|560509169|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
154956628|NCT02883452|559268778|FG003|Overall Study|Withdrawal by Subject|0|||
155295176|NCT03299816|560509168|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
155295177|NCT03299816|560509169|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
155295178|NCT00082810|560509170|FG000|Overall Study|Adverse Event|3|||
155295179|NCT00082810|560509170|FG000|Overall Study|Progressive disease|24|||
155295180|NCT00082810|560509170|FG000|Overall Study|Withdrawal by Subject|4|||
155295181|NCT01184508|560509173|FG000|Overall Study|Adverse Event|4|||
155295182|NCT01184508|560509174|FG001|Overall Study|Adverse Event|6|||
155295183|NCT01184508|560509173|FG000|Overall Study|Lack of Efficacy|1|||
155295184|NCT01184508|560509174|FG001|Overall Study|Lack of Efficacy|1|||
155295185|NCT01184508|560509173|FG000|Overall Study|Lost to Follow-up|1|||
155295186|NCT01184508|560509174|FG001|Overall Study|Lost to Follow-up|1|||
155295187|NCT01184508|560509173|FG000|Overall Study|Physician Decision|1|||
155295188|NCT01184508|560509174|FG001|Overall Study|Physician Decision|0|||
155295189|NCT01184508|560509173|FG000|Overall Study|Protocol Violation|3|||
155295190|NCT01184508|560509174|FG001|Overall Study|Protocol Violation|1|||
155295191|NCT01184508|560509173|FG000|Overall Study|Sponsor Decision|5|||
155295192|NCT01184508|560509174|FG001|Overall Study|Sponsor Decision|2|||
155295193|NCT01184508|560509173|FG000|Overall Study|Withdrawal by Subject|1|||
155295194|NCT01184508|560509174|FG001|Overall Study|Withdrawal by Subject|3|||
155295195|NCT01184508|560509173|FG000|Overall Study|Randomized, Not Treated|0|||
155295196|NCT01184508|560509174|FG001|Overall Study|Randomized, Not Treated|1|||
155295197|NCT02194933|560509177|FG000|Overall Study|Lost to Follow-up|1|||
155295198|NCT02194933|560509178|FG001|Overall Study|Lost to Follow-up|2|||
155295199|NCT02194933|560509177|FG000|Overall Study|Participant met withdrawal criteria|1|||
155295200|NCT02194933|560509178|FG001|Overall Study|Participant met withdrawal criteria|3|||
155295201|NCT02194933|560509177|FG000|Overall Study|Withdrawal by Subject|0|||
155295202|NCT02194933|560509178|FG001|Overall Study|Withdrawal by Subject|2|||
155295203|NCT02194933|560509177|FG000|Overall Study|Lack of Efficacy|1|||
155295204|NCT02194933|560509178|FG001|Overall Study|Lack of Efficacy|2|||
155295205|NCT03210402|560509179|FG000|Overall Study|Withdrawal by Subject|0|||
155295206|NCT03210402|560509180|FG001|Overall Study|Withdrawal by Subject|1|||
155295207|NCT02517307|560509195|FG000|Overall Study|Withdrawal by Subject|1|||
155295208|NCT02517307|560509196|FG001|Overall Study|Withdrawal by Subject|0|||
155295209|NCT02517307|560509197|FG002|Overall Study|Withdrawal by Subject|1|||
155295210|NCT02517307|560509198|FG003|Overall Study|Withdrawal by Subject|0|||
155295211|NCT02517307|560509195|FG000|Overall Study|Protocol Violation|0|||
155295212|NCT02517307|560509196|FG001|Overall Study|Protocol Violation|0|||
155295213|NCT02517307|560509197|FG002|Overall Study|Protocol Violation|1|||
155295214|NCT02517307|560509198|FG003|Overall Study|Protocol Violation|1|||
155295215|NCT03863834|560509205|FG000|Overall Study|Lost to Follow-up|3|||
155295216|NCT02685488|560509206|FG000|Overall Study|Withdrawal by Subject|0|||
155295217|NCT02685488|560509207|FG001|Overall Study|Withdrawal by Subject|1|||
155295218|NCT02351180|560509210|FG000|Overall Study|Withdrawal by Subject|1|||
155295219|NCT02351180|560509211|FG001|Overall Study|Withdrawal by Subject|0|||
155295220|NCT00605033|560509218|FG000|Overall Study|Adverse Event|2|||
155295221|NCT00605033|560509219|FG001|Overall Study|Adverse Event|2|||
155295222|NCT00605033|560509218|FG000|Overall Study|Lost to Follow-up|1|||
155295223|NCT00605033|560509219|FG001|Overall Study|Lost to Follow-up|1|||
155295224|NCT00605033|560509218|FG000|Overall Study|Withdrawal by Subject|3|||
155295225|NCT00605033|560509219|FG001|Overall Study|Withdrawal by Subject|4|||
155295226|NCT00605033|560509218|FG000|Overall Study|Protocol Violation|1|||
155295227|NCT00605033|560509219|FG001|Overall Study|Protocol Violation|1|||
155295228|NCT03768206|560509222|FG000|Overall Study|Lost to Follow-up|2|||
155295229|NCT03768206|560509223|FG001|Overall Study|Lost to Follow-up|1|||
155295230|NCT03768206|560509222|FG000|Overall Study|Withdrawal by Subject|0|||
155295231|NCT03768206|560509223|FG001|Overall Study|Withdrawal by Subject|1|||
155295232|NCT05328297|560511463|FG000|Overall Study|Adverse Event|5|||
155295233|NCT05328297|560511464|FG001|Overall Study|Adverse Event|7|||
155295234|NCT05328297|560511463|FG000|Overall Study|Withdrawal by Subject|4|||
155295235|NCT05328297|560511464|FG001|Overall Study|Withdrawal by Subject|3|||
155295236|NCT05328297|560511463|FG000|Overall Study|Lack of Efficacy|1|||
155295237|NCT05328297|560511464|FG001|Overall Study|Lack of Efficacy|0|||
155295238|NCT05328297|560511463|FG000|Overall Study|Lost to Follow-up|1|||
155295239|NCT05328297|560511464|FG001|Overall Study|Lost to Follow-up|0|||
155295240|NCT05328297|560511463|FG000|Overall Study|Protocol Violation|1|||
155295241|NCT05328297|560511464|FG001|Overall Study|Protocol Violation|0|||
155295242|NCT05328297|560511463|FG000|Overall Study|Randomized but not treated|1|||
155295243|NCT05328297|560511464|FG001|Overall Study|Randomized but not treated|1|||
155295244|NCT05147233|560511465|FG000|Overall Study|Adverse Event|0|||
155295245|NCT05147233|560511466|FG001|Overall Study|Adverse Event|1|||
155295246|NCT05147233|560511465|FG000|Overall Study|Lost to Follow-up|1|||
155295247|NCT05147233|560511466|FG001|Overall Study|Lost to Follow-up|1|||
155295248|NCT05147233|560511465|FG000|Overall Study|Protocol Violation|0|||
155295249|NCT05147233|560511466|FG001|Overall Study|Protocol Violation|1|||
155295250|NCT05147233|560511465|FG000|Overall Study|Withdrawal by Subject|2|||
155295251|NCT05147233|560511466|FG001|Overall Study|Withdrawal by Subject|1|||
155295252|NCT04513522|560511467|FG000|Overall Study|Other reasons|1|||
155295253|NCT04513522|560511467|FG000|Overall Study|Adverse event unrelated to study drug|9|||
155295254|NCT04513522|560511467|FG000|Overall Study|Study drug toxicity|14|||
155295255|NCT04513522|560511467|FG000|Overall Study|Disease progression|39|||
155295256|NCT04513522|560511467|FG000|Overall Study|Participants withdrew consent|2|||
155295257|NCT03284957|560511468|FG000|Overall Study|Adverse Event|0|||
155295258|NCT03284957|560511469|FG001|Overall Study|Adverse Event|0|||
155295259|NCT03284957|560511470|FG002|Overall Study|Adverse Event|0|||
155157689|NCT01213472|560016514|FG000|Overall Study|Physician Decision|1|||
155157690|NCT00129402|560016515|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155157691|NCT00129402|560016516|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
155157692|NCT00129402|560016517|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
155157693|NCT00129402|560016518|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155157694|NCT00129402|560016519|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155157695|NCT00129402|560016520|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
155157696|NCT00129402|560016521|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
155157697|NCT00129402|560016515|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155157698|NCT00129402|560016516|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155157699|NCT00129402|560016517|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155157700|NCT00129402|560016518|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155157701|NCT00129402|560016519|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155157702|NCT00129402|560016520|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
155157703|NCT00129402|560016521|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
155157704|NCT00129402|560016515|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155157705|NCT00129402|560016516|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155157706|NCT00129402|560016517|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155157707|NCT00129402|560016518|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
155157708|NCT00129402|560016519|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155157709|NCT00129402|560016520|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155157710|NCT00129402|560016521|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
155157711|NCT00129402|560016515|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155157712|NCT00129402|560016516|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155157713|NCT00129402|560016517|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
155157714|NCT00129402|560016518|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155157715|NCT00129402|560016519|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
155157716|NCT00129402|560016520|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155157717|NCT00129402|560016521|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
155157718|NCT00129402|560016515|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155157719|NCT00129402|560016516|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155157720|NCT00129402|560016517|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
155157721|NCT00129402|560016518|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155157722|NCT00129402|560016519|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155157723|NCT00129402|560016520|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155157724|NCT00129402|560016521|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
155157725|NCT00129402|560016515|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155157726|NCT00129402|560016516|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155157727|NCT00129402|560016517|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
155157728|NCT00129402|560016518|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155157729|NCT00129402|560016519|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155157730|NCT00129402|560016520|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
155157731|NCT00129402|560016521|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
155157732|NCT00129402|560016515|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155157733|NCT00129402|560016516|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155157734|NCT00129402|560016517|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
155157735|NCT00129402|560016518|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155157736|NCT00129402|560016519|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155157737|NCT00129402|560016520|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155170029|NCT00830869|560062408|FG003|Period 2: Part 2|Adverse Event|0|||
155295260|NCT03284957|560511471|FG003|Overall Study|Adverse Event|0|||
155295261|NCT03284957|560511472|FG004|Overall Study|Adverse Event|0|||
155295262|NCT03284957|560511473|FG005|Overall Study|Adverse Event|1|||
155295263|NCT03284957|560511474|FG006|Overall Study|Adverse Event|1|||
155295264|NCT03284957|560511475|FG007|Overall Study|Adverse Event|1|||
155295265|NCT03284957|560511476|FG008|Overall Study|Adverse Event|0|||
155295266|NCT03284957|560511477|FG009|Overall Study|Adverse Event|4|||
155295267|NCT03284957|560511478|FG010|Overall Study|Adverse Event|1|||
155295268|NCT03284957|560511479|FG011|Overall Study|Adverse Event|1|||
155295269|NCT03284957|560511480|FG012|Overall Study|Adverse Event|0|||
155295270|NCT03284957|560511481|FG013|Overall Study|Adverse Event|0|||
155295271|NCT03284957|560511482|FG014|Overall Study|Adverse Event|0|||
155295272|NCT03284957|560511483|FG015|Overall Study|Adverse Event|0|||
155295273|NCT03284957|560511468|FG000|Overall Study|Progressive Disease|3|||
155295274|NCT03284957|560511469|FG001|Overall Study|Progressive Disease|3|||
155295275|NCT03284957|560511470|FG002|Overall Study|Progressive Disease|4|||
155295276|NCT03284957|560511471|FG003|Overall Study|Progressive Disease|3|||
155295277|NCT03284957|560511472|FG004|Overall Study|Progressive Disease|3|||
155295278|NCT03284957|560511473|FG005|Overall Study|Progressive Disease|5|||
155295279|NCT03284957|560511474|FG006|Overall Study|Progressive Disease|45|||
155295280|NCT03284957|560511475|FG007|Overall Study|Progressive Disease|8|||
155295281|NCT03284957|560511476|FG008|Overall Study|Progressive Disease|5|||
155295282|NCT03284957|560511477|FG009|Overall Study|Progressive Disease|18|||
155295283|NCT03284957|560511478|FG010|Overall Study|Progressive Disease|7|||
155295284|NCT03284957|560511479|FG011|Overall Study|Progressive Disease|2|||
155295285|NCT03284957|560511480|FG012|Overall Study|Progressive Disease|3|||
155295286|NCT03284957|560511481|FG013|Overall Study|Progressive Disease|1|||
155295287|NCT03284957|560511482|FG014|Overall Study|Progressive Disease|1|||
155295288|NCT03284957|560511483|FG015|Overall Study|Progressive Disease|2|||
155295289|NCT03284957|560511468|FG000|Overall Study|Withdrawal by Subject|0|||
155295290|NCT03284957|560511469|FG001|Overall Study|Withdrawal by Subject|0|||
155295291|NCT03284957|560511470|FG002|Overall Study|Withdrawal by Subject|0|||
155295292|NCT03284957|560511471|FG003|Overall Study|Withdrawal by Subject|0|||
155295293|NCT03284957|560511472|FG004|Overall Study|Withdrawal by Subject|0|||
155295294|NCT03284957|560511473|FG005|Overall Study|Withdrawal by Subject|0|||
155295295|NCT03284957|560511474|FG006|Overall Study|Withdrawal by Subject|0|||
155295296|NCT03284957|560511475|FG007|Overall Study|Withdrawal by Subject|0|||
155295297|NCT03284957|560511476|FG008|Overall Study|Withdrawal by Subject|0|||
155295298|NCT03284957|560511477|FG009|Overall Study|Withdrawal by Subject|2|||
155295299|NCT03284957|560511478|FG010|Overall Study|Withdrawal by Subject|0|||
155295300|NCT03284957|560511479|FG011|Overall Study|Withdrawal by Subject|0|||
155295301|NCT03284957|560511480|FG012|Overall Study|Withdrawal by Subject|0|||
155295302|NCT03284957|560511481|FG013|Overall Study|Withdrawal by Subject|0|||
155295303|NCT03284957|560511482|FG014|Overall Study|Withdrawal by Subject|0|||
155295304|NCT03284957|560511483|FG015|Overall Study|Withdrawal by Subject|0|||
155295305|NCT03284957|560511468|FG000|Overall Study|Other|0|||
155295306|NCT03284957|560511469|FG001|Overall Study|Other|0|||
155295307|NCT03284957|560511470|FG002|Overall Study|Other|0|||
155295308|NCT03284957|560511471|FG003|Overall Study|Other|0|||
155295309|NCT03284957|560511472|FG004|Overall Study|Other|0|||
155295310|NCT03284957|560511473|FG005|Overall Study|Other|0|||
155295311|NCT03284957|560511474|FG006|Overall Study|Other|3|||
155295312|NCT03284957|560511475|FG007|Overall Study|Other|0|||
155295313|NCT03284957|560511476|FG008|Overall Study|Other|1|||
155295314|NCT03284957|560511477|FG009|Overall Study|Other|6|||
155295315|NCT03284957|560511478|FG010|Overall Study|Other|0|||
155295316|NCT03284957|560511479|FG011|Overall Study|Other|0|||
155295317|NCT03284957|560511480|FG012|Overall Study|Other|0|||
155295318|NCT03284957|560511481|FG013|Overall Study|Other|0|||
155295319|NCT03284957|560511482|FG014|Overall Study|Other|2|||
155295320|NCT03284957|560511483|FG015|Overall Study|Other|0|||
155295321|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Adverse Event|1|||
155295322|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Adverse Event|0|||
155295323|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Adverse Event|0|||
155295324|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
155295325|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
155295326|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
155295327|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
155295328|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
155295329|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
155295330|NCT04517864|560511484|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
155295331|NCT04517864|560511485|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
155295332|NCT04517864|560511486|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
155295333|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Adverse Event|1|||
155295334|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Adverse Event|0|||
155295335|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Adverse Event|0|||
155295336|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
155295337|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
155295338|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
155295339|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
155295340|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
155295341|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
155295342|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Physician Decision|1|||
155295343|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Physician Decision|0|||
155295344|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Physician Decision|0|||
155295345|NCT04517864|560511484|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
155295346|NCT04517864|560511485|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
155295347|NCT04517864|560511486|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
155295348|NCT04517864|560511484|FG000|Extension Phase|Adverse Event|0|||
155295349|NCT04517864|560511485|FG001|Extension Phase|Adverse Event|0|||
155295350|NCT04517864|560511486|FG002|Extension Phase|Adverse Event|1|||
155295351|NCT04517864|560511484|FG000|Extension Phase|Lack of Efficacy|0|||
155295352|NCT04517864|560511485|FG001|Extension Phase|Lack of Efficacy|0|||
155295353|NCT04517864|560511486|FG002|Extension Phase|Lack of Efficacy|2|||
155295354|NCT04517864|560511484|FG000|Extension Phase|Study Terminated By Sponsor|0|||
155295355|NCT04517864|560511485|FG001|Extension Phase|Study Terminated By Sponsor|0|||
155295356|NCT04517864|560511486|FG002|Extension Phase|Study Terminated By Sponsor|32|||
155295357|NCT04517864|560511484|FG000|Extension Phase|Withdrawal by Subject|0|||
155295358|NCT04517864|560511485|FG001|Extension Phase|Withdrawal by Subject|0|||
155295359|NCT04517864|560511486|FG002|Extension Phase|Withdrawal by Subject|3|||
155295360|NCT04517864|560511484|FG000|Extension Phase|Approved Drug Available for Indication|0|||
155295361|NCT04517864|560511485|FG001|Extension Phase|Approved Drug Available for Indication|0|||
155295362|NCT04517864|560511486|FG002|Extension Phase|Approved Drug Available for Indication|7|||
155295363|NCT04722003|560511489|FG000|Overall Study|Lost to Follow-up|2|||
155295364|NCT04722003|560511490|FG001|Overall Study|Lost to Follow-up|0|||
155295365|NCT04722003|560511489|FG000|Overall Study|Physician Decision|1|||
155295366|NCT04722003|560511490|FG001|Overall Study|Physician Decision|0|||
155157738|NCT00129402|560016521|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
155157739|NCT00129402|560016515|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155157740|NCT00129402|560016516|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155157741|NCT00129402|560016517|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
155157742|NCT00129402|560016518|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155295367|NCT04860258|560511491|FG000|Overall Study|Withdrawal by Subject|0|||
155295368|NCT04860258|560511492|FG001|Overall Study|Withdrawal by Subject|0|||
155295369|NCT04860258|560511493|FG002|Overall Study|Withdrawal by Subject|4|||
155295370|NCT04860258|560511494|FG003|Overall Study|Withdrawal by Subject|1|||
155295371|NCT04860258|560511495|FG004|Overall Study|Withdrawal by Subject|4|||
155295372|NCT04860258|560511496|FG005|Overall Study|Withdrawal by Subject|1|||
155295373|NCT04860258|560511497|FG006|Overall Study|Withdrawal by Subject|0|||
155295374|NCT00028769|560511500|FG000|Overall Study|Adverse Event|2|||
155295375|NCT00028769|560511500|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
155295376|NCT00028769|560511500|FG000|Overall Study|Progression or Death|31|||
155295377|NCT00028769|560511500|FG000|Overall Study|Other - Not Protocol Specified|1|||
155295378|NCT00028769|560511500|FG000|Overall Study|Ineligible|5|||
155295379|NCT00028769|560511500|FG000|Overall Study|Not Analyzable|1|||
155295380|NCT02496702|560511503|FG000|Overall Study|Lost to Follow-up|8|||
155295381|NCT02496702|560511504|FG001|Overall Study|Lost to Follow-up|6|||
155295382|NCT02496702|560511503|FG000|Overall Study|Only partially tested|0|||
155295383|NCT02496702|560511504|FG001|Overall Study|Only partially tested|2|||
155295384|NCT01499134|560511507|FG000|Overall Study|Withdrawal by Subject|0|||
155295385|NCT01499134|560511508|FG001|Overall Study|Withdrawal by Subject|1|||
155295386|NCT00708032|560511509|FG000|Overall Study|Adverse Event|0|||
155295387|NCT00708032|560511510|FG001|Overall Study|Adverse Event|2|||
155295388|NCT00708032|560511509|FG000|Overall Study|Lost to Follow-up|1|||
155295389|NCT00708032|560511510|FG001|Overall Study|Lost to Follow-up|2|||
155295390|NCT00708032|560511509|FG000|Overall Study|Pregnancy|0|||
155295391|NCT00708032|560511510|FG001|Overall Study|Pregnancy|1|||
155295392|NCT00708032|560511509|FG000|Overall Study|Poor vision|0|||
155295393|NCT00708032|560511510|FG001|Overall Study|Poor vision|6|||
155295394|NCT00708032|560511509|FG000|Overall Study|Visit out of range at month 12|4|||
155295395|NCT00708032|560511510|FG001|Overall Study|Visit out of range at month 12|1|||
155295396|NCT00708032|560511509|FG000|Overall Study|Did not meet protocol criteria|1|||
155295397|NCT00708032|560511510|FG001|Overall Study|Did not meet protocol criteria|2|||
155295398|NCT00708032|560511509|FG000|Overall Study|Protocol Violation|4|||
155295399|NCT00708032|560511510|FG001|Overall Study|Protocol Violation|1|||
155295400|NCT00708032|560511509|FG000|Overall Study|Withdrawal by Subject|0|||
155295401|NCT00708032|560511510|FG001|Overall Study|Withdrawal by Subject|1|||
155295402|NCT00446550|560511515|FG000|Overall Study|Adverse Event|1|||
155295403|NCT00446550|560511516|FG001|Overall Study|Adverse Event|0|||
155295404|NCT01759264|560511517|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
155295405|NCT01759264|560511517|FG000|Overall Study|Adverse Event|1|||
155295406|NCT01759264|560511517|FG000|Overall Study|Other|2|||
155295407|NCT01759264|560511517|FG000|Overall Study|Lost to Follow-up|2|||
155295408|NCT01759264|560511517|FG000|Overall Study|Withdrawal by Subject|3|||
155295409|NCT01759264|560511517|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
155295410|NCT03557008|560511518|FG000|Overall Study|Withdrawal by Subject|2|||
155295411|NCT03557008|560511519|FG001|Overall Study|Withdrawal by Subject|2|||
155295412|NCT03557008|560511518|FG000|Overall Study|Early termination from study|3|||
155295413|NCT03557008|560511519|FG001|Overall Study|Early termination from study|1|||
155295414|NCT03020745|560511522|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295415|NCT03020745|560511523|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295416|NCT03020745|560511524|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295417|NCT03020745|560511525|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295418|NCT03020745|560511526|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295419|NCT03020745|560511527|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295420|NCT03020745|560511528|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295421|NCT03020745|560511529|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295422|NCT03020745|560511530|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
155295423|NCT03020745|560511531|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
155295424|NCT03020745|560511522|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295425|NCT03020745|560511523|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295426|NCT03020745|560511524|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295427|NCT03020745|560511525|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295428|NCT03020745|560511526|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295429|NCT03020745|560511527|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295430|NCT03020745|560511528|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295431|NCT03020745|560511529|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
155295432|NCT03020745|560511530|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295433|NCT03020745|560511531|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
155295434|NCT03020745|560511522|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295435|NCT03020745|560511523|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295436|NCT03020745|560511524|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295437|NCT03020745|560511525|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295438|NCT03020745|560511526|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295439|NCT03020745|560511527|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
155295440|NCT03020745|560511528|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295441|NCT03020745|560511529|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295442|NCT03020745|560511530|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
155295443|NCT03020745|560511531|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
155295444|NCT03020745|560511522|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295445|NCT03020745|560511523|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295446|NCT03020745|560511524|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295447|NCT03020745|560511525|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295448|NCT03020745|560511526|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295449|NCT03020745|560511527|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295450|NCT03020745|560511528|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295451|NCT03020745|560511529|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295452|NCT03020745|560511530|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
155295453|NCT03020745|560511531|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
155295454|NCT00743444|560511532|FG000|First Intervention|Catheter placement problems|0|||
155295455|NCT00743444|560511533|FG001|First Intervention|Catheter placement problems|1|||
155295456|NCT00743444|560511532|FG000|Washout Period|Adverse Event|0|||
155295457|NCT00743444|560511533|FG001|Washout Period|Adverse Event|1|||
155295458|NCT00186186|560511534|FG000|Overall Study|Lack of Efficacy|3|||
155295459|NCT00186186|560511534|FG000|Overall Study|Withdrawal by Subject|3|||
155295460|NCT00186186|560511534|FG000|Overall Study|Not reported as to reason|2|||
155295461|NCT00807144|560511535|FG000|Overall Study|Lost to Follow-up|0|||
155295462|NCT00807144|560511536|FG001|Overall Study|Lost to Follow-up|1|||
155295463|NCT00813904|560511543|FG000|Overall Study|Death|1|||
155295464|NCT01405924|560511544|FG000|Overall Study|Protocol Violation|8|||
155295465|NCT01405924|560511544|FG000|Overall Study|Missing/Incomplete Data|2|||
155295466|NCT02393716|560511545|FG000|Overall Study|Death|29|||
155295467|NCT02393716|560511545|FG000|Overall Study|Withdrawal by Subject|8|||
155295468|NCT02393716|560511545|FG000|Overall Study|Device Explanted|8|||
155295469|NCT02393716|560511545|FG000|Overall Study|Missed visit|16|||
155295470|NCT01924767|560511546|FG000|Overall Study|Adverse Event|1|||
155295471|NCT01924767|560511547|FG001|Overall Study|Adverse Event|0|||
155295472|NCT01924767|560511548|FG002|Overall Study|Adverse Event|1|||
155295473|NCT01924767|560511549|FG003|Overall Study|Adverse Event|0|||
155295474|NCT01924767|560511550|FG004|Overall Study|Adverse Event|0|||
155295475|NCT01648140|560511551|FG000|Overall Study|Physician Decision|1|||
155295476|NCT01648140|560511552|FG001|Overall Study|Physician Decision|0|||
155295477|NCT01648140|560511553|FG002|Overall Study|Physician Decision|0|||
155295478|NCT01648140|560511554|FG003|Overall Study|Physician Decision|0|||
155295479|NCT01648140|560511551|FG000|Overall Study|Lack of Efficacy|4|||
155295480|NCT01648140|560511552|FG001|Overall Study|Lack of Efficacy|7|||
155295481|NCT01648140|560511553|FG002|Overall Study|Lack of Efficacy|1|||
155295482|NCT01648140|560511554|FG003|Overall Study|Lack of Efficacy|0|||
155295483|NCT01648140|560511551|FG000|Overall Study|Adverse Event|3|||
155295484|NCT01648140|560511552|FG001|Overall Study|Adverse Event|1|||
155295485|NCT01648140|560511553|FG002|Overall Study|Adverse Event|2|||
155295486|NCT01648140|560511554|FG003|Overall Study|Adverse Event|0|||
155295487|NCT01648140|560511551|FG000|Overall Study|Withdrawal by Subject|2|||
155295488|NCT01648140|560511552|FG001|Overall Study|Withdrawal by Subject|3|||
155295489|NCT01648140|560511553|FG002|Overall Study|Withdrawal by Subject|3|||
155295490|NCT01648140|560511554|FG003|Overall Study|Withdrawal by Subject|2|||
155295491|NCT01648140|560511551|FG000|Overall Study|Lost to Follow-up|2|||
155295492|NCT01648140|560511552|FG001|Overall Study|Lost to Follow-up|1|||
155295493|NCT01648140|560511553|FG002|Overall Study|Lost to Follow-up|2|||
155295494|NCT01648140|560511554|FG003|Overall Study|Lost to Follow-up|0|||
155295495|NCT03987451|560511555|FG000|Overall Study|Lost to Follow-up|1|||
155295496|NCT03987451|560511556|FG001|Overall Study|Lost to Follow-up|0|||
155295497|NCT03987451|560511555|FG000|Overall Study|Withdrawal by Subject|1|||
155295498|NCT03987451|560511556|FG001|Overall Study|Withdrawal by Subject|1|||
155295499|NCT03192046|560511557|FG000|Overall Study|Withdrawal by Subject|1|||
155295500|NCT03192046|560511558|FG001|Overall Study|Withdrawal by Subject|1|||
155295501|NCT01194154|560511559|FG000|Overall Study|Adverse Event|12|||
155295502|NCT01194154|560511560|FG001|Overall Study|Adverse Event|7|||
155295503|NCT01194154|560511559|FG000|Overall Study|Lost to Follow-up|2|||
155295504|NCT01194154|560511560|FG001|Overall Study|Lost to Follow-up|3|||
155157743|NCT00129402|560016519|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155157744|NCT00129402|560016520|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
155157745|NCT00129402|560016521|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
155295505|NCT01194154|560511559|FG000|Overall Study|Protocol Violation|0|||
155295506|NCT01194154|560511560|FG001|Overall Study|Protocol Violation|1|||
155295507|NCT01194154|560511559|FG000|Overall Study|Withdrawal by Subject|5|||
155295508|NCT01194154|560511560|FG001|Overall Study|Withdrawal by Subject|6|||
155295509|NCT01194154|560511559|FG000|Overall Study|Blood pressure increase|5|||
155295510|NCT01194154|560511560|FG001|Overall Study|Blood pressure increase|3|||
155295511|NCT01194154|560511559|FG000|Overall Study|Hemoglobin decrease|0|||
155295512|NCT01194154|560511560|FG001|Overall Study|Hemoglobin decrease|1|||
155295513|NCT01194154|560511559|FG000|Overall Study|Hemoglobin increase|12|||
155295514|NCT01194154|560511560|FG001|Overall Study|Hemoglobin increase|3|||
155295515|NCT01194154|560511559|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
155295516|NCT01194154|560511560|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
155295517|NCT01194154|560511559|FG000|Overall Study|Treatment with prohibited medication|4|||
155295518|NCT01194154|560511560|FG001|Overall Study|Treatment with prohibited medication|5|||
155295519|NCT01194154|560511559|FG000|Overall Study|Other|4|||
155295520|NCT01194154|560511560|FG001|Overall Study|Other|0|||
155295521|NCT01194154|560511559|FG000|Overall Study|Did not receive study medication|2|||
155295522|NCT01194154|560511560|FG001|Overall Study|Did not receive study medication|4|||
155295523|NCT01505881|560511561|FG000|Overall Study|Adverse Event|0|||
155295524|NCT01505881|560511562|FG001|Overall Study|Adverse Event|1|||
155295525|NCT01505881|560511561|FG000|Overall Study|Lost to Follow-up|2|||
155295526|NCT01505881|560511562|FG001|Overall Study|Lost to Follow-up|0|||
155295527|NCT01505881|560511561|FG000|Overall Study|Withdrawal by Subject|2|||
155295528|NCT01505881|560511562|FG001|Overall Study|Withdrawal by Subject|0|||
155295529|NCT01147341|560511563|FG000|Double Blind Period|Lack of Efficacy|1|||
155295530|NCT01147341|560511564|FG001|Double Blind Period|Lack of Efficacy|1|||
155295531|NCT01147341|560511563|FG000|Double Blind Period|Withdrawal by Subject|0|||
155295532|NCT01147341|560511564|FG001|Double Blind Period|Withdrawal by Subject|1|||
155295533|NCT01147341|560511563|FG000|Open Label Period|Lack of Efficacy|3|||
155295534|NCT01147341|560511564|FG001|Open Label Period|Lack of Efficacy|0|||
155295535|NCT01147341|560511563|FG000|Open Label Period|Subject moved|1|||
155295536|NCT01147341|560511564|FG001|Open Label Period|Subject moved|0|||
155295537|NCT01901276|560511565|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
155295538|NCT01901276|560511566|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
155295539|NCT02314117|560511567|FG000|Overall Study|Lost to Follow-up|9|||
155295540|NCT02314117|560511568|FG001|Overall Study|Lost to Follow-up|14|||
155295541|NCT02314117|560511567|FG000|Overall Study|Withdrawal by Subject|3|||
155295542|NCT02314117|560511568|FG001|Overall Study|Withdrawal by Subject|2|||
155295543|NCT02950558|560511572|FG000|Overall Study|Lost to Follow-up|2|||
155295544|NCT02950558|560511573|FG001|Overall Study|Lost to Follow-up|0|||
155295545|NCT03383146|560511574|FG000|Overall Study|Screen Failure|1|||
155295546|NCT03383146|560511575|FG001|Overall Study|Screen Failure|0|||
155295547|NCT03383146|560511574|FG000|Overall Study|Adverse Event|6|||
155295548|NCT03383146|560511575|FG001|Overall Study|Adverse Event|18|||
155295549|NCT03383146|560511574|FG000|Overall Study|Lack of Efficacy|0|||
155295550|NCT03383146|560511575|FG001|Overall Study|Lack of Efficacy|3|||
155295551|NCT03383146|560511574|FG000|Overall Study|Withdrawal by Subject|20|||
155295552|NCT03383146|560511575|FG001|Overall Study|Withdrawal by Subject|36|||
155295553|NCT03383146|560511574|FG000|Overall Study|Lost to Follow-up|5|||
155295554|NCT03383146|560511575|FG001|Overall Study|Lost to Follow-up|15|||
155295555|NCT03383146|560511574|FG000|Overall Study|Death|0|||
155295556|NCT03383146|560511575|FG001|Overall Study|Death|2|||
155295557|NCT03383146|560511574|FG000|Overall Study|Physician Decision|0|||
155295558|NCT03383146|560511575|FG001|Overall Study|Physician Decision|1|||
155295559|NCT03383146|560511574|FG000|Overall Study|Protocol Deviation|1|||
155295560|NCT03383146|560511575|FG001|Overall Study|Protocol Deviation|8|||
155295561|NCT03383146|560511574|FG000|Overall Study|Study Terminated by the Sponsor|48|||
154956629|NCT02883452|559268779|FG004|Overall Study|Withdrawal by Subject|2|||
154956630|NCT02883452|559268780|FG005|Overall Study|Withdrawal by Subject|5|||
154956631|NCT02883452|559268775|FG000|Overall Study|Disease progression|1|||
154956632|NCT02883452|559268776|FG001|Overall Study|Disease progression|0|||
154956633|NCT02883452|559268777|FG002|Overall Study|Disease progression|0|||
154956634|NCT02883452|559268778|FG003|Overall Study|Disease progression|1|||
154956635|NCT02883452|559268779|FG004|Overall Study|Disease progression|4|||
154956636|NCT02883452|559268780|FG005|Overall Study|Disease progression|5|||
154956637|NCT02883452|559268775|FG000|Overall Study|Adverse Event|2|||
154956638|NCT02883452|559268776|FG001|Overall Study|Adverse Event|1|||
154956639|NCT02883452|559268777|FG002|Overall Study|Adverse Event|1|||
154956640|NCT02883452|559268778|FG003|Overall Study|Adverse Event|1|||
154956641|NCT02883452|559268779|FG004|Overall Study|Adverse Event|1|||
154956642|NCT02883452|559268780|FG005|Overall Study|Adverse Event|3|||
154956643|NCT02883452|559268775|FG000|Overall Study|Physician Decision|0|||
154956644|NCT02883452|559268776|FG001|Overall Study|Physician Decision|0|||
154956645|NCT02883452|559268777|FG002|Overall Study|Physician Decision|0|||
154956646|NCT02883452|559268778|FG003|Overall Study|Physician Decision|0|||
154956647|NCT02883452|559268779|FG004|Overall Study|Physician Decision|4|||
154956648|NCT02883452|559268780|FG005|Overall Study|Physician Decision|1|||
154956649|NCT02883452|559268775|FG000|Overall Study|Death|1|||
155295562|NCT03383146|560511575|FG001|Overall Study|Study Terminated by the Sponsor|95|||
155295563|NCT03383146|560511574|FG000|Overall Study|Reason not Specified|4|||
155295564|NCT03383146|560511575|FG001|Overall Study|Reason not Specified|6|||
155295565|NCT01317420|560511576|FG000|Overall Study|Progressive disease according to RECIST|2|||
155295566|NCT01317420|560511577|FG001|Overall Study|Progressive disease according to RECIST|3|||
155295567|NCT01317420|560511578|FG002|Overall Study|Progressive disease according to RECIST|3|||
155295568|NCT01317420|560511579|FG003|Overall Study|Progressive disease according to RECIST|3|||
155295569|NCT01317420|560511580|FG004|Overall Study|Progressive disease according to RECIST|3|||
155295570|NCT01317420|560511581|FG005|Overall Study|Progressive disease according to RECIST|3|||
154956650|NCT02883452|559268776|FG001|Overall Study|Death|0|||
154956651|NCT02883452|559268777|FG002|Overall Study|Death|1|||
154956652|NCT02883452|559268778|FG003|Overall Study|Death|0|||
155295571|NCT01317420|560511582|FG006|Overall Study|Progressive disease according to RECIST|3|||
155295572|NCT01317420|560511583|FG007|Overall Study|Progressive disease according to RECIST|3|||
155295573|NCT01317420|560511584|FG008|Overall Study|Progressive disease according to RECIST|3|||
155295574|NCT01317420|560511585|FG009|Overall Study|Progressive disease according to RECIST|2|||
155295575|NCT01317420|560511586|FG010|Overall Study|Progressive disease according to RECIST|3|||
155295576|NCT01317420|560511587|FG011|Overall Study|Progressive disease according to RECIST|11|||
155295577|NCT01317420|560511588|FG012|Overall Study|Progressive disease according to RECIST|16|||
155295578|NCT01317420|560511576|FG000|Overall Study|Other adverse event|1|||
155295579|NCT01317420|560511577|FG001|Overall Study|Other adverse event|0|||
155295580|NCT01317420|560511578|FG002|Overall Study|Other adverse event|0|||
155295581|NCT01317420|560511579|FG003|Overall Study|Other adverse event|0|||
155295582|NCT01317420|560511580|FG004|Overall Study|Other adverse event|0|||
155295583|NCT01317420|560511581|FG005|Overall Study|Other adverse event|0|||
155295584|NCT01317420|560511582|FG006|Overall Study|Other adverse event|0|||
155295585|NCT01317420|560511583|FG007|Overall Study|Other adverse event|0|||
155295586|NCT01317420|560511584|FG008|Overall Study|Other adverse event|0|||
155295587|NCT01317420|560511585|FG009|Overall Study|Other adverse event|0|||
155295588|NCT01317420|560511586|FG010|Overall Study|Other adverse event|0|||
155295589|NCT01317420|560511587|FG011|Overall Study|Other adverse event|0|||
155295590|NCT01317420|560511588|FG012|Overall Study|Other adverse event|2|||
155295591|NCT01317420|560511576|FG000|Overall Study|Non-compliant with protocol|0|||
155295592|NCT01317420|560511577|FG001|Overall Study|Non-compliant with protocol|0|||
155295593|NCT01317420|560511578|FG002|Overall Study|Non-compliant with protocol|0|||
155295594|NCT01317420|560511579|FG003|Overall Study|Non-compliant with protocol|0|||
155295595|NCT01317420|560511580|FG004|Overall Study|Non-compliant with protocol|0|||
155295596|NCT01317420|560511581|FG005|Overall Study|Non-compliant with protocol|0|||
155295597|NCT01317420|560511582|FG006|Overall Study|Non-compliant with protocol|0|||
155157746|NCT00129402|560016515|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155157747|NCT00129402|560016516|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155157748|NCT00129402|560016517|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
155157749|NCT00129402|560016518|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155157750|NCT00129402|560016519|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155157751|NCT00129402|560016520|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
155157752|NCT00129402|560016521|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
155157753|NCT00129402|560016515|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155157754|NCT00129402|560016516|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155157755|NCT00129402|560016517|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155157756|NCT00129402|560016518|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155157757|NCT00129402|560016519|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155157758|NCT00129402|560016520|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
155295598|NCT01317420|560511583|FG007|Overall Study|Non-compliant with protocol|0|||
155295599|NCT01317420|560511584|FG008|Overall Study|Non-compliant with protocol|0|||
155295600|NCT01317420|560511585|FG009|Overall Study|Non-compliant with protocol|0|||
155295601|NCT01317420|560511586|FG010|Overall Study|Non-compliant with protocol|0|||
155295602|NCT01317420|560511587|FG011|Overall Study|Non-compliant with protocol|0|||
155295603|NCT01317420|560511588|FG012|Overall Study|Non-compliant with protocol|1|||
155295604|NCT01317420|560511576|FG000|Overall Study|Refused to cont. taking trial medication|0|||
155295605|NCT01317420|560511577|FG001|Overall Study|Refused to cont. taking trial medication|0|||
155295606|NCT01317420|560511578|FG002|Overall Study|Refused to cont. taking trial medication|0|||
155295607|NCT01317420|560511579|FG003|Overall Study|Refused to cont. taking trial medication|0|||
155295608|NCT01317420|560511580|FG004|Overall Study|Refused to cont. taking trial medication|0|||
155295609|NCT01317420|560511581|FG005|Overall Study|Refused to cont. taking trial medication|0|||
155295610|NCT01317420|560511582|FG006|Overall Study|Refused to cont. taking trial medication|0|||
155295611|NCT01317420|560511583|FG007|Overall Study|Refused to cont. taking trial medication|0|||
155295612|NCT01317420|560511584|FG008|Overall Study|Refused to cont. taking trial medication|0|||
155295613|NCT01317420|560511585|FG009|Overall Study|Refused to cont. taking trial medication|0|||
155295614|NCT01317420|560511586|FG010|Overall Study|Refused to cont. taking trial medication|0|||
155295615|NCT01317420|560511587|FG011|Overall Study|Refused to cont. taking trial medication|0|||
155295616|NCT01317420|560511588|FG012|Overall Study|Refused to cont. taking trial medication|1|||
155295617|NCT01317420|560511576|FG000|Overall Study|Reason other than those specified|0|||
155295618|NCT01317420|560511577|FG001|Overall Study|Reason other than those specified|0|||
155295619|NCT01317420|560511578|FG002|Overall Study|Reason other than those specified|0|||
155295620|NCT01317420|560511579|FG003|Overall Study|Reason other than those specified|0|||
155295621|NCT01317420|560511580|FG004|Overall Study|Reason other than those specified|0|||
155295622|NCT01317420|560511581|FG005|Overall Study|Reason other than those specified|0|||
155295623|NCT01317420|560511582|FG006|Overall Study|Reason other than those specified|0|||
155295624|NCT01317420|560511583|FG007|Overall Study|Reason other than those specified|0|||
155295625|NCT01317420|560511584|FG008|Overall Study|Reason other than those specified|0|||
155295626|NCT01317420|560511585|FG009|Overall Study|Reason other than those specified|1|||
155295627|NCT01317420|560511586|FG010|Overall Study|Reason other than those specified|0|||
155295628|NCT01317420|560511587|FG011|Overall Study|Reason other than those specified|0|||
155295629|NCT01317420|560511588|FG012|Overall Study|Reason other than those specified|0|||
155295630|NCT03586544|560511590|FG000|First Intervention|Adverse Event|0|||
155295631|NCT03586544|560511591|FG001|First Intervention|Adverse Event|1|||
155295632|NCT03586544|560511590|FG000|Second Intervention|Withdrawal by Subject|0|||
155295633|NCT03586544|560511591|FG001|Second Intervention|Withdrawal by Subject|1|||
155295634|NCT02020616|560511595|FG000|Overall Study|Adverse Event|0|||
155295635|NCT02020616|560511596|FG001|Overall Study|Adverse Event|0|||
155295636|NCT02020616|560511597|FG002|Overall Study|Adverse Event|0|||
155295637|NCT02020616|560511598|FG003|Overall Study|Adverse Event|0|||
155295638|NCT02020616|560511599|FG004|Overall Study|Adverse Event|0|||
155295639|NCT02020616|560511600|FG005|Overall Study|Adverse Event|1|||
155295640|NCT02020616|560511601|FG006|Overall Study|Adverse Event|1|||
155295641|NCT02020616|560511595|FG000|Overall Study|Physician Decision|0|||
155295642|NCT02020616|560511596|FG001|Overall Study|Physician Decision|0|||
155295643|NCT02020616|560511597|FG002|Overall Study|Physician Decision|0|||
155295644|NCT02020616|560511598|FG003|Overall Study|Physician Decision|0|||
155295645|NCT02020616|560511599|FG004|Overall Study|Physician Decision|0|||
155295646|NCT02020616|560511600|FG005|Overall Study|Physician Decision|1|||
155295647|NCT02020616|560511601|FG006|Overall Study|Physician Decision|2|||
155295648|NCT02020616|560511595|FG000|Overall Study|Withdrawal by Subject|0|||
155295649|NCT02020616|560511596|FG001|Overall Study|Withdrawal by Subject|0|||
155295650|NCT02020616|560511597|FG002|Overall Study|Withdrawal by Subject|1|||
155295651|NCT02020616|560511598|FG003|Overall Study|Withdrawal by Subject|0|||
155295652|NCT02020616|560511599|FG004|Overall Study|Withdrawal by Subject|0|||
155295653|NCT02020616|560511600|FG005|Overall Study|Withdrawal by Subject|1|||
155295654|NCT02020616|560511601|FG006|Overall Study|Withdrawal by Subject|1|||
155295655|NCT02020616|560511595|FG000|Overall Study|Lost to Follow-up|0|||
155061176|NCT03055013|559659259|FG001|Overall Study|Benign mass/non-RCC|0|||
155061177|NCT03055013|559659258|FG000|Overall Study|Enrolled in another trial|1|||
155061178|NCT03055013|559659259|FG001|Overall Study|Enrolled in another trial|0|||
155061179|NCT03055013|559659258|FG000|Overall Study|Non-protocol therapy|1|||
155061180|NCT03055013|559659259|FG001|Overall Study|Non-protocol therapy|0|||
155061181|NCT03055013|559659258|FG000|Overall Study|Incompliance|1|||
155061182|NCT03055013|559659259|FG001|Overall Study|Incompliance|0|||
155061183|NCT03055013|559659258|FG000|Overall Study|Insurance issues|1|||
155061184|NCT03055013|559659259|FG001|Overall Study|Insurance issues|0|||
155061185|NCT03055013|559659258|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
155061186|NCT03055013|559659259|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
155061187|NCT03055013|559659258|FG000|Overall Study|Did not receive nivolumab|10|||
154956653|NCT02883452|559268779|FG004|Overall Study|Death|0|||
154956654|NCT02883452|559268780|FG005|Overall Study|Death|0|||
154956655|NCT02883452|559268775|FG000|Overall Study|Other|0|||
154956656|NCT02883452|559268776|FG001|Overall Study|Other|0|||
154956657|NCT02883452|559268777|FG002|Overall Study|Other|0|||
154956658|NCT02883452|559268778|FG003|Overall Study|Other|0|||
154956659|NCT02883452|559268779|FG004|Overall Study|Other|0|||
154956660|NCT02883452|559268780|FG005|Overall Study|Other|1|||
154956661|NCT00905346|559268783|FG000|Period 1|Withdrawal by Subject|1|||
154956662|NCT00905346|559268784|FG001|Period 1|Withdrawal by Subject|0|||
154956663|NCT00909610|559268785|FG000|Period: First Intervention|Adverse Event|0|||
154956664|NCT00909610|559268786|FG001|Period: First Intervention|Adverse Event|1|||
154956665|NCT00909610|559268785|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
154956666|NCT00909610|559268786|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
154956667|NCT00909610|559268785|FG000|Period: Second Intervention|Adverse Event|1|||
154956668|NCT00909610|559268786|FG001|Period: Second Intervention|Adverse Event|0|||
154956669|NCT02736721|559268794|FG000|Overall Study|Adverse Event|8|||
154956670|NCT02736721|559268794|FG000|Overall Study|Lost to Follow-up|3|||
154956671|NCT02736721|559268794|FG000|Overall Study|Other|5|||
154956672|NCT00418184|559268799|FG000|Double-blind Phase|Withdrawal by Subject|22|||
154956673|NCT00418184|559268800|FG001|Double-blind Phase|Withdrawal by Subject|9|||
154956674|NCT00418184|559268799|FG000|Double-blind Phase|Adverse Event|2|||
154956675|NCT00418184|559268800|FG001|Double-blind Phase|Adverse Event|1|||
154956676|NCT00418184|559268799|FG000|Double-blind Phase|Poor compliance|3|||
154956677|NCT00418184|559268800|FG001|Double-blind Phase|Poor compliance|1|||
154956678|NCT00834249|559268801|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
154956679|NCT00834249|559268802|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
154956680|NCT00834249|559268801|FG000|Second Intervention|Adverse Event|1|||
154956681|NCT00834249|559268802|FG001|Second Intervention|Adverse Event|0|||
154956682|NCT00851877|559268803|FG000|Phase I-1|Death|1|||
154956683|NCT00851877|559268804|FG001|Phase I-1|Death|0|||
154956684|NCT00851877|559268805|FG002|Phase I-1|Death|0|||
154956685|NCT00851877|559268803|FG000|Phase II|Withdrawal by Subject|0|||
154956686|NCT00851877|559268804|FG001|Phase II|Withdrawal by Subject|0|||
154956687|NCT00851877|559268805|FG002|Phase II|Withdrawal by Subject|3|||
154956688|NCT00620074|559268806|FG000|Overall Study|Adverse Event|1|||
154956689|NCT00096447|559268807|FG000|Overall Study|Never treated|1|||
154956690|NCT01534663|559268808|FG000|Overall Study|Lost to Follow-up|0|||
154956691|NCT01534663|559268809|FG001|Overall Study|Lost to Follow-up|2|||
154956692|NCT01534663|559268808|FG000|Overall Study|Adverse Event|2|||
154956693|NCT01534663|559268809|FG001|Overall Study|Adverse Event|1|||
154956694|NCT00627016|559268810|FG000|Overall Study|Adverse Event|1|||
154956695|NCT00627016|559268811|FG001|Overall Study|Adverse Event|1|||
154956696|NCT00627016|559268810|FG000|Overall Study|Protocol Violation|0|||
154956697|NCT00627016|559268811|FG001|Overall Study|Protocol Violation|2|||
154956698|NCT00627016|559268810|FG000|Overall Study|Lost to Follow-up|0|||
154956699|NCT00627016|559268811|FG001|Overall Study|Lost to Follow-up|1|||
154956700|NCT00627016|559268810|FG000|Overall Study|Withdrawal by Subject|2|||
154956701|NCT00627016|559268811|FG001|Overall Study|Withdrawal by Subject|1|||
154956702|NCT00627016|559268810|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
154956703|NCT00627016|559268811|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
154956704|NCT00627016|559268810|FG000|Overall Study|Lack of Efficacy|1|||
154956705|NCT00627016|559268811|FG001|Overall Study|Lack of Efficacy|0|||
154956706|NCT00627016|559268810|FG000|Overall Study|Placed on Excluded Drugs|1|||
154956707|NCT00627016|559268811|FG001|Overall Study|Placed on Excluded Drugs|0|||
154956708|NCT00627016|559268810|FG000|Overall Study|Pregnancy|1|||
154956709|NCT00627016|559268811|FG001|Overall Study|Pregnancy|0|||
154956710|NCT04112823|559268816|FG000|Overall Study|Lost to Follow-up|2|||
154956711|NCT04112823|559268817|FG001|Overall Study|Lost to Follow-up|3|||
154956712|NCT03107091|559268818|FG000|Overall Study|Physician Decision|1|||
154956713|NCT03025880|559268823|FG000|Overall Study|Adverse Event|1|||
154956714|NCT03025880|559268824|FG001|Overall Study|Adverse Event|0|||
154956715|NCT03025880|559268823|FG000|Overall Study|Death|1|||
154956716|NCT03025880|559268824|FG001|Overall Study|Death|1|||
154956717|NCT03025880|559268823|FG000|Overall Study|Withdrawal by Subject|0|||
154956718|NCT03025880|559268824|FG001|Overall Study|Withdrawal by Subject|1|||
154956719|NCT03025880|559268823|FG000|Overall Study|Physician Decision|0|||
154956720|NCT03025880|559268824|FG001|Overall Study|Physician Decision|1|||
154956721|NCT03025880|559268823|FG000|Overall Study|Progressive Disease|12|||
154956722|NCT03025880|559268824|FG001|Overall Study|Progressive Disease|19|||
154956723|NCT02587962|559268825|FG000|Overall Study|Adverse Event|0|||
154956724|NCT02587962|559268826|FG001|Overall Study|Adverse Event|0|||
154956725|NCT02587962|559268827|FG002|Overall Study|Adverse Event|1|||
154956726|NCT02587962|559268828|FG003|Overall Study|Adverse Event|0|||
154956727|NCT02587962|559268829|FG004|Overall Study|Adverse Event|0|||
154956728|NCT02587962|559268825|FG000|Overall Study|Withdrawal by Subject|0|||
154956729|NCT02587962|559268826|FG001|Overall Study|Withdrawal by Subject|0|||
154956730|NCT02587962|559268827|FG002|Overall Study|Withdrawal by Subject|1|||
155061188|NCT03055013|559659259|FG001|Overall Study|Did not receive nivolumab|0|||
155061189|NCT03055013|559659258|FG000|Overall Study|Did not receive surgery|0|||
155061190|NCT03055013|559659259|FG001|Overall Study|Did not receive surgery|28|||
155295656|NCT02020616|560511596|FG001|Overall Study|Lost to Follow-up|1|||
155295657|NCT02020616|560511597|FG002|Overall Study|Lost to Follow-up|0|||
155295658|NCT02020616|560511598|FG003|Overall Study|Lost to Follow-up|1|||
155295659|NCT02020616|560511599|FG004|Overall Study|Lost to Follow-up|1|||
155295660|NCT02020616|560511600|FG005|Overall Study|Lost to Follow-up|1|||
155295661|NCT02020616|560511601|FG006|Overall Study|Lost to Follow-up|0|||
155295662|NCT02020616|560511595|FG000|Overall Study|Early Termination Criteria Met|0|||
155295663|NCT02020616|560511596|FG001|Overall Study|Early Termination Criteria Met|0|||
155295664|NCT02020616|560511597|FG002|Overall Study|Early Termination Criteria Met|1|||
155295665|NCT02020616|560511598|FG003|Overall Study|Early Termination Criteria Met|0|||
155295666|NCT02020616|560511599|FG004|Overall Study|Early Termination Criteria Met|0|||
155295667|NCT02020616|560511600|FG005|Overall Study|Early Termination Criteria Met|1|||
155295668|NCT02020616|560511601|FG006|Overall Study|Early Termination Criteria Met|0|||
155295669|NCT02020616|560511595|FG000|Overall Study|Randomized in Error|0|||
155295670|NCT02020616|560511596|FG001|Overall Study|Randomized in Error|0|||
155295671|NCT02020616|560511597|FG002|Overall Study|Randomized in Error|0|||
155295672|NCT02020616|560511598|FG003|Overall Study|Randomized in Error|1|||
155295673|NCT02020616|560511599|FG004|Overall Study|Randomized in Error|0|||
155295674|NCT02020616|560511600|FG005|Overall Study|Randomized in Error|0|||
155295675|NCT02020616|560511601|FG006|Overall Study|Randomized in Error|0|||
155295676|NCT02020616|560511595|FG000|Overall Study|Lack of Efficacy|0|||
155295677|NCT02020616|560511596|FG001|Overall Study|Lack of Efficacy|0|||
155295678|NCT02020616|560511597|FG002|Overall Study|Lack of Efficacy|0|||
155295679|NCT02020616|560511598|FG003|Overall Study|Lack of Efficacy|0|||
155295680|NCT02020616|560511599|FG004|Overall Study|Lack of Efficacy|1|||
155295681|NCT02020616|560511600|FG005|Overall Study|Lack of Efficacy|0|||
155295682|NCT02020616|560511601|FG006|Overall Study|Lack of Efficacy|0|||
155295683|NCT05019729|560511602|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295684|NCT05019729|560511603|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295685|NCT05019729|560511604|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295686|NCT05019729|560511605|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155295687|NCT05019729|560511606|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
155295688|NCT05019729|560511607|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
155061191|NCT00827567|559659267|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
155061192|NCT01259245|559659268|FG000|Overall Study|Withdrawal by Subject|27|||
155061193|NCT01259245|559659269|FG001|Overall Study|Withdrawal by Subject|24|||
155295689|NCT02770248|560511609|FG000|Overall Study|Adverse Event|0|||
155295690|NCT02770248|560511610|FG001|Overall Study|Adverse Event|1|||
155061194|NCT01259245|559659268|FG000|Overall Study|Death|1|||
155295691|NCT02770248|560511609|FG000|Overall Study|Randomized in error, prior to treatment|0|||
155295692|NCT02770248|560511610|FG001|Overall Study|Randomized in error, prior to treatment|1|||
155295693|NCT01579916|560511611|FG000|Overall Study|Lost to Follow-up|6|||
155295694|NCT01579916|560511612|FG001|Overall Study|Lost to Follow-up|1|||
155295695|NCT01579916|560511611|FG000|Overall Study|Withdrawal by Subject|1|||
155295696|NCT01579916|560511612|FG001|Overall Study|Withdrawal by Subject|1|||
155295697|NCT01579916|560511611|FG000|Overall Study|Death|1|||
155295698|NCT01579916|560511612|FG001|Overall Study|Death|0|||
155295699|NCT03351075|560513122|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
155295700|NCT03351075|560513123|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
155295701|NCT03351075|560513122|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
155295702|NCT03351075|560513123|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
155295703|NCT03351075|560513122|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
155295704|NCT03351075|560513123|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
155295705|NCT03351075|560513122|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
155295706|NCT03351075|560513123|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
155295707|NCT05219253|560513128|FG000|Overall Study|Withdrawal by Subject|1|||
155295708|NCT05219253|560513129|FG001|Overall Study|Withdrawal by Subject|2|||
155295709|NCT03086369|560513130|FG000|Overall Study|Lost to Follow-up|1|||
155295710|NCT03086369|560513131|FG001|Overall Study|Lost to Follow-up|0|||
155295711|NCT03086369|560513132|FG002|Overall Study|Lost to Follow-up|0|||
155295712|NCT03086369|560513133|FG003|Overall Study|Lost to Follow-up|2|||
155295713|NCT03086369|560513134|FG004|Overall Study|Lost to Follow-up|1|||
155295714|NCT03086369|560513130|FG000|Overall Study|Physician Decision|0|||
155295715|NCT03086369|560513131|FG001|Overall Study|Physician Decision|0|||
155295716|NCT03086369|560513132|FG002|Overall Study|Physician Decision|0|||
155295717|NCT03086369|560513133|FG003|Overall Study|Physician Decision|1|||
155295718|NCT03086369|560513134|FG004|Overall Study|Physician Decision|2|||
155295719|NCT03086369|560513130|FG000|Overall Study|Withdrawal by Subject|0|||
155295720|NCT03086369|560513131|FG001|Overall Study|Withdrawal by Subject|0|||
155295721|NCT03086369|560513132|FG002|Overall Study|Withdrawal by Subject|0|||
155295722|NCT03086369|560513133|FG003|Overall Study|Withdrawal by Subject|5|||
155295723|NCT03086369|560513134|FG004|Overall Study|Withdrawal by Subject|3|||
155295724|NCT03086369|560513130|FG000|Overall Study|Progressive Disease|0|||
155295725|NCT03086369|560513131|FG001|Overall Study|Progressive Disease|0|||
155295726|NCT03086369|560513132|FG002|Overall Study|Progressive Disease|0|||
155295727|NCT03086369|560513133|FG003|Overall Study|Progressive Disease|1|||
155295728|NCT03086369|560513134|FG004|Overall Study|Progressive Disease|1|||
155295729|NCT05011396|560513135|FG000|Overall Study|Lost to Follow-up|3|||
155295730|NCT05011396|560513136|FG001|Overall Study|Lost to Follow-up|1|||
155295731|NCT05011396|560513135|FG000|Overall Study|Withdrawal by Subject|0|||
155295732|NCT05011396|560513136|FG001|Overall Study|Withdrawal by Subject|1|||
155295733|NCT05011396|560513135|FG000|Overall Study|Positive Drug Screen|0|||
155295734|NCT05011396|560513136|FG001|Overall Study|Positive Drug Screen|1|||
155295735|NCT04668339|560513137|FG000|Overall Study|Physician Decision|1|||
155295736|NCT04668339|560513138|FG001|Overall Study|Physician Decision|0|||
155295737|NCT04668339|560513139|FG002|Overall Study|Physician Decision|1|||
155295738|NCT04668339|560513140|FG003|Overall Study|Physician Decision|1|||
155295739|NCT04668339|560513137|FG000|Overall Study|Lost to Follow-up|14|||
155295740|NCT04668339|560513138|FG001|Overall Study|Lost to Follow-up|12|||
155295741|NCT04668339|560513139|FG002|Overall Study|Lost to Follow-up|8|||
155295742|NCT04668339|560513140|FG003|Overall Study|Lost to Follow-up|5|||
155295743|NCT04668339|560513137|FG000|Overall Study|Adverse Event|0|||
155295744|NCT04668339|560513138|FG001|Overall Study|Adverse Event|0|||
155295745|NCT04668339|560513139|FG002|Overall Study|Adverse Event|1|||
155295746|NCT04668339|560513140|FG003|Overall Study|Adverse Event|0|||
155295747|NCT04668339|560513137|FG000|Overall Study|Other than specified|3|||
155295748|NCT04668339|560513138|FG001|Overall Study|Other than specified|0|||
155295749|NCT04668339|560513139|FG002|Overall Study|Other than specified|1|||
155295750|NCT04668339|560513140|FG003|Overall Study|Other than specified|0|||
155295751|NCT04668339|560513137|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
155295752|NCT04668339|560513138|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
154956731|NCT02587962|559268828|FG003|Overall Study|Withdrawal by Subject|1|||
155295753|NCT04668339|560513139|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
155295754|NCT04668339|560513140|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
155295755|NCT04668339|560513137|FG000|Overall Study|Vaccine not Administered|0|||
154956732|NCT02587962|559268829|FG004|Overall Study|Withdrawal by Subject|4|||
155295756|NCT04668339|560513138|FG001|Overall Study|Vaccine not Administered|0|||
155295757|NCT04668339|560513139|FG002|Overall Study|Vaccine not Administered|1|||
155295758|NCT04668339|560513140|FG003|Overall Study|Vaccine not Administered|0|||
155295759|NCT04668339|560513137|FG000|Overall Study|Protocol Violation|18|||
155295760|NCT04668339|560513138|FG001|Overall Study|Protocol Violation|23|||
154956733|NCT02587962|559268825|FG000|Overall Study|Radiological progression|2|||
154956734|NCT02587962|559268826|FG001|Overall Study|Radiological progression|2|||
155295761|NCT04668339|560513139|FG002|Overall Study|Protocol Violation|12|||
155295762|NCT04668339|560513140|FG003|Overall Study|Protocol Violation|20|||
155295763|NCT04668339|560513137|FG000|Overall Study|Withdrawal by Subject|45|||
155295764|NCT04668339|560513138|FG001|Overall Study|Withdrawal by Subject|46|||
155295765|NCT04668339|560513139|FG002|Overall Study|Withdrawal by Subject|46|||
155295766|NCT04668339|560513140|FG003|Overall Study|Withdrawal by Subject|27|||
155295767|NCT04668339|560513137|FG000|Overall Study|Study Terminated by Sponsor|59|||
155295768|NCT04668339|560513138|FG001|Overall Study|Study Terminated by Sponsor|59|||
155295769|NCT04668339|560513139|FG002|Overall Study|Study Terminated by Sponsor|71|||
155295770|NCT04668339|560513140|FG003|Overall Study|Study Terminated by Sponsor|1|||
155295771|NCT03253848|560513144|FG000|Overall Study|Adverse Event|7|||
155295772|NCT03253848|560513144|FG000|Overall Study|Death|5|||
155295773|NCT03253848|560513144|FG000|Overall Study|initiation of other treatments|3|||
155295774|NCT03253848|560513144|FG000|Overall Study|Other complicating disease|1|||
155295775|NCT03253848|560513144|FG000|Overall Study|Withdrawal by Subject|1|||
155295776|NCT03253848|560513144|FG000|Overall Study|Declining health|1|||
155295777|NCT00941655|560513147|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
155295778|NCT00941655|560513148|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
155295779|NCT00941655|560513147|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
155295780|NCT00941655|560513148|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
155295781|NCT00941655|560513147|FG000|Overall Study|progressed while on chemo|0|||
155295782|NCT00941655|560513148|FG001|Overall Study|progressed while on chemo|2|||
155295783|NCT00941655|560513147|FG000|Overall Study|refused further treatment|0|||
155295784|NCT00941655|560513148|FG001|Overall Study|refused further treatment|1|||
155295785|NCT00941655|560513147|FG000|Overall Study|withdrew consent|0|||
155295786|NCT00941655|560513148|FG001|Overall Study|withdrew consent|1|||
155295787|NCT00941655|560513147|FG000|Overall Study|non-compliant|0|||
155295788|NCT00941655|560513148|FG001|Overall Study|non-compliant|1|||
155295789|NCT02698891|560513151|FG000|Overall Study|Withdrawal by Subject|2|||
155295790|NCT02698891|560513151|FG000|Overall Study|deemed ineligible|1|||
155295791|NCT02698891|560513151|FG000|Overall Study|Adverse Event|9|||
155295792|NCT04218110|560513152|FG000|Overall Study|Withdrawal by Subject|0|||
155295793|NCT04218110|560513153|FG001|Overall Study|Withdrawal by Subject|0|||
155295794|NCT04218110|560513154|FG002|Overall Study|Withdrawal by Subject|0|||
155295795|NCT04218110|560513155|FG003|Overall Study|Withdrawal by Subject|1|||
155295796|NCT00516386|560513156|FG000|Overall Study|not interested in the study|4|||
155295797|NCT00516386|560513156|FG000|Overall Study|Lost to Follow-up|2|||
155295798|NCT03262935|560513159|FG000|Overall Study|Withdrawal by Subject|6|||
155295799|NCT03262935|560513160|FG001|Overall Study|Withdrawal by Subject|7|||
155295800|NCT03262935|560513159|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
155295801|NCT03262935|560513160|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
155295802|NCT03262935|560513159|FG000|Overall Study|Death|181|||
155295803|NCT03262935|560513160|FG001|Overall Study|Death|94|||
155295804|NCT03262935|560513159|FG000|Overall Study|Lost to Follow-up|9|||
155295805|NCT03262935|560513160|FG001|Overall Study|Lost to Follow-up|4|||
155295806|NCT03262935|560513159|FG000|Overall Study|Other reason|5|||
155295807|NCT03262935|560513160|FG001|Overall Study|Other reason|0|||
155295808|NCT00831415|560513163|FG000|Overall Study|Adverse Event|14|||
155295809|NCT00831415|560513163|FG000|Overall Study|Failed to return|3|||
155295810|NCT00831415|560513163|FG000|Overall Study|Physician Decision|6|||
155295811|NCT00831415|560513163|FG000|Overall Study|Lost to Follow-up|9|||
155295812|NCT00831415|560513163|FG000|Overall Study|Protocol Violation|3|||
155295813|NCT00831415|560513163|FG000|Overall Study|Withdrawal by Subject|35|||
155295814|NCT00831415|560513163|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
155157759|NCT00129402|560016521|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
154956735|NCT02587962|559268827|FG002|Overall Study|Radiological progression|2|||
154956736|NCT02587962|559268828|FG003|Overall Study|Radiological progression|5|||
154956737|NCT02587962|559268829|FG004|Overall Study|Radiological progression|10|||
154956738|NCT02587962|559268825|FG000|Overall Study|Clinical progression|0|||
154956739|NCT02587962|559268826|FG001|Overall Study|Clinical progression|1|||
154956740|NCT02587962|559268827|FG002|Overall Study|Clinical progression|2|||
155157760|NCT00129402|560016515|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155157761|NCT00129402|560016516|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155157762|NCT00129402|560016517|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155157763|NCT00129402|560016518|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155157764|NCT00129402|560016519|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155295815|NCT00831415|560513163|FG000|Overall Study|Death|1|||
155295816|NCT01290224|560513164|FG000|Overall Study|Adverse Event|1|||
155295817|NCT01290224|560513164|FG000|Overall Study|Refused Further Treatment|4|||
155295818|NCT05694065|560513165|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
155295819|NCT05694065|560513165|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
155295820|NCT05694065|560513165|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
155295821|NCT00424762|560513166|FG000|Overall Study|Withdrawal by Subject|18|||
155295822|NCT00424762|560513167|FG001|Overall Study|Withdrawal by Subject|19|||
154956741|NCT02587962|559268828|FG003|Overall Study|Clinical progression|0|||
155295823|NCT00424762|560513166|FG000|Overall Study|Lost to Follow-up|2|||
154956742|NCT02587962|559268829|FG004|Overall Study|Clinical progression|1|||
154956743|NCT01185548|559268830|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
154956744|NCT00086996|559268831|FG000|Overall Study|Adverse Event|29|||
154956745|NCT00086996|559268831|FG000|Overall Study|Death|4|||
154956746|NCT00086996|559268831|FG000|Overall Study|progression/relapse|7|||
154956747|NCT00086996|559268831|FG000|Overall Study|Withdrawal by Subject|13|||
154956748|NCT00086996|559268831|FG000|Overall Study|Other|6|||
154956749|NCT00086996|559268831|FG000|Overall Study|not eligible|5|||
154956750|NCT01422538|559268833|FG000|Overall Study|Lost to Follow-up|0|||
154956751|NCT01422538|559268834|FG001|Overall Study|Lost to Follow-up|1|||
154956752|NCT01422538|559268835|FG002|Overall Study|Lost to Follow-up|1|||
154956753|NCT01422538|559268833|FG000|Overall Study|Missed visit|0|||
154956754|NCT01422538|559268834|FG001|Overall Study|Missed visit|1|||
154956755|NCT01422538|559268835|FG002|Overall Study|Missed visit|1|||
154956756|NCT02770820|559268836|FG000|Overall Study|Death|1|||
154956757|NCT02770820|559268836|FG000|Overall Study|Physician Decision|2|||
154956758|NCT01387022|559268838|FG000|Overall Study|Death|1|||
154956759|NCT01387022|559268839|FG001|Overall Study|Death|1|||
154956760|NCT01387022|559268838|FG000|Overall Study|Lost to Follow-up|0|||
154956761|NCT01387022|559268839|FG001|Overall Study|Lost to Follow-up|3|||
154956762|NCT02076022|559268840|FG000|Overall Study|Withdrawal by Subject|2|||
154956763|NCT02076022|559268841|FG001|Overall Study|Withdrawal by Subject|0|||
154956764|NCT00286754|559268844|FG000|Overall Study|Adverse Event|2|||
154956765|NCT00286754|559268845|FG001|Overall Study|Adverse Event|2|||
154956766|NCT00286754|559268846|FG002|Overall Study|Adverse Event|3|||
154956767|NCT00286754|559268844|FG000|Overall Study|Withdrawal by Subject|6|||
154956768|NCT00286754|559268845|FG001|Overall Study|Withdrawal by Subject|2|||
154956769|NCT00286754|559268846|FG002|Overall Study|Withdrawal by Subject|0|||
154956770|NCT00286754|559268844|FG000|Overall Study|Lost to Follow-up|12|||
154956771|NCT00286754|559268845|FG001|Overall Study|Lost to Follow-up|14|||
154956772|NCT00286754|559268846|FG002|Overall Study|Lost to Follow-up|6|||
154956773|NCT00286754|559268844|FG000|Overall Study|Moved out of state|0|||
154956774|NCT00286754|559268845|FG001|Overall Study|Moved out of state|0|||
154956775|NCT00286754|559268846|FG002|Overall Study|Moved out of state|1|||
154956776|NCT01536405|559268847|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
154956777|NCT01536405|559268848|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
154956778|NCT01536405|559268847|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
154956779|NCT01536405|559268848|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
154956780|NCT01536405|559268847|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
154956781|NCT01536405|559268848|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
154956782|NCT01536405|559268847|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
154956783|NCT01536405|559268848|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
154956784|NCT01536405|559268847|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
154956785|NCT01536405|559268848|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
154956786|NCT01536405|559268847|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
154956787|NCT01536405|559268848|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
154956788|NCT01536405|559268847|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
154956789|NCT01536405|559268848|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
154956790|NCT01536405|559268847|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
154956791|NCT01536405|559268848|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
154956792|NCT01536405|559268847|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
154956793|NCT01536405|559268848|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
154956794|NCT01536405|559268847|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
154956795|NCT01536405|559268848|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
154956796|NCT01536405|559268847|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
154956797|NCT01536405|559268848|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
154956798|NCT01536405|559268847|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
154956799|NCT01536405|559268848|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
154956800|NCT01536405|559268847|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
154956801|NCT01536405|559268848|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
154956802|NCT01061866|559268849|FG000|Overall Study|Adverse Event|2|||
154956803|NCT04786184|559268850|FG000|Overall Study|Adverse Event|4|||
154956804|NCT04786184|559268851|FG001|Overall Study|Adverse Event|0|||
154956805|NCT04786184|559268850|FG000|Overall Study|Withdrawal by Subject|3|||
154956806|NCT04786184|559268851|FG001|Overall Study|Withdrawal by Subject|1|||
154956807|NCT04786184|559268850|FG000|Overall Study|Lost to Follow-up|4|||
154956808|NCT04786184|559268851|FG001|Overall Study|Lost to Follow-up|2|||
154956809|NCT00420238|559268852|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
154956810|NCT00420238|559268853|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
154956811|NCT00420238|559268852|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
154956812|NCT00420238|559268853|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
154956813|NCT00420238|559268852|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
154956814|NCT00420238|559268853|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
155295824|NCT00424762|560513167|FG001|Overall Study|Lost to Follow-up|3|||
155295825|NCT04347954|560513177|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
155295826|NCT04347954|560513178|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
155295827|NCT04347954|560513179|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
155295828|NCT04347954|560513177|FG000|Overall Study|Lost to Follow-up|0|||
155295829|NCT04347954|560513178|FG001|Overall Study|Lost to Follow-up|1|||
155295830|NCT04347954|560513179|FG002|Overall Study|Lost to Follow-up|0|||
155295831|NCT05641311|560513180|FG000|Dosing Period 1|Adverse Event|1|||
155295832|NCT05641311|560513181|FG001|Dosing Period 1|Adverse Event|0|||
155295833|NCT00922207|560513182|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
155295834|NCT00922207|560513183|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
155295835|NCT00922207|560513184|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
155295836|NCT00922207|560513182|FG000|Overall Study|Insufficient Therapeutic Response|0|||
155295837|NCT00922207|560513183|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155295838|NCT00922207|560513184|FG002|Overall Study|Insufficient Therapeutic Response|1|||
155295839|NCT00922207|560513182|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155295840|NCT00922207|560513183|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155295841|NCT00922207|560513184|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
155295842|NCT00922207|560513182|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
155295843|NCT00922207|560513183|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155295844|NCT00922207|560513184|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155295845|NCT00922207|560513182|FG000|Overall Study|Withdrew Consent|2|||
155295846|NCT00922207|560513183|FG001|Overall Study|Withdrew Consent|5|||
155295847|NCT00922207|560513184|FG002|Overall Study|Withdrew Consent|2|||
155295848|NCT00922207|560513182|FG000|Overall Study|Abnormality of Laboratory Test|0|||
155295849|NCT00922207|560513183|FG001|Overall Study|Abnormality of Laboratory Test|1|||
155295850|NCT00922207|560513184|FG002|Overall Study|Abnormality of Laboratory Test|1|||
155295851|NCT00367991|560513185|FG000|Overall Study|Withdrawal by Subject|1|||
155295852|NCT00367991|560513186|FG001|Overall Study|Withdrawal by Subject|1|||
155295853|NCT00367991|560513185|FG000|Overall Study|Adverse Event|1|||
155295854|NCT00367991|560513186|FG001|Overall Study|Adverse Event|1|||
155295855|NCT03515304|560513187|FG000|Overall Study|Lost to Follow-up|0|||
155295856|NCT03515304|560513188|FG001|Overall Study|Lost to Follow-up|3|||
155295857|NCT02969863|560513193|FG000|Overall Study|Physician Decision|1|||
155295858|NCT02969863|560513194|FG001|Overall Study|Physician Decision|0|||
155295859|NCT02969863|560513195|FG002|Overall Study|Physician Decision|0|||
155295860|NCT02969863|560513196|FG003|Overall Study|Physician Decision|0|||
155295861|NCT02969863|560513197|FG004|Overall Study|Physician Decision|0|||
155295862|NCT02969863|560513198|FG005|Overall Study|Physician Decision|0|||
155295863|NCT02705586|560513199|FG000|Overall Study|Health Issues|2|||
155295864|NCT02705586|560513199|FG000|Overall Study|Transportation Difficulties|5|||
155295865|NCT02705586|560513199|FG000|Overall Study|Vacation/Planned Absence|1|||
155295866|NCT02045836|560513200|FG000|Overall Study|Adverse Event|4|||
155295867|NCT02045836|560513201|FG001|Overall Study|Adverse Event|4|||
155295868|NCT02045836|560513200|FG000|Overall Study|Withdrawal by Subject|1|||
155295869|NCT02045836|560513201|FG001|Overall Study|Withdrawal by Subject|1|||
155295870|NCT02045836|560513200|FG000|Overall Study|Lost to Follow-up|4|||
155295871|NCT02045836|560513201|FG001|Overall Study|Lost to Follow-up|7|||
155295872|NCT02045836|560513200|FG000|Overall Study|Migrated from study area|0|||
155295873|NCT02045836|560513201|FG001|Overall Study|Migrated from study area|2|||
155295874|NCT00057837|560513202|FG000|Overall Study|Progression/relapse|12|||
155295875|NCT00057837|560513203|FG001|Overall Study|Progression/relapse|14|||
155295876|NCT00057837|560513202|FG000|Overall Study|Adverse Event|2|||
155295877|NCT00057837|560513203|FG001|Overall Study|Adverse Event|12|||
155295878|NCT00057837|560513202|FG000|Overall Study|Death|5|||
155295879|NCT00057837|560513203|FG001|Overall Study|Death|4|||
155295880|NCT00057837|560513202|FG000|Overall Study|Withdrawal by Subject|5|||
155295881|NCT00057837|560513203|FG001|Overall Study|Withdrawal by Subject|3|||
154956815|NCT00420238|559268852|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
155295882|NCT00057837|560513202|FG000|Overall Study|Alternative therapy|0|||
155295883|NCT00057837|560513203|FG001|Overall Study|Alternative therapy|1|||
155295884|NCT00057837|560513202|FG000|Overall Study|Other complicating disease|2|||
155295885|NCT00057837|560513203|FG001|Overall Study|Other complicating disease|1|||
154956816|NCT00420238|559268853|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
155295886|NCT00057837|560513202|FG000|Overall Study|Physician Decision|1|||
155295887|NCT00057837|560513203|FG001|Overall Study|Physician Decision|0|||
155295888|NCT00057837|560513202|FG000|Overall Study|Ineligible|3|||
155295889|NCT00057837|560513203|FG001|Overall Study|Ineligible|3|||
155061195|NCT01259245|559659269|FG001|Overall Study|Death|2|||
155061196|NCT01206764|559659271|FG000|Overall Study|Adverse Event|20|||
155061197|NCT01206764|559659271|FG000|Overall Study|Abnormal laboratory value|2|||
155061198|NCT01206764|559659271|FG000|Overall Study|Abnormal test procedure result|1|||
155061199|NCT01206764|559659271|FG000|Overall Study|Patient withdrew consent|5|||
155061200|NCT01206764|559659271|FG000|Overall Study|Lost to Follow-up|6|||
155061201|NCT01206764|559659271|FG000|Overall Study|Death|11|||
155061202|NCT01206764|559659271|FG000|Overall Study|New cancer therapy|2|||
155295890|NCT00057837|560513202|FG000|Overall Study|Never started treatment|1|||
155295891|NCT00057837|560513203|FG001|Overall Study|Never started treatment|1|||
155295892|NCT02000817|560513204|FG000|Overall Study|Withdrawal by Subject|2|||
155295893|NCT02000817|560513205|FG001|Overall Study|Withdrawal by Subject|0|||
155295894|NCT02000817|560513206|FG002|Overall Study|Withdrawal by Subject|0|||
155295895|NCT02000817|560513207|FG003|Overall Study|Withdrawal by Subject|0|||
155295896|NCT02000817|560513204|FG000|Overall Study|Adverse Event|0|||
155295897|NCT02000817|560513205|FG001|Overall Study|Adverse Event|1|||
155157765|NCT00129402|560016520|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
155157766|NCT00129402|560016521|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
155157767|NCT00129402|560016515|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155157768|NCT00129402|560016516|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155157769|NCT00129402|560016517|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155157770|NCT00129402|560016518|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155157771|NCT00129402|560016519|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155157772|NCT00129402|560016520|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
155157773|NCT00129402|560016521|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
155157774|NCT00129402|560016515|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155157775|NCT00129402|560016516|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155157776|NCT00129402|560016517|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155157777|NCT00129402|560016518|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155157778|NCT00129402|560016519|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155157779|NCT00129402|560016520|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
155157780|NCT00129402|560016521|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
155157781|NCT02131259|560016522|FG000|Overall Study|Progressive disease|751|||
155157782|NCT02131259|560016522|FG000|Overall Study|Adverse Event|341|||
155157783|NCT02131259|560016522|FG000|Overall Study|Lost to Follow-up|7|||
155157784|NCT02131259|560016522|FG000|Overall Study|Relocation|32|||
155157785|NCT02131259|560016522|FG000|Overall Study|Other|63|||
155157786|NCT02131259|560016522|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
155157787|NCT02131259|560016522|FG000|Overall Study|Progressive disease/relocation|1|||
155157788|NCT02131259|560016522|FG000|Overall Study|Progressive disease/other|2|||
155157789|NCT02131259|560016522|FG000|Overall Study|AE/lost to follow-up|1|||
155157790|NCT02131259|560016522|FG000|Overall Study|AE/other|1|||
155157791|NCT02131259|560016522|FG000|Overall Study|Progressive disease/AE/other|1|||
155157792|NCT02131259|560016522|FG000|Overall Study|Missing|3|||
155157793|NCT01472289|560016523|FG000|Overall Study|Death|2|||
155157794|NCT00907335|560016524|FG000|Overall Study|Withdrawal by Subject|2|||
155157795|NCT00907335|560016525|FG001|Overall Study|Withdrawal by Subject|0|||
154956817|NCT00420238|559268852|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
154956818|NCT00420238|559268853|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
154956819|NCT00420238|559268852|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
155157796|NCT00907335|560016524|FG000|Overall Study|Adverse Event|4|||
155157797|NCT00907335|560016525|FG001|Overall Study|Adverse Event|1|||
155157798|NCT00907335|560016524|FG000|Overall Study|Lost to Follow-up|2|||
155157799|NCT00907335|560016525|FG001|Overall Study|Lost to Follow-up|0|||
155157800|NCT03879772|560016526|FG000|Overall Study|Adverse Event|2|||
155157801|NCT03879772|560016527|FG001|Overall Study|Adverse Event|2|||
155295898|NCT02000817|560513206|FG002|Overall Study|Adverse Event|0|||
155295899|NCT02000817|560513207|FG003|Overall Study|Adverse Event|0|||
155157802|NCT03879772|560016528|FG002|Overall Study|Adverse Event|3|||
155157803|NCT03879772|560016529|FG003|Overall Study|Adverse Event|4|||
155157804|NCT03879772|560016530|FG004|Overall Study|Adverse Event|3|||
155157805|NCT03879772|560016526|FG000|Overall Study|Treatment Failure|1|||
155157806|NCT03879772|560016527|FG001|Overall Study|Treatment Failure|0|||
155157807|NCT03879772|560016528|FG002|Overall Study|Treatment Failure|0|||
155157808|NCT03879772|560016529|FG003|Overall Study|Treatment Failure|2|||
155157809|NCT03879772|560016530|FG004|Overall Study|Treatment Failure|1|||
155157810|NCT03879772|560016526|FG000|Overall Study|Lost to Follow-up|0|||
155295900|NCT02000817|560513204|FG000|Overall Study|Lost to Follow-up|0|||
155157811|NCT03879772|560016527|FG001|Overall Study|Lost to Follow-up|0|||
155157812|NCT03879772|560016528|FG002|Overall Study|Lost to Follow-up|0|||
155157813|NCT03879772|560016529|FG003|Overall Study|Lost to Follow-up|0|||
155157814|NCT03879772|560016530|FG004|Overall Study|Lost to Follow-up|1|||
155157815|NCT03879772|560016526|FG000|Overall Study|Withdrawal by Subject|0|||
155157816|NCT03879772|560016527|FG001|Overall Study|Withdrawal by Subject|1|||
155157817|NCT03879772|560016528|FG002|Overall Study|Withdrawal by Subject|3|||
155157818|NCT03879772|560016529|FG003|Overall Study|Withdrawal by Subject|1|||
155157819|NCT03879772|560016530|FG004|Overall Study|Withdrawal by Subject|1|||
155157820|NCT03879772|560016526|FG000|Overall Study|Protocol Violation|0|||
155157821|NCT03879772|560016527|FG001|Overall Study|Protocol Violation|0|||
155157822|NCT03879772|560016528|FG002|Overall Study|Protocol Violation|3|||
155157823|NCT03879772|560016529|FG003|Overall Study|Protocol Violation|1|||
155295901|NCT02000817|560513205|FG001|Overall Study|Lost to Follow-up|0|||
155295902|NCT02000817|560513206|FG002|Overall Study|Lost to Follow-up|1|||
155295903|NCT02000817|560513207|FG003|Overall Study|Lost to Follow-up|0|||
155295904|NCT05686421|560513208|FG000|Overall Study|Screen failure|22|||
155295905|NCT05686421|560513209|FG001|Overall Study|Screen failure|0|||
155295906|NCT05686421|560513210|FG002|Overall Study|Screen failure|0|||
155295907|NCT05686421|560513211|FG003|Overall Study|Screen failure|0|||
155295908|NCT00367055|560513212|FG000|Overall Study|Adverse Event|6|||
155295909|NCT00367055|560513213|FG001|Overall Study|Adverse Event|3|||
155295910|NCT00367055|560513212|FG000|Overall Study|Patient's Willing|3|||
155295911|NCT00367055|560513213|FG001|Overall Study|Patient's Willing|2|||
155295912|NCT00367055|560513212|FG000|Overall Study|Lack of Efficacy|1|||
155295913|NCT00367055|560513213|FG001|Overall Study|Lack of Efficacy|2|||
155295914|NCT00367055|560513212|FG000|Overall Study|Lost to Follow-up|1|||
155295915|NCT00367055|560513213|FG001|Overall Study|Lost to Follow-up|1|||
155295916|NCT00367055|560513212|FG000|Overall Study|Protocol Violation|0|||
155295917|NCT00367055|560513213|FG001|Overall Study|Protocol Violation|1|||
155295918|NCT00367055|560513212|FG000|Overall Study|Stopping Criterion Met|0|||
155295919|NCT00367055|560513213|FG001|Overall Study|Stopping Criterion Met|1|||
155295920|NCT00367055|560513212|FG000|Overall Study|Participant Living too Far from Hospital|0|||
155295921|NCT00367055|560513213|FG001|Overall Study|Participant Living too Far from Hospital|1|||
155295922|NCT00539292|560513214|FG000|Overall Study|Physician Decision|1|||
155295923|NCT00539292|560513215|FG001|Overall Study|Physician Decision|0|||
155295924|NCT00324038|560513224|FG000|Overall Study|Adverse Event|38|||
155295925|NCT00324038|560513225|FG001|Overall Study|Adverse Event|23|||
155295926|NCT00324038|560513224|FG000|Overall Study|Lack of Efficacy|5|||
155295927|NCT00324038|560513225|FG001|Overall Study|Lack of Efficacy|13|||
155295928|NCT00324038|560513224|FG000|Overall Study|Lost to Follow-up|0|||
155295929|NCT00324038|560513225|FG001|Overall Study|Lost to Follow-up|2|||
155295930|NCT00324038|560513224|FG000|Overall Study|Other|6|||
155295931|NCT00324038|560513225|FG001|Overall Study|Other|13|||
155295932|NCT00361283|560513227|FG000|Overall Study|Lost to Follow-up|27|||
155295933|NCT01837641|560513228|FG000|Overall Study|Sponsor decision|1|||
155295934|NCT01837641|560513229|FG001|Overall Study|Sponsor decision|0|||
155295935|NCT01837641|560513230|FG002|Overall Study|Sponsor decision|0|||
155295936|NCT01837641|560513231|FG003|Overall Study|Sponsor decision|0|||
155295937|NCT01837641|560513232|FG004|Overall Study|Sponsor decision|0|||
155295938|NCT01837641|560513233|FG005|Overall Study|Sponsor decision|1|||
155295939|NCT01837641|560513234|FG006|Overall Study|Sponsor decision|0|||
155295940|NCT01837641|560513235|FG007|Overall Study|Sponsor decision|0|||
155295941|NCT01837641|560513228|FG000|Overall Study|Adverse Event|0|||
155295942|NCT01837641|560513229|FG001|Overall Study|Adverse Event|0|||
155295943|NCT01837641|560513230|FG002|Overall Study|Adverse Event|0|||
155295944|NCT01837641|560513231|FG003|Overall Study|Adverse Event|0|||
155295945|NCT01837641|560513232|FG004|Overall Study|Adverse Event|0|||
155295946|NCT01837641|560513233|FG005|Overall Study|Adverse Event|1|||
155295947|NCT01837641|560513234|FG006|Overall Study|Adverse Event|0|||
155295948|NCT01837641|560513235|FG007|Overall Study|Adverse Event|0|||
155295949|NCT01837641|560513228|FG000|Overall Study|Withdrawal by Subject|0|||
155295950|NCT01837641|560513229|FG001|Overall Study|Withdrawal by Subject|0|||
155295951|NCT01837641|560513230|FG002|Overall Study|Withdrawal by Subject|0|||
155295952|NCT01837641|560513231|FG003|Overall Study|Withdrawal by Subject|0|||
155295953|NCT01837641|560513232|FG004|Overall Study|Withdrawal by Subject|1|||
155295954|NCT01837641|560513233|FG005|Overall Study|Withdrawal by Subject|0|||
155295955|NCT01837641|560513234|FG006|Overall Study|Withdrawal by Subject|1|||
155295956|NCT01837641|560513235|FG007|Overall Study|Withdrawal by Subject|0|||
155295957|NCT03264456|560513236|FG000|Overall Study|Withdrawal by Subject|3|||
155295958|NCT03264456|560513236|FG000|Overall Study|Lost to Follow-up|1|||
155295959|NCT01123083|560513237|FG000|Overall Study|Investigator recommendation|1|||
155295960|NCT01123083|560513238|FG001|Overall Study|Investigator recommendation|1|||
155295961|NCT01123083|560513237|FG000|Overall Study|Administrative reasons|0|||
155295962|NCT01123083|560513238|FG001|Overall Study|Administrative reasons|4|||
155295963|NCT01123083|560513237|FG000|Overall Study|Lost to Follow-up|2|||
155295964|NCT01123083|560513238|FG001|Overall Study|Lost to Follow-up|6|||
155295965|NCT01123083|560513237|FG000|Overall Study|Adverse Event|1|||
155295966|NCT01123083|560513238|FG001|Overall Study|Adverse Event|0|||
155295967|NCT01123083|560513237|FG000|Overall Study|Withdrew for another reason not covered|0|||
155295968|NCT01123083|560513238|FG001|Overall Study|Withdrew for another reason not covered|1|||
155295969|NCT01123083|560513237|FG000|Overall Study|Participant/legal representative request|7|||
155295970|NCT01123083|560513238|FG001|Overall Study|Participant/legal representative request|3|||
155295971|NCT00961636|560513239|FG000|Overall Study|Adverse Event|35|||
155295972|NCT00961636|560513240|FG001|Overall Study|Adverse Event|54|||
155295973|NCT00961636|560513241|FG002|Overall Study|Adverse Event|13|||
155295974|NCT00961636|560513239|FG000|Overall Study|Flushing Symptoms|29|||
155295975|NCT00961636|560513240|FG001|Overall Study|Flushing Symptoms|46|||
155295976|NCT00961636|560513241|FG002|Overall Study|Flushing Symptoms|3|||
155295977|NCT00961636|560513239|FG000|Overall Study|Lost to Follow-up|2|||
155295978|NCT00961636|560513240|FG001|Overall Study|Lost to Follow-up|3|||
155295979|NCT00961636|560513241|FG002|Overall Study|Lost to Follow-up|1|||
155295980|NCT00961636|560513239|FG000|Overall Study|Physician Decision|3|||
155295981|NCT00961636|560513240|FG001|Overall Study|Physician Decision|1|||
155295982|NCT00961636|560513241|FG002|Overall Study|Physician Decision|1|||
155295983|NCT00961636|560513239|FG000|Overall Study|Protocol Violation|9|||
155295984|NCT00961636|560513240|FG001|Overall Study|Protocol Violation|5|||
155295985|NCT00961636|560513241|FG002|Overall Study|Protocol Violation|1|||
155295986|NCT00961636|560513239|FG000|Overall Study|Withdrawal by Subject|29|||
155295987|NCT00961636|560513240|FG001|Overall Study|Withdrawal by Subject|22|||
155295988|NCT00961636|560513241|FG002|Overall Study|Withdrawal by Subject|13|||
155295989|NCT00290706|560513244|FG000|Overall Study|Withdrawal by Subject|2|||
155295990|NCT00290706|560513245|FG001|Overall Study|Withdrawal by Subject|0|||
155295991|NCT00290706|560513246|FG002|Overall Study|Withdrawal by Subject|0|||
155295992|NCT00290706|560513247|FG003|Overall Study|Withdrawal by Subject|0|||
155295993|NCT00290706|560513244|FG000|Overall Study|Progressive Disease|3|||
155295994|NCT00290706|560513245|FG001|Overall Study|Progressive Disease|5|||
155295995|NCT00290706|560513246|FG002|Overall Study|Progressive Disease|4|||
155295996|NCT00290706|560513247|FG003|Overall Study|Progressive Disease|10|||
155295997|NCT00290706|560513244|FG000|Overall Study|Adverse Event|0|||
155295998|NCT00290706|560513245|FG001|Overall Study|Adverse Event|1|||
155295999|NCT00290706|560513246|FG002|Overall Study|Adverse Event|2|||
155296000|NCT00290706|560513247|FG003|Overall Study|Adverse Event|0|||
155296001|NCT00290706|560513244|FG000|Overall Study|Receive auto transplant or radiation|0|||
155296002|NCT00290706|560513245|FG001|Overall Study|Receive auto transplant or radiation|0|||
155296003|NCT00290706|560513246|FG002|Overall Study|Receive auto transplant or radiation|0|||
155296004|NCT00290706|560513247|FG003|Overall Study|Receive auto transplant or radiation|1|||
155296005|NCT00290706|560513244|FG000|Overall Study|Physician Decision|0|||
155296006|NCT00290706|560513245|FG001|Overall Study|Physician Decision|0|||
155296007|NCT00290706|560513246|FG002|Overall Study|Physician Decision|0|||
155296008|NCT00290706|560513247|FG003|Overall Study|Physician Decision|1|||
155296009|NCT01196429|560513249|FG000|Overall Study|Ineligible - inadequate pathology|1|||
155296010|NCT01196429|560513250|FG001|Overall Study|Ineligible - inadequate pathology|0|||
155296011|NCT01196429|560513249|FG000|Overall Study|Ineligible - wrong cell type|1|||
155296012|NCT01196429|560513250|FG001|Overall Study|Ineligible - wrong cell type|0|||
155296013|NCT01196429|560513249|FG000|Overall Study|Refused - Never Treated|1|||
155296014|NCT01196429|560513250|FG001|Overall Study|Refused - Never Treated|0|||
155296015|NCT00688519|560513251|FG000|Overall Study|Adverse Event|2|||
155296016|NCT00688519|560513252|FG001|Overall Study|Adverse Event|3|||
155296017|NCT00688519|560513251|FG000|Overall Study|Lost to Follow-up|3|||
155296018|NCT00688519|560513252|FG001|Overall Study|Lost to Follow-up|3|||
155296019|NCT00688519|560513251|FG000|Overall Study|Lack of Efficacy|3|||
155296020|NCT00688519|560513252|FG001|Overall Study|Lack of Efficacy|1|||
155296021|NCT00688519|560513251|FG000|Overall Study|Withdrawal by Subject|7|||
155296022|NCT00688519|560513252|FG001|Overall Study|Withdrawal by Subject|6|||
155296023|NCT00688519|560513251|FG000|Overall Study|Prohibited medication|1|||
155296024|NCT00688519|560513252|FG001|Overall Study|Prohibited medication|0|||
155296025|NCT00688519|560513251|FG000|Overall Study|Non-compliance|0|||
155296026|NCT00688519|560513252|FG001|Overall Study|Non-compliance|1|||
155296027|NCT00688519|560513251|FG000|Overall Study|Subject moved out of state|1|||
155296028|NCT00688519|560513252|FG001|Overall Study|Subject moved out of state|0|||
155296029|NCT00688519|560513251|FG000|Overall Study|Investigator decision|1|||
155296030|NCT00688519|560513252|FG001|Overall Study|Investigator decision|0|||
155296031|NCT00688519|560513251|FG000|Overall Study|Subject moved out of area|1|||
155296032|NCT00688519|560513252|FG001|Overall Study|Subject moved out of area|0|||
155296033|NCT00688519|560513251|FG000|Overall Study|Pregnancy|0|||
155296034|NCT00688519|560513252|FG001|Overall Study|Pregnancy|1|||
155296035|NCT02486588|560513253|FG000|Overall Study|Randomized in error- ineligible|738|||
155296036|NCT02486588|560513254|FG001|Overall Study|Randomized in error- ineligible|750|||
155296037|NCT02486588|560513255|FG002|Overall Study|Randomized in error- ineligible|755|||
155296038|NCT02486588|560513256|FG003|Overall Study|Randomized in error- ineligible|738|||
155296039|NCT02486588|560513257|FG004|Overall Study|Randomized in error- ineligible|746|||
155296040|NCT02486588|560513258|FG005|Overall Study|Randomized in error- ineligible|746|||
155296041|NCT02551055|560513261|FG000|Overall Study|Death|2|||
155296042|NCT02551055|560513262|FG001|Overall Study|Death|4|||
155296043|NCT02551055|560513263|FG002|Overall Study|Death|2|||
155296044|NCT02551055|560513264|FG003|Overall Study|Death|2|||
155296045|NCT02551055|560513265|FG004|Overall Study|Death|2|||
155296046|NCT02551055|560513266|FG005|Overall Study|Death|1|||
155296047|NCT02551055|560513267|FG006|Overall Study|Death|2|||
155296048|NCT02551055|560513268|FG007|Overall Study|Death|0|||
155296049|NCT02551055|560513261|FG000|Overall Study|Study Terminated by Sponsor|1|||
155296050|NCT02551055|560513262|FG001|Overall Study|Study Terminated by Sponsor|1|||
155296051|NCT02551055|560513263|FG002|Overall Study|Study Terminated by Sponsor|0|||
155296052|NCT02551055|560513264|FG003|Overall Study|Study Terminated by Sponsor|2|||
155296053|NCT02551055|560513265|FG004|Overall Study|Study Terminated by Sponsor|2|||
155296054|NCT02551055|560513266|FG005|Overall Study|Study Terminated by Sponsor|0|||
155296055|NCT02551055|560513267|FG006|Overall Study|Study Terminated by Sponsor|0|||
155296056|NCT02551055|560513268|FG007|Overall Study|Study Terminated by Sponsor|0|||
155296057|NCT02551055|560513261|FG000|Overall Study|Withdrawal by Subject|1|||
155296058|NCT02551055|560513262|FG001|Overall Study|Withdrawal by Subject|1|||
155296059|NCT02551055|560513263|FG002|Overall Study|Withdrawal by Subject|0|||
155296060|NCT02551055|560513264|FG003|Overall Study|Withdrawal by Subject|1|||
155296061|NCT02551055|560513265|FG004|Overall Study|Withdrawal by Subject|2|||
155296062|NCT02551055|560513266|FG005|Overall Study|Withdrawal by Subject|0|||
155296063|NCT02551055|560513267|FG006|Overall Study|Withdrawal by Subject|0|||
155296064|NCT02551055|560513268|FG007|Overall Study|Withdrawal by Subject|0|||
155296065|NCT02551055|560513261|FG000|Overall Study|Reason not specified|0|||
155296066|NCT02551055|560513262|FG001|Overall Study|Reason not specified|0|||
155296067|NCT02551055|560513263|FG002|Overall Study|Reason not specified|0|||
155296068|NCT02551055|560513264|FG003|Overall Study|Reason not specified|0|||
155296069|NCT02551055|560513265|FG004|Overall Study|Reason not specified|1|||
155296070|NCT02551055|560513266|FG005|Overall Study|Reason not specified|0|||
155296071|NCT02551055|560513267|FG006|Overall Study|Reason not specified|1|||
155296072|NCT02551055|560513268|FG007|Overall Study|Reason not specified|0|||
155296073|NCT00430300|560513269|FG000|Overall Study|Adverse Event|0|||
155296074|NCT00430300|560513270|FG001|Overall Study|Adverse Event|2|||
155296075|NCT00430300|560513271|FG002|Overall Study|Adverse Event|1|||
155296076|NCT00430300|560513272|FG003|Overall Study|Adverse Event|1|||
155296077|NCT00430300|560513269|FG000|Overall Study|Withdrawal by Subject|1|||
155296078|NCT00430300|560513270|FG001|Overall Study|Withdrawal by Subject|0|||
155296079|NCT00430300|560513271|FG002|Overall Study|Withdrawal by Subject|5|||
155296080|NCT00430300|560513272|FG003|Overall Study|Withdrawal by Subject|0|||
155296081|NCT00430300|560513269|FG000|Overall Study|Laboratory abnormality|1|||
155296082|NCT00430300|560513270|FG001|Overall Study|Laboratory abnormality|0|||
155296083|NCT00430300|560513271|FG002|Overall Study|Laboratory abnormality|0|||
155296084|NCT00430300|560513272|FG003|Overall Study|Laboratory abnormality|0|||
154956820|NCT00420238|559268853|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
154956821|NCT03555305|559268854|FG000|Period 1|Physician Decision|0|||
154956822|NCT03555305|559268855|FG001|Period 1|Physician Decision|1|||
154956823|NCT03555305|559268854|FG000|Period 1|Adverse Event|0|||
154956824|NCT03555305|559268855|FG001|Period 1|Adverse Event|1|||
154956825|NCT03135834|559268858|FG000|Stage 1|Adverse Event|1|||
154956826|NCT03135834|559268859|FG001|Stage 1|Adverse Event|2|||
154956827|NCT03135834|559268860|FG002|Stage 1|Adverse Event|2|||
154956828|NCT03135834|559268861|FG003|Stage 1|Adverse Event|1|||
154956829|NCT03135834|559268858|FG000|Stage 1|Death|1|||
154956830|NCT03135834|559268859|FG001|Stage 1|Death|0|||
154956831|NCT03135834|559268860|FG002|Stage 1|Death|0|||
154956832|NCT03135834|559268861|FG003|Stage 1|Death|0|||
154956833|NCT03135834|559268858|FG000|Stage 1|Lost to Follow-up|17|||
154956834|NCT03135834|559268859|FG001|Stage 1|Lost to Follow-up|24|||
154956835|NCT03135834|559268860|FG002|Stage 1|Lost to Follow-up|21|||
154956836|NCT03135834|559268861|FG003|Stage 1|Lost to Follow-up|38|||
154956837|NCT03135834|559268858|FG000|Stage 1|No longer met eligibility criteria|1|||
154956838|NCT03135834|559268859|FG001|Stage 1|No longer met eligibility criteria|6|||
154956839|NCT03135834|559268860|FG002|Stage 1|No longer met eligibility criteria|2|||
154956840|NCT03135834|559268861|FG003|Stage 1|No longer met eligibility criteria|5|||
154956841|NCT03135834|559268858|FG000|Stage 1|Other|0|||
154956842|NCT03135834|559268859|FG001|Stage 1|Other|2|||
154956843|NCT03135834|559268860|FG002|Stage 1|Other|1|||
154956844|NCT03135834|559268861|FG003|Stage 1|Other|0|||
154956845|NCT03135834|559268858|FG000|Stage 1|Physician Decision|0|||
154956846|NCT03135834|559268859|FG001|Stage 1|Physician Decision|1|||
154956847|NCT03135834|559268860|FG002|Stage 1|Physician Decision|0|||
154956848|NCT03135834|559268861|FG003|Stage 1|Physician Decision|0|||
154956849|NCT03135834|559268858|FG000|Stage 1|Pregnancy|0|||
154956850|NCT03135834|559268859|FG001|Stage 1|Pregnancy|4|||
154956851|NCT03135834|559268860|FG002|Stage 1|Pregnancy|2|||
154956852|NCT03135834|559268861|FG003|Stage 1|Pregnancy|4|||
154956853|NCT03135834|559268858|FG000|Stage 1|Protocol Violation|1|||
154956854|NCT03135834|559268859|FG001|Stage 1|Protocol Violation|1|||
154956855|NCT03135834|559268860|FG002|Stage 1|Protocol Violation|2|||
154956856|NCT03135834|559268861|FG003|Stage 1|Protocol Violation|1|||
154956857|NCT03135834|559268858|FG000|Stage 1|Withdrawal by parent/guardian|2|||
155296085|NCT00430300|560513269|FG000|Overall Study|Other|0|||
155296086|NCT00430300|560513270|FG001|Overall Study|Other|0|||
155296087|NCT00430300|560513271|FG002|Overall Study|Other|0|||
155296088|NCT00430300|560513272|FG003|Overall Study|Other|1|||
155296089|NCT01063517|560513277|FG000|Overall Study|Consent withdrawal|1|||
155296090|NCT01063517|560513278|FG001|Overall Study|Consent withdrawal|0|||
155296091|NCT01063517|560513277|FG000|Overall Study|Study reached data cut-off|19|||
155296092|NCT01063517|560513278|FG001|Overall Study|Study reached data cut-off|7|||
155296093|NCT01063517|560513277|FG000|Overall Study|Lost to Follow-up|4|||
155296094|NCT01063517|560513278|FG001|Overall Study|Lost to Follow-up|3|||
155296095|NCT01063517|560513277|FG000|Overall Study|Withdrawal by Subject|1|||
155296096|NCT01063517|560513278|FG001|Overall Study|Withdrawal by Subject|2|||
155296097|NCT01063517|560513277|FG000|Overall Study|Death|33|||
155296098|NCT01063517|560513278|FG001|Overall Study|Death|48|||
155296099|NCT02041104|560513279|FG000|Overall Study|Lost to Follow-up|1|||
155296100|NCT02041104|560513280|FG001|Overall Study|Lost to Follow-up|4|||
155296101|NCT02041104|560513279|FG000|Overall Study|discomfort during OGTT|0|||
155296102|NCT02041104|560513280|FG001|Overall Study|discomfort during OGTT|3|||
155296103|NCT02106442|560513281|FG000|Overall Study|Case Report Forms Uncollected|7|||
155296104|NCT02106442|560513281|FG000|Overall Study|Protocol Deviation|30|||
154956858|NCT03135834|559268859|FG001|Stage 1|Withdrawal by parent/guardian|10|||
154956859|NCT03135834|559268860|FG002|Stage 1|Withdrawal by parent/guardian|2|||
154956860|NCT03135834|559268861|FG003|Stage 1|Withdrawal by parent/guardian|1|||
154956861|NCT03135834|559268858|FG000|Stage 1|Withdrawal by Subject|16|||
154956862|NCT03135834|559268859|FG001|Stage 1|Withdrawal by Subject|22|||
154956863|NCT03135834|559268860|FG002|Stage 1|Withdrawal by Subject|7|||
154956864|NCT03135834|559268861|FG003|Stage 1|Withdrawal by Subject|10|||
154956865|NCT03135834|559268858|FG000|Stage 1|Randomized but not Vaccinated|0|||
154956866|NCT03135834|559268859|FG001|Stage 1|Randomized but not Vaccinated|3|||
154956867|NCT03135834|559268860|FG002|Stage 1|Randomized but not Vaccinated|1|||
154956868|NCT03135834|559268861|FG003|Stage 1|Randomized but not Vaccinated|6|||
154956869|NCT03135834|559268858|FG000|Stage 2|Lost to Follow-up|0|||
154956870|NCT03135834|559268859|FG001|Stage 2|Lost to Follow-up|1|||
154956871|NCT03135834|559268860|FG002|Stage 2|Lost to Follow-up|0|||
154956872|NCT03135834|559268861|FG003|Stage 2|Lost to Follow-up|0|||
154956873|NCT03135834|559268858|FG000|Stage 2|Withdrawal by Subject|0|||
154956874|NCT03135834|559268859|FG001|Stage 2|Withdrawal by Subject|1|||
154956875|NCT03135834|559268860|FG002|Stage 2|Withdrawal by Subject|0|||
154956876|NCT03135834|559268861|FG003|Stage 2|Withdrawal by Subject|0|||
154956877|NCT03135834|559268858|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
154956878|NCT03135834|559268859|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
154956879|NCT03135834|559268860|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
154956880|NCT03135834|559268861|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
155061203|NCT01206764|559659271|FG000|Overall Study|Disease progression|88|||
154956881|NCT03135834|559268858|FG000|Stage 2|Did not receive Booster Vaccination|1|||
154956882|NCT03135834|559268859|FG001|Stage 2|Did not receive Booster Vaccination|1|||
154956883|NCT03135834|559268860|FG002|Stage 2|Did not receive Booster Vaccination|0|||
154956884|NCT03135834|559268861|FG003|Stage 2|Did not receive Booster Vaccination|0|||
154956885|NCT03966365|559268862|FG000|Overall Study|Protocol Violation|1|||
154956886|NCT03966365|559268863|FG001|Overall Study|Protocol Violation|0|||
154956887|NCT00214422|559268864|FG000|Overall Study|Physician Decision|2|||
154956888|NCT00214422|559268865|FG001|Overall Study|Physician Decision|0|||
154956889|NCT00214422|559268866|FG002|Overall Study|Physician Decision|0|||
154956890|NCT00214422|559268864|FG000|Overall Study|Developed esophageal ca|1|||
154956891|NCT00214422|559268865|FG001|Overall Study|Developed esophageal ca|0|||
154956892|NCT00214422|559268866|FG002|Overall Study|Developed esophageal ca|0|||
154956893|NCT00214422|559268864|FG000|Overall Study|Pt taken off study|1|||
154956894|NCT00214422|559268865|FG001|Overall Study|Pt taken off study|1|||
154956895|NCT00214422|559268866|FG002|Overall Study|Pt taken off study|0|||
154956896|NCT00214422|559268864|FG000|Overall Study|Disease progression on study|1|||
154956897|NCT00214422|559268865|FG001|Overall Study|Disease progression on study|0|||
154956898|NCT00214422|559268866|FG002|Overall Study|Disease progression on study|0|||
155157824|NCT03879772|560016530|FG004|Overall Study|Protocol Violation|2|||
155157825|NCT03879772|560016526|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
154956899|NCT00214422|559268864|FG000|Overall Study|Unable to make a radiation treatment|0|||
154956900|NCT00214422|559268865|FG001|Overall Study|Unable to make a radiation treatment|0|||
154956901|NCT00214422|559268866|FG002|Overall Study|Unable to make a radiation treatment|1|||
154956902|NCT01223365|559268871|FG000|Open-label Titration Period|Enrolled but not treated|1|||
155157826|NCT03879772|560016527|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
155157827|NCT03879772|560016528|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
155157828|NCT03879772|560016529|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
155157829|NCT03879772|560016530|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
155157830|NCT01210313|560016535|FG000|Overall Study|Withdrawal by Subject|3|||
155157831|NCT01210313|560016535|FG000|Overall Study|Adverse Event|2|||
155157832|NCT01210313|560016535|FG000|Overall Study|Distant recurrence|4|||
155157833|NCT01210313|560016535|FG000|Overall Study|Non-compliance|7|||
155157834|NCT03113487|560016540|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
155157835|NCT03777982|560016541|FG000|Overall Study|Physician Decision|0|||
155157836|NCT03777982|560016542|FG001|Overall Study|Physician Decision|1|||
155157837|NCT00870740|560016545|FG000|Overall Study|Adverse Event|2|||
155157838|NCT00870740|560016546|FG001|Overall Study|Adverse Event|1|||
155157839|NCT00870740|560016547|FG002|Overall Study|Adverse Event|3|||
155157840|NCT00870740|560016548|FG003|Overall Study|Adverse Event|2|||
155157841|NCT00870740|560016549|FG004|Overall Study|Adverse Event|1|||
155157842|NCT00870740|560016550|FG005|Overall Study|Adverse Event|6|||
155157843|NCT00870740|560016545|FG000|Overall Study|Consent Withdrawn|6|||
155157844|NCT00870740|560016546|FG001|Overall Study|Consent Withdrawn|3|||
155157845|NCT00870740|560016547|FG002|Overall Study|Consent Withdrawn|4|||
155157846|NCT00870740|560016548|FG003|Overall Study|Consent Withdrawn|6|||
155157847|NCT00870740|560016549|FG004|Overall Study|Consent Withdrawn|6|||
155157848|NCT00870740|560016550|FG005|Overall Study|Consent Withdrawn|5|||
155157849|NCT00870740|560016545|FG000|Overall Study|Investigator Decision|2|||
155157850|NCT00870740|560016546|FG001|Overall Study|Investigator Decision|0|||
155157851|NCT00870740|560016547|FG002|Overall Study|Investigator Decision|1|||
155157852|NCT00870740|560016548|FG003|Overall Study|Investigator Decision|0|||
155157853|NCT00870740|560016549|FG004|Overall Study|Investigator Decision|0|||
155157854|NCT00870740|560016550|FG005|Overall Study|Investigator Decision|0|||
155157855|NCT00870740|560016545|FG000|Overall Study|Subject Non-compliance|0|||
155157856|NCT00870740|560016546|FG001|Overall Study|Subject Non-compliance|0|||
155157857|NCT00870740|560016547|FG002|Overall Study|Subject Non-compliance|0|||
155157858|NCT00870740|560016548|FG003|Overall Study|Subject Non-compliance|0|||
155157859|NCT00870740|560016549|FG004|Overall Study|Subject Non-compliance|0|||
155157860|NCT00870740|560016550|FG005|Overall Study|Subject Non-compliance|1|||
155157861|NCT00870740|560016545|FG000|Overall Study|Death|0|||
155157862|NCT00870740|560016546|FG001|Overall Study|Death|0|||
155157863|NCT00870740|560016547|FG002|Overall Study|Death|0|||
155157864|NCT00870740|560016548|FG003|Overall Study|Death|0|||
155157865|NCT00870740|560016549|FG004|Overall Study|Death|1|||
155157866|NCT00870740|560016550|FG005|Overall Study|Death|0|||
154956903|NCT01223365|559268871|FG000|Open-label Titration Period|Adverse Event|23|||
154956904|NCT01223365|559268871|FG000|Open-label Titration Period|Lack of Efficacy|3|||
154956905|NCT01223365|559268871|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
155157867|NCT00870740|560016545|FG000|Overall Study|Other|2|||
155157868|NCT00870740|560016546|FG001|Overall Study|Other|5|||
155157869|NCT00870740|560016547|FG002|Overall Study|Other|2|||
155157870|NCT00870740|560016548|FG003|Overall Study|Other|4|||
155157871|NCT00870740|560016549|FG004|Overall Study|Other|3|||
155157872|NCT00870740|560016550|FG005|Overall Study|Other|5|||
155157873|NCT04298697|560016551|FG000|Overall Study|Lost to Follow-up|5|||
155157874|NCT04298697|560016552|FG001|Overall Study|Lost to Follow-up|5|||
155157875|NCT04298697|560016553|FG002|Overall Study|Lost to Follow-up|1|||
155296105|NCT03215927|560514640|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
155296106|NCT03215927|560514641|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
155296107|NCT03215927|560514640|FG000|Open Label Extension|Adverse Event|1|||
155296108|NCT03215927|560514641|FG001|Open Label Extension|Adverse Event|0|||
155296109|NCT03215927|560514640|FG000|Open Label Extension|Lack of Efficacy|1|||
155296110|NCT03215927|560514641|FG001|Open Label Extension|Lack of Efficacy|0|||
155296111|NCT03215927|560514640|FG000|Open Label Extension|Death|0|||
155296112|NCT03215927|560514641|FG001|Open Label Extension|Death|1|||
155296113|NCT04001829|560514644|FG000|Overall Study|Never start protocol therapy|5|||
155296114|NCT04001829|560514645|FG001|Overall Study|Never start protocol therapy|5|||
155296115|NCT04001829|560514644|FG000|Overall Study|Adverse Event|11|||
155296116|NCT04001829|560514645|FG001|Overall Study|Adverse Event|7|||
155296117|NCT04001829|560514644|FG000|Overall Study|Alternative therapy|1|||
155296118|NCT04001829|560514645|FG001|Overall Study|Alternative therapy|2|||
155296119|NCT04001829|560514644|FG000|Overall Study|Disease progression/relapse|2|||
155296120|NCT04001829|560514645|FG001|Overall Study|Disease progression/relapse|1|||
155296121|NCT04001829|560514644|FG000|Overall Study|Other complicating disease|1|||
155296122|NCT04001829|560514645|FG001|Overall Study|Other complicating disease|0|||
155296123|NCT04001829|560514644|FG000|Overall Study|Withdrawal by Subject|1|||
155296124|NCT04001829|560514645|FG001|Overall Study|Withdrawal by Subject|4|||
155296125|NCT04001829|560514644|FG000|Overall Study|Ineligible|2|||
155296126|NCT04001829|560514645|FG001|Overall Study|Ineligible|2|||
155296127|NCT04001829|560514644|FG000|Overall Study|Reason missing due to delinquent data|1|||
155296128|NCT04001829|560514645|FG001|Overall Study|Reason missing due to delinquent data|0|||
155296129|NCT03175172|560514646|FG000|Overall Study|Death|3|||
155296130|NCT03175172|560514646|FG000|Overall Study|Withdrawal by Subject|3|||
155296131|NCT03175172|560514646|FG000|Overall Study|Lost to Follow-up|1|||
155296132|NCT03175172|560514646|FG000|Overall Study|Study Terminated by Sponsor|3|||
155296133|NCT02974634|560514647|FG000|Overall Study|Advanced disease|12|||
155296134|NCT02974634|560514648|FG001|Overall Study|Advanced disease|3|||
155296135|NCT02974634|560514647|FG000|Overall Study|Noncompliance|3|||
155296136|NCT02974634|560514648|FG001|Overall Study|Noncompliance|7|||
155296137|NCT02974634|560514647|FG000|Overall Study|intervention technology related issues|5|||
155296138|NCT02974634|560514648|FG001|Overall Study|intervention technology related issues|0|||
155296139|NCT02974634|560514647|FG000|Overall Study|Death|8|||
155296140|NCT02974634|560514648|FG001|Overall Study|Death|11|||
155296141|NCT01393119|560514649|FG000|Overall Study|Adverse Event|1|||
155296142|NCT01393119|560514650|FG001|Overall Study|Adverse Event|1|||
155296143|NCT01393119|560514651|FG002|Overall Study|Adverse Event|0|||
155296144|NCT01393119|560514652|FG003|Overall Study|Adverse Event|1|||
155296145|NCT01393119|560514649|FG000|Overall Study|Withdrawal by Subject|0|||
155296146|NCT01393119|560514650|FG001|Overall Study|Withdrawal by Subject|1|||
155296147|NCT01393119|560514651|FG002|Overall Study|Withdrawal by Subject|1|||
155296148|NCT01393119|560514652|FG003|Overall Study|Withdrawal by Subject|0|||
155296149|NCT01393119|560514649|FG000|Overall Study|Lack of Efficacy|1|||
155296150|NCT01393119|560514650|FG001|Overall Study|Lack of Efficacy|0|||
155296151|NCT01393119|560514651|FG002|Overall Study|Lack of Efficacy|2|||
155296152|NCT01393119|560514652|FG003|Overall Study|Lack of Efficacy|1|||
155296153|NCT01393119|560514649|FG000|Overall Study|Protocol Violation|0|||
155296154|NCT01393119|560514650|FG001|Overall Study|Protocol Violation|0|||
155296155|NCT01393119|560514651|FG002|Overall Study|Protocol Violation|1|||
155296156|NCT01393119|560514652|FG003|Overall Study|Protocol Violation|0|||
155296157|NCT01393119|560514649|FG000|Overall Study|Death|0|||
155296158|NCT01393119|560514650|FG001|Overall Study|Death|0|||
155296159|NCT01393119|560514651|FG002|Overall Study|Death|0|||
155296160|NCT01393119|560514652|FG003|Overall Study|Death|1|||
155296161|NCT01393119|560514649|FG000|Overall Study|Randomized but Not treated|1|||
155296162|NCT01393119|560514650|FG001|Overall Study|Randomized but Not treated|0|||
155296163|NCT01393119|560514651|FG002|Overall Study|Randomized but Not treated|1|||
155296164|NCT01393119|560514652|FG003|Overall Study|Randomized but Not treated|1|||
155296165|NCT01393119|560514649|FG000|Overall Study|Sponsor Termination of Study|11|||
155296166|NCT01393119|560514650|FG001|Overall Study|Sponsor Termination of Study|12|||
155296167|NCT01393119|560514651|FG002|Overall Study|Sponsor Termination of Study|9|||
155296168|NCT01393119|560514652|FG003|Overall Study|Sponsor Termination of Study|12|||
155296169|NCT01266265|560514653|FG000|Overall Study|Death|95|||
155296170|NCT01266265|560514654|FG001|Overall Study|Death|73|||
154956906|NCT01223365|559268871|FG000|Open-label Titration Period|Protocol Violation|1|||
155296171|NCT01266265|560514653|FG000|Overall Study|Lost to Follow-up|23|||
155296172|NCT01266265|560514654|FG001|Overall Study|Lost to Follow-up|28|||
155296173|NCT01266265|560514653|FG000|Overall Study|Withdrawal by Subject|13|||
155296174|NCT01266265|560514654|FG001|Overall Study|Withdrawal by Subject|11|||
154956907|NCT01223365|559268871|FG000|Open-label Titration Period|Lost to Follow-up|2|||
154956908|NCT01223365|559268871|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
154956909|NCT01223365|559268871|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
154956910|NCT01223365|559268871|FG000|Open-label Titration Period|Starting physical therapy|1|||
154956911|NCT01223365|559268871|FG000|Open-label Treatment Period|Adverse Event|39|||
154956912|NCT01223365|559268871|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
155296175|NCT01266265|560514653|FG000|Overall Study|Respiratory-related adverse event|2|||
155296176|NCT01266265|560514654|FG001|Overall Study|Respiratory-related adverse event|1|||
155296177|NCT01266265|560514653|FG000|Overall Study|Transferred care to another provider|22|||
155296178|NCT01266265|560514654|FG001|Overall Study|Transferred care to another provider|28|||
155296179|NCT01266265|560514653|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
155296180|NCT01266265|560514654|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
155296181|NCT01266265|560514653|FG000|Overall Study|Enrolled in another clinical study|15|||
155296182|NCT01266265|560514654|FG001|Overall Study|Enrolled in another clinical study|26|||
155296183|NCT01266265|560514653|FG000|Overall Study|Non-compliance|8|||
155296184|NCT01266265|560514654|FG001|Overall Study|Non-compliance|5|||
155296185|NCT01266265|560514653|FG000|Overall Study|Lung transplant|6|||
155296186|NCT01266265|560514654|FG001|Overall Study|Lung transplant|5|||
155296187|NCT01266265|560514653|FG000|Overall Study|Site closed early|4|||
155296188|NCT01266265|560514654|FG001|Overall Study|Site closed early|3|||
155296189|NCT01266265|560514653|FG000|Overall Study|Clinical worsening|1|||
155296190|NCT01266265|560514654|FG001|Overall Study|Clinical worsening|1|||
155296191|NCT01580293|560514655|FG000|Part A_Main Trial|Adverse Event|0|||
155296192|NCT01580293|560514656|FG001|Part A_Main Trial|Adverse Event|2|||
155296193|NCT01580293|560514657|FG002|Part A_Main Trial|Adverse Event|0|||
155296194|NCT01580293|560514655|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
155296195|NCT01580293|560514656|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
155296196|NCT01580293|560514657|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
155296197|NCT01580293|560514655|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
155296198|NCT01580293|560514656|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
155296199|NCT01580293|560514657|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
155296200|NCT01580293|560514655|FG000|Part A_Extension|Adverse Event|0|||
155296201|NCT01580293|560514656|FG001|Part A_Extension|Adverse Event|2|||
155296202|NCT01580293|560514657|FG002|Part A_Extension|Adverse Event|0|||
155296203|NCT01580293|560514655|FG000|Part A_Extension|Withdrawal by Subject|0|||
155296204|NCT01580293|560514656|FG001|Part A_Extension|Withdrawal by Subject|3|||
155296205|NCT01580293|560514657|FG002|Part A_Extension|Withdrawal by Subject|0|||
155296206|NCT01580293|560514655|FG000|Part A_Extension|Lost to Follow-up|0|||
155296207|NCT01580293|560514656|FG001|Part A_Extension|Lost to Follow-up|1|||
155296208|NCT01580293|560514657|FG002|Part A_Extension|Lost to Follow-up|0|||
155296209|NCT01580293|560514655|FG000|Part A_Extension|Other Reason|0|||
155296210|NCT01580293|560514656|FG001|Part A_Extension|Other Reason|1|||
155296211|NCT01580293|560514657|FG002|Part A_Extension|Other Reason|0|||
155296212|NCT01580293|560514655|FG000|Part A_Extension|Completed Japan only|0|||
155296213|NCT01580293|560514656|FG001|Part A_Extension|Completed Japan only|5|||
155296214|NCT01580293|560514657|FG002|Part A_Extension|Completed Japan only|0|||
155296215|NCT01580293|560514655|FG000|Part B|Withdrawal by Subject|0|||
155296216|NCT01580293|560514656|FG001|Part B|Withdrawal by Subject|0|||
155296217|NCT01580293|560514657|FG002|Part B|Withdrawal by Subject|1|||
155296218|NCT01580293|560514655|FG000|Part B|Other reason|0|||
155296219|NCT01580293|560514656|FG001|Part B|Other reason|0|||
155296220|NCT01580293|560514657|FG002|Part B|Other reason|1|||
155296221|NCT01400776|560514658|FG000|Overall Study|Adverse Event|7|||
155296222|NCT01400776|560514659|FG001|Overall Study|Adverse Event|2|||
155296223|NCT01400776|560514660|FG002|Overall Study|Adverse Event|9|||
155296224|NCT01400776|560514661|FG003|Overall Study|Adverse Event|2|||
155296225|NCT01400776|560514658|FG000|Overall Study|Lost to Follow-up|1|||
155296226|NCT01400776|560514659|FG001|Overall Study|Lost to Follow-up|0|||
155296227|NCT01400776|560514660|FG002|Overall Study|Lost to Follow-up|4|||
155296228|NCT01400776|560514661|FG003|Overall Study|Lost to Follow-up|1|||
155296229|NCT01400776|560514658|FG000|Overall Study|Withdrew Consent|4|||
155296230|NCT01400776|560514659|FG001|Overall Study|Withdrew Consent|2|||
155296231|NCT01400776|560514660|FG002|Overall Study|Withdrew Consent|6|||
155296232|NCT01400776|560514661|FG003|Overall Study|Withdrew Consent|1|||
155296233|NCT01400776|560514658|FG000|Overall Study|Protocol Deviation|6|||
155296234|NCT01400776|560514659|FG001|Overall Study|Protocol Deviation|1|||
155296235|NCT01400776|560514660|FG002|Overall Study|Protocol Deviation|5|||
155296236|NCT01400776|560514661|FG003|Overall Study|Protocol Deviation|2|||
155296237|NCT01400776|560514658|FG000|Overall Study|Reason not Specified|3|||
155296238|NCT01400776|560514659|FG001|Overall Study|Reason not Specified|0|||
154956913|NCT01223365|559268871|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
154956914|NCT01223365|559268871|FG000|Open-label Treatment Period|Protocol Violation|15|||
154956915|NCT01223365|559268871|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
155296239|NCT01400776|560514660|FG002|Overall Study|Reason not Specified|4|||
155296240|NCT01400776|560514661|FG003|Overall Study|Reason not Specified|3|||
155296241|NCT02983617|560514673|FG000|Overall Study|Adverse Event|0|||
155296242|NCT02983617|560514674|FG001|Overall Study|Adverse Event|7|||
155296243|NCT02983617|560514673|FG000|Overall Study|Death|0|||
155296244|NCT02983617|560514674|FG001|Overall Study|Death|1|||
155296245|NCT02983617|560514673|FG000|Overall Study|Investigator's Discretion|0|||
155296246|NCT02983617|560514674|FG001|Overall Study|Investigator's Discretion|1|||
155296247|NCT00002842|560514675|FG000|Overall Study|ineligible for surgical resection|27|||
155296248|NCT02383472|560514676|FG000|Overall Study|Withdrawal by Subject|1|||
154956916|NCT01223365|559268871|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
154956917|NCT01223365|559268871|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
154956918|NCT01223365|559268871|FG000|Open-label Treatment Period|Moved out of area|2|||
154956919|NCT01223365|559268871|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
154956920|NCT01223365|559268871|FG000|Open-label Treatment Period|"Out of window"|1|||
154956921|NCT01223365|559268871|FG000|Open-label Treatment Period|Starting physical therapy|1|||
154956922|NCT01223365|559268871|FG000|Open-label Treatment Period|Physician Decision|2|||
154956923|NCT02865122|559268872|FG000|Overall Study|Adverse Event|1|||
154956924|NCT02865122|559268873|FG001|Overall Study|Adverse Event|0|||
154956925|NCT02865122|559268874|FG002|Overall Study|Adverse Event|0|||
154956926|NCT05369208|559270669|FG000|Core Phase|Prohibited Medication Required|2|||
154956927|NCT05369208|559270669|FG000|Core Phase|Adverse Event|1|||
154956928|NCT05369208|559270669|FG000|Core Phase|Lack of Efficacy|1|||
154956929|NCT02262377|559270670|FG000|Overall Study|Lost to Follow-up|5|||
154956930|NCT02262377|559270671|FG001|Overall Study|Lost to Follow-up|6|||
154956931|NCT02262377|559270670|FG000|Overall Study|Found ineligible after enrollment|3|||
154956932|NCT02262377|559270671|FG001|Overall Study|Found ineligible after enrollment|0|||
154956933|NCT02262377|559270670|FG000|Overall Study|Withdrawal by Subject|4|||
154956934|NCT02262377|559270671|FG001|Overall Study|Withdrawal by Subject|0|||
154956935|NCT00371839|559270672|FG000|Overall Study|Death|4|||
154956936|NCT00371839|559270673|FG001|Overall Study|Death|0|||
154956937|NCT00371839|559270674|FG002|Overall Study|Death|0|||
154956938|NCT00371839|559270672|FG000|Overall Study|Withdrawal by Subject|7|||
154956939|NCT00371839|559270673|FG001|Overall Study|Withdrawal by Subject|4|||
154956940|NCT00371839|559270674|FG002|Overall Study|Withdrawal by Subject|0|||
154956941|NCT00371839|559270672|FG000|Overall Study|Lost to Follow-up|6|||
154956942|NCT00371839|559270673|FG001|Overall Study|Lost to Follow-up|3|||
154956943|NCT00371839|559270674|FG002|Overall Study|Lost to Follow-up|2|||
154956944|NCT01049334|559270676|FG000|Overall Study|Withdrawal by Subject|5|||
154956945|NCT01049334|559270677|FG001|Overall Study|Withdrawal by Subject|3|||
154956946|NCT01049334|559270676|FG000|Overall Study|Adverse Event|2|||
154956947|NCT01049334|559270677|FG001|Overall Study|Adverse Event|3|||
154956948|NCT01049334|559270676|FG000|Overall Study|Physician Decision|2|||
154956949|NCT01049334|559270677|FG001|Overall Study|Physician Decision|0|||
154956950|NCT01049334|559270676|FG000|Overall Study|Protocol Violation|0|||
154956951|NCT01049334|559270677|FG001|Overall Study|Protocol Violation|1|||
154956952|NCT04089735|559270678|FG000|Overall Study|Adverse Event|1|||
154956953|NCT04089735|559270679|FG001|Overall Study|Adverse Event|0|||
154956954|NCT04089735|559270680|FG002|Overall Study|Adverse Event|1|||
154956955|NCT04089735|559270681|FG003|Overall Study|Adverse Event|1|||
154956956|NCT04089735|559270682|FG004|Overall Study|Adverse Event|0|||
154956957|NCT04089735|559270683|FG005|Overall Study|Adverse Event|0|||
154956958|NCT04089735|559270678|FG000|Overall Study|Physician Decision|0|||
154956959|NCT04089735|559270679|FG001|Overall Study|Physician Decision|3|||
154956960|NCT04089735|559270680|FG002|Overall Study|Physician Decision|0|||
154956961|NCT04089735|559270681|FG003|Overall Study|Physician Decision|0|||
154956962|NCT04089735|559270682|FG004|Overall Study|Physician Decision|0|||
154956963|NCT04089735|559270683|FG005|Overall Study|Physician Decision|0|||
154956964|NCT04089735|559270678|FG000|Overall Study|Withdrawal by Subject|0|||
154956965|NCT04089735|559270679|FG001|Overall Study|Withdrawal by Subject|0|||
154956966|NCT04089735|559270680|FG002|Overall Study|Withdrawal by Subject|1|||
154956967|NCT04089735|559270681|FG003|Overall Study|Withdrawal by Subject|0|||
154956968|NCT04089735|559270682|FG004|Overall Study|Withdrawal by Subject|0|||
154956969|NCT04089735|559270683|FG005|Overall Study|Withdrawal by Subject|0|||
154956970|NCT04089735|559270678|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
154956971|NCT04089735|559270679|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
154956972|NCT04089735|559270680|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
154956973|NCT04089735|559270681|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
154956974|NCT04089735|559270682|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
154956975|NCT04089735|559270683|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
154956976|NCT00573066|559270689|FG000|Overall Study|Exclusion criteria|18|||
154956977|NCT00573066|559270689|FG000|Overall Study|IV malfunction|1|||
154956978|NCT00573066|559270689|FG000|Overall Study|Postoperative bleeding|1|||
155296249|NCT02383472|560514677|FG001|Overall Study|Withdrawal by Subject|1|||
155296250|NCT02013830|560514678|FG000|Overall Study|Adverse Event|3|||
155296251|NCT02013830|560514678|FG000|Overall Study|Death|1|||
155296252|NCT02013830|560514678|FG000|Overall Study|Insufficient therapeutic response|25|||
155296253|NCT02013830|560514678|FG000|Overall Study|Refused treatment|1|||
155296254|NCT01111526|560514679|FG000|Overall Study|GVHD Disease Progression|0|||
155296255|NCT01111526|560514680|FG001|Overall Study|GVHD Disease Progression|1|||
155296256|NCT01111526|560514681|FG002|Overall Study|GVHD Disease Progression|2|||
155296257|NCT01171625|560514682|FG000|Overall Study|On-Protocol|67|||
155296258|NCT01171625|560514682|FG000|Overall Study|Death|38|||
155296259|NCT01171625|560514682|FG000|Overall Study|Withdrawal by Subject|31|||
155296260|NCT01171625|560514682|FG000|Overall Study|Explanted|10|||
155296261|NCT01171625|560514682|FG000|Overall Study|Lost to Follow-up|5|||
155296262|NCT01171625|560514682|FG000|Overall Study|Patient received valve-in-valve|3|||
155296263|NCT01171625|560514682|FG000|Overall Study|Other|1|||
155296264|NCT01171625|560514682|FG000|Overall Study|Consented but did not receive device|25|||
155296265|NCT01867216|560514683|FG000|Overall Study|Withdrawal by Subject|2|||
155296266|NCT01867216|560514684|FG001|Overall Study|Withdrawal by Subject|0|||
155296267|NCT01867216|560514685|FG002|Overall Study|Withdrawal by Subject|0|||
155296268|NCT01867216|560514686|FG003|Overall Study|Withdrawal by Subject|0|||
155296269|NCT01867216|560514687|FG004|Overall Study|Withdrawal by Subject|1|||
155296270|NCT01867216|560514688|FG005|Overall Study|Withdrawal by Subject|0|||
155296271|NCT01867216|560514689|FG006|Overall Study|Withdrawal by Subject|1|||
155296272|NCT01867216|560514683|FG000|Overall Study|Physician Decision|1|||
155296273|NCT01867216|560514684|FG001|Overall Study|Physician Decision|0|||
155296274|NCT01867216|560514685|FG002|Overall Study|Physician Decision|0|||
155296275|NCT01867216|560514686|FG003|Overall Study|Physician Decision|0|||
155296276|NCT01867216|560514687|FG004|Overall Study|Physician Decision|0|||
155296277|NCT01867216|560514688|FG005|Overall Study|Physician Decision|0|||
155296278|NCT01867216|560514689|FG006|Overall Study|Physician Decision|0|||
155296279|NCT01867216|560514683|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
155296280|NCT01867216|560514684|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296281|NCT01867216|560514685|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296282|NCT01867216|560514686|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296283|NCT01867216|560514687|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296284|NCT01867216|560514688|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296285|NCT01867216|560514689|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
155296286|NCT01337635|560514696|FG000|Overall Study|Lost to Follow-up|0|||
155296287|NCT01337635|560514697|FG001|Overall Study|Lost to Follow-up|1|||
155296288|NCT01113931|560514698|FG000|Overall Study|Adverse Event|2|||
155296289|NCT01113931|560514699|FG001|Overall Study|Adverse Event|2|||
155296290|NCT01113931|560514698|FG000|Overall Study|Physician Decision|0|||
155296291|NCT01113931|560514699|FG001|Overall Study|Physician Decision|2|||
155296292|NCT01113931|560514698|FG000|Overall Study|Lost to Follow-up|12|||
155296293|NCT01113931|560514699|FG001|Overall Study|Lost to Follow-up|9|||
155296294|NCT01113931|560514698|FG000|Overall Study|Various|2|||
155296295|NCT01113931|560514699|FG001|Overall Study|Various|4|||
155296296|NCT01113931|560514698|FG000|Overall Study|Withdrawal by Subject|3|||
155296297|NCT01113931|560514699|FG001|Overall Study|Withdrawal by Subject|0|||
155296298|NCT00842257|560514704|FG000|Overall Study|Adverse Event|1|||
155296299|NCT00909363|560514705|FG000|Overall Study|Withdrawal by Subject|1|||
155296300|NCT00909363|560514706|FG001|Overall Study|Withdrawal by Subject|0|||
155296301|NCT00909363|560514707|FG002|Overall Study|Withdrawal by Subject|0|||
155296302|NCT00909363|560514705|FG000|Overall Study|Lack of Efficacy|1|||
155296303|NCT00909363|560514706|FG001|Overall Study|Lack of Efficacy|0|||
155157876|NCT04298697|560016554|FG003|Overall Study|Lost to Follow-up|0|||
155157877|NCT04298697|560016551|FG000|Overall Study|Withdrawal by Subject|0|||
155157878|NCT04298697|560016552|FG001|Overall Study|Withdrawal by Subject|3|||
155157879|NCT04298697|560016553|FG002|Overall Study|Withdrawal by Subject|2|||
154956979|NCT02246166|559270692|FG000|Overall Study|Protocol Violation|1|||
154956980|NCT02246166|559270693|FG001|Overall Study|Protocol Violation|0|||
154956981|NCT00834743|559270694|FG000|Second Intervention|Withdrawal by Subject|1|||
154956982|NCT00834743|559270695|FG001|Second Intervention|Withdrawal by Subject|0|||
154956983|NCT03136380|559270699|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
154956984|NCT03136380|559270700|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
155296304|NCT00909363|560514707|FG002|Overall Study|Lack of Efficacy|0|||
155296305|NCT02547922|560514722|FG000|Overall Study|Withdrawal by Subject|9|||
155296306|NCT02547922|560514723|FG001|Overall Study|Withdrawal by Subject|6|||
155296307|NCT02547922|560514724|FG002|Overall Study|Withdrawal by Subject|10|||
155296308|NCT02547922|560514722|FG000|Overall Study|Adverse Event|3|||
155296309|NCT02547922|560514723|FG001|Overall Study|Adverse Event|1|||
154956985|NCT03136380|559270701|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
155157880|NCT04298697|560016554|FG003|Overall Study|Withdrawal by Subject|3|||
155296310|NCT02547922|560514724|FG002|Overall Study|Adverse Event|2|||
155296311|NCT02547922|560514722|FG000|Overall Study|Lost to Follow-up|1|||
155296312|NCT02547922|560514723|FG001|Overall Study|Lost to Follow-up|0|||
155296313|NCT02547922|560514724|FG002|Overall Study|Lost to Follow-up|0|||
155157881|NCT03995368|560016555|FG000|Overall Study|Lost to Follow-up|1|||
155157882|NCT03995368|560016556|FG001|Overall Study|Lost to Follow-up|4|||
155157883|NCT03995368|560016557|FG002|Overall Study|Lost to Follow-up|1|||
155157884|NCT03995368|560016555|FG000|Overall Study|Did not meet inclusion criteria|1|||
155157885|NCT03995368|560016556|FG001|Overall Study|Did not meet inclusion criteria|6|||
155157886|NCT03995368|560016557|FG002|Overall Study|Did not meet inclusion criteria|3|||
155157887|NCT03995368|560016555|FG000|Overall Study|Withdrawal by Subject|0|||
155157888|NCT03995368|560016556|FG001|Overall Study|Withdrawal by Subject|1|||
155157889|NCT03995368|560016557|FG002|Overall Study|Withdrawal by Subject|1|||
155157890|NCT03592186|560016558|FG000|Overall Study|Withdrawal by Subject|1|||
155157891|NCT03592186|560016559|FG001|Overall Study|Withdrawal by Subject|0|||
155157892|NCT03592186|560016558|FG000|Overall Study|Lost to Follow-up|16|||
155157893|NCT03592186|560016559|FG001|Overall Study|Lost to Follow-up|11|||
155157894|NCT03755934|560016560|FG000|Overall Study|Adverse Event|4|||
155157895|NCT03755934|560016561|FG001|Overall Study|Adverse Event|1|||
155157896|NCT03755934|560016562|FG002|Overall Study|Adverse Event|1|||
155157897|NCT03755934|560016563|FG003|Overall Study|Adverse Event|3|||
155157898|NCT03755934|560016560|FG000|Overall Study|Physician Decision|2|||
155157899|NCT03755934|560016561|FG001|Overall Study|Physician Decision|0|||
155157900|NCT03755934|560016562|FG002|Overall Study|Physician Decision|0|||
155157901|NCT03755934|560016563|FG003|Overall Study|Physician Decision|1|||
155157902|NCT03755934|560016560|FG000|Overall Study|Withdrawal by Subject|5|||
155157903|NCT03755934|560016561|FG001|Overall Study|Withdrawal by Subject|0|||
155157904|NCT03755934|560016562|FG002|Overall Study|Withdrawal by Subject|0|||
155157905|NCT03755934|560016563|FG003|Overall Study|Withdrawal by Subject|1|||
155157906|NCT03755934|560016560|FG000|Overall Study|Other|3|||
155157907|NCT03755934|560016561|FG001|Overall Study|Other|1|||
155157908|NCT03755934|560016562|FG002|Overall Study|Other|3|||
155157909|NCT03755934|560016563|FG003|Overall Study|Other|1|||
155157910|NCT00361296|560016566|FG000|Overall Study|Physician Decision|1|||
155157911|NCT00361296|560016566|FG000|Overall Study|Lack of Efficacy|2|||
155157912|NCT02072668|560016570|FG000|Second Intervention|Lost to Follow-up|1|||
155157913|NCT02072668|560016571|FG001|Second Intervention|Lost to Follow-up|0|||
155157914|NCT01352793|560016577|FG000|Overall Study|Lost to Follow-up|289|||
155157915|NCT01352793|560016578|FG001|Overall Study|Lost to Follow-up|125|||
155157916|NCT01352793|560016577|FG000|Overall Study|Withdrawal by Subject|120|||
155157917|NCT01352793|560016578|FG001|Overall Study|Withdrawal by Subject|55|||
155157918|NCT01352793|560016577|FG000|Overall Study|Protocol Violation|44|||
155157919|NCT01352793|560016578|FG001|Overall Study|Protocol Violation|23|||
155157920|NCT01352793|560016577|FG000|Overall Study|Adverse Event|44|||
155157921|NCT01352793|560016578|FG001|Overall Study|Adverse Event|10|||
155157922|NCT01352793|560016577|FG000|Overall Study|Physician Decision|1|||
155157923|NCT01352793|560016578|FG001|Overall Study|Physician Decision|0|||
155157924|NCT01352793|560016577|FG000|Overall Study|Pregnancy|26|||
155157925|NCT01352793|560016578|FG001|Overall Study|Pregnancy|8|||
155157926|NCT01352793|560016577|FG000|Overall Study|Other|25|||
155157927|NCT01352793|560016578|FG001|Overall Study|Other|7|||
155157928|NCT01352793|560016577|FG000|Overall Study|Medication error|2|||
155157929|NCT01352793|560016578|FG001|Overall Study|Medication error|2|||
155157930|NCT01352793|560016577|FG000|Overall Study|Death|1|||
155157931|NCT01352793|560016578|FG001|Overall Study|Death|0|||
155157932|NCT01352793|560016577|FG000|Overall Study|Randomized but not vaccinated|8|||
155157933|NCT01352793|560016578|FG001|Overall Study|Randomized but not vaccinated|0|||
155157934|NCT01352793|560016577|FG000|Overall Study|No longer meets eligibility criteria|25|||
155157935|NCT01352793|560016578|FG001|Overall Study|No longer meets eligibility criteria|15|||
155157936|NCT04322526|560016581|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
155157937|NCT04322526|560016582|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155157938|NCT04322526|560016581|FG000|Washout (1 Week)|Lost to Follow-up|1|||
155157939|NCT04322526|560016582|FG001|Washout (1 Week)|Lost to Follow-up|2|||
155157940|NCT01716234|560016586|FG000|Overall Study|Protocol Violation|0|||
155157941|NCT01716234|560016587|FG001|Overall Study|Protocol Violation|0|||
155157942|NCT01716234|560016588|FG002|Overall Study|Protocol Violation|0|||
155157943|NCT01716234|560016589|FG003|Overall Study|Protocol Violation|1|||
155157944|NCT01716234|560016590|FG004|Overall Study|Protocol Violation|1|||
155157945|NCT01716234|560016591|FG005|Overall Study|Protocol Violation|1|||
155157946|NCT01716234|560016592|FG006|Overall Study|Protocol Violation|0|||
155157947|NCT01716234|560016586|FG000|Overall Study|Lack of Efficacy|0|||
155157948|NCT01716234|560016587|FG001|Overall Study|Lack of Efficacy|0|||
155157949|NCT01716234|560016588|FG002|Overall Study|Lack of Efficacy|0|||
155157950|NCT01716234|560016589|FG003|Overall Study|Lack of Efficacy|1|||
155157951|NCT01716234|560016590|FG004|Overall Study|Lack of Efficacy|0|||
155157952|NCT01716234|560016591|FG005|Overall Study|Lack of Efficacy|0|||
155157953|NCT01716234|560016592|FG006|Overall Study|Lack of Efficacy|0|||
155157954|NCT01716234|560016586|FG000|Overall Study|Did not meet protocol eligibility|0|||
155157955|NCT01716234|560016587|FG001|Overall Study|Did not meet protocol eligibility|0|||
155157956|NCT01716234|560016588|FG002|Overall Study|Did not meet protocol eligibility|1|||
155157957|NCT01716234|560016589|FG003|Overall Study|Did not meet protocol eligibility|0|||
155157958|NCT01716234|560016590|FG004|Overall Study|Did not meet protocol eligibility|0|||
155296314|NCT02547922|560514722|FG000|Overall Study|Lack of Efficacy|5|||
155296315|NCT02547922|560514723|FG001|Overall Study|Lack of Efficacy|7|||
155296316|NCT02547922|560514724|FG002|Overall Study|Lack of Efficacy|4|||
155296317|NCT02547922|560514722|FG000|Overall Study|Death|1|||
155296318|NCT02547922|560514723|FG001|Overall Study|Death|0|||
155296319|NCT02547922|560514724|FG002|Overall Study|Death|0|||
155296320|NCT02547922|560514722|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
155296321|NCT02547922|560514723|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
155296322|NCT02547922|560514724|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
155296323|NCT02547922|560514722|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
155296324|NCT02547922|560514723|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
155296325|NCT02547922|560514724|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
155296326|NCT02547922|560514722|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
155296327|NCT02547922|560514723|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
155296328|NCT02547922|560514724|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
155296329|NCT02547922|560514722|FG000|Overall Study|Physician Decision|2|||
155296330|NCT02547922|560514723|FG001|Overall Study|Physician Decision|1|||
155296331|NCT02547922|560514724|FG002|Overall Study|Physician Decision|2|||
155296332|NCT02547922|560514722|FG000|Overall Study|Patients did not receive IP|1|||
155296333|NCT02547922|560514723|FG001|Overall Study|Patients did not receive IP|1|||
155296334|NCT02547922|560514724|FG002|Overall Study|Patients did not receive IP|0|||
155296335|NCT00468052|560514725|FG000|Overall Study|Protocol Violation|7|||
155296336|NCT00468052|560514726|FG001|Overall Study|Protocol Violation|8|||
155296337|NCT00857649|560514727|FG000|Overall Study|Adverse Event|15|||
155296338|NCT00857649|560514728|FG001|Overall Study|Adverse Event|10|||
155296339|NCT00857649|560514727|FG000|Overall Study|Non-compliance|1|||
155296340|NCT00857649|560514728|FG001|Overall Study|Non-compliance|1|||
155296341|NCT00857649|560514727|FG000|Overall Study|Protocol Violation|2|||
155296342|NCT00857649|560514728|FG001|Overall Study|Protocol Violation|2|||
155296343|NCT00857649|560514727|FG000|Overall Study|Withdrawal of Consent|10|||
155296344|NCT00857649|560514728|FG001|Overall Study|Withdrawal of Consent|7|||
155296345|NCT00857649|560514727|FG000|Overall Study|Nursing Home Placement|2|||
155296346|NCT00857649|560514728|FG001|Overall Study|Nursing Home Placement|9|||
155296347|NCT00857649|560514727|FG000|Overall Study|Other Reasons|1|||
155296348|NCT00857649|560514728|FG001|Overall Study|Other Reasons|3|||
155296349|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
155296350|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
155296351|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
155296352|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
155296353|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
155296354|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
155296355|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
155296356|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
155296357|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
155296358|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155296359|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155296360|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
154956986|NCT03136380|559270702|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
154956987|NCT03136380|559270703|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
154956988|NCT00376623|559270706|FG000|Overall Study|Progressive disease|35|||
154956989|NCT00376623|559270707|FG001|Overall Study|Progressive disease|22|||
154956990|NCT00376623|559270708|FG002|Overall Study|Progressive disease|17|||
154956991|NCT00376623|559270706|FG000|Overall Study|Lost to Follow-up|0|||
154956992|NCT00376623|559270707|FG001|Overall Study|Lost to Follow-up|1|||
154956993|NCT00376623|559270708|FG002|Overall Study|Lost to Follow-up|0|||
154956994|NCT00376623|559270706|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
154956995|NCT00376623|559270707|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
154956996|NCT00376623|559270708|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
155157959|NCT01716234|560016591|FG005|Overall Study|Did not meet protocol eligibility|4|||
155296361|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
155296362|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
155296363|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
155296364|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296365|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296366|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
155296367|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296368|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296369|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296370|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296371|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296372|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
154956997|NCT00376623|559270706|FG000|Overall Study|Not treated with BI 2536|1|||
155296373|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296374|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
155296375|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
155296376|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
155296377|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
155296378|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
155296379|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
155296380|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
155296381|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
155296382|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
155296383|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
155296384|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296385|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296386|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296387|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
155296388|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296389|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
155296390|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
155296391|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296392|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
155296393|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296394|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296395|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296396|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296397|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296398|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296399|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296400|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
155296401|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296402|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
155296403|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296404|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296405|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
155296406|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296407|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296408|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296409|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
155296410|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296411|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296412|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296413|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
155296414|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
155296415|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296416|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296417|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296418|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296419|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
155296420|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
155296421|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
155296422|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296423|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296424|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296425|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296426|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
155296427|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
155296428|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
155296429|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
155296430|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
155296431|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
154956998|NCT00376623|559270707|FG001|Overall Study|Not treated with BI 2536|0|||
154956999|NCT00376623|559270708|FG002|Overall Study|Not treated with BI 2536|0|||
154957000|NCT00376623|559270706|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
154957001|NCT00376623|559270707|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
154957002|NCT00376623|559270708|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
154957003|NCT00376623|559270706|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
155296432|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
155296433|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
155296434|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
155296435|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
155296436|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296437|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296438|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296439|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
155296440|NCT04707313|560514729|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296441|NCT04707313|560514730|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296442|NCT04707313|560514731|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
155296443|NCT04707313|560514732|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296444|NCT04707313|560514733|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296445|NCT04707313|560514734|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296446|NCT04707313|560514735|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296447|NCT04707313|560514736|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
155296448|NCT04707313|560514737|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296449|NCT04707313|560514738|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296450|NCT04707313|560514739|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296451|NCT04707313|560514740|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296452|NCT04707313|560514741|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
155296453|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296454|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296455|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296456|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296457|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296458|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296459|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296460|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296461|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296462|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
155296463|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
155296464|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
155296465|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
155296466|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296467|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296468|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296469|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296470|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296471|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296472|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296473|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296474|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296475|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
155296476|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
155296477|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
155296478|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
155296479|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296480|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296481|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296482|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296483|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296484|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296485|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296486|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296487|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
155296488|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
155296489|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
155296490|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
155296491|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
155296492|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296493|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296494|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296495|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296496|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
154957004|NCT00376623|559270707|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
154957005|NCT00376623|559270708|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
155061204|NCT01206764|559659271|FG000|Overall Study|Protocol deviation|3|||
155296497|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296498|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296499|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296500|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296501|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296502|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
155296503|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
155296504|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
155296505|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296506|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296507|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296508|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296509|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296510|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155170030|NCT00830869|560062409|FG004|Period 2: Part 2|Adverse Event|0|||
155296511|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296512|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155157960|NCT01716234|560016592|FG006|Overall Study|Did not meet protocol eligibility|0|||
155157961|NCT01716234|560016586|FG000|Overall Study|Adverse Event|7|||
155157962|NCT01716234|560016587|FG001|Overall Study|Adverse Event|10|||
155157963|NCT01716234|560016588|FG002|Overall Study|Adverse Event|2|||
155296513|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296514|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
155296515|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
155296516|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296517|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
155296518|NCT04707313|560514729|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296519|NCT04707313|560514730|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296520|NCT04707313|560514731|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296521|NCT04707313|560514732|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296522|NCT04707313|560514733|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296523|NCT04707313|560514734|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296524|NCT04707313|560514735|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296525|NCT04707313|560514736|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296526|NCT04707313|560514737|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
155296527|NCT04707313|560514738|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
155296528|NCT04707313|560514739|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
155296529|NCT04707313|560514740|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
155296530|NCT04707313|560514741|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
155296531|NCT00940992|560514742|FG000|Overall Study|Adverse Event|2|||
155296532|NCT00940992|560514743|FG001|Overall Study|Adverse Event|0|||
155296533|NCT00940992|560514744|FG002|Overall Study|Adverse Event|1|||
155296534|NCT00940992|560514742|FG000|Overall Study|subject request|2|||
155296535|NCT00940992|560514743|FG001|Overall Study|subject request|1|||
155296536|NCT00940992|560514744|FG002|Overall Study|subject request|0|||
155296537|NCT00940992|560514742|FG000|Overall Study|Lost to Follow-up|0|||
155296538|NCT00940992|560514743|FG001|Overall Study|Lost to Follow-up|1|||
155296539|NCT00940992|560514744|FG002|Overall Study|Lost to Follow-up|1|||
155296540|NCT04221438|560514745|FG000|Overall Study|Adverse Event|1|||
155296541|NCT04221438|560514745|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
155296542|NCT02248480|560514748|FG000|Overall Study|Lack of Efficacy|4|||
155296543|NCT02248480|560514749|FG001|Overall Study|Lack of Efficacy|6|||
155296544|NCT02248480|560514748|FG000|Overall Study|Adverse Event|11|||
155296545|NCT02248480|560514749|FG001|Overall Study|Adverse Event|2|||
155296546|NCT02248480|560514748|FG000|Overall Study|Withdrawal by Subject|2|||
155296547|NCT02248480|560514749|FG001|Overall Study|Withdrawal by Subject|4|||
155296548|NCT02248480|560514748|FG000|Overall Study|Entry Criteria Not Met|0|||
155296549|NCT02248480|560514749|FG001|Overall Study|Entry Criteria Not Met|1|||
155296550|NCT02248480|560514748|FG000|Overall Study|Other:Physician Decision|0|||
155296551|NCT02248480|560514749|FG001|Overall Study|Other:Physician Decision|1|||
155296552|NCT00546871|560514759|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
155296553|NCT00546871|560514760|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
155296554|NCT00546871|560514759|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
155296555|NCT00546871|560514760|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
155296556|NCT00546871|560514759|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
155296557|NCT00546871|560514760|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
155296558|NCT00546871|560514759|FG000|Study Extension Period|Protocol Violation|1|||
155296559|NCT00546871|560514760|FG001|Study Extension Period|Protocol Violation|0|||
155296560|NCT00546871|560514759|FG000|Study Extension Period|Withdrawal by Subject|0|||
155296561|NCT00546871|560514760|FG001|Study Extension Period|Withdrawal by Subject|1|||
155296562|NCT01713946|560514761|FG000|Overall Study|Death|0|||
155296563|NCT01713946|560514762|FG001|Overall Study|Death|2|||
155296564|NCT01713946|560514763|FG002|Overall Study|Death|2|||
155296565|NCT01713946|560514761|FG000|Overall Study|Adverse Event|19|||
155296566|NCT01713946|560514762|FG001|Overall Study|Adverse Event|14|||
155296567|NCT01713946|560514763|FG002|Overall Study|Adverse Event|13|||
155296568|NCT01713946|560514761|FG000|Overall Study|Withdrawal by Subject|12|||
155296569|NCT01713946|560514762|FG001|Overall Study|Withdrawal by Subject|12|||
155296570|NCT01713946|560514763|FG002|Overall Study|Withdrawal by Subject|8|||
155296571|NCT01713946|560514761|FG000|Overall Study|Lack of Efficacy|8|||
155296572|NCT01713946|560514762|FG001|Overall Study|Lack of Efficacy|8|||
155296573|NCT01713946|560514763|FG002|Overall Study|Lack of Efficacy|14|||
155296574|NCT01713946|560514761|FG000|Overall Study|Protocol Violation|2|||
155296575|NCT01713946|560514762|FG001|Overall Study|Protocol Violation|4|||
155157964|NCT01716234|560016589|FG003|Overall Study|Adverse Event|8|||
155296576|NCT01713946|560514763|FG002|Overall Study|Protocol Violation|1|||
155296577|NCT01713946|560514761|FG000|Overall Study|Lost to Follow-up|0|||
155157965|NCT01716234|560016590|FG004|Overall Study|Adverse Event|3|||
155157966|NCT01716234|560016591|FG005|Overall Study|Adverse Event|6|||
155157967|NCT01716234|560016592|FG006|Overall Study|Adverse Event|0|||
155296578|NCT01713946|560514762|FG001|Overall Study|Lost to Follow-up|0|||
155157968|NCT01716234|560016586|FG000|Overall Study|Withdrawal by Subject|3|||
155157969|NCT01716234|560016587|FG001|Overall Study|Withdrawal by Subject|0|||
155296579|NCT01713946|560514763|FG002|Overall Study|Lost to Follow-up|1|||
155296580|NCT01713946|560514761|FG000|Overall Study|Administrative problems|1|||
154957006|NCT00376623|559270706|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
154957007|NCT00376623|559270707|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
154957008|NCT00376623|559270708|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
154957009|NCT00376623|559270706|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
154957010|NCT00376623|559270707|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
154957011|NCT00376623|559270708|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
154957012|NCT00376623|559270706|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
154957013|NCT00376623|559270707|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
154957014|NCT00376623|559270708|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
154957015|NCT00376623|559270706|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
154957016|NCT00376623|559270707|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
154957017|NCT00376623|559270708|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
154957018|NCT00376623|559270706|FG000|Overall Study|Increase of tumour markers|0|||
154957019|NCT00376623|559270707|FG001|Overall Study|Increase of tumour markers|1|||
154957020|NCT00376623|559270708|FG002|Overall Study|Increase of tumour markers|0|||
154957021|NCT00376623|559270706|FG000|Overall Study|Bone metastasis|1|||
154957022|NCT00376623|559270707|FG001|Overall Study|Bone metastasis|0|||
154957023|NCT00376623|559270708|FG002|Overall Study|Bone metastasis|0|||
154957024|NCT02331394|559270709|FG000|Overall Study|Disease progression|1|||
154957025|NCT01313273|559270712|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
154957026|NCT01313273|559270713|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
154957027|NCT01313273|559270712|FG000|Overall Study|Withdrawal by Subject|1|||
154957028|NCT01313273|559270713|FG001|Overall Study|Withdrawal by Subject|0|||
154957029|NCT01313273|559270712|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
154957030|NCT01313273|559270713|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
154957031|NCT02865850|559270714|FG000|Overall Study|Death|15|||
154957032|NCT02865850|559270715|FG001|Overall Study|Death|19|||
154957033|NCT02865850|559270714|FG000|Overall Study|Withdrawal by Subject|3|||
154957034|NCT02865850|559270715|FG001|Overall Study|Withdrawal by Subject|2|||
154957035|NCT02865850|559270714|FG000|Overall Study|Lost to Follow-up|3|||
154957036|NCT02865850|559270715|FG001|Overall Study|Lost to Follow-up|2|||
154957037|NCT02098876|559270717|FG000|Overall Study|Withdrawal by Subject|5|||
154957038|NCT02098876|559270718|FG001|Overall Study|Withdrawal by Subject|5|||
154957039|NCT01263704|559270719|FG000|Overall Study|Progressive disease|18|||
154957040|NCT01263704|559270719|FG000|Overall Study|Adverse Event|3|||
154957041|NCT01263704|559270719|FG000|Overall Study|Death|2|||
154957042|NCT01263704|559270719|FG000|Overall Study|Patient withdrew consent|2|||
154957043|NCT01263704|559270719|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
154957044|NCT01263704|559270719|FG000|Overall Study|Lost to Follow-up|1|||
154957045|NCT01263704|559270719|FG000|Overall Study|Colon metastases|1|||
154957046|NCT01263704|559270719|FG000|Overall Study|Principal Investigator (PI) decision|1|||
154957047|NCT02514122|559270720|FG000|Overall Study|Withdrawal by Subject|2|||
154957048|NCT02514122|559270721|FG001|Overall Study|Withdrawal by Subject|0|||
154957049|NCT01792635|559270722|FG000|Part B|Adverse Event|0|||
154957050|NCT01792635|559270723|FG001|Part B|Adverse Event|0|||
154957051|NCT01792635|559270724|FG002|Part B|Adverse Event|1|||
154957052|NCT01792635|559270722|FG000|Part B|Study terminated|0|||
154957053|NCT01792635|559270723|FG001|Part B|Study terminated|4|||
154957054|NCT01792635|559270724|FG002|Part B|Study terminated|3|||
154957055|NCT01118312|559270725|FG000|Overall Study|Lost to Follow-up|33|||
154957056|NCT01118312|559270726|FG001|Overall Study|Lost to Follow-up|32|||
154957057|NCT01118312|559270725|FG000|Overall Study|Withdrawal by Subject|1|||
154957058|NCT01118312|559270726|FG001|Overall Study|Withdrawal by Subject|3|||
154957059|NCT03965091|559270728|FG000|Overall Study|Adverse Event|0|||
154957060|NCT03965091|559270729|FG001|Overall Study|Adverse Event|2|||
154957061|NCT03965091|559270730|FG002|Overall Study|Adverse Event|3|||
154957062|NCT03965091|559270728|FG000|Overall Study|Withdrawal by Subject|11|||
154957063|NCT03965091|559270729|FG001|Overall Study|Withdrawal by Subject|3|||
154957064|NCT03965091|559270730|FG002|Overall Study|Withdrawal by Subject|5|||
154957065|NCT03965091|559270728|FG000|Overall Study|Non-compliance with study drug|0|||
154957066|NCT03965091|559270729|FG001|Overall Study|Non-compliance with study drug|0|||
154957067|NCT03965091|559270730|FG002|Overall Study|Non-compliance with study drug|1|||
154957068|NCT03965091|559270728|FG000|Overall Study|Lost to Follow-up|1|||
154957069|NCT03965091|559270729|FG001|Overall Study|Lost to Follow-up|1|||
154957070|NCT03965091|559270730|FG002|Overall Study|Lost to Follow-up|1|||
154957071|NCT03965091|559270728|FG000|Overall Study|Lack of Efficacy|2|||
154957072|NCT03965091|559270729|FG001|Overall Study|Lack of Efficacy|0|||
154957073|NCT03965091|559270730|FG002|Overall Study|Lack of Efficacy|0|||
154957074|NCT03965091|559270728|FG000|Overall Study|Other than specified|9|||
155296581|NCT01713946|560514762|FG001|Overall Study|Administrative problems|0|||
155296582|NCT01713946|560514763|FG002|Overall Study|Administrative problems|0|||
155296583|NCT01713946|560514761|FG000|Overall Study|Did not continue in Ext|0|||
155296584|NCT01713946|560514762|FG001|Overall Study|Did not continue in Ext|3|||
155296585|NCT01713946|560514763|FG002|Overall Study|Did not continue in Ext|0|||
155296586|NCT01713946|560514761|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
155296587|NCT01713946|560514762|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
155296588|NCT01713946|560514763|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
155296589|NCT01713946|560514761|FG000|Overall Study|Patients never switched to everolimus|0|||
155296590|NCT01713946|560514762|FG001|Overall Study|Patients never switched to everolimus|0|||
155296591|NCT01713946|560514763|FG002|Overall Study|Patients never switched to everolimus|5|||
155296592|NCT03516942|560514764|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
155296593|NCT03516942|560514764|FG000|Registration through baseline survey com|Death|8|||
155296594|NCT03516942|560514764|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
155296595|NCT03516942|560514764|FG000|T0: Baseline|LOST|13|||
155296596|NCT03516942|560514764|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
155296597|NCT03516942|560514764|FG000|T1: 3 Months Survey|Death|10|||
155296598|NCT03516942|560514764|FG000|T1: 3 Months Survey|Lost|163|||
155296599|NCT03516942|560514764|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
155296600|NCT03516942|560514764|FG000|T2: 6 Month Survey|Death|14|||
155296601|NCT03516942|560514764|FG000|T2: 6 Month Survey|Lost|180|||
155296602|NCT03516942|560514764|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
155296603|NCT03516942|560514764|FG000|T3: 12 Month Survey|Death|19|||
155296604|NCT03516942|560514764|FG000|T3: 12 Month Survey|Lost|209|||
155296605|NCT03779048|560516459|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
155296606|NCT03779048|560516460|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
155296607|NCT03779048|560516461|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
155296608|NCT03779048|560516459|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
155296609|NCT03779048|560516460|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
155296610|NCT03779048|560516461|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
155296611|NCT03779048|560516459|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
155296612|NCT03779048|560516460|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
155296613|NCT03779048|560516461|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
155296614|NCT01286272|560516462|FG000|Overall Study|Ineligible after beginning treatment|1|||
155296615|NCT01286272|560516463|FG001|Overall Study|Ineligible after beginning treatment|3|||
155296616|NCT04496960|560516464|FG000|Overall Study|Physician Decision|0|||
155296617|NCT04496960|560516465|FG001|Overall Study|Physician Decision|1|||
155296618|NCT02932410|560516466|FG000|Overall Study|Death|7|||
155296619|NCT02932410|560516467|FG001|Overall Study|Death|6|||
155296620|NCT02932410|560516468|FG002|Overall Study|Death|0|||
155296621|NCT02932410|560516469|FG003|Overall Study|Death|0|||
155296622|NCT02932410|560516466|FG000|Overall Study|Lost to Follow-up|1|||
155296623|NCT02932410|560516467|FG001|Overall Study|Lost to Follow-up|2|||
155296624|NCT02932410|560516468|FG002|Overall Study|Lost to Follow-up|0|||
155296625|NCT02932410|560516469|FG003|Overall Study|Lost to Follow-up|0|||
155296626|NCT02932410|560516466|FG000|Overall Study|Parent/Subjects decision|6|||
155296627|NCT02932410|560516467|FG001|Overall Study|Parent/Subjects decision|6|||
155296628|NCT02932410|560516468|FG002|Overall Study|Parent/Subjects decision|1|||
155296629|NCT02932410|560516469|FG003|Overall Study|Parent/Subjects decision|0|||
155296630|NCT02932410|560516466|FG000|Overall Study|Physician Decision|0|||
155296631|NCT02932410|560516467|FG001|Overall Study|Physician Decision|1|||
155296632|NCT02932410|560516468|FG002|Overall Study|Physician Decision|0|||
155296633|NCT02932410|560516469|FG003|Overall Study|Physician Decision|0|||
155296634|NCT05758415|560516473|FG000|Overall Study|Subject Decision|2|||
155296635|NCT05758415|560516474|FG001|Overall Study|Subject Decision|5|||
155157970|NCT01716234|560016588|FG002|Overall Study|Withdrawal by Subject|2|||
155296636|NCT05758415|560516473|FG000|Overall Study|Lost to Follow-up|0|||
155296637|NCT05758415|560516474|FG001|Overall Study|Lost to Follow-up|1|||
155296638|NCT03622593|560516475|FG000|Overall Study|Withdrawal by Subject|11|||
155296639|NCT03622593|560516476|FG001|Overall Study|Withdrawal by Subject|9|||
155296640|NCT03622593|560516477|FG002|Overall Study|Withdrawal by Subject|13|||
155296641|NCT03622593|560516475|FG000|Overall Study|Death|12|||
155296642|NCT03622593|560516476|FG001|Overall Study|Death|9|||
155296643|NCT03622593|560516477|FG002|Overall Study|Death|10|||
155296644|NCT03622593|560516475|FG000|Overall Study|Lost to Follow-up|11|||
155296645|NCT03622593|560516476|FG001|Overall Study|Lost to Follow-up|5|||
155296646|NCT03622593|560516477|FG002|Overall Study|Lost to Follow-up|8|||
155296647|NCT03622593|560516475|FG000|Overall Study|Adverse Event|4|||
155296648|NCT03622593|560516476|FG001|Overall Study|Adverse Event|5|||
155296649|NCT03622593|560516477|FG002|Overall Study|Adverse Event|6|||
155296650|NCT03622593|560516475|FG000|Overall Study|Physician Decision|2|||
155296651|NCT03622593|560516476|FG001|Overall Study|Physician Decision|1|||
155296652|NCT03622593|560516477|FG002|Overall Study|Physician Decision|6|||
155296653|NCT03622593|560516475|FG000|Overall Study|Other|2|||
155296654|NCT03622593|560516476|FG001|Overall Study|Other|2|||
155296655|NCT03622593|560516477|FG002|Overall Study|Other|3|||
155296656|NCT03622593|560516475|FG000|Overall Study|Protocol Violation|0|||
155296657|NCT03622593|560516476|FG001|Overall Study|Protocol Violation|0|||
155296658|NCT03622593|560516477|FG002|Overall Study|Protocol Violation|1|||
155296659|NCT03622593|560516475|FG000|Overall Study|Pregnancy|0|||
155296660|NCT03622593|560516476|FG001|Overall Study|Pregnancy|0|||
155296661|NCT03622593|560516477|FG002|Overall Study|Pregnancy|1|||
155296662|NCT01134562|560516480|FG000|Overall Study|Adverse Event|0|||
155296663|NCT01134562|560516481|FG001|Overall Study|Adverse Event|1|||
155296664|NCT01134562|560516482|FG002|Overall Study|Adverse Event|0|||
155296665|NCT01134562|560516483|FG003|Overall Study|Adverse Event|0|||
155296666|NCT01134562|560516484|FG004|Overall Study|Adverse Event|0|||
155296667|NCT00423098|560516485|FG000|Overall Study|Adverse Event|1|||
155296668|NCT00423098|560516486|FG001|Overall Study|Adverse Event|2|||
155296669|NCT00423098|560516485|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155296670|NCT00423098|560516486|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155296671|NCT00423098|560516485|FG000|Overall Study|Administrative problems|0|||
155296672|NCT00423098|560516486|FG001|Overall Study|Administrative problems|1|||
155296673|NCT00423098|560516485|FG000|Overall Study|Death|2|||
155296674|NCT00423098|560516486|FG001|Overall Study|Death|0|||
155296675|NCT00711958|560516488|FG000|Overall Study|Withdrawal by Subject|6|||
155296676|NCT00711958|560516489|FG001|Overall Study|Withdrawal by Subject|8|||
155296677|NCT00711958|560516488|FG000|Overall Study|Lack of Efficacy|3|||
155296678|NCT00711958|560516489|FG001|Overall Study|Lack of Efficacy|1|||
155296679|NCT00711958|560516488|FG000|Overall Study|Clinical deterioration|1|||
155296680|NCT00711958|560516489|FG001|Overall Study|Clinical deterioration|0|||
155296681|NCT00711958|560516488|FG000|Overall Study|Adverse Event|9|||
155296682|NCT00711958|560516489|FG001|Overall Study|Adverse Event|7|||
155296683|NCT00711958|560516488|FG000|Overall Study|Protocol Violation|1|||
155296684|NCT00711958|560516489|FG001|Overall Study|Protocol Violation|0|||
155296685|NCT00711958|560516488|FG000|Overall Study|Lost to Follow-up|2|||
155296686|NCT00711958|560516489|FG001|Overall Study|Lost to Follow-up|2|||
155296687|NCT00711958|560516488|FG000|Overall Study|Death|10|||
155296688|NCT00711958|560516489|FG001|Overall Study|Death|5|||
155296689|NCT00711958|560516488|FG000|Overall Study|Progression of disease|1|||
155296690|NCT00711958|560516489|FG001|Overall Study|Progression of disease|0|||
155296691|NCT02015546|560516490|FG000|Overall Study|Withdrawal by Subject|1|||
155296692|NCT02015546|560516491|FG001|Overall Study|Withdrawal by Subject|1|||
155296693|NCT02015546|560516492|FG002|Overall Study|Withdrawal by Subject|1|||
155296694|NCT02015546|560516490|FG000|Overall Study|Screem Failure|2|||
155296695|NCT02015546|560516491|FG001|Overall Study|Screem Failure|1|||
155296696|NCT02015546|560516492|FG002|Overall Study|Screem Failure|3|||
155296697|NCT04424641|560516493|FG000|Overall Study|Death|1|||
155157971|NCT01716234|560016589|FG003|Overall Study|Withdrawal by Subject|2|||
155157972|NCT01716234|560016590|FG004|Overall Study|Withdrawal by Subject|1|||
155157973|NCT01716234|560016591|FG005|Overall Study|Withdrawal by Subject|3|||
155296698|NCT04424641|560516494|FG001|Overall Study|Death|2|||
155296699|NCT04424641|560516495|FG002|Overall Study|Death|3|||
155296700|NCT04424641|560516496|FG003|Overall Study|Death|0|||
154957075|NCT03965091|559270729|FG001|Overall Study|Other than specified|11|||
154957076|NCT03965091|559270730|FG002|Overall Study|Other than specified|8|||
154957077|NCT01185821|559270734|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155296701|NCT04424641|560516497|FG004|Overall Study|Death|3|||
155296702|NCT04424641|560516498|FG005|Overall Study|Death|0|||
154957078|NCT01185821|559270735|FG001|Overall Study|Abnormal laboratory value(s)|2|||
154957079|NCT01185821|559270736|FG002|Overall Study|Abnormal laboratory value(s)|1|||
155157974|NCT01716234|560016592|FG006|Overall Study|Withdrawal by Subject|0|||
155157975|NCT02667119|560016593|FG000|Overall Study|Lost to Follow-up|3|||
155296703|NCT04424641|560516499|FG006|Overall Study|Death|1|||
155296704|NCT04424641|560516500|FG007|Overall Study|Death|2|||
155296705|NCT04424641|560516493|FG000|Overall Study|Sponsor decision|0|||
155296706|NCT04424641|560516494|FG001|Overall Study|Sponsor decision|2|||
155296707|NCT04424641|560516495|FG002|Overall Study|Sponsor decision|3|||
155296708|NCT04424641|560516496|FG003|Overall Study|Sponsor decision|7|||
155296709|NCT04424641|560516497|FG004|Overall Study|Sponsor decision|2|||
155296710|NCT04424641|560516498|FG005|Overall Study|Sponsor decision|2|||
155296711|NCT04424641|560516499|FG006|Overall Study|Sponsor decision|3|||
155296712|NCT04424641|560516500|FG007|Overall Study|Sponsor decision|4|||
155296713|NCT04424641|560516493|FG000|Overall Study|Withdrawal by Subject|0|||
155296714|NCT04424641|560516494|FG001|Overall Study|Withdrawal by Subject|0|||
155296715|NCT04424641|560516495|FG002|Overall Study|Withdrawal by Subject|0|||
155296716|NCT04424641|560516496|FG003|Overall Study|Withdrawal by Subject|0|||
155296717|NCT04424641|560516497|FG004|Overall Study|Withdrawal by Subject|1|||
155296718|NCT04424641|560516498|FG005|Overall Study|Withdrawal by Subject|0|||
155296719|NCT04424641|560516499|FG006|Overall Study|Withdrawal by Subject|0|||
155296720|NCT04424641|560516500|FG007|Overall Study|Withdrawal by Subject|0|||
155296721|NCT04424641|560516493|FG000|Overall Study|Other|0|||
155296722|NCT04424641|560516494|FG001|Overall Study|Other|0|||
155296723|NCT04424641|560516495|FG002|Overall Study|Other|1|||
155296724|NCT04424641|560516496|FG003|Overall Study|Other|0|||
155296725|NCT04424641|560516497|FG004|Overall Study|Other|0|||
155296726|NCT04424641|560516498|FG005|Overall Study|Other|0|||
155296727|NCT04424641|560516499|FG006|Overall Study|Other|0|||
155296728|NCT04424641|560516500|FG007|Overall Study|Other|0|||
155296729|NCT05855655|560516503|FG000|Overall Study|Withdrawal by Subject|0|||
155296730|NCT05855655|560516504|FG001|Overall Study|Withdrawal by Subject|1|||
155296731|NCT05855655|560516503|FG000|Overall Study|Lost to Follow-up|4|||
155296732|NCT05855655|560516504|FG001|Overall Study|Lost to Follow-up|0|||
155296733|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Adverse Event|5|||
155296734|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Adverse Event|0|||
155296735|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Adverse Event|0|||
155296736|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
155296737|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
155296738|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
155296739|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
155296740|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
155296741|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
155296742|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
155296743|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
155296744|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
155296745|NCT01426269|560516505|FG000|Period 1: 12 Weeks|Pregnancy|1|||
155296746|NCT01426269|560516506|FG001|Period 1: 12 Weeks|Pregnancy|0|||
155296747|NCT01426269|560516507|FG002|Period 1: 12 Weeks|Pregnancy|0|||
155296748|NCT01426269|560516505|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
155296749|NCT01426269|560516506|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
155296750|NCT01426269|560516507|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
155296751|NCT01426269|560516505|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
155296752|NCT01426269|560516506|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
155296753|NCT01426269|560516507|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
155296754|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Adverse Event|0|||
155296755|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Adverse Event|1|||
155296756|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Adverse Event|2|||
155296757|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
155296758|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
155296759|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
155296760|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
155296761|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
155296762|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
155296763|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
155296764|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
155157976|NCT02667119|560016594|FG001|Overall Study|Lost to Follow-up|0|||
155157977|NCT01523756|560016595|FG000|Baseline Period|Adverse Event|0|||
155157978|NCT01523756|560016596|FG001|Baseline Period|Adverse Event|1|||
155157979|NCT01523756|560016595|FG000|Test Period 1|Adverse Event|1|||
155157980|NCT01523756|560016596|FG001|Test Period 1|Adverse Event|0|||
155157981|NCT01523756|560016595|FG000|Test Period 2|Withdrawal by Subject|0|||
155296765|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
155296766|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Site closed|0|||
155296767|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Site closed|6|||
155296768|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Site closed|5|||
155296769|NCT01426269|560516505|FG000|Period 2: 40 Weeks|Relapsed|0|||
155296770|NCT01426269|560516506|FG001|Period 2: 40 Weeks|Relapsed|9|||
155157982|NCT01523756|560016596|FG001|Test Period 2|Withdrawal by Subject|1|||
155157983|NCT00993967|560016597|FG000|Overall Study|Adverse Event|8|||
155157984|NCT00993967|560016597|FG000|Overall Study|Death|1|||
155157985|NCT00993967|560016597|FG000|Overall Study|Lost to Follow-up|14|||
155157986|NCT00993967|560016597|FG000|Overall Study|Withdrawal by Subject|36|||
155157987|NCT00993967|560016597|FG000|Overall Study|Protocol Violation|2|||
155157988|NCT03783078|560016600|FG000|Overall Study|Death|31|||
155157989|NCT03783078|560016600|FG000|Overall Study|Sponsor Decision|23|||
155157990|NCT03783078|560016600|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155157991|NCT03043794|560016606|FG000|Overall Study|Lost to Follow-up|1|||
155157992|NCT03205423|560016609|FG000|Overall Study|Personal|1|||
155157993|NCT03205423|560016610|FG001|Overall Study|Personal|1|||
155157994|NCT03205423|560016609|FG000|Overall Study|Physician Decision|0|||
155157995|NCT03205423|560016610|FG001|Overall Study|Physician Decision|2|||
155157996|NCT02749422|560016611|FG000|Overall Study|Lost to Follow-up|0|||
155157997|NCT02749422|560016612|FG001|Overall Study|Lost to Follow-up|2|||
155157998|NCT02749422|560016611|FG000|Overall Study|Ineligible|0|||
155157999|NCT02749422|560016612|FG001|Overall Study|Ineligible|1|||
155158000|NCT00911170|560016613|FG000|Treatment Period|Randomized in error|1|||
155158001|NCT00911170|560016614|FG001|Treatment Period|Randomized in error|1|||
155158002|NCT00911170|560016613|FG000|Treatment Period|Ineligibility determined|1|||
155158003|NCT00911170|560016614|FG001|Treatment Period|Ineligibility determined|3|||
155158004|NCT00911170|560016613|FG000|Treatment Period|Protocol deviation|1|||
155158005|NCT00911170|560016614|FG001|Treatment Period|Protocol deviation|2|||
155158006|NCT00911170|560016613|FG000|Treatment Period|Adverse Event|9|||
155158007|NCT00911170|560016614|FG001|Treatment Period|Adverse Event|10|||
155158008|NCT00911170|560016613|FG000|Treatment Period|Withdrawal by Subject|4|||
155158009|NCT00911170|560016614|FG001|Treatment Period|Withdrawal by Subject|4|||
155158010|NCT00911170|560016613|FG000|Treatment Period|Disease progression|0|||
155158011|NCT00911170|560016614|FG001|Treatment Period|Disease progression|2|||
155158012|NCT00911170|560016613|FG000|Treatment Period|Physician Decision|5|||
155158013|NCT00911170|560016614|FG001|Treatment Period|Physician Decision|5|||
155158014|NCT00911170|560016613|FG000|Treatment Period|Lost to Follow-up|0|||
155158015|NCT00911170|560016614|FG001|Treatment Period|Lost to Follow-up|1|||
155158016|NCT00911170|560016613|FG000|Treatment Period|Death|6|||
155158017|NCT00911170|560016614|FG001|Treatment Period|Death|9|||
155158018|NCT00911170|560016613|FG000|Long Term Follow-Up|Continuing in study|274|||
155158019|NCT00911170|560016614|FG001|Long Term Follow-Up|Continuing in study|269|||
155158020|NCT00911170|560016613|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
155158021|NCT00911170|560016614|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
155158022|NCT00911170|560016613|FG000|Long Term Follow-Up|Physician Decision|5|||
155158023|NCT00911170|560016614|FG001|Long Term Follow-Up|Physician Decision|4|||
155158024|NCT00911170|560016613|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
155158025|NCT00911170|560016614|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
155158026|NCT00911170|560016613|FG000|Long Term Follow-Up|Death|116|||
155158027|NCT00911170|560016614|FG001|Long Term Follow-Up|Death|121|||
155158028|NCT02594124|560016615|FG000|Overall Study|Adverse Event|0|||
155158029|NCT02594124|560016616|FG001|Overall Study|Adverse Event|5|||
155158030|NCT02594124|560016617|FG002|Overall Study|Adverse Event|8|||
155158031|NCT02594124|560016618|FG003|Overall Study|Adverse Event|1|||
155158032|NCT02594124|560016619|FG004|Overall Study|Adverse Event|0|||
155158033|NCT02594124|560016620|FG005|Overall Study|Adverse Event|0|||
155158034|NCT02594124|560016621|FG006|Overall Study|Adverse Event|2|||
155158035|NCT02594124|560016622|FG007|Overall Study|Adverse Event|2|||
155158036|NCT02594124|560016623|FG008|Overall Study|Adverse Event|0|||
155158037|NCT02594124|560016615|FG000|Overall Study|Withdrawal by Subject|2|||
155158038|NCT02594124|560016616|FG001|Overall Study|Withdrawal by Subject|3|||
155158039|NCT02594124|560016617|FG002|Overall Study|Withdrawal by Subject|5|||
155158040|NCT02594124|560016618|FG003|Overall Study|Withdrawal by Subject|1|||
155158041|NCT02594124|560016619|FG004|Overall Study|Withdrawal by Subject|8|||
155158042|NCT02594124|560016620|FG005|Overall Study|Withdrawal by Subject|4|||
155158043|NCT02594124|560016621|FG006|Overall Study|Withdrawal by Subject|13|||
155158044|NCT02594124|560016622|FG007|Overall Study|Withdrawal by Subject|19|||
155158045|NCT02594124|560016623|FG008|Overall Study|Withdrawal by Subject|0|||
155158046|NCT02594124|560016615|FG000|Overall Study|Physician Decision|0|||
155158047|NCT02594124|560016616|FG001|Overall Study|Physician Decision|2|||
155158048|NCT02594124|560016617|FG002|Overall Study|Physician Decision|0|||
155158049|NCT02594124|560016618|FG003|Overall Study|Physician Decision|0|||
155158050|NCT02594124|560016619|FG004|Overall Study|Physician Decision|0|||
155296771|NCT01426269|560516507|FG002|Period 2: 40 Weeks|Relapsed|18|||
155296772|NCT02296424|560516510|FG000|Part 1|New therapy for study indication|0|||
155296773|NCT02296424|560516511|FG001|Part 1|New therapy for study indication|1|||
155296774|NCT02296424|560516512|FG002|Part 1|New therapy for study indication|0|||
155296775|NCT02296424|560516513|FG003|Part 1|New therapy for study indication|0|||
155296776|NCT02296424|560516510|FG000|Part 1|Protocol Violation|0|||
155296777|NCT02296424|560516511|FG001|Part 1|Protocol Violation|1|||
155296778|NCT02296424|560516512|FG002|Part 1|Protocol Violation|0|||
155296779|NCT02296424|560516513|FG003|Part 1|Protocol Violation|0|||
155296780|NCT02296424|560516510|FG000|Part 1|Withdrawal by Subject|0|||
155296781|NCT02296424|560516511|FG001|Part 1|Withdrawal by Subject|2|||
155296782|NCT02296424|560516512|FG002|Part 1|Withdrawal by Subject|0|||
155296783|NCT02296424|560516513|FG003|Part 1|Withdrawal by Subject|0|||
155296784|NCT02296424|560516510|FG000|Part 1|Study terminated by sponsor|0|||
155296785|NCT02296424|560516511|FG001|Part 1|Study terminated by sponsor|1|||
155296786|NCT02296424|560516512|FG002|Part 1|Study terminated by sponsor|0|||
155296787|NCT02296424|560516513|FG003|Part 1|Study terminated by sponsor|0|||
155296788|NCT02296424|560516510|FG000|Part 1|Adverse Event|2|||
155296789|NCT02296424|560516511|FG001|Part 1|Adverse Event|11|||
155296790|NCT02296424|560516512|FG002|Part 1|Adverse Event|0|||
155296791|NCT02296424|560516513|FG003|Part 1|Adverse Event|0|||
155296792|NCT02296424|560516510|FG000|Part 1|Lack of Efficacy|5|||
155296793|NCT02296424|560516511|FG001|Part 1|Lack of Efficacy|17|||
155296794|NCT02296424|560516512|FG002|Part 1|Lack of Efficacy|0|||
155296795|NCT02296424|560516513|FG003|Part 1|Lack of Efficacy|0|||
155296796|NCT02296424|560516510|FG000|Part 1|16 directly started part II|16|||
155296797|NCT02296424|560516511|FG001|Part 1|16 directly started part II|0|||
155296798|NCT02296424|560516512|FG002|Part 1|16 directly started part II|0|||
155296799|NCT02296424|560516513|FG003|Part 1|16 directly started part II|0|||
155296800|NCT02296424|560516510|FG000|Part 2|Lack of Efficacy|0|||
155296801|NCT02296424|560516511|FG001|Part 2|Lack of Efficacy|0|||
155296802|NCT02296424|560516512|FG002|Part 2|Lack of Efficacy|1|||
155296803|NCT02296424|560516513|FG003|Part 2|Lack of Efficacy|0|||
155296804|NCT02296424|560516510|FG000|Part 2|Adverse Event|0|||
155296805|NCT02296424|560516511|FG001|Part 2|Adverse Event|0|||
155296806|NCT02296424|560516512|FG002|Part 2|Adverse Event|1|||
154957080|NCT01185821|559270737|FG003|Overall Study|Abnormal laboratory value(s)|0|||
154957081|NCT01185821|559270738|FG004|Overall Study|Abnormal laboratory value(s)|0|||
154957082|NCT01185821|559270734|FG000|Overall Study|Protocol Violation|0|||
154957083|NCT01185821|559270735|FG001|Overall Study|Protocol Violation|0|||
154957084|NCT01185821|559270736|FG002|Overall Study|Protocol Violation|0|||
154957085|NCT01185821|559270737|FG003|Overall Study|Protocol Violation|1|||
154957086|NCT01185821|559270738|FG004|Overall Study|Protocol Violation|1|||
154957087|NCT01185821|559270734|FG000|Overall Study|Abnormal test procedure result|0|||
154957088|NCT01185821|559270735|FG001|Overall Study|Abnormal test procedure result|0|||
155296807|NCT02296424|560516513|FG003|Part 2|Adverse Event|0|||
155296808|NCT02296424|560516510|FG000|Part 2|Lost to Follow-up|0|||
154957089|NCT01185821|559270736|FG002|Overall Study|Abnormal test procedure result|0|||
154957090|NCT01185821|559270737|FG003|Overall Study|Abnormal test procedure result|0|||
154957091|NCT01185821|559270738|FG004|Overall Study|Abnormal test procedure result|1|||
154957092|NCT01185821|559270734|FG000|Overall Study|Death|0|||
154957093|NCT01185821|559270735|FG001|Overall Study|Death|1|||
154957094|NCT01185821|559270736|FG002|Overall Study|Death|0|||
154957095|NCT01185821|559270737|FG003|Overall Study|Death|0|||
154957096|NCT01185821|559270738|FG004|Overall Study|Death|0|||
154957097|NCT01185821|559270734|FG000|Overall Study|Condition no longer required study drug|0|||
154957098|NCT01185821|559270735|FG001|Overall Study|Condition no longer required study drug|0|||
154957099|NCT01185821|559270736|FG002|Overall Study|Condition no longer required study drug|0|||
154957100|NCT01185821|559270737|FG003|Overall Study|Condition no longer required study drug|0|||
154957101|NCT01185821|559270738|FG004|Overall Study|Condition no longer required study drug|1|||
154957102|NCT01185821|559270734|FG000|Overall Study|Adverse Event|2|||
154957103|NCT01185821|559270735|FG001|Overall Study|Adverse Event|3|||
154957104|NCT01185821|559270736|FG002|Overall Study|Adverse Event|1|||
154957105|NCT01185821|559270737|FG003|Overall Study|Adverse Event|2|||
155296809|NCT02296424|560516511|FG001|Part 2|Lost to Follow-up|0|||
155296810|NCT02296424|560516512|FG002|Part 2|Lost to Follow-up|1|||
155296811|NCT02296424|560516513|FG003|Part 2|Lost to Follow-up|0|||
155296812|NCT00854906|560516514|FG000|Overall Study|One person had no ocular history|1|||
155296813|NCT00814346|560516519|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
155296814|NCT00814346|560516520|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
155296815|NCT00814346|560516519|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
155296816|NCT00814346|560516520|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
155296817|NCT00814346|560516519|FG000|Open Phase (17 Months)|Adverse Event|5|||
155296818|NCT00814346|560516520|FG001|Open Phase (17 Months)|Adverse Event|0|||
155296819|NCT00814346|560516519|FG000|Open Phase (17 Months)|Consent|2|||
155296820|NCT00814346|560516520|FG001|Open Phase (17 Months)|Consent|0|||
154957106|NCT01185821|559270738|FG004|Overall Study|Adverse Event|5|||
154957107|NCT01185821|559270734|FG000|Overall Study|Lack of Efficacy|0|||
155296821|NCT00814346|560516519|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
155296822|NCT00814346|560516520|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
155296823|NCT00814346|560516519|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
155296824|NCT00814346|560516520|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
155296825|NCT05136443|560516522|FG000|Overall Study|Lost to Follow-up|2|||
155296826|NCT05136443|560516522|FG000|Overall Study|Adverse Event|2|||
155296827|NCT00507689|560516525|FG000|Pre-Randomization Period|Adverse Event|1|||
155296828|NCT00507689|560516526|FG001|Pre-Randomization Period|Adverse Event|0|||
155296829|NCT00507689|560516525|FG000|Pre-Randomization Period|Physician Decision|1|||
155296830|NCT00507689|560516526|FG001|Pre-Randomization Period|Physician Decision|0|||
155296831|NCT00507689|560516525|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
155296832|NCT00507689|560516526|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
155296833|NCT00507689|560516525|FG000|Randomized Period|Adverse Event|1|||
155296834|NCT00507689|560516526|FG001|Randomized Period|Adverse Event|1|||
155296835|NCT00507689|560516525|FG000|Randomized Period|Withdrawal by Subject|0|||
155296836|NCT00507689|560516526|FG001|Randomized Period|Withdrawal by Subject|1|||
155296837|NCT01145885|560516532|FG000|Overall Study|Progressive Disease|7|||
155296838|NCT05299606|560516533|FG000|Overall Study|Death|1|||
155296839|NCT03946670|560516537|FG000|Overall Study|Progressive Disease|34|||
155296840|NCT03946670|560516538|FG001|Overall Study|Progressive Disease|27|||
155296841|NCT03946670|560516537|FG000|Overall Study|Adverse Event|7|||
155296842|NCT03946670|560516538|FG001|Overall Study|Adverse Event|10|||
155296843|NCT03946670|560516537|FG000|Overall Study|Physician Decision|6|||
155296844|NCT03946670|560516538|FG001|Overall Study|Physician Decision|5|||
155296845|NCT03946670|560516537|FG000|Overall Study|Death|5|||
155296846|NCT03946670|560516538|FG001|Overall Study|Death|8|||
155296847|NCT03946670|560516537|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
155296848|NCT03946670|560516538|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
155296849|NCT03946670|560516537|FG000|Overall Study|Subject Decision|4|||
155296850|NCT03946670|560516538|FG001|Overall Study|Subject Decision|5|||
155296851|NCT03946670|560516537|FG000|Overall Study|Study Terminated By Sponsor|2|||
155296852|NCT03946670|560516538|FG001|Overall Study|Study Terminated By Sponsor|0|||
155296853|NCT03946670|560516537|FG000|Overall Study|New Therapy For Study Indication|1|||
155296854|NCT03946670|560516538|FG001|Overall Study|New Therapy For Study Indication|0|||
155296855|NCT03946670|560516537|FG000|Overall Study|Not Treated|1|||
155296856|NCT03946670|560516538|FG001|Overall Study|Not Treated|1|||
155296857|NCT01135511|560516542|FG000|Overall Study|Adverse Event|0|||
155296858|NCT01135511|560516543|FG001|Overall Study|Adverse Event|1|||
155296859|NCT01135511|560516544|FG002|Overall Study|Adverse Event|2|||
155296860|NCT01135511|560516545|FG003|Overall Study|Adverse Event|0|||
155296861|NCT01135511|560516546|FG004|Overall Study|Adverse Event|0|||
155296862|NCT01135511|560516547|FG005|Overall Study|Adverse Event|1|||
155296863|NCT01135511|560516548|FG006|Overall Study|Adverse Event|0|||
155296864|NCT01135511|560516549|FG007|Overall Study|Adverse Event|1|||
155296865|NCT01135511|560516550|FG008|Overall Study|Adverse Event|0|||
155296866|NCT01135511|560516542|FG000|Overall Study|Lack of Efficacy|0|||
155296867|NCT01135511|560516543|FG001|Overall Study|Lack of Efficacy|1|||
155296868|NCT01135511|560516544|FG002|Overall Study|Lack of Efficacy|1|||
155296869|NCT01135511|560516545|FG003|Overall Study|Lack of Efficacy|2|||
155296870|NCT01135511|560516546|FG004|Overall Study|Lack of Efficacy|0|||
155296871|NCT01135511|560516547|FG005|Overall Study|Lack of Efficacy|0|||
155296872|NCT01135511|560516548|FG006|Overall Study|Lack of Efficacy|0|||
155296873|NCT01135511|560516549|FG007|Overall Study|Lack of Efficacy|0|||
155296874|NCT01135511|560516550|FG008|Overall Study|Lack of Efficacy|0|||
155296875|NCT01135511|560516542|FG000|Overall Study|Protocol Violation|0|||
155296876|NCT01135511|560516543|FG001|Overall Study|Protocol Violation|0|||
155296877|NCT01135511|560516544|FG002|Overall Study|Protocol Violation|3|||
155296878|NCT01135511|560516545|FG003|Overall Study|Protocol Violation|0|||
155296879|NCT01135511|560516546|FG004|Overall Study|Protocol Violation|0|||
155296880|NCT01135511|560516547|FG005|Overall Study|Protocol Violation|0|||
155296881|NCT01135511|560516548|FG006|Overall Study|Protocol Violation|0|||
155296882|NCT01135511|560516549|FG007|Overall Study|Protocol Violation|0|||
155296883|NCT01135511|560516550|FG008|Overall Study|Protocol Violation|0|||
155296884|NCT01135511|560516542|FG000|Overall Study|Pregnancy|0|||
155061205|NCT03895086|559659277|FG000|Overall Study|Early termination study|1|||
155296885|NCT01135511|560516543|FG001|Overall Study|Pregnancy|0|||
155296886|NCT01135511|560516544|FG002|Overall Study|Pregnancy|0|||
155296887|NCT01135511|560516545|FG003|Overall Study|Pregnancy|1|||
155296888|NCT01135511|560516546|FG004|Overall Study|Pregnancy|0|||
155296889|NCT01135511|560516547|FG005|Overall Study|Pregnancy|0|||
155296890|NCT01135511|560516548|FG006|Overall Study|Pregnancy|0|||
155296891|NCT01135511|560516549|FG007|Overall Study|Pregnancy|0|||
155296892|NCT01135511|560516550|FG008|Overall Study|Pregnancy|0|||
155296893|NCT01135511|560516542|FG000|Overall Study|could not visit the clinic|0|||
155296894|NCT01135511|560516543|FG001|Overall Study|could not visit the clinic|1|||
155296895|NCT01135511|560516544|FG002|Overall Study|could not visit the clinic|2|||
155296896|NCT01135511|560516545|FG003|Overall Study|could not visit the clinic|0|||
155296897|NCT01135511|560516546|FG004|Overall Study|could not visit the clinic|0|||
155296898|NCT01135511|560516547|FG005|Overall Study|could not visit the clinic|0|||
155296899|NCT01135511|560516548|FG006|Overall Study|could not visit the clinic|0|||
155296900|NCT01135511|560516549|FG007|Overall Study|could not visit the clinic|0|||
155296901|NCT01135511|560516550|FG008|Overall Study|could not visit the clinic|0|||
155296902|NCT01135511|560516542|FG000|Overall Study|noncompliance with study drug taken|0|||
155296903|NCT01135511|560516543|FG001|Overall Study|noncompliance with study drug taken|0|||
155296904|NCT01135511|560516544|FG002|Overall Study|noncompliance with study drug taken|0|||
155296905|NCT01135511|560516545|FG003|Overall Study|noncompliance with study drug taken|0|||
155296906|NCT01135511|560516546|FG004|Overall Study|noncompliance with study drug taken|1|||
155296907|NCT01135511|560516547|FG005|Overall Study|noncompliance with study drug taken|0|||
155296908|NCT01135511|560516548|FG006|Overall Study|noncompliance with study drug taken|0|||
155296909|NCT01135511|560516549|FG007|Overall Study|noncompliance with study drug taken|0|||
155296910|NCT01135511|560516550|FG008|Overall Study|noncompliance with study drug taken|0|||
155296911|NCT01135511|560516542|FG000|Overall Study|Withdrawal by Subject|0|||
155296912|NCT01135511|560516543|FG001|Overall Study|Withdrawal by Subject|0|||
155296913|NCT01135511|560516544|FG002|Overall Study|Withdrawal by Subject|0|||
155296914|NCT01135511|560516545|FG003|Overall Study|Withdrawal by Subject|0|||
155296915|NCT01135511|560516546|FG004|Overall Study|Withdrawal by Subject|0|||
155296916|NCT01135511|560516547|FG005|Overall Study|Withdrawal by Subject|0|||
155296917|NCT01135511|560516548|FG006|Overall Study|Withdrawal by Subject|1|||
155296918|NCT01135511|560516549|FG007|Overall Study|Withdrawal by Subject|0|||
155296919|NCT01135511|560516550|FG008|Overall Study|Withdrawal by Subject|1|||
155296920|NCT02537522|560516555|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
155296921|NCT02537522|560516556|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
155296922|NCT02537522|560516557|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
155296923|NCT02537522|560516558|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
155296924|NCT02537522|560516555|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
155296925|NCT02537522|560516556|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
155296926|NCT02537522|560516557|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
155296927|NCT02537522|560516558|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
155296928|NCT02537522|560516555|FG000|Phase I - Contralateral|incorrect randomization|0|||
155296929|NCT02537522|560516556|FG001|Phase I - Contralateral|incorrect randomization|1|||
155296930|NCT02537522|560516557|FG002|Phase I - Contralateral|incorrect randomization|0|||
155296931|NCT02537522|560516558|FG003|Phase I - Contralateral|incorrect randomization|0|||
155296932|NCT02537522|560516555|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
155296933|NCT02537522|560516556|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
155296934|NCT02537522|560516557|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
155296935|NCT02537522|560516558|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
155296936|NCT02537522|560516555|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
155296937|NCT02537522|560516556|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
155296938|NCT02537522|560516557|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
155296939|NCT02537522|560516558|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
155296940|NCT03920215|560516560|FG000|Overall Study|Lost to Follow-up|1|||
155296941|NCT03920215|560516561|FG001|Overall Study|Lost to Follow-up|2|||
155296942|NCT03920215|560516562|FG002|Overall Study|Lost to Follow-up|0|||
155296943|NCT03920215|560516563|FG003|Overall Study|Lost to Follow-up|0|||
155296944|NCT03920215|560516560|FG000|Overall Study|Death|0|||
155296945|NCT03920215|560516561|FG001|Overall Study|Death|0|||
155296946|NCT03920215|560516562|FG002|Overall Study|Death|0|||
155296947|NCT03920215|560516563|FG003|Overall Study|Death|1|||
155296948|NCT02425111|560516566|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
155296949|NCT02425111|560516566|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
155296950|NCT02425111|560516566|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
155296951|NCT02425111|560516566|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
155296952|NCT02425111|560516566|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
155296953|NCT02425111|560516566|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
155296954|NCT00585533|560516567|FG000|Overall Study|objective or symptomatic progression|9|||
155296955|NCT02798835|560516568|FG000|Overall Study|Protocol Violation|0|||
155296956|NCT02798835|560516569|FG001|Overall Study|Protocol Violation|0|||
155296957|NCT02798835|560516570|FG002|Overall Study|Protocol Violation|3|||
155296958|NCT03024606|560516571|FG000|Overall Study|Withdrawal by Subject|9|||
155296959|NCT03024606|560516572|FG001|Overall Study|Withdrawal by Subject|10|||
155296960|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
155296961|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
155296962|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
155296963|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
154957108|NCT01185821|559270735|FG001|Overall Study|Lack of Efficacy|0|||
155296964|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155296965|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
155158051|NCT02594124|560016620|FG005|Overall Study|Physician Decision|0|||
155158052|NCT02594124|560016621|FG006|Overall Study|Physician Decision|0|||
155158053|NCT02594124|560016622|FG007|Overall Study|Physician Decision|1|||
155158054|NCT02594124|560016623|FG008|Overall Study|Physician Decision|0|||
155158055|NCT02594124|560016615|FG000|Overall Study|Commercial drug|0|||
155158056|NCT02594124|560016616|FG001|Overall Study|Commercial drug|1|||
155158057|NCT02594124|560016617|FG002|Overall Study|Commercial drug|6|||
155158058|NCT02594124|560016618|FG003|Overall Study|Commercial drug|3|||
155158059|NCT02594124|560016619|FG004|Overall Study|Commercial drug|0|||
155158060|NCT02594124|560016620|FG005|Overall Study|Commercial drug|0|||
155158061|NCT02594124|560016621|FG006|Overall Study|Commercial drug|7|||
155158062|NCT02594124|560016622|FG007|Overall Study|Commercial drug|11|||
155158063|NCT02594124|560016623|FG008|Overall Study|Commercial drug|2|||
155158064|NCT02594124|560016615|FG000|Overall Study|Reason Not Specified|1|||
155158065|NCT02594124|560016616|FG001|Overall Study|Reason Not Specified|3|||
155158066|NCT02594124|560016617|FG002|Overall Study|Reason Not Specified|4|||
155158067|NCT02594124|560016618|FG003|Overall Study|Reason Not Specified|0|||
155158068|NCT02594124|560016619|FG004|Overall Study|Reason Not Specified|0|||
155158069|NCT02594124|560016620|FG005|Overall Study|Reason Not Specified|1|||
155158070|NCT02594124|560016621|FG006|Overall Study|Reason Not Specified|1|||
155158071|NCT02594124|560016622|FG007|Overall Study|Reason Not Specified|6|||
155158072|NCT02594124|560016623|FG008|Overall Study|Reason Not Specified|1|||
155158073|NCT01824836|560016624|FG000|Overall Study|Adverse Event|48|||
155158074|NCT01824836|560016624|FG000|Overall Study|Withdrawal by Subject|63|||
155158075|NCT01824836|560016624|FG000|Overall Study|Other complicating disease|116|||
155158076|NCT01824836|560016624|FG000|Overall Study|Disease progression|5|||
155158077|NCT01824836|560016624|FG000|Overall Study|Alternative therapy|2|||
155158078|NCT01824836|560016624|FG000|Overall Study|Depression|1|||
155158079|NCT01824836|560016624|FG000|Overall Study|Non-compliance|3|||
155158080|NCT01824836|560016624|FG000|Overall Study|Patient regained ovarian function|3|||
155158081|NCT01824836|560016624|FG000|Overall Study|Lost to Follow-up|8|||
155158082|NCT01824836|560016624|FG000|Overall Study|Physician Decision|2|||
155158083|NCT01824836|560016624|FG000|Overall Study|Research office was closed|3|||
155296966|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
155296967|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
155296968|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
155158084|NCT01824836|560016624|FG000|Overall Study|Relocation|3|||
155158085|NCT01824836|560016624|FG000|Overall Study|Insurance-related issue|1|||
154957109|NCT01185821|559270736|FG002|Overall Study|Lack of Efficacy|3|||
155158086|NCT01824836|560016624|FG000|Overall Study|Transportation issue|1|||
155158087|NCT01824836|560016624|FG000|Overall Study|Patient transferred care|1|||
155158088|NCT01824836|560016624|FG000|Overall Study|Unknown reasons|4|||
155158089|NCT01824836|560016624|FG000|Overall Study|Never started treatment|16|||
155296969|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
155158090|NCT05523089|560016625|FG000|Overall Study|Withdrawal by Subject|1|||
155158091|NCT05523089|560016626|FG001|Overall Study|Withdrawal by Subject|0|||
155158092|NCT05523089|560016627|FG002|Overall Study|Withdrawal by Subject|0|||
155158093|NCT05523089|560016625|FG000|Overall Study|Lost to Follow-up|1|||
155158094|NCT05523089|560016626|FG001|Overall Study|Lost to Follow-up|0|||
155158095|NCT05523089|560016627|FG002|Overall Study|Lost to Follow-up|0|||
155158096|NCT03312634|560018632|FG000|Overall Study|Adverse Event|11|||
155158097|NCT03312634|560018633|FG001|Overall Study|Adverse Event|0|||
155158098|NCT03312634|560018632|FG000|Overall Study|Sponsor request|2|||
155158099|NCT03312634|560018633|FG001|Overall Study|Sponsor request|0|||
155158100|NCT03312634|560018632|FG000|Overall Study|Withdrawal by Subject|31|||
155158101|NCT03312634|560018633|FG001|Overall Study|Withdrawal by Subject|9|||
155158102|NCT03312634|560018632|FG000|Overall Study|Enrolled in an interventional study|0|||
155158103|NCT03312634|560018633|FG001|Overall Study|Enrolled in an interventional study|52|||
155158104|NCT03312634|560018632|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
155158105|NCT03312634|560018633|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
155158106|NCT03312634|560018632|FG000|Overall Study|Death|0|||
155158107|NCT03312634|560018633|FG001|Overall Study|Death|1|||
155158108|NCT03312634|560018632|FG000|Overall Study|Non-compliance|0|||
155158109|NCT03312634|560018633|FG001|Overall Study|Non-compliance|2|||
155158110|NCT03312634|560018632|FG000|Overall Study|Lost to Follow-up|0|||
155158111|NCT03312634|560018633|FG001|Overall Study|Lost to Follow-up|1|||
155296970|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296971|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296972|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296973|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296974|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296975|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155296976|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296977|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
155296978|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296979|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296980|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296981|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296982|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296983|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
155296984|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
155296985|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
155296986|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
155158112|NCT03312634|560018632|FG000|Overall Study|Enrolled into non-interventional study|0|||
155158113|NCT03312634|560018633|FG001|Overall Study|Enrolled into non-interventional study|5|||
155158114|NCT03312634|560018632|FG000|Overall Study|Worsening clinical condition|0|||
155158115|NCT03312634|560018633|FG001|Overall Study|Worsening clinical condition|1|||
155158116|NCT03312634|560018632|FG000|Overall Study|Participant did not want to travel|0|||
155158117|NCT03312634|560018633|FG001|Overall Study|Participant did not want to travel|1|||
155158118|NCT03312634|560018632|FG000|Overall Study|Physician Decision|1|||
155158119|NCT03312634|560018633|FG001|Overall Study|Physician Decision|0|||
155158120|NCT03312634|560018632|FG000|Overall Study|Other|13|||
155158121|NCT03312634|560018633|FG001|Overall Study|Other|0|||
155158122|NCT00777153|560018634|FG000|Overall Study|Lost to Follow-up|1|||
155158123|NCT00777153|560018635|FG001|Overall Study|Lost to Follow-up|1|||
155158124|NCT00777153|560018636|FG002|Overall Study|Lost to Follow-up|0|||
155158125|NCT00777153|560018634|FG000|Overall Study|Death|85|||
155158126|NCT00777153|560018635|FG001|Overall Study|Death|73|||
155158127|NCT00777153|560018636|FG002|Overall Study|Death|33|||
154957110|NCT01185821|559270737|FG003|Overall Study|Lack of Efficacy|0|||
154957111|NCT01185821|559270738|FG004|Overall Study|Lack of Efficacy|9|||
154957112|NCT01185821|559270734|FG000|Overall Study|Withdrawal by Subject|3|||
154957113|NCT01185821|559270735|FG001|Overall Study|Withdrawal by Subject|2|||
154957114|NCT01185821|559270736|FG002|Overall Study|Withdrawal by Subject|2|||
154957115|NCT01185821|559270737|FG003|Overall Study|Withdrawal by Subject|1|||
154957116|NCT01185821|559270738|FG004|Overall Study|Withdrawal by Subject|3|||
154957117|NCT01185821|559270734|FG000|Overall Study|Lost to Follow-up|1|||
155296987|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
155296988|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
155296989|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
155296990|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
155158128|NCT00777153|560018634|FG000|Overall Study|Withdrawal by Subject|3|||
155158129|NCT00777153|560018635|FG001|Overall Study|Withdrawal by Subject|4|||
155158130|NCT00777153|560018636|FG002|Overall Study|Withdrawal by Subject|3|||
155158131|NCT00777153|560018634|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
155158132|NCT00777153|560018635|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
155158133|NCT00777153|560018636|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
155158134|NCT05462756|560018649|FG000|Treatment Period|Adverse Event|3|||
155158135|NCT05462756|560018650|FG001|Treatment Period|Adverse Event|0|||
155158136|NCT05462756|560018649|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
155296991|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
155296992|NCT03482011|560516583|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
155296993|NCT03482011|560516584|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
155296994|NCT03482011|560516585|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296995|NCT03482011|560516586|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296996|NCT03482011|560516587|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296997|NCT03482011|560516588|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296998|NCT03482011|560516589|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155296999|NCT03482011|560516590|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155297000|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297001|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297002|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297003|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297004|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
155297005|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
155297006|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
155297007|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
155297008|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155297009|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155297010|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
155297011|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
155297012|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
155297013|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
155297014|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155297015|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
155297016|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297017|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297018|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297019|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297020|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
155297021|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297022|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155297023|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
155297024|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297025|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297026|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297027|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297028|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
155297029|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297030|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297031|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
155297032|NCT03482011|560516583|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155297033|NCT03482011|560516584|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155297034|NCT03482011|560516585|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155297035|NCT03482011|560516586|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
155297036|NCT03482011|560516587|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155297037|NCT03482011|560516588|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
155297038|NCT03482011|560516589|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155297039|NCT03482011|560516590|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
155297040|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297041|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297042|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297043|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
155297044|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
155297045|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
155297046|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
155297047|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
155297048|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297049|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297050|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297051|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297052|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297053|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
155297054|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
155297055|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
155297056|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297057|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297058|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
155297059|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
155297060|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297061|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297062|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
155297063|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
155297064|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297065|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297066|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297067|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297068|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297069|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297070|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
155297071|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
155297072|NCT03482011|560516583|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297073|NCT03482011|560516584|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297074|NCT03482011|560516585|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297075|NCT03482011|560516586|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297076|NCT03482011|560516587|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297077|NCT03482011|560516588|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297078|NCT03482011|560516589|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155297079|NCT03482011|560516590|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
155297080|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
155297081|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297082|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297083|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297084|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
155297085|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
155297086|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297087|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297088|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297089|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
155297090|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
155297091|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297092|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297093|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297094|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
155297095|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
155297096|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297097|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297098|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297099|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
155297100|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
155297101|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297102|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297103|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297104|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
155297105|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
155297106|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297107|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297108|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297109|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
155297110|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
155297111|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297112|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297113|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297114|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
155297115|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
155297116|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297117|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297118|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297119|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
155297120|NCT02709655|560516591|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
155297121|NCT02709655|560516592|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297122|NCT02709655|560516593|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297123|NCT02709655|560516594|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297124|NCT02709655|560516595|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
155297125|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
155297126|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
155297127|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
155297128|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
155297129|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
155297130|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
155297131|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
155297132|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
155297133|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
154957118|NCT01185821|559270735|FG001|Overall Study|Lost to Follow-up|1|||
155297134|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
155297135|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
155297136|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
154957119|NCT01185821|559270736|FG002|Overall Study|Lost to Follow-up|2|||
154957120|NCT01185821|559270737|FG003|Overall Study|Lost to Follow-up|1|||
155297137|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
155297138|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
155297139|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
155297140|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297141|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
155297142|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297143|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297144|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
155297145|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
155297146|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
155297147|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
155297148|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
155297149|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
155297150|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
155297151|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
155297152|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
155297153|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
155297154|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
155297155|NCT02709655|560516591|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
155297156|NCT02709655|560516592|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
155297157|NCT02709655|560516593|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
155297158|NCT02709655|560516594|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
155297159|NCT02709655|560516595|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
155297160|NCT00102063|560516596|FG000|Overall Study|Lack of Efficacy|5|||
155297161|NCT00102063|560516597|FG001|Overall Study|Lack of Efficacy|1|||
155297162|NCT00102063|560516598|FG002|Overall Study|Lack of Efficacy|1|||
155297163|NCT00102063|560516596|FG000|Overall Study|Adverse Event|7|||
155297164|NCT00102063|560516597|FG001|Overall Study|Adverse Event|4|||
155297165|NCT00102063|560516598|FG002|Overall Study|Adverse Event|2|||
155297166|NCT00102063|560516596|FG000|Overall Study|Withdrawal by Subject|4|||
155297167|NCT00102063|560516597|FG001|Overall Study|Withdrawal by Subject|12|||
155297168|NCT00102063|560516598|FG002|Overall Study|Withdrawal by Subject|5|||
155297169|NCT00102063|560516596|FG000|Overall Study|Lost to Follow-up|0|||
155297170|NCT00102063|560516597|FG001|Overall Study|Lost to Follow-up|0|||
155297171|NCT00102063|560516598|FG002|Overall Study|Lost to Follow-up|1|||
155297172|NCT00102063|560516596|FG000|Overall Study|Protocol Violation|0|||
155297173|NCT00102063|560516597|FG001|Overall Study|Protocol Violation|1|||
155297174|NCT00102063|560516598|FG002|Overall Study|Protocol Violation|1|||
155297175|NCT00630786|560516602|FG000|Overall Study|Physician Decision|0|||
155297176|NCT00630786|560516603|FG001|Overall Study|Physician Decision|0|||
155297177|NCT00630786|560516604|FG002|Overall Study|Physician Decision|1|||
155297178|NCT00630786|560516602|FG000|Overall Study|Withdrawal by Subject|0|||
155297179|NCT00630786|560516603|FG001|Overall Study|Withdrawal by Subject|1|||
155297180|NCT00630786|560516604|FG002|Overall Study|Withdrawal by Subject|1|||
155297181|NCT00630786|560516602|FG000|Overall Study|Lost to Follow-up|0|||
155297182|NCT00630786|560516603|FG001|Overall Study|Lost to Follow-up|1|||
155297183|NCT00630786|560516604|FG002|Overall Study|Lost to Follow-up|0|||
155297184|NCT00630786|560516602|FG000|Overall Study|Other|1|||
155297185|NCT00630786|560516603|FG001|Overall Study|Other|0|||
155297186|NCT00630786|560516604|FG002|Overall Study|Other|0|||
155297187|NCT02031471|560516605|FG000|24 Week Treatment Period|Adverse Event|6|||
155297188|NCT02031471|560516605|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
155297189|NCT02031471|560516605|FG000|24 Week Treatment Period|Protocol Violation|1|||
155297190|NCT02031471|560516605|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
155297191|NCT02031471|560516605|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
155297192|NCT02031471|560516605|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
155297193|NCT02031471|560516605|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
155297194|NCT03070483|560516606|FG000|Overall Study|Lost to Follow-up|2|||
155297195|NCT06269640|560517736|FG000|Overall Study|Death|1|||
155297196|NCT03723616|560517739|FG000|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|17|||
155297197|NCT03723616|560517740|FG001|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|16|||
155297198|NCT03723616|560517741|FG002|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|20|||
155297199|NCT03723616|560517742|FG003|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|6|||
155297200|NCT03723616|560517743|FG004|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
155297201|NCT03723616|560517744|FG005|Overall Study|Attempted to take the survey as both a smoker and a susceptible non-smoker.|13|||
155297202|NCT03979365|560517745|FG000|Overall Study|Death|1|||
155297203|NCT03979365|560517746|FG001|Overall Study|Death|3|||
155297204|NCT03979365|560517745|FG000|Overall Study|Withdrawal by Subject|0|||
155297205|NCT03979365|560517746|FG001|Overall Study|Withdrawal by Subject|1|||
155297206|NCT03979365|560517745|FG000|Overall Study|Drug Conversion|0|||
155297207|NCT03979365|560517746|FG001|Overall Study|Drug Conversion|3|||
155297208|NCT06001177|560517749|FG000|Treatment Phase|Adverse Event|1|||
155297209|NCT06001177|560517750|FG001|Treatment Phase|Adverse Event|0|||
155297210|NCT06001177|560517749|FG000|Treatment Phase|Withdrawal by Subject|1|||
155297211|NCT06001177|560517750|FG001|Treatment Phase|Withdrawal by Subject|0|||
155297212|NCT06001177|560517749|FG000|Observation Phase|Adverse Event|1|||
155297213|NCT06001177|560517750|FG001|Observation Phase|Adverse Event|1|||
155297214|NCT06001177|560517749|FG000|Observation Phase|Withdrawal by Subject|0|||
155297215|NCT06001177|560517750|FG001|Observation Phase|Withdrawal by Subject|1|||
155297216|NCT00799396|560517753|FG000|Clopidogrel Treatment|Adverse Event|6|||
155297217|NCT00799396|560517753|FG000|Clopidogrel Treatment|Physician Decision|5|||
155297218|NCT00799396|560517753|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
155297219|NCT00799396|560517753|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
155297220|NCT00799396|560517753|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
155297221|NCT03593876|560517754|FG000|Overall Study|Withdrawal by Subject|1|||
155297222|NCT03593876|560517754|FG000|Overall Study|Discharged home before intervention completion|2|||
155297223|NCT06119113|560517757|FG000|Overall Study|Lost to Follow-up|15|||
155297224|NCT06119113|560517758|FG001|Overall Study|Lost to Follow-up|13|||
155297225|NCT06119113|560517759|FG002|Overall Study|Lost to Follow-up|21|||
155297226|NCT05309668|560517760|FG000|Overall Study|Ongoing at data cut-off|14|||
155297227|NCT05309668|560517761|FG001|Overall Study|Ongoing at data cut-off|17|||
155297228|NCT05309668|560517762|FG002|Overall Study|Ongoing at data cut-off|4|||
155297229|NCT02696707|560517763|FG000|Per Protocol Population|Physician Decision|2|||
155297230|NCT02696707|560517764|FG001|Per Protocol Population|Physician Decision|1|||
155297231|NCT02696707|560517763|FG000|Per Protocol Population|Participant Decision|0|||
155297232|NCT02696707|560517764|FG001|Per Protocol Population|Participant Decision|2|||
155297233|NCT02696707|560517763|FG000|Completed Study as Planned|Reason = LVEF|2|||
155297234|NCT02696707|560517764|FG001|Completed Study as Planned|Reason = LVEF|2|||
155297235|NCT02696707|560517763|FG000|Completed Study as Planned|Protocol Violation|2|||
155297236|NCT02696707|560517764|FG001|Completed Study as Planned|Protocol Violation|6|||
155297237|NCT02696707|560517763|FG000|Completed Study as Planned|Metastatic disease|3|||
155297238|NCT02696707|560517764|FG001|Completed Study as Planned|Metastatic disease|0|||
155297239|NCT02696707|560517763|FG000|Completed Study as Planned|Location|1|||
155297240|NCT02696707|560517764|FG001|Completed Study as Planned|Location|1|||
155297241|NCT00071799|560517765|FG000|Overall Study|Adverse Event|19|||
155297242|NCT00071799|560517766|FG001|Overall Study|Adverse Event|10|||
155297243|NCT00071799|560517765|FG000|Overall Study|Protocol Violation|1|||
155297244|NCT00071799|560517766|FG001|Overall Study|Protocol Violation|7|||
155297245|NCT00071799|560517765|FG000|Overall Study|Lost to Follow-up|1|||
155297246|NCT00071799|560517766|FG001|Overall Study|Lost to Follow-up|1|||
155297247|NCT00071799|560517765|FG000|Overall Study|Withdrawal by Subject|15|||
155297248|NCT00071799|560517766|FG001|Overall Study|Withdrawal by Subject|37|||
155297249|NCT00071799|560517765|FG000|Overall Study|Physician Decision|0|||
155297250|NCT00071799|560517766|FG001|Overall Study|Physician Decision|2|||
154957121|NCT01185821|559270738|FG004|Overall Study|Lost to Follow-up|2|||
154957122|NCT01185821|559270734|FG000|Overall Study|Administrative problems|0|||
154957123|NCT01185821|559270735|FG001|Overall Study|Administrative problems|0|||
154957124|NCT01185821|559270736|FG002|Overall Study|Administrative problems|1|||
154957125|NCT01185821|559270737|FG003|Overall Study|Administrative problems|1|||
154957126|NCT01185821|559270738|FG004|Overall Study|Administrative problems|2|||
154957127|NCT01534520|559270739|FG000|Overall Study|Adverse Event|0|||
154957128|NCT01534520|559270740|FG001|Overall Study|Adverse Event|1|||
154957129|NCT05615935|559270743|FG000|Overall Study|Lost to Follow-up|1|||
155297251|NCT00071799|560517765|FG000|Overall Study|Lack of Efficacy|11|||
155297252|NCT00071799|560517766|FG001|Overall Study|Lack of Efficacy|18|||
155297253|NCT00071799|560517765|FG000|Overall Study|Disease Progression|23|||
155297254|NCT00071799|560517766|FG001|Overall Study|Disease Progression|20|||
155297255|NCT00071799|560517765|FG000|Overall Study|Different Central+Local Pathology Review|0|||
155297256|NCT00071799|560517766|FG001|Overall Study|Different Central+Local Pathology Review|1|||
155297257|NCT00071799|560517765|FG000|Overall Study|Not Documented|0|||
155297258|NCT00071799|560517766|FG001|Overall Study|Not Documented|2|||
155297259|NCT05526248|560517767|FG000|Overall Study|Lost to Follow-up|1|||
154957130|NCT05615935|559270744|FG001|Overall Study|Lost to Follow-up|1|||
154957131|NCT00537979|559270751|FG000|Overall Study|Adverse Event|2|||
154957132|NCT00537979|559270752|FG001|Overall Study|Adverse Event|2|||
155297260|NCT05526248|560517767|FG000|Overall Study|Adverse Event|2|||
155297261|NCT05526248|560517767|FG000|Overall Study|Withdrawal by Subject|1|||
155297262|NCT04527549|560517768|FG000|Overall Study|Withdrawal by Subject|1|||
155297263|NCT04527549|560517769|FG001|Overall Study|Withdrawal by Subject|1|||
155297264|NCT05764161|560517770|FG000|12-week DBVC Period|Lack of Efficacy|2|||
155158137|NCT05462756|560018650|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
155158138|NCT05462756|560018649|FG000|Treatment Period|Death|0|||
155158139|NCT05462756|560018650|FG001|Treatment Period|Death|1|||
155158140|NCT05462756|560018649|FG000|Treatment Period|Lost to Follow-up|2|||
155158141|NCT05462756|560018650|FG001|Treatment Period|Lost to Follow-up|1|||
155158142|NCT05462756|560018649|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
155158143|NCT05462756|560018650|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
155158144|NCT05462756|560018649|FG000|Treatment Period|Physician Decision|2|||
155158145|NCT05462756|560018650|FG001|Treatment Period|Physician Decision|0|||
155158146|NCT05462756|560018649|FG000|Treatment Period|Protocol Violation|0|||
155158147|NCT05462756|560018650|FG001|Treatment Period|Protocol Violation|1|||
155158148|NCT05462756|560018649|FG000|Treatment Period|Withdrawal by Subject|5|||
155158149|NCT05462756|560018650|FG001|Treatment Period|Withdrawal by Subject|12|||
155158150|NCT05462756|560018649|FG000|Follow-Up Period|Adverse Event|1|||
155158151|NCT05462756|560018650|FG001|Follow-Up Period|Adverse Event|0|||
155158152|NCT05462756|560018649|FG000|Follow-Up Period|Death|1|||
155158153|NCT05462756|560018650|FG001|Follow-Up Period|Death|0|||
155158154|NCT05462756|560018649|FG000|Follow-Up Period|Lost to Follow-up|3|||
155158155|NCT05462756|560018650|FG001|Follow-Up Period|Lost to Follow-up|1|||
155158156|NCT05462756|560018649|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155158157|NCT05462756|560018650|FG001|Follow-Up Period|Withdrawal by Subject|4|||
155158158|NCT02079246|560018651|FG000|OLEX|Withdrawal before treatment|1|||
155158159|NCT02079246|560018652|FG001|OLEX|Withdrawal before treatment|0|||
155158160|NCT02079246|560018651|FG000|OLEX|Death|11|||
155158161|NCT02079246|560018652|FG001|OLEX|Death|0|||
155158162|NCT02079246|560018651|FG000|OLEX|Adverse Event|66|||
155158163|NCT02079246|560018652|FG001|OLEX|Adverse Event|0|||
155158164|NCT02079246|560018651|FG000|OLEX|Withdrawal by Subject|60|||
155158165|NCT02079246|560018652|FG001|OLEX|Withdrawal by Subject|0|||
155158166|NCT02079246|560018651|FG000|OLEX|Lost to Follow-up|6|||
155158167|NCT02079246|560018652|FG001|OLEX|Lost to Follow-up|0|||
155158168|NCT02079246|560018651|FG000|OLEX|Protocol Violation|6|||
155158169|NCT02079246|560018652|FG001|OLEX|Protocol Violation|0|||
155158170|NCT02079246|560018651|FG000|OLEX|Lack of Efficacy|3|||
155158171|NCT02079246|560018652|FG001|OLEX|Lack of Efficacy|0|||
155158172|NCT02079246|560018651|FG000|OLEX|Results of the lead-in studies|58|||
155158173|NCT02079246|560018652|FG001|OLEX|Results of the lead-in studies|0|||
155158174|NCT02079246|560018651|FG000|OLEX|Other: Disallowed medication|8|||
155158175|NCT02079246|560018652|FG001|OLEX|Other: Disallowed medication|0|||
155158176|NCT02079246|560018651|FG000|OLEX|Other: Insufficient compliance|2|||
155158177|NCT02079246|560018652|FG001|OLEX|Other: Insufficient compliance|0|||
155158178|NCT02079246|560018651|FG000|OLEX|Other: Caregiver unavailable|3|||
155158179|NCT02079246|560018652|FG001|OLEX|Other: Caregiver unavailable|0|||
155158180|NCT02079246|560018651|FG000|OLEX|Other: Coordinator decision|1|||
155158181|NCT02079246|560018652|FG001|OLEX|Other: Coordinator decision|0|||
155158182|NCT02079246|560018651|FG000|OLEX|Other: Worsening of condition|1|||
155158183|NCT02079246|560018652|FG001|OLEX|Other: Worsening of condition|0|||
155158184|NCT02079246|560018651|FG000|OLEX|Other: Moved to nursing home|1|||
155158185|NCT02079246|560018652|FG001|OLEX|Other: Moved to nursing home|0|||
155158186|NCT02079246|560018651|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
155158187|NCT02079246|560018652|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
155158188|NCT02079246|560018651|FG000|OLEX-MEM|Adverse Event|0|||
155158189|NCT02079246|560018652|FG001|OLEX-MEM|Adverse Event|6|||
155158190|NCT02079246|560018651|FG000|OLEX-MEM|Withdrawal by Subject|0|||
155158191|NCT02079246|560018652|FG001|OLEX-MEM|Withdrawal by Subject|7|||
155158192|NCT02079246|560018651|FG000|OLEX-MEM|Protocol Violation|0|||
155158193|NCT02079246|560018652|FG001|OLEX-MEM|Protocol Violation|2|||
155158194|NCT02079246|560018651|FG000|OLEX-MEM|Lost to Follow-up|0|||
155158195|NCT02079246|560018652|FG001|OLEX-MEM|Lost to Follow-up|1|||
155158196|NCT02079246|560018651|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
155158197|NCT02079246|560018652|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
155158198|NCT02536976|560018662|FG000|Overall Study|Physician Decision|0|||
155158199|NCT02536976|560018663|FG001|Overall Study|Physician Decision|1|||
155158200|NCT01671319|560018666|FG000|Overall Study|Withdrawal by Subject|1|||
155158201|NCT01389596|560018667|FG000|Overall Study|Protocol Violation|3|||
155158202|NCT01389596|560018668|FG001|Overall Study|Protocol Violation|4|||
155158203|NCT01389596|560018669|FG002|Overall Study|Protocol Violation|3|||
155158204|NCT01389596|560018667|FG000|Overall Study|Withdrawal by Subject|1|||
155158205|NCT01389596|560018668|FG001|Overall Study|Withdrawal by Subject|2|||
155158206|NCT01389596|560018669|FG002|Overall Study|Withdrawal by Subject|2|||
155158207|NCT01389596|560018667|FG000|Overall Study|Insufficient Clinical Response|3|||
155158208|NCT01389596|560018668|FG001|Overall Study|Insufficient Clinical Response|4|||
155158209|NCT01389596|560018669|FG002|Overall Study|Insufficient Clinical Response|5|||
155158210|NCT01389596|560018667|FG000|Overall Study|Adverse Event|1|||
155158211|NCT01389596|560018668|FG001|Overall Study|Adverse Event|4|||
155158212|NCT01389596|560018669|FG002|Overall Study|Adverse Event|0|||
155158213|NCT01389596|560018667|FG000|Overall Study|Death|0|||
155158214|NCT01389596|560018668|FG001|Overall Study|Death|1|||
155158215|NCT01389596|560018669|FG002|Overall Study|Death|0|||
155158216|NCT01389596|560018667|FG000|Overall Study|Other Unspecified|2|||
155297265|NCT05764161|560517771|FG001|12-week DBVC Period|Lack of Efficacy|1|||
155297266|NCT05764161|560517770|FG000|12-week DBVC Period|Lost to Follow-up|0|||
155297267|NCT05764161|560517771|FG001|12-week DBVC Period|Lost to Follow-up|2|||
155297268|NCT05764161|560517770|FG000|12-week DBVC Period|Protocol Violation|2|||
155297269|NCT05764161|560517771|FG001|12-week DBVC Period|Protocol Violation|4|||
155297270|NCT05764161|560517770|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
155297271|NCT05764161|560517771|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
155297272|NCT05764161|560517770|FG000|40-week OLE Period|Lack of Efficacy|0|||
155297273|NCT05764161|560517771|FG001|40-week OLE Period|Lack of Efficacy|1|||
155297274|NCT05764161|560517770|FG000|40-week OLE Period|Lost to Follow-up|1|||
155297275|NCT05764161|560517771|FG001|40-week OLE Period|Lost to Follow-up|4|||
155297276|NCT05764161|560517770|FG000|40-week OLE Period|Withdrawal by Subject|2|||
155297277|NCT05764161|560517771|FG001|40-week OLE Period|Withdrawal by Subject|7|||
155297278|NCT05764161|560517770|FG000|40-week OLE Period|Extended Travel|0|||
155297279|NCT05764161|560517771|FG001|40-week OLE Period|Extended Travel|1|||
155297280|NCT05764161|560517770|FG000|40-week OLE Period|Ongoing|66|||
155297281|NCT05764161|560517771|FG001|40-week OLE Period|Ongoing|59|||
155297282|NCT03460756|560517780|FG000|Overall Study|Adverse Event|0|||
155297283|NCT03460756|560517781|FG001|Overall Study|Adverse Event|0|||
155297284|NCT03460756|560517782|FG002|Overall Study|Adverse Event|0|||
155297285|NCT03460756|560517783|FG003|Overall Study|Adverse Event|1|||
155297286|NCT03460756|560517780|FG000|Overall Study|Lack of Efficacy|0|||
155297287|NCT03460756|560517781|FG001|Overall Study|Lack of Efficacy|0|||
155297288|NCT03460756|560517782|FG002|Overall Study|Lack of Efficacy|0|||
155297289|NCT03460756|560517783|FG003|Overall Study|Lack of Efficacy|2|||
155297290|NCT03460756|560517780|FG000|Overall Study|Lost to Follow-up|0|||
155297291|NCT03460756|560517781|FG001|Overall Study|Lost to Follow-up|1|||
155297292|NCT03460756|560517782|FG002|Overall Study|Lost to Follow-up|2|||
155297293|NCT03460756|560517783|FG003|Overall Study|Lost to Follow-up|1|||
155297294|NCT03460756|560517780|FG000|Overall Study|Pregnancy|0|||
155297295|NCT03460756|560517781|FG001|Overall Study|Pregnancy|0|||
155297296|NCT03460756|560517782|FG002|Overall Study|Pregnancy|0|||
155297297|NCT03460756|560517783|FG003|Overall Study|Pregnancy|1|||
155297298|NCT03460756|560517780|FG000|Overall Study|Protocol Violation|0|||
155297299|NCT03460756|560517781|FG001|Overall Study|Protocol Violation|0|||
155297300|NCT03460756|560517782|FG002|Overall Study|Protocol Violation|0|||
155297301|NCT03460756|560517783|FG003|Overall Study|Protocol Violation|1|||
155297302|NCT03460756|560517780|FG000|Overall Study|Withdrawal by Subject|0|||
155297303|NCT03460756|560517781|FG001|Overall Study|Withdrawal by Subject|4|||
155297304|NCT03460756|560517782|FG002|Overall Study|Withdrawal by Subject|7|||
155297305|NCT03460756|560517783|FG003|Overall Study|Withdrawal by Subject|3|||
155297306|NCT00723450|560517785|FG000|Open-Label Phase|Adverse Event|26|||
155297307|NCT00723450|560517786|FG001|Open-Label Phase|Adverse Event|0|||
155297308|NCT00723450|560517787|FG002|Open-Label Phase|Adverse Event|0|||
155297309|NCT00723450|560517785|FG000|Open-Label Phase|Lack of Efficacy|18|||
155297310|NCT00723450|560517786|FG001|Open-Label Phase|Lack of Efficacy|0|||
155297311|NCT00723450|560517787|FG002|Open-Label Phase|Lack of Efficacy|0|||
155297312|NCT00723450|560517785|FG000|Open-Label Phase|Protocol Violation|35|||
155297313|NCT00723450|560517786|FG001|Open-Label Phase|Protocol Violation|0|||
155297314|NCT00723450|560517787|FG002|Open-Label Phase|Protocol Violation|0|||
155297315|NCT00723450|560517785|FG000|Open-Label Phase|Lost to Follow-up|7|||
155297316|NCT00723450|560517786|FG001|Open-Label Phase|Lost to Follow-up|0|||
155297317|NCT00723450|560517787|FG002|Open-Label Phase|Lost to Follow-up|0|||
155158217|NCT01389596|560018668|FG001|Overall Study|Other Unspecified|1|||
155158218|NCT01389596|560018669|FG002|Overall Study|Other Unspecified|0|||
155158219|NCT01709084|560018670|FG000|Overall Study|Lost to Follow-up|4|||
155158220|NCT01709084|560018671|FG001|Overall Study|Lost to Follow-up|7|||
155297318|NCT00723450|560517785|FG000|Open-Label Phase|Physician Decision|2|||
155297319|NCT00723450|560517786|FG001|Open-Label Phase|Physician Decision|0|||
155297320|NCT00723450|560517787|FG002|Open-Label Phase|Physician Decision|0|||
155297321|NCT00723450|560517785|FG000|Open-Label Phase|Withdrawal by Subject|37|||
155297322|NCT00723450|560517786|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155297323|NCT00723450|560517787|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155297324|NCT00723450|560517785|FG000|Randomized Phase|Adverse Event|0|||
155297325|NCT00723450|560517786|FG001|Randomized Phase|Adverse Event|26|||
155297326|NCT00723450|560517787|FG002|Randomized Phase|Adverse Event|17|||
155297327|NCT00723450|560517785|FG000|Randomized Phase|Lack of Efficacy|0|||
155297328|NCT00723450|560517786|FG001|Randomized Phase|Lack of Efficacy|11|||
155297329|NCT00723450|560517787|FG002|Randomized Phase|Lack of Efficacy|11|||
155297330|NCT00723450|560517785|FG000|Randomized Phase|Protocol Violation|0|||
155297331|NCT00723450|560517786|FG001|Randomized Phase|Protocol Violation|9|||
155297332|NCT00723450|560517787|FG002|Randomized Phase|Protocol Violation|13|||
155297333|NCT00723450|560517785|FG000|Randomized Phase|Lost to Follow-up|0|||
155297334|NCT00723450|560517786|FG001|Randomized Phase|Lost to Follow-up|2|||
155297335|NCT00723450|560517787|FG002|Randomized Phase|Lost to Follow-up|3|||
155297336|NCT00723450|560517785|FG000|Randomized Phase|Physician Decision|0|||
155158221|NCT01709084|560018670|FG000|Overall Study|Withdrawal by Subject|2|||
155297337|NCT00723450|560517786|FG001|Randomized Phase|Physician Decision|3|||
155297338|NCT00723450|560517787|FG002|Randomized Phase|Physician Decision|1|||
155297339|NCT00723450|560517785|FG000|Randomized Phase|Withdrawal by Subject|0|||
155297340|NCT00723450|560517786|FG001|Randomized Phase|Withdrawal by Subject|14|||
155297341|NCT00723450|560517787|FG002|Randomized Phase|Withdrawal by Subject|22|||
155297342|NCT02459899|560517788|FG000|Overall Study|Adverse Event|1|||
155297343|NCT02459899|560517789|FG001|Overall Study|Adverse Event|1|||
155297344|NCT02459899|560517790|FG002|Overall Study|Adverse Event|0|||
155297345|NCT02459899|560517791|FG003|Overall Study|Adverse Event|0|||
155297346|NCT02459899|560517788|FG000|Overall Study|Lost to Follow-up|1|||
155297347|NCT02459899|560517789|FG001|Overall Study|Lost to Follow-up|2|||
155297348|NCT02459899|560517790|FG002|Overall Study|Lost to Follow-up|0|||
155297349|NCT02459899|560517791|FG003|Overall Study|Lost to Follow-up|1|||
155297350|NCT02459899|560517788|FG000|Overall Study|Non-compliance with the treatment|0|||
155297351|NCT02459899|560517789|FG001|Overall Study|Non-compliance with the treatment|0|||
155297352|NCT02459899|560517790|FG002|Overall Study|Non-compliance with the treatment|0|||
155297353|NCT02459899|560517791|FG003|Overall Study|Non-compliance with the treatment|1|||
155297354|NCT02459899|560517788|FG000|Overall Study|Withdrawal by Subject|1|||
155297355|NCT02459899|560517789|FG001|Overall Study|Withdrawal by Subject|3|||
155297356|NCT02459899|560517790|FG002|Overall Study|Withdrawal by Subject|0|||
155297357|NCT02459899|560517791|FG003|Overall Study|Withdrawal by Subject|0|||
155297358|NCT02739035|560517794|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
155297359|NCT02739035|560517795|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
155297360|NCT02739035|560517794|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
155297361|NCT02739035|560517795|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
155297362|NCT02739035|560517794|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
155297363|NCT02739035|560517795|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
155297364|NCT02739035|560517794|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
155297365|NCT02739035|560517795|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
155297366|NCT04177394|560517805|FG000|Overall Study|Death|16|||
155297367|NCT04177394|560517805|FG000|Overall Study|Withdrawal by Subject|19|||
155297368|NCT04177394|560517805|FG000|Overall Study|Missed visits|61|||
155297369|NCT04177394|560517805|FG000|Overall Study|Expected Visits|15|||
155297370|NCT00843882|560517806|FG000|Step 1|Lack of Efficacy|14|||
155297371|NCT00843882|560517807|FG001|Step 1|Lack of Efficacy|10|||
155297372|NCT00843882|560517808|FG002|Step 1|Lack of Efficacy|21|||
155297373|NCT00843882|560517806|FG000|Step 1|Adverse Event|8|||
155297374|NCT00843882|560517807|FG001|Step 1|Adverse Event|17|||
155297375|NCT00843882|560517808|FG002|Step 1|Adverse Event|20|||
155297376|NCT00843882|560517806|FG000|Step 1|Death|1|||
155297377|NCT00843882|560517807|FG001|Step 1|Death|2|||
155297378|NCT00843882|560517808|FG002|Step 1|Death|4|||
155297379|NCT00843882|560517806|FG000|Step 1|Withdrawal by Subject|6|||
155297380|NCT00843882|560517807|FG001|Step 1|Withdrawal by Subject|12|||
155297381|NCT00843882|560517808|FG002|Step 1|Withdrawal by Subject|9|||
155297382|NCT00843882|560517806|FG000|Step 1|Physician Decision|0|||
155297383|NCT00843882|560517807|FG001|Step 1|Physician Decision|5|||
155297384|NCT00843882|560517808|FG002|Step 1|Physician Decision|1|||
155297385|NCT00843882|560517806|FG000|Step 1|Patient and physician's decision|0|||
155297386|NCT00843882|560517807|FG001|Step 1|Patient and physician's decision|0|||
155297387|NCT00843882|560517808|FG002|Step 1|Patient and physician's decision|1|||
155297388|NCT00843882|560517806|FG000|Step 1|Other complicating disease|1|||
155297389|NCT00843882|560517807|FG001|Step 1|Other complicating disease|3|||
155297390|NCT00843882|560517808|FG002|Step 1|Other complicating disease|4|||
155297391|NCT00843882|560517806|FG000|Step 1|Alternative therapy|0|||
155297392|NCT00843882|560517807|FG001|Step 1|Alternative therapy|1|||
155297393|NCT00843882|560517808|FG002|Step 1|Alternative therapy|1|||
155297394|NCT00843882|560517806|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
155297395|NCT00843882|560517807|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
155297396|NCT00843882|560517808|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
155297397|NCT00843882|560517806|FG000|Step 1|Off treatment reason unknown|0|||
155297398|NCT00843882|560517807|FG001|Step 1|Off treatment reason unknown|1|||
155297399|NCT00843882|560517808|FG002|Step 1|Off treatment reason unknown|4|||
155061206|NCT03895086|559659278|FG001|Overall Study|Early termination study|0|||
155061207|NCT04656652|559659279|FG000|Overall Study|Lost to Follow-up|2|||
155061208|NCT04656652|559659280|FG001|Overall Study|Lost to Follow-up|2|||
155061209|NCT04656652|559659279|FG000|Overall Study|Death|213|||
155061210|NCT04656652|559659280|FG001|Overall Study|Death|212|||
155061211|NCT04656652|559659279|FG000|Overall Study|Other|1|||
155061212|NCT04656652|559659280|FG001|Overall Study|Other|0|||
155061213|NCT04656652|559659279|FG000|Overall Study|Withdrawal by Subject|15|||
155061214|NCT04656652|559659280|FG001|Overall Study|Withdrawal by Subject|29|||
155061215|NCT05911841|559659281|FG000|Induction Period|Study Terminated by Sponsor|2|||
155158222|NCT01709084|560018671|FG001|Overall Study|Withdrawal by Subject|2|||
155158223|NCT01709084|560018670|FG000|Overall Study|Adverse Event|5|||
155158224|NCT01709084|560018671|FG001|Overall Study|Adverse Event|0|||
155158225|NCT01709084|560018670|FG000|Overall Study|Other|5|||
155158226|NCT01709084|560018671|FG001|Overall Study|Other|3|||
155158227|NCT01709084|560018670|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
155158228|NCT01709084|560018671|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
155158229|NCT01709084|560018670|FG000|Overall Study|Not Treated|0|||
155158230|NCT01709084|560018671|FG001|Overall Study|Not Treated|2|||
155158231|NCT00214201|560018672|FG000|Overall Study|Withdrawal by Subject|2|||
155158232|NCT00214201|560018673|FG001|Overall Study|Withdrawal by Subject|0|||
155158233|NCT00214201|560018672|FG000|Overall Study|Death|0|||
155158234|NCT00214201|560018673|FG001|Overall Study|Death|2|||
155158235|NCT01354899|560018674|FG000|Overall Study|discharge from the hospital|2|||
155158236|NCT01354899|560018674|FG000|Overall Study|Protocol Violation|1|||
155158237|NCT00463567|560018675|FG000|Overall Study|Adverse Event|29|||
155158238|NCT00463567|560018676|FG001|Overall Study|Adverse Event|26|||
155158239|NCT00463567|560018677|FG002|Overall Study|Adverse Event|17|||
155158240|NCT00463567|560018678|FG003|Overall Study|Adverse Event|46|||
155158241|NCT00463567|560018679|FG004|Overall Study|Adverse Event|10|||
155158242|NCT00463567|560018680|FG005|Overall Study|Adverse Event|10|||
155158243|NCT00463567|560018681|FG006|Overall Study|Adverse Event|4|||
155158244|NCT00463567|560018675|FG000|Overall Study|Withdrawal by Subject|29|||
155158245|NCT00463567|560018676|FG001|Overall Study|Withdrawal by Subject|22|||
155158246|NCT00463567|560018677|FG002|Overall Study|Withdrawal by Subject|20|||
155158247|NCT00463567|560018678|FG003|Overall Study|Withdrawal by Subject|37|||
155158248|NCT00463567|560018679|FG004|Overall Study|Withdrawal by Subject|6|||
155158249|NCT00463567|560018680|FG005|Overall Study|Withdrawal by Subject|5|||
155158250|NCT00463567|560018681|FG006|Overall Study|Withdrawal by Subject|1|||
155158251|NCT00463567|560018675|FG000|Overall Study|Protocol Deviation|13|||
155158252|NCT00463567|560018676|FG001|Overall Study|Protocol Deviation|9|||
155158253|NCT00463567|560018677|FG002|Overall Study|Protocol Deviation|14|||
155158254|NCT00463567|560018678|FG003|Overall Study|Protocol Deviation|11|||
155158255|NCT00463567|560018679|FG004|Overall Study|Protocol Deviation|1|||
155158256|NCT00463567|560018680|FG005|Overall Study|Protocol Deviation|1|||
155158257|NCT00463567|560018681|FG006|Overall Study|Protocol Deviation|2|||
155158258|NCT00463567|560018675|FG000|Overall Study|Lost to Follow-up|12|||
155158259|NCT00463567|560018676|FG001|Overall Study|Lost to Follow-up|6|||
155158260|NCT00463567|560018677|FG002|Overall Study|Lost to Follow-up|13|||
155158261|NCT00463567|560018678|FG003|Overall Study|Lost to Follow-up|8|||
155158262|NCT00463567|560018679|FG004|Overall Study|Lost to Follow-up|1|||
155158263|NCT00463567|560018680|FG005|Overall Study|Lost to Follow-up|1|||
155158264|NCT00463567|560018681|FG006|Overall Study|Lost to Follow-up|1|||
155158265|NCT00463567|560018675|FG000|Overall Study|Administrative problems|5|||
155158266|NCT00463567|560018676|FG001|Overall Study|Administrative problems|3|||
155158267|NCT00463567|560018677|FG002|Overall Study|Administrative problems|6|||
155158268|NCT00463567|560018678|FG003|Overall Study|Administrative problems|9|||
155158269|NCT00463567|560018679|FG004|Overall Study|Administrative problems|3|||
155158270|NCT00463567|560018680|FG005|Overall Study|Administrative problems|2|||
155158271|NCT00463567|560018681|FG006|Overall Study|Administrative problems|2|||
155158272|NCT00463567|560018675|FG000|Overall Study|Lack of Efficacy|4|||
155158273|NCT00463567|560018676|FG001|Overall Study|Lack of Efficacy|9|||
155158274|NCT00463567|560018677|FG002|Overall Study|Lack of Efficacy|9|||
155158275|NCT00463567|560018678|FG003|Overall Study|Lack of Efficacy|17|||
155158276|NCT00463567|560018679|FG004|Overall Study|Lack of Efficacy|1|||
155158277|NCT00463567|560018680|FG005|Overall Study|Lack of Efficacy|0|||
155158278|NCT00463567|560018681|FG006|Overall Study|Lack of Efficacy|1|||
155158279|NCT00463567|560018675|FG000|Overall Study|Abnormal lab value(s)|1|||
155158280|NCT00463567|560018676|FG001|Overall Study|Abnormal lab value(s)|1|||
155158281|NCT00463567|560018677|FG002|Overall Study|Abnormal lab value(s)|2|||
155158282|NCT00463567|560018678|FG003|Overall Study|Abnormal lab value(s)|1|||
155158283|NCT00463567|560018679|FG004|Overall Study|Abnormal lab value(s)|1|||
155061216|NCT05911841|559659282|FG001|Induction Period|Study Terminated by Sponsor|0|||
155061217|NCT05911841|559659283|FG002|Induction Period|Study Terminated by Sponsor|14|||
155061218|NCT05911841|559659284|FG003|Induction Period|Study Terminated by Sponsor|6|||
155158284|NCT00463567|560018680|FG005|Overall Study|Abnormal lab value(s)|0|||
155158285|NCT00463567|560018681|FG006|Overall Study|Abnormal lab value(s)|0|||
155170031|NCT00830869|560062410|FG005|Period 2: Part 2|Adverse Event|0|||
155061219|NCT05911841|559659285|FG004|Induction Period|Study Terminated by Sponsor|0|||
155061220|NCT05911841|559659286|FG005|Induction Period|Study Terminated by Sponsor|0|||
155061221|NCT05911841|559659287|FG006|Induction Period|Study Terminated by Sponsor|0|||
155061222|NCT05911841|559659288|FG007|Induction Period|Study Terminated by Sponsor|0|||
155061223|NCT05911841|559659289|FG008|Induction Period|Study Terminated by Sponsor|0|||
155061224|NCT05911841|559659290|FG009|Induction Period|Study Terminated by Sponsor|0|||
155061225|NCT05911841|559659281|FG000|Induction Period|Withdrawal by Subject|4|||
155061226|NCT05911841|559659282|FG001|Induction Period|Withdrawal by Subject|3|||
155061227|NCT05911841|559659283|FG002|Induction Period|Withdrawal by Subject|4|||
155061228|NCT05911841|559659284|FG003|Induction Period|Withdrawal by Subject|6|||
155061229|NCT05911841|559659285|FG004|Induction Period|Withdrawal by Subject|0|||
155061230|NCT05911841|559659286|FG005|Induction Period|Withdrawal by Subject|0|||
155061231|NCT05911841|559659287|FG006|Induction Period|Withdrawal by Subject|0|||
155061232|NCT05911841|559659288|FG007|Induction Period|Withdrawal by Subject|0|||
155061233|NCT05911841|559659289|FG008|Induction Period|Withdrawal by Subject|0|||
155061234|NCT05911841|559659290|FG009|Induction Period|Withdrawal by Subject|0|||
155061235|NCT05911841|559659281|FG000|Induction Period|Lack of Efficacy|3|||
155061236|NCT05911841|559659282|FG001|Induction Period|Lack of Efficacy|0|||
155061237|NCT05911841|559659283|FG002|Induction Period|Lack of Efficacy|3|||
155061238|NCT05911841|559659284|FG003|Induction Period|Lack of Efficacy|3|||
155061239|NCT05911841|559659285|FG004|Induction Period|Lack of Efficacy|0|||
155061240|NCT05911841|559659286|FG005|Induction Period|Lack of Efficacy|0|||
155061241|NCT05911841|559659287|FG006|Induction Period|Lack of Efficacy|0|||
155061242|NCT05911841|559659288|FG007|Induction Period|Lack of Efficacy|0|||
155061243|NCT05911841|559659289|FG008|Induction Period|Lack of Efficacy|0|||
155061244|NCT05911841|559659290|FG009|Induction Period|Lack of Efficacy|0|||
155061245|NCT05911841|559659281|FG000|Induction Period|Adverse Event|3|||
155061246|NCT05911841|559659282|FG001|Induction Period|Adverse Event|1|||
155061247|NCT05911841|559659283|FG002|Induction Period|Adverse Event|2|||
155061248|NCT05911841|559659284|FG003|Induction Period|Adverse Event|0|||
155061249|NCT05911841|559659285|FG004|Induction Period|Adverse Event|0|||
155061250|NCT05911841|559659286|FG005|Induction Period|Adverse Event|0|||
155061251|NCT05911841|559659287|FG006|Induction Period|Adverse Event|0|||
155061252|NCT05911841|559659288|FG007|Induction Period|Adverse Event|0|||
155061253|NCT05911841|559659289|FG008|Induction Period|Adverse Event|0|||
155061254|NCT05911841|559659290|FG009|Induction Period|Adverse Event|0|||
155061255|NCT05911841|559659281|FG000|Induction Period|Assigned Treatment by Mistake|0|||
155061256|NCT05911841|559659282|FG001|Induction Period|Assigned Treatment by Mistake|1|||
155061257|NCT05911841|559659283|FG002|Induction Period|Assigned Treatment by Mistake|0|||
155061258|NCT05911841|559659284|FG003|Induction Period|Assigned Treatment by Mistake|1|||
155061259|NCT05911841|559659285|FG004|Induction Period|Assigned Treatment by Mistake|0|||
155061260|NCT05911841|559659286|FG005|Induction Period|Assigned Treatment by Mistake|0|||
155061261|NCT05911841|559659287|FG006|Induction Period|Assigned Treatment by Mistake|0|||
155061262|NCT05911841|559659288|FG007|Induction Period|Assigned Treatment by Mistake|0|||
155061263|NCT05911841|559659289|FG008|Induction Period|Assigned Treatment by Mistake|0|||
155061264|NCT05911841|559659290|FG009|Induction Period|Assigned Treatment by Mistake|0|||
155061265|NCT05911841|559659281|FG000|Induction Period|Lost to Follow-up|0|||
155061266|NCT05911841|559659282|FG001|Induction Period|Lost to Follow-up|0|||
155061267|NCT05911841|559659283|FG002|Induction Period|Lost to Follow-up|1|||
155061268|NCT05911841|559659284|FG003|Induction Period|Lost to Follow-up|1|||
155061269|NCT05911841|559659285|FG004|Induction Period|Lost to Follow-up|0|||
155158286|NCT00463567|560018675|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155158287|NCT00463567|560018676|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155158288|NCT00463567|560018677|FG002|Overall Study|Abnormal test procedure result(s)|6|||
155158289|NCT00463567|560018678|FG003|Overall Study|Abnormal test procedure result(s)|2|||
155158290|NCT00463567|560018679|FG004|Overall Study|Abnormal test procedure result(s)|0|||
155158291|NCT00463567|560018680|FG005|Overall Study|Abnormal test procedure result(s)|2|||
155158292|NCT00463567|560018681|FG006|Overall Study|Abnormal test procedure result(s)|0|||
155158293|NCT00463567|560018675|FG000|Overall Study|Death|1|||
155158294|NCT00463567|560018676|FG001|Overall Study|Death|0|||
155158295|NCT00463567|560018677|FG002|Overall Study|Death|2|||
155158296|NCT00463567|560018678|FG003|Overall Study|Death|0|||
155158297|NCT00463567|560018679|FG004|Overall Study|Death|0|||
155158298|NCT00463567|560018680|FG005|Overall Study|Death|0|||
155061270|NCT05911841|559659286|FG005|Induction Period|Lost to Follow-up|0|||
155061271|NCT05911841|559659287|FG006|Induction Period|Lost to Follow-up|0|||
155061272|NCT05911841|559659288|FG007|Induction Period|Lost to Follow-up|0|||
155061273|NCT05911841|559659289|FG008|Induction Period|Lost to Follow-up|0|||
155061274|NCT05911841|559659290|FG009|Induction Period|Lost to Follow-up|0|||
155158299|NCT00463567|560018681|FG006|Overall Study|Death|0|||
155158300|NCT00641667|560018684|FG000|Overall Study|Withdrawal by Subject|1|||
155158301|NCT00641667|560018684|FG000|Overall Study|Adverse Event|1|||
155061275|NCT05911841|559659281|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
155158302|NCT00641667|560018684|FG000|Overall Study|Physician Decision|1|||
155158303|NCT00641667|560018684|FG000|Overall Study|Worsening of underlying disease|3|||
155297400|NCT00843882|560517806|FG000|Step 1|Never started treatment|2|||
155297401|NCT00843882|560517807|FG001|Step 1|Never started treatment|0|||
155297402|NCT00843882|560517808|FG002|Step 1|Never started treatment|0|||
155297403|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
155297404|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
155297405|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
155297406|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
155297407|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
155297408|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
155297409|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
155297410|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
155297411|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
155297412|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
155297413|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
155297414|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
155297415|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
155297416|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
155297417|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
155297418|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
155297419|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
155297420|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
155297421|NCT00843882|560517806|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
155297422|NCT00843882|560517807|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
155297423|NCT00843882|560517808|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
155297424|NCT01582269|560517809|FG000|Overall Study|Withdrawal by Subject|1|||
155297425|NCT01582269|560517810|FG001|Overall Study|Withdrawal by Subject|0|||
155158304|NCT01124006|560018685|FG000|Overall Study|Withdrawal by Subject|2|||
155061276|NCT05911841|559659282|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
155061277|NCT05911841|559659283|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
155061278|NCT05911841|559659284|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
155061279|NCT05911841|559659285|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
155061280|NCT05911841|559659286|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
155061281|NCT05911841|559659287|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
155061282|NCT05911841|559659288|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
155061283|NCT05911841|559659289|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
155061284|NCT05911841|559659290|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
155061285|NCT05911841|559659281|FG000|Maintenance Period|Lack of Efficacy|0|||
155061286|NCT05911841|559659282|FG001|Maintenance Period|Lack of Efficacy|0|||
155061287|NCT05911841|559659283|FG002|Maintenance Period|Lack of Efficacy|0|||
155061288|NCT05911841|559659284|FG003|Maintenance Period|Lack of Efficacy|0|||
155061289|NCT05911841|559659285|FG004|Maintenance Period|Lack of Efficacy|1|||
155061290|NCT05911841|559659286|FG005|Maintenance Period|Lack of Efficacy|0|||
155061291|NCT05911841|559659287|FG006|Maintenance Period|Lack of Efficacy|1|||
155061292|NCT05911841|559659288|FG007|Maintenance Period|Lack of Efficacy|0|||
155061293|NCT05911841|559659289|FG008|Maintenance Period|Lack of Efficacy|0|||
155061294|NCT05911841|559659290|FG009|Maintenance Period|Lack of Efficacy|0|||
155061295|NCT05911841|559659281|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
155061296|NCT05911841|559659282|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
155061297|NCT05911841|559659283|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
155061298|NCT05911841|559659284|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
155061299|NCT05911841|559659285|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
155061300|NCT05911841|559659286|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
155158305|NCT01124006|560018686|FG001|Overall Study|Withdrawal by Subject|2|||
155158306|NCT01124006|560018687|FG002|Overall Study|Withdrawal by Subject|0|||
155297426|NCT01582269|560517811|FG002|Overall Study|Withdrawal by Subject|0|||
155297427|NCT06218251|560517812|FG000|Overall Study|Lost to Follow-up|4|||
155297428|NCT05076266|560517813|FG000|Overall Study|Survey not complete - Participant refusal|2|||
155297429|NCT05076266|560517814|FG001|Overall Study|Survey not complete - Participant refusal|0|||
154957133|NCT00537979|559270751|FG000|Overall Study|Withdrawal by Subject|1|||
154957134|NCT00537979|559270752|FG001|Overall Study|Withdrawal by Subject|4|||
155158307|NCT01124006|560018685|FG000|Overall Study|Lost to Follow-up|1|||
155158308|NCT01124006|560018686|FG001|Overall Study|Lost to Follow-up|0|||
155158309|NCT01124006|560018687|FG002|Overall Study|Lost to Follow-up|1|||
155297430|NCT00997386|560517815|FG000|Overall Study|Death|7|||
154957135|NCT00537979|559270751|FG000|Overall Study|Lost to Follow-up|1|||
154957136|NCT00537979|559270752|FG001|Overall Study|Lost to Follow-up|4|||
154957137|NCT00537979|559270751|FG000|Overall Study|Lack of Efficacy|0|||
154957138|NCT00537979|559270752|FG001|Overall Study|Lack of Efficacy|1|||
154957139|NCT00537979|559270751|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
154957140|NCT00537979|559270752|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
154957141|NCT00537979|559270751|FG000|Overall Study|Death|0|||
154957142|NCT00537979|559270752|FG001|Overall Study|Death|3|||
154957143|NCT00537979|559270751|FG000|Overall Study|Kidney transplant|0|||
155297431|NCT05797155|560517816|FG000|Overall Study|Lost to Follow-up|33|||
155158310|NCT01124006|560018685|FG000|Overall Study|Other|0|||
155158311|NCT01124006|560018686|FG001|Overall Study|Other|0|||
155158312|NCT01124006|560018687|FG002|Overall Study|Other|1|||
155158313|NCT01712399|560018691|FG000|Overall Study|Lost to Follow-up|1|||
155158314|NCT01712399|560018691|FG000|Overall Study|Withdrawal by Subject|39|||
155158315|NCT01712399|560018691|FG000|Overall Study|Death|1|||
155158316|NCT01712399|560018691|FG000|Overall Study|Adverse Event|11|||
155158317|NCT01712399|560018691|FG000|Overall Study|Study closure|345|||
155158318|NCT01357850|560018692|FG000|Overall Study|Lost to Follow-up|1|||
155158319|NCT01357850|560018693|FG001|Overall Study|Lost to Follow-up|0|||
155158320|NCT01357850|560018694|FG002|Overall Study|Lost to Follow-up|0|||
155158321|NCT01357850|560018695|FG003|Overall Study|Lost to Follow-up|0|||
155158322|NCT04610281|560018696|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
155158323|NCT04610281|560018697|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
155158324|NCT02266888|560018705|FG000|Overall Study|Death|2|||
155158325|NCT02266888|560018706|FG001|Overall Study|Death|2|||
155158326|NCT02266888|560018707|FG002|Overall Study|Death|4|||
155158327|NCT02266888|560018708|FG003|Overall Study|Death|2|||
155158328|NCT02266888|560018705|FG000|Overall Study|Physician Decision|0|||
155158329|NCT02266888|560018706|FG001|Overall Study|Physician Decision|1|||
155158330|NCT02266888|560018707|FG002|Overall Study|Physician Decision|2|||
155158331|NCT02266888|560018708|FG003|Overall Study|Physician Decision|2|||
155158332|NCT02266888|560018705|FG000|Overall Study|Study Terminated|5|||
155158333|NCT02266888|560018706|FG001|Overall Study|Study Terminated|1|||
155158334|NCT02266888|560018707|FG002|Overall Study|Study Terminated|0|||
155158335|NCT02266888|560018708|FG003|Overall Study|Study Terminated|0|||
155158336|NCT02266888|560018705|FG000|Overall Study|No Longer Eligible|0|||
155158337|NCT02266888|560018706|FG001|Overall Study|No Longer Eligible|0|||
155158338|NCT02266888|560018707|FG002|Overall Study|No Longer Eligible|0|||
155158339|NCT02266888|560018708|FG003|Overall Study|No Longer Eligible|2|||
155158340|NCT02266888|560018705|FG000|Overall Study|Randomization Closed|0|||
155158341|NCT02266888|560018706|FG001|Overall Study|Randomization Closed|0|||
155158342|NCT02266888|560018707|FG002|Overall Study|Randomization Closed|4|||
155158343|NCT02266888|560018708|FG003|Overall Study|Randomization Closed|0|||
155158344|NCT02266888|560018705|FG000|Overall Study|Personnel unavailable at transplant|0|||
155158345|NCT02266888|560018706|FG001|Overall Study|Personnel unavailable at transplant|0|||
155158346|NCT02266888|560018707|FG002|Overall Study|Personnel unavailable at transplant|0|||
155158347|NCT02266888|560018708|FG003|Overall Study|Personnel unavailable at transplant|1|||
155158348|NCT02266888|560018705|FG000|Overall Study|Transfer of care|0|||
155158349|NCT02266888|560018706|FG001|Overall Study|Transfer of care|0|||
155158350|NCT02266888|560018707|FG002|Overall Study|Transfer of care|1|||
155158351|NCT02266888|560018708|FG003|Overall Study|Transfer of care|0|||
155158352|NCT02351856|560018709|FG000|Overall Study|Adverse Event|2|||
155158353|NCT02351856|560018709|FG000|Overall Study|Physician Decision|5|||
155158354|NCT02351856|560018709|FG000|Overall Study|Study terminated by sponsor|1|||
155158355|NCT01458392|560018716|FG000|Overall Study|Death|2|||
155158356|NCT01458392|560018717|FG001|Overall Study|Death|11|||
154957144|NCT00537979|559270752|FG001|Overall Study|Kidney transplant|3|||
155158357|NCT01458392|560018718|FG002|Overall Study|Death|22|||
155158358|NCT01458392|560018716|FG000|Overall Study|At the discretion of the sponsor|0|||
155158359|NCT01458392|560018717|FG001|Overall Study|At the discretion of the sponsor|2|||
155158360|NCT01458392|560018718|FG002|Overall Study|At the discretion of the sponsor|7|||
155158361|NCT01458392|560018716|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
155158362|NCT01458392|560018717|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
155158363|NCT01458392|560018718|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
155158364|NCT03038100|560018727|FG000|Overall Study|Death|289|||
155158365|NCT03038100|560018728|FG001|Overall Study|Death|272|||
155158366|NCT03038100|560018727|FG000|Overall Study|Lost to Follow-up|9|||
155158367|NCT03038100|560018728|FG001|Overall Study|Lost to Follow-up|10|||
155158368|NCT03038100|560018727|FG000|Overall Study|Protocol Deviation|1|||
154957145|NCT00537979|559270751|FG000|Overall Study|Heart failure|0|||
154957146|NCT00537979|559270752|FG001|Overall Study|Heart failure|1|||
154957147|NCT01417078|559270755|FG000|Overall Study|Withdrawal by Subject|1|||
154957148|NCT00626548|559270756|FG000|Overall Study|Adverse Event|164|||
154957149|NCT00626548|559270757|FG001|Overall Study|Adverse Event|44|||
154957150|NCT00626548|559270756|FG000|Overall Study|Withdrawal by Subject|42|||
154957151|NCT00626548|559270757|FG001|Overall Study|Withdrawal by Subject|46|||
155158369|NCT03038100|560018728|FG001|Overall Study|Protocol Deviation|4|||
155158370|NCT03038100|560018727|FG000|Overall Study|Withdrawal by Subject|45|||
155158371|NCT03038100|560018728|FG001|Overall Study|Withdrawal by Subject|51|||
155158372|NCT03038100|560018727|FG000|Overall Study|Study Terminated By Sponsor|305|||
155158373|NCT03038100|560018728|FG001|Overall Study|Study Terminated By Sponsor|311|||
155158374|NCT03038100|560018727|FG000|Overall Study|Physician Decision|1|||
155158375|NCT03038100|560018728|FG001|Overall Study|Physician Decision|3|||
155158376|NCT01198795|560018729|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
155158377|NCT01198795|560018729|FG000|Overall Study|Withdrawal by Subject|17|||
155158378|NCT01198795|560018729|FG000|Overall Study|Lost to Follow-up|15|||
155158379|NCT01198795|560018729|FG000|Overall Study|Adverse Event|9|||
155061301|NCT05911841|559659287|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
155061302|NCT05911841|559659288|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
155061303|NCT05911841|559659289|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
155061304|NCT05911841|559659290|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
155061305|NCT05911841|559659281|FG000|Maintenance Period|Withdrawal by Subject|0|||
155061306|NCT05911841|559659282|FG001|Maintenance Period|Withdrawal by Subject|0|||
155061307|NCT05911841|559659283|FG002|Maintenance Period|Withdrawal by Subject|0|||
155297432|NCT05797155|560517817|FG001|Overall Study|Lost to Follow-up|12|||
155297433|NCT00617201|560517818|FG000|Overall Study|Lost to Follow-up|9|||
155297434|NCT00617201|560517819|FG001|Overall Study|Lost to Follow-up|13|||
155297435|NCT01350804|560517820|FG000|Core Study|Withdrawal by Subject|11|||
155297436|NCT01350804|560517821|FG001|Core Study|Withdrawal by Subject|17|||
155297437|NCT01350804|560517822|FG002|Core Study|Withdrawal by Subject|16|||
155297438|NCT01350804|560517823|FG003|Core Study|Withdrawal by Subject|7|||
155297439|NCT01350804|560517820|FG000|Core Study|Study terminated by Sponsor|0|||
155297440|NCT01350804|560517821|FG001|Core Study|Study terminated by Sponsor|0|||
155297441|NCT01350804|560517822|FG002|Core Study|Study terminated by Sponsor|0|||
155297442|NCT01350804|560517823|FG003|Core Study|Study terminated by Sponsor|2|||
155297443|NCT01350804|560517820|FG000|Core Study|Protocol deviation|1|||
155297444|NCT01350804|560517821|FG001|Core Study|Protocol deviation|0|||
155158380|NCT01198795|560018729|FG000|Overall Study|Lack of Efficacy|5|||
155158381|NCT01198795|560018729|FG000|Overall Study|Protocol Violation|2|||
155158382|NCT01198795|560018729|FG000|Overall Study|Other Reason|4|||
155158383|NCT04154904|560018762|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
155158384|NCT04154904|560018763|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
155158385|NCT04154904|560018764|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
155158386|NCT02282605|560018765|FG000|Overall Study|negative SA result on Day -1|3|||
155158387|NCT02282605|560018766|FG001|Overall Study|negative SA result on Day -1|0|||
155158388|NCT02282605|560018767|FG002|Overall Study|negative SA result on Day -1|0|||
155158389|NCT03938259|560018768|FG000|Overall Study|unable to establish baseline for ventilation|1|||
155158390|NCT03938259|560018769|FG001|Overall Study|unable to establish baseline for ventilation|1|||
155158391|NCT00763035|560018770|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
155158392|NCT00763035|560018771|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
155158393|NCT00763035|560018770|FG000|First Intervention|Adverse Event|0|||
155158394|NCT00763035|560018771|FG001|First Intervention|Adverse Event|1|||
155158395|NCT00763035|560018770|FG000|Second Intervention|Adverse Event|1|||
155158396|NCT00763035|560018771|FG001|Second Intervention|Adverse Event|0|||
155158397|NCT00763035|560018770|FG000|Second Intervention|Physician Decision|2|||
155158398|NCT00763035|560018771|FG001|Second Intervention|Physician Decision|0|||
155158399|NCT02435992|560018776|FG000|Overall Study|non compliance with protocol|2|||
155158400|NCT02435992|560018777|FG001|Overall Study|non compliance with protocol|0|||
155158401|NCT02435992|560018778|FG002|Overall Study|non compliance with protocol|1|||
155158402|NCT02435992|560018779|FG003|Overall Study|non compliance with protocol|0|||
155158403|NCT02435992|560018780|FG004|Overall Study|non compliance with protocol|0|||
155158404|NCT02435992|560018776|FG000|Overall Study|Adverse Event|11|||
155158405|NCT02435992|560018777|FG001|Overall Study|Adverse Event|6|||
155297445|NCT01350804|560517822|FG002|Core Study|Protocol deviation|1|||
155297446|NCT01350804|560517823|FG003|Core Study|Protocol deviation|0|||
155158406|NCT02435992|560018778|FG002|Overall Study|Adverse Event|12|||
155158407|NCT02435992|560018779|FG003|Overall Study|Adverse Event|0|||
155158408|NCT02435992|560018780|FG004|Overall Study|Adverse Event|0|||
155158409|NCT02435992|560018776|FG000|Overall Study|Lack of Efficacy|4|||
155158410|NCT02435992|560018777|FG001|Overall Study|Lack of Efficacy|10|||
155158411|NCT02435992|560018778|FG002|Overall Study|Lack of Efficacy|9|||
155158412|NCT02435992|560018779|FG003|Overall Study|Lack of Efficacy|0|||
155158413|NCT02435992|560018780|FG004|Overall Study|Lack of Efficacy|0|||
155158414|NCT02435992|560018776|FG000|Overall Study|Withdrawal by Subject|10|||
155158415|NCT02435992|560018777|FG001|Overall Study|Withdrawal by Subject|8|||
155158416|NCT02435992|560018778|FG002|Overall Study|Withdrawal by Subject|20|||
155158417|NCT02435992|560018779|FG003|Overall Study|Withdrawal by Subject|0|||
155158418|NCT02435992|560018780|FG004|Overall Study|Withdrawal by Subject|0|||
155158419|NCT02435992|560018776|FG000|Overall Study|Other Reason|1|||
155158420|NCT02435992|560018777|FG001|Overall Study|Other Reason|0|||
155158421|NCT02435992|560018778|FG002|Overall Study|Other Reason|0|||
155158422|NCT02435992|560018779|FG003|Overall Study|Other Reason|0|||
155158423|NCT02435992|560018780|FG004|Overall Study|Other Reason|0|||
155158424|NCT02435992|560018776|FG000|Overall Study|Physician Decision|0|||
155158425|NCT02435992|560018777|FG001|Overall Study|Physician Decision|0|||
155158426|NCT02435992|560018778|FG002|Overall Study|Physician Decision|1|||
155158427|NCT02435992|560018779|FG003|Overall Study|Physician Decision|0|||
155158428|NCT02435992|560018780|FG004|Overall Study|Physician Decision|0|||
155158429|NCT00930046|560018781|FG000|Overall Study|Wound catheter malfunctioned|1|||
155158430|NCT00930046|560018782|FG001|Overall Study|Wound catheter malfunctioned|2|||
155158431|NCT01598532|560018783|FG000|Overall Study|Lost to Follow-up|3|||
155158432|NCT01598532|560018783|FG000|Overall Study|Did not meet inclusion criteria|8|||
155061308|NCT05911841|559659284|FG003|Maintenance Period|Withdrawal by Subject|0|||
155061309|NCT05911841|559659285|FG004|Maintenance Period|Withdrawal by Subject|0|||
155061310|NCT05911841|559659286|FG005|Maintenance Period|Withdrawal by Subject|1|||
155061311|NCT05911841|559659287|FG006|Maintenance Period|Withdrawal by Subject|0|||
155061312|NCT05911841|559659288|FG007|Maintenance Period|Withdrawal by Subject|1|||
155061313|NCT05911841|559659289|FG008|Maintenance Period|Withdrawal by Subject|0|||
155061314|NCT05911841|559659290|FG009|Maintenance Period|Withdrawal by Subject|0|||
155061315|NCT05911841|559659281|FG000|Maintenance Period|Adverse Event|0|||
155061316|NCT05911841|559659282|FG001|Maintenance Period|Adverse Event|0|||
155061317|NCT05911841|559659283|FG002|Maintenance Period|Adverse Event|0|||
155061318|NCT05911841|559659284|FG003|Maintenance Period|Adverse Event|0|||
155061319|NCT05911841|559659285|FG004|Maintenance Period|Adverse Event|0|||
155061320|NCT05911841|559659286|FG005|Maintenance Period|Adverse Event|0|||
155061321|NCT05911841|559659287|FG006|Maintenance Period|Adverse Event|0|||
155061322|NCT05911841|559659288|FG007|Maintenance Period|Adverse Event|1|||
155061323|NCT05911841|559659289|FG008|Maintenance Period|Adverse Event|0|||
155061324|NCT05911841|559659290|FG009|Maintenance Period|Adverse Event|0|||
155061325|NCT05911841|559659281|FG000|Escape Period|Adverse Event|0|||
155061326|NCT05911841|559659282|FG001|Escape Period|Adverse Event|0|||
155061327|NCT05911841|559659283|FG002|Escape Period|Adverse Event|0|||
155061328|NCT05911841|559659284|FG003|Escape Period|Adverse Event|0|||
155061329|NCT05911841|559659285|FG004|Escape Period|Adverse Event|0|||
155061330|NCT05911841|559659286|FG005|Escape Period|Adverse Event|0|||
155061331|NCT05911841|559659287|FG006|Escape Period|Adverse Event|0|||
155061332|NCT05911841|559659288|FG007|Escape Period|Adverse Event|0|||
155158433|NCT00912808|560018784|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
155061333|NCT05911841|559659289|FG008|Escape Period|Adverse Event|0|||
155061334|NCT05911841|559659290|FG009|Escape Period|Adverse Event|1|||
155061335|NCT05911841|559659281|FG000|Escape Period|Lack of Efficacy|0|||
155061336|NCT05911841|559659282|FG001|Escape Period|Lack of Efficacy|0|||
155061337|NCT05911841|559659283|FG002|Escape Period|Lack of Efficacy|0|||
155061338|NCT05911841|559659284|FG003|Escape Period|Lack of Efficacy|0|||
155061339|NCT05911841|559659285|FG004|Escape Period|Lack of Efficacy|0|||
155061340|NCT05911841|559659286|FG005|Escape Period|Lack of Efficacy|0|||
155061341|NCT05911841|559659287|FG006|Escape Period|Lack of Efficacy|0|||
155061342|NCT05911841|559659288|FG007|Escape Period|Lack of Efficacy|0|||
155061343|NCT05911841|559659289|FG008|Escape Period|Lack of Efficacy|0|||
155158434|NCT00912808|560018785|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155158435|NCT00912808|560018784|FG000|Washout|Withdrawal by Subject|0|||
154957152|NCT00626548|559270756|FG000|Overall Study|Protocol Violation|4|||
154957153|NCT00626548|559270757|FG001|Overall Study|Protocol Violation|11|||
154957154|NCT00626548|559270756|FG000|Overall Study|Lost to Follow-up|2|||
154957155|NCT00626548|559270757|FG001|Overall Study|Lost to Follow-up|2|||
154957156|NCT00626548|559270756|FG000|Overall Study|Other termination reason|493|||
154957157|NCT00626548|559270757|FG001|Overall Study|Other termination reason|613|||
154957158|NCT01059903|559270761|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
154957159|NCT01059903|559270762|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
154957160|NCT02392000|559270765|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
154957161|NCT02392000|559270765|FG000|Overall Study|Withdrawal by Subject|1|||
154957162|NCT02392000|559270765|FG000|Overall Study|Lost to Follow-up|8|||
154957163|NCT00385593|559270766|FG000|Overall Study|Adverse Event|3|||
154957164|NCT00385593|559270767|FG001|Overall Study|Adverse Event|2|||
154957165|NCT00385593|559270766|FG000|Overall Study|Withdrawal by Subject|17|||
154957166|NCT00385593|559270767|FG001|Overall Study|Withdrawal by Subject|7|||
154957167|NCT00385593|559270766|FG000|Overall Study|Lost to Follow-up|12|||
154957168|NCT00385593|559270767|FG001|Overall Study|Lost to Follow-up|8|||
154957169|NCT00385593|559270766|FG000|Overall Study|Protocol Violation|7|||
154957170|NCT00385593|559270767|FG001|Overall Study|Protocol Violation|4|||
154957171|NCT00385593|559270766|FG000|Overall Study|Several reasons|17|||
154957172|NCT00385593|559270767|FG001|Overall Study|Several reasons|15|||
154957173|NCT00385593|559270766|FG000|Overall Study|Incorrect inclusion|2|||
154957174|NCT00385593|559270767|FG001|Overall Study|Incorrect inclusion|0|||
154957175|NCT00385593|559270766|FG000|Overall Study|Incorrect randomization|0|||
154957176|NCT00385593|559270767|FG001|Overall Study|Incorrect randomization|1|||
154957177|NCT04384978|559270768|FG000|Overall Study|Withdrawal by Subject|4|||
154957178|NCT04384978|559270769|FG001|Overall Study|Withdrawal by Subject|0|||
154957179|NCT00858845|559270783|FG000|Overall Study|Patient underwent heart transplant.|0|||
154957180|NCT00858845|559270784|FG001|Overall Study|Patient underwent heart transplant.|1|||
154957181|NCT02100228|559270786|FG000|Overall Study|Other|19|||
154957182|NCT02100228|559270787|FG001|Overall Study|Other|19|||
155061344|NCT05911841|559659290|FG009|Escape Period|Lack of Efficacy|31|||
155061345|NCT05911841|559659281|FG000|Escape Period|Lost to Follow-up|0|||
155297447|NCT01350804|560517820|FG000|Core Study|Physician Decision|1|||
154957183|NCT02100228|559270786|FG000|Overall Study|Administrative reason|0|||
154957184|NCT02100228|559270787|FG001|Overall Study|Administrative reason|1|||
154957185|NCT02100228|559270786|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
154957186|NCT02100228|559270787|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
155061346|NCT05911841|559659282|FG001|Escape Period|Lost to Follow-up|0|||
155061347|NCT05911841|559659283|FG002|Escape Period|Lost to Follow-up|0|||
155061348|NCT05911841|559659284|FG003|Escape Period|Lost to Follow-up|0|||
155061349|NCT05911841|559659285|FG004|Escape Period|Lost to Follow-up|0|||
155061350|NCT05911841|559659286|FG005|Escape Period|Lost to Follow-up|0|||
155061351|NCT05911841|559659287|FG006|Escape Period|Lost to Follow-up|0|||
155061352|NCT05911841|559659288|FG007|Escape Period|Lost to Follow-up|0|||
155061353|NCT05911841|559659289|FG008|Escape Period|Lost to Follow-up|0|||
155061354|NCT05911841|559659290|FG009|Escape Period|Lost to Follow-up|1|||
155061355|NCT05911841|559659281|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061356|NCT05911841|559659282|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061357|NCT05911841|559659283|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061358|NCT05911841|559659284|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061359|NCT05911841|559659285|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061360|NCT05911841|559659286|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061361|NCT05911841|559659287|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061362|NCT05911841|559659288|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061363|NCT05911841|559659289|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
155061364|NCT05911841|559659290|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
155061365|NCT05911841|559659281|FG000|Escape Period|Site Terminated by Sponsor|0|||
155061366|NCT05911841|559659282|FG001|Escape Period|Site Terminated by Sponsor|0|||
155061367|NCT05911841|559659283|FG002|Escape Period|Site Terminated by Sponsor|0|||
155061368|NCT05911841|559659284|FG003|Escape Period|Site Terminated by Sponsor|0|||
155061369|NCT05911841|559659285|FG004|Escape Period|Site Terminated by Sponsor|0|||
155061370|NCT05911841|559659286|FG005|Escape Period|Site Terminated by Sponsor|0|||
155061371|NCT05911841|559659287|FG006|Escape Period|Site Terminated by Sponsor|0|||
155158436|NCT00912808|560018785|FG001|Washout|Withdrawal by Subject|1|||
155061372|NCT05911841|559659288|FG007|Escape Period|Site Terminated by Sponsor|0|||
155061373|NCT05911841|559659289|FG008|Escape Period|Site Terminated by Sponsor|0|||
155061374|NCT05911841|559659290|FG009|Escape Period|Site Terminated by Sponsor|1|||
155061375|NCT05911841|559659281|FG000|Escape Period|Study Terminated by Sponsor|0|||
155061376|NCT05911841|559659282|FG001|Escape Period|Study Terminated by Sponsor|0|||
155061377|NCT05911841|559659283|FG002|Escape Period|Study Terminated by Sponsor|0|||
155061378|NCT05911841|559659284|FG003|Escape Period|Study Terminated by Sponsor|0|||
155061379|NCT05911841|559659285|FG004|Escape Period|Study Terminated by Sponsor|0|||
155061380|NCT05911841|559659286|FG005|Escape Period|Study Terminated by Sponsor|0|||
155061381|NCT05911841|559659287|FG006|Escape Period|Study Terminated by Sponsor|0|||
155061382|NCT05911841|559659288|FG007|Escape Period|Study Terminated by Sponsor|0|||
155061383|NCT05911841|559659289|FG008|Escape Period|Study Terminated by Sponsor|0|||
155061384|NCT05911841|559659290|FG009|Escape Period|Study Terminated by Sponsor|34|||
155061385|NCT05911841|559659281|FG000|Escape Period|Withdrawal by Subject|0|||
155158437|NCT00912808|560018784|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155158438|NCT00912808|560018785|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
155158439|NCT00912808|560018784|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
155158440|NCT00912808|560018785|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
155158441|NCT00702221|560018786|FG000|Overall Study|Adverse Event|4|||
155061386|NCT05911841|559659282|FG001|Escape Period|Withdrawal by Subject|0|||
155061387|NCT05911841|559659283|FG002|Escape Period|Withdrawal by Subject|0|||
155061388|NCT05911841|559659284|FG003|Escape Period|Withdrawal by Subject|0|||
155061389|NCT05911841|559659285|FG004|Escape Period|Withdrawal by Subject|0|||
155061390|NCT05911841|559659286|FG005|Escape Period|Withdrawal by Subject|0|||
155061391|NCT05911841|559659287|FG006|Escape Period|Withdrawal by Subject|0|||
155061392|NCT05911841|559659288|FG007|Escape Period|Withdrawal by Subject|0|||
155061393|NCT05911841|559659289|FG008|Escape Period|Withdrawal by Subject|0|||
155061394|NCT05911841|559659290|FG009|Escape Period|Withdrawal by Subject|10|||
155061395|NCT05595369|559659291|FG000|Overall Study|Adverse Event|2|||
155061396|NCT05595369|559659292|FG001|Overall Study|Adverse Event|0|||
155061397|NCT05595369|559659293|FG002|Overall Study|Adverse Event|0|||
155061398|NCT05595369|559659291|FG000|Overall Study|Lost to Follow-up|11|||
155061399|NCT05595369|559659292|FG001|Overall Study|Lost to Follow-up|10|||
155061400|NCT05595369|559659293|FG002|Overall Study|Lost to Follow-up|10|||
155061401|NCT05595369|559659291|FG000|Overall Study|Physician Decision|1|||
155061402|NCT05595369|559659292|FG001|Overall Study|Physician Decision|0|||
155061403|NCT05595369|559659293|FG002|Overall Study|Physician Decision|0|||
155061404|NCT05595369|559659291|FG000|Overall Study|Withdrawal by Subject|5|||
155061405|NCT05595369|559659292|FG001|Overall Study|Withdrawal by Subject|7|||
155158442|NCT00702221|560018787|FG001|Overall Study|Adverse Event|3|||
155158443|NCT03345784|560018792|FG000|Overall Study|Withdrawal by Subject|2|||
155297448|NCT01350804|560517821|FG001|Core Study|Physician Decision|0|||
155158444|NCT03345784|560018793|FG001|Overall Study|Withdrawal by Subject|1|||
155158445|NCT01249261|560018794|FG000|Overall Study|Withdrawal by Subject|1|||
155061406|NCT05595369|559659293|FG002|Overall Study|Withdrawal by Subject|6|||
155061407|NCT05595369|559659291|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155061408|NCT05595369|559659292|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
155297449|NCT01350804|560517822|FG002|Core Study|Physician Decision|1|||
155297450|NCT01350804|560517823|FG003|Core Study|Physician Decision|3|||
155297451|NCT01350804|560517820|FG000|Core Study|Lost to Follow-up|3|||
155297452|NCT01350804|560517821|FG001|Core Study|Lost to Follow-up|0|||
155297453|NCT01350804|560517822|FG002|Core Study|Lost to Follow-up|2|||
155297454|NCT01350804|560517823|FG003|Core Study|Lost to Follow-up|1|||
155297455|NCT01350804|560517820|FG000|Core Study|Lack of Efficacy|16|||
155297456|NCT01350804|560517821|FG001|Core Study|Lack of Efficacy|19|||
155297457|NCT01350804|560517822|FG002|Core Study|Lack of Efficacy|18|||
155297458|NCT01350804|560517823|FG003|Core Study|Lack of Efficacy|5|||
155297459|NCT01350804|560517820|FG000|Core Study|Death|1|||
155297460|NCT01350804|560517821|FG001|Core Study|Death|1|||
155297461|NCT01350804|560517822|FG002|Core Study|Death|1|||
155297462|NCT01350804|560517823|FG003|Core Study|Death|0|||
155297463|NCT01350804|560517820|FG000|Core Study|Adverse Event|8|||
155297464|NCT01350804|560517821|FG001|Core Study|Adverse Event|10|||
155297465|NCT01350804|560517822|FG002|Core Study|Adverse Event|8|||
155297466|NCT01350804|560517823|FG003|Core Study|Adverse Event|8|||
155297467|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
155297468|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
155297469|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
155297470|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
155297471|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
155297472|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
155297473|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
155297474|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
155297475|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
155297476|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
155297477|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
155297478|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
155297479|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
155297480|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
155297481|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
155297482|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
155297483|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
155297484|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
155297485|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
155297486|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
155297487|NCT01350804|560517820|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
155297488|NCT01350804|560517821|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
155297489|NCT01350804|560517822|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
155297490|NCT01350804|560517823|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
155297491|NCT01307267|560519189|FG000|Overall Study|Death|4|||
155297492|NCT01307267|560519190|FG001|Overall Study|Death|3|||
155297493|NCT01307267|560519191|FG002|Overall Study|Death|5|||
155297494|NCT01307267|560519192|FG003|Overall Study|Death|3|||
155297495|NCT01307267|560519193|FG004|Overall Study|Death|1|||
155297496|NCT01307267|560519194|FG005|Overall Study|Death|26|||
155297497|NCT01307267|560519195|FG006|Overall Study|Death|2|||
155297498|NCT01307267|560519196|FG007|Overall Study|Death|2|||
155297499|NCT01307267|560519197|FG008|Overall Study|Death|21|||
155297500|NCT01307267|560519198|FG009|Overall Study|Death|2|||
155297501|NCT01307267|560519199|FG010|Overall Study|Death|3|||
155297502|NCT01307267|560519200|FG011|Overall Study|Death|9|||
155297503|NCT01307267|560519201|FG012|Overall Study|Death|0|||
155297504|NCT01307267|560519202|FG013|Overall Study|Death|0|||
155297505|NCT01307267|560519203|FG014|Overall Study|Death|0|||
155297506|NCT01307267|560519204|FG015|Overall Study|Death|0|||
155297507|NCT01307267|560519205|FG016|Overall Study|Death|1|||
155297508|NCT01307267|560519206|FG017|Overall Study|Death|1|||
155297509|NCT01307267|560519207|FG018|Overall Study|Death|2|||
155297510|NCT01307267|560519208|FG019|Overall Study|Death|8|||
155297511|NCT01307267|560519209|FG020|Overall Study|Death|1|||
155158446|NCT01249261|560018795|FG001|Overall Study|Withdrawal by Subject|0|||
155158447|NCT01055197|560018803|FG000|Overall Study|Protocol Violation|7|||
155297512|NCT01307267|560519210|FG021|Overall Study|Death|2|||
155297513|NCT01307267|560519211|FG022|Overall Study|Death|2|||
155297514|NCT01307267|560519189|FG000|Overall Study|Lost to Follow-up|0|||
155297515|NCT01307267|560519190|FG001|Overall Study|Lost to Follow-up|0|||
155297516|NCT01307267|560519191|FG002|Overall Study|Lost to Follow-up|0|||
155158448|NCT01055197|560018804|FG001|Overall Study|Protocol Violation|2|||
155158449|NCT01055197|560018803|FG000|Overall Study|Withdrawal by Subject|2|||
155297517|NCT01307267|560519192|FG003|Overall Study|Lost to Follow-up|0|||
155297518|NCT01307267|560519193|FG004|Overall Study|Lost to Follow-up|0|||
155297519|NCT01307267|560519194|FG005|Overall Study|Lost to Follow-up|7|||
155297520|NCT01307267|560519195|FG006|Overall Study|Lost to Follow-up|0|||
155297521|NCT01307267|560519196|FG007|Overall Study|Lost to Follow-up|0|||
155297522|NCT01307267|560519197|FG008|Overall Study|Lost to Follow-up|1|||
155297523|NCT01307267|560519198|FG009|Overall Study|Lost to Follow-up|2|||
155297524|NCT01307267|560519199|FG010|Overall Study|Lost to Follow-up|1|||
155297525|NCT01307267|560519200|FG011|Overall Study|Lost to Follow-up|0|||
155297526|NCT01307267|560519201|FG012|Overall Study|Lost to Follow-up|0|||
155297527|NCT01307267|560519202|FG013|Overall Study|Lost to Follow-up|0|||
155297528|NCT01307267|560519203|FG014|Overall Study|Lost to Follow-up|0|||
155297529|NCT01307267|560519204|FG015|Overall Study|Lost to Follow-up|0|||
155297530|NCT01307267|560519205|FG016|Overall Study|Lost to Follow-up|0|||
155297531|NCT01307267|560519206|FG017|Overall Study|Lost to Follow-up|0|||
155297532|NCT01307267|560519207|FG018|Overall Study|Lost to Follow-up|0|||
155297533|NCT01307267|560519208|FG019|Overall Study|Lost to Follow-up|2|||
155297534|NCT01307267|560519209|FG020|Overall Study|Lost to Follow-up|0|||
155297535|NCT01307267|560519210|FG021|Overall Study|Lost to Follow-up|0|||
155297536|NCT01307267|560519211|FG022|Overall Study|Lost to Follow-up|0|||
155297537|NCT01307267|560519189|FG000|Overall Study|Withdrawal by Subject|0|||
155297538|NCT01307267|560519190|FG001|Overall Study|Withdrawal by Subject|0|||
155297539|NCT01307267|560519191|FG002|Overall Study|Withdrawal by Subject|0|||
155297540|NCT01307267|560519192|FG003|Overall Study|Withdrawal by Subject|0|||
155297541|NCT01307267|560519193|FG004|Overall Study|Withdrawal by Subject|0|||
155297542|NCT01307267|560519194|FG005|Overall Study|Withdrawal by Subject|1|||
155297543|NCT01307267|560519195|FG006|Overall Study|Withdrawal by Subject|0|||
155297544|NCT01307267|560519196|FG007|Overall Study|Withdrawal by Subject|1|||
155297545|NCT01307267|560519197|FG008|Overall Study|Withdrawal by Subject|5|||
155297546|NCT01307267|560519198|FG009|Overall Study|Withdrawal by Subject|1|||
155297547|NCT01307267|560519199|FG010|Overall Study|Withdrawal by Subject|1|||
155297548|NCT01307267|560519200|FG011|Overall Study|Withdrawal by Subject|1|||
155297549|NCT01307267|560519201|FG012|Overall Study|Withdrawal by Subject|0|||
155297550|NCT01307267|560519202|FG013|Overall Study|Withdrawal by Subject|0|||
155297551|NCT01307267|560519203|FG014|Overall Study|Withdrawal by Subject|0|||
155297552|NCT01307267|560519204|FG015|Overall Study|Withdrawal by Subject|0|||
155297553|NCT01307267|560519205|FG016|Overall Study|Withdrawal by Subject|0|||
155297554|NCT01307267|560519206|FG017|Overall Study|Withdrawal by Subject|0|||
155297555|NCT01307267|560519207|FG018|Overall Study|Withdrawal by Subject|0|||
155297556|NCT01307267|560519208|FG019|Overall Study|Withdrawal by Subject|3|||
155297557|NCT01307267|560519209|FG020|Overall Study|Withdrawal by Subject|0|||
155297558|NCT01307267|560519210|FG021|Overall Study|Withdrawal by Subject|0|||
155297559|NCT01307267|560519211|FG022|Overall Study|Withdrawal by Subject|0|||
155297560|NCT01307267|560519189|FG000|Overall Study|Other|0|||
155297561|NCT01307267|560519190|FG001|Overall Study|Other|0|||
155297562|NCT01307267|560519191|FG002|Overall Study|Other|0|||
155297563|NCT01307267|560519192|FG003|Overall Study|Other|0|||
155297564|NCT01307267|560519193|FG004|Overall Study|Other|0|||
155297565|NCT01307267|560519194|FG005|Overall Study|Other|7|||
155297566|NCT01307267|560519195|FG006|Overall Study|Other|0|||
155297567|NCT01307267|560519196|FG007|Overall Study|Other|1|||
155297568|NCT01307267|560519197|FG008|Overall Study|Other|3|||
155297569|NCT01307267|560519198|FG009|Overall Study|Other|0|||
155297570|NCT01307267|560519199|FG010|Overall Study|Other|1|||
155297571|NCT01307267|560519200|FG011|Overall Study|Other|1|||
155297572|NCT01307267|560519201|FG012|Overall Study|Other|1|||
155297573|NCT01307267|560519202|FG013|Overall Study|Other|0|||
155297574|NCT01307267|560519203|FG014|Overall Study|Other|2|||
155297575|NCT01307267|560519204|FG015|Overall Study|Other|1|||
155297576|NCT01307267|560519205|FG016|Overall Study|Other|0|||
155297577|NCT01307267|560519206|FG017|Overall Study|Other|0|||
155297578|NCT01307267|560519207|FG018|Overall Study|Other|0|||
155297579|NCT01307267|560519208|FG019|Overall Study|Other|19|||
155297580|NCT01307267|560519209|FG020|Overall Study|Other|2|||
155297581|NCT01307267|560519210|FG021|Overall Study|Other|3|||
155297582|NCT01307267|560519211|FG022|Overall Study|Other|2|||
155297583|NCT04956575|560519212|FG000|Overall Study|Death|1|||
155297584|NCT04956575|560519213|FG001|Overall Study|Death|0|||
155297585|NCT04956575|560519214|FG002|Overall Study|Death|0|||
155158450|NCT01055197|560018804|FG001|Overall Study|Withdrawal by Subject|0|||
155158451|NCT00389610|560018805|FG000|Overall Study|Disease Progression|0|||
155158452|NCT00389610|560018806|FG001|Overall Study|Disease Progression|19|||
155158453|NCT00389610|560018805|FG000|Overall Study|Death|0|||
155158454|NCT00389610|560018806|FG001|Overall Study|Death|1|||
155297586|NCT04956575|560519215|FG003|Overall Study|Death|0|||
155297587|NCT04956575|560519216|FG004|Overall Study|Death|0|||
155297588|NCT04956575|560519217|FG005|Overall Study|Death|0|||
155297589|NCT04956575|560519218|FG006|Overall Study|Death|0|||
155297590|NCT04956575|560519219|FG007|Overall Study|Death|1|||
155297591|NCT04956575|560519220|FG008|Overall Study|Death|0|||
155297592|NCT04956575|560519221|FG009|Overall Study|Death|1|||
155297593|NCT04956575|560519222|FG010|Overall Study|Death|0|||
155158455|NCT00389610|560018805|FG000|Overall Study|Physician Decision|0|||
155158456|NCT00389610|560018806|FG001|Overall Study|Physician Decision|1|||
155297594|NCT04956575|560519223|FG011|Overall Study|Death|0|||
155297595|NCT04956575|560519212|FG000|Overall Study|Lost to Follow-up|3|||
155297596|NCT04956575|560519213|FG001|Overall Study|Lost to Follow-up|4|||
155297597|NCT04956575|560519214|FG002|Overall Study|Lost to Follow-up|2|||
155297598|NCT04956575|560519215|FG003|Overall Study|Lost to Follow-up|3|||
155297599|NCT04956575|560519216|FG004|Overall Study|Lost to Follow-up|1|||
155297600|NCT04956575|560519217|FG005|Overall Study|Lost to Follow-up|10|||
155297601|NCT04956575|560519218|FG006|Overall Study|Lost to Follow-up|11|||
155297602|NCT04956575|560519219|FG007|Overall Study|Lost to Follow-up|7|||
155297603|NCT04956575|560519220|FG008|Overall Study|Lost to Follow-up|4|||
155297604|NCT04956575|560519221|FG009|Overall Study|Lost to Follow-up|2|||
155297605|NCT04956575|560519222|FG010|Overall Study|Lost to Follow-up|3|||
155297606|NCT04956575|560519223|FG011|Overall Study|Lost to Follow-up|8|||
155297607|NCT04956575|560519212|FG000|Overall Study|Withdrawal by Subject|1|||
155297608|NCT04956575|560519213|FG001|Overall Study|Withdrawal by Subject|2|||
155297609|NCT04956575|560519214|FG002|Overall Study|Withdrawal by Subject|1|||
155297610|NCT04956575|560519215|FG003|Overall Study|Withdrawal by Subject|4|||
155297611|NCT04956575|560519216|FG004|Overall Study|Withdrawal by Subject|2|||
155297612|NCT04956575|560519217|FG005|Overall Study|Withdrawal by Subject|8|||
155297613|NCT04956575|560519218|FG006|Overall Study|Withdrawal by Subject|5|||
155297614|NCT04956575|560519219|FG007|Overall Study|Withdrawal by Subject|1|||
155297615|NCT04956575|560519220|FG008|Overall Study|Withdrawal by Subject|1|||
155297616|NCT04956575|560519221|FG009|Overall Study|Withdrawal by Subject|0|||
155297617|NCT04956575|560519222|FG010|Overall Study|Withdrawal by Subject|3|||
155297618|NCT04956575|560519223|FG011|Overall Study|Withdrawal by Subject|1|||
155297619|NCT01786564|560519224|FG000|Overall Study|Lost to Follow-up|47|||
155297620|NCT01786564|560519224|FG000|Overall Study|Ineligible|17|||
155297621|NCT03034915|560519225|FG000|Overall Study|Adverse Event|29|||
155297622|NCT03034915|560519226|FG001|Overall Study|Adverse Event|32|||
155297623|NCT03034915|560519227|FG002|Overall Study|Adverse Event|22|||
155297624|NCT03034915|560519225|FG000|Overall Study|Lost to Follow-up|5|||
155297625|NCT03034915|560519226|FG001|Overall Study|Lost to Follow-up|13|||
155297626|NCT03034915|560519227|FG002|Overall Study|Lost to Follow-up|3|||
155297627|NCT03034915|560519225|FG000|Overall Study|Withdrawal by Subject|29|||
155297628|NCT03034915|560519226|FG001|Overall Study|Withdrawal by Subject|46|||
155297629|NCT03034915|560519227|FG002|Overall Study|Withdrawal by Subject|41|||
155297630|NCT03034915|560519225|FG000|Overall Study|Protocol Deviation|2|||
155297631|NCT03034915|560519226|FG001|Overall Study|Protocol Deviation|14|||
155297632|NCT03034915|560519227|FG002|Overall Study|Protocol Deviation|7|||
155297633|NCT03034915|560519225|FG000|Overall Study|Lack of Efficacy|8|||
155297634|NCT03034915|560519226|FG001|Overall Study|Lack of Efficacy|16|||
155297635|NCT03034915|560519227|FG002|Overall Study|Lack of Efficacy|18|||
155297636|NCT03034915|560519225|FG000|Overall Study|Site closed|2|||
155297637|NCT03034915|560519226|FG001|Overall Study|Site closed|2|||
155158457|NCT00389610|560018805|FG000|Overall Study|Withdrawal by Subject|0|||
155158458|NCT00389610|560018806|FG001|Overall Study|Withdrawal by Subject|1|||
155158459|NCT00538902|560018807|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
155158460|NCT00538902|560018808|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
155158461|NCT00538902|560018809|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
155158462|NCT00538902|560018807|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
155158463|NCT00538902|560018808|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
155158464|NCT00538902|560018809|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
155297638|NCT03034915|560519227|FG002|Overall Study|Site closed|4|||
155061409|NCT05595369|559659293|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
155061410|NCT05595369|559659291|FG000|Overall Study|Study Drug Non-compliance|0|||
155061411|NCT05595369|559659292|FG001|Overall Study|Study Drug Non-compliance|1|||
155061412|NCT05595369|559659293|FG002|Overall Study|Study Drug Non-compliance|0|||
155061413|NCT05595369|559659291|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
155061414|NCT05595369|559659292|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
155297639|NCT03034915|560519225|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
155297640|NCT03034915|560519226|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
155297641|NCT03034915|560519227|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
155297642|NCT03034915|560519225|FG000|Overall Study|Physician Decision|1|||
155158465|NCT00538902|560018807|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
155061415|NCT05595369|559659293|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
155297643|NCT03034915|560519226|FG001|Overall Study|Physician Decision|5|||
155297644|NCT03034915|560519227|FG002|Overall Study|Physician Decision|2|||
155297645|NCT03861767|560519230|FG000|Overall Study|Withdrawal by Subject|2|||
155297646|NCT03861767|560519231|FG001|Overall Study|Withdrawal by Subject|1|||
155297647|NCT03861767|560519232|FG002|Overall Study|Withdrawal by Subject|0|||
155297648|NCT03861767|560519233|FG003|Overall Study|Withdrawal by Subject|5|||
155297649|NCT03861767|560519234|FG004|Overall Study|Withdrawal by Subject|2|||
155061416|NCT00111761|559659300|FG000|Part 1|Physician Decision|0|||
155061417|NCT00111761|559659301|FG001|Part 1|Physician Decision|1|||
155061418|NCT00111761|559659300|FG000|Part 1|Death|0|||
155158466|NCT00538902|560018808|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
155158467|NCT00538902|560018809|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
155061419|NCT00111761|559659301|FG001|Part 1|Death|2|||
155061420|NCT00111761|559659300|FG000|Part 1|Other|0|||
155061421|NCT00111761|559659301|FG001|Part 1|Other|1|||
155061422|NCT00111761|559659300|FG000|Part 1|Withdrawal by Subject|0|||
155297650|NCT03861767|560519235|FG005|Overall Study|Withdrawal by Subject|1|||
155297651|NCT03861767|560519236|FG006|Overall Study|Withdrawal by Subject|3|||
155297652|NCT03861767|560519237|FG007|Overall Study|Withdrawal by Subject|1|||
155297653|NCT03861767|560519238|FG008|Overall Study|Withdrawal by Subject|0|||
155297654|NCT03861767|560519239|FG009|Overall Study|Withdrawal by Subject|5|||
155297655|NCT00346333|560519240|FG000|Overall Study|Death|1|||
155297656|NCT00346333|560519241|FG001|Overall Study|Death|0|||
155297657|NCT00346333|560519240|FG000|Overall Study|unwilling or unable to continue|4|||
155297658|NCT00346333|560519241|FG001|Overall Study|unwilling or unable to continue|8|||
155297659|NCT00117286|560519242|FG000|Overall Study|Adverse Event|12|||
155297660|NCT00117286|560519243|FG001|Overall Study|Adverse Event|6|||
155297661|NCT00117286|560519242|FG000|Overall Study|Lost to Follow-up|2|||
155297662|NCT00117286|560519243|FG001|Overall Study|Lost to Follow-up|0|||
155297663|NCT00117286|560519242|FG000|Overall Study|Protocol Violation|3|||
155297664|NCT00117286|560519243|FG001|Overall Study|Protocol Violation|3|||
155297665|NCT00117286|560519242|FG000|Overall Study|Withdrawal by Subject|6|||
155297666|NCT00117286|560519243|FG001|Overall Study|Withdrawal by Subject|2|||
155297667|NCT00117286|560519242|FG000|Overall Study|Physician Decision|3|||
155297668|NCT00117286|560519243|FG001|Overall Study|Physician Decision|7|||
155297669|NCT00117286|560519242|FG000|Overall Study|Lack of Efficacy|2|||
155297670|NCT00117286|560519243|FG001|Overall Study|Lack of Efficacy|1|||
155297671|NCT00117286|560519242|FG000|Overall Study|Research site closing|0|||
155297672|NCT00117286|560519243|FG001|Overall Study|Research site closing|2|||
155297673|NCT00189202|560519244|FG000|Overall Study|Physician Decision|5|||
155297674|NCT04446117|560519247|FG000|Overall Study|No Study Treatment Given|4|||
155297675|NCT04446117|560519248|FG001|Overall Study|No Study Treatment Given|3|||
155297676|NCT04446117|560519247|FG000|Overall Study|Radiographic Disease Progression|132|||
155297677|NCT04446117|560519248|FG001|Overall Study|Radiographic Disease Progression|158|||
155297678|NCT04446117|560519247|FG000|Overall Study|Adverse Event|79|||
155297679|NCT04446117|560519248|FG001|Overall Study|Adverse Event|43|||
155297680|NCT04446117|560519247|FG000|Overall Study|Lack of Clinical Benefit|1|||
155297681|NCT04446117|560519248|FG001|Overall Study|Lack of Clinical Benefit|1|||
155297682|NCT04446117|560519247|FG000|Overall Study|Withdrawal by Subject|24|||
155297683|NCT04446117|560519248|FG001|Overall Study|Withdrawal by Subject|22|||
155297684|NCT04446117|560519247|FG000|Overall Study|Lost to Follow-up|0|||
155297685|NCT04446117|560519248|FG001|Overall Study|Lost to Follow-up|3|||
155297686|NCT04446117|560519247|FG000|Overall Study|Miscellaneous|26|||
155297687|NCT04446117|560519248|FG001|Overall Study|Miscellaneous|36|||
155297688|NCT04446117|560519247|FG000|Overall Study|Missing Data/Data not yet Received|1|||
155297689|NCT04446117|560519248|FG001|Overall Study|Missing Data/Data not yet Received|0|||
155297690|NCT03654768|560519249|FG000|Overall Study|Adverse Event|1|||
155297691|NCT03654768|560519250|FG001|Overall Study|Adverse Event|6|||
155297692|NCT03654768|560519249|FG000|Overall Study|Loss of response|2|||
155297693|NCT03654768|560519250|FG001|Overall Study|Loss of response|2|||
155297694|NCT03654768|560519249|FG000|Overall Study|Non-compliance|0|||
155297695|NCT03654768|560519250|FG001|Overall Study|Non-compliance|1|||
155297696|NCT03654768|560519249|FG000|Overall Study|Refusal not related to toxicity|1|||
155297697|NCT03654768|560519250|FG001|Overall Study|Refusal not related to toxicity|5|||
155297698|NCT03654768|560519249|FG000|Overall Study|Did not receive protocol therapy|1|||
155297699|NCT03654768|560519250|FG001|Overall Study|Did not receive protocol therapy|1|||
155297700|NCT00588770|560519251|FG000|Overall Study|Disease progression|85|||
155297701|NCT00588770|560519252|FG001|Overall Study|Disease progression|68|||
155297702|NCT00588770|560519251|FG000|Overall Study|Adverse Event|29|||
155297703|NCT00588770|560519252|FG001|Overall Study|Adverse Event|58|||
155297704|NCT00588770|560519251|FG000|Overall Study|Death|13|||
155297705|NCT00588770|560519252|FG001|Overall Study|Death|22|||
155297706|NCT00588770|560519251|FG000|Overall Study|Withdrawal by Subject|15|||
155297707|NCT00588770|560519252|FG001|Overall Study|Withdrawal by Subject|25|||
155297708|NCT00588770|560519251|FG000|Overall Study|Alternative therapy|2|||
154957187|NCT02100228|559270786|FG000|Overall Study|Non-compliance|0|||
154957188|NCT02100228|559270787|FG001|Overall Study|Non-compliance|3|||
154957189|NCT02100228|559270786|FG000|Overall Study|Lost to Follow-up|0|||
154957190|NCT02100228|559270787|FG001|Overall Study|Lost to Follow-up|1|||
154957191|NCT02100228|559270786|FG000|Overall Study|Withdrawal by Subject|27|||
154957192|NCT02100228|559270787|FG001|Overall Study|Withdrawal by Subject|37|||
154957193|NCT02100228|559270786|FG000|Overall Study|Adverse Event|16|||
154957194|NCT02100228|559270787|FG001|Overall Study|Adverse Event|12|||
154957195|NCT02100228|559270786|FG000|Overall Study|Death|1|||
154957196|NCT02100228|559270787|FG001|Overall Study|Death|1|||
154957197|NCT00854100|559270796|FG000|Overall Study|Inability to complete the study visits|0|||
154957198|NCT00854100|559270797|FG001|Overall Study|Inability to complete the study visits|0|||
154957199|NCT00854100|559270798|FG002|Overall Study|Inability to complete the study visits|1|||
155297709|NCT00588770|560519252|FG001|Overall Study|Alternative therapy|4|||
155297710|NCT00588770|560519251|FG000|Overall Study|Other complicating disease|3|||
155297711|NCT00588770|560519252|FG001|Overall Study|Other complicating disease|2|||
155297712|NCT00588770|560519251|FG000|Overall Study|Not start protocol therapy|0|||
154957200|NCT00854100|559270796|FG000|Overall Study|Lost to Follow-up|2|||
154957201|NCT00854100|559270797|FG001|Overall Study|Lost to Follow-up|0|||
155297713|NCT00588770|560519252|FG001|Overall Study|Not start protocol therapy|9|||
155297714|NCT00588770|560519251|FG000|Overall Study|Lack of Efficacy|8|||
155297715|NCT00588770|560519252|FG001|Overall Study|Lack of Efficacy|10|||
155297716|NCT00588770|560519251|FG000|Overall Study|Physician discretion|2|||
155297717|NCT00588770|560519252|FG001|Overall Study|Physician discretion|0|||
155297718|NCT00588770|560519251|FG000|Overall Study|Patient non-compliance|2|||
155297719|NCT00588770|560519252|FG001|Overall Study|Patient non-compliance|2|||
155297720|NCT04697628|560519253|FG000|Overall Study|Withdrawal by Subject|17|||
155297721|NCT04697628|560519254|FG001|Overall Study|Withdrawal by Subject|23|||
155297722|NCT04697628|560519253|FG000|Overall Study|Lost to Follow-up|0|||
155297723|NCT04697628|560519254|FG001|Overall Study|Lost to Follow-up|4|||
155297724|NCT04697628|560519253|FG000|Overall Study|On-going in study|122|||
155297725|NCT04697628|560519254|FG001|Overall Study|On-going in study|91|||
155297726|NCT03388632|560519257|FG000|Triplet C|Clinical progression|0|||
155297727|NCT03388632|560519258|FG001|Triplet C|Clinical progression|0|||
155297728|NCT03388632|560519259|FG002|Triplet C|Clinical progression|0|||
155297729|NCT03388632|560519260|FG003|Triplet C|Clinical progression|0|||
155297730|NCT03388632|560519261|FG004|Triplet C|Clinical progression|1|||
155297731|NCT03388632|560519262|FG005|Triplet C|Clinical progression|0|||
155297732|NCT03388632|560519263|FG006|Triplet C|Clinical progression|0|||
155297733|NCT03388632|560519264|FG007|Triplet C|Clinical progression|0|||
155297734|NCT03388632|560519265|FG008|Triplet C|Clinical progression|0|||
155297735|NCT03388632|560519257|FG000|Triplet C|42-day lapse in tx|0|||
155297736|NCT03388632|560519258|FG001|Triplet C|42-day lapse in tx|0|||
155297737|NCT03388632|560519259|FG002|Triplet C|42-day lapse in tx|0|||
155297738|NCT03388632|560519260|FG003|Triplet C|42-day lapse in tx|0|||
155297739|NCT03388632|560519261|FG004|Triplet C|42-day lapse in tx|1|||
155297740|NCT03388632|560519262|FG005|Triplet C|42-day lapse in tx|0|||
155297741|NCT03388632|560519263|FG006|Triplet C|42-day lapse in tx|0|||
155297742|NCT03388632|560519264|FG007|Triplet C|42-day lapse in tx|0|||
155297743|NCT03388632|560519265|FG008|Triplet C|42-day lapse in tx|0|||
155297744|NCT03388632|560519257|FG000|Triplet C|Adverse Event|0|||
155297745|NCT03388632|560519258|FG001|Triplet C|Adverse Event|0|||
155297746|NCT03388632|560519259|FG002|Triplet C|Adverse Event|0|||
155297747|NCT03388632|560519260|FG003|Triplet C|Adverse Event|0|||
155297748|NCT03388632|560519261|FG004|Triplet C|Adverse Event|0|||
155297749|NCT03388632|560519262|FG005|Triplet C|Adverse Event|0|||
155297750|NCT03388632|560519263|FG006|Triplet C|Adverse Event|0|||
155297751|NCT03388632|560519264|FG007|Triplet C|Adverse Event|0|||
155297752|NCT03388632|560519265|FG008|Triplet C|Adverse Event|1|||
155297753|NCT03388632|560519257|FG000|Triplet C|Switched to alternative treatment|0|||
155297754|NCT03388632|560519258|FG001|Triplet C|Switched to alternative treatment|0|||
155297755|NCT03388632|560519259|FG002|Triplet C|Switched to alternative treatment|0|||
155297756|NCT03388632|560519260|FG003|Triplet C|Switched to alternative treatment|0|||
155297757|NCT03388632|560519261|FG004|Triplet C|Switched to alternative treatment|0|||
155297758|NCT03388632|560519262|FG005|Triplet C|Switched to alternative treatment|0|||
155297759|NCT03388632|560519263|FG006|Triplet C|Switched to alternative treatment|0|||
155297760|NCT03388632|560519264|FG007|Triplet C|Switched to alternative treatment|1|||
155297761|NCT03388632|560519265|FG008|Triplet C|Switched to alternative treatment|0|||
155297762|NCT03388632|560519257|FG000|Triplet C|Participant choice|0|||
155297763|NCT03388632|560519258|FG001|Triplet C|Participant choice|0|||
155297764|NCT03388632|560519259|FG002|Triplet C|Participant choice|0|||
155061423|NCT00111761|559659301|FG001|Part 1|Withdrawal by Subject|1|||
155061424|NCT00111761|559659300|FG000|Part 2|Adverse Event|1|||
155061425|NCT00111761|559659301|FG001|Part 2|Adverse Event|0|||
155061426|NCT00111761|559659300|FG000|Part 2|Physician Decision|1|||
155061427|NCT00111761|559659301|FG001|Part 2|Physician Decision|0|||
155061428|NCT00111761|559659300|FG000|Part 2|Death|1|||
155061429|NCT00111761|559659301|FG001|Part 2|Death|0|||
155297765|NCT03388632|560519260|FG003|Triplet C|Participant choice|0|||
155297766|NCT03388632|560519261|FG004|Triplet C|Participant choice|0|||
155297767|NCT03388632|560519262|FG005|Triplet C|Participant choice|1|||
155297768|NCT03388632|560519263|FG006|Triplet C|Participant choice|0|||
155297769|NCT03388632|560519264|FG007|Triplet C|Participant choice|0|||
155297770|NCT03388632|560519265|FG008|Triplet C|Participant choice|0|||
155297771|NCT04108208|560519266|FG000|Overall Study|Withdrawal by Subject|2|||
155297772|NCT04108208|560519267|FG001|Overall Study|Withdrawal by Subject|6|||
155297773|NCT04108208|560519266|FG000|Overall Study|other-ongoing|20|||
155297774|NCT04108208|560519267|FG001|Overall Study|other-ongoing|40|||
155297775|NCT04108208|560519266|FG000|Overall Study|Death|1|||
155297776|NCT04108208|560519267|FG001|Overall Study|Death|4|||
155297777|NCT04108208|560519266|FG000|Overall Study|Lost to Follow-up|2|||
155297778|NCT04108208|560519267|FG001|Overall Study|Lost to Follow-up|0|||
155297779|NCT02115282|560519268|FG000|Overall Study|Disease progression during treatment|216|||
155297780|NCT02115282|560519269|FG001|Overall Study|Disease progression during treatment|229|||
155297781|NCT02115282|560519268|FG000|Overall Study|Adverse Event|49|||
155297782|NCT02115282|560519269|FG001|Overall Study|Adverse Event|23|||
155061430|NCT00111761|559659300|FG000|Part 2|Disease progression|3|||
155061431|NCT00111761|559659301|FG001|Part 2|Disease progression|0|||
155061432|NCT00111761|559659300|FG000|Part 2|Protocol-specified criteria|1|||
155297783|NCT02115282|560519268|FG000|Overall Study|Death|1|||
155297784|NCT02115282|560519269|FG001|Overall Study|Death|3|||
155297785|NCT02115282|560519268|FG000|Overall Study|Alternative therapy|1|||
155297786|NCT02115282|560519269|FG001|Overall Study|Alternative therapy|1|||
155297787|NCT02115282|560519268|FG000|Overall Study|Complicating disease|0|||
155297788|NCT02115282|560519269|FG001|Overall Study|Complicating disease|3|||
155297789|NCT02115282|560519268|FG000|Overall Study|Withdrawal by Subject|12|||
155297790|NCT02115282|560519269|FG001|Overall Study|Withdrawal by Subject|10|||
155297791|NCT02115282|560519268|FG000|Overall Study|Symptomatic progression/deterioration|7|||
155297792|NCT02115282|560519269|FG001|Overall Study|Symptomatic progression/deterioration|18|||
155297793|NCT02115282|560519268|FG000|Overall Study|Non-compliance|5|||
155297794|NCT02115282|560519269|FG001|Overall Study|Non-compliance|1|||
155297795|NCT02115282|560519268|FG000|Overall Study|Protocol Violation|2|||
155297796|NCT02115282|560519269|FG001|Overall Study|Protocol Violation|2|||
155297797|NCT02115282|560519268|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
155297798|NCT02115282|560519269|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
155297799|NCT02115282|560519268|FG000|Overall Study|Not start protocol therapy|9|||
155297800|NCT02115282|560519269|FG001|Overall Study|Not start protocol therapy|10|||
155297801|NCT04795752|560519271|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
155297802|NCT04795752|560519272|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
155297803|NCT04795752|560519271|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
155297804|NCT04795752|560519272|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
155297805|NCT04795752|560519271|FG000|Primary Endpoint Phase|Physician Decision|2|||
155297806|NCT04795752|560519272|FG001|Primary Endpoint Phase|Physician Decision|0|||
155297807|NCT04795752|560519271|FG000|Primary Endpoint Phase|Other|4|||
155297808|NCT04795752|560519272|FG001|Primary Endpoint Phase|Other|1|||
155297809|NCT04795752|560519271|FG000|Primary Endpoint Phase|Protocol Violation|1|||
155297810|NCT04795752|560519272|FG001|Primary Endpoint Phase|Protocol Violation|0|||
155297811|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
155297812|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
155297813|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
155297814|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
155297815|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
155297816|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
155297817|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
155297818|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
155297819|NCT04795752|560519271|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
155297820|NCT04795752|560519272|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
155297821|NCT06129045|560519273|FG000|Overall Study|Lost to Follow-up|1|||
155297822|NCT06129045|560519274|FG001|Overall Study|Lost to Follow-up|1|||
155297823|NCT06129045|560519275|FG002|Overall Study|Lost to Follow-up|4|||
155297824|NCT03492177|560519282|FG000|Overall Study|Adverse Event|1|||
155297825|NCT03492177|560519283|FG001|Overall Study|Adverse Event|0|||
155297826|NCT03492177|560519284|FG002|Overall Study|Adverse Event|0|||
155297827|NCT03492177|560519282|FG000|Overall Study|Death|3|||
155297828|NCT03492177|560519283|FG001|Overall Study|Death|0|||
155297829|NCT03492177|560519284|FG002|Overall Study|Death|3|||
155297830|NCT03492177|560519282|FG000|Overall Study|Lack of Efficacy|1|||
155297831|NCT03492177|560519283|FG001|Overall Study|Lack of Efficacy|2|||
155297832|NCT03492177|560519284|FG002|Overall Study|Lack of Efficacy|0|||
155297833|NCT03492177|560519282|FG000|Overall Study|Other|1|||
155297834|NCT03492177|560519283|FG001|Overall Study|Other|0|||
155297835|NCT03492177|560519284|FG002|Overall Study|Other|0|||
155297836|NCT03492177|560519282|FG000|Overall Study|Ongoing|16|||
155297837|NCT03492177|560519283|FG001|Overall Study|Ongoing|19|||
155297838|NCT03492177|560519284|FG002|Overall Study|Ongoing|17|||
155297839|NCT02320123|560519859|FG000|Overall Study|Lost to Follow-up|4|||
155297840|NCT02320123|560519860|FG001|Overall Study|Lost to Follow-up|6|||
155297841|NCT02320123|560519859|FG000|Overall Study|Death|6|||
155297842|NCT02320123|560519860|FG001|Overall Study|Death|5|||
155297843|NCT01765543|560519865|FG000|Overall Study|Death|1|||
155297844|NCT01765543|560519865|FG000|Overall Study|Withdrawal by Subject|2|||
155297845|NCT03718767|560519866|FG000|Overall Study|Declined to participate (before treatment started)|0|||
155297846|NCT03718767|560519867|FG001|Overall Study|Declined to participate (before treatment started)|0|||
155297847|NCT03718767|560519868|FG002|Overall Study|Declined to participate (before treatment started)|7|||
155297848|NCT03718767|560519866|FG000|Overall Study|Ineligible|0|||
155297849|NCT03718767|560519867|FG001|Overall Study|Ineligible|0|||
155297850|NCT03718767|560519868|FG002|Overall Study|Ineligible|17|||
155297851|NCT01241292|560519869|FG000|Overall Study|Administrative Reason by Sponsor|1|||
155297852|NCT01241292|560519870|FG001|Overall Study|Administrative Reason by Sponsor|0|||
155297853|NCT01241292|560519869|FG000|Overall Study|Disease Progression|2|||
155297854|NCT01241292|560519870|FG001|Overall Study|Disease Progression|0|||
155297855|NCT01241292|560519869|FG000|Overall Study|Study Drug Toxicity|0|||
155297856|NCT01241292|560519870|FG001|Overall Study|Study Drug Toxicity|1|||
155297857|NCT01241292|560519869|FG000|Overall Study|Participant Discontinued Treatment|0|||
155297858|NCT01241292|560519870|FG001|Overall Study|Participant Discontinued Treatment|2|||
155297859|NCT01190007|560519873|FG000|Overall Study|Withdrawal by Subject|4|||
155297860|NCT01190007|560519873|FG000|Overall Study|Adverse Event|8|||
155297861|NCT01190007|560519873|FG000|Overall Study|Difficulty of visit for complications|1|||
155297862|NCT01190007|560519873|FG000|Overall Study|Participant was arrested|1|||
155297863|NCT01254019|560519875|FG000|Overall Study|Adverse Event|0|||
155297864|NCT01254019|560519876|FG001|Overall Study|Adverse Event|2|||
155297865|NCT01254019|560519875|FG000|Overall Study|Protocol Violation|1|||
155297866|NCT01254019|560519876|FG001|Overall Study|Protocol Violation|0|||
155297867|NCT01254019|560519875|FG000|Overall Study|Withdrawal by Subject|0|||
155297868|NCT01254019|560519876|FG001|Overall Study|Withdrawal by Subject|2|||
155297869|NCT00792948|560519879|FG000|Overall Study|Adverse Event|6|||
155297870|NCT00792948|560519879|FG000|Overall Study|Death|4|||
155297871|NCT00792948|560519879|FG000|Overall Study|Withdrawal by Subject|3|||
155158468|NCT00538902|560018807|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
155061433|NCT00111761|559659301|FG001|Part 2|Protocol-specified criteria|0|||
155061434|NCT00111761|559659300|FG000|Part 2|Other|1|||
155061435|NCT00111761|559659301|FG001|Part 2|Other|0|||
155061436|NCT00471497|559659304|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
155061437|NCT00471497|559659305|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
155061438|NCT00471497|559659306|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
155061439|NCT00471497|559659304|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
155061440|NCT00471497|559659305|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
155061441|NCT00471497|559659306|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
155061442|NCT00471497|559659304|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
155061443|NCT00471497|559659305|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
155061444|NCT00471497|559659306|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
155061445|NCT00471497|559659304|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
155061446|NCT00471497|559659305|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
155061447|NCT00471497|559659306|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
155061448|NCT00471497|559659304|FG000|Core Treatment Phase|Lost to Follow-up|6|||
155061449|NCT00471497|559659305|FG001|Core Treatment Phase|Lost to Follow-up|6|||
155061450|NCT00471497|559659306|FG002|Core Treatment Phase|Lost to Follow-up|3|||
155061451|NCT00471497|559659304|FG000|Core Treatment Phase|Death|3|||
155061452|NCT00471497|559659305|FG001|Core Treatment Phase|Death|9|||
155061453|NCT00471497|559659306|FG002|Core Treatment Phase|Death|3|||
155061454|NCT00471497|559659304|FG000|Core Treatment Phase|Disease Progression|10|||
155061455|NCT00471497|559659305|FG001|Core Treatment Phase|Disease Progression|2|||
155061456|NCT00471497|559659306|FG002|Core Treatment Phase|Disease Progression|4|||
155061457|NCT00471497|559659304|FG000|Core Treatment Phase|Protocol Violation|6|||
155061458|NCT00471497|559659305|FG001|Core Treatment Phase|Protocol Violation|15|||
155061459|NCT00471497|559659306|FG002|Core Treatment Phase|Protocol Violation|11|||
155061460|NCT00471497|559659304|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
155061461|NCT00471497|559659305|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
155061462|NCT00471497|559659306|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
155061463|NCT00471497|559659304|FG000|Core Treatment Phase|Administrative problems|14|||
155061464|NCT00471497|559659305|FG001|Core Treatment Phase|Administrative problems|14|||
155297872|NCT00792948|560519879|FG000|Overall Study|Ineligible|2|||
155297873|NCT00792948|560519879|FG000|Overall Study|Insurance denial - not treated|1|||
155297874|NCT00792948|560519879|FG000|Overall Study|Physician Decision|11|||
155158469|NCT00538902|560018808|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
155061465|NCT00471497|559659306|FG002|Core Treatment Phase|Administrative problems|12|||
155061466|NCT00471497|559659304|FG000|Core Treatment Phase|Adverse Event|43|||
155061467|NCT00471497|559659305|FG001|Core Treatment Phase|Adverse Event|53|||
155061468|NCT00471497|559659306|FG002|Core Treatment Phase|Adverse Event|89|||
155061469|NCT00471497|559659304|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
155061470|NCT00471497|559659305|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
155061471|NCT00471497|559659306|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
155061472|NCT00471497|559659304|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
155061473|NCT00471497|559659305|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
155061474|NCT00471497|559659306|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
155061475|NCT00471497|559659304|FG000|Extension Phase|Adverse Event|9|||
155061476|NCT00471497|559659305|FG001|Extension Phase|Adverse Event|5|||
155061477|NCT00471497|559659306|FG002|Extension Phase|Adverse Event|1|||
155061478|NCT00471497|559659304|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
155061479|NCT00471497|559659305|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
155061480|NCT00471497|559659306|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
155061481|NCT00471497|559659304|FG000|Extension Phase|Withdrawal by Subject|3|||
155061482|NCT00471497|559659305|FG001|Extension Phase|Withdrawal by Subject|1|||
155061483|NCT00471497|559659306|FG002|Extension Phase|Withdrawal by Subject|0|||
155061484|NCT00471497|559659304|FG000|Extension Phase|Lost to Follow-up|2|||
155061485|NCT00471497|559659305|FG001|Extension Phase|Lost to Follow-up|0|||
155061486|NCT00471497|559659306|FG002|Extension Phase|Lost to Follow-up|0|||
155170032|NCT00830869|560062411|FG006|Period 2: Part 2|Adverse Event|0|||
155297875|NCT00792948|560519879|FG000|Overall Study|Protocol Violation|1|||
155297876|NCT01390402|560519886|FG000|Overall Study|Death|1|||
155297877|NCT01390402|560519886|FG000|Overall Study|Disease Progression|4|||
155297878|NCT02445391|560519887|FG000|Overall Study|No active protocol treatment|3|||
155297879|NCT02445391|560519888|FG001|Overall Study|No active protocol treatment|0|||
155297880|NCT02445391|560519889|FG002|Overall Study|No active protocol treatment|0|||
155297881|NCT02445391|560519887|FG000|Overall Study|Adverse Event|0|||
155297882|NCT02445391|560519888|FG001|Overall Study|Adverse Event|21|||
155297883|NCT02445391|560519889|FG002|Overall Study|Adverse Event|12|||
155297884|NCT02445391|560519887|FG000|Overall Study|Alternative therapy|0|||
155297885|NCT02445391|560519888|FG001|Overall Study|Alternative therapy|0|||
155297886|NCT02445391|560519889|FG002|Overall Study|Alternative therapy|1|||
155297887|NCT02445391|560519887|FG000|Overall Study|Disease progression|0|||
155297888|NCT02445391|560519888|FG001|Overall Study|Disease progression|7|||
155297889|NCT02445391|560519889|FG002|Overall Study|Disease progression|22|||
155297890|NCT02445391|560519887|FG000|Overall Study|Complicating disease|0|||
155297891|NCT02445391|560519888|FG001|Overall Study|Complicating disease|2|||
155297892|NCT02445391|560519889|FG002|Overall Study|Complicating disease|1|||
155297893|NCT02445391|560519887|FG000|Overall Study|Withdrawal by Subject|0|||
155297894|NCT02445391|560519888|FG001|Overall Study|Withdrawal by Subject|4|||
155297895|NCT02445391|560519889|FG002|Overall Study|Withdrawal by Subject|9|||
155297896|NCT02445391|560519887|FG000|Overall Study|Financial issue|0|||
155297897|NCT02445391|560519888|FG001|Overall Study|Financial issue|0|||
155297898|NCT02445391|560519889|FG002|Overall Study|Financial issue|2|||
155297899|NCT02445391|560519887|FG000|Overall Study|Still on treatment|0|||
155297900|NCT02445391|560519888|FG001|Overall Study|Still on treatment|7|||
155297901|NCT02445391|560519889|FG002|Overall Study|Still on treatment|16|||
155297902|NCT02445391|560519887|FG000|Overall Study|Not start protocol therapy|0|||
155158470|NCT00538902|560018809|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
155158471|NCT00538902|560018807|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
155158472|NCT00538902|560018808|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
155158473|NCT00538902|560018809|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
155158474|NCT00538902|560018807|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
155158475|NCT00538902|560018808|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
155158476|NCT00538902|560018809|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
155158477|NCT00538902|560018807|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
155158478|NCT00538902|560018808|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
155158479|NCT00538902|560018809|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
155158480|NCT00538902|560018807|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
155158481|NCT00538902|560018808|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
155158482|NCT00538902|560018809|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
155158483|NCT01967940|560018814|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
155158484|NCT01967940|560018815|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
155158485|NCT01967940|560018816|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
155158486|NCT01967940|560018817|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
155158487|NCT01967940|560018814|FG000|Part 2|Adverse Event|0|||
155158488|NCT01967940|560018815|FG001|Part 2|Adverse Event|0|||
155158489|NCT01967940|560018816|FG002|Part 2|Adverse Event|0|||
155158490|NCT01967940|560018817|FG003|Part 2|Adverse Event|1|||
155158491|NCT01967940|560018814|FG000|Part 2|Unknown Reason|0|||
155158492|NCT01967940|560018815|FG001|Part 2|Unknown Reason|0|||
155158493|NCT01967940|560018816|FG002|Part 2|Unknown Reason|0|||
155158494|NCT01967940|560018817|FG003|Part 2|Unknown Reason|1|||
155158495|NCT04109547|560018818|FG000|Overall Study|Withdrawal by Subject|3|||
155158496|NCT04109547|560018819|FG001|Overall Study|Withdrawal by Subject|2|||
155158497|NCT04109547|560018820|FG002|Overall Study|Withdrawal by Subject|6|||
155158498|NCT04109547|560018821|FG003|Overall Study|Withdrawal by Subject|6|||
155158499|NCT04109547|560018818|FG000|Overall Study|Lost to Follow-up|0|||
155158500|NCT04109547|560018819|FG001|Overall Study|Lost to Follow-up|0|||
155158501|NCT04109547|560018820|FG002|Overall Study|Lost to Follow-up|0|||
155158502|NCT04109547|560018821|FG003|Overall Study|Lost to Follow-up|1|||
155158503|NCT04109547|560018818|FG000|Overall Study|Physician Decision|1|||
155297903|NCT02445391|560519888|FG001|Overall Study|Not start protocol therapy|12|||
155297904|NCT02445391|560519889|FG002|Overall Study|Not start protocol therapy|9|||
155297905|NCT02611037|560519890|FG000|Overall Study|Withdrawal prior to treatment|2|||
155297906|NCT02611037|560519891|FG001|Overall Study|Withdrawal prior to treatment|0|||
155297907|NCT05850520|560519892|FG000|Overall Study|Withdrawal by Subject|8|||
155158504|NCT04109547|560018819|FG001|Overall Study|Physician Decision|2|||
155158505|NCT04109547|560018820|FG002|Overall Study|Physician Decision|0|||
155158506|NCT04109547|560018821|FG003|Overall Study|Physician Decision|0|||
155158507|NCT01550003|560018822|FG000|Overall Study|Adverse Event|0|||
155158508|NCT01550003|560018823|FG001|Overall Study|Adverse Event|9|||
155297908|NCT05850520|560519893|FG001|Overall Study|Withdrawal by Subject|8|||
155297909|NCT05850520|560519894|FG002|Overall Study|Withdrawal by Subject|16|||
155297910|NCT05850520|560519892|FG000|Overall Study|Lost to Follow-up|2|||
155297911|NCT05850520|560519893|FG001|Overall Study|Lost to Follow-up|2|||
155297912|NCT05850520|560519894|FG002|Overall Study|Lost to Follow-up|2|||
155297913|NCT05850520|560519892|FG000|Overall Study|Death|2|||
155297914|NCT05850520|560519893|FG001|Overall Study|Death|2|||
155297915|NCT05850520|560519894|FG002|Overall Study|Death|3|||
155297916|NCT05850520|560519892|FG000|Overall Study|Adverse Event|2|||
155297917|NCT05850520|560519893|FG001|Overall Study|Adverse Event|0|||
155297918|NCT05850520|560519894|FG002|Overall Study|Adverse Event|1|||
155297919|NCT05850520|560519892|FG000|Overall Study|Physician Decision|0|||
155297920|NCT05850520|560519893|FG001|Overall Study|Physician Decision|1|||
155297921|NCT05850520|560519894|FG002|Overall Study|Physician Decision|0|||
155297922|NCT05850520|560519892|FG000|Overall Study|Protocol deviation|0|||
155297923|NCT05850520|560519893|FG001|Overall Study|Protocol deviation|0|||
155297924|NCT05850520|560519894|FG002|Overall Study|Protocol deviation|1|||
155297925|NCT05850520|560519892|FG000|Overall Study|No information was available on whether follow-up was completed or not|0|||
155297926|NCT05850520|560519893|FG001|Overall Study|No information was available on whether follow-up was completed or not|2|||
155297927|NCT05850520|560519894|FG002|Overall Study|No information was available on whether follow-up was completed or not|2|||
155297928|NCT03889925|560520675|FG000|Overall Study|Lost to Follow-up|11|||
155297929|NCT03889925|560520676|FG001|Overall Study|Lost to Follow-up|10|||
155297930|NCT00925899|560520682|FG000|Part 1|Death|1|||
155297931|NCT00925899|560520683|FG001|Part 1|Death|2|||
155297932|NCT00925899|560520682|FG000|Part 1|Withdrawal by Subject|10|||
155297933|NCT00925899|560520683|FG001|Part 1|Withdrawal by Subject|9|||
155297934|NCT03648762|560520684|FG000|Overall Study|Lost to Follow-up|1|||
155297935|NCT03648762|560520685|FG001|Overall Study|Lost to Follow-up|2|||
155297936|NCT03648762|560520686|FG002|Overall Study|Lost to Follow-up|0|||
155297937|NCT03648762|560520684|FG000|Overall Study|Withdrawal by Subject|5|||
155297938|NCT03648762|560520685|FG001|Overall Study|Withdrawal by Subject|2|||
155297939|NCT03648762|560520686|FG002|Overall Study|Withdrawal by Subject|1|||
155297940|NCT04480827|560520694|FG000|Overall Study|Adverse Event|0|||
155297941|NCT04480827|560520695|FG001|Overall Study|Adverse Event|0|||
155297942|NCT04480827|560520696|FG002|Overall Study|Adverse Event|0|||
155297943|NCT04480827|560520697|FG003|Overall Study|Adverse Event|0|||
155297944|NCT04480827|560520698|FG004|Overall Study|Adverse Event|0|||
155297945|NCT04480827|560520699|FG005|Overall Study|Adverse Event|1|||
155297946|NCT04480827|560520700|FG006|Overall Study|Adverse Event|0|||
155297947|NCT01582100|560520703|FG000|Overall Study|Adverse Event|1|||
155297948|NCT01582100|560520703|FG000|Overall Study|Withdrawal by Subject|1|||
155297949|NCT00360698|560520704|FG000|Run-In|Physician Decision|0|||
155297950|NCT00360698|560520705|FG001|Run-In|Physician Decision|1|||
155297951|NCT00360698|560520704|FG000|Run-In|Withdrawal by Subject|0|||
155297952|NCT00360698|560520705|FG001|Run-In|Withdrawal by Subject|2|||
155297953|NCT00360698|560520704|FG000|Run-In|Non compliance with treatment procedure|0|||
155297954|NCT00360698|560520705|FG001|Run-In|Non compliance with treatment procedure|1|||
155297955|NCT00360698|560520704|FG000|Run-In|Sponsor request|0|||
155297956|NCT00360698|560520705|FG001|Run-In|Sponsor request|2|||
155297957|NCT00360698|560520704|FG000|Run-In|Patient did not meet inclusion criteria|0|||
155297958|NCT00360698|560520705|FG001|Run-In|Patient did not meet inclusion criteria|1|||
155297959|NCT00360698|560520704|FG000|Run-In|Patient personal reasons|0|||
155297960|NCT00360698|560520705|FG001|Run-In|Patient personal reasons|2|||
155297961|NCT00360698|560520704|FG000|Run-In|Need of insulin with meals|0|||
155297962|NCT00360698|560520705|FG001|Run-In|Need of insulin with meals|1|||
155297963|NCT00360698|560520704|FG000|Treatment Period|Non compliance with treatment procedure|1|||
155297964|NCT00360698|560520705|FG001|Treatment Period|Non compliance with treatment procedure|0|||
155297965|NCT00360698|560520704|FG000|Treatment Period|Early termination by error|0|||
155297966|NCT00360698|560520705|FG001|Treatment Period|Early termination by error|1|||
155297967|NCT03401112|560520712|FG000|Overall Study|Adverse Event|1|||
155297968|NCT03401112|560520713|FG001|Overall Study|Adverse Event|2|||
155297969|NCT03401112|560520714|FG002|Overall Study|Adverse Event|3|||
154957202|NCT00854100|559270798|FG002|Overall Study|Lost to Follow-up|3|||
155297970|NCT03401112|560520715|FG003|Overall Study|Adverse Event|2|||
155297971|NCT03401112|560520716|FG004|Overall Study|Adverse Event|0|||
155297972|NCT03401112|560520712|FG000|Overall Study|Lost to Follow-up|1|||
155297973|NCT03401112|560520713|FG001|Overall Study|Lost to Follow-up|0|||
155297974|NCT03401112|560520714|FG002|Overall Study|Lost to Follow-up|0|||
155297975|NCT03401112|560520715|FG003|Overall Study|Lost to Follow-up|0|||
155297976|NCT03401112|560520716|FG004|Overall Study|Lost to Follow-up|0|||
155297977|NCT03401112|560520712|FG000|Overall Study|Noncompliance|1|||
155297978|NCT03401112|560520713|FG001|Overall Study|Noncompliance|2|||
155297979|NCT03401112|560520714|FG002|Overall Study|Noncompliance|3|||
155297980|NCT03401112|560520715|FG003|Overall Study|Noncompliance|0|||
155297981|NCT03401112|560520716|FG004|Overall Study|Noncompliance|0|||
155297982|NCT03401112|560520712|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
155297983|NCT03401112|560520713|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
154957203|NCT00854100|559270796|FG000|Overall Study|Withdrawal by Subject|3|||
155297984|NCT03401112|560520714|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
155297985|NCT03401112|560520715|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
155297986|NCT03401112|560520716|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
155297987|NCT03401112|560520712|FG000|Overall Study|Withdrawal by Subject|0|||
155297988|NCT03401112|560520713|FG001|Overall Study|Withdrawal by Subject|3|||
155297989|NCT03401112|560520714|FG002|Overall Study|Withdrawal by Subject|2|||
155297990|NCT03401112|560520715|FG003|Overall Study|Withdrawal by Subject|1|||
155297991|NCT03401112|560520716|FG004|Overall Study|Withdrawal by Subject|0|||
155297992|NCT03401112|560520712|FG000|Overall Study|Physician Decision|0|||
155297993|NCT03401112|560520713|FG001|Overall Study|Physician Decision|0|||
155297994|NCT03401112|560520714|FG002|Overall Study|Physician Decision|0|||
155297995|NCT03401112|560520715|FG003|Overall Study|Physician Decision|2|||
155297996|NCT03401112|560520716|FG004|Overall Study|Physician Decision|0|||
155297997|NCT03401112|560520712|FG000|Overall Study|Study was Terminated by Sponsor|0|||
155297998|NCT03401112|560520713|FG001|Overall Study|Study was Terminated by Sponsor|0|||
155297999|NCT03401112|560520714|FG002|Overall Study|Study was Terminated by Sponsor|0|||
155298000|NCT03401112|560520715|FG003|Overall Study|Study was Terminated by Sponsor|1|||
155298001|NCT03401112|560520716|FG004|Overall Study|Study was Terminated by Sponsor|0|||
155298002|NCT03401112|560520712|FG000|Overall Study|Day 1 Assessment not Done|1|||
155298003|NCT03401112|560520713|FG001|Overall Study|Day 1 Assessment not Done|0|||
155298004|NCT03401112|560520714|FG002|Overall Study|Day 1 Assessment not Done|0|||
155298005|NCT03401112|560520715|FG003|Overall Study|Day 1 Assessment not Done|0|||
155298006|NCT03401112|560520716|FG004|Overall Study|Day 1 Assessment not Done|0|||
155298007|NCT03401112|560520712|FG000|Overall Study|Not Dosed|0|||
155298008|NCT03401112|560520713|FG001|Overall Study|Not Dosed|0|||
155298009|NCT03401112|560520714|FG002|Overall Study|Not Dosed|1|||
155298010|NCT03401112|560520715|FG003|Overall Study|Not Dosed|0|||
155298011|NCT03401112|560520716|FG004|Overall Study|Not Dosed|0|||
155298012|NCT03401112|560520712|FG000|Overall Study|Missed Clinical Visit|0|||
155298013|NCT03401112|560520713|FG001|Overall Study|Missed Clinical Visit|0|||
155298014|NCT03401112|560520714|FG002|Overall Study|Missed Clinical Visit|1|||
155298015|NCT03401112|560520715|FG003|Overall Study|Missed Clinical Visit|0|||
155298016|NCT03401112|560520716|FG004|Overall Study|Missed Clinical Visit|0|||
155298017|NCT03401112|560520712|FG000|Overall Study|Missed Doses|0|||
155298018|NCT03401112|560520713|FG001|Overall Study|Missed Doses|0|||
155298019|NCT03401112|560520714|FG002|Overall Study|Missed Doses|1|||
155298020|NCT03401112|560520715|FG003|Overall Study|Missed Doses|0|||
155298021|NCT03401112|560520716|FG004|Overall Study|Missed Doses|0|||
155298022|NCT01264679|560520717|FG000|Overall Study|Participation in Another Clinical Trial|1|||
155298023|NCT01264679|560520717|FG000|Overall Study|Physician Decision|1|||
155298024|NCT01264679|560520717|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
155298025|NCT01264679|560520717|FG000|Overall Study|Withdrawal by Subject|1|||
155298026|NCT03475316|560520718|FG000|6 Month Intervention|Adverse Event|2|||
155061487|NCT00471497|559659304|FG000|Extension Phase|Death|1|||
155061488|NCT00471497|559659305|FG001|Extension Phase|Death|0|||
155061489|NCT00471497|559659306|FG002|Extension Phase|Death|0|||
155061490|NCT00471497|559659304|FG000|Extension Phase|Disease progression|2|||
155061491|NCT00471497|559659305|FG001|Extension Phase|Disease progression|0|||
155061492|NCT00471497|559659306|FG002|Extension Phase|Disease progression|0|||
155061493|NCT00471497|559659304|FG000|Extension Phase|Protocol Violation|2|||
155298027|NCT03475316|560520719|FG001|6 Month Intervention|Adverse Event|1|||
155298028|NCT03475316|560520718|FG000|6 Month Intervention|Withdrawal by Subject|2|||
155298029|NCT03475316|560520719|FG001|6 Month Intervention|Withdrawal by Subject|0|||
155061494|NCT00471497|559659305|FG001|Extension Phase|Protocol Violation|2|||
155061495|NCT00471497|559659306|FG002|Extension Phase|Protocol Violation|0|||
155061496|NCT04004000|559659307|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
155061497|NCT06121609|559659308|FG000|Overall Study|Lack of Efficacy|0|||
155061498|NCT06121609|559659309|FG001|Overall Study|Lack of Efficacy|0|||
155061499|NCT06121609|559659310|FG002|Overall Study|Lack of Efficacy|45|||
155061500|NCT06494761|559659311|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
155061501|NCT06494761|559659311|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
155061502|NCT04865289|559659313|FG000|Overall Study|Death|34|||
155061503|NCT04865289|559659314|FG001|Overall Study|Death|25|||
155061504|NCT04865289|559659313|FG000|Overall Study|Physician Decision|27|||
155061505|NCT04865289|559659314|FG001|Overall Study|Physician Decision|27|||
155061506|NCT04865289|559659313|FG000|Overall Study|Sponsor Decision|11|||
155061507|NCT04865289|559659314|FG001|Overall Study|Sponsor Decision|1|||
155061508|NCT04865289|559659313|FG000|Overall Study|Withdrawal by Subject|2|||
155061509|NCT04865289|559659314|FG001|Overall Study|Withdrawal by Subject|3|||
155061510|NCT03104374|559659315|FG000|Period 1|Adverse Event|7|||
155061511|NCT03104374|559659316|FG001|Period 1|Adverse Event|7|||
155061512|NCT03104374|559659317|FG002|Period 1|Adverse Event|12|||
155061513|NCT03104374|559659318|FG003|Period 1|Adverse Event|14|||
155061514|NCT03104374|559659315|FG000|Period 1|Withdrawal by Subject|18|||
155061515|NCT03104374|559659316|FG001|Period 1|Withdrawal by Subject|9|||
155061516|NCT03104374|559659317|FG002|Period 1|Withdrawal by Subject|10|||
155061517|NCT03104374|559659318|FG003|Period 1|Withdrawal by Subject|17|||
155061518|NCT03104374|559659315|FG000|Period 1|Lost to Follow-up|4|||
155061519|NCT03104374|559659316|FG001|Period 1|Lost to Follow-up|4|||
155061520|NCT03104374|559659317|FG002|Period 1|Lost to Follow-up|6|||
155298030|NCT03475316|560520718|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
155298031|NCT03475316|560520719|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
155298032|NCT03475316|560520718|FG000|9 Months|Study stopped due to COVID pandemic|3|||
155298033|NCT03475316|560520719|FG001|9 Months|Study stopped due to COVID pandemic|4|||
155298034|NCT00424645|560520720|FG000|Overall Study|Death|1|||
155298035|NCT00424645|560520721|FG001|Overall Study|Death|0|||
155298036|NCT01595061|560520722|FG000|Overall Study|Never Treated|3|||
155298037|NCT01595061|560520722|FG000|Overall Study|Inadequate Pathology|1|||
155298038|NCT03194958|560520725|FG000|Overall Study|Death|0|||
155298039|NCT03194958|560520726|FG001|Overall Study|Death|1|||
155298040|NCT03194958|560520727|FG002|Overall Study|Death|1|||
155298041|NCT03194958|560520728|FG003|Overall Study|Death|1|||
155298042|NCT03194958|560520725|FG000|Overall Study|Withdrawal by Subject|24|||
155298043|NCT03194958|560520726|FG001|Overall Study|Withdrawal by Subject|27|||
155298044|NCT03194958|560520727|FG002|Overall Study|Withdrawal by Subject|7|||
155298045|NCT03194958|560520728|FG003|Overall Study|Withdrawal by Subject|22|||
155298046|NCT03194958|560520725|FG000|Overall Study|Lost to Follow-up|168|||
155298047|NCT03194958|560520726|FG001|Overall Study|Lost to Follow-up|196|||
155298048|NCT03194958|560520727|FG002|Overall Study|Lost to Follow-up|174|||
155298049|NCT03194958|560520728|FG003|Overall Study|Lost to Follow-up|186|||
155298050|NCT01179334|560520731|FG000|Treatment Period|Adverse Event|1|||
155298051|NCT01179334|560520732|FG001|Treatment Period|Adverse Event|0|||
155298052|NCT01179334|560520731|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
155298053|NCT01179334|560520732|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
155298054|NCT01179334|560520731|FG000|Long-term Extension (LTE) Period|Death|3|||
155298055|NCT01179334|560520732|FG001|Long-term Extension (LTE) Period|Death|0|||
155298056|NCT01179334|560520731|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
155298057|NCT01179334|560520732|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
155298058|NCT00256243|560520733|FG000|Overall Study|Lost to Follow-up|2|||
155298059|NCT00256243|560520733|FG000|Overall Study|Death|7|||
155298060|NCT00256243|560520733|FG000|Overall Study|Not treated|1|||
155298061|NCT01152190|560520734|FG000|Overall Study|Adverse Event|2|||
155298062|NCT01152190|560520735|FG001|Overall Study|Adverse Event|4|||
155298063|NCT01152190|560520734|FG000|Overall Study|Death|1|||
155298064|NCT01152190|560520735|FG001|Overall Study|Death|0|||
155298065|NCT01152190|560520734|FG000|Overall Study|Protocol Violation|1|||
155298066|NCT01152190|560520735|FG001|Overall Study|Protocol Violation|1|||
155298067|NCT01152190|560520734|FG000|Overall Study|Withdrawal by Subject|1|||
155061521|NCT03104374|559659318|FG003|Period 1|Lost to Follow-up|8|||
155061522|NCT03104374|559659315|FG000|Period 1|Lack of Efficacy|6|||
155061523|NCT03104374|559659316|FG001|Period 1|Lack of Efficacy|7|||
155061524|NCT03104374|559659317|FG002|Period 1|Lack of Efficacy|12|||
155061525|NCT03104374|559659318|FG003|Period 1|Lack of Efficacy|6|||
155061526|NCT03104374|559659315|FG000|Period 1|Other|2|||
155061527|NCT03104374|559659316|FG001|Period 1|Other|2|||
155061528|NCT03104374|559659317|FG002|Period 1|Other|4|||
155061529|NCT03104374|559659318|FG003|Period 1|Other|7|||
155298068|NCT01152190|560520735|FG001|Overall Study|Withdrawal by Subject|3|||
155298069|NCT01595321|560520738|FG000|Overall Study|Adverse Event|1|||
155298070|NCT01595321|560520739|FG001|Overall Study|Adverse Event|1|||
155298071|NCT01595321|560520740|FG002|Overall Study|Adverse Event|1|||
155298072|NCT01595321|560520738|FG000|Overall Study|Lack of Efficacy|0|||
155298073|NCT01595321|560520739|FG001|Overall Study|Lack of Efficacy|0|||
155298074|NCT01595321|560520740|FG002|Overall Study|Lack of Efficacy|4|||
155298075|NCT00834834|560520741|FG000|Overall Study|Withdrawal by Subject|4|||
155298076|NCT00834834|560520742|FG001|Overall Study|Withdrawal by Subject|3|||
155298077|NCT00373529|560520743|FG000|Overall Study|Physician Decision|19|||
155298078|NCT00373529|560520743|FG000|Overall Study|Withdrawal by Subject|7|||
155298079|NCT00373529|560520743|FG000|Overall Study|Adverse Event|7|||
155298080|NCT00373529|560520743|FG000|Overall Study|Treatment failure|36|||
155298081|NCT00373529|560520743|FG000|Overall Study|Disease recurrence|10|||
155298082|NCT00373529|560520743|FG000|Overall Study|Death|16|||
155298083|NCT00373529|560520743|FG000|Overall Study|Need for treatment prohibited by study|1|||
155298084|NCT00373529|560520743|FG000|Overall Study|Other|8|||
155298085|NCT00373529|560520743|FG000|Overall Study|Failed independent confirmation of AML|3|||
155298086|NCT00373529|560520743|FG000|Overall Study|Consent violation|1|||
155298087|NCT01585558|560520746|FG000|Overall Study|Withdrawal by Subject|4|||
155298088|NCT01585558|560520747|FG001|Overall Study|Withdrawal by Subject|5|||
155298089|NCT01585558|560520748|FG002|Overall Study|Withdrawal by Subject|8|||
155298090|NCT01585558|560520746|FG000|Overall Study|Lost to Follow-up|2|||
155298091|NCT01585558|560520747|FG001|Overall Study|Lost to Follow-up|0|||
155298092|NCT01585558|560520748|FG002|Overall Study|Lost to Follow-up|3|||
155298093|NCT01585558|560520746|FG000|Overall Study|Adverse Event|3|||
155298094|NCT01585558|560520747|FG001|Overall Study|Adverse Event|4|||
155061530|NCT03104374|559659315|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
155298095|NCT01585558|560520748|FG002|Overall Study|Adverse Event|1|||
155298096|NCT01585558|560520746|FG000|Overall Study|Protocol Violation|4|||
155298097|NCT01585558|560520747|FG001|Overall Study|Protocol Violation|3|||
155298098|NCT01585558|560520748|FG002|Overall Study|Protocol Violation|2|||
155092586|NCT00560417|559773638|FG001|Overall Study|Entry Criteria Not Met|0|||
155298099|NCT01585558|560520746|FG000|Overall Study|Lack of Efficacy|0|||
155298100|NCT01585558|560520747|FG001|Overall Study|Lack of Efficacy|0|||
155298101|NCT01585558|560520748|FG002|Overall Study|Lack of Efficacy|1|||
155298102|NCT01810263|560520762|FG000|Overall Study|Lost to Follow-up|8|||
155298103|NCT01810263|560520763|FG001|Overall Study|Lost to Follow-up|7|||
155298104|NCT00026312|560520764|FG000|Overall Study|Adverse Event|0|||
155298105|NCT00026312|560520765|FG001|Overall Study|Adverse Event|32|||
155298106|NCT00026312|560520764|FG000|Overall Study|Death|1|||
154957204|NCT00854100|559270797|FG001|Overall Study|Withdrawal by Subject|1|||
154957205|NCT00854100|559270798|FG002|Overall Study|Withdrawal by Subject|2|||
154957206|NCT00854100|559270796|FG000|Overall Study|Protocol Violation|2|||
154957207|NCT00854100|559270797|FG001|Overall Study|Protocol Violation|4|||
154957208|NCT00854100|559270798|FG002|Overall Study|Protocol Violation|3|||
154957209|NCT00854100|559270796|FG000|Overall Study|Adverse Event|2|||
154957210|NCT00854100|559270797|FG001|Overall Study|Adverse Event|1|||
154957211|NCT00854100|559270798|FG002|Overall Study|Adverse Event|2|||
154957212|NCT00389064|559270800|FG000|Overall Study|Adverse Event|11|||
154957213|NCT00389064|559270801|FG001|Overall Study|Adverse Event|3|||
154957214|NCT00389064|559270800|FG000|Overall Study|Lack of Efficacy|3|||
154957215|NCT00389064|559270801|FG001|Overall Study|Lack of Efficacy|14|||
154957216|NCT00389064|559270800|FG000|Overall Study|Withdrawal by Subject|17|||
154957217|NCT00389064|559270801|FG001|Overall Study|Withdrawal by Subject|27|||
154957218|NCT00389064|559270800|FG000|Overall Study|Physician Decision|2|||
154957219|NCT00389064|559270801|FG001|Overall Study|Physician Decision|2|||
154957220|NCT00389064|559270800|FG000|Overall Study|Lost to Follow-up|1|||
154957221|NCT00389064|559270801|FG001|Overall Study|Lost to Follow-up|2|||
154957222|NCT00389064|559270800|FG000|Overall Study|Protocol Violation|2|||
154957223|NCT00389064|559270801|FG001|Overall Study|Protocol Violation|0|||
154957224|NCT00389064|559270800|FG000|Overall Study|Multiple Reasons|9|||
154957225|NCT00389064|559270801|FG001|Overall Study|Multiple Reasons|11|||
154957226|NCT03616106|559270802|FG000|Overall Study|Removed by PI|6|||
154957227|NCT03616106|559270803|FG001|Overall Study|Removed by PI|0|||
154957228|NCT03616106|559270802|FG000|Overall Study|Withdrawal by Subject|1|||
154957229|NCT03616106|559270803|FG001|Overall Study|Withdrawal by Subject|1|||
154957230|NCT03616106|559270802|FG000|Overall Study|Lost to Follow-up|7|||
154957231|NCT03616106|559270803|FG001|Overall Study|Lost to Follow-up|0|||
154957232|NCT01880593|559270806|FG000|Overall Study|Adverse Event|1|||
154957233|NCT01880593|559270807|FG001|Overall Study|Adverse Event|0|||
154957234|NCT01880593|559270806|FG000|Overall Study|Lack of Efficacy|1|||
154957235|NCT01880593|559270807|FG001|Overall Study|Lack of Efficacy|5|||
154957236|NCT01880593|559270806|FG000|Overall Study|Withdrawal by Subject|6|||
154957237|NCT01880593|559270807|FG001|Overall Study|Withdrawal by Subject|1|||
154957238|NCT05275205|559270808|FG000|Overall Study|Adverse Event|1|||
154957239|NCT05275205|559270809|FG001|Overall Study|Adverse Event|2|||
154957240|NCT05275205|559270808|FG000|Overall Study|Physician Decision|1|||
154957241|NCT05275205|559270809|FG001|Overall Study|Physician Decision|1|||
154957242|NCT05275205|559270808|FG000|Overall Study|Withdrawal by Subject|2|||
154957243|NCT05275205|559270809|FG001|Overall Study|Withdrawal by Subject|3|||
154957244|NCT05275205|559270808|FG000|Overall Study|Death|1|||
154957245|NCT05275205|559270809|FG001|Overall Study|Death|0|||
154957246|NCT05275205|559270808|FG000|Overall Study|Patient unable to attend visits|1|||
154957247|NCT05275205|559270809|FG001|Overall Study|Patient unable to attend visits|0|||
154957248|NCT03041025|559270812|FG000|Overall Study|Adverse Event|0|||
154957249|NCT03041025|559270813|FG001|Overall Study|Adverse Event|0|||
154957250|NCT03041025|559270814|FG002|Overall Study|Adverse Event|1|||
154957251|NCT03041025|559270812|FG000|Overall Study|Lost to Follow-up|1|||
154957252|NCT03041025|559270813|FG001|Overall Study|Lost to Follow-up|0|||
154957253|NCT03041025|559270814|FG002|Overall Study|Lost to Follow-up|0|||
154957254|NCT03041025|559270812|FG000|Overall Study|Withdrawal by Subject|0|||
154957255|NCT03041025|559270813|FG001|Overall Study|Withdrawal by Subject|0|||
154957256|NCT03041025|559270814|FG002|Overall Study|Withdrawal by Subject|1|||
154957257|NCT02963259|559270816|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
154957258|NCT02963259|559270816|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
154957259|NCT02963259|559270816|FG000|Overall Study|Death|1|||
154957260|NCT02963259|559270816|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
154957261|NCT03243630|559270817|FG000|Overall Study|Protocol Violation|1|||
154957262|NCT03243630|559270817|FG000|Overall Study|Physician Decision|1|||
154957263|NCT00939003|559270820|FG000|Double-blind Treatment Period|Adverse Event|1|||
154957264|NCT00939003|559270821|FG001|Double-blind Treatment Period|Adverse Event|1|||
154957265|NCT00939003|559270820|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
154957266|NCT00939003|559270821|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
154957267|NCT00939003|559270820|FG000|Double-blind Treatment Period|Pregnancy|0|||
154957268|NCT00939003|559270821|FG001|Double-blind Treatment Period|Pregnancy|1|||
154957269|NCT00939003|559270820|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
154957270|NCT00939003|559270821|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
155092587|NCT00560417|559773637|FG000|Overall Study|Lost to Follow-up|0|||
155298107|NCT00026312|560520765|FG001|Overall Study|Death|7|||
155298108|NCT00026312|560520764|FG000|Overall Study|Lack of Efficacy|19|||
155158509|NCT01550003|560018824|FG002|Overall Study|Adverse Event|15|||
155158510|NCT01550003|560018822|FG000|Overall Study|Lack of Efficacy|4|||
155061531|NCT03104374|559659316|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
155061532|NCT03104374|559659317|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
155061533|NCT03104374|559659318|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
155061534|NCT03104374|559659315|FG000|Period 2|Adverse Event|4|||
155061535|NCT03104374|559659316|FG001|Period 2|Adverse Event|7|||
155061536|NCT03104374|559659317|FG002|Period 2|Adverse Event|10|||
155061537|NCT03104374|559659318|FG003|Period 2|Adverse Event|10|||
155061538|NCT03104374|559659315|FG000|Period 2|Withdrawal by Subject|3|||
155061539|NCT03104374|559659316|FG001|Period 2|Withdrawal by Subject|7|||
155061540|NCT03104374|559659317|FG002|Period 2|Withdrawal by Subject|13|||
155061541|NCT03104374|559659318|FG003|Period 2|Withdrawal by Subject|16|||
155061542|NCT03104374|559659315|FG000|Period 2|Lost to Follow-up|2|||
155061543|NCT03104374|559659316|FG001|Period 2|Lost to Follow-up|2|||
155061544|NCT03104374|559659317|FG002|Period 2|Lost to Follow-up|3|||
155061545|NCT03104374|559659318|FG003|Period 2|Lost to Follow-up|5|||
155061546|NCT03104374|559659315|FG000|Period 2|Lack of Efficacy|2|||
155158511|NCT01550003|560018823|FG001|Overall Study|Lack of Efficacy|11|||
155158512|NCT01550003|560018824|FG002|Overall Study|Lack of Efficacy|15|||
155158513|NCT01550003|560018822|FG000|Overall Study|Protocol Violation|0|||
155158514|NCT01550003|560018823|FG001|Overall Study|Protocol Violation|3|||
154957271|NCT00939003|559270820|FG000|Open-label Treatment Period|Adverse Event|4|||
154957272|NCT00939003|559270821|FG001|Open-label Treatment Period|Adverse Event|8|||
154957273|NCT00939003|559270820|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
154957274|NCT00939003|559270821|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
154957275|NCT00939003|559270820|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
154957276|NCT00939003|559270821|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
154957277|NCT00939003|559270820|FG000|Open-label Treatment Period|Pregnancy|1|||
154957278|NCT00939003|559270821|FG001|Open-label Treatment Period|Pregnancy|1|||
154957279|NCT00939003|559270820|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
154957280|NCT00939003|559270821|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
154957281|NCT00939003|559270820|FG000|Open-label Treatment Period|Site Closure|3|||
154957282|NCT00939003|559270821|FG001|Open-label Treatment Period|Site Closure|4|||
154957283|NCT02131129|559270822|FG000|Overall Study|Withdrawal by Subject|1|||
154957284|NCT02131129|559270823|FG001|Overall Study|Withdrawal by Subject|0|||
154957285|NCT03707912|559270824|FG000|Overall Study|Violation of inclusion criteria|1|||
154957286|NCT03707912|559270825|FG001|Overall Study|Violation of inclusion criteria|0|||
154957287|NCT03880266|559270826|FG000|Overall Study|Withdrawal by Subject|0|||
154957288|NCT03880266|559270827|FG001|Overall Study|Withdrawal by Subject|1|||
154957289|NCT03880266|559270828|FG002|Overall Study|Withdrawal by Subject|1|||
154957290|NCT03880266|559270829|FG003|Overall Study|Withdrawal by Subject|0|||
154957291|NCT03880266|559270830|FG004|Overall Study|Withdrawal by Subject|0|||
154957292|NCT03880266|559270831|FG005|Overall Study|Withdrawal by Subject|0|||
154957293|NCT03880266|559270832|FG006|Overall Study|Withdrawal by Subject|0|||
154957294|NCT03880266|559270833|FG007|Overall Study|Withdrawal by Subject|0|||
154957295|NCT00467896|559272388|FG000|Overall Study|Consent Withdrawal|18|||
154957296|NCT00467896|559272388|FG000|Overall Study|Adverse Event|7|||
154957297|NCT00467896|559272388|FG000|Overall Study|Serious Adverse Event|13|||
154957298|NCT00467896|559272388|FG000|Overall Study|Non-compliance|3|||
154957299|NCT00467896|559272388|FG000|Overall Study|Changed therapy|2|||
154957300|NCT00467896|559272388|FG000|Overall Study|Patient received transplant|2|||
154957301|NCT00467896|559272388|FG000|Overall Study|Patient had atrial septostomy|1|||
154957302|NCT00467896|559272388|FG000|Overall Study|Patient weaned off iloprost|1|||
154957303|NCT00467896|559272388|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
154957304|NCT00467896|559272388|FG000|Overall Study|Started intravenous prostacyclin|1|||
154957305|NCT00467896|559272388|FG000|Overall Study|Started inhaled Remodulin|1|||
155061547|NCT03104374|559659316|FG001|Period 2|Lack of Efficacy|4|||
155061548|NCT03104374|559659317|FG002|Period 2|Lack of Efficacy|7|||
155061549|NCT03104374|559659318|FG003|Period 2|Lack of Efficacy|4|||
155061550|NCT03104374|559659315|FG000|Period 2|COVID-19 Infection|0|||
155061551|NCT03104374|559659316|FG001|Period 2|COVID-19 Infection|0|||
155061552|NCT03104374|559659317|FG002|Period 2|COVID-19 Infection|1|||
155061553|NCT03104374|559659318|FG003|Period 2|COVID-19 Infection|0|||
155061554|NCT03104374|559659315|FG000|Period 2|Other|3|||
155061555|NCT03104374|559659316|FG001|Period 2|Other|2|||
155061556|NCT03104374|559659317|FG002|Period 2|Other|2|||
155158515|NCT01550003|560018824|FG002|Overall Study|Protocol Violation|2|||
154957306|NCT00467896|559272388|FG000|Overall Study|Patient had no improvement|1|||
154957307|NCT03818581|559272393|FG000|Overall Study|Adverse Event|1|||
154957308|NCT03818581|559272394|FG001|Overall Study|Adverse Event|0|||
155061557|NCT03104374|559659318|FG003|Period 2|Other|4|||
155061558|NCT02867592|559659319|FG000|Overall Study|Adverse Event|3|||
155158516|NCT01550003|560018822|FG000|Overall Study|Lost to Follow-up|1|||
155158517|NCT01550003|560018823|FG001|Overall Study|Lost to Follow-up|4|||
155158518|NCT01550003|560018824|FG002|Overall Study|Lost to Follow-up|8|||
155298109|NCT00026312|560520765|FG001|Overall Study|Lack of Efficacy|114|||
155298110|NCT00026312|560520764|FG000|Overall Study|Lost to Follow-up|0|||
155298111|NCT00026312|560520765|FG001|Overall Study|Lost to Follow-up|5|||
155298112|NCT00026312|560520764|FG000|Overall Study|Physician Decision|1|||
155298113|NCT00026312|560520765|FG001|Overall Study|Physician Decision|37|||
155298114|NCT00026312|560520764|FG000|Overall Study|Protocol Violation|0|||
155298115|NCT00026312|560520765|FG001|Overall Study|Protocol Violation|3|||
155298116|NCT00026312|560520764|FG000|Overall Study|Withdrawal by Subject|1|||
155298117|NCT00026312|560520765|FG001|Overall Study|Withdrawal by Subject|6|||
155298118|NCT00026312|560520764|FG000|Overall Study|Ineligible|4|||
155298119|NCT00026312|560520765|FG001|Overall Study|Ineligible|5|||
155298120|NCT00026312|560520764|FG000|Overall Study|Entry onto another COG study|0|||
155298121|NCT00026312|560520765|FG001|Overall Study|Entry onto another COG study|1|||
155298122|NCT00026312|560520764|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
155298123|NCT00026312|560520765|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
155298124|NCT03785782|560521771|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
155298125|NCT03785782|560521772|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
155298126|NCT03785782|560521771|FG000|Overall Study|Withdrawal by Subject|1|||
155158519|NCT01550003|560018822|FG000|Overall Study|Consent withdrawn|2|||
155158520|NCT01550003|560018823|FG001|Overall Study|Consent withdrawn|11|||
155298127|NCT03785782|560521772|FG001|Overall Study|Withdrawal by Subject|1|||
155298128|NCT03785782|560521771|FG000|Overall Study|insufficient image quality.|3|||
155298129|NCT03785782|560521772|FG001|Overall Study|insufficient image quality.|0|||
155298130|NCT05777785|560521773|FG000|Overall Study|Withdrawal by Subject|5|||
155298131|NCT05777785|560521773|FG000|Overall Study|Lost to Follow-up|1|||
154957309|NCT03818581|559272395|FG002|Overall Study|Adverse Event|0|||
154957310|NCT03818581|559272396|FG003|Overall Study|Adverse Event|0|||
155298132|NCT05644444|560521774|FG000|Tolerance Phase|Adverse Event|0|||
155298133|NCT05644444|560521775|FG001|Tolerance Phase|Adverse Event|2|||
155298134|NCT05644444|560521774|FG000|Treatment Phase|Adverse Event|0|||
155298135|NCT05644444|560521775|FG001|Treatment Phase|Adverse Event|2|||
155298136|NCT00493649|560521776|FG000|Overall Study|Adverse Event|44|||
155298137|NCT00493649|560521776|FG000|Overall Study|Patient Request|21|||
155298138|NCT00493649|560521776|FG000|Overall Study|Investigator Request|2|||
155298139|NCT00493649|560521776|FG000|Overall Study|Disease Progression|1|||
155298140|NCT00493649|560521776|FG000|Overall Study|Lost to Follow-up|1|||
155298141|NCT00493649|560521776|FG000|Overall Study|Other|13|||
155298142|NCT01823536|560521781|FG000|Overall Study|Lost to Follow-up|1|||
155298143|NCT01823536|560521782|FG001|Overall Study|Lost to Follow-up|0|||
155298144|NCT01823536|560521783|FG002|Overall Study|Lost to Follow-up|0|||
155298145|NCT01823536|560521784|FG003|Overall Study|Lost to Follow-up|1|||
155298146|NCT01823536|560521785|FG004|Overall Study|Lost to Follow-up|1|||
155298147|NCT01823536|560521786|FG005|Overall Study|Lost to Follow-up|0|||
155298148|NCT01823536|560521781|FG000|Overall Study|Protocol Violation|0|||
155298149|NCT01823536|560521782|FG001|Overall Study|Protocol Violation|1|||
155298150|NCT01823536|560521783|FG002|Overall Study|Protocol Violation|0|||
155298151|NCT01823536|560521784|FG003|Overall Study|Protocol Violation|0|||
155298152|NCT01823536|560521785|FG004|Overall Study|Protocol Violation|0|||
155298153|NCT01823536|560521786|FG005|Overall Study|Protocol Violation|0|||
155298154|NCT01823536|560521781|FG000|Overall Study|Withdrawal by Subject|1|||
155298155|NCT01823536|560521782|FG001|Overall Study|Withdrawal by Subject|1|||
155298156|NCT01823536|560521783|FG002|Overall Study|Withdrawal by Subject|0|||
155298157|NCT01823536|560521784|FG003|Overall Study|Withdrawal by Subject|0|||
155298158|NCT01823536|560521785|FG004|Overall Study|Withdrawal by Subject|0|||
155298159|NCT01823536|560521786|FG005|Overall Study|Withdrawal by Subject|0|||
155298160|NCT01823536|560521781|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298161|NCT01823536|560521782|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298162|NCT01823536|560521783|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
155298163|NCT01823536|560521784|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298164|NCT01823536|560521785|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
155298165|NCT01823536|560521786|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
154957311|NCT03818581|559272397|FG004|Overall Study|Adverse Event|0|||
154957312|NCT03818581|559272393|FG000|Overall Study|Covid-19|2|||
154957313|NCT03818581|559272394|FG001|Overall Study|Covid-19|0|||
154957314|NCT03818581|559272395|FG002|Overall Study|Covid-19|0|||
155298166|NCT01823536|560521781|FG000|Overall Study|Met exclusion criterion No 6|0|||
155298167|NCT01823536|560521782|FG001|Overall Study|Met exclusion criterion No 6|0|||
154957315|NCT03818581|559272396|FG003|Overall Study|Covid-19|0|||
154957316|NCT03818581|559272397|FG004|Overall Study|Covid-19|1|||
154957317|NCT03818581|559272393|FG000|Overall Study|Withdrawal by Subject|0|||
154957318|NCT03818581|559272394|FG001|Overall Study|Withdrawal by Subject|0|||
155298168|NCT01823536|560521783|FG002|Overall Study|Met exclusion criterion No 6|0|||
155298169|NCT01823536|560521784|FG003|Overall Study|Met exclusion criterion No 6|1|||
155298170|NCT01823536|560521785|FG004|Overall Study|Met exclusion criterion No 6|0|||
155298171|NCT01823536|560521786|FG005|Overall Study|Met exclusion criterion No 6|0|||
155298172|NCT01823536|560521781|FG000|Overall Study|Subject moved out of the state|0|||
154957319|NCT03818581|559272395|FG002|Overall Study|Withdrawal by Subject|0|||
154957320|NCT03818581|559272396|FG003|Overall Study|Withdrawal by Subject|0|||
154957321|NCT03818581|559272397|FG004|Overall Study|Withdrawal by Subject|1|||
154957322|NCT03818581|559272393|FG000|Overall Study|No longer met study criteria|0|||
154957323|NCT03818581|559272394|FG001|Overall Study|No longer met study criteria|0|||
154957324|NCT03818581|559272395|FG002|Overall Study|No longer met study criteria|0|||
154957325|NCT03818581|559272396|FG003|Overall Study|No longer met study criteria|0|||
154957326|NCT03818581|559272397|FG004|Overall Study|No longer met study criteria|1|||
154957327|NCT01466166|559272403|FG000|Overall Study|Death|1|||
154957328|NCT01466166|559272403|FG000|Overall Study|Lost to Follow-up|7|||
154957329|NCT01466166|559272403|FG000|Overall Study|Infusion Reaction (IR)|27|||
154957330|NCT01466166|559272403|FG000|Overall Study|Adverse Event (Other than IR)|11|||
154957331|NCT01466166|559272403|FG000|Overall Study|Elevated Serum Uric Acid|78|||
154957332|NCT01466166|559272403|FG000|Overall Study|Withdrawal by Subject|13|||
154957333|NCT01466166|559272403|FG000|Overall Study|Sponsor Decision|4|||
154957334|NCT01466166|559272403|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
154957335|NCT01466166|559272403|FG000|Overall Study|Other|20|||
154957336|NCT02096211|559272404|FG000|Overall Study|Death|2|||
154957337|NCT02096211|559272404|FG000|Overall Study|Withdrawal by Subject|8|||
154957338|NCT02096211|559272404|FG000|Overall Study|Revision of implant|7|||
154957339|NCT02096211|559272404|FG000|Overall Study|Lost to Follow-up|43|||
154957340|NCT01439880|559272411|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
154957341|NCT01439880|559272412|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
154957342|NCT01439880|559272411|FG000|SOC-controlled Period (Year 1)|Death|2|||
154957343|NCT01439880|559272412|FG001|SOC-controlled Period (Year 1)|Death|1|||
154957344|NCT01439880|559272411|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
154957345|NCT01439880|559272412|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
154957346|NCT01439880|559272411|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
154957347|NCT01439880|559272412|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
154957348|NCT01439880|559272411|FG000|SOC-controlled Period (Year 1)|Other|8|||
154957349|NCT01439880|559272412|FG001|SOC-controlled Period (Year 1)|Other|13|||
154957350|NCT01439880|559272411|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
154957351|NCT01439880|559272412|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
154957352|NCT01439880|559272411|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
154957353|NCT01439880|559272412|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
154957354|NCT01439880|559272411|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
154957355|NCT01439880|559272412|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
154957356|NCT01439880|559272411|FG000|All-IP Period (Years 2 to 5)|Death|3|||
154957357|NCT01439880|559272412|FG001|All-IP Period (Years 2 to 5)|Death|13|||
154957358|NCT01439880|559272411|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
154957359|NCT01439880|559272412|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
154957360|NCT01439880|559272411|FG000|All-IP Period (Years 2 to 5)|Other|14|||
154957361|NCT01439880|559272412|FG001|All-IP Period (Years 2 to 5)|Other|31|||
154957362|NCT01439880|559272411|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
154957363|NCT01439880|559272412|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
154957364|NCT00328926|559272413|FG000|Overall Study|Pregnancy|2|||
154957365|NCT00328926|559272414|FG001|Overall Study|Pregnancy|1|||
154957366|NCT00328926|559272415|FG002|Overall Study|Pregnancy|0|||
154957367|NCT00328926|559272413|FG000|Overall Study|Lost to Follow-up|0|||
154957368|NCT00328926|559272414|FG001|Overall Study|Lost to Follow-up|1|||
154957369|NCT00328926|559272415|FG002|Overall Study|Lost to Follow-up|0|||
154957370|NCT00328926|559272413|FG000|Overall Study|Death|0|||
154957371|NCT00328926|559272414|FG001|Overall Study|Death|0|||
154957372|NCT00328926|559272415|FG002|Overall Study|Death|1|||
154957373|NCT00328926|559272413|FG000|Overall Study|In vitro fertilization treatment|0|||
155158521|NCT01550003|560018824|FG002|Overall Study|Consent withdrawn|23|||
155158522|NCT01550003|560018822|FG000|Overall Study|Missing|1|||
155158523|NCT01550003|560018823|FG001|Overall Study|Missing|0|||
155158524|NCT01550003|560018824|FG002|Overall Study|Missing|2|||
155158525|NCT01550003|560018822|FG000|Overall Study|Study closure as announced by sponsor|7|||
155158526|NCT01550003|560018823|FG001|Overall Study|Study closure as announced by sponsor|6|||
155158527|NCT01550003|560018824|FG002|Overall Study|Study closure as announced by sponsor|24|||
155158528|NCT01550003|560018822|FG000|Overall Study|Protocol Noncompliance|1|||
155158529|NCT01550003|560018823|FG001|Overall Study|Protocol Noncompliance|0|||
155158530|NCT01550003|560018824|FG002|Overall Study|Protocol Noncompliance|0|||
155158531|NCT01550003|560018822|FG000|Overall Study|Study closure|0|||
155158532|NCT01550003|560018823|FG001|Overall Study|Study closure|1|||
155158533|NCT01550003|560018824|FG002|Overall Study|Study closure|1|||
155158534|NCT01550003|560018822|FG000|Overall Study|Patient reached adulthood|0|||
155158535|NCT01550003|560018823|FG001|Overall Study|Patient reached adulthood|1|||
154957374|NCT00328926|559272414|FG001|Overall Study|In vitro fertilization treatment|0|||
154957375|NCT00328926|559272415|FG002|Overall Study|In vitro fertilization treatment|1|||
154957376|NCT00328926|559272413|FG000|Overall Study|Lack of ovarian response|0|||
154957377|NCT00328926|559272414|FG001|Overall Study|Lack of ovarian response|1|||
154957378|NCT00328926|559272415|FG002|Overall Study|Lack of ovarian response|0|||
155298173|NCT01823536|560521782|FG001|Overall Study|Subject moved out of the state|0|||
155298174|NCT01823536|560521783|FG002|Overall Study|Subject moved out of the state|0|||
155298175|NCT01823536|560521784|FG003|Overall Study|Subject moved out of the state|0|||
155298176|NCT01823536|560521785|FG004|Overall Study|Subject moved out of the state|1|||
155298177|NCT01823536|560521786|FG005|Overall Study|Subject moved out of the state|0|||
155298178|NCT00768664|560521787|FG000|Overall Study|Death|57|||
155298179|NCT00768664|560521787|FG000|Overall Study|Lost to Follow-up|2|||
155298180|NCT00768664|560521787|FG000|Overall Study|Other|9|||
155298181|NCT00768664|560521787|FG000|Overall Study|Participant refused|1|||
155298182|NCT02544152|560521788|FG000|Overall Study|Adverse Event|0|||
155298183|NCT02544152|560521789|FG001|Overall Study|Adverse Event|4|||
155298184|NCT02544152|560521788|FG000|Overall Study|Withdrawal by Subject|0|||
155298185|NCT02544152|560521789|FG001|Overall Study|Withdrawal by Subject|3|||
155298186|NCT02544152|560521788|FG000|Overall Study|Other|1|||
155298187|NCT02544152|560521789|FG001|Overall Study|Other|0|||
155298188|NCT00465816|560521790|FG000|Overall Study|Lost to Follow-up|0|||
155298189|NCT00465816|560521791|FG001|Overall Study|Lost to Follow-up|0|||
155298190|NCT00465816|560521792|FG002|Overall Study|Lost to Follow-up|2|||
155298191|NCT02139046|560521793|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155298192|NCT02139046|560521794|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
155298193|NCT02139046|560521795|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
155298194|NCT02139046|560521796|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
155298195|NCT02139046|560521797|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
155298196|NCT02139046|560521793|FG000|Overall Study|Major Protocol Deviation|9|||
155298197|NCT02139046|560521794|FG001|Overall Study|Major Protocol Deviation|10|||
155298198|NCT02139046|560521795|FG002|Overall Study|Major Protocol Deviation|16|||
155298199|NCT02139046|560521796|FG003|Overall Study|Major Protocol Deviation|12|||
155298200|NCT02139046|560521797|FG004|Overall Study|Major Protocol Deviation|6|||
155298201|NCT02139046|560521793|FG000|Overall Study|Lost to Follow-up|13|||
155298202|NCT02139046|560521794|FG001|Overall Study|Lost to Follow-up|16|||
155298203|NCT02139046|560521795|FG002|Overall Study|Lost to Follow-up|16|||
155298204|NCT02139046|560521796|FG003|Overall Study|Lost to Follow-up|18|||
155298205|NCT02139046|560521797|FG004|Overall Study|Lost to Follow-up|13|||
155298206|NCT02139046|560521793|FG000|Overall Study|Voluntary Withdrawal|20|||
155298207|NCT02139046|560521794|FG001|Overall Study|Voluntary Withdrawal|8|||
155298208|NCT02139046|560521795|FG002|Overall Study|Voluntary Withdrawal|10|||
155298209|NCT02139046|560521796|FG003|Overall Study|Voluntary Withdrawal|15|||
155298210|NCT02139046|560521797|FG004|Overall Study|Voluntary Withdrawal|16|||
155298211|NCT02139046|560521793|FG000|Overall Study|Lack of Efficacy|0|||
155298212|NCT02139046|560521794|FG001|Overall Study|Lack of Efficacy|1|||
155298213|NCT02139046|560521795|FG002|Overall Study|Lack of Efficacy|2|||
155298214|NCT02139046|560521796|FG003|Overall Study|Lack of Efficacy|1|||
155298215|NCT02139046|560521797|FG004|Overall Study|Lack of Efficacy|2|||
155298216|NCT02139046|560521793|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
155158536|NCT01550003|560018824|FG002|Overall Study|Patient reached adulthood|0|||
155158537|NCT01550003|560018822|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
155158538|NCT01550003|560018823|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
155158539|NCT01550003|560018824|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
155158540|NCT01550003|560018822|FG000|Overall Study|Sponsor's order|0|||
155158541|NCT01550003|560018823|FG001|Overall Study|Sponsor's order|3|||
155158542|NCT01550003|560018824|FG002|Overall Study|Sponsor's order|3|||
155158543|NCT01550003|560018822|FG000|Overall Study|Sponsor's decision|1|||
155158544|NCT01550003|560018823|FG001|Overall Study|Sponsor's decision|5|||
155158545|NCT01550003|560018824|FG002|Overall Study|Sponsor's decision|4|||
155158546|NCT01550003|560018822|FG000|Overall Study|Subject mother passed away|0|||
155158547|NCT01550003|560018823|FG001|Overall Study|Subject mother passed away|1|||
155158548|NCT01550003|560018824|FG002|Overall Study|Subject mother passed away|0|||
155158549|NCT01550003|560018822|FG000|Overall Study|Discontinuation|0|||
155298217|NCT02139046|560521794|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
155298218|NCT02139046|560521795|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
155158550|NCT01550003|560018823|FG001|Overall Study|Discontinuation|1|||
155158551|NCT01550003|560018824|FG002|Overall Study|Discontinuation|0|||
155158552|NCT01550003|560018822|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
155158553|NCT01550003|560018823|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
155158554|NCT01550003|560018824|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
155158555|NCT01550003|560018822|FG000|Overall Study|Site closure|0|||
155158556|NCT01550003|560018823|FG001|Overall Study|Site closure|2|||
155158557|NCT01550003|560018824|FG002|Overall Study|Site closure|0|||
155158558|NCT01550003|560018822|FG000|Overall Study|Pregnancy|0|||
155158559|NCT01550003|560018823|FG001|Overall Study|Pregnancy|1|||
155298219|NCT02139046|560521796|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
155298220|NCT02139046|560521797|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
155158560|NCT01550003|560018824|FG002|Overall Study|Pregnancy|0|||
155170033|NCT00830869|560062412|FG007|Period 2: Part 2|Adverse Event|4|||
155298221|NCT02139046|560521793|FG000|Overall Study|Other Miscellaneous Reasons|10|||
155298222|NCT02139046|560521794|FG001|Overall Study|Other Miscellaneous Reasons|9|||
155298223|NCT02139046|560521795|FG002|Overall Study|Other Miscellaneous Reasons|4|||
155298224|NCT02139046|560521796|FG003|Overall Study|Other Miscellaneous Reasons|9|||
155298225|NCT02139046|560521797|FG004|Overall Study|Other Miscellaneous Reasons|12|||
155298226|NCT00818454|560521800|FG000|Treatment Period 1|Adverse Event|0|||
155298227|NCT00818454|560521801|FG001|Treatment Period 1|Adverse Event|1|||
155298228|NCT00818454|560521802|FG002|Treatment Period 1|Adverse Event|0|||
155298229|NCT00818454|560521803|FG003|Treatment Period 1|Adverse Event|0|||
155298230|NCT00818454|560521800|FG000|Treatment Period 1|Other|3|||
155298231|NCT00818454|560521801|FG001|Treatment Period 1|Other|0|||
155298232|NCT00818454|560521802|FG002|Treatment Period 1|Other|0|||
155298233|NCT00818454|560521803|FG003|Treatment Period 1|Other|0|||
155298234|NCT00818454|560521800|FG000|Washout Period of 1 Week|Adverse Event|1|||
155298235|NCT00818454|560521801|FG001|Washout Period of 1 Week|Adverse Event|1|||
155298236|NCT00818454|560521802|FG002|Washout Period of 1 Week|Adverse Event|0|||
155298237|NCT00818454|560521803|FG003|Washout Period of 1 Week|Adverse Event|0|||
155298238|NCT00818454|560521800|FG000|Washout Period of 1 Week|Protocol Violation|2|||
155298239|NCT00818454|560521801|FG001|Washout Period of 1 Week|Protocol Violation|0|||
155298240|NCT00818454|560521802|FG002|Washout Period of 1 Week|Protocol Violation|0|||
155298241|NCT00818454|560521803|FG003|Washout Period of 1 Week|Protocol Violation|0|||
155298242|NCT00818454|560521800|FG000|Washout Period of 1 Week|Other|1|||
155298243|NCT00818454|560521801|FG001|Washout Period of 1 Week|Other|2|||
155298244|NCT00818454|560521802|FG002|Washout Period of 1 Week|Other|0|||
155298245|NCT00818454|560521803|FG003|Washout Period of 1 Week|Other|0|||
155298246|NCT00818454|560521800|FG000|Treatment Period 2|Other|2|||
155298247|NCT00818454|560521801|FG001|Treatment Period 2|Other|1|||
155298248|NCT00818454|560521802|FG002|Treatment Period 2|Other|0|||
155298249|NCT00818454|560521803|FG003|Treatment Period 2|Other|0|||
155298250|NCT00818454|560521800|FG000|Treatment Period 3|Adverse Event|0|||
155298251|NCT00818454|560521801|FG001|Treatment Period 3|Adverse Event|0|||
155298252|NCT00818454|560521802|FG002|Treatment Period 3|Adverse Event|0|||
155298253|NCT00818454|560521803|FG003|Treatment Period 3|Adverse Event|1|||
155298254|NCT03454529|560521804|FG000|Overall Study|Did not receive treatment|6|||
155298255|NCT03454529|560521804|FG000|Overall Study|Received < 80% doses|1|||
155298256|NCT01040689|560521809|FG000|Overall Study|Adverse Event|0|||
155298257|NCT01040689|560521810|FG001|Overall Study|Adverse Event|0|||
155298258|NCT01040689|560521811|FG002|Overall Study|Adverse Event|2|||
155298259|NCT01040689|560521812|FG003|Overall Study|Adverse Event|4|||
155298260|NCT01040689|560521809|FG000|Overall Study|Lack of Efficacy|0|||
155298261|NCT01040689|560521810|FG001|Overall Study|Lack of Efficacy|0|||
155298262|NCT01040689|560521811|FG002|Overall Study|Lack of Efficacy|1|||
155298263|NCT01040689|560521812|FG003|Overall Study|Lack of Efficacy|0|||
155298264|NCT01040689|560521809|FG000|Overall Study|Lost to Follow-up|1|||
155298265|NCT01040689|560521810|FG001|Overall Study|Lost to Follow-up|0|||
155298266|NCT01040689|560521811|FG002|Overall Study|Lost to Follow-up|0|||
155298267|NCT01040689|560521812|FG003|Overall Study|Lost to Follow-up|0|||
155298268|NCT01040689|560521809|FG000|Overall Study|Withdrawal by Subject|2|||
155298269|NCT01040689|560521810|FG001|Overall Study|Withdrawal by Subject|1|||
155298270|NCT01040689|560521811|FG002|Overall Study|Withdrawal by Subject|1|||
155158561|NCT01550003|560018822|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
155158562|NCT01550003|560018823|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
155158563|NCT01550003|560018824|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
155158564|NCT01550003|560018822|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
155158565|NCT01550003|560018823|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
155158566|NCT01550003|560018824|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
155158567|NCT01550003|560018822|FG000|Overall Study|Switching to adult rheumatologist|0|||
155158568|NCT01550003|560018823|FG001|Overall Study|Switching to adult rheumatologist|0|||
155158569|NCT01550003|560018824|FG002|Overall Study|Switching to adult rheumatologist|1|||
155158570|NCT01550003|560018822|FG000|Overall Study|Patient transition to adult care|0|||
155158571|NCT01550003|560018823|FG001|Overall Study|Patient transition to adult care|0|||
155158572|NCT01550003|560018824|FG002|Overall Study|Patient transition to adult care|1|||
155158573|NCT01550003|560018822|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
155158574|NCT01550003|560018823|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
155158575|NCT01550003|560018824|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
155158576|NCT01550003|560018822|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
155298271|NCT01040689|560521812|FG003|Overall Study|Withdrawal by Subject|0|||
155158577|NCT01550003|560018823|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
155298272|NCT01040689|560521809|FG000|Overall Study|Other reasons not listed above|0|||
155298273|NCT01040689|560521810|FG001|Overall Study|Other reasons not listed above|1|||
155298274|NCT01040689|560521811|FG002|Overall Study|Other reasons not listed above|0|||
155298275|NCT01040689|560521812|FG003|Overall Study|Other reasons not listed above|0|||
155298276|NCT00494442|560521819|FG000|Overall Study|Death|1|||
155298277|NCT00494442|560521820|FG001|Overall Study|Death|1|||
155298278|NCT00494442|560521819|FG000|Overall Study|Lack of Efficacy|16|||
155298279|NCT00494442|560521820|FG001|Overall Study|Lack of Efficacy|10|||
155298280|NCT00494442|560521819|FG000|Overall Study|Adverse Event|0|||
155298281|NCT00494442|560521820|FG001|Overall Study|Adverse Event|2|||
155298282|NCT00494442|560521819|FG000|Overall Study|Physician Decision|0|||
155298283|NCT00494442|560521820|FG001|Overall Study|Physician Decision|1|||
155298284|NCT00494442|560521819|FG000|Overall Study|Non-compliance|0|||
155298285|NCT00494442|560521820|FG001|Overall Study|Non-compliance|1|||
155298286|NCT00494442|560521819|FG000|Overall Study|Intercurrent illness|0|||
155298287|NCT00494442|560521820|FG001|Overall Study|Intercurrent illness|1|||
155298288|NCT03184558|560521823|FG000|Overall Study|Withdrawal by Subject|2|||
155298289|NCT03184558|560521823|FG000|Overall Study|Death|16|||
155298290|NCT03184558|560521823|FG000|Overall Study|Lost to Follow-up|2|||
155298291|NCT03184558|560521823|FG000|Overall Study|Other|9|||
155298292|NCT03061474|560521828|FG000|Overall Study|Adverse Event|2|||
155298293|NCT03061474|560521829|FG001|Overall Study|Adverse Event|0|||
155298294|NCT03061474|560521828|FG000|Overall Study|Safety Risk|0|||
155298295|NCT03061474|560521829|FG001|Overall Study|Safety Risk|1|||
155298296|NCT03061474|560521828|FG000|Overall Study|Participant unwilling or unable to participate|0|||
155298297|NCT03061474|560521829|FG001|Overall Study|Participant unwilling or unable to participate|2|||
155298298|NCT03061474|560521828|FG000|Overall Study|Lost to Follow-up|0|||
155298299|NCT03061474|560521829|FG001|Overall Study|Lost to Follow-up|1|||
155298300|NCT01391130|560521832|FG000|Overall Study|Withdrawal by Subject|3|||
155298301|NCT01391130|560521833|FG001|Overall Study|Withdrawal by Subject|2|||
155298302|NCT01391130|560521832|FG000|Overall Study|Physician Decision|2|||
155298303|NCT01391130|560521833|FG001|Overall Study|Physician Decision|3|||
155298304|NCT01391130|560521832|FG000|Overall Study|Did not Receive Drug|1|||
155298305|NCT01391130|560521833|FG001|Overall Study|Did not Receive Drug|1|||
155298306|NCT03520413|560521840|FG000|Overall Study|Lost to Follow-up|1|||
155298307|NCT03520413|560521841|FG001|Overall Study|Lost to Follow-up|1|||
155298308|NCT03520413|560521840|FG000|Overall Study|Withdrawal by Subject|1|||
155298309|NCT03520413|560521841|FG001|Overall Study|Withdrawal by Subject|2|||
155298310|NCT03520413|560521840|FG000|Overall Study|Death|0|||
155298311|NCT03520413|560521841|FG001|Overall Study|Death|1|||
155298312|NCT03520413|560521840|FG000|Overall Study|Physician Decision|3|||
155298313|NCT03520413|560521841|FG001|Overall Study|Physician Decision|3|||
155298314|NCT03520413|560521840|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
155298315|NCT03520413|560521841|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
155298316|NCT00638963|560521842|FG000|Overall Study|Withdrawal by Subject|1|||
155298317|NCT00638963|560521843|FG001|Overall Study|Withdrawal by Subject|0|||
155298318|NCT00463788|560521845|FG000|Overall Study|Progressive Disease|86|||
155298319|NCT00463788|560521846|FG001|Overall Study|Progressive Disease|42|||
155298320|NCT00463788|560521845|FG000|Overall Study|Adverse Event|6|||
155298321|NCT00463788|560521846|FG001|Overall Study|Adverse Event|2|||
155298322|NCT00463788|560521845|FG000|Overall Study|Withdrawal by Subject|6|||
155298323|NCT00463788|560521846|FG001|Overall Study|Withdrawal by Subject|2|||
155298324|NCT00463788|560521845|FG000|Overall Study|Death|4|||
155298325|NCT00463788|560521846|FG001|Overall Study|Death|3|||
155298326|NCT00463788|560521845|FG000|Overall Study|Symptomatic Deterioration|2|||
155298327|NCT00463788|560521846|FG001|Overall Study|Symptomatic Deterioration|3|||
155298328|NCT00463788|560521845|FG000|Overall Study|Lost to Follow-up|1|||
155298329|NCT00463788|560521846|FG001|Overall Study|Lost to Follow-up|0|||
155298330|NCT00463788|560521845|FG000|Overall Study|Protocol Violation|0|||
155298331|NCT00463788|560521846|FG001|Overall Study|Protocol Violation|1|||
155298332|NCT00463788|560521845|FG000|Overall Study|Other|3|||
155298333|NCT00463788|560521846|FG001|Overall Study|Other|0|||
155298334|NCT00463788|560521845|FG000|Overall Study|Randomized but not treated|1|||
155298335|NCT00463788|560521846|FG001|Overall Study|Randomized but not treated|1|||
155298336|NCT02755116|560521848|FG000|Overall Study|surgery converted to open, pt admitted|3|||
155298337|NCT02755116|560521849|FG001|Overall Study|surgery converted to open, pt admitted|1|||
155298338|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
155298339|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
155298340|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
155298341|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
155298342|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
155298343|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
155298344|NCT02200770|560521850|FG000|Randomized-controlled Period (RCP)|Other|1|||
155298345|NCT02200770|560521851|FG001|Randomized-controlled Period (RCP)|Other|2|||
155298346|NCT02200770|560521850|FG000|Open-label Period (OLP)|Adverse Event|1|||
155298347|NCT02200770|560521851|FG001|Open-label Period (OLP)|Adverse Event|2|||
155298348|NCT02200770|560521850|FG000|Open-label Period (OLP)|Death|1|||
155298349|NCT02200770|560521851|FG001|Open-label Period (OLP)|Death|2|||
155298350|NCT02200770|560521850|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
155298351|NCT02200770|560521851|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
155298352|NCT02200770|560521850|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
155298353|NCT02200770|560521851|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
155298354|NCT02200770|560521850|FG000|Open-label Period (OLP)|Other|6|||
155298355|NCT02200770|560521851|FG001|Open-label Period (OLP)|Other|15|||
155298356|NCT05283395|560521856|FG000|Overall Study|Adverse Event|4|||
155298357|NCT05283395|560521857|FG001|Overall Study|Adverse Event|4|||
155298358|NCT05283395|560521858|FG002|Overall Study|Adverse Event|0|||
155298359|NCT05283395|560521856|FG000|Overall Study|Patient Lost to Follow-Up|0|||
155298360|NCT05283395|560521857|FG001|Overall Study|Patient Lost to Follow-Up|0|||
155298361|NCT05283395|560521858|FG002|Overall Study|Patient Lost to Follow-Up|1|||
155298362|NCT05283395|560521856|FG000|Overall Study|Patient Withdrawal|2|||
155298363|NCT05283395|560521857|FG001|Overall Study|Patient Withdrawal|4|||
155298364|NCT05283395|560521858|FG002|Overall Study|Patient Withdrawal|2|||
155298365|NCT05283395|560521856|FG000|Overall Study|Investigator Decision|1|||
155298366|NCT05283395|560521857|FG001|Overall Study|Investigator Decision|0|||
155298367|NCT05283395|560521858|FG002|Overall Study|Investigator Decision|1|||
155298368|NCT05283395|560521856|FG000|Overall Study|Enrolled in error|0|||
155298369|NCT05283395|560521857|FG001|Overall Study|Enrolled in error|0|||
155298370|NCT05283395|560521858|FG002|Overall Study|Enrolled in error|1|||
155298371|NCT00712335|560521860|FG000|Overall Study|Withdrawal by Subject|0|||
155298372|NCT00712335|560521861|FG001|Overall Study|Withdrawal by Subject|7|||
155298373|NCT00712335|560521862|FG002|Overall Study|Withdrawal by Subject|2|||
155298374|NCT00712335|560521863|FG003|Overall Study|Withdrawal by Subject|3|||
155298375|NCT00712335|560521864|FG004|Overall Study|Withdrawal by Subject|0|||
155298376|NCT00712335|560521860|FG000|Overall Study|Lost to Follow-up|2|||
155298377|NCT00712335|560521861|FG001|Overall Study|Lost to Follow-up|5|||
155298378|NCT00712335|560521862|FG002|Overall Study|Lost to Follow-up|0|||
155298379|NCT00712335|560521863|FG003|Overall Study|Lost to Follow-up|1|||
155298380|NCT00712335|560521864|FG004|Overall Study|Lost to Follow-up|0|||
155298381|NCT00712335|560521860|FG000|Overall Study|Protocol Violation|1|||
155298382|NCT00712335|560521861|FG001|Overall Study|Protocol Violation|2|||
155298383|NCT00712335|560521862|FG002|Overall Study|Protocol Violation|1|||
155298384|NCT00712335|560521863|FG003|Overall Study|Protocol Violation|0|||
155298385|NCT00712335|560521864|FG004|Overall Study|Protocol Violation|0|||
155298386|NCT00712335|560521860|FG000|Overall Study|Lack of Efficacy|0|||
155298387|NCT00712335|560521861|FG001|Overall Study|Lack of Efficacy|0|||
155298388|NCT00712335|560521862|FG002|Overall Study|Lack of Efficacy|1|||
155298389|NCT00712335|560521863|FG003|Overall Study|Lack of Efficacy|1|||
155298390|NCT00712335|560521864|FG004|Overall Study|Lack of Efficacy|0|||
155298391|NCT00712335|560521860|FG000|Overall Study|Other Reason|0|||
155298392|NCT00712335|560521861|FG001|Overall Study|Other Reason|3|||
155298393|NCT00712335|560521862|FG002|Overall Study|Other Reason|1|||
155298394|NCT00712335|560521863|FG003|Overall Study|Other Reason|0|||
155298395|NCT00712335|560521864|FG004|Overall Study|Other Reason|0|||
155298396|NCT00356265|560521866|FG000|Overall Study|Withdrawal by Subject|0|||
155298397|NCT00356265|560521867|FG001|Overall Study|Withdrawal by Subject|0|||
155298398|NCT00356265|560521868|FG002|Overall Study|Withdrawal by Subject|1|||
155298399|NCT02115139|560521872|FG000|Overall Study|Protocol Violation|1|||
155298400|NCT02115139|560521872|FG000|Overall Study|treatment discontinuation|6|||
155298401|NCT00258895|560521873|FG000|Overall Study|Lost to Follow-up|3|||
155298402|NCT00258895|560521874|FG001|Overall Study|Lost to Follow-up|1|||
155298403|NCT00258895|560521873|FG000|Overall Study|Protocol Violation|6|||
155298404|NCT00258895|560521874|FG001|Overall Study|Protocol Violation|2|||
155298405|NCT00258895|560521873|FG000|Overall Study|Withdrawal by Subject|1|||
155298406|NCT00258895|560521874|FG001|Overall Study|Withdrawal by Subject|0|||
155298407|NCT00547118|560521875|FG000|Overall Study|Did not qualify prior to starting drug|1|||
155298408|NCT00547118|560521876|FG001|Overall Study|Did not qualify prior to starting drug|1|||
155298409|NCT00547118|560521875|FG000|Overall Study|Study suspended|7|||
155298410|NCT00547118|560521876|FG001|Overall Study|Study suspended|8|||
155298411|NCT00433199|560521877|FG000|Double-Blind Period|Adverse Event|0|||
155298412|NCT00433199|560521878|FG001|Double-Blind Period|Adverse Event|25|||
155298413|NCT00433199|560521877|FG000|Double-Blind Period|Lack of Efficacy|0|||
155298414|NCT00433199|560521878|FG001|Double-Blind Period|Lack of Efficacy|2|||
155298415|NCT00433199|560521877|FG000|Double-Blind Period|Lost to Follow-up|2|||
155298416|NCT00433199|560521878|FG001|Double-Blind Period|Lost to Follow-up|5|||
155298417|NCT00433199|560521877|FG000|Double-Blind Period|Withdrawal by Subject|8|||
155298418|NCT00433199|560521878|FG001|Double-Blind Period|Withdrawal by Subject|19|||
155298419|NCT00433199|560521877|FG000|Double-Blind Period|Protocol Violation|1|||
155298420|NCT00433199|560521878|FG001|Double-Blind Period|Protocol Violation|10|||
155298421|NCT00433199|560521877|FG000|Double-Blind Period|Administrative|1|||
155298422|NCT00433199|560521878|FG001|Double-Blind Period|Administrative|5|||
155298423|NCT00433199|560521877|FG000|Open-Label Period|Adverse Event|0|||
155298424|NCT00433199|560521878|FG001|Open-Label Period|Adverse Event|19|||
155298425|NCT00433199|560521877|FG000|Open-Label Period|Lack of Efficacy|0|||
155298426|NCT00433199|560521878|FG001|Open-Label Period|Lack of Efficacy|2|||
155298427|NCT00433199|560521877|FG000|Open-Label Period|Lost to Follow-up|0|||
155298428|NCT00433199|560521878|FG001|Open-Label Period|Lost to Follow-up|3|||
155298429|NCT00433199|560521877|FG000|Open-Label Period|Withdrawal by Subject|0|||
155298430|NCT00433199|560521878|FG001|Open-Label Period|Withdrawal by Subject|7|||
155298431|NCT00433199|560521877|FG000|Open-Label Period|Protocol Violation|0|||
155298432|NCT00433199|560521878|FG001|Open-Label Period|Protocol Violation|2|||
155298433|NCT00433199|560521877|FG000|Open-Label Period|Administrative|0|||
155298434|NCT00433199|560521878|FG001|Open-Label Period|Administrative|1|||
155298435|NCT03603717|560521881|FG000|Overall Study|Lost to Follow-up|20|||
155298436|NCT03603717|560521882|FG001|Overall Study|Lost to Follow-up|20|||
155298437|NCT03603717|560521881|FG000|Overall Study|Withdrawal by Subject|16|||
155298438|NCT03603717|560521882|FG001|Overall Study|Withdrawal by Subject|10|||
155298439|NCT00732381|560521883|FG000|Overall Study|Adverse Event|1|||
155298440|NCT00732381|560521884|FG001|Overall Study|Adverse Event|0|||
155298441|NCT00732381|560521883|FG000|Overall Study|Treatment Failure|1|||
155298442|NCT00732381|560521884|FG001|Overall Study|Treatment Failure|1|||
155298443|NCT01170026|560523118|FG000|Overall Study|Lost to Follow-up|4|||
155298444|NCT01170026|560523119|FG001|Overall Study|Lost to Follow-up|2|||
155298445|NCT04817670|560523120|FG000|Overall Study|Withdrawal by Subject|1|||
155298446|NCT04817670|560523121|FG001|Overall Study|Withdrawal by Subject|0|||
155298447|NCT04817670|560523122|FG002|Overall Study|Withdrawal by Subject|0|||
155298448|NCT04817670|560523123|FG003|Overall Study|Withdrawal by Subject|0|||
155298449|NCT04817670|560523124|FG004|Overall Study|Withdrawal by Subject|0|||
155298450|NCT04817670|560523120|FG000|Overall Study|Lost to Follow-up|0|||
155298451|NCT04817670|560523121|FG001|Overall Study|Lost to Follow-up|0|||
155298452|NCT04817670|560523122|FG002|Overall Study|Lost to Follow-up|1|||
155298453|NCT04817670|560523123|FG003|Overall Study|Lost to Follow-up|0|||
155298454|NCT04817670|560523124|FG004|Overall Study|Lost to Follow-up|0|||
155298455|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
155298456|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
155298457|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
155298458|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
155298459|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
155298460|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
155298461|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
155298462|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
155298463|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
155298464|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
155298465|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
155298466|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
155298467|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
155298468|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
155298469|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
155298470|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
155298471|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
155298472|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
155298473|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
155298474|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
155298475|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
155298476|NCT00304031|560523125|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
155298477|NCT00304031|560523126|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
155298478|NCT00304031|560523127|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
155298479|NCT00304031|560523125|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
155298480|NCT00304031|560523126|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
155298481|NCT00304031|560523127|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
155298482|NCT01188655|560523128|FG000|Overall Study|Lack of Efficacy|1|||
155298483|NCT01188655|560523128|FG000|Overall Study|Lost to Follow-up|1|||
155298484|NCT01188655|560523128|FG000|Overall Study|Other|11|||
155298485|NCT00683696|560523129|FG000|Overall Study|Withdrawn due to study closure|337|||
155298486|NCT00683696|560523130|FG001|Overall Study|Withdrawn due to study closure|338|||
155158578|NCT01550003|560018824|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
155158579|NCT01550003|560018822|FG000|Overall Study|Per Sponsor request|1|||
155158580|NCT01550003|560018823|FG001|Overall Study|Per Sponsor request|0|||
155158581|NCT01550003|560018824|FG002|Overall Study|Per Sponsor request|1|||
155158582|NCT01550003|560018822|FG000|Overall Study|Patient not compliance|0|||
155158583|NCT01550003|560018823|FG001|Overall Study|Patient not compliance|0|||
155158584|NCT01550003|560018824|FG002|Overall Study|Patient not compliance|1|||
155158585|NCT01550003|560018822|FG000|Overall Study|Non-compliance|0|||
155158586|NCT01550003|560018823|FG001|Overall Study|Non-compliance|0|||
155158587|NCT01550003|560018824|FG002|Overall Study|Non-compliance|1|||
155158588|NCT01550003|560018822|FG000|Overall Study|Study closed|0|||
155158589|NCT01550003|560018823|FG001|Overall Study|Study closed|1|||
155298487|NCT00683696|560523129|FG000|Overall Study|Withdrawn prior to study closure|13|||
155298488|NCT00683696|560523130|FG001|Overall Study|Withdrawn prior to study closure|28|||
155298489|NCT00683696|560523129|FG000|Overall Study|Lost to Follow-up|5|||
155298490|NCT00683696|560523130|FG001|Overall Study|Lost to Follow-up|6|||
155298491|NCT00683696|560523129|FG000|Overall Study|Vital status follow-up only|3|||
155158590|NCT01550003|560018824|FG002|Overall Study|Study closed|0|||
155298492|NCT00683696|560523130|FG001|Overall Study|Vital status follow-up only|3|||
155298493|NCT00683696|560523129|FG000|Overall Study|Death|46|||
155298494|NCT00683696|560523130|FG001|Overall Study|Death|30|||
155298495|NCT00089544|560523131|FG000|Overall Study|Ineligible|1|||
155298496|NCT00089544|560523132|FG001|Overall Study|Ineligible|0|||
155298497|NCT02396316|560523133|FG000|Overall Study|Physician Decision|1|||
155298498|NCT02396316|560523134|FG001|Overall Study|Physician Decision|0|||
155298499|NCT02396316|560523133|FG000|Overall Study|Progressive disease|6|||
155298500|NCT02396316|560523134|FG001|Overall Study|Progressive disease|3|||
155298501|NCT02396316|560523133|FG000|Overall Study|Protocol Violation|0|||
155298502|NCT02396316|560523134|FG001|Overall Study|Protocol Violation|1|||
155298503|NCT02396316|560523133|FG000|Overall Study|Treatment unblinded|0|||
155298504|NCT02396316|560523134|FG001|Overall Study|Treatment unblinded|1|||
155298505|NCT01662336|560523140|FG000|Overall Study|Adverse Event|1|||
155298506|NCT01662336|560523140|FG000|Overall Study|No longer on LPV/r|30|||
155298507|NCT01662336|560523140|FG000|Overall Study|Other|29|||
155298508|NCT01662336|560523140|FG000|Overall Study|Withdrawal by Subject|6|||
155298509|NCT02189252|560523141|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
155298510|NCT02189252|560523142|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
155298511|NCT02189252|560523143|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
155298512|NCT02189252|560523144|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
155298513|NCT02189252|560523141|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
155298514|NCT02189252|560523142|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
155298515|NCT02189252|560523143|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
155298516|NCT02189252|560523144|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
155298517|NCT00566735|560523145|FG000|Overall Study|Withdrawal by Subject|0|||
155298518|NCT00566735|560523146|FG001|Overall Study|Withdrawal by Subject|1|||
155298519|NCT00566735|560523145|FG000|Overall Study|Refused neuropsychological testing|2|||
155298520|NCT00566735|560523146|FG001|Overall Study|Refused neuropsychological testing|5|||
155298521|NCT00566735|560523145|FG000|Overall Study|Switched into a manic episode|0|||
155298522|NCT00566735|560523146|FG001|Overall Study|Switched into a manic episode|1|||
155298523|NCT05876949|560523147|FG000|Overall Study|Withdrawal by Subject|1|||
155298524|NCT05876949|560523148|FG001|Overall Study|Withdrawal by Subject|3|||
155298525|NCT05876949|560523147|FG000|Overall Study|Physician Decision|0|||
155298526|NCT05876949|560523148|FG001|Overall Study|Physician Decision|2|||
155298527|NCT05876949|560523147|FG000|Overall Study|Death|0|||
155298528|NCT05876949|560523148|FG001|Overall Study|Death|1|||
155298529|NCT00508924|560523149|FG000|Overall Study|Protocol Violation|0|||
155298530|NCT00508924|560523150|FG001|Overall Study|Protocol Violation|0|||
155298531|NCT00508924|560523151|FG002|Overall Study|Protocol Violation|1|||
155298532|NCT00508924|560523152|FG003|Overall Study|Protocol Violation|1|||
155298533|NCT02755805|560523153|FG000|Overall Study|Lost to Follow-up|1|||
155298534|NCT02755805|560523154|FG001|Overall Study|Lost to Follow-up|2|||
155298535|NCT02755805|560523153|FG000|Overall Study|Refused assessments|1|||
155298536|NCT02755805|560523154|FG001|Overall Study|Refused assessments|0|||
155298537|NCT02755805|560523153|FG000|Overall Study|Withdrawal by Subject|0|||
155298538|NCT02755805|560523154|FG001|Overall Study|Withdrawal by Subject|2|||
155298539|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
155298540|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
155298541|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
155298542|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
155298543|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
155298544|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
155298545|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
155298546|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
155298547|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
155298548|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
155298549|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
155298550|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
155298551|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
155298552|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
155298553|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
155298554|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
155298555|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
155298556|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
155298557|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
155298558|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
155298559|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
155298560|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
155298561|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
155298562|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
155298563|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
155298564|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
155298565|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
155298566|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
155298567|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
155298568|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
155298569|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
155298570|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
155298571|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
155298572|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
155298573|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
155298574|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
155298575|NCT03593213|560523158|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
155298576|NCT03593213|560523159|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
155298577|NCT03593213|560523160|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
155298578|NCT03593213|560523161|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
155298579|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
155298580|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
155298581|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
155298582|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
155298583|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
155298584|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
155298585|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
155298586|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
155298587|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
155298588|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
155298589|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
155298590|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
155298591|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
155298592|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
155298593|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
155298594|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
155298595|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
155298596|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
155298597|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
155298598|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
155298599|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
155298600|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
155298601|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
155298602|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
155298603|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
155298604|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
155298605|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
155298606|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
155298607|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
155298608|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
155298609|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
155298610|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
155298611|NCT03593213|560523158|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
155298612|NCT03593213|560523159|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
155298613|NCT03593213|560523160|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
155298614|NCT03593213|560523161|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
155298615|NCT01831791|560523164|FG000|Overall Study|Withdrawal by Subject|10|||
155298616|NCT00494780|560523165|FG000|Overall Study|Adverse Event|1|||
155298617|NCT00494780|560523166|FG001|Overall Study|Adverse Event|0|||
155298618|NCT00494780|560523165|FG000|Overall Study|Withdrew before Dosed|0|||
155298619|NCT00494780|560523166|FG001|Overall Study|Withdrew before Dosed|1|||
155298620|NCT00494780|560523165|FG000|Overall Study|Progression of Study Disease|7|||
155298621|NCT00494780|560523166|FG001|Overall Study|Progression of Study Disease|8|||
155298622|NCT00494780|560523165|FG000|Overall Study|New Treatment|2|||
155298623|NCT00494780|560523166|FG001|Overall Study|New Treatment|2|||
155298624|NCT00494780|560523165|FG000|Overall Study|Non-compliance|1|||
155298625|NCT00494780|560523166|FG001|Overall Study|Non-compliance|0|||
155298626|NCT00494780|560523165|FG000|Overall Study|Residual Tumour Mass|0|||
155298627|NCT00494780|560523166|FG001|Overall Study|Residual Tumour Mass|1|||
155298628|NCT00494780|560523165|FG000|Overall Study|Insurance Issues|0|||
155298629|NCT00494780|560523166|FG001|Overall Study|Insurance Issues|1|||
155298630|NCT00845832|560523167|FG000|Treatment Period|Adverse Event|0|||
155298631|NCT00845832|560523168|FG001|Treatment Period|Adverse Event|2|||
155298632|NCT00845832|560523169|FG002|Treatment Period|Adverse Event|0|||
155298633|NCT00845832|560523167|FG000|Treatment Period|Protocol Violation|1|||
155298634|NCT00845832|560523168|FG001|Treatment Period|Protocol Violation|1|||
155298635|NCT00845832|560523169|FG002|Treatment Period|Protocol Violation|0|||
155298636|NCT00845832|560523167|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
155298637|NCT00845832|560523168|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
155298638|NCT00845832|560523169|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
155298639|NCT00845832|560523167|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
155298640|NCT00845832|560523168|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
155298641|NCT00845832|560523169|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
155298642|NCT00869323|560523172|FG000|Maintenance Therapy|concurrent illness|1|||
155298643|NCT02880241|560523175|FG000|Overall Study|Lack of Efficacy|1|||
155298644|NCT02880241|560523176|FG001|Overall Study|Lack of Efficacy|0|||
155298645|NCT02880241|560523177|FG002|Overall Study|Lack of Efficacy|0|||
155298646|NCT02880241|560523178|FG003|Overall Study|Lack of Efficacy|0|||
155298647|NCT02880241|560523179|FG004|Overall Study|Lack of Efficacy|0|||
155298648|NCT02880241|560523180|FG005|Overall Study|Lack of Efficacy|0|||
155298649|NCT02570711|560523186|FG000|Overall Study|Death|1|||
155298650|NCT02570711|560523187|FG001|Overall Study|Death|0|||
155298651|NCT02570711|560523186|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
155298652|NCT02570711|560523187|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
155298653|NCT01254188|560523188|FG000|Overall Study|Disease Progression|6|||
155298654|NCT01254188|560523188|FG000|Overall Study|Protocol Violation|6|||
155298655|NCT01254188|560523188|FG000|Overall Study|Pregnancy|2|||
155298656|NCT01254188|560523188|FG000|Overall Study|Death|4|||
155298657|NCT01254188|560523188|FG000|Overall Study|Lost to Follow-up|5|||
155298658|NCT01254188|560523188|FG000|Overall Study|Withdrawal by Subject|7|||
155298659|NCT01254188|560523188|FG000|Overall Study|Adverse Event|43|||
155298660|NCT01254188|560523188|FG000|Overall Study|per investigator discretion|20|||
155298661|NCT00545077|560523190|FG000|Overall Study|Treatment not received|5|||
155298662|NCT00545077|560523191|FG001|Overall Study|Treatment not received|1|||
155298663|NCT00545077|560523190|FG000|Overall Study|Disease Progression|131|||
155298664|NCT00545077|560523191|FG001|Overall Study|Disease Progression|98|||
155298665|NCT00545077|560523190|FG000|Overall Study|Withdrawal by Subject|3|||
155298666|NCT00545077|560523191|FG001|Overall Study|Withdrawal by Subject|14|||
155298667|NCT00545077|560523190|FG000|Overall Study|Physician Decision|6|||
155298668|NCT00545077|560523191|FG001|Overall Study|Physician Decision|3|||
155298669|NCT00545077|560523190|FG000|Overall Study|Lost to Follow-up|2|||
155298670|NCT00545077|560523191|FG001|Overall Study|Lost to Follow-up|0|||
155298671|NCT00545077|560523190|FG000|Overall Study|Protocol Violation|1|||
155298672|NCT00545077|560523191|FG001|Overall Study|Protocol Violation|0|||
155298673|NCT00545077|560523190|FG000|Overall Study|Adverse Event|0|||
155298674|NCT00545077|560523191|FG001|Overall Study|Adverse Event|31|||
155298675|NCT00545077|560523190|FG000|Overall Study|Death|0|||
155298676|NCT00545077|560523191|FG001|Overall Study|Death|8|||
155298677|NCT03260140|560523192|FG000|Overall Study|Death|4|||
155298678|NCT03260140|560523193|FG001|Overall Study|Death|1|||
155298679|NCT03260140|560523192|FG000|Overall Study|Withdrawal by Subject|1|||
155298680|NCT03260140|560523193|FG001|Overall Study|Withdrawal by Subject|4|||
155298681|NCT01692938|560523196|FG000|Overall Study|Protocol Deviation|1|||
155298682|NCT01692938|560523197|FG001|Overall Study|Protocol Deviation|1|||
154957379|NCT02269657|559272416|FG000|Overall Study|Protocol Violation|3|||
154957380|NCT02956460|559272417|FG000|Lens 1|Lost to Follow-up|1|||
154957381|NCT02956460|559272418|FG001|Lens 1|Lost to Follow-up|0|||
154957382|NCT00829673|559272421|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155298683|NCT01692938|560523196|FG000|Overall Study|Study completed prior to site completion|3|||
155298684|NCT01692938|560523197|FG001|Overall Study|Study completed prior to site completion|3|||
154957383|NCT00829673|559272422|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
154957384|NCT00272779|559272423|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
155298685|NCT02423291|560523201|FG000|Overall Study|Lack of Efficacy|14|||
155061559|NCT02867592|559659320|FG001|Overall Study|Adverse Event|0|||
155298686|NCT02423291|560523201|FG000|Overall Study|Adverse Event|1|||
155298687|NCT01063972|560523202|FG000|Overall Study|Death|12|||
155298688|NCT01063972|560523203|FG001|Overall Study|Death|11|||
155298689|NCT01063972|560523202|FG000|Overall Study|Incarcerated|2|||
155298690|NCT01063972|560523203|FG001|Overall Study|Incarcerated|1|||
155298691|NCT00959946|560523204|FG000|Overall Study|Adverse Event|0|||
155298692|NCT00959946|560523205|FG001|Overall Study|Adverse Event|0|||
155298693|NCT00959946|560523206|FG002|Overall Study|Adverse Event|2|||
155298694|NCT00959946|560523207|FG003|Overall Study|Adverse Event|1|||
155298695|NCT00959946|560523208|FG004|Overall Study|Adverse Event|0|||
155298696|NCT00959946|560523209|FG005|Overall Study|Adverse Event|1|||
155298697|NCT00959946|560523210|FG006|Overall Study|Adverse Event|0|||
155298698|NCT00959946|560523211|FG007|Overall Study|Adverse Event|0|||
155298699|NCT00959946|560523204|FG000|Overall Study|Death|0|||
155298700|NCT00959946|560523205|FG001|Overall Study|Death|0|||
155298701|NCT00959946|560523206|FG002|Overall Study|Death|0|||
155298702|NCT00959946|560523207|FG003|Overall Study|Death|0|||
155298703|NCT00959946|560523208|FG004|Overall Study|Death|0|||
155298704|NCT00959946|560523209|FG005|Overall Study|Death|1|||
155298705|NCT00959946|560523210|FG006|Overall Study|Death|0|||
155298706|NCT00959946|560523211|FG007|Overall Study|Death|0|||
155298707|NCT00959946|560523204|FG000|Overall Study|Disease Progression|2|||
155298708|NCT00959946|560523205|FG001|Overall Study|Disease Progression|4|||
155298709|NCT00959946|560523206|FG002|Overall Study|Disease Progression|2|||
155298710|NCT00959946|560523207|FG003|Overall Study|Disease Progression|4|||
155298711|NCT00959946|560523208|FG004|Overall Study|Disease Progression|4|||
155298712|NCT00959946|560523209|FG005|Overall Study|Disease Progression|6|||
155298713|NCT00959946|560523210|FG006|Overall Study|Disease Progression|2|||
155298714|NCT00959946|560523211|FG007|Overall Study|Disease Progression|2|||
155298715|NCT00959946|560523204|FG000|Overall Study|Withdrawal by Subject|0|||
155298716|NCT00959946|560523205|FG001|Overall Study|Withdrawal by Subject|0|||
155298717|NCT00959946|560523206|FG002|Overall Study|Withdrawal by Subject|0|||
155298718|NCT00959946|560523207|FG003|Overall Study|Withdrawal by Subject|0|||
155298719|NCT00959946|560523208|FG004|Overall Study|Withdrawal by Subject|0|||
155298720|NCT00959946|560523209|FG005|Overall Study|Withdrawal by Subject|1|||
155298721|NCT00959946|560523210|FG006|Overall Study|Withdrawal by Subject|0|||
155298722|NCT00959946|560523211|FG007|Overall Study|Withdrawal by Subject|0|||
155298723|NCT00566527|560523212|FG000|Overall Study|Reason not provided|3|||
155298724|NCT00566527|560523213|FG001|Overall Study|Reason not provided|11|||
155298725|NCT00566527|560523214|FG002|Overall Study|Reason not provided|10|||
155298726|NCT00566527|560523212|FG000|Overall Study|Adverse Event|2|||
155298727|NCT00566527|560523213|FG001|Overall Study|Adverse Event|0|||
155298728|NCT00566527|560523214|FG002|Overall Study|Adverse Event|1|||
155298729|NCT00566527|560523212|FG000|Overall Study|Physician Decision|3|||
155298730|NCT00566527|560523213|FG001|Overall Study|Physician Decision|8|||
155298731|NCT00566527|560523214|FG002|Overall Study|Physician Decision|20|||
155298732|NCT00566527|560523212|FG000|Overall Study|Lost to Follow-up|3|||
155298733|NCT00566527|560523213|FG001|Overall Study|Lost to Follow-up|4|||
155298734|NCT00566527|560523214|FG002|Overall Study|Lost to Follow-up|4|||
155298735|NCT00566527|560523212|FG000|Overall Study|Withdrawal by Subject|6|||
155298736|NCT00566527|560523213|FG001|Overall Study|Withdrawal by Subject|43|||
155298737|NCT00566527|560523214|FG002|Overall Study|Withdrawal by Subject|43|||
155298738|NCT01837966|560523215|FG000|Overall Study|Withdrawal by Subject|2|||
155298739|NCT01837966|560523216|FG001|Overall Study|Withdrawal by Subject|1|||
155298740|NCT04975308|560523220|FG000|Overall Study|Withdrawal by Subject|6|||
155298741|NCT04975308|560523221|FG001|Overall Study|Withdrawal by Subject|16|||
155298742|NCT04975308|560523222|FG002|Overall Study|Withdrawal by Subject|6|||
155298743|NCT04975308|560523220|FG000|Overall Study|Physician Decision|0|||
155298744|NCT04975308|560523221|FG001|Overall Study|Physician Decision|3|||
155298745|NCT04975308|560523222|FG002|Overall Study|Physician Decision|1|||
155298746|NCT04975308|560523220|FG000|Overall Study|Adverse Event|10|||
155298747|NCT04975308|560523221|FG001|Overall Study|Adverse Event|1|||
155298748|NCT04975308|560523222|FG002|Overall Study|Adverse Event|12|||
155298749|NCT04975308|560523220|FG000|Overall Study|On study treatment (Ongoing)|65|||
155298750|NCT04975308|560523221|FG001|Overall Study|On study treatment (Ongoing)|43|||
155298751|NCT04975308|560523222|FG002|Overall Study|On study treatment (Ongoing)|75|||
155298752|NCT04975308|560523220|FG000|Overall Study|Protocol Deviation|4|||
155298753|NCT04975308|560523221|FG001|Overall Study|Protocol Deviation|3|||
155158591|NCT01550003|560018822|FG000|Overall Study|Transitioned to adult rheumatology|0|||
155158592|NCT01550003|560018823|FG001|Overall Study|Transitioned to adult rheumatology|0|||
155158593|NCT01550003|560018824|FG002|Overall Study|Transitioned to adult rheumatology|1|||
155158594|NCT05567783|560018825|FG000|Overall Study|Death|2|||
155158595|NCT05567783|560018826|FG001|Overall Study|Death|3|||
155158596|NCT05567783|560018827|FG002|Overall Study|Death|0|||
155298754|NCT04975308|560523222|FG002|Overall Study|Protocol Deviation|2|||
155298755|NCT00841035|560523228|FG000|Phase 1 Overall Study|Physician Decision|13|||
155298756|NCT00357097|560523233|FG000|Overall Study|Did not meet inclusion criteria|5|||
155298757|NCT00357097|560523234|FG001|Overall Study|Did not meet inclusion criteria|3|||
155158597|NCT05567783|560018825|FG000|Overall Study|Lost to Follow-up|25|||
155158598|NCT05567783|560018826|FG001|Overall Study|Lost to Follow-up|19|||
155298758|NCT00357097|560523233|FG000|Overall Study|Adverse Event|34|||
155298759|NCT00357097|560523234|FG001|Overall Study|Adverse Event|6|||
155298760|NCT00357097|560523233|FG000|Overall Study|Withdrawal by Subject|8|||
155298761|NCT00357097|560523234|FG001|Overall Study|Withdrawal by Subject|7|||
155298762|NCT00357097|560523233|FG000|Overall Study|Non-compliance|1|||
155298763|NCT00357097|560523234|FG001|Overall Study|Non-compliance|2|||
155298764|NCT00357097|560523233|FG000|Overall Study|Lack of Efficacy|2|||
155298765|NCT00357097|560523234|FG001|Overall Study|Lack of Efficacy|8|||
155298766|NCT00357097|560523233|FG000|Overall Study|Met Exclusion Criteria|3|||
155298767|NCT00357097|560523234|FG001|Overall Study|Met Exclusion Criteria|1|||
155298768|NCT00357097|560523233|FG000|Overall Study|Other|1|||
155298769|NCT00357097|560523234|FG001|Overall Study|Other|1|||
155298770|NCT00357097|560523233|FG000|Overall Study|Increase of RLS Symptoms|0|||
155298771|NCT00357097|560523234|FG001|Overall Study|Increase of RLS Symptoms|1|||
155298772|NCT00658996|560523235|FG000|First Intervention|Positive slit lamp finding|1|||
155298773|NCT00658996|560523236|FG001|First Intervention|Positive slit lamp finding|0|||
155298774|NCT00658996|560523235|FG000|First Intervention|Lack of lenses|0|||
155298775|NCT00658996|560523236|FG001|First Intervention|Lack of lenses|1|||
155298776|NCT00658996|560523235|FG000|Crossover Period|Physician Decision|1|||
155298777|NCT00658996|560523236|FG001|Crossover Period|Physician Decision|0|||
155298778|NCT00658996|560523235|FG000|Crossover Period|Ineligible|1|||
155298779|NCT00658996|560523236|FG001|Crossover Period|Ineligible|1|||
155298780|NCT00658996|560523235|FG000|Second Intervention|Developed a stye on upper lid|1|||
155298781|NCT00658996|560523236|FG001|Second Intervention|Developed a stye on upper lid|0|||
155298782|NCT00658996|560523235|FG000|Second Intervention|Positive slit lamp finding|0|||
155298783|NCT00658996|560523236|FG001|Second Intervention|Positive slit lamp finding|1|||
155298784|NCT02994654|560523238|FG000|Overall Study|Lost to Follow-up|1|||
155298785|NCT01121549|560523247|FG000|Overall Study|Adverse Event|10|||
155298786|NCT01121549|560523247|FG000|Overall Study|Lack of Efficacy|11|||
155298787|NCT01121549|560523247|FG000|Overall Study|Lost to Follow-up|12|||
155298788|NCT01121549|560523247|FG000|Overall Study|Did not meet entrance criteria|9|||
155298789|NCT01121549|560523247|FG000|Overall Study|Study terminated by sponsor|197|||
155298790|NCT01121549|560523247|FG000|Overall Study|Pregnancy|1|||
155298791|NCT01121549|560523247|FG000|Overall Study|Protocol Violation|33|||
155298792|NCT01121549|560523247|FG000|Overall Study|Withdrawal by Subject|16|||
155298793|NCT01121549|560523247|FG000|Overall Study|Other|58|||
155298794|NCT04250883|560524470|FG000|Overall Study|Lost to Follow-up|1|||
155298795|NCT04250883|560524471|FG001|Overall Study|Lost to Follow-up|0|||
155298796|NCT02763319|560524475|FG000|Overall Study|Adverse Event|12|||
155298797|NCT02763319|560524476|FG001|Overall Study|Adverse Event|3|||
155298798|NCT02763319|560524475|FG000|Overall Study|Death|123|||
155298799|NCT02763319|560524476|FG001|Overall Study|Death|123|||
155298800|NCT02763319|560524475|FG000|Overall Study|Lost to Follow-up|6|||
155298801|NCT02763319|560524476|FG001|Overall Study|Lost to Follow-up|7|||
155298802|NCT02763319|560524475|FG000|Overall Study|Noncompliance with Study Drug|2|||
155298803|NCT02763319|560524476|FG001|Overall Study|Noncompliance with Study Drug|0|||
155298804|NCT02763319|560524475|FG000|Overall Study|"Captured as Other in Database"|29|||
155298805|NCT02763319|560524476|FG001|Overall Study|"Captured as Other in Database"|34|||
155298806|NCT02763319|560524475|FG000|Overall Study|Physician Decision|1|||
155298807|NCT02763319|560524476|FG001|Overall Study|Physician Decision|7|||
155298808|NCT02763319|560524475|FG000|Overall Study|Progressive Disease|24|||
155298809|NCT02763319|560524476|FG001|Overall Study|Progressive Disease|27|||
155298810|NCT02763319|560524475|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
155298811|NCT02763319|560524476|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
155298812|NCT02763319|560524475|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
155298813|NCT02763319|560524476|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
155298814|NCT02763319|560524475|FG000|Overall Study|Withdrawal by Subject|26|||
155298815|NCT02763319|560524476|FG001|Overall Study|Withdrawal by Subject|25|||
155298816|NCT04603924|560524478|FG000|Overall Study|Not Dosed|2|||
155298817|NCT04603924|560524479|FG001|Overall Study|Not Dosed|1|||
155298818|NCT04603924|560524478|FG000|Overall Study|Withdrawal by Subject|6|||
155298819|NCT04603924|560524479|FG001|Overall Study|Withdrawal by Subject|6|||
155298820|NCT04603924|560524478|FG000|Overall Study|Adverse Event|2|||
155298821|NCT04603924|560524479|FG001|Overall Study|Adverse Event|2|||
155298822|NCT03762668|560524482|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
155298823|NCT03762668|560524483|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
155298824|NCT00686855|560524487|FG000|Overall Study|Lost to Follow-up|1|||
155298825|NCT00686855|560524488|FG001|Overall Study|Lost to Follow-up|0|||
155298826|NCT00686855|560524487|FG000|Overall Study|Progressive GVHD|0|||
155298827|NCT00686855|560524488|FG001|Overall Study|Progressive GVHD|1|||
155298828|NCT02731755|560524491|FG000|First Intervention|Withdrawal by Subject|0|||
155298829|NCT02731755|560524492|FG001|First Intervention|Withdrawal by Subject|2|||
155298830|NCT01460446|560524493|FG000|Overall Study|Non-compliance|2|||
155298831|NCT01460446|560524494|FG001|Overall Study|Non-compliance|9|||
155298832|NCT01460446|560524493|FG000|Overall Study|Consent Withdrawn|0|||
155298833|NCT01460446|560524494|FG001|Overall Study|Consent Withdrawn|4|||
155298834|NCT01460446|560524493|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
155298835|NCT01460446|560524494|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
155298836|NCT01460446|560524493|FG000|Overall Study|Surgery/Illness|1|||
155298837|NCT01460446|560524494|FG001|Overall Study|Surgery/Illness|1|||
155298838|NCT01460446|560524493|FG000|Overall Study|Pregnancy|1|||
155298839|NCT01460446|560524494|FG001|Overall Study|Pregnancy|0|||
155298840|NCT01460446|560524493|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
155298841|NCT01460446|560524494|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
155298842|NCT00714714|560524495|FG000|Overall Study|Adverse Event|1|||
155298843|NCT02616900|560524496|FG000|Overall Study|Lack of Efficacy|7|||
155298844|NCT02616900|560524496|FG000|Overall Study|Lost to Follow-up|2|||
155298845|NCT02616900|560524496|FG000|Overall Study|Protocol Violation|5|||
155298846|NCT02616900|560524496|FG000|Overall Study|Withdrawal by Subject|3|||
155298847|NCT02616900|560524496|FG000|Overall Study|Incomplete data|6|||
155298848|NCT03644849|560524499|FG000|Overall Study|Lost to Follow-up|1|||
155298849|NCT03644849|560524500|FG001|Overall Study|Lost to Follow-up|3|||
155298850|NCT02613871|560524501|FG000|Overall Study|Death|2|||
155298851|NCT02613871|560524501|FG000|Overall Study|Withdrew Consent|1|||
155298852|NCT00980330|560524502|FG000|Overall Study|Adverse Event|0|||
155298853|NCT00980330|560524503|FG001|Overall Study|Adverse Event|0|||
155298854|NCT00980330|560524504|FG002|Overall Study|Adverse Event|0|||
155298855|NCT00980330|560524505|FG003|Overall Study|Adverse Event|1|||
155298856|NCT00980330|560524506|FG004|Overall Study|Adverse Event|0|||
155298857|NCT00980330|560524507|FG005|Overall Study|Adverse Event|0|||
155298858|NCT00980330|560524508|FG006|Overall Study|Adverse Event|0|||
155298859|NCT00980330|560524502|FG000|Overall Study|Lost to Follow-up|1|||
155298860|NCT00980330|560524503|FG001|Overall Study|Lost to Follow-up|1|||
155298861|NCT00980330|560524504|FG002|Overall Study|Lost to Follow-up|4|||
155298862|NCT00980330|560524505|FG003|Overall Study|Lost to Follow-up|2|||
155298863|NCT00980330|560524506|FG004|Overall Study|Lost to Follow-up|1|||
155298864|NCT00980330|560524507|FG005|Overall Study|Lost to Follow-up|1|||
155298865|NCT00980330|560524508|FG006|Overall Study|Lost to Follow-up|2|||
155298866|NCT00980330|560524502|FG000|Overall Study|Withdrawal by Subject|2|||
155298867|NCT00980330|560524503|FG001|Overall Study|Withdrawal by Subject|4|||
155298868|NCT00980330|560524504|FG002|Overall Study|Withdrawal by Subject|4|||
155298869|NCT00980330|560524505|FG003|Overall Study|Withdrawal by Subject|1|||
155298870|NCT00980330|560524506|FG004|Overall Study|Withdrawal by Subject|3|||
155298871|NCT00980330|560524507|FG005|Overall Study|Withdrawal by Subject|2|||
155298872|NCT00980330|560524508|FG006|Overall Study|Withdrawal by Subject|5|||
155298873|NCT00980330|560524502|FG000|Overall Study|(not specified)|2|||
155298874|NCT00980330|560524503|FG001|Overall Study|(not specified)|0|||
155298875|NCT00980330|560524504|FG002|Overall Study|(not specified)|0|||
155298876|NCT00980330|560524505|FG003|Overall Study|(not specified)|1|||
155298877|NCT00980330|560524506|FG004|Overall Study|(not specified)|1|||
155298878|NCT00980330|560524507|FG005|Overall Study|(not specified)|1|||
155298879|NCT00980330|560524508|FG006|Overall Study|(not specified)|0|||
155298880|NCT04054635|560524509|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
155298881|NCT04054635|560524510|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
155298882|NCT04054635|560524511|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
155298883|NCT04054635|560524509|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
155298884|NCT04054635|560524510|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
155298885|NCT04054635|560524511|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
155298886|NCT03737240|560524512|FG000|Overall Study|Lost to Follow-up|16|||
155298887|NCT03737240|560524513|FG001|Overall Study|Lost to Follow-up|15|||
155298888|NCT00891930|560524514|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
155298889|NCT00891930|560524514|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
155298890|NCT00891930|560524514|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
155298891|NCT00891930|560524514|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
155298892|NCT00891930|560524514|FG000|Part 2 Panitumumab + AMG479|Death|30|||
155158599|NCT05567783|560018827|FG002|Overall Study|Lost to Follow-up|17|||
155158600|NCT05567783|560018825|FG000|Overall Study|Physician Decision|10|||
155158601|NCT05567783|560018826|FG001|Overall Study|Physician Decision|7|||
155158602|NCT05567783|560018827|FG002|Overall Study|Physician Decision|9|||
155158603|NCT05567783|560018825|FG000|Overall Study|Study Terminated by Sponsor|924|||
155158604|NCT05567783|560018826|FG001|Overall Study|Study Terminated by Sponsor|937|||
155158605|NCT05567783|560018827|FG002|Overall Study|Study Terminated by Sponsor|941|||
155158606|NCT05567783|560018825|FG000|Overall Study|Withdrawal by Subject|23|||
155158607|NCT05567783|560018826|FG001|Overall Study|Withdrawal by Subject|27|||
155158608|NCT05567783|560018827|FG002|Overall Study|Withdrawal by Subject|24|||
155298893|NCT05001945|560524515|FG000|Overall Study|Adverse Event|0|||
155298894|NCT05001945|560524516|FG001|Overall Study|Adverse Event|0|||
155298895|NCT05001945|560524517|FG002|Overall Study|Adverse Event|0|||
155298896|NCT05001945|560524518|FG003|Overall Study|Adverse Event|1|||
155158609|NCT05567783|560018825|FG000|Overall Study|Incarcerated|1|||
155158610|NCT05567783|560018826|FG001|Overall Study|Incarcerated|0|||
155298897|NCT05001945|560524519|FG004|Overall Study|Adverse Event|0|||
155298898|NCT05001945|560524520|FG005|Overall Study|Adverse Event|0|||
155298899|NCT05001945|560524521|FG006|Overall Study|Adverse Event|0|||
155298900|NCT05001945|560524522|FG007|Overall Study|Adverse Event|0|||
155298901|NCT05001945|560524515|FG000|Overall Study|Lost to Follow-up|0|||
155158611|NCT05567783|560018827|FG002|Overall Study|Incarcerated|0|||
155158612|NCT05567783|560018825|FG000|Overall Study|Participant randomized in error|4|||
155298902|NCT05001945|560524516|FG001|Overall Study|Lost to Follow-up|1|||
155298903|NCT05001945|560524517|FG002|Overall Study|Lost to Follow-up|1|||
155298904|NCT05001945|560524518|FG003|Overall Study|Lost to Follow-up|2|||
155298905|NCT05001945|560524519|FG004|Overall Study|Lost to Follow-up|0|||
155298906|NCT05001945|560524520|FG005|Overall Study|Lost to Follow-up|1|||
155298907|NCT05001945|560524521|FG006|Overall Study|Lost to Follow-up|0|||
155298908|NCT05001945|560524522|FG007|Overall Study|Lost to Follow-up|0|||
155298909|NCT05001945|560524515|FG000|Overall Study|Protocol Violation|1|||
155298910|NCT05001945|560524516|FG001|Overall Study|Protocol Violation|0|||
155298911|NCT05001945|560524517|FG002|Overall Study|Protocol Violation|1|||
155298912|NCT05001945|560524518|FG003|Overall Study|Protocol Violation|1|||
154957385|NCT00272779|559272424|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
154957386|NCT00272779|559272423|FG000|Baseline Through Week 48|Death before Week 48|4|||
154957387|NCT00272779|559272424|FG001|Baseline Through Week 48|Death before Week 48|4|||
154957388|NCT00272779|559272423|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
154957389|NCT00272779|559272424|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
154957390|NCT00272779|559272423|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
154957391|NCT00272779|559272424|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
154957392|NCT00272779|559272423|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
154957393|NCT00272779|559272424|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
154957394|NCT00272779|559272423|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
154957395|NCT00272779|559272424|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
154957396|NCT00272779|559272423|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
154957397|NCT00272779|559272424|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
154957398|NCT00272779|559272423|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
154957399|NCT00272779|559272424|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
154957400|NCT00272779|559272423|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
155298913|NCT05001945|560524519|FG004|Overall Study|Protocol Violation|0|||
155298914|NCT05001945|560524520|FG005|Overall Study|Protocol Violation|1|||
154957401|NCT00272779|559272424|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
154957402|NCT00272779|559272423|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
154957403|NCT00272779|559272424|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
155061560|NCT02867592|559659321|FG002|Overall Study|Adverse Event|2|||
155061561|NCT02867592|559659322|FG003|Overall Study|Adverse Event|1|||
155061562|NCT02867592|559659323|FG004|Overall Study|Adverse Event|1|||
155061563|NCT02867592|559659324|FG005|Overall Study|Adverse Event|5|||
155061564|NCT02867592|559659319|FG000|Overall Study|Death|0|||
155061565|NCT02867592|559659320|FG001|Overall Study|Death|0|||
155061566|NCT02867592|559659321|FG002|Overall Study|Death|0|||
155298915|NCT05001945|560524521|FG006|Overall Study|Protocol Violation|0|||
155298916|NCT05001945|560524522|FG007|Overall Study|Protocol Violation|0|||
155298917|NCT05001945|560524515|FG000|Overall Study|Withdrawal by Subject|0|||
155298918|NCT05001945|560524516|FG001|Overall Study|Withdrawal by Subject|0|||
155298919|NCT05001945|560524517|FG002|Overall Study|Withdrawal by Subject|0|||
155298920|NCT05001945|560524518|FG003|Overall Study|Withdrawal by Subject|1|||
155061567|NCT02867592|559659322|FG003|Overall Study|Death|1|||
155061568|NCT02867592|559659323|FG004|Overall Study|Death|0|||
155298921|NCT05001945|560524519|FG004|Overall Study|Withdrawal by Subject|1|||
155298922|NCT05001945|560524520|FG005|Overall Study|Withdrawal by Subject|1|||
155298923|NCT05001945|560524521|FG006|Overall Study|Withdrawal by Subject|0|||
155298924|NCT05001945|560524522|FG007|Overall Study|Withdrawal by Subject|1|||
155298925|NCT05001945|560524515|FG000|Overall Study|Not specified by Investigator|0|||
155298926|NCT05001945|560524516|FG001|Overall Study|Not specified by Investigator|3|||
155061569|NCT02867592|559659324|FG005|Overall Study|Death|1|||
155298927|NCT05001945|560524517|FG002|Overall Study|Not specified by Investigator|0|||
155298928|NCT05001945|560524518|FG003|Overall Study|Not specified by Investigator|0|||
155061570|NCT02867592|559659319|FG000|Overall Study|Lack of Efficacy|8|||
155061571|NCT02867592|559659320|FG001|Overall Study|Lack of Efficacy|10|||
155061572|NCT02867592|559659321|FG002|Overall Study|Lack of Efficacy|8|||
155298929|NCT05001945|560524519|FG004|Overall Study|Not specified by Investigator|1|||
155298930|NCT05001945|560524520|FG005|Overall Study|Not specified by Investigator|0|||
155298931|NCT05001945|560524521|FG006|Overall Study|Not specified by Investigator|0|||
155298932|NCT05001945|560524522|FG007|Overall Study|Not specified by Investigator|0|||
155298933|NCT02448446|560524523|FG000|Overall Study|Withdrawal by Subject|1|||
155298934|NCT02448446|560524524|FG001|Overall Study|Withdrawal by Subject|0|||
155298935|NCT02957136|560524530|FG000|Overall Study|Withdrawal by Subject|2|||
155298936|NCT02957136|560524531|FG001|Overall Study|Withdrawal by Subject|1|||
155061573|NCT02867592|559659322|FG003|Overall Study|Lack of Efficacy|8|||
155061574|NCT02867592|559659323|FG004|Overall Study|Lack of Efficacy|12|||
155298937|NCT00439569|560524532|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
155298938|NCT00439569|560524532|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
155298939|NCT00439569|560524532|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
155298940|NCT02214160|560524533|FG000|Overall Study|Withdrawal by Subject|1|||
155298941|NCT02214160|560524534|FG001|Overall Study|Withdrawal by Subject|0|||
155061575|NCT02867592|559659324|FG005|Overall Study|Lack of Efficacy|17|||
155061576|NCT02867592|559659319|FG000|Overall Study|Physician Decision|1|||
155061577|NCT02867592|559659320|FG001|Overall Study|Physician Decision|2|||
155061578|NCT02867592|559659321|FG002|Overall Study|Physician Decision|2|||
155298942|NCT02214160|560524535|FG002|Overall Study|Withdrawal by Subject|6|||
155298943|NCT02214160|560524533|FG000|Overall Study|Death|2|||
155298944|NCT02214160|560524534|FG001|Overall Study|Death|2|||
155298945|NCT02214160|560524535|FG002|Overall Study|Death|1|||
155298946|NCT02214160|560524533|FG000|Overall Study|Subject Non-Compliance|0|||
155298947|NCT02214160|560524534|FG001|Overall Study|Subject Non-Compliance|3|||
155298948|NCT02214160|560524535|FG002|Overall Study|Subject Non-Compliance|1|||
155298949|NCT02214160|560524533|FG000|Overall Study|Adverse Event|0|||
155298950|NCT02214160|560524534|FG001|Overall Study|Adverse Event|1|||
155298951|NCT02214160|560524535|FG002|Overall Study|Adverse Event|1|||
155298952|NCT02214160|560524533|FG000|Overall Study|Sponsor Decision|0|||
155298953|NCT02214160|560524534|FG001|Overall Study|Sponsor Decision|2|||
155298954|NCT02214160|560524535|FG002|Overall Study|Sponsor Decision|0|||
155298955|NCT02214160|560524533|FG000|Overall Study|Protocol Violation|1|||
155298956|NCT02214160|560524534|FG001|Overall Study|Protocol Violation|0|||
155298957|NCT02214160|560524535|FG002|Overall Study|Protocol Violation|0|||
155298958|NCT02214160|560524533|FG000|Overall Study|Physician Decision|0|||
155298959|NCT02214160|560524534|FG001|Overall Study|Physician Decision|0|||
155298960|NCT02214160|560524535|FG002|Overall Study|Physician Decision|1|||
155298961|NCT01510717|560524536|FG000|Overall Study|Adverse Event|1|||
155298962|NCT01510717|560524537|FG001|Overall Study|Adverse Event|2|||
155298963|NCT01510717|560524536|FG000|Overall Study|Death|1|||
155298964|NCT01510717|560524537|FG001|Overall Study|Death|0|||
155298965|NCT01510717|560524536|FG000|Overall Study|Lost to Follow-up|0|||
155298966|NCT01510717|560524537|FG001|Overall Study|Lost to Follow-up|1|||
155298967|NCT01510717|560524536|FG000|Overall Study|Withdrawal by Subject|0|||
155298968|NCT01510717|560524537|FG001|Overall Study|Withdrawal by Subject|2|||
155298969|NCT02555215|560524543|FG000|Overall Study|Other|1|||
155298970|NCT02555215|560524543|FG000|Overall Study|Investigator Decision|2|||
155298971|NCT00529789|560524544|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
155298972|NCT00529789|560524544|FG000|Study Period II/III|Adverse Event|3|||
155298973|NCT00529789|560524544|FG000|Study Period II/III|Lack of Efficacy|2|||
155298974|NCT00529789|560524544|FG000|Study Period II/III|Withdrawal by Subject|1|||
155298975|NCT00529789|560524544|FG000|Study Period II/III|Protocol Violation|3|||
155298976|NCT00529789|560524544|FG000|Study Period II/III|Physician Decision|3|||
155298977|NCT00529789|560524544|FG000|Study Period II/III|Lost to Follow-up|3|||
155298978|NCT00529789|560524544|FG000|Study Period IV|Parent/Caregiver Decision|1|||
155298979|NCT00529789|560524544|FG000|Study Period IV|Adverse Event|1|||
155298980|NCT00529789|560524544|FG000|Study Period IV|Lack of Efficacy|1|||
155298981|NCT00529789|560524544|FG000|Study Period IV|Lost to Follow-up|3|||
155298982|NCT01968226|560524545|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
155298983|NCT00457743|560524549|FG000|Overall Study|Adverse Event|0|||
155298984|NCT00457743|560524550|FG001|Overall Study|Adverse Event|4|||
155298985|NCT00457743|560524551|FG002|Overall Study|Adverse Event|0|||
155298986|NCT00457743|560524549|FG000|Overall Study|Lack of Efficacy|3|||
155298987|NCT00457743|560524550|FG001|Overall Study|Lack of Efficacy|23|||
155298988|NCT00457743|560524551|FG002|Overall Study|Lack of Efficacy|3|||
155298989|NCT01202955|560524552|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
155298990|NCT01202955|560524553|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
155298991|NCT02928224|560524554|FG000|Overall Study|Lost to Follow-up|1|||
155298992|NCT02928224|560524555|FG001|Overall Study|Lost to Follow-up|1|||
155298993|NCT02928224|560524556|FG002|Overall Study|Lost to Follow-up|3|||
155298994|NCT02928224|560524557|FG003|Overall Study|Lost to Follow-up|0|||
155298995|NCT02928224|560524554|FG000|Overall Study|Death|30|||
155298996|NCT02928224|560524555|FG001|Overall Study|Death|209|||
155298997|NCT02928224|560524556|FG002|Overall Study|Death|193|||
155298998|NCT02928224|560524557|FG003|Overall Study|Death|198|||
155298999|NCT02928224|560524554|FG000|Overall Study|Withdrawal by Subject|0|||
155299000|NCT02928224|560524555|FG001|Overall Study|Withdrawal by Subject|3|||
155061579|NCT02867592|559659322|FG003|Overall Study|Physician Decision|0|||
155061580|NCT02867592|559659323|FG004|Overall Study|Physician Decision|5|||
155061581|NCT02867592|559659324|FG005|Overall Study|Physician Decision|1|||
155061582|NCT02867592|559659319|FG000|Overall Study|Protocol Violation|0|||
155061583|NCT02867592|559659320|FG001|Overall Study|Protocol Violation|0|||
155061584|NCT02867592|559659321|FG002|Overall Study|Protocol Violation|0|||
155061585|NCT02867592|559659322|FG003|Overall Study|Protocol Violation|0|||
155061586|NCT02867592|559659323|FG004|Overall Study|Protocol Violation|1|||
155061587|NCT02867592|559659324|FG005|Overall Study|Protocol Violation|1|||
155061588|NCT02867592|559659319|FG000|Overall Study|Withdrawal by Subject|0|||
155061589|NCT02867592|559659320|FG001|Overall Study|Withdrawal by Subject|1|||
155061590|NCT02867592|559659321|FG002|Overall Study|Withdrawal by Subject|0|||
155061591|NCT02867592|559659322|FG003|Overall Study|Withdrawal by Subject|1|||
155061592|NCT02867592|559659323|FG004|Overall Study|Withdrawal by Subject|3|||
155061593|NCT02867592|559659324|FG005|Overall Study|Withdrawal by Subject|3|||
155061594|NCT02867592|559659319|FG000|Overall Study|Ineligible|1|||
155061595|NCT02867592|559659320|FG001|Overall Study|Ineligible|1|||
155061596|NCT02867592|559659321|FG002|Overall Study|Ineligible|0|||
155061597|NCT02867592|559659322|FG003|Overall Study|Ineligible|0|||
155299001|NCT02928224|560524556|FG002|Overall Study|Withdrawal by Subject|7|||
155299002|NCT02928224|560524557|FG003|Overall Study|Withdrawal by Subject|20|||
155299003|NCT02928224|560524554|FG000|Overall Study|Study participation terminated by sponsor|3|||
155299004|NCT02928224|560524555|FG001|Overall Study|Study participation terminated by sponsor|8|||
155299005|NCT02928224|560524556|FG002|Overall Study|Study participation terminated by sponsor|12|||
155299006|NCT02928224|560524557|FG003|Overall Study|Study participation terminated by sponsor|3|||
155299007|NCT02928224|560524554|FG000|Overall Study|Other|3|||
155299008|NCT02928224|560524555|FG001|Overall Study|Other|3|||
155299009|NCT02928224|560524556|FG002|Overall Study|Other|5|||
155299010|NCT02928224|560524557|FG003|Overall Study|Other|0|||
155299011|NCT01278394|560524558|FG000|Overall Study|Lost to Follow-up|1|||
155299012|NCT00468910|560524559|FG000|Overall Study|Lost to Follow-up|2|||
155299013|NCT00468910|560524560|FG001|Overall Study|Lost to Follow-up|1|||
155299014|NCT00468910|560524559|FG000|Overall Study|Withdrawal by Subject|2|||
155299015|NCT00468910|560524560|FG001|Overall Study|Withdrawal by Subject|1|||
155299016|NCT00468910|560524559|FG000|Overall Study|Medical Contraindication|0|||
155299017|NCT00468910|560524560|FG001|Overall Study|Medical Contraindication|1|||
155299018|NCT01909778|560524561|FG000|Overall Study|failed screening|1|||
155299019|NCT05323734|560524563|FG000|Overall Study|Adverse Event|5|||
155299020|NCT05323734|560524564|FG001|Overall Study|Adverse Event|2|||
155299021|NCT05323734|560524563|FG000|Overall Study|Physician Decision|1|||
155299022|NCT05323734|560524564|FG001|Overall Study|Physician Decision|0|||
155299023|NCT05323734|560524563|FG000|Overall Study|Lack of Efficacy|1|||
155299024|NCT05323734|560524564|FG001|Overall Study|Lack of Efficacy|2|||
155299025|NCT05323734|560524563|FG000|Overall Study|Withdrawal by Subject|2|||
155299026|NCT05323734|560524564|FG001|Overall Study|Withdrawal by Subject|0|||
155299027|NCT05323734|560524563|FG000|Overall Study|Participant Withdrawn Due|0|||
155299028|NCT05323734|560524564|FG001|Overall Study|Participant Withdrawn Due|1|||
155299029|NCT00457691|560524568|FG000|Overall Study|Adverse Event|4|||
155299030|NCT00457691|560524569|FG001|Overall Study|Adverse Event|1|||
155299031|NCT00457691|560524568|FG000|Overall Study|Death|163|||
155299032|NCT00457691|560524569|FG001|Overall Study|Death|148|||
155299033|NCT00457691|560524568|FG000|Overall Study|Protocol Violation|1|||
155299034|NCT00457691|560524569|FG001|Overall Study|Protocol Violation|3|||
155299035|NCT00457691|560524568|FG000|Overall Study|Lost to Follow-up|23|||
155299036|NCT00457691|560524569|FG001|Overall Study|Lost to Follow-up|14|||
155299037|NCT00457691|560524568|FG000|Overall Study|Study terminated by Sponsor|1|||
155299038|NCT00457691|560524569|FG001|Overall Study|Study terminated by Sponsor|1|||
155299039|NCT00457691|560524568|FG000|Overall Study|Subject refused (reason other than AE)|14|||
155299040|NCT00457691|560524569|FG001|Overall Study|Subject refused (reason other than AE)|19|||
155299041|NCT00457691|560524568|FG000|Overall Study|Disease progression, study terminated|180|||
155299042|NCT00457691|560524569|FG001|Overall Study|Disease progression, study terminated|196|||
155299043|NCT01353963|560524570|FG000|Overall Study|Adverse Event|2|||
155299044|NCT01420549|560524571|FG000|Overall Study|Adverse Event|1|||
155299045|NCT01420549|560524572|FG001|Overall Study|Adverse Event|1|||
155299046|NCT01420549|560524571|FG000|Overall Study|Lost to Follow-up|2|||
155299047|NCT01420549|560524572|FG001|Overall Study|Lost to Follow-up|2|||
155299048|NCT01420549|560524571|FG000|Overall Study|Protocol Violation|0|||
155299049|NCT01420549|560524572|FG001|Overall Study|Protocol Violation|1|||
155299050|NCT01420549|560524571|FG000|Overall Study|Non-adherence to medication|4|||
155299051|NCT01420549|560524572|FG001|Overall Study|Non-adherence to medication|1|||
155299052|NCT03073941|560526336|FG000|Overall Study|Received non-study device intraoperatively|0|||
155299053|NCT03073941|560526337|FG001|Overall Study|Received non-study device intraoperatively|2|||
155299054|NCT03073941|560526336|FG000|Overall Study|Death|1|||
155299055|NCT03073941|560526337|FG001|Overall Study|Death|0|||
155299056|NCT03073941|560526336|FG000|Overall Study|Withdrawal by Subject|1|||
155299057|NCT03073941|560526337|FG001|Overall Study|Withdrawal by Subject|3|||
155061598|NCT02867592|559659323|FG004|Overall Study|Ineligible|2|||
155299058|NCT03073941|560526336|FG000|Overall Study|Lost to Follow-up|5|||
155299059|NCT03073941|560526337|FG001|Overall Study|Lost to Follow-up|4|||
155299060|NCT03073941|560526336|FG000|Overall Study|Adverse Event|4|||
155299061|NCT03073941|560526337|FG001|Overall Study|Adverse Event|2|||
155299062|NCT03073941|560526336|FG000|Overall Study|Met an exclusion criterion|0|||
155299063|NCT03073941|560526337|FG001|Overall Study|Met an exclusion criterion|1|||
155299064|NCT03936660|560526339|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
155299065|NCT03936660|560526340|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
155061599|NCT02867592|559659324|FG005|Overall Study|Ineligible|0|||
155061600|NCT02867592|559659319|FG000|Overall Study|No Treatment|1|||
155061601|NCT02867592|559659320|FG001|Overall Study|No Treatment|0|||
155061602|NCT02867592|559659321|FG002|Overall Study|No Treatment|0|||
155061603|NCT02867592|559659322|FG003|Overall Study|No Treatment|0|||
155061604|NCT02867592|559659323|FG004|Overall Study|No Treatment|0|||
155061605|NCT02867592|559659324|FG005|Overall Study|No Treatment|0|||
155061606|NCT02867592|559659319|FG000|Overall Study|Still on Therapy|0|||
155061607|NCT02867592|559659320|FG001|Overall Study|Still on Therapy|0|||
155061608|NCT02867592|559659321|FG002|Overall Study|Still on Therapy|0|||
155299066|NCT01391832|560526341|FG000|Overall Study|Withdrawal by Subject|21|||
155299067|NCT01391832|560526342|FG001|Overall Study|Withdrawal by Subject|22|||
155061609|NCT02867592|559659322|FG003|Overall Study|Still on Therapy|0|||
155061610|NCT02867592|559659323|FG004|Overall Study|Still on Therapy|1|||
155299068|NCT01391832|560526341|FG000|Overall Study|Lost to Follow-up|0|||
155299069|NCT01391832|560526342|FG001|Overall Study|Lost to Follow-up|1|||
155299070|NCT00722046|560526345|FG000|Overall Study|Adverse Event|0|||
155299071|NCT00722046|560526346|FG001|Overall Study|Adverse Event|1|||
155299072|NCT00722046|560526347|FG002|Overall Study|Adverse Event|2|||
155299073|NCT00722046|560526348|FG003|Overall Study|Adverse Event|1|||
155299074|NCT00722046|560526349|FG004|Overall Study|Adverse Event|2|||
155299075|NCT00722046|560526350|FG005|Overall Study|Adverse Event|1|||
155299076|NCT00722046|560526351|FG006|Overall Study|Adverse Event|0|||
155299077|NCT00722046|560526345|FG000|Overall Study|Death|0|||
155299078|NCT00722046|560526346|FG001|Overall Study|Death|1|||
155299079|NCT00722046|560526347|FG002|Overall Study|Death|0|||
155299080|NCT00722046|560526348|FG003|Overall Study|Death|0|||
155299081|NCT00722046|560526349|FG004|Overall Study|Death|0|||
155299082|NCT00722046|560526350|FG005|Overall Study|Death|0|||
155299083|NCT00722046|560526351|FG006|Overall Study|Death|2|||
155299084|NCT00722046|560526345|FG000|Overall Study|Protocol Violation|1|||
155299085|NCT00722046|560526346|FG001|Overall Study|Protocol Violation|0|||
155299086|NCT00722046|560526347|FG002|Overall Study|Protocol Violation|0|||
155299087|NCT00722046|560526348|FG003|Overall Study|Protocol Violation|0|||
155299088|NCT00722046|560526349|FG004|Overall Study|Protocol Violation|0|||
155299089|NCT00722046|560526350|FG005|Overall Study|Protocol Violation|1|||
155299090|NCT00722046|560526351|FG006|Overall Study|Protocol Violation|0|||
155299091|NCT00722046|560526345|FG000|Overall Study|Withdrawal by Subject|3|||
155299092|NCT00722046|560526346|FG001|Overall Study|Withdrawal by Subject|3|||
155299093|NCT00722046|560526347|FG002|Overall Study|Withdrawal by Subject|4|||
155299094|NCT00722046|560526348|FG003|Overall Study|Withdrawal by Subject|4|||
155299095|NCT00722046|560526349|FG004|Overall Study|Withdrawal by Subject|4|||
155299096|NCT00722046|560526350|FG005|Overall Study|Withdrawal by Subject|7|||
155299097|NCT00722046|560526351|FG006|Overall Study|Withdrawal by Subject|3|||
155299098|NCT00722046|560526345|FG000|Overall Study|Randomized, but not treated|1|||
155299099|NCT00722046|560526346|FG001|Overall Study|Randomized, but not treated|1|||
155299100|NCT00722046|560526347|FG002|Overall Study|Randomized, but not treated|0|||
155299101|NCT00722046|560526348|FG003|Overall Study|Randomized, but not treated|2|||
155299102|NCT00722046|560526349|FG004|Overall Study|Randomized, but not treated|0|||
155299103|NCT00722046|560526350|FG005|Overall Study|Randomized, but not treated|0|||
155299104|NCT00722046|560526351|FG006|Overall Study|Randomized, but not treated|0|||
155299105|NCT00722046|560526345|FG000|Overall Study|Other|0|||
155299106|NCT00722046|560526346|FG001|Overall Study|Other|0|||
155299107|NCT00722046|560526347|FG002|Overall Study|Other|1|||
155299108|NCT00722046|560526348|FG003|Overall Study|Other|1|||
155299109|NCT00722046|560526349|FG004|Overall Study|Other|3|||
155299110|NCT00722046|560526350|FG005|Overall Study|Other|2|||
155299111|NCT00722046|560526351|FG006|Overall Study|Other|1|||
155299112|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
155299113|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
155299114|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
154957404|NCT00272779|559272423|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
155158613|NCT05567783|560018826|FG001|Overall Study|Participant randomized in error|2|||
155158614|NCT05567783|560018827|FG002|Overall Study|Participant randomized in error|2|||
155158615|NCT03675126|560018830|FG000|Overall Study|Study Terminated by Sponsor|9|||
155158616|NCT03675126|560018830|FG000|Overall Study|Death|2|||
155158617|NCT03675126|560018830|FG000|Overall Study|Withdrawal by Subject|4|||
155158618|NCT00001959|560018831|FG000|Overall Study|newly diagnosed colon cancer|1|||
155158619|NCT00001959|560018831|FG000|Overall Study|disabling sedation|1|||
155158620|NCT00001959|560018831|FG000|Overall Study|non-compliance|1|||
155158621|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
155158622|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
155158623|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
155158624|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
155158625|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
155158626|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
155158627|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
155158628|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
155158629|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
155158630|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
155158631|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
155158632|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
155158633|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
155158634|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
155299115|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
155299116|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
155299117|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
155299118|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
155299119|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
155299120|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
155299121|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
155299122|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
155299123|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
155299124|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
155299125|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
155299126|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
155299127|NCT00516321|560526359|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
155299128|NCT00516321|560526360|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
155299129|NCT00516321|560526361|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
155299130|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
155299131|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
155299132|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
155299133|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
155299134|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
155299135|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
155299136|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
155299137|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
155299138|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
155299139|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
155299140|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
155299141|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
155299142|NCT00516321|560526359|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
155299143|NCT00516321|560526360|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
155299144|NCT00516321|560526361|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
155299145|NCT01599104|560526366|FG000|Overall Study|Withdrawal by Subject|1|||
155299146|NCT01599104|560526367|FG001|Overall Study|Withdrawal by Subject|1|||
155299147|NCT01599104|560526368|FG002|Overall Study|Withdrawal by Subject|2|||
155299148|NCT01599104|560526366|FG000|Overall Study|Technical Problems|1|||
155299149|NCT01599104|560526367|FG001|Overall Study|Technical Problems|0|||
155299150|NCT01599104|560526368|FG002|Overall Study|Technical Problems|0|||
155299151|NCT01599104|560526366|FG000|Overall Study|Physician Decision|3|||
155299152|NCT01599104|560526367|FG001|Overall Study|Physician Decision|2|||
155299153|NCT01599104|560526368|FG002|Overall Study|Physician Decision|2|||
155299154|NCT01599104|560526366|FG000|Overall Study|Non-compliance with study treatment|0|||
155299155|NCT01599104|560526367|FG001|Overall Study|Non-compliance with study treatment|1|||
155299156|NCT01599104|560526368|FG002|Overall Study|Non-compliance with study treatment|0|||
155299157|NCT01599104|560526366|FG000|Overall Study|Lack of Efficacy|4|||
155299158|NCT01599104|560526367|FG001|Overall Study|Lack of Efficacy|4|||
155299159|NCT01599104|560526368|FG002|Overall Study|Lack of Efficacy|10|||
155299160|NCT01599104|560526366|FG000|Overall Study|Adverse Event|7|||
155299161|NCT01599104|560526367|FG001|Overall Study|Adverse Event|6|||
155299162|NCT01599104|560526368|FG002|Overall Study|Adverse Event|12|||
155299163|NCT02271854|560526371|FG000|Overall Study|Withdrawal by Subject|2|||
155299164|NCT02271854|560526371|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
155299165|NCT02271854|560526371|FG000|Overall Study|Lost to Follow-up|1|||
155299166|NCT01185561|560526374|FG000|Overall Study|Lost to Follow-up|0|||
155299167|NCT01185561|560526375|FG001|Overall Study|Lost to Follow-up|4|||
155299168|NCT01185561|560526374|FG000|Overall Study|Withdrawal by Subject|2|||
155299169|NCT01185561|560526375|FG001|Overall Study|Withdrawal by Subject|8|||
155299170|NCT01078116|560526376|FG000|Overall Study|Lost to Follow-up|17|||
155299171|NCT01078116|560526376|FG000|Overall Study|Adverse Event|5|||
155299172|NCT01078116|560526376|FG000|Overall Study|Withdrawal by Subject|8|||
155299173|NCT01078116|560526376|FG000|Overall Study|Lack of effectiveness|15|||
155299174|NCT01078116|560526376|FG000|Overall Study|Case report form not completed|3|||
155299175|NCT02499159|560526377|FG000|Randomization|Protocol Violation|1|||
155299176|NCT02499159|560526378|FG001|Randomization|Protocol Violation|1|||
155299177|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
155299178|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
155299179|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
155299180|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
155299181|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
154957405|NCT00272779|559272424|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
154957406|NCT00272779|559272423|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
154957407|NCT00272779|559272424|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
155299182|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
155299183|NCT02499159|560526377|FG000|30-Day Follow-Up Phone Call|Other|1|||
155299184|NCT02499159|560526378|FG001|30-Day Follow-Up Phone Call|Other|0|||
155299185|NCT02242487|560526379|FG000|Overall Study|Adverse Event|13|||
155299186|NCT02242487|560526380|FG001|Overall Study|Adverse Event|15|||
155299187|NCT02242487|560526379|FG000|Overall Study|Lack of Efficacy|4|||
155299188|NCT02242487|560526380|FG001|Overall Study|Lack of Efficacy|6|||
155299189|NCT02242487|560526379|FG000|Overall Study|Protocol Violation|2|||
155299190|NCT02242487|560526380|FG001|Overall Study|Protocol Violation|0|||
155299191|NCT02242487|560526379|FG000|Overall Study|Lost to Follow-up|2|||
155299192|NCT02242487|560526380|FG001|Overall Study|Lost to Follow-up|1|||
155299193|NCT02242487|560526379|FG000|Overall Study|Other - Miscellaneous|4|||
155299194|NCT02242487|560526380|FG001|Overall Study|Other - Miscellaneous|6|||
155299195|NCT02242487|560526379|FG000|Overall Study|Withdrawal by Subject|37|||
155299196|NCT02242487|560526380|FG001|Overall Study|Withdrawal by Subject|19|||
155299197|NCT02564744|560526383|FG000|Overall Study|Investigator decision|0|||
155299198|NCT02564744|560526384|FG001|Overall Study|Investigator decision|0|||
155299199|NCT02564744|560526385|FG002|Overall Study|Investigator decision|0|||
155299200|NCT02564744|560526386|FG003|Overall Study|Investigator decision|0|||
155299201|NCT02564744|560526387|FG004|Overall Study|Investigator decision|1|||
155299202|NCT02564744|560526383|FG000|Overall Study|Death|10|||
155299203|NCT02564744|560526384|FG001|Overall Study|Death|5|||
155299204|NCT02564744|560526385|FG002|Overall Study|Death|4|||
155299205|NCT02564744|560526386|FG003|Overall Study|Death|16|||
155299206|NCT02564744|560526387|FG004|Overall Study|Death|16|||
155299207|NCT02564744|560526383|FG000|Overall Study|End of study Page Missing|0|||
155299208|NCT02564744|560526384|FG001|Overall Study|End of study Page Missing|0|||
155299209|NCT02564744|560526385|FG002|Overall Study|End of study Page Missing|3|||
155299210|NCT02564744|560526386|FG003|Overall Study|End of study Page Missing|3|||
155299211|NCT02564744|560526387|FG004|Overall Study|End of study Page Missing|0|||
155299212|NCT02564744|560526383|FG000|Overall Study|Subject Withdrew Consent|1|||
155299213|NCT02564744|560526384|FG001|Overall Study|Subject Withdrew Consent|1|||
155299214|NCT02564744|560526385|FG002|Overall Study|Subject Withdrew Consent|1|||
155299215|NCT02564744|560526386|FG003|Overall Study|Subject Withdrew Consent|0|||
155299216|NCT02564744|560526387|FG004|Overall Study|Subject Withdrew Consent|2|||
155299217|NCT02564744|560526383|FG000|Overall Study|Lost to Follow-up|0|||
155299218|NCT02564744|560526384|FG001|Overall Study|Lost to Follow-up|1|||
155299219|NCT02564744|560526385|FG002|Overall Study|Lost to Follow-up|0|||
155299220|NCT02564744|560526386|FG003|Overall Study|Lost to Follow-up|0|||
155299221|NCT02564744|560526387|FG004|Overall Study|Lost to Follow-up|1|||
155299222|NCT02564744|560526383|FG000|Overall Study|Reason not specified|1|||
155299223|NCT02564744|560526384|FG001|Overall Study|Reason not specified|0|||
155299224|NCT02564744|560526385|FG002|Overall Study|Reason not specified|0|||
155299225|NCT02564744|560526386|FG003|Overall Study|Reason not specified|0|||
155299226|NCT02564744|560526387|FG004|Overall Study|Reason not specified|0|||
155299227|NCT02252042|560526392|FG000|Overall Study|Adverse Event|9|||
155299228|NCT02252042|560526393|FG001|Overall Study|Adverse Event|6|||
155299229|NCT02252042|560526392|FG000|Overall Study|Death|209|||
155299230|NCT02252042|560526393|FG001|Overall Study|Death|217|||
155299231|NCT02252042|560526392|FG000|Overall Study|Physician Decision|0|||
155299232|NCT02252042|560526393|FG001|Overall Study|Physician Decision|2|||
155299233|NCT02252042|560526392|FG000|Overall Study|Transferred to Extension Study|7|||
155299234|NCT02252042|560526393|FG001|Overall Study|Transferred to Extension Study|1|||
155299235|NCT02252042|560526392|FG000|Overall Study|Did Not Continue on Extension Study|7|||
155299236|NCT02252042|560526393|FG001|Overall Study|Did Not Continue on Extension Study|2|||
155299237|NCT02252042|560526392|FG000|Overall Study|Withdrawal by Subject|15|||
155299238|NCT02252042|560526393|FG001|Overall Study|Withdrawal by Subject|20|||
155299239|NCT02593149|560526394|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
155299240|NCT02593149|560526395|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
155061611|NCT02867592|559659324|FG005|Overall Study|Still on Therapy|0|||
155061612|NCT02867592|559659319|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155061613|NCT02867592|559659320|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155061614|NCT02867592|559659321|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155061615|NCT02867592|559659322|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155061616|NCT02867592|559659323|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
155061617|NCT02867592|559659324|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
155061618|NCT02867592|559659319|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
155061619|NCT02867592|559659320|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
155061620|NCT02867592|559659321|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
155061621|NCT02867592|559659322|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
155092588|NCT00560417|559773638|FG001|Overall Study|Lost to Follow-up|1|||
155299241|NCT02593149|560526394|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
155299242|NCT02593149|560526395|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
155299243|NCT01177670|560526397|FG000|Overall Study|Study Terminated|115|||
155299244|NCT01177670|560526397|FG000|Overall Study|Physician Decision|50|||
155299245|NCT01177670|560526397|FG000|Overall Study|Withdrawal by Subject|4|||
155299246|NCT00979992|560526398|FG000|Overall Study|Ineligible - inadequate pathology|1|||
155299247|NCT00979992|560526398|FG000|Overall Study|Ineligible - wrong cell type|2|||
155299248|NCT00979992|560526398|FG000|Overall Study|Refused - Never Treated|2|||
155299249|NCT04532528|560526404|FG000|Overall Study|Adverse Event|12|||
155299250|NCT04532528|560526405|FG001|Overall Study|Adverse Event|17|||
155299251|NCT04532528|560526404|FG000|Overall Study|Withdrawal of consent|16|||
155299252|NCT04532528|560526405|FG001|Overall Study|Withdrawal of consent|17|||
155299253|NCT04532528|560526404|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
155299254|NCT04532528|560526405|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
155299255|NCT04532528|560526404|FG000|Overall Study|Lost to Follow-up|69|||
155299256|NCT04532528|560526405|FG001|Overall Study|Lost to Follow-up|68|||
155299257|NCT04532528|560526404|FG000|Overall Study|Administrative problems|12|||
155299258|NCT04532528|560526405|FG001|Overall Study|Administrative problems|14|||
155299259|NCT04532528|560526404|FG000|Overall Study|Death|3|||
155299260|NCT04532528|560526405|FG001|Overall Study|Death|3|||
155299261|NCT04532528|560526404|FG000|Overall Study|Other|38|||
155299262|NCT04532528|560526405|FG001|Overall Study|Other|46|||
155299263|NCT01636687|560526406|FG000|Induction Period|Withdrawal by Subject|1|||
155299264|NCT01636687|560526407|FG001|Induction Period|Withdrawal by Subject|0|||
155299265|NCT01636687|560526408|FG002|Induction Period|Withdrawal by Subject|0|||
155299266|NCT01636687|560526409|FG003|Induction Period|Withdrawal by Subject|0|||
155299267|NCT01636687|560526410|FG004|Induction Period|Withdrawal by Subject|0|||
155299268|NCT01636687|560526406|FG000|Induction Period|Adverse Event|1|||
155299269|NCT01636687|560526407|FG001|Induction Period|Adverse Event|0|||
155299270|NCT01636687|560526408|FG002|Induction Period|Adverse Event|0|||
155299271|NCT01636687|560526409|FG003|Induction Period|Adverse Event|0|||
155299272|NCT01636687|560526410|FG004|Induction Period|Adverse Event|1|||
155299273|NCT01636687|560526406|FG000|Induction Period|Lack of Efficacy|0|||
155299274|NCT01636687|560526407|FG001|Induction Period|Lack of Efficacy|0|||
155299275|NCT01636687|560526408|FG002|Induction Period|Lack of Efficacy|0|||
155299276|NCT01636687|560526409|FG003|Induction Period|Lack of Efficacy|0|||
155299277|NCT01636687|560526410|FG004|Induction Period|Lack of Efficacy|1|||
155299278|NCT01636687|560526406|FG000|Induction Period|Physician Decision|1|||
155299279|NCT01636687|560526407|FG001|Induction Period|Physician Decision|0|||
155299280|NCT01636687|560526408|FG002|Induction Period|Physician Decision|0|||
155299281|NCT01636687|560526409|FG003|Induction Period|Physician Decision|0|||
155299282|NCT01636687|560526410|FG004|Induction Period|Physician Decision|0|||
155299283|NCT01636687|560526406|FG000|Maintenance Period|Withdrawal by Subject|2|||
155299284|NCT01636687|560526407|FG001|Maintenance Period|Withdrawal by Subject|0|||
155299285|NCT01636687|560526408|FG002|Maintenance Period|Withdrawal by Subject|2|||
155299286|NCT01636687|560526409|FG003|Maintenance Period|Withdrawal by Subject|0|||
155299287|NCT01636687|560526410|FG004|Maintenance Period|Withdrawal by Subject|0|||
155299288|NCT01636687|560526406|FG000|Maintenance Period|Adverse Event|1|||
155299289|NCT01636687|560526407|FG001|Maintenance Period|Adverse Event|0|||
155299290|NCT01636687|560526408|FG002|Maintenance Period|Adverse Event|0|||
155299291|NCT01636687|560526409|FG003|Maintenance Period|Adverse Event|0|||
155299292|NCT01636687|560526410|FG004|Maintenance Period|Adverse Event|0|||
155299293|NCT01636687|560526406|FG000|Maintenance Period|Lack of Efficacy|4|||
155299294|NCT01636687|560526407|FG001|Maintenance Period|Lack of Efficacy|1|||
155299295|NCT01636687|560526408|FG002|Maintenance Period|Lack of Efficacy|0|||
155299296|NCT01636687|560526409|FG003|Maintenance Period|Lack of Efficacy|0|||
155299297|NCT01636687|560526410|FG004|Maintenance Period|Lack of Efficacy|0|||
155299298|NCT01636687|560526406|FG000|Maintenance Period|Lost to Follow-up|1|||
155299299|NCT01636687|560526407|FG001|Maintenance Period|Lost to Follow-up|1|||
155299300|NCT01636687|560526408|FG002|Maintenance Period|Lost to Follow-up|0|||
155299301|NCT01636687|560526409|FG003|Maintenance Period|Lost to Follow-up|0|||
155299302|NCT01636687|560526410|FG004|Maintenance Period|Lost to Follow-up|1|||
155299303|NCT01636687|560526406|FG000|Maintenance Period|Physician Decision|0|||
155299304|NCT01636687|560526407|FG001|Maintenance Period|Physician Decision|0|||
155299305|NCT01636687|560526408|FG002|Maintenance Period|Physician Decision|0|||
155299306|NCT01636687|560526409|FG003|Maintenance Period|Physician Decision|0|||
155299307|NCT01636687|560526410|FG004|Maintenance Period|Physician Decision|1|||
155299308|NCT01636687|560526406|FG000|Extension Period|technical problems|0|||
155299309|NCT01636687|560526407|FG001|Extension Period|technical problems|1|||
155299310|NCT01636687|560526408|FG002|Extension Period|technical problems|2|||
155299311|NCT01636687|560526409|FG003|Extension Period|technical problems|1|||
155299312|NCT01636687|560526410|FG004|Extension Period|technical problems|0|||
155299313|NCT01636687|560526406|FG000|Extension Period|Adverse Event|4|||
155299314|NCT01636687|560526407|FG001|Extension Period|Adverse Event|3|||
155299315|NCT01636687|560526408|FG002|Extension Period|Adverse Event|2|||
155299316|NCT01636687|560526409|FG003|Extension Period|Adverse Event|1|||
155299317|NCT01636687|560526410|FG004|Extension Period|Adverse Event|0|||
155092589|NCT00560417|559773637|FG000|Overall Study|Physician Decision|2|||
155299318|NCT01636687|560526406|FG000|Extension Period|Lack of Efficacy|7|||
155299319|NCT01636687|560526407|FG001|Extension Period|Lack of Efficacy|0|||
155299320|NCT01636687|560526408|FG002|Extension Period|Lack of Efficacy|2|||
155299321|NCT01636687|560526409|FG003|Extension Period|Lack of Efficacy|1|||
155299322|NCT01636687|560526410|FG004|Extension Period|Lack of Efficacy|0|||
155299323|NCT01636687|560526406|FG000|Extension Period|Lost to Follow-up|1|||
155299324|NCT01636687|560526407|FG001|Extension Period|Lost to Follow-up|0|||
155299325|NCT01636687|560526408|FG002|Extension Period|Lost to Follow-up|1|||
155299326|NCT01636687|560526409|FG003|Extension Period|Lost to Follow-up|0|||
155299327|NCT01636687|560526410|FG004|Extension Period|Lost to Follow-up|0|||
155299328|NCT01636687|560526406|FG000|Extension Period|Physician Decision|1|||
155299329|NCT01636687|560526407|FG001|Extension Period|Physician Decision|0|||
155299330|NCT01636687|560526408|FG002|Extension Period|Physician Decision|0|||
155299331|NCT01636687|560526409|FG003|Extension Period|Physician Decision|1|||
155299332|NCT01636687|560526410|FG004|Extension Period|Physician Decision|0|||
155299333|NCT01636687|560526406|FG000|Extension Period|study terminated by sponsor|33|||
155299334|NCT01636687|560526407|FG001|Extension Period|study terminated by sponsor|50|||
155299335|NCT01636687|560526408|FG002|Extension Period|study terminated by sponsor|17|||
155299336|NCT01636687|560526409|FG003|Extension Period|study terminated by sponsor|23|||
155299337|NCT01636687|560526410|FG004|Extension Period|study terminated by sponsor|0|||
155299338|NCT01636687|560526406|FG000|Extension Period|Withdrawal by Subject|1|||
155299339|NCT01636687|560526407|FG001|Extension Period|Withdrawal by Subject|0|||
155299340|NCT01636687|560526408|FG002|Extension Period|Withdrawal by Subject|1|||
155299341|NCT01636687|560526409|FG003|Extension Period|Withdrawal by Subject|1|||
155299342|NCT01636687|560526410|FG004|Extension Period|Withdrawal by Subject|0|||
155299343|NCT01636687|560526406|FG000|Follow-up Period|Withdrawal by Subject|1|||
155299344|NCT01636687|560526407|FG001|Follow-up Period|Withdrawal by Subject|0|||
155299345|NCT01636687|560526408|FG002|Follow-up Period|Withdrawal by Subject|0|||
155299346|NCT01636687|560526409|FG003|Follow-up Period|Withdrawal by Subject|0|||
155299347|NCT01636687|560526410|FG004|Follow-up Period|Withdrawal by Subject|1|||
155299348|NCT03691428|560526418|FG000|Overall Study|Withdrawal by Subject|6|||
155299349|NCT03691428|560526419|FG001|Overall Study|Withdrawal by Subject|8|||
155299350|NCT01460290|560526420|FG000|Overall Study|Adverse Event|3|||
155299351|NCT01460290|560526420|FG000|Overall Study|Elevated liver function|1|||
155299352|NCT02527148|560526421|FG000|Overall Study|Did not receive study intervention|1|||
155299353|NCT02527148|560526422|FG001|Overall Study|Did not receive study intervention|0|||
155299354|NCT02918279|560526423|FG000|Overall Study|Lost to Follow-up|3|||
155299355|NCT02918279|560526424|FG001|Overall Study|Lost to Follow-up|6|||
155299356|NCT02918279|560526423|FG000|Overall Study|Withdrawal by Subject|5|||
155299357|NCT02918279|560526424|FG001|Overall Study|Withdrawal by Subject|15|||
155299358|NCT02918279|560526423|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155299359|NCT02918279|560526424|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155299360|NCT02918279|560526423|FG000|Overall Study|Other|3|||
155299361|NCT02918279|560526424|FG001|Overall Study|Other|1|||
155299362|NCT00309907|560526425|FG000|Overall Study|Death|4|||
155299363|NCT00309907|560526425|FG000|Overall Study|Physician Decision|1|||
155299364|NCT00309907|560526425|FG000|Overall Study|Ineligible|11|||
155299365|NCT00309907|560526425|FG000|Overall Study|Major infectious event|4|||
155299366|NCT00869258|560526426|FG000|Overall Study|Physician Decision|1|||
155299367|NCT02888080|560526427|FG000|Overall Study|Subject / Guardian decision|1|||
155299368|NCT02888080|560526428|FG001|Overall Study|Subject / Guardian decision|3|||
155299369|NCT02888080|560526427|FG000|Overall Study|New Therapy for study indication|1|||
155299370|NCT02888080|560526428|FG001|Overall Study|New Therapy for study indication|0|||
155299371|NCT02888080|560526427|FG000|Overall Study|Lack of Efficacy|0|||
155299372|NCT02888080|560526428|FG001|Overall Study|Lack of Efficacy|1|||
155299373|NCT02888080|560526427|FG000|Overall Study|Adverse Event|0|||
155299374|NCT02888080|560526428|FG001|Overall Study|Adverse Event|1|||
155299375|NCT01641198|560526429|FG000|After 12 Months of Function|Lost to Follow-up|3|||
155299376|NCT01641198|560526430|FG001|After 12 Months of Function|Lost to Follow-up|2|||
155299377|NCT01641198|560526431|FG002|After 12 Months of Function|Lost to Follow-up|2|||
155299378|NCT01641198|560526429|FG000|After 12 Months of Function|Protocol Violation|1|||
155299379|NCT01641198|560526430|FG001|After 12 Months of Function|Protocol Violation|0|||
155299380|NCT01641198|560526431|FG002|After 12 Months of Function|Protocol Violation|0|||
155299381|NCT01641198|560526429|FG000|After 12 Months of Function|Adverse Event|0|||
155299382|NCT01641198|560526430|FG001|After 12 Months of Function|Adverse Event|1|||
155299383|NCT01641198|560526431|FG002|After 12 Months of Function|Adverse Event|0|||
155299384|NCT01641198|560526429|FG000|After 24 Months of Function|Lost to Follow-up|4|||
155299385|NCT01641198|560526430|FG001|After 24 Months of Function|Lost to Follow-up|9|||
155299386|NCT01641198|560526431|FG002|After 24 Months of Function|Lost to Follow-up|6|||
155299387|NCT01641198|560526429|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
155299388|NCT01641198|560526430|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
155299389|NCT01641198|560526431|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
155299390|NCT01641198|560526429|FG000|At 15-20 Years of Function|Death|1|||
155299391|NCT01641198|560526430|FG001|At 15-20 Years of Function|Death|0|||
155299392|NCT01641198|560526431|FG002|At 15-20 Years of Function|Death|1|||
155299393|NCT01039688|560526432|FG000|Overall Study|Adverse Event|38|||
155299394|NCT01039688|560526433|FG001|Overall Study|Adverse Event|39|||
155158635|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
155299395|NCT01039688|560526434|FG002|Overall Study|Adverse Event|24|||
155299396|NCT01039688|560526432|FG000|Overall Study|Lack of Efficacy|20|||
155061622|NCT02867592|559659323|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
155061623|NCT02867592|559659324|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
155061624|NCT00909870|559659325|FG000|Overall Study|Adverse Event|13|||
155061625|NCT00909870|559659326|FG001|Overall Study|Adverse Event|7|||
155061626|NCT00909870|559659325|FG000|Overall Study|Protocol Violation|1|||
155061627|NCT00909870|559659326|FG001|Overall Study|Protocol Violation|2|||
155061628|NCT00909870|559659325|FG000|Overall Study|Withdrawal by Subject|5|||
155061629|NCT00909870|559659326|FG001|Overall Study|Withdrawal by Subject|8|||
155061630|NCT00909870|559659325|FG000|Overall Study|Lost to Follow-up|3|||
155061631|NCT00909870|559659326|FG001|Overall Study|Lost to Follow-up|3|||
155061632|NCT00909870|559659325|FG000|Overall Study|Physician Decision|0|||
155061633|NCT00909870|559659326|FG001|Overall Study|Physician Decision|2|||
155061634|NCT00909870|559659325|FG000|Overall Study|Other|1|||
155061635|NCT00909870|559659326|FG001|Overall Study|Other|5|||
155061636|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
155061637|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
155061638|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061639|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061640|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061641|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061642|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061643|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061644|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061645|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
155061646|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
155061647|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
155061648|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061649|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061650|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061651|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061652|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061653|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061654|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061655|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
155061656|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
155061657|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061658|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061659|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061660|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061661|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061662|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061663|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061664|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061665|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
155061666|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
155061667|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
155061668|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061669|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061670|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061671|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061672|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061673|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061674|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061675|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
155061676|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
155061677|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
155061678|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061679|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061680|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061681|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061682|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061683|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061684|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061685|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
155061686|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
155299397|NCT01039688|560526433|FG001|Overall Study|Lack of Efficacy|11|||
155299398|NCT01039688|560526434|FG002|Overall Study|Lack of Efficacy|26|||
155299399|NCT01039688|560526432|FG000|Overall Study|Lost to Follow-up|11|||
155299400|NCT01039688|560526433|FG001|Overall Study|Lost to Follow-up|9|||
155299401|NCT01039688|560526434|FG002|Overall Study|Lost to Follow-up|5|||
155299402|NCT01039688|560526432|FG000|Overall Study|Other|13|||
155299403|NCT01039688|560526433|FG001|Overall Study|Other|25|||
155299404|NCT01039688|560526434|FG002|Overall Study|Other|12|||
155299405|NCT01039688|560526432|FG000|Overall Study|Withdrawal by Subject|23|||
155299406|NCT01039688|560526433|FG001|Overall Study|Withdrawal by Subject|27|||
155299407|NCT01039688|560526434|FG002|Overall Study|Withdrawal by Subject|13|||
155299408|NCT01039688|560526432|FG000|Overall Study|Death|2|||
155299409|NCT01039688|560526433|FG001|Overall Study|Death|0|||
155299410|NCT01039688|560526434|FG002|Overall Study|Death|0|||
155299411|NCT00346151|560526435|FG000|Overall Study|Withdrawal by Subject|3|||
155299412|NCT00535145|560526438|FG000|Phase I|Adverse Event|3|||
155299413|NCT00535145|560526438|FG000|Phase I|Lost to Follow-up|7|||
155299414|NCT00535145|560526438|FG000|Phase I|Withdrawal by Subject|6|||
155299415|NCT00535145|560526438|FG000|Phase I|(eligibility)|8|||
155299416|NCT00535145|560526438|FG000|Phase I|(protocol violation)|1|||
155299417|NCT00535145|560526438|FG000|Phase I|(PI decision)|1|||
155299418|NCT00535145|560526438|FG000|Phase I|(diagnosis)|3|||
155299419|NCT00535145|560526438|FG000|Phase II|Adverse Event|2|||
155299420|NCT00535145|560526438|FG000|Phase II|Lack of Efficacy|1|||
155299421|NCT00535145|560526438|FG000|Phase II|Lost to Follow-up|5|||
155299422|NCT00535145|560526438|FG000|Phase II|Withdrawal by Subject|5|||
155299423|NCT00535145|560526438|FG000|Phase II|Subject non-compliance|2|||
155299424|NCT01124734|560526440|FG000|Overall Study|Disease progression|13|||
155299425|NCT01124734|560526440|FG000|Overall Study|Adverse Event|1|||
155299426|NCT01124734|560526440|FG000|Overall Study|Withdrawal by Subject|1|||
155299427|NCT01124734|560526440|FG000|Overall Study|Elected for alternative treatment|2|||
155299428|NCT02423798|560526441|FG000|Overall Study|Withdrawal by Subject|3|||
155299429|NCT01430611|560526445|FG000|Overall Study|Adverse Event|0|||
155299430|NCT01430611|560526446|FG001|Overall Study|Adverse Event|1|||
155299431|NCT01430611|560526445|FG000|Overall Study|Protocol Violation|1|||
155299432|NCT01430611|560526446|FG001|Overall Study|Protocol Violation|0|||
155299433|NCT01430611|560526445|FG000|Overall Study|Lost to Follow-up|1|||
155299434|NCT01430611|560526446|FG001|Overall Study|Lost to Follow-up|0|||
155299435|NCT01430611|560526445|FG000|Overall Study|Withdrawal by Subject|15|||
155299436|NCT01430611|560526446|FG001|Overall Study|Withdrawal by Subject|14|||
155299437|NCT02204982|560526447|FG000|Overall Study|Patient ineligible-medical monitor|1|||
155299438|NCT02204982|560526448|FG001|Overall Study|Patient ineligible-medical monitor|0|||
155299439|NCT02204982|560526447|FG000|Overall Study|Withdrawal by Subject|1|||
155299440|NCT02204982|560526448|FG001|Overall Study|Withdrawal by Subject|0|||
155299441|NCT02204982|560526447|FG000|Overall Study|Adverse Event|1|||
155299442|NCT02204982|560526448|FG001|Overall Study|Adverse Event|0|||
155299443|NCT02204982|560526447|FG000|Overall Study|Adverse Event and Investigator decision|1|||
155299444|NCT02204982|560526448|FG001|Overall Study|Adverse Event and Investigator decision|0|||
155299445|NCT02204982|560526447|FG000|Overall Study|Physician Decision|0|||
155299446|NCT02204982|560526448|FG001|Overall Study|Physician Decision|2|||
155299447|NCT02204982|560526447|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
155299448|NCT02204982|560526448|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
155299449|NCT02204982|560526447|FG000|Overall Study|Termination of Study bySponsor|0|||
155299450|NCT02204982|560526448|FG001|Overall Study|Termination of Study bySponsor|1|||
155299451|NCT01943916|560526453|FG000|Overall Study|Technically invalid images|10|||
155299452|NCT01943916|560526453|FG000|Overall Study|Enrollment Failure|23|||
155299453|NCT01943916|560526453|FG000|Overall Study|Pilot Phase exclusion|100|||
155299454|NCT01943916|560526453|FG000|Overall Study|Quality Assurance Reader Fail|130|||
155299455|NCT01943916|560526453|FG000|Overall Study|Technical Failure|39|||
155299456|NCT01943916|560526453|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
155299457|NCT01943916|560526453|FG000|Overall Study|No Truth Panel Review|38|||
155299458|NCT01943916|560526453|FG000|Overall Study|Protocol Deviation|1|||
155299459|NCT00919763|560526454|FG000|Overall Study|Adverse Event|7|||
154957408|NCT00272779|559272423|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
154957409|NCT00272779|559272424|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
154957410|NCT00272779|559272423|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
154957411|NCT00272779|559272424|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
154957412|NCT00272779|559272423|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
154957413|NCT00272779|559272424|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
154957414|NCT00272779|559272423|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
154957415|NCT00272779|559272424|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
154957416|NCT00272779|559272423|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
154957417|NCT00272779|559272424|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
155299460|NCT00919763|560526455|FG001|Overall Study|Adverse Event|1|||
155299461|NCT00919763|560526454|FG000|Overall Study|Lost to Follow-up|1|||
154957418|NCT00272779|559272423|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
155299462|NCT00919763|560526455|FG001|Overall Study|Lost to Follow-up|0|||
155299463|NCT00919763|560526454|FG000|Overall Study|Protocol Violation|1|||
155299464|NCT00919763|560526455|FG001|Overall Study|Protocol Violation|1|||
155299465|NCT00919763|560526454|FG000|Overall Study|Withdrawal by Subject|3|||
155299466|NCT00919763|560526455|FG001|Overall Study|Withdrawal by Subject|1|||
155299467|NCT00919763|560526454|FG000|Overall Study|Non-compliance|0|||
155299468|NCT00919763|560526455|FG001|Overall Study|Non-compliance|1|||
155299469|NCT04740164|560526456|FG000|Overall Study|Lack of Efficacy|4|||
155299470|NCT04740164|560526457|FG001|Overall Study|Lack of Efficacy|0|||
155299471|NCT04740164|560526456|FG000|Overall Study|Physician Decision|3|||
155299472|NCT04740164|560526457|FG001|Overall Study|Physician Decision|3|||
155299473|NCT00442117|560526461|FG000|Overall Study|Adverse Event|3|||
155299474|NCT00442117|560526462|FG001|Overall Study|Adverse Event|2|||
155299475|NCT00442117|560526461|FG000|Overall Study|Lack of Efficacy|2|||
155299476|NCT00442117|560526462|FG001|Overall Study|Lack of Efficacy|6|||
155299477|NCT00442117|560526461|FG000|Overall Study|Lost to Follow-up|1|||
155299478|NCT00442117|560526462|FG001|Overall Study|Lost to Follow-up|2|||
155299479|NCT00442117|560526461|FG000|Overall Study|Withdrawal by Subject|2|||
155299480|NCT00442117|560526462|FG001|Overall Study|Withdrawal by Subject|2|||
155299481|NCT00442117|560526461|FG000|Overall Study|Major Deviation|25|||
155299482|NCT00442117|560526462|FG001|Overall Study|Major Deviation|20|||
155299483|NCT00442117|560526461|FG000|Overall Study|Non compliance with protocol|3|||
155299484|NCT00442117|560526462|FG001|Overall Study|Non compliance with protocol|5|||
155299485|NCT00442117|560526461|FG000|Overall Study|Met Withdrawal Criteria|2|||
155299486|NCT00442117|560526462|FG001|Overall Study|Met Withdrawal Criteria|1|||
155299487|NCT00206375|560526463|FG000|Overall Study|Lost to Follow-up|1|||
155299488|NCT00206375|560526464|FG001|Overall Study|Lost to Follow-up|0|||
155299489|NCT00206375|560526465|FG002|Overall Study|Lost to Follow-up|0|||
155299490|NCT00206375|560526463|FG000|Overall Study|Withdrawal by Subject|2|||
155299491|NCT00206375|560526464|FG001|Overall Study|Withdrawal by Subject|1|||
155299492|NCT00206375|560526465|FG002|Overall Study|Withdrawal by Subject|3|||
155299493|NCT00206375|560526463|FG000|Overall Study|Study terminated due to lack of funds|0|||
155299494|NCT00206375|560526464|FG001|Overall Study|Study terminated due to lack of funds|1|||
155299495|NCT00206375|560526465|FG002|Overall Study|Study terminated due to lack of funds|1|||
155299496|NCT04789408|560526466|FG000|Overall Study|Death|4|||
155299497|NCT04789408|560526467|FG001|Overall Study|Death|3|||
155299498|NCT04789408|560526468|FG002|Overall Study|Death|6|||
155299499|NCT04789408|560526466|FG000|Overall Study|Did not meet eligibility criteria|1|||
155299500|NCT04789408|560526467|FG001|Overall Study|Did not meet eligibility criteria|0|||
155299501|NCT04789408|560526468|FG002|Overall Study|Did not meet eligibility criteria|0|||
155299502|NCT04789408|560526466|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
155299503|NCT04789408|560526467|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
155299504|NCT04789408|560526468|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
155299505|NCT00840177|560527921|FG000|Overall Study|Adverse Event|5|||
155299506|NCT00840177|560527922|FG001|Overall Study|Adverse Event|1|||
155299507|NCT00840177|560527923|FG002|Overall Study|Adverse Event|1|||
155299508|NCT00840177|560527921|FG000|Overall Study|Refusal unrelated to adverse events|1|||
155299509|NCT00840177|560527922|FG001|Overall Study|Refusal unrelated to adverse events|0|||
155299510|NCT00840177|560527923|FG002|Overall Study|Refusal unrelated to adverse events|1|||
155299511|NCT00840177|560527921|FG000|Overall Study|Progression/relapse|2|||
155299512|NCT00840177|560527922|FG001|Overall Study|Progression/relapse|0|||
155299513|NCT00840177|560527923|FG002|Overall Study|Progression/relapse|0|||
155299514|NCT00840177|560527921|FG000|Overall Study|Death|4|||
155299515|NCT00840177|560527922|FG001|Overall Study|Death|5|||
155299516|NCT00840177|560527923|FG002|Overall Study|Death|5|||
155299517|NCT00840177|560527921|FG000|Overall Study|not protocol specified|6|||
155299518|NCT00840177|560527922|FG001|Overall Study|not protocol specified|3|||
155299519|NCT00840177|560527923|FG002|Overall Study|not protocol specified|0|||
155299520|NCT00840177|560527921|FG000|Overall Study|Ineligible|0|||
155299521|NCT00840177|560527922|FG001|Overall Study|Ineligible|0|||
155299522|NCT00840177|560527923|FG002|Overall Study|Ineligible|3|||
155299523|NCT00840177|560527921|FG000|Overall Study|Did not start treatment|0|||
155299524|NCT00840177|560527922|FG001|Overall Study|Did not start treatment|0|||
155299525|NCT00840177|560527923|FG002|Overall Study|Did not start treatment|1|||
155299526|NCT03345901|560527927|FG000|Overall Study|The study was terminated|18|||
155299527|NCT00925587|560527928|FG000|Overall Study|Protocol Specified Criteria|6|||
155061687|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
155061688|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061689|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061690|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061691|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061692|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061693|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061694|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155061695|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
155158636|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
155158637|NCT03773978|560018832|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
155158638|NCT03773978|560018833|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
155158639|NCT03773978|560018832|FG000|DBW Period|Adverse Event|2|||
155158640|NCT03773978|560018833|FG001|DBW Period|Adverse Event|2|||
155158641|NCT03773978|560018832|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
155158642|NCT03773978|560018833|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
155158643|NCT03773978|560018832|FG000|DBW Period|Withdrawal by Subject|2|||
155158644|NCT03773978|560018833|FG001|DBW Period|Withdrawal by Subject|1|||
155158645|NCT03773978|560018832|FG000|DBW Period|Due to epidemic or pandemic|5|||
155158646|NCT03773978|560018833|FG001|DBW Period|Due to epidemic or pandemic|6|||
155158647|NCT03773978|560018832|FG000|DBW Period|Study team decision|1|||
154957419|NCT00272779|559272424|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
154957420|NCT00272779|559272423|FG000|Baseline Through Week 48|Continuing treatment|385|||
155158648|NCT03773978|560018833|FG001|DBW Period|Study team decision|0|||
155158649|NCT04189952|560018834|FG000|Follow-up Period|Death|1|||
154957421|NCT00272779|559272424|FG001|Baseline Through Week 48|Continuing treatment|368|||
154957422|NCT00272779|559272423|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
154957423|NCT00272779|559272424|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
154957424|NCT00272779|559272423|FG000|Baseline Through Week 48|Never treated|2|||
154957425|NCT00272779|559272424|FG001|Baseline Through Week 48|Never treated|3|||
154957426|NCT00272779|559272423|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
154957427|NCT00272779|559272424|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
154957428|NCT00272779|559272423|FG000|Baseline Through Week 96|Death before Week 96|6|||
154957429|NCT00272779|559272424|FG001|Baseline Through Week 96|Death before Week 96|5|||
154957430|NCT00272779|559272423|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
154957431|NCT00272779|559272424|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
154957432|NCT00272779|559272423|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
154957433|NCT00272779|559272424|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
154957434|NCT00272779|559272423|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
154957435|NCT00272779|559272424|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
154957436|NCT00272779|559272423|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
154957437|NCT00272779|559272424|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
154957438|NCT00272779|559272423|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
154957439|NCT00272779|559272424|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
154957440|NCT00272779|559272423|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
154957441|NCT00272779|559272424|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
154957442|NCT00272779|559272423|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
154957443|NCT00272779|559272424|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
154957444|NCT00272779|559272423|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
154957445|NCT00272779|559272424|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
154957446|NCT00272779|559272423|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
154957447|NCT00272779|559272424|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
154957448|NCT00272779|559272423|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
154957449|NCT00272779|559272424|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
154957450|NCT00272779|559272423|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
154957451|NCT00272779|559272424|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
154957452|NCT00272779|559272423|FG000|Baseline Through Week 96|Never treated|2|||
154957453|NCT00272779|559272424|FG001|Baseline Through Week 96|Never treated|3|||
154957454|NCT00272779|559272423|FG000|Baseline Through Week 96|Continuing on treatment|61|||
154957455|NCT00272779|559272424|FG001|Baseline Through Week 96|Continuing on treatment|38|||
154957456|NCT03450057|559272427|FG000|Overall Study|Death|17|||
154957457|NCT03450057|559272427|FG000|Overall Study|ICF withdrawal|4|||
154957458|NCT03450057|559272427|FG000|Overall Study|Lost to Follow-up|2|||
154957459|NCT05755282|559272428|FG000|Overall Study|Protocol Violation|0|||
154957460|NCT05755282|559272429|FG001|Overall Study|Protocol Violation|1|||
154957461|NCT04129346|559272430|FG000|Overall Study|Death|1|||
154957462|NCT04129346|559272431|FG001|Overall Study|Death|0|||
154957463|NCT02924883|559272432|FG000|Overall Study|Death|39|||
154957464|NCT02924883|559272433|FG001|Overall Study|Death|20|||
154957465|NCT02924883|559272432|FG000|Overall Study|Lost to Follow-up|1|||
154957466|NCT02924883|559272433|FG001|Overall Study|Lost to Follow-up|0|||
154957467|NCT02924883|559272432|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
154957468|NCT02924883|559272433|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
154957469|NCT02924883|559272432|FG000|Overall Study|Protocol Violation|1|||
154957470|NCT02924883|559272433|FG001|Overall Study|Protocol Violation|0|||
154957471|NCT02924883|559272432|FG000|Overall Study|Withdrawal by Subject|22|||
154957472|NCT02924883|559272433|FG001|Overall Study|Withdrawal by Subject|16|||
154957473|NCT02924883|559272432|FG000|Overall Study|Progressive Disease|1|||
155158650|NCT04189952|560018834|FG000|Follow-up Period|Withdrawal by Subject|1|||
155158651|NCT01342211|560018842|FG000|Overall Study|Lost to Follow-up|0|||
155299528|NCT00925587|560527929|FG001|Overall Study|Protocol Specified Criteria|6|||
155299529|NCT00925587|560527928|FG000|Overall Study|Physician Decision|4|||
155299530|NCT00925587|560527929|FG001|Overall Study|Physician Decision|1|||
155299531|NCT00925587|560527928|FG000|Overall Study|Protocol Violation|6|||
155299532|NCT00925587|560527929|FG001|Overall Study|Protocol Violation|4|||
155299533|NCT00925587|560527928|FG000|Overall Study|Withdrawal by Subject|9|||
155299534|NCT00925587|560527929|FG001|Overall Study|Withdrawal by Subject|6|||
155299535|NCT00925587|560527928|FG000|Overall Study|Death|5|||
155299536|NCT00925587|560527929|FG001|Overall Study|Death|5|||
155299537|NCT00925587|560527928|FG000|Overall Study|Adverse Event|6|||
155299538|NCT00925587|560527929|FG001|Overall Study|Adverse Event|2|||
155299539|NCT00925587|560527928|FG000|Overall Study|Lost to Follow-up|0|||
155299540|NCT00925587|560527929|FG001|Overall Study|Lost to Follow-up|1|||
155299541|NCT00414544|560527930|FG000|Overall Study|Lost to Follow-up|14|||
155299542|NCT01318382|560527932|FG000|Overall Study|Physician Decision|2|||
155299543|NCT01318382|560527932|FG000|Overall Study|Device Malfunction|10|||
155299544|NCT01318382|560527932|FG000|Overall Study|Protocol Violation|1|||
155299545|NCT01308567|560527935|FG000|Overall Study|Lost to Follow-up|2|||
155299546|NCT01308567|560527936|FG001|Overall Study|Lost to Follow-up|4|||
155299547|NCT01308567|560527937|FG002|Overall Study|Lost to Follow-up|4|||
155299548|NCT01571596|560527938|FG000|Overall Study|Adverse Event|2|||
155299549|NCT01571596|560527939|FG001|Overall Study|Adverse Event|0|||
155299550|NCT01571596|560527940|FG002|Overall Study|Adverse Event|0|||
155299551|NCT01571596|560527938|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155299552|NCT01571596|560527939|FG001|Overall Study|Study Terminated by the Sponsor|1|||
155299553|NCT01571596|560527940|FG002|Overall Study|Study Terminated by the Sponsor|1|||
155299554|NCT00585052|560527949|FG000|Overall Study|Withdrawal by Subject|1|||
155299555|NCT04425863|560527950|FG000|Overall Study|Death|0|||
155299556|NCT04425863|560527951|FG001|Overall Study|Death|0|||
155299557|NCT04425863|560527952|FG002|Overall Study|Death|1|||
155299558|NCT00277355|560527957|FG000|Overall Study|Withdrawal by Subject|3|||
155299559|NCT00277355|560527958|FG001|Overall Study|Withdrawal by Subject|3|||
155299560|NCT00277355|560527957|FG000|Overall Study|Lost to Follow-up|2|||
155299561|NCT00277355|560527958|FG001|Overall Study|Lost to Follow-up|2|||
155299562|NCT00277355|560527957|FG000|Overall Study|Adverse Event|5|||
155299563|NCT00277355|560527958|FG001|Overall Study|Adverse Event|0|||
155299564|NCT00277355|560527957|FG000|Overall Study|Death|3|||
155299565|NCT00277355|560527958|FG001|Overall Study|Death|0|||
155299566|NCT00277355|560527957|FG000|Overall Study|Physician Decision|1|||
155299567|NCT00277355|560527958|FG001|Overall Study|Physician Decision|0|||
155299568|NCT01140048|560527961|FG000|Overall Study|Physician Decision|1|||
155299569|NCT01140048|560527961|FG000|Overall Study|Withdrawal by Subject|13|||
155158652|NCT01342211|560018843|FG001|Overall Study|Lost to Follow-up|0|||
155158653|NCT01342211|560018844|FG002|Overall Study|Lost to Follow-up|0|||
155158654|NCT01342211|560018845|FG003|Overall Study|Lost to Follow-up|1|||
155158655|NCT01342211|560018846|FG004|Overall Study|Lost to Follow-up|0|||
155158656|NCT01342211|560018842|FG000|Overall Study|Adverse Event|0|||
155158657|NCT01342211|560018843|FG001|Overall Study|Adverse Event|0|||
155158658|NCT01342211|560018844|FG002|Overall Study|Adverse Event|0|||
155158659|NCT01342211|560018845|FG003|Overall Study|Adverse Event|0|||
155158660|NCT01342211|560018846|FG004|Overall Study|Adverse Event|1|||
155158661|NCT01342211|560018842|FG000|Overall Study|Withdrawal by Subject|0|||
155158662|NCT01342211|560018843|FG001|Overall Study|Withdrawal by Subject|0|||
155158663|NCT01342211|560018844|FG002|Overall Study|Withdrawal by Subject|0|||
155158664|NCT01342211|560018845|FG003|Overall Study|Withdrawal by Subject|1|||
155158665|NCT01342211|560018846|FG004|Overall Study|Withdrawal by Subject|0|||
155158666|NCT01342211|560018842|FG000|Overall Study|Randomized, but not Treated|0|||
155158667|NCT01342211|560018843|FG001|Overall Study|Randomized, but not Treated|2|||
155158668|NCT01342211|560018844|FG002|Overall Study|Randomized, but not Treated|0|||
155158669|NCT01342211|560018845|FG003|Overall Study|Randomized, but not Treated|0|||
155158670|NCT01342211|560018846|FG004|Overall Study|Randomized, but not Treated|1|||
155158671|NCT02638220|560018852|FG000|Overall Study|Lost to Follow-up|6|||
155299570|NCT01140048|560527961|FG000|Overall Study|Lost to Follow-up|31|||
155158672|NCT02638220|560018852|FG000|Overall Study|Withdrawal by Subject|3|||
155158673|NCT02638220|560018852|FG000|Overall Study|Physician Decision|1|||
155158674|NCT02638220|560018852|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
155158675|NCT04323124|560018854|FG000|Overall Study|Adverse Event|0|||
155158676|NCT04323124|560018855|FG001|Overall Study|Adverse Event|0|||
155158677|NCT04323124|560018856|FG002|Overall Study|Adverse Event|0|||
155158678|NCT04323124|560018857|FG003|Overall Study|Adverse Event|0|||
155299571|NCT00636207|560527962|FG000|Overall Study|Adverse Event|1|||
155299572|NCT00636207|560527963|FG001|Overall Study|Adverse Event|0|||
155299573|NCT00636207|560527964|FG002|Overall Study|Adverse Event|0|||
155299574|NCT00636207|560527965|FG003|Overall Study|Adverse Event|0|||
155299575|NCT00636207|560527966|FG004|Overall Study|Adverse Event|0|||
155158679|NCT04323124|560018858|FG004|Overall Study|Adverse Event|0|||
155299576|NCT00636207|560527967|FG005|Overall Study|Adverse Event|0|||
155299577|NCT00636207|560527968|FG006|Overall Study|Adverse Event|0|||
155299578|NCT00636207|560527962|FG000|Overall Study|Withdrawal by Subject|0|||
155299579|NCT00636207|560527963|FG001|Overall Study|Withdrawal by Subject|1|||
155299580|NCT00636207|560527964|FG002|Overall Study|Withdrawal by Subject|0|||
155299581|NCT00636207|560527965|FG003|Overall Study|Withdrawal by Subject|0|||
155299582|NCT00636207|560527966|FG004|Overall Study|Withdrawal by Subject|1|||
155299583|NCT00636207|560527967|FG005|Overall Study|Withdrawal by Subject|0|||
155299584|NCT00636207|560527968|FG006|Overall Study|Withdrawal by Subject|0|||
155299585|NCT00666276|560527972|FG000|Overall Study|Protocol Violation|34|||
155299586|NCT02594735|560527973|FG000|Overall Study|Adverse Event|1|||
155299587|NCT00668863|560527974|FG000|Overall Study|Objective Progression or Relapse|42|||
155299588|NCT00668863|560527974|FG000|Overall Study|Adverse Event|13|||
155299589|NCT00668863|560527974|FG000|Overall Study|Study Terminated by Sponsor|8|||
155299590|NCT00668863|560527974|FG000|Overall Study|Global Deterioration of Health Status|4|||
155299591|NCT00668863|560527974|FG000|Overall Study|Withdrawal by Subject|1|||
155299592|NCT00668863|560527974|FG000|Overall Study|Surgery|1|||
155299593|NCT00668863|560527974|FG000|Overall Study|Subject's work scheduling problem|1|||
155299594|NCT00668863|560527974|FG000|Overall Study|Physician Decision|1|||
155299595|NCT03844269|560527980|FG000|Overall Study|Withdrawal pre-intervention|1|||
155299596|NCT03844269|560527980|FG000|Overall Study|Did not complete the intervention|2|||
155299597|NCT01075217|560527986|FG000|Overall Study|Adverse Event|1|||
155299598|NCT01075217|560527987|FG001|Overall Study|Adverse Event|1|||
155299599|NCT01075217|560527986|FG000|Overall Study|Physician Decision|1|||
155299600|NCT01075217|560527987|FG001|Overall Study|Physician Decision|0|||
155299601|NCT01068743|560527992|FG000|Period 3|Adverse Event|0|||
155299602|NCT01068743|560527993|FG001|Period 3|Adverse Event|1|||
155299603|NCT01068743|560527994|FG002|Period 3|Adverse Event|0|||
155299604|NCT01068743|560527995|FG003|Period 3|Adverse Event|0|||
155299605|NCT00293293|560527996|FG000|Overall Study|Withdrawal by Subject|1|||
155299606|NCT00293293|560527997|FG001|Overall Study|Withdrawal by Subject|1|||
155299607|NCT00293293|560527996|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
155299608|NCT00293293|560527997|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
155299609|NCT00293293|560527996|FG000|Overall Study|Patient discontinued chemotherapy|0|||
155299610|NCT00293293|560527997|FG001|Overall Study|Patient discontinued chemotherapy|1|||
155299611|NCT02512965|560527999|FG000|Overall Study|Withdrawal by Subject|0|||
155299612|NCT02512965|560528000|FG001|Overall Study|Withdrawal by Subject|4|||
155299613|NCT00835770|560528001|FG000|Overall Study|MS Relapse|17|||
155299614|NCT00835770|560528002|FG001|Overall Study|MS Relapse|23|||
155299615|NCT00835770|560528001|FG000|Overall Study|MS Progression|14|||
155299616|NCT00835770|560528002|FG001|Overall Study|MS Progression|9|||
155299617|NCT00835770|560528001|FG000|Overall Study|Adverse Event|113|||
155299618|NCT00835770|560528002|FG001|Overall Study|Adverse Event|124|||
155299619|NCT00835770|560528001|FG000|Overall Study|Lost to Follow-up|22|||
155299620|NCT00835770|560528002|FG001|Overall Study|Lost to Follow-up|19|||
155299621|NCT00835770|560528001|FG000|Overall Study|Consent Withdrawn|144|||
155299622|NCT00835770|560528002|FG001|Overall Study|Consent Withdrawn|156|||
155299623|NCT00835770|560528001|FG000|Overall Study|Investigator Decision|42|||
155299624|NCT00835770|560528002|FG001|Overall Study|Investigator Decision|42|||
155299625|NCT00835770|560528001|FG000|Overall Study|Participant Non-Compliance|11|||
155299626|NCT00835770|560528002|FG001|Overall Study|Participant Non-Compliance|9|||
155299627|NCT00835770|560528001|FG000|Overall Study|Death|4|||
155299628|NCT00835770|560528002|FG001|Overall Study|Death|6|||
155299629|NCT00835770|560528001|FG000|Overall Study|Other|115|||
155299630|NCT00835770|560528002|FG001|Overall Study|Other|104|||
155299631|NCT00835770|560528001|FG000|Overall Study|Other|2|||
155299632|NCT00835770|560528002|FG001|Overall Study|Other|1|||
155299633|NCT02507752|560528003|FG000|Overall Study|Adverse Event|1|||
155299634|NCT02507752|560528003|FG000|Overall Study|Protocol Violation|6|||
155299635|NCT02507752|560528003|FG000|Overall Study|Lost to Follow-up|7|||
155299636|NCT02507752|560528003|FG000|Overall Study|Infusion reaction at first infusion|1|||
155299637|NCT02507752|560528003|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
155299638|NCT02507752|560528003|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
155158680|NCT04323124|560018859|FG005|Overall Study|Adverse Event|1|||
155158681|NCT04323124|560018860|FG006|Overall Study|Adverse Event|0|||
155158682|NCT04323124|560018861|FG007|Overall Study|Adverse Event|1|||
155158683|NCT04323124|560018862|FG008|Overall Study|Adverse Event|1|||
154957474|NCT02924883|559272433|FG001|Overall Study|Progressive Disease|0|||
154957475|NCT02924883|559272432|FG000|Overall Study|Study Terminated by Sponsor|69|||
154957476|NCT02924883|559272433|FG001|Overall Study|Study Terminated by Sponsor|32|||
154957477|NCT00004562|559272434|FG000|Overall Study|Lost to Follow-up|102|||
154957478|NCT00004562|559272435|FG001|Overall Study|Lost to Follow-up|91|||
154957479|NCT00312663|559272436|FG000|Immunization Phase|Adverse Event|0|||
155299639|NCT01369498|560528004|FG000|Overall Study|Lack of Efficacy|9|||
155299640|NCT01369498|560528005|FG001|Overall Study|Lack of Efficacy|9|||
155299641|NCT01369498|560528006|FG002|Overall Study|Lack of Efficacy|1|||
155299642|NCT01369498|560528007|FG003|Overall Study|Lack of Efficacy|3|||
155299643|NCT01369498|560528004|FG000|Overall Study|Adverse Event|1|||
155299644|NCT01369498|560528005|FG001|Overall Study|Adverse Event|2|||
155158684|NCT04323124|560018863|FG009|Overall Study|Adverse Event|0|||
155299645|NCT01369498|560528006|FG002|Overall Study|Adverse Event|0|||
155299646|NCT01369498|560528007|FG003|Overall Study|Adverse Event|1|||
154957480|NCT00312663|559272437|FG001|Immunization Phase|Adverse Event|1|||
154957481|NCT00312663|559272438|FG002|Immunization Phase|Adverse Event|0|||
154957482|NCT04247282|559272439|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
155299647|NCT01369498|560528004|FG000|Overall Study|Withdrawal of Consent|0|||
155299648|NCT01369498|560528005|FG001|Overall Study|Withdrawal of Consent|1|||
155299649|NCT01369498|560528006|FG002|Overall Study|Withdrawal of Consent|1|||
155299650|NCT01369498|560528007|FG003|Overall Study|Withdrawal of Consent|1|||
155299651|NCT01369498|560528004|FG000|Overall Study|Death|0|||
155299652|NCT01369498|560528005|FG001|Overall Study|Death|0|||
155299653|NCT01369498|560528006|FG002|Overall Study|Death|1|||
155299654|NCT01369498|560528007|FG003|Overall Study|Death|0|||
155299655|NCT01369498|560528004|FG000|Overall Study|Investigator's Discretion|1|||
155299656|NCT01369498|560528005|FG001|Overall Study|Investigator's Discretion|0|||
155299657|NCT01369498|560528006|FG002|Overall Study|Investigator's Discretion|1|||
155299658|NCT01369498|560528007|FG003|Overall Study|Investigator's Discretion|3|||
155299659|NCT01369498|560528004|FG000|Overall Study|Unknown Reason|1|||
155299660|NCT01369498|560528005|FG001|Overall Study|Unknown Reason|0|||
155299661|NCT01369498|560528006|FG002|Overall Study|Unknown Reason|11|||
155299662|NCT01369498|560528007|FG003|Overall Study|Unknown Reason|6|||
155299663|NCT01369498|560528004|FG000|Overall Study|Disease Progression|0|||
155299664|NCT01369498|560528005|FG001|Overall Study|Disease Progression|0|||
155299665|NCT01369498|560528006|FG002|Overall Study|Disease Progression|0|||
155299666|NCT01369498|560528007|FG003|Overall Study|Disease Progression|1|||
155299667|NCT02202499|560528014|FG000|Overall Study|Cancer diagnosis|0|||
155299668|NCT02202499|560528015|FG001|Overall Study|Cancer diagnosis|0|||
155299669|NCT02202499|560528016|FG002|Overall Study|Cancer diagnosis|1|||
155299670|NCT02202499|560528014|FG000|Overall Study|Moved from area|0|||
155299671|NCT02202499|560528015|FG001|Overall Study|Moved from area|0|||
155299672|NCT02202499|560528016|FG002|Overall Study|Moved from area|1|||
155299673|NCT02202499|560528014|FG000|Overall Study|Declined before randomization|1|||
155299674|NCT02202499|560528015|FG001|Overall Study|Declined before randomization|0|||
155299675|NCT02202499|560528016|FG002|Overall Study|Declined before randomization|0|||
155299676|NCT02202499|560528014|FG000|Overall Study|Auto accident|1|||
155299677|NCT02202499|560528015|FG001|Overall Study|Auto accident|0|||
155299678|NCT02202499|560528016|FG002|Overall Study|Auto accident|0|||
155299679|NCT00159783|560528020|FG000|Overall Study|Adverse Event|5|||
155299680|NCT00159783|560528021|FG001|Overall Study|Adverse Event|7|||
155299681|NCT00159783|560528022|FG002|Overall Study|Adverse Event|9|||
155299682|NCT00159783|560528020|FG000|Overall Study|Lack of Efficacy|1|||
155299683|NCT00159783|560528021|FG001|Overall Study|Lack of Efficacy|2|||
155299684|NCT00159783|560528022|FG002|Overall Study|Lack of Efficacy|3|||
155299685|NCT00159783|560528020|FG000|Overall Study|Withdrawal by Subject|7|||
155299686|NCT00159783|560528021|FG001|Overall Study|Withdrawal by Subject|11|||
155299687|NCT00159783|560528022|FG002|Overall Study|Withdrawal by Subject|12|||
155299688|NCT00159783|560528020|FG000|Overall Study|Lost to Follow-up|6|||
155299689|NCT00159783|560528021|FG001|Overall Study|Lost to Follow-up|5|||
155299690|NCT00159783|560528022|FG002|Overall Study|Lost to Follow-up|11|||
155299691|NCT00159783|560528020|FG000|Overall Study|Other|0|||
155299692|NCT00159783|560528021|FG001|Overall Study|Other|2|||
155299693|NCT00159783|560528022|FG002|Overall Study|Other|4|||
155299694|NCT02538107|560528023|FG000|Overall Study|Did not receive any Mircera dose|11|||
155299695|NCT02538107|560528023|FG000|Overall Study|Missing|5|||
155299696|NCT02538107|560528023|FG000|Overall Study|Necessity of dialysis|20|||
155299697|NCT02538107|560528023|FG000|Overall Study|Administration of other ESA|11|||
155299698|NCT02538107|560528023|FG000|Overall Study|No further treatment necessary|18|||
155299699|NCT02538107|560528023|FG000|Overall Study|Withdrawal by Subject|17|||
154957483|NCT04247282|559272440|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
154957484|NCT04247282|559272441|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
154957485|NCT04247282|559272442|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
154957486|NCT04247282|559272439|FG000|Overall Study|Refused further treatment|0|||
154957487|NCT04247282|559272440|FG001|Overall Study|Refused further treatment|1|||
154957488|NCT04247282|559272441|FG002|Overall Study|Refused further treatment|0|||
154957489|NCT04247282|559272442|FG003|Overall Study|Refused further treatment|0|||
154957490|NCT00301366|559272443|FG000|Overall Study|Adverse Event|1|||
154957491|NCT00552669|559272448|FG000|Overall Study|Death|3|||
155299700|NCT02538107|560528023|FG000|Overall Study|Death|4|||
155299701|NCT02538107|560528023|FG000|Overall Study|Administrative reason|5|||
155299702|NCT02538107|560528023|FG000|Overall Study|Adverse Event|4|||
155299703|NCT02538107|560528023|FG000|Overall Study|Surgery|1|||
155061696|NCT01232283|559659329|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
155061697|NCT01232283|559659330|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
155061698|NCT01232283|559659331|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155299704|NCT02538107|560528023|FG000|Overall Study|Other|7|||
155299705|NCT02538107|560528023|FG000|Overall Study|Not recorded|7|||
155299706|NCT01236560|560528024|FG000|Overall Study|Adverse Event|0|||
155299707|NCT01236560|560528025|FG001|Overall Study|Adverse Event|2|||
155299708|NCT01236560|560528026|FG002|Overall Study|Adverse Event|1|||
155299709|NCT01236560|560528027|FG003|Overall Study|Adverse Event|3|||
155299710|NCT01236560|560528028|FG004|Overall Study|Adverse Event|0|||
155299711|NCT01236560|560528029|FG005|Overall Study|Adverse Event|0|||
155299712|NCT01236560|560528024|FG000|Overall Study|Death|0|||
155299713|NCT01236560|560528025|FG001|Overall Study|Death|1|||
155299714|NCT01236560|560528026|FG002|Overall Study|Death|0|||
155299715|NCT01236560|560528027|FG003|Overall Study|Death|1|||
155299716|NCT01236560|560528028|FG004|Overall Study|Death|0|||
155299717|NCT01236560|560528029|FG005|Overall Study|Death|0|||
155299718|NCT01236560|560528024|FG000|Overall Study|Lost to Follow-up|0|||
155299719|NCT01236560|560528025|FG001|Overall Study|Lost to Follow-up|1|||
155299720|NCT01236560|560528026|FG002|Overall Study|Lost to Follow-up|1|||
155299721|NCT01236560|560528027|FG003|Overall Study|Lost to Follow-up|0|||
155299722|NCT01236560|560528028|FG004|Overall Study|Lost to Follow-up|0|||
155299723|NCT01236560|560528029|FG005|Overall Study|Lost to Follow-up|0|||
155299724|NCT01236560|560528024|FG000|Overall Study|Physician Decision|0|||
155299725|NCT01236560|560528025|FG001|Overall Study|Physician Decision|1|||
155299726|NCT01236560|560528026|FG002|Overall Study|Physician Decision|8|||
155299727|NCT01236560|560528027|FG003|Overall Study|Physician Decision|0|||
155299728|NCT01236560|560528028|FG004|Overall Study|Physician Decision|0|||
155299729|NCT01236560|560528029|FG005|Overall Study|Physician Decision|0|||
155299730|NCT01236560|560528024|FG000|Overall Study|Withdrawal by Subject|0|||
155299731|NCT01236560|560528025|FG001|Overall Study|Withdrawal by Subject|0|||
155299732|NCT01236560|560528026|FG002|Overall Study|Withdrawal by Subject|1|||
155299733|NCT01236560|560528027|FG003|Overall Study|Withdrawal by Subject|2|||
155299734|NCT01236560|560528028|FG004|Overall Study|Withdrawal by Subject|0|||
155299735|NCT01236560|560528029|FG005|Overall Study|Withdrawal by Subject|0|||
155299736|NCT01236560|560528024|FG000|Overall Study|Progressive disease|5|||
155299737|NCT01236560|560528025|FG001|Overall Study|Progressive disease|19|||
155299738|NCT01236560|560528026|FG002|Overall Study|Progressive disease|9|||
155299739|NCT01236560|560528027|FG003|Overall Study|Progressive disease|16|||
155299740|NCT01236560|560528028|FG004|Overall Study|Progressive disease|0|||
155299741|NCT01236560|560528029|FG005|Overall Study|Progressive disease|0|||
155299742|NCT02471755|560528030|FG000|Overall Study|Withdrawal by Subject|1|||
155299743|NCT02471755|560528031|FG001|Overall Study|Withdrawal by Subject|0|||
155299744|NCT02471755|560528030|FG000|Overall Study|Lost to Follow-up|0|||
155299745|NCT02471755|560528031|FG001|Overall Study|Lost to Follow-up|1|||
155299746|NCT01576484|560528032|FG000|Overall Study|Adverse Event|1|||
155299747|NCT01576484|560528033|FG001|Overall Study|Adverse Event|1|||
155299748|NCT01576484|560528032|FG000|Overall Study|Protocol Violation|0|||
155299749|NCT01576484|560528033|FG001|Overall Study|Protocol Violation|2|||
155299750|NCT01576484|560528032|FG000|Overall Study|Sponsor Decision|2|||
155299751|NCT01576484|560528033|FG001|Overall Study|Sponsor Decision|8|||
155299752|NCT01576484|560528032|FG000|Overall Study|Withdrawal by Subject|0|||
155299753|NCT01576484|560528033|FG001|Overall Study|Withdrawal by Subject|3|||
155299754|NCT01576484|560528032|FG000|Overall Study|Other|2|||
155299755|NCT01576484|560528033|FG001|Overall Study|Other|5|||
155299756|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
155299757|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
155299758|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
155299759|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
155299760|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
155299761|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
155299762|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
155299763|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
155299764|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
155299765|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
155299766|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
155158685|NCT04323124|560018864|FG010|Overall Study|Adverse Event|0|||
155158686|NCT04323124|560018865|FG011|Overall Study|Adverse Event|0|||
155158687|NCT04323124|560018866|FG012|Overall Study|Adverse Event|0|||
155158688|NCT04323124|560018867|FG013|Overall Study|Adverse Event|0|||
155158689|NCT04323124|560018868|FG014|Overall Study|Adverse Event|0|||
155158690|NCT04323124|560018854|FG000|Overall Study|Other|0|||
155158691|NCT04323124|560018855|FG001|Overall Study|Other|0|||
155158692|NCT04323124|560018856|FG002|Overall Study|Other|0|||
155299767|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
155158693|NCT04323124|560018857|FG003|Overall Study|Other|0|||
155158694|NCT04323124|560018858|FG004|Overall Study|Other|1|||
155158695|NCT04323124|560018859|FG005|Overall Study|Other|0|||
155158696|NCT04323124|560018860|FG006|Overall Study|Other|0|||
155299768|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
155299769|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
155299770|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
155299771|NCT00958633|560528035|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
155299772|NCT00958633|560528036|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
155299773|NCT00958633|560528037|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
155299774|NCT00958633|560528035|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
155299775|NCT00958633|560528036|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
155299776|NCT00958633|560528037|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
155299777|NCT00094575|560528044|FG000|Overall Study|Death|146|||
155299778|NCT00094575|560528045|FG001|Overall Study|Death|146|||
155299779|NCT00794118|560528046|FG000|Overall Study|Lost to Follow-up|16|||
155299780|NCT00794118|560528046|FG000|Overall Study|Withdrawal by Subject|9|||
155299781|NCT00794118|560528046|FG000|Overall Study|Changed hospital center|2|||
155299782|NCT00837616|560528047|FG000|Overall Study|Withdrawal by Subject|0|||
155299783|NCT00837616|560528048|FG001|Overall Study|Withdrawal by Subject|1|||
155299784|NCT03512756|560528052|FG000|Part 1|Death|23|||
155299785|NCT03512756|560528053|FG001|Part 1|Death|18|||
155299786|NCT03512756|560528054|FG002|Part 1|Death|0|||
155299787|NCT03512756|560528055|FG003|Part 1|Death|0|||
155299788|NCT03512756|560528052|FG000|Part 1|Lost to Follow-up|0|||
155299789|NCT03512756|560528053|FG001|Part 1|Lost to Follow-up|3|||
155299790|NCT03512756|560528054|FG002|Part 1|Lost to Follow-up|0|||
155299791|NCT03512756|560528055|FG003|Part 1|Lost to Follow-up|0|||
155299792|NCT03512756|560528052|FG000|Part 1|Physician Decision|0|||
155299793|NCT03512756|560528053|FG001|Part 1|Physician Decision|1|||
155299794|NCT03512756|560528054|FG002|Part 1|Physician Decision|0|||
155299795|NCT03512756|560528055|FG003|Part 1|Physician Decision|0|||
155299796|NCT03512756|560528052|FG000|Part 1|Withdrawal by Subject|2|||
155299797|NCT03512756|560528053|FG001|Part 1|Withdrawal by Subject|2|||
155299798|NCT03512756|560528054|FG002|Part 1|Withdrawal by Subject|0|||
155299799|NCT03512756|560528055|FG003|Part 1|Withdrawal by Subject|0|||
155299800|NCT03512756|560528052|FG000|Part 2|Death|0|||
155299801|NCT03512756|560528053|FG001|Part 2|Death|0|||
155299802|NCT03512756|560528054|FG002|Part 2|Death|32|||
155299803|NCT03512756|560528055|FG003|Part 2|Death|21|||
155299804|NCT03512756|560528052|FG000|Part 2|Lost to Follow-up|0|||
155299805|NCT03512756|560528053|FG001|Part 2|Lost to Follow-up|0|||
155299806|NCT03512756|560528054|FG002|Part 2|Lost to Follow-up|1|||
155299807|NCT03512756|560528055|FG003|Part 2|Lost to Follow-up|0|||
155299808|NCT03512756|560528052|FG000|Part 2|Physician Decision|0|||
155299809|NCT03512756|560528053|FG001|Part 2|Physician Decision|0|||
155299810|NCT03512756|560528054|FG002|Part 2|Physician Decision|2|||
155299811|NCT03512756|560528055|FG003|Part 2|Physician Decision|4|||
155299812|NCT03512756|560528052|FG000|Part 2|Study Terminated by Sponsor|0|||
155299813|NCT03512756|560528053|FG001|Part 2|Study Terminated by Sponsor|0|||
155299814|NCT03512756|560528054|FG002|Part 2|Study Terminated by Sponsor|2|||
155299815|NCT03512756|560528055|FG003|Part 2|Study Terminated by Sponsor|6|||
155158697|NCT04323124|560018861|FG007|Overall Study|Other|0|||
155158698|NCT04323124|560018862|FG008|Overall Study|Other|1|||
155299816|NCT03512756|560528052|FG000|Part 2|Protocol Violation|0|||
155299817|NCT03512756|560528053|FG001|Part 2|Protocol Violation|0|||
155299818|NCT03512756|560528054|FG002|Part 2|Protocol Violation|1|||
155299819|NCT03512756|560528055|FG003|Part 2|Protocol Violation|0|||
155299820|NCT03512756|560528052|FG000|Part 2|Withdrawal by Subject|0|||
155299821|NCT03512756|560528053|FG001|Part 2|Withdrawal by Subject|0|||
155299822|NCT03512756|560528054|FG002|Part 2|Withdrawal by Subject|3|||
154957492|NCT00552669|559272449|FG001|Overall Study|Death|7|||
154957493|NCT03687736|559272450|FG000|Overall Study|Lost to Follow-up|7|||
155158699|NCT04323124|560018863|FG009|Overall Study|Other|0|||
155158700|NCT04323124|560018864|FG010|Overall Study|Other|0|||
155158701|NCT04323124|560018865|FG011|Overall Study|Other|0|||
155158702|NCT04323124|560018866|FG012|Overall Study|Other|0|||
155158703|NCT04323124|560018867|FG013|Overall Study|Other|0|||
155158704|NCT04323124|560018868|FG014|Overall Study|Other|0|||
154957494|NCT03687736|559272450|FG000|Overall Study|Withdrawal by Subject|3|||
154957495|NCT03195491|559272452|FG000|Overall Study|Study drug toxicity|25|||
154957496|NCT03195491|559272453|FG001|Overall Study|Study drug toxicity|3|||
154957497|NCT03195491|559272452|FG000|Overall Study|Maximum clinical benefit|5|||
154957498|NCT03195491|559272453|FG001|Overall Study|Maximum clinical benefit|0|||
154957499|NCT03195491|559272452|FG000|Overall Study|Lost to Follow-up|1|||
154957500|NCT03195491|559272453|FG001|Overall Study|Lost to Follow-up|0|||
154957501|NCT03195491|559272452|FG000|Overall Study|Death|3|||
154957502|NCT03195491|559272453|FG001|Overall Study|Death|0|||
154957503|NCT03195491|559272452|FG000|Overall Study|Adverse event unrelated to study drug|19|||
154957504|NCT03195491|559272453|FG001|Overall Study|Adverse event unrelated to study drug|2|||
154957505|NCT03195491|559272452|FG000|Overall Study|Disease progression|266|||
155299823|NCT03512756|560528055|FG003|Part 2|Withdrawal by Subject|9|||
155299824|NCT03312907|560529588|FG000|Overall Study|Adverse Event|1|||
154957506|NCT03195491|559272453|FG001|Overall Study|Disease progression|8|||
154957507|NCT03195491|559272452|FG000|Overall Study|Other reasons|10|||
154957508|NCT03195491|559272453|FG001|Overall Study|Other reasons|0|||
155158705|NCT04323124|560018854|FG000|Overall Study|Coming from a red zone (COVID)|0|||
155158706|NCT04323124|560018855|FG001|Overall Study|Coming from a red zone (COVID)|0|||
155299825|NCT03312907|560529589|FG001|Overall Study|Adverse Event|6|||
155299826|NCT03312907|560529590|FG002|Overall Study|Adverse Event|1|||
155299827|NCT03312907|560529588|FG000|Overall Study|Protocol Violation|2|||
155299828|NCT03312907|560529589|FG001|Overall Study|Protocol Violation|3|||
155299829|NCT03312907|560529590|FG002|Overall Study|Protocol Violation|4|||
155061699|NCT01232283|559659332|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061700|NCT01232283|559659333|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061701|NCT01232283|559659334|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061702|NCT01232283|559659335|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061703|NCT01232283|559659336|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061704|NCT01232283|559659337|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061705|NCT01232283|559659338|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
155061706|NCT01232283|559659329|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061707|NCT01232283|559659330|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061708|NCT01232283|559659331|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
155061709|NCT01232283|559659332|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
155061710|NCT01232283|559659333|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061711|NCT01232283|559659334|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061712|NCT01232283|559659335|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061713|NCT01232283|559659336|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155299830|NCT03312907|560529588|FG000|Overall Study|Lost to Follow-up|2|||
155299831|NCT03312907|560529589|FG001|Overall Study|Lost to Follow-up|3|||
155299832|NCT03312907|560529590|FG002|Overall Study|Lost to Follow-up|2|||
155299833|NCT03312907|560529588|FG000|Overall Study|Physician Decision|3|||
155299834|NCT03312907|560529589|FG001|Overall Study|Physician Decision|4|||
155299835|NCT03312907|560529590|FG002|Overall Study|Physician Decision|2|||
155061714|NCT01232283|559659337|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061715|NCT01232283|559659338|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
155061716|NCT01232283|559659329|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061717|NCT01232283|559659330|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061718|NCT01232283|559659331|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
155061719|NCT01232283|559659332|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
155061720|NCT01232283|559659333|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061721|NCT01232283|559659334|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061722|NCT01232283|559659335|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155299836|NCT03312907|560529588|FG000|Overall Study|Withdrawal by Subject|9|||
155299837|NCT03312907|560529589|FG001|Overall Study|Withdrawal by Subject|14|||
155061723|NCT01232283|559659336|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061724|NCT01232283|559659337|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061725|NCT01232283|559659338|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
155061726|NCT01232283|559659329|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061727|NCT01232283|559659330|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061728|NCT01232283|559659331|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
155061729|NCT01232283|559659332|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061730|NCT01232283|559659333|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061731|NCT01232283|559659334|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061732|NCT01232283|559659335|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061733|NCT01232283|559659336|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061734|NCT01232283|559659337|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061735|NCT01232283|559659338|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
155061736|NCT01232283|559659329|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061737|NCT01232283|559659330|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061738|NCT01232283|559659331|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
155061739|NCT01232283|559659332|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
155061740|NCT01232283|559659333|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061741|NCT01232283|559659334|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061742|NCT01232283|559659335|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061743|NCT01232283|559659336|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061744|NCT01232283|559659337|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155092590|NCT00560417|559773638|FG001|Overall Study|Physician Decision|6|||
155299838|NCT03312907|560529590|FG002|Overall Study|Withdrawal by Subject|10|||
155299839|NCT04688450|560529591|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
155299840|NCT04688450|560529591|FG000|Overall Study|Withdrawal by Subject|1|||
155299841|NCT03189524|560529593|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
155299842|NCT03189524|560529594|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
155299843|NCT03189524|560529595|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
155299844|NCT03189524|560529593|FG000|Overall Study|Death|2|||
155299845|NCT03189524|560529594|FG001|Overall Study|Death|2|||
155299846|NCT03189524|560529595|FG002|Overall Study|Death|1|||
155299847|NCT03189524|560529593|FG000|Overall Study|Lost to Follow-up|1|||
155299848|NCT03189524|560529594|FG001|Overall Study|Lost to Follow-up|0|||
155299849|NCT03189524|560529595|FG002|Overall Study|Lost to Follow-up|8|||
155299850|NCT03189524|560529593|FG000|Overall Study|Withdrawal by Subject|1|||
155061745|NCT01232283|559659338|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
155061746|NCT01232283|559659329|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061747|NCT01232283|559659330|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061748|NCT01232283|559659331|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
155061749|NCT01232283|559659332|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
155061750|NCT01232283|559659333|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061751|NCT01232283|559659334|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061752|NCT01232283|559659335|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061753|NCT01232283|559659336|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061754|NCT01232283|559659337|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061755|NCT01232283|559659338|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
155061756|NCT01232283|559659329|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
155061757|NCT01232283|559659330|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
155061758|NCT01232283|559659331|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
155061759|NCT01232283|559659332|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
155061760|NCT01232283|559659333|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
155061761|NCT01232283|559659334|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
155061762|NCT01232283|559659335|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
155061763|NCT01232283|559659336|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
155061764|NCT01232283|559659337|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
155061765|NCT01232283|559659338|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
155061766|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155061767|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155061768|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155061769|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155299851|NCT03189524|560529594|FG001|Overall Study|Withdrawal by Subject|1|||
155299852|NCT03189524|560529595|FG002|Overall Study|Withdrawal by Subject|3|||
155299853|NCT03189524|560529593|FG000|Overall Study|Progressive Disease|0|||
155299854|NCT03189524|560529594|FG001|Overall Study|Progressive Disease|2|||
155299855|NCT03189524|560529595|FG002|Overall Study|Progressive Disease|0|||
155299856|NCT01780298|560529597|FG000|Overall Study|Physician Decision|1|||
155299857|NCT01780298|560529598|FG001|Overall Study|Physician Decision|5|||
155299858|NCT01780298|560529599|FG002|Overall Study|Physician Decision|1|||
155299859|NCT01780298|560529600|FG003|Overall Study|Physician Decision|1|||
155299860|NCT01780298|560529597|FG000|Overall Study|Subject not matched|1|||
155061770|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
155061771|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
155061772|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155061773|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
155061774|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155061775|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
155061776|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061777|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061778|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061779|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061780|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
155061781|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061782|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
155061783|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
155061784|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061785|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
155061786|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155061787|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155061788|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155061789|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155061790|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
155061791|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
155092591|NCT00560417|559773637|FG000|Overall Study|Protocol Violation|6|||
155092592|NCT00560417|559773638|FG001|Overall Study|Protocol Violation|5|||
155092593|NCT00560417|559773637|FG000|Overall Study|Sponsor Decision|2|||
155092594|NCT00560417|559773638|FG001|Overall Study|Sponsor Decision|0|||
155092595|NCT00560417|559773637|FG000|Overall Study|Withdrawal by Subject|3|||
155092596|NCT00560417|559773638|FG001|Overall Study|Withdrawal by Subject|3|||
155092597|NCT02164864|559773639|FG000|Overall Study|Trial disease worsening|7|||
155092598|NCT02164864|559773640|FG001|Overall Study|Trial disease worsening|5|||
155092599|NCT02164864|559773641|FG002|Overall Study|Trial disease worsening|1|||
155092600|NCT02164864|559773639|FG000|Overall Study|Other pre-existing disease worsening|6|||
155092601|NCT02164864|559773640|FG001|Overall Study|Other pre-existing disease worsening|4|||
155092602|NCT02164864|559773641|FG002|Overall Study|Other pre-existing disease worsening|9|||
155092603|NCT02164864|559773639|FG000|Overall Study|Other Adverse Event (AE)|52|||
155299861|NCT01780298|560529598|FG001|Overall Study|Subject not matched|0|||
155299862|NCT01780298|560529599|FG002|Overall Study|Subject not matched|1|||
155299863|NCT01780298|560529600|FG003|Overall Study|Subject not matched|0|||
155299864|NCT01780298|560529597|FG000|Overall Study|Adverse Event|0|||
155299865|NCT01780298|560529598|FG001|Overall Study|Adverse Event|0|||
155299866|NCT01780298|560529599|FG002|Overall Study|Adverse Event|2|||
155299867|NCT01780298|560529600|FG003|Overall Study|Adverse Event|0|||
155299868|NCT01875848|560529607|FG000|Overall Study|Withdrawal by Subject|2|||
155299869|NCT01875848|560529608|FG001|Overall Study|Withdrawal by Subject|0|||
155299870|NCT02407249|560529609|FG000|Overall Study|Did not complete 12-month follow-up|13|||
155299871|NCT02407249|560529609|FG000|Overall Study|Not treated|13|||
155299872|NCT01622868|560529610|FG000|Overall Study|Protocol Violation|7|||
155299873|NCT01622868|560529611|FG001|Overall Study|Protocol Violation|0|||
155299874|NCT04252586|560529612|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155299875|NCT04252586|560529612|FG000|Overall Study|Adverse Event|1|||
155299876|NCT04252586|560529612|FG000|Overall Study|Death|2|||
155299877|NCT04252586|560529612|FG000|Overall Study|Study terminated by sponsor|4|||
155299878|NCT04252586|560529612|FG000|Overall Study|Sponsor request|10|||
155299879|NCT04252586|560529612|FG000|Overall Study|Did not complete treatment period|1|||
155299880|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Death|186|||
155299881|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Death|222|||
155299882|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Death|0|||
155299883|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
155299884|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
155299885|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
155158707|NCT04323124|560018856|FG002|Overall Study|Coming from a red zone (COVID)|0|||
155158708|NCT04323124|560018857|FG003|Overall Study|Coming from a red zone (COVID)|0|||
155158709|NCT04323124|560018858|FG004|Overall Study|Coming from a red zone (COVID)|1|||
155158710|NCT04323124|560018859|FG005|Overall Study|Coming from a red zone (COVID)|1|||
155158711|NCT04323124|560018860|FG006|Overall Study|Coming from a red zone (COVID)|0|||
155158712|NCT04323124|560018861|FG007|Overall Study|Coming from a red zone (COVID)|0|||
155158713|NCT04323124|560018862|FG008|Overall Study|Coming from a red zone (COVID)|0|||
155158714|NCT04323124|560018863|FG009|Overall Study|Coming from a red zone (COVID)|0|||
155158715|NCT04323124|560018864|FG010|Overall Study|Coming from a red zone (COVID)|0|||
155158716|NCT04323124|560018865|FG011|Overall Study|Coming from a red zone (COVID)|0|||
155158717|NCT04323124|560018866|FG012|Overall Study|Coming from a red zone (COVID)|0|||
155158718|NCT04323124|560018867|FG013|Overall Study|Coming from a red zone (COVID)|0|||
155158719|NCT04323124|560018868|FG014|Overall Study|Coming from a red zone (COVID)|0|||
155158720|NCT04323124|560018854|FG000|Overall Study|No longer meets eligibility criteria|0|||
155158721|NCT04323124|560018855|FG001|Overall Study|No longer meets eligibility criteria|0|||
155158722|NCT04323124|560018856|FG002|Overall Study|No longer meets eligibility criteria|0|||
155158723|NCT04323124|560018857|FG003|Overall Study|No longer meets eligibility criteria|0|||
155158724|NCT04323124|560018858|FG004|Overall Study|No longer meets eligibility criteria|0|||
155158725|NCT04323124|560018859|FG005|Overall Study|No longer meets eligibility criteria|0|||
155158726|NCT04323124|560018860|FG006|Overall Study|No longer meets eligibility criteria|0|||
155158727|NCT04323124|560018861|FG007|Overall Study|No longer meets eligibility criteria|1|||
155158728|NCT04323124|560018862|FG008|Overall Study|No longer meets eligibility criteria|0|||
155158729|NCT04323124|560018863|FG009|Overall Study|No longer meets eligibility criteria|0|||
155158730|NCT04323124|560018864|FG010|Overall Study|No longer meets eligibility criteria|0|||
155158731|NCT04323124|560018865|FG011|Overall Study|No longer meets eligibility criteria|0|||
155158732|NCT04323124|560018866|FG012|Overall Study|No longer meets eligibility criteria|0|||
155158733|NCT04323124|560018867|FG013|Overall Study|No longer meets eligibility criteria|1|||
155158734|NCT04323124|560018868|FG014|Overall Study|No longer meets eligibility criteria|1|||
155158735|NCT04323124|560018854|FG000|Overall Study|Study terminated by sponsor|0|||
155158736|NCT04323124|560018855|FG001|Overall Study|Study terminated by sponsor|0|||
155158737|NCT04323124|560018856|FG002|Overall Study|Study terminated by sponsor|0|||
155158738|NCT04323124|560018857|FG003|Overall Study|Study terminated by sponsor|0|||
155158739|NCT04323124|560018858|FG004|Overall Study|Study terminated by sponsor|0|||
155158740|NCT04323124|560018859|FG005|Overall Study|Study terminated by sponsor|0|||
155158741|NCT04323124|560018860|FG006|Overall Study|Study terminated by sponsor|0|||
155158742|NCT04323124|560018861|FG007|Overall Study|Study terminated by sponsor|0|||
155158743|NCT04323124|560018862|FG008|Overall Study|Study terminated by sponsor|0|||
155299886|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
155299887|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
155299888|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
155299889|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
155299890|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
155299891|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
155299892|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Adverse Event|83|||
155158744|NCT04323124|560018863|FG009|Overall Study|Study terminated by sponsor|0|||
155158745|NCT04323124|560018864|FG010|Overall Study|Study terminated by sponsor|0|||
155299893|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Adverse Event|100|||
155299894|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Adverse Event|0|||
155061792|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
155061793|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
155061794|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155061795|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
155061796|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061797|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061798|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061799|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061800|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
155061801|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061802|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061803|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061804|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061805|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
155061806|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155061807|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155061808|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155061809|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155061810|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
155061811|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155299895|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Other|70|||
155299896|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Other|75|||
155299897|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Other|0|||
155299898|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
155299899|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
155299900|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
155299901|NCT00232180|560529613|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
155299902|NCT00232180|560529614|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
155299903|NCT00232180|560529615|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
155299904|NCT00232180|560529613|FG000|Open Label Phase|Death|0|||
155061812|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
155061813|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
155061814|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155061815|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
155061816|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061817|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061818|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061819|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061820|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061821|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061822|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061823|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
155061824|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061825|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
155061826|NCT01232283|559659329|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061827|NCT01232283|559659330|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061828|NCT01232283|559659331|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061829|NCT01232283|559659332|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061830|NCT01232283|559659333|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061831|NCT01232283|559659334|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
155299905|NCT00232180|560529614|FG001|Open Label Phase|Death|0|||
155299906|NCT00232180|560529615|FG002|Open Label Phase|Death|48|||
155299907|NCT00232180|560529613|FG000|Open Label Phase|Lost to Follow-up|0|||
155158746|NCT04323124|560018865|FG011|Overall Study|Study terminated by sponsor|2|||
155061832|NCT01232283|559659335|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061833|NCT01232283|559659336|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061834|NCT01232283|559659337|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061835|NCT01232283|559659338|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
155061836|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061837|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061838|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061839|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061840|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061841|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061842|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155061843|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
155158747|NCT04323124|560018866|FG012|Overall Study|Study terminated by sponsor|1|||
155299908|NCT00232180|560529614|FG001|Open Label Phase|Lost to Follow-up|0|||
155299909|NCT00232180|560529615|FG002|Open Label Phase|Lost to Follow-up|5|||
155299910|NCT00232180|560529613|FG000|Open Label Phase|Protocol Violation|0|||
155299911|NCT00232180|560529614|FG001|Open Label Phase|Protocol Violation|0|||
155299912|NCT00232180|560529615|FG002|Open Label Phase|Protocol Violation|3|||
155299913|NCT00232180|560529613|FG000|Open Label Phase|Study terminated by sponsor|0|||
155299914|NCT00232180|560529614|FG001|Open Label Phase|Study terminated by sponsor|0|||
155299915|NCT00232180|560529615|FG002|Open Label Phase|Study terminated by sponsor|3|||
155299916|NCT00232180|560529613|FG000|Open Label Phase|Withdrawal by Subject|0|||
155299917|NCT00232180|560529614|FG001|Open Label Phase|Withdrawal by Subject|0|||
155299918|NCT00232180|560529615|FG002|Open Label Phase|Withdrawal by Subject|37|||
155299919|NCT00232180|560529613|FG000|Open Label Phase|Other|0|||
155299920|NCT00232180|560529614|FG001|Open Label Phase|Other|0|||
155299921|NCT00232180|560529615|FG002|Open Label Phase|Other|16|||
155299922|NCT00232180|560529613|FG000|Open Label Phase|Adverse Event|0|||
155299923|NCT00232180|560529614|FG001|Open Label Phase|Adverse Event|0|||
155299924|NCT00232180|560529615|FG002|Open Label Phase|Adverse Event|25|||
155299925|NCT00232180|560529613|FG000|Open Label Phase|Laboratory abnormality|0|||
155299926|NCT00232180|560529614|FG001|Open Label Phase|Laboratory abnormality|0|||
155299927|NCT00232180|560529615|FG002|Open Label Phase|Laboratory abnormality|10|||
155299928|NCT00232180|560529613|FG000|Open Label Phase|Randomized but not treated|0|||
155299929|NCT00232180|560529614|FG001|Open Label Phase|Randomized but not treated|0|||
155299930|NCT00232180|560529615|FG002|Open Label Phase|Randomized but not treated|1|||
155299931|NCT02748317|560529616|FG000|Overall Study|Withdrawal by Subject|14|||
155158748|NCT04323124|560018867|FG013|Overall Study|Study terminated by sponsor|0|||
155158749|NCT04323124|560018868|FG014|Overall Study|Study terminated by sponsor|0|||
155158750|NCT02083354|560020634|FG000|Overall Study|Withdrawal by Subject|9|||
155158751|NCT02083354|560020634|FG000|Overall Study|Lost to Follow-up|1|||
155158752|NCT02083354|560020634|FG000|Overall Study|Adverse Event|3|||
155158753|NCT02083354|560020634|FG000|Overall Study|Disease progression|46|||
155158754|NCT02083354|560020634|FG000|Overall Study|Study closed/terminated|5|||
155158755|NCT01148979|560020643|FG000|Overall Study|Lost to Follow-up|0|||
155158756|NCT01148979|560020644|FG001|Overall Study|Lost to Follow-up|1|||
155158757|NCT00554216|560020648|FG000|Overall Study|Lost to Follow-up|92|||
155158758|NCT00554216|560020649|FG001|Overall Study|Lost to Follow-up|31|||
155158759|NCT00554216|560020650|FG002|Overall Study|Lost to Follow-up|63|||
155158760|NCT00554216|560020648|FG000|Overall Study|Adverse Event|16|||
155158761|NCT00554216|560020649|FG001|Overall Study|Adverse Event|16|||
155158762|NCT00554216|560020650|FG002|Overall Study|Adverse Event|36|||
155158763|NCT00554216|560020648|FG000|Overall Study|Withdrawal by Subject|92|||
155158764|NCT00554216|560020649|FG001|Overall Study|Withdrawal by Subject|31|||
155158765|NCT00554216|560020650|FG002|Overall Study|Withdrawal by Subject|43|||
155158766|NCT00554216|560020648|FG000|Overall Study|Non compliance|10|||
155158767|NCT00554216|560020649|FG001|Overall Study|Non compliance|4|||
155158768|NCT00554216|560020650|FG002|Overall Study|Non compliance|5|||
155158769|NCT00554216|560020648|FG000|Overall Study|Pregnancy|2|||
155158770|NCT00554216|560020649|FG001|Overall Study|Pregnancy|1|||
155158771|NCT00554216|560020650|FG002|Overall Study|Pregnancy|14|||
155158772|NCT00554216|560020648|FG000|Overall Study|Restricted med|3|||
155158773|NCT00554216|560020649|FG001|Overall Study|Restricted med|1|||
155158774|NCT00554216|560020650|FG002|Overall Study|Restricted med|1|||
155158775|NCT00554216|560020648|FG000|Overall Study|Other|12|||
155158776|NCT00554216|560020649|FG001|Overall Study|Other|7|||
155158777|NCT00554216|560020650|FG002|Overall Study|Other|10|||
155158778|NCT00554216|560020648|FG000|Overall Study|Lack of Efficacy|15|||
155158779|NCT00554216|560020649|FG001|Overall Study|Lack of Efficacy|3|||
155158780|NCT00554216|560020650|FG002|Overall Study|Lack of Efficacy|0|||
155158781|NCT01803607|560020655|FG000|Overall Study|Adverse Event|5|||
155299932|NCT02748317|560529616|FG000|Overall Study|Lost to Follow-up|8|||
154957509|NCT03195491|559272452|FG000|Overall Study|Participant withdrew consent|8|||
154957510|NCT03195491|559272453|FG001|Overall Study|Participant withdrew consent|1|||
154957511|NCT03195491|559272452|FG000|Overall Study|Participant no longer meets study criteria|0|||
154957512|NCT03195491|559272453|FG001|Overall Study|Participant no longer meets study criteria|1|||
154957513|NCT03195491|559272452|FG000|Overall Study|Participant request to discontinue study treatment|10|||
154957514|NCT03195491|559272453|FG001|Overall Study|Participant request to discontinue study treatment|0|||
154957515|NCT03496623|559272456|FG000|Run-In Period (2 Weeks)|Death|1|||
155158782|NCT01803607|560020656|FG001|Overall Study|Adverse Event|3|||
155158783|NCT01803607|560020655|FG000|Overall Study|Lack of Efficacy|0|||
155158784|NCT01803607|560020656|FG001|Overall Study|Lack of Efficacy|1|||
155158785|NCT01803607|560020655|FG000|Overall Study|Protocol Violation|3|||
155158786|NCT01803607|560020656|FG001|Overall Study|Protocol Violation|2|||
155158787|NCT01803607|560020655|FG000|Overall Study|Study terminated by sponsor|54|||
155158788|NCT01803607|560020656|FG001|Overall Study|Study terminated by sponsor|56|||
155158789|NCT01803607|560020655|FG000|Overall Study|Withdrawal by Subject|6|||
155158790|NCT01803607|560020656|FG001|Overall Study|Withdrawal by Subject|5|||
155299933|NCT02748317|560529616|FG000|Overall Study|Death|1|||
155299934|NCT01149369|560529619|FG000|Overall Study|Adverse Event|6|||
155299935|NCT01149369|560529620|FG001|Overall Study|Adverse Event|3|||
155299936|NCT02767765|560529621|FG000|Overall Study|Adverse Event|4|||
155299937|NCT02767765|560529621|FG000|Overall Study|Death|1|||
155299938|NCT02767765|560529621|FG000|Overall Study|Insufficient response|1|||
155299939|NCT02767765|560529621|FG000|Overall Study|Lost to Follow-up|2|||
155299940|NCT02767765|560529621|FG000|Overall Study|Investigator decision|1|||
155299941|NCT02767765|560529621|FG000|Overall Study|Non-Compliance|1|||
155158791|NCT01281124|560020660|FG000|Overall Study|Death|1|||
155158792|NCT00918255|560020661|FG000|Overall Study|Adverse Event|1|||
155158793|NCT00918255|560020662|FG001|Overall Study|Adverse Event|0|||
155158794|NCT00918255|560020663|FG002|Overall Study|Adverse Event|0|||
155158795|NCT00918255|560020661|FG000|Overall Study|Withdrawal by Subject|1|||
155158796|NCT00918255|560020662|FG001|Overall Study|Withdrawal by Subject|0|||
155158797|NCT00918255|560020663|FG002|Overall Study|Withdrawal by Subject|2|||
155158798|NCT00918255|560020661|FG000|Overall Study|Lack of Efficacy|1|||
155158799|NCT00918255|560020662|FG001|Overall Study|Lack of Efficacy|0|||
155299942|NCT02767765|560529621|FG000|Overall Study|Withdrawal by Subject|1|||
155299943|NCT04723394|560529622|FG000|Overall Study|Adverse Event|0|||
155299944|NCT04723394|560529623|FG001|Overall Study|Adverse Event|3|||
155158800|NCT00918255|560020663|FG002|Overall Study|Lack of Efficacy|0|||
155158801|NCT00918255|560020661|FG000|Overall Study|Lost to Follow-up|1|||
155158802|NCT00918255|560020662|FG001|Overall Study|Lost to Follow-up|0|||
155158803|NCT00918255|560020663|FG002|Overall Study|Lost to Follow-up|2|||
155158804|NCT00918255|560020661|FG000|Overall Study|Exceeded allowed number of interventions|0|||
155158805|NCT00918255|560020662|FG001|Overall Study|Exceeded allowed number of interventions|0|||
155158806|NCT00918255|560020663|FG002|Overall Study|Exceeded allowed number of interventions|1|||
155158807|NCT00918255|560020661|FG000|Overall Study|Non-compliance|1|||
155158808|NCT00918255|560020662|FG001|Overall Study|Non-compliance|0|||
155158809|NCT00918255|560020663|FG002|Overall Study|Non-compliance|0|||
155158810|NCT00918255|560020661|FG000|Overall Study|Investigator discretion|1|||
155158811|NCT00918255|560020662|FG001|Overall Study|Investigator discretion|0|||
155158812|NCT00918255|560020663|FG002|Overall Study|Investigator discretion|0|||
155158813|NCT02038933|560020664|FG000|Overall Study|Disease progression|104|||
155158814|NCT02038933|560020664|FG000|Overall Study|Study drug toxicity|6|||
155158815|NCT02038933|560020664|FG000|Overall Study|Adverse event unrelated to study drug|6|||
155158816|NCT02038933|560020664|FG000|Overall Study|Participant request to discontinue treatment|2|||
155158817|NCT02038933|560020664|FG000|Overall Study|Lost to Follow-up|1|||
155158818|NCT02038933|560020664|FG000|Overall Study|Other reasons|2|||
155158819|NCT03250273|560020665|FG000|Overall Study|Disease Progression|2|||
155158820|NCT03250273|560020666|FG001|Overall Study|Disease Progression|11|||
155158821|NCT03250273|560020665|FG000|Overall Study|Death|0|||
155158822|NCT03250273|560020666|FG001|Overall Study|Death|1|||
154957516|NCT03496623|559272457|FG001|Run-In Period (2 Weeks)|Death|0|||
154957517|NCT03496623|559272458|FG002|Run-In Period (2 Weeks)|Death|0|||
155158823|NCT00706238|560020667|FG000|Overall Study|Disease progression|4|||
155158824|NCT00706238|560020667|FG000|Overall Study|Other|1|||
155158825|NCT00936715|560020668|FG000|Overall Study|Investigators Discretion|1|||
155158826|NCT00936715|560020668|FG000|Overall Study|Protocol Violation|1|||
155158827|NCT00936715|560020668|FG000|Overall Study|Safety or Tolerability Reasons|4|||
155158828|NCT01337960|560020671|FG000|Overall Study|Lost to Follow-up|1|||
155158829|NCT01337960|560020672|FG001|Overall Study|Lost to Follow-up|0|||
155158830|NCT01337960|560020673|FG002|Overall Study|Lost to Follow-up|0|||
155158831|NCT01337960|560020671|FG000|Overall Study|Withdrawal by Subject|1|||
155158832|NCT01337960|560020672|FG001|Overall Study|Withdrawal by Subject|0|||
155158833|NCT01337960|560020673|FG002|Overall Study|Withdrawal by Subject|0|||
155158834|NCT03877510|560020674|FG000|Overall Study|Death|6|||
155158835|NCT03877510|560020674|FG000|Overall Study|Lost to Follow-up|2|||
155158836|NCT03877510|560020674|FG000|Overall Study|Non-compliance with study drug|2|||
155158837|NCT03877510|560020674|FG000|Overall Study|Lack of Efficacy|14|||
154957518|NCT03496623|559272459|FG003|Run-In Period (2 Weeks)|Death|0|||
154957519|NCT03496623|559272460|FG004|Run-In Period (2 Weeks)|Death|0|||
154957520|NCT03496623|559272456|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
154957521|NCT03496623|559272457|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
154957522|NCT03496623|559272458|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
154957523|NCT03496623|559272459|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
154957524|NCT03496623|559272460|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
154957525|NCT03496623|559272456|FG000|Period 1 (12 Weeks)|Death|0|||
154957526|NCT03496623|559272457|FG001|Period 1 (12 Weeks)|Death|3|||
154957527|NCT03496623|559272458|FG002|Period 1 (12 Weeks)|Death|0|||
154957528|NCT03496623|559272459|FG003|Period 1 (12 Weeks)|Death|0|||
154957529|NCT03496623|559272460|FG004|Period 1 (12 Weeks)|Death|0|||
155158838|NCT03877510|560020674|FG000|Overall Study|Adverse Event|20|||
155158839|NCT03877510|560020674|FG000|Overall Study|Withdrawal by Subject|22|||
155299945|NCT04723394|560529622|FG000|Overall Study|Death|8|||
155299946|NCT04723394|560529623|FG001|Overall Study|Death|8|||
154957530|NCT03496623|559272456|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
155158840|NCT03877510|560020674|FG000|Overall Study|Miscellaneous|1|||
155158841|NCT03763877|560020676|FG000|Overall Study|Withdrawal by Subject|3|||
155299947|NCT04723394|560529622|FG000|Overall Study|Lost to Follow-up|20|||
155061844|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
155061845|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
155061846|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061847|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061848|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061849|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061850|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061851|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061852|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061853|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
155061854|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
155061855|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
155061856|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061857|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061858|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061859|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061860|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061861|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061862|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061863|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
155061864|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
155061865|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
155061866|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061867|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061868|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061869|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061870|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061871|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061872|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061873|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
155061874|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
155061875|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
155061876|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061877|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061878|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061879|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061880|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061881|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061882|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061883|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
155061884|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
155061885|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
155299948|NCT04723394|560529623|FG001|Overall Study|Lost to Follow-up|17|||
155299949|NCT04723394|560529622|FG000|Overall Study|Physician Decision|1|||
155299950|NCT04723394|560529623|FG001|Overall Study|Physician Decision|0|||
155299951|NCT04723394|560529622|FG000|Overall Study|Withdrawal by Subject|20|||
155299952|NCT04723394|560529623|FG001|Overall Study|Withdrawal by Subject|34|||
155299953|NCT04723394|560529622|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
155299954|NCT04723394|560529623|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
155299955|NCT00774397|560529624|FG000|Overall Study|Adverse Event|1|||
155299956|NCT00774397|560529625|FG001|Overall Study|Adverse Event|3|||
155299957|NCT00774397|560529626|FG002|Overall Study|Adverse Event|16|||
155299958|NCT00774397|560529627|FG003|Overall Study|Adverse Event|8|||
155299959|NCT00774397|560529628|FG004|Overall Study|Adverse Event|8|||
155299960|NCT00774397|560529629|FG005|Overall Study|Adverse Event|3|||
155299961|NCT00774397|560529630|FG006|Overall Study|Adverse Event|16|||
155299962|NCT00774397|560529624|FG000|Overall Study|Lack of Efficacy|11|||
155299963|NCT00774397|560529625|FG001|Overall Study|Lack of Efficacy|4|||
155299964|NCT00774397|560529626|FG002|Overall Study|Lack of Efficacy|5|||
155299965|NCT00774397|560529627|FG003|Overall Study|Lack of Efficacy|3|||
155299966|NCT00774397|560529628|FG004|Overall Study|Lack of Efficacy|27|||
155299967|NCT00774397|560529629|FG005|Overall Study|Lack of Efficacy|15|||
155299968|NCT00774397|560529630|FG006|Overall Study|Lack of Efficacy|9|||
155299969|NCT00774397|560529624|FG000|Overall Study|Protocol Violation|0|||
155299970|NCT00774397|560529625|FG001|Overall Study|Protocol Violation|1|||
155299971|NCT00774397|560529626|FG002|Overall Study|Protocol Violation|3|||
155299972|NCT00774397|560529627|FG003|Overall Study|Protocol Violation|1|||
155299973|NCT00774397|560529628|FG004|Overall Study|Protocol Violation|2|||
155299974|NCT00774397|560529629|FG005|Overall Study|Protocol Violation|1|||
155061886|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061887|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061888|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061889|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061890|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061891|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061892|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061893|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061894|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
155061895|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
155061896|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061897|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061898|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061899|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061900|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061901|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061902|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061903|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061904|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
155061905|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
155061906|NCT01232283|559659329|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061907|NCT01232283|559659330|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061908|NCT01232283|559659331|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061909|NCT01232283|559659332|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155299975|NCT00774397|560529630|FG006|Overall Study|Protocol Violation|0|||
155299976|NCT00774397|560529624|FG000|Overall Study|Lost to Follow-up|0|||
155299977|NCT00774397|560529625|FG001|Overall Study|Lost to Follow-up|1|||
155299978|NCT00774397|560529626|FG002|Overall Study|Lost to Follow-up|1|||
155299979|NCT00774397|560529627|FG003|Overall Study|Lost to Follow-up|1|||
155299980|NCT00774397|560529628|FG004|Overall Study|Lost to Follow-up|0|||
155299981|NCT00774397|560529629|FG005|Overall Study|Lost to Follow-up|1|||
155299982|NCT00774397|560529630|FG006|Overall Study|Lost to Follow-up|0|||
155299983|NCT00774397|560529624|FG000|Overall Study|Refused to continue trial medication|1|||
155299984|NCT00774397|560529625|FG001|Overall Study|Refused to continue trial medication|3|||
155061910|NCT01232283|559659333|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061911|NCT01232283|559659334|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061912|NCT01232283|559659335|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061913|NCT01232283|559659336|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
155061914|NCT01232283|559659337|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
155061915|NCT01232283|559659338|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
155061916|NCT03824561|559659339|FG000|Overall Study|Protocol Violation|19|||
155299985|NCT00774397|560529626|FG002|Overall Study|Refused to continue trial medication|2|||
155299986|NCT00774397|560529627|FG003|Overall Study|Refused to continue trial medication|2|||
155299987|NCT00774397|560529628|FG004|Overall Study|Refused to continue trial medication|6|||
155299988|NCT00774397|560529629|FG005|Overall Study|Refused to continue trial medication|2|||
155299989|NCT00774397|560529630|FG006|Overall Study|Refused to continue trial medication|3|||
155158842|NCT03763877|560020677|FG001|Overall Study|Withdrawal by Subject|1|||
155158843|NCT03763877|560020678|FG002|Overall Study|Withdrawal by Subject|3|||
155158844|NCT03763877|560020679|FG003|Overall Study|Withdrawal by Subject|4|||
155158845|NCT03763877|560020676|FG000|Overall Study|Adverse Event|1|||
155158846|NCT03763877|560020677|FG001|Overall Study|Adverse Event|1|||
155158847|NCT03763877|560020678|FG002|Overall Study|Adverse Event|3|||
155061917|NCT01773928|559659341|FG000|Overall Study|Adverse Event|0|||
155061918|NCT01773928|559659342|FG001|Overall Study|Adverse Event|0|||
155061919|NCT01773928|559659343|FG002|Overall Study|Adverse Event|0|||
155061920|NCT01773928|559659344|FG003|Overall Study|Adverse Event|0|||
155061921|NCT01773928|559659345|FG004|Overall Study|Adverse Event|0|||
155061922|NCT01773928|559659346|FG005|Overall Study|Adverse Event|0|||
155061923|NCT01773928|559659347|FG006|Overall Study|Adverse Event|0|||
155061924|NCT01773928|559659348|FG007|Overall Study|Adverse Event|1|||
155061925|NCT01773928|559659349|FG008|Overall Study|Adverse Event|0|||
155061926|NCT01773928|559659341|FG000|Overall Study|Physician Decision|0|||
155061927|NCT01773928|559659342|FG001|Overall Study|Physician Decision|0|||
155299990|NCT00774397|560529624|FG000|Overall Study|Not treated|0|||
155299991|NCT00774397|560529625|FG001|Overall Study|Not treated|0|||
155158848|NCT03763877|560020679|FG003|Overall Study|Adverse Event|1|||
155158849|NCT03763877|560020676|FG000|Overall Study|Protocol Violation|1|||
155299992|NCT00774397|560529626|FG002|Overall Study|Not treated|0|||
155299993|NCT00774397|560529627|FG003|Overall Study|Not treated|0|||
155299994|NCT00774397|560529628|FG004|Overall Study|Not treated|1|||
155299995|NCT00774397|560529629|FG005|Overall Study|Not treated|0|||
155299996|NCT00774397|560529630|FG006|Overall Study|Not treated|1|||
155061928|NCT01773928|559659343|FG002|Overall Study|Physician Decision|0|||
155061929|NCT01773928|559659344|FG003|Overall Study|Physician Decision|1|||
155061930|NCT01773928|559659345|FG004|Overall Study|Physician Decision|0|||
155061931|NCT01773928|559659346|FG005|Overall Study|Physician Decision|0|||
155061932|NCT01773928|559659347|FG006|Overall Study|Physician Decision|0|||
155061933|NCT01773928|559659348|FG007|Overall Study|Physician Decision|0|||
155061934|NCT01773928|559659349|FG008|Overall Study|Physician Decision|0|||
155061935|NCT01773928|559659341|FG000|Overall Study|Withdrawal by Subject|5|||
155061936|NCT01773928|559659342|FG001|Overall Study|Withdrawal by Subject|4|||
155061937|NCT01773928|559659343|FG002|Overall Study|Withdrawal by Subject|4|||
155061938|NCT01773928|559659344|FG003|Overall Study|Withdrawal by Subject|4|||
155061939|NCT01773928|559659345|FG004|Overall Study|Withdrawal by Subject|7|||
155061940|NCT01773928|559659346|FG005|Overall Study|Withdrawal by Subject|1|||
155061941|NCT01773928|559659347|FG006|Overall Study|Withdrawal by Subject|0|||
155061942|NCT01773928|559659348|FG007|Overall Study|Withdrawal by Subject|0|||
155061943|NCT01773928|559659349|FG008|Overall Study|Withdrawal by Subject|1|||
155061944|NCT01773928|559659341|FG000|Overall Study|Lost to Follow-up|0|||
155061945|NCT01773928|559659342|FG001|Overall Study|Lost to Follow-up|0|||
155061946|NCT01773928|559659343|FG002|Overall Study|Lost to Follow-up|0|||
155061947|NCT01773928|559659344|FG003|Overall Study|Lost to Follow-up|0|||
155061948|NCT01773928|559659345|FG004|Overall Study|Lost to Follow-up|0|||
155061949|NCT01773928|559659346|FG005|Overall Study|Lost to Follow-up|1|||
155299997|NCT00774397|560529624|FG000|Overall Study|Other than those stated above|1|||
154957531|NCT03496623|559272457|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
154957532|NCT03496623|559272458|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
154957533|NCT03496623|559272459|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
154957534|NCT03496623|559272460|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
154957535|NCT03496623|559272456|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
154957536|NCT03496623|559272457|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
154957537|NCT03496623|559272458|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
154957538|NCT03496623|559272459|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
154957539|NCT03496623|559272460|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
154957540|NCT03496623|559272456|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
154957541|NCT03496623|559272457|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
154957542|NCT03496623|559272458|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
154957543|NCT03496623|559272459|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
154957544|NCT03496623|559272460|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
154957545|NCT03496623|559272456|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
154957546|NCT03496623|559272457|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
154957547|NCT03496623|559272458|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
154957548|NCT03496623|559272459|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
154957549|NCT03496623|559272460|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
154957550|NCT03496623|559272456|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
154957551|NCT03496623|559272457|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
154957552|NCT03496623|559272458|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
154957553|NCT03496623|559272459|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
154957554|NCT03496623|559272460|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
154957555|NCT03496623|559272456|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
154957556|NCT03496623|559272457|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
154957557|NCT03496623|559272458|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
154957558|NCT03496623|559272459|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
154957559|NCT03496623|559272460|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
154957560|NCT01270503|559272461|FG000|Overall Study|Lost to Follow-up|1|||
154957561|NCT02543203|559272462|FG000|Overall Study|Unpalatable Fragrance|2|||
154957562|NCT02543203|559272463|FG001|Overall Study|Unpalatable Fragrance|2|||
154957563|NCT02543203|559272462|FG000|Overall Study|Lost to Follow-up|1|||
154957564|NCT02543203|559272463|FG001|Overall Study|Lost to Follow-up|0|||
154957565|NCT02543203|559272462|FG000|Overall Study|Increased Irritability|1|||
154957566|NCT02543203|559272463|FG001|Overall Study|Increased Irritability|0|||
154957567|NCT02543203|559272462|FG000|Overall Study|Family|1|||
154957568|NCT02543203|559272463|FG001|Overall Study|Family|2|||
154957569|NCT02543203|559272462|FG000|Overall Study|Negative Behavior|1|||
154957570|NCT02543203|559272463|FG001|Overall Study|Negative Behavior|0|||
154957571|NCT02543203|559272462|FG000|Overall Study|Withdrawal by Subject|0|||
154957572|NCT02543203|559272463|FG001|Overall Study|Withdrawal by Subject|1|||
154957573|NCT02459951|559272464|FG000|Overall Study|Unable to meet holding requirement|1|||
154957574|NCT00772941|559272467|FG000|Overall Study|CRFs not available|195|||
154957575|NCT00772941|559272467|FG000|Overall Study|Study not completed|16|||
154957576|NCT00772941|559272467|FG000|Overall Study|Missed Visits|374|||
154957577|NCT00772941|559272467|FG000|Overall Study|Poor Compliance|7|||
154957578|NCT00772941|559272467|FG000|Overall Study|GPSP Violation|90|||
154957579|NCT02255097|559272468|FG000|Overall Study|Death|151|||
154957580|NCT02255097|559272468|FG000|Overall Study|Lost to Follow-up|5|||
154957581|NCT02255097|559272468|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
154957582|NCT02255097|559272468|FG000|Overall Study|Withdrawal by Subject|7|||
154957583|NCT02255097|559272468|FG000|Overall Study|Allocated but not treated|1|||
155299998|NCT00774397|560529625|FG001|Overall Study|Other than those stated above|1|||
154957584|NCT01745120|559272474|FG000|Overall Study|Investigator decision|1|||
154957585|NCT01745120|559272475|FG001|Overall Study|Investigator decision|0|||
154957586|NCT02714062|559272476|FG000|Overall Study|Adverse Event|0|||
154957587|NCT02714062|559272477|FG001|Overall Study|Adverse Event|0|||
154957588|NCT02714062|559272478|FG002|Overall Study|Adverse Event|2|||
154957589|NCT02714062|559272476|FG000|Overall Study|Withdrawal by Subject|1|||
154957590|NCT02714062|559272477|FG001|Overall Study|Withdrawal by Subject|0|||
154957591|NCT02714062|559272478|FG002|Overall Study|Withdrawal by Subject|1|||
154957592|NCT02714062|559272476|FG000|Overall Study|Protocol Violation|0|||
154957593|NCT02714062|559272477|FG001|Overall Study|Protocol Violation|1|||
154957594|NCT02714062|559272478|FG002|Overall Study|Protocol Violation|0|||
154957595|NCT03956862|559272479|FG000|Overall Study|Lost to Follow-up|1|||
154957596|NCT03956862|559272480|FG001|Overall Study|Lost to Follow-up|1|||
154957597|NCT03956862|559272479|FG000|Overall Study|Withdrawal by Subject|1|||
154957598|NCT03956862|559272480|FG001|Overall Study|Withdrawal by Subject|1|||
154957599|NCT02017223|559272491|FG000|Overall Study|Algorithm problems|2|||
154957600|NCT01401647|559272492|FG000|Overall Study|Withdrawal by Subject|1|||
154957601|NCT01401647|559272493|FG001|Overall Study|Withdrawal by Subject|5|||
154957602|NCT01401647|559272494|FG002|Overall Study|Withdrawal by Subject|2|||
154957603|NCT01401647|559272492|FG000|Overall Study|Lost to Follow-up|3|||
154957604|NCT01401647|559272493|FG001|Overall Study|Lost to Follow-up|3|||
154957605|NCT01401647|559272494|FG002|Overall Study|Lost to Follow-up|1|||
154957606|NCT05169710|559272497|FG000|Overall Study|Adverse Event|1|||
154957607|NCT05169710|559272498|FG001|Overall Study|Adverse Event|2|||
154957608|NCT05169710|559272499|FG002|Overall Study|Adverse Event|2|||
154957609|NCT05169710|559272497|FG000|Overall Study|Lost to Follow-up|0|||
154957610|NCT05169710|559272498|FG001|Overall Study|Lost to Follow-up|0|||
154957611|NCT05169710|559272499|FG002|Overall Study|Lost to Follow-up|1|||
154957612|NCT05169710|559272497|FG000|Overall Study|Withdrawal by Subject|2|||
154957613|NCT05169710|559272498|FG001|Overall Study|Withdrawal by Subject|1|||
154957614|NCT05169710|559272499|FG002|Overall Study|Withdrawal by Subject|0|||
154957615|NCT05169710|559272497|FG000|Overall Study|Other Study Discontinuation Reason|0|||
154957616|NCT05169710|559272498|FG001|Overall Study|Other Study Discontinuation Reason|2|||
154957617|NCT05169710|559272499|FG002|Overall Study|Other Study Discontinuation Reason|0|||
154957618|NCT03459807|559272507|FG000|Overall Study|Withdrawal due to transplant|0|||
154957619|NCT03459807|559272508|FG001|Overall Study|Withdrawal due to transplant|1|||
154957620|NCT03197883|559272509|FG000|Overall Study|Adverse Event|1|||
154957621|NCT03197883|559272510|FG001|Overall Study|Adverse Event|1|||
154957622|NCT03197883|559272509|FG000|Overall Study|Lost to Follow-up|1|||
154957623|NCT03197883|559272510|FG001|Overall Study|Lost to Follow-up|0|||
154957624|NCT03197883|559272509|FG000|Overall Study|Protocol Violation|1|||
154957625|NCT03197883|559272510|FG001|Overall Study|Protocol Violation|0|||
154957626|NCT03197883|559272509|FG000|Overall Study|Other (Not Specified)|0|||
154957627|NCT03197883|559272510|FG001|Overall Study|Other (Not Specified)|5|||
154957628|NCT01908205|559272511|FG000|Overall Study|Lost to Follow-up|2|||
154957629|NCT01908205|559272512|FG001|Overall Study|Lost to Follow-up|0|||
154957630|NCT01908205|559272511|FG000|Overall Study|Withdrawal by Subject|3|||
154957631|NCT01908205|559272512|FG001|Overall Study|Withdrawal by Subject|1|||
154957632|NCT02612337|559272514|FG000|Overall Study|Lack of Efficacy|1|||
154957633|NCT02612337|559272515|FG001|Overall Study|Lack of Efficacy|0|||
154957634|NCT02612337|559272514|FG000|Overall Study|Withdrawal by Subject|2|||
154957635|NCT02612337|559272515|FG001|Overall Study|Withdrawal by Subject|2|||
154957636|NCT02612337|559272514|FG000|Overall Study|Did not receive study drug|0|||
154957637|NCT02612337|559272515|FG001|Overall Study|Did not receive study drug|1|||
154957638|NCT01424644|559272518|FG000|Overall Study|Adverse Event|2|||
154957639|NCT01424644|559272519|FG001|Overall Study|Adverse Event|0|||
154957640|NCT01424644|559272518|FG000|Overall Study|Withdrawal by Subject|9|||
154957641|NCT01424644|559272519|FG001|Overall Study|Withdrawal by Subject|12|||
154957642|NCT01424644|559272518|FG000|Overall Study|Lost to Follow-up|16|||
154957643|NCT01424644|559272519|FG001|Overall Study|Lost to Follow-up|12|||
154957644|NCT01424644|559272518|FG000|Overall Study|Protocol Violation|4|||
154957645|NCT01424644|559272519|FG001|Overall Study|Protocol Violation|3|||
154957646|NCT01424644|559272518|FG000|Overall Study|Administrative Reason|1|||
154957647|NCT01424644|559272519|FG001|Overall Study|Administrative Reason|0|||
154957648|NCT01424644|559272518|FG000|Overall Study|Unable to Classify|1|||
154957649|NCT01424644|559272519|FG001|Overall Study|Unable to Classify|0|||
154957650|NCT01577381|559272527|FG000|Overall Study|Discontinued|2|||
154957651|NCT01577381|559272528|FG001|Overall Study|Discontinued|1|||
154957652|NCT01577381|559272529|FG002|Overall Study|Discontinued|2|||
154957653|NCT01577381|559272530|FG003|Overall Study|Discontinued|2|||
155299999|NCT00774397|560529626|FG002|Overall Study|Other than those stated above|3|||
155300000|NCT00774397|560529627|FG003|Overall Study|Other than those stated above|2|||
154957654|NCT01577381|559272527|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
154957655|NCT01577381|559272528|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
154957656|NCT01577381|559272529|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
154957657|NCT01577381|559272530|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
155061950|NCT01773928|559659347|FG006|Overall Study|Lost to Follow-up|0|||
155061951|NCT01773928|559659348|FG007|Overall Study|Lost to Follow-up|0|||
155061952|NCT01773928|559659349|FG008|Overall Study|Lost to Follow-up|0|||
155061953|NCT01773928|559659341|FG000|Overall Study|Subject misrepresented age|0|||
155061954|NCT01773928|559659342|FG001|Overall Study|Subject misrepresented age|1|||
155061955|NCT01773928|559659343|FG002|Overall Study|Subject misrepresented age|0|||
155061956|NCT01773928|559659344|FG003|Overall Study|Subject misrepresented age|0|||
155061957|NCT01773928|559659345|FG004|Overall Study|Subject misrepresented age|0|||
155061958|NCT01773928|559659346|FG005|Overall Study|Subject misrepresented age|0|||
155061959|NCT01773928|559659347|FG006|Overall Study|Subject misrepresented age|0|||
155061960|NCT01773928|559659348|FG007|Overall Study|Subject misrepresented age|0|||
155061961|NCT01773928|559659349|FG008|Overall Study|Subject misrepresented age|0|||
155061962|NCT01773928|559659341|FG000|Overall Study|Subject met exclusion criteria|0|||
155061963|NCT01773928|559659342|FG001|Overall Study|Subject met exclusion criteria|0|||
155061964|NCT01773928|559659343|FG002|Overall Study|Subject met exclusion criteria|0|||
155061965|NCT01773928|559659344|FG003|Overall Study|Subject met exclusion criteria|0|||
155061966|NCT01773928|559659345|FG004|Overall Study|Subject met exclusion criteria|0|||
155061967|NCT01773928|559659346|FG005|Overall Study|Subject met exclusion criteria|0|||
155061968|NCT01773928|559659347|FG006|Overall Study|Subject met exclusion criteria|0|||
155158850|NCT03763877|560020677|FG001|Overall Study|Protocol Violation|1|||
155158851|NCT03763877|560020678|FG002|Overall Study|Protocol Violation|0|||
155158852|NCT03763877|560020679|FG003|Overall Study|Protocol Violation|0|||
155158853|NCT03763877|560020676|FG000|Overall Study|Lost to Follow-up|0|||
155158854|NCT03763877|560020677|FG001|Overall Study|Lost to Follow-up|1|||
155158855|NCT03763877|560020678|FG002|Overall Study|Lost to Follow-up|1|||
155158856|NCT03763877|560020679|FG003|Overall Study|Lost to Follow-up|0|||
155158857|NCT03040336|560020681|FG000|Overall Study|Death|1|||
155158858|NCT03040336|560020682|FG001|Overall Study|Death|0|||
155158859|NCT03040336|560020681|FG000|Overall Study|Withdrawal by Subject|2|||
155158860|NCT03040336|560020682|FG001|Overall Study|Withdrawal by Subject|3|||
155158861|NCT01774721|560020687|FG000|Overall Study|Death|133|||
155158862|NCT01774721|560020688|FG001|Overall Study|Death|152|||
155158863|NCT01774721|560020687|FG000|Overall Study|Withdrawal by Subject|20|||
155158864|NCT01774721|560020688|FG001|Overall Study|Withdrawal by Subject|14|||
155158865|NCT01774721|560020687|FG000|Overall Study|Lost to Follow-up|6|||
155158866|NCT01774721|560020688|FG001|Overall Study|Lost to Follow-up|7|||
155158867|NCT01774721|560020687|FG000|Overall Study|Did not meet eligibility criteria|0|||
155158868|NCT01774721|560020688|FG001|Overall Study|Did not meet eligibility criteria|3|||
155158869|NCT01774721|560020687|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
155158870|NCT01774721|560020688|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
155158871|NCT01774721|560020687|FG000|Overall Study|Study terminated by sponsor|5|||
155158872|NCT01774721|560020688|FG001|Overall Study|Study terminated by sponsor|0|||
155158873|NCT01774721|560020687|FG000|Overall Study|Disease progression|5|||
155158874|NCT01774721|560020688|FG001|Overall Study|Disease progression|0|||
155158875|NCT00248040|560020693|FG000|Overall Study|transplantectomy|2|||
155158876|NCT00248040|560020694|FG001|Overall Study|transplantectomy|1|||
155158877|NCT00248040|560020695|FG002|Overall Study|transplantectomy|3|||
155158878|NCT00248040|560020693|FG000|Overall Study|transplant cancelled post treat start|1|||
155158879|NCT00248040|560020694|FG001|Overall Study|transplant cancelled post treat start|0|||
155158880|NCT00248040|560020695|FG002|Overall Study|transplant cancelled post treat start|0|||
155158881|NCT00248040|560020693|FG000|Overall Study|Death|0|||
155158882|NCT00248040|560020694|FG001|Overall Study|Death|0|||
155158883|NCT00248040|560020695|FG002|Overall Study|Death|1|||
155158884|NCT00628108|560020703|FG000|Overall Study|Adverse Event|0|||
155158885|NCT00628108|560020704|FG001|Overall Study|Adverse Event|3|||
155158886|NCT00628108|560020703|FG000|Overall Study|Withdrawal by Subject|1|||
155158887|NCT00628108|560020704|FG001|Overall Study|Withdrawal by Subject|0|||
155158888|NCT03848832|560020705|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
155158889|NCT03848832|560020706|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
155158890|NCT03848832|560020707|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
155158891|NCT03848832|560020705|FG000|Overall Study|Withdrawal by Subject|0|||
155158892|NCT03848832|560020706|FG001|Overall Study|Withdrawal by Subject|0|||
155158893|NCT03848832|560020707|FG002|Overall Study|Withdrawal by Subject|1|||
155158894|NCT03848832|560020705|FG000|Overall Study|Withdrawal (Covid-19)|0|||
155158895|NCT03848832|560020706|FG001|Overall Study|Withdrawal (Covid-19)|2|||
155158896|NCT03848832|560020707|FG002|Overall Study|Withdrawal (Covid-19)|0|||
155158897|NCT03848832|560020705|FG000|Overall Study|Physician Decision|2|||
155158898|NCT03848832|560020706|FG001|Overall Study|Physician Decision|1|||
155158899|NCT03848832|560020707|FG002|Overall Study|Physician Decision|3|||
155158900|NCT03848832|560020705|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
155158901|NCT03848832|560020706|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
155158902|NCT03848832|560020707|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
155158903|NCT03848832|560020705|FG000|Overall Study|Adverse Event|1|||
155300001|NCT00774397|560529628|FG004|Overall Study|Other than those stated above|2|||
155061969|NCT01773928|559659348|FG007|Overall Study|Subject met exclusion criteria|0|||
155061970|NCT01773928|559659349|FG008|Overall Study|Subject met exclusion criteria|1|||
155061971|NCT01773928|559659341|FG000|Overall Study|Randomized, had to leave, never returned|0|||
155061972|NCT01773928|559659342|FG001|Overall Study|Randomized, had to leave, never returned|0|||
155061973|NCT01773928|559659343|FG002|Overall Study|Randomized, had to leave, never returned|0|||
155061974|NCT01773928|559659344|FG003|Overall Study|Randomized, had to leave, never returned|1|||
155061975|NCT01773928|559659345|FG004|Overall Study|Randomized, had to leave, never returned|0|||
155061976|NCT01773928|559659346|FG005|Overall Study|Randomized, had to leave, never returned|0|||
155061977|NCT01773928|559659347|FG006|Overall Study|Randomized, had to leave, never returned|0|||
155061978|NCT01773928|559659348|FG007|Overall Study|Randomized, had to leave, never returned|0|||
155061979|NCT01773928|559659349|FG008|Overall Study|Randomized, had to leave, never returned|0|||
155061980|NCT01773928|559659341|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
155061981|NCT01773928|559659342|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
155061982|NCT01773928|559659343|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
155061983|NCT01773928|559659344|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
155061984|NCT01773928|559659345|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
155061985|NCT01773928|559659346|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
155061986|NCT01773928|559659347|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
155061987|NCT01773928|559659348|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
155061988|NCT01773928|559659349|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
155061989|NCT03054428|559659350|FG000|Overall Study|Physician Decision|0|||
155061990|NCT03054428|559659351|FG001|Overall Study|Physician Decision|1|||
155061991|NCT03054428|559659352|FG002|Overall Study|Physician Decision|1|||
155061992|NCT03054428|559659350|FG000|Overall Study|Lack of Efficacy|3|||
155061993|NCT03054428|559659351|FG001|Overall Study|Lack of Efficacy|1|||
155061994|NCT03054428|559659352|FG002|Overall Study|Lack of Efficacy|0|||
155061995|NCT03054428|559659350|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
155061996|NCT03054428|559659351|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
155061997|NCT03054428|559659352|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
155061998|NCT03054428|559659350|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
155061999|NCT03054428|559659351|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
155062000|NCT03054428|559659352|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
155062001|NCT03054428|559659350|FG000|Overall Study|Transitioned to OLE study|76|||
155062002|NCT03054428|559659351|FG001|Overall Study|Transitioned to OLE study|76|||
155062003|NCT03054428|559659352|FG002|Overall Study|Transitioned to OLE study|73|||
155062004|NCT03054428|559659350|FG000|Overall Study|Withdrawal by Subject|3|||
155062005|NCT03054428|559659351|FG001|Overall Study|Withdrawal by Subject|2|||
155062006|NCT03054428|559659352|FG002|Overall Study|Withdrawal by Subject|3|||
155062007|NCT03054428|559659350|FG000|Overall Study|Lost to Follow-up|0|||
155062008|NCT03054428|559659351|FG001|Overall Study|Lost to Follow-up|0|||
155062009|NCT03054428|559659352|FG002|Overall Study|Lost to Follow-up|1|||
155062010|NCT03225287|559659353|FG000|Overall Study|Adverse Event|0|||
155062011|NCT03225287|559659354|FG001|Overall Study|Adverse Event|0|||
155062012|NCT03225287|559659355|FG002|Overall Study|Adverse Event|1|||
155062013|NCT03225287|559659353|FG000|Overall Study|Protocol non-compliance|0|||
155062014|NCT03225287|559659354|FG001|Overall Study|Protocol non-compliance|0|||
155062015|NCT03225287|559659355|FG002|Overall Study|Protocol non-compliance|1|||
155062016|NCT03225287|559659353|FG000|Overall Study|Subject withdraws consent|3|||
155062017|NCT03225287|559659354|FG001|Overall Study|Subject withdraws consent|0|||
155062018|NCT03225287|559659355|FG002|Overall Study|Subject withdraws consent|0|||
155062019|NCT03225287|559659353|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
155062020|NCT03225287|559659354|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
155062021|NCT03225287|559659355|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
155062022|NCT03225287|559659353|FG000|Overall Study|Trial drug not effective|0|||
155062023|NCT03225287|559659354|FG001|Overall Study|Trial drug not effective|1|||
155062024|NCT03225287|559659355|FG002|Overall Study|Trial drug not effective|0|||
155062025|NCT03225287|559659353|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
155062026|NCT03225287|559659354|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
155158904|NCT03848832|560020706|FG001|Overall Study|Adverse Event|0|||
155062027|NCT03225287|559659355|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
155062028|NCT03225287|559659353|FG000|Overall Study|Stem cell transplantation|0|||
155062029|NCT03225287|559659354|FG001|Overall Study|Stem cell transplantation|1|||
155062030|NCT03225287|559659355|FG002|Overall Study|Stem cell transplantation|0|||
155158905|NCT03848832|560020707|FG002|Overall Study|Adverse Event|0|||
155158906|NCT01760733|560020709|FG000|Waiting List|Death|18|||
155158907|NCT01760733|560020709|FG000|Waiting List|Removed from waiting list|41|||
155158908|NCT01760733|560020709|FG000|Waiting List|Not received a transplant yet|13|||
155158909|NCT01760733|560020709|FG000|Transplanted|Not reached 10 years post transplant|184|||
155158910|NCT01760733|560020709|FG000|Transplanted|Death|26|||
155158911|NCT01760733|560020709|FG000|Transplanted|Graft loss|7|||
155062031|NCT01499810|559659357|FG000|Overall Study|Lost to Follow-up|10|||
155158912|NCT00719472|560020710|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
155158913|NCT00719472|560020710|FG000|Enrolled in Study|Subject decision to withdraw|8|||
155158914|NCT00719472|560020710|FG000|Enrolled in Study|Various Reasons|17|||
155158915|NCT00719472|560020710|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
155062032|NCT01499810|559659357|FG000|Overall Study|Protocol Violation|1|||
155062033|NCT01499810|559659357|FG000|Overall Study|Withdrawal by Subject|1|||
155062034|NCT03834961|559660462|FG000|Overall Study|Lack of Efficacy|1|||
155062035|NCT03834961|559660463|FG001|Overall Study|Lack of Efficacy|1|||
155062036|NCT03834961|559660464|FG002|Overall Study|Lack of Efficacy|0|||
155062037|NCT03834961|559660462|FG000|Overall Study|Physician Decision|0|||
155062038|NCT03834961|559660463|FG001|Overall Study|Physician Decision|1|||
155062039|NCT03834961|559660464|FG002|Overall Study|Physician Decision|0|||
155062040|NCT04736199|559660467|FG000|Overall Study|Adverse Event|28|||
155062041|NCT04736199|559660468|FG001|Overall Study|Adverse Event|22|||
155062042|NCT04736199|559660467|FG000|Overall Study|Death|9|||
155062043|NCT04736199|559660468|FG001|Overall Study|Death|3|||
155062044|NCT04736199|559660467|FG000|Overall Study|Lost to Follow-up|4|||
155062045|NCT04736199|559660468|FG001|Overall Study|Lost to Follow-up|1|||
155062046|NCT04736199|559660467|FG000|Overall Study|Physician Decision|5|||
155062047|NCT04736199|559660468|FG001|Overall Study|Physician Decision|9|||
155062048|NCT04736199|559660467|FG000|Overall Study|Withdrawal by Subject|21|||
155062049|NCT04736199|559660468|FG001|Overall Study|Withdrawal by Subject|9|||
155062050|NCT04736199|559660467|FG000|Overall Study|Progressive disease|120|||
155062051|NCT04736199|559660468|FG001|Overall Study|Progressive disease|101|||
155062052|NCT04736199|559660467|FG000|Overall Study|Subject decision|13|||
155062053|NCT04736199|559660468|FG001|Overall Study|Subject decision|13|||
155062054|NCT04736199|559660467|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
155062055|NCT04736199|559660468|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
155062056|NCT04736199|559660467|FG000|Overall Study|Additional primary malignancy|1|||
155062057|NCT04736199|559660468|FG001|Overall Study|Additional primary malignancy|0|||
155062058|NCT04736199|559660467|FG000|Overall Study|Non-compliance with study drug|0|||
155062059|NCT04736199|559660468|FG001|Overall Study|Non-compliance with study drug|1|||
155062060|NCT04736199|559660467|FG000|Overall Study|Other reason|0|||
155062061|NCT04736199|559660468|FG001|Overall Study|Other reason|1|||
155062062|NCT04736199|559660467|FG000|Overall Study|Ongoing with study drug|240|||
155062063|NCT04736199|559660468|FG001|Overall Study|Ongoing with study drug|63|||
155062064|NCT04736199|559660467|FG000|Overall Study|Study drug never administered|3|||
155062065|NCT04736199|559660468|FG001|Overall Study|Study drug never administered|0|||
155062066|NCT03370172|559660469|FG000|Overall Study|Withdrawal by Subject|0|||
155062067|NCT03370172|559660470|FG001|Overall Study|Withdrawal by Subject|1|||
155062068|NCT05918055|559660471|FG000|Phase I - Dose Level 1|Ineligible|0|||
155062069|NCT05918055|559660472|FG001|Phase I - Dose Level 1|Ineligible|0|||
155062070|NCT05918055|559660473|FG002|Phase I - Dose Level 1|Ineligible|1|||
155062071|NCT05918055|559660471|FG000|Phase I - Dose Level -1|Physician Decision|1|||
155062072|NCT05918055|559660472|FG001|Phase I - Dose Level -1|Physician Decision|0|||
155062073|NCT05918055|559660473|FG002|Phase I - Dose Level -1|Physician Decision|0|||
155062074|NCT05610605|559660476|FG000|6-month Assessment|Death|1|||
155062075|NCT05610605|559660477|FG001|6-month Assessment|Death|1|||
155062076|NCT05610605|559660476|FG000|6-month Assessment|Lost to Follow-up|20|||
155062077|NCT05610605|559660477|FG001|6-month Assessment|Lost to Follow-up|0|||
155158916|NCT00719472|560020710|FG000|Received Cycle 1 Treatment|Death|5|||
155158917|NCT00719472|560020710|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
155158918|NCT00719472|560020710|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
155158919|NCT00719472|560020710|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
155158920|NCT00719472|560020710|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
155158921|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
155158922|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Death|6|||
155158923|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Disease progression|3|||
155158924|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
155158925|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
155158926|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
155158927|NCT00719472|560020710|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
155158928|NCT00815659|560020711|FG000|Overall Study|Adverse Event|9|||
155158929|NCT00815659|560020711|FG000|Overall Study|Withdrawal by Subject|9|||
155158930|NCT00815659|560020711|FG000|Overall Study|Lost to Follow-up|4|||
155158931|NCT00815659|560020711|FG000|Overall Study|Protocol Violation|1|||
155158932|NCT03847896|560020712|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155062078|NCT05610605|559660476|FG000|6-month Assessment|Institutionalized|1|||
155062079|NCT05610605|559660477|FG001|6-month Assessment|Institutionalized|2|||
155062080|NCT05610605|559660476|FG000|12-month Assessment|Death|2|||
155062081|NCT05610605|559660477|FG001|12-month Assessment|Death|1|||
155062082|NCT05610605|559660476|FG000|12-month Assessment|Lost to Follow-up|1|||
155062083|NCT05610605|559660477|FG001|12-month Assessment|Lost to Follow-up|4|||
155062084|NCT05610605|559660476|FG000|12-month Assessment|Institutionalized|2|||
155062085|NCT05610605|559660477|FG001|12-month Assessment|Institutionalized|1|||
155062086|NCT00753519|559660478|FG000|Overall Study|Withdrawal by Subject|0|||
155062087|NCT00753519|559660479|FG001|Overall Study|Withdrawal by Subject|2|||
155062088|NCT01171534|559660480|FG000|Overall Study|Lost to Follow-up|0|||
155062089|NCT01171534|559660481|FG001|Overall Study|Lost to Follow-up|2|||
155062090|NCT01171534|559660480|FG000|Overall Study|screen failure|0|||
155062091|NCT01171534|559660481|FG001|Overall Study|screen failure|1|||
155062092|NCT00548327|559660482|FG000|Overall Study|Adverse Event|0|||
155062093|NCT00548327|559660483|FG001|Overall Study|Adverse Event|1|||
155062094|NCT02100631|559660484|FG000|Overall Study|Withdrawal by Subject|1|||
155062095|NCT02100631|559660485|FG001|Overall Study|Withdrawal by Subject|0|||
155062096|NCT02100631|559660486|FG002|Overall Study|Withdrawal by Subject|0|||
155062097|NCT02100631|559660484|FG000|Overall Study|Lost to Follow-up|3|||
155062098|NCT02100631|559660485|FG001|Overall Study|Lost to Follow-up|4|||
155062099|NCT02100631|559660486|FG002|Overall Study|Lost to Follow-up|0|||
155062100|NCT02100631|559660484|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
155062101|NCT02100631|559660485|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
155062102|NCT02100631|559660486|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
155062103|NCT01316614|559660487|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
155062104|NCT01316614|559660487|FG000|Overall Study|Cytology slides not available for review|4|||
155062105|NCT01316614|559660487|FG000|Overall Study|Cystic lesion|5|||
155062106|NCT01316614|559660487|FG000|Overall Study|Inadequate number of passes|2|||
155062107|NCT01316614|559660487|FG000|Overall Study|Medically unstable|1|||
155062108|NCT00089648|559660488|FG000|Overall Study|Adverse Event|7|||
155062109|NCT00089648|559660488|FG000|Overall Study|Withdrawal by Subject|1|||
155062110|NCT00089648|559660488|FG000|Overall Study|Lack of Efficacy|33|||
155062111|NCT00420745|559660489|FG000|Overall Study|Adverse Event|2|||
155062112|NCT00420745|559660490|FG001|Overall Study|Adverse Event|2|||
155062113|NCT00420745|559660489|FG000|Overall Study|Lost to Follow-up|10|||
155062114|NCT00420745|559660490|FG001|Overall Study|Lost to Follow-up|2|||
155062115|NCT00420745|559660489|FG000|Overall Study|Protocol Violation|1|||
155062116|NCT00420745|559660490|FG001|Overall Study|Protocol Violation|0|||
155062117|NCT00420745|559660489|FG000|Overall Study|Physician Decision|1|||
155062118|NCT00420745|559660490|FG001|Overall Study|Physician Decision|1|||
155062119|NCT00420745|559660489|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
155062120|NCT00420745|559660490|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
155062121|NCT00420745|559660489|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
155062122|NCT00420745|559660490|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
155062123|NCT00423605|559660491|FG000|Overall Study|Adverse Event|129|||
155062124|NCT00423605|559660491|FG000|Overall Study|Withdrawal by Subject|36|||
155062125|NCT00423605|559660491|FG000|Overall Study|Lost to Follow-up|15|||
155062126|NCT00423605|559660491|FG000|Overall Study|Lack of Efficacy|38|||
155062127|NCT00423605|559660491|FG000|Overall Study|Sponsor Decision|3|||
155062128|NCT00423605|559660491|FG000|Overall Study|Physician Decision|8|||
155062129|NCT00423605|559660491|FG000|Overall Study|Protocol Violation|7|||
155062130|NCT00423605|559660491|FG000|Overall Study|Not one of the pre-specified options|5|||
155062131|NCT00726453|559660493|FG000|Primary Enrollment Group|Death|18|||
155062132|NCT00726453|559660494|FG001|Primary Enrollment Group|Death|0|||
155062133|NCT00726453|559660493|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
155062134|NCT00726453|559660494|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
155062135|NCT00726453|559660493|FG000|38 mm Length Group|Death|0|||
155062136|NCT00726453|559660494|FG001|38 mm Length Group|Death|3|||
155062137|NCT01588509|559660496|FG000|Overall Study|Lost to Follow-up|1|||
155062138|NCT01588509|559660497|FG001|Overall Study|Lost to Follow-up|0|||
155062139|NCT01454284|559660498|FG000|Overall Study|Adverse Event|20|||
155062140|NCT01454284|559660499|FG001|Overall Study|Adverse Event|7|||
155062141|NCT01454284|559660498|FG000|Overall Study|Death|0|||
155062142|NCT01454284|559660499|FG001|Overall Study|Death|3|||
155062143|NCT01454284|559660498|FG000|Overall Study|Lost to Follow-up|13|||
155062144|NCT01454284|559660499|FG001|Overall Study|Lost to Follow-up|8|||
155062145|NCT01454284|559660498|FG000|Overall Study|Protocol Violation|9|||
155062146|NCT01454284|559660499|FG001|Overall Study|Protocol Violation|6|||
155062147|NCT01454284|559660498|FG000|Overall Study|Withdrawal by Subject|58|||
155062148|NCT01454284|559660499|FG001|Overall Study|Withdrawal by Subject|36|||
155062149|NCT01454284|559660498|FG000|Overall Study|Physician Decision|16|||
155062150|NCT01454284|559660499|FG001|Overall Study|Physician Decision|11|||
155300002|NCT00774397|560529629|FG005|Overall Study|Other than those stated above|0|||
155300003|NCT00774397|560529630|FG006|Overall Study|Other than those stated above|1|||
155300004|NCT01599793|560529631|FG000|Overall Study|Adverse Event|2|||
155300005|NCT00665444|560529633|FG000|Overall Study|Physician Decision|1|||
155300006|NCT00665444|560529633|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
155300007|NCT00101010|560529634|FG000|Overall Study|Physician Decision|1|||
155300008|NCT01185782|560529635|FG000|Overall Study|Adverse Event|0|||
155300009|NCT01185782|560529636|FG001|Overall Study|Adverse Event|1|||
155170034|NCT00830869|560062413|FG008|Period 2: Part 2|Adverse Event|3|||
155062151|NCT01454284|559660498|FG000|Overall Study|Sponsor Decision|0|||
155062152|NCT01454284|559660499|FG001|Overall Study|Sponsor Decision|2|||
155062153|NCT03435055|559660500|FG000|Screening|Physician Decision|2|||
155062154|NCT03435055|559660500|FG000|Received Intervention|Did not complete nitrous administration|3|||
155062155|NCT03817528|559660503|FG000|Overall Study|Withdrawal by Subject|1|||
155300010|NCT01185782|560529635|FG000|Overall Study|Protocol Violation|1|||
155300011|NCT01185782|560529636|FG001|Overall Study|Protocol Violation|0|||
155300012|NCT01185782|560529635|FG000|Overall Study|Poor Response to Treatment|3|||
155300013|NCT01185782|560529636|FG001|Overall Study|Poor Response to Treatment|1|||
155300014|NCT01185782|560529635|FG000|Overall Study|Other|2|||
155300015|NCT01185782|560529636|FG001|Overall Study|Other|5|||
155300016|NCT01185782|560529635|FG000|Overall Study|Randomized but not treated|0|||
155300017|NCT01185782|560529636|FG001|Overall Study|Randomized but not treated|4|||
155300018|NCT03740009|560529641|FG000|Overall Study|Physician Decision|9|||
155300019|NCT03740009|560529641|FG000|Overall Study|Lost to Follow-up|1|||
155300020|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
155300021|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
155300022|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
155300023|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
155300024|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
155300025|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
155300026|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
155300027|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
155300028|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
155300029|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
155300030|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
155300031|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
154957658|NCT03235739|559273867|FG000|Overall Study|Withdrawal by Subject|2|||
154957659|NCT03235739|559273868|FG001|Overall Study|Withdrawal by Subject|2|||
154957660|NCT03235739|559273867|FG000|Overall Study|Physician Decision|0|||
154957661|NCT03235739|559273868|FG001|Overall Study|Physician Decision|1|||
154957662|NCT02378935|559273869|FG000|Overall Study|Lack of Efficacy|10|||
154957663|NCT02378935|559273870|FG001|Overall Study|Lack of Efficacy|0|||
155300032|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
155300033|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
154957664|NCT02378935|559273871|FG002|Overall Study|Lack of Efficacy|2|||
154957665|NCT02378935|559273872|FG003|Overall Study|Lack of Efficacy|6|||
154957666|NCT02378935|559273873|FG004|Overall Study|Lack of Efficacy|0|||
154957667|NCT02378935|559273874|FG005|Overall Study|Lack of Efficacy|0|||
154957668|NCT02378935|559273875|FG006|Overall Study|Lack of Efficacy|0|||
154957669|NCT02378935|559273869|FG000|Overall Study|Death|0|||
154957670|NCT02378935|559273870|FG001|Overall Study|Death|0|||
154957671|NCT02378935|559273871|FG002|Overall Study|Death|1|||
154957672|NCT02378935|559273872|FG003|Overall Study|Death|0|||
154957673|NCT02378935|559273873|FG004|Overall Study|Death|0|||
154957674|NCT02378935|559273874|FG005|Overall Study|Death|0|||
154957675|NCT02378935|559273875|FG006|Overall Study|Death|0|||
154957676|NCT00829790|559273879|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
154957677|NCT00829790|559273880|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
154957678|NCT03214952|559273881|FG000|Overall Study|Protocol Deviation|45|||
154957679|NCT03214952|559273881|FG000|Overall Study|Case Report Forms Uncollected|13|||
154957680|NCT03935880|559273882|FG000|Overall Study|Lost to Follow-up|0|||
154957681|NCT03935880|559273883|FG001|Overall Study|Lost to Follow-up|1|||
154957682|NCT03020615|559273888|FG000|Overall Study|Physician Decision|3|||
154957683|NCT03020615|559273889|FG001|Overall Study|Physician Decision|1|||
154957684|NCT03020615|559273890|FG002|Overall Study|Physician Decision|2|||
154957685|NCT03020615|559273888|FG000|Overall Study|Parent/guardian/patient choice|3|||
154957686|NCT03020615|559273889|FG001|Overall Study|Parent/guardian/patient choice|0|||
154957687|NCT03020615|559273890|FG002|Overall Study|Parent/guardian/patient choice|4|||
154957688|NCT03020615|559273888|FG000|Overall Study|Screen failure|0|||
155300034|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
155300035|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
155300036|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
155300037|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
155300038|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
155300039|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
155300040|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
155300041|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
155300042|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
155300043|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
155300044|NCT01061151|560529643|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
155300045|NCT01061151|560529644|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
154957689|NCT03020615|559273889|FG001|Overall Study|Screen failure|0|||
154957690|NCT03020615|559273890|FG002|Overall Study|Screen failure|1|||
154957691|NCT03020615|559273888|FG000|Overall Study|Death|1|||
154957692|NCT03020615|559273889|FG001|Overall Study|Death|0|||
154957693|NCT03020615|559273890|FG002|Overall Study|Death|0|||
154957694|NCT03020615|559273888|FG000|Overall Study|Lost to Follow-up|0|||
154957695|NCT03020615|559273889|FG001|Overall Study|Lost to Follow-up|1|||
155300046|NCT01061151|560529645|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
155300047|NCT01061151|560529646|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
155300048|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
155300049|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
155300050|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
155300051|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
155300052|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
155300053|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
155300054|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
155300055|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
155300056|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
155300057|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
155300058|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
155300059|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
155300060|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
155300061|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
155300062|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
154957696|NCT03020615|559273890|FG002|Overall Study|Lost to Follow-up|0|||
154957697|NCT01273805|559273891|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
154957698|NCT01273805|559273892|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
154957699|NCT00252720|559273893|FG000|Overall Study|Withdrawal by Subject|95|||
154957700|NCT00252720|559273894|FG001|Overall Study|Withdrawal by Subject|97|||
154957701|NCT00252720|559273893|FG000|Overall Study|Death|7|||
154957702|NCT00252720|559273894|FG001|Overall Study|Death|8|||
154957703|NCT00252720|559273893|FG000|Overall Study|Moving|23|||
154957704|NCT00252720|559273894|FG001|Overall Study|Moving|42|||
154957705|NCT00252720|559273893|FG000|Overall Study|Mainly patients lost to follow-up|7|||
154957706|NCT00252720|559273894|FG001|Overall Study|Mainly patients lost to follow-up|18|||
154957707|NCT02647944|559273895|FG000|Overall Study|Withdrawal by Subject|0|||
154957708|NCT02647944|559273896|FG001|Overall Study|Withdrawal by Subject|3|||
154957709|NCT02647944|559273895|FG000|Overall Study|Adverse Event|2|||
154957710|NCT02647944|559273896|FG001|Overall Study|Adverse Event|0|||
154957711|NCT02077465|559273899|FG000|Overall Study|Withdrew Consent|0|||
154957712|NCT02077465|559273900|FG001|Overall Study|Withdrew Consent|1|||
154957713|NCT02077465|559273899|FG000|Overall Study|Lost to Follow-up|1|||
154957714|NCT02077465|559273900|FG001|Overall Study|Lost to Follow-up|0|||
154957715|NCT02481830|559273902|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
154957716|NCT02481830|559273903|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
154957717|NCT02481830|559273902|FG000|Pre-treatment|Withdrawal by Subject|0|||
154957718|NCT02481830|559273903|FG001|Pre-treatment|Withdrawal by Subject|10|||
154957719|NCT02481830|559273902|FG000|Pre-treatment|Disease Progression|1|||
154957720|NCT02481830|559273903|FG001|Pre-treatment|Disease Progression|1|||
154957721|NCT02481830|559273902|FG000|Pre-treatment|Other reasons|0|||
154957722|NCT02481830|559273903|FG001|Pre-treatment|Other reasons|1|||
154957723|NCT02481830|559273902|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
154957724|NCT02481830|559273903|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
154957725|NCT02481830|559273902|FG000|Treatment|Disease Progression|233|||
154957726|NCT02481830|559273903|FG001|Treatment|Disease Progression|171|||
154957727|NCT02481830|559273902|FG000|Treatment|Study drug toxicity|18|||
154957728|NCT02481830|559273903|FG001|Treatment|Study drug toxicity|38|||
154957729|NCT02481830|559273902|FG000|Treatment|Death|1|||
154957730|NCT02481830|559273903|FG001|Treatment|Death|1|||
154957731|NCT02481830|559273902|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
154957732|NCT02481830|559273903|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
154957733|NCT02481830|559273902|FG000|Treatment|Participants request to discontinue Study treatment|6|||
154957734|NCT02481830|559273903|FG001|Treatment|Participants request to discontinue Study treatment|34|||
154957735|NCT02481830|559273902|FG000|Treatment|Withdrawal by Subject|2|||
154957736|NCT02481830|559273903|FG001|Treatment|Withdrawal by Subject|3|||
154957737|NCT02481830|559273902|FG000|Treatment|Lost to Follow-up|1|||
154957738|NCT02481830|559273903|FG001|Treatment|Lost to Follow-up|0|||
154957739|NCT02481830|559273902|FG000|Treatment|Maximum Clinical Benefit|0|||
154957740|NCT02481830|559273903|FG001|Treatment|Maximum Clinical Benefit|5|||
154957741|NCT02481830|559273902|FG000|Treatment|Administrative reason by sponsor|1|||
154957742|NCT02481830|559273903|FG001|Treatment|Administrative reason by sponsor|1|||
154957743|NCT02481830|559273902|FG000|Treatment|Other reasons|6|||
154957744|NCT02481830|559273903|FG001|Treatment|Other reasons|1|||
154957745|NCT04627038|559273904|FG000|Overall Study|Adverse Event|36|||
154957746|NCT04627038|559273905|FG001|Overall Study|Adverse Event|8|||
154957747|NCT04627038|559273904|FG000|Overall Study|Lost to Follow-up|1|||
154957748|NCT04627038|559273905|FG001|Overall Study|Lost to Follow-up|0|||
154957749|NCT04627038|559273904|FG000|Overall Study|Physician Decision|0|||
154957750|NCT04627038|559273905|FG001|Overall Study|Physician Decision|1|||
155062156|NCT03817528|559660503|FG000|Overall Study|Adverse Event|2|||
155062157|NCT00671749|559660509|FG000|Overall Study|Adverse Event|2|||
155062158|NCT00671749|559660509|FG000|Overall Study|Withdrawal by Subject|4|||
155062159|NCT00671749|559660509|FG000|Overall Study|Protocol Violation|1|||
155062160|NCT00671749|559660509|FG000|Overall Study|Lost to Follow-up|1|||
155062161|NCT03937778|559660517|FG000|Overall Study|Withdrawal by Subject|1|||
155062162|NCT03937778|559660517|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
155062163|NCT01200355|559660518|FG000|Overall Study|Death|7|||
155062164|NCT01200355|559660519|FG001|Overall Study|Death|2|||
155062165|NCT00485303|559660520|FG000|Overall Study|Adverse Event|5|||
155062166|NCT00485303|559660520|FG000|Overall Study|Progressive Disease|44|||
155062167|NCT00485303|559660520|FG000|Overall Study|Other|3|||
155062168|NCT00485303|559660520|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
155062169|NCT00485303|559660520|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
155062170|NCT01281306|559660522|FG000|Overall Study|Lack of Efficacy|0|||
155062171|NCT01281306|559660523|FG001|Overall Study|Lack of Efficacy|1|||
155062172|NCT01281306|559660524|FG002|Overall Study|Lack of Efficacy|3|||
155062173|NCT01281306|559660525|FG003|Overall Study|Lack of Efficacy|0|||
155062174|NCT01281306|559660526|FG004|Overall Study|Lack of Efficacy|2|||
155062175|NCT01281306|559660527|FG005|Overall Study|Lack of Efficacy|0|||
155062176|NCT01281306|559660528|FG006|Overall Study|Lack of Efficacy|1|||
155062177|NCT01281306|559660522|FG000|Overall Study|Withdrawal by Subject|1|||
155062178|NCT01281306|559660523|FG001|Overall Study|Withdrawal by Subject|0|||
155062179|NCT01281306|559660524|FG002|Overall Study|Withdrawal by Subject|2|||
155062180|NCT01281306|559660525|FG003|Overall Study|Withdrawal by Subject|4|||
155062181|NCT01281306|559660526|FG004|Overall Study|Withdrawal by Subject|1|||
155062182|NCT01281306|559660527|FG005|Overall Study|Withdrawal by Subject|3|||
155062183|NCT01281306|559660528|FG006|Overall Study|Withdrawal by Subject|1|||
155062184|NCT01281306|559660522|FG000|Overall Study|Protocol deviation|0|||
155062185|NCT01281306|559660523|FG001|Overall Study|Protocol deviation|1|||
155062186|NCT01281306|559660524|FG002|Overall Study|Protocol deviation|1|||
155062187|NCT01281306|559660525|FG003|Overall Study|Protocol deviation|1|||
155062188|NCT01281306|559660526|FG004|Overall Study|Protocol deviation|1|||
155062189|NCT01281306|559660527|FG005|Overall Study|Protocol deviation|0|||
155062190|NCT01281306|559660528|FG006|Overall Study|Protocol deviation|0|||
155062191|NCT01281306|559660522|FG000|Overall Study|Condition no longer requires study drug|1|||
155062192|NCT01281306|559660523|FG001|Overall Study|Condition no longer requires study drug|0|||
155062193|NCT01281306|559660524|FG002|Overall Study|Condition no longer requires study drug|0|||
155062194|NCT01281306|559660525|FG003|Overall Study|Condition no longer requires study drug|0|||
155062195|NCT01281306|559660526|FG004|Overall Study|Condition no longer requires study drug|0|||
155062196|NCT01281306|559660527|FG005|Overall Study|Condition no longer requires study drug|1|||
155062197|NCT01281306|559660528|FG006|Overall Study|Condition no longer requires study drug|1|||
155062198|NCT01281306|559660522|FG000|Overall Study|Lost to Follow-up|1|||
155062199|NCT01281306|559660523|FG001|Overall Study|Lost to Follow-up|0|||
155062200|NCT01281306|559660524|FG002|Overall Study|Lost to Follow-up|0|||
155062201|NCT01281306|559660525|FG003|Overall Study|Lost to Follow-up|2|||
155062202|NCT01281306|559660526|FG004|Overall Study|Lost to Follow-up|0|||
155062203|NCT01281306|559660527|FG005|Overall Study|Lost to Follow-up|0|||
155062204|NCT01281306|559660528|FG006|Overall Study|Lost to Follow-up|1|||
155062205|NCT01281306|559660522|FG000|Overall Study|Death|1|||
155062206|NCT01281306|559660523|FG001|Overall Study|Death|0|||
155062207|NCT01281306|559660524|FG002|Overall Study|Death|0|||
155062208|NCT01281306|559660525|FG003|Overall Study|Death|0|||
155062209|NCT01281306|559660526|FG004|Overall Study|Death|0|||
155062210|NCT01281306|559660527|FG005|Overall Study|Death|0|||
155062211|NCT01281306|559660528|FG006|Overall Study|Death|0|||
155062212|NCT01281306|559660522|FG000|Overall Study|Adverse Event|3|||
155062213|NCT01281306|559660523|FG001|Overall Study|Adverse Event|2|||
155062214|NCT01281306|559660524|FG002|Overall Study|Adverse Event|2|||
155062215|NCT01281306|559660525|FG003|Overall Study|Adverse Event|3|||
155062216|NCT01281306|559660526|FG004|Overall Study|Adverse Event|5|||
155062217|NCT01281306|559660527|FG005|Overall Study|Adverse Event|3|||
155062218|NCT01281306|559660528|FG006|Overall Study|Adverse Event|3|||
155062219|NCT01281306|559660522|FG000|Overall Study|Randomized in error|1|||
155062220|NCT01281306|559660523|FG001|Overall Study|Randomized in error|0|||
155062221|NCT01281306|559660524|FG002|Overall Study|Randomized in error|0|||
155062222|NCT01281306|559660525|FG003|Overall Study|Randomized in error|1|||
155062223|NCT01281306|559660526|FG004|Overall Study|Randomized in error|0|||
155062224|NCT01281306|559660527|FG005|Overall Study|Randomized in error|0|||
155062225|NCT01281306|559660528|FG006|Overall Study|Randomized in error|0|||
155062226|NCT00368550|559660529|FG000|Overall Study|Adverse Event|7|||
155062227|NCT00368550|559660530|FG001|Overall Study|Adverse Event|4|||
155062228|NCT00368550|559660529|FG000|Overall Study|Lack of Efficacy|4|||
155062229|NCT00368550|559660530|FG001|Overall Study|Lack of Efficacy|9|||
155062230|NCT00368550|559660529|FG000|Overall Study|Withdrawal by Subject|17|||
155062231|NCT00368550|559660530|FG001|Overall Study|Withdrawal by Subject|10|||
155062232|NCT01401322|559660531|FG000|Overall Study|Withdrawal by Subject|1|||
155062233|NCT01401322|559660531|FG000|Overall Study|Physician Decision|1|||
155062234|NCT02410629|559660533|FG000|Overall Study|Family cannot commit to the study|2|||
155062235|NCT02410629|559660534|FG001|Overall Study|Family cannot commit to the study|1|||
155062236|NCT02410629|559660533|FG000|Overall Study|Subject returned to work|1|||
155062237|NCT02410629|559660534|FG001|Overall Study|Subject returned to work|0|||
155062238|NCT02410629|559660533|FG000|Overall Study|Subject moved back to home country|0|||
155062239|NCT02410629|559660534|FG001|Overall Study|Subject moved back to home country|1|||
155062240|NCT02410629|559660533|FG000|Overall Study|Subject underwent heart surgery|0|||
155062241|NCT02410629|559660534|FG001|Overall Study|Subject underwent heart surgery|1|||
155062242|NCT05282823|559660535|FG000|Overall Study|Withdrawal by Subject|9|||
155062243|NCT05282823|559660535|FG000|Overall Study|Adverse Event|1|||
155062244|NCT05282823|559660535|FG000|Overall Study|did not meet protocol criteria|2|||
155062245|NCT05282823|559660535|FG000|Overall Study|Withdrawal by Subject|7|||
155062246|NCT00997893|559660536|FG000|Overall Study|Adverse Event|1|||
155062247|NCT00997893|559660537|FG001|Overall Study|Adverse Event|0|||
155062248|NCT00997893|559660538|FG002|Overall Study|Adverse Event|0|||
155062249|NCT00997893|559660536|FG000|Overall Study|Unable to meet study timelines|1|||
155062250|NCT00997893|559660537|FG001|Overall Study|Unable to meet study timelines|0|||
155062251|NCT00997893|559660538|FG002|Overall Study|Unable to meet study timelines|0|||
155062252|NCT00997893|559660536|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
155062253|NCT00997893|559660537|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
155062254|NCT00997893|559660538|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
155062255|NCT06129149|559660540|FG000|Overall Study|Death|1|||
155062256|NCT04649359|559660541|FG000|Overall Study|Withdrawal by Subject|7|||
155062257|NCT04649359|559660542|FG001|Overall Study|Withdrawal by Subject|7|||
155300063|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
155300064|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
155300065|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
155300066|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
155300067|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
155300068|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
155300069|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
155300070|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
155300071|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
155300072|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
155300073|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
155300074|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
155300075|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
155300076|NCT01061151|560529643|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
155300077|NCT01061151|560529644|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
155300078|NCT01061151|560529645|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
155300079|NCT01061151|560529646|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
155300080|NCT01236001|560529647|FG000|Overall Study|Adverse Event|5|||
155300081|NCT01236001|560529648|FG001|Overall Study|Adverse Event|14|||
155300082|NCT01236001|560529647|FG000|Overall Study|Lack of Efficacy|6|||
155300083|NCT01236001|560529648|FG001|Overall Study|Lack of Efficacy|6|||
155300084|NCT01236001|560529647|FG000|Overall Study|Lost to Follow-up|6|||
155300085|NCT01236001|560529648|FG001|Overall Study|Lost to Follow-up|1|||
155300086|NCT01236001|560529647|FG000|Overall Study|Incompliance|1|||
155300087|NCT01236001|560529648|FG001|Overall Study|Incompliance|0|||
155300088|NCT01236001|560529647|FG000|Overall Study|Planned Visit After End of Study|0|||
155300089|NCT01236001|560529648|FG001|Overall Study|Planned Visit After End of Study|1|||
155300090|NCT05082935|560529651|FG000|Overall Study|Lost to Follow-up|549|||
155300091|NCT05082935|560529652|FG001|Overall Study|Lost to Follow-up|631|||
155158933|NCT03847896|560020713|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155158934|NCT03847896|560020714|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
155062258|NCT04649359|559660541|FG000|Overall Study|Death|41|||
155062259|NCT04649359|559660542|FG001|Overall Study|Death|26|||
155062260|NCT04649359|559660541|FG000|Overall Study|Ongoing in the study|75|||
155062261|NCT04649359|559660542|FG001|Overall Study|Ongoing in the study|31|||
155062262|NCT04108468|559660544|FG000|Overall Study|Physician Decision|0|||
155062263|NCT04108468|559660545|FG001|Overall Study|Physician Decision|1|||
155062264|NCT04108468|559660544|FG000|Overall Study|Lost to Follow-up|0|||
155300092|NCT05082935|560529651|FG000|Overall Study|Withdrawal by Subject|27|||
155300093|NCT05082935|560529652|FG001|Overall Study|Withdrawal by Subject|58|||
155158935|NCT03847896|560020715|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155062265|NCT04108468|559660545|FG001|Overall Study|Lost to Follow-up|1|||
155062266|NCT04108468|559660544|FG000|Overall Study|Non-compliance|1|||
155062267|NCT04108468|559660545|FG001|Overall Study|Non-compliance|1|||
155062268|NCT04108468|559660544|FG000|Overall Study|Unable to attend final visit|2|||
155170035|NCT00830869|560062414|FG009|Period 2: Part 2|Adverse Event|2|||
155062269|NCT04108468|559660545|FG001|Overall Study|Unable to attend final visit|0|||
155062270|NCT04108468|559660544|FG000|Overall Study|Missed study medication|0|||
155062271|NCT04108468|559660545|FG001|Overall Study|Missed study medication|1|||
155062272|NCT04935879|559660549|FG000|Overall Study|Adverse Event|2|||
155062273|NCT04935879|559660550|FG001|Overall Study|Adverse Event|1|||
155062274|NCT04935879|559660549|FG000|Overall Study|Lost to Follow-up|1|||
155062275|NCT04935879|559660550|FG001|Overall Study|Lost to Follow-up|1|||
155062276|NCT04935879|559660549|FG000|Overall Study|Pregnancy|2|||
155062277|NCT04935879|559660550|FG001|Overall Study|Pregnancy|3|||
155062278|NCT04935879|559660549|FG000|Overall Study|Withdrawal by Subject|8|||
155062279|NCT04935879|559660550|FG001|Overall Study|Withdrawal by Subject|6|||
155062280|NCT04935879|559660549|FG000|Overall Study|Other|3|||
155062281|NCT04935879|559660550|FG001|Overall Study|Other|3|||
155062282|NCT01652690|559660551|FG000|Overall Study|Withdrawal by Subject|16|||
155062283|NCT01652690|559660552|FG001|Overall Study|Withdrawal by Subject|4|||
155062284|NCT01652690|559660551|FG000|Overall Study|Other|8|||
155062285|NCT01652690|559660552|FG001|Overall Study|Other|9|||
155062286|NCT01652690|559660551|FG000|Overall Study|Lost to Follow-up|6|||
155062287|NCT01652690|559660552|FG001|Overall Study|Lost to Follow-up|6|||
155062288|NCT01652690|559660551|FG000|Overall Study|Death|5|||
155062289|NCT01652690|559660552|FG001|Overall Study|Death|2|||
155062290|NCT02634710|559660557|FG000|Overall Study|Death|4|||
155062291|NCT04530630|559661894|FG000|Overall Study|Physician Decision|1|||
155062292|NCT06125964|559661895|FG000|Overall Study|Lost to Follow-up|0|||
155062293|NCT06125964|559661896|FG001|Overall Study|Lost to Follow-up|1|||
155062294|NCT06125964|559661897|FG002|Overall Study|Lost to Follow-up|0|||
155062295|NCT06125964|559661898|FG003|Overall Study|Lost to Follow-up|0|||
155062296|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
155062297|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
155062298|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
155062299|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Death|1|||
155062300|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Death|1|||
155062301|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Death|0|||
155062302|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
155062303|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
155062304|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
155062305|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
155062306|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
155062307|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
155062308|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
155062309|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
155062310|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
155062311|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
155062312|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
155062313|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
155062314|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
155062315|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
155062316|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
155062317|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
155062318|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
155062319|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
155062320|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
155062321|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
155062322|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
155062323|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
155062324|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
155062325|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
155062326|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Other|10|||
155062327|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Other|4|||
155158936|NCT03847896|560020716|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
155158937|NCT03847896|560020712|FG000|Overall Study|Withdrawal by Subject|2|||
155062328|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Other|0|||
155062329|NCT04006457|559661899|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
155062330|NCT04006457|559661900|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
155062331|NCT04006457|559661901|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
155062332|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
155158938|NCT03847896|560020713|FG001|Overall Study|Withdrawal by Subject|10|||
155158939|NCT03847896|560020714|FG002|Overall Study|Withdrawal by Subject|5|||
155158940|NCT03847896|560020715|FG003|Overall Study|Withdrawal by Subject|9|||
155062333|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
155062334|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
155062335|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
155300094|NCT01444417|560529655|FG000|Overall Study|Ineligibility Determined|0|||
155300095|NCT01444417|560529656|FG001|Overall Study|Ineligibility Determined|1|||
155062336|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
155062337|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
155300096|NCT01444417|560529655|FG000|Overall Study|Withdrawal by Subject|2|||
155300097|NCT01444417|560529656|FG001|Overall Study|Withdrawal by Subject|0|||
155300098|NCT03531840|560529658|FG000|Overall Study|Death on study|3|||
155062338|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
155062339|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
155062340|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
155062341|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
155062342|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
155062343|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
155062344|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
155062345|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
155062346|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
155062347|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Other|2|||
155062348|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Other|3|||
155062349|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Other|0|||
155062350|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
155062351|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
155062352|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
155062353|NCT04006457|559661899|FG000|Main Study: Treatment Period 2|Ongoing|86|||
155062354|NCT04006457|559661900|FG001|Main Study: Treatment Period 2|Ongoing|96|||
155062355|NCT04006457|559661901|FG002|Main Study: Treatment Period 2|Ongoing|0|||
155062356|NCT04006457|559661899|FG000|Main Study Observation Period|Adverse Event|1|||
155062357|NCT04006457|559661900|FG001|Main Study Observation Period|Adverse Event|1|||
155062358|NCT04006457|559661901|FG002|Main Study Observation Period|Adverse Event|0|||
155062359|NCT04006457|559661899|FG000|Main Study Observation Period|Lost to Follow-up|0|||
155062360|NCT04006457|559661900|FG001|Main Study Observation Period|Lost to Follow-up|1|||
155062361|NCT04006457|559661901|FG002|Main Study Observation Period|Lost to Follow-up|0|||
155062362|NCT04006457|559661899|FG000|Main Study Observation Period|Pregnancy|1|||
155062363|NCT04006457|559661900|FG001|Main Study Observation Period|Pregnancy|0|||
155062364|NCT04006457|559661901|FG002|Main Study Observation Period|Pregnancy|0|||
155062365|NCT04006457|559661899|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
155062366|NCT04006457|559661900|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
155062367|NCT04006457|559661901|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
155062368|NCT04006457|559661899|FG000|Main Study Observation Period|Other|8|||
155062369|NCT04006457|559661900|FG001|Main Study Observation Period|Other|16|||
155062370|NCT04006457|559661901|FG002|Main Study Observation Period|Other|0|||
155062371|NCT04006457|559661899|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
155062372|NCT04006457|559661900|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
155062373|NCT04006457|559661901|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
155062374|NCT04006457|559661899|FG000|Main Study Observation Period|Ongoing|2|||
155300099|NCT03531840|560529659|FG001|Overall Study|Death on study|2|||
155300100|NCT03531840|560529660|FG002|Overall Study|Death on study|1|||
155300101|NCT03531840|560529661|FG003|Overall Study|Death on study|2|||
155300102|NCT03531840|560529658|FG000|Overall Study|Death during follow up|2|||
155300103|NCT03531840|560529659|FG001|Overall Study|Death during follow up|3|||
155300104|NCT03531840|560529660|FG002|Overall Study|Death during follow up|4|||
155300105|NCT03531840|560529661|FG003|Overall Study|Death during follow up|1|||
155300106|NCT02092116|560529662|FG000|Overall Study|Withdrawal by Subject|0|||
155300107|NCT02092116|560529663|FG001|Overall Study|Withdrawal by Subject|3|||
155300108|NCT02092116|560529662|FG000|Overall Study|Adverse Event|0|||
155300109|NCT02092116|560529663|FG001|Overall Study|Adverse Event|1|||
155300110|NCT01546753|560529665|FG000|Overall Study|anxiety|1|||
155300111|NCT01546753|560529666|FG001|Overall Study|anxiety|1|||
155062375|NCT04006457|559661900|FG001|Main Study Observation Period|Ongoing|1|||
155062376|NCT04006457|559661901|FG002|Main Study Observation Period|Ongoing|0|||
155062377|NCT04006457|559661899|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
155062378|NCT04006457|559661900|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
155158941|NCT03847896|560020716|FG004|Overall Study|Withdrawal by Subject|8|||
155062379|NCT04006457|559661901|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
155158942|NCT03847896|560020712|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155158943|NCT03847896|560020713|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155158944|NCT03847896|560020714|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155158945|NCT03847896|560020715|FG003|Overall Study|Withdrawal by parent/guardian|0|||
155300112|NCT01546753|560529665|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
155300113|NCT01546753|560529666|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
155300114|NCT00939510|560529667|FG000|Overall Study|Withdrawal by Subject|1|||
155300115|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
155300116|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
155300117|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
155300118|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300119|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300120|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300121|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300122|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300123|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300124|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300125|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300126|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
155300127|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
155300128|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
155300129|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
155300130|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
155300131|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
155300132|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
155300133|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
155300134|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
155300135|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
155300136|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
155300137|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
155300138|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
155300139|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
155300140|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300141|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155158946|NCT03847896|560020716|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155158947|NCT03847896|560020712|FG000|Overall Study|Adverse Event|2|||
154957751|NCT04627038|559273904|FG000|Overall Study|Protocol Violation|3|||
154957752|NCT04627038|559273905|FG001|Overall Study|Protocol Violation|1|||
154957753|NCT04627038|559273904|FG000|Overall Study|Withdrawal by Subject|13|||
154957754|NCT04627038|559273905|FG001|Overall Study|Withdrawal by Subject|3|||
154957755|NCT04627038|559273904|FG000|Overall Study|Non-compliance with study drug|0|||
154957756|NCT04627038|559273905|FG001|Overall Study|Non-compliance with study drug|1|||
154957757|NCT04627038|559273904|FG000|Overall Study|Prohibited Concomitant Medication|1|||
154957758|NCT04627038|559273905|FG001|Overall Study|Prohibited Concomitant Medication|0|||
154957759|NCT02760368|559273910|FG000|Overall Study|Withdrawal by Subject|8|||
154957760|NCT02760368|559273911|FG001|Overall Study|Withdrawal by Subject|12|||
154957761|NCT02760368|559273912|FG002|Overall Study|Withdrawal by Subject|9|||
154957762|NCT02760368|559273910|FG000|Overall Study|Screen Failure|0|||
154957763|NCT02760368|559273911|FG001|Overall Study|Screen Failure|0|||
154957764|NCT02760368|559273912|FG002|Overall Study|Screen Failure|1|||
154957765|NCT02760368|559273910|FG000|Overall Study|Death|0|||
154957766|NCT02760368|559273911|FG001|Overall Study|Death|1|||
154957767|NCT02760368|559273912|FG002|Overall Study|Death|0|||
154957768|NCT02760368|559273910|FG000|Overall Study|Withdrawal by Sponsor|0|||
154957769|NCT02760368|559273911|FG001|Overall Study|Withdrawal by Sponsor|0|||
154957770|NCT02760368|559273912|FG002|Overall Study|Withdrawal by Sponsor|1|||
154957771|NCT00794963|559273913|FG000|Overall Study|Withdrawal by Subject|1|||
154957772|NCT00794963|559273914|FG001|Overall Study|Withdrawal by Subject|4|||
154957773|NCT01602419|559273915|FG000|Overall Study|Not treated with Wilate|9|||
154957774|NCT01602419|559273915|FG000|Overall Study|Adverse Drug Reaction|4|||
154957775|NCT01602419|559273915|FG000|Overall Study|Insurance issues|3|||
154957776|NCT01602419|559273915|FG000|Overall Study|Changed treatment centre|1|||
154957777|NCT01602419|559273915|FG000|Overall Study|Treatment centre closed|1|||
154957778|NCT01602419|559273915|FG000|Overall Study|Withdrawal by Subject|5|||
154957779|NCT01602419|559273915|FG000|Overall Study|Lost to Follow-up|6|||
154957780|NCT02294604|559273918|FG000|Overall Study|Did not provide samples for culture|0|||
154957781|NCT02294604|559273919|FG001|Overall Study|Did not provide samples for culture|1|||
154957782|NCT02294604|559273920|FG002|Overall Study|Did not provide samples for culture|0|||
154957783|NCT02294604|559273918|FG000|Overall Study|Culture contamination|1|||
154957784|NCT02294604|559273919|FG001|Overall Study|Culture contamination|2|||
154957785|NCT02294604|559273920|FG002|Overall Study|Culture contamination|0|||
154957786|NCT01675765|559273925|FG000|Overall Study|Progressive disease|4|||
154957787|NCT01675765|559273926|FG001|Overall Study|Progressive disease|4|||
154957788|NCT01675765|559273925|FG000|Overall Study|Adverse Event|1|||
154957789|NCT01675765|559273926|FG001|Overall Study|Adverse Event|2|||
154957790|NCT01675765|559273925|FG000|Overall Study|Withdrawal by Subject|2|||
154957791|NCT01675765|559273926|FG001|Overall Study|Withdrawal by Subject|0|||
154957792|NCT01675765|559273925|FG000|Overall Study|Death|1|||
154957793|NCT01675765|559273926|FG001|Overall Study|Death|0|||
155158948|NCT03847896|560020713|FG001|Overall Study|Adverse Event|1|||
155158949|NCT03847896|560020714|FG002|Overall Study|Adverse Event|3|||
155300142|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300143|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300144|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300145|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300146|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300147|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300148|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155300149|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155158950|NCT03847896|560020715|FG003|Overall Study|Adverse Event|2|||
155158951|NCT03847896|560020716|FG004|Overall Study|Adverse Event|4|||
155158952|NCT03847896|560020712|FG000|Overall Study|A severe exacerbation event|0|||
155158953|NCT03847896|560020713|FG001|Overall Study|A severe exacerbation event|0|||
155158954|NCT03847896|560020714|FG002|Overall Study|A severe exacerbation event|0|||
155158955|NCT03847896|560020715|FG003|Overall Study|A severe exacerbation event|0|||
155158956|NCT03847896|560020716|FG004|Overall Study|A severe exacerbation event|3|||
155300150|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
155158957|NCT03847896|560020712|FG000|Overall Study|Protocol Violation|0|||
155158958|NCT03847896|560020713|FG001|Overall Study|Protocol Violation|2|||
155158959|NCT03847896|560020714|FG002|Overall Study|Protocol Violation|1|||
155158960|NCT03847896|560020715|FG003|Overall Study|Protocol Violation|0|||
155158961|NCT03847896|560020716|FG004|Overall Study|Protocol Violation|2|||
155158962|NCT03847896|560020712|FG000|Overall Study|Lost to Follow-up|0|||
155158963|NCT03847896|560020713|FG001|Overall Study|Lost to Follow-up|0|||
155158964|NCT03847896|560020714|FG002|Overall Study|Lost to Follow-up|0|||
155158965|NCT03847896|560020715|FG003|Overall Study|Lost to Follow-up|1|||
155158966|NCT03847896|560020716|FG004|Overall Study|Lost to Follow-up|0|||
155158967|NCT03847896|560020712|FG000|Overall Study|Condition under investigation worsened|0|||
155158968|NCT03847896|560020713|FG001|Overall Study|Condition under investigation worsened|0|||
155158969|NCT03847896|560020714|FG002|Overall Study|Condition under investigation worsened|0|||
154957794|NCT01675765|559273925|FG000|Overall Study|Clinical progression|3|||
155158970|NCT03847896|560020715|FG003|Overall Study|Condition under investigation worsened|1|||
155158971|NCT03847896|560020716|FG004|Overall Study|Condition under investigation worsened|1|||
155158972|NCT03847896|560020712|FG000|Overall Study|Lack of Efficacy|0|||
155158973|NCT03847896|560020713|FG001|Overall Study|Lack of Efficacy|0|||
155158974|NCT03847896|560020714|FG002|Overall Study|Lack of Efficacy|0|||
155158975|NCT03847896|560020715|FG003|Overall Study|Lack of Efficacy|2|||
155300151|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
154957795|NCT01675765|559273926|FG001|Overall Study|Clinical progression|2|||
154957796|NCT04263649|559273934|FG000|Overall Study|Adverse Event|53|||
154957797|NCT04263649|559273934|FG000|Overall Study|Lost to Follow-up|3|||
154957798|NCT04263649|559273934|FG000|Overall Study|Death|29|||
154957799|NCT04263649|559273934|FG000|Overall Study|Device deficiency|19|||
154957800|NCT04263649|559273934|FG000|Overall Study|other reasons|11|||
154957801|NCT02057458|559273935|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
154957802|NCT02057458|559273936|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
154957803|NCT02057458|559273937|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
154957804|NCT02057458|559273935|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
154957805|NCT02057458|559273936|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
154957806|NCT02057458|559273937|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
154957807|NCT02057458|559273935|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
154957808|NCT02057458|559273936|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
154957809|NCT02057458|559273937|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
154957810|NCT00836056|559273941|FG000|First Intervention|Adverse Event|1|||
154957811|NCT00836056|559273942|FG001|First Intervention|Adverse Event|0|||
154957812|NCT00846495|559273946|FG000|Overall Study|Lost to Follow-up|1|||
154957813|NCT00846495|559273947|FG001|Overall Study|Lost to Follow-up|0|||
154957814|NCT00846495|559273946|FG000|Overall Study|Adverse Event|5|||
154957815|NCT00846495|559273947|FG001|Overall Study|Adverse Event|1|||
154957816|NCT00846495|559273946|FG000|Overall Study|Lack of Efficacy|1|||
154957817|NCT00846495|559273947|FG001|Overall Study|Lack of Efficacy|2|||
154957818|NCT00846495|559273946|FG000|Overall Study|Physician Decision|1|||
154957819|NCT00846495|559273947|FG001|Overall Study|Physician Decision|0|||
154957820|NCT01079988|559273948|FG000|Overall Study|Lost to Follow-up|0|||
154957821|NCT01079988|559273949|FG001|Overall Study|Lost to Follow-up|0|||
154957822|NCT01079988|559273950|FG002|Overall Study|Lost to Follow-up|0|||
154957823|NCT01079988|559273951|FG003|Overall Study|Lost to Follow-up|1|||
154957824|NCT01079988|559273952|FG004|Overall Study|Lost to Follow-up|0|||
154957825|NCT01079988|559273948|FG000|Overall Study|Lack of Efficacy|1|||
154957826|NCT01079988|559273949|FG001|Overall Study|Lack of Efficacy|0|||
154957827|NCT01079988|559273950|FG002|Overall Study|Lack of Efficacy|0|||
154957828|NCT01079988|559273951|FG003|Overall Study|Lack of Efficacy|0|||
155158976|NCT03847896|560020716|FG004|Overall Study|Lack of Efficacy|2|||
155158977|NCT03847896|560020712|FG000|Overall Study|Other reasons|3|||
155158978|NCT03847896|560020713|FG001|Overall Study|Other reasons|3|||
155158979|NCT03847896|560020714|FG002|Overall Study|Other reasons|1|||
155062380|NCT04780659|559661902|FG000|Overall Study|Adverse event, serious fatal|3|||
155062381|NCT04780659|559661903|FG001|Overall Study|Adverse event, serious fatal|0|||
155062382|NCT04780659|559661902|FG000|Overall Study|Withdrawal by Subject|3|||
155062383|NCT04780659|559661903|FG001|Overall Study|Withdrawal by Subject|0|||
155062384|NCT04780659|559661902|FG000|Overall Study|Physician Decision|1|||
155062385|NCT04780659|559661903|FG001|Overall Study|Physician Decision|0|||
155062386|NCT04780659|559661902|FG000|Overall Study|Died in original disease|2|||
155062387|NCT04780659|559661903|FG001|Overall Study|Died in original disease|0|||
155062388|NCT04780659|559661902|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
155062389|NCT04780659|559661903|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
155062390|NCT05507437|559661904|FG000|Overall Study|Withdrawal by Subject|1|||
155062391|NCT05507437|559661905|FG001|Overall Study|Withdrawal by Subject|1|||
155062392|NCT05507437|559661904|FG000|Overall Study|Death|3|||
155062393|NCT05507437|559661905|FG001|Overall Study|Death|0|||
155062394|NCT06583096|559661906|FG000|Overall Study|Lost to Follow-up|4|||
155062395|NCT06583096|559661907|FG001|Overall Study|Lost to Follow-up|10|||
155062396|NCT06583096|559661906|FG000|Overall Study|Withdrawal by Subject|0|||
155062397|NCT06583096|559661907|FG001|Overall Study|Withdrawal by Subject|2|||
155062398|NCT03729362|559661908|FG000|Overall Study|Withdrawal by Subject|2|||
155062399|NCT03729362|559661909|FG001|Overall Study|Withdrawal by Subject|0|||
155062400|NCT03729362|559661908|FG000|Overall Study|Physician Decision|1|||
155062401|NCT03729362|559661909|FG001|Overall Study|Physician Decision|0|||
155062402|NCT03729362|559661908|FG000|Overall Study|COVID-19 Pandemic|1|||
155062403|NCT03729362|559661909|FG001|Overall Study|COVID-19 Pandemic|0|||
155062404|NCT03729362|559661908|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
155062405|NCT03729362|559661909|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
155062406|NCT03729362|559661908|FG000|Overall Study|Adverse Event|0|||
155062407|NCT03729362|559661909|FG001|Overall Study|Adverse Event|1|||
155062408|NCT03729362|559661908|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
155062409|NCT03729362|559661909|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
155062410|NCT03405870|559661910|FG000|Overall Study|Withdrawal|1|||
155062411|NCT03405870|559661911|FG001|Overall Study|Withdrawal|0|||
155062412|NCT03405870|559661912|FG002|Overall Study|Withdrawal|1|||
155062413|NCT03405870|559661913|FG003|Overall Study|Withdrawal|0|||
155062414|NCT03405870|559661914|FG004|Overall Study|Withdrawal|0|||
155062415|NCT03405870|559661915|FG005|Overall Study|Withdrawal|0|||
155062416|NCT03405870|559661916|FG006|Overall Study|Withdrawal|1|||
155062417|NCT03405870|559661917|FG007|Overall Study|Withdrawal|0|||
155062418|NCT05172609|559661918|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
155062419|NCT05172609|559661919|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
155062420|NCT05172609|559661918|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
155062421|NCT05172609|559661919|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
155062422|NCT05172609|559661918|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
155062423|NCT05172609|559661919|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
155062424|NCT00109343|559661920|FG000|Overall Study|Adverse Event|1|||
155062425|NCT00109343|559661921|FG001|Overall Study|Adverse Event|0|||
155062426|NCT00109343|559661922|FG002|Overall Study|Adverse Event|2|||
155062427|NCT00109343|559661920|FG000|Overall Study|Lack of Efficacy|1|||
155062428|NCT00109343|559661921|FG001|Overall Study|Lack of Efficacy|0|||
155062429|NCT00109343|559661922|FG002|Overall Study|Lack of Efficacy|0|||
155062430|NCT00109343|559661920|FG000|Overall Study|Lost to Follow-up|35|||
155062431|NCT00109343|559661921|FG001|Overall Study|Lost to Follow-up|20|||
155062432|NCT00109343|559661922|FG002|Overall Study|Lost to Follow-up|14|||
155062433|NCT00109343|559661920|FG000|Overall Study|Protocol Violation|1|||
155062434|NCT00109343|559661921|FG001|Overall Study|Protocol Violation|2|||
155062435|NCT00109343|559661922|FG002|Overall Study|Protocol Violation|2|||
155062436|NCT00109343|559661920|FG000|Overall Study|Withdrawal by Subject|15|||
155062437|NCT00109343|559661921|FG001|Overall Study|Withdrawal by Subject|11|||
155062438|NCT00109343|559661922|FG002|Overall Study|Withdrawal by Subject|10|||
155062439|NCT00109343|559661920|FG000|Overall Study|Subject Moved|6|||
155062440|NCT00109343|559661921|FG001|Overall Study|Subject Moved|2|||
155062441|NCT00109343|559661922|FG002|Overall Study|Subject Moved|1|||
155062442|NCT00109343|559661920|FG000|Overall Study|Other|5|||
155062443|NCT00109343|559661921|FG001|Overall Study|Other|2|||
155158980|NCT03847896|560020715|FG003|Overall Study|Other reasons|2|||
155062444|NCT00109343|559661922|FG002|Overall Study|Other|1|||
155062445|NCT01721798|559661925|FG000|Overall Study|Death|0|||
155062446|NCT01721798|559661926|FG001|Overall Study|Death|0|||
155062447|NCT01721798|559661927|FG002|Overall Study|Death|1|||
155062448|NCT01721798|559661928|FG003|Overall Study|Death|1|||
155062449|NCT01721798|559661925|FG000|Overall Study|Lost to Follow-up|2|||
155062450|NCT01721798|559661926|FG001|Overall Study|Lost to Follow-up|2|||
155062451|NCT01721798|559661927|FG002|Overall Study|Lost to Follow-up|9|||
155062452|NCT01721798|559661928|FG003|Overall Study|Lost to Follow-up|9|||
155062453|NCT01721798|559661925|FG000|Overall Study|Pregnancy|0|||
155062454|NCT01721798|559661926|FG001|Overall Study|Pregnancy|0|||
155062455|NCT01721798|559661927|FG002|Overall Study|Pregnancy|1|||
155062456|NCT01721798|559661928|FG003|Overall Study|Pregnancy|1|||
155062457|NCT01721798|559661925|FG000|Overall Study|Withdrawal by Subject|1|||
155062458|NCT01721798|559661926|FG001|Overall Study|Withdrawal by Subject|0|||
155062459|NCT01721798|559661927|FG002|Overall Study|Withdrawal by Subject|2|||
155062460|NCT01721798|559661928|FG003|Overall Study|Withdrawal by Subject|1|||
155062461|NCT01721798|559661925|FG000|Overall Study|Not eligible for 24 month visit|1|||
155062462|NCT01721798|559661926|FG001|Overall Study|Not eligible for 24 month visit|0|||
155062463|NCT01721798|559661927|FG002|Overall Study|Not eligible for 24 month visit|8|||
155062464|NCT01721798|559661928|FG003|Overall Study|Not eligible for 24 month visit|7|||
155062465|NCT00715208|559661929|FG000|Overall Study|Withdrawal by Subject|1|||
155062466|NCT00715208|559661930|FG001|Overall Study|Withdrawal by Subject|1|||
155062467|NCT00715208|559661929|FG000|Overall Study|Adverse Event|0|||
155062468|NCT00715208|559661930|FG001|Overall Study|Adverse Event|6|||
155062469|NCT00715208|559661929|FG000|Overall Study|Lack of Efficacy|0|||
155062470|NCT00715208|559661930|FG001|Overall Study|Lack of Efficacy|2|||
155062471|NCT00076570|559661931|FG000|Overall Study|Drug intolerance|8|||
155062472|NCT00076570|559661932|FG001|Overall Study|Drug intolerance|8|||
155062473|NCT00903968|559661933|FG000|Overall Study|Adverse Event|0|||
155062474|NCT00903968|559661934|FG001|Overall Study|Adverse Event|0|||
155062475|NCT00903968|559661935|FG002|Overall Study|Adverse Event|0|||
155062476|NCT00903968|559661936|FG003|Overall Study|Adverse Event|0|||
155062477|NCT00903968|559661937|FG004|Overall Study|Adverse Event|0|||
155062478|NCT00903968|559661938|FG005|Overall Study|Adverse Event|0|||
155062479|NCT00903968|559661939|FG006|Overall Study|Adverse Event|1|||
155062480|NCT00903968|559661940|FG007|Overall Study|Adverse Event|8|||
155062481|NCT00903968|559661933|FG000|Overall Study|DLT|0|||
155062482|NCT00903968|559661934|FG001|Overall Study|DLT|0|||
155062483|NCT00903968|559661935|FG002|Overall Study|DLT|0|||
155062484|NCT00903968|559661936|FG003|Overall Study|DLT|0|||
155062485|NCT00903968|559661937|FG004|Overall Study|DLT|0|||
155062486|NCT00903968|559661938|FG005|Overall Study|DLT|0|||
155062487|NCT00903968|559661939|FG006|Overall Study|DLT|2|||
155062488|NCT00903968|559661940|FG007|Overall Study|DLT|0|||
155062489|NCT00903968|559661933|FG000|Overall Study|Withdrawal by Subject|1|||
155062490|NCT00903968|559661934|FG001|Overall Study|Withdrawal by Subject|0|||
155062491|NCT00903968|559661935|FG002|Overall Study|Withdrawal by Subject|1|||
155062492|NCT00903968|559661936|FG003|Overall Study|Withdrawal by Subject|0|||
155062493|NCT00903968|559661937|FG004|Overall Study|Withdrawal by Subject|1|||
155062494|NCT00903968|559661938|FG005|Overall Study|Withdrawal by Subject|1|||
155062495|NCT00903968|559661939|FG006|Overall Study|Withdrawal by Subject|0|||
155062496|NCT00903968|559661940|FG007|Overall Study|Withdrawal by Subject|4|||
155062497|NCT00903968|559661933|FG000|Overall Study|Non-Compliance|0|||
155062498|NCT00903968|559661934|FG001|Overall Study|Non-Compliance|0|||
155062499|NCT00903968|559661935|FG002|Overall Study|Non-Compliance|0|||
155062500|NCT00903968|559661936|FG003|Overall Study|Non-Compliance|0|||
155062501|NCT00903968|559661937|FG004|Overall Study|Non-Compliance|0|||
155062502|NCT00903968|559661938|FG005|Overall Study|Non-Compliance|1|||
155062503|NCT00903968|559661939|FG006|Overall Study|Non-Compliance|0|||
155062504|NCT00903968|559661940|FG007|Overall Study|Non-Compliance|0|||
155062505|NCT00903968|559661933|FG000|Overall Study|Physician Decision|0|||
155062506|NCT00903968|559661934|FG001|Overall Study|Physician Decision|0|||
155062507|NCT00903968|559661935|FG002|Overall Study|Physician Decision|0|||
155062508|NCT00903968|559661936|FG003|Overall Study|Physician Decision|0|||
155062509|NCT00903968|559661937|FG004|Overall Study|Physician Decision|0|||
155062510|NCT00903968|559661938|FG005|Overall Study|Physician Decision|1|||
155062511|NCT00903968|559661939|FG006|Overall Study|Physician Decision|0|||
155062512|NCT00903968|559661940|FG007|Overall Study|Physician Decision|0|||
155062513|NCT00903968|559661933|FG000|Overall Study|Progressive Disease|2|||
155062514|NCT00903968|559661934|FG001|Overall Study|Progressive Disease|3|||
155062515|NCT00903968|559661935|FG002|Overall Study|Progressive Disease|2|||
155062516|NCT00903968|559661936|FG003|Overall Study|Progressive Disease|3|||
155158981|NCT03847896|560020716|FG004|Overall Study|Other reasons|1|||
155062517|NCT00903968|559661937|FG004|Overall Study|Progressive Disease|3|||
155062518|NCT00903968|559661938|FG005|Overall Study|Progressive Disease|3|||
155062519|NCT00903968|559661939|FG006|Overall Study|Progressive Disease|0|||
155158982|NCT02395471|560020717|FG000|Overall Study|Lost to Follow-up|2|||
155062520|NCT00903968|559661940|FG007|Overall Study|Progressive Disease|18|||
155062521|NCT00903968|559661933|FG000|Overall Study|Lack of Efficacy|0|||
155062522|NCT00903968|559661934|FG001|Overall Study|Lack of Efficacy|0|||
155062523|NCT00903968|559661935|FG002|Overall Study|Lack of Efficacy|0|||
155062524|NCT00903968|559661936|FG003|Overall Study|Lack of Efficacy|0|||
155062525|NCT00903968|559661937|FG004|Overall Study|Lack of Efficacy|0|||
155062526|NCT00903968|559661938|FG005|Overall Study|Lack of Efficacy|0|||
155062527|NCT00903968|559661939|FG006|Overall Study|Lack of Efficacy|0|||
155062528|NCT00903968|559661940|FG007|Overall Study|Lack of Efficacy|3|||
155062529|NCT01983930|559661946|FG000|Overall Study|Withdrawal by Subject|9|||
155062530|NCT01983930|559661947|FG001|Overall Study|Withdrawal by Subject|8|||
155062531|NCT01983930|559661946|FG000|Overall Study|Adverse Event|0|||
155062532|NCT01983930|559661947|FG001|Overall Study|Adverse Event|1|||
155062533|NCT00393367|559661950|FG000|Overall Study|Protocol Violation|2|||
155158983|NCT02395471|560020718|FG001|Overall Study|Lost to Follow-up|0|||
155062534|NCT00393367|559661951|FG001|Overall Study|Protocol Violation|5|||
155062535|NCT00393367|559661950|FG000|Overall Study|Withdrawal by Subject|0|||
155062536|NCT00393367|559661951|FG001|Overall Study|Withdrawal by Subject|2|||
155062537|NCT01027949|559661952|FG000|Overall Study|Death|174|||
155062538|NCT01027949|559661952|FG000|Overall Study|Progressive Disease|163|||
155062539|NCT01027949|559661952|FG000|Overall Study|Adverse Event|172|||
155062540|NCT01027949|559661952|FG000|Overall Study|Withdrawal by Subject|113|||
155062541|NCT01027949|559661952|FG000|Overall Study|Lost to Follow-up|17|||
155062542|NCT01027949|559661952|FG000|Overall Study|Protocol Violation|13|||
155062543|NCT01027949|559661952|FG000|Overall Study|PI Decision|8|||
155062544|NCT01027949|559661952|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
155062545|NCT01027949|559661952|FG000|Overall Study|Non-compliance with Study Procedures|7|||
155062546|NCT01027949|559661952|FG000|Overall Study|Lung Transplant|5|||
155062547|NCT01027949|559661952|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
155062548|NCT01027949|559661952|FG000|Overall Study|Use of Excluded Medication|2|||
155062549|NCT01027949|559661952|FG000|Overall Study|Patient Self-discontinuation|1|||
155062550|NCT01027949|559661952|FG000|Overall Study|Pregnancy|1|||
155062551|NCT01027949|559661952|FG000|Overall Study|Surgery|1|||
155062552|NCT00091819|559661957|FG000|Overall Study|Adverse Event|1|||
155062553|NCT00091819|559661958|FG001|Overall Study|Adverse Event|1|||
155062554|NCT00091819|559661957|FG000|Overall Study|Death|4|||
155062555|NCT00091819|559661958|FG001|Overall Study|Death|5|||
155062556|NCT00091819|559661957|FG000|Overall Study|Lost to Follow-up|26|||
155062557|NCT00091819|559661958|FG001|Overall Study|Lost to Follow-up|23|||
155062558|NCT00091819|559661957|FG000|Overall Study|Withdrawal by Subject|5|||
155062559|NCT00091819|559661958|FG001|Overall Study|Withdrawal by Subject|8|||
155062560|NCT00091819|559661957|FG000|Overall Study|Protocol Violation|1|||
155062561|NCT00091819|559661958|FG001|Overall Study|Protocol Violation|2|||
155062562|NCT00091819|559661957|FG000|Overall Study|Other|2|||
155062563|NCT00091819|559661958|FG001|Overall Study|Other|3|||
155062564|NCT00091819|559661957|FG000|Overall Study|Never received study treatment|3|||
155062565|NCT00091819|559661958|FG001|Overall Study|Never received study treatment|4|||
155062566|NCT00856180|559661959|FG000|Overall Study|Adverse Event|4|||
155062567|NCT00856180|559661959|FG000|Overall Study|Progressive Disease|16|||
155062568|NCT00481676|559661960|FG000|Overall Study|Adverse Event|0|||
155062569|NCT00481676|559661961|FG001|Overall Study|Adverse Event|1|||
155062570|NCT00481676|559661960|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155062571|NCT00481676|559661961|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155062572|NCT00481676|559661960|FG000|Overall Study|Administrative problem|1|||
155062573|NCT00481676|559661961|FG001|Overall Study|Administrative problem|0|||
155062574|NCT02911116|559661962|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155062575|NCT02911116|559661963|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155062576|NCT02911116|559661962|FG000|Overall Study|Lost to Follow-up|0|||
155062577|NCT02911116|559661963|FG001|Overall Study|Lost to Follow-up|1|||
155062578|NCT04796415|559661964|FG000|Overall Study|not interested|12|||
155062579|NCT04796415|559661964|FG000|Overall Study|health issue|8|||
155062580|NCT04796415|559661964|FG000|Overall Study|Other|4|||
155062581|NCT04796415|559661964|FG000|Overall Study|discharged from home health service|3|||
155062582|NCT04796415|559661964|FG000|Overall Study|re-hospitalization|2|||
155062583|NCT04796415|559661964|FG000|Overall Study|moving to nursing home|1|||
155062584|NCT04796415|559661964|FG000|Overall Study|lost contact|1|||
155062585|NCT01513590|559661965|FG000|Overall Study|Adverse Event|2|||
155062586|NCT01513590|559661966|FG001|Overall Study|Adverse Event|3|||
155062587|NCT01513590|559661965|FG000|Overall Study|Withdrawal Criteria|3|||
155062588|NCT01513590|559661966|FG001|Overall Study|Withdrawal Criteria|0|||
155062589|NCT01513590|559661965|FG000|Overall Study|Unclassified|5|||
155300152|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155062590|NCT01513590|559661966|FG001|Overall Study|Unclassified|10|||
155062591|NCT04810962|559661967|FG000|Overall Study|Adverse Event|0|||
155062592|NCT04810962|559661968|FG001|Overall Study|Adverse Event|1|||
155062593|NCT04810962|559661967|FG000|Overall Study|Lost to Follow-up|2|||
155300153|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
155300154|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300155|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300156|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300157|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300158|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300159|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155062594|NCT04810962|559661968|FG001|Overall Study|Lost to Follow-up|1|||
155062595|NCT04810962|559661967|FG000|Overall Study|Physician Decision|1|||
155062596|NCT04810962|559661968|FG001|Overall Study|Physician Decision|0|||
155062597|NCT04810962|559661967|FG000|Overall Study|Withdrawal by Subject|1|||
155062598|NCT04810962|559661968|FG001|Overall Study|Withdrawal by Subject|3|||
155062599|NCT04810962|559661967|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
155062600|NCT04810962|559661968|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
155062601|NCT00486044|559661969|FG000|Overall Study|Withdrawal by Subject|2|||
155062602|NCT00486044|559661970|FG001|Overall Study|Withdrawal by Subject|1|||
155062603|NCT00486044|559661969|FG000|Overall Study|Adverse Event|0|||
155062604|NCT00486044|559661970|FG001|Overall Study|Adverse Event|1|||
155062605|NCT00486044|559661969|FG000|Overall Study|Lost to Follow-up|0|||
155062606|NCT00486044|559661970|FG001|Overall Study|Lost to Follow-up|1|||
155062607|NCT03466346|559661973|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155062608|NCT03466346|559661974|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
155062609|NCT03466346|559661975|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155062610|NCT03466346|559661976|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155158984|NCT02395471|560020717|FG000|Overall Study|Withdrawal by Subject|2|||
155158985|NCT02395471|560020718|FG001|Overall Study|Withdrawal by Subject|1|||
154957829|NCT01079988|559273952|FG004|Overall Study|Lack of Efficacy|0|||
155062611|NCT03466346|559661977|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
155062612|NCT03466346|559661973|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
155062613|NCT03466346|559661974|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
155062614|NCT03466346|559661975|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
155062615|NCT03466346|559661976|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
155062616|NCT03466346|559661977|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
155062617|NCT03466346|559661973|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
155062618|NCT03466346|559661974|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
155062619|NCT03466346|559661975|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
155062620|NCT03466346|559661976|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
155062621|NCT03466346|559661977|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
155062622|NCT03466346|559661973|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
155062623|NCT03466346|559661974|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
155062624|NCT03466346|559661975|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
155062625|NCT03466346|559661976|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
155062626|NCT03466346|559661977|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
155062627|NCT03466346|559661973|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
155062628|NCT03466346|559661974|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
155062629|NCT03466346|559661975|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
155062630|NCT03466346|559661976|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
155062631|NCT03466346|559661977|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
155062632|NCT03466346|559661973|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
155062633|NCT03466346|559661974|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
155062634|NCT03466346|559661975|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
155158986|NCT02395471|560020717|FG000|Overall Study|Physician Decision|1|||
155158987|NCT02395471|560020718|FG001|Overall Study|Physician Decision|0|||
155158988|NCT02395471|560020717|FG000|Overall Study|Protocol Violation|0|||
155158989|NCT02395471|560020718|FG001|Overall Study|Protocol Violation|1|||
155158990|NCT02395471|560020717|FG000|Overall Study|Failure to swollow sponge twice|1|||
155158991|NCT02395471|560020718|FG001|Overall Study|Failure to swollow sponge twice|0|||
155158992|NCT02395471|560020717|FG000|Overall Study|Patient did not return for procedure|0|||
155158993|NCT02395471|560020718|FG001|Overall Study|Patient did not return for procedure|1|||
155158994|NCT02395471|560020717|FG000|Overall Study|Subject not eligible|1|||
155158995|NCT02395471|560020718|FG001|Overall Study|Subject not eligible|0|||
155158996|NCT00118417|560020719|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
155158997|NCT00118417|560020720|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
155158998|NCT00118417|560020719|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
154957830|NCT01079988|559273948|FG000|Overall Study|Other|0|||
154957831|NCT01079988|559273949|FG001|Overall Study|Other|0|||
154957832|NCT01079988|559273950|FG002|Overall Study|Other|0|||
154957833|NCT01079988|559273951|FG003|Overall Study|Other|2|||
154957834|NCT01079988|559273952|FG004|Overall Study|Other|1|||
154957835|NCT03546842|559273953|FG000|Overall Study|Protocol Violation|1|||
154957836|NCT03546842|559273953|FG000|Overall Study|Withdrawal by Subject|2|||
154957837|NCT02158663|559273955|FG000|Overall Study|Withdrawal by Subject|5|||
154957838|NCT02158663|559273956|FG001|Overall Study|Withdrawal by Subject|4|||
154957839|NCT01265056|559273957|FG000|Initial Study Period|Withdrawal by Subject|1|||
154957840|NCT01265056|559273958|FG001|Initial Study Period|Withdrawal by Subject|1|||
154957841|NCT01265056|559273957|FG000|Initial Study Period|Withdrawal by Subject|1|||
154957842|NCT01265056|559273958|FG001|Initial Study Period|Withdrawal by Subject|1|||
154957843|NCT01265056|559273957|FG000|Follow up|Lost to Follow-up|7|||
154957844|NCT01265056|559273958|FG001|Follow up|Lost to Follow-up|3|||
154957845|NCT02711852|559273959|FG000|Overall Study|Death|5|||
154957846|NCT02711852|559273959|FG000|Overall Study|Lost to Follow-up|1|||
154957847|NCT02711852|559273959|FG000|Overall Study|Completed follow-up|3|||
155062635|NCT03466346|559661976|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
155062636|NCT03466346|559661977|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
155158999|NCT00118417|560020720|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
155170036|NCT00830869|560062415|FG010|Period 2: Part 2|Adverse Event|2|||
155062637|NCT03466346|559661973|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
155062638|NCT03466346|559661974|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
155062639|NCT03466346|559661975|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
155062640|NCT03466346|559661976|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
155062641|NCT03466346|559661977|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
155062642|NCT02701634|559661982|FG000|Overall Study|Adverse Event|2|||
155062643|NCT02701634|559661983|FG001|Overall Study|Adverse Event|3|||
155062644|NCT02701634|559661982|FG000|Overall Study|Death|1|||
155062645|NCT02701634|559661983|FG001|Overall Study|Death|0|||
155062646|NCT02701634|559661982|FG000|Overall Study|Investigator's Discretion|7|||
155062647|NCT02701634|559661983|FG001|Overall Study|Investigator's Discretion|4|||
155062648|NCT02701634|559661982|FG000|Overall Study|Study terminated by Sponsor|15|||
155062649|NCT02701634|559661983|FG001|Overall Study|Study terminated by Sponsor|17|||
155062650|NCT02701634|559661982|FG000|Overall Study|Withdrew Consent|6|||
155062651|NCT02701634|559661983|FG001|Overall Study|Withdrew Consent|7|||
155062652|NCT02701634|559661982|FG000|Overall Study|Randomized but not treated|1|||
155062653|NCT02701634|559661983|FG001|Overall Study|Randomized but not treated|0|||
155062654|NCT04530552|559661987|FG000|Overall Study|Physician Decision|0|||
155062655|NCT04530552|559661988|FG001|Overall Study|Physician Decision|1|||
155062656|NCT04530552|559661987|FG000|Overall Study|Withdrawal by Subject|0|||
155062657|NCT04530552|559661988|FG001|Overall Study|Withdrawal by Subject|1|||
155062658|NCT04530552|559661987|FG000|Overall Study|Adverse Event|0|||
155062659|NCT04530552|559661988|FG001|Overall Study|Adverse Event|1|||
155062660|NCT04530552|559661987|FG000|Overall Study|No surgery|0|||
155062661|NCT04530552|559661988|FG001|Overall Study|No surgery|1|||
155062662|NCT00560404|559661992|FG000|Overall Study|Adverse Event|2|||
155062663|NCT00560404|559661993|FG001|Overall Study|Adverse Event|3|||
155062664|NCT00560404|559661992|FG000|Overall Study|Death|3|||
155062665|NCT00560404|559661993|FG001|Overall Study|Death|3|||
155062666|NCT00560404|559661992|FG000|Overall Study|Protocol Violation|12|||
155062667|NCT00560404|559661993|FG001|Overall Study|Protocol Violation|7|||
155062668|NCT00560404|559661992|FG000|Overall Study|Administrative Reasons|1|||
155062669|NCT00560404|559661993|FG001|Overall Study|Administrative Reasons|1|||
155062670|NCT00560404|559661992|FG000|Overall Study|Withdrew Consent|4|||
155062671|NCT00560404|559661993|FG001|Overall Study|Withdrew Consent|0|||
155062672|NCT00560404|559661992|FG000|Overall Study|Failure to return|1|||
155062673|NCT00560404|559661993|FG001|Overall Study|Failure to return|2|||
155062674|NCT00560404|559661992|FG000|Overall Study|Other withdrawal reason|13|||
155062675|NCT00560404|559661993|FG001|Overall Study|Other withdrawal reason|5|||
155062676|NCT05035407|559661994|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
155062677|NCT05035407|559661995|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155062678|NCT05035407|559661996|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155062679|NCT05035407|559661997|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155062680|NCT05035407|559661998|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155062681|NCT05035407|559661999|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
155062682|NCT04220021|559662000|FG000|Overall Study|Withdrawal by Subject|11|||
155062683|NCT04220021|559662000|FG000|Overall Study|Physician Decision|2|||
155062684|NCT04220021|559662000|FG000|Overall Study|Non-study related illness|5|||
155062685|NCT02187783|559662001|FG000|Overall Study|Adverse Event|8|||
155062686|NCT02187783|559662001|FG000|Overall Study|Death|3|||
155062687|NCT02187783|559662001|FG000|Overall Study|Progressive disease|80|||
155062688|NCT02187783|559662001|FG000|Overall Study|Protocol Violation|3|||
155062689|NCT02187783|559662001|FG000|Overall Study|Physician Decision|2|||
155062690|NCT02187783|559662001|FG000|Overall Study|Withdrawal by Subject|9|||
155062691|NCT02187783|559662001|FG000|Overall Study|Study terminated by sponsor|1|||
155062692|NCT00171249|559662002|FG000|Overall Study|Withdrawal by Subject|2|||
155062693|NCT00171249|559662003|FG001|Overall Study|Withdrawal by Subject|0|||
155062694|NCT00171249|559662004|FG002|Overall Study|Withdrawal by Subject|0|||
155062695|NCT00171249|559662005|FG003|Overall Study|Withdrawal by Subject|6|||
155062696|NCT00171249|559662006|FG004|Overall Study|Withdrawal by Subject|0|||
155062697|NCT00171249|559662007|FG005|Overall Study|Withdrawal by Subject|0|||
155062698|NCT00171249|559662008|FG006|Overall Study|Withdrawal by Subject|0|||
155062699|NCT00171249|559662002|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
155062700|NCT00171249|559662003|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155062701|NCT00171249|559662004|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
155062702|NCT00171249|559662005|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
155062703|NCT00171249|559662006|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155062704|NCT00171249|559662007|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
155062705|NCT00171249|559662008|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155062706|NCT00171249|559662002|FG000|Overall Study|Death|7|||
155062707|NCT00171249|559662003|FG001|Overall Study|Death|1|||
155062708|NCT00171249|559662004|FG002|Overall Study|Death|0|||
155062709|NCT00171249|559662005|FG003|Overall Study|Death|4|||
155062710|NCT00171249|559662006|FG004|Overall Study|Death|0|||
155062711|NCT00171249|559662007|FG005|Overall Study|Death|3|||
155062712|NCT00171249|559662008|FG006|Overall Study|Death|1|||
155062713|NCT00171249|559662002|FG000|Overall Study|Other|10|||
155062714|NCT00171249|559662003|FG001|Overall Study|Other|0|||
155062715|NCT00171249|559662004|FG002|Overall Study|Other|0|||
155062716|NCT00171249|559662005|FG003|Overall Study|Other|43|||
155062717|NCT00171249|559662006|FG004|Overall Study|Other|0|||
155062718|NCT00171249|559662007|FG005|Overall Study|Other|2|||
155062719|NCT00171249|559662008|FG006|Overall Study|Other|0|||
155062720|NCT00171249|559662002|FG000|Overall Study|No Longer Requires Study Drug|4|||
155062721|NCT00171249|559662003|FG001|Overall Study|No Longer Requires Study Drug|0|||
155062722|NCT00171249|559662004|FG002|Overall Study|No Longer Requires Study Drug|0|||
155062723|NCT00171249|559662005|FG003|Overall Study|No Longer Requires Study Drug|3|||
155062724|NCT00171249|559662006|FG004|Overall Study|No Longer Requires Study Drug|0|||
155062725|NCT00171249|559662007|FG005|Overall Study|No Longer Requires Study Drug|5|||
155062726|NCT00171249|559662008|FG006|Overall Study|No Longer Requires Study Drug|0|||
155062727|NCT00171249|559662002|FG000|Overall Study|Administrative Problems|1|||
155062728|NCT00171249|559662003|FG001|Overall Study|Administrative Problems|0|||
155062729|NCT00171249|559662004|FG002|Overall Study|Administrative Problems|0|||
155062730|NCT00171249|559662005|FG003|Overall Study|Administrative Problems|2|||
155062731|NCT00171249|559662006|FG004|Overall Study|Administrative Problems|0|||
155062732|NCT00171249|559662007|FG005|Overall Study|Administrative Problems|0|||
155062733|NCT00171249|559662008|FG006|Overall Study|Administrative Problems|0|||
155062734|NCT00171249|559662002|FG000|Overall Study|Adverse Event|3|||
155062735|NCT00171249|559662003|FG001|Overall Study|Adverse Event|1|||
155062736|NCT00171249|559662004|FG002|Overall Study|Adverse Event|0|||
155062737|NCT00171249|559662005|FG003|Overall Study|Adverse Event|15|||
155062738|NCT00171249|559662006|FG004|Overall Study|Adverse Event|0|||
155062739|NCT00171249|559662007|FG005|Overall Study|Adverse Event|2|||
155062740|NCT00171249|559662008|FG006|Overall Study|Adverse Event|0|||
155062741|NCT00171249|559662002|FG000|Overall Study|Lost to Follow-up|5|||
155062742|NCT00171249|559662003|FG001|Overall Study|Lost to Follow-up|0|||
155062743|NCT00171249|559662004|FG002|Overall Study|Lost to Follow-up|0|||
155062744|NCT00171249|559662005|FG003|Overall Study|Lost to Follow-up|9|||
155062745|NCT00171249|559662006|FG004|Overall Study|Lost to Follow-up|0|||
155062746|NCT00171249|559662007|FG005|Overall Study|Lost to Follow-up|0|||
155062747|NCT00171249|559662008|FG006|Overall Study|Lost to Follow-up|0|||
155062748|NCT02908347|559662009|FG000|Overall Study|Adverse Event|0|||
155300160|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155062749|NCT02908347|559662010|FG001|Overall Study|Adverse Event|1|||
155062750|NCT02908347|559662009|FG000|Overall Study|Lost to Follow-up|1|||
155062751|NCT02908347|559662010|FG001|Overall Study|Lost to Follow-up|0|||
155062752|NCT00848497|559662011|FG000|Overall Study|Screen failure|2|||
155062753|NCT00848497|559662012|FG001|Overall Study|Screen failure|0|||
155062754|NCT00848497|559662011|FG000|Overall Study|Withdrawal by Subject|0|||
155062755|NCT00848497|559662012|FG001|Overall Study|Withdrawal by Subject|1|||
155062756|NCT01420536|559662022|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
155062757|NCT01420536|559662023|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
155062758|NCT04711005|559662024|FG000|Overall Study|Withdrawal by Subject|0|||
155062759|NCT04711005|559662025|FG001|Overall Study|Withdrawal by Subject|0|||
155062760|NCT04711005|559662026|FG002|Overall Study|Withdrawal by Subject|0|||
155062761|NCT04711005|559662027|FG003|Overall Study|Withdrawal by Subject|0|||
155300161|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300162|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
155300163|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
155300164|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
155300165|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
155062762|NCT04711005|559662028|FG004|Overall Study|Withdrawal by Subject|0|||
155062763|NCT04711005|559662029|FG005|Overall Study|Withdrawal by Subject|0|||
155300166|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
155300167|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300168|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300169|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155062764|NCT04711005|559662030|FG006|Overall Study|Withdrawal by Subject|0|||
155062765|NCT04711005|559662031|FG007|Overall Study|Withdrawal by Subject|1|||
155062766|NCT04711005|559662032|FG008|Overall Study|Withdrawal by Subject|0|||
155062767|NCT04711005|559662033|FG009|Overall Study|Withdrawal by Subject|0|||
155062768|NCT04711005|559662024|FG000|Overall Study|Physician Decision|0|||
155062769|NCT04711005|559662025|FG001|Overall Study|Physician Decision|0|||
155062770|NCT04711005|559662026|FG002|Overall Study|Physician Decision|0|||
155159000|NCT00118417|560020719|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
155062771|NCT04711005|559662027|FG003|Overall Study|Physician Decision|0|||
155062772|NCT04711005|559662028|FG004|Overall Study|Physician Decision|0|||
155062773|NCT04711005|559662029|FG005|Overall Study|Physician Decision|0|||
155062774|NCT04711005|559662030|FG006|Overall Study|Physician Decision|0|||
155062775|NCT04711005|559662031|FG007|Overall Study|Physician Decision|2|||
155062776|NCT04711005|559662032|FG008|Overall Study|Physician Decision|1|||
155062777|NCT04711005|559662033|FG009|Overall Study|Physician Decision|0|||
155062778|NCT00764790|559662034|FG000|Overall Study|Protocol Violation|0|||
155062779|NCT00764790|559662035|FG001|Overall Study|Protocol Violation|0|||
155062780|NCT00764790|559662036|FG002|Overall Study|Protocol Violation|1|||
155062781|NCT00764790|559662034|FG000|Overall Study|Withdrawal by Subject|10|||
155062782|NCT00764790|559662035|FG001|Overall Study|Withdrawal by Subject|12|||
155062783|NCT00764790|559662036|FG002|Overall Study|Withdrawal by Subject|6|||
155062784|NCT00764790|559662034|FG000|Overall Study|Lost to Follow-up|28|||
155062785|NCT00764790|559662035|FG001|Overall Study|Lost to Follow-up|29|||
155062786|NCT00764790|559662036|FG002|Overall Study|Lost to Follow-up|23|||
155062787|NCT03533751|559662037|FG000|Overall Study|Withdrawal by Subject|12|||
155062788|NCT03533751|559662038|FG001|Overall Study|Withdrawal by Subject|6|||
155062789|NCT03533751|559662039|FG002|Overall Study|Withdrawal by Subject|11|||
155062790|NCT03533751|559662040|FG003|Overall Study|Withdrawal by Subject|9|||
155062791|NCT03533751|559662041|FG004|Overall Study|Withdrawal by Subject|10|||
155062792|NCT03533751|559662037|FG000|Overall Study|Adverse Event|4|||
155062793|NCT03533751|559662038|FG001|Overall Study|Adverse Event|7|||
155062794|NCT03533751|559662039|FG002|Overall Study|Adverse Event|2|||
155062795|NCT03533751|559662040|FG003|Overall Study|Adverse Event|4|||
155062796|NCT03533751|559662041|FG004|Overall Study|Adverse Event|5|||
155062797|NCT03533751|559662037|FG000|Overall Study|Physician Decision|0|||
155062798|NCT03533751|559662038|FG001|Overall Study|Physician Decision|2|||
155062799|NCT03533751|559662039|FG002|Overall Study|Physician Decision|1|||
155062800|NCT03533751|559662040|FG003|Overall Study|Physician Decision|2|||
155062801|NCT03533751|559662041|FG004|Overall Study|Physician Decision|1|||
155062802|NCT03533751|559662037|FG000|Overall Study|Sponsor Decision|0|||
155062803|NCT03533751|559662038|FG001|Overall Study|Sponsor Decision|0|||
155062804|NCT03533751|559662039|FG002|Overall Study|Sponsor Decision|1|||
155062805|NCT03533751|559662040|FG003|Overall Study|Sponsor Decision|1|||
155062806|NCT03533751|559662041|FG004|Overall Study|Sponsor Decision|0|||
155062807|NCT03533751|559662037|FG000|Overall Study|Lost to Follow-up|3|||
155062808|NCT03533751|559662038|FG001|Overall Study|Lost to Follow-up|7|||
155062809|NCT03533751|559662039|FG002|Overall Study|Lost to Follow-up|6|||
155062810|NCT03533751|559662040|FG003|Overall Study|Lost to Follow-up|4|||
155062811|NCT03533751|559662041|FG004|Overall Study|Lost to Follow-up|3|||
155062812|NCT03533751|559662037|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
155062813|NCT03533751|559662038|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
155062814|NCT03533751|559662039|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
155062815|NCT03533751|559662040|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
155062816|NCT03533751|559662041|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
155062817|NCT03533751|559662037|FG000|Overall Study|Other|0|||
155062818|NCT03533751|559662038|FG001|Overall Study|Other|2|||
155062819|NCT03533751|559662039|FG002|Overall Study|Other|1|||
155062820|NCT03533751|559662040|FG003|Overall Study|Other|0|||
155062821|NCT03533751|559662041|FG004|Overall Study|Other|3|||
155062822|NCT06070610|559662045|FG000|Washout period|Adverse Event|1|||
155062823|NCT06070610|559662045|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
155062824|NCT00042289|559663974|FG000|Overall Study|Lost to Follow-up|3|||
155062825|NCT00042289|559663975|FG001|Overall Study|Lost to Follow-up|0|||
155062826|NCT00042289|559663976|FG002|Overall Study|Lost to Follow-up|0|||
155062827|NCT00042289|559663977|FG003|Overall Study|Lost to Follow-up|1|||
155062828|NCT00042289|559663978|FG004|Overall Study|Lost to Follow-up|3|||
155062829|NCT00042289|559663979|FG005|Overall Study|Lost to Follow-up|3|||
155062830|NCT00042289|559663980|FG006|Overall Study|Lost to Follow-up|6|||
155062831|NCT00042289|559663981|FG007|Overall Study|Lost to Follow-up|1|||
155062832|NCT00042289|559663982|FG008|Overall Study|Lost to Follow-up|1|||
155062833|NCT00042289|559663983|FG009|Overall Study|Lost to Follow-up|0|||
155062834|NCT00042289|559663984|FG010|Overall Study|Lost to Follow-up|0|||
155062835|NCT00042289|559663985|FG011|Overall Study|Lost to Follow-up|0|||
155062836|NCT00042289|559663986|FG012|Overall Study|Lost to Follow-up|0|||
155062837|NCT00042289|559663987|FG013|Overall Study|Lost to Follow-up|0|||
155062838|NCT00042289|559663988|FG014|Overall Study|Lost to Follow-up|0|||
155062839|NCT00042289|559663989|FG015|Overall Study|Lost to Follow-up|1|||
155062840|NCT00042289|559663990|FG016|Overall Study|Lost to Follow-up|1|||
155062841|NCT00042289|559663991|FG017|Overall Study|Lost to Follow-up|0|||
155062842|NCT00042289|559663992|FG018|Overall Study|Lost to Follow-up|3|||
155062843|NCT00042289|559663993|FG019|Overall Study|Lost to Follow-up|2|||
155062844|NCT00042289|559663994|FG020|Overall Study|Lost to Follow-up|0|||
155062845|NCT00042289|559663995|FG021|Overall Study|Lost to Follow-up|0|||
155062846|NCT00042289|559663996|FG022|Overall Study|Lost to Follow-up|0|||
155062847|NCT00042289|559663997|FG023|Overall Study|Lost to Follow-up|0|||
155062848|NCT00042289|559663998|FG024|Overall Study|Lost to Follow-up|0|||
155062849|NCT00042289|559663999|FG025|Overall Study|Lost to Follow-up|0|||
155062850|NCT00042289|559664000|FG026|Overall Study|Lost to Follow-up|2|||
155062851|NCT00042289|559664001|FG027|Overall Study|Lost to Follow-up|2|||
155062852|NCT00042289|559664002|FG028|Overall Study|Lost to Follow-up|2|||
155062853|NCT00042289|559664003|FG029|Overall Study|Lost to Follow-up|0|||
155062854|NCT00042289|559664004|FG030|Overall Study|Lost to Follow-up|0|||
155062855|NCT00042289|559664005|FG031|Overall Study|Lost to Follow-up|2|||
155062856|NCT00042289|559664006|FG032|Overall Study|Lost to Follow-up|1|||
155062857|NCT00042289|559664007|FG033|Overall Study|Lost to Follow-up|1|||
155062858|NCT00042289|559664008|FG034|Overall Study|Lost to Follow-up|1|||
155062859|NCT00042289|559664009|FG035|Overall Study|Lost to Follow-up|2|||
155062860|NCT00042289|559664010|FG036|Overall Study|Lost to Follow-up|1|||
155062861|NCT00042289|559664011|FG037|Overall Study|Lost to Follow-up|1|||
155062862|NCT00042289|559664012|FG038|Overall Study|Lost to Follow-up|0|||
155062863|NCT00042289|559664013|FG039|Overall Study|Lost to Follow-up|5|||
155062864|NCT00042289|559664014|FG040|Overall Study|Lost to Follow-up|0|||
155062865|NCT00042289|559664015|FG041|Overall Study|Lost to Follow-up|2|||
155300170|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300171|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300172|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300173|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300174|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
155300175|NCT05061693|560529670|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
155300176|NCT05061693|560529671|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
155300177|NCT05061693|560529672|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
155300178|NCT05061693|560529673|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
155300179|NCT05061693|560529674|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300180|NCT05061693|560529675|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300181|NCT05061693|560529676|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300182|NCT05061693|560529677|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300183|NCT05061693|560529678|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300184|NCT05061693|560529679|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300185|NCT05061693|560529680|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300186|NCT05061693|560529681|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
155300187|NCT05061693|560529670|FG000|24-week Extension Period|Adverse Event|0|||
155300188|NCT05061693|560529671|FG001|24-week Extension Period|Adverse Event|0|||
155300189|NCT05061693|560529672|FG002|24-week Extension Period|Adverse Event|0|||
155300190|NCT05061693|560529673|FG003|24-week Extension Period|Adverse Event|0|||
155300191|NCT05061693|560529674|FG004|24-week Extension Period|Adverse Event|0|||
155300192|NCT05061693|560529675|FG005|24-week Extension Period|Adverse Event|0|||
155300193|NCT05061693|560529676|FG006|24-week Extension Period|Adverse Event|0|||
155062866|NCT00042289|559664016|FG042|Overall Study|Lost to Follow-up|2|||
155062867|NCT00042289|559664017|FG043|Overall Study|Lost to Follow-up|0|||
155062868|NCT00042289|559664018|FG044|Overall Study|Lost to Follow-up|0|||
155062869|NCT00042289|559664019|FG045|Overall Study|Lost to Follow-up|1|||
155062870|NCT00042289|559664020|FG046|Overall Study|Lost to Follow-up|0|||
155062871|NCT00042289|559663974|FG000|Overall Study|Other reason|0|||
155062872|NCT00042289|559663975|FG001|Overall Study|Other reason|0|||
155062873|NCT00042289|559663976|FG002|Overall Study|Other reason|0|||
155062874|NCT00042289|559663977|FG003|Overall Study|Other reason|2|||
155062875|NCT00042289|559663978|FG004|Overall Study|Other reason|0|||
155062876|NCT00042289|559663979|FG005|Overall Study|Other reason|0|||
155062877|NCT00042289|559663980|FG006|Overall Study|Other reason|0|||
155062878|NCT00042289|559663981|FG007|Overall Study|Other reason|0|||
155062879|NCT00042289|559663982|FG008|Overall Study|Other reason|0|||
155062880|NCT00042289|559663983|FG009|Overall Study|Other reason|0|||
155062881|NCT00042289|559663984|FG010|Overall Study|Other reason|0|||
155062882|NCT00042289|559663985|FG011|Overall Study|Other reason|0|||
155062883|NCT00042289|559663986|FG012|Overall Study|Other reason|0|||
155062884|NCT00042289|559663987|FG013|Overall Study|Other reason|0|||
155062885|NCT00042289|559663988|FG014|Overall Study|Other reason|0|||
155062886|NCT00042289|559663989|FG015|Overall Study|Other reason|0|||
155062887|NCT00042289|559663990|FG016|Overall Study|Other reason|0|||
155062888|NCT00042289|559663991|FG017|Overall Study|Other reason|0|||
155300194|NCT05061693|560529677|FG007|24-week Extension Period|Adverse Event|2|||
155300195|NCT05061693|560529678|FG008|24-week Extension Period|Adverse Event|2|||
155300196|NCT05061693|560529679|FG009|24-week Extension Period|Adverse Event|0|||
155062889|NCT00042289|559663992|FG018|Overall Study|Other reason|1|||
155300197|NCT05061693|560529680|FG010|24-week Extension Period|Adverse Event|1|||
155300198|NCT05061693|560529681|FG011|24-week Extension Period|Adverse Event|3|||
155300199|NCT05061693|560529670|FG000|24-week Extension Period|Lack of Efficacy|0|||
155300200|NCT05061693|560529671|FG001|24-week Extension Period|Lack of Efficacy|0|||
155300201|NCT05061693|560529672|FG002|24-week Extension Period|Lack of Efficacy|0|||
155062890|NCT00042289|559663993|FG019|Overall Study|Other reason|0|||
155062891|NCT00042289|559663994|FG020|Overall Study|Other reason|0|||
155062892|NCT00042289|559663995|FG021|Overall Study|Other reason|0|||
155062893|NCT00042289|559663996|FG022|Overall Study|Other reason|0|||
155062894|NCT00042289|559663997|FG023|Overall Study|Other reason|1|||
155062895|NCT00042289|559663998|FG024|Overall Study|Other reason|0|||
155062896|NCT00042289|559663999|FG025|Overall Study|Other reason|0|||
155062897|NCT00042289|559664000|FG026|Overall Study|Other reason|1|||
155300202|NCT05061693|560529673|FG003|24-week Extension Period|Lack of Efficacy|0|||
155300203|NCT05061693|560529674|FG004|24-week Extension Period|Lack of Efficacy|0|||
155300204|NCT05061693|560529675|FG005|24-week Extension Period|Lack of Efficacy|0|||
155300205|NCT05061693|560529676|FG006|24-week Extension Period|Lack of Efficacy|0|||
155300206|NCT05061693|560529677|FG007|24-week Extension Period|Lack of Efficacy|0|||
155300207|NCT05061693|560529678|FG008|24-week Extension Period|Lack of Efficacy|0|||
155300208|NCT05061693|560529679|FG009|24-week Extension Period|Lack of Efficacy|0|||
155300209|NCT05061693|560529680|FG010|24-week Extension Period|Lack of Efficacy|2|||
155300210|NCT05061693|560529681|FG011|24-week Extension Period|Lack of Efficacy|0|||
155300211|NCT05061693|560529670|FG000|24-week Extension Period|Lost to Follow-up|0|||
155300212|NCT05061693|560529671|FG001|24-week Extension Period|Lost to Follow-up|0|||
155300213|NCT05061693|560529672|FG002|24-week Extension Period|Lost to Follow-up|0|||
155300214|NCT05061693|560529673|FG003|24-week Extension Period|Lost to Follow-up|0|||
155300215|NCT05061693|560529674|FG004|24-week Extension Period|Lost to Follow-up|0|||
155300216|NCT05061693|560529675|FG005|24-week Extension Period|Lost to Follow-up|0|||
155300217|NCT05061693|560529676|FG006|24-week Extension Period|Lost to Follow-up|1|||
155300218|NCT05061693|560529677|FG007|24-week Extension Period|Lost to Follow-up|0|||
155300219|NCT05061693|560529678|FG008|24-week Extension Period|Lost to Follow-up|1|||
155300220|NCT05061693|560529679|FG009|24-week Extension Period|Lost to Follow-up|1|||
155300221|NCT05061693|560529680|FG010|24-week Extension Period|Lost to Follow-up|0|||
155300222|NCT05061693|560529681|FG011|24-week Extension Period|Lost to Follow-up|0|||
155300223|NCT05061693|560529670|FG000|24-week Extension Period|Withdrawal by Subject|0|||
155300224|NCT05061693|560529671|FG001|24-week Extension Period|Withdrawal by Subject|0|||
155300225|NCT05061693|560529672|FG002|24-week Extension Period|Withdrawal by Subject|0|||
155300226|NCT05061693|560529673|FG003|24-week Extension Period|Withdrawal by Subject|0|||
155300227|NCT05061693|560529674|FG004|24-week Extension Period|Withdrawal by Subject|0|||
155300228|NCT05061693|560529675|FG005|24-week Extension Period|Withdrawal by Subject|0|||
155300229|NCT05061693|560529676|FG006|24-week Extension Period|Withdrawal by Subject|0|||
155300230|NCT05061693|560529677|FG007|24-week Extension Period|Withdrawal by Subject|0|||
155300231|NCT05061693|560529678|FG008|24-week Extension Period|Withdrawal by Subject|1|||
155300232|NCT05061693|560529679|FG009|24-week Extension Period|Withdrawal by Subject|2|||
155300233|NCT05061693|560529680|FG010|24-week Extension Period|Withdrawal by Subject|2|||
155300234|NCT05061693|560529681|FG011|24-week Extension Period|Withdrawal by Subject|1|||
155300235|NCT05061693|560529670|FG000|24-week Extension Period|Sponsor Decision|0|||
155300236|NCT05061693|560529671|FG001|24-week Extension Period|Sponsor Decision|0|||
155300237|NCT05061693|560529672|FG002|24-week Extension Period|Sponsor Decision|0|||
155300238|NCT05061693|560529673|FG003|24-week Extension Period|Sponsor Decision|0|||
155300239|NCT05061693|560529674|FG004|24-week Extension Period|Sponsor Decision|0|||
155300240|NCT05061693|560529675|FG005|24-week Extension Period|Sponsor Decision|0|||
155300241|NCT05061693|560529676|FG006|24-week Extension Period|Sponsor Decision|0|||
155300242|NCT05061693|560529677|FG007|24-week Extension Period|Sponsor Decision|1|||
155300243|NCT05061693|560529678|FG008|24-week Extension Period|Sponsor Decision|0|||
155300244|NCT05061693|560529679|FG009|24-week Extension Period|Sponsor Decision|0|||
155300245|NCT05061693|560529680|FG010|24-week Extension Period|Sponsor Decision|0|||
155300246|NCT05061693|560529681|FG011|24-week Extension Period|Sponsor Decision|0|||
155159001|NCT00118417|560020720|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
155159002|NCT00118417|560020719|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
155159003|NCT00118417|560020720|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
155159004|NCT00118417|560020719|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
155159005|NCT00118417|560020720|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
155159006|NCT02978781|560020721|FG000|Part A|Adverse Event|1|||
155159007|NCT02978781|560020722|FG001|Part A|Adverse Event|1|||
155062898|NCT00042289|559664001|FG027|Overall Study|Other reason|0|||
155062899|NCT00042289|559664002|FG028|Overall Study|Other reason|3|||
155062900|NCT00042289|559664003|FG029|Overall Study|Other reason|0|||
155300247|NCT05061693|560529670|FG000|24-week Extension Period|Site Closure|0|||
155062901|NCT00042289|559664004|FG030|Overall Study|Other reason|0|||
155062902|NCT00042289|559664005|FG031|Overall Study|Other reason|1|||
155062903|NCT00042289|559664006|FG032|Overall Study|Other reason|0|||
155062904|NCT00042289|559664007|FG033|Overall Study|Other reason|1|||
155062905|NCT00042289|559664008|FG034|Overall Study|Other reason|0|||
155062906|NCT00042289|559664009|FG035|Overall Study|Other reason|2|||
155062907|NCT00042289|559664010|FG036|Overall Study|Other reason|0|||
155062908|NCT00042289|559664011|FG037|Overall Study|Other reason|0|||
155062909|NCT00042289|559664012|FG038|Overall Study|Other reason|0|||
155062910|NCT00042289|559664013|FG039|Overall Study|Other reason|0|||
155062911|NCT00042289|559664014|FG040|Overall Study|Other reason|0|||
155062912|NCT00042289|559664015|FG041|Overall Study|Other reason|0|||
155159008|NCT02978781|560020723|FG002|Part A|Adverse Event|0|||
155300248|NCT05061693|560529671|FG001|24-week Extension Period|Site Closure|0|||
155300249|NCT05061693|560529672|FG002|24-week Extension Period|Site Closure|0|||
155062913|NCT00042289|559664016|FG042|Overall Study|Other reason|0|||
155062914|NCT00042289|559664017|FG043|Overall Study|Other reason|1|||
155062915|NCT00042289|559664018|FG044|Overall Study|Other reason|0|||
155159009|NCT02978781|560020724|FG003|Part A|Adverse Event|0|||
155300250|NCT05061693|560529673|FG003|24-week Extension Period|Site Closure|0|||
155300251|NCT05061693|560529674|FG004|24-week Extension Period|Site Closure|0|||
155300252|NCT05061693|560529675|FG005|24-week Extension Period|Site Closure|0|||
155300253|NCT05061693|560529676|FG006|24-week Extension Period|Site Closure|0|||
155300254|NCT05061693|560529677|FG007|24-week Extension Period|Site Closure|0|||
155300255|NCT05061693|560529678|FG008|24-week Extension Period|Site Closure|1|||
155300256|NCT05061693|560529679|FG009|24-week Extension Period|Site Closure|0|||
155300257|NCT05061693|560529680|FG010|24-week Extension Period|Site Closure|0|||
155300258|NCT05061693|560529681|FG011|24-week Extension Period|Site Closure|1|||
155300259|NCT03823911|560529682|FG000|Overall Study|Lost to Follow-up|1|||
155300260|NCT03823911|560529683|FG001|Overall Study|Lost to Follow-up|5|||
155300261|NCT03823911|560529684|FG002|Overall Study|Lost to Follow-up|2|||
155300262|NCT03823911|560529682|FG000|Overall Study|Did not meet eligibility criteria|13|||
155300263|NCT03823911|560529683|FG001|Overall Study|Did not meet eligibility criteria|7|||
155300264|NCT03823911|560529684|FG002|Overall Study|Did not meet eligibility criteria|4|||
155300265|NCT03823911|560529682|FG000|Overall Study|Death|0|||
155300266|NCT03823911|560529683|FG001|Overall Study|Death|1|||
155300267|NCT03823911|560529684|FG002|Overall Study|Death|0|||
155300268|NCT04009577|560529685|FG000|Core Study|Adverse Event|1|||
155300269|NCT04009577|560529686|FG001|Core Study|Adverse Event|0|||
155300270|NCT04009577|560529687|FG002|Core Study|Adverse Event|2|||
155300271|NCT04009577|560529688|FG003|Core Study|Adverse Event|4|||
155300272|NCT04009577|560529685|FG000|Core Study|Withdrawal by Subject|0|||
155300273|NCT04009577|560529686|FG001|Core Study|Withdrawal by Subject|0|||
155300274|NCT04009577|560529687|FG002|Core Study|Withdrawal by Subject|2|||
155300275|NCT04009577|560529688|FG003|Core Study|Withdrawal by Subject|0|||
155300276|NCT04009577|560529685|FG000|Core Study|Other|0|||
155159010|NCT02978781|560020725|FG004|Part A|Adverse Event|0|||
155159011|NCT02978781|560020721|FG000|Part A|Withdrawal by Subject|0|||
155159012|NCT02978781|560020722|FG001|Part A|Withdrawal by Subject|1|||
155159013|NCT02978781|560020723|FG002|Part A|Withdrawal by Subject|0|||
155062916|NCT00042289|559664019|FG045|Overall Study|Other reason|0|||
155062917|NCT00042289|559664020|FG046|Overall Study|Other reason|0|||
155062918|NCT00042289|559663974|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155062919|NCT00042289|559663975|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155062920|NCT00042289|559663976|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155062921|NCT00042289|559663977|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155062922|NCT00042289|559663978|FG004|Overall Study|Severe debilitation, unable to continue|0|||
155062923|NCT00042289|559663979|FG005|Overall Study|Severe debilitation, unable to continue|0|||
155062924|NCT00042289|559663980|FG006|Overall Study|Severe debilitation, unable to continue|0|||
155062925|NCT00042289|559663981|FG007|Overall Study|Severe debilitation, unable to continue|0|||
155062926|NCT00042289|559663982|FG008|Overall Study|Severe debilitation, unable to continue|0|||
155062927|NCT00042289|559663983|FG009|Overall Study|Severe debilitation, unable to continue|0|||
155062928|NCT00042289|559663984|FG010|Overall Study|Severe debilitation, unable to continue|0|||
155159014|NCT02978781|560020724|FG003|Part A|Withdrawal by Subject|0|||
155159015|NCT02978781|560020725|FG004|Part A|Withdrawal by Subject|0|||
155159016|NCT02978781|560020721|FG000|Part B|Withdrawal by Subject|0|||
155159017|NCT02978781|560020722|FG001|Part B|Withdrawal by Subject|0|||
155159018|NCT02978781|560020723|FG002|Part B|Withdrawal by Subject|0|||
155159019|NCT02978781|560020724|FG003|Part B|Withdrawal by Subject|1|||
155159020|NCT02978781|560020725|FG004|Part B|Withdrawal by Subject|0|||
155062929|NCT00042289|559663985|FG011|Overall Study|Severe debilitation, unable to continue|0|||
155062930|NCT00042289|559663986|FG012|Overall Study|Severe debilitation, unable to continue|0|||
155062931|NCT00042289|559663987|FG013|Overall Study|Severe debilitation, unable to continue|0|||
155062932|NCT00042289|559663988|FG014|Overall Study|Severe debilitation, unable to continue|0|||
155062933|NCT00042289|559663989|FG015|Overall Study|Severe debilitation, unable to continue|0|||
155062934|NCT00042289|559663990|FG016|Overall Study|Severe debilitation, unable to continue|0|||
155062935|NCT00042289|559663991|FG017|Overall Study|Severe debilitation, unable to continue|0|||
155062936|NCT00042289|559663992|FG018|Overall Study|Severe debilitation, unable to continue|0|||
155062937|NCT00042289|559663993|FG019|Overall Study|Severe debilitation, unable to continue|0|||
155159021|NCT02978781|560020721|FG000|Part C|Adverse Event|0|||
155159022|NCT02978781|560020722|FG001|Part C|Adverse Event|0|||
155159023|NCT02978781|560020723|FG002|Part C|Adverse Event|0|||
155159024|NCT02978781|560020724|FG003|Part C|Adverse Event|0|||
155062938|NCT00042289|559663994|FG020|Overall Study|Severe debilitation, unable to continue|0|||
155159025|NCT02978781|560020725|FG004|Part C|Adverse Event|2|||
155159026|NCT02978781|560020721|FG000|Part C|Withdrawal by Subject|0|||
155300277|NCT04009577|560529686|FG001|Core Study|Other|0|||
155300278|NCT04009577|560529687|FG002|Core Study|Other|0|||
155300279|NCT04009577|560529688|FG003|Core Study|Other|1|||
155300280|NCT04009577|560529685|FG000|Extension Phase|Adverse Event|0|||
155159027|NCT02978781|560020722|FG001|Part C|Withdrawal by Subject|0|||
155159028|NCT02978781|560020723|FG002|Part C|Withdrawal by Subject|0|||
155159029|NCT02978781|560020724|FG003|Part C|Withdrawal by Subject|0|||
155159030|NCT02978781|560020725|FG004|Part C|Withdrawal by Subject|1|||
155170037|NCT00830869|560062416|FG011|Period 2: Part 2|Adverse Event|0|||
155300281|NCT04009577|560529686|FG001|Extension Phase|Adverse Event|0|||
155300282|NCT04009577|560529687|FG002|Extension Phase|Adverse Event|0|||
155300283|NCT04009577|560529688|FG003|Extension Phase|Adverse Event|1|||
155300284|NCT04009577|560529685|FG000|Extension Phase|Inadequate therapeutic effect|0|||
155300285|NCT04009577|560529686|FG001|Extension Phase|Inadequate therapeutic effect|0|||
155300286|NCT04009577|560529687|FG002|Extension Phase|Inadequate therapeutic effect|1|||
155300287|NCT04009577|560529688|FG003|Extension Phase|Inadequate therapeutic effect|0|||
155300288|NCT04009577|560529685|FG000|Extension Phase|Withdrawal by Subject|0|||
155300289|NCT04009577|560529686|FG001|Extension Phase|Withdrawal by Subject|0|||
155300290|NCT04009577|560529687|FG002|Extension Phase|Withdrawal by Subject|1|||
155300291|NCT04009577|560529688|FG003|Extension Phase|Withdrawal by Subject|0|||
155300292|NCT04009577|560529685|FG000|Extension Phase|Not Treated|0|||
155300293|NCT04009577|560529686|FG001|Extension Phase|Not Treated|0|||
155300294|NCT04009577|560529687|FG002|Extension Phase|Not Treated|2|||
155300295|NCT04009577|560529688|FG003|Extension Phase|Not Treated|0|||
155300296|NCT00305695|560529698|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
155300297|NCT00305695|560529699|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
155300298|NCT00305695|560529698|FG000|Overall Study|Did not have baseline scan|1|||
155300299|NCT00305695|560529699|FG001|Overall Study|Did not have baseline scan|1|||
155300300|NCT04305405|560529703|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155300301|NCT04305405|560529704|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155300302|NCT02674750|560529707|FG000|Overall Study|Death|4|||
155300303|NCT02674750|560529708|FG001|Overall Study|Death|5|||
155300304|NCT02674750|560529709|FG002|Overall Study|Death|8|||
155300305|NCT02674750|560529707|FG000|Overall Study|Lost to Follow-up|0|||
155300306|NCT02674750|560529708|FG001|Overall Study|Lost to Follow-up|8|||
155300307|NCT02674750|560529709|FG002|Overall Study|Lost to Follow-up|0|||
155300308|NCT02674750|560529707|FG000|Overall Study|Lack of Efficacy|1|||
155300309|NCT02674750|560529708|FG001|Overall Study|Lack of Efficacy|17|||
155300310|NCT02674750|560529709|FG002|Overall Study|Lack of Efficacy|3|||
155300311|NCT02674750|560529707|FG000|Overall Study|Withdrawal by Subject|0|||
155300312|NCT02674750|560529708|FG001|Overall Study|Withdrawal by Subject|7|||
155300313|NCT02674750|560529709|FG002|Overall Study|Withdrawal by Subject|1|||
155300314|NCT02674750|560529707|FG000|Overall Study|Other|0|||
155300315|NCT02674750|560529708|FG001|Overall Study|Other|8|||
155300316|NCT02674750|560529709|FG002|Overall Study|Other|0|||
155300317|NCT01685606|560529712|FG000|Overall Study|Withdrawal by Subject|1|||
155300318|NCT01787760|560529715|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
155300319|NCT01787760|560529716|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
155300320|NCT01787760|560529717|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
155300321|NCT01787760|560529715|FG000|Overall Study|Decompensated on left exotropia|0|||
155300322|NCT01787760|560529716|FG001|Overall Study|Decompensated on left exotropia|0|||
155300323|NCT01787760|560529717|FG002|Overall Study|Decompensated on left exotropia|1|||
155300324|NCT01787760|560529715|FG000|Overall Study|Dryness|0|||
155300325|NCT01787760|560529716|FG001|Overall Study|Dryness|1|||
155300326|NCT01787760|560529717|FG002|Overall Study|Dryness|0|||
155300327|NCT01787760|560529715|FG000|Overall Study|Relocation|1|||
155300328|NCT01787760|560529716|FG001|Overall Study|Relocation|1|||
155300329|NCT01787760|560529717|FG002|Overall Study|Relocation|0|||
155300330|NCT01787760|560529715|FG000|Overall Study|Lens discomfort|3|||
155300331|NCT01787760|560529716|FG001|Overall Study|Lens discomfort|0|||
155300332|NCT01787760|560529717|FG002|Overall Study|Lens discomfort|0|||
155300333|NCT01787760|560529715|FG000|Overall Study|Lens handling difficulty|1|||
155300334|NCT01787760|560529716|FG001|Overall Study|Lens handling difficulty|2|||
155300335|NCT01787760|560529717|FG002|Overall Study|Lens handling difficulty|0|||
155300336|NCT01787760|560529715|FG000|Overall Study|Protocol Violation|6|||
155300337|NCT01787760|560529716|FG001|Overall Study|Protocol Violation|0|||
155300338|NCT01787760|560529717|FG002|Overall Study|Protocol Violation|1|||
155300339|NCT01787760|560529715|FG000|Overall Study|Withdrawal by Subject|5|||
155300340|NCT01787760|560529716|FG001|Overall Study|Withdrawal by Subject|1|||
155300341|NCT01787760|560529717|FG002|Overall Study|Withdrawal by Subject|2|||
155300342|NCT01787760|560529715|FG000|Overall Study|Lost to Follow-up|1|||
155300343|NCT01787760|560529716|FG001|Overall Study|Lost to Follow-up|0|||
155300344|NCT01787760|560529717|FG002|Overall Study|Lost to Follow-up|1|||
155300345|NCT01787760|560529715|FG000|Overall Study|Stroke|1|||
155300346|NCT01787760|560529716|FG001|Overall Study|Stroke|0|||
155300347|NCT01787760|560529717|FG002|Overall Study|Stroke|0|||
155300348|NCT01787760|560529715|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
155300349|NCT01787760|560529716|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
155300350|NCT01787760|560529717|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
155300351|NCT01787760|560529715|FG000|Overall Study|Unsatisfactory physiological response|2|||
155300352|NCT01787760|560529716|FG001|Overall Study|Unsatisfactory physiological response|4|||
155300353|NCT01787760|560529717|FG002|Overall Study|Unsatisfactory physiological response|0|||
155300354|NCT01787760|560529715|FG000|Overall Study|Unsatisfactory visual response|1|||
155062939|NCT00042289|559663995|FG021|Overall Study|Severe debilitation, unable to continue|1|||
155062940|NCT00042289|559663996|FG022|Overall Study|Severe debilitation, unable to continue|0|||
155300355|NCT01787760|560529716|FG001|Overall Study|Unsatisfactory visual response|1|||
155300356|NCT01787760|560529717|FG002|Overall Study|Unsatisfactory visual response|0|||
155300357|NCT01787760|560529715|FG000|Overall Study|Near vision blur|1|||
155300358|NCT01787760|560529716|FG001|Overall Study|Near vision blur|0|||
155300359|NCT01787760|560529717|FG002|Overall Study|Near vision blur|0|||
155300360|NCT01597258|560529718|FG000|Overall Study|No Drug Administration|1|||
155300361|NCT01212991|560529719|FG000|Double-blind|Lost to Follow-up|8|||
155300362|NCT01212991|560529720|FG001|Double-blind|Lost to Follow-up|4|||
155300363|NCT01212991|560529721|FG002|Double-blind|Lost to Follow-up|0|||
155300364|NCT01212991|560529719|FG000|Double-blind|Death|699|||
155300365|NCT01212991|560529720|FG001|Double-blind|Death|550|||
155300366|NCT01212991|560529721|FG002|Double-blind|Death|0|||
155300367|NCT01212991|560529719|FG000|Double-blind|Withdrawal by Subject|16|||
155300368|NCT01212991|560529720|FG001|Double-blind|Withdrawal by Subject|19|||
155300369|NCT01212991|560529721|FG002|Double-blind|Withdrawal by Subject|0|||
155300370|NCT01212991|560529719|FG000|Double-blind|Other|7|||
155300371|NCT01212991|560529720|FG001|Double-blind|Other|0|||
155300372|NCT01212991|560529721|FG002|Double-blind|Other|0|||
155300373|NCT01212991|560529719|FG000|Double-blind|Sponsor decision|142|||
155300374|NCT01212991|560529720|FG001|Double-blind|Sponsor decision|38|||
155300375|NCT01212991|560529721|FG002|Double-blind|Sponsor decision|0|||
155300376|NCT01212991|560529719|FG000|Open-label|Death|0|||
155300377|NCT01212991|560529720|FG001|Open-label|Death|0|||
155300378|NCT01212991|560529721|FG002|Open-label|Death|166|||
155300379|NCT01212991|560529719|FG000|Open-label|Lost to Follow-up|0|||
155300380|NCT01212991|560529720|FG001|Open-label|Lost to Follow-up|0|||
155300381|NCT01212991|560529721|FG002|Open-label|Lost to Follow-up|5|||
155300382|NCT01212991|560529719|FG000|Open-label|Withdrawal by Subject|0|||
155300383|NCT01212991|560529720|FG001|Open-label|Withdrawal by Subject|0|||
155300384|NCT01212991|560529721|FG002|Open-label|Withdrawal by Subject|7|||
155300385|NCT01212991|560529719|FG000|Open-label|Sponsor decision|0|||
155300386|NCT01212991|560529720|FG001|Open-label|Sponsor decision|0|||
155300387|NCT01212991|560529721|FG002|Open-label|Sponsor decision|53|||
155300388|NCT01212991|560529719|FG000|Open-label|Other|0|||
155300389|NCT01212991|560529720|FG001|Open-label|Other|0|||
155300390|NCT01212991|560529721|FG002|Open-label|Other|3|||
155300391|NCT02531113|560529722|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
155300392|NCT02531113|560529722|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
155300393|NCT02531113|560529722|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
155300394|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
155300395|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
155300396|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
155300397|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
155300398|NCT02531113|560529722|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
155300399|NCT04411056|560530866|FG000|Overall Study|surgery cancelled|1|||
155300400|NCT04411056|560530867|FG001|Overall Study|surgery cancelled|0|||
155300401|NCT04411056|560530866|FG000|Overall Study|Equipment problem during intubation|0|||
155300402|NCT04411056|560530867|FG001|Overall Study|Equipment problem during intubation|1|||
155300403|NCT04623008|560530868|FG000|Baseline to T2|Withdrawal by Subject|4|||
155300404|NCT04623008|560530869|FG001|Baseline to T2|Withdrawal by Subject|2|||
155300405|NCT04623008|560530868|FG000|Baseline to T3|Withdrawal by Subject|4|||
155300406|NCT04623008|560530869|FG001|Baseline to T3|Withdrawal by Subject|2|||
155300407|NCT03122886|560530878|FG000|Overall Study|Withdrawal by Subject|1|||
155300408|NCT03122886|560530879|FG001|Overall Study|Withdrawal by Subject|2|||
155300409|NCT02279095|560530885|FG000|Overall Study|Non-Compliance|1|||
155300410|NCT02279095|560530885|FG000|Overall Study|Withdrawal by Subject|8|||
155062941|NCT00042289|559663997|FG023|Overall Study|Severe debilitation, unable to continue|1|||
155062942|NCT00042289|559663998|FG024|Overall Study|Severe debilitation, unable to continue|0|||
155062943|NCT00042289|559663999|FG025|Overall Study|Severe debilitation, unable to continue|0|||
155062944|NCT00042289|559664000|FG026|Overall Study|Severe debilitation, unable to continue|0|||
155062945|NCT00042289|559664001|FG027|Overall Study|Severe debilitation, unable to continue|1|||
155062946|NCT00042289|559664002|FG028|Overall Study|Severe debilitation, unable to continue|0|||
155062947|NCT00042289|559664003|FG029|Overall Study|Severe debilitation, unable to continue|0|||
155062948|NCT00042289|559664004|FG030|Overall Study|Severe debilitation, unable to continue|0|||
155062949|NCT00042289|559664005|FG031|Overall Study|Severe debilitation, unable to continue|1|||
155062950|NCT00042289|559664006|FG032|Overall Study|Severe debilitation, unable to continue|1|||
155300411|NCT02279095|560530885|FG000|Overall Study|Adverse Event|2|||
155300412|NCT02279095|560530885|FG000|Overall Study|Other|7|||
155300413|NCT02279095|560530885|FG000|Overall Study|Lost to Follow-up|1|||
155300414|NCT05938413|560530886|FG000|Overall Study|Lost to Follow-up|1|||
155300415|NCT05938413|560530887|FG001|Overall Study|Lost to Follow-up|7|||
155300416|NCT05938413|560530886|FG000|Overall Study|Withdrawal by Subject|1|||
155300417|NCT05938413|560530887|FG001|Overall Study|Withdrawal by Subject|1|||
155300418|NCT03481777|560530888|FG000|Overall Study|Withdrawal by Subject|36|||
155300419|NCT03481777|560530889|FG001|Overall Study|Withdrawal by Subject|31|||
155300420|NCT03481777|560530888|FG000|Overall Study|Non stroke = non target population|277|||
155300421|NCT03481777|560530889|FG001|Overall Study|Non stroke = non target population|254|||
155300422|NCT03613740|560530900|FG000|Overall Study|Lost to Follow-up|1|||
155300423|NCT03613740|560530901|FG001|Overall Study|Lost to Follow-up|1|||
155300424|NCT03452189|560530902|FG000|First Intervention (3 Months)|Adverse Event|1|||
155300425|NCT03452189|560530903|FG001|First Intervention (3 Months)|Adverse Event|0|||
155300426|NCT03452189|560530902|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
155300427|NCT03452189|560530903|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
155300428|NCT02724592|560530904|FG000|Overall Study|Lost to Follow-up|4|||
155300429|NCT02724592|560530905|FG001|Overall Study|Lost to Follow-up|1|||
155300430|NCT02374463|560530908|FG000|Overall Study|Withdrawal by Subject|3|||
155300431|NCT02374463|560530909|FG001|Overall Study|Withdrawal by Subject|3|||
155300432|NCT01424397|560530910|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300433|NCT01424397|560530911|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300434|NCT01424397|560530912|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
155300435|NCT01424397|560530913|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300436|NCT01424397|560530914|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300437|NCT01424397|560530915|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300438|NCT01424397|560530916|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300439|NCT01424397|560530917|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300440|NCT01424397|560530918|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300441|NCT01424397|560530919|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300442|NCT01424397|560530920|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300443|NCT01424397|560530921|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
155300444|NCT01951170|560530922|FG000|Overall Study|Investigator decision|1|||
155300445|NCT00077675|560530927|FG000|Overall Study|Adverse Event|1|||
155300446|NCT00077675|560530928|FG001|Overall Study|Adverse Event|2|||
155300447|NCT00077675|560530927|FG000|Overall Study|Lost to Follow-up|6|||
155300448|NCT00077675|560530928|FG001|Overall Study|Lost to Follow-up|3|||
155300449|NCT00077675|560530927|FG000|Overall Study|Withdrawal by Subject|1|||
155300450|NCT00077675|560530928|FG001|Overall Study|Withdrawal by Subject|0|||
155300451|NCT00077675|560530927|FG000|Overall Study|Other|0|||
155300452|NCT00077675|560530928|FG001|Overall Study|Other|1|||
155300453|NCT00077675|560530927|FG000|Overall Study|Never received study treatment|3|||
155300454|NCT00077675|560530928|FG001|Overall Study|Never received study treatment|3|||
155300455|NCT02601820|560530930|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
155300456|NCT02601820|560530930|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
155300457|NCT02601820|560530930|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
155300458|NCT02601820|560530930|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
155300459|NCT01972724|560530931|FG000|Double-Blind|Rescue Criteria Met|1|||
155300460|NCT01972724|560530932|FG001|Double-Blind|Rescue Criteria Met|0|||
155300461|NCT01972724|560530933|FG002|Double-Blind|Rescue Criteria Met|0|||
155300462|NCT01972724|560530931|FG000|Double-Blind|Adverse Event|1|||
155300463|NCT01972724|560530932|FG001|Double-Blind|Adverse Event|0|||
155300464|NCT01972724|560530933|FG002|Double-Blind|Adverse Event|0|||
155300465|NCT01972724|560530931|FG000|Double-Blind|Withdrawal of Consent|2|||
155300466|NCT01972724|560530932|FG001|Double-Blind|Withdrawal of Consent|1|||
155300467|NCT01972724|560530933|FG002|Double-Blind|Withdrawal of Consent|0|||
155300468|NCT01972724|560530931|FG000|Double-Blind|Significant Protocol Deviation|5|||
155300469|NCT01972724|560530932|FG001|Double-Blind|Significant Protocol Deviation|8|||
155159031|NCT02978781|560020721|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
155159032|NCT02978781|560020722|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
155159033|NCT02978781|560020723|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
155159034|NCT02978781|560020724|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
155300470|NCT01972724|560530933|FG002|Double-Blind|Significant Protocol Deviation|0|||
155159035|NCT02978781|560020725|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
155159036|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
155159037|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
155159038|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Adverse Event|31|||
155159039|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Adverse Event|21|||
155159040|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
155159041|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
155159042|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
155159043|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
155300471|NCT01972724|560530931|FG000|Open-Label|Withdrew Consent|0|||
155159044|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
155300472|NCT01972724|560530932|FG001|Open-Label|Withdrew Consent|0|||
155300473|NCT01972724|560530933|FG002|Open-Label|Withdrew Consent|3|||
155300474|NCT01972724|560530931|FG000|Open-Label|Significant Protocol Deviation|0|||
155300475|NCT01972724|560530932|FG001|Open-Label|Significant Protocol Deviation|0|||
155300476|NCT01972724|560530933|FG002|Open-Label|Significant Protocol Deviation|2|||
155300477|NCT02652442|560530938|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
155300478|NCT00244855|560530939|FG000|Overall Study|Withdrawal by Subject|0|||
155300479|NCT00244855|560530940|FG001|Overall Study|Withdrawal by Subject|1|||
155300480|NCT00364013|560530943|FG000|Overall Study|Ineligibility determined|4|||
155300481|NCT00364013|560530944|FG001|Overall Study|Ineligibility determined|2|||
155300482|NCT00364013|560530943|FG000|Overall Study|Adverse Event|4|||
155300483|NCT00364013|560530944|FG001|Overall Study|Adverse Event|3|||
155300484|NCT00364013|560530943|FG000|Overall Study|Withdrawal by Subject|13|||
155300485|NCT00364013|560530944|FG001|Overall Study|Withdrawal by Subject|18|||
155300486|NCT00364013|560530943|FG000|Overall Study|Physician Decision|3|||
155300487|NCT00364013|560530944|FG001|Overall Study|Physician Decision|3|||
155300488|NCT00364013|560530943|FG000|Overall Study|Lost to Follow-up|10|||
155300489|NCT00364013|560530944|FG001|Overall Study|Lost to Follow-up|3|||
155300490|NCT00364013|560530943|FG000|Overall Study|Protocol-specified criteria|6|||
155300491|NCT00364013|560530944|FG001|Overall Study|Protocol-specified criteria|6|||
155300492|NCT00364013|560530943|FG000|Overall Study|Other|41|||
155300493|NCT00364013|560530944|FG001|Overall Study|Other|47|||
155300494|NCT00364013|560530943|FG000|Overall Study|Ongoing|20|||
155300495|NCT00364013|560530944|FG001|Overall Study|Ongoing|13|||
155300496|NCT04530747|560530948|FG000|Overall Study|Withdrawal by Subject|1|||
155300497|NCT04530747|560530949|FG001|Overall Study|Withdrawal by Subject|0|||
155300498|NCT03292913|560530950|FG000|Overall Study|Death|9|||
155300499|NCT03292913|560530951|FG001|Overall Study|Death|3|||
155300500|NCT03292913|560530950|FG000|Overall Study|Lost to Follow-up|49|||
155300501|NCT03292913|560530951|FG001|Overall Study|Lost to Follow-up|49|||
155300502|NCT03292913|560530950|FG000|Overall Study|Withdrawal by Subject|2|||
155300503|NCT03292913|560530951|FG001|Overall Study|Withdrawal by Subject|0|||
155300504|NCT03292913|560530950|FG000|Overall Study|Clinic closed due to COVID|22|||
155300505|NCT03292913|560530951|FG001|Overall Study|Clinic closed due to COVID|36|||
155300506|NCT03950622|560530952|FG000|Overall Study|Withdrawal by Subject|1|||
155300507|NCT03950622|560530953|FG001|Overall Study|Withdrawal by Subject|0|||
155300508|NCT03950622|560530952|FG000|Overall Study|Protocol Deviation|0|||
155300509|NCT03950622|560530953|FG001|Overall Study|Protocol Deviation|1|||
155300510|NCT03950622|560530952|FG000|Overall Study|Physician Decision|1|||
155300511|NCT03950622|560530953|FG001|Overall Study|Physician Decision|0|||
155300512|NCT03950622|560530952|FG000|Overall Study|Lost to Follow-up|5|||
155300513|NCT03950622|560530953|FG001|Overall Study|Lost to Follow-up|5|||
155300514|NCT03950622|560530952|FG000|Overall Study|Death|1|||
155300515|NCT03950622|560530953|FG001|Overall Study|Death|1|||
155300516|NCT04056624|560530954|FG000|Overall Study|Withdrawal by Subject|0|||
155300517|NCT04056624|560530955|FG001|Overall Study|Withdrawal by Subject|0|||
155300518|NCT04056624|560530956|FG002|Overall Study|Withdrawal by Subject|1|||
155300519|NCT04056624|560530954|FG000|Overall Study|Protocol Violation|1|||
155300520|NCT04056624|560530955|FG001|Overall Study|Protocol Violation|2|||
155300521|NCT04056624|560530956|FG002|Overall Study|Protocol Violation|0|||
155300522|NCT02267824|560530959|FG000|Overall Study|Pregnancy|1|||
155300523|NCT02267824|560530960|FG001|Overall Study|Pregnancy|1|||
155300524|NCT02267824|560530959|FG000|Overall Study|Lost to Follow-up|4|||
155300525|NCT02267824|560530960|FG001|Overall Study|Lost to Follow-up|0|||
155300526|NCT02267824|560530959|FG000|Overall Study|Protocol Violation|3|||
155300527|NCT02267824|560530960|FG001|Overall Study|Protocol Violation|0|||
155300528|NCT02267824|560530959|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
155300529|NCT02267824|560530960|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
155300530|NCT01832480|560530969|FG000|Overall Study|Lost to Follow-up|33|||
155300531|NCT01832480|560530970|FG001|Overall Study|Lost to Follow-up|30|||
155300532|NCT01832480|560530969|FG000|Overall Study|Withdrawal by Subject|0|||
155300533|NCT01832480|560530970|FG001|Overall Study|Withdrawal by Subject|2|||
155300534|NCT01832480|560530969|FG000|Overall Study|post randomization ineligible|8|||
155300535|NCT01832480|560530970|FG001|Overall Study|post randomization ineligible|10|||
155300536|NCT02261467|560530971|FG000|Overall Study|Enrolled in Error|1|||
155300537|NCT02261467|560530972|FG001|Overall Study|Enrolled in Error|0|||
155300538|NCT02261467|560530971|FG000|Overall Study|Protocol Violation|0|||
155300539|NCT02261467|560530972|FG001|Overall Study|Protocol Violation|1|||
155300540|NCT02261467|560530971|FG000|Overall Study|Personal Reasons|17|||
155300541|NCT02261467|560530972|FG001|Overall Study|Personal Reasons|22|||
155300542|NCT02261467|560530971|FG000|Overall Study|Lost to Follow-up|2|||
155300543|NCT02261467|560530972|FG001|Overall Study|Lost to Follow-up|13|||
155300544|NCT02261467|560530971|FG000|Overall Study|Adverse Event|1|||
155300545|NCT02261467|560530972|FG001|Overall Study|Adverse Event|1|||
155062951|NCT00042289|559664007|FG033|Overall Study|Severe debilitation, unable to continue|0|||
155062952|NCT00042289|559664008|FG034|Overall Study|Severe debilitation, unable to continue|0|||
155300546|NCT00736853|560530973|FG000|Open-Label Period|Physician Decision|2|||
155300547|NCT00736853|560530974|FG001|Open-Label Period|Physician Decision|0|||
155300548|NCT00736853|560530975|FG002|Open-Label Period|Physician Decision|0|||
155300549|NCT00736853|560530973|FG000|Open-Label Period|Adverse Event|31|||
155300550|NCT00736853|560530974|FG001|Open-Label Period|Adverse Event|0|||
155300551|NCT00736853|560530975|FG002|Open-Label Period|Adverse Event|0|||
155300552|NCT00736853|560530973|FG000|Open-Label Period|Withdrawal by Subject|16|||
155300553|NCT00736853|560530974|FG001|Open-Label Period|Withdrawal by Subject|0|||
155062953|NCT00042289|559664009|FG035|Overall Study|Severe debilitation, unable to continue|0|||
155062954|NCT00042289|559664010|FG036|Overall Study|Severe debilitation, unable to continue|0|||
155062955|NCT00042289|559664011|FG037|Overall Study|Severe debilitation, unable to continue|0|||
155062956|NCT00042289|559664012|FG038|Overall Study|Severe debilitation, unable to continue|0|||
155062957|NCT00042289|559664013|FG039|Overall Study|Severe debilitation, unable to continue|0|||
155062958|NCT00042289|559664014|FG040|Overall Study|Severe debilitation, unable to continue|0|||
155062959|NCT00042289|559664015|FG041|Overall Study|Severe debilitation, unable to continue|0|||
155300554|NCT00736853|560530975|FG002|Open-Label Period|Withdrawal by Subject|0|||
155300555|NCT00736853|560530973|FG000|Open-Label Period|Started but not treated|42|||
155300556|NCT00736853|560530974|FG001|Open-Label Period|Started but not treated|0|||
155300557|NCT00736853|560530975|FG002|Open-Label Period|Started but not treated|0|||
155300558|NCT00736853|560530973|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
155300559|NCT00736853|560530974|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
155300560|NCT00736853|560530975|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
155300561|NCT00736853|560530973|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
155300562|NCT00736853|560530974|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
155300563|NCT00736853|560530975|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
155300564|NCT00736853|560530973|FG000|Double-Blind Period|Lack of Efficacy|0|||
155300565|NCT00736853|560530974|FG001|Double-Blind Period|Lack of Efficacy|19|||
155300566|NCT00736853|560530975|FG002|Double-Blind Period|Lack of Efficacy|42|||
155300567|NCT00736853|560530973|FG000|Double-Blind Period|Adverse Event|0|||
155300568|NCT00736853|560530974|FG001|Double-Blind Period|Adverse Event|3|||
155300569|NCT00736853|560530975|FG002|Double-Blind Period|Adverse Event|2|||
155300570|NCT00736853|560530973|FG000|Double-Blind Period|Withdrawal by Subject|0|||
155300571|NCT00736853|560530974|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155300572|NCT00736853|560530975|FG002|Double-Blind Period|Withdrawal by Subject|4|||
155300573|NCT00736853|560530973|FG000|Double-Blind Period|Ineligible to participate the study|0|||
155300574|NCT00736853|560530974|FG001|Double-Blind Period|Ineligible to participate the study|1|||
155300575|NCT00736853|560530975|FG002|Double-Blind Period|Ineligible to participate the study|0|||
155159045|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
155159046|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
155062960|NCT00042289|559664016|FG042|Overall Study|Severe debilitation, unable to continue|0|||
155062961|NCT00042289|559664017|FG043|Overall Study|Severe debilitation, unable to continue|0|||
155062962|NCT00042289|559664018|FG044|Overall Study|Severe debilitation, unable to continue|0|||
155062963|NCT00042289|559664019|FG045|Overall Study|Severe debilitation, unable to continue|0|||
155062964|NCT00042289|559664020|FG046|Overall Study|Severe debilitation, unable to continue|0|||
155062965|NCT00042289|559663974|FG000|Overall Study|Site closed|0|||
155062966|NCT00042289|559663975|FG001|Overall Study|Site closed|0|||
155062967|NCT00042289|559663976|FG002|Overall Study|Site closed|0|||
155062968|NCT00042289|559663977|FG003|Overall Study|Site closed|0|||
155062969|NCT00042289|559663978|FG004|Overall Study|Site closed|0|||
155062970|NCT00042289|559663979|FG005|Overall Study|Site closed|0|||
155062971|NCT00042289|559663980|FG006|Overall Study|Site closed|0|||
155062972|NCT00042289|559663981|FG007|Overall Study|Site closed|0|||
155062973|NCT00042289|559663982|FG008|Overall Study|Site closed|0|||
155062974|NCT00042289|559663983|FG009|Overall Study|Site closed|0|||
155062975|NCT00042289|559663984|FG010|Overall Study|Site closed|0|||
155062976|NCT00042289|559663985|FG011|Overall Study|Site closed|0|||
155062977|NCT00042289|559663986|FG012|Overall Study|Site closed|0|||
155062978|NCT00042289|559663987|FG013|Overall Study|Site closed|0|||
155062979|NCT00042289|559663988|FG014|Overall Study|Site closed|0|||
155062980|NCT00042289|559663989|FG015|Overall Study|Site closed|0|||
155062981|NCT00042289|559663990|FG016|Overall Study|Site closed|0|||
155062982|NCT00042289|559663991|FG017|Overall Study|Site closed|0|||
155062983|NCT00042289|559663992|FG018|Overall Study|Site closed|0|||
155062984|NCT00042289|559663993|FG019|Overall Study|Site closed|0|||
155062985|NCT00042289|559663994|FG020|Overall Study|Site closed|0|||
155062986|NCT00042289|559663995|FG021|Overall Study|Site closed|0|||
155062987|NCT00042289|559663996|FG022|Overall Study|Site closed|0|||
155062988|NCT00042289|559663997|FG023|Overall Study|Site closed|0|||
155062989|NCT00042289|559663998|FG024|Overall Study|Site closed|0|||
155062990|NCT00042289|559663999|FG025|Overall Study|Site closed|0|||
155062991|NCT00042289|559664000|FG026|Overall Study|Site closed|0|||
155062992|NCT00042289|559664001|FG027|Overall Study|Site closed|0|||
155062993|NCT00042289|559664002|FG028|Overall Study|Site closed|0|||
155062994|NCT00042289|559664003|FG029|Overall Study|Site closed|0|||
155062995|NCT00042289|559664004|FG030|Overall Study|Site closed|0|||
155300576|NCT01764464|560530976|FG000|First Intervention|Withdrawal by Subject|1|||
155300577|NCT01764464|560530977|FG001|First Intervention|Withdrawal by Subject|0|||
155300578|NCT01764464|560530976|FG000|First Intervention|Lost to Follow-up|1|||
155300579|NCT01764464|560530977|FG001|First Intervention|Lost to Follow-up|0|||
155300580|NCT01764464|560530976|FG000|First Intervention|Adverse Event|0|||
155062996|NCT00042289|559664005|FG031|Overall Study|Site closed|3|||
155062997|NCT00042289|559664006|FG032|Overall Study|Site closed|0|||
155062998|NCT00042289|559664007|FG033|Overall Study|Site closed|0|||
155062999|NCT00042289|559664008|FG034|Overall Study|Site closed|0|||
155063000|NCT00042289|559664009|FG035|Overall Study|Site closed|0|||
155063001|NCT00042289|559664010|FG036|Overall Study|Site closed|1|||
155063002|NCT00042289|559664011|FG037|Overall Study|Site closed|0|||
155063003|NCT00042289|559664012|FG038|Overall Study|Site closed|0|||
155063004|NCT00042289|559664013|FG039|Overall Study|Site closed|0|||
155063005|NCT00042289|559664014|FG040|Overall Study|Site closed|0|||
155300581|NCT01764464|560530977|FG001|First Intervention|Adverse Event|2|||
155300582|NCT01764464|560530976|FG000|First Intervention|did not receive study drug|0|||
155300583|NCT01764464|560530977|FG001|First Intervention|did not receive study drug|1|||
155300584|NCT01764464|560530976|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
155300585|NCT01764464|560530977|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
155300586|NCT02918071|560530980|FG000|Overall Study|Withdrawal by Subject|2|||
155300587|NCT02918071|560530980|FG000|Overall Study|Lost to Follow-up|1|||
155300588|NCT03473340|560530981|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
155300589|NCT03473340|560530982|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
155300590|NCT03473340|560530981|FG000|Overall Study|Withdrawal by Subject|1|||
155300591|NCT03473340|560530982|FG001|Overall Study|Withdrawal by Subject|0|||
155300592|NCT03473340|560530981|FG000|Overall Study|Lost to Follow-up|1|||
155300593|NCT03473340|560530982|FG001|Overall Study|Lost to Follow-up|2|||
155300594|NCT02079844|560530983|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
155300595|NCT02079844|560530984|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
155300596|NCT02079844|560530985|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
155300597|NCT02079844|560530983|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
155300598|NCT02079844|560530984|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
155300599|NCT02079844|560530985|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
155300600|NCT03394885|560530987|FG000|Overall Study|Adverse Event|4|||
155300601|NCT03394885|560530987|FG000|Overall Study|Lack of Efficacy|1|||
155300602|NCT03394885|560530987|FG000|Overall Study|Physician Decision|1|||
155300603|NCT03394885|560530987|FG000|Overall Study|Withdrawal by Subject|8|||
155300604|NCT03394885|560530987|FG000|Overall Study|Alternative Therapy|1|||
155300605|NCT00203411|560530988|FG000|Follow-up|Progressive Disease|4|||
155300606|NCT04980755|560530989|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
155300607|NCT04980755|560530989|FG000|Body Reprogramming Courses|Work commitment|2|||
155300608|NCT04980755|560530989|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
155300609|NCT04980755|560530989|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
155300610|NCT00632424|560530996|FG000|Overall Study|Disease Progression|17|||
155300611|NCT00632424|560530996|FG000|Overall Study|Study Drug Toxicity|1|||
155300612|NCT00801983|560530997|FG000|Period 1|Lost to Follow-up|2|||
155300613|NCT00801983|560530998|FG001|Period 1|Lost to Follow-up|0|||
155300614|NCT00801983|560530997|FG000|Period 1|Withdrawal by Subject|2|||
155300615|NCT00801983|560530998|FG001|Period 1|Withdrawal by Subject|8|||
155300616|NCT00801983|560530997|FG000|Period 2|Withdrawal by Subject|2|||
155159047|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
155159048|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Administrative problems|3|||
155159049|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Administrative problems|3|||
155300617|NCT00801983|560530998|FG001|Period 2|Withdrawal by Subject|1|||
155300618|NCT05985044|560533600|FG000|Overall Study|Death|6|||
155159050|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Death|5|||
155159051|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Death|8|||
155159052|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Disease progression|139|||
155159053|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Disease progression|119|||
155159054|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
155159055|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
155159056|NCT00785785|560020726|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
155159057|NCT00785785|560020727|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
155159058|NCT00785785|560020726|FG000|Optional Extension Phase|Adverse Event|4|||
155159059|NCT00785785|560020727|FG001|Optional Extension Phase|Adverse Event|5|||
155159060|NCT00785785|560020726|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
155159061|NCT00785785|560020727|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
155159062|NCT00785785|560020726|FG000|Optional Extension Phase|Lost to Follow-up|1|||
155159063|NCT00785785|560020727|FG001|Optional Extension Phase|Lost to Follow-up|0|||
155159064|NCT00785785|560020726|FG000|Optional Extension Phase|Administrative problems|2|||
155159065|NCT00785785|560020727|FG001|Optional Extension Phase|Administrative problems|0|||
155159066|NCT00785785|560020726|FG000|Optional Extension Phase|Death|1|||
155159067|NCT00785785|560020727|FG001|Optional Extension Phase|Death|5|||
155159068|NCT00785785|560020726|FG000|Optional Extension Phase|Disease progression|22|||
154957848|NCT02711852|559273959|FG000|Overall Study|Withdrawal by Subject|1|||
154957849|NCT03586726|559273965|FG000|Overall Study|Withdrawal by Subject|1|||
154957850|NCT00965185|559273966|FG000|Overall Study|Lost to Follow-up|2|||
154957851|NCT00965185|559273967|FG001|Overall Study|Lost to Follow-up|0|||
155300619|NCT05985044|560533600|FG000|Overall Study|Lost to Follow-up|4|||
155300620|NCT05985044|560533600|FG000|Overall Study|Incapacitation|3|||
155300621|NCT05985044|560533600|FG000|Overall Study|Withdrawal by Subject|2|||
155300622|NCT04714320|560533609|FG000|Overall Study|Voluntary Withdrawal|4|||
155300623|NCT04714320|560533610|FG001|Overall Study|Voluntary Withdrawal|1|||
155300624|NCT04714320|560533611|FG002|Overall Study|Voluntary Withdrawal|2|||
155159069|NCT00785785|560020727|FG001|Optional Extension Phase|Disease progression|70|||
155159070|NCT00785785|560020726|FG000|Optional Extension Phase|Protocol deviation|0|||
155159071|NCT00785785|560020727|FG001|Optional Extension Phase|Protocol deviation|2|||
155159072|NCT00785785|560020726|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
155159073|NCT00785785|560020727|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
155159074|NCT02453321|560020728|FG000|Overall Study|Weakness|1|||
155159075|NCT02453321|560020729|FG001|Overall Study|Weakness|1|||
155063006|NCT00042289|559664015|FG041|Overall Study|Site closed|0|||
155063007|NCT00042289|559664016|FG042|Overall Study|Site closed|1|||
155063008|NCT00042289|559664017|FG043|Overall Study|Site closed|0|||
155063009|NCT00042289|559664018|FG044|Overall Study|Site closed|0|||
155159076|NCT02453321|560020730|FG002|Overall Study|Weakness|2|||
155159077|NCT02453321|560020728|FG000|Overall Study|Deep Venous Thrombosis|0|||
155063010|NCT00042289|559664019|FG045|Overall Study|Site closed|0|||
155063011|NCT00042289|559664020|FG046|Overall Study|Site closed|0|||
155063012|NCT00042289|559663974|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
155063013|NCT00042289|559663975|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
155159078|NCT02453321|560020729|FG001|Overall Study|Deep Venous Thrombosis|1|||
155159079|NCT02453321|560020730|FG002|Overall Study|Deep Venous Thrombosis|0|||
155063014|NCT00042289|559663976|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
155063015|NCT00042289|559663977|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
155063016|NCT00042289|559663978|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
155063017|NCT00042289|559663979|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
155063018|NCT00042289|559663980|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
155063019|NCT00042289|559663981|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
155159080|NCT01244893|560020731|FG000|Baseline|Protocol Violation|0|||
155159081|NCT01244893|560020732|FG001|Baseline|Protocol Violation|1|||
155159082|NCT01244893|560020731|FG000|1-Week Follow Up|Lost to Follow-up|1|||
155159083|NCT01244893|560020732|FG001|1-Week Follow Up|Lost to Follow-up|0|||
155159084|NCT00357552|560020733|FG000|Screening|Did not meet eligibility criteria|84|||
155159085|NCT00357552|560020733|FG000|Weeks 0 to 24|Death|1|||
155159086|NCT00357552|560020733|FG000|Weeks 24 to 104|Death|3|||
155159087|NCT00357552|560020733|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
155159088|NCT00711191|560020738|FG000|Overall Study|Adverse Event|1|||
155159089|NCT00711191|560020739|FG001|Overall Study|Adverse Event|1|||
155159090|NCT00711191|560020740|FG002|Overall Study|Adverse Event|2|||
155159091|NCT00711191|560020738|FG000|Overall Study|Objective progression or relapse|2|||
155159092|NCT00711191|560020739|FG001|Overall Study|Objective progression or relapse|3|||
155159093|NCT00711191|560020740|FG002|Overall Study|Objective progression or relapse|7|||
155159094|NCT00711191|560020738|FG000|Overall Study|Withdrawal by Subject|0|||
155159095|NCT00711191|560020739|FG001|Overall Study|Withdrawal by Subject|1|||
155159096|NCT00711191|560020740|FG002|Overall Study|Withdrawal by Subject|3|||
155159097|NCT03926611|560020741|FG000|Overall Study|Adverse Event|0|||
155159098|NCT03926611|560020742|FG001|Overall Study|Adverse Event|0|||
155159099|NCT03926611|560020743|FG002|Overall Study|Adverse Event|0|||
155159100|NCT03926611|560020744|FG003|Overall Study|Adverse Event|3|||
155159101|NCT03926611|560020745|FG004|Overall Study|Adverse Event|1|||
155159102|NCT03926611|560020746|FG005|Overall Study|Adverse Event|3|||
155159103|NCT03926611|560020747|FG006|Overall Study|Adverse Event|0|||
155159104|NCT03926611|560020741|FG000|Overall Study|Lack of Efficacy|1|||
155159105|NCT03926611|560020742|FG001|Overall Study|Lack of Efficacy|2|||
155159106|NCT03926611|560020743|FG002|Overall Study|Lack of Efficacy|0|||
155159107|NCT03926611|560020744|FG003|Overall Study|Lack of Efficacy|0|||
155159108|NCT03926611|560020745|FG004|Overall Study|Lack of Efficacy|1|||
155159109|NCT03926611|560020746|FG005|Overall Study|Lack of Efficacy|0|||
155159110|NCT03926611|560020747|FG006|Overall Study|Lack of Efficacy|1|||
155159111|NCT03926611|560020741|FG000|Overall Study|Physician Decision|0|||
155159112|NCT03926611|560020742|FG001|Overall Study|Physician Decision|0|||
155159113|NCT03926611|560020743|FG002|Overall Study|Physician Decision|0|||
155159114|NCT03926611|560020744|FG003|Overall Study|Physician Decision|0|||
155159115|NCT03926611|560020745|FG004|Overall Study|Physician Decision|0|||
155063020|NCT00042289|559663982|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
155063021|NCT00042289|559663983|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
155063022|NCT00042289|559663984|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
155063023|NCT00042289|559663985|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
155063024|NCT00042289|559663986|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
155063025|NCT00042289|559663987|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
155063026|NCT00042289|559663988|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
155159116|NCT03926611|560020746|FG005|Overall Study|Physician Decision|1|||
155159117|NCT03926611|560020747|FG006|Overall Study|Physician Decision|0|||
155159118|NCT03926611|560020741|FG000|Overall Study|Protocol Violation|1|||
155159119|NCT03926611|560020742|FG001|Overall Study|Protocol Violation|0|||
155159120|NCT03926611|560020743|FG002|Overall Study|Protocol Violation|0|||
155159121|NCT03926611|560020744|FG003|Overall Study|Protocol Violation|1|||
155159122|NCT03926611|560020745|FG004|Overall Study|Protocol Violation|1|||
155159123|NCT03926611|560020746|FG005|Overall Study|Protocol Violation|1|||
155159124|NCT03926611|560020747|FG006|Overall Study|Protocol Violation|1|||
155159125|NCT03926611|560020741|FG000|Overall Study|Technical problems|0|||
155159126|NCT03926611|560020742|FG001|Overall Study|Technical problems|0|||
155159127|NCT03926611|560020743|FG002|Overall Study|Technical problems|0|||
155300625|NCT04714320|560533609|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
155300626|NCT04714320|560533610|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
155300627|NCT04714320|560533611|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
155300628|NCT04714320|560533609|FG000|Overall Study|Reason Not Specified|1|||
155300629|NCT04714320|560533610|FG001|Overall Study|Reason Not Specified|3|||
155300630|NCT04714320|560533611|FG002|Overall Study|Reason Not Specified|3|||
155300631|NCT04425629|560533613|FG000|Overall Study|Adverse Event|0|||
155300632|NCT04425629|560533614|FG001|Overall Study|Adverse Event|0|||
155300633|NCT04425629|560533615|FG002|Overall Study|Adverse Event|0|||
155300634|NCT04425629|560533616|FG003|Overall Study|Adverse Event|0|||
155300635|NCT04425629|560533617|FG004|Overall Study|Adverse Event|1|||
155300636|NCT04425629|560533618|FG005|Overall Study|Adverse Event|0|||
155300637|NCT04425629|560533619|FG006|Overall Study|Adverse Event|0|||
155300638|NCT04425629|560533620|FG007|Overall Study|Adverse Event|0|||
155300639|NCT04425629|560533621|FG008|Overall Study|Adverse Event|0|||
155300640|NCT04425629|560533622|FG009|Overall Study|Adverse Event|3|||
155300641|NCT04425629|560533623|FG010|Overall Study|Adverse Event|2|||
155300642|NCT04425629|560533624|FG011|Overall Study|Adverse Event|1|||
155300643|NCT04425629|560533625|FG012|Overall Study|Adverse Event|1|||
155300644|NCT04425629|560533626|FG013|Overall Study|Adverse Event|0|||
155300645|NCT04425629|560533627|FG014|Overall Study|Adverse Event|0|||
155300646|NCT04425629|560533628|FG015|Overall Study|Adverse Event|0|||
155300647|NCT04425629|560533629|FG016|Overall Study|Adverse Event|0|||
155300648|NCT04425629|560533630|FG017|Overall Study|Adverse Event|0|||
155300649|NCT04425629|560533631|FG018|Overall Study|Adverse Event|0|||
155300650|NCT04425629|560533613|FG000|Overall Study|Lost to Follow-up|1|||
155300651|NCT04425629|560533614|FG001|Overall Study|Lost to Follow-up|3|||
155300652|NCT04425629|560533615|FG002|Overall Study|Lost to Follow-up|1|||
155300653|NCT04425629|560533616|FG003|Overall Study|Lost to Follow-up|7|||
155300654|NCT04425629|560533617|FG004|Overall Study|Lost to Follow-up|1|||
155300655|NCT04425629|560533618|FG005|Overall Study|Lost to Follow-up|2|||
155300656|NCT04425629|560533619|FG006|Overall Study|Lost to Follow-up|1|||
155300657|NCT04425629|560533620|FG007|Overall Study|Lost to Follow-up|0|||
155300658|NCT04425629|560533621|FG008|Overall Study|Lost to Follow-up|1|||
155300659|NCT04425629|560533622|FG009|Overall Study|Lost to Follow-up|64|||
155300660|NCT04425629|560533623|FG010|Overall Study|Lost to Follow-up|70|||
155300661|NCT04425629|560533624|FG011|Overall Study|Lost to Follow-up|98|||
155300662|NCT04425629|560533625|FG012|Overall Study|Lost to Follow-up|30|||
155300663|NCT04425629|560533626|FG013|Overall Study|Lost to Follow-up|0|||
155300664|NCT04425629|560533627|FG014|Overall Study|Lost to Follow-up|5|||
155300665|NCT04425629|560533628|FG015|Overall Study|Lost to Follow-up|4|||
155300666|NCT04425629|560533629|FG016|Overall Study|Lost to Follow-up|0|||
155300667|NCT04425629|560533630|FG017|Overall Study|Lost to Follow-up|3|||
155300668|NCT04425629|560533631|FG018|Overall Study|Lost to Follow-up|1|||
155300669|NCT04425629|560533613|FG000|Overall Study|Subject Decision|0|||
155300670|NCT04425629|560533614|FG001|Overall Study|Subject Decision|2|||
155300671|NCT04425629|560533615|FG002|Overall Study|Subject Decision|1|||
155300672|NCT04425629|560533616|FG003|Overall Study|Subject Decision|3|||
155300673|NCT04425629|560533617|FG004|Overall Study|Subject Decision|6|||
155300674|NCT04425629|560533618|FG005|Overall Study|Subject Decision|6|||
155300675|NCT04425629|560533619|FG006|Overall Study|Subject Decision|3|||
155300676|NCT04425629|560533620|FG007|Overall Study|Subject Decision|3|||
155300677|NCT04425629|560533621|FG008|Overall Study|Subject Decision|1|||
155300678|NCT04425629|560533622|FG009|Overall Study|Subject Decision|70|||
155300679|NCT04425629|560533623|FG010|Overall Study|Subject Decision|95|||
155159128|NCT03926611|560020744|FG003|Overall Study|Technical problems|0|||
155159129|NCT03926611|560020745|FG004|Overall Study|Technical problems|0|||
155159130|NCT03926611|560020746|FG005|Overall Study|Technical problems|1|||
155159131|NCT03926611|560020747|FG006|Overall Study|Technical problems|0|||
155159132|NCT03926611|560020741|FG000|Overall Study|Withdrawal by Subject|1|||
155159133|NCT03926611|560020742|FG001|Overall Study|Withdrawal by Subject|1|||
155159134|NCT03926611|560020743|FG002|Overall Study|Withdrawal by Subject|1|||
155159135|NCT03926611|560020744|FG003|Overall Study|Withdrawal by Subject|0|||
155159136|NCT03926611|560020745|FG004|Overall Study|Withdrawal by Subject|0|||
155159137|NCT03926611|560020746|FG005|Overall Study|Withdrawal by Subject|1|||
155300680|NCT04425629|560533624|FG011|Overall Study|Subject Decision|124|||
155300681|NCT04425629|560533625|FG012|Overall Study|Subject Decision|25|||
155300682|NCT04425629|560533626|FG013|Overall Study|Subject Decision|0|||
155300683|NCT04425629|560533627|FG014|Overall Study|Subject Decision|1|||
155300684|NCT04425629|560533628|FG015|Overall Study|Subject Decision|4|||
155300685|NCT04425629|560533629|FG016|Overall Study|Subject Decision|1|||
155300686|NCT04425629|560533630|FG017|Overall Study|Subject Decision|0|||
155300687|NCT04425629|560533631|FG018|Overall Study|Subject Decision|2|||
155300688|NCT04425629|560533613|FG000|Overall Study|Death|0|||
155300689|NCT04425629|560533614|FG001|Overall Study|Death|0|||
155300690|NCT04425629|560533615|FG002|Overall Study|Death|0|||
155300691|NCT04425629|560533616|FG003|Overall Study|Death|0|||
155300692|NCT04425629|560533617|FG004|Overall Study|Death|0|||
155300693|NCT04425629|560533618|FG005|Overall Study|Death|0|||
155300694|NCT04425629|560533619|FG006|Overall Study|Death|0|||
155159138|NCT03926611|560020747|FG006|Overall Study|Withdrawal by Subject|3|||
155159139|NCT03926611|560020741|FG000|Overall Study|Covid-19 pandemic|0|||
155159140|NCT03926611|560020742|FG001|Overall Study|Covid-19 pandemic|0|||
155159141|NCT03926611|560020743|FG002|Overall Study|Covid-19 pandemic|1|||
155159142|NCT03926611|560020744|FG003|Overall Study|Covid-19 pandemic|0|||
155159143|NCT03926611|560020745|FG004|Overall Study|Covid-19 pandemic|1|||
155159144|NCT03926611|560020746|FG005|Overall Study|Covid-19 pandemic|2|||
155159145|NCT03926611|560020747|FG006|Overall Study|Covid-19 pandemic|0|||
155159146|NCT00084136|560020748|FG000|PI Comparison|Death|10|||
155159147|NCT00084136|560020749|FG001|PI Comparison|Death|9|||
155159148|NCT00084136|560020750|FG002|PI Comparison|Death|0|||
155159149|NCT00084136|560020748|FG000|PI Comparison|Lost to Follow-up|11|||
155159150|NCT00084136|560020749|FG001|PI Comparison|Lost to Follow-up|8|||
155159151|NCT00084136|560020750|FG002|PI Comparison|Lost to Follow-up|0|||
155159152|NCT00084136|560020748|FG000|PI Comparison|Withdrawal by Subject|33|||
155159153|NCT00084136|560020749|FG001|PI Comparison|Withdrawal by Subject|30|||
155159154|NCT00084136|560020750|FG002|PI Comparison|Withdrawal by Subject|0|||
155159155|NCT00084136|560020748|FG000|PI Comparison|Clinic site closed|1|||
155159156|NCT00084136|560020749|FG001|PI Comparison|Clinic site closed|0|||
155159157|NCT00084136|560020750|FG002|PI Comparison|Clinic site closed|0|||
155159158|NCT00084136|560020748|FG000|NRTI Comparison|Death|20|||
155159159|NCT00084136|560020749|FG001|NRTI Comparison|Death|0|||
155159160|NCT00084136|560020750|FG002|NRTI Comparison|Death|18|||
155159161|NCT00084136|560020748|FG000|NRTI Comparison|Lost to Follow-up|14|||
155159162|NCT00084136|560020749|FG001|NRTI Comparison|Lost to Follow-up|0|||
155159163|NCT00084136|560020750|FG002|NRTI Comparison|Lost to Follow-up|12|||
155159164|NCT00084136|560020748|FG000|NRTI Comparison|Withdrawal by Subject|54|||
155159165|NCT00084136|560020749|FG001|NRTI Comparison|Withdrawal by Subject|0|||
155159166|NCT00084136|560020750|FG002|NRTI Comparison|Withdrawal by Subject|38|||
155159167|NCT00084136|560020748|FG000|NRTI Comparison|Clinic site closed|12|||
155159168|NCT00084136|560020749|FG001|NRTI Comparison|Clinic site closed|0|||
155159169|NCT00084136|560020750|FG002|NRTI Comparison|Clinic site closed|14|||
155159170|NCT00084136|560020748|FG000|NRTI Comparison|Not reason above|1|||
155159171|NCT00084136|560020749|FG001|NRTI Comparison|Not reason above|0|||
155159172|NCT00084136|560020750|FG002|NRTI Comparison|Not reason above|0|||
155159173|NCT02612779|560020754|FG000|Overall Study|Administrative reason by sponsor|4|||
155159174|NCT02612779|560020755|FG001|Overall Study|Administrative reason by sponsor|1|||
155159175|NCT02612779|560020754|FG000|Overall Study|No longer meet study criteria|0|||
155159176|NCT02612779|560020755|FG001|Overall Study|No longer meet study criteria|1|||
155159177|NCT02612779|560020754|FG000|Overall Study|Disease progression|29|||
155159178|NCT02612779|560020755|FG001|Overall Study|Disease progression|2|||
155159179|NCT02612779|560020754|FG000|Overall Study|Study drug toxicity|10|||
155159180|NCT02612779|560020755|FG001|Overall Study|Study drug toxicity|1|||
155159181|NCT02612779|560020754|FG000|Overall Study|Death|1|||
155159182|NCT02612779|560020755|FG001|Overall Study|Death|0|||
155159183|NCT02612779|560020754|FG000|Overall Study|Adverse event unrelated to study drug|5|||
155159184|NCT02612779|560020755|FG001|Overall Study|Adverse event unrelated to study drug|0|||
155159185|NCT02612779|560020754|FG000|Overall Study|Participant withdrew consent|4|||
155159186|NCT02612779|560020755|FG001|Overall Study|Participant withdrew consent|0|||
155159187|NCT02612779|560020754|FG000|Overall Study|Lost to Follow-up|1|||
155159188|NCT02612779|560020755|FG001|Overall Study|Lost to Follow-up|0|||
155159189|NCT02612779|560020754|FG000|Overall Study|Maximum clinical benefit|10|||
155159190|NCT02612779|560020755|FG001|Overall Study|Maximum clinical benefit|1|||
155159191|NCT02612779|560020754|FG000|Overall Study|Other reasons|4|||
155159192|NCT02612779|560020755|FG001|Overall Study|Other reasons|0|||
155159193|NCT02633306|560020758|FG000|Overall Study|Withdrawal by Subject|3|||
155159194|NCT01744977|560020759|FG000|Overall Study|Withdrawal by Subject|1|||
155159195|NCT01744977|560020760|FG001|Overall Study|Withdrawal by Subject|2|||
155159196|NCT01744977|560020759|FG000|Overall Study|Death|2|||
155159197|NCT01744977|560020760|FG001|Overall Study|Death|3|||
155159198|NCT01744977|560020759|FG000|Overall Study|Lost to Follow-up|2|||
155159199|NCT01744977|560020760|FG001|Overall Study|Lost to Follow-up|0|||
155159200|NCT01744977|560020759|FG000|Overall Study|No longer meets inclusion|6|||
155159201|NCT01744977|560020760|FG001|Overall Study|No longer meets inclusion|0|||
155159202|NCT03774576|560020761|FG000|Period 2|Adverse Event|1|||
155159203|NCT03041038|560020762|FG000|Overall Study|Withdrawal by Subject|4|||
155159204|NCT03041038|560020763|FG001|Overall Study|Withdrawal by Subject|0|||
155159205|NCT03041038|560020762|FG000|Overall Study|Lost to Follow-up|1|||
155159206|NCT03041038|560020763|FG001|Overall Study|Lost to Follow-up|1|||
155159207|NCT03041038|560020762|FG000|Overall Study|Protocol Violation|1|||
155159208|NCT03041038|560020763|FG001|Overall Study|Protocol Violation|1|||
155159209|NCT04798196|560020767|FG000|Overall Study|Lost to Follow-up|3|||
155159210|NCT04798196|560020768|FG001|Overall Study|Lost to Follow-up|1|||
155159211|NCT04798196|560020769|FG002|Overall Study|Lost to Follow-up|3|||
155159212|NCT04119414|560020778|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
155159213|NCT01929317|560020784|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
155159214|NCT01929317|560020785|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
155159215|NCT01929317|560020784|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
155300695|NCT04425629|560533620|FG007|Overall Study|Death|0|||
155300696|NCT04425629|560533621|FG008|Overall Study|Death|0|||
155300697|NCT04425629|560533622|FG009|Overall Study|Death|11|||
155300698|NCT04425629|560533623|FG010|Overall Study|Death|2|||
155300699|NCT04425629|560533624|FG011|Overall Study|Death|4|||
155300700|NCT04425629|560533625|FG012|Overall Study|Death|0|||
155300701|NCT04425629|560533626|FG013|Overall Study|Death|0|||
155300702|NCT04425629|560533627|FG014|Overall Study|Death|0|||
155300703|NCT04425629|560533628|FG015|Overall Study|Death|0|||
155300704|NCT04425629|560533629|FG016|Overall Study|Death|0|||
155300705|NCT04425629|560533630|FG017|Overall Study|Death|0|||
155300706|NCT04425629|560533631|FG018|Overall Study|Death|0|||
155300707|NCT04425629|560533613|FG000|Overall Study|Sponsor Request|0|||
155300708|NCT04425629|560533614|FG001|Overall Study|Sponsor Request|0|||
155300709|NCT04425629|560533615|FG002|Overall Study|Sponsor Request|0|||
155300710|NCT04425629|560533616|FG003|Overall Study|Sponsor Request|2|||
155300711|NCT04425629|560533617|FG004|Overall Study|Sponsor Request|2|||
155300712|NCT04425629|560533618|FG005|Overall Study|Sponsor Request|2|||
155300713|NCT04425629|560533619|FG006|Overall Study|Sponsor Request|1|||
155300714|NCT04425629|560533620|FG007|Overall Study|Sponsor Request|0|||
155300715|NCT04425629|560533621|FG008|Overall Study|Sponsor Request|0|||
155300716|NCT04425629|560533622|FG009|Overall Study|Sponsor Request|9|||
155300717|NCT04425629|560533623|FG010|Overall Study|Sponsor Request|9|||
155300718|NCT04425629|560533624|FG011|Overall Study|Sponsor Request|10|||
155300719|NCT04425629|560533625|FG012|Overall Study|Sponsor Request|8|||
155300720|NCT04425629|560533626|FG013|Overall Study|Sponsor Request|0|||
155300721|NCT04425629|560533627|FG014|Overall Study|Sponsor Request|0|||
155300722|NCT04425629|560533628|FG015|Overall Study|Sponsor Request|1|||
155300723|NCT04425629|560533629|FG016|Overall Study|Sponsor Request|0|||
155300724|NCT04425629|560533630|FG017|Overall Study|Sponsor Request|0|||
155300725|NCT04425629|560533631|FG018|Overall Study|Sponsor Request|0|||
155300726|NCT04425629|560533613|FG000|Overall Study|Physician Decision|0|||
155300727|NCT04425629|560533614|FG001|Overall Study|Physician Decision|0|||
155300728|NCT04425629|560533615|FG002|Overall Study|Physician Decision|0|||
155300729|NCT04425629|560533616|FG003|Overall Study|Physician Decision|0|||
155300730|NCT04425629|560533617|FG004|Overall Study|Physician Decision|0|||
155300731|NCT04425629|560533618|FG005|Overall Study|Physician Decision|0|||
155300732|NCT04425629|560533619|FG006|Overall Study|Physician Decision|0|||
155300733|NCT04425629|560533620|FG007|Overall Study|Physician Decision|0|||
155300734|NCT04425629|560533621|FG008|Overall Study|Physician Decision|0|||
155300735|NCT04425629|560533622|FG009|Overall Study|Physician Decision|4|||
155300736|NCT04425629|560533623|FG010|Overall Study|Physician Decision|3|||
155300737|NCT04425629|560533624|FG011|Overall Study|Physician Decision|5|||
155300738|NCT04425629|560533625|FG012|Overall Study|Physician Decision|1|||
155300739|NCT04425629|560533626|FG013|Overall Study|Physician Decision|0|||
155300740|NCT04425629|560533627|FG014|Overall Study|Physician Decision|0|||
155300741|NCT04425629|560533628|FG015|Overall Study|Physician Decision|1|||
155159216|NCT01929317|560020785|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
155159217|NCT01929317|560020784|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
155159218|NCT01929317|560020785|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
155159219|NCT01929317|560020784|FG000|Long-term Phase|Adverse Event|5|||
155159220|NCT01929317|560020785|FG001|Long-term Phase|Adverse Event|1|||
155159221|NCT01929317|560020784|FG000|Long-term Phase|Physician Decision|3|||
155159222|NCT01929317|560020785|FG001|Long-term Phase|Physician Decision|0|||
155159223|NCT01929317|560020784|FG000|Long-term Phase|Withdrawal by Subject|4|||
155159224|NCT01929317|560020785|FG001|Long-term Phase|Withdrawal by Subject|0|||
155159225|NCT01929317|560020784|FG000|Long-term Phase|Protocol Violation|1|||
155159226|NCT01929317|560020785|FG001|Long-term Phase|Protocol Violation|0|||
155159227|NCT01929317|560020784|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
155300742|NCT04425629|560533629|FG016|Overall Study|Physician Decision|0|||
155300743|NCT04425629|560533630|FG017|Overall Study|Physician Decision|0|||
155300744|NCT04425629|560533631|FG018|Overall Study|Physician Decision|0|||
155300745|NCT04425629|560533613|FG000|Overall Study|Lack of Efficacy|0|||
155300746|NCT04425629|560533614|FG001|Overall Study|Lack of Efficacy|0|||
155300747|NCT04425629|560533615|FG002|Overall Study|Lack of Efficacy|0|||
155300748|NCT04425629|560533616|FG003|Overall Study|Lack of Efficacy|0|||
155300749|NCT04425629|560533617|FG004|Overall Study|Lack of Efficacy|0|||
155300750|NCT04425629|560533618|FG005|Overall Study|Lack of Efficacy|0|||
155300751|NCT04425629|560533619|FG006|Overall Study|Lack of Efficacy|0|||
155300752|NCT04425629|560533620|FG007|Overall Study|Lack of Efficacy|0|||
155300753|NCT04425629|560533621|FG008|Overall Study|Lack of Efficacy|0|||
155300754|NCT04425629|560533622|FG009|Overall Study|Lack of Efficacy|0|||
155300755|NCT04425629|560533623|FG010|Overall Study|Lack of Efficacy|1|||
155300756|NCT04425629|560533624|FG011|Overall Study|Lack of Efficacy|0|||
155300757|NCT04425629|560533625|FG012|Overall Study|Lack of Efficacy|0|||
155300758|NCT04425629|560533626|FG013|Overall Study|Lack of Efficacy|0|||
155300759|NCT04425629|560533627|FG014|Overall Study|Lack of Efficacy|0|||
155300760|NCT04425629|560533628|FG015|Overall Study|Lack of Efficacy|0|||
155300761|NCT04425629|560533629|FG016|Overall Study|Lack of Efficacy|0|||
155300762|NCT04425629|560533630|FG017|Overall Study|Lack of Efficacy|0|||
155159228|NCT01929317|560020785|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
155300763|NCT04425629|560533631|FG018|Overall Study|Lack of Efficacy|0|||
155300764|NCT04259450|560533633|FG000|Overall Study|Adverse event/ Toxicity|0|||
155300765|NCT04259450|560533634|FG001|Overall Study|Adverse event/ Toxicity|3|||
155300766|NCT04259450|560533635|FG002|Overall Study|Adverse event/ Toxicity|0|||
155300767|NCT04259450|560533636|FG003|Overall Study|Adverse event/ Toxicity|1|||
155300768|NCT04259450|560533637|FG004|Overall Study|Adverse event/ Toxicity|0|||
155300769|NCT04259450|560533638|FG005|Overall Study|Adverse event/ Toxicity|0|||
155300770|NCT04259450|560533639|FG006|Overall Study|Adverse event/ Toxicity|0|||
155300771|NCT04259450|560533640|FG007|Overall Study|Adverse event/ Toxicity|1|||
155300772|NCT04259450|560533641|FG008|Overall Study|Adverse event/ Toxicity|0|||
155300773|NCT04259450|560533642|FG009|Overall Study|Adverse event/ Toxicity|3|||
155300774|NCT04259450|560533633|FG000|Overall Study|Disease progression|2|||
155300775|NCT04259450|560533634|FG001|Overall Study|Disease progression|3|||
155300776|NCT04259450|560533635|FG002|Overall Study|Disease progression|4|||
155300777|NCT04259450|560533636|FG003|Overall Study|Disease progression|4|||
155300778|NCT04259450|560533637|FG004|Overall Study|Disease progression|6|||
155300779|NCT04259450|560533638|FG005|Overall Study|Disease progression|6|||
155300780|NCT04259450|560533639|FG006|Overall Study|Disease progression|6|||
155300781|NCT04259450|560533640|FG007|Overall Study|Disease progression|15|||
155300782|NCT04259450|560533641|FG008|Overall Study|Disease progression|6|||
155300783|NCT04259450|560533642|FG009|Overall Study|Disease progression|18|||
155300784|NCT04259450|560533633|FG000|Overall Study|Death|0|||
155300785|NCT04259450|560533634|FG001|Overall Study|Death|0|||
155300786|NCT04259450|560533635|FG002|Overall Study|Death|0|||
155300787|NCT04259450|560533636|FG003|Overall Study|Death|0|||
155300788|NCT04259450|560533637|FG004|Overall Study|Death|0|||
155300789|NCT04259450|560533638|FG005|Overall Study|Death|0|||
155300790|NCT04259450|560533639|FG006|Overall Study|Death|0|||
155300791|NCT04259450|560533640|FG007|Overall Study|Death|1|||
155300792|NCT04259450|560533641|FG008|Overall Study|Death|1|||
155159229|NCT01929317|560020784|FG000|Long-term Phase|Study Closed/Terminated|5|||
155159230|NCT01929317|560020785|FG001|Long-term Phase|Study Closed/Terminated|3|||
155159231|NCT02514083|560020786|FG000|Overall Study|Adverse Event|1|||
155159232|NCT01899040|560020787|FG000|Overall Study|Randomized in error|0|||
155159233|NCT01899040|560020788|FG001|Overall Study|Randomized in error|1|||
155159234|NCT01899040|560020789|FG002|Overall Study|Randomized in error|1|||
155159235|NCT01899040|560020787|FG000|Overall Study|Adverse Event|3|||
155159236|NCT01899040|560020788|FG001|Overall Study|Adverse Event|1|||
155159237|NCT01899040|560020789|FG002|Overall Study|Adverse Event|2|||
155159238|NCT01899040|560020787|FG000|Overall Study|Unspecified reasons|4|||
155159239|NCT01899040|560020788|FG001|Overall Study|Unspecified reasons|4|||
155159240|NCT01899040|560020789|FG002|Overall Study|Unspecified reasons|0|||
155159241|NCT01899040|560020787|FG000|Overall Study|Compliance issues|1|||
155159242|NCT01899040|560020788|FG001|Overall Study|Compliance issues|2|||
155159243|NCT01899040|560020789|FG002|Overall Study|Compliance issues|0|||
155159244|NCT04586205|560020797|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
155159245|NCT04586205|560020798|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
155159246|NCT04040933|560022717|FG000|Overall Study|Protocol Violation|1|||
155159247|NCT04040933|560022717|FG000|Overall Study|Withdrawal by Subject|2|||
155159248|NCT02066181|560022718|FG000|Overall Study|Withdrawal by Subject|1|||
155159249|NCT02066181|560022719|FG001|Overall Study|Withdrawal by Subject|1|||
155159250|NCT00775190|560022720|FG000|Overall Study|Lost to Follow-up|2|||
155159251|NCT00775190|560022721|FG001|Overall Study|Lost to Follow-up|3|||
155159252|NCT00775190|560022720|FG000|Overall Study|Withdrawal by Subject|1|||
155159253|NCT00775190|560022721|FG001|Overall Study|Withdrawal by Subject|2|||
155159254|NCT00775190|560022720|FG000|Overall Study|Protocol Violation|1|||
155159255|NCT00775190|560022721|FG001|Overall Study|Protocol Violation|0|||
155300793|NCT04259450|560533642|FG009|Overall Study|Death|0|||
155159256|NCT02141295|560022722|FG000|Overall Study|Adverse Event|1|||
155159257|NCT02141295|560022723|FG001|Overall Study|Adverse Event|18|||
155159258|NCT02141295|560022724|FG002|Overall Study|Adverse Event|11|||
155159259|NCT02141295|560022722|FG000|Overall Study|Physician Decision|2|||
155159260|NCT02141295|560022723|FG001|Overall Study|Physician Decision|19|||
155159261|NCT02141295|560022724|FG002|Overall Study|Physician Decision|14|||
155159262|NCT02141295|560022722|FG000|Overall Study|Study terminated by sponsor|0|||
155159263|NCT02141295|560022723|FG001|Overall Study|Study terminated by sponsor|6|||
155159264|NCT02141295|560022724|FG002|Overall Study|Study terminated by sponsor|6|||
155300794|NCT04259450|560533633|FG000|Overall Study|Withdrawal by Subject|0|||
155300795|NCT04259450|560533634|FG001|Overall Study|Withdrawal by Subject|0|||
155300796|NCT04259450|560533635|FG002|Overall Study|Withdrawal by Subject|0|||
155300797|NCT04259450|560533636|FG003|Overall Study|Withdrawal by Subject|0|||
155300798|NCT04259450|560533637|FG004|Overall Study|Withdrawal by Subject|0|||
155159265|NCT02141295|560022722|FG000|Overall Study|Non-compliance|0|||
155300799|NCT04259450|560533638|FG005|Overall Study|Withdrawal by Subject|0|||
155300800|NCT04259450|560533639|FG006|Overall Study|Withdrawal by Subject|0|||
155300801|NCT04259450|560533640|FG007|Overall Study|Withdrawal by Subject|1|||
155300802|NCT04259450|560533641|FG008|Overall Study|Withdrawal by Subject|0|||
155300803|NCT04259450|560533642|FG009|Overall Study|Withdrawal by Subject|0|||
155300804|NCT04259450|560533633|FG000|Overall Study|Other than listed|0|||
155300805|NCT04259450|560533634|FG001|Overall Study|Other than listed|0|||
155300806|NCT04259450|560533635|FG002|Overall Study|Other than listed|0|||
155300807|NCT04259450|560533636|FG003|Overall Study|Other than listed|0|||
155300808|NCT04259450|560533637|FG004|Overall Study|Other than listed|0|||
155300809|NCT04259450|560533638|FG005|Overall Study|Other than listed|0|||
155300810|NCT04259450|560533639|FG006|Overall Study|Other than listed|0|||
155300811|NCT04259450|560533640|FG007|Overall Study|Other than listed|1|||
155300812|NCT04259450|560533641|FG008|Overall Study|Other than listed|1|||
155300813|NCT04259450|560533642|FG009|Overall Study|Other than listed|2|||
155300814|NCT00542789|560533649|FG000|Overall Study|Adverse Event|18|||
155300815|NCT00542789|560533650|FG001|Overall Study|Adverse Event|17|||
155300816|NCT00542789|560533649|FG000|Overall Study|Withdrawal by Subject|7|||
155300817|NCT00542789|560533650|FG001|Overall Study|Withdrawal by Subject|3|||
155300818|NCT00542789|560533649|FG000|Overall Study|Protocol Violation|8|||
155300819|NCT00542789|560533650|FG001|Overall Study|Protocol Violation|1|||
155300820|NCT00542789|560533649|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
155300821|NCT00542789|560533650|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
155300822|NCT02584829|560533652|FG000|Overall Study|Physician Decision|1|||
155300823|NCT02584829|560533653|FG001|Overall Study|Physician Decision|0|||
155300824|NCT02584829|560533652|FG000|Overall Study|Withdrawal by Subject|0|||
155300825|NCT02584829|560533653|FG001|Overall Study|Withdrawal by Subject|1|||
155300826|NCT02584829|560533652|FG000|Overall Study|Progressive Disease|0|||
155300827|NCT02584829|560533653|FG001|Overall Study|Progressive Disease|3|||
155300828|NCT00434304|560533655|FG000|Overall Study|Adverse Event|14|||
155300829|NCT00434304|560533655|FG000|Overall Study|Lack of Efficacy|2|||
155300830|NCT00434304|560533655|FG000|Overall Study|Withdrawal by Subject|4|||
155300831|NCT05262738|560533656|FG000|Overall Study|Withdrawal by Subject|1|||
155300832|NCT05262738|560533657|FG001|Overall Study|Withdrawal by Subject|0|||
155300833|NCT00446459|560533670|FG000|8 Months|Protocol Violation|12|||
155159266|NCT02141295|560022723|FG001|Overall Study|Non-compliance|1|||
155159267|NCT02141295|560022724|FG002|Overall Study|Non-compliance|0|||
155159268|NCT02141295|560022722|FG000|Overall Study|Progressive disease|3|||
155300834|NCT00446459|560533670|FG000|12 Months|Protocol Violation|4|||
155159269|NCT02141295|560022723|FG001|Overall Study|Progressive disease|32|||
155159270|NCT02141295|560022724|FG002|Overall Study|Progressive disease|50|||
155159271|NCT02141295|560022722|FG000|Overall Study|Reason not specified|0|||
155159272|NCT02141295|560022723|FG001|Overall Study|Reason not specified|9|||
155159273|NCT02141295|560022724|FG002|Overall Study|Reason not specified|10|||
155159274|NCT02141295|560022722|FG000|Overall Study|Withdrawal by Subject|0|||
155159275|NCT02141295|560022723|FG001|Overall Study|Withdrawal by Subject|9|||
155159276|NCT02141295|560022724|FG002|Overall Study|Withdrawal by Subject|4|||
155159277|NCT01710501|560022725|FG000|Overall Study|Lost to Follow-up|2|||
155159278|NCT01710501|560022726|FG001|Overall Study|Lost to Follow-up|0|||
155159279|NCT01710501|560022727|FG002|Overall Study|Lost to Follow-up|0|||
155063027|NCT00042289|559663989|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
155063028|NCT00042289|559663990|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
155063029|NCT00042289|559663991|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
155063030|NCT00042289|559663992|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
155063031|NCT00042289|559663993|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
155063032|NCT00042289|559663994|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
155063033|NCT00042289|559663995|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
155063034|NCT00042289|559663996|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
155063035|NCT00042289|559663997|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
155063036|NCT00042289|559663998|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
155063037|NCT00042289|559663999|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
155063038|NCT00042289|559664000|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
155063039|NCT00042289|559664001|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
155063040|NCT00042289|559664002|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
155063041|NCT00042289|559664003|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
155063042|NCT00042289|559664004|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
155063043|NCT00042289|559664005|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
155063044|NCT00042289|559664006|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
155063045|NCT00042289|559664007|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
155063046|NCT00042289|559664008|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
155063047|NCT00042289|559664009|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
155159280|NCT01432730|560022734|FG000|Period 1|Adverse Event|2|||
155300835|NCT00446459|560533670|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
155300836|NCT00858117|560533673|FG000|Treatment on Study|Adverse Event|2|||
155300837|NCT00858117|560533673|FG000|Follow up for 5 Years|Death|4|||
155300838|NCT00858117|560533673|FG000|Follow up for 5 Years|No further data collected for study|9|||
155300839|NCT00371787|560533674|FG000|Overall Study|Withdrawal by Subject|3|||
155300840|NCT00371787|560533675|FG001|Overall Study|Withdrawal by Subject|1|||
155300841|NCT02765100|560533677|FG000|Overall Study|subject found ineligible after baseline|1|||
155300842|NCT02765100|560533678|FG001|Overall Study|subject found ineligible after baseline|1|||
155300843|NCT02765100|560533677|FG000|Overall Study|Lost to Follow-up|0|||
155300844|NCT02765100|560533678|FG001|Overall Study|Lost to Follow-up|1|||
155300845|NCT02597920|560533684|FG000|Overall Study|Worsening of other pre-existing disease|0|||
155300846|NCT02597920|560533685|FG001|Overall Study|Worsening of other pre-existing disease|1|||
155300847|NCT02597920|560533686|FG002|Overall Study|Worsening of other pre-existing disease|0|||
155300848|NCT02597920|560533684|FG000|Overall Study|Other adverse event|20|||
155300849|NCT02597920|560533685|FG001|Overall Study|Other adverse event|30|||
155300850|NCT02597920|560533686|FG002|Overall Study|Other adverse event|0|||
155300851|NCT02597920|560533684|FG000|Overall Study|Lost to Follow-up|7|||
155300852|NCT02597920|560533685|FG001|Overall Study|Lost to Follow-up|9|||
155300853|NCT02597920|560533686|FG002|Overall Study|Lost to Follow-up|0|||
155300854|NCT02597920|560533684|FG000|Overall Study|Refuse to continue in the study|3|||
155300855|NCT02597920|560533685|FG001|Overall Study|Refuse to continue in the study|13|||
155300856|NCT02597920|560533686|FG002|Overall Study|Refuse to continue in the study|1|||
155300857|NCT02597920|560533684|FG000|Overall Study|Other than specified|10|||
155300858|NCT02597920|560533685|FG001|Overall Study|Other than specified|31|||
155300859|NCT02597920|560533686|FG002|Overall Study|Other than specified|5|||
155300860|NCT02597920|560533684|FG000|Overall Study|Other|1|||
155300861|NCT02597920|560533685|FG001|Overall Study|Other|0|||
155300862|NCT02597920|560533686|FG002|Overall Study|Other|0|||
155300863|NCT02675244|560533689|FG000|Overall Study|Death|9|||
155300864|NCT02675244|560533690|FG001|Overall Study|Death|6|||
155300865|NCT02675244|560533689|FG000|Overall Study|Withdrawal by Subject|3|||
155300866|NCT02675244|560533690|FG001|Overall Study|Withdrawal by Subject|6|||
155300867|NCT02675244|560533689|FG000|Overall Study|Lost to Follow-up|1|||
155300868|NCT02675244|560533690|FG001|Overall Study|Lost to Follow-up|1|||
155300869|NCT02675244|560533689|FG000|Overall Study|Ongoing at 2 Years|190|||
155300870|NCT02675244|560533690|FG001|Overall Study|Ongoing at 2 Years|185|||
155300871|NCT00391898|560533696|FG000|Overall Study|Adverse Event|3|||
155300872|NCT00391898|560533697|FG001|Overall Study|Adverse Event|0|||
155300873|NCT00391898|560533696|FG000|Overall Study|Other|8|||
155300874|NCT00391898|560533697|FG001|Overall Study|Other|10|||
155300875|NCT02529995|560533702|FG000|Part A|Ongoing Study at Data Cut-off|14|||
155300876|NCT02529995|560533703|FG001|Part A|Ongoing Study at Data Cut-off|16|||
155300877|NCT02529995|560533702|FG000|Part A|Discontinued Study|1|||
155300878|NCT02529995|560533703|FG001|Part A|Discontinued Study|0|||
155300879|NCT02529995|560533702|FG000|Part B|Ongoing Study at Data Cut-off|0|||
155300880|NCT02529995|560533703|FG001|Part B|Ongoing Study at Data Cut-off|7|||
155300881|NCT02529995|560533702|FG000|Part B|Discontinued Study|6|||
155300882|NCT02529995|560533703|FG001|Part B|Discontinued Study|5|||
155300883|NCT02988817|560533704|FG000|Overall Study|Withdrawal by Subject|1|||
155300884|NCT02988817|560533705|FG001|Overall Study|Withdrawal by Subject|0|||
155300885|NCT02988817|560533706|FG002|Overall Study|Withdrawal by Subject|0|||
155300886|NCT02988817|560533707|FG003|Overall Study|Withdrawal by Subject|1|||
155300887|NCT02988817|560533708|FG004|Overall Study|Withdrawal by Subject|3|||
155300888|NCT02988817|560533709|FG005|Overall Study|Withdrawal by Subject|1|||
155300889|NCT02988817|560533710|FG006|Overall Study|Withdrawal by Subject|2|||
155300890|NCT02988817|560533711|FG007|Overall Study|Withdrawal by Subject|1|||
155300891|NCT02988817|560533712|FG008|Overall Study|Withdrawal by Subject|1|||
155300892|NCT02988817|560533713|FG009|Overall Study|Withdrawal by Subject|1|||
155300893|NCT02988817|560533714|FG010|Overall Study|Withdrawal by Subject|1|||
155159281|NCT01432730|560022735|FG001|Period 1|Adverse Event|0|||
155159282|NCT01432730|560022734|FG000|Period 2|Adverse Event|0|||
155159283|NCT01432730|560022735|FG001|Period 2|Adverse Event|4|||
155159284|NCT01235741|560022736|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
155159285|NCT01235741|560022737|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
155159286|NCT01235741|560022738|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
155159287|NCT01235741|560022736|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
155159288|NCT01235741|560022737|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
155300894|NCT02988817|560533715|FG011|Overall Study|Withdrawal by Subject|12|||
155159289|NCT01235741|560022738|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
155159290|NCT01235741|560022736|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
155300895|NCT02988817|560533716|FG012|Overall Study|Withdrawal by Subject|6|||
155300896|NCT02988817|560533717|FG013|Overall Study|Withdrawal by Subject|6|||
155300897|NCT02988817|560533718|FG014|Overall Study|Withdrawal by Subject|4|||
155300898|NCT02988817|560533719|FG015|Overall Study|Withdrawal by Subject|5|||
155300899|NCT02988817|560533720|FG016|Overall Study|Withdrawal by Subject|4|||
155300900|NCT02988817|560533721|FG017|Overall Study|Withdrawal by Subject|11|||
155300901|NCT02988817|560533722|FG018|Overall Study|Withdrawal by Subject|4|||
155300902|NCT02988817|560533723|FG019|Overall Study|Withdrawal by Subject|2|||
155300903|NCT02988817|560533704|FG000|Overall Study|Death|0|||
155300904|NCT02988817|560533705|FG001|Overall Study|Death|1|||
155300905|NCT02988817|560533706|FG002|Overall Study|Death|3|||
155300906|NCT02988817|560533707|FG003|Overall Study|Death|1|||
155300907|NCT02988817|560533708|FG004|Overall Study|Death|6|||
155300908|NCT02988817|560533709|FG005|Overall Study|Death|10|||
155300909|NCT02988817|560533710|FG006|Overall Study|Death|1|||
155300910|NCT02988817|560533711|FG007|Overall Study|Death|2|||
155300911|NCT02988817|560533712|FG008|Overall Study|Death|1|||
155300912|NCT02988817|560533713|FG009|Overall Study|Death|5|||
155300913|NCT02988817|560533714|FG010|Overall Study|Death|1|||
155300914|NCT02988817|560533715|FG011|Overall Study|Death|8|||
155300915|NCT02988817|560533716|FG012|Overall Study|Death|9|||
155300916|NCT02988817|560533717|FG013|Overall Study|Death|17|||
155300917|NCT02988817|560533718|FG014|Overall Study|Death|18|||
155300918|NCT02988817|560533719|FG015|Overall Study|Death|30|||
155300919|NCT02988817|560533720|FG016|Overall Study|Death|17|||
155300920|NCT02988817|560533721|FG017|Overall Study|Death|38|||
155300921|NCT02988817|560533722|FG018|Overall Study|Death|14|||
155300922|NCT02988817|560533723|FG019|Overall Study|Death|16|||
155300923|NCT02988817|560533704|FG000|Overall Study|Other|0|||
155300924|NCT02988817|560533705|FG001|Overall Study|Other|0|||
155300925|NCT02988817|560533706|FG002|Overall Study|Other|0|||
155300926|NCT02988817|560533707|FG003|Overall Study|Other|1|||
155300927|NCT02988817|560533708|FG004|Overall Study|Other|1|||
155300928|NCT02988817|560533709|FG005|Overall Study|Other|0|||
155300929|NCT02988817|560533710|FG006|Overall Study|Other|0|||
155300930|NCT02988817|560533711|FG007|Overall Study|Other|0|||
155300931|NCT02988817|560533712|FG008|Overall Study|Other|0|||
155300932|NCT02988817|560533713|FG009|Overall Study|Other|0|||
155300933|NCT02988817|560533714|FG010|Overall Study|Other|0|||
155300934|NCT02988817|560533715|FG011|Overall Study|Other|0|||
155300935|NCT02988817|560533716|FG012|Overall Study|Other|0|||
155300936|NCT02988817|560533717|FG013|Overall Study|Other|0|||
155300937|NCT02988817|560533718|FG014|Overall Study|Other|0|||
155300938|NCT02988817|560533719|FG015|Overall Study|Other|1|||
155300939|NCT02988817|560533720|FG016|Overall Study|Other|0|||
155300940|NCT02988817|560533721|FG017|Overall Study|Other|0|||
155300941|NCT02988817|560533722|FG018|Overall Study|Other|0|||
155300942|NCT02988817|560533723|FG019|Overall Study|Other|0|||
155300943|NCT02988817|560533704|FG000|Overall Study|Lost to Follow-up|0|||
155300944|NCT02988817|560533705|FG001|Overall Study|Lost to Follow-up|0|||
155300945|NCT02988817|560533706|FG002|Overall Study|Lost to Follow-up|0|||
155300946|NCT02988817|560533707|FG003|Overall Study|Lost to Follow-up|0|||
155300947|NCT02988817|560533708|FG004|Overall Study|Lost to Follow-up|0|||
155300948|NCT02988817|560533709|FG005|Overall Study|Lost to Follow-up|0|||
155300949|NCT02988817|560533710|FG006|Overall Study|Lost to Follow-up|0|||
155300950|NCT02988817|560533711|FG007|Overall Study|Lost to Follow-up|0|||
155300951|NCT02988817|560533712|FG008|Overall Study|Lost to Follow-up|1|||
155300952|NCT02988817|560533713|FG009|Overall Study|Lost to Follow-up|0|||
155300953|NCT02988817|560533714|FG010|Overall Study|Lost to Follow-up|1|||
155300954|NCT02988817|560533715|FG011|Overall Study|Lost to Follow-up|1|||
155300955|NCT02988817|560533716|FG012|Overall Study|Lost to Follow-up|0|||
155300956|NCT02988817|560533717|FG013|Overall Study|Lost to Follow-up|0|||
155300957|NCT02988817|560533718|FG014|Overall Study|Lost to Follow-up|1|||
155300958|NCT02988817|560533719|FG015|Overall Study|Lost to Follow-up|1|||
155300959|NCT02988817|560533720|FG016|Overall Study|Lost to Follow-up|2|||
155300960|NCT02988817|560533721|FG017|Overall Study|Lost to Follow-up|3|||
155063048|NCT00042289|559664010|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
155063049|NCT00042289|559664011|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
155063050|NCT00042289|559664012|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
155300961|NCT02988817|560533722|FG018|Overall Study|Lost to Follow-up|0|||
155300962|NCT02988817|560533723|FG019|Overall Study|Lost to Follow-up|0|||
155300963|NCT02988817|560533704|FG000|Overall Study|Sponsor decision|0|||
155300964|NCT02988817|560533705|FG001|Overall Study|Sponsor decision|0|||
155300965|NCT02988817|560533706|FG002|Overall Study|Sponsor decision|0|||
155300966|NCT02988817|560533707|FG003|Overall Study|Sponsor decision|0|||
155300967|NCT02988817|560533708|FG004|Overall Study|Sponsor decision|0|||
155300968|NCT02988817|560533709|FG005|Overall Study|Sponsor decision|0|||
155300969|NCT02988817|560533710|FG006|Overall Study|Sponsor decision|0|||
155300970|NCT02988817|560533711|FG007|Overall Study|Sponsor decision|0|||
155300971|NCT02988817|560533712|FG008|Overall Study|Sponsor decision|0|||
155300972|NCT02988817|560533713|FG009|Overall Study|Sponsor decision|0|||
155300973|NCT02988817|560533714|FG010|Overall Study|Sponsor decision|0|||
155300974|NCT02988817|560533715|FG011|Overall Study|Sponsor decision|1|||
155300975|NCT02988817|560533716|FG012|Overall Study|Sponsor decision|1|||
155300976|NCT02988817|560533717|FG013|Overall Study|Sponsor decision|2|||
155300977|NCT02988817|560533718|FG014|Overall Study|Sponsor decision|2|||
155300978|NCT02988817|560533719|FG015|Overall Study|Sponsor decision|6|||
155300979|NCT02988817|560533720|FG016|Overall Study|Sponsor decision|2|||
155300980|NCT02988817|560533721|FG017|Overall Study|Sponsor decision|3|||
155300981|NCT02988817|560533722|FG018|Overall Study|Sponsor decision|2|||
155300982|NCT02988817|560533723|FG019|Overall Study|Sponsor decision|7|||
155300983|NCT02988817|560533704|FG000|Overall Study|Physician Decision|0|||
155300984|NCT02988817|560533705|FG001|Overall Study|Physician Decision|0|||
155300985|NCT02988817|560533706|FG002|Overall Study|Physician Decision|0|||
155300986|NCT02988817|560533707|FG003|Overall Study|Physician Decision|0|||
155300987|NCT02988817|560533708|FG004|Overall Study|Physician Decision|0|||
155300988|NCT02988817|560533709|FG005|Overall Study|Physician Decision|0|||
155300989|NCT02988817|560533710|FG006|Overall Study|Physician Decision|0|||
155300990|NCT02988817|560533711|FG007|Overall Study|Physician Decision|0|||
155300991|NCT02988817|560533712|FG008|Overall Study|Physician Decision|0|||
155300992|NCT02988817|560533713|FG009|Overall Study|Physician Decision|0|||
155300993|NCT02988817|560533714|FG010|Overall Study|Physician Decision|0|||
155300994|NCT02988817|560533715|FG011|Overall Study|Physician Decision|0|||
155300995|NCT02988817|560533716|FG012|Overall Study|Physician Decision|0|||
155300996|NCT02988817|560533717|FG013|Overall Study|Physician Decision|0|||
155300997|NCT02988817|560533718|FG014|Overall Study|Physician Decision|0|||
155300998|NCT02988817|560533719|FG015|Overall Study|Physician Decision|1|||
155300999|NCT02988817|560533720|FG016|Overall Study|Physician Decision|0|||
155301000|NCT02988817|560533721|FG017|Overall Study|Physician Decision|0|||
155301001|NCT02988817|560533722|FG018|Overall Study|Physician Decision|1|||
155301002|NCT02988817|560533723|FG019|Overall Study|Physician Decision|1|||
155301003|NCT03036813|560533726|FG000|Overall Study|Adverse Event|6|||
155301004|NCT03036813|560533727|FG001|Overall Study|Adverse Event|11|||
155301005|NCT03036813|560533728|FG002|Overall Study|Adverse Event|6|||
155301006|NCT03036813|560533726|FG000|Overall Study|Withdrawal by Subject|12|||
155301007|NCT03036813|560533727|FG001|Overall Study|Withdrawal by Subject|6|||
155301008|NCT03036813|560533728|FG002|Overall Study|Withdrawal by Subject|10|||
155301009|NCT03036813|560533726|FG000|Overall Study|Lost to Follow-up|1|||
155301010|NCT03036813|560533727|FG001|Overall Study|Lost to Follow-up|1|||
155301011|NCT03036813|560533728|FG002|Overall Study|Lost to Follow-up|0|||
155301012|NCT03036813|560533726|FG000|Overall Study|Physician Decision|2|||
155301013|NCT03036813|560533727|FG001|Overall Study|Physician Decision|1|||
155301014|NCT03036813|560533728|FG002|Overall Study|Physician Decision|1|||
155301015|NCT03036813|560533726|FG000|Overall Study|Non-Compliance|1|||
155301016|NCT03036813|560533727|FG001|Overall Study|Non-Compliance|5|||
155301017|NCT03036813|560533728|FG002|Overall Study|Non-Compliance|3|||
155301018|NCT03036813|560533726|FG000|Overall Study|Pregnancy|0|||
155301019|NCT03036813|560533727|FG001|Overall Study|Pregnancy|0|||
155301020|NCT03036813|560533728|FG002|Overall Study|Pregnancy|1|||
155301021|NCT03036813|560533726|FG000|Overall Study|Other|0|||
155301022|NCT03036813|560533727|FG001|Overall Study|Other|3|||
155301023|NCT03036813|560533728|FG002|Overall Study|Other|5|||
155301024|NCT01102231|560533729|FG000|Overall Study|Protocol Violation|3|||
155301025|NCT01102231|560533729|FG000|Overall Study|Lack of Efficacy|2|||
155301026|NCT01102231|560533729|FG000|Overall Study|Death|2|||
155301027|NCT01102231|560533729|FG000|Overall Study|Adverse Event|3|||
155301028|NCT01102231|560533729|FG000|Overall Study|Withdrawal by Subject|1|||
155301029|NCT01102231|560533729|FG000|Overall Study|Did not received the treatment|4|||
155301030|NCT00546754|560533730|FG000|Overall Study|Serious Adverse Event|1|||
155301031|NCT00546754|560533731|FG001|Overall Study|Serious Adverse Event|1|||
155301032|NCT00546754|560533730|FG000|Overall Study|Adverse Event|11|||
155301033|NCT00546754|560533731|FG001|Overall Study|Adverse Event|16|||
155301034|NCT00546754|560533730|FG000|Overall Study|Lack of Efficacy|1|||
155301035|NCT00546754|560533731|FG001|Overall Study|Lack of Efficacy|1|||
155301036|NCT00546754|560533730|FG000|Overall Study|Lost to Follow-up|9|||
155301037|NCT00546754|560533731|FG001|Overall Study|Lost to Follow-up|15|||
155301038|NCT00546754|560533730|FG000|Overall Study|Protocol Violation|3|||
155301039|NCT00546754|560533731|FG001|Overall Study|Protocol Violation|0|||
154957852|NCT00965185|559273966|FG000|Overall Study|Withdrawal by Subject|0|||
154957853|NCT00965185|559273967|FG001|Overall Study|Withdrawal by Subject|1|||
154957854|NCT00576056|559273968|FG000|Overall Study|Adverse Event|1|||
154957855|NCT00576056|559273968|FG000|Overall Study|Death|1|||
154957856|NCT00576056|559273968|FG000|Overall Study|Lack of Efficacy|1|||
154957857|NCT00576056|559273968|FG000|Overall Study|Withdrawal by Subject|2|||
154957858|NCT00576056|559273968|FG000|Overall Study|did not meet eligibility criteria|8|||
154957859|NCT00576056|559273968|FG000|Overall Study|Physician Decision|1|||
154957860|NCT03031847|559273969|FG000|Overall Study|Death|1|||
154957861|NCT03031847|559273970|FG001|Overall Study|Death|1|||
154957862|NCT03031847|559273971|FG002|Overall Study|Death|2|||
154957863|NCT03031847|559273972|FG003|Overall Study|Death|3|||
154957864|NCT03031847|559273969|FG000|Overall Study|Lost to Follow-up|1|||
154957865|NCT03031847|559273970|FG001|Overall Study|Lost to Follow-up|1|||
154957866|NCT03031847|559273971|FG002|Overall Study|Lost to Follow-up|2|||
154957867|NCT03031847|559273972|FG003|Overall Study|Lost to Follow-up|3|||
154957868|NCT03273153|559273973|FG000|Overall Study|Adverse Event|1|||
154957869|NCT03273153|559273974|FG001|Overall Study|Adverse Event|2|||
155301040|NCT00546754|560533730|FG000|Overall Study|Withdrawal by Subject|6|||
155301041|NCT00546754|560533731|FG001|Overall Study|Withdrawal by Subject|7|||
155301042|NCT00546754|560533730|FG000|Overall Study|Dyspnea|1|||
154957870|NCT03273153|559273973|FG000|Overall Study|Missing|0|||
154957871|NCT03273153|559273974|FG001|Overall Study|Missing|2|||
154957872|NCT03273153|559273973|FG000|Overall Study|Other|3|||
154957873|NCT03273153|559273974|FG001|Overall Study|Other|2|||
155301043|NCT00546754|560533731|FG001|Overall Study|Dyspnea|0|||
155301044|NCT00546754|560533730|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
155301045|NCT00546754|560533731|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
155063051|NCT00042289|559664013|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
155159291|NCT01235741|560022737|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
155159292|NCT01235741|560022738|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
155159293|NCT01235741|560022736|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
155159294|NCT01235741|560022737|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
155159295|NCT01235741|560022738|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
155159296|NCT01235741|560022736|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
155159297|NCT01235741|560022737|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
155159298|NCT01235741|560022738|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
155159299|NCT01235741|560022736|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
155159300|NCT01235741|560022737|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
155159301|NCT01235741|560022738|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
155159302|NCT01235741|560022736|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
155159303|NCT01235741|560022737|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
155159304|NCT01235741|560022738|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
155159305|NCT01235741|560022736|FG000|Randomized to Treatment|Adverse Event|0|||
155159306|NCT01235741|560022737|FG001|Randomized to Treatment|Adverse Event|1|||
155159307|NCT01235741|560022738|FG002|Randomized to Treatment|Adverse Event|1|||
155159308|NCT01235741|560022736|FG000|Randomized to Treatment|Sponsor terminated study|0|||
155159309|NCT01235741|560022737|FG001|Randomized to Treatment|Sponsor terminated study|35|||
155159310|NCT01235741|560022738|FG002|Randomized to Treatment|Sponsor terminated study|34|||
155159311|NCT01235741|560022736|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
155159312|NCT01235741|560022737|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
155159313|NCT01235741|560022738|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
155159314|NCT01235741|560022736|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
155159315|NCT01235741|560022737|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
155159316|NCT01235741|560022738|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
155063052|NCT00042289|559664014|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
155063053|NCT00042289|559664015|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
155063054|NCT00042289|559664016|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
155063055|NCT00042289|559664017|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
155063056|NCT00042289|559664018|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
155063057|NCT00042289|559664019|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
155063058|NCT00042289|559664020|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
155063059|NCT00042289|559663974|FG000|Overall Study|Protocol Violation|0|||
155063060|NCT00042289|559663975|FG001|Overall Study|Protocol Violation|0|||
155159317|NCT01235741|560022736|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
155159318|NCT01235741|560022737|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
155159319|NCT01235741|560022738|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
155159320|NCT01421719|560022739|FG000|Overall Study|Withdrawal by Subject|4|||
155159321|NCT01942837|560022748|FG000|Overall Study|Death|1|||
155159322|NCT01942837|560022748|FG000|Overall Study|Symptomatic or radiographic progression|49|||
155159323|NCT01942837|560022748|FG000|Overall Study|Adverse Event|6|||
155159324|NCT01942837|560022748|FG000|Overall Study|Physician Decision|3|||
155159325|NCT01942837|560022748|FG000|Overall Study|Withdrawal by Subject|2|||
155159326|NCT01942837|560022748|FG000|Overall Study|Intercurrent Illness|1|||
155159327|NCT01942837|560022748|FG000|Overall Study|On treatment|3|||
155159328|NCT01942837|560022748|FG000|Overall Study|Never initiate the treatment|2|||
155159329|NCT01298648|560022749|FG000|Overall Study|Withdrawal by Subject|2|||
155159330|NCT01298648|560022749|FG000|Overall Study|Lost to Follow-up|21|||
155159331|NCT02392624|560022750|FG000|Overall Study|Withdrawal by Subject|15|||
155159332|NCT02392624|560022751|FG001|Overall Study|Withdrawal by Subject|12|||
155159333|NCT02392624|560022752|FG002|Overall Study|Withdrawal by Subject|9|||
155159334|NCT02392624|560022750|FG000|Overall Study|Adverse Event|4|||
155159335|NCT02392624|560022751|FG001|Overall Study|Adverse Event|1|||
155159336|NCT02392624|560022752|FG002|Overall Study|Adverse Event|2|||
155159337|NCT02392624|560022750|FG000|Overall Study|Pregnancy|1|||
155159338|NCT02392624|560022751|FG001|Overall Study|Pregnancy|0|||
155159339|NCT02392624|560022752|FG002|Overall Study|Pregnancy|0|||
155159340|NCT02392624|560022750|FG000|Overall Study|Protocol Violation|0|||
155159341|NCT02392624|560022751|FG001|Overall Study|Protocol Violation|0|||
155159342|NCT02392624|560022752|FG002|Overall Study|Protocol Violation|1|||
155159343|NCT02392624|560022750|FG000|Overall Study|Sponsor/Investigator Decision|2|||
155159344|NCT02392624|560022751|FG001|Overall Study|Sponsor/Investigator Decision|1|||
155159345|NCT02392624|560022752|FG002|Overall Study|Sponsor/Investigator Decision|0|||
155159346|NCT02392624|560022750|FG000|Overall Study|Other|49|||
155159347|NCT02392624|560022751|FG001|Overall Study|Other|1|||
155159348|NCT02392624|560022752|FG002|Overall Study|Other|1|||
155159349|NCT03819114|560022753|FG000|Overall Study|Protocol Violation|0|||
155159350|NCT03819114|560022754|FG001|Overall Study|Protocol Violation|1|||
155159351|NCT03819114|560022755|FG002|Overall Study|Protocol Violation|1|||
155301046|NCT00546754|560533730|FG000|Overall Study|Hip Replacement|1|||
155301047|NCT00546754|560533731|FG001|Overall Study|Hip Replacement|0|||
155301048|NCT00546754|560533730|FG000|Overall Study|Suicide|1|||
155301049|NCT00546754|560533731|FG001|Overall Study|Suicide|0|||
155301050|NCT00546754|560533730|FG000|Overall Study|Missing Cooperation|1|||
155301051|NCT00546754|560533731|FG001|Overall Study|Missing Cooperation|0|||
155301052|NCT00546754|560533730|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
155301053|NCT00546754|560533731|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
155301054|NCT00546754|560533730|FG000|Overall Study|Patient's Decision|0|||
155301055|NCT00546754|560533731|FG001|Overall Study|Patient's Decision|1|||
155301056|NCT00546754|560533730|FG000|Overall Study|Missing|14|||
155301057|NCT00546754|560533731|FG001|Overall Study|Missing|7|||
155301058|NCT01792830|560533741|FG000|Overall Study|Withdrawal by Subject|22|||
155301059|NCT01792830|560533742|FG001|Overall Study|Withdrawal by Subject|0|||
155301060|NCT01792830|560533743|FG002|Overall Study|Withdrawal by Subject|0|||
155301061|NCT01792830|560533744|FG003|Overall Study|Withdrawal by Subject|2|||
155301062|NCT01792830|560533745|FG004|Overall Study|Withdrawal by Subject|1|||
155301063|NCT01792830|560533746|FG005|Overall Study|Withdrawal by Subject|1|||
155301064|NCT01792830|560533747|FG006|Overall Study|Withdrawal by Subject|1|||
155301065|NCT01792830|560533748|FG007|Overall Study|Withdrawal by Subject|1|||
155301066|NCT01792830|560533749|FG008|Overall Study|Withdrawal by Subject|7|||
155301067|NCT01792830|560533750|FG009|Overall Study|Withdrawal by Subject|0|||
155301068|NCT01792830|560533751|FG010|Overall Study|Withdrawal by Subject|2|||
155301069|NCT01792830|560533741|FG000|Overall Study|Death|3|||
155301070|NCT01792830|560533742|FG001|Overall Study|Death|0|||
155301071|NCT01792830|560533743|FG002|Overall Study|Death|0|||
155301072|NCT01792830|560533744|FG003|Overall Study|Death|1|||
155301073|NCT01792830|560533745|FG004|Overall Study|Death|0|||
155301074|NCT01792830|560533746|FG005|Overall Study|Death|0|||
155301075|NCT01792830|560533747|FG006|Overall Study|Death|1|||
155301076|NCT01792830|560533748|FG007|Overall Study|Death|0|||
155301077|NCT01792830|560533749|FG008|Overall Study|Death|1|||
155301078|NCT01792830|560533750|FG009|Overall Study|Death|0|||
155301079|NCT01792830|560533751|FG010|Overall Study|Death|1|||
155301080|NCT01792830|560533741|FG000|Overall Study|Adverse Event|0|||
155301081|NCT01792830|560533742|FG001|Overall Study|Adverse Event|0|||
155301082|NCT01792830|560533743|FG002|Overall Study|Adverse Event|0|||
155301083|NCT01792830|560533744|FG003|Overall Study|Adverse Event|0|||
155301084|NCT01792830|560533745|FG004|Overall Study|Adverse Event|0|||
155301085|NCT01792830|560533746|FG005|Overall Study|Adverse Event|0|||
155301086|NCT01792830|560533747|FG006|Overall Study|Adverse Event|0|||
155301087|NCT01792830|560533748|FG007|Overall Study|Adverse Event|0|||
155301088|NCT01792830|560533749|FG008|Overall Study|Adverse Event|1|||
155301089|NCT01792830|560533750|FG009|Overall Study|Adverse Event|0|||
155301090|NCT01792830|560533751|FG010|Overall Study|Adverse Event|0|||
155301091|NCT01943799|560533767|FG000|Overall Study|Lost to Follow-up|0|||
155301092|NCT01943799|560533768|FG001|Overall Study|Lost to Follow-up|1|||
155301093|NCT01943799|560533769|FG002|Overall Study|Lost to Follow-up|1|||
155301094|NCT01943799|560533770|FG003|Overall Study|Lost to Follow-up|0|||
155301095|NCT01943799|560533767|FG000|Overall Study|Protocol Violation|1|||
155301096|NCT01943799|560533768|FG001|Overall Study|Protocol Violation|0|||
155301097|NCT01943799|560533769|FG002|Overall Study|Protocol Violation|0|||
155301098|NCT01943799|560533770|FG003|Overall Study|Protocol Violation|0|||
155301099|NCT01943799|560533767|FG000|Overall Study|Withdrawal by Subject|4|||
155301100|NCT01943799|560533768|FG001|Overall Study|Withdrawal by Subject|2|||
155301101|NCT01943799|560533769|FG002|Overall Study|Withdrawal by Subject|1|||
155301102|NCT01943799|560533770|FG003|Overall Study|Withdrawal by Subject|0|||
155301103|NCT04594759|560533771|FG000|Overall Study|Lost to Follow-up|3|||
155301104|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
155301105|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
155301106|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
155301107|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
155301108|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
155301109|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
155301110|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
155301111|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
155301112|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
155301113|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
155301114|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
155301115|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
155301116|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
155301117|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
155301118|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
155301119|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
155301120|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
155301121|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
155301122|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
155301123|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
155301124|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
155301125|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
155301126|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
155301127|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
155301128|NCT00311363|560533772|FG000|24-Week Single-Blind Treatment Period|Death|1|||
155301129|NCT00311363|560533773|FG001|24-Week Single-Blind Treatment Period|Death|0|||
155301130|NCT00311363|560533774|FG002|24-Week Single-Blind Treatment Period|Death|0|||
155301131|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
155301132|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
155301133|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
155301134|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
155301135|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
155301136|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155301137|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
155301138|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
155301139|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
155301140|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
155301141|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
155301142|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
155301143|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
155301144|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
155301145|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
155301146|NCT00311363|560533772|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
155301147|NCT00311363|560533773|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
155301148|NCT00311363|560533774|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
155301149|NCT00396084|560533777|FG000|Overall Study|Adverse Event|0|||
155301150|NCT00396084|560533778|FG001|Overall Study|Adverse Event|0|||
155301151|NCT00396084|560533779|FG002|Overall Study|Adverse Event|0|||
155301152|NCT00396084|560533780|FG003|Overall Study|Adverse Event|0|||
155301153|NCT00396084|560533781|FG004|Overall Study|Adverse Event|1|||
155301154|NCT00396084|560533782|FG005|Overall Study|Adverse Event|2|||
155301155|NCT00396084|560533777|FG000|Overall Study|Withdrawal by Subject|0|||
155301156|NCT00396084|560533778|FG001|Overall Study|Withdrawal by Subject|0|||
155301157|NCT00396084|560533779|FG002|Overall Study|Withdrawal by Subject|0|||
155301158|NCT00396084|560533780|FG003|Overall Study|Withdrawal by Subject|1|||
155301159|NCT00396084|560533781|FG004|Overall Study|Withdrawal by Subject|0|||
155301160|NCT00396084|560533782|FG005|Overall Study|Withdrawal by Subject|0|||
155301161|NCT03811574|560533783|FG000|Overall Study|Withdrawal by Subject|2|||
155301162|NCT03811574|560533784|FG001|Overall Study|Withdrawal by Subject|4|||
155301163|NCT03811574|560533785|FG002|Overall Study|Withdrawal by Subject|0|||
155301164|NCT01697969|560533786|FG000|Overall Study|Did not meet inc/exc criteria|3|||
155301165|NCT03144674|560533791|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
155301166|NCT03144674|560533792|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
155301167|NCT03144674|560533793|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
155301168|NCT03144674|560533794|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
155301169|NCT03144674|560533791|FG000|Overall Study|Death|3|||
155301170|NCT03144674|560533792|FG001|Overall Study|Death|2|||
155301171|NCT03144674|560533793|FG002|Overall Study|Death|6|||
155301172|NCT03144674|560533794|FG003|Overall Study|Death|24|||
155301173|NCT03144674|560533791|FG000|Overall Study|Lost to Follow-up|0|||
155301174|NCT03144674|560533792|FG001|Overall Study|Lost to Follow-up|1|||
155301175|NCT03144674|560533793|FG002|Overall Study|Lost to Follow-up|0|||
155301176|NCT03144674|560533794|FG003|Overall Study|Lost to Follow-up|4|||
155301177|NCT03144674|560533791|FG000|Overall Study|Withdrawal by Participant|0|||
155301178|NCT03144674|560533792|FG001|Overall Study|Withdrawal by Participant|0|||
155301179|NCT03144674|560533793|FG002|Overall Study|Withdrawal by Participant|2|||
155301180|NCT03144674|560533794|FG003|Overall Study|Withdrawal by Participant|6|||
155301181|NCT03144674|560533791|FG000|Overall Study|Discharged from the Trust|0|||
155301182|NCT03144674|560533792|FG001|Overall Study|Discharged from the Trust|0|||
155301183|NCT03144674|560533793|FG002|Overall Study|Discharged from the Trust|1|||
155301184|NCT03144674|560533794|FG003|Overall Study|Discharged from the Trust|0|||
155159352|NCT03819114|560022756|FG003|Overall Study|Protocol Violation|0|||
155301185|NCT03144674|560533791|FG000|Overall Study|Exclusion Criteria Met|0|||
155159353|NCT03819114|560022753|FG000|Overall Study|Lost to Follow-up|0|||
155159354|NCT03819114|560022754|FG001|Overall Study|Lost to Follow-up|0|||
155159355|NCT03819114|560022755|FG002|Overall Study|Lost to Follow-up|1|||
155301186|NCT03144674|560533792|FG001|Overall Study|Exclusion Criteria Met|0|||
155301187|NCT03144674|560533793|FG002|Overall Study|Exclusion Criteria Met|1|||
155301188|NCT03144674|560533794|FG003|Overall Study|Exclusion Criteria Met|0|||
155159356|NCT03819114|560022756|FG003|Overall Study|Lost to Follow-up|0|||
155301189|NCT03144674|560533791|FG000|Overall Study|Changed Physicians|0|||
155301190|NCT03144674|560533792|FG001|Overall Study|Changed Physicians|0|||
155301191|NCT03144674|560533793|FG002|Overall Study|Changed Physicians|0|||
155301192|NCT03144674|560533794|FG003|Overall Study|Changed Physicians|1|||
155301193|NCT03144674|560533791|FG000|Overall Study|Removed for Safety|0|||
155301194|NCT03144674|560533792|FG001|Overall Study|Removed for Safety|0|||
155301195|NCT03144674|560533793|FG002|Overall Study|Removed for Safety|0|||
155301196|NCT03144674|560533794|FG003|Overall Study|Removed for Safety|1|||
155301197|NCT03144674|560533791|FG000|Overall Study|Site Closed|0|||
155301198|NCT03144674|560533792|FG001|Overall Study|Site Closed|0|||
155301199|NCT03144674|560533793|FG002|Overall Study|Site Closed|0|||
155301200|NCT03144674|560533794|FG003|Overall Study|Site Closed|1|||
155301201|NCT03144674|560533791|FG000|Overall Study|Histological Criteria Not Met|0|||
155301202|NCT03144674|560533792|FG001|Overall Study|Histological Criteria Not Met|0|||
155301203|NCT03144674|560533793|FG002|Overall Study|Histological Criteria Not Met|0|||
155301204|NCT03144674|560533794|FG003|Overall Study|Histological Criteria Not Met|1|||
155301205|NCT03144674|560533791|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
155301206|NCT03144674|560533792|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
155301207|NCT03144674|560533793|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
155301208|NCT03144674|560533794|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
155301209|NCT03144674|560533791|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
155301210|NCT03144674|560533792|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
155301211|NCT03144674|560533793|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
155301212|NCT03144674|560533794|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
155301213|NCT01395758|560533795|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
155301214|NCT01395758|560533796|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155301215|NCT01395758|560533797|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155301216|NCT01759771|560533798|FG000|Overall Study|Withdrawal by Subject|1|||
155301217|NCT01759771|560533799|FG001|Overall Study|Withdrawal by Subject|1|||
155301218|NCT00933400|560533804|FG000|Overall Study|Withdrawal by Subject|21|||
155301219|NCT00933400|560533805|FG001|Overall Study|Withdrawal by Subject|1|||
155301220|NCT02139943|560533806|FG000|Overall Study|Adverse Event|0|||
155301221|NCT02139943|560533807|FG001|Overall Study|Adverse Event|1|||
155301222|NCT02139943|560533808|FG002|Overall Study|Adverse Event|2|||
155301223|NCT02139943|560533806|FG000|Overall Study|Lost to Follow-up|3|||
155301224|NCT02139943|560533807|FG001|Overall Study|Lost to Follow-up|2|||
155301225|NCT02139943|560533808|FG002|Overall Study|Lost to Follow-up|2|||
155301226|NCT02139943|560533806|FG000|Overall Study|Withdrawal by Subject|4|||
155301227|NCT02139943|560533807|FG001|Overall Study|Withdrawal by Subject|3|||
155301228|NCT02139943|560533808|FG002|Overall Study|Withdrawal by Subject|0|||
155301229|NCT02139943|560533806|FG000|Overall Study|Other|0|||
155301230|NCT02139943|560533807|FG001|Overall Study|Other|0|||
155301231|NCT02139943|560533808|FG002|Overall Study|Other|1|||
155301232|NCT02139943|560533806|FG000|Overall Study|Participant wishes to discontinue|2|||
155301233|NCT02139943|560533807|FG001|Overall Study|Participant wishes to discontinue|0|||
155301234|NCT02139943|560533808|FG002|Overall Study|Participant wishes to discontinue|0|||
155301235|NCT02139943|560533806|FG000|Overall Study|Participant in Poor Compliance|1|||
155301236|NCT02139943|560533807|FG001|Overall Study|Participant in Poor Compliance|0|||
155159357|NCT03841604|560022757|FG000|Overall Study|Withdrawal by Subject|3|||
155159358|NCT03841604|560022758|FG001|Overall Study|Withdrawal by Subject|1|||
155159359|NCT03841604|560022757|FG000|Overall Study|Adverse Event|4|||
155159360|NCT03841604|560022758|FG001|Overall Study|Adverse Event|2|||
155159361|NCT03841604|560022757|FG000|Overall Study|Physician Decision|1|||
155159362|NCT03841604|560022758|FG001|Overall Study|Physician Decision|0|||
155159363|NCT01193244|560022761|FG000|Overall Study|Withdrawal by Subject|79|||
155159364|NCT01193244|560022762|FG001|Overall Study|Withdrawal by Subject|97|||
155159365|NCT01193244|560022761|FG000|Overall Study|Other|303|||
155159366|NCT01193244|560022762|FG001|Overall Study|Other|278|||
155159367|NCT01193244|560022761|FG000|Overall Study|Lost to Follow-up|6|||
155159368|NCT01193244|560022762|FG001|Overall Study|Lost to Follow-up|15|||
155159369|NCT02085161|560022763|FG000|Overall Study|Not Treated|1|||
155159370|NCT02085161|560022764|FG001|Overall Study|Not Treated|0|||
155159371|NCT02085161|560022765|FG002|Overall Study|Not Treated|0|||
155159372|NCT02085161|560022766|FG003|Overall Study|Not Treated|0|||
155159373|NCT02085161|560022763|FG000|Overall Study|Adverse Event|8|||
155159374|NCT02085161|560022764|FG001|Overall Study|Adverse Event|5|||
155159375|NCT02085161|560022765|FG002|Overall Study|Adverse Event|4|||
155159376|NCT02085161|560022766|FG003|Overall Study|Adverse Event|5|||
155159377|NCT02085161|560022763|FG000|Overall Study|Protocol Violation|0|||
155159378|NCT02085161|560022764|FG001|Overall Study|Protocol Violation|1|||
155159379|NCT02085161|560022765|FG002|Overall Study|Protocol Violation|0|||
155159380|NCT02085161|560022766|FG003|Overall Study|Protocol Violation|1|||
155159381|NCT02085161|560022763|FG000|Overall Study|Withdrawal by Subject|2|||
155159382|NCT02085161|560022764|FG001|Overall Study|Withdrawal by Subject|4|||
155159383|NCT02085161|560022765|FG002|Overall Study|Withdrawal by Subject|0|||
155159384|NCT02085161|560022766|FG003|Overall Study|Withdrawal by Subject|3|||
155159385|NCT02085161|560022763|FG000|Overall Study|Other Reason|1|||
155159386|NCT02085161|560022764|FG001|Overall Study|Other Reason|0|||
155159387|NCT02085161|560022765|FG002|Overall Study|Other Reason|1|||
155159388|NCT02085161|560022766|FG003|Overall Study|Other Reason|1|||
155159389|NCT00068692|560022779|FG000|Step 1: Registration|Disese progression/relapse|5|||
155301237|NCT02139943|560533808|FG002|Overall Study|Participant in Poor Compliance|1|||
155301238|NCT02139943|560533806|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
155301239|NCT02139943|560533807|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
155301240|NCT02139943|560533808|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
155301241|NCT01041417|560533809|FG000|Overall Study|Adverse Event|5|||
155301242|NCT01041417|560533810|FG001|Overall Study|Adverse Event|2|||
155301243|NCT01041417|560533809|FG000|Overall Study|Lost to Follow-up|1|||
155301244|NCT01041417|560533810|FG001|Overall Study|Lost to Follow-up|1|||
155301245|NCT01041417|560533809|FG000|Overall Study|Death|1|||
155301246|NCT01041417|560533810|FG001|Overall Study|Death|0|||
155301247|NCT01616459|560533816|FG000|Overall Study|Adverse Event|1|||
155301248|NCT01616459|560533817|FG001|Overall Study|Adverse Event|1|||
155301249|NCT01616459|560533818|FG002|Overall Study|Adverse Event|2|||
155301250|NCT01616459|560533819|FG003|Overall Study|Adverse Event|0|||
155301251|NCT01616459|560533816|FG000|Overall Study|Lost to Follow-up|1|||
155301252|NCT01616459|560533817|FG001|Overall Study|Lost to Follow-up|11|||
155301253|NCT01616459|560533818|FG002|Overall Study|Lost to Follow-up|3|||
155301254|NCT01616459|560533819|FG003|Overall Study|Lost to Follow-up|2|||
155301255|NCT01616459|560533816|FG000|Overall Study|Protocol Violation|0|||
155301256|NCT01616459|560533817|FG001|Overall Study|Protocol Violation|0|||
155301257|NCT01616459|560533818|FG002|Overall Study|Protocol Violation|0|||
155301258|NCT01616459|560533819|FG003|Overall Study|Protocol Violation|2|||
155301259|NCT01616459|560533816|FG000|Overall Study|Withdrawal by Subject|2|||
155301260|NCT01616459|560533817|FG001|Overall Study|Withdrawal by Subject|4|||
155301261|NCT01616459|560533818|FG002|Overall Study|Withdrawal by Subject|4|||
155301262|NCT01616459|560533819|FG003|Overall Study|Withdrawal by Subject|4|||
155301263|NCT01616459|560533816|FG000|Overall Study|Other reason|0|||
155301264|NCT01616459|560533817|FG001|Overall Study|Other reason|1|||
155301265|NCT01616459|560533818|FG002|Overall Study|Other reason|1|||
155301266|NCT01616459|560533819|FG003|Overall Study|Other reason|0|||
155301267|NCT04300647|560534866|FG000|Pre-Crossover|Death|19|||
155301268|NCT04300647|560534867|FG001|Pre-Crossover|Death|58|||
155301269|NCT04300647|560534868|FG002|Pre-Crossover|Death|0|||
155301270|NCT04300647|560534866|FG000|Pre-Crossover|Lost to Follow-up|0|||
155301271|NCT04300647|560534867|FG001|Pre-Crossover|Lost to Follow-up|3|||
155301272|NCT04300647|560534868|FG002|Pre-Crossover|Lost to Follow-up|0|||
155301273|NCT04300647|560534866|FG000|Pre-Crossover|Withdrawal by Subject|2|||
155301274|NCT04300647|560534867|FG001|Pre-Crossover|Withdrawal by Subject|4|||
155301275|NCT04300647|560534868|FG002|Pre-Crossover|Withdrawal by Subject|0|||
155301276|NCT04300647|560534866|FG000|Pre-Crossover|On-going in Study|24|||
155301277|NCT04300647|560534867|FG001|Pre-Crossover|On-going in Study|61|||
155301278|NCT04300647|560534868|FG002|Pre-Crossover|On-going in Study|0|||
155301279|NCT04300647|560534866|FG000|Post-Crossover|Death|0|||
155301280|NCT04300647|560534867|FG001|Post-Crossover|Death|0|||
155301281|NCT04300647|560534868|FG002|Post-Crossover|Death|3|||
155301282|NCT04300647|560534866|FG000|Post-Crossover|Lost to Follow-up|0|||
155301283|NCT04300647|560534867|FG001|Post-Crossover|Lost to Follow-up|0|||
155301284|NCT04300647|560534868|FG002|Post-Crossover|Lost to Follow-up|1|||
155301285|NCT04300647|560534866|FG000|Post-Crossover|Withdrawal by Subject|0|||
155301286|NCT04300647|560534867|FG001|Post-Crossover|Withdrawal by Subject|0|||
155301287|NCT04300647|560534868|FG002|Post-Crossover|Withdrawal by Subject|1|||
155301288|NCT04300647|560534866|FG000|Post-Crossover|On-going in Study|0|||
155301289|NCT04300647|560534867|FG001|Post-Crossover|On-going in Study|0|||
155301290|NCT04300647|560534868|FG002|Post-Crossover|On-going in Study|8|||
154957874|NCT03273153|559273973|FG000|Overall Study|Symptomatic Deterioration|0|||
154957875|NCT03273153|559273974|FG001|Overall Study|Symptomatic Deterioration|1|||
155301291|NCT05386238|560534869|FG000|Overall Study|Lost to Follow-up|3|||
155159390|NCT00068692|560022780|FG001|Step 1: Registration|Disese progression/relapse|0|||
155301292|NCT05386238|560534870|FG001|Overall Study|Lost to Follow-up|2|||
155301293|NCT05386238|560534869|FG000|Overall Study|Withdrawal by Subject|0|||
155301294|NCT05386238|560534870|FG001|Overall Study|Withdrawal by Subject|1|||
155301295|NCT04907474|560534871|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
155301296|NCT04907474|560534872|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
155301297|NCT01353313|560534874|FG000|Overall Study|Lost to Follow-up|22|||
154957876|NCT03273153|559273973|FG000|Overall Study|Progressive Disease|6|||
154957877|NCT03273153|559273974|FG001|Overall Study|Progressive Disease|5|||
155159391|NCT00068692|560022781|FG002|Step 1: Registration|Disese progression/relapse|0|||
155159392|NCT00068692|560022782|FG003|Step 1: Registration|Disese progression/relapse|0|||
155301298|NCT01353313|560534875|FG001|Overall Study|Lost to Follow-up|23|||
155301299|NCT01353313|560534874|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
155301300|NCT01353313|560534875|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
155301301|NCT04755660|560534876|FG000|Overall Study|Lost to Follow-up|1|||
155301302|NCT04755660|560534877|FG001|Overall Study|Lost to Follow-up|1|||
155301303|NCT04755660|560534878|FG002|Overall Study|Lost to Follow-up|0|||
155301304|NCT04755660|560534876|FG000|Overall Study|Withdrawal by Subject|0|||
155301305|NCT04755660|560534877|FG001|Overall Study|Withdrawal by Subject|1|||
155301306|NCT04755660|560534878|FG002|Overall Study|Withdrawal by Subject|1|||
155063061|NCT00042289|559663976|FG002|Overall Study|Protocol Violation|0|||
155063062|NCT00042289|559663977|FG003|Overall Study|Protocol Violation|0|||
155301307|NCT04755660|560534876|FG000|Overall Study|Physician Decision|0|||
155301308|NCT04755660|560534877|FG001|Overall Study|Physician Decision|0|||
155063063|NCT00042289|559663978|FG004|Overall Study|Protocol Violation|0|||
155063064|NCT00042289|559663979|FG005|Overall Study|Protocol Violation|1|||
155063065|NCT00042289|559663980|FG006|Overall Study|Protocol Violation|0|||
155063066|NCT00042289|559663981|FG007|Overall Study|Protocol Violation|1|||
155063067|NCT00042289|559663982|FG008|Overall Study|Protocol Violation|0|||
155063068|NCT00042289|559663983|FG009|Overall Study|Protocol Violation|0|||
155063069|NCT00042289|559663984|FG010|Overall Study|Protocol Violation|0|||
155063070|NCT00042289|559663985|FG011|Overall Study|Protocol Violation|0|||
155063071|NCT00042289|559663986|FG012|Overall Study|Protocol Violation|0|||
155063072|NCT00042289|559663987|FG013|Overall Study|Protocol Violation|0|||
155063073|NCT00042289|559663988|FG014|Overall Study|Protocol Violation|0|||
155063074|NCT00042289|559663989|FG015|Overall Study|Protocol Violation|0|||
155063075|NCT00042289|559663990|FG016|Overall Study|Protocol Violation|0|||
155301309|NCT04755660|560534878|FG002|Overall Study|Physician Decision|1|||
155301310|NCT02824029|560534879|FG000|Overall Study|Didn't receive treatment|2|||
155301311|NCT02824029|560534879|FG000|Overall Study|Patient decision to discontinue treatment|3|||
155301312|NCT02824029|560534879|FG000|Overall Study|Non-compliant|5|||
155301313|NCT02824029|560534879|FG000|Overall Study|Progression of disease|15|||
155301314|NCT02824029|560534879|FG000|Overall Study|Inadequate response to therapy|2|||
155301315|NCT02824029|560534879|FG000|Overall Study|Possible progression per treating physician|1|||
155301316|NCT05672667|560534880|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
155301317|NCT04524390|560534881|FG000|Double Blind|Consent Withdrawal by subject|2|||
155301318|NCT04524390|560534882|FG001|Double Blind|Consent Withdrawal by subject|1|||
155301319|NCT04524390|560534883|FG002|Double Blind|Consent Withdrawal by subject|0|||
155301320|NCT04524390|560534881|FG000|Double Blind|Adverse Event|5|||
155301321|NCT04524390|560534882|FG001|Double Blind|Adverse Event|3|||
155301322|NCT04524390|560534883|FG002|Double Blind|Adverse Event|0|||
155301323|NCT04524390|560534881|FG000|Double Blind|Liver Transplant|5|||
155301324|NCT04524390|560534882|FG001|Double Blind|Liver Transplant|6|||
155301325|NCT04524390|560534883|FG002|Double Blind|Liver Transplant|0|||
155301326|NCT04524390|560534881|FG000|Double Blind|Disease Progression|0|||
155301327|NCT04524390|560534882|FG001|Double Blind|Disease Progression|1|||
155301328|NCT04524390|560534883|FG002|Double Blind|Disease Progression|0|||
155301329|NCT04524390|560534881|FG000|Open-Label|Drug interruption criteria|0|||
155301330|NCT04524390|560534882|FG001|Open-Label|Drug interruption criteria|0|||
155301331|NCT04524390|560534883|FG002|Open-Label|Drug interruption criteria|1|||
155301332|NCT04524390|560534881|FG000|Open-Label|Liver Transplant|0|||
155301333|NCT04524390|560534882|FG001|Open-Label|Liver Transplant|0|||
155301334|NCT04524390|560534883|FG002|Open-Label|Liver Transplant|1|||
155301335|NCT04524390|560534881|FG000|Open-Label|Disease Progression|0|||
155301336|NCT04524390|560534882|FG001|Open-Label|Disease Progression|0|||
155301337|NCT04524390|560534883|FG002|Open-Label|Disease Progression|1|||
155301338|NCT04524390|560534881|FG000|Open-Label|Adverse Event|0|||
155301339|NCT04524390|560534882|FG001|Open-Label|Adverse Event|0|||
155301340|NCT04524390|560534883|FG002|Open-Label|Adverse Event|3|||
155301341|NCT04524390|560534881|FG000|Open-Label|Study Termination by sponsor|0|||
155301342|NCT04524390|560534882|FG001|Open-Label|Study Termination by sponsor|0|||
155301343|NCT04524390|560534883|FG002|Open-Label|Study Termination by sponsor|45|||
155301344|NCT03873779|560534884|FG000|Overall Study|Withdrawal by Subject|1|||
155301345|NCT02581215|560534885|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
155301346|NCT02581215|560534886|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
155301347|NCT02581215|560534885|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155301348|NCT02581215|560534886|FG001|Overall Study|Eligibility Criteria Not Met|1|||
155301349|NCT01693120|560534895|FG000|Enrollment|Lost to Follow-up|1|||
155301350|NCT01693120|560534895|FG000|Enrollment|Withdrawal by Subject|10|||
155301351|NCT01693120|560534895|FG000|Enrollment|Protocol Violation|46|||
155301352|NCT01693120|560534895|FG000|Enrollment|Physician Decision|3|||
155301353|NCT01693120|560534895|FG000|Enrollment|Adverse Event|1|||
155301354|NCT01693120|560534895|FG000|Enrollment|Study closed|8|||
155301355|NCT01693120|560534895|FG000|Enrollment|Other|1|||
155301356|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
155301357|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
155301358|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
155301359|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
155301360|NCT01693120|560534895|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
155301361|NCT04153565|560534896|FG000|Overall Study|Death|13|||
155301362|NCT02300298|560534904|FG000|Disposition for Nintedanib|Progressive disease|10|||
155063076|NCT00042289|559663991|FG017|Overall Study|Protocol Violation|0|||
155301363|NCT02300298|560534905|FG001|Disposition for Nintedanib|Progressive disease|0|||
155301364|NCT02300298|560534904|FG000|Disposition for Docetaxel|Progressive disease|0|||
155301365|NCT02300298|560534905|FG001|Disposition for Docetaxel|Progressive disease|6|||
155301366|NCT02300298|560534904|FG000|Disposition for Docetaxel|other adverse event|0|||
155301367|NCT02300298|560534905|FG001|Disposition for Docetaxel|other adverse event|4|||
155301368|NCT03285763|560534906|FG000|Overall Study|Death|470|||
155301369|NCT03285763|560534906|FG000|Overall Study|Lost to Follow-up|18|||
155301370|NCT03285763|560534906|FG000|Overall Study|Physician Decision|2|||
155301371|NCT03285763|560534906|FG000|Overall Study|Study Terminated By Sponsor|79|||
155301372|NCT03285763|560534906|FG000|Overall Study|Withdrawal by Subject|33|||
155063077|NCT00042289|559663992|FG018|Overall Study|Protocol Violation|0|||
155063078|NCT00042289|559663993|FG019|Overall Study|Protocol Violation|0|||
155063079|NCT00042289|559663994|FG020|Overall Study|Protocol Violation|0|||
155063080|NCT00042289|559663995|FG021|Overall Study|Protocol Violation|0|||
155063081|NCT00042289|559663996|FG022|Overall Study|Protocol Violation|0|||
155063082|NCT00042289|559663997|FG023|Overall Study|Protocol Violation|1|||
155063083|NCT00042289|559663998|FG024|Overall Study|Protocol Violation|1|||
155301373|NCT00610649|560534907|FG000|Overall Study|Adverse Event|1|||
155301374|NCT00610649|560534908|FG001|Overall Study|Adverse Event|0|||
155301375|NCT00610649|560534909|FG002|Overall Study|Adverse Event|0|||
155301376|NCT00610649|560534910|FG003|Overall Study|Adverse Event|0|||
155301377|NCT00610649|560534911|FG004|Overall Study|Adverse Event|0|||
155301378|NCT00610649|560534912|FG005|Overall Study|Adverse Event|0|||
155301379|NCT00610649|560534913|FG006|Overall Study|Adverse Event|0|||
155301380|NCT00610649|560534914|FG007|Overall Study|Adverse Event|0|||
155301381|NCT00610649|560534915|FG008|Overall Study|Adverse Event|0|||
155301382|NCT00610649|560534916|FG009|Overall Study|Adverse Event|0|||
155301383|NCT00610649|560534917|FG010|Overall Study|Adverse Event|1|||
155301384|NCT00610649|560534907|FG000|Overall Study|Family Emergency|0|||
155301385|NCT00610649|560534908|FG001|Overall Study|Family Emergency|1|||
155301386|NCT00610649|560534909|FG002|Overall Study|Family Emergency|0|||
155301387|NCT00610649|560534910|FG003|Overall Study|Family Emergency|0|||
155301388|NCT00610649|560534911|FG004|Overall Study|Family Emergency|0|||
155301389|NCT00610649|560534912|FG005|Overall Study|Family Emergency|0|||
155063084|NCT00042289|559663999|FG025|Overall Study|Protocol Violation|0|||
155063085|NCT00042289|559664000|FG026|Overall Study|Protocol Violation|2|||
155063086|NCT00042289|559664001|FG027|Overall Study|Protocol Violation|0|||
155063087|NCT00042289|559664002|FG028|Overall Study|Protocol Violation|0|||
155063088|NCT00042289|559664003|FG029|Overall Study|Protocol Violation|0|||
155063089|NCT00042289|559664004|FG030|Overall Study|Protocol Violation|1|||
155301390|NCT00610649|560534913|FG006|Overall Study|Family Emergency|0|||
155301391|NCT00610649|560534914|FG007|Overall Study|Family Emergency|0|||
155301392|NCT00610649|560534915|FG008|Overall Study|Family Emergency|0|||
155301393|NCT00610649|560534916|FG009|Overall Study|Family Emergency|0|||
155301394|NCT00610649|560534917|FG010|Overall Study|Family Emergency|0|||
155159393|NCT00068692|560022783|FG004|Step 1: Registration|Disese progression/relapse|0|||
155159394|NCT00068692|560022784|FG005|Step 1: Registration|Disese progression/relapse|0|||
155159395|NCT00068692|560022785|FG006|Step 1: Registration|Disese progression/relapse|0|||
155159396|NCT00068692|560022786|FG007|Step 1: Registration|Disese progression/relapse|0|||
155159397|NCT00068692|560022779|FG000|Step 1: Registration|Adverse Event|7|||
155159398|NCT00068692|560022780|FG001|Step 1: Registration|Adverse Event|0|||
155159399|NCT00068692|560022781|FG002|Step 1: Registration|Adverse Event|0|||
155159400|NCT00068692|560022782|FG003|Step 1: Registration|Adverse Event|0|||
155159401|NCT00068692|560022783|FG004|Step 1: Registration|Adverse Event|0|||
155159402|NCT00068692|560022784|FG005|Step 1: Registration|Adverse Event|0|||
155159403|NCT00068692|560022785|FG006|Step 1: Registration|Adverse Event|0|||
155159404|NCT00068692|560022786|FG007|Step 1: Registration|Adverse Event|0|||
155063090|NCT00042289|559664005|FG031|Overall Study|Protocol Violation|0|||
155063091|NCT00042289|559664006|FG032|Overall Study|Protocol Violation|0|||
155063092|NCT00042289|559664007|FG033|Overall Study|Protocol Violation|0|||
155063093|NCT00042289|559664008|FG034|Overall Study|Protocol Violation|0|||
155301395|NCT00610649|560534907|FG000|Overall Study|Withdrawal by Subject|0|||
155063094|NCT00042289|559664009|FG035|Overall Study|Protocol Violation|0|||
155063095|NCT00042289|559664010|FG036|Overall Study|Protocol Violation|0|||
155063096|NCT00042289|559664011|FG037|Overall Study|Protocol Violation|0|||
155063097|NCT00042289|559664012|FG038|Overall Study|Protocol Violation|0|||
155063098|NCT00042289|559664013|FG039|Overall Study|Protocol Violation|0|||
155063099|NCT00042289|559664014|FG040|Overall Study|Protocol Violation|0|||
155063100|NCT00042289|559664015|FG041|Overall Study|Protocol Violation|1|||
155063101|NCT00042289|559664016|FG042|Overall Study|Protocol Violation|1|||
155063102|NCT00042289|559664017|FG043|Overall Study|Protocol Violation|1|||
155301396|NCT00610649|560534908|FG001|Overall Study|Withdrawal by Subject|0|||
155159405|NCT00068692|560022779|FG000|Step 1: Registration|Death|1|||
155159406|NCT00068692|560022780|FG001|Step 1: Registration|Death|0|||
155301397|NCT00610649|560534909|FG002|Overall Study|Withdrawal by Subject|0|||
155301398|NCT00610649|560534910|FG003|Overall Study|Withdrawal by Subject|0|||
155301399|NCT00610649|560534911|FG004|Overall Study|Withdrawal by Subject|0|||
155301400|NCT00610649|560534912|FG005|Overall Study|Withdrawal by Subject|0|||
155063103|NCT00042289|559664018|FG044|Overall Study|Protocol Violation|0|||
155301401|NCT00610649|560534913|FG006|Overall Study|Withdrawal by Subject|0|||
155301402|NCT00610649|560534914|FG007|Overall Study|Withdrawal by Subject|0|||
155301403|NCT00610649|560534915|FG008|Overall Study|Withdrawal by Subject|0|||
155301404|NCT00610649|560534916|FG009|Overall Study|Withdrawal by Subject|1|||
155301405|NCT00610649|560534917|FG010|Overall Study|Withdrawal by Subject|0|||
155301406|NCT02379819|560534925|FG000|Overall Study|Withdrawal by Subject|10|||
155301407|NCT02379819|560534925|FG000|Overall Study|Death|2|||
155301408|NCT02379819|560534925|FG000|Overall Study|Lack of Efficacy|1|||
155301409|NCT02379819|560534925|FG000|Overall Study|Lost to Follow-up|1|||
155301410|NCT01839331|560534926|FG000|Overall Study|Early Termination|3|||
155301411|NCT01839331|560534927|FG001|Overall Study|Early Termination|0|||
155301412|NCT01839331|560534928|FG002|Overall Study|Early Termination|1|||
155301413|NCT01839331|560534929|FG003|Overall Study|Early Termination|2|||
155301414|NCT01839331|560534926|FG000|Overall Study|Protocol Violation|1|||
155301415|NCT01839331|560534927|FG001|Overall Study|Protocol Violation|6|||
155301416|NCT01839331|560534928|FG002|Overall Study|Protocol Violation|4|||
155301417|NCT01839331|560534929|FG003|Overall Study|Protocol Violation|3|||
155301418|NCT03074331|560534935|FG000|Overall Study|Enrolled but Not Treated|1|||
155301419|NCT03074331|560534935|FG000|Overall Study|Lost to Follow-up|5|||
155301420|NCT03074331|560534935|FG000|Overall Study|Withdrew Consent|1|||
155301421|NCT00350792|560534937|FG000|Overall Study|Adverse Event|11|||
155301422|NCT00350792|560534937|FG000|Overall Study|Death from Study Disease|1|||
155301423|NCT00350792|560534937|FG000|Overall Study|Death from Study Drug Toxicity|1|||
155301424|NCT00350792|560534937|FG000|Overall Study|Death Not Study Drug Related|2|||
155301425|NCT00350792|560534937|FG000|Overall Study|Protocol Violation|1|||
155301426|NCT00350792|560534937|FG000|Overall Study|Withdrawal by Subject|4|||
155301427|NCT00350792|560534937|FG000|Overall Study|Physician Decision|2|||
155301428|NCT00350792|560534937|FG000|Overall Study|Lack of Efficacy|11|||
155301429|NCT03451721|560534938|FG000|Overall Study|Death|1|||
155301430|NCT00960141|560534939|FG000|Overall Study|Adverse Event|4|||
155301431|NCT00960141|560534940|FG001|Overall Study|Adverse Event|8|||
155301432|NCT00960141|560534941|FG002|Overall Study|Adverse Event|2|||
155301433|NCT00960141|560534939|FG000|Overall Study|Lack of Efficacy|3|||
155301434|NCT00960141|560534940|FG001|Overall Study|Lack of Efficacy|4|||
155301435|NCT00960141|560534941|FG002|Overall Study|Lack of Efficacy|2|||
155301436|NCT00960141|560534939|FG000|Overall Study|Lost to Follow-up|1|||
155301437|NCT00960141|560534940|FG001|Overall Study|Lost to Follow-up|0|||
155301438|NCT00960141|560534941|FG002|Overall Study|Lost to Follow-up|0|||
155301439|NCT00960141|560534939|FG000|Overall Study|Protocol Violation|1|||
155301440|NCT00960141|560534940|FG001|Overall Study|Protocol Violation|3|||
155301441|NCT00960141|560534941|FG002|Overall Study|Protocol Violation|2|||
155301442|NCT00960141|560534939|FG000|Overall Study|Withdrawal by Subject|1|||
155301443|NCT00960141|560534940|FG001|Overall Study|Withdrawal by Subject|2|||
155301444|NCT00960141|560534941|FG002|Overall Study|Withdrawal by Subject|1|||
155301445|NCT05274217|560534942|FG000|Overall Study|Study terminated.|11|||
155301446|NCT05274217|560534943|FG001|Overall Study|Study terminated.|0|||
155301447|NCT04556981|560534945|FG000|Overall Study|Death|0|||
155301448|NCT04556981|560534946|FG001|Overall Study|Death|1|||
155301449|NCT04556981|560534945|FG000|Overall Study|Lost to Follow-up|2|||
155301450|NCT04556981|560534946|FG001|Overall Study|Lost to Follow-up|11|||
154957878|NCT03273153|559273973|FG000|Overall Study|Physician Decision|1|||
154957879|NCT03273153|559273974|FG001|Overall Study|Physician Decision|3|||
154957880|NCT03273153|559273973|FG000|Overall Study|Study Terminated by Sponsor|112|||
154957881|NCT03273153|559273974|FG001|Overall Study|Study Terminated by Sponsor|102|||
154957882|NCT03273153|559273973|FG000|Overall Study|Withdrawal by Subject|26|||
154957883|NCT03273153|559273974|FG001|Overall Study|Withdrawal by Subject|25|||
154957884|NCT03273153|559273973|FG000|Overall Study|Protocol Deviation|3|||
154957885|NCT03273153|559273974|FG001|Overall Study|Protocol Deviation|0|||
154957886|NCT03273153|559273973|FG000|Overall Study|Lost to Follow-up|6|||
154957887|NCT03273153|559273974|FG001|Overall Study|Lost to Follow-up|11|||
155301451|NCT04556981|560534945|FG000|Overall Study|Moved from the study area|1|||
155301452|NCT04556981|560534946|FG001|Overall Study|Moved from the study area|4|||
155301453|NCT04556981|560534945|FG000|Overall Study|Withdrawal by Subject|2|||
155301454|NCT04556981|560534946|FG001|Overall Study|Withdrawal by Subject|2|||
155301455|NCT04556981|560534945|FG000|Overall Study|Other|2|||
155301456|NCT04556981|560534946|FG001|Overall Study|Other|1|||
155301457|NCT03764475|560534947|FG000|Overall Study|Adverse Event|11|||
155301458|NCT03764475|560534948|FG001|Overall Study|Adverse Event|2|||
155301459|NCT03764475|560534947|FG000|Overall Study|Lost to Follow-up|24|||
155301460|NCT03764475|560534948|FG001|Overall Study|Lost to Follow-up|10|||
154957888|NCT03273153|559273973|FG000|Overall Study|Death|66|||
154957889|NCT03273153|559273974|FG001|Overall Study|Death|69|||
154957890|NCT00838539|559273977|FG000|Overall Study|Disease Progression|2|||
155301461|NCT03764475|560534947|FG000|Overall Study|Withdrawal by Subject|26|||
155301462|NCT03764475|560534948|FG001|Overall Study|Withdrawal by Subject|10|||
155301463|NCT03764475|560534947|FG000|Overall Study|Lack of Efficacy|3|||
155301464|NCT03764475|560534948|FG001|Overall Study|Lack of Efficacy|0|||
154957891|NCT00838539|559273978|FG001|Overall Study|Disease Progression|4|||
154957892|NCT00838539|559273979|FG002|Overall Study|Disease Progression|3|||
154957893|NCT00838539|559273980|FG003|Overall Study|Disease Progression|2|||
155301465|NCT03764475|560534947|FG000|Overall Study|COVID-19 Disruption|2|||
155301466|NCT03764475|560534948|FG001|Overall Study|COVID-19 Disruption|0|||
155301467|NCT00580866|560534949|FG000|Overall Study|Lost to Follow-up|2|||
155301468|NCT00580866|560534950|FG001|Overall Study|Lost to Follow-up|2|||
155301469|NCT02574455|560534954|FG000|Overall Study|Death|197|||
155301470|NCT02574455|560534955|FG001|Overall Study|Death|210|||
155301471|NCT02574455|560534954|FG000|Overall Study|Withdrawal of Consent|11|||
155301472|NCT02574455|560534955|FG001|Overall Study|Withdrawal of Consent|28|||
155301473|NCT02574455|560534954|FG000|Overall Study|Lost to Follow-up|4|||
155301474|NCT02574455|560534955|FG001|Overall Study|Lost to Follow-up|4|||
155301475|NCT02574455|560534954|FG000|Overall Study|Sponsor's Decision|55|||
155301476|NCT02574455|560534955|FG001|Overall Study|Sponsor's Decision|20|||
155301477|NCT05510245|560534959|FG000|Overall Study|Withdrawal by Subject|1|||
155301478|NCT05510245|560534960|FG001|Overall Study|Withdrawal by Subject|0|||
155301479|NCT05510245|560534961|FG002|Overall Study|Withdrawal by Subject|0|||
155301480|NCT01415349|560534967|FG000|Treatment Period 1|Adverse Event|0|||
155301481|NCT01415349|560534968|FG001|Treatment Period 1|Adverse Event|1|||
155301482|NCT01415349|560534967|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155301483|NCT01415349|560534968|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155301484|NCT00716859|560534971|FG000|Overall Study|Adverse Event|4|||
155301485|NCT00716859|560534972|FG001|Overall Study|Adverse Event|1|||
155301486|NCT00716859|560534971|FG000|Overall Study|Lack of Efficacy|3|||
155301487|NCT00716859|560534972|FG001|Overall Study|Lack of Efficacy|0|||
155301488|NCT00716859|560534971|FG000|Overall Study|Withdrawal by Subject|1|||
155301489|NCT00716859|560534972|FG001|Overall Study|Withdrawal by Subject|3|||
155301490|NCT00716859|560534971|FG000|Overall Study|Not treated|1|||
155301491|NCT00716859|560534972|FG001|Overall Study|Not treated|1|||
155301492|NCT00411216|560534973|FG000|Overall Study|Ten participants were entered into the c|0|||
155301493|NCT00411216|560534974|FG001|Overall Study|Ten participants were entered into the c|2|||
155301494|NCT04922021|560536304|FG000|Overall Study|Withdrawal by Subject|4|||
155301495|NCT04922021|560536305|FG001|Overall Study|Withdrawal by Subject|10|||
155301496|NCT04922021|560536304|FG000|Overall Study|Adverse Event|2|||
155301497|NCT04922021|560536305|FG001|Overall Study|Adverse Event|2|||
155301498|NCT04922021|560536304|FG000|Overall Study|Lack of Efficacy|0|||
155301499|NCT04922021|560536305|FG001|Overall Study|Lack of Efficacy|1|||
155301500|NCT04922021|560536304|FG000|Overall Study|Multiple reasons|1|||
155301501|NCT04922021|560536305|FG001|Overall Study|Multiple reasons|0|||
155301502|NCT03237481|560536308|FG000|Overall Study|Lost to Follow-up|1|||
155301503|NCT03237481|560536309|FG001|Overall Study|Lost to Follow-up|0|||
155301504|NCT03237481|560536310|FG002|Overall Study|Lost to Follow-up|0|||
155301505|NCT03237481|560536308|FG000|Overall Study|Protocol Violation|1|||
155301506|NCT03237481|560536309|FG001|Overall Study|Protocol Violation|0|||
155301507|NCT03237481|560536310|FG002|Overall Study|Protocol Violation|0|||
155301508|NCT03237481|560536308|FG000|Overall Study|Withdrawal by Subject|3|||
155301509|NCT03237481|560536309|FG001|Overall Study|Withdrawal by Subject|2|||
155301510|NCT03237481|560536310|FG002|Overall Study|Withdrawal by Subject|1|||
155301511|NCT02544074|560536311|FG000|Overall Study|Withdrawal by Subject|0|||
155159407|NCT00068692|560022781|FG002|Step 1: Registration|Death|0|||
155159408|NCT00068692|560022782|FG003|Step 1: Registration|Death|0|||
155159409|NCT00068692|560022783|FG004|Step 1: Registration|Death|0|||
155159410|NCT00068692|560022784|FG005|Step 1: Registration|Death|0|||
155159411|NCT00068692|560022785|FG006|Step 1: Registration|Death|0|||
155159412|NCT00068692|560022786|FG007|Step 1: Registration|Death|0|||
155159413|NCT00068692|560022779|FG000|Step 1: Registration|Withdrawal by Subject|11|||
155159414|NCT00068692|560022780|FG001|Step 1: Registration|Withdrawal by Subject|0|||
155159415|NCT00068692|560022781|FG002|Step 1: Registration|Withdrawal by Subject|0|||
155159416|NCT00068692|560022782|FG003|Step 1: Registration|Withdrawal by Subject|0|||
155159417|NCT00068692|560022783|FG004|Step 1: Registration|Withdrawal by Subject|0|||
155159418|NCT00068692|560022784|FG005|Step 1: Registration|Withdrawal by Subject|0|||
155301512|NCT02544074|560536312|FG001|Overall Study|Withdrawal by Subject|1|||
155159419|NCT00068692|560022785|FG006|Step 1: Registration|Withdrawal by Subject|0|||
155159420|NCT00068692|560022786|FG007|Step 1: Registration|Withdrawal by Subject|0|||
155159421|NCT00068692|560022779|FG000|Step 1: Registration|Alternative therapy|2|||
155159422|NCT00068692|560022780|FG001|Step 1: Registration|Alternative therapy|0|||
155159423|NCT00068692|560022781|FG002|Step 1: Registration|Alternative therapy|0|||
155159424|NCT00068692|560022782|FG003|Step 1: Registration|Alternative therapy|0|||
155159425|NCT00068692|560022783|FG004|Step 1: Registration|Alternative therapy|0|||
155301513|NCT02544074|560536313|FG002|Overall Study|Withdrawal by Subject|0|||
155301514|NCT02544074|560536314|FG003|Overall Study|Withdrawal by Subject|0|||
155301515|NCT02544074|560536315|FG004|Overall Study|Withdrawal by Subject|0|||
155301516|NCT02544074|560536316|FG005|Overall Study|Withdrawal by Subject|0|||
155159426|NCT00068692|560022784|FG005|Step 1: Registration|Alternative therapy|0|||
155159427|NCT00068692|560022785|FG006|Step 1: Registration|Alternative therapy|0|||
155301517|NCT02544074|560536317|FG006|Overall Study|Withdrawal by Subject|0|||
155301518|NCT02544074|560536318|FG007|Overall Study|Withdrawal by Subject|0|||
155301519|NCT02544074|560536319|FG008|Overall Study|Withdrawal by Subject|0|||
155301520|NCT02544074|560536320|FG009|Overall Study|Withdrawal by Subject|0|||
155301521|NCT02544074|560536321|FG010|Overall Study|Withdrawal by Subject|0|||
155301522|NCT02544074|560536322|FG011|Overall Study|Withdrawal by Subject|0|||
155301523|NCT02544074|560536323|FG012|Overall Study|Withdrawal by Subject|0|||
155301524|NCT02544074|560536324|FG013|Overall Study|Withdrawal by Subject|0|||
155301525|NCT02544074|560536325|FG014|Overall Study|Withdrawal by Subject|0|||
155301526|NCT02544074|560536326|FG015|Overall Study|Withdrawal by Subject|0|||
155301527|NCT02544074|560536327|FG016|Overall Study|Withdrawal by Subject|0|||
155301528|NCT02544074|560536328|FG017|Overall Study|Withdrawal by Subject|0|||
155301529|NCT02544074|560536329|FG018|Overall Study|Withdrawal by Subject|0|||
155301530|NCT02544074|560536330|FG019|Overall Study|Withdrawal by Subject|0|||
155301531|NCT02544074|560536331|FG020|Overall Study|Withdrawal by Subject|0|||
155301532|NCT02544074|560536311|FG000|Overall Study|Tablet error|0|||
155301533|NCT02544074|560536312|FG001|Overall Study|Tablet error|0|||
155301534|NCT02544074|560536313|FG002|Overall Study|Tablet error|0|||
155301535|NCT02544074|560536314|FG003|Overall Study|Tablet error|0|||
155301536|NCT02544074|560536315|FG004|Overall Study|Tablet error|0|||
155301537|NCT02544074|560536316|FG005|Overall Study|Tablet error|1|||
155301538|NCT02544074|560536317|FG006|Overall Study|Tablet error|0|||
155301539|NCT02544074|560536318|FG007|Overall Study|Tablet error|0|||
155301540|NCT02544074|560536319|FG008|Overall Study|Tablet error|0|||
155301541|NCT02544074|560536320|FG009|Overall Study|Tablet error|1|||
155301542|NCT02544074|560536321|FG010|Overall Study|Tablet error|0|||
155301543|NCT02544074|560536322|FG011|Overall Study|Tablet error|0|||
155301544|NCT02544074|560536323|FG012|Overall Study|Tablet error|0|||
155301545|NCT02544074|560536324|FG013|Overall Study|Tablet error|0|||
155301546|NCT02544074|560536325|FG014|Overall Study|Tablet error|0|||
155301547|NCT02544074|560536326|FG015|Overall Study|Tablet error|0|||
155301548|NCT02544074|560536327|FG016|Overall Study|Tablet error|0|||
155301549|NCT02544074|560536328|FG017|Overall Study|Tablet error|0|||
155301550|NCT02544074|560536329|FG018|Overall Study|Tablet error|0|||
155301551|NCT02544074|560536330|FG019|Overall Study|Tablet error|0|||
155301552|NCT02544074|560536331|FG020|Overall Study|Tablet error|0|||
155301553|NCT01998984|560536332|FG000|Overall Study|Adverse Event|0|||
155301554|NCT01998984|560536333|FG001|Overall Study|Adverse Event|0|||
155301555|NCT01998984|560536334|FG002|Overall Study|Adverse Event|0|||
155301556|NCT01998984|560536335|FG003|Overall Study|Adverse Event|1|||
155301557|NCT01998984|560536332|FG000|Overall Study|Lost to Follow-up|0|||
155301558|NCT01998984|560536333|FG001|Overall Study|Lost to Follow-up|1|||
155301559|NCT01998984|560536334|FG002|Overall Study|Lost to Follow-up|0|||
155301560|NCT01998984|560536335|FG003|Overall Study|Lost to Follow-up|1|||
155301561|NCT01998984|560536332|FG000|Overall Study|Withdrawal by Subject|0|||
155301562|NCT01998984|560536333|FG001|Overall Study|Withdrawal by Subject|0|||
155301563|NCT01998984|560536334|FG002|Overall Study|Withdrawal by Subject|1|||
155301564|NCT01998984|560536335|FG003|Overall Study|Withdrawal by Subject|0|||
155301565|NCT01998984|560536332|FG000|Overall Study|Other|0|||
155301566|NCT01998984|560536333|FG001|Overall Study|Other|0|||
155301567|NCT01998984|560536334|FG002|Overall Study|Other|0|||
155301568|NCT01998984|560536335|FG003|Overall Study|Other|1|||
155301569|NCT04279574|560536337|FG000|Overall Study|Death|1|||
155301570|NCT04279574|560536338|FG001|Overall Study|Death|0|||
155301571|NCT04279574|560536337|FG000|Overall Study|lost restoration, tooth fracture|1|||
155301572|NCT04279574|560536338|FG001|Overall Study|lost restoration, tooth fracture|0|||
155301573|NCT04279574|560536337|FG000|Overall Study|Lost to Follow-up|0|||
155301574|NCT04279574|560536338|FG001|Overall Study|Lost to Follow-up|1|||
155301575|NCT02566902|560536340|FG000|Overall Study|Protocol Violation|2|||
155301576|NCT02566902|560536341|FG001|Overall Study|Protocol Violation|1|||
155301577|NCT02411084|560536342|FG000|Overall Study|Lack of Efficacy|6|||
155301578|NCT02411084|560536343|FG001|Overall Study|Lack of Efficacy|3|||
155301579|NCT02411084|560536342|FG000|Overall Study|Death|5|||
155301580|NCT02411084|560536343|FG001|Overall Study|Death|4|||
155301581|NCT02411084|560536342|FG000|Overall Study|Adverse Event|2|||
155301582|NCT02411084|560536343|FG001|Overall Study|Adverse Event|1|||
155301583|NCT02411084|560536342|FG000|Overall Study|Other reasons|0|||
155301584|NCT02411084|560536343|FG001|Overall Study|Other reasons|5|||
155301585|NCT03624972|560536344|FG000|Overall Study|Lost to Follow-up|2|||
155301586|NCT03624972|560536345|FG001|Overall Study|Lost to Follow-up|0|||
155301587|NCT03624972|560536346|FG002|Overall Study|Lost to Follow-up|0|||
155301588|NCT03624972|560536344|FG000|Overall Study|Withdrawal by Subject|0|||
155301589|NCT03624972|560536345|FG001|Overall Study|Withdrawal by Subject|2|||
155301590|NCT03624972|560536346|FG002|Overall Study|Withdrawal by Subject|0|||
155301591|NCT02647905|560536359|FG000|Overall Study|Lost to Follow-up|1|||
155301592|NCT02647905|560536359|FG000|Overall Study|Withdrawal by Subject|2|||
155301593|NCT00642850|560536361|FG000|Overall Study|Death|7|||
155301594|NCT00642850|560536361|FG000|Overall Study|Adverse Event|2|||
155301595|NCT00642850|560536361|FG000|Overall Study|Lack of Efficacy|1|||
155301596|NCT00642850|560536361|FG000|Overall Study|Protocol Violation|2|||
155301597|NCT00642850|560536361|FG000|Overall Study|Kidney transplantation|8|||
155301598|NCT00642850|560536361|FG000|Overall Study|Blood transfusion|6|||
155301599|NCT00642850|560536361|FG000|Overall Study|Other reasons|7|||
155301600|NCT05489484|560536364|FG000|Overall Study|withdrawn|1|||
155301601|NCT00444600|560536370|FG000|Overall Study|Death|7|||
155301602|NCT00444600|560536371|FG001|Overall Study|Death|5|||
155301603|NCT00444600|560536372|FG002|Overall Study|Death|3|||
155301604|NCT00444600|560536373|FG003|Overall Study|Death|2|||
155301605|NCT00444600|560536370|FG000|Overall Study|Dropped|11|||
155301606|NCT00444600|560536371|FG001|Overall Study|Dropped|11|||
155301607|NCT00444600|560536372|FG002|Overall Study|Dropped|7|||
155301608|NCT00444600|560536373|FG003|Overall Study|Dropped|7|||
155301609|NCT00444600|560536370|FG000|Overall Study|Missed visit|1|||
155301610|NCT00444600|560536371|FG001|Overall Study|Missed visit|0|||
155301611|NCT00444600|560536372|FG002|Overall Study|Missed visit|0|||
155301612|NCT00444600|560536373|FG003|Overall Study|Missed visit|1|||
155301613|NCT05132478|560536374|FG000|Overall Study|did not complete survey after consent|1|||
155301614|NCT05132478|560536375|FG001|Overall Study|did not complete survey after consent|1|||
155301615|NCT05132478|560536374|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
155301616|NCT05132478|560536375|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
155301617|NCT00106080|560536376|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
155301618|NCT00106080|560536377|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
155301619|NCT01414738|560536379|FG000|Overall Study|Death|26|||
155301620|NCT01414738|560536379|FG000|Overall Study|Refused testing|5|||
155301621|NCT01414738|560536379|FG000|Overall Study|Lost to Follow-up|2|||
155301622|NCT01414738|560536379|FG000|Overall Study|Refused, disease progression|8|||
155301623|NCT01414738|560536379|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
155301624|NCT01266122|560536380|FG000|Overall Study|Lost to Follow-up|6|||
155301625|NCT01266122|560536381|FG001|Overall Study|Lost to Follow-up|6|||
155301626|NCT00421889|560536382|FG000|Overall Study|Adverse Event|1|||
155301627|NCT00421889|560536383|FG001|Overall Study|Adverse Event|0|||
155301628|NCT00421889|560536384|FG002|Overall Study|Adverse Event|1|||
155301629|NCT00421889|560536385|FG003|Overall Study|Adverse Event|1|||
155301630|NCT00421889|560536386|FG004|Overall Study|Adverse Event|1|||
155301631|NCT00421889|560536387|FG005|Overall Study|Adverse Event|4|||
155301632|NCT00421889|560536388|FG006|Overall Study|Adverse Event|1|||
155301633|NCT00421889|560536389|FG007|Overall Study|Adverse Event|0|||
155301634|NCT00421889|560536390|FG008|Overall Study|Adverse Event|2|||
155301635|NCT00421889|560536382|FG000|Overall Study|Withdrawal by Subject|1|||
155301636|NCT00421889|560536383|FG001|Overall Study|Withdrawal by Subject|3|||
155301637|NCT00421889|560536384|FG002|Overall Study|Withdrawal by Subject|0|||
155301638|NCT00421889|560536385|FG003|Overall Study|Withdrawal by Subject|0|||
155301639|NCT00421889|560536386|FG004|Overall Study|Withdrawal by Subject|2|||
155301640|NCT00421889|560536387|FG005|Overall Study|Withdrawal by Subject|0|||
155301641|NCT00421889|560536388|FG006|Overall Study|Withdrawal by Subject|0|||
155301642|NCT00421889|560536389|FG007|Overall Study|Withdrawal by Subject|0|||
155301643|NCT00421889|560536390|FG008|Overall Study|Withdrawal by Subject|0|||
155301644|NCT00421889|560536382|FG000|Overall Study|Death|0|||
155301645|NCT00421889|560536383|FG001|Overall Study|Death|0|||
155301646|NCT00421889|560536384|FG002|Overall Study|Death|0|||
155301647|NCT00421889|560536385|FG003|Overall Study|Death|0|||
155301648|NCT00421889|560536386|FG004|Overall Study|Death|1|||
155301649|NCT00421889|560536387|FG005|Overall Study|Death|1|||
155301650|NCT00421889|560536388|FG006|Overall Study|Death|0|||
155301651|NCT00421889|560536389|FG007|Overall Study|Death|0|||
155301652|NCT00421889|560536390|FG008|Overall Study|Death|0|||
155301653|NCT00421889|560536382|FG000|Overall Study|Progressive disease|3|||
155301654|NCT00421889|560536383|FG001|Overall Study|Progressive disease|2|||
155159428|NCT00068692|560022786|FG007|Step 1: Registration|Alternative therapy|0|||
155159429|NCT00068692|560022779|FG000|Step 1: Registration|Complicating disease|2|||
155159430|NCT00068692|560022780|FG001|Step 1: Registration|Complicating disease|0|||
155159431|NCT00068692|560022781|FG002|Step 1: Registration|Complicating disease|0|||
155159432|NCT00068692|560022782|FG003|Step 1: Registration|Complicating disease|0|||
155159433|NCT00068692|560022783|FG004|Step 1: Registration|Complicating disease|0|||
155159434|NCT00068692|560022784|FG005|Step 1: Registration|Complicating disease|0|||
155159435|NCT00068692|560022785|FG006|Step 1: Registration|Complicating disease|0|||
155159436|NCT00068692|560022786|FG007|Step 1: Registration|Complicating disease|0|||
155159437|NCT00068692|560022779|FG000|Step 1: Registration|Protocol Violation|1|||
155159438|NCT00068692|560022780|FG001|Step 1: Registration|Protocol Violation|0|||
155301655|NCT00421889|560536384|FG002|Overall Study|Progressive disease|2|||
155301656|NCT00421889|560536385|FG003|Overall Study|Progressive disease|3|||
155301657|NCT00421889|560536386|FG004|Overall Study|Progressive disease|2|||
155301658|NCT00421889|560536387|FG005|Overall Study|Progressive disease|21|||
155301659|NCT00421889|560536388|FG006|Overall Study|Progressive disease|3|||
155301660|NCT00421889|560536389|FG007|Overall Study|Progressive disease|1|||
155301661|NCT00421889|560536390|FG008|Overall Study|Progressive disease|5|||
155301662|NCT00421889|560536382|FG000|Overall Study|Patient/Investigator request|0|||
155301663|NCT00421889|560536383|FG001|Overall Study|Patient/Investigator request|0|||
155159439|NCT00068692|560022781|FG002|Step 1: Registration|Protocol Violation|0|||
155301664|NCT00421889|560536384|FG002|Overall Study|Patient/Investigator request|0|||
155301665|NCT00421889|560536385|FG003|Overall Study|Patient/Investigator request|0|||
155301666|NCT00421889|560536386|FG004|Overall Study|Patient/Investigator request|0|||
155301667|NCT00421889|560536387|FG005|Overall Study|Patient/Investigator request|9|||
155301668|NCT00421889|560536388|FG006|Overall Study|Patient/Investigator request|0|||
155301669|NCT00421889|560536389|FG007|Overall Study|Patient/Investigator request|1|||
155301670|NCT00421889|560536390|FG008|Overall Study|Patient/Investigator request|3|||
155301671|NCT00421889|560536382|FG000|Overall Study|Lost to Follow-up|0|||
155301672|NCT00421889|560536383|FG001|Overall Study|Lost to Follow-up|0|||
155301673|NCT00421889|560536384|FG002|Overall Study|Lost to Follow-up|0|||
155301674|NCT00421889|560536385|FG003|Overall Study|Lost to Follow-up|0|||
155301675|NCT00421889|560536386|FG004|Overall Study|Lost to Follow-up|0|||
155301676|NCT00421889|560536387|FG005|Overall Study|Lost to Follow-up|0|||
155301677|NCT00421889|560536388|FG006|Overall Study|Lost to Follow-up|0|||
155301678|NCT00421889|560536389|FG007|Overall Study|Lost to Follow-up|0|||
155301679|NCT00421889|560536390|FG008|Overall Study|Lost to Follow-up|1|||
155301680|NCT03756571|560536391|FG000|Overall Study|Lost to Follow-up|1|||
155301681|NCT03756571|560536392|FG001|Overall Study|Lost to Follow-up|1|||
155301682|NCT00978042|560536393|FG000|Initial Treatment Period|Treated in Error|0|||
155301683|NCT00978042|560536394|FG001|Initial Treatment Period|Treated in Error|3|||
155301684|NCT00978042|560536393|FG000|Initial Treatment Period|Ineligibility|1|||
155301685|NCT00978042|560536394|FG001|Initial Treatment Period|Ineligibility|0|||
155301686|NCT00978042|560536393|FG000|Initial Treatment Period|Lost to Follow-up|21|||
155301687|NCT00978042|560536394|FG001|Initial Treatment Period|Lost to Follow-up|3|||
155301688|NCT00978042|560536393|FG000|Initial Treatment Period|Adverse Event|2|||
155301689|NCT00978042|560536394|FG001|Initial Treatment Period|Adverse Event|0|||
155301690|NCT00978042|560536393|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
155301691|NCT00978042|560536394|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
155301692|NCT00978042|560536393|FG000|Initial Treatment Period|Consent withdrawn|22|||
155063104|NCT00042289|559664019|FG045|Overall Study|Protocol Violation|0|||
155063105|NCT00042289|559664020|FG046|Overall Study|Protocol Violation|0|||
155063106|NCT00042289|559663974|FG000|Overall Study|Withdrawal by Subject|4|||
155063107|NCT00042289|559663975|FG001|Overall Study|Withdrawal by Subject|1|||
155301693|NCT00978042|560536394|FG001|Initial Treatment Period|Consent withdrawn|9|||
155301694|NCT00978042|560536393|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
155301695|NCT00978042|560536394|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
155301696|NCT00529516|560536395|FG000|Overall Study|Adverse Event|2|||
155301697|NCT00529516|560536396|FG001|Overall Study|Adverse Event|1|||
155301698|NCT00529516|560536397|FG002|Overall Study|Adverse Event|0|||
155301699|NCT00529516|560536395|FG000|Overall Study|Withdrawal by Subject|1|||
155301700|NCT00529516|560536396|FG001|Overall Study|Withdrawal by Subject|1|||
155301701|NCT00529516|560536397|FG002|Overall Study|Withdrawal by Subject|0|||
155301702|NCT00529516|560536395|FG000|Overall Study|Lost to Follow-up|0|||
155301703|NCT00529516|560536396|FG001|Overall Study|Lost to Follow-up|0|||
155301704|NCT00529516|560536397|FG002|Overall Study|Lost to Follow-up|1|||
155301705|NCT03752151|560536398|FG000|Overall Study|Withdrawal by Subject|1|||
155301706|NCT03752151|560536398|FG000|Overall Study|Protocol Violation|1|||
155301707|NCT00703820|560536401|FG000|Overall Study|Adverse Event|12|||
155301708|NCT00703820|560536402|FG001|Overall Study|Adverse Event|17|||
155301709|NCT00703820|560536401|FG000|Overall Study|Death|5|||
155301710|NCT00703820|560536402|FG001|Overall Study|Death|0|||
155301711|NCT00703820|560536401|FG000|Overall Study|Lack of Efficacy|11|||
155301712|NCT00703820|560536402|FG001|Overall Study|Lack of Efficacy|11|||
155301713|NCT00703820|560536401|FG000|Overall Study|Received non-protocol therapy|1|||
155301714|NCT00703820|560536402|FG001|Overall Study|Received non-protocol therapy|0|||
155301715|NCT00703820|560536401|FG000|Overall Study|Physician Decision|4|||
155301716|NCT00703820|560536402|FG001|Overall Study|Physician Decision|5|||
155301717|NCT00703820|560536401|FG000|Overall Study|Withdrawal by Subject|2|||
155301718|NCT00703820|560536402|FG001|Overall Study|Withdrawal by Subject|1|||
155301719|NCT00761605|560536403|FG000|Overall Study|Adverse Event|26|||
155301720|NCT00761605|560536403|FG000|Overall Study|Death|2|||
155301721|NCT00761605|560536403|FG000|Overall Study|Lack of Efficacy|26|||
155301722|NCT00761605|560536403|FG000|Overall Study|Lost to Follow-up|29|||
155301723|NCT00761605|560536403|FG000|Overall Study|Withdrawal by Subject|37|||
155301724|NCT00761605|560536403|FG000|Overall Study|Other|21|||
155301725|NCT01007396|560536404|FG000|Overall Study|Lost to Follow-up|47|||
155301726|NCT03283371|560536407|FG000|Placebo-controlled|Adverse Event|1|||
155063108|NCT00042289|559663976|FG002|Overall Study|Withdrawal by Subject|0|||
155063109|NCT00042289|559663977|FG003|Overall Study|Withdrawal by Subject|2|||
155301727|NCT03283371|560536408|FG001|Placebo-controlled|Adverse Event|1|||
155301728|NCT03283371|560536409|FG002|Placebo-controlled|Adverse Event|0|||
155301729|NCT03283371|560536410|FG003|Placebo-controlled|Adverse Event|0|||
155301730|NCT03283371|560536407|FG000|Placebo-controlled|Lack of Efficacy|1|||
155301731|NCT03283371|560536408|FG001|Placebo-controlled|Lack of Efficacy|0|||
155301732|NCT03283371|560536409|FG002|Placebo-controlled|Lack of Efficacy|0|||
155301733|NCT03283371|560536410|FG003|Placebo-controlled|Lack of Efficacy|0|||
155301734|NCT03283371|560536407|FG000|Placebo-controlled|Withdrawal by Subject|1|||
155063110|NCT00042289|559663978|FG004|Overall Study|Withdrawal by Subject|0|||
155301735|NCT03283371|560536408|FG001|Placebo-controlled|Withdrawal by Subject|1|||
155301736|NCT03283371|560536409|FG002|Placebo-controlled|Withdrawal by Subject|0|||
155301737|NCT03283371|560536410|FG003|Placebo-controlled|Withdrawal by Subject|0|||
155301738|NCT03283371|560536407|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
155301739|NCT03283371|560536408|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
155301740|NCT03283371|560536409|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
155301741|NCT03283371|560536410|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
155301742|NCT03283371|560536407|FG000|Open-label Phase|Adverse Event|0|||
155301743|NCT03283371|560536408|FG001|Open-label Phase|Adverse Event|0|||
155301744|NCT03283371|560536409|FG002|Open-label Phase|Adverse Event|2|||
155301745|NCT03283371|560536410|FG003|Open-label Phase|Adverse Event|0|||
155301746|NCT03283371|560536407|FG000|Open-label Phase|Withdrawal by Subject|0|||
155301747|NCT03283371|560536408|FG001|Open-label Phase|Withdrawal by Subject|0|||
155301748|NCT03283371|560536409|FG002|Open-label Phase|Withdrawal by Subject|1|||
155301749|NCT03283371|560536410|FG003|Open-label Phase|Withdrawal by Subject|0|||
155301750|NCT03283371|560536407|FG000|Open-label Phase|Other|0|||
155301751|NCT03283371|560536408|FG001|Open-label Phase|Other|0|||
155301752|NCT03283371|560536409|FG002|Open-label Phase|Other|1|||
155301753|NCT03283371|560536410|FG003|Open-label Phase|Other|1|||
155301754|NCT01373346|560536411|FG000|Overall Study|Death|1|||
155301755|NCT01198028|560536412|FG000|Overall Study|Adverse Event|5|||
155301756|NCT01198028|560536412|FG000|Overall Study|Death|3|||
155301757|NCT01198028|560536412|FG000|Overall Study|Physician Decision|2|||
155301758|NCT00970359|560536414|FG000|Overall Study|Not Treated|4|||
155301759|NCT03887650|560536417|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
155301760|NCT03887650|560536418|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
155301761|NCT03887650|560536417|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
155301762|NCT03887650|560536418|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
155301763|NCT03887650|560536417|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
155301764|NCT03887650|560536418|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
155301765|NCT03942042|560536421|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
155301766|NCT03942042|560536422|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
155301767|NCT03942042|560536421|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
155301768|NCT03942042|560536422|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
155301769|NCT01499199|560536423|FG000|Overall Study|Adverse Event|1|||
155301770|NCT01499199|560536423|FG000|Overall Study|Lack of Efficacy|1|||
155301771|NCT01199705|560536424|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
155301772|NCT01692730|560536425|FG000|Overall Study|Lost to Follow-up|225|||
155301773|NCT01692730|560536426|FG001|Overall Study|Lost to Follow-up|227|||
155301774|NCT01199575|560536427|FG000|Overall Study|Withdrawal by Subject|5|||
155301775|NCT00704184|560536430|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
155301776|NCT00704184|560536431|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
155301777|NCT00704184|560536432|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
155301778|NCT00704184|560536433|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
155301779|NCT00704184|560536434|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
155301780|NCT00704184|560536430|FG000|Open-Label Treatment|Adverse Event|0|||
155159440|NCT00068692|560022782|FG003|Step 1: Registration|Protocol Violation|0|||
155159441|NCT00068692|560022783|FG004|Step 1: Registration|Protocol Violation|0|||
155301781|NCT00704184|560536431|FG001|Open-Label Treatment|Adverse Event|0|||
155301782|NCT00704184|560536432|FG002|Open-Label Treatment|Adverse Event|2|||
155301783|NCT00704184|560536433|FG003|Open-Label Treatment|Adverse Event|0|||
155301784|NCT00704184|560536434|FG004|Open-Label Treatment|Adverse Event|1|||
155301785|NCT00704184|560536430|FG000|Open-Label Treatment|Lack of Efficacy|0|||
155301786|NCT00704184|560536431|FG001|Open-Label Treatment|Lack of Efficacy|2|||
155301787|NCT00704184|560536432|FG002|Open-Label Treatment|Lack of Efficacy|2|||
155301788|NCT00704184|560536433|FG003|Open-Label Treatment|Lack of Efficacy|2|||
155301789|NCT00704184|560536434|FG004|Open-Label Treatment|Lack of Efficacy|1|||
155301790|NCT00704184|560536430|FG000|Open-Label Treatment|Physician Decision|0|||
155301791|NCT00704184|560536431|FG001|Open-Label Treatment|Physician Decision|0|||
155159442|NCT00068692|560022784|FG005|Step 1: Registration|Protocol Violation|0|||
155301792|NCT00704184|560536432|FG002|Open-Label Treatment|Physician Decision|0|||
155301793|NCT00704184|560536433|FG003|Open-Label Treatment|Physician Decision|0|||
155301794|NCT00704184|560536434|FG004|Open-Label Treatment|Physician Decision|1|||
155301795|NCT00704184|560536430|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
155301796|NCT00704184|560536431|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155301797|NCT00704184|560536432|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
155301798|NCT00704184|560536433|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
154957894|NCT00838539|559273981|FG004|Overall Study|Disease Progression|4|||
154957895|NCT00838539|559273982|FG005|Overall Study|Disease Progression|2|||
154957896|NCT00838539|559273983|FG006|Overall Study|Disease Progression|3|||
154957897|NCT00838539|559273984|FG007|Overall Study|Disease Progression|4|||
154957898|NCT00838539|559273985|FG008|Overall Study|Disease Progression|4|||
154957899|NCT00838539|559273986|FG009|Overall Study|Disease Progression|5|||
154957900|NCT00838539|559273987|FG010|Overall Study|Disease Progression|1|||
154957901|NCT00838539|559273988|FG011|Overall Study|Disease Progression|4|||
154957902|NCT00838539|559273977|FG000|Overall Study|Adverse Event|1|||
155063111|NCT00042289|559663979|FG005|Overall Study|Withdrawal by Subject|2|||
155063112|NCT00042289|559663980|FG006|Overall Study|Withdrawal by Subject|0|||
155063113|NCT00042289|559663981|FG007|Overall Study|Withdrawal by Subject|0|||
155063114|NCT00042289|559663982|FG008|Overall Study|Withdrawal by Subject|0|||
155301799|NCT00704184|560536434|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
155301800|NCT01251354|560536444|FG000|Overall Study|Adverse Event|1|||
155301801|NCT01251354|560536444|FG000|Overall Study|Investigator's Decision|1|||
155301802|NCT01251354|560536444|FG000|Overall Study|Disease Progression|4|||
155301803|NCT03960463|560538358|FG000|Overall Study|Withdrawal by Subject|2|||
155301804|NCT03960463|560538359|FG001|Overall Study|Withdrawal by Subject|0|||
155301805|NCT03422276|560538360|FG000|Overall Study|Withdrawal by Subject|21|||
155301806|NCT03422276|560538361|FG001|Overall Study|Withdrawal by Subject|25|||
155301807|NCT03422276|560538362|FG002|Overall Study|Withdrawal by Subject|14|||
155301808|NCT03422276|560538363|FG003|Overall Study|Withdrawal by Subject|16|||
155301809|NCT03422276|560538360|FG000|Overall Study|Death|14|||
155301810|NCT03422276|560538361|FG001|Overall Study|Death|21|||
155301811|NCT03422276|560538362|FG002|Overall Study|Death|3|||
155301812|NCT03422276|560538363|FG003|Overall Study|Death|1|||
155301813|NCT03422276|560538360|FG000|Overall Study|Discontinued, ineligible|4|||
155301814|NCT03422276|560538361|FG001|Overall Study|Discontinued, ineligible|3|||
155301815|NCT03422276|560538362|FG002|Overall Study|Discontinued, ineligible|0|||
155301816|NCT03422276|560538363|FG003|Overall Study|Discontinued, ineligible|0|||
155301817|NCT03422276|560538360|FG000|Overall Study|Lost to Follow-up|15|||
155301818|NCT03422276|560538361|FG001|Overall Study|Lost to Follow-up|8|||
155301819|NCT03422276|560538362|FG002|Overall Study|Lost to Follow-up|13|||
155301820|NCT03422276|560538363|FG003|Overall Study|Lost to Follow-up|4|||
155301821|NCT03422276|560538360|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
155301822|NCT03422276|560538361|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
155301823|NCT03422276|560538362|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
155301824|NCT03422276|560538363|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
155301825|NCT03422276|560538360|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
155301826|NCT03422276|560538361|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
155301827|NCT03422276|560538362|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
155301828|NCT03422276|560538363|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
155301829|NCT03422276|560538360|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
155301830|NCT03422276|560538361|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
155301831|NCT03422276|560538362|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
155301832|NCT03422276|560538363|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
155301833|NCT03422276|560538360|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
155301834|NCT03422276|560538361|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
155301835|NCT03422276|560538362|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
155301836|NCT03422276|560538363|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
155301837|NCT03422276|560538360|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
155301838|NCT03422276|560538361|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
155301839|NCT03422276|560538362|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
155301840|NCT03422276|560538363|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
155301841|NCT05194917|560538364|FG000|Overall Study|Lost to Follow-up|7|||
155301842|NCT05194917|560538365|FG001|Overall Study|Lost to Follow-up|5|||
155301843|NCT05194917|560538366|FG002|Overall Study|Lost to Follow-up|6|||
155301844|NCT05194917|560538367|FG003|Overall Study|Lost to Follow-up|5|||
155301845|NCT04941287|560538379|FG000|Overall Study|Rapid decline before starting treatment|3|||
155301846|NCT04941287|560538380|FG001|Overall Study|Rapid decline before starting treatment|1|||
155301847|NCT02991807|560538385|FG000|Overall Study|Withdrawal by Subject|2|||
155301848|NCT02991807|560538386|FG001|Overall Study|Withdrawal by Subject|1|||
155301849|NCT02991807|560538385|FG000|Overall Study|Physician Decision|0|||
155301850|NCT02991807|560538386|FG001|Overall Study|Physician Decision|1|||
155301851|NCT02991807|560538385|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
155301852|NCT02991807|560538386|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
155301853|NCT00332241|560538391|FG000|Overall Study|Lack of Efficacy|6|||
155301854|NCT00332241|560538392|FG001|Overall Study|Lack of Efficacy|1|||
155301855|NCT00332241|560538391|FG000|Overall Study|Adverse Event|3|||
155301856|NCT00332241|560538392|FG001|Overall Study|Adverse Event|5|||
155301857|NCT00332241|560538391|FG000|Overall Study|Withdrawal by Subject|2|||
155301858|NCT00332241|560538392|FG001|Overall Study|Withdrawal by Subject|1|||
155301859|NCT00332241|560538391|FG000|Overall Study|Lost to Follow-up|4|||
155301860|NCT00332241|560538392|FG001|Overall Study|Lost to Follow-up|1|||
155301861|NCT00802464|560538393|FG000|Month 0 - Month 8|Adverse Event|0|||
155063115|NCT00042289|559663983|FG009|Overall Study|Withdrawal by Subject|1|||
155063116|NCT00042289|559663984|FG010|Overall Study|Withdrawal by Subject|0|||
155301862|NCT00802464|560538394|FG001|Month 0 - Month 8|Adverse Event|1|||
155301863|NCT00802464|560538395|FG002|Month 0 - Month 8|Adverse Event|1|||
155159443|NCT00068692|560022785|FG006|Step 1: Registration|Protocol Violation|0|||
155159444|NCT00068692|560022786|FG007|Step 1: Registration|Protocol Violation|0|||
155159445|NCT00068692|560022779|FG000|Step 1: Registration|Not eligible|6|||
155159446|NCT00068692|560022780|FG001|Step 1: Registration|Not eligible|0|||
155159447|NCT00068692|560022781|FG002|Step 1: Registration|Not eligible|0|||
155159448|NCT00068692|560022782|FG003|Step 1: Registration|Not eligible|0|||
155301864|NCT00802464|560538396|FG003|Month 0 - Month 8|Adverse Event|2|||
155301865|NCT00802464|560538393|FG000|Month 0 - Month 8|Protocol Violation|0|||
155301866|NCT00802464|560538394|FG001|Month 0 - Month 8|Protocol Violation|0|||
155301867|NCT00802464|560538395|FG002|Month 0 - Month 8|Protocol Violation|1|||
155301868|NCT00802464|560538396|FG003|Month 0 - Month 8|Protocol Violation|0|||
155301869|NCT00802464|560538393|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
155301870|NCT00802464|560538394|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
155301871|NCT00802464|560538395|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
155301872|NCT00802464|560538396|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
155301873|NCT00802464|560538393|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
155301874|NCT00802464|560538394|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
155301875|NCT00802464|560538395|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
155301876|NCT00802464|560538396|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
155301877|NCT00802464|560538393|FG000|Month 0 - Month 8|Other|0|||
155301878|NCT00802464|560538394|FG001|Month 0 - Month 8|Other|0|||
155301879|NCT00802464|560538395|FG002|Month 0 - Month 8|Other|1|||
155301880|NCT00802464|560538396|FG003|Month 0 - Month 8|Other|0|||
155301881|NCT00802464|560538393|FG000|Month 8 - Month 14|Adverse Event|0|||
155301882|NCT00802464|560538394|FG001|Month 8 - Month 14|Adverse Event|1|||
155159449|NCT00068692|560022783|FG004|Step 1: Registration|Not eligible|0|||
155159450|NCT00068692|560022784|FG005|Step 1: Registration|Not eligible|0|||
155159451|NCT00068692|560022785|FG006|Step 1: Registration|Not eligible|0|||
155159452|NCT00068692|560022786|FG007|Step 1: Registration|Not eligible|0|||
155159453|NCT00068692|560022779|FG000|Step 1: Registration|Other|2|||
155159454|NCT00068692|560022780|FG001|Step 1: Registration|Other|0|||
155159455|NCT00068692|560022781|FG002|Step 1: Registration|Other|0|||
155159456|NCT00068692|560022782|FG003|Step 1: Registration|Other|0|||
155159457|NCT00068692|560022783|FG004|Step 1: Registration|Other|0|||
155159458|NCT00068692|560022784|FG005|Step 1: Registration|Other|0|||
155301883|NCT00802464|560538395|FG002|Month 8 - Month 14|Adverse Event|0|||
155159459|NCT00068692|560022785|FG006|Step 1: Registration|Other|0|||
155301884|NCT00802464|560538396|FG003|Month 8 - Month 14|Adverse Event|0|||
155301885|NCT00802464|560538393|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
155301886|NCT00802464|560538394|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
155301887|NCT00802464|560538395|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
155301888|NCT00802464|560538396|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
155159460|NCT00068692|560022786|FG007|Step 1: Registration|Other|0|||
155159461|NCT00068692|560022779|FG000|Step 1: Registration|Not start protocol therapy|3|||
155159462|NCT00068692|560022780|FG001|Step 1: Registration|Not start protocol therapy|0|||
155159463|NCT00068692|560022781|FG002|Step 1: Registration|Not start protocol therapy|0|||
155159464|NCT00068692|560022782|FG003|Step 1: Registration|Not start protocol therapy|0|||
155159465|NCT00068692|560022783|FG004|Step 1: Registration|Not start protocol therapy|0|||
155159466|NCT00068692|560022784|FG005|Step 1: Registration|Not start protocol therapy|0|||
155159467|NCT00068692|560022785|FG006|Step 1: Registration|Not start protocol therapy|0|||
155159468|NCT00068692|560022786|FG007|Step 1: Registration|Not start protocol therapy|0|||
155159469|NCT00068692|560022779|FG000|Step 1: Registration|Registered but not randomized|0|||
155159470|NCT00068692|560022780|FG001|Step 1: Registration|Registered but not randomized|1|||
155159471|NCT00068692|560022781|FG002|Step 1: Registration|Registered but not randomized|0|||
155159472|NCT00068692|560022782|FG003|Step 1: Registration|Registered but not randomized|0|||
155159473|NCT00068692|560022783|FG004|Step 1: Registration|Registered but not randomized|0|||
155159474|NCT00068692|560022784|FG005|Step 1: Registration|Registered but not randomized|0|||
155159475|NCT00068692|560022785|FG006|Step 1: Registration|Registered but not randomized|0|||
155159476|NCT00068692|560022786|FG007|Step 1: Registration|Registered but not randomized|0|||
155159477|NCT00068692|560022779|FG000|Step 2: Randomization|Disesae progression/replase|0|||
155159478|NCT00068692|560022780|FG001|Step 2: Randomization|Disesae progression/replase|0|||
155159479|NCT00068692|560022781|FG002|Step 2: Randomization|Disesae progression/replase|1|||
155159480|NCT00068692|560022782|FG003|Step 2: Randomization|Disesae progression/replase|1|||
155301889|NCT00802464|560538393|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
155159481|NCT00068692|560022783|FG004|Step 2: Randomization|Disesae progression/replase|0|||
155301890|NCT00802464|560538394|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
155301891|NCT00802464|560538395|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
155301892|NCT00802464|560538396|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
155301893|NCT00402246|560538397|FG000|Overall Study|Death|62|||
155301894|NCT00402246|560538398|FG001|Overall Study|Death|58|||
155159482|NCT00068692|560022784|FG005|Step 2: Randomization|Disesae progression/replase|0|||
155301895|NCT00402246|560538397|FG000|Overall Study|Lost to Follow-up|20|||
155301896|NCT00402246|560538398|FG001|Overall Study|Lost to Follow-up|28|||
155301897|NCT00402246|560538397|FG000|Overall Study|Withdrawal by Subject|72|||
155301898|NCT00402246|560538398|FG001|Overall Study|Withdrawal by Subject|87|||
155301899|NCT00402246|560538397|FG000|Overall Study|Physician Decision|24|||
155301900|NCT00402246|560538398|FG001|Overall Study|Physician Decision|26|||
155301901|NCT00402246|560538397|FG000|Overall Study|Protocol Violation|25|||
155301902|NCT00402246|560538398|FG001|Overall Study|Protocol Violation|24|||
155301903|NCT00402246|560538397|FG000|Overall Study|Missed Final Visit|1|||
155301904|NCT00402246|560538398|FG001|Overall Study|Missed Final Visit|2|||
155301905|NCT00402246|560538397|FG000|Overall Study|Insurance Issues|2|||
155301906|NCT00402246|560538398|FG001|Overall Study|Insurance Issues|1|||
155301907|NCT00402246|560538397|FG000|Overall Study|Heart Transplant|0|||
155301908|NCT00402246|560538398|FG001|Overall Study|Heart Transplant|1|||
155301909|NCT00402246|560538397|FG000|Overall Study|Patient's device explanted|6|||
155301910|NCT00402246|560538398|FG001|Overall Study|Patient's device explanted|2|||
155301911|NCT00402246|560538397|FG000|Overall Study|Center Closure|5|||
155159483|NCT00068692|560022785|FG006|Step 2: Randomization|Disesae progression/replase|0|||
155159484|NCT00068692|560022786|FG007|Step 2: Randomization|Disesae progression/replase|0|||
155301912|NCT00402246|560538398|FG001|Overall Study|Center Closure|3|||
155301913|NCT00402246|560538397|FG000|Overall Study|Deterioriating Condition|3|||
155301914|NCT00402246|560538398|FG001|Overall Study|Deterioriating Condition|2|||
155301915|NCT02622568|560538399|FG000|Overall Study|Lost to Follow-up|5|||
155159485|NCT00068692|560022779|FG000|Step 2: Randomization|Adverse Event|0|||
155159486|NCT00068692|560022780|FG001|Step 2: Randomization|Adverse Event|0|||
155159487|NCT00068692|560022781|FG002|Step 2: Randomization|Adverse Event|4|||
155159488|NCT00068692|560022782|FG003|Step 2: Randomization|Adverse Event|2|||
155159489|NCT00068692|560022783|FG004|Step 2: Randomization|Adverse Event|2|||
155159490|NCT00068692|560022784|FG005|Step 2: Randomization|Adverse Event|3|||
155159491|NCT00068692|560022785|FG006|Step 2: Randomization|Adverse Event|4|||
155159492|NCT00068692|560022786|FG007|Step 2: Randomization|Adverse Event|4|||
155159493|NCT00068692|560022779|FG000|Step 2: Randomization|Death|0|||
155159494|NCT00068692|560022780|FG001|Step 2: Randomization|Death|0|||
155159495|NCT00068692|560022781|FG002|Step 2: Randomization|Death|0|||
155159496|NCT00068692|560022782|FG003|Step 2: Randomization|Death|0|||
155159497|NCT00068692|560022783|FG004|Step 2: Randomization|Death|1|||
155159498|NCT00068692|560022784|FG005|Step 2: Randomization|Death|0|||
155159499|NCT00068692|560022785|FG006|Step 2: Randomization|Death|0|||
155159500|NCT00068692|560022786|FG007|Step 2: Randomization|Death|1|||
155159501|NCT00068692|560022779|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
155159502|NCT00068692|560022780|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
155159503|NCT00068692|560022781|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
155159504|NCT00068692|560022782|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
155159505|NCT00068692|560022783|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
155159506|NCT00068692|560022784|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
155159507|NCT00068692|560022785|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
155159508|NCT00068692|560022786|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
155159509|NCT00068692|560022779|FG000|Step 2: Randomization|alternative therapy|0|||
155159510|NCT00068692|560022780|FG001|Step 2: Randomization|alternative therapy|0|||
155159511|NCT00068692|560022781|FG002|Step 2: Randomization|alternative therapy|0|||
155159512|NCT00068692|560022782|FG003|Step 2: Randomization|alternative therapy|1|||
155159513|NCT00068692|560022783|FG004|Step 2: Randomization|alternative therapy|1|||
155159514|NCT00068692|560022784|FG005|Step 2: Randomization|alternative therapy|0|||
155159515|NCT00068692|560022785|FG006|Step 2: Randomization|alternative therapy|0|||
155159516|NCT00068692|560022786|FG007|Step 2: Randomization|alternative therapy|0|||
155159517|NCT00068692|560022779|FG000|Step 2: Randomization|Physician Decision|0|||
155159518|NCT00068692|560022780|FG001|Step 2: Randomization|Physician Decision|0|||
155159519|NCT00068692|560022781|FG002|Step 2: Randomization|Physician Decision|0|||
155159520|NCT00068692|560022782|FG003|Step 2: Randomization|Physician Decision|1|||
155159521|NCT00068692|560022783|FG004|Step 2: Randomization|Physician Decision|1|||
155159522|NCT00068692|560022784|FG005|Step 2: Randomization|Physician Decision|0|||
155159523|NCT00068692|560022785|FG006|Step 2: Randomization|Physician Decision|0|||
155159524|NCT00068692|560022786|FG007|Step 2: Randomization|Physician Decision|0|||
155159525|NCT00068692|560022779|FG000|Step 2: Randomization|Other|0|||
155159526|NCT00068692|560022780|FG001|Step 2: Randomization|Other|0|||
155159527|NCT00068692|560022781|FG002|Step 2: Randomization|Other|0|||
155159528|NCT00068692|560022782|FG003|Step 2: Randomization|Other|1|||
155159529|NCT00068692|560022783|FG004|Step 2: Randomization|Other|0|||
155159530|NCT00068692|560022784|FG005|Step 2: Randomization|Other|1|||
155159531|NCT00068692|560022785|FG006|Step 2: Randomization|Other|0|||
155159532|NCT00068692|560022786|FG007|Step 2: Randomization|Other|0|||
155159533|NCT00068692|560022779|FG000|Step 2: Randomization|never start protocol therapy|0|||
155159534|NCT00068692|560022780|FG001|Step 2: Randomization|never start protocol therapy|0|||
155301916|NCT02622568|560538400|FG001|Overall Study|Lost to Follow-up|5|||
155301917|NCT04788641|560538403|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
155159535|NCT00068692|560022781|FG002|Step 2: Randomization|never start protocol therapy|1|||
155301918|NCT04788641|560538404|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
155301919|NCT04788641|560538405|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
155301920|NCT04788641|560538406|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
155301921|NCT04788641|560538403|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
155301922|NCT04788641|560538404|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
155301923|NCT04788641|560538405|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
155301924|NCT04788641|560538406|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
155301925|NCT04788641|560538403|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
155301926|NCT04788641|560538404|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
155301927|NCT04788641|560538405|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
155301928|NCT04788641|560538406|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
155301929|NCT01985334|560538407|FG000|Overall Study|Administrative problems|1|||
155301930|NCT01985334|560538408|FG001|Overall Study|Administrative problems|1|||
155301931|NCT01985334|560538409|FG002|Overall Study|Administrative problems|0|||
155301932|NCT01985334|560538410|FG003|Overall Study|Administrative problems|2|||
155159536|NCT00068692|560022782|FG003|Step 2: Randomization|never start protocol therapy|0|||
155159537|NCT00068692|560022783|FG004|Step 2: Randomization|never start protocol therapy|1|||
155301933|NCT01985334|560538411|FG004|Overall Study|Administrative problems|0|||
155301934|NCT01985334|560538412|FG005|Overall Study|Administrative problems|1|||
155301935|NCT01985334|560538413|FG006|Overall Study|Administrative problems|1|||
155301936|NCT01985334|560538414|FG007|Overall Study|Administrative problems|3|||
155301937|NCT01985334|560538407|FG000|Overall Study|Death|1|||
155301938|NCT01985334|560538408|FG001|Overall Study|Death|0|||
155301939|NCT01985334|560538409|FG002|Overall Study|Death|0|||
155301940|NCT01985334|560538410|FG003|Overall Study|Death|3|||
155301941|NCT01985334|560538411|FG004|Overall Study|Death|0|||
155301942|NCT01985334|560538412|FG005|Overall Study|Death|0|||
155301943|NCT01985334|560538413|FG006|Overall Study|Death|1|||
155301944|NCT01985334|560538414|FG007|Overall Study|Death|2|||
155301945|NCT01985334|560538407|FG000|Overall Study|Worsening of disease|0|||
155301946|NCT01985334|560538408|FG001|Overall Study|Worsening of disease|0|||
155301947|NCT01985334|560538409|FG002|Overall Study|Worsening of disease|0|||
155301948|NCT01985334|560538410|FG003|Overall Study|Worsening of disease|1|||
155301949|NCT01985334|560538411|FG004|Overall Study|Worsening of disease|0|||
155301950|NCT01985334|560538412|FG005|Overall Study|Worsening of disease|3|||
155301951|NCT01985334|560538413|FG006|Overall Study|Worsening of disease|0|||
155301952|NCT01985334|560538414|FG007|Overall Study|Worsening of disease|1|||
155301953|NCT01985334|560538407|FG000|Overall Study|Other|2|||
155301954|NCT01985334|560538408|FG001|Overall Study|Other|9|||
155301955|NCT01985334|560538409|FG002|Overall Study|Other|7|||
155301956|NCT01985334|560538410|FG003|Overall Study|Other|17|||
155063117|NCT00042289|559663985|FG011|Overall Study|Withdrawal by Subject|0|||
155063118|NCT00042289|559663986|FG012|Overall Study|Withdrawal by Subject|2|||
155063119|NCT00042289|559663987|FG013|Overall Study|Withdrawal by Subject|0|||
155063120|NCT00042289|559663988|FG014|Overall Study|Withdrawal by Subject|0|||
155063121|NCT00042289|559663989|FG015|Overall Study|Withdrawal by Subject|0|||
155063122|NCT00042289|559663990|FG016|Overall Study|Withdrawal by Subject|0|||
155063123|NCT00042289|559663991|FG017|Overall Study|Withdrawal by Subject|0|||
155063124|NCT00042289|559663992|FG018|Overall Study|Withdrawal by Subject|0|||
155063125|NCT00042289|559663993|FG019|Overall Study|Withdrawal by Subject|0|||
155063126|NCT00042289|559663994|FG020|Overall Study|Withdrawal by Subject|0|||
155063127|NCT00042289|559663995|FG021|Overall Study|Withdrawal by Subject|1|||
155063128|NCT00042289|559663996|FG022|Overall Study|Withdrawal by Subject|1|||
155063129|NCT00042289|559663997|FG023|Overall Study|Withdrawal by Subject|1|||
155063130|NCT00042289|559663998|FG024|Overall Study|Withdrawal by Subject|0|||
155063131|NCT00042289|559663999|FG025|Overall Study|Withdrawal by Subject|0|||
155063132|NCT00042289|559664000|FG026|Overall Study|Withdrawal by Subject|1|||
155063133|NCT00042289|559664001|FG027|Overall Study|Withdrawal by Subject|0|||
155063134|NCT00042289|559664002|FG028|Overall Study|Withdrawal by Subject|2|||
155063135|NCT00042289|559664003|FG029|Overall Study|Withdrawal by Subject|0|||
155063136|NCT00042289|559664004|FG030|Overall Study|Withdrawal by Subject|0|||
155063137|NCT00042289|559664005|FG031|Overall Study|Withdrawal by Subject|1|||
155063138|NCT00042289|559664006|FG032|Overall Study|Withdrawal by Subject|2|||
155063139|NCT00042289|559664007|FG033|Overall Study|Withdrawal by Subject|1|||
155063140|NCT00042289|559664008|FG034|Overall Study|Withdrawal by Subject|0|||
155063141|NCT00042289|559664009|FG035|Overall Study|Withdrawal by Subject|0|||
155063142|NCT00042289|559664010|FG036|Overall Study|Withdrawal by Subject|0|||
155063143|NCT00042289|559664011|FG037|Overall Study|Withdrawal by Subject|1|||
155063144|NCT00042289|559664012|FG038|Overall Study|Withdrawal by Subject|0|||
155063145|NCT00042289|559664013|FG039|Overall Study|Withdrawal by Subject|0|||
155063146|NCT00042289|559664014|FG040|Overall Study|Withdrawal by Subject|0|||
155063147|NCT00042289|559664015|FG041|Overall Study|Withdrawal by Subject|0|||
155063148|NCT00042289|559664016|FG042|Overall Study|Withdrawal by Subject|1|||
155063149|NCT00042289|559664017|FG043|Overall Study|Withdrawal by Subject|0|||
155063150|NCT00042289|559664018|FG044|Overall Study|Withdrawal by Subject|0|||
155063151|NCT00042289|559664019|FG045|Overall Study|Withdrawal by Subject|0|||
155063152|NCT00042289|559664020|FG046|Overall Study|Withdrawal by Subject|0|||
155063153|NCT01673386|559664025|FG000|Overall Study|Study terminated by sponsor|16|||
155301957|NCT01985334|560538411|FG004|Overall Study|Other|4|||
155301958|NCT01985334|560538412|FG005|Overall Study|Other|8|||
155301959|NCT01985334|560538413|FG006|Overall Study|Other|4|||
155301960|NCT01985334|560538414|FG007|Overall Study|Other|7|||
155301961|NCT01985334|560538407|FG000|Overall Study|Protocol deviation|6|||
155301962|NCT01985334|560538408|FG001|Overall Study|Protocol deviation|31|||
155301963|NCT01985334|560538409|FG002|Overall Study|Protocol deviation|25|||
155301964|NCT01985334|560538410|FG003|Overall Study|Protocol deviation|84|||
155301965|NCT01985334|560538411|FG004|Overall Study|Protocol deviation|17|||
155301966|NCT01985334|560538412|FG005|Overall Study|Protocol deviation|47|||
155301967|NCT01985334|560538413|FG006|Overall Study|Protocol deviation|15|||
155301968|NCT01985334|560538414|FG007|Overall Study|Protocol deviation|42|||
155301969|NCT01985334|560538407|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
154957903|NCT00838539|559273978|FG001|Overall Study|Adverse Event|1|||
154957904|NCT00838539|559273979|FG002|Overall Study|Adverse Event|1|||
154957905|NCT00838539|559273980|FG003|Overall Study|Adverse Event|1|||
154957906|NCT00838539|559273981|FG004|Overall Study|Adverse Event|2|||
154957907|NCT00838539|559273982|FG005|Overall Study|Adverse Event|1|||
154957908|NCT00838539|559273983|FG006|Overall Study|Adverse Event|0|||
154957909|NCT00838539|559273984|FG007|Overall Study|Adverse Event|2|||
154957910|NCT00838539|559273985|FG008|Overall Study|Adverse Event|0|||
154957911|NCT00838539|559273986|FG009|Overall Study|Adverse Event|1|||
154957912|NCT00838539|559273987|FG010|Overall Study|Adverse Event|2|||
155301970|NCT01985334|560538408|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
155301971|NCT01985334|560538409|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
155301972|NCT01985334|560538410|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
155301973|NCT01985334|560538411|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
155301974|NCT01985334|560538412|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
155301975|NCT01985334|560538413|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
155301976|NCT01985334|560538414|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
155301977|NCT01985334|560538407|FG000|Overall Study|Subject withdrawal of consent|3|||
155301978|NCT01985334|560538408|FG001|Overall Study|Subject withdrawal of consent|6|||
155301979|NCT01985334|560538409|FG002|Overall Study|Subject withdrawal of consent|2|||
155301980|NCT01985334|560538410|FG003|Overall Study|Subject withdrawal of consent|28|||
155301981|NCT01985334|560538411|FG004|Overall Study|Subject withdrawal of consent|4|||
155301982|NCT01985334|560538412|FG005|Overall Study|Subject withdrawal of consent|19|||
155301983|NCT01985334|560538413|FG006|Overall Study|Subject withdrawal of consent|0|||
155301984|NCT01985334|560538414|FG007|Overall Study|Subject withdrawal of consent|20|||
155301985|NCT01985334|560538407|FG000|Overall Study|Adverse Event|0|||
155301986|NCT01985334|560538408|FG001|Overall Study|Adverse Event|8|||
155301987|NCT01985334|560538409|FG002|Overall Study|Adverse Event|2|||
155301988|NCT01985334|560538410|FG003|Overall Study|Adverse Event|26|||
155301989|NCT01985334|560538411|FG004|Overall Study|Adverse Event|3|||
155301990|NCT01985334|560538412|FG005|Overall Study|Adverse Event|18|||
155301991|NCT01985334|560538413|FG006|Overall Study|Adverse Event|3|||
155301992|NCT01985334|560538414|FG007|Overall Study|Adverse Event|15|||
155301993|NCT01985334|560538407|FG000|Overall Study|Other|4|||
155301994|NCT01985334|560538408|FG001|Overall Study|Other|2|||
155301995|NCT01985334|560538409|FG002|Overall Study|Other|3|||
155301996|NCT01985334|560538410|FG003|Overall Study|Other|10|||
155301997|NCT01985334|560538411|FG004|Overall Study|Other|1|||
155301998|NCT01985334|560538412|FG005|Overall Study|Other|6|||
155301999|NCT01985334|560538413|FG006|Overall Study|Other|2|||
155302000|NCT01985334|560538414|FG007|Overall Study|Other|2|||
155302001|NCT01985334|560538407|FG000|Overall Study|Medication non-compliance|0|||
155302002|NCT01985334|560538408|FG001|Overall Study|Medication non-compliance|4|||
155302003|NCT01985334|560538409|FG002|Overall Study|Medication non-compliance|1|||
155302004|NCT01985334|560538410|FG003|Overall Study|Medication non-compliance|6|||
155302005|NCT01985334|560538411|FG004|Overall Study|Medication non-compliance|2|||
155302006|NCT01985334|560538412|FG005|Overall Study|Medication non-compliance|3|||
155302007|NCT01985334|560538413|FG006|Overall Study|Medication non-compliance|1|||
155302008|NCT01985334|560538414|FG007|Overall Study|Medication non-compliance|3|||
155302009|NCT01985334|560538407|FG000|Overall Study|Use of prohibited treatment|1|||
155302010|NCT01985334|560538408|FG001|Overall Study|Use of prohibited treatment|4|||
155302011|NCT01985334|560538409|FG002|Overall Study|Use of prohibited treatment|1|||
155302012|NCT01985334|560538410|FG003|Overall Study|Use of prohibited treatment|2|||
155302013|NCT01985334|560538411|FG004|Overall Study|Use of prohibited treatment|1|||
155302014|NCT01985334|560538412|FG005|Overall Study|Use of prohibited treatment|6|||
155302015|NCT01985334|560538413|FG006|Overall Study|Use of prohibited treatment|2|||
155302016|NCT01985334|560538414|FG007|Overall Study|Use of prohibited treatment|0|||
154957913|NCT00838539|559273988|FG011|Overall Study|Adverse Event|0|||
154957914|NCT00838539|559273977|FG000|Overall Study|Withdrawal by Subject|0|||
155302017|NCT01985334|560538407|FG000|Overall Study|Investigator decision|0|||
155302018|NCT01985334|560538408|FG001|Overall Study|Investigator decision|3|||
155302019|NCT01985334|560538409|FG002|Overall Study|Investigator decision|0|||
155302020|NCT01985334|560538410|FG003|Overall Study|Investigator decision|7|||
154957915|NCT00838539|559273978|FG001|Overall Study|Withdrawal by Subject|1|||
154957916|NCT00838539|559273979|FG002|Overall Study|Withdrawal by Subject|0|||
155159538|NCT00068692|560022784|FG005|Step 2: Randomization|never start protocol therapy|0|||
155159539|NCT00068692|560022785|FG006|Step 2: Randomization|never start protocol therapy|0|||
155159540|NCT00068692|560022786|FG007|Step 2: Randomization|never start protocol therapy|0|||
155159541|NCT01936870|560022787|FG000|Overall Study|No Visit After Treatment|176|||
155159542|NCT01936870|560022787|FG000|Overall Study|Protocol Violation|12|||
155159543|NCT01936870|560022787|FG000|Overall Study|No Drug Administration|1|||
155159544|NCT01600716|560022789|FG000|Overall Study|Other Reasons|3|||
155159545|NCT01600716|560022790|FG001|Overall Study|Other Reasons|1|||
155159546|NCT01600716|560022789|FG000|Overall Study|Personal Reasons|0|||
155159547|NCT01600716|560022790|FG001|Overall Study|Personal Reasons|2|||
155159548|NCT01600716|560022789|FG000|Overall Study|Lost to Follow-up|0|||
155159549|NCT01600716|560022790|FG001|Overall Study|Lost to Follow-up|2|||
155159550|NCT01600716|560022789|FG000|Overall Study|Pregnancy|1|||
155159551|NCT01600716|560022790|FG001|Overall Study|Pregnancy|0|||
155159552|NCT01600716|560022789|FG000|Overall Study|Lack of Efficacy|2|||
155159553|NCT01600716|560022790|FG001|Overall Study|Lack of Efficacy|1|||
155159554|NCT01600716|560022789|FG000|Overall Study|Adverse Event|1|||
155159555|NCT01600716|560022790|FG001|Overall Study|Adverse Event|1|||
155159556|NCT03557034|560022793|FG000|Overall Study|Withdrawal by Subject|1|||
155159557|NCT03557034|560022794|FG001|Overall Study|Withdrawal by Subject|0|||
155159558|NCT01759446|560022797|FG000|Overall Study|Protocol Violation|1|||
155159559|NCT01759446|560022798|FG001|Overall Study|Protocol Violation|0|||
155159560|NCT01759446|560022799|FG002|Overall Study|Protocol Violation|1|||
155159561|NCT01759446|560022800|FG003|Overall Study|Protocol Violation|0|||
155159562|NCT01759446|560022801|FG004|Overall Study|Protocol Violation|0|||
155159563|NCT01759446|560022797|FG000|Overall Study|Withdrawal by Subject|0|||
155063154|NCT01673386|559664026|FG001|Overall Study|Study terminated by sponsor|22|||
155063155|NCT01673386|559664025|FG000|Overall Study|Adverse Event|5|||
155063156|NCT01673386|559664026|FG001|Overall Study|Adverse Event|2|||
155063157|NCT01673386|559664025|FG000|Overall Study|Progressive disease|4|||
155063158|NCT01673386|559664026|FG001|Overall Study|Progressive disease|1|||
155063159|NCT01673386|559664025|FG000|Overall Study|Withdrawal by Subject|0|||
155063160|NCT01673386|559664026|FG001|Overall Study|Withdrawal by Subject|2|||
155063161|NCT01140906|559664030|FG000|Overall Study|Adverse Event|7|||
155063162|NCT01140906|559664031|FG001|Overall Study|Adverse Event|10|||
155063163|NCT01140906|559664032|FG002|Overall Study|Adverse Event|17|||
155063164|NCT01140906|559664033|FG003|Overall Study|Adverse Event|7|||
155063165|NCT01140906|559664030|FG000|Overall Study|Lack of Efficacy|6|||
155063166|NCT01140906|559664031|FG001|Overall Study|Lack of Efficacy|8|||
155063167|NCT01140906|559664032|FG002|Overall Study|Lack of Efficacy|2|||
155063168|NCT01140906|559664033|FG003|Overall Study|Lack of Efficacy|1|||
155063169|NCT01140906|559664030|FG000|Overall Study|Non-compliance|0|||
155063170|NCT01140906|559664031|FG001|Overall Study|Non-compliance|1|||
155063171|NCT01140906|559664032|FG002|Overall Study|Non-compliance|0|||
155063172|NCT01140906|559664033|FG003|Overall Study|Non-compliance|1|||
155063173|NCT01140906|559664030|FG000|Overall Study|Protocol Violation|5|||
155063174|NCT01140906|559664031|FG001|Overall Study|Protocol Violation|3|||
155063175|NCT01140906|559664032|FG002|Overall Study|Protocol Violation|2|||
155063176|NCT01140906|559664033|FG003|Overall Study|Protocol Violation|1|||
155063177|NCT01140906|559664030|FG000|Overall Study|Withdrawal of consent|6|||
155063178|NCT01140906|559664031|FG001|Overall Study|Withdrawal of consent|6|||
155302021|NCT01985334|560538411|FG004|Overall Study|Investigator decision|1|||
155302022|NCT01985334|560538412|FG005|Overall Study|Investigator decision|1|||
155302023|NCT01985334|560538413|FG006|Overall Study|Investigator decision|0|||
155302024|NCT01985334|560538414|FG007|Overall Study|Investigator decision|4|||
155302025|NCT01985334|560538407|FG000|Overall Study|Lost to Follow-up|0|||
155302026|NCT01985334|560538408|FG001|Overall Study|Lost to Follow-up|2|||
155302027|NCT01985334|560538409|FG002|Overall Study|Lost to Follow-up|0|||
155302028|NCT01985334|560538410|FG003|Overall Study|Lost to Follow-up|3|||
155159564|NCT01759446|560022798|FG001|Overall Study|Withdrawal by Subject|1|||
155063179|NCT01140906|559664032|FG002|Overall Study|Withdrawal of consent|2|||
155063180|NCT01140906|559664033|FG003|Overall Study|Withdrawal of consent|2|||
155063181|NCT01140906|559664030|FG000|Overall Study|Lost to Follow-up|1|||
155063182|NCT01140906|559664031|FG001|Overall Study|Lost to Follow-up|1|||
155159565|NCT01759446|560022799|FG002|Overall Study|Withdrawal by Subject|0|||
155063183|NCT01140906|559664032|FG002|Overall Study|Lost to Follow-up|0|||
155159566|NCT01759446|560022800|FG003|Overall Study|Withdrawal by Subject|1|||
155063184|NCT01140906|559664033|FG003|Overall Study|Lost to Follow-up|2|||
155063185|NCT01140906|559664030|FG000|Overall Study|Administrative or other reason|0|||
155063186|NCT01140906|559664031|FG001|Overall Study|Administrative or other reason|5|||
155063187|NCT01140906|559664032|FG002|Overall Study|Administrative or other reason|3|||
155159567|NCT01759446|560022801|FG004|Overall Study|Withdrawal by Subject|0|||
155159568|NCT01524796|560022804|FG000|Overall Study|Adverse Event|13|||
155159569|NCT01524796|560022804|FG000|Overall Study|Lack of Efficacy|3|||
155159570|NCT01524796|560022804|FG000|Overall Study|Lost to Follow-up|1|||
155159571|NCT01524796|560022804|FG000|Overall Study|The price|1|||
155302029|NCT01985334|560538411|FG004|Overall Study|Lost to Follow-up|1|||
155302030|NCT01985334|560538412|FG005|Overall Study|Lost to Follow-up|4|||
155302031|NCT01985334|560538413|FG006|Overall Study|Lost to Follow-up|0|||
155302032|NCT01985334|560538414|FG007|Overall Study|Lost to Follow-up|3|||
155302033|NCT03988023|560538415|FG000|Overall Study|Non-compliance|3|||
155302034|NCT03988023|560538416|FG001|Overall Study|Non-compliance|0|||
155302035|NCT03988023|560538415|FG000|Overall Study|Withdrawal by Subject|39|||
155302036|NCT03988023|560538416|FG001|Overall Study|Withdrawal by Subject|37|||
155302037|NCT03988023|560538415|FG000|Overall Study|Adverse Event|0|||
155302038|NCT03988023|560538416|FG001|Overall Study|Adverse Event|2|||
155302039|NCT03988023|560538415|FG000|Overall Study|Physician Decision|0|||
155302040|NCT03988023|560538416|FG001|Overall Study|Physician Decision|1|||
155302041|NCT03988023|560538415|FG000|Overall Study|Lost to Follow-up|5|||
155302042|NCT03988023|560538416|FG001|Overall Study|Lost to Follow-up|8|||
155302043|NCT03988023|560538415|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
155159572|NCT01524796|560022804|FG000|Overall Study|Withdrawal by Subject|4|||
155159573|NCT01524796|560022804|FG000|Overall Study|Move|1|||
155159574|NCT01524796|560022804|FG000|Overall Study|Deterioration of pains|1|||
155159575|NCT01524796|560022804|FG000|Overall Study|Gall stone surgery|1|||
155159576|NCT01524796|560022804|FG000|Overall Study|Nervous about confidentiality|1|||
155159577|NCT01524796|560022804|FG000|Overall Study|Switch to carbamazapine|1|||
155159578|NCT01524796|560022804|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
155159579|NCT00803569|560022809|FG000|Overall Study|Progressive Disease|3|||
155159580|NCT00803569|560022809|FG000|Overall Study|Noncompliance|1|||
155159581|NCT01208207|560022810|FG000|Part I|Adverse Event|19|||
155159582|NCT01208207|560022811|FG001|Part I|Adverse Event|2|||
155159583|NCT01208207|560022812|FG002|Part I|Adverse Event|6|||
155159584|NCT01208207|560022813|FG003|Part I|Adverse Event|0|||
155159585|NCT01208207|560022814|FG004|Part I|Adverse Event|0|||
155159586|NCT01208207|560022815|FG005|Part I|Adverse Event|0|||
155159587|NCT01208207|560022816|FG006|Part I|Adverse Event|0|||
155159588|NCT01208207|560022810|FG000|Part I|Lack of Efficacy|21|||
155159589|NCT01208207|560022811|FG001|Part I|Lack of Efficacy|3|||
155159590|NCT01208207|560022812|FG002|Part I|Lack of Efficacy|2|||
155159591|NCT01208207|560022813|FG003|Part I|Lack of Efficacy|0|||
155159592|NCT01208207|560022814|FG004|Part I|Lack of Efficacy|0|||
155159593|NCT01208207|560022815|FG005|Part I|Lack of Efficacy|0|||
155159594|NCT01208207|560022816|FG006|Part I|Lack of Efficacy|0|||
155159595|NCT01208207|560022810|FG000|Part I|Lost to Follow-up|6|||
155159596|NCT01208207|560022811|FG001|Part I|Lost to Follow-up|1|||
155159597|NCT01208207|560022812|FG002|Part I|Lost to Follow-up|0|||
155159598|NCT01208207|560022813|FG003|Part I|Lost to Follow-up|0|||
155159599|NCT01208207|560022814|FG004|Part I|Lost to Follow-up|0|||
155159600|NCT01208207|560022815|FG005|Part I|Lost to Follow-up|0|||
155159601|NCT01208207|560022816|FG006|Part I|Lost to Follow-up|0|||
155159602|NCT01208207|560022810|FG000|Part I|Non-Compliance With Study Drug|1|||
155159603|NCT01208207|560022811|FG001|Part I|Non-Compliance With Study Drug|0|||
155159604|NCT01208207|560022812|FG002|Part I|Non-Compliance With Study Drug|1|||
155159605|NCT01208207|560022813|FG003|Part I|Non-Compliance With Study Drug|0|||
155159606|NCT01208207|560022814|FG004|Part I|Non-Compliance With Study Drug|0|||
155159607|NCT01208207|560022815|FG005|Part I|Non-Compliance With Study Drug|0|||
155159608|NCT01208207|560022816|FG006|Part I|Non-Compliance With Study Drug|0|||
155159609|NCT01208207|560022810|FG000|Part I|Physician Decision|0|||
155159610|NCT01208207|560022811|FG001|Part I|Physician Decision|1|||
155159611|NCT01208207|560022812|FG002|Part I|Physician Decision|0|||
155159612|NCT01208207|560022813|FG003|Part I|Physician Decision|0|||
155159613|NCT01208207|560022814|FG004|Part I|Physician Decision|0|||
155159614|NCT01208207|560022815|FG005|Part I|Physician Decision|0|||
155159615|NCT01208207|560022816|FG006|Part I|Physician Decision|0|||
154957917|NCT00838539|559273980|FG003|Overall Study|Withdrawal by Subject|0|||
154957918|NCT00838539|559273981|FG004|Overall Study|Withdrawal by Subject|0|||
155302044|NCT03988023|560538416|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
155302045|NCT03988023|560538415|FG000|Overall Study|Lack of Efficacy|3|||
155302046|NCT03988023|560538416|FG001|Overall Study|Lack of Efficacy|1|||
154957919|NCT00838539|559273982|FG005|Overall Study|Withdrawal by Subject|0|||
155159616|NCT01208207|560022810|FG000|Part I|Progressive Disease|1|||
155159617|NCT01208207|560022811|FG001|Part I|Progressive Disease|0|||
155159618|NCT01208207|560022812|FG002|Part I|Progressive Disease|0|||
155159619|NCT01208207|560022813|FG003|Part I|Progressive Disease|0|||
155159620|NCT01208207|560022814|FG004|Part I|Progressive Disease|0|||
155159621|NCT01208207|560022815|FG005|Part I|Progressive Disease|0|||
155159622|NCT01208207|560022816|FG006|Part I|Progressive Disease|0|||
155159623|NCT01208207|560022810|FG000|Part I|Protocol Violation|8|||
155159624|NCT01208207|560022811|FG001|Part I|Protocol Violation|0|||
155159625|NCT01208207|560022812|FG002|Part I|Protocol Violation|2|||
155159626|NCT01208207|560022813|FG003|Part I|Protocol Violation|0|||
155159627|NCT01208207|560022814|FG004|Part I|Protocol Violation|0|||
155159628|NCT01208207|560022815|FG005|Part I|Protocol Violation|0|||
155159629|NCT01208207|560022816|FG006|Part I|Protocol Violation|0|||
155159630|NCT01208207|560022810|FG000|Part I|Withdrawal by Subject|14|||
155159631|NCT01208207|560022811|FG001|Part I|Withdrawal by Subject|4|||
155302047|NCT03988023|560538415|FG000|Overall Study|COVID-19 pandemic|225|||
155302048|NCT03988023|560538416|FG001|Overall Study|COVID-19 pandemic|227|||
155302049|NCT00174382|560538421|FG000|Overall Study|Death|2|||
155302050|NCT00174382|560538421|FG000|Overall Study|Adverse Event|19|||
155159632|NCT01208207|560022812|FG002|Part I|Withdrawal by Subject|4|||
155159633|NCT01208207|560022813|FG003|Part I|Withdrawal by Subject|0|||
155159634|NCT01208207|560022814|FG004|Part I|Withdrawal by Subject|0|||
155063188|NCT01140906|559664033|FG003|Overall Study|Administrative or other reason|2|||
155063189|NCT00336544|559664034|FG000|Overall Study|Lack of Efficacy|8|||
155063190|NCT00336544|559664035|FG001|Overall Study|Lack of Efficacy|5|||
155063191|NCT00336544|559664034|FG000|Overall Study|Adverse Event|4|||
155063192|NCT00336544|559664035|FG001|Overall Study|Adverse Event|9|||
155063193|NCT00336544|559664034|FG000|Overall Study|Withdrawal by Subject|4|||
155063194|NCT00336544|559664035|FG001|Overall Study|Withdrawal by Subject|3|||
155063195|NCT00336544|559664034|FG000|Overall Study|Other|3|||
155063196|NCT00336544|559664035|FG001|Overall Study|Other|5|||
155063197|NCT01649765|559664036|FG000|Overall Study|Adverse Event|5|||
155063198|NCT01649765|559664037|FG001|Overall Study|Adverse Event|3|||
155063199|NCT01649765|559664036|FG000|Overall Study|Lack of Efficacy|1|||
155063200|NCT01649765|559664037|FG001|Overall Study|Lack of Efficacy|1|||
155302051|NCT00174382|560538421|FG000|Overall Study|Withdrawal by Subject|6|||
155302052|NCT00174382|560538421|FG000|Overall Study|Protocol Violation|3|||
155302053|NCT00174382|560538421|FG000|Overall Study|Arrived early for last visit in error|1|||
155302054|NCT00174382|560538421|FG000|Overall Study|Subject felt pill not effective enough|1|||
155063201|NCT01649765|559664036|FG000|Overall Study|Physician Decision|0|||
155063202|NCT01649765|559664037|FG001|Overall Study|Physician Decision|3|||
155063203|NCT01649765|559664036|FG000|Overall Study|Protocol Violation|1|||
155063204|NCT01649765|559664037|FG001|Overall Study|Protocol Violation|0|||
155063205|NCT01649765|559664036|FG000|Overall Study|Withdrawal by Subject|2|||
155063206|NCT01649765|559664037|FG001|Overall Study|Withdrawal by Subject|1|||
155063207|NCT00961064|559664038|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
155063208|NCT00961064|559664038|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
155063209|NCT00961064|559664038|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
155063210|NCT00961064|559664038|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
155063211|NCT00961064|559664038|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
155063212|NCT00961064|559664038|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
155302055|NCT00174382|560538421|FG000|Overall Study|Lost to Follow-up|1|||
155302056|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
155302057|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
155302058|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302059|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302060|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302061|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
155302062|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
155302063|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
155302064|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302065|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302066|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302067|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302068|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
155302069|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
155302070|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302071|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
155302072|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302073|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302074|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302075|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302076|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302077|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
155302078|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
155302079|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
155302080|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302081|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
155302082|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302083|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302084|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302085|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302086|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302087|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
155302088|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302089|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302090|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302091|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
155063213|NCT00961064|559664038|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
155159635|NCT01208207|560022815|FG005|Part I|Withdrawal by Subject|0|||
155063214|NCT00961064|559664038|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
155063215|NCT01408641|559664039|FG000|Overall Study|Physician Decision|1|||
155063216|NCT01408641|559664040|FG001|Overall Study|Physician Decision|0|||
155302092|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
155302093|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302094|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302095|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
155302096|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302097|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155159636|NCT01208207|560022816|FG006|Part I|Withdrawal by Subject|0|||
155159637|NCT01208207|560022810|FG000|Part II|Withdrawal by Subject|0|||
155159638|NCT01208207|560022811|FG001|Part II|Withdrawal by Subject|0|||
155159639|NCT01208207|560022812|FG002|Part II|Withdrawal by Subject|0|||
155159640|NCT01208207|560022813|FG003|Part II|Withdrawal by Subject|10|||
155159641|NCT01208207|560022814|FG004|Part II|Withdrawal by Subject|9|||
155159642|NCT01208207|560022815|FG005|Part II|Withdrawal by Subject|3|||
155159643|NCT01208207|560022816|FG006|Part II|Withdrawal by Subject|5|||
155159644|NCT01208207|560022810|FG000|Part II|Adverse Event|0|||
155159645|NCT01208207|560022811|FG001|Part II|Adverse Event|0|||
155159646|NCT01208207|560022812|FG002|Part II|Adverse Event|0|||
155159647|NCT01208207|560022813|FG003|Part II|Adverse Event|5|||
155159648|NCT01208207|560022814|FG004|Part II|Adverse Event|9|||
155159649|NCT01208207|560022815|FG005|Part II|Adverse Event|4|||
155159650|NCT01208207|560022816|FG006|Part II|Adverse Event|2|||
155159651|NCT01208207|560022810|FG000|Part II|Lack of Efficacy|0|||
155159652|NCT01208207|560022811|FG001|Part II|Lack of Efficacy|0|||
155159653|NCT01208207|560022812|FG002|Part II|Lack of Efficacy|0|||
155159654|NCT01208207|560022813|FG003|Part II|Lack of Efficacy|6|||
155159655|NCT01208207|560022814|FG004|Part II|Lack of Efficacy|4|||
155159656|NCT01208207|560022815|FG005|Part II|Lack of Efficacy|3|||
155159657|NCT01208207|560022816|FG006|Part II|Lack of Efficacy|3|||
155159658|NCT01208207|560022810|FG000|Part II|Lost to Follow-up|0|||
155159659|NCT01208207|560022811|FG001|Part II|Lost to Follow-up|0|||
155159660|NCT01208207|560022812|FG002|Part II|Lost to Follow-up|0|||
155159661|NCT01208207|560022813|FG003|Part II|Lost to Follow-up|4|||
155159662|NCT01208207|560022814|FG004|Part II|Lost to Follow-up|0|||
155159663|NCT01208207|560022815|FG005|Part II|Lost to Follow-up|2|||
155159664|NCT01208207|560022816|FG006|Part II|Lost to Follow-up|1|||
155159665|NCT01208207|560022810|FG000|Part II|Non-Compliance With Study Drug|0|||
155159666|NCT01208207|560022811|FG001|Part II|Non-Compliance With Study Drug|0|||
155159667|NCT01208207|560022812|FG002|Part II|Non-Compliance With Study Drug|0|||
155159668|NCT01208207|560022813|FG003|Part II|Non-Compliance With Study Drug|4|||
155159669|NCT01208207|560022814|FG004|Part II|Non-Compliance With Study Drug|1|||
155159670|NCT01208207|560022815|FG005|Part II|Non-Compliance With Study Drug|1|||
155159671|NCT01208207|560022816|FG006|Part II|Non-Compliance With Study Drug|0|||
155159672|NCT01208207|560022810|FG000|Part II|Physician Decision|0|||
155159673|NCT01208207|560022811|FG001|Part II|Physician Decision|0|||
155159674|NCT01208207|560022812|FG002|Part II|Physician Decision|0|||
155159675|NCT01208207|560022813|FG003|Part II|Physician Decision|1|||
155159676|NCT01208207|560022814|FG004|Part II|Physician Decision|0|||
155159677|NCT01208207|560022815|FG005|Part II|Physician Decision|2|||
155159678|NCT01208207|560022816|FG006|Part II|Physician Decision|0|||
155159679|NCT01208207|560022810|FG000|Part II|Protocol Violation|0|||
155159680|NCT01208207|560022811|FG001|Part II|Protocol Violation|0|||
155159681|NCT01208207|560022812|FG002|Part II|Protocol Violation|0|||
155159682|NCT01208207|560022813|FG003|Part II|Protocol Violation|1|||
155159683|NCT01208207|560022814|FG004|Part II|Protocol Violation|0|||
155159684|NCT01208207|560022815|FG005|Part II|Protocol Violation|0|||
155159685|NCT01208207|560022816|FG006|Part II|Protocol Violation|0|||
155159686|NCT01208207|560022810|FG000|Part II|Technical Problems|0|||
155159687|NCT01208207|560022811|FG001|Part II|Technical Problems|0|||
155159688|NCT01208207|560022812|FG002|Part II|Technical Problems|0|||
155159689|NCT01208207|560022813|FG003|Part II|Technical Problems|1|||
155159690|NCT01208207|560022814|FG004|Part II|Technical Problems|0|||
155159691|NCT01208207|560022815|FG005|Part II|Technical Problems|1|||
155159692|NCT01208207|560022816|FG006|Part II|Technical Problems|0|||
155159693|NCT02177032|560022817|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
155159694|NCT02177032|560022818|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
155302098|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155159695|NCT02177032|560022819|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
155159696|NCT02177032|560022820|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
155159697|NCT02177032|560022817|FG000|Overall Study|Lost to Follow-up|0|||
155302099|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
155302100|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155159698|NCT02177032|560022818|FG001|Overall Study|Lost to Follow-up|2|||
155159699|NCT02177032|560022819|FG002|Overall Study|Lost to Follow-up|0|||
155159700|NCT02177032|560022820|FG003|Overall Study|Lost to Follow-up|0|||
154957920|NCT00838539|559273983|FG006|Overall Study|Withdrawal by Subject|0|||
155159701|NCT02177032|560022817|FG000|Overall Study|OTHER|2|||
155159702|NCT02177032|560022818|FG001|Overall Study|OTHER|0|||
155159703|NCT02177032|560022819|FG002|Overall Study|OTHER|1|||
155159704|NCT02177032|560022820|FG003|Overall Study|OTHER|0|||
155159705|NCT02177032|560022817|FG000|Overall Study|Withdrawal by Subject|1|||
155159706|NCT02177032|560022818|FG001|Overall Study|Withdrawal by Subject|0|||
155159707|NCT02177032|560022819|FG002|Overall Study|Withdrawal by Subject|1|||
155159708|NCT02177032|560022820|FG003|Overall Study|Withdrawal by Subject|0|||
155159709|NCT02900378|560022826|FG000|Randomization (Visit 2)|Adverse Event|14|||
155159710|NCT02900378|560022827|FG001|Randomization (Visit 2)|Adverse Event|11|||
155159711|NCT02900378|560022826|FG000|Randomization (Visit 2)|Death|1|||
155159712|NCT02900378|560022827|FG001|Randomization (Visit 2)|Death|4|||
155159713|NCT02900378|560022826|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
155159714|NCT02900378|560022827|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
155159715|NCT02900378|560022826|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
155159716|NCT02900378|560022827|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
155159717|NCT02900378|560022826|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
155159718|NCT02900378|560022827|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
155159719|NCT02900378|560022826|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
155159720|NCT02900378|560022827|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
155159721|NCT02900378|560022826|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
155159722|NCT02900378|560022827|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
155159723|NCT01134055|560022828|FG000|Overall Study|Adverse Event|5|||
155159724|NCT01134055|560022829|FG001|Overall Study|Adverse Event|2|||
155159725|NCT01134055|560022830|FG002|Overall Study|Adverse Event|2|||
155159726|NCT01134055|560022831|FG003|Overall Study|Adverse Event|2|||
155159727|NCT01134055|560022832|FG004|Overall Study|Adverse Event|5|||
155159728|NCT01134055|560022833|FG005|Overall Study|Adverse Event|7|||
155159729|NCT01134055|560022834|FG006|Overall Study|Adverse Event|2|||
155159730|NCT01134055|560022828|FG000|Overall Study|Lost to Follow-up|0|||
155159731|NCT01134055|560022829|FG001|Overall Study|Lost to Follow-up|1|||
155159732|NCT01134055|560022830|FG002|Overall Study|Lost to Follow-up|0|||
155159733|NCT01134055|560022831|FG003|Overall Study|Lost to Follow-up|1|||
155159734|NCT01134055|560022832|FG004|Overall Study|Lost to Follow-up|0|||
155159735|NCT01134055|560022833|FG005|Overall Study|Lost to Follow-up|0|||
155159736|NCT01134055|560022834|FG006|Overall Study|Lost to Follow-up|0|||
155159737|NCT01134055|560022828|FG000|Overall Study|Withdrawal by Subject|3|||
155159738|NCT01134055|560022829|FG001|Overall Study|Withdrawal by Subject|3|||
155159739|NCT01134055|560022830|FG002|Overall Study|Withdrawal by Subject|1|||
155159740|NCT01134055|560022831|FG003|Overall Study|Withdrawal by Subject|2|||
155159741|NCT01134055|560022832|FG004|Overall Study|Withdrawal by Subject|0|||
155159742|NCT01134055|560022833|FG005|Overall Study|Withdrawal by Subject|0|||
155159743|NCT01134055|560022834|FG006|Overall Study|Withdrawal by Subject|8|||
155159744|NCT01134055|560022828|FG000|Overall Study|Protocol Violation|0|||
155159745|NCT01134055|560022829|FG001|Overall Study|Protocol Violation|0|||
155159746|NCT01134055|560022830|FG002|Overall Study|Protocol Violation|0|||
155159747|NCT01134055|560022831|FG003|Overall Study|Protocol Violation|1|||
155159748|NCT01134055|560022832|FG004|Overall Study|Protocol Violation|1|||
155159749|NCT01134055|560022833|FG005|Overall Study|Protocol Violation|0|||
155159750|NCT01134055|560022834|FG006|Overall Study|Protocol Violation|0|||
155159751|NCT01134055|560022828|FG000|Overall Study|Physician Decision|0|||
155159752|NCT01134055|560022829|FG001|Overall Study|Physician Decision|0|||
155159753|NCT01134055|560022830|FG002|Overall Study|Physician Decision|0|||
155159754|NCT01134055|560022831|FG003|Overall Study|Physician Decision|0|||
155159755|NCT01134055|560022832|FG004|Overall Study|Physician Decision|0|||
155159756|NCT01134055|560022833|FG005|Overall Study|Physician Decision|0|||
155159757|NCT01134055|560022834|FG006|Overall Study|Physician Decision|1|||
155159758|NCT01605799|560022842|FG000|Overall Study|Withdrawal by Subject|2|||
155159759|NCT01605799|560022843|FG001|Overall Study|Withdrawal by Subject|1|||
155159760|NCT00734539|560022844|FG000|Main Study|Death|33|||
155159761|NCT00734539|560022845|FG001|Main Study|Death|32|||
155159762|NCT00734539|560022844|FG000|Main Study|Physician Decision|2|||
155159763|NCT00734539|560022845|FG001|Main Study|Physician Decision|0|||
155159764|NCT00734539|560022844|FG000|Main Study|Withdrawal by Subject|1|||
155159765|NCT00734539|560022845|FG001|Main Study|Withdrawal by Subject|3|||
155159766|NCT00734539|560022844|FG000|Main Study|Enrolled in error; ineligible|1|||
154957921|NCT00838539|559273984|FG007|Overall Study|Withdrawal by Subject|0|||
155159767|NCT00734539|560022845|FG001|Main Study|Enrolled in error; ineligible|0|||
155159768|NCT00705016|560022848|FG000|Overall Study|Adverse Event|6|||
155159769|NCT00705016|560022849|FG001|Overall Study|Adverse Event|11|||
155159770|NCT00705016|560022850|FG002|Overall Study|Adverse Event|10|||
155159771|NCT00705016|560022848|FG000|Overall Study|Death|5|||
155159772|NCT00705016|560022849|FG001|Overall Study|Death|7|||
155159773|NCT00705016|560022850|FG002|Overall Study|Death|5|||
155159774|NCT00705016|560022848|FG000|Overall Study|Protocol Violation|0|||
155159775|NCT00705016|560022849|FG001|Overall Study|Protocol Violation|1|||
155159776|NCT00705016|560022850|FG002|Overall Study|Protocol Violation|1|||
155159777|NCT00705016|560022848|FG000|Overall Study|Withdrawal by Subject|4|||
155159778|NCT00705016|560022849|FG001|Overall Study|Withdrawal by Subject|3|||
155159779|NCT00705016|560022850|FG002|Overall Study|Withdrawal by Subject|2|||
155159780|NCT00705016|560022848|FG000|Overall Study|Progressive Disease|33|||
155159781|NCT00705016|560022849|FG001|Overall Study|Progressive Disease|29|||
155159782|NCT00705016|560022850|FG002|Overall Study|Progressive Disease|33|||
155159783|NCT00705016|560022848|FG000|Overall Study|Symptomatic Deterioration|3|||
155302101|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302102|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302103|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
155302104|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155159784|NCT00705016|560022849|FG001|Overall Study|Symptomatic Deterioration|1|||
155159785|NCT00705016|560022850|FG002|Overall Study|Symptomatic Deterioration|1|||
155159786|NCT00705016|560022848|FG000|Overall Study|Other|9|||
155159787|NCT00705016|560022849|FG001|Overall Study|Other|6|||
155159788|NCT00705016|560022850|FG002|Overall Study|Other|6|||
155159789|NCT00942604|560022853|FG000|Overall Study|Protocol Violation|1|||
155159790|NCT00942604|560022854|FG001|Overall Study|Protocol Violation|1|||
155159791|NCT00942604|560022853|FG000|Overall Study|Adverse Event|0|||
155159792|NCT00942604|560022854|FG001|Overall Study|Adverse Event|1|||
155159793|NCT00942604|560022853|FG000|Overall Study|Withdrawal by Subject|0|||
155159794|NCT00942604|560022854|FG001|Overall Study|Withdrawal by Subject|1|||
155159795|NCT00942604|560022853|FG000|Overall Study|Patient relocation|1|||
155302105|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
155302106|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302107|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302108|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
155302109|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
155302110|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
155302111|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
155302112|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
155302113|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302114|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302115|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302116|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302117|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
155302118|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302119|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
155302120|NCT03903822|560538422|FG000|Treatment Phase (6 Weeks)|Other|2|||
155302121|NCT03903822|560538423|FG001|Treatment Phase (6 Weeks)|Other|1|||
155302122|NCT03903822|560538424|FG002|Treatment Phase (6 Weeks)|Other|0|||
155302123|NCT03903822|560538425|FG003|Treatment Phase (6 Weeks)|Other|0|||
155302124|NCT03903822|560538426|FG004|Treatment Phase (6 Weeks)|Other|1|||
155302125|NCT03903822|560538427|FG005|Treatment Phase (6 Weeks)|Other|1|||
155302126|NCT03903822|560538428|FG006|Treatment Phase (6 Weeks)|Other|0|||
155302127|NCT03903822|560538429|FG007|Treatment Phase (6 Weeks)|Other|0|||
155302128|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
155302129|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
155302130|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
155302131|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
155302132|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
155302133|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
155302134|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
155302135|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
155302136|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302137|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302138|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302139|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302140|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
155302141|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302142|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302143|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
155302144|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
155302145|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302146|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302147|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302148|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302149|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
155302150|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
155302151|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
155302152|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302153|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302154|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302155|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
155302156|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
155159796|NCT00942604|560022854|FG001|Overall Study|Patient relocation|1|||
155159797|NCT01656408|560022855|FG000|Overall Study|Adverse Event|0|||
155302157|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302158|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
155159798|NCT01656408|560022856|FG001|Overall Study|Adverse Event|0|||
155159799|NCT01656408|560022857|FG002|Overall Study|Adverse Event|1|||
155302159|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
155302160|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302161|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
155302162|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
155302163|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302164|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302165|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
155302166|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
155302167|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
155302168|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302169|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302170|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302171|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155063217|NCT01648764|559664041|FG000|Overall Study|Progressive Disease|0|||
155063218|NCT01648764|559664042|FG001|Overall Study|Progressive Disease|1|||
155063219|NCT01648764|559664043|FG002|Overall Study|Progressive Disease|0|||
155063220|NCT01648764|559664044|FG003|Overall Study|Progressive Disease|0|||
155063221|NCT01648764|559664045|FG004|Overall Study|Progressive Disease|0|||
155063222|NCT01648764|559664046|FG005|Overall Study|Progressive Disease|1|||
155063223|NCT01648764|559664047|FG006|Overall Study|Progressive Disease|1|||
155063224|NCT01648764|559664048|FG007|Overall Study|Progressive Disease|0|||
155063225|NCT01648764|559664049|FG008|Overall Study|Progressive Disease|0|||
155063226|NCT01648764|559664050|FG009|Overall Study|Progressive Disease|2|||
155063227|NCT01648764|559664051|FG010|Overall Study|Progressive Disease|0|||
155063228|NCT01648764|559664052|FG011|Overall Study|Progressive Disease|1|||
155063229|NCT01648764|559664053|FG012|Overall Study|Progressive Disease|2|||
155063230|NCT01648764|559664054|FG013|Overall Study|Progressive Disease|1|||
155063231|NCT01648764|559664041|FG000|Overall Study|Adverse Event|0|||
155063232|NCT01648764|559664042|FG001|Overall Study|Adverse Event|0|||
155063233|NCT01648764|559664043|FG002|Overall Study|Adverse Event|0|||
155063234|NCT01648764|559664044|FG003|Overall Study|Adverse Event|0|||
155063235|NCT01648764|559664045|FG004|Overall Study|Adverse Event|0|||
155063236|NCT01648764|559664046|FG005|Overall Study|Adverse Event|1|||
155063237|NCT01648764|559664047|FG006|Overall Study|Adverse Event|0|||
155063238|NCT01648764|559664048|FG007|Overall Study|Adverse Event|0|||
155063239|NCT01648764|559664049|FG008|Overall Study|Adverse Event|0|||
155063240|NCT01648764|559664050|FG009|Overall Study|Adverse Event|1|||
155063241|NCT01648764|559664051|FG010|Overall Study|Adverse Event|0|||
155063242|NCT01648764|559664052|FG011|Overall Study|Adverse Event|3|||
155063243|NCT01648764|559664053|FG012|Overall Study|Adverse Event|1|||
155063244|NCT01648764|559664054|FG013|Overall Study|Adverse Event|1|||
155063245|NCT01648764|559664041|FG000|Overall Study|Death|0|||
155063246|NCT01648764|559664042|FG001|Overall Study|Death|0|||
155063247|NCT01648764|559664043|FG002|Overall Study|Death|0|||
155063248|NCT01648764|559664044|FG003|Overall Study|Death|0|||
155063249|NCT01648764|559664045|FG004|Overall Study|Death|0|||
155063250|NCT01648764|559664046|FG005|Overall Study|Death|0|||
155063251|NCT01648764|559664047|FG006|Overall Study|Death|1|||
155063252|NCT01648764|559664048|FG007|Overall Study|Death|0|||
155063253|NCT01648764|559664049|FG008|Overall Study|Death|0|||
155063254|NCT01648764|559664050|FG009|Overall Study|Death|0|||
155063255|NCT01648764|559664051|FG010|Overall Study|Death|0|||
155063256|NCT01648764|559664052|FG011|Overall Study|Death|0|||
155063257|NCT01648764|559664053|FG012|Overall Study|Death|0|||
155063258|NCT01648764|559664054|FG013|Overall Study|Death|1|||
155063259|NCT01648764|559664041|FG000|Overall Study|Withdrawal by Subject|0|||
155063260|NCT01648764|559664042|FG001|Overall Study|Withdrawal by Subject|0|||
155063261|NCT01648764|559664043|FG002|Overall Study|Withdrawal by Subject|0|||
155063262|NCT01648764|559664044|FG003|Overall Study|Withdrawal by Subject|0|||
155063263|NCT01648764|559664045|FG004|Overall Study|Withdrawal by Subject|0|||
155063264|NCT01648764|559664046|FG005|Overall Study|Withdrawal by Subject|0|||
155063265|NCT01648764|559664047|FG006|Overall Study|Withdrawal by Subject|2|||
155063266|NCT01648764|559664048|FG007|Overall Study|Withdrawal by Subject|0|||
155063267|NCT01648764|559664049|FG008|Overall Study|Withdrawal by Subject|0|||
155063268|NCT01648764|559664050|FG009|Overall Study|Withdrawal by Subject|0|||
155063269|NCT01648764|559664051|FG010|Overall Study|Withdrawal by Subject|0|||
155063270|NCT01648764|559664052|FG011|Overall Study|Withdrawal by Subject|0|||
155063271|NCT01648764|559664053|FG012|Overall Study|Withdrawal by Subject|1|||
155063272|NCT01648764|559664054|FG013|Overall Study|Withdrawal by Subject|0|||
155063273|NCT01648764|559664041|FG000|Overall Study|Investigator Decision|0|||
155063274|NCT01648764|559664042|FG001|Overall Study|Investigator Decision|0|||
155063275|NCT01648764|559664043|FG002|Overall Study|Investigator Decision|0|||
155063276|NCT01648764|559664044|FG003|Overall Study|Investigator Decision|0|||
155063277|NCT01648764|559664045|FG004|Overall Study|Investigator Decision|0|||
155063278|NCT01648764|559664046|FG005|Overall Study|Investigator Decision|0|||
155063279|NCT01648764|559664047|FG006|Overall Study|Investigator Decision|1|||
155063280|NCT01648764|559664048|FG007|Overall Study|Investigator Decision|0|||
155063281|NCT01648764|559664049|FG008|Overall Study|Investigator Decision|0|||
155159800|NCT01656408|560022858|FG003|Overall Study|Adverse Event|0|||
155159801|NCT01656408|560022859|FG004|Overall Study|Adverse Event|0|||
155159802|NCT01656408|560022860|FG005|Overall Study|Adverse Event|1|||
155159803|NCT01656408|560022861|FG006|Overall Study|Adverse Event|1|||
155063282|NCT01648764|559664050|FG009|Overall Study|Investigator Decision|0|||
155063283|NCT01648764|559664051|FG010|Overall Study|Investigator Decision|0|||
155063284|NCT01648764|559664052|FG011|Overall Study|Investigator Decision|1|||
155063285|NCT01648764|559664053|FG012|Overall Study|Investigator Decision|0|||
155063286|NCT01648764|559664054|FG013|Overall Study|Investigator Decision|0|||
155063287|NCT00576758|559664055|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
155302172|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302173|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
155302174|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302175|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
155302176|NCT03903822|560538422|FG000|Follow up Phase (4 Weeks)|Other|1|||
155302177|NCT03903822|560538423|FG001|Follow up Phase (4 Weeks)|Other|1|||
155302178|NCT03903822|560538424|FG002|Follow up Phase (4 Weeks)|Other|0|||
155159804|NCT01656408|560022862|FG007|Overall Study|Adverse Event|0|||
155159805|NCT01656408|560022863|FG008|Overall Study|Adverse Event|1|||
155159806|NCT01656408|560022864|FG009|Overall Study|Adverse Event|0|||
155159807|NCT01656408|560022855|FG000|Overall Study|Physician Decision|1|||
155159808|NCT01656408|560022856|FG001|Overall Study|Physician Decision|0|||
155159809|NCT01656408|560022857|FG002|Overall Study|Physician Decision|1|||
155159810|NCT01656408|560022858|FG003|Overall Study|Physician Decision|0|||
155159811|NCT01656408|560022859|FG004|Overall Study|Physician Decision|1|||
155159812|NCT01656408|560022860|FG005|Overall Study|Physician Decision|1|||
155159813|NCT01656408|560022861|FG006|Overall Study|Physician Decision|0|||
155159814|NCT01656408|560022862|FG007|Overall Study|Physician Decision|1|||
155159815|NCT01656408|560022863|FG008|Overall Study|Physician Decision|1|||
155159816|NCT01656408|560022864|FG009|Overall Study|Physician Decision|3|||
155159817|NCT00904982|560022867|FG000|Overall Study|Withdrawal by Subject|2|||
155159818|NCT00904982|560022868|FG001|Overall Study|Withdrawal by Subject|0|||
155063288|NCT00576758|559664056|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
155063289|NCT00576758|559664055|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
155159819|NCT00904982|560022869|FG002|Overall Study|Withdrawal by Subject|0|||
155302179|NCT03903822|560538425|FG003|Follow up Phase (4 Weeks)|Other|0|||
155302180|NCT03903822|560538426|FG004|Follow up Phase (4 Weeks)|Other|0|||
155302181|NCT03903822|560538427|FG005|Follow up Phase (4 Weeks)|Other|0|||
155302182|NCT03903822|560538428|FG006|Follow up Phase (4 Weeks)|Other|0|||
155302183|NCT03903822|560538429|FG007|Follow up Phase (4 Weeks)|Other|0|||
155302184|NCT00785512|560538432|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
155302185|NCT00785512|560538433|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
155302186|NCT00785512|560538432|FG000|Overall Study|Adverse Event|0|||
155302187|NCT00785512|560538433|FG001|Overall Study|Adverse Event|0|||
155302188|NCT00785512|560538432|FG000|Overall Study|Lack of Efficacy|0|||
155302189|NCT00785512|560538433|FG001|Overall Study|Lack of Efficacy|2|||
155302190|NCT00785512|560538432|FG000|Overall Study|Withdrawal by Subject|0|||
155302191|NCT00785512|560538433|FG001|Overall Study|Withdrawal by Subject|1|||
155302192|NCT00785512|560538432|FG000|Overall Study|Lost to Follow-up|3|||
155302193|NCT00785512|560538433|FG001|Overall Study|Lost to Follow-up|0|||
155302194|NCT00785512|560538432|FG000|Overall Study|Precedure Refused|0|||
155302195|NCT00785512|560538433|FG001|Overall Study|Precedure Refused|0|||
155302196|NCT00785512|560538432|FG000|Overall Study|IVRS Programing Error|0|||
155302197|NCT00785512|560538433|FG001|Overall Study|IVRS Programing Error|0|||
155302198|NCT00785512|560538432|FG000|Overall Study|Physician Decision|0|||
155302199|NCT00785512|560538433|FG001|Overall Study|Physician Decision|0|||
155302200|NCT00785512|560538432|FG000|Overall Study|Lack of compliance|0|||
155302201|NCT00785512|560538433|FG001|Overall Study|Lack of compliance|1|||
155302202|NCT03403413|560538434|FG000|Overall Study|Lack of Efficacy|2|||
155302203|NCT05609032|560538442|FG000|Overall Study|Lost to Follow-up|3|||
155302204|NCT05609032|560538443|FG001|Overall Study|Lost to Follow-up|1|||
155302205|NCT05609032|560538442|FG000|Overall Study|Withdrawal by Subject|1|||
155302206|NCT05609032|560538443|FG001|Overall Study|Withdrawal by Subject|0|||
155302207|NCT02477605|560538447|FG000|Overall Study|Discontinued prior to treatment|1|||
155302208|NCT02477605|560538448|FG001|Overall Study|Discontinued prior to treatment|0|||
155302209|NCT02477605|560538447|FG000|Overall Study|Lost to Follow-up|0|||
155302210|NCT02477605|560538448|FG001|Overall Study|Lost to Follow-up|2|||
155302211|NCT02477605|560538447|FG000|Overall Study|Withdrawal by Subject|0|||
155302212|NCT02477605|560538448|FG001|Overall Study|Withdrawal by Subject|1|||
155302213|NCT02477605|560538447|FG000|Overall Study|Administered gas during surgery|0|||
155302214|NCT02477605|560538448|FG001|Overall Study|Administered gas during surgery|1|||
155302215|NCT01565148|560538451|FG000|Overall Study|Withdrawal by Subject|1|||
155302216|NCT01565148|560538452|FG001|Overall Study|Withdrawal by Subject|1|||
155302217|NCT01565148|560538453|FG002|Overall Study|Withdrawal by Subject|1|||
155302218|NCT01565148|560538454|FG003|Overall Study|Withdrawal by Subject|2|||
155302219|NCT01565148|560538451|FG000|Overall Study|Lost to Follow-up|4|||
155302220|NCT01565148|560538452|FG001|Overall Study|Lost to Follow-up|4|||
155302221|NCT01565148|560538453|FG002|Overall Study|Lost to Follow-up|0|||
155302222|NCT01565148|560538454|FG003|Overall Study|Lost to Follow-up|3|||
155302223|NCT01565148|560538451|FG000|Overall Study|Rescue Therapy|8|||
155302224|NCT01565148|560538452|FG001|Overall Study|Rescue Therapy|5|||
155302225|NCT01565148|560538453|FG002|Overall Study|Rescue Therapy|5|||
155302226|NCT01565148|560538454|FG003|Overall Study|Rescue Therapy|8|||
155302227|NCT01565148|560538451|FG000|Overall Study|Death|0|||
155302228|NCT01565148|560538452|FG001|Overall Study|Death|0|||
155302229|NCT01565148|560538453|FG002|Overall Study|Death|1|||
155302230|NCT01565148|560538454|FG003|Overall Study|Death|0|||
155302231|NCT01565148|560538451|FG000|Overall Study|Physician Decision|2|||
155302232|NCT01565148|560538452|FG001|Overall Study|Physician Decision|5|||
155302233|NCT01565148|560538453|FG002|Overall Study|Physician Decision|0|||
155302234|NCT01565148|560538454|FG003|Overall Study|Physician Decision|0|||
155302235|NCT01388361|560538455|FG000|Overall Study|Adverse Event|0|||
155302236|NCT01388361|560538456|FG001|Overall Study|Adverse Event|5|||
155302237|NCT01388361|560538457|FG002|Overall Study|Adverse Event|1|||
155302238|NCT01388361|560538455|FG000|Overall Study|Protocol Violation|0|||
155302239|NCT01388361|560538456|FG001|Overall Study|Protocol Violation|0|||
155302240|NCT01388361|560538457|FG002|Overall Study|Protocol Violation|2|||
155302241|NCT01388361|560538455|FG000|Overall Study|Withdrawal criteria|12|||
155302242|NCT01388361|560538456|FG001|Overall Study|Withdrawal criteria|7|||
155302243|NCT01388361|560538457|FG002|Overall Study|Withdrawal criteria|10|||
155302244|NCT01388361|560538455|FG000|Overall Study|Unclassified|0|||
155302245|NCT01388361|560538456|FG001|Overall Study|Unclassified|0|||
155302246|NCT01388361|560538457|FG002|Overall Study|Unclassified|1|||
155302247|NCT02528188|560538459|FG000|Overall Study|Adverse Event|23|||
155302248|NCT02528188|560538460|FG001|Overall Study|Adverse Event|22|||
155302249|NCT02528188|560538461|FG002|Overall Study|Adverse Event|8|||
155302250|NCT02528188|560538459|FG000|Overall Study|Protocol Violation|4|||
155302251|NCT02528188|560538460|FG001|Overall Study|Protocol Violation|6|||
155159820|NCT00904982|560022870|FG003|Overall Study|Withdrawal by Subject|0|||
155159821|NCT00686712|560022871|FG000|Overall Study|Protocol Violation|8|||
155159822|NCT00686712|560022872|FG001|Overall Study|Protocol Violation|8|||
155159823|NCT00686712|560022873|FG002|Overall Study|Protocol Violation|10|||
155159824|NCT00686712|560022871|FG000|Overall Study|Lost to Follow-up|1|||
155159825|NCT00686712|560022872|FG001|Overall Study|Lost to Follow-up|2|||
155159826|NCT00686712|560022873|FG002|Overall Study|Lost to Follow-up|3|||
155159827|NCT00686712|560022871|FG000|Overall Study|Adverse Event|1|||
155159828|NCT00686712|560022872|FG001|Overall Study|Adverse Event|1|||
155159829|NCT00686712|560022873|FG002|Overall Study|Adverse Event|0|||
155159830|NCT01318915|560022876|FG000|Overall Study|Lost to Follow-up|1|||
155159831|NCT00926237|560022877|FG000|Overall Study|Withdrawal by Subject|2|||
155159832|NCT00926237|560022878|FG001|Overall Study|Withdrawal by Subject|1|||
155159833|NCT02760498|560022887|FG000|Overall Study|Adverse Event|3|||
155159834|NCT02760498|560022888|FG001|Overall Study|Adverse Event|3|||
155159835|NCT02760498|560022889|FG002|Overall Study|Adverse Event|1|||
155159836|NCT02760498|560022890|FG003|Overall Study|Adverse Event|1|||
155159837|NCT02760498|560022891|FG004|Overall Study|Adverse Event|0|||
155159838|NCT02760498|560022892|FG005|Overall Study|Adverse Event|6|||
155159839|NCT02760498|560022887|FG000|Overall Study|Death|7|||
155159840|NCT02760498|560022888|FG001|Overall Study|Death|5|||
155159841|NCT02760498|560022889|FG002|Overall Study|Death|5|||
155159842|NCT02760498|560022890|FG003|Overall Study|Death|7|||
155159843|NCT02760498|560022891|FG004|Overall Study|Death|0|||
155159844|NCT02760498|560022892|FG005|Overall Study|Death|23|||
155159845|NCT02760498|560022887|FG000|Overall Study|Lost to Follow-up|0|||
155159846|NCT02760498|560022888|FG001|Overall Study|Lost to Follow-up|0|||
155159847|NCT02760498|560022889|FG002|Overall Study|Lost to Follow-up|0|||
155159848|NCT02760498|560022890|FG003|Overall Study|Lost to Follow-up|0|||
155159849|NCT02760498|560022891|FG004|Overall Study|Lost to Follow-up|0|||
155302252|NCT02528188|560538461|FG002|Overall Study|Protocol Violation|4|||
155302253|NCT02528188|560538459|FG000|Overall Study|Lack of Efficacy|19|||
155159850|NCT02760498|560022892|FG005|Overall Study|Lost to Follow-up|3|||
155159851|NCT02760498|560022887|FG000|Overall Study|Non-compliance with study drug|0|||
155159852|NCT02760498|560022888|FG001|Overall Study|Non-compliance with study drug|2|||
155159853|NCT02760498|560022889|FG002|Overall Study|Non-compliance with study drug|0|||
155159854|NCT02760498|560022890|FG003|Overall Study|Non-compliance with study drug|0|||
155159855|NCT02760498|560022891|FG004|Overall Study|Non-compliance with study drug|0|||
155159856|NCT02760498|560022892|FG005|Overall Study|Non-compliance with study drug|0|||
155302254|NCT02528188|560538460|FG001|Overall Study|Lack of Efficacy|21|||
155302255|NCT02528188|560538461|FG002|Overall Study|Lack of Efficacy|22|||
155302256|NCT02528188|560538459|FG000|Overall Study|Withdrawal by Subject|97|||
155302257|NCT02528188|560538460|FG001|Overall Study|Withdrawal by Subject|104|||
155302258|NCT02528188|560538461|FG002|Overall Study|Withdrawal by Subject|100|||
155302259|NCT02528188|560538459|FG000|Overall Study|Lost to Follow-up|25|||
155302260|NCT02528188|560538460|FG001|Overall Study|Lost to Follow-up|21|||
155159857|NCT02760498|560022887|FG000|Overall Study|Participant decision|1|||
155302261|NCT02528188|560538461|FG002|Overall Study|Lost to Follow-up|31|||
155302262|NCT02528188|560538459|FG000|Overall Study|Death|4|||
155302263|NCT02528188|560538460|FG001|Overall Study|Death|4|||
155302264|NCT02528188|560538461|FG002|Overall Study|Death|0|||
155302265|NCT02528188|560538459|FG000|Overall Study|Other|89|||
155302266|NCT02528188|560538460|FG001|Overall Study|Other|91|||
155302267|NCT02528188|560538461|FG002|Overall Study|Other|74|||
155159858|NCT02760498|560022888|FG001|Overall Study|Participant decision|4|||
155159859|NCT02760498|560022889|FG002|Overall Study|Participant decision|2|||
155159860|NCT02760498|560022890|FG003|Overall Study|Participant decision|2|||
155159861|NCT02760498|560022891|FG004|Overall Study|Participant decision|1|||
155063290|NCT00576758|559664056|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
155063291|NCT00576758|559664055|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
155063292|NCT00576758|559664056|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
155063293|NCT00576758|559664055|FG000|Induction Treatment Period|Death|1|||
155063294|NCT00576758|559664056|FG001|Induction Treatment Period|Death|0|||
155063295|NCT00576758|559664055|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
155063296|NCT00576758|559664056|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
155063297|NCT00576758|559664055|FG000|Induction Treatment Period|Withdrew consent|1|||
155063298|NCT00576758|559664056|FG001|Induction Treatment Period|Withdrew consent|0|||
155063299|NCT00576758|559664055|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
155063300|NCT00576758|559664056|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
155063301|NCT00576758|559664055|FG000|Extension Treatment Period|Death|1|||
155063302|NCT00576758|559664056|FG001|Extension Treatment Period|Death|1|||
155063303|NCT00576758|559664055|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
155063304|NCT00576758|559664056|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
155063305|NCT00576758|559664055|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
155063306|NCT00576758|559664056|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
155063307|NCT00576758|559664055|FG000|Extension Treatment Period|Administrative/Other|3|||
155063308|NCT00576758|559664056|FG001|Extension Treatment Period|Administrative/Other|1|||
155302268|NCT02528188|560538459|FG000|Overall Study|Randomized but not treated|6|||
155302269|NCT02528188|560538460|FG001|Overall Study|Randomized but not treated|7|||
155302270|NCT02528188|560538461|FG002|Overall Study|Randomized but not treated|12|||
155159862|NCT02760498|560022892|FG005|Overall Study|Participant decision|6|||
155159863|NCT02760498|560022887|FG000|Overall Study|Sponsor decision|0|||
155159864|NCT02760498|560022888|FG001|Overall Study|Sponsor decision|0|||
155159865|NCT02760498|560022889|FG002|Overall Study|Sponsor decision|0|||
155159866|NCT02760498|560022890|FG003|Overall Study|Sponsor decision|3|||
155159867|NCT02760498|560022891|FG004|Overall Study|Sponsor decision|0|||
155159868|NCT02760498|560022892|FG005|Overall Study|Sponsor decision|0|||
155159869|NCT02760498|560022887|FG000|Overall Study|Physician Decision|3|||
155159870|NCT02760498|560022888|FG001|Overall Study|Physician Decision|4|||
155159871|NCT02760498|560022889|FG002|Overall Study|Physician Decision|1|||
155159872|NCT02760498|560022890|FG003|Overall Study|Physician Decision|4|||
155159873|NCT02760498|560022891|FG004|Overall Study|Physician Decision|0|||
155159874|NCT02760498|560022892|FG005|Overall Study|Physician Decision|2|||
155159875|NCT02760498|560022887|FG000|Overall Study|Disease progression|21|||
155159876|NCT02760498|560022888|FG001|Overall Study|Disease progression|19|||
155159877|NCT02760498|560022889|FG002|Overall Study|Disease progression|20|||
155159878|NCT02760498|560022890|FG003|Overall Study|Disease progression|18|||
155159879|NCT02760498|560022891|FG004|Overall Study|Disease progression|4|||
155159880|NCT02760498|560022892|FG005|Overall Study|Disease progression|55|||
155159881|NCT02760498|560022887|FG000|Overall Study|Withdrawal by Subject|4|||
155159882|NCT02760498|560022888|FG001|Overall Study|Withdrawal by Subject|7|||
155159883|NCT02760498|560022889|FG002|Overall Study|Withdrawal by Subject|5|||
155159884|NCT02760498|560022890|FG003|Overall Study|Withdrawal by Subject|1|||
155159885|NCT02760498|560022891|FG004|Overall Study|Withdrawal by Subject|0|||
155159886|NCT02760498|560022892|FG005|Overall Study|Withdrawal by Subject|6|||
155159887|NCT02760498|560022887|FG000|Overall Study|Other than specified|1|||
155063309|NCT00576758|559664055|FG000|Follow-up Period|Administrative/Other|6|||
155063310|NCT00576758|559664056|FG001|Follow-up Period|Administrative/Other|8|||
155063311|NCT00576758|559664055|FG000|Follow-up Period|Death|3|||
155063312|NCT00576758|559664056|FG001|Follow-up Period|Death|3|||
155063313|NCT00576758|559664055|FG000|Follow-up Period|Insufficient therapeutic response|16|||
155063314|NCT00576758|559664056|FG001|Follow-up Period|Insufficient therapeutic response|5|||
155063315|NCT00576758|559664055|FG000|Follow-up Period|Withdrew consent|2|||
155159888|NCT02760498|560022888|FG001|Overall Study|Other than specified|6|||
155159889|NCT02760498|560022889|FG002|Overall Study|Other than specified|0|||
155159890|NCT02760498|560022890|FG003|Overall Study|Other than specified|3|||
155159891|NCT02760498|560022891|FG004|Overall Study|Other than specified|1|||
155159892|NCT02760498|560022892|FG005|Overall Study|Other than specified|0|||
155159893|NCT02760498|560022887|FG000|Overall Study|Not treated|0|||
155159894|NCT02760498|560022888|FG001|Overall Study|Not treated|0|||
155159895|NCT02760498|560022889|FG002|Overall Study|Not treated|0|||
155302271|NCT00529659|560538464|FG000|Overall Study|Adverse Event|8|||
155159896|NCT02760498|560022890|FG003|Overall Study|Not treated|0|||
155159897|NCT02760498|560022891|FG004|Overall Study|Not treated|0|||
155302272|NCT00529659|560538465|FG001|Overall Study|Adverse Event|7|||
155302273|NCT00529659|560538464|FG000|Overall Study|Lost to Follow-up|0|||
155302274|NCT00529659|560538465|FG001|Overall Study|Lost to Follow-up|2|||
155302275|NCT00529659|560538464|FG000|Overall Study|Physician Decision|0|||
155302276|NCT00529659|560538465|FG001|Overall Study|Physician Decision|2|||
155302277|NCT00529659|560538464|FG000|Overall Study|Protocol Violation|2|||
155302278|NCT00529659|560538465|FG001|Overall Study|Protocol Violation|6|||
155302279|NCT00529659|560538464|FG000|Overall Study|Withdrawal by Subject|1|||
155302280|NCT00529659|560538465|FG001|Overall Study|Withdrawal by Subject|6|||
155302281|NCT03565315|560538466|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
155302282|NCT03565315|560538467|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
155302283|NCT03565315|560538468|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
155302284|NCT03565315|560538469|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
155302285|NCT01170962|560538470|FG000|Treatment Period|Lack of Efficacy|96|||
155302286|NCT01170962|560538471|FG001|Treatment Period|Lack of Efficacy|91|||
155302287|NCT01170962|560538472|FG002|Treatment Period|Lack of Efficacy|7|||
155302288|NCT01170962|560538470|FG000|Treatment Period|Adverse Event|11|||
155159898|NCT02760498|560022892|FG005|Overall Study|Not treated|2|||
155159899|NCT02205736|560022893|FG000|Overall Study|Lost to Follow-up|106|||
155159900|NCT01588522|560022898|FG000|Overall Study|Withdrawal by Subject|1|||
155302289|NCT01170962|560538471|FG001|Treatment Period|Adverse Event|12|||
155302290|NCT01170962|560538472|FG002|Treatment Period|Adverse Event|3|||
155302291|NCT01170962|560538470|FG000|Treatment Period|Withdrawal by Subject|2|||
155302292|NCT01170962|560538471|FG001|Treatment Period|Withdrawal by Subject|1|||
155302293|NCT01170962|560538472|FG002|Treatment Period|Withdrawal by Subject|0|||
155159901|NCT01588522|560022899|FG001|Overall Study|Withdrawal by Subject|5|||
155159902|NCT01588522|560022900|FG002|Overall Study|Withdrawal by Subject|3|||
155159903|NCT01588522|560022901|FG003|Overall Study|Withdrawal by Subject|1|||
155159904|NCT01588522|560022902|FG004|Overall Study|Withdrawal by Subject|2|||
155159905|NCT01588522|560022903|FG005|Overall Study|Withdrawal by Subject|0|||
155159906|NCT01588522|560022898|FG000|Overall Study|Lack of Efficacy|0|||
155159907|NCT01588522|560022899|FG001|Overall Study|Lack of Efficacy|0|||
155302294|NCT01170962|560538470|FG000|Treatment Period|Lost to Follow-up|1|||
155302295|NCT01170962|560538471|FG001|Treatment Period|Lost to Follow-up|1|||
155302296|NCT01170962|560538472|FG002|Treatment Period|Lost to Follow-up|1|||
155302297|NCT01170962|560538470|FG000|Treatment Period|Participant no longer meets criteria|0|||
155302298|NCT01170962|560538471|FG001|Treatment Period|Participant no longer meets criteria|1|||
155159908|NCT01588522|560022900|FG002|Overall Study|Lack of Efficacy|0|||
155159909|NCT01588522|560022901|FG003|Overall Study|Lack of Efficacy|0|||
155159910|NCT01588522|560022902|FG004|Overall Study|Lack of Efficacy|1|||
155159911|NCT01588522|560022903|FG005|Overall Study|Lack of Efficacy|0|||
155159912|NCT01588522|560022898|FG000|Overall Study|Adverse Event|0|||
155159913|NCT01588522|560022899|FG001|Overall Study|Adverse Event|0|||
155159914|NCT01588522|560022900|FG002|Overall Study|Adverse Event|0|||
155159915|NCT01588522|560022901|FG003|Overall Study|Adverse Event|1|||
155159916|NCT01588522|560022902|FG004|Overall Study|Adverse Event|0|||
155159917|NCT01588522|560022903|FG005|Overall Study|Adverse Event|0|||
155159918|NCT01588522|560022898|FG000|Overall Study|Grade 2 alopecia|1|||
155159919|NCT01588522|560022899|FG001|Overall Study|Grade 2 alopecia|0|||
155159920|NCT01588522|560022900|FG002|Overall Study|Grade 2 alopecia|0|||
155159921|NCT01588522|560022901|FG003|Overall Study|Grade 2 alopecia|0|||
155159922|NCT01588522|560022902|FG004|Overall Study|Grade 2 alopecia|0|||
155159923|NCT01588522|560022903|FG005|Overall Study|Grade 2 alopecia|0|||
155159924|NCT01588522|560022898|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
155159925|NCT01588522|560022899|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
155159926|NCT01588522|560022900|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
155159927|NCT01588522|560022901|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
155159928|NCT01588522|560022902|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
155159929|NCT01588522|560022903|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
155159930|NCT01588522|560022898|FG000|Overall Study|Taken off taxane-based regimen|0|||
155159931|NCT01588522|560022899|FG001|Overall Study|Taken off taxane-based regimen|0|||
155159932|NCT01588522|560022900|FG002|Overall Study|Taken off taxane-based regimen|0|||
155159933|NCT01588522|560022901|FG003|Overall Study|Taken off taxane-based regimen|1|||
155159934|NCT01588522|560022902|FG004|Overall Study|Taken off taxane-based regimen|0|||
155159935|NCT01588522|560022903|FG005|Overall Study|Taken off taxane-based regimen|0|||
155159936|NCT01588522|560022898|FG000|Overall Study|Did not initiate chemotherapy|0|||
155159937|NCT01588522|560022899|FG001|Overall Study|Did not initiate chemotherapy|0|||
155159938|NCT01588522|560022900|FG002|Overall Study|Did not initiate chemotherapy|0|||
155159939|NCT01588522|560022901|FG003|Overall Study|Did not initiate chemotherapy|0|||
155159940|NCT01588522|560022902|FG004|Overall Study|Did not initiate chemotherapy|1|||
155159941|NCT01588522|560022903|FG005|Overall Study|Did not initiate chemotherapy|0|||
155302299|NCT01170962|560538472|FG002|Treatment Period|Participant no longer meets criteria|0|||
155159942|NCT02855125|560022906|FG000|Overall Study|Withdrawal by Subject|2|||
155302300|NCT01170962|560538470|FG000|Treatment Period|Request to discontinue treatment|7|||
155302301|NCT01170962|560538471|FG001|Treatment Period|Request to discontinue treatment|3|||
155302302|NCT01170962|560538472|FG002|Treatment Period|Request to discontinue treatment|1|||
155159943|NCT02855125|560022907|FG001|Overall Study|Withdrawal by Subject|2|||
155159944|NCT02855125|560022906|FG000|Overall Study|Clinical Disease Progression|5|||
155159945|NCT02855125|560022907|FG001|Overall Study|Clinical Disease Progression|4|||
155159946|NCT02855125|560022906|FG000|Overall Study|Radiologic Disease Progression|36|||
155159947|NCT02855125|560022907|FG001|Overall Study|Radiologic Disease Progression|39|||
155159948|NCT02855125|560022906|FG000|Overall Study|Adverse Event|11|||
155159949|NCT02855125|560022907|FG001|Overall Study|Adverse Event|7|||
155159950|NCT02855125|560022906|FG000|Overall Study|Physician Decision|1|||
155159951|NCT02855125|560022907|FG001|Overall Study|Physician Decision|0|||
155159952|NCT02855125|560022906|FG000|Overall Study|On Treatment|9|||
155159953|NCT02855125|560022907|FG001|Overall Study|On Treatment|11|||
155159954|NCT02855125|560022906|FG000|Overall Study|Randomized but not treated|0|||
155159955|NCT02855125|560022907|FG001|Overall Study|Randomized but not treated|1|||
155159956|NCT04467905|560022908|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
155159957|NCT04467905|560022909|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
155159958|NCT04467905|560022910|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
155159959|NCT04467905|560022908|FG000|Overall Study|Conversion to SR|0|||
155159960|NCT04467905|560022909|FG001|Overall Study|Conversion to SR|0|||
155159961|NCT04467905|560022910|FG002|Overall Study|Conversion to SR|3|||
155159962|NCT04467905|560022908|FG000|Overall Study|Technical issue with Holter ECG|0|||
155159963|NCT04467905|560022909|FG001|Overall Study|Technical issue with Holter ECG|0|||
155159964|NCT04467905|560022910|FG002|Overall Study|Technical issue with Holter ECG|3|||
155302303|NCT01170962|560538470|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
155302304|NCT01170962|560538471|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
155159965|NCT04467905|560022908|FG000|Overall Study|Hemodynamic instability|0|||
155159966|NCT04467905|560022909|FG001|Overall Study|Hemodynamic instability|0|||
155159967|NCT04467905|560022910|FG002|Overall Study|Hemodynamic instability|1|||
155159968|NCT04467905|560022908|FG000|Overall Study|Site misinterpretation of protocol|0|||
155159969|NCT04467905|560022909|FG001|Overall Study|Site misinterpretation of protocol|0|||
155159970|NCT04467905|560022910|FG002|Overall Study|Site misinterpretation of protocol|1|||
155159971|NCT04226742|560024802|FG000|Overall Study|Lost to Follow-up|16|||
155159972|NCT04226742|560024803|FG001|Overall Study|Lost to Follow-up|13|||
155159973|NCT04226742|560024802|FG000|Overall Study|Withdrawal by Subject|5|||
155159974|NCT04226742|560024803|FG001|Overall Study|Withdrawal by Subject|3|||
155159975|NCT02492763|560024804|FG000|Overall Study|Withdrawal by Subject|0|||
155159976|NCT02492763|560024805|FG001|Overall Study|Withdrawal by Subject|2|||
155159977|NCT02492763|560024806|FG002|Overall Study|Withdrawal by Subject|1|||
155159978|NCT02492763|560024807|FG003|Overall Study|Withdrawal by Subject|0|||
155159979|NCT02492763|560024804|FG000|Overall Study|Adverse Event|3|||
155302305|NCT01170962|560538472|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
155302306|NCT01170962|560538470|FG000|Follow up Period|Withdrawal by Subject|14|||
155302307|NCT01170962|560538471|FG001|Follow up Period|Withdrawal by Subject|10|||
155302308|NCT01170962|560538472|FG002|Follow up Period|Withdrawal by Subject|2|||
155302309|NCT01170962|560538470|FG000|Follow up Period|Lost to Follow-up|13|||
155302310|NCT01170962|560538471|FG001|Follow up Period|Lost to Follow-up|8|||
155302311|NCT01170962|560538472|FG002|Follow up Period|Lost to Follow-up|1|||
155302312|NCT01170962|560538470|FG000|Follow up Period|Death|2|||
155302313|NCT01170962|560538471|FG001|Follow up Period|Death|2|||
155302314|NCT01170962|560538472|FG002|Follow up Period|Death|0|||
155302315|NCT01170962|560538470|FG000|Follow up Period|Others|10|||
155302316|NCT01170962|560538471|FG001|Follow up Period|Others|7|||
155302317|NCT01170962|560538472|FG002|Follow up Period|Others|3|||
155302318|NCT00440011|560538473|FG000|Overall Study|Adverse Event|2|||
155302319|NCT00440011|560538474|FG001|Overall Study|Adverse Event|0|||
155302320|NCT00440011|560538473|FG000|Overall Study|Lost to Follow-up|0|||
155302321|NCT00440011|560538474|FG001|Overall Study|Lost to Follow-up|2|||
155302322|NCT00440011|560538473|FG000|Overall Study|Protocol Violation|1|||
155302323|NCT00440011|560538474|FG001|Overall Study|Protocol Violation|1|||
155302324|NCT00440011|560538473|FG000|Overall Study|Withdrawal by Subject|1|||
155302325|NCT00440011|560538474|FG001|Overall Study|Withdrawal by Subject|0|||
155302326|NCT01083316|560538478|FG000|Overall Study|Adverse Event|2|||
155302327|NCT01083316|560538478|FG000|Overall Study|Withdrawal by Subject|1|||
155302328|NCT01849055|560538488|FG000|Overall Study|Withdrawal by Subject|0|||
155302329|NCT01849055|560538489|FG001|Overall Study|Withdrawal by Subject|0|||
155302330|NCT01849055|560538490|FG002|Overall Study|Withdrawal by Subject|1|||
155302331|NCT01849055|560538491|FG003|Overall Study|Withdrawal by Subject|0|||
155302332|NCT01849055|560538492|FG004|Overall Study|Withdrawal by Subject|0|||
155302333|NCT01849055|560538493|FG005|Overall Study|Withdrawal by Subject|0|||
155159980|NCT02492763|560024805|FG001|Overall Study|Adverse Event|1|||
155159981|NCT02492763|560024806|FG002|Overall Study|Adverse Event|1|||
155159982|NCT02492763|560024807|FG003|Overall Study|Adverse Event|2|||
155159983|NCT02492763|560024804|FG000|Overall Study|Death|0|||
155159984|NCT02492763|560024805|FG001|Overall Study|Death|0|||
154957922|NCT00838539|559273985|FG008|Overall Study|Withdrawal by Subject|0|||
155159985|NCT02492763|560024806|FG002|Overall Study|Death|1|||
155159986|NCT02492763|560024807|FG003|Overall Study|Death|0|||
155302334|NCT00223795|560538498|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
155159987|NCT02492763|560024804|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
155159988|NCT02492763|560024805|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
155159989|NCT02492763|560024806|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
155159990|NCT02492763|560024807|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
155159991|NCT02492763|560024804|FG000|Overall Study|Lost to Follow-up|0|||
155159992|NCT02492763|560024805|FG001|Overall Study|Lost to Follow-up|0|||
155159993|NCT02492763|560024806|FG002|Overall Study|Lost to Follow-up|1|||
155159994|NCT02492763|560024807|FG003|Overall Study|Lost to Follow-up|0|||
155159995|NCT02492763|560024804|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155159996|NCT02492763|560024805|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155159997|NCT02492763|560024806|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155159998|NCT02492763|560024807|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155159999|NCT02492763|560024804|FG000|Overall Study|Screen Failure|0|||
155160000|NCT02492763|560024805|FG001|Overall Study|Screen Failure|0|||
155160001|NCT02492763|560024806|FG002|Overall Study|Screen Failure|0|||
155160002|NCT02492763|560024807|FG003|Overall Study|Screen Failure|1|||
155160003|NCT02492763|560024804|FG000|Overall Study|Study Terminated by Sponsor|13|||
155160004|NCT02492763|560024805|FG001|Overall Study|Study Terminated by Sponsor|10|||
155160005|NCT02492763|560024806|FG002|Overall Study|Study Terminated by Sponsor|6|||
155160006|NCT02492763|560024807|FG003|Overall Study|Study Terminated by Sponsor|10|||
155160007|NCT01772316|560024808|FG000|Overall Study|Serious adverse event|1|||
155160008|NCT01772316|560024808|FG000|Overall Study|Inform consent withdrawn|1|||
155160009|NCT01772316|560024808|FG000|Overall Study|Withdrawn by sponsor decision|5|||
155160010|NCT00521404|560024809|FG000|Overall Study|Adverse Event|13|||
155160011|NCT00521404|560024809|FG000|Overall Study|Disease Progression|33|||
155160012|NCT00521404|560024809|FG000|Overall Study|Investigator decision|5|||
155160013|NCT00521404|560024809|FG000|Overall Study|Withdrawal of consent|3|||
155160014|NCT00521404|560024809|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
155160015|NCT00521404|560024809|FG000|Overall Study|Other|7|||
155160016|NCT00882557|560024810|FG000|Overall Study|Withdrawal by Subject|1|||
155160017|NCT00882557|560024811|FG001|Overall Study|Withdrawal by Subject|0|||
155160018|NCT00882557|560024810|FG000|Overall Study|Trouble with Vein Access|1|||
155160019|NCT00882557|560024811|FG001|Overall Study|Trouble with Vein Access|0|||
155160020|NCT00882557|560024810|FG000|Overall Study|Randomized Not Treated|0|||
155160021|NCT00882557|560024811|FG001|Overall Study|Randomized Not Treated|1|||
155160022|NCT01383356|560024812|FG000|Period 1|Adverse Event|5|||
155160023|NCT01383356|560024813|FG001|Period 1|Adverse Event|3|||
155160024|NCT01383356|560024812|FG000|Period 1|Non-compliance|3|||
155160025|NCT01383356|560024813|FG001|Period 1|Non-compliance|0|||
155160026|NCT01383356|560024812|FG000|Period 1|Out of Range Mid-study-Test|0|||
155160027|NCT01383356|560024813|FG001|Period 1|Out of Range Mid-study-Test|1|||
155160028|NCT01383356|560024812|FG000|Period 1|Personal|0|||
155160029|NCT01383356|560024813|FG001|Period 1|Personal|2|||
155160030|NCT02035267|560024814|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
155160031|NCT02035267|560024815|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
155160032|NCT02035267|560024816|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
155160033|NCT02035267|560024817|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
155160034|NCT02035267|560024814|FG000|Overall Study|Adverse Event|0|||
155160035|NCT02035267|560024815|FG001|Overall Study|Adverse Event|0|||
155160036|NCT02035267|560024816|FG002|Overall Study|Adverse Event|1|||
155160037|NCT02035267|560024817|FG003|Overall Study|Adverse Event|0|||
155160038|NCT02035267|560024814|FG000|Overall Study|Lost to Follow-up|0|||
155160039|NCT02035267|560024815|FG001|Overall Study|Lost to Follow-up|0|||
155160040|NCT02035267|560024816|FG002|Overall Study|Lost to Follow-up|0|||
155160041|NCT02035267|560024817|FG003|Overall Study|Lost to Follow-up|1|||
155160042|NCT02035267|560024814|FG000|Overall Study|Other unspecified|0|||
155160043|NCT02035267|560024815|FG001|Overall Study|Other unspecified|1|||
155160044|NCT02035267|560024816|FG002|Overall Study|Other unspecified|0|||
155160045|NCT02035267|560024817|FG003|Overall Study|Other unspecified|0|||
155160046|NCT03038880|560024824|FG000|Overall Study|Death|1|||
155160047|NCT03038880|560024825|FG001|Overall Study|Death|2|||
155160048|NCT03038880|560024826|FG002|Overall Study|Death|0|||
155160049|NCT03038880|560024824|FG000|Overall Study|Physician Decision|2|||
155160050|NCT03038880|560024825|FG001|Overall Study|Physician Decision|1|||
155160051|NCT03038880|560024826|FG002|Overall Study|Physician Decision|0|||
155160052|NCT00956007|560024829|FG000|Overall Study|Protocol Violation|27|||
155160053|NCT00956007|560024830|FG001|Overall Study|Protocol Violation|23|||
155160054|NCT01750229|560024831|FG000|Randomized Crossover Phase|Adverse Event|1|||
155160055|NCT01750229|560024831|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
155160056|NCT01750229|560024831|FG000|Long-term Follow-up Phase|Adverse Event|2|||
155160057|NCT01750229|560024831|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
155160058|NCT01746901|560024832|FG000|Naloxone Challenge Phase|Adverse Event|2|||
155160059|NCT01746901|560024833|FG001|Naloxone Challenge Phase|Adverse Event|0|||
155160060|NCT01746901|560024834|FG002|Naloxone Challenge Phase|Adverse Event|0|||
155160061|NCT01746901|560024835|FG003|Naloxone Challenge Phase|Adverse Event|0|||
155160062|NCT01746901|560024836|FG004|Naloxone Challenge Phase|Adverse Event|0|||
155160063|NCT01746901|560024837|FG005|Naloxone Challenge Phase|Adverse Event|0|||
155160064|NCT01746901|560024838|FG006|Naloxone Challenge Phase|Adverse Event|0|||
155160065|NCT01746901|560024839|FG007|Naloxone Challenge Phase|Adverse Event|0|||
155160066|NCT01746901|560024840|FG008|Naloxone Challenge Phase|Adverse Event|0|||
155160067|NCT01746901|560024832|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
155160068|NCT01746901|560024833|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160069|NCT01746901|560024834|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160070|NCT01746901|560024835|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155302335|NCT00223795|560538499|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
155302336|NCT00223795|560538498|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
155302337|NCT00223795|560538499|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
155302338|NCT01239316|560538500|FG000|Overall Study|Progression/Relapse|11|||
155302339|NCT01239316|560538500|FG000|Overall Study|Adverse Event|1|||
155302340|NCT02299375|560538506|FG000|Overall Study|Adverse Event, serious fatal|1|||
155302341|NCT02299375|560538507|FG001|Overall Study|Adverse Event, serious fatal|3|||
155302342|NCT02299375|560538506|FG000|Overall Study|Adverse Event, non-fatal|8|||
155302343|NCT02299375|560538507|FG001|Overall Study|Adverse Event, non-fatal|9|||
155302344|NCT02299375|560538506|FG000|Overall Study|Lack of Efficacy|1|||
155302345|NCT02299375|560538507|FG001|Overall Study|Lack of Efficacy|3|||
155302346|NCT02299375|560538506|FG000|Overall Study|Protocol Violation|1|||
155302347|NCT02299375|560538507|FG001|Overall Study|Protocol Violation|3|||
155302348|NCT02299375|560538506|FG000|Overall Study|Other: Met stopping criteria|1|||
155302349|NCT02299375|560538507|FG001|Overall Study|Other: Met stopping criteria|0|||
155302350|NCT02299375|560538506|FG000|Overall Study|Other: Study closed/terminated|66|||
155302351|NCT02299375|560538507|FG001|Overall Study|Other: Study closed/terminated|55|||
155302352|NCT02299375|560538506|FG000|Overall Study|Lost to Follow-up|0|||
155160071|NCT01746901|560024836|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160072|NCT01746901|560024837|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160073|NCT01746901|560024838|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160074|NCT01746901|560024839|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160075|NCT01746901|560024840|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
155160076|NCT01746901|560024832|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160077|NCT01746901|560024833|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
155160078|NCT01746901|560024834|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160079|NCT01746901|560024835|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160080|NCT01746901|560024836|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160081|NCT01746901|560024837|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160082|NCT01746901|560024838|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160083|NCT01746901|560024839|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160084|NCT01746901|560024840|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
155160085|NCT01746901|560024832|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160086|NCT01746901|560024833|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
155160087|NCT01746901|560024834|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
155160088|NCT01746901|560024835|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160089|NCT01746901|560024836|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160090|NCT01746901|560024837|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160091|NCT01746901|560024838|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160092|NCT01746901|560024839|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160093|NCT01746901|560024840|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
155160094|NCT01746901|560024832|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155160095|NCT01746901|560024833|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
155160096|NCT01746901|560024834|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
155160097|NCT01746901|560024835|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
154957923|NCT00838539|559273986|FG009|Overall Study|Withdrawal by Subject|1|||
154957924|NCT00838539|559273987|FG010|Overall Study|Withdrawal by Subject|2|||
154957925|NCT00838539|559273988|FG011|Overall Study|Withdrawal by Subject|0|||
154957926|NCT00838539|559273977|FG000|Overall Study|Death|0|||
154957927|NCT00838539|559273978|FG001|Overall Study|Death|0|||
154957928|NCT00838539|559273979|FG002|Overall Study|Death|0|||
154957929|NCT00838539|559273980|FG003|Overall Study|Death|0|||
154957930|NCT00838539|559273981|FG004|Overall Study|Death|0|||
154957931|NCT00838539|559273982|FG005|Overall Study|Death|0|||
154957932|NCT00838539|559273983|FG006|Overall Study|Death|1|||
154957933|NCT00838539|559273984|FG007|Overall Study|Death|0|||
154957934|NCT00838539|559273985|FG008|Overall Study|Death|0|||
154957935|NCT00838539|559273986|FG009|Overall Study|Death|0|||
154957936|NCT00838539|559273987|FG010|Overall Study|Death|0|||
154957937|NCT00838539|559273988|FG011|Overall Study|Death|0|||
154957938|NCT00838539|559273977|FG000|Overall Study|Physician Decision|0|||
154957939|NCT00838539|559273978|FG001|Overall Study|Physician Decision|0|||
154957940|NCT00838539|559273979|FG002|Overall Study|Physician Decision|0|||
154957941|NCT00838539|559273980|FG003|Overall Study|Physician Decision|0|||
154957942|NCT00838539|559273981|FG004|Overall Study|Physician Decision|0|||
154957943|NCT00838539|559273982|FG005|Overall Study|Physician Decision|0|||
155160098|NCT01746901|560024836|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155160099|NCT01746901|560024837|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155160100|NCT01746901|560024838|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155160101|NCT01746901|560024839|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155160102|NCT01746901|560024840|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
155160103|NCT01746901|560024832|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154957944|NCT00838539|559273983|FG006|Overall Study|Physician Decision|0|||
155160104|NCT01746901|560024833|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
155160105|NCT01746901|560024834|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
155160106|NCT01746901|560024835|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155160107|NCT01746901|560024836|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155160108|NCT01746901|560024837|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155160109|NCT01746901|560024838|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155160110|NCT01746901|560024839|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155160111|NCT01746901|560024840|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
155160112|NCT01746901|560024832|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
155160113|NCT01746901|560024833|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
155160114|NCT01746901|560024834|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
155160115|NCT01746901|560024835|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
155160116|NCT01746901|560024836|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
155160117|NCT01746901|560024837|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
155160118|NCT01746901|560024838|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
155160119|NCT01746901|560024839|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
155160120|NCT01746901|560024840|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
155160121|NCT01746901|560024832|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160122|NCT01746901|560024833|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160123|NCT01746901|560024834|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160124|NCT01746901|560024835|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160125|NCT01746901|560024836|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160126|NCT01746901|560024837|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160127|NCT01746901|560024838|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160128|NCT01746901|560024839|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
155160129|NCT01746901|560024840|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
155160130|NCT01746901|560024832|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160131|NCT01746901|560024833|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160132|NCT01746901|560024834|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160133|NCT01746901|560024835|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160134|NCT01746901|560024836|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160135|NCT01746901|560024837|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
155160136|NCT01746901|560024838|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
155160137|NCT01746901|560024839|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160138|NCT01746901|560024840|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
155160139|NCT01746901|560024832|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155160140|NCT01746901|560024833|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155160141|NCT01746901|560024834|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155160142|NCT01746901|560024835|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
155160143|NCT01746901|560024836|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155160144|NCT01746901|560024837|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155160145|NCT01746901|560024838|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155160146|NCT01746901|560024839|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155302353|NCT02299375|560538507|FG001|Overall Study|Lost to Follow-up|2|||
154957945|NCT00838539|559273984|FG007|Overall Study|Physician Decision|0|||
154957946|NCT00838539|559273985|FG008|Overall Study|Physician Decision|1|||
154957947|NCT00838539|559273986|FG009|Overall Study|Physician Decision|0|||
154957948|NCT00838539|559273987|FG010|Overall Study|Physician Decision|0|||
154957949|NCT00838539|559273988|FG011|Overall Study|Physician Decision|0|||
154957950|NCT00838539|559273977|FG000|Overall Study|Clinical Progression|0|||
154957951|NCT00838539|559273978|FG001|Overall Study|Clinical Progression|0|||
154957952|NCT00838539|559273979|FG002|Overall Study|Clinical Progression|0|||
154957953|NCT00838539|559273980|FG003|Overall Study|Clinical Progression|0|||
154957954|NCT00838539|559273981|FG004|Overall Study|Clinical Progression|0|||
154957955|NCT00838539|559273982|FG005|Overall Study|Clinical Progression|0|||
154957956|NCT00838539|559273983|FG006|Overall Study|Clinical Progression|1|||
154957957|NCT00838539|559273984|FG007|Overall Study|Clinical Progression|0|||
154957958|NCT00838539|559273985|FG008|Overall Study|Clinical Progression|0|||
154957959|NCT00838539|559273986|FG009|Overall Study|Clinical Progression|0|||
154957960|NCT00838539|559273987|FG010|Overall Study|Clinical Progression|0|||
155063316|NCT00576758|559664056|FG001|Follow-up Period|Withdrew consent|1|||
155063317|NCT03427411|559664057|FG000|Overall Study|Screen failure - platelets too low|0|||
155063318|NCT03427411|559664058|FG001|Overall Study|Screen failure - platelets too low|1|||
155063319|NCT01294046|559664059|FG000|Overall Study|Infection and surgical explant|1|||
155063320|NCT01294046|559664059|FG000|Overall Study|Eligibility criteria expanded|1|||
155063321|NCT01294046|559664059|FG000|Overall Study|Stimulation response inadqequate|1|||
155063322|NCT03979313|559664060|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
155063323|NCT03979313|559664061|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
155063324|NCT03979313|559664060|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
155160147|NCT01746901|560024840|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
155063325|NCT03979313|559664061|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
155063326|NCT03979313|559664060|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
155063327|NCT03979313|559664061|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
155063328|NCT03979313|559664060|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
155063329|NCT03979313|559664061|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
155160148|NCT01746901|560024832|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160149|NCT01746901|560024833|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160150|NCT01746901|560024834|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160151|NCT01746901|560024835|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160152|NCT01746901|560024836|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160153|NCT01746901|560024837|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
155160154|NCT01746901|560024838|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160155|NCT01746901|560024839|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
155160156|NCT01746901|560024840|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
155160157|NCT01746901|560024832|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155160158|NCT01746901|560024833|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155160159|NCT01746901|560024834|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155160160|NCT01746901|560024835|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155160161|NCT01746901|560024836|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155160162|NCT01746901|560024837|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155160163|NCT01746901|560024838|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
155160164|NCT01746901|560024839|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
155302354|NCT02299375|560538506|FG000|Overall Study|Physician Decision|1|||
154957961|NCT00838539|559273988|FG011|Overall Study|Clinical Progression|0|||
154957962|NCT00838539|559273977|FG000|Overall Study|Symptomatic Deterioration|0|||
154957963|NCT00838539|559273978|FG001|Overall Study|Symptomatic Deterioration|0|||
154957964|NCT00838539|559273979|FG002|Overall Study|Symptomatic Deterioration|1|||
154957965|NCT00838539|559273980|FG003|Overall Study|Symptomatic Deterioration|1|||
154957966|NCT00838539|559273981|FG004|Overall Study|Symptomatic Deterioration|0|||
154957967|NCT00838539|559273982|FG005|Overall Study|Symptomatic Deterioration|1|||
154957968|NCT00838539|559273983|FG006|Overall Study|Symptomatic Deterioration|0|||
154957969|NCT00838539|559273984|FG007|Overall Study|Symptomatic Deterioration|0|||
154957970|NCT00838539|559273985|FG008|Overall Study|Symptomatic Deterioration|0|||
154957971|NCT00838539|559273986|FG009|Overall Study|Symptomatic Deterioration|1|||
154957972|NCT00838539|559273987|FG010|Overall Study|Symptomatic Deterioration|0|||
154957973|NCT00838539|559273988|FG011|Overall Study|Symptomatic Deterioration|0|||
154957974|NCT05323396|559273989|FG000|Overall Study|Lost to Follow-up|1|||
154957975|NCT05323396|559273990|FG001|Overall Study|Lost to Follow-up|35|||
154957976|NCT05323396|559273989|FG000|Overall Study|Pregnancy|1|||
154957977|NCT05323396|559273990|FG001|Overall Study|Pregnancy|0|||
154957978|NCT03420300|559273991|FG000|Overall Study|Death|2|||
154957979|NCT02242201|559273999|FG000|Overall Study|preoperative identified neuropathy|2|||
154957980|NCT02242201|559274000|FG001|Overall Study|preoperative identified neuropathy|0|||
154957981|NCT02242201|559274001|FG002|Overall Study|preoperative identified neuropathy|0|||
154957982|NCT02242201|559273999|FG000|Overall Study|planned post-op anticoagulation|1|||
154957983|NCT02242201|559274000|FG001|Overall Study|planned post-op anticoagulation|0|||
154957984|NCT02242201|559274001|FG002|Overall Study|planned post-op anticoagulation|0|||
154957985|NCT02242201|559273999|FG000|Overall Study|changed surgical procedure|1|||
154957986|NCT02242201|559274000|FG001|Overall Study|changed surgical procedure|0|||
154957987|NCT02242201|559274001|FG002|Overall Study|changed surgical procedure|0|||
154957988|NCT02242201|559273999|FG000|Overall Study|postponed surgery|0|||
154957989|NCT02242201|559274000|FG001|Overall Study|postponed surgery|0|||
154957990|NCT02242201|559274001|FG002|Overall Study|postponed surgery|1|||
154957991|NCT02242201|559273999|FG000|Overall Study|preoperative opioid consumption|0|||
154957992|NCT02242201|559274000|FG001|Overall Study|preoperative opioid consumption|1|||
154957993|NCT02242201|559274001|FG002|Overall Study|preoperative opioid consumption|0|||
154957994|NCT03681470|559274003|FG000|Overall Study|Lack of Efficacy|3|||
154957995|NCT03681470|559274003|FG000|Overall Study|Lost to Follow-up|1|||
154957996|NCT03681470|559274003|FG000|Overall Study|Protocol Violation|3|||
154957997|NCT03681470|559274003|FG000|Overall Study|Withdrawal by Subject|1|||
154957998|NCT03500692|559274008|FG000|Overall Study|Death|163|||
154957999|NCT03500692|559274008|FG000|Overall Study|Lost to Follow-up|75|||
155160165|NCT01746901|560024840|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
155160166|NCT03594110|560024844|FG000|Interventional Part|Participant concerned about study treatment|23|||
155160167|NCT03594110|560024845|FG001|Interventional Part|Participant concerned about study treatment|28|||
155160168|NCT03594110|560024844|FG000|Interventional Part|Doctor advice|38|||
155160169|NCT03594110|560024845|FG001|Interventional Part|Doctor advice|40|||
155160170|NCT03594110|560024844|FG000|Interventional Part|Participants' wish|89|||
155160171|NCT03594110|560024845|FG001|Interventional Part|Participants' wish|68|||
155160172|NCT03594110|560024844|FG000|Interventional Part|Adverse event-non-fatal events|119|||
155160173|NCT03594110|560024845|FG001|Interventional Part|Adverse event-non-fatal events|116|||
155160174|NCT03594110|560024844|FG000|Interventional Part|Study drug stopped, reason missing|336|||
155160175|NCT03594110|560024845|FG001|Interventional Part|Study drug stopped, reason missing|294|||
155160176|NCT03594110|560024844|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
155160177|NCT03594110|560024845|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
155160178|NCT03594110|560024844|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
155160179|NCT03594110|560024845|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
155160180|NCT03594110|560024844|FG000|Interventional Part|Contraindicated drug started|32|||
155160181|NCT03594110|560024845|FG001|Interventional Part|Contraindicated drug started|18|||
155160182|NCT03594110|560024844|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
155160183|NCT03594110|560024845|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
155160184|NCT03594110|560024844|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
155160185|NCT03594110|560024845|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
155160186|NCT03594110|560024844|FG000|Non-interventional Part|Withdrawal by Subject|3|||
155160187|NCT03594110|560024845|FG001|Non-interventional Part|Withdrawal by Subject|4|||
155160188|NCT03594110|560024844|FG000|Non-interventional Part|Lost to Follow-up|45|||
155160189|NCT03594110|560024845|FG001|Non-interventional Part|Lost to Follow-up|41|||
155160190|NCT02085460|560024848|FG000|Overall Study|Adverse Event|2|||
155160191|NCT02085460|560024849|FG001|Overall Study|Adverse Event|2|||
155160192|NCT02085460|560024850|FG002|Overall Study|Adverse Event|1|||
154958000|NCT03500692|559274008|FG000|Overall Study|Termination Reasons|3|||
154958001|NCT04149964|559274009|FG000|Overall Study|Lost to Follow-up|19|||
154958002|NCT04149964|559274010|FG001|Overall Study|Lost to Follow-up|18|||
154958003|NCT01697696|559274011|FG000|Overall Study|Study terminated by sponsor|0|||
154958004|NCT01697696|559274012|FG001|Overall Study|Study terminated by sponsor|3|||
154958005|NCT01697696|559274011|FG000|Overall Study|Protocol deviation|1|||
154958006|NCT01697696|559274012|FG001|Overall Study|Protocol deviation|0|||
154958007|NCT01697696|559274011|FG000|Overall Study|Physician Decision|1|||
154958008|NCT01697696|559274012|FG001|Overall Study|Physician Decision|0|||
154958009|NCT01697696|559274011|FG000|Overall Study|Death|4|||
154958010|NCT01697696|559274012|FG001|Overall Study|Death|2|||
154958011|NCT01697696|559274011|FG000|Overall Study|Lost to Follow-up|10|||
154958012|NCT01697696|559274012|FG001|Overall Study|Lost to Follow-up|7|||
154958013|NCT01697696|559274011|FG000|Overall Study|Subject/guardian decision|31|||
154958014|NCT01697696|559274012|FG001|Overall Study|Subject/guardian decision|35|||
154958015|NCT02066922|559274015|FG000|Overall Study|Adverse Event|1|||
154958016|NCT03238781|559274016|FG000|Overall Study|Adverse Event|1|||
154958017|NCT03238781|559274017|FG001|Overall Study|Adverse Event|1|||
154958018|NCT03238781|559274018|FG002|Overall Study|Adverse Event|2|||
154958019|NCT03238781|559274016|FG000|Overall Study|Lost to Follow-up|2|||
155160193|NCT02085460|560024848|FG000|Overall Study|Physician Decision|1|||
155160194|NCT02085460|560024849|FG001|Overall Study|Physician Decision|1|||
155302355|NCT02299375|560538507|FG001|Overall Study|Physician Decision|1|||
155302356|NCT02299375|560538506|FG000|Overall Study|Withdrawal by Subject|1|||
155302357|NCT02299375|560538507|FG001|Overall Study|Withdrawal by Subject|4|||
155302358|NCT05135000|560538513|FG000|Overall Study|Adverse Event|2|||
155302359|NCT05135000|560538514|FG001|Overall Study|Adverse Event|0|||
155302360|NCT05135000|560538513|FG000|Overall Study|Lost to Follow-up|1|||
155302361|NCT05135000|560538514|FG001|Overall Study|Lost to Follow-up|0|||
155302362|NCT05135000|560538513|FG000|Overall Study|Study Terminated by Sponsor|6|||
155302363|NCT05135000|560538514|FG001|Overall Study|Study Terminated by Sponsor|3|||
155302364|NCT04201834|560540102|FG000|Overall Study|Screen fail|1|||
155302365|NCT04104321|560540106|FG000|Overall Study|didn't take the study drug|3|||
155302366|NCT01903811|560540118|FG000|Overall Study|No measurable disease|1|||
155302367|NCT01903811|560540119|FG001|Overall Study|No measurable disease|1|||
155302368|NCT01903811|560540118|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
155302369|NCT01903811|560540119|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
155302370|NCT01903811|560540118|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
155302371|NCT01903811|560540119|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
155302372|NCT01903811|560540118|FG000|Overall Study|Withdrawal by Subject|0|||
155302373|NCT01903811|560540119|FG001|Overall Study|Withdrawal by Subject|1|||
155160195|NCT02085460|560024850|FG002|Overall Study|Physician Decision|2|||
154958020|NCT03238781|559274017|FG001|Overall Study|Lost to Follow-up|1|||
154958021|NCT03238781|559274018|FG002|Overall Study|Lost to Follow-up|2|||
154958022|NCT03238781|559274016|FG000|Overall Study|Withdrawal by Subject|23|||
155160196|NCT02085460|560024848|FG000|Overall Study|Withdrawal by Subject|11|||
155160197|NCT02085460|560024849|FG001|Overall Study|Withdrawal by Subject|5|||
155160198|NCT02085460|560024850|FG002|Overall Study|Withdrawal by Subject|7|||
155160199|NCT02351817|560024851|FG000|Period 1|Adverse Event|1|||
155160200|NCT02351817|560024852|FG001|Period 1|Adverse Event|2|||
155160201|NCT02351817|560024851|FG000|Period 1|Lack of Efficacy|0|||
155160202|NCT02351817|560024852|FG001|Period 1|Lack of Efficacy|1|||
155160203|NCT02351817|560024851|FG000|Period 2|Adverse Event|0|||
155160204|NCT02351817|560024852|FG001|Period 2|Adverse Event|2|||
155160205|NCT02351817|560024851|FG000|Period 2|Protocol Violation|1|||
155160206|NCT02351817|560024852|FG001|Period 2|Protocol Violation|0|||
155160207|NCT00891904|560024859|FG000|Overall Study|Death|1|||
155160208|NCT00891904|560024859|FG000|Overall Study|Adverse Event|1|||
155160209|NCT01046396|560024860|FG000|Overall Study|Withdrawal by Subject|5|||
155160210|NCT04041414|560024863|FG000|Overall Study|Lost to Follow-up|1|||
155160211|NCT04041414|560024864|FG001|Overall Study|Lost to Follow-up|2|||
155160212|NCT00665652|560024865|FG000|Overall Study|Adverse Event|4|||
155160213|NCT00665652|560024865|FG000|Overall Study|Death|1|||
155160214|NCT00665652|560024865|FG000|Overall Study|No longer met inclusion criteria.|1|||
155160215|NCT02161016|560024866|FG000|Overall Study|withdrawn by IRB|1|||
155160216|NCT00380367|560024875|FG000|Overall Study|Lost to Follow-up|1|||
155160217|NCT00380367|560024875|FG000|Overall Study|Withdrawal by Subject|1|||
155160218|NCT02504151|560024880|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
155160219|NCT02504151|560024881|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
155160220|NCT02504151|560024880|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
155160221|NCT02504151|560024881|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
155160222|NCT02504151|560024880|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155160223|NCT02504151|560024881|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155160224|NCT02504151|560024880|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
155160225|NCT02504151|560024881|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
155160226|NCT05038982|560024882|FG000|Overall Study|Withdrawal by Subject|0|||
155160227|NCT05038982|560024883|FG001|Overall Study|Withdrawal by Subject|2|||
155160228|NCT01454102|560024887|FG000|Overall Study|Continuing in the treatment period|0|||
155160229|NCT01454102|560024888|FG001|Overall Study|Continuing in the treatment period|0|||
155160230|NCT01454102|560024889|FG002|Overall Study|Continuing in the treatment period|0|||
155160231|NCT01454102|560024890|FG003|Overall Study|Continuing in the treatment period|0|||
155160232|NCT01454102|560024891|FG004|Overall Study|Continuing in the treatment period|3|||
155160233|NCT01454102|560024892|FG005|Overall Study|Continuing in the treatment period|3|||
155160234|NCT01454102|560024893|FG006|Overall Study|Continuing in the treatment period|2|||
155160235|NCT01454102|560024894|FG007|Overall Study|Continuing in the treatment period|0|||
155160236|NCT01454102|560024895|FG008|Overall Study|Continuing in the treatment period|1|||
155160237|NCT01454102|560024896|FG009|Overall Study|Continuing in the treatment period|0|||
155160238|NCT01454102|560024897|FG010|Overall Study|Continuing in the treatment period|0|||
155160239|NCT01454102|560024898|FG011|Overall Study|Continuing in the treatment period|4|||
155160240|NCT01454102|560024899|FG012|Overall Study|Continuing in the treatment period|7|||
155160241|NCT01454102|560024900|FG013|Overall Study|Continuing in the treatment period|4|||
155160242|NCT01454102|560024901|FG014|Overall Study|Continuing in the treatment period|3|||
155160243|NCT01454102|560024902|FG015|Overall Study|Continuing in the treatment period|1|||
155160244|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
155160245|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
155160246|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
155160247|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
155160248|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155160249|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
155160250|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
155160251|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
155160252|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
155160253|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
155160254|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
155160255|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
155160256|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
155160257|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
155160258|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
155160259|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
155160260|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
155160261|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
155160262|NCT03739203|560024905|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
155160263|NCT03739203|560024906|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
155160264|NCT03739203|560024907|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
155160265|NCT03739203|560024905|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
155160266|NCT03739203|560024906|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
155160267|NCT03739203|560024907|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
155160268|NCT03739203|560024905|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
155160269|NCT03739203|560024906|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
155160270|NCT03739203|560024907|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
155160271|NCT03739203|560024905|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
155160272|NCT03739203|560024906|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
155160273|NCT03739203|560024907|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
155160274|NCT03739203|560024905|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
155160275|NCT03739203|560024906|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
155160276|NCT03739203|560024907|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
155160277|NCT01782378|560024908|FG000|First Series|Lost to Follow-up|7|||
155160278|NCT01782378|560024909|FG001|First Series|Lost to Follow-up|8|||
155160279|NCT01782378|560024908|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
155160280|NCT01782378|560024909|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
155160281|NCT01782378|560024908|FG000|Second Series|Lost to Follow-up|8|||
155160282|NCT01782378|560024909|FG001|Second Series|Lost to Follow-up|7|||
155160283|NCT01782378|560024908|FG000|Second Series|Did not choose to complete S2 Optional|18|||
155160284|NCT01782378|560024909|FG001|Second Series|Did not choose to complete S2 Optional|0|||
155160285|NCT00830440|560024910|FG000|Overall Study|Protocol Violation|1|||
155160286|NCT00830440|560024911|FG001|Overall Study|Protocol Violation|0|||
155160287|NCT00830440|560024910|FG000|Overall Study|Withdrawal by Subject|1|||
155160288|NCT00830440|560024911|FG001|Overall Study|Withdrawal by Subject|0|||
155160289|NCT00830440|560024910|FG000|Overall Study|unsuccessful procedure|4|||
155160290|NCT00830440|560024911|FG001|Overall Study|unsuccessful procedure|0|||
155160291|NCT00830440|560024910|FG000|Overall Study|Adverse Event|2|||
155160292|NCT00830440|560024911|FG001|Overall Study|Adverse Event|0|||
155160293|NCT02592798|560024912|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
155160294|NCT02592798|560024913|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
155160295|NCT02592798|560024912|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
155160296|NCT02592798|560024913|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
155160297|NCT02592798|560024912|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
155160298|NCT02592798|560024913|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
155160299|NCT02592798|560024912|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
155160300|NCT02592798|560024913|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
155160301|NCT02592798|560024912|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
155160302|NCT02592798|560024913|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
155160303|NCT02592798|560024912|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
155160304|NCT02592798|560024913|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
155160305|NCT02592798|560024912|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
155160306|NCT02592798|560024913|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
155160307|NCT02592798|560024912|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
155160308|NCT02592798|560024913|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
155160309|NCT02592798|560024912|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
155160310|NCT02592798|560024913|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
155160311|NCT02592798|560024912|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
155160312|NCT02592798|560024913|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
155160313|NCT02592798|560024912|FG000|Transition From DB2 to OLE|Other reasons|1|||
155160314|NCT02592798|560024913|FG001|Transition From DB2 to OLE|Other reasons|0|||
155160315|NCT02592798|560024912|FG000|Open Label Period (OLE)|Other reasons|0|||
155160316|NCT02592798|560024913|FG001|Open Label Period (OLE)|Other reasons|2|||
155160317|NCT02592798|560024912|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
155160318|NCT02592798|560024913|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
155160319|NCT02592798|560024912|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
155160320|NCT02592798|560024913|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
155160321|NCT02592798|560024912|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
155160322|NCT02592798|560024913|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
155160323|NCT02592798|560024912|FG000|Open Label Period (OLE)|Adverse Event|0|||
155160324|NCT02592798|560024913|FG001|Open Label Period (OLE)|Adverse Event|1|||
155160325|NCT01188343|560024914|FG000|Overall Study|Not vaccinated|0|||
155160326|NCT01188343|560024915|FG001|Overall Study|Not vaccinated|2|||
155160327|NCT01188343|560024916|FG002|Overall Study|Not vaccinated|1|||
155160328|NCT01188343|560024914|FG000|Overall Study|Withdrawal by Subject|1|||
155160329|NCT01188343|560024915|FG001|Overall Study|Withdrawal by Subject|24|||
155160330|NCT01188343|560024916|FG002|Overall Study|Withdrawal by Subject|0|||
155160331|NCT01143246|560024917|FG000|Overall Study|Adverse Event|24|||
155160332|NCT01143246|560024918|FG001|Overall Study|Adverse Event|28|||
155160333|NCT01143246|560024917|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
155160334|NCT01143246|560024918|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
155160335|NCT01143246|560024917|FG000|Overall Study|Lost to Follow-up|0|||
155160336|NCT01143246|560024918|FG001|Overall Study|Lost to Follow-up|1|||
155160337|NCT01143246|560024917|FG000|Overall Study|Death|16|||
155160338|NCT01143246|560024918|FG001|Overall Study|Death|15|||
155160339|NCT01143246|560024917|FG000|Overall Study|Reason not Specified|3|||
155160340|NCT01143246|560024918|FG001|Overall Study|Reason not Specified|5|||
155160341|NCT01663103|560024919|FG000|Overall Study|Withdrawal by Subject|1|||
155160342|NCT01663103|560024920|FG001|Overall Study|Withdrawal by Subject|2|||
155160343|NCT01663103|560024919|FG000|Overall Study|Adverse Event|1|||
155160344|NCT01663103|560024920|FG001|Overall Study|Adverse Event|0|||
155160345|NCT01663103|560024919|FG000|Overall Study|dog bite|1|||
155160346|NCT01663103|560024920|FG001|Overall Study|dog bite|0|||
155160347|NCT00363480|560024921|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
155160348|NCT00363480|560024921|FG000|Overall Study|Adverse Event|4|||
155160349|NCT00363480|560024921|FG000|Overall Study|Lost to Follow-up|5|||
155160350|NCT00363480|560024921|FG000|Overall Study|Withdrawal by Subject|5|||
155160351|NCT00363480|560024921|FG000|Overall Study|Non-compliance of subject|1|||
155160352|NCT00363480|560024921|FG000|Overall Study|Participant discontinued on its own|1|||
155160353|NCT04634253|560024924|FG000|Overall Study|Adverse Event|1|||
155160354|NCT04634253|560024925|FG001|Overall Study|Adverse Event|1|||
155160355|NCT04634253|560024926|FG002|Overall Study|Adverse Event|0|||
155160356|NCT04634253|560024924|FG000|Overall Study|Physician Decision|0|||
155160357|NCT04634253|560024925|FG001|Overall Study|Physician Decision|1|||
155160358|NCT04634253|560024926|FG002|Overall Study|Physician Decision|0|||
155160359|NCT04634253|560024924|FG000|Overall Study|Withdrawal by Subject|1|||
155160360|NCT04634253|560024925|FG001|Overall Study|Withdrawal by Subject|0|||
155160361|NCT04634253|560024926|FG002|Overall Study|Withdrawal by Subject|3|||
155160362|NCT01457703|560024933|FG000|Overall Study|Screen Failure|5|||
155160363|NCT01457703|560024934|FG001|Overall Study|Screen Failure|7|||
155160364|NCT01457703|560024933|FG000|Overall Study|Withdrawal by Subject|1|||
155160365|NCT01457703|560024934|FG001|Overall Study|Withdrawal by Subject|4|||
155160366|NCT01658436|560024935|FG000|Overall Study|Adverse Event|6|||
155160367|NCT01658436|560024936|FG001|Overall Study|Adverse Event|5|||
155160368|NCT01658436|560024935|FG000|Overall Study|Physician Decision|1|||
155160369|NCT01658436|560024936|FG001|Overall Study|Physician Decision|0|||
155160370|NCT01658436|560024935|FG000|Overall Study|Progressive disease|12|||
155160371|NCT01658436|560024936|FG001|Overall Study|Progressive disease|4|||
155160372|NCT01658436|560024935|FG000|Overall Study|Study terminated by sponsor|0|||
155160373|NCT01658436|560024936|FG001|Overall Study|Study terminated by sponsor|1|||
155160374|NCT01658436|560024935|FG000|Overall Study|Subject/guardian decision|0|||
155160375|NCT01658436|560024936|FG001|Overall Study|Subject/guardian decision|1|||
155160376|NCT01658436|560024935|FG000|Overall Study|Death|1|||
155160377|NCT01658436|560024936|FG001|Overall Study|Death|0|||
155160378|NCT03987503|560024937|FG000|Overall Study|Lost to Follow-up|20|||
155160379|NCT03987503|560024937|FG000|Overall Study|Withdrawal by Subject|2|||
155160380|NCT00888940|560024941|FG000|Overall Study|Adverse Event|12|||
155160381|NCT00888940|560024942|FG001|Overall Study|Adverse Event|3|||
155160382|NCT00888940|560024941|FG000|Overall Study|Lost to Follow-up|5|||
155160383|NCT00888940|560024942|FG001|Overall Study|Lost to Follow-up|5|||
155160384|NCT00888940|560024941|FG000|Overall Study|Randomized Not Treated|11|||
155160385|NCT00888940|560024942|FG001|Overall Study|Randomized Not Treated|13|||
155160386|NCT03815929|560024947|FG000|Overall Study|Lost to Follow-up|2|||
155160387|NCT03815929|560024948|FG001|Overall Study|Lost to Follow-up|1|||
155160388|NCT03815929|560024949|FG002|Overall Study|Lost to Follow-up|0|||
155160389|NCT03815929|560024947|FG000|Overall Study|Physician Decision|2|||
155160390|NCT03815929|560024948|FG001|Overall Study|Physician Decision|2|||
155160391|NCT03815929|560024949|FG002|Overall Study|Physician Decision|0|||
155160392|NCT03815929|560024947|FG000|Overall Study|Withdrawal by Subject|0|||
155160393|NCT03815929|560024948|FG001|Overall Study|Withdrawal by Subject|0|||
155160394|NCT03815929|560024949|FG002|Overall Study|Withdrawal by Subject|1|||
155160395|NCT03313037|560024950|FG000|Overall Study|Protocol Violation|4|||
155160396|NCT03313037|560024951|FG001|Overall Study|Protocol Violation|1|||
155160397|NCT03313037|560024950|FG000|Overall Study|Other|1|||
155160398|NCT03313037|560024951|FG001|Overall Study|Other|1|||
155160399|NCT03313037|560024950|FG000|Overall Study|Withdrawal by Subject|4|||
155160400|NCT03313037|560024951|FG001|Overall Study|Withdrawal by Subject|3|||
155160401|NCT03313037|560024950|FG000|Overall Study|No longer meets eligibility criteria|1|||
155160402|NCT03313037|560024951|FG001|Overall Study|No longer meets eligibility criteria|7|||
155160403|NCT03313037|560024950|FG000|Overall Study|Lost to Follow-up|9|||
155160404|NCT03313037|560024951|FG001|Overall Study|Lost to Follow-up|8|||
155160405|NCT03313037|560024950|FG000|Overall Study|Randomized but not treated|1|||
155160406|NCT03313037|560024951|FG001|Overall Study|Randomized but not treated|0|||
155160407|NCT01198977|560024956|FG000|Overall Study|Lost to Follow-up|1|||
155160408|NCT01198977|560024957|FG001|Overall Study|Lost to Follow-up|0|||
155160409|NCT02202759|560026630|FG000|Overall Study|Study Terminated by Sponsor|3|||
155160410|NCT02202759|560026631|FG001|Overall Study|Study Terminated by Sponsor|3|||
155160411|NCT02202759|560026632|FG002|Overall Study|Study Terminated by Sponsor|3|||
155160412|NCT02202759|560026630|FG000|Overall Study|Withdrawal by Subject|2|||
155160413|NCT02202759|560026631|FG001|Overall Study|Withdrawal by Subject|1|||
155160414|NCT02202759|560026632|FG002|Overall Study|Withdrawal by Subject|1|||
155160415|NCT02202759|560026630|FG000|Overall Study|Reason not Specified|4|||
155160416|NCT02202759|560026631|FG001|Overall Study|Reason not Specified|11|||
155160417|NCT02202759|560026632|FG002|Overall Study|Reason not Specified|10|||
155160418|NCT01987453|560026633|FG000|Overall Study|Death|0|||
155160419|NCT01987453|560026634|FG001|Overall Study|Death|0|||
155160420|NCT01987453|560026635|FG002|Overall Study|Death|1|||
155160421|NCT01987453|560026633|FG000|Overall Study|Lack of Efficacy|1|||
155160422|NCT01987453|560026634|FG001|Overall Study|Lack of Efficacy|12|||
155160423|NCT01987453|560026635|FG002|Overall Study|Lack of Efficacy|0|||
155160424|NCT01590888|560026636|FG000|Overall Study|Adverse Event|3|||
155160425|NCT01590888|560026637|FG001|Overall Study|Adverse Event|0|||
155160426|NCT01590888|560026638|FG002|Overall Study|Adverse Event|1|||
155160427|NCT01590888|560026636|FG000|Overall Study|Lost to Follow-up|1|||
155160428|NCT01590888|560026637|FG001|Overall Study|Lost to Follow-up|0|||
155160429|NCT01590888|560026638|FG002|Overall Study|Lost to Follow-up|0|||
155160430|NCT04953728|560026639|FG000|Overall Study|Withdrawal by Subject|3|||
155160431|NCT04953728|560026639|FG000|Overall Study|Physician Decision|1|||
155160432|NCT01646125|560026640|FG000|Overall Study|Untreated|2|||
155160433|NCT01646125|560026641|FG001|Overall Study|Untreated|5|||
155160434|NCT01646125|560026640|FG000|Overall Study|Adverse Event|2|||
155160435|NCT01646125|560026641|FG001|Overall Study|Adverse Event|1|||
155160436|NCT01646125|560026640|FG000|Overall Study|Death|1|||
155160437|NCT01646125|560026641|FG001|Overall Study|Death|1|||
155160438|NCT01646125|560026640|FG000|Overall Study|Physician Decision|1|||
155160439|NCT01646125|560026641|FG001|Overall Study|Physician Decision|3|||
155160440|NCT01646125|560026640|FG000|Overall Study|Progressive disease|22|||
155160441|NCT01646125|560026641|FG001|Overall Study|Progressive disease|16|||
155160442|NCT01646125|560026640|FG000|Overall Study|Study terminated by sponsor|2|||
155160443|NCT01646125|560026641|FG001|Overall Study|Study terminated by sponsor|1|||
155160444|NCT01646125|560026640|FG000|Overall Study|Subject/Guardian decision|1|||
155160445|NCT01646125|560026641|FG001|Overall Study|Subject/Guardian decision|1|||
155160446|NCT02105662|560026642|FG000|Overall Study|Lost to Follow-up|5|||
155160447|NCT02105662|560026642|FG000|Overall Study|Withdrawal by Subject|1|||
155160448|NCT02331277|560026645|FG000|Overall Study|Withdrawal by Subject|1|||
155160449|NCT02331277|560026646|FG001|Overall Study|Withdrawal by Subject|0|||
155160450|NCT01376804|560026649|FG000|Treatment Period|Withdrawal by Subject|1|||
155160451|NCT01376804|560026649|FG000|Treatment Period|Adverse Event|6|||
155160452|NCT01376804|560026649|FG000|Treatment Period|Patient did not receive study drug|1|||
155160453|NCT01071798|560026650|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
155160454|NCT01071798|560026650|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
155160455|NCT01071798|560026650|FG000|Participants Who Received One Cycle|Patient requirement|20|||
155160456|NCT01071798|560026650|FG000|Participants Who Received One Cycle|Death|5|||
155160457|NCT01071798|560026650|FG000|Participants Who Received One Cycle|Change of therapy|6|||
155160458|NCT01071798|560026650|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
155160459|NCT01071798|560026650|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
155160460|NCT01071798|560026650|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
155160461|NCT01071798|560026650|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
155160462|NCT01071798|560026650|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
155160463|NCT01705509|560026656|FG000|Inclusion CPET|Screen Failure|5|||
155160464|NCT01705509|560026656|FG000|Inclusion CPET|Withdrawal by Subject|2|||
155160465|NCT01705509|560026656|FG000|CPET w/ Ranexa|Screen Failure|2|||
155160466|NCT00904033|560026657|FG000|Overall Study|Withdrawal by Subject|1|||
155160467|NCT00904033|560026658|FG001|Overall Study|Withdrawal by Subject|1|||
155160468|NCT00904033|560026659|FG002|Overall Study|Withdrawal by Subject|0|||
155160469|NCT00904033|560026660|FG003|Overall Study|Withdrawal by Subject|0|||
155160470|NCT00904033|560026657|FG000|Overall Study|Physician Decision|0|||
155160471|NCT00904033|560026658|FG001|Overall Study|Physician Decision|0|||
155160472|NCT00904033|560026659|FG002|Overall Study|Physician Decision|1|||
155160473|NCT00904033|560026660|FG003|Overall Study|Physician Decision|0|||
155160474|NCT00904033|560026657|FG000|Overall Study|Unable to obtain final blood draw|0|||
155160475|NCT00904033|560026658|FG001|Overall Study|Unable to obtain final blood draw|0|||
155160476|NCT00904033|560026659|FG002|Overall Study|Unable to obtain final blood draw|0|||
155160477|NCT00904033|560026660|FG003|Overall Study|Unable to obtain final blood draw|2|||
155160478|NCT02736890|560026661|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
155160479|NCT02736890|560026662|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
155160480|NCT02736890|560026661|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
155160481|NCT02736890|560026662|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
155160482|NCT03077412|560026664|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
155160483|NCT03077412|560026665|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
155160484|NCT03077412|560026666|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
155160485|NCT03077412|560026664|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
155160486|NCT03077412|560026665|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
155160487|NCT03077412|560026666|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
155160488|NCT03077412|560026664|FG000|Overall Study|Adverse Event|1|||
155160489|NCT03077412|560026665|FG001|Overall Study|Adverse Event|2|||
155160490|NCT03077412|560026666|FG002|Overall Study|Adverse Event|2|||
155063330|NCT03979313|559664060|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
155063331|NCT03979313|559664061|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
155063332|NCT03979313|559664060|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
155063333|NCT03979313|559664061|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
155063334|NCT03979313|559664060|FG000|All Subjects|Any Other Reason|16|||
155063335|NCT03979313|559664061|FG001|All Subjects|Any Other Reason|23|||
155063336|NCT03979313|559664060|FG000|All Subjects|Covid-19|1|||
155063337|NCT03979313|559664061|FG001|All Subjects|Covid-19|3|||
155063338|NCT03979313|559664060|FG000|All Subjects|Withdrawal by Subject|35|||
155063339|NCT03979313|559664061|FG001|All Subjects|Withdrawal by Subject|44|||
155063340|NCT03979313|559664060|FG000|All Subjects|Death|0|||
155063341|NCT03979313|559664061|FG001|All Subjects|Death|5|||
155063342|NCT03979313|559664060|FG000|All Subjects|Lost to Follow-up|28|||
155063343|NCT03979313|559664061|FG001|All Subjects|Lost to Follow-up|61|||
155063344|NCT03183908|559664062|FG000|Overall Study|Missing Symptom Diary Data|0|||
155063345|NCT03183908|559664063|FG001|Overall Study|Missing Symptom Diary Data|2|||
155063346|NCT03738696|559664064|FG000|Overall Study|Withdrawal by Subject|0|||
155063347|NCT03738696|559664065|FG001|Overall Study|Withdrawal by Subject|1|||
155063348|NCT03738696|559664064|FG000|Overall Study|Lost to Follow-up|8|||
155063349|NCT03738696|559664065|FG001|Overall Study|Lost to Follow-up|14|||
155063350|NCT01712178|559664066|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
155063351|NCT01712178|559664067|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
155063352|NCT01712178|559664066|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
155063353|NCT01712178|559664067|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
155063354|NCT01712178|559664066|FG000|Overall Study|Lost to Follow-up|0|||
155063355|NCT01712178|559664067|FG001|Overall Study|Lost to Follow-up|1|||
155063356|NCT05001620|559664068|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
155063357|NCT05001620|559664069|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
155063358|NCT00819039|559664070|FG000|Overall Study|Physician Decision|1|||
155063359|NCT00819039|559664071|FG001|Overall Study|Physician Decision|0|||
155063360|NCT00819039|559664072|FG002|Overall Study|Physician Decision|1|||
155063361|NCT00819039|559664070|FG000|Overall Study|Protocol Violation|1|||
155063362|NCT00819039|559664071|FG001|Overall Study|Protocol Violation|0|||
155063363|NCT00819039|559664072|FG002|Overall Study|Protocol Violation|0|||
155063364|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
155063365|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
155063366|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
155063367|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
155063368|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
155063369|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
155063370|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
155063371|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
155063372|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
155063373|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
155063374|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Death|3|||
155063375|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Death|1|||
155063376|NCT01056276|559664073|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
155063377|NCT01056276|559664074|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
155063378|NCT01056276|559664073|FG000|Maintenance Therapy|Toxicity|0|||
155063379|NCT01056276|559664074|FG001|Maintenance Therapy|Toxicity|2|||
155063380|NCT01056276|559664073|FG000|Maintenance Therapy|Progressive Disease|0|||
155063381|NCT01056276|559664074|FG001|Maintenance Therapy|Progressive Disease|9|||
155063382|NCT01056276|559664073|FG000|Maintenance Therapy|Physician Decision|0|||
155063383|NCT01056276|559664074|FG001|Maintenance Therapy|Physician Decision|1|||
155063384|NCT01056276|559664073|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
155063385|NCT01056276|559664074|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
155063386|NCT01056276|559664073|FG000|Maintenance Therapy|Intercurrent Illness|0|||
155063387|NCT01056276|559664074|FG001|Maintenance Therapy|Intercurrent Illness|1|||
155063388|NCT01056276|559664073|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
155063389|NCT01056276|559664074|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
155063390|NCT04154956|559664079|FG000|Overall Study|Death|109|||
155063391|NCT04154956|559664080|FG001|Overall Study|Death|110|||
155063392|NCT04154956|559664079|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
155063393|NCT04154956|559664080|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
155063394|NCT04154956|559664079|FG000|Overall Study|Withdrawal by Subject|1|||
155063395|NCT04154956|559664080|FG001|Overall Study|Withdrawal by Subject|7|||
155063396|NCT04154956|559664079|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
155063397|NCT04154956|559664080|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
155063398|NCT00147238|559664081|FG000|Overall Study|Inevaluable|8|||
155063399|NCT04424901|559664082|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
155063400|NCT04424901|559664083|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
155063401|NCT01348269|559664084|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
155063402|NCT01348269|559664085|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
155160491|NCT03077412|560026664|FG000|Overall Study|Investigator's Discretion|0|||
155160492|NCT03077412|560026665|FG001|Overall Study|Investigator's Discretion|1|||
155160493|NCT03077412|560026666|FG002|Overall Study|Investigator's Discretion|1|||
155160494|NCT03077412|560026664|FG000|Overall Study|Withdrew Consent|0|||
155160495|NCT03077412|560026665|FG001|Overall Study|Withdrew Consent|2|||
155160496|NCT03077412|560026666|FG002|Overall Study|Withdrew Consent|0|||
155160497|NCT02904954|560026667|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
155160498|NCT02904954|560026668|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
155160499|NCT02904954|560026667|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
155160500|NCT02904954|560026668|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
155160501|NCT02904954|560026667|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
155160502|NCT02904954|560026668|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
155160503|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Recurrence|2|||
155160504|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Recurrence|0|||
155160505|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Adverse Event|2|||
155160506|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Adverse Event|6|||
155160507|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Participant wishes|12|||
155160508|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Participant wishes|7|||
155160509|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Physician Decision|2|||
155160510|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Physician Decision|1|||
155160511|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
155160512|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
155160513|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Death|0|||
155160514|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Death|1|||
155160515|NCT02904954|560026667|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
155160516|NCT02904954|560026668|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
155160517|NCT00753506|560026669|FG000|Overall Study|Withdrawal by Subject|4|||
155160518|NCT00753506|560026670|FG001|Overall Study|Withdrawal by Subject|1|||
155160519|NCT00753506|560026669|FG000|Overall Study|Lost to Follow-up|2|||
155160520|NCT00753506|560026670|FG001|Overall Study|Lost to Follow-up|0|||
155160521|NCT00753506|560026669|FG000|Overall Study|Other reason|1|||
155160522|NCT00753506|560026670|FG001|Overall Study|Other reason|1|||
155160523|NCT05097963|560026671|FG000|Overall Study|Protocol Violation|13|||
155160524|NCT05097963|560026671|FG000|Overall Study|Withdrawal by Subject|21|||
155160525|NCT01417377|560026674|FG000|Overall Study|Lost to Follow-up|12|||
155160526|NCT01417377|560026674|FG000|Overall Study|Enrolled, but not treated|1|||
155160527|NCT02113982|560026675|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
155160528|NCT02113982|560026676|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
155160529|NCT02113982|560026677|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
155160530|NCT02113982|560026678|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
155160531|NCT02113982|560026679|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
155160532|NCT02113982|560026680|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
155160533|NCT02113982|560026681|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
155160534|NCT02113982|560026682|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
155160535|NCT02113982|560026683|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
155160536|NCT02113982|560026684|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
155160537|NCT02113982|560026685|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
155160538|NCT02113982|560026686|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
155160539|NCT02113982|560026687|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
155160540|NCT02113982|560026688|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
155160541|NCT02113982|560026675|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
155160542|NCT02113982|560026676|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
155160543|NCT02113982|560026677|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
155160544|NCT02113982|560026678|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
155160545|NCT02113982|560026679|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
155160546|NCT02113982|560026680|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
155160547|NCT02113982|560026681|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
155160548|NCT02113982|560026682|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
155160549|NCT02113982|560026683|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
155160550|NCT02113982|560026684|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
155160551|NCT02113982|560026685|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
155160552|NCT02113982|560026686|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
155160553|NCT02113982|560026687|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
155160554|NCT02113982|560026688|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
155160555|NCT02113982|560026675|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160556|NCT02113982|560026676|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160557|NCT02113982|560026677|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160558|NCT02113982|560026678|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160559|NCT02113982|560026679|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160560|NCT02113982|560026680|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160561|NCT02113982|560026681|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
155160562|NCT02113982|560026682|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160563|NCT02113982|560026683|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155063403|NCT01348269|559664084|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
155063404|NCT01348269|559664085|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
155063405|NCT01348269|559664084|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
155063406|NCT01348269|559664085|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
155063407|NCT00805532|559664086|FG000|Overall Study|invalid data|0|||
155063408|NCT00805532|559664087|FG001|Overall Study|invalid data|1|||
155063409|NCT01859741|559664088|FG000|Overall Study|Death|3|||
155063410|NCT01859741|559664089|FG001|Overall Study|Death|2|||
155063411|NCT01859741|559664090|FG002|Overall Study|Death|4|||
155063412|NCT01859741|559664091|FG003|Overall Study|Death|3|||
155063413|NCT01859741|559664092|FG004|Overall Study|Death|5|||
155063414|NCT01859741|559664093|FG005|Overall Study|Death|4|||
155063415|NCT01859741|559664094|FG006|Overall Study|Death|51|||
155063416|NCT01859741|559664095|FG007|Overall Study|Death|51|||
155063417|NCT01859741|559664088|FG000|Overall Study|Lost to Follow-up|0|||
155063418|NCT01859741|559664089|FG001|Overall Study|Lost to Follow-up|0|||
155063419|NCT01859741|559664090|FG002|Overall Study|Lost to Follow-up|0|||
155063420|NCT01859741|559664091|FG003|Overall Study|Lost to Follow-up|0|||
155063421|NCT01859741|559664092|FG004|Overall Study|Lost to Follow-up|0|||
155063422|NCT01859741|559664093|FG005|Overall Study|Lost to Follow-up|1|||
155063423|NCT01859741|559664094|FG006|Overall Study|Lost to Follow-up|0|||
155063424|NCT01859741|559664095|FG007|Overall Study|Lost to Follow-up|4|||
155063425|NCT01859741|559664088|FG000|Overall Study|Withdrawal by Subject|0|||
155063426|NCT01859741|559664089|FG001|Overall Study|Withdrawal by Subject|1|||
155063427|NCT01859741|559664090|FG002|Overall Study|Withdrawal by Subject|2|||
155063428|NCT01859741|559664091|FG003|Overall Study|Withdrawal by Subject|0|||
155063429|NCT01859741|559664092|FG004|Overall Study|Withdrawal by Subject|0|||
155063430|NCT01859741|559664093|FG005|Overall Study|Withdrawal by Subject|1|||
155063431|NCT01859741|559664094|FG006|Overall Study|Withdrawal by Subject|1|||
155063432|NCT01859741|559664095|FG007|Overall Study|Withdrawal by Subject|1|||
155063433|NCT01859741|559664088|FG000|Overall Study|Study Terminated by Sponsor|0|||
155063434|NCT01859741|559664089|FG001|Overall Study|Study Terminated by Sponsor|0|||
155063435|NCT01859741|559664090|FG002|Overall Study|Study Terminated by Sponsor|0|||
155063436|NCT01859741|559664091|FG003|Overall Study|Study Terminated by Sponsor|0|||
155063437|NCT01859741|559664092|FG004|Overall Study|Study Terminated by Sponsor|1|||
155063438|NCT01859741|559664093|FG005|Overall Study|Study Terminated by Sponsor|0|||
155063439|NCT01859741|559664094|FG006|Overall Study|Study Terminated by Sponsor|16|||
155063440|NCT01859741|559664095|FG007|Overall Study|Study Terminated by Sponsor|14|||
155063441|NCT01859741|559664088|FG000|Overall Study|Other|0|||
155063442|NCT01859741|559664089|FG001|Overall Study|Other|0|||
155063443|NCT01859741|559664090|FG002|Overall Study|Other|0|||
155063444|NCT01859741|559664091|FG003|Overall Study|Other|0|||
155063445|NCT01859741|559664092|FG004|Overall Study|Other|0|||
155063446|NCT01859741|559664093|FG005|Overall Study|Other|0|||
155063447|NCT01859741|559664094|FG006|Overall Study|Other|2|||
155063448|NCT01859741|559664095|FG007|Overall Study|Other|0|||
155063449|NCT02412657|559664096|FG000|Overall Study|Lost to Follow-up|1|||
155063450|NCT02412657|559664097|FG001|Overall Study|Lost to Follow-up|0|||
155063451|NCT02412657|559664098|FG002|Overall Study|Lost to Follow-up|0|||
155063452|NCT02412657|559664096|FG000|Overall Study|Protocol Violation|0|||
155063453|NCT02412657|559664097|FG001|Overall Study|Protocol Violation|2|||
155063454|NCT02412657|559664098|FG002|Overall Study|Protocol Violation|3|||
155063455|NCT03185208|559664102|FG000|Overall Study|Did not start study medication|0|||
155063456|NCT03185208|559664103|FG001|Overall Study|Did not start study medication|3|||
155063457|NCT03834350|559664104|FG000|Overall Study|Withdrawal by Subject|1|||
155063458|NCT00537277|559664105|FG000|Overall Study|Adverse Event|1|||
155063459|NCT00537277|559664105|FG000|Overall Study|Lack of Efficacy|2|||
155063460|NCT00537277|559664105|FG000|Overall Study|Lost to Follow-up|12|||
155063461|NCT00537277|559664105|FG000|Overall Study|Protocol Violation|11|||
155063462|NCT00537277|559664105|FG000|Overall Study|Unclassified|4|||
155063463|NCT00537277|559664105|FG000|Overall Study|Inability to tolerate trial medication|4|||
155063464|NCT00537277|559664105|FG000|Overall Study|Non-compliance with trial procedures|15|||
155063465|NCT03620162|559664106|FG000|Overall Study|Physician Decision|4|||
155063466|NCT03620162|559664107|FG001|Overall Study|Physician Decision|0|||
155063467|NCT03620162|559664108|FG002|Overall Study|Physician Decision|1|||
155063468|NCT03620162|559664109|FG003|Overall Study|Physician Decision|0|||
155063469|NCT03620162|559664110|FG004|Overall Study|Physician Decision|2|||
155063470|NCT03620162|559664106|FG000|Overall Study|Lost to Follow-up|2|||
155063471|NCT03620162|559664107|FG001|Overall Study|Lost to Follow-up|6|||
155063472|NCT03620162|559664108|FG002|Overall Study|Lost to Follow-up|7|||
155063473|NCT03620162|559664109|FG003|Overall Study|Lost to Follow-up|3|||
155063474|NCT03620162|559664110|FG004|Overall Study|Lost to Follow-up|2|||
155063475|NCT03620162|559664106|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
155063476|NCT03620162|559664107|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
155063477|NCT03620162|559664108|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
155063478|NCT03620162|559664109|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
155063479|NCT03620162|559664110|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
155063480|NCT04009837|559664114|FG000|Overall Study|Withdrawal by Subject|5|||
155160564|NCT02113982|560026684|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160565|NCT02113982|560026685|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160566|NCT02113982|560026686|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160567|NCT02113982|560026687|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160568|NCT02113982|560026688|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
155160569|NCT02113982|560026675|FG000|Stage 1: Dose Escalation|Transplant|0|||
155160570|NCT02113982|560026676|FG001|Stage 1: Dose Escalation|Transplant|1|||
155160571|NCT02113982|560026677|FG002|Stage 1: Dose Escalation|Transplant|0|||
155160572|NCT02113982|560026678|FG003|Stage 1: Dose Escalation|Transplant|0|||
155160573|NCT02113982|560026679|FG004|Stage 1: Dose Escalation|Transplant|0|||
155160574|NCT02113982|560026680|FG005|Stage 1: Dose Escalation|Transplant|1|||
155160575|NCT02113982|560026681|FG006|Stage 1: Dose Escalation|Transplant|0|||
155160576|NCT02113982|560026682|FG007|Stage 1: Dose Escalation|Transplant|0|||
155160577|NCT02113982|560026683|FG008|Stage 1: Dose Escalation|Transplant|0|||
155160578|NCT02113982|560026684|FG009|Stage 1: Dose Escalation|Transplant|0|||
155160579|NCT02113982|560026685|FG010|Stage 1: Dose Escalation|Transplant|0|||
155160580|NCT02113982|560026686|FG011|Stage 1: Dose Escalation|Transplant|0|||
155160581|NCT02113982|560026687|FG012|Stage 1: Dose Escalation|Transplant|0|||
155160582|NCT02113982|560026688|FG013|Stage 1: Dose Escalation|Transplant|0|||
155160583|NCT02113982|560026675|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
155160584|NCT02113982|560026676|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
155160585|NCT02113982|560026677|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
155160586|NCT02113982|560026678|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
155160587|NCT02113982|560026679|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
155160588|NCT02113982|560026680|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
155160589|NCT02113982|560026681|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
155160590|NCT02113982|560026682|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
155160591|NCT02113982|560026683|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
155160592|NCT02113982|560026684|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
155160593|NCT02113982|560026685|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
155160594|NCT02113982|560026686|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
155160595|NCT02113982|560026687|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
155160596|NCT02113982|560026688|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
155160597|NCT02113982|560026675|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
155160598|NCT02113982|560026676|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
155160599|NCT02113982|560026677|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
155160600|NCT02113982|560026678|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
155160601|NCT02113982|560026679|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
155160602|NCT02113982|560026680|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
155160603|NCT02113982|560026681|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
154958023|NCT03238781|559274017|FG001|Overall Study|Withdrawal by Subject|14|||
154958024|NCT03238781|559274018|FG002|Overall Study|Withdrawal by Subject|16|||
154958025|NCT03238781|559274016|FG000|Overall Study|Decision by sponsor|0|||
154958026|NCT03238781|559274017|FG001|Overall Study|Decision by sponsor|1|||
154958027|NCT03238781|559274018|FG002|Overall Study|Decision by sponsor|0|||
154958028|NCT03161405|559274019|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
154958029|NCT01313780|559274020|FG000|Overall Study|Lack of Efficacy|4|||
154958030|NCT01313780|559274021|FG001|Overall Study|Lack of Efficacy|2|||
154958031|NCT01313780|559274020|FG000|Overall Study|Adverse Event|6|||
154958032|NCT01313780|559274021|FG001|Overall Study|Adverse Event|11|||
154958033|NCT01313780|559274020|FG000|Overall Study|Withdrawal by Subject|2|||
154958034|NCT01313780|559274021|FG001|Overall Study|Withdrawal by Subject|8|||
154958035|NCT01313780|559274020|FG000|Overall Study|Protocol Violation|10|||
154958036|NCT01313780|559274021|FG001|Overall Study|Protocol Violation|4|||
154958037|NCT01313780|559274020|FG000|Overall Study|missing data|3|||
154958038|NCT01313780|559274021|FG001|Overall Study|missing data|3|||
154958039|NCT05472038|559275440|FG000|Overall Study|Adverse Event|0|||
154958040|NCT05472038|559275441|FG001|Overall Study|Adverse Event|0|||
154958041|NCT05472038|559275442|FG002|Overall Study|Adverse Event|1|||
154958042|NCT05472038|559275443|FG003|Overall Study|Adverse Event|0|||
154958043|NCT05472038|559275444|FG004|Overall Study|Adverse Event|0|||
155160604|NCT02113982|560026682|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
155160605|NCT02113982|560026683|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
155160606|NCT02113982|560026684|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
155160607|NCT02113982|560026685|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
155160608|NCT02113982|560026686|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
155160609|NCT02113982|560026687|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
155160610|NCT02113982|560026688|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
155160611|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
155160612|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
155160613|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
154958044|NCT05472038|559275445|FG005|Overall Study|Adverse Event|0|||
154958045|NCT05472038|559275446|FG006|Overall Study|Adverse Event|0|||
154958046|NCT05472038|559275447|FG007|Overall Study|Adverse Event|0|||
154958047|NCT05472038|559275448|FG008|Overall Study|Adverse Event|0|||
155160614|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
155160615|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
155160616|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
155160617|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
155160618|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
155160619|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
155160620|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
155160621|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
155160622|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
155160623|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
155160624|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
155160625|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
155160626|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
155160627|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
155160628|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
155160629|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
155160630|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
155160631|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
155160632|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
155160633|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
155160634|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
155063481|NCT04009837|559664115|FG001|Overall Study|Withdrawal by Subject|4|||
155063482|NCT04009837|559664114|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
155160635|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
155160636|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
155160637|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
155160638|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
155160639|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160640|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160641|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160642|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160643|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160644|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160645|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160646|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
155160647|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160648|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
155160649|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
155160650|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
155063483|NCT04009837|559664115|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
155063484|NCT00226655|559664116|FG000|Overall Study|Death|13|||
155063485|NCT00226655|559664116|FG000|Overall Study|Withdrawal by Subject|15|||
155063486|NCT00226655|559664116|FG000|Overall Study|Adverse Event|35|||
155063487|NCT00226655|559664116|FG000|Overall Study|Physician Decision|6|||
155063488|NCT00226655|559664116|FG000|Overall Study|Clinical deterioration|10|||
155063489|NCT05144945|559664117|FG000|Overall Study|Withdrawal by Subject|1|||
155063490|NCT05144945|559664118|FG001|Overall Study|Withdrawal by Subject|0|||
155063491|NCT02855268|559664119|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
155063492|NCT02855268|559664120|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
155063493|NCT02855268|559664119|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
155063494|NCT02855268|559664120|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
155063495|NCT02855268|559664119|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
155063496|NCT02855268|559664120|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
155063497|NCT02855268|559664119|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
155063498|NCT02855268|559664120|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
155063499|NCT02855268|559664119|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
155160651|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
155063500|NCT02855268|559664120|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
155063501|NCT02855268|559664119|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
155063502|NCT02855268|559664120|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
155063503|NCT00465517|559664121|FG000|Overall Study|Adverse Event|7|||
155063504|NCT00465517|559664122|FG001|Overall Study|Adverse Event|3|||
155063505|NCT00465517|559664121|FG000|Overall Study|Lost to Follow-up|1|||
155063506|NCT00465517|559664122|FG001|Overall Study|Lost to Follow-up|0|||
155063507|NCT00465517|559664121|FG000|Overall Study|Withdrawal by Subject|4|||
155063508|NCT00465517|559664122|FG001|Overall Study|Withdrawal by Subject|1|||
155063509|NCT00289276|559664135|FG000|Second Part of FAST Study (Expansion)|Death|0|||
155063510|NCT00289276|559664136|FG001|Second Part of FAST Study (Expansion)|Death|2|||
155063511|NCT00289276|559664135|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
155063512|NCT00289276|559664136|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
155063513|NCT00071981|559664139|FG000|Overall Study|Lack of Efficacy|37|||
155063514|NCT00071981|559664140|FG001|Overall Study|Lack of Efficacy|29|||
155063515|NCT00071981|559664141|FG002|Overall Study|Lack of Efficacy|30|||
155063516|NCT00071981|559664142|FG003|Overall Study|Lack of Efficacy|43|||
155063517|NCT00071981|559664139|FG000|Overall Study|Adverse Event|4|||
155063518|NCT00071981|559664140|FG001|Overall Study|Adverse Event|4|||
155063519|NCT00071981|559664141|FG002|Overall Study|Adverse Event|3|||
155063520|NCT00071981|559664142|FG003|Overall Study|Adverse Event|1|||
155063521|NCT00071981|559664139|FG000|Overall Study|Death|0|||
155063522|NCT00071981|559664140|FG001|Overall Study|Death|0|||
155063523|NCT00071981|559664141|FG002|Overall Study|Death|1|||
155063524|NCT00071981|559664142|FG003|Overall Study|Death|1|||
155063525|NCT00071981|559664139|FG000|Overall Study|Withdrawal by Subject|3|||
155063526|NCT00071981|559664140|FG001|Overall Study|Withdrawal by Subject|1|||
155063527|NCT00071981|559664141|FG002|Overall Study|Withdrawal by Subject|0|||
155063528|NCT00071981|559664142|FG003|Overall Study|Withdrawal by Subject|0|||
155063529|NCT00071981|559664139|FG000|Overall Study|No protocol therapy|2|||
155063530|NCT00071981|559664140|FG001|Overall Study|No protocol therapy|5|||
155063531|NCT00071981|559664141|FG002|Overall Study|No protocol therapy|1|||
155063532|NCT00071981|559664142|FG003|Overall Study|No protocol therapy|0|||
155063533|NCT00071981|559664139|FG000|Overall Study|others (not specified in the study)|0|||
155063534|NCT00071981|559664140|FG001|Overall Study|others (not specified in the study)|2|||
155063535|NCT00071981|559664141|FG002|Overall Study|others (not specified in the study)|2|||
155063536|NCT00071981|559664142|FG003|Overall Study|others (not specified in the study)|0|||
155063537|NCT00465179|559664143|FG000|Overall Study|Adverse Event|4|||
155063538|NCT00465179|559664143|FG000|Overall Study|Withdrawal by Subject|2|||
155063539|NCT00465179|559664143|FG000|Overall Study|Progression of Disease|47|||
155063540|NCT00833755|559664146|FG000|Overall Study|Physician Decision|4|||
155063541|NCT00833755|559664147|FG001|Overall Study|Physician Decision|4|||
155063542|NCT00833755|559664148|FG002|Overall Study|Physician Decision|2|||
155063543|NCT00833755|559664149|FG003|Overall Study|Physician Decision|6|||
155063544|NCT00833755|559664146|FG000|Overall Study|Subject had scheduling issues|0|||
155063545|NCT00833755|559664147|FG001|Overall Study|Subject had scheduling issues|1|||
155063546|NCT00833755|559664148|FG002|Overall Study|Subject had scheduling issues|0|||
155063547|NCT00833755|559664149|FG003|Overall Study|Subject had scheduling issues|0|||
155063548|NCT00262925|559664150|FG000|Overall Study|Lack of Efficacy|3|||
155063549|NCT00262925|559664150|FG000|Overall Study|Adverse Event|4|||
155063550|NCT00262925|559664150|FG000|Overall Study|Death|2|||
155063551|NCT00262925|559664150|FG000|Overall Study|alternative therapy|1|||
155063552|NCT00262925|559664150|FG000|Overall Study|Other|1|||
155063553|NCT04682301|559664152|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
155063554|NCT04682301|559664152|FG000|Overall Study|Death|2|||
155063555|NCT05219162|559664153|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
155063556|NCT05219162|559664153|FG000|Overall Study|Withdrawal by Subject|23|||
155063557|NCT02642042|559664160|FG000|Overall Study|Adverse Event|22|||
155063558|NCT02642042|559664160|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155063559|NCT02642042|559664160|FG000|Overall Study|Progression/Relapse|28|||
155063560|NCT02642042|559664160|FG000|Overall Study|Death|1|||
155063561|NCT02642042|559664160|FG000|Overall Study|Not Protocol Specified|2|||
155063562|NCT03260023|559664161|FG000|Overall Study|Adverse Event|0|||
155063563|NCT03260023|559664162|FG001|Overall Study|Adverse Event|0|||
155063564|NCT03260023|559664163|FG002|Overall Study|Adverse Event|4|||
155063565|NCT03260023|559664164|FG003|Overall Study|Adverse Event|4|||
155063566|NCT03260023|559664165|FG004|Overall Study|Adverse Event|4|||
155063567|NCT03260023|559664166|FG005|Overall Study|Adverse Event|1|||
155063568|NCT03260023|559664167|FG006|Overall Study|Adverse Event|2|||
155063569|NCT03260023|559664161|FG000|Overall Study|Clinical Progression|0|||
155063570|NCT03260023|559664162|FG001|Overall Study|Clinical Progression|1|||
155063571|NCT03260023|559664163|FG002|Overall Study|Clinical Progression|3|||
155063572|NCT03260023|559664164|FG003|Overall Study|Clinical Progression|1|||
155063573|NCT03260023|559664165|FG004|Overall Study|Clinical Progression|0|||
155063574|NCT03260023|559664166|FG005|Overall Study|Clinical Progression|0|||
155063575|NCT03260023|559664167|FG006|Overall Study|Clinical Progression|0|||
155063576|NCT03260023|559664161|FG000|Overall Study|Physician Decision|0|||
155063577|NCT03260023|559664162|FG001|Overall Study|Physician Decision|0|||
155063578|NCT03260023|559664163|FG002|Overall Study|Physician Decision|0|||
155063579|NCT03260023|559664164|FG003|Overall Study|Physician Decision|1|||
155063580|NCT03260023|559664165|FG004|Overall Study|Physician Decision|1|||
155063581|NCT03260023|559664166|FG005|Overall Study|Physician Decision|0|||
155063582|NCT03260023|559664167|FG006|Overall Study|Physician Decision|0|||
155063583|NCT03260023|559664161|FG000|Overall Study|Withdrawal by Subject|0|||
155063584|NCT03260023|559664162|FG001|Overall Study|Withdrawal by Subject|0|||
155063585|NCT03260023|559664163|FG002|Overall Study|Withdrawal by Subject|0|||
155063586|NCT03260023|559664164|FG003|Overall Study|Withdrawal by Subject|0|||
155063587|NCT03260023|559664165|FG004|Overall Study|Withdrawal by Subject|3|||
155063588|NCT03260023|559664166|FG005|Overall Study|Withdrawal by Subject|0|||
155063589|NCT03260023|559664167|FG006|Overall Study|Withdrawal by Subject|0|||
155063590|NCT03260023|559664161|FG000|Overall Study|Under trial intervention|0|||
155063591|NCT03260023|559664162|FG001|Overall Study|Under trial intervention|0|||
155063592|NCT03260023|559664163|FG002|Overall Study|Under trial intervention|2|||
155063593|NCT03260023|559664164|FG003|Overall Study|Under trial intervention|5|||
155063594|NCT03260023|559664165|FG004|Overall Study|Under trial intervention|3|||
155063595|NCT03260023|559664166|FG005|Overall Study|Under trial intervention|0|||
155063596|NCT03260023|559664167|FG006|Overall Study|Under trial intervention|0|||
155063597|NCT04513366|559664170|FG000|Treatment Phase|Withdrawal by Subject|6|||
155063598|NCT04513366|559664171|FG001|Treatment Phase|Withdrawal by Subject|8|||
155063599|NCT04513366|559664172|FG002|Treatment Phase|Withdrawal by Subject|3|||
155063600|NCT04513366|559664170|FG000|Treatment Phase|Lost to Follow-up|1|||
155063601|NCT04513366|559664171|FG001|Treatment Phase|Lost to Follow-up|2|||
155063602|NCT04513366|559664172|FG002|Treatment Phase|Lost to Follow-up|5|||
155063603|NCT04513366|559664170|FG000|Treatment Phase|Other than Specified|1|||
155063604|NCT04513366|559664171|FG001|Treatment Phase|Other than Specified|0|||
155063605|NCT04513366|559664172|FG002|Treatment Phase|Other than Specified|2|||
155063606|NCT04513366|559664170|FG000|Treatment Phase|Physician Decision|2|||
155063607|NCT04513366|559664171|FG001|Treatment Phase|Physician Decision|0|||
155063608|NCT04513366|559664172|FG002|Treatment Phase|Physician Decision|0|||
155063609|NCT04513366|559664170|FG000|Treatment Phase|Adverse Event|0|||
155063610|NCT04513366|559664171|FG001|Treatment Phase|Adverse Event|1|||
155063611|NCT04513366|559664172|FG002|Treatment Phase|Adverse Event|1|||
155063612|NCT04513366|559664170|FG000|Extension Phase|Withdrawal by Subject|3|||
155063613|NCT04513366|559664171|FG001|Extension Phase|Withdrawal by Subject|1|||
155063614|NCT04513366|559664172|FG002|Extension Phase|Withdrawal by Subject|1|||
155063615|NCT04513366|559664170|FG000|Extension Phase|Other than Specified|4|||
155063616|NCT04513366|559664171|FG001|Extension Phase|Other than Specified|0|||
155063617|NCT04513366|559664172|FG002|Extension Phase|Other than Specified|1|||
155063618|NCT04513366|559664170|FG000|Extension Phase|Lost to Follow-up|1|||
155063619|NCT04513366|559664171|FG001|Extension Phase|Lost to Follow-up|1|||
155063620|NCT04513366|559664172|FG002|Extension Phase|Lost to Follow-up|1|||
155063621|NCT04513366|559664170|FG000|Extension Phase|Sponsor Decision|0|||
155063622|NCT04513366|559664171|FG001|Extension Phase|Sponsor Decision|1|||
155063623|NCT04513366|559664172|FG002|Extension Phase|Sponsor Decision|0|||
155063624|NCT04513366|559664170|FG000|Extension Phase|Death|0|||
155063625|NCT04513366|559664171|FG001|Extension Phase|Death|1|||
155063626|NCT04513366|559664172|FG002|Extension Phase|Death|0|||
155063627|NCT04513366|559664170|FG000|Extension Phase|Adverse Event|0|||
155063628|NCT04513366|559664171|FG001|Extension Phase|Adverse Event|0|||
155063629|NCT04513366|559664172|FG002|Extension Phase|Adverse Event|1|||
155063630|NCT00392223|559664173|FG000|Overall Study|Adverse Event|5|||
155063631|NCT00392223|559664174|FG001|Overall Study|Adverse Event|4|||
155063632|NCT00392223|559664173|FG000|Overall Study|Lost to Follow-up|1|||
155063633|NCT00392223|559664174|FG001|Overall Study|Lost to Follow-up|4|||
155063634|NCT00392223|559664173|FG000|Overall Study|Protocol Violation|0|||
155063635|NCT00392223|559664174|FG001|Overall Study|Protocol Violation|3|||
155063636|NCT00392223|559664173|FG000|Overall Study|Withdrawal by Subject|3|||
155063637|NCT00392223|559664174|FG001|Overall Study|Withdrawal by Subject|2|||
155063638|NCT02814526|559664175|FG000|Overall Study|Adverse Event|4|||
155063639|NCT02814526|559664176|FG001|Overall Study|Adverse Event|3|||
155063640|NCT02814526|559664175|FG000|Overall Study|Death|1|||
155063641|NCT02814526|559664176|FG001|Overall Study|Death|1|||
155063642|NCT02814526|559664175|FG000|Overall Study|Lost to Follow-up|3|||
155063643|NCT02814526|559664176|FG001|Overall Study|Lost to Follow-up|4|||
155063644|NCT02814526|559664175|FG000|Overall Study|non site physician decision|1|||
155063645|NCT02814526|559664176|FG001|Overall Study|non site physician decision|0|||
155063646|NCT02814526|559664175|FG000|Overall Study|participant noncompliance|1|||
155063647|NCT02814526|559664176|FG001|Overall Study|participant noncompliance|1|||
155063648|NCT02814526|559664175|FG000|Overall Study|Withdrawal by Subject|20|||
155063649|NCT02814526|559664176|FG001|Overall Study|Withdrawal by Subject|14|||
155063650|NCT02814526|559664175|FG000|Overall Study|safety risk|2|||
155063651|NCT02814526|559664176|FG001|Overall Study|safety risk|1|||
155063652|NCT02814526|559664175|FG000|Overall Study|early termination-study terminated|1|||
155063653|NCT02814526|559664176|FG001|Overall Study|early termination-study terminated|2|||
155063654|NCT02814526|559664175|FG000|Overall Study|Other|0|||
155063655|NCT02814526|559664176|FG001|Overall Study|Other|4|||
155063656|NCT04585893|559664179|FG000|Overall Study|Death|1|||
155063657|NCT04585893|559664180|FG001|Overall Study|Death|0|||
155063658|NCT02485860|559664182|FG000|Overall Study|Lost to Follow-up|4|||
155063659|NCT02485860|559664183|FG001|Overall Study|Lost to Follow-up|1|||
155063660|NCT02485860|559664182|FG000|Overall Study|Physician Decision|1|||
155063661|NCT02485860|559664183|FG001|Overall Study|Physician Decision|2|||
155063662|NCT02485860|559664182|FG000|Overall Study|Health context (COVID-19)|1|||
155063663|NCT02485860|559664183|FG001|Overall Study|Health context (COVID-19)|0|||
155063664|NCT03082729|559664184|FG000|Overall Study|Lost to Follow-up|7|||
155302374|NCT04440176|560540120|FG000|Overall Study|Withdrawal by Subject|5|||
155302375|NCT04440176|560540121|FG001|Overall Study|Withdrawal by Subject|3|||
155302376|NCT04440176|560540120|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155302377|NCT04440176|560540121|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155302378|NCT04440176|560540120|FG000|Overall Study|Adverse Event|2|||
155302379|NCT04440176|560540121|FG001|Overall Study|Adverse Event|6|||
155302380|NCT04440176|560540120|FG000|Overall Study|Lost to Follow-up|22|||
155302381|NCT04440176|560540121|FG001|Overall Study|Lost to Follow-up|23|||
155302382|NCT04440176|560540120|FG000|Overall Study|Medication error without associated adverse event|0|||
155063665|NCT03082729|559664184|FG000|Overall Study|Physician Decision|2|||
155063666|NCT03082729|559664184|FG000|Overall Study|Withdrawal by Subject|1|||
155063667|NCT03082729|559664184|FG000|Overall Study|Lack of Efficacy|9|||
155063668|NCT03082729|559664184|FG000|Overall Study|Adverse Event|4|||
155063669|NCT03082729|559664184|FG000|Overall Study|Protocol Violation|6|||
155063670|NCT03082729|559664184|FG000|Overall Study|Fear of study procedure|1|||
155063671|NCT03082729|559664184|FG000|Overall Study|Scheduling conflict|1|||
155063672|NCT03454555|559665470|FG000|Overall Study|Death|6|||
155063673|NCT03454555|559665471|FG001|Overall Study|Death|6|||
155063674|NCT03454555|559665470|FG000|Overall Study|Lost to Follow-up|31|||
155063675|NCT03454555|559665471|FG001|Overall Study|Lost to Follow-up|12|||
154958048|NCT05472038|559275449|FG009|Overall Study|Adverse Event|0|||
154958049|NCT05472038|559275450|FG010|Overall Study|Adverse Event|0|||
154958050|NCT05472038|559275451|FG011|Overall Study|Adverse Event|0|||
154958051|NCT05472038|559275440|FG000|Overall Study|Death|0|||
154958052|NCT05472038|559275441|FG001|Overall Study|Death|0|||
155302383|NCT04440176|560540121|FG001|Overall Study|Medication error without associated adverse event|1|||
155302384|NCT04440176|560540120|FG000|Overall Study|No longer met eligibility criteria|7|||
155302385|NCT04440176|560540121|FG001|Overall Study|No longer met eligibility criteria|1|||
155302386|NCT04440176|560540120|FG000|Overall Study|Other|1|||
155302387|NCT04440176|560540121|FG001|Overall Study|Other|2|||
155302388|NCT04440176|560540120|FG000|Overall Study|Protocol deviation|6|||
155302389|NCT04440176|560540121|FG001|Overall Study|Protocol deviation|8|||
155302390|NCT04440176|560540120|FG000|Overall Study|Randomized but not vaccinated|6|||
155302391|NCT04440176|560540121|FG001|Overall Study|Randomized but not vaccinated|3|||
155302392|NCT01631214|560540125|FG000|Overall Study|Withdrawal by Subject|276|||
155302393|NCT01631214|560540126|FG001|Overall Study|Withdrawal by Subject|290|||
155302394|NCT01631214|560540125|FG000|Overall Study|Death|113|||
155302395|NCT01631214|560540126|FG001|Overall Study|Death|106|||
155302396|NCT01631214|560540125|FG000|Overall Study|Lost to Follow-up|54|||
155302397|NCT01631214|560540126|FG001|Overall Study|Lost to Follow-up|40|||
155302398|NCT01631214|560540125|FG000|Overall Study|Adverse Event|45|||
155302399|NCT01631214|560540126|FG001|Overall Study|Adverse Event|45|||
155302400|NCT01631214|560540125|FG000|Overall Study|Other|22|||
155302401|NCT01631214|560540126|FG001|Overall Study|Other|19|||
155302402|NCT01631214|560540125|FG000|Overall Study|Noncompliance|16|||
155302403|NCT01631214|560540126|FG001|Overall Study|Noncompliance|15|||
155302404|NCT01631214|560540125|FG000|Overall Study|Requirement for Alternative Therapy|8|||
155302405|NCT01631214|560540126|FG001|Overall Study|Requirement for Alternative Therapy|3|||
155302406|NCT01631214|560540125|FG000|Overall Study|Protocol Deviation|4|||
155302407|NCT01631214|560540126|FG001|Overall Study|Protocol Deviation|3|||
155302408|NCT01631214|560540125|FG000|Overall Study|Ineligibility determined|5|||
155302409|NCT01631214|560540126|FG001|Overall Study|Ineligibility determined|2|||
155302410|NCT01631214|560540125|FG000|Overall Study|Administrative Decision|1|||
155302411|NCT01631214|560540126|FG001|Overall Study|Administrative Decision|0|||
155302412|NCT03575052|560540127|FG000|Overall Study|Adverse Event|6|||
155302413|NCT03575052|560540128|FG001|Overall Study|Adverse Event|10|||
154958053|NCT05472038|559275442|FG002|Overall Study|Death|0|||
154958054|NCT05472038|559275443|FG003|Overall Study|Death|0|||
154958055|NCT05472038|559275444|FG004|Overall Study|Death|0|||
154958056|NCT05472038|559275445|FG005|Overall Study|Death|1|||
155302414|NCT03575052|560540127|FG000|Overall Study|Not further specified|5|||
155302415|NCT03575052|560540128|FG001|Overall Study|Not further specified|7|||
155302416|NCT03575052|560540127|FG000|Overall Study|Withdrawal by Subject|5|||
155302417|NCT03575052|560540128|FG001|Overall Study|Withdrawal by Subject|6|||
155302418|NCT03575052|560540127|FG000|Overall Study|Lost to Follow-up|3|||
155302419|NCT03575052|560540128|FG001|Overall Study|Lost to Follow-up|0|||
155302420|NCT03575052|560540127|FG000|Overall Study|Death|2|||
155302421|NCT03575052|560540128|FG001|Overall Study|Death|1|||
155302422|NCT03575052|560540127|FG000|Overall Study|Lack of Efficacy|2|||
155302423|NCT03575052|560540128|FG001|Overall Study|Lack of Efficacy|1|||
155302424|NCT03575052|560540127|FG000|Overall Study|Study drug noncompliance|1|||
155302425|NCT03575052|560540128|FG001|Overall Study|Study drug noncompliance|2|||
155302426|NCT03575052|560540127|FG000|Overall Study|Protocol Violation|0|||
155302427|NCT03575052|560540128|FG001|Overall Study|Protocol Violation|2|||
155302428|NCT03575052|560540127|FG000|Overall Study|Physician Decision|1|||
155302429|NCT03575052|560540128|FG001|Overall Study|Physician Decision|0|||
155302430|NCT04188379|560540129|FG000|Overall Study|Withdrawal by Subject|10|||
155302431|NCT04188379|560540130|FG001|Overall Study|Withdrawal by Subject|3|||
155302432|NCT04188379|560540129|FG000|Overall Study|Physician Decision|0|||
155302433|NCT04188379|560540130|FG001|Overall Study|Physician Decision|1|||
155302434|NCT04188379|560540129|FG000|Overall Study|Adverse Event|3|||
155302435|NCT04188379|560540130|FG001|Overall Study|Adverse Event|1|||
155302436|NCT04188379|560540129|FG000|Overall Study|Pregnancy|1|||
155302437|NCT04188379|560540130|FG001|Overall Study|Pregnancy|0|||
155302438|NCT04188379|560540129|FG000|Overall Study|Lack of Efficacy|8|||
155302439|NCT04188379|560540130|FG001|Overall Study|Lack of Efficacy|5|||
155302440|NCT04188379|560540129|FG000|Overall Study|Other|0|||
155302441|NCT04188379|560540130|FG001|Overall Study|Other|3|||
155302442|NCT05288283|560540132|FG000|Overall Study|Study Terminated Early|1|||
155302443|NCT05288283|560540133|FG001|Overall Study|Study Terminated Early|1|||
155302444|NCT03112174|560540134|FG000|Overall Study|Withdrawal by Subject|3|||
155302445|NCT03112174|560540135|FG001|Overall Study|Withdrawal by Subject|0|||
155302446|NCT03112174|560540136|FG002|Overall Study|Withdrawal by Subject|11|||
155302447|NCT03112174|560540137|FG003|Overall Study|Withdrawal by Subject|9|||
155302448|NCT03112174|560540138|FG004|Overall Study|Withdrawal by Subject|7|||
155302449|NCT03112174|560540134|FG000|Overall Study|Lost to Follow-up|1|||
155302450|NCT03112174|560540135|FG001|Overall Study|Lost to Follow-up|1|||
155302451|NCT03112174|560540136|FG002|Overall Study|Lost to Follow-up|2|||
155302452|NCT03112174|560540137|FG003|Overall Study|Lost to Follow-up|3|||
155302453|NCT03112174|560540138|FG004|Overall Study|Lost to Follow-up|2|||
155302454|NCT03112174|560540134|FG000|Overall Study|Death|8|||
155302455|NCT03112174|560540135|FG001|Overall Study|Death|3|||
155302456|NCT03112174|560540136|FG002|Overall Study|Death|67|||
155302457|NCT03112174|560540137|FG003|Overall Study|Death|73|||
155302458|NCT03112174|560540138|FG004|Overall Study|Death|18|||
155302459|NCT03112174|560540134|FG000|Overall Study|Other, Not Specified|1|||
155302460|NCT03112174|560540135|FG001|Overall Study|Other, Not Specified|0|||
155302461|NCT03112174|560540136|FG002|Overall Study|Other, Not Specified|1|||
155302462|NCT03112174|560540137|FG003|Overall Study|Other, Not Specified|2|||
155302463|NCT03112174|560540138|FG004|Overall Study|Other, Not Specified|0|||
154958057|NCT05472038|559275446|FG006|Overall Study|Death|0|||
154958058|NCT05472038|559275447|FG007|Overall Study|Death|0|||
154958059|NCT05472038|559275448|FG008|Overall Study|Death|0|||
154958060|NCT05472038|559275449|FG009|Overall Study|Death|0|||
154958061|NCT05472038|559275450|FG010|Overall Study|Death|0|||
154958062|NCT05472038|559275451|FG011|Overall Study|Death|0|||
154958063|NCT05472038|559275440|FG000|Overall Study|Lost to Follow-up|1|||
154958064|NCT05472038|559275441|FG001|Overall Study|Lost to Follow-up|3|||
154958065|NCT05472038|559275442|FG002|Overall Study|Lost to Follow-up|3|||
154958066|NCT05472038|559275443|FG003|Overall Study|Lost to Follow-up|9|||
155302464|NCT05773313|560540141|FG000|Overall Study|Lost to Follow-up|3|||
155302465|NCT01534494|560540142|FG000|Overall Study|Withdrawal by Subject|1|||
155302466|NCT05137236|560540143|FG000|Part A|Other than Specified|1|||
155302467|NCT05137236|560540144|FG001|Part A|Other than Specified|0|||
155302468|NCT05137236|560540145|FG002|Part A|Other than Specified|0|||
155302469|NCT05137236|560540146|FG003|Part A|Other than Specified|0|||
155302470|NCT05137236|560540147|FG004|Part A|Other than Specified|0|||
155302471|NCT05137236|560540148|FG005|Part A|Other than Specified|0|||
155302472|NCT05137236|560540149|FG006|Part A|Other than Specified|0|||
155302473|NCT05137236|560540150|FG007|Part A|Other than Specified|0|||
155302474|NCT05137236|560540143|FG000|Part A|Withdrawal by Subject|0|||
155302475|NCT05137236|560540144|FG001|Part A|Withdrawal by Subject|4|||
155302476|NCT05137236|560540145|FG002|Part A|Withdrawal by Subject|1|||
155302477|NCT05137236|560540146|FG003|Part A|Withdrawal by Subject|1|||
155302478|NCT05137236|560540147|FG004|Part A|Withdrawal by Subject|3|||
155302479|NCT05137236|560540148|FG005|Part A|Withdrawal by Subject|2|||
155302480|NCT05137236|560540149|FG006|Part A|Withdrawal by Subject|0|||
155302481|NCT05137236|560540150|FG007|Part A|Withdrawal by Subject|0|||
155302482|NCT05137236|560540143|FG000|Part A|Lost to Follow-up|5|||
155302483|NCT05137236|560540144|FG001|Part A|Lost to Follow-up|7|||
155302484|NCT05137236|560540145|FG002|Part A|Lost to Follow-up|1|||
155302485|NCT05137236|560540146|FG003|Part A|Lost to Follow-up|3|||
155302486|NCT05137236|560540147|FG004|Part A|Lost to Follow-up|3|||
155302487|NCT05137236|560540148|FG005|Part A|Lost to Follow-up|8|||
155302488|NCT05137236|560540149|FG006|Part A|Lost to Follow-up|0|||
155302489|NCT05137236|560540150|FG007|Part A|Lost to Follow-up|0|||
155302490|NCT05137236|560540143|FG000|Part B|Withdrawal by Subject|0|||
155302491|NCT05137236|560540144|FG001|Part B|Withdrawal by Subject|0|||
155302492|NCT05137236|560540145|FG002|Part B|Withdrawal by Subject|0|||
155302493|NCT05137236|560540146|FG003|Part B|Withdrawal by Subject|0|||
155302494|NCT05137236|560540147|FG004|Part B|Withdrawal by Subject|0|||
155302495|NCT05137236|560540148|FG005|Part B|Withdrawal by Subject|0|||
155302496|NCT05137236|560540149|FG006|Part B|Withdrawal by Subject|0|||
155302497|NCT05137236|560540150|FG007|Part B|Withdrawal by Subject|2|||
155302498|NCT05137236|560540143|FG000|Part B|Lost to Follow-up|0|||
155302499|NCT05137236|560540144|FG001|Part B|Lost to Follow-up|0|||
155302500|NCT05137236|560540145|FG002|Part B|Lost to Follow-up|0|||
155302501|NCT05137236|560540146|FG003|Part B|Lost to Follow-up|0|||
155302502|NCT05137236|560540147|FG004|Part B|Lost to Follow-up|0|||
155302503|NCT05137236|560540148|FG005|Part B|Lost to Follow-up|0|||
155302504|NCT05137236|560540149|FG006|Part B|Lost to Follow-up|5|||
155302505|NCT05137236|560540150|FG007|Part B|Lost to Follow-up|5|||
155302506|NCT05137236|560540143|FG000|Part B|Death|0|||
155302507|NCT05137236|560540144|FG001|Part B|Death|0|||
155302508|NCT05137236|560540145|FG002|Part B|Death|0|||
155302509|NCT05137236|560540146|FG003|Part B|Death|0|||
155160652|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
155160653|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160654|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
154958067|NCT05472038|559275444|FG004|Overall Study|Lost to Follow-up|2|||
154958068|NCT05472038|559275445|FG005|Overall Study|Lost to Follow-up|2|||
154958069|NCT05472038|559275446|FG006|Overall Study|Lost to Follow-up|1|||
154958070|NCT05472038|559275447|FG007|Overall Study|Lost to Follow-up|0|||
154958071|NCT05472038|559275448|FG008|Overall Study|Lost to Follow-up|1|||
154958072|NCT05472038|559275449|FG009|Overall Study|Lost to Follow-up|0|||
154958073|NCT05472038|559275450|FG010|Overall Study|Lost to Follow-up|2|||
154958074|NCT05472038|559275451|FG011|Overall Study|Lost to Follow-up|1|||
154958075|NCT05472038|559275440|FG000|Overall Study|Physician Decision|0|||
154958076|NCT05472038|559275441|FG001|Overall Study|Physician Decision|0|||
154958077|NCT05472038|559275442|FG002|Overall Study|Physician Decision|0|||
154958078|NCT05472038|559275443|FG003|Overall Study|Physician Decision|0|||
154958079|NCT05472038|559275444|FG004|Overall Study|Physician Decision|1|||
154958080|NCT05472038|559275445|FG005|Overall Study|Physician Decision|0|||
154958081|NCT05472038|559275446|FG006|Overall Study|Physician Decision|0|||
154958082|NCT05472038|559275447|FG007|Overall Study|Physician Decision|0|||
154958083|NCT05472038|559275448|FG008|Overall Study|Physician Decision|0|||
154958084|NCT05472038|559275449|FG009|Overall Study|Physician Decision|0|||
154958085|NCT05472038|559275450|FG010|Overall Study|Physician Decision|0|||
154958086|NCT05472038|559275451|FG011|Overall Study|Physician Decision|0|||
154958087|NCT05472038|559275440|FG000|Overall Study|Withdrawal by Subject|1|||
154958088|NCT05472038|559275441|FG001|Overall Study|Withdrawal by Subject|3|||
154958089|NCT05472038|559275442|FG002|Overall Study|Withdrawal by Subject|1|||
154958090|NCT05472038|559275443|FG003|Overall Study|Withdrawal by Subject|6|||
154958091|NCT05472038|559275444|FG004|Overall Study|Withdrawal by Subject|1|||
154958092|NCT05472038|559275445|FG005|Overall Study|Withdrawal by Subject|3|||
154958093|NCT05472038|559275446|FG006|Overall Study|Withdrawal by Subject|0|||
154958094|NCT05472038|559275447|FG007|Overall Study|Withdrawal by Subject|2|||
154958095|NCT05472038|559275448|FG008|Overall Study|Withdrawal by Subject|3|||
154958096|NCT05472038|559275449|FG009|Overall Study|Withdrawal by Subject|1|||
154958097|NCT05472038|559275450|FG010|Overall Study|Withdrawal by Subject|2|||
154958098|NCT05472038|559275451|FG011|Overall Study|Withdrawal by Subject|2|||
154958099|NCT05472038|559275440|FG000|Overall Study|Protocol Violation|0|||
154958100|NCT05472038|559275441|FG001|Overall Study|Protocol Violation|0|||
154958101|NCT05472038|559275442|FG002|Overall Study|Protocol Violation|0|||
154958102|NCT05472038|559275443|FG003|Overall Study|Protocol Violation|0|||
154958103|NCT05472038|559275444|FG004|Overall Study|Protocol Violation|0|||
154958104|NCT05472038|559275445|FG005|Overall Study|Protocol Violation|0|||
154958105|NCT05472038|559275446|FG006|Overall Study|Protocol Violation|0|||
154958106|NCT05472038|559275447|FG007|Overall Study|Protocol Violation|1|||
154958107|NCT05472038|559275448|FG008|Overall Study|Protocol Violation|1|||
154958108|NCT05472038|559275449|FG009|Overall Study|Protocol Violation|1|||
154958109|NCT05472038|559275450|FG010|Overall Study|Protocol Violation|1|||
154958110|NCT05472038|559275451|FG011|Overall Study|Protocol Violation|1|||
154958111|NCT05472038|559275440|FG000|Overall Study|Not vaccinated|0|||
154958112|NCT05472038|559275441|FG001|Overall Study|Not vaccinated|0|||
154958113|NCT05472038|559275442|FG002|Overall Study|Not vaccinated|0|||
154958114|NCT05472038|559275443|FG003|Overall Study|Not vaccinated|1|||
154958115|NCT05472038|559275444|FG004|Overall Study|Not vaccinated|0|||
154958116|NCT05472038|559275445|FG005|Overall Study|Not vaccinated|0|||
154958117|NCT05472038|559275446|FG006|Overall Study|Not vaccinated|0|||
154958118|NCT05472038|559275447|FG007|Overall Study|Not vaccinated|0|||
154958119|NCT05472038|559275448|FG008|Overall Study|Not vaccinated|0|||
154958120|NCT05472038|559275449|FG009|Overall Study|Not vaccinated|0|||
154958121|NCT05472038|559275450|FG010|Overall Study|Not vaccinated|0|||
154958122|NCT05472038|559275451|FG011|Overall Study|Not vaccinated|0|||
154958123|NCT03255733|559275454|FG000|Overall Study|Lost to Follow-up|4|||
154958124|NCT02440711|559275459|FG000|Second Intervention|Lost to Follow-up|1|||
154958125|NCT02440711|559275460|FG001|Second Intervention|Lost to Follow-up|0|||
154958126|NCT02476994|559275463|FG000|Overall Study|Based on feedback from FDA|1|||
154958127|NCT02476994|559275464|FG001|Overall Study|Based on feedback from FDA|0|||
154958128|NCT02563561|559275465|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
154958129|NCT02563561|559275466|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
154958130|NCT02563561|559275467|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
154958131|NCT02563561|559275465|FG000|Overall Study|Withdrew of Consent|1|||
154958132|NCT02563561|559275466|FG001|Overall Study|Withdrew of Consent|1|||
155302510|NCT05137236|560540147|FG004|Part B|Death|0|||
155302511|NCT05137236|560540148|FG005|Part B|Death|0|||
155302512|NCT05137236|560540149|FG006|Part B|Death|0|||
155302513|NCT05137236|560540150|FG007|Part B|Death|2|||
155302514|NCT04512482|560540156|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
155302515|NCT04512482|560540157|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
155302516|NCT01939899|560540158|FG000|Lead-in Dose Finding Phase|Death|0|||
155302517|NCT01939899|560540159|FG001|Lead-in Dose Finding Phase|Death|3|||
155302518|NCT01939899|560540160|FG002|Lead-in Dose Finding Phase|Death|1|||
155302519|NCT01939899|560540161|FG003|Lead-in Dose Finding Phase|Death|0|||
155302520|NCT01939899|560540162|FG004|Lead-in Dose Finding Phase|Death|0|||
154958133|NCT02563561|559275467|FG002|Overall Study|Withdrew of Consent|2|||
154958134|NCT02563561|559275465|FG000|Overall Study|Lost to Follow-up|1|||
154958135|NCT02563561|559275466|FG001|Overall Study|Lost to Follow-up|1|||
154958136|NCT02563561|559275467|FG002|Overall Study|Lost to Follow-up|0|||
154958137|NCT02563561|559275465|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
155302521|NCT01939899|560540158|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
155302522|NCT01939899|560540159|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
155302523|NCT01939899|560540160|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
154958138|NCT02563561|559275466|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
154958139|NCT02563561|559275467|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
154958140|NCT02563561|559275465|FG000|Overall Study|Investigator Decision|3|||
154958141|NCT02563561|559275466|FG001|Overall Study|Investigator Decision|4|||
155302524|NCT01939899|560540161|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
155302525|NCT01939899|560540162|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
155302526|NCT01939899|560540158|FG000|Lead-in Dose Finding Phase|Other|0|||
155302527|NCT01939899|560540159|FG001|Lead-in Dose Finding Phase|Other|0|||
155302528|NCT01939899|560540160|FG002|Lead-in Dose Finding Phase|Other|1|||
155302529|NCT01939899|560540161|FG003|Lead-in Dose Finding Phase|Other|0|||
155302530|NCT01939899|560540162|FG004|Lead-in Dose Finding Phase|Other|0|||
155302531|NCT01939899|560540158|FG000|Phase 2|Withdrawal by Subject|0|||
155302532|NCT01939899|560540159|FG001|Phase 2|Withdrawal by Subject|0|||
155302533|NCT01939899|560540160|FG002|Phase 2|Withdrawal by Subject|0|||
155302534|NCT01939899|560540161|FG003|Phase 2|Withdrawal by Subject|2|||
155302535|NCT01939899|560540162|FG004|Phase 2|Withdrawal by Subject|0|||
155302536|NCT01939899|560540158|FG000|Phase 2|Disease Progression|0|||
155302537|NCT01939899|560540159|FG001|Phase 2|Disease Progression|0|||
155302538|NCT01939899|560540160|FG002|Phase 2|Disease Progression|0|||
155302539|NCT01939899|560540161|FG003|Phase 2|Disease Progression|9|||
155302540|NCT01939899|560540162|FG004|Phase 2|Disease Progression|1|||
155302541|NCT05119855|560540166|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
155302542|NCT05119855|560540167|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
155302543|NCT05119855|560540166|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
155302544|NCT05119855|560540167|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
155302545|NCT05119855|560540166|FG000|Overall Study|Lost to Follow-up|6|||
155302546|NCT05119855|560540167|FG001|Overall Study|Lost to Follow-up|8|||
155302547|NCT02932579|560540168|FG000|Overall Study|Withdrawal by Subject|4|||
155302548|NCT02932579|560540169|FG001|Overall Study|Withdrawal by Subject|1|||
155302549|NCT02706717|560540172|FG000|Overall Study|Withdrawal by Subject|1|||
155302550|NCT02706717|560540173|FG001|Overall Study|Withdrawal by Subject|8|||
155302551|NCT02706717|560540172|FG000|Overall Study|Lost to Follow-up|0|||
155302552|NCT02706717|560540173|FG001|Overall Study|Lost to Follow-up|1|||
155302553|NCT02706717|560540172|FG000|Overall Study|Physician Decision|0|||
155302554|NCT02706717|560540173|FG001|Overall Study|Physician Decision|1|||
155302555|NCT02706717|560540172|FG000|Overall Study|Death|0|||
155302556|NCT02706717|560540173|FG001|Overall Study|Death|1|||
155302557|NCT02549170|560540176|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
155302558|NCT02549170|560540177|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
155302559|NCT02549170|560540178|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
155302560|NCT02549170|560540179|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
155302561|NCT02549170|560540180|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
155302562|NCT02549170|560540176|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
155302563|NCT02549170|560540177|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
155302564|NCT02549170|560540178|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
155302565|NCT02549170|560540179|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
155302566|NCT02549170|560540180|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
155302567|NCT02549170|560540176|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
155302568|NCT02549170|560540177|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
155302569|NCT02549170|560540178|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
155302570|NCT02549170|560540179|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
154958142|NCT02563561|559275467|FG002|Overall Study|Investigator Decision|2|||
155063676|NCT03454555|559665470|FG000|Overall Study|Physician Decision|2|||
155063677|NCT03454555|559665471|FG001|Overall Study|Physician Decision|6|||
155063678|NCT03454555|559665470|FG000|Overall Study|Withdrawal by Subject|34|||
155063679|NCT03454555|559665471|FG001|Overall Study|Withdrawal by Subject|5|||
155063680|NCT03454555|559665470|FG000|Overall Study|Ineligible|1|||
155063681|NCT03454555|559665471|FG001|Overall Study|Ineligible|5|||
155063682|NCT04770753|559665478|FG000|Overall Study|Randomized, never treated|1|||
155063683|NCT04770753|559665479|FG001|Overall Study|Randomized, never treated|1|||
155063684|NCT04770753|559665478|FG000|Overall Study|Withdrawal by Subject|3|||
155063685|NCT04770753|559665479|FG001|Overall Study|Withdrawal by Subject|1|||
155063686|NCT04770753|559665478|FG000|Overall Study|Adverse Event|2|||
155063687|NCT04770753|559665479|FG001|Overall Study|Adverse Event|0|||
155063688|NCT04770753|559665478|FG000|Overall Study|Pregnancy|1|||
155063689|NCT04770753|559665479|FG001|Overall Study|Pregnancy|0|||
155063690|NCT04770753|559665478|FG000|Overall Study|Other un-specified|1|||
155063691|NCT04770753|559665479|FG001|Overall Study|Other un-specified|0|||
155063692|NCT00274456|559665484|FG000|Overall Study|Still on treatment|2|||
155063693|NCT00274456|559665485|FG001|Overall Study|Still on treatment|3|||
155063694|NCT00274456|559665486|FG002|Overall Study|Still on treatment|5|||
155063695|NCT00274456|559665487|FG003|Overall Study|Still on treatment|1|||
155063696|NCT00274456|559665484|FG000|Overall Study|Unacceptable toxicity|10|||
155063697|NCT00274456|559665485|FG001|Overall Study|Unacceptable toxicity|5|||
155063698|NCT00274456|559665486|FG002|Overall Study|Unacceptable toxicity|12|||
155063699|NCT00274456|559665487|FG003|Overall Study|Unacceptable toxicity|16|||
155063700|NCT00274456|559665484|FG000|Overall Study|Adverse Event|0|||
155063701|NCT00274456|559665485|FG001|Overall Study|Adverse Event|1|||
155063702|NCT00274456|559665486|FG002|Overall Study|Adverse Event|2|||
155063703|NCT00274456|559665487|FG003|Overall Study|Adverse Event|2|||
155063704|NCT00274456|559665484|FG000|Overall Study|Physician Decision|7|||
155063705|NCT00274456|559665485|FG001|Overall Study|Physician Decision|5|||
155063706|NCT00274456|559665486|FG002|Overall Study|Physician Decision|6|||
155063707|NCT00274456|559665487|FG003|Overall Study|Physician Decision|13|||
155063708|NCT00274456|559665484|FG000|Overall Study|Lost to Follow-up|0|||
155063709|NCT00274456|559665485|FG001|Overall Study|Lost to Follow-up|0|||
155063710|NCT00274456|559665486|FG002|Overall Study|Lost to Follow-up|1|||
155063711|NCT00274456|559665487|FG003|Overall Study|Lost to Follow-up|0|||
155063712|NCT00274456|559665484|FG000|Overall Study|Withdrawal by Subject|18|||
155063713|NCT00274456|559665485|FG001|Overall Study|Withdrawal by Subject|13|||
155063714|NCT00274456|559665486|FG002|Overall Study|Withdrawal by Subject|9|||
155063715|NCT00274456|559665487|FG003|Overall Study|Withdrawal by Subject|13|||
155063716|NCT04460885|559665491|FG000|Overall Study|Withdrawal by Subject|6|||
155063717|NCT04460885|559665492|FG001|Overall Study|Withdrawal by Subject|8|||
155063718|NCT04460885|559665491|FG000|Overall Study|Site closure|1|||
155063719|NCT04460885|559665492|FG001|Overall Study|Site closure|0|||
155063720|NCT04460885|559665491|FG000|Overall Study|Death|5|||
155063721|NCT04460885|559665492|FG001|Overall Study|Death|4|||
155063722|NCT04460885|559665491|FG000|Overall Study|Physician Decision|2|||
155063723|NCT04460885|559665492|FG001|Overall Study|Physician Decision|1|||
155063724|NCT04460885|559665491|FG000|Overall Study|Lost to Follow-up|4|||
155063725|NCT04460885|559665492|FG001|Overall Study|Lost to Follow-up|4|||
155063726|NCT04889040|559665498|FG000|Overall Study|Withdrawal by Subject|3|||
155063727|NCT04889040|559665499|FG001|Overall Study|Withdrawal by Subject|3|||
155063728|NCT04889040|559665498|FG000|Overall Study|Lost to Follow-up|0|||
155063729|NCT04889040|559665499|FG001|Overall Study|Lost to Follow-up|1|||
155063730|NCT04889040|559665498|FG000|Overall Study|Adverse Event|2|||
155063731|NCT04889040|559665499|FG001|Overall Study|Adverse Event|1|||
155063732|NCT03801252|559665502|FG000|Overall Study|Protocol Violation|1|||
155063733|NCT03801252|559665503|FG001|Overall Study|Protocol Violation|2|||
155063734|NCT02690727|559665504|FG000|Overall Study|Adverse Event|2|||
155063735|NCT02690727|559665505|FG001|Overall Study|Adverse Event|2|||
155063736|NCT02030600|559665506|FG000|Treatment Period 1|Adverse Event|5|||
155063737|NCT02030600|559665507|FG001|Treatment Period 1|Adverse Event|7|||
155063738|NCT02030600|559665506|FG000|Treatment Period 1|Lack of Efficacy|0|||
155063739|NCT02030600|559665507|FG001|Treatment Period 1|Lack of Efficacy|1|||
155063740|NCT02030600|559665506|FG000|Treatment Period 1|Lost to Follow-up|11|||
155063741|NCT02030600|559665507|FG001|Treatment Period 1|Lost to Follow-up|3|||
155063742|NCT02030600|559665506|FG000|Treatment Period 1|Protocol Violation|22|||
155063743|NCT02030600|559665507|FG001|Treatment Period 1|Protocol Violation|17|||
155063744|NCT02030600|559665506|FG000|Treatment Period 1|Withdrawal by Subject|13|||
155063745|NCT02030600|559665507|FG001|Treatment Period 1|Withdrawal by Subject|17|||
155063746|NCT02030600|559665506|FG000|Treatment Period 1|Casebook Unsigned|1|||
155063747|NCT02030600|559665507|FG001|Treatment Period 1|Casebook Unsigned|0|||
155063748|NCT02030600|559665506|FG000|Treatment Period 1|Unclassified|1|||
155063749|NCT02030600|559665507|FG001|Treatment Period 1|Unclassified|0|||
155063750|NCT02030600|559665506|FG000|Treatment Period 2|Adverse Event|4|||
155063751|NCT02030600|559665507|FG001|Treatment Period 2|Adverse Event|4|||
155063752|NCT02030600|559665506|FG000|Treatment Period 2|Lack of Efficacy|2|||
155063753|NCT02030600|559665507|FG001|Treatment Period 2|Lack of Efficacy|1|||
155063754|NCT02030600|559665506|FG000|Treatment Period 2|Lost to Follow-up|4|||
155302571|NCT02549170|560540180|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
155302572|NCT03051165|560540181|FG000|Overall Study|Withdrawal by Subject|1|||
155302573|NCT03051165|560540181|FG000|Overall Study|Early termination of study|12|||
155302574|NCT00818246|560540182|FG000|Overall Study|Impossible to match pictures|5|||
155302575|NCT02121002|560540183|FG000|Overall Study|Physician Decision|2|||
155302576|NCT02121002|560540184|FG001|Overall Study|Physician Decision|0|||
155302577|NCT02121002|560540185|FG002|Overall Study|Physician Decision|0|||
155302578|NCT02121002|560540183|FG000|Overall Study|Withdrawal by Subject|3|||
155302579|NCT02121002|560540184|FG001|Overall Study|Withdrawal by Subject|1|||
155302580|NCT02121002|560540185|FG002|Overall Study|Withdrawal by Subject|4|||
155302581|NCT02121002|560540183|FG000|Overall Study|Protocol Violation|1|||
155302582|NCT02121002|560540184|FG001|Overall Study|Protocol Violation|2|||
155302583|NCT02121002|560540185|FG002|Overall Study|Protocol Violation|4|||
155302584|NCT02121002|560540183|FG000|Overall Study|Concomitant therapy|0|||
155302585|NCT02121002|560540184|FG001|Overall Study|Concomitant therapy|1|||
155302586|NCT02121002|560540185|FG002|Overall Study|Concomitant therapy|1|||
155302587|NCT02121002|560540183|FG000|Overall Study|Others|1|||
155063755|NCT02030600|559665507|FG001|Treatment Period 2|Lost to Follow-up|2|||
155063756|NCT02030600|559665506|FG000|Treatment Period 2|Protocol Violation|1|||
155063757|NCT02030600|559665507|FG001|Treatment Period 2|Protocol Violation|2|||
155302588|NCT02121002|560540184|FG001|Overall Study|Others|0|||
155302589|NCT02121002|560540185|FG002|Overall Study|Others|1|||
155302590|NCT00409838|560540186|FG000|Short-term Period|Adverse Event|0|||
155302591|NCT00409838|560540187|FG001|Short-term Period|Adverse Event|1|||
155302592|NCT00409838|560540186|FG000|Short-term Period|Lost to Follow-up|0|||
155302593|NCT00409838|560540187|FG001|Short-term Period|Lost to Follow-up|1|||
155302594|NCT00409838|560540186|FG000|Short-term Period|Withdrawal by Subject|2|||
155302595|NCT00409838|560540187|FG001|Short-term Period|Withdrawal by Subject|3|||
155302596|NCT00409838|560540186|FG000|Short-term Period|Never Treated|1|||
155302597|NCT00409838|560540187|FG001|Short-term Period|Never Treated|0|||
155302598|NCT00409838|560540186|FG000|Long-term Extension Period|Adverse Event|10|||
155302599|NCT00409838|560540187|FG001|Long-term Extension Period|Adverse Event|0|||
155302600|NCT00409838|560540186|FG000|Long-term Extension Period|Death|1|||
155302601|NCT00409838|560540187|FG001|Long-term Extension Period|Death|0|||
155302602|NCT00409838|560540186|FG000|Long-term Extension Period|Lack of Efficacy|2|||
155063758|NCT02030600|559665506|FG000|Treatment Period 2|Withdrawal by Subject|13|||
155063759|NCT02030600|559665507|FG001|Treatment Period 2|Withdrawal by Subject|9|||
155302603|NCT00409838|560540187|FG001|Long-term Extension Period|Lack of Efficacy|0|||
155302604|NCT00409838|560540186|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
155063760|NCT02030600|559665506|FG000|Treatment Period 2|Unclassified|1|||
155063761|NCT02030600|559665507|FG001|Treatment Period 2|Unclassified|0|||
155063762|NCT01240694|559665508|FG000|Overall Study|Adverse Event|9|||
155063763|NCT01240694|559665508|FG000|Overall Study|Lack of Efficacy|6|||
155063764|NCT01240694|559665508|FG000|Overall Study|Withdrawal by Subject|6|||
155063765|NCT01240694|559665508|FG000|Overall Study|Protocol Violation|2|||
155063766|NCT01240694|559665508|FG000|Overall Study|Lost to Follow-up|2|||
155063767|NCT01240694|559665508|FG000|Overall Study|Other than specified|3|||
155063768|NCT01240694|559665508|FG000|Overall Study|Withdrawn due to early study termination|107|||
155063769|NCT01881425|559665509|FG000|Overall Study|Death|5|||
155063770|NCT01881425|559665510|FG001|Overall Study|Death|1|||
155063771|NCT01881425|559665509|FG000|Overall Study|Withdrawal by Subject|8|||
155063772|NCT01881425|559665510|FG001|Overall Study|Withdrawal by Subject|3|||
155063773|NCT01881425|559665509|FG000|Overall Study|Physician Decision|2|||
155063774|NCT01881425|559665510|FG001|Overall Study|Physician Decision|1|||
155063775|NCT01881425|559665509|FG000|Overall Study|Adverse Event|3|||
155063776|NCT01881425|559665510|FG001|Overall Study|Adverse Event|0|||
155063777|NCT01881425|559665509|FG000|Overall Study|General Anesthesia panic attack|0|||
155063778|NCT01881425|559665510|FG001|Overall Study|General Anesthesia panic attack|1|||
155063779|NCT01881425|559665509|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
155063780|NCT01881425|559665510|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
155063781|NCT01881425|559665509|FG000|Overall Study|Lost to Follow-up|7|||
155063782|NCT01881425|559665510|FG001|Overall Study|Lost to Follow-up|2|||
155063783|NCT05352815|559665511|FG000|Overall Study|Withdrawal by Subject|28|||
155063784|NCT05352815|559665512|FG001|Overall Study|Withdrawal by Subject|24|||
155063785|NCT05352815|559665511|FG000|Overall Study|Lost to Follow-up|4|||
155063786|NCT05352815|559665512|FG001|Overall Study|Lost to Follow-up|7|||
155063787|NCT05352815|559665511|FG000|Overall Study|Death|2|||
155063788|NCT05352815|559665512|FG001|Overall Study|Death|3|||
155063789|NCT05352815|559665511|FG000|Overall Study|Site closure|1|||
155063790|NCT05352815|559665512|FG001|Overall Study|Site closure|0|||
155063791|NCT00701363|559665514|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
155063792|NCT00701363|559665515|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
155063793|NCT00701363|559665516|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
155063794|NCT00701363|559665517|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
155063795|NCT00701363|559665514|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
155063796|NCT00701363|559665515|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
155063797|NCT00701363|559665516|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
155063798|NCT00701363|559665517|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
155063799|NCT00701363|559665514|FG000|Treatment Phase 1|Adverse Event|7|||
155063800|NCT00701363|559665515|FG001|Treatment Phase 1|Adverse Event|0|||
155063801|NCT00701363|559665516|FG002|Treatment Phase 1|Adverse Event|0|||
155063802|NCT00701363|559665517|FG003|Treatment Phase 1|Adverse Event|0|||
155063803|NCT00701363|559665514|FG000|Treatment Phase 1|Protocol Violation|1|||
155063804|NCT00701363|559665515|FG001|Treatment Phase 1|Protocol Violation|0|||
155063805|NCT00701363|559665516|FG002|Treatment Phase 1|Protocol Violation|0|||
155063806|NCT00701363|559665517|FG003|Treatment Phase 1|Protocol Violation|0|||
155063807|NCT00701363|559665514|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
155302605|NCT00409838|560540187|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
155302606|NCT00409838|560540186|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
155302607|NCT00409838|560540187|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
155302608|NCT00409838|560540186|FG000|Long-term Extension Period|Pregnancy|1|||
155302609|NCT00409838|560540187|FG001|Long-term Extension Period|Pregnancy|0|||
155302610|NCT01250769|560540189|FG000|Overall Study|Withdrawal by Subject|0|||
155063808|NCT00701363|559665515|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
155063809|NCT00701363|559665516|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
155063810|NCT00701363|559665517|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
155063811|NCT00701363|559665514|FG000|Treatment Phase 1|Lack of Efficacy|1|||
155063812|NCT00701363|559665515|FG001|Treatment Phase 1|Lack of Efficacy|0|||
155063813|NCT00701363|559665516|FG002|Treatment Phase 1|Lack of Efficacy|0|||
155063814|NCT00701363|559665517|FG003|Treatment Phase 1|Lack of Efficacy|0|||
155063815|NCT00701363|559665514|FG000|Treatment Phase 2|Adverse Event|0|||
155063816|NCT00701363|559665515|FG001|Treatment Phase 2|Adverse Event|0|||
155063817|NCT00701363|559665516|FG002|Treatment Phase 2|Adverse Event|1|||
155302611|NCT01250769|560540190|FG001|Overall Study|Withdrawal by Subject|1|||
155302612|NCT01250769|560540191|FG002|Overall Study|Withdrawal by Subject|1|||
155302613|NCT01250769|560540192|FG003|Overall Study|Withdrawal by Subject|0|||
155302614|NCT01250769|560540189|FG000|Overall Study|Adverse Event|0|||
155302615|NCT01250769|560540190|FG001|Overall Study|Adverse Event|0|||
155302616|NCT01250769|560540191|FG002|Overall Study|Adverse Event|1|||
155302617|NCT01250769|560540192|FG003|Overall Study|Adverse Event|0|||
155302618|NCT01290341|560540193|FG000|Overall Study|Protocol Violation|7|||
155302619|NCT01290341|560540194|FG001|Overall Study|Protocol Violation|3|||
155302620|NCT01290341|560540193|FG000|Overall Study|Adverse Event|1|||
155302621|NCT01290341|560540194|FG001|Overall Study|Adverse Event|0|||
155302622|NCT01290341|560540193|FG000|Overall Study|Lost to Follow-up|21|||
155302623|NCT01290341|560540194|FG001|Overall Study|Lost to Follow-up|10|||
155302624|NCT01290341|560540193|FG000|Overall Study|Withdrawal by Subject|19|||
155302625|NCT01290341|560540194|FG001|Overall Study|Withdrawal by Subject|5|||
154958143|NCT02563561|559275465|FG000|Overall Study|Sponsor Decision|5|||
154958144|NCT02563561|559275466|FG001|Overall Study|Sponsor Decision|2|||
154958145|NCT02563561|559275467|FG002|Overall Study|Sponsor Decision|4|||
154958146|NCT02563561|559275465|FG000|Overall Study|Other|1|||
154958147|NCT02563561|559275466|FG001|Overall Study|Other|5|||
154958148|NCT02563561|559275467|FG002|Overall Study|Other|2|||
154958149|NCT03769896|559275468|FG000|Open-label Phase|Lack of Efficacy|5|||
154958150|NCT03769896|559275469|FG001|Open-label Phase|Lack of Efficacy|0|||
154958151|NCT03769896|559275468|FG000|Open-label Phase|Adverse Event|3|||
154958152|NCT03769896|559275469|FG001|Open-label Phase|Adverse Event|0|||
154958153|NCT03769896|559275468|FG000|Open-label Phase|Withdrawal by Subject|1|||
154958154|NCT03769896|559275469|FG001|Open-label Phase|Withdrawal by Subject|0|||
154958155|NCT01015703|559275470|FG000|Overall Study|Withdrawal by Subject|0|||
154958156|NCT01015703|559275471|FG001|Overall Study|Withdrawal by Subject|1|||
154958157|NCT01015703|559275472|FG002|Overall Study|Withdrawal by Subject|0|||
154958158|NCT01015703|559275473|FG003|Overall Study|Withdrawal by Subject|0|||
154958159|NCT01015703|559275474|FG004|Overall Study|Withdrawal by Subject|0|||
154958160|NCT01015703|559275470|FG000|Overall Study|Adverse Event|1|||
154958161|NCT01015703|559275471|FG001|Overall Study|Adverse Event|0|||
154958162|NCT01015703|559275472|FG002|Overall Study|Adverse Event|0|||
154958163|NCT01015703|559275473|FG003|Overall Study|Adverse Event|0|||
154958164|NCT01015703|559275474|FG004|Overall Study|Adverse Event|0|||
154958165|NCT01015703|559275470|FG000|Overall Study|Protocol Violation|1|||
154958166|NCT01015703|559275471|FG001|Overall Study|Protocol Violation|0|||
154958167|NCT01015703|559275472|FG002|Overall Study|Protocol Violation|0|||
154958168|NCT01015703|559275473|FG003|Overall Study|Protocol Violation|0|||
154958169|NCT01015703|559275474|FG004|Overall Study|Protocol Violation|0|||
154958170|NCT03122535|559275475|FG000|Overall Study|Lost to Follow-up|68|||
154958171|NCT03122535|559275476|FG001|Overall Study|Lost to Follow-up|68|||
154958172|NCT03122535|559275475|FG000|Overall Study|Physician Decision|3|||
154958173|NCT03122535|559275476|FG001|Overall Study|Physician Decision|3|||
154958174|NCT03122535|559275475|FG000|Overall Study|Withdrawal by Subject|2|||
154958175|NCT03122535|559275476|FG001|Overall Study|Withdrawal by Subject|2|||
154958176|NCT02646124|559275477|FG000|Overall Study|Lost to Follow-up|0|||
154958177|NCT02646124|559275478|FG001|Overall Study|Lost to Follow-up|2|||
154958178|NCT01796171|559275481|FG000|Enrolled|Death|0|||
154958179|NCT01796171|559275482|FG001|Enrolled|Death|0|||
154958180|NCT01796171|559275483|FG002|Enrolled|Death|0|||
154958181|NCT01796171|559275484|FG003|Enrolled|Death|0|||
154958182|NCT01796171|559275485|FG004|Enrolled|Death|0|||
154958183|NCT01796171|559275486|FG005|Enrolled|Death|0|||
154958184|NCT01796171|559275487|FG006|Enrolled|Death|0|||
154958185|NCT01796171|559275488|FG007|Enrolled|Death|0|||
154958186|NCT01796171|559275489|FG008|Enrolled|Death|0|||
154958187|NCT01796171|559275490|FG009|Enrolled|Death|0|||
154958188|NCT01796171|559275491|FG010|Enrolled|Death|0|||
154958189|NCT01796171|559275492|FG011|Enrolled|Death|0|||
154958190|NCT01796171|559275493|FG012|Enrolled|Death|0|||
154958191|NCT01796171|559275494|FG013|Enrolled|Death|0|||
154958192|NCT01796171|559275495|FG014|Enrolled|Death|1|||
154958193|NCT01796171|559275481|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
154958194|NCT01796171|559275482|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
154958195|NCT01796171|559275483|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
154958196|NCT01796171|559275484|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
154958197|NCT01796171|559275485|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
154958198|NCT01796171|559275486|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
154958199|NCT01796171|559275487|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
154958200|NCT01796171|559275488|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
154958201|NCT01796171|559275489|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
154958202|NCT01796171|559275490|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
154958203|NCT01796171|559275491|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
154958204|NCT01796171|559275492|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
154958205|NCT01796171|559275493|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
154958206|NCT01796171|559275494|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
155302626|NCT01290341|560540193|FG000|Overall Study|Negative baseline culture and others|44|||
155302627|NCT01290341|560540194|FG001|Overall Study|Negative baseline culture and others|11|||
155302628|NCT03951805|560540195|FG000|Overall Study|Adverse Event|1|||
155302629|NCT03951805|560540196|FG001|Overall Study|Adverse Event|0|||
155063818|NCT00701363|559665517|FG003|Treatment Phase 2|Adverse Event|0|||
155063819|NCT00701363|559665514|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
155063820|NCT00701363|559665515|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
155063821|NCT00701363|559665516|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
155063822|NCT00701363|559665517|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
155063823|NCT04759131|559665518|FG000|Overall Study|Investigator's discretion|1|||
155063824|NCT04759131|559665519|FG001|Overall Study|Investigator's discretion|0|||
155063825|NCT04759131|559665518|FG000|Overall Study|Subject withdrawal|1|||
155063826|NCT04759131|559665519|FG001|Overall Study|Subject withdrawal|0|||
155063827|NCT00284856|559665523|FG000|Overall Study|Adverse Event|3|||
155063828|NCT00284856|559665524|FG001|Overall Study|Adverse Event|3|||
155063829|NCT00284856|559665525|FG002|Overall Study|Adverse Event|3|||
155063830|NCT00284856|559665523|FG000|Overall Study|Lack of Efficacy|2|||
155063831|NCT00284856|559665524|FG001|Overall Study|Lack of Efficacy|1|||
155063832|NCT00284856|559665525|FG002|Overall Study|Lack of Efficacy|8|||
155063833|NCT00284856|559665523|FG000|Overall Study|Lost to Follow-up|25|||
155063834|NCT00284856|559665524|FG001|Overall Study|Lost to Follow-up|21|||
155063835|NCT00284856|559665525|FG002|Overall Study|Lost to Follow-up|22|||
155063836|NCT00284856|559665523|FG000|Overall Study|Protocol Violation|5|||
155063837|NCT00284856|559665524|FG001|Overall Study|Protocol Violation|4|||
155063838|NCT00284856|559665525|FG002|Overall Study|Protocol Violation|5|||
155063839|NCT00284856|559665523|FG000|Overall Study|Withdrawal by Subject|12|||
155063840|NCT00284856|559665524|FG001|Overall Study|Withdrawal by Subject|16|||
155063841|NCT00284856|559665525|FG002|Overall Study|Withdrawal by Subject|18|||
155063842|NCT00284856|559665523|FG000|Overall Study|Other|4|||
155063843|NCT00284856|559665524|FG001|Overall Study|Other|5|||
155063844|NCT00284856|559665525|FG002|Overall Study|Other|4|||
155063845|NCT02592824|559665526|FG000|Overall Study|Protocol Violation|5|||
155063846|NCT02592824|559665527|FG001|Overall Study|Protocol Violation|3|||
155063847|NCT02592824|559665526|FG000|Overall Study|Lost to Follow-up|2|||
155063848|NCT02592824|559665527|FG001|Overall Study|Lost to Follow-up|1|||
155063849|NCT05082025|559665528|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
155063850|NCT00726609|559665529|FG000|Overall Study|Adverse Event|10|||
155063851|NCT00726609|559665529|FG000|Overall Study|Withdrawal by Subject|2|||
155063852|NCT00726609|559665529|FG000|Overall Study|Lack of Efficacy|25|||
155063853|NCT00726609|559665529|FG000|Overall Study|Other|16|||
155063854|NCT00726609|559665529|FG000|Overall Study|Missing|42|||
155063855|NCT00726609|559665529|FG000|Overall Study|Other|3|||
155063856|NCT00746551|559665533|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
155063857|NCT00746551|559665534|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
155063858|NCT00746551|559665533|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
155063859|NCT00746551|559665534|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
155063860|NCT00746551|559665533|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
155063861|NCT00746551|559665534|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
155063862|NCT02029417|559665537|FG000|Overall Study|Death|1|||
155063863|NCT02029417|559665537|FG000|Overall Study|Adverse Event|1|||
155063864|NCT04458922|559665539|FG000|Overall Study|Withdrawal by Subject|1|||
155063865|NCT04458922|559665540|FG001|Overall Study|Withdrawal by Subject|0|||
155063866|NCT04458922|559665541|FG002|Overall Study|Withdrawal by Subject|2|||
155063867|NCT04458922|559665539|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
155063868|NCT04458922|559665540|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
155302630|NCT03951805|560540197|FG002|Overall Study|Adverse Event|0|||
155302631|NCT03951805|560540198|FG003|Overall Study|Adverse Event|0|||
155302632|NCT03684044|560540199|FG000|Overall Study|Adverse Event|3|||
155302633|NCT03684044|560540200|FG001|Overall Study|Adverse Event|0|||
155302634|NCT03684044|560540199|FG000|Overall Study|Death|4|||
155302635|NCT03684044|560540200|FG001|Overall Study|Death|7|||
155302636|NCT03684044|560540199|FG000|Overall Study|Lost to Follow-up|3|||
155302637|NCT03684044|560540200|FG001|Overall Study|Lost to Follow-up|2|||
155302638|NCT03684044|560540199|FG000|Overall Study|Patient Not Available|0|||
155302639|NCT03684044|560540200|FG001|Overall Study|Patient Not Available|2|||
155302640|NCT03684044|560540199|FG000|Overall Study|Physician Decision|1|||
155302641|NCT03684044|560540200|FG001|Overall Study|Physician Decision|0|||
155302642|NCT03684044|560540199|FG000|Overall Study|Withdrawal by Subject|11|||
155302643|NCT03684044|560540200|FG001|Overall Study|Withdrawal by Subject|9|||
155302644|NCT03703336|560540201|FG000|Overall Study|Parent withdrew consent|29|||
155063869|NCT04458922|559665541|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
155063870|NCT04458922|559665539|FG000|Overall Study|Adverse Event|1|||
155063871|NCT04458922|559665540|FG001|Overall Study|Adverse Event|0|||
155063872|NCT04458922|559665541|FG002|Overall Study|Adverse Event|0|||
155063873|NCT04458922|559665539|FG000|Overall Study|Started new study|0|||
155063874|NCT04458922|559665540|FG001|Overall Study|Started new study|0|||
155063875|NCT04458922|559665541|FG002|Overall Study|Started new study|1|||
155063876|NCT04458922|559665539|FG000|Overall Study|Progressive disease|6|||
155063877|NCT04458922|559665540|FG001|Overall Study|Progressive disease|8|||
155302645|NCT03703336|560540202|FG001|Overall Study|Parent withdrew consent|8|||
155302646|NCT03703336|560540201|FG000|Overall Study|Migration|3|||
155302647|NCT03703336|560540202|FG001|Overall Study|Migration|3|||
155063878|NCT04458922|559665541|FG002|Overall Study|Progressive disease|2|||
155063879|NCT04458922|559665539|FG000|Overall Study|Death|1|||
155063880|NCT04458922|559665540|FG001|Overall Study|Death|0|||
155063881|NCT04458922|559665541|FG002|Overall Study|Death|2|||
155063882|NCT04458922|559665539|FG000|Overall Study|Participant started chemotherapy|0|||
155063883|NCT04458922|559665540|FG001|Overall Study|Participant started chemotherapy|1|||
155063884|NCT04458922|559665541|FG002|Overall Study|Participant started chemotherapy|0|||
155063885|NCT03344757|559665542|FG000|Overall Study|Withdrawal by Subject|18|||
155063886|NCT03344757|559665543|FG001|Overall Study|Withdrawal by Subject|16|||
155063887|NCT03344757|559665542|FG000|Overall Study|Lost to Follow-up|0|||
155063888|NCT03344757|559665543|FG001|Overall Study|Lost to Follow-up|2|||
155063889|NCT01316575|559665544|FG000|Overall Study|Withdrawal by Subject|2|||
155063890|NCT01316575|559665545|FG001|Overall Study|Withdrawal by Subject|0|||
155063891|NCT01316575|559665544|FG000|Overall Study|Required alternate treatment|0|||
155063892|NCT01316575|559665545|FG001|Overall Study|Required alternate treatment|1|||
155063893|NCT00402831|559665546|FG000|Overall Study|Lost to Follow-up|1|||
155063894|NCT00402831|559665547|FG001|Overall Study|Lost to Follow-up|2|||
155063895|NCT00402831|559665546|FG000|Overall Study|Non-compliance with protocol|0|||
155063896|NCT00402831|559665547|FG001|Overall Study|Non-compliance with protocol|1|||
155063897|NCT02792504|559665550|FG000|Overall Study|Lost to Follow-up|24|||
155063898|NCT02792504|559665550|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
155063899|NCT01832766|559665557|FG000|Washout|Lost to Follow-up|0|||
155063900|NCT01832766|559665558|FG001|Washout|Lost to Follow-up|1|||
155063901|NCT01114724|559665559|FG000|Overall Study|Death|8|||
155063902|NCT01114724|559665559|FG000|Overall Study|Lost to Follow-up|1|||
155063903|NCT01114724|559665559|FG000|Overall Study|Withdrawal by Subject|1|||
155063904|NCT06178991|559665566|FG000|Overall Study|Withdrawal by Subject|2|||
155063905|NCT06178991|559665567|FG001|Overall Study|Withdrawal by Subject|6|||
155063906|NCT06178991|559665568|FG002|Overall Study|Withdrawal by Subject|44|||
155063907|NCT06178991|559665569|FG003|Overall Study|Withdrawal by Subject|23|||
155063908|NCT06178991|559665570|FG004|Overall Study|Withdrawal by Subject|7|||
155063909|NCT06178991|559665571|FG005|Overall Study|Withdrawal by Subject|7|||
155063910|NCT06178991|559665572|FG006|Overall Study|Withdrawal by Subject|7|||
155063911|NCT06178991|559665573|FG007|Overall Study|Withdrawal by Subject|5|||
155063912|NCT06178991|559665566|FG000|Overall Study|Lost to Follow-up|2|||
155063913|NCT06178991|559665567|FG001|Overall Study|Lost to Follow-up|4|||
155063914|NCT06178991|559665568|FG002|Overall Study|Lost to Follow-up|133|||
155063915|NCT06178991|559665569|FG003|Overall Study|Lost to Follow-up|65|||
155063916|NCT06178991|559665570|FG004|Overall Study|Lost to Follow-up|68|||
155063917|NCT06178991|559665571|FG005|Overall Study|Lost to Follow-up|57|||
155063918|NCT06178991|559665572|FG006|Overall Study|Lost to Follow-up|25|||
155063919|NCT06178991|559665573|FG007|Overall Study|Lost to Follow-up|18|||
155063920|NCT06178991|559665566|FG000|Overall Study|Death|1|||
155063921|NCT06178991|559665567|FG001|Overall Study|Death|0|||
155063922|NCT06178991|559665568|FG002|Overall Study|Death|2|||
155302648|NCT03703336|560540201|FG000|Overall Study|Protocol Violation|3|||
155302649|NCT03703336|560540202|FG001|Overall Study|Protocol Violation|1|||
155302650|NCT03703336|560540201|FG000|Overall Study|Physician Decision|2|||
155302651|NCT03703336|560540202|FG001|Overall Study|Physician Decision|0|||
155302652|NCT03703336|560540201|FG000|Overall Study|Adverse Event|0|||
155302653|NCT03703336|560540202|FG001|Overall Study|Adverse Event|2|||
155160655|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160656|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160657|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155063923|NCT06178991|559665569|FG003|Overall Study|Death|1|||
155063924|NCT06178991|559665570|FG004|Overall Study|Death|1|||
155063925|NCT06178991|559665571|FG005|Overall Study|Death|0|||
155063926|NCT06178991|559665572|FG006|Overall Study|Death|1|||
155063927|NCT06178991|559665573|FG007|Overall Study|Death|1|||
155063928|NCT06178991|559665566|FG000|Overall Study|Randomized but not Vaccinated|4|||
155063929|NCT06178991|559665567|FG001|Overall Study|Randomized but not Vaccinated|1|||
155063930|NCT06178991|559665568|FG002|Overall Study|Randomized but not Vaccinated|15|||
155063931|NCT06178991|559665569|FG003|Overall Study|Randomized but not Vaccinated|9|||
155063932|NCT06178991|559665570|FG004|Overall Study|Randomized but not Vaccinated|8|||
155063933|NCT06178991|559665571|FG005|Overall Study|Randomized but not Vaccinated|4|||
155063934|NCT06178991|559665572|FG006|Overall Study|Randomized but not Vaccinated|2|||
155063935|NCT06178991|559665573|FG007|Overall Study|Randomized but not Vaccinated|2|||
155063936|NCT06178991|559665566|FG000|Overall Study|Other: Unspecified|0|||
155063937|NCT06178991|559665567|FG001|Overall Study|Other: Unspecified|1|||
155063938|NCT06178991|559665568|FG002|Overall Study|Other: Unspecified|7|||
155302654|NCT03703336|560540201|FG000|Overall Study|Lost to Follow-up|1|||
155302655|NCT03703336|560540202|FG001|Overall Study|Lost to Follow-up|0|||
155063939|NCT06178991|559665569|FG003|Overall Study|Other: Unspecified|6|||
155063940|NCT06178991|559665570|FG004|Overall Study|Other: Unspecified|1|||
155063941|NCT06178991|559665571|FG005|Overall Study|Other: Unspecified|1|||
155063942|NCT06178991|559665572|FG006|Overall Study|Other: Unspecified|1|||
155063943|NCT06178991|559665573|FG007|Overall Study|Other: Unspecified|0|||
155302656|NCT00595413|560540203|FG000|Overall Study|Adverse Event|0|||
154958207|NCT01796171|559275495|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
154958208|NCT01796171|559275481|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958209|NCT01796171|559275482|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958210|NCT01796171|559275483|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958211|NCT01796171|559275484|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958212|NCT01796171|559275485|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958213|NCT01796171|559275486|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958214|NCT01796171|559275487|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958215|NCT01796171|559275488|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958216|NCT01796171|559275489|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958217|NCT01796171|559275490|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958218|NCT01796171|559275491|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958219|NCT01796171|559275492|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958220|NCT01796171|559275493|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958221|NCT01796171|559275494|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
154958222|NCT01796171|559275495|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
154958223|NCT01796171|559275481|FG000|Treatment Period With Betalutin|Progressive disease|0|||
154958224|NCT01796171|559275482|FG001|Treatment Period With Betalutin|Progressive disease|1|||
154958225|NCT01796171|559275483|FG002|Treatment Period With Betalutin|Progressive disease|0|||
154958226|NCT01796171|559275484|FG003|Treatment Period With Betalutin|Progressive disease|0|||
154958227|NCT01796171|559275485|FG004|Treatment Period With Betalutin|Progressive disease|0|||
154958228|NCT01796171|559275486|FG005|Treatment Period With Betalutin|Progressive disease|0|||
154958229|NCT01796171|559275487|FG006|Treatment Period With Betalutin|Progressive disease|0|||
154958230|NCT01796171|559275488|FG007|Treatment Period With Betalutin|Progressive disease|0|||
154958231|NCT01796171|559275489|FG008|Treatment Period With Betalutin|Progressive disease|0|||
154958232|NCT01796171|559275490|FG009|Treatment Period With Betalutin|Progressive disease|0|||
154958233|NCT01796171|559275491|FG010|Treatment Period With Betalutin|Progressive disease|0|||
154958234|NCT01796171|559275492|FG011|Treatment Period With Betalutin|Progressive disease|0|||
154958235|NCT01796171|559275493|FG012|Treatment Period With Betalutin|Progressive disease|0|||
154958236|NCT01796171|559275494|FG013|Treatment Period With Betalutin|Progressive disease|0|||
154958237|NCT01796171|559275495|FG014|Treatment Period With Betalutin|Progressive disease|0|||
154958238|NCT01796171|559275481|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958239|NCT01796171|559275482|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958240|NCT01796171|559275483|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958241|NCT01796171|559275484|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958242|NCT01796171|559275485|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958243|NCT01796171|559275486|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958244|NCT01796171|559275487|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958245|NCT01796171|559275488|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958246|NCT01796171|559275489|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
154958247|NCT01796171|559275490|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958248|NCT01796171|559275491|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
154958249|NCT01796171|559275492|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
154958250|NCT01796171|559275493|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958251|NCT01796171|559275494|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958252|NCT01796171|559275495|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
154958253|NCT01796171|559275481|FG000|Treatment Period With Betalutin|Physician Decision|0|||
154958254|NCT01796171|559275482|FG001|Treatment Period With Betalutin|Physician Decision|0|||
154958255|NCT01796171|559275483|FG002|Treatment Period With Betalutin|Physician Decision|0|||
154958256|NCT01796171|559275484|FG003|Treatment Period With Betalutin|Physician Decision|0|||
154958257|NCT01796171|559275485|FG004|Treatment Period With Betalutin|Physician Decision|0|||
154958258|NCT01796171|559275486|FG005|Treatment Period With Betalutin|Physician Decision|0|||
154958259|NCT01796171|559275487|FG006|Treatment Period With Betalutin|Physician Decision|0|||
154958260|NCT01796171|559275488|FG007|Treatment Period With Betalutin|Physician Decision|0|||
154958261|NCT01796171|559275489|FG008|Treatment Period With Betalutin|Physician Decision|0|||
155063944|NCT06178991|559665566|FG000|Overall Study|Physician Decision|0|||
155063945|NCT06178991|559665567|FG001|Overall Study|Physician Decision|0|||
155063946|NCT06178991|559665568|FG002|Overall Study|Physician Decision|2|||
155063947|NCT06178991|559665569|FG003|Overall Study|Physician Decision|0|||
155063948|NCT06178991|559665570|FG004|Overall Study|Physician Decision|2|||
155063949|NCT06178991|559665571|FG005|Overall Study|Physician Decision|1|||
155063950|NCT06178991|559665572|FG006|Overall Study|Physician Decision|0|||
155063951|NCT06178991|559665573|FG007|Overall Study|Physician Decision|0|||
155063952|NCT06178991|559665566|FG000|Overall Study|Protocol Violation|0|||
155063953|NCT06178991|559665567|FG001|Overall Study|Protocol Violation|0|||
155063954|NCT06178991|559665568|FG002|Overall Study|Protocol Violation|1|||
155063955|NCT06178991|559665569|FG003|Overall Study|Protocol Violation|0|||
155063956|NCT06178991|559665570|FG004|Overall Study|Protocol Violation|0|||
155063957|NCT06178991|559665571|FG005|Overall Study|Protocol Violation|0|||
155063958|NCT06178991|559665572|FG006|Overall Study|Protocol Violation|0|||
155063959|NCT06178991|559665573|FG007|Overall Study|Protocol Violation|0|||
155063960|NCT01366092|559665576|FG000|Overall Study|Progressive cGVHD|2|||
155063961|NCT01366092|559665576|FG000|Overall Study|Physician Decision|1|||
155063962|NCT01366092|559665576|FG000|Overall Study|Withdrawal by Subject|1|||
155063963|NCT00834041|559665577|FG000|Overall Study|Withdrawal by Subject|1|||
155063964|NCT00834041|559665578|FG001|Overall Study|Withdrawal by Subject|0|||
155063965|NCT00834041|559665577|FG000|Overall Study|Lost to Follow-up|0|||
155063966|NCT00834041|559665578|FG001|Overall Study|Lost to Follow-up|1|||
155063967|NCT03074500|559665579|FG000|Overall Study|Lost to Follow-up|1|||
155063968|NCT03074500|559665580|FG001|Overall Study|Lost to Follow-up|0|||
155063969|NCT03074500|559665581|FG002|Overall Study|Lost to Follow-up|0|||
155063970|NCT03074500|559665579|FG000|Overall Study|Lack of Efficacy|0|||
155063971|NCT03074500|559665580|FG001|Overall Study|Lack of Efficacy|1|||
155063972|NCT03074500|559665581|FG002|Overall Study|Lack of Efficacy|0|||
155063973|NCT03074500|559665579|FG000|Overall Study|Adverse Event|0|||
155063974|NCT03074500|559665580|FG001|Overall Study|Adverse Event|0|||
155063975|NCT03074500|559665581|FG002|Overall Study|Adverse Event|1|||
155063976|NCT03608163|559665582|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
155063977|NCT03608163|559665583|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
155063978|NCT03586479|559665584|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
155063979|NCT03586479|559665585|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
155063980|NCT03586479|559665586|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
155063981|NCT03586479|559665584|FG000|Overall Study|Protocol Violation|2|||
155063982|NCT03586479|559665585|FG001|Overall Study|Protocol Violation|0|||
155063983|NCT03586479|559665586|FG002|Overall Study|Protocol Violation|0|||
155063984|NCT03586479|559665584|FG000|Overall Study|Lost to Follow-up|1|||
155063985|NCT03586479|559665585|FG001|Overall Study|Lost to Follow-up|1|||
155063986|NCT03586479|559665586|FG002|Overall Study|Lost to Follow-up|2|||
155063987|NCT03586479|559665584|FG000|Overall Study|Behavioral Issues|1|||
155063988|NCT03586479|559665585|FG001|Overall Study|Behavioral Issues|0|||
155302657|NCT00595413|560540204|FG001|Overall Study|Adverse Event|2|||
155302658|NCT00595413|560540205|FG002|Overall Study|Adverse Event|1|||
155302659|NCT00595413|560540206|FG003|Overall Study|Adverse Event|1|||
155302660|NCT00595413|560540203|FG000|Overall Study|Lost to Follow-up|2|||
155063989|NCT03586479|559665586|FG002|Overall Study|Behavioral Issues|0|||
155063990|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
155063991|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
155063992|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
155063993|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
155063994|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
155063995|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
155063996|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
155063997|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
155063998|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
155063999|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
155064000|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
155064001|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
155064002|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
155064003|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
155302661|NCT00595413|560540204|FG001|Overall Study|Lost to Follow-up|2|||
155302662|NCT00595413|560540205|FG002|Overall Study|Lost to Follow-up|1|||
155302663|NCT00595413|560540206|FG003|Overall Study|Lost to Follow-up|3|||
155302664|NCT00595413|560540203|FG000|Overall Study|Death|0|||
155302665|NCT00595413|560540204|FG001|Overall Study|Death|0|||
155302666|NCT00595413|560540205|FG002|Overall Study|Death|1|||
155302667|NCT00595413|560540206|FG003|Overall Study|Death|0|||
155302668|NCT00595413|560540203|FG000|Overall Study|Other|5|||
155302669|NCT00595413|560540204|FG001|Overall Study|Other|1|||
155302670|NCT00595413|560540205|FG002|Overall Study|Other|5|||
155302671|NCT00595413|560540206|FG003|Overall Study|Other|0|||
155302672|NCT03233633|560540207|FG000|Overall Study|Adverse Event|2|||
155302673|NCT03233633|560540207|FG000|Overall Study|Less Than 3 Days of Data|6|||
155302674|NCT02088853|560540208|FG000|Overall Study|Pregnancy|1|||
155064004|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
155064005|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
155064006|NCT00849056|559666722|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
155064007|NCT00849056|559666723|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
155064008|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
155064009|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
155064010|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
155064011|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
155064012|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
155064013|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
155064014|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
155064015|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
155064016|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
155064017|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
155064018|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
155064019|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
155064020|NCT00849056|559666722|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
155064021|NCT00849056|559666723|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
155064022|NCT04588259|559666724|FG000|Run-in period|Run-in failure|0|||
155064023|NCT04588259|559666725|FG001|Run-in period|Run-in failure|23|||
155064024|NCT04588259|559666724|FG000|Run-in period|Withdrawn before randomisation|0|||
155064025|NCT04588259|559666725|FG001|Run-in period|Withdrawn before randomisation|8|||
155064026|NCT04588259|559666724|FG000|Treatment period|Withdrawal by Subject|6|||
155064027|NCT04588259|559666725|FG001|Treatment period|Withdrawal by Subject|6|||
155064028|NCT00375752|559666726|FG000|Overall Study|Lack of Efficacy|4|||
155064029|NCT00375752|559666727|FG001|Overall Study|Lack of Efficacy|4|||
155064030|NCT00375752|559666726|FG000|Overall Study|Adverse Event|1|||
155064031|NCT00375752|559666727|FG001|Overall Study|Adverse Event|6|||
155064032|NCT00375752|559666726|FG000|Overall Study|Withdrawal by Subject|6|||
155064033|NCT00375752|559666727|FG001|Overall Study|Withdrawal by Subject|1|||
155064034|NCT00375752|559666726|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155064035|NCT00375752|559666727|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
155064036|NCT00375752|559666726|FG000|Overall Study|Protocol Violation|0|||
155064037|NCT00375752|559666727|FG001|Overall Study|Protocol Violation|2|||
155064038|NCT00375752|559666726|FG000|Overall Study|Administrative Problems|0|||
155064039|NCT00375752|559666727|FG001|Overall Study|Administrative Problems|1|||
155064040|NCT02469233|559666729|FG000|Overall Study|Death|1|||
155064041|NCT02469233|559666730|FG001|Overall Study|Death|1|||
155064042|NCT02469233|559666729|FG000|Overall Study|Lost to post or 6 month follow up|7|||
155064043|NCT02469233|559666730|FG001|Overall Study|Lost to post or 6 month follow up|2|||
155064044|NCT00855582|559666731|FG000|Overall Study|Adverse Event|2|||
155064045|NCT00855582|559666732|FG001|Overall Study|Adverse Event|6|||
155064046|NCT00855582|559666733|FG002|Overall Study|Adverse Event|3|||
155064047|NCT00855582|559666731|FG000|Overall Study|Death|1|||
155064048|NCT00855582|559666732|FG001|Overall Study|Death|0|||
155064049|NCT00855582|559666733|FG002|Overall Study|Death|0|||
155160658|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160659|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160660|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
155160661|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160662|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
155160663|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160664|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160665|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155160666|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
155064050|NCT00855582|559666731|FG000|Overall Study|Lack of Efficacy|1|||
155160667|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155064051|NCT00855582|559666732|FG001|Overall Study|Lack of Efficacy|3|||
155160668|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160669|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160670|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160671|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160672|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160673|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160674|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
155160675|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160676|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160677|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160678|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160679|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160680|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
155160681|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Transplant|0|||
155160682|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Transplant|0|||
155160683|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Transplant|0|||
155160684|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Transplant|0|||
155160685|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Transplant|0|||
155160686|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Transplant|0|||
155160687|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Transplant|0|||
155160688|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Transplant|0|||
155160689|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Transplant|0|||
155160690|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Transplant|4|||
154958262|NCT01796171|559275490|FG009|Treatment Period With Betalutin|Physician Decision|0|||
154958263|NCT01796171|559275491|FG010|Treatment Period With Betalutin|Physician Decision|5|||
154958264|NCT01796171|559275492|FG011|Treatment Period With Betalutin|Physician Decision|1|||
154958265|NCT01796171|559275493|FG012|Treatment Period With Betalutin|Physician Decision|1|||
154958266|NCT01796171|559275494|FG013|Treatment Period With Betalutin|Physician Decision|0|||
154958267|NCT01796171|559275495|FG014|Treatment Period With Betalutin|Physician Decision|0|||
154958268|NCT01796171|559275481|FG000|Treatment Period With Betalutin|Death|0|||
154958269|NCT01796171|559275482|FG001|Treatment Period With Betalutin|Death|0|||
154958270|NCT01796171|559275483|FG002|Treatment Period With Betalutin|Death|0|||
154958271|NCT01796171|559275484|FG003|Treatment Period With Betalutin|Death|0|||
154958272|NCT01796171|559275485|FG004|Treatment Period With Betalutin|Death|0|||
154958273|NCT01796171|559275486|FG005|Treatment Period With Betalutin|Death|0|||
154958274|NCT01796171|559275487|FG006|Treatment Period With Betalutin|Death|0|||
154958275|NCT01796171|559275488|FG007|Treatment Period With Betalutin|Death|0|||
154958276|NCT01796171|559275489|FG008|Treatment Period With Betalutin|Death|0|||
154958277|NCT01796171|559275490|FG009|Treatment Period With Betalutin|Death|0|||
154958278|NCT01796171|559275491|FG010|Treatment Period With Betalutin|Death|2|||
154958279|NCT01796171|559275492|FG011|Treatment Period With Betalutin|Death|0|||
154958280|NCT01796171|559275493|FG012|Treatment Period With Betalutin|Death|0|||
154958281|NCT01796171|559275494|FG013|Treatment Period With Betalutin|Death|0|||
154958282|NCT01796171|559275495|FG014|Treatment Period With Betalutin|Death|0|||
154958283|NCT01796171|559275481|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
154958284|NCT01796171|559275482|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
154958285|NCT01796171|559275483|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
154958286|NCT01796171|559275484|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
154958287|NCT01796171|559275485|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
154958288|NCT01796171|559275486|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
154958289|NCT01796171|559275487|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
154958290|NCT01796171|559275488|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
154958291|NCT01796171|559275489|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
154958292|NCT01796171|559275490|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
154958293|NCT01796171|559275491|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
154958294|NCT01796171|559275492|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
154958295|NCT01796171|559275493|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
154958296|NCT01796171|559275494|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
154958297|NCT01796171|559275495|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
154958298|NCT01796171|559275481|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958299|NCT01796171|559275482|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958300|NCT01796171|559275483|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958301|NCT01796171|559275484|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958302|NCT01796171|559275485|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958303|NCT01796171|559275486|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155160691|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Transplant|2|||
155160692|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Transplant|0|||
155160693|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Transplant|0|||
154958304|NCT01796171|559275487|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
155064052|NCT00855582|559666733|FG002|Overall Study|Lack of Efficacy|8|||
155064053|NCT00855582|559666731|FG000|Overall Study|Lost to Follow-up|1|||
155064054|NCT00855582|559666732|FG001|Overall Study|Lost to Follow-up|3|||
155064055|NCT00855582|559666733|FG002|Overall Study|Lost to Follow-up|1|||
155064056|NCT00855582|559666731|FG000|Overall Study|Physician Decision|0|||
155064057|NCT00855582|559666732|FG001|Overall Study|Physician Decision|0|||
155064058|NCT00855582|559666733|FG002|Overall Study|Physician Decision|1|||
155064059|NCT00855582|559666731|FG000|Overall Study|Protocol Violation|6|||
155064060|NCT00855582|559666732|FG001|Overall Study|Protocol Violation|2|||
155064061|NCT00855582|559666733|FG002|Overall Study|Protocol Violation|6|||
155064062|NCT00855582|559666731|FG000|Overall Study|Entry Criteria Not Met|8|||
155064063|NCT00855582|559666732|FG001|Overall Study|Entry Criteria Not Met|6|||
155064064|NCT00855582|559666733|FG002|Overall Study|Entry Criteria Not Met|3|||
155064065|NCT00855582|559666731|FG000|Overall Study|Withdrawal by Subject|7|||
155064066|NCT00855582|559666732|FG001|Overall Study|Withdrawal by Subject|4|||
155064067|NCT00855582|559666733|FG002|Overall Study|Withdrawal by Subject|8|||
155064068|NCT00656617|559666740|FG000|Overall Study|Adverse Event|1|||
155064069|NCT00656617|559666740|FG000|Overall Study|Death|2|||
155064070|NCT00656617|559666740|FG000|Overall Study|Insurance Issues|2|||
155064071|NCT00656617|559666740|FG000|Overall Study|Move to different clinical trial|2|||
155064072|NCT01155323|559666745|FG000|First Intervention|exclusion criteria|1|||
155064073|NCT01155323|559666746|FG001|First Intervention|exclusion criteria|1|||
155064074|NCT01155323|559666745|FG000|Second Intervention|Lost to Follow-up|1|||
155064075|NCT01155323|559666746|FG001|Second Intervention|Lost to Follow-up|1|||
155064076|NCT02736617|559666747|FG000|Treatment|Adverse Event|1|||
155064077|NCT02736617|559666747|FG000|Treatment|Lack of Efficacy|1|||
155064078|NCT02736617|559666747|FG000|Treatment|Withdrawal by Subject|1|||
155064079|NCT02736617|559666747|FG000|Maintenance|Lack of Efficacy|4|||
155064080|NCT02736617|559666747|FG000|Maintenance|Physician Decision|1|||
155064081|NCT02606253|559666750|FG000|Overall Study|Adverse Event|2|||
155064082|NCT02606253|559666751|FG001|Overall Study|Adverse Event|0|||
155064083|NCT02606253|559666752|FG002|Overall Study|Adverse Event|0|||
155064084|NCT02606253|559666750|FG000|Overall Study|Protocol Violation|2|||
155064085|NCT02606253|559666751|FG001|Overall Study|Protocol Violation|1|||
155064086|NCT02606253|559666752|FG002|Overall Study|Protocol Violation|0|||
155064087|NCT02606253|559666750|FG000|Overall Study|Physician Decision|1|||
155064088|NCT02606253|559666751|FG001|Overall Study|Physician Decision|1|||
155064089|NCT02606253|559666752|FG002|Overall Study|Physician Decision|0|||
155064090|NCT01311661|559666757|FG000|Overall Study|Adverse Event|2|||
155064091|NCT01311661|559666757|FG000|Overall Study|Protocol Violation|3|||
155064092|NCT01311661|559666757|FG000|Overall Study|Withdrawal by Subject|2|||
155064093|NCT05853120|559666758|FG000|Overall Study|Lost to Follow-up|4|||
155064094|NCT05853120|559666759|FG001|Overall Study|Lost to Follow-up|4|||
155064095|NCT05853120|559666758|FG000|Overall Study|Physician Decision|3|||
155064096|NCT05853120|559666759|FG001|Overall Study|Physician Decision|0|||
155064097|NCT05853120|559666758|FG000|Overall Study|Withdrawal by Subject|5|||
155302675|NCT02088853|560540209|FG001|Overall Study|Pregnancy|0|||
155064098|NCT05853120|559666759|FG001|Overall Study|Withdrawal by Subject|2|||
155064099|NCT03426878|559666761|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
155064100|NCT03426878|559666761|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
155064101|NCT03426878|559666761|FG000|Overall Study|Declined to receive results|3|||
155064102|NCT03426878|559666761|FG000|Overall Study|Received negative results by mailed letter|65|||
155064103|NCT03426878|559666761|FG000|Overall Study|Lost to Follow-up|177|||
155064104|NCT00869960|559666763|FG000|Overall Study|Lost to Follow-up|2|||
155064105|NCT02921256|559666764|FG000|Arm 1a v. Arm II|Adverse Event|6|||
155064106|NCT02921256|559666765|FG001|Arm 1a v. Arm II|Adverse Event|15|||
155064107|NCT02921256|559666766|FG002|Arm 1a v. Arm II|Adverse Event|0|||
155064108|NCT02921256|559666764|FG000|Arm 1a v. Arm II|Death|0|||
155064109|NCT02921256|559666765|FG001|Arm 1a v. Arm II|Death|2|||
155064110|NCT02921256|559666766|FG002|Arm 1a v. Arm II|Death|0|||
155064111|NCT02921256|559666764|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
155064112|NCT02921256|559666765|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
155064113|NCT02921256|559666766|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
155064114|NCT02921256|559666764|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
155064115|NCT02921256|559666765|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
155064116|NCT02921256|559666766|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
155064117|NCT02921256|559666764|FG000|Arm 1a v. Arm II|Physician Decision|1|||
155064118|NCT02921256|559666765|FG001|Arm 1a v. Arm II|Physician Decision|1|||
155064119|NCT02921256|559666766|FG002|Arm 1a v. Arm II|Physician Decision|0|||
155064120|NCT02921256|559666764|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
155064121|NCT02921256|559666765|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
155064122|NCT02921256|559666766|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
155064123|NCT02921256|559666764|FG000|Arm Ib v Arm III|Adverse Event|9|||
155302676|NCT00603954|560540210|FG000|Overall Study|Protocol Violation|1|||
155064124|NCT02921256|559666765|FG001|Arm Ib v Arm III|Adverse Event|0|||
155064125|NCT02921256|559666766|FG002|Arm Ib v Arm III|Adverse Event|4|||
155064126|NCT02921256|559666764|FG000|Arm Ib v Arm III|Death|1|||
155064127|NCT02921256|559666765|FG001|Arm Ib v Arm III|Death|0|||
155064128|NCT02921256|559666766|FG002|Arm Ib v Arm III|Death|1|||
155064129|NCT02921256|559666764|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
155064130|NCT02921256|559666765|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
155064131|NCT02921256|559666766|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
155064132|NCT02921256|559666764|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
155064133|NCT02921256|559666765|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
155064134|NCT02921256|559666766|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
155064135|NCT02921256|559666764|FG000|Arm Ib v Arm III|Physician Decision|4|||
155064136|NCT02921256|559666765|FG001|Arm Ib v Arm III|Physician Decision|0|||
155064137|NCT02921256|559666766|FG002|Arm Ib v Arm III|Physician Decision|1|||
155064138|NCT02921256|559666764|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
155064139|NCT02921256|559666765|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
155064140|NCT02921256|559666766|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
155064141|NCT00269152|559666768|FG000|Overall Study|Adverse Event|9|||
155064142|NCT00269152|559666769|FG001|Overall Study|Adverse Event|3|||
155064143|NCT00269152|559666768|FG000|Overall Study|Withdrawal by Subject|7|||
155064144|NCT00269152|559666769|FG001|Overall Study|Withdrawal by Subject|3|||
155064145|NCT00269152|559666768|FG000|Overall Study|Physician Decision|2|||
155064146|NCT00269152|559666769|FG001|Overall Study|Physician Decision|3|||
155064147|NCT00269152|559666768|FG000|Overall Study|Protocol Violation|0|||
155064148|NCT00269152|559666769|FG001|Overall Study|Protocol Violation|1|||
155064149|NCT05516758|559666772|FG000|Overall Study|Adverse Event|5|||
155064150|NCT05516758|559666773|FG001|Overall Study|Adverse Event|1|||
155064151|NCT05516758|559666774|FG002|Overall Study|Adverse Event|3|||
155302677|NCT00603954|560540211|FG001|Overall Study|Protocol Violation|2|||
155302678|NCT02708108|560540212|FG000|Overall Study|Death|1|||
155302679|NCT02708108|560540213|FG001|Overall Study|Death|2|||
155302680|NCT02708108|560540212|FG000|Overall Study|Regimen change|1|||
155302681|NCT02708108|560540213|FG001|Overall Study|Regimen change|0|||
155302682|NCT02708108|560540212|FG000|Overall Study|No MRD and no imaging available|0|||
155302683|NCT02708108|560540213|FG001|Overall Study|No MRD and no imaging available|1|||
155302684|NCT05368831|560540214|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
155302685|NCT00419341|560540216|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
155302686|NCT00419341|560540216|FG000|Wash in/Wash Out Period|Adverse Event|2|||
155302687|NCT00419341|560540216|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
155302688|NCT00419341|560540216|FG000|Efficacy Period|Withdrawal by Subject|6|||
155302689|NCT00419341|560540216|FG000|Efficacy Period|Protocol Violation|1|||
155302690|NCT00419341|560540216|FG000|Efficacy Period|Lost to Follow-up|1|||
155064152|NCT05516758|559666775|FG003|Overall Study|Adverse Event|0|||
155064153|NCT05516758|559666776|FG004|Overall Study|Adverse Event|1|||
155064154|NCT05516758|559666777|FG005|Overall Study|Adverse Event|3|||
155064155|NCT05516758|559666778|FG006|Overall Study|Adverse Event|5|||
155064156|NCT05516758|559666772|FG000|Overall Study|Assigned treatment by mistake|1|||
155064157|NCT05516758|559666773|FG001|Overall Study|Assigned treatment by mistake|0|||
155064158|NCT05516758|559666774|FG002|Overall Study|Assigned treatment by mistake|0|||
155302691|NCT00419341|560540216|FG000|Efficacy Period|Non-compliance|1|||
155302692|NCT00419341|560540216|FG000|Efficacy Period|Termination of study site|1|||
155302693|NCT04200365|560540217|FG000|Overall Study|Adverse Event|2|||
155302694|NCT04200365|560540217|FG000|Overall Study|Progressive Disease|4|||
155302695|NCT04200365|560540217|FG000|Overall Study|Lack of Efficacy|1|||
155302696|NCT04200365|560540217|FG000|Overall Study|Study Closure|4|||
155064159|NCT05516758|559666775|FG003|Overall Study|Assigned treatment by mistake|0|||
155064160|NCT05516758|559666776|FG004|Overall Study|Assigned treatment by mistake|1|||
155064161|NCT05516758|559666777|FG005|Overall Study|Assigned treatment by mistake|0|||
155064162|NCT05516758|559666778|FG006|Overall Study|Assigned treatment by mistake|0|||
155064163|NCT05516758|559666772|FG000|Overall Study|Lack of Efficacy|6|||
155064164|NCT05516758|559666773|FG001|Overall Study|Lack of Efficacy|0|||
155302697|NCT03783026|560542617|FG000|Treatment Phase|Adverse Event|15|||
155302698|NCT03783026|560542617|FG000|Treatment Phase|Lack of Efficacy|11|||
155302699|NCT03783026|560542617|FG000|Treatment Phase|Withdrawal by Subject|6|||
155064165|NCT05516758|559666774|FG002|Overall Study|Lack of Efficacy|2|||
155064166|NCT05516758|559666775|FG003|Overall Study|Lack of Efficacy|0|||
155064167|NCT05516758|559666776|FG004|Overall Study|Lack of Efficacy|3|||
155064168|NCT05516758|559666777|FG005|Overall Study|Lack of Efficacy|6|||
155064169|NCT05516758|559666778|FG006|Overall Study|Lack of Efficacy|3|||
155302700|NCT03783026|560542617|FG000|Treatment Phase|Lost to Follow-up|2|||
155064170|NCT05516758|559666772|FG000|Overall Study|Lost to Follow-up|2|||
155064171|NCT05516758|559666773|FG001|Overall Study|Lost to Follow-up|0|||
155064172|NCT05516758|559666774|FG002|Overall Study|Lost to Follow-up|2|||
155064173|NCT05516758|559666775|FG003|Overall Study|Lost to Follow-up|0|||
155064174|NCT05516758|559666776|FG004|Overall Study|Lost to Follow-up|3|||
155064175|NCT05516758|559666777|FG005|Overall Study|Lost to Follow-up|2|||
155064176|NCT05516758|559666778|FG006|Overall Study|Lost to Follow-up|1|||
155064177|NCT05516758|559666772|FG000|Overall Study|Other- As reported by the site|2|||
155302701|NCT03783026|560542617|FG000|Treatment Phase|Protocol Deviation|8|||
155302702|NCT03783026|560542617|FG000|Treatment Phase|Did Not Receive Treatment|1|||
155302703|NCT03783026|560542617|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
155302704|NCT04814186|560542618|FG000|Treatment Phase|Adverse Event|1|||
155302705|NCT04814186|560542618|FG000|Treatment Phase|Death|6|||
155064178|NCT05516758|559666773|FG001|Overall Study|Other- As reported by the site|1|||
155064179|NCT05516758|559666774|FG002|Overall Study|Other- As reported by the site|8|||
155064180|NCT05516758|559666775|FG003|Overall Study|Other- As reported by the site|1|||
155064181|NCT05516758|559666776|FG004|Overall Study|Other- As reported by the site|2|||
155064182|NCT05516758|559666777|FG005|Overall Study|Other- As reported by the site|3|||
155064183|NCT05516758|559666778|FG006|Overall Study|Other- As reported by the site|8|||
155064184|NCT05516758|559666772|FG000|Overall Study|Physician Decision|1|||
155064185|NCT05516758|559666773|FG001|Overall Study|Physician Decision|0|||
155064186|NCT05516758|559666774|FG002|Overall Study|Physician Decision|7|||
155064187|NCT05516758|559666775|FG003|Overall Study|Physician Decision|0|||
155064188|NCT05516758|559666776|FG004|Overall Study|Physician Decision|1|||
155064189|NCT05516758|559666777|FG005|Overall Study|Physician Decision|1|||
155064190|NCT05516758|559666778|FG006|Overall Study|Physician Decision|2|||
155064191|NCT05516758|559666772|FG000|Overall Study|Protocol Deviation|1|||
155064192|NCT05516758|559666773|FG001|Overall Study|Protocol Deviation|0|||
155064193|NCT05516758|559666774|FG002|Overall Study|Protocol Deviation|0|||
155064194|NCT05516758|559666775|FG003|Overall Study|Protocol Deviation|0|||
155064195|NCT05516758|559666776|FG004|Overall Study|Protocol Deviation|0|||
155064196|NCT05516758|559666777|FG005|Overall Study|Protocol Deviation|1|||
155064197|NCT05516758|559666778|FG006|Overall Study|Protocol Deviation|5|||
155064198|NCT05516758|559666772|FG000|Overall Study|Withdrawal by Subject|11|||
155064199|NCT05516758|559666773|FG001|Overall Study|Withdrawal by Subject|1|||
155064200|NCT05516758|559666774|FG002|Overall Study|Withdrawal by Subject|15|||
155064201|NCT05516758|559666775|FG003|Overall Study|Withdrawal by Subject|2|||
155064202|NCT05516758|559666776|FG004|Overall Study|Withdrawal by Subject|7|||
155064203|NCT05516758|559666777|FG005|Overall Study|Withdrawal by Subject|7|||
155064204|NCT05516758|559666778|FG006|Overall Study|Withdrawal by Subject|6|||
155064205|NCT05516758|559666772|FG000|Overall Study|Death|1|||
155064206|NCT05516758|559666773|FG001|Overall Study|Death|0|||
155064207|NCT05516758|559666774|FG002|Overall Study|Death|0|||
155064208|NCT05516758|559666775|FG003|Overall Study|Death|0|||
155064209|NCT05516758|559666776|FG004|Overall Study|Death|0|||
155064210|NCT05516758|559666777|FG005|Overall Study|Death|0|||
155064211|NCT05516758|559666778|FG006|Overall Study|Death|0|||
155064212|NCT05516758|559666772|FG000|Overall Study|Non-compliance With Study Drug|0|||
155064213|NCT05516758|559666773|FG001|Overall Study|Non-compliance With Study Drug|0|||
155064214|NCT05516758|559666774|FG002|Overall Study|Non-compliance With Study Drug|1|||
155064215|NCT05516758|559666775|FG003|Overall Study|Non-compliance With Study Drug|0|||
155064216|NCT05516758|559666776|FG004|Overall Study|Non-compliance With Study Drug|0|||
155064217|NCT05516758|559666777|FG005|Overall Study|Non-compliance With Study Drug|0|||
155064218|NCT05516758|559666778|FG006|Overall Study|Non-compliance With Study Drug|0|||
155064219|NCT05516758|559666772|FG000|Overall Study|Site Terminated by Sponsor|2|||
155064220|NCT05516758|559666773|FG001|Overall Study|Site Terminated by Sponsor|0|||
155064221|NCT05516758|559666774|FG002|Overall Study|Site Terminated by Sponsor|0|||
155064222|NCT05516758|559666775|FG003|Overall Study|Site Terminated by Sponsor|0|||
155064223|NCT05516758|559666776|FG004|Overall Study|Site Terminated by Sponsor|0|||
155064224|NCT05516758|559666777|FG005|Overall Study|Site Terminated by Sponsor|0|||
155064225|NCT05516758|559666778|FG006|Overall Study|Site Terminated by Sponsor|0|||
155064226|NCT05516758|559666772|FG000|Overall Study|Study Terminated by Sponsor|4|||
155064227|NCT05516758|559666773|FG001|Overall Study|Study Terminated by Sponsor|0|||
155160694|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Transplant|0|||
155160695|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
155160696|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
155160697|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
155160698|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
155160699|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
155160700|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
155160701|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
155160702|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
155160703|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
155160704|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
155160705|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
155160706|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
155160707|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
155160708|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
155160709|NCT02113982|560026675|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
155160710|NCT02113982|560026676|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
155160711|NCT02113982|560026677|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
155160712|NCT02113982|560026678|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
155064228|NCT05516758|559666774|FG002|Overall Study|Study Terminated by Sponsor|3|||
155064229|NCT05516758|559666775|FG003|Overall Study|Study Terminated by Sponsor|0|||
155160713|NCT02113982|560026679|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
155160714|NCT02113982|560026680|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
155160715|NCT02113982|560026681|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
155064230|NCT05516758|559666776|FG004|Overall Study|Study Terminated by Sponsor|2|||
155064231|NCT05516758|559666777|FG005|Overall Study|Study Terminated by Sponsor|3|||
155064232|NCT05516758|559666778|FG006|Overall Study|Study Terminated by Sponsor|0|||
155064233|NCT05516758|559666772|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
155064234|NCT05516758|559666773|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
155064235|NCT05516758|559666774|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
155064236|NCT05516758|559666775|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
155064237|NCT05516758|559666776|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
155064238|NCT05516758|559666777|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
155064239|NCT05516758|559666778|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
155064240|NCT05516758|559666772|FG000|Overall Study|Other|0|||
155064241|NCT05516758|559666773|FG001|Overall Study|Other|0|||
155064242|NCT05516758|559666774|FG002|Overall Study|Other|0|||
155064243|NCT05516758|559666775|FG003|Overall Study|Other|0|||
155064244|NCT05516758|559666776|FG004|Overall Study|Other|0|||
155064245|NCT05516758|559666777|FG005|Overall Study|Other|0|||
155302706|NCT04814186|560542618|FG000|Treatment Phase|Withdrawal by Subject|2|||
155302707|NCT04814186|560542618|FG000|Treatment Phase|Other|1|||
155302708|NCT04814186|560542618|FG000|Follow-Up Phase|Adverse Event|1|||
155064246|NCT05516758|559666778|FG006|Overall Study|Other|1|||
155302709|NCT04814186|560542618|FG000|Follow-Up Phase|Death|6|||
155064247|NCT00671788|559666781|FG000|Overall Study|Adverse Event|8|||
155064248|NCT00671788|559666781|FG000|Overall Study|Refused further treatment|3|||
155064249|NCT00671788|559666781|FG000|Overall Study|Ineligible|1|||
155064250|NCT00671788|559666781|FG000|Overall Study|MD Decision|1|||
155064251|NCT00671788|559666781|FG000|Overall Study|Other|1|||
155064252|NCT01035138|559666782|FG000|Overall Study|Adverse Event|4|||
155064253|NCT01035138|559666783|FG001|Overall Study|Adverse Event|0|||
155064254|NCT01035138|559666784|FG002|Overall Study|Adverse Event|2|||
155064255|NCT01035138|559666782|FG000|Overall Study|Caregiver Decision|2|||
155064256|NCT01035138|559666783|FG001|Overall Study|Caregiver Decision|0|||
155064257|NCT01035138|559666784|FG002|Overall Study|Caregiver Decision|1|||
155064258|NCT01035138|559666782|FG000|Overall Study|Withdrawal by Subject|1|||
155064259|NCT01035138|559666783|FG001|Overall Study|Withdrawal by Subject|0|||
155064260|NCT01035138|559666784|FG002|Overall Study|Withdrawal by Subject|0|||
155064261|NCT01035138|559666782|FG000|Overall Study|Physician Decision|0|||
155064262|NCT01035138|559666783|FG001|Overall Study|Physician Decision|0|||
155064263|NCT01035138|559666784|FG002|Overall Study|Physician Decision|1|||
155064264|NCT01035138|559666782|FG000|Overall Study|Sponsor Decision|66|||
155064265|NCT01035138|559666783|FG001|Overall Study|Sponsor Decision|60|||
155064266|NCT01035138|559666784|FG002|Overall Study|Sponsor Decision|42|||
155064267|NCT01035138|559666782|FG000|Overall Study|Lost to Follow-up|0|||
155064268|NCT01035138|559666783|FG001|Overall Study|Lost to Follow-up|0|||
155064269|NCT01035138|559666784|FG002|Overall Study|Lost to Follow-up|1|||
155064270|NCT00655889|559666785|FG000|Overall Study|Inadequate cell growth|1|||
155064271|NCT00655889|559666785|FG000|Overall Study|Protocol Violation|1|||
155064272|NCT04739800|559666786|FG000|Overall Study|Adverse Event|2|||
155064273|NCT04739800|559666787|FG001|Overall Study|Adverse Event|1|||
155064274|NCT04739800|559666788|FG002|Overall Study|Adverse Event|4|||
155064275|NCT04739800|559666789|FG003|Overall Study|Adverse Event|5|||
155064276|NCT04739800|559666786|FG000|Overall Study|Never Treated|2|||
155064277|NCT04739800|559666787|FG001|Overall Study|Never Treated|0|||
155064278|NCT04739800|559666788|FG002|Overall Study|Never Treated|1|||
155064279|NCT04739800|559666789|FG003|Overall Study|Never Treated|1|||
155064280|NCT04739800|559666786|FG000|Overall Study|On Treatment|5|||
155064281|NCT04739800|559666787|FG001|Overall Study|On Treatment|9|||
155302710|NCT04814186|560542618|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
155302711|NCT04814186|560542618|FG000|Follow-Up Phase|Other|1|||
155302712|NCT01853748|560542621|FG000|Allocation|Withdrawal by Subject|1|||
155302713|NCT01853748|560542622|FG001|Allocation|Withdrawal by Subject|13|||
155302714|NCT01853748|560542621|FG000|Allocation|not sufficient to receive intervention|0|||
155302715|NCT01853748|560542622|FG001|Allocation|not sufficient to receive intervention|1|||
155302716|NCT01853748|560542621|FG000|Follow-Up|Withdrawal by Subject|7|||
155302717|NCT01853748|560542622|FG001|Follow-Up|Withdrawal by Subject|6|||
155302718|NCT01853748|560542621|FG000|Follow-Up|Adverse Event|67|||
155302719|NCT01853748|560542622|FG001|Follow-Up|Adverse Event|7|||
155302720|NCT01853748|560542621|FG000|Follow-Up|not available for data collection|16|||
155064282|NCT04739800|559666788|FG002|Overall Study|On Treatment|9|||
155302721|NCT01853748|560542622|FG001|Follow-Up|not available for data collection|4|||
155302722|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
155064283|NCT04739800|559666789|FG003|Overall Study|On Treatment|9|||
155064284|NCT04739800|559666786|FG000|Overall Study|Symptomatic Deterioration|1|||
155064285|NCT04739800|559666787|FG001|Overall Study|Symptomatic Deterioration|1|||
155064286|NCT04739800|559666788|FG002|Overall Study|Symptomatic Deterioration|3|||
155064287|NCT04739800|559666789|FG003|Overall Study|Symptomatic Deterioration|0|||
155064288|NCT04739800|559666786|FG000|Overall Study|Withdrawal by Subject|1|||
155064289|NCT04739800|559666787|FG001|Overall Study|Withdrawal by Subject|2|||
155302723|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
155064290|NCT04739800|559666788|FG002|Overall Study|Withdrawal by Subject|1|||
155160716|NCT02113982|560026682|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
155160717|NCT02113982|560026683|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
155160718|NCT02113982|560026684|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
155160719|NCT02113982|560026685|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
155160720|NCT02113982|560026686|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
155160721|NCT02113982|560026687|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
155160722|NCT02113982|560026688|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
155160723|NCT02113982|560026675|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160724|NCT02113982|560026676|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160725|NCT02113982|560026677|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160726|NCT02113982|560026678|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160727|NCT02113982|560026679|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160728|NCT02113982|560026680|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160729|NCT02113982|560026681|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160730|NCT02113982|560026682|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160731|NCT02113982|560026683|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160732|NCT02113982|560026684|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160733|NCT02113982|560026685|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160734|NCT02113982|560026686|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
155160735|NCT02113982|560026687|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160736|NCT02113982|560026688|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
155160737|NCT02113982|560026675|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160738|NCT02113982|560026676|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160739|NCT02113982|560026677|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160740|NCT02113982|560026678|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160741|NCT02113982|560026679|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160742|NCT02113982|560026680|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160743|NCT02113982|560026681|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
155064291|NCT04739800|559666789|FG003|Overall Study|Withdrawal by Subject|3|||
155064292|NCT04739800|559666786|FG000|Overall Study|Other Reason|1|||
155064293|NCT04739800|559666787|FG001|Overall Study|Other Reason|3|||
155064294|NCT04739800|559666788|FG002|Overall Study|Other Reason|5|||
155064295|NCT04739800|559666789|FG003|Overall Study|Other Reason|4|||
155064296|NCT03415178|559666791|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
155064297|NCT03415178|559666792|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
155064298|NCT03415178|559666791|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
155064299|NCT03415178|559666792|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
155064300|NCT02273167|559666796|FG000|Overall Study|Adverse Event|1|||
155302724|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
155302725|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
155302726|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
155302727|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
155302728|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
155302729|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
155160744|NCT02113982|560026682|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160745|NCT02113982|560026683|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
155064301|NCT02273167|559666797|FG001|Overall Study|Adverse Event|0|||
155064302|NCT02273167|559666798|FG002|Overall Study|Adverse Event|0|||
155064303|NCT02273167|559666796|FG000|Overall Study|Protocol Violation|3|||
155064304|NCT02273167|559666797|FG001|Overall Study|Protocol Violation|1|||
155064305|NCT02273167|559666798|FG002|Overall Study|Protocol Violation|1|||
155064306|NCT02273167|559666796|FG000|Overall Study|Lost to Follow-up|0|||
155064307|NCT02273167|559666797|FG001|Overall Study|Lost to Follow-up|1|||
155064308|NCT02273167|559666798|FG002|Overall Study|Lost to Follow-up|1|||
155064309|NCT02273167|559666796|FG000|Overall Study|Withdrawal by Subject|10|||
155064310|NCT02273167|559666797|FG001|Overall Study|Withdrawal by Subject|12|||
155064311|NCT02273167|559666798|FG002|Overall Study|Withdrawal by Subject|11|||
155064312|NCT02273167|559666796|FG000|Overall Study|Various|10|||
155064313|NCT02273167|559666797|FG001|Overall Study|Various|9|||
155064314|NCT02273167|559666798|FG002|Overall Study|Various|8|||
155064315|NCT01416571|559666805|FG000|Overall Study|Lost to Follow-up|2|||
155064316|NCT03353220|559666811|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
155064317|NCT03353220|559666812|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
155064318|NCT00661388|559666821|FG000|Overall Study|Adverse Event|14|||
155160746|NCT02113982|560026684|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160747|NCT02113982|560026685|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
155064319|NCT00661388|559666821|FG000|Overall Study|Protocol Violation|7|||
155160748|NCT02113982|560026686|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
155064320|NCT00661388|559666821|FG000|Overall Study|Renal transplantation|1|||
155064321|NCT00661388|559666821|FG000|Overall Study|Dialysis initiation|1|||
155160749|NCT02113982|560026687|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
155160750|NCT02113982|560026688|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
155302730|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
155064322|NCT00661388|559666821|FG000|Overall Study|Administrative reasons|1|||
155064323|NCT01288430|559668391|FG000|Part 1|Progressive disease|2|||
155064324|NCT01288430|559668392|FG001|Part 1|Progressive disease|1|||
155064325|NCT01288430|559668393|FG002|Part 1|Progressive disease|1|||
155064326|NCT01288430|559668394|FG003|Part 1|Progressive disease|6|||
155064327|NCT01288430|559668395|FG004|Part 1|Progressive disease|2|||
155064328|NCT01288430|559668396|FG005|Part 1|Progressive disease|4|||
155064329|NCT01288430|559668397|FG006|Part 1|Progressive disease|2|||
155064330|NCT01288430|559668398|FG007|Part 1|Progressive disease|0|||
155064331|NCT01288430|559668399|FG008|Part 1|Progressive disease|0|||
155064332|NCT01288430|559668400|FG009|Part 1|Progressive disease|0|||
155064333|NCT01288430|559668391|FG000|Part 1|Clinical disease progression|0|||
155064334|NCT01288430|559668392|FG001|Part 1|Clinical disease progression|0|||
155064335|NCT01288430|559668393|FG002|Part 1|Clinical disease progression|1|||
155064336|NCT01288430|559668394|FG003|Part 1|Clinical disease progression|0|||
155064337|NCT01288430|559668395|FG004|Part 1|Clinical disease progression|0|||
155064338|NCT01288430|559668396|FG005|Part 1|Clinical disease progression|2|||
155064339|NCT01288430|559668397|FG006|Part 1|Clinical disease progression|2|||
155064340|NCT01288430|559668398|FG007|Part 1|Clinical disease progression|0|||
155064341|NCT01288430|559668399|FG008|Part 1|Clinical disease progression|0|||
155064342|NCT01288430|559668400|FG009|Part 1|Clinical disease progression|0|||
155064343|NCT01288430|559668391|FG000|Part 1|Death due to disease progression|0|||
155064344|NCT01288430|559668392|FG001|Part 1|Death due to disease progression|0|||
155064345|NCT01288430|559668393|FG002|Part 1|Death due to disease progression|0|||
155064346|NCT01288430|559668394|FG003|Part 1|Death due to disease progression|0|||
155064347|NCT01288430|559668395|FG004|Part 1|Death due to disease progression|1|||
155064348|NCT01288430|559668396|FG005|Part 1|Death due to disease progression|0|||
155064349|NCT01288430|559668397|FG006|Part 1|Death due to disease progression|0|||
155064350|NCT01288430|559668398|FG007|Part 1|Death due to disease progression|0|||
155064351|NCT01288430|559668399|FG008|Part 1|Death due to disease progression|0|||
155064352|NCT01288430|559668400|FG009|Part 1|Death due to disease progression|0|||
155064353|NCT01288430|559668391|FG000|Part 1|Adverse Event|0|||
155064354|NCT01288430|559668392|FG001|Part 1|Adverse Event|0|||
155064355|NCT01288430|559668393|FG002|Part 1|Adverse Event|3|||
155064356|NCT01288430|559668394|FG003|Part 1|Adverse Event|1|||
155064357|NCT01288430|559668395|FG004|Part 1|Adverse Event|0|||
155064358|NCT01288430|559668396|FG005|Part 1|Adverse Event|0|||
155064359|NCT01288430|559668397|FG006|Part 1|Adverse Event|2|||
155064360|NCT01288430|559668398|FG007|Part 1|Adverse Event|0|||
155064361|NCT01288430|559668399|FG008|Part 1|Adverse Event|0|||
155064362|NCT01288430|559668400|FG009|Part 1|Adverse Event|0|||
155064363|NCT01288430|559668391|FG000|Part 1|Other|0|||
155064364|NCT01288430|559668392|FG001|Part 1|Other|2|||
155064365|NCT01288430|559668393|FG002|Part 1|Other|0|||
155064366|NCT01288430|559668394|FG003|Part 1|Other|0|||
155064367|NCT01288430|559668395|FG004|Part 1|Other|0|||
155064368|NCT01288430|559668396|FG005|Part 1|Other|0|||
155064369|NCT01288430|559668397|FG006|Part 1|Other|1|||
155064370|NCT01288430|559668398|FG007|Part 1|Other|0|||
155064371|NCT01288430|559668399|FG008|Part 1|Other|0|||
155064372|NCT01288430|559668400|FG009|Part 1|Other|0|||
155064373|NCT01288430|559668391|FG000|Part 2|Progressive disease|0|||
155064374|NCT01288430|559668392|FG001|Part 2|Progressive disease|0|||
155064375|NCT01288430|559668393|FG002|Part 2|Progressive disease|0|||
155064376|NCT01288430|559668394|FG003|Part 2|Progressive disease|0|||
155064377|NCT01288430|559668395|FG004|Part 2|Progressive disease|0|||
155064378|NCT01288430|559668396|FG005|Part 2|Progressive disease|0|||
155064379|NCT01288430|559668397|FG006|Part 2|Progressive disease|0|||
155064380|NCT01288430|559668398|FG007|Part 2|Progressive disease|8|||
155064381|NCT01288430|559668399|FG008|Part 2|Progressive disease|7|||
155064382|NCT01288430|559668400|FG009|Part 2|Progressive disease|2|||
155064383|NCT01288430|559668391|FG000|Part 2|Clinical disease progression|0|||
155064384|NCT01288430|559668392|FG001|Part 2|Clinical disease progression|0|||
155064385|NCT01288430|559668393|FG002|Part 2|Clinical disease progression|0|||
155064386|NCT01288430|559668394|FG003|Part 2|Clinical disease progression|0|||
155064387|NCT01288430|559668395|FG004|Part 2|Clinical disease progression|0|||
155064388|NCT01288430|559668396|FG005|Part 2|Clinical disease progression|0|||
155064389|NCT01288430|559668397|FG006|Part 2|Clinical disease progression|0|||
155064390|NCT01288430|559668398|FG007|Part 2|Clinical disease progression|2|||
155064391|NCT01288430|559668399|FG008|Part 2|Clinical disease progression|0|||
155064392|NCT01288430|559668400|FG009|Part 2|Clinical disease progression|0|||
155064393|NCT01288430|559668391|FG000|Part 2|Withdrawal by Subject|0|||
155064394|NCT01288430|559668392|FG001|Part 2|Withdrawal by Subject|0|||
155064395|NCT01288430|559668393|FG002|Part 2|Withdrawal by Subject|0|||
155064396|NCT01288430|559668394|FG003|Part 2|Withdrawal by Subject|0|||
155064397|NCT01288430|559668395|FG004|Part 2|Withdrawal by Subject|0|||
155064398|NCT01288430|559668396|FG005|Part 2|Withdrawal by Subject|0|||
155064399|NCT01288430|559668397|FG006|Part 2|Withdrawal by Subject|0|||
155064400|NCT01288430|559668398|FG007|Part 2|Withdrawal by Subject|1|||
155064401|NCT01288430|559668399|FG008|Part 2|Withdrawal by Subject|4|||
155064402|NCT01288430|559668400|FG009|Part 2|Withdrawal by Subject|0|||
155064403|NCT01288430|559668391|FG000|Part 2|Adverse Event|0|||
155064404|NCT01288430|559668392|FG001|Part 2|Adverse Event|0|||
155064405|NCT01288430|559668393|FG002|Part 2|Adverse Event|0|||
155064406|NCT01288430|559668394|FG003|Part 2|Adverse Event|0|||
155064407|NCT01288430|559668395|FG004|Part 2|Adverse Event|0|||
155064408|NCT01288430|559668396|FG005|Part 2|Adverse Event|0|||
155064409|NCT01288430|559668397|FG006|Part 2|Adverse Event|0|||
155064410|NCT01288430|559668398|FG007|Part 2|Adverse Event|1|||
155064411|NCT01288430|559668399|FG008|Part 2|Adverse Event|1|||
155064412|NCT01288430|559668400|FG009|Part 2|Adverse Event|0|||
155064413|NCT01288430|559668391|FG000|Part 2|Other|0|||
155064414|NCT01288430|559668392|FG001|Part 2|Other|0|||
155064415|NCT01288430|559668393|FG002|Part 2|Other|0|||
155064416|NCT01288430|559668394|FG003|Part 2|Other|0|||
155064417|NCT01288430|559668395|FG004|Part 2|Other|0|||
155064418|NCT01288430|559668396|FG005|Part 2|Other|0|||
155064419|NCT01288430|559668397|FG006|Part 2|Other|0|||
155064420|NCT01288430|559668398|FG007|Part 2|Other|0|||
155064421|NCT01288430|559668399|FG008|Part 2|Other|0|||
155064422|NCT01288430|559668400|FG009|Part 2|Other|1|||
155064423|NCT05493111|559668401|FG000|Overall Study|Adverse Event|3|||
155064424|NCT05493111|559668402|FG001|Overall Study|Adverse Event|4|||
155064425|NCT05493111|559668401|FG000|Overall Study|Withdrawal of Consent|19|||
155064426|NCT05493111|559668402|FG001|Overall Study|Withdrawal of Consent|10|||
155064427|NCT05493111|559668401|FG000|Overall Study|Non-compliance|1|||
155064428|NCT05493111|559668402|FG001|Overall Study|Non-compliance|1|||
155064429|NCT05493111|559668401|FG000|Overall Study|Lost to Follow-up|8|||
155064430|NCT05493111|559668402|FG001|Overall Study|Lost to Follow-up|1|||
155064431|NCT05493111|559668401|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
155064432|NCT05493111|559668402|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
155064433|NCT05493111|559668401|FG000|Overall Study|Withdrawal by Subject|1|||
155064434|NCT05493111|559668402|FG001|Overall Study|Withdrawal by Subject|1|||
155064435|NCT03836053|559668405|FG000|Overall Study|Protocol-specified criteria|0|||
155064436|NCT03836053|559668406|FG001|Overall Study|Protocol-specified criteria|2|||
155064437|NCT03836053|559668407|FG002|Overall Study|Protocol-specified criteria|1|||
155064438|NCT03836053|559668405|FG000|Overall Study|Death|1|||
155064439|NCT03836053|559668406|FG001|Overall Study|Death|6|||
155064440|NCT03836053|559668407|FG002|Overall Study|Death|4|||
155064441|NCT03836053|559668405|FG000|Overall Study|Withdrawal of consent from study|0|||
155064442|NCT03836053|559668406|FG001|Overall Study|Withdrawal of consent from study|0|||
155064443|NCT03836053|559668407|FG002|Overall Study|Withdrawal of consent from study|1|||
155064444|NCT03836053|559668405|FG000|Overall Study|Decision by sponsor|0|||
155064445|NCT03836053|559668406|FG001|Overall Study|Decision by sponsor|2|||
155064446|NCT03836053|559668407|FG002|Overall Study|Decision by sponsor|4|||
155064447|NCT00788671|559668408|FG000|Overall Study|Death|2|||
155064448|NCT00788671|559668408|FG000|Overall Study|Unable to biopsy|1|||
155064449|NCT00788671|559668408|FG000|Overall Study|Withdrawal by Subject|4|||
155064450|NCT00788671|559668408|FG000|Overall Study|IUD expulsed|1|||
155064451|NCT00788671|559668408|FG000|Overall Study|Lost to follow up|2|||
155064452|NCT04486716|559668409|FG000|Core Phase|Subject decision|6|||
155064453|NCT04486716|559668409|FG000|Core Phase|Adverse Event|5|||
155064454|NCT04486716|559668409|FG000|Core Phase|Lost to Follow-up|1|||
155064455|NCT04486716|559668409|FG000|Core Phase|Physician Decision|1|||
155064456|NCT04486716|559668409|FG000|Core Phase|Enrolled subjects not treated|9|||
155064457|NCT02807259|559668410|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
155064458|NCT02807259|559668411|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
155064459|NCT02807259|559668410|FG000|Midline (3 Months)|migration, refusal, not available|30|||
155064460|NCT02807259|559668411|FG001|Midline (3 Months)|migration, refusal, not available|34|||
155064461|NCT02807259|559668410|FG000|Endline (3 Months)|migration, refusal, not available|35|||
155064462|NCT02807259|559668411|FG001|Endline (3 Months)|migration, refusal, not available|87|||
155064463|NCT02332707|559668412|FG000|Overall Study|Adverse Event|0|||
155064464|NCT02332707|559668413|FG001|Overall Study|Adverse Event|0|||
155064465|NCT02332707|559668414|FG002|Overall Study|Adverse Event|0|||
155064466|NCT02332707|559668415|FG003|Overall Study|Adverse Event|0|||
155064467|NCT02332707|559668416|FG004|Overall Study|Adverse Event|0|||
155064468|NCT02332707|559668417|FG005|Overall Study|Adverse Event|0|||
155064469|NCT02332707|559668418|FG006|Overall Study|Adverse Event|0|||
155064470|NCT02332707|559668419|FG007|Overall Study|Adverse Event|0|||
155064471|NCT02332707|559668420|FG008|Overall Study|Adverse Event|0|||
155064472|NCT02332707|559668421|FG009|Overall Study|Adverse Event|0|||
155064473|NCT02332707|559668422|FG010|Overall Study|Adverse Event|0|||
155064474|NCT02332707|559668423|FG011|Overall Study|Adverse Event|0|||
155064475|NCT02332707|559668424|FG012|Overall Study|Adverse Event|1|||
155064476|NCT02332707|559668425|FG013|Overall Study|Adverse Event|0|||
155064477|NCT02332707|559668426|FG014|Overall Study|Adverse Event|0|||
155064478|NCT02332707|559668427|FG015|Overall Study|Adverse Event|0|||
155064479|NCT02332707|559668428|FG016|Overall Study|Adverse Event|0|||
155064480|NCT02332707|559668429|FG017|Overall Study|Adverse Event|0|||
155064481|NCT02332707|559668412|FG000|Overall Study|Lost to Follow-up|0|||
155064482|NCT02332707|559668413|FG001|Overall Study|Lost to Follow-up|0|||
155064483|NCT02332707|559668414|FG002|Overall Study|Lost to Follow-up|0|||
155064484|NCT02332707|559668415|FG003|Overall Study|Lost to Follow-up|0|||
155064485|NCT02332707|559668416|FG004|Overall Study|Lost to Follow-up|0|||
155064486|NCT02332707|559668417|FG005|Overall Study|Lost to Follow-up|1|||
155064487|NCT02332707|559668418|FG006|Overall Study|Lost to Follow-up|0|||
155064488|NCT02332707|559668419|FG007|Overall Study|Lost to Follow-up|0|||
155064489|NCT02332707|559668420|FG008|Overall Study|Lost to Follow-up|0|||
155064490|NCT02332707|559668421|FG009|Overall Study|Lost to Follow-up|0|||
155064491|NCT02332707|559668422|FG010|Overall Study|Lost to Follow-up|2|||
155064492|NCT02332707|559668423|FG011|Overall Study|Lost to Follow-up|0|||
155064493|NCT02332707|559668424|FG012|Overall Study|Lost to Follow-up|3|||
155064494|NCT02332707|559668425|FG013|Overall Study|Lost to Follow-up|0|||
155064495|NCT02332707|559668426|FG014|Overall Study|Lost to Follow-up|0|||
155064496|NCT02332707|559668427|FG015|Overall Study|Lost to Follow-up|0|||
155064497|NCT02332707|559668428|FG016|Overall Study|Lost to Follow-up|0|||
155064498|NCT02332707|559668429|FG017|Overall Study|Lost to Follow-up|0|||
155064499|NCT02332707|559668412|FG000|Overall Study|Physician Decision|0|||
155064500|NCT02332707|559668413|FG001|Overall Study|Physician Decision|0|||
155064501|NCT02332707|559668414|FG002|Overall Study|Physician Decision|0|||
155064502|NCT02332707|559668415|FG003|Overall Study|Physician Decision|1|||
155064503|NCT02332707|559668416|FG004|Overall Study|Physician Decision|0|||
155064504|NCT02332707|559668417|FG005|Overall Study|Physician Decision|0|||
155064505|NCT02332707|559668418|FG006|Overall Study|Physician Decision|0|||
155064506|NCT02332707|559668419|FG007|Overall Study|Physician Decision|0|||
155064507|NCT02332707|559668420|FG008|Overall Study|Physician Decision|0|||
155064508|NCT02332707|559668421|FG009|Overall Study|Physician Decision|0|||
155064509|NCT02332707|559668422|FG010|Overall Study|Physician Decision|0|||
155064510|NCT02332707|559668423|FG011|Overall Study|Physician Decision|0|||
155064511|NCT02332707|559668424|FG012|Overall Study|Physician Decision|1|||
155064512|NCT02332707|559668425|FG013|Overall Study|Physician Decision|0|||
155064513|NCT02332707|559668426|FG014|Overall Study|Physician Decision|0|||
155064514|NCT02332707|559668427|FG015|Overall Study|Physician Decision|0|||
155064515|NCT02332707|559668428|FG016|Overall Study|Physician Decision|0|||
155064516|NCT02332707|559668429|FG017|Overall Study|Physician Decision|0|||
155064517|NCT02332707|559668412|FG000|Overall Study|Withdrawal by Subject|0|||
155064518|NCT02332707|559668413|FG001|Overall Study|Withdrawal by Subject|0|||
155064519|NCT02332707|559668414|FG002|Overall Study|Withdrawal by Subject|1|||
155064520|NCT02332707|559668415|FG003|Overall Study|Withdrawal by Subject|0|||
155064521|NCT02332707|559668416|FG004|Overall Study|Withdrawal by Subject|0|||
155064522|NCT02332707|559668417|FG005|Overall Study|Withdrawal by Subject|0|||
155064523|NCT02332707|559668418|FG006|Overall Study|Withdrawal by Subject|0|||
155064524|NCT02332707|559668419|FG007|Overall Study|Withdrawal by Subject|0|||
155064525|NCT02332707|559668420|FG008|Overall Study|Withdrawal by Subject|0|||
155064526|NCT02332707|559668421|FG009|Overall Study|Withdrawal by Subject|3|||
155064527|NCT02332707|559668422|FG010|Overall Study|Withdrawal by Subject|0|||
155064528|NCT02332707|559668423|FG011|Overall Study|Withdrawal by Subject|0|||
155064529|NCT02332707|559668424|FG012|Overall Study|Withdrawal by Subject|0|||
155064530|NCT02332707|559668425|FG013|Overall Study|Withdrawal by Subject|0|||
155064531|NCT02332707|559668426|FG014|Overall Study|Withdrawal by Subject|0|||
155064532|NCT02332707|559668427|FG015|Overall Study|Withdrawal by Subject|0|||
155064533|NCT02332707|559668428|FG016|Overall Study|Withdrawal by Subject|0|||
155064534|NCT02332707|559668429|FG017|Overall Study|Withdrawal by Subject|0|||
155064535|NCT01473134|559668430|FG000|Overall Study|Lost to Follow-up|21|||
155064536|NCT01473134|559668431|FG001|Overall Study|Lost to Follow-up|13|||
155064537|NCT01473134|559668430|FG000|Overall Study|Protocol Violation|32|||
155064538|NCT01473134|559668431|FG001|Overall Study|Protocol Violation|19|||
155064539|NCT01473134|559668430|FG000|Overall Study|Withdrawal by Subject|1|||
155064540|NCT01473134|559668431|FG001|Overall Study|Withdrawal by Subject|2|||
155064541|NCT01473134|559668430|FG000|Overall Study|Death|0|||
155064542|NCT01473134|559668431|FG001|Overall Study|Death|1|||
155064543|NCT01473134|559668430|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
155064544|NCT01473134|559668431|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
155064545|NCT04757636|559668438|FG000|Overall Study|Adverse Event|25|||
155064546|NCT04757636|559668439|FG001|Overall Study|Adverse Event|8|||
155064547|NCT04757636|559668440|FG002|Overall Study|Adverse Event|11|||
155064548|NCT04757636|559668438|FG000|Overall Study|Death|9|||
155064549|NCT04757636|559668439|FG001|Overall Study|Death|12|||
155064550|NCT04757636|559668440|FG002|Overall Study|Death|6|||
155064551|NCT04757636|559668438|FG000|Overall Study|Lack of Efficacy|2|||
155064552|NCT04757636|559668439|FG001|Overall Study|Lack of Efficacy|0|||
155064553|NCT04757636|559668440|FG002|Overall Study|Lack of Efficacy|0|||
155064554|NCT04757636|559668438|FG000|Overall Study|Lost to Follow-up|1|||
155064555|NCT04757636|559668439|FG001|Overall Study|Lost to Follow-up|6|||
155064556|NCT04757636|559668440|FG002|Overall Study|Lost to Follow-up|7|||
155064557|NCT04757636|559668438|FG000|Overall Study|Physician Decision|1|||
155064558|NCT04757636|559668439|FG001|Overall Study|Physician Decision|3|||
155064559|NCT04757636|559668440|FG002|Overall Study|Physician Decision|4|||
155064560|NCT04757636|559668438|FG000|Overall Study|Withdrawal by Subject|20|||
155064561|NCT04757636|559668439|FG001|Overall Study|Withdrawal by Subject|23|||
155064562|NCT04757636|559668440|FG002|Overall Study|Withdrawal by Subject|18|||
155064563|NCT04757636|559668438|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
155064564|NCT04757636|559668439|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
155064565|NCT04757636|559668440|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
155064566|NCT04757636|559668438|FG000|Overall Study|Study Terminated by Sponsor|103|||
155064567|NCT04757636|559668439|FG001|Overall Study|Study Terminated by Sponsor|104|||
155064568|NCT04757636|559668440|FG002|Overall Study|Study Terminated by Sponsor|114|||
155064569|NCT04757636|559668438|FG000|Overall Study|Sponsor Decision|0|||
155064570|NCT04757636|559668439|FG001|Overall Study|Sponsor Decision|0|||
155064571|NCT04757636|559668440|FG002|Overall Study|Sponsor Decision|1|||
155064572|NCT04757636|559668438|FG000|Overall Study|Randomized in Error|0|||
155064573|NCT04757636|559668439|FG001|Overall Study|Randomized in Error|0|||
155064574|NCT04757636|559668440|FG002|Overall Study|Randomized in Error|2|||
155064575|NCT01732692|559668441|FG000|Overall Study|Adverse Event|0|||
155064576|NCT01732692|559668442|FG001|Overall Study|Adverse Event|1|||
155064577|NCT01208051|559668445|FG000|Total Enrollment|Withdrawal by Subject|0|||
155064578|NCT01208051|559668446|FG001|Total Enrollment|Withdrawal by Subject|1|||
155064579|NCT01208051|559668447|FG002|Total Enrollment|Withdrawal by Subject|0|||
155064580|NCT01208051|559668448|FG003|Total Enrollment|Withdrawal by Subject|0|||
155064581|NCT01208051|559668449|FG004|Total Enrollment|Withdrawal by Subject|2|||
155064582|NCT01208051|559668445|FG000|Total Enrollment|Brain metastases|0|||
155064583|NCT01208051|559668446|FG001|Total Enrollment|Brain metastases|0|||
155064584|NCT01208051|559668447|FG002|Total Enrollment|Brain metastases|1|||
155064585|NCT01208051|559668448|FG003|Total Enrollment|Brain metastases|0|||
155064586|NCT01208051|559668449|FG004|Total Enrollment|Brain metastases|0|||
155064587|NCT02349386|559668450|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
155064588|NCT02349386|559668451|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
155064589|NCT02349386|559668452|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
155064590|NCT02349386|559668453|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
155064591|NCT02349386|559668450|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
155064592|NCT02349386|559668451|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
155064593|NCT02349386|559668452|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
155064594|NCT02349386|559668453|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
155064595|NCT02349386|559668450|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
155064596|NCT02349386|559668451|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
155064597|NCT02349386|559668452|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
155064598|NCT02349386|559668453|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
155064599|NCT02349386|559668450|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
155064600|NCT02349386|559668451|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
155064601|NCT02349386|559668452|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
155064602|NCT02349386|559668453|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
155064603|NCT02349386|559668450|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
155064604|NCT02349386|559668451|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
155064605|NCT02349386|559668452|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
155064606|NCT02349386|559668453|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
155064607|NCT02349386|559668450|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
155064608|NCT02349386|559668451|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
155064609|NCT02349386|559668452|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
155064610|NCT02349386|559668453|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
155064611|NCT00973973|559668454|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
155064612|NCT00973973|559668455|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
155064613|NCT00973973|559668454|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
155064614|NCT00973973|559668455|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
155064615|NCT00973973|559668454|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
155064616|NCT00973973|559668455|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
155064617|NCT00973973|559668454|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
155064618|NCT00973973|559668455|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
155064619|NCT00973973|559668454|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
155064620|NCT00973973|559668455|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
155064621|NCT00973973|559668454|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
155064622|NCT00973973|559668455|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
155064623|NCT00973973|559668454|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
155064624|NCT00973973|559668455|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
155064625|NCT00973973|559668454|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
155064626|NCT00973973|559668455|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
155064627|NCT00973973|559668454|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
155064628|NCT00973973|559668455|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
155064629|NCT00973973|559668454|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
155064630|NCT00973973|559668455|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
155064631|NCT00973973|559668454|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
155064632|NCT00973973|559668455|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
155064633|NCT00973973|559668454|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
155064634|NCT00973973|559668455|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
155064635|NCT02471339|559668456|FG000|Overall Study|Did not provide follow-up data|2|||
155064636|NCT02471339|559668457|FG001|Overall Study|Did not provide follow-up data|0|||
155064637|NCT06057064|559668458|FG000|Overall Study|Death|2|||
155064638|NCT06057064|559668459|FG001|Overall Study|Death|0|||
155064639|NCT06057064|559668458|FG000|Overall Study|Physician Decision|1|||
155064640|NCT06057064|559668459|FG001|Overall Study|Physician Decision|0|||
155302731|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
155302732|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
155302733|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
155302734|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302735|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
155302736|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
155302737|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302738|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302739|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
155302740|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
155302741|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
155302742|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
155302743|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
155302744|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
155302745|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
155302746|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302747|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
155064641|NCT06057064|559668458|FG000|Overall Study|Withdrawal by Subject|1|||
155064642|NCT06057064|559668459|FG001|Overall Study|Withdrawal by Subject|1|||
155064643|NCT00851591|559668461|FG000|Overall Study|Withdrawal by Subject|2|||
155064644|NCT00851591|559668462|FG001|Overall Study|Withdrawal by Subject|0|||
155064645|NCT02110693|559668465|FG000|Overall Study|Withdrawal by Subject|6|||
155064646|NCT02110693|559668466|FG001|Overall Study|Withdrawal by Subject|7|||
155064647|NCT02110693|559668465|FG000|Overall Study|skipped assessment|15|||
155064648|NCT02110693|559668466|FG001|Overall Study|skipped assessment|18|||
155064649|NCT02110693|559668465|FG000|Overall Study|technical difficulties|6|||
155064650|NCT02110693|559668466|FG001|Overall Study|technical difficulties|4|||
155064651|NCT02110693|559668465|FG000|Overall Study|Other|1|||
155064652|NCT02110693|559668466|FG001|Overall Study|Other|0|||
155064653|NCT00920816|559668467|FG000|Overall Study|Death|116|||
155064654|NCT00920816|559668468|FG001|Overall Study|Death|63|||
155064655|NCT00920816|559668469|FG002|Overall Study|Death|8|||
155064656|NCT00920816|559668470|FG003|Overall Study|Death|3|||
155092604|NCT02164864|559773640|FG001|Overall Study|Other Adverse Event (AE)|32|||
155092605|NCT02164864|559773641|FG002|Overall Study|Other Adverse Event (AE)|49|||
155092606|NCT02164864|559773639|FG000|Overall Study|Protocol Violation|2|||
155092607|NCT02164864|559773640|FG001|Overall Study|Protocol Violation|4|||
155092608|NCT02164864|559773641|FG002|Overall Study|Protocol Violation|1|||
155092609|NCT02164864|559773639|FG000|Overall Study|Lost to Follow-up|4|||
155092610|NCT02164864|559773640|FG001|Overall Study|Lost to Follow-up|3|||
155092611|NCT02164864|559773641|FG002|Overall Study|Lost to Follow-up|2|||
155092612|NCT02164864|559773639|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
155092613|NCT02164864|559773640|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
155092614|NCT02164864|559773641|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
155092615|NCT02164864|559773639|FG000|Overall Study|Other than stated|3|||
155092616|NCT02164864|559773640|FG001|Overall Study|Other than stated|4|||
155092617|NCT02164864|559773641|FG002|Overall Study|Other than stated|14|||
155092618|NCT00320606|559773642|FG000|Overall Study|Adverse Event|1|||
155092619|NCT00320606|559773642|FG000|Overall Study|Protocol Violation|1|||
155092620|NCT00320606|559773642|FG000|Overall Study|Withdrawal by Subject|1|||
155092621|NCT03984825|559773643|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
155092622|NCT03984825|559773643|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
155092623|NCT03984825|559773643|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
155092624|NCT00261833|559773644|FG000|Overall Study|Death|1|||
155092625|NCT00261833|559773645|FG001|Overall Study|Death|3|||
155092626|NCT00261833|559773644|FG000|Overall Study|Adverse Event|1|||
155092627|NCT00261833|559773645|FG001|Overall Study|Adverse Event|4|||
155092628|NCT00261833|559773644|FG000|Overall Study|Withdrawal by Subject|5|||
155064657|NCT00920816|559668467|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
155064658|NCT00920816|559668468|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
155064659|NCT00920816|559668469|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
155064660|NCT00920816|559668470|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
155064661|NCT00920816|559668467|FG000|Overall Study|Global deterioration of health status|2|||
155064662|NCT00920816|559668468|FG001|Overall Study|Global deterioration of health status|0|||
155064663|NCT00920816|559668469|FG002|Overall Study|Global deterioration of health status|0|||
155064664|NCT00920816|559668470|FG003|Overall Study|Global deterioration of health status|0|||
155064665|NCT00920816|559668467|FG000|Overall Study|Objective progression or relapse|6|||
155064666|NCT00920816|559668468|FG001|Overall Study|Objective progression or relapse|2|||
155064667|NCT00920816|559668469|FG002|Overall Study|Objective progression or relapse|0|||
155064668|NCT00920816|559668470|FG003|Overall Study|Objective progression or relapse|0|||
155064669|NCT00920816|559668467|FG000|Overall Study|Other|26|||
155064670|NCT00920816|559668468|FG001|Overall Study|Other|15|||
155064671|NCT00920816|559668469|FG002|Overall Study|Other|1|||
155064672|NCT00920816|559668470|FG003|Overall Study|Other|2|||
155064673|NCT00920816|559668467|FG000|Overall Study|Lost to Follow-up|11|||
155064674|NCT00920816|559668468|FG001|Overall Study|Lost to Follow-up|2|||
155064675|NCT00920816|559668469|FG002|Overall Study|Lost to Follow-up|0|||
155064676|NCT00920816|559668470|FG003|Overall Study|Lost to Follow-up|0|||
155064677|NCT00920816|559668467|FG000|Overall Study|Adverse Event|1|||
155064678|NCT00920816|559668468|FG001|Overall Study|Adverse Event|1|||
155064679|NCT00920816|559668469|FG002|Overall Study|Adverse Event|1|||
155064680|NCT00920816|559668470|FG003|Overall Study|Adverse Event|0|||
155064681|NCT00920816|559668467|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
155064682|NCT00920816|559668468|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
155064683|NCT00920816|559668469|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
155064684|NCT00920816|559668470|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
155064685|NCT00920816|559668467|FG000|Overall Study|Randomized but not treated|3|||
155064686|NCT00920816|559668468|FG001|Overall Study|Randomized but not treated|0|||
155064687|NCT00920816|559668469|FG002|Overall Study|Randomized but not treated|0|||
155064688|NCT00920816|559668470|FG003|Overall Study|Randomized but not treated|0|||
155064689|NCT01180777|559668471|FG000|Overall Study|Protocol Violation|6|||
155064690|NCT01180777|559668471|FG000|Overall Study|Poor lens fit|4|||
155064691|NCT01180777|559668471|FG000|Overall Study|Lost to Follow-up|1|||
155064692|NCT01180777|559668471|FG000|Overall Study|Adverse Event|1|||
155064693|NCT04167462|559668472|FG000|Overall Study|Other reasons|3|||
155064694|NCT04167462|559668473|FG001|Overall Study|Other reasons|2|||
155064695|NCT04167462|559668472|FG000|Overall Study|Withdrawal by Subject|6|||
155064696|NCT04167462|559668473|FG001|Overall Study|Withdrawal by Subject|7|||
155064697|NCT04167462|559668472|FG000|Overall Study|Adverse Event|4|||
155064698|NCT04167462|559668473|FG001|Overall Study|Adverse Event|0|||
155064699|NCT04167462|559668472|FG000|Overall Study|Pregnancy|1|||
155064700|NCT04167462|559668473|FG001|Overall Study|Pregnancy|0|||
155064701|NCT04167462|559668472|FG000|Overall Study|Lack of Efficacy|0|||
155064702|NCT04167462|559668473|FG001|Overall Study|Lack of Efficacy|1|||
155064703|NCT02765165|559668474|FG000|Treatment Period|Progressive disease|3|||
155064704|NCT02765165|559668475|FG001|Treatment Period|Progressive disease|2|||
155064705|NCT02765165|559668476|FG002|Treatment Period|Progressive disease|3|||
155064706|NCT02765165|559668477|FG003|Treatment Period|Progressive disease|3|||
155064707|NCT02765165|559668478|FG004|Treatment Period|Progressive disease|4|||
155064708|NCT02765165|559668479|FG005|Treatment Period|Progressive disease|2|||
155064709|NCT02765165|559668480|FG006|Treatment Period|Progressive disease|2|||
155064710|NCT02765165|559668474|FG000|Treatment Period|Physician Decision|0|||
155064711|NCT02765165|559668475|FG001|Treatment Period|Physician Decision|1|||
155064712|NCT02765165|559668476|FG002|Treatment Period|Physician Decision|0|||
155064713|NCT02765165|559668477|FG003|Treatment Period|Physician Decision|0|||
155064714|NCT02765165|559668478|FG004|Treatment Period|Physician Decision|0|||
155064715|NCT02765165|559668479|FG005|Treatment Period|Physician Decision|0|||
155064716|NCT02765165|559668480|FG006|Treatment Period|Physician Decision|0|||
155064717|NCT02765165|559668474|FG000|Treatment Period|Adverse Event|0|||
155064718|NCT02765165|559668475|FG001|Treatment Period|Adverse Event|1|||
155064719|NCT02765165|559668476|FG002|Treatment Period|Adverse Event|0|||
155064720|NCT02765165|559668477|FG003|Treatment Period|Adverse Event|0|||
155064721|NCT02765165|559668478|FG004|Treatment Period|Adverse Event|0|||
155064722|NCT02765165|559668479|FG005|Treatment Period|Adverse Event|0|||
155064723|NCT02765165|559668480|FG006|Treatment Period|Adverse Event|0|||
155160751|NCT02113982|560026675|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155064724|NCT02765165|559668474|FG000|Treatment Period|Withdrawal by Subject|0|||
155064725|NCT02765165|559668475|FG001|Treatment Period|Withdrawal by Subject|0|||
155064726|NCT02765165|559668476|FG002|Treatment Period|Withdrawal by Subject|0|||
155064727|NCT02765165|559668477|FG003|Treatment Period|Withdrawal by Subject|0|||
155064728|NCT02765165|559668478|FG004|Treatment Period|Withdrawal by Subject|2|||
155064729|NCT02765165|559668479|FG005|Treatment Period|Withdrawal by Subject|0|||
155064730|NCT02765165|559668480|FG006|Treatment Period|Withdrawal by Subject|0|||
155064731|NCT02765165|559668474|FG000|Treatment Period|Study terminated|0|||
155064732|NCT02765165|559668475|FG001|Treatment Period|Study terminated|0|||
155064733|NCT02765165|559668476|FG002|Treatment Period|Study terminated|0|||
155064734|NCT02765165|559668477|FG003|Treatment Period|Study terminated|0|||
155064735|NCT02765165|559668478|FG004|Treatment Period|Study terminated|0|||
155064736|NCT02765165|559668479|FG005|Treatment Period|Study terminated|1|||
155064737|NCT02765165|559668480|FG006|Treatment Period|Study terminated|2|||
155064738|NCT02765165|559668474|FG000|Post-treatment Follow-up|Death|1|||
155064739|NCT02765165|559668475|FG001|Post-treatment Follow-up|Death|2|||
155064740|NCT02765165|559668476|FG002|Post-treatment Follow-up|Death|1|||
155064741|NCT02765165|559668477|FG003|Post-treatment Follow-up|Death|1|||
155064742|NCT02765165|559668478|FG004|Post-treatment Follow-up|Death|1|||
155064743|NCT02765165|559668479|FG005|Post-treatment Follow-up|Death|1|||
155064744|NCT02765165|559668480|FG006|Post-treatment Follow-up|Death|0|||
155064745|NCT02765165|559668474|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
155064746|NCT02765165|559668475|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
155064747|NCT02765165|559668476|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
155064748|NCT02765165|559668477|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
155064749|NCT02765165|559668478|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
155064750|NCT02765165|559668479|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
155064751|NCT02765165|559668480|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
155064752|NCT02765165|559668474|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
155064753|NCT02765165|559668475|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
155064754|NCT02765165|559668476|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
155064755|NCT02765165|559668477|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
155064756|NCT02765165|559668478|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
155064757|NCT02765165|559668479|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
155064758|NCT02765165|559668480|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
155064759|NCT02765165|559668474|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155064760|NCT02765165|559668475|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155064761|NCT02765165|559668476|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
155064762|NCT02765165|559668477|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
155064763|NCT02765165|559668478|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155064764|NCT02765165|559668479|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155160752|NCT02113982|560026676|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160753|NCT02113982|560026677|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160754|NCT02113982|560026678|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160755|NCT02113982|560026679|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160756|NCT02113982|560026680|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160757|NCT02113982|560026681|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160758|NCT02113982|560026682|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160759|NCT02113982|560026683|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160760|NCT02113982|560026684|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160761|NCT02113982|560026685|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160762|NCT02113982|560026686|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
155160763|NCT02113982|560026687|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160764|NCT02113982|560026688|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
155160765|NCT02113982|560026675|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
155160766|NCT02113982|560026676|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
155160767|NCT02113982|560026677|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
155160768|NCT02113982|560026678|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
155160769|NCT02113982|560026679|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
155160770|NCT02113982|560026680|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
155160771|NCT02113982|560026681|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
155160772|NCT02113982|560026682|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
155064765|NCT02765165|559668480|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
155064766|NCT02765165|559668474|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
155064767|NCT02765165|559668475|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
155064768|NCT02765165|559668476|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
155064769|NCT02765165|559668477|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
155064770|NCT02765165|559668478|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
155064771|NCT02765165|559668479|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
155160773|NCT02113982|560026683|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
155064772|NCT02765165|559668480|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
155064773|NCT02765165|559668474|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155064774|NCT02765165|559668475|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155064775|NCT02765165|559668476|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155064776|NCT02765165|559668477|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
155064777|NCT02765165|559668478|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
155064778|NCT02765165|559668479|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
155064779|NCT02765165|559668480|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
155064780|NCT01189266|559668481|FG000|Overall Study|Adverse Event|1|||
155064781|NCT01189266|559668482|FG001|Overall Study|Adverse Event|0|||
155064782|NCT01189266|559668483|FG002|Overall Study|Adverse Event|5|||
155064783|NCT01189266|559668481|FG000|Overall Study|Death|0|||
155064784|NCT01189266|559668482|FG001|Overall Study|Death|0|||
155064785|NCT01189266|559668483|FG002|Overall Study|Death|5|||
155064786|NCT01189266|559668481|FG000|Overall Study|Lack of Efficacy|4|||
155064787|NCT01189266|559668482|FG001|Overall Study|Lack of Efficacy|5|||
155064788|NCT01189266|559668483|FG002|Overall Study|Lack of Efficacy|44|||
155064789|NCT01189266|559668481|FG000|Overall Study|Physician Decision|0|||
155064790|NCT01189266|559668482|FG001|Overall Study|Physician Decision|0|||
155302748|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302749|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302750|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302751|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
155302752|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
155302753|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302754|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302755|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302756|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302757|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
155302758|NCT04043455|560542627|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302759|NCT04043455|560542628|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
155302760|NCT04043455|560542629|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302761|NCT04043455|560542630|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302762|NCT04043455|560542631|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302763|NCT04043455|560542632|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
155302764|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302765|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302766|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302767|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302768|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
155302769|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
155302770|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155302771|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155302772|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155302773|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
155160774|NCT02113982|560026684|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
155160775|NCT02113982|560026685|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
155064791|NCT01189266|559668483|FG002|Overall Study|Physician Decision|1|||
155064792|NCT01189266|559668481|FG000|Overall Study|Protocol Violation|0|||
155064793|NCT01189266|559668482|FG001|Overall Study|Protocol Violation|1|||
155064794|NCT01189266|559668483|FG002|Overall Study|Protocol Violation|1|||
155160776|NCT02113982|560026686|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
155160777|NCT02113982|560026687|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
155160778|NCT02113982|560026688|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
155160779|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160780|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160781|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160782|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160783|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160784|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160785|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160786|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160787|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160788|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160789|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160790|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160791|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
155064795|NCT01189266|559668481|FG000|Overall Study|Withdrawal by Subject|0|||
155064796|NCT01189266|559668482|FG001|Overall Study|Withdrawal by Subject|0|||
155064797|NCT01189266|559668483|FG002|Overall Study|Withdrawal by Subject|1|||
155064798|NCT01189266|559668481|FG000|Overall Study|Patient refuses further therapy|1|||
155064799|NCT01189266|559668482|FG001|Overall Study|Patient refuses further therapy|0|||
155064800|NCT01189266|559668483|FG002|Overall Study|Patient refuses further therapy|7|||
155064801|NCT01189266|559668481|FG000|Overall Study|No treatment|0|||
155064802|NCT01189266|559668482|FG001|Overall Study|No treatment|0|||
155064803|NCT01189266|559668483|FG002|Overall Study|No treatment|1|||
155064804|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
155064805|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
155064806|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
155064807|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
155064808|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
155064809|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
155064810|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
155064811|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
155064812|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
155064813|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
155064814|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
155064815|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
155064816|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
155064817|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
155064818|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
155064819|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
155064820|NCT00410163|559668484|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
155064821|NCT00410163|559668485|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
155064822|NCT00410163|559668484|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
155064823|NCT00410163|559668485|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
155064824|NCT00410163|559668484|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
155064825|NCT00410163|559668485|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
155064826|NCT00410163|559668484|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
155064827|NCT00410163|559668485|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
155064828|NCT00410163|559668484|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
155064829|NCT00410163|559668485|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
155064830|NCT00410163|559668484|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
155064831|NCT00410163|559668485|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
155064832|NCT05452239|559668488|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
155064833|NCT05452239|559668489|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
155064834|NCT05452239|559668488|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
155064835|NCT05452239|559668489|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
155064836|NCT05452239|559668488|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
155064837|NCT05452239|559668489|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
155064838|NCT05452239|559668488|FG000|Placebo-controlled Period|Randomized but not treated|2|||
155064839|NCT05452239|559668489|FG001|Placebo-controlled Period|Randomized but not treated|2|||
155064840|NCT05452239|559668488|FG000|Placebo-controlled Period|Other than specified|1|||
155064841|NCT05452239|559668489|FG001|Placebo-controlled Period|Other than specified|1|||
155064842|NCT05452239|559668488|FG000|Open-label Period|Withdrawal by Subject|2|||
155064843|NCT05452239|559668489|FG001|Open-label Period|Withdrawal by Subject|1|||
155064844|NCT05452239|559668488|FG000|Open-label Period|Lost to Follow-up|3|||
155064845|NCT05452239|559668489|FG001|Open-label Period|Lost to Follow-up|0|||
155302774|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
155302775|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
155064846|NCT05452239|559668488|FG000|Open-label Period|Other than specified|1|||
155064847|NCT05452239|559668489|FG001|Open-label Period|Other than specified|2|||
155064848|NCT03692949|559668490|FG000|Overall Study|Lost to Follow-up|0|||
155064849|NCT03692949|559668491|FG001|Overall Study|Lost to Follow-up|0|||
155064850|NCT03692949|559668492|FG002|Overall Study|Lost to Follow-up|0|||
155064851|NCT03692949|559668493|FG003|Overall Study|Lost to Follow-up|0|||
155064852|NCT03692949|559668494|FG004|Overall Study|Lost to Follow-up|0|||
155064853|NCT03692949|559668495|FG005|Overall Study|Lost to Follow-up|0|||
155064854|NCT03692949|559668496|FG006|Overall Study|Lost to Follow-up|0|||
155064855|NCT03692949|559668497|FG007|Overall Study|Lost to Follow-up|1|||
155302776|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302777|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302778|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302779|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302780|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
155064856|NCT02966834|559668508|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155302781|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
155302782|NCT04043455|560542627|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302783|NCT04043455|560542628|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302784|NCT04043455|560542629|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302785|NCT04043455|560542630|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
155302786|NCT04043455|560542631|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
155302787|NCT04043455|560542632|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
155302788|NCT05568615|560542633|FG000|Overall Study|Death|1|||
155302789|NCT05568615|560542633|FG000|Overall Study|Physician Decision|1|||
155160792|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
155160793|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155064857|NCT02966834|559668509|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155064858|NCT02966834|559668510|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155064859|NCT02966834|559668511|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155064860|NCT02966834|559668512|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
155064861|NCT02966834|559668513|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
155160794|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155064862|NCT02966834|559668508|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
155064863|NCT02966834|559668509|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155064864|NCT02966834|559668510|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155160795|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155302790|NCT05505045|560542634|FG000|Overall Study|Withdrawal by Subject|2|||
155302791|NCT05505045|560542635|FG001|Overall Study|Withdrawal by Subject|1|||
155302792|NCT01643070|560542636|FG000|Overall Study|Withdrawal by Subject|3|||
155064865|NCT02966834|559668511|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155064866|NCT02966834|559668512|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155064867|NCT02966834|559668513|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155064868|NCT02966834|559668508|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
155064869|NCT02966834|559668509|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
155064870|NCT02966834|559668510|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
155064871|NCT02966834|559668511|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
155160796|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160797|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160798|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160799|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160800|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160801|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160802|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160803|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160804|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
155160805|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
155160806|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
155160807|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160808|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160809|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160810|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160811|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160812|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160813|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160814|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160815|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160816|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160817|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160818|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
155160819|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
155160820|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
155160821|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160822|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160823|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160824|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160825|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160826|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160827|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160828|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160829|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160830|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155160831|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155064872|NCT02966834|559668512|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
155064873|NCT02966834|559668513|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
155064874|NCT02966834|559668508|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
155064875|NCT02966834|559668509|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
155064876|NCT02966834|559668510|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
155064877|NCT02966834|559668511|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
155160832|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
155064878|NCT02966834|559668512|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
155160833|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
155160834|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
155160835|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155064879|NCT02966834|559668513|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
155064880|NCT02966834|559668508|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155064881|NCT02966834|559668509|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155064882|NCT02966834|559668510|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155064883|NCT02966834|559668511|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
155064884|NCT02966834|559668512|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155064885|NCT02966834|559668513|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155064886|NCT02966834|559668508|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155064887|NCT02966834|559668509|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155064888|NCT02966834|559668510|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155064889|NCT02966834|559668511|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
155064890|NCT02966834|559668512|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155064891|NCT02966834|559668513|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
155064892|NCT03573297|559668514|FG000|Open Label Treatment Period|Adverse Event|67|||
155064893|NCT03573297|559668515|FG001|Open Label Treatment Period|Adverse Event|0|||
155064894|NCT03573297|559668516|FG002|Open Label Treatment Period|Adverse Event|0|||
155064895|NCT03573297|559668517|FG003|Open Label Treatment Period|Adverse Event|0|||
155064896|NCT03573297|559668514|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
155064897|NCT03573297|559668515|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
155064898|NCT03573297|559668516|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
155064899|NCT03573297|559668517|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
155064900|NCT03573297|559668514|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
155064901|NCT03573297|559668515|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
155064902|NCT03573297|559668516|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
155064903|NCT03573297|559668517|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
155064904|NCT03573297|559668514|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
155064905|NCT03573297|559668515|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
155064906|NCT03573297|559668516|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
155064907|NCT03573297|559668517|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
155064908|NCT03573297|559668514|FG000|Open Label Treatment Period|Pregnancy|1|||
155064909|NCT03573297|559668515|FG001|Open Label Treatment Period|Pregnancy|0|||
155064910|NCT03573297|559668516|FG002|Open Label Treatment Period|Pregnancy|0|||
155064911|NCT03573297|559668517|FG003|Open Label Treatment Period|Pregnancy|0|||
155064912|NCT03573297|559668514|FG000|Open Label Treatment Period|Protocol Violation|17|||
155064913|NCT03573297|559668515|FG001|Open Label Treatment Period|Protocol Violation|0|||
155064914|NCT03573297|559668516|FG002|Open Label Treatment Period|Protocol Violation|0|||
155064915|NCT03573297|559668517|FG003|Open Label Treatment Period|Protocol Violation|0|||
155064916|NCT03573297|559668514|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
155064917|NCT03573297|559668515|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
155064918|NCT03573297|559668516|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
155064919|NCT03573297|559668517|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
155064920|NCT03573297|559668514|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
155064921|NCT03573297|559668515|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
155064922|NCT03573297|559668516|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
155064923|NCT03573297|559668517|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
155064924|NCT03573297|559668514|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
155064925|NCT03573297|559668515|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
155064926|NCT03573297|559668516|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
155064927|NCT03573297|559668517|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
155064928|NCT03573297|559668514|FG000|Open Label Treatment Period|Other, Not Specified|7|||
155064929|NCT03573297|559668515|FG001|Open Label Treatment Period|Other, Not Specified|0|||
155064930|NCT03573297|559668516|FG002|Open Label Treatment Period|Other, Not Specified|0|||
155064931|NCT03573297|559668517|FG003|Open Label Treatment Period|Other, Not Specified|0|||
155064932|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
155064933|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
155160836|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155064934|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
155064935|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
155064936|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155160837|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160838|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155064937|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155064938|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Adverse Event|5|||
155064939|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Adverse Event|1|||
155064940|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155064941|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
155064942|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
155064943|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
155064944|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155064945|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
155064946|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
155064947|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
155064948|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155064949|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
155064950|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
155064951|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
155064952|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155064953|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
155160839|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160840|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160841|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160842|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160843|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160844|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160845|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160846|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155160847|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
155064954|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
155064955|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
155064956|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
155064957|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
155064958|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
155064959|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
155064960|NCT03573297|559668514|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
155064961|NCT03573297|559668515|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
155064962|NCT03573297|559668516|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
155064963|NCT03573297|559668517|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
155064964|NCT03907488|559668518|FG000|Overall Study|Adverse Event|20|||
155064965|NCT03907488|559668519|FG001|Overall Study|Adverse Event|20|||
155064966|NCT03907488|559668518|FG000|Overall Study|Withdrawal by Subject|9|||
155064967|NCT03907488|559668519|FG001|Overall Study|Withdrawal by Subject|13|||
155064968|NCT03907488|559668518|FG000|Overall Study|Lack of Efficacy|0|||
155064969|NCT03907488|559668519|FG001|Overall Study|Lack of Efficacy|9|||
155064970|NCT03907488|559668518|FG000|Overall Study|Death|3|||
155064971|NCT03907488|559668519|FG001|Overall Study|Death|8|||
155064972|NCT03907488|559668518|FG000|Overall Study|not protocol specified|5|||
155064973|NCT03907488|559668519|FG001|Overall Study|not protocol specified|8|||
155064974|NCT03907488|559668518|FG000|Overall Study|Ineligible|9|||
155064975|NCT03907488|559668519|FG001|Overall Study|Ineligible|15|||
155064976|NCT01093846|559668521|FG000|Overall Study|Adverse Event|0|||
155064977|NCT01093846|559668522|FG001|Overall Study|Adverse Event|0|||
155064978|NCT01093846|559668523|FG002|Overall Study|Adverse Event|1|||
155064979|NCT01093846|559668521|FG000|Overall Study|Lack of Efficacy|0|||
155064980|NCT01093846|559668522|FG001|Overall Study|Lack of Efficacy|0|||
155064981|NCT01093846|559668523|FG002|Overall Study|Lack of Efficacy|4|||
155064982|NCT01093846|559668521|FG000|Overall Study|Condition no longer required study drug|1|||
155064983|NCT01093846|559668522|FG001|Overall Study|Condition no longer required study drug|1|||
155064984|NCT01093846|559668523|FG002|Overall Study|Condition no longer required study drug|1|||
155160848|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
155064985|NCT01093846|559668521|FG000|Overall Study|Administrative Problems|18|||
155064986|NCT01093846|559668522|FG001|Overall Study|Administrative Problems|17|||
155064987|NCT01093846|559668523|FG002|Overall Study|Administrative Problems|15|||
155064988|NCT03321721|559668524|FG000|Overall Study|Lost to Follow-up|4|||
155064989|NCT03321721|559668525|FG001|Overall Study|Lost to Follow-up|8|||
155064990|NCT03321721|559668526|FG002|Overall Study|Lost to Follow-up|11|||
155064991|NCT03846479|559669885|FG000|Overall Study|Death|8|||
155064992|NCT03846479|559669885|FG000|Overall Study|Lost to Follow-up|1|||
155064993|NCT04761822|559669888|FG000|Overall Study|Adverse Event|3|||
155064994|NCT04761822|559669889|FG001|Overall Study|Adverse Event|1|||
155064995|NCT04761822|559669890|FG002|Overall Study|Adverse Event|1|||
155064996|NCT04761822|559669891|FG003|Overall Study|Adverse Event|3|||
155064997|NCT04761822|559669888|FG000|Overall Study|Lost to Follow-up|1|||
155064998|NCT04761822|559669889|FG001|Overall Study|Lost to Follow-up|0|||
155160849|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155064999|NCT04761822|559669890|FG002|Overall Study|Lost to Follow-up|2|||
155065000|NCT04761822|559669891|FG003|Overall Study|Lost to Follow-up|3|||
155065001|NCT04761822|559669888|FG000|Overall Study|Physician Decision|0|||
155065002|NCT04761822|559669889|FG001|Overall Study|Physician Decision|1|||
155065003|NCT04761822|559669890|FG002|Overall Study|Physician Decision|0|||
155065004|NCT04761822|559669891|FG003|Overall Study|Physician Decision|0|||
155065005|NCT04761822|559669888|FG000|Overall Study|Withdrawal by Subject|3|||
155065006|NCT04761822|559669889|FG001|Overall Study|Withdrawal by Subject|8|||
155065007|NCT04761822|559669890|FG002|Overall Study|Withdrawal by Subject|1|||
155065008|NCT04761822|559669891|FG003|Overall Study|Withdrawal by Subject|11|||
155065009|NCT04761822|559669888|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
155065010|NCT04761822|559669889|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
155065011|NCT04761822|559669890|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
155065012|NCT04761822|559669891|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
155065013|NCT04761822|559669888|FG000|Overall Study|Participant requested unblinding|0|||
155065014|NCT04761822|559669889|FG001|Overall Study|Participant requested unblinding|0|||
155065015|NCT04761822|559669890|FG002|Overall Study|Participant requested unblinding|0|||
155065016|NCT04761822|559669891|FG003|Overall Study|Participant requested unblinding|1|||
155065017|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
155065018|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
155065019|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Death|1|||
155065020|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Death|3|||
155065021|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
155065022|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
155065023|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
155065024|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
155065025|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
155065026|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
155065027|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
155065028|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
155065029|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
155065030|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
155065031|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
155065032|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
155065033|NCT00362232|559669892|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
155065034|NCT00362232|559669893|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
155065035|NCT00362232|559669892|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
155065036|NCT00362232|559669893|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
155065037|NCT00362232|559669892|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
155065038|NCT00362232|559669893|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
155065039|NCT00362232|559669892|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
155065040|NCT00362232|559669893|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
155065041|NCT00362232|559669892|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
155065042|NCT00362232|559669893|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
155065043|NCT02233413|559669896|FG000|Overall Study|Lost to Follow-up|7|||
155065044|NCT02233413|559669897|FG001|Overall Study|Lost to Follow-up|9|||
155065045|NCT02233413|559669896|FG000|Overall Study|Withdrawal by Subject|4|||
155065046|NCT02233413|559669897|FG001|Overall Study|Withdrawal by Subject|5|||
155065047|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
155065048|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
155065049|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
155160850|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160851|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160852|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160853|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160854|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160855|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160856|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160857|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155065050|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
155065051|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
155065052|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
154958305|NCT01796171|559275488|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958306|NCT01796171|559275489|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958307|NCT01796171|559275490|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958308|NCT01796171|559275491|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
154958309|NCT01796171|559275492|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
154958310|NCT01796171|559275493|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958311|NCT01796171|559275494|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958312|NCT01796171|559275495|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
154958313|NCT01796171|559275481|FG000|Follow-up Period|Start of further anticancer therapy|4|||
154958314|NCT01796171|559275482|FG001|Follow-up Period|Start of further anticancer therapy|25|||
154958315|NCT01796171|559275483|FG002|Follow-up Period|Start of further anticancer therapy|2|||
154958316|NCT01796171|559275484|FG003|Follow-up Period|Start of further anticancer therapy|1|||
154958317|NCT01796171|559275485|FG004|Follow-up Period|Start of further anticancer therapy|2|||
154958318|NCT01796171|559275486|FG005|Follow-up Period|Start of further anticancer therapy|2|||
154958319|NCT01796171|559275487|FG006|Follow-up Period|Start of further anticancer therapy|1|||
154958320|NCT01796171|559275488|FG007|Follow-up Period|Start of further anticancer therapy|15|||
154958321|NCT01796171|559275489|FG008|Follow-up Period|Start of further anticancer therapy|2|||
154958322|NCT01796171|559275490|FG009|Follow-up Period|Start of further anticancer therapy|0|||
154958323|NCT01796171|559275491|FG010|Follow-up Period|Start of further anticancer therapy|0|||
154958324|NCT01796171|559275492|FG011|Follow-up Period|Start of further anticancer therapy|0|||
154958325|NCT01796171|559275493|FG012|Follow-up Period|Start of further anticancer therapy|0|||
154958326|NCT01796171|559275494|FG013|Follow-up Period|Start of further anticancer therapy|0|||
154958327|NCT01796171|559275495|FG014|Follow-up Period|Start of further anticancer therapy|0|||
154958328|NCT01796171|559275481|FG000|Follow-up Period|Progressive disease|0|||
154958329|NCT01796171|559275482|FG001|Follow-up Period|Progressive disease|1|||
154958330|NCT01796171|559275483|FG002|Follow-up Period|Progressive disease|0|||
154958331|NCT01796171|559275484|FG003|Follow-up Period|Progressive disease|0|||
154958332|NCT01796171|559275485|FG004|Follow-up Period|Progressive disease|0|||
154958333|NCT01796171|559275486|FG005|Follow-up Period|Progressive disease|0|||
154958334|NCT01796171|559275487|FG006|Follow-up Period|Progressive disease|0|||
154958335|NCT01796171|559275488|FG007|Follow-up Period|Progressive disease|3|||
154958336|NCT01796171|559275489|FG008|Follow-up Period|Progressive disease|0|||
154958337|NCT01796171|559275490|FG009|Follow-up Period|Progressive disease|0|||
154958338|NCT01796171|559275491|FG010|Follow-up Period|Progressive disease|0|||
154958339|NCT01796171|559275492|FG011|Follow-up Period|Progressive disease|0|||
154958340|NCT01796171|559275493|FG012|Follow-up Period|Progressive disease|0|||
154958341|NCT01796171|559275494|FG013|Follow-up Period|Progressive disease|0|||
154958342|NCT01796171|559275495|FG014|Follow-up Period|Progressive disease|0|||
154958343|NCT01796171|559275481|FG000|Follow-up Period|Physician Decision|0|||
154958344|NCT01796171|559275482|FG001|Follow-up Period|Physician Decision|2|||
154958345|NCT01796171|559275483|FG002|Follow-up Period|Physician Decision|0|||
154958346|NCT01796171|559275484|FG003|Follow-up Period|Physician Decision|0|||
154958347|NCT01796171|559275485|FG004|Follow-up Period|Physician Decision|0|||
154958348|NCT01796171|559275486|FG005|Follow-up Period|Physician Decision|0|||
154958349|NCT01796171|559275487|FG006|Follow-up Period|Physician Decision|0|||
154958350|NCT01796171|559275488|FG007|Follow-up Period|Physician Decision|0|||
154958351|NCT01796171|559275489|FG008|Follow-up Period|Physician Decision|0|||
154958352|NCT01796171|559275490|FG009|Follow-up Period|Physician Decision|0|||
154958353|NCT01796171|559275491|FG010|Follow-up Period|Physician Decision|5|||
154958354|NCT01796171|559275492|FG011|Follow-up Period|Physician Decision|0|||
154958355|NCT01796171|559275493|FG012|Follow-up Period|Physician Decision|0|||
154958356|NCT01796171|559275494|FG013|Follow-up Period|Physician Decision|0|||
154958357|NCT01796171|559275495|FG014|Follow-up Period|Physician Decision|0|||
155065053|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
155065054|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
155065055|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
154958358|NCT01796171|559275481|FG000|Follow-up Period|Withdrawal by Subject|0|||
154958359|NCT01796171|559275482|FG001|Follow-up Period|Withdrawal by Subject|1|||
154958360|NCT01796171|559275483|FG002|Follow-up Period|Withdrawal by Subject|0|||
154958361|NCT01796171|559275484|FG003|Follow-up Period|Withdrawal by Subject|0|||
154958362|NCT01796171|559275485|FG004|Follow-up Period|Withdrawal by Subject|0|||
154958363|NCT01796171|559275486|FG005|Follow-up Period|Withdrawal by Subject|1|||
154958364|NCT01796171|559275487|FG006|Follow-up Period|Withdrawal by Subject|0|||
155065056|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
155065057|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
155065058|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
155065059|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
155065060|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
155065061|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
155302793|NCT01643070|560542637|FG001|Overall Study|Withdrawal by Subject|1|||
155302794|NCT01643070|560542636|FG000|Overall Study|Death|1|||
155302795|NCT01643070|560542637|FG001|Overall Study|Death|0|||
155302796|NCT01643070|560542636|FG000|Overall Study|Pregressive disease|0|||
155302797|NCT01643070|560542637|FG001|Overall Study|Pregressive disease|2|||
155302798|NCT04842500|560542640|FG000|Overall Study|Withdrawal by Subject|4|||
155302799|NCT04842500|560542641|FG001|Overall Study|Withdrawal by Subject|1|||
155302800|NCT04842500|560542642|FG002|Overall Study|Withdrawal by Subject|2|||
155302801|NCT04842500|560542643|FG003|Overall Study|Withdrawal by Subject|3|||
155302802|NCT04842500|560542640|FG000|Overall Study|Protocol Violation|1|||
155302803|NCT04842500|560542641|FG001|Overall Study|Protocol Violation|0|||
155302804|NCT04842500|560542642|FG002|Overall Study|Protocol Violation|0|||
155302805|NCT04842500|560542643|FG003|Overall Study|Protocol Violation|1|||
155302806|NCT02980276|560542644|FG000|Overall Study|Withdrawal by Subject|4|||
155302807|NCT02980276|560542645|FG001|Overall Study|Withdrawal by Subject|4|||
155302808|NCT02980276|560542644|FG000|Overall Study|Physician Decision|0|||
155302809|NCT02980276|560542645|FG001|Overall Study|Physician Decision|1|||
155302810|NCT02980276|560542644|FG000|Overall Study|Lost to Follow-up|18|||
155302811|NCT02980276|560542645|FG001|Overall Study|Lost to Follow-up|18|||
155302812|NCT02980276|560542644|FG000|Overall Study|Death|1|||
155302813|NCT02980276|560542645|FG001|Overall Study|Death|0|||
155302814|NCT02980276|560542644|FG000|Overall Study|Miscellaneous other|10|||
155302815|NCT02980276|560542645|FG001|Overall Study|Miscellaneous other|4|||
155302816|NCT04139668|560542647|FG000|Overall Study|Withdrawal by Subject|1|||
155302817|NCT03025789|560542648|FG000|Overall Study|Lack of Efficacy|6|||
155302818|NCT03025789|560542649|FG001|Overall Study|Lack of Efficacy|1|||
155302819|NCT03025789|560542648|FG000|Overall Study|Death|1|||
155302820|NCT03025789|560542649|FG001|Overall Study|Death|0|||
155302821|NCT03025789|560542648|FG000|Overall Study|Withdrawal by Subject|0|||
155302822|NCT03025789|560542649|FG001|Overall Study|Withdrawal by Subject|2|||
155302823|NCT03554265|560542650|FG000|Overall Study|Withdrawal by Subject|2|||
155302824|NCT03554265|560542651|FG001|Overall Study|Withdrawal by Subject|2|||
155302825|NCT03554265|560542652|FG002|Overall Study|Withdrawal by Subject|3|||
155302826|NCT03554265|560542650|FG000|Overall Study|Physician Decision|0|||
155302827|NCT03554265|560542651|FG001|Overall Study|Physician Decision|0|||
155302828|NCT03554265|560542652|FG002|Overall Study|Physician Decision|1|||
155302829|NCT02652260|560542653|FG000|Base Study|Pregnancy|0|||
155302830|NCT02652260|560542654|FG001|Base Study|Pregnancy|1|||
155065062|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
155302831|NCT02652260|560542653|FG000|Base Study|Withdrawal by Subject|0|||
155302832|NCT02652260|560542654|FG001|Base Study|Withdrawal by Subject|1|||
155302833|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
155302834|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
155302835|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
155302836|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
155302837|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
155302838|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
155302839|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
155302840|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
155302841|NCT02652260|560542653|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
155302842|NCT02652260|560542654|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
155302843|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
155302844|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
155302845|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
155302846|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
155302847|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
155302848|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
155302849|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
155302850|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
155302851|NCT02652260|560542653|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
155302852|NCT02652260|560542654|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
155302853|NCT02652260|560542653|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
155302854|NCT02652260|560542654|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
155302855|NCT02652260|560542653|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
155302856|NCT02652260|560542654|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
155302857|NCT02723955|560542655|FG000|Escalation Phase|Death|1|||
155302858|NCT02723955|560542656|FG001|Escalation Phase|Death|1|||
155302859|NCT02723955|560542657|FG002|Escalation Phase|Death|2|||
155302860|NCT02723955|560542658|FG003|Escalation Phase|Death|7|||
155302861|NCT02723955|560542659|FG004|Escalation Phase|Death|18|||
155065063|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
155065064|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
155065065|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
155065066|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
155065067|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
155302862|NCT02723955|560542660|FG005|Escalation Phase|Death|17|||
155302863|NCT02723955|560542661|FG006|Escalation Phase|Death|11|||
155302864|NCT02723955|560542662|FG007|Escalation Phase|Death|21|||
155302865|NCT02723955|560542663|FG008|Escalation Phase|Death|3|||
155302866|NCT02723955|560542664|FG009|Escalation Phase|Death|0|||
155302867|NCT02723955|560542665|FG010|Escalation Phase|Death|0|||
155302868|NCT02723955|560542666|FG011|Escalation Phase|Death|0|||
155302869|NCT02723955|560542667|FG012|Escalation Phase|Death|2|||
155302870|NCT02723955|560542668|FG013|Escalation Phase|Death|4|||
155302871|NCT02723955|560542669|FG014|Escalation Phase|Death|5|||
155302872|NCT02723955|560542670|FG015|Escalation Phase|Death|6|||
155302873|NCT02723955|560542671|FG016|Escalation Phase|Death|6|||
155302874|NCT02723955|560542672|FG017|Escalation Phase|Death|7|||
155302875|NCT02723955|560542673|FG018|Escalation Phase|Death|1|||
155302876|NCT02723955|560542674|FG019|Escalation Phase|Death|3|||
155302877|NCT02723955|560542675|FG020|Escalation Phase|Death|13|||
155302878|NCT02723955|560542676|FG021|Escalation Phase|Death|3|||
155302879|NCT02723955|560542677|FG022|Escalation Phase|Death|2|||
155302880|NCT02723955|560542678|FG023|Escalation Phase|Death|4|||
155302881|NCT02723955|560542679|FG024|Escalation Phase|Death|31|||
155302882|NCT02723955|560542680|FG025|Escalation Phase|Death|7|||
155160858|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160859|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160860|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160861|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
155160862|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
155160863|NCT02113982|560026675|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160864|NCT02113982|560026676|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160865|NCT02113982|560026677|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160866|NCT02113982|560026678|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
154958365|NCT01796171|559275488|FG007|Follow-up Period|Withdrawal by Subject|0|||
154958366|NCT01796171|559275489|FG008|Follow-up Period|Withdrawal by Subject|0|||
154958367|NCT01796171|559275490|FG009|Follow-up Period|Withdrawal by Subject|0|||
154958368|NCT01796171|559275491|FG010|Follow-up Period|Withdrawal by Subject|3|||
154958369|NCT01796171|559275492|FG011|Follow-up Period|Withdrawal by Subject|1|||
154958370|NCT01796171|559275493|FG012|Follow-up Period|Withdrawal by Subject|0|||
154958371|NCT01796171|559275494|FG013|Follow-up Period|Withdrawal by Subject|0|||
154958372|NCT01796171|559275495|FG014|Follow-up Period|Withdrawal by Subject|0|||
154958373|NCT01796171|559275481|FG000|Follow-up Period|Death|0|||
154958374|NCT01796171|559275482|FG001|Follow-up Period|Death|0|||
154958375|NCT01796171|559275483|FG002|Follow-up Period|Death|0|||
154958376|NCT01796171|559275484|FG003|Follow-up Period|Death|0|||
154958377|NCT01796171|559275485|FG004|Follow-up Period|Death|0|||
154958378|NCT01796171|559275486|FG005|Follow-up Period|Death|0|||
154958379|NCT01796171|559275487|FG006|Follow-up Period|Death|1|||
154958380|NCT01796171|559275488|FG007|Follow-up Period|Death|0|||
154958381|NCT01796171|559275489|FG008|Follow-up Period|Death|0|||
154958382|NCT01796171|559275490|FG009|Follow-up Period|Death|0|||
154958383|NCT01796171|559275491|FG010|Follow-up Period|Death|17|||
154958384|NCT01796171|559275492|FG011|Follow-up Period|Death|9|||
154958385|NCT01796171|559275493|FG012|Follow-up Period|Death|1|||
154958386|NCT01796171|559275494|FG013|Follow-up Period|Death|0|||
154958387|NCT01796171|559275495|FG014|Follow-up Period|Death|0|||
154958388|NCT01796171|559275481|FG000|Follow-up Period|Patient transferred to other hospital|0|||
154958389|NCT01796171|559275482|FG001|Follow-up Period|Patient transferred to other hospital|1|||
154958390|NCT01796171|559275483|FG002|Follow-up Period|Patient transferred to other hospital|0|||
154958391|NCT01796171|559275484|FG003|Follow-up Period|Patient transferred to other hospital|0|||
155160867|NCT02113982|560026679|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160868|NCT02113982|560026680|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160869|NCT02113982|560026681|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160870|NCT02113982|560026682|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160871|NCT02113982|560026683|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155302883|NCT02723955|560542681|FG026|Escalation Phase|Death|13|||
155302884|NCT02723955|560542682|FG027|Escalation Phase|Death|0|||
155302885|NCT02723955|560542683|FG028|Escalation Phase|Death|1|||
155302886|NCT02723955|560542684|FG029|Escalation Phase|Death|0|||
154958392|NCT01796171|559275485|FG004|Follow-up Period|Patient transferred to other hospital|0|||
154958393|NCT01796171|559275486|FG005|Follow-up Period|Patient transferred to other hospital|0|||
154958394|NCT01796171|559275487|FG006|Follow-up Period|Patient transferred to other hospital|0|||
154958395|NCT01796171|559275488|FG007|Follow-up Period|Patient transferred to other hospital|0|||
154958396|NCT01796171|559275489|FG008|Follow-up Period|Patient transferred to other hospital|0|||
154958397|NCT01796171|559275490|FG009|Follow-up Period|Patient transferred to other hospital|0|||
155302887|NCT02723955|560542685|FG030|Escalation Phase|Death|0|||
155302888|NCT02723955|560542686|FG031|Escalation Phase|Death|0|||
155302889|NCT02723955|560542687|FG032|Escalation Phase|Death|0|||
155302890|NCT02723955|560542688|FG033|Escalation Phase|Death|0|||
155302891|NCT02723955|560542689|FG034|Escalation Phase|Death|0|||
155302892|NCT02723955|560542690|FG035|Escalation Phase|Death|0|||
155302893|NCT02723955|560542691|FG036|Escalation Phase|Death|0|||
154958398|NCT01796171|559275491|FG010|Follow-up Period|Patient transferred to other hospital|0|||
154958399|NCT01796171|559275492|FG011|Follow-up Period|Patient transferred to other hospital|0|||
154958400|NCT01796171|559275493|FG012|Follow-up Period|Patient transferred to other hospital|0|||
154958401|NCT01796171|559275494|FG013|Follow-up Period|Patient transferred to other hospital|0|||
154958402|NCT01796171|559275495|FG014|Follow-up Period|Patient transferred to other hospital|0|||
154958403|NCT01796171|559275481|FG000|Follow-up Period|Sponsor Decision|0|||
154958404|NCT01796171|559275482|FG001|Follow-up Period|Sponsor Decision|0|||
154958405|NCT01796171|559275483|FG002|Follow-up Period|Sponsor Decision|0|||
154958406|NCT01796171|559275484|FG003|Follow-up Period|Sponsor Decision|0|||
154958407|NCT01796171|559275485|FG004|Follow-up Period|Sponsor Decision|0|||
154958408|NCT01796171|559275486|FG005|Follow-up Period|Sponsor Decision|0|||
154958409|NCT01796171|559275487|FG006|Follow-up Period|Sponsor Decision|0|||
154958410|NCT01796171|559275488|FG007|Follow-up Period|Sponsor Decision|0|||
154958411|NCT01796171|559275489|FG008|Follow-up Period|Sponsor Decision|0|||
154958412|NCT01796171|559275490|FG009|Follow-up Period|Sponsor Decision|0|||
154958413|NCT01796171|559275491|FG010|Follow-up Period|Sponsor Decision|40|||
154958414|NCT01796171|559275492|FG011|Follow-up Period|Sponsor Decision|15|||
154958415|NCT01796171|559275493|FG012|Follow-up Period|Sponsor Decision|7|||
154958416|NCT01796171|559275494|FG013|Follow-up Period|Sponsor Decision|0|||
154958417|NCT01796171|559275495|FG014|Follow-up Period|Sponsor Decision|0|||
154958418|NCT00418561|559275496|FG000|Overall Study|Participant's (guardian's) decision|0|||
154958419|NCT00418561|559275497|FG001|Overall Study|Participant's (guardian's) decision|1|||
154958420|NCT00418561|559275498|FG002|Overall Study|Participant's (guardian's) decision|0|||
154958421|NCT01083693|559275501|FG000|Overall Study|Adverse Event|1|||
154958422|NCT01083693|559275502|FG001|Overall Study|Adverse Event|1|||
154958423|NCT01083693|559275503|FG002|Overall Study|Adverse Event|0|||
154958424|NCT01083693|559275501|FG000|Overall Study|Lost to Follow-up|2|||
154958425|NCT01083693|559275502|FG001|Overall Study|Lost to Follow-up|0|||
154958426|NCT01083693|559275503|FG002|Overall Study|Lost to Follow-up|2|||
154958427|NCT01083693|559275501|FG000|Overall Study|Lack of effectiveness|13|||
154958428|NCT01083693|559275502|FG001|Overall Study|Lack of effectiveness|2|||
154958429|NCT01083693|559275503|FG002|Overall Study|Lack of effectiveness|2|||
154958430|NCT01083693|559275501|FG000|Overall Study|Patient Moved|0|||
154958431|NCT01083693|559275502|FG001|Overall Study|Patient Moved|1|||
154958432|NCT01083693|559275503|FG002|Overall Study|Patient Moved|0|||
154958433|NCT01083693|559275501|FG000|Overall Study|Complete remission|0|||
154958434|NCT01083693|559275502|FG001|Overall Study|Complete remission|1|||
154958435|NCT01083693|559275503|FG002|Overall Study|Complete remission|0|||
154958436|NCT01083693|559275501|FG000|Overall Study|Other medical condition/surgery|1|||
154958437|NCT01083693|559275502|FG001|Overall Study|Other medical condition/surgery|1|||
154958438|NCT01083693|559275503|FG002|Overall Study|Other medical condition/surgery|0|||
154958439|NCT01083693|559275501|FG000|Overall Study|Withdrawal by Subject|3|||
154958440|NCT01083693|559275502|FG001|Overall Study|Withdrawal by Subject|0|||
154958441|NCT01083693|559275503|FG002|Overall Study|Withdrawal by Subject|2|||
154958442|NCT01083693|559275501|FG000|Overall Study|Reason unknown|0|||
154958443|NCT01083693|559275502|FG001|Overall Study|Reason unknown|0|||
154958444|NCT01083693|559275503|FG002|Overall Study|Reason unknown|1|||
154958445|NCT01693523|559275504|FG000|Overall Study|Adverse Event|2|||
154958446|NCT01693523|559275505|FG001|Overall Study|Adverse Event|1|||
154958447|NCT01693523|559275506|FG002|Overall Study|Adverse Event|0|||
154958448|NCT01693523|559275504|FG000|Overall Study|Death|0|||
154958449|NCT01693523|559275505|FG001|Overall Study|Death|1|||
154958450|NCT01693523|559275506|FG002|Overall Study|Death|1|||
154958451|NCT01693523|559275504|FG000|Overall Study|Lost to Follow-up|0|||
154958452|NCT01693523|559275505|FG001|Overall Study|Lost to Follow-up|0|||
154958453|NCT01693523|559275506|FG002|Overall Study|Lost to Follow-up|4|||
154958454|NCT01693523|559275504|FG000|Overall Study|Physician Decision|0|||
154958455|NCT01693523|559275505|FG001|Overall Study|Physician Decision|0|||
154958456|NCT01693523|559275506|FG002|Overall Study|Physician Decision|1|||
154958457|NCT01693523|559275504|FG000|Overall Study|Withdrawal by Subject|1|||
154958458|NCT01693523|559275505|FG001|Overall Study|Withdrawal by Subject|2|||
154958459|NCT01693523|559275506|FG002|Overall Study|Withdrawal by Subject|2|||
154958460|NCT01693523|559275504|FG000|Overall Study|Lack of compliance study medication|1|||
154958461|NCT01693523|559275505|FG001|Overall Study|Lack of compliance study medication|2|||
154958462|NCT01693523|559275506|FG002|Overall Study|Lack of compliance study medication|0|||
154958463|NCT01693523|559275504|FG000|Overall Study|Chemotherapy was held|1|||
154958464|NCT01693523|559275505|FG001|Overall Study|Chemotherapy was held|2|||
154958465|NCT01693523|559275506|FG002|Overall Study|Chemotherapy was held|0|||
154958466|NCT04567186|559275508|FG000|Period 1|COVID-19 related|1|||
154958467|NCT04567186|559275509|FG001|Period 1|COVID-19 related|0|||
154958468|NCT04567186|559275508|FG000|Period 1|Protocol Violation|0|||
154958469|NCT04567186|559275509|FG001|Period 1|Protocol Violation|1|||
154958470|NCT04567186|559275508|FG000|Period 1|Adverse Event|0|||
154958471|NCT04567186|559275509|FG001|Period 1|Adverse Event|2|||
154958472|NCT04567186|559275508|FG000|Period 2|COVID-19 Related|0|||
154958473|NCT04567186|559275509|FG001|Period 2|COVID-19 Related|1|||
155065068|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
155065069|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
155065070|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
155065071|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
155065072|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
155065073|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
155065074|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
155065075|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
155065076|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
155065077|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
155065078|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
155065079|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
155065080|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
155065081|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
155065082|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
155065083|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
155065084|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
155302894|NCT02723955|560542692|FG037|Escalation Phase|Death|0|||
155302895|NCT02723955|560542693|FG038|Escalation Phase|Death|0|||
155302896|NCT02723955|560542694|FG039|Escalation Phase|Death|0|||
155302897|NCT02723955|560542695|FG040|Escalation Phase|Death|0|||
155302898|NCT02723955|560542696|FG041|Escalation Phase|Death|0|||
155302899|NCT02723955|560542697|FG042|Escalation Phase|Death|0|||
155302900|NCT02723955|560542655|FG000|Escalation Phase|Lost to Follow-up|0|||
155302901|NCT02723955|560542656|FG001|Escalation Phase|Lost to Follow-up|0|||
155302902|NCT02723955|560542657|FG002|Escalation Phase|Lost to Follow-up|0|||
155302903|NCT02723955|560542658|FG003|Escalation Phase|Lost to Follow-up|0|||
155302904|NCT02723955|560542659|FG004|Escalation Phase|Lost to Follow-up|0|||
155302905|NCT02723955|560542660|FG005|Escalation Phase|Lost to Follow-up|2|||
155302906|NCT02723955|560542661|FG006|Escalation Phase|Lost to Follow-up|1|||
155302907|NCT02723955|560542662|FG007|Escalation Phase|Lost to Follow-up|1|||
155302908|NCT02723955|560542663|FG008|Escalation Phase|Lost to Follow-up|1|||
155302909|NCT02723955|560542664|FG009|Escalation Phase|Lost to Follow-up|0|||
155302910|NCT02723955|560542665|FG010|Escalation Phase|Lost to Follow-up|0|||
155302911|NCT02723955|560542666|FG011|Escalation Phase|Lost to Follow-up|0|||
155302912|NCT02723955|560542667|FG012|Escalation Phase|Lost to Follow-up|1|||
155302913|NCT02723955|560542668|FG013|Escalation Phase|Lost to Follow-up|0|||
155302914|NCT02723955|560542669|FG014|Escalation Phase|Lost to Follow-up|0|||
155302915|NCT02723955|560542670|FG015|Escalation Phase|Lost to Follow-up|0|||
155302916|NCT02723955|560542671|FG016|Escalation Phase|Lost to Follow-up|1|||
155302917|NCT02723955|560542672|FG017|Escalation Phase|Lost to Follow-up|2|||
155302918|NCT02723955|560542673|FG018|Escalation Phase|Lost to Follow-up|0|||
155302919|NCT02723955|560542674|FG019|Escalation Phase|Lost to Follow-up|1|||
155302920|NCT02723955|560542675|FG020|Escalation Phase|Lost to Follow-up|2|||
155302921|NCT02723955|560542676|FG021|Escalation Phase|Lost to Follow-up|1|||
155302922|NCT02723955|560542677|FG022|Escalation Phase|Lost to Follow-up|0|||
155302923|NCT02723955|560542678|FG023|Escalation Phase|Lost to Follow-up|0|||
155302924|NCT02723955|560542679|FG024|Escalation Phase|Lost to Follow-up|1|||
155302925|NCT02723955|560542680|FG025|Escalation Phase|Lost to Follow-up|1|||
155302926|NCT02723955|560542681|FG026|Escalation Phase|Lost to Follow-up|3|||
155302927|NCT02723955|560542682|FG027|Escalation Phase|Lost to Follow-up|0|||
155302928|NCT02723955|560542683|FG028|Escalation Phase|Lost to Follow-up|1|||
155302929|NCT02723955|560542684|FG029|Escalation Phase|Lost to Follow-up|0|||
155302930|NCT02723955|560542685|FG030|Escalation Phase|Lost to Follow-up|0|||
155302931|NCT02723955|560542686|FG031|Escalation Phase|Lost to Follow-up|0|||
155302932|NCT02723955|560542687|FG032|Escalation Phase|Lost to Follow-up|0|||
155302933|NCT02723955|560542688|FG033|Escalation Phase|Lost to Follow-up|0|||
155302934|NCT02723955|560542689|FG034|Escalation Phase|Lost to Follow-up|0|||
155302935|NCT02723955|560542690|FG035|Escalation Phase|Lost to Follow-up|0|||
155302936|NCT02723955|560542691|FG036|Escalation Phase|Lost to Follow-up|0|||
155302937|NCT02723955|560542692|FG037|Escalation Phase|Lost to Follow-up|0|||
155302938|NCT02723955|560542693|FG038|Escalation Phase|Lost to Follow-up|0|||
155302939|NCT02723955|560542694|FG039|Escalation Phase|Lost to Follow-up|0|||
155302940|NCT02723955|560542695|FG040|Escalation Phase|Lost to Follow-up|0|||
155302941|NCT02723955|560542696|FG041|Escalation Phase|Lost to Follow-up|0|||
155302942|NCT02723955|560542697|FG042|Escalation Phase|Lost to Follow-up|0|||
155302943|NCT02723955|560542655|FG000|Escalation Phase|Physician Decision|0|||
155302944|NCT02723955|560542656|FG001|Escalation Phase|Physician Decision|0|||
155302945|NCT02723955|560542657|FG002|Escalation Phase|Physician Decision|0|||
155302946|NCT02723955|560542658|FG003|Escalation Phase|Physician Decision|0|||
155302947|NCT02723955|560542659|FG004|Escalation Phase|Physician Decision|0|||
155302948|NCT02723955|560542660|FG005|Escalation Phase|Physician Decision|2|||
155302949|NCT02723955|560542661|FG006|Escalation Phase|Physician Decision|0|||
155302950|NCT02723955|560542662|FG007|Escalation Phase|Physician Decision|0|||
155302951|NCT02723955|560542663|FG008|Escalation Phase|Physician Decision|0|||
155302952|NCT02723955|560542664|FG009|Escalation Phase|Physician Decision|0|||
155302953|NCT02723955|560542665|FG010|Escalation Phase|Physician Decision|0|||
155302954|NCT02723955|560542666|FG011|Escalation Phase|Physician Decision|0|||
155302955|NCT02723955|560542667|FG012|Escalation Phase|Physician Decision|0|||
155302956|NCT02723955|560542668|FG013|Escalation Phase|Physician Decision|0|||
155302957|NCT02723955|560542669|FG014|Escalation Phase|Physician Decision|0|||
155302958|NCT02723955|560542670|FG015|Escalation Phase|Physician Decision|0|||
155302959|NCT02723955|560542671|FG016|Escalation Phase|Physician Decision|0|||
155302960|NCT02723955|560542672|FG017|Escalation Phase|Physician Decision|0|||
155302961|NCT02723955|560542673|FG018|Escalation Phase|Physician Decision|0|||
155302962|NCT02723955|560542674|FG019|Escalation Phase|Physician Decision|0|||
155302963|NCT02723955|560542675|FG020|Escalation Phase|Physician Decision|0|||
155302964|NCT02723955|560542676|FG021|Escalation Phase|Physician Decision|0|||
155302965|NCT02723955|560542677|FG022|Escalation Phase|Physician Decision|0|||
155302966|NCT02723955|560542678|FG023|Escalation Phase|Physician Decision|0|||
155302967|NCT02723955|560542679|FG024|Escalation Phase|Physician Decision|0|||
155302968|NCT02723955|560542680|FG025|Escalation Phase|Physician Decision|0|||
155302969|NCT02723955|560542681|FG026|Escalation Phase|Physician Decision|2|||
155302970|NCT02723955|560542682|FG027|Escalation Phase|Physician Decision|0|||
155302971|NCT02723955|560542683|FG028|Escalation Phase|Physician Decision|0|||
155302972|NCT02723955|560542684|FG029|Escalation Phase|Physician Decision|0|||
154958474|NCT04567186|559275508|FG000|Period 2|Protocol Violation|0|||
154958475|NCT04567186|559275509|FG001|Period 2|Protocol Violation|1|||
154958476|NCT04567186|559275508|FG000|Period 2|Lost to Follow-up|0|||
154958477|NCT04567186|559275509|FG001|Period 2|Lost to Follow-up|1|||
154958478|NCT04567186|559275508|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
154958479|NCT04567186|559275509|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
154958480|NCT00448019|559275514|FG000|Overall Study|Withdrawal by Subject|3|||
154958481|NCT00448019|559275514|FG000|Overall Study|Disease progression|1|||
154958482|NCT00448019|559275514|FG000|Overall Study|Death|2|||
154958483|NCT00448019|559275514|FG000|Overall Study|Insurance Issues|1|||
154958484|NCT00089661|559275515|FG000|Overall Study|Adverse Event|0|||
154958485|NCT00089661|559275516|FG001|Overall Study|Adverse Event|2|||
154958486|NCT00089661|559275515|FG000|Overall Study|Death|1|||
154958487|NCT00089661|559275516|FG001|Overall Study|Death|0|||
154958488|NCT00089661|559275515|FG000|Overall Study|Lost to Follow-up|0|||
154958489|NCT00089661|559275516|FG001|Overall Study|Lost to Follow-up|3|||
154958490|NCT00089661|559275515|FG000|Overall Study|Withdrawal by Subject|11|||
154958491|NCT00089661|559275516|FG001|Overall Study|Withdrawal by Subject|9|||
154958492|NCT00089661|559275515|FG000|Overall Study|Disease progression|1|||
154958493|NCT00089661|559275516|FG001|Overall Study|Disease progression|3|||
154958494|NCT00089661|559275515|FG000|Overall Study|Ineligibility determined|4|||
154958495|NCT00089661|559275516|FG001|Overall Study|Ineligibility determined|4|||
154958496|NCT00089661|559275515|FG000|Overall Study|Noncompliance|2|||
154958497|NCT00089661|559275516|FG001|Overall Study|Noncompliance|4|||
154958498|NCT00089661|559275515|FG000|Overall Study|Other|2|||
154958499|NCT00089661|559275516|FG001|Overall Study|Other|1|||
154958500|NCT01037114|559275517|FG000|Year 20|Others|1|||
154958501|NCT00850174|559275522|FG000|Washout: One Week|Withdrawal by Subject|0|||
154958502|NCT00850174|559275523|FG001|Washout: One Week|Withdrawal by Subject|2|||
154958503|NCT00850174|559275522|FG000|Second Intervention|Withdrawal by Subject|1|||
154958504|NCT00850174|559275523|FG001|Second Intervention|Withdrawal by Subject|0|||
154958505|NCT01363765|559275524|FG000|Overall Study|non-diagnostic|2621|||
154958506|NCT01363765|559275525|FG001|Overall Study|non-diagnostic|1124|||
154958507|NCT01363765|559275524|FG000|Overall Study|duplicate records|736|||
154958508|NCT01363765|559275525|FG001|Overall Study|duplicate records|3177|||
154958509|NCT01363765|559275524|FG000|Overall Study|non-resident|156|||
154958510|NCT01363765|559275525|FG001|Overall Study|non-resident|76|||
154958511|NCT01363765|559275524|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
154958512|NCT01363765|559275525|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
154958513|NCT01363765|559275524|FG000|Overall Study|smear during intervention|2170|||
154958514|NCT01363765|559275525|FG001|Overall Study|smear during intervention|0|||
154958515|NCT00635492|559275526|FG000|Overall Study|Death|12|||
154958516|NCT00635492|559275527|FG001|Overall Study|Death|40|||
154958517|NCT00635492|559275526|FG000|Overall Study|Lost to Follow-up|151|||
154958518|NCT00635492|559275527|FG001|Overall Study|Lost to Follow-up|172|||
154958519|NCT00635492|559275526|FG000|Overall Study|Physician Decision|32|||
154958520|NCT00635492|559275527|FG001|Overall Study|Physician Decision|22|||
154958521|NCT00635492|559275526|FG000|Overall Study|Sponsor decision|2|||
154958522|NCT00635492|559275527|FG001|Overall Study|Sponsor decision|3|||
154958523|NCT00635492|559275526|FG000|Overall Study|Withdrawal by Subject|82|||
154958524|NCT00635492|559275527|FG001|Overall Study|Withdrawal by Subject|45|||
154958525|NCT02682784|559275533|FG000|Overall Study|Withdrawal by Subject|0|||
154958526|NCT02682784|559275534|FG001|Overall Study|Withdrawal by Subject|2|||
154958527|NCT02682784|559275535|FG002|Overall Study|Withdrawal by Subject|1|||
154958528|NCT02682784|559275536|FG003|Overall Study|Withdrawal by Subject|2|||
154958529|NCT02682784|559275533|FG000|Overall Study|Physician Decision|1|||
154958530|NCT02682784|559275534|FG001|Overall Study|Physician Decision|0|||
154958531|NCT02682784|559275535|FG002|Overall Study|Physician Decision|1|||
154958532|NCT02682784|559275536|FG003|Overall Study|Physician Decision|1|||
154958533|NCT01702987|559275537|FG000|Overall Study|Withdrawal by Subject|1|||
154958534|NCT01702987|559275538|FG001|Overall Study|Withdrawal by Subject|0|||
154958535|NCT00467363|559275539|FG000|Overall Study|Lost to Follow-up|80|||
154958536|NCT00467363|559275540|FG001|Overall Study|Lost to Follow-up|70|||
154958537|NCT04533594|559275541|FG000|Overall Study|Death|26|||
154958538|NCT00473330|559275548|FG000|Core Study|Adverse Event|4|||
154958539|NCT00473330|559275549|FG001|Core Study|Adverse Event|4|||
154958540|NCT00473330|559275550|FG002|Core Study|Adverse Event|1|||
154958541|NCT00473330|559275548|FG000|Core Study|Death|6|||
154958542|NCT00473330|559275549|FG001|Core Study|Death|4|||
154958543|NCT00473330|559275550|FG002|Core Study|Death|4|||
154958544|NCT00473330|559275548|FG000|Core Study|Lost to Follow-up|5|||
154958545|NCT00473330|559275549|FG001|Core Study|Lost to Follow-up|5|||
154958546|NCT00473330|559275550|FG002|Core Study|Lost to Follow-up|10|||
154958547|NCT00473330|559275548|FG000|Core Study|Physician Decision|2|||
154958548|NCT00473330|559275549|FG001|Core Study|Physician Decision|1|||
155302973|NCT02723955|560542685|FG030|Escalation Phase|Physician Decision|0|||
155302974|NCT02723955|560542686|FG031|Escalation Phase|Physician Decision|0|||
155302975|NCT02723955|560542687|FG032|Escalation Phase|Physician Decision|0|||
155302976|NCT02723955|560542688|FG033|Escalation Phase|Physician Decision|0|||
155302977|NCT02723955|560542689|FG034|Escalation Phase|Physician Decision|0|||
155302978|NCT02723955|560542690|FG035|Escalation Phase|Physician Decision|0|||
155302979|NCT02723955|560542691|FG036|Escalation Phase|Physician Decision|0|||
155302980|NCT02723955|560542692|FG037|Escalation Phase|Physician Decision|0|||
155302981|NCT02723955|560542693|FG038|Escalation Phase|Physician Decision|0|||
155302982|NCT02723955|560542694|FG039|Escalation Phase|Physician Decision|0|||
155302983|NCT02723955|560542695|FG040|Escalation Phase|Physician Decision|0|||
154958549|NCT00473330|559275550|FG002|Core Study|Physician Decision|3|||
154958550|NCT00473330|559275548|FG000|Core Study|Subject Non-compliance|1|||
154958551|NCT00473330|559275549|FG001|Core Study|Subject Non-compliance|2|||
154958552|NCT00473330|559275550|FG002|Core Study|Subject Non-compliance|1|||
154958553|NCT00473330|559275548|FG000|Core Study|Subject Required Other Therapy|0|||
154958554|NCT00473330|559275549|FG001|Core Study|Subject Required Other Therapy|1|||
154958555|NCT00473330|559275550|FG002|Core Study|Subject Required Other Therapy|3|||
154958556|NCT00473330|559275548|FG000|Core Study|Subject's Decision|9|||
154958557|NCT00473330|559275549|FG001|Core Study|Subject's Decision|8|||
154958558|NCT00473330|559275550|FG002|Core Study|Subject's Decision|19|||
154958559|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
154958560|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
154958561|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
154958562|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Death|2|||
154958563|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Death|0|||
154958564|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Death|0|||
154958565|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
154958566|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
154958567|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
154958568|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
154958569|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
154958570|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
154958571|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
154958572|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
154958573|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
154958574|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
154958575|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
154958576|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
154958577|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
154958578|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
154958579|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
154958580|NCT00473330|559275548|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
154958581|NCT00473330|559275549|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
154958582|NCT00473330|559275550|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
154958583|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
154958584|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
154958585|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
154958586|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Death|2|||
154958587|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Death|2|||
154958588|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Death|1|||
154958589|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
154958590|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
154958591|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
154958592|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
154958593|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
154958594|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
154958595|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
154958596|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
154958597|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
154958598|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
154958599|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
154958600|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
154958601|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
154958602|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
155302984|NCT02723955|560542696|FG041|Escalation Phase|Physician Decision|0|||
155302985|NCT02723955|560542697|FG042|Escalation Phase|Physician Decision|0|||
155302986|NCT02723955|560542655|FG000|Escalation Phase|Withdrawal by Subject|0|||
155302987|NCT02723955|560542656|FG001|Escalation Phase|Withdrawal by Subject|0|||
155302988|NCT02723955|560542657|FG002|Escalation Phase|Withdrawal by Subject|0|||
155302989|NCT02723955|560542658|FG003|Escalation Phase|Withdrawal by Subject|0|||
155302990|NCT02723955|560542659|FG004|Escalation Phase|Withdrawal by Subject|1|||
155302991|NCT02723955|560542660|FG005|Escalation Phase|Withdrawal by Subject|1|||
155302992|NCT02723955|560542661|FG006|Escalation Phase|Withdrawal by Subject|1|||
155302993|NCT02723955|560542662|FG007|Escalation Phase|Withdrawal by Subject|1|||
155302994|NCT02723955|560542663|FG008|Escalation Phase|Withdrawal by Subject|0|||
155302995|NCT02723955|560542664|FG009|Escalation Phase|Withdrawal by Subject|0|||
155302996|NCT02723955|560542665|FG010|Escalation Phase|Withdrawal by Subject|0|||
155302997|NCT02723955|560542666|FG011|Escalation Phase|Withdrawal by Subject|0|||
155302998|NCT02723955|560542667|FG012|Escalation Phase|Withdrawal by Subject|1|||
155302999|NCT02723955|560542668|FG013|Escalation Phase|Withdrawal by Subject|0|||
155303000|NCT02723955|560542669|FG014|Escalation Phase|Withdrawal by Subject|0|||
155303001|NCT02723955|560542670|FG015|Escalation Phase|Withdrawal by Subject|0|||
155303002|NCT02723955|560542671|FG016|Escalation Phase|Withdrawal by Subject|1|||
155303003|NCT02723955|560542672|FG017|Escalation Phase|Withdrawal by Subject|0|||
155303004|NCT02723955|560542673|FG018|Escalation Phase|Withdrawal by Subject|0|||
155303005|NCT02723955|560542674|FG019|Escalation Phase|Withdrawal by Subject|0|||
155303006|NCT02723955|560542675|FG020|Escalation Phase|Withdrawal by Subject|0|||
155303007|NCT02723955|560542676|FG021|Escalation Phase|Withdrawal by Subject|0|||
155303008|NCT02723955|560542677|FG022|Escalation Phase|Withdrawal by Subject|0|||
155303009|NCT02723955|560542678|FG023|Escalation Phase|Withdrawal by Subject|2|||
155303010|NCT02723955|560542679|FG024|Escalation Phase|Withdrawal by Subject|0|||
155303011|NCT02723955|560542680|FG025|Escalation Phase|Withdrawal by Subject|1|||
155303012|NCT02723955|560542681|FG026|Escalation Phase|Withdrawal by Subject|0|||
155303013|NCT02723955|560542682|FG027|Escalation Phase|Withdrawal by Subject|0|||
155303014|NCT02723955|560542683|FG028|Escalation Phase|Withdrawal by Subject|1|||
155303015|NCT02723955|560542684|FG029|Escalation Phase|Withdrawal by Subject|0|||
155303016|NCT02723955|560542685|FG030|Escalation Phase|Withdrawal by Subject|0|||
155303017|NCT02723955|560542686|FG031|Escalation Phase|Withdrawal by Subject|0|||
155303018|NCT02723955|560542687|FG032|Escalation Phase|Withdrawal by Subject|0|||
155303019|NCT02723955|560542688|FG033|Escalation Phase|Withdrawal by Subject|0|||
155303020|NCT02723955|560542689|FG034|Escalation Phase|Withdrawal by Subject|0|||
155303021|NCT02723955|560542690|FG035|Escalation Phase|Withdrawal by Subject|0|||
155303022|NCT02723955|560542691|FG036|Escalation Phase|Withdrawal by Subject|0|||
155303023|NCT02723955|560542692|FG037|Escalation Phase|Withdrawal by Subject|0|||
155303024|NCT02723955|560542693|FG038|Escalation Phase|Withdrawal by Subject|0|||
155303025|NCT02723955|560542694|FG039|Escalation Phase|Withdrawal by Subject|0|||
155303026|NCT02723955|560542695|FG040|Escalation Phase|Withdrawal by Subject|0|||
155303027|NCT02723955|560542696|FG041|Escalation Phase|Withdrawal by Subject|0|||
155303028|NCT02723955|560542697|FG042|Escalation Phase|Withdrawal by Subject|0|||
155303029|NCT02723955|560542655|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303030|NCT02723955|560542656|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303031|NCT02723955|560542657|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303032|NCT02723955|560542658|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303033|NCT02723955|560542659|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
155303034|NCT02723955|560542660|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
155303035|NCT02723955|560542661|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
155303036|NCT02723955|560542662|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
155303037|NCT02723955|560542663|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
155303038|NCT02723955|560542664|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303039|NCT02723955|560542665|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303040|NCT02723955|560542666|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303041|NCT02723955|560542667|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303042|NCT02723955|560542668|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303043|NCT02723955|560542669|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303044|NCT02723955|560542670|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303045|NCT02723955|560542671|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303046|NCT02723955|560542672|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303047|NCT02723955|560542673|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303048|NCT02723955|560542674|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303049|NCT02723955|560542675|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303050|NCT02723955|560542676|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303051|NCT02723955|560542677|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303052|NCT02723955|560542678|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303053|NCT02723955|560542679|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303054|NCT02723955|560542680|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303055|NCT02723955|560542681|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303056|NCT02723955|560542682|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303057|NCT02723955|560542683|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303058|NCT02723955|560542684|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303059|NCT02723955|560542685|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303060|NCT02723955|560542686|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303061|NCT02723955|560542687|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303062|NCT02723955|560542688|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303063|NCT02723955|560542689|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303064|NCT02723955|560542690|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303065|NCT02723955|560542691|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303066|NCT02723955|560542692|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303067|NCT02723955|560542693|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303068|NCT02723955|560542694|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303069|NCT02723955|560542695|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303070|NCT02723955|560542696|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303071|NCT02723955|560542697|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
155303072|NCT02723955|560542655|FG000|Escalation Phase|Site Closed|0|||
155303073|NCT02723955|560542656|FG001|Escalation Phase|Site Closed|0|||
155303074|NCT02723955|560542657|FG002|Escalation Phase|Site Closed|0|||
155303075|NCT02723955|560542658|FG003|Escalation Phase|Site Closed|0|||
155303076|NCT02723955|560542659|FG004|Escalation Phase|Site Closed|0|||
155303077|NCT02723955|560542660|FG005|Escalation Phase|Site Closed|0|||
155303078|NCT02723955|560542661|FG006|Escalation Phase|Site Closed|0|||
155303079|NCT02723955|560542662|FG007|Escalation Phase|Site Closed|0|||
155303080|NCT02723955|560542663|FG008|Escalation Phase|Site Closed|0|||
155303081|NCT02723955|560542664|FG009|Escalation Phase|Site Closed|0|||
155303082|NCT02723955|560542665|FG010|Escalation Phase|Site Closed|0|||
155303083|NCT02723955|560542666|FG011|Escalation Phase|Site Closed|0|||
155303084|NCT02723955|560542667|FG012|Escalation Phase|Site Closed|0|||
155303085|NCT02723955|560542668|FG013|Escalation Phase|Site Closed|0|||
155303086|NCT02723955|560542669|FG014|Escalation Phase|Site Closed|0|||
155303087|NCT02723955|560542670|FG015|Escalation Phase|Site Closed|1|||
155303088|NCT02723955|560542671|FG016|Escalation Phase|Site Closed|0|||
155303089|NCT02723955|560542672|FG017|Escalation Phase|Site Closed|2|||
155303090|NCT02723955|560542673|FG018|Escalation Phase|Site Closed|0|||
155303091|NCT02723955|560542674|FG019|Escalation Phase|Site Closed|0|||
155303092|NCT02723955|560542675|FG020|Escalation Phase|Site Closed|1|||
155303093|NCT02723955|560542676|FG021|Escalation Phase|Site Closed|0|||
155303094|NCT02723955|560542677|FG022|Escalation Phase|Site Closed|0|||
155303095|NCT02723955|560542678|FG023|Escalation Phase|Site Closed|0|||
155303096|NCT02723955|560542679|FG024|Escalation Phase|Site Closed|3|||
155303097|NCT02723955|560542680|FG025|Escalation Phase|Site Closed|1|||
155303098|NCT02723955|560542681|FG026|Escalation Phase|Site Closed|3|||
155303099|NCT02723955|560542682|FG027|Escalation Phase|Site Closed|1|||
155303100|NCT02723955|560542683|FG028|Escalation Phase|Site Closed|1|||
155303101|NCT02723955|560542684|FG029|Escalation Phase|Site Closed|0|||
155303102|NCT02723955|560542685|FG030|Escalation Phase|Site Closed|0|||
155303103|NCT02723955|560542686|FG031|Escalation Phase|Site Closed|0|||
155303104|NCT02723955|560542687|FG032|Escalation Phase|Site Closed|0|||
155303105|NCT02723955|560542688|FG033|Escalation Phase|Site Closed|0|||
155303106|NCT02723955|560542689|FG034|Escalation Phase|Site Closed|0|||
155303107|NCT02723955|560542690|FG035|Escalation Phase|Site Closed|0|||
155303108|NCT02723955|560542691|FG036|Escalation Phase|Site Closed|0|||
155303109|NCT02723955|560542692|FG037|Escalation Phase|Site Closed|0|||
155303110|NCT02723955|560542693|FG038|Escalation Phase|Site Closed|0|||
155303111|NCT02723955|560542694|FG039|Escalation Phase|Site Closed|0|||
155303112|NCT02723955|560542695|FG040|Escalation Phase|Site Closed|0|||
155303113|NCT02723955|560542696|FG041|Escalation Phase|Site Closed|0|||
155303114|NCT02723955|560542697|FG042|Escalation Phase|Site Closed|0|||
155303115|NCT02723955|560542655|FG000|Expansion Phase|Death|0|||
155303116|NCT02723955|560542656|FG001|Expansion Phase|Death|0|||
155303117|NCT02723955|560542657|FG002|Expansion Phase|Death|0|||
155303118|NCT02723955|560542658|FG003|Expansion Phase|Death|0|||
155303119|NCT02723955|560542659|FG004|Expansion Phase|Death|0|||
155303120|NCT02723955|560542660|FG005|Expansion Phase|Death|0|||
155303121|NCT02723955|560542661|FG006|Expansion Phase|Death|0|||
155303122|NCT02723955|560542662|FG007|Expansion Phase|Death|0|||
155303123|NCT02723955|560542663|FG008|Expansion Phase|Death|0|||
155303124|NCT02723955|560542664|FG009|Expansion Phase|Death|25|||
155303125|NCT02723955|560542665|FG010|Expansion Phase|Death|69|||
155303126|NCT02723955|560542666|FG011|Expansion Phase|Death|48|||
155303127|NCT02723955|560542667|FG012|Expansion Phase|Death|0|||
155303128|NCT02723955|560542668|FG013|Expansion Phase|Death|0|||
155303129|NCT02723955|560542669|FG014|Expansion Phase|Death|0|||
155303130|NCT02723955|560542670|FG015|Expansion Phase|Death|0|||
155303131|NCT02723955|560542671|FG016|Expansion Phase|Death|0|||
155303132|NCT02723955|560542672|FG017|Expansion Phase|Death|0|||
155303133|NCT02723955|560542673|FG018|Expansion Phase|Death|0|||
155303134|NCT02723955|560542674|FG019|Expansion Phase|Death|0|||
155303135|NCT02723955|560542675|FG020|Expansion Phase|Death|0|||
155303136|NCT02723955|560542676|FG021|Expansion Phase|Death|0|||
155065085|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
155303137|NCT02723955|560542677|FG022|Expansion Phase|Death|0|||
155303138|NCT02723955|560542678|FG023|Expansion Phase|Death|0|||
155303139|NCT02723955|560542679|FG024|Expansion Phase|Death|0|||
155303140|NCT02723955|560542680|FG025|Expansion Phase|Death|0|||
155303141|NCT02723955|560542681|FG026|Expansion Phase|Death|0|||
155303142|NCT02723955|560542682|FG027|Expansion Phase|Death|0|||
155303143|NCT02723955|560542683|FG028|Expansion Phase|Death|0|||
155303144|NCT02723955|560542684|FG029|Expansion Phase|Death|12|||
155303145|NCT02723955|560542685|FG030|Expansion Phase|Death|202|||
155303146|NCT02723955|560542686|FG031|Expansion Phase|Death|31|||
155303147|NCT02723955|560542687|FG032|Expansion Phase|Death|17|||
155303148|NCT02723955|560542688|FG033|Expansion Phase|Death|2|||
155303149|NCT02723955|560542689|FG034|Expansion Phase|Death|3|||
155303150|NCT02723955|560542690|FG035|Expansion Phase|Death|3|||
155303151|NCT02723955|560542691|FG036|Expansion Phase|Death|1|||
155303152|NCT02723955|560542692|FG037|Expansion Phase|Death|0|||
155303153|NCT02723955|560542693|FG038|Expansion Phase|Death|0|||
155303154|NCT02723955|560542694|FG039|Expansion Phase|Death|0|||
155303155|NCT02723955|560542695|FG040|Expansion Phase|Death|0|||
155303156|NCT02723955|560542696|FG041|Expansion Phase|Death|0|||
155303157|NCT02723955|560542697|FG042|Expansion Phase|Death|0|||
155303158|NCT02723955|560542655|FG000|Expansion Phase|Lost to Follow-up|0|||
155303159|NCT02723955|560542656|FG001|Expansion Phase|Lost to Follow-up|0|||
155303160|NCT02723955|560542657|FG002|Expansion Phase|Lost to Follow-up|0|||
155303161|NCT02723955|560542658|FG003|Expansion Phase|Lost to Follow-up|0|||
155303162|NCT02723955|560542659|FG004|Expansion Phase|Lost to Follow-up|0|||
155303163|NCT02723955|560542660|FG005|Expansion Phase|Lost to Follow-up|0|||
155303164|NCT02723955|560542661|FG006|Expansion Phase|Lost to Follow-up|0|||
155303165|NCT02723955|560542662|FG007|Expansion Phase|Lost to Follow-up|0|||
155303166|NCT02723955|560542663|FG008|Expansion Phase|Lost to Follow-up|0|||
155303167|NCT02723955|560542664|FG009|Expansion Phase|Lost to Follow-up|0|||
155303168|NCT02723955|560542665|FG010|Expansion Phase|Lost to Follow-up|4|||
155303169|NCT02723955|560542666|FG011|Expansion Phase|Lost to Follow-up|1|||
155303170|NCT02723955|560542667|FG012|Expansion Phase|Lost to Follow-up|0|||
155303171|NCT02723955|560542668|FG013|Expansion Phase|Lost to Follow-up|0|||
155303172|NCT02723955|560542669|FG014|Expansion Phase|Lost to Follow-up|0|||
155303173|NCT02723955|560542670|FG015|Expansion Phase|Lost to Follow-up|0|||
155303174|NCT02723955|560542671|FG016|Expansion Phase|Lost to Follow-up|0|||
155303175|NCT02723955|560542672|FG017|Expansion Phase|Lost to Follow-up|0|||
155303176|NCT02723955|560542673|FG018|Expansion Phase|Lost to Follow-up|0|||
155303177|NCT02723955|560542674|FG019|Expansion Phase|Lost to Follow-up|0|||
155303178|NCT02723955|560542675|FG020|Expansion Phase|Lost to Follow-up|0|||
155303179|NCT02723955|560542676|FG021|Expansion Phase|Lost to Follow-up|0|||
155303180|NCT02723955|560542677|FG022|Expansion Phase|Lost to Follow-up|0|||
155303181|NCT02723955|560542678|FG023|Expansion Phase|Lost to Follow-up|0|||
155303182|NCT02723955|560542679|FG024|Expansion Phase|Lost to Follow-up|0|||
155303183|NCT02723955|560542680|FG025|Expansion Phase|Lost to Follow-up|0|||
155303184|NCT02723955|560542681|FG026|Expansion Phase|Lost to Follow-up|0|||
155303185|NCT02723955|560542682|FG027|Expansion Phase|Lost to Follow-up|0|||
155303186|NCT02723955|560542683|FG028|Expansion Phase|Lost to Follow-up|0|||
155303187|NCT02723955|560542684|FG029|Expansion Phase|Lost to Follow-up|1|||
155303188|NCT02723955|560542685|FG030|Expansion Phase|Lost to Follow-up|19|||
155303189|NCT02723955|560542686|FG031|Expansion Phase|Lost to Follow-up|2|||
154958603|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
154958604|NCT00473330|559275548|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
154958605|NCT00473330|559275549|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
155303190|NCT02723955|560542687|FG032|Expansion Phase|Lost to Follow-up|1|||
155303191|NCT02723955|560542688|FG033|Expansion Phase|Lost to Follow-up|0|||
155303192|NCT02723955|560542689|FG034|Expansion Phase|Lost to Follow-up|0|||
155303193|NCT02723955|560542690|FG035|Expansion Phase|Lost to Follow-up|0|||
155303194|NCT02723955|560542691|FG036|Expansion Phase|Lost to Follow-up|0|||
155303195|NCT02723955|560542692|FG037|Expansion Phase|Lost to Follow-up|0|||
155303196|NCT02723955|560542693|FG038|Expansion Phase|Lost to Follow-up|0|||
155303197|NCT02723955|560542694|FG039|Expansion Phase|Lost to Follow-up|0|||
155303198|NCT02723955|560542695|FG040|Expansion Phase|Lost to Follow-up|0|||
155303199|NCT02723955|560542696|FG041|Expansion Phase|Lost to Follow-up|0|||
155303200|NCT02723955|560542697|FG042|Expansion Phase|Lost to Follow-up|0|||
155303201|NCT02723955|560542655|FG000|Expansion Phase|Physician Decision|0|||
155303202|NCT02723955|560542656|FG001|Expansion Phase|Physician Decision|0|||
155303203|NCT02723955|560542657|FG002|Expansion Phase|Physician Decision|0|||
155303204|NCT02723955|560542658|FG003|Expansion Phase|Physician Decision|0|||
155303205|NCT02723955|560542659|FG004|Expansion Phase|Physician Decision|0|||
155303206|NCT02723955|560542660|FG005|Expansion Phase|Physician Decision|0|||
155303207|NCT02723955|560542661|FG006|Expansion Phase|Physician Decision|0|||
155303208|NCT02723955|560542662|FG007|Expansion Phase|Physician Decision|0|||
155303209|NCT02723955|560542663|FG008|Expansion Phase|Physician Decision|0|||
155303210|NCT02723955|560542664|FG009|Expansion Phase|Physician Decision|0|||
155303211|NCT02723955|560542665|FG010|Expansion Phase|Physician Decision|0|||
155303212|NCT02723955|560542666|FG011|Expansion Phase|Physician Decision|0|||
155303213|NCT02723955|560542667|FG012|Expansion Phase|Physician Decision|0|||
155303214|NCT02723955|560542668|FG013|Expansion Phase|Physician Decision|0|||
155303215|NCT02723955|560542669|FG014|Expansion Phase|Physician Decision|0|||
155303216|NCT02723955|560542670|FG015|Expansion Phase|Physician Decision|0|||
155303217|NCT02723955|560542671|FG016|Expansion Phase|Physician Decision|0|||
155303218|NCT02723955|560542672|FG017|Expansion Phase|Physician Decision|0|||
155303219|NCT02723955|560542673|FG018|Expansion Phase|Physician Decision|0|||
155303220|NCT02723955|560542674|FG019|Expansion Phase|Physician Decision|0|||
155303221|NCT02723955|560542675|FG020|Expansion Phase|Physician Decision|0|||
155303222|NCT02723955|560542676|FG021|Expansion Phase|Physician Decision|0|||
155303223|NCT02723955|560542677|FG022|Expansion Phase|Physician Decision|0|||
155303224|NCT02723955|560542678|FG023|Expansion Phase|Physician Decision|0|||
155303225|NCT02723955|560542679|FG024|Expansion Phase|Physician Decision|0|||
155303226|NCT02723955|560542680|FG025|Expansion Phase|Physician Decision|0|||
155303227|NCT02723955|560542681|FG026|Expansion Phase|Physician Decision|0|||
155303228|NCT02723955|560542682|FG027|Expansion Phase|Physician Decision|0|||
155303229|NCT02723955|560542683|FG028|Expansion Phase|Physician Decision|0|||
155303230|NCT02723955|560542684|FG029|Expansion Phase|Physician Decision|0|||
155303231|NCT02723955|560542685|FG030|Expansion Phase|Physician Decision|1|||
155303232|NCT02723955|560542686|FG031|Expansion Phase|Physician Decision|1|||
155303233|NCT02723955|560542687|FG032|Expansion Phase|Physician Decision|0|||
155303234|NCT02723955|560542688|FG033|Expansion Phase|Physician Decision|0|||
155303235|NCT02723955|560542689|FG034|Expansion Phase|Physician Decision|0|||
155303236|NCT02723955|560542690|FG035|Expansion Phase|Physician Decision|0|||
155303237|NCT02723955|560542691|FG036|Expansion Phase|Physician Decision|0|||
155065086|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
155065087|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
155065088|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
155065089|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
155065090|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
155065091|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
155065092|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
155065093|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
155065094|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
155065095|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
155065096|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
155065097|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
155065098|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
155065099|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
155065100|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
155065101|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
155065102|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
155065103|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
155065104|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
155065105|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
155065106|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
155160872|NCT02113982|560026684|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160873|NCT02113982|560026685|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155303238|NCT02723955|560542692|FG037|Expansion Phase|Physician Decision|0|||
155303239|NCT02723955|560542693|FG038|Expansion Phase|Physician Decision|0|||
155303240|NCT02723955|560542694|FG039|Expansion Phase|Physician Decision|0|||
155303241|NCT02723955|560542695|FG040|Expansion Phase|Physician Decision|0|||
155303242|NCT02723955|560542696|FG041|Expansion Phase|Physician Decision|0|||
155303243|NCT02723955|560542697|FG042|Expansion Phase|Physician Decision|0|||
155303244|NCT02723955|560542655|FG000|Expansion Phase|Withdrawal by Subject|0|||
155303245|NCT02723955|560542656|FG001|Expansion Phase|Withdrawal by Subject|0|||
155303246|NCT02723955|560542657|FG002|Expansion Phase|Withdrawal by Subject|0|||
155303247|NCT02723955|560542658|FG003|Expansion Phase|Withdrawal by Subject|0|||
155303248|NCT02723955|560542659|FG004|Expansion Phase|Withdrawal by Subject|0|||
155303249|NCT02723955|560542660|FG005|Expansion Phase|Withdrawal by Subject|0|||
155303250|NCT02723955|560542661|FG006|Expansion Phase|Withdrawal by Subject|0|||
155303251|NCT02723955|560542662|FG007|Expansion Phase|Withdrawal by Subject|0|||
155303252|NCT02723955|560542663|FG008|Expansion Phase|Withdrawal by Subject|0|||
155303253|NCT02723955|560542664|FG009|Expansion Phase|Withdrawal by Subject|2|||
155303254|NCT02723955|560542665|FG010|Expansion Phase|Withdrawal by Subject|1|||
155303255|NCT02723955|560542666|FG011|Expansion Phase|Withdrawal by Subject|0|||
155303256|NCT02723955|560542667|FG012|Expansion Phase|Withdrawal by Subject|0|||
155303257|NCT02723955|560542668|FG013|Expansion Phase|Withdrawal by Subject|0|||
155303258|NCT02723955|560542669|FG014|Expansion Phase|Withdrawal by Subject|0|||
155303259|NCT02723955|560542670|FG015|Expansion Phase|Withdrawal by Subject|0|||
155303260|NCT02723955|560542671|FG016|Expansion Phase|Withdrawal by Subject|0|||
155303261|NCT02723955|560542672|FG017|Expansion Phase|Withdrawal by Subject|0|||
155303262|NCT02723955|560542673|FG018|Expansion Phase|Withdrawal by Subject|0|||
155303263|NCT02723955|560542674|FG019|Expansion Phase|Withdrawal by Subject|0|||
155303264|NCT02723955|560542675|FG020|Expansion Phase|Withdrawal by Subject|0|||
155303265|NCT02723955|560542676|FG021|Expansion Phase|Withdrawal by Subject|0|||
155303266|NCT02723955|560542677|FG022|Expansion Phase|Withdrawal by Subject|0|||
155303267|NCT02723955|560542678|FG023|Expansion Phase|Withdrawal by Subject|0|||
155303268|NCT02723955|560542679|FG024|Expansion Phase|Withdrawal by Subject|0|||
155303269|NCT02723955|560542680|FG025|Expansion Phase|Withdrawal by Subject|0|||
155303270|NCT02723955|560542681|FG026|Expansion Phase|Withdrawal by Subject|0|||
155303271|NCT02723955|560542682|FG027|Expansion Phase|Withdrawal by Subject|0|||
155303272|NCT02723955|560542683|FG028|Expansion Phase|Withdrawal by Subject|0|||
155303273|NCT02723955|560542684|FG029|Expansion Phase|Withdrawal by Subject|0|||
155303274|NCT02723955|560542685|FG030|Expansion Phase|Withdrawal by Subject|8|||
155303275|NCT02723955|560542686|FG031|Expansion Phase|Withdrawal by Subject|4|||
155303276|NCT02723955|560542687|FG032|Expansion Phase|Withdrawal by Subject|0|||
155303277|NCT02723955|560542688|FG033|Expansion Phase|Withdrawal by Subject|0|||
155303278|NCT02723955|560542689|FG034|Expansion Phase|Withdrawal by Subject|0|||
155303279|NCT02723955|560542690|FG035|Expansion Phase|Withdrawal by Subject|1|||
155303280|NCT02723955|560542691|FG036|Expansion Phase|Withdrawal by Subject|0|||
155303281|NCT02723955|560542692|FG037|Expansion Phase|Withdrawal by Subject|0|||
155303282|NCT02723955|560542693|FG038|Expansion Phase|Withdrawal by Subject|0|||
155303283|NCT02723955|560542694|FG039|Expansion Phase|Withdrawal by Subject|0|||
155303284|NCT02723955|560542695|FG040|Expansion Phase|Withdrawal by Subject|0|||
155303285|NCT02723955|560542696|FG041|Expansion Phase|Withdrawal by Subject|0|||
155303286|NCT02723955|560542697|FG042|Expansion Phase|Withdrawal by Subject|0|||
155303287|NCT02723955|560542655|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303288|NCT02723955|560542656|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303289|NCT02723955|560542657|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303290|NCT02723955|560542658|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303291|NCT02723955|560542659|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303292|NCT02723955|560542660|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303293|NCT02723955|560542661|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303294|NCT02723955|560542662|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303295|NCT02723955|560542663|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303296|NCT02723955|560542664|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
155303297|NCT02723955|560542665|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
155303298|NCT02723955|560542666|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
155303299|NCT02723955|560542667|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303300|NCT02723955|560542668|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303301|NCT02723955|560542669|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303302|NCT02723955|560542670|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303303|NCT02723955|560542671|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303304|NCT02723955|560542672|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303305|NCT02723955|560542673|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303306|NCT02723955|560542674|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303307|NCT02723955|560542675|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303308|NCT02723955|560542676|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303309|NCT02723955|560542677|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303310|NCT02723955|560542678|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303311|NCT02723955|560542679|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303312|NCT02723955|560542680|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303313|NCT02723955|560542681|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303314|NCT02723955|560542682|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303315|NCT02723955|560542683|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303316|NCT02723955|560542684|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303317|NCT02723955|560542685|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
155303318|NCT02723955|560542686|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303319|NCT02723955|560542687|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303320|NCT02723955|560542688|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303321|NCT02723955|560542689|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303322|NCT02723955|560542690|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303323|NCT02723955|560542691|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303324|NCT02723955|560542692|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303325|NCT02723955|560542693|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303326|NCT02723955|560542694|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303327|NCT02723955|560542695|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303328|NCT02723955|560542696|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303329|NCT02723955|560542697|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
155303330|NCT02723955|560542655|FG000|Expansion Phase|Site Closed|0|||
155303331|NCT02723955|560542656|FG001|Expansion Phase|Site Closed|0|||
155303332|NCT02723955|560542657|FG002|Expansion Phase|Site Closed|0|||
155303333|NCT02723955|560542658|FG003|Expansion Phase|Site Closed|0|||
155303334|NCT02723955|560542659|FG004|Expansion Phase|Site Closed|0|||
155303335|NCT02723955|560542660|FG005|Expansion Phase|Site Closed|0|||
155303336|NCT02723955|560542661|FG006|Expansion Phase|Site Closed|0|||
155303337|NCT02723955|560542662|FG007|Expansion Phase|Site Closed|0|||
155160874|NCT02113982|560026686|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160875|NCT02113982|560026687|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
155160876|NCT02113982|560026688|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
155160877|NCT03349034|560026690|FG000|Overall Study|catheters dislodged during transport|2|||
155065107|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
155065108|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
155065109|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
155065110|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
155065111|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
155065112|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
155065113|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
155065114|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
155065115|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
155065116|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
155065117|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
155160878|NCT03349034|560026691|FG001|Overall Study|catheters dislodged during transport|0|||
155160879|NCT03349034|560026690|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
155303338|NCT02723955|560542663|FG008|Expansion Phase|Site Closed|0|||
155303339|NCT02723955|560542664|FG009|Expansion Phase|Site Closed|1|||
155303340|NCT02723955|560542665|FG010|Expansion Phase|Site Closed|2|||
155303341|NCT02723955|560542666|FG011|Expansion Phase|Site Closed|6|||
155303342|NCT02723955|560542667|FG012|Expansion Phase|Site Closed|0|||
155160880|NCT03349034|560026691|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
155160881|NCT03349034|560026690|FG000|Overall Study|soft tissue flap used|1|||
155160882|NCT03349034|560026691|FG001|Overall Study|soft tissue flap used|0|||
155303343|NCT02723955|560542668|FG013|Expansion Phase|Site Closed|0|||
155303344|NCT02723955|560542669|FG014|Expansion Phase|Site Closed|0|||
155303345|NCT02723955|560542670|FG015|Expansion Phase|Site Closed|0|||
155303346|NCT02723955|560542671|FG016|Expansion Phase|Site Closed|0|||
155303347|NCT02723955|560542672|FG017|Expansion Phase|Site Closed|0|||
155303348|NCT02723955|560542673|FG018|Expansion Phase|Site Closed|0|||
155303349|NCT02723955|560542674|FG019|Expansion Phase|Site Closed|0|||
155303350|NCT02723955|560542675|FG020|Expansion Phase|Site Closed|0|||
155303351|NCT02723955|560542676|FG021|Expansion Phase|Site Closed|0|||
155303352|NCT02723955|560542677|FG022|Expansion Phase|Site Closed|0|||
155303353|NCT02723955|560542678|FG023|Expansion Phase|Site Closed|0|||
155303354|NCT02723955|560542679|FG024|Expansion Phase|Site Closed|0|||
155303355|NCT02723955|560542680|FG025|Expansion Phase|Site Closed|0|||
155303356|NCT02723955|560542681|FG026|Expansion Phase|Site Closed|0|||
155303357|NCT02723955|560542682|FG027|Expansion Phase|Site Closed|0|||
155303358|NCT02723955|560542683|FG028|Expansion Phase|Site Closed|0|||
155303359|NCT02723955|560542684|FG029|Expansion Phase|Site Closed|0|||
155303360|NCT02723955|560542685|FG030|Expansion Phase|Site Closed|8|||
155303361|NCT02723955|560542686|FG031|Expansion Phase|Site Closed|4|||
155303362|NCT02723955|560542687|FG032|Expansion Phase|Site Closed|2|||
155303363|NCT02723955|560542688|FG033|Expansion Phase|Site Closed|2|||
155303364|NCT02723955|560542689|FG034|Expansion Phase|Site Closed|0|||
155303365|NCT02723955|560542690|FG035|Expansion Phase|Site Closed|0|||
155303366|NCT02723955|560542691|FG036|Expansion Phase|Site Closed|0|||
155303367|NCT02723955|560542692|FG037|Expansion Phase|Site Closed|0|||
155303368|NCT02723955|560542693|FG038|Expansion Phase|Site Closed|0|||
155303369|NCT02723955|560542694|FG039|Expansion Phase|Site Closed|0|||
155303370|NCT02723955|560542695|FG040|Expansion Phase|Site Closed|0|||
155303371|NCT02723955|560542696|FG041|Expansion Phase|Site Closed|0|||
155303372|NCT02723955|560542697|FG042|Expansion Phase|Site Closed|0|||
155303373|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Death|0|||
155303374|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Death|0|||
155303375|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Death|0|||
155303376|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Death|0|||
155303377|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Death|0|||
155303378|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Death|0|||
155303379|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Death|0|||
155303380|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Death|0|||
155303381|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Death|0|||
155303382|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Death|0|||
155303383|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Death|0|||
155303384|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Death|0|||
155303385|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Death|0|||
155303386|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Death|0|||
155303387|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Death|0|||
155303388|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Death|0|||
155303389|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Death|0|||
155303390|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Death|0|||
155303391|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Death|0|||
155303392|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Death|0|||
155303393|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Death|0|||
155303394|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Death|0|||
155303395|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Death|0|||
155303396|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Death|0|||
155160883|NCT03349034|560026690|FG000|Overall Study|Other|0|||
155160884|NCT03349034|560026691|FG001|Overall Study|Other|1|||
155160885|NCT00865566|560026692|FG000|Overall Study|Death|1|||
155160886|NCT00865566|560026693|FG001|Overall Study|Death|11|||
155160887|NCT00865566|560026692|FG000|Overall Study|Lost to Follow-up|314|||
155160888|NCT00865566|560026693|FG001|Overall Study|Lost to Follow-up|315|||
155160889|NCT00865566|560026692|FG000|Overall Study|Withdrawal by Subject|45|||
155160890|NCT00865566|560026693|FG001|Overall Study|Withdrawal by Subject|65|||
155160891|NCT00865566|560026692|FG000|Overall Study|Physician Decision|0|||
155160892|NCT00865566|560026693|FG001|Overall Study|Physician Decision|1|||
155303397|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Death|0|||
155303398|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Death|0|||
155303399|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Death|0|||
155303400|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Death|0|||
155303401|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Death|0|||
155303402|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Death|0|||
155303403|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Death|0|||
155303404|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Death|0|||
155303405|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Death|0|||
155160893|NCT00865566|560026692|FG000|Overall Study|Participant relocated|78|||
155303406|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Death|0|||
155303407|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Death|0|||
155303408|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Death|0|||
155303409|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Death|0|||
155303410|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Death|1|||
155303411|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Death|14|||
155303412|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Death|32|||
155303413|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Death|2|||
155303414|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Death|1|||
155303415|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Death|0|||
155303416|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303417|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303418|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303419|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303420|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303421|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303422|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303423|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303424|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303425|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303426|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303427|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303428|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303429|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303430|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303431|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303432|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303433|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303434|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303435|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303436|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303437|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303438|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303439|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303440|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303441|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303442|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303443|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303444|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303445|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303446|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303447|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303448|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303449|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303450|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303451|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303452|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303453|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303454|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303455|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
155303456|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303457|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303458|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
155303459|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303460|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303461|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303462|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303463|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303464|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303465|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303466|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303467|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303468|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
154958606|NCT00473330|559275550|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
155303469|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303470|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
154958607|NCT01975948|559275552|FG000|Overall Study|Withdrawal by Subject|17|||
155303471|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303472|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303473|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303474|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303475|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303476|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303477|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303478|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303479|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303480|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303481|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303482|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303483|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303484|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303485|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303486|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303487|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303488|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303489|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303490|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303491|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303492|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303493|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303494|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303495|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303496|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303497|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
155303498|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
155303499|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303500|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
155303501|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
155303502|NCT02723955|560542655|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
155303503|NCT02723955|560542656|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
155303504|NCT02723955|560542657|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
155303505|NCT02723955|560542658|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
155303506|NCT02723955|560542659|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
155303507|NCT02723955|560542660|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
155303508|NCT02723955|560542661|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
155303509|NCT02723955|560542662|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
155303510|NCT02723955|560542663|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
155303511|NCT02723955|560542664|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
155303512|NCT02723955|560542665|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
155303513|NCT02723955|560542666|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
155303514|NCT02723955|560542667|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
155303515|NCT02723955|560542668|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
155303516|NCT02723955|560542669|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
155303517|NCT02723955|560542670|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
155303518|NCT02723955|560542671|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
155303519|NCT02723955|560542672|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
155303520|NCT02723955|560542673|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
155303521|NCT02723955|560542674|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
155303522|NCT02723955|560542675|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
155303523|NCT02723955|560542676|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
155303524|NCT02723955|560542677|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
155303525|NCT02723955|560542678|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
155303526|NCT02723955|560542679|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
155303527|NCT02723955|560542680|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
155303528|NCT02723955|560542681|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
155303529|NCT02723955|560542682|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
155303530|NCT02723955|560542683|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
155303531|NCT02723955|560542684|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
155303532|NCT02723955|560542685|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
155303533|NCT02723955|560542686|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
155303534|NCT02723955|560542687|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
155303535|NCT02723955|560542688|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
155303536|NCT02723955|560542689|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
155303537|NCT02723955|560542690|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
155303538|NCT02723955|560542691|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
155303539|NCT02723955|560542692|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
155303540|NCT02723955|560542693|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
155303541|NCT02723955|560542694|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
155303542|NCT02723955|560542695|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
155303543|NCT02723955|560542696|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
155303544|NCT02723955|560542697|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
155303545|NCT04999085|560542700|FG000|Overall Study|Death|1|||
155303546|NCT05056246|560542703|FG000|Overall Study|Adverse Event|0|||
155303547|NCT05056246|560542704|FG001|Overall Study|Adverse Event|0|||
155303548|NCT05056246|560542705|FG002|Overall Study|Adverse Event|0|||
155303549|NCT05056246|560542706|FG003|Overall Study|Adverse Event|0|||
155303550|NCT05056246|560542707|FG004|Overall Study|Adverse Event|1|||
155303551|NCT05056246|560542703|FG000|Overall Study|Lost to Follow-up|0|||
155303552|NCT05056246|560542704|FG001|Overall Study|Lost to Follow-up|0|||
155303553|NCT05056246|560542705|FG002|Overall Study|Lost to Follow-up|0|||
155303554|NCT05056246|560542706|FG003|Overall Study|Lost to Follow-up|2|||
155303555|NCT05056246|560542707|FG004|Overall Study|Lost to Follow-up|0|||
155303556|NCT05056246|560542703|FG000|Overall Study|Withdrawal by Subject|0|||
155303557|NCT05056246|560542704|FG001|Overall Study|Withdrawal by Subject|1|||
155303558|NCT05056246|560542705|FG002|Overall Study|Withdrawal by Subject|0|||
155303559|NCT05056246|560542706|FG003|Overall Study|Withdrawal by Subject|0|||
155303560|NCT05056246|560542707|FG004|Overall Study|Withdrawal by Subject|0|||
155303561|NCT05057897|560542708|FG000|Overall Study|Site closure|2|||
155303562|NCT05057897|560542709|FG001|Overall Study|Site closure|2|||
155303563|NCT05057897|560542708|FG000|Overall Study|Death|1|||
155303564|NCT05057897|560542709|FG001|Overall Study|Death|0|||
155303565|NCT05096819|560542714|FG000|Overall Study|Withdrawal by Subject|3|||
155303566|NCT05096819|560542715|FG001|Overall Study|Withdrawal by Subject|0|||
155303567|NCT03324984|560542716|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
155303568|NCT03324984|560542717|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
155303569|NCT03346538|560542718|FG000|Overall Study|Physician Decision|0|||
155303570|NCT03346538|560542719|FG001|Overall Study|Physician Decision|1|||
155303571|NCT03346538|560542720|FG002|Overall Study|Physician Decision|0|||
155303572|NCT03346538|560542718|FG000|Overall Study|Withdrawal by Subject|3|||
155303573|NCT03346538|560542719|FG001|Overall Study|Withdrawal by Subject|2|||
155303574|NCT03346538|560542720|FG002|Overall Study|Withdrawal by Subject|0|||
155303575|NCT03346538|560542718|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
155303576|NCT03346538|560542719|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
155303577|NCT03346538|560542720|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
155303578|NCT03088813|560542721|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
155303579|NCT03088813|560542722|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
155303580|NCT03088813|560542723|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
155303581|NCT03088813|560542724|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
155303582|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
155303583|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
155303584|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
154958608|NCT01975948|559275553|FG001|Overall Study|Withdrawal by Subject|21|||
154958609|NCT01975948|559275554|FG002|Overall Study|Withdrawal by Subject|7|||
155303585|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
155303586|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
155303587|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
155303588|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
155303589|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
155303590|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
155303591|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
155303592|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
155303593|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
155303594|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
155303595|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
155303596|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
155303597|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
155303598|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
155303599|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
155303600|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
155303601|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
155303602|NCT03088813|560542721|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
155303603|NCT03088813|560542722|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
155303604|NCT03088813|560542723|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
155303605|NCT03088813|560542724|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
155303606|NCT01808339|560542738|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303607|NCT01808339|560542739|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303608|NCT01808339|560542740|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303609|NCT01808339|560542741|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
155303610|NCT01808339|560542742|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
155303611|NCT01808339|560542743|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
155303612|NCT01808339|560542738|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303613|NCT01808339|560542739|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155303614|NCT01808339|560542740|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303615|NCT01808339|560542741|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155303616|NCT01808339|560542742|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303617|NCT01808339|560542743|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155303618|NCT01808339|560542738|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303619|NCT01808339|560542739|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303620|NCT01808339|560542740|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
155303621|NCT01808339|560542741|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303622|NCT01808339|560542742|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
155303623|NCT01808339|560542743|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
154958610|NCT01975948|559275555|FG003|Overall Study|Withdrawal by Subject|6|||
154958611|NCT00365846|559275556|FG000|Overall Study|Lost to Follow-up|1|||
154958612|NCT00904215|559275557|FG000|Overall Study|Adverse Event|25|||
154958613|NCT00904215|559275557|FG000|Overall Study|Protocol Violation|10|||
154958614|NCT00904215|559275557|FG000|Overall Study|Lost to Follow-up|63|||
154958615|NCT00904215|559275557|FG000|Overall Study|Withdrawal by Subject|9|||
154958616|NCT00904215|559275557|FG000|Overall Study|Other|28|||
154958617|NCT00640562|559275558|FG000|Overall Study|Adverse Event|8|||
154958618|NCT00640562|559275559|FG001|Overall Study|Adverse Event|5|||
154958619|NCT00640562|559275558|FG000|Overall Study|Lack of Efficacy|1|||
154958620|NCT00640562|559275559|FG001|Overall Study|Lack of Efficacy|4|||
154958621|NCT00640562|559275558|FG000|Overall Study|Protocol Violation|2|||
154958622|NCT00640562|559275559|FG001|Overall Study|Protocol Violation|4|||
154958623|NCT00640562|559275558|FG000|Overall Study|Withdrawal by Subject|6|||
155303624|NCT00111813|560542753|FG000|Overall Study|Adverse Event|1|||
155303625|NCT00111813|560542754|FG001|Overall Study|Adverse Event|2|||
155303626|NCT00111813|560542755|FG002|Overall Study|Adverse Event|4|||
155303627|NCT00111813|560542756|FG003|Overall Study|Adverse Event|2|||
155303628|NCT00111813|560542757|FG004|Overall Study|Adverse Event|2|||
155303629|NCT00111813|560542758|FG005|Overall Study|Adverse Event|2|||
155303630|NCT00111813|560542753|FG000|Overall Study|Progressive disease|2|||
155303631|NCT00111813|560542754|FG001|Overall Study|Progressive disease|1|||
155303632|NCT00111813|560542755|FG002|Overall Study|Progressive disease|5|||
155303633|NCT00111813|560542756|FG003|Overall Study|Progressive disease|3|||
155303634|NCT00111813|560542757|FG004|Overall Study|Progressive disease|4|||
155303635|NCT00111813|560542758|FG005|Overall Study|Progressive disease|3|||
155303636|NCT00111813|560542753|FG000|Overall Study|Lack of Efficacy|0|||
155303637|NCT00111813|560542754|FG001|Overall Study|Lack of Efficacy|0|||
155303638|NCT00111813|560542755|FG002|Overall Study|Lack of Efficacy|0|||
155303639|NCT00111813|560542756|FG003|Overall Study|Lack of Efficacy|0|||
155303640|NCT00111813|560542757|FG004|Overall Study|Lack of Efficacy|0|||
155303641|NCT00111813|560542758|FG005|Overall Study|Lack of Efficacy|1|||
155303642|NCT00111813|560542753|FG000|Overall Study|Other|0|||
155303643|NCT00111813|560542754|FG001|Overall Study|Other|0|||
155303644|NCT00111813|560542755|FG002|Overall Study|Other|1|||
155303645|NCT00111813|560542756|FG003|Overall Study|Other|0|||
154958624|NCT00640562|559275559|FG001|Overall Study|Withdrawal by Subject|10|||
154958625|NCT00640562|559275558|FG000|Overall Study|Known risperidone intolerance|0|||
154958626|NCT00640562|559275559|FG001|Overall Study|Known risperidone intolerance|1|||
155303646|NCT00111813|560542757|FG004|Overall Study|Other|0|||
155303647|NCT00111813|560542758|FG005|Overall Study|Other|0|||
155303648|NCT00093015|560542766|FG000|Overall Study|Withdrawal by Subject|194|||
155303649|NCT00093015|560542767|FG001|Overall Study|Withdrawal by Subject|171|||
155303650|NCT00093015|560542766|FG000|Overall Study|Lost to Follow-up|96|||
155303651|NCT00093015|560542767|FG001|Overall Study|Lost to Follow-up|108|||
155303652|NCT00093015|560542766|FG000|Overall Study|Death|375|||
155303653|NCT00093015|560542767|FG001|Overall Study|Death|385|||
155303654|NCT03076515|560542770|FG000|Overall Study|DMC decision based on interim analysis|25|||
155303655|NCT03076515|560542771|FG001|Overall Study|DMC decision based on interim analysis|29|||
155303656|NCT02101281|560542772|FG000|Overall Study|Adverse Event|0|||
155303657|NCT02101281|560542773|FG001|Overall Study|Adverse Event|1|||
155303658|NCT00296036|560542774|FG000|Overall Study|Withdrawal by Subject|1|||
155303659|NCT00296036|560542775|FG001|Overall Study|Withdrawal by Subject|0|||
155303660|NCT00296036|560542776|FG002|Overall Study|Withdrawal by Subject|2|||
155303661|NCT00296036|560542777|FG003|Overall Study|Withdrawal by Subject|1|||
155303662|NCT00296036|560542778|FG004|Overall Study|Withdrawal by Subject|2|||
155303663|NCT00296036|560542779|FG005|Overall Study|Withdrawal by Subject|1|||
155303664|NCT00296036|560542774|FG000|Overall Study|Protocol Violation|0|||
155303665|NCT00296036|560542775|FG001|Overall Study|Protocol Violation|0|||
155303666|NCT00296036|560542776|FG002|Overall Study|Protocol Violation|0|||
155303667|NCT00296036|560542777|FG003|Overall Study|Protocol Violation|0|||
155303668|NCT00296036|560542778|FG004|Overall Study|Protocol Violation|0|||
155303669|NCT00296036|560542779|FG005|Overall Study|Protocol Violation|3|||
155303670|NCT00529100|560542784|FG000|Overall Study|Adverse Event|0|||
155303671|NCT00529100|560542785|FG001|Overall Study|Adverse Event|5|||
155303672|NCT00529100|560542784|FG000|Overall Study|Protocol Violation|0|||
155303673|NCT00529100|560542785|FG001|Overall Study|Protocol Violation|1|||
155303674|NCT00529100|560542784|FG000|Overall Study|Progressive Disease|0|||
155303675|NCT00529100|560542785|FG001|Overall Study|Progressive Disease|1|||
155303676|NCT00529100|560542784|FG000|Overall Study|Withdrawal by Subject|0|||
155303677|NCT00529100|560542785|FG001|Overall Study|Withdrawal by Subject|1|||
155303678|NCT00529100|560542784|FG000|Overall Study|Participant Ineligibility|0|||
155303679|NCT00529100|560542785|FG001|Overall Study|Participant Ineligibility|1|||
155303680|NCT03733119|560542786|FG000|Overall Study|Physician Decision|2|||
155303681|NCT03733119|560542787|FG001|Overall Study|Physician Decision|1|||
155303682|NCT03733119|560542786|FG000|Overall Study|ineligible to treat per protocol|0|||
155303683|NCT03733119|560542787|FG001|Overall Study|ineligible to treat per protocol|1|||
155303684|NCT00807937|560542788|FG000|Overall Study|Adverse Event|12|||
155303685|NCT00807937|560542789|FG001|Overall Study|Adverse Event|12|||
154958627|NCT00640562|559275558|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
155303686|NCT00807937|560542790|FG002|Overall Study|Adverse Event|5|||
155303687|NCT00807937|560542791|FG003|Overall Study|Adverse Event|4|||
155303688|NCT00807937|560542788|FG000|Overall Study|Protocol Violation|4|||
155303689|NCT00807937|560542789|FG001|Overall Study|Protocol Violation|5|||
155303690|NCT00807937|560542790|FG002|Overall Study|Protocol Violation|3|||
155303691|NCT00807937|560542791|FG003|Overall Study|Protocol Violation|3|||
155303692|NCT00807937|560542788|FG000|Overall Study|Withdrawal by Subject|5|||
155303693|NCT00807937|560542789|FG001|Overall Study|Withdrawal by Subject|4|||
155303694|NCT00807937|560542790|FG002|Overall Study|Withdrawal by Subject|1|||
155303695|NCT00807937|560542791|FG003|Overall Study|Withdrawal by Subject|4|||
155303696|NCT00807937|560542788|FG000|Overall Study|Lost to Follow-up|4|||
155303697|NCT00807937|560542789|FG001|Overall Study|Lost to Follow-up|0|||
155303698|NCT00807937|560542790|FG002|Overall Study|Lost to Follow-up|2|||
155303699|NCT00807937|560542791|FG003|Overall Study|Lost to Follow-up|1|||
155303700|NCT00807937|560542788|FG000|Overall Study|Lack of Efficacy|0|||
155303701|NCT00807937|560542789|FG001|Overall Study|Lack of Efficacy|0|||
155303702|NCT00807937|560542790|FG002|Overall Study|Lack of Efficacy|1|||
155303703|NCT00807937|560542791|FG003|Overall Study|Lack of Efficacy|2|||
155303704|NCT00807937|560542788|FG000|Overall Study|Intake of prohibited medicine|0|||
155303705|NCT00807937|560542789|FG001|Overall Study|Intake of prohibited medicine|0|||
155303706|NCT00807937|560542790|FG002|Overall Study|Intake of prohibited medicine|2|||
155303707|NCT00807937|560542791|FG003|Overall Study|Intake of prohibited medicine|0|||
155303708|NCT00807937|560542788|FG000|Overall Study|All other reasons (not provided)|2|||
155303709|NCT00807937|560542789|FG001|Overall Study|All other reasons (not provided)|4|||
155303710|NCT00807937|560542790|FG002|Overall Study|All other reasons (not provided)|0|||
155303711|NCT00807937|560542791|FG003|Overall Study|All other reasons (not provided)|1|||
155303712|NCT04629950|560542794|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
155303713|NCT04629950|560542795|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
155303714|NCT04629950|560542796|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
155303715|NCT04629950|560542797|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
155303716|NCT04629950|560542794|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
155303717|NCT04629950|560542795|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
155303718|NCT04629950|560542796|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
155303719|NCT04629950|560542797|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
155303720|NCT04629950|560542794|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
155303721|NCT04629950|560542795|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
155303722|NCT04629950|560542796|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
155303723|NCT04629950|560542797|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
155303724|NCT04629950|560542794|FG000|Extension Study|Withdrawal by Subject|0|||
155303725|NCT04629950|560542795|FG001|Extension Study|Withdrawal by Subject|0|||
155303726|NCT04629950|560542796|FG002|Extension Study|Withdrawal by Subject|1|||
155303727|NCT04629950|560542797|FG003|Extension Study|Withdrawal by Subject|0|||
155303728|NCT04629950|560542794|FG000|Extension Study|Adverse Event|0|||
155303729|NCT04629950|560542795|FG001|Extension Study|Adverse Event|0|||
155303730|NCT04629950|560542796|FG002|Extension Study|Adverse Event|0|||
155303731|NCT04629950|560542797|FG003|Extension Study|Adverse Event|1|||
155303732|NCT01198145|560542798|FG000|Overall Study|Withdrawal by Subject|1|||
155303733|NCT01198145|560542799|FG001|Overall Study|Withdrawal by Subject|1|||
155303734|NCT02568683|560542801|FG000|Overall Study|Death|0|||
155303735|NCT02568683|560542802|FG001|Overall Study|Death|2|||
155303736|NCT02568683|560542801|FG000|Overall Study|Withdrew Consent|1|||
155303737|NCT02568683|560542802|FG001|Overall Study|Withdrew Consent|0|||
155303738|NCT02568683|560542801|FG000|Overall Study|Study Terminated By Sponsor|5|||
155303739|NCT02568683|560542802|FG001|Overall Study|Study Terminated By Sponsor|2|||
155303740|NCT01561989|560542805|FG000|Overall Study|accural target not met.|5|||
155303741|NCT01561989|560542806|FG001|Overall Study|accural target not met.|6|||
155303742|NCT03485950|560542811|FG000|Overall Study|Adverse Event|1|||
155303743|NCT03485950|560542812|FG001|Overall Study|Adverse Event|0|||
155303744|NCT03485950|560542811|FG000|Overall Study|Death|3|||
155303745|NCT03485950|560542812|FG001|Overall Study|Death|2|||
155303746|NCT03485950|560542811|FG000|Overall Study|Withdrawal by Subject|3|||
155303747|NCT03485950|560542812|FG001|Overall Study|Withdrawal by Subject|0|||
155303748|NCT03930420|560542813|FG000|Overall Study|Withdrawal by Subject|7|||
155303749|NCT03930420|560542814|FG001|Overall Study|Withdrawal by Subject|9|||
155303750|NCT00609336|560542815|FG000|Overall Study|Protocol Violation|3|||
155303751|NCT00609336|560542815|FG000|Overall Study|Death|1|||
155303752|NCT00609336|560542815|FG000|Overall Study|LA or Met at Surgery|9|||
155303753|NCT00567489|560542816|FG000|Overall Study|Adverse Event|6|||
155303754|NCT00567489|560542817|FG001|Overall Study|Adverse Event|14|||
155303755|NCT00567489|560542816|FG000|Overall Study|Physician Decision|0|||
155303756|NCT00567489|560542817|FG001|Overall Study|Physician Decision|4|||
155303757|NCT00567489|560542816|FG000|Overall Study|Withdrawal by Subject|0|||
155303758|NCT00567489|560542817|FG001|Overall Study|Withdrawal by Subject|2|||
155303759|NCT00567489|560542816|FG000|Overall Study|Renal Transplantation|0|||
155303760|NCT00567489|560542817|FG001|Overall Study|Renal Transplantation|3|||
155303761|NCT00567489|560542816|FG000|Overall Study|Other|1|||
155303762|NCT00567489|560542817|FG001|Overall Study|Other|0|||
155303763|NCT00068601|560542820|FG000|Overall Study|Ineligible|11|||
155303764|NCT00068601|560542821|FG001|Overall Study|Ineligible|13|||
155303765|NCT00068601|560542820|FG000|Overall Study|Not evaluable: withdrew consent|5|||
155303766|NCT00068601|560542821|FG001|Overall Study|Not evaluable: withdrew consent|4|||
155303767|NCT00068601|560542820|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
155303768|NCT00068601|560542821|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
155303769|NCT00068601|560542820|FG000|Overall Study|Death|11|||
155303770|NCT00068601|560542821|FG001|Overall Study|Death|3|||
155303771|NCT00068601|560542820|FG000|Overall Study|Lost to Follow-up|3|||
155303772|NCT00068601|560542821|FG001|Overall Study|Lost to Follow-up|2|||
155303773|NCT00068601|560542820|FG000|Overall Study|Missing primary outcome data|30|||
155303774|NCT00068601|560542821|FG001|Overall Study|Missing primary outcome data|34|||
155303775|NCT01061671|560542822|FG000|Overall Study|Withdrawal by Subject|16|||
155303776|NCT01061671|560542823|FG001|Overall Study|Withdrawal by Subject|20|||
155303777|NCT01061671|560542822|FG000|Overall Study|Lost to Follow-up|3|||
155303778|NCT01061671|560542823|FG001|Overall Study|Lost to Follow-up|5|||
155303779|NCT01061671|560542822|FG000|Overall Study|Death|28|||
155303780|NCT01061671|560542823|FG001|Overall Study|Death|30|||
155303781|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
155303782|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303783|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303784|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303785|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
155303786|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
155303787|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303788|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303789|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303790|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
155303791|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
155303792|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303793|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303794|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303795|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
155303796|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
155303797|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303798|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303799|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303800|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
155303801|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
155303802|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303803|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303804|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303805|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
155303806|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
155303807|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303808|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303809|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303810|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
155303811|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
155303812|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155303813|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155303814|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155065118|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
155065119|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
155303815|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
155303816|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
155303817|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155303818|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155303819|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155303820|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
155303821|NCT02409667|560542826|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
155303822|NCT02409667|560542827|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303823|NCT02409667|560542828|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303824|NCT02409667|560542829|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303825|NCT02409667|560542830|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
155303826|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
155303827|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
155303828|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
155303829|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
155303830|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
155303831|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303832|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303833|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303834|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
155303835|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
155303836|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
155303837|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
155303838|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
155303839|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
155303840|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
155303841|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
155303842|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
155303843|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
155303844|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
155303845|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
155303846|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
155303847|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
155303848|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
155303849|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
155303850|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
155303851|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
155303852|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
155303853|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
155303854|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
155303855|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
155303856|NCT02409667|560542826|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303857|NCT02409667|560542827|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303858|NCT02409667|560542828|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
155303859|NCT02409667|560542829|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303860|NCT02409667|560542830|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
155303861|NCT01205048|560542833|FG000|Overall Study|Withdrawal by Subject|14|||
155303862|NCT01205048|560542833|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
155303863|NCT01205048|560542833|FG000|Overall Study|Lost to Follow-up|4|||
155303864|NCT01205048|560542833|FG000|Overall Study|Other|2|||
155303865|NCT01255670|560542834|FG000|Overall Study|Adverse Event|10|||
155303866|NCT01255670|560542835|FG001|Overall Study|Adverse Event|10|||
155303867|NCT01255670|560542834|FG000|Overall Study|Lost to Follow-up|16|||
155303868|NCT01255670|560542835|FG001|Overall Study|Lost to Follow-up|10|||
155303869|NCT00823472|560542836|FG000|Overall Study|Physician Decision|24|||
155303870|NCT00823472|560542837|FG001|Overall Study|Physician Decision|28|||
155303871|NCT04992390|560542845|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
155303872|NCT04992390|560542846|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
155303873|NCT04992390|560542847|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
155303874|NCT04992390|560542845|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
155303875|NCT04992390|560542846|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
155303876|NCT04992390|560542847|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
155303877|NCT04992390|560542845|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
155303878|NCT04992390|560542846|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
155303879|NCT04992390|560542847|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
155303880|NCT04992390|560542845|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
155303881|NCT04992390|560542846|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
155303882|NCT04992390|560542847|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
155303883|NCT04992390|560542845|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
155303884|NCT04992390|560542846|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
155303885|NCT04992390|560542847|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
155303886|NCT04992390|560542845|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
155303887|NCT04992390|560542846|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
155303888|NCT04992390|560542847|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
155303889|NCT04992390|560542845|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
155303890|NCT04992390|560542846|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
155303891|NCT04992390|560542847|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
155303892|NCT04992390|560542845|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
155303893|NCT04992390|560542846|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
155303894|NCT04992390|560542847|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
155303895|NCT04992390|560542845|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
155303896|NCT04992390|560542846|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
155303897|NCT04992390|560542847|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
155303898|NCT04992390|560542845|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
155303899|NCT04992390|560542846|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
155303900|NCT04992390|560542847|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
155303901|NCT04992390|560542845|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
155303902|NCT04992390|560542846|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
155303903|NCT04992390|560542847|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
155303904|NCT04992390|560542845|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
155303905|NCT04992390|560542846|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
155303906|NCT04992390|560542847|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
155303907|NCT04992390|560542845|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
155303908|NCT04992390|560542846|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
155303909|NCT04992390|560542847|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
155303910|NCT04992390|560542845|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
155303911|NCT04992390|560542846|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
155303912|NCT04992390|560542847|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
155303913|NCT04992390|560542845|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
155303914|NCT04992390|560542846|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
155303915|NCT04992390|560542847|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
155303916|NCT04992390|560542845|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
155303917|NCT04992390|560542846|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
155303918|NCT04992390|560542847|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
155303919|NCT02769858|560542850|FG000|Overall Study|Withdrawal by Subject|2|||
155303920|NCT02152137|560544453|FG000|Overall Study|Withdrawal by Subject|1|||
155303921|NCT02152137|560544453|FG000|Overall Study|Originally assigned to Arm B|3|||
155303922|NCT04878354|560544454|FG000|Overall Study|Adverse Event|4|||
155303923|NCT04878354|560544455|FG001|Overall Study|Adverse Event|13|||
155303924|NCT04878354|560544454|FG000|Overall Study|Withdrawal by Subject|14|||
155303925|NCT04878354|560544455|FG001|Overall Study|Withdrawal by Subject|12|||
155303926|NCT04878354|560544454|FG000|Overall Study|Lost to Follow-up|4|||
155303927|NCT04878354|560544455|FG001|Overall Study|Lost to Follow-up|1|||
155303928|NCT04878354|560544454|FG000|Overall Study|Lack of Efficacy|1|||
155303929|NCT04878354|560544455|FG001|Overall Study|Lack of Efficacy|0|||
155303930|NCT04878354|560544454|FG000|Overall Study|Protocol Violation|0|||
155303931|NCT04878354|560544455|FG001|Overall Study|Protocol Violation|1|||
155303932|NCT04878354|560544454|FG000|Overall Study|"Reason stated as other in CRF"|2|||
155303933|NCT04878354|560544455|FG001|Overall Study|"Reason stated as other in CRF"|3|||
155303934|NCT03358875|560544456|FG000|Overall Study|Death|409|||
155303935|NCT03358875|560544457|FG001|Overall Study|Death|223|||
155303936|NCT03358875|560544456|FG000|Overall Study|Study Closed by Sponsor|66|||
155303937|NCT03358875|560544457|FG001|Overall Study|Study Closed by Sponsor|29|||
155303938|NCT03358875|560544456|FG000|Overall Study|Withdrawal by Subject|13|||
155303939|NCT03358875|560544457|FG001|Overall Study|Withdrawal by Subject|16|||
155303940|NCT03358875|560544456|FG000|Overall Study|Lost to Follow-up|13|||
155303941|NCT03358875|560544457|FG001|Overall Study|Lost to Follow-up|2|||
155303942|NCT03358875|560544456|FG000|Overall Study|Miscellaneous|33|||
155303943|NCT03358875|560544457|FG001|Overall Study|Miscellaneous|0|||
155303944|NCT03358875|560544456|FG000|Overall Study|Remained on Study|1|||
155303945|NCT03358875|560544457|FG001|Overall Study|Remained on Study|0|||
155303946|NCT05307783|560544470|FG000|Overall Study|Death|7|||
155303947|NCT05307783|560544470|FG000|Overall Study|Lost to Follow-up|4|||
155303948|NCT04883645|560544471|FG000|Overall Study|Death|1|||
155303949|NCT03460236|560544476|FG000|Overall Study|failed radiographic screening|16|||
155303950|NCT03460236|560544476|FG000|Overall Study|Withdrawal by Subject|11|||
155303951|NCT06194214|560544477|FG000|Overall Study|Adverse Event|1|||
155303952|NCT04540913|560544478|FG000|Overall Study|Withdrawal by Subject|14|||
155303953|NCT04540913|560544479|FG001|Overall Study|Withdrawal by Subject|3|||
155303954|NCT05687903|560544480|FG000|Overall Study|Protocol Deviation|1|||
155303955|NCT05687903|560544481|FG001|Overall Study|Protocol Deviation|1|||
155303956|NCT05687903|560544482|FG002|Overall Study|Protocol Deviation|0|||
155303957|NCT05687903|560544483|FG003|Overall Study|Protocol Deviation|1|||
155303958|NCT05687903|560544484|FG004|Overall Study|Protocol Deviation|0|||
155303959|NCT05613205|560544485|FG000|Overall Study|Lost to Follow-up|0|||
155303960|NCT05613205|560544486|FG001|Overall Study|Lost to Follow-up|0|||
155303961|NCT05613205|560544487|FG002|Overall Study|Lost to Follow-up|1|||
155303962|NCT05613205|560544488|FG003|Overall Study|Lost to Follow-up|1|||
155303963|NCT05613205|560544489|FG004|Overall Study|Lost to Follow-up|0|||
155303964|NCT05613205|560544485|FG000|Overall Study|Withdrawal by Subject|0|||
155303965|NCT05613205|560544486|FG001|Overall Study|Withdrawal by Subject|0|||
155303966|NCT05613205|560544487|FG002|Overall Study|Withdrawal by Subject|1|||
155303967|NCT05613205|560544488|FG003|Overall Study|Withdrawal by Subject|1|||
155303968|NCT05613205|560544489|FG004|Overall Study|Withdrawal by Subject|0|||
155303969|NCT04300231|560544490|FG000|Overall Study|Protocol Violation|4|||
155303970|NCT04300231|560544491|FG001|Overall Study|Protocol Violation|3|||
155303971|NCT04300231|560544492|FG002|Overall Study|Protocol Violation|0|||
155303972|NCT04300231|560544493|FG003|Overall Study|Protocol Violation|2|||
155303973|NCT03050814|560544495|FG000|Overall Study|Screen failures|0|||
155303974|NCT03050814|560544496|FG001|Overall Study|Screen failures|0|||
155303975|NCT03050814|560544497|FG002|Overall Study|Screen failures|4|||
155303976|NCT00431834|560544501|FG000|Overall Study|Withdrawal by Subject|7|||
155303977|NCT00431834|560544501|FG000|Overall Study|Death|3|||
155303978|NCT00431834|560544501|FG000|Overall Study|Missed Endpoint Visit|2|||
155303979|NCT00431834|560544501|FG000|Overall Study|Lost to Follow-up|1|||
155303980|NCT01610297|560544502|FG000|Overall Study|Lost to Follow-up|1|||
155303981|NCT00243503|560544503|FG000|Overall Study|Adverse Event|11|||
155303982|NCT00243503|560544503|FG000|Overall Study|Withdrawal by Subject|1|||
155303983|NCT00243503|560544503|FG000|Overall Study|Lack of Efficacy|44|||
155303984|NCT00243503|560544503|FG000|Overall Study|Death|1|||
155303985|NCT00243503|560544503|FG000|Overall Study|Other|1|||
155303986|NCT00914589|560544504|FG000|Overall Study|Adverse Event|1|||
155303987|NCT00914589|560544505|FG001|Overall Study|Adverse Event|0|||
155303988|NCT00914589|560544506|FG002|Overall Study|Adverse Event|1|||
155303989|NCT00914589|560544504|FG000|Overall Study|Protocol Violation|8|||
155303990|NCT00914589|560544505|FG001|Overall Study|Protocol Violation|6|||
155303991|NCT00914589|560544506|FG002|Overall Study|Protocol Violation|3|||
155303992|NCT00914589|560544504|FG000|Overall Study|unclassified|16|||
155303993|NCT00914589|560544505|FG001|Overall Study|unclassified|9|||
155303994|NCT00914589|560544506|FG002|Overall Study|unclassified|7|||
155303995|NCT00914589|560544504|FG000|Overall Study|Death|0|||
155303996|NCT00914589|560544505|FG001|Overall Study|Death|1|||
155303997|NCT00914589|560544506|FG002|Overall Study|Death|1|||
155303998|NCT00510887|560544507|FG000|Overall Study|Lost to Follow-up|1|||
155303999|NCT02238483|560544511|FG000|Overall Study|Withdrawal by Subject|2|||
155304000|NCT02238483|560544512|FG001|Overall Study|Withdrawal by Subject|7|||
155304001|NCT02238483|560544511|FG000|Overall Study|Lost to Follow-up|1|||
155304002|NCT02238483|560544512|FG001|Overall Study|Lost to Follow-up|1|||
155304003|NCT02238483|560544511|FG000|Overall Study|Protocol Violation|1|||
155304004|NCT02238483|560544512|FG001|Overall Study|Protocol Violation|2|||
155304005|NCT02238483|560544511|FG000|Overall Study|Death|1|||
155304006|NCT02238483|560544512|FG001|Overall Study|Death|0|||
155304007|NCT02238483|560544511|FG000|Overall Study|Adverse Event|7|||
155304008|NCT02238483|560544512|FG001|Overall Study|Adverse Event|3|||
155304009|NCT02238483|560544511|FG000|Overall Study|Withdrawn due to physician decision|1|||
155304010|NCT02238483|560544512|FG001|Overall Study|Withdrawn due to physician decision|0|||
155304011|NCT02238483|560544511|FG000|Overall Study|Completion status not recorded|1|||
155304012|NCT02238483|560544512|FG001|Overall Study|Completion status not recorded|1|||
155304013|NCT02238483|560544511|FG000|Overall Study|Illness in family member|1|||
155304014|NCT02238483|560544512|FG001|Overall Study|Illness in family member|0|||
155304015|NCT02321514|560544518|FG000|Overall Study|Death|15|||
155304016|NCT02321514|560544518|FG000|Overall Study|Missed Visit|7|||
155304017|NCT02321514|560544518|FG000|Overall Study|Study Exit|3|||
155304018|NCT02372253|560544526|FG000|Overall Study|Non Compliance|2|||
155304019|NCT02372253|560544527|FG001|Overall Study|Non Compliance|0|||
155304020|NCT01803555|560544530|FG000|Overall Study|Adverse Event|3|||
155304021|NCT01803555|560544531|FG001|Overall Study|Adverse Event|2|||
155304022|NCT01803555|560544530|FG000|Overall Study|Withdrawal by Subject|3|||
155304023|NCT01803555|560544531|FG001|Overall Study|Withdrawal by Subject|3|||
155304024|NCT01803555|560544530|FG000|Overall Study|Non-compliance|1|||
155304025|NCT01803555|560544531|FG001|Overall Study|Non-compliance|1|||
155304026|NCT01803555|560544530|FG000|Overall Study|Protocol Violation|3|||
155304027|NCT01803555|560544531|FG001|Overall Study|Protocol Violation|5|||
155304028|NCT01803555|560544530|FG000|Overall Study|Lost to Follow-up|0|||
155304029|NCT01803555|560544531|FG001|Overall Study|Lost to Follow-up|2|||
155304030|NCT01803555|560544530|FG000|Overall Study|Other than specified|3|||
155304031|NCT01803555|560544531|FG001|Overall Study|Other than specified|5|||
155304032|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
155304033|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
155304034|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
155304035|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
155304036|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
155304037|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
155304038|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
155304039|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
155304040|NCT00393484|560544532|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
155304041|NCT00393484|560544533|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
155304042|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
155304043|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
155304044|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
155304045|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
155304046|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
155304047|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
155304048|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
155304049|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
155304050|NCT00393484|560544532|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
155304051|NCT00393484|560544533|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
155304052|NCT02178098|560544539|FG000|Overall Study|Withdrawal by Subject|0|||
155304053|NCT02178098|560544540|FG001|Overall Study|Withdrawal by Subject|6|||
155304054|NCT02178098|560544539|FG000|Overall Study|Adverse Event|1|||
155304055|NCT02178098|560544540|FG001|Overall Study|Adverse Event|2|||
155304056|NCT02178098|560544539|FG000|Overall Study|Protocol Violation|1|||
155304057|NCT02178098|560544540|FG001|Overall Study|Protocol Violation|1|||
155304058|NCT02178098|560544539|FG000|Overall Study|Lost to Follow-up|0|||
155304059|NCT02178098|560544540|FG001|Overall Study|Lost to Follow-up|1|||
155304060|NCT02178098|560544539|FG000|Overall Study|Sponsor Request|1|||
155304061|NCT02178098|560544540|FG001|Overall Study|Sponsor Request|0|||
155304062|NCT02178098|560544539|FG000|Overall Study|Other|2|||
155304063|NCT02178098|560544540|FG001|Overall Study|Other|2|||
155304064|NCT01109524|560544543|FG000|Overall Study|Disease Progression|29|||
155304065|NCT01109524|560544543|FG000|Overall Study|Study Drug toxicity|6|||
155304066|NCT01109524|560544543|FG000|Overall Study|Adverse Event|4|||
155304067|NCT01109524|560544543|FG000|Overall Study|Withdrawal by Subject|2|||
155304068|NCT01109524|560544543|FG000|Overall Study|Maximum clinical benefit|3|||
155304069|NCT01109524|560544543|FG000|Overall Study|Death|2|||
155304070|NCT01109524|560544543|FG000|Overall Study|No longer meets criteria|2|||
155304071|NCT01109524|560544543|FG000|Overall Study|Participant requested to end treatment|4|||
155304072|NCT01109524|560544543|FG000|Overall Study|Other|5|||
155304073|NCT01551355|560544550|FG000|Overall Study|Lost to Follow-up|51|||
155304074|NCT01551355|560544551|FG001|Overall Study|Lost to Follow-up|49|||
155304075|NCT01551355|560544552|FG002|Overall Study|Lost to Follow-up|34|||
155304076|NCT01551355|560544553|FG003|Overall Study|Lost to Follow-up|24|||
155304077|NCT01551355|560544554|FG004|Overall Study|Lost to Follow-up|9|||
155304078|NCT01551355|560544555|FG005|Overall Study|Lost to Follow-up|6|||
155304079|NCT02318134|560544556|FG000|Overall Study|Withdrawal by Subject|2|||
155304080|NCT02318134|560544557|FG001|Overall Study|Withdrawal by Subject|1|||
155304081|NCT01925339|560544558|FG000|Overall Study|Adverse Event|2|||
155304082|NCT01925339|560544559|FG001|Overall Study|Adverse Event|0|||
155304083|NCT03664960|560544560|FG000|Overall Study|Adverse Event|0|||
155304084|NCT03664960|560544561|FG001|Overall Study|Adverse Event|3|||
155304085|NCT03664960|560544560|FG000|Overall Study|Lost to Follow-up|3|||
155304086|NCT03664960|560544561|FG001|Overall Study|Lost to Follow-up|2|||
155304087|NCT03664960|560544560|FG000|Overall Study|Physician Decision|1|||
155304088|NCT03664960|560544561|FG001|Overall Study|Physician Decision|0|||
155304089|NCT03664960|560544560|FG000|Overall Study|Withdrawal by Subject|3|||
155304090|NCT03664960|560544561|FG001|Overall Study|Withdrawal by Subject|14|||
155304091|NCT03664960|560544560|FG000|Overall Study|Sponsor Decision|1|||
155304092|NCT03664960|560544561|FG001|Overall Study|Sponsor Decision|1|||
155304093|NCT03664960|560544560|FG000|Overall Study|Other|1|||
155304094|NCT03664960|560544561|FG001|Overall Study|Other|2|||
155304095|NCT04019444|560544562|FG000|Overall Study|Withdrawal by Subject|0|||
155304096|NCT04019444|560544563|FG001|Overall Study|Withdrawal by Subject|1|||
155304097|NCT04019444|560544564|FG002|Overall Study|Withdrawal by Subject|0|||
155304098|NCT04019444|560544565|FG003|Overall Study|Withdrawal by Subject|1|||
155304099|NCT04019444|560544562|FG000|Overall Study|Solicited Event|0|||
155304100|NCT04019444|560544563|FG001|Overall Study|Solicited Event|0|||
155304101|NCT04019444|560544564|FG002|Overall Study|Solicited Event|2|||
155304102|NCT04019444|560544565|FG003|Overall Study|Solicited Event|0|||
155304103|NCT03997916|560544572|FG000|Overall Study|Protocol Violation|35|||
155304104|NCT03807778|560544575|FG000|Overall Study|Adverse Event|0|||
155304105|NCT03807778|560544576|FG001|Overall Study|Adverse Event|0|||
155304106|NCT03807778|560544577|FG002|Overall Study|Adverse Event|3|||
155304107|NCT03807778|560544578|FG003|Overall Study|Adverse Event|5|||
155304108|NCT03807778|560544575|FG000|Overall Study|Progressive Disease|4|||
155304109|NCT03807778|560544576|FG001|Overall Study|Progressive Disease|2|||
155304110|NCT03807778|560544577|FG002|Overall Study|Progressive Disease|8|||
155304111|NCT03807778|560544578|FG003|Overall Study|Progressive Disease|15|||
155304112|NCT03807778|560544575|FG000|Overall Study|Symptomatic Deterioration|0|||
155304113|NCT03807778|560544576|FG001|Overall Study|Symptomatic Deterioration|1|||
155304114|NCT03807778|560544577|FG002|Overall Study|Symptomatic Deterioration|0|||
155304115|NCT03807778|560544578|FG003|Overall Study|Symptomatic Deterioration|1|||
155304116|NCT03807778|560544575|FG000|Overall Study|Withdrawal by Subject|0|||
155304117|NCT03807778|560544576|FG001|Overall Study|Withdrawal by Subject|1|||
155304118|NCT03807778|560544577|FG002|Overall Study|Withdrawal by Subject|0|||
155304119|NCT03807778|560544578|FG003|Overall Study|Withdrawal by Subject|1|||
155304120|NCT03807778|560544575|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
155304121|NCT03807778|560544576|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
155304122|NCT03807778|560544577|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
155304123|NCT03807778|560544578|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
155304124|NCT05028582|560544580|FG000|Overall Study|Lost to Follow-up|11|||
155304125|NCT05028582|560544581|FG001|Overall Study|Lost to Follow-up|9|||
155304126|NCT05028582|560544580|FG000|Overall Study|Withdrawal by Subject|9|||
155304127|NCT05028582|560544581|FG001|Overall Study|Withdrawal by Subject|10|||
155304128|NCT05028582|560544580|FG000|Overall Study|Adverse Event|5|||
155304129|NCT05028582|560544581|FG001|Overall Study|Adverse Event|2|||
155304130|NCT05028582|560544580|FG000|Overall Study|Miscellaneous|3|||
155304131|NCT05028582|560544581|FG001|Overall Study|Miscellaneous|2|||
155304132|NCT05028582|560544580|FG000|Overall Study|Lack of Efficacy|3|||
155304133|NCT05028582|560544581|FG001|Overall Study|Lack of Efficacy|1|||
155304134|NCT05028582|560544580|FG000|Overall Study|Physician Decision|0|||
155304135|NCT05028582|560544581|FG001|Overall Study|Physician Decision|1|||
155304136|NCT04939246|560544582|FG000|After Treatment|Death|4|||
155304137|NCT04939246|560544582|FG000|After Treatment|Lost to Follow-up|1|||
155304138|NCT04939246|560544582|FG000|After Treatment|Discharged to hospice|2|||
154958628|NCT00640562|559275559|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
155304139|NCT04337372|560545983|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
155304140|NCT04337372|560545984|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
155304141|NCT04337372|560545985|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
155304142|NCT04337372|560545986|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
155304143|NCT04337372|560545983|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
155304144|NCT04337372|560545984|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
155304145|NCT04337372|560545985|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
155304146|NCT04337372|560545986|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
155304147|NCT04337372|560545983|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
155304148|NCT04337372|560545984|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
155304149|NCT04337372|560545985|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
155304150|NCT04337372|560545986|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
155304151|NCT04337372|560545983|FG000|Day 2: EEG Measures|Protocol Violation|6|||
155304152|NCT04337372|560545984|FG001|Day 2: EEG Measures|Protocol Violation|6|||
155304153|NCT04337372|560545985|FG002|Day 2: EEG Measures|Protocol Violation|5|||
155304154|NCT04337372|560545986|FG003|Day 2: EEG Measures|Protocol Violation|17|||
155304155|NCT04869982|560545990|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
155304156|NCT04869982|560545991|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
155304157|NCT04869982|560545990|FG000|Overall Study|Migrated / moved from the study area|1|||
155304158|NCT04869982|560545991|FG001|Overall Study|Migrated / moved from the study area|1|||
155304159|NCT04869982|560545990|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
155304160|NCT04869982|560545991|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
155304161|NCT04869982|560545990|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
155304162|NCT04869982|560545991|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
155304163|NCT04869982|560545990|FG000|Overall Study|Solicited adverse event|2|||
155304164|NCT04869982|560545991|FG001|Overall Study|Solicited adverse event|1|||
155304165|NCT04608045|560545992|FG000|Overall Study|Physician Decision|1|||
155304166|NCT02473250|560545994|FG000|Overall Study|Lost to Follow-up|10|||
155304167|NCT02473250|560545994|FG000|Overall Study|Physician Decision|5|||
155304168|NCT02473250|560545994|FG000|Overall Study|Did not tolerate medication washout|3|||
155304169|NCT02473250|560545994|FG000|Overall Study|Antidepressant effect of divalproex|2|||
155304170|NCT03103321|560545995|FG000|Overall Study|Protocol Violation|1|||
155304171|NCT03103321|560545996|FG001|Overall Study|Protocol Violation|1|||
155304172|NCT03103321|560545997|FG002|Overall Study|Protocol Violation|1|||
155304173|NCT03103321|560545998|FG003|Overall Study|Protocol Violation|0|||
155304174|NCT04847999|560545999|FG000|Overall Study|Lost to Follow-up|0|||
155304175|NCT04847999|560546000|FG001|Overall Study|Lost to Follow-up|1|||
155304176|NCT02879448|560546001|FG000|Overall Study|Death|251|||
155304177|NCT02879448|560546002|FG001|Overall Study|Death|263|||
155304178|NCT02879448|560546001|FG000|Overall Study|Lost to Follow-up|23|||
155304179|NCT02879448|560546002|FG001|Overall Study|Lost to Follow-up|28|||
155304180|NCT02879448|560546001|FG000|Overall Study|Withdrawal by Subject|42|||
155304181|NCT02879448|560546002|FG001|Overall Study|Withdrawal by Subject|79|||
155304182|NCT02879448|560546001|FG000|Overall Study|Other Reasons|8|||
155304183|NCT02879448|560546002|FG001|Overall Study|Other Reasons|12|||
155304184|NCT03602014|560546004|FG000|Overall Study|Lost to Follow-up|2|||
155304185|NCT03602014|560546005|FG001|Overall Study|Lost to Follow-up|0|||
155304186|NCT03602014|560546006|FG002|Overall Study|Lost to Follow-up|0|||
155304187|NCT06629454|560546007|FG000|Overall Study|Withdraw by Clinician Decision|1|||
155304188|NCT01704079|560546008|FG000|Overall Study|Withdrawal by Subject|5|||
155304189|NCT01704079|560546009|FG001|Overall Study|Withdrawal by Subject|7|||
155304190|NCT01704079|560546008|FG000|Overall Study|Lost to Follow-up|2|||
155304191|NCT01704079|560546009|FG001|Overall Study|Lost to Follow-up|5|||
155304192|NCT01704079|560546008|FG000|Overall Study|Adverse Event|4|||
155304193|NCT01704079|560546009|FG001|Overall Study|Adverse Event|7|||
155304194|NCT01704079|560546008|FG000|Overall Study|Protocol Violation|1|||
155304195|NCT01704079|560546009|FG001|Overall Study|Protocol Violation|0|||
155304196|NCT01704079|560546008|FG000|Overall Study|Subject noncompliance|2|||
155304197|NCT01704079|560546009|FG001|Overall Study|Subject noncompliance|3|||
155304198|NCT01704079|560546008|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
155304199|NCT01704079|560546009|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
155304200|NCT06023082|560546010|FG000|Overall Study|Withdrawal by Subject|2|||
155304201|NCT06023082|560546010|FG000|Overall Study|Lost to Follow-up|15|||
155304202|NCT06023082|560546010|FG000|Overall Study|Side effects|5|||
155304203|NCT03584516|560546016|FG000|Part 1|Death|2|||
155304204|NCT03584516|560546017|FG001|Part 1|Death|3|||
155304205|NCT03584516|560546018|FG002|Part 1|Death|0|||
155304206|NCT03584516|560546019|FG003|Part 1|Death|0|||
155304207|NCT03584516|560546020|FG004|Part 1|Death|0|||
155304208|NCT03584516|560546021|FG005|Part 1|Death|0|||
155304209|NCT03584516|560546016|FG000|Part 1|Withdrawal by Subject|2|||
155304210|NCT03584516|560546017|FG001|Part 1|Withdrawal by Subject|0|||
155304211|NCT03584516|560546018|FG002|Part 1|Withdrawal by Subject|0|||
155304212|NCT03584516|560546019|FG003|Part 1|Withdrawal by Subject|0|||
155304213|NCT03584516|560546020|FG004|Part 1|Withdrawal by Subject|0|||
155304214|NCT03584516|560546021|FG005|Part 1|Withdrawal by Subject|0|||
155304215|NCT03584516|560546016|FG000|Part 1|Lost to Follow-up|1|||
155304216|NCT03584516|560546017|FG001|Part 1|Lost to Follow-up|0|||
155304217|NCT03584516|560546018|FG002|Part 1|Lost to Follow-up|0|||
155304218|NCT03584516|560546019|FG003|Part 1|Lost to Follow-up|0|||
155304219|NCT03584516|560546020|FG004|Part 1|Lost to Follow-up|0|||
155304220|NCT03584516|560546021|FG005|Part 1|Lost to Follow-up|0|||
155304221|NCT03584516|560546016|FG000|Part 1|Study Terminated by Sponsor|0|||
155304222|NCT03584516|560546017|FG001|Part 1|Study Terminated by Sponsor|2|||
155304223|NCT03584516|560546018|FG002|Part 1|Study Terminated by Sponsor|0|||
155304224|NCT03584516|560546019|FG003|Part 1|Study Terminated by Sponsor|0|||
155304225|NCT03584516|560546020|FG004|Part 1|Study Terminated by Sponsor|0|||
155304226|NCT03584516|560546021|FG005|Part 1|Study Terminated by Sponsor|0|||
155304227|NCT03584516|560546016|FG000|Part 1 Expansion|Death|0|||
155304228|NCT03584516|560546017|FG001|Part 1 Expansion|Death|0|||
155304229|NCT03584516|560546018|FG002|Part 1 Expansion|Death|9|||
155304230|NCT03584516|560546019|FG003|Part 1 Expansion|Death|8|||
155304231|NCT03584516|560546020|FG004|Part 1 Expansion|Death|4|||
155304232|NCT03584516|560546021|FG005|Part 1 Expansion|Death|5|||
155304233|NCT03584516|560546016|FG000|Part 1 Expansion|Lost to Follow-up|0|||
155304234|NCT03584516|560546017|FG001|Part 1 Expansion|Lost to Follow-up|0|||
155304235|NCT03584516|560546018|FG002|Part 1 Expansion|Lost to Follow-up|0|||
155304236|NCT03584516|560546019|FG003|Part 1 Expansion|Lost to Follow-up|1|||
155304237|NCT03584516|560546020|FG004|Part 1 Expansion|Lost to Follow-up|0|||
155304238|NCT03584516|560546021|FG005|Part 1 Expansion|Lost to Follow-up|0|||
155304239|NCT03584516|560546016|FG000|Part 1 Expansion|Physician Decision|0|||
155304240|NCT03584516|560546017|FG001|Part 1 Expansion|Physician Decision|0|||
155304241|NCT03584516|560546018|FG002|Part 1 Expansion|Physician Decision|4|||
155304242|NCT03584516|560546019|FG003|Part 1 Expansion|Physician Decision|3|||
155304243|NCT03584516|560546020|FG004|Part 1 Expansion|Physician Decision|2|||
155304244|NCT03584516|560546021|FG005|Part 1 Expansion|Physician Decision|3|||
155304245|NCT03584516|560546016|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
155304246|NCT03584516|560546017|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
155304247|NCT03584516|560546018|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
155304248|NCT03584516|560546019|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
155304249|NCT03584516|560546020|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
155304250|NCT03584516|560546021|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
155304251|NCT03584516|560546016|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
155304252|NCT03584516|560546017|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
155304253|NCT03584516|560546018|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
155304254|NCT03584516|560546019|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
155304255|NCT03584516|560546020|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
155304256|NCT03584516|560546021|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
155304257|NCT03584516|560546016|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304258|NCT03584516|560546017|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304259|NCT03584516|560546018|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304260|NCT03584516|560546019|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
155304261|NCT03584516|560546020|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304262|NCT03584516|560546021|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
155304263|NCT03584516|560546016|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304264|NCT03584516|560546017|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304265|NCT03584516|560546018|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304266|NCT03584516|560546019|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304267|NCT03584516|560546020|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
155304268|NCT03584516|560546021|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
155304269|NCT05846646|560546022|FG000|Overall Study|Physician Decision|1|||
155304270|NCT05846646|560546023|FG001|Overall Study|Physician Decision|0|||
155304271|NCT05846646|560546024|FG002|Overall Study|Physician Decision|0|||
155304272|NCT05846646|560546022|FG000|Overall Study|Lack of Efficacy|1|||
155304273|NCT05846646|560546023|FG001|Overall Study|Lack of Efficacy|1|||
155304274|NCT05846646|560546024|FG002|Overall Study|Lack of Efficacy|0|||
155304275|NCT05846646|560546022|FG000|Overall Study|Early Study Termination|1|||
155304276|NCT05846646|560546023|FG001|Overall Study|Early Study Termination|2|||
155304277|NCT05846646|560546024|FG002|Overall Study|Early Study Termination|0|||
155304278|NCT00670046|560546025|FG000|Overall Study|Lost to Follow-up|1|||
155304279|NCT00670046|560546026|FG001|Overall Study|Lost to Follow-up|1|||
155304280|NCT00670046|560546025|FG000|Overall Study|Withdrawal by Subject|0|||
155304281|NCT00670046|560546026|FG001|Overall Study|Withdrawal by Subject|1|||
155304282|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
155304283|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
155304284|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
155304285|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
155304286|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
155304287|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
155304288|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
155304289|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
155304290|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
155304291|NCT03990649|560546027|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
155304292|NCT03990649|560546028|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
155304293|NCT03990649|560546029|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
155304294|NCT03990649|560546027|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
155304295|NCT03990649|560546028|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
155304296|NCT03990649|560546029|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
155304297|NCT03990649|560546027|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
155304298|NCT03990649|560546028|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
155304299|NCT03990649|560546029|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
155304300|NCT03990649|560546027|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
155304301|NCT03990649|560546028|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
155304302|NCT03990649|560546029|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
155304303|NCT01443845|560546030|FG000|Overall Study|Protocol Violation|43|||
155304304|NCT01443845|560546031|FG001|Overall Study|Protocol Violation|45|||
155304305|NCT01443845|560546030|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
155304306|NCT01443845|560546031|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
155304307|NCT01443845|560546030|FG000|Overall Study|Deterioration in pulmonary function|1|||
155304308|NCT01443845|560546031|FG001|Overall Study|Deterioration in pulmonary function|4|||
155304309|NCT01443845|560546030|FG000|Overall Study|Lack of Efficacy|10|||
155304310|NCT01443845|560546031|FG001|Overall Study|Lack of Efficacy|5|||
155304311|NCT01443845|560546030|FG000|Overall Study|Adverse Event|64|||
155304312|NCT01443845|560546031|FG001|Overall Study|Adverse Event|138|||
155304313|NCT01443845|560546030|FG000|Overall Study|Withdrawal by Subject|63|||
155304314|NCT01443845|560546031|FG001|Overall Study|Withdrawal by Subject|67|||
155304315|NCT01443845|560546030|FG000|Overall Study|Military Conflict - Site Terminated|20|||
155304316|NCT01443845|560546031|FG001|Overall Study|Military Conflict - Site Terminated|21|||
155304317|NCT01443845|560546030|FG000|Overall Study|Lost to Follow-up|9|||
155304318|NCT01443845|560546031|FG001|Overall Study|Lost to Follow-up|13|||
155304319|NCT01471691|560546032|FG000|Overall Study|Lack of Efficacy|0|||
155304320|NCT01471691|560546033|FG001|Overall Study|Lack of Efficacy|1|||
155304321|NCT02461628|560546034|FG000|Overall Study|Refused to complete survey|4|||
155304322|NCT02461628|560546035|FG001|Overall Study|Refused to complete survey|7|||
155304323|NCT02015520|560546036|FG000|Overall Study|Lack of Efficacy|1|||
155304324|NCT02015520|560546037|FG001|Overall Study|Lack of Efficacy|0|||
155304325|NCT02015520|560546038|FG002|Overall Study|Lack of Efficacy|3|||
155304326|NCT02015520|560546039|FG003|Overall Study|Lack of Efficacy|2|||
155304327|NCT02015520|560546036|FG000|Overall Study|Adverse Event|0|||
155304328|NCT02015520|560546037|FG001|Overall Study|Adverse Event|0|||
155304329|NCT02015520|560546038|FG002|Overall Study|Adverse Event|0|||
155304330|NCT02015520|560546039|FG003|Overall Study|Adverse Event|1|||
155304331|NCT02015520|560546036|FG000|Overall Study|Withdrawal by Subject|2|||
155304332|NCT02015520|560546037|FG001|Overall Study|Withdrawal by Subject|2|||
155304333|NCT02015520|560546038|FG002|Overall Study|Withdrawal by Subject|1|||
155304334|NCT02015520|560546039|FG003|Overall Study|Withdrawal by Subject|0|||
155304335|NCT02015520|560546036|FG000|Overall Study|Death|1|||
155304336|NCT02015520|560546037|FG001|Overall Study|Death|0|||
155304337|NCT02015520|560546038|FG002|Overall Study|Death|0|||
155304338|NCT02015520|560546039|FG003|Overall Study|Death|0|||
155304339|NCT02015520|560546036|FG000|Overall Study|Lost to Follow-up|0|||
155304340|NCT02015520|560546037|FG001|Overall Study|Lost to Follow-up|0|||
155304341|NCT02015520|560546038|FG002|Overall Study|Lost to Follow-up|1|||
155304342|NCT02015520|560546039|FG003|Overall Study|Lost to Follow-up|0|||
155304343|NCT02015520|560546036|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
155304344|NCT02015520|560546037|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
155304345|NCT02015520|560546038|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
155304346|NCT02015520|560546039|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
155304347|NCT02015520|560546036|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
155304348|NCT02015520|560546037|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
155304349|NCT02015520|560546038|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
155304350|NCT02015520|560546039|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
155304351|NCT01854385|560546040|FG000|Pre-Treatment|Withdrawal by Subject|4|||
155304352|NCT01854385|560546040|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
155304353|NCT01854385|560546040|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
155304354|NCT01854385|560546040|FG000|Pre-Treatment|Unable to come for study visits|1|||
155304355|NCT01854385|560546040|FG000|Treatment|Lost to Follow-up|1|||
155304356|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
155304357|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
155304358|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
155304359|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
155304360|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
155304361|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304362|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304363|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
155304364|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304365|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
155304366|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
155304367|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
154958629|NCT00640562|559275558|FG000|Overall Study|Low study drug dose|0|||
155304368|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
155304369|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
155304370|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
155304371|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
155304372|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
155304373|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
155304374|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
155304375|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
155304376|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
155304377|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
155304378|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
155304379|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
155304380|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
155304381|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304382|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304383|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
155160894|NCT00865566|560026693|FG001|Overall Study|Participant relocated|107|||
155160895|NCT00865566|560026692|FG000|Overall Study|Participant unable to adhere|27|||
155160896|NCT00865566|560026693|FG001|Overall Study|Participant unable to adhere|42|||
155160897|NCT00865566|560026692|FG000|Overall Study|Other; N=245 due to early study closure|154|||
155304384|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304385|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
155304386|NCT04759833|560546041|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304387|NCT04759833|560546042|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
155304388|NCT04759833|560546043|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304389|NCT04759833|560546044|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304390|NCT04759833|560546045|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
155304391|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
155304392|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
155304393|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
155304394|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
155304395|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
155304396|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304397|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304398|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304399|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
155304400|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
155304401|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
155304402|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
155304403|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
155304404|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
155304405|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
155304406|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
155304407|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
155304408|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
155304409|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
155304410|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
155304411|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
155304412|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
155304413|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
155304414|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
155304415|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
155304416|NCT04759833|560546041|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
155304417|NCT04759833|560546042|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
155304418|NCT04759833|560546043|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
155304419|NCT04759833|560546044|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
155304420|NCT04759833|560546045|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
155304421|NCT02590432|560546050|FG000|Open-label Treatment Period|Adverse Event|97|||
155304422|NCT02590432|560546051|FG001|Open-label Treatment Period|Adverse Event|79|||
155304423|NCT02590432|560546052|FG002|Open-label Treatment Period|Adverse Event|0|||
155304424|NCT02590432|560546053|FG003|Open-label Treatment Period|Adverse Event|0|||
155304425|NCT02590432|560546054|FG004|Open-label Treatment Period|Adverse Event|0|||
155304426|NCT02590432|560546055|FG005|Open-label Treatment Period|Adverse Event|0|||
155304427|NCT02590432|560546056|FG006|Open-label Treatment Period|Adverse Event|0|||
155304428|NCT02590432|560546057|FG007|Open-label Treatment Period|Adverse Event|0|||
155304429|NCT02590432|560546058|FG008|Open-label Treatment Period|Adverse Event|0|||
155304430|NCT02590432|560546050|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
155304431|NCT02590432|560546051|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
155304432|NCT02590432|560546052|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
155304433|NCT02590432|560546053|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
155304434|NCT02590432|560546054|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
155304435|NCT02590432|560546055|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
155304436|NCT02590432|560546056|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
155304437|NCT02590432|560546057|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
155304438|NCT02590432|560546058|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
155304439|NCT02590432|560546050|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
155304440|NCT02590432|560546051|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
155304441|NCT02590432|560546052|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
155304442|NCT02590432|560546053|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
155304443|NCT02590432|560546054|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
155304444|NCT02590432|560546055|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
155304445|NCT02590432|560546056|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
155304446|NCT02590432|560546057|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
155304447|NCT02590432|560546058|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
155304448|NCT02590432|560546050|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
155304449|NCT02590432|560546051|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
155304450|NCT02590432|560546052|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155304451|NCT02590432|560546053|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
155304452|NCT02590432|560546054|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
155304453|NCT02590432|560546055|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
155304454|NCT02590432|560546056|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
155304455|NCT02590432|560546057|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
155304456|NCT02590432|560546058|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
155304457|NCT02590432|560546050|FG000|Open-label Treatment Period|Protocol Violation|10|||
155304458|NCT02590432|560546051|FG001|Open-label Treatment Period|Protocol Violation|4|||
155304459|NCT02590432|560546052|FG002|Open-label Treatment Period|Protocol Violation|0|||
155304460|NCT02590432|560546053|FG003|Open-label Treatment Period|Protocol Violation|0|||
155304461|NCT02590432|560546054|FG004|Open-label Treatment Period|Protocol Violation|0|||
155304462|NCT02590432|560546055|FG005|Open-label Treatment Period|Protocol Violation|0|||
155304463|NCT02590432|560546056|FG006|Open-label Treatment Period|Protocol Violation|0|||
155304464|NCT02590432|560546057|FG007|Open-label Treatment Period|Protocol Violation|0|||
155304465|NCT02590432|560546058|FG008|Open-label Treatment Period|Protocol Violation|0|||
155304466|NCT02590432|560546050|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
155304467|NCT02590432|560546051|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
155304468|NCT02590432|560546052|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304469|NCT02590432|560546053|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304470|NCT02590432|560546054|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304471|NCT02590432|560546055|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304472|NCT02590432|560546056|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304473|NCT02590432|560546057|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304474|NCT02590432|560546058|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
155304475|NCT02590432|560546050|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
155304476|NCT02590432|560546051|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
155304477|NCT02590432|560546052|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
154958630|NCT00640562|559275559|FG001|Overall Study|Low study drug dose|1|||
155304478|NCT02590432|560546053|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304479|NCT02590432|560546054|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304480|NCT02590432|560546055|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304481|NCT02590432|560546056|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304482|NCT02590432|560546057|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304483|NCT02590432|560546058|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
155304484|NCT02590432|560546050|FG000|Double-blind Treatment Period|Adverse Event|0|||
155304485|NCT02590432|560546051|FG001|Double-blind Treatment Period|Adverse Event|0|||
155304486|NCT02590432|560546052|FG002|Double-blind Treatment Period|Adverse Event|14|||
155304487|NCT02590432|560546053|FG003|Double-blind Treatment Period|Adverse Event|12|||
155304488|NCT02590432|560546054|FG004|Double-blind Treatment Period|Adverse Event|6|||
155304489|NCT02590432|560546055|FG005|Double-blind Treatment Period|Adverse Event|22|||
155304490|NCT02590432|560546056|FG006|Double-blind Treatment Period|Adverse Event|20|||
155304491|NCT02590432|560546057|FG007|Double-blind Treatment Period|Adverse Event|0|||
155304492|NCT02590432|560546058|FG008|Double-blind Treatment Period|Adverse Event|0|||
155304493|NCT02590432|560546050|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155304494|NCT02590432|560546051|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155304495|NCT02590432|560546052|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
155304496|NCT02590432|560546053|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
155304497|NCT02590432|560546054|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
155304498|NCT02590432|560546055|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
155304499|NCT02590432|560546056|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
155304500|NCT02590432|560546057|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
155304501|NCT02590432|560546058|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
155304502|NCT02590432|560546050|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304503|NCT02590432|560546051|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304504|NCT02590432|560546052|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
155304505|NCT02590432|560546053|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
155304506|NCT02590432|560546054|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
155304507|NCT02590432|560546055|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
155304508|NCT02590432|560546056|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
155304509|NCT02590432|560546057|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304510|NCT02590432|560546058|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
155304511|NCT02590432|560546050|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155304512|NCT02590432|560546051|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155160898|NCT00865566|560026693|FG001|Overall Study|Other; N=245 due to early study closure|139|||
155160899|NCT00865566|560026692|FG000|Overall Study|HIV infection|5|||
155160900|NCT00865566|560026693|FG001|Overall Study|HIV infection|7|||
155160901|NCT01039376|560026696|FG000|Overall Study|Lost to Follow-up|5|||
155160902|NCT01039376|560026697|FG001|Overall Study|Lost to Follow-up|12|||
155160903|NCT01039376|560026696|FG000|Overall Study|Physician Decision|15|||
155160904|NCT01039376|560026697|FG001|Overall Study|Physician Decision|10|||
155160905|NCT01039376|560026696|FG000|Overall Study|Withdrawal by Subject|20|||
155160906|NCT01039376|560026697|FG001|Overall Study|Withdrawal by Subject|32|||
155160907|NCT01039376|560026696|FG000|Overall Study|Study terminated by Sponsor|90|||
155160908|NCT01039376|560026697|FG001|Overall Study|Study terminated by Sponsor|72|||
155160909|NCT03252925|560026698|FG000|Overall Study|Withdrawal by Subject|1|||
155304513|NCT02590432|560546052|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
155304514|NCT02590432|560546053|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155304515|NCT02590432|560546054|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
155304516|NCT02590432|560546055|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
155304517|NCT02590432|560546056|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
155160910|NCT03252925|560026699|FG001|Overall Study|Withdrawal by Subject|0|||
155160911|NCT03252925|560026698|FG000|Overall Study|Protocol Violation|6|||
155160912|NCT03252925|560026699|FG001|Overall Study|Protocol Violation|0|||
155160913|NCT03252925|560026698|FG000|Overall Study|Adverse Event|1|||
155160914|NCT03252925|560026699|FG001|Overall Study|Adverse Event|0|||
155160915|NCT03252925|560026698|FG000|Overall Study|Lost to Follow-up|6|||
155160916|NCT03252925|560026699|FG001|Overall Study|Lost to Follow-up|6|||
155160917|NCT00123422|560026700|FG000|Overall Study|Physician Decision|2|||
155160918|NCT00123422|560026701|FG001|Overall Study|Physician Decision|2|||
155304518|NCT02590432|560546057|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
155160919|NCT00123422|560026702|FG002|Overall Study|Physician Decision|6|||
155160920|NCT00123422|560026700|FG000|Overall Study|Withdrawal by Subject|1|||
155160921|NCT00123422|560026701|FG001|Overall Study|Withdrawal by Subject|2|||
155160922|NCT00123422|560026702|FG002|Overall Study|Withdrawal by Subject|2|||
155160923|NCT00123422|560026700|FG000|Overall Study|Lost to Follow-up|1|||
155160924|NCT00123422|560026701|FG001|Overall Study|Lost to Follow-up|2|||
155304519|NCT02590432|560546058|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
155304520|NCT02590432|560546050|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304521|NCT02590432|560546051|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304522|NCT02590432|560546052|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304523|NCT02590432|560546053|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304524|NCT02590432|560546054|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155160925|NCT00123422|560026702|FG002|Overall Study|Lost to Follow-up|2|||
155304525|NCT02590432|560546055|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
155304526|NCT02590432|560546056|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155160926|NCT04555616|560026705|FG000|Overall Study|Death|1|||
155160927|NCT04555616|560026706|FG001|Overall Study|Death|0|||
155160928|NCT04555616|560026707|FG002|Overall Study|Death|1|||
155160929|NCT04555616|560026705|FG000|Overall Study|Withdrawal by Subject|2|||
155160930|NCT04555616|560026706|FG001|Overall Study|Withdrawal by Subject|1|||
155160931|NCT04555616|560026707|FG002|Overall Study|Withdrawal by Subject|0|||
155160932|NCT01528969|560026711|FG000|Overall Study|absent from the school at baseline|2|||
155160933|NCT01528969|560026712|FG001|Overall Study|absent from the school at baseline|0|||
155160934|NCT03584789|560026715|FG000|Overall Study|refused EHR permission|19|||
155160935|NCT03584789|560026716|FG001|Overall Study|refused EHR permission|28|||
155160936|NCT03584789|560026717|FG002|Overall Study|refused EHR permission|23|||
155160937|NCT03584789|560026715|FG000|Overall Study|patients tied to a provider who retired|0|||
155304527|NCT02590432|560546057|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304528|NCT02590432|560546058|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
155304529|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155160938|NCT03584789|560026716|FG001|Overall Study|patients tied to a provider who retired|0|||
155160939|NCT03584789|560026717|FG002|Overall Study|patients tied to a provider who retired|3|||
155160940|NCT04646044|560026719|FG000|Overall Study|Lost to Follow-up|0|||
155160941|NCT04646044|560026720|FG001|Overall Study|Lost to Follow-up|0|||
155160942|NCT04646044|560026721|FG002|Overall Study|Lost to Follow-up|1|||
155160943|NCT04646044|560026722|FG003|Overall Study|Lost to Follow-up|0|||
155160944|NCT04646044|560026719|FG000|Overall Study|Withdrawal by Subject|0|||
155160945|NCT04646044|560026720|FG001|Overall Study|Withdrawal by Subject|1|||
155160946|NCT04646044|560026721|FG002|Overall Study|Withdrawal by Subject|0|||
155160947|NCT04646044|560026722|FG003|Overall Study|Withdrawal by Subject|0|||
155160948|NCT00602472|560026723|FG000|Overall Study|Adverse Event|5|||
155160949|NCT00602472|560026724|FG001|Overall Study|Adverse Event|23|||
155160950|NCT00602472|560026723|FG000|Overall Study|Protocol Violation|4|||
155160951|NCT00602472|560026724|FG001|Overall Study|Protocol Violation|19|||
155160952|NCT00602472|560026723|FG000|Overall Study|Withdrawal by Subject|8|||
155160953|NCT00602472|560026724|FG001|Overall Study|Withdrawal by Subject|14|||
155160954|NCT00602472|560026723|FG000|Overall Study|Other incl. lack of efficacy|4|||
155160955|NCT00602472|560026724|FG001|Overall Study|Other incl. lack of efficacy|2|||
155160956|NCT01938716|560026725|FG000|Overall Study|Physician Decision|2|||
155160957|NCT01938716|560026725|FG000|Overall Study|Withdrawal by Subject|2|||
155160958|NCT02803580|560026726|FG000|Overall Study|Death|13|||
155160959|NCT02803580|560026726|FG000|Overall Study|Lost to Follow-up|19|||
155160960|NCT02803580|560026726|FG000|Overall Study|Withdrawal by Subject|3|||
155160961|NCT02803580|560026726|FG000|Overall Study|Inclusion in clinical trial|1|||
155160962|NCT02054104|560026731|FG000|Overall Study|Did not want to continue due to college classes|1|||
155160963|NCT02054104|560026732|FG001|Overall Study|Did not want to continue due to college classes|0|||
155160964|NCT02054104|560026731|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
155160965|NCT02054104|560026732|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
155304530|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304531|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304532|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304533|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304534|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304535|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
155304536|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
155304537|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
155304538|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304539|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304540|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304541|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155160966|NCT02054104|560026731|FG000|Overall Study|No evidence of immunologic response|2|||
155160967|NCT02054104|560026732|FG001|Overall Study|No evidence of immunologic response|2|||
155160968|NCT02054104|560026731|FG000|Overall Study|Disease Progression On Study|4|||
155160969|NCT02054104|560026732|FG001|Overall Study|Disease Progression On Study|5|||
155160970|NCT02054104|560026731|FG000|Overall Study|Diagnosis of lymphoma|0|||
155160971|NCT02054104|560026732|FG001|Overall Study|Diagnosis of lymphoma|1|||
155160972|NCT02054104|560026731|FG000|Overall Study|Inconclusive response|0|||
155304542|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304543|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304544|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155304545|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
155304546|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
155160973|NCT02054104|560026732|FG001|Overall Study|Inconclusive response|1|||
155160974|NCT01908803|560026733|FG000|Overall Study|Adverse Event|1|||
155160975|NCT01908803|560026734|FG001|Overall Study|Adverse Event|0|||
155160976|NCT01908803|560026733|FG000|Overall Study|Physician Decision|0|||
155160977|NCT01908803|560026734|FG001|Overall Study|Physician Decision|1|||
155160978|NCT01908803|560026733|FG000|Overall Study|Withdrawal by Subject|1|||
155160979|NCT01908803|560026734|FG001|Overall Study|Withdrawal by Subject|0|||
155160980|NCT01908803|560026733|FG000|Overall Study|Randomization Error|1|||
155160981|NCT01908803|560026734|FG001|Overall Study|Randomization Error|0|||
155160982|NCT01908803|560026733|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
155160983|NCT01908803|560026734|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
155160984|NCT02404025|560026735|FG000|Overall Study|Adverse Event|1|||
155160985|NCT02404025|560026735|FG000|Overall Study|Lack of Efficacy|3|||
155160986|NCT00823615|560026736|FG000|Period 2|Lost to Follow-up|2|||
155160987|NCT00823615|560026737|FG001|Period 2|Lost to Follow-up|0|||
155160988|NCT00823615|560026736|FG000|Period 2|Time/Job Conflict|1|||
155160989|NCT00823615|560026737|FG001|Period 2|Time/Job Conflict|2|||
155160990|NCT00098813|560026738|FG000|Overall Study|Death|8|||
155160991|NCT00098813|560026738|FG000|Overall Study|Protocol Violation|1|||
155160992|NCT00098813|560026738|FG000|Overall Study|Withdrawal by Subject|7|||
155160993|NCT00098813|560026738|FG000|Overall Study|Progression of Disease|1|||
155160994|NCT00098813|560026738|FG000|Overall Study|Other complicating disease|1|||
155160995|NCT00098813|560026738|FG000|Overall Study|Reversal of RAI resistance|1|||
155160996|NCT02230670|560026740|FG000|Overall Study|Adverse Event|1|||
155160997|NCT02230670|560026741|FG001|Overall Study|Adverse Event|2|||
155160998|NCT02230670|560026740|FG000|Overall Study|Withdrawal by Subject|2|||
155160999|NCT02230670|560026741|FG001|Overall Study|Withdrawal by Subject|2|||
155161000|NCT02230670|560026740|FG000|Overall Study|Physician Decision|0|||
155161001|NCT02230670|560026741|FG001|Overall Study|Physician Decision|1|||
155161002|NCT02230670|560026740|FG000|Overall Study|Protocol Violation|0|||
155161003|NCT02230670|560026741|FG001|Overall Study|Protocol Violation|1|||
155161004|NCT02230670|560026740|FG000|Overall Study|Progression to Child-Pugh C|1|||
155161005|NCT02230670|560026741|FG001|Overall Study|Progression to Child-Pugh C|2|||
155161006|NCT01907854|560026746|FG000|Overall Study|Protocol Violation|1|||
155161007|NCT01907854|560026747|FG001|Overall Study|Protocol Violation|1|||
155161008|NCT01907854|560026746|FG000|Overall Study|Withdrawal by Subject|9|||
155161009|NCT01907854|560026747|FG001|Overall Study|Withdrawal by Subject|7|||
155161010|NCT01907854|560026746|FG000|Overall Study|Lost to Follow-up|2|||
155161011|NCT01907854|560026747|FG001|Overall Study|Lost to Follow-up|2|||
155161012|NCT01907854|560026746|FG000|Overall Study|Unclassified|4|||
155161013|NCT01907854|560026747|FG001|Overall Study|Unclassified|3|||
155161014|NCT02215252|560026748|FG000|Overall Study|Adverse Event|1|||
155161015|NCT02215252|560026749|FG001|Overall Study|Adverse Event|5|||
155161016|NCT02215252|560026750|FG002|Overall Study|Adverse Event|2|||
155161017|NCT02215252|560026748|FG000|Overall Study|Lost to Follow-up|0|||
155161018|NCT02215252|560026749|FG001|Overall Study|Lost to Follow-up|0|||
155161019|NCT02215252|560026750|FG002|Overall Study|Lost to Follow-up|1|||
155161020|NCT02215252|560026748|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
155304547|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304548|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304549|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304550|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304551|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304552|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304553|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
155304554|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
155304555|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
155304556|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304557|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304558|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304559|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304560|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304561|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304562|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304563|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
155304564|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
155304565|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304566|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304567|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304568|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304569|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304570|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304571|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304572|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
155304573|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
155304574|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304575|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304576|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304577|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304578|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304579|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304580|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304581|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
155304582|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
155304583|NCT02590432|560546050|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304584|NCT02590432|560546051|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304585|NCT02590432|560546052|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304586|NCT02590432|560546053|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304587|NCT02590432|560546054|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304588|NCT02590432|560546055|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304589|NCT02590432|560546056|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304590|NCT02590432|560546057|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
155304591|NCT02590432|560546058|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
155304592|NCT02006758|560546059|FG000|Overall Study|Protocol Violation|1|||
155304593|NCT02006758|560546059|FG000|Overall Study|Death|1|||
155304594|NCT02006758|560546059|FG000|Overall Study|Lost to Follow-up|4|||
155304595|NCT02006758|560546059|FG000|Overall Study|Withdrawal by Subject|4|||
155161021|NCT02215252|560026749|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
155161022|NCT02215252|560026750|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
155161023|NCT02215252|560026748|FG000|Overall Study|Protocol Violation|0|||
155161024|NCT02215252|560026749|FG001|Overall Study|Protocol Violation|1|||
154958631|NCT00640562|559275558|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
154958632|NCT00640562|559275559|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
154958633|NCT00448591|559275560|FG000|Overall Study|Withdrawal by Subject|178|||
154958634|NCT00448591|559275560|FG000|Overall Study|Progressive Disease|1382|||
154958635|NCT00448591|559275560|FG000|Overall Study|Adverse Event|382|||
154958636|NCT00448591|559275560|FG000|Overall Study|Protocol Violation|41|||
154958637|NCT00448591|559275560|FG000|Overall Study|Lost to Follow-up|19|||
154958638|NCT00448591|559275560|FG000|Overall Study|Treatment Regimen Completed|70|||
154958639|NCT00448591|559275560|FG000|Overall Study|Other|154|||
154958640|NCT00448591|559275560|FG000|Overall Study|Termination of Study|70|||
154958641|NCT02937870|559275561|FG000|Overall Study|Adverse Event|1|||
155304596|NCT02006758|560546059|FG000|Overall Study|Procedurally excluded|1|||
155304597|NCT02006758|560546059|FG000|Overall Study|Other|2|||
155304598|NCT00520546|560546061|FG000|Overall Study|Withdrawal by Subject|1|||
155304599|NCT00520546|560546061|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
155304600|NCT02554786|560546066|FG000|Overall Study|Subject/guardian decision|29|||
155304601|NCT02554786|560546067|FG001|Overall Study|Subject/guardian decision|17|||
155304602|NCT02554786|560546068|FG002|Overall Study|Subject/guardian decision|18|||
155304603|NCT02554786|560546069|FG003|Overall Study|Subject/guardian decision|30|||
155304604|NCT02554786|560546070|FG004|Overall Study|Subject/guardian decision|20|||
155304605|NCT02554786|560546066|FG000|Overall Study|Lost to Follow-up|4|||
155304606|NCT02554786|560546067|FG001|Overall Study|Lost to Follow-up|3|||
155304607|NCT02554786|560546068|FG002|Overall Study|Lost to Follow-up|4|||
155304608|NCT02554786|560546069|FG003|Overall Study|Lost to Follow-up|2|||
155304609|NCT02554786|560546070|FG004|Overall Study|Lost to Follow-up|2|||
155304610|NCT02554786|560546066|FG000|Overall Study|Protocol deviation|1|||
155304611|NCT02554786|560546067|FG001|Overall Study|Protocol deviation|3|||
155304612|NCT02554786|560546068|FG002|Overall Study|Protocol deviation|3|||
155304613|NCT02554786|560546069|FG003|Overall Study|Protocol deviation|4|||
155304614|NCT02554786|560546070|FG004|Overall Study|Protocol deviation|2|||
155304615|NCT02554786|560546066|FG000|Overall Study|Technical problems|1|||
155304616|NCT02554786|560546067|FG001|Overall Study|Technical problems|1|||
155304617|NCT02554786|560546068|FG002|Overall Study|Technical problems|0|||
155304618|NCT02554786|560546069|FG003|Overall Study|Technical problems|2|||
155304619|NCT02554786|560546070|FG004|Overall Study|Technical problems|1|||
155304620|NCT02554786|560546066|FG000|Overall Study|Adverse Event|0|||
155304621|NCT02554786|560546067|FG001|Overall Study|Adverse Event|0|||
155304622|NCT02554786|560546068|FG002|Overall Study|Adverse Event|0|||
155304623|NCT02554786|560546069|FG003|Overall Study|Adverse Event|0|||
155161025|NCT02215252|560026750|FG002|Overall Study|Protocol Violation|0|||
155161026|NCT02215252|560026748|FG000|Overall Study|Withdrawal by Subject|1|||
155161027|NCT02215252|560026749|FG001|Overall Study|Withdrawal by Subject|0|||
155161028|NCT02215252|560026750|FG002|Overall Study|Withdrawal by Subject|0|||
155161029|NCT02215252|560026748|FG000|Overall Study|Other|0|||
155161030|NCT02215252|560026749|FG001|Overall Study|Other|1|||
155161031|NCT02215252|560026750|FG002|Overall Study|Other|1|||
155161032|NCT02118961|560026751|FG000|Overall Study|Withdrawal by Subject|1|||
155161033|NCT02118961|560026752|FG001|Overall Study|Withdrawal by Subject|0|||
155161034|NCT00892099|560026754|FG000|Overall Study|Death|1|||
155161035|NCT00892099|560026755|FG001|Overall Study|Death|0|||
155161036|NCT00892099|560026756|FG002|Overall Study|Death|1|||
154958642|NCT02937870|559275561|FG000|Overall Study|Protocol Deviation|2|||
155304624|NCT02554786|560546070|FG004|Overall Study|Adverse Event|2|||
155304625|NCT02554786|560546066|FG000|Overall Study|Death|0|||
155304626|NCT02554786|560546067|FG001|Overall Study|Death|0|||
155304627|NCT02554786|560546068|FG002|Overall Study|Death|0|||
155304628|NCT02554786|560546069|FG003|Overall Study|Death|1|||
155304629|NCT02554786|560546070|FG004|Overall Study|Death|0|||
155304630|NCT02554786|560546066|FG000|Overall Study|Non-compliance with study treatment|0|||
155304631|NCT02554786|560546067|FG001|Overall Study|Non-compliance with study treatment|1|||
155304632|NCT02554786|560546068|FG002|Overall Study|Non-compliance with study treatment|1|||
155304633|NCT02554786|560546069|FG003|Overall Study|Non-compliance with study treatment|0|||
155304634|NCT02554786|560546070|FG004|Overall Study|Non-compliance with study treatment|1|||
155304635|NCT02554786|560546066|FG000|Overall Study|Physician Decision|0|||
155304636|NCT02554786|560546067|FG001|Overall Study|Physician Decision|1|||
155304637|NCT02554786|560546068|FG002|Overall Study|Physician Decision|4|||
155304638|NCT02554786|560546069|FG003|Overall Study|Physician Decision|1|||
155304639|NCT02554786|560546070|FG004|Overall Study|Physician Decision|1|||
155304640|NCT02554786|560546066|FG000|Overall Study|Pregnancy|0|||
155304641|NCT02554786|560546067|FG001|Overall Study|Pregnancy|0|||
155304642|NCT02554786|560546068|FG002|Overall Study|Pregnancy|0|||
155304643|NCT02554786|560546069|FG003|Overall Study|Pregnancy|1|||
155304644|NCT02554786|560546070|FG004|Overall Study|Pregnancy|1|||
155304645|NCT05052996|560546071|FG000|Overall Study|Still on study|0|||
155304646|NCT05052996|560546072|FG001|Overall Study|Still on study|0|||
155304647|NCT05052996|560546073|FG002|Overall Study|Still on study|47|||
155304648|NCT05052996|560546074|FG003|Overall Study|Still on study|44|||
155304649|NCT05052996|560546071|FG000|Overall Study|Cohort terminated by sponsor|21|||
155304650|NCT05052996|560546072|FG001|Overall Study|Cohort terminated by sponsor|12|||
155304651|NCT05052996|560546073|FG002|Overall Study|Cohort terminated by sponsor|0|||
155304652|NCT05052996|560546074|FG003|Overall Study|Cohort terminated by sponsor|0|||
155161037|NCT00892099|560026754|FG000|Overall Study|Adverse Event|1|||
155161038|NCT00892099|560026755|FG001|Overall Study|Adverse Event|0|||
155304653|NCT05052996|560546071|FG000|Overall Study|Withdrew consent|1|||
155304654|NCT05052996|560546072|FG001|Overall Study|Withdrew consent|0|||
155304655|NCT05052996|560546073|FG002|Overall Study|Withdrew consent|1|||
155304656|NCT05052996|560546074|FG003|Overall Study|Withdrew consent|2|||
155304657|NCT05052996|560546071|FG000|Overall Study|Lost to Follow-up|1|||
155161039|NCT00892099|560026756|FG002|Overall Study|Adverse Event|0|||
155161040|NCT00892099|560026754|FG000|Overall Study|replocated|1|||
155161041|NCT00892099|560026755|FG001|Overall Study|replocated|0|||
155161042|NCT00892099|560026756|FG002|Overall Study|replocated|2|||
155161043|NCT00892099|560026754|FG000|Overall Study|Prolonged hospitalization|1|||
155161044|NCT00892099|560026755|FG001|Overall Study|Prolonged hospitalization|0|||
155161045|NCT00892099|560026756|FG002|Overall Study|Prolonged hospitalization|1|||
155161046|NCT00892099|560026754|FG000|Overall Study|no further details|1|||
155161047|NCT00892099|560026755|FG001|Overall Study|no further details|0|||
155161048|NCT00892099|560026756|FG002|Overall Study|no further details|1|||
155161049|NCT00892099|560026754|FG000|Overall Study|kidney function recovered|0|||
154958643|NCT00244764|559275562|FG000|Overall Study|Adverse Event|37|||
154958644|NCT00244764|559275562|FG000|Overall Study|Lost to Follow-up|23|||
154958645|NCT00244764|559275562|FG000|Overall Study|Withdrawal by Subject|12|||
154958646|NCT00244764|559275562|FG000|Overall Study|Disease Progression|13|||
154958647|NCT00244764|559275562|FG000|Overall Study|Protocol Violation|2|||
154958648|NCT00244764|559275562|FG000|Overall Study|Death|1|||
154958649|NCT00244764|559275562|FG000|Overall Study|Off Study Medication for >21 Days|1|||
154958650|NCT00244764|559275562|FG000|Overall Study|Declining Performance Status|1|||
154958651|NCT00244764|559275562|FG000|Overall Study|Participant was Hospitalized until Death|1|||
154958652|NCT00244764|559275562|FG000|Overall Study|Primary Investigator Discretion|2|||
154958653|NCT00244764|559275562|FG000|Overall Study|Sponsor Terminated Study|2|||
154958654|NCT00244764|559275562|FG000|Overall Study|Developed Secondary Malignancy|1|||
154958655|NCT04022954|559275565|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
154958656|NCT04022954|559275565|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
154958657|NCT04022954|559275565|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
154958658|NCT03017885|559275566|FG000|Overall Study|Adverse Event|2|||
154958659|NCT03017885|559275567|FG001|Overall Study|Adverse Event|0|||
154958660|NCT03017885|559275568|FG002|Overall Study|Adverse Event|0|||
154958661|NCT03017885|559275569|FG003|Overall Study|Adverse Event|0|||
154958662|NCT03017885|559275570|FG004|Overall Study|Adverse Event|0|||
154958663|NCT03017885|559275571|FG005|Overall Study|Adverse Event|0|||
154958664|NCT03017885|559275566|FG000|Overall Study|Progression of disease|4|||
154958665|NCT03017885|559275567|FG001|Overall Study|Progression of disease|3|||
154958666|NCT03017885|559275568|FG002|Overall Study|Progression of disease|4|||
154958667|NCT03017885|559275569|FG003|Overall Study|Progression of disease|0|||
154958668|NCT03017885|559275570|FG004|Overall Study|Progression of disease|0|||
154958669|NCT03017885|559275571|FG005|Overall Study|Progression of disease|0|||
154958670|NCT03017885|559275566|FG000|Overall Study|Other than listed|1|||
154958671|NCT03017885|559275567|FG001|Overall Study|Other than listed|2|||
154958672|NCT03017885|559275568|FG002|Overall Study|Other than listed|1|||
154958673|NCT03017885|559275569|FG003|Overall Study|Other than listed|0|||
154958674|NCT03017885|559275570|FG004|Overall Study|Other than listed|0|||
154958675|NCT03017885|559275571|FG005|Overall Study|Other than listed|0|||
154958676|NCT03017885|559275566|FG000|Overall Study|Lost to Follow-up|2|||
154958677|NCT03017885|559275567|FG001|Overall Study|Lost to Follow-up|0|||
154958678|NCT03017885|559275568|FG002|Overall Study|Lost to Follow-up|3|||
154958679|NCT03017885|559275569|FG003|Overall Study|Lost to Follow-up|0|||
154958680|NCT03017885|559275570|FG004|Overall Study|Lost to Follow-up|0|||
154958681|NCT03017885|559275571|FG005|Overall Study|Lost to Follow-up|0|||
154958682|NCT03017885|559275566|FG000|Overall Study|Change to other anti-cancer therapy|0|||
154958683|NCT03017885|559275567|FG001|Overall Study|Change to other anti-cancer therapy|0|||
154958684|NCT03017885|559275568|FG002|Overall Study|Change to other anti-cancer therapy|1|||
154958685|NCT03017885|559275569|FG003|Overall Study|Change to other anti-cancer therapy|0|||
154958686|NCT03017885|559275570|FG004|Overall Study|Change to other anti-cancer therapy|0|||
154958687|NCT03017885|559275571|FG005|Overall Study|Change to other anti-cancer therapy|0|||
154958688|NCT04400890|559275572|FG000|Overall Study|Withdrawal by Subject|3|||
154958689|NCT04400890|559275573|FG001|Overall Study|Withdrawal by Subject|2|||
154958690|NCT03925532|559275574|FG000|Overall Study|Lost to Follow-up|1|||
154958691|NCT01001208|559275579|FG000|Overall Study|Adverse Event|10|||
154958692|NCT01001208|559275580|FG001|Overall Study|Adverse Event|5|||
154958693|NCT01001208|559275579|FG000|Overall Study|Lost to Follow-up|5|||
154958694|NCT01001208|559275580|FG001|Overall Study|Lost to Follow-up|9|||
154958695|NCT01001208|559275579|FG000|Overall Study|Physician Decision|1|||
154958696|NCT01001208|559275580|FG001|Overall Study|Physician Decision|0|||
154958697|NCT01001208|559275579|FG000|Overall Study|Withdrawal by Subject|4|||
154958698|NCT01001208|559275580|FG001|Overall Study|Withdrawal by Subject|5|||
154958699|NCT01001208|559275579|FG000|Overall Study|Ineligibility Determined|4|||
154958700|NCT01001208|559275580|FG001|Overall Study|Ineligibility Determined|2|||
154958701|NCT01001208|559275579|FG000|Overall Study|Noncompliance|4|||
154958702|NCT01001208|559275580|FG001|Overall Study|Noncompliance|7|||
154958703|NCT01001208|559275579|FG000|Overall Study|Disease Progression|0|||
154958704|NCT01001208|559275580|FG001|Overall Study|Disease Progression|3|||
154958705|NCT01001208|559275579|FG000|Overall Study|Other|0|||
154958706|NCT01001208|559275580|FG001|Overall Study|Other|2|||
154958707|NCT02739997|559275581|FG000|Overall Study|Death|1|||
154958708|NCT02739997|559275581|FG000|Overall Study|Withdrawal by Subject|1|||
155161050|NCT00892099|560026755|FG001|Overall Study|kidney function recovered|1|||
155304658|NCT05052996|560546072|FG001|Overall Study|Lost to Follow-up|0|||
155304659|NCT05052996|560546073|FG002|Overall Study|Lost to Follow-up|0|||
155304660|NCT05052996|560546074|FG003|Overall Study|Lost to Follow-up|2|||
155304661|NCT05052996|560546071|FG000|Overall Study|Adverse Event|0|||
154958709|NCT01723397|559275582|FG000|Study Period 1|Protocol Violation|0|||
154958710|NCT01723397|559275583|FG001|Study Period 1|Protocol Violation|1|||
154958711|NCT01723397|559275582|FG000|Study Period 2|Protocol Violation|0|||
154958712|NCT01723397|559275583|FG001|Study Period 2|Protocol Violation|1|||
154958713|NCT00833937|559275584|FG000|Washout|Withdrawal by Subject|1|||
154958714|NCT00833937|559275585|FG001|Washout|Withdrawal by Subject|0|||
155304662|NCT05052996|560546072|FG001|Overall Study|Adverse Event|0|||
155304663|NCT05052996|560546073|FG002|Overall Study|Adverse Event|2|||
155304664|NCT05052996|560546074|FG003|Overall Study|Adverse Event|0|||
155304665|NCT05052996|560546071|FG000|Overall Study|Randomized but never treated|0|||
154958715|NCT01353664|559275588|FG000|Overall Study|Other|3|||
154958716|NCT01353664|559275588|FG000|Overall Study|Disease Progression|16|||
154958717|NCT03206177|559275589|FG000|Overall Study|Withdrawal by Subject|1|||
154958718|NCT00837486|559275590|FG000|Blinded-treatment Phase|Physician Decision|1|||
154958719|NCT00837486|559275591|FG001|Blinded-treatment Phase|Physician Decision|0|||
154958720|NCT00837486|559275590|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
155065120|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
155065121|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
155065122|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
155065123|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
155161051|NCT00892099|560026756|FG002|Overall Study|kidney function recovered|0|||
155161052|NCT00892099|560026754|FG000|Overall Study|investigator decision|0|||
154958721|NCT00837486|559275591|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
154958722|NCT00837486|559275590|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
154958723|NCT00837486|559275591|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
154958724|NCT00837486|559275590|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
154958725|NCT00837486|559275591|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
154958726|NCT02655679|559275592|FG000|Overall Study|Adverse Event|0|||
154958727|NCT02655679|559275593|FG001|Overall Study|Adverse Event|1|||
154958728|NCT02655679|559275594|FG002|Overall Study|Adverse Event|0|||
154958729|NCT02655679|559275595|FG003|Overall Study|Adverse Event|0|||
154958730|NCT02655679|559275596|FG004|Overall Study|Adverse Event|0|||
154958731|NCT02655679|559275592|FG000|Overall Study|Withdrawal by Subject|1|||
154958732|NCT02655679|559275593|FG001|Overall Study|Withdrawal by Subject|1|||
154958733|NCT02655679|559275594|FG002|Overall Study|Withdrawal by Subject|0|||
154958734|NCT02655679|559275595|FG003|Overall Study|Withdrawal by Subject|3|||
154958735|NCT02655679|559275596|FG004|Overall Study|Withdrawal by Subject|1|||
154958736|NCT02655679|559275592|FG000|Overall Study|Inability to Comply with the Protocol|1|||
154958737|NCT02655679|559275593|FG001|Overall Study|Inability to Comply with the Protocol|0|||
154958738|NCT02655679|559275594|FG002|Overall Study|Inability to Comply with the Protocol|0|||
154958739|NCT02655679|559275595|FG003|Overall Study|Inability to Comply with the Protocol|0|||
154958740|NCT02655679|559275596|FG004|Overall Study|Inability to Comply with the Protocol|0|||
154958741|NCT02655679|559275592|FG000|Overall Study|Lost to Follow-up|0|||
155065124|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
155065125|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
155065126|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
155065127|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
155065128|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
155065129|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
155065130|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
155065131|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
155161053|NCT00892099|560026755|FG001|Overall Study|investigator decision|0|||
155065132|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
155065133|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
155065134|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
155065135|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
155065136|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
155065137|NCT00090103|559669900|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
155065138|NCT00090103|559669901|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
155065139|NCT00090103|559669902|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
155065140|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
155065141|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
155065142|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
155065143|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
155065144|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
155065145|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
155065146|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
155065147|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
155065148|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
155065149|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
155065150|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
155065151|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
155065152|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
155065153|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
155065154|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
155065155|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
155065156|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
155065157|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
155065158|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
155065159|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
155065160|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
155065161|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
155065162|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
155065163|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
155065164|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
155065165|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
155065166|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
155065167|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
155065168|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
155065169|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
155065170|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
155065171|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
155065172|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
155065173|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
155065174|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
155065175|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
155065176|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
155065177|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
155065178|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
155065179|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
155065180|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
155065181|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
155065182|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
155065183|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
155304666|NCT05052996|560546072|FG001|Overall Study|Randomized but never treated|0|||
155304667|NCT05052996|560546073|FG002|Overall Study|Randomized but never treated|1|||
155304668|NCT05052996|560546074|FG003|Overall Study|Randomized but never treated|1|||
155304669|NCT05052996|560546071|FG000|Overall Study|Protocol Violation|1|||
155304670|NCT05052996|560546072|FG001|Overall Study|Protocol Violation|0|||
155304671|NCT05052996|560546073|FG002|Overall Study|Protocol Violation|0|||
155304672|NCT05052996|560546074|FG003|Overall Study|Protocol Violation|0|||
155304673|NCT03830866|560546078|FG000|Overall Study|Death|90|||
155304674|NCT03830866|560546079|FG001|Overall Study|Death|111|||
155065184|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
155065185|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
155065186|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
155304675|NCT03830866|560546078|FG000|Overall Study|Lost to Follow-up|7|||
155304676|NCT03830866|560546079|FG001|Overall Study|Lost to Follow-up|7|||
154958742|NCT02655679|559275593|FG001|Overall Study|Lost to Follow-up|1|||
154958743|NCT02655679|559275594|FG002|Overall Study|Lost to Follow-up|1|||
154958744|NCT02655679|559275595|FG003|Overall Study|Lost to Follow-up|1|||
154958745|NCT02655679|559275596|FG004|Overall Study|Lost to Follow-up|0|||
154958746|NCT02655679|559275592|FG000|Overall Study|Other Miscellaneous Reasons|1|||
154958747|NCT02655679|559275593|FG001|Overall Study|Other Miscellaneous Reasons|0|||
154958748|NCT02655679|559275594|FG002|Overall Study|Other Miscellaneous Reasons|0|||
154958749|NCT02655679|559275595|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155304677|NCT03830866|560546078|FG000|Overall Study|Withdrawal by Subject|19|||
155304678|NCT03830866|560546079|FG001|Overall Study|Withdrawal by Subject|16|||
155304679|NCT03830866|560546078|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
155304680|NCT03830866|560546079|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
155304681|NCT03830866|560546078|FG000|Overall Study|Other|1|||
155304682|NCT03830866|560546079|FG001|Overall Study|Other|1|||
155304683|NCT01736215|560546089|FG000|Overall Study|Early termination of erythropoietin use|1|||
155304684|NCT01736215|560546089|FG000|Overall Study|Adverse Event|4|||
155304685|NCT01736215|560546089|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
155304686|NCT01736215|560546089|FG000|Overall Study|Insufficient data to perform analysis|8|||
155304687|NCT01248936|560546090|FG000|Overall Study|Sponsor Decision|259|||
155304688|NCT01248936|560546090|FG000|Overall Study|Progression of Disease|50|||
155304689|NCT01248936|560546090|FG000|Overall Study|Death|26|||
155304690|NCT01248936|560546090|FG000|Overall Study|Withdrawal of Consent|20|||
155304691|NCT01248936|560546090|FG000|Overall Study|Adverse Event|8|||
155304692|NCT01248936|560546090|FG000|Overall Study|Lost to Follow-up|7|||
155304693|NCT01248936|560546090|FG000|Overall Study|Refused Treatment|1|||
155304694|NCT01248936|560546090|FG000|Overall Study|Other reason|3|||
155304695|NCT00331136|560546093|FG000|Overall Study|Adverse Event|3|||
155304696|NCT00331136|560546094|FG001|Overall Study|Adverse Event|5|||
155304697|NCT00331136|560546095|FG002|Overall Study|Adverse Event|0|||
155304698|NCT00331136|560546096|FG003|Overall Study|Adverse Event|1|||
155304699|NCT00331136|560546093|FG000|Overall Study|Withdrawal by Subject|0|||
155304700|NCT00331136|560546094|FG001|Overall Study|Withdrawal by Subject|1|||
155304701|NCT00331136|560546095|FG002|Overall Study|Withdrawal by Subject|0|||
155304702|NCT00331136|560546096|FG003|Overall Study|Withdrawal by Subject|0|||
155304703|NCT00331136|560546093|FG000|Overall Study|Lost to Follow-up|0|||
155304704|NCT00331136|560546094|FG001|Overall Study|Lost to Follow-up|1|||
155304705|NCT00331136|560546095|FG002|Overall Study|Lost to Follow-up|0|||
155304706|NCT00331136|560546096|FG003|Overall Study|Lost to Follow-up|0|||
155304707|NCT00331136|560546093|FG000|Overall Study|Protocol Violation|1|||
155161054|NCT00892099|560026756|FG002|Overall Study|investigator decision|1|||
155161055|NCT00892099|560026754|FG000|Overall Study|Lost to Follow-up|0|||
155161056|NCT00892099|560026755|FG001|Overall Study|Lost to Follow-up|0|||
155161057|NCT00892099|560026756|FG002|Overall Study|Lost to Follow-up|1|||
155161058|NCT01657019|560026757|FG000|Overall Study|Withdrawal by Subject|65|||
155161059|NCT01657019|560026757|FG000|Overall Study|Adverse Event|55|||
155161060|NCT01657019|560026757|FG000|Overall Study|Lost to Follow-up|48|||
155161061|NCT01657019|560026757|FG000|Overall Study|Protocol Violation|6|||
155161062|NCT01657019|560026757|FG000|Overall Study|Lack of Efficacy|3|||
155161063|NCT01657019|560026757|FG000|Overall Study|Other|58|||
155161064|NCT03910244|560026758|FG000|Overall Study|Adverse Event|14|||
155161065|NCT03910244|560026759|FG001|Overall Study|Adverse Event|0|||
155161066|NCT03910244|560026758|FG000|Overall Study|Death|1|||
155304708|NCT00331136|560546094|FG001|Overall Study|Protocol Violation|0|||
155304709|NCT00331136|560546095|FG002|Overall Study|Protocol Violation|0|||
155304710|NCT00331136|560546096|FG003|Overall Study|Protocol Violation|0|||
155304711|NCT00331136|560546093|FG000|Overall Study|Not treated|1|||
155304712|NCT00331136|560546094|FG001|Overall Study|Not treated|0|||
154958750|NCT02655679|559275596|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155304713|NCT00331136|560546095|FG002|Overall Study|Not treated|0|||
155161067|NCT03910244|560026759|FG001|Overall Study|Death|0|||
155161068|NCT03910244|560026758|FG000|Overall Study|Lost to Follow-up|0|||
155161069|NCT03910244|560026759|FG001|Overall Study|Lost to Follow-up|2|||
155161070|NCT03910244|560026758|FG000|Overall Study|Joint withdrawal decision|1|||
155161071|NCT03910244|560026759|FG001|Overall Study|Joint withdrawal decision|0|||
155161072|NCT03910244|560026758|FG000|Overall Study|Study Terminated by Sponsor|7|||
155161073|NCT03910244|560026759|FG001|Overall Study|Study Terminated by Sponsor|4|||
154958751|NCT00731783|559275597|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
154958752|NCT00731783|559275598|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
154958753|NCT00731783|559275597|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
154958754|NCT00731783|559275598|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
154958755|NCT00731783|559275597|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
154958756|NCT00731783|559275598|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
154958757|NCT00731783|559275597|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
154958758|NCT00731783|559275598|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
154958759|NCT02847650|559276813|FG000|Overall Study|Adverse Event|2|||
154958760|NCT02847650|559276814|FG001|Overall Study|Adverse Event|4|||
154958761|NCT02847650|559276813|FG000|Overall Study|Lost to Follow-up|1|||
154958762|NCT02847650|559276814|FG001|Overall Study|Lost to Follow-up|0|||
154958763|NCT02847650|559276813|FG000|Overall Study|Protocol Violation|0|||
154958764|NCT02847650|559276814|FG001|Overall Study|Protocol Violation|1|||
154958765|NCT02847650|559276813|FG000|Overall Study|Withdrawal by Subject|1|||
154958766|NCT02847650|559276814|FG001|Overall Study|Withdrawal by Subject|1|||
154958767|NCT03772522|559276815|FG000|Pre-intervention|Withdrawal by Subject|3|||
154958768|NCT03772522|559276816|FG001|Pre-intervention|Withdrawal by Subject|4|||
154958769|NCT03772522|559276815|FG000|Intervention|Withdrawal by Subject|1|||
155304714|NCT00331136|560546096|FG003|Overall Study|Not treated|0|||
155304715|NCT02692417|560546097|FG000|Overall Study|Withdrawal by Subject|5|||
155304716|NCT02692417|560546098|FG001|Overall Study|Withdrawal by Subject|1|||
154958770|NCT03772522|559276816|FG001|Intervention|Withdrawal by Subject|0|||
154958771|NCT03772522|559276815|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
154958772|NCT03772522|559276816|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
154958773|NCT00218257|559276817|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
154958774|NCT00218257|559276818|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
155304717|NCT02692417|560546097|FG000|Overall Study|Adverse Event|1|||
155304718|NCT02692417|560546098|FG001|Overall Study|Adverse Event|0|||
155304719|NCT03201562|560546103|FG000|Overall Study|Physician Decision|0|||
155304720|NCT03201562|560546104|FG001|Overall Study|Physician Decision|0|||
155304721|NCT03201562|560546105|FG002|Overall Study|Physician Decision|1|||
155304722|NCT03201562|560546103|FG000|Overall Study|Adverse Event|0|||
155304723|NCT03201562|560546104|FG001|Overall Study|Adverse Event|0|||
155304724|NCT03201562|560546105|FG002|Overall Study|Adverse Event|1|||
155304725|NCT03201562|560546103|FG000|Overall Study|Lost to Follow-up|0|||
155304726|NCT03201562|560546104|FG001|Overall Study|Lost to Follow-up|1|||
155304727|NCT03201562|560546105|FG002|Overall Study|Lost to Follow-up|2|||
155304728|NCT01094184|560546111|FG000|Overall Study|Death|35|||
155304729|NCT01094184|560546112|FG001|Overall Study|Death|11|||
155304730|NCT00031694|560546113|FG000|Overall Study|Adverse Event|12|||
155304731|NCT00031694|560546113|FG000|Overall Study|Death|2|||
155304732|NCT00031694|560546113|FG000|Overall Study|Withdrawal by Subject|5|||
155304733|NCT03892564|560546114|FG000|Overall Study|Withdrawal by Subject|2|||
155304734|NCT01207492|560546115|FG000|Overall Study|Still on study|1|||
155304735|NCT01207492|560546115|FG000|Overall Study|Withdrawal by Subject|9|||
155304736|NCT01207492|560546115|FG000|Overall Study|Physician Decision|1|||
155304737|NCT01207492|560546115|FG000|Overall Study|Progressive disease|3|||
155304738|NCT01207492|560546115|FG000|Overall Study|Toxicity|1|||
155304739|NCT00212355|560547524|FG000|Overall Study|Adverse Event|1|||
155304740|NCT00212355|560547524|FG000|Overall Study|Withdrawal by Subject|1|||
155304741|NCT00212355|560547524|FG000|Overall Study|A change of address|1|||
155304742|NCT04310735|560547527|FG000|Overall Study|Withdrawal by Subject|1|||
155304743|NCT04310735|560547528|FG001|Overall Study|Withdrawal by Subject|3|||
155304744|NCT04310735|560547529|FG002|Overall Study|Withdrawal by Subject|8|||
155304745|NCT04310735|560547527|FG000|Overall Study|Equipment malfunction|0|||
155304746|NCT04310735|560547528|FG001|Overall Study|Equipment malfunction|1|||
155304747|NCT04310735|560547529|FG002|Overall Study|Equipment malfunction|0|||
155304748|NCT03012841|560547530|FG000|Overall Study|Protocol Violation|0|||
155304749|NCT03012841|560547531|FG001|Overall Study|Protocol Violation|10|||
155304750|NCT03012841|560547530|FG000|Overall Study|Lost to Follow-up|6|||
155304751|NCT03012841|560547531|FG001|Overall Study|Lost to Follow-up|1|||
155304752|NCT03012841|560547530|FG000|Overall Study|Withdrawal by Subject|6|||
155304753|NCT03012841|560547531|FG001|Overall Study|Withdrawal by Subject|0|||
155304754|NCT03012841|560547530|FG000|Overall Study|Unable to complete 12 month visit|6|||
155304755|NCT03012841|560547531|FG001|Overall Study|Unable to complete 12 month visit|0|||
155304756|NCT03012841|560547530|FG000|Overall Study|Subject relocation|1|||
155304757|NCT03012841|560547531|FG001|Overall Study|Subject relocation|0|||
155304758|NCT03012841|560547530|FG000|Overall Study|Seasonal winter travel|1|||
155304759|NCT03012841|560547531|FG001|Overall Study|Seasonal winter travel|0|||
155304760|NCT03012841|560547530|FG000|Overall Study|Physician Decision|0|||
155304761|NCT03012841|560547531|FG001|Overall Study|Physician Decision|2|||
155304762|NCT03012841|560547530|FG000|Overall Study|No ablation performed|0|||
155304763|NCT03012841|560547531|FG001|Overall Study|No ablation performed|2|||
155304764|NCT03012841|560547530|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
155304765|NCT03012841|560547531|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
155065187|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
155065188|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Death|1|||
155065189|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Death|0|||
155065190|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Death|1|||
155065191|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
155065192|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
155065193|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
155065194|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
155065195|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
155065196|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
155065197|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
155065198|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
155065199|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
155065200|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
155065201|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
155065202|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
155065203|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
155065204|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
155065205|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
155304766|NCT03012841|560547530|FG000|Overall Study|Insurance change|0|||
155304767|NCT03012841|560547531|FG001|Overall Study|Insurance change|1|||
155304768|NCT00186992|560547532|FG000|Overall Study|Withdrawal by Subject|5|||
155304769|NCT00186992|560547532|FG000|Overall Study|Physician's discretion|13|||
155304770|NCT00186992|560547532|FG000|Overall Study|PI Discretion|4|||
155065206|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
155065207|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
155065208|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
155065209|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
155065210|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
155065211|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
155065212|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Depression|0|||
155065213|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Depression|1|||
155065214|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Depression|0|||
155065215|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
155065216|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
155065217|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
155065218|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Jailed|0|||
155065219|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Jailed|1|||
155065220|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Jailed|0|||
155065221|NCT00090103|559669900|FG000|16-Week Safety Follow-up Period|Other|0|||
155065222|NCT00090103|559669901|FG001|16-Week Safety Follow-up Period|Other|1|||
155065223|NCT00090103|559669902|FG002|16-Week Safety Follow-up Period|Other|0|||
155065224|NCT01799889|559669903|FG000|Overall Study|Adverse Event|4|||
155065225|NCT01799889|559669904|FG001|Overall Study|Adverse Event|4|||
155065226|NCT01799889|559669905|FG002|Overall Study|Adverse Event|5|||
155065227|NCT01799889|559669906|FG003|Overall Study|Adverse Event|1|||
155065228|NCT01799889|559669907|FG004|Overall Study|Adverse Event|11|||
155065229|NCT01799889|559669908|FG005|Overall Study|Adverse Event|1|||
155065230|NCT01799889|559669909|FG006|Overall Study|Adverse Event|5|||
155065231|NCT01799889|559669910|FG007|Overall Study|Adverse Event|2|||
155065232|NCT01799889|559669911|FG008|Overall Study|Adverse Event|3|||
155065233|NCT01799889|559669912|FG009|Overall Study|Adverse Event|1|||
155065234|NCT01799889|559669913|FG010|Overall Study|Adverse Event|1|||
155065235|NCT01799889|559669914|FG011|Overall Study|Adverse Event|0|||
155065236|NCT01799889|559669903|FG000|Overall Study|Death|1|||
155065237|NCT01799889|559669904|FG001|Overall Study|Death|0|||
155304771|NCT00186992|560547532|FG000|Overall Study|Ineligible|2|||
155304772|NCT00186992|560547532|FG000|Overall Study|Lost to Follow-up|2|||
155304773|NCT00186992|560547532|FG000|Overall Study|Still on Study|9|||
155304774|NCT05696080|560547533|FG000|Overall Study|Lost to Follow-up|2|||
155304775|NCT05696080|560547534|FG001|Overall Study|Lost to Follow-up|1|||
155304776|NCT05696080|560547533|FG000|Overall Study|Physician Decision|1|||
155304777|NCT05696080|560547534|FG001|Overall Study|Physician Decision|0|||
155065238|NCT01799889|559669905|FG002|Overall Study|Death|5|||
155065239|NCT01799889|559669906|FG003|Overall Study|Death|3|||
155065240|NCT01799889|559669907|FG004|Overall Study|Death|1|||
155065241|NCT01799889|559669908|FG005|Overall Study|Death|0|||
155065242|NCT01799889|559669909|FG006|Overall Study|Death|0|||
155065243|NCT01799889|559669910|FG007|Overall Study|Death|0|||
155065244|NCT01799889|559669911|FG008|Overall Study|Death|1|||
155304778|NCT05696080|560547533|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155304779|NCT05696080|560547534|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155304780|NCT05696080|560547533|FG000|Overall Study|Withdrawal by Subject|12|||
155304781|NCT05696080|560547534|FG001|Overall Study|Withdrawal by Subject|0|||
155304782|NCT03954184|560547535|FG000|Overall Study|Lost to Follow-up|500|||
155304783|NCT03954184|560547536|FG001|Overall Study|Lost to Follow-up|0|||
155304784|NCT03398200|560547537|FG000|Overall Study|Withdrawal by Subject|0|||
155304785|NCT03398200|560547538|FG001|Overall Study|Withdrawal by Subject|1|||
155304786|NCT04065048|560547541|FG000|Overall Study|Withdrawal by Subject|1|||
155304787|NCT04065048|560547542|FG001|Overall Study|Withdrawal by Subject|2|||
155304788|NCT04065048|560547543|FG002|Overall Study|Withdrawal by Subject|1|||
155304789|NCT04065048|560547544|FG003|Overall Study|Withdrawal by Subject|1|||
155304790|NCT04065048|560547541|FG000|Overall Study|Adverse Event|1|||
155304791|NCT04065048|560547542|FG001|Overall Study|Adverse Event|0|||
155304792|NCT04065048|560547543|FG002|Overall Study|Adverse Event|1|||
155304793|NCT04065048|560547544|FG003|Overall Study|Adverse Event|0|||
155304794|NCT03397108|560547545|FG000|Overall Study|Lost to Follow-up|15|||
155304795|NCT03397108|560547546|FG001|Overall Study|Lost to Follow-up|0|||
155304796|NCT03397108|560547545|FG000|Overall Study|Insufficient milk production|3|||
155304797|NCT03397108|560547546|FG001|Overall Study|Insufficient milk production|2|||
155304798|NCT03397108|560547545|FG000|Overall Study|Withdrawal by Subject|2|||
155304799|NCT03397108|560547546|FG001|Overall Study|Withdrawal by Subject|0|||
155304800|NCT02728557|560547552|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
155304801|NCT02728557|560547553|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
155304802|NCT02728557|560547552|FG000|Overall Study|Dissatisfaction with research tasks|0|||
155304803|NCT02728557|560547553|FG001|Overall Study|Dissatisfaction with research tasks|1|||
155304804|NCT02728557|560547552|FG000|Overall Study|Scheduling or change in availability|1|||
155304805|NCT02728557|560547553|FG001|Overall Study|Scheduling or change in availability|1|||
155304806|NCT01718743|560547554|FG000|Overall Study|Physician Decision|7|||
155304807|NCT01718743|560547554|FG000|Overall Study|Withdrawal by Subject|14|||
155304808|NCT01718743|560547554|FG000|Overall Study|Progressive Disease|22|||
155304809|NCT01718743|560547554|FG000|Overall Study|Toxicity|1|||
155304810|NCT01718743|560547554|FG000|Overall Study|Malignancy|1|||
155065245|NCT01799889|559669912|FG009|Overall Study|Death|0|||
155065246|NCT01799889|559669913|FG010|Overall Study|Death|1|||
155065247|NCT01799889|559669914|FG011|Overall Study|Death|0|||
155065248|NCT01799889|559669903|FG000|Overall Study|Lack of Efficacy|1|||
155065249|NCT01799889|559669904|FG001|Overall Study|Lack of Efficacy|1|||
155065250|NCT01799889|559669905|FG002|Overall Study|Lack of Efficacy|0|||
155065251|NCT01799889|559669906|FG003|Overall Study|Lack of Efficacy|1|||
155065252|NCT01799889|559669907|FG004|Overall Study|Lack of Efficacy|2|||
155065253|NCT01799889|559669908|FG005|Overall Study|Lack of Efficacy|2|||
155065254|NCT01799889|559669909|FG006|Overall Study|Lack of Efficacy|0|||
155065255|NCT01799889|559669910|FG007|Overall Study|Lack of Efficacy|0|||
155065256|NCT01799889|559669911|FG008|Overall Study|Lack of Efficacy|2|||
155065257|NCT01799889|559669912|FG009|Overall Study|Lack of Efficacy|0|||
155065258|NCT01799889|559669913|FG010|Overall Study|Lack of Efficacy|1|||
155065259|NCT01799889|559669914|FG011|Overall Study|Lack of Efficacy|0|||
155065260|NCT01799889|559669903|FG000|Overall Study|Lost to Follow-up|0|||
155065261|NCT01799889|559669904|FG001|Overall Study|Lost to Follow-up|1|||
155065262|NCT01799889|559669905|FG002|Overall Study|Lost to Follow-up|0|||
155065263|NCT01799889|559669906|FG003|Overall Study|Lost to Follow-up|0|||
155065264|NCT01799889|559669907|FG004|Overall Study|Lost to Follow-up|0|||
155065265|NCT01799889|559669908|FG005|Overall Study|Lost to Follow-up|0|||
155065266|NCT01799889|559669909|FG006|Overall Study|Lost to Follow-up|0|||
155065267|NCT01799889|559669910|FG007|Overall Study|Lost to Follow-up|0|||
155065268|NCT01799889|559669911|FG008|Overall Study|Lost to Follow-up|0|||
155065269|NCT01799889|559669912|FG009|Overall Study|Lost to Follow-up|0|||
155304811|NCT03416010|560547555|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
155304812|NCT03416010|560547556|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
155304813|NCT03416010|560547555|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
155304814|NCT03416010|560547556|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
155304815|NCT03416010|560547555|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
155304816|NCT03416010|560547556|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
155304817|NCT03416010|560547555|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
155304818|NCT03416010|560547556|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
155304819|NCT03416010|560547555|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
155304820|NCT03416010|560547556|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
155304821|NCT03416010|560547555|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
155304822|NCT03416010|560547556|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
155304823|NCT03416010|560547555|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
155304824|NCT03416010|560547556|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
155304825|NCT03948763|560547560|FG000|Overall Study|Sponsor's decision|0|||
155304826|NCT03948763|560547561|FG001|Overall Study|Sponsor's decision|2|||
155304827|NCT03948763|560547562|FG002|Overall Study|Sponsor's decision|6|||
155304828|NCT03948763|560547563|FG003|Overall Study|Sponsor's decision|4|||
155304829|NCT03948763|560547564|FG004|Overall Study|Sponsor's decision|0|||
155304830|NCT03948763|560547560|FG000|Overall Study|Physician Decision|0|||
155304831|NCT03948763|560547561|FG001|Overall Study|Physician Decision|0|||
155304832|NCT03948763|560547562|FG002|Overall Study|Physician Decision|1|||
155304833|NCT03948763|560547563|FG003|Overall Study|Physician Decision|0|||
155304834|NCT03948763|560547564|FG004|Overall Study|Physician Decision|0|||
155304835|NCT03948763|560547560|FG000|Overall Study|Lost to Follow-up|0|||
155304836|NCT03948763|560547561|FG001|Overall Study|Lost to Follow-up|0|||
155304837|NCT03948763|560547562|FG002|Overall Study|Lost to Follow-up|0|||
155304838|NCT03948763|560547563|FG003|Overall Study|Lost to Follow-up|0|||
155304839|NCT03948763|560547564|FG004|Overall Study|Lost to Follow-up|1|||
155161074|NCT03910244|560026758|FG000|Overall Study|Physician Decision|1|||
155161075|NCT03910244|560026759|FG001|Overall Study|Physician Decision|0|||
155161076|NCT03910244|560026758|FG000|Overall Study|Protocol Violation|1|||
155304840|NCT03948763|560547560|FG000|Overall Study|Death|2|||
154958775|NCT00857454|559276819|FG000|Overall Study|Withdrawal by Subject|2|||
154958776|NCT00857454|559276819|FG000|Overall Study|Lost to Follow-up|1|||
154958777|NCT00857454|559276819|FG000|Overall Study|Adverse Event|2|||
154958778|NCT00857454|559276819|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
154958779|NCT00857454|559276819|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
154958780|NCT00857454|559276819|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
154958781|NCT03154047|559276820|FG000|Overall Study|Death|1|||
154958782|NCT03154047|559276820|FG000|Overall Study|Study terminated by sponsor|76|||
154958783|NCT03154047|559276820|FG000|Overall Study|Withdrawal by Subject|3|||
154958784|NCT00365365|559276821|FG000|Overall Study|Randomized but not treated|0|||
154958785|NCT00365365|559276822|FG001|Overall Study|Randomized but not treated|2|||
154958786|NCT00365365|559276823|FG002|Overall Study|Randomized but not treated|0|||
154958787|NCT00365365|559276821|FG000|Overall Study|Poor compliance to protocol|0|||
154958788|NCT00365365|559276822|FG001|Overall Study|Poor compliance to protocol|1|||
154958789|NCT00365365|559276823|FG002|Overall Study|Poor compliance to protocol|0|||
154958790|NCT00365365|559276821|FG000|Overall Study|Lost to Follow-up|3|||
154958791|NCT00365365|559276822|FG001|Overall Study|Lost to Follow-up|3|||
154958792|NCT00365365|559276823|FG002|Overall Study|Lost to Follow-up|3|||
154958793|NCT00365365|559276821|FG000|Overall Study|Death|1|||
154958794|NCT00365365|559276822|FG001|Overall Study|Death|3|||
154958795|NCT00365365|559276823|FG002|Overall Study|Death|0|||
154958796|NCT00365365|559276821|FG000|Overall Study|Subject's request|11|||
154958797|NCT00365365|559276822|FG001|Overall Study|Subject's request|13|||
154958798|NCT00365365|559276823|FG002|Overall Study|Subject's request|1|||
154958799|NCT00365365|559276821|FG000|Overall Study|Disease progression/relapse|9|||
154958800|NCT00365365|559276822|FG001|Overall Study|Disease progression/relapse|6|||
154958801|NCT00365365|559276823|FG002|Overall Study|Disease progression/relapse|7|||
154958802|NCT00365365|559276821|FG000|Overall Study|Adverse Event|6|||
154958803|NCT00365365|559276822|FG001|Overall Study|Adverse Event|6|||
154958804|NCT00365365|559276823|FG002|Overall Study|Adverse Event|3|||
154958805|NCT00365365|559276821|FG000|Overall Study|Moved|2|||
154958806|NCT00365365|559276822|FG001|Overall Study|Moved|0|||
154958807|NCT00365365|559276823|FG002|Overall Study|Moved|0|||
154958808|NCT00365365|559276821|FG000|Overall Study|New cancer|1|||
154958809|NCT00365365|559276822|FG001|Overall Study|New cancer|0|||
154958810|NCT00365365|559276823|FG002|Overall Study|New cancer|0|||
154958811|NCT00365365|559276821|FG000|Overall Study|Withdrew consent|1|||
154958812|NCT00365365|559276822|FG001|Overall Study|Withdrew consent|1|||
154958813|NCT00365365|559276823|FG002|Overall Study|Withdrew consent|0|||
154958814|NCT00365365|559276821|FG000|Overall Study|Second malignancy|0|||
154958815|NCT00365365|559276822|FG001|Overall Study|Second malignancy|1|||
154958816|NCT00365365|559276823|FG002|Overall Study|Second malignancy|0|||
154958817|NCT00365365|559276821|FG000|Overall Study|Patient/physician decision|0|||
155161077|NCT03910244|560026759|FG001|Overall Study|Protocol Violation|0|||
154958818|NCT00365365|559276822|FG001|Overall Study|Patient/physician decision|0|||
154958819|NCT00365365|559276823|FG002|Overall Study|Patient/physician decision|1|||
154958820|NCT00984022|559276824|FG000|Overall Study|Lost to Follow-up|10|||
154958821|NCT00984022|559276825|FG001|Overall Study|Lost to Follow-up|14|||
154958822|NCT00573443|559276829|FG000|Double-Blind Phase|Lost to Follow-up|1|||
154958823|NCT00573443|559276830|FG001|Double-Blind Phase|Lost to Follow-up|3|||
154958824|NCT00573443|559276831|FG002|Double-Blind Phase|Lost to Follow-up|2|||
154958825|NCT00573443|559276829|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
154958826|NCT00573443|559276830|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
154958827|NCT00573443|559276831|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
154958828|NCT00573443|559276829|FG000|Double-Blind Phase|Adverse Event|1|||
154958829|NCT00573443|559276830|FG001|Double-Blind Phase|Adverse Event|5|||
154958830|NCT00573443|559276831|FG002|Double-Blind Phase|Adverse Event|0|||
154958831|NCT00573443|559276829|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
154958832|NCT00573443|559276830|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
154958833|NCT00573443|559276831|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
155161078|NCT03910244|560026758|FG000|Overall Study|Withdrawal by Subject|7|||
155161079|NCT03910244|560026759|FG001|Overall Study|Withdrawal by Subject|2|||
155161080|NCT02968004|560026760|FG000|Main Study Phase|Adverse Event|1|||
155161081|NCT02968004|560026761|FG001|Main Study Phase|Adverse Event|0|||
154958834|NCT00573443|559276829|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
154958835|NCT00573443|559276830|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
154958836|NCT00573443|559276831|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
154958837|NCT00573443|559276829|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155161082|NCT02968004|560026760|FG000|Main Study Phase|Withdrawal by Subject|0|||
155161083|NCT02968004|560026761|FG001|Main Study Phase|Withdrawal by Subject|1|||
154958838|NCT00573443|559276830|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
154958839|NCT00573443|559276831|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
154958840|NCT00573443|559276829|FG000|Double-Blind Phase|Protocol Violation|0|||
154958841|NCT00573443|559276830|FG001|Double-Blind Phase|Protocol Violation|2|||
154958842|NCT00573443|559276831|FG002|Double-Blind Phase|Protocol Violation|1|||
154958843|NCT00573443|559276829|FG000|Double-Blind Phase|Other|0|||
154958844|NCT00573443|559276830|FG001|Double-Blind Phase|Other|2|||
154958845|NCT00573443|559276831|FG002|Double-Blind Phase|Other|3|||
154958846|NCT00573443|559276829|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
154958847|NCT00573443|559276830|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
154958848|NCT00573443|559276831|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
154958849|NCT00573443|559276829|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
154958850|NCT00573443|559276830|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
154958851|NCT00573443|559276831|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
154958852|NCT00573443|559276829|FG000|Open-Label Extension Phase|Adverse Event|3|||
154958853|NCT00573443|559276830|FG001|Open-Label Extension Phase|Adverse Event|0|||
154958854|NCT00573443|559276831|FG002|Open-Label Extension Phase|Adverse Event|0|||
154958855|NCT00573443|559276829|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
154958856|NCT00573443|559276830|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
154958857|NCT00573443|559276831|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
154958858|NCT00573443|559276829|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
155161084|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
155161085|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
155161086|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
155161087|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
155161088|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
155304841|NCT03948763|560547561|FG001|Overall Study|Death|12|||
155304842|NCT03948763|560547562|FG002|Overall Study|Death|13|||
155304843|NCT03948763|560547563|FG003|Overall Study|Death|10|||
155304844|NCT03948763|560547564|FG004|Overall Study|Death|11|||
155304845|NCT03948763|560547560|FG000|Overall Study|Withdrawal by Subject|1|||
155304846|NCT03948763|560547561|FG001|Overall Study|Withdrawal by Subject|1|||
155304847|NCT03948763|560547562|FG002|Overall Study|Withdrawal by Subject|0|||
155304848|NCT03948763|560547563|FG003|Overall Study|Withdrawal by Subject|2|||
155304849|NCT03948763|560547564|FG004|Overall Study|Withdrawal by Subject|4|||
155304850|NCT05986565|560547568|FG000|Overall Study|Lost to Follow-up|8|||
155304851|NCT05986565|560547569|FG001|Overall Study|Lost to Follow-up|3|||
155304852|NCT05986565|560547568|FG000|Overall Study|Withdrawal by Subject|0|||
155304853|NCT05986565|560547569|FG001|Overall Study|Withdrawal by Subject|1|||
155304854|NCT03446157|560547572|FG000|Overall Study|Death|11|||
155304855|NCT03446157|560547573|FG001|Overall Study|Death|9|||
155304856|NCT03446157|560547572|FG000|Overall Study|Lost to Follow-up|0|||
155304857|NCT03446157|560547573|FG001|Overall Study|Lost to Follow-up|1|||
155304858|NCT03446157|560547572|FG000|Overall Study|Withdrawal by Subject|2|||
155304859|NCT03446157|560547573|FG001|Overall Study|Withdrawal by Subject|1|||
155304860|NCT02386553|560547574|FG000|Overall Study|Reason Not Specified|1|||
155304861|NCT02386553|560547575|FG001|Overall Study|Reason Not Specified|1|||
155304862|NCT02386553|560547574|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
155065270|NCT01799889|559669913|FG010|Overall Study|Lost to Follow-up|0|||
155065271|NCT01799889|559669914|FG011|Overall Study|Lost to Follow-up|0|||
155065272|NCT01799889|559669903|FG000|Overall Study|Physician Decision|3|||
155065273|NCT01799889|559669904|FG001|Overall Study|Physician Decision|2|||
155065274|NCT01799889|559669905|FG002|Overall Study|Physician Decision|4|||
155065275|NCT01799889|559669906|FG003|Overall Study|Physician Decision|4|||
155065276|NCT01799889|559669907|FG004|Overall Study|Physician Decision|5|||
155065277|NCT01799889|559669908|FG005|Overall Study|Physician Decision|5|||
155065278|NCT01799889|559669909|FG006|Overall Study|Physician Decision|5|||
155065279|NCT01799889|559669910|FG007|Overall Study|Physician Decision|2|||
155065280|NCT01799889|559669911|FG008|Overall Study|Physician Decision|6|||
155065281|NCT01799889|559669912|FG009|Overall Study|Physician Decision|0|||
155065282|NCT01799889|559669913|FG010|Overall Study|Physician Decision|0|||
155065283|NCT01799889|559669914|FG011|Overall Study|Physician Decision|1|||
155065284|NCT01799889|559669903|FG000|Overall Study|Progressive Disease|30|||
155065285|NCT01799889|559669904|FG001|Overall Study|Progressive Disease|26|||
155065286|NCT01799889|559669905|FG002|Overall Study|Progressive Disease|25|||
155065287|NCT01799889|559669906|FG003|Overall Study|Progressive Disease|30|||
155065288|NCT01799889|559669907|FG004|Overall Study|Progressive Disease|23|||
155065289|NCT01799889|559669908|FG005|Overall Study|Progressive Disease|9|||
155065290|NCT01799889|559669909|FG006|Overall Study|Progressive Disease|8|||
155065291|NCT01799889|559669910|FG007|Overall Study|Progressive Disease|13|||
155065292|NCT01799889|559669911|FG008|Overall Study|Progressive Disease|18|||
155065293|NCT01799889|559669912|FG009|Overall Study|Progressive Disease|5|||
155065294|NCT01799889|559669913|FG010|Overall Study|Progressive Disease|3|||
155065295|NCT01799889|559669914|FG011|Overall Study|Progressive Disease|1|||
155065296|NCT01799889|559669903|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
155065297|NCT01799889|559669904|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
155065298|NCT01799889|559669905|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
155065299|NCT01799889|559669906|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
155065300|NCT01799889|559669907|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
155065301|NCT01799889|559669908|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
155065302|NCT01799889|559669909|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
155065303|NCT01799889|559669910|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
155065304|NCT01799889|559669911|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
155065305|NCT01799889|559669912|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
155065306|NCT01799889|559669913|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
155065307|NCT01799889|559669914|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
155065308|NCT01799889|559669903|FG000|Overall Study|Study Terminated By Sponsor|1|||
155065309|NCT01799889|559669904|FG001|Overall Study|Study Terminated By Sponsor|0|||
155065310|NCT01799889|559669905|FG002|Overall Study|Study Terminated By Sponsor|0|||
155065311|NCT01799889|559669906|FG003|Overall Study|Study Terminated By Sponsor|0|||
155065312|NCT01799889|559669907|FG004|Overall Study|Study Terminated By Sponsor|2|||
155065313|NCT01799889|559669908|FG005|Overall Study|Study Terminated By Sponsor|1|||
155065314|NCT01799889|559669909|FG006|Overall Study|Study Terminated By Sponsor|0|||
155065315|NCT01799889|559669910|FG007|Overall Study|Study Terminated By Sponsor|2|||
155065316|NCT01799889|559669911|FG008|Overall Study|Study Terminated By Sponsor|1|||
155065317|NCT01799889|559669912|FG009|Overall Study|Study Terminated By Sponsor|1|||
155304863|NCT02386553|560547575|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
155304864|NCT00998881|560547579|FG000|Overall Study|Adverse Event|2|||
155304865|NCT00998881|560547580|FG001|Overall Study|Adverse Event|2|||
155304866|NCT00998881|560547579|FG000|Overall Study|Lack of Efficacy|1|||
155065318|NCT01799889|559669913|FG010|Overall Study|Study Terminated By Sponsor|0|||
155304867|NCT00998881|560547580|FG001|Overall Study|Lack of Efficacy|0|||
155161089|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
155161090|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
155161091|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
155161092|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
155161093|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
155161094|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
155065319|NCT01799889|559669914|FG011|Overall Study|Study Terminated By Sponsor|0|||
155065320|NCT01799889|559669903|FG000|Overall Study|Withdrawal by Subject|1|||
155304868|NCT00998881|560547579|FG000|Overall Study|Physician Decision|3|||
155304869|NCT00998881|560547580|FG001|Overall Study|Physician Decision|0|||
155304870|NCT00998881|560547579|FG000|Overall Study|Withdrawal by Subject|1|||
155304871|NCT00998881|560547580|FG001|Overall Study|Withdrawal by Subject|0|||
155065321|NCT01799889|559669904|FG001|Overall Study|Withdrawal by Subject|6|||
155161095|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
155065322|NCT01799889|559669905|FG002|Overall Study|Withdrawal by Subject|4|||
155065323|NCT01799889|559669906|FG003|Overall Study|Withdrawal by Subject|0|||
155065324|NCT01799889|559669907|FG004|Overall Study|Withdrawal by Subject|5|||
155065325|NCT01799889|559669908|FG005|Overall Study|Withdrawal by Subject|1|||
155065326|NCT01799889|559669909|FG006|Overall Study|Withdrawal by Subject|3|||
155161096|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
155304872|NCT00998881|560547579|FG000|Overall Study|Personal matter|1|||
155065327|NCT01799889|559669910|FG007|Overall Study|Withdrawal by Subject|1|||
155304873|NCT00998881|560547580|FG001|Overall Study|Personal matter|0|||
155304874|NCT01121991|560547581|FG000|Overall Study|Lack of Ovarian Response|2|||
155304875|NCT01121991|560547581|FG000|Overall Study|No Oocytes Retrieved|3|||
155304876|NCT01121991|560547581|FG000|Overall Study|No Fertilization|1|||
155304877|NCT01619410|560547582|FG000|Overall Study|Lost to Follow-up|7|||
155304878|NCT01619410|560547583|FG001|Overall Study|Lost to Follow-up|4|||
155304879|NCT02462759|560547584|FG000|Part 1: Double Blind|Death|1|||
155304880|NCT02462759|560547585|FG001|Part 1: Double Blind|Death|0|||
155304881|NCT02462759|560547586|FG002|Part 1: Double Blind|Death|0|||
155304882|NCT02740231|560547587|FG000|Overall Study|Withdrawal by Subject|1|||
155304883|NCT02740231|560547588|FG001|Overall Study|Withdrawal by Subject|1|||
155304884|NCT02740231|560547589|FG002|Overall Study|Withdrawal by Subject|1|||
155304885|NCT02740231|560547590|FG003|Overall Study|Withdrawal by Subject|0|||
155304886|NCT02740231|560547587|FG000|Overall Study|Lack of Efficacy|0|||
155304887|NCT02740231|560547588|FG001|Overall Study|Lack of Efficacy|1|||
155304888|NCT02740231|560547589|FG002|Overall Study|Lack of Efficacy|0|||
155304889|NCT02740231|560547590|FG003|Overall Study|Lack of Efficacy|4|||
155304890|NCT02740231|560547587|FG000|Overall Study|Lost to Follow-up|1|||
155304891|NCT02740231|560547588|FG001|Overall Study|Lost to Follow-up|3|||
155304892|NCT02740231|560547589|FG002|Overall Study|Lost to Follow-up|0|||
155304893|NCT02740231|560547590|FG003|Overall Study|Lost to Follow-up|3|||
155304894|NCT02740231|560547587|FG000|Overall Study|Adverse Event|0|||
155304895|NCT02740231|560547588|FG001|Overall Study|Adverse Event|1|||
155304896|NCT02740231|560547589|FG002|Overall Study|Adverse Event|0|||
155304897|NCT02740231|560547590|FG003|Overall Study|Adverse Event|1|||
155304898|NCT04110054|560547591|FG000|Overall Study|COVID-19 reason other than AE|0|||
155304899|NCT04110054|560547592|FG001|Overall Study|COVID-19 reason other than AE|0|||
155304900|NCT04110054|560547593|FG002|Overall Study|COVID-19 reason other than AE|2|||
155304901|NCT04110054|560547594|FG003|Overall Study|COVID-19 reason other than AE|0|||
155304902|NCT04110054|560547591|FG000|Overall Study|Withdrawal by Subject|0|||
155304903|NCT04110054|560547592|FG001|Overall Study|Withdrawal by Subject|3|||
155304904|NCT04110054|560547593|FG002|Overall Study|Withdrawal by Subject|2|||
155304905|NCT04110054|560547594|FG003|Overall Study|Withdrawal by Subject|0|||
155304906|NCT04110054|560547591|FG000|Overall Study|Adverse Event|1|||
155304907|NCT04110054|560547592|FG001|Overall Study|Adverse Event|1|||
155304908|NCT04110054|560547593|FG002|Overall Study|Adverse Event|4|||
155304909|NCT04110054|560547594|FG003|Overall Study|Adverse Event|3|||
155304910|NCT03655262|560547597|FG000|Overall Study|Withdrawal by Subject|0|||
155304911|NCT03655262|560547598|FG001|Overall Study|Withdrawal by Subject|0|||
155304912|NCT03655262|560547599|FG002|Overall Study|Withdrawal by Subject|1|||
155304913|NCT01695954|560547603|FG000|Overall Study|Withdrawal by Subject|4|||
155304914|NCT01695954|560547604|FG001|Overall Study|Withdrawal by Subject|0|||
155304915|NCT01695954|560547603|FG000|Overall Study|Adverse Event|0|||
155304916|NCT01695954|560547604|FG001|Overall Study|Adverse Event|2|||
155304917|NCT04583423|560547616|FG000|Overall Study|Lost to Follow-up|0|||
155304918|NCT04583423|560547617|FG001|Overall Study|Lost to Follow-up|1|||
155304919|NCT04583423|560547618|FG002|Overall Study|Lost to Follow-up|0|||
155304920|NCT04583423|560547619|FG003|Overall Study|Lost to Follow-up|2|||
155304921|NCT04583423|560547616|FG000|Overall Study|Study Terminated by Sponsor|32|||
155304922|NCT04583423|560547617|FG001|Overall Study|Study Terminated by Sponsor|35|||
155304923|NCT04583423|560547618|FG002|Overall Study|Study Terminated by Sponsor|36|||
155304924|NCT04583423|560547619|FG003|Overall Study|Study Terminated by Sponsor|33|||
155304925|NCT04583423|560547616|FG000|Overall Study|Withdrawal by Subject|3|||
155304926|NCT04583423|560547617|FG001|Overall Study|Withdrawal by Subject|1|||
155304927|NCT04583423|560547618|FG002|Overall Study|Withdrawal by Subject|2|||
155304928|NCT04583423|560547619|FG003|Overall Study|Withdrawal by Subject|1|||
155304929|NCT04704284|560547625|FG000|Overall Study|Withdrawal by Subject|1|||
155304930|NCT03330795|560547627|FG000|Overall Study|Death|3|||
155304931|NCT03330795|560547627|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
155304932|NCT05782231|560547628|FG000|Overall Study|Withdrawal by Subject|1|||
155304933|NCT05575076|560547629|FG000|Overall Study|Adverse Event|24|||
155304934|NCT05575076|560547629|FG000|Overall Study|Death|7|||
155065328|NCT01799889|559669911|FG008|Overall Study|Withdrawal by Subject|2|||
155065329|NCT01799889|559669912|FG009|Overall Study|Withdrawal by Subject|1|||
155065330|NCT01799889|559669913|FG010|Overall Study|Withdrawal by Subject|1|||
155065331|NCT01799889|559669914|FG011|Overall Study|Withdrawal by Subject|1|||
155065332|NCT01799889|559669903|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155065333|NCT01799889|559669904|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155065334|NCT01799889|559669905|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155065335|NCT01799889|559669906|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155065336|NCT01799889|559669907|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155065337|NCT01799889|559669908|FG005|Overall Study|Non-Compliance With Study Drug|1|||
155304935|NCT05575076|560547629|FG000|Overall Study|Lost to Follow-up|16|||
155304936|NCT05575076|560547629|FG000|Overall Study|Non-Compliance|3|||
155304937|NCT05575076|560547629|FG000|Overall Study|Physician Decision|6|||
155065338|NCT01799889|559669909|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155304938|NCT05575076|560547629|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
155304939|NCT05575076|560547629|FG000|Overall Study|Withdrawal by Subject|71|||
155304940|NCT05575076|560547629|FG000|Overall Study|Study Terminated by Sponsor|630|||
155304941|NCT05575076|560547629|FG000|Overall Study|Other|17|||
155304942|NCT02538341|560547637|FG000|Overall Study|Lost to Follow-up|51|||
155304943|NCT02538341|560547638|FG001|Overall Study|Lost to Follow-up|46|||
155304944|NCT02538341|560547637|FG000|Overall Study|Withdrawal by Subject|3|||
155304945|NCT02538341|560547638|FG001|Overall Study|Withdrawal by Subject|1|||
155304946|NCT02538341|560547637|FG000|Overall Study|Death|2|||
155304947|NCT02538341|560547638|FG001|Overall Study|Death|0|||
155304948|NCT00065260|560547640|FG000|Overall Study|Death|0|||
155304949|NCT00065260|560547641|FG001|Overall Study|Death|1|||
155304950|NCT03750968|560547642|FG000|Overall Study|Adverse Event|2|||
155304951|NCT03750968|560547643|FG001|Overall Study|Adverse Event|0|||
155304952|NCT03750968|560547642|FG000|Overall Study|Lost to Follow-up|1|||
155304953|NCT03750968|560547643|FG001|Overall Study|Lost to Follow-up|3|||
155304954|NCT04766034|560547648|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304955|NCT04766034|560547649|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304956|NCT04766034|560547650|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304957|NCT04766034|560547651|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
155304958|NCT04766034|560547652|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
155304959|NCT04766034|560547648|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304960|NCT04766034|560547649|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304961|NCT04766034|560547650|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304962|NCT04766034|560547651|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
155304963|NCT04766034|560547652|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
155304964|NCT04766034|560547648|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
155304965|NCT04766034|560547649|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
155304966|NCT04766034|560547650|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
155304967|NCT04766034|560547651|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
155304968|NCT04766034|560547652|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
155304969|NCT04766034|560547648|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
155304970|NCT04766034|560547649|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
155304971|NCT04766034|560547650|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
155304972|NCT04766034|560547651|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
155304973|NCT04766034|560547652|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
155304974|NCT05094141|560547656|FG000|Overall Study|Death|0|||
155304975|NCT05094141|560547657|FG001|Overall Study|Death|0|||
155304976|NCT05094141|560547658|FG002|Overall Study|Death|1|||
155304977|NCT05094141|560547656|FG000|Overall Study|Withdrawal by Subject|0|||
155304978|NCT05094141|560547657|FG001|Overall Study|Withdrawal by Subject|0|||
155304979|NCT05094141|560547658|FG002|Overall Study|Withdrawal by Subject|1|||
155304980|NCT05094141|560547656|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
155304981|NCT05094141|560547657|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
155304982|NCT05094141|560547658|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
155304983|NCT05094141|560547656|FG000|Overall Study|Did not participate in randomization|0|||
155304984|NCT05094141|560547657|FG001|Overall Study|Did not participate in randomization|0|||
155304985|NCT05094141|560547658|FG002|Overall Study|Did not participate in randomization|33|||
155304986|NCT02576509|560549294|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
155304987|NCT02576509|560549295|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
155304988|NCT02576509|560549294|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
155304989|NCT02576509|560549295|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
155161097|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
155161098|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
155161099|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
155161100|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
155161101|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
155161102|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
155161103|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
155161104|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
155161105|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
155161106|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
155161107|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
155304990|NCT02576509|560549294|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
155304991|NCT02576509|560549295|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
155304992|NCT02576509|560549294|FG000|Treatment Period|Disease progression|263|||
155304993|NCT02576509|560549295|FG001|Treatment Period|Disease progression|244|||
155304994|NCT02576509|560549294|FG000|Treatment Period|Study drug toxicity|37|||
155304995|NCT02576509|560549295|FG001|Treatment Period|Study drug toxicity|41|||
155304996|NCT02576509|560549294|FG000|Treatment Period|Death|1|||
155304997|NCT02576509|560549295|FG001|Treatment Period|Death|1|||
155304998|NCT02576509|560549294|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
155304999|NCT02576509|560549295|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
155305000|NCT02576509|560549294|FG000|Treatment Period|Participant request to stop treatment|8|||
155305001|NCT02576509|560549295|FG001|Treatment Period|Participant request to stop treatment|18|||
155305002|NCT02576509|560549294|FG000|Treatment Period|Participant withdrew consent|3|||
155161108|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
155161109|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
155161110|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
155161111|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
155161112|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
155161113|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
155161114|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
155305003|NCT02576509|560549295|FG001|Treatment Period|Participant withdrew consent|7|||
155065339|NCT01799889|559669910|FG007|Overall Study|Non-Compliance With Study Drug|0|||
155065340|NCT01799889|559669911|FG008|Overall Study|Non-Compliance With Study Drug|0|||
155065341|NCT01799889|559669912|FG009|Overall Study|Non-Compliance With Study Drug|0|||
155065342|NCT01799889|559669913|FG010|Overall Study|Non-Compliance With Study Drug|0|||
155065343|NCT01799889|559669914|FG011|Overall Study|Non-Compliance With Study Drug|0|||
155065344|NCT04476043|559669917|FG000|Overall Study|Withdrawal by Subject|1|||
155065345|NCT04476043|559669918|FG001|Overall Study|Withdrawal by Subject|3|||
155065346|NCT04476043|559669919|FG002|Overall Study|Withdrawal by Subject|4|||
155065347|NCT04476043|559669920|FG003|Overall Study|Withdrawal by Subject|1|||
155065348|NCT04476043|559669917|FG000|Overall Study|Lost to Follow-up|1|||
155065349|NCT04476043|559669918|FG001|Overall Study|Lost to Follow-up|1|||
155065350|NCT04476043|559669919|FG002|Overall Study|Lost to Follow-up|2|||
155065351|NCT04476043|559669920|FG003|Overall Study|Lost to Follow-up|1|||
155065352|NCT04476043|559669917|FG000|Overall Study|Adverse Event|2|||
155065353|NCT04476043|559669918|FG001|Overall Study|Adverse Event|0|||
155065354|NCT04476043|559669919|FG002|Overall Study|Adverse Event|1|||
155065355|NCT04476043|559669920|FG003|Overall Study|Adverse Event|0|||
155065356|NCT04476043|559669917|FG000|Overall Study|Protocol Violation|0|||
155065357|NCT04476043|559669918|FG001|Overall Study|Protocol Violation|1|||
155065358|NCT04476043|559669919|FG002|Overall Study|Protocol Violation|0|||
155065359|NCT04476043|559669920|FG003|Overall Study|Protocol Violation|0|||
155065360|NCT06217380|559669921|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
155065361|NCT06217380|559669921|FG000|Overall Study|Physician Decision|1|||
155065362|NCT06217380|559669921|FG000|Overall Study|Withdrawal by Subject|2|||
155065363|NCT03095287|559669925|FG000|Overall Study|Treatment Failure|1|||
155065364|NCT03095287|559669925|FG000|Overall Study|Adverse Event|1|||
155065365|NCT03286504|559669928|FG000|Overall Study|Lost to Follow-up|19|||
155065366|NCT03286504|559669929|FG001|Overall Study|Lost to Follow-up|16|||
155065367|NCT02832037|559669946|FG000|Overall Study|Administrative reasons|0|||
155065368|NCT02832037|559669947|FG001|Overall Study|Administrative reasons|0|||
155065369|NCT02832037|559669948|FG002|Overall Study|Administrative reasons|1|||
155065370|NCT02832037|559669949|FG003|Overall Study|Administrative reasons|0|||
155065371|NCT02832037|559669950|FG004|Overall Study|Administrative reasons|0|||
155305004|NCT02576509|560549294|FG000|Treatment Period|Lost to Follow-up|0|||
155065372|NCT02832037|559669946|FG000|Overall Study|Protocol Violation|3|||
155065373|NCT02832037|559669947|FG001|Overall Study|Protocol Violation|0|||
155065374|NCT02832037|559669948|FG002|Overall Study|Protocol Violation|4|||
155065375|NCT02832037|559669949|FG003|Overall Study|Protocol Violation|1|||
155065376|NCT02832037|559669950|FG004|Overall Study|Protocol Violation|2|||
155065377|NCT02832037|559669946|FG000|Overall Study|Lost to Follow-up|2|||
155065378|NCT02832037|559669947|FG001|Overall Study|Lost to Follow-up|0|||
155065379|NCT02832037|559669948|FG002|Overall Study|Lost to Follow-up|3|||
155065380|NCT02832037|559669949|FG003|Overall Study|Lost to Follow-up|0|||
155065381|NCT02832037|559669950|FG004|Overall Study|Lost to Follow-up|5|||
155065382|NCT02832037|559669946|FG000|Overall Study|Withdrawal by Subject|9|||
155065383|NCT02832037|559669947|FG001|Overall Study|Withdrawal by Subject|8|||
155065384|NCT02832037|559669948|FG002|Overall Study|Withdrawal by Subject|0|||
155065385|NCT02832037|559669949|FG003|Overall Study|Withdrawal by Subject|4|||
155065386|NCT02832037|559669950|FG004|Overall Study|Withdrawal by Subject|8|||
155065387|NCT02832037|559669946|FG000|Overall Study|Adverse Event|5|||
155065388|NCT02832037|559669947|FG001|Overall Study|Adverse Event|4|||
155065389|NCT02832037|559669948|FG002|Overall Study|Adverse Event|0|||
155065390|NCT02832037|559669949|FG003|Overall Study|Adverse Event|2|||
155065391|NCT02832037|559669950|FG004|Overall Study|Adverse Event|4|||
155065392|NCT02326883|559669951|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
155065393|NCT02326883|559669952|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
155065394|NCT02326883|559669953|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
155065395|NCT03329989|559669955|FG000|Overall Study|Withdrawal by Subject|9|||
155065396|NCT03329989|559669955|FG000|Overall Study|Lost to Follow-up|8|||
155065397|NCT03329989|559669955|FG000|Overall Study|Adverse Event|5|||
155065398|NCT03329989|559669955|FG000|Overall Study|Protocol Violation|1|||
155065399|NCT00634504|559669956|FG000|Overall Study|Protocol Violation|1|||
155065400|NCT00634504|559669957|FG001|Overall Study|Protocol Violation|0|||
155065401|NCT00297167|559669966|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
155065402|NCT00297167|559669967|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
155065403|NCT00297167|559669968|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
155065404|NCT00297167|559669966|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
155065405|NCT00297167|559669967|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
155065406|NCT00297167|559669968|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
155065407|NCT01572792|559669973|FG000|Lead-in Study|Lost to Follow-up|5|||
155065408|NCT01572792|559669974|FG001|Lead-in Study|Lost to Follow-up|9|||
155065409|NCT01572792|559669975|FG002|Lead-in Study|Lost to Follow-up|4|||
155065410|NCT01572792|559669976|FG003|Lead-in Study|Lost to Follow-up|2|||
155065411|NCT01572792|559669977|FG004|Lead-in Study|Lost to Follow-up|4|||
155065412|NCT01572792|559669973|FG000|Lead-in Study|Withdrawal by Subject|22|||
155065413|NCT01572792|559669974|FG001|Lead-in Study|Withdrawal by Subject|11|||
155065414|NCT01572792|559669975|FG002|Lead-in Study|Withdrawal by Subject|12|||
155305005|NCT02576509|560549295|FG001|Treatment Period|Lost to Follow-up|1|||
155305006|NCT02576509|560549294|FG000|Treatment Period|Maximum clinical benefit|1|||
155305007|NCT02576509|560549295|FG001|Treatment Period|Maximum clinical benefit|0|||
155305008|NCT02576509|560549294|FG000|Treatment Period|Poor/non-compliance|1|||
155305009|NCT02576509|560549295|FG001|Treatment Period|Poor/non-compliance|1|||
155305010|NCT02576509|560549294|FG000|Treatment Period|Participant no longer meets criteria|1|||
155305011|NCT02576509|560549295|FG001|Treatment Period|Participant no longer meets criteria|0|||
155305012|NCT02576509|560549294|FG000|Treatment Period|Other reason|12|||
155305013|NCT02576509|560549295|FG001|Treatment Period|Other reason|8|||
155065415|NCT01572792|559669976|FG003|Lead-in Study|Withdrawal by Subject|24|||
155065416|NCT01572792|559669977|FG004|Lead-in Study|Withdrawal by Subject|11|||
155065417|NCT01572792|559669973|FG000|Lead-in Study|Protocol Violation|19|||
155065418|NCT01572792|559669974|FG001|Lead-in Study|Protocol Violation|10|||
155065419|NCT01572792|559669975|FG002|Lead-in Study|Protocol Violation|12|||
155065420|NCT01572792|559669976|FG003|Lead-in Study|Protocol Violation|13|||
155065421|NCT01572792|559669977|FG004|Lead-in Study|Protocol Violation|21|||
155065422|NCT01572792|559669973|FG000|Lead-in Study|Lack of Efficacy|20|||
155065423|NCT01572792|559669974|FG001|Lead-in Study|Lack of Efficacy|5|||
155065424|NCT01572792|559669975|FG002|Lead-in Study|Lack of Efficacy|4|||
155065425|NCT01572792|559669976|FG003|Lead-in Study|Lack of Efficacy|8|||
155065426|NCT01572792|559669977|FG004|Lead-in Study|Lack of Efficacy|10|||
155065427|NCT01572792|559669973|FG000|Lead-in Study|Adverse Event|21|||
155065428|NCT01572792|559669974|FG001|Lead-in Study|Adverse Event|21|||
155065429|NCT01572792|559669975|FG002|Lead-in Study|Adverse Event|22|||
155065430|NCT01572792|559669976|FG003|Lead-in Study|Adverse Event|16|||
155065431|NCT01572792|559669977|FG004|Lead-in Study|Adverse Event|14|||
155065432|NCT01572792|559669973|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
155065433|NCT01572792|559669974|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
155065434|NCT01572792|559669975|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
155065435|NCT01572792|559669976|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
155065436|NCT01572792|559669977|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
155065437|NCT01572792|559669973|FG000|Extension Study|Lost to Follow-up|6|||
155065438|NCT01572792|559669974|FG001|Extension Study|Lost to Follow-up|2|||
155065439|NCT01572792|559669975|FG002|Extension Study|Lost to Follow-up|0|||
155305014|NCT02576509|560549294|FG000|Treatment Period|NOT REPORTED|1|||
155305015|NCT02576509|560549295|FG001|Treatment Period|NOT REPORTED|0|||
155305016|NCT02576509|560549294|FG000|Treatment Period|Administrative reason by sponsor|0|||
155305017|NCT02576509|560549295|FG001|Treatment Period|Administrative reason by sponsor|1|||
155305018|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
155305019|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
155305020|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
155305021|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
155305022|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
155305023|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
155305024|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
155305025|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
155305026|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
155305027|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
155305028|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
155305029|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
155305030|NCT01600014|560549298|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
155305031|NCT01600014|560549299|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
155305032|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
155305033|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
155305034|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
155305035|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
155305036|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
155305037|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
154958859|NCT00573443|559276830|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
154958860|NCT00573443|559276831|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
154958861|NCT00573443|559276829|FG000|Open-Label Extension Phase|Protocol Violation|2|||
154958862|NCT00573443|559276830|FG001|Open-Label Extension Phase|Protocol Violation|0|||
154958863|NCT00573443|559276831|FG002|Open-Label Extension Phase|Protocol Violation|0|||
154958864|NCT00573443|559276829|FG000|Open-Label Extension Phase|Other|2|||
154958865|NCT00573443|559276830|FG001|Open-Label Extension Phase|Other|0|||
154958866|NCT00573443|559276831|FG002|Open-Label Extension Phase|Other|0|||
154958867|NCT00829309|559276834|FG000|Washout: 7 Days|Protocol Violation|1|||
154958868|NCT00829309|559276835|FG001|Washout: 7 Days|Protocol Violation|0|||
154958869|NCT00834418|559276836|FG000|Overall Study|Adverse Event|0|||
154958870|NCT00834418|559276837|FG001|Overall Study|Adverse Event|2|||
154958871|NCT01705574|559276838|FG000|Double-Blind Phase|Lost to Follow-up|12|||
154958872|NCT01705574|559276839|FG001|Double-Blind Phase|Lost to Follow-up|16|||
154958873|NCT01705574|559276840|FG002|Double-Blind Phase|Lost to Follow-up|0|||
154958874|NCT01705574|559276841|FG003|Double-Blind Phase|Lost to Follow-up|0|||
154958875|NCT01705574|559276838|FG000|Double-Blind Phase|Adverse Event|3|||
154958876|NCT01705574|559276839|FG001|Double-Blind Phase|Adverse Event|10|||
154958877|NCT01705574|559276840|FG002|Double-Blind Phase|Adverse Event|0|||
154958878|NCT01705574|559276841|FG003|Double-Blind Phase|Adverse Event|0|||
154958879|NCT01705574|559276838|FG000|Double-Blind Phase|Withdrew Consent|8|||
154958880|NCT01705574|559276839|FG001|Double-Blind Phase|Withdrew Consent|5|||
155065440|NCT01572792|559669976|FG003|Extension Study|Lost to Follow-up|3|||
155065441|NCT01572792|559669977|FG004|Extension Study|Lost to Follow-up|3|||
155065442|NCT01572792|559669973|FG000|Extension Study|Withdrawal by Subject|7|||
155065443|NCT01572792|559669974|FG001|Extension Study|Withdrawal by Subject|6|||
155065444|NCT01572792|559669975|FG002|Extension Study|Withdrawal by Subject|11|||
155065445|NCT01572792|559669976|FG003|Extension Study|Withdrawal by Subject|8|||
155065446|NCT01572792|559669977|FG004|Extension Study|Withdrawal by Subject|14|||
155065447|NCT01572792|559669973|FG000|Extension Study|Protocol Violation|0|||
155065448|NCT01572792|559669974|FG001|Extension Study|Protocol Violation|4|||
155065449|NCT01572792|559669975|FG002|Extension Study|Protocol Violation|3|||
155065450|NCT01572792|559669976|FG003|Extension Study|Protocol Violation|4|||
155065451|NCT01572792|559669977|FG004|Extension Study|Protocol Violation|3|||
155065452|NCT01572792|559669973|FG000|Extension Study|Lack of Efficacy|2|||
155065453|NCT01572792|559669974|FG001|Extension Study|Lack of Efficacy|3|||
155065454|NCT01572792|559669975|FG002|Extension Study|Lack of Efficacy|3|||
155065455|NCT01572792|559669976|FG003|Extension Study|Lack of Efficacy|2|||
155065456|NCT01572792|559669977|FG004|Extension Study|Lack of Efficacy|2|||
155065457|NCT01572792|559669973|FG000|Extension Study|Adverse Event|7|||
155065458|NCT01572792|559669974|FG001|Extension Study|Adverse Event|6|||
155065459|NCT01572792|559669975|FG002|Extension Study|Adverse Event|5|||
155065460|NCT01572792|559669976|FG003|Extension Study|Adverse Event|6|||
155065461|NCT01572792|559669977|FG004|Extension Study|Adverse Event|4|||
155065462|NCT01572792|559669973|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
155065463|NCT01572792|559669974|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
155065464|NCT01572792|559669975|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
155065465|NCT01572792|559669976|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
155065466|NCT01572792|559669977|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
154958881|NCT01705574|559276840|FG002|Double-Blind Phase|Withdrew Consent|0|||
154958882|NCT01705574|559276841|FG003|Double-Blind Phase|Withdrew Consent|0|||
154958883|NCT01705574|559276838|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
154958884|NCT01705574|559276839|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
154958885|NCT01705574|559276840|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
154958886|NCT01705574|559276841|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
154958887|NCT01705574|559276838|FG000|Double-Blind Phase|Pregnancy|1|||
154958888|NCT01705574|559276839|FG001|Double-Blind Phase|Pregnancy|1|||
154958889|NCT01705574|559276840|FG002|Double-Blind Phase|Pregnancy|0|||
154958890|NCT01705574|559276841|FG003|Double-Blind Phase|Pregnancy|0|||
154958891|NCT01705574|559276838|FG000|Double-Blind Phase|Protocol Violation|1|||
154958892|NCT01705574|559276839|FG001|Double-Blind Phase|Protocol Violation|0|||
154958893|NCT01705574|559276840|FG002|Double-Blind Phase|Protocol Violation|0|||
154958894|NCT01705574|559276841|FG003|Double-Blind Phase|Protocol Violation|0|||
154958895|NCT01705574|559276838|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
154958896|NCT01705574|559276839|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
154958897|NCT01705574|559276840|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
154958898|NCT01705574|559276841|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
154958899|NCT01705574|559276838|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
154958900|NCT01705574|559276839|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
154958901|NCT01705574|559276840|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
154958902|NCT01705574|559276841|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
154958903|NCT01705574|559276838|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
154958904|NCT01705574|559276839|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
154958905|NCT01705574|559276840|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
154958906|NCT01705574|559276841|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
154958907|NCT01705574|559276838|FG000|Open-Label Extension Phase|Adverse Event|3|||
154958908|NCT01705574|559276839|FG001|Open-Label Extension Phase|Adverse Event|0|||
154958909|NCT01705574|559276840|FG002|Open-Label Extension Phase|Adverse Event|0|||
154958910|NCT01705574|559276841|FG003|Open-Label Extension Phase|Adverse Event|1|||
154958911|NCT01705574|559276838|FG000|Open-Label Extension Phase|Death|2|||
154958912|NCT01705574|559276839|FG001|Open-Label Extension Phase|Death|0|||
154958913|NCT01705574|559276840|FG002|Open-Label Extension Phase|Death|1|||
154958914|NCT01705574|559276841|FG003|Open-Label Extension Phase|Death|0|||
154958915|NCT01705574|559276838|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
154958916|NCT01705574|559276839|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
154958917|NCT01705574|559276840|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
154958918|NCT01705574|559276841|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
154958919|NCT01705574|559276838|FG000|Open-Label Extension Phase|Physician Decision|0|||
154958920|NCT01705574|559276839|FG001|Open-Label Extension Phase|Physician Decision|0|||
154958921|NCT01705574|559276840|FG002|Open-Label Extension Phase|Physician Decision|2|||
154958922|NCT01705574|559276841|FG003|Open-Label Extension Phase|Physician Decision|0|||
154958923|NCT01705574|559276838|FG000|Open-Label Extension Phase|Pregnancy|0|||
154958924|NCT01705574|559276839|FG001|Open-Label Extension Phase|Pregnancy|0|||
154958925|NCT01705574|559276840|FG002|Open-Label Extension Phase|Pregnancy|1|||
154958926|NCT01705574|559276841|FG003|Open-Label Extension Phase|Pregnancy|1|||
154958927|NCT02472366|559276845|FG000|Overall Study|Lost to Follow-up|1|||
154958928|NCT02472366|559276846|FG001|Overall Study|Lost to Follow-up|0|||
154958929|NCT03699020|559276847|FG000|Overall Study|Withdrawal by Subject|3|||
155065467|NCT03530696|559669978|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
155065468|NCT03530696|559669979|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
155065469|NCT01129128|559669980|FG000|Overall Study|Lost to Follow-up|2|||
155065470|NCT01129128|559669981|FG001|Overall Study|Lost to Follow-up|2|||
155065471|NCT01129128|559669982|FG002|Overall Study|Lost to Follow-up|1|||
155065472|NCT01129128|559669980|FG000|Overall Study|Protocol Violation|0|||
155065473|NCT01129128|559669981|FG001|Overall Study|Protocol Violation|1|||
155305038|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
155305039|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
155305040|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
155305041|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
155305042|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
155305043|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
155305044|NCT01600014|560549298|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
155305045|NCT01600014|560549299|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
155305046|NCT01600014|560549298|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
155305047|NCT01600014|560549299|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
155305048|NCT01600014|560549298|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
155305049|NCT01600014|560549299|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
155305050|NCT01600014|560549298|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
155305051|NCT01600014|560549299|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
155305052|NCT03481660|560549300|FG000|Overall Study|Adverse Event|5|||
155305053|NCT03481660|560549301|FG001|Overall Study|Adverse Event|4|||
155305054|NCT03481660|560549300|FG000|Overall Study|Death|13|||
155305055|NCT03481660|560549301|FG001|Overall Study|Death|9|||
155305056|NCT03481660|560549300|FG000|Overall Study|Lost to Follow-up|2|||
155305057|NCT03481660|560549301|FG001|Overall Study|Lost to Follow-up|2|||
155305058|NCT03481660|560549300|FG000|Overall Study|Physician Decision|2|||
155305059|NCT03481660|560549301|FG001|Overall Study|Physician Decision|3|||
155305060|NCT03481660|560549300|FG000|Overall Study|Withdrawal by Subject|14|||
155305061|NCT03481660|560549301|FG001|Overall Study|Withdrawal by Subject|7|||
155305062|NCT03398148|560549302|FG000|Substudy 1 Period 1|Adverse Event|5|||
155305063|NCT03398148|560549303|FG001|Substudy 1 Period 1|Adverse Event|2|||
155305064|NCT03398148|560549304|FG002|Substudy 1 Period 1|Adverse Event|2|||
155305065|NCT03398148|560549305|FG003|Substudy 1 Period 1|Adverse Event|0|||
155305066|NCT03398148|560549306|FG004|Substudy 1 Period 1|Adverse Event|8|||
155305067|NCT03398148|560549307|FG005|Substudy 1 Period 1|Adverse Event|0|||
155305068|NCT03398148|560549308|FG006|Substudy 1 Period 1|Adverse Event|0|||
155305069|NCT03398148|560549309|FG007|Substudy 1 Period 1|Adverse Event|0|||
155305070|NCT03398148|560549310|FG008|Substudy 1 Period 1|Adverse Event|0|||
155305071|NCT03398148|560549311|FG009|Substudy 1 Period 1|Adverse Event|0|||
155305072|NCT03398148|560549312|FG010|Substudy 1 Period 1|Adverse Event|0|||
155305073|NCT03398148|560549313|FG011|Substudy 1 Period 1|Adverse Event|0|||
155305074|NCT03398148|560549314|FG012|Substudy 1 Period 1|Adverse Event|0|||
155305075|NCT03398148|560549315|FG013|Substudy 1 Period 1|Adverse Event|0|||
155305076|NCT03398148|560549316|FG014|Substudy 1 Period 1|Adverse Event|0|||
155305077|NCT03398148|560549302|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
155305078|NCT03398148|560549303|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
155305079|NCT03398148|560549304|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305080|NCT03398148|560549305|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
155305081|NCT03398148|560549306|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
155305082|NCT03398148|560549307|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305083|NCT03398148|560549308|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305084|NCT03398148|560549309|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305085|NCT03398148|560549310|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305086|NCT03398148|560549311|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305087|NCT03398148|560549312|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305088|NCT03398148|560549313|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305089|NCT03398148|560549314|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305090|NCT03398148|560549315|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305091|NCT03398148|560549316|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
155305092|NCT03398148|560549302|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
155305093|NCT03398148|560549303|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
155305094|NCT03398148|560549304|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
155305095|NCT03398148|560549305|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
155305096|NCT03398148|560549306|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
155065474|NCT01129128|559669982|FG002|Overall Study|Protocol Violation|0|||
155305097|NCT03398148|560549307|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
155305098|NCT03398148|560549308|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
155305099|NCT03398148|560549309|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
155305100|NCT03398148|560549310|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
155305101|NCT03398148|560549311|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
155305102|NCT03398148|560549312|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
155305103|NCT03398148|560549313|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
155305104|NCT03398148|560549314|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
155305105|NCT03398148|560549315|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
155305106|NCT03398148|560549316|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
155305107|NCT03398148|560549302|FG000|Substudy 1 Period 1|Other|0|||
155305108|NCT03398148|560549303|FG001|Substudy 1 Period 1|Other|1|||
155305109|NCT03398148|560549304|FG002|Substudy 1 Period 1|Other|0|||
155305110|NCT03398148|560549305|FG003|Substudy 1 Period 1|Other|0|||
155305111|NCT03398148|560549306|FG004|Substudy 1 Period 1|Other|3|||
155305112|NCT03398148|560549307|FG005|Substudy 1 Period 1|Other|0|||
155305113|NCT03398148|560549308|FG006|Substudy 1 Period 1|Other|0|||
155305114|NCT03398148|560549309|FG007|Substudy 1 Period 1|Other|0|||
155305115|NCT03398148|560549310|FG008|Substudy 1 Period 1|Other|0|||
155305116|NCT03398148|560549311|FG009|Substudy 1 Period 1|Other|0|||
155305117|NCT03398148|560549312|FG010|Substudy 1 Period 1|Other|0|||
155305118|NCT03398148|560549313|FG011|Substudy 1 Period 1|Other|0|||
155305119|NCT03398148|560549314|FG012|Substudy 1 Period 1|Other|0|||
155305120|NCT03398148|560549315|FG013|Substudy 1 Period 1|Other|0|||
155305121|NCT03398148|560549316|FG014|Substudy 1 Period 1|Other|0|||
155305122|NCT03398148|560549302|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305123|NCT03398148|560549303|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305124|NCT03398148|560549304|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305125|NCT03398148|560549305|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305126|NCT03398148|560549306|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
155305127|NCT03398148|560549307|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305128|NCT03398148|560549308|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
155065475|NCT01129128|559669980|FG000|Overall Study|Withdrawal by Subject|0|||
155065476|NCT01129128|559669981|FG001|Overall Study|Withdrawal by Subject|1|||
155305129|NCT03398148|560549309|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305130|NCT03398148|560549310|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305131|NCT03398148|560549311|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305132|NCT03398148|560549312|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305133|NCT03398148|560549313|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305134|NCT03398148|560549314|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305135|NCT03398148|560549315|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305136|NCT03398148|560549316|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
155305137|NCT03398148|560549302|FG000|Substudy 1 Period 2|Adverse Event|0|||
155305138|NCT03398148|560549303|FG001|Substudy 1 Period 2|Adverse Event|0|||
155305139|NCT03398148|560549304|FG002|Substudy 1 Period 2|Adverse Event|0|||
155305140|NCT03398148|560549305|FG003|Substudy 1 Period 2|Adverse Event|0|||
155305141|NCT03398148|560549306|FG004|Substudy 1 Period 2|Adverse Event|0|||
154958930|NCT03699020|559276848|FG001|Overall Study|Withdrawal by Subject|2|||
154958931|NCT04274686|559276849|FG000|Overall Study|Physician Decision|1|||
155305142|NCT03398148|560549307|FG005|Substudy 1 Period 2|Adverse Event|2|||
155305143|NCT03398148|560549308|FG006|Substudy 1 Period 2|Adverse Event|4|||
155305144|NCT03398148|560549309|FG007|Substudy 1 Period 2|Adverse Event|0|||
155305145|NCT03398148|560549310|FG008|Substudy 1 Period 2|Adverse Event|0|||
155305146|NCT03398148|560549311|FG009|Substudy 1 Period 2|Adverse Event|0|||
155305147|NCT03398148|560549312|FG010|Substudy 1 Period 2|Adverse Event|0|||
155305148|NCT03398148|560549313|FG011|Substudy 1 Period 2|Adverse Event|0|||
155305149|NCT03398148|560549314|FG012|Substudy 1 Period 2|Adverse Event|0|||
155305150|NCT03398148|560549315|FG013|Substudy 1 Period 2|Adverse Event|0|||
155305151|NCT03398148|560549316|FG014|Substudy 1 Period 2|Adverse Event|0|||
155305152|NCT03398148|560549302|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305153|NCT03398148|560549303|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305154|NCT03398148|560549304|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305155|NCT03398148|560549305|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305156|NCT03398148|560549306|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305157|NCT03398148|560549307|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305158|NCT03398148|560549308|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
155305159|NCT03398148|560549309|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
155305160|NCT03398148|560549310|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305161|NCT03398148|560549311|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305162|NCT03398148|560549312|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305163|NCT03398148|560549313|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305164|NCT03398148|560549314|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305165|NCT03398148|560549315|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305166|NCT03398148|560549316|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
155305167|NCT03398148|560549302|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
155305168|NCT03398148|560549303|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
155305169|NCT03398148|560549304|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
155305170|NCT03398148|560549305|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
155305171|NCT03398148|560549306|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
155305172|NCT03398148|560549307|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
155305173|NCT03398148|560549308|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
155305174|NCT03398148|560549309|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
155305175|NCT03398148|560549310|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
155305176|NCT03398148|560549311|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
155305177|NCT03398148|560549312|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
155305178|NCT03398148|560549313|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
155305179|NCT03398148|560549314|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
155305180|NCT03398148|560549315|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
155305181|NCT03398148|560549316|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
155305182|NCT03398148|560549302|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305183|NCT03398148|560549303|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305184|NCT03398148|560549304|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305185|NCT03398148|560549305|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305186|NCT03398148|560549306|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305187|NCT03398148|560549307|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305188|NCT03398148|560549308|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
155305189|NCT03398148|560549309|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305190|NCT03398148|560549310|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305191|NCT03398148|560549311|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305192|NCT03398148|560549312|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305193|NCT03398148|560549313|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305194|NCT03398148|560549314|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305195|NCT03398148|560549315|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305196|NCT03398148|560549316|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305197|NCT03398148|560549302|FG000|Substudy 1 Period 2|Other|0|||
155305198|NCT03398148|560549303|FG001|Substudy 1 Period 2|Other|0|||
155305199|NCT03398148|560549304|FG002|Substudy 1 Period 2|Other|0|||
155305200|NCT03398148|560549305|FG003|Substudy 1 Period 2|Other|0|||
155305201|NCT03398148|560549306|FG004|Substudy 1 Period 2|Other|0|||
155305202|NCT03398148|560549307|FG005|Substudy 1 Period 2|Other|0|||
155305203|NCT03398148|560549308|FG006|Substudy 1 Period 2|Other|1|||
155305204|NCT03398148|560549309|FG007|Substudy 1 Period 2|Other|0|||
155305205|NCT03398148|560549310|FG008|Substudy 1 Period 2|Other|0|||
155305206|NCT03398148|560549311|FG009|Substudy 1 Period 2|Other|0|||
155305207|NCT03398148|560549312|FG010|Substudy 1 Period 2|Other|0|||
155305208|NCT03398148|560549313|FG011|Substudy 1 Period 2|Other|0|||
155305209|NCT03398148|560549314|FG012|Substudy 1 Period 2|Other|0|||
155305210|NCT03398148|560549315|FG013|Substudy 1 Period 2|Other|0|||
155305211|NCT03398148|560549316|FG014|Substudy 1 Period 2|Other|0|||
155305212|NCT03398148|560549302|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305213|NCT03398148|560549303|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305214|NCT03398148|560549304|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305215|NCT03398148|560549305|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305216|NCT03398148|560549306|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305217|NCT03398148|560549307|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305218|NCT03398148|560549308|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
155305219|NCT03398148|560549309|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305220|NCT03398148|560549310|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305221|NCT03398148|560549311|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305222|NCT03398148|560549312|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
155161115|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
155161116|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
155161117|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
155161118|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
155161119|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
155161120|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
155161121|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
155161122|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
155161123|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
155161124|NCT02968004|560026760|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
155161125|NCT02968004|560026761|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
155161126|NCT05029362|560026762|FG000|Overall Study|Lost to Follow-up|9|||
155161127|NCT00419952|560026764|FG000|Overall Study|Adverse Event|8|||
155161128|NCT00419952|560026765|FG001|Overall Study|Adverse Event|10|||
155161129|NCT00419952|560026764|FG000|Overall Study|Withdrawal by Subject|44|||
155161130|NCT00419952|560026765|FG001|Overall Study|Withdrawal by Subject|43|||
155161131|NCT00419952|560026764|FG000|Overall Study|Lost to Follow-up|43|||
155161132|NCT00419952|560026765|FG001|Overall Study|Lost to Follow-up|34|||
155161133|NCT00419952|560026764|FG000|Overall Study|Protocol Violation|32|||
155161134|NCT00419952|560026765|FG001|Overall Study|Protocol Violation|24|||
155161135|NCT00419952|560026764|FG000|Overall Study|Pregnancy|4|||
155161136|NCT00419952|560026765|FG001|Overall Study|Pregnancy|2|||
155161137|NCT00419952|560026764|FG000|Overall Study|Physician Decision|1|||
155161138|NCT00419952|560026765|FG001|Overall Study|Physician Decision|3|||
155161139|NCT00419952|560026764|FG000|Overall Study|Incorrectly enrolled|10|||
155161140|NCT00419952|560026765|FG001|Overall Study|Incorrectly enrolled|3|||
155161141|NCT00419952|560026764|FG000|Overall Study|Intake of prohibited medication|2|||
155161142|NCT00419952|560026765|FG001|Overall Study|Intake of prohibited medication|2|||
155161143|NCT00419952|560026764|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
155161144|NCT00419952|560026765|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
155161145|NCT00419952|560026764|FG000|Overall Study|Diary or medication non-compliance|2|||
155161146|NCT00419952|560026765|FG001|Overall Study|Diary or medication non-compliance|4|||
155161147|NCT00419952|560026764|FG000|Overall Study|Abnormal ECG|1|||
155161148|NCT00419952|560026765|FG001|Overall Study|Abnormal ECG|0|||
155161149|NCT03126591|560026766|FG000|Overall Study|Death|6|||
155161150|NCT03126591|560026767|FG001|Overall Study|Death|3|||
155161151|NCT03126591|560026768|FG002|Overall Study|Death|17|||
155161152|NCT03126591|560026766|FG000|Overall Study|Progressive Disease|0|||
155161153|NCT03126591|560026767|FG001|Overall Study|Progressive Disease|1|||
155305223|NCT03398148|560549313|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
155161154|NCT03126591|560026768|FG002|Overall Study|Progressive Disease|2|||
155161155|NCT03126591|560026766|FG000|Overall Study|Terminated by Sponsor|0|||
155305224|NCT03398148|560549314|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305225|NCT03398148|560549315|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305226|NCT03398148|560549316|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
155305227|NCT03398148|560549302|FG000|Substudy 2 Period 1|Adverse Event|0|||
155305228|NCT03398148|560549303|FG001|Substudy 2 Period 1|Adverse Event|0|||
155305229|NCT03398148|560549304|FG002|Substudy 2 Period 1|Adverse Event|0|||
155305230|NCT03398148|560549305|FG003|Substudy 2 Period 1|Adverse Event|0|||
155305231|NCT03398148|560549306|FG004|Substudy 2 Period 1|Adverse Event|0|||
155305232|NCT03398148|560549307|FG005|Substudy 2 Period 1|Adverse Event|0|||
155305233|NCT03398148|560549308|FG006|Substudy 2 Period 1|Adverse Event|0|||
155305234|NCT03398148|560549309|FG007|Substudy 2 Period 1|Adverse Event|0|||
155305235|NCT03398148|560549310|FG008|Substudy 2 Period 1|Adverse Event|0|||
155305236|NCT03398148|560549311|FG009|Substudy 2 Period 1|Adverse Event|12|||
155305237|NCT03398148|560549312|FG010|Substudy 2 Period 1|Adverse Event|2|||
155305238|NCT03398148|560549313|FG011|Substudy 2 Period 1|Adverse Event|0|||
155305239|NCT03398148|560549314|FG012|Substudy 2 Period 1|Adverse Event|0|||
155305240|NCT03398148|560549315|FG013|Substudy 2 Period 1|Adverse Event|0|||
155305241|NCT03398148|560549316|FG014|Substudy 2 Period 1|Adverse Event|0|||
155305242|NCT03398148|560549302|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305243|NCT03398148|560549303|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305244|NCT03398148|560549304|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305245|NCT03398148|560549305|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305246|NCT03398148|560549306|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305247|NCT03398148|560549307|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305248|NCT03398148|560549308|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305249|NCT03398148|560549309|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305250|NCT03398148|560549310|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305251|NCT03398148|560549311|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
155305252|NCT03398148|560549312|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
155305253|NCT03398148|560549313|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305254|NCT03398148|560549314|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305255|NCT03398148|560549315|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305256|NCT03398148|560549316|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
155305257|NCT03398148|560549302|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
155305258|NCT03398148|560549303|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
155305259|NCT03398148|560549304|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
155305260|NCT03398148|560549305|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
155305261|NCT03398148|560549306|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
155305262|NCT03398148|560549307|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
155305263|NCT03398148|560549308|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
155305264|NCT03398148|560549309|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
155305265|NCT03398148|560549310|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
155305266|NCT03398148|560549311|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
155305267|NCT03398148|560549312|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
155305268|NCT03398148|560549313|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
155305269|NCT03398148|560549314|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
155305270|NCT03398148|560549315|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
155305271|NCT03398148|560549316|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
155305272|NCT03398148|560549302|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305273|NCT03398148|560549303|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305274|NCT03398148|560549304|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305275|NCT03398148|560549305|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305276|NCT03398148|560549306|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305277|NCT03398148|560549307|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305278|NCT03398148|560549308|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305279|NCT03398148|560549309|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305280|NCT03398148|560549310|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305281|NCT03398148|560549311|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305282|NCT03398148|560549312|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
155305283|NCT03398148|560549313|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305284|NCT03398148|560549314|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305285|NCT03398148|560549315|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305286|NCT03398148|560549316|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
155305287|NCT03398148|560549302|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305288|NCT03398148|560549303|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305289|NCT03398148|560549304|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305290|NCT03398148|560549305|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305291|NCT03398148|560549306|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305292|NCT03398148|560549307|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305293|NCT03398148|560549308|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305294|NCT03398148|560549309|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305295|NCT03398148|560549310|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305296|NCT03398148|560549311|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305297|NCT03398148|560549312|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
155305298|NCT03398148|560549313|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305299|NCT03398148|560549314|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305300|NCT03398148|560549315|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305301|NCT03398148|560549316|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
155305302|NCT03398148|560549302|FG000|Substudy 2 Period 1|Other|0|||
155305303|NCT03398148|560549303|FG001|Substudy 2 Period 1|Other|0|||
155305304|NCT03398148|560549304|FG002|Substudy 2 Period 1|Other|0|||
155305305|NCT03398148|560549305|FG003|Substudy 2 Period 1|Other|0|||
155305306|NCT03398148|560549306|FG004|Substudy 2 Period 1|Other|0|||
155305307|NCT03398148|560549307|FG005|Substudy 2 Period 1|Other|0|||
155305308|NCT03398148|560549308|FG006|Substudy 2 Period 1|Other|0|||
155305309|NCT03398148|560549309|FG007|Substudy 2 Period 1|Other|0|||
155305310|NCT03398148|560549310|FG008|Substudy 2 Period 1|Other|0|||
155305311|NCT03398148|560549311|FG009|Substudy 2 Period 1|Other|4|||
155305312|NCT03398148|560549312|FG010|Substudy 2 Period 1|Other|4|||
155305313|NCT03398148|560549313|FG011|Substudy 2 Period 1|Other|0|||
155305314|NCT03398148|560549314|FG012|Substudy 2 Period 1|Other|0|||
155305315|NCT03398148|560549315|FG013|Substudy 2 Period 1|Other|0|||
155305316|NCT03398148|560549316|FG014|Substudy 2 Period 1|Other|0|||
155305317|NCT03398148|560549302|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305318|NCT03398148|560549303|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305319|NCT03398148|560549304|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305320|NCT03398148|560549305|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305321|NCT03398148|560549306|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305322|NCT03398148|560549307|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305323|NCT03398148|560549308|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305324|NCT03398148|560549309|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305325|NCT03398148|560549310|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305326|NCT03398148|560549311|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305327|NCT03398148|560549312|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
155305328|NCT03398148|560549313|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305329|NCT03398148|560549314|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305330|NCT03398148|560549315|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305331|NCT03398148|560549316|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
155305332|NCT03398148|560549302|FG000|Substudy 2 Period 2|Adverse Event|0|||
155305333|NCT03398148|560549303|FG001|Substudy 2 Period 2|Adverse Event|0|||
155305334|NCT03398148|560549304|FG002|Substudy 2 Period 2|Adverse Event|0|||
155305335|NCT03398148|560549305|FG003|Substudy 2 Period 2|Adverse Event|0|||
155305336|NCT03398148|560549306|FG004|Substudy 2 Period 2|Adverse Event|0|||
155305337|NCT03398148|560549307|FG005|Substudy 2 Period 2|Adverse Event|0|||
155305338|NCT03398148|560549308|FG006|Substudy 2 Period 2|Adverse Event|0|||
155305339|NCT03398148|560549309|FG007|Substudy 2 Period 2|Adverse Event|0|||
155305340|NCT03398148|560549310|FG008|Substudy 2 Period 2|Adverse Event|0|||
155305341|NCT03398148|560549311|FG009|Substudy 2 Period 2|Adverse Event|0|||
155305342|NCT03398148|560549312|FG010|Substudy 2 Period 2|Adverse Event|0|||
155305343|NCT03398148|560549313|FG011|Substudy 2 Period 2|Adverse Event|0|||
155305344|NCT03398148|560549314|FG012|Substudy 2 Period 2|Adverse Event|0|||
155305345|NCT03398148|560549315|FG013|Substudy 2 Period 2|Adverse Event|1|||
155305346|NCT03398148|560549316|FG014|Substudy 2 Period 2|Adverse Event|3|||
155305347|NCT03398148|560549302|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
155305348|NCT03398148|560549303|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
155305349|NCT03398148|560549304|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
155305350|NCT03398148|560549305|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
155305351|NCT03398148|560549306|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
155305352|NCT03398148|560549307|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
155305353|NCT03398148|560549308|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
155305354|NCT03398148|560549309|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
155305355|NCT03398148|560549310|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
155305356|NCT03398148|560549311|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
155305357|NCT03398148|560549312|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
155305358|NCT03398148|560549313|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
155305359|NCT03398148|560549314|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
155305360|NCT03398148|560549315|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
155305361|NCT03398148|560549316|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
155305362|NCT03398148|560549302|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305363|NCT03398148|560549303|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305364|NCT03398148|560549304|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305365|NCT03398148|560549305|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305366|NCT03398148|560549306|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305367|NCT03398148|560549307|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305368|NCT03398148|560549308|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305369|NCT03398148|560549309|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
154958932|NCT04274686|559276850|FG001|Overall Study|Physician Decision|0|||
154958933|NCT00905840|559276851|FG000|Overall Study|Lost to Follow-up|11|||
155305370|NCT03398148|560549310|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305371|NCT03398148|560549311|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305372|NCT03398148|560549312|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305373|NCT03398148|560549313|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
155305374|NCT03398148|560549314|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
155305375|NCT03398148|560549315|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
155305376|NCT03398148|560549316|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
155305377|NCT03398148|560549302|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
155305378|NCT03398148|560549303|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
155305379|NCT03398148|560549304|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
155305380|NCT03398148|560549305|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
155305381|NCT03398148|560549306|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
155305382|NCT03398148|560549307|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
155305383|NCT03398148|560549308|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
155305384|NCT03398148|560549309|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
155305385|NCT03398148|560549310|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
155305386|NCT03398148|560549311|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
155305387|NCT03398148|560549312|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
155305388|NCT03398148|560549313|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
155305389|NCT03398148|560549314|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
155305390|NCT03398148|560549315|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
155305391|NCT03398148|560549316|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
155305392|NCT03398148|560549302|FG000|Substudy 2 Period 2|Other|0|||
155305393|NCT03398148|560549303|FG001|Substudy 2 Period 2|Other|0|||
155305394|NCT03398148|560549304|FG002|Substudy 2 Period 2|Other|0|||
155305395|NCT03398148|560549305|FG003|Substudy 2 Period 2|Other|0|||
155305396|NCT03398148|560549306|FG004|Substudy 2 Period 2|Other|0|||
155305397|NCT03398148|560549307|FG005|Substudy 2 Period 2|Other|0|||
155305398|NCT03398148|560549308|FG006|Substudy 2 Period 2|Other|0|||
155305399|NCT03398148|560549309|FG007|Substudy 2 Period 2|Other|0|||
155305400|NCT03398148|560549310|FG008|Substudy 2 Period 2|Other|0|||
155305401|NCT03398148|560549311|FG009|Substudy 2 Period 2|Other|0|||
155305402|NCT03398148|560549312|FG010|Substudy 2 Period 2|Other|0|||
155305403|NCT03398148|560549313|FG011|Substudy 2 Period 2|Other|0|||
155305404|NCT03398148|560549314|FG012|Substudy 2 Period 2|Other|0|||
155305405|NCT03398148|560549315|FG013|Substudy 2 Period 2|Other|1|||
155305406|NCT03398148|560549316|FG014|Substudy 2 Period 2|Other|1|||
155305407|NCT03398148|560549302|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305408|NCT03398148|560549303|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305409|NCT03398148|560549304|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305410|NCT03398148|560549305|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305411|NCT03398148|560549306|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305412|NCT03398148|560549307|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305413|NCT03398148|560549308|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305414|NCT03398148|560549309|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305415|NCT03398148|560549310|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305416|NCT03398148|560549311|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305417|NCT03398148|560549312|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305418|NCT03398148|560549313|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305419|NCT03398148|560549314|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
155161156|NCT03126591|560026767|FG001|Overall Study|Terminated by Sponsor|1|||
155305420|NCT03398148|560549315|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
155305421|NCT03398148|560549316|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
155305422|NCT04278586|560549317|FG000|Overall Study|Withdrawal by Subject|13|||
155305423|NCT04278586|560549318|FG001|Overall Study|Withdrawal by Subject|6|||
154958934|NCT00905840|559276851|FG000|Overall Study|Death|3|||
155305424|NCT04278586|560549317|FG000|Overall Study|Lost to Follow-up|37|||
155305425|NCT04278586|560549318|FG001|Overall Study|Lost to Follow-up|24|||
155305426|NCT04607044|560549328|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
155305427|NCT04607044|560549328|FG000|Overall Study|Adverse Event|1|||
155305428|NCT04607044|560549328|FG000|Overall Study|Did not receive study device|3|||
155305429|NCT04607044|560549328|FG000|Overall Study|Death|1|||
155305430|NCT05403801|560549329|FG000|Overall Study|Withdrawal by Subject|2|||
155305431|NCT05075408|560549330|FG000|Overall Study|Withdrawal by Subject|5|||
155305432|NCT05075408|560549331|FG001|Overall Study|Withdrawal by Subject|3|||
155305433|NCT05075408|560549332|FG002|Overall Study|Withdrawal by Subject|4|||
155305434|NCT05075408|560549330|FG000|Overall Study|Adverse Event|5|||
155305435|NCT05075408|560549331|FG001|Overall Study|Adverse Event|7|||
155305436|NCT05075408|560549332|FG002|Overall Study|Adverse Event|8|||
155305437|NCT05075408|560549330|FG000|Overall Study|Protocol Violation|0|||
155305438|NCT05075408|560549331|FG001|Overall Study|Protocol Violation|1|||
155305439|NCT05075408|560549332|FG002|Overall Study|Protocol Violation|0|||
155305440|NCT05075408|560549330|FG000|Overall Study|Lost to Follow-up|2|||
155305441|NCT05075408|560549331|FG001|Overall Study|Lost to Follow-up|1|||
155305442|NCT05075408|560549332|FG002|Overall Study|Lost to Follow-up|1|||
155305443|NCT05075408|560549330|FG000|Overall Study|Physician Decision|1|||
155305444|NCT05075408|560549331|FG001|Overall Study|Physician Decision|0|||
155305445|NCT05075408|560549332|FG002|Overall Study|Physician Decision|0|||
155305446|NCT05075408|560549330|FG000|Overall Study|Other-unspecified|3|||
155305447|NCT05075408|560549331|FG001|Overall Study|Other-unspecified|2|||
155305448|NCT05075408|560549332|FG002|Overall Study|Other-unspecified|0|||
155305449|NCT03416023|560549333|FG000|Overall Study|Exclusion criteria failure|1|||
155305450|NCT03416023|560549333|FG000|Overall Study|Withdrawal by Subject|6|||
155305451|NCT03416023|560549333|FG000|Overall Study|Explanted|7|||
155305452|NCT03416023|560549333|FG000|Overall Study|Physician Decision|1|||
155305453|NCT03416023|560549333|FG000|Overall Study|Lost to Follow-up|1|||
155305454|NCT03416023|560549333|FG000|Overall Study|Death|1|||
155305455|NCT04468776|560549334|FG000|Overall Study|Lost to Follow-up|4|||
155305456|NCT04468776|560549335|FG001|Overall Study|Lost to Follow-up|3|||
155305457|NCT04468776|560549336|FG002|Overall Study|Lost to Follow-up|4|||
155305458|NCT04468776|560549334|FG000|Overall Study|Withdrawal by Subject|1|||
155305459|NCT04468776|560549335|FG001|Overall Study|Withdrawal by Subject|10|||
155065477|NCT01129128|559669982|FG002|Overall Study|Withdrawal by Subject|3|||
155065478|NCT01129128|559669980|FG000|Overall Study|Physician Decision|1|||
155305460|NCT04468776|560549336|FG002|Overall Study|Withdrawal by Subject|4|||
155305461|NCT04468776|560549334|FG000|Overall Study|Physician Decision|0|||
155305462|NCT04468776|560549335|FG001|Overall Study|Physician Decision|1|||
155305463|NCT04468776|560549336|FG002|Overall Study|Physician Decision|1|||
155305464|NCT00505934|560549347|FG000|Overall Study|Adverse Event|1|||
155305465|NCT00505934|560549347|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
155305466|NCT00505934|560549347|FG000|Overall Study|Other: IV dose needed to be changed|1|||
155305467|NCT05384730|560549350|FG000|Overall Study|Adverse Event|1|||
155305468|NCT05384730|560549351|FG001|Overall Study|Adverse Event|0|||
155305469|NCT05384730|560549350|FG000|Overall Study|Lack of social support|2|||
155305470|NCT05384730|560549351|FG001|Overall Study|Lack of social support|0|||
155305471|NCT05384730|560549350|FG000|Overall Study|Hospital readmission|2|||
155305472|NCT05384730|560549351|FG001|Overall Study|Hospital readmission|0|||
155305473|NCT05384730|560549350|FG000|Overall Study|Disease progression|5|||
155305474|NCT05384730|560549351|FG001|Overall Study|Disease progression|0|||
155305475|NCT05384730|560549350|FG000|Overall Study|Overwhelmed with College commitments|0|||
155305476|NCT05384730|560549351|FG001|Overall Study|Overwhelmed with College commitments|2|||
155305477|NCT01000480|560549352|FG000|Induction Phase|Adverse Event|2|||
155305478|NCT01000480|560549352|FG000|Induction Phase|Lost to Follow-up|1|||
155305479|NCT01000480|560549352|FG000|Induction Phase|Physician Decision|1|||
155305480|NCT01000480|560549352|FG000|Induction Phase|Entry Criteria Not Met|3|||
155305481|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Adverse Event|4|||
155305482|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
155305483|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
155305484|NCT01000480|560549352|FG000|Concurrent Therapy Phase|Physician Decision|1|||
155305485|NCT04328727|560549358|FG000|Overall Study|Guardian Decision|1|||
155305486|NCT04328727|560549358|FG000|Overall Study|Participant decision|4|||
155305487|NCT04328727|560549358|FG000|Overall Study|Death|3|||
155305488|NCT04149002|560549362|FG000|Overall Study|Lost to Follow-up|1|||
155305489|NCT04149002|560549363|FG001|Overall Study|Lost to Follow-up|0|||
155305490|NCT04149002|560549362|FG000|Overall Study|Withdrawal by Subject|1|||
155305491|NCT04149002|560549363|FG001|Overall Study|Withdrawal by Subject|0|||
155305492|NCT02252172|560549364|FG000|Overall Study|Lost to Follow-up|9|||
155305493|NCT02252172|560549365|FG001|Overall Study|Lost to Follow-up|6|||
155305494|NCT02252172|560549364|FG000|Overall Study|Death|218|||
155065479|NCT01129128|559669981|FG001|Overall Study|Physician Decision|0|||
155305495|NCT02252172|560549365|FG001|Overall Study|Death|175|||
155305496|NCT02252172|560549364|FG000|Overall Study|Withdrawal by Subject|20|||
155305497|NCT02252172|560549365|FG001|Overall Study|Withdrawal by Subject|15|||
155305498|NCT02252172|560549364|FG000|Overall Study|Physician Decision|0|||
155065480|NCT01129128|559669982|FG002|Overall Study|Physician Decision|0|||
155065481|NCT06438601|559669983|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
155065482|NCT06438601|559669984|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
155305499|NCT02252172|560549365|FG001|Overall Study|Physician Decision|1|||
155305500|NCT02252172|560549364|FG000|Overall Study|End of data collection|122|||
155305501|NCT02252172|560549365|FG001|Overall Study|End of data collection|170|||
155305502|NCT02252172|560549364|FG000|Overall Study|Site closure|0|||
155305503|NCT02252172|560549365|FG001|Overall Study|Site closure|1|||
155305504|NCT03447249|560549369|FG000|Overall Study|Adverse Event|1|||
155305505|NCT03447249|560549370|FG001|Overall Study|Adverse Event|0|||
155065483|NCT06438601|559669983|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
155065484|NCT06438601|559669984|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
155065485|NCT01900314|559669985|FG000|Overall Study|Lost to Follow-up|1|||
155065486|NCT01900314|559669986|FG001|Overall Study|Lost to Follow-up|0|||
155065487|NCT01900314|559669985|FG000|Overall Study|Protocol Violation|0|||
155065488|NCT01900314|559669986|FG001|Overall Study|Protocol Violation|1|||
155065489|NCT01900314|559669985|FG000|Overall Study|Withdrawal by Subject|3|||
155305506|NCT03447249|560549369|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155305507|NCT03447249|560549370|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155305508|NCT03447249|560549369|FG000|Overall Study|Other|3|||
155065490|NCT01900314|559669986|FG001|Overall Study|Withdrawal by Subject|3|||
155065491|NCT01385176|559669988|FG000|Randomization Phase|Death|1|||
155305509|NCT03447249|560549370|FG001|Overall Study|Other|0|||
155305510|NCT01426412|560549371|FG000|Overall Study|Withdrawal by Subject|1|||
155305511|NCT01426412|560549372|FG001|Overall Study|Withdrawal by Subject|0|||
155305512|NCT01426412|560549373|FG002|Overall Study|Withdrawal by Subject|0|||
155305513|NCT01426412|560549374|FG003|Overall Study|Withdrawal by Subject|0|||
155305514|NCT01426412|560549375|FG004|Overall Study|Withdrawal by Subject|1|||
155305515|NCT01426412|560549376|FG005|Overall Study|Withdrawal by Subject|0|||
155305516|NCT01426412|560549377|FG006|Overall Study|Withdrawal by Subject|0|||
155305517|NCT01426412|560549378|FG007|Overall Study|Withdrawal by Subject|3|||
155305518|NCT01426412|560549379|FG008|Overall Study|Withdrawal by Subject|1|||
155305519|NCT00988858|560549381|FG000|Overall Study|Adverse Event|7|||
155305520|NCT00988858|560549381|FG000|Overall Study|Death|1|||
155305521|NCT00988858|560549381|FG000|Overall Study|Physician Decision|1|||
155305522|NCT00988858|560549381|FG000|Overall Study|Sponsor Decision|1|||
155305523|NCT02376790|560549382|FG000|Overall Study|Withdrawal by Subject|43|||
155305524|NCT02376790|560549383|FG001|Overall Study|Withdrawal by Subject|36|||
155305525|NCT02376790|560549384|FG002|Overall Study|Withdrawal by Subject|37|||
155305526|NCT02376790|560549382|FG000|Overall Study|Decision by Sponsor|2|||
155305527|NCT02376790|560549383|FG001|Overall Study|Decision by Sponsor|1|||
155305528|NCT02376790|560549384|FG002|Overall Study|Decision by Sponsor|4|||
155305529|NCT02376790|560549382|FG000|Overall Study|Lost to Follow-up|15|||
155305530|NCT02376790|560549383|FG001|Overall Study|Lost to Follow-up|10|||
155305531|NCT02376790|560549384|FG002|Overall Study|Lost to Follow-up|12|||
155305532|NCT03014453|560549385|FG000|Overall Study|Lost to Follow-up|12|||
155305533|NCT03014453|560549385|FG000|Overall Study|Discontinued GER|3|||
155305534|NCT03014453|560549385|FG000|Overall Study|Excluded|19|||
155305535|NCT03014453|560549385|FG000|Overall Study|Refused to take part in|37|||
155305536|NCT00390299|560549386|FG000|Overall Study|Cancellation|1|||
155305537|NCT00390299|560549387|FG001|Overall Study|Cancellation|0|||
155305538|NCT00390299|560549388|FG002|Overall Study|Cancellation|0|||
155305539|NCT00390299|560549389|FG003|Overall Study|Cancellation|0|||
155305540|NCT00390299|560549390|FG004|Overall Study|Cancellation|0|||
155305541|NCT01070069|560549392|FG000|Overall Study|Death|1|||
155305542|NCT01070069|560549393|FG001|Overall Study|Death|0|||
155305543|NCT01070069|560549394|FG002|Overall Study|Death|2|||
155305544|NCT01070069|560549395|FG003|Overall Study|Death|0|||
155305545|NCT01070069|560549396|FG004|Overall Study|Death|1|||
155305546|NCT01070069|560549392|FG000|Overall Study|Withdrawal by Subject|1|||
155305547|NCT01070069|560549393|FG001|Overall Study|Withdrawal by Subject|1|||
155305548|NCT01070069|560549394|FG002|Overall Study|Withdrawal by Subject|4|||
155305549|NCT01070069|560549395|FG003|Overall Study|Withdrawal by Subject|0|||
155305550|NCT01070069|560549396|FG004|Overall Study|Withdrawal by Subject|0|||
155305551|NCT01070069|560549392|FG000|Overall Study|Lost to Follow-up|4|||
155305552|NCT01070069|560549393|FG001|Overall Study|Lost to Follow-up|1|||
155305553|NCT01070069|560549394|FG002|Overall Study|Lost to Follow-up|0|||
155305554|NCT01070069|560549395|FG003|Overall Study|Lost to Follow-up|0|||
155305555|NCT01070069|560549396|FG004|Overall Study|Lost to Follow-up|3|||
155305556|NCT03101930|560549399|FG000|Overall Study|Withdrawal by Subject|2|||
155305557|NCT03101930|560549400|FG001|Overall Study|Withdrawal by Subject|1|||
155305558|NCT03101930|560549401|FG002|Overall Study|Withdrawal by Subject|2|||
155305559|NCT00262301|560549402|FG000|Double-blind Phase|Lost to Follow-up|1|||
155305560|NCT00262301|560549403|FG001|Double-blind Phase|Lost to Follow-up|0|||
155305561|NCT00262301|560549404|FG002|Double-blind Phase|Lost to Follow-up|0|||
155305562|NCT00262301|560549402|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
155305563|NCT00262301|560549403|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
155305564|NCT00262301|560549404|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
155305565|NCT04732338|560549410|FG000|Overall Study|Lost to Follow-up|3|||
155305566|NCT04732338|560549411|FG001|Overall Study|Lost to Follow-up|3|||
155305567|NCT00001277|560549412|FG000|Overall Study|Adverse Event|0|||
155305568|NCT00001277|560549413|FG001|Overall Study|Adverse Event|0|||
155305569|NCT00001277|560549414|FG002|Overall Study|Adverse Event|1|||
155305570|NCT00001277|560549412|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
155305571|NCT00001277|560549413|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
155305572|NCT00001277|560549414|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
155305573|NCT00088413|560549420|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
155305574|NCT00088413|560549421|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
155305575|NCT00088413|560549422|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
155305576|NCT00088413|560549423|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
155305577|NCT00088413|560549420|FG000|Overall Study|Adverse Events/Side Effects|0|||
155305578|NCT00088413|560549421|FG001|Overall Study|Adverse Events/Side Effects|1|||
155305579|NCT00088413|560549422|FG002|Overall Study|Adverse Events/Side Effects|1|||
155305580|NCT00088413|560549423|FG003|Overall Study|Adverse Events/Side Effects|0|||
155305581|NCT00088413|560549420|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
155305582|NCT00088413|560549421|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
155305583|NCT00088413|560549422|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
155305584|NCT00088413|560549423|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
155305585|NCT00088413|560549420|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
155305586|NCT00088413|560549421|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
155305587|NCT00088413|560549422|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
155305588|NCT00088413|560549423|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
155305589|NCT00088413|560549420|FG000|Overall Study|Death|0|||
155305590|NCT00088413|560549421|FG001|Overall Study|Death|1|||
155305591|NCT00088413|560549422|FG002|Overall Study|Death|0|||
155305592|NCT00088413|560549423|FG003|Overall Study|Death|0|||
155305593|NCT00088413|560549420|FG000|Overall Study|Progressive disease|9|||
155305594|NCT00088413|560549421|FG001|Overall Study|Progressive disease|11|||
155305595|NCT00088413|560549422|FG002|Overall Study|Progressive disease|8|||
155305596|NCT00088413|560549423|FG003|Overall Study|Progressive disease|14|||
155305597|NCT00088413|560549420|FG000|Overall Study|Other|0|||
155305598|NCT00088413|560549421|FG001|Overall Study|Other|1|||
155305599|NCT00088413|560549422|FG002|Overall Study|Other|0|||
155305600|NCT00088413|560549423|FG003|Overall Study|Other|0|||
155305601|NCT00088413|560549420|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
155305602|NCT00088413|560549421|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
155305603|NCT00088413|560549422|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
155305604|NCT00088413|560549423|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
155305605|NCT02539225|560549424|FG000|Part A|Adverse Event|13|||
155305606|NCT02539225|560549425|FG001|Part A|Adverse Event|4|||
155305607|NCT02539225|560549424|FG000|Part A|Withdrawal by Subject|2|||
155305608|NCT02539225|560549425|FG001|Part A|Withdrawal by Subject|4|||
155305609|NCT02539225|560549424|FG000|Part A|Physician Decision|4|||
155305610|NCT02539225|560549425|FG001|Part A|Physician Decision|7|||
155305611|NCT02539225|560549424|FG000|Part A|Did Not Receive study Drug|1|||
155305612|NCT02539225|560549425|FG001|Part A|Did Not Receive study Drug|1|||
155305613|NCT02539225|560549424|FG000|Pre Treatment for Part B|Progressive disease|1|||
155305614|NCT02539225|560549425|FG001|Pre Treatment for Part B|Progressive disease|1|||
155065492|NCT01385176|559669989|FG001|Randomization Phase|Death|2|||
155065493|NCT01385176|559669988|FG000|6-18 Month All VNS Active|Death|1|||
155065494|NCT01385176|559669989|FG001|6-18 Month All VNS Active|Death|2|||
155065495|NCT01385176|559669988|FG000|6-18 Month All VNS Active|Physician Decision|0|||
155065496|NCT01385176|559669989|FG001|6-18 Month All VNS Active|Physician Decision|1|||
155065497|NCT01385176|559669988|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
155065498|NCT01385176|559669989|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
155065499|NCT01385176|559669988|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
155065500|NCT01385176|559669989|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
155065501|NCT04848480|559669996|FG000|Main Phase (26 Weeks)|Death|1|||
155065502|NCT04848480|559669997|FG001|Main Phase (26 Weeks)|Death|0|||
155065503|NCT04848480|559669996|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
155065504|NCT04848480|559669997|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
155065505|NCT04848480|559669996|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
155065506|NCT04848480|559669997|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
155065507|NCT04848480|559669996|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
155065508|NCT04848480|559669997|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
155065509|NCT04848480|559669996|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
155065510|NCT04848480|559669997|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
155305615|NCT02539225|560549424|FG000|Pre Treatment for Part B|Adverse Event|1|||
155305616|NCT02539225|560549425|FG001|Pre Treatment for Part B|Adverse Event|1|||
155305617|NCT02539225|560549424|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
155305618|NCT02539225|560549425|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
155305619|NCT02539225|560549424|FG000|Pre Treatment for Part B|Physician Decision|2|||
155305620|NCT02539225|560549425|FG001|Pre Treatment for Part B|Physician Decision|0|||
155305621|NCT02539225|560549424|FG000|Part B|Adverse Event|4|||
155305622|NCT02539225|560549425|FG001|Part B|Adverse Event|4|||
155305623|NCT02539225|560549424|FG000|Part B|Withdrawal by Subject|0|||
155305624|NCT02539225|560549425|FG001|Part B|Withdrawal by Subject|3|||
155305625|NCT02539225|560549424|FG000|Part B|Physician Decision|0|||
155305626|NCT02539225|560549425|FG001|Part B|Physician Decision|9|||
155305627|NCT03101371|560549428|FG000|Overall Study|Physician Decision|0|||
155305628|NCT03101371|560549429|FG001|Overall Study|Physician Decision|1|||
155305629|NCT03101371|560549428|FG000|Overall Study|Lost to Follow-up|1|||
155305630|NCT03101371|560549429|FG001|Overall Study|Lost to Follow-up|4|||
155305631|NCT03101371|560549428|FG000|Overall Study|Did not meet eligibility criteria|2|||
155305632|NCT03101371|560549429|FG001|Overall Study|Did not meet eligibility criteria|1|||
155305633|NCT03988842|560549430|FG000|Overall Study|Death|1|||
155305634|NCT01976312|560549431|FG000|Overall Study|Pregnancy|0|||
155305635|NCT01976312|560549432|FG001|Overall Study|Pregnancy|1|||
155305636|NCT01976312|560549431|FG000|Overall Study|Lost to Follow-up|2|||
155305637|NCT01976312|560549432|FG001|Overall Study|Lost to Follow-up|0|||
155305638|NCT01976312|560549431|FG000|Overall Study|Withdrawal by Subject|7|||
155305639|NCT01976312|560549432|FG001|Overall Study|Withdrawal by Subject|2|||
155305640|NCT01976312|560549431|FG000|Overall Study|Adverse Event|6|||
155305641|NCT01976312|560549432|FG001|Overall Study|Adverse Event|6|||
155305642|NCT01976312|560549431|FG000|Overall Study|Protocol Violation|2|||
155305643|NCT01976312|560549432|FG001|Overall Study|Protocol Violation|0|||
155305644|NCT01538719|560549433|FG000|Overall Study|Lost to Follow-up|2|||
155305645|NCT01538719|560549434|FG001|Overall Study|Lost to Follow-up|0|||
155305646|NCT02556138|560549439|FG000|Overall Study|Withdrawal by Subject|1|||
155305647|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
155305648|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
155305649|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
155305650|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
155305651|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
155065511|NCT04848480|559669996|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
155065512|NCT04848480|559669997|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
155065513|NCT04428151|559669998|FG000|Overall Study|Death|100|||
155065514|NCT04428151|559669999|FG001|Overall Study|Death|86|||
155065515|NCT04428151|559670000|FG002|Overall Study|Death|57|||
155065516|NCT04428151|559669998|FG000|Overall Study|Lost to Follow-up|1|||
155065517|NCT04428151|559669999|FG001|Overall Study|Lost to Follow-up|1|||
155065518|NCT04428151|559670000|FG002|Overall Study|Lost to Follow-up|0|||
155065519|NCT04428151|559669998|FG000|Overall Study|Withdrawal by Subject|2|||
155065520|NCT04428151|559669999|FG001|Overall Study|Withdrawal by Subject|2|||
155065521|NCT04428151|559670000|FG002|Overall Study|Withdrawal by Subject|3|||
155065522|NCT04428151|559669998|FG000|Overall Study|Participant Ongoing in Study|41|||
155065523|NCT04428151|559669999|FG001|Overall Study|Participant Ongoing in Study|53|||
155065524|NCT04428151|559670000|FG002|Overall Study|Participant Ongoing in Study|28|||
155065525|NCT02783690|559670001|FG000|Overall Study|Withdrawal by Subject|3|||
155065526|NCT02783690|559670002|FG001|Overall Study|Withdrawal by Subject|3|||
155065527|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
155065528|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
155065529|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
155065530|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
155065531|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Death|38|||
155065532|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Death|10|||
155065533|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
155065534|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
155065535|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
155065536|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
155065537|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
155065538|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
155065539|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
155065540|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
155065541|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
155065542|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
155065543|NCT02421939|559670003|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
155065544|NCT02421939|559670004|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
155161157|NCT03126591|560026768|FG002|Overall Study|Terminated by Sponsor|4|||
155161158|NCT03126591|560026766|FG000|Overall Study|Withdrawal by Subject|1|||
155161159|NCT03126591|560026767|FG001|Overall Study|Withdrawal by Subject|1|||
155161160|NCT03126591|560026768|FG002|Overall Study|Withdrawal by Subject|4|||
155161161|NCT03722238|560026771|FG000|Overall Study|Protocol Violation|1|||
155161162|NCT03722238|560026772|FG001|Overall Study|Protocol Violation|0|||
155161163|NCT03722238|560026771|FG000|Overall Study|Physician Decision|1|||
155161164|NCT03722238|560026772|FG001|Overall Study|Physician Decision|0|||
155161165|NCT03722238|560026771|FG000|Overall Study|Death|1|||
155161166|NCT03722238|560026772|FG001|Overall Study|Death|0|||
155161167|NCT03722238|560026771|FG000|Overall Study|Lost to Follow-up|6|||
155161168|NCT03722238|560026772|FG001|Overall Study|Lost to Follow-up|0|||
155161169|NCT03722238|560026771|FG000|Overall Study|Partial missing data|44|||
155161170|NCT03722238|560026772|FG001|Overall Study|Partial missing data|1|||
155161171|NCT03722238|560026771|FG000|Overall Study|Withdrawal by Subject|2|||
155305652|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
155305653|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
155305654|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
155305655|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
155305656|NCT03939312|560549440|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
155305657|NCT03939312|560549440|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
155305658|NCT03939312|560549440|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
155305659|NCT03481816|560549442|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
155305660|NCT03481816|560549443|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
155305661|NCT03481816|560549442|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
155305662|NCT03481816|560549443|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
155305663|NCT03481816|560549442|FG000|Dose Expansion|Withdrawal by Subject|0|||
155305664|NCT03481816|560549443|FG001|Dose Expansion|Withdrawal by Subject|2|||
155305665|NCT03481816|560549442|FG000|Dose Expansion|Physician Decision|0|||
154958935|NCT00905840|559276851|FG000|Overall Study|Withdrawal by Subject|1|||
154958936|NCT00905840|559276851|FG000|Overall Study|Adverse Event|1|||
154958937|NCT01827163|559276852|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
154958938|NCT01827163|559276852|FG000|Overall Study|Adverse Event|9|||
154958939|NCT03375463|559276853|FG000|Period 1|Lost to Follow-up|0|||
154958940|NCT03375463|559276854|FG001|Period 1|Lost to Follow-up|0|||
154958941|NCT03375463|559276855|FG002|Period 1|Lost to Follow-up|1|||
154958942|NCT03375463|559276856|FG003|Period 1|Lost to Follow-up|0|||
154958943|NCT03375463|559276857|FG004|Period 1|Lost to Follow-up|0|||
154958944|NCT03375463|559276858|FG005|Period 1|Lost to Follow-up|0|||
154958945|NCT03375463|559276853|FG000|Period 1|Adverse Event|0|||
154958946|NCT03375463|559276854|FG001|Period 1|Adverse Event|0|||
154958947|NCT03375463|559276855|FG002|Period 1|Adverse Event|0|||
154958948|NCT03375463|559276856|FG003|Period 1|Adverse Event|0|||
154958949|NCT03375463|559276857|FG004|Period 1|Adverse Event|1|||
154958950|NCT03375463|559276858|FG005|Period 1|Adverse Event|0|||
154958951|NCT03375463|559276853|FG000|Period 2|Lost to Follow-up|1|||
154958952|NCT03375463|559276854|FG001|Period 2|Lost to Follow-up|1|||
154958953|NCT03375463|559276855|FG002|Period 2|Lost to Follow-up|0|||
154958954|NCT03375463|559276856|FG003|Period 2|Lost to Follow-up|0|||
154958955|NCT03375463|559276857|FG004|Period 2|Lost to Follow-up|0|||
154958956|NCT03375463|559276858|FG005|Period 2|Lost to Follow-up|0|||
154958957|NCT03620747|559276861|FG000|Overall Study|Participant decision|7|||
154958958|NCT03620747|559276861|FG000|Overall Study|Adverse Event|6|||
154958959|NCT03620747|559276861|FG000|Overall Study|Lack of Efficacy|1|||
154958960|NCT03620747|559276861|FG000|Overall Study|Poor compliance to protocol|2|||
154958961|NCT03620747|559276861|FG000|Overall Study|Other-unspecified|3|||
154958962|NCT01513174|559276871|FG000|Overall Study|Inclusion Error|1|||
154958963|NCT01513174|559276872|FG001|Overall Study|Inclusion Error|7|||
155305666|NCT03481816|560549443|FG001|Dose Expansion|Physician Decision|5|||
155305667|NCT01216176|560551115|FG000|Overall Study|Adverse Event|0|||
155305668|NCT01216176|560551116|FG001|Overall Study|Adverse Event|8|||
154958964|NCT01513174|559276871|FG000|Overall Study|Not receive study treatment|3|||
154958965|NCT01513174|559276872|FG001|Overall Study|Not receive study treatment|1|||
154958966|NCT01900626|559276875|FG000|Overall Study|study was closed due to low enrollment|1|||
155305669|NCT01216176|560551117|FG002|Overall Study|Adverse Event|0|||
155305670|NCT01216176|560551115|FG000|Overall Study|Physician Decision|0|||
155305671|NCT01216176|560551116|FG001|Overall Study|Physician Decision|0|||
155305672|NCT01216176|560551117|FG002|Overall Study|Physician Decision|1|||
155305673|NCT02791230|560551118|FG000|Overall Study|Adverse Event|10|||
155305674|NCT02791230|560551119|FG001|Overall Study|Adverse Event|9|||
155305675|NCT02791230|560551120|FG002|Overall Study|Adverse Event|66|||
155305676|NCT02791230|560551118|FG000|Overall Study|Death|38|||
155305677|NCT02791230|560551119|FG001|Overall Study|Death|25|||
155305678|NCT02791230|560551120|FG002|Overall Study|Death|184|||
155305679|NCT02791230|560551118|FG000|Overall Study|Lack of Efficacy|1|||
155305680|NCT02791230|560551119|FG001|Overall Study|Lack of Efficacy|0|||
155305681|NCT02791230|560551120|FG002|Overall Study|Lack of Efficacy|3|||
155305682|NCT02791230|560551118|FG000|Overall Study|Lost to Follow-up|0|||
155305683|NCT02791230|560551119|FG001|Overall Study|Lost to Follow-up|0|||
155305684|NCT02791230|560551120|FG002|Overall Study|Lost to Follow-up|10|||
155305685|NCT02791230|560551118|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
155305686|NCT02791230|560551119|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
155305687|NCT02791230|560551120|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
155305688|NCT02791230|560551118|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
155305689|NCT02791230|560551119|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
155305690|NCT02791230|560551120|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
155305691|NCT02791230|560551118|FG000|Overall Study|Study sites terminated by sponsor|1|||
155305692|NCT02791230|560551119|FG001|Overall Study|Study sites terminated by sponsor|0|||
155305693|NCT02791230|560551120|FG002|Overall Study|Study sites terminated by sponsor|5|||
155305694|NCT02791230|560551118|FG000|Overall Study|Other|9|||
155305695|NCT02791230|560551119|FG001|Overall Study|Other|1|||
155305696|NCT02791230|560551120|FG002|Overall Study|Other|28|||
155305697|NCT02791230|560551118|FG000|Overall Study|Protocol Violation|0|||
155305698|NCT02791230|560551119|FG001|Overall Study|Protocol Violation|0|||
155305699|NCT02791230|560551120|FG002|Overall Study|Protocol Violation|4|||
155305700|NCT02791230|560551118|FG000|Overall Study|Withdrawal by Subject|24|||
155305701|NCT02791230|560551119|FG001|Overall Study|Withdrawal by Subject|13|||
155305702|NCT02791230|560551120|FG002|Overall Study|Withdrawal by Subject|172|||
155305703|NCT02791230|560551118|FG000|Overall Study|Enrolled but not treated|0|||
155305704|NCT02791230|560551119|FG001|Overall Study|Enrolled but not treated|0|||
155305705|NCT02791230|560551120|FG002|Overall Study|Enrolled but not treated|5|||
155305706|NCT05756075|560551125|FG000|Overall Study|Withdrawal by Subject|16|||
155305707|NCT05756075|560551126|FG001|Overall Study|Withdrawal by Subject|9|||
155305708|NCT03821844|560551128|FG000|Overall Study|Death|37|||
155305709|NCT03821844|560551129|FG001|Overall Study|Death|31|||
155305710|NCT03821844|560551128|FG000|Overall Study|Discharged|10|||
155305711|NCT03821844|560551129|FG001|Overall Study|Discharged|14|||
155305712|NCT03821844|560551128|FG000|Overall Study|Not present in facility at followup|2|||
155305713|NCT03821844|560551129|FG001|Overall Study|Not present in facility at followup|3|||
155305714|NCT02605837|560551130|FG000|Overall Study|Adverse Event|3|||
155305715|NCT02605837|560551131|FG001|Overall Study|Adverse Event|1|||
155305716|NCT02605837|560551130|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155305717|NCT02605837|560551131|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155305718|NCT02605837|560551130|FG000|Overall Study|Withdrawal by Subject|8|||
155305719|NCT02605837|560551131|FG001|Overall Study|Withdrawal by Subject|8|||
155305720|NCT02605837|560551130|FG000|Overall Study|Physician Decision|0|||
155305721|NCT02605837|560551131|FG001|Overall Study|Physician Decision|1|||
155305722|NCT05104697|560551132|FG000|Overall Study|Withdrawal by Subject|0|||
155305723|NCT05104697|560551133|FG001|Overall Study|Withdrawal by Subject|1|||
155305724|NCT03899961|560551134|FG000|Overall Study|-delivery prior to|2|||
155305725|NCT03899961|560551135|FG001|Overall Study|-delivery prior to|7|||
155305726|NCT03899961|560551134|FG000|Overall Study|req general anesth|1|||
155305727|NCT03899961|560551135|FG001|Overall Study|req general anesth|2|||
155305728|NCT03899961|560551134|FG000|Overall Study|capacity|5|||
155305729|NCT03899961|560551135|FG001|Overall Study|capacity|6|||
155305730|NCT03899961|560551134|FG000|Overall Study|Withdrawal by Subject|1|||
155305731|NCT03899961|560551135|FG001|Overall Study|Withdrawal by Subject|1|||
155305732|NCT05307978|560551136|FG000|Overall Study|Lost to Follow-up|0|||
155305733|NCT05307978|560551137|FG001|Overall Study|Lost to Follow-up|1|||
155305734|NCT05307978|560551138|FG002|Overall Study|Lost to Follow-up|0|||
155305735|NCT05307978|560551139|FG003|Overall Study|Lost to Follow-up|4|||
155305736|NCT05307978|560551140|FG004|Overall Study|Lost to Follow-up|0|||
155305737|NCT05307978|560551141|FG005|Overall Study|Lost to Follow-up|0|||
155305738|NCT05307978|560551142|FG006|Overall Study|Lost to Follow-up|1|||
155305739|NCT03651895|560551143|FG000|First Drug Assignment|Adverse Event|4|||
155305740|NCT03651895|560551144|FG001|First Drug Assignment|Adverse Event|5|||
155305741|NCT03651895|560551143|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
155305742|NCT03651895|560551144|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
155305743|NCT02837510|560551145|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
155305744|NCT02837510|560551146|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
155305745|NCT02837510|560551145|FG000|Washout (2 Weeks)|Adverse Event|0|||
155305746|NCT02837510|560551146|FG001|Washout (2 Weeks)|Adverse Event|1|||
155305747|NCT02837510|560551145|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
155305748|NCT02837510|560551146|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
155305749|NCT02837510|560551145|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
155305750|NCT02837510|560551146|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
155305751|NCT02837510|560551145|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
155305752|NCT02837510|560551146|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
155305753|NCT02837510|560551145|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
155305754|NCT02837510|560551146|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
155305755|NCT05419505|560551148|FG000|Overall Study|Adverse Event|0|||
155305756|NCT05419505|560551149|FG001|Overall Study|Adverse Event|0|||
155305757|NCT05419505|560551150|FG002|Overall Study|Adverse Event|0|||
155065545|NCT02421939|559670003|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
155065546|NCT02421939|559670004|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
155065547|NCT02421939|559670003|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
155065548|NCT02421939|559670004|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
155065549|NCT02421939|559670003|FG000|Long Term Follow up: up to 3 Years|Death|118|||
155065550|NCT02421939|559670004|FG001|Long Term Follow up: up to 3 Years|Death|65|||
155065551|NCT02421939|559670003|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
155305758|NCT05419505|560551151|FG003|Overall Study|Adverse Event|1|||
155305759|NCT05419505|560551152|FG004|Overall Study|Adverse Event|0|||
155305760|NCT05419505|560551153|FG005|Overall Study|Adverse Event|0|||
155305761|NCT05419505|560551154|FG006|Overall Study|Adverse Event|0|||
155305762|NCT05419505|560551155|FG007|Overall Study|Adverse Event|0|||
155305763|NCT05419505|560551148|FG000|Overall Study|Withdrawal by Subject|1|||
155305764|NCT05419505|560551149|FG001|Overall Study|Withdrawal by Subject|2|||
155305765|NCT05419505|560551150|FG002|Overall Study|Withdrawal by Subject|0|||
155305766|NCT05419505|560551151|FG003|Overall Study|Withdrawal by Subject|0|||
155305767|NCT05419505|560551152|FG004|Overall Study|Withdrawal by Subject|0|||
155305768|NCT05419505|560551153|FG005|Overall Study|Withdrawal by Subject|0|||
155305769|NCT05419505|560551154|FG006|Overall Study|Withdrawal by Subject|1|||
155305770|NCT05419505|560551155|FG007|Overall Study|Withdrawal by Subject|0|||
155305771|NCT05419505|560551148|FG000|Overall Study|Lost to Follow-up|2|||
155305772|NCT05419505|560551149|FG001|Overall Study|Lost to Follow-up|1|||
155305773|NCT05419505|560551150|FG002|Overall Study|Lost to Follow-up|0|||
155305774|NCT05419505|560551151|FG003|Overall Study|Lost to Follow-up|0|||
155305775|NCT05419505|560551152|FG004|Overall Study|Lost to Follow-up|1|||
155305776|NCT05419505|560551153|FG005|Overall Study|Lost to Follow-up|2|||
155305777|NCT05419505|560551154|FG006|Overall Study|Lost to Follow-up|0|||
155305778|NCT05419505|560551155|FG007|Overall Study|Lost to Follow-up|1|||
155305779|NCT02780388|560551158|FG000|Overall Study|Lost to Follow-up|0|||
155305780|NCT02780388|560551159|FG001|Overall Study|Lost to Follow-up|1|||
155305781|NCT02780388|560551160|FG002|Overall Study|Lost to Follow-up|0|||
155305782|NCT02780388|560551161|FG003|Overall Study|Lost to Follow-up|0|||
155305783|NCT02780388|560551162|FG004|Overall Study|Lost to Follow-up|0|||
155305784|NCT02780388|560551158|FG000|Overall Study|Withdrawal by Subject|1|||
155305785|NCT02780388|560551159|FG001|Overall Study|Withdrawal by Subject|1|||
155305786|NCT02780388|560551160|FG002|Overall Study|Withdrawal by Subject|0|||
155305787|NCT02780388|560551161|FG003|Overall Study|Withdrawal by Subject|0|||
155305788|NCT02780388|560551162|FG004|Overall Study|Withdrawal by Subject|0|||
155305789|NCT04527146|560551163|FG000|Overall Study|Withdrawal by Subject|12|||
155305790|NCT04527146|560551164|FG001|Overall Study|Withdrawal by Subject|15|||
155305791|NCT04527146|560551165|FG002|Overall Study|Withdrawal by Subject|7|||
155305792|NCT04527146|560551166|FG003|Overall Study|Withdrawal by Subject|16|||
155305793|NCT04527146|560551163|FG000|Overall Study|Lost to Follow-up|13|||
155305794|NCT04527146|560551164|FG001|Overall Study|Lost to Follow-up|9|||
155305795|NCT04527146|560551165|FG002|Overall Study|Lost to Follow-up|16|||
155305796|NCT04527146|560551166|FG003|Overall Study|Lost to Follow-up|13|||
155305797|NCT04527146|560551163|FG000|Overall Study|Death|0|||
155305798|NCT04527146|560551164|FG001|Overall Study|Death|1|||
155305799|NCT04527146|560551165|FG002|Overall Study|Death|1|||
155305800|NCT04527146|560551166|FG003|Overall Study|Death|0|||
155305801|NCT04527146|560551163|FG000|Overall Study|Adverse Event|0|||
155305802|NCT04527146|560551164|FG001|Overall Study|Adverse Event|0|||
155305803|NCT04527146|560551165|FG002|Overall Study|Adverse Event|1|||
155305804|NCT04527146|560551166|FG003|Overall Study|Adverse Event|0|||
155305805|NCT04527146|560551163|FG000|Overall Study|Ineligible after randomization|2|||
155305806|NCT04527146|560551164|FG001|Overall Study|Ineligible after randomization|0|||
155305807|NCT04527146|560551165|FG002|Overall Study|Ineligible after randomization|2|||
155305808|NCT04527146|560551166|FG003|Overall Study|Ineligible after randomization|2|||
155305809|NCT04527146|560551163|FG000|Overall Study|Moved to a different group|6|||
155305810|NCT04527146|560551164|FG001|Overall Study|Moved to a different group|3|||
155305811|NCT04527146|560551165|FG002|Overall Study|Moved to a different group|0|||
155305812|NCT04527146|560551166|FG003|Overall Study|Moved to a different group|2|||
155305813|NCT05107401|560551167|FG000|Overall Study|Lost to Follow-up|13|||
155065552|NCT02421939|559670004|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
155065553|NCT04880850|559670007|FG000|Overall Study|Death|2|||
155305814|NCT05107401|560551168|FG001|Overall Study|Lost to Follow-up|12|||
155305815|NCT05510232|560551169|FG000|Overall Study|Withdrawal by Subject|2|||
155065554|NCT04880850|559670008|FG001|Overall Study|Death|1|||
155065555|NCT04880850|559670007|FG000|Overall Study|Lost to Follow-up|3|||
155305816|NCT05510232|560551170|FG001|Overall Study|Withdrawal by Subject|7|||
155305817|NCT05510232|560551171|FG002|Overall Study|Withdrawal by Subject|6|||
155305818|NCT05952076|560551183|FG000|Overall Study|Death|1|||
155305819|NCT05952076|560551184|FG001|Overall Study|Death|1|||
155305820|NCT05952076|560551183|FG000|Overall Study|Lost to Follow-up|0|||
155305821|NCT05952076|560551184|FG001|Overall Study|Lost to Follow-up|1|||
155305822|NCT04143061|560551185|FG000|Overall Study|Protocol Deviation|0|||
155305823|NCT04143061|560551186|FG001|Overall Study|Protocol Deviation|0|||
155305824|NCT04143061|560551187|FG002|Overall Study|Protocol Deviation|0|||
155305825|NCT04143061|560551188|FG003|Overall Study|Protocol Deviation|0|||
155305826|NCT04143061|560551189|FG004|Overall Study|Protocol Deviation|0|||
155305827|NCT04143061|560551190|FG005|Overall Study|Protocol Deviation|0|||
155305828|NCT04143061|560551191|FG006|Overall Study|Protocol Deviation|5|||
155305829|NCT04143061|560551192|FG007|Overall Study|Protocol Deviation|5|||
155305830|NCT04143061|560551185|FG000|Overall Study|Withdrawal by Subject|2|||
155305831|NCT04143061|560551186|FG001|Overall Study|Withdrawal by Subject|0|||
155305832|NCT04143061|560551187|FG002|Overall Study|Withdrawal by Subject|0|||
155305833|NCT04143061|560551188|FG003|Overall Study|Withdrawal by Subject|0|||
155305834|NCT04143061|560551189|FG004|Overall Study|Withdrawal by Subject|0|||
155305835|NCT04143061|560551190|FG005|Overall Study|Withdrawal by Subject|1|||
155305836|NCT04143061|560551191|FG006|Overall Study|Withdrawal by Subject|0|||
155305837|NCT04143061|560551192|FG007|Overall Study|Withdrawal by Subject|0|||
155305838|NCT04143061|560551185|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155305839|NCT04143061|560551186|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155305840|NCT04143061|560551187|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155305841|NCT04143061|560551188|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155305842|NCT04143061|560551189|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
155305843|NCT04143061|560551190|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
155305844|NCT04143061|560551191|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
155305845|NCT04143061|560551192|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
155305846|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305847|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305848|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305849|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
155305850|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
155305851|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305852|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305853|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305854|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
155305855|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
155305856|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305857|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305858|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305859|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
155305860|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
155305861|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305862|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305863|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305864|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
155305865|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
155305866|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305867|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305868|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305869|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
155305870|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
155305871|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305872|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305873|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305874|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
155305875|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
155305876|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155305877|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155305878|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155305879|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
155305880|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
155305881|NCT01898494|560551202|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305882|NCT01898494|560551203|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305883|NCT01898494|560551204|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305884|NCT01898494|560551205|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
155305885|NCT01898494|560551206|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
155305886|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
155305887|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
155305888|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
155305889|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
155305890|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
155305891|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
155305892|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
155305893|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
155305894|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
155305895|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
155305896|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
155305897|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
155305898|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
155305899|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
155305900|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
155305901|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305902|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
155305903|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305904|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305905|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
155305906|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305907|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305908|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
155305909|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305910|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
155305911|NCT01898494|560551202|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
155305912|NCT01898494|560551203|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
155305913|NCT01898494|560551204|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
155305914|NCT01898494|560551205|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
155305915|NCT01898494|560551206|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
155305916|NCT03289039|560551207|FG000|Overall Study|Withdrawal by Subject|0|||
155305917|NCT03289039|560551208|FG001|Overall Study|Withdrawal by Subject|1|||
155305918|NCT03289039|560551207|FG000|Overall Study|Became ineligible prior to treatment start|0|||
155305919|NCT03289039|560551208|FG001|Overall Study|Became ineligible prior to treatment start|1|||
155305920|NCT03289039|560551207|FG000|Overall Study|progressed before treatment start|1|||
155305921|NCT03289039|560551208|FG001|Overall Study|progressed before treatment start|0|||
155305922|NCT02819843|560551209|FG000|Overall Study|Disease progression before RT|0|||
155305923|NCT02819843|560551210|FG001|Overall Study|Disease progression before RT|1|||
155305924|NCT04732494|560551211|FG000|Overall Study|Death|39|||
155305925|NCT04732494|560551212|FG001|Overall Study|Death|36|||
155305926|NCT04732494|560551211|FG000|Overall Study|Study Closed by Sponsor|20|||
155305927|NCT04732494|560551212|FG001|Overall Study|Study Closed by Sponsor|15|||
155305928|NCT04732494|560551211|FG000|Overall Study|Withdrawal by Subject|2|||
155305929|NCT04732494|560551212|FG001|Overall Study|Withdrawal by Subject|7|||
155305930|NCT04732494|560551211|FG000|Overall Study|Lost to Follow-up|1|||
155305931|NCT04732494|560551212|FG001|Overall Study|Lost to Follow-up|5|||
155305932|NCT03055858|560551213|FG000|Overall Study|Death|9|||
155305933|NCT03055858|560551213|FG000|Overall Study|Withdrawal by Subject|11|||
155305934|NCT03055858|560551213|FG000|Overall Study|Lost to Follow-up|6|||
155305935|NCT03055858|560551213|FG000|Overall Study|Missed Follow-Up Visits|18|||
155305936|NCT04586920|560551214|FG000|Overall Study|Lost to Follow-up|0|||
155305937|NCT04586920|560551215|FG001|Overall Study|Lost to Follow-up|0|||
155305938|NCT04586920|560551216|FG002|Overall Study|Lost to Follow-up|0|||
155305939|NCT04586920|560551217|FG003|Overall Study|Lost to Follow-up|0|||
155305940|NCT04586920|560551218|FG004|Overall Study|Lost to Follow-up|0|||
155305941|NCT04586920|560551219|FG005|Overall Study|Lost to Follow-up|0|||
155305942|NCT04586920|560551220|FG006|Overall Study|Lost to Follow-up|1|||
155305943|NCT04586920|560551221|FG007|Overall Study|Lost to Follow-up|1|||
155305944|NCT04586920|560551222|FG008|Overall Study|Lost to Follow-up|0|||
155305945|NCT04586920|560551223|FG009|Overall Study|Lost to Follow-up|1|||
155305946|NCT04586920|560551224|FG010|Overall Study|Lost to Follow-up|0|||
155305947|NCT04586920|560551225|FG011|Overall Study|Lost to Follow-up|0|||
155305948|NCT04586920|560551226|FG012|Overall Study|Lost to Follow-up|0|||
155305949|NCT04586920|560551227|FG013|Overall Study|Lost to Follow-up|1|||
155305950|NCT04586920|560551228|FG014|Overall Study|Lost to Follow-up|0|||
155305951|NCT04586920|560551229|FG015|Overall Study|Lost to Follow-up|0|||
155305952|NCT04586920|560551230|FG016|Overall Study|Lost to Follow-up|0|||
155305953|NCT04586920|560551231|FG017|Overall Study|Lost to Follow-up|0|||
155305954|NCT04586920|560551214|FG000|Overall Study|Withdrawal by Subject|0|||
155305955|NCT04586920|560551215|FG001|Overall Study|Withdrawal by Subject|0|||
155305956|NCT04586920|560551216|FG002|Overall Study|Withdrawal by Subject|0|||
155305957|NCT04586920|560551217|FG003|Overall Study|Withdrawal by Subject|0|||
155305958|NCT04586920|560551218|FG004|Overall Study|Withdrawal by Subject|0|||
155305959|NCT04586920|560551219|FG005|Overall Study|Withdrawal by Subject|0|||
155305960|NCT04586920|560551220|FG006|Overall Study|Withdrawal by Subject|0|||
155305961|NCT04586920|560551221|FG007|Overall Study|Withdrawal by Subject|1|||
155305962|NCT04586920|560551222|FG008|Overall Study|Withdrawal by Subject|0|||
155305963|NCT04586920|560551223|FG009|Overall Study|Withdrawal by Subject|1|||
155305964|NCT04586920|560551224|FG010|Overall Study|Withdrawal by Subject|0|||
155305965|NCT04586920|560551225|FG011|Overall Study|Withdrawal by Subject|1|||
155305966|NCT04586920|560551226|FG012|Overall Study|Withdrawal by Subject|0|||
155305967|NCT04586920|560551227|FG013|Overall Study|Withdrawal by Subject|0|||
155305968|NCT04586920|560551228|FG014|Overall Study|Withdrawal by Subject|0|||
155305969|NCT04586920|560551229|FG015|Overall Study|Withdrawal by Subject|0|||
155305970|NCT04586920|560551230|FG016|Overall Study|Withdrawal by Subject|0|||
155305971|NCT04586920|560551231|FG017|Overall Study|Withdrawal by Subject|0|||
155305972|NCT05136404|560551237|FG000|Period 1|Adverse Event|0|||
155305973|NCT05136404|560551238|FG001|Period 1|Adverse Event|1|||
155305974|NCT05136404|560551239|FG002|Period 1|Adverse Event|1|||
155305975|NCT05136404|560551237|FG000|Period 2|Inappropriate Behavior|0|||
155305976|NCT05136404|560551238|FG001|Period 2|Inappropriate Behavior|0|||
155305977|NCT05136404|560551239|FG002|Period 2|Inappropriate Behavior|1|||
155305978|NCT05136404|560551237|FG000|Period 3|Adverse Event|0|||
155305979|NCT05136404|560551238|FG001|Period 3|Adverse Event|0|||
155305980|NCT05136404|560551239|FG002|Period 3|Adverse Event|1|||
155305981|NCT02553642|560551240|FG000|Overall Study|Withdrawal by Subject|0|||
155305982|NCT02553642|560551241|FG001|Overall Study|Withdrawal by Subject|3|||
155305983|NCT02553642|560551240|FG000|Overall Study|Physician Decision|0|||
155305984|NCT02553642|560551241|FG001|Overall Study|Physician Decision|1|||
155305985|NCT02553642|560551240|FG000|Overall Study|Additional cancer dx|0|||
155305986|NCT02553642|560551241|FG001|Overall Study|Additional cancer dx|1|||
155305987|NCT02553642|560551240|FG000|Overall Study|Never started treatment|0|||
155305988|NCT02553642|560551241|FG001|Overall Study|Never started treatment|1|||
155305989|NCT01820260|560551244|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305990|NCT01820260|560551245|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305991|NCT01820260|560551246|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305992|NCT01820260|560551247|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305993|NCT01820260|560551248|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305994|NCT01820260|560551249|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305995|NCT01820260|560551250|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
155305996|NCT01820260|560551251|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305997|NCT01820260|560551252|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305998|NCT01820260|560551253|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155305999|NCT01820260|560551254|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306000|NCT01820260|560551255|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306001|NCT01820260|560551256|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306002|NCT01820260|560551257|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
155306003|NCT01820260|560551244|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306004|NCT01820260|560551245|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306005|NCT01820260|560551246|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306006|NCT01820260|560551247|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306007|NCT01820260|560551248|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306008|NCT01820260|560551249|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306009|NCT01820260|560551250|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306010|NCT01820260|560551251|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306011|NCT01820260|560551252|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306012|NCT01820260|560551253|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
155306013|NCT01820260|560551254|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306014|NCT01820260|560551255|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306015|NCT01820260|560551256|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306016|NCT01820260|560551257|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
155306017|NCT05444192|560551258|FG000|Overall Study|Lost to Follow-up|1|||
155306018|NCT05444192|560551259|FG001|Overall Study|Lost to Follow-up|0|||
155306019|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
155306020|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
155306021|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
155306022|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
155306023|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
155306024|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
155306025|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306026|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306027|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306028|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
155306029|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
155306030|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306031|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306032|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306033|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
155306034|NCT04424927|560551264|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
154958967|NCT01900626|559276876|FG001|Overall Study|study was closed due to low enrollment|1|||
154958968|NCT03181594|559276877|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
154958969|NCT03181594|559276877|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
154958970|NCT03181594|559276877|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
154958971|NCT03181594|559276877|FG000|Initial Study Protocol (12-month FU)|Death|1|||
155306035|NCT04424927|560551265|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306036|NCT04424927|560551266|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306037|NCT04424927|560551267|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306038|NCT04424927|560551268|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
155306039|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
155306040|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
155306041|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
155306042|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
155306043|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
155306044|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
155306045|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
155306046|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
155306047|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
155306048|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
155306049|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
155306050|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
155306051|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
155306052|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
155306053|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
155306054|NCT04424927|560551264|FG000|Double-blind Period (24 Weeks)|Other|0|||
155306055|NCT04424927|560551265|FG001|Double-blind Period (24 Weeks)|Other|1|||
155306056|NCT04424927|560551266|FG002|Double-blind Period (24 Weeks)|Other|3|||
155306057|NCT04424927|560551267|FG003|Double-blind Period (24 Weeks)|Other|1|||
155306058|NCT04424927|560551268|FG004|Double-blind Period (24 Weeks)|Other|0|||
155306059|NCT00894543|560551272|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
155306060|NCT00894543|560551273|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
155306061|NCT00894543|560551272|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
155306062|NCT00894543|560551273|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
155306063|NCT04048681|560551274|FG000|Overall Study|family emergency|0|||
155306064|NCT04048681|560551275|FG001|Overall Study|family emergency|0|||
155306065|NCT04048681|560551276|FG002|Overall Study|family emergency|0|||
155306066|NCT04048681|560551277|FG003|Overall Study|family emergency|1|||
155306067|NCT04048681|560551278|FG004|Overall Study|family emergency|0|||
155306068|NCT03380390|560551279|FG000|Overall Study|Adverse Event|3|||
155306069|NCT02886286|560551280|FG000|Overall Study|pump motor stall|0|||
155306070|NCT02886286|560551281|FG001|Overall Study|pump motor stall|1|||
155306071|NCT01771731|560551282|FG000|Overall Study|Physician Decision|1|||
155306072|NCT01771731|560551283|FG001|Overall Study|Physician Decision|0|||
155306073|NCT01771731|560551282|FG000|Overall Study|Protocol Violation|0|||
155306074|NCT01771731|560551283|FG001|Overall Study|Protocol Violation|1|||
155306075|NCT01771731|560551282|FG000|Overall Study|Adverse event: Pain Crisis|1|||
155306076|NCT01771731|560551283|FG001|Overall Study|Adverse event: Pain Crisis|1|||
155306077|NCT00976495|560551284|FG000|Overall Study|Withdrawal by Subject|0|||
155306078|NCT00976495|560551285|FG001|Overall Study|Withdrawal by Subject|1|||
154958972|NCT03181594|559276877|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
154958973|NCT03181594|559276877|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
154958974|NCT01200810|559276878|FG000|Overall Study|Physician Decision|1|||
155306079|NCT00976495|560551286|FG002|Overall Study|Withdrawal by Subject|0|||
155306080|NCT05321069|560551287|FG000|Overall Study|Adverse Event|52|||
155306081|NCT05321069|560551288|FG001|Overall Study|Adverse Event|52|||
155306082|NCT05321069|560551289|FG002|Overall Study|Adverse Event|64|||
155306083|NCT05321069|560551287|FG000|Overall Study|Protocol Violation|1|||
155306084|NCT05321069|560551288|FG001|Overall Study|Protocol Violation|1|||
155306085|NCT05321069|560551289|FG002|Overall Study|Protocol Violation|0|||
155306086|NCT05321069|560551287|FG000|Overall Study|Withdrawal by Subject|23|||
155306087|NCT05321069|560551288|FG001|Overall Study|Withdrawal by Subject|18|||
155306088|NCT05321069|560551289|FG002|Overall Study|Withdrawal by Subject|12|||
155306089|NCT05321069|560551287|FG000|Overall Study|Lost to Follow-up|1|||
155306090|NCT05321069|560551288|FG001|Overall Study|Lost to Follow-up|0|||
155306091|NCT05321069|560551289|FG002|Overall Study|Lost to Follow-up|1|||
155306092|NCT05321069|560551287|FG000|Overall Study|No reason stated by the participants|23|||
155306093|NCT05321069|560551288|FG001|Overall Study|No reason stated by the participants|22|||
155306094|NCT05321069|560551289|FG002|Overall Study|No reason stated by the participants|16|||
155306095|NCT05321069|560551287|FG000|Overall Study|Lack of Efficacy|1|||
155306096|NCT05321069|560551288|FG001|Overall Study|Lack of Efficacy|1|||
155306097|NCT05321069|560551289|FG002|Overall Study|Lack of Efficacy|0|||
155306098|NCT01044303|560551292|FG000|Overall Study|Lost to Follow-up|2|||
155306099|NCT01609218|560551293|FG000|Period 1|Adverse Event|3|||
155306100|NCT01609218|560551294|FG001|Period 1|Adverse Event|5|||
155306101|NCT01609218|560551293|FG000|Period 1|Sponsor Decision|0|||
155306102|NCT01609218|560551294|FG001|Period 1|Sponsor Decision|1|||
155306103|NCT01609218|560551293|FG000|Period 2|Adverse Event|1|||
155306104|NCT01609218|560551294|FG001|Period 2|Adverse Event|0|||
155306105|NCT00774852|560551297|FG000|Overall Study|Adverse Event|9|||
155306106|NCT00774852|560551298|FG001|Overall Study|Adverse Event|6|||
154958975|NCT01200810|559276879|FG001|Overall Study|Physician Decision|0|||
154958976|NCT01200810|559276878|FG000|Overall Study|Withdrawal by Subject|1|||
154958977|NCT01200810|559276879|FG001|Overall Study|Withdrawal by Subject|2|||
154958978|NCT01200810|559276878|FG000|Overall Study|Sponsor stopped making study drug|3|||
155306107|NCT00774852|560551297|FG000|Overall Study|Death|2|||
154958979|NCT01200810|559276879|FG001|Overall Study|Sponsor stopped making study drug|3|||
155306108|NCT00774852|560551298|FG001|Overall Study|Death|1|||
155306109|NCT00774852|560551297|FG000|Overall Study|Lack of Efficacy|3|||
155306110|NCT00774852|560551298|FG001|Overall Study|Lack of Efficacy|7|||
155306111|NCT00774852|560551297|FG000|Overall Study|Lost to Follow-up|9|||
155306112|NCT00774852|560551298|FG001|Overall Study|Lost to Follow-up|5|||
155306113|NCT00774852|560551297|FG000|Overall Study|Physician Decision|2|||
155306114|NCT00774852|560551298|FG001|Overall Study|Physician Decision|6|||
154958980|NCT00003659|559276881|FG000|Overall Study|Withdrawal by Subject|3|||
154958981|NCT00723710|559276882|FG000|Overall Study|Disease progression|48|||
155306115|NCT00774852|560551297|FG000|Overall Study|Pregnancy|1|||
155306116|NCT00774852|560551298|FG001|Overall Study|Pregnancy|2|||
155306117|NCT00774852|560551297|FG000|Overall Study|Withdrawal by Subject|2|||
155306118|NCT00774852|560551298|FG001|Overall Study|Withdrawal by Subject|2|||
155306119|NCT00774852|560551297|FG000|Overall Study|Non-responder|15|||
155306120|NCT00774852|560551298|FG001|Overall Study|Non-responder|11|||
155306121|NCT00774852|560551297|FG000|Overall Study|Subject non-compliance|0|||
155306122|NCT00774852|560551298|FG001|Overall Study|Subject non-compliance|1|||
155306123|NCT00774852|560551297|FG000|Overall Study|Protocol Violation|1|||
155306124|NCT00774852|560551298|FG001|Overall Study|Protocol Violation|0|||
155306125|NCT00774852|560551297|FG000|Overall Study|Subject received prohibited medication|1|||
155306126|NCT00774852|560551298|FG001|Overall Study|Subject received prohibited medication|0|||
155306127|NCT04428112|560551299|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
155306128|NCT04428112|560551300|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
155306129|NCT04428112|560551299|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
155306130|NCT04428112|560551300|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
155306131|NCT04428112|560551299|FG000|Overall Study|Withdrawal by Subject|9|||
155306132|NCT04428112|560551300|FG001|Overall Study|Withdrawal by Subject|4|||
155306133|NCT04428112|560551299|FG000|Overall Study|Lost to Follow-up|27|||
155306134|NCT04428112|560551300|FG001|Overall Study|Lost to Follow-up|7|||
155306135|NCT02807779|560551302|FG000|Overall Study|Lost to Follow-up|1|||
155306136|NCT02807779|560551303|FG001|Overall Study|Lost to Follow-up|0|||
155306137|NCT02807779|560551304|FG002|Overall Study|Lost to Follow-up|0|||
155306138|NCT02807779|560551302|FG000|Overall Study|Physician Decision|2|||
155306139|NCT02807779|560551303|FG001|Overall Study|Physician Decision|0|||
155306140|NCT02807779|560551304|FG002|Overall Study|Physician Decision|1|||
155306141|NCT02807779|560551302|FG000|Overall Study|Death|1|||
155306142|NCT02807779|560551303|FG001|Overall Study|Death|1|||
155306143|NCT02807779|560551304|FG002|Overall Study|Death|0|||
155306144|NCT03582722|560551305|FG000|Overall Study|Lost to Follow-up|1|||
155306145|NCT03582722|560551306|FG001|Overall Study|Lost to Follow-up|4|||
155306146|NCT03582722|560551305|FG000|Overall Study|Withdrawal by Subject|3|||
155306147|NCT03582722|560551306|FG001|Overall Study|Withdrawal by Subject|3|||
155306148|NCT06024174|560551307|FG000|Overall Study|Other Reasons|1|||
155306149|NCT06024174|560551307|FG000|Overall Study|Study terminated by Sponsor|4|||
155306150|NCT01649271|560553310|FG000|Overall Study|Progressive disease|4|||
155306151|NCT01649271|560553311|FG001|Overall Study|Progressive disease|5|||
155306152|NCT01649271|560553310|FG000|Overall Study|Other Adverse Event|0|||
155306153|NCT01649271|560553311|FG001|Overall Study|Other Adverse Event|2|||
155306154|NCT01649271|560553310|FG000|Overall Study|Withdrawal by Subject|1|||
155306155|NCT01649271|560553311|FG001|Overall Study|Withdrawal by Subject|0|||
155306156|NCT01649271|560553310|FG000|Overall Study|Other than stated above|1|||
155306157|NCT01649271|560553311|FG001|Overall Study|Other than stated above|0|||
155306158|NCT05644002|560553312|FG000|Overall Study|Lost to Follow-up|1|||
155306159|NCT05644002|560553313|FG001|Overall Study|Lost to Follow-up|2|||
155306160|NCT05644002|560553312|FG000|Overall Study|Withdrawal by Subject|0|||
155306161|NCT05644002|560553313|FG001|Overall Study|Withdrawal by Subject|1|||
155306162|NCT04038957|560553316|FG000|Overall Study|Withdrawal by Subject|1|||
155306163|NCT04038957|560553316|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
155306164|NCT03913195|560553317|FG000|Overall Study|Adverse Event|0|||
155306165|NCT03913195|560553318|FG001|Overall Study|Adverse Event|0|||
154958982|NCT00723710|559276882|FG000|Overall Study|Adverse Event|88|||
155306166|NCT03913195|560553319|FG002|Overall Study|Adverse Event|1|||
155306167|NCT03913195|560553320|FG003|Overall Study|Adverse Event|1|||
155306168|NCT03913195|560553321|FG004|Overall Study|Adverse Event|0|||
155306169|NCT03913195|560553317|FG000|Overall Study|Withdrawal by Subject|0|||
155306170|NCT03913195|560553318|FG001|Overall Study|Withdrawal by Subject|0|||
155306171|NCT03913195|560553319|FG002|Overall Study|Withdrawal by Subject|1|||
155306172|NCT03913195|560553320|FG003|Overall Study|Withdrawal by Subject|0|||
155306173|NCT03913195|560553321|FG004|Overall Study|Withdrawal by Subject|1|||
155306174|NCT03913195|560553317|FG000|Overall Study|non adherence to study|0|||
155306175|NCT03913195|560553318|FG001|Overall Study|non adherence to study|0|||
155306176|NCT03913195|560553319|FG002|Overall Study|non adherence to study|1|||
155306177|NCT03913195|560553320|FG003|Overall Study|non adherence to study|0|||
155306178|NCT03913195|560553321|FG004|Overall Study|non adherence to study|0|||
155306179|NCT04840199|560553322|FG000|Overall Study|Study Terminated by Sponsor|8|||
155306180|NCT04840199|560553323|FG001|Overall Study|Study Terminated by Sponsor|9|||
155306181|NCT04840199|560553322|FG000|Overall Study|Lost to Follow-up|0|||
155306182|NCT04840199|560553323|FG001|Overall Study|Lost to Follow-up|2|||
155306183|NCT04840199|560553322|FG000|Overall Study|Withdrawal by Subject|2|||
155306184|NCT04840199|560553323|FG001|Overall Study|Withdrawal by Subject|0|||
155306185|NCT04840199|560553322|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
155306186|NCT04840199|560553323|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
155306187|NCT03857620|560553324|FG000|Overall Study|Death|4|||
155306188|NCT03857620|560553325|FG001|Overall Study|Death|5|||
155306189|NCT03857620|560553326|FG002|Overall Study|Death|7|||
155306190|NCT03857620|560553324|FG000|Overall Study|Lost to Follow-up|2|||
155306191|NCT03857620|560553325|FG001|Overall Study|Lost to Follow-up|5|||
155306192|NCT03857620|560553326|FG002|Overall Study|Lost to Follow-up|3|||
155306193|NCT03857620|560553324|FG000|Overall Study|Disease progression or relapse after study registration|1|||
155306194|NCT03857620|560553325|FG001|Overall Study|Disease progression or relapse after study registration|5|||
155306195|NCT03857620|560553326|FG002|Overall Study|Disease progression or relapse after study registration|1|||
155306196|NCT03857620|560553324|FG000|Overall Study|Ineligible|5|||
155306197|NCT03857620|560553325|FG001|Overall Study|Ineligible|0|||
155306198|NCT03857620|560553326|FG002|Overall Study|Ineligible|2|||
155306199|NCT03857620|560553324|FG000|Overall Study|No malignancy|1|||
155306200|NCT03857620|560553325|FG001|Overall Study|No malignancy|0|||
155306201|NCT03857620|560553326|FG002|Overall Study|No malignancy|1|||
155306202|NCT03857620|560553324|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
155306203|NCT03857620|560553325|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
155306204|NCT03857620|560553326|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
155306205|NCT03857620|560553324|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
155306206|NCT03857620|560553325|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
155306207|NCT03857620|560553326|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
155306208|NCT03857620|560553324|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
155306209|NCT03857620|560553325|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
155065556|NCT04880850|559670008|FG001|Overall Study|Lost to Follow-up|6|||
155306210|NCT03857620|560553326|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
155306211|NCT03857620|560553324|FG000|Overall Study|Surgery not performed, patient decision|0|||
155306212|NCT03857620|560553325|FG001|Overall Study|Surgery not performed, patient decision|3|||
155306213|NCT03857620|560553326|FG002|Overall Study|Surgery not performed, patient decision|1|||
155306214|NCT03857620|560553324|FG000|Overall Study|Surgery not performed, other reason|3|||
155306215|NCT03857620|560553325|FG001|Overall Study|Surgery not performed, other reason|1|||
155306216|NCT03857620|560553326|FG002|Overall Study|Surgery not performed, other reason|4|||
155306217|NCT03857620|560553324|FG000|Overall Study|Worsening performance status after surgery performed|0|||
155306218|NCT03857620|560553325|FG001|Overall Study|Worsening performance status after surgery performed|1|||
155306219|NCT03857620|560553326|FG002|Overall Study|Worsening performance status after surgery performed|1|||
155306220|NCT03271151|560553327|FG000|Overall Study|Lost to Follow-up|1|||
155306221|NCT03271151|560553328|FG001|Overall Study|Lost to Follow-up|3|||
155306222|NCT03271151|560553327|FG000|Overall Study|Withdrawal by Subject|1|||
155306223|NCT03271151|560553328|FG001|Overall Study|Withdrawal by Subject|0|||
155306224|NCT02201108|560553331|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
155306225|NCT02201108|560553332|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
155306226|NCT02201108|560553333|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
155306227|NCT02201108|560553331|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
155306228|NCT02201108|560553332|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
155306229|NCT02201108|560553333|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
155306230|NCT02201108|560553331|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
155306231|NCT02201108|560553332|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
155306232|NCT02201108|560553333|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
155306233|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
155306234|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
155306235|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
155306236|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
155306237|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
155306238|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
155306239|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Other reason|4|||
155306240|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Other reason|7|||
155306241|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Other reason|0|||
155306242|NCT02201108|560553331|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
155306243|NCT02201108|560553332|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
155306244|NCT02201108|560553333|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
155306245|NCT02201108|560553331|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
155306246|NCT02201108|560553332|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
155306247|NCT02201108|560553333|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
155306248|NCT02201108|560553331|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
155306249|NCT02201108|560553332|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
155306250|NCT02201108|560553333|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
155306251|NCT04118452|560553334|FG000|Overall Study|Lost to Follow-up|5|||
155306252|NCT04118452|560553335|FG001|Overall Study|Lost to Follow-up|5|||
155306253|NCT04118452|560553334|FG000|Overall Study|Withdrawal by Subject|17|||
155306254|NCT04118452|560553335|FG001|Overall Study|Withdrawal by Subject|17|||
155306255|NCT03438188|560553336|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
155306256|NCT03438188|560553337|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
154958983|NCT00723710|559276882|FG000|Overall Study|Withdrawal by Subject|36|||
154958984|NCT00723710|559276882|FG000|Overall Study|Physician Decision|2|||
154958985|NCT04405570|559276883|FG000|Overall Study|Adverse Event|0|||
154958986|NCT04405570|559276884|FG001|Overall Study|Adverse Event|1|||
154958987|NCT04405570|559276885|FG002|Overall Study|Adverse Event|1|||
154958988|NCT04405570|559276886|FG003|Overall Study|Adverse Event|1|||
154958989|NCT04405570|559276883|FG000|Overall Study|Lost to Follow-up|0|||
154958990|NCT04405570|559276884|FG001|Overall Study|Lost to Follow-up|1|||
155161172|NCT03722238|560026772|FG001|Overall Study|Withdrawal by Subject|0|||
155161173|NCT03722238|560026771|FG000|Overall Study|Other|4|||
155161174|NCT03722238|560026772|FG001|Overall Study|Other|0|||
155161175|NCT03722238|560026771|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
155161176|NCT03722238|560026772|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
155161177|NCT03722238|560026771|FG000|Overall Study|Did not meet risk classification group criteria|90|||
155161178|NCT03722238|560026772|FG001|Overall Study|Did not meet risk classification group criteria|0|||
155161179|NCT03722238|560026771|FG000|Overall Study|Did not sign consent|17|||
155161180|NCT03722238|560026772|FG001|Overall Study|Did not sign consent|0|||
155161181|NCT03722238|560026771|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
155161182|NCT03722238|560026772|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
155161183|NCT03722238|560026771|FG000|Overall Study|Not willing to purchase study medication|142|||
155161184|NCT03722238|560026772|FG001|Overall Study|Not willing to purchase study medication|0|||
155161185|NCT03722238|560026771|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
155306257|NCT03438188|560553338|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
155306258|NCT03438188|560553336|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
155306259|NCT03438188|560553337|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
155306260|NCT03438188|560553338|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
155306261|NCT03438188|560553336|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
155306262|NCT03438188|560553337|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
155306263|NCT03438188|560553338|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
155306264|NCT03438188|560553336|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
155306265|NCT03438188|560553337|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
155306266|NCT03438188|560553338|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
155306267|NCT03438188|560553336|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
155306268|NCT03438188|560553337|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
155306269|NCT03438188|560553338|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
155306270|NCT05215847|560553339|FG000|Overall Study|Lost to Follow-up|1|||
155306271|NCT03433339|560553340|FG000|Overall Study|Lost to Follow-up|2|||
155306272|NCT03433339|560553341|FG001|Overall Study|Lost to Follow-up|0|||
155306273|NCT03433339|560553340|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
155306274|NCT03433339|560553341|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
155306275|NCT03433339|560553340|FG000|Overall Study|Withdrawal by Subject|0|||
155306276|NCT03433339|560553341|FG001|Overall Study|Withdrawal by Subject|2|||
155306277|NCT00150813|560553356|FG000|Overall Study|Adverse Event|1|||
155306278|NCT00150813|560553356|FG000|Overall Study|Lack of Efficacy|1|||
155306279|NCT00150813|560553356|FG000|Overall Study|Lost to Follow-up|5|||
155306280|NCT00150813|560553356|FG000|Overall Study|Withdrawal by Subject|5|||
155306281|NCT00150813|560553356|FG000|Overall Study|Remission|3|||
155306282|NCT00150813|560553356|FG000|Overall Study|Planned pregancy|1|||
155306283|NCT00150813|560553356|FG000|Overall Study|Switch to commercially available LEV|2|||
155306284|NCT01046136|560553364|FG000|Overall Study|Withdrawal by Subject|0|||
155306285|NCT01046136|560553365|FG001|Overall Study|Withdrawal by Subject|4|||
155306286|NCT01046136|560553364|FG000|Overall Study|Physician Decision|1|||
155306287|NCT01046136|560553365|FG001|Overall Study|Physician Decision|1|||
155306288|NCT01046136|560553364|FG000|Overall Study|Lost to Follow-up|3|||
155306289|NCT01046136|560553365|FG001|Overall Study|Lost to Follow-up|3|||
155306290|NCT04579250|560553366|FG000|Overall Study|Withdrawal by Subject|1|||
155306291|NCT04579250|560553367|FG001|Overall Study|Withdrawal by Subject|1|||
155306292|NCT04579250|560553368|FG002|Overall Study|Withdrawal by Subject|0|||
155306293|NCT04579250|560553366|FG000|Overall Study|Lost to Follow-up|1|||
155306294|NCT04579250|560553367|FG001|Overall Study|Lost to Follow-up|1|||
155306295|NCT04579250|560553368|FG002|Overall Study|Lost to Follow-up|0|||
155306296|NCT04579250|560553366|FG000|Overall Study|Moved from area|0|||
155306297|NCT04579250|560553367|FG001|Overall Study|Moved from area|1|||
155306298|NCT04579250|560553368|FG002|Overall Study|Moved from area|2|||
155306299|NCT02919449|560553369|FG000|Overall Study|Withdrawal by Subject|1|||
155306300|NCT02919449|560553369|FG000|Overall Study|Investigator decision|1|||
155306301|NCT02058108|560553370|FG000|Overall Study|Abnormal Laboratory Values|0|||
155306302|NCT02058108|560553371|FG001|Overall Study|Abnormal Laboratory Values|1|||
155306303|NCT02058108|560553370|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
155306304|NCT02058108|560553371|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155306305|NCT02058108|560553370|FG000|Overall Study|No longer requires study drug|0|||
155306306|NCT02058108|560553371|FG001|Overall Study|No longer requires study drug|1|||
155306307|NCT02058108|560553370|FG000|Overall Study|Withdrawal by Subject|1|||
154958991|NCT04405570|559276885|FG002|Overall Study|Lost to Follow-up|0|||
155306308|NCT02058108|560553371|FG001|Overall Study|Withdrawal by Subject|0|||
155306309|NCT02058108|560553370|FG000|Overall Study|Administrative problems|3|||
155306310|NCT02058108|560553371|FG001|Overall Study|Administrative problems|3|||
155306311|NCT02058108|560553370|FG000|Overall Study|Protocol Violation|0|||
154958992|NCT04405570|559276886|FG003|Overall Study|Lost to Follow-up|0|||
155306312|NCT02058108|560553371|FG001|Overall Study|Protocol Violation|1|||
155306313|NCT01376700|560553375|FG000|Overall Study|Sponsor terminated study early|8|||
155306314|NCT01376700|560553375|FG000|Overall Study|Low or high titer inhibitor|8|||
155306315|NCT00727909|560553376|FG000|Overall Study|Withdrawal by Subject|5|||
155306316|NCT00727909|560553377|FG001|Overall Study|Withdrawal by Subject|11|||
155306317|NCT00727909|560553378|FG002|Overall Study|Withdrawal by Subject|8|||
155306318|NCT00727909|560553379|FG003|Overall Study|Withdrawal by Subject|5|||
155306319|NCT00727909|560553376|FG000|Overall Study|Death|0|||
155306320|NCT00727909|560553377|FG001|Overall Study|Death|0|||
155306321|NCT00727909|560553378|FG002|Overall Study|Death|1|||
155306322|NCT00727909|560553379|FG003|Overall Study|Death|0|||
155306323|NCT01696773|560553380|FG000|Days 15-27, Washout|Adverse Event|1|||
155306324|NCT01696773|560553381|FG001|Days 15-27, Washout|Adverse Event|0|||
155306325|NCT05623345|560553390|FG000|Overall Study|Withdrawal by Subject|14|||
155306326|NCT05623345|560553391|FG001|Overall Study|Withdrawal by Subject|0|||
155306327|NCT05623345|560553392|FG002|Overall Study|Withdrawal by Subject|9|||
155306328|NCT05623345|560553393|FG003|Overall Study|Withdrawal by Subject|20|||
155306329|NCT05623345|560553390|FG000|Overall Study|Lost to Follow-up|3|||
155306330|NCT05623345|560553391|FG001|Overall Study|Lost to Follow-up|0|||
155306331|NCT05623345|560553392|FG002|Overall Study|Lost to Follow-up|7|||
155306332|NCT05623345|560553393|FG003|Overall Study|Lost to Follow-up|2|||
155306333|NCT05623345|560553390|FG000|Overall Study|Termination of Study By Sponsor|37|||
155306334|NCT05623345|560553391|FG001|Overall Study|Termination of Study By Sponsor|4|||
155306335|NCT05623345|560553392|FG002|Overall Study|Termination of Study By Sponsor|40|||
155306336|NCT05623345|560553393|FG003|Overall Study|Termination of Study By Sponsor|38|||
155306337|NCT00411151|560553394|FG000|Overall Study|Death|38|||
155306338|NCT00411151|560553394|FG000|Overall Study|Withdrawal by Subject|2|||
155306339|NCT00411151|560553394|FG000|Overall Study|Lost to Follow-up|2|||
155306340|NCT00411151|560553394|FG000|Overall Study|Protocol Violation|1|||
155306341|NCT00411151|560553394|FG000|Overall Study|Trial prematurely closed|4|||
155306342|NCT02374307|560553404|FG000|3-months Follow-up|Lost to Follow-up|1|||
155306343|NCT02374307|560553405|FG001|3-months Follow-up|Lost to Follow-up|2|||
155306344|NCT02374307|560553404|FG000|3-months Follow-up|Withdrawal by Subject|1|||
155306345|NCT02374307|560553405|FG001|3-months Follow-up|Withdrawal by Subject|4|||
155306346|NCT02374307|560553404|FG000|3-months Follow-up|Death|1|||
155306347|NCT02374307|560553405|FG001|3-months Follow-up|Death|2|||
155306348|NCT02374307|560553404|FG000|3-months Follow-up|Missed first follow-up|5|||
155306349|NCT02374307|560553405|FG001|3-months Follow-up|Missed first follow-up|1|||
155306350|NCT02374307|560553404|FG000|6-months Follow-up|Lost to Follow-up|1|||
155306351|NCT02374307|560553405|FG001|6-months Follow-up|Lost to Follow-up|2|||
155306352|NCT02374307|560553404|FG000|6-months Follow-up|Death|2|||
155306353|NCT02374307|560553405|FG001|6-months Follow-up|Death|1|||
155306354|NCT02374307|560553404|FG000|6-months Follow-up|Withdrawal by Subject|0|||
155306355|NCT02374307|560553405|FG001|6-months Follow-up|Withdrawal by Subject|3|||
155306356|NCT04452318|560553406|FG000|Overall Study|Physician Decision|1|||
155306357|NCT04452318|560553407|FG001|Overall Study|Physician Decision|2|||
155306358|NCT04452318|560553408|FG002|Overall Study|Physician Decision|0|||
155306359|NCT04452318|560553409|FG003|Overall Study|Physician Decision|2|||
155306360|NCT04452318|560553410|FG004|Overall Study|Physician Decision|0|||
155306361|NCT04452318|560553411|FG005|Overall Study|Physician Decision|2|||
155306362|NCT04452318|560553412|FG006|Overall Study|Physician Decision|5|||
155306363|NCT04452318|560553406|FG000|Overall Study|Death|2|||
155306364|NCT04452318|560553407|FG001|Overall Study|Death|3|||
155306365|NCT04452318|560553408|FG002|Overall Study|Death|0|||
155306366|NCT04452318|560553409|FG003|Overall Study|Death|0|||
155306367|NCT04452318|560553410|FG004|Overall Study|Death|0|||
155306368|NCT04452318|560553411|FG005|Overall Study|Death|0|||
155306369|NCT04452318|560553412|FG006|Overall Study|Death|0|||
155306370|NCT04452318|560553406|FG000|Overall Study|Lost to Follow-up|38|||
155306371|NCT04452318|560553407|FG001|Overall Study|Lost to Follow-up|28|||
155306372|NCT04452318|560553408|FG002|Overall Study|Lost to Follow-up|0|||
155306373|NCT04452318|560553409|FG003|Overall Study|Lost to Follow-up|3|||
155306374|NCT04452318|560553410|FG004|Overall Study|Lost to Follow-up|3|||
155306375|NCT04452318|560553411|FG005|Overall Study|Lost to Follow-up|2|||
155306376|NCT04452318|560553412|FG006|Overall Study|Lost to Follow-up|1|||
155306377|NCT04452318|560553406|FG000|Overall Study|Withdrawal by Subject|46|||
155306378|NCT04452318|560553407|FG001|Overall Study|Withdrawal by Subject|40|||
155306379|NCT04452318|560553408|FG002|Overall Study|Withdrawal by Subject|0|||
155306380|NCT04452318|560553409|FG003|Overall Study|Withdrawal by Subject|18|||
155306381|NCT04452318|560553410|FG004|Overall Study|Withdrawal by Subject|6|||
155306382|NCT04452318|560553411|FG005|Overall Study|Withdrawal by Subject|8|||
155306383|NCT04452318|560553412|FG006|Overall Study|Withdrawal by Subject|6|||
155306384|NCT02638337|560553413|FG000|Overall Study|Adverse Event|6|||
155306385|NCT02638337|560553414|FG001|Overall Study|Adverse Event|10|||
155306386|NCT02638337|560553413|FG000|Overall Study|Protocol Violation|3|||
155306387|NCT02638337|560553414|FG001|Overall Study|Protocol Violation|0|||
155306388|NCT02638337|560553413|FG000|Overall Study|Withdrawal by Subject|13|||
155306389|NCT02638337|560553414|FG001|Overall Study|Withdrawal by Subject|16|||
155306390|NCT02638337|560553413|FG000|Overall Study|Lost to Follow-up|7|||
155306391|NCT02638337|560553414|FG001|Overall Study|Lost to Follow-up|7|||
155306392|NCT02638337|560553413|FG000|Overall Study|Other - Miscellaneous|4|||
155306393|NCT02638337|560553414|FG001|Overall Study|Other - Miscellaneous|3|||
155306394|NCT00604669|560553415|FG000|Overall Study|lack of information in chart|7|||
155306395|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Adverse Event|4|||
155306396|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Adverse Event|1|||
155306397|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
155306398|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
155306399|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
155306400|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
155306401|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
155306402|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
155306403|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
155306404|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
155306405|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Other|6|||
155306406|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Other|1|||
155306407|NCT03271489|560553421|FG000|Double-Blind (DB) Period|Missing|1|||
155306408|NCT03271489|560553422|FG001|Double-Blind (DB) Period|Missing|0|||
155306409|NCT03271489|560553421|FG000|Open-Label (OL) Period|Adverse Event|2|||
155306410|NCT03271489|560553422|FG001|Open-Label (OL) Period|Adverse Event|0|||
155306411|NCT03271489|560553421|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
155306412|NCT03271489|560553422|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
155306413|NCT03271489|560553421|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
155306414|NCT03271489|560553422|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
155306415|NCT03271489|560553421|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
155306416|NCT03271489|560553422|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
155306417|NCT03271489|560553421|FG000|Open-Label (OL) Period|No Specified|2|||
155306418|NCT03271489|560553422|FG001|Open-Label (OL) Period|No Specified|2|||
155306419|NCT03271489|560553421|FG000|Open-Label (OL) Period|Missing|2|||
155306420|NCT03271489|560553422|FG001|Open-Label (OL) Period|Missing|0|||
155306421|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
155306422|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
155306423|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
155306424|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
155306425|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
155306426|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
155306427|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
155306428|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
155306429|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
155306430|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
155306431|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
155306432|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
155306433|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
155306434|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
155306435|NCT03271489|560553421|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
155306436|NCT03271489|560553422|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
155306437|NCT06061081|560553423|FG000|Overall Study|Withdrawal by Subject|1|||
155306438|NCT06061081|560553424|FG001|Overall Study|Withdrawal by Subject|0|||
155306439|NCT06061081|560553425|FG002|Overall Study|Withdrawal by Subject|0|||
155306440|NCT06061081|560553426|FG003|Overall Study|Withdrawal by Subject|0|||
155306441|NCT06061081|560553427|FG004|Overall Study|Withdrawal by Subject|0|||
155306442|NCT01127373|560553428|FG000|Overall Study|Not Treated|3|||
155306443|NCT01127373|560553428|FG000|Overall Study|Lost to Follow-up|7|||
155306444|NCT01127373|560553428|FG000|Overall Study|Withdrawal by Subject|1|||
155306445|NCT01127373|560553428|FG000|Overall Study|Disease progression|1|||
155306446|NCT05450458|560553429|FG000|Overall Study|Lost to Follow-up|4|||
155306447|NCT02965846|560553434|FG000|Overall Study|Lost to Follow-up|1|||
155306448|NCT02965846|560553435|FG001|Overall Study|Lost to Follow-up|0|||
155306449|NCT02965846|560553436|FG002|Overall Study|Lost to Follow-up|0|||
155306450|NCT02965846|560553434|FG000|Overall Study|Withdrawal by Subject|0|||
155306451|NCT02965846|560553435|FG001|Overall Study|Withdrawal by Subject|1|||
155306452|NCT02965846|560553436|FG002|Overall Study|Withdrawal by Subject|0|||
155306453|NCT02965846|560553434|FG000|Overall Study|Study Terminated By Sponsor|4|||
155306454|NCT02965846|560553435|FG001|Overall Study|Study Terminated By Sponsor|4|||
155306455|NCT02965846|560553436|FG002|Overall Study|Study Terminated By Sponsor|0|||
155306456|NCT02965846|560553434|FG000|Overall Study|Participants not randomized|0|||
155306457|NCT02965846|560553435|FG001|Overall Study|Participants not randomized|0|||
155306458|NCT02965846|560553436|FG002|Overall Study|Participants not randomized|33|||
155306459|NCT00539734|560553437|FG000|Overall Study|Protocol Violation|1|||
155306460|NCT02814838|560553438|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
155306461|NCT02814838|560553439|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
155306462|NCT02814838|560553438|FG000|Overall Study|Consent withdrawal|1|||
155306463|NCT02814838|560553439|FG001|Overall Study|Consent withdrawal|1|||
155306464|NCT00073749|560553440|FG000|Overall Study|Disease Progression|2|||
155306465|NCT00073749|560553441|FG001|Overall Study|Disease Progression|0|||
155306466|NCT00073749|560553442|FG002|Overall Study|Disease Progression|3|||
155306467|NCT00073749|560553443|FG003|Overall Study|Disease Progression|2|||
155306468|NCT00073749|560553444|FG004|Overall Study|Disease Progression|3|||
155306469|NCT00073749|560553445|FG005|Overall Study|Disease Progression|1|||
155306470|NCT00073749|560553446|FG006|Overall Study|Disease Progression|3|||
155306471|NCT00073749|560553440|FG000|Overall Study|Death|0|||
155306472|NCT00073749|560553441|FG001|Overall Study|Death|1|||
155306473|NCT00073749|560553442|FG002|Overall Study|Death|1|||
155306474|NCT00073749|560553443|FG003|Overall Study|Death|0|||
155306475|NCT00073749|560553444|FG004|Overall Study|Death|0|||
155306476|NCT00073749|560553445|FG005|Overall Study|Death|0|||
155306477|NCT00073749|560553446|FG006|Overall Study|Death|29|||
155306478|NCT00073749|560553440|FG000|Overall Study|Adverse Event|0|||
155306479|NCT00073749|560553441|FG001|Overall Study|Adverse Event|3|||
155306480|NCT00073749|560553442|FG002|Overall Study|Adverse Event|6|||
155306481|NCT00073749|560553443|FG003|Overall Study|Adverse Event|4|||
155306482|NCT00073749|560553444|FG004|Overall Study|Adverse Event|2|||
155306483|NCT00073749|560553445|FG005|Overall Study|Adverse Event|1|||
155306484|NCT00073749|560553446|FG006|Overall Study|Adverse Event|0|||
155306485|NCT00073749|560553440|FG000|Overall Study|Physician Decision|0|||
155306486|NCT00073749|560553441|FG001|Overall Study|Physician Decision|0|||
155306487|NCT00073749|560553442|FG002|Overall Study|Physician Decision|1|||
155306488|NCT00073749|560553443|FG003|Overall Study|Physician Decision|0|||
155306489|NCT00073749|560553444|FG004|Overall Study|Physician Decision|0|||
155306490|NCT00073749|560553445|FG005|Overall Study|Physician Decision|2|||
155306491|NCT00073749|560553446|FG006|Overall Study|Physician Decision|0|||
155306492|NCT00073749|560553440|FG000|Overall Study|Withdrawal by Subject|0|||
155306493|NCT00073749|560553441|FG001|Overall Study|Withdrawal by Subject|1|||
155306494|NCT00073749|560553442|FG002|Overall Study|Withdrawal by Subject|0|||
155306495|NCT00073749|560553443|FG003|Overall Study|Withdrawal by Subject|0|||
155306496|NCT00073749|560553444|FG004|Overall Study|Withdrawal by Subject|1|||
155306497|NCT00073749|560553445|FG005|Overall Study|Withdrawal by Subject|0|||
155306498|NCT00073749|560553446|FG006|Overall Study|Withdrawal by Subject|2|||
155306499|NCT00073749|560553440|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
155306500|NCT00073749|560553441|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155306501|NCT00073749|560553442|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
155306502|NCT00073749|560553443|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155306503|NCT00073749|560553444|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
155306504|NCT00073749|560553445|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
155306505|NCT00073749|560553446|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
155306506|NCT00073749|560553440|FG000|Overall Study|Lost to Follow-up|0|||
155306507|NCT00073749|560553441|FG001|Overall Study|Lost to Follow-up|0|||
155306508|NCT00073749|560553442|FG002|Overall Study|Lost to Follow-up|0|||
155306509|NCT00073749|560553443|FG003|Overall Study|Lost to Follow-up|0|||
155306510|NCT00073749|560553444|FG004|Overall Study|Lost to Follow-up|0|||
155306511|NCT00073749|560553445|FG005|Overall Study|Lost to Follow-up|0|||
155306512|NCT00073749|560553446|FG006|Overall Study|Lost to Follow-up|2|||
155306513|NCT00073749|560553440|FG000|Overall Study|Other|0|||
155306514|NCT00073749|560553441|FG001|Overall Study|Other|0|||
155306515|NCT00073749|560553442|FG002|Overall Study|Other|0|||
155306516|NCT00073749|560553443|FG003|Overall Study|Other|0|||
154958993|NCT04405570|559276883|FG000|Overall Study|Physician Decision|0|||
155306517|NCT00073749|560553444|FG004|Overall Study|Other|0|||
155306518|NCT00073749|560553445|FG005|Overall Study|Other|2|||
155306519|NCT00073749|560553446|FG006|Overall Study|Other|0|||
155306520|NCT04154384|560553447|FG000|Overall Study|Lost to Follow-up|24|||
155306521|NCT04154384|560553448|FG001|Overall Study|Lost to Follow-up|33|||
155306522|NCT04154384|560553449|FG002|Overall Study|Lost to Follow-up|0|||
155306523|NCT04154384|560553447|FG000|Overall Study|Withdrawal by Subject|7|||
155306524|NCT04154384|560553448|FG001|Overall Study|Withdrawal by Subject|18|||
155306525|NCT04154384|560553449|FG002|Overall Study|Withdrawal by Subject|0|||
155306526|NCT04154384|560553447|FG000|Overall Study|Missing outcome data|1|||
155306527|NCT04154384|560553448|FG001|Overall Study|Missing outcome data|0|||
155306528|NCT04154384|560553449|FG002|Overall Study|Missing outcome data|0|||
155306529|NCT01136876|560553450|FG000|Overall Study|Lost to Follow-up|0|||
155306530|NCT01136876|560553451|FG001|Overall Study|Lost to Follow-up|1|||
155306531|NCT01136876|560553450|FG000|Overall Study|Physician Decision|3|||
155306532|NCT01136876|560553451|FG001|Overall Study|Physician Decision|5|||
155065557|NCT04880850|559670007|FG000|Overall Study|Physician Decision|2|||
155065558|NCT04880850|559670008|FG001|Overall Study|Physician Decision|1|||
155065559|NCT04880850|559670007|FG000|Overall Study|Withdrawal by Subject|9|||
155065560|NCT04880850|559670008|FG001|Overall Study|Withdrawal by Subject|10|||
155065561|NCT02781324|559670009|FG000|Overall Study|Withdrawal by Subject|1|||
155065562|NCT02781324|559670010|FG001|Overall Study|Withdrawal by Subject|0|||
155306533|NCT01136876|560553450|FG000|Overall Study|Missing NGAL measurement|2|||
155306534|NCT01136876|560553451|FG001|Overall Study|Missing NGAL measurement|5|||
155306535|NCT04128319|560553452|FG000|Overall Study|Death|3|||
155306536|NCT04484935|560553453|FG000|Overall Study|Other|0|||
155306537|NCT04484935|560553454|FG001|Overall Study|Other|1|||
155306538|NCT04484935|560553453|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155306539|NCT04484935|560553454|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155306540|NCT04484935|560553453|FG000|Overall Study|Lost to Follow-up|1|||
155306541|NCT04484935|560553454|FG001|Overall Study|Lost to Follow-up|0|||
155306542|NCT04484935|560553453|FG000|Overall Study|Death|2|||
155306543|NCT04484935|560553454|FG001|Overall Study|Death|1|||
155306544|NCT04820686|560553455|FG000|Overall Study|Withdrawal by Subject|5|||
155306545|NCT04820686|560553456|FG001|Overall Study|Withdrawal by Subject|2|||
155306546|NCT04820686|560553457|FG002|Overall Study|Withdrawal by Subject|3|||
155306547|NCT04820686|560553455|FG000|Overall Study|Study Termination|25|||
155306548|NCT04820686|560553456|FG001|Overall Study|Study Termination|13|||
155306549|NCT04820686|560553457|FG002|Overall Study|Study Termination|14|||
155306550|NCT04820686|560553455|FG000|Overall Study|Adverse Event|0|||
155306551|NCT04820686|560553456|FG001|Overall Study|Adverse Event|1|||
155306552|NCT04820686|560553457|FG002|Overall Study|Adverse Event|0|||
155306553|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
155306554|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
155306555|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
155306556|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
155306557|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
155306558|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
155306559|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
155306560|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
155306561|NCT01424670|560553458|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
155306562|NCT01424670|560553459|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
155306563|NCT01424670|560553458|FG000|Continuation Period|Adverse Event|13|||
155306564|NCT01424670|560553459|FG001|Continuation Period|Adverse Event|5|||
155306565|NCT01424670|560553458|FG000|Continuation Period|Lost to Follow-up|2|||
155306566|NCT01424670|560553459|FG001|Continuation Period|Lost to Follow-up|0|||
155306567|NCT01424670|560553458|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
155306568|NCT01424670|560553459|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
155306569|NCT01424670|560553458|FG000|Continuation Period|Physician Decision|5|||
155306570|NCT01424670|560553459|FG001|Continuation Period|Physician Decision|4|||
155306571|NCT01424670|560553458|FG000|Continuation Period|Withdrawal by Subject|13|||
155306572|NCT01424670|560553459|FG001|Continuation Period|Withdrawal by Subject|4|||
155065563|NCT02781324|559670009|FG000|Overall Study|Physician Decision|1|||
155065564|NCT02781324|559670010|FG001|Overall Study|Physician Decision|2|||
155306573|NCT02759016|560553460|FG000|Overall Study|Not treated with BI 836826|1|||
155306574|NCT02759016|560553461|FG001|Overall Study|Not treated with BI 836826|0|||
155065565|NCT03570892|559670011|FG000|Overall Study|Death|51|||
155306575|NCT02759016|560553460|FG000|Overall Study|Progressive disease|1|||
155306576|NCT02759016|560553461|FG001|Overall Study|Progressive disease|0|||
155306577|NCT02759016|560553460|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
155306578|NCT02759016|560553461|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
155306579|NCT02759016|560553460|FG000|Overall Study|Other not defined above|2|||
155306580|NCT02759016|560553461|FG001|Overall Study|Other not defined above|1|||
155306581|NCT04377308|560553462|FG000|Overall Study|Withdrawal by Subject|0|||
155306582|NCT04377308|560553463|FG001|Overall Study|Withdrawal by Subject|1|||
155306583|NCT02891915|560553470|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
155306584|NCT02891915|560553471|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
155306585|NCT02891915|560553470|FG000|Overall Study|Withdrawal by Subject|3|||
155306586|NCT02891915|560553471|FG001|Overall Study|Withdrawal by Subject|3|||
155306587|NCT02891915|560553470|FG000|Overall Study|Became Ineligible After Enrollment|2|||
155306588|NCT02891915|560553471|FG001|Overall Study|Became Ineligible After Enrollment|1|||
155306589|NCT02891915|560553470|FG000|Overall Study|Lost to Follow-up|1|||
155306590|NCT02891915|560553471|FG001|Overall Study|Lost to Follow-up|4|||
155306591|NCT02891915|560553470|FG000|Overall Study|Physician Decision|1|||
155306592|NCT02891915|560553471|FG001|Overall Study|Physician Decision|0|||
155306593|NCT04048382|560553477|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
155306594|NCT04048382|560553478|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
155306595|NCT04048382|560553477|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
155306596|NCT04048382|560553478|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
155306597|NCT04048382|560553477|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
155306598|NCT04048382|560553478|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
155306599|NCT00709098|560553480|FG000|Double-blind Period|Withdrawal of consent|3|||
155306600|NCT00709098|560553481|FG001|Double-blind Period|Withdrawal of consent|3|||
155306601|NCT00709098|560553482|FG002|Double-blind Period|Withdrawal of consent|0|||
155306602|NCT00709098|560553480|FG000|Double-blind Period|Administrative reason|1|||
155306603|NCT00709098|560553481|FG001|Double-blind Period|Administrative reason|3|||
155306604|NCT00709098|560553482|FG002|Double-blind Period|Administrative reason|0|||
155306605|NCT00709098|560553480|FG000|Double-blind Period|Death|1|||
155306606|NCT00709098|560553481|FG001|Double-blind Period|Death|1|||
155306607|NCT00709098|560553482|FG002|Double-blind Period|Death|0|||
155306608|NCT00709098|560553480|FG000|Double-blind Period|Lost to Follow-up|1|||
155306609|NCT00709098|560553481|FG001|Double-blind Period|Lost to Follow-up|1|||
155306610|NCT00709098|560553482|FG002|Double-blind Period|Lost to Follow-up|0|||
155306611|NCT00709098|560553480|FG000|Open-label Period|Withdrawal of consent|0|||
155306612|NCT00709098|560553481|FG001|Open-label Period|Withdrawal of consent|0|||
155306613|NCT00709098|560553482|FG002|Open-label Period|Withdrawal of consent|7|||
155306614|NCT00709098|560553480|FG000|Open-label Period|Administrative reason|0|||
155306615|NCT00709098|560553481|FG001|Open-label Period|Administrative reason|0|||
155306616|NCT00709098|560553482|FG002|Open-label Period|Administrative reason|5|||
155306617|NCT00709098|560553480|FG000|Open-label Period|Death|0|||
155306618|NCT00709098|560553481|FG001|Open-label Period|Death|0|||
155306619|NCT00709098|560553482|FG002|Open-label Period|Death|1|||
155306620|NCT00709098|560553480|FG000|Open-label Period|Lost to Follow-up|0|||
155306621|NCT00709098|560553481|FG001|Open-label Period|Lost to Follow-up|0|||
155306622|NCT00709098|560553482|FG002|Open-label Period|Lost to Follow-up|1|||
155065566|NCT03570892|559670012|FG001|Overall Study|Death|45|||
155065567|NCT03570892|559670011|FG000|Overall Study|Subject decision|5|||
155065568|NCT03570892|559670012|FG001|Overall Study|Subject decision|3|||
155065569|NCT03570892|559670011|FG000|Overall Study|Protocol Violation|1|||
155306623|NCT02119650|560553484|FG000|Overall Study|Adverse Event|3|||
155306624|NCT02119650|560553485|FG001|Overall Study|Adverse Event|4|||
155306625|NCT02119650|560553484|FG000|Overall Study|Subject decision|2|||
155306626|NCT02119650|560553485|FG001|Overall Study|Subject decision|3|||
155306627|NCT02119650|560553484|FG000|Overall Study|Disease progression|11|||
155306628|NCT02119650|560553485|FG001|Overall Study|Disease progression|14|||
155306629|NCT02119650|560553484|FG000|Overall Study|Death|5|||
155306630|NCT02119650|560553485|FG001|Overall Study|Death|1|||
155306631|NCT02119650|560553484|FG000|Overall Study|Noncompliance with study treatment|1|||
155306632|NCT02119650|560553485|FG001|Overall Study|Noncompliance with study treatment|1|||
155306633|NCT02119650|560553484|FG000|Overall Study|Study terminated by the sponsor|1|||
155306634|NCT02119650|560553485|FG001|Overall Study|Study terminated by the sponsor|0|||
155306635|NCT02119650|560553484|FG000|Overall Study|Physician Decision|0|||
155306636|NCT02119650|560553485|FG001|Overall Study|Physician Decision|2|||
155306637|NCT02119650|560553484|FG000|Overall Study|Multiple reasons for termination|2|||
155306638|NCT02119650|560553485|FG001|Overall Study|Multiple reasons for termination|1|||
155306639|NCT04994509|560553487|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
155306640|NCT04994509|560553488|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
155065570|NCT03570892|559670012|FG001|Overall Study|Protocol Violation|4|||
155065571|NCT03570892|559670011|FG000|Overall Study|Physician Decision|0|||
155306641|NCT04994509|560553489|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
155306642|NCT04994509|560553487|FG000|Overall Study|Withdrew Consent|73|||
155306643|NCT04994509|560553488|FG001|Overall Study|Withdrew Consent|72|||
155306644|NCT04994509|560553489|FG002|Overall Study|Withdrew Consent|46|||
155306645|NCT04994509|560553487|FG000|Overall Study|Lost to Follow-up|39|||
155306646|NCT04994509|560553488|FG001|Overall Study|Lost to Follow-up|36|||
155306647|NCT04994509|560553489|FG002|Overall Study|Lost to Follow-up|26|||
155306648|NCT04994509|560553487|FG000|Overall Study|HIV-1 Infection|4|||
155306649|NCT04994509|560553488|FG001|Overall Study|HIV-1 Infection|20|||
155306650|NCT04994509|560553489|FG002|Overall Study|HIV-1 Infection|12|||
155306651|NCT04994509|560553487|FG000|Overall Study|Investigator's Discretion|9|||
155306652|NCT04994509|560553488|FG001|Overall Study|Investigator's Discretion|8|||
155306653|NCT04994509|560553489|FG002|Overall Study|Investigator's Discretion|11|||
155306654|NCT04994509|560553487|FG000|Overall Study|Randomized but Never Treated|10|||
155306655|NCT04994509|560553488|FG001|Overall Study|Randomized but Never Treated|10|||
155306656|NCT04994509|560553489|FG002|Overall Study|Randomized but Never Treated|3|||
155306657|NCT04994509|560553487|FG000|Overall Study|Pregnancy|5|||
155306658|NCT04994509|560553488|FG001|Overall Study|Pregnancy|5|||
155306659|NCT04994509|560553489|FG002|Overall Study|Pregnancy|0|||
155306660|NCT04994509|560553487|FG000|Overall Study|Death|0|||
155306661|NCT04994509|560553488|FG001|Overall Study|Death|5|||
155306662|NCT04994509|560553489|FG002|Overall Study|Death|0|||
155306663|NCT04994509|560553487|FG000|Overall Study|Adverse Event|2|||
155306664|NCT04994509|560553488|FG001|Overall Study|Adverse Event|1|||
155306665|NCT04994509|560553489|FG002|Overall Study|Adverse Event|0|||
155306666|NCT04994509|560553487|FG000|Overall Study|Non-compliance With Study Drug|1|||
155306667|NCT04994509|560553488|FG001|Overall Study|Non-compliance With Study Drug|1|||
155306668|NCT04994509|560553489|FG002|Overall Study|Non-compliance With Study Drug|1|||
155306669|NCT04994509|560553487|FG000|Overall Study|Withdrew Assent|3|||
155306670|NCT04994509|560553488|FG001|Overall Study|Withdrew Assent|0|||
155306671|NCT04994509|560553489|FG002|Overall Study|Withdrew Assent|0|||
155306672|NCT04994509|560553487|FG000|Overall Study|Protocol Violation|1|||
155306673|NCT04994509|560553488|FG001|Overall Study|Protocol Violation|0|||
155306674|NCT04994509|560553489|FG002|Overall Study|Protocol Violation|0|||
155306675|NCT04402294|560553490|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
155306676|NCT04402294|560553491|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
155306677|NCT04402294|560553490|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
155306678|NCT04402294|560553491|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
155306679|NCT04459416|560555864|FG000|Overall Study|Lost to Follow-up|2|||
155306680|NCT04459416|560555865|FG001|Overall Study|Lost to Follow-up|0|||
155306681|NCT04459416|560555864|FG000|Overall Study|Withdrawal by Subject|8|||
155306682|NCT04459416|560555865|FG001|Overall Study|Withdrawal by Subject|10|||
155306683|NCT04459416|560555864|FG000|Overall Study|Disease progression|0|||
155306684|NCT04459416|560555865|FG001|Overall Study|Disease progression|3|||
155306685|NCT03744312|560555866|FG000|Overall Study|Withdrawal by Subject|0|||
155306686|NCT03744312|560555867|FG001|Overall Study|Withdrawal by Subject|1|||
155306687|NCT03744312|560555866|FG000|Overall Study|Screen fail|0|||
155306688|NCT03744312|560555867|FG001|Overall Study|Screen fail|1|||
155306689|NCT05134337|560555868|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
155306690|NCT05134337|560555869|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
155306691|NCT03725722|560555870|FG000|Overall Study|Lack of Efficacy|2|||
155306692|NCT03725722|560555871|FG001|Overall Study|Lack of Efficacy|1|||
155306693|NCT03725722|560555872|FG002|Overall Study|Lack of Efficacy|2|||
155306694|NCT03725722|560555873|FG003|Overall Study|Lack of Efficacy|0|||
155306695|NCT03725722|560555874|FG004|Overall Study|Lack of Efficacy|2|||
155306696|NCT03725722|560555870|FG000|Overall Study|Adverse Event|2|||
155306697|NCT03725722|560555871|FG001|Overall Study|Adverse Event|2|||
155306698|NCT03725722|560555872|FG002|Overall Study|Adverse Event|1|||
155306699|NCT03725722|560555873|FG003|Overall Study|Adverse Event|0|||
155306700|NCT03725722|560555874|FG004|Overall Study|Adverse Event|6|||
155306701|NCT03725722|560555870|FG000|Overall Study|Withdrawal by Subject|4|||
155306702|NCT03725722|560555871|FG001|Overall Study|Withdrawal by Subject|1|||
155306703|NCT03725722|560555872|FG002|Overall Study|Withdrawal by Subject|0|||
155306704|NCT03725722|560555873|FG003|Overall Study|Withdrawal by Subject|4|||
155306705|NCT03725722|560555874|FG004|Overall Study|Withdrawal by Subject|4|||
155306706|NCT03725722|560555870|FG000|Overall Study|Lost to Follow-up|3|||
155306707|NCT03725722|560555871|FG001|Overall Study|Lost to Follow-up|1|||
155306708|NCT03725722|560555872|FG002|Overall Study|Lost to Follow-up|2|||
155306709|NCT03725722|560555873|FG003|Overall Study|Lost to Follow-up|2|||
155306710|NCT03725722|560555874|FG004|Overall Study|Lost to Follow-up|1|||
155306711|NCT03725722|560555870|FG000|Overall Study|Personal reasons|0|||
155306712|NCT03725722|560555871|FG001|Overall Study|Personal reasons|0|||
155306713|NCT03725722|560555872|FG002|Overall Study|Personal reasons|1|||
155306714|NCT03725722|560555873|FG003|Overall Study|Personal reasons|0|||
155306715|NCT03725722|560555874|FG004|Overall Study|Personal reasons|1|||
155306716|NCT03725722|560555870|FG000|Overall Study|COVID-19 situation|0|||
155306717|NCT03725722|560555871|FG001|Overall Study|COVID-19 situation|1|||
155306718|NCT03725722|560555872|FG002|Overall Study|COVID-19 situation|0|||
155306719|NCT03725722|560555873|FG003|Overall Study|COVID-19 situation|0|||
155306720|NCT03725722|560555874|FG004|Overall Study|COVID-19 situation|0|||
155306721|NCT01259401|560555878|FG000|4-month Follow-up|Death|0|||
155306722|NCT01259401|560555879|FG001|4-month Follow-up|Death|1|||
155306723|NCT01259401|560555878|FG000|4-month Follow-up|Lost to Follow-up|0|||
155306724|NCT01259401|560555879|FG001|4-month Follow-up|Lost to Follow-up|1|||
155306725|NCT03683069|560555880|FG000|Overall Study|see limitations|12|||
155306726|NCT03683069|560555881|FG001|Overall Study|see limitations|13|||
155306727|NCT05478525|560555884|FG000|Overall Study|Withdrawal by Subject|0|||
155306728|NCT05478525|560555885|FG001|Overall Study|Withdrawal by Subject|1|||
155306729|NCT05478525|560555886|FG002|Overall Study|Withdrawal by Subject|2|||
155306730|NCT05478525|560555887|FG003|Overall Study|Withdrawal by Subject|0|||
155306731|NCT05478525|560555884|FG000|Overall Study|COVID-19 Infection|2|||
155306732|NCT05478525|560555885|FG001|Overall Study|COVID-19 Infection|0|||
155306733|NCT05478525|560555886|FG002|Overall Study|COVID-19 Infection|1|||
155306734|NCT05478525|560555887|FG003|Overall Study|COVID-19 Infection|1|||
155306735|NCT01991977|560555890|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
155306736|NCT01991977|560555890|FG000|Overall Study|Withdrew after start of treatment|5|||
155306737|NCT03845465|560555892|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
154958994|NCT04405570|559276884|FG001|Overall Study|Physician Decision|0|||
154958995|NCT04405570|559276885|FG002|Overall Study|Physician Decision|1|||
154958996|NCT04405570|559276886|FG003|Overall Study|Physician Decision|0|||
154958997|NCT04405570|559276883|FG000|Overall Study|Withdrawal by Subject|0|||
154958998|NCT04405570|559276884|FG001|Overall Study|Withdrawal by Subject|1|||
154958999|NCT04405570|559276885|FG002|Overall Study|Withdrawal by Subject|1|||
154959000|NCT04405570|559276886|FG003|Overall Study|Withdrawal by Subject|0|||
154959001|NCT04405570|559276883|FG000|Overall Study|Randomized not dosed|0|||
154959002|NCT04405570|559276884|FG001|Overall Study|Randomized not dosed|2|||
154959003|NCT04405570|559276885|FG002|Overall Study|Randomized not dosed|0|||
154959004|NCT04405570|559276886|FG003|Overall Study|Randomized not dosed|0|||
154959005|NCT04499963|559276887|FG000|Overall Study|Adverse Event|3|||
154959006|NCT04499963|559276888|FG001|Overall Study|Adverse Event|0|||
154959007|NCT04499963|559276887|FG000|Overall Study|Death|3|||
154959008|NCT04499963|559276888|FG001|Overall Study|Death|0|||
154959009|NCT04499963|559276887|FG000|Overall Study|Lack of Efficacy|7|||
154959010|NCT04499963|559276888|FG001|Overall Study|Lack of Efficacy|0|||
154959011|NCT04499963|559276887|FG000|Overall Study|Lost to Follow-up|2|||
154959012|NCT04499963|559276888|FG001|Overall Study|Lost to Follow-up|0|||
154959013|NCT01237054|559276899|FG000|Overall Study|imaging 10C0096|1|||
154959014|NCT00095212|559276911|FG000|Overall Study|Withdrawal by Subject|1|||
155306738|NCT03845465|560555893|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
154959015|NCT00095212|559276912|FG001|Overall Study|Withdrawal by Subject|3|||
154959016|NCT02374853|559276916|FG000|Overall Study|Surgery Cancelled|5|||
154959017|NCT02374853|559276917|FG001|Overall Study|Surgery Cancelled|11|||
154959018|NCT02281084|559276918|FG000|Overall Study|Death|21|||
154959019|NCT02281084|559276919|FG001|Overall Study|Death|18|||
154959020|NCT02281084|559276920|FG002|Overall Study|Death|3|||
154959021|NCT02281084|559276921|FG003|Overall Study|Death|5|||
154959022|NCT02281084|559276918|FG000|Overall Study|Adverse Event|1|||
154959023|NCT02281084|559276919|FG001|Overall Study|Adverse Event|0|||
154959024|NCT02281084|559276920|FG002|Overall Study|Adverse Event|0|||
154959025|NCT02281084|559276921|FG003|Overall Study|Adverse Event|0|||
154959026|NCT02281084|559276918|FG000|Overall Study|Withdrawal by Subject|2|||
154959027|NCT02281084|559276919|FG001|Overall Study|Withdrawal by Subject|2|||
154959028|NCT02281084|559276920|FG002|Overall Study|Withdrawal by Subject|0|||
154959029|NCT02281084|559276921|FG003|Overall Study|Withdrawal by Subject|0|||
154959030|NCT02281084|559276918|FG000|Overall Study|Site Closure by Sponsor|5|||
154959031|NCT02281084|559276919|FG001|Overall Study|Site Closure by Sponsor|1|||
154959032|NCT02281084|559276920|FG002|Overall Study|Site Closure by Sponsor|2|||
154959033|NCT02281084|559276921|FG003|Overall Study|Site Closure by Sponsor|0|||
154959034|NCT02305758|559276922|FG000|Overall Study|Death|27|||
155306739|NCT03845465|560555892|FG000|6-month Data Collection|Withdrawal by Subject|0|||
155306740|NCT03845465|560555893|FG001|6-month Data Collection|Withdrawal by Subject|2|||
155306741|NCT03845465|560555892|FG000|12-month Data Collection|Withdrawal by Subject|0|||
155306742|NCT03845465|560555893|FG001|12-month Data Collection|Withdrawal by Subject|2|||
155306743|NCT05656911|560555896|FG000|Treatment Phase|Physician Decision|2|||
155306744|NCT05656911|560555897|FG001|Treatment Phase|Physician Decision|0|||
155306745|NCT05656911|560555896|FG000|Treatment Phase|Lack of Efficacy|6|||
155306746|NCT05656911|560555897|FG001|Treatment Phase|Lack of Efficacy|3|||
155306747|NCT05656911|560555896|FG000|Treatment Phase|Subject Decision|4|||
155306748|NCT05656911|560555897|FG001|Treatment Phase|Subject Decision|2|||
155306749|NCT05656911|560555896|FG000|Treatment Phase|Other Reasons|1|||
155306750|NCT05656911|560555897|FG001|Treatment Phase|Other Reasons|0|||
155306751|NCT05656911|560555896|FG000|Treatment Phase|Adverse Event|3|||
155306752|NCT05656911|560555897|FG001|Treatment Phase|Adverse Event|1|||
155306753|NCT05656911|560555896|FG000|Follow-up Phase|Subject Decision|0|||
155306754|NCT05656911|560555897|FG001|Follow-up Phase|Subject Decision|1|||
155306755|NCT05656911|560555896|FG000|Follow-up Phase|Missing|1|||
155306756|NCT05656911|560555897|FG001|Follow-up Phase|Missing|0|||
155306757|NCT02525692|560555901|FG000|Overall Study|Withdrawal by Subject|1|||
155306758|NCT02525692|560555902|FG001|Overall Study|Withdrawal by Subject|1|||
155306759|NCT02525692|560555903|FG002|Overall Study|Withdrawal by Subject|0|||
155306760|NCT02525692|560555904|FG003|Overall Study|Withdrawal by Subject|5|||
155306761|NCT02525692|560555905|FG004|Overall Study|Withdrawal by Subject|0|||
155306762|NCT02525692|560555906|FG005|Overall Study|Withdrawal by Subject|1|||
154959035|NCT02305758|559276923|FG001|Overall Study|Death|27|||
154959036|NCT02305758|559276922|FG000|Overall Study|Withdrew consent|9|||
154959037|NCT02305758|559276923|FG001|Overall Study|Withdrew consent|2|||
154959038|NCT02305758|559276922|FG000|Overall Study|Lost to Follow-up|6|||
154959039|NCT02305758|559276923|FG001|Overall Study|Lost to Follow-up|1|||
154959040|NCT02305758|559276922|FG000|Overall Study|Study Terminated by Sponsor|21|||
154959041|NCT02305758|559276923|FG001|Overall Study|Study Terminated by Sponsor|34|||
154959042|NCT02305758|559276922|FG000|Overall Study|Other, not specified|2|||
154959043|NCT02305758|559276923|FG001|Overall Study|Other, not specified|1|||
154959044|NCT05593965|559276924|FG000|1st Intervention (1 Day)|Technical error|1|||
155306763|NCT02525692|560555901|FG000|Overall Study|Death|16|||
155306764|NCT02525692|560555902|FG001|Overall Study|Death|18|||
155306765|NCT02525692|560555903|FG002|Overall Study|Death|7|||
155306766|NCT02525692|560555904|FG003|Overall Study|Death|20|||
155306767|NCT02525692|560555905|FG004|Overall Study|Death|3|||
155306768|NCT02525692|560555906|FG005|Overall Study|Death|6|||
155306769|NCT02525692|560555901|FG000|Overall Study|Lost to Follow-up|0|||
155306770|NCT02525692|560555902|FG001|Overall Study|Lost to Follow-up|0|||
155306771|NCT02525692|560555903|FG002|Overall Study|Lost to Follow-up|1|||
155306772|NCT02525692|560555904|FG003|Overall Study|Lost to Follow-up|5|||
155306773|NCT02525692|560555905|FG004|Overall Study|Lost to Follow-up|0|||
155306774|NCT02525692|560555906|FG005|Overall Study|Lost to Follow-up|0|||
155306775|NCT00567398|560555909|FG000|Overall Study|Adverse Event|6|||
155306776|NCT00567398|560555910|FG001|Overall Study|Adverse Event|14|||
155306777|NCT00567398|560555909|FG000|Overall Study|Physician Decision|0|||
155306778|NCT00567398|560555910|FG001|Overall Study|Physician Decision|4|||
154959045|NCT05593965|559276925|FG001|1st Intervention (1 Day)|Technical error|0|||
154959046|NCT02272777|559276926|FG000|Overall Study|Adverse Event|0|||
154959047|NCT02272777|559276927|FG001|Overall Study|Adverse Event|1|||
154959048|NCT02272777|559276926|FG000|Overall Study|Withdrawal by Subject|0|||
154959049|NCT02272777|559276927|FG001|Overall Study|Withdrawal by Subject|3|||
154959050|NCT02272777|559276926|FG000|Overall Study|Lost to Follow-up|2|||
154959051|NCT02272777|559276927|FG001|Overall Study|Lost to Follow-up|0|||
154959052|NCT02272777|559276926|FG000|Overall Study|Other|2|||
155306779|NCT00567398|560555909|FG000|Overall Study|Withdrawal by Subject|0|||
155306780|NCT00567398|560555910|FG001|Overall Study|Withdrawal by Subject|2|||
155306781|NCT00567398|560555909|FG000|Overall Study|Renal Transplantation|0|||
155306782|NCT00567398|560555910|FG001|Overall Study|Renal Transplantation|3|||
154959053|NCT02272777|559276927|FG001|Overall Study|Other|0|||
154959054|NCT00440297|559276928|FG000|Overall Study|Adverse Event|8|||
155306783|NCT00567398|560555909|FG000|Overall Study|Other|1|||
155306784|NCT00567398|560555910|FG001|Overall Study|Other|0|||
155306785|NCT03517553|560555911|FG000|Overall Study|Withdrawal by Subject|2|||
155306786|NCT04093362|560555914|FG000|Overall Study|Study Termination|1|||
155306787|NCT04093362|560555915|FG001|Overall Study|Study Termination|1|||
155306788|NCT04093362|560555914|FG000|Overall Study|Withdrawal of Consent|1|||
155306789|NCT04093362|560555915|FG001|Overall Study|Withdrawal of Consent|0|||
155306790|NCT04093362|560555914|FG000|Overall Study|Death|1|||
155306791|NCT04093362|560555915|FG001|Overall Study|Death|3|||
155306792|NCT04093362|560555914|FG000|Overall Study|Reason not Specified|1|||
155306793|NCT04093362|560555915|FG001|Overall Study|Reason not Specified|2|||
155306794|NCT04247542|560555916|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
155306795|NCT04247542|560555917|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
155306796|NCT04247542|560555918|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
155306797|NCT04247542|560555916|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
155306798|NCT04247542|560555917|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
155306799|NCT04247542|560555918|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
154959055|NCT00440297|559276929|FG001|Overall Study|Adverse Event|5|||
155306800|NCT02597946|560555919|FG000|Overall Study|Withdrawal by Subject|1|||
155306801|NCT02597946|560555919|FG000|Overall Study|Progressive disease|16|||
154959056|NCT00440297|559276928|FG000|Overall Study|Lost to Follow-up|1|||
154959057|NCT00440297|559276929|FG001|Overall Study|Lost to Follow-up|0|||
154959058|NCT00440297|559276928|FG000|Overall Study|Physician Decision|1|||
154959059|NCT00440297|559276929|FG001|Overall Study|Physician Decision|0|||
154959060|NCT00440297|559276928|FG000|Overall Study|Protocol Violation|11|||
154959061|NCT00440297|559276929|FG001|Overall Study|Protocol Violation|7|||
154959062|NCT00440297|559276928|FG000|Overall Study|Withdrawal by Subject|1|||
154959063|NCT00440297|559276929|FG001|Overall Study|Withdrawal by Subject|6|||
154959064|NCT00440297|559276928|FG000|Overall Study|Randomized by mistake|1|||
154959065|NCT00440297|559276929|FG001|Overall Study|Randomized by mistake|0|||
154959066|NCT02024932|559276930|FG000|Overall Study|Adverse Event|2|||
154959067|NCT02024932|559276931|FG001|Overall Study|Adverse Event|3|||
155306802|NCT02597946|560555919|FG000|Overall Study|Other than above|1|||
155306803|NCT01938547|560555926|FG000|Overall Study|Physician Decision|1|||
155306804|NCT01673984|560555932|FG000|Overall Study|Adverse Event|1|||
155306805|NCT01673984|560555933|FG001|Overall Study|Adverse Event|0|||
155306806|NCT01673984|560555932|FG000|Overall Study|Study termination|9|||
155306807|NCT01673984|560555933|FG001|Overall Study|Study termination|6|||
155306808|NCT04600752|560555938|FG000|Overall Study|Physician Decision|0|||
155306809|NCT04600752|560555939|FG001|Overall Study|Physician Decision|0|||
155306810|NCT04600752|560555940|FG002|Overall Study|Physician Decision|1|||
155306811|NCT04600752|560555938|FG000|Overall Study|Adverse Event|0|||
155306812|NCT04600752|560555939|FG001|Overall Study|Adverse Event|1|||
155306813|NCT04600752|560555940|FG002|Overall Study|Adverse Event|0|||
155306814|NCT04600752|560555938|FG000|Overall Study|Withdrawal by Subject|2|||
155306815|NCT04600752|560555939|FG001|Overall Study|Withdrawal by Subject|1|||
155306816|NCT04600752|560555940|FG002|Overall Study|Withdrawal by Subject|0|||
155306817|NCT04600752|560555938|FG000|Overall Study|Lack of Efficacy|1|||
155306818|NCT04600752|560555939|FG001|Overall Study|Lack of Efficacy|0|||
155306819|NCT04600752|560555940|FG002|Overall Study|Lack of Efficacy|0|||
155306820|NCT03732820|560555941|FG000|Overall Study|Death|168|||
155306821|NCT03732820|560555942|FG001|Overall Study|Death|203|||
155306822|NCT03732820|560555941|FG000|Overall Study|Other|2|||
155306823|NCT03732820|560555942|FG001|Overall Study|Other|2|||
155306824|NCT03732820|560555941|FG000|Overall Study|Failure to meet randomisation criteria|1|||
155306825|NCT03732820|560555942|FG001|Overall Study|Failure to meet randomisation criteria|1|||
155306826|NCT03732820|560555941|FG000|Overall Study|Patient decision|14|||
155306827|NCT03732820|560555942|FG001|Overall Study|Patient decision|10|||
155306828|NCT03732820|560555941|FG000|Overall Study|Screen failure|0|||
155306829|NCT03732820|560555942|FG001|Overall Study|Screen failure|1|||
155306830|NCT03732820|560555941|FG000|Overall Study|Patients ongoing study at data cut off|210|||
155306831|NCT03732820|560555942|FG001|Overall Study|Patients ongoing study at data cut off|178|||
155306832|NCT03732820|560555941|FG000|Overall Study|Lost to Follow-up|4|||
155306833|NCT03732820|560555942|FG001|Overall Study|Lost to Follow-up|2|||
155306834|NCT04436107|560555943|FG000|Overall Study|Sponsor Ended Study|2|||
155306835|NCT04436107|560555944|FG001|Overall Study|Sponsor Ended Study|4|||
155306836|NCT04436107|560555945|FG002|Overall Study|Sponsor Ended Study|8|||
155306837|NCT04436107|560555946|FG003|Overall Study|Sponsor Ended Study|20|||
155306838|NCT04436107|560555943|FG000|Overall Study|Death|3|||
155306839|NCT04436107|560555944|FG001|Overall Study|Death|5|||
155306840|NCT04436107|560555945|FG002|Overall Study|Death|3|||
155306841|NCT04436107|560555946|FG003|Overall Study|Death|18|||
155306842|NCT04436107|560555943|FG000|Overall Study|Withdrawal by Subject|1|||
155306843|NCT04436107|560555944|FG001|Overall Study|Withdrawal by Subject|1|||
155306844|NCT04436107|560555945|FG002|Overall Study|Withdrawal by Subject|0|||
155306845|NCT04436107|560555946|FG003|Overall Study|Withdrawal by Subject|1|||
155306846|NCT01095796|560555947|FG000|Overall Study|Randomized but Not Treated|5|||
155306847|NCT01095796|560555948|FG001|Overall Study|Randomized but Not Treated|2|||
155306848|NCT01095796|560555947|FG000|Overall Study|Adverse Event|9|||
155306849|NCT01095796|560555948|FG001|Overall Study|Adverse Event|19|||
155306850|NCT01095796|560555947|FG000|Overall Study|Death|3|||
155306851|NCT01095796|560555948|FG001|Overall Study|Death|2|||
155306852|NCT01095796|560555947|FG000|Overall Study|Pregnancy|2|||
155306853|NCT01095796|560555948|FG001|Overall Study|Pregnancy|0|||
155306854|NCT01095796|560555947|FG000|Overall Study|Lack of Efficacy|5|||
155306855|NCT01095796|560555948|FG001|Overall Study|Lack of Efficacy|3|||
155306856|NCT01095796|560555947|FG000|Overall Study|Investigator's Discretion|7|||
155306857|NCT01095796|560555948|FG001|Overall Study|Investigator's Discretion|2|||
155306858|NCT01095796|560555947|FG000|Overall Study|Withdrew Consent|16|||
155306859|NCT01095796|560555948|FG001|Overall Study|Withdrew Consent|22|||
155306860|NCT01095796|560555947|FG000|Overall Study|Lost to Follow-up|27|||
155306861|NCT01095796|560555948|FG001|Overall Study|Lost to Follow-up|29|||
154959068|NCT02024932|559276932|FG002|Overall Study|Adverse Event|0|||
154959069|NCT02024932|559276933|FG003|Overall Study|Adverse Event|0|||
155306862|NCT01095796|560555947|FG000|Overall Study|Participant Noncompliance|5|||
155306863|NCT01095796|560555948|FG001|Overall Study|Participant Noncompliance|10|||
154959070|NCT02024932|559276934|FG004|Overall Study|Adverse Event|2|||
155306864|NCT01095796|560555947|FG000|Overall Study|Protocol Violation|1|||
155306865|NCT01095796|560555948|FG001|Overall Study|Protocol Violation|0|||
155306866|NCT01095796|560555947|FG000|Overall Study|Participant Transferred to Another Study|215|||
155306867|NCT01095796|560555948|FG001|Overall Study|Participant Transferred to Another Study|200|||
155306868|NCT01989455|560555949|FG000|Overall Study|Adverse Event|0|||
155306869|NCT01989455|560555950|FG001|Overall Study|Adverse Event|1|||
155306870|NCT01989455|560555951|FG002|Overall Study|Adverse Event|0|||
155306871|NCT01989455|560555952|FG003|Overall Study|Adverse Event|0|||
155306872|NCT01989455|560555953|FG004|Overall Study|Adverse Event|0|||
155306873|NCT01989455|560555949|FG000|Overall Study|Withdrawal by Subject|0|||
155306874|NCT01989455|560555950|FG001|Overall Study|Withdrawal by Subject|1|||
155306875|NCT01989455|560555951|FG002|Overall Study|Withdrawal by Subject|0|||
155306876|NCT01989455|560555952|FG003|Overall Study|Withdrawal by Subject|0|||
155306877|NCT01989455|560555953|FG004|Overall Study|Withdrawal by Subject|0|||
155306878|NCT01989455|560555949|FG000|Overall Study|Technical problems with infusion|0|||
155306879|NCT01989455|560555950|FG001|Overall Study|Technical problems with infusion|0|||
155306880|NCT01989455|560555951|FG002|Overall Study|Technical problems with infusion|1|||
155306881|NCT01989455|560555952|FG003|Overall Study|Technical problems with infusion|0|||
155306882|NCT01989455|560555953|FG004|Overall Study|Technical problems with infusion|1|||
155306883|NCT00632203|560555954|FG000|Overall Study|Did not start study treatment|1|||
155306884|NCT00632203|560555955|FG001|Overall Study|Did not start study treatment|0|||
155306885|NCT00448669|560555963|FG000|Overall Study|Lost to Follow-up|52|||
155306886|NCT00448669|560555964|FG001|Overall Study|Lost to Follow-up|63|||
155306887|NCT00448669|560555963|FG000|Overall Study|Withdrawal by Subject|90|||
155306888|NCT00448669|560555964|FG001|Overall Study|Withdrawal by Subject|74|||
155306889|NCT00448669|560555963|FG000|Overall Study|Relocated|49|||
155306890|NCT00448669|560555964|FG001|Overall Study|Relocated|36|||
155306891|NCT00448669|560555963|FG000|Overall Study|Were withdrawn by investigator|10|||
155306892|NCT00448669|560555964|FG001|Overall Study|Were withdrawn by investigator|6|||
155306893|NCT00448669|560555963|FG000|Overall Study|Death|2|||
155306894|NCT00448669|560555964|FG001|Overall Study|Death|4|||
155306895|NCT00448669|560555963|FG000|Overall Study|Had other reasons|5|||
155306896|NCT00448669|560555964|FG001|Overall Study|Had other reasons|6|||
155306897|NCT00448669|560555963|FG000|Overall Study|HIV-infected at enrollment|1|||
155306898|NCT00448669|560555964|FG001|Overall Study|HIV-infected at enrollment|2|||
155306899|NCT00448669|560555963|FG000|Overall Study|Never started drug|9|||
155306900|NCT00448669|560555964|FG001|Overall Study|Never started drug|7|||
155306901|NCT04287985|560555965|FG000|Overall Study|Adverse Event|1|||
155306902|NCT04287985|560555966|FG001|Overall Study|Adverse Event|0|||
155306903|NCT04287985|560555967|FG002|Overall Study|Adverse Event|0|||
155306904|NCT04287985|560555968|FG003|Overall Study|Adverse Event|0|||
155306905|NCT04287985|560555965|FG000|Overall Study|Protocol Violation|0|||
155306906|NCT04287985|560555966|FG001|Overall Study|Protocol Violation|1|||
155306907|NCT04287985|560555967|FG002|Overall Study|Protocol Violation|0|||
155306908|NCT04287985|560555968|FG003|Overall Study|Protocol Violation|0|||
155306909|NCT04287985|560555965|FG000|Overall Study|Physician Decision|0|||
155306910|NCT04287985|560555966|FG001|Overall Study|Physician Decision|0|||
155306911|NCT04287985|560555967|FG002|Overall Study|Physician Decision|0|||
155306912|NCT04287985|560555968|FG003|Overall Study|Physician Decision|1|||
155306913|NCT04287985|560555965|FG000|Overall Study|Withdrawal by Subject|2|||
155306914|NCT04287985|560555966|FG001|Overall Study|Withdrawal by Subject|1|||
155306915|NCT04287985|560555967|FG002|Overall Study|Withdrawal by Subject|1|||
155306916|NCT04287985|560555968|FG003|Overall Study|Withdrawal by Subject|2|||
155306917|NCT01340066|560555973|FG000|Placebo Run in Period|Screen Failures|27|||
155306918|NCT01340066|560555974|FG001|Placebo Run in Period|Screen Failures|0|||
155306919|NCT01340066|560555975|FG002|Placebo Run in Period|Screen Failures|0|||
155306920|NCT01340066|560555973|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
155306921|NCT01340066|560555974|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
155306922|NCT01340066|560555975|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
155306923|NCT01340066|560555973|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
155306924|NCT01340066|560555974|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
155306925|NCT01340066|560555975|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
155306926|NCT01340066|560555973|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
155306927|NCT01340066|560555974|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
155306928|NCT01340066|560555975|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
155306929|NCT03771352|560555983|FG000|Overall Study|Screen failure|2|||
155306930|NCT03771352|560555983|FG000|Overall Study|Withdrawal by Subject|2|||
155306931|NCT00274469|560555984|FG000|Overall Study|Death|63|||
155306932|NCT00274469|560555985|FG001|Overall Study|Death|74|||
155306933|NCT00274469|560555984|FG000|Overall Study|Did not consent to OS follow-up|16|||
155306934|NCT00274469|560555985|FG001|Overall Study|Did not consent to OS follow-up|19|||
155306935|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
155306936|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
155306937|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
155306938|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
155306939|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
155306940|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
155306941|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
155306942|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
155306943|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
155306944|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
155306945|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
155306946|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
155306947|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
155306948|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
155306949|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
155306950|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
155306951|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
155306952|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
155306953|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
155306954|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
155306955|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
155306956|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
155306957|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
155306958|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
155306959|NCT03338816|560555986|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
155306960|NCT03338816|560555987|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
155306961|NCT03338816|560555988|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
155306962|NCT03338816|560555989|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
155306963|NCT05494788|560555999|FG000|Initial Treatment Period|Adverse Event|2|||
155306964|NCT05494788|560555999|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
155306965|NCT05494788|560555999|FG000|Extension Period|Adverse Event|1|||
155306966|NCT05494788|560555999|FG000|Extension Period|Withdrawal by Subject|1|||
154959071|NCT02024932|559276935|FG005|Overall Study|Adverse Event|0|||
155306967|NCT00136435|560556000|FG000|Overall Study|Ineligible|8|||
154959072|NCT02024932|559276930|FG000|Overall Study|Abnormal laboratory value|0|||
154959073|NCT02024932|559276931|FG001|Overall Study|Abnormal laboratory value|0|||
154959074|NCT02024932|559276932|FG002|Overall Study|Abnormal laboratory value|0|||
154959075|NCT02024932|559276933|FG003|Overall Study|Abnormal laboratory value|2|||
154959076|NCT02024932|559276934|FG004|Overall Study|Abnormal laboratory value|0|||
154959077|NCT02024932|559276935|FG005|Overall Study|Abnormal laboratory value|0|||
154959078|NCT02445339|559276936|FG000|Overall Study|Physician Decision|1|||
154959079|NCT02445339|559276937|FG001|Overall Study|Physician Decision|0|||
154959080|NCT02445339|559276936|FG000|Overall Study|Lost to Follow-up|11|||
154959081|NCT02445339|559276937|FG001|Overall Study|Lost to Follow-up|15|||
154959082|NCT03020641|559276938|FG000|Overall Study|Lost to Follow-up|0|||
154959083|NCT03020641|559276939|FG001|Overall Study|Lost to Follow-up|1|||
154959084|NCT03020641|559276938|FG000|Overall Study|Converted to open surgery|2|||
154959085|NCT03020641|559276939|FG001|Overall Study|Converted to open surgery|1|||
154959086|NCT03020641|559276938|FG000|Overall Study|for surgery not performed|0|||
154959087|NCT03020641|559276939|FG001|Overall Study|for surgery not performed|1|||
154959088|NCT00727961|559276941|FG000|Overall Study|Lost to Follow-up|1|||
154959089|NCT00727961|559276941|FG000|Overall Study|Adverse Event|4|||
154959090|NCT00727961|559276941|FG000|Overall Study|Patient's refusal|2|||
154959091|NCT00727961|559276941|FG000|Overall Study|Progression|30|||
154959092|NCT02186821|559276942|FG000|Overall Study|Adverse Event|9|||
155306968|NCT00136435|560556000|FG000|Overall Study|Induction Death|1|||
155306969|NCT00136435|560556000|FG000|Overall Study|Induction Failure|10|||
155306970|NCT00136435|560556000|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
155306971|NCT00136435|560556000|FG000|Overall Study|Withdrawal by Subject|3|||
155306972|NCT00136435|560556000|FG000|Overall Study|Adverse Event|19|||
155306973|NCT00136435|560556000|FG000|Overall Study|Relapse|4|||
155306974|NCT00136435|560556000|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
155306975|NCT01017146|560556001|FG000|Overall Study|Adverse Event|11|||
155306976|NCT01017146|560556002|FG001|Overall Study|Adverse Event|1|||
155306977|NCT01017146|560556001|FG000|Overall Study|Lost to Follow-up|14|||
155306978|NCT01017146|560556002|FG001|Overall Study|Lost to Follow-up|14|||
155306979|NCT01017146|560556001|FG000|Overall Study|Noncompliance with Study Product|1|||
155306980|NCT01017146|560556002|FG001|Overall Study|Noncompliance with Study Product|1|||
155306981|NCT01017146|560556001|FG000|Overall Study|Withdrawal by Subject|32|||
155306982|NCT01017146|560556002|FG001|Overall Study|Withdrawal by Subject|16|||
155306983|NCT01017146|560556001|FG000|Overall Study|Relocation|0|||
155306984|NCT01017146|560556002|FG001|Overall Study|Relocation|4|||
155306985|NCT01017146|560556001|FG000|Overall Study|Pregnancy|2|||
155306986|NCT01017146|560556002|FG001|Overall Study|Pregnancy|1|||
155306987|NCT01017146|560556001|FG000|Overall Study|Protocol Violation|2|||
155306988|NCT01017146|560556002|FG001|Overall Study|Protocol Violation|0|||
155306989|NCT01017146|560556001|FG000|Overall Study|Took Excluded Medication|2|||
155306990|NCT01017146|560556002|FG001|Overall Study|Took Excluded Medication|0|||
155306991|NCT01017146|560556001|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155306992|NCT01017146|560556002|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
155306993|NCT01017146|560556001|FG000|Overall Study|Change in Work Situation|1|||
155306994|NCT01017146|560556002|FG001|Overall Study|Change in Work Situation|0|||
155306995|NCT00087139|560556003|FG000|Overall Study|Adverse Event|18|||
155306996|NCT00087139|560556004|FG001|Overall Study|Adverse Event|17|||
155306997|NCT00087139|560556005|FG002|Overall Study|Adverse Event|13|||
155306998|NCT00087139|560556003|FG000|Overall Study|Death|2|||
155306999|NCT00087139|560556004|FG001|Overall Study|Death|1|||
155307000|NCT00087139|560556005|FG002|Overall Study|Death|0|||
155307001|NCT00087139|560556003|FG000|Overall Study|Withdrawal by Subject|3|||
155307002|NCT00087139|560556004|FG001|Overall Study|Withdrawal by Subject|2|||
155307003|NCT00087139|560556005|FG002|Overall Study|Withdrawal by Subject|2|||
155307004|NCT00087139|560556003|FG000|Overall Study|Physician Decision|1|||
155307005|NCT00087139|560556004|FG001|Overall Study|Physician Decision|1|||
155307006|NCT00087139|560556005|FG002|Overall Study|Physician Decision|1|||
155307007|NCT00087139|560556003|FG000|Overall Study|Disease progression|9|||
155307008|NCT00087139|560556004|FG001|Overall Study|Disease progression|19|||
155307009|NCT00087139|560556005|FG002|Overall Study|Disease progression|12|||
155307010|NCT00087139|560556003|FG000|Overall Study|Ineligible|4|||
155307011|NCT00087139|560556004|FG001|Overall Study|Ineligible|7|||
155307012|NCT00087139|560556005|FG002|Overall Study|Ineligible|4|||
155307013|NCT00087139|560556003|FG000|Overall Study|Symptomatic deterioration|1|||
155307014|NCT00087139|560556004|FG001|Overall Study|Symptomatic deterioration|1|||
155307015|NCT00087139|560556005|FG002|Overall Study|Symptomatic deterioration|3|||
155307016|NCT00087139|560556003|FG000|Overall Study|Use of coumadin|1|||
155307017|NCT00087139|560556004|FG001|Overall Study|Use of coumadin|0|||
155307018|NCT00087139|560556005|FG002|Overall Study|Use of coumadin|0|||
155307019|NCT00087139|560556003|FG000|Overall Study|Response achieved|0|||
155307020|NCT00087139|560556004|FG001|Overall Study|Response achieved|1|||
155307021|NCT00087139|560556005|FG002|Overall Study|Response achieved|0|||
155307022|NCT00087139|560556003|FG000|Overall Study|Extradural disease|0|||
155307023|NCT00087139|560556004|FG001|Overall Study|Extradural disease|0|||
155307024|NCT00087139|560556005|FG002|Overall Study|Extradural disease|1|||
155307025|NCT02671435|560556014|FG000|Overall Study|Death|1|||
155307026|NCT02671435|560556015|FG001|Overall Study|Death|3|||
155307027|NCT02671435|560556016|FG002|Overall Study|Death|0|||
155307028|NCT02671435|560556017|FG003|Overall Study|Death|16|||
155307029|NCT02671435|560556018|FG004|Overall Study|Death|14|||
155307030|NCT02671435|560556019|FG005|Overall Study|Death|29|||
155307031|NCT02671435|560556020|FG006|Overall Study|Death|34|||
155307032|NCT02671435|560556021|FG007|Overall Study|Death|28|||
155307033|NCT02671435|560556022|FG008|Overall Study|Death|19|||
155307034|NCT02671435|560556023|FG009|Overall Study|Death|10|||
154959093|NCT02186821|559276942|FG000|Overall Study|Death|2|||
154959094|NCT02186821|559276942|FG000|Overall Study|Disease progression|32|||
154959095|NCT02186821|559276942|FG000|Overall Study|Protocol Violation|1|||
155307035|NCT02671435|560556024|FG010|Overall Study|Death|8|||
154959096|NCT02186821|559276942|FG000|Overall Study|Physician Decision|1|||
154959097|NCT02186821|559276942|FG000|Overall Study|Study terminated by sponsor|2|||
154959098|NCT01421277|559276943|FG000|Overall Study|Lack of qualifying event|0|||
154959099|NCT01421277|559276944|FG001|Overall Study|Lack of qualifying event|61|||
154959100|NCT01421277|559276943|FG000|Overall Study|Incomplete baseline data|0|||
155307036|NCT02671435|560556025|FG011|Overall Study|Death|29|||
155307037|NCT02671435|560556026|FG012|Overall Study|Death|29|||
155307038|NCT02671435|560556027|FG013|Overall Study|Death|29|||
155307039|NCT02671435|560556028|FG014|Overall Study|Death|27|||
155307040|NCT02671435|560556014|FG000|Overall Study|Lost to Follow-up|0|||
155307041|NCT02671435|560556015|FG001|Overall Study|Lost to Follow-up|0|||
155307042|NCT02671435|560556016|FG002|Overall Study|Lost to Follow-up|1|||
155307043|NCT02671435|560556017|FG003|Overall Study|Lost to Follow-up|0|||
155307044|NCT02671435|560556018|FG004|Overall Study|Lost to Follow-up|1|||
155161186|NCT03722238|560026772|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
155307045|NCT02671435|560556019|FG005|Overall Study|Lost to Follow-up|1|||
155307046|NCT02671435|560556020|FG006|Overall Study|Lost to Follow-up|2|||
155307047|NCT02671435|560556021|FG007|Overall Study|Lost to Follow-up|2|||
155307048|NCT02671435|560556022|FG008|Overall Study|Lost to Follow-up|0|||
155307049|NCT02671435|560556023|FG009|Overall Study|Lost to Follow-up|2|||
155307050|NCT02671435|560556024|FG010|Overall Study|Lost to Follow-up|0|||
155307051|NCT02671435|560556025|FG011|Overall Study|Lost to Follow-up|3|||
155307052|NCT02671435|560556026|FG012|Overall Study|Lost to Follow-up|3|||
155307053|NCT02671435|560556027|FG013|Overall Study|Lost to Follow-up|2|||
155307054|NCT02671435|560556028|FG014|Overall Study|Lost to Follow-up|0|||
155307055|NCT02671435|560556014|FG000|Overall Study|Withdrawal by Subject|2|||
155307056|NCT02671435|560556015|FG001|Overall Study|Withdrawal by Subject|0|||
155307057|NCT02671435|560556016|FG002|Overall Study|Withdrawal by Subject|2|||
155307058|NCT02671435|560556017|FG003|Overall Study|Withdrawal by Subject|2|||
155307059|NCT02671435|560556018|FG004|Overall Study|Withdrawal by Subject|2|||
155307060|NCT02671435|560556019|FG005|Overall Study|Withdrawal by Subject|7|||
155307061|NCT02671435|560556020|FG006|Overall Study|Withdrawal by Subject|2|||
155307062|NCT02671435|560556021|FG007|Overall Study|Withdrawal by Subject|7|||
155307063|NCT02671435|560556022|FG008|Overall Study|Withdrawal by Subject|1|||
155307064|NCT02671435|560556023|FG009|Overall Study|Withdrawal by Subject|1|||
155307065|NCT02671435|560556024|FG010|Overall Study|Withdrawal by Subject|2|||
155307066|NCT02671435|560556025|FG011|Overall Study|Withdrawal by Subject|4|||
155307067|NCT02671435|560556026|FG012|Overall Study|Withdrawal by Subject|4|||
155307068|NCT02671435|560556027|FG013|Overall Study|Withdrawal by Subject|4|||
155307069|NCT02671435|560556028|FG014|Overall Study|Withdrawal by Subject|2|||
155307070|NCT02671435|560556014|FG000|Overall Study|Un-specified|0|||
155307071|NCT02671435|560556015|FG001|Overall Study|Un-specified|0|||
155307072|NCT02671435|560556016|FG002|Overall Study|Un-specified|0|||
155307073|NCT02671435|560556017|FG003|Overall Study|Un-specified|0|||
155307074|NCT02671435|560556018|FG004|Overall Study|Un-specified|1|||
155307075|NCT02671435|560556019|FG005|Overall Study|Un-specified|3|||
155307076|NCT02671435|560556020|FG006|Overall Study|Un-specified|2|||
155307077|NCT02671435|560556021|FG007|Overall Study|Un-specified|3|||
155307078|NCT02671435|560556022|FG008|Overall Study|Un-specified|0|||
155307079|NCT02671435|560556023|FG009|Overall Study|Un-specified|5|||
155307080|NCT02671435|560556024|FG010|Overall Study|Un-specified|8|||
155307081|NCT02671435|560556025|FG011|Overall Study|Un-specified|4|||
155307082|NCT02671435|560556026|FG012|Overall Study|Un-specified|5|||
155307083|NCT02671435|560556027|FG013|Overall Study|Un-specified|9|||
155307084|NCT02671435|560556028|FG014|Overall Study|Un-specified|8|||
155307085|NCT04095104|560556029|FG000|Overall Study|Withdrawal by Subject|0|||
155307086|NCT04095104|560556030|FG001|Overall Study|Withdrawal by Subject|1|||
155307087|NCT05048186|560556033|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
155307088|NCT05048186|560556034|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
155307089|NCT05048186|560556033|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
155307090|NCT05048186|560556034|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
155307091|NCT02412748|560556035|FG000|Overall Study|Lost to Follow-up|38|||
155307092|NCT02412748|560556036|FG001|Overall Study|Lost to Follow-up|39|||
155307093|NCT00976937|560556037|FG000|Overall Study|Adverse Event|4|||
155307094|NCT00976937|560556038|FG001|Overall Study|Adverse Event|5|||
155307095|NCT00976937|560556037|FG000|Overall Study|Lost to Follow-up|2|||
155307096|NCT00976937|560556038|FG001|Overall Study|Lost to Follow-up|1|||
155307097|NCT00976937|560556037|FG000|Overall Study|Withdrawal by Subject|5|||
155307098|NCT00976937|560556038|FG001|Overall Study|Withdrawal by Subject|3|||
155307099|NCT00976937|560556037|FG000|Overall Study|Poor compliance to protocol|3|||
155307100|NCT00976937|560556038|FG001|Overall Study|Poor compliance to protocol|0|||
155307101|NCT00976937|560556037|FG000|Overall Study|Personal and Familial Reason|2|||
155307102|NCT00976937|560556038|FG001|Overall Study|Personal and Familial Reason|2|||
155307103|NCT04218266|560556039|FG000|Overall Study|Death|1|||
155307104|NCT04218266|560556040|FG001|Overall Study|Death|2|||
155307105|NCT04218266|560556041|FG002|Overall Study|Death|3|||
155307106|NCT04218266|560556039|FG000|Overall Study|Adverse Event|13|||
155307107|NCT04218266|560556040|FG001|Overall Study|Adverse Event|14|||
155307108|NCT04218266|560556041|FG002|Overall Study|Adverse Event|11|||
155307109|NCT04218266|560556039|FG000|Overall Study|Other|7|||
155307110|NCT04218266|560556040|FG001|Overall Study|Other|5|||
155307111|NCT04218266|560556041|FG002|Overall Study|Other|14|||
155307112|NCT04218266|560556039|FG000|Overall Study|Physician Decision|1|||
155307113|NCT04218266|560556040|FG001|Overall Study|Physician Decision|3|||
155307114|NCT04218266|560556041|FG002|Overall Study|Physician Decision|2|||
155307115|NCT04218266|560556039|FG000|Overall Study|Non-compliance with study drug|0|||
155307116|NCT04218266|560556040|FG001|Overall Study|Non-compliance with study drug|0|||
155307117|NCT04218266|560556041|FG002|Overall Study|Non-compliance with study drug|1|||
155307118|NCT04218266|560556039|FG000|Overall Study|Withdrawal by Subject|1|||
155307119|NCT04218266|560556040|FG001|Overall Study|Withdrawal by Subject|3|||
155307120|NCT04218266|560556041|FG002|Overall Study|Withdrawal by Subject|1|||
155307121|NCT04218266|560556039|FG000|Overall Study|Study drug never administered|2|||
155307122|NCT04218266|560556040|FG001|Overall Study|Study drug never administered|0|||
155307123|NCT04218266|560556041|FG002|Overall Study|Study drug never administered|0|||
155307124|NCT00761189|560556043|FG000|Overall Study|Adverse Event|42|||
155307125|NCT00761189|560556043|FG000|Overall Study|Lack of Efficacy|45|||
155307126|NCT00761189|560556043|FG000|Overall Study|Lost to Follow-up|36|||
155307127|NCT00761189|560556043|FG000|Overall Study|Withdrawal by Subject|49|||
155307128|NCT00761189|560556043|FG000|Overall Study|Other|13|||
155307129|NCT01494922|560556044|FG000|Overall Study|Adverse Event|1|||
155307130|NCT01227265|560556046|FG000|Overall Study|Did Not Receive Treatment|1|||
155307131|NCT01227265|560556047|FG001|Overall Study|Did Not Receive Treatment|2|||
155307132|NCT01227265|560556048|FG002|Overall Study|Did Not Receive Treatment|0|||
155307133|NCT01227265|560556046|FG000|Overall Study|Administrative|1|||
155307134|NCT01227265|560556047|FG001|Overall Study|Administrative|0|||
155307135|NCT01227265|560556048|FG002|Overall Study|Administrative|2|||
155307136|NCT01227265|560556046|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
155307137|NCT01227265|560556047|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
155307138|NCT01227265|560556048|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
155307139|NCT01227265|560556046|FG000|Overall Study|Protocol Violation|2|||
155307140|NCT01227265|560556047|FG001|Overall Study|Protocol Violation|1|||
155307141|NCT01227265|560556048|FG002|Overall Study|Protocol Violation|0|||
155307142|NCT01227265|560556046|FG000|Overall Study|Withdrawal by Subject|7|||
155307143|NCT01227265|560556047|FG001|Overall Study|Withdrawal by Subject|7|||
155307144|NCT01227265|560556048|FG002|Overall Study|Withdrawal by Subject|3|||
155307145|NCT01227265|560556046|FG000|Overall Study|Lost to Follow-up|2|||
155307146|NCT01227265|560556047|FG001|Overall Study|Lost to Follow-up|0|||
155307147|NCT01227265|560556048|FG002|Overall Study|Lost to Follow-up|3|||
155307148|NCT01227265|560556046|FG000|Overall Study|Adverse Event|6|||
155307149|NCT01227265|560556047|FG001|Overall Study|Adverse Event|10|||
155307150|NCT01227265|560556048|FG002|Overall Study|Adverse Event|5|||
155307151|NCT02269475|560556049|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
155307152|NCT02269475|560556050|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
155307153|NCT02269475|560556049|FG000|Overall Study|Withdrawal by Subject|0|||
155307154|NCT02269475|560556050|FG001|Overall Study|Withdrawal by Subject|1|||
155307155|NCT01037985|560556051|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
154959101|NCT01421277|559276944|FG001|Overall Study|Incomplete baseline data|31|||
154959102|NCT02039908|559276945|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
154959103|NCT02039908|559276946|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
155161187|NCT01285323|560026773|FG000|Overall Study|Adverse Event|9|||
154959104|NCT02039908|559276947|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
154959105|NCT02039908|559276948|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
154959106|NCT02039908|559276945|FG000|Phase 1-Summer|Protocol Violation|6|||
154959107|NCT02039908|559276946|FG001|Phase 1-Summer|Protocol Violation|0|||
154959108|NCT02039908|559276947|FG002|Phase 1-Summer|Protocol Violation|0|||
154959109|NCT02039908|559276948|FG003|Phase 1-Summer|Protocol Violation|0|||
154959110|NCT02039908|559276945|FG000|Phase 2-School Year|Lost to Follow-up|0|||
154959111|NCT02039908|559276946|FG001|Phase 2-School Year|Lost to Follow-up|0|||
154959112|NCT02039908|559276947|FG002|Phase 2-School Year|Lost to Follow-up|1|||
154959113|NCT02039908|559276948|FG003|Phase 2-School Year|Lost to Follow-up|3|||
154959114|NCT02039908|559276945|FG000|Phase 2-School Year|Protocol Violation|0|||
155161188|NCT01285323|560026774|FG001|Overall Study|Adverse Event|8|||
155307156|NCT01037985|560556052|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
155307157|NCT01037985|560556051|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
155307158|NCT01037985|560556052|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
155307159|NCT01037985|560556051|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
155307160|NCT01037985|560556052|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
155307161|NCT01037985|560556051|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
155307162|NCT01037985|560556052|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
155307163|NCT02730871|560556055|FG000|Overall Study|Adverse Event|6|||
155307164|NCT02730871|560556056|FG001|Overall Study|Adverse Event|0|||
155307165|NCT05368558|560556057|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
155307166|NCT05368558|560556058|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
155307167|NCT05368558|560556059|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
155307168|NCT05368558|560556060|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307169|NCT05368558|560556061|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307170|NCT05368558|560556062|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307171|NCT05368558|560556063|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307172|NCT05368558|560556064|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307173|NCT05368558|560556065|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307174|NCT05368558|560556066|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307175|NCT05368558|560556067|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
155307176|NCT05368558|560556068|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
154959115|NCT02039908|559276946|FG001|Phase 2-School Year|Protocol Violation|0|||
154959116|NCT02039908|559276947|FG002|Phase 2-School Year|Protocol Violation|3|||
154959117|NCT02039908|559276948|FG003|Phase 2-School Year|Protocol Violation|0|||
154959118|NCT02039908|559276945|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
154959119|NCT02039908|559276946|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
154959120|NCT02039908|559276947|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
154959121|NCT02039908|559276948|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
154959122|NCT01597245|559276949|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
154959123|NCT01597245|559276950|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
154959124|NCT01597245|559276951|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
154959125|NCT01597245|559276952|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
154959126|NCT01597245|559276953|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959127|NCT01597245|559276954|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959128|NCT01597245|559276955|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959129|NCT01597245|559276956|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959130|NCT01597245|559276957|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959131|NCT01597245|559276958|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959132|NCT01597245|559276959|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959133|NCT01597245|559276960|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959134|NCT01597245|559276961|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959135|NCT01597245|559276962|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959136|NCT01597245|559276963|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959137|NCT01597245|559276964|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959138|NCT01597245|559276965|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959139|NCT01597245|559276966|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959140|NCT01597245|559276967|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959141|NCT01597245|559276968|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959142|NCT01597245|559276969|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
154959143|NCT01597245|559276949|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
154959144|NCT01597245|559276950|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
154959145|NCT01597245|559276951|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
154959146|NCT01597245|559276952|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
154959147|NCT01597245|559276953|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959148|NCT01597245|559276954|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959149|NCT01597245|559276955|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959150|NCT01597245|559276956|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959151|NCT01597245|559276957|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959152|NCT01597245|559276958|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959153|NCT01597245|559276959|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959154|NCT01597245|559276960|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959155|NCT01597245|559276961|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959156|NCT01597245|559276962|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959157|NCT01597245|559276963|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155307177|NCT05368558|560556057|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307178|NCT05368558|560556058|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307179|NCT05368558|560556059|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307180|NCT05368558|560556060|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
155307181|NCT05368558|560556061|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307182|NCT05368558|560556062|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
155307183|NCT05368558|560556063|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307184|NCT05368558|560556064|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307185|NCT05368558|560556065|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307186|NCT05368558|560556066|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307187|NCT05368558|560556067|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307188|NCT05368558|560556068|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
155307189|NCT05368558|560556057|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307190|NCT05368558|560556058|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307191|NCT05368558|560556059|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307192|NCT05368558|560556060|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
155307193|NCT05368558|560556061|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307194|NCT05368558|560556062|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307195|NCT05368558|560556063|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307196|NCT05368558|560556064|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307197|NCT05368558|560556065|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307198|NCT05368558|560556066|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307199|NCT05368558|560556067|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307200|NCT05368558|560556068|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
155307201|NCT05368558|560556057|FG000|Blinded Extension Period (BEP)|other|0|||
155307202|NCT05368558|560556058|FG001|Blinded Extension Period (BEP)|other|0|||
155307203|NCT05368558|560556059|FG002|Blinded Extension Period (BEP)|other|0|||
155307204|NCT05368558|560556060|FG003|Blinded Extension Period (BEP)|other|0|||
155307205|NCT05368558|560556061|FG004|Blinded Extension Period (BEP)|other|0|||
155307206|NCT05368558|560556062|FG005|Blinded Extension Period (BEP)|other|1|||
155307207|NCT05368558|560556063|FG006|Blinded Extension Period (BEP)|other|0|||
155307208|NCT05368558|560556064|FG007|Blinded Extension Period (BEP)|other|0|||
155307209|NCT05368558|560556065|FG008|Blinded Extension Period (BEP)|other|0|||
155307210|NCT05368558|560556066|FG009|Blinded Extension Period (BEP)|other|0|||
155307211|NCT05368558|560556067|FG010|Blinded Extension Period (BEP)|other|0|||
155307212|NCT05368558|560556068|FG011|Blinded Extension Period (BEP)|other|0|||
155307213|NCT01303445|560556071|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
155307214|NCT01303445|560556072|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
155307215|NCT01303445|560556071|FG000|Second Intervention (7 Days)|Adverse Event|0|||
155307216|NCT01303445|560556072|FG001|Second Intervention (7 Days)|Adverse Event|2|||
155307217|NCT01303445|560556071|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
155307218|NCT01303445|560556072|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
155307219|NCT01303445|560556071|FG000|Washout (14 Days)|Protocol Violation|1|||
155307220|NCT01303445|560556072|FG001|Washout (14 Days)|Protocol Violation|0|||
155307221|NCT01303445|560556071|FG000|Washout (14 Days)|Lost to Follow-up|0|||
155307222|NCT01303445|560556072|FG001|Washout (14 Days)|Lost to Follow-up|2|||
155307223|NCT01303445|560556071|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
155307224|NCT01303445|560556072|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
155307225|NCT01303445|560556071|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
155307226|NCT01303445|560556072|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
155307227|NCT04923347|560557357|FG000|Overall Study|Withdrawal by Subject|14|||
155307228|NCT03547908|560557360|FG000|Blinded Phase|Lost to Follow-up|3|||
155307229|NCT03547908|560557361|FG001|Blinded Phase|Lost to Follow-up|3|||
155307230|NCT03547908|560557362|FG002|Blinded Phase|Lost to Follow-up|0|||
155307231|NCT03547908|560557363|FG003|Blinded Phase|Lost to Follow-up|0|||
155307232|NCT03547908|560557360|FG000|Blinded Phase|Withdrew Consent|2|||
155307233|NCT03547908|560557361|FG001|Blinded Phase|Withdrew Consent|3|||
155307234|NCT03547908|560557362|FG002|Blinded Phase|Withdrew Consent|0|||
155307235|NCT03547908|560557363|FG003|Blinded Phase|Withdrew Consent|0|||
155307236|NCT03547908|560557360|FG000|Blinded Phase|Investigator's Discretion|2|||
155307237|NCT03547908|560557361|FG001|Blinded Phase|Investigator's Discretion|1|||
155307238|NCT03547908|560557362|FG002|Blinded Phase|Investigator's Discretion|0|||
154959158|NCT01597245|559276964|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155307239|NCT03547908|560557363|FG003|Blinded Phase|Investigator's Discretion|0|||
155307240|NCT03547908|560557360|FG000|Blinded Phase|Death|2|||
155307241|NCT03547908|560557361|FG001|Blinded Phase|Death|0|||
155307242|NCT03547908|560557362|FG002|Blinded Phase|Death|0|||
155307243|NCT03547908|560557363|FG003|Blinded Phase|Death|0|||
155307244|NCT03547908|560557360|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
155307245|NCT03547908|560557361|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
155307246|NCT03547908|560557362|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
155307247|NCT03547908|560557363|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
155307248|NCT03547908|560557360|FG000|Blinded Phase|Adverse Event|1|||
155307249|NCT03547908|560557361|FG001|Blinded Phase|Adverse Event|0|||
155307250|NCT03547908|560557362|FG002|Blinded Phase|Adverse Event|0|||
155307251|NCT03547908|560557363|FG003|Blinded Phase|Adverse Event|0|||
155307252|NCT03547908|560557360|FG000|Blinded Phase|Randomized But Never Treated|1|||
155307253|NCT03547908|560557361|FG001|Blinded Phase|Randomized But Never Treated|0|||
155307254|NCT03547908|560557362|FG002|Blinded Phase|Randomized But Never Treated|0|||
155307255|NCT03547908|560557363|FG003|Blinded Phase|Randomized But Never Treated|0|||
155307256|NCT03547908|560557360|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
155307257|NCT03547908|560557361|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
155307258|NCT03547908|560557362|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
155307259|NCT03547908|560557363|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
155307260|NCT03547908|560557360|FG000|Open-label Extension Phase|Death|0|||
155307261|NCT03547908|560557361|FG001|Open-label Extension Phase|Death|0|||
155307262|NCT03547908|560557362|FG002|Open-label Extension Phase|Death|1|||
155307263|NCT03547908|560557363|FG003|Open-label Extension Phase|Death|0|||
155307264|NCT04059354|560557366|FG000|Overall Study|COVID-19 pandemic|3|||
155307265|NCT02396199|560557367|FG000|Overall Study|Lost to Follow-up|1|||
155307266|NCT02396199|560557367|FG000|Overall Study|Death|4|||
155307267|NCT02349412|560557368|FG000|Overall Study|Withdrawal by Subject|7|||
155307268|NCT02349412|560557369|FG001|Overall Study|Withdrawal by Subject|7|||
155307269|NCT00979576|560557372|FG000|Combination Treatment Phase|Progressive disease|3|||
155307270|NCT00979576|560557373|FG001|Combination Treatment Phase|Progressive disease|1|||
155307271|NCT00979576|560557374|FG002|Combination Treatment Phase|Progressive disease|5|||
155307272|NCT00979576|560557372|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
155307273|NCT00979576|560557373|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
155307274|NCT00979576|560557374|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
155307275|NCT00979576|560557372|FG000|Combination Treatment Phase|Adverse Event|0|||
155307276|NCT00979576|560557373|FG001|Combination Treatment Phase|Adverse Event|2|||
155307277|NCT00979576|560557374|FG002|Combination Treatment Phase|Adverse Event|2|||
155307278|NCT00979576|560557372|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
155307279|NCT00979576|560557373|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
155307280|NCT00979576|560557374|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
155307281|NCT04855760|560557375|FG000|Overall Study|Adverse Event|21|||
155307282|NCT04855760|560557375|FG000|Overall Study|Withdrawal by Subject|116|||
155307283|NCT04855760|560557375|FG000|Overall Study|Lack of Efficacy|21|||
155307284|NCT04855760|560557375|FG000|Overall Study|Lost to Follow-up|49|||
155307285|NCT04855760|560557375|FG000|Overall Study|Protocol Violation|2|||
155161189|NCT01285323|560026773|FG000|Overall Study|Lack of Efficacy|4|||
155161190|NCT01285323|560026774|FG001|Overall Study|Lack of Efficacy|2|||
155307286|NCT04855760|560557375|FG000|Overall Study|Physician Decision|5|||
155307287|NCT04855760|560557375|FG000|Overall Study|Pregnancy|1|||
155307288|NCT04855760|560557375|FG000|Overall Study|Non-Compliance with Study Drug|11|||
155161191|NCT01285323|560026773|FG000|Overall Study|Withdrawal by Subject|15|||
155307289|NCT04855760|560557375|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
155307290|NCT04855760|560557375|FG000|Overall Study|Study Completed by Sponsor|202|||
155307291|NCT04855760|560557375|FG000|Overall Study|Other|13|||
155307292|NCT03424811|560557380|FG000|Overall Study|Lost to Follow-up|9|||
155307293|NCT03424811|560557381|FG001|Overall Study|Lost to Follow-up|0|||
155307294|NCT03055377|560557383|FG000|Treatment Phase|Lost to Follow-up|28|||
155307295|NCT03055377|560557384|FG001|Treatment Phase|Lost to Follow-up|24|||
155307296|NCT03055377|560557383|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
155307297|NCT03055377|560557384|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
155307298|NCT03157167|560557387|FG000|Overall Study|Withdrawal by Subject|1|||
155307299|NCT03157167|560557388|FG001|Overall Study|Withdrawal by Subject|0|||
155307300|NCT03157167|560557389|FG002|Overall Study|Withdrawal by Subject|0|||
155307301|NCT04905407|560557390|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
155307302|NCT04905407|560557391|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
155307303|NCT04905407|560557392|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
155307304|NCT04905407|560557393|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
155307305|NCT04905407|560557390|FG000|Part 1 and Part 2|Death|7|||
155307306|NCT04905407|560557391|FG001|Part 1 and Part 2|Death|7|||
155307307|NCT04905407|560557392|FG002|Part 1 and Part 2|Death|7|||
155307308|NCT04905407|560557393|FG003|Part 1 and Part 2|Death|0|||
155307309|NCT04905407|560557390|FG000|Part 1 and Part 2|Other than specified|0|||
155307310|NCT04905407|560557391|FG001|Part 1 and Part 2|Other than specified|0|||
155307311|NCT04905407|560557392|FG002|Part 1 and Part 2|Other than specified|1|||
155307312|NCT04905407|560557393|FG003|Part 1 and Part 2|Other than specified|0|||
155307313|NCT04905407|560557390|FG000|Part 3|Death|0|||
155307314|NCT04905407|560557391|FG001|Part 3|Death|0|||
155307315|NCT04905407|560557392|FG002|Part 3|Death|0|||
155307316|NCT04905407|560557393|FG003|Part 3|Death|2|||
155307317|NCT03263026|560557396|FG000|Overall Study|Withdrawal by Subject|1|||
155307318|NCT03263026|560557397|FG001|Overall Study|Withdrawal by Subject|0|||
154959159|NCT01597245|559276965|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959160|NCT01597245|559276966|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959161|NCT01597245|559276967|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959162|NCT01597245|559276968|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
154959163|NCT01597245|559276969|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
155307319|NCT03263026|560557396|FG000|Overall Study|Death|1|||
155307320|NCT03263026|560557397|FG001|Overall Study|Death|0|||
155307321|NCT03263026|560557396|FG000|Overall Study|Other/ Various|41|||
155307322|NCT03263026|560557397|FG001|Overall Study|Other/ Various|29|||
155307323|NCT04868110|560557398|FG000|Overall Study|Withdrawal by Subject|3|||
155307324|NCT04868110|560557399|FG001|Overall Study|Withdrawal by Subject|4|||
155307325|NCT04178733|560557406|FG000|Overall Study|Investigator Decision|0|||
155307326|NCT04178733|560557407|FG001|Overall Study|Investigator Decision|0|||
155307327|NCT04178733|560557408|FG002|Overall Study|Investigator Decision|0|||
155307328|NCT04178733|560557409|FG003|Overall Study|Investigator Decision|1|||
155307329|NCT04178733|560557410|FG004|Overall Study|Investigator Decision|2|||
155307330|NCT03655132|560557413|FG000|Overall Study|Lost to Follow-up|2|||
155307331|NCT03655132|560557414|FG001|Overall Study|Lost to Follow-up|1|||
155307332|NCT03655132|560557413|FG000|Overall Study|Withdrawal by Subject|0|||
155307333|NCT03655132|560557414|FG001|Overall Study|Withdrawal by Subject|1|||
155307334|NCT03655132|560557413|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
155307335|NCT03655132|560557414|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
155307336|NCT02651324|560557416|FG000|Overall Study|drug not administered, due dispensing issue|1|||
155307337|NCT02651324|560557417|FG001|Overall Study|drug not administered, due dispensing issue|0|||
155307338|NCT05919082|560557418|FG000|Overall Study|Adverse Event|3|||
154959164|NCT01597245|559276949|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
154959165|NCT01597245|559276950|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
154959166|NCT01597245|559276951|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
155307339|NCT05919082|560557419|FG001|Overall Study|Adverse Event|0|||
155307340|NCT05919082|560557418|FG000|Overall Study|Lost to Follow-up|0|||
155307341|NCT05919082|560557419|FG001|Overall Study|Lost to Follow-up|1|||
155307342|NCT05919082|560557418|FG000|Overall Study|Withdrawal by Subject|8|||
154959167|NCT01597245|559276952|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
154959168|NCT01597245|559276953|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959169|NCT01597245|559276954|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959170|NCT01597245|559276955|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959171|NCT01597245|559276956|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959172|NCT01597245|559276957|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959173|NCT01597245|559276958|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959174|NCT01597245|559276959|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959175|NCT01597245|559276960|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959176|NCT01597245|559276961|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959177|NCT01597245|559276962|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959178|NCT01597245|559276963|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959179|NCT01597245|559276964|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959180|NCT01597245|559276965|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959181|NCT01597245|559276966|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959182|NCT01597245|559276967|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959183|NCT01597245|559276968|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959184|NCT01597245|559276969|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
154959185|NCT01597245|559276949|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
154959186|NCT01597245|559276950|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
154959187|NCT01597245|559276951|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
154959188|NCT01597245|559276952|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959189|NCT01597245|559276953|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959190|NCT01597245|559276954|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959191|NCT01597245|559276955|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959192|NCT01597245|559276956|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959193|NCT01597245|559276957|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959194|NCT01597245|559276958|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155307343|NCT05919082|560557419|FG001|Overall Study|Withdrawal by Subject|9|||
155307344|NCT05919082|560557418|FG000|Overall Study|Lack of Efficacy|0|||
155307345|NCT05919082|560557419|FG001|Overall Study|Lack of Efficacy|1|||
154959195|NCT01597245|559276959|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959196|NCT01597245|559276960|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959197|NCT01597245|559276961|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959198|NCT01597245|559276962|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959199|NCT01597245|559276963|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959200|NCT01597245|559276964|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959201|NCT01597245|559276965|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959202|NCT01597245|559276966|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959203|NCT01597245|559276967|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959204|NCT01597245|559276968|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
154959205|NCT01597245|559276969|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
155307346|NCT05919082|560557418|FG000|Overall Study|Investigator Decision|1|||
155307347|NCT05919082|560557419|FG001|Overall Study|Investigator Decision|0|||
155307348|NCT02287311|560557420|FG000|Cohort 1: Dose Level 1|Death|2|||
155307349|NCT02287311|560557421|FG001|Cohort 1: Dose Level 1|Death|0|||
155307350|NCT02287311|560557422|FG002|Cohort 1: Dose Level 1|Death|0|||
155307351|NCT02287311|560557423|FG003|Cohort 1: Dose Level 1|Death|3|||
155307352|NCT02287311|560557424|FG004|Cohort 1: Dose Level 1|Death|0|||
155307353|NCT02287311|560557425|FG005|Cohort 1: Dose Level 1|Death|0|||
155307354|NCT02287311|560557426|FG006|Cohort 1: Dose Level 1|Death|1|||
155307355|NCT02287311|560557427|FG007|Cohort 1: Dose Level 1|Death|0|||
155307356|NCT02287311|560557428|FG008|Cohort 1: Dose Level 1|Death|0|||
155307357|NCT02287311|560557420|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307358|NCT02287311|560557421|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307359|NCT02287311|560557422|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307360|NCT02287311|560557423|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
155307361|NCT02287311|560557424|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307362|NCT02287311|560557425|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307363|NCT02287311|560557426|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
155307364|NCT02287311|560557427|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307365|NCT02287311|560557428|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
155307366|NCT02287311|560557420|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
155307367|NCT02287311|560557421|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
155307368|NCT02287311|560557422|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
155307369|NCT02287311|560557423|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
155307370|NCT02287311|560557424|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
155307371|NCT02287311|560557425|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
155307372|NCT02287311|560557426|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
155307373|NCT02287311|560557427|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
155307374|NCT02287311|560557428|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
155307375|NCT02287311|560557420|FG000|Cohort 2: Dose Level 2|Death|0|||
155307376|NCT02287311|560557421|FG001|Cohort 2: Dose Level 2|Death|2|||
155307377|NCT02287311|560557422|FG002|Cohort 2: Dose Level 2|Death|0|||
155307378|NCT02287311|560557423|FG003|Cohort 2: Dose Level 2|Death|0|||
155307379|NCT02287311|560557424|FG004|Cohort 2: Dose Level 2|Death|2|||
155307380|NCT02287311|560557425|FG005|Cohort 2: Dose Level 2|Death|0|||
155307381|NCT02287311|560557426|FG006|Cohort 2: Dose Level 2|Death|0|||
155307382|NCT02287311|560557427|FG007|Cohort 2: Dose Level 2|Death|2|||
155307383|NCT02287311|560557428|FG008|Cohort 2: Dose Level 2|Death|0|||
155307384|NCT02287311|560557420|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307385|NCT02287311|560557421|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307386|NCT02287311|560557422|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307387|NCT02287311|560557423|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307388|NCT02287311|560557424|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
155307389|NCT02287311|560557425|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307390|NCT02287311|560557426|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307391|NCT02287311|560557427|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307392|NCT02287311|560557428|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
155307393|NCT02287311|560557420|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307394|NCT02287311|560557421|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
155065572|NCT03570892|559670012|FG001|Overall Study|Physician Decision|2|||
155065573|NCT05020015|559672100|FG000|Overall Study|Ongoing on study|1|||
155065574|NCT05020015|559672101|FG001|Overall Study|Ongoing on study|3|||
155065575|NCT05020015|559672102|FG002|Overall Study|Ongoing on study|4|||
155065576|NCT05020015|559672103|FG003|Overall Study|Ongoing on study|7|||
155065577|NCT05020015|559672100|FG000|Overall Study|Death|2|||
155065578|NCT05020015|559672101|FG001|Overall Study|Death|3|||
155065579|NCT05020015|559672102|FG002|Overall Study|Death|4|||
155065580|NCT05020015|559672103|FG003|Overall Study|Death|0|||
155065581|NCT05020015|559672100|FG000|Overall Study|Withdrawal by Subject|0|||
155065582|NCT05020015|559672101|FG001|Overall Study|Withdrawal by Subject|0|||
155065583|NCT05020015|559672102|FG002|Overall Study|Withdrawal by Subject|1|||
155065584|NCT05020015|559672103|FG003|Overall Study|Withdrawal by Subject|0|||
155065585|NCT05020015|559672100|FG000|Overall Study|Reason Not Specified|0|||
155065586|NCT05020015|559672101|FG001|Overall Study|Reason Not Specified|0|||
155065587|NCT05020015|559672102|FG002|Overall Study|Reason Not Specified|2|||
155307395|NCT02287311|560557422|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307396|NCT02287311|560557423|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307397|NCT02287311|560557424|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307398|NCT02287311|560557425|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307399|NCT02287311|560557426|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307400|NCT02287311|560557427|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307401|NCT02287311|560557428|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
155307402|NCT02287311|560557420|FG000|Cohort 3: Dose Level 3|Death|0|||
155307403|NCT02287311|560557421|FG001|Cohort 3: Dose Level 3|Death|0|||
155307404|NCT02287311|560557422|FG002|Cohort 3: Dose Level 3|Death|4|||
155307405|NCT02287311|560557423|FG003|Cohort 3: Dose Level 3|Death|0|||
155307406|NCT02287311|560557424|FG004|Cohort 3: Dose Level 3|Death|0|||
155307407|NCT02287311|560557425|FG005|Cohort 3: Dose Level 3|Death|4|||
155307408|NCT02287311|560557426|FG006|Cohort 3: Dose Level 3|Death|0|||
155307409|NCT02287311|560557427|FG007|Cohort 3: Dose Level 3|Death|0|||
155307410|NCT02287311|560557428|FG008|Cohort 3: Dose Level 3|Death|2|||
155307411|NCT02287311|560557420|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307412|NCT02287311|560557421|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307413|NCT02287311|560557422|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
155307414|NCT02287311|560557423|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307415|NCT02287311|560557424|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307416|NCT02287311|560557425|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
155307417|NCT02287311|560557426|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307418|NCT02287311|560557427|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307419|NCT02287311|560557428|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
155307420|NCT02287311|560557420|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307421|NCT02287311|560557421|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307422|NCT02287311|560557422|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307423|NCT02287311|560557423|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307424|NCT02287311|560557424|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307425|NCT02287311|560557425|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
155307426|NCT02287311|560557426|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307427|NCT02287311|560557427|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
155307428|NCT02287311|560557428|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
155307429|NCT05415410|560557433|FG000|Overall Study|Death|3|||
155307430|NCT05415410|560557434|FG001|Overall Study|Death|6|||
155307431|NCT05415410|560557435|FG002|Overall Study|Death|1|||
155307432|NCT05415410|560557433|FG000|Overall Study|Trial Terminated by Sponsor|1|||
155307433|NCT05415410|560557434|FG001|Overall Study|Trial Terminated by Sponsor|5|||
155307434|NCT05415410|560557435|FG002|Overall Study|Trial Terminated by Sponsor|0|||
155307435|NCT05415410|560557433|FG000|Overall Study|Adverse Event|2|||
155307436|NCT05415410|560557434|FG001|Overall Study|Adverse Event|1|||
155307437|NCT05415410|560557435|FG002|Overall Study|Adverse Event|0|||
155307438|NCT05415410|560557433|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
155307439|NCT05415410|560557434|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
155307440|NCT05415410|560557435|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
155307441|NCT05415410|560557433|FG000|Overall Study|Withdrawal by Subject|1|||
155307442|NCT05415410|560557434|FG001|Overall Study|Withdrawal by Subject|0|||
155307443|NCT05415410|560557435|FG002|Overall Study|Withdrawal by Subject|0|||
155307444|NCT05415410|560557433|FG000|Overall Study|Pregnancy|5|||
155307445|NCT05415410|560557434|FG001|Overall Study|Pregnancy|2|||
155307446|NCT05415410|560557435|FG002|Overall Study|Pregnancy|0|||
155307447|NCT02365766|560557436|FG000|Overall Study|Withdrawal by Subject|0|||
155307448|NCT02365766|560557437|FG001|Overall Study|Withdrawal by Subject|0|||
155307449|NCT02365766|560557438|FG002|Overall Study|Withdrawal by Subject|1|||
155307450|NCT02365766|560557436|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155307451|NCT02365766|560557437|FG001|Overall Study|Eligibility Criteria Not Met|0|||
155307452|NCT02365766|560557438|FG002|Overall Study|Eligibility Criteria Not Met|1|||
155307453|NCT04791709|560557445|FG000|Overall Study|Withdrawal by Subject|3|||
155307454|NCT02724956|560557446|FG000|Overall Study|Physician Decision|1|||
155307455|NCT02724956|560557447|FG001|Overall Study|Physician Decision|0|||
155307456|NCT02724956|560557446|FG000|Overall Study|Lack of Efficacy|0|||
155307457|NCT02724956|560557447|FG001|Overall Study|Lack of Efficacy|1|||
155307458|NCT02724956|560557446|FG000|Overall Study|Withdrawal by Subject|0|||
155307459|NCT02724956|560557447|FG001|Overall Study|Withdrawal by Subject|1|||
155307460|NCT00650104|560557448|FG000|Overall Study|Adverse Event|17|||
155307461|NCT00650104|560557448|FG000|Overall Study|Death|2|||
155307462|NCT00650104|560557448|FG000|Overall Study|Withdrawal by Subject|11|||
155307463|NCT00650104|560557448|FG000|Overall Study|Physician Decision|7|||
155307464|NCT00650104|560557448|FG000|Overall Study|Lost to Follow-up|1|||
155307465|NCT00650104|560557448|FG000|Overall Study|Non-compliance|2|||
155307466|NCT00650104|560557448|FG000|Overall Study|Sponsor Terminated Dosing|1|||
155307467|NCT03385629|560557449|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
155307468|NCT03385629|560557450|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
155307469|NCT03385629|560557449|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
155307470|NCT03385629|560557450|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
155065588|NCT05020015|559672103|FG003|Overall Study|Reason Not Specified|0|||
155065589|NCT06633965|559672104|FG000|Overall Study|Withdrawal by Subject|0|||
155065590|NCT06633965|559672105|FG001|Overall Study|Withdrawal by Subject|1|||
155307471|NCT03385629|560557449|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
155307472|NCT03385629|560557450|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
155307473|NCT01532388|560557451|FG000|3-month Follow-up|Lost to Follow-up|68|||
155307474|NCT01532388|560557452|FG001|3-month Follow-up|Lost to Follow-up|68|||
155307475|NCT01532388|560557451|FG000|6-month Follow-up|Lost to Follow-up|74|||
155307476|NCT01532388|560557452|FG001|6-month Follow-up|Lost to Follow-up|66|||
155307477|NCT01532388|560557451|FG000|12-month Follow-up|Lost to Follow-up|69|||
155307478|NCT01532388|560557452|FG001|12-month Follow-up|Lost to Follow-up|67|||
155307479|NCT02697136|560557456|FG000|Overall Study|Adverse Event|3|||
155307480|NCT02697136|560557457|FG001|Overall Study|Adverse Event|0|||
155307481|NCT03578536|560557458|FG000|Overall Study|Lost to Follow-up|1|||
155307482|NCT02538900|560557459|FG000|Overall Study|Death|2|||
155307483|NCT02538900|560557460|FG001|Overall Study|Death|2|||
155307484|NCT02538900|560557461|FG002|Overall Study|Death|2|||
155307485|NCT02538900|560557459|FG000|Overall Study|Withdrawal by Subject|18|||
155307486|NCT02538900|560557460|FG001|Overall Study|Withdrawal by Subject|16|||
155307487|NCT02538900|560557461|FG002|Overall Study|Withdrawal by Subject|15|||
155307488|NCT00999167|560557462|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
155307489|NCT00999167|560557463|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
155307490|NCT00999167|560557464|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
155307491|NCT00999167|560557462|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
155307492|NCT00999167|560557463|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
155307493|NCT00999167|560557464|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
155307494|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
155307495|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
155307496|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
155307497|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
155307498|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
155307499|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
155307500|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
155065591|NCT00947544|559672110|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
155065592|NCT00947544|559672111|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
155065593|NCT00300053|559672112|FG000|Overall Study|Patient/Caregiver Preference|2|||
155065594|NCT00300053|559672113|FG001|Overall Study|Patient/Caregiver Preference|2|||
155065595|NCT00300053|559672114|FG002|Overall Study|Patient/Caregiver Preference|3|||
155065596|NCT00300053|559672112|FG000|Overall Study|Death|0|||
155065597|NCT00300053|559672113|FG001|Overall Study|Death|0|||
155307501|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
155307502|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
155307503|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
155307504|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
155307505|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
155307506|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
155307507|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
155307508|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
155307509|NCT00999167|560557462|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
155307510|NCT00999167|560557463|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
155307511|NCT00999167|560557464|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
155307512|NCT02789020|560557465|FG000|Overall Study|Withdrawal by Subject|6|||
155307513|NCT02789020|560557466|FG001|Overall Study|Withdrawal by Subject|5|||
155307514|NCT04238247|560557467|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
155307515|NCT04238247|560557468|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
155161192|NCT01285323|560026774|FG001|Overall Study|Withdrawal by Subject|11|||
155161193|NCT01285323|560026773|FG000|Overall Study|Protocol Violation|1|||
155161194|NCT01285323|560026774|FG001|Overall Study|Protocol Violation|2|||
155307516|NCT04238247|560557469|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
155307517|NCT04238247|560557470|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
155307518|NCT04238247|560557467|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
155307519|NCT04238247|560557468|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
155307520|NCT04238247|560557469|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
155307521|NCT04238247|560557470|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
155307522|NCT04238247|560557467|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
155307523|NCT04238247|560557468|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
155307524|NCT04238247|560557469|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
155307525|NCT04238247|560557470|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
155307526|NCT04238247|560557467|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
155307527|NCT04238247|560557468|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
155307528|NCT04238247|560557469|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
155307529|NCT04238247|560557470|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
155307530|NCT05512962|560557471|FG000|Overall Study|Withdrawal by Subject|1|||
155307531|NCT05512962|560557472|FG001|Overall Study|Withdrawal by Subject|0|||
155307532|NCT04950127|560557473|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
155307533|NCT04950127|560557474|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
155307534|NCT04950127|560557475|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307535|NCT04950127|560557476|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307536|NCT04950127|560557477|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307537|NCT04950127|560557478|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
155307538|NCT04950127|560557473|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
155307539|NCT04950127|560557474|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
155307540|NCT04950127|560557475|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307541|NCT04950127|560557476|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307542|NCT04950127|560557477|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307543|NCT04950127|560557478|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
155307544|NCT04950127|560557473|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
155307545|NCT04950127|560557474|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
155307546|NCT04950127|560557475|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307547|NCT04950127|560557476|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307548|NCT04950127|560557477|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307549|NCT04950127|560557478|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
155307550|NCT04950127|560557473|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307551|NCT04950127|560557474|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307552|NCT04950127|560557475|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307553|NCT04950127|560557476|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307554|NCT04950127|560557477|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
155307555|NCT04950127|560557478|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
155307556|NCT04950127|560557473|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307557|NCT04950127|560557474|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307558|NCT04950127|560557475|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307559|NCT04950127|560557476|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307560|NCT04950127|560557477|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
155307561|NCT04950127|560557478|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
155307562|NCT01711632|560557479|FG000|Overall Study|Adverse Event|4|||
155307563|NCT01711632|560557479|FG000|Overall Study|Death|3|||
155065598|NCT00300053|559672114|FG002|Overall Study|Death|3|||
155065599|NCT00300053|559672112|FG000|Overall Study|Lost to Follow-up|0|||
155307564|NCT01711632|560557479|FG000|Overall Study|Lost to Follow-up|3|||
155307565|NCT01711632|560557479|FG000|Overall Study|Withdrawal by Subject|4|||
155307566|NCT01711632|560557479|FG000|Overall Study|Progressive disease|2|||
155307567|NCT01711632|560557479|FG000|Overall Study|No follow up required in re-treatment|3|||
155307568|NCT01711632|560557479|FG000|Overall Study|No follow up required in re-treatment|3|||
155307569|NCT04315181|560557480|FG000|Overall Study|Non-responsive to drug conditions.|1|||
155307570|NCT01948661|560557481|FG000|Overall Study|Withdrawal by Subject|2|||
155307571|NCT01948661|560557482|FG001|Overall Study|Withdrawal by Subject|4|||
155307572|NCT03517969|560557483|FG000|Overall Study|Never started protocol treatment|3|||
155307573|NCT03517969|560557484|FG001|Overall Study|Never started protocol treatment|5|||
155307574|NCT03517969|560557483|FG000|Overall Study|Disease progression|11|||
155307575|NCT03517969|560557484|FG001|Overall Study|Disease progression|16|||
155307576|NCT03517969|560557483|FG000|Overall Study|PSA progression|8|||
155307577|NCT03517969|560557484|FG001|Overall Study|PSA progression|1|||
155307578|NCT03517969|560557483|FG000|Overall Study|Clinical progression|4|||
155307579|NCT03517969|560557484|FG001|Overall Study|Clinical progression|2|||
155307580|NCT03517969|560557483|FG000|Overall Study|Adverse Event|5|||
155307581|NCT03517969|560557484|FG001|Overall Study|Adverse Event|4|||
155307582|NCT03517969|560557483|FG000|Overall Study|Intercurrent illness|1|||
155307583|NCT03517969|560557484|FG001|Overall Study|Intercurrent illness|2|||
155307584|NCT03517969|560557483|FG000|Overall Study|Death|1|||
155307585|NCT03517969|560557484|FG001|Overall Study|Death|1|||
155065600|NCT00300053|559672113|FG001|Overall Study|Lost to Follow-up|1|||
155065601|NCT00300053|559672114|FG002|Overall Study|Lost to Follow-up|0|||
155065602|NCT02566005|559672115|FG000|Overall Study|vaginal bleeding|0|||
155065603|NCT02566005|559672116|FG001|Overall Study|vaginal bleeding|1|||
155307586|NCT03517969|560557483|FG000|Overall Study|Withdrawal by Subject|1|||
155307587|NCT03517969|560557484|FG001|Overall Study|Withdrawal by Subject|2|||
155307588|NCT03517969|560557483|FG000|Overall Study|Physician Decision|1|||
155307589|NCT03517969|560557484|FG001|Overall Study|Physician Decision|1|||
155307590|NCT03517969|560557483|FG000|Overall Study|No clinical benefit|1|||
154959206|NCT01597245|559276949|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
154959207|NCT01597245|559276950|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959208|NCT01597245|559276951|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959209|NCT01597245|559276952|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
154959210|NCT01597245|559276953|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959211|NCT01597245|559276954|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959212|NCT01597245|559276955|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959213|NCT01597245|559276956|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959214|NCT01597245|559276957|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959215|NCT01597245|559276958|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959216|NCT01597245|559276959|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959217|NCT01597245|559276960|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959218|NCT01597245|559276961|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959219|NCT01597245|559276962|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959220|NCT01597245|559276963|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959221|NCT01597245|559276964|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959222|NCT01597245|559276965|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959223|NCT01597245|559276966|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959224|NCT01597245|559276967|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959225|NCT01597245|559276968|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
154959226|NCT01597245|559276969|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
155065604|NCT02566005|559672115|FG000|Overall Study|received foley|8|||
155307591|NCT03517969|560557484|FG001|Overall Study|No clinical benefit|0|||
155307592|NCT03517969|560557483|FG000|Overall Study|Delayed treatment for dental treatment|1|||
155307593|NCT03517969|560557484|FG001|Overall Study|Delayed treatment for dental treatment|0|||
155065605|NCT02566005|559672116|FG001|Overall Study|received foley|0|||
155065606|NCT02566005|559672115|FG000|Overall Study|did not receive foley|0|||
155065607|NCT02566005|559672116|FG001|Overall Study|did not receive foley|1|||
155065608|NCT02566005|559672115|FG000|Overall Study|labor after randomization|0|||
155065609|NCT02566005|559672116|FG001|Overall Study|labor after randomization|4|||
155065610|NCT01294514|559672119|FG000|Overall Study|Excluded due to Arrhythmia|1|||
155065611|NCT02394275|559672120|FG000|Overall Study|Adverse Event|22|||
155065612|NCT02394275|559672120|FG000|Overall Study|Lost to Follow-up|7|||
155307594|NCT03517969|560557483|FG000|Overall Study|Difficult to maintain appointment|0|||
155307595|NCT03517969|560557484|FG001|Overall Study|Difficult to maintain appointment|1|||
155307596|NCT03517969|560557483|FG000|Overall Study|Protocol Violation|0|||
155307597|NCT03517969|560557484|FG001|Overall Study|Protocol Violation|1|||
155307598|NCT00522951|560557487|FG000|Period 1|body motion|0|||
155307599|NCT00522951|560557488|FG001|Period 1|body motion|1|||
155307600|NCT00522951|560557487|FG000|Washout Period|Adverse Event|0|||
155307601|NCT00522951|560557488|FG001|Washout Period|Adverse Event|1|||
155307602|NCT00522951|560557487|FG000|Washout Period|Death|0|||
155307603|NCT00522951|560557488|FG001|Washout Period|Death|1|||
155307604|NCT00522951|560557487|FG000|Period 2|Withdrawal by Subject|1|||
155307605|NCT00522951|560557488|FG001|Period 2|Withdrawal by Subject|0|||
155307606|NCT00522951|560557487|FG000|Period 2|residual contrast medium|1|||
155307607|NCT00522951|560557488|FG001|Period 2|residual contrast medium|1|||
155307608|NCT01101451|560557492|FG000|Overall Study|Eligible and never treated|0|||
155307609|NCT01101451|560557493|FG001|Overall Study|Eligible and never treated|5|||
155307610|NCT01101451|560557492|FG000|Overall Study|Ineligible and treated|12|||
155307611|NCT01101451|560557493|FG001|Overall Study|Ineligible and treated|8|||
155307612|NCT01101451|560557492|FG000|Overall Study|Ineligible and never treated|2|||
155307613|NCT01101451|560557493|FG001|Overall Study|Ineligible and never treated|2|||
155307614|NCT05480943|560557494|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
155307615|NCT05480943|560557494|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
155307616|NCT05480943|560557494|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
155307617|NCT05480943|560557494|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
155307618|NCT02272816|560557495|FG000|Overall Study|Adverse Event|1|||
155307619|NCT04999592|560557496|FG000|Overall Study|Withdrawal by Subject|1|||
155307620|NCT04999592|560557497|FG001|Overall Study|Withdrawal by Subject|0|||
155307621|NCT04924062|560559038|FG000|Overall Study|Death|49|||
155307622|NCT04924062|560559039|FG001|Overall Study|Death|63|||
155307623|NCT04924062|560559038|FG000|Overall Study|Participant On-going|26|||
155307624|NCT04924062|560559039|FG001|Overall Study|Participant On-going|20|||
155307625|NCT04823611|560559049|FG000|Overall Study|Adverse Event|2|||
155307626|NCT04823611|560559050|FG001|Overall Study|Adverse Event|0|||
155307627|NCT04823611|560559051|FG002|Overall Study|Adverse Event|1|||
155307628|NCT04823611|560559052|FG003|Overall Study|Adverse Event|0|||
155307629|NCT04823611|560559053|FG004|Overall Study|Adverse Event|0|||
155307630|NCT04823611|560559054|FG005|Overall Study|Adverse Event|0|||
155307631|NCT04823611|560559055|FG006|Overall Study|Adverse Event|0|||
155307632|NCT05320432|560559056|FG000|Overall Study|Withdrawal by Subject|0|||
155307633|NCT05320432|560559057|FG001|Overall Study|Withdrawal by Subject|2|||
155307634|NCT05038566|560559058|FG000|Overall Study|Technical Difficulties with the Device|0|||
155307635|NCT05038566|560559059|FG001|Overall Study|Technical Difficulties with the Device|1|||
155307636|NCT03739996|560559064|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
155307637|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
155307638|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
155307639|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
155307640|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
155307641|NCT03739996|560559064|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
155307642|NCT03739996|560559064|FG000|Step 3 (SOC ART)|Death|1|||
155307643|NCT03739996|560559064|FG000|Step 3 (SOC ART)|Participant moved|1|||
155307644|NCT05141903|560559065|FG000|Overall Study|Withdrawal by Subject|0|||
155307645|NCT05141903|560559066|FG001|Overall Study|Withdrawal by Subject|1|||
155307646|NCT05141903|560559067|FG002|Overall Study|Withdrawal by Subject|1|||
155307647|NCT05141903|560559068|FG003|Overall Study|Withdrawal by Subject|0|||
155307648|NCT05141903|560559069|FG004|Overall Study|Withdrawal by Subject|0|||
155307649|NCT05141903|560559065|FG000|Overall Study|Other|1|||
155307650|NCT05141903|560559066|FG001|Overall Study|Other|1|||
155307651|NCT05141903|560559067|FG002|Overall Study|Other|0|||
155307652|NCT05141903|560559068|FG003|Overall Study|Other|0|||
155307653|NCT05141903|560559069|FG004|Overall Study|Other|0|||
155307654|NCT05387447|560559073|FG000|Overall Study|Participants changed their minds about study participation.|3|||
155307655|NCT05387447|560559074|FG001|Overall Study|Participants changed their minds about study participation.|5|||
155307656|NCT05461131|560559080|FG000|Overall Study|Lost to Follow-up|0|||
155307657|NCT05461131|560559081|FG001|Overall Study|Lost to Follow-up|2|||
155307658|NCT05054374|560559102|FG000|Overall Study|Withdrawal by Subject|1|||
155307659|NCT05054374|560559103|FG001|Overall Study|Withdrawal by Subject|0|||
155307660|NCT05054374|560559104|FG002|Overall Study|Withdrawal by Subject|0|||
155307661|NCT05054374|560559105|FG003|Overall Study|Withdrawal by Subject|0|||
155307662|NCT05054374|560559102|FG000|Overall Study|Progressive Disease|5|||
155307663|NCT05054374|560559103|FG001|Overall Study|Progressive Disease|0|||
155307664|NCT05054374|560559104|FG002|Overall Study|Progressive Disease|0|||
155307665|NCT05054374|560559105|FG003|Overall Study|Progressive Disease|0|||
155307666|NCT05691309|560559106|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
155307667|NCT05691309|560559106|FG000|Overall Study|vancomycin levels not evaluable|2|||
155307668|NCT01707030|560559107|FG000|Overall Study|Death|1|||
155307669|NCT01707030|560559108|FG001|Overall Study|Death|1|||
155307670|NCT01707030|560559107|FG000|Overall Study|Withdrawal by Subject|2|||
155307671|NCT01707030|560559108|FG001|Overall Study|Withdrawal by Subject|3|||
155307672|NCT01707030|560559107|FG000|Overall Study|Lost to Follow-up|8|||
155307673|NCT01707030|560559108|FG001|Overall Study|Lost to Follow-up|13|||
155307674|NCT04437433|560559110|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
155307675|NCT04437433|560559111|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
155307676|NCT04437433|560559110|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
155307677|NCT04437433|560559111|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
155307678|NCT04437433|560559110|FG000|Overall Study|Adverse Event|9|||
155307679|NCT04437433|560559111|FG001|Overall Study|Adverse Event|0|||
155307680|NCT04437433|560559110|FG000|Overall Study|Lack of Efficacy|4|||
155307681|NCT04437433|560559111|FG001|Overall Study|Lack of Efficacy|0|||
155307682|NCT04437433|560559110|FG000|Overall Study|Withdrawal by Subject|4|||
155307683|NCT04437433|560559111|FG001|Overall Study|Withdrawal by Subject|1|||
155307684|NCT04437433|560559110|FG000|Overall Study|Protocol Deviation|0|||
155307685|NCT04437433|560559111|FG001|Overall Study|Protocol Deviation|1|||
155307686|NCT04437433|560559110|FG000|Overall Study|Other, not specified|0|||
155307687|NCT04437433|560559111|FG001|Overall Study|Other, not specified|1|||
155307688|NCT00792636|560559112|FG000|Overall Study|Protocol Violation|17|||
155307689|NCT00792636|560559113|FG001|Overall Study|Protocol Violation|23|||
155307690|NCT00792636|560559114|FG002|Overall Study|Protocol Violation|20|||
155307691|NCT00792636|560559112|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
155307692|NCT00792636|560559113|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
155307693|NCT00792636|560559114|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
155307694|NCT00792636|560559112|FG000|Overall Study|Lost to Follow-up|13|||
155307695|NCT00792636|560559113|FG001|Overall Study|Lost to Follow-up|19|||
155307696|NCT00792636|560559114|FG002|Overall Study|Lost to Follow-up|14|||
155307697|NCT00792636|560559112|FG000|Overall Study|Withdrew Consent|10|||
155307698|NCT00792636|560559113|FG001|Overall Study|Withdrew Consent|13|||
155307699|NCT00792636|560559114|FG002|Overall Study|Withdrew Consent|9|||
155307700|NCT00792636|560559112|FG000|Overall Study|Lack of Efficacy|3|||
155307701|NCT00792636|560559113|FG001|Overall Study|Lack of Efficacy|4|||
155307702|NCT00792636|560559114|FG002|Overall Study|Lack of Efficacy|13|||
155307703|NCT00792636|560559112|FG000|Overall Study|Adverse Event|4|||
155307704|NCT00792636|560559113|FG001|Overall Study|Adverse Event|2|||
155307705|NCT00792636|560559114|FG002|Overall Study|Adverse Event|3|||
155307706|NCT00792636|560559112|FG000|Overall Study|Investigator Discretion|2|||
155307707|NCT00792636|560559113|FG001|Overall Study|Investigator Discretion|0|||
155307708|NCT00792636|560559114|FG002|Overall Study|Investigator Discretion|2|||
155307709|NCT04711135|560559118|FG000|Overall Study|Physician Decision|0|||
155307710|NCT04711135|560559119|FG001|Overall Study|Physician Decision|1|||
155307711|NCT04711135|560559118|FG000|Overall Study|Ongoing treatment|0|||
155307712|NCT04711135|560559119|FG001|Overall Study|Ongoing treatment|1|||
155307713|NCT04431726|560559128|FG000|Overall Study|Ongoing in the Study|55|||
155307714|NCT02860130|560559133|FG000|Overall Study|Adverse Event|2|||
155307715|NCT02860130|560559134|FG001|Overall Study|Adverse Event|3|||
155307716|NCT02860130|560559133|FG000|Overall Study|Protocol Violation|1|||
155307717|NCT02860130|560559134|FG001|Overall Study|Protocol Violation|1|||
155307718|NCT02860130|560559133|FG000|Overall Study|Withdrawal by Subject|0|||
155307719|NCT02860130|560559134|FG001|Overall Study|Withdrawal by Subject|2|||
155307720|NCT02860130|560559133|FG000|Overall Study|Physician Decision|2|||
155307721|NCT02860130|560559134|FG001|Overall Study|Physician Decision|2|||
155307722|NCT02860130|560559133|FG000|Overall Study|Other|2|||
155307723|NCT02860130|560559134|FG001|Overall Study|Other|1|||
155307724|NCT02140645|560559137|FG000|Overall Study|Not linked|5489|||
155307725|NCT02140645|560559138|FG001|Overall Study|Not linked|61654|||
155307726|NCT02140645|560559139|FG002|Overall Study|Not linked|4236|||
155307727|NCT02140645|560559140|FG003|Overall Study|Not linked|13833|||
155307728|NCT02140645|560559141|FG004|Overall Study|Not linked|3286|||
155307729|NCT02140645|560559142|FG005|Overall Study|Not linked|70896|||
155307730|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
155307731|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
155307732|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
155307733|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
155307734|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
155307735|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
155307736|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
155307737|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
155307738|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155307739|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155307740|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155307741|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
155307742|NCT02794480|560559143|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155307743|NCT02794480|560559144|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
155307744|NCT02794480|560559145|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155307745|NCT02794480|560559146|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155307746|NCT02794480|560559143|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
155307747|NCT02794480|560559144|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155307748|NCT02794480|560559145|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155307749|NCT02794480|560559146|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
155307750|NCT00593489|560559147|FG000|Allocation|did not attend workshop; allocation not|2|||
155307751|NCT00593489|560559148|FG001|Allocation|did not attend workshop; allocation not|1|||
155307752|NCT01747486|560559152|FG000|Stage 1|Physician Decision|3|||
155307753|NCT01747486|560559153|FG001|Stage 1|Physician Decision|0|||
155307754|NCT01747486|560559152|FG000|Stage 1|Withdrawal by Subject|4|||
155307755|NCT01747486|560559153|FG001|Stage 1|Withdrawal by Subject|3|||
155307756|NCT01747486|560559152|FG000|Stage 1|Disease progression|4|||
155307757|NCT01747486|560559153|FG001|Stage 1|Disease progression|9|||
155307758|NCT01747486|560559152|FG000|Stage 1|Death|1|||
155307759|NCT01747486|560559153|FG001|Stage 1|Death|1|||
155307760|NCT01747486|560559152|FG000|Stage 2|Physician Decision|2|||
155307761|NCT01747486|560559153|FG001|Stage 2|Physician Decision|0|||
155307762|NCT01747486|560559152|FG000|Stage 2|Withdrawal by Subject|1|||
155307763|NCT01747486|560559153|FG001|Stage 2|Withdrawal by Subject|0|||
155307764|NCT01747486|560559152|FG000|Stage 2|New Cancer Therapy|3|||
155307765|NCT01747486|560559153|FG001|Stage 2|New Cancer Therapy|0|||
155307766|NCT01747486|560559152|FG000|Stage 2|Disease Progression|3|||
155307767|NCT01747486|560559153|FG001|Stage 2|Disease Progression|0|||
155307768|NCT00632749|560559154|FG000|Overall Study|Progressive disease|3|||
155307769|NCT00632749|560559155|FG001|Overall Study|Progressive disease|2|||
155307770|NCT00632749|560559156|FG002|Overall Study|Progressive disease|2|||
155307771|NCT00632749|560559157|FG003|Overall Study|Progressive disease|2|||
155307772|NCT00632749|560559158|FG004|Overall Study|Progressive disease|4|||
155307773|NCT00632749|560559159|FG005|Overall Study|Progressive disease|4|||
155307774|NCT00632749|560559160|FG006|Overall Study|Progressive disease|3|||
155307775|NCT00632749|560559161|FG007|Overall Study|Progressive disease|2|||
155307776|NCT00632749|560559162|FG008|Overall Study|Progressive disease|3|||
155307777|NCT00632749|560559163|FG009|Overall Study|Progressive disease|2|||
155307778|NCT00632749|560559164|FG010|Overall Study|Progressive disease|4|||
155307779|NCT00632749|560559165|FG011|Overall Study|Progressive disease|3|||
155307780|NCT00632749|560559166|FG012|Overall Study|Progressive disease|2|||
155307781|NCT00632749|560559167|FG013|Overall Study|Progressive disease|4|||
155307782|NCT00632749|560559154|FG000|Overall Study|Other Adverse event|1|||
155307783|NCT00632749|560559155|FG001|Overall Study|Other Adverse event|1|||
155307784|NCT00632749|560559156|FG002|Overall Study|Other Adverse event|1|||
155307785|NCT00632749|560559157|FG003|Overall Study|Other Adverse event|1|||
155307786|NCT00632749|560559158|FG004|Overall Study|Other Adverse event|2|||
155307787|NCT00632749|560559159|FG005|Overall Study|Other Adverse event|4|||
155307788|NCT00632749|560559160|FG006|Overall Study|Other Adverse event|1|||
155307789|NCT00632749|560559161|FG007|Overall Study|Other Adverse event|2|||
155307790|NCT00632749|560559162|FG008|Overall Study|Other Adverse event|2|||
155307791|NCT00632749|560559163|FG009|Overall Study|Other Adverse event|0|||
155307792|NCT00632749|560559164|FG010|Overall Study|Other Adverse event|1|||
155307793|NCT00632749|560559165|FG011|Overall Study|Other Adverse event|0|||
155307794|NCT00632749|560559166|FG012|Overall Study|Other Adverse event|1|||
155307795|NCT00632749|560559167|FG013|Overall Study|Other Adverse event|0|||
155307796|NCT00632749|560559154|FG000|Overall Study|Refuse to continue medication|0|||
155307797|NCT00632749|560559155|FG001|Overall Study|Refuse to continue medication|0|||
155307798|NCT00632749|560559156|FG002|Overall Study|Refuse to continue medication|0|||
155307799|NCT00632749|560559157|FG003|Overall Study|Refuse to continue medication|1|||
155307800|NCT00632749|560559158|FG004|Overall Study|Refuse to continue medication|0|||
155307801|NCT00632749|560559159|FG005|Overall Study|Refuse to continue medication|0|||
155307802|NCT00632749|560559160|FG006|Overall Study|Refuse to continue medication|0|||
155307803|NCT00632749|560559161|FG007|Overall Study|Refuse to continue medication|0|||
155307804|NCT00632749|560559162|FG008|Overall Study|Refuse to continue medication|0|||
155307805|NCT00632749|560559163|FG009|Overall Study|Refuse to continue medication|1|||
155307806|NCT00632749|560559164|FG010|Overall Study|Refuse to continue medication|0|||
155307807|NCT00632749|560559165|FG011|Overall Study|Refuse to continue medication|0|||
155307808|NCT00632749|560559166|FG012|Overall Study|Refuse to continue medication|0|||
155307809|NCT00632749|560559167|FG013|Overall Study|Refuse to continue medication|0|||
155307810|NCT00632749|560559154|FG000|Overall Study|Reason other than those specified above|0|||
155307811|NCT00632749|560559155|FG001|Overall Study|Reason other than those specified above|2|||
155307812|NCT00632749|560559156|FG002|Overall Study|Reason other than those specified above|0|||
155307813|NCT00632749|560559157|FG003|Overall Study|Reason other than those specified above|0|||
155307814|NCT00632749|560559158|FG004|Overall Study|Reason other than those specified above|1|||
155307815|NCT00632749|560559159|FG005|Overall Study|Reason other than those specified above|0|||
155307816|NCT00632749|560559160|FG006|Overall Study|Reason other than those specified above|1|||
155307817|NCT00632749|560559161|FG007|Overall Study|Reason other than those specified above|0|||
155307818|NCT00632749|560559162|FG008|Overall Study|Reason other than those specified above|0|||
155307819|NCT00632749|560559163|FG009|Overall Study|Reason other than those specified above|0|||
155307820|NCT00632749|560559164|FG010|Overall Study|Reason other than those specified above|2|||
155307821|NCT00632749|560559165|FG011|Overall Study|Reason other than those specified above|1|||
155307822|NCT00632749|560559166|FG012|Overall Study|Reason other than those specified above|0|||
155307823|NCT00632749|560559167|FG013|Overall Study|Reason other than those specified above|2|||
155307824|NCT00611559|560559168|FG000|Overall Study|Lost to Follow-up|0|||
155307825|NCT00611559|560559169|FG001|Overall Study|Lost to Follow-up|1|||
155307826|NCT00611559|560559170|FG002|Overall Study|Lost to Follow-up|0|||
155307827|NCT00611559|560559168|FG000|Overall Study|Protocol Violation|1|||
155307828|NCT00611559|560559169|FG001|Overall Study|Protocol Violation|0|||
155307829|NCT00611559|560559170|FG002|Overall Study|Protocol Violation|1|||
155307830|NCT00879333|560559171|FG000|Overall Study|Adverse Event|94|||
155307831|NCT00879333|560559172|FG001|Overall Study|Adverse Event|34|||
155307832|NCT00879333|560559171|FG000|Overall Study|Abnormal Laboratory Value|1|||
155307833|NCT00879333|560559172|FG001|Overall Study|Abnormal Laboratory Value|0|||
155307834|NCT00879333|560559171|FG000|Overall Study|Withdrawal by Subject|20|||
155307835|NCT00879333|560559172|FG001|Overall Study|Withdrawal by Subject|7|||
155307836|NCT00879333|560559171|FG000|Overall Study|Lost to Follow-up|2|||
155307837|NCT00879333|560559172|FG001|Overall Study|Lost to Follow-up|1|||
155307838|NCT00879333|560559171|FG000|Overall Study|Administrative Problems|2|||
155307839|NCT00879333|560559172|FG001|Overall Study|Administrative Problems|0|||
155307840|NCT00879333|560559171|FG000|Overall Study|Death|16|||
155307841|NCT00879333|560559172|FG001|Overall Study|Death|5|||
155307842|NCT00879333|560559171|FG000|Overall Study|Disease Progression|292|||
155307843|NCT00879333|560559172|FG001|Overall Study|Disease Progression|169|||
155307844|NCT00879333|560559171|FG000|Overall Study|Protocol Violation|1|||
155307845|NCT00879333|560559172|FG001|Overall Study|Protocol Violation|1|||
155307846|NCT03069313|560559173|FG000|Overall Study|Adverse Event|5|||
155307847|NCT01011946|560559175|FG000|Overall Study|Transferred to another hospital|2|||
155307848|NCT01011946|560559175|FG000|Overall Study|No pathological lab value|1|||
155307849|NCT01872078|560559177|FG000|Overall Study|Adverse Event|0|||
155307850|NCT01872078|560559178|FG001|Overall Study|Adverse Event|0|||
155307851|NCT01872078|560559179|FG002|Overall Study|Adverse Event|1|||
155307852|NCT01872078|560559180|FG003|Overall Study|Adverse Event|0|||
155307853|NCT01872078|560559177|FG000|Overall Study|Dose administration non-compliance|0|||
155307854|NCT01872078|560559178|FG001|Overall Study|Dose administration non-compliance|0|||
155307855|NCT01872078|560559179|FG002|Overall Study|Dose administration non-compliance|0|||
155307856|NCT01872078|560559180|FG003|Overall Study|Dose administration non-compliance|1|||
155307857|NCT01872078|560559177|FG000|Overall Study|Protocol Violation|0|||
155307858|NCT01872078|560559178|FG001|Overall Study|Protocol Violation|0|||
155307859|NCT01872078|560559179|FG002|Overall Study|Protocol Violation|1|||
155065613|NCT00782067|559672121|FG000|Overall Study|Adverse Event|35|||
155307860|NCT01872078|560559180|FG003|Overall Study|Protocol Violation|0|||
155307861|NCT01872078|560559177|FG000|Overall Study|Withdrawal by Subject|0|||
155307862|NCT01872078|560559178|FG001|Overall Study|Withdrawal by Subject|0|||
155307863|NCT01872078|560559179|FG002|Overall Study|Withdrawal by Subject|1|||
155307864|NCT01872078|560559180|FG003|Overall Study|Withdrawal by Subject|0|||
155307865|NCT01872078|560559177|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
155307866|NCT01872078|560559178|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
155307867|NCT01872078|560559179|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
155307868|NCT01872078|560559180|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
155307869|NCT02910713|560559181|FG000|Overall Study|Protocol Violation|2|||
155307870|NCT02910713|560559181|FG000|Overall Study|Subject Choice|4|||
155307871|NCT02910713|560559181|FG000|Overall Study|Received One Application|10|||
155307872|NCT02910713|560559181|FG000|Overall Study|Received Neither Application|18|||
155307873|NCT02910713|560559181|FG000|Overall Study|Enrollment cap|7|||
155307874|NCT02910713|560559181|FG000|Overall Study|Investigator Discretion|1|||
155307875|NCT04442126|560559185|FG000|Overall Study|Withdrawal by Subject|0|||
155307876|NCT04442126|560559186|FG001|Overall Study|Withdrawal by Subject|0|||
155307877|NCT04442126|560559187|FG002|Overall Study|Withdrawal by Subject|0|||
155307878|NCT04442126|560559188|FG003|Overall Study|Withdrawal by Subject|2|||
155307879|NCT04442126|560559189|FG004|Overall Study|Withdrawal by Subject|1|||
155307880|NCT04442126|560559190|FG005|Overall Study|Withdrawal by Subject|0|||
155307881|NCT04442126|560559191|FG006|Overall Study|Withdrawal by Subject|1|||
155307882|NCT04442126|560559192|FG007|Overall Study|Withdrawal by Subject|1|||
155307883|NCT04442126|560559193|FG008|Overall Study|Withdrawal by Subject|3|||
155307884|NCT04442126|560559185|FG000|Overall Study|Death|1|||
155307885|NCT04442126|560559186|FG001|Overall Study|Death|0|||
155307886|NCT04442126|560559187|FG002|Overall Study|Death|0|||
155307887|NCT04442126|560559188|FG003|Overall Study|Death|1|||
155307888|NCT04442126|560559189|FG004|Overall Study|Death|2|||
155307889|NCT04442126|560559190|FG005|Overall Study|Death|2|||
155307890|NCT04442126|560559191|FG006|Overall Study|Death|4|||
155307891|NCT04442126|560559192|FG007|Overall Study|Death|1|||
155307892|NCT04442126|560559193|FG008|Overall Study|Death|5|||
155307893|NCT04442126|560559185|FG000|Overall Study|Study Terminated by Sponsor|0|||
155307894|NCT04442126|560559186|FG001|Overall Study|Study Terminated by Sponsor|0|||
155307895|NCT04442126|560559187|FG002|Overall Study|Study Terminated by Sponsor|0|||
155307896|NCT04442126|560559188|FG003|Overall Study|Study Terminated by Sponsor|0|||
155307897|NCT04442126|560559189|FG004|Overall Study|Study Terminated by Sponsor|0|||
155307898|NCT04442126|560559190|FG005|Overall Study|Study Terminated by Sponsor|1|||
155307899|NCT04442126|560559191|FG006|Overall Study|Study Terminated by Sponsor|4|||
155307900|NCT04442126|560559192|FG007|Overall Study|Study Terminated by Sponsor|2|||
155307901|NCT04442126|560559193|FG008|Overall Study|Study Terminated by Sponsor|10|||
155307902|NCT04442126|560559185|FG000|Overall Study|Lost to Follow-up|0|||
155307903|NCT04442126|560559186|FG001|Overall Study|Lost to Follow-up|0|||
155307904|NCT04442126|560559187|FG002|Overall Study|Lost to Follow-up|0|||
155307905|NCT04442126|560559188|FG003|Overall Study|Lost to Follow-up|0|||
155307906|NCT04442126|560559189|FG004|Overall Study|Lost to Follow-up|0|||
155307907|NCT04442126|560559190|FG005|Overall Study|Lost to Follow-up|0|||
155307908|NCT04442126|560559191|FG006|Overall Study|Lost to Follow-up|0|||
155307909|NCT04442126|560559192|FG007|Overall Study|Lost to Follow-up|1|||
155307910|NCT04442126|560559193|FG008|Overall Study|Lost to Follow-up|2|||
155307911|NCT04442126|560559185|FG000|Overall Study|Progressive Disease|0|||
155307912|NCT04442126|560559186|FG001|Overall Study|Progressive Disease|1|||
155307913|NCT04442126|560559187|FG002|Overall Study|Progressive Disease|3|||
155307914|NCT04442126|560559188|FG003|Overall Study|Progressive Disease|0|||
155307915|NCT04442126|560559189|FG004|Overall Study|Progressive Disease|3|||
155307916|NCT04442126|560559190|FG005|Overall Study|Progressive Disease|0|||
155307917|NCT04442126|560559191|FG006|Overall Study|Progressive Disease|0|||
155307918|NCT04442126|560559192|FG007|Overall Study|Progressive Disease|0|||
155307919|NCT04442126|560559193|FG008|Overall Study|Progressive Disease|0|||
155307920|NCT04442126|560559185|FG000|Overall Study|Other|0|||
155307921|NCT04442126|560559186|FG001|Overall Study|Other|0|||
155307922|NCT04442126|560559187|FG002|Overall Study|Other|0|||
155307923|NCT04442126|560559188|FG003|Overall Study|Other|0|||
155307924|NCT04442126|560559189|FG004|Overall Study|Other|0|||
155307925|NCT04442126|560559190|FG005|Overall Study|Other|0|||
155307926|NCT04442126|560559191|FG006|Overall Study|Other|0|||
155307927|NCT04442126|560559192|FG007|Overall Study|Other|0|||
155307928|NCT04442126|560559193|FG008|Overall Study|Other|1|||
155307929|NCT06450405|560559194|FG000|Overall Study|Study funding terminated.|0|||
155307930|NCT06450405|560559195|FG001|Overall Study|Study funding terminated.|2|||
155307931|NCT03767517|560559196|FG000|Overall Study|Lost to Follow-up|16|||
155307932|NCT03767517|560559197|FG001|Overall Study|Lost to Follow-up|10|||
155307933|NCT03767517|560559196|FG000|Overall Study|Death|2|||
155307934|NCT03767517|560559197|FG001|Overall Study|Death|3|||
155307935|NCT03152786|560560722|FG000|Overall Study|Withdrawal by Subject|2|||
155307936|NCT03152786|560560723|FG001|Overall Study|Withdrawal by Subject|1|||
155307937|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
155307938|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307939|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307940|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307941|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
155307942|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
155307943|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
155307944|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
155307945|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
155307946|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
155307947|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
155307948|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
155307949|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
155307950|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
155307951|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
155307952|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
155307953|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307954|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307955|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307956|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
155307957|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
155307958|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
155307959|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
155307960|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
155307961|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
155307962|NCT05338086|560560724|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
155307963|NCT05338086|560560725|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
155307964|NCT05338086|560560726|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
155307965|NCT05338086|560560727|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
155307966|NCT05338086|560560728|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
155307967|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Death|0|||
155307968|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Death|0|||
155307969|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Death|1|||
155307970|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Death|0|||
155307971|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Death|0|||
155307972|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
155307973|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
155307974|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
155307975|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
155307976|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
155307977|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307978|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307979|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
155307980|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307981|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
155307982|NCT05338086|560560724|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
155307983|NCT05338086|560560725|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
155307984|NCT05338086|560560726|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
155307985|NCT05338086|560560727|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
155307986|NCT05338086|560560728|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
155307987|NCT04112316|560560729|FG000|First Period (8 Weeks)|Protocol Violation|1|||
155307988|NCT04112316|560560730|FG001|First Period (8 Weeks)|Protocol Violation|0|||
155307989|NCT04112316|560560729|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
155307990|NCT04112316|560560730|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
155307991|NCT06066541|560560740|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
155307992|NCT06066541|560560741|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
155307993|NCT06066541|560560742|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
155307994|NCT06066541|560560743|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
155307995|NCT06066541|560560744|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
155307996|NCT06066541|560560745|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
155065614|NCT00782067|559672121|FG000|Overall Study|Subject withdrew consent|11|||
155307997|NCT06066541|560560746|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
155307998|NCT06066541|560560740|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
155307999|NCT06066541|560560741|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
155308000|NCT06066541|560560742|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
155308001|NCT06066541|560560743|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
155308002|NCT06066541|560560744|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
155308003|NCT06066541|560560745|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
155065615|NCT00782067|559672121|FG000|Overall Study|Lost to Follow-up|2|||
155065616|NCT00782067|559672121|FG000|Overall Study|Administrative problems|14|||
155065617|NCT00782067|559672121|FG000|Overall Study|Death|9|||
155308004|NCT06066541|560560746|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
155308005|NCT04533022|560560747|FG000|Overall Study|Withdrawal by Subject|15|||
155308006|NCT04533022|560560747|FG000|Overall Study|Adverse Event|6|||
155308007|NCT04533022|560560747|FG000|Overall Study|Death|1|||
155308008|NCT04533022|560560747|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
155308009|NCT04533022|560560747|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
155308010|NCT02163447|560560748|FG000|Overall Study|Withdrawal by Subject|2|||
155308011|NCT02163447|560560749|FG001|Overall Study|Withdrawal by Subject|0|||
155308012|NCT02163447|560560750|FG002|Overall Study|Withdrawal by Subject|1|||
155065618|NCT00782067|559672121|FG000|Overall Study|Disease progression|43|||
155065619|NCT00782067|559672121|FG000|Overall Study|Protocol deviation|2|||
155065620|NCT02471183|559672122|FG000|Main Treatment Period|Adverse Event|1|||
155308013|NCT02163447|560560748|FG000|Overall Study|Lost to Follow-up|1|||
155065621|NCT02471183|559672122|FG000|Main Treatment Period|Withdrawal by Subject|1|||
155308014|NCT02163447|560560749|FG001|Overall Study|Lost to Follow-up|3|||
154959227|NCT01597245|559276949|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
154959228|NCT01597245|559276950|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
154959229|NCT01597245|559276951|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
154959230|NCT01597245|559276952|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
155308015|NCT02163447|560560750|FG002|Overall Study|Lost to Follow-up|0|||
155308016|NCT02163447|560560748|FG000|Overall Study|Moved out of study area|2|||
155308017|NCT02163447|560560749|FG001|Overall Study|Moved out of study area|3|||
155308018|NCT02163447|560560750|FG002|Overall Study|Moved out of study area|2|||
155308019|NCT02163447|560560748|FG000|Overall Study|Became HIV infected at time of delivery|1|||
155308020|NCT02163447|560560749|FG001|Overall Study|Became HIV infected at time of delivery|0|||
155308021|NCT02163447|560560750|FG002|Overall Study|Became HIV infected at time of delivery|0|||
155308022|NCT04850807|560560760|FG000|Overall Study|Death|50|||
155308023|NCT04850807|560560761|FG001|Overall Study|Death|55|||
155308024|NCT04850807|560560760|FG000|Overall Study|Discharged|17|||
155308025|NCT04850807|560560761|FG001|Overall Study|Discharged|13|||
155308026|NCT04850807|560560760|FG000|Overall Study|Incomplete baseline data|3|||
155308027|NCT04850807|560560761|FG001|Overall Study|Incomplete baseline data|2|||
155308028|NCT05439603|560560770|FG000|Overall Study|met withdrawal criteria|2|||
155308029|NCT03896516|560560771|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
155308030|NCT03896516|560560772|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
155308031|NCT03896516|560560771|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
155308032|NCT03896516|560560772|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
155308033|NCT03896516|560560771|FG000|Washout Period|Physician Decision|3|||
155308034|NCT03896516|560560772|FG001|Washout Period|Physician Decision|1|||
155308035|NCT03896516|560560771|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
155308036|NCT03896516|560560772|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
155308037|NCT04549168|560560780|FG000|Randomization Phase|Adverse Event|0|||
155308038|NCT04549168|560560781|FG001|Randomization Phase|Adverse Event|0|||
155308039|NCT04549168|560560782|FG002|Randomization Phase|Adverse Event|1|||
155308040|NCT04549168|560560780|FG000|Randomization Phase|Other|0|||
155308041|NCT04549168|560560781|FG001|Randomization Phase|Other|2|||
155308042|NCT04549168|560560782|FG002|Randomization Phase|Other|0|||
155308043|NCT04549168|560560780|FG000|Randomization Phase|Withdrawal by Subject|0|||
155308044|NCT04549168|560560781|FG001|Randomization Phase|Withdrawal by Subject|2|||
155308045|NCT04549168|560560782|FG002|Randomization Phase|Withdrawal by Subject|1|||
155308046|NCT02323321|560560787|FG000|Overall Study|Re-Transplant|1|||
155308047|NCT02323321|560560787|FG000|Overall Study|Death|12|||
155308048|NCT04281485|560560788|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
155308049|NCT04281485|560560789|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
155308050|NCT04281485|560560788|FG000|Overall Study|Ongoing (Safety data collection)|10|||
155308051|NCT04281485|560560789|FG001|Overall Study|Ongoing (Safety data collection)|5|||
155308052|NCT04093752|560560792|FG000|Overall Study|Adverse Event|7|||
155308053|NCT04093752|560560793|FG001|Overall Study|Adverse Event|19|||
155308054|NCT04093752|560560794|FG002|Overall Study|Adverse Event|18|||
155308055|NCT04093752|560560795|FG003|Overall Study|Adverse Event|4|||
155308056|NCT04093752|560560792|FG000|Overall Study|Withdrawal by Subject|6|||
155308057|NCT04093752|560560793|FG001|Overall Study|Withdrawal by Subject|6|||
155308058|NCT04093752|560560794|FG002|Overall Study|Withdrawal by Subject|8|||
155308059|NCT04093752|560560795|FG003|Overall Study|Withdrawal by Subject|20|||
155308060|NCT04093752|560560792|FG000|Overall Study|Lost to Follow-up|2|||
155308061|NCT04093752|560560793|FG001|Overall Study|Lost to Follow-up|1|||
155308062|NCT04093752|560560794|FG002|Overall Study|Lost to Follow-up|1|||
155308063|NCT04093752|560560795|FG003|Overall Study|Lost to Follow-up|1|||
155308064|NCT04093752|560560792|FG000|Overall Study|Death|0|||
155308065|NCT04093752|560560793|FG001|Overall Study|Death|0|||
155308066|NCT04093752|560560794|FG002|Overall Study|Death|1|||
155308067|NCT04093752|560560795|FG003|Overall Study|Death|2|||
155308068|NCT04093752|560560792|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
155308069|NCT04093752|560560793|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
155308070|NCT04093752|560560794|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
155308071|NCT04093752|560560795|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
155308072|NCT04093752|560560792|FG000|Overall Study|Covid 19|0|||
155308073|NCT04093752|560560793|FG001|Overall Study|Covid 19|0|||
155308074|NCT04093752|560560794|FG002|Overall Study|Covid 19|0|||
155308075|NCT04093752|560560795|FG003|Overall Study|Covid 19|1|||
155308076|NCT04093752|560560792|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
155308077|NCT04093752|560560793|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
155308078|NCT04093752|560560794|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
155308079|NCT04093752|560560795|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
155308080|NCT04093752|560560792|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
155308081|NCT04093752|560560793|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
155308082|NCT04093752|560560794|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
155308083|NCT04093752|560560795|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
155308084|NCT04093752|560560792|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
155308085|NCT04093752|560560793|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
155308086|NCT04093752|560560794|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
155308087|NCT04093752|560560795|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
155308088|NCT01084707|560560796|FG000|Overall Study|Withdrawal by Subject|6|||
155308089|NCT00901901|560560797|FG000|Treatment Period|Adverse Event|120|||
155308090|NCT00901901|560560798|FG001|Treatment Period|Adverse Event|128|||
155308091|NCT00901901|560560797|FG000|Treatment Period|Withdrawal by Subject|26|||
155308092|NCT00901901|560560798|FG001|Treatment Period|Withdrawal by Subject|24|||
155308093|NCT00901901|560560797|FG000|Treatment Period|Physician Decision|2|||
155308094|NCT00901901|560560798|FG001|Treatment Period|Physician Decision|2|||
155308095|NCT00901901|560560797|FG000|Treatment Period|Lost to Follow-up|3|||
155308096|NCT00901901|560560798|FG001|Treatment Period|Lost to Follow-up|5|||
155308097|NCT00901901|560560797|FG000|Treatment Period|Noncompliance with study medication|4|||
155308098|NCT00901901|560560798|FG001|Treatment Period|Noncompliance with study medication|1|||
155308099|NCT00901901|560560797|FG000|Treatment Period|Missing|1|||
154959231|NCT01597245|559276953|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959232|NCT01597245|559276954|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959233|NCT01597245|559276955|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959234|NCT01597245|559276956|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959235|NCT01597245|559276957|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959236|NCT01597245|559276958|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959237|NCT01597245|559276959|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959238|NCT01597245|559276960|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959239|NCT01597245|559276961|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959240|NCT01597245|559276962|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959241|NCT01597245|559276963|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959242|NCT01597245|559276964|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959243|NCT01597245|559276965|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959244|NCT01597245|559276966|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959245|NCT01597245|559276967|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959246|NCT01597245|559276968|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959247|NCT01597245|559276969|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
154959248|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959249|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959250|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959251|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959252|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959253|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
154959254|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
154959255|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959256|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959257|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959258|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959259|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959260|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959261|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959262|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959263|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959264|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
155161195|NCT01285323|560026773|FG000|Overall Study|Non-compliance with study procedures|2|||
155161196|NCT01285323|560026774|FG001|Overall Study|Non-compliance with study procedures|3|||
155161197|NCT01285323|560026773|FG000|Overall Study|Lost to Follow-up|1|||
155161198|NCT01285323|560026774|FG001|Overall Study|Lost to Follow-up|1|||
155161199|NCT01285323|560026773|FG000|Overall Study|Other|1|||
155161200|NCT01285323|560026774|FG001|Overall Study|Other|3|||
155161201|NCT02606643|560026775|FG000|Overall Study|did not meet inclusion criteria|1|||
155161202|NCT02606643|560026776|FG001|Overall Study|did not meet inclusion criteria|3|||
155161203|NCT02158546|560026784|FG000|Overall Study|Physician Decision|0|||
155161204|NCT02158546|560026785|FG001|Overall Study|Physician Decision|1|||
155161205|NCT02158546|560026786|FG002|Overall Study|Physician Decision|0|||
155161206|NCT02158546|560026787|FG003|Overall Study|Physician Decision|0|||
155161207|NCT02158546|560026784|FG000|Overall Study|Non-compliance|0|||
155161208|NCT02158546|560026785|FG001|Overall Study|Non-compliance|1|||
155161209|NCT02158546|560026786|FG002|Overall Study|Non-compliance|0|||
155161210|NCT02158546|560026787|FG003|Overall Study|Non-compliance|1|||
155161211|NCT02158546|560026784|FG000|Overall Study|Failure to meet eligibility criteria|0|||
155161212|NCT02158546|560026785|FG001|Overall Study|Failure to meet eligibility criteria|1|||
154959265|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959266|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959267|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959268|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
154959269|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959270|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959271|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959272|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959273|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
154959274|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
154959275|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
154959276|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
154959277|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959278|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
154959279|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959280|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959281|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959282|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959283|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959284|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959285|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959286|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959287|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959288|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959289|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
154959290|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959291|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959292|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959293|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959294|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959295|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
154959296|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959297|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155161213|NCT02158546|560026786|FG002|Overall Study|Failure to meet eligibility criteria|0|||
155161214|NCT02158546|560026787|FG003|Overall Study|Failure to meet eligibility criteria|0|||
155161215|NCT02158546|560026784|FG000|Overall Study|Lack of Efficacy|1|||
155161216|NCT02158546|560026785|FG001|Overall Study|Lack of Efficacy|1|||
155161217|NCT02158546|560026786|FG002|Overall Study|Lack of Efficacy|0|||
155161218|NCT02158546|560026787|FG003|Overall Study|Lack of Efficacy|0|||
155161219|NCT02158546|560026784|FG000|Overall Study|Adverse Event|2|||
155065622|NCT02471183|559672122|FG000|Extended Treatment Period|Lack of Efficacy|1|||
155065623|NCT05350423|559672128|FG000|Overall Study|Lost to Follow-up|3|||
155065624|NCT05350423|559672129|FG001|Overall Study|Lost to Follow-up|3|||
155065625|NCT05350423|559672128|FG000|Overall Study|screen failure|5|||
155065626|NCT05350423|559672129|FG001|Overall Study|screen failure|6|||
155065627|NCT02097277|559672131|FG000|Overall Study|Subject no longer meets study criteria|0|||
155065628|NCT02097277|559672132|FG001|Overall Study|Subject no longer meets study criteria|1|||
155065629|NCT02097277|559672133|FG002|Overall Study|Subject no longer meets study criteria|0|||
155065630|NCT02097277|559672134|FG003|Overall Study|Subject no longer meets study criteria|1|||
155065631|NCT02097277|559672135|FG004|Overall Study|Subject no longer meets study criteria|0|||
155065632|NCT02097277|559672131|FG000|Overall Study|Subject request to discontinue treatment|0|||
155065633|NCT02097277|559672132|FG001|Overall Study|Subject request to discontinue treatment|0|||
155065634|NCT02097277|559672133|FG002|Overall Study|Subject request to discontinue treatment|0|||
155065635|NCT02097277|559672134|FG003|Overall Study|Subject request to discontinue treatment|0|||
155065636|NCT02097277|559672135|FG004|Overall Study|Subject request to discontinue treatment|1|||
155065637|NCT02097277|559672131|FG000|Overall Study|Lost to Follow-up|0|||
155065638|NCT02097277|559672132|FG001|Overall Study|Lost to Follow-up|1|||
155065639|NCT02097277|559672133|FG002|Overall Study|Lost to Follow-up|1|||
155065640|NCT02097277|559672134|FG003|Overall Study|Lost to Follow-up|0|||
155065641|NCT02097277|559672135|FG004|Overall Study|Lost to Follow-up|0|||
155065642|NCT02097277|559672131|FG000|Overall Study|Withdrawal by Subject|2|||
155065643|NCT02097277|559672132|FG001|Overall Study|Withdrawal by Subject|1|||
155065644|NCT02097277|559672133|FG002|Overall Study|Withdrawal by Subject|0|||
155065645|NCT02097277|559672134|FG003|Overall Study|Withdrawal by Subject|1|||
155065646|NCT02097277|559672135|FG004|Overall Study|Withdrawal by Subject|0|||
155065647|NCT02097277|559672131|FG000|Overall Study|Adverse Event|0|||
155065648|NCT02097277|559672132|FG001|Overall Study|Adverse Event|0|||
155065649|NCT02097277|559672133|FG002|Overall Study|Adverse Event|1|||
155065650|NCT02097277|559672134|FG003|Overall Study|Adverse Event|2|||
155065651|NCT02097277|559672135|FG004|Overall Study|Adverse Event|0|||
155065652|NCT00141921|559672137|FG000|Overall Study|Remain on Study|28|||
155065653|NCT00141921|559672137|FG000|Overall Study|Withdrawal by Subject|42|||
155065654|NCT00141921|559672137|FG000|Overall Study|Lost to Follow-up|19|||
155065655|NCT00141921|559672137|FG000|Overall Study|Noncompliance|17|||
155065656|NCT00141921|559672137|FG000|Overall Study|Disease Progression|7|||
155065657|NCT00141921|559672137|FG000|Overall Study|Protocol Deviation|7|||
155065658|NCT00141921|559672137|FG000|Overall Study|Adverse Event|5|||
155065659|NCT00141921|559672137|FG000|Overall Study|Administrative Decision|2|||
155065660|NCT00141921|559672137|FG000|Overall Study|Pregnancy|4|||
155065661|NCT00141921|559672137|FG000|Overall Study|Ineligibility Determined|2|||
155065662|NCT00141921|559672137|FG000|Overall Study|Other|8|||
155065663|NCT03320369|559672138|FG000|Overall Study|Adverse Event|1|||
155065664|NCT03320369|559672138|FG000|Overall Study|Withdrawal by Subject|2|||
155065665|NCT03473197|559672149|FG000|Overall Study|Adverse Event|4|||
155065666|NCT03473197|559672149|FG000|Overall Study|Lost to Follow-up|1|||
155065667|NCT03473197|559672149|FG000|Overall Study|Withdrawal by Subject|5|||
155065668|NCT02320396|559672152|FG000|Overall Study|Adverse Event|2|||
155065669|NCT02320396|559672153|FG001|Overall Study|Adverse Event|2|||
155065670|NCT02320396|559672152|FG000|Overall Study|Pregnancy|0|||
155065671|NCT02320396|559672153|FG001|Overall Study|Pregnancy|1|||
155065672|NCT02320396|559672152|FG000|Overall Study|Protocol Violation|0|||
155065673|NCT02320396|559672153|FG001|Overall Study|Protocol Violation|1|||
155065674|NCT02320396|559672152|FG000|Overall Study|Withdrawal by Subject|2|||
155065675|NCT02320396|559672153|FG001|Overall Study|Withdrawal by Subject|0|||
155065676|NCT02441283|559672154|FG000|Overall Study|Withdrew consent|15|||
155065677|NCT02441283|559672154|FG000|Overall Study|Lost to Follow-up|42|||
155065678|NCT02441283|559672154|FG000|Overall Study|Death|1|||
155065679|NCT02441283|559672154|FG000|Overall Study|Other, not specified|32|||
155065680|NCT02382939|559672155|FG000|Overall Study|Adverse Event|1|||
155065681|NCT02382939|559672156|FG001|Overall Study|Adverse Event|1|||
155065682|NCT02382939|559672155|FG000|Overall Study|Withdrawal by Subject|2|||
155065683|NCT02382939|559672156|FG001|Overall Study|Withdrawal by Subject|2|||
155065684|NCT00142415|559672157|FG000|Overall Study|Physician Decision|0|||
155065685|NCT00142415|559672158|FG001|Overall Study|Physician Decision|0|||
155065686|NCT00142415|559672159|FG002|Overall Study|Physician Decision|0|||
155065687|NCT00142415|559672160|FG003|Overall Study|Physician Decision|0|||
155161220|NCT02158546|560026785|FG001|Overall Study|Adverse Event|2|||
155161221|NCT02158546|560026786|FG002|Overall Study|Adverse Event|0|||
155161222|NCT02158546|560026787|FG003|Overall Study|Adverse Event|0|||
155161223|NCT02158546|560026784|FG000|Overall Study|Withdrawal by Subject|6|||
155161224|NCT02158546|560026785|FG001|Overall Study|Withdrawal by Subject|2|||
155161225|NCT02158546|560026786|FG002|Overall Study|Withdrawal by Subject|1|||
155161226|NCT02158546|560026787|FG003|Overall Study|Withdrawal by Subject|0|||
155161227|NCT02158546|560026784|FG000|Overall Study|Lost to Follow-up|5|||
155161228|NCT02158546|560026785|FG001|Overall Study|Lost to Follow-up|4|||
155161229|NCT02158546|560026786|FG002|Overall Study|Lost to Follow-up|0|||
155161230|NCT02158546|560026787|FG003|Overall Study|Lost to Follow-up|1|||
155161231|NCT02158546|560026784|FG000|Overall Study|Site Excluded|5|||
155161232|NCT02158546|560026785|FG001|Overall Study|Site Excluded|5|||
155161233|NCT02158546|560026786|FG002|Overall Study|Site Excluded|3|||
155161234|NCT02158546|560026787|FG003|Overall Study|Site Excluded|4|||
155161235|NCT02488915|560026790|FG000|Overall Study|Death|21|||
155161236|NCT02488915|560026790|FG000|Overall Study|Lost to Follow-up|4|||
155161237|NCT02488915|560026790|FG000|Overall Study|Withdrawal by Subject|1|||
155161238|NCT00885170|560026793|FG000|Overall Study|Adverse Event|12|||
155161239|NCT00885170|560026794|FG001|Overall Study|Adverse Event|4|||
155161240|NCT00885170|560026793|FG000|Overall Study|Excessive bone loss|6|||
155161241|NCT00885170|560026794|FG001|Overall Study|Excessive bone loss|3|||
155161242|NCT00885170|560026793|FG000|Overall Study|Lost to Follow-up|2|||
155161243|NCT00885170|560026794|FG001|Overall Study|Lost to Follow-up|1|||
155161244|NCT00885170|560026793|FG000|Overall Study|Physician Decision|2|||
155161245|NCT00885170|560026794|FG001|Overall Study|Physician Decision|1|||
155161246|NCT00885170|560026793|FG000|Overall Study|Protocol Violation|3|||
155161247|NCT00885170|560026794|FG001|Overall Study|Protocol Violation|1|||
155161248|NCT00885170|560026793|FG000|Overall Study|Withdrawal by Subject|13|||
155161249|NCT00885170|560026794|FG001|Overall Study|Withdrawal by Subject|13|||
155161250|NCT00684021|560026795|FG000|Overall Study|MRI Contraindicated|1|||
155161251|NCT00684021|560026796|FG001|Overall Study|MRI Contraindicated|1|||
155161252|NCT00684021|560026797|FG002|Overall Study|MRI Contraindicated|1|||
155161253|NCT00684021|560026798|FG003|Overall Study|MRI Contraindicated|0|||
155161254|NCT00684021|560026795|FG000|Overall Study|MRI not performed|0|||
155161255|NCT00684021|560026796|FG001|Overall Study|MRI not performed|1|||
155161256|NCT00684021|560026797|FG002|Overall Study|MRI not performed|1|||
155161257|NCT00684021|560026798|FG003|Overall Study|MRI not performed|2|||
155161258|NCT00684021|560026795|FG000|Overall Study|Death|1|||
155161259|NCT00684021|560026796|FG001|Overall Study|Death|0|||
155161260|NCT00684021|560026797|FG002|Overall Study|Death|0|||
155161261|NCT00684021|560026798|FG003|Overall Study|Death|0|||
155161262|NCT01285557|560026800|FG000|Overall Study|Death|173|||
155161263|NCT01285557|560026801|FG001|Overall Study|Death|90|||
155161264|NCT01285557|560026800|FG000|Overall Study|Lost to Follow-up|6|||
155161265|NCT01285557|560026801|FG001|Overall Study|Lost to Follow-up|2|||
155161266|NCT01285557|560026800|FG000|Overall Study|Withdrew Consent|6|||
155161267|NCT01285557|560026801|FG001|Overall Study|Withdrew Consent|1|||
155308100|NCT00901901|560560798|FG001|Treatment Period|Missing|0|||
155308101|NCT00901901|560560797|FG000|Treatment Period|Never treated|0|||
155308102|NCT00901901|560560798|FG001|Treatment Period|Never treated|3|||
155308103|NCT00901901|560560797|FG000|Treatment Period|Protocol driven decision point|0|||
155308104|NCT00901901|560560798|FG001|Treatment Period|Protocol driven decision point|2|||
155308105|NCT00901901|560560797|FG000|Treatment Period|Study terminated by sponsor|2|||
155308106|NCT00901901|560560798|FG001|Treatment Period|Study terminated by sponsor|0|||
155308107|NCT00901901|560560797|FG000|Treatment Period|Protocol Violation|5|||
155308108|NCT00901901|560560798|FG001|Treatment Period|Protocol Violation|9|||
155308109|NCT00901901|560560797|FG000|Treatment Period|Switch to commercial drug|1|||
155308110|NCT00901901|560560798|FG001|Treatment Period|Switch to commercial drug|1|||
155308111|NCT00901901|560560797|FG000|Treatment Period|Transfer to treatment continuation study|5|||
155308112|NCT00901901|560560798|FG001|Treatment Period|Transfer to treatment continuation study|2|||
155308113|NCT00901901|560560797|FG000|Follow-up Period|Death|181|||
155308114|NCT00901901|560560798|FG001|Follow-up Period|Death|208|||
155308115|NCT00901901|560560797|FG000|Follow-up Period|Protocol driven decision point|47|||
155308116|NCT00901901|560560798|FG001|Follow-up Period|Protocol driven decision point|36|||
155308117|NCT00901901|560560797|FG000|Follow-up Period|Withdrawal by Subject|6|||
154959298|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
154959299|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959300|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
154959301|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
154959302|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
154959303|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959304|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959305|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
155308118|NCT00901901|560560798|FG001|Follow-up Period|Withdrawal by Subject|9|||
154959306|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959307|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959308|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959309|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959310|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
154959311|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959312|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959313|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959314|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959315|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
154959316|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
154959317|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
154959318|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
154959319|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
154959320|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
154959321|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
154959322|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
154959323|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
154959324|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959325|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959326|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959327|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
155065688|NCT00142415|559672161|FG004|Overall Study|Physician Decision|1|||
154959328|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959329|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959330|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959331|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
154959332|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959333|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959334|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959335|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959336|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
154959337|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
154959338|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
154959339|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959340|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
154959341|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
154959342|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
154959343|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
154959344|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
154959345|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155065689|NCT00142415|559672162|FG005|Overall Study|Physician Decision|2|||
154959346|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959347|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959348|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959349|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959350|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
155308119|NCT00901901|560560797|FG000|Follow-up Period|Lost to Follow-up|12|||
155308120|NCT00901901|560560798|FG001|Follow-up Period|Lost to Follow-up|8|||
155308121|NCT00901901|560560797|FG000|Follow-up Period|Missing|94|||
155308122|NCT00901901|560560798|FG001|Follow-up Period|Missing|80|||
155308123|NCT00951379|560560799|FG000|Overall Study|Adverse Event|4|||
155308124|NCT00951379|560560800|FG001|Overall Study|Adverse Event|1|||
155308125|NCT00951379|560560799|FG000|Overall Study|Withdrawal by Subject|1|||
155308126|NCT00951379|560560800|FG001|Overall Study|Withdrawal by Subject|0|||
155308127|NCT00951379|560560799|FG000|Overall Study|Noncompliance|1|||
155308128|NCT00951379|560560800|FG001|Overall Study|Noncompliance|0|||
155308129|NCT00951379|560560799|FG000|Overall Study|Disease Progression|0|||
155308130|NCT00951379|560560800|FG001|Overall Study|Disease Progression|1|||
155308131|NCT02742519|560560801|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
154959351|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959352|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
154959353|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959354|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959355|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155065690|NCT00321763|559672165|FG000|Overall Study|Adverse Event|1|||
155308132|NCT02742519|560560802|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
155308133|NCT02742519|560560803|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
155308134|NCT02742519|560560801|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
154959356|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959357|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
154959358|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959359|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959360|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959361|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
154959362|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
154959363|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
154959364|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959365|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
154959366|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959367|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959368|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
155065691|NCT00321763|559672166|FG001|Overall Study|Adverse Event|1|||
155065692|NCT00321763|559672167|FG002|Overall Study|Adverse Event|0|||
155308135|NCT02742519|560560802|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
155308136|NCT02742519|560560803|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
155308137|NCT02742519|560560801|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
155308138|NCT02742519|560560802|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
155065693|NCT00321763|559672168|FG003|Overall Study|Adverse Event|1|||
155065694|NCT00321763|559672165|FG000|Overall Study|Withdrawal by Subject|2|||
155308139|NCT02742519|560560803|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
155308140|NCT03432858|560560805|FG000|Overall Study|Protocol Violation|2|||
155308141|NCT03432858|560560806|FG001|Overall Study|Protocol Violation|1|||
155065695|NCT00321763|559672166|FG001|Overall Study|Withdrawal by Subject|0|||
155065696|NCT00321763|559672167|FG002|Overall Study|Withdrawal by Subject|1|||
155065697|NCT00321763|559672168|FG003|Overall Study|Withdrawal by Subject|0|||
155308142|NCT03432858|560560807|FG002|Overall Study|Protocol Violation|9|||
155308143|NCT03432858|560560805|FG000|Overall Study|Withdrawal by Subject|0|||
155308144|NCT03432858|560560806|FG001|Overall Study|Withdrawal by Subject|1|||
155308145|NCT03432858|560560807|FG002|Overall Study|Withdrawal by Subject|1|||
155308146|NCT03432858|560560805|FG000|Overall Study|Procedure canceled/rescheduled|0|||
155308147|NCT03432858|560560806|FG001|Overall Study|Procedure canceled/rescheduled|9|||
155308148|NCT03432858|560560807|FG002|Overall Study|Procedure canceled/rescheduled|6|||
155308149|NCT03432858|560560805|FG000|Overall Study|Required postop mobilization with splinting|0|||
155308150|NCT03432858|560560806|FG001|Overall Study|Required postop mobilization with splinting|0|||
155308151|NCT03432858|560560807|FG002|Overall Study|Required postop mobilization with splinting|1|||
155308152|NCT03580369|560560810|FG000|Overall Study|No treatment due to mis-randomization|1|||
155308153|NCT03580369|560560811|FG001|Overall Study|No treatment due to mis-randomization|0|||
155308154|NCT03580369|560560812|FG002|Overall Study|No treatment due to mis-randomization|0|||
155308155|NCT03580369|560560813|FG003|Overall Study|No treatment due to mis-randomization|0|||
155308156|NCT03580369|560560814|FG004|Overall Study|No treatment due to mis-randomization|3|||
155308157|NCT03580369|560560815|FG005|Overall Study|No treatment due to mis-randomization|0|||
155065698|NCT00321763|559672165|FG000|Overall Study|Lost to Follow-up|3|||
155065699|NCT00321763|559672166|FG001|Overall Study|Lost to Follow-up|1|||
155065700|NCT00321763|559672167|FG002|Overall Study|Lost to Follow-up|5|||
155065701|NCT00321763|559672168|FG003|Overall Study|Lost to Follow-up|4|||
155065702|NCT03282097|559672169|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
155065703|NCT03282097|559672170|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
155308158|NCT03580369|560560816|FG006|Overall Study|No treatment due to mis-randomization|0|||
155308159|NCT03580369|560560817|FG007|Overall Study|No treatment due to mis-randomization|0|||
155308160|NCT03580369|560560810|FG000|Overall Study|Reason unknown|0|||
155308161|NCT03580369|560560811|FG001|Overall Study|Reason unknown|0|||
155308162|NCT03580369|560560812|FG002|Overall Study|Reason unknown|1|||
155308163|NCT03580369|560560813|FG003|Overall Study|Reason unknown|0|||
155308164|NCT03580369|560560814|FG004|Overall Study|Reason unknown|0|||
155308165|NCT03580369|560560815|FG005|Overall Study|Reason unknown|0|||
154959369|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959370|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959371|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959372|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959373|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
154959374|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959375|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959376|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959377|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959378|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
154959379|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
154959380|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
154959381|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959382|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
154959383|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
154959384|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
154959385|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
154959386|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
154959387|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959388|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959389|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959390|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959391|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959392|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959393|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959394|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
154959395|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959396|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959397|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959398|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959399|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959400|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
154959401|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959402|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959403|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
154959404|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
154959405|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
154959406|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
154959407|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959408|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959409|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959410|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959411|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959412|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959413|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959414|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959415|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
154959416|NCT01597245|559276949|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959417|NCT01597245|559276950|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959418|NCT01597245|559276951|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959419|NCT01597245|559276952|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959420|NCT01597245|559276953|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959421|NCT01597245|559276954|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959422|NCT01597245|559276955|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959423|NCT01597245|559276956|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959424|NCT01597245|559276957|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959425|NCT01597245|559276958|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959426|NCT01597245|559276959|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
154959427|NCT01597245|559276960|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959428|NCT01597245|559276961|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959429|NCT01597245|559276962|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959430|NCT01597245|559276963|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959431|NCT01597245|559276964|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959432|NCT01597245|559276965|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959433|NCT01597245|559276966|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959434|NCT01597245|559276967|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959435|NCT01597245|559276968|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959436|NCT01597245|559276969|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
154959437|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959438|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959439|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959440|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959441|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959442|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959443|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959444|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959445|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959446|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959447|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959448|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959449|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959450|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
154959451|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
154959452|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
154959453|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155161268|NCT01285557|560026800|FG000|Overall Study|Sponsor Study Termination|23|||
155308166|NCT03580369|560560816|FG006|Overall Study|Reason unknown|0|||
155308167|NCT03580369|560560817|FG007|Overall Study|Reason unknown|0|||
155308168|NCT03580369|560560810|FG000|Overall Study|Technical problems|0|||
155308169|NCT03580369|560560811|FG001|Overall Study|Technical problems|0|||
155308170|NCT03580369|560560812|FG002|Overall Study|Technical problems|0|||
155308171|NCT03580369|560560813|FG003|Overall Study|Technical problems|0|||
155308172|NCT03580369|560560814|FG004|Overall Study|Technical problems|1|||
155308173|NCT03580369|560560815|FG005|Overall Study|Technical problems|0|||
155308174|NCT03580369|560560816|FG006|Overall Study|Technical problems|2|||
155308175|NCT03580369|560560817|FG007|Overall Study|Technical problems|0|||
155308176|NCT03580369|560560810|FG000|Overall Study|Pregnancy|2|||
155308177|NCT03580369|560560811|FG001|Overall Study|Pregnancy|0|||
155308178|NCT03580369|560560812|FG002|Overall Study|Pregnancy|3|||
155308179|NCT03580369|560560813|FG003|Overall Study|Pregnancy|0|||
155308180|NCT03580369|560560814|FG004|Overall Study|Pregnancy|2|||
155308181|NCT03580369|560560815|FG005|Overall Study|Pregnancy|0|||
155308182|NCT03580369|560560816|FG006|Overall Study|Pregnancy|0|||
155308183|NCT03580369|560560817|FG007|Overall Study|Pregnancy|0|||
155308184|NCT03580369|560560810|FG000|Overall Study|Lost to Follow-up|2|||
155308185|NCT03580369|560560811|FG001|Overall Study|Lost to Follow-up|0|||
155308186|NCT03580369|560560812|FG002|Overall Study|Lost to Follow-up|2|||
155308187|NCT03580369|560560813|FG003|Overall Study|Lost to Follow-up|0|||
155308188|NCT03580369|560560814|FG004|Overall Study|Lost to Follow-up|3|||
155308189|NCT03580369|560560815|FG005|Overall Study|Lost to Follow-up|0|||
155308190|NCT03580369|560560816|FG006|Overall Study|Lost to Follow-up|1|||
155308191|NCT03580369|560560817|FG007|Overall Study|Lost to Follow-up|0|||
155161269|NCT01285557|560026801|FG001|Overall Study|Sponsor Study Termination|13|||
155161270|NCT01285557|560026800|FG000|Overall Study|Randomized but not treated|1|||
155161271|NCT01285557|560026801|FG001|Overall Study|Randomized but not treated|1|||
155161272|NCT01285557|560026800|FG000|Overall Study|Study follow-up ongoing|28|||
155308192|NCT03580369|560560810|FG000|Overall Study|Physician Decision|4|||
155308193|NCT03580369|560560811|FG001|Overall Study|Physician Decision|0|||
155308194|NCT03580369|560560812|FG002|Overall Study|Physician Decision|4|||
155308195|NCT03580369|560560813|FG003|Overall Study|Physician Decision|1|||
155308196|NCT03580369|560560814|FG004|Overall Study|Physician Decision|1|||
155308197|NCT03580369|560560815|FG005|Overall Study|Physician Decision|0|||
155308198|NCT03580369|560560816|FG006|Overall Study|Physician Decision|0|||
155308199|NCT03580369|560560817|FG007|Overall Study|Physician Decision|0|||
155308200|NCT03580369|560560810|FG000|Overall Study|Lack of Efficacy|3|||
155308201|NCT03580369|560560811|FG001|Overall Study|Lack of Efficacy|0|||
155308202|NCT03580369|560560812|FG002|Overall Study|Lack of Efficacy|7|||
155308203|NCT03580369|560560813|FG003|Overall Study|Lack of Efficacy|0|||
155308204|NCT03580369|560560814|FG004|Overall Study|Lack of Efficacy|2|||
155308205|NCT03580369|560560815|FG005|Overall Study|Lack of Efficacy|0|||
155308206|NCT03580369|560560816|FG006|Overall Study|Lack of Efficacy|3|||
155308207|NCT03580369|560560817|FG007|Overall Study|Lack of Efficacy|0|||
155308208|NCT03580369|560560810|FG000|Overall Study|Protocol Violation|6|||
155308209|NCT03580369|560560811|FG001|Overall Study|Protocol Violation|0|||
155308210|NCT03580369|560560812|FG002|Overall Study|Protocol Violation|6|||
155308211|NCT03580369|560560813|FG003|Overall Study|Protocol Violation|1|||
155308212|NCT03580369|560560814|FG004|Overall Study|Protocol Violation|8|||
155308213|NCT03580369|560560815|FG005|Overall Study|Protocol Violation|2|||
155308214|NCT03580369|560560816|FG006|Overall Study|Protocol Violation|1|||
155308215|NCT03580369|560560817|FG007|Overall Study|Protocol Violation|0|||
155308216|NCT03580369|560560810|FG000|Overall Study|Adverse Event|7|||
155308217|NCT03580369|560560811|FG001|Overall Study|Adverse Event|0|||
155308218|NCT03580369|560560812|FG002|Overall Study|Adverse Event|14|||
155308219|NCT03580369|560560813|FG003|Overall Study|Adverse Event|1|||
155308220|NCT03580369|560560814|FG004|Overall Study|Adverse Event|6|||
155308221|NCT03580369|560560815|FG005|Overall Study|Adverse Event|0|||
155308222|NCT03580369|560560816|FG006|Overall Study|Adverse Event|1|||
155308223|NCT03580369|560560817|FG007|Overall Study|Adverse Event|0|||
155308224|NCT03580369|560560810|FG000|Overall Study|Withdrawal by Subject|19|||
155308225|NCT03580369|560560811|FG001|Overall Study|Withdrawal by Subject|0|||
155308226|NCT03580369|560560812|FG002|Overall Study|Withdrawal by Subject|17|||
155308227|NCT03580369|560560813|FG003|Overall Study|Withdrawal by Subject|0|||
155308228|NCT03580369|560560814|FG004|Overall Study|Withdrawal by Subject|16|||
155308229|NCT03580369|560560815|FG005|Overall Study|Withdrawal by Subject|1|||
155308230|NCT03580369|560560816|FG006|Overall Study|Withdrawal by Subject|7|||
155308231|NCT03580369|560560817|FG007|Overall Study|Withdrawal by Subject|0|||
155308232|NCT03912831|560560818|FG000|Overall Study|Death|1|||
155308233|NCT03912831|560560819|FG001|Overall Study|Death|1|||
155161273|NCT01285557|560026801|FG001|Overall Study|Study follow-up ongoing|14|||
155161274|NCT01285557|560026800|FG000|Overall Study|Sponsor Decision|2|||
155308234|NCT03912831|560560820|FG002|Overall Study|Death|1|||
155308235|NCT03912831|560560821|FG003|Overall Study|Death|1|||
155308236|NCT03912831|560560822|FG004|Overall Study|Death|1|||
155308237|NCT03912831|560560823|FG005|Overall Study|Death|1|||
155308238|NCT03912831|560560818|FG000|Overall Study|Reason not Specified|0|||
155308239|NCT03912831|560560819|FG001|Overall Study|Reason not Specified|0|||
155308240|NCT03912831|560560820|FG002|Overall Study|Reason not Specified|0|||
155308241|NCT03912831|560560821|FG003|Overall Study|Reason not Specified|0|||
155308242|NCT03912831|560560822|FG004|Overall Study|Reason not Specified|1|||
155308243|NCT03912831|560560823|FG005|Overall Study|Reason not Specified|0|||
155308244|NCT03912831|560560818|FG000|Overall Study|Withdrawal by Participant|0|||
155308245|NCT03912831|560560819|FG001|Overall Study|Withdrawal by Participant|0|||
155308246|NCT03912831|560560820|FG002|Overall Study|Withdrawal by Participant|0|||
155308247|NCT03912831|560560821|FG003|Overall Study|Withdrawal by Participant|0|||
155308248|NCT03912831|560560822|FG004|Overall Study|Withdrawal by Participant|1|||
155308249|NCT03912831|560560823|FG005|Overall Study|Withdrawal by Participant|0|||
155308250|NCT03527160|560560824|FG000|Overall Study|No urine collected|13|||
155308251|NCT03527160|560560824|FG000|Overall Study|No clinical serum creatinine collected|6|||
155308252|NCT03527160|560560824|FG000|Overall Study|Did not meet inclusion|2|||
155308253|NCT01721291|560560826|FG000|Overall Study|Withdrawal by Subject|1|||
155308254|NCT01721291|560560827|FG001|Overall Study|Withdrawal by Subject|0|||
155308255|NCT01721291|560560826|FG000|Overall Study|did not like the treatment|1|||
155065704|NCT03282097|559672169|FG000|Intervention Visit Complete|Patient Death|13|||
155308256|NCT01721291|560560827|FG001|Overall Study|did not like the treatment|0|||
155308257|NCT01091168|560560828|FG000|Overall Study|Progressive disease|250|||
155308258|NCT01091168|560560829|FG001|Overall Study|Progressive disease|234|||
155308259|NCT01091168|560560828|FG000|Overall Study|Adverse Event|21|||
155308260|NCT01091168|560560829|FG001|Overall Study|Adverse Event|24|||
155308261|NCT01091168|560560828|FG000|Overall Study|Lost to Follow-up|0|||
155308262|NCT01091168|560560829|FG001|Overall Study|Lost to Follow-up|1|||
155308263|NCT01091168|560560828|FG000|Overall Study|Physician, patient's decision, other|27|||
155308264|NCT01091168|560560829|FG001|Overall Study|Physician, patient's decision, other|37|||
155308265|NCT04623775|560560839|FG000|Randomization|No Longer Meets Study Criteria|2|||
155308266|NCT04623775|560560840|FG001|Randomization|No Longer Meets Study Criteria|1|||
155308267|NCT04623775|560560841|FG002|Randomization|No Longer Meets Study Criteria|0|||
155308268|NCT04623775|560560842|FG003|Randomization|No Longer Meets Study Criteria|0|||
155308269|NCT04623775|560560839|FG000|Randomization|Withdrew Consent|0|||
155308270|NCT04623775|560560840|FG001|Randomization|Withdrew Consent|0|||
155308271|NCT04623775|560560841|FG002|Randomization|Withdrew Consent|0|||
155308272|NCT04623775|560560842|FG003|Randomization|Withdrew Consent|1|||
155308273|NCT04623775|560560839|FG000|Randomization|Other Reasons|0|||
155308274|NCT04623775|560560840|FG001|Randomization|Other Reasons|0|||
155308275|NCT04623775|560560841|FG002|Randomization|Other Reasons|0|||
155308276|NCT04623775|560560842|FG003|Randomization|Other Reasons|1|||
155308277|NCT04623775|560560839|FG000|Treatment Period|participant withdrew consent|4|||
155308278|NCT04623775|560560840|FG001|Treatment Period|participant withdrew consent|0|||
155308279|NCT04623775|560560841|FG002|Treatment Period|participant withdrew consent|1|||
155308280|NCT04623775|560560842|FG003|Treatment Period|participant withdrew consent|2|||
155308281|NCT04623775|560560839|FG000|Treatment Period|Death|3|||
155308282|NCT04623775|560560840|FG001|Treatment Period|Death|1|||
155308283|NCT04623775|560560841|FG002|Treatment Period|Death|4|||
155308284|NCT04623775|560560842|FG003|Treatment Period|Death|2|||
155308285|NCT04623775|560560839|FG000|Treatment Period|Lost to Follow-up|0|||
155308286|NCT04623775|560560840|FG001|Treatment Period|Lost to Follow-up|2|||
155308287|NCT04623775|560560841|FG002|Treatment Period|Lost to Follow-up|0|||
155308288|NCT04623775|560560842|FG003|Treatment Period|Lost to Follow-up|0|||
155308289|NCT04623775|560560839|FG000|Treatment Period|poor/non compliance|0|||
155308290|NCT04623775|560560840|FG001|Treatment Period|poor/non compliance|0|||
155308291|NCT04623775|560560841|FG002|Treatment Period|poor/non compliance|1|||
155308292|NCT04623775|560560842|FG003|Treatment Period|poor/non compliance|0|||
155308293|NCT04623775|560560839|FG000|Treatment Period|participant no longer meets study criteria|0|||
154959454|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155308294|NCT04623775|560560840|FG001|Treatment Period|participant no longer meets study criteria|1|||
155308295|NCT04623775|560560841|FG002|Treatment Period|participant no longer meets study criteria|0|||
155308296|NCT04623775|560560842|FG003|Treatment Period|participant no longer meets study criteria|0|||
155308297|NCT04623775|560560839|FG000|Treatment Period|administrative reasons by sponsor|3|||
155308298|NCT04623775|560560840|FG001|Treatment Period|administrative reasons by sponsor|2|||
155308299|NCT04623775|560560841|FG002|Treatment Period|administrative reasons by sponsor|0|||
155308300|NCT04623775|560560842|FG003|Treatment Period|administrative reasons by sponsor|0|||
155308301|NCT04623775|560560839|FG000|Treatment Period|other reasons|2|||
155308302|NCT04623775|560560840|FG001|Treatment Period|other reasons|0|||
155308303|NCT04623775|560560841|FG002|Treatment Period|other reasons|1|||
155308304|NCT04623775|560560842|FG003|Treatment Period|other reasons|1|||
155308305|NCT04623775|560560839|FG000|Treatment Period|disease progression|40|||
155308306|NCT04623775|560560840|FG001|Treatment Period|disease progression|35|||
155308307|NCT04623775|560560841|FG002|Treatment Period|disease progression|63|||
155308308|NCT04623775|560560842|FG003|Treatment Period|disease progression|63|||
155308309|NCT04623775|560560839|FG000|Treatment Period|study drug toxicity|12|||
155308310|NCT04623775|560560840|FG001|Treatment Period|study drug toxicity|15|||
155308311|NCT04623775|560560841|FG002|Treatment Period|study drug toxicity|13|||
155308312|NCT04623775|560560842|FG003|Treatment Period|study drug toxicity|12|||
155308313|NCT04623775|560560839|FG000|Treatment Period|AE unrelated to study drug|4|||
155308314|NCT04623775|560560840|FG001|Treatment Period|AE unrelated to study drug|9|||
155308315|NCT04623775|560560841|FG002|Treatment Period|AE unrelated to study drug|12|||
155308316|NCT04623775|560560842|FG003|Treatment Period|AE unrelated to study drug|9|||
155308317|NCT04623775|560560839|FG000|Treatment Period|participant request to discontinue treatment|0|||
155308318|NCT04623775|560560840|FG001|Treatment Period|participant request to discontinue treatment|2|||
155308319|NCT04623775|560560841|FG002|Treatment Period|participant request to discontinue treatment|2|||
155308320|NCT04623775|560560842|FG003|Treatment Period|participant request to discontinue treatment|0|||
155308321|NCT03978637|560560845|FG000|Overall Study|Death|0|||
155308322|NCT03978637|560560846|FG001|Overall Study|Death|2|||
155308323|NCT03978637|560560847|FG002|Overall Study|Death|2|||
155308324|NCT03978637|560560848|FG003|Overall Study|Death|0|||
155308325|NCT03978637|560560845|FG000|Overall Study|Withdrawal by Subject|0|||
154959455|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959456|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
155161275|NCT01285557|560026801|FG001|Overall Study|Sponsor Decision|1|||
155308326|NCT03978637|560560846|FG001|Overall Study|Withdrawal by Subject|0|||
155308327|NCT03978637|560560847|FG002|Overall Study|Withdrawal by Subject|1|||
155308328|NCT03978637|560560848|FG003|Overall Study|Withdrawal by Subject|0|||
155308329|NCT03978637|560560845|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
155065705|NCT03282097|559672170|FG001|Intervention Visit Complete|Patient Death|15|||
155065706|NCT03282097|559672169|FG000|Intervention Visit Complete|Caregiver Death|0|||
155065707|NCT03282097|559672170|FG001|Intervention Visit Complete|Caregiver Death|3|||
155308330|NCT03978637|560560846|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
155308331|NCT03978637|560560847|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
155308332|NCT03978637|560560848|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
155308333|NCT01959698|560560849|FG000|Overall Study|Adverse Event|0|||
155308334|NCT01959698|560560850|FG001|Overall Study|Adverse Event|0|||
155308335|NCT01959698|560560851|FG002|Overall Study|Adverse Event|0|||
155308336|NCT01959698|560560852|FG003|Overall Study|Adverse Event|0|||
155308337|NCT01959698|560560853|FG004|Overall Study|Adverse Event|0|||
155308338|NCT01959698|560560854|FG005|Overall Study|Adverse Event|0|||
155308339|NCT01959698|560560855|FG006|Overall Study|Adverse Event|1|||
155308340|NCT01959698|560560849|FG000|Overall Study|Physician Decision|1|||
155308341|NCT01959698|560560850|FG001|Overall Study|Physician Decision|0|||
155308342|NCT01959698|560560851|FG002|Overall Study|Physician Decision|1|||
155308343|NCT01959698|560560852|FG003|Overall Study|Physician Decision|2|||
155308344|NCT01959698|560560853|FG004|Overall Study|Physician Decision|0|||
155308345|NCT01959698|560560854|FG005|Overall Study|Physician Decision|3|||
155308346|NCT01959698|560560855|FG006|Overall Study|Physician Decision|3|||
155308347|NCT05415436|560562120|FG000|Overall Study|Surgeon cancelled procedure|1|||
155308348|NCT05415436|560562121|FG001|Overall Study|Surgeon cancelled procedure|0|||
155308349|NCT05415436|560562120|FG000|Overall Study|Death|1|||
155308350|NCT05415436|560562121|FG001|Overall Study|Death|0|||
155308351|NCT05386355|560562132|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308352|NCT05386355|560562133|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308353|NCT05386355|560562134|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308354|NCT05386355|560562135|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
155308355|NCT03775109|560562138|FG000|Overall Study|Adverse Event|1|||
155308356|NCT03775109|560562139|FG001|Overall Study|Adverse Event|0|||
155308357|NCT03775109|560562138|FG000|Overall Study|COVID-19 outbreak|2|||
155308358|NCT03775109|560562139|FG001|Overall Study|COVID-19 outbreak|0|||
155308359|NCT03775109|560562138|FG000|Overall Study|Lost to Follow-up|0|||
155308360|NCT03775109|560562139|FG001|Overall Study|Lost to Follow-up|2|||
155308361|NCT03775109|560562138|FG000|Overall Study|Withdrawal by Subject|1|||
155308362|NCT03775109|560562139|FG001|Overall Study|Withdrawal by Subject|1|||
155308363|NCT03775109|560562138|FG000|Overall Study|Death|0|||
155308364|NCT03775109|560562139|FG001|Overall Study|Death|1|||
155308365|NCT03775109|560562138|FG000|Overall Study|Lack of Efficacy|1|||
155308366|NCT03775109|560562139|FG001|Overall Study|Lack of Efficacy|0|||
155308367|NCT03484702|560562142|FG000|Treatment Period|Death|3|||
155308368|NCT03484702|560562143|FG001|Treatment Period|Death|1|||
155308369|NCT03484702|560562144|FG002|Treatment Period|Death|0|||
155308370|NCT03484702|560562145|FG003|Treatment Period|Death|0|||
155308371|NCT03484702|560562146|FG004|Treatment Period|Death|0|||
155308372|NCT03484702|560562147|FG005|Treatment Period|Death|0|||
155308373|NCT03484702|560562142|FG000|Treatment Period|Adverse Event|1|||
155308374|NCT03484702|560562143|FG001|Treatment Period|Adverse Event|0|||
155308375|NCT03484702|560562144|FG002|Treatment Period|Adverse Event|0|||
155308376|NCT03484702|560562145|FG003|Treatment Period|Adverse Event|0|||
155308377|NCT03484702|560562146|FG004|Treatment Period|Adverse Event|0|||
155308378|NCT03484702|560562147|FG005|Treatment Period|Adverse Event|0|||
155308379|NCT03484702|560562142|FG000|Treatment Period|Participant Withdrew from Study|0|||
155308380|NCT03484702|560562143|FG001|Treatment Period|Participant Withdrew from Study|1|||
155308381|NCT03484702|560562144|FG002|Treatment Period|Participant Withdrew from Study|0|||
155308382|NCT03484702|560562145|FG003|Treatment Period|Participant Withdrew from Study|0|||
155308383|NCT03484702|560562146|FG004|Treatment Period|Participant Withdrew from Study|0|||
155308384|NCT03484702|560562147|FG005|Treatment Period|Participant Withdrew from Study|0|||
155308385|NCT03484702|560562142|FG000|Treatment Period|Physician Decision|0|||
155308386|NCT03484702|560562143|FG001|Treatment Period|Physician Decision|1|||
155308387|NCT03484702|560562144|FG002|Treatment Period|Physician Decision|0|||
155308388|NCT03484702|560562145|FG003|Treatment Period|Physician Decision|0|||
155308389|NCT03484702|560562146|FG004|Treatment Period|Physician Decision|0|||
155308390|NCT03484702|560562147|FG005|Treatment Period|Physician Decision|1|||
155308391|NCT01894061|560562152|FG000|Overall Study|Screen failure|1|||
155308392|NCT01894061|560562152|FG000|Overall Study|Withdrawal by Subject|1|||
155308393|NCT00739648|560562153|FG000|Overall Study|Adverse Event|3|||
155308394|NCT00739648|560562154|FG001|Overall Study|Adverse Event|15|||
155308395|NCT00739648|560562153|FG000|Overall Study|Withdrawal by Subject|13|||
155308396|NCT00739648|560562154|FG001|Overall Study|Withdrawal by Subject|25|||
155308397|NCT00739648|560562153|FG000|Overall Study|Lost to Follow-up|4|||
155308398|NCT00739648|560562154|FG001|Overall Study|Lost to Follow-up|7|||
155308399|NCT00739648|560562153|FG000|Overall Study|Death|2|||
155308400|NCT00739648|560562154|FG001|Overall Study|Death|0|||
155308401|NCT00739648|560562153|FG000|Overall Study|Do not know|4|||
155308402|NCT00739648|560562154|FG001|Overall Study|Do not know|6|||
154959457|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
154959458|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959459|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959460|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959461|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959462|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959463|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959464|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959465|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959466|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959467|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959468|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959469|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959470|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959471|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
154959472|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
154959473|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
154959474|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959475|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959476|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959477|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959478|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
154959479|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959480|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959481|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959482|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959483|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959484|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959485|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959486|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959487|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959488|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959489|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959490|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959491|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959492|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959493|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
154959494|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
154959495|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959496|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959497|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959498|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959499|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
154959500|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959501|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959502|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959503|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959504|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959505|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959506|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959507|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959508|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959509|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959510|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959511|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959512|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959513|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959514|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
154959515|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
154959516|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959517|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959518|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959519|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
155161276|NCT05786651|560026803|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
155161277|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
155308403|NCT05110495|560562155|FG000|Overall Study|Lost to Follow-up|1|||
155308404|NCT05110495|560562155|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
155308405|NCT04173663|560562156|FG000|Overall Study|Withdrawal by Subject|1|||
155308406|NCT04173663|560562157|FG001|Overall Study|Withdrawal by Subject|6|||
155308407|NCT04173663|560562156|FG000|Overall Study|Lost to Follow-up|17|||
155308408|NCT04173663|560562157|FG001|Overall Study|Lost to Follow-up|24|||
155308409|NCT02840474|560562159|FG000|Overall Study|Lost to Follow-up|1|||
155308410|NCT02840474|560562160|FG001|Overall Study|Lost to Follow-up|0|||
155308411|NCT04716634|560562161|FG000|Overall Study|Death|24|||
155308412|NCT04716634|560562162|FG001|Overall Study|Death|24|||
155308413|NCT04716634|560562163|FG002|Overall Study|Death|8|||
155308414|NCT04716634|560562161|FG000|Overall Study|Closed by Sponsor|4|||
155308415|NCT04716634|560562162|FG001|Overall Study|Closed by Sponsor|4|||
155308416|NCT04716634|560562163|FG002|Overall Study|Closed by Sponsor|5|||
155308417|NCT04716634|560562161|FG000|Overall Study|Lost to Follow-up|1|||
155308418|NCT04716634|560562162|FG001|Overall Study|Lost to Follow-up|0|||
155308419|NCT04716634|560562163|FG002|Overall Study|Lost to Follow-up|1|||
155308420|NCT04716634|560562161|FG000|Overall Study|Withdrawal by Subject|0|||
155308421|NCT04716634|560562162|FG001|Overall Study|Withdrawal by Subject|0|||
155308422|NCT04716634|560562163|FG002|Overall Study|Withdrawal by Subject|1|||
155308423|NCT03089398|560562166|FG000|Overall Study|Death|4|||
155308424|NCT03089398|560562167|FG001|Overall Study|Death|9|||
155308425|NCT03089398|560562166|FG000|Overall Study|Lost to Follow-up|21|||
155308426|NCT03089398|560562167|FG001|Overall Study|Lost to Follow-up|30|||
155308427|NCT03089398|560562166|FG000|Overall Study|Withdrawal by Subject|2|||
155308428|NCT03089398|560562167|FG001|Overall Study|Withdrawal by Subject|2|||
155308429|NCT05418296|560562172|FG000|Overall Study|Withdrawal by Subject|4|||
155308430|NCT05418296|560562173|FG001|Overall Study|Withdrawal by Subject|1|||
155308431|NCT04419168|560562176|FG000|Overall Study|Protocol Violation|1|||
155308432|NCT04419168|560562177|FG001|Overall Study|Protocol Violation|1|||
155308433|NCT04419168|560562176|FG000|Overall Study|Lost to Follow-up|7|||
155308434|NCT04419168|560562177|FG001|Overall Study|Lost to Follow-up|7|||
155308435|NCT04419168|560562176|FG000|Overall Study|Missed 6-month Visit|48|||
155308436|NCT04419168|560562177|FG001|Overall Study|Missed 6-month Visit|45|||
155308437|NCT03713086|560562181|FG000|Overall Study|Withdrawal by Subject|0|||
155308438|NCT03713086|560562182|FG001|Overall Study|Withdrawal by Subject|2|||
155308439|NCT03713086|560562183|FG002|Overall Study|Withdrawal by Subject|1|||
155308440|NCT03713086|560562184|FG003|Overall Study|Withdrawal by Subject|0|||
155308441|NCT03713086|560562181|FG000|Overall Study|Lost to Follow-up|0|||
154959520|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
154959521|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959522|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959523|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959524|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959525|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959526|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959527|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959528|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959529|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959530|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155308442|NCT03713086|560562182|FG001|Overall Study|Lost to Follow-up|1|||
155308443|NCT03713086|560562183|FG002|Overall Study|Lost to Follow-up|0|||
154959531|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959532|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
155308444|NCT03713086|560562184|FG003|Overall Study|Lost to Follow-up|1|||
155308445|NCT04737772|560562188|FG000|Phase 2 Study|Lost to Follow-up|15|||
155308446|NCT04737772|560562189|FG001|Phase 2 Study|Lost to Follow-up|15|||
154959533|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959534|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
155308447|NCT04737772|560562188|FG000|Phase 2 Study|Withdrawal by Subject|0|||
155308448|NCT04737772|560562189|FG001|Phase 2 Study|Withdrawal by Subject|1|||
155308449|NCT04737772|560562188|FG000|Phase 2 Study|Did not take any coaching calls|4|||
155308450|NCT04737772|560562189|FG001|Phase 2 Study|Did not take any coaching calls|0|||
155308451|NCT04737772|560562188|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
155308452|NCT04737772|560562189|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
155308453|NCT04737772|560562188|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
155308454|NCT04737772|560562189|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
155308455|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
155308456|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
155308457|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
155308458|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
155308459|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
155308460|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
155308461|NCT02549339|560562190|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
155308462|NCT02549339|560562191|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
155308463|NCT02549339|560562190|FG000|12-month Follow-up|Lack of Efficacy|0|||
155308464|NCT02549339|560562191|FG001|12-month Follow-up|Lack of Efficacy|2|||
155308465|NCT02549339|560562190|FG000|12-month Follow-up|Withdrawal by Subject|8|||
155308466|NCT02549339|560562191|FG001|12-month Follow-up|Withdrawal by Subject|3|||
155308467|NCT02549339|560562190|FG000|12-month Follow-up|Lost to Follow-up|1|||
155308468|NCT02549339|560562191|FG001|12-month Follow-up|Lost to Follow-up|3|||
155308469|NCT02549339|560562190|FG000|12-month Follow-up|Other|0|||
155308470|NCT02549339|560562191|FG001|12-month Follow-up|Other|3|||
155308471|NCT02728076|560562192|FG000|Overall Study|Physician Decision|4|||
155308472|NCT04820855|560562193|FG000|Overall Study|Lost to Follow-up|6|||
155308473|NCT04820855|560562194|FG001|Overall Study|Lost to Follow-up|9|||
155308474|NCT04838262|560562195|FG000|Overall Study|Withdrawal by Subject|9|||
155308475|NCT04838262|560562196|FG001|Overall Study|Withdrawal by Subject|4|||
155308476|NCT02927769|560562197|FG000|Induction Phase|Study drug toxicity|1|||
155308477|NCT02927769|560562198|FG001|Induction Phase|Study drug toxicity|1|||
155308478|NCT02927769|560562197|FG000|Induction Phase|Disease progression|0|||
155308479|NCT02927769|560562198|FG001|Induction Phase|Disease progression|1|||
155308480|NCT02927769|560562197|FG000|Intensification Phase|Study drug toxicity|1|||
155308481|NCT02927769|560562198|FG001|Intensification Phase|Study drug toxicity|0|||
155308482|NCT05956002|560562199|FG000|Treatment Period 3|Adverse Event|0|||
155308483|NCT05956002|560562200|FG001|Treatment Period 3|Adverse Event|0|||
155308484|NCT05956002|560562201|FG002|Treatment Period 3|Adverse Event|1|||
155308485|NCT05956002|560562202|FG003|Treatment Period 3|Adverse Event|0|||
155308486|NCT02307565|560562203|FG000|Overall Study|Adverse Event|3|||
155308487|NCT02307565|560562204|FG001|Overall Study|Adverse Event|2|||
155308488|NCT02307565|560562203|FG000|Overall Study|Withdrawal by Subject|2|||
155308489|NCT02307565|560562204|FG001|Overall Study|Withdrawal by Subject|2|||
155308490|NCT04838613|560562207|FG000|Overall Study|Withdrawal by Subject|3|||
155308491|NCT04838613|560562208|FG001|Overall Study|Withdrawal by Subject|6|||
155308492|NCT04838613|560562207|FG000|Overall Study|Protocol Deviation|3|||
155308493|NCT04838613|560562208|FG001|Overall Study|Protocol Deviation|2|||
155308494|NCT04838613|560562207|FG000|Overall Study|Technical Problems|0|||
155308495|NCT04838613|560562208|FG001|Overall Study|Technical Problems|5|||
155308496|NCT04838613|560562207|FG000|Overall Study|Physician Decision|2|||
155308497|NCT04838613|560562208|FG001|Overall Study|Physician Decision|0|||
155308498|NCT04970654|560562209|FG000|Overall Study|Withdrawal by parents/guardian|1|||
155308499|NCT04970654|560562210|FG001|Overall Study|Withdrawal by parents/guardian|2|||
155308500|NCT04970654|560562209|FG000|Overall Study|Unclassified|2|||
155308501|NCT04970654|560562210|FG001|Overall Study|Unclassified|1|||
155308502|NCT04970654|560562209|FG000|Overall Study|Lost to Follow-up|1|||
155308503|NCT04970654|560562210|FG001|Overall Study|Lost to Follow-up|0|||
155308504|NCT05239039|560562223|FG000|Overall Study|Withdrawal by Subject|0|||
155308505|NCT05239039|560562224|FG001|Overall Study|Withdrawal by Subject|1|||
155308506|NCT03690206|560562225|FG000|Overall Study|Withdrawal by Subject|2|||
155308507|NCT03690206|560562226|FG001|Overall Study|Withdrawal by Subject|0|||
155308508|NCT03690206|560562227|FG002|Overall Study|Withdrawal by Subject|0|||
155308509|NCT03690206|560562225|FG000|Overall Study|ICF withdrawal|2|||
155308510|NCT03690206|560562226|FG001|Overall Study|ICF withdrawal|0|||
155308511|NCT03690206|560562227|FG002|Overall Study|ICF withdrawal|0|||
155308512|NCT03897686|560563623|FG000|Overall Study|Protocol Violation|1|||
155308513|NCT03897686|560563624|FG001|Overall Study|Protocol Violation|1|||
155308514|NCT03897686|560563623|FG000|Overall Study|Withdrawal by Subject|1|||
155308515|NCT03897686|560563624|FG001|Overall Study|Withdrawal by Subject|1|||
155308516|NCT04052516|560563625|FG000|Overall Study|Withdrawal by Subject|4|||
155308517|NCT04052516|560563626|FG001|Overall Study|Withdrawal by Subject|5|||
155308518|NCT04052516|560563627|FG002|Overall Study|Withdrawal by Subject|6|||
155308519|NCT04052516|560563625|FG000|Overall Study|Adverse Event|3|||
155308520|NCT04052516|560563626|FG001|Overall Study|Adverse Event|2|||
155308521|NCT04052516|560563627|FG002|Overall Study|Adverse Event|8|||
155308522|NCT04052516|560563625|FG000|Overall Study|Lost to Follow-up|2|||
155308523|NCT04052516|560563626|FG001|Overall Study|Lost to Follow-up|5|||
155308524|NCT04052516|560563627|FG002|Overall Study|Lost to Follow-up|3|||
155308525|NCT04052516|560563625|FG000|Overall Study|Protocol Violation|1|||
155308526|NCT04052516|560563626|FG001|Overall Study|Protocol Violation|1|||
155308527|NCT04052516|560563627|FG002|Overall Study|Protocol Violation|0|||
155308528|NCT04052516|560563625|FG000|Overall Study|Death|1|||
155308529|NCT04052516|560563626|FG001|Overall Study|Death|0|||
155161278|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
155308530|NCT04052516|560563627|FG002|Overall Study|Death|0|||
155308531|NCT04052516|560563625|FG000|Overall Study|Physician Decision|0|||
155308532|NCT04052516|560563626|FG001|Overall Study|Physician Decision|1|||
155308533|NCT04052516|560563627|FG002|Overall Study|Physician Decision|0|||
155308534|NCT04052516|560563625|FG000|Overall Study|Pregnancy|1|||
155308535|NCT04052516|560563626|FG001|Overall Study|Pregnancy|0|||
155308536|NCT04052516|560563627|FG002|Overall Study|Pregnancy|0|||
155308537|NCT04052516|560563625|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
155308538|NCT04052516|560563626|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
155308539|NCT04052516|560563627|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
155308540|NCT04052516|560563625|FG000|Overall Study|Reason not recorded|0|||
155308541|NCT04052516|560563626|FG001|Overall Study|Reason not recorded|1|||
155308542|NCT04052516|560563627|FG002|Overall Study|Reason not recorded|0|||
155308543|NCT06143670|560563629|FG000|Overall Study|Lost to Follow-up|0|||
155308544|NCT06143670|560563630|FG001|Overall Study|Lost to Follow-up|1|||
155308545|NCT06143670|560563629|FG000|Overall Study|Withdrawal by Subject|3|||
155308546|NCT06143670|560563630|FG001|Overall Study|Withdrawal by Subject|0|||
155308547|NCT03625882|560563632|FG000|Overall Study|Protocol Violation|3|||
155308548|NCT05058391|560563633|FG000|Overall Study|Adverse Event|1|||
155308549|NCT05009251|560563634|FG000|Overall Study|Protocol Violation|100|||
155308550|NCT05009251|560563635|FG001|Overall Study|Protocol Violation|105|||
155308551|NCT05009251|560563636|FG002|Overall Study|Protocol Violation|119|||
155308552|NCT05009251|560563637|FG003|Overall Study|Protocol Violation|120|||
155308553|NCT05009251|560563638|FG004|Overall Study|Protocol Violation|119|||
155308554|NCT05009251|560563634|FG000|Overall Study|Death|25|||
155308555|NCT05009251|560563635|FG001|Overall Study|Death|22|||
155308556|NCT05009251|560563636|FG002|Overall Study|Death|24|||
155308557|NCT05009251|560563637|FG003|Overall Study|Death|19|||
155308558|NCT05009251|560563638|FG004|Overall Study|Death|15|||
155308559|NCT02662062|560563644|FG000|Overall Study|Withdrawal by Subject|1|||
155308560|NCT05249439|560563650|FG000|Overall Study|Withdrawal by Subject|2|||
155308561|NCT05249439|560563651|FG001|Overall Study|Withdrawal by Subject|5|||
155308562|NCT05249439|560563650|FG000|Overall Study|Physician Decision|3|||
155308563|NCT05249439|560563651|FG001|Overall Study|Physician Decision|1|||
155308564|NCT00616967|560563652|FG000|Overall Study|Withdrawal by Subject|0|||
155308565|NCT00616967|560563653|FG001|Overall Study|Withdrawal by Subject|0|||
155308566|NCT00616967|560563654|FG002|Overall Study|Withdrawal by Subject|1|||
155308567|NCT02910583|560563655|FG000|Overall Study|Death|7|||
155308568|NCT02910583|560563656|FG001|Overall Study|Death|3|||
155308569|NCT02910583|560563655|FG000|Overall Study|Lost to Follow-up|1|||
155308570|NCT02910583|560563656|FG001|Overall Study|Lost to Follow-up|0|||
155308571|NCT02910583|560563655|FG000|Overall Study|Withdrawal by Subject|12|||
155308572|NCT02910583|560563656|FG001|Overall Study|Withdrawal by Subject|8|||
155308573|NCT02910583|560563655|FG000|Overall Study|Other, Not Specified|6|||
155308574|NCT02910583|560563656|FG001|Overall Study|Other, Not Specified|3|||
155308575|NCT02249949|560563657|FG000|Overall Study|Cancelled prior to treatment|2|||
155308576|NCT02097420|560563660|FG000|Overall Study|Death|6|||
155308577|NCT02097420|560563660|FG000|Overall Study|Valve explanted|13|||
155308578|NCT02097420|560563660|FG000|Overall Study|Other Reason|1|||
155308579|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
155308580|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
155308581|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
155308582|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
155308583|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
155308584|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
155308585|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
155308586|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
155308587|NCT05059262|560563661|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
155308588|NCT05059262|560563662|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
155308589|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
155308590|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
155308591|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
155308592|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
155308593|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
155308594|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
155308595|NCT05059262|560563661|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
155308596|NCT05059262|560563662|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
155308597|NCT04263311|560563663|FG000|Overall Study|Lost to Follow-up|1|||
155308598|NCT04263311|560563664|FG001|Overall Study|Lost to Follow-up|2|||
155308599|NCT04263311|560563665|FG002|Overall Study|Lost to Follow-up|0|||
155308600|NCT04263311|560563663|FG000|Overall Study|Health Issues|1|||
155308601|NCT04263311|560563664|FG001|Overall Study|Health Issues|0|||
155308602|NCT04263311|560563665|FG002|Overall Study|Health Issues|0|||
155308603|NCT04263311|560563663|FG000|Overall Study|Left the country|1|||
155308604|NCT04263311|560563664|FG001|Overall Study|Left the country|0|||
155308605|NCT04263311|560563665|FG002|Overall Study|Left the country|0|||
155308606|NCT04263311|560563663|FG000|Overall Study|Unable to maintain time commitment|1|||
155308607|NCT04263311|560563664|FG001|Overall Study|Unable to maintain time commitment|0|||
155308608|NCT04263311|560563665|FG002|Overall Study|Unable to maintain time commitment|0|||
155308609|NCT04263311|560563663|FG000|Overall Study|No longer interested|1|||
155308610|NCT04263311|560563664|FG001|Overall Study|No longer interested|0|||
155308611|NCT04263311|560563665|FG002|Overall Study|No longer interested|0|||
155308612|NCT04263311|560563663|FG000|Overall Study|Ineligible post consent|0|||
155308613|NCT04263311|560563664|FG001|Overall Study|Ineligible post consent|0|||
155308614|NCT04263311|560563665|FG002|Overall Study|Ineligible post consent|5|||
155308615|NCT03315754|560563669|FG000|Overall Study|COVID-19 complications leading to death|1|||
155308616|NCT03315754|560563669|FG000|Overall Study|insurance coverage issue|1|||
155308617|NCT02954341|560563670|FG000|Overall Study|Attempted Implant unsuccessful|5|||
155308618|NCT02954341|560563670|FG000|Overall Study|Death|90|||
155308619|NCT02954341|560563670|FG000|Overall Study|Withdrawal by Subject|4|||
155308620|NCT02954341|560563670|FG000|Overall Study|Physician Decision|13|||
155308621|NCT02954341|560563670|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
155308622|NCT02954341|560563670|FG000|Overall Study|Not implanted due to physician's decision|1|||
155308623|NCT02954341|560563670|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
155308624|NCT04245501|560563688|FG000|Overall Study|Adverse Event|2|||
155308625|NCT04245501|560563689|FG001|Overall Study|Adverse Event|0|||
155308626|NCT04245501|560563688|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
155308627|NCT04245501|560563689|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
155308628|NCT03526861|560563691|FG000|Initial Treatment Period|Not dosed|1|||
155308629|NCT03526861|560563692|FG001|Initial Treatment Period|Not dosed|1|||
155308630|NCT03526861|560563693|FG002|Initial Treatment Period|Not dosed|1|||
155308631|NCT03526861|560563694|FG003|Initial Treatment Period|Not dosed|0|||
155308632|NCT03526861|560563695|FG004|Initial Treatment Period|Not dosed|0|||
155308633|NCT03526861|560563696|FG005|Initial Treatment Period|Not dosed|0|||
155308634|NCT03526861|560563697|FG006|Initial Treatment Period|Not dosed|0|||
155308635|NCT03526861|560563698|FG007|Initial Treatment Period|Not dosed|0|||
155308636|NCT03526861|560563699|FG008|Initial Treatment Period|Not dosed|0|||
155308637|NCT03526861|560563691|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
155308638|NCT03526861|560563692|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
155308639|NCT03526861|560563693|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
155308640|NCT03526861|560563694|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308641|NCT03526861|560563695|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308642|NCT03526861|560563696|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308643|NCT03526861|560563697|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308644|NCT03526861|560563698|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308645|NCT03526861|560563699|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308646|NCT03526861|560563691|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
155308647|NCT03526861|560563692|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
155308648|NCT03526861|560563693|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
155308649|NCT03526861|560563694|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308650|NCT03526861|560563695|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308651|NCT03526861|560563696|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308652|NCT03526861|560563697|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308653|NCT03526861|560563698|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308654|NCT03526861|560563699|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
155308655|NCT03526861|560563691|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308656|NCT03526861|560563692|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308657|NCT03526861|560563693|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308658|NCT03526861|560563694|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
155308659|NCT03526861|560563695|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
155308660|NCT03526861|560563696|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308661|NCT03526861|560563697|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
155308662|NCT03526861|560563698|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308663|NCT03526861|560563699|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308664|NCT03526861|560563691|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308665|NCT03526861|560563692|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308666|NCT03526861|560563693|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308667|NCT03526861|560563694|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
155308668|NCT03526861|560563695|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
155308669|NCT03526861|560563696|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
155308670|NCT03526861|560563697|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
155308671|NCT03526861|560563698|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
155308672|NCT03526861|560563699|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
155308673|NCT03526861|560563691|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308674|NCT03526861|560563692|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308675|NCT03526861|560563693|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308676|NCT03526861|560563694|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
155308677|NCT03526861|560563695|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308678|NCT03526861|560563696|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308679|NCT03526861|560563697|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308680|NCT03526861|560563698|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308681|NCT03526861|560563699|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308682|NCT03526861|560563691|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308683|NCT03526861|560563692|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308684|NCT03526861|560563693|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308685|NCT03526861|560563694|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308686|NCT03526861|560563695|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308687|NCT03526861|560563696|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308688|NCT03526861|560563697|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308689|NCT03526861|560563698|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
155308690|NCT03526861|560563699|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
155308691|NCT03526861|560563691|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308692|NCT03526861|560563692|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308693|NCT03526861|560563693|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308694|NCT03526861|560563694|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308695|NCT03526861|560563695|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308696|NCT03526861|560563696|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308697|NCT03526861|560563697|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308698|NCT03526861|560563698|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
155308699|NCT03526861|560563699|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
155308700|NCT03526861|560563691|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308701|NCT03526861|560563692|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308702|NCT03526861|560563693|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308703|NCT03526861|560563694|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308704|NCT03526861|560563695|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308705|NCT03526861|560563696|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308706|NCT03526861|560563697|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308707|NCT03526861|560563698|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
155308708|NCT03526861|560563699|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
155308709|NCT05524233|560563702|FG000|Overall Study|Lost to Follow-up|2|||
155308710|NCT05524233|560563702|FG000|Overall Study|Adverse Event|2|||
155308711|NCT05524233|560563702|FG000|Overall Study|Withdrawal by Subject|1|||
155308712|NCT04382898|560563704|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
155308713|NCT04382898|560563705|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308714|NCT04382898|560563706|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308715|NCT04382898|560563707|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308716|NCT04382898|560563708|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
155308717|NCT04382898|560563704|FG000|Part 1: Dose Titration|Death|6|||
155308718|NCT04382898|560563705|FG001|Part 1: Dose Titration|Death|0|||
155308719|NCT04382898|560563706|FG002|Part 1: Dose Titration|Death|0|||
155308720|NCT04382898|560563707|FG003|Part 1: Dose Titration|Death|0|||
155308721|NCT04382898|560563708|FG004|Part 1: Dose Titration|Death|0|||
155308722|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308723|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308724|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
155308725|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308726|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155308727|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308728|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308729|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
155308730|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308731|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
155308732|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Death|0|||
155308733|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Death|17|||
155308734|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Death|13|||
155308735|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Death|1|||
155308736|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Death|0|||
155308737|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
155308738|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
155308739|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
155308740|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
155308741|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
155308742|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
155308743|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
155308744|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
154959535|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
155308745|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
154959536|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
154959537|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959538|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959539|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959540|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959541|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
154959542|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959543|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959544|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959545|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959546|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959547|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
155308746|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
155308747|NCT04382898|560563704|FG000|Part 2: Dose Expansion|Other|0|||
155308748|NCT04382898|560563705|FG001|Part 2: Dose Expansion|Other|0|||
155308749|NCT04382898|560563706|FG002|Part 2: Dose Expansion|Other|1|||
155308750|NCT04382898|560563707|FG003|Part 2: Dose Expansion|Other|0|||
155308751|NCT04382898|560563708|FG004|Part 2: Dose Expansion|Other|0|||
155308752|NCT01772472|560563709|FG000|Overall Study|Death|126|||
155308753|NCT01772472|560563710|FG001|Overall Study|Death|94|||
155308754|NCT01772472|560563709|FG000|Overall Study|Lost to Follow-up|51|||
155308755|NCT01772472|560563710|FG001|Overall Study|Lost to Follow-up|50|||
155308756|NCT01772472|560563709|FG000|Overall Study|Other|9|||
155308757|NCT01772472|560563710|FG001|Overall Study|Other|7|||
155308758|NCT01772472|560563709|FG000|Overall Study|Physician Decision|1|||
155308759|NCT01772472|560563710|FG001|Overall Study|Physician Decision|7|||
155308760|NCT01772472|560563709|FG000|Overall Study|Withdrawal by Subject|115|||
155308761|NCT01772472|560563710|FG001|Overall Study|Withdrawal by Subject|90|||
155308762|NCT01772472|560563709|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
155308763|NCT01772472|560563710|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
155308764|NCT04391894|560563711|FG000|Overall Study|Adverse Event|1|||
155308765|NCT04391894|560563712|FG001|Overall Study|Adverse Event|1|||
155308766|NCT04391894|560563713|FG002|Overall Study|Adverse Event|1|||
155308767|NCT04391894|560563714|FG003|Overall Study|Adverse Event|1|||
155308768|NCT04391894|560563715|FG004|Overall Study|Adverse Event|1|||
155308769|NCT04391894|560563711|FG000|Overall Study|Lost to Follow-up|1|||
155308770|NCT04391894|560563712|FG001|Overall Study|Lost to Follow-up|0|||
155308771|NCT04391894|560563713|FG002|Overall Study|Lost to Follow-up|0|||
155308772|NCT04391894|560563714|FG003|Overall Study|Lost to Follow-up|0|||
154959548|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959549|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959550|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
155308773|NCT04391894|560563715|FG004|Overall Study|Lost to Follow-up|0|||
155308774|NCT04391894|560563711|FG000|Overall Study|Protocol Violation|0|||
155308775|NCT04391894|560563712|FG001|Overall Study|Protocol Violation|0|||
155308776|NCT04391894|560563713|FG002|Overall Study|Protocol Violation|0|||
155308777|NCT04391894|560563714|FG003|Overall Study|Protocol Violation|1|||
155308778|NCT04391894|560563715|FG004|Overall Study|Protocol Violation|0|||
155308779|NCT04391894|560563711|FG000|Overall Study|Withdrawal by Subject|2|||
155308780|NCT04391894|560563712|FG001|Overall Study|Withdrawal by Subject|0|||
155308781|NCT04391894|560563713|FG002|Overall Study|Withdrawal by Subject|3|||
155308782|NCT04391894|560563714|FG003|Overall Study|Withdrawal by Subject|0|||
155308783|NCT04391894|560563715|FG004|Overall Study|Withdrawal by Subject|1|||
155308784|NCT04391894|560563711|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308785|NCT04391894|560563712|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308786|NCT04391894|560563713|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308787|NCT04391894|560563714|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
155308788|NCT04391894|560563715|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
155308789|NCT00446225|560563719|FG000|Overall Study|Protocol Violation|1|||
155308790|NCT00446225|560563720|FG001|Overall Study|Protocol Violation|0|||
155308791|NCT04450342|560563721|FG000|Overall Study|Adverse Event|1|||
155308792|NCT04450342|560563722|FG001|Overall Study|Adverse Event|1|||
155308793|NCT04450342|560563723|FG002|Overall Study|Adverse Event|0|||
155308794|NCT04450342|560563721|FG000|Overall Study|Device not used|1|||
155308795|NCT04450342|560563722|FG001|Overall Study|Device not used|0|||
155308796|NCT04450342|560563723|FG002|Overall Study|Device not used|0|||
155308797|NCT04450342|560563721|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
155308798|NCT04450342|560563722|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
155308799|NCT04450342|560563723|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
155308800|NCT04450342|560563721|FG000|Overall Study|Physician Decision|1|||
155308801|NCT04450342|560563722|FG001|Overall Study|Physician Decision|0|||
155308802|NCT04450342|560563723|FG002|Overall Study|Physician Decision|1|||
155308803|NCT04450342|560563721|FG000|Overall Study|Protocol Deviation|0|||
155308804|NCT04450342|560563722|FG001|Overall Study|Protocol Deviation|1|||
155308805|NCT04450342|560563723|FG002|Overall Study|Protocol Deviation|0|||
155308806|NCT04450342|560563721|FG000|Overall Study|Reoperation|1|||
155308807|NCT04450342|560563722|FG001|Overall Study|Reoperation|1|||
155308808|NCT04450342|560563723|FG002|Overall Study|Reoperation|0|||
155308809|NCT04450342|560563721|FG000|Overall Study|Screen Failures|0|||
155308810|NCT04450342|560563722|FG001|Overall Study|Screen Failures|0|||
155308811|NCT04450342|560563723|FG002|Overall Study|Screen Failures|2|||
155308812|NCT04450342|560563721|FG000|Overall Study|Site Terminated by Sponsor|1|||
155308813|NCT04450342|560563722|FG001|Overall Study|Site Terminated by Sponsor|1|||
155308814|NCT04450342|560563723|FG002|Overall Study|Site Terminated by Sponsor|1|||
155161279|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
155161280|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
155161281|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
155161282|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
155161283|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
155161284|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
155161285|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
155161286|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
155161287|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
155161288|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
155161289|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
155161290|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
155161291|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
155161292|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155161293|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155161294|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155161295|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
155161296|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155161297|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
155161298|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
155161299|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155161300|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
155161301|NCT01106690|560028622|FG000|Core Period: Baseline to Week 26|Other|10|||
155161302|NCT01106690|560028623|FG001|Core Period: Baseline to Week 26|Other|2|||
155161303|NCT01106690|560028624|FG002|Core Period: Baseline to Week 26|Other|6|||
155161304|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155065708|NCT03282097|559672169|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
155065709|NCT03282097|559672170|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
155065710|NCT03282097|559672169|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
155065711|NCT03282097|559672170|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
155065712|NCT03282097|559672169|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
155065713|NCT03282097|559672170|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
155065714|NCT03282097|559672169|FG000|Primary Outcome Data Collection Complete|Missing|2|||
155065715|NCT03282097|559672170|FG001|Primary Outcome Data Collection Complete|Missing|3|||
155308815|NCT04450342|560563721|FG000|Overall Study|Study Terminated by Sponsor|31|||
155308816|NCT04450342|560563722|FG001|Overall Study|Study Terminated by Sponsor|29|||
155308817|NCT04450342|560563723|FG002|Overall Study|Study Terminated by Sponsor|6|||
155308818|NCT04450342|560563721|FG000|Overall Study|Withdrawal by Subject|0|||
155308819|NCT04450342|560563722|FG001|Overall Study|Withdrawal by Subject|1|||
155308820|NCT04450342|560563723|FG002|Overall Study|Withdrawal by Subject|2|||
155308821|NCT05633407|560563724|FG000|Overall Study|Physician Decision|2|||
155308822|NCT05633407|560563725|FG001|Overall Study|Physician Decision|0|||
155308823|NCT05633407|560563724|FG000|Overall Study|Adverse Event|1|||
155308824|NCT05633407|560563725|FG001|Overall Study|Adverse Event|0|||
155308825|NCT05633407|560563724|FG000|Overall Study|Withdrawal by Subject|1|||
155308826|NCT05633407|560563725|FG001|Overall Study|Withdrawal by Subject|0|||
155308827|NCT05633407|560563724|FG000|Overall Study|Other|1|||
155308828|NCT05633407|560563725|FG001|Overall Study|Other|1|||
155308829|NCT02500758|560563728|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
155308830|NCT02500758|560563729|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
155308831|NCT02500758|560563728|FG000|Washout (1 Week)|Lost to Follow-up|2|||
155308832|NCT02500758|560563729|FG001|Washout (1 Week)|Lost to Follow-up|2|||
155308833|NCT02500758|560563728|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
155308834|NCT02500758|560563729|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
155308835|NCT02500758|560563728|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
155308836|NCT02500758|560563729|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
155308837|NCT02500758|560563728|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
155308838|NCT02500758|560563729|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
155308839|NCT00220740|560563730|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
155308840|NCT00220740|560563731|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
155308841|NCT00220740|560563730|FG000|Efficacy Period|Adverse Event|1|||
155308842|NCT00220740|560563731|FG001|Efficacy Period|Adverse Event|1|||
155308843|NCT00220740|560563730|FG000|Efficacy Period|Withdrawal by Subject|1|||
154959551|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959552|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959553|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
155308844|NCT00220740|560563731|FG001|Efficacy Period|Withdrawal by Subject|0|||
155308845|NCT00220740|560563730|FG000|Efficacy Period|Protocol Violation|1|||
155308846|NCT00220740|560563731|FG001|Efficacy Period|Protocol Violation|0|||
155308847|NCT00220740|560563730|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
155308848|NCT00220740|560563731|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
155308849|NCT01057433|560563732|FG000|Overall Study|Adverse Event|1|||
155308850|NCT02874534|560563734|FG000|Overall Study|Withdrawal by Subject|5|||
155308851|NCT02874534|560563735|FG001|Overall Study|Withdrawal by Subject|8|||
155308852|NCT02874534|560563734|FG000|Overall Study|Lost to Follow-up|2|||
155308853|NCT02874534|560563735|FG001|Overall Study|Lost to Follow-up|2|||
155308854|NCT02874534|560563734|FG000|Overall Study|Ongoing in study|1|||
155308855|NCT02874534|560563735|FG001|Overall Study|Ongoing in study|1|||
155308856|NCT02923180|560563736|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
155308857|NCT02923180|560563736|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
155308858|NCT05198310|560563737|FG000|Overall Study|Lost to Follow-up|0|||
155308859|NCT05198310|560563738|FG001|Overall Study|Lost to Follow-up|1|||
155308860|NCT05198310|560563739|FG002|Overall Study|Lost to Follow-up|0|||
155308861|NCT05198310|560563740|FG003|Overall Study|Lost to Follow-up|0|||
155308862|NCT05198310|560563741|FG004|Overall Study|Lost to Follow-up|0|||
155308863|NCT05198310|560563742|FG005|Overall Study|Lost to Follow-up|0|||
155308864|NCT05198310|560563743|FG006|Overall Study|Lost to Follow-up|0|||
155308865|NCT05198310|560563744|FG007|Overall Study|Lost to Follow-up|0|||
155308866|NCT05198310|560563737|FG000|Overall Study|Withdrawal by Subject|0|||
155308867|NCT05198310|560563738|FG001|Overall Study|Withdrawal by Subject|0|||
155308868|NCT05198310|560563739|FG002|Overall Study|Withdrawal by Subject|0|||
155308869|NCT05198310|560563740|FG003|Overall Study|Withdrawal by Subject|2|||
155308870|NCT05198310|560563741|FG004|Overall Study|Withdrawal by Subject|0|||
155308871|NCT05198310|560563742|FG005|Overall Study|Withdrawal by Subject|2|||
155308872|NCT05198310|560563743|FG006|Overall Study|Withdrawal by Subject|1|||
155308873|NCT05198310|560563744|FG007|Overall Study|Withdrawal by Subject|3|||
155308874|NCT04116736|560563745|FG000|Overall Study|Withdrew consent during study|3|||
155308875|NCT04116736|560563746|FG001|Overall Study|Withdrew consent during study|1|||
155308876|NCT04116736|560563745|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
155308877|NCT04116736|560563746|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
155308878|NCT04116736|560563745|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
155308879|NCT04116736|560563746|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
155308880|NCT04116736|560563745|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
155308881|NCT04116736|560563746|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
155308882|NCT04116736|560563745|FG000|Overall Study|Subject was enrolled in error|2|||
155308883|NCT04116736|560563746|FG001|Overall Study|Subject was enrolled in error|0|||
155308884|NCT04116736|560563745|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
155308885|NCT04116736|560563746|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
155308886|NCT04116736|560563745|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
155308887|NCT04116736|560563746|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
155308888|NCT04116736|560563745|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
155308889|NCT04116736|560563746|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
155308890|NCT03361748|560563753|FG000|Overall Study|Death|77|||
155308891|NCT03361748|560563753|FG000|Overall Study|Lost to Follow-up|4|||
154959554|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
155308892|NCT03361748|560563753|FG000|Overall Study|Withdrawal by Subject|20|||
155308893|NCT04854096|560563755|FG000|Overall Study|Adverse Event|1|||
155308894|NCT04854096|560563756|FG001|Overall Study|Adverse Event|0|||
155308895|NCT04854096|560563755|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
155308896|NCT04854096|560563756|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
155308897|NCT04854096|560563755|FG000|Overall Study|Withdrawal by Subject|1|||
154959555|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959556|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
154959557|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
154959558|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959559|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
155308898|NCT04854096|560563756|FG001|Overall Study|Withdrawal by Subject|0|||
155308899|NCT04854096|560563755|FG000|Overall Study|Other reasons|1|||
155308900|NCT04854096|560563756|FG001|Overall Study|Other reasons|0|||
155308901|NCT04757610|560563757|FG000|Overall Study|Adverse Event|13|||
155308902|NCT04757610|560563758|FG001|Overall Study|Adverse Event|10|||
155308903|NCT04757610|560563759|FG002|Overall Study|Adverse Event|5|||
155308904|NCT04757610|560563757|FG000|Overall Study|Death|5|||
155308905|NCT04757610|560563758|FG001|Overall Study|Death|13|||
155308906|NCT04757610|560563759|FG002|Overall Study|Death|8|||
155308907|NCT04757610|560563757|FG000|Overall Study|Lack of Efficacy|1|||
155308908|NCT04757610|560563758|FG001|Overall Study|Lack of Efficacy|2|||
155308909|NCT04757610|560563759|FG002|Overall Study|Lack of Efficacy|3|||
155308910|NCT04757610|560563757|FG000|Overall Study|Lost to Follow-up|7|||
155308911|NCT04757610|560563758|FG001|Overall Study|Lost to Follow-up|2|||
155308912|NCT04757610|560563759|FG002|Overall Study|Lost to Follow-up|7|||
155308913|NCT04757610|560563757|FG000|Overall Study|Physician Decision|4|||
155308914|NCT04757610|560563758|FG001|Overall Study|Physician Decision|1|||
155308915|NCT04757610|560563759|FG002|Overall Study|Physician Decision|2|||
155308916|NCT04757610|560563757|FG000|Overall Study|Withdrawal by Subject|26|||
155308917|NCT04757610|560563758|FG001|Overall Study|Withdrawal by Subject|25|||
155308918|NCT04757610|560563759|FG002|Overall Study|Withdrawal by Subject|25|||
155308919|NCT04757610|560563757|FG000|Overall Study|Study Terminated by Sponsor|105|||
155308920|NCT04757610|560563758|FG001|Overall Study|Study Terminated by Sponsor|105|||
155308921|NCT04757610|560563759|FG002|Overall Study|Study Terminated by Sponsor|110|||
155308922|NCT04757610|560563757|FG000|Overall Study|Randomized in Error|1|||
155308923|NCT04757610|560563758|FG001|Overall Study|Randomized in Error|0|||
155308924|NCT04757610|560563759|FG002|Overall Study|Randomized in Error|0|||
155308925|NCT03819686|560565376|FG000|Overall Study|Lost to Follow-up|2|||
155308926|NCT03819686|560565377|FG001|Overall Study|Lost to Follow-up|3|||
155308927|NCT03747484|560565378|FG000|Overall Study|Lack of Efficacy|0|||
155308928|NCT03747484|560565379|FG001|Overall Study|Lack of Efficacy|1|||
155308929|NCT03747484|560565380|FG002|Overall Study|Lack of Efficacy|1|||
155308930|NCT03747484|560565381|FG003|Overall Study|Lack of Efficacy|2|||
155308931|NCT03747484|560565382|FG004|Overall Study|Lack of Efficacy|2|||
155308932|NCT03833245|560565386|FG000|Overall Study|Death|0|||
155308933|NCT03833245|560565387|FG001|Overall Study|Death|1|||
155308934|NCT03347383|560565388|FG000|Overall Study|Death|39|||
155308935|NCT03347383|560565388|FG000|Overall Study|Withdrawal by Subject|3|||
155308936|NCT03347383|560565388|FG000|Overall Study|Lost to Follow-up|9|||
155308937|NCT05691452|560565390|FG000|Overall Study|Withdrawal by Subject|1|||
155308938|NCT05691452|560565391|FG001|Overall Study|Withdrawal by Subject|1|||
155308939|NCT05691452|560565392|FG002|Overall Study|Withdrawal by Subject|0|||
155308940|NCT05691452|560565390|FG000|Overall Study|Physician Decision|1|||
155308941|NCT05691452|560565391|FG001|Overall Study|Physician Decision|0|||
155308942|NCT05691452|560565392|FG002|Overall Study|Physician Decision|0|||
155308943|NCT05691452|560565390|FG000|Overall Study|Lost to Follow-up|0|||
155308944|NCT05691452|560565391|FG001|Overall Study|Lost to Follow-up|0|||
155308945|NCT05691452|560565392|FG002|Overall Study|Lost to Follow-up|1|||
155308946|NCT05691452|560565390|FG000|Overall Study|Adverse Event|0|||
155308947|NCT05691452|560565391|FG001|Overall Study|Adverse Event|0|||
155308948|NCT05691452|560565392|FG002|Overall Study|Adverse Event|1|||
155308949|NCT04842643|560565395|FG000|Overall Study|Physician Decision|1|||
155308950|NCT04842643|560565395|FG000|Overall Study|Other|1|||
155308951|NCT03192891|560565396|FG000|Overall Study|Lost to Follow-up|55|||
155308952|NCT02630823|560565398|FG000|Overall Study|Withdrawal by Subject|1|||
155308953|NCT02630823|560565398|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
155308954|NCT05062265|560565401|FG000|Overall Study|Withdrawal by Subject|1|||
155308955|NCT05062265|560565402|FG001|Overall Study|Withdrawal by Subject|0|||
155308956|NCT04630262|560565406|FG000|Overall Study|Intraoperative Screen Failure|5|||
155308957|NCT04630262|560565406|FG000|Overall Study|Study terminated prematurely|71|||
155308958|NCT04630262|560565406|FG000|Overall Study|Withdrawal by Subject|2|||
155308959|NCT04630262|560565406|FG000|Overall Study|Physician Decision|2|||
155308960|NCT04703322|560565408|FG000|Overall Study|Ongoing|8|||
155308961|NCT04703322|560565408|FG000|Overall Study|Withdrawal by Subject|1|||
155308962|NCT04638998|560565409|FG000|Overall Study|Withdrawal by Subject|1|||
155308963|NCT04638998|560565410|FG001|Overall Study|Withdrawal by Subject|3|||
155308964|NCT03988634|560565411|FG000|Double-Blind|Adverse Event|4|||
155308965|NCT03988634|560565412|FG001|Double-Blind|Adverse Event|0|||
155308966|NCT03988634|560565413|FG002|Double-Blind|Adverse Event|0|||
155308967|NCT03988634|560565411|FG000|Double-Blind|Death|18|||
155308968|NCT03988634|560565412|FG001|Double-Blind|Death|26|||
155308969|NCT03988634|560565413|FG002|Double-Blind|Death|0|||
155308970|NCT03988634|560565411|FG000|Double-Blind|Lost to Follow-up|6|||
155308971|NCT03988634|560565412|FG001|Double-Blind|Lost to Follow-up|7|||
155308972|NCT03988634|560565413|FG002|Double-Blind|Lost to Follow-up|0|||
155308973|NCT03988634|560565411|FG000|Double-Blind|Physician Decision|9|||
155308974|NCT03988634|560565412|FG001|Double-Blind|Physician Decision|5|||
155308975|NCT03988634|560565413|FG002|Double-Blind|Physician Decision|0|||
155308976|NCT03988634|560565411|FG000|Double-Blind|Subject decision|24|||
155308977|NCT03988634|560565412|FG001|Double-Blind|Subject decision|13|||
154959560|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959561|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
155065716|NCT03282097|559672169|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
155065717|NCT03282097|559672170|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
155065718|NCT03282097|559672169|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
155065719|NCT03282097|559672170|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
155065720|NCT03282097|559672169|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
155065721|NCT03282097|559672170|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
155065722|NCT01056536|559672171|FG000|Overall Study|Lost to Follow-up|202|||
155065723|NCT01056536|559672172|FG001|Overall Study|Lost to Follow-up|116|||
155065724|NCT01056536|559672173|FG002|Overall Study|Lost to Follow-up|248|||
155065725|NCT03034967|559672176|FG000|Overall Study|Withdrawal by Subject|9|||
155065726|NCT03034967|559672177|FG001|Overall Study|Withdrawal by Subject|2|||
155065727|NCT03034967|559672178|FG002|Overall Study|Withdrawal by Subject|6|||
155065728|NCT03034967|559672179|FG003|Overall Study|Withdrawal by Subject|6|||
154959562|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
154959563|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959564|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959565|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959566|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959567|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959568|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959569|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959570|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959571|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959572|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959573|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959574|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959575|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959576|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959577|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
154959578|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
154959579|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959580|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959581|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959582|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959583|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
154959584|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959585|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959586|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959587|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959588|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959589|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959590|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959591|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959592|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959593|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959594|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959595|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959596|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959597|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959598|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
154959599|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
155065729|NCT03034967|559672180|FG004|Overall Study|Withdrawal by Subject|9|||
155065730|NCT03034967|559672181|FG005|Overall Study|Withdrawal by Subject|2|||
155308978|NCT03988634|560565413|FG002|Double-Blind|Subject decision|0|||
155308979|NCT03988634|560565411|FG000|Open-Label|Adverse Event|0|||
155308980|NCT03988634|560565412|FG001|Open-Label|Adverse Event|0|||
155308981|NCT03988634|560565413|FG002|Open-Label|Adverse Event|7|||
155308982|NCT03988634|560565411|FG000|Open-Label|Physician Decision|0|||
155308983|NCT03988634|560565412|FG001|Open-Label|Physician Decision|0|||
155308984|NCT03988634|560565413|FG002|Open-Label|Physician Decision|1|||
155308985|NCT03988634|560565411|FG000|Open-Label|Technical problems|0|||
155308986|NCT03988634|560565412|FG001|Open-Label|Technical problems|0|||
155308987|NCT03988634|560565413|FG002|Open-Label|Technical problems|1|||
155308988|NCT05374837|560565414|FG000|Overall Study|Lost to Follow-up|17|||
155308989|NCT05374837|560565415|FG001|Overall Study|Lost to Follow-up|18|||
155065731|NCT03034967|559672176|FG000|Overall Study|Physician Decision|1|||
155065732|NCT03034967|559672177|FG001|Overall Study|Physician Decision|0|||
155161305|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155161306|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
155161307|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155161308|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155161309|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
155161310|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
155161311|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155161312|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155161313|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155308990|NCT05406921|560565420|FG000|Overall Study|Withdrawal by Subject|25|||
155308991|NCT05406921|560565421|FG001|Overall Study|Withdrawal by Subject|0|||
155308992|NCT05406921|560565422|FG002|Overall Study|Withdrawal by Subject|25|||
155308993|NCT05406921|560565420|FG000|Overall Study|Protocol Violation|0|||
155308994|NCT05406921|560565421|FG001|Overall Study|Protocol Violation|12|||
155308995|NCT05406921|560565422|FG002|Overall Study|Protocol Violation|0|||
155308996|NCT00676715|560565425|FG000|Treatment Period (TP)|Adverse Event|0|||
155308997|NCT00676715|560565426|FG001|Treatment Period (TP)|Adverse Event|3|||
155308998|NCT00676715|560565427|FG002|Treatment Period (TP)|Adverse Event|2|||
155308999|NCT00676715|560565428|FG003|Treatment Period (TP)|Adverse Event|2|||
155309000|NCT00676715|560565425|FG000|Treatment Period (TP)|Death|0|||
155309001|NCT00676715|560565426|FG001|Treatment Period (TP)|Death|0|||
155309002|NCT00676715|560565427|FG002|Treatment Period (TP)|Death|1|||
155309003|NCT00676715|560565428|FG003|Treatment Period (TP)|Death|0|||
155309004|NCT00676715|560565425|FG000|Treatment Period (TP)|Failure to return|1|||
155309005|NCT00676715|560565426|FG001|Treatment Period (TP)|Failure to return|0|||
155309006|NCT00676715|560565427|FG002|Treatment Period (TP)|Failure to return|0|||
155309007|NCT00676715|560565428|FG003|Treatment Period (TP)|Failure to return|0|||
155309008|NCT00676715|560565425|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
155309009|NCT00676715|560565426|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
155309010|NCT00676715|560565427|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
155309011|NCT00676715|560565428|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
155309012|NCT00676715|560565425|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
155309013|NCT00676715|560565426|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
155309014|NCT00676715|560565427|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
155309015|NCT00676715|560565428|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
155309016|NCT00676715|560565425|FG000|Treatment Period (TP)|Withdrew consent|3|||
155309017|NCT00676715|560565426|FG001|Treatment Period (TP)|Withdrew consent|3|||
155309018|NCT00676715|560565427|FG002|Treatment Period (TP)|Withdrew consent|3|||
155309019|NCT00676715|560565428|FG003|Treatment Period (TP)|Withdrew consent|3|||
155309020|NCT00676715|560565425|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
155309021|NCT00676715|560565426|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
155309022|NCT00676715|560565427|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
155309023|NCT00676715|560565428|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
155309024|NCT00676715|560565425|FG000|Treatment Period (TP)|Administrative|0|||
155309025|NCT00676715|560565426|FG001|Treatment Period (TP)|Administrative|0|||
155309026|NCT00676715|560565427|FG002|Treatment Period (TP)|Administrative|0|||
155309027|NCT00676715|560565428|FG003|Treatment Period (TP)|Administrative|1|||
155309028|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
155309029|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
155309030|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
155309031|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
155309032|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
155309033|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
155309034|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
155309035|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
155309036|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
155309037|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
155309038|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
155309039|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
155309040|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
155309041|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
155309042|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
155309043|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
155065733|NCT03034967|559672178|FG002|Overall Study|Physician Decision|1|||
155065734|NCT03034967|559672179|FG003|Overall Study|Physician Decision|1|||
155065735|NCT03034967|559672180|FG004|Overall Study|Physician Decision|1|||
155065736|NCT03034967|559672181|FG005|Overall Study|Physician Decision|0|||
155065737|NCT03034967|559672176|FG000|Overall Study|Lost to Follow-up|0|||
155065738|NCT03034967|559672177|FG001|Overall Study|Lost to Follow-up|0|||
155309044|NCT00676715|560565425|FG000|Treatment-free Period (TFP)|Death|1|||
155309045|NCT00676715|560565426|FG001|Treatment-free Period (TFP)|Death|1|||
155309046|NCT00676715|560565427|FG002|Treatment-free Period (TFP)|Death|1|||
155309047|NCT00676715|560565428|FG003|Treatment-free Period (TFP)|Death|0|||
155309048|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Reason not provided|3|||
155309049|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Reason not provided|4|||
155065739|NCT03034967|559672178|FG002|Overall Study|Lost to Follow-up|0|||
155065740|NCT03034967|559672179|FG003|Overall Study|Lost to Follow-up|1|||
155309050|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Reason not provided|1|||
155309051|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Reason not provided|4|||
155309052|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
155309053|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
155309054|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
155309055|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
155309056|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
155309057|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
155309058|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
155309059|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
155309060|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Adverse Event|0|||
155309061|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Adverse Event|3|||
155309062|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Adverse Event|1|||
155309063|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Adverse Event|0|||
155309064|NCT00676715|560565425|FG000|Open Label Extension (OLE)|Death|2|||
155309065|NCT00676715|560565426|FG001|Open Label Extension (OLE)|Death|0|||
155309066|NCT00676715|560565427|FG002|Open Label Extension (OLE)|Death|2|||
155309067|NCT00676715|560565428|FG003|Open Label Extension (OLE)|Death|2|||
155309068|NCT04831281|560565432|FG000|Overall Study|Adverse Event|1|||
155309069|NCT04831281|560565433|FG001|Overall Study|Adverse Event|0|||
155309070|NCT04831281|560565434|FG002|Overall Study|Adverse Event|3|||
155309071|NCT04831281|560565432|FG000|Overall Study|Withdrawal by Subject|0|||
155309072|NCT04831281|560565433|FG001|Overall Study|Withdrawal by Subject|1|||
155309073|NCT04831281|560565434|FG002|Overall Study|Withdrawal by Subject|2|||
155309074|NCT04831281|560565432|FG000|Overall Study|Undetermined|1|||
155309075|NCT04831281|560565433|FG001|Overall Study|Undetermined|1|||
155309076|NCT04831281|560565434|FG002|Overall Study|Undetermined|0|||
155309077|NCT03161379|560565435|FG000|Overall Study|Withdrawal by Subject|4|||
155309078|NCT03161379|560565435|FG000|Overall Study|disease progression during chemotherapy|5|||
155309079|NCT03161379|560565435|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
155309080|NCT03161379|560565435|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
155309081|NCT03393975|560565437|FG000|Urgent Treatment Period|Physician Decision|0|||
155309082|NCT03393975|560565438|FG001|Urgent Treatment Period|Physician Decision|0|||
155309083|NCT03393975|560565439|FG002|Urgent Treatment Period|Physician Decision|0|||
155309084|NCT03393975|560565440|FG003|Urgent Treatment Period|Physician Decision|1|||
155309085|NCT03393975|560565437|FG000|Prophylaxis Period 1|Reason not Specified|0|||
155309086|NCT03393975|560565438|FG001|Prophylaxis Period 1|Reason not Specified|1|||
155309087|NCT03393975|560565439|FG002|Prophylaxis Period 1|Reason not Specified|0|||
155309088|NCT03393975|560565440|FG003|Prophylaxis Period 1|Reason not Specified|0|||
155309089|NCT03393975|560565437|FG000|Prophylaxis Period 2|Reason not Specified|0|||
155309090|NCT03393975|560565438|FG001|Prophylaxis Period 2|Reason not Specified|1|||
155309091|NCT03393975|560565439|FG002|Prophylaxis Period 2|Reason not Specified|0|||
155309092|NCT03393975|560565440|FG003|Prophylaxis Period 2|Reason not Specified|0|||
155309093|NCT05021640|560565441|FG000|Overall Study|Lost to Follow-up|0|||
155309094|NCT05021640|560565442|FG001|Overall Study|Lost to Follow-up|0|||
155309095|NCT05021640|560565443|FG002|Overall Study|Lost to Follow-up|0|||
155309096|NCT05021640|560565444|FG003|Overall Study|Lost to Follow-up|0|||
155309097|NCT05021640|560565445|FG004|Overall Study|Lost to Follow-up|1|||
155309098|NCT02312960|560565446|FG000|Overall Study|Death|24|||
155309099|NCT02312960|560565447|FG001|Overall Study|Death|32|||
155309100|NCT02312960|560565448|FG002|Overall Study|Death|25|||
155309101|NCT02312960|560565449|FG003|Overall Study|Death|11|||
155309102|NCT02312960|560565450|FG004|Overall Study|Death|5|||
155309103|NCT02312960|560565451|FG005|Overall Study|Death|5|||
155309104|NCT02312960|560565452|FG006|Overall Study|Death|8|||
155309105|NCT02312960|560565453|FG007|Overall Study|Death|5|||
155309106|NCT02312960|560565454|FG008|Overall Study|Death|7|||
155309107|NCT02312960|560565455|FG009|Overall Study|Death|3|||
155309108|NCT02312960|560565456|FG010|Overall Study|Death|3|||
155309109|NCT02312960|560565457|FG011|Overall Study|Death|1|||
155309110|NCT02312960|560565458|FG012|Overall Study|Death|25|||
155309111|NCT02312960|560565459|FG013|Overall Study|Death|19|||
155309112|NCT02312960|560565446|FG000|Overall Study|Missing|0|||
155309113|NCT02312960|560565447|FG001|Overall Study|Missing|0|||
155309114|NCT02312960|560565448|FG002|Overall Study|Missing|2|||
155309115|NCT02312960|560565449|FG003|Overall Study|Missing|0|||
155309116|NCT02312960|560565450|FG004|Overall Study|Missing|0|||
155309117|NCT02312960|560565451|FG005|Overall Study|Missing|0|||
155309118|NCT02312960|560565452|FG006|Overall Study|Missing|0|||
155309119|NCT02312960|560565453|FG007|Overall Study|Missing|0|||
155309120|NCT02312960|560565454|FG008|Overall Study|Missing|0|||
155309121|NCT02312960|560565455|FG009|Overall Study|Missing|0|||
155309122|NCT02312960|560565456|FG010|Overall Study|Missing|0|||
155309123|NCT02312960|560565457|FG011|Overall Study|Missing|0|||
155309124|NCT02312960|560565458|FG012|Overall Study|Missing|0|||
155309125|NCT02312960|560565459|FG013|Overall Study|Missing|0|||
155309126|NCT02312960|560565446|FG000|Overall Study|Lost to Follow-up|0|||
155309127|NCT02312960|560565447|FG001|Overall Study|Lost to Follow-up|0|||
155309128|NCT02312960|560565448|FG002|Overall Study|Lost to Follow-up|1|||
155309129|NCT02312960|560565449|FG003|Overall Study|Lost to Follow-up|0|||
155309130|NCT02312960|560565450|FG004|Overall Study|Lost to Follow-up|0|||
155309131|NCT02312960|560565451|FG005|Overall Study|Lost to Follow-up|0|||
155309132|NCT02312960|560565452|FG006|Overall Study|Lost to Follow-up|1|||
155309133|NCT02312960|560565453|FG007|Overall Study|Lost to Follow-up|1|||
155309134|NCT02312960|560565454|FG008|Overall Study|Lost to Follow-up|0|||
155309135|NCT02312960|560565455|FG009|Overall Study|Lost to Follow-up|1|||
155309136|NCT02312960|560565456|FG010|Overall Study|Lost to Follow-up|0|||
155309137|NCT02312960|560565457|FG011|Overall Study|Lost to Follow-up|0|||
155309138|NCT02312960|560565458|FG012|Overall Study|Lost to Follow-up|1|||
155309139|NCT02312960|560565459|FG013|Overall Study|Lost to Follow-up|0|||
155309140|NCT02312960|560565446|FG000|Overall Study|Withdrawal by Subject|1|||
155309141|NCT02312960|560565447|FG001|Overall Study|Withdrawal by Subject|2|||
155309142|NCT02312960|560565448|FG002|Overall Study|Withdrawal by Subject|0|||
155309143|NCT02312960|560565449|FG003|Overall Study|Withdrawal by Subject|0|||
155309144|NCT02312960|560565450|FG004|Overall Study|Withdrawal by Subject|1|||
155309145|NCT02312960|560565451|FG005|Overall Study|Withdrawal by Subject|0|||
155309146|NCT02312960|560565452|FG006|Overall Study|Withdrawal by Subject|1|||
155309147|NCT02312960|560565453|FG007|Overall Study|Withdrawal by Subject|2|||
155309148|NCT02312960|560565454|FG008|Overall Study|Withdrawal by Subject|2|||
155309149|NCT02312960|560565455|FG009|Overall Study|Withdrawal by Subject|3|||
155309150|NCT02312960|560565456|FG010|Overall Study|Withdrawal by Subject|0|||
155309151|NCT02312960|560565457|FG011|Overall Study|Withdrawal by Subject|0|||
155309152|NCT02312960|560565458|FG012|Overall Study|Withdrawal by Subject|2|||
155309153|NCT02312960|560565459|FG013|Overall Study|Withdrawal by Subject|0|||
155309154|NCT02807636|560565461|FG000|Overall Study|Lost to Follow-up|10|||
155309155|NCT02807636|560565462|FG001|Overall Study|Lost to Follow-up|13|||
155309156|NCT02807636|560565463|FG002|Overall Study|Lost to Follow-up|6|||
155309157|NCT02807636|560565461|FG000|Overall Study|Protocol Deviation|1|||
155309158|NCT02807636|560565462|FG001|Overall Study|Protocol Deviation|0|||
155309159|NCT02807636|560565463|FG002|Overall Study|Protocol Deviation|0|||
155309160|NCT02807636|560565461|FG000|Overall Study|Symptomatic Deterioration|0|||
155309161|NCT02807636|560565462|FG001|Overall Study|Symptomatic Deterioration|1|||
155309162|NCT02807636|560565463|FG002|Overall Study|Symptomatic Deterioration|0|||
155309163|NCT02807636|560565461|FG000|Overall Study|Withdrawal by Subject|39|||
155309164|NCT02807636|560565462|FG001|Overall Study|Withdrawal by Subject|28|||
155309165|NCT02807636|560565463|FG002|Overall Study|Withdrawal by Subject|24|||
155309166|NCT02807636|560565461|FG000|Overall Study|Death|303|||
155309167|NCT02807636|560565462|FG001|Overall Study|Death|332|||
155309168|NCT02807636|560565463|FG002|Overall Study|Death|272|||
155309169|NCT02807636|560565461|FG000|Overall Study|Study Terminated By Sponsor|47|||
155309170|NCT02807636|560565462|FG001|Overall Study|Study Terminated By Sponsor|76|||
155309171|NCT02807636|560565463|FG002|Overall Study|Study Terminated By Sponsor|60|||
155309172|NCT02807636|560565461|FG000|Overall Study|Physician Decision|0|||
155309173|NCT02807636|560565462|FG001|Overall Study|Physician Decision|1|||
155309174|NCT02807636|560565463|FG002|Overall Study|Physician Decision|0|||
155309175|NCT05227209|560565464|FG000|Overall Study|Adverse Event|11|||
155309176|NCT05227209|560565464|FG000|Overall Study|Lost to Follow-up|1|||
154959600|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959601|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959602|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959603|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959604|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
154959605|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959606|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959607|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959608|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155309177|NCT05227209|560565464|FG000|Overall Study|Withdrawal by Subject|7|||
155309178|NCT05227209|560565464|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
155309179|NCT05633953|560565465|FG000|Overall Study|Adverse Event|7|||
155309180|NCT05633953|560565465|FG000|Overall Study|Death|30|||
155309181|NCT05633953|560565465|FG000|Overall Study|Lost to Follow-up|1|||
155309182|NCT05633953|560565465|FG000|Overall Study|Osilodrostat discontinued|4|||
155309183|NCT05633953|560565465|FG000|Overall Study|Physician Decision|1|||
155309184|NCT05633953|560565465|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
155309185|NCT05633953|560565465|FG000|Overall Study|Progressive disease|2|||
155309186|NCT05337748|560565471|FG000|Overall Study|Withdrawal by Subject|1|||
155309187|NCT05337748|560565472|FG001|Overall Study|Withdrawal by Subject|0|||
155309188|NCT05337748|560565471|FG000|Overall Study|Death|1|||
155309189|NCT05337748|560565472|FG001|Overall Study|Death|0|||
155309190|NCT02506959|560565473|FG000|Overall Study|Physician Decision|2|||
155309191|NCT02506959|560565474|FG001|Overall Study|Physician Decision|1|||
155309192|NCT03453619|560565477|FG000|Core Study (Part A)|Physician Decision|0|||
155309193|NCT03453619|560565478|FG001|Core Study (Part A)|Physician Decision|0|||
155309194|NCT03453619|560565479|FG002|Core Study (Part A)|Physician Decision|2|||
155309195|NCT03453619|560565480|FG003|Core Study (Part A)|Physician Decision|0|||
155309196|NCT03453619|560565477|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
155309197|NCT03453619|560565478|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
155309198|NCT03453619|560565479|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
155309199|NCT03453619|560565480|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
155309200|NCT03453619|560565477|FG000|Core Study (Part A)|Other|0|||
155309201|NCT03453619|560565478|FG001|Core Study (Part A)|Other|1|||
155309202|NCT03453619|560565479|FG002|Core Study (Part A)|Other|0|||
155309203|NCT03453619|560565480|FG003|Core Study (Part A)|Other|0|||
155309204|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
155309205|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
155309206|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
155309207|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
155309208|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
155309209|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
155309210|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
155309211|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
155309212|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
155309213|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
155309214|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
155309215|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
155309216|NCT03453619|560565477|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
155309217|NCT03453619|560565478|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
155309218|NCT03453619|560565479|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
155309219|NCT03453619|560565480|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
155309220|NCT04089371|560565481|FG000|Overall Study|Withdrawal by Subject|0|||
155309221|NCT04089371|560565482|FG001|Overall Study|Withdrawal by Subject|1|||
155309222|NCT04089371|560565481|FG000|Overall Study|Study terminated early|0|||
155065741|NCT03034967|559672180|FG004|Overall Study|Lost to Follow-up|0|||
155065742|NCT03034967|559672181|FG005|Overall Study|Lost to Follow-up|2|||
155065743|NCT03034967|559672176|FG000|Overall Study|Liver function test abnormality|0|||
155065744|NCT03034967|559672177|FG001|Overall Study|Liver function test abnormality|0|||
155309223|NCT04089371|560565482|FG001|Overall Study|Study terminated early|9|||
155309224|NCT05229120|560565483|FG000|Overall Study|Withdrawal by Subject|8|||
155309225|NCT03932682|560565486|FG000|Overall Study|Death|1|||
155309226|NCT03932682|560565487|FG001|Overall Study|Death|2|||
155309227|NCT03932682|560565486|FG000|Overall Study|Withdrawal by Subject|37|||
155309228|NCT03932682|560565487|FG001|Overall Study|Withdrawal by Subject|45|||
155309229|NCT03932682|560565486|FG000|Overall Study|Lost to Follow-up|19|||
155309230|NCT03932682|560565487|FG001|Overall Study|Lost to Follow-up|25|||
155309231|NCT03932682|560565486|FG000|Overall Study|Protocol Violation|0|||
155309232|NCT03932682|560565487|FG001|Overall Study|Protocol Violation|2|||
155309233|NCT03932682|560565486|FG000|Overall Study|Other|9|||
155309234|NCT03932682|560565487|FG001|Overall Study|Other|23|||
155309235|NCT05323084|560565491|FG000|Period 2 - Washout|Lost to Follow-up|0|||
155309236|NCT05323084|560565492|FG001|Period 2 - Washout|Lost to Follow-up|1|||
155309237|NCT04401800|560565499|FG000|Overall Study|Death|17|||
155309238|NCT04401800|560565499|FG000|Overall Study|Lost to Follow-up|5|||
155309239|NCT04401800|560565499|FG000|Overall Study|Withdrawal by Subject|4|||
155309240|NCT03941860|560565504|FG000|Overall Study|Withdrawal by Subject|0|||
155309241|NCT03941860|560565505|FG001|Overall Study|Withdrawal by Subject|1|||
155309242|NCT05792423|560565511|FG000|Overall Study|Withdrawal by Subject|2|||
155309243|NCT04402489|560567239|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155309244|NCT04402489|560567240|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
155309245|NCT04402489|560567241|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155309246|NCT04402489|560567242|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155309247|NCT04402489|560567243|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
155309248|NCT04402489|560567239|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
155309249|NCT04402489|560567240|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155309250|NCT04402489|560567241|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155309251|NCT04402489|560567242|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155309252|NCT04402489|560567243|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
155309253|NCT04402489|560567239|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
155309254|NCT04402489|560567240|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
155309255|NCT04402489|560567241|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
155309256|NCT04402489|560567242|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
155309257|NCT04402489|560567243|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
155309258|NCT04402489|560567239|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
154959609|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959610|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959611|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959612|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155309259|NCT04402489|560567240|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155309260|NCT04402489|560567241|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
155309261|NCT04402489|560567242|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155309262|NCT04402489|560567243|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
155309263|NCT04402489|560567239|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155309264|NCT04402489|560567240|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155309265|NCT04402489|560567241|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155309266|NCT04402489|560567242|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
155309267|NCT04402489|560567243|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
155309268|NCT04402489|560567239|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
155309269|NCT04402489|560567240|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
155309270|NCT04402489|560567241|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
155309271|NCT04402489|560567242|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
155309272|NCT04402489|560567243|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
155309273|NCT04833777|560567260|FG000|Overall Study|Lost to Follow-up|1|||
155309274|NCT04833777|560567261|FG001|Overall Study|Lost to Follow-up|0|||
155309275|NCT02682316|560567266|FG000|Overall Study|Benign Final Pathology|27|||
155309276|NCT02682316|560567267|FG001|Overall Study|Benign Final Pathology|26|||
155309277|NCT02682316|560567266|FG000|Overall Study|Reoperation before 30 days|7|||
155309278|NCT02682316|560567267|FG001|Overall Study|Reoperation before 30 days|6|||
155309279|NCT02682316|560567266|FG000|Overall Study|Ineligible|1|||
155309280|NCT02682316|560567267|FG001|Overall Study|Ineligible|0|||
155309281|NCT02682316|560567266|FG000|Overall Study|Death|1|||
155309282|NCT02682316|560567267|FG001|Overall Study|Death|0|||
155309283|NCT02682316|560567266|FG000|Overall Study|Lost to Follow-up|7|||
155309284|NCT02682316|560567267|FG001|Overall Study|Lost to Follow-up|3|||
155309285|NCT03101904|560567268|FG000|Wash Out (10 Days)|Adverse Event|1|||
155309286|NCT03101904|560567269|FG001|Wash Out (10 Days)|Adverse Event|0|||
155309287|NCT03101904|560567268|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
155309288|NCT03101904|560567269|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
155309289|NCT04538417|560567270|FG000|Overall Study|Withdrawal by Subject|2|||
155309290|NCT06311084|560567272|FG000|Overall Study|Lost to Follow-up|14|||
155309291|NCT01331005|560567274|FG000|Overall Study|Lost to Follow-up|2|||
155309292|NCT01331005|560567275|FG001|Overall Study|Lost to Follow-up|1|||
155309293|NCT01331005|560567274|FG000|Overall Study|Withdrawal by Subject|2|||
155309294|NCT01331005|560567275|FG001|Overall Study|Withdrawal by Subject|3|||
155309295|NCT03131648|560567293|FG000|Initial Treatment Period|Not dosed|2|||
155309296|NCT03131648|560567294|FG001|Initial Treatment Period|Not dosed|2|||
155309297|NCT03131648|560567295|FG002|Initial Treatment Period|Not dosed|0|||
155309298|NCT03131648|560567296|FG003|Initial Treatment Period|Not dosed|0|||
155309299|NCT03131648|560567297|FG004|Initial Treatment Period|Not dosed|0|||
155309300|NCT03131648|560567298|FG005|Initial Treatment Period|Not dosed|0|||
155309301|NCT03131648|560567299|FG006|Initial Treatment Period|Not dosed|0|||
155309302|NCT03131648|560567300|FG007|Initial Treatment Period|Not dosed|0|||
155309303|NCT03131648|560567293|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
155309304|NCT03131648|560567294|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
155065745|NCT03034967|559672178|FG002|Overall Study|Liver function test abnormality|1|||
155065746|NCT03034967|559672179|FG003|Overall Study|Liver function test abnormality|0|||
155065747|NCT03034967|559672180|FG004|Overall Study|Liver function test abnormality|0|||
155065748|NCT03034967|559672181|FG005|Overall Study|Liver function test abnormality|0|||
155065749|NCT03034967|559672176|FG000|Overall Study|Protocol Violation|1|||
155065750|NCT03034967|559672177|FG001|Overall Study|Protocol Violation|0|||
155065751|NCT03034967|559672178|FG002|Overall Study|Protocol Violation|0|||
155309305|NCT03131648|560567295|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309306|NCT03131648|560567296|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309307|NCT03131648|560567297|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309308|NCT03131648|560567298|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309309|NCT03131648|560567299|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309310|NCT03131648|560567300|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155309311|NCT03131648|560567293|FG000|Open-label Treatment|Discontinued IMP|0|||
155309312|NCT03131648|560567294|FG001|Open-label Treatment|Discontinued IMP|0|||
155309313|NCT03131648|560567295|FG002|Open-label Treatment|Discontinued IMP|0|||
155309314|NCT03131648|560567296|FG003|Open-label Treatment|Discontinued IMP|0|||
155309315|NCT03131648|560567297|FG004|Open-label Treatment|Discontinued IMP|0|||
155309316|NCT03131648|560567298|FG005|Open-label Treatment|Discontinued IMP|0|||
155309317|NCT03131648|560567299|FG006|Open-label Treatment|Discontinued IMP|112|||
155309318|NCT03131648|560567300|FG007|Open-label Treatment|Discontinued IMP|0|||
155309319|NCT03131648|560567293|FG000|Open-label Treatment|Completed Week 50|0|||
155309320|NCT03131648|560567294|FG001|Open-label Treatment|Completed Week 50|0|||
155309321|NCT03131648|560567295|FG002|Open-label Treatment|Completed Week 50|0|||
155309322|NCT03131648|560567296|FG003|Open-label Treatment|Completed Week 50|0|||
155309323|NCT03131648|560567297|FG004|Open-label Treatment|Completed Week 50|0|||
155309324|NCT03131648|560567298|FG005|Open-label Treatment|Completed Week 50|0|||
155309325|NCT03131648|560567299|FG006|Open-label Treatment|Completed Week 50|6|||
155309326|NCT03131648|560567300|FG007|Open-label Treatment|Completed Week 50|0|||
155309327|NCT03131648|560567293|FG000|Maintenance Treatment Period|Not dosed|0|||
155309328|NCT03131648|560567294|FG001|Maintenance Treatment Period|Not dosed|0|||
155309329|NCT03131648|560567295|FG002|Maintenance Treatment Period|Not dosed|3|||
155309330|NCT03131648|560567296|FG003|Maintenance Treatment Period|Not dosed|2|||
155309331|NCT03131648|560567297|FG004|Maintenance Treatment Period|Not dosed|1|||
155309332|NCT03131648|560567298|FG005|Maintenance Treatment Period|Not dosed|0|||
155309333|NCT03131648|560567299|FG006|Maintenance Treatment Period|Not dosed|0|||
155309334|NCT03131648|560567300|FG007|Maintenance Treatment Period|Not dosed|0|||
155309335|NCT03131648|560567293|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
155309336|NCT03131648|560567294|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
155309337|NCT03131648|560567295|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
155309338|NCT03131648|560567296|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
155309339|NCT03131648|560567297|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
155309340|NCT03131648|560567298|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
155309341|NCT03131648|560567299|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
155309342|NCT03131648|560567300|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
155309343|NCT03131648|560567293|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309344|NCT03131648|560567294|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309345|NCT03131648|560567295|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
155309346|NCT03131648|560567296|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
155309347|NCT03131648|560567297|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
155309348|NCT03131648|560567298|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
155309349|NCT03131648|560567299|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309350|NCT03131648|560567300|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155309351|NCT03131648|560567293|FG000|Maintenance Treatment Period|Completed Week 50|0|||
155309352|NCT03131648|560567294|FG001|Maintenance Treatment Period|Completed Week 50|0|||
155309353|NCT03131648|560567295|FG002|Maintenance Treatment Period|Completed Week 50|0|||
155309354|NCT03131648|560567296|FG003|Maintenance Treatment Period|Completed Week 50|0|||
155309355|NCT03131648|560567297|FG004|Maintenance Treatment Period|Completed Week 50|1|||
155309356|NCT03131648|560567298|FG005|Maintenance Treatment Period|Completed Week 50|0|||
155309357|NCT03131648|560567299|FG006|Maintenance Treatment Period|Completed Week 50|0|||
155309358|NCT03131648|560567300|FG007|Maintenance Treatment Period|Completed Week 50|0|||
155309359|NCT03131648|560567293|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309360|NCT03131648|560567294|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309361|NCT03131648|560567295|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309362|NCT03131648|560567296|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309363|NCT03131648|560567297|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309364|NCT03131648|560567298|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309365|NCT03131648|560567299|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
155309366|NCT03131648|560567300|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
155309367|NCT02724878|560567301|FG000|Overall Study|Still on Active Therapy|15|||
155309368|NCT02724878|560567301|FG000|Overall Study|Disease Progression|31|||
155309369|NCT02724878|560567301|FG000|Overall Study|Toxicity|5|||
155309370|NCT02724878|560567301|FG000|Overall Study|Death|1|||
155309371|NCT02724878|560567301|FG000|Overall Study|Withdrawal by Subject|4|||
155309372|NCT02724878|560567301|FG000|Overall Study|Lost to Follow-up|2|||
155309373|NCT02724878|560567301|FG000|Overall Study|Protocol Violation|1|||
155309374|NCT02724878|560567301|FG000|Overall Study|Ineligible for Study Drug|5|||
155309375|NCT02724878|560567301|FG000|Overall Study|not started|1|||
155309376|NCT04421378|560567306|FG000|Overall Study|Adverse Event|2|||
155309377|NCT04421378|560567307|FG001|Overall Study|Adverse Event|7|||
155309378|NCT04421378|560567308|FG002|Overall Study|Adverse Event|0|||
155309379|NCT04421378|560567309|FG003|Overall Study|Adverse Event|1|||
155309380|NCT04421378|560567310|FG004|Overall Study|Adverse Event|0|||
155309381|NCT04421378|560567306|FG000|Overall Study|Physician Decision|1|||
155309382|NCT04421378|560567307|FG001|Overall Study|Physician Decision|2|||
155309383|NCT04421378|560567308|FG002|Overall Study|Physician Decision|0|||
155309384|NCT04421378|560567309|FG003|Overall Study|Physician Decision|0|||
155309385|NCT04421378|560567310|FG004|Overall Study|Physician Decision|0|||
155309386|NCT04421378|560567306|FG000|Overall Study|Progressive Disease|16|||
155065752|NCT03034967|559672179|FG003|Overall Study|Protocol Violation|0|||
155065753|NCT03034967|559672180|FG004|Overall Study|Protocol Violation|0|||
155065754|NCT03034967|559672181|FG005|Overall Study|Protocol Violation|2|||
155065755|NCT03034967|559672176|FG000|Overall Study|Lack of Efficacy|0|||
155065756|NCT03034967|559672177|FG001|Overall Study|Lack of Efficacy|1|||
155065757|NCT03034967|559672178|FG002|Overall Study|Lack of Efficacy|2|||
155065758|NCT03034967|559672179|FG003|Overall Study|Lack of Efficacy|1|||
155065759|NCT03034967|559672180|FG004|Overall Study|Lack of Efficacy|1|||
155065760|NCT03034967|559672181|FG005|Overall Study|Lack of Efficacy|0|||
155065761|NCT03034967|559672176|FG000|Overall Study|Adverse Event, non-fatal|3|||
155065762|NCT03034967|559672177|FG001|Overall Study|Adverse Event, non-fatal|1|||
155065763|NCT03034967|559672178|FG002|Overall Study|Adverse Event, non-fatal|2|||
155065764|NCT03034967|559672179|FG003|Overall Study|Adverse Event, non-fatal|0|||
155065765|NCT03034967|559672180|FG004|Overall Study|Adverse Event, non-fatal|2|||
155065766|NCT03034967|559672181|FG005|Overall Study|Adverse Event, non-fatal|8|||
155065767|NCT03034967|559672176|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
155065768|NCT03034967|559672177|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
155065769|NCT03034967|559672178|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
155065770|NCT03034967|559672179|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
155065771|NCT03034967|559672180|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
155065772|NCT03034967|559672181|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
155065773|NCT03806296|559672182|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
155065774|NCT03806296|559672183|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
155065775|NCT03806296|559672184|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
155065776|NCT03806296|559672182|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
155065777|NCT03806296|559672183|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
155065778|NCT03806296|559672184|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
155065779|NCT03806296|559672182|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
155065780|NCT03806296|559672183|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
155065781|NCT03806296|559672184|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
155065782|NCT03197129|559672185|FG000|Overall Study|did not answer the VPT: shyness|4|||
155065783|NCT03197129|559672186|FG001|Overall Study|did not answer the VPT: shyness|5|||
155065784|NCT05233761|559672187|FG000|Treatment Period A|Withdrawal by Subject|12|||
155065785|NCT05233761|559672188|FG001|Treatment Period A|Withdrawal by Subject|10|||
155065786|NCT05233761|559672187|FG000|Treatment Period A|Lost to Follow-up|6|||
155065787|NCT05233761|559672188|FG001|Treatment Period A|Lost to Follow-up|12|||
155065788|NCT05233761|559672187|FG000|Treatment Period A|Protocol Violation|8|||
155065789|NCT05233761|559672188|FG001|Treatment Period A|Protocol Violation|15|||
155065790|NCT01285518|559672189|FG000|Overall Study|Lost to Follow-up|0|||
155065791|NCT01285518|559672190|FG001|Overall Study|Lost to Follow-up|0|||
155065792|NCT01285518|559672191|FG002|Overall Study|Lost to Follow-up|0|||
155065793|NCT01285518|559672192|FG003|Overall Study|Lost to Follow-up|0|||
155065794|NCT01285518|559672193|FG004|Overall Study|Lost to Follow-up|0|||
155065795|NCT01285518|559672194|FG005|Overall Study|Lost to Follow-up|1|||
155065796|NCT01285518|559672195|FG006|Overall Study|Lost to Follow-up|0|||
155065797|NCT01285518|559672196|FG007|Overall Study|Lost to Follow-up|0|||
155065798|NCT00879658|559672199|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155065799|NCT00879658|559672200|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155065800|NCT00879658|559672201|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155065801|NCT00879658|559672202|FG003|Overall Study|Abnormal laboratory value(s)|1|||
155065802|NCT00879658|559672203|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155065803|NCT00879658|559672204|FG005|Overall Study|Abnormal laboratory value(s)|0|||
155065804|NCT00879658|559672205|FG006|Overall Study|Abnormal laboratory value(s)|0|||
155065805|NCT00879658|559672199|FG000|Overall Study|Administrative problems|2|||
155065806|NCT00879658|559672200|FG001|Overall Study|Administrative problems|1|||
155065807|NCT00879658|559672201|FG002|Overall Study|Administrative problems|0|||
155065808|NCT00879658|559672202|FG003|Overall Study|Administrative problems|1|||
155065809|NCT00879658|559672203|FG004|Overall Study|Administrative problems|0|||
155065810|NCT00879658|559672204|FG005|Overall Study|Administrative problems|0|||
155065811|NCT00879658|559672205|FG006|Overall Study|Administrative problems|0|||
155065812|NCT00879658|559672199|FG000|Overall Study|Adverse Event|6|||
155065813|NCT00879658|559672200|FG001|Overall Study|Adverse Event|4|||
155065814|NCT00879658|559672201|FG002|Overall Study|Adverse Event|3|||
155065815|NCT00879658|559672202|FG003|Overall Study|Adverse Event|1|||
155065816|NCT00879658|559672203|FG004|Overall Study|Adverse Event|2|||
155065817|NCT00879658|559672204|FG005|Overall Study|Adverse Event|0|||
155065818|NCT00879658|559672205|FG006|Overall Study|Adverse Event|0|||
155065819|NCT00879658|559672199|FG000|Overall Study|Protocol Violation|1|||
155065820|NCT00879658|559672200|FG001|Overall Study|Protocol Violation|0|||
155065821|NCT00879658|559672201|FG002|Overall Study|Protocol Violation|0|||
155065822|NCT00879658|559672202|FG003|Overall Study|Protocol Violation|0|||
155065823|NCT00879658|559672203|FG004|Overall Study|Protocol Violation|0|||
155065824|NCT00879658|559672204|FG005|Overall Study|Protocol Violation|0|||
155065825|NCT00879658|559672205|FG006|Overall Study|Protocol Violation|0|||
155065826|NCT00879658|559672199|FG000|Overall Study|Withdrawal by Subject|3|||
155065827|NCT00879658|559672200|FG001|Overall Study|Withdrawal by Subject|0|||
155065828|NCT00879658|559672201|FG002|Overall Study|Withdrawal by Subject|2|||
155065829|NCT00879658|559672202|FG003|Overall Study|Withdrawal by Subject|0|||
155065830|NCT00879658|559672203|FG004|Overall Study|Withdrawal by Subject|0|||
155065831|NCT00879658|559672204|FG005|Overall Study|Withdrawal by Subject|1|||
155065832|NCT00879658|559672205|FG006|Overall Study|Withdrawal by Subject|0|||
155065833|NCT00879658|559672199|FG000|Overall Study|Lack of Efficacy|0|||
155065834|NCT00879658|559672200|FG001|Overall Study|Lack of Efficacy|0|||
155065835|NCT00879658|559672201|FG002|Overall Study|Lack of Efficacy|2|||
155065836|NCT00879658|559672202|FG003|Overall Study|Lack of Efficacy|0|||
155065837|NCT00879658|559672203|FG004|Overall Study|Lack of Efficacy|0|||
155065838|NCT00879658|559672204|FG005|Overall Study|Lack of Efficacy|0|||
155065839|NCT00879658|559672205|FG006|Overall Study|Lack of Efficacy|0|||
155065840|NCT00879658|559672199|FG000|Overall Study|misrandomized (never received study med)|0|||
155065841|NCT00879658|559672200|FG001|Overall Study|misrandomized (never received study med)|0|||
155065842|NCT00879658|559672201|FG002|Overall Study|misrandomized (never received study med)|0|||
155065843|NCT00879658|559672202|FG003|Overall Study|misrandomized (never received study med)|1|||
155065844|NCT00879658|559672203|FG004|Overall Study|misrandomized (never received study med)|0|||
155065845|NCT00879658|559672204|FG005|Overall Study|misrandomized (never received study med)|0|||
155065846|NCT00879658|559672205|FG006|Overall Study|misrandomized (never received study med)|0|||
155065847|NCT00639509|559672210|FG000|Overall Study|Death|1|||
155065848|NCT01394276|559672211|FG000|Overall Study|Related Adverse event (AEs)|15|||
155065849|NCT01394276|559672211|FG000|Overall Study|Not related AEs|9|||
155065850|NCT01394276|559672211|FG000|Overall Study|Remission of disease|2|||
155065851|NCT01394276|559672211|FG000|Overall Study|Insufficient therapeutic effect|17|||
155065852|NCT01394276|559672211|FG000|Overall Study|Insufficient compliance|9|||
155065853|NCT01394276|559672211|FG000|Overall Study|Lost to Follow-up|5|||
155065854|NCT01394276|559672211|FG000|Overall Study|Participant moved to another site|1|||
155065855|NCT01394276|559672211|FG000|Overall Study|Pregnancy|1|||
155065856|NCT01394276|559672211|FG000|Overall Study|unavailability of drug at the Hospital|2|||
155065857|NCT01394276|559672211|FG000|Overall Study|Symptoms of concurrent diseases|1|||
155065858|NCT01933594|559672212|FG000|Overall Study|Lost to Follow-up|1|||
155065859|NCT01933594|559672213|FG001|Overall Study|Lost to Follow-up|0|||
155065860|NCT01933594|559672214|FG002|Overall Study|Lost to Follow-up|0|||
155065861|NCT01933594|559672215|FG003|Overall Study|Lost to Follow-up|0|||
155065862|NCT01933594|559672216|FG004|Overall Study|Lost to Follow-up|1|||
155065863|NCT01933594|559672217|FG005|Overall Study|Lost to Follow-up|0|||
155065864|NCT01933594|559672212|FG000|Overall Study|Ineligible for subsequent study step|0|||
155065865|NCT01933594|559672213|FG001|Overall Study|Ineligible for subsequent study step|0|||
155065866|NCT01933594|559672214|FG002|Overall Study|Ineligible for subsequent study step|0|||
155065867|NCT01933594|559672215|FG003|Overall Study|Ineligible for subsequent study step|0|||
155065868|NCT01933594|559672216|FG004|Overall Study|Ineligible for subsequent study step|1|||
155065869|NCT01933594|559672217|FG005|Overall Study|Ineligible for subsequent study step|0|||
155065870|NCT04770779|559672219|FG000|Overall Study|Randomized, never treated|0|||
155065871|NCT04770779|559672220|FG001|Overall Study|Randomized, never treated|1|||
155309387|NCT04421378|560567307|FG001|Overall Study|Progressive Disease|4|||
155309388|NCT04421378|560567308|FG002|Overall Study|Progressive Disease|18|||
155309389|NCT04421378|560567309|FG003|Overall Study|Progressive Disease|11|||
155309390|NCT04421378|560567310|FG004|Overall Study|Progressive Disease|3|||
155309391|NCT04421378|560567306|FG000|Overall Study|Study Terminated by Sponsor|0|||
155309392|NCT04421378|560567307|FG001|Overall Study|Study Terminated by Sponsor|1|||
155309393|NCT04421378|560567308|FG002|Overall Study|Study Terminated by Sponsor|1|||
155309394|NCT04421378|560567309|FG003|Overall Study|Study Terminated by Sponsor|0|||
155309395|NCT04421378|560567310|FG004|Overall Study|Study Terminated by Sponsor|0|||
155309396|NCT04421378|560567306|FG000|Overall Study|Withdrawal by Subject|3|||
155309397|NCT04421378|560567307|FG001|Overall Study|Withdrawal by Subject|1|||
155309398|NCT04421378|560567308|FG002|Overall Study|Withdrawal by Subject|0|||
155309399|NCT04421378|560567309|FG003|Overall Study|Withdrawal by Subject|2|||
155309400|NCT04421378|560567310|FG004|Overall Study|Withdrawal by Subject|0|||
155309401|NCT04421378|560567306|FG000|Overall Study|Other|1|||
155309402|NCT04421378|560567307|FG001|Overall Study|Other|0|||
155309403|NCT04421378|560567308|FG002|Overall Study|Other|0|||
155309404|NCT04421378|560567309|FG003|Overall Study|Other|0|||
155309405|NCT04421378|560567310|FG004|Overall Study|Other|0|||
155065872|NCT04770779|559672219|FG000|Overall Study|Adverse Event|9|||
155065873|NCT04770779|559672220|FG001|Overall Study|Adverse Event|1|||
155065874|NCT04770779|559672219|FG000|Overall Study|Withdrawal by Subject|7|||
155065875|NCT04770779|559672220|FG001|Overall Study|Withdrawal by Subject|1|||
155309406|NCT04258709|560567311|FG000|Overall Study|Lost to Follow-up|10|||
155309407|NCT04258709|560567312|FG001|Overall Study|Lost to Follow-up|4|||
155309408|NCT04258709|560567311|FG000|Overall Study|Withdrawal by Subject|1|||
155309409|NCT04258709|560567312|FG001|Overall Study|Withdrawal by Subject|0|||
155309410|NCT04258709|560567311|FG000|Overall Study|Fetal demise|0|||
155309411|NCT04258709|560567312|FG001|Overall Study|Fetal demise|1|||
155309412|NCT04258709|560567311|FG000|Overall Study|Protocol Violation|1|||
155309413|NCT04258709|560567312|FG001|Overall Study|Protocol Violation|1|||
155065876|NCT04770779|559672219|FG000|Overall Study|Pregnancy|0|||
155309414|NCT02592330|560567313|FG000|Overall Study|Withdrawal by Subject|1|||
155309415|NCT02592330|560567314|FG001|Overall Study|Withdrawal by Subject|0|||
155309416|NCT02592330|560567313|FG000|Overall Study|Failed Biopsy|1|||
155309417|NCT02592330|560567314|FG001|Overall Study|Failed Biopsy|0|||
155309418|NCT03090152|560567315|FG000|Overall Study|Withdrawal by Subject|0|||
155309419|NCT03090152|560567316|FG001|Overall Study|Withdrawal by Subject|2|||
155309420|NCT03090152|560567317|FG002|Overall Study|Withdrawal by Subject|1|||
155309421|NCT03090152|560567315|FG000|Overall Study|Surgery Canceled|1|||
155309422|NCT03090152|560567316|FG001|Overall Study|Surgery Canceled|0|||
155309423|NCT03090152|560567317|FG002|Overall Study|Surgery Canceled|0|||
155309424|NCT03090152|560567315|FG000|Overall Study|Epidural catheter could not be placed|0|||
155309425|NCT03090152|560567316|FG001|Overall Study|Epidural catheter could not be placed|2|||
155309426|NCT03090152|560567317|FG002|Overall Study|Epidural catheter could not be placed|0|||
155309427|NCT01566695|560567318|FG000|Overall Study|Lack of Efficacy|1|||
155309428|NCT01566695|560567319|FG001|Overall Study|Lack of Efficacy|0|||
155065877|NCT04770779|559672220|FG001|Overall Study|Pregnancy|1|||
155065878|NCT02799602|559672221|FG000|Overall Study|Protocol Violation|1|||
155065879|NCT02799602|559672222|FG001|Overall Study|Protocol Violation|0|||
155309429|NCT01566695|560567318|FG000|Overall Study|Adverse Event|3|||
155309430|NCT01566695|560567319|FG001|Overall Study|Adverse Event|0|||
155309431|NCT01566695|560567318|FG000|Overall Study|Death|79|||
155309432|NCT01566695|560567319|FG001|Overall Study|Death|86|||
155309433|NCT01566695|560567318|FG000|Overall Study|Withdrawal by Subject|13|||
155309434|NCT01566695|560567319|FG001|Overall Study|Withdrawal by Subject|12|||
155309435|NCT01566695|560567318|FG000|Overall Study|Lost to Follow-up|0|||
155309436|NCT01566695|560567319|FG001|Overall Study|Lost to Follow-up|3|||
155065880|NCT02799602|559672221|FG000|Overall Study|Physician Decision|5|||
155065881|NCT02799602|559672222|FG001|Overall Study|Physician Decision|6|||
155065882|NCT02799602|559672221|FG000|Overall Study|Lost to Follow-up|4|||
155065883|NCT02799602|559672222|FG001|Overall Study|Lost to Follow-up|2|||
155065884|NCT02799602|559672221|FG000|Overall Study|Additional primary malignancy|11|||
155065885|NCT02799602|559672222|FG001|Overall Study|Additional primary malignancy|6|||
155065886|NCT02799602|559672221|FG000|Overall Study|Non-compliance with study drug|14|||
155065887|NCT02799602|559672222|FG001|Overall Study|Non-compliance with study drug|12|||
155161314|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
155161315|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
155161316|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155161317|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155161318|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155161319|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Other|8|||
155161320|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Other|3|||
155161321|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Other|4|||
155161322|NCT01106690|560028622|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
155161323|NCT01106690|560028623|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155161324|NCT01106690|560028624|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155065888|NCT02799602|559672221|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
155065889|NCT02799602|559672222|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
155065890|NCT02799602|559672221|FG000|Overall Study|Withdrawal by Subject|26|||
155065891|NCT02799602|559672222|FG001|Overall Study|Withdrawal by Subject|40|||
155161325|NCT02346721|560028625|FG000|Overall Study|Withdrew Consent|3|||
155309437|NCT01566695|560567318|FG000|Overall Study|Other reasons|11|||
155309438|NCT01566695|560567319|FG001|Overall Study|Other reasons|8|||
155309439|NCT05470400|560567320|FG000|Overall Study|Lost to Follow-up|0|||
155309440|NCT05470400|560567321|FG001|Overall Study|Lost to Follow-up|0|||
155309441|NCT05470400|560567322|FG002|Overall Study|Lost to Follow-up|0|||
155309442|NCT05470400|560567323|FG003|Overall Study|Lost to Follow-up|0|||
155309443|NCT05470400|560567324|FG004|Overall Study|Lost to Follow-up|0|||
155309444|NCT05470400|560567325|FG005|Overall Study|Lost to Follow-up|0|||
155309445|NCT05470400|560567326|FG006|Overall Study|Lost to Follow-up|0|||
155309446|NCT05470400|560567327|FG007|Overall Study|Lost to Follow-up|1|||
155309447|NCT05470400|560567320|FG000|Overall Study|Withdrawal by Subject|1|||
155309448|NCT05470400|560567321|FG001|Overall Study|Withdrawal by Subject|0|||
155309449|NCT05470400|560567322|FG002|Overall Study|Withdrawal by Subject|0|||
155309450|NCT05470400|560567323|FG003|Overall Study|Withdrawal by Subject|0|||
155309451|NCT05470400|560567324|FG004|Overall Study|Withdrawal by Subject|0|||
155309452|NCT05470400|560567325|FG005|Overall Study|Withdrawal by Subject|1|||
155309453|NCT05470400|560567326|FG006|Overall Study|Withdrawal by Subject|0|||
155309454|NCT05470400|560567327|FG007|Overall Study|Withdrawal by Subject|2|||
155309455|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
155309456|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
155309457|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
155309458|NCT04294225|560567329|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
155309459|NCT04294225|560567329|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
155309460|NCT04812535|560567331|FG000|Overall Study|Withdrawal by Subject|0|||
155309461|NCT04812535|560567332|FG001|Overall Study|Withdrawal by Subject|0|||
155309462|NCT04812535|560567333|FG002|Overall Study|Withdrawal by Subject|0|||
155309463|NCT04812535|560567334|FG003|Overall Study|Withdrawal by Subject|1|||
155309464|NCT04812535|560567331|FG000|Overall Study|Death|7|||
155309465|NCT04812535|560567332|FG001|Overall Study|Death|2|||
155309466|NCT04812535|560567333|FG002|Overall Study|Death|4|||
155309467|NCT04812535|560567334|FG003|Overall Study|Death|1|||
155309468|NCT04812535|560567331|FG000|Overall Study|Due to premature study termination by sponsor|2|||
155309469|NCT04812535|560567332|FG001|Overall Study|Due to premature study termination by sponsor|0|||
155309470|NCT04812535|560567333|FG002|Overall Study|Due to premature study termination by sponsor|1|||
155309471|NCT04812535|560567334|FG003|Overall Study|Due to premature study termination by sponsor|3|||
155309472|NCT03436745|560567335|FG000|Overall Study|Ineligible|0|||
155309473|NCT03436745|560567336|FG001|Overall Study|Ineligible|0|||
155309474|NCT03436745|560567337|FG002|Overall Study|Ineligible|1|||
155309475|NCT00931710|560567342|FG000|Overall Study|Adverse Event|16|||
155309476|NCT00931710|560567343|FG001|Overall Study|Adverse Event|10|||
155309477|NCT00931710|560567342|FG000|Overall Study|Abnormal test procedure results|2|||
155161326|NCT02346721|560028625|FG000|Overall Study|Lack of Efficacy|1|||
155309478|NCT00931710|560567343|FG001|Overall Study|Abnormal test procedure results|0|||
155309479|NCT00931710|560567342|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
155309480|NCT00931710|560567343|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
155309481|NCT00931710|560567342|FG000|Overall Study|Patient withdrew consent|4|||
155309482|NCT00931710|560567343|FG001|Overall Study|Patient withdrew consent|9|||
155309483|NCT00931710|560567342|FG000|Overall Study|Lost to Follow-up|6|||
155309484|NCT00931710|560567343|FG001|Overall Study|Lost to Follow-up|5|||
155309485|NCT00931710|560567342|FG000|Overall Study|Protocol deviation|1|||
155309486|NCT00931710|560567343|FG001|Overall Study|Protocol deviation|2|||
155309487|NCT04927065|560567344|FG000|First Booster|Adverse Event|1|||
155065892|NCT02799602|559672221|FG000|Overall Study|Progressive disease - clinical progression|131|||
155065893|NCT02799602|559672222|FG001|Overall Study|Progressive disease - clinical progression|276|||
155065894|NCT02799602|559672221|FG000|Overall Study|Progressive disease - radiological progression|90|||
155065895|NCT02799602|559672222|FG001|Overall Study|Progressive disease - radiological progression|133|||
155065896|NCT02799602|559672221|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
155065897|NCT02799602|559672222|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
155065898|NCT02799602|559672221|FG000|Overall Study|Death|9|||
155065899|NCT02799602|559672222|FG001|Overall Study|Death|5|||
155065900|NCT02799602|559672221|FG000|Overall Study|Other|287|||
155065901|NCT02799602|559672222|FG001|Overall Study|Other|118|||
155065902|NCT02799602|559672221|FG000|Overall Study|Study drug never administered|0|||
155065903|NCT02799602|559672222|FG001|Overall Study|Study drug never administered|3|||
155065904|NCT01925417|559672237|FG000|Overall Study|Withdrawal by Subject|2|||
155065905|NCT01925417|559672237|FG000|Overall Study|Death|1|||
155065906|NCT02696798|559672239|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
155065907|NCT02696798|559672240|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
155161327|NCT04455815|560028626|FG000|Randomisation Phase|Adverse Event|1|||
155065908|NCT02696798|559672241|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
155065909|NCT02696798|559672239|FG000|Blinded Treatment Dosing Period|Death|0|||
155065910|NCT02696798|559672240|FG001|Blinded Treatment Dosing Period|Death|0|||
155065911|NCT02696798|559672241|FG002|Blinded Treatment Dosing Period|Death|1|||
155065912|NCT02696798|559672239|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
155065913|NCT02696798|559672240|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
155161328|NCT04455815|560028627|FG001|Randomisation Phase|Adverse Event|0|||
155309488|NCT04927065|560567345|FG001|First Booster|Adverse Event|0|||
155309489|NCT04927065|560567346|FG002|First Booster|Adverse Event|0|||
155309490|NCT04927065|560567347|FG003|First Booster|Adverse Event|0|||
155309491|NCT04927065|560567348|FG004|First Booster|Adverse Event|0|||
155309492|NCT04927065|560567349|FG005|First Booster|Adverse Event|0|||
155309493|NCT04927065|560567350|FG006|First Booster|Adverse Event|0|||
155309494|NCT04927065|560567351|FG007|First Booster|Adverse Event|1|||
155309495|NCT04927065|560567352|FG008|First Booster|Adverse Event|0|||
155309496|NCT04927065|560567353|FG009|First Booster|Adverse Event|0|||
155309497|NCT04927065|560567354|FG010|First Booster|Adverse Event|0|||
155309498|NCT04927065|560567355|FG011|First Booster|Adverse Event|0|||
155309499|NCT04927065|560567356|FG012|First Booster|Adverse Event|0|||
155309500|NCT04927065|560567357|FG013|First Booster|Adverse Event|0|||
155309501|NCT04927065|560567358|FG014|First Booster|Adverse Event|0|||
155309502|NCT04927065|560567359|FG015|First Booster|Adverse Event|0|||
155309503|NCT04927065|560567344|FG000|First Booster|Death|1|||
155309504|NCT04927065|560567345|FG001|First Booster|Death|0|||
155309505|NCT04927065|560567346|FG002|First Booster|Death|0|||
155309506|NCT04927065|560567347|FG003|First Booster|Death|1|||
155309507|NCT04927065|560567348|FG004|First Booster|Death|0|||
155309508|NCT04927065|560567349|FG005|First Booster|Death|1|||
155309509|NCT04927065|560567350|FG006|First Booster|Death|0|||
155309510|NCT04927065|560567351|FG007|First Booster|Death|0|||
155309511|NCT04927065|560567352|FG008|First Booster|Death|0|||
155309512|NCT04927065|560567353|FG009|First Booster|Death|0|||
155309513|NCT04927065|560567354|FG010|First Booster|Death|0|||
155309514|NCT04927065|560567355|FG011|First Booster|Death|0|||
155309515|NCT04927065|560567356|FG012|First Booster|Death|0|||
155309516|NCT04927065|560567357|FG013|First Booster|Death|0|||
155309517|NCT04927065|560567358|FG014|First Booster|Death|0|||
155309518|NCT04927065|560567359|FG015|First Booster|Death|0|||
155309519|NCT04927065|560567344|FG000|First Booster|Lost to Follow-up|8|||
155309520|NCT04927065|560567345|FG001|First Booster|Lost to Follow-up|20|||
155309521|NCT04927065|560567346|FG002|First Booster|Lost to Follow-up|0|||
155309522|NCT04927065|560567347|FG003|First Booster|Lost to Follow-up|11|||
155309523|NCT04927065|560567348|FG004|First Booster|Lost to Follow-up|43|||
155309524|NCT04927065|560567349|FG005|First Booster|Lost to Follow-up|30|||
155309525|NCT04927065|560567350|FG006|First Booster|Lost to Follow-up|28|||
155309526|NCT04927065|560567351|FG007|First Booster|Lost to Follow-up|23|||
155309527|NCT04927065|560567352|FG008|First Booster|Lost to Follow-up|4|||
155309528|NCT04927065|560567353|FG009|First Booster|Lost to Follow-up|15|||
155309529|NCT04927065|560567354|FG010|First Booster|Lost to Follow-up|0|||
155309530|NCT04927065|560567355|FG011|First Booster|Lost to Follow-up|0|||
155309531|NCT04927065|560567356|FG012|First Booster|Lost to Follow-up|0|||
155309532|NCT04927065|560567357|FG013|First Booster|Lost to Follow-up|0|||
155309533|NCT04927065|560567358|FG014|First Booster|Lost to Follow-up|0|||
155309534|NCT04927065|560567359|FG015|First Booster|Lost to Follow-up|0|||
155309535|NCT04927065|560567344|FG000|First Booster|Physician Decision|1|||
155309536|NCT04927065|560567345|FG001|First Booster|Physician Decision|0|||
155309537|NCT04927065|560567346|FG002|First Booster|Physician Decision|0|||
155309538|NCT04927065|560567347|FG003|First Booster|Physician Decision|3|||
155309539|NCT04927065|560567348|FG004|First Booster|Physician Decision|1|||
155309540|NCT04927065|560567349|FG005|First Booster|Physician Decision|1|||
155309541|NCT04927065|560567350|FG006|First Booster|Physician Decision|0|||
155309542|NCT04927065|560567351|FG007|First Booster|Physician Decision|3|||
155309543|NCT04927065|560567352|FG008|First Booster|Physician Decision|0|||
155309544|NCT04927065|560567353|FG009|First Booster|Physician Decision|0|||
155309545|NCT04927065|560567354|FG010|First Booster|Physician Decision|0|||
155309546|NCT04927065|560567355|FG011|First Booster|Physician Decision|0|||
155309547|NCT04927065|560567356|FG012|First Booster|Physician Decision|0|||
155309548|NCT04927065|560567357|FG013|First Booster|Physician Decision|0|||
155309549|NCT04927065|560567358|FG014|First Booster|Physician Decision|0|||
155161329|NCT04455815|560028626|FG000|Treatment Phase|Adverse Event|0|||
155309550|NCT04927065|560567359|FG015|First Booster|Physician Decision|0|||
155309551|NCT04927065|560567344|FG000|First Booster|Protocol Violation|4|||
155309552|NCT04927065|560567345|FG001|First Booster|Protocol Violation|4|||
155309553|NCT04927065|560567346|FG002|First Booster|Protocol Violation|0|||
155309554|NCT04927065|560567347|FG003|First Booster|Protocol Violation|3|||
155309555|NCT04927065|560567348|FG004|First Booster|Protocol Violation|0|||
155309556|NCT04927065|560567349|FG005|First Booster|Protocol Violation|0|||
155309557|NCT04927065|560567350|FG006|First Booster|Protocol Violation|0|||
155309558|NCT04927065|560567351|FG007|First Booster|Protocol Violation|2|||
155309559|NCT04927065|560567352|FG008|First Booster|Protocol Violation|0|||
155309560|NCT04927065|560567353|FG009|First Booster|Protocol Violation|0|||
155309561|NCT04927065|560567354|FG010|First Booster|Protocol Violation|0|||
155309562|NCT04927065|560567355|FG011|First Booster|Protocol Violation|0|||
155309563|NCT04927065|560567356|FG012|First Booster|Protocol Violation|0|||
155309564|NCT04927065|560567357|FG013|First Booster|Protocol Violation|0|||
155309565|NCT04927065|560567358|FG014|First Booster|Protocol Violation|0|||
155309566|NCT04927065|560567359|FG015|First Booster|Protocol Violation|0|||
155309567|NCT04927065|560567344|FG000|First Booster|Withdrawal by Subject|8|||
155309568|NCT04927065|560567345|FG001|First Booster|Withdrawal by Subject|23|||
155309569|NCT04927065|560567346|FG002|First Booster|Withdrawal by Subject|0|||
155309570|NCT04927065|560567347|FG003|First Booster|Withdrawal by Subject|19|||
155309571|NCT04927065|560567348|FG004|First Booster|Withdrawal by Subject|20|||
155309572|NCT04927065|560567349|FG005|First Booster|Withdrawal by Subject|15|||
155309573|NCT04927065|560567350|FG006|First Booster|Withdrawal by Subject|6|||
155309574|NCT04927065|560567351|FG007|First Booster|Withdrawal by Subject|24|||
155309575|NCT04927065|560567352|FG008|First Booster|Withdrawal by Subject|0|||
155309576|NCT04927065|560567353|FG009|First Booster|Withdrawal by Subject|4|||
155309577|NCT04927065|560567354|FG010|First Booster|Withdrawal by Subject|0|||
155309578|NCT04927065|560567355|FG011|First Booster|Withdrawal by Subject|0|||
155309579|NCT04927065|560567356|FG012|First Booster|Withdrawal by Subject|0|||
155309580|NCT04927065|560567357|FG013|First Booster|Withdrawal by Subject|0|||
155309581|NCT04927065|560567358|FG014|First Booster|Withdrawal by Subject|0|||
155309582|NCT04927065|560567359|FG015|First Booster|Withdrawal by Subject|0|||
155309583|NCT04927065|560567344|FG000|First Booster|Other Than Specified|1|||
155309584|NCT04927065|560567345|FG001|First Booster|Other Than Specified|1|||
155309585|NCT04927065|560567346|FG002|First Booster|Other Than Specified|0|||
155309586|NCT04927065|560567347|FG003|First Booster|Other Than Specified|1|||
155309587|NCT04927065|560567348|FG004|First Booster|Other Than Specified|2|||
155309588|NCT04927065|560567349|FG005|First Booster|Other Than Specified|3|||
155309589|NCT04927065|560567350|FG006|First Booster|Other Than Specified|2|||
155309590|NCT04927065|560567351|FG007|First Booster|Other Than Specified|6|||
155309591|NCT04927065|560567352|FG008|First Booster|Other Than Specified|0|||
155309592|NCT04927065|560567353|FG009|First Booster|Other Than Specified|4|||
155309593|NCT04927065|560567354|FG010|First Booster|Other Than Specified|0|||
155309594|NCT04927065|560567355|FG011|First Booster|Other Than Specified|0|||
155309595|NCT04927065|560567356|FG012|First Booster|Other Than Specified|0|||
155309596|NCT04927065|560567357|FG013|First Booster|Other Than Specified|0|||
155309597|NCT04927065|560567358|FG014|First Booster|Other Than Specified|0|||
155309598|NCT04927065|560567359|FG015|First Booster|Other Than Specified|0|||
155309599|NCT04927065|560567344|FG000|Second Booster|Death|0|||
155309600|NCT04927065|560567345|FG001|Second Booster|Death|0|||
155309601|NCT04927065|560567346|FG002|Second Booster|Death|0|||
155309602|NCT04927065|560567347|FG003|Second Booster|Death|0|||
155309603|NCT04927065|560567348|FG004|Second Booster|Death|0|||
155309604|NCT04927065|560567349|FG005|Second Booster|Death|0|||
155309605|NCT04927065|560567350|FG006|Second Booster|Death|0|||
155309606|NCT04927065|560567351|FG007|Second Booster|Death|0|||
155309607|NCT04927065|560567352|FG008|Second Booster|Death|0|||
155309608|NCT04927065|560567353|FG009|Second Booster|Death|0|||
155309609|NCT04927065|560567354|FG010|Second Booster|Death|2|||
155309610|NCT04927065|560567355|FG011|Second Booster|Death|0|||
155309611|NCT04927065|560567356|FG012|Second Booster|Death|2|||
155309612|NCT04927065|560567357|FG013|Second Booster|Death|2|||
155309613|NCT04927065|560567358|FG014|Second Booster|Death|0|||
155065914|NCT02696798|559672241|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
155065915|NCT02696798|559672239|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
155065916|NCT02696798|559672240|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
155065917|NCT02696798|559672241|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
155065918|NCT02696798|559672239|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
155309614|NCT04927065|560567359|FG015|Second Booster|Death|0|||
155309615|NCT04927065|560567344|FG000|Second Booster|Lost to Follow-up|0|||
155309616|NCT04927065|560567345|FG001|Second Booster|Lost to Follow-up|0|||
155309617|NCT04927065|560567346|FG002|Second Booster|Lost to Follow-up|3|||
155309618|NCT04927065|560567347|FG003|Second Booster|Lost to Follow-up|0|||
155309619|NCT04927065|560567348|FG004|Second Booster|Lost to Follow-up|0|||
155309620|NCT04927065|560567349|FG005|Second Booster|Lost to Follow-up|0|||
155309621|NCT04927065|560567350|FG006|Second Booster|Lost to Follow-up|0|||
155309622|NCT04927065|560567351|FG007|Second Booster|Lost to Follow-up|0|||
155309623|NCT04927065|560567352|FG008|Second Booster|Lost to Follow-up|0|||
155309624|NCT04927065|560567353|FG009|Second Booster|Lost to Follow-up|0|||
155309625|NCT04927065|560567354|FG010|Second Booster|Lost to Follow-up|14|||
155309626|NCT04927065|560567355|FG011|Second Booster|Lost to Follow-up|10|||
155309627|NCT04927065|560567356|FG012|Second Booster|Lost to Follow-up|13|||
155309628|NCT04927065|560567357|FG013|Second Booster|Lost to Follow-up|16|||
155309629|NCT04927065|560567358|FG014|Second Booster|Lost to Follow-up|0|||
155309630|NCT04927065|560567359|FG015|Second Booster|Lost to Follow-up|0|||
155309631|NCT04927065|560567344|FG000|Second Booster|Physician Decision|0|||
155309632|NCT04927065|560567345|FG001|Second Booster|Physician Decision|0|||
155309633|NCT04927065|560567346|FG002|Second Booster|Physician Decision|0|||
155309634|NCT04927065|560567347|FG003|Second Booster|Physician Decision|0|||
155309635|NCT04927065|560567348|FG004|Second Booster|Physician Decision|0|||
155309636|NCT04927065|560567349|FG005|Second Booster|Physician Decision|0|||
155309637|NCT04927065|560567350|FG006|Second Booster|Physician Decision|0|||
155309638|NCT04927065|560567351|FG007|Second Booster|Physician Decision|0|||
155309639|NCT04927065|560567352|FG008|Second Booster|Physician Decision|0|||
155309640|NCT04927065|560567353|FG009|Second Booster|Physician Decision|0|||
155309641|NCT04927065|560567354|FG010|Second Booster|Physician Decision|0|||
155309642|NCT04927065|560567355|FG011|Second Booster|Physician Decision|3|||
155309643|NCT04927065|560567356|FG012|Second Booster|Physician Decision|0|||
155309644|NCT04927065|560567357|FG013|Second Booster|Physician Decision|1|||
155309645|NCT04927065|560567358|FG014|Second Booster|Physician Decision|0|||
155309646|NCT04927065|560567359|FG015|Second Booster|Physician Decision|0|||
155309647|NCT04927065|560567344|FG000|Second Booster|Withdrawal by Subject|0|||
155309648|NCT04927065|560567345|FG001|Second Booster|Withdrawal by Subject|0|||
155309649|NCT04927065|560567346|FG002|Second Booster|Withdrawal by Subject|4|||
155309650|NCT04927065|560567347|FG003|Second Booster|Withdrawal by Subject|0|||
155309651|NCT04927065|560567348|FG004|Second Booster|Withdrawal by Subject|0|||
155309652|NCT04927065|560567349|FG005|Second Booster|Withdrawal by Subject|0|||
155309653|NCT04927065|560567350|FG006|Second Booster|Withdrawal by Subject|0|||
155309654|NCT04927065|560567351|FG007|Second Booster|Withdrawal by Subject|0|||
155309655|NCT04927065|560567352|FG008|Second Booster|Withdrawal by Subject|0|||
155309656|NCT04927065|560567353|FG009|Second Booster|Withdrawal by Subject|0|||
155309657|NCT04927065|560567354|FG010|Second Booster|Withdrawal by Subject|3|||
155309658|NCT04927065|560567355|FG011|Second Booster|Withdrawal by Subject|16|||
155309659|NCT04927065|560567356|FG012|Second Booster|Withdrawal by Subject|13|||
155309660|NCT04927065|560567357|FG013|Second Booster|Withdrawal by Subject|9|||
155309661|NCT04927065|560567358|FG014|Second Booster|Withdrawal by Subject|0|||
155309662|NCT04927065|560567359|FG015|Second Booster|Withdrawal by Subject|0|||
155309663|NCT04927065|560567344|FG000|Second Booster|Other Than Specified|0|||
155309664|NCT04927065|560567345|FG001|Second Booster|Other Than Specified|0|||
155309665|NCT04927065|560567346|FG002|Second Booster|Other Than Specified|0|||
155309666|NCT04927065|560567347|FG003|Second Booster|Other Than Specified|0|||
155309667|NCT04927065|560567348|FG004|Second Booster|Other Than Specified|0|||
155309668|NCT04927065|560567349|FG005|Second Booster|Other Than Specified|0|||
155309669|NCT04927065|560567350|FG006|Second Booster|Other Than Specified|0|||
155309670|NCT04927065|560567351|FG007|Second Booster|Other Than Specified|0|||
155309671|NCT04927065|560567352|FG008|Second Booster|Other Than Specified|0|||
155309672|NCT04927065|560567353|FG009|Second Booster|Other Than Specified|0|||
155309673|NCT04927065|560567354|FG010|Second Booster|Other Than Specified|1|||
155309674|NCT04927065|560567355|FG011|Second Booster|Other Than Specified|1|||
155309675|NCT04927065|560567356|FG012|Second Booster|Other Than Specified|4|||
155309676|NCT04927065|560567357|FG013|Second Booster|Other Than Specified|0|||
155309677|NCT04927065|560567358|FG014|Second Booster|Other Than Specified|0|||
155309678|NCT04927065|560567359|FG015|Second Booster|Other Than Specified|0|||
155309679|NCT04927065|560567344|FG000|Third Booster|Lost to Follow-up|0|||
155309680|NCT04927065|560567345|FG001|Third Booster|Lost to Follow-up|0|||
155309681|NCT04927065|560567346|FG002|Third Booster|Lost to Follow-up|0|||
155309682|NCT04927065|560567347|FG003|Third Booster|Lost to Follow-up|0|||
155309683|NCT04927065|560567348|FG004|Third Booster|Lost to Follow-up|0|||
155309684|NCT04927065|560567349|FG005|Third Booster|Lost to Follow-up|0|||
155309685|NCT04927065|560567350|FG006|Third Booster|Lost to Follow-up|0|||
155309686|NCT04927065|560567351|FG007|Third Booster|Lost to Follow-up|0|||
155309687|NCT04927065|560567352|FG008|Third Booster|Lost to Follow-up|0|||
155309688|NCT04927065|560567353|FG009|Third Booster|Lost to Follow-up|0|||
155309689|NCT04927065|560567354|FG010|Third Booster|Lost to Follow-up|0|||
155309690|NCT04927065|560567355|FG011|Third Booster|Lost to Follow-up|0|||
155309691|NCT04927065|560567356|FG012|Third Booster|Lost to Follow-up|0|||
155309692|NCT04927065|560567357|FG013|Third Booster|Lost to Follow-up|0|||
155309693|NCT04927065|560567358|FG014|Third Booster|Lost to Follow-up|0|||
155161330|NCT04455815|560028627|FG001|Treatment Phase|Adverse Event|1|||
155309694|NCT04927065|560567359|FG015|Third Booster|Lost to Follow-up|1|||
155309695|NCT04927065|560567344|FG000|Third Booster|Withdrawal by Subject|0|||
155309696|NCT04927065|560567345|FG001|Third Booster|Withdrawal by Subject|0|||
155309697|NCT04927065|560567346|FG002|Third Booster|Withdrawal by Subject|0|||
155309698|NCT04927065|560567347|FG003|Third Booster|Withdrawal by Subject|0|||
155309699|NCT04927065|560567348|FG004|Third Booster|Withdrawal by Subject|0|||
155309700|NCT04927065|560567349|FG005|Third Booster|Withdrawal by Subject|0|||
155309701|NCT04927065|560567350|FG006|Third Booster|Withdrawal by Subject|0|||
155309702|NCT04927065|560567351|FG007|Third Booster|Withdrawal by Subject|0|||
155309703|NCT04927065|560567352|FG008|Third Booster|Withdrawal by Subject|0|||
155309704|NCT04927065|560567353|FG009|Third Booster|Withdrawal by Subject|0|||
155309705|NCT04927065|560567354|FG010|Third Booster|Withdrawal by Subject|0|||
155309706|NCT04927065|560567355|FG011|Third Booster|Withdrawal by Subject|0|||
155309707|NCT04927065|560567356|FG012|Third Booster|Withdrawal by Subject|0|||
155309708|NCT04927065|560567357|FG013|Third Booster|Withdrawal by Subject|0|||
155309709|NCT04927065|560567358|FG014|Third Booster|Withdrawal by Subject|0|||
155309710|NCT04927065|560567359|FG015|Third Booster|Withdrawal by Subject|1|||
155309711|NCT03338790|560567363|FG000|Overall Study|Disease Progression|65|||
155309712|NCT03338790|560567364|FG001|Overall Study|Disease Progression|43|||
155309713|NCT03338790|560567365|FG002|Overall Study|Disease Progression|50|||
155309714|NCT03338790|560567366|FG003|Overall Study|Disease Progression|37|||
155309715|NCT03338790|560567363|FG000|Overall Study|Study Drug Toxicity|9|||
155309716|NCT03338790|560567364|FG001|Overall Study|Study Drug Toxicity|8|||
155309717|NCT03338790|560567365|FG002|Overall Study|Study Drug Toxicity|15|||
155309718|NCT03338790|560567366|FG003|Overall Study|Study Drug Toxicity|0|||
155309719|NCT03338790|560567363|FG000|Overall Study|Death|1|||
155309720|NCT03338790|560567364|FG001|Overall Study|Death|1|||
155309721|NCT03338790|560567365|FG002|Overall Study|Death|1|||
155309722|NCT03338790|560567366|FG003|Overall Study|Death|0|||
155309723|NCT03338790|560567363|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
155309724|NCT03338790|560567364|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
155309725|NCT03338790|560567365|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
155309726|NCT03338790|560567366|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
155309727|NCT03338790|560567363|FG000|Overall Study|Participant request to discontinue study treatment|3|||
155309728|NCT03338790|560567364|FG001|Overall Study|Participant request to discontinue study treatment|3|||
155309729|NCT03338790|560567365|FG002|Overall Study|Participant request to discontinue study treatment|2|||
155309730|NCT03338790|560567366|FG003|Overall Study|Participant request to discontinue study treatment|1|||
155309731|NCT03338790|560567363|FG000|Overall Study|Poor/non-compliance|0|||
155309732|NCT03338790|560567364|FG001|Overall Study|Poor/non-compliance|1|||
155309733|NCT03338790|560567365|FG002|Overall Study|Poor/non-compliance|0|||
155309734|NCT03338790|560567366|FG003|Overall Study|Poor/non-compliance|0|||
155309735|NCT03338790|560567363|FG000|Overall Study|Participant withdrew consent|1|||
155309736|NCT03338790|560567364|FG001|Overall Study|Participant withdrew consent|0|||
155309737|NCT03338790|560567365|FG002|Overall Study|Participant withdrew consent|1|||
155309738|NCT03338790|560567366|FG003|Overall Study|Participant withdrew consent|1|||
155309739|NCT03338790|560567363|FG000|Overall Study|Other reasons|0|||
155309740|NCT03338790|560567364|FG001|Overall Study|Other reasons|5|||
155309741|NCT03338790|560567365|FG002|Overall Study|Other reasons|0|||
155309742|NCT03338790|560567366|FG003|Overall Study|Other reasons|2|||
155309743|NCT03338790|560567363|FG000|Overall Study|Not reported|0|||
155309744|NCT03338790|560567364|FG001|Overall Study|Not reported|0|||
155309745|NCT03338790|560567365|FG002|Overall Study|Not reported|1|||
155309746|NCT03338790|560567366|FG003|Overall Study|Not reported|0|||
155309747|NCT03338790|560567363|FG000|Overall Study|Completed treatment period|1|||
155309748|NCT03338790|560567364|FG001|Overall Study|Completed treatment period|2|||
155309749|NCT03338790|560567365|FG002|Overall Study|Completed treatment period|0|||
155309750|NCT03338790|560567366|FG003|Overall Study|Completed treatment period|0|||
155309751|NCT03846505|560567367|FG000|Treatment Phase|Withdrawal by Subject|9|||
155309752|NCT03846505|560567368|FG001|Treatment Phase|Withdrawal by Subject|11|||
155309753|NCT03846505|560567367|FG000|Treatment Phase|Lost to Follow-up|6|||
155309754|NCT03846505|560567368|FG001|Treatment Phase|Lost to Follow-up|2|||
155309755|NCT03846505|560567367|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
155309756|NCT03846505|560567368|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
155309757|NCT03846505|560567367|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
155309758|NCT03846505|560567368|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
155309759|NCT00601900|560567369|FG000|Overall Study|Withdrawal by Subject|0|||
155309760|NCT00601900|560567370|FG001|Overall Study|Withdrawal by Subject|3|||
155309761|NCT03924986|560567371|FG000|Overall Study|Death|57|||
155309762|NCT03924986|560567372|FG001|Overall Study|Death|66|||
155309763|NCT03924986|560567371|FG000|Overall Study|Study Concluded by Sponsor|51|||
155309764|NCT03924986|560567372|FG001|Overall Study|Study Concluded by Sponsor|41|||
155309765|NCT03924986|560567371|FG000|Overall Study|Withdrawal by Subject|15|||
155309766|NCT03924986|560567372|FG001|Overall Study|Withdrawal by Subject|20|||
155309767|NCT03924986|560567371|FG000|Overall Study|Lost to Follow-up|7|||
155309768|NCT03924986|560567372|FG001|Overall Study|Lost to Follow-up|5|||
155309769|NCT03924986|560567371|FG000|Overall Study|Miscellaneous|1|||
155309770|NCT03924986|560567372|FG001|Overall Study|Miscellaneous|0|||
155309771|NCT05592418|560567378|FG000|Overall Study|Adverse Event|1|||
155309772|NCT05592418|560567379|FG001|Overall Study|Adverse Event|0|||
155309773|NCT05592418|560567378|FG000|Overall Study|Lost to Follow-up|1|||
155309774|NCT05592418|560567379|FG001|Overall Study|Lost to Follow-up|3|||
155309775|NCT05592418|560567378|FG000|Overall Study|Withdrawal by Subject|2|||
155309776|NCT05592418|560567379|FG001|Overall Study|Withdrawal by Subject|7|||
155309777|NCT01494662|560567382|FG000|Overall Study|Withdrawal by Subject|0|||
155309778|NCT01494662|560567383|FG001|Overall Study|Withdrawal by Subject|0|||
155309779|NCT01494662|560567384|FG002|Overall Study|Withdrawal by Subject|1|||
155309780|NCT01494662|560567385|FG003|Overall Study|Withdrawal by Subject|0|||
155309781|NCT01494662|560567386|FG004|Overall Study|Withdrawal by Subject|0|||
155309782|NCT01494662|560567387|FG005|Overall Study|Withdrawal by Subject|0|||
155309783|NCT01494662|560567388|FG006|Overall Study|Withdrawal by Subject|0|||
155309784|NCT01494662|560567382|FG000|Overall Study|Physician Decision|0|||
155309785|NCT01494662|560567383|FG001|Overall Study|Physician Decision|0|||
155309786|NCT01494662|560567384|FG002|Overall Study|Physician Decision|1|||
155309787|NCT01494662|560567385|FG003|Overall Study|Physician Decision|0|||
155309788|NCT01494662|560567386|FG004|Overall Study|Physician Decision|0|||
155309789|NCT01494662|560567387|FG005|Overall Study|Physician Decision|0|||
155309790|NCT01494662|560567388|FG006|Overall Study|Physician Decision|0|||
155309791|NCT04072822|560567389|FG000|Treatment|Adverse Event|9|||
155309792|NCT04072822|560567390|FG001|Treatment|Adverse Event|5|||
155309793|NCT04072822|560567389|FG000|Treatment|Met Stopping Criteria|13|||
155309794|NCT04072822|560567390|FG001|Treatment|Met Stopping Criteria|24|||
155309795|NCT04072822|560567389|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
155309796|NCT04072822|560567390|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
155309797|NCT04072822|560567389|FG000|Treatment|Withdrawal by Subject|0|||
155309798|NCT04072822|560567390|FG001|Treatment|Withdrawal by Subject|2|||
155309799|NCT04072822|560567389|FG000|Treatment|Death|0|||
155309800|NCT04072822|560567390|FG001|Treatment|Death|2|||
155309801|NCT04072822|560567389|FG000|Treatment|Lost to Follow-up|11|||
155309802|NCT04072822|560567390|FG001|Treatment|Lost to Follow-up|3|||
155309803|NCT04072822|560567389|FG000|Treatment|Physician Decision|1|||
155309804|NCT04072822|560567390|FG001|Treatment|Physician Decision|0|||
155309805|NCT04072822|560567389|FG000|Treatment|Other|7|||
155309806|NCT04072822|560567390|FG001|Treatment|Other|9|||
155309807|NCT04072822|560567389|FG000|Follow-up|Withdrawal by Subject|1|||
155309808|NCT04072822|560567390|FG001|Follow-up|Withdrawal by Subject|0|||
155309809|NCT04072822|560567389|FG000|Follow-up|Lost to Follow-up|5|||
155309810|NCT04072822|560567390|FG001|Follow-up|Lost to Follow-up|4|||
155309811|NCT05481320|560567391|FG000|Overall Study|Withdrawal by Subject|1|||
155309812|NCT05481320|560567392|FG001|Overall Study|Withdrawal by Subject|1|||
155309813|NCT05481320|560567391|FG000|Overall Study|Care recipent passed away|0|||
155309814|NCT05481320|560567392|FG001|Overall Study|Care recipent passed away|1|||
155309815|NCT05481320|560567391|FG000|Overall Study|Out-of-window assessment|0|||
155309816|NCT05481320|560567392|FG001|Overall Study|Out-of-window assessment|1|||
155309817|NCT05481320|560567391|FG000|Overall Study|No longer a primary caregiver|3|||
155309818|NCT05481320|560567392|FG001|Overall Study|No longer a primary caregiver|0|||
155309819|NCT05481320|560567391|FG000|Overall Study|Unable to contact|1|||
155309820|NCT05481320|560567392|FG001|Overall Study|Unable to contact|0|||
155309821|NCT04314895|560567398|FG000|Overall Study|Lost to Follow-up|1|||
155309822|NCT04314895|560567398|FG000|Overall Study|Death|10|||
155309823|NCT04314895|560567398|FG000|Overall Study|Physician Decision|2|||
155309824|NCT03930342|560567402|FG000|Overall Study|Lost to Follow-up|70|||
155309825|NCT03930342|560567403|FG001|Overall Study|Lost to Follow-up|77|||
155309826|NCT02596126|560567404|FG000|Overall Study|Lost to Follow-up|12|||
155309827|NCT02596126|560567405|FG001|Overall Study|Lost to Follow-up|21|||
155309828|NCT02596126|560567404|FG000|Overall Study|Protocol Violation|7|||
155309829|NCT02596126|560567405|FG001|Overall Study|Protocol Violation|9|||
155309830|NCT04774237|560567406|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309831|NCT04774237|560567407|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309832|NCT04774237|560567408|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309833|NCT04774237|560567409|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309834|NCT04774237|560567410|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
155309835|NCT04774237|560567411|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
155309836|NCT04521478|560569134|FG000|Overall Study|Protocol Violation|2|||
155309837|NCT04521478|560569135|FG001|Overall Study|Protocol Violation|0|||
155309838|NCT04521478|560569136|FG002|Overall Study|Protocol Violation|1|||
155309839|NCT04521478|560569137|FG003|Overall Study|Protocol Violation|0|||
155309840|NCT04521478|560569138|FG004|Overall Study|Protocol Violation|0|||
155309841|NCT04521478|560569139|FG005|Overall Study|Protocol Violation|0|||
155309842|NCT04521478|560569134|FG000|Overall Study|Technical Problems|0|||
155309843|NCT04521478|560569135|FG001|Overall Study|Technical Problems|0|||
155309844|NCT04521478|560569136|FG002|Overall Study|Technical Problems|0|||
155309845|NCT04521478|560569137|FG003|Overall Study|Technical Problems|1|||
155309846|NCT04521478|560569138|FG004|Overall Study|Technical Problems|0|||
155309847|NCT04521478|560569139|FG005|Overall Study|Technical Problems|0|||
155309848|NCT04521478|560569134|FG000|Overall Study|Burden of Study Procedures|1|||
155309849|NCT04521478|560569135|FG001|Overall Study|Burden of Study Procedures|0|||
155309850|NCT04521478|560569136|FG002|Overall Study|Burden of Study Procedures|0|||
155309851|NCT04521478|560569137|FG003|Overall Study|Burden of Study Procedures|1|||
155309852|NCT04521478|560569138|FG004|Overall Study|Burden of Study Procedures|0|||
155309853|NCT04521478|560569139|FG005|Overall Study|Burden of Study Procedures|1|||
155309854|NCT04521478|560569134|FG000|Overall Study|Lack of Efficacy|0|||
155309855|NCT04521478|560569135|FG001|Overall Study|Lack of Efficacy|0|||
155309856|NCT04521478|560569136|FG002|Overall Study|Lack of Efficacy|0|||
155309857|NCT04521478|560569137|FG003|Overall Study|Lack of Efficacy|0|||
155309858|NCT04521478|560569138|FG004|Overall Study|Lack of Efficacy|1|||
155309859|NCT04521478|560569139|FG005|Overall Study|Lack of Efficacy|1|||
155309860|NCT04521478|560569134|FG000|Overall Study|Adverse Event|7|||
155161331|NCT04455815|560028626|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
155309861|NCT04521478|560569135|FG001|Overall Study|Adverse Event|0|||
155309862|NCT04521478|560569136|FG002|Overall Study|Adverse Event|2|||
155309863|NCT04521478|560569137|FG003|Overall Study|Adverse Event|1|||
155309864|NCT04521478|560569138|FG004|Overall Study|Adverse Event|2|||
155309865|NCT04521478|560569139|FG005|Overall Study|Adverse Event|7|||
155309866|NCT04521478|560569134|FG000|Overall Study|No Reason Available|0|||
155309867|NCT04521478|560569135|FG001|Overall Study|No Reason Available|2|||
155309868|NCT04521478|560569136|FG002|Overall Study|No Reason Available|0|||
155309869|NCT04521478|560569137|FG003|Overall Study|No Reason Available|0|||
155309870|NCT04521478|560569138|FG004|Overall Study|No Reason Available|1|||
155309871|NCT04521478|560569139|FG005|Overall Study|No Reason Available|0|||
155309872|NCT04521478|560569134|FG000|Overall Study|Other than listed|3|||
155309873|NCT04521478|560569135|FG001|Overall Study|Other than listed|3|||
155309874|NCT04521478|560569136|FG002|Overall Study|Other than listed|3|||
155309875|NCT04521478|560569137|FG003|Overall Study|Other than listed|2|||
155309876|NCT04521478|560569138|FG004|Overall Study|Other than listed|3|||
155309877|NCT04521478|560569139|FG005|Overall Study|Other than listed|3|||
155309878|NCT04521478|560569134|FG000|Overall Study|Not treated|0|||
155309879|NCT04521478|560569135|FG001|Overall Study|Not treated|0|||
155309880|NCT04521478|560569136|FG002|Overall Study|Not treated|0|||
155309881|NCT04521478|560569137|FG003|Overall Study|Not treated|0|||
155309882|NCT04521478|560569138|FG004|Overall Study|Not treated|0|||
155309883|NCT04521478|560569139|FG005|Overall Study|Not treated|1|||
155309884|NCT02187003|560569143|FG000|Overall Study|Adverse Event|2|||
155309885|NCT02187003|560569144|FG001|Overall Study|Adverse Event|0|||
155309886|NCT02187003|560569143|FG000|Overall Study|Lost to Follow-up|14|||
155309887|NCT02187003|560569144|FG001|Overall Study|Lost to Follow-up|10|||
155309888|NCT02187003|560569143|FG000|Overall Study|Withdrawal by Subject|3|||
155161332|NCT04455815|560028627|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
155309889|NCT02187003|560569144|FG001|Overall Study|Withdrawal by Subject|7|||
155309890|NCT02187003|560569143|FG000|Overall Study|Protocol Violation|2|||
155309891|NCT02187003|560569144|FG001|Overall Study|Protocol Violation|4|||
155309892|NCT02187003|560569143|FG000|Overall Study|Other|5|||
155309893|NCT02187003|560569144|FG001|Overall Study|Other|5|||
155309894|NCT02187003|560569143|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155309895|NCT02187003|560569144|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
155309896|NCT01195831|560569152|FG000|Overall Study|Lost to Follow-up|2|||
155309897|NCT01195831|560569153|FG001|Overall Study|Lost to Follow-up|4|||
155161333|NCT04455815|560028626|FG000|Treatment Phase|Withdrawal by Subject|1|||
155309898|NCT01195831|560569152|FG000|Overall Study|Withdrawal by Subject|2|||
155309899|NCT01195831|560569153|FG001|Overall Study|Withdrawal by Subject|2|||
155309900|NCT01195831|560569152|FG000|Overall Study|Adverse Event|4|||
155309901|NCT01195831|560569153|FG001|Overall Study|Adverse Event|2|||
155309902|NCT01195831|560569152|FG000|Overall Study|Protocol Violation|0|||
155309903|NCT01195831|560569153|FG001|Overall Study|Protocol Violation|2|||
155309904|NCT04725240|560569154|FG000|Overall Study|Adverse Event|2|||
155309905|NCT01140880|560569155|FG000|Overall Study|Death|0|||
155309906|NCT01140880|560569156|FG001|Overall Study|Death|1|||
155309907|NCT01140880|560569155|FG000|Overall Study|Withdrawal by Subject|6|||
155309908|NCT01140880|560569156|FG001|Overall Study|Withdrawal by Subject|3|||
155309909|NCT01140880|560569155|FG000|Overall Study|Lost to Follow-up|8|||
155309910|NCT01140880|560569156|FG001|Overall Study|Lost to Follow-up|10|||
155309911|NCT01140880|560569155|FG000|Overall Study|Protocol Violation|0|||
155309912|NCT01140880|560569156|FG001|Overall Study|Protocol Violation|30|||
155309913|NCT03779204|560569157|FG000|Overall Study|Lost to Follow-up|2|||
155309914|NCT03779204|560569158|FG001|Overall Study|Lost to Follow-up|0|||
155309915|NCT03958955|560569159|FG000|Overall Study|Adverse Event|1|||
155309916|NCT04673929|560569160|FG000|Overall Study|Death|73|||
155309917|NCT04673929|560569160|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
155309918|NCT05082909|560569161|FG000|Overall Study|Protocol Violation|0|||
155309919|NCT05082909|560569162|FG001|Overall Study|Protocol Violation|0|||
155309920|NCT05082909|560569163|FG002|Overall Study|Protocol Violation|1|||
155309921|NCT05082909|560569164|FG003|Overall Study|Protocol Violation|0|||
155309922|NCT05082909|560569165|FG004|Overall Study|Protocol Violation|0|||
155065919|NCT02696798|559672240|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
155065920|NCT02696798|559672241|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
155065921|NCT02696798|559672239|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
155065922|NCT02696798|559672240|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
155065923|NCT02696798|559672241|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
155065924|NCT02696798|559672239|FG000|Extended Treatment Period|Adverse Event|1|||
155065925|NCT02696798|559672240|FG001|Extended Treatment Period|Adverse Event|4|||
155065926|NCT02696798|559672241|FG002|Extended Treatment Period|Adverse Event|5|||
155065927|NCT02696798|559672239|FG000|Extended Treatment Period|Lack of Efficacy|7|||
155065928|NCT02696798|559672240|FG001|Extended Treatment Period|Lack of Efficacy|2|||
155065929|NCT02696798|559672241|FG002|Extended Treatment Period|Lack of Efficacy|2|||
155065930|NCT02696798|559672239|FG000|Extended Treatment Period|Lost to Follow-up|1|||
155065931|NCT02696798|559672240|FG001|Extended Treatment Period|Lost to Follow-up|0|||
155065932|NCT02696798|559672241|FG002|Extended Treatment Period|Lost to Follow-up|0|||
155065933|NCT02696798|559672239|FG000|Extended Treatment Period|Physician Decision|0|||
155065934|NCT02696798|559672240|FG001|Extended Treatment Period|Physician Decision|1|||
155065935|NCT02696798|559672241|FG002|Extended Treatment Period|Physician Decision|0|||
155065936|NCT02696798|559672239|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
155065937|NCT02696798|559672240|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
155065938|NCT02696798|559672241|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
155065939|NCT02696798|559672239|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
155065940|NCT02696798|559672240|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
155065941|NCT02696798|559672241|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
155065942|NCT02696798|559672239|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
155065943|NCT02696798|559672240|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
155065944|NCT02696798|559672241|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
155065945|NCT02696798|559672239|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
155065946|NCT02696798|559672240|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
155065947|NCT02696798|559672241|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
155065948|NCT02696798|559672239|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
155065949|NCT02696798|559672240|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
155065950|NCT02696798|559672241|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
155065951|NCT02696798|559672239|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
155065952|NCT02696798|559672240|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
155065953|NCT02696798|559672241|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
155065954|NCT02696798|559672239|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
155065955|NCT02696798|559672240|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
155065956|NCT02696798|559672241|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
155065957|NCT04091451|559672242|FG000|Overall Study|Adverse Event|15|||
155065958|NCT04091451|559672243|FG001|Overall Study|Adverse Event|10|||
155065959|NCT04091451|559672242|FG000|Overall Study|Lost to Follow-up|8|||
155065960|NCT04091451|559672243|FG001|Overall Study|Lost to Follow-up|8|||
155065961|NCT04091451|559672242|FG000|Overall Study|Protocol Violation|5|||
155065962|NCT04091451|559672243|FG001|Overall Study|Protocol Violation|4|||
155065963|NCT04091451|559672242|FG000|Overall Study|Withdrawal by Subject|21|||
155065964|NCT04091451|559672243|FG001|Overall Study|Withdrawal by Subject|27|||
155065965|NCT04091451|559672242|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
155065966|NCT04091451|559672243|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
155065967|NCT04091451|559672242|FG000|Overall Study|Migrated/moved from the study area|3|||
155065968|NCT04091451|559672243|FG001|Overall Study|Migrated/moved from the study area|5|||
155065969|NCT04091451|559672242|FG000|Overall Study|Suspected HZ episode|1|||
155309923|NCT05082909|560569166|FG005|Overall Study|Protocol Violation|0|||
155309924|NCT04088630|560569167|FG000|Overall Study|Lost to Follow-up|3|||
155309925|NCT04088630|560569168|FG001|Overall Study|Lost to Follow-up|2|||
155309926|NCT04088630|560569169|FG002|Overall Study|Lost to Follow-up|6|||
155309927|NCT04088630|560569167|FG000|Overall Study|Death|3|||
155309928|NCT04088630|560569168|FG001|Overall Study|Death|1|||
155309929|NCT04088630|560569169|FG002|Overall Study|Death|1|||
155309930|NCT04088630|560569167|FG000|Overall Study|Physician Decision|0|||
155309931|NCT04088630|560569168|FG001|Overall Study|Physician Decision|1|||
155309932|NCT04088630|560569169|FG002|Overall Study|Physician Decision|1|||
155309933|NCT04024813|560569172|FG000|Overall Study|Study terminated by Sponsor|1|||
155309934|NCT02729311|560569173|FG000|Overall Study|Withdrawal by Subject|8|||
155309935|NCT02729311|560569174|FG001|Overall Study|Withdrawal by Subject|2|||
155309936|NCT02287610|560569175|FG000|Overall Study|Lost to Follow-up|3|||
155161334|NCT04455815|560028627|FG001|Treatment Phase|Withdrawal by Subject|1|||
155161335|NCT02106390|560028628|FG000|Overall Study|Withdrawal by Subject|15|||
155161336|NCT02106390|560028629|FG001|Overall Study|Withdrawal by Subject|16|||
155161337|NCT02106390|560028630|FG002|Overall Study|Withdrawal by Subject|15|||
155161338|NCT02106390|560028628|FG000|Overall Study|Lost to Follow-up|25|||
155161339|NCT02106390|560028629|FG001|Overall Study|Lost to Follow-up|20|||
155161340|NCT02106390|560028630|FG002|Overall Study|Lost to Follow-up|13|||
155161341|NCT02106390|560028628|FG000|Overall Study|Other: Administrative Reason|8|||
155161342|NCT02106390|560028629|FG001|Overall Study|Other: Administrative Reason|5|||
155161343|NCT02106390|560028630|FG002|Overall Study|Other: Administrative Reason|12|||
155161344|NCT02106390|560028628|FG000|Overall Study|Other: Unspecified|1|||
155161345|NCT02106390|560028629|FG001|Overall Study|Other: Unspecified|4|||
155161346|NCT02106390|560028630|FG002|Overall Study|Other: Unspecified|2|||
155161347|NCT02106390|560028628|FG000|Overall Study|Adverse Event|0|||
155161348|NCT02106390|560028629|FG001|Overall Study|Adverse Event|2|||
155161349|NCT02106390|560028630|FG002|Overall Study|Adverse Event|1|||
155161350|NCT02106390|560028628|FG000|Overall Study|Protocol Violation|0|||
155161351|NCT02106390|560028629|FG001|Overall Study|Protocol Violation|1|||
155161352|NCT02106390|560028630|FG002|Overall Study|Protocol Violation|0|||
155161353|NCT03219528|560028631|FG000|Overall Study|Lost to Follow-up|5|||
155161354|NCT03219528|560028632|FG001|Overall Study|Lost to Follow-up|4|||
155161355|NCT03219528|560028631|FG000|Overall Study|Withdrawal by Subject|4|||
155161356|NCT03219528|560028632|FG001|Overall Study|Withdrawal by Subject|4|||
155161357|NCT00790842|560028633|FG000|Dose Level 1|Adverse Event|1|||
155161358|NCT00790842|560028634|FG001|Dose Level 1|Adverse Event|0|||
155161359|NCT00790842|560028635|FG002|Dose Level 1|Adverse Event|0|||
155161360|NCT00790842|560028636|FG003|Dose Level 1|Adverse Event|2|||
155161361|NCT00790842|560028637|FG004|Dose Level 1|Adverse Event|0|||
155161362|NCT00790842|560028638|FG005|Dose Level 1|Adverse Event|0|||
155161363|NCT00790842|560028639|FG006|Dose Level 1|Adverse Event|0|||
155161364|NCT00790842|560028640|FG007|Dose Level 1|Adverse Event|1|||
155161365|NCT00790842|560028641|FG008|Dose Level 1|Adverse Event|0|||
155161366|NCT00790842|560028642|FG009|Dose Level 1|Adverse Event|0|||
155161367|NCT00790842|560028643|FG010|Dose Level 1|Adverse Event|0|||
155161368|NCT00790842|560028633|FG000|Dose Level 1|Physician Decision|1|||
155161369|NCT00790842|560028634|FG001|Dose Level 1|Physician Decision|0|||
155161370|NCT00790842|560028635|FG002|Dose Level 1|Physician Decision|0|||
155161371|NCT00790842|560028636|FG003|Dose Level 1|Physician Decision|0|||
155161372|NCT00790842|560028637|FG004|Dose Level 1|Physician Decision|0|||
155161373|NCT00790842|560028638|FG005|Dose Level 1|Physician Decision|0|||
155161374|NCT00790842|560028639|FG006|Dose Level 1|Physician Decision|0|||
155161375|NCT00790842|560028640|FG007|Dose Level 1|Physician Decision|1|||
155161376|NCT00790842|560028641|FG008|Dose Level 1|Physician Decision|0|||
155161377|NCT00790842|560028642|FG009|Dose Level 1|Physician Decision|0|||
155161378|NCT00790842|560028643|FG010|Dose Level 1|Physician Decision|0|||
155161379|NCT00790842|560028633|FG000|Dose Level 1|Withdrawal by Subject|1|||
155161380|NCT00790842|560028634|FG001|Dose Level 1|Withdrawal by Subject|0|||
155309937|NCT02287610|560569175|FG000|Overall Study|Withdrawal by Subject|8|||
155309938|NCT02287610|560569175|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
155161381|NCT00790842|560028635|FG002|Dose Level 1|Withdrawal by Subject|0|||
155161382|NCT00790842|560028636|FG003|Dose Level 1|Withdrawal by Subject|0|||
155161383|NCT00790842|560028637|FG004|Dose Level 1|Withdrawal by Subject|0|||
155161384|NCT00790842|560028638|FG005|Dose Level 1|Withdrawal by Subject|0|||
155161385|NCT00790842|560028639|FG006|Dose Level 1|Withdrawal by Subject|0|||
155161386|NCT00790842|560028640|FG007|Dose Level 1|Withdrawal by Subject|0|||
155161387|NCT00790842|560028641|FG008|Dose Level 1|Withdrawal by Subject|0|||
155161388|NCT00790842|560028642|FG009|Dose Level 1|Withdrawal by Subject|0|||
155161389|NCT00790842|560028643|FG010|Dose Level 1|Withdrawal by Subject|0|||
155161390|NCT00790842|560028633|FG000|Dose Level 2|Death|0|||
155161391|NCT00790842|560028634|FG001|Dose Level 2|Death|1|||
155161392|NCT00790842|560028635|FG002|Dose Level 2|Death|0|||
155161393|NCT00790842|560028636|FG003|Dose Level 2|Death|0|||
155161394|NCT00790842|560028637|FG004|Dose Level 2|Death|1|||
155161395|NCT00790842|560028638|FG005|Dose Level 2|Death|0|||
155161396|NCT00790842|560028639|FG006|Dose Level 2|Death|0|||
155161397|NCT00790842|560028640|FG007|Dose Level 2|Death|0|||
155161398|NCT00790842|560028641|FG008|Dose Level 2|Death|0|||
155161399|NCT00790842|560028642|FG009|Dose Level 2|Death|0|||
155161400|NCT00790842|560028643|FG010|Dose Level 2|Death|0|||
155161401|NCT00790842|560028633|FG000|Dose Level 2|Physician Decision|0|||
155161402|NCT00790842|560028634|FG001|Dose Level 2|Physician Decision|1|||
155161403|NCT00790842|560028635|FG002|Dose Level 2|Physician Decision|0|||
155161404|NCT00790842|560028636|FG003|Dose Level 2|Physician Decision|0|||
155161405|NCT00790842|560028637|FG004|Dose Level 2|Physician Decision|0|||
155161406|NCT00790842|560028638|FG005|Dose Level 2|Physician Decision|0|||
155161407|NCT00790842|560028639|FG006|Dose Level 2|Physician Decision|0|||
155161408|NCT00790842|560028640|FG007|Dose Level 2|Physician Decision|0|||
155161409|NCT00790842|560028641|FG008|Dose Level 2|Physician Decision|0|||
155161410|NCT00790842|560028642|FG009|Dose Level 2|Physician Decision|0|||
155161411|NCT00790842|560028643|FG010|Dose Level 2|Physician Decision|0|||
155161412|NCT00790842|560028633|FG000|Dose Level 2|Withdrawal by Subject|0|||
155161413|NCT00790842|560028634|FG001|Dose Level 2|Withdrawal by Subject|1|||
155161414|NCT00790842|560028635|FG002|Dose Level 2|Withdrawal by Subject|0|||
155161415|NCT00790842|560028636|FG003|Dose Level 2|Withdrawal by Subject|0|||
155161416|NCT00790842|560028637|FG004|Dose Level 2|Withdrawal by Subject|0|||
155161417|NCT00790842|560028638|FG005|Dose Level 2|Withdrawal by Subject|0|||
155161418|NCT00790842|560028639|FG006|Dose Level 2|Withdrawal by Subject|0|||
155161419|NCT00790842|560028640|FG007|Dose Level 2|Withdrawal by Subject|0|||
155161420|NCT00790842|560028641|FG008|Dose Level 2|Withdrawal by Subject|0|||
155161421|NCT00790842|560028642|FG009|Dose Level 2|Withdrawal by Subject|0|||
155161422|NCT00790842|560028643|FG010|Dose Level 2|Withdrawal by Subject|0|||
155161423|NCT00790842|560028633|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161424|NCT00790842|560028634|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161425|NCT00790842|560028635|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161426|NCT00790842|560028636|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161427|NCT00790842|560028637|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161428|NCT00790842|560028638|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161429|NCT00790842|560028639|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161430|NCT00790842|560028640|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161431|NCT00790842|560028641|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
155161432|NCT00790842|560028642|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161433|NCT00790842|560028643|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
155161434|NCT00790842|560028633|FG000|Dose Level 3|Adverse Event|0|||
155161435|NCT00790842|560028634|FG001|Dose Level 3|Adverse Event|0|||
155161436|NCT00790842|560028635|FG002|Dose Level 3|Adverse Event|1|||
155161437|NCT00790842|560028636|FG003|Dose Level 3|Adverse Event|0|||
155161438|NCT00790842|560028637|FG004|Dose Level 3|Adverse Event|0|||
155161439|NCT00790842|560028638|FG005|Dose Level 3|Adverse Event|0|||
155161440|NCT00790842|560028639|FG006|Dose Level 3|Adverse Event|0|||
155161441|NCT00790842|560028640|FG007|Dose Level 3|Adverse Event|0|||
155161442|NCT00790842|560028641|FG008|Dose Level 3|Adverse Event|0|||
155161443|NCT00790842|560028642|FG009|Dose Level 3|Adverse Event|0|||
155161444|NCT00790842|560028643|FG010|Dose Level 3|Adverse Event|0|||
155161445|NCT00790842|560028633|FG000|Dose Level 3|Withdrawal by Subject|0|||
155161446|NCT00790842|560028634|FG001|Dose Level 3|Withdrawal by Subject|0|||
155161447|NCT00790842|560028635|FG002|Dose Level 3|Withdrawal by Subject|3|||
155161448|NCT00790842|560028636|FG003|Dose Level 3|Withdrawal by Subject|0|||
155161449|NCT00790842|560028637|FG004|Dose Level 3|Withdrawal by Subject|0|||
155161450|NCT00790842|560028638|FG005|Dose Level 3|Withdrawal by Subject|0|||
155161451|NCT00790842|560028639|FG006|Dose Level 3|Withdrawal by Subject|0|||
155161452|NCT00790842|560028640|FG007|Dose Level 3|Withdrawal by Subject|0|||
155161453|NCT00790842|560028641|FG008|Dose Level 3|Withdrawal by Subject|0|||
155161454|NCT00790842|560028642|FG009|Dose Level 3|Withdrawal by Subject|2|||
155161455|NCT00790842|560028643|FG010|Dose Level 3|Withdrawal by Subject|0|||
155161456|NCT00790842|560028633|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161457|NCT00790842|560028634|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161458|NCT00790842|560028635|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161459|NCT00790842|560028636|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161460|NCT00790842|560028637|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161461|NCT00790842|560028638|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
155161462|NCT00790842|560028639|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155309939|NCT06074523|560569176|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
155309940|NCT06074523|560569176|FG000|Overall Study|Withdrawal by Subject|1|||
155309941|NCT00512070|560569182|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
155309942|NCT00512070|560569183|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
155309943|NCT00512070|560569184|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
155309944|NCT00512070|560569182|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
155309945|NCT00512070|560569183|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
155309946|NCT00512070|560569184|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
155309947|NCT00961571|560569185|FG000|Overall Study|Physician Decision|39|||
155309948|NCT05862870|560569191|FG000|Overall Study|Lost to Follow-up|3|||
155309949|NCT04321031|560569192|FG000|Overall Study|Adverse Event|0|||
155309950|NCT04321031|560569193|FG001|Overall Study|Adverse Event|2|||
155309951|NCT04321031|560569194|FG002|Overall Study|Adverse Event|2|||
155309952|NCT04321031|560569195|FG003|Overall Study|Adverse Event|2|||
155309953|NCT04321031|560569196|FG004|Overall Study|Adverse Event|2|||
155309954|NCT04321031|560569197|FG005|Overall Study|Adverse Event|2|||
155309955|NCT04321031|560569198|FG006|Overall Study|Adverse Event|0|||
155309956|NCT04321031|560569192|FG000|Overall Study|Lost to Follow-up|0|||
155309957|NCT04321031|560569193|FG001|Overall Study|Lost to Follow-up|0|||
155309958|NCT04321031|560569194|FG002|Overall Study|Lost to Follow-up|0|||
155309959|NCT04321031|560569195|FG003|Overall Study|Lost to Follow-up|1|||
155309960|NCT04321031|560569196|FG004|Overall Study|Lost to Follow-up|0|||
155309961|NCT04321031|560569197|FG005|Overall Study|Lost to Follow-up|2|||
155309962|NCT04321031|560569198|FG006|Overall Study|Lost to Follow-up|1|||
155309963|NCT04321031|560569192|FG000|Overall Study|Withdrawal by Subject|2|||
155309964|NCT04321031|560569193|FG001|Overall Study|Withdrawal by Subject|2|||
155309965|NCT04321031|560569194|FG002|Overall Study|Withdrawal by Subject|1|||
155309966|NCT04321031|560569195|FG003|Overall Study|Withdrawal by Subject|3|||
155309967|NCT04321031|560569196|FG004|Overall Study|Withdrawal by Subject|1|||
155309968|NCT04321031|560569197|FG005|Overall Study|Withdrawal by Subject|0|||
155309969|NCT04321031|560569198|FG006|Overall Study|Withdrawal by Subject|1|||
155309970|NCT04321031|560569192|FG000|Overall Study|Non-compliance with study drug|0|||
155309971|NCT04321031|560569193|FG001|Overall Study|Non-compliance with study drug|0|||
155309972|NCT04321031|560569194|FG002|Overall Study|Non-compliance with study drug|0|||
155309973|NCT04321031|560569195|FG003|Overall Study|Non-compliance with study drug|0|||
155309974|NCT04321031|560569196|FG004|Overall Study|Non-compliance with study drug|0|||
155309975|NCT04321031|560569197|FG005|Overall Study|Non-compliance with study drug|1|||
155309976|NCT04321031|560569198|FG006|Overall Study|Non-compliance with study drug|0|||
155309977|NCT04321031|560569192|FG000|Overall Study|Other|0|||
155309978|NCT04321031|560569193|FG001|Overall Study|Other|0|||
155309979|NCT04321031|560569194|FG002|Overall Study|Other|0|||
155309980|NCT04321031|560569195|FG003|Overall Study|Other|1|||
155309981|NCT04321031|560569196|FG004|Overall Study|Other|0|||
155309982|NCT04321031|560569197|FG005|Overall Study|Other|0|||
155309983|NCT04321031|560569198|FG006|Overall Study|Other|0|||
155309984|NCT02900924|560569199|FG000|Overall Study|Death|52|||
155309985|NCT02900924|560569199|FG000|Overall Study|Lost to Follow-up|4|||
155309986|NCT02900924|560569199|FG000|Overall Study|Withdrawal by Subject|20|||
155309987|NCT02900924|560569199|FG000|Overall Study|Missed Visit|33|||
155309988|NCT03143153|560569202|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
155309989|NCT03143153|560569203|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
155309990|NCT03143153|560569204|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
155309991|NCT03143153|560569202|FG000|Pre-Treatment|Participant withdrew consent|0|||
155309992|NCT03143153|560569203|FG001|Pre-Treatment|Participant withdrew consent|1|||
155309993|NCT03143153|560569204|FG002|Pre-Treatment|Participant withdrew consent|12|||
155309994|NCT03143153|560569202|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
155309995|NCT03143153|560569203|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
155309996|NCT03143153|560569204|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
155309997|NCT03143153|560569202|FG000|Pre-Treatment|Other Reasons|1|||
155309998|NCT03143153|560569203|FG001|Pre-Treatment|Other Reasons|2|||
155309999|NCT03143153|560569204|FG002|Pre-Treatment|Other Reasons|1|||
155310000|NCT03143153|560569202|FG000|Pre-Treatment|Disease Progression|1|||
155310001|NCT03143153|560569203|FG001|Pre-Treatment|Disease Progression|1|||
155310002|NCT03143153|560569204|FG002|Pre-Treatment|Disease Progression|2|||
155310003|NCT03143153|560569202|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
155310004|NCT03143153|560569203|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
155310005|NCT03143153|560569204|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
155310006|NCT03143153|560569202|FG000|Treatment|Disease progression|174|||
155310007|NCT03143153|560569203|FG001|Treatment|Disease progression|184|||
155310008|NCT03143153|560569204|FG002|Treatment|Disease progression|193|||
155310009|NCT03143153|560569202|FG000|Treatment|Study drug toxicity|59|||
155310010|NCT03143153|560569203|FG001|Treatment|Study drug toxicity|33|||
155310011|NCT03143153|560569204|FG002|Treatment|Study drug toxicity|40|||
155310012|NCT03143153|560569202|FG000|Treatment|Death|5|||
155310013|NCT03143153|560569203|FG001|Treatment|Death|3|||
155310014|NCT03143153|560569204|FG002|Treatment|Death|4|||
155310015|NCT03143153|560569202|FG000|Treatment|Adverse event unrelated to study drug|19|||
155310016|NCT03143153|560569203|FG001|Treatment|Adverse event unrelated to study drug|28|||
155310017|NCT03143153|560569204|FG002|Treatment|Adverse event unrelated to study drug|12|||
155310018|NCT03143153|560569202|FG000|Treatment|Participant request to discontinue study treatment|13|||
155310019|NCT03143153|560569203|FG001|Treatment|Participant request to discontinue study treatment|15|||
155310020|NCT03143153|560569204|FG002|Treatment|Participant request to discontinue study treatment|20|||
155310021|NCT03143153|560569202|FG000|Treatment|Participant withdrew consent|3|||
155310022|NCT03143153|560569203|FG001|Treatment|Participant withdrew consent|4|||
155310023|NCT03143153|560569204|FG002|Treatment|Participant withdrew consent|12|||
155310024|NCT03143153|560569202|FG000|Treatment|Pregnancy|1|||
155310025|NCT03143153|560569203|FG001|Treatment|Pregnancy|0|||
155310026|NCT03143153|560569204|FG002|Treatment|Pregnancy|0|||
155310027|NCT03143153|560569202|FG000|Treatment|Maximum clinical benefit|1|||
155310028|NCT03143153|560569203|FG001|Treatment|Maximum clinical benefit|3|||
155310029|NCT03143153|560569204|FG002|Treatment|Maximum clinical benefit|4|||
155310030|NCT03143153|560569202|FG000|Treatment|Completed treatment as per Protocol|13|||
155310031|NCT03143153|560569203|FG001|Treatment|Completed treatment as per Protocol|8|||
155310032|NCT03143153|560569204|FG002|Treatment|Completed treatment as per Protocol|0|||
155310033|NCT03143153|560569202|FG000|Treatment|Other reasons|12|||
155310034|NCT03143153|560569203|FG001|Treatment|Other reasons|7|||
155310035|NCT03143153|560569204|FG002|Treatment|Other reasons|15|||
155310036|NCT03143153|560569202|FG000|Treatment|Not reported|1|||
155310037|NCT03143153|560569203|FG001|Treatment|Not reported|0|||
155310038|NCT03143153|560569204|FG002|Treatment|Not reported|0|||
155310039|NCT04237298|560569205|FG000|Overall Study|Lost to Follow-up|4|||
155310040|NCT04237298|560569206|FG001|Overall Study|Lost to Follow-up|5|||
155310041|NCT04556656|560569209|FG000|Overall Study|Withdrawal by Subject|14|||
155310042|NCT04556656|560569210|FG001|Overall Study|Withdrawal by Subject|12|||
155310043|NCT04556656|560569209|FG000|Overall Study|Physician Decision|1|||
155310044|NCT04556656|560569210|FG001|Overall Study|Physician Decision|0|||
155310045|NCT04556656|560569209|FG000|Overall Study|Adverse Event|4|||
155310046|NCT04556656|560569210|FG001|Overall Study|Adverse Event|7|||
155310047|NCT04556656|560569209|FG000|Overall Study|Death|4|||
155310048|NCT04556656|560569210|FG001|Overall Study|Death|0|||
155310049|NCT04556656|560569209|FG000|Overall Study|Lost to Follow-up|3|||
155310050|NCT04556656|560569210|FG001|Overall Study|Lost to Follow-up|2|||
155310051|NCT04556656|560569209|FG000|Overall Study|Not further specified|2|||
155310052|NCT04556656|560569210|FG001|Overall Study|Not further specified|1|||
155310053|NCT04541706|560569211|FG000|Overall Study|Withdrawal by Subject|3|||
155310054|NCT04541706|560569211|FG000|Overall Study|Progressive disease|33|||
155310055|NCT04541706|560569211|FG000|Overall Study|Physician Decision|1|||
155310056|NCT04541706|560569211|FG000|Overall Study|Lost to Follow-up|2|||
155310057|NCT04541706|560569211|FG000|Overall Study|Death|5|||
155310058|NCT04541706|560569211|FG000|Overall Study|Adverse Event|1|||
155310059|NCT05536440|560569212|FG000|Overall Study|Adverse Event|0|||
155310060|NCT05536440|560569213|FG001|Overall Study|Adverse Event|0|||
155310061|NCT05536440|560569214|FG002|Overall Study|Adverse Event|0|||
155310062|NCT05536440|560569215|FG003|Overall Study|Adverse Event|0|||
155310063|NCT05536440|560569216|FG004|Overall Study|Adverse Event|0|||
155310064|NCT05536440|560569217|FG005|Overall Study|Adverse Event|0|||
155310065|NCT05536440|560569218|FG006|Overall Study|Adverse Event|0|||
155310066|NCT05536440|560569219|FG007|Overall Study|Adverse Event|0|||
155310067|NCT05536440|560569220|FG008|Overall Study|Adverse Event|1|||
155310068|NCT01416831|560569223|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
155310069|NCT01416831|560569224|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
155310070|NCT04784559|560569225|FG000|Overall Study|Withdrawal by Subject|3|||
155310071|NCT04784559|560569226|FG001|Overall Study|Withdrawal by Subject|2|||
155310072|NCT04784559|560569227|FG002|Overall Study|Withdrawal by Subject|1|||
155310073|NCT04784559|560569225|FG000|Overall Study|Death|2|||
155310074|NCT04784559|560569226|FG001|Overall Study|Death|1|||
155310075|NCT04784559|560569227|FG002|Overall Study|Death|2|||
155310076|NCT04784559|560569225|FG000|Overall Study|Lost to Follow-up|0|||
155310077|NCT04784559|560569226|FG001|Overall Study|Lost to Follow-up|0|||
155310078|NCT04784559|560569227|FG002|Overall Study|Lost to Follow-up|2|||
155310079|NCT04784559|560569225|FG000|Overall Study|Participant worsened, PI decision|1|||
155310080|NCT04784559|560569226|FG001|Overall Study|Participant worsened, PI decision|0|||
155310081|NCT04784559|560569227|FG002|Overall Study|Participant worsened, PI decision|0|||
155310082|NCT04784559|560569225|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
155310083|NCT04784559|560569226|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
155310084|NCT04784559|560569227|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
155310085|NCT04784559|560569225|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
155310086|NCT04784559|560569226|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
155310087|NCT04784559|560569227|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
155310088|NCT04784559|560569225|FG000|Overall Study|Did not meet all inclusion criteria|0|||
155310089|NCT04784559|560569226|FG001|Overall Study|Did not meet all inclusion criteria|1|||
155310090|NCT04784559|560569227|FG002|Overall Study|Did not meet all inclusion criteria|0|||
155310091|NCT04784559|560569225|FG000|Overall Study|The participant was transferred to IRCU|0|||
155310092|NCT04784559|560569226|FG001|Overall Study|The participant was transferred to IRCU|1|||
155310093|NCT04784559|560569227|FG002|Overall Study|The participant was transferred to IRCU|0|||
155310094|NCT04784559|560569225|FG000|Overall Study|SAE|0|||
155310095|NCT04784559|560569226|FG001|Overall Study|SAE|1|||
155310096|NCT04784559|560569227|FG002|Overall Study|SAE|0|||
155310097|NCT04784559|560569225|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
155310098|NCT04784559|560569226|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
155310099|NCT04784559|560569227|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
155310100|NCT04588298|560569232|FG000|Overall Study|Adverse Event|0|||
155310101|NCT04588298|560569233|FG001|Overall Study|Adverse Event|0|||
155310102|NCT04588298|560569234|FG002|Overall Study|Adverse Event|1|||
155310103|NCT04588298|560569235|FG003|Overall Study|Adverse Event|0|||
155310104|NCT04588298|560569236|FG004|Overall Study|Adverse Event|2|||
155310105|NCT04588298|560569232|FG000|Overall Study|Withdrawal by Subject|1|||
155310106|NCT04588298|560569233|FG001|Overall Study|Withdrawal by Subject|0|||
155310107|NCT04588298|560569234|FG002|Overall Study|Withdrawal by Subject|0|||
155310108|NCT04588298|560569235|FG003|Overall Study|Withdrawal by Subject|1|||
155310109|NCT04588298|560569236|FG004|Overall Study|Withdrawal by Subject|0|||
155310110|NCT04021602|560569241|FG000|Overall Study|Lost to Follow-up|3|||
155310111|NCT04021602|560569242|FG001|Overall Study|Lost to Follow-up|3|||
155310112|NCT04021602|560569243|FG002|Overall Study|Lost to Follow-up|1|||
155310113|NCT04021602|560569241|FG000|Overall Study|Adverse Event|1|||
155310114|NCT04021602|560569242|FG001|Overall Study|Adverse Event|0|||
155310115|NCT04021602|560569243|FG002|Overall Study|Adverse Event|1|||
155310116|NCT03892616|560569244|FG000|Washout Period 2|Met discontinuation criterion|0|||
155310117|NCT03892616|560569245|FG001|Washout Period 2|Met discontinuation criterion|0|||
155310118|NCT03892616|560569246|FG002|Washout Period 2|Met discontinuation criterion|0|||
155310119|NCT03892616|560569247|FG003|Washout Period 2|Met discontinuation criterion|0|||
155310120|NCT03892616|560569248|FG004|Washout Period 2|Met discontinuation criterion|0|||
155310121|NCT03892616|560569249|FG005|Washout Period 2|Met discontinuation criterion|0|||
155310122|NCT03892616|560569250|FG006|Washout Period 2|Met discontinuation criterion|0|||
155310123|NCT03892616|560569251|FG007|Washout Period 2|Met discontinuation criterion|0|||
155310124|NCT03892616|560569252|FG008|Washout Period 2|Met discontinuation criterion|1|||
155310125|NCT03892616|560569253|FG009|Washout Period 2|Met discontinuation criterion|0|||
155310126|NCT03892616|560569254|FG010|Washout Period 2|Met discontinuation criterion|0|||
155310127|NCT03892616|560569255|FG011|Washout Period 2|Met discontinuation criterion|0|||
155310128|NCT02243709|560569256|FG000|Phase 1|Lost to Follow-up|0|||
155310129|NCT02243709|560569257|FG001|Phase 1|Lost to Follow-up|1|||
155310130|NCT02243709|560569256|FG000|Phase 1|Withdrawal by Subject|1|||
155310131|NCT02243709|560569257|FG001|Phase 1|Withdrawal by Subject|0|||
155310132|NCT02243709|560569256|FG000|Phase 1|Protocol Violation|0|||
155310133|NCT02243709|560569257|FG001|Phase 1|Protocol Violation|1|||
155310134|NCT02243709|560569256|FG000|Phase 1|Adverse Event|0|||
155310135|NCT02243709|560569257|FG001|Phase 1|Adverse Event|1|||
155310136|NCT03683719|560569258|FG000|Overall Study|Lack of Efficacy|1|||
155310137|NCT03683719|560569259|FG001|Overall Study|Lack of Efficacy|3|||
155310138|NCT03683719|560569260|FG002|Overall Study|Lack of Efficacy|4|||
155310139|NCT03683719|560569261|FG003|Overall Study|Lack of Efficacy|0|||
155310140|NCT03683719|560569262|FG004|Overall Study|Lack of Efficacy|4|||
155310141|NCT03683719|560569258|FG000|Overall Study|Adverse Event|6|||
155310142|NCT03683719|560569259|FG001|Overall Study|Adverse Event|6|||
155310143|NCT03683719|560569260|FG002|Overall Study|Adverse Event|0|||
155310144|NCT03683719|560569261|FG003|Overall Study|Adverse Event|1|||
155310145|NCT03683719|560569262|FG004|Overall Study|Adverse Event|3|||
155310146|NCT03683719|560569258|FG000|Overall Study|Withdrawal by Subject|4|||
155310147|NCT03683719|560569259|FG001|Overall Study|Withdrawal by Subject|4|||
155310148|NCT03683719|560569260|FG002|Overall Study|Withdrawal by Subject|3|||
155310149|NCT03683719|560569261|FG003|Overall Study|Withdrawal by Subject|5|||
155161463|NCT00790842|560028640|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161464|NCT00790842|560028641|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155310150|NCT03683719|560569262|FG004|Overall Study|Withdrawal by Subject|5|||
155310151|NCT03683719|560569258|FG000|Overall Study|Lost to Follow-up|1|||
155310152|NCT03683719|560569259|FG001|Overall Study|Lost to Follow-up|0|||
155310153|NCT03683719|560569260|FG002|Overall Study|Lost to Follow-up|0|||
155310154|NCT03683719|560569261|FG003|Overall Study|Lost to Follow-up|1|||
155310155|NCT03683719|560569262|FG004|Overall Study|Lost to Follow-up|1|||
155310156|NCT03683719|560569258|FG000|Overall Study|Other personal reasons|0|||
155310157|NCT03683719|560569259|FG001|Overall Study|Other personal reasons|0|||
155161465|NCT00790842|560028642|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161466|NCT00790842|560028643|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
155161467|NCT00790842|560028633|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161468|NCT00790842|560028634|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161469|NCT00790842|560028635|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
155161470|NCT00790842|560028636|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161471|NCT00790842|560028637|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161472|NCT00790842|560028638|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161473|NCT00790842|560028639|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161474|NCT00790842|560028640|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161475|NCT00790842|560028641|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161476|NCT00790842|560028642|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161477|NCT00790842|560028643|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
155161478|NCT00790842|560028633|FG000|Dose Level 4|Adverse Event|0|||
155161479|NCT00790842|560028634|FG001|Dose Level 4|Adverse Event|0|||
155161480|NCT00790842|560028635|FG002|Dose Level 4|Adverse Event|0|||
155161481|NCT00790842|560028636|FG003|Dose Level 4|Adverse Event|0|||
155161482|NCT00790842|560028637|FG004|Dose Level 4|Adverse Event|0|||
155161483|NCT00790842|560028638|FG005|Dose Level 4|Adverse Event|0|||
155161484|NCT00790842|560028639|FG006|Dose Level 4|Adverse Event|1|||
155161485|NCT00790842|560028640|FG007|Dose Level 4|Adverse Event|0|||
155161486|NCT00790842|560028641|FG008|Dose Level 4|Adverse Event|0|||
155161487|NCT00790842|560028642|FG009|Dose Level 4|Adverse Event|0|||
155161488|NCT00790842|560028643|FG010|Dose Level 4|Adverse Event|0|||
155161489|NCT00790842|560028633|FG000|Dose Level 4|Physician Decision|0|||
155161490|NCT00790842|560028634|FG001|Dose Level 4|Physician Decision|0|||
155161491|NCT00790842|560028635|FG002|Dose Level 4|Physician Decision|0|||
155161492|NCT00790842|560028636|FG003|Dose Level 4|Physician Decision|0|||
155161493|NCT00790842|560028637|FG004|Dose Level 4|Physician Decision|0|||
155161494|NCT00790842|560028638|FG005|Dose Level 4|Physician Decision|0|||
155161495|NCT00790842|560028639|FG006|Dose Level 4|Physician Decision|1|||
155161496|NCT00790842|560028640|FG007|Dose Level 4|Physician Decision|0|||
155161497|NCT00790842|560028641|FG008|Dose Level 4|Physician Decision|0|||
155161498|NCT00790842|560028642|FG009|Dose Level 4|Physician Decision|0|||
155161499|NCT00790842|560028643|FG010|Dose Level 4|Physician Decision|1|||
155161500|NCT00790842|560028633|FG000|Dose Level 4|Withdrawal by Subject|0|||
155161501|NCT00790842|560028634|FG001|Dose Level 4|Withdrawal by Subject|0|||
155161502|NCT00790842|560028635|FG002|Dose Level 4|Withdrawal by Subject|0|||
155161503|NCT00790842|560028636|FG003|Dose Level 4|Withdrawal by Subject|0|||
155161504|NCT00790842|560028637|FG004|Dose Level 4|Withdrawal by Subject|0|||
155161505|NCT00790842|560028638|FG005|Dose Level 4|Withdrawal by Subject|0|||
155161506|NCT00790842|560028639|FG006|Dose Level 4|Withdrawal by Subject|0|||
155161507|NCT00790842|560028640|FG007|Dose Level 4|Withdrawal by Subject|0|||
155161508|NCT00790842|560028641|FG008|Dose Level 4|Withdrawal by Subject|0|||
155161509|NCT00790842|560028642|FG009|Dose Level 4|Withdrawal by Subject|0|||
155161510|NCT00790842|560028643|FG010|Dose Level 4|Withdrawal by Subject|1|||
155161511|NCT00790842|560028633|FG000|Expansion Cohort|Adverse Event|0|||
155161512|NCT00790842|560028634|FG001|Expansion Cohort|Adverse Event|0|||
155161513|NCT00790842|560028635|FG002|Expansion Cohort|Adverse Event|0|||
155161514|NCT00790842|560028636|FG003|Expansion Cohort|Adverse Event|0|||
155161515|NCT00790842|560028637|FG004|Expansion Cohort|Adverse Event|0|||
155161516|NCT00790842|560028638|FG005|Expansion Cohort|Adverse Event|0|||
155161517|NCT00790842|560028639|FG006|Expansion Cohort|Adverse Event|1|||
155161518|NCT00790842|560028640|FG007|Expansion Cohort|Adverse Event|0|||
155161519|NCT00790842|560028641|FG008|Expansion Cohort|Adverse Event|0|||
155161520|NCT00790842|560028642|FG009|Expansion Cohort|Adverse Event|0|||
155161521|NCT00790842|560028643|FG010|Expansion Cohort|Adverse Event|0|||
155161522|NCT00790842|560028633|FG000|Expansion Cohort|Death|0|||
155161523|NCT00790842|560028634|FG001|Expansion Cohort|Death|0|||
155161524|NCT00790842|560028635|FG002|Expansion Cohort|Death|2|||
154959613|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155161525|NCT00790842|560028636|FG003|Expansion Cohort|Death|0|||
155161526|NCT00790842|560028637|FG004|Expansion Cohort|Death|0|||
155161527|NCT00790842|560028638|FG005|Expansion Cohort|Death|0|||
155161528|NCT00790842|560028639|FG006|Expansion Cohort|Death|0|||
155161529|NCT00790842|560028640|FG007|Expansion Cohort|Death|0|||
155161530|NCT00790842|560028641|FG008|Expansion Cohort|Death|0|||
155161531|NCT00790842|560028642|FG009|Expansion Cohort|Death|0|||
155161532|NCT00790842|560028643|FG010|Expansion Cohort|Death|0|||
155161533|NCT00790842|560028633|FG000|Expansion Cohort|Physician Decision|0|||
155161534|NCT00790842|560028634|FG001|Expansion Cohort|Physician Decision|0|||
155161535|NCT00790842|560028635|FG002|Expansion Cohort|Physician Decision|1|||
155161536|NCT00790842|560028636|FG003|Expansion Cohort|Physician Decision|0|||
155065970|NCT04091451|559672243|FG001|Overall Study|Suspected HZ episode|0|||
155065971|NCT01963611|559673767|FG000|Overall Study|Adverse Event|1|||
155065972|NCT01963611|559673768|FG001|Overall Study|Adverse Event|1|||
155065973|NCT01963611|559673769|FG002|Overall Study|Adverse Event|3|||
155310158|NCT03683719|560569260|FG002|Overall Study|Other personal reasons|1|||
155065974|NCT01963611|559673770|FG003|Overall Study|Adverse Event|4|||
155065975|NCT01963611|559673771|FG004|Overall Study|Adverse Event|3|||
155065976|NCT01963611|559673767|FG000|Overall Study|Protocol Violation|0|||
155065977|NCT01963611|559673768|FG001|Overall Study|Protocol Violation|0|||
155065978|NCT01963611|559673769|FG002|Overall Study|Protocol Violation|0|||
155065979|NCT01963611|559673770|FG003|Overall Study|Protocol Violation|1|||
155065980|NCT01963611|559673771|FG004|Overall Study|Protocol Violation|0|||
155065981|NCT01963611|559673767|FG000|Overall Study|Lack of Efficacy|0|||
155065982|NCT01963611|559673768|FG001|Overall Study|Lack of Efficacy|0|||
155065983|NCT01963611|559673769|FG002|Overall Study|Lack of Efficacy|0|||
155065984|NCT01963611|559673770|FG003|Overall Study|Lack of Efficacy|1|||
155065985|NCT01963611|559673771|FG004|Overall Study|Lack of Efficacy|0|||
155065986|NCT01963611|559673767|FG000|Overall Study|Withdrawal by Subject|3|||
155065987|NCT01963611|559673768|FG001|Overall Study|Withdrawal by Subject|2|||
155065988|NCT01963611|559673769|FG002|Overall Study|Withdrawal by Subject|1|||
155065989|NCT01963611|559673770|FG003|Overall Study|Withdrawal by Subject|1|||
155065990|NCT01963611|559673771|FG004|Overall Study|Withdrawal by Subject|3|||
155065991|NCT01963611|559673767|FG000|Overall Study|Other|47|||
155065992|NCT01963611|559673768|FG001|Overall Study|Other|46|||
155065993|NCT01963611|559673769|FG002|Overall Study|Other|48|||
155065994|NCT01963611|559673770|FG003|Overall Study|Other|45|||
155065995|NCT01963611|559673771|FG004|Overall Study|Other|45|||
155065996|NCT01126424|559673773|FG000|Overall Study|Adverse Event|0|||
155065997|NCT01126424|559673774|FG001|Overall Study|Adverse Event|0|||
155065998|NCT01126424|559673775|FG002|Overall Study|Adverse Event|0|||
155065999|NCT01126424|559673776|FG003|Overall Study|Adverse Event|0|||
155066000|NCT01126424|559673777|FG004|Overall Study|Adverse Event|1|||
155066001|NCT01126424|559673778|FG005|Overall Study|Adverse Event|0|||
155066002|NCT01126424|559673773|FG000|Overall Study|Withdrawal by Subject|0|||
155066003|NCT01126424|559673774|FG001|Overall Study|Withdrawal by Subject|0|||
155066004|NCT01126424|559673775|FG002|Overall Study|Withdrawal by Subject|1|||
155066005|NCT01126424|559673776|FG003|Overall Study|Withdrawal by Subject|3|||
155066006|NCT01126424|559673777|FG004|Overall Study|Withdrawal by Subject|1|||
155066007|NCT01126424|559673778|FG005|Overall Study|Withdrawal by Subject|0|||
155066008|NCT02127671|559673779|FG000|Overall Study|Death|2|||
155066009|NCT02127671|559673780|FG001|Overall Study|Death|2|||
155066010|NCT02127671|559673779|FG000|Overall Study|Lost to Follow-up|4|||
155066011|NCT02127671|559673780|FG001|Overall Study|Lost to Follow-up|2|||
155066012|NCT02127671|559673779|FG000|Overall Study|Physician Decision|1|||
155066013|NCT02127671|559673780|FG001|Overall Study|Physician Decision|0|||
155066014|NCT02127671|559673779|FG000|Overall Study|incarceration|0|||
155066015|NCT02127671|559673780|FG001|Overall Study|incarceration|1|||
155066016|NCT02127671|559673779|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
155066017|NCT02127671|559673780|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
155066018|NCT00614393|559673782|FG000|Overall Study|Adverse Event|20|||
155066019|NCT00614393|559673783|FG001|Overall Study|Adverse Event|2|||
155066020|NCT00614393|559673784|FG002|Overall Study|Adverse Event|3|||
155066021|NCT00614393|559673785|FG003|Overall Study|Adverse Event|13|||
155066022|NCT00614393|559673786|FG004|Overall Study|Adverse Event|21|||
155066023|NCT00614393|559673782|FG000|Overall Study|Lost to Follow-up|0|||
155066024|NCT00614393|559673783|FG001|Overall Study|Lost to Follow-up|0|||
155066025|NCT00614393|559673784|FG002|Overall Study|Lost to Follow-up|0|||
155066026|NCT00614393|559673785|FG003|Overall Study|Lost to Follow-up|1|||
155066027|NCT00614393|559673786|FG004|Overall Study|Lost to Follow-up|2|||
155066028|NCT00614393|559673782|FG000|Overall Study|Physician Decision|17|||
155066029|NCT00614393|559673783|FG001|Overall Study|Physician Decision|0|||
155066030|NCT00614393|559673784|FG002|Overall Study|Physician Decision|1|||
155066031|NCT00614393|559673785|FG003|Overall Study|Physician Decision|8|||
155066032|NCT00614393|559673786|FG004|Overall Study|Physician Decision|9|||
155066033|NCT00614393|559673782|FG000|Overall Study|Progressive Disease|118|||
155066034|NCT00614393|559673783|FG001|Overall Study|Progressive Disease|5|||
155066035|NCT00614393|559673784|FG002|Overall Study|Progressive Disease|5|||
155066036|NCT00614393|559673785|FG003|Overall Study|Progressive Disease|138|||
155066037|NCT00614393|559673786|FG004|Overall Study|Progressive Disease|130|||
155066038|NCT00614393|559673782|FG000|Overall Study|Protocol Violation|1|||
155066039|NCT00614393|559673783|FG001|Overall Study|Protocol Violation|0|||
155066040|NCT00614393|559673784|FG002|Overall Study|Protocol Violation|0|||
155066041|NCT00614393|559673785|FG003|Overall Study|Protocol Violation|0|||
155066042|NCT00614393|559673786|FG004|Overall Study|Protocol Violation|0|||
155066043|NCT00614393|559673782|FG000|Overall Study|Terminated by Sponsor|0|||
155066044|NCT00614393|559673783|FG001|Overall Study|Terminated by Sponsor|0|||
155310159|NCT03683719|560569261|FG003|Overall Study|Other personal reasons|0|||
155066045|NCT00614393|559673784|FG002|Overall Study|Terminated by Sponsor|0|||
155066046|NCT00614393|559673785|FG003|Overall Study|Terminated by Sponsor|0|||
155066047|NCT00614393|559673786|FG004|Overall Study|Terminated by Sponsor|1|||
155310160|NCT03683719|560569262|FG004|Overall Study|Other personal reasons|1|||
155310161|NCT02689284|560569263|FG000|Overall Study|Adverse Event|1|||
155310162|NCT02689284|560569264|FG001|Overall Study|Adverse Event|8|||
155310163|NCT02689284|560569263|FG000|Overall Study|Death|0|||
155310164|NCT02689284|560569264|FG001|Overall Study|Death|1|||
155310165|NCT02689284|560569263|FG000|Overall Study|Physician Decision|1|||
155310166|NCT02689284|560569264|FG001|Overall Study|Physician Decision|2|||
155310167|NCT02689284|560569263|FG000|Overall Study|Withdrawal by Subject|0|||
155310168|NCT02689284|560569264|FG001|Overall Study|Withdrawal by Subject|1|||
155310169|NCT02689284|560569263|FG000|Overall Study|progression of cancer|1|||
155310170|NCT02689284|560569264|FG001|Overall Study|progression of cancer|72|||
155310171|NCT02689284|560569263|FG000|Overall Study|decreased heart function|0|||
155310172|NCT02689284|560569264|FG001|Overall Study|decreased heart function|1|||
155310173|NCT02689284|560569263|FG000|Overall Study|concern for anemia|0|||
155310174|NCT02689284|560569264|FG001|Overall Study|concern for anemia|1|||
155310175|NCT02689284|560569263|FG000|Overall Study|no measurable cancer for evaluation|0|||
155310176|NCT02689284|560569264|FG001|Overall Study|no measurable cancer for evaluation|1|||
155310177|NCT05569252|560569265|FG000|Overall Study|Adverse event (central vision loss)|1|||
155310178|NCT05569252|560569266|FG001|Overall Study|Adverse event (central vision loss)|0|||
155310179|NCT05569252|560569267|FG002|Overall Study|Adverse event (central vision loss)|0|||
155310180|NCT05569252|560569268|FG003|Overall Study|Adverse event (central vision loss)|0|||
155310181|NCT03665597|560569269|FG000|Period 1|Adverse Event|1|||
155310182|NCT03665597|560569270|FG001|Period 1|Adverse Event|0|||
155310183|NCT03665597|560569271|FG002|Period 1|Adverse Event|0|||
155310184|NCT03665597|560569272|FG003|Period 1|Adverse Event|1|||
155310185|NCT03665597|560569273|FG004|Period 1|Adverse Event|0|||
155310186|NCT03665597|560569274|FG005|Period 1|Adverse Event|0|||
155310187|NCT03665597|560569275|FG006|Period 1|Adverse Event|0|||
155310188|NCT03665597|560569269|FG000|Period 1|Screen Failure|0|||
155310189|NCT03665597|560569270|FG001|Period 1|Screen Failure|0|||
155310190|NCT03665597|560569271|FG002|Period 1|Screen Failure|0|||
155310191|NCT03665597|560569272|FG003|Period 1|Screen Failure|1|||
155310192|NCT03665597|560569273|FG004|Period 1|Screen Failure|0|||
155310193|NCT03665597|560569274|FG005|Period 1|Screen Failure|0|||
155310194|NCT03665597|560569275|FG006|Period 1|Screen Failure|0|||
155310195|NCT03665597|560569269|FG000|Period 1|Death|0|||
155310196|NCT03665597|560569270|FG001|Period 1|Death|0|||
155310197|NCT03665597|560569271|FG002|Period 1|Death|0|||
155310198|NCT03665597|560569272|FG003|Period 1|Death|0|||
155310199|NCT03665597|560569273|FG004|Period 1|Death|0|||
155310200|NCT03665597|560569274|FG005|Period 1|Death|0|||
155310201|NCT03665597|560569275|FG006|Period 1|Death|45|||
155161537|NCT00790842|560028637|FG004|Expansion Cohort|Physician Decision|0|||
155310202|NCT03665597|560569269|FG000|Period 1|Withdrawal by Subject|0|||
155310203|NCT03665597|560569270|FG001|Period 1|Withdrawal by Subject|0|||
155310204|NCT03665597|560569271|FG002|Period 1|Withdrawal by Subject|0|||
155310205|NCT03665597|560569272|FG003|Period 1|Withdrawal by Subject|0|||
155310206|NCT03665597|560569273|FG004|Period 1|Withdrawal by Subject|0|||
155310207|NCT03665597|560569274|FG005|Period 1|Withdrawal by Subject|0|||
155310208|NCT03665597|560569275|FG006|Period 1|Withdrawal by Subject|5|||
155310209|NCT03665597|560569269|FG000|Period 2|Adverse Event|0|||
155161538|NCT00790842|560028638|FG005|Expansion Cohort|Physician Decision|0|||
155161539|NCT00790842|560028639|FG006|Expansion Cohort|Physician Decision|0|||
155161540|NCT00790842|560028640|FG007|Expansion Cohort|Physician Decision|0|||
155161541|NCT00790842|560028641|FG008|Expansion Cohort|Physician Decision|0|||
155161542|NCT00790842|560028642|FG009|Expansion Cohort|Physician Decision|0|||
155161543|NCT00790842|560028643|FG010|Expansion Cohort|Physician Decision|0|||
154959614|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959615|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959616|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959617|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155161544|NCT00790842|560028633|FG000|Expansion Cohort|Withdrawal by Subject|0|||
155161545|NCT00790842|560028634|FG001|Expansion Cohort|Withdrawal by Subject|0|||
155161546|NCT00790842|560028635|FG002|Expansion Cohort|Withdrawal by Subject|3|||
155161547|NCT00790842|560028636|FG003|Expansion Cohort|Withdrawal by Subject|0|||
155161548|NCT00790842|560028637|FG004|Expansion Cohort|Withdrawal by Subject|0|||
155161549|NCT00790842|560028638|FG005|Expansion Cohort|Withdrawal by Subject|0|||
155161550|NCT00790842|560028639|FG006|Expansion Cohort|Withdrawal by Subject|0|||
155161551|NCT00790842|560028640|FG007|Expansion Cohort|Withdrawal by Subject|0|||
155161552|NCT00790842|560028641|FG008|Expansion Cohort|Withdrawal by Subject|0|||
155161553|NCT00790842|560028642|FG009|Expansion Cohort|Withdrawal by Subject|0|||
155161554|NCT00790842|560028643|FG010|Expansion Cohort|Withdrawal by Subject|0|||
155161555|NCT00790842|560028633|FG000|Expansion Cohort|Study Closure|0|||
155161556|NCT00790842|560028634|FG001|Expansion Cohort|Study Closure|0|||
154959618|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959619|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
154959620|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
154959621|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959622|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959623|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155161557|NCT00790842|560028635|FG002|Expansion Cohort|Study Closure|1|||
155161558|NCT00790842|560028636|FG003|Expansion Cohort|Study Closure|0|||
155161559|NCT00790842|560028637|FG004|Expansion Cohort|Study Closure|0|||
155161560|NCT00790842|560028638|FG005|Expansion Cohort|Study Closure|0|||
155161561|NCT00790842|560028639|FG006|Expansion Cohort|Study Closure|0|||
155310210|NCT03665597|560569270|FG001|Period 2|Adverse Event|0|||
155310211|NCT03665597|560569271|FG002|Period 2|Adverse Event|0|||
155310212|NCT03665597|560569272|FG003|Period 2|Adverse Event|0|||
155310213|NCT03665597|560569273|FG004|Period 2|Adverse Event|0|||
155310214|NCT03665597|560569274|FG005|Period 2|Adverse Event|1|||
155310215|NCT03665597|560569275|FG006|Period 2|Adverse Event|0|||
155310216|NCT03665597|560569269|FG000|Period 3|Adverse Event|0|||
155310217|NCT03665597|560569270|FG001|Period 3|Adverse Event|1|||
155310218|NCT03665597|560569271|FG002|Period 3|Adverse Event|0|||
155310219|NCT03665597|560569272|FG003|Period 3|Adverse Event|0|||
155310220|NCT03665597|560569273|FG004|Period 3|Adverse Event|0|||
155310221|NCT03665597|560569274|FG005|Period 3|Adverse Event|0|||
155066048|NCT00614393|559673782|FG000|Overall Study|Withdrawal by Subject|20|||
155066049|NCT00614393|559673783|FG001|Overall Study|Withdrawal by Subject|1|||
155066050|NCT00614393|559673784|FG002|Overall Study|Withdrawal by Subject|1|||
155066051|NCT00614393|559673785|FG003|Overall Study|Withdrawal by Subject|16|||
155066052|NCT00614393|559673786|FG004|Overall Study|Withdrawal by Subject|13|||
155066053|NCT00614393|559673782|FG000|Overall Study|Other|4|||
155066054|NCT00614393|559673783|FG001|Overall Study|Other|0|||
155066055|NCT00614393|559673784|FG002|Overall Study|Other|0|||
155066056|NCT00614393|559673785|FG003|Overall Study|Other|4|||
155066057|NCT00614393|559673786|FG004|Overall Study|Other|2|||
155066058|NCT00614393|559673782|FG000|Overall Study|Not Treated|0|||
155066059|NCT00614393|559673783|FG001|Overall Study|Not Treated|0|||
155066060|NCT00614393|559673784|FG002|Overall Study|Not Treated|0|||
155066061|NCT00614393|559673785|FG003|Overall Study|Not Treated|0|||
155066062|NCT00614393|559673786|FG004|Overall Study|Not Treated|2|||
155066063|NCT02328105|559673787|FG000|Overall Study|Death|6|||
155066064|NCT02328105|559673787|FG000|Overall Study|Withdrawal by Subject|1|||
155066065|NCT02328105|559673787|FG000|Overall Study|Still On Study in Follow-Up|4|||
155066066|NCT03813654|559673788|FG000|Overall Study|Protocol Violation|0|||
155066067|NCT03813654|559673789|FG001|Overall Study|Protocol Violation|1|||
155066068|NCT03813654|559673790|FG002|Overall Study|Protocol Violation|2|||
155066069|NCT03813654|559673788|FG000|Overall Study|Withdrawal by Subject|1|||
155066070|NCT03813654|559673789|FG001|Overall Study|Withdrawal by Subject|0|||
155066071|NCT03813654|559673790|FG002|Overall Study|Withdrawal by Subject|0|||
155066072|NCT00984867|559673791|FG000|Overall Study|Adverse Event|3|||
155066073|NCT00984867|559673792|FG001|Overall Study|Adverse Event|7|||
155066074|NCT00984867|559673791|FG000|Overall Study|Death|1|||
155066075|NCT00984867|559673792|FG001|Overall Study|Death|0|||
155066076|NCT00984867|559673791|FG000|Overall Study|Withdrawal by Subject|13|||
155066077|NCT00984867|559673792|FG001|Overall Study|Withdrawal by Subject|4|||
155066078|NCT00984867|559673791|FG000|Overall Study|Lost to Follow-up|3|||
155066079|NCT00984867|559673792|FG001|Overall Study|Lost to Follow-up|4|||
155066080|NCT00984867|559673791|FG000|Overall Study|Poor/non-compliance|0|||
155066081|NCT00984867|559673792|FG001|Overall Study|Poor/non-compliance|1|||
155066082|NCT00984867|559673791|FG000|Overall Study|Subject no longer meets study criteria|1|||
155066083|NCT00984867|559673792|FG001|Overall Study|Subject no longer meets study criteria|1|||
155066084|NCT00984867|559673791|FG000|Overall Study|site closing|1|||
155066085|NCT00984867|559673792|FG001|Overall Study|site closing|0|||
155066086|NCT00984867|559673791|FG000|Overall Study|lack of efficacy and subject compliance|1|||
155066087|NCT00984867|559673792|FG001|Overall Study|lack of efficacy and subject compliance|0|||
155066088|NCT00626639|559673793|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
155066089|NCT00626639|559673794|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
155066090|NCT01461551|559673795|FG000|Overall Study|Physician Decision|2|||
155066091|NCT01461551|559673796|FG001|Overall Study|Physician Decision|1|||
155066092|NCT01461551|559673797|FG002|Overall Study|Physician Decision|2|||
155066093|NCT01155141|559673798|FG000|Overall Study|Withdrawal by Subject|1|||
155066094|NCT01155141|559673798|FG000|Overall Study|Screen Failure|1|||
155066095|NCT00303186|559673799|FG000|Overall Study|Other|52|||
155066096|NCT02020941|559673800|FG000|Overall Study|Adverse Event|1|||
155066097|NCT02020941|559673800|FG000|Overall Study|Physician Decision|2|||
155310222|NCT03665597|560569275|FG006|Period 3|Adverse Event|0|||
155310223|NCT03665597|560569269|FG000|Period 3|Death|0|||
155310224|NCT03665597|560569270|FG001|Period 3|Death|0|||
155066098|NCT02020941|559673800|FG000|Overall Study|Withdrawal by Subject|1|||
155066099|NCT02020941|559673800|FG000|Overall Study|Disease Progression|4|||
155066100|NCT02469857|559673802|FG000|Overall Study|Death|24|||
155066101|NCT02469857|559673803|FG001|Overall Study|Death|29|||
155066102|NCT02469857|559673802|FG000|Overall Study|Discontinuation|1|||
155066103|NCT02469857|559673803|FG001|Overall Study|Discontinuation|3|||
155310225|NCT03665597|560569271|FG002|Period 3|Death|0|||
155310226|NCT03665597|560569272|FG003|Period 3|Death|0|||
155310227|NCT03665597|560569273|FG004|Period 3|Death|1|||
155310228|NCT03665597|560569274|FG005|Period 3|Death|0|||
155310229|NCT03665597|560569275|FG006|Period 3|Death|0|||
155310230|NCT03665597|560569269|FG000|Period 4|Adverse Event|2|||
155310231|NCT03665597|560569270|FG001|Period 4|Adverse Event|2|||
155310232|NCT03665597|560569271|FG002|Period 4|Adverse Event|2|||
155310233|NCT03665597|560569272|FG003|Period 4|Adverse Event|2|||
155310234|NCT03665597|560569273|FG004|Period 4|Adverse Event|1|||
155310235|NCT03665597|560569274|FG005|Period 4|Adverse Event|0|||
155310236|NCT03665597|560569275|FG006|Period 4|Adverse Event|0|||
155310237|NCT03665597|560569269|FG000|Period 4|Death|0|||
155310238|NCT03665597|560569270|FG001|Period 4|Death|0|||
155310239|NCT03665597|560569271|FG002|Period 4|Death|2|||
155310240|NCT03665597|560569272|FG003|Period 4|Death|0|||
155310241|NCT03665597|560569273|FG004|Period 4|Death|0|||
155066104|NCT00937950|559673804|FG000|Overall Study|Withdrawal by Subject|23|||
155310242|NCT03665597|560569274|FG005|Period 4|Death|0|||
155310243|NCT03665597|560569275|FG006|Period 4|Death|0|||
155310244|NCT03665597|560569269|FG000|Period 4|Physician Decision|1|||
155310245|NCT03665597|560569270|FG001|Period 4|Physician Decision|2|||
155310246|NCT03665597|560569271|FG002|Period 4|Physician Decision|0|||
155310247|NCT03665597|560569272|FG003|Period 4|Physician Decision|0|||
155310248|NCT03665597|560569273|FG004|Period 4|Physician Decision|0|||
155310249|NCT03665597|560569274|FG005|Period 4|Physician Decision|0|||
155310250|NCT03665597|560569275|FG006|Period 4|Physician Decision|0|||
155310251|NCT05516147|560569276|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
155310252|NCT05371652|560569280|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
155310253|NCT05371652|560569280|FG000|Overall Study|Withdrawal by Subject|12|||
155310254|NCT05371652|560569280|FG000|Overall Study|Adverse Event|1|||
155310255|NCT05371652|560569280|FG000|Overall Study|Other|11|||
155310256|NCT05256706|560569281|FG000|Overall Study|Lost to Follow-up|9|||
155310257|NCT05256706|560569282|FG001|Overall Study|Lost to Follow-up|3|||
155310258|NCT05256706|560569281|FG000|Overall Study|Withdrawal by Subject|7|||
155310259|NCT05256706|560569282|FG001|Overall Study|Withdrawal by Subject|11|||
155310260|NCT05256706|560569281|FG000|Overall Study|Screen Failures|3|||
155310261|NCT05256706|560569282|FG001|Overall Study|Screen Failures|0|||
155310262|NCT04410042|560569284|FG000|Overall Study|Not Eligible|1|||
155310263|NCT04410042|560569285|FG001|Overall Study|Not Eligible|1|||
155310264|NCT03302494|560569286|FG000|Overall Study|Other|7|||
155310265|NCT03302494|560569287|FG001|Overall Study|Other|4|||
155310266|NCT03302494|560569288|FG002|Overall Study|Other|6|||
155310267|NCT03302494|560569286|FG000|Overall Study|Withdrawal by Subject|10|||
155310268|NCT03302494|560569287|FG001|Overall Study|Withdrawal by Subject|2|||
155310269|NCT03302494|560569288|FG002|Overall Study|Withdrawal by Subject|9|||
155310270|NCT03302494|560569286|FG000|Overall Study|Study Terminated by Sponsor|32|||
155310271|NCT03302494|560569287|FG001|Overall Study|Study Terminated by Sponsor|29|||
155310272|NCT03302494|560569288|FG002|Overall Study|Study Terminated by Sponsor|30|||
155310273|NCT03302494|560569286|FG000|Overall Study|Physician Decision|1|||
155310274|NCT03302494|560569287|FG001|Overall Study|Physician Decision|0|||
155310275|NCT03302494|560569288|FG002|Overall Study|Physician Decision|1|||
155310276|NCT03302494|560569286|FG000|Overall Study|Lost to Follow-up|1|||
155310277|NCT03302494|560569287|FG001|Overall Study|Lost to Follow-up|3|||
155310278|NCT03302494|560569288|FG002|Overall Study|Lost to Follow-up|3|||
155310279|NCT03302494|560569286|FG000|Overall Study|Death|13|||
155310280|NCT03302494|560569287|FG001|Overall Study|Death|11|||
155310281|NCT03302494|560569288|FG002|Overall Study|Death|4|||
155310282|NCT03302494|560569286|FG000|Overall Study|Adverse Event|1|||
155066105|NCT00937950|559673804|FG000|Overall Study|Migrated/moved from study area|27|||
155310283|NCT03302494|560569287|FG001|Overall Study|Adverse Event|2|||
155310284|NCT03302494|560569288|FG002|Overall Study|Adverse Event|0|||
155310285|NCT03302494|560569286|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
155310286|NCT03302494|560569287|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
155310287|NCT03302494|560569288|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
155310288|NCT03978871|560569289|FG000|Overall Study|Lost to Follow-up|11|||
155310289|NCT03978871|560569290|FG001|Overall Study|Lost to Follow-up|12|||
155310290|NCT05710107|560569291|FG000|Overall Study|Withdrawal by Subject|1|||
155310291|NCT05710107|560569292|FG001|Overall Study|Withdrawal by Subject|1|||
155310292|NCT05710107|560569291|FG000|Overall Study|Lost to Follow-up|8|||
155066106|NCT00937950|559673804|FG000|Overall Study|Lost to Follow-up|144|||
155066107|NCT00937950|559673804|FG000|Overall Study|Missing confirmed|4|||
155310293|NCT05710107|560569292|FG001|Overall Study|Lost to Follow-up|9|||
155310294|NCT05710107|560569291|FG000|Overall Study|Unable to place assigned block|2|||
155310295|NCT05710107|560569292|FG001|Overall Study|Unable to place assigned block|0|||
155310296|NCT05710107|560569291|FG000|Overall Study|Withdrawn by study team|0|||
155310297|NCT05710107|560569292|FG001|Overall Study|Withdrawn by study team|1|||
155310298|NCT04166773|560569293|FG000|Overall Study|Adverse Event|2|||
155310299|NCT04166773|560569294|FG001|Overall Study|Adverse Event|0|||
155310300|NCT04166773|560569295|FG002|Overall Study|Adverse Event|2|||
155310301|NCT04166773|560569296|FG003|Overall Study|Adverse Event|1|||
155310302|NCT04166773|560569293|FG000|Overall Study|Lost to Follow-up|4|||
155310303|NCT04166773|560569294|FG001|Overall Study|Lost to Follow-up|2|||
155310304|NCT04166773|560569295|FG002|Overall Study|Lost to Follow-up|1|||
155310305|NCT04166773|560569296|FG003|Overall Study|Lost to Follow-up|3|||
155310306|NCT04166773|560569293|FG000|Overall Study|Physician Decision|0|||
155310307|NCT04166773|560569294|FG001|Overall Study|Physician Decision|0|||
155310308|NCT04166773|560569295|FG002|Overall Study|Physician Decision|0|||
155310309|NCT04166773|560569296|FG003|Overall Study|Physician Decision|1|||
155310310|NCT04166773|560569293|FG000|Overall Study|Withdrawal by Subject|1|||
155310311|NCT04166773|560569294|FG001|Overall Study|Withdrawal by Subject|1|||
155310312|NCT04166773|560569295|FG002|Overall Study|Withdrawal by Subject|2|||
155310313|NCT04166773|560569296|FG003|Overall Study|Withdrawal by Subject|5|||
155310314|NCT05268302|560569297|FG000|Overall Study|Death|0|||
155066108|NCT00937950|559673804|FG000|Overall Study|Other|18|||
155066109|NCT01531153|559673807|FG000|Overall Study|Withdrawal by Subject|10|||
155310315|NCT05268302|560569298|FG001|Overall Study|Death|1|||
155310316|NCT02811679|560569299|FG000|Overall Study|Adverse Event|1|||
155310317|NCT02811679|560569299|FG000|Overall Study|Lack of Efficacy|6|||
155310318|NCT02811679|560569299|FG000|Overall Study|Early study closure due to slow accrual|3|||
155310319|NCT05319860|560569300|FG000|Overall Study|Death|1|||
155310320|NCT05319860|560569301|FG001|Overall Study|Death|1|||
155310321|NCT05319860|560569300|FG000|Overall Study|Lost to Follow-up|3|||
155310322|NCT05319860|560569301|FG001|Overall Study|Lost to Follow-up|1|||
155310323|NCT05319860|560569300|FG000|Overall Study|Withdrawal by Subject|1|||
155310324|NCT05319860|560569301|FG001|Overall Study|Withdrawal by Subject|7|||
155310325|NCT01361711|560569302|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
155310326|NCT01361711|560569302|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
155310327|NCT01361711|560569302|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
155310328|NCT01361711|560569302|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
155310329|NCT01361711|560569302|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
155310330|NCT01361711|560569302|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
155310331|NCT01361711|560569302|FG000|Completed Week 18 of Treatment|Other|9|||
155310332|NCT01361711|560569302|FG000|10 Year Follow-up|Still in follow-up|22|||
155310333|NCT01361711|560569302|FG000|10 Year Follow-up|Death|7|||
155310334|NCT01361711|560569302|FG000|10 Year Follow-up|Developed new cancer|1|||
155310335|NCT01361711|560569302|FG000|10 Year Follow-up|Lost to Follow-up|2|||
155310336|NCT01361711|560569302|FG000|10 Year Follow-up|New treatment started|6|||
155310337|NCT01361711|560569302|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
155310338|NCT01361711|560569302|FG000|10 Year Follow-up|Progressive Disease|1|||
155310339|NCT00753090|560570486|FG000|Overall Study|Withdrawal by Subject|10|||
155310340|NCT00753090|560570487|FG001|Overall Study|Withdrawal by Subject|10|||
155310341|NCT00753090|560570486|FG000|Overall Study|Death|17|||
155310342|NCT00753090|560570487|FG001|Overall Study|Death|6|||
155310343|NCT00753090|560570486|FG000|Overall Study|Study Prosthesis Removed|12|||
155310344|NCT00753090|560570487|FG001|Overall Study|Study Prosthesis Removed|3|||
155310345|NCT00753090|560570486|FG000|Overall Study|Lost to Follow-up|2|||
155310346|NCT00753090|560570487|FG001|Overall Study|Lost to Follow-up|2|||
155310347|NCT00753090|560570486|FG000|Overall Study|Other|127|||
155310348|NCT00753090|560570487|FG001|Overall Study|Other|75|||
155310349|NCT05113966|560570488|FG000|Overall Study|Death|21|||
155310350|NCT05113966|560570488|FG000|Overall Study|Study Terminated by Sponsor|9|||
155310351|NCT05816551|560570491|FG000|Overall Study|Withdrawal by Subject|0|||
155310352|NCT05816551|560570492|FG001|Overall Study|Withdrawal by Subject|1|||
155310353|NCT05816551|560570491|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
155310354|NCT05816551|560570492|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
155310355|NCT04593472|560570493|FG000|Overall Study|Death|31|||
155310356|NCT04593472|560570494|FG001|Overall Study|Death|27|||
155310357|NCT04593472|560570493|FG000|Overall Study|Withdrawal by Subject|12|||
155310358|NCT04593472|560570494|FG001|Overall Study|Withdrawal by Subject|12|||
155066110|NCT01531153|559673808|FG001|Overall Study|Withdrawal by Subject|9|||
155066111|NCT01531153|559673809|FG002|Overall Study|Withdrawal by Subject|15|||
155310359|NCT04593472|560570493|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
155310360|NCT04593472|560570494|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
155066112|NCT03483103|559673810|FG000|Pre-Treatment Phase|Other reasons|1|||
155310361|NCT04593472|560570493|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
155310362|NCT04593472|560570494|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
155310363|NCT04593472|560570493|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
155310364|NCT04593472|560570494|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
155310365|NCT04593472|560570493|FG000|Overall Study|Lost to Follow-up|0|||
155310366|NCT04593472|560570494|FG001|Overall Study|Lost to Follow-up|2|||
155310367|NCT04593472|560570493|FG000|Overall Study|Still collecting 24-month assessment|17|||
155310368|NCT04593472|560570494|FG001|Overall Study|Still collecting 24-month assessment|10|||
155310369|NCT03648840|560570495|FG000|First IV Infusion Session|Adverse Event|0|||
155310370|NCT03648840|560570496|FG001|First IV Infusion Session|Adverse Event|2|||
155310371|NCT03648840|560570495|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
155310372|NCT03648840|560570496|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
155310373|NCT03648840|560570495|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
155310374|NCT03648840|560570496|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
155310375|NCT03648840|560570495|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
155310376|NCT03648840|560570496|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
155310377|NCT05382936|560570498|FG000|Overall Study|Progressive Disease|3|||
155310378|NCT05382936|560570499|FG001|Overall Study|Progressive Disease|5|||
155310379|NCT05382936|560570500|FG002|Overall Study|Progressive Disease|2|||
155310380|NCT05382936|560570501|FG003|Overall Study|Progressive Disease|5|||
155310381|NCT05382936|560570498|FG000|Overall Study|Adverse Event|0|||
155310382|NCT05382936|560570499|FG001|Overall Study|Adverse Event|1|||
155310383|NCT05382936|560570500|FG002|Overall Study|Adverse Event|1|||
155310384|NCT05382936|560570501|FG003|Overall Study|Adverse Event|0|||
155310385|NCT05382936|560570498|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
155310386|NCT05382936|560570499|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
155310387|NCT05382936|560570500|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
155310388|NCT05382936|560570501|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
155310389|NCT05382936|560570498|FG000|Overall Study|Withdrawal by Subject|0|||
155310390|NCT05382936|560570499|FG001|Overall Study|Withdrawal by Subject|0|||
155310391|NCT05382936|560570500|FG002|Overall Study|Withdrawal by Subject|1|||
155310392|NCT05382936|560570501|FG003|Overall Study|Withdrawal by Subject|1|||
155310393|NCT05063994|560570502|FG000|Cortef Run-In|Withdrawal of Consent|1|||
155310394|NCT05063994|560570503|FG001|Cortef Run-In|Withdrawal of Consent|0|||
155310395|NCT05063994|560570504|FG002|Cortef Run-In|Withdrawal of Consent|0|||
155310396|NCT05063994|560570502|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
155310397|NCT05063994|560570503|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
155310398|NCT05063994|560570504|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
155310399|NCT05063994|560570502|FG000|Treatment|Physician Decision|0|||
155310400|NCT05063994|560570503|FG001|Treatment|Physician Decision|0|||
155310401|NCT05063994|560570504|FG002|Treatment|Physician Decision|1|||
155310402|NCT05063994|560570502|FG000|Treatment|Withdrawal by Subject|0|||
155310403|NCT05063994|560570503|FG001|Treatment|Withdrawal by Subject|0|||
155310404|NCT05063994|560570504|FG002|Treatment|Withdrawal by Subject|1|||
155310405|NCT05063994|560570502|FG000|Treatment|Withdrawal of Consent|0|||
155310406|NCT05063994|560570503|FG001|Treatment|Withdrawal of Consent|0|||
155310407|NCT05063994|560570504|FG002|Treatment|Withdrawal of Consent|1|||
155310408|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior use|4424|||
155310409|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior use|24726|||
155310410|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior use|0|||
155310411|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior use|0|||
155310412|NCT03692676|560570510|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
155310413|NCT03692676|560570511|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
155310414|NCT03692676|560570512|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
155310415|NCT03692676|560570513|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
155310416|NCT03692676|560570510|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
155310417|NCT03692676|560570511|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
155310418|NCT03692676|560570512|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
155310419|NCT03692676|560570513|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
155310420|NCT03692676|560570510|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
155310421|NCT03692676|560570511|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
155310422|NCT03692676|560570512|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
155310423|NCT03692676|560570513|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
155310424|NCT03692676|560570510|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
155310425|NCT03692676|560570511|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
155310426|NCT03692676|560570512|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
155310427|NCT03692676|560570513|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
155310428|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
155310429|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
155310430|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
155310431|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
155310432|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
155310433|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
155310434|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
155310435|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
155310436|NCT03692676|560570510|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
155310437|NCT03692676|560570511|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
155310438|NCT03692676|560570512|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
155310439|NCT03692676|560570513|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
155310440|NCT03692676|560570510|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
155310441|NCT03692676|560570511|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
155310442|NCT03692676|560570512|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
155310443|NCT03692676|560570513|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
155310444|NCT03692676|560570510|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
155310445|NCT03692676|560570511|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
155310446|NCT03692676|560570512|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
155310447|NCT03692676|560570513|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
155310448|NCT03692676|560570510|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
155310449|NCT03692676|560570511|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
155310450|NCT03692676|560570512|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
155310451|NCT03692676|560570513|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
155310452|NCT03692676|560570510|FG000|Overall Study|Other|0|||
155310453|NCT03692676|560570511|FG001|Overall Study|Other|805|||
155310454|NCT03692676|560570512|FG002|Overall Study|Other|758|||
155310455|NCT03692676|560570513|FG003|Overall Study|Other|277|||
155310456|NCT03692676|560570510|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
155310457|NCT03692676|560570511|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
155310458|NCT03692676|560570512|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
155310459|NCT03692676|560570513|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
155310460|NCT01180634|560570514|FG000|Overall Study|Adverse Event|4|||
155310461|NCT01180634|560570515|FG001|Overall Study|Adverse Event|1|||
155310462|NCT01180634|560570514|FG000|Overall Study|Miscellaneous|2|||
155310463|NCT01180634|560570515|FG001|Overall Study|Miscellaneous|0|||
155310464|NCT01180634|560570514|FG000|Overall Study|Withdrawal by Subject|4|||
155310465|NCT01180634|560570515|FG001|Overall Study|Withdrawal by Subject|0|||
155310466|NCT03692611|560570516|FG000|Overall Study|Found to be ineligible postrandomization|3|||
155310467|NCT03692611|560570517|FG001|Overall Study|Found to be ineligible postrandomization|0|||
155310468|NCT04490915|560570519|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
155310469|NCT04490915|560570520|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
155310470|NCT04490915|560570519|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155310471|NCT04490915|560570520|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155310472|NCT04490915|560570519|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155310473|NCT04490915|560570520|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
155310474|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
155310475|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
155310476|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
155310477|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
155310478|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
155310479|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
155310480|NCT04490915|560570519|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
155310481|NCT04490915|560570520|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
155310482|NCT04083235|560570527|FG000|Overall Study|Death|252|||
155310483|NCT04083235|560570528|FG001|Overall Study|Death|277|||
155310484|NCT04083235|560570527|FG000|Overall Study|Withdrawal by Subject|13|||
155310485|NCT04083235|560570528|FG001|Overall Study|Withdrawal by Subject|17|||
155310486|NCT04083235|560570527|FG000|Overall Study|Lost to Follow-up|1|||
155310487|NCT04083235|560570528|FG001|Overall Study|Lost to Follow-up|1|||
155310488|NCT04083235|560570527|FG000|Overall Study|Does not meet entry criteria|1|||
155310489|NCT04083235|560570528|FG001|Overall Study|Does not meet entry criteria|0|||
155310490|NCT04083235|560570527|FG000|Overall Study|Did not receive treatment|13|||
155310491|NCT04083235|560570528|FG001|Overall Study|Did not receive treatment|8|||
155310492|NCT04083235|560570527|FG000|Overall Study|Ongoing at the time of DCO|44|||
155310493|NCT04083235|560570528|FG001|Overall Study|Ongoing at the time of DCO|7|||
155310494|NCT03016169|560570529|FG000|Overall Study|Lost to Follow-up|4|||
155310495|NCT03016169|560570529|FG000|Overall Study|Death|54|||
155310496|NCT03016169|560570529|FG000|Overall Study|Device Explant|11|||
155310497|NCT03016169|560570529|FG000|Overall Study|Withdrawal by Subject|19|||
155066113|NCT03483103|559673810|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
155066114|NCT03483103|559673810|FG000|Pre-Treatment Phase|Disease-related complications|1|||
155310498|NCT03016169|560570529|FG000|Overall Study|Other Reasons|1|||
155310499|NCT04060355|560570530|FG000|Overall Study|Lost to Follow-up|41|||
155310500|NCT04150718|560570534|FG000|Overall Study|Withdrawal by Subject|2|||
155310501|NCT04150718|560570535|FG001|Overall Study|Withdrawal by Subject|7|||
155310502|NCT04150718|560570536|FG002|Overall Study|Withdrawal by Subject|1|||
155310503|NCT04150718|560570534|FG000|Overall Study|Lost to Follow-up|1|||
155310504|NCT04150718|560570535|FG001|Overall Study|Lost to Follow-up|2|||
155310505|NCT04150718|560570536|FG002|Overall Study|Lost to Follow-up|0|||
155310506|NCT04150718|560570534|FG000|Overall Study|Ineligible|1|||
155310507|NCT04150718|560570535|FG001|Overall Study|Ineligible|0|||
155310508|NCT04150718|560570536|FG002|Overall Study|Ineligible|10|||
155310509|NCT05324124|560570537|FG000|Period 1|Withdrawal by Subject|1|||
155310510|NCT05324124|560570538|FG001|Period 1|Withdrawal by Subject|0|||
155310511|NCT05324124|560570537|FG000|Period 1|Physician Decision|0|||
155310512|NCT05324124|560570538|FG001|Period 1|Physician Decision|1|||
155310513|NCT05034952|560570539|FG000|Overall Study|Adverse Event|1|||
155310514|NCT05034952|560570540|FG001|Overall Study|Adverse Event|0|||
155310515|NCT05034952|560570541|FG002|Overall Study|Adverse Event|0|||
155310516|NCT05034952|560570542|FG003|Overall Study|Adverse Event|0|||
155310517|NCT05034952|560570539|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155310518|NCT05034952|560570540|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155310519|NCT05034952|560570541|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
155310520|NCT05034952|560570542|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
155310521|NCT05034952|560570539|FG000|Overall Study|Lost to Follow-up|1|||
155310522|NCT05034952|560570540|FG001|Overall Study|Lost to Follow-up|4|||
155310523|NCT05034952|560570541|FG002|Overall Study|Lost to Follow-up|3|||
155310524|NCT05034952|560570542|FG003|Overall Study|Lost to Follow-up|3|||
155310525|NCT05034952|560570539|FG000|Overall Study|Other|0|||
155310526|NCT05034952|560570540|FG001|Overall Study|Other|0|||
155310527|NCT05034952|560570541|FG002|Overall Study|Other|0|||
155310528|NCT05034952|560570542|FG003|Overall Study|Other|1|||
155310529|NCT04783935|560570549|FG000|Overall Study|Withdrawal by Subject|6|||
155310530|NCT04783935|560570549|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
155310531|NCT04783935|560570549|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
155310532|NCT04783935|560570549|FG000|Overall Study|Lost to Follow-up|3|||
155310533|NCT04783935|560570549|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
155310534|NCT00920621|560570553|FG000|Overall Study|Lost to Follow-up|16|||
155310535|NCT00920621|560570554|FG001|Overall Study|Lost to Follow-up|17|||
155310536|NCT00920621|560570555|FG002|Overall Study|Lost to Follow-up|19|||
155310537|NCT00920621|560570556|FG003|Overall Study|Lost to Follow-up|21|||
155310538|NCT00920621|560570553|FG000|Overall Study|Fetal/neonatal deaths|16|||
155310539|NCT00920621|560570554|FG001|Overall Study|Fetal/neonatal deaths|14|||
155310540|NCT00920621|560570555|FG002|Overall Study|Fetal/neonatal deaths|16|||
155310541|NCT00920621|560570556|FG003|Overall Study|Fetal/neonatal deaths|14|||
155310542|NCT00920621|560570553|FG000|Overall Study|Blood sample not collected|22|||
155310543|NCT00920621|560570554|FG001|Overall Study|Blood sample not collected|14|||
155310544|NCT00920621|560570555|FG002|Overall Study|Blood sample not collected|0|||
155310545|NCT00920621|560570556|FG003|Overall Study|Blood sample not collected|0|||
155310546|NCT01426425|560570557|FG000|Overall Study|Exited prior to EP study|22|||
155310547|NCT01426425|560570557|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
155310548|NCT01426425|560570557|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
155310549|NCT03763708|560570559|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
155310550|NCT03763708|560570560|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310551|NCT03763708|560570561|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310552|NCT03763708|560570562|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310553|NCT03763708|560570563|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310554|NCT03763708|560570564|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310555|NCT03763708|560570565|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310556|NCT03763708|560570566|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310557|NCT03763708|560570567|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
155310558|NCT03763708|560570559|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310559|NCT03763708|560570560|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310560|NCT03763708|560570561|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
155310561|NCT03763708|560570562|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310562|NCT03763708|560570563|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310563|NCT03763708|560570564|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310564|NCT03763708|560570565|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310565|NCT03763708|560570566|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310566|NCT03763708|560570567|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
155310567|NCT03763708|560570559|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310568|NCT03763708|560570560|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310569|NCT03763708|560570561|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310570|NCT03763708|560570562|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
155310571|NCT03763708|560570563|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310572|NCT03763708|560570564|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310573|NCT03763708|560570565|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310574|NCT03763708|560570566|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310575|NCT03763708|560570567|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
155310576|NCT03763708|560570559|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310577|NCT03763708|560570560|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310578|NCT03763708|560570561|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310579|NCT03763708|560570562|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310580|NCT03763708|560570563|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
155310581|NCT03763708|560570564|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310582|NCT03763708|560570565|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310583|NCT03763708|560570566|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310584|NCT03763708|560570567|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
155310585|NCT03763708|560570559|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310586|NCT03763708|560570560|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310587|NCT03763708|560570561|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310588|NCT03763708|560570562|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310589|NCT03763708|560570563|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310590|NCT03763708|560570564|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
155310591|NCT03763708|560570565|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310592|NCT03763708|560570566|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310593|NCT03763708|560570567|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
155310594|NCT03763708|560570559|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310595|NCT03763708|560570560|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310596|NCT03763708|560570561|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310597|NCT03763708|560570562|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310598|NCT03763708|560570563|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310599|NCT03763708|560570564|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310600|NCT03763708|560570565|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
155310601|NCT03763708|560570566|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310602|NCT03763708|560570567|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
155310603|NCT03763708|560570559|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
155310604|NCT03763708|560570560|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
155310605|NCT03763708|560570561|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
155310606|NCT03763708|560570562|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
155310607|NCT03763708|560570563|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
155310608|NCT03763708|560570564|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
155310609|NCT03763708|560570565|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
155310610|NCT03763708|560570566|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
155310611|NCT03763708|560570567|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
155310612|NCT03763708|560570559|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
155310613|NCT03763708|560570560|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
155310614|NCT03763708|560570561|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
155310615|NCT03763708|560570562|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
155310616|NCT03763708|560570563|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
155310617|NCT03763708|560570564|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
155310618|NCT03763708|560570565|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
155310619|NCT03763708|560570566|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
155310620|NCT03763708|560570567|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
155310621|NCT03763708|560570559|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
155310622|NCT03763708|560570560|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
155310623|NCT03763708|560570561|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
155310624|NCT03763708|560570562|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
155310625|NCT03763708|560570563|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
155310626|NCT03763708|560570564|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
155310627|NCT03763708|560570565|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
154959624|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
155310628|NCT03763708|560570566|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
155310629|NCT03763708|560570567|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
155310630|NCT04382404|560570568|FG000|Overall Study|Adverse Event|1|||
155310631|NCT04382404|560570568|FG000|Overall Study|Lost to Follow-up|2|||
155310632|NCT05687916|560570569|FG000|Overall Study|Adverse Event|1|||
155310633|NCT05687916|560570570|FG001|Overall Study|Adverse Event|2|||
155310634|NCT05687916|560570571|FG002|Overall Study|Adverse Event|0|||
155310635|NCT05687916|560570569|FG000|Overall Study|Withdrawal by Subject|1|||
155310636|NCT05687916|560570570|FG001|Overall Study|Withdrawal by Subject|0|||
154959625|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
154959626|NCT01597245|559276949|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959627|NCT01597245|559276950|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155310637|NCT05687916|560570571|FG002|Overall Study|Withdrawal by Subject|1|||
155310638|NCT05687916|560570569|FG000|Overall Study|Protocol Violation|0|||
155310639|NCT05687916|560570570|FG001|Overall Study|Protocol Violation|2|||
155310640|NCT05687916|560570571|FG002|Overall Study|Protocol Violation|1|||
155310641|NCT05687916|560570569|FG000|Overall Study|Reason not Specified|1|||
155310642|NCT05687916|560570570|FG001|Overall Study|Reason not Specified|0|||
155310643|NCT05687916|560570571|FG002|Overall Study|Reason not Specified|0|||
154959628|NCT01597245|559276951|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155310644|NCT03332017|560570572|FG000|Overall Study|Lost to Follow-up|1|||
155310645|NCT03332017|560570573|FG001|Overall Study|Lost to Follow-up|2|||
155310646|NCT03332017|560570572|FG000|Overall Study|Death|17|||
155310647|NCT03332017|560570573|FG001|Overall Study|Death|16|||
155310648|NCT03332017|560570572|FG000|Overall Study|Withdrawal by Subject|6|||
155310649|NCT03332017|560570573|FG001|Overall Study|Withdrawal by Subject|14|||
155310650|NCT03332017|560570572|FG000|Overall Study|Other|1|||
155310651|NCT03332017|560570573|FG001|Overall Study|Other|3|||
155310652|NCT03332017|560570572|FG000|Overall Study|Remained in Study (Ongoing)|47|||
155310653|NCT03332017|560570573|FG001|Overall Study|Remained in Study (Ongoing)|110|||
155310654|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
155310655|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
155310656|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
155310657|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310658|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310659|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310660|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310661|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310662|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310663|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310664|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310665|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310666|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
155310667|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
155310668|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
155310669|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310670|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310671|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310672|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310673|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310674|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310675|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310676|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310677|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310678|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310679|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
155310680|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
155310681|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
155310682|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310683|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310684|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310685|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310686|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310687|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310688|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310689|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310690|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310691|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310692|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
155310693|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
155161562|NCT00790842|560028640|FG007|Expansion Cohort|Study Closure|0|||
155161563|NCT00790842|560028641|FG008|Expansion Cohort|Study Closure|0|||
155161564|NCT00790842|560028642|FG009|Expansion Cohort|Study Closure|0|||
155161565|NCT00790842|560028643|FG010|Expansion Cohort|Study Closure|0|||
155161566|NCT03771664|560028645|FG000|Overall Study|Adverse Event|1|||
155161567|NCT03771664|560028646|FG001|Overall Study|Adverse Event|0|||
155161568|NCT03771664|560028645|FG000|Overall Study|Lost to Follow-up|1|||
155161569|NCT03771664|560028646|FG001|Overall Study|Lost to Follow-up|0|||
155161570|NCT03771664|560028645|FG000|Overall Study|Withdrawal by Participant|1|||
155161571|NCT03771664|560028646|FG001|Overall Study|Withdrawal by Participant|4|||
155310694|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
155310695|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310696|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310697|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310698|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155161572|NCT03771664|560028645|FG000|Overall Study|Randomized but not Treated|0|||
155161573|NCT03771664|560028646|FG001|Overall Study|Randomized but not Treated|1|||
155310699|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310700|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310701|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310702|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310703|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310704|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310705|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
155310706|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
155310707|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
155310708|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
155310709|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310710|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310711|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310712|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310713|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310714|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310715|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310716|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310717|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310718|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
155310719|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
155310720|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
155310721|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
155310722|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310723|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310724|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310725|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310726|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310727|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310728|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310729|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310730|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310731|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
155310732|NCT01261312|560570574|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
155310733|NCT01261312|560570575|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310734|NCT01261312|560570576|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
155310735|NCT01261312|560570577|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310736|NCT01261312|560570578|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310737|NCT01261312|560570579|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310738|NCT01261312|560570580|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310739|NCT01261312|560570581|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310740|NCT01261312|560570582|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310741|NCT01261312|560570583|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310742|NCT01261312|560570584|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310743|NCT01261312|560570585|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310744|NCT01261312|560570586|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
155310745|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310746|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310747|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310748|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
155310749|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
155066115|NCT03483103|559673810|FG000|Pre-Treatment Phase|Death|5|||
155066116|NCT03483103|559673810|FG000|Treatment Phase|Withdrawal by Subject|7|||
155066117|NCT03483103|559673810|FG000|Treatment Phase|Other reasons|1|||
155066118|NCT03483103|559673810|FG000|Treatment Phase|Death|23|||
155066119|NCT03483103|559673810|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
155066120|NCT03483103|559673810|FG000|Treatment Phase|Received nonconforming product|1|||
155066121|NCT00435942|559673811|FG000|Overall Study|Death|17|||
155066122|NCT00435942|559673812|FG001|Overall Study|Death|10|||
155066123|NCT00435942|559673811|FG000|Overall Study|Withdrawal by Subject|2|||
155066124|NCT00435942|559673812|FG001|Overall Study|Withdrawal by Subject|0|||
155161574|NCT02120898|560028647|FG000|Overall Study|Withdrawal by Subject|4|||
155066125|NCT00435942|559673811|FG000|Overall Study|Lost to Follow-up|0|||
155310750|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
155310751|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310752|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310753|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310754|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310755|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310756|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310757|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
155310758|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310759|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310760|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310761|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310762|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
155310763|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
155310764|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310765|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310766|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310767|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310768|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310769|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310770|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
155310771|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310772|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310773|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310774|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310775|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
155310776|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
155310777|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310778|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310779|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310780|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310781|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310782|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310783|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
155310784|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310785|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310786|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310787|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
155310788|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
154959629|NCT01597245|559276952|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155066126|NCT00435942|559673812|FG001|Overall Study|Lost to Follow-up|16|||
155310789|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
155310790|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310791|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310792|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310793|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310794|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310795|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310796|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
155310797|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310798|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
154959630|NCT01597245|559276953|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959631|NCT01597245|559276954|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959632|NCT01597245|559276955|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959633|NCT01597245|559276956|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959634|NCT01597245|559276957|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959635|NCT01597245|559276958|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959636|NCT01597245|559276959|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959637|NCT01597245|559276960|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959638|NCT01597245|559276961|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959639|NCT01597245|559276962|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
154959640|NCT01597245|559276963|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155310799|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310800|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310801|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310802|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
155310803|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310804|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310805|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310806|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310807|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310808|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310809|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
155310810|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310811|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310812|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310813|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
155310814|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
155310815|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
155310816|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310817|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310818|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310819|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310820|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310821|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310822|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
155310823|NCT01261312|560570574|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310824|NCT01261312|560570575|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310825|NCT01261312|560570576|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310826|NCT01261312|560570577|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
155310827|NCT01261312|560570578|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
155310828|NCT01261312|560570579|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
155310829|NCT01261312|560570580|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310830|NCT01261312|560570581|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310831|NCT01261312|560570582|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310832|NCT01261312|560570583|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310833|NCT01261312|560570584|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310834|NCT01261312|560570585|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310835|NCT01261312|560570586|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
155310836|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310837|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310838|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310839|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310840|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310841|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310842|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
155310843|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
155310844|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
155310845|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155161575|NCT02120898|560028648|FG001|Overall Study|Withdrawal by Subject|2|||
155161576|NCT02120898|560028649|FG002|Overall Study|Withdrawal by Subject|2|||
155161577|NCT02120898|560028647|FG000|Overall Study|Non-compliance with study drug|3|||
155161578|NCT02120898|560028648|FG001|Overall Study|Non-compliance with study drug|0|||
155161579|NCT02120898|560028649|FG002|Overall Study|Non-compliance with study drug|0|||
155161580|NCT02120898|560028647|FG000|Overall Study|Adverse Event|1|||
155310846|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310847|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310848|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
155310849|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310850|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310851|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310852|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310853|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310854|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310855|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310856|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
155310857|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
155310858|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
154959641|NCT01597245|559276964|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959642|NCT01597245|559276965|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959643|NCT01597245|559276966|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959644|NCT01597245|559276967|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959645|NCT01597245|559276968|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
154959646|NCT01597245|559276969|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
155161581|NCT02120898|560028648|FG001|Overall Study|Adverse Event|2|||
155310859|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310860|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310861|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
155310862|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310863|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310864|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310865|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310866|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310867|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310868|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
155310869|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
155310870|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
155310871|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310872|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310873|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310874|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
155310875|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
155310876|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
155310877|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
155310878|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
155310879|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
155310880|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
155310881|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
155310882|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
155310883|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
155310884|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
155310885|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
155310886|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
155310887|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
155310888|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310889|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310890|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310891|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310892|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155066127|NCT00435942|559673811|FG000|Overall Study|Conversion to Open Repair|1|||
155310893|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310894|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
155066128|NCT00435942|559673812|FG001|Overall Study|Conversion to Open Repair|0|||
155066129|NCT00435942|559673811|FG000|Overall Study|Technical Failure|3|||
155310895|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
155310896|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
155310897|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310898|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310899|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155066130|NCT00435942|559673812|FG001|Overall Study|Technical Failure|0|||
155066131|NCT00435942|559673811|FG000|Overall Study|Other|0|||
155066132|NCT00435942|559673812|FG001|Overall Study|Other|1|||
155066133|NCT02378181|559673813|FG000|Overall Study|Lost to Follow-up|2|||
155066134|NCT02378181|559673814|FG001|Overall Study|Lost to Follow-up|5|||
155310900|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
155310901|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310902|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310903|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310904|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310905|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310906|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310907|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
155310908|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
155310909|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
155310910|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310911|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310912|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310913|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
155310914|NCT01261312|560570574|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310915|NCT01261312|560570575|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155066135|NCT02378181|559673813|FG000|Overall Study|Withdrawal by Subject|1|||
155066136|NCT02378181|559673814|FG001|Overall Study|Withdrawal by Subject|1|||
155066137|NCT02378181|559673813|FG000|Overall Study|Incarcerated|0|||
155310916|NCT01261312|560570576|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310917|NCT01261312|560570577|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310918|NCT01261312|560570578|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310919|NCT01261312|560570579|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310920|NCT01261312|560570580|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
155310921|NCT01261312|560570581|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
155310922|NCT01261312|560570582|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
155310923|NCT01261312|560570583|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310924|NCT01261312|560570584|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310925|NCT01261312|560570585|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310926|NCT01261312|560570586|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
155310927|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310928|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310929|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310930|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310931|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310932|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310933|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310934|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310935|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
155310936|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
155310937|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
155066138|NCT02378181|559673814|FG001|Overall Study|Incarcerated|1|||
155310938|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
155310939|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
155310940|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310941|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310942|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310943|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310944|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310945|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310946|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310947|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310948|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310949|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
155310950|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
155310951|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
155310952|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
155310953|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310954|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310955|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310956|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310957|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310958|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310959|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310960|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155310961|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
155066139|NCT01898130|559673816|FG000|Treatment|Withdrawal by Subject|2|||
155066140|NCT01898130|559673816|FG000|Treatment|Progressive Disease|4|||
155066141|NCT01898130|559673816|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
155066142|NCT04491994|559673817|FG000|Overall Study|Withdrawal by Subject|10|||
155066143|NCT04491994|559673818|FG001|Overall Study|Withdrawal by Subject|5|||
155066144|NCT04491994|559673817|FG000|Overall Study|developed fever > 3 days|4|||
155066145|NCT04491994|559673818|FG001|Overall Study|developed fever > 3 days|1|||
155066146|NCT04491994|559673817|FG000|Overall Study|Protocol Violation|11|||
155310962|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
155310963|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
155310964|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
155310965|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
155310966|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310967|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310968|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310969|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310970|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310971|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310972|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310973|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310974|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
155310975|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
155310976|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
155310977|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
155310978|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
155310979|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310980|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310981|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310982|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310983|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310984|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310985|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310986|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310987|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
155310988|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
155310989|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
155310990|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
155310991|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
155310992|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310993|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310994|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310995|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310996|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310997|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310998|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155310999|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155311000|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
155311001|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
155311002|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
155311003|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
155311004|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
155311005|NCT01261312|560570574|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311006|NCT01261312|560570575|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311007|NCT01261312|560570576|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311008|NCT01261312|560570577|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311009|NCT01261312|560570578|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311010|NCT01261312|560570579|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311011|NCT01261312|560570580|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311012|NCT01261312|560570581|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311013|NCT01261312|560570582|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
155311014|NCT01261312|560570583|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
155311015|NCT01261312|560570584|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
155311016|NCT01261312|560570585|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
155311017|NCT01261312|560570586|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
155311018|NCT01809691|560570591|FG000|Overall Study|Currently on Treatment|192|||
155311019|NCT01809691|560570592|FG001|Overall Study|Currently on Treatment|100|||
155311020|NCT01809691|560570591|FG000|Overall Study|No Protocol Treatment|10|||
155311021|NCT01809691|560570592|FG001|Overall Study|No Protocol Treatment|11|||
154959647|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959648|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959649|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
155311022|NCT01809691|560570591|FG000|Overall Study|Adverse Event|80|||
155311023|NCT01809691|560570592|FG001|Overall Study|Adverse Event|21|||
155311024|NCT01809691|560570591|FG000|Overall Study|Disease Progression|226|||
155311025|NCT01809691|560570592|FG001|Overall Study|Disease Progression|372|||
155311026|NCT01809691|560570591|FG000|Overall Study|Death|26|||
155311027|NCT01809691|560570592|FG001|Overall Study|Death|13|||
155311028|NCT01809691|560570591|FG000|Overall Study|Participant Refusal|70|||
155311029|NCT01809691|560570592|FG001|Overall Study|Participant Refusal|72|||
155311030|NCT01809691|560570591|FG000|Overall Study|Other, Not Specified|34|||
155311031|NCT01809691|560570592|FG001|Overall Study|Other, Not Specified|52|||
155311032|NCT01580488|560570593|FG000|Overall Study|Withdrawal by Subject|1|||
155311033|NCT03336333|560570594|FG000|Overall Study|Remained on study at time of data cut-off|202|||
155311034|NCT03336333|560570595|FG001|Overall Study|Remained on study at time of data cut-off|219|||
155311035|NCT03336333|560570596|FG002|Overall Study|Remained on study at time of data cut-off|102|||
155311036|NCT03336333|560570594|FG000|Overall Study|Death|14|||
155311037|NCT03336333|560570595|FG001|Overall Study|Death|16|||
155311038|NCT03336333|560570596|FG002|Overall Study|Death|8|||
155311039|NCT03336333|560570594|FG000|Overall Study|Withdrawal by Subject|16|||
155311040|NCT03336333|560570595|FG001|Overall Study|Withdrawal by Subject|5|||
155311041|NCT03336333|560570596|FG002|Overall Study|Withdrawal by Subject|1|||
155311042|NCT03336333|560570594|FG000|Overall Study|Physician Decision|5|||
155311043|NCT03336333|560570595|FG001|Overall Study|Physician Decision|1|||
155311044|NCT03336333|560570596|FG002|Overall Study|Physician Decision|0|||
155311045|NCT03336333|560570594|FG000|Overall Study|Lost to Follow-up|1|||
155311046|NCT03336333|560570595|FG001|Overall Study|Lost to Follow-up|0|||
155311047|NCT03336333|560570596|FG002|Overall Study|Lost to Follow-up|0|||
155311048|NCT03406871|560570600|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
155311049|NCT03406871|560570601|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
155311050|NCT03406871|560570602|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
155311051|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
155311052|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
155311053|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
155311054|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
155311055|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
155311056|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
155311057|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
155311058|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
155311059|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
155311060|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Death|0|||
155311061|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Death|1|||
155311062|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Death|0|||
155311063|NCT03406871|560570600|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
155311064|NCT03406871|560570601|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
155311065|NCT03406871|560570602|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
155311066|NCT02281955|560570603|FG000|Overall Study|Death|1|||
155311067|NCT01748448|560570607|FG000|Treatment Period|Consent withdrawn by subject|1|||
155311068|NCT01748448|560570608|FG001|Treatment Period|Consent withdrawn by subject|0|||
155311069|NCT01748448|560570607|FG000|Treatment Period|Adverse Event|1|||
155311070|NCT01748448|560570608|FG001|Treatment Period|Adverse Event|0|||
155311071|NCT01748448|560570607|FG000|Treatment Period|Personal|0|||
155311072|NCT01748448|560570608|FG001|Treatment Period|Personal|1|||
155311073|NCT03699709|560570609|FG000|Overall Study|Death|1|||
155311074|NCT03699709|560570610|FG001|Overall Study|Death|2|||
155311075|NCT03699709|560570609|FG000|Overall Study|Lost to Follow-up|10|||
155311076|NCT03699709|560570610|FG001|Overall Study|Lost to Follow-up|3|||
155311077|NCT03699709|560570609|FG000|Overall Study|Withdrawal by Subject|5|||
155311078|NCT03699709|560570610|FG001|Overall Study|Withdrawal by Subject|0|||
155311079|NCT03699709|560570609|FG000|Overall Study|incarcerated|1|||
155311080|NCT03699709|560570610|FG001|Overall Study|incarcerated|0|||
155161582|NCT02120898|560028649|FG002|Overall Study|Adverse Event|1|||
155161583|NCT02120898|560028647|FG000|Overall Study|Protocol Violation|1|||
155161584|NCT02120898|560028648|FG001|Overall Study|Protocol Violation|2|||
155161585|NCT02120898|560028649|FG002|Overall Study|Protocol Violation|0|||
155161586|NCT02120898|560028647|FG000|Overall Study|Lost to Follow-up|0|||
155161587|NCT02120898|560028648|FG001|Overall Study|Lost to Follow-up|0|||
155311081|NCT03699709|560570609|FG000|Overall Study|scheduled, but no show|0|||
155311082|NCT03699709|560570610|FG001|Overall Study|scheduled, but no show|1|||
155311083|NCT02907099|560570611|FG000|Overall Study|Adverse Event|1|||
155311084|NCT02907099|560570611|FG000|Overall Study|Withdrawal by Subject|2|||
155311085|NCT02907099|560570611|FG000|Overall Study|Screen Fail|2|||
155311086|NCT03110315|560570612|FG000|Overall Study|Withdrawal by Subject|1|||
155311087|NCT03110315|560570613|FG001|Overall Study|Withdrawal by Subject|0|||
155161588|NCT02120898|560028649|FG002|Overall Study|Lost to Follow-up|1|||
155311088|NCT02992925|560572863|FG000|Cohort 2|Physician Decision|0|||
155311089|NCT02992925|560572864|FG001|Cohort 2|Physician Decision|0|||
155311090|NCT02992925|560572865|FG002|Cohort 2|Physician Decision|1|||
155311091|NCT02992925|560572866|FG003|Cohort 2|Physician Decision|0|||
155311092|NCT02992925|560572863|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
155311093|NCT02992925|560572864|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
155311094|NCT02992925|560572865|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
155311095|NCT02992925|560572866|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
155311096|NCT03175029|560572869|FG000|Overall Study|Withdrawal by Subject|2|||
155311097|NCT03175029|560572870|FG001|Overall Study|Withdrawal by Subject|1|||
155311098|NCT03175029|560572869|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
155311099|NCT03175029|560572870|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
155311100|NCT03047928|560572874|FG000|Overall Study|Adverse Event|0|||
155311101|NCT03047928|560572875|FG001|Overall Study|Adverse Event|2|||
155311102|NCT03047928|560572876|FG002|Overall Study|Adverse Event|0|||
155311103|NCT03047928|560572874|FG000|Overall Study|Protocol Violation|0|||
155311104|NCT03047928|560572875|FG001|Overall Study|Protocol Violation|1|||
155311105|NCT03047928|560572876|FG002|Overall Study|Protocol Violation|0|||
155311106|NCT03047928|560572874|FG000|Overall Study|included in another protocol|0|||
155311107|NCT03047928|560572875|FG001|Overall Study|included in another protocol|1|||
155311108|NCT03047928|560572876|FG002|Overall Study|included in another protocol|0|||
155311109|NCT04034251|560572877|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
155311110|NCT04034251|560572878|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
155311111|NCT04034251|560572879|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
155311112|NCT04950660|560572880|FG000|Overall Study|Protocol Violation|4|||
155311113|NCT04950660|560572881|FG001|Overall Study|Protocol Violation|2|||
155311114|NCT04950660|560572880|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
155311115|NCT04950660|560572881|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
155311116|NCT04950660|560572880|FG000|Overall Study|Withdrawal by Subject|0|||
155311117|NCT04950660|560572881|FG001|Overall Study|Withdrawal by Subject|1|||
155311118|NCT04950660|560572880|FG000|Overall Study|Hypotension|1|||
155311119|NCT04950660|560572881|FG001|Overall Study|Hypotension|0|||
155311120|NCT02437318|560572882|FG000|Overall Study|Progressive disease|207|||
155311121|NCT02437318|560572883|FG001|Overall Study|Progressive disease|240|||
155066147|NCT04491994|559673818|FG001|Overall Study|Protocol Violation|2|||
155066148|NCT04491994|559673817|FG000|Overall Study|Lost to Follow-up|4|||
155066149|NCT04491994|559673818|FG001|Overall Study|Lost to Follow-up|3|||
155066150|NCT02475213|559673821|FG000|Overall Study|Adverse Event|2|||
155066151|NCT02475213|559673822|FG001|Overall Study|Adverse Event|0|||
155066152|NCT02475213|559673823|FG002|Overall Study|Adverse Event|0|||
155066153|NCT02475213|559673824|FG003|Overall Study|Adverse Event|1|||
155066154|NCT02475213|559673825|FG004|Overall Study|Adverse Event|1|||
155066155|NCT02475213|559673826|FG005|Overall Study|Adverse Event|4|||
155311122|NCT02437318|560572882|FG000|Overall Study|Subject/guardian decision|24|||
155311123|NCT02437318|560572883|FG001|Overall Study|Subject/guardian decision|11|||
155311124|NCT02437318|560572882|FG000|Overall Study|Physician Decision|29|||
155311125|NCT02437318|560572883|FG001|Overall Study|Physician Decision|22|||
155311126|NCT02437318|560572882|FG000|Overall Study|Adverse Event|14|||
155311127|NCT02437318|560572883|FG001|Overall Study|Adverse Event|4|||
155311128|NCT02437318|560572882|FG000|Overall Study|Death|4|||
155311129|NCT02437318|560572883|FG001|Overall Study|Death|4|||
155311130|NCT02437318|560572882|FG000|Overall Study|Protocol deviation|5|||
155311131|NCT02437318|560572883|FG001|Overall Study|Protocol deviation|7|||
155311132|NCT02437318|560572882|FG000|Overall Study|Sponsor decision|1|||
155311133|NCT02437318|560572883|FG001|Overall Study|Sponsor decision|0|||
155311134|NCT05273749|560572885|FG000|Overall Study|Adverse Event|14|||
155311135|NCT05273749|560572886|FG001|Overall Study|Adverse Event|8|||
155311136|NCT05273749|560572885|FG000|Overall Study|Lack of Efficacy|2|||
155311137|NCT05273749|560572886|FG001|Overall Study|Lack of Efficacy|8|||
155311138|NCT05273749|560572885|FG000|Overall Study|Physician Decision|0|||
155311139|NCT05273749|560572886|FG001|Overall Study|Physician Decision|2|||
155311140|NCT05273749|560572885|FG000|Overall Study|Withdrawal by Subject|14|||
155311141|NCT05273749|560572886|FG001|Overall Study|Withdrawal by Subject|16|||
155311142|NCT05273749|560572885|FG000|Overall Study|Lost to Follow-up|10|||
155311143|NCT05273749|560572886|FG001|Overall Study|Lost to Follow-up|10|||
155311144|NCT05273749|560572885|FG000|Overall Study|Pregnancy|1|||
155311145|NCT05273749|560572886|FG001|Overall Study|Pregnancy|0|||
155311146|NCT05273749|560572885|FG000|Overall Study|Non-Compliance|3|||
155311147|NCT05273749|560572886|FG001|Overall Study|Non-Compliance|2|||
155311148|NCT05273749|560572885|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
155311149|NCT05273749|560572886|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
155311150|NCT03281291|560572887|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
155066156|NCT02475213|559673827|FG006|Overall Study|Adverse Event|6|||
155066157|NCT02475213|559673828|FG007|Overall Study|Adverse Event|2|||
155066158|NCT02475213|559673821|FG000|Overall Study|Physician Decision|1|||
155311151|NCT03281291|560572888|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
155066159|NCT02475213|559673822|FG001|Overall Study|Physician Decision|1|||
155311152|NCT03281291|560572889|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
155311153|NCT03281291|560572890|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
155311154|NCT03281291|560572891|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
155311155|NCT03281291|560572887|FG000|Overall Study|Protocol Deviation|2|||
155311156|NCT03281291|560572888|FG001|Overall Study|Protocol Deviation|0|||
155311157|NCT03281291|560572889|FG002|Overall Study|Protocol Deviation|1|||
155311158|NCT03281291|560572890|FG003|Overall Study|Protocol Deviation|2|||
155311159|NCT03281291|560572891|FG004|Overall Study|Protocol Deviation|1|||
155311160|NCT03281291|560572887|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
155311161|NCT03281291|560572888|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
155311162|NCT03281291|560572889|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
155311163|NCT03281291|560572890|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
155311164|NCT03281291|560572891|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
155311165|NCT03281291|560572887|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
155311166|NCT03281291|560572888|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
155311167|NCT03281291|560572889|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
155311168|NCT03281291|560572890|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
155311169|NCT03281291|560572891|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
155311170|NCT03281291|560572887|FG000|Overall Study|Lost to Follow-up|10|||
155311171|NCT03281291|560572888|FG001|Overall Study|Lost to Follow-up|10|||
155311172|NCT03281291|560572889|FG002|Overall Study|Lost to Follow-up|4|||
155311173|NCT03281291|560572890|FG003|Overall Study|Lost to Follow-up|6|||
155311174|NCT03281291|560572891|FG004|Overall Study|Lost to Follow-up|10|||
155311175|NCT03281291|560572887|FG000|Overall Study|Other|0|||
155311176|NCT03281291|560572888|FG001|Overall Study|Other|2|||
155311177|NCT03281291|560572889|FG002|Overall Study|Other|0|||
155311178|NCT03281291|560572890|FG003|Overall Study|Other|2|||
155311179|NCT03281291|560572891|FG004|Overall Study|Other|1|||
155311180|NCT04956861|560572892|FG000|Overall Study|Withdrawal by Subject|4|||
155311181|NCT04956861|560572893|FG001|Overall Study|Withdrawal by Subject|4|||
155311182|NCT04956861|560572894|FG002|Overall Study|Withdrawal by Subject|2|||
155311183|NCT04956861|560572892|FG000|Overall Study|Physician Decision|4|||
155311184|NCT04956861|560572893|FG001|Overall Study|Physician Decision|5|||
155311185|NCT04956861|560572894|FG002|Overall Study|Physician Decision|1|||
155311186|NCT02530671|560572895|FG000|Overall Study|Lost to Follow-up|2|||
154959650|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959651|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959652|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959653|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959654|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959655|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959656|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959657|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959658|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959659|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959660|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959661|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959662|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
154959663|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
154959664|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
154959665|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
154959666|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
154959667|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
154959668|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959669|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959670|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959671|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959672|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959673|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959674|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959675|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959676|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959677|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959678|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959679|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959680|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959681|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959682|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
155311187|NCT02530671|560572896|FG001|Overall Study|Lost to Follow-up|0|||
155311188|NCT02530671|560572895|FG000|Overall Study|Withdrawal by Subject|1|||
155311189|NCT02530671|560572896|FG001|Overall Study|Withdrawal by Subject|0|||
155311190|NCT02736409|560572902|FG000|Overall Study|Withdrawal by Subject|4|||
155311191|NCT02736409|560572903|FG001|Overall Study|Withdrawal by Subject|2|||
155311192|NCT02736409|560572904|FG002|Overall Study|Withdrawal by Subject|17|||
155311193|NCT02736409|560572905|FG003|Overall Study|Withdrawal by Subject|3|||
155311194|NCT02736409|560572902|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155311195|NCT02736409|560572903|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155311196|NCT02736409|560572904|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155311197|NCT02736409|560572905|FG003|Overall Study|Non-Compliance with Study Drug|1|||
155311198|NCT02736409|560572902|FG000|Overall Study|Adverse Event|0|||
155311199|NCT02736409|560572903|FG001|Overall Study|Adverse Event|1|||
155311200|NCT02736409|560572904|FG002|Overall Study|Adverse Event|5|||
155311201|NCT02736409|560572905|FG003|Overall Study|Adverse Event|4|||
155311202|NCT02736409|560572902|FG000|Overall Study|Other|0|||
155311203|NCT02736409|560572903|FG001|Overall Study|Other|0|||
155311204|NCT02736409|560572904|FG002|Overall Study|Other|1|||
155311205|NCT02736409|560572905|FG003|Overall Study|Other|1|||
155311206|NCT02736409|560572902|FG000|Overall Study|Pregnancy|0|||
155311207|NCT02736409|560572903|FG001|Overall Study|Pregnancy|0|||
155311208|NCT02736409|560572904|FG002|Overall Study|Pregnancy|1|||
155311209|NCT02736409|560572905|FG003|Overall Study|Pregnancy|0|||
155311210|NCT02736409|560572902|FG000|Overall Study|Lost to Follow-up|0|||
155311211|NCT02736409|560572903|FG001|Overall Study|Lost to Follow-up|0|||
155311212|NCT02736409|560572904|FG002|Overall Study|Lost to Follow-up|2|||
155311213|NCT02736409|560572905|FG003|Overall Study|Lost to Follow-up|1|||
155311214|NCT02736409|560572902|FG000|Overall Study|Physician Decision|0|||
155311215|NCT02736409|560572903|FG001|Overall Study|Physician Decision|0|||
155311216|NCT02736409|560572904|FG002|Overall Study|Physician Decision|0|||
155311217|NCT02736409|560572905|FG003|Overall Study|Physician Decision|2|||
155311218|NCT01415154|560572906|FG000|Overall Study|Lack of Efficacy|4|||
155311219|NCT01415154|560572907|FG001|Overall Study|Lack of Efficacy|5|||
155311220|NCT01415154|560572906|FG000|Overall Study|Withdrawal by Subject|7|||
155311221|NCT01415154|560572907|FG001|Overall Study|Withdrawal by Subject|8|||
155311222|NCT01415154|560572906|FG000|Overall Study|Lost to Follow-up|1|||
155311223|NCT01415154|560572907|FG001|Overall Study|Lost to Follow-up|4|||
155311224|NCT01415154|560572906|FG000|Overall Study|Protocol Violation|0|||
155311225|NCT01415154|560572907|FG001|Overall Study|Protocol Violation|1|||
155311226|NCT01415154|560572906|FG000|Overall Study|Satisfactory Response|0|||
155311227|NCT01415154|560572907|FG001|Overall Study|Satisfactory Response|1|||
155311228|NCT01415154|560572906|FG000|Overall Study|Adverse Event|1|||
155311229|NCT01415154|560572907|FG001|Overall Study|Adverse Event|1|||
155311230|NCT03126019|560572909|FG000|Overall Study|Death|5|||
155311231|NCT03126019|560572910|FG001|Overall Study|Death|27|||
155311232|NCT03126019|560572909|FG000|Overall Study|Lost to Follow-up|2|||
155311233|NCT03126019|560572910|FG001|Overall Study|Lost to Follow-up|4|||
155311234|NCT03126019|560572909|FG000|Overall Study|Withdrawal by Subject|1|||
155311235|NCT03126019|560572910|FG001|Overall Study|Withdrawal by Subject|9|||
154959683|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959684|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
154959685|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
154959686|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
154959687|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
154959688|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
154959689|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959690|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959691|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959692|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959693|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959694|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959695|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959696|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959697|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959698|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959699|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959700|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155066160|NCT02475213|559673823|FG002|Overall Study|Physician Decision|1|||
155066161|NCT02475213|559673824|FG003|Overall Study|Physician Decision|0|||
155311236|NCT03126019|560572909|FG000|Overall Study|Physician Decision|1|||
155311237|NCT03126019|560572910|FG001|Overall Study|Physician Decision|0|||
155311238|NCT03126019|560572909|FG000|Overall Study|Transitioned to Rollover Study|0|||
155311239|NCT03126019|560572910|FG001|Overall Study|Transitioned to Rollover Study|11|||
155066162|NCT02475213|559673825|FG004|Overall Study|Physician Decision|0|||
155066163|NCT02475213|559673826|FG005|Overall Study|Physician Decision|1|||
155066164|NCT02475213|559673827|FG006|Overall Study|Physician Decision|4|||
155066165|NCT02475213|559673828|FG007|Overall Study|Physician Decision|0|||
155066166|NCT02475213|559673821|FG000|Overall Study|Progressive Disease|3|||
155066167|NCT02475213|559673822|FG001|Overall Study|Progressive Disease|2|||
155066168|NCT02475213|559673823|FG002|Overall Study|Progressive Disease|2|||
155066169|NCT02475213|559673824|FG003|Overall Study|Progressive Disease|13|||
155066170|NCT02475213|559673825|FG004|Overall Study|Progressive Disease|15|||
155066171|NCT02475213|559673826|FG005|Overall Study|Progressive Disease|25|||
155066172|NCT02475213|559673827|FG006|Overall Study|Progressive Disease|30|||
155066173|NCT02475213|559673828|FG007|Overall Study|Progressive Disease|10|||
155066174|NCT02475213|559673821|FG000|Overall Study|Death|0|||
155066175|NCT02475213|559673822|FG001|Overall Study|Death|0|||
155066176|NCT02475213|559673823|FG002|Overall Study|Death|0|||
155066177|NCT02475213|559673824|FG003|Overall Study|Death|0|||
155066178|NCT02475213|559673825|FG004|Overall Study|Death|0|||
155066179|NCT02475213|559673826|FG005|Overall Study|Death|4|||
155066180|NCT02475213|559673827|FG006|Overall Study|Death|1|||
155066181|NCT02475213|559673828|FG007|Overall Study|Death|0|||
155066182|NCT02475213|559673821|FG000|Overall Study|Protocol Violation|0|||
155161589|NCT00561925|560028650|FG000|14 Day Lead-In Period|Adverse Event|38|||
155161590|NCT00561925|560028651|FG001|14 Day Lead-In Period|Adverse Event|0|||
155161591|NCT00561925|560028652|FG002|14 Day Lead-In Period|Adverse Event|0|||
155161592|NCT00561925|560028653|FG003|14 Day Lead-In Period|Adverse Event|0|||
155161593|NCT00561925|560028654|FG004|14 Day Lead-In Period|Adverse Event|0|||
155311240|NCT03126019|560572909|FG000|Overall Study|Did Not Return to Site for Care|0|||
155311241|NCT03126019|560572910|FG001|Overall Study|Did Not Return to Site for Care|1|||
155311242|NCT03126019|560572909|FG000|Overall Study|Site Closed|0|||
155311243|NCT03126019|560572910|FG001|Overall Study|Site Closed|1|||
155311244|NCT00170573|560572914|FG000|Overall Study|Violation of inclusion criteria|13|||
155311245|NCT06283173|560572947|FG000|Overall Study|Did not show for first visit|10|||
155311246|NCT06283173|560572947|FG000|Overall Study|Lost to Follow-up|12|||
155311247|NCT06283173|560572947|FG000|Overall Study|Physician Decision|7|||
155311248|NCT05563246|560572955|FG000|Overall Study|Withdrawal by Subject|1|||
155311249|NCT05563246|560572956|FG001|Overall Study|Withdrawal by Subject|2|||
155311250|NCT05563246|560572957|FG002|Overall Study|Withdrawal by Subject|0|||
155311251|NCT05563246|560572958|FG003|Overall Study|Withdrawal by Subject|0|||
155311252|NCT05563246|560572955|FG000|Overall Study|Protocol Deviation|0|||
155311253|NCT05563246|560572956|FG001|Overall Study|Protocol Deviation|1|||
155311254|NCT05563246|560572957|FG002|Overall Study|Protocol Deviation|0|||
155311255|NCT05563246|560572958|FG003|Overall Study|Protocol Deviation|0|||
155311256|NCT05563246|560572955|FG000|Overall Study|Physician Decision|0|||
155311257|NCT05563246|560572956|FG001|Overall Study|Physician Decision|1|||
155311258|NCT05563246|560572957|FG002|Overall Study|Physician Decision|0|||
155311259|NCT05563246|560572958|FG003|Overall Study|Physician Decision|0|||
155311260|NCT05563246|560572955|FG000|Overall Study|Adverse Event|0|||
155311261|NCT05563246|560572956|FG001|Overall Study|Adverse Event|0|||
155311262|NCT05563246|560572957|FG002|Overall Study|Adverse Event|2|||
155311263|NCT05563246|560572958|FG003|Overall Study|Adverse Event|0|||
155311264|NCT05563246|560572955|FG000|Overall Study|Lost to Follow-up|0|||
155311265|NCT05563246|560572956|FG001|Overall Study|Lost to Follow-up|0|||
155311266|NCT05563246|560572957|FG002|Overall Study|Lost to Follow-up|1|||
155311267|NCT05563246|560572958|FG003|Overall Study|Lost to Follow-up|0|||
155311268|NCT03138512|560572963|FG000|Randomization|Participants withdrew consent|0|||
155311269|NCT03138512|560572964|FG001|Randomization|Participants withdrew consent|1|||
155311270|NCT03138512|560572965|FG002|Randomization|Participants withdrew consent|1|||
155311271|NCT03138512|560572966|FG003|Randomization|Participants withdrew consent|0|||
155311272|NCT03138512|560572967|FG004|Randomization|Participants withdrew consent|0|||
155311273|NCT03138512|560572963|FG000|Randomization|Participant no longer meets study criteria|0|||
155311274|NCT03138512|560572964|FG001|Randomization|Participant no longer meets study criteria|3|||
155311275|NCT03138512|560572965|FG002|Randomization|Participant no longer meets study criteria|1|||
155311276|NCT03138512|560572966|FG003|Randomization|Participant no longer meets study criteria|1|||
155311277|NCT03138512|560572967|FG004|Randomization|Participant no longer meets study criteria|3|||
155311278|NCT03138512|560572963|FG000|Randomization|Other reasons|1|||
155311279|NCT03138512|560572964|FG001|Randomization|Other reasons|0|||
155311280|NCT03138512|560572965|FG002|Randomization|Other reasons|0|||
155311281|NCT03138512|560572966|FG003|Randomization|Other reasons|0|||
155311282|NCT03138512|560572967|FG004|Randomization|Other reasons|0|||
155311283|NCT03138512|560572963|FG000|Treatment Part A|Disease recurrence|10|||
155311284|NCT03138512|560572964|FG001|Treatment Part A|Disease recurrence|20|||
155311285|NCT03138512|560572965|FG002|Treatment Part A|Disease recurrence|0|||
155311286|NCT03138512|560572966|FG003|Treatment Part A|Disease recurrence|0|||
155311287|NCT03138512|560572967|FG004|Treatment Part A|Disease recurrence|0|||
155311288|NCT03138512|560572963|FG000|Treatment Part A|Study Drug Toxicity|132|||
155311289|NCT03138512|560572964|FG001|Treatment Part A|Study Drug Toxicity|5|||
155311290|NCT03138512|560572965|FG002|Treatment Part A|Study Drug Toxicity|0|||
155311291|NCT03138512|560572966|FG003|Treatment Part A|Study Drug Toxicity|0|||
155161594|NCT00561925|560028650|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
155161595|NCT00561925|560028651|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
155161596|NCT00561925|560028652|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
155161597|NCT00561925|560028653|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
155161598|NCT00561925|560028654|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
154959701|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959702|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
155161599|NCT00561925|560028650|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
155161600|NCT00561925|560028651|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
155161601|NCT00561925|560028652|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
155161602|NCT00561925|560028653|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
155161603|NCT00561925|560028654|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
155161604|NCT00561925|560028650|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
155161605|NCT00561925|560028651|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
155161606|NCT00561925|560028652|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
155161607|NCT00561925|560028653|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
155161608|NCT00561925|560028654|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
155161609|NCT00561925|560028650|FG000|14 Day Lead-In Period|Other|5|||
155161610|NCT00561925|560028651|FG001|14 Day Lead-In Period|Other|0|||
155161611|NCT00561925|560028652|FG002|14 Day Lead-In Period|Other|0|||
155161612|NCT00561925|560028653|FG003|14 Day Lead-In Period|Other|0|||
155161613|NCT00561925|560028654|FG004|14 Day Lead-In Period|Other|0|||
155161614|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
155161615|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
155161616|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
155161617|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
155161618|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
155161619|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
155161620|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
155161621|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
155161622|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
155161623|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
155161624|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
155161625|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
155161626|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
155161627|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
155161628|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
155161629|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
155161630|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
155161631|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
155161632|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
155161633|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
155161634|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
155066183|NCT02475213|559673822|FG001|Overall Study|Protocol Violation|0|||
155066184|NCT02475213|559673823|FG002|Overall Study|Protocol Violation|0|||
155066185|NCT02475213|559673824|FG003|Overall Study|Protocol Violation|0|||
155066186|NCT02475213|559673825|FG004|Overall Study|Protocol Violation|1|||
155066187|NCT02475213|559673826|FG005|Overall Study|Protocol Violation|0|||
155066188|NCT02475213|559673827|FG006|Overall Study|Protocol Violation|0|||
155066189|NCT02475213|559673828|FG007|Overall Study|Protocol Violation|0|||
155066190|NCT02475213|559673821|FG000|Overall Study|Withdrawal by Subject|0|||
155066191|NCT02475213|559673822|FG001|Overall Study|Withdrawal by Subject|0|||
155066192|NCT02475213|559673823|FG002|Overall Study|Withdrawal by Subject|0|||
155066193|NCT02475213|559673824|FG003|Overall Study|Withdrawal by Subject|1|||
155066194|NCT02475213|559673825|FG004|Overall Study|Withdrawal by Subject|0|||
155066195|NCT02475213|559673826|FG005|Overall Study|Withdrawal by Subject|2|||
155066196|NCT02475213|559673827|FG006|Overall Study|Withdrawal by Subject|2|||
155066197|NCT02475213|559673828|FG007|Overall Study|Withdrawal by Subject|0|||
155066198|NCT02475213|559673821|FG000|Overall Study|Other|0|||
155066199|NCT02475213|559673822|FG001|Overall Study|Other|0|||
155066200|NCT02475213|559673823|FG002|Overall Study|Other|0|||
155066201|NCT02475213|559673824|FG003|Overall Study|Other|1|||
155066202|NCT02475213|559673825|FG004|Overall Study|Other|3|||
155066203|NCT02475213|559673826|FG005|Overall Study|Other|1|||
155066204|NCT02475213|559673827|FG006|Overall Study|Other|0|||
155066205|NCT02475213|559673828|FG007|Overall Study|Other|0|||
155066206|NCT01033136|559673829|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
155066207|NCT01033136|559673830|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
155066208|NCT05383209|559673831|FG000|Overall Study|Adverse Event: Non-ocular|0|||
155066209|NCT05383209|559673832|FG001|Overall Study|Adverse Event: Non-ocular|1|||
155066210|NCT05383209|559673833|FG002|Overall Study|Adverse Event: Non-ocular|0|||
155066211|NCT05383209|559673831|FG000|Overall Study|Lost to Follow-up|2|||
155066212|NCT05383209|559673832|FG001|Overall Study|Lost to Follow-up|1|||
155066213|NCT05383209|559673833|FG002|Overall Study|Lost to Follow-up|4|||
155066214|NCT05383209|559673831|FG000|Overall Study|Withdrawal by Subject|2|||
155066215|NCT05383209|559673832|FG001|Overall Study|Withdrawal by Subject|0|||
155066216|NCT05383209|559673833|FG002|Overall Study|Withdrawal by Subject|1|||
155066217|NCT05383209|559673831|FG000|Overall Study|Death|1|||
155066218|NCT05383209|559673832|FG001|Overall Study|Death|0|||
155066219|NCT05383209|559673833|FG002|Overall Study|Death|0|||
155066220|NCT05383209|559673831|FG000|Overall Study|Other|0|||
155066221|NCT05383209|559673832|FG001|Overall Study|Other|1|||
155066222|NCT05383209|559673833|FG002|Overall Study|Other|0|||
155066223|NCT00717886|559673834|FG000|Overall Study|Withdrawal by Subject|3|||
155066224|NCT00717886|559673834|FG000|Overall Study|Treatment Failure|1|||
155066225|NCT02101294|559673835|FG000|Overall Study|Withdrawal by Subject|5|||
155066226|NCT02101294|559673835|FG000|Overall Study|Lost to Follow-up|6|||
155066227|NCT00797563|559673836|FG000|Overall Study|Adverse Event|1|||
155066228|NCT03416179|559673837|FG000|Overall Study|Death|90|||
155066229|NCT03416179|559673838|FG001|Overall Study|Death|87|||
155066230|NCT03416179|559673839|FG002|Overall Study|Death|117|||
155066231|NCT03416179|559673840|FG003|Overall Study|Death|113|||
155066232|NCT03416179|559673837|FG000|Overall Study|Withdrawal by Subject|15|||
155066233|NCT03416179|559673838|FG001|Overall Study|Withdrawal by Subject|20|||
155066234|NCT03416179|559673839|FG002|Overall Study|Withdrawal by Subject|6|||
155066235|NCT03416179|559673840|FG003|Overall Study|Withdrawal by Subject|9|||
155066236|NCT03416179|559673837|FG000|Overall Study|Lost to Follow-up|1|||
155066237|NCT03416179|559673838|FG001|Overall Study|Lost to Follow-up|1|||
155066238|NCT03416179|559673839|FG002|Overall Study|Lost to Follow-up|0|||
155066239|NCT03416179|559673840|FG003|Overall Study|Lost to Follow-up|3|||
155066240|NCT03416179|559673837|FG000|Overall Study|Study participation terminated by Sponsor|93|||
155066241|NCT03416179|559673838|FG001|Overall Study|Study participation terminated by Sponsor|91|||
155066242|NCT03416179|559673839|FG002|Overall Study|Study participation terminated by Sponsor|26|||
155066243|NCT03416179|559673840|FG003|Overall Study|Study participation terminated by Sponsor|31|||
155066244|NCT03416179|559673837|FG000|Overall Study|Other|2|||
155066245|NCT03416179|559673838|FG001|Overall Study|Other|3|||
155066246|NCT03416179|559673839|FG002|Overall Study|Other|1|||
155066247|NCT03416179|559673840|FG003|Overall Study|Other|0|||
155066248|NCT00688597|559673841|FG000|Overall Study|Adverse Event|2|||
155066249|NCT00688597|559673842|FG001|Overall Study|Adverse Event|0|||
155066250|NCT00688597|559673843|FG002|Overall Study|Adverse Event|0|||
155066251|NCT00688597|559673841|FG000|Overall Study|Physician Decision|1|||
155066252|NCT00688597|559673842|FG001|Overall Study|Physician Decision|0|||
155066253|NCT00688597|559673843|FG002|Overall Study|Physician Decision|0|||
155066254|NCT02709369|559673844|FG000|Overall Study|Lost to Follow-up|15|||
155066255|NCT02709369|559673844|FG000|Overall Study|Withdrawal by Subject|10|||
155066256|NCT02709369|559673844|FG000|Overall Study|Did not received intervention|2|||
155066257|NCT02755090|559673846|FG000|Overall Study|equipment malfunction|1|||
155066258|NCT02755090|559673847|FG001|Overall Study|equipment malfunction|0|||
155066259|NCT00207740|559673848|FG000|Overall Study|Adverse Event|4|||
155066260|NCT00207740|559673849|FG001|Overall Study|Adverse Event|14|||
155066261|NCT00207740|559673850|FG002|Overall Study|Adverse Event|14|||
155066262|NCT00207740|559673851|FG003|Overall Study|Adverse Event|11|||
155066263|NCT00207740|559673848|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155066264|NCT00207740|559673849|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155066265|NCT00207740|559673850|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155066266|NCT00207740|559673851|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
155066267|NCT00207740|559673848|FG000|Overall Study|Lost to Follow-up|0|||
155066268|NCT00207740|559673849|FG001|Overall Study|Lost to Follow-up|2|||
155066269|NCT00207740|559673850|FG002|Overall Study|Lost to Follow-up|1|||
155066270|NCT00207740|559673851|FG003|Overall Study|Lost to Follow-up|1|||
155066271|NCT00207740|559673848|FG000|Overall Study|Death|0|||
155066272|NCT00207740|559673849|FG001|Overall Study|Death|0|||
155066273|NCT00207740|559673850|FG002|Overall Study|Death|0|||
155066274|NCT00207740|559673851|FG003|Overall Study|Death|1|||
155066275|NCT00207740|559673848|FG000|Overall Study|Sponsor Directive|22|||
155066276|NCT00207740|559673849|FG001|Overall Study|Sponsor Directive|15|||
155066277|NCT00207740|559673850|FG002|Overall Study|Sponsor Directive|16|||
155311292|NCT03138512|560572967|FG004|Treatment Part A|Study Drug Toxicity|0|||
155311293|NCT03138512|560572963|FG000|Treatment Part A|Death|1|||
155311294|NCT03138512|560572964|FG001|Treatment Part A|Death|0|||
155311295|NCT03138512|560572965|FG002|Treatment Part A|Death|0|||
155311296|NCT03138512|560572966|FG003|Treatment Part A|Death|0|||
155311297|NCT03138512|560572967|FG004|Treatment Part A|Death|0|||
155311298|NCT03138512|560572963|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
155311299|NCT03138512|560572964|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
155311300|NCT03138512|560572965|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
155311301|NCT03138512|560572966|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
155311302|NCT03138512|560572967|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
155311303|NCT03138512|560572963|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
155311304|NCT03138512|560572964|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
155311305|NCT03138512|560572965|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
155311306|NCT03138512|560572966|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
155311307|NCT03138512|560572967|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
155311308|NCT03138512|560572963|FG000|Treatment Part A|Participant withdrew consent|2|||
155311309|NCT03138512|560572964|FG001|Treatment Part A|Participant withdrew consent|4|||
155311310|NCT03138512|560572965|FG002|Treatment Part A|Participant withdrew consent|0|||
155311311|NCT03138512|560572966|FG003|Treatment Part A|Participant withdrew consent|0|||
155311312|NCT03138512|560572967|FG004|Treatment Part A|Participant withdrew consent|0|||
155066278|NCT00207740|559673851|FG003|Overall Study|Sponsor Directive|21|||
155066279|NCT00207740|559673848|FG000|Overall Study|Other|2|||
155066280|NCT00207740|559673849|FG001|Overall Study|Other|10|||
155066281|NCT00207740|559673850|FG002|Overall Study|Other|7|||
155311313|NCT03138512|560572963|FG000|Treatment Part A|Lost to Follow-up|0|||
155311314|NCT03138512|560572964|FG001|Treatment Part A|Lost to Follow-up|1|||
155311315|NCT03138512|560572965|FG002|Treatment Part A|Lost to Follow-up|0|||
155311316|NCT03138512|560572966|FG003|Treatment Part A|Lost to Follow-up|0|||
155311317|NCT03138512|560572967|FG004|Treatment Part A|Lost to Follow-up|0|||
155311318|NCT03138512|560572963|FG000|Treatment Part A|Poor/non-compliance|1|||
155311319|NCT03138512|560572964|FG001|Treatment Part A|Poor/non-compliance|0|||
155066282|NCT00207740|559673851|FG003|Overall Study|Other|5|||
155311320|NCT03138512|560572965|FG002|Treatment Part A|Poor/non-compliance|0|||
155311321|NCT03138512|560572966|FG003|Treatment Part A|Poor/non-compliance|0|||
155311322|NCT03138512|560572967|FG004|Treatment Part A|Poor/non-compliance|0|||
155311323|NCT03138512|560572963|FG000|Treatment Part A|Pregnancy|0|||
155311324|NCT03138512|560572964|FG001|Treatment Part A|Pregnancy|1|||
155311325|NCT03138512|560572965|FG002|Treatment Part A|Pregnancy|0|||
155311326|NCT03138512|560572966|FG003|Treatment Part A|Pregnancy|0|||
155311327|NCT03138512|560572967|FG004|Treatment Part A|Pregnancy|0|||
155311328|NCT03138512|560572963|FG000|Treatment Part A|Other reasons|11|||
155311329|NCT03138512|560572964|FG001|Treatment Part A|Other reasons|8|||
155311330|NCT03138512|560572965|FG002|Treatment Part A|Other reasons|0|||
155066283|NCT04797169|559673852|FG000|Overall Study|Lost to Follow-up|84|||
155311331|NCT03138512|560572966|FG003|Treatment Part A|Other reasons|0|||
155311332|NCT03138512|560572967|FG004|Treatment Part A|Other reasons|0|||
155311333|NCT03138512|560572963|FG000|Treatment Part B|Disease recurrence|0|||
155311334|NCT03138512|560572964|FG001|Treatment Part B|Disease recurrence|0|||
155311335|NCT03138512|560572965|FG002|Treatment Part B|Disease recurrence|6|||
155311336|NCT03138512|560572966|FG003|Treatment Part B|Disease recurrence|12|||
155311337|NCT03138512|560572967|FG004|Treatment Part B|Disease recurrence|10|||
155066284|NCT04797169|559673853|FG001|Overall Study|Lost to Follow-up|67|||
155066285|NCT04797169|559673852|FG000|Overall Study|Pregnancy|1|||
155066286|NCT04797169|559673853|FG001|Overall Study|Pregnancy|3|||
155066287|NCT04797169|559673852|FG000|Overall Study|Withdrawal by Subject|27|||
155066288|NCT04797169|559673853|FG001|Overall Study|Withdrawal by Subject|35|||
155066289|NCT03916926|559673854|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
155066290|NCT03916926|559673855|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
155066291|NCT03916926|559673854|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
155311338|NCT03138512|560572963|FG000|Treatment Part B|Study drug toxicity|0|||
155311339|NCT03138512|560572964|FG001|Treatment Part B|Study drug toxicity|0|||
155311340|NCT03138512|560572965|FG002|Treatment Part B|Study drug toxicity|63|||
155311341|NCT03138512|560572966|FG003|Treatment Part B|Study drug toxicity|3|||
155311342|NCT03138512|560572967|FG004|Treatment Part B|Study drug toxicity|45|||
155311343|NCT03138512|560572963|FG000|Treatment Part B|Death|0|||
155311344|NCT03138512|560572964|FG001|Treatment Part B|Death|0|||
155311345|NCT03138512|560572965|FG002|Treatment Part B|Death|1|||
155311346|NCT03138512|560572966|FG003|Treatment Part B|Death|0|||
155311347|NCT03138512|560572967|FG004|Treatment Part B|Death|0|||
155311348|NCT03138512|560572963|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
155311349|NCT03138512|560572964|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
155311350|NCT03138512|560572965|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
155311351|NCT03138512|560572966|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
155311352|NCT03138512|560572967|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
155311353|NCT03138512|560572963|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
155311354|NCT03138512|560572964|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
155311355|NCT03138512|560572965|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
155311356|NCT03138512|560572966|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
155311357|NCT03138512|560572967|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
155311358|NCT03138512|560572963|FG000|Treatment Part B|Participant withdrew consent|0|||
155311359|NCT03138512|560572964|FG001|Treatment Part B|Participant withdrew consent|0|||
155066292|NCT03916926|559673855|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
155066293|NCT03916926|559673854|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
155066294|NCT03916926|559673855|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
155066295|NCT03916926|559673854|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
155066296|NCT03916926|559673855|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
155066297|NCT02337829|559673858|FG000|Overall Study|Death|0|||
155066298|NCT02337829|559673859|FG001|Overall Study|Death|1|||
155066299|NCT02337829|559673860|FG002|Overall Study|Death|0|||
155066300|NCT02337829|559673861|FG003|Overall Study|Death|0|||
155066301|NCT02337829|559673858|FG000|Overall Study|Study terminated by sponsor|12|||
155066302|NCT02337829|559673859|FG001|Overall Study|Study terminated by sponsor|10|||
155066303|NCT02337829|559673860|FG002|Overall Study|Study terminated by sponsor|5|||
155066304|NCT02337829|559673861|FG003|Overall Study|Study terminated by sponsor|6|||
155066305|NCT02337829|559673858|FG000|Overall Study|discontinued for other reasons|6|||
155066306|NCT02337829|559673859|FG001|Overall Study|discontinued for other reasons|3|||
155066307|NCT02337829|559673860|FG002|Overall Study|discontinued for other reasons|1|||
155066308|NCT02337829|559673861|FG003|Overall Study|discontinued for other reasons|4|||
155066309|NCT02763566|559673871|FG000|Overall Study|Lost to Follow-up|1|||
155066310|NCT02763566|559673872|FG001|Overall Study|Lost to Follow-up|4|||
155066311|NCT02763566|559673873|FG002|Overall Study|Lost to Follow-up|0|||
155066312|NCT02763566|559673874|FG003|Overall Study|Lost to Follow-up|1|||
155066313|NCT02763566|559673871|FG000|Overall Study|On study treatment at study conclusion|114|||
155066314|NCT02763566|559673872|FG001|Overall Study|On study treatment at study conclusion|34|||
155066315|NCT02763566|559673873|FG002|Overall Study|On study treatment at study conclusion|54|||
155066316|NCT02763566|559673874|FG003|Overall Study|On study treatment at study conclusion|13|||
155066317|NCT02763566|559673871|FG000|Overall Study|Withdrawal by Subject|3|||
155066318|NCT02763566|559673872|FG001|Overall Study|Withdrawal by Subject|1|||
155066319|NCT02763566|559673873|FG002|Overall Study|Withdrawal by Subject|0|||
155066320|NCT02763566|559673874|FG003|Overall Study|Withdrawal by Subject|0|||
155066321|NCT00790036|559673875|FG000|Overall Study|Abnormal lab values|3|||
155066322|NCT00790036|559673876|FG001|Overall Study|Abnormal lab values|2|||
155066323|NCT00790036|559673875|FG000|Overall Study|Administrative problems|5|||
155066324|NCT00790036|559673876|FG001|Overall Study|Administrative problems|9|||
155066325|NCT00790036|559673875|FG000|Overall Study|Adverse Event|113|||
155066326|NCT00790036|559673876|FG001|Overall Study|Adverse Event|44|||
155066327|NCT00790036|559673875|FG000|Overall Study|Death|1|||
155066328|NCT00790036|559673876|FG001|Overall Study|Death|0|||
155066329|NCT00790036|559673875|FG000|Overall Study|Disease progression|24|||
155066330|NCT00790036|559673876|FG001|Overall Study|Disease progression|48|||
155066331|NCT00790036|559673875|FG000|Overall Study|Lost to Follow-up|1|||
155066332|NCT00790036|559673876|FG001|Overall Study|Lost to Follow-up|2|||
155066333|NCT00790036|559673875|FG000|Overall Study|Protocol Violation|10|||
155066334|NCT00790036|559673876|FG001|Overall Study|Protocol Violation|2|||
155066335|NCT00790036|559673875|FG000|Overall Study|Withdrawal by Subject|18|||
155066336|NCT00790036|559673876|FG001|Overall Study|Withdrawal by Subject|7|||
155066337|NCT00790036|559673875|FG000|Overall Study|Subject/guardian decision|20|||
155066338|NCT00790036|559673876|FG001|Overall Study|Subject/guardian decision|7|||
155311360|NCT03138512|560572965|FG002|Treatment Part B|Participant withdrew consent|1|||
155311361|NCT03138512|560572966|FG003|Treatment Part B|Participant withdrew consent|1|||
155311362|NCT03138512|560572967|FG004|Treatment Part B|Participant withdrew consent|2|||
155311363|NCT03138512|560572963|FG000|Treatment Part B|Lost to Follow-up|0|||
155311364|NCT03138512|560572964|FG001|Treatment Part B|Lost to Follow-up|0|||
155311365|NCT03138512|560572965|FG002|Treatment Part B|Lost to Follow-up|0|||
155311366|NCT03138512|560572966|FG003|Treatment Part B|Lost to Follow-up|1|||
155311367|NCT03138512|560572967|FG004|Treatment Part B|Lost to Follow-up|0|||
155311368|NCT03138512|560572963|FG000|Treatment Part B|Poor/non-compliance|0|||
155161635|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
155161636|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
155161637|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
155161638|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
155161639|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
155161640|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
155161641|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
155161642|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
155161643|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
155161644|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Death|0|||
155311369|NCT03138512|560572964|FG001|Treatment Part B|Poor/non-compliance|0|||
155311370|NCT03138512|560572965|FG002|Treatment Part B|Poor/non-compliance|1|||
155311371|NCT03138512|560572966|FG003|Treatment Part B|Poor/non-compliance|1|||
155311372|NCT03138512|560572967|FG004|Treatment Part B|Poor/non-compliance|1|||
155311373|NCT03138512|560572963|FG000|Treatment Part B|Other reasons|0|||
155311374|NCT03138512|560572964|FG001|Treatment Part B|Other reasons|0|||
155161645|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Death|6|||
155161646|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Death|3|||
155161647|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Death|0|||
155161648|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Death|0|||
155161649|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155161650|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
155161651|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155161652|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155161653|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
155161654|NCT00561925|560028650|FG000|144-week Double-blind, Double-dummy|Other|0|||
155161655|NCT00561925|560028651|FG001|144-week Double-blind, Double-dummy|Other|8|||
155161656|NCT00561925|560028652|FG002|144-week Double-blind, Double-dummy|Other|11|||
155161657|NCT00561925|560028653|FG003|144-week Double-blind, Double-dummy|Other|0|||
155161658|NCT00561925|560028654|FG004|144-week Double-blind, Double-dummy|Other|0|||
155161659|NCT00561925|560028650|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
155161660|NCT00561925|560028651|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
155161661|NCT00561925|560028652|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
155161662|NCT00561925|560028653|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
155161663|NCT00561925|560028654|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
155161664|NCT02556177|560028655|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
155161665|NCT02556177|560028656|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
155161666|NCT03818321|560028658|FG000|Overall Study|Withdrawal by Subject|1|||
155161667|NCT03818321|560028659|FG001|Overall Study|Withdrawal by Subject|2|||
155161668|NCT01721044|560028664|FG000|Treatment Period|Adverse Event|7|||
155161669|NCT01721044|560028665|FG001|Treatment Period|Adverse Event|7|||
155161670|NCT01721044|560028666|FG002|Treatment Period|Adverse Event|10|||
155066339|NCT02442349|559673877|FG000|Overall Study|Death|95|||
155066340|NCT02442349|559673877|FG000|Overall Study|Withdrawal by Subject|27|||
155066341|NCT02442349|559673877|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
155066342|NCT02442349|559673877|FG000|Overall Study|Lost to Follow-up|1|||
155066343|NCT01551173|559673878|FG000|Overall Study|Withdrawal by Subject|11|||
155066344|NCT01551173|559673879|FG001|Overall Study|Withdrawal by Subject|16|||
155066345|NCT01551173|559673878|FG000|Overall Study|Adverse Event|7|||
155066346|NCT01551173|559673879|FG001|Overall Study|Adverse Event|6|||
155066347|NCT01551173|559673878|FG000|Overall Study|Lost to Follow-up|5|||
155066348|NCT01551173|559673879|FG001|Overall Study|Lost to Follow-up|7|||
155066349|NCT01551173|559673878|FG000|Overall Study|Other|5|||
155066350|NCT01551173|559673879|FG001|Overall Study|Other|3|||
155066351|NCT04530344|559673880|FG000|Overall Study|Lost to Follow-up|3|||
155066352|NCT04530344|559673881|FG001|Overall Study|Lost to Follow-up|3|||
155066353|NCT04530344|559673882|FG002|Overall Study|Lost to Follow-up|3|||
155066354|NCT04530344|559673883|FG003|Overall Study|Lost to Follow-up|10|||
155066355|NCT04530344|559673880|FG000|Overall Study|Withdrawal by Subject|14|||
155066356|NCT04530344|559673881|FG001|Overall Study|Withdrawal by Subject|5|||
155311375|NCT03138512|560572965|FG002|Treatment Part B|Other reasons|3|||
155311376|NCT03138512|560572966|FG003|Treatment Part B|Other reasons|1|||
155161671|NCT01721044|560028664|FG000|Treatment Period|Death|0|||
155161672|NCT01721044|560028665|FG001|Treatment Period|Death|0|||
155161673|NCT01721044|560028666|FG002|Treatment Period|Death|1|||
155161674|NCT01721044|560028664|FG000|Treatment Period|Lack of Efficacy|16|||
155161675|NCT01721044|560028665|FG001|Treatment Period|Lack of Efficacy|4|||
155161676|NCT01721044|560028666|FG002|Treatment Period|Lack of Efficacy|4|||
155311377|NCT03138512|560572967|FG004|Treatment Part B|Other reasons|5|||
155311378|NCT04177823|560572976|FG000|Overall Study|Physician Decision|1|||
155311379|NCT04177823|560572976|FG000|Overall Study|Withdrawal by Subject|1|||
155311380|NCT04229992|560572977|FG000|Overall Study|Withdrawal by Subject|0|||
155311381|NCT04229992|560572978|FG001|Overall Study|Withdrawal by Subject|2|||
155311382|NCT04229992|560572979|FG002|Overall Study|Withdrawal by Subject|1|||
155311383|NCT04229992|560572980|FG003|Overall Study|Withdrawal by Subject|1|||
155311384|NCT04229992|560572977|FG000|Overall Study|Adverse Event|1|||
155311385|NCT04229992|560572978|FG001|Overall Study|Adverse Event|1|||
155311386|NCT04229992|560572979|FG002|Overall Study|Adverse Event|3|||
155311387|NCT04229992|560572980|FG003|Overall Study|Adverse Event|1|||
155311388|NCT04229992|560572977|FG000|Overall Study|Lost to Follow-up|0|||
155311389|NCT04229992|560572978|FG001|Overall Study|Lost to Follow-up|0|||
155311390|NCT04229992|560572979|FG002|Overall Study|Lost to Follow-up|0|||
155311391|NCT04229992|560572980|FG003|Overall Study|Lost to Follow-up|1|||
155311392|NCT04169373|560572981|FG000|Week 1 to Week 14|Adverse Event|1|||
155311393|NCT04169373|560572982|FG001|Week 1 to Week 14|Adverse Event|0|||
155311394|NCT04169373|560572983|FG002|Week 1 to Week 14|Adverse Event|1|||
155311395|NCT04169373|560572984|FG003|Week 1 to Week 14|Adverse Event|2|||
155311396|NCT04169373|560572981|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
155311397|NCT04169373|560572982|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
155311398|NCT04169373|560572983|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
155311399|NCT04169373|560572984|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
155311400|NCT04169373|560572981|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
155311401|NCT04169373|560572982|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
155311402|NCT04169373|560572983|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
155311403|NCT04169373|560572984|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
155311404|NCT04169373|560572981|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
155311405|NCT04169373|560572982|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
155311406|NCT04169373|560572983|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
155311407|NCT04169373|560572984|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
155311408|NCT04169373|560572981|FG000|Week 1 to Week 14|Other|1|||
155311409|NCT04169373|560572982|FG001|Week 1 to Week 14|Other|3|||
155311410|NCT04169373|560572983|FG002|Week 1 to Week 14|Other|3|||
155311411|NCT04169373|560572984|FG003|Week 1 to Week 14|Other|5|||
155311412|NCT04169373|560572981|FG000|Week 14 to Week 52|Adverse Event|1|||
155311413|NCT04169373|560572982|FG001|Week 14 to Week 52|Adverse Event|0|||
155311414|NCT04169373|560572983|FG002|Week 14 to Week 52|Adverse Event|0|||
155311415|NCT04169373|560572984|FG003|Week 14 to Week 52|Adverse Event|1|||
155311416|NCT04169373|560572981|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
155311417|NCT04169373|560572982|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
155311418|NCT04169373|560572983|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
155311419|NCT04169373|560572984|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
155311420|NCT04169373|560572981|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
155311421|NCT04169373|560572982|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
155161677|NCT01721044|560028664|FG000|Treatment Period|Lost to Follow-up|0|||
155161678|NCT01721044|560028665|FG001|Treatment Period|Lost to Follow-up|0|||
155161679|NCT01721044|560028666|FG002|Treatment Period|Lost to Follow-up|1|||
155161680|NCT01721044|560028664|FG000|Treatment Period|Physician Decision|1|||
155161681|NCT01721044|560028665|FG001|Treatment Period|Physician Decision|0|||
155161682|NCT01721044|560028666|FG002|Treatment Period|Physician Decision|2|||
155161683|NCT01721044|560028664|FG000|Treatment Period|Protocol Violation|1|||
155161684|NCT01721044|560028665|FG001|Treatment Period|Protocol Violation|0|||
155161685|NCT01721044|560028666|FG002|Treatment Period|Protocol Violation|0|||
155161686|NCT01721044|560028664|FG000|Treatment Period|Withdrawal by Subject|7|||
155161687|NCT01721044|560028665|FG001|Treatment Period|Withdrawal by Subject|6|||
155161688|NCT01721044|560028666|FG002|Treatment Period|Withdrawal by Subject|1|||
155161689|NCT01499355|560028667|FG000|Run-In Period|Study Termination|15|||
155161690|NCT01499355|560028668|FG001|Run-In Period|Study Termination|0|||
155161691|NCT01499355|560028669|FG002|Run-In Period|Study Termination|0|||
155161692|NCT01499355|560028670|FG003|Run-In Period|Study Termination|0|||
155161693|NCT01499355|560028667|FG000|Run-In Period|Other|3|||
155161694|NCT01499355|560028668|FG001|Run-In Period|Other|0|||
155161695|NCT01499355|560028669|FG002|Run-In Period|Other|0|||
155161696|NCT01499355|560028670|FG003|Run-In Period|Other|0|||
155161697|NCT01499355|560028667|FG000|Run-In Period|Death|2|||
155161698|NCT01499355|560028668|FG001|Run-In Period|Death|0|||
155161699|NCT01499355|560028669|FG002|Run-In Period|Death|0|||
155161700|NCT01499355|560028670|FG003|Run-In Period|Death|0|||
155161701|NCT01499355|560028667|FG000|Run-In Period|Investigator Decision|2|||
155161702|NCT01499355|560028668|FG001|Run-In Period|Investigator Decision|0|||
155161703|NCT01499355|560028669|FG002|Run-In Period|Investigator Decision|0|||
155161704|NCT01499355|560028670|FG003|Run-In Period|Investigator Decision|0|||
155161705|NCT01499355|560028667|FG000|Run-In Period|Consent Withdrawn|1|||
155161706|NCT01499355|560028668|FG001|Run-In Period|Consent Withdrawn|0|||
155161707|NCT01499355|560028669|FG002|Run-In Period|Consent Withdrawn|0|||
155161708|NCT01499355|560028670|FG003|Run-In Period|Consent Withdrawn|0|||
155161709|NCT01499355|560028667|FG000|Run-In Period|Adverse Event|8|||
155161710|NCT01499355|560028668|FG001|Run-In Period|Adverse Event|0|||
155161711|NCT01499355|560028669|FG002|Run-In Period|Adverse Event|0|||
155161712|NCT01499355|560028670|FG003|Run-In Period|Adverse Event|0|||
155161713|NCT01499355|560028667|FG000|Double-Blind Period|Adverse Event|0|||
155161714|NCT01499355|560028668|FG001|Double-Blind Period|Adverse Event|2|||
155161715|NCT01499355|560028669|FG002|Double-Blind Period|Adverse Event|3|||
155161716|NCT01499355|560028670|FG003|Double-Blind Period|Adverse Event|2|||
155161717|NCT01499355|560028667|FG000|Double-Blind Period|Study Termination|0|||
155161718|NCT01499355|560028668|FG001|Double-Blind Period|Study Termination|18|||
155161719|NCT01499355|560028669|FG002|Double-Blind Period|Study Termination|16|||
155161720|NCT01499355|560028670|FG003|Double-Blind Period|Study Termination|14|||
155161721|NCT01499355|560028667|FG000|Double-Blind Period|Other|0|||
155161722|NCT01499355|560028668|FG001|Double-Blind Period|Other|1|||
155161723|NCT01499355|560028669|FG002|Double-Blind Period|Other|2|||
155161724|NCT01499355|560028670|FG003|Double-Blind Period|Other|2|||
155161725|NCT01499355|560028667|FG000|Double-Blind Period|Death|0|||
155161726|NCT01499355|560028668|FG001|Double-Blind Period|Death|1|||
155161727|NCT01499355|560028669|FG002|Double-Blind Period|Death|0|||
155161728|NCT01499355|560028670|FG003|Double-Blind Period|Death|0|||
155161729|NCT01499355|560028667|FG000|Double-Blind Period|Investigator Decision|0|||
155161730|NCT01499355|560028668|FG001|Double-Blind Period|Investigator Decision|0|||
155161731|NCT01499355|560028669|FG002|Double-Blind Period|Investigator Decision|3|||
155161732|NCT01499355|560028670|FG003|Double-Blind Period|Investigator Decision|3|||
155161733|NCT01499355|560028667|FG000|Double-Blind Period|Consent Withdrawn|0|||
155161734|NCT01499355|560028668|FG001|Double-Blind Period|Consent Withdrawn|0|||
155161735|NCT01499355|560028669|FG002|Double-Blind Period|Consent Withdrawn|1|||
155161736|NCT01499355|560028670|FG003|Double-Blind Period|Consent Withdrawn|2|||
155161737|NCT01499355|560028667|FG000|Double-Blind Period|Lost to Follow-up|0|||
155161738|NCT01499355|560028668|FG001|Double-Blind Period|Lost to Follow-up|1|||
155161739|NCT01499355|560028669|FG002|Double-Blind Period|Lost to Follow-up|0|||
155161740|NCT01499355|560028670|FG003|Double-Blind Period|Lost to Follow-up|0|||
155161741|NCT02420821|560028672|FG000|Overall Study|Lost to Follow-up|6|||
155161742|NCT02420821|560028673|FG001|Overall Study|Lost to Follow-up|6|||
155161743|NCT02420821|560028672|FG000|Overall Study|Non-compliance|0|||
155161744|NCT02420821|560028673|FG001|Overall Study|Non-compliance|2|||
155161745|NCT02420821|560028672|FG000|Overall Study|Physician Decision|6|||
155161746|NCT02420821|560028673|FG001|Overall Study|Physician Decision|2|||
155161747|NCT02420821|560028672|FG000|Overall Study|Withdrawal by Subject|32|||
155161748|NCT02420821|560028673|FG001|Overall Study|Withdrawal by Subject|25|||
155161749|NCT02420821|560028672|FG000|Overall Study|Death|270|||
155161750|NCT02420821|560028673|FG001|Overall Study|Death|263|||
155161751|NCT02420821|560028672|FG000|Overall Study|Study Terminated By Sponsor|145|||
155161752|NCT02420821|560028673|FG001|Overall Study|Study Terminated By Sponsor|149|||
155161753|NCT02420821|560028672|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
155161754|NCT02420821|560028673|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
155161755|NCT02420821|560028672|FG000|Overall Study|Adverse Event|0|||
155161756|NCT02420821|560028673|FG001|Overall Study|Adverse Event|1|||
155161757|NCT02420821|560028672|FG000|Overall Study|Protinuria|0|||
155161758|NCT02420821|560028673|FG001|Overall Study|Protinuria|1|||
155161759|NCT02420821|560028672|FG000|Overall Study|Progressive Disease|1|||
155161760|NCT02420821|560028673|FG001|Overall Study|Progressive Disease|1|||
155161761|NCT02420821|560028672|FG000|Overall Study|Disease Progression|0|||
155161762|NCT02420821|560028673|FG001|Overall Study|Disease Progression|1|||
155161763|NCT02420821|560028672|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
155161764|NCT02420821|560028673|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
155161765|NCT03133793|560028682|FG000|Overall Study|Withdrawal by Subject|0|||
155161766|NCT03133793|560028683|FG001|Overall Study|Withdrawal by Subject|4|||
155161767|NCT03133793|560028684|FG002|Overall Study|Withdrawal by Subject|2|||
155161768|NCT03133793|560028685|FG003|Overall Study|Withdrawal by Subject|4|||
155161769|NCT03133793|560028682|FG000|Overall Study|Lost to Follow-up|1|||
155161770|NCT03133793|560028683|FG001|Overall Study|Lost to Follow-up|0|||
155161771|NCT03133793|560028684|FG002|Overall Study|Lost to Follow-up|2|||
155161772|NCT03133793|560028685|FG003|Overall Study|Lost to Follow-up|0|||
155161773|NCT03133793|560028682|FG000|Overall Study|Death|0|||
155161774|NCT03133793|560028683|FG001|Overall Study|Death|0|||
155161775|NCT03133793|560028684|FG002|Overall Study|Death|0|||
155161776|NCT03133793|560028685|FG003|Overall Study|Death|1|||
155161777|NCT03486834|560028686|FG000|Overall Study|Withdrawal by Subject|46|||
155161778|NCT03486834|560028687|FG001|Overall Study|Withdrawal by Subject|46|||
155161779|NCT03486834|560028688|FG002|Overall Study|Withdrawal by Subject|52|||
155161780|NCT03486834|560028686|FG000|Overall Study|Adverse Event|8|||
155161781|NCT03486834|560028687|FG001|Overall Study|Adverse Event|7|||
155161782|NCT03486834|560028688|FG002|Overall Study|Adverse Event|0|||
155161783|NCT03486834|560028686|FG000|Overall Study|Lost to Follow-up|41|||
155161784|NCT03486834|560028687|FG001|Overall Study|Lost to Follow-up|24|||
155161785|NCT03486834|560028688|FG002|Overall Study|Lost to Follow-up|39|||
155161786|NCT03486834|560028686|FG000|Overall Study|Non-compliance with Study Drug|2|||
155161787|NCT03486834|560028687|FG001|Overall Study|Non-compliance with Study Drug|2|||
155161788|NCT03486834|560028688|FG002|Overall Study|Non-compliance with Study Drug|0|||
155161789|NCT03486834|560028686|FG000|Overall Study|Physician Decision|5|||
155161790|NCT03486834|560028687|FG001|Overall Study|Physician Decision|2|||
155161791|NCT03486834|560028688|FG002|Overall Study|Physician Decision|3|||
155161792|NCT03486834|560028686|FG000|Overall Study|Pregnancy|10|||
155161793|NCT03486834|560028687|FG001|Overall Study|Pregnancy|12|||
155161794|NCT03486834|560028688|FG002|Overall Study|Pregnancy|12|||
155161795|NCT03486834|560028686|FG000|Overall Study|Protocol Deviation|2|||
155161796|NCT03486834|560028687|FG001|Overall Study|Protocol Deviation|3|||
155161797|NCT03486834|560028688|FG002|Overall Study|Protocol Deviation|3|||
155161798|NCT03486834|560028686|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155161799|NCT03486834|560028687|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155161800|NCT03486834|560028688|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155161801|NCT03486834|560028686|FG000|Overall Study|Randomized but not treated|4|||
155161802|NCT03486834|560028687|FG001|Overall Study|Randomized but not treated|4|||
155161803|NCT03486834|560028688|FG002|Overall Study|Randomized but not treated|1|||
155161804|NCT02745119|560028690|FG000|Overall Study|Adverse Event|1|||
155161805|NCT02745119|560028691|FG001|Overall Study|Adverse Event|0|||
155161806|NCT02745119|560028692|FG002|Overall Study|Adverse Event|1|||
155311422|NCT04169373|560572983|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
155311423|NCT04169373|560572984|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
155311424|NCT04169373|560572981|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
155311425|NCT04169373|560572982|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
155311426|NCT04169373|560572983|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
155311427|NCT04169373|560572984|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
155311428|NCT04169373|560572981|FG000|Week 14 to Week 52|Other|4|||
155311429|NCT04169373|560572982|FG001|Week 14 to Week 52|Other|5|||
155311430|NCT04169373|560572983|FG002|Week 14 to Week 52|Other|4|||
155311431|NCT04169373|560572984|FG003|Week 14 to Week 52|Other|5|||
155311432|NCT04169373|560572981|FG000|Week 14 to Week 52|Ongoing|0|||
155311433|NCT04169373|560572982|FG001|Week 14 to Week 52|Ongoing|1|||
155311434|NCT04169373|560572983|FG002|Week 14 to Week 52|Ongoing|0|||
155311435|NCT04169373|560572984|FG003|Week 14 to Week 52|Ongoing|0|||
155311436|NCT04610892|560572985|FG000|Overall Study|Adverse Event|1|||
155311437|NCT04610892|560572986|FG001|Overall Study|Adverse Event|0|||
155311438|NCT04610892|560572987|FG002|Overall Study|Adverse Event|0|||
155311439|NCT04610892|560572988|FG003|Overall Study|Adverse Event|1|||
155311440|NCT04610892|560572989|FG004|Overall Study|Adverse Event|3|||
155311441|NCT04610892|560572985|FG000|Overall Study|Death|0|||
155311442|NCT04610892|560572986|FG001|Overall Study|Death|1|||
155311443|NCT04610892|560572987|FG002|Overall Study|Death|0|||
155066357|NCT04530344|559673882|FG002|Overall Study|Withdrawal by Subject|18|||
155066358|NCT04530344|559673883|FG003|Overall Study|Withdrawal by Subject|33|||
155066359|NCT04530344|559673880|FG000|Overall Study|Adverse Event|0|||
155066360|NCT04530344|559673881|FG001|Overall Study|Adverse Event|0|||
155066361|NCT04530344|559673882|FG002|Overall Study|Adverse Event|0|||
155066362|NCT04530344|559673883|FG003|Overall Study|Adverse Event|1|||
155066363|NCT04530344|559673880|FG000|Overall Study|Lack of Efficacy|0|||
155066364|NCT04530344|559673881|FG001|Overall Study|Lack of Efficacy|0|||
155066365|NCT04530344|559673882|FG002|Overall Study|Lack of Efficacy|0|||
155066366|NCT04530344|559673883|FG003|Overall Study|Lack of Efficacy|1|||
155066367|NCT04530344|559673880|FG000|Overall Study|Physician Decision|0|||
155066368|NCT04530344|559673881|FG001|Overall Study|Physician Decision|0|||
155066369|NCT04530344|559673882|FG002|Overall Study|Physician Decision|1|||
155066370|NCT04530344|559673883|FG003|Overall Study|Physician Decision|1|||
155066371|NCT04530344|559673880|FG000|Overall Study|Pregnancy|0|||
155066372|NCT04530344|559673881|FG001|Overall Study|Pregnancy|0|||
155066373|NCT04530344|559673882|FG002|Overall Study|Pregnancy|2|||
155066374|NCT04530344|559673883|FG003|Overall Study|Pregnancy|1|||
155066375|NCT04530344|559673880|FG000|Overall Study|Protocol Violation|0|||
155066376|NCT04530344|559673881|FG001|Overall Study|Protocol Violation|0|||
155066377|NCT04530344|559673882|FG002|Overall Study|Protocol Violation|0|||
155066378|NCT04530344|559673883|FG003|Overall Study|Protocol Violation|1|||
155066379|NCT04530344|559673880|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
155066380|NCT04530344|559673881|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
155066381|NCT04530344|559673882|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
155066382|NCT04530344|559673883|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
155066383|NCT04530344|559673880|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
155066384|NCT04530344|559673881|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
155066385|NCT04530344|559673882|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
155066386|NCT04530344|559673883|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
155066387|NCT04530344|559673880|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
155066388|NCT04530344|559673881|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
155066389|NCT04530344|559673882|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
155066390|NCT04530344|559673883|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
155066391|NCT04530344|559673880|FG000|Overall Study|Personal Reasons|0|||
155066392|NCT04530344|559673881|FG001|Overall Study|Personal Reasons|0|||
155066393|NCT04530344|559673882|FG002|Overall Study|Personal Reasons|0|||
155066394|NCT04530344|559673883|FG003|Overall Study|Personal Reasons|1|||
155066395|NCT04530344|559673880|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
155066396|NCT04530344|559673881|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
155066397|NCT04530344|559673882|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
155066398|NCT04530344|559673883|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
155066399|NCT01402700|559673884|FG000|Overall Study|Death|3|||
155066400|NCT01402700|559673884|FG000|Overall Study|Withdrawal by Subject|3|||
155066401|NCT01402700|559673884|FG000|Overall Study|Missed Visit|1|||
155066402|NCT03507790|559673885|FG000|Overall Study|Adverse Event|0|||
155066403|NCT03507790|559673886|FG001|Overall Study|Adverse Event|11|||
155066404|NCT03507790|559673887|FG002|Overall Study|Adverse Event|3|||
155066405|NCT03507790|559673885|FG000|Overall Study|Withdrawal by Subject|2|||
155066406|NCT03507790|559673886|FG001|Overall Study|Withdrawal by Subject|0|||
155066407|NCT03507790|559673887|FG002|Overall Study|Withdrawal by Subject|0|||
155066408|NCT03507790|559673885|FG000|Overall Study|Subject moved to another location|1|||
155066409|NCT03507790|559673886|FG001|Overall Study|Subject moved to another location|2|||
155066410|NCT03507790|559673887|FG002|Overall Study|Subject moved to another location|0|||
155066411|NCT03507790|559673885|FG000|Overall Study|Non-compliance with study drug|0|||
155066412|NCT03507790|559673886|FG001|Overall Study|Non-compliance with study drug|0|||
155066413|NCT03507790|559673887|FG002|Overall Study|Non-compliance with study drug|1|||
155066414|NCT03507790|559673885|FG000|Overall Study|COVID 19 Pandemic|0|||
155066415|NCT03507790|559673886|FG001|Overall Study|COVID 19 Pandemic|1|||
155066416|NCT03507790|559673887|FG002|Overall Study|COVID 19 Pandemic|0|||
155066417|NCT03507790|559673885|FG000|Overall Study|Lost to Follow-up|0|||
155066418|NCT03507790|559673886|FG001|Overall Study|Lost to Follow-up|1|||
155066419|NCT03507790|559673887|FG002|Overall Study|Lost to Follow-up|0|||
155066420|NCT03507790|559673885|FG000|Overall Study|Discontinuation of the trial at the site|1|||
155066421|NCT03507790|559673886|FG001|Overall Study|Discontinuation of the trial at the site|1|||
155066422|NCT03507790|559673887|FG002|Overall Study|Discontinuation of the trial at the site|0|||
154959703|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959704|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959705|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
154959706|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959707|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
154959708|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
154959709|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
154959710|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959711|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959712|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155311444|NCT04610892|560572988|FG003|Overall Study|Death|1|||
155311445|NCT04610892|560572989|FG004|Overall Study|Death|0|||
155311446|NCT04610892|560572985|FG000|Overall Study|Withdrawal by Subject|3|||
155311447|NCT04610892|560572986|FG001|Overall Study|Withdrawal by Subject|2|||
155311448|NCT04610892|560572987|FG002|Overall Study|Withdrawal by Subject|0|||
155311449|NCT04610892|560572988|FG003|Overall Study|Withdrawal by Subject|6|||
155311450|NCT04610892|560572989|FG004|Overall Study|Withdrawal by Subject|6|||
155311451|NCT04610892|560572985|FG000|Overall Study|Subjects who did not receive treatment|1|||
155311452|NCT04610892|560572986|FG001|Overall Study|Subjects who did not receive treatment|0|||
155311453|NCT04610892|560572987|FG002|Overall Study|Subjects who did not receive treatment|0|||
155311454|NCT04610892|560572988|FG003|Overall Study|Subjects who did not receive treatment|0|||
155311455|NCT04610892|560572989|FG004|Overall Study|Subjects who did not receive treatment|2|||
155311456|NCT04760678|560572991|FG000|Overall Study|Death|13|||
155311457|NCT04760678|560572991|FG000|Overall Study|Lost to Follow-up|48|||
155311458|NCT04760678|560572991|FG000|Overall Study|Withdrawal by Subject|1|||
155311459|NCT03720795|560572994|FG000|Phase 1|Lost to Follow-up|4|||
155311460|NCT03720795|560572994|FG000|Phase 1|Withdrawal by Subject|6|||
155311461|NCT03720795|560572994|FG000|Phase 1|Protocol Violation|1|||
155311462|NCT03720795|560572994|FG000|Phase 1|Other|1|||
155311463|NCT03720795|560572994|FG000|Phase 2|Lost to Follow-up|5|||
155311464|NCT03720795|560572994|FG000|Phase 2|Withdrawal by Subject|10|||
155311465|NCT03720795|560572994|FG000|Phase 2|Protocol Violation|2|||
155311466|NCT03720795|560572994|FG000|3 Month Follow Up|Lost to Follow-up|2|||
155311467|NCT04322643|560572995|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
155311468|NCT05486078|560572998|FG000|Overall Study|4 drop out and one withdrawn|5|||
155311469|NCT05134233|560572999|FG000|Overall Study|Pregnancy|1|||
155311470|NCT05134233|560572999|FG000|Overall Study|MEP value too low|2|||
155311471|NCT05134233|560572999|FG000|Overall Study|Lost to Follow-up|1|||
155311472|NCT01573442|560573000|FG000|Overall Study|Cancels|9|||
155311473|NCT01573442|560573001|FG001|Overall Study|Cancels|10|||
155311474|NCT04763265|560573007|FG000|Overall Study|Adverse Event|1|||
155311475|NCT04763265|560573008|FG001|Overall Study|Adverse Event|0|||
155311476|NCT04763265|560573007|FG000|Overall Study|Lost to Follow-up|2|||
155311477|NCT04763265|560573008|FG001|Overall Study|Lost to Follow-up|4|||
155311478|NCT04763265|560573007|FG000|Overall Study|Withdrawal by Subject|0|||
155311479|NCT04763265|560573008|FG001|Overall Study|Withdrawal by Subject|1|||
155311480|NCT02908477|560573009|FG000|Overall Study|Withdrawal by Subject|8|||
155311481|NCT02908477|560573010|FG001|Overall Study|Withdrawal by Subject|28|||
155311482|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Other|0|||
155311483|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Other|0|||
155311484|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Other|0|||
155311485|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Other|0|||
155311486|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Other|0|||
155311487|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Other|0|||
155311488|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Other|0|||
155311489|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Other|0|||
155311490|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Other|0|||
155311491|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Other|0|||
155311492|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Other|1|||
155311493|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Other|1|||
155311494|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Other|1|||
155311495|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Other|0|||
155311496|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Other|3|||
155311497|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Other|1|||
155311498|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Other|1|||
155311499|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Other|0|||
155311500|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311501|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311502|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311503|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311504|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311505|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311506|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
155311507|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311508|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
155311509|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311510|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311511|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311512|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
155311513|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311514|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311515|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311516|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
155311517|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
155161807|NCT02745119|560028693|FG003|Overall Study|Adverse Event|3|||
155066423|NCT03507790|559673885|FG000|Overall Study|Randomized in error|0|||
155066424|NCT03507790|559673886|FG001|Overall Study|Randomized in error|0|||
155066425|NCT03507790|559673887|FG002|Overall Study|Randomized in error|1|||
155066426|NCT00157755|559673889|FG000|Overall Study|Death|2|||
155066427|NCT00157755|559673890|FG001|Overall Study|Death|3|||
155066428|NCT00157755|559673891|FG002|Overall Study|Death|3|||
155066429|NCT00157755|559673892|FG003|Overall Study|Death|2|||
155066430|NCT00157755|559673893|FG004|Overall Study|Death|0|||
155066431|NCT00157755|559673894|FG005|Overall Study|Death|0|||
155066432|NCT00157755|559673889|FG000|Overall Study|Lost to Follow-up|0|||
155066433|NCT00157755|559673890|FG001|Overall Study|Lost to Follow-up|0|||
155066434|NCT00157755|559673891|FG002|Overall Study|Lost to Follow-up|1|||
155066435|NCT00157755|559673892|FG003|Overall Study|Lost to Follow-up|0|||
155066436|NCT00157755|559673893|FG004|Overall Study|Lost to Follow-up|0|||
155066437|NCT00157755|559673894|FG005|Overall Study|Lost to Follow-up|0|||
155066438|NCT00157755|559673889|FG000|Overall Study|Withdrawal by Subject|0|||
155066439|NCT00157755|559673890|FG001|Overall Study|Withdrawal by Subject|0|||
155066440|NCT00157755|559673891|FG002|Overall Study|Withdrawal by Subject|1|||
155066441|NCT00157755|559673892|FG003|Overall Study|Withdrawal by Subject|1|||
155066442|NCT00157755|559673893|FG004|Overall Study|Withdrawal by Subject|1|||
155066443|NCT00157755|559673894|FG005|Overall Study|Withdrawal by Subject|2|||
155066444|NCT00157755|559673889|FG000|Overall Study|Explant due to infection|0|||
155066445|NCT00157755|559673890|FG001|Overall Study|Explant due to infection|0|||
155066446|NCT00157755|559673891|FG002|Overall Study|Explant due to infection|1|||
155066447|NCT00157755|559673892|FG003|Overall Study|Explant due to infection|0|||
155066448|NCT00157755|559673893|FG004|Overall Study|Explant due to infection|0|||
155066449|NCT00157755|559673894|FG005|Overall Study|Explant due to infection|0|||
155066450|NCT00157755|559673889|FG000|Overall Study|Medical reason|0|||
155066451|NCT00157755|559673890|FG001|Overall Study|Medical reason|0|||
155066452|NCT00157755|559673891|FG002|Overall Study|Medical reason|1|||
155066453|NCT00157755|559673892|FG003|Overall Study|Medical reason|1|||
155311518|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311519|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311520|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311521|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311522|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311523|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311524|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311525|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
155311526|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311527|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311528|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311529|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311530|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311531|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311532|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311533|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311534|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311535|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
155311536|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311537|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311538|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311539|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311540|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311541|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311542|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311543|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311544|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311545|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
155311546|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311547|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311548|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311549|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311550|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311551|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311552|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311553|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
155311554|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Death|0|||
155311555|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Death|0|||
155311556|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Death|0|||
155311557|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Death|0|||
155311558|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Death|0|||
155311559|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Death|0|||
155311560|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Death|0|||
155311561|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Death|0|||
155311562|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Death|0|||
155311563|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Death|1|||
155311564|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Death|0|||
155311565|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Death|1|||
155311566|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Death|0|||
155311567|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Death|1|||
155311568|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Death|0|||
155311569|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Death|0|||
155311570|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Death|2|||
155311571|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Death|0|||
155311572|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
155311573|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
155311574|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
155311575|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
155311576|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
155311577|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
155311578|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
155311579|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
155311580|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
155311581|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
155311582|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
155311583|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
155311584|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
155311585|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
155311586|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
155311587|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
155311588|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
155311589|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
155161808|NCT02745119|560028690|FG000|Overall Study|Death|3|||
155161809|NCT02745119|560028691|FG001|Overall Study|Death|3|||
155161810|NCT02745119|560028692|FG002|Overall Study|Death|0|||
155161811|NCT02745119|560028693|FG003|Overall Study|Death|4|||
155161812|NCT02745119|560028690|FG000|Overall Study|Lost to Follow-up|0|||
155161813|NCT02745119|560028691|FG001|Overall Study|Lost to Follow-up|0|||
155161814|NCT02745119|560028692|FG002|Overall Study|Lost to Follow-up|0|||
155311590|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Adverse Event|0|||
155311591|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Adverse Event|0|||
155311592|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Adverse Event|0|||
155311593|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Adverse Event|0|||
155311594|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Adverse Event|0|||
155311595|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Adverse Event|0|||
155311596|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Adverse Event|2|||
155311597|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Adverse Event|0|||
155311598|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Adverse Event|0|||
155311599|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Adverse Event|0|||
155311600|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Adverse Event|1|||
155311601|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Adverse Event|2|||
155311602|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Adverse Event|0|||
155311603|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Adverse Event|1|||
155311604|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Adverse Event|0|||
155311605|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Adverse Event|0|||
155311606|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Adverse Event|1|||
155311607|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Adverse Event|0|||
155311608|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
155311609|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
155311610|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
155311611|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
155311612|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
155311613|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
155311614|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
155311615|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
155311616|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
155311617|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
155311618|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
155311619|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
155311620|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
155311621|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
155311622|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
155311623|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
155311624|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
155311625|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
155311626|NCT03269136|560573019|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311627|NCT03269136|560573020|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311628|NCT03269136|560573021|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311629|NCT03269136|560573022|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311630|NCT03269136|560573023|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311631|NCT03269136|560573024|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311632|NCT03269136|560573025|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311633|NCT03269136|560573026|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311634|NCT03269136|560573027|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311635|NCT03269136|560573028|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311636|NCT03269136|560573029|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311637|NCT03269136|560573030|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311638|NCT03269136|560573031|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155311639|NCT03269136|560573032|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155311640|NCT03269136|560573033|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
155311641|NCT03269136|560573034|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311642|NCT03269136|560573035|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155311643|NCT03269136|560573036|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155311644|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Other|0|||
155311645|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Other|0|||
155161815|NCT02745119|560028693|FG003|Overall Study|Lost to Follow-up|1|||
155161816|NCT02745119|560028690|FG000|Overall Study|Protocol Deviation|0|||
155311646|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Other|0|||
155311647|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Other|0|||
155311648|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Other|0|||
155311649|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Other|0|||
155311650|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Other|0|||
155311651|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Other|0|||
155311652|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Other|0|||
155311653|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Other|0|||
155161817|NCT02745119|560028691|FG001|Overall Study|Protocol Deviation|0|||
155161818|NCT02745119|560028692|FG002|Overall Study|Protocol Deviation|0|||
155161819|NCT02745119|560028693|FG003|Overall Study|Protocol Deviation|1|||
155161820|NCT02745119|560028690|FG000|Overall Study|Withdrawal by Subject|7|||
155161821|NCT02745119|560028691|FG001|Overall Study|Withdrawal by Subject|15|||
155161822|NCT02745119|560028692|FG002|Overall Study|Withdrawal by Subject|8|||
155161823|NCT02745119|560028693|FG003|Overall Study|Withdrawal by Subject|14|||
155161824|NCT02745119|560028690|FG000|Overall Study|Study Terminated by Sponsor|134|||
155161825|NCT02745119|560028691|FG001|Overall Study|Study Terminated by Sponsor|252|||
155161826|NCT02745119|560028692|FG002|Overall Study|Study Terminated by Sponsor|135|||
155161827|NCT02745119|560028693|FG003|Overall Study|Study Terminated by Sponsor|251|||
155161828|NCT02745119|560028690|FG000|Overall Study|Physician Decision|0|||
155161829|NCT02745119|560028691|FG001|Overall Study|Physician Decision|2|||
155161830|NCT02745119|560028692|FG002|Overall Study|Physician Decision|2|||
155161831|NCT02745119|560028693|FG003|Overall Study|Physician Decision|2|||
155161832|NCT02745119|560028690|FG000|Overall Study|Reason Not Specified|0|||
155161833|NCT02745119|560028691|FG001|Overall Study|Reason Not Specified|2|||
155161834|NCT02745119|560028692|FG002|Overall Study|Reason Not Specified|0|||
155161835|NCT02745119|560028693|FG003|Overall Study|Reason Not Specified|1|||
155161836|NCT00432172|560028694|FG000|Overall Study|Physician Decision|0|||
155161837|NCT00432172|560028695|FG001|Overall Study|Physician Decision|0|||
155161838|NCT00432172|560028696|FG002|Overall Study|Physician Decision|2|||
155161839|NCT00432172|560028697|FG003|Overall Study|Physician Decision|0|||
155161840|NCT00432172|560028694|FG000|Overall Study|Adverse Event|4|||
155161841|NCT00432172|560028695|FG001|Overall Study|Adverse Event|2|||
155161842|NCT00432172|560028696|FG002|Overall Study|Adverse Event|4|||
155161843|NCT00432172|560028697|FG003|Overall Study|Adverse Event|3|||
155161844|NCT00432172|560028694|FG000|Overall Study|Disease progression|0|||
155161845|NCT00432172|560028695|FG001|Overall Study|Disease progression|2|||
155161846|NCT00432172|560028696|FG002|Overall Study|Disease progression|5|||
155161847|NCT00432172|560028697|FG003|Overall Study|Disease progression|1|||
155161848|NCT00432172|560028694|FG000|Overall Study|Withdrawal by Subject|0|||
155161849|NCT00432172|560028695|FG001|Overall Study|Withdrawal by Subject|1|||
155161850|NCT00432172|560028696|FG002|Overall Study|Withdrawal by Subject|0|||
155161851|NCT00432172|560028697|FG003|Overall Study|Withdrawal by Subject|2|||
155161852|NCT00432172|560028694|FG000|Overall Study|No treatment received|2|||
155161853|NCT00432172|560028695|FG001|Overall Study|No treatment received|2|||
155161854|NCT00432172|560028696|FG002|Overall Study|No treatment received|0|||
155161855|NCT00432172|560028697|FG003|Overall Study|No treatment received|1|||
155161856|NCT02536963|560028698|FG000|Overall Study|Withdrawal by Subject|18|||
155161857|NCT02668393|560028699|FG000|Overall Study|Progressive disease|6|||
155161858|NCT02668393|560028700|FG001|Overall Study|Progressive disease|3|||
155161859|NCT02668393|560028699|FG000|Overall Study|Adverse Event|0|||
155161860|NCT02668393|560028700|FG001|Overall Study|Adverse Event|2|||
155161861|NCT02668393|560028699|FG000|Overall Study|Withdrawal from the trial|0|||
155161862|NCT02668393|560028700|FG001|Overall Study|Withdrawal from the trial|1|||
155161863|NCT02668393|560028699|FG000|Overall Study|Lack of benefit and side effects|1|||
155161864|NCT02668393|560028700|FG001|Overall Study|Lack of benefit and side effects|0|||
155161865|NCT02141204|560028701|FG000|Overall Study|Lost to Follow-up|2|||
155161866|NCT02141204|560028702|FG001|Overall Study|Lost to Follow-up|1|||
155161867|NCT02141204|560028701|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
155161868|NCT02141204|560028702|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
155161869|NCT02141204|560028701|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
155161870|NCT02141204|560028702|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
155161871|NCT02141204|560028701|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
155161872|NCT02141204|560028702|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
154959713|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959714|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959715|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155161873|NCT00515619|560028705|FG000|Overall Study|Adverse Event|34|||
155161874|NCT00515619|560028705|FG000|Overall Study|Lack of Efficacy|92|||
155161875|NCT00515619|560028705|FG000|Overall Study|Withdrawal by Subject|66|||
155161876|NCT00515619|560028705|FG000|Overall Study|Protocol Violation|3|||
155161877|NCT00515619|560028705|FG000|Overall Study|Lost to Follow-up|4|||
155161878|NCT00515619|560028705|FG000|Overall Study|Unsatisfactory compliance|6|||
154959716|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155161879|NCT00515619|560028705|FG000|Overall Study|Other: Site discontinuing trials|2|||
155161880|NCT00515619|560028705|FG000|Overall Study|Other: Subject cannot attend visits|2|||
155161881|NCT00515619|560028705|FG000|Overall Study|Other: Subject required surgery|1|||
155161882|NCT00515619|560028705|FG000|Overall Study|Other: Subject moved to another country|1|||
155161883|NCT00515619|560028705|FG000|Overall Study|Other: Investigator decision|1|||
155161884|NCT00515619|560028705|FG000|Overall Study|Other: Subject became pregnant|1|||
155161885|NCT00515619|560028705|FG000|Overall Study|Other: Request from sponsor|1|||
155161886|NCT00515619|560028705|FG000|Overall Study|Other: Drug available on license|1|||
155161887|NCT00515619|560028705|FG000|Overall Study|Other: Subject interested in other AED|1|||
155161888|NCT02379091|560028706|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155161889|NCT02379091|560028707|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155161890|NCT02379091|560028708|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155161891|NCT02379091|560028709|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155161892|NCT02379091|560028706|FG000|Overall Study|Principal Investigator Discretion|0|||
155161893|NCT02379091|560028707|FG001|Overall Study|Principal Investigator Discretion|1|||
155161894|NCT02379091|560028708|FG002|Overall Study|Principal Investigator Discretion|0|||
155161895|NCT02379091|560028709|FG003|Overall Study|Principal Investigator Discretion|0|||
155161896|NCT02379091|560028706|FG000|Overall Study|Lost to Follow-up|0|||
155161897|NCT02379091|560028707|FG001|Overall Study|Lost to Follow-up|0|||
155161898|NCT02379091|560028708|FG002|Overall Study|Lost to Follow-up|0|||
155161899|NCT02379091|560028709|FG003|Overall Study|Lost to Follow-up|1|||
155161900|NCT02379091|560028706|FG000|Overall Study|Voluntary Withdrawal|2|||
155161901|NCT02379091|560028707|FG001|Overall Study|Voluntary Withdrawal|5|||
155161902|NCT02379091|560028708|FG002|Overall Study|Voluntary Withdrawal|2|||
155161903|NCT02379091|560028709|FG003|Overall Study|Voluntary Withdrawal|4|||
155161904|NCT02379091|560028706|FG000|Overall Study|Study Termination|7|||
155161905|NCT02379091|560028707|FG001|Overall Study|Study Termination|2|||
155161906|NCT02379091|560028708|FG002|Overall Study|Study Termination|5|||
155161907|NCT02379091|560028709|FG003|Overall Study|Study Termination|8|||
155161908|NCT02379091|560028706|FG000|Overall Study|Lack of Efficacy|3|||
155161909|NCT02379091|560028707|FG001|Overall Study|Lack of Efficacy|0|||
155161910|NCT02379091|560028708|FG002|Overall Study|Lack of Efficacy|0|||
155161911|NCT02379091|560028709|FG003|Overall Study|Lack of Efficacy|0|||
155161912|NCT03326713|560028711|FG000|Overall Study|Death|2|||
155161913|NCT03326713|560028712|FG001|Overall Study|Death|1|||
154959717|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959718|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959719|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959720|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959721|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959722|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959723|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959724|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959725|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
154959726|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155161914|NCT03326713|560028713|FG002|Overall Study|Death|0|||
155161915|NCT03326713|560028711|FG000|Overall Study|Lost to Follow-up|20|||
155161916|NCT03326713|560028712|FG001|Overall Study|Lost to Follow-up|21|||
155161917|NCT03326713|560028713|FG002|Overall Study|Lost to Follow-up|33|||
155161918|NCT03326713|560028711|FG000|Overall Study|Withdrawal by Subject|1|||
155161919|NCT03326713|560028712|FG001|Overall Study|Withdrawal by Subject|2|||
155066454|NCT00157755|559673893|FG004|Overall Study|Medical reason|0|||
155066455|NCT00157755|559673894|FG005|Overall Study|Medical reason|0|||
155066456|NCT00157755|559673889|FG000|Overall Study|Study site closure|0|||
155066457|NCT00157755|559673890|FG001|Overall Study|Study site closure|1|||
155066458|NCT00157755|559673891|FG002|Overall Study|Study site closure|0|||
155066459|NCT00157755|559673892|FG003|Overall Study|Study site closure|0|||
155066460|NCT00157755|559673893|FG004|Overall Study|Study site closure|0|||
155066461|NCT00157755|559673894|FG005|Overall Study|Study site closure|0|||
155161920|NCT03326713|560028713|FG002|Overall Study|Withdrawal by Subject|11|||
155161921|NCT03326713|560028711|FG000|Overall Study|Found Ineligible|11|||
155161922|NCT03326713|560028712|FG001|Overall Study|Found Ineligible|11|||
155161923|NCT03326713|560028713|FG002|Overall Study|Found Ineligible|8|||
155161924|NCT00771758|560028714|FG000|Overall Study|Adverse Event|2|||
155161925|NCT00771758|560028715|FG001|Overall Study|Adverse Event|8|||
155161926|NCT00771758|560028716|FG002|Overall Study|Adverse Event|1|||
155161927|NCT00771758|560028714|FG000|Overall Study|Lack of Efficacy|0|||
155161928|NCT00771758|560028715|FG001|Overall Study|Lack of Efficacy|2|||
155161929|NCT00771758|560028716|FG002|Overall Study|Lack of Efficacy|1|||
155161930|NCT00771758|560028714|FG000|Overall Study|Lost to Follow-up|1|||
155161931|NCT00771758|560028715|FG001|Overall Study|Lost to Follow-up|0|||
155161932|NCT00771758|560028716|FG002|Overall Study|Lost to Follow-up|0|||
155161933|NCT00771758|560028714|FG000|Overall Study|Protocol Violation|1|||
155161934|NCT00771758|560028715|FG001|Overall Study|Protocol Violation|0|||
155161935|NCT00771758|560028716|FG002|Overall Study|Protocol Violation|0|||
155161936|NCT00771758|560028714|FG000|Overall Study|Withdrawal by Subject|1|||
155161937|NCT00771758|560028715|FG001|Overall Study|Withdrawal by Subject|0|||
155161938|NCT00771758|560028716|FG002|Overall Study|Withdrawal by Subject|0|||
155161939|NCT00771758|560028714|FG000|Overall Study|Other|3|||
155161940|NCT00771758|560028715|FG001|Overall Study|Other|2|||
155161941|NCT00771758|560028716|FG002|Overall Study|Other|0|||
155161942|NCT03067077|560028717|FG000|Overall Study|Did not receive surgery|4|||
155161943|NCT03067077|560028718|FG001|Overall Study|Did not receive surgery|5|||
155161944|NCT03067077|560028717|FG000|Overall Study|Lost to Follow-up|3|||
155066462|NCT00157755|559673889|FG000|Overall Study|Subject non-compliance|0|||
155066463|NCT00157755|559673890|FG001|Overall Study|Subject non-compliance|0|||
155066464|NCT00157755|559673891|FG002|Overall Study|Subject non-compliance|0|||
155161945|NCT03067077|560028718|FG001|Overall Study|Lost to Follow-up|2|||
155161946|NCT00935584|560028719|FG000|Overall Study|Withdrawal by Subject|9|||
155161947|NCT00935584|560028720|FG001|Overall Study|Withdrawal by Subject|0|||
155161948|NCT00935584|560028719|FG000|Overall Study|Death|3|||
155161949|NCT00935584|560028720|FG001|Overall Study|Death|0|||
155161950|NCT00935584|560028719|FG000|Overall Study|Lost to Follow-up|8|||
154959727|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
155161951|NCT00935584|560028720|FG001|Overall Study|Lost to Follow-up|0|||
155161952|NCT00935584|560028719|FG000|Overall Study|No show|9|||
155161953|NCT00935584|560028720|FG001|Overall Study|No show|0|||
155161954|NCT00935584|560028719|FG000|Overall Study|Relocated|3|||
155311654|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Other|0|||
155311655|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Other|0|||
155311656|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Other|0|||
155311657|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Other|0|||
155311658|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Other|0|||
155311659|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Other|0|||
155311660|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Other|0|||
155311661|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Other|1|||
155311662|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311663|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311664|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311665|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311666|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311667|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311668|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311669|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311670|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311671|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311672|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311673|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311674|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311675|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311676|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311677|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311678|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
155311679|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
155311680|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
155311681|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
155311682|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
155311683|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
155311684|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
155311685|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
155311686|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
155311687|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
155311688|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
155311689|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
155311690|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
155311691|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
155311692|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
155311693|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
155311694|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
155311695|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
155311696|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
155311697|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
155311698|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
155311699|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
155311700|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
155161955|NCT00935584|560028720|FG001|Overall Study|Relocated|0|||
155311701|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
155311702|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
155311703|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
155311704|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
155311705|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
155311706|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
155311707|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
155161956|NCT00935584|560028719|FG000|Overall Study|Patient changed provider|3|||
155311708|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
155311709|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
155311710|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
155311711|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
155311712|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
155311713|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
155311714|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
155311715|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
155311716|NCT03269136|560573019|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
155311717|NCT03269136|560573020|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
155311718|NCT03269136|560573021|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
155311719|NCT03269136|560573022|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
155311720|NCT03269136|560573023|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
155311721|NCT03269136|560573024|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
155311722|NCT03269136|560573025|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
155311723|NCT03269136|560573026|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
155311724|NCT03269136|560573027|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
155311725|NCT03269136|560573028|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
155311726|NCT03269136|560573029|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
155311727|NCT03269136|560573030|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
155311728|NCT03269136|560573031|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
155311729|NCT03269136|560573032|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
155311730|NCT03269136|560573033|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
155311731|NCT03269136|560573034|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
155311732|NCT03269136|560573035|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
155311733|NCT03269136|560573036|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
155311734|NCT05071807|560573039|FG000|Overall Study|Withdrawal by Subject|4|||
155311735|NCT05071807|560573040|FG001|Overall Study|Withdrawal by Subject|0|||
155311736|NCT05071807|560573039|FG000|Overall Study|Unrelated medical issues|3|||
155311737|NCT05071807|560573040|FG001|Overall Study|Unrelated medical issues|0|||
155311738|NCT05071807|560573039|FG000|Overall Study|Relocated|0|||
155311739|NCT05071807|560573040|FG001|Overall Study|Relocated|1|||
155311740|NCT04952909|560573041|FG000|Overall Study|Death|3|||
155311741|NCT04552223|560573049|FG000|Overall Study|Withdrawal by Subject|1|||
155311742|NCT04856163|560573050|FG000|Overall Study|Lost to Follow-up|97|||
155311743|NCT04856163|560573051|FG001|Overall Study|Lost to Follow-up|100|||
155311744|NCT00881621|560573052|FG000|Overall Study|Physician Decision|34|||
155311745|NCT04359108|560573056|FG000|Overall Study|Withdrawal by Subject|1|||
155066465|NCT00157755|559673892|FG003|Overall Study|Subject non-compliance|0|||
155311746|NCT04359108|560573057|FG001|Overall Study|Withdrawal by Subject|0|||
155311747|NCT04359108|560573056|FG000|Overall Study|Unable or too feeble to walk independently|0|||
155311748|NCT04359108|560573057|FG001|Overall Study|Unable or too feeble to walk independently|2|||
155311749|NCT04359108|560573056|FG000|Overall Study|Argus II system stopped functioning|0|||
155311750|NCT04359108|560573057|FG001|Overall Study|Argus II system stopped functioning|1|||
155311751|NCT04359108|560573056|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
155311752|NCT04359108|560573057|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
155311753|NCT02515773|560573058|FG000|Overall Study|Withdrawal by Subject|12|||
155311754|NCT02515773|560573059|FG001|Overall Study|Withdrawal by Subject|2|||
155311755|NCT02515773|560573058|FG000|Overall Study|Lost to Follow-up|119|||
155311756|NCT02515773|560573059|FG001|Overall Study|Lost to Follow-up|126|||
155311757|NCT02515773|560573058|FG000|Overall Study|Discharged from Clinic Services|53|||
155311758|NCT02515773|560573059|FG001|Overall Study|Discharged from Clinic Services|84|||
155311759|NCT02515773|560573058|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
155311760|NCT02515773|560573059|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
155311761|NCT02515773|560573058|FG000|Overall Study|Follow-up at non-study site|8|||
155311762|NCT02515773|560573059|FG001|Overall Study|Follow-up at non-study site|16|||
155311763|NCT02515773|560573058|FG000|Overall Study|Moved from area|9|||
155311764|NCT02515773|560573059|FG001|Overall Study|Moved from area|14|||
155311765|NCT04176965|560573060|FG000|Overall Study|Death|1|||
155311766|NCT04176965|560573061|FG001|Overall Study|Death|2|||
155311767|NCT04176965|560573060|FG000|Overall Study|Lost to Follow-up|10|||
155311768|NCT04176965|560573061|FG001|Overall Study|Lost to Follow-up|2|||
155311769|NCT04176965|560573060|FG000|Overall Study|Withdrawal by Subject|6|||
155311770|NCT04176965|560573061|FG001|Overall Study|Withdrawal by Subject|1|||
155311771|NCT03468218|560573062|FG000|Overall Study|Adverse Event|5|||
155066466|NCT00157755|559673893|FG004|Overall Study|Subject non-compliance|0|||
155066467|NCT00157755|559673894|FG005|Overall Study|Subject non-compliance|1|||
155311772|NCT03468218|560573062|FG000|Overall Study|Progressive Disease|16|||
155311773|NCT03468218|560573062|FG000|Overall Study|Death|1|||
155311774|NCT03468218|560573062|FG000|Overall Study|Alternate therapy|1|||
155311775|NCT03468218|560573062|FG000|Overall Study|Withdrawal by Subject|2|||
155311776|NCT03033576|560573063|FG000|Overall Study|Ineligible|1|||
155311777|NCT03033576|560573064|FG001|Overall Study|Ineligible|1|||
155311778|NCT03033576|560573063|FG000|Overall Study|Adverse Event|4|||
155311779|NCT03033576|560573064|FG001|Overall Study|Adverse Event|20|||
155311780|NCT03033576|560573063|FG000|Overall Study|Progression/relapse|9|||
155311781|NCT03033576|560573064|FG001|Overall Study|Progression/relapse|36|||
155311782|NCT03033576|560573063|FG000|Overall Study|Death|1|||
155311783|NCT03033576|560573064|FG001|Overall Study|Death|1|||
155311784|NCT03033576|560573063|FG000|Overall Study|Patient refusal|1|||
155311785|NCT03033576|560573064|FG001|Overall Study|Patient refusal|6|||
155311786|NCT03033576|560573063|FG000|Overall Study|Other, unspecified reasons|0|||
155311787|NCT03033576|560573064|FG001|Overall Study|Other, unspecified reasons|4|||
155311788|NCT03033576|560573063|FG000|Overall Study|Currently on protocol therapy|0|||
155311789|NCT03033576|560573064|FG001|Overall Study|Currently on protocol therapy|2|||
155311790|NCT01214616|560573065|FG000|Overall Study|Progressive disease|2|||
155311791|NCT01214616|560573066|FG001|Overall Study|Progressive disease|2|||
155311792|NCT01214616|560573067|FG002|Overall Study|Progressive disease|2|||
155311793|NCT01214616|560573068|FG003|Overall Study|Progressive disease|4|||
155311794|NCT01214616|560573065|FG000|Overall Study|Dose limiting toxicity|0|||
155066468|NCT00157755|559673889|FG000|Overall Study|Study completion|0|||
155311795|NCT01214616|560573066|FG001|Overall Study|Dose limiting toxicity|2|||
155311796|NCT01214616|560573067|FG002|Overall Study|Dose limiting toxicity|0|||
155311797|NCT01214616|560573068|FG003|Overall Study|Dose limiting toxicity|0|||
155311798|NCT01214616|560573065|FG000|Overall Study|Other adverse events|0|||
155311799|NCT01214616|560573066|FG001|Overall Study|Other adverse events|1|||
155311800|NCT01214616|560573067|FG002|Overall Study|Other adverse events|1|||
155311801|NCT01214616|560573068|FG003|Overall Study|Other adverse events|1|||
155311802|NCT01214616|560573065|FG000|Overall Study|Withdrawal by Subject|1|||
155311803|NCT01214616|560573066|FG001|Overall Study|Withdrawal by Subject|0|||
155311804|NCT01214616|560573067|FG002|Overall Study|Withdrawal by Subject|0|||
155311805|NCT01214616|560573068|FG003|Overall Study|Withdrawal by Subject|1|||
155311806|NCT02949362|560573069|FG000|Retrospective Period|Inform consent not signed by participant|4|||
155311807|NCT02949362|560573070|FG001|Retrospective Period|Inform consent not signed by participant|1|||
155311808|NCT02949362|560573071|FG002|Retrospective Period|Inform consent not signed by participant|0|||
155311809|NCT02949362|560573072|FG003|Retrospective Period|Inform consent not signed by participant|0|||
155311810|NCT02949362|560573069|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
155311811|NCT02949362|560573070|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
155311812|NCT02949362|560573071|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
155311813|NCT02949362|560573072|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
155311814|NCT02949362|560573069|FG000|Prospective Period|Other|0|||
155311815|NCT02949362|560573070|FG001|Prospective Period|Other|0|||
155311816|NCT02949362|560573071|FG002|Prospective Period|Other|0|||
155311817|NCT02949362|560573072|FG003|Prospective Period|Other|4|||
155311818|NCT02471638|560573076|FG000|Overall Study|Early Term Withdrawal|10|||
155311819|NCT00667251|560575160|FG000|Overall Study|Disease progression|232|||
155311820|NCT00667251|560575161|FG001|Overall Study|Disease progression|203|||
155311821|NCT00667251|560575160|FG000|Overall Study|Toxicity|44|||
155311822|NCT00667251|560575161|FG001|Overall Study|Toxicity|23|||
155311823|NCT00667251|560575160|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
155311824|NCT00667251|560575161|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
155311825|NCT00667251|560575160|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
155311826|NCT00667251|560575161|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
155311827|NCT00667251|560575160|FG000|Overall Study|Symptomatic progression|8|||
155311828|NCT00667251|560575161|FG001|Overall Study|Symptomatic progression|4|||
155311829|NCT00667251|560575160|FG000|Overall Study|Death|6|||
155311830|NCT00667251|560575161|FG001|Overall Study|Death|11|||
155311831|NCT00667251|560575160|FG000|Overall Study|Intercurrent illness|5|||
155311832|NCT00667251|560575161|FG001|Overall Study|Intercurrent illness|6|||
155311833|NCT00667251|560575160|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
155311834|NCT00667251|560575161|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
155311835|NCT00667251|560575160|FG000|Overall Study|Randomized not Treated|4|||
155311836|NCT00667251|560575161|FG001|Overall Study|Randomized not Treated|1|||
155311837|NCT02671903|560575167|FG000|Period 0 (Run-In)|Death|0|||
155311838|NCT02671903|560575168|FG001|Period 0 (Run-In)|Death|0|||
155311839|NCT02671903|560575169|FG002|Period 0 (Run-In)|Death|3|||
155311840|NCT02671903|560575167|FG000|Period 0 (Run-In)|Physician Decision|0|||
155311841|NCT02671903|560575168|FG001|Period 0 (Run-In)|Physician Decision|0|||
155311842|NCT02671903|560575169|FG002|Period 0 (Run-In)|Physician Decision|4|||
155311843|NCT02671903|560575167|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
155311844|NCT02671903|560575168|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
155311845|NCT02671903|560575169|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
155311846|NCT02671903|560575167|FG000|Period 0 (Run-In)|Protocol Violation|0|||
155311847|NCT02671903|560575168|FG001|Period 0 (Run-In)|Protocol Violation|0|||
155066469|NCT00157755|559673890|FG001|Overall Study|Study completion|0|||
155311848|NCT02671903|560575169|FG002|Period 0 (Run-In)|Protocol Violation|1|||
155311849|NCT02671903|560575167|FG000|Period 0 (Run-In)|Adverse Event|0|||
155311850|NCT02671903|560575168|FG001|Period 0 (Run-In)|Adverse Event|0|||
155311851|NCT02671903|560575169|FG002|Period 0 (Run-In)|Adverse Event|1|||
155311852|NCT02671903|560575167|FG000|Period 0 (Run-In)|Implantation Failure|0|||
155311853|NCT02671903|560575168|FG001|Period 0 (Run-In)|Implantation Failure|0|||
155311854|NCT02671903|560575169|FG002|Period 0 (Run-In)|Implantation Failure|2|||
155311855|NCT02671903|560575167|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
155311856|NCT02671903|560575168|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
155311857|NCT02671903|560575169|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
155311858|NCT03376321|560575170|FG000|Overall Study|Other|5|||
155311859|NCT03376321|560575171|FG001|Overall Study|Other|1|||
155311860|NCT03376321|560575170|FG000|Overall Study|Withdrawal by Subject|8|||
155311861|NCT03376321|560575171|FG001|Overall Study|Withdrawal by Subject|14|||
155311862|NCT03376321|560575170|FG000|Overall Study|Lost to Follow-up|1|||
155311863|NCT03376321|560575171|FG001|Overall Study|Lost to Follow-up|7|||
155311864|NCT03376321|560575170|FG000|Overall Study|Death|4|||
155311865|NCT03376321|560575171|FG001|Overall Study|Death|0|||
155311866|NCT03376321|560575170|FG000|Overall Study|Randomized, not treated|5|||
155311867|NCT03376321|560575171|FG001|Overall Study|Randomized, not treated|3|||
155311868|NCT02995434|560575172|FG000|Overall Study|Adverse Event|1|||
155311869|NCT02995434|560575173|FG001|Overall Study|Adverse Event|0|||
155311870|NCT02995434|560575172|FG000|Overall Study|Withdrawal by Subject|6|||
155311871|NCT02995434|560575173|FG001|Overall Study|Withdrawal by Subject|3|||
155311872|NCT02543281|560575180|FG000|Overall Study|Lost to Follow-up|0|||
155311873|NCT02543281|560575181|FG001|Overall Study|Lost to Follow-up|0|||
155311874|NCT02543281|560575182|FG002|Overall Study|Lost to Follow-up|1|||
155311875|NCT05247489|560575183|FG000|Overall Study|Lost to Follow-up|5|||
155311876|NCT05247489|560575184|FG001|Overall Study|Lost to Follow-up|1|||
155311877|NCT05247489|560575183|FG000|Overall Study|Withdrawal by Subject|6|||
155311878|NCT05247489|560575184|FG001|Overall Study|Withdrawal by Subject|7|||
155311879|NCT05247489|560575183|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
155311880|NCT05247489|560575184|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
155311881|NCT05247489|560575183|FG000|Overall Study|Left Country|1|||
155311882|NCT05247489|560575184|FG001|Overall Study|Left Country|0|||
155311883|NCT05247489|560575183|FG000|Overall Study|Noncompliance with Investigational Product|1|||
155311884|NCT05247489|560575184|FG001|Overall Study|Noncompliance with Investigational Product|0|||
155311885|NCT05247489|560575183|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
155311886|NCT05247489|560575184|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
155311887|NCT04390048|560575185|FG000|Overall Study|Withdrawal by Subject|1|||
155311888|NCT04390048|560575186|FG001|Overall Study|Withdrawal by Subject|3|||
155311889|NCT04179500|560575193|FG000|Treatment|Withdrawal by Subject|1|||
155311890|NCT04179500|560575193|FG000|Treatment|Adverse Event|2|||
155311891|NCT04179500|560575193|FG000|Treatment|pyrazinamide resistance|1|||
155311892|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311893|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311894|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311895|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311896|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311897|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311898|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
155311899|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311900|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311901|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311902|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311903|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311904|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311905|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311906|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311907|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311908|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311909|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311910|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311911|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155066470|NCT00157755|559673891|FG002|Overall Study|Study completion|0|||
155066471|NCT00157755|559673892|FG003|Overall Study|Study completion|0|||
155311912|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311913|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311914|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311915|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311916|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311917|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311918|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
155311919|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311920|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311921|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311922|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
155066472|NCT00157755|559673893|FG004|Overall Study|Study completion|1|||
155311923|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311924|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311925|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311926|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311927|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155066473|NCT00157755|559673894|FG005|Overall Study|Study completion|2|||
155311928|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155066474|NCT05352399|559673914|FG000|Overall Study|Discontinued intervention|6|||
155066475|NCT02657551|559673915|FG000|Overall Study|Adverse Event|2|||
155066476|NCT02657551|559673915|FG000|Overall Study|Withdrawal by Subject|1|||
155066477|NCT02657551|559673915|FG000|Overall Study|Non-Compliance|1|||
155066478|NCT02657551|559673915|FG000|Overall Study|Progression / Relapse|4|||
155066479|NCT04058717|559673916|FG000|Randomization Period|Lost to Follow-up|2|||
155066480|NCT04058717|559673917|FG001|Randomization Period|Lost to Follow-up|3|||
155066481|NCT04058717|559673918|FG002|Randomization Period|Lost to Follow-up|4|||
155066482|NCT04058717|559673919|FG003|Randomization Period|Lost to Follow-up|4|||
155066483|NCT04058717|559673916|FG000|Randomization Period|Withdrawal by Subject|1|||
155066484|NCT04058717|559673917|FG001|Randomization Period|Withdrawal by Subject|3|||
155066485|NCT04058717|559673918|FG002|Randomization Period|Withdrawal by Subject|3|||
155311929|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311930|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311931|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311932|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311933|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311934|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311935|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311936|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311937|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311938|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311939|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311940|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311941|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311942|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311943|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311944|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311945|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
155311946|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
155311947|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
155311948|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
155311949|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
155311950|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
155311951|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
155311952|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
155311953|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
155311954|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
155311955|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
155311956|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
155311957|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
155311958|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
155311959|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
155311960|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
155311961|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
155311962|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
155311963|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
155311964|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
155311965|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
155311966|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
155311967|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
155311968|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
155311969|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
155311970|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
155311971|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
155311972|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
155311973|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311974|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311975|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311976|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311977|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311978|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311979|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
155311980|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311981|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311982|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311983|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311984|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311985|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
155311986|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311987|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311988|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311989|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311990|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311991|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311992|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311993|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311994|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311995|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311996|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311997|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311998|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155311999|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
155312000|NCT02783300|560575212|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312001|NCT02783300|560575213|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312002|NCT02783300|560575214|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312003|NCT02783300|560575215|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312004|NCT02783300|560575216|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
155312005|NCT02783300|560575217|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312006|NCT02783300|560575218|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
155312007|NCT02783300|560575219|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312008|NCT02783300|560575220|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312009|NCT02783300|560575221|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
155312010|NCT02783300|560575222|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312011|NCT02783300|560575223|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312012|NCT02783300|560575224|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
155312013|NCT02783300|560575225|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312014|NCT02783300|560575226|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312015|NCT02783300|560575227|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312016|NCT02783300|560575228|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312017|NCT02783300|560575229|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312018|NCT02783300|560575230|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312019|NCT02783300|560575231|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312020|NCT02783300|560575232|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312021|NCT02783300|560575233|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312022|NCT02783300|560575234|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312023|NCT02783300|560575235|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312024|NCT02783300|560575236|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312025|NCT02783300|560575237|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312026|NCT02783300|560575238|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
155312027|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312028|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312029|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312030|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312031|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312032|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312033|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312034|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312035|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312036|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312037|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312038|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312039|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312040|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312041|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312042|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
155312043|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312044|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
155312045|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
155312046|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
155066486|NCT04058717|559673919|FG003|Randomization Period|Withdrawal by Subject|3|||
155066487|NCT04058717|559673916|FG000|Randomization Period|PI decision|0|||
155066488|NCT04058717|559673917|FG001|Randomization Period|PI decision|1|||
155066489|NCT04058717|559673918|FG002|Randomization Period|PI decision|0|||
155066490|NCT04058717|559673919|FG003|Randomization Period|PI decision|0|||
155066491|NCT03345004|559675236|FG000|Overall Study|Physician Decision|1|||
155066492|NCT03345004|559675237|FG001|Overall Study|Physician Decision|0|||
155312047|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312048|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312049|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312050|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312051|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
155312052|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312053|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
155312054|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312055|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312056|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312057|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312058|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312059|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312060|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312061|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312062|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312063|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312064|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312065|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312066|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312067|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312068|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312069|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312070|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
155312071|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312072|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
155312073|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
155312074|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312075|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312076|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312077|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312078|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312079|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312080|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
155312081|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312082|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312083|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312084|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312085|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312086|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312087|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312088|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312089|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312090|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312091|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312092|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312093|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312094|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312095|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312096|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312097|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
155312098|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312099|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
155312100|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
155312101|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
155312102|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312103|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312104|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312105|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312106|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
154959728|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
155312107|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
155312108|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312109|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312110|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312111|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312112|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312113|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312114|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312115|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312116|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312117|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312118|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312119|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312120|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312121|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312122|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312123|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
155312124|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312125|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312126|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155066493|NCT03345004|559675236|FG000|Overall Study|Withdrawal by Subject|0|||
155066494|NCT03345004|559675237|FG001|Overall Study|Withdrawal by Subject|1|||
155066495|NCT01013753|559675240|FG000|Overall Study|Adverse Event|8|||
155066496|NCT01013753|559675240|FG000|Overall Study|Protocol Violation|3|||
155066497|NCT01013753|559675240|FG000|Overall Study|Lost to Follow-up|1|||
155066498|NCT01013753|559675240|FG000|Overall Study|Withdrawal by Subject|2|||
155066499|NCT01013753|559675240|FG000|Overall Study|Other|2|||
155066500|NCT00671060|559675243|FG000|Overall Study|Protocol Violation|1|||
155066501|NCT00671060|559675244|FG001|Overall Study|Protocol Violation|0|||
155066502|NCT00671060|559675243|FG000|Overall Study|Physician Decision|0|||
155066503|NCT00671060|559675244|FG001|Overall Study|Physician Decision|1|||
155066504|NCT01541748|559675245|FG000|Overall Study|Lost to Follow-up|17|||
155066505|NCT01541748|559675245|FG000|Overall Study|Moved out of state|1|||
155066506|NCT01541748|559675245|FG000|Overall Study|Withdrawal by Subject|7|||
155066507|NCT01541748|559675245|FG000|Overall Study|Screen failure|5|||
155066508|NCT01541748|559675245|FG000|Overall Study|Did not receive study device|1|||
155066509|NCT00785629|559675246|FG000|Overall Study|Adverse Event|2|||
155312127|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312128|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312129|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312130|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
155312131|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312132|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312133|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155312134|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
155066510|NCT00785629|559675247|FG001|Overall Study|Adverse Event|1|||
155066511|NCT00785629|559675248|FG002|Overall Study|Adverse Event|1|||
155066512|NCT00785629|559675249|FG003|Overall Study|Adverse Event|5|||
155066513|NCT00785629|559675246|FG000|Overall Study|Protocol Violation|1|||
155066514|NCT00785629|559675247|FG001|Overall Study|Protocol Violation|2|||
155066515|NCT00785629|559675248|FG002|Overall Study|Protocol Violation|4|||
155066516|NCT00785629|559675249|FG003|Overall Study|Protocol Violation|5|||
155066517|NCT00785629|559675246|FG000|Overall Study|administrative decision|5|||
155066518|NCT00785629|559675247|FG001|Overall Study|administrative decision|1|||
155066519|NCT00785629|559675248|FG002|Overall Study|administrative decision|3|||
155066520|NCT00785629|559675249|FG003|Overall Study|administrative decision|4|||
155066521|NCT00785629|559675246|FG000|Overall Study|Withdrawal by Subject|0|||
155066522|NCT00785629|559675247|FG001|Overall Study|Withdrawal by Subject|1|||
155066523|NCT00785629|559675248|FG002|Overall Study|Withdrawal by Subject|2|||
155066524|NCT00785629|559675249|FG003|Overall Study|Withdrawal by Subject|2|||
155066525|NCT02107898|559675252|FG000|Overall Study|Adverse Event|4|||
155066526|NCT02107898|559675253|FG001|Overall Study|Adverse Event|7|||
155066527|NCT02107898|559675252|FG000|Overall Study|Poor compliance to protocol|0|||
155066528|NCT02107898|559675253|FG001|Overall Study|Poor compliance to protocol|1|||
155066529|NCT02107898|559675252|FG000|Overall Study|Participant moved|0|||
155066530|NCT02107898|559675253|FG001|Overall Study|Participant moved|2|||
155066531|NCT02107898|559675252|FG000|Overall Study|Consent withdrawn by participant|2|||
155066532|NCT02107898|559675253|FG001|Overall Study|Consent withdrawn by participant|1|||
155066533|NCT02107898|559675252|FG000|Overall Study|Randomized but not treated|0|||
155066534|NCT02107898|559675253|FG001|Overall Study|Randomized but not treated|1|||
155066535|NCT01283386|559675254|FG000|Overall Study|Death|2|||
155066536|NCT01283386|559675255|FG001|Overall Study|Death|0|||
155066537|NCT01283386|559675254|FG000|Overall Study|Withdrawal by Subject|2|||
155066538|NCT01283386|559675255|FG001|Overall Study|Withdrawal by Subject|1|||
155066539|NCT01283386|559675254|FG000|Overall Study|Relapse of underlying disease|1|||
155066540|NCT01283386|559675255|FG001|Overall Study|Relapse of underlying disease|3|||
155066541|NCT01283386|559675254|FG000|Overall Study|Progression of underlying disease|2|||
155066542|NCT01283386|559675255|FG001|Overall Study|Progression of underlying disease|7|||
155066543|NCT01283386|559675254|FG000|Overall Study|Reason not specified|1|||
155066544|NCT01283386|559675255|FG001|Overall Study|Reason not specified|0|||
155066545|NCT01283386|559675254|FG000|Overall Study|Protocol Violation|0|||
155066546|NCT01283386|559675255|FG001|Overall Study|Protocol Violation|1|||
155161957|NCT00935584|560028720|FG001|Overall Study|Patient changed provider|0|||
155066547|NCT04727749|559675256|FG000|Overall Study|Lost to Follow-up|10|||
155066548|NCT04727749|559675257|FG001|Overall Study|Lost to Follow-up|3|||
155066549|NCT03331562|559675261|FG000|Overall Study|Adverse Event|2|||
155066550|NCT03331562|559675262|FG001|Overall Study|Adverse Event|0|||
155066551|NCT03331562|559675261|FG000|Overall Study|Death|1|||
155066552|NCT03331562|559675262|FG001|Overall Study|Death|0|||
155066553|NCT03718000|559675263|FG000|Overall Study|Relocation|2|||
155066554|NCT03718000|559675264|FG001|Overall Study|Relocation|4|||
155066555|NCT03718000|559675263|FG000|Overall Study|Pregnancy|0|||
155066556|NCT03718000|559675264|FG001|Overall Study|Pregnancy|1|||
155066557|NCT01186770|559675267|FG000|Overall Study|Ineligibility|0|||
155066558|NCT01186770|559675268|FG001|Overall Study|Ineligibility|0|||
155066559|NCT01186770|559675269|FG002|Overall Study|Ineligibility|2|||
155066560|NCT01186770|559675270|FG003|Overall Study|Ineligibility|0|||
155066561|NCT01186770|559675267|FG000|Overall Study|Protocol Violation|7|||
155066562|NCT01186770|559675268|FG001|Overall Study|Protocol Violation|9|||
155066563|NCT01186770|559675269|FG002|Overall Study|Protocol Violation|12|||
155066564|NCT01186770|559675270|FG003|Overall Study|Protocol Violation|14|||
155066565|NCT01186770|559675267|FG000|Overall Study|Adverse Event|2|||
155066566|NCT01186770|559675268|FG001|Overall Study|Adverse Event|9|||
155066567|NCT01186770|559675269|FG002|Overall Study|Adverse Event|7|||
155066568|NCT01186770|559675270|FG003|Overall Study|Adverse Event|9|||
155066569|NCT01186770|559675267|FG000|Overall Study|Withdrawal by Subject|15|||
155066570|NCT01186770|559675268|FG001|Overall Study|Withdrawal by Subject|13|||
155066571|NCT01186770|559675269|FG002|Overall Study|Withdrawal by Subject|11|||
155066572|NCT01186770|559675270|FG003|Overall Study|Withdrawal by Subject|17|||
155066573|NCT01186770|559675267|FG000|Overall Study|Lost to Follow-up|10|||
155066574|NCT01186770|559675268|FG001|Overall Study|Lost to Follow-up|6|||
155066575|NCT01186770|559675269|FG002|Overall Study|Lost to Follow-up|14|||
155066576|NCT01186770|559675270|FG003|Overall Study|Lost to Follow-up|9|||
155066577|NCT01186770|559675267|FG000|Overall Study|Insufficient response to treatment|7|||
155066578|NCT01186770|559675268|FG001|Overall Study|Insufficient response to treatment|8|||
155312135|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312136|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312137|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312138|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312139|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312140|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312141|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312142|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312143|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312144|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312145|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312146|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312147|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312148|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
155312149|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
154959729|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
154959730|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
154959731|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959732|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959733|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959734|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959735|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959736|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959737|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959738|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959739|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959740|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959741|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959742|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
155066579|NCT01186770|559675269|FG002|Overall Study|Insufficient response to treatment|5|||
155066580|NCT01186770|559675270|FG003|Overall Study|Insufficient response to treatment|7|||
155066581|NCT01186770|559675267|FG000|Overall Study|Other than specified|0|||
155312150|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
155312151|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
155312152|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155066582|NCT01186770|559675268|FG001|Overall Study|Other than specified|1|||
155066583|NCT01186770|559675269|FG002|Overall Study|Other than specified|1|||
155066584|NCT01186770|559675270|FG003|Overall Study|Other than specified|2|||
155066585|NCT00505921|559675271|FG000|Overall Study|Ineligible|1|||
155066586|NCT00505921|559675271|FG000|Overall Study|Failed to Mobilize|8|||
155066587|NCT02567188|559675272|FG000|Overall Study|Death|10|||
155066588|NCT02567188|559675272|FG000|Overall Study|Terminated Mircera Treatment|9|||
155066589|NCT02567188|559675272|FG000|Overall Study|Lost to Follow-up|5|||
155066590|NCT02567188|559675272|FG000|Overall Study|Adverse Event|1|||
155066591|NCT02567188|559675272|FG000|Overall Study|Withdrawal by Subject|1|||
155066592|NCT02567188|559675272|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
155066593|NCT02567188|559675272|FG000|Overall Study|Moved and Changed Clinic|1|||
155066594|NCT02567188|559675272|FG000|Overall Study|Started Hemodialysis|2|||
155066595|NCT02567188|559675272|FG000|Overall Study|Protocol Violation|5|||
155066596|NCT00630292|559675273|FG000|Overall Study|Withdrawal by Subject|1|||
155066597|NCT00716417|559675275|FG000|Overall Study|Adverse Event|0|||
155066598|NCT00716417|559675276|FG001|Overall Study|Adverse Event|0|||
155066599|NCT00716417|559675277|FG002|Overall Study|Adverse Event|2|||
155066600|NCT00716417|559675278|FG003|Overall Study|Adverse Event|1|||
155161958|NCT00935584|560028719|FG000|Overall Study|Provider dropped out of study|14|||
155161959|NCT00935584|560028720|FG001|Overall Study|Provider dropped out of study|4|||
155161960|NCT00687193|560028721|FG000|Overall Study|Adverse Event|0|||
155161961|NCT00687193|560028722|FG001|Overall Study|Adverse Event|1|||
155161962|NCT00687193|560028723|FG002|Overall Study|Adverse Event|2|||
155161963|NCT00687193|560028724|FG003|Overall Study|Adverse Event|3|||
155161964|NCT00687193|560028725|FG004|Overall Study|Adverse Event|0|||
155161965|NCT00687193|560028726|FG005|Overall Study|Adverse Event|2|||
155161966|NCT00687193|560028721|FG000|Overall Study|Lack of Efficacy|1|||
155161967|NCT00687193|560028722|FG001|Overall Study|Lack of Efficacy|1|||
155161968|NCT00687193|560028723|FG002|Overall Study|Lack of Efficacy|0|||
155161969|NCT00687193|560028724|FG003|Overall Study|Lack of Efficacy|0|||
155161970|NCT00687193|560028725|FG004|Overall Study|Lack of Efficacy|0|||
155161971|NCT00687193|560028726|FG005|Overall Study|Lack of Efficacy|2|||
155161972|NCT00687193|560028721|FG000|Overall Study|Protocol Violation|1|||
155161973|NCT00687193|560028722|FG001|Overall Study|Protocol Violation|2|||
155161974|NCT00687193|560028723|FG002|Overall Study|Protocol Violation|0|||
155161975|NCT00687193|560028724|FG003|Overall Study|Protocol Violation|1|||
155161976|NCT00687193|560028725|FG004|Overall Study|Protocol Violation|2|||
155161977|NCT00687193|560028726|FG005|Overall Study|Protocol Violation|0|||
155161978|NCT02129699|560028727|FG000|Overall Study|Did not start treatment|3|||
155161979|NCT02129699|560028728|FG001|Overall Study|Did not start treatment|2|||
155161980|NCT01394016|560028729|FG000|Overall Study|Progressive Disease|2|||
155161981|NCT01394016|560028730|FG001|Overall Study|Progressive Disease|0|||
155161982|NCT01394016|560028731|FG002|Overall Study|Progressive Disease|0|||
155161983|NCT01394016|560028732|FG003|Overall Study|Progressive Disease|0|||
155161984|NCT01394016|560028733|FG004|Overall Study|Progressive Disease|0|||
155161985|NCT01394016|560028734|FG005|Overall Study|Progressive Disease|0|||
155161986|NCT01394016|560028735|FG006|Overall Study|Progressive Disease|0|||
155161987|NCT01394016|560028736|FG007|Overall Study|Progressive Disease|0|||
155161988|NCT01394016|560028737|FG008|Overall Study|Progressive Disease|0|||
155161989|NCT01394016|560028738|FG009|Overall Study|Progressive Disease|0|||
155161990|NCT01394016|560028739|FG010|Overall Study|Progressive Disease|0|||
155161991|NCT01394016|560028740|FG011|Overall Study|Progressive Disease|0|||
155066601|NCT00716417|559675279|FG004|Overall Study|Adverse Event|0|||
155066602|NCT00716417|559675280|FG005|Overall Study|Adverse Event|0|||
155066603|NCT00716417|559675281|FG006|Overall Study|Adverse Event|3|||
155066604|NCT00716417|559675282|FG007|Overall Study|Adverse Event|1|||
155066605|NCT00716417|559675283|FG008|Overall Study|Adverse Event|0|||
155066606|NCT00716417|559675284|FG009|Overall Study|Adverse Event|3|||
155161992|NCT01394016|560028741|FG012|Overall Study|Progressive Disease|0|||
155161993|NCT01394016|560028742|FG013|Overall Study|Progressive Disease|0|||
155161994|NCT01394016|560028743|FG014|Overall Study|Progressive Disease|0|||
155161995|NCT01394016|560028744|FG015|Overall Study|Progressive Disease|0|||
155161996|NCT01394016|560028745|FG016|Overall Study|Progressive Disease|0|||
155161997|NCT01394016|560028746|FG017|Overall Study|Progressive Disease|0|||
154959743|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959744|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959745|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959746|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959747|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
154959748|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959749|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
154959750|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
154959751|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
154959752|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959753|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959754|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959755|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959756|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959757|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959758|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959759|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959760|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959761|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959762|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959763|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959764|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959765|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959766|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959767|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959768|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
154959769|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959770|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
154959771|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
154959772|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
154959773|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959774|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959775|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959776|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959777|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959778|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959779|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959780|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959781|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959782|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959783|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959784|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959785|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959786|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959787|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959788|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959789|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
154959790|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959791|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959792|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
155066607|NCT00716417|559675275|FG000|Overall Study|Withdrawal by Subject|0|||
155066608|NCT00716417|559675276|FG001|Overall Study|Withdrawal by Subject|1|||
155066609|NCT00716417|559675277|FG002|Overall Study|Withdrawal by Subject|0|||
155066610|NCT00716417|559675278|FG003|Overall Study|Withdrawal by Subject|2|||
155066611|NCT00716417|559675279|FG004|Overall Study|Withdrawal by Subject|0|||
155066612|NCT00716417|559675280|FG005|Overall Study|Withdrawal by Subject|0|||
155066613|NCT00716417|559675281|FG006|Overall Study|Withdrawal by Subject|1|||
155066614|NCT00716417|559675282|FG007|Overall Study|Withdrawal by Subject|0|||
155066615|NCT00716417|559675283|FG008|Overall Study|Withdrawal by Subject|0|||
155066616|NCT00716417|559675284|FG009|Overall Study|Withdrawal by Subject|0|||
155066617|NCT00716417|559675275|FG000|Overall Study|Progressive disease|3|||
155066618|NCT00716417|559675276|FG001|Overall Study|Progressive disease|5|||
155312153|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
155312154|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
155066619|NCT00716417|559675277|FG002|Overall Study|Progressive disease|3|||
155161998|NCT01394016|560028747|FG018|Overall Study|Progressive Disease|0|||
155312155|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312156|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312157|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312158|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312159|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312160|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312161|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
155312162|NCT02783300|560575212|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312163|NCT02783300|560575213|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312164|NCT02783300|560575214|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312165|NCT02783300|560575215|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312166|NCT02783300|560575216|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312167|NCT02783300|560575217|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312168|NCT02783300|560575218|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312169|NCT02783300|560575219|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312170|NCT02783300|560575220|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312171|NCT02783300|560575221|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312172|NCT02783300|560575222|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312173|NCT02783300|560575223|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155066620|NCT00716417|559675278|FG003|Overall Study|Progressive disease|8|||
155066621|NCT00716417|559675279|FG004|Overall Study|Progressive disease|0|||
155161999|NCT01394016|560028729|FG000|Overall Study|Withdrawal by Subject|0|||
155066622|NCT00716417|559675280|FG005|Overall Study|Progressive disease|3|||
155066623|NCT00716417|559675281|FG006|Overall Study|Progressive disease|3|||
155066624|NCT00716417|559675282|FG007|Overall Study|Progressive disease|1|||
155066625|NCT00716417|559675283|FG008|Overall Study|Progressive disease|5|||
155066626|NCT00716417|559675284|FG009|Overall Study|Progressive disease|0|||
155066627|NCT00716417|559675275|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
155066628|NCT00716417|559675276|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
155066629|NCT00716417|559675277|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
155066630|NCT00716417|559675278|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
155066631|NCT00716417|559675279|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
155066632|NCT00716417|559675280|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
155066633|NCT00716417|559675281|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
155066634|NCT00716417|559675282|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
155066635|NCT00716417|559675283|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
155066636|NCT00716417|559675284|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
155066637|NCT00716417|559675275|FG000|Overall Study|On patient request due to toxicities|0|||
155066638|NCT00716417|559675276|FG001|Overall Study|On patient request due to toxicities|0|||
155066639|NCT00716417|559675277|FG002|Overall Study|On patient request due to toxicities|0|||
155066640|NCT00716417|559675278|FG003|Overall Study|On patient request due to toxicities|0|||
155066641|NCT00716417|559675279|FG004|Overall Study|On patient request due to toxicities|0|||
155066642|NCT00716417|559675280|FG005|Overall Study|On patient request due to toxicities|0|||
155066643|NCT00716417|559675281|FG006|Overall Study|On patient request due to toxicities|0|||
155066644|NCT00716417|559675282|FG007|Overall Study|On patient request due to toxicities|1|||
155066645|NCT00716417|559675283|FG008|Overall Study|On patient request due to toxicities|0|||
155066646|NCT00716417|559675284|FG009|Overall Study|On patient request due to toxicities|0|||
155066647|NCT01553851|559675285|FG000|Overall Study|Adverse Event|2|||
155066648|NCT01553851|559675285|FG000|Overall Study|constipation|1|||
155066649|NCT02472353|559675287|FG000|Overall Study|Lost to Follow-up|1|||
155066650|NCT02472353|559675288|FG001|Overall Study|Lost to Follow-up|1|||
155066651|NCT02472353|559675287|FG000|Overall Study|Withdrawal by Subject|2|||
155066652|NCT02472353|559675288|FG001|Overall Study|Withdrawal by Subject|1|||
155066653|NCT02472353|559675287|FG000|Overall Study|Study Termination|1|||
155066654|NCT02472353|559675288|FG001|Overall Study|Study Termination|4|||
155066655|NCT04666298|559675291|FG000|Overall Study|Subject decision|1|||
155066656|NCT04666298|559675292|FG001|Overall Study|Subject decision|0|||
155066657|NCT04666298|559675293|FG002|Overall Study|Subject decision|0|||
155066658|NCT04666298|559675294|FG003|Overall Study|Subject decision|2|||
155066659|NCT04666298|559675291|FG000|Overall Study|Death|1|||
155066660|NCT04666298|559675292|FG001|Overall Study|Death|0|||
155066661|NCT04666298|559675293|FG002|Overall Study|Death|0|||
155066662|NCT04666298|559675294|FG003|Overall Study|Death|0|||
155066663|NCT04666298|559675291|FG000|Overall Study|Lost to Follow-up|0|||
155066664|NCT04666298|559675292|FG001|Overall Study|Lost to Follow-up|0|||
155066665|NCT04666298|559675293|FG002|Overall Study|Lost to Follow-up|0|||
155066666|NCT04666298|559675294|FG003|Overall Study|Lost to Follow-up|1|||
155066667|NCT04666298|559675291|FG000|Overall Study|Physician Decision|0|||
155066668|NCT04666298|559675292|FG001|Overall Study|Physician Decision|0|||
155066669|NCT04666298|559675293|FG002|Overall Study|Physician Decision|0|||
155162000|NCT01394016|560028730|FG001|Overall Study|Withdrawal by Subject|0|||
155066670|NCT04666298|559675294|FG003|Overall Study|Physician Decision|1|||
155066671|NCT04666298|559675291|FG000|Overall Study|Protocol deviation|0|||
155066672|NCT04666298|559675292|FG001|Overall Study|Protocol deviation|0|||
155312174|NCT02783300|560575224|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312175|NCT02783300|560575225|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
155312176|NCT02783300|560575226|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155066673|NCT04666298|559675293|FG002|Overall Study|Protocol deviation|1|||
155312177|NCT02783300|560575227|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155312178|NCT02783300|560575228|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155066674|NCT04666298|559675294|FG003|Overall Study|Protocol deviation|0|||
155066675|NCT00844519|559675297|FG000|Overall Study|Withdrawal by Subject|1|||
155066676|NCT00844519|559675298|FG001|Overall Study|Withdrawal by Subject|1|||
155066677|NCT00844519|559675297|FG000|Overall Study|Adverse Event|1|||
155066678|NCT00844519|559675298|FG001|Overall Study|Adverse Event|0|||
155066679|NCT01341470|559675299|FG000|Overall Study|Sponsor decision|0|||
155066680|NCT01341470|559675300|FG001|Overall Study|Sponsor decision|0|||
155066681|NCT01341470|559675301|FG002|Overall Study|Sponsor decision|1|||
155066682|NCT01341470|559675302|FG003|Overall Study|Sponsor decision|1|||
155066683|NCT01341470|559675303|FG004|Overall Study|Sponsor decision|0|||
155066684|NCT01341470|559675304|FG005|Overall Study|Sponsor decision|1|||
155066685|NCT03188822|559675308|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
155066686|NCT03188822|559675308|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
155066687|NCT02340949|559675309|FG000|Overall Study|Adverse Event|4|||
155066688|NCT02340949|559675310|FG001|Overall Study|Adverse Event|2|||
155066689|NCT02340949|559675309|FG000|Overall Study|Withdrawal by Subject|2|||
155066690|NCT02340949|559675310|FG001|Overall Study|Withdrawal by Subject|0|||
155066691|NCT02340949|559675309|FG000|Overall Study|Progression disease|6|||
155066692|NCT02340949|559675310|FG001|Overall Study|Progression disease|2|||
155312179|NCT02783300|560575229|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312180|NCT02783300|560575230|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155312181|NCT02783300|560575231|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
155312182|NCT02783300|560575232|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312183|NCT02783300|560575233|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312184|NCT02783300|560575234|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
155312185|NCT02783300|560575235|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
155312186|NCT02783300|560575236|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
155312187|NCT02783300|560575237|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
155312188|NCT02783300|560575238|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
155312189|NCT02783300|560575212|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312190|NCT02783300|560575213|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312191|NCT02783300|560575214|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312192|NCT02783300|560575215|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312193|NCT02783300|560575216|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312194|NCT02783300|560575217|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312195|NCT02783300|560575218|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312196|NCT02783300|560575219|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312197|NCT02783300|560575220|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312198|NCT02783300|560575221|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312199|NCT02783300|560575222|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312200|NCT02783300|560575223|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312201|NCT02783300|560575224|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312202|NCT02783300|560575225|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312203|NCT02783300|560575226|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312204|NCT02783300|560575227|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312205|NCT02783300|560575228|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312206|NCT02783300|560575229|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312207|NCT02783300|560575230|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312208|NCT02783300|560575231|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312209|NCT02783300|560575232|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312210|NCT02783300|560575233|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312211|NCT02783300|560575234|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312212|NCT02783300|560575235|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312213|NCT02783300|560575236|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312214|NCT02783300|560575237|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
155312215|NCT02783300|560575238|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
155312216|NCT02783300|560575212|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312217|NCT02783300|560575213|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312218|NCT02783300|560575214|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312219|NCT02783300|560575215|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312220|NCT02783300|560575216|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312221|NCT02783300|560575217|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
155066693|NCT02340949|559675309|FG000|Overall Study|Death|3|||
155066694|NCT02340949|559675310|FG001|Overall Study|Death|0|||
155066695|NCT02340949|559675309|FG000|Overall Study|Physician Decision|1|||
155066696|NCT02340949|559675310|FG001|Overall Study|Physician Decision|0|||
155066697|NCT00296517|559675311|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
155066698|NCT00296517|559675312|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
155066699|NCT00296517|559675311|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
155066700|NCT00296517|559675312|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
155312222|NCT02783300|560575218|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312223|NCT02783300|560575219|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312224|NCT02783300|560575220|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312225|NCT02783300|560575221|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312226|NCT02783300|560575222|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
155066701|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
155066702|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
155066703|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
155066704|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
155066705|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
155066706|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
155066707|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
155066708|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
155066709|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
155066710|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
155066711|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
155066712|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
155066713|NCT00296517|559675311|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
155066714|NCT00296517|559675312|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
155066715|NCT00596635|559675318|FG000|Overall Study|Lost to Follow-up|0|||
155066716|NCT00596635|559675319|FG001|Overall Study|Lost to Follow-up|2|||
155066717|NCT00596635|559675320|FG002|Overall Study|Lost to Follow-up|0|||
155066718|NCT00596635|559675318|FG000|Overall Study|Treatment for symptomatic UTI|4|||
155066719|NCT00596635|559675319|FG001|Overall Study|Treatment for symptomatic UTI|6|||
155066720|NCT00596635|559675320|FG002|Overall Study|Treatment for symptomatic UTI|3|||
155066721|NCT00596635|559675318|FG000|Overall Study|Hip fracture|2|||
155066722|NCT00596635|559675319|FG001|Overall Study|Hip fracture|3|||
155066723|NCT00596635|559675320|FG002|Overall Study|Hip fracture|3|||
155066724|NCT00596635|559675318|FG000|Overall Study|Could not provide urine specimen|1|||
155066725|NCT00596635|559675319|FG001|Overall Study|Could not provide urine specimen|2|||
155066726|NCT00596635|559675320|FG002|Overall Study|Could not provide urine specimen|2|||
155066727|NCT01143324|559675322|FG000|Overall Study|Lost to Follow-up|11|||
155066728|NCT01143324|559675322|FG000|Overall Study|Withdrawal by Subject|4|||
155066729|NCT01143324|559675322|FG000|Overall Study|Explant of the device|4|||
155312227|NCT02783300|560575223|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312228|NCT02783300|560575224|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312229|NCT02783300|560575225|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312230|NCT02783300|560575226|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312231|NCT02783300|560575227|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312232|NCT02783300|560575228|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312233|NCT02783300|560575229|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312234|NCT02783300|560575230|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
155066730|NCT01850641|559675327|FG000|Overall Study|Physician Decision|1|||
155066731|NCT01850641|559675327|FG000|Overall Study|Decrease in serum phosphorus|1|||
155066732|NCT01850641|559675327|FG000|Overall Study|Decrease in serum calcium|2|||
155066733|NCT01850641|559675327|FG000|Overall Study|Increase in serum ferritin|1|||
155066734|NCT00141817|559675328|FG000|Overall Study|Protocol Violation|0|||
155066735|NCT00141817|559675329|FG001|Overall Study|Protocol Violation|0|||
155066736|NCT00141817|559675330|FG002|Overall Study|Protocol Violation|1|||
155066737|NCT00141817|559675331|FG003|Overall Study|Protocol Violation|0|||
155066738|NCT00141817|559675328|FG000|Overall Study|Parent request|1|||
155066739|NCT00141817|559675329|FG001|Overall Study|Parent request|0|||
155066740|NCT00141817|559675330|FG002|Overall Study|Parent request|0|||
155066741|NCT00141817|559675331|FG003|Overall Study|Parent request|0|||
155066742|NCT00846365|559675332|FG000|Overall Study|Adverse Event|20|||
155066743|NCT00846365|559675333|FG001|Overall Study|Adverse Event|30|||
155066744|NCT00846365|559675334|FG002|Overall Study|Adverse Event|11|||
155066745|NCT00846365|559675332|FG000|Overall Study|Protocol Violation|5|||
155312235|NCT02783300|560575231|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312236|NCT02783300|560575232|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312237|NCT02783300|560575233|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312238|NCT02783300|560575234|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312239|NCT02783300|560575235|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312240|NCT02783300|560575236|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312241|NCT02783300|560575237|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
155312242|NCT02783300|560575238|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
155312243|NCT03535272|560575239|FG000|Overall Study|Lost to Follow-up|71|||
155312244|NCT03535272|560575240|FG001|Overall Study|Lost to Follow-up|73|||
155312245|NCT01744782|560575241|FG000|Overall Study|Death|1|||
155312246|NCT00378105|560575242|FG000|Overall Study|Adverse Event|3|||
155312247|NCT00378105|560575243|FG001|Overall Study|Adverse Event|1|||
155312248|NCT00378105|560575242|FG000|Overall Study|Withdrawal by Subject|3|||
155312249|NCT00378105|560575243|FG001|Overall Study|Withdrawal by Subject|3|||
155312250|NCT00378105|560575242|FG000|Overall Study|Death|1|||
155312251|NCT00378105|560575243|FG001|Overall Study|Death|0|||
155312252|NCT00378105|560575242|FG000|Overall Study|Going to transplant|7|||
155312253|NCT00378105|560575243|FG001|Overall Study|Going to transplant|8|||
155312254|NCT00378105|560575242|FG000|Overall Study|Progressive disease|3|||
155066746|NCT00846365|559675333|FG001|Overall Study|Protocol Violation|4|||
155066747|NCT00846365|559675334|FG002|Overall Study|Protocol Violation|0|||
155162001|NCT01394016|560028731|FG002|Overall Study|Withdrawal by Subject|0|||
155312255|NCT00378105|560575243|FG001|Overall Study|Progressive disease|3|||
155312256|NCT00378105|560575242|FG000|Overall Study|remain on study|3|||
155312257|NCT00378105|560575243|FG001|Overall Study|remain on study|11|||
155066748|NCT00846365|559675332|FG000|Overall Study|Lost to Follow-up|8|||
155066749|NCT00846365|559675333|FG001|Overall Study|Lost to Follow-up|2|||
155066750|NCT00846365|559675334|FG002|Overall Study|Lost to Follow-up|5|||
155066751|NCT00846365|559675332|FG000|Overall Study|Withdrawal by Subject|11|||
155066752|NCT00846365|559675333|FG001|Overall Study|Withdrawal by Subject|11|||
155066753|NCT00846365|559675334|FG002|Overall Study|Withdrawal by Subject|9|||
155312258|NCT00378105|560575242|FG000|Overall Study|Physician Decision|0|||
155312259|NCT00378105|560575243|FG001|Overall Study|Physician Decision|2|||
155312260|NCT00378105|560575242|FG000|Overall Study|Going non-protocol therapy|0|||
155066754|NCT00846365|559675332|FG000|Overall Study|Pregnancy|1|||
155066755|NCT00846365|559675333|FG001|Overall Study|Pregnancy|0|||
155066756|NCT00846365|559675334|FG002|Overall Study|Pregnancy|0|||
155066757|NCT00846365|559675332|FG000|Overall Study|Lack of Efficacy|1|||
155066758|NCT00846365|559675333|FG001|Overall Study|Lack of Efficacy|1|||
155066759|NCT00846365|559675334|FG002|Overall Study|Lack of Efficacy|2|||
155066760|NCT00846365|559675332|FG000|Overall Study|Other|9|||
155066761|NCT00846365|559675333|FG001|Overall Study|Other|1|||
155066762|NCT00846365|559675334|FG002|Overall Study|Other|6|||
155066763|NCT01277861|559675344|FG000|Overall Study|Physician Decision|2|||
155312261|NCT00378105|560575243|FG001|Overall Study|Going non-protocol therapy|1|||
155066764|NCT01277861|559675345|FG001|Overall Study|Physician Decision|2|||
155066765|NCT05032196|559675346|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155312262|NCT00378105|560575242|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
155312263|NCT00378105|560575243|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
155312264|NCT03623321|560575244|FG000|Overall Study|Adverse Event|32|||
155312265|NCT03623321|560575244|FG000|Overall Study|Death|9|||
155312266|NCT03623321|560575244|FG000|Overall Study|Lack of Efficacy|9|||
155312267|NCT03623321|560575244|FG000|Overall Study|Lost to Follow-up|6|||
155312268|NCT03623321|560575244|FG000|Overall Study|Noncompliance with study drug|6|||
155066766|NCT05032196|559675347|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
155066767|NCT05032196|559675348|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155066768|NCT05032196|559675349|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155066769|NCT05032196|559675350|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155066770|NCT05032196|559675351|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
155066771|NCT05032196|559675346|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155162002|NCT01394016|560028732|FG003|Overall Study|Withdrawal by Subject|0|||
155162003|NCT01394016|560028733|FG004|Overall Study|Withdrawal by Subject|0|||
155162004|NCT01394016|560028734|FG005|Overall Study|Withdrawal by Subject|0|||
155162005|NCT01394016|560028735|FG006|Overall Study|Withdrawal by Subject|0|||
155162006|NCT01394016|560028736|FG007|Overall Study|Withdrawal by Subject|1|||
155162007|NCT01394016|560028737|FG008|Overall Study|Withdrawal by Subject|1|||
155162008|NCT01394016|560028738|FG009|Overall Study|Withdrawal by Subject|1|||
155162009|NCT01394016|560028739|FG010|Overall Study|Withdrawal by Subject|4|||
155162010|NCT01394016|560028740|FG011|Overall Study|Withdrawal by Subject|0|||
155162011|NCT01394016|560028741|FG012|Overall Study|Withdrawal by Subject|0|||
155162012|NCT01394016|560028742|FG013|Overall Study|Withdrawal by Subject|3|||
155162013|NCT01394016|560028743|FG014|Overall Study|Withdrawal by Subject|1|||
155162014|NCT01394016|560028744|FG015|Overall Study|Withdrawal by Subject|3|||
155162015|NCT01394016|560028745|FG016|Overall Study|Withdrawal by Subject|1|||
155162016|NCT01394016|560028746|FG017|Overall Study|Withdrawal by Subject|1|||
155312269|NCT03623321|560575244|FG000|Overall Study|Use of prohibited medication|3|||
155312270|NCT03623321|560575244|FG000|Overall Study|Physician Decision|5|||
155066772|NCT05032196|559675347|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155066773|NCT05032196|559675348|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155066774|NCT05032196|559675349|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
155162017|NCT01394016|560028747|FG018|Overall Study|Withdrawal by Subject|2|||
155312271|NCT03623321|560575244|FG000|Overall Study|Protocol Violation|1|||
155312272|NCT03623321|560575244|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
155066775|NCT05032196|559675350|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155066776|NCT05032196|559675351|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
155066777|NCT05032196|559675346|FG000|Period 2 (Multidose)|Physician Decision|0|||
155066778|NCT05032196|559675347|FG001|Period 2 (Multidose)|Physician Decision|0|||
155066779|NCT05032196|559675348|FG002|Period 2 (Multidose)|Physician Decision|0|||
155162018|NCT01394016|560028729|FG000|Overall Study|Adverse Event|0|||
155312273|NCT03623321|560575244|FG000|Overall Study|Not further specified|43|||
155312274|NCT04241068|560575247|FG000|Core Treatment Period|Adverse Event|91|||
155312275|NCT04241068|560575247|FG000|Core Treatment Period|Change of Treatment|4|||
155312276|NCT04241068|560575247|FG000|Core Treatment Period|Consent Withdrawn|143|||
155312277|NCT04241068|560575247|FG000|Core Treatment Period|Death|26|||
155312278|NCT04241068|560575247|FG000|Core Treatment Period|Disease Progression|67|||
155312279|NCT04241068|560575247|FG000|Core Treatment Period|Investigator Decision|40|||
155312280|NCT04241068|560575247|FG000|Core Treatment Period|Loss of Capacity|9|||
155312281|NCT04241068|560575247|FG000|Core Treatment Period|Lost to Follow-up|11|||
155312282|NCT04241068|560575247|FG000|Core Treatment Period|Relocation|4|||
155312283|NCT04241068|560575247|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
155312284|NCT04241068|560575247|FG000|Core Treatment Period|Study Visit Burden|40|||
155312285|NCT04241068|560575247|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
155066780|NCT05032196|559675349|FG003|Period 2 (Multidose)|Physician Decision|0|||
155066781|NCT05032196|559675350|FG004|Period 2 (Multidose)|Physician Decision|1|||
155066782|NCT05032196|559675351|FG005|Period 2 (Multidose)|Physician Decision|0|||
155066783|NCT00857389|559675352|FG000|Overall Study|Did not proceed to transplant|2|||
155066784|NCT05260008|559675353|FG000|Overall Study|Physician Decision|0|||
155066785|NCT05260008|559675354|FG001|Overall Study|Physician Decision|1|||
155066786|NCT05260008|559675355|FG002|Overall Study|Physician Decision|0|||
155066787|NCT05260008|559675356|FG003|Overall Study|Physician Decision|0|||
155066788|NCT04584788|559675360|FG000|Overall Study|Physician Decision|8|||
155066789|NCT04584788|559675360|FG000|Overall Study|Withdrawal by Subject|1|||
155066790|NCT04584788|559675360|FG000|Overall Study|Adverse Event|3|||
155066791|NCT04284774|559675362|FG000|Overall Study|Progressive disease|5|||
155092629|NCT00261833|559773645|FG001|Overall Study|Withdrawal by Subject|7|||
155092630|NCT00261833|559773644|FG000|Overall Study|Protocol Violation|0|||
155092631|NCT00261833|559773645|FG001|Overall Study|Protocol Violation|1|||
155092632|NCT00261833|559773644|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
155092633|NCT00261833|559773645|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
155092634|NCT00261833|559773644|FG000|Overall Study|Lung transplantation|1|||
155092635|NCT00261833|559773645|FG001|Overall Study|Lung transplantation|1|||
155092636|NCT00261833|559773644|FG000|Overall Study|Missing reason|1|||
155092637|NCT00261833|559773645|FG001|Overall Study|Missing reason|0|||
155092638|NCT00261833|559773644|FG000|Overall Study|Not interested in being participant|0|||
155092639|NCT00261833|559773645|FG001|Overall Study|Not interested in being participant|1|||
155092640|NCT00622726|559773646|FG000|March, 2008 to August, 2010|Death|5|||
155092641|NCT00622726|559773647|FG001|March, 2008 to August, 2010|Death|2|||
155092642|NCT00622726|559773646|FG000|August, 2010 to April, 2013|Death|1|||
155092643|NCT00622726|559773647|FG001|August, 2010 to April, 2013|Death|5|||
155092644|NCT00854360|559773650|FG000|Overall Study|Adverse Event|0|||
155312286|NCT04241068|560575247|FG000|Core Treatment Period|Missing|2|||
155066792|NCT04817410|559676871|FG000|Overall Study|Withdrawal by Subject|5|||
155066793|NCT04817410|559676871|FG000|Overall Study|Physician Decision|3|||
155066794|NCT03595748|559676872|FG000|Overall Study|Death|11|||
155066795|NCT03595748|559676873|FG001|Overall Study|Death|12|||
155066796|NCT03595748|559676872|FG000|Overall Study|Withdrawal by Subject|28|||
155066797|NCT03595748|559676873|FG001|Overall Study|Withdrawal by Subject|29|||
155066798|NCT03595748|559676872|FG000|Overall Study|Protocol Violation|0|||
155066799|NCT03595748|559676873|FG001|Overall Study|Protocol Violation|1|||
155066800|NCT04809974|559676874|FG000|Lead-in Phase|Withdrawal by Subject|3|||
155066801|NCT04809974|559676875|FG001|Lead-in Phase|Withdrawal by Subject|0|||
155066802|NCT04809974|559676876|FG002|Lead-in Phase|Withdrawal by Subject|0|||
155066803|NCT04809974|559676874|FG000|Lead-in Phase|No longer eligible|11|||
155066804|NCT04809974|559676875|FG001|Lead-in Phase|No longer eligible|0|||
155066805|NCT04809974|559676876|FG002|Lead-in Phase|No longer eligible|0|||
155066806|NCT04809974|559676874|FG000|Randomized Phase|Lost to Follow-up|0|||
155066807|NCT04809974|559676875|FG001|Randomized Phase|Lost to Follow-up|1|||
155066808|NCT04809974|559676876|FG002|Randomized Phase|Lost to Follow-up|5|||
155066809|NCT04809974|559676874|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
155066810|NCT04809974|559676875|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
155066811|NCT04809974|559676876|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
155066812|NCT04809974|559676874|FG000|Randomized Phase|Adverse Event|0|||
155162019|NCT01394016|560028730|FG001|Overall Study|Adverse Event|0|||
155066813|NCT04809974|559676875|FG001|Randomized Phase|Adverse Event|1|||
155066814|NCT04809974|559676876|FG002|Randomized Phase|Adverse Event|4|||
155066815|NCT04809974|559676874|FG000|Randomized Phase|Withdrawal by Subject|0|||
155066816|NCT04809974|559676875|FG001|Randomized Phase|Withdrawal by Subject|0|||
155066817|NCT04809974|559676876|FG002|Randomized Phase|Withdrawal by Subject|5|||
155066818|NCT00549055|559676885|FG000|Overall Study|Adverse Event|4|||
155066819|NCT00549055|559676885|FG000|Overall Study|Lack of Efficacy|18|||
155066820|NCT00549055|559676885|FG000|Overall Study|Stabilization|5|||
155066821|NCT00549055|559676885|FG000|Overall Study|Progression to fibrosis|2|||
155066822|NCT00549055|559676885|FG000|Overall Study|Decrease of size|1|||
155066823|NCT00549055|559676885|FG000|Overall Study|Active choroidal neovascula increased|1|||
155312287|NCT04241068|560575247|FG000|Core Treatment Period|Reason Not Specified|41|||
155312288|NCT04241068|560575247|FG000|LTE Period|Adverse Event|19|||
155312289|NCT04241068|560575247|FG000|LTE Period|Change of Treatment|1|||
155312290|NCT04241068|560575247|FG000|LTE Period|Consent Withdrawn|71|||
155312291|NCT04241068|560575247|FG000|LTE Period|Death|8|||
155312292|NCT04241068|560575247|FG000|LTE Period|Disease Progression|11|||
155312293|NCT04241068|560575247|FG000|LTE Period|Investigator Decision|12|||
155312294|NCT04241068|560575247|FG000|LTE Period|Loss of Capacity|2|||
155312295|NCT04241068|560575247|FG000|LTE Period|Lost to Follow-up|7|||
155312296|NCT04241068|560575247|FG000|LTE Period|Relocation|6|||
155312297|NCT04241068|560575247|FG000|LTE Period|Site Terminated by Sponsor|26|||
155312298|NCT04241068|560575247|FG000|LTE Period|Study Terminated by Sponsor|276|||
155312299|NCT04241068|560575247|FG000|LTE Period|Study Visit Burden|10|||
155312300|NCT04241068|560575247|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
155312301|NCT04241068|560575247|FG000|LTE Period|Reason Not Specified|65|||
155312302|NCT04492007|560575253|FG000|Overall Study|Lost to Follow-up|1|||
155312303|NCT04492007|560575254|FG001|Overall Study|Lost to Follow-up|1|||
155312304|NCT04492007|560575255|FG002|Overall Study|Lost to Follow-up|2|||
155312305|NCT04492007|560575256|FG003|Overall Study|Lost to Follow-up|2|||
155312306|NCT04492007|560575253|FG000|Overall Study|Protocol Violation|1|||
155312307|NCT04492007|560575254|FG001|Overall Study|Protocol Violation|1|||
155312308|NCT04492007|560575255|FG002|Overall Study|Protocol Violation|1|||
155312309|NCT04492007|560575256|FG003|Overall Study|Protocol Violation|1|||
155312310|NCT04492007|560575253|FG000|Overall Study|Withdrawal by Subject|0|||
155312311|NCT04492007|560575254|FG001|Overall Study|Withdrawal by Subject|0|||
155312312|NCT04492007|560575255|FG002|Overall Study|Withdrawal by Subject|1|||
155312313|NCT04492007|560575256|FG003|Overall Study|Withdrawal by Subject|1|||
155312314|NCT05178316|560575257|FG000|Overall Study|Adverse Event|5|||
155312315|NCT05178316|560575258|FG001|Overall Study|Adverse Event|4|||
155312316|NCT05178316|560575259|FG002|Overall Study|Adverse Event|9|||
155312317|NCT05178316|560575257|FG000|Overall Study|Enrolled in Error|1|||
155312318|NCT05178316|560575258|FG001|Overall Study|Enrolled in Error|2|||
155312319|NCT05178316|560575259|FG002|Overall Study|Enrolled in Error|1|||
155312320|NCT05178316|560575257|FG000|Overall Study|Lost to Follow-up|3|||
155312321|NCT05178316|560575258|FG001|Overall Study|Lost to Follow-up|15|||
155312322|NCT05178316|560575259|FG002|Overall Study|Lost to Follow-up|11|||
155312323|NCT05178316|560575257|FG000|Overall Study|Noncompliance|1|||
155312324|NCT05178316|560575258|FG001|Overall Study|Noncompliance|3|||
155312325|NCT05178316|560575259|FG002|Overall Study|Noncompliance|1|||
155312326|NCT05178316|560575257|FG000|Overall Study|Other|0|||
155312327|NCT05178316|560575258|FG001|Overall Study|Other|1|||
155312328|NCT05178316|560575259|FG002|Overall Study|Other|0|||
155312329|NCT05178316|560575257|FG000|Overall Study|Physician Decision|0|||
155312330|NCT05178316|560575258|FG001|Overall Study|Physician Decision|3|||
155312331|NCT05178316|560575259|FG002|Overall Study|Physician Decision|2|||
155312332|NCT05178316|560575257|FG000|Overall Study|Protocol deviation|1|||
155312333|NCT05178316|560575258|FG001|Overall Study|Protocol deviation|0|||
155312334|NCT05178316|560575259|FG002|Overall Study|Protocol deviation|1|||
155312335|NCT05178316|560575257|FG000|Overall Study|Sponsor decision|1|||
155312336|NCT05178316|560575258|FG001|Overall Study|Sponsor decision|0|||
155312337|NCT05178316|560575259|FG002|Overall Study|Sponsor decision|1|||
155312338|NCT05178316|560575257|FG000|Overall Study|Withdrawal by Subject|5|||
155312339|NCT05178316|560575258|FG001|Overall Study|Withdrawal by Subject|11|||
155312340|NCT05178316|560575259|FG002|Overall Study|Withdrawal by Subject|5|||
155162020|NCT01394016|560028731|FG002|Overall Study|Adverse Event|0|||
155312341|NCT03907397|560575262|FG000|Overall Study|Lost to Follow-up|0|||
155312342|NCT03907397|560575263|FG001|Overall Study|Lost to Follow-up|1|||
155312343|NCT03907397|560575262|FG000|Overall Study|Physician Decision|2|||
155162021|NCT01394016|560028732|FG003|Overall Study|Adverse Event|0|||
155162022|NCT01394016|560028733|FG004|Overall Study|Adverse Event|0|||
155312344|NCT03907397|560575263|FG001|Overall Study|Physician Decision|1|||
155312345|NCT03907397|560575262|FG000|Overall Study|Withdrawal by Subject|5|||
155312346|NCT03907397|560575263|FG001|Overall Study|Withdrawal by Subject|4|||
155312347|NCT03907397|560575262|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
155312348|NCT03907397|560575263|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
155312349|NCT01413100|560575264|FG000|Overall Study|Withdrawal by Subject|1|||
155312350|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
155162023|NCT01394016|560028734|FG005|Overall Study|Adverse Event|0|||
155162024|NCT01394016|560028735|FG006|Overall Study|Adverse Event|0|||
155162025|NCT01394016|560028736|FG007|Overall Study|Adverse Event|0|||
155162026|NCT01394016|560028737|FG008|Overall Study|Adverse Event|0|||
155162027|NCT01394016|560028738|FG009|Overall Study|Adverse Event|1|||
155162028|NCT01394016|560028739|FG010|Overall Study|Adverse Event|0|||
155162029|NCT01394016|560028740|FG011|Overall Study|Adverse Event|0|||
155162030|NCT01394016|560028741|FG012|Overall Study|Adverse Event|0|||
155162031|NCT01394016|560028742|FG013|Overall Study|Adverse Event|0|||
155162032|NCT01394016|560028743|FG014|Overall Study|Adverse Event|0|||
155312351|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
155162033|NCT01394016|560028744|FG015|Overall Study|Adverse Event|0|||
155162034|NCT01394016|560028745|FG016|Overall Study|Adverse Event|1|||
155162035|NCT01394016|560028746|FG017|Overall Study|Adverse Event|1|||
155162036|NCT01394016|560028747|FG018|Overall Study|Adverse Event|0|||
155312352|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
155312353|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
155312354|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
155312355|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
155312356|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
155312357|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
155312358|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
155312359|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
155312360|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
155312361|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
155312362|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
155312363|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
155312364|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
155312365|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
155312366|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
155312367|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
155312368|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
155312369|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
155312370|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
155312371|NCT05369403|560575265|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
155312372|NCT05369403|560575266|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
155312373|NCT05369403|560575267|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
155312374|NCT05369403|560575265|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
155312375|NCT05369403|560575266|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
155312376|NCT05369403|560575267|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
155312377|NCT05369403|560575265|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
155312378|NCT05369403|560575266|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
155312379|NCT05369403|560575267|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
155312380|NCT05369403|560575265|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
155312381|NCT05369403|560575266|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
155312382|NCT05369403|560575267|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
155312383|NCT03792256|560575274|FG000|Overall Study|Death|0|||
155312384|NCT03792256|560575275|FG001|Overall Study|Death|1|||
155312385|NCT03792256|560575274|FG000|Overall Study|Lack of Efficacy|0|||
155312386|NCT03792256|560575275|FG001|Overall Study|Lack of Efficacy|1|||
155312387|NCT03792256|560575274|FG000|Overall Study|Withdrawal by Subject|0|||
155312388|NCT03792256|560575275|FG001|Overall Study|Withdrawal by Subject|1|||
155312389|NCT04831216|560575290|FG000|Overall Study|Lost to Follow-up|32|||
155312390|NCT02913872|560575295|FG000|Overall Study|Withdrawal by Subject|1|||
155312391|NCT04739956|560575298|FG000|Overall Study|Withdrawal by Subject|1|||
155312392|NCT04739956|560575299|FG001|Overall Study|Withdrawal by Subject|1|||
155312393|NCT03519581|560575302|FG000|Overall Study|Lost to Follow-up|3|||
155312394|NCT03519581|560575303|FG001|Overall Study|Lost to Follow-up|2|||
155312395|NCT03519581|560575302|FG000|Overall Study|Adverse Event|5|||
155312396|NCT03519581|560575303|FG001|Overall Study|Adverse Event|2|||
155312397|NCT03519581|560575302|FG000|Overall Study|Withdrawal by Subject|2|||
155312398|NCT03519581|560575303|FG001|Overall Study|Withdrawal by Subject|0|||
155312399|NCT03519581|560575302|FG000|Overall Study|Change to insurance|2|||
155312400|NCT03519581|560575303|FG001|Overall Study|Change to insurance|1|||
155312401|NCT03519581|560575302|FG000|Overall Study|Other|2|||
155312402|NCT03519581|560575303|FG001|Overall Study|Other|4|||
155312403|NCT05177848|560575304|FG000|Overall Study|Lost to Follow-up|1|||
155312404|NCT05177848|560575305|FG001|Overall Study|Lost to Follow-up|4|||
155312405|NCT05177848|560575304|FG000|Overall Study|Discontinued|2|||
155162037|NCT01394016|560028729|FG000|Overall Study|Sponsor Decision|0|||
155066824|NCT00549055|559676885|FG000|Overall Study|Vitreous hemorrhage|1|||
155066825|NCT00549055|559676885|FG000|Overall Study|Growth choroidal neovascularisation|1|||
155066826|NCT00549055|559676885|FG000|Overall Study|Choroidal neovascularization|1|||
155066827|NCT00549055|559676885|FG000|Overall Study|Very low visual acuity (VA)|1|||
155066828|NCT02472405|559676887|FG000|Overall Study|Lost to Follow-up|9|||
155066829|NCT02472405|559676887|FG000|Overall Study|Adverse Event|1|||
155066830|NCT01431976|559676888|FG000|Overall Study|Adverse Event|6|||
155066831|NCT01431976|559676888|FG000|Overall Study|Lack of Efficacy|2|||
155066832|NCT01431976|559676888|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
155066833|NCT01431976|559676888|FG000|Overall Study|Physician Decision|1|||
155066834|NCT01431976|559676888|FG000|Overall Study|Withdrawal by Subject|1|||
155066835|NCT01134042|559676891|FG000|Overall Study|Adverse Event|3|||
155066836|NCT01134042|559676892|FG001|Overall Study|Adverse Event|7|||
155066837|NCT01134042|559676893|FG002|Overall Study|Adverse Event|2|||
155066838|NCT01134042|559676891|FG000|Overall Study|Lack of Efficacy|21|||
155066839|NCT01134042|559676892|FG001|Overall Study|Lack of Efficacy|6|||
155066840|NCT01134042|559676893|FG002|Overall Study|Lack of Efficacy|18|||
155066841|NCT01134042|559676891|FG000|Overall Study|Protocol Violation|5|||
155066842|NCT01134042|559676892|FG001|Overall Study|Protocol Violation|3|||
155066843|NCT01134042|559676893|FG002|Overall Study|Protocol Violation|5|||
155066844|NCT01134042|559676891|FG000|Overall Study|Lost to Follow-up|2|||
155066845|NCT01134042|559676892|FG001|Overall Study|Lost to Follow-up|0|||
155066846|NCT01134042|559676893|FG002|Overall Study|Lost to Follow-up|1|||
155066847|NCT01134042|559676891|FG000|Overall Study|Physician Decision|4|||
155066848|NCT01134042|559676892|FG001|Overall Study|Physician Decision|8|||
155066849|NCT01134042|559676893|FG002|Overall Study|Physician Decision|1|||
155066850|NCT01134042|559676891|FG000|Overall Study|Withdrawal by Subject|13|||
155066851|NCT01134042|559676892|FG001|Overall Study|Withdrawal by Subject|4|||
155066852|NCT01134042|559676893|FG002|Overall Study|Withdrawal by Subject|7|||
155066853|NCT00764517|559676894|FG000|Overall Study|Adverse Event|9|||
155066854|NCT00764517|559676895|FG001|Overall Study|Adverse Event|3|||
155066855|NCT00764517|559676894|FG000|Overall Study|Death|3|||
155066856|NCT00764517|559676895|FG001|Overall Study|Death|11|||
155066857|NCT00764517|559676894|FG000|Overall Study|Physician Decision|3|||
155066858|NCT00764517|559676895|FG001|Overall Study|Physician Decision|0|||
155066859|NCT01091259|559676905|FG000|Overall Study|Adverse Event|3|||
155066860|NCT01091259|559676905|FG000|Overall Study|Lack of Efficacy|2|||
155066861|NCT00770367|559676906|FG000|First Intervention|Withdrawal by Subject|0|||
155066862|NCT00770367|559676907|FG001|First Intervention|Withdrawal by Subject|2|||
155066863|NCT00770367|559676906|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
155066864|NCT00770367|559676907|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
155066865|NCT00770367|559676906|FG000|Second Intervention|Lost to Follow-up|2|||
155066866|NCT00770367|559676907|FG001|Second Intervention|Lost to Follow-up|0|||
155066867|NCT04115059|559676908|FG000|Overall Study|Withdrawal by Subject|1|||
155066868|NCT04115059|559676908|FG000|Overall Study|Lack of Efficacy|2|||
155066869|NCT03517137|559676919|FG000|Overall Study|Lack of Efficacy|1|||
155066870|NCT03517137|559676919|FG000|Overall Study|Adverse Event|2|||
155312406|NCT05177848|560575305|FG001|Overall Study|Discontinued|1|||
155066871|NCT03517137|559676919|FG000|Overall Study|Withdrawal by Subject|2|||
155066872|NCT03517137|559676919|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
155066873|NCT03575364|559676920|FG000|Overall Study|Death|45|||
155066874|NCT03575364|559676920|FG000|Overall Study|Lost to Follow-up|114|||
155066875|NCT03575364|559676920|FG000|Overall Study|Withdrawal by Subject|21|||
155066876|NCT03575364|559676920|FG000|Overall Study|Physician Decision|11|||
155066877|NCT03575364|559676920|FG000|Overall Study|Subject Refused Follow-up|13|||
155066878|NCT03575364|559676920|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
155066879|NCT03575364|559676920|FG000|Overall Study|Patient moved out of the state|1|||
155066880|NCT03575364|559676920|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
155066881|NCT03575364|559676920|FG000|Overall Study|Patient is lost to follow up|1|||
155066882|NCT03575364|559676920|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
155066883|NCT01369433|559676921|FG000|Overall Study|Adverse Event|31|||
155312407|NCT06414213|560575306|FG000|Overall Study|Lost to Follow-up|1|||
155312408|NCT06414213|560575307|FG001|Overall Study|Lost to Follow-up|1|||
155312409|NCT06414213|560575308|FG002|Overall Study|Lost to Follow-up|3|||
155312410|NCT00450658|560575310|FG000|Overall Study|Adverse Event|24|||
155066884|NCT01369433|559676922|FG001|Overall Study|Adverse Event|1|||
155066885|NCT01369433|559676921|FG000|Overall Study|Required significant surgical procedure|1|||
155066886|NCT01369433|559676922|FG001|Overall Study|Required significant surgical procedure|0|||
155066887|NCT01369433|559676921|FG000|Overall Study|Non-compliance|1|||
155066888|NCT01369433|559676922|FG001|Overall Study|Non-compliance|0|||
155066889|NCT01369433|559676921|FG000|Overall Study|Withdrawal by Subject|5|||
155066890|NCT01369433|559676922|FG001|Overall Study|Withdrawal by Subject|2|||
155066891|NCT01369433|559676921|FG000|Overall Study|Study terminated by Sponsor|67|||
155066892|NCT01369433|559676922|FG001|Overall Study|Study terminated by Sponsor|0|||
155162038|NCT01394016|560028730|FG001|Overall Study|Sponsor Decision|0|||
155312411|NCT00450658|560575311|FG001|Overall Study|Adverse Event|15|||
155162039|NCT01394016|560028731|FG002|Overall Study|Sponsor Decision|0|||
155312412|NCT00450658|560575310|FG000|Overall Study|Withdrawal by Subject|43|||
155312413|NCT00450658|560575311|FG001|Overall Study|Withdrawal by Subject|26|||
155312414|NCT00450658|560575310|FG000|Overall Study|Lost to Follow-up|22|||
155312415|NCT00450658|560575311|FG001|Overall Study|Lost to Follow-up|5|||
155312416|NCT00450658|560575310|FG000|Overall Study|UGI ulcer|33|||
155312417|NCT00450658|560575311|FG001|Overall Study|UGI ulcer|34|||
155312418|NCT00450658|560575310|FG000|Overall Study|misc|21|||
155312419|NCT00450658|560575311|FG001|Overall Study|misc|10|||
155312420|NCT03850678|560575314|FG000|Overall Study|Withdrawal by Subject|3|||
155312421|NCT03850678|560575315|FG001|Overall Study|Withdrawal by Subject|0|||
155312422|NCT03850678|560575314|FG000|Overall Study|Experimenter Error|1|||
155312423|NCT03850678|560575315|FG001|Overall Study|Experimenter Error|1|||
155312424|NCT03850678|560575314|FG000|Overall Study|Did Not Condition To Experiment|7|||
155312425|NCT03850678|560575315|FG001|Overall Study|Did Not Condition To Experiment|2|||
155312426|NCT04072380|560575322|FG000|Overall Study|Adverse Event|4|||
155312427|NCT04072380|560575323|FG001|Overall Study|Adverse Event|6|||
155312428|NCT04072380|560575324|FG002|Overall Study|Adverse Event|0|||
155312429|NCT04072380|560575322|FG000|Overall Study|Withdrawal by Subject|3|||
155312430|NCT04072380|560575323|FG001|Overall Study|Withdrawal by Subject|1|||
155312431|NCT04072380|560575324|FG002|Overall Study|Withdrawal by Subject|1|||
155312432|NCT04072380|560575322|FG000|Overall Study|Physician Decision|2|||
155312433|NCT04072380|560575323|FG001|Overall Study|Physician Decision|0|||
155312434|NCT04072380|560575324|FG002|Overall Study|Physician Decision|0|||
155312435|NCT04072380|560575322|FG000|Overall Study|Protocol Violation|0|||
155312436|NCT04072380|560575323|FG001|Overall Study|Protocol Violation|2|||
155312437|NCT04072380|560575324|FG002|Overall Study|Protocol Violation|3|||
155312438|NCT04072380|560575322|FG000|Overall Study|Intercurrent Illness and Others|3|||
155312439|NCT04072380|560575323|FG001|Overall Study|Intercurrent Illness and Others|5|||
155312440|NCT04072380|560575324|FG002|Overall Study|Intercurrent Illness and Others|6|||
155312441|NCT04015167|560575327|FG000|Overall Study|Lost to Follow-up|40|||
155312442|NCT04015167|560575327|FG000|Overall Study|Adverse Event|5|||
155312443|NCT04015167|560575327|FG000|Overall Study|Withdrawal by Subject|2|||
155312444|NCT04015167|560575327|FG000|Overall Study|Subject went to jail|1|||
154959793|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
154959794|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959795|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959796|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959797|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959798|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959799|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959800|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959801|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959802|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959803|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959804|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959805|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959806|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959807|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959808|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959809|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959810|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
154959811|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959812|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
154959813|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
154959814|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
155312445|NCT03640312|560575328|FG000|Overall Study|Lost to Follow-up|3|||
155312446|NCT03640312|560575329|FG001|Overall Study|Lost to Follow-up|6|||
155312447|NCT05008835|560575331|FG000|Overall Study|Adverse Event|5|||
155312448|NCT05008835|560575332|FG001|Overall Study|Adverse Event|2|||
155312449|NCT05008835|560575333|FG002|Overall Study|Adverse Event|1|||
155312450|NCT05008835|560575331|FG000|Overall Study|Lack of Efficacy|0|||
155312451|NCT05008835|560575332|FG001|Overall Study|Lack of Efficacy|0|||
155312452|NCT05008835|560575333|FG002|Overall Study|Lack of Efficacy|1|||
155312453|NCT05008835|560575331|FG000|Overall Study|Study terminated by sponsor|0|||
155312454|NCT05008835|560575332|FG001|Overall Study|Study terminated by sponsor|0|||
155312455|NCT05008835|560575333|FG002|Overall Study|Study terminated by sponsor|1|||
155312456|NCT05008835|560575331|FG000|Overall Study|Not further specified|3|||
155312457|NCT05008835|560575332|FG001|Overall Study|Not further specified|2|||
155312458|NCT05008835|560575333|FG002|Overall Study|Not further specified|1|||
155312459|NCT03366649|560577360|FG000|Overall Study|Failed preoperative screening|4|||
155312460|NCT03366649|560577361|FG001|Overall Study|Failed preoperative screening|0|||
155312461|NCT03366649|560577362|FG002|Overall Study|Failed preoperative screening|0|||
155312462|NCT03366649|560577360|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
155312463|NCT03366649|560577361|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
155312464|NCT03366649|560577362|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
155312465|NCT03673111|560577364|FG000|Overall Study|Protocol Violation|0|||
155312466|NCT03673111|560577365|FG001|Overall Study|Protocol Violation|0|||
155312467|NCT03673111|560577366|FG002|Overall Study|Protocol Violation|0|||
155312468|NCT03673111|560577367|FG003|Overall Study|Protocol Violation|0|||
155312469|NCT03673111|560577368|FG004|Overall Study|Protocol Violation|0|||
155312470|NCT03673111|560577369|FG005|Overall Study|Protocol Violation|0|||
155312471|NCT03673111|560577370|FG006|Overall Study|Protocol Violation|0|||
155312472|NCT03673111|560577371|FG007|Overall Study|Protocol Violation|0|||
155312473|NCT03673111|560577372|FG008|Overall Study|Protocol Violation|0|||
155312474|NCT03673111|560577373|FG009|Overall Study|Protocol Violation|0|||
155312475|NCT03673111|560577374|FG010|Overall Study|Protocol Violation|1|||
155312476|NCT03673111|560577375|FG011|Overall Study|Protocol Violation|0|||
155312477|NCT03673111|560577376|FG012|Overall Study|Protocol Violation|0|||
155312478|NCT03673111|560577377|FG013|Overall Study|Protocol Violation|0|||
155312479|NCT03673111|560577364|FG000|Overall Study|Adverse Event|1|||
155312480|NCT03673111|560577365|FG001|Overall Study|Adverse Event|0|||
155312481|NCT03673111|560577366|FG002|Overall Study|Adverse Event|0|||
155312482|NCT03673111|560577367|FG003|Overall Study|Adverse Event|0|||
155312483|NCT03673111|560577368|FG004|Overall Study|Adverse Event|0|||
155312484|NCT03673111|560577369|FG005|Overall Study|Adverse Event|0|||
155312485|NCT03673111|560577370|FG006|Overall Study|Adverse Event|0|||
155312486|NCT03673111|560577371|FG007|Overall Study|Adverse Event|0|||
155312487|NCT03673111|560577372|FG008|Overall Study|Adverse Event|0|||
155312488|NCT03673111|560577373|FG009|Overall Study|Adverse Event|0|||
155312489|NCT03673111|560577374|FG010|Overall Study|Adverse Event|0|||
155312490|NCT03673111|560577375|FG011|Overall Study|Adverse Event|0|||
155312491|NCT03673111|560577376|FG012|Overall Study|Adverse Event|0|||
155312492|NCT03673111|560577377|FG013|Overall Study|Adverse Event|0|||
155312493|NCT03792555|560577378|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
155312494|NCT03792555|560577379|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
155312495|NCT03792555|560577380|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
155312496|NCT03792555|560577378|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
155312497|NCT03792555|560577379|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
155312498|NCT03792555|560577380|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
155312499|NCT03792555|560577378|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
155312500|NCT03792555|560577379|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
155312501|NCT03792555|560577380|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
155312502|NCT04485039|560577381|FG000|TPOXX Only|Adverse Event|2|||
155312503|NCT04485039|560577381|FG000|TPOXX Only|Physician Decision|1|||
155312504|NCT04485039|560577381|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
155312505|NCT04485039|560577381|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
155312506|NCT04005716|560577385|FG000|Overall Study|Death|175|||
155312507|NCT04005716|560577386|FG001|Overall Study|Death|196|||
155312508|NCT04005716|560577385|FG000|Overall Study|Withdrawal by Subject|1|||
155312509|NCT04005716|560577386|FG001|Overall Study|Withdrawal by Subject|6|||
155312510|NCT04005716|560577385|FG000|Overall Study|Lost to Follow-up|2|||
155312511|NCT04005716|560577386|FG001|Overall Study|Lost to Follow-up|2|||
155312512|NCT00418886|560577389|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
155312513|NCT00418886|560577390|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
155312514|NCT00418886|560577389|FG000|Randomized Period|Death|122|||
155312515|NCT00418886|560577390|FG001|Randomized Period|Death|147|||
155312516|NCT00418886|560577389|FG000|Randomized Period|Withdrawal by Subject|9|||
155312517|NCT00418886|560577390|FG001|Randomized Period|Withdrawal by Subject|10|||
155312518|NCT00418886|560577389|FG000|Randomized Period|Lost to Follow-up|4|||
155312519|NCT00418886|560577390|FG001|Randomized Period|Lost to Follow-up|6|||
155312520|NCT00418886|560577389|FG000|Randomized Period|withdrawn due to other reason|1|||
155312521|NCT00418886|560577390|FG001|Randomized Period|withdrawn due to other reason|0|||
155312522|NCT00418886|560577389|FG000|Randomized Period|randomised but no treatment received|0|||
155312523|NCT00418886|560577390|FG001|Randomized Period|randomised but no treatment received|1|||
155312524|NCT03707951|560577391|FG000|Overall Study|Lost to Follow-up|8|||
155312525|NCT03707951|560577392|FG001|Overall Study|Lost to Follow-up|17|||
155312526|NCT03707951|560577391|FG000|Overall Study|Withdrawal by Subject|6|||
155312527|NCT03707951|560577392|FG001|Overall Study|Withdrawal by Subject|6|||
155312528|NCT04347161|560577393|FG000|Overall Study|Death|0|||
155312529|NCT04347161|560577394|FG001|Overall Study|Death|2|||
155312530|NCT04347161|560577393|FG000|Overall Study|Withdrawal by Subject|1|||
155312531|NCT04347161|560577394|FG001|Overall Study|Withdrawal by Subject|0|||
155312532|NCT04347161|560577393|FG000|Overall Study|Lost to Follow-up|0|||
155312533|NCT04347161|560577394|FG001|Overall Study|Lost to Follow-up|1|||
155312534|NCT04347161|560577393|FG000|Overall Study|No longer on study medication|1|||
155312535|NCT04347161|560577394|FG001|Overall Study|No longer on study medication|1|||
155312536|NCT04533347|560577396|FG000|Overall Study|Adverse Event|1|||
155312537|NCT04533347|560577397|FG001|Overall Study|Adverse Event|2|||
155312538|NCT04533347|560577396|FG000|Overall Study|Lost to Follow-up|2|||
155312539|NCT04533347|560577397|FG001|Overall Study|Lost to Follow-up|0|||
155312540|NCT04533347|560577396|FG000|Overall Study|Withdrawal by Subject|1|||
155312541|NCT04533347|560577397|FG001|Overall Study|Withdrawal by Subject|0|||
155312542|NCT05520190|560577398|FG000|Overall Study|Lost to Follow-up|7|||
155312543|NCT05520190|560577398|FG000|Overall Study|Withdrawal by Subject|2|||
155312544|NCT01999075|560577399|FG000|Overall Study|Lost to Follow-up|0|||
155312545|NCT01999075|560577400|FG001|Overall Study|Lost to Follow-up|2|||
155312546|NCT01999075|560577399|FG000|Overall Study|Withdrawal by Subject|2|||
155312547|NCT01999075|560577400|FG001|Overall Study|Withdrawal by Subject|7|||
155312548|NCT01999075|560577399|FG000|Overall Study|Enrolled in drug trial|3|||
155312549|NCT01999075|560577400|FG001|Overall Study|Enrolled in drug trial|1|||
155312550|NCT01999075|560577399|FG000|Overall Study|Became ineligible|0|||
155312551|NCT01999075|560577400|FG001|Overall Study|Became ineligible|2|||
155312552|NCT05948670|560577405|FG000|Overall Study|Protocol Violation|6|||
155312553|NCT05948670|560577406|FG001|Overall Study|Protocol Violation|8|||
155312554|NCT05948670|560577405|FG000|Overall Study|Withdrawal by Subject|0|||
155312555|NCT05948670|560577406|FG001|Overall Study|Withdrawal by Subject|1|||
155066893|NCT01369433|559676921|FG000|Overall Study|Lost to Follow-up|1|||
155066894|NCT01369433|559676922|FG001|Overall Study|Lost to Follow-up|0|||
155066895|NCT01369433|559676921|FG000|Overall Study|Death|5|||
155066896|NCT01369433|559676922|FG001|Overall Study|Death|0|||
155312556|NCT04562649|560577407|FG000|Overall Study|Withdrawal by Subject|11|||
155312557|NCT04562649|560577408|FG001|Overall Study|Withdrawal by Subject|8|||
155312558|NCT04562649|560577407|FG000|Overall Study|Lost to Follow-up|26|||
155312559|NCT04562649|560577408|FG001|Overall Study|Lost to Follow-up|20|||
155312560|NCT05368103|560577409|FG000|Overall Study|Withdrawal by Subject|4|||
155312561|NCT05368103|560577409|FG000|Overall Study|Lost to Follow-up|1|||
155312562|NCT05368103|560577409|FG000|Overall Study|Lack of Efficacy|3|||
155312563|NCT03675282|560577412|FG000|Overall Study|Lost to Follow-up|4|||
155312564|NCT03675282|560577413|FG001|Overall Study|Lost to Follow-up|8|||
155066897|NCT01369433|559676921|FG000|Overall Study|Investigator discretion|6|||
155312565|NCT03675282|560577414|FG002|Overall Study|Lost to Follow-up|1|||
155312566|NCT03675282|560577415|FG003|Overall Study|Lost to Follow-up|0|||
155312567|NCT03675282|560577416|FG004|Overall Study|Lost to Follow-up|2|||
155312568|NCT03675282|560577417|FG005|Overall Study|Lost to Follow-up|7|||
155312569|NCT03675282|560577412|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
155312570|NCT03675282|560577413|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
155312571|NCT03675282|560577414|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
155312572|NCT03675282|560577415|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
155312573|NCT03675282|560577416|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
155312574|NCT03675282|560577417|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
155312575|NCT03675282|560577412|FG000|Overall Study|Physician Decision|1|||
155312576|NCT03675282|560577413|FG001|Overall Study|Physician Decision|0|||
155066898|NCT01369433|559676922|FG001|Overall Study|Investigator discretion|1|||
155066899|NCT01369433|559676921|FG000|Overall Study|Progressive Disease|92|||
155066900|NCT01369433|559676922|FG001|Overall Study|Progressive Disease|12|||
155066901|NCT02313155|559676926|FG000|Overall Study|Lost to Follow-up|0|||
155066902|NCT02313155|559676927|FG001|Overall Study|Lost to Follow-up|1|||
155066903|NCT03822416|559676932|FG000|Overall Study|Lost to Follow-up|1|||
155066904|NCT03822416|559676933|FG001|Overall Study|Lost to Follow-up|0|||
155066905|NCT03822416|559676932|FG000|Overall Study|Withdrawal by Subject|0|||
155066906|NCT03822416|559676933|FG001|Overall Study|Withdrawal by Subject|1|||
155066907|NCT01303419|559676936|FG000|Overall Study|Discontinuation of study|60|||
155066908|NCT01303419|559676936|FG000|Overall Study|Did not complete both imaging methods|5|||
155066909|NCT01303419|559676936|FG000|Overall Study|Did not meet all I/E after screening|31|||
155066910|NCT01995201|559676937|FG000|From Baseline Until Week 24|Adverse Event|4|||
155066911|NCT01995201|559676938|FG001|From Baseline Until Week 24|Adverse Event|15|||
155066912|NCT01995201|559676939|FG002|From Baseline Until Week 24|Adverse Event|0|||
155066913|NCT01995201|559676940|FG003|From Baseline Until Week 24|Adverse Event|0|||
155312577|NCT03675282|560577414|FG002|Overall Study|Physician Decision|0|||
155312578|NCT03675282|560577415|FG003|Overall Study|Physician Decision|0|||
155312579|NCT03675282|560577416|FG004|Overall Study|Physician Decision|0|||
155312580|NCT03675282|560577417|FG005|Overall Study|Physician Decision|0|||
155312581|NCT05784662|560577418|FG000|Overall Study|Lost to Follow-up|21|||
155066914|NCT01995201|559676941|FG004|From Baseline Until Week 24|Adverse Event|0|||
155066915|NCT01995201|559676942|FG005|From Baseline Until Week 24|Adverse Event|0|||
155066916|NCT01995201|559676943|FG006|From Baseline Until Week 24|Adverse Event|0|||
155066917|NCT01995201|559676937|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155066918|NCT01995201|559676938|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
155066919|NCT01995201|559676939|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155066920|NCT01995201|559676940|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155066921|NCT01995201|559676941|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155066922|NCT01995201|559676942|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155066923|NCT01995201|559676943|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
155066924|NCT01995201|559676937|FG000|From Baseline Until Week 24|Death|0|||
155066925|NCT01995201|559676938|FG001|From Baseline Until Week 24|Death|1|||
155066926|NCT01995201|559676939|FG002|From Baseline Until Week 24|Death|0|||
155066927|NCT01995201|559676940|FG003|From Baseline Until Week 24|Death|0|||
155066928|NCT01995201|559676941|FG004|From Baseline Until Week 24|Death|0|||
155066929|NCT01995201|559676942|FG005|From Baseline Until Week 24|Death|0|||
155066930|NCT01995201|559676943|FG006|From Baseline Until Week 24|Death|0|||
155066931|NCT01995201|559676937|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
155066932|NCT01995201|559676938|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
155066933|NCT01995201|559676939|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
155066934|NCT01995201|559676940|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
155066935|NCT01995201|559676941|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
155066936|NCT01995201|559676942|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
155066937|NCT01995201|559676943|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
155066938|NCT01995201|559676937|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
155066939|NCT01995201|559676938|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
155066940|NCT01995201|559676939|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
155312582|NCT05784662|560577419|FG001|Overall Study|Lost to Follow-up|17|||
155312583|NCT03232138|560577420|FG000|Overall Study|Physician Decision|1|||
155312584|NCT03232138|560577421|FG001|Overall Study|Physician Decision|0|||
155312585|NCT03232138|560577420|FG000|Overall Study|Adverse Event|2|||
155066941|NCT01995201|559676940|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
155066942|NCT01995201|559676941|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
155066943|NCT01995201|559676942|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
155312586|NCT03232138|560577421|FG001|Overall Study|Adverse Event|0|||
155312587|NCT03232138|560577420|FG000|Overall Study|Withdrawal by Subject|1|||
155312588|NCT03232138|560577421|FG001|Overall Study|Withdrawal by Subject|2|||
155312589|NCT03920111|560577422|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
155312590|NCT03920111|560577423|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
155312591|NCT03920111|560577424|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
155312592|NCT05268393|560577425|FG000|Overall Study|Withdrawal by Subject|2|||
155312593|NCT05268393|560577426|FG001|Overall Study|Withdrawal by Subject|1|||
155312594|NCT05763823|560577427|FG000|Overall Study|Death|6|||
155312595|NCT05763823|560577427|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155312596|NCT05763823|560577427|FG000|Overall Study|Withdrawal by Subject|6|||
155312597|NCT01997840|560577432|FG000|Overall Study|Lost to Follow-up|0|||
155312598|NCT01997840|560577433|FG001|Overall Study|Lost to Follow-up|0|||
155312599|NCT01997840|560577434|FG002|Overall Study|Lost to Follow-up|1|||
155312600|NCT01997840|560577435|FG003|Overall Study|Lost to Follow-up|0|||
155312601|NCT01997840|560577432|FG000|Overall Study|Withdrawal by participant|0|||
155312602|NCT01997840|560577433|FG001|Overall Study|Withdrawal by participant|0|||
155312603|NCT01997840|560577434|FG002|Overall Study|Withdrawal by participant|8|||
155312604|NCT01997840|560577435|FG003|Overall Study|Withdrawal by participant|1|||
155312605|NCT01997840|560577432|FG000|Overall Study|Physician Decision|0|||
155312606|NCT01997840|560577433|FG001|Overall Study|Physician Decision|0|||
155312607|NCT01997840|560577434|FG002|Overall Study|Physician Decision|3|||
155312608|NCT01997840|560577435|FG003|Overall Study|Physician Decision|0|||
155312609|NCT01997840|560577432|FG000|Overall Study|Progressive disease|3|||
155312610|NCT01997840|560577433|FG001|Overall Study|Progressive disease|4|||
154959815|NCT01597245|559276949|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959816|NCT01597245|559276950|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959817|NCT01597245|559276951|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959818|NCT01597245|559276952|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959819|NCT01597245|559276953|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959820|NCT01597245|559276954|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959821|NCT01597245|559276955|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959822|NCT01597245|559276956|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959823|NCT01597245|559276957|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959824|NCT01597245|559276958|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959825|NCT01597245|559276959|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959826|NCT01597245|559276960|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959827|NCT01597245|559276961|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959828|NCT01597245|559276962|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959829|NCT01597245|559276963|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959830|NCT01597245|559276964|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959831|NCT01597245|559276965|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959832|NCT01597245|559276966|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959833|NCT01597245|559276967|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959834|NCT01597245|559276968|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
154959835|NCT01597245|559276969|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
154959836|NCT01802320|559276970|FG000|Overall Study|Death|1|||
154959837|NCT01802320|559276970|FG000|Overall Study|Withdrawal by Subject|1|||
154959838|NCT02674152|559278616|FG000|Overall Study|Personal Reasons|1|||
154959839|NCT02674152|559278617|FG001|Overall Study|Personal Reasons|0|||
154959840|NCT02674152|559278618|FG002|Overall Study|Personal Reasons|0|||
154959841|NCT02674152|559278619|FG003|Overall Study|Personal Reasons|1|||
154959842|NCT02674152|559278620|FG004|Overall Study|Personal Reasons|1|||
154959843|NCT02674152|559278616|FG000|Overall Study|Other adverse event or clinical progression|0|||
154959844|NCT02674152|559278617|FG001|Overall Study|Other adverse event or clinical progression|1|||
154959845|NCT02674152|559278618|FG002|Overall Study|Other adverse event or clinical progression|0|||
154959846|NCT02674152|559278619|FG003|Overall Study|Other adverse event or clinical progression|3|||
154959847|NCT02674152|559278620|FG004|Overall Study|Other adverse event or clinical progression|0|||
154959848|NCT02674152|559278616|FG000|Overall Study|Dose-limiting toxicity|0|||
154959849|NCT02674152|559278617|FG001|Overall Study|Dose-limiting toxicity|0|||
154959850|NCT02674152|559278618|FG002|Overall Study|Dose-limiting toxicity|0|||
154959851|NCT02674152|559278619|FG003|Overall Study|Dose-limiting toxicity|0|||
154959852|NCT02674152|559278620|FG004|Overall Study|Dose-limiting toxicity|1|||
154959853|NCT02674152|559278616|FG000|Overall Study|Progressive Disease|2|||
155066944|NCT01995201|559676943|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
155066945|NCT01995201|559676937|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
155066946|NCT01995201|559676938|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
155066947|NCT01995201|559676939|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
155066948|NCT01995201|559676940|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
155066949|NCT01995201|559676941|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
155066950|NCT01995201|559676942|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
155066951|NCT01995201|559676943|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
155066952|NCT01995201|559676937|FG000|From Baseline Until Week 24|Physician Decision|0|||
155066953|NCT01995201|559676938|FG001|From Baseline Until Week 24|Physician Decision|2|||
155066954|NCT01995201|559676939|FG002|From Baseline Until Week 24|Physician Decision|0|||
155066955|NCT01995201|559676940|FG003|From Baseline Until Week 24|Physician Decision|0|||
155066956|NCT01995201|559676941|FG004|From Baseline Until Week 24|Physician Decision|0|||
155066957|NCT01995201|559676942|FG005|From Baseline Until Week 24|Physician Decision|0|||
155066958|NCT01995201|559676943|FG006|From Baseline Until Week 24|Physician Decision|0|||
155066959|NCT01995201|559676937|FG000|From Baseline Until Week 24|Protocol Violation|0|||
155066960|NCT01995201|559676938|FG001|From Baseline Until Week 24|Protocol Violation|9|||
155066961|NCT01995201|559676939|FG002|From Baseline Until Week 24|Protocol Violation|0|||
155066962|NCT01995201|559676940|FG003|From Baseline Until Week 24|Protocol Violation|0|||
155066963|NCT01995201|559676941|FG004|From Baseline Until Week 24|Protocol Violation|0|||
155066964|NCT01995201|559676942|FG005|From Baseline Until Week 24|Protocol Violation|0|||
155066965|NCT01995201|559676943|FG006|From Baseline Until Week 24|Protocol Violation|0|||
155066966|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Adverse Event|0|||
155066967|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Adverse Event|0|||
155066968|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Adverse Event|2|||
155066969|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Adverse Event|1|||
155066970|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Adverse Event|1|||
155066971|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Adverse Event|3|||
155066972|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Adverse Event|1|||
155066973|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Death|0|||
155066974|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Death|0|||
155066975|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Death|0|||
155066976|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Death|0|||
155066977|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Death|0|||
155066978|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Death|2|||
155066979|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Death|0|||
155066980|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
155066981|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
155066982|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
155066983|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
155312611|NCT01997840|560577434|FG002|Overall Study|Progressive disease|57|||
155312612|NCT01997840|560577435|FG003|Overall Study|Progressive disease|8|||
155312613|NCT01997840|560577432|FG000|Overall Study|Other reasons|0|||
155312614|NCT01997840|560577433|FG001|Overall Study|Other reasons|0|||
155312615|NCT01997840|560577434|FG002|Overall Study|Other reasons|1|||
155312616|NCT01997840|560577435|FG003|Overall Study|Other reasons|0|||
155312617|NCT01997840|560577432|FG000|Overall Study|Adverse Event|0|||
155312618|NCT01997840|560577433|FG001|Overall Study|Adverse Event|0|||
155312619|NCT01997840|560577434|FG002|Overall Study|Adverse Event|15|||
155312620|NCT01997840|560577435|FG003|Overall Study|Adverse Event|2|||
155312621|NCT05308004|560577445|FG000|Overall Study|Not seen by Palliative Care NP|0|||
155312622|NCT05308004|560577446|FG001|Overall Study|Not seen by Palliative Care NP|1|||
155312623|NCT03150810|560577448|FG000|Overall Study|Death|4|||
155312624|NCT03150810|560577449|FG001|Overall Study|Death|8|||
155312625|NCT03150810|560577450|FG002|Overall Study|Death|7|||
155312626|NCT03150810|560577451|FG003|Overall Study|Death|2|||
155312627|NCT03150810|560577452|FG004|Overall Study|Death|2|||
155312628|NCT03150810|560577453|FG005|Overall Study|Death|10|||
155312629|NCT03150810|560577454|FG006|Overall Study|Death|8|||
155312630|NCT03150810|560577455|FG007|Overall Study|Death|6|||
155312631|NCT03150810|560577456|FG008|Overall Study|Death|18|||
155312632|NCT03150810|560577457|FG009|Overall Study|Death|3|||
155066984|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
155066985|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
155066986|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
155066987|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
155066988|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
155066989|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
155092645|NCT00854360|559773651|FG001|Overall Study|Adverse Event|1|||
155312633|NCT03150810|560577458|FG010|Overall Study|Death|19|||
155312634|NCT03150810|560577459|FG011|Overall Study|Death|1|||
155312635|NCT03150810|560577460|FG012|Overall Study|Death|19|||
155312636|NCT03150810|560577448|FG000|Overall Study|Withdrawal by Subject|0|||
155092646|NCT00854360|559773652|FG002|Overall Study|Adverse Event|2|||
155092647|NCT00854360|559773653|FG003|Overall Study|Adverse Event|6|||
155162040|NCT01394016|560028732|FG003|Overall Study|Sponsor Decision|0|||
155162041|NCT01394016|560028733|FG004|Overall Study|Sponsor Decision|0|||
155162042|NCT01394016|560028734|FG005|Overall Study|Sponsor Decision|0|||
155162043|NCT01394016|560028735|FG006|Overall Study|Sponsor Decision|0|||
155162044|NCT01394016|560028736|FG007|Overall Study|Sponsor Decision|0|||
155162045|NCT01394016|560028737|FG008|Overall Study|Sponsor Decision|0|||
155162046|NCT01394016|560028738|FG009|Overall Study|Sponsor Decision|0|||
155162047|NCT01394016|560028739|FG010|Overall Study|Sponsor Decision|0|||
155162048|NCT01394016|560028740|FG011|Overall Study|Sponsor Decision|0|||
155162049|NCT01394016|560028741|FG012|Overall Study|Sponsor Decision|1|||
155162050|NCT01394016|560028742|FG013|Overall Study|Sponsor Decision|0|||
155162051|NCT01394016|560028743|FG014|Overall Study|Sponsor Decision|0|||
155162052|NCT01394016|560028744|FG015|Overall Study|Sponsor Decision|0|||
155162053|NCT01394016|560028745|FG016|Overall Study|Sponsor Decision|0|||
155162054|NCT01394016|560028746|FG017|Overall Study|Sponsor Decision|0|||
154959854|NCT02674152|559278617|FG001|Overall Study|Progressive Disease|1|||
154959855|NCT02674152|559278618|FG002|Overall Study|Progressive Disease|1|||
154959856|NCT02674152|559278619|FG003|Overall Study|Progressive Disease|13|||
154959857|NCT02674152|559278620|FG004|Overall Study|Progressive Disease|2|||
154959858|NCT02674152|559278616|FG000|Overall Study|Adverse Event|0|||
154959859|NCT02674152|559278617|FG001|Overall Study|Adverse Event|0|||
154959860|NCT02674152|559278618|FG002|Overall Study|Adverse Event|1|||
154959861|NCT02674152|559278619|FG003|Overall Study|Adverse Event|0|||
154959862|NCT02674152|559278620|FG004|Overall Study|Adverse Event|1|||
154959863|NCT02571907|559278621|FG000|Overall Study|Death|4|||
154959864|NCT02571907|559278621|FG000|Overall Study|Lost to Follow-up|3|||
154959865|NCT02571907|559278621|FG000|Overall Study|Withdrawal by Subject|3|||
154959866|NCT00579345|559278622|FG000|Overall Study|Withdrawal by Subject|2|||
154959867|NCT00579345|559278623|FG001|Overall Study|Withdrawal by Subject|0|||
154959868|NCT00579345|559278624|FG002|Overall Study|Withdrawal by Subject|0|||
154959869|NCT00579345|559278625|FG003|Overall Study|Withdrawal by Subject|0|||
154959870|NCT00579345|559278626|FG004|Overall Study|Withdrawal by Subject|0|||
154959871|NCT00579345|559278627|FG005|Overall Study|Withdrawal by Subject|0|||
154959872|NCT00579345|559278628|FG006|Overall Study|Withdrawal by Subject|0|||
154959873|NCT00579345|559278629|FG007|Overall Study|Withdrawal by Subject|1|||
154959874|NCT00579345|559278622|FG000|Overall Study|Lost to Follow-up|1|||
154959875|NCT00579345|559278623|FG001|Overall Study|Lost to Follow-up|0|||
154959876|NCT00579345|559278624|FG002|Overall Study|Lost to Follow-up|0|||
154959877|NCT00579345|559278625|FG003|Overall Study|Lost to Follow-up|0|||
154959878|NCT00579345|559278626|FG004|Overall Study|Lost to Follow-up|0|||
154959879|NCT00579345|559278627|FG005|Overall Study|Lost to Follow-up|0|||
154959880|NCT00579345|559278628|FG006|Overall Study|Lost to Follow-up|0|||
154959881|NCT00579345|559278629|FG007|Overall Study|Lost to Follow-up|0|||
154959882|NCT00579345|559278622|FG000|Overall Study|Adverse Event|0|||
154959883|NCT00579345|559278623|FG001|Overall Study|Adverse Event|0|||
154959884|NCT00579345|559278624|FG002|Overall Study|Adverse Event|1|||
154959885|NCT00579345|559278625|FG003|Overall Study|Adverse Event|0|||
154959886|NCT00579345|559278626|FG004|Overall Study|Adverse Event|0|||
154959887|NCT00579345|559278627|FG005|Overall Study|Adverse Event|0|||
154959888|NCT00579345|559278628|FG006|Overall Study|Adverse Event|0|||
154959889|NCT00579345|559278629|FG007|Overall Study|Adverse Event|0|||
154959890|NCT00579345|559278622|FG000|Overall Study|Protocol Violation|1|||
154959891|NCT00579345|559278623|FG001|Overall Study|Protocol Violation|0|||
154959892|NCT00579345|559278624|FG002|Overall Study|Protocol Violation|0|||
154959893|NCT00579345|559278625|FG003|Overall Study|Protocol Violation|0|||
154959894|NCT00579345|559278626|FG004|Overall Study|Protocol Violation|0|||
155162055|NCT01394016|560028747|FG018|Overall Study|Sponsor Decision|0|||
154959895|NCT00579345|559278627|FG005|Overall Study|Protocol Violation|0|||
154959896|NCT00579345|559278628|FG006|Overall Study|Protocol Violation|0|||
154959897|NCT00579345|559278629|FG007|Overall Study|Protocol Violation|1|||
154959898|NCT00579345|559278622|FG000|Overall Study|Death|1|||
155066990|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
155066991|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
155066992|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
155066993|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
155066994|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155066995|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155066996|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
155066997|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155066998|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
155066999|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155067000|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
155067001|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Physician Decision|0|||
155067002|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Physician Decision|0|||
155067003|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Physician Decision|0|||
155312637|NCT03150810|560577449|FG001|Overall Study|Withdrawal by Subject|1|||
155312638|NCT03150810|560577450|FG002|Overall Study|Withdrawal by Subject|1|||
155312639|NCT03150810|560577451|FG003|Overall Study|Withdrawal by Subject|1|||
155312640|NCT03150810|560577452|FG004|Overall Study|Withdrawal by Subject|0|||
155312641|NCT03150810|560577453|FG005|Overall Study|Withdrawal by Subject|0|||
155312642|NCT03150810|560577454|FG006|Overall Study|Withdrawal by Subject|2|||
155312643|NCT03150810|560577455|FG007|Overall Study|Withdrawal by Subject|0|||
155067004|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Physician Decision|0|||
155312644|NCT03150810|560577456|FG008|Overall Study|Withdrawal by Subject|2|||
155312645|NCT03150810|560577457|FG009|Overall Study|Withdrawal by Subject|0|||
155067005|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Physician Decision|1|||
155162056|NCT01394016|560028729|FG000|Overall Study|Lost to Follow-up|0|||
155312646|NCT03150810|560577458|FG010|Overall Study|Withdrawal by Subject|1|||
155162057|NCT01394016|560028730|FG001|Overall Study|Lost to Follow-up|0|||
155312647|NCT03150810|560577459|FG011|Overall Study|Withdrawal by Subject|0|||
155312648|NCT03150810|560577460|FG012|Overall Study|Withdrawal by Subject|1|||
155312649|NCT03150810|560577448|FG000|Overall Study|Sponsor Decision|0|||
155312650|NCT03150810|560577449|FG001|Overall Study|Sponsor Decision|2|||
155312651|NCT03150810|560577450|FG002|Overall Study|Sponsor Decision|0|||
155312652|NCT03150810|560577451|FG003|Overall Study|Sponsor Decision|0|||
155312653|NCT03150810|560577452|FG004|Overall Study|Sponsor Decision|1|||
155312654|NCT03150810|560577453|FG005|Overall Study|Sponsor Decision|1|||
155312655|NCT03150810|560577454|FG006|Overall Study|Sponsor Decision|0|||
155312656|NCT03150810|560577455|FG007|Overall Study|Sponsor Decision|0|||
155312657|NCT03150810|560577456|FG008|Overall Study|Sponsor Decision|1|||
155312658|NCT03150810|560577457|FG009|Overall Study|Sponsor Decision|0|||
155312659|NCT03150810|560577458|FG010|Overall Study|Sponsor Decision|0|||
155312660|NCT03150810|560577459|FG011|Overall Study|Sponsor Decision|0|||
155312661|NCT03150810|560577460|FG012|Overall Study|Sponsor Decision|5|||
155312662|NCT03150810|560577448|FG000|Overall Study|Lost to Follow-up|0|||
155312663|NCT03150810|560577449|FG001|Overall Study|Lost to Follow-up|1|||
155312664|NCT03150810|560577450|FG002|Overall Study|Lost to Follow-up|1|||
155312665|NCT03150810|560577451|FG003|Overall Study|Lost to Follow-up|0|||
155312666|NCT03150810|560577452|FG004|Overall Study|Lost to Follow-up|0|||
155312667|NCT03150810|560577453|FG005|Overall Study|Lost to Follow-up|0|||
155312668|NCT03150810|560577454|FG006|Overall Study|Lost to Follow-up|1|||
155312669|NCT03150810|560577455|FG007|Overall Study|Lost to Follow-up|0|||
155312670|NCT03150810|560577456|FG008|Overall Study|Lost to Follow-up|0|||
155312671|NCT03150810|560577457|FG009|Overall Study|Lost to Follow-up|0|||
155312672|NCT03150810|560577458|FG010|Overall Study|Lost to Follow-up|1|||
155312673|NCT03150810|560577459|FG011|Overall Study|Lost to Follow-up|0|||
155312674|NCT03150810|560577460|FG012|Overall Study|Lost to Follow-up|0|||
155312675|NCT03150810|560577448|FG000|Overall Study|Physician Decision|0|||
155312676|NCT03150810|560577449|FG001|Overall Study|Physician Decision|0|||
155312677|NCT03150810|560577450|FG002|Overall Study|Physician Decision|0|||
155312678|NCT03150810|560577451|FG003|Overall Study|Physician Decision|0|||
155312679|NCT03150810|560577452|FG004|Overall Study|Physician Decision|0|||
155312680|NCT03150810|560577453|FG005|Overall Study|Physician Decision|1|||
155312681|NCT03150810|560577454|FG006|Overall Study|Physician Decision|1|||
155312682|NCT03150810|560577455|FG007|Overall Study|Physician Decision|0|||
155312683|NCT03150810|560577456|FG008|Overall Study|Physician Decision|0|||
155312684|NCT03150810|560577457|FG009|Overall Study|Physician Decision|0|||
155312685|NCT03150810|560577458|FG010|Overall Study|Physician Decision|0|||
155312686|NCT03150810|560577459|FG011|Overall Study|Physician Decision|0|||
155312687|NCT03150810|560577460|FG012|Overall Study|Physician Decision|0|||
155312688|NCT03150810|560577448|FG000|Overall Study|Site withdrawal from study|0|||
155312689|NCT03150810|560577449|FG001|Overall Study|Site withdrawal from study|1|||
155312690|NCT03150810|560577450|FG002|Overall Study|Site withdrawal from study|0|||
155312691|NCT03150810|560577451|FG003|Overall Study|Site withdrawal from study|0|||
155312692|NCT03150810|560577452|FG004|Overall Study|Site withdrawal from study|0|||
155312693|NCT03150810|560577453|FG005|Overall Study|Site withdrawal from study|0|||
155312694|NCT03150810|560577454|FG006|Overall Study|Site withdrawal from study|0|||
155312695|NCT03150810|560577455|FG007|Overall Study|Site withdrawal from study|0|||
155312696|NCT03150810|560577456|FG008|Overall Study|Site withdrawal from study|0|||
155312697|NCT03150810|560577457|FG009|Overall Study|Site withdrawal from study|1|||
155067006|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Physician Decision|0|||
155312698|NCT03150810|560577458|FG010|Overall Study|Site withdrawal from study|1|||
155312699|NCT03150810|560577459|FG011|Overall Study|Site withdrawal from study|0|||
155312700|NCT03150810|560577460|FG012|Overall Study|Site withdrawal from study|0|||
155312701|NCT03150810|560577448|FG000|Overall Study|Hospice|0|||
155312702|NCT03150810|560577449|FG001|Overall Study|Hospice|0|||
155312703|NCT03150810|560577450|FG002|Overall Study|Hospice|0|||
155312704|NCT03150810|560577451|FG003|Overall Study|Hospice|0|||
155312705|NCT03150810|560577452|FG004|Overall Study|Hospice|0|||
155312706|NCT03150810|560577453|FG005|Overall Study|Hospice|1|||
155312707|NCT03150810|560577454|FG006|Overall Study|Hospice|0|||
155312708|NCT03150810|560577455|FG007|Overall Study|Hospice|0|||
155312709|NCT03150810|560577456|FG008|Overall Study|Hospice|0|||
155312710|NCT03150810|560577457|FG009|Overall Study|Hospice|0|||
155312711|NCT03150810|560577458|FG010|Overall Study|Hospice|0|||
155312712|NCT03150810|560577459|FG011|Overall Study|Hospice|0|||
155312713|NCT03150810|560577460|FG012|Overall Study|Hospice|0|||
154959899|NCT00579345|559278623|FG001|Overall Study|Death|1|||
154959900|NCT00579345|559278624|FG002|Overall Study|Death|1|||
155312714|NCT03150810|560577448|FG000|Overall Study|Participant relocated abroad.|0|||
155312715|NCT03150810|560577449|FG001|Overall Study|Participant relocated abroad.|0|||
155312716|NCT03150810|560577450|FG002|Overall Study|Participant relocated abroad.|0|||
155312717|NCT03150810|560577451|FG003|Overall Study|Participant relocated abroad.|0|||
155312718|NCT03150810|560577452|FG004|Overall Study|Participant relocated abroad.|0|||
155312719|NCT03150810|560577453|FG005|Overall Study|Participant relocated abroad.|1|||
155312720|NCT03150810|560577454|FG006|Overall Study|Participant relocated abroad.|0|||
154959901|NCT00579345|559278625|FG003|Overall Study|Death|1|||
155312721|NCT03150810|560577455|FG007|Overall Study|Participant relocated abroad.|0|||
155312722|NCT03150810|560577456|FG008|Overall Study|Participant relocated abroad.|0|||
155312723|NCT03150810|560577457|FG009|Overall Study|Participant relocated abroad.|0|||
155312724|NCT03150810|560577458|FG010|Overall Study|Participant relocated abroad.|0|||
155312725|NCT03150810|560577459|FG011|Overall Study|Participant relocated abroad.|0|||
155312726|NCT03150810|560577460|FG012|Overall Study|Participant relocated abroad.|0|||
155312727|NCT03150810|560577448|FG000|Overall Study|Transferred care to oncologist|0|||
155312728|NCT03150810|560577449|FG001|Overall Study|Transferred care to oncologist|0|||
155312729|NCT03150810|560577450|FG002|Overall Study|Transferred care to oncologist|0|||
155312730|NCT03150810|560577451|FG003|Overall Study|Transferred care to oncologist|0|||
155312731|NCT03150810|560577452|FG004|Overall Study|Transferred care to oncologist|0|||
155312732|NCT03150810|560577453|FG005|Overall Study|Transferred care to oncologist|0|||
155312733|NCT03150810|560577454|FG006|Overall Study|Transferred care to oncologist|2|||
155312734|NCT03150810|560577455|FG007|Overall Study|Transferred care to oncologist|0|||
154959902|NCT00579345|559278626|FG004|Overall Study|Death|0|||
154959903|NCT00579345|559278627|FG005|Overall Study|Death|0|||
154959904|NCT00579345|559278628|FG006|Overall Study|Death|0|||
154959905|NCT00579345|559278629|FG007|Overall Study|Death|0|||
155312735|NCT03150810|560577456|FG008|Overall Study|Transferred care to oncologist|0|||
155067007|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Physician Decision|0|||
155067008|NCT01995201|559676937|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
154959906|NCT03874715|559278635|FG000|Overall Study|Adverse Event|2|||
154959907|NCT03874715|559278636|FG001|Overall Study|Adverse Event|0|||
154959908|NCT03874715|559278635|FG000|Overall Study|Poor compliance to protocol|5|||
155312736|NCT03150810|560577457|FG009|Overall Study|Transferred care to oncologist|0|||
155312737|NCT03150810|560577458|FG010|Overall Study|Transferred care to oncologist|0|||
155312738|NCT03150810|560577459|FG011|Overall Study|Transferred care to oncologist|0|||
155312739|NCT03150810|560577460|FG012|Overall Study|Transferred care to oncologist|0|||
155312740|NCT04526704|560577461|FG000|Overall Study|Adverse Event|1|||
155312741|NCT04526704|560577462|FG001|Overall Study|Adverse Event|0|||
155312742|NCT04526704|560577461|FG000|Overall Study|Physician Decision|1|||
155312743|NCT04526704|560577462|FG001|Overall Study|Physician Decision|0|||
155312744|NCT04526704|560577461|FG000|Overall Study|Withdrawal by Subject|2|||
155312745|NCT04526704|560577462|FG001|Overall Study|Withdrawal by Subject|0|||
155312746|NCT06393088|560577463|FG000|Overall Study|Withdrawal by Subject|0|||
155312747|NCT06393088|560577464|FG001|Overall Study|Withdrawal by Subject|2|||
155312748|NCT03903146|560577465|FG000|Overall Study|Lost to Follow-up|6|||
155312749|NCT03903146|560577466|FG001|Overall Study|Lost to Follow-up|4|||
155312750|NCT03903146|560577465|FG000|Overall Study|Withdrawal by Subject|0|||
155312751|NCT03903146|560577466|FG001|Overall Study|Withdrawal by Subject|1|||
155312752|NCT05434078|560577467|FG000|Overall Study|Lost to Follow-up|2|||
155312753|NCT05434078|560577468|FG001|Overall Study|Lost to Follow-up|1|||
155067009|NCT01995201|559676938|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
155067010|NCT01995201|559676939|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
155067011|NCT01995201|559676940|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
155312754|NCT05434078|560577467|FG000|Overall Study|Withdrawal by Subject|1|||
155312755|NCT05434078|560577468|FG001|Overall Study|Withdrawal by Subject|0|||
155312756|NCT03652688|560577470|FG000|Baseline|Withdrawal by Subject|0|||
155312757|NCT03652688|560577471|FG001|Baseline|Withdrawal by Subject|3|||
155312758|NCT03652688|560577470|FG000|Follow-up|Lost to Follow-up|56|||
155312759|NCT03652688|560577471|FG001|Follow-up|Lost to Follow-up|54|||
155312760|NCT03719443|560577475|FG000|Overall Study|Lost to Follow-up|0|||
155312761|NCT03719443|560577476|FG001|Overall Study|Lost to Follow-up|0|||
155312762|NCT03719443|560577477|FG002|Overall Study|Lost to Follow-up|1|||
155312763|NCT03719443|560577478|FG003|Overall Study|Lost to Follow-up|0|||
155312764|NCT03719443|560577479|FG004|Overall Study|Lost to Follow-up|1|||
155312765|NCT03719443|560577480|FG005|Overall Study|Lost to Follow-up|0|||
155312766|NCT03719443|560577481|FG006|Overall Study|Lost to Follow-up|1|||
155312767|NCT03719443|560577475|FG000|Overall Study|Withdrawal by Subject|0|||
155312768|NCT03719443|560577476|FG001|Overall Study|Withdrawal by Subject|0|||
155312769|NCT03719443|560577477|FG002|Overall Study|Withdrawal by Subject|1|||
155312770|NCT03719443|560577478|FG003|Overall Study|Withdrawal by Subject|0|||
155312771|NCT03719443|560577479|FG004|Overall Study|Withdrawal by Subject|0|||
155312772|NCT03719443|560577480|FG005|Overall Study|Withdrawal by Subject|0|||
155312773|NCT03719443|560577481|FG006|Overall Study|Withdrawal by Subject|0|||
155312774|NCT04924660|560577482|FG000|United States|Death|29|||
155312775|NCT04924660|560577483|FG001|United States|Death|32|||
155162058|NCT01394016|560028731|FG002|Overall Study|Lost to Follow-up|0|||
155162059|NCT01394016|560028732|FG003|Overall Study|Lost to Follow-up|0|||
155162060|NCT01394016|560028733|FG004|Overall Study|Lost to Follow-up|0|||
155162061|NCT01394016|560028734|FG005|Overall Study|Lost to Follow-up|0|||
155162062|NCT01394016|560028735|FG006|Overall Study|Lost to Follow-up|0|||
155162063|NCT01394016|560028736|FG007|Overall Study|Lost to Follow-up|0|||
155162064|NCT01394016|560028737|FG008|Overall Study|Lost to Follow-up|0|||
155162065|NCT01394016|560028738|FG009|Overall Study|Lost to Follow-up|0|||
155162066|NCT01394016|560028739|FG010|Overall Study|Lost to Follow-up|0|||
155162067|NCT01394016|560028740|FG011|Overall Study|Lost to Follow-up|0|||
155162068|NCT01394016|560028741|FG012|Overall Study|Lost to Follow-up|0|||
155162069|NCT01394016|560028742|FG013|Overall Study|Lost to Follow-up|0|||
155162070|NCT01394016|560028743|FG014|Overall Study|Lost to Follow-up|0|||
155162071|NCT01394016|560028744|FG015|Overall Study|Lost to Follow-up|0|||
155162072|NCT01394016|560028745|FG016|Overall Study|Lost to Follow-up|0|||
155162073|NCT01394016|560028746|FG017|Overall Study|Lost to Follow-up|0|||
155162074|NCT01394016|560028747|FG018|Overall Study|Lost to Follow-up|1|||
155162075|NCT03534804|560028748|FG000|Overall Study|Withdrawal by Subject|1|||
155162076|NCT00174187|560028752|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
155312776|NCT04924660|560577484|FG002|United States|Death|34|||
155162077|NCT00174187|560028753|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
155162078|NCT00174187|560028754|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
155162079|NCT00174187|560028752|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
155162080|NCT00174187|560028753|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
155162081|NCT00174187|560028754|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
155162082|NCT00174187|560028752|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
155162083|NCT00174187|560028753|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
155162084|NCT00174187|560028754|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
155067012|NCT01995201|559676941|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
155312777|NCT04924660|560577485|FG003|United States|Death|25|||
155312778|NCT04924660|560577486|FG004|United States|Death|26|||
155312779|NCT04924660|560577487|FG005|United States|Death|23|||
155312780|NCT04924660|560577482|FG000|United States|Lost to Follow-up|15|||
155312781|NCT04924660|560577483|FG001|United States|Lost to Follow-up|10|||
155312782|NCT04924660|560577484|FG002|United States|Lost to Follow-up|13|||
155312783|NCT04924660|560577485|FG003|United States|Lost to Follow-up|5|||
155312784|NCT04924660|560577486|FG004|United States|Lost to Follow-up|19|||
155312785|NCT04924660|560577487|FG005|United States|Lost to Follow-up|20|||
155312786|NCT04924660|560577482|FG000|United States|Withdrawal by Subject|8|||
155312787|NCT04924660|560577483|FG001|United States|Withdrawal by Subject|3|||
155312788|NCT04924660|560577484|FG002|United States|Withdrawal by Subject|3|||
155312789|NCT04924660|560577485|FG003|United States|Withdrawal by Subject|3|||
155312790|NCT04924660|560577486|FG004|United States|Withdrawal by Subject|8|||
155312791|NCT04924660|560577487|FG005|United States|Withdrawal by Subject|4|||
155312792|NCT04924660|560577482|FG000|Spain|Death|0|||
155312793|NCT04924660|560577483|FG001|Spain|Death|0|||
155312794|NCT04924660|560577484|FG002|Spain|Death|0|||
155312795|NCT04924660|560577485|FG003|Spain|Death|0|||
155312796|NCT04924660|560577486|FG004|Spain|Death|0|||
155312797|NCT04924660|560577487|FG005|Spain|Death|2|||
155312798|NCT04924660|560577482|FG000|Spain|Lost to Follow-up|0|||
155312799|NCT04924660|560577483|FG001|Spain|Lost to Follow-up|0|||
155312800|NCT04924660|560577484|FG002|Spain|Lost to Follow-up|0|||
155312801|NCT04924660|560577485|FG003|Spain|Lost to Follow-up|0|||
155312802|NCT04924660|560577486|FG004|Spain|Lost to Follow-up|1|||
155312803|NCT04924660|560577487|FG005|Spain|Lost to Follow-up|0|||
155312804|NCT04924660|560577482|FG000|Brazil|Death|0|||
155312805|NCT04924660|560577483|FG001|Brazil|Death|0|||
155312806|NCT04924660|560577484|FG002|Brazil|Death|0|||
155312807|NCT04924660|560577485|FG003|Brazil|Death|0|||
155312808|NCT04924660|560577486|FG004|Brazil|Death|1|||
155312809|NCT04924660|560577487|FG005|Brazil|Death|0|||
155312810|NCT04924660|560577482|FG000|Italy|Lost to Follow-up|0|||
155312811|NCT04924660|560577483|FG001|Italy|Lost to Follow-up|0|||
155312812|NCT04924660|560577484|FG002|Italy|Lost to Follow-up|0|||
155312813|NCT04924660|560577485|FG003|Italy|Lost to Follow-up|0|||
155312814|NCT04924660|560577486|FG004|Italy|Lost to Follow-up|0|||
155312815|NCT04924660|560577487|FG005|Italy|Lost to Follow-up|1|||
155312816|NCT04924660|560577482|FG000|South Africa|Death|0|||
155162085|NCT00174187|560028752|FG000|Period 1 (up to 3 Years)|Other|0|||
155312817|NCT04924660|560577483|FG001|South Africa|Death|0|||
155312818|NCT04924660|560577484|FG002|South Africa|Death|0|||
155312819|NCT04924660|560577485|FG003|South Africa|Death|0|||
155312820|NCT04924660|560577486|FG004|South Africa|Death|0|||
155312821|NCT04924660|560577487|FG005|South Africa|Death|1|||
155312822|NCT04924660|560577482|FG000|South Africa|Lost to Follow-up|0|||
155312823|NCT04924660|560577483|FG001|South Africa|Lost to Follow-up|0|||
155312824|NCT04924660|560577484|FG002|South Africa|Lost to Follow-up|0|||
155312825|NCT04924660|560577485|FG003|South Africa|Lost to Follow-up|0|||
155312826|NCT04924660|560577486|FG004|South Africa|Lost to Follow-up|0|||
155312827|NCT04924660|560577487|FG005|South Africa|Lost to Follow-up|1|||
155312828|NCT00554788|560577488|FG000|Overall Study|Adverse Event|0|||
155312829|NCT00554788|560577489|FG001|Overall Study|Adverse Event|1|||
155312830|NCT00554788|560577490|FG002|Overall Study|Adverse Event|2|||
155162086|NCT00174187|560028753|FG001|Period 1 (up to 3 Years)|Other|1|||
155312831|NCT00554788|560577488|FG000|Overall Study|Lost to Follow-up|4|||
155312832|NCT00554788|560577489|FG001|Overall Study|Lost to Follow-up|3|||
155312833|NCT00554788|560577490|FG002|Overall Study|Lost to Follow-up|3|||
155312834|NCT00554788|560577488|FG000|Overall Study|Physician Decision|1|||
155312835|NCT00554788|560577489|FG001|Overall Study|Physician Decision|1|||
155312836|NCT00554788|560577490|FG002|Overall Study|Physician Decision|3|||
155312837|NCT00554788|560577488|FG000|Overall Study|Withdrawal by Subject|0|||
155312838|NCT00554788|560577489|FG001|Overall Study|Withdrawal by Subject|0|||
155312839|NCT00554788|560577490|FG002|Overall Study|Withdrawal by Subject|1|||
155312840|NCT00554788|560577488|FG000|Overall Study|Refusal of further protocol therapy|0|||
155312841|NCT00554788|560577489|FG001|Overall Study|Refusal of further protocol therapy|1|||
155312842|NCT00554788|560577490|FG002|Overall Study|Refusal of further protocol therapy|1|||
155312843|NCT00554788|560577488|FG000|Overall Study|Progressive disease|0|||
155312844|NCT00554788|560577489|FG001|Overall Study|Progressive disease|0|||
155312845|NCT00554788|560577490|FG002|Overall Study|Progressive disease|3|||
155312846|NCT00554788|560577488|FG000|Overall Study|Ineligible|2|||
155312847|NCT00554788|560577489|FG001|Overall Study|Ineligible|0|||
155312848|NCT00554788|560577490|FG002|Overall Study|Ineligible|1|||
155312849|NCT03557697|560577491|FG000|Overall Study|Withdrawal by Subject|2|||
155312850|NCT03557697|560577492|FG001|Overall Study|Withdrawal by Subject|4|||
155312851|NCT03197662|560577503|FG000|Overall Study|Withdrawn by family|0|||
155312852|NCT03197662|560577504|FG001|Overall Study|Withdrawn by family|2|||
155312853|NCT03721952|560577505|FG000|Overall Study|Lost to Follow-up|0|||
155312854|NCT03721952|560577506|FG001|Overall Study|Lost to Follow-up|0|||
155312855|NCT03721952|560577507|FG002|Overall Study|Lost to Follow-up|2|||
155312856|NCT03721952|560577508|FG003|Overall Study|Lost to Follow-up|0|||
155312857|NCT03721952|560577509|FG004|Overall Study|Lost to Follow-up|0|||
155312858|NCT03721952|560577505|FG000|Overall Study|Protocol Violation|0|||
155312859|NCT03721952|560577506|FG001|Overall Study|Protocol Violation|1|||
155312860|NCT03721952|560577507|FG002|Overall Study|Protocol Violation|0|||
155312861|NCT03721952|560577508|FG003|Overall Study|Protocol Violation|0|||
155312862|NCT03721952|560577509|FG004|Overall Study|Protocol Violation|0|||
155312863|NCT03721952|560577505|FG000|Overall Study|Withdrawal by Subject|1|||
155312864|NCT03721952|560577506|FG001|Overall Study|Withdrawal by Subject|0|||
155312865|NCT03721952|560577507|FG002|Overall Study|Withdrawal by Subject|40|||
155312866|NCT03721952|560577508|FG003|Overall Study|Withdrawal by Subject|28|||
155312867|NCT03721952|560577509|FG004|Overall Study|Withdrawal by Subject|0|||
155312868|NCT04495894|560577510|FG000|Overall Study|Withdrawal by Subject|2|||
155312869|NCT04495894|560577511|FG001|Overall Study|Withdrawal by Subject|0|||
155312870|NCT04495894|560577512|FG002|Overall Study|Withdrawal by Subject|2|||
155312871|NCT04495894|560577513|FG003|Overall Study|Withdrawal by Subject|3|||
155312872|NCT04495894|560577510|FG000|Overall Study|Early termination|0|||
155312873|NCT04495894|560577511|FG001|Overall Study|Early termination|0|||
155312874|NCT04495894|560577512|FG002|Overall Study|Early termination|3|||
155312875|NCT04495894|560577513|FG003|Overall Study|Early termination|0|||
155312876|NCT03364647|560577514|FG000|Overall Study|Withdrawal by Subject|3|||
155312877|NCT03364647|560577515|FG001|Overall Study|Withdrawal by Subject|1|||
155312878|NCT01000961|560577516|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
155312879|NCT01000961|560577517|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155312880|NCT01000961|560577516|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
155312881|NCT01000961|560577517|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
155312882|NCT03476460|560577520|FG000|Overall Study|Withdrawal by Subject|3|||
155312883|NCT03476460|560577521|FG001|Overall Study|Withdrawal by Subject|2|||
155312884|NCT03476460|560577520|FG000|Overall Study|Non-compliance with treatment|3|||
155312885|NCT03476460|560577521|FG001|Overall Study|Non-compliance with treatment|0|||
155312886|NCT03476460|560577520|FG000|Overall Study|Missing laboratory tests|5|||
155312887|NCT03476460|560577521|FG001|Overall Study|Missing laboratory tests|5|||
155312888|NCT03476460|560577520|FG000|Overall Study|Adverse Event|0|||
155312889|NCT03476460|560577521|FG001|Overall Study|Adverse Event|1|||
155312890|NCT05746455|560577525|FG000|Overall Study|Discharged from Clinical Service|1|||
155312891|NCT05746455|560577525|FG000|Overall Study|Lost to Follow-up|1|||
155312892|NCT03447470|560577526|FG000|Overall Study|Death|0|||
155162087|NCT00174187|560028754|FG002|Period 1 (up to 3 Years)|Other|0|||
155162088|NCT00174187|560028752|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
155312893|NCT03447470|560577527|FG001|Overall Study|Death|1|||
155312894|NCT03447470|560577528|FG002|Overall Study|Death|3|||
155312895|NCT03447470|560577529|FG003|Overall Study|Death|0|||
155312896|NCT03447470|560577530|FG004|Overall Study|Death|1|||
155312897|NCT03447470|560577531|FG005|Overall Study|Death|0|||
155312898|NCT03447470|560577532|FG006|Overall Study|Death|3|||
155312899|NCT03447470|560577533|FG007|Overall Study|Death|3|||
155312900|NCT03447470|560577534|FG008|Overall Study|Death|1|||
155312901|NCT03447470|560577526|FG000|Overall Study|Withdrawal by Subject|1|||
155312902|NCT03447470|560577527|FG001|Overall Study|Withdrawal by Subject|0|||
155312903|NCT03447470|560577528|FG002|Overall Study|Withdrawal by Subject|0|||
155312904|NCT03447470|560577529|FG003|Overall Study|Withdrawal by Subject|0|||
155312905|NCT03447470|560577530|FG004|Overall Study|Withdrawal by Subject|1|||
155312906|NCT03447470|560577531|FG005|Overall Study|Withdrawal by Subject|0|||
155312907|NCT03447470|560577532|FG006|Overall Study|Withdrawal by Subject|1|||
155312908|NCT03447470|560577533|FG007|Overall Study|Withdrawal by Subject|1|||
155312909|NCT03447470|560577534|FG008|Overall Study|Withdrawal by Subject|3|||
155312910|NCT03447470|560577526|FG000|Overall Study|Treatment discontinued|3|||
155312911|NCT03447470|560577527|FG001|Overall Study|Treatment discontinued|2|||
155312912|NCT03447470|560577528|FG002|Overall Study|Treatment discontinued|4|||
155312913|NCT03447470|560577529|FG003|Overall Study|Treatment discontinued|6|||
155312914|NCT03447470|560577530|FG004|Overall Study|Treatment discontinued|2|||
155312915|NCT03447470|560577531|FG005|Overall Study|Treatment discontinued|1|||
155312916|NCT03447470|560577532|FG006|Overall Study|Treatment discontinued|2|||
155312917|NCT03447470|560577533|FG007|Overall Study|Treatment discontinued|4|||
155312918|NCT03447470|560577534|FG008|Overall Study|Treatment discontinued|3|||
155312919|NCT05184192|560577535|FG000|Overall Study|Lost to Follow-up|4|||
155312920|NCT05184192|560577536|FG001|Overall Study|Lost to Follow-up|7|||
155312921|NCT05184192|560577535|FG000|Overall Study|Adverse Event|1|||
155312922|NCT05184192|560577536|FG001|Overall Study|Adverse Event|4|||
155312923|NCT05184192|560577535|FG000|Overall Study|PI withdrawal|1|||
155312924|NCT05184192|560577536|FG001|Overall Study|PI withdrawal|2|||
155312925|NCT05184192|560577535|FG000|Overall Study|Withdrew due to adverse effect|1|||
155312926|NCT05184192|560577536|FG001|Overall Study|Withdrew due to adverse effect|0|||
155312927|NCT05184192|560577535|FG000|Overall Study|Medication schedule|1|||
155312928|NCT05184192|560577536|FG001|Overall Study|Medication schedule|0|||
155312929|NCT05184192|560577535|FG000|Overall Study|Concern for adverse effects|0|||
155312930|NCT05184192|560577536|FG001|Overall Study|Concern for adverse effects|4|||
155312931|NCT04624633|560577537|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
155312932|NCT04624633|560577538|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
155312933|NCT04624633|560577537|FG000|Overall Study|Death|1|||
155312934|NCT04624633|560577538|FG001|Overall Study|Death|0|||
155312935|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
155312936|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312937|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312938|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312939|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312940|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
155312941|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
155312942|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312943|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312944|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312945|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312946|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
155312947|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312948|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
155312949|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312950|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312951|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155312952|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
155170038|NCT00830869|560062405|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
155162089|NCT00174187|560028753|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
155312953|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312954|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
155312955|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312956|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312957|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312958|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
155312959|NCT01902173|560577539|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312960|NCT01902173|560577540|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
155312961|NCT01902173|560577541|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312962|NCT01902173|560577542|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312963|NCT01902173|560577543|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312964|NCT01902173|560577544|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
155312965|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312966|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312967|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
155312968|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312969|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312970|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
155312971|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312972|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312973|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
155312974|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312975|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312976|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
155312977|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312978|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312979|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312980|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
155312981|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
154959909|NCT03874715|559278636|FG001|Overall Study|Poor compliance to protocol|1|||
154959910|NCT03874715|559278635|FG000|Overall Study|Withdrawal by Subject|1|||
154959911|NCT03874715|559278636|FG001|Overall Study|Withdrawal by Subject|0|||
155162090|NCT00174187|560028754|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
155162091|NCT00174187|560028752|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
155162092|NCT00174187|560028753|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
155162093|NCT00174187|560028754|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
155162094|NCT00174187|560028752|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
155162095|NCT00174187|560028753|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
155162096|NCT00174187|560028754|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
155162097|NCT00174187|560028752|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
155162098|NCT00174187|560028753|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
155312982|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
155312983|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312984|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312985|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312986|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
155312987|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312988|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
155312989|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312990|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312991|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312992|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312993|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
155312994|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
155312995|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312996|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312997|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312998|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155312999|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
155313000|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
155313001|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313002|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313003|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313004|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313005|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
155313006|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
155313007|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313008|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313009|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313010|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313011|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
155313012|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
155313013|NCT01902173|560577539|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313014|NCT01902173|560577540|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313015|NCT01902173|560577541|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313016|NCT01902173|560577542|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313017|NCT01902173|560577543|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
155313018|NCT01902173|560577544|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
155313019|NCT04876118|560577553|FG000|Overall Study|Pregnancy|1|||
155313020|NCT04876118|560577553|FG000|Overall Study|Withdrawal by Subject|14|||
155313021|NCT05089734|560577554|FG000|Overall Study|Still on study|122|||
155313022|NCT05089734|560577555|FG001|Overall Study|Still on study|101|||
155313023|NCT05089734|560577554|FG000|Overall Study|Death|161|||
155313024|NCT05089734|560577555|FG001|Overall Study|Death|179|||
155313025|NCT05089734|560577554|FG000|Overall Study|Withdrew consent|11|||
155067013|NCT01995201|559676942|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
154959912|NCT03874715|559278635|FG000|Overall Study|Other-unspecified|1|||
154959913|NCT03874715|559278636|FG001|Overall Study|Other-unspecified|0|||
155067014|NCT01995201|559676943|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
155313026|NCT05089734|560577555|FG001|Overall Study|Withdrew consent|24|||
155313027|NCT05089734|560577554|FG000|Overall Study|Lost to Follow-up|5|||
155313028|NCT05089734|560577555|FG001|Overall Study|Lost to Follow-up|0|||
155313029|NCT05093829|560577557|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313030|NCT05093829|560577558|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313031|NCT05093829|560577559|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
155313032|NCT05093829|560577560|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313033|NCT05093829|560577561|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
155313034|NCT04353661|560579439|FG000|Overall Study|Protocol Violation|0|||
155313035|NCT04353661|560579440|FG001|Overall Study|Protocol Violation|0|||
155313036|NCT04353661|560579441|FG002|Overall Study|Protocol Violation|1|||
155313037|NCT04353661|560579439|FG000|Overall Study|Study termination by the Sponsor|1|||
155313038|NCT04353661|560579440|FG001|Overall Study|Study termination by the Sponsor|1|||
155313039|NCT04353661|560579441|FG002|Overall Study|Study termination by the Sponsor|1|||
155313040|NCT05215314|560579442|FG000|Overall Study|Lost to Follow-up|2|||
155313041|NCT05215314|560579443|FG001|Overall Study|Lost to Follow-up|2|||
155313042|NCT05215314|560579442|FG000|Overall Study|Withdrawal by Subject|2|||
155313043|NCT05215314|560579443|FG001|Overall Study|Withdrawal by Subject|0|||
155313044|NCT05215314|560579442|FG000|Overall Study|Physician Decision|1|||
155313045|NCT05215314|560579443|FG001|Overall Study|Physician Decision|0|||
155313046|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Physician Decision|1|||
155313047|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Physician Decision|0|||
155313048|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
155313049|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
155313050|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
155313051|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
155313052|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Pregnancy|0|||
155313053|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Pregnancy|2|||
155313054|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
155313055|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
154959914|NCT00461786|559278639|FG000|Overall Study|Entry Criteria Not Met|2|||
154959915|NCT00461786|559278639|FG000|Overall Study|Inevaluable (Never Treated)|1|||
154959916|NCT00934050|559278640|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
154959917|NCT00934050|559278641|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155313056|NCT01785719|560579447|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
155313057|NCT01785719|560579448|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
155313058|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
155313059|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
155313060|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
155313061|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
155313062|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
155313063|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
155313064|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
155313065|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
155313066|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
155313067|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
155313068|NCT01785719|560579447|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
155313069|NCT01785719|560579448|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
155313070|NCT01785719|560579447|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
155313071|NCT01785719|560579448|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
155313072|NCT01785719|560579447|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
155313073|NCT01785719|560579448|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
155313074|NCT01785719|560579447|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
155313075|NCT01785719|560579448|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
155313076|NCT03443323|560579449|FG000|Overall Study|Lost to Follow-up|2|||
155313077|NCT03443323|560579450|FG001|Overall Study|Lost to Follow-up|2|||
155313078|NCT03443323|560579449|FG000|Overall Study|PI withdrawal|1|||
155313079|NCT03443323|560579450|FG001|Overall Study|PI withdrawal|0|||
155313080|NCT03457142|560579453|FG000|Overall Study|Death|1|||
155313081|NCT03770273|560579454|FG000|Overall Study|Adverse Event|2|||
155313082|NCT03770273|560579455|FG001|Overall Study|Adverse Event|0|||
155313083|NCT03770273|560579454|FG000|Overall Study|Lost to Follow-up|1|||
155313084|NCT03770273|560579455|FG001|Overall Study|Lost to Follow-up|1|||
155313085|NCT04060654|560579456|FG000|Overall Study|Withdrawal by Subject|1|||
155313086|NCT04060654|560579456|FG000|Overall Study|Lost to Follow-up|5|||
155313087|NCT04887129|560579457|FG000|Overall Study|Lost to Follow-up|0|||
155313088|NCT04887129|560579458|FG001|Overall Study|Lost to Follow-up|24|||
155313089|NCT04887129|560579457|FG000|Overall Study|Withdrawal by Subject|9|||
155313090|NCT04887129|560579458|FG001|Overall Study|Withdrawal by Subject|57|||
155313091|NCT04887129|560579457|FG000|Overall Study|Other|2|||
155313092|NCT04887129|560579458|FG001|Overall Study|Other|9|||
155313093|NCT04896476|560579459|FG000|Overall Study|Withdrawal by Subject|1|||
155313094|NCT04896476|560579459|FG000|Overall Study|Lost to Follow-up|2|||
155313095|NCT03476187|560579460|FG000|Overall Study|Protocol Violation|7|||
155313096|NCT03476187|560579460|FG000|Overall Study|Physician Decision|5|||
155313097|NCT03056040|560579464|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
155313098|NCT03056040|560579465|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
155313099|NCT03056040|560579464|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
155313100|NCT03056040|560579465|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
155313101|NCT03056040|560579464|FG000|Primary Evaluation Period|Pregnancy|0|||
155313102|NCT03056040|560579465|FG001|Primary Evaluation Period|Pregnancy|1|||
155313103|NCT03056040|560579464|FG000|Primary Evaluation Period|Randomized, not treated|1|||
155313104|NCT03056040|560579465|FG001|Primary Evaluation Period|Randomized, not treated|1|||
155313105|NCT03056040|560579464|FG000|Extension Period|Physician Decision|3|||
155313106|NCT03056040|560579465|FG001|Extension Period|Physician Decision|3|||
155313107|NCT03056040|560579464|FG000|Extension Period|Lost to Follow-up|0|||
155313108|NCT03056040|560579465|FG001|Extension Period|Lost to Follow-up|1|||
155313109|NCT03056040|560579464|FG000|Extension Period|Death|0|||
155313110|NCT03056040|560579465|FG001|Extension Period|Death|3|||
155313111|NCT03056040|560579464|FG000|Extension Period|Withdrawal by Subject|1|||
155313112|NCT03056040|560579465|FG001|Extension Period|Withdrawal by Subject|0|||
155313113|NCT02921230|560579466|FG000|Overall Study|Withdrawal by Subject|20|||
155313114|NCT02921230|560579467|FG001|Overall Study|Withdrawal by Subject|8|||
155313115|NCT02921230|560579466|FG000|Overall Study|Death|12|||
155313116|NCT02921230|560579467|FG001|Overall Study|Death|3|||
155313117|NCT02921230|560579466|FG000|Overall Study|Protocol Violation|17|||
155313118|NCT02921230|560579467|FG001|Overall Study|Protocol Violation|6|||
155313119|NCT02921230|560579466|FG000|Overall Study|Early completion|5|||
155313120|NCT02921230|560579467|FG001|Overall Study|Early completion|1|||
155313121|NCT02921230|560579466|FG000|Overall Study|Pending data entry|1|||
155313122|NCT02921230|560579467|FG001|Overall Study|Pending data entry|0|||
155313123|NCT04142788|560579473|FG000|Overall Study|Trial terminated prematurely|2|||
155313124|NCT04142788|560579474|FG001|Overall Study|Trial terminated prematurely|2|||
155313125|NCT03396926|560579481|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
155162099|NCT00174187|560028754|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
155162100|NCT00174187|560028752|FG000|Period 2 (After 3 Years)|Other|0|||
155162101|NCT00174187|560028753|FG001|Period 2 (After 3 Years)|Other|0|||
155162102|NCT00174187|560028754|FG002|Period 2 (After 3 Years)|Other|5|||
155162103|NCT04161157|560028755|FG000|Overall Study|Lost to Follow-up|4|||
155162104|NCT04161157|560028755|FG000|Overall Study|Death|3|||
155162105|NCT04161157|560028755|FG000|Overall Study|Ineligible|2|||
155162106|NCT04161157|560028755|FG000|Overall Study|Withdrawal by Subject|4|||
155162107|NCT02991768|560028764|FG000|Overall Study|Physician Decision|4|||
155162108|NCT04922216|560028768|FG000|Overall Study|Withdrawal by Subject|0|||
155162109|NCT04922216|560028769|FG001|Overall Study|Withdrawal by Subject|1|||
155162110|NCT04922216|560028770|FG002|Overall Study|Withdrawal by Subject|0|||
155162111|NCT04922216|560028771|FG003|Overall Study|Withdrawal by Subject|0|||
155162112|NCT04922216|560028772|FG004|Overall Study|Withdrawal by Subject|0|||
155162113|NCT04922216|560028773|FG005|Overall Study|Withdrawal by Subject|0|||
155162114|NCT04922216|560028774|FG006|Overall Study|Withdrawal by Subject|0|||
155162115|NCT04922216|560028775|FG007|Overall Study|Withdrawal by Subject|2|||
155162116|NCT04922216|560028776|FG008|Overall Study|Withdrawal by Subject|0|||
155162117|NCT04922216|560028777|FG009|Overall Study|Withdrawal by Subject|0|||
155162118|NCT04922216|560028778|FG010|Overall Study|Withdrawal by Subject|0|||
155162119|NCT04922216|560028779|FG011|Overall Study|Withdrawal by Subject|0|||
155162120|NCT04922216|560028780|FG012|Overall Study|Withdrawal by Subject|1|||
155162121|NCT04922216|560028781|FG013|Overall Study|Withdrawal by Subject|1|||
155162122|NCT04922216|560028782|FG014|Overall Study|Withdrawal by Subject|1|||
155162123|NCT04922216|560028783|FG015|Overall Study|Withdrawal by Subject|0|||
155162124|NCT04922216|560028784|FG016|Overall Study|Withdrawal by Subject|0|||
155162125|NCT04922216|560028785|FG017|Overall Study|Withdrawal by Subject|1|||
155162126|NCT04922216|560028786|FG018|Overall Study|Withdrawal by Subject|1|||
155162127|NCT04922216|560028787|FG019|Overall Study|Withdrawal by Subject|1|||
155162128|NCT04922216|560028788|FG020|Overall Study|Withdrawal by Subject|1|||
155162129|NCT04922216|560028789|FG021|Overall Study|Withdrawal by Subject|0|||
155162130|NCT04922216|560028790|FG022|Overall Study|Withdrawal by Subject|0|||
155162131|NCT04922216|560028791|FG023|Overall Study|Withdrawal by Subject|2|||
155162132|NCT04922216|560028792|FG024|Overall Study|Withdrawal by Subject|0|||
155162133|NCT04922216|560028793|FG025|Overall Study|Withdrawal by Subject|0|||
155162134|NCT04922216|560028794|FG026|Overall Study|Withdrawal by Subject|1|||
155162135|NCT04922216|560028795|FG027|Overall Study|Withdrawal by Subject|0|||
155162136|NCT04922216|560028796|FG028|Overall Study|Withdrawal by Subject|0|||
155162137|NCT04922216|560028797|FG029|Overall Study|Withdrawal by Subject|0|||
155162138|NCT04922216|560028798|FG030|Overall Study|Withdrawal by Subject|1|||
155162139|NCT04922216|560028799|FG031|Overall Study|Withdrawal by Subject|0|||
155162140|NCT04922216|560028768|FG000|Overall Study|Lost to Follow-up|1|||
155162141|NCT04922216|560028769|FG001|Overall Study|Lost to Follow-up|0|||
155162142|NCT04922216|560028770|FG002|Overall Study|Lost to Follow-up|2|||
155162143|NCT04922216|560028771|FG003|Overall Study|Lost to Follow-up|0|||
155162144|NCT04922216|560028772|FG004|Overall Study|Lost to Follow-up|0|||
155162145|NCT04922216|560028773|FG005|Overall Study|Lost to Follow-up|2|||
155162146|NCT04922216|560028774|FG006|Overall Study|Lost to Follow-up|0|||
155162147|NCT04922216|560028775|FG007|Overall Study|Lost to Follow-up|1|||
155162148|NCT04922216|560028776|FG008|Overall Study|Lost to Follow-up|1|||
155162149|NCT04922216|560028777|FG009|Overall Study|Lost to Follow-up|2|||
155162150|NCT04922216|560028778|FG010|Overall Study|Lost to Follow-up|2|||
155162151|NCT04922216|560028779|FG011|Overall Study|Lost to Follow-up|1|||
155162152|NCT04922216|560028780|FG012|Overall Study|Lost to Follow-up|1|||
155162153|NCT04922216|560028781|FG013|Overall Study|Lost to Follow-up|0|||
155162154|NCT04922216|560028782|FG014|Overall Study|Lost to Follow-up|1|||
155162155|NCT04922216|560028783|FG015|Overall Study|Lost to Follow-up|0|||
155162156|NCT04922216|560028784|FG016|Overall Study|Lost to Follow-up|0|||
155162157|NCT04922216|560028785|FG017|Overall Study|Lost to Follow-up|2|||
155162158|NCT04922216|560028786|FG018|Overall Study|Lost to Follow-up|1|||
155313126|NCT03396926|560579482|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
155313127|NCT02035787|560579483|FG000|Overall Study- 12 Months|Adverse Event|3|||
155313128|NCT02035787|560579484|FG001|Overall Study- 12 Months|Adverse Event|0|||
155313129|NCT02035787|560579483|FG000|Overall Study- 12 Months|Complete response|4|||
155313130|NCT02035787|560579484|FG001|Overall Study- 12 Months|Complete response|1|||
155313131|NCT02035787|560579483|FG000|Overall Study- 12 Months|Protocol Violation|1|||
155313132|NCT02035787|560579484|FG001|Overall Study- 12 Months|Protocol Violation|1|||
155313133|NCT03853746|560579486|FG000|Overall Study|Withdrawal by Subject|1|||
155313134|NCT01396278|560579487|FG000|Overall Study|Adverse Event|0|||
155313135|NCT01396278|560579488|FG001|Overall Study|Adverse Event|0|||
155313136|NCT01396278|560579489|FG002|Overall Study|Adverse Event|0|||
155313137|NCT01396278|560579490|FG003|Overall Study|Adverse Event|2|||
155313138|NCT01396278|560579491|FG004|Overall Study|Adverse Event|0|||
155313139|NCT01396278|560579487|FG000|Overall Study|Withdraw due to trial termination|2|||
155313140|NCT01396278|560579488|FG001|Overall Study|Withdraw due to trial termination|1|||
155313141|NCT01396278|560579489|FG002|Overall Study|Withdraw due to trial termination|1|||
155313142|NCT01396278|560579490|FG003|Overall Study|Withdraw due to trial termination|0|||
155313143|NCT01396278|560579491|FG004|Overall Study|Withdraw due to trial termination|2|||
155313144|NCT01084876|560579493|FG000|Main Study Treatment Period|Adverse Event|12|||
155313145|NCT01084876|560579494|FG001|Main Study Treatment Period|Adverse Event|7|||
155313146|NCT01084876|560579493|FG000|Main Study Treatment Period|Disease Progression|41|||
155313147|NCT01084876|560579494|FG001|Main Study Treatment Period|Disease Progression|24|||
155313148|NCT01084876|560579493|FG000|Main Study Treatment Period|Physician Decision|2|||
155313149|NCT01084876|560579494|FG001|Main Study Treatment Period|Physician Decision|0|||
155313150|NCT01084876|560579493|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
155313151|NCT01084876|560579494|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
155313152|NCT01084876|560579493|FG000|Main Study Treatment Period|Other Reason|0|||
155313153|NCT01084876|560579494|FG001|Main Study Treatment Period|Other Reason|1|||
155313154|NCT01084876|560579493|FG000|Main Study Treatment Period|Other|0|||
155313155|NCT01084876|560579494|FG001|Main Study Treatment Period|Other|1|||
155313156|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
155313157|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
155313158|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
155313159|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
155313160|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
155313161|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
155313162|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
155313163|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
155313164|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
155313165|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
155313166|NCT01084876|560579493|FG000|Treatment Period Beyond Cycle 8|Other|6|||
155313167|NCT01084876|560579494|FG001|Treatment Period Beyond Cycle 8|Other|9|||
155313168|NCT04727554|560579495|FG000|Overall Study|Lost to Follow-up|0|||
155313169|NCT04727554|560579496|FG001|Overall Study|Lost to Follow-up|1|||
155313170|NCT04727554|560579495|FG000|Overall Study|Death|2|||
155313171|NCT04727554|560579496|FG001|Overall Study|Death|6|||
155313172|NCT04727554|560579495|FG000|Overall Study|Withdrawal by Subject|1|||
155313173|NCT04727554|560579496|FG001|Overall Study|Withdrawal by Subject|0|||
155313174|NCT00999804|560579497|FG000|Overall Study|Lack of Efficacy|9|||
155313175|NCT00999804|560579498|FG001|Overall Study|Lack of Efficacy|2|||
155313176|NCT00999804|560579497|FG000|Overall Study|Adverse Event|4|||
155313177|NCT00999804|560579498|FG001|Overall Study|Adverse Event|3|||
155313178|NCT00999804|560579497|FG000|Overall Study|Withdrawal by Subject|4|||
155313179|NCT00999804|560579498|FG001|Overall Study|Withdrawal by Subject|0|||
155313180|NCT00999804|560579497|FG000|Overall Study|Death|1|||
155313181|NCT00999804|560579498|FG001|Overall Study|Death|0|||
155313182|NCT00999804|560579497|FG000|Overall Study|Ineligible|3|||
155313183|NCT00999804|560579498|FG001|Overall Study|Ineligible|0|||
155313184|NCT05028634|560579499|FG000|Overall Study|Withdrawal by Subject|0|||
155313185|NCT05028634|560579500|FG001|Overall Study|Withdrawal by Subject|1|||
155313186|NCT05653427|560579501|FG000|Overall Study|Study Terminated by Sponsor|13|||
155313187|NCT05311384|560579505|FG000|Overall Study|Uncontrolled health conditions|2|||
155313188|NCT05311384|560579505|FG000|Overall Study|Withdrawal by Subject|1|||
155313189|NCT04256941|560579508|FG000|Overall Study|Withdrawal by Subject|0|||
155313190|NCT04256941|560579509|FG001|Overall Study|Withdrawal by Subject|1|||
155313191|NCT04256941|560579508|FG000|Overall Study|Death|1|||
155313192|NCT04256941|560579509|FG001|Overall Study|Death|0|||
155313193|NCT04256941|560579508|FG000|Overall Study|Disease Progession|0|||
155313194|NCT04256941|560579509|FG001|Overall Study|Disease Progession|2|||
155313195|NCT02724631|560579522|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
155313196|NCT05076708|560579523|FG000|Overall Study|Withdrawal by Subject|4|||
155313197|NCT05076708|560579523|FG000|Overall Study|Lost to study during switch phase|8|||
155313198|NCT05590403|560579524|FG000|Overall Study|Lost to Follow-up|13|||
155313199|NCT05590403|560579525|FG001|Overall Study|Lost to Follow-up|1|||
155313200|NCT05590403|560579526|FG002|Overall Study|Lost to Follow-up|7|||
155313201|NCT05590403|560579527|FG003|Overall Study|Lost to Follow-up|3|||
155313202|NCT05590403|560579528|FG004|Overall Study|Lost to Follow-up|4|||
155313203|NCT05590403|560579524|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
155313204|NCT05590403|560579525|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
155313205|NCT05590403|560579526|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
155313206|NCT05590403|560579527|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
155313207|NCT05590403|560579528|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
155313208|NCT05590403|560579524|FG000|Overall Study|Other|2|||
155313209|NCT05590403|560579525|FG001|Overall Study|Other|0|||
155313210|NCT05590403|560579526|FG002|Overall Study|Other|2|||
155313211|NCT05590403|560579527|FG003|Overall Study|Other|2|||
155313212|NCT05590403|560579528|FG004|Overall Study|Other|0|||
155313213|NCT05590403|560579524|FG000|Overall Study|Migrated / moved from the study area|1|||
155313214|NCT05590403|560579525|FG001|Overall Study|Migrated / moved from the study area|1|||
155313215|NCT05590403|560579526|FG002|Overall Study|Migrated / moved from the study area|0|||
155313216|NCT05590403|560579527|FG003|Overall Study|Migrated / moved from the study area|3|||
155313217|NCT05590403|560579528|FG004|Overall Study|Migrated / moved from the study area|1|||
155313218|NCT05590403|560579524|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
155313219|NCT05590403|560579525|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
155313220|NCT05590403|560579526|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
155313221|NCT05590403|560579527|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
155313222|NCT05590403|560579528|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
155313223|NCT04971395|560579534|FG000|Overall Study|Withdrawal by Subject|0|||
155313224|NCT04971395|560579535|FG001|Overall Study|Withdrawal by Subject|1|||
155313225|NCT04971395|560579536|FG002|Overall Study|Withdrawal by Subject|0|||
155313226|NCT04717492|560579537|FG000|Overall Study|Withdrawal by Subject|2|||
155313227|NCT04717492|560579538|FG001|Overall Study|Withdrawal by Subject|13|||
155313228|NCT04717492|560579537|FG000|Overall Study|Lost to Follow-up|2|||
155313229|NCT04717492|560579538|FG001|Overall Study|Lost to Follow-up|9|||
155313230|NCT03766009|560579542|FG000|Usual Care|Death|0|||
155313231|NCT03766009|560579543|FG001|Usual Care|Death|0|||
155313232|NCT03766009|560579544|FG002|Usual Care|Death|0|||
155313233|NCT03766009|560579545|FG003|Usual Care|Death|1|||
155313234|NCT03766009|560579546|FG004|Usual Care|Death|0|||
155313235|NCT03766009|560579547|FG005|Usual Care|Death|0|||
155313236|NCT03766009|560579542|FG000|Usual Care|Lost to Follow-up|0|||
155313237|NCT03766009|560579543|FG001|Usual Care|Lost to Follow-up|0|||
155313238|NCT03766009|560579544|FG002|Usual Care|Lost to Follow-up|0|||
155313239|NCT03766009|560579545|FG003|Usual Care|Lost to Follow-up|1|||
155313240|NCT03766009|560579546|FG004|Usual Care|Lost to Follow-up|0|||
155313241|NCT03766009|560579547|FG005|Usual Care|Lost to Follow-up|0|||
155313242|NCT03766009|560579542|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313243|NCT03766009|560579543|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313244|NCT03766009|560579544|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
155313245|NCT03766009|560579545|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313246|NCT03766009|560579546|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
155313247|NCT03766009|560579547|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
155313248|NCT03766009|560579542|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313249|NCT03766009|560579543|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
155313250|NCT03766009|560579544|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313251|NCT03766009|560579545|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
155313252|NCT03766009|560579546|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313253|NCT03766009|560579547|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
155313254|NCT03766009|560579542|FG000|Usual Care|No treatment or declined surgery|0|||
155313255|NCT03766009|560579543|FG001|Usual Care|No treatment or declined surgery|0|||
155313256|NCT03766009|560579544|FG002|Usual Care|No treatment or declined surgery|0|||
155313257|NCT03766009|560579545|FG003|Usual Care|No treatment or declined surgery|2|||
155313258|NCT03766009|560579546|FG004|Usual Care|No treatment or declined surgery|0|||
155313259|NCT03766009|560579547|FG005|Usual Care|No treatment or declined surgery|0|||
155313260|NCT03766009|560579542|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
155313261|NCT03766009|560579543|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
155313262|NCT03766009|560579544|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
155313263|NCT03766009|560579545|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
155313264|NCT03766009|560579546|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
155313265|NCT03766009|560579547|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
155313266|NCT03766009|560579542|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313267|NCT03766009|560579543|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
155313268|NCT03766009|560579544|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313269|NCT03766009|560579545|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313270|NCT03766009|560579546|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313271|NCT03766009|560579547|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
155313272|NCT03766009|560579542|FG000|Usual Care|Ineligible|0|||
155313273|NCT03766009|560579543|FG001|Usual Care|Ineligible|1|||
155313274|NCT03766009|560579544|FG002|Usual Care|Ineligible|0|||
155313275|NCT03766009|560579545|FG003|Usual Care|Ineligible|0|||
155313276|NCT03766009|560579546|FG004|Usual Care|Ineligible|0|||
155313277|NCT03766009|560579547|FG005|Usual Care|Ineligible|0|||
155313278|NCT03766009|560579542|FG000|Usual Care|Other: Staff turnover|0|||
155313279|NCT03766009|560579543|FG001|Usual Care|Other: Staff turnover|0|||
155313280|NCT03766009|560579544|FG002|Usual Care|Other: Staff turnover|0|||
155313281|NCT03766009|560579545|FG003|Usual Care|Other: Staff turnover|0|||
155313282|NCT03766009|560579546|FG004|Usual Care|Other: Staff turnover|0|||
155313283|NCT03766009|560579547|FG005|Usual Care|Other: Staff turnover|2|||
155313284|NCT02924272|560579549|FG000|Overall Study|Site Terminated by Sponsor|4|||
155313285|NCT02924272|560579550|FG001|Overall Study|Site Terminated by Sponsor|1|||
155313286|NCT02924272|560579549|FG000|Overall Study|Withdrawal by Subject|2|||
155313287|NCT02924272|560579550|FG001|Overall Study|Withdrawal by Subject|0|||
155313288|NCT02924272|560579549|FG000|Overall Study|Adverse Event|3|||
155313289|NCT02924272|560579550|FG001|Overall Study|Adverse Event|0|||
155313290|NCT02924272|560579549|FG000|Overall Study|Progressive Disease|11|||
155313291|NCT02924272|560579550|FG001|Overall Study|Progressive Disease|8|||
155313292|NCT02924272|560579549|FG000|Overall Study|Clinical Deterioration|1|||
155313293|NCT02924272|560579550|FG001|Overall Study|Clinical Deterioration|0|||
155313294|NCT02924272|560579549|FG000|Overall Study|Death|1|||
155313295|NCT02924272|560579550|FG001|Overall Study|Death|0|||
155313296|NCT02924272|560579549|FG000|Overall Study|Reason Not Specified|1|||
155313297|NCT02924272|560579550|FG001|Overall Study|Reason Not Specified|0|||
155313298|NCT03575897|560579553|FG000|Overall Study|Lost to Follow-up|12|||
155313299|NCT03575897|560579554|FG001|Overall Study|Lost to Follow-up|13|||
155313300|NCT05116787|560579560|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
155313301|NCT05116787|560579561|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
155313302|NCT05116787|560579560|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
155313303|NCT05116787|560579561|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
155313304|NCT05116787|560579560|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
155313305|NCT05116787|560579561|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
155313306|NCT05116787|560579560|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
155092648|NCT00854360|559773650|FG000|Overall Study|Withdrawal by Subject|0|||
155313307|NCT05116787|560579561|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
155313308|NCT02737436|560579562|FG000|Washout Period|Lost to Follow-up|5|||
155313309|NCT02737436|560579563|FG001|Washout Period|Lost to Follow-up|11|||
155313310|NCT02737436|560579562|FG000|Data Analysis|Scanning data problems|5|||
155313311|NCT02737436|560579563|FG001|Data Analysis|Scanning data problems|8|||
155313312|NCT02919683|560579564|FG000|Post-Surgery Follow-Up|Death|2|||
155313313|NCT02919683|560579565|FG001|Post-Surgery Follow-Up|Death|2|||
155313314|NCT02919683|560579564|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
155313315|NCT02919683|560579565|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
155313316|NCT05551637|560579568|FG000|Overall Study|Lack of Efficacy|0|||
155313317|NCT05551637|560579569|FG001|Overall Study|Lack of Efficacy|6|||
155313318|NCT05551637|560579568|FG000|Overall Study|Lost to Follow-up|1|||
155313319|NCT05551637|560579569|FG001|Overall Study|Lost to Follow-up|1|||
155313320|NCT05179837|560579572|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
155313321|NCT05179837|560579572|FG000|Overall Study|Device malfunctioned|1|||
155313322|NCT05179837|560579572|FG000|Overall Study|Image quality too low|2|||
155313323|NCT05051124|560579573|FG000|Overall Study|Lost to Follow-up|2|||
155313324|NCT05051124|560579573|FG000|Overall Study|Withdrawal by Subject|1|||
155313325|NCT05051124|560579573|FG000|Overall Study|Residential relocation|2|||
155313326|NCT05051124|560579573|FG000|Overall Study|Death|1|||
155313327|NCT04782973|560579574|FG000|Overall Study|Withdrawal by Subject|5|||
155313328|NCT04782973|560579574|FG000|Overall Study|Protocol Violation|6|||
155313329|NCT04782973|560579574|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
155313330|NCT03307343|560579575|FG000|Overall Study|Withdrawal by Subject|1|||
155313331|NCT03307343|560579576|FG001|Overall Study|Withdrawal by Subject|2|||
155313332|NCT03307343|560579575|FG000|Overall Study|Pregnancy|0|||
155313333|NCT03307343|560579576|FG001|Overall Study|Pregnancy|2|||
155313334|NCT03307343|560579575|FG000|Overall Study|Physician Decision|1|||
155313335|NCT03307343|560579576|FG001|Overall Study|Physician Decision|0|||
155313336|NCT03307343|560579575|FG000|Overall Study|Lost to Follow-up|0|||
155313337|NCT03307343|560579576|FG001|Overall Study|Lost to Follow-up|2|||
155313338|NCT05364671|560579579|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
155313339|NCT05364671|560579580|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
155313340|NCT05364671|560579579|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
155313341|NCT05364671|560579580|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
155313342|NCT05364671|560579579|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
155313343|NCT05364671|560579580|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
155313344|NCT05364671|560579579|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
155313345|NCT05364671|560579580|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
155313346|NCT05364671|560579579|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
155313347|NCT05364671|560579580|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
155313348|NCT03536754|560579581|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
155313349|NCT03536754|560579582|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
155313350|NCT03536754|560579583|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
155313351|NCT03536754|560579584|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
155313352|NCT03536754|560579585|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
155313353|NCT03536754|560579581|FG000|Open Label Extension|Other|0|||
155313354|NCT03536754|560579582|FG001|Open Label Extension|Other|0|||
155313355|NCT03536754|560579583|FG002|Open Label Extension|Other|0|||
155313356|NCT03536754|560579584|FG003|Open Label Extension|Other|0|||
155313357|NCT03536754|560579585|FG004|Open Label Extension|Other|1|||
155313358|NCT03382652|560579588|FG000|Overall Study|Lost to Follow-up|6|||
155313359|NCT03382652|560579588|FG000|Overall Study|Death|4|||
155313360|NCT03382652|560579588|FG000|Overall Study|Revision|5|||
155313361|NCT03382652|560579588|FG000|Overall Study|Patient withdrew|3|||
155313362|NCT03382652|560579588|FG000|Overall Study|Other reasons|21|||
155313363|NCT04810650|560579590|FG000|Overall Study|Disenrolled in error|0|||
155313364|NCT04810650|560579591|FG001|Overall Study|Disenrolled in error|0|||
155313365|NCT04810650|560579592|FG002|Overall Study|Disenrolled in error|0|||
155313366|NCT04810650|560579593|FG003|Overall Study|Disenrolled in error|0|||
155313367|NCT04810650|560579594|FG004|Overall Study|Disenrolled in error|0|||
155313368|NCT04810650|560579595|FG005|Overall Study|Disenrolled in error|0|||
155313369|NCT04810650|560579596|FG006|Overall Study|Disenrolled in error|0|||
155313370|NCT04810650|560579597|FG007|Overall Study|Disenrolled in error|0|||
155313371|NCT04810650|560579598|FG008|Overall Study|Disenrolled in error|1|||
155313372|NCT04810650|560579599|FG009|Overall Study|Disenrolled in error|0|||
155313373|NCT04810650|560579600|FG010|Overall Study|Disenrolled in error|0|||
155313374|NCT04810650|560579601|FG011|Overall Study|Disenrolled in error|0|||
155313375|NCT04810650|560579602|FG012|Overall Study|Disenrolled in error|0|||
155313376|NCT04810650|560579603|FG013|Overall Study|Disenrolled in error|0|||
155313377|NCT04810650|560579590|FG000|Overall Study|Death|0|||
155313378|NCT04810650|560579591|FG001|Overall Study|Death|0|||
155313379|NCT04810650|560579592|FG002|Overall Study|Death|0|||
155162159|NCT04922216|560028787|FG019|Overall Study|Lost to Follow-up|0|||
155162160|NCT04922216|560028788|FG020|Overall Study|Lost to Follow-up|1|||
155162161|NCT04922216|560028789|FG021|Overall Study|Lost to Follow-up|0|||
155162162|NCT04922216|560028790|FG022|Overall Study|Lost to Follow-up|2|||
155162163|NCT04922216|560028791|FG023|Overall Study|Lost to Follow-up|1|||
155162164|NCT04922216|560028792|FG024|Overall Study|Lost to Follow-up|0|||
155162165|NCT04922216|560028793|FG025|Overall Study|Lost to Follow-up|2|||
155162166|NCT04922216|560028794|FG026|Overall Study|Lost to Follow-up|0|||
155162167|NCT04922216|560028795|FG027|Overall Study|Lost to Follow-up|0|||
155162168|NCT04922216|560028796|FG028|Overall Study|Lost to Follow-up|1|||
155162169|NCT04922216|560028797|FG029|Overall Study|Lost to Follow-up|0|||
155162170|NCT04922216|560028798|FG030|Overall Study|Lost to Follow-up|2|||
155162171|NCT04922216|560028799|FG031|Overall Study|Lost to Follow-up|1|||
155162172|NCT02017405|560028800|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155162173|NCT02017405|560028801|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155162174|NCT02017405|560028802|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155162175|NCT02017405|560028803|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155162176|NCT02017405|560028804|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
155162177|NCT02017405|560028805|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
155162178|NCT02017405|560028800|FG000|Open-label Phase|Adverse Event|1|||
155162179|NCT02017405|560028801|FG001|Open-label Phase|Adverse Event|1|||
155162180|NCT02017405|560028802|FG002|Open-label Phase|Adverse Event|0|||
155162181|NCT02017405|560028803|FG003|Open-label Phase|Adverse Event|0|||
155162182|NCT02017405|560028804|FG004|Open-label Phase|Adverse Event|0|||
155162183|NCT02017405|560028805|FG005|Open-label Phase|Adverse Event|0|||
155162184|NCT03207763|560029797|FG000|Overall Study|Lost to Follow-up|1|||
155162185|NCT03207763|560029798|FG001|Overall Study|Lost to Follow-up|0|||
155162186|NCT00990704|560029799|FG000|Overall Study|Adverse Event|1|||
155162187|NCT00990704|560029800|FG001|Overall Study|Adverse Event|1|||
155162188|NCT00990704|560029799|FG000|Overall Study|Physician Decision|0|||
155162189|NCT00990704|560029800|FG001|Overall Study|Physician Decision|1|||
155162190|NCT01399372|560029801|FG000|Overall Study|Protocol Violation|3|||
155162191|NCT01399372|560029802|FG001|Overall Study|Protocol Violation|1|||
155162192|NCT01358721|560029808|FG000|Overall Study|Withdrawal by Subject|0|||
155162193|NCT01358721|560029809|FG001|Overall Study|Withdrawal by Subject|0|||
155162194|NCT01358721|560029810|FG002|Overall Study|Withdrawal by Subject|0|||
155162195|NCT01358721|560029811|FG003|Overall Study|Withdrawal by Subject|1|||
155162196|NCT01358721|560029808|FG000|Overall Study|Death|0|||
155162197|NCT01358721|560029809|FG001|Overall Study|Death|2|||
155162198|NCT01358721|560029810|FG002|Overall Study|Death|0|||
155162199|NCT01358721|560029811|FG003|Overall Study|Death|0|||
155162200|NCT01358721|560029808|FG000|Overall Study|Study Drug Toxicity|1|||
155162201|NCT01358721|560029809|FG001|Overall Study|Study Drug Toxicity|3|||
155162202|NCT01358721|560029810|FG002|Overall Study|Study Drug Toxicity|4|||
155162203|NCT01358721|560029811|FG003|Overall Study|Study Drug Toxicity|5|||
155162204|NCT01358721|560029808|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
155162205|NCT01358721|560029809|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
155162206|NCT01358721|560029810|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
155162207|NCT01358721|560029811|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
155162208|NCT01358721|560029808|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155162209|NCT01358721|560029809|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
155162210|NCT01358721|560029810|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
155162211|NCT01358721|560029811|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
155162212|NCT01358721|560029808|FG000|Overall Study|Adverse Event related to study drug|1|||
155162213|NCT01358721|560029809|FG001|Overall Study|Adverse Event related to study drug|0|||
155162214|NCT01358721|560029810|FG002|Overall Study|Adverse Event related to study drug|0|||
155162215|NCT01358721|560029811|FG003|Overall Study|Adverse Event related to study drug|1|||
155162216|NCT01358721|560029808|FG000|Overall Study|Disease Progression|19|||
155162217|NCT01358721|560029809|FG001|Overall Study|Disease Progression|15|||
155162218|NCT01358721|560029810|FG002|Overall Study|Disease Progression|17|||
155162219|NCT01358721|560029811|FG003|Overall Study|Disease Progression|15|||
155162220|NCT01358721|560029808|FG000|Overall Study|Out of State/Unmet Criteria|0|||
155162221|NCT01358721|560029809|FG001|Overall Study|Out of State/Unmet Criteria|0|||
155162222|NCT01358721|560029810|FG002|Overall Study|Out of State/Unmet Criteria|1|||
155162223|NCT01358721|560029811|FG003|Overall Study|Out of State/Unmet Criteria|0|||
155162224|NCT01554241|560029812|FG000|Overall Study|Death|3|||
155162225|NCT01554241|560029813|FG001|Overall Study|Death|1|||
155162226|NCT01554241|560029814|FG002|Overall Study|Death|1|||
155313380|NCT04810650|560579593|FG003|Overall Study|Death|0|||
155313381|NCT04810650|560579594|FG004|Overall Study|Death|0|||
155313382|NCT04810650|560579595|FG005|Overall Study|Death|0|||
155313383|NCT04810650|560579596|FG006|Overall Study|Death|2|||
155313384|NCT04810650|560579597|FG007|Overall Study|Death|2|||
155313385|NCT04810650|560579598|FG008|Overall Study|Death|0|||
155313386|NCT04810650|560579599|FG009|Overall Study|Death|1|||
155313387|NCT04810650|560579600|FG010|Overall Study|Death|0|||
155313388|NCT04810650|560579601|FG011|Overall Study|Death|0|||
155313389|NCT04810650|560579602|FG012|Overall Study|Death|2|||
155313390|NCT04810650|560579603|FG013|Overall Study|Death|1|||
155313391|NCT04810650|560579590|FG000|Overall Study|Moved/transferred care|0|||
155313392|NCT04810650|560579591|FG001|Overall Study|Moved/transferred care|0|||
155313393|NCT04810650|560579592|FG002|Overall Study|Moved/transferred care|0|||
155313394|NCT04810650|560579593|FG003|Overall Study|Moved/transferred care|0|||
155313395|NCT04810650|560579594|FG004|Overall Study|Moved/transferred care|0|||
155313396|NCT04810650|560579595|FG005|Overall Study|Moved/transferred care|0|||
155313397|NCT04810650|560579596|FG006|Overall Study|Moved/transferred care|0|||
155313398|NCT04810650|560579597|FG007|Overall Study|Moved/transferred care|1|||
155313399|NCT04810650|560579598|FG008|Overall Study|Moved/transferred care|12|||
155313400|NCT04810650|560579599|FG009|Overall Study|Moved/transferred care|10|||
155313401|NCT04810650|560579600|FG010|Overall Study|Moved/transferred care|0|||
155313402|NCT04810650|560579601|FG011|Overall Study|Moved/transferred care|0|||
155313403|NCT04810650|560579602|FG012|Overall Study|Moved/transferred care|0|||
155313404|NCT04810650|560579603|FG013|Overall Study|Moved/transferred care|0|||
155313405|NCT04810650|560579590|FG000|Overall Study|Lost to Follow-up|15|||
155313406|NCT04810650|560579591|FG001|Overall Study|Lost to Follow-up|12|||
155313407|NCT04810650|560579592|FG002|Overall Study|Lost to Follow-up|7|||
155313408|NCT04810650|560579593|FG003|Overall Study|Lost to Follow-up|9|||
155313409|NCT04810650|560579594|FG004|Overall Study|Lost to Follow-up|10|||
155313410|NCT04810650|560579595|FG005|Overall Study|Lost to Follow-up|6|||
155313411|NCT04810650|560579596|FG006|Overall Study|Lost to Follow-up|0|||
155313412|NCT04810650|560579597|FG007|Overall Study|Lost to Follow-up|0|||
155313413|NCT04810650|560579598|FG008|Overall Study|Lost to Follow-up|0|||
155313414|NCT04810650|560579599|FG009|Overall Study|Lost to Follow-up|0|||
155313415|NCT04810650|560579600|FG010|Overall Study|Lost to Follow-up|1|||
155313416|NCT04810650|560579601|FG011|Overall Study|Lost to Follow-up|0|||
155313417|NCT04810650|560579602|FG012|Overall Study|Lost to Follow-up|3|||
155313418|NCT04810650|560579603|FG013|Overall Study|Lost to Follow-up|9|||
155313419|NCT04810650|560579590|FG000|Overall Study|Participant declined|0|||
155313420|NCT04810650|560579591|FG001|Overall Study|Participant declined|0|||
155313421|NCT04810650|560579592|FG002|Overall Study|Participant declined|0|||
155313422|NCT04810650|560579593|FG003|Overall Study|Participant declined|0|||
155313423|NCT04810650|560579594|FG004|Overall Study|Participant declined|0|||
155313424|NCT04810650|560579595|FG005|Overall Study|Participant declined|0|||
155313425|NCT04810650|560579596|FG006|Overall Study|Participant declined|0|||
155162227|NCT01554241|560029815|FG003|Overall Study|Death|0|||
155162228|NCT01554241|560029812|FG000|Overall Study|protocol specified renal stone|0|||
155162229|NCT01554241|560029813|FG001|Overall Study|protocol specified renal stone|0|||
155162230|NCT01554241|560029814|FG002|Overall Study|protocol specified renal stone|0|||
155162231|NCT01554241|560029815|FG003|Overall Study|protocol specified renal stone|1|||
155162232|NCT01554241|560029812|FG000|Overall Study|protocol specified change in eGFR|0|||
155162233|NCT01554241|560029813|FG001|Overall Study|protocol specified change in eGFR|0|||
155162234|NCT01554241|560029814|FG002|Overall Study|protocol specified change in eGFR|1|||
155162235|NCT01554241|560029815|FG003|Overall Study|protocol specified change in eGFR|0|||
155162236|NCT01554241|560029812|FG000|Overall Study|Withdrawal by Subject|0|||
155162237|NCT01554241|560029813|FG001|Overall Study|Withdrawal by Subject|0|||
155162238|NCT01554241|560029814|FG002|Overall Study|Withdrawal by Subject|2|||
155162239|NCT01554241|560029815|FG003|Overall Study|Withdrawal by Subject|0|||
155162240|NCT01002339|560029816|FG000|Overall Study|Withdrawal by Subject|0|||
155162241|NCT01002339|560029817|FG001|Overall Study|Withdrawal by Subject|1|||
155162242|NCT01002339|560029818|FG002|Overall Study|Withdrawal by Subject|0|||
155162243|NCT01002339|560029816|FG000|Overall Study|Incorrect treatment assignment|0|||
155162244|NCT01002339|560029817|FG001|Overall Study|Incorrect treatment assignment|0|||
155162245|NCT01002339|560029818|FG002|Overall Study|Incorrect treatment assignment|1|||
155162246|NCT01002339|560029816|FG000|Overall Study|Protocol Violation|0|||
155162247|NCT01002339|560029817|FG001|Overall Study|Protocol Violation|0|||
155162248|NCT01002339|560029818|FG002|Overall Study|Protocol Violation|2|||
155162249|NCT01002339|560029816|FG000|Overall Study|Lung cancer detected before transplant|0|||
155162250|NCT01002339|560029817|FG001|Overall Study|Lung cancer detected before transplant|0|||
155162251|NCT01002339|560029818|FG002|Overall Study|Lung cancer detected before transplant|1|||
155162252|NCT01002339|560029816|FG000|Overall Study|Randomized. Not transplanted|0|||
155162253|NCT01002339|560029817|FG001|Overall Study|Randomized. Not transplanted|0|||
155162254|NCT01002339|560029818|FG002|Overall Study|Randomized. Not transplanted|1|||
155162255|NCT02223858|560029825|FG000|Overall Study|Death|1|||
155162256|NCT02223858|560029826|FG001|Overall Study|Death|1|||
155162257|NCT02223858|560029825|FG000|Overall Study|Lost to Follow-up|6|||
155162258|NCT02223858|560029826|FG001|Overall Study|Lost to Follow-up|11|||
155162259|NCT02223858|560029825|FG000|Overall Study|Withdrawal by Subject|8|||
155162260|NCT02223858|560029826|FG001|Overall Study|Withdrawal by Subject|5|||
155162261|NCT02223858|560029825|FG000|Overall Study|Refused|9|||
155162262|NCT02223858|560029826|FG001|Overall Study|Refused|9|||
155162263|NCT01532986|560029833|FG000|Overall Study|Death|9|||
155162264|NCT01532986|560029834|FG001|Overall Study|Death|9|||
155162265|NCT01532986|560029833|FG000|Overall Study|Withdrawal by Subject|7|||
155162266|NCT01532986|560029834|FG001|Overall Study|Withdrawal by Subject|10|||
155162267|NCT01532986|560029833|FG000|Overall Study|Physician Decision|7|||
155162268|NCT01532986|560029834|FG001|Overall Study|Physician Decision|5|||
155162269|NCT00831181|560029835|FG000|Overall Study|Adverse Event|12|||
155162270|NCT04313244|560029836|FG000|Overall Study|Withdrawal of Consent|3|||
155162271|NCT04313244|560029837|FG001|Overall Study|Withdrawal of Consent|3|||
155162272|NCT04313244|560029836|FG000|Overall Study|Met Exclusion Criteria|1|||
155162273|NCT04313244|560029837|FG001|Overall Study|Met Exclusion Criteria|0|||
155162274|NCT04313244|560029836|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
155162275|NCT04313244|560029837|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
155162276|NCT00927953|560029838|FG000|Overall Study|Death|2|||
155162277|NCT00927953|560029839|FG001|Overall Study|Death|1|||
155162278|NCT02976038|560029840|FG000|Overall Study|Physician Decision|22|||
155162279|NCT02976038|560029840|FG000|Overall Study|Withdrawal by Subject|3|||
155162280|NCT02976038|560029840|FG000|Overall Study|Lost to Follow-up|2|||
155162281|NCT02976038|560029840|FG000|Overall Study|Adverse Event|1|||
155162282|NCT00724698|560029841|FG000|Overall Study|Adverse Event|9|||
155162283|NCT00724698|560029841|FG000|Overall Study|Failure of Therapy|4|||
155162284|NCT00724698|560029841|FG000|Overall Study|Poor Compliance|16|||
155162285|NCT00724698|560029841|FG000|Overall Study|Lost to Follow-up|36|||
155162286|NCT00724698|560029841|FG000|Overall Study|No Info|25|||
155162287|NCT01995838|560029844|FG000|Overall Study|Lost to Follow-up|0|||
155162288|NCT01995838|560029845|FG001|Overall Study|Lost to Follow-up|1|||
155162289|NCT01995838|560029846|FG002|Overall Study|Lost to Follow-up|0|||
155162290|NCT01995838|560029847|FG003|Overall Study|Lost to Follow-up|0|||
155162291|NCT01995838|560029848|FG004|Overall Study|Lost to Follow-up|0|||
155162292|NCT01995838|560029849|FG005|Overall Study|Lost to Follow-up|0|||
155162293|NCT01995838|560029850|FG006|Overall Study|Lost to Follow-up|1|||
155162294|NCT01995838|560029844|FG000|Overall Study|Participant choice|2|||
155162295|NCT01995838|560029845|FG001|Overall Study|Participant choice|0|||
155313426|NCT04810650|560579597|FG007|Overall Study|Participant declined|0|||
155313427|NCT04810650|560579598|FG008|Overall Study|Participant declined|0|||
155313428|NCT04810650|560579599|FG009|Overall Study|Participant declined|0|||
155313429|NCT04810650|560579600|FG010|Overall Study|Participant declined|2|||
155313430|NCT04810650|560579601|FG011|Overall Study|Participant declined|0|||
155313431|NCT04810650|560579602|FG012|Overall Study|Participant declined|0|||
155313432|NCT04810650|560579603|FG013|Overall Study|Participant declined|0|||
155313433|NCT05794243|560579604|FG000|Overall Study|Withdrawal by Subject|1|||
155313434|NCT05794243|560579605|FG001|Overall Study|Withdrawal by Subject|0|||
155313435|NCT05794243|560579606|FG002|Overall Study|Withdrawal by Subject|1|||
155313436|NCT05794243|560579604|FG000|Overall Study|Physician Decision|0|||
155313437|NCT05794243|560579605|FG001|Overall Study|Physician Decision|3|||
155313438|NCT05794243|560579606|FG002|Overall Study|Physician Decision|1|||
155313439|NCT02761057|560579607|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
155313440|NCT02761057|560579608|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
155313441|NCT02761057|560579609|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
155313442|NCT02761057|560579610|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
155313443|NCT02761057|560579607|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
155313444|NCT02761057|560579608|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
155313445|NCT02761057|560579609|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
155313446|NCT02761057|560579610|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
155313447|NCT02761057|560579607|FG000|Overall Study|Currently On Study Treatment|0|||
155313448|NCT02761057|560579608|FG001|Overall Study|Currently On Study Treatment|3|||
155313449|NCT02761057|560579609|FG002|Overall Study|Currently On Study Treatment|0|||
155313450|NCT02761057|560579610|FG003|Overall Study|Currently On Study Treatment|0|||
155313451|NCT02761057|560579607|FG000|Overall Study|Adverse Event|11|||
155313452|NCT02761057|560579608|FG001|Overall Study|Adverse Event|9|||
155313453|NCT02761057|560579609|FG002|Overall Study|Adverse Event|5|||
155313454|NCT02761057|560579610|FG003|Overall Study|Adverse Event|3|||
155313455|NCT02761057|560579607|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
155313456|NCT02761057|560579608|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
155313457|NCT02761057|560579609|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
155313458|NCT02761057|560579610|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
155313459|NCT02761057|560579607|FG000|Overall Study|Progression/Relapse|29|||
155313460|NCT02761057|560579608|FG001|Overall Study|Progression/Relapse|27|||
155313461|NCT02761057|560579609|FG002|Overall Study|Progression/Relapse|20|||
155313462|NCT02761057|560579610|FG003|Overall Study|Progression/Relapse|23|||
155313463|NCT02761057|560579607|FG000|Overall Study|Death|2|||
155313464|NCT02761057|560579608|FG001|Overall Study|Death|2|||
155313465|NCT02761057|560579609|FG002|Overall Study|Death|1|||
155313466|NCT02761057|560579610|FG003|Overall Study|Death|1|||
155313467|NCT02761057|560579607|FG000|Overall Study|Other - Not Protocol Specified|2|||
155313468|NCT02761057|560579608|FG001|Overall Study|Other - Not Protocol Specified|1|||
155313469|NCT02761057|560579609|FG002|Overall Study|Other - Not Protocol Specified|2|||
155313470|NCT02761057|560579610|FG003|Overall Study|Other - Not Protocol Specified|0|||
155313471|NCT02727699|560581339|FG000|Overall Study|Adverse Event|2|||
155313472|NCT02727699|560581340|FG001|Overall Study|Adverse Event|0|||
155313473|NCT02727699|560581339|FG000|Overall Study|Withdrawal by Subject|5|||
155313474|NCT02727699|560581340|FG001|Overall Study|Withdrawal by Subject|3|||
155313475|NCT02727699|560581339|FG000|Overall Study|Protocol Violation|0|||
155313476|NCT02727699|560581340|FG001|Overall Study|Protocol Violation|1|||
155313477|NCT02727699|560581339|FG000|Overall Study|Physician Decision|0|||
155313478|NCT02727699|560581340|FG001|Overall Study|Physician Decision|1|||
155313479|NCT02727699|560581339|FG000|Overall Study|Lost to Follow-up|1|||
155313480|NCT02727699|560581340|FG001|Overall Study|Lost to Follow-up|0|||
155313481|NCT02727699|560581339|FG000|Overall Study|Sponsor Decision|1|||
155313482|NCT02727699|560581340|FG001|Overall Study|Sponsor Decision|0|||
155313483|NCT04806594|560581354|FG000|Overall Study|Withdrawal by Subject|2|||
155313484|NCT04806594|560581354|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
155313485|NCT04318548|560581355|FG000|Overall Study|Adverse Event|0|||
155313486|NCT04318548|560581356|FG001|Overall Study|Adverse Event|0|||
155313487|NCT04318548|560581357|FG002|Overall Study|Adverse Event|1|||
155313488|NCT04318548|560581355|FG000|Overall Study|Lost to Follow-up|6|||
155313489|NCT04318548|560581356|FG001|Overall Study|Lost to Follow-up|13|||
155313490|NCT04318548|560581357|FG002|Overall Study|Lost to Follow-up|9|||
155313491|NCT04318548|560581355|FG000|Overall Study|Protocol Violation|1|||
155313492|NCT04318548|560581356|FG001|Overall Study|Protocol Violation|0|||
155313493|NCT04318548|560581357|FG002|Overall Study|Protocol Violation|2|||
155313494|NCT04318548|560581355|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
155313495|NCT04318548|560581356|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
155313496|NCT04318548|560581357|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
155313497|NCT04318548|560581355|FG000|Overall Study|Migrated / moved from the study area|0|||
155313498|NCT04318548|560581356|FG001|Overall Study|Migrated / moved from the study area|0|||
155313499|NCT04318548|560581357|FG002|Overall Study|Migrated / moved from the study area|1|||
155313500|NCT04318548|560581355|FG000|Overall Study|Other|1|||
155313501|NCT04318548|560581356|FG001|Overall Study|Other|2|||
155313502|NCT04318548|560581357|FG002|Overall Study|Other|3|||
155313503|NCT02120456|560581361|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313504|NCT02120456|560581362|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313505|NCT02120456|560581363|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313506|NCT02120456|560581364|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313507|NCT02120456|560581365|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313508|NCT02120456|560581366|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313509|NCT02120456|560581367|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
155313510|NCT02120456|560581368|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313511|NCT02120456|560581369|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
155313512|NCT02120456|560581361|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313513|NCT02120456|560581362|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313514|NCT02120456|560581363|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313515|NCT02120456|560581364|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313516|NCT02120456|560581365|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313517|NCT02120456|560581366|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313518|NCT02120456|560581367|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
155313519|NCT02120456|560581368|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313520|NCT02120456|560581369|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
155313521|NCT02120456|560581361|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313522|NCT02120456|560581362|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313523|NCT02120456|560581363|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313524|NCT02120456|560581364|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313525|NCT02120456|560581365|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313526|NCT02120456|560581366|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313527|NCT02120456|560581367|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313528|NCT02120456|560581368|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
155313529|NCT02120456|560581369|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
155313530|NCT05192200|560581370|FG000|Treatment Period|Other|1|||
155313531|NCT05192200|560581370|FG000|Treatment Period|Lack of Efficacy|1|||
155313532|NCT05192200|560581370|FG000|Treatment Period|Withdrawal by Subject|1|||
155313533|NCT05192200|560581370|FG000|Follow-up|Withdrawal by Subject|1|||
155313534|NCT03445988|560581376|FG000|Overall Study|Lost to Follow-up|14|||
155313535|NCT03445988|560581377|FG001|Overall Study|Lost to Follow-up|26|||
155313536|NCT03445988|560581378|FG002|Overall Study|Lost to Follow-up|27|||
155313537|NCT03445988|560581379|FG003|Overall Study|Lost to Follow-up|66|||
155313538|NCT03445988|560581376|FG000|Overall Study|Withdrawal by Subject|7|||
155313539|NCT03445988|560581377|FG001|Overall Study|Withdrawal by Subject|4|||
155313540|NCT03445988|560581378|FG002|Overall Study|Withdrawal by Subject|3|||
155313541|NCT03445988|560581379|FG003|Overall Study|Withdrawal by Subject|5|||
155313542|NCT03445988|560581376|FG000|Overall Study|Death (unrelated to study)|5|||
155313543|NCT03445988|560581377|FG001|Overall Study|Death (unrelated to study)|1|||
155313544|NCT03445988|560581378|FG002|Overall Study|Death (unrelated to study)|2|||
155313545|NCT03445988|560581379|FG003|Overall Study|Death (unrelated to study)|4|||
155313546|NCT04274764|560581390|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
155313547|NCT04274764|560581391|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
155313548|NCT03611621|560581407|FG000|Overall Study|Graft loss|3|||
155313549|NCT03611621|560581407|FG000|Overall Study|Death|3|||
155313550|NCT03611621|560581407|FG000|Overall Study|Lost to Follow-up|1|||
155313551|NCT04764448|560581410|FG000|Overall Study|Study terminated by sponsor|2|||
155313552|NCT04764448|560581411|FG001|Overall Study|Study terminated by sponsor|2|||
155313553|NCT04764448|560581412|FG002|Overall Study|Study terminated by sponsor|5|||
155313554|NCT04764448|560581410|FG000|Overall Study|Withdrawal by Subject|3|||
155313555|NCT04764448|560581411|FG001|Overall Study|Withdrawal by Subject|3|||
155313556|NCT04764448|560581412|FG002|Overall Study|Withdrawal by Subject|1|||
155313557|NCT02975882|560581414|FG000|Overall Study|Adverse Event|1|||
155313558|NCT02975882|560581415|FG001|Overall Study|Adverse Event|2|||
155313559|NCT02975882|560581416|FG002|Overall Study|Adverse Event|1|||
155313560|NCT02975882|560581417|FG003|Overall Study|Adverse Event|1|||
154959918|NCT00934050|559278642|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
154959919|NCT00934050|559278643|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
155313561|NCT02975882|560581414|FG000|Overall Study|Death|0|||
155313562|NCT02975882|560581415|FG001|Overall Study|Death|1|||
155313563|NCT02975882|560581416|FG002|Overall Study|Death|0|||
155313564|NCT02975882|560581417|FG003|Overall Study|Death|0|||
155313565|NCT02975882|560581414|FG000|Overall Study|Lack of Efficacy|3|||
155313566|NCT02975882|560581415|FG001|Overall Study|Lack of Efficacy|7|||
155313567|NCT02975882|560581416|FG002|Overall Study|Lack of Efficacy|4|||
155313568|NCT02975882|560581417|FG003|Overall Study|Lack of Efficacy|3|||
155313569|NCT02975882|560581414|FG000|Overall Study|Physician Decision|0|||
155313570|NCT02975882|560581415|FG001|Overall Study|Physician Decision|2|||
155313571|NCT02975882|560581416|FG002|Overall Study|Physician Decision|4|||
155313572|NCT02975882|560581417|FG003|Overall Study|Physician Decision|2|||
155313573|NCT02975882|560581414|FG000|Overall Study|Ineligible|0|||
155313574|NCT02975882|560581415|FG001|Overall Study|Ineligible|1|||
155313575|NCT02975882|560581416|FG002|Overall Study|Ineligible|0|||
155313576|NCT02975882|560581417|FG003|Overall Study|Ineligible|0|||
155313577|NCT03936322|560581418|FG000|Overall Study|Lost to Follow-up|1|||
155313578|NCT03936322|560581418|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
155313579|NCT01160211|560581420|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
155313580|NCT01160211|560581421|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
155313581|NCT01160211|560581422|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
155313582|NCT01160211|560581420|FG000|Overall Study|Lost to Follow-up|4|||
155313583|NCT01160211|560581421|FG001|Overall Study|Lost to Follow-up|8|||
155313584|NCT01160211|560581422|FG002|Overall Study|Lost to Follow-up|4|||
155313585|NCT01160211|560581420|FG000|Overall Study|Physician Decision|1|||
155313586|NCT01160211|560581421|FG001|Overall Study|Physician Decision|0|||
155313587|NCT01160211|560581422|FG002|Overall Study|Physician Decision|0|||
155313588|NCT01160211|560581420|FG000|Overall Study|Withdrawal by Subject|4|||
155313589|NCT01160211|560581421|FG001|Overall Study|Withdrawal by Subject|2|||
155313590|NCT01160211|560581422|FG002|Overall Study|Withdrawal by Subject|2|||
155313591|NCT01160211|560581420|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
155313592|NCT01160211|560581421|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
155313593|NCT01160211|560581422|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
155313594|NCT02734290|560581423|FG000|Overall Study|Adverse Event|1|||
155313595|NCT02734290|560581424|FG001|Overall Study|Adverse Event|0|||
155313596|NCT02734290|560581423|FG000|Overall Study|Death|1|||
155313597|NCT02734290|560581424|FG001|Overall Study|Death|0|||
155313598|NCT03829410|560581426|FG000|Overall Study|Adverse Event|1|||
155313599|NCT03829410|560581427|FG001|Overall Study|Adverse Event|0|||
155313600|NCT03829410|560581428|FG002|Overall Study|Adverse Event|1|||
155313601|NCT03829410|560581429|FG003|Overall Study|Adverse Event|4|||
155313602|NCT03829410|560581426|FG000|Overall Study|Physician Decision|0|||
155313603|NCT03829410|560581427|FG001|Overall Study|Physician Decision|0|||
155313604|NCT03829410|560581428|FG002|Overall Study|Physician Decision|0|||
155313605|NCT03829410|560581429|FG003|Overall Study|Physician Decision|2|||
155313606|NCT03829410|560581426|FG000|Overall Study|Disease Progressing|3|||
155313607|NCT03829410|560581427|FG001|Overall Study|Disease Progressing|4|||
155313608|NCT03829410|560581428|FG002|Overall Study|Disease Progressing|2|||
155313609|NCT03829410|560581429|FG003|Overall Study|Disease Progressing|31|||
155313610|NCT03829410|560581426|FG000|Overall Study|Miscellaneous|2|||
155313611|NCT03829410|560581427|FG001|Overall Study|Miscellaneous|4|||
155313612|NCT03829410|560581428|FG002|Overall Study|Miscellaneous|3|||
155313613|NCT03829410|560581429|FG003|Overall Study|Miscellaneous|10|||
155313614|NCT03158129|560581430|FG000|Overall Study|Adverse Event|0|||
155313615|NCT03158129|560581431|FG001|Overall Study|Adverse Event|1|||
155313616|NCT03158129|560581432|FG002|Overall Study|Adverse Event|0|||
155313617|NCT03158129|560581433|FG003|Overall Study|Adverse Event|0|||
155313618|NCT03158129|560581430|FG000|Overall Study|Death|0|||
155313619|NCT03158129|560581431|FG001|Overall Study|Death|0|||
155313620|NCT03158129|560581432|FG002|Overall Study|Death|0|||
155313621|NCT03158129|560581433|FG003|Overall Study|Death|1|||
155313622|NCT03158129|560581430|FG000|Overall Study|High surgical risk|1|||
155313623|NCT03158129|560581431|FG001|Overall Study|High surgical risk|1|||
155313624|NCT03158129|560581432|FG002|Overall Study|High surgical risk|0|||
155313625|NCT03158129|560581433|FG003|Overall Study|High surgical risk|0|||
155313626|NCT03158129|560581430|FG000|Overall Study|Progression|1|||
155313627|NCT03158129|560581431|FG001|Overall Study|Progression|1|||
155313628|NCT03158129|560581432|FG002|Overall Study|Progression|0|||
155313629|NCT03158129|560581433|FG003|Overall Study|Progression|0|||
155313630|NCT03158129|560581430|FG000|Overall Study|Lack of resectability|0|||
155313631|NCT03158129|560581431|FG001|Overall Study|Lack of resectability|1|||
155313632|NCT03158129|560581432|FG002|Overall Study|Lack of resectability|0|||
155313633|NCT03158129|560581433|FG003|Overall Study|Lack of resectability|0|||
155313634|NCT03158129|560581430|FG000|Overall Study|Declined surgery|0|||
155313635|NCT03158129|560581431|FG001|Overall Study|Declined surgery|1|||
155313636|NCT03158129|560581432|FG002|Overall Study|Declined surgery|0|||
155313637|NCT03158129|560581433|FG003|Overall Study|Declined surgery|0|||
155313638|NCT03158129|560581430|FG000|Overall Study|No longer surgical candidate|0|||
155313639|NCT03158129|560581431|FG001|Overall Study|No longer surgical candidate|0|||
155313640|NCT03158129|560581432|FG002|Overall Study|No longer surgical candidate|0|||
155313641|NCT03158129|560581433|FG003|Overall Study|No longer surgical candidate|1|||
155313642|NCT06205407|560581438|FG000|Period 2|Withdrawal by Subject|0|||
155313643|NCT06205407|560581439|FG001|Period 2|Withdrawal by Subject|1|||
155313644|NCT06205407|560581438|FG000|Period 2|Adverse Event|2|||
154959920|NCT00934050|559278644|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155313645|NCT06205407|560581439|FG001|Period 2|Adverse Event|1|||
155313646|NCT06491433|560581440|FG000|Overall Study|Protocol Violation|51|||
155313647|NCT06491433|560581440|FG000|Overall Study|consent withdrawal|2|||
155313648|NCT06491433|560581440|FG000|Overall Study|screen failure|1|||
155313649|NCT04676022|560581444|FG000|Overall Study|Screen Failure/|1|||
155313650|NCT04676022|560581445|FG001|Overall Study|Screen Failure/|1|||
155313651|NCT04676022|560581446|FG002|Overall Study|Screen Failure/|85|||
155313652|NCT04676022|560581444|FG000|Overall Study|Lost to Follow-up|1|||
154959921|NCT00934050|559278645|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
155313653|NCT04676022|560581445|FG001|Overall Study|Lost to Follow-up|1|||
155313654|NCT04676022|560581446|FG002|Overall Study|Lost to Follow-up|0|||
155313655|NCT04676022|560581444|FG000|Overall Study|Adverse Event|2|||
155313656|NCT04676022|560581445|FG001|Overall Study|Adverse Event|0|||
155313657|NCT04676022|560581446|FG002|Overall Study|Adverse Event|1|||
155313658|NCT04676022|560581444|FG000|Overall Study|Physician Decision|2|||
155313659|NCT04676022|560581445|FG001|Overall Study|Physician Decision|0|||
155313660|NCT04676022|560581446|FG002|Overall Study|Physician Decision|1|||
155313661|NCT04676022|560581444|FG000|Overall Study|Withdrawal by Subject|3|||
155313662|NCT04676022|560581445|FG001|Overall Study|Withdrawal by Subject|1|||
155313663|NCT04676022|560581446|FG002|Overall Study|Withdrawal by Subject|6|||
155313664|NCT04676022|560581444|FG000|Overall Study|Will not move forward with permanent implant|6|||
155313665|NCT04676022|560581445|FG001|Overall Study|Will not move forward with permanent implant|0|||
155313666|NCT04676022|560581446|FG002|Overall Study|Will not move forward with permanent implant|0|||
155313667|NCT04676022|560581444|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
155313668|NCT04676022|560581445|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
155313669|NCT04676022|560581446|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
155313670|NCT02274662|560581464|FG000|Overall Study|Death|1|||
155313671|NCT02274662|560581464|FG000|Overall Study|Lost to Follow-up|3|||
155162296|NCT01995838|560029846|FG002|Overall Study|Participant choice|0|||
155313672|NCT03194217|560581465|FG000|Overall Study|Adverse Event|0|||
154959922|NCT00934050|559278640|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
155313673|NCT03194217|560581466|FG001|Overall Study|Adverse Event|2|||
155313674|NCT03194217|560581467|FG002|Overall Study|Adverse Event|3|||
155313675|NCT03194217|560581468|FG003|Overall Study|Adverse Event|3|||
155313676|NCT03194217|560581465|FG000|Overall Study|Failure to meet randomisation criteria|0|||
155313677|NCT03194217|560581466|FG001|Overall Study|Failure to meet randomisation criteria|0|||
155313678|NCT03194217|560581467|FG002|Overall Study|Failure to meet randomisation criteria|0|||
155313679|NCT03194217|560581468|FG003|Overall Study|Failure to meet randomisation criteria|1|||
155313680|NCT03194217|560581465|FG000|Overall Study|Other|0|||
155313681|NCT03194217|560581466|FG001|Overall Study|Other|1|||
155313682|NCT03194217|560581467|FG002|Overall Study|Other|1|||
155313683|NCT03194217|560581468|FG003|Overall Study|Other|0|||
155313684|NCT03134196|560581479|FG000|Overall Study|Death|2|||
155313685|NCT03134196|560581480|FG001|Overall Study|Death|1|||
155313686|NCT03134196|560581479|FG000|Overall Study|Lost to Follow-up|13|||
155313687|NCT03134196|560581480|FG001|Overall Study|Lost to Follow-up|15|||
155313688|NCT03134196|560581479|FG000|Overall Study|Physician Decision|0|||
155313689|NCT03134196|560581480|FG001|Overall Study|Physician Decision|1|||
155313690|NCT03134196|560581479|FG000|Overall Study|Withdrawal by Subject|19|||
155313691|NCT03134196|560581480|FG001|Overall Study|Withdrawal by Subject|12|||
155313692|NCT03134196|560581479|FG000|Overall Study|Site Unable to Contact Participant|2|||
155313693|NCT03134196|560581480|FG001|Overall Study|Site Unable to Contact Participant|0|||
155313694|NCT03134196|560581479|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
155313695|NCT03134196|560581480|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
155313696|NCT03134196|560581479|FG000|Overall Study|Scheduling Conflict|1|||
155313697|NCT03134196|560581480|FG001|Overall Study|Scheduling Conflict|0|||
155313698|NCT04683744|560581486|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
155313699|NCT04683744|560581487|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
155313700|NCT04683744|560581488|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
155313701|NCT04592549|560581491|FG000|Overall Study|Withdrawal by Subject|0|||
155313702|NCT04592549|560581492|FG001|Overall Study|Withdrawal by Subject|1|||
155313703|NCT04592549|560581493|FG002|Overall Study|Withdrawal by Subject|0|||
155313704|NCT04592549|560581494|FG003|Overall Study|Withdrawal by Subject|1|||
154959923|NCT00934050|559278641|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
155313705|NCT04592549|560581495|FG004|Overall Study|Withdrawal by Subject|1|||
155313706|NCT04592549|560581496|FG005|Overall Study|Withdrawal by Subject|0|||
154959924|NCT00934050|559278642|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
155313707|NCT04592549|560581491|FG000|Overall Study|Lost to Follow-up|2|||
155313708|NCT04592549|560581492|FG001|Overall Study|Lost to Follow-up|0|||
155313709|NCT04592549|560581493|FG002|Overall Study|Lost to Follow-up|0|||
154959925|NCT00934050|559278643|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
155313710|NCT04592549|560581494|FG003|Overall Study|Lost to Follow-up|1|||
155313711|NCT04592549|560581495|FG004|Overall Study|Lost to Follow-up|1|||
155313712|NCT04592549|560581496|FG005|Overall Study|Lost to Follow-up|1|||
155313713|NCT00686335|560581497|FG000|Run-in Period|Adverse Event|1|||
155313714|NCT00686335|560581497|FG000|Run-in Period|asthma exacerbation|1|||
155313715|NCT00686335|560581497|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
155313716|NCT05603143|560581500|FG000|Overall Study|Withdrew consent|6|||
155313717|NCT05603143|560581501|FG001|Overall Study|Withdrew consent|2|||
155313718|NCT05603143|560581500|FG000|Overall Study|Randomized but never treated|0|||
155313719|NCT05603143|560581501|FG001|Overall Study|Randomized but never treated|3|||
155313720|NCT05603143|560581500|FG000|Overall Study|Adverse Event|2|||
155313721|NCT05603143|560581501|FG001|Overall Study|Adverse Event|0|||
155313722|NCT05603143|560581500|FG000|Overall Study|Death|0|||
155313723|NCT05603143|560581501|FG001|Overall Study|Death|1|||
155313724|NCT05603143|560581500|FG000|Overall Study|Investigator's discretion|1|||
155313725|NCT05603143|560581501|FG001|Overall Study|Investigator's discretion|0|||
155313726|NCT05603143|560581500|FG000|Overall Study|Lost to Follow-up|0|||
155313727|NCT05603143|560581501|FG001|Overall Study|Lost to Follow-up|1|||
155313728|NCT05603143|560581500|FG000|Overall Study|Protocol Violation|0|||
155313729|NCT05603143|560581501|FG001|Overall Study|Protocol Violation|1|||
155313730|NCT03524612|560581506|FG000|Overall Study|Lack of Efficacy|10|||
155313731|NCT03524612|560581506|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
155313732|NCT03524612|560581506|FG000|Overall Study|Adverse Event|10|||
155313733|NCT03524612|560581506|FG000|Overall Study|Withdrawal by Subject|7|||
155313734|NCT03524612|560581506|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
155313735|NCT03524612|560581506|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
155313736|NCT03524612|560581506|FG000|Overall Study|New therapy for study indication|6|||
155313737|NCT03524612|560581506|FG000|Overall Study|Death|3|||
155313738|NCT03524612|560581506|FG000|Overall Study|Lost to Follow-up|2|||
155313739|NCT03524612|560581506|FG000|Overall Study|Protocol Violation|1|||
155313740|NCT05609760|560581507|FG000|Overall Study|Lost to Follow-up|0|||
155313741|NCT05609760|560581508|FG001|Overall Study|Lost to Follow-up|1|||
155313742|NCT05609760|560581507|FG000|Overall Study|Withdrawal by Subject|1|||
155313743|NCT05609760|560581508|FG001|Overall Study|Withdrawal by Subject|0|||
155313744|NCT03396588|560581511|FG000|Overall Study|Physician Decision|2|||
155313745|NCT03396588|560581512|FG001|Overall Study|Physician Decision|3|||
155313746|NCT05179395|560581513|FG000|Overall Study|Lack of Efficacy|1|||
155313747|NCT00812461|560581515|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
155313748|NCT00812461|560581516|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
155313749|NCT00812461|560581515|FG000|All Treated Patients|Adverse Event|8|||
155313750|NCT00812461|560581516|FG001|All Treated Patients|Adverse Event|15|||
155313751|NCT00812461|560581515|FG000|All Treated Patients|Lack of Efficacy|13|||
155313752|NCT00812461|560581516|FG001|All Treated Patients|Lack of Efficacy|7|||
155313753|NCT00812461|560581515|FG000|All Treated Patients|Non-compliance|6|||
155313754|NCT00812461|560581516|FG001|All Treated Patients|Non-compliance|9|||
155313755|NCT00812461|560581515|FG000|All Treated Patients|Protocol Violation|36|||
155313756|NCT00812461|560581516|FG001|All Treated Patients|Protocol Violation|27|||
155313757|NCT00812461|560581515|FG000|All Treated Patients|Withdrawal by Subject|45|||
155313758|NCT00812461|560581516|FG001|All Treated Patients|Withdrawal by Subject|54|||
155313759|NCT00812461|560581515|FG000|All Treated Patients|Lost to Follow-up|11|||
155313760|NCT00812461|560581516|FG001|All Treated Patients|Lost to Follow-up|14|||
155313761|NCT00812461|560581515|FG000|All Treated Patients|Other Reason|13|||
155313762|NCT00812461|560581516|FG001|All Treated Patients|Other Reason|21|||
155313763|NCT03891667|560583136|FG000|Overall Study|Physician Decision|1|||
155313764|NCT03891667|560583137|FG001|Overall Study|Physician Decision|1|||
155313765|NCT03891667|560583136|FG000|Overall Study|COVID related pause|1|||
155313766|NCT03891667|560583137|FG001|Overall Study|COVID related pause|0|||
155313767|NCT03891667|560583136|FG000|Overall Study|Withdrawal by Subject|0|||
155313768|NCT03891667|560583137|FG001|Overall Study|Withdrawal by Subject|1|||
155313769|NCT03891667|560583136|FG000|Overall Study|Adverse Event|0|||
155313770|NCT03891667|560583137|FG001|Overall Study|Adverse Event|1|||
155313771|NCT05659537|560583138|FG000|Overall Study|Adverse Event|5|||
155313772|NCT05659537|560583138|FG000|Overall Study|Lost to Follow-up|4|||
155313773|NCT05659537|560583138|FG000|Overall Study|Withdrawal by Subject|13|||
155313774|NCT05659537|560583138|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
155313775|NCT05659537|560583138|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
155313776|NCT05659537|560583138|FG000|Overall Study|Participant was suffering from anaemia|1|||
155313777|NCT00506519|560583144|FG000|Overall Study|Death|4|||
155313778|NCT00506519|560583145|FG001|Overall Study|Death|6|||
155313779|NCT00506519|560583146|FG002|Overall Study|Death|0|||
155313780|NCT00506519|560583144|FG000|Overall Study|Adverse Event|1|||
155313781|NCT00506519|560583145|FG001|Overall Study|Adverse Event|0|||
155313782|NCT00506519|560583146|FG002|Overall Study|Adverse Event|0|||
155313783|NCT02105766|560583147|FG000|Overall Study|Physician Decision|1|||
155313784|NCT02105766|560583148|FG001|Overall Study|Physician Decision|1|||
155313785|NCT02105766|560583149|FG002|Overall Study|Physician Decision|0|||
155313786|NCT02105766|560583147|FG000|Overall Study|Lost to Follow-up|2|||
155313787|NCT02105766|560583148|FG001|Overall Study|Lost to Follow-up|0|||
155313788|NCT02105766|560583149|FG002|Overall Study|Lost to Follow-up|0|||
155313789|NCT02105766|560583147|FG000|Overall Study|Death|1|||
155313790|NCT02105766|560583148|FG001|Overall Study|Death|1|||
155313791|NCT02105766|560583149|FG002|Overall Study|Death|0|||
155313792|NCT03867500|560583150|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
155313793|NCT02577835|560583151|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
155313794|NCT04749615|560583152|FG000|Overall Study|Lost to Follow-up|6|||
155313795|NCT04749615|560583153|FG001|Overall Study|Lost to Follow-up|10|||
155313796|NCT03611491|560583154|FG000|Overall Study|Lost to Follow-up|1|||
155313797|NCT05119023|560583156|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
155313798|NCT05119023|560583156|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
155313799|NCT05119023|560583156|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
155313800|NCT05409183|560583158|FG000|Complete Study|Adverse Event|1|||
155313801|NCT05409183|560583159|FG001|Complete Study|Adverse Event|2|||
155162297|NCT01995838|560029847|FG003|Overall Study|Participant choice|0|||
155313802|NCT05409183|560583158|FG000|Complete Study|Withdrawal by Subject|3|||
155313803|NCT05409183|560583159|FG001|Complete Study|Withdrawal by Subject|0|||
155313804|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
155313805|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
155313806|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
155313807|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313808|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313809|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313810|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
155313811|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313812|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
155313813|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313814|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313815|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313816|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313817|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
155313818|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313819|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
155313820|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
155313821|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313822|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313823|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313824|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
155313825|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
155313826|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313827|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313828|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313829|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313830|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313831|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
155313832|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313833|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
155313834|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313835|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313836|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313837|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313838|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
155313839|NCT02962895|560583160|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313840|NCT02962895|560583161|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313841|NCT02962895|560583162|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313842|NCT02962895|560583163|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
155313843|NCT02962895|560583164|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313844|NCT02962895|560583165|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
154959926|NCT00934050|559278644|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
155313845|NCT02962895|560583166|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
155313846|NCT02962895|560583160|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313847|NCT02962895|560583161|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313848|NCT02962895|560583162|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313849|NCT02962895|560583163|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313850|NCT02962895|560583164|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313851|NCT02962895|560583165|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
155313852|NCT02962895|560583166|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
155313853|NCT02962895|560583160|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313854|NCT02962895|560583161|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313855|NCT02962895|560583162|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313856|NCT02962895|560583163|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313857|NCT02962895|560583164|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
155313858|NCT02962895|560583165|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
155313859|NCT02962895|560583166|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
155313860|NCT02962895|560583160|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313861|NCT02962895|560583161|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313862|NCT02962895|560583162|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313863|NCT02962895|560583163|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313864|NCT02962895|560583164|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313865|NCT02962895|560583165|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
155313866|NCT02962895|560583166|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
155313867|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313868|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
155313869|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313870|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313871|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313872|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313873|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
155313874|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313875|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313876|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313877|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313878|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
155313879|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313880|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
155313881|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313882|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313883|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313884|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313885|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
155313886|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313887|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
155313888|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313889|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
155313890|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
155313891|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
155313892|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313893|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313894|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
155313895|NCT02962895|560583160|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
155313896|NCT02962895|560583161|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
155313897|NCT02962895|560583162|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
155313898|NCT02962895|560583163|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
155313899|NCT02962895|560583164|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
155313900|NCT02962895|560583165|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
154959927|NCT00934050|559278645|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
155162298|NCT01995838|560029848|FG004|Overall Study|Participant choice|0|||
155313901|NCT02962895|560583166|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
155313902|NCT04806451|560583167|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
155313903|NCT04806451|560583168|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
155313904|NCT04806451|560583167|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
155313905|NCT04806451|560583168|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
155313906|NCT04806451|560583167|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
155313907|NCT04806451|560583168|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
155313908|NCT02936752|560583169|FG000|Overall Study|Death|2|||
155313909|NCT02936752|560583170|FG001|Overall Study|Death|1|||
155313910|NCT02936752|560583169|FG000|Overall Study|Physician Decision|4|||
155313911|NCT02936752|560583170|FG001|Overall Study|Physician Decision|0|||
155313912|NCT02936752|560583169|FG000|Overall Study|Withdrawal by Subject|0|||
155313913|NCT02936752|560583170|FG001|Overall Study|Withdrawal by Subject|2|||
155313914|NCT05894577|560583173|FG000|Overall Study|No receipt of study drug|14|||
155313915|NCT05894577|560583174|FG001|Overall Study|No receipt of study drug|13|||
155313916|NCT05894577|560583173|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
155313917|NCT05894577|560583174|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
155313918|NCT05894577|560583173|FG000|Overall Study|Screen Fail|2|||
155313919|NCT05894577|560583174|FG001|Overall Study|Screen Fail|0|||
155313920|NCT05894577|560583173|FG000|Overall Study|Study drug recall|86|||
155313921|NCT05894577|560583174|FG001|Overall Study|Study drug recall|63|||
154959928|NCT00934050|559278640|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
154959929|NCT00934050|559278641|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155313922|NCT05292365|560583179|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
155313923|NCT05292365|560583180|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
155313924|NCT05292365|560583181|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
155313925|NCT05292365|560583182|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
155313926|NCT05282173|560583183|FG000|Overall Study|Missed|3|||
155313927|NCT05282173|560583184|FG001|Overall Study|Missed|2|||
155313928|NCT05282173|560583185|FG002|Overall Study|Missed|4|||
155313929|NCT02023866|560583195|FG000|Overall Study|Non-compliance|2|||
155313930|NCT02023866|560583195|FG000|Overall Study|Adverse Event|3|||
155313931|NCT02023866|560583195|FG000|Overall Study|Withdrawal by Subject|1|||
155313932|NCT01798498|560583203|FG000|Overall Study|Lost to Follow-up|1|||
155313933|NCT04295798|560583208|FG000|Overall Study|Lost to Follow-up|1|||
155313934|NCT03524118|560583211|FG000|Overall Study|Lost to Follow-up|0|||
155313935|NCT03524118|560583212|FG001|Overall Study|Lost to Follow-up|0|||
155313936|NCT03524118|560583213|FG002|Overall Study|Lost to Follow-up|0|||
155313937|NCT03524118|560583214|FG003|Overall Study|Lost to Follow-up|0|||
155313938|NCT03524118|560583215|FG004|Overall Study|Lost to Follow-up|1|||
155313939|NCT03524118|560583216|FG005|Overall Study|Lost to Follow-up|0|||
155313940|NCT03524118|560583211|FG000|Overall Study|Other|0|||
155313941|NCT03524118|560583212|FG001|Overall Study|Other|1|||
155313942|NCT03524118|560583213|FG002|Overall Study|Other|0|||
155313943|NCT03524118|560583214|FG003|Overall Study|Other|0|||
155313944|NCT03524118|560583215|FG004|Overall Study|Other|1|||
155313945|NCT03524118|560583216|FG005|Overall Study|Other|1|||
155313946|NCT03524118|560583211|FG000|Overall Study|Physician Decision|0|||
155313947|NCT03524118|560583212|FG001|Overall Study|Physician Decision|0|||
155313948|NCT03524118|560583213|FG002|Overall Study|Physician Decision|0|||
155313949|NCT03524118|560583214|FG003|Overall Study|Physician Decision|0|||
155313950|NCT03524118|560583215|FG004|Overall Study|Physician Decision|1|||
155313951|NCT03524118|560583216|FG005|Overall Study|Physician Decision|0|||
155313952|NCT03524118|560583211|FG000|Overall Study|Protocol Violation|0|||
155313953|NCT03524118|560583212|FG001|Overall Study|Protocol Violation|0|||
155313954|NCT03524118|560583213|FG002|Overall Study|Protocol Violation|1|||
155313955|NCT03524118|560583214|FG003|Overall Study|Protocol Violation|0|||
155313956|NCT03524118|560583215|FG004|Overall Study|Protocol Violation|1|||
155313957|NCT03524118|560583216|FG005|Overall Study|Protocol Violation|0|||
155313958|NCT03524118|560583211|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155313959|NCT03524118|560583212|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155313960|NCT03524118|560583213|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155313961|NCT03524118|560583214|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
155313962|NCT03524118|560583215|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
155313963|NCT03524118|560583216|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155313966|NCT04650269|560583220|FG000|Overall Study|Death|3|||
155313967|NCT04650269|560583220|FG000|Overall Study|Lost to Follow-up|6|||
155313968|NCT01437709|560583221|FG000|Overall Study|Adverse Event|0|||
155313969|NCT01437709|560583222|FG001|Overall Study|Adverse Event|1|||
155313970|NCT01437709|560583223|FG002|Overall Study|Adverse Event|0|||
155313971|NCT01437709|560583221|FG000|Overall Study|Pt trasnferred care|0|||
155313972|NCT01437709|560583222|FG001|Overall Study|Pt trasnferred care|1|||
155313973|NCT01437709|560583223|FG002|Overall Study|Pt trasnferred care|0|||
155313974|NCT04091750|560583224|FG000|Overall Study|Adverse Event|4|||
155313975|NCT04091750|560583224|FG000|Overall Study|Withdrawal by Subject|1|||
155313976|NCT02319759|560583225|FG000|Week 0 - 16|Lack of Efficacy|1|||
155313977|NCT02319759|560583226|FG001|Week 0 - 16|Lack of Efficacy|0|||
155313978|NCT02319759|560583227|FG002|Week 0 - 16|Lack of Efficacy|0|||
155313979|NCT02319759|560583228|FG003|Week 0 - 16|Lack of Efficacy|0|||
155313980|NCT02319759|560583229|FG004|Week 0 - 16|Lack of Efficacy|0|||
155313981|NCT02319759|560583225|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313982|NCT02319759|560583226|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313983|NCT02319759|560583227|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
155313984|NCT02319759|560583228|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313985|NCT02319759|560583229|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
155313986|NCT02319759|560583225|FG000|Week 16 - 24|Lack of Efficacy|1|||
155313987|NCT02319759|560583226|FG001|Week 16 - 24|Lack of Efficacy|0|||
155313988|NCT02319759|560583227|FG002|Week 16 - 24|Lack of Efficacy|1|||
155313989|NCT02319759|560583228|FG003|Week 16 - 24|Lack of Efficacy|0|||
155313990|NCT02319759|560583229|FG004|Week 16 - 24|Lack of Efficacy|0|||
155313991|NCT02319759|560583225|FG000|Week 16 - 24|Lost to Follow-up|1|||
155313992|NCT02319759|560583226|FG001|Week 16 - 24|Lost to Follow-up|0|||
155313993|NCT02319759|560583227|FG002|Week 16 - 24|Lost to Follow-up|0|||
155313994|NCT02319759|560583228|FG003|Week 16 - 24|Lost to Follow-up|0|||
155313995|NCT02319759|560583229|FG004|Week 16 - 24|Lost to Follow-up|0|||
155313996|NCT02319759|560583225|FG000|Week 16 - 24|Withdrawal by Subject|0|||
155313997|NCT02319759|560583226|FG001|Week 16 - 24|Withdrawal by Subject|0|||
155313998|NCT02319759|560583227|FG002|Week 16 - 24|Withdrawal by Subject|2|||
155313999|NCT02319759|560583228|FG003|Week 16 - 24|Withdrawal by Subject|0|||
155314000|NCT02319759|560583229|FG004|Week 16 - 24|Withdrawal by Subject|0|||
155314001|NCT02319759|560583225|FG000|Week 24 - 56|Adverse Event|0|||
155314002|NCT02319759|560583226|FG001|Week 24 - 56|Adverse Event|0|||
155314003|NCT02319759|560583227|FG002|Week 24 - 56|Adverse Event|2|||
155314004|NCT02319759|560583228|FG003|Week 24 - 56|Adverse Event|0|||
155314005|NCT02319759|560583229|FG004|Week 24 - 56|Adverse Event|0|||
155314006|NCT02319759|560583225|FG000|Week 24 - 56|Lack of Efficacy|0|||
155314007|NCT02319759|560583226|FG001|Week 24 - 56|Lack of Efficacy|0|||
155314008|NCT02319759|560583227|FG002|Week 24 - 56|Lack of Efficacy|0|||
155314009|NCT02319759|560583228|FG003|Week 24 - 56|Lack of Efficacy|2|||
155314010|NCT02319759|560583229|FG004|Week 24 - 56|Lack of Efficacy|1|||
155314011|NCT02319759|560583225|FG000|Week 24 - 56|Withdrawal by Subject|0|||
155314012|NCT02319759|560583226|FG001|Week 24 - 56|Withdrawal by Subject|1|||
155314013|NCT02319759|560583227|FG002|Week 24 - 56|Withdrawal by Subject|0|||
155314014|NCT02319759|560583228|FG003|Week 24 - 56|Withdrawal by Subject|0|||
155314015|NCT02319759|560583229|FG004|Week 24 - 56|Withdrawal by Subject|0|||
155314016|NCT02319759|560583225|FG000|Week 24 - 56|Lost to Follow-up|0|||
155314017|NCT02319759|560583226|FG001|Week 24 - 56|Lost to Follow-up|0|||
155314018|NCT02319759|560583227|FG002|Week 24 - 56|Lost to Follow-up|0|||
155314019|NCT02319759|560583228|FG003|Week 24 - 56|Lost to Follow-up|0|||
155314020|NCT02319759|560583229|FG004|Week 24 - 56|Lost to Follow-up|1|||
155314021|NCT01959425|560583230|FG000|Overall Study|Withdrawal by Subject|5|||
155314022|NCT01959425|560583231|FG001|Overall Study|Withdrawal by Subject|4|||
155314023|NCT01959425|560583230|FG000|Overall Study|Lost to Follow-up|1|||
155314024|NCT01959425|560583231|FG001|Overall Study|Lost to Follow-up|0|||
155314025|NCT01959425|560583230|FG000|Overall Study|Discontinued Subjects|6|||
155314026|NCT01959425|560583231|FG001|Overall Study|Discontinued Subjects|4|||
155314027|NCT04625283|560583237|FG000|Overall Study|post randomization exclusion|28|||
155314028|NCT04625283|560583238|FG001|Overall Study|post randomization exclusion|20|||
155314029|NCT02262728|560583239|FG000|Follow-up Phase (3 Years)|Death|0|||
155314030|NCT02262728|560583240|FG001|Follow-up Phase (3 Years)|Death|1|||
155314031|NCT02262728|560583239|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
155314032|NCT02262728|560583240|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
155314033|NCT02262728|560583239|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
155314034|NCT02262728|560583240|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
155314035|NCT01824394|560583241|FG000|Overall Study|Early Termination|1|||
155314036|NCT01824394|560583242|FG001|Overall Study|Early Termination|1|||
155314037|NCT01824394|560583243|FG002|Overall Study|Early Termination|3|||
155314038|NCT01824394|560583241|FG000|Overall Study|Withdrawn due to Study Termination|91|||
155314039|NCT01824394|560583242|FG001|Overall Study|Withdrawn due to Study Termination|83|||
155314040|NCT01824394|560583243|FG002|Overall Study|Withdrawn due to Study Termination|41|||
155314041|NCT01824394|560583241|FG000|Overall Study|Lost to Follow-up|0|||
155314042|NCT01824394|560583242|FG001|Overall Study|Lost to Follow-up|9|||
155314043|NCT01824394|560583243|FG002|Overall Study|Lost to Follow-up|3|||
155314044|NCT01824394|560583241|FG000|Overall Study|Death|3|||
155314045|NCT01824394|560583242|FG001|Overall Study|Death|2|||
155314046|NCT01824394|560583243|FG002|Overall Study|Death|4|||
155314047|NCT01824394|560583241|FG000|Overall Study|Discontinued Subjects|1|||
155314048|NCT01824394|560583242|FG001|Overall Study|Discontinued Subjects|1|||
155314049|NCT01824394|560583243|FG002|Overall Study|Discontinued Subjects|2|||
155314050|NCT01824394|560583241|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
155314051|NCT01824394|560583242|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
155314052|NCT01824394|560583243|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
155314053|NCT02619838|560583244|FG000|Overall Study|Lost to Follow-up|9|||
155314054|NCT02619838|560583244|FG000|Overall Study|Withdrawal by Subject|15|||
155314055|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
155314056|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
155314057|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
155314058|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
155314059|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
155314060|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
155314061|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
155314062|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
155314063|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
155314064|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
155314065|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
155314066|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
155314067|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
155314068|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
155314069|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
155314070|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
155314071|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
155314072|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
155314073|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
155314074|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
155314075|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
155314076|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
155314077|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
155314078|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
155314079|NCT01715285|560583245|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
155314080|NCT01715285|560583246|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
155314081|NCT01715285|560583247|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
155314082|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
155314083|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
155314084|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
155314085|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
155314086|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
155314087|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
155314088|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
155314089|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
155314090|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
155314091|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
155314092|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
155314093|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
155314094|NCT01715285|560583245|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
155314095|NCT01715285|560583246|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
155314096|NCT01715285|560583247|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
155314097|NCT05020249|560583248|FG000|Overall Study|Protocol Violation|1|||
155314098|NCT05020249|560583249|FG001|Overall Study|Protocol Violation|0|||
155314099|NCT04971681|560583253|FG000|Followup|Lost to Follow-up|1|||
155314100|NCT04971681|560583254|FG001|Followup|Lost to Follow-up|0|||
155314101|NCT06037369|560583257|FG000|Overall Study|Lost to Follow-up|0|||
155314102|NCT06037369|560583258|FG001|Overall Study|Lost to Follow-up|1|||
155314103|NCT05783102|560583259|FG000|Overall Study|Lost to Follow-up|1|||
155314104|NCT05783102|560583259|FG000|Overall Study|Withdrawal by Subject|2|||
155314105|NCT04505904|560583260|FG000|Overall Study|Withdrawal by Subject|1|||
155314106|NCT04505904|560583261|FG001|Overall Study|Withdrawal by Subject|2|||
155314107|NCT04505904|560583262|FG002|Overall Study|Withdrawal by Subject|0|||
155314108|NCT04505904|560583263|FG003|Overall Study|Withdrawal by Subject|0|||
155314109|NCT04505904|560583260|FG000|Overall Study|Physician Decision|1|||
155314110|NCT04505904|560583261|FG001|Overall Study|Physician Decision|0|||
155314111|NCT04505904|560583262|FG002|Overall Study|Physician Decision|0|||
155314112|NCT04505904|560583263|FG003|Overall Study|Physician Decision|0|||
155314113|NCT04505904|560583260|FG000|Overall Study|Adverse Event|0|||
155314114|NCT04505904|560583261|FG001|Overall Study|Adverse Event|1|||
155314115|NCT04505904|560583262|FG002|Overall Study|Adverse Event|0|||
155314116|NCT04505904|560583263|FG003|Overall Study|Adverse Event|0|||
155314117|NCT04277442|560583266|FG000|Overall Study|Death|1|||
155314118|NCT06181760|560583267|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
155314119|NCT06181760|560583268|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
155314120|NCT06181760|560583269|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
155314121|NCT06181760|560583270|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
155314122|NCT04938492|560583272|FG000|Overall Study|Lost to Follow-up|17|||
155314123|NCT04938492|560583273|FG001|Overall Study|Lost to Follow-up|18|||
155314124|NCT05084508|560583274|FG000|Overall Study|Lost to Follow-up|6|||
155314125|NCT05084508|560583275|FG001|Overall Study|Lost to Follow-up|3|||
155314126|NCT05084508|560583276|FG002|Overall Study|Lost to Follow-up|7|||
155314127|NCT05084508|560583277|FG003|Overall Study|Lost to Follow-up|3|||
155314128|NCT05084508|560583274|FG000|Overall Study|Withdrawal by Subject|0|||
155314129|NCT05084508|560583275|FG001|Overall Study|Withdrawal by Subject|2|||
155314130|NCT05084508|560583276|FG002|Overall Study|Withdrawal by Subject|3|||
155314131|NCT05084508|560583277|FG003|Overall Study|Withdrawal by Subject|1|||
155314132|NCT05084508|560583274|FG000|Overall Study|Other|0|||
155314133|NCT05084508|560583275|FG001|Overall Study|Other|0|||
155314134|NCT05084508|560583276|FG002|Overall Study|Other|0|||
155314135|NCT05084508|560583277|FG003|Overall Study|Other|1|||
155314136|NCT04137289|560583278|FG000|Overall Study|Death|0|||
155314137|NCT04137289|560583279|FG001|Overall Study|Death|0|||
155314138|NCT04137289|560583280|FG002|Overall Study|Death|0|||
155314139|NCT04137289|560583281|FG003|Overall Study|Death|0|||
155314140|NCT04137289|560583282|FG004|Overall Study|Death|0|||
155314141|NCT04137289|560583283|FG005|Overall Study|Death|0|||
155314142|NCT04137289|560583284|FG006|Overall Study|Death|1|||
155314143|NCT04137289|560583285|FG007|Overall Study|Death|0|||
155314144|NCT04137289|560583286|FG008|Overall Study|Death|0|||
155314145|NCT04137289|560583278|FG000|Overall Study|Clinical disease progression|0|||
155314146|NCT04137289|560583279|FG001|Overall Study|Clinical disease progression|0|||
155314147|NCT04137289|560583280|FG002|Overall Study|Clinical disease progression|0|||
155314148|NCT04137289|560583281|FG003|Overall Study|Clinical disease progression|4|||
155314149|NCT04137289|560583282|FG004|Overall Study|Clinical disease progression|4|||
155314150|NCT04137289|560583283|FG005|Overall Study|Clinical disease progression|2|||
155314151|NCT04137289|560583284|FG006|Overall Study|Clinical disease progression|5|||
155314152|NCT04137289|560583285|FG007|Overall Study|Clinical disease progression|1|||
155314153|NCT04137289|560583286|FG008|Overall Study|Clinical disease progression|0|||
155314154|NCT04137289|560583278|FG000|Overall Study|Lost to Follow-up|0|||
155314155|NCT04137289|560583279|FG001|Overall Study|Lost to Follow-up|0|||
155314156|NCT04137289|560583280|FG002|Overall Study|Lost to Follow-up|0|||
155314157|NCT04137289|560583281|FG003|Overall Study|Lost to Follow-up|1|||
155314158|NCT04137289|560583282|FG004|Overall Study|Lost to Follow-up|0|||
155314159|NCT04137289|560583283|FG005|Overall Study|Lost to Follow-up|0|||
155314160|NCT04137289|560583284|FG006|Overall Study|Lost to Follow-up|0|||
155314161|NCT04137289|560583285|FG007|Overall Study|Lost to Follow-up|0|||
155314162|NCT04137289|560583286|FG008|Overall Study|Lost to Follow-up|0|||
155314163|NCT04137289|560583278|FG000|Overall Study|Adverse Event|0|||
155314164|NCT04137289|560583279|FG001|Overall Study|Adverse Event|0|||
155314165|NCT04137289|560583280|FG002|Overall Study|Adverse Event|1|||
155314166|NCT04137289|560583281|FG003|Overall Study|Adverse Event|0|||
155314167|NCT04137289|560583282|FG004|Overall Study|Adverse Event|0|||
155314168|NCT04137289|560583283|FG005|Overall Study|Adverse Event|1|||
155314169|NCT04137289|560583284|FG006|Overall Study|Adverse Event|0|||
155314170|NCT04137289|560583285|FG007|Overall Study|Adverse Event|0|||
155314171|NCT04137289|560583286|FG008|Overall Study|Adverse Event|0|||
155314172|NCT04137289|560583278|FG000|Overall Study|Lack of clinical benefit|0|||
155314173|NCT04137289|560583279|FG001|Overall Study|Lack of clinical benefit|0|||
155314174|NCT04137289|560583280|FG002|Overall Study|Lack of clinical benefit|0|||
155314175|NCT04137289|560583281|FG003|Overall Study|Lack of clinical benefit|0|||
155314176|NCT04137289|560583282|FG004|Overall Study|Lack of clinical benefit|0|||
155314177|NCT04137289|560583283|FG005|Overall Study|Lack of clinical benefit|0|||
155314178|NCT04137289|560583284|FG006|Overall Study|Lack of clinical benefit|0|||
155314179|NCT04137289|560583285|FG007|Overall Study|Lack of clinical benefit|0|||
155314180|NCT04137289|560583286|FG008|Overall Study|Lack of clinical benefit|1|||
155314181|NCT04137289|560583278|FG000|Overall Study|Objective disease progression|1|||
155314182|NCT04137289|560583279|FG001|Overall Study|Objective disease progression|1|||
155314183|NCT04137289|560583280|FG002|Overall Study|Objective disease progression|6|||
155314184|NCT04137289|560583281|FG003|Overall Study|Objective disease progression|18|||
155314185|NCT04137289|560583282|FG004|Overall Study|Objective disease progression|12|||
155314186|NCT04137289|560583283|FG005|Overall Study|Objective disease progression|20|||
155314187|NCT04137289|560583284|FG006|Overall Study|Objective disease progression|18|||
155314188|NCT04137289|560583285|FG007|Overall Study|Objective disease progression|7|||
155314189|NCT04137289|560583286|FG008|Overall Study|Objective disease progression|6|||
155314190|NCT03931174|560583291|FG000|Providers|Staff left organization|26|||
155314191|NCT03931174|560583292|FG001|Providers|Staff left organization|25|||
155314192|NCT03931174|560583291|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
155314193|NCT03931174|560583292|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
155314194|NCT03931174|560583291|FG000|Providers|Lost to Follow-up|4|||
155314195|NCT03931174|560583292|FG001|Providers|Lost to Follow-up|4|||
155314196|NCT03931174|560583291|FG000|Patients|Post-consent screening failure|1|||
155314197|NCT03931174|560583292|FG001|Patients|Post-consent screening failure|1|||
155314198|NCT03931174|560583291|FG000|Patients|Death|1|||
155314199|NCT03931174|560583292|FG001|Patients|Death|1|||
155314200|NCT03931174|560583291|FG000|Patients|Lost to Follow-up|60|||
155314201|NCT03931174|560583292|FG001|Patients|Lost to Follow-up|89|||
155314202|NCT05386030|560583293|FG000|Overall Study|Death|1|||
155314203|NCT05386030|560583294|FG001|Overall Study|Death|0|||
155314204|NCT05386030|560583293|FG000|Overall Study|Physician Decision|2|||
155314205|NCT05386030|560583294|FG001|Overall Study|Physician Decision|1|||
155314206|NCT05386030|560583293|FG000|Overall Study|Lost to Follow-up|19|||
155314207|NCT05386030|560583294|FG001|Overall Study|Lost to Follow-up|7|||
155314208|NCT05386030|560583293|FG000|Overall Study|Withdrawal by Subject|20|||
155314209|NCT05386030|560583294|FG001|Overall Study|Withdrawal by Subject|10|||
155314210|NCT05386030|560583293|FG000|Overall Study|Eligibility criteria violation|1|||
155314211|NCT05386030|560583294|FG001|Overall Study|Eligibility criteria violation|1|||
155314212|NCT05386030|560583293|FG000|Overall Study|Personal Reasons|1|||
155314213|NCT05386030|560583294|FG001|Overall Study|Personal Reasons|0|||
155314214|NCT03213691|560583297|FG000|Overall Study|Adverse Event|2|||
155314215|NCT03213691|560583297|FG000|Overall Study|Death|3|||
155314216|NCT03213691|560583297|FG000|Overall Study|Physician Decision|1|||
155314217|NCT03213691|560583297|FG000|Overall Study|Progressive Disease|14|||
155314218|NCT03213691|560583297|FG000|Overall Study|Ineligible|1|||
155314219|NCT05302596|560583298|FG000|Overall Study|Withdrawal by Subject|1|||
155314220|NCT05302596|560583299|FG001|Overall Study|Withdrawal by Subject|1|||
155314221|NCT04977947|560585438|FG000|Overall Study|Lost to Follow-up|1|||
155314222|NCT04977947|560585439|FG001|Overall Study|Lost to Follow-up|1|||
155314223|NCT04029688|560585440|FG000|Overall Study|Death|8|||
155314224|NCT04029688|560585441|FG001|Overall Study|Death|3|||
155314225|NCT04029688|560585442|FG002|Overall Study|Death|6|||
155314226|NCT04029688|560585443|FG003|Overall Study|Death|2|||
155314227|NCT04029688|560585444|FG004|Overall Study|Death|5|||
155314228|NCT04029688|560585445|FG005|Overall Study|Death|0|||
155314229|NCT04029688|560585446|FG006|Overall Study|Death|2|||
155314230|NCT04029688|560585447|FG007|Overall Study|Death|3|||
155314231|NCT04029688|560585440|FG000|Overall Study|Study Terminated by Sponsor|0|||
155314232|NCT04029688|560585441|FG001|Overall Study|Study Terminated by Sponsor|0|||
155314233|NCT04029688|560585442|FG002|Overall Study|Study Terminated by Sponsor|0|||
155314234|NCT04029688|560585443|FG003|Overall Study|Study Terminated by Sponsor|0|||
155314235|NCT04029688|560585444|FG004|Overall Study|Study Terminated by Sponsor|1|||
155314236|NCT04029688|560585445|FG005|Overall Study|Study Terminated by Sponsor|3|||
155314237|NCT04029688|560585446|FG006|Overall Study|Study Terminated by Sponsor|1|||
155314238|NCT04029688|560585447|FG007|Overall Study|Study Terminated by Sponsor|3|||
155314239|NCT04029688|560585440|FG000|Overall Study|Withdrawal by Subject|0|||
155314240|NCT04029688|560585441|FG001|Overall Study|Withdrawal by Subject|0|||
155314241|NCT04029688|560585442|FG002|Overall Study|Withdrawal by Subject|0|||
155314242|NCT04029688|560585443|FG003|Overall Study|Withdrawal by Subject|1|||
155314243|NCT04029688|560585444|FG004|Overall Study|Withdrawal by Subject|0|||
155314244|NCT04029688|560585445|FG005|Overall Study|Withdrawal by Subject|0|||
155314245|NCT04029688|560585446|FG006|Overall Study|Withdrawal by Subject|0|||
155314246|NCT04029688|560585447|FG007|Overall Study|Withdrawal by Subject|0|||
155314247|NCT05875142|560585448|FG000|Overall Study|Lost to Follow-up|0|||
155314248|NCT05875142|560585449|FG001|Overall Study|Lost to Follow-up|1|||
155314249|NCT05875142|560585450|FG002|Overall Study|Lost to Follow-up|1|||
155314250|NCT03436290|560585451|FG000|Overall Study|Post-randomization Exclusion|1|||
155162299|NCT01995838|560029849|FG005|Overall Study|Participant choice|1|||
155162300|NCT01995838|560029850|FG006|Overall Study|Participant choice|1|||
155162301|NCT01995838|560029844|FG000|Overall Study|Adverse Event|0|||
155162302|NCT01995838|560029845|FG001|Overall Study|Adverse Event|0|||
155162303|NCT01995838|560029846|FG002|Overall Study|Adverse Event|0|||
155162304|NCT01995838|560029847|FG003|Overall Study|Adverse Event|0|||
155162305|NCT01995838|560029848|FG004|Overall Study|Adverse Event|0|||
155162306|NCT01995838|560029849|FG005|Overall Study|Adverse Event|0|||
155162307|NCT01995838|560029850|FG006|Overall Study|Adverse Event|1|||
155162308|NCT01995838|560029844|FG000|Overall Study|Withdrawal by Subject|0|||
155162309|NCT01995838|560029845|FG001|Overall Study|Withdrawal by Subject|0|||
155162310|NCT01995838|560029846|FG002|Overall Study|Withdrawal by Subject|0|||
155162311|NCT01995838|560029847|FG003|Overall Study|Withdrawal by Subject|0|||
155162312|NCT01995838|560029848|FG004|Overall Study|Withdrawal by Subject|1|||
155162313|NCT01995838|560029849|FG005|Overall Study|Withdrawal by Subject|0|||
155162314|NCT01995838|560029850|FG006|Overall Study|Withdrawal by Subject|0|||
155162315|NCT01995838|560029844|FG000|Overall Study|Other|3|||
155162316|NCT01995838|560029845|FG001|Overall Study|Other|1|||
155162317|NCT01995838|560029846|FG002|Overall Study|Other|0|||
155162318|NCT01995838|560029847|FG003|Overall Study|Other|2|||
155162319|NCT01995838|560029848|FG004|Overall Study|Other|1|||
155162320|NCT01995838|560029849|FG005|Overall Study|Other|1|||
155162321|NCT01995838|560029850|FG006|Overall Study|Other|2|||
155162322|NCT03196349|560029851|FG000|Overall Study|Did not receive study drug|0|||
155162323|NCT03196349|560029852|FG001|Overall Study|Did not receive study drug|1|||
155162324|NCT03196349|560029853|FG002|Overall Study|Did not receive study drug|2|||
155162325|NCT03196349|560029851|FG000|Overall Study|No data entered|2|||
155162326|NCT03196349|560029852|FG001|Overall Study|No data entered|4|||
155162327|NCT03196349|560029853|FG002|Overall Study|No data entered|0|||
155162328|NCT03196349|560029851|FG000|Overall Study|Study Terminated early|15|||
155162329|NCT03196349|560029852|FG001|Overall Study|Study Terminated early|9|||
155162330|NCT03196349|560029853|FG002|Overall Study|Study Terminated early|11|||
155162331|NCT02819804|560029854|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
155162332|NCT03967444|560029855|FG000|Overall Study|Lost to Follow-up|1|||
155162333|NCT03967444|560029856|FG001|Overall Study|Lost to Follow-up|2|||
155162334|NCT01821118|560029863|FG000|Overall Study|Death|0|||
155162335|NCT01821118|560029864|FG001|Overall Study|Death|1|||
155162336|NCT00318643|560029865|FG000|Overall Study|Adverse Event|0|||
155162337|NCT00318643|560029866|FG001|Overall Study|Adverse Event|0|||
155162338|NCT00318643|560029867|FG002|Overall Study|Adverse Event|0|||
155162339|NCT00318643|560029868|FG003|Overall Study|Adverse Event|0|||
155162340|NCT00318643|560029869|FG004|Overall Study|Adverse Event|1|||
155162341|NCT00318643|560029865|FG000|Overall Study|Participant's Decision|0|||
155162342|NCT00318643|560029866|FG001|Overall Study|Participant's Decision|0|||
155162343|NCT00318643|560029867|FG002|Overall Study|Participant's Decision|0|||
155162344|NCT00318643|560029868|FG003|Overall Study|Participant's Decision|0|||
155162345|NCT00318643|560029869|FG004|Overall Study|Participant's Decision|1|||
155162346|NCT00318643|560029865|FG000|Overall Study|Investigator's Decision|0|||
155162347|NCT00318643|560029866|FG001|Overall Study|Investigator's Decision|0|||
155162348|NCT00318643|560029867|FG002|Overall Study|Investigator's Decision|0|||
155162349|NCT00318643|560029868|FG003|Overall Study|Investigator's Decision|0|||
155162350|NCT00318643|560029869|FG004|Overall Study|Investigator's Decision|1|||
155162351|NCT01812252|560029870|FG000|Overall Study|Persistent Disease|1|||
155162352|NCT01812252|560029871|FG001|Overall Study|Persistent Disease|0|||
155162353|NCT01812252|560029870|FG000|Overall Study|Not transplanted|11|||
155162354|NCT01812252|560029871|FG001|Overall Study|Not transplanted|11|||
155162355|NCT01812252|560029870|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
155162356|NCT01812252|560029871|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
155162357|NCT01812252|560029870|FG000|Overall Study|Withdrawal by Subject|1|||
155162358|NCT01812252|560029871|FG001|Overall Study|Withdrawal by Subject|1|||
155162359|NCT01812252|560029870|FG000|Overall Study|Screen Failure|1|||
155162360|NCT01812252|560029871|FG001|Overall Study|Screen Failure|0|||
155162361|NCT01519921|560029872|FG000|Overall Study|Adverse Event|10|||
155162362|NCT01519921|560029873|FG001|Overall Study|Adverse Event|9|||
155162363|NCT01519921|560029872|FG000|Overall Study|Lack of Efficacy|4|||
155162364|NCT01519921|560029873|FG001|Overall Study|Lack of Efficacy|3|||
155162365|NCT01519921|560029872|FG000|Overall Study|Withdrawal by Subject|3|||
155162366|NCT01519921|560029873|FG001|Overall Study|Withdrawal by Subject|0|||
155162367|NCT01519921|560029872|FG000|Overall Study|Lost to Follow-up|2|||
155162368|NCT01519921|560029873|FG001|Overall Study|Lost to Follow-up|1|||
155162369|NCT01519921|560029872|FG000|Overall Study|Treatment refusal|2|||
155162370|NCT01519921|560029873|FG001|Overall Study|Treatment refusal|1|||
155162371|NCT01519921|560029872|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
155162372|NCT01519921|560029873|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
155162373|NCT01216189|560029874|FG000|Overall Study|Lost to Follow-up|21|||
155162374|NCT01216189|560029875|FG001|Overall Study|Lost to Follow-up|3|||
155162375|NCT01216189|560029874|FG000|Overall Study|Death|4|||
155314251|NCT03436290|560585452|FG001|Overall Study|Post-randomization Exclusion|0|||
155314252|NCT03436290|560585451|FG000|Overall Study|Death|6|||
155314253|NCT03436290|560585452|FG001|Overall Study|Death|0|||
155314254|NCT03436290|560585451|FG000|Overall Study|Withdrawal by Subject|4|||
155314255|NCT03436290|560585452|FG001|Overall Study|Withdrawal by Subject|0|||
155314256|NCT03436290|560585451|FG000|Overall Study|Protocol Violation|30|||
155314257|NCT03436290|560585452|FG001|Overall Study|Protocol Violation|0|||
155314258|NCT02677298|560585453|FG000|Double Blind Phase|Adverse Event|2|||
155314259|NCT02677298|560585454|FG001|Double Blind Phase|Adverse Event|1|||
155314260|NCT02677298|560585455|FG002|Double Blind Phase|Adverse Event|0|||
155314261|NCT02677298|560585453|FG000|Double Blind Phase|Physician Decision|5|||
155314262|NCT02677298|560585454|FG001|Double Blind Phase|Physician Decision|0|||
155314263|NCT02677298|560585455|FG002|Double Blind Phase|Physician Decision|0|||
155314264|NCT02677298|560585453|FG000|Double Blind Phase|Lost to Follow-up|11|||
155314265|NCT02677298|560585454|FG001|Double Blind Phase|Lost to Follow-up|7|||
155314266|NCT02677298|560585455|FG002|Double Blind Phase|Lost to Follow-up|0|||
155314267|NCT02677298|560585453|FG000|Double Blind Phase|Withdrawal by Subject|11|||
155314268|NCT02677298|560585454|FG001|Double Blind Phase|Withdrawal by Subject|8|||
155314269|NCT02677298|560585455|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155314270|NCT02677298|560585453|FG000|Double Blind Phase|No study drug available at site|0|||
155314271|NCT02677298|560585454|FG001|Double Blind Phase|No study drug available at site|1|||
155314272|NCT02677298|560585455|FG002|Double Blind Phase|No study drug available at site|0|||
155162376|NCT01216189|560029875|FG001|Overall Study|Death|2|||
155162377|NCT00960999|560029878|FG000|Overall Study|Withdrawal by Subject|1|||
155314273|NCT02677298|560585453|FG000|Open Label Phase|Adverse Event|0|||
155314274|NCT02677298|560585454|FG001|Open Label Phase|Adverse Event|0|||
155314275|NCT02677298|560585455|FG002|Open Label Phase|Adverse Event|4|||
155314276|NCT02677298|560585453|FG000|Open Label Phase|Physician Decision|0|||
155314277|NCT02677298|560585454|FG001|Open Label Phase|Physician Decision|0|||
155314278|NCT02677298|560585455|FG002|Open Label Phase|Physician Decision|1|||
155314279|NCT02677298|560585453|FG000|Open Label Phase|Lost to Follow-up|0|||
155314280|NCT02677298|560585454|FG001|Open Label Phase|Lost to Follow-up|0|||
155314281|NCT02677298|560585455|FG002|Open Label Phase|Lost to Follow-up|17|||
155314282|NCT02677298|560585453|FG000|Open Label Phase|Withdrawal by Subject|0|||
155314283|NCT02677298|560585454|FG001|Open Label Phase|Withdrawal by Subject|0|||
155314284|NCT02677298|560585455|FG002|Open Label Phase|Withdrawal by Subject|38|||
155314285|NCT04130438|560585456|FG000|Overall Study|Lost to Follow-up|0|||
155314286|NCT04130438|560585457|FG001|Overall Study|Lost to Follow-up|0|||
155314287|NCT04130438|560585458|FG002|Overall Study|Lost to Follow-up|1|||
155314288|NCT03988608|560585460|FG000|Overall Study|Adverse Event|1|||
155314289|NCT03988608|560585460|FG000|Overall Study|Lost to Follow-up|1|||
155314290|NCT03988608|560585460|FG000|Overall Study|Withdrawal by Subject|3|||
155314291|NCT03988608|560585460|FG000|Overall Study|Death|1|||
155314292|NCT03338933|560585465|FG000|Screening Visit|Lost to Follow-up|1|||
155314293|NCT03338933|560585466|FG001|Screening Visit|Lost to Follow-up|3|||
155314294|NCT03338933|560585467|FG002|Screening Visit|Lost to Follow-up|1|||
155314295|NCT03338933|560585468|FG003|Screening Visit|Lost to Follow-up|4|||
155314296|NCT03338933|560585465|FG000|Screening Visit|Screen fail after consent|2|||
155314297|NCT03338933|560585466|FG001|Screening Visit|Screen fail after consent|7|||
155314298|NCT03338933|560585467|FG002|Screening Visit|Screen fail after consent|1|||
155314299|NCT03338933|560585468|FG003|Screening Visit|Screen fail after consent|4|||
155314300|NCT03338933|560585465|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
155314301|NCT03338933|560585466|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
155314302|NCT03338933|560585467|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
155314303|NCT03338933|560585468|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
155314304|NCT03338933|560585465|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
155314305|NCT03338933|560585466|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
155314306|NCT03338933|560585467|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
155314307|NCT03338933|560585468|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
155314308|NCT03338933|560585465|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
155314309|NCT03338933|560585466|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
155314310|NCT03338933|560585467|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
155314311|NCT03338933|560585468|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
155314312|NCT04515576|560585469|FG000|Overall Study|Withdrawal by Subject|0|||
155314313|NCT04515576|560585470|FG001|Overall Study|Withdrawal by Subject|0|||
155314314|NCT04515576|560585471|FG002|Overall Study|Withdrawal by Subject|0|||
155314315|NCT04515576|560585472|FG003|Overall Study|Withdrawal by Subject|0|||
155314316|NCT04515576|560585473|FG004|Overall Study|Withdrawal by Subject|0|||
155314317|NCT04515576|560585474|FG005|Overall Study|Withdrawal by Subject|1|||
155314318|NCT03812679|560585475|FG000|Overall Study|Adverse Event|2|||
155314319|NCT03812679|560585475|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
155314320|NCT03812679|560585475|FG000|Overall Study|Renal transplant|1|||
155314321|NCT03812679|560585475|FG000|Overall Study|Withdrawal by Subject|1|||
155314322|NCT03812679|560585475|FG000|Overall Study|Termination of study|2|||
155314323|NCT03812679|560585475|FG000|Overall Study|Water device replacement|1|||
155314324|NCT02140554|560585482|FG000|Overall Study|Withdrawal of consent|1|||
155314325|NCT02140554|560585483|FG001|Overall Study|Withdrawal of consent|0|||
155314326|NCT02140554|560585484|FG002|Overall Study|Withdrawal of consent|4|||
155314327|NCT02140554|560585482|FG000|Overall Study|Physician Decision|1|||
155314328|NCT02140554|560585483|FG001|Overall Study|Physician Decision|0|||
155314329|NCT02140554|560585484|FG002|Overall Study|Physician Decision|2|||
155314330|NCT02140554|560585482|FG000|Overall Study|Death|0|||
155314331|NCT02140554|560585483|FG001|Overall Study|Death|0|||
155314332|NCT02140554|560585484|FG002|Overall Study|Death|1|||
155314333|NCT02140554|560585482|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
155314334|NCT02140554|560585483|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
155314335|NCT02140554|560585484|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
155314336|NCT03953508|560585486|FG000|Baseline|Lost to Follow-up|3|||
155314337|NCT03953508|560585487|FG001|Baseline|Lost to Follow-up|2|||
155314338|NCT03953508|560585486|FG000|6-month Follow-up|Lost to Follow-up|62|||
155314339|NCT03953508|560585487|FG001|6-month Follow-up|Lost to Follow-up|70|||
155314340|NCT03771417|560585488|FG000|Overall Study|Withdrawal by Subject|1|||
155314341|NCT03771417|560585489|FG001|Overall Study|Withdrawal by Subject|0|||
155314342|NCT03771417|560585490|FG002|Overall Study|Withdrawal by Subject|0|||
155314343|NCT03771417|560585488|FG000|Overall Study|Covid-19 Shutdown|0|||
155314344|NCT03771417|560585489|FG001|Overall Study|Covid-19 Shutdown|1|||
155314345|NCT03771417|560585490|FG002|Overall Study|Covid-19 Shutdown|0|||
155314346|NCT04456517|560585491|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
155314347|NCT04456517|560585492|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
155314348|NCT02100813|560585493|FG000|Overall Study|Adverse Event|0|||
155314349|NCT02100813|560585494|FG001|Overall Study|Adverse Event|0|||
155314350|NCT02100813|560585495|FG002|Overall Study|Adverse Event|0|||
155314351|NCT02100813|560585496|FG003|Overall Study|Adverse Event|0|||
155314352|NCT02100813|560585497|FG004|Overall Study|Adverse Event|0|||
155314353|NCT02100813|560585498|FG005|Overall Study|Adverse Event|0|||
155314354|NCT02100813|560585499|FG006|Overall Study|Adverse Event|0|||
155314355|NCT02100813|560585500|FG007|Overall Study|Adverse Event|1|||
155314356|NCT01186367|560585501|FG000|Overall Study|Lost to Follow-up|7|||
155314357|NCT01186367|560585502|FG001|Overall Study|Lost to Follow-up|4|||
155314358|NCT01186367|560585503|FG002|Overall Study|Lost to Follow-up|7|||
155314359|NCT01186367|560585501|FG000|Overall Study|Did not receive study treatment|0|||
155314360|NCT01186367|560585502|FG001|Overall Study|Did not receive study treatment|1|||
155314361|NCT01186367|560585503|FG002|Overall Study|Did not receive study treatment|0|||
155314362|NCT04509674|560585505|FG000|Overall Study|Not treated|33|||
155314363|NCT04509674|560585506|FG001|Overall Study|Not treated|26|||
155314364|NCT04509674|560585505|FG000|Overall Study|Protocol Violation|9|||
155314365|NCT04509674|560585506|FG001|Overall Study|Protocol Violation|10|||
155314366|NCT04509674|560585505|FG000|Overall Study|Lost to Follow-up|31|||
155314367|NCT04509674|560585506|FG001|Overall Study|Lost to Follow-up|39|||
155314368|NCT04509674|560585505|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
155314369|NCT04509674|560585506|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
155314370|NCT04509674|560585505|FG000|Overall Study|Adverse event, serious fatal event|11|||
155314371|NCT04509674|560585506|FG001|Overall Study|Adverse event, serious fatal event|4|||
155314372|NCT04509674|560585505|FG000|Overall Study|Adverse event, non-fatal event|107|||
155314373|NCT04509674|560585506|FG001|Overall Study|Adverse event, non-fatal event|118|||
155314374|NCT04509674|560585505|FG000|Overall Study|Other reason than listed|106|||
155314375|NCT04509674|560585506|FG001|Overall Study|Other reason than listed|95|||
155314376|NCT04064164|560585510|FG000|Overall Study|Withdrawal by Subject|8|||
155314377|NCT04064164|560585511|FG001|Overall Study|Withdrawal by Subject|8|||
155314378|NCT01606215|560585522|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
155314379|NCT01606215|560585523|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
155314380|NCT04316871|560585532|FG000|Overall Study|Protocol Violation|2|||
155314381|NCT04316871|560585533|FG001|Overall Study|Protocol Violation|2|||
155314382|NCT04316871|560585534|FG002|Overall Study|Protocol Violation|2|||
155314383|NCT04316871|560585535|FG003|Overall Study|Protocol Violation|2|||
155314384|NCT05087992|560585536|FG000|Overall Study|Adverse Event|0|||
155314385|NCT05087992|560585537|FG001|Overall Study|Adverse Event|1|||
155314386|NCT05087992|560585538|FG002|Overall Study|Adverse Event|0|||
155314387|NCT05087992|560585536|FG000|Overall Study|Withdrawal by Subject|2|||
155314388|NCT05087992|560585537|FG001|Overall Study|Withdrawal by Subject|0|||
155314389|NCT05087992|560585538|FG002|Overall Study|Withdrawal by Subject|0|||
155314390|NCT05087992|560585536|FG000|Overall Study|clinical disease progression|3|||
155314391|NCT05087992|560585537|FG001|Overall Study|clinical disease progression|1|||
155314392|NCT05087992|560585538|FG002|Overall Study|clinical disease progression|0|||
155314393|NCT05087992|560585536|FG000|Overall Study|objective disease progression|4|||
155314394|NCT05087992|560585537|FG001|Overall Study|objective disease progression|1|||
155314395|NCT05087992|560585538|FG002|Overall Study|objective disease progression|0|||
155314396|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
155314397|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
155314398|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
155314399|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
155314400|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
155314401|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
155314402|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
155314403|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
155314404|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
155314405|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
155314406|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
155314407|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
155314408|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
155314409|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
155314410|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
155314411|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
155314412|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
155314413|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
155314414|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314415|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
155314416|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
155314417|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314418|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314419|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
155162378|NCT00960999|560029879|FG001|Overall Study|Withdrawal by Subject|0|||
155314420|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314421|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314422|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
155314423|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
155314424|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314425|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
155314426|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
155314427|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
155314428|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
155314429|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314430|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314431|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
155314432|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
155314433|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
155314434|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
155314435|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
155314436|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
155314437|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
155314438|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
155314439|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
155314440|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
155314441|NCT01369355|560585540|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
155314442|NCT01369355|560585541|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
155314443|NCT01369355|560585542|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
155314444|NCT01369355|560585543|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
155314445|NCT01369355|560585544|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
155314446|NCT01369355|560585545|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
155314447|NCT01369355|560585546|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
155314448|NCT01369355|560585547|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
155314449|NCT01369355|560585548|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
155314450|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314451|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314452|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314453|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314454|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314455|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
155314456|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
155314457|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
155314458|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
155314459|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Death|0|||
155314460|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Death|0|||
155314461|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Death|0|||
155314462|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Death|0|||
155314463|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Death|0|||
155314464|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Death|0|||
155314465|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Death|0|||
155314466|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Death|1|||
155314467|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Death|3|||
155314468|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314469|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314470|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314471|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314472|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314473|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
155314474|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
155314475|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
155314476|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
155314477|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314478|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314479|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314480|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314481|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314482|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314483|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
155314484|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
155314485|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
155314486|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314487|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314488|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314489|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314490|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314491|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
155314492|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
155314493|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
155314494|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
155314495|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314496|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314497|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314498|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314499|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314500|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
155314501|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
155314502|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
155314503|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
155314504|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314505|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314506|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314507|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314508|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314509|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
155314510|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
155314511|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
155314512|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
155314513|NCT01369355|560585540|FG000|Long-term Extension (Week 44-272)|Other|0|||
155314514|NCT01369355|560585541|FG001|Long-term Extension (Week 44-272)|Other|0|||
155314515|NCT01369355|560585542|FG002|Long-term Extension (Week 44-272)|Other|0|||
155314516|NCT01369355|560585543|FG003|Long-term Extension (Week 44-272)|Other|0|||
155314517|NCT01369355|560585544|FG004|Long-term Extension (Week 44-272)|Other|0|||
155314518|NCT01369355|560585545|FG005|Long-term Extension (Week 44-272)|Other|0|||
155314519|NCT01369355|560585546|FG006|Long-term Extension (Week 44-272)|Other|110|||
155314520|NCT01369355|560585547|FG007|Long-term Extension (Week 44-272)|Other|9|||
155314521|NCT01369355|560585548|FG008|Long-term Extension (Week 44-272)|Other|17|||
155314522|NCT06424236|560585551|FG000|Overall Study|Adverse Event|0|||
155314523|NCT06424236|560585552|FG001|Overall Study|Adverse Event|1|||
155314524|NCT06424236|560585553|FG002|Overall Study|Adverse Event|0|||
155314525|NCT06424236|560585551|FG000|Overall Study|Withdrawal by Subject|3|||
155314526|NCT06424236|560585552|FG001|Overall Study|Withdrawal by Subject|1|||
155314527|NCT06424236|560585553|FG002|Overall Study|Withdrawal by Subject|2|||
155314528|NCT06424236|560585551|FG000|Overall Study|Physician Decision|0|||
155314529|NCT06424236|560585552|FG001|Overall Study|Physician Decision|1|||
155314530|NCT06424236|560585553|FG002|Overall Study|Physician Decision|0|||
155314531|NCT06424236|560585551|FG000|Overall Study|Study Terminated by Sponsor|11|||
155067015|NCT03329001|559676944|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155314532|NCT06424236|560585552|FG001|Overall Study|Study Terminated by Sponsor|20|||
155314533|NCT06424236|560585553|FG002|Overall Study|Study Terminated by Sponsor|16|||
155314534|NCT06424236|560585551|FG000|Overall Study|Lost to Follow-up|0|||
155314535|NCT06424236|560585552|FG001|Overall Study|Lost to Follow-up|1|||
155314536|NCT06424236|560585553|FG002|Overall Study|Lost to Follow-up|0|||
155314537|NCT06424236|560585551|FG000|Overall Study|Disease Progression|0|||
155067016|NCT03329001|559676945|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155314538|NCT06424236|560585552|FG001|Overall Study|Disease Progression|1|||
155314539|NCT06424236|560585553|FG002|Overall Study|Disease Progression|2|||
155314540|NCT06424236|560585551|FG000|Overall Study|Other|0|||
155314541|NCT06424236|560585552|FG001|Overall Study|Other|0|||
155314542|NCT06424236|560585553|FG002|Overall Study|Other|1|||
155314543|NCT00227344|560585555|FG000|Overall Study|study terminated early|12|||
155314544|NCT00227344|560585556|FG001|Overall Study|study terminated early|5|||
155314545|NCT04149704|560585562|FG000|Three Month Follow-up|Death|2|||
155314546|NCT04149704|560585563|FG001|Three Month Follow-up|Death|0|||
155314547|NCT04149704|560585564|FG002|Three Month Follow-up|Death|0|||
155314548|NCT04149704|560585565|FG003|Three Month Follow-up|Death|0|||
155314549|NCT04149704|560585562|FG000|Three Month Follow-up|Lost to Follow-up|1|||
155314550|NCT04149704|560585563|FG001|Three Month Follow-up|Lost to Follow-up|4|||
155314551|NCT04149704|560585564|FG002|Three Month Follow-up|Lost to Follow-up|5|||
155314552|NCT04149704|560585565|FG003|Three Month Follow-up|Lost to Follow-up|5|||
155314553|NCT04149704|560585562|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
155314554|NCT04149704|560585563|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
155314555|NCT04149704|560585564|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
155314556|NCT04149704|560585565|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
155162379|NCT00960999|560029878|FG000|Overall Study|Protocol Violation|5|||
155314557|NCT04149704|560585562|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
155314558|NCT04149704|560585563|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
155314559|NCT04149704|560585564|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
155314560|NCT04149704|560585565|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
155314561|NCT04376502|560585570|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
155314562|NCT04632992|560585571|FG000|Overall Study|Adverse Event|0|||
155314563|NCT04632992|560585572|FG001|Overall Study|Adverse Event|0|||
155314564|NCT04632992|560585573|FG002|Overall Study|Adverse Event|0|||
155314565|NCT04632992|560585574|FG003|Overall Study|Adverse Event|0|||
155314566|NCT04632992|560585575|FG004|Overall Study|Adverse Event|0|||
155314567|NCT04632992|560585576|FG005|Overall Study|Adverse Event|0|||
155314568|NCT04632992|560585577|FG006|Overall Study|Adverse Event|0|||
155314569|NCT04632992|560585578|FG007|Overall Study|Adverse Event|0|||
155314570|NCT04632992|560585579|FG008|Overall Study|Adverse Event|0|||
155314571|NCT04632992|560585580|FG009|Overall Study|Adverse Event|0|||
155314572|NCT04632992|560585581|FG010|Overall Study|Adverse Event|0|||
155314573|NCT04632992|560585582|FG011|Overall Study|Adverse Event|0|||
155314574|NCT04632992|560585583|FG012|Overall Study|Adverse Event|1|||
155314575|NCT04632992|560585584|FG013|Overall Study|Adverse Event|0|||
155314576|NCT04632992|560585571|FG000|Overall Study|Death|17|||
155314577|NCT04632992|560585572|FG001|Overall Study|Death|1|||
155314578|NCT04632992|560585573|FG002|Overall Study|Death|14|||
155314579|NCT04632992|560585574|FG003|Overall Study|Death|14|||
155314580|NCT04632992|560585575|FG004|Overall Study|Death|13|||
155314581|NCT04632992|560585576|FG005|Overall Study|Death|6|||
155314582|NCT04632992|560585577|FG006|Overall Study|Death|7|||
155314583|NCT04632992|560585578|FG007|Overall Study|Death|12|||
155314584|NCT04632992|560585579|FG008|Overall Study|Death|15|||
155314585|NCT04632992|560585580|FG009|Overall Study|Death|20|||
155314586|NCT04632992|560585581|FG010|Overall Study|Death|8|||
155314587|NCT04632992|560585582|FG011|Overall Study|Death|2|||
155314588|NCT04632992|560585583|FG012|Overall Study|Death|10|||
155314589|NCT04632992|560585584|FG013|Overall Study|Death|1|||
155314590|NCT04632992|560585571|FG000|Overall Study|Lost to Follow-up|1|||
155314591|NCT04632992|560585572|FG001|Overall Study|Lost to Follow-up|0|||
155314592|NCT04632992|560585573|FG002|Overall Study|Lost to Follow-up|1|||
155314593|NCT04632992|560585574|FG003|Overall Study|Lost to Follow-up|0|||
155314594|NCT04632992|560585575|FG004|Overall Study|Lost to Follow-up|2|||
155314595|NCT04632992|560585576|FG005|Overall Study|Lost to Follow-up|0|||
155314596|NCT04632992|560585577|FG006|Overall Study|Lost to Follow-up|1|||
155314597|NCT04632992|560585578|FG007|Overall Study|Lost to Follow-up|1|||
155314598|NCT04632992|560585579|FG008|Overall Study|Lost to Follow-up|1|||
155314599|NCT04632992|560585580|FG009|Overall Study|Lost to Follow-up|1|||
155314600|NCT04632992|560585581|FG010|Overall Study|Lost to Follow-up|2|||
155314601|NCT04632992|560585582|FG011|Overall Study|Lost to Follow-up|0|||
155314602|NCT04632992|560585583|FG012|Overall Study|Lost to Follow-up|0|||
155314603|NCT04632992|560585584|FG013|Overall Study|Lost to Follow-up|0|||
155314604|NCT04632992|560585571|FG000|Overall Study|Reason not Specified|2|||
155314605|NCT04632992|560585572|FG001|Overall Study|Reason not Specified|0|||
155314606|NCT04632992|560585573|FG002|Overall Study|Reason not Specified|1|||
155314607|NCT04632992|560585574|FG003|Overall Study|Reason not Specified|1|||
155314608|NCT04632992|560585575|FG004|Overall Study|Reason not Specified|0|||
155314609|NCT04632992|560585576|FG005|Overall Study|Reason not Specified|0|||
155314610|NCT04632992|560585577|FG006|Overall Study|Reason not Specified|0|||
155314611|NCT04632992|560585578|FG007|Overall Study|Reason not Specified|0|||
155314612|NCT04632992|560585579|FG008|Overall Study|Reason not Specified|0|||
155314613|NCT04632992|560585580|FG009|Overall Study|Reason not Specified|0|||
155314614|NCT04632992|560585581|FG010|Overall Study|Reason not Specified|1|||
155314615|NCT04632992|560585582|FG011|Overall Study|Reason not Specified|0|||
154959930|NCT00934050|559278642|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
155314616|NCT04632992|560585583|FG012|Overall Study|Reason not Specified|0|||
155314617|NCT04632992|560585584|FG013|Overall Study|Reason not Specified|0|||
155314618|NCT04632992|560585571|FG000|Overall Study|Physician Decision|0|||
155314619|NCT04632992|560585572|FG001|Overall Study|Physician Decision|0|||
155314620|NCT04632992|560585573|FG002|Overall Study|Physician Decision|0|||
155314621|NCT04632992|560585574|FG003|Overall Study|Physician Decision|2|||
155314622|NCT04632992|560585575|FG004|Overall Study|Physician Decision|1|||
155314623|NCT04632992|560585576|FG005|Overall Study|Physician Decision|0|||
155314624|NCT04632992|560585577|FG006|Overall Study|Physician Decision|0|||
155314625|NCT04632992|560585578|FG007|Overall Study|Physician Decision|0|||
155314626|NCT04632992|560585579|FG008|Overall Study|Physician Decision|0|||
155314627|NCT04632992|560585580|FG009|Overall Study|Physician Decision|0|||
155162380|NCT00960999|560029879|FG001|Overall Study|Protocol Violation|2|||
155314628|NCT04632992|560585581|FG010|Overall Study|Physician Decision|0|||
155314629|NCT04632992|560585582|FG011|Overall Study|Physician Decision|0|||
155314630|NCT04632992|560585583|FG012|Overall Study|Physician Decision|3|||
155314631|NCT04632992|560585584|FG013|Overall Study|Physician Decision|0|||
155314632|NCT04632992|560585571|FG000|Overall Study|Progressive Disease|0|||
155314633|NCT04632992|560585572|FG001|Overall Study|Progressive Disease|0|||
155314634|NCT04632992|560585573|FG002|Overall Study|Progressive Disease|0|||
155314635|NCT04632992|560585574|FG003|Overall Study|Progressive Disease|0|||
155314636|NCT04632992|560585575|FG004|Overall Study|Progressive Disease|1|||
155314637|NCT04632992|560585576|FG005|Overall Study|Progressive Disease|0|||
155314638|NCT04632992|560585577|FG006|Overall Study|Progressive Disease|0|||
155314639|NCT04632992|560585578|FG007|Overall Study|Progressive Disease|0|||
155314640|NCT04632992|560585579|FG008|Overall Study|Progressive Disease|0|||
155314641|NCT04632992|560585580|FG009|Overall Study|Progressive Disease|1|||
155314642|NCT04632992|560585581|FG010|Overall Study|Progressive Disease|1|||
155314643|NCT04632992|560585582|FG011|Overall Study|Progressive Disease|0|||
155314644|NCT04632992|560585583|FG012|Overall Study|Progressive Disease|2|||
155314645|NCT04632992|560585584|FG013|Overall Study|Progressive Disease|0|||
155314646|NCT04632992|560585571|FG000|Overall Study|Withdrawal by Subject|4|||
155314647|NCT04632992|560585572|FG001|Overall Study|Withdrawal by Subject|1|||
155314648|NCT04632992|560585573|FG002|Overall Study|Withdrawal by Subject|5|||
155314649|NCT04632992|560585574|FG003|Overall Study|Withdrawal by Subject|4|||
155314650|NCT04632992|560585575|FG004|Overall Study|Withdrawal by Subject|3|||
155314651|NCT04632992|560585576|FG005|Overall Study|Withdrawal by Subject|3|||
155314652|NCT04632992|560585577|FG006|Overall Study|Withdrawal by Subject|0|||
155314653|NCT04632992|560585578|FG007|Overall Study|Withdrawal by Subject|5|||
155314654|NCT04632992|560585579|FG008|Overall Study|Withdrawal by Subject|0|||
155314655|NCT04632992|560585580|FG009|Overall Study|Withdrawal by Subject|2|||
155314656|NCT04632992|560585581|FG010|Overall Study|Withdrawal by Subject|8|||
155314657|NCT04632992|560585582|FG011|Overall Study|Withdrawal by Subject|0|||
155314658|NCT04632992|560585583|FG012|Overall Study|Withdrawal by Subject|1|||
155314659|NCT04632992|560585584|FG013|Overall Study|Withdrawal by Subject|1|||
155314660|NCT02677805|560585585|FG000|Double Blind Phase|Lost to Follow-up|8|||
155314661|NCT02677805|560585586|FG001|Double Blind Phase|Lost to Follow-up|3|||
155314662|NCT02677805|560585587|FG002|Double Blind Phase|Lost to Follow-up|0|||
155314663|NCT02677805|560585585|FG000|Double Blind Phase|Withdrawal by Subject|5|||
155314664|NCT02677805|560585586|FG001|Double Blind Phase|Withdrawal by Subject|2|||
155314665|NCT02677805|560585587|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155314666|NCT02677805|560585585|FG000|Open Label Phase|Lost to Follow-up|0|||
155314667|NCT02677805|560585586|FG001|Open Label Phase|Lost to Follow-up|0|||
155314668|NCT02677805|560585587|FG002|Open Label Phase|Lost to Follow-up|10|||
155314669|NCT02677805|560585585|FG000|Open Label Phase|Withdrawal by Subject|0|||
155314670|NCT02677805|560585586|FG001|Open Label Phase|Withdrawal by Subject|0|||
155314671|NCT02677805|560585587|FG002|Open Label Phase|Withdrawal by Subject|6|||
155314672|NCT04111536|560585588|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155314673|NCT04111536|560585589|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155314674|NCT04111536|560585588|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
155314675|NCT04111536|560585589|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
155314676|NCT04111536|560585588|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
155314677|NCT04111536|560585589|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155314678|NCT04111536|560585588|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
155314679|NCT04111536|560585589|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
155314680|NCT04187833|560585590|FG000|Overall Study|Withdrawal by Subject|1|||
155314681|NCT04209465|560585594|FG000|Overall Study|Adverse Event|0|||
155314682|NCT04209465|560585595|FG001|Overall Study|Adverse Event|0|||
155314683|NCT04209465|560585596|FG002|Overall Study|Adverse Event|0|||
155314684|NCT04209465|560585597|FG003|Overall Study|Adverse Event|0|||
155314685|NCT04209465|560585598|FG004|Overall Study|Adverse Event|0|||
155314686|NCT04209465|560585599|FG005|Overall Study|Adverse Event|1|||
155314687|NCT04209465|560585600|FG006|Overall Study|Adverse Event|0|||
155314688|NCT04209465|560585601|FG007|Overall Study|Adverse Event|0|||
155314689|NCT04209465|560585602|FG008|Overall Study|Adverse Event|1|||
155314690|NCT04209465|560585603|FG009|Overall Study|Adverse Event|0|||
155314691|NCT04209465|560585604|FG010|Overall Study|Adverse Event|2|||
155314692|NCT04209465|560585605|FG011|Overall Study|Adverse Event|1|||
155314693|NCT04209465|560585606|FG012|Overall Study|Adverse Event|1|||
155314694|NCT04209465|560585594|FG000|Overall Study|Death|1|||
155314695|NCT04209465|560585595|FG001|Overall Study|Death|0|||
155314696|NCT04209465|560585596|FG002|Overall Study|Death|0|||
155314697|NCT04209465|560585597|FG003|Overall Study|Death|0|||
155314698|NCT04209465|560585598|FG004|Overall Study|Death|2|||
155314699|NCT04209465|560585599|FG005|Overall Study|Death|7|||
155314700|NCT04209465|560585600|FG006|Overall Study|Death|2|||
155314701|NCT04209465|560585601|FG007|Overall Study|Death|2|||
155314702|NCT04209465|560585602|FG008|Overall Study|Death|1|||
155314703|NCT04209465|560585603|FG009|Overall Study|Death|1|||
155314704|NCT04209465|560585604|FG010|Overall Study|Death|1|||
155314705|NCT04209465|560585605|FG011|Overall Study|Death|0|||
155314706|NCT04209465|560585606|FG012|Overall Study|Death|10|||
155314707|NCT04209465|560585594|FG000|Overall Study|Physician Decision|0|||
155314708|NCT04209465|560585595|FG001|Overall Study|Physician Decision|1|||
155314709|NCT04209465|560585596|FG002|Overall Study|Physician Decision|0|||
155314710|NCT04209465|560585597|FG003|Overall Study|Physician Decision|0|||
155314711|NCT04209465|560585598|FG004|Overall Study|Physician Decision|0|||
155314712|NCT04209465|560585599|FG005|Overall Study|Physician Decision|0|||
155314713|NCT04209465|560585600|FG006|Overall Study|Physician Decision|0|||
155314714|NCT04209465|560585601|FG007|Overall Study|Physician Decision|0|||
155314715|NCT04209465|560585602|FG008|Overall Study|Physician Decision|0|||
155314716|NCT04209465|560585603|FG009|Overall Study|Physician Decision|0|||
155314717|NCT04209465|560585604|FG010|Overall Study|Physician Decision|0|||
155314718|NCT04209465|560585605|FG011|Overall Study|Physician Decision|0|||
155314719|NCT04209465|560585606|FG012|Overall Study|Physician Decision|0|||
155314720|NCT04209465|560585594|FG000|Overall Study|Progressive Disease|0|||
155314721|NCT04209465|560585595|FG001|Overall Study|Progressive Disease|0|||
155314722|NCT04209465|560585596|FG002|Overall Study|Progressive Disease|1|||
155314723|NCT04209465|560585597|FG003|Overall Study|Progressive Disease|2|||
155314724|NCT04209465|560585598|FG004|Overall Study|Progressive Disease|8|||
155314725|NCT04209465|560585599|FG005|Overall Study|Progressive Disease|5|||
155314726|NCT04209465|560585600|FG006|Overall Study|Progressive Disease|3|||
155314727|NCT04209465|560585601|FG007|Overall Study|Progressive Disease|4|||
155314728|NCT04209465|560585602|FG008|Overall Study|Progressive Disease|1|||
155314729|NCT04209465|560585603|FG009|Overall Study|Progressive Disease|3|||
155314730|NCT04209465|560585604|FG010|Overall Study|Progressive Disease|2|||
155314731|NCT04209465|560585605|FG011|Overall Study|Progressive Disease|1|||
155314732|NCT04209465|560585606|FG012|Overall Study|Progressive Disease|0|||
155314733|NCT04209465|560585594|FG000|Overall Study|Withdrawal by Subject|0|||
155314734|NCT04209465|560585595|FG001|Overall Study|Withdrawal by Subject|0|||
155314735|NCT04209465|560585596|FG002|Overall Study|Withdrawal by Subject|0|||
155314736|NCT04209465|560585597|FG003|Overall Study|Withdrawal by Subject|0|||
155314737|NCT04209465|560585598|FG004|Overall Study|Withdrawal by Subject|0|||
155314738|NCT04209465|560585599|FG005|Overall Study|Withdrawal by Subject|1|||
155314739|NCT04209465|560585600|FG006|Overall Study|Withdrawal by Subject|2|||
155314740|NCT04209465|560585601|FG007|Overall Study|Withdrawal by Subject|0|||
155314741|NCT04209465|560585602|FG008|Overall Study|Withdrawal by Subject|1|||
155314742|NCT04209465|560585603|FG009|Overall Study|Withdrawal by Subject|0|||
155314743|NCT04209465|560585604|FG010|Overall Study|Withdrawal by Subject|0|||
155314744|NCT04209465|560585605|FG011|Overall Study|Withdrawal by Subject|2|||
155314745|NCT04209465|560585606|FG012|Overall Study|Withdrawal by Subject|2|||
155314746|NCT04209465|560585594|FG000|Overall Study|Lost to Follow-up|0|||
155314747|NCT04209465|560585595|FG001|Overall Study|Lost to Follow-up|0|||
155314748|NCT04209465|560585596|FG002|Overall Study|Lost to Follow-up|0|||
155314749|NCT04209465|560585597|FG003|Overall Study|Lost to Follow-up|0|||
155314750|NCT04209465|560585598|FG004|Overall Study|Lost to Follow-up|0|||
155314751|NCT04209465|560585599|FG005|Overall Study|Lost to Follow-up|1|||
155314752|NCT04209465|560585600|FG006|Overall Study|Lost to Follow-up|0|||
155314753|NCT04209465|560585601|FG007|Overall Study|Lost to Follow-up|0|||
155314754|NCT04209465|560585602|FG008|Overall Study|Lost to Follow-up|1|||
155314755|NCT04209465|560585603|FG009|Overall Study|Lost to Follow-up|0|||
155314756|NCT04209465|560585604|FG010|Overall Study|Lost to Follow-up|0|||
155314757|NCT04209465|560585605|FG011|Overall Study|Lost to Follow-up|1|||
155314758|NCT04209465|560585606|FG012|Overall Study|Lost to Follow-up|0|||
155314759|NCT04209465|560585594|FG000|Overall Study|Started new therapy|0|||
155314760|NCT04209465|560585595|FG001|Overall Study|Started new therapy|0|||
155314761|NCT04209465|560585596|FG002|Overall Study|Started new therapy|0|||
155314762|NCT04209465|560585597|FG003|Overall Study|Started new therapy|0|||
155314763|NCT04209465|560585598|FG004|Overall Study|Started new therapy|0|||
155314764|NCT04209465|560585599|FG005|Overall Study|Started new therapy|1|||
155314765|NCT04209465|560585600|FG006|Overall Study|Started new therapy|0|||
155314766|NCT04209465|560585601|FG007|Overall Study|Started new therapy|0|||
155314767|NCT04209465|560585602|FG008|Overall Study|Started new therapy|0|||
155314768|NCT04209465|560585603|FG009|Overall Study|Started new therapy|0|||
155314769|NCT04209465|560585604|FG010|Overall Study|Started new therapy|0|||
155314770|NCT04209465|560585605|FG011|Overall Study|Started new therapy|0|||
155314771|NCT04209465|560585606|FG012|Overall Study|Started new therapy|0|||
155314772|NCT04209465|560585594|FG000|Overall Study|Study terminated early by sponsor|0|||
155314773|NCT04209465|560585595|FG001|Overall Study|Study terminated early by sponsor|0|||
155314774|NCT04209465|560585596|FG002|Overall Study|Study terminated early by sponsor|0|||
155314775|NCT04209465|560585597|FG003|Overall Study|Study terminated early by sponsor|0|||
155314776|NCT04209465|560585598|FG004|Overall Study|Study terminated early by sponsor|0|||
155314777|NCT04209465|560585599|FG005|Overall Study|Study terminated early by sponsor|0|||
155314778|NCT04209465|560585600|FG006|Overall Study|Study terminated early by sponsor|3|||
155314779|NCT04209465|560585601|FG007|Overall Study|Study terminated early by sponsor|0|||
155314780|NCT04209465|560585602|FG008|Overall Study|Study terminated early by sponsor|0|||
155314781|NCT04209465|560585603|FG009|Overall Study|Study terminated early by sponsor|0|||
155314782|NCT04209465|560585604|FG010|Overall Study|Study terminated early by sponsor|0|||
155314783|NCT04209465|560585605|FG011|Overall Study|Study terminated early by sponsor|0|||
155314784|NCT04209465|560585606|FG012|Overall Study|Study terminated early by sponsor|3|||
155314785|NCT04209465|560585594|FG000|Overall Study|Other|0|||
155314786|NCT04209465|560585595|FG001|Overall Study|Other|0|||
155314787|NCT04209465|560585596|FG002|Overall Study|Other|0|||
155314788|NCT04209465|560585597|FG003|Overall Study|Other|0|||
155314789|NCT04209465|560585598|FG004|Overall Study|Other|0|||
155314790|NCT04209465|560585599|FG005|Overall Study|Other|0|||
155314791|NCT04209465|560585600|FG006|Overall Study|Other|0|||
155314792|NCT04209465|560585601|FG007|Overall Study|Other|0|||
155314793|NCT04209465|560585602|FG008|Overall Study|Other|1|||
155314794|NCT04209465|560585603|FG009|Overall Study|Other|0|||
155314795|NCT04209465|560585604|FG010|Overall Study|Other|0|||
155314796|NCT04209465|560585605|FG011|Overall Study|Other|0|||
155314797|NCT04209465|560585606|FG012|Overall Study|Other|0|||
155314798|NCT05647304|560585607|FG000|Overall Study|Withdrawal by Subject|1|||
155314799|NCT05647304|560585608|FG001|Overall Study|Withdrawal by Subject|0|||
155314800|NCT04171999|560585609|FG000|Overall Study|deemed ineligible after randomization|2|||
155314801|NCT04171999|560585610|FG001|Overall Study|deemed ineligible after randomization|1|||
155314802|NCT03092518|560585611|FG000|Overall Study|Ineligible|2|||
155314803|NCT02547987|560585612|FG000|Overall Study|Withdrawal by Subject|1|||
155314804|NCT02547987|560585612|FG000|Overall Study|Adverse Event|2|||
155314805|NCT05089019|560585624|FG000|Period 1|Withdrawal by Subject|0|||
155314806|NCT05089019|560585625|FG001|Period 1|Withdrawal by Subject|1|||
155314807|NCT05089019|560585624|FG000|Washout Period|Adverse Event|3|||
155314808|NCT05089019|560585625|FG001|Washout Period|Adverse Event|4|||
155314809|NCT05089019|560585624|FG000|Washout Period|Lost to Follow-up|1|||
155314810|NCT05089019|560585625|FG001|Washout Period|Lost to Follow-up|0|||
155314811|NCT05089019|560585624|FG000|Washout Period|Physician Decision|2|||
155314812|NCT05089019|560585625|FG001|Washout Period|Physician Decision|0|||
155314813|NCT05089019|560585624|FG000|Washout Period|Withdrawal by Subject|6|||
155314814|NCT05089019|560585625|FG001|Washout Period|Withdrawal by Subject|3|||
155314815|NCT05089019|560585624|FG000|Period 2|Adverse Event|4|||
155314816|NCT05089019|560585625|FG001|Period 2|Adverse Event|2|||
155314817|NCT05089019|560585624|FG000|Period 2|Lost to Follow-up|1|||
155314818|NCT05089019|560585625|FG001|Period 2|Lost to Follow-up|0|||
155314819|NCT05089019|560585624|FG000|Period 2|Withdrawal by Subject|0|||
155314820|NCT05089019|560585625|FG001|Period 2|Withdrawal by Subject|1|||
155314821|NCT05170009|560585626|FG000|Overall Study|Physician Decision|0|||
155314822|NCT05170009|560585627|FG001|Overall Study|Physician Decision|1|||
155314823|NCT04925986|560585628|FG000|Overall Study|Death|0|||
155314824|NCT04925986|560585629|FG001|Overall Study|Death|0|||
155314825|NCT04925986|560585630|FG002|Overall Study|Death|2|||
155314826|NCT04925986|560585631|FG003|Overall Study|Death|0|||
155314827|NCT04925986|560585628|FG000|Overall Study|Lack of Efficacy|1|||
155314828|NCT04925986|560585629|FG001|Overall Study|Lack of Efficacy|2|||
155314829|NCT04925986|560585630|FG002|Overall Study|Lack of Efficacy|0|||
155314830|NCT04925986|560585631|FG003|Overall Study|Lack of Efficacy|1|||
155314831|NCT04925986|560585628|FG000|Overall Study|Withdrawal by Subject|0|||
155314832|NCT04925986|560585629|FG001|Overall Study|Withdrawal by Subject|0|||
155314833|NCT04925986|560585630|FG002|Overall Study|Withdrawal by Subject|1|||
155314834|NCT04925986|560585631|FG003|Overall Study|Withdrawal by Subject|2|||
155314835|NCT05457647|560585633|FG000|Overall Study|Lost to Follow-up|3|||
155314836|NCT03115476|560585634|FG000|LP0084-1369|Death|1|||
155314837|NCT03115476|560585635|FG001|LP0084-1369|Death|0|||
155314838|NCT03115476|560585636|FG002|LP0084-1369|Death|2|||
155314839|NCT03115476|560585634|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
155314840|NCT03115476|560585635|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
155314841|NCT03115476|560585636|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
155314842|NCT03865498|560585637|FG000|Overall Study|Lack of Efficacy|12|||
155314843|NCT03865498|560585638|FG001|Overall Study|Lack of Efficacy|11|||
155314844|NCT03865498|560585637|FG000|Overall Study|Lost to Follow-up|125|||
155314845|NCT03865498|560585638|FG001|Overall Study|Lost to Follow-up|133|||
155314846|NCT03865498|560585637|FG000|Overall Study|Withdrawal by Subject|2|||
155314847|NCT03865498|560585638|FG001|Overall Study|Withdrawal by Subject|4|||
155314848|NCT01648023|560585639|FG000|Overall Study|Screen Fail Post Randomization|1|||
155314849|NCT01648023|560585640|FG001|Overall Study|Screen Fail Post Randomization|2|||
155314850|NCT05296525|560585644|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
155314851|NCT05296525|560585645|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
155314852|NCT05296525|560585646|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
155314853|NCT05296525|560585647|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
155314854|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
155314855|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
155314856|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
155314857|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
155314858|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
155314859|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
155314860|NCT02547363|560585650|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
155314861|NCT02547363|560585651|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
155314862|NCT02547363|560585650|FG000|12-month Follow-up|Withdrawal by Subject|4|||
155314863|NCT02547363|560585651|FG001|12-month Follow-up|Withdrawal by Subject|3|||
155314864|NCT02547363|560585650|FG000|12-month Follow-up|Lost to Follow-up|4|||
155314865|NCT02547363|560585651|FG001|12-month Follow-up|Lost to Follow-up|1|||
155314866|NCT02547363|560585650|FG000|12-month Follow-up|Lack of Efficacy|1|||
155314867|NCT02547363|560585651|FG001|12-month Follow-up|Lack of Efficacy|1|||
155314868|NCT02547363|560585650|FG000|12-month Follow-up|Other|1|||
155314869|NCT02547363|560585651|FG001|12-month Follow-up|Other|0|||
155314870|NCT05228457|560585652|FG000|Overall Study|Withdrawal by Subject|1|||
155314871|NCT05228457|560585653|FG001|Overall Study|Withdrawal by Subject|1|||
155314872|NCT03161028|560585656|FG000|Overall Study|Withdrawal by Subject|6|||
155314873|NCT03161028|560585657|FG001|Overall Study|Withdrawal by Subject|4|||
155314874|NCT03161028|560585656|FG000|Overall Study|Adverse Event|5|||
155314875|NCT03161028|560585657|FG001|Overall Study|Adverse Event|1|||
155314876|NCT03161028|560585656|FG000|Overall Study|Study drug side effects|2|||
155314877|NCT03161028|560585657|FG001|Overall Study|Study drug side effects|2|||
155314878|NCT03161028|560585656|FG000|Overall Study|Administrative PD/UP|4|||
155314879|NCT03161028|560585657|FG001|Overall Study|Administrative PD/UP|2|||
155314880|NCT03161028|560585656|FG000|Overall Study|Lost to Follow-up|2|||
155314881|NCT03161028|560585657|FG001|Overall Study|Lost to Follow-up|0|||
155314882|NCT03161028|560585656|FG000|Overall Study|Unable to comply with procedures|1|||
155314883|NCT03161028|560585657|FG001|Overall Study|Unable to comply with procedures|1|||
155314884|NCT00736723|560585660|FG000|Overall Study|Withdrawal by Subject|4|||
155314885|NCT00736723|560585661|FG001|Overall Study|Withdrawal by Subject|3|||
155314886|NCT03492216|560585662|FG000|Overall Study|Death|1|||
155314887|NCT03492216|560585663|FG001|Overall Study|Death|0|||
155314888|NCT03492216|560585664|FG002|Overall Study|Death|4|||
155314889|NCT03492216|560585665|FG003|Overall Study|Death|0|||
155314890|NCT03492216|560585662|FG000|Overall Study|Withdrawal by Subject|5|||
155314891|NCT03492216|560585663|FG001|Overall Study|Withdrawal by Subject|3|||
155314892|NCT03492216|560585664|FG002|Overall Study|Withdrawal by Subject|1|||
155314893|NCT03492216|560585665|FG003|Overall Study|Withdrawal by Subject|1|||
155314894|NCT03492216|560585662|FG000|Overall Study|Lost to Follow-up|9|||
155314895|NCT03492216|560585663|FG001|Overall Study|Lost to Follow-up|2|||
155314896|NCT03492216|560585664|FG002|Overall Study|Lost to Follow-up|7|||
155314897|NCT03492216|560585665|FG003|Overall Study|Lost to Follow-up|8|||
155314898|NCT03492216|560585662|FG000|Overall Study|Moved|5|||
155314899|NCT03492216|560585663|FG001|Overall Study|Moved|3|||
155314900|NCT03492216|560585664|FG002|Overall Study|Moved|3|||
155314901|NCT03492216|560585665|FG003|Overall Study|Moved|5|||
155314902|NCT03492216|560585662|FG000|Overall Study|Too ill|0|||
155314903|NCT03492216|560585663|FG001|Overall Study|Too ill|1|||
155314904|NCT03492216|560585664|FG002|Overall Study|Too ill|0|||
155314905|NCT03492216|560585665|FG003|Overall Study|Too ill|0|||
155314906|NCT03492216|560585662|FG000|Overall Study|Incarcerated|0|||
155314907|NCT03492216|560585663|FG001|Overall Study|Incarcerated|0|||
155314908|NCT03492216|560585664|FG002|Overall Study|Incarcerated|2|||
155314909|NCT03492216|560585665|FG003|Overall Study|Incarcerated|0|||
155314910|NCT01799265|560585668|FG000|Overall Study|Lost to Follow-up|1|||
155314911|NCT01799265|560585669|FG001|Overall Study|Lost to Follow-up|0|||
155314912|NCT01799265|560585668|FG000|Overall Study|Protocol Violation|2|||
155314913|NCT01799265|560585669|FG001|Overall Study|Protocol Violation|1|||
155314914|NCT01799265|560585668|FG000|Overall Study|inadequate sleep study|0|||
155314915|NCT01799265|560585669|FG001|Overall Study|inadequate sleep study|2|||
155314916|NCT05351554|560585680|FG000|Overall Study|Study terminated by sponsor|1|||
155314917|NCT05030233|560585681|FG000|Overall Study|withdrawn for transfer|1|||
155314918|NCT05030233|560585682|FG001|Overall Study|withdrawn for transfer|0|||
155314919|NCT04342494|560587677|FG000|Overall Study|Questionnaire partially completed|1|||
155314920|NCT04342494|560587678|FG001|Overall Study|Questionnaire partially completed|0|||
155314921|NCT04342494|560587679|FG002|Overall Study|Questionnaire partially completed|2|||
155314922|NCT04342494|560587680|FG003|Overall Study|Questionnaire partially completed|0|||
155314923|NCT04342494|560587681|FG004|Overall Study|Questionnaire partially completed|1|||
155314924|NCT04342494|560587677|FG000|Overall Study|Lost to Follow-up|49|||
155314925|NCT04342494|560587678|FG001|Overall Study|Lost to Follow-up|38|||
155314926|NCT04342494|560587679|FG002|Overall Study|Lost to Follow-up|34|||
155314927|NCT04342494|560587680|FG003|Overall Study|Lost to Follow-up|34|||
155314928|NCT04342494|560587681|FG004|Overall Study|Lost to Follow-up|35|||
155314929|NCT06190691|560587690|FG000|Overall Study|Adverse Event|2|||
155314930|NCT06190691|560587691|FG001|Overall Study|Adverse Event|0|||
155314931|NCT06190691|560587692|FG002|Overall Study|Adverse Event|0|||
155314932|NCT06190691|560587693|FG003|Overall Study|Adverse Event|0|||
155314933|NCT03016754|560587694|FG000|Overall Study|Death|5|||
155314934|NCT03016754|560587695|FG001|Overall Study|Death|4|||
155314935|NCT03016754|560587696|FG002|Overall Study|Death|5|||
155314936|NCT03016754|560587697|FG003|Overall Study|Death|1|||
155314937|NCT03016754|560587694|FG000|Overall Study|Lost to Follow-up|23|||
155314938|NCT03016754|560587695|FG001|Overall Study|Lost to Follow-up|17|||
155314939|NCT03016754|560587696|FG002|Overall Study|Lost to Follow-up|4|||
155314940|NCT03016754|560587697|FG003|Overall Study|Lost to Follow-up|2|||
155314941|NCT03016754|560587694|FG000|Overall Study|Withdrawal by Subject|6|||
155314942|NCT03016754|560587695|FG001|Overall Study|Withdrawal by Subject|6|||
155314943|NCT03016754|560587696|FG002|Overall Study|Withdrawal by Subject|2|||
155314944|NCT03016754|560587697|FG003|Overall Study|Withdrawal by Subject|2|||
155314945|NCT03016754|560587694|FG000|Overall Study|Other/Unknown|2|||
155314946|NCT03016754|560587695|FG001|Overall Study|Other/Unknown|4|||
155314947|NCT03016754|560587696|FG002|Overall Study|Other/Unknown|2|||
155314948|NCT03016754|560587697|FG003|Overall Study|Other/Unknown|1|||
155314949|NCT03016754|560587694|FG000|Overall Study|Protocol Violation|0|||
155314950|NCT03016754|560587695|FG001|Overall Study|Protocol Violation|0|||
155314951|NCT03016754|560587696|FG002|Overall Study|Protocol Violation|0|||
155314952|NCT03016754|560587697|FG003|Overall Study|Protocol Violation|4|||
155314953|NCT04019873|560587698|FG000|Overall Study|Discontinued from the treatment|1|||
155314954|NCT04019873|560587699|FG001|Overall Study|Discontinued from the treatment|39|||
155314955|NCT04019873|560587700|FG002|Overall Study|Discontinued from the treatment|2|||
155314956|NCT04185298|560587702|FG000|Overall Study|Lost to Follow-up|1|||
155314957|NCT04185298|560587703|FG001|Overall Study|Lost to Follow-up|3|||
155314958|NCT04185298|560587702|FG000|Overall Study|Withdrawal by Subject|0|||
155314959|NCT04185298|560587703|FG001|Overall Study|Withdrawal by Subject|3|||
155314960|NCT03896789|560587704|FG000|Baseline|Lost to Follow-up|1|||
155314961|NCT03896789|560587705|FG001|Baseline|Lost to Follow-up|2|||
155314962|NCT03896789|560587704|FG000|Baseline|Death|3|||
155314963|NCT03896789|560587705|FG001|Baseline|Death|6|||
155314964|NCT03896789|560587704|FG000|Post-Randomization|Lost to Follow-up|12|||
155314965|NCT03896789|560587705|FG001|Post-Randomization|Lost to Follow-up|11|||
155314966|NCT03896789|560587704|FG000|Post-Randomization|Death|12|||
155314967|NCT03896789|560587705|FG001|Post-Randomization|Death|13|||
155314968|NCT01842542|560587706|FG000|Overall Study|Withdrawal by Subject|2|||
155314969|NCT01842542|560587706|FG000|Overall Study|Lack of Efficacy|1|||
155314970|NCT01842542|560587706|FG000|Overall Study|Protocol Non-compliance|2|||
155314971|NCT01842542|560587706|FG000|Overall Study|Lost to Follow-up|1|||
155314972|NCT02919306|560587707|FG000|Overall Study|Withdrawal by Subject|1|||
155314973|NCT02919306|560587708|FG001|Overall Study|Withdrawal by Subject|0|||
155314974|NCT02919306|560587707|FG000|Overall Study|Protocol Violation|1|||
155314975|NCT02919306|560587708|FG001|Overall Study|Protocol Violation|0|||
155314976|NCT04473222|560587709|FG000|Overall Study|Lost to Follow-up|13|||
155314977|NCT04473222|560587710|FG001|Overall Study|Lost to Follow-up|13|||
155314978|NCT04473222|560587709|FG000|Overall Study|Withdrawal by Subject|0|||
155314979|NCT04473222|560587710|FG001|Overall Study|Withdrawal by Subject|1|||
155314980|NCT04473222|560587709|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
155314981|NCT04473222|560587710|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
155314982|NCT04293055|560587711|FG000|Overall Study|Lost to Follow-up|1|||
155314983|NCT04293055|560587712|FG001|Overall Study|Lost to Follow-up|1|||
155314984|NCT04293055|560587711|FG000|Overall Study|Did not trigger randomization|6|||
155314985|NCT04293055|560587712|FG001|Overall Study|Did not trigger randomization|5|||
155314986|NCT03560609|560587713|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
155314987|NCT03560609|560587714|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
155314988|NCT01098812|560587723|FG000|Overall Study|Death|2|||
155314989|NCT01098812|560587724|FG001|Overall Study|Death|0|||
155314990|NCT01098812|560587725|FG002|Overall Study|Death|1|||
155314991|NCT01098812|560587723|FG000|Overall Study|Lost to Follow-up|0|||
155314992|NCT01098812|560587724|FG001|Overall Study|Lost to Follow-up|1|||
155314993|NCT01098812|560587725|FG002|Overall Study|Lost to Follow-up|0|||
155314994|NCT01987895|560587729|FG000|Overall Study|Withdrawal by Subject|12|||
155314995|NCT01987895|560587730|FG001|Overall Study|Withdrawal by Subject|7|||
155314996|NCT01987895|560587729|FG000|Overall Study|Physician Decision|8|||
155314997|NCT01987895|560587730|FG001|Overall Study|Physician Decision|10|||
155314998|NCT01987895|560587729|FG000|Overall Study|Death|7|||
155314999|NCT01987895|560587730|FG001|Overall Study|Death|7|||
155315000|NCT01987895|560587729|FG000|Overall Study|Lost to Follow-up|3|||
155315001|NCT01987895|560587730|FG001|Overall Study|Lost to Follow-up|5|||
155315002|NCT01987895|560587729|FG000|Overall Study|randomized before giving IC|0|||
155315003|NCT01987895|560587730|FG001|Overall Study|randomized before giving IC|1|||
155315004|NCT01073566|560587731|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
155315005|NCT01073566|560587732|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
155315006|NCT03452579|560587743|FG000|Overall Study|Death|0|||
155315007|NCT03452579|560587744|FG001|Overall Study|Death|1|||
155315008|NCT03452579|560587743|FG000|Overall Study|Withdrawal by Subject|2|||
155315009|NCT03452579|560587744|FG001|Overall Study|Withdrawal by Subject|0|||
155315010|NCT03452579|560587743|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
155315011|NCT03452579|560587744|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
155315012|NCT03452579|560587743|FG000|Overall Study|Physician Decision|1|||
155315013|NCT03452579|560587744|FG001|Overall Study|Physician Decision|1|||
155315014|NCT03452579|560587743|FG000|Overall Study|Adverse Event|1|||
155315015|NCT03452579|560587744|FG001|Overall Study|Adverse Event|4|||
155315016|NCT04858321|560587747|FG000|Overall Study|Withdrawal by Subject|3|||
155315017|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
155315018|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
155315019|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
155315020|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
155315021|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
155315022|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
155315023|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Death|6|||
155315024|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Death|0|||
155315025|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Death|0|||
155315026|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
155315027|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
155315028|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
155315029|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
155315030|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
155315031|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
155315032|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
155315033|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
155315034|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
155315035|NCT01539083|560587748|FG000|Before Randomization (VCD Induction)|Other|5|||
155315036|NCT01539083|560587749|FG001|Before Randomization (VCD Induction)|Other|0|||
155315037|NCT01539083|560587750|FG002|Before Randomization (VCD Induction)|Other|0|||
155315038|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
155315039|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
155315040|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
155315041|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Other|0|||
155315042|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Other|1|||
155315043|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Other|1|||
155315044|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
155315045|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
155315046|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
155315047|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
155315048|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
155315049|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
155315050|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
155315051|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
155315052|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
155315053|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
155315054|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
155315055|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
155315056|NCT01539083|560587748|FG000|After Randomization (TP and VTP)|Death|0|||
155315057|NCT01539083|560587749|FG001|After Randomization (TP and VTP)|Death|6|||
155315058|NCT01539083|560587750|FG002|After Randomization (TP and VTP)|Death|11|||
155315059|NCT05006872|560587759|FG000|Overall Study|Lost to Follow-up|37|||
155315060|NCT05006872|560587760|FG001|Overall Study|Lost to Follow-up|31|||
155315061|NCT05499377|560587766|FG000|Overall Study|Withdrawal by Subject|2|||
155315062|NCT05499377|560587767|FG001|Overall Study|Withdrawal by Subject|0|||
155315063|NCT05499377|560587766|FG000|Overall Study|Physician Decision|1|||
155315064|NCT05499377|560587767|FG001|Overall Study|Physician Decision|0|||
155315065|NCT02573493|560587768|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
155315066|NCT02573493|560587769|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
155315067|NCT02573493|560587770|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
155315068|NCT02573493|560587771|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
155315069|NCT04332926|560587772|FG000|Overall Study|Withdrawal by Subject|6|||
155315070|NCT04332926|560587772|FG000|Overall Study|Physician Decision|6|||
155315071|NCT04350463|560587780|FG000|Overall Study|Other reason|0|||
155315072|NCT04350463|560587781|FG001|Overall Study|Other reason|0|||
155315073|NCT04350463|560587782|FG002|Overall Study|Other reason|0|||
155315074|NCT04350463|560587783|FG003|Overall Study|Other reason|1|||
155315075|NCT04350463|560587780|FG000|Overall Study|Lost to Follow-up|0|||
155315076|NCT04350463|560587781|FG001|Overall Study|Lost to Follow-up|0|||
155315077|NCT04350463|560587782|FG002|Overall Study|Lost to Follow-up|0|||
155315078|NCT04350463|560587783|FG003|Overall Study|Lost to Follow-up|2|||
155315079|NCT04350463|560587780|FG000|Overall Study|Withdrawal by Subject|4|||
155315080|NCT04350463|560587781|FG001|Overall Study|Withdrawal by Subject|0|||
155315081|NCT04350463|560587782|FG002|Overall Study|Withdrawal by Subject|1|||
155315082|NCT04350463|560587783|FG003|Overall Study|Withdrawal by Subject|4|||
155315083|NCT04350463|560587780|FG000|Overall Study|Adverse Event|0|||
155315084|NCT04350463|560587781|FG001|Overall Study|Adverse Event|0|||
155315085|NCT04350463|560587782|FG002|Overall Study|Adverse Event|0|||
155315086|NCT04350463|560587783|FG003|Overall Study|Adverse Event|2|||
155315087|NCT04350463|560587780|FG000|Overall Study|Death|27|||
155315088|NCT04350463|560587781|FG001|Overall Study|Death|2|||
155315089|NCT04350463|560587782|FG002|Overall Study|Death|13|||
155315090|NCT04350463|560587783|FG003|Overall Study|Death|26|||
155315091|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
155315092|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
155315093|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
155315094|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
155315095|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
155315096|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
155315097|NCT04652700|560587784|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
155315098|NCT04652700|560587785|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
155315099|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
155315100|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
155315101|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
155315102|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
155315103|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
155315104|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
155315105|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
155315106|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
155315107|NCT04652700|560587784|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
155315108|NCT04652700|560587785|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
155315109|NCT03097549|560587786|FG000|Overall Study|Withdrawal by Subject|1|||
155315110|NCT03097549|560587787|FG001|Overall Study|Withdrawal by Subject|0|||
155315111|NCT03097549|560587786|FG000|Overall Study|Lost to Follow-up|1|||
155315112|NCT03097549|560587787|FG001|Overall Study|Lost to Follow-up|0|||
155315113|NCT01824537|560587790|FG000|Overall Study|Lost to Follow-up|78|||
155315114|NCT01824537|560587791|FG001|Overall Study|Lost to Follow-up|87|||
155315115|NCT04282148|560587792|FG000|Overall Study|Death|7|||
155315116|NCT04282148|560587792|FG000|Overall Study|Withdrawal by Subject|1|||
155315117|NCT04282148|560587792|FG000|Overall Study|Physician Decision|1|||
155315118|NCT02146378|560587793|FG000|Overall Study|No information of administration|2|||
155315119|NCT06215521|560587794|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315120|NCT06215521|560587795|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
155315121|NCT06215521|560587796|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315122|NCT06215521|560587797|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315123|NCT06215521|560587798|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315124|NCT06215521|560587799|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
155315125|NCT04096040|560587800|FG000|Overall Study|Protocol Violation|12|||
155315126|NCT04096040|560587800|FG000|Overall Study|Non-compliant site|4|||
155315127|NCT04973254|560587801|FG000|Overall Study|Not adherent|0|||
155315128|NCT04973254|560587802|FG001|Overall Study|Not adherent|1|||
155315129|NCT04973254|560587803|FG002|Overall Study|Not adherent|0|||
155315130|NCT04044768|560587804|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
155315131|NCT04044768|560587805|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
155315132|NCT03858634|560587806|FG000|Overall Study|Withdrawal by Subject|1|||
155315133|NCT03858634|560587807|FG001|Overall Study|Withdrawal by Subject|0|||
155315134|NCT03858634|560587806|FG000|Overall Study|Adverse Event|1|||
155315135|NCT03858634|560587807|FG001|Overall Study|Adverse Event|0|||
155315136|NCT03858634|560587806|FG000|Overall Study|Lost to Follow-up|0|||
155315137|NCT03858634|560587807|FG001|Overall Study|Lost to Follow-up|1|||
155315138|NCT03858634|560587806|FG000|Overall Study|Other, Not Specified|1|||
155315139|NCT03858634|560587807|FG001|Overall Study|Other, Not Specified|1|||
155315140|NCT03808818|560587808|FG000|Overall Study|Death|6|||
155315141|NCT03808818|560587809|FG001|Overall Study|Death|6|||
155315142|NCT03808818|560587808|FG000|Overall Study|Withdrawal by Subject|7|||
155315143|NCT03808818|560587809|FG001|Overall Study|Withdrawal by Subject|18|||
155315144|NCT03808818|560587808|FG000|Overall Study|Lost to Follow-up|31|||
155315145|NCT03808818|560587809|FG001|Overall Study|Lost to Follow-up|33|||
155315146|NCT05415722|560587810|FG000|Overall Study|Lost to Follow-up|0|||
155315147|NCT05415722|560587811|FG001|Overall Study|Lost to Follow-up|2|||
155315148|NCT05415722|560587812|FG002|Overall Study|Lost to Follow-up|0|||
155315149|NCT05415722|560587813|FG003|Overall Study|Lost to Follow-up|1|||
155315150|NCT05415722|560587814|FG004|Overall Study|Lost to Follow-up|0|||
155315151|NCT05415722|560587815|FG005|Overall Study|Lost to Follow-up|0|||
155315152|NCT05415722|560587816|FG006|Overall Study|Lost to Follow-up|1|||
155315153|NCT05415722|560587810|FG000|Overall Study|Physician Decision|0|||
155315154|NCT05415722|560587811|FG001|Overall Study|Physician Decision|0|||
155315155|NCT05415722|560587812|FG002|Overall Study|Physician Decision|0|||
155315156|NCT05415722|560587813|FG003|Overall Study|Physician Decision|1|||
155315157|NCT05415722|560587814|FG004|Overall Study|Physician Decision|0|||
155315158|NCT05415722|560587815|FG005|Overall Study|Physician Decision|0|||
155315159|NCT05415722|560587816|FG006|Overall Study|Physician Decision|1|||
155315160|NCT05415722|560587810|FG000|Overall Study|Protocol Violation|0|||
155315161|NCT05415722|560587811|FG001|Overall Study|Protocol Violation|0|||
155315162|NCT05415722|560587812|FG002|Overall Study|Protocol Violation|0|||
155315163|NCT05415722|560587813|FG003|Overall Study|Protocol Violation|1|||
155315164|NCT05415722|560587814|FG004|Overall Study|Protocol Violation|0|||
155315165|NCT05415722|560587815|FG005|Overall Study|Protocol Violation|0|||
155315166|NCT05415722|560587816|FG006|Overall Study|Protocol Violation|0|||
155315167|NCT05415722|560587810|FG000|Overall Study|Sponsor Discretion|0|||
155315168|NCT05415722|560587811|FG001|Overall Study|Sponsor Discretion|0|||
155315169|NCT05415722|560587812|FG002|Overall Study|Sponsor Discretion|0|||
155315170|NCT05415722|560587813|FG003|Overall Study|Sponsor Discretion|0|||
155315171|NCT05415722|560587814|FG004|Overall Study|Sponsor Discretion|1|||
155315172|NCT05415722|560587815|FG005|Overall Study|Sponsor Discretion|1|||
155315173|NCT05415722|560587816|FG006|Overall Study|Sponsor Discretion|0|||
155315174|NCT05415722|560587810|FG000|Overall Study|Withdrawal by Subject|0|||
155315175|NCT05415722|560587811|FG001|Overall Study|Withdrawal by Subject|1|||
155315176|NCT05415722|560587812|FG002|Overall Study|Withdrawal by Subject|0|||
155315177|NCT05415722|560587813|FG003|Overall Study|Withdrawal by Subject|1|||
155315178|NCT05415722|560587814|FG004|Overall Study|Withdrawal by Subject|1|||
155315179|NCT05415722|560587815|FG005|Overall Study|Withdrawal by Subject|0|||
155315180|NCT05415722|560587816|FG006|Overall Study|Withdrawal by Subject|1|||
155315181|NCT04629716|560587817|FG000|Overall Study|Lost to Follow-up|7|||
155315182|NCT04629716|560587818|FG001|Overall Study|Lost to Follow-up|3|||
155315183|NCT04537715|560587820|FG000|Overall Study|Death|3|||
155315184|NCT04537715|560587821|FG001|Overall Study|Death|1|||
155315185|NCT04537715|560587820|FG000|Overall Study|Withdrawal by Subject|3|||
155315186|NCT04537715|560587821|FG001|Overall Study|Withdrawal by Subject|1|||
155315187|NCT04537715|560587820|FG000|Overall Study|Other|4|||
155315188|NCT04537715|560587821|FG001|Overall Study|Other|3|||
155315189|NCT04537715|560587820|FG000|Overall Study|Progressive disease|1|||
155315190|NCT04537715|560587821|FG001|Overall Study|Progressive disease|0|||
155315191|NCT03448107|560587822|FG000|Overall Study|Lost to Follow-up|229|||
155315192|NCT03448107|560587823|FG001|Overall Study|Lost to Follow-up|258|||
155315193|NCT04700163|560587824|FG000|Overall Study|Lost to Follow-up|0|||
155315194|NCT04700163|560587825|FG001|Overall Study|Lost to Follow-up|0|||
155315195|NCT04700163|560587826|FG002|Overall Study|Lost to Follow-up|0|||
155315196|NCT04700163|560587827|FG003|Overall Study|Lost to Follow-up|0|||
155315197|NCT04700163|560587828|FG004|Overall Study|Lost to Follow-up|0|||
155315198|NCT04700163|560587829|FG005|Overall Study|Lost to Follow-up|1|||
155315199|NCT05543629|560587836|FG000|Overall Study|Death|1|||
155315200|NCT05543629|560587837|FG001|Overall Study|Death|0|||
155315201|NCT05543629|560587838|FG002|Overall Study|Death|1|||
155315202|NCT05543629|560587839|FG003|Overall Study|Death|0|||
155315203|NCT05543629|560587840|FG004|Overall Study|Death|0|||
155315204|NCT05543629|560587841|FG005|Overall Study|Death|1|||
155315205|NCT05543629|560587842|FG006|Overall Study|Death|2|||
155315206|NCT05543629|560587843|FG007|Overall Study|Death|2|||
155315207|NCT05543629|560587836|FG000|Overall Study|Other Reasons|0|||
155315208|NCT05543629|560587837|FG001|Overall Study|Other Reasons|0|||
155315209|NCT05543629|560587838|FG002|Overall Study|Other Reasons|0|||
155315210|NCT05543629|560587839|FG003|Overall Study|Other Reasons|0|||
155315211|NCT05543629|560587840|FG004|Overall Study|Other Reasons|1|||
155315212|NCT05543629|560587841|FG005|Overall Study|Other Reasons|0|||
155315213|NCT05543629|560587842|FG006|Overall Study|Other Reasons|0|||
154959931|NCT00934050|559278643|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155315214|NCT05543629|560587843|FG007|Overall Study|Other Reasons|0|||
155315215|NCT05543629|560587836|FG000|Overall Study|Physician Decision|0|||
155315216|NCT05543629|560587837|FG001|Overall Study|Physician Decision|0|||
155315217|NCT05543629|560587838|FG002|Overall Study|Physician Decision|3|||
155315218|NCT05543629|560587839|FG003|Overall Study|Physician Decision|0|||
155315219|NCT05543629|560587840|FG004|Overall Study|Physician Decision|0|||
155315220|NCT05543629|560587841|FG005|Overall Study|Physician Decision|0|||
155315221|NCT05543629|560587842|FG006|Overall Study|Physician Decision|1|||
155315222|NCT05543629|560587843|FG007|Overall Study|Physician Decision|0|||
155315223|NCT05543629|560587836|FG000|Overall Study|Study terminated by Sponsor|1|||
155315224|NCT05543629|560587837|FG001|Overall Study|Study terminated by Sponsor|0|||
155315225|NCT05543629|560587838|FG002|Overall Study|Study terminated by Sponsor|0|||
155315226|NCT05543629|560587839|FG003|Overall Study|Study terminated by Sponsor|1|||
155315227|NCT05543629|560587840|FG004|Overall Study|Study terminated by Sponsor|0|||
155315228|NCT05543629|560587841|FG005|Overall Study|Study terminated by Sponsor|4|||
155315229|NCT05543629|560587842|FG006|Overall Study|Study terminated by Sponsor|1|||
155315230|NCT05543629|560587843|FG007|Overall Study|Study terminated by Sponsor|0|||
155315231|NCT05543629|560587836|FG000|Overall Study|Withdrawal by Subject|1|||
155315232|NCT05543629|560587837|FG001|Overall Study|Withdrawal by Subject|1|||
155315233|NCT05543629|560587838|FG002|Overall Study|Withdrawal by Subject|0|||
155315234|NCT05543629|560587839|FG003|Overall Study|Withdrawal by Subject|2|||
155315235|NCT05543629|560587840|FG004|Overall Study|Withdrawal by Subject|1|||
155315236|NCT05543629|560587841|FG005|Overall Study|Withdrawal by Subject|1|||
155315237|NCT05543629|560587842|FG006|Overall Study|Withdrawal by Subject|1|||
155315238|NCT05543629|560587843|FG007|Overall Study|Withdrawal by Subject|1|||
155315239|NCT05543629|560587836|FG000|Overall Study|Not Reported|2|||
155315240|NCT05543629|560587837|FG001|Overall Study|Not Reported|2|||
155315241|NCT05543629|560587838|FG002|Overall Study|Not Reported|0|||
155315242|NCT05543629|560587839|FG003|Overall Study|Not Reported|0|||
155315243|NCT05543629|560587840|FG004|Overall Study|Not Reported|1|||
155315244|NCT05543629|560587841|FG005|Overall Study|Not Reported|1|||
155315245|NCT05543629|560587842|FG006|Overall Study|Not Reported|3|||
155315246|NCT05543629|560587843|FG007|Overall Study|Not Reported|0|||
155315247|NCT04568603|560587844|FG000|Overall Study|Physician Decision|1|||
155315248|NCT04564742|560587845|FG000|Overall Study|Lost to Follow-up|1|||
155315249|NCT04564742|560587846|FG001|Overall Study|Lost to Follow-up|0|||
155315250|NCT04564742|560587845|FG000|Overall Study|Consent Withdrawal|4|||
155315251|NCT04564742|560587846|FG001|Overall Study|Consent Withdrawal|4|||
155315252|NCT05869383|560587849|FG000|Overall Study|Withdrawal by Subject|2|||
155315253|NCT05869383|560587850|FG001|Overall Study|Withdrawal by Subject|0|||
155315254|NCT03084536|560587857|FG000|Overall Study|Determined to be ineligible|0|||
155315255|NCT03084536|560587858|FG001|Overall Study|Determined to be ineligible|0|||
155315256|NCT03084536|560587859|FG002|Overall Study|Determined to be ineligible|16|||
155315257|NCT03084536|560587857|FG000|Overall Study|Withdrawal by Subject|0|||
155315258|NCT03084536|560587858|FG001|Overall Study|Withdrawal by Subject|0|||
155315259|NCT03084536|560587859|FG002|Overall Study|Withdrawal by Subject|4|||
155315260|NCT03084536|560587857|FG000|Overall Study|Physician Decision|0|||
155315261|NCT03084536|560587858|FG001|Overall Study|Physician Decision|0|||
155315262|NCT03084536|560587859|FG002|Overall Study|Physician Decision|3|||
155315263|NCT03084536|560587857|FG000|Overall Study|Death|0|||
155315264|NCT03084536|560587858|FG001|Overall Study|Death|0|||
155315265|NCT03084536|560587859|FG002|Overall Study|Death|1|||
155315266|NCT03084536|560587857|FG000|Overall Study|Lost to Follow-up|0|||
155315267|NCT03084536|560587858|FG001|Overall Study|Lost to Follow-up|0|||
155315268|NCT03084536|560587859|FG002|Overall Study|Lost to Follow-up|1|||
155315269|NCT03084536|560587857|FG000|Overall Study|Protocol Violation|0|||
155315270|NCT03084536|560587858|FG001|Overall Study|Protocol Violation|0|||
155315271|NCT03084536|560587859|FG002|Overall Study|Protocol Violation|1|||
155315272|NCT03084536|560587857|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
155315273|NCT03084536|560587858|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
155315274|NCT03084536|560587859|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
155315275|NCT04728347|560589884|FG000|Overall Study|Sponsor decision|0|||
155315276|NCT04728347|560589885|FG001|Overall Study|Sponsor decision|0|||
155315277|NCT04728347|560589886|FG002|Overall Study|Sponsor decision|1|||
155315278|NCT04728347|560589887|FG003|Overall Study|Sponsor decision|0|||
155315279|NCT05835336|560589888|FG000|Overall Study|Withdrawal by Subject|5|||
155315280|NCT05835336|560589888|FG000|Overall Study|Did not complete the personalization process|3|||
155315281|NCT04489771|560589889|FG000|Overall Study|Death|27|||
155315282|NCT04489771|560589890|FG001|Overall Study|Death|25|||
155315283|NCT04489771|560589889|FG000|Overall Study|Withdrawal by Subject|1|||
155315284|NCT04489771|560589890|FG001|Overall Study|Withdrawal by Subject|0|||
155315285|NCT04489771|560589889|FG000|Overall Study|Participants Ongoing in Study|50|||
155315286|NCT04489771|560589890|FG001|Overall Study|Participants Ongoing in Study|51|||
155315287|NCT04059484|560589892|FG000|Overall Study|Adverse Event|2|||
155315288|NCT04059484|560589893|FG001|Overall Study|Adverse Event|5|||
155315289|NCT04059484|560589892|FG000|Overall Study|Withdrawal by Subject|5|||
155315290|NCT04059484|560589893|FG001|Overall Study|Withdrawal by Subject|3|||
155315291|NCT04059484|560589892|FG000|Overall Study|Progressive disease|112|||
155315292|NCT04059484|560589893|FG001|Overall Study|Progressive disease|112|||
155315293|NCT04059484|560589892|FG000|Overall Study|Other|8|||
155315294|NCT04059484|560589893|FG001|Overall Study|Other|3|||
155315295|NCT04059484|560589892|FG000|Overall Study|Ongoing|20|||
155315296|NCT04059484|560589893|FG001|Overall Study|Ongoing|20|||
155315297|NCT04719390|560589894|FG000|Overall Study|Withdrawal by Subject|1|||
155315298|NCT04292223|560589895|FG000|Overall Study|Adverse Event|1|||
155315299|NCT04292223|560589895|FG000|Overall Study|Lost to Follow-up|1|||
155315300|NCT04292223|560589895|FG000|Overall Study|Noncompliance with study drug|2|||
155315301|NCT04292223|560589895|FG000|Overall Study|Patient moved out of the state|1|||
155315302|NCT00753545|560589896|FG000|Overall Study|Death|98|||
155315303|NCT00753545|560589897|FG001|Overall Study|Death|112|||
155315304|NCT00753545|560589896|FG000|Overall Study|Lost to Follow-up|2|||
155315305|NCT00753545|560589897|FG001|Overall Study|Lost to Follow-up|3|||
155315306|NCT00753545|560589896|FG000|Overall Study|Protocol Violation|1|||
155315307|NCT00753545|560589897|FG001|Overall Study|Protocol Violation|0|||
155315308|NCT00753545|560589896|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
155315309|NCT00753545|560589897|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
155315310|NCT05453773|560589898|FG000|Overall Study|Withdrawal by Subject|3|||
155315311|NCT05453773|560589898|FG000|Overall Study|Lost to Follow-up|3|||
155315312|NCT05453773|560589898|FG000|Overall Study|Difficult Blood Draw|3|||
155315313|NCT04633122|560589901|FG000|Overall Study|Remained on treatment|19|||
155315314|NCT04633122|560589902|FG001|Overall Study|Remained on treatment|14|||
155315315|NCT04633122|560589901|FG000|Overall Study|Survival follow-up stopped|22|||
155315316|NCT04633122|560589902|FG001|Overall Study|Survival follow-up stopped|25|||
155315317|NCT03839940|560589903|FG000|Overall Study|Withdrawal by Subject|3|||
155315318|NCT03839940|560589904|FG001|Overall Study|Withdrawal by Subject|0|||
155315319|NCT03839940|560589903|FG000|Overall Study|Protocol Violation|0|||
155315320|NCT03839940|560589904|FG001|Overall Study|Protocol Violation|1|||
155315321|NCT03839940|560589903|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
155315322|NCT03839940|560589904|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
155315323|NCT04799899|560589905|FG000|Overall Study|Lost to Follow-up|2|||
155315324|NCT04799899|560589906|FG001|Overall Study|Lost to Follow-up|4|||
155315325|NCT02561247|560589907|FG000|Overall Study|Protocol Violation|1|||
155315326|NCT02561247|560589907|FG000|Overall Study|Withdrawal by Subject|1|||
155315327|NCT02561247|560589907|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
155315328|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
155315329|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
155315330|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
155315331|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
155315332|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155315333|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
155315334|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155315335|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155315336|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
155315337|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155315338|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155315339|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155315340|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
155315341|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
155315342|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
155315343|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
155315344|NCT04963270|560589908|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
155315345|NCT04963270|560589909|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
155315346|NCT04963270|560589910|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
155315347|NCT04963270|560589911|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
155315348|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
155315349|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
155315350|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
155315351|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
155315352|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
155315353|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
155315354|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
155315355|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
155315356|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
155315357|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
155315358|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
155315359|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
155315360|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
155315361|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
155315362|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
155315363|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
155315364|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
155315365|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
155315366|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
155315367|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
155315368|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
155315369|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
155315370|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
155315371|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
155315372|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
155315373|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
155315374|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
155315375|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
155315376|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
155315377|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
155315378|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
155315379|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
155315380|NCT04963270|560589908|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
155315381|NCT04963270|560589909|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
155315382|NCT04963270|560589910|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
155315383|NCT04963270|560589911|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
155315384|NCT04908722|560589916|FG000|Overall Study|Protocol deviation|1|||
155315385|NCT04908722|560589917|FG001|Overall Study|Protocol deviation|0|||
155315386|NCT04908722|560589918|FG002|Overall Study|Protocol deviation|0|||
155315387|NCT04908722|560589919|FG003|Overall Study|Protocol deviation|0|||
155315388|NCT04908722|560589920|FG004|Overall Study|Protocol deviation|0|||
155315389|NCT04908722|560589921|FG005|Overall Study|Protocol deviation|1|||
155315390|NCT04908722|560589916|FG000|Overall Study|Lost to Follow-up|33|||
155315391|NCT04908722|560589917|FG001|Overall Study|Lost to Follow-up|33|||
155315392|NCT04908722|560589918|FG002|Overall Study|Lost to Follow-up|36|||
155315393|NCT04908722|560589919|FG003|Overall Study|Lost to Follow-up|30|||
155315394|NCT04908722|560589920|FG004|Overall Study|Lost to Follow-up|32|||
155315395|NCT04908722|560589921|FG005|Overall Study|Lost to Follow-up|34|||
155315396|NCT04908722|560589916|FG000|Overall Study|Physician Decision|1|||
155315397|NCT04908722|560589917|FG001|Overall Study|Physician Decision|1|||
155315398|NCT04908722|560589918|FG002|Overall Study|Physician Decision|1|||
155315399|NCT04908722|560589919|FG003|Overall Study|Physician Decision|2|||
155315400|NCT04908722|560589920|FG004|Overall Study|Physician Decision|0|||
155315401|NCT04908722|560589921|FG005|Overall Study|Physician Decision|0|||
155315402|NCT04908722|560589916|FG000|Overall Study|Death|1|||
155315403|NCT04908722|560589917|FG001|Overall Study|Death|0|||
155315404|NCT04908722|560589918|FG002|Overall Study|Death|0|||
155315405|NCT04908722|560589919|FG003|Overall Study|Death|0|||
155315406|NCT04908722|560589920|FG004|Overall Study|Death|0|||
155315407|NCT04908722|560589921|FG005|Overall Study|Death|1|||
155315408|NCT04908722|560589916|FG000|Overall Study|Withdrawal by Subject|12|||
155315409|NCT04908722|560589917|FG001|Overall Study|Withdrawal by Subject|8|||
155315410|NCT04908722|560589918|FG002|Overall Study|Withdrawal by Subject|7|||
155315411|NCT04908722|560589919|FG003|Overall Study|Withdrawal by Subject|6|||
155315412|NCT04908722|560589920|FG004|Overall Study|Withdrawal by Subject|12|||
155315413|NCT04908722|560589921|FG005|Overall Study|Withdrawal by Subject|14|||
155315414|NCT04908722|560589916|FG000|Overall Study|Other|3|||
155315415|NCT04908722|560589917|FG001|Overall Study|Other|1|||
155315416|NCT04908722|560589918|FG002|Overall Study|Other|3|||
155315417|NCT04908722|560589919|FG003|Overall Study|Other|2|||
155315418|NCT04908722|560589920|FG004|Overall Study|Other|4|||
155315419|NCT04908722|560589921|FG005|Overall Study|Other|1|||
155315420|NCT04908722|560589916|FG000|Overall Study|Initiated prohibited medication|0|||
155315421|NCT04908722|560589917|FG001|Overall Study|Initiated prohibited medication|0|||
155315422|NCT04908722|560589918|FG002|Overall Study|Initiated prohibited medication|0|||
155315423|NCT04908722|560589919|FG003|Overall Study|Initiated prohibited medication|1|||
155315424|NCT04908722|560589920|FG004|Overall Study|Initiated prohibited medication|0|||
155315425|NCT04908722|560589921|FG005|Overall Study|Initiated prohibited medication|1|||
155315426|NCT04908722|560589916|FG000|Overall Study|Randomized but not vaccinated|3|||
155315427|NCT04908722|560589917|FG001|Overall Study|Randomized but not vaccinated|1|||
155315428|NCT04908722|560589918|FG002|Overall Study|Randomized but not vaccinated|2|||
155315429|NCT04908722|560589919|FG003|Overall Study|Randomized but not vaccinated|2|||
155315430|NCT04908722|560589920|FG004|Overall Study|Randomized but not vaccinated|3|||
155315431|NCT04908722|560589921|FG005|Overall Study|Randomized but not vaccinated|4|||
155315432|NCT02979327|560589925|FG000|First Intervention|Protocol Violation|1|||
155315433|NCT02979327|560589926|FG001|First Intervention|Protocol Violation|0|||
155315434|NCT05780437|560589932|FG000|Overall Study|Withdrawal by Subject|22|||
155315435|NCT05780437|560589933|FG001|Overall Study|Withdrawal by Subject|16|||
155315436|NCT03474679|560589937|FG000|Overall Study|Death|7|||
155315437|NCT03474679|560589937|FG000|Overall Study|Withdrawal by Subject|1|||
155315438|NCT04623671|560589946|FG000|Overall Study|Adverse Event|0|||
155315439|NCT04623671|560589947|FG001|Overall Study|Adverse Event|1|||
155315440|NCT04623671|560589946|FG000|Overall Study|Lost to Follow-up|2|||
155315441|NCT04623671|560589947|FG001|Overall Study|Lost to Follow-up|1|||
155315442|NCT04623671|560589946|FG000|Overall Study|Death|5|||
155315443|NCT04623671|560589947|FG001|Overall Study|Death|5|||
155315444|NCT04025554|560589948|FG000|Overall Study|Adverse Event|3|||
155315445|NCT01802788|560589952|FG000|Overall Study|Withdrawal by Subject|102|||
155315446|NCT01802788|560589953|FG001|Overall Study|Withdrawal by Subject|5|||
155315447|NCT01802788|560589952|FG000|Overall Study|Death|382|||
155315448|NCT01802788|560589953|FG001|Overall Study|Death|18|||
155315449|NCT01802788|560589952|FG000|Overall Study|Lost to Follow-up|31|||
155315450|NCT01802788|560589953|FG001|Overall Study|Lost to Follow-up|2|||
155315451|NCT01802788|560589952|FG000|Overall Study|Physician Decision|3|||
155315452|NCT01802788|560589953|FG001|Overall Study|Physician Decision|0|||
155315453|NCT01802788|560589952|FG000|Overall Study|Patient Non-Compliance|1|||
155315454|NCT01802788|560589953|FG001|Overall Study|Patient Non-Compliance|0|||
155315455|NCT01802788|560589952|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
155315456|NCT01802788|560589953|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
155315457|NCT01802788|560589952|FG000|Overall Study|Other Reasons|19|||
155315458|NCT01802788|560589953|FG001|Overall Study|Other Reasons|0|||
155315459|NCT05257486|560589954|FG000|Overall Study|Protocol Violation|3|||
155315460|NCT03021096|560589955|FG000|Overall Study|Lost to Follow-up|4|||
155315461|NCT03021096|560589955|FG000|Overall Study|Protocol Violation|2|||
155315462|NCT03848065|560589956|FG000|Overall Study|Death|0|||
155315463|NCT03848065|560589957|FG001|Overall Study|Death|1|||
155315464|NCT03848065|560589958|FG002|Overall Study|Death|0|||
155315465|NCT03848065|560589956|FG000|Overall Study|Lost to Follow-up|0|||
155315466|NCT03848065|560589957|FG001|Overall Study|Lost to Follow-up|0|||
155315467|NCT03848065|560589958|FG002|Overall Study|Lost to Follow-up|1|||
155315468|NCT03848065|560589956|FG000|Overall Study|Physician Decision|0|||
155315469|NCT03848065|560589957|FG001|Overall Study|Physician Decision|0|||
155315470|NCT03848065|560589958|FG002|Overall Study|Physician Decision|1|||
155315471|NCT03313076|560589960|FG000|Overall Study|Withdrawal by Subject|2|||
155315472|NCT03313076|560589961|FG001|Overall Study|Withdrawal by Subject|0|||
155315473|NCT03313076|560589962|FG002|Overall Study|Withdrawal by Subject|0|||
155315474|NCT03313076|560589963|FG003|Overall Study|Withdrawal by Subject|0|||
155315475|NCT03313076|560589960|FG000|Overall Study|Lost to Follow-up|0|||
155315476|NCT03313076|560589961|FG001|Overall Study|Lost to Follow-up|2|||
155315477|NCT03313076|560589962|FG002|Overall Study|Lost to Follow-up|2|||
155315478|NCT03313076|560589963|FG003|Overall Study|Lost to Follow-up|2|||
155315479|NCT05144009|560589966|FG000|Overall Study|Lost to Follow-up|0|||
155315480|NCT05144009|560589967|FG001|Overall Study|Lost to Follow-up|1|||
155315481|NCT05144009|560589966|FG000|Overall Study|Study Termination by the Sponsor|11|||
155315482|NCT05144009|560589967|FG001|Overall Study|Study Termination by the Sponsor|11|||
155315483|NCT05144009|560589966|FG000|Overall Study|Disease Progression|1|||
155315484|NCT05144009|560589967|FG001|Overall Study|Disease Progression|0|||
155315485|NCT05144009|560589966|FG000|Overall Study|Participant Decision|0|||
155315486|NCT05144009|560589967|FG001|Overall Study|Participant Decision|2|||
155315487|NCT05144009|560589966|FG000|Overall Study|Death|5|||
155315488|NCT05144009|560589967|FG001|Overall Study|Death|10|||
155315489|NCT03270501|560589968|FG000|Overall Study|Screen failure|6|||
155315490|NCT03270501|560589968|FG000|Overall Study|Lost to Follow-up|2|||
155315491|NCT03270501|560589968|FG000|Overall Study|Adverse Event|1|||
155315492|NCT00764751|560589971|FG000|Overall Study|Adverse Event|1|||
155315493|NCT00764751|560589972|FG001|Overall Study|Adverse Event|1|||
155315494|NCT00764751|560589971|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
155315495|NCT00764751|560589972|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
155315496|NCT04307355|560589979|FG000|Overall Study|Non-Compliance|3|||
155315497|NCT04307355|560589980|FG001|Overall Study|Non-Compliance|3|||
155315498|NCT04307355|560589981|FG002|Overall Study|Non-Compliance|0|||
155315499|NCT04065841|560589982|FG000|Overall Study|Adverse Event|4|||
155315500|NCT04065841|560589983|FG001|Overall Study|Adverse Event|2|||
155315501|NCT04065841|560589984|FG002|Overall Study|Adverse Event|10|||
155315502|NCT04065841|560589985|FG003|Overall Study|Adverse Event|1|||
155315503|NCT04065841|560589982|FG000|Overall Study|Lost to Follow-up|1|||
155315504|NCT04065841|560589983|FG001|Overall Study|Lost to Follow-up|2|||
155315505|NCT04065841|560589984|FG002|Overall Study|Lost to Follow-up|2|||
155315506|NCT04065841|560589985|FG003|Overall Study|Lost to Follow-up|2|||
155315507|NCT04065841|560589982|FG000|Overall Study|Physician Decision|1|||
155315508|NCT04065841|560589983|FG001|Overall Study|Physician Decision|0|||
155315509|NCT04065841|560589984|FG002|Overall Study|Physician Decision|0|||
155315510|NCT04065841|560589985|FG003|Overall Study|Physician Decision|0|||
155315511|NCT04065841|560589982|FG000|Overall Study|Protocol Violation|0|||
155315512|NCT04065841|560589983|FG001|Overall Study|Protocol Violation|1|||
155315513|NCT04065841|560589984|FG002|Overall Study|Protocol Violation|0|||
155067017|NCT03329001|559676946|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
155315514|NCT04065841|560589985|FG003|Overall Study|Protocol Violation|0|||
155315515|NCT04065841|560589982|FG000|Overall Study|Study terminated by Sponsor|22|||
155315516|NCT04065841|560589983|FG001|Overall Study|Study terminated by Sponsor|16|||
155315517|NCT04065841|560589984|FG002|Overall Study|Study terminated by Sponsor|28|||
155315518|NCT04065841|560589985|FG003|Overall Study|Study terminated by Sponsor|17|||
155315519|NCT04065841|560589982|FG000|Overall Study|Withdrawal by Subject|1|||
155315520|NCT04065841|560589983|FG001|Overall Study|Withdrawal by Subject|1|||
155315521|NCT04065841|560589984|FG002|Overall Study|Withdrawal by Subject|2|||
155315522|NCT04065841|560589985|FG003|Overall Study|Withdrawal by Subject|0|||
155315523|NCT01420237|560589988|FG000|Overall Study|Death|13|||
155315524|NCT01420237|560589988|FG000|Overall Study|Withdrawal by Subject|41|||
155315525|NCT01420237|560589988|FG000|Overall Study|Lost to Follow-up|32|||
155315526|NCT01420237|560589988|FG000|Overall Study|Adverse Event|10|||
155315527|NCT01420237|560589988|FG000|Overall Study|Investigative Site Termination|43|||
155315528|NCT01420237|560589988|FG000|Overall Study|Censored because study device not implanted|21|||
155315529|NCT01420237|560589988|FG000|Overall Study|Censored because surgery not performed|2|||
155315530|NCT01420237|560589988|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
155315531|NCT01420237|560589988|FG000|Overall Study|Sponsor terminated study early|127|||
155315532|NCT05269667|560589989|FG000|Overall Study|Study Terminated by Sponsor|4|||
155315533|NCT05270408|560589993|FG000|Started Treatment|Withdrawal by Subject|0|||
155315534|NCT05270408|560589994|FG001|Started Treatment|Withdrawal by Subject|0|||
155315535|NCT05270408|560589995|FG002|Started Treatment|Withdrawal by Subject|3|||
155315536|NCT05270408|560589993|FG000|Started Treatment|Adverse Event|0|||
155315537|NCT05270408|560589994|FG001|Started Treatment|Adverse Event|0|||
155315538|NCT05270408|560589995|FG002|Started Treatment|Adverse Event|1|||
155315539|NCT05270408|560589993|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
155315540|NCT05270408|560589994|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
155315541|NCT05270408|560589995|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
155315542|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
155315543|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
155315544|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
155315545|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
155315546|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
155315547|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
155315548|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
155315549|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
155315550|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
155315551|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
155315552|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
155315553|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
155315554|NCT04338061|560589999|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
155315555|NCT04338061|560590000|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
155315556|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
155315557|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
155315558|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
155315559|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
155315560|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
155315561|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
155315562|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
155315563|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
155315564|NCT04338061|560589999|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
155315565|NCT04338061|560590000|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
155315566|NCT04492722|560590002|FG000|Overall Study|Adverse Event|7|||
154959932|NCT00934050|559278644|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
155162381|NCT00960999|560029878|FG000|Overall Study|RT dose constraints not met|2|||
155315567|NCT04492722|560590003|FG001|Overall Study|Adverse Event|2|||
155315568|NCT04492722|560590004|FG002|Overall Study|Adverse Event|3|||
155315569|NCT04492722|560590005|FG003|Overall Study|Adverse Event|0|||
155315570|NCT04492722|560590002|FG000|Overall Study|Death|0|||
155315571|NCT04492722|560590003|FG001|Overall Study|Death|0|||
155315572|NCT04492722|560590004|FG002|Overall Study|Death|0|||
155315573|NCT04492722|560590005|FG003|Overall Study|Death|1|||
155315574|NCT04492722|560590002|FG000|Overall Study|Lost to Follow-up|0|||
155315575|NCT04492722|560590003|FG001|Overall Study|Lost to Follow-up|1|||
155315576|NCT04492722|560590004|FG002|Overall Study|Lost to Follow-up|0|||
155315577|NCT04492722|560590005|FG003|Overall Study|Lost to Follow-up|1|||
155315578|NCT04492722|560590002|FG000|Overall Study|Physician Decision|0|||
155315579|NCT04492722|560590003|FG001|Overall Study|Physician Decision|3|||
155315580|NCT04492722|560590004|FG002|Overall Study|Physician Decision|1|||
155315581|NCT04492722|560590005|FG003|Overall Study|Physician Decision|1|||
155315582|NCT04492722|560590002|FG000|Overall Study|Withdrawal by Subject|6|||
155315583|NCT04492722|560590003|FG001|Overall Study|Withdrawal by Subject|6|||
155315584|NCT04492722|560590004|FG002|Overall Study|Withdrawal by Subject|0|||
155315585|NCT04492722|560590005|FG003|Overall Study|Withdrawal by Subject|3|||
155315586|NCT04492722|560590002|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
155315587|NCT04492722|560590003|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
155315588|NCT04492722|560590004|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
155315589|NCT04492722|560590005|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
155315590|NCT04492722|560590002|FG000|Overall Study|Due to Covid-19 pandemic|7|||
155315591|NCT04492722|560590003|FG001|Overall Study|Due to Covid-19 pandemic|3|||
155315592|NCT04492722|560590004|FG002|Overall Study|Due to Covid-19 pandemic|7|||
155315593|NCT04492722|560590005|FG003|Overall Study|Due to Covid-19 pandemic|6|||
155315594|NCT04492722|560590002|FG000|Overall Study|Failure to meet randomisation criteria|2|||
155315595|NCT04492722|560590003|FG001|Overall Study|Failure to meet randomisation criteria|3|||
155315596|NCT04492722|560590004|FG002|Overall Study|Failure to meet randomisation criteria|4|||
155315597|NCT04492722|560590005|FG003|Overall Study|Failure to meet randomisation criteria|2|||
155315598|NCT04492722|560590002|FG000|Overall Study|Early termination from the study|54|||
155315599|NCT04492722|560590003|FG001|Overall Study|Early termination from the study|51|||
155315600|NCT04492722|560590004|FG002|Overall Study|Early termination from the study|50|||
155315601|NCT04492722|560590005|FG003|Overall Study|Early termination from the study|50|||
155315602|NCT04492722|560590002|FG000|Overall Study|Missing|3|||
155315603|NCT04492722|560590003|FG001|Overall Study|Missing|0|||
155315604|NCT04492722|560590004|FG002|Overall Study|Missing|0|||
155315605|NCT04492722|560590005|FG003|Overall Study|Missing|5|||
155315606|NCT04492722|560590002|FG000|Overall Study|Participants who did not receive treatment|0|||
155315607|NCT04492722|560590003|FG001|Overall Study|Participants who did not receive treatment|1|||
155315608|NCT04492722|560590004|FG002|Overall Study|Participants who did not receive treatment|4|||
155315609|NCT04492722|560590005|FG003|Overall Study|Participants who did not receive treatment|0|||
155315610|NCT04074759|560590006|FG000|Overall Study|Withdrawal by Subject|0|||
155315611|NCT04074759|560590007|FG001|Overall Study|Withdrawal by Subject|0|||
155315612|NCT04074759|560590008|FG002|Overall Study|Withdrawal by Subject|0|||
155315613|NCT04074759|560590009|FG003|Overall Study|Withdrawal by Subject|0|||
155315614|NCT04074759|560590010|FG004|Overall Study|Withdrawal by Subject|0|||
155315615|NCT04074759|560590011|FG005|Overall Study|Withdrawal by Subject|2|||
155315616|NCT04074759|560590012|FG006|Overall Study|Withdrawal by Subject|0|||
155315617|NCT04074759|560590013|FG007|Overall Study|Withdrawal by Subject|2|||
155315618|NCT04074759|560590014|FG008|Overall Study|Withdrawal by Subject|1|||
155315619|NCT04074759|560590015|FG009|Overall Study|Withdrawal by Subject|2|||
155315620|NCT04074759|560590016|FG010|Overall Study|Withdrawal by Subject|9|||
155315621|NCT04074759|560590017|FG011|Overall Study|Withdrawal by Subject|2|||
155315622|NCT04074759|560590018|FG012|Overall Study|Withdrawal by Subject|1|||
155315623|NCT04074759|560590019|FG013|Overall Study|Withdrawal by Subject|3|||
155315624|NCT04074759|560590020|FG014|Overall Study|Withdrawal by Subject|2|||
155315625|NCT04074759|560590021|FG015|Overall Study|Withdrawal by Subject|0|||
155315626|NCT04074759|560590022|FG016|Overall Study|Withdrawal by Subject|0|||
155315627|NCT04074759|560590023|FG017|Overall Study|Withdrawal by Subject|3|||
155315628|NCT04074759|560590024|FG018|Overall Study|Withdrawal by Subject|1|||
155315629|NCT04074759|560590006|FG000|Overall Study|Death|1|||
155315630|NCT04074759|560590007|FG001|Overall Study|Death|0|||
155315631|NCT04074759|560590008|FG002|Overall Study|Death|1|||
155315632|NCT04074759|560590009|FG003|Overall Study|Death|1|||
155315633|NCT04074759|560590010|FG004|Overall Study|Death|2|||
155315634|NCT04074759|560590011|FG005|Overall Study|Death|0|||
155315635|NCT04074759|560590012|FG006|Overall Study|Death|1|||
155315636|NCT04074759|560590013|FG007|Overall Study|Death|0|||
155315637|NCT04074759|560590014|FG008|Overall Study|Death|3|||
155315638|NCT04074759|560590015|FG009|Overall Study|Death|2|||
155315639|NCT04074759|560590016|FG010|Overall Study|Death|4|||
155315640|NCT04074759|560590017|FG011|Overall Study|Death|1|||
155315641|NCT04074759|560590018|FG012|Overall Study|Death|0|||
155315642|NCT04074759|560590019|FG013|Overall Study|Death|2|||
155315643|NCT04074759|560590020|FG014|Overall Study|Death|1|||
155315644|NCT04074759|560590021|FG015|Overall Study|Death|0|||
155315645|NCT04074759|560590022|FG016|Overall Study|Death|1|||
155315646|NCT04074759|560590023|FG017|Overall Study|Death|0|||
155315647|NCT04074759|560590024|FG018|Overall Study|Death|1|||
155315648|NCT04074759|560590006|FG000|Overall Study|Lost to Follow-up|0|||
155315649|NCT04074759|560590007|FG001|Overall Study|Lost to Follow-up|0|||
155315650|NCT04074759|560590008|FG002|Overall Study|Lost to Follow-up|0|||
155315651|NCT04074759|560590009|FG003|Overall Study|Lost to Follow-up|0|||
155315652|NCT04074759|560590010|FG004|Overall Study|Lost to Follow-up|0|||
155315653|NCT04074759|560590011|FG005|Overall Study|Lost to Follow-up|0|||
155315654|NCT04074759|560590012|FG006|Overall Study|Lost to Follow-up|0|||
155315655|NCT04074759|560590013|FG007|Overall Study|Lost to Follow-up|0|||
155315656|NCT04074759|560590014|FG008|Overall Study|Lost to Follow-up|0|||
155315657|NCT04074759|560590015|FG009|Overall Study|Lost to Follow-up|0|||
155315658|NCT04074759|560590016|FG010|Overall Study|Lost to Follow-up|1|||
155315659|NCT04074759|560590017|FG011|Overall Study|Lost to Follow-up|0|||
155315660|NCT04074759|560590018|FG012|Overall Study|Lost to Follow-up|0|||
155315661|NCT04074759|560590019|FG013|Overall Study|Lost to Follow-up|0|||
155315662|NCT04074759|560590020|FG014|Overall Study|Lost to Follow-up|0|||
155315663|NCT04074759|560590021|FG015|Overall Study|Lost to Follow-up|0|||
155315664|NCT04074759|560590022|FG016|Overall Study|Lost to Follow-up|1|||
155315665|NCT04074759|560590023|FG017|Overall Study|Lost to Follow-up|0|||
155315666|NCT04074759|560590024|FG018|Overall Study|Lost to Follow-up|1|||
155315667|NCT04074759|560590006|FG000|Overall Study|Other|0|||
155315668|NCT04074759|560590007|FG001|Overall Study|Other|1|||
155315669|NCT04074759|560590008|FG002|Overall Study|Other|1|||
155315670|NCT04074759|560590009|FG003|Overall Study|Other|0|||
155315671|NCT04074759|560590010|FG004|Overall Study|Other|2|||
155315672|NCT04074759|560590011|FG005|Overall Study|Other|1|||
155315673|NCT04074759|560590012|FG006|Overall Study|Other|2|||
155315674|NCT04074759|560590013|FG007|Overall Study|Other|1|||
155315675|NCT04074759|560590014|FG008|Overall Study|Other|1|||
155315676|NCT04074759|560590015|FG009|Overall Study|Other|4|||
155315677|NCT04074759|560590016|FG010|Overall Study|Other|4|||
155315678|NCT04074759|560590017|FG011|Overall Study|Other|2|||
155315679|NCT04074759|560590018|FG012|Overall Study|Other|0|||
155315680|NCT04074759|560590019|FG013|Overall Study|Other|0|||
155315681|NCT04074759|560590020|FG014|Overall Study|Other|0|||
155315682|NCT04074759|560590021|FG015|Overall Study|Other|1|||
155315683|NCT04074759|560590022|FG016|Overall Study|Other|0|||
155315684|NCT04074759|560590023|FG017|Overall Study|Other|0|||
155315685|NCT04074759|560590024|FG018|Overall Study|Other|0|||
155315686|NCT04074759|560590006|FG000|Overall Study|Missing end of study status|0|||
155315687|NCT04074759|560590007|FG001|Overall Study|Missing end of study status|0|||
155315688|NCT04074759|560590008|FG002|Overall Study|Missing end of study status|0|||
155315689|NCT04074759|560590009|FG003|Overall Study|Missing end of study status|0|||
155315690|NCT04074759|560590010|FG004|Overall Study|Missing end of study status|0|||
155315691|NCT04074759|560590011|FG005|Overall Study|Missing end of study status|0|||
155315692|NCT04074759|560590012|FG006|Overall Study|Missing end of study status|0|||
155315693|NCT04074759|560590013|FG007|Overall Study|Missing end of study status|0|||
155315694|NCT04074759|560590014|FG008|Overall Study|Missing end of study status|0|||
155315695|NCT04074759|560590015|FG009|Overall Study|Missing end of study status|0|||
155315696|NCT04074759|560590016|FG010|Overall Study|Missing end of study status|2|||
155315697|NCT04074759|560590017|FG011|Overall Study|Missing end of study status|0|||
155315698|NCT04074759|560590018|FG012|Overall Study|Missing end of study status|0|||
155315699|NCT04074759|560590019|FG013|Overall Study|Missing end of study status|0|||
155315700|NCT04074759|560590020|FG014|Overall Study|Missing end of study status|0|||
155315701|NCT04074759|560590021|FG015|Overall Study|Missing end of study status|0|||
155315702|NCT04074759|560590022|FG016|Overall Study|Missing end of study status|1|||
155315703|NCT04074759|560590023|FG017|Overall Study|Missing end of study status|0|||
155315704|NCT04074759|560590024|FG018|Overall Study|Missing end of study status|0|||
155315705|NCT03631784|560590026|FG000|Overall Study|Participants Ongoing|1|||
155315706|NCT03631784|560590027|FG001|Overall Study|Participants Ongoing|0|||
155315707|NCT03631784|560590026|FG000|Overall Study|Withdrawal by Subject|3|||
155315708|NCT03631784|560590027|FG001|Overall Study|Withdrawal by Subject|3|||
155315709|NCT03631784|560590026|FG000|Overall Study|Sponsor's Decision|36|||
155315710|NCT03631784|560590027|FG001|Overall Study|Sponsor's Decision|52|||
155315711|NCT03631784|560590026|FG000|Overall Study|Lost to Follow-up|1|||
155315712|NCT03631784|560590027|FG001|Overall Study|Lost to Follow-up|0|||
155315713|NCT03631784|560590026|FG000|Overall Study|Death|71|||
155315714|NCT03631784|560590027|FG001|Overall Study|Death|49|||
155315715|NCT05329220|560590028|FG000|Active Trial Period|Adverse Event|0|||
155315716|NCT05329220|560590029|FG001|Active Trial Period|Adverse Event|0|||
155315717|NCT05329220|560590030|FG002|Active Trial Period|Adverse Event|0|||
155315718|NCT05329220|560590031|FG003|Active Trial Period|Adverse Event|0|||
155315719|NCT05329220|560590032|FG004|Active Trial Period|Adverse Event|1|||
155315720|NCT05329220|560590033|FG005|Active Trial Period|Adverse Event|0|||
155315721|NCT05329220|560590028|FG000|Active Trial Period|Lost to Follow-up|0|||
155315722|NCT05329220|560590029|FG001|Active Trial Period|Lost to Follow-up|0|||
155315723|NCT05329220|560590030|FG002|Active Trial Period|Lost to Follow-up|0|||
155315724|NCT05329220|560590031|FG003|Active Trial Period|Lost to Follow-up|0|||
155315725|NCT05329220|560590032|FG004|Active Trial Period|Lost to Follow-up|32|||
155315726|NCT05329220|560590033|FG005|Active Trial Period|Lost to Follow-up|28|||
155315727|NCT05329220|560590028|FG000|Active Trial Period|Physician Decision|0|||
155315728|NCT05329220|560590029|FG001|Active Trial Period|Physician Decision|0|||
155315729|NCT05329220|560590030|FG002|Active Trial Period|Physician Decision|0|||
155315730|NCT05329220|560590031|FG003|Active Trial Period|Physician Decision|0|||
155315731|NCT05329220|560590032|FG004|Active Trial Period|Physician Decision|2|||
155315732|NCT05329220|560590033|FG005|Active Trial Period|Physician Decision|0|||
155315733|NCT05329220|560590028|FG000|Active Trial Period|Protocol Violation|0|||
155315734|NCT05329220|560590029|FG001|Active Trial Period|Protocol Violation|0|||
155315735|NCT05329220|560590030|FG002|Active Trial Period|Protocol Violation|0|||
155315736|NCT05329220|560590031|FG003|Active Trial Period|Protocol Violation|0|||
155315737|NCT05329220|560590032|FG004|Active Trial Period|Protocol Violation|1|||
155315738|NCT05329220|560590033|FG005|Active Trial Period|Protocol Violation|3|||
155315739|NCT05329220|560590028|FG000|Active Trial Period|Withdrawal by Subject|0|||
155315740|NCT05329220|560590029|FG001|Active Trial Period|Withdrawal by Subject|0|||
155315741|NCT05329220|560590030|FG002|Active Trial Period|Withdrawal by Subject|0|||
155315742|NCT05329220|560590031|FG003|Active Trial Period|Withdrawal by Subject|1|||
155315743|NCT05329220|560590032|FG004|Active Trial Period|Withdrawal by Subject|12|||
155315744|NCT05329220|560590033|FG005|Active Trial Period|Withdrawal by Subject|13|||
155315745|NCT05329220|560590028|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315746|NCT05329220|560590029|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315747|NCT05329220|560590030|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315748|NCT05329220|560590031|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315749|NCT05329220|560590032|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
155315750|NCT05329220|560590033|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
155315751|NCT05329220|560590028|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315752|NCT05329220|560590029|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315753|NCT05329220|560590030|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315754|NCT05329220|560590031|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315755|NCT05329220|560590032|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
155315756|NCT05329220|560590033|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
155315757|NCT05329220|560590028|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
155315758|NCT05329220|560590029|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
155315759|NCT05329220|560590030|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
155315760|NCT05329220|560590031|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
155315761|NCT05329220|560590032|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
155315762|NCT05329220|560590033|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
155315763|NCT05329220|560590028|FG000|Follow-up Period|Adverse Event|0|||
155315764|NCT05329220|560590029|FG001|Follow-up Period|Adverse Event|0|||
155315765|NCT05329220|560590030|FG002|Follow-up Period|Adverse Event|0|||
155315766|NCT05329220|560590031|FG003|Follow-up Period|Adverse Event|0|||
155315767|NCT05329220|560590032|FG004|Follow-up Period|Adverse Event|2|||
155315768|NCT05329220|560590033|FG005|Follow-up Period|Adverse Event|1|||
155315769|NCT05329220|560590028|FG000|Follow-up Period|Death|0|||
155315770|NCT05329220|560590029|FG001|Follow-up Period|Death|0|||
155315771|NCT05329220|560590030|FG002|Follow-up Period|Death|1|||
155315772|NCT05329220|560590031|FG003|Follow-up Period|Death|1|||
155315773|NCT05329220|560590032|FG004|Follow-up Period|Death|0|||
155315774|NCT05329220|560590033|FG005|Follow-up Period|Death|1|||
155315775|NCT05329220|560590028|FG000|Follow-up Period|Lost to Follow-up|0|||
155315776|NCT05329220|560590029|FG001|Follow-up Period|Lost to Follow-up|1|||
155315777|NCT05329220|560590030|FG002|Follow-up Period|Lost to Follow-up|2|||
155315778|NCT05329220|560590031|FG003|Follow-up Period|Lost to Follow-up|2|||
155315779|NCT05329220|560590032|FG004|Follow-up Period|Lost to Follow-up|113|||
155315780|NCT05329220|560590033|FG005|Follow-up Period|Lost to Follow-up|89|||
155315781|NCT05329220|560590028|FG000|Follow-up Period|Physician Decision|0|||
154959933|NCT00934050|559278645|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
154959934|NCT00934050|559278640|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
154959935|NCT00934050|559278641|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
155315782|NCT05329220|560590029|FG001|Follow-up Period|Physician Decision|0|||
155315783|NCT05329220|560590030|FG002|Follow-up Period|Physician Decision|0|||
155315784|NCT05329220|560590031|FG003|Follow-up Period|Physician Decision|0|||
155315785|NCT05329220|560590032|FG004|Follow-up Period|Physician Decision|2|||
155315786|NCT05329220|560590033|FG005|Follow-up Period|Physician Decision|2|||
155315787|NCT05329220|560590028|FG000|Follow-up Period|Protocol Violation|0|||
155315788|NCT05329220|560590029|FG001|Follow-up Period|Protocol Violation|0|||
155315789|NCT05329220|560590030|FG002|Follow-up Period|Protocol Violation|0|||
155315790|NCT05329220|560590031|FG003|Follow-up Period|Protocol Violation|0|||
155315791|NCT05329220|560590032|FG004|Follow-up Period|Protocol Violation|0|||
155315792|NCT05329220|560590033|FG005|Follow-up Period|Protocol Violation|1|||
155067018|NCT03329001|559676947|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
155315793|NCT05329220|560590028|FG000|Follow-up Period|Withdrawal by Subject|0|||
155315794|NCT05329220|560590029|FG001|Follow-up Period|Withdrawal by Subject|0|||
155315795|NCT05329220|560590030|FG002|Follow-up Period|Withdrawal by Subject|1|||
155315796|NCT05329220|560590031|FG003|Follow-up Period|Withdrawal by Subject|1|||
155315797|NCT05329220|560590032|FG004|Follow-up Period|Withdrawal by Subject|34|||
155315798|NCT05329220|560590033|FG005|Follow-up Period|Withdrawal by Subject|35|||
155315799|NCT05329220|560590028|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315800|NCT05329220|560590029|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315801|NCT05329220|560590030|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
155315802|NCT05329220|560590031|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315803|NCT05329220|560590032|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315804|NCT05329220|560590033|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
155315805|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315806|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315807|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315808|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315809|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
155315810|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
155315811|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315812|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315813|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315814|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315815|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
155315816|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
155315817|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315818|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315819|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315820|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315821|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
155315822|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
155315823|NCT05329220|560590028|FG000|Follow-up Period|EARLY TERMINATION|0|||
155315824|NCT05329220|560590029|FG001|Follow-up Period|EARLY TERMINATION|0|||
155315825|NCT05329220|560590030|FG002|Follow-up Period|EARLY TERMINATION|0|||
155315826|NCT05329220|560590031|FG003|Follow-up Period|EARLY TERMINATION|0|||
155315827|NCT05329220|560590032|FG004|Follow-up Period|EARLY TERMINATION|0|||
155315828|NCT05329220|560590033|FG005|Follow-up Period|EARLY TERMINATION|1|||
155315829|NCT05329220|560590028|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315830|NCT05329220|560590029|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315831|NCT05329220|560590030|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315832|NCT05329220|560590031|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315833|NCT05329220|560590032|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
155315834|NCT05329220|560590033|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
155315835|NCT05329220|560590028|FG000|Follow-up Period|DROPPED|0|||
155315836|NCT05329220|560590029|FG001|Follow-up Period|DROPPED|0|||
155315837|NCT05329220|560590030|FG002|Follow-up Period|DROPPED|0|||
155315838|NCT05329220|560590031|FG003|Follow-up Period|DROPPED|0|||
155315839|NCT05329220|560590032|FG004|Follow-up Period|DROPPED|0|||
155315840|NCT05329220|560590033|FG005|Follow-up Period|DROPPED|1|||
155315841|NCT05329220|560590028|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315842|NCT05329220|560590029|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315843|NCT05329220|560590030|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315844|NCT05329220|560590031|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315845|NCT05329220|560590032|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
155315846|NCT05329220|560590033|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
155315847|NCT02465268|560590035|FG000|Overall Study|Withdrawal by Subject|4|||
155315848|NCT02465268|560590036|FG001|Overall Study|Withdrawal by Subject|3|||
155315849|NCT02465268|560590037|FG002|Overall Study|Withdrawal by Subject|1|||
155315850|NCT02465268|560590035|FG000|Overall Study|Not evaluable per protocol criteria|3|||
155315851|NCT02465268|560590036|FG001|Overall Study|Not evaluable per protocol criteria|2|||
155315852|NCT02465268|560590037|FG002|Overall Study|Not evaluable per protocol criteria|1|||
155315853|NCT02465268|560590035|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
155315854|NCT02465268|560590036|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
155315855|NCT02465268|560590037|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
155315856|NCT02465268|560590035|FG000|Overall Study|Study drug did not pass QA/QC|1|||
155315857|NCT02465268|560590036|FG001|Overall Study|Study drug did not pass QA/QC|0|||
155315858|NCT02465268|560590037|FG002|Overall Study|Study drug did not pass QA/QC|0|||
155315859|NCT02465268|560590035|FG000|Overall Study|Adverse Event|0|||
155315860|NCT02465268|560590036|FG001|Overall Study|Adverse Event|1|||
155315861|NCT02465268|560590037|FG002|Overall Study|Adverse Event|0|||
155315862|NCT02465268|560590035|FG000|Overall Study|Physician Decision|0|||
155315863|NCT02465268|560590036|FG001|Overall Study|Physician Decision|1|||
155315864|NCT02465268|560590037|FG002|Overall Study|Physician Decision|0|||
155315865|NCT03322267|560590039|FG000|Overall Study|Lack of Efficacy|11|||
155315866|NCT03322267|560590039|FG000|Overall Study|Adverse Event|1|||
155315867|NCT03322267|560590039|FG000|Overall Study|Withdrawal by Subject|2|||
155315868|NCT04719832|560590043|FG000|Overall Study|Adverse Event|2|||
155315869|NCT04719832|560590044|FG001|Overall Study|Adverse Event|0|||
155315870|NCT04719832|560590043|FG000|Overall Study|Lack of Efficacy|2|||
155315871|NCT04719832|560590044|FG001|Overall Study|Lack of Efficacy|4|||
155315872|NCT04719832|560590043|FG000|Overall Study|Lost to Follow-up|0|||
155315873|NCT04719832|560590044|FG001|Overall Study|Lost to Follow-up|2|||
155315874|NCT04719832|560590043|FG000|Overall Study|Physician Decision|0|||
155315875|NCT04719832|560590044|FG001|Overall Study|Physician Decision|1|||
155315876|NCT04719832|560590043|FG000|Overall Study|Pregnancy|1|||
155315877|NCT04719832|560590044|FG001|Overall Study|Pregnancy|1|||
155315878|NCT04719832|560590043|FG000|Overall Study|Withdrawal by Subject|5|||
155315879|NCT04719832|560590044|FG001|Overall Study|Withdrawal by Subject|5|||
155315880|NCT04719832|560590043|FG000|Overall Study|Randomized, not treated|0|||
155315881|NCT04719832|560590044|FG001|Overall Study|Randomized, not treated|2|||
155315882|NCT04719832|560590043|FG000|Overall Study|GCP violations|4|||
155315883|NCT04719832|560590044|FG001|Overall Study|GCP violations|7|||
155315884|NCT05704543|560590048|FG000|Overall Study|Withdrawal by Subject|1|||
155315885|NCT05704543|560590049|FG001|Overall Study|Withdrawal by Subject|1|||
155315886|NCT05704543|560590050|FG002|Overall Study|Withdrawal by Subject|0|||
155315887|NCT05704543|560590051|FG003|Overall Study|Withdrawal by Subject|2|||
155315888|NCT05704543|560590048|FG000|Overall Study|Lost to Follow-up|1|||
155315889|NCT05704543|560590049|FG001|Overall Study|Lost to Follow-up|2|||
155315890|NCT05704543|560590050|FG002|Overall Study|Lost to Follow-up|0|||
155315891|NCT05704543|560590051|FG003|Overall Study|Lost to Follow-up|0|||
155315892|NCT04830800|560590056|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
155315893|NCT04830800|560590057|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
155315894|NCT04830800|560590058|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
155315895|NCT04830800|560590059|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
155315896|NCT04830800|560590060|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
155315897|NCT05192109|560590065|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155315898|NCT05192109|560590066|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155315899|NCT05192109|560590067|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315900|NCT05192109|560590068|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315901|NCT05192109|560590065|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155315902|NCT05192109|560590066|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155315903|NCT05192109|560590067|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315904|NCT05192109|560590068|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155315905|NCT03287817|560592299|FG000|Overall Study|Progressive disease|4|||
155315906|NCT03287817|560592300|FG001|Overall Study|Progressive disease|2|||
155315907|NCT03287817|560592301|FG002|Overall Study|Progressive disease|3|||
155315908|NCT03287817|560592302|FG003|Overall Study|Progressive disease|10|||
155315909|NCT03287817|560592303|FG004|Overall Study|Progressive disease|8|||
155315910|NCT03287817|560592299|FG000|Overall Study|Death|0|||
155315911|NCT03287817|560592300|FG001|Overall Study|Death|0|||
155315912|NCT03287817|560592301|FG002|Overall Study|Death|2|||
155315913|NCT03287817|560592302|FG003|Overall Study|Death|3|||
155315914|NCT03287817|560592303|FG004|Overall Study|Death|4|||
155315915|NCT03287817|560592299|FG000|Overall Study|Physician Decision|0|||
155315916|NCT03287817|560592300|FG001|Overall Study|Physician Decision|0|||
155315917|NCT03287817|560592301|FG002|Overall Study|Physician Decision|0|||
155315918|NCT03287817|560592302|FG003|Overall Study|Physician Decision|1|||
155315919|NCT03287817|560592303|FG004|Overall Study|Physician Decision|0|||
155315920|NCT03287817|560592299|FG000|Overall Study|Withdrawal by Subject|0|||
155315921|NCT03287817|560592300|FG001|Overall Study|Withdrawal by Subject|0|||
155315922|NCT03287817|560592301|FG002|Overall Study|Withdrawal by Subject|0|||
155315923|NCT03287817|560592302|FG003|Overall Study|Withdrawal by Subject|0|||
155315924|NCT03287817|560592303|FG004|Overall Study|Withdrawal by Subject|4|||
155315925|NCT05251909|560592308|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
155315926|NCT05251909|560592309|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
155315927|NCT03869866|560592315|FG000|Overall Study|Protocol Violation|1|||
155315928|NCT03869866|560592315|FG000|Overall Study|Withdrawal by Subject|3|||
155315929|NCT06181227|560592316|FG000|Overall Study|Study terminated by sponsor|7|||
155315930|NCT06181227|560592317|FG001|Overall Study|Study terminated by sponsor|9|||
155315931|NCT05543915|560592318|FG000|Overall Study|Lost to Follow-up|0|||
155315932|NCT05543915|560592319|FG001|Overall Study|Lost to Follow-up|1|||
155315933|NCT06516705|560592326|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
155315934|NCT06516705|560592327|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
155315935|NCT06516705|560592326|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
155315936|NCT06516705|560592327|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
155315937|NCT06516705|560592326|FG000|T3 ( 3 Month After Education)|covid-19|1|||
155315938|NCT06516705|560592327|FG001|T3 ( 3 Month After Education)|covid-19|2|||
155315939|NCT06516705|560592326|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
155315940|NCT06516705|560592327|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
155315941|NCT06516705|560592326|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
155315942|NCT06516705|560592327|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
155315943|NCT06516705|560592326|FG000|T4 ( 6 Month After Education)|covid-19|3|||
155315944|NCT06516705|560592327|FG001|T4 ( 6 Month After Education)|covid-19|2|||
155315945|NCT06516705|560592326|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
155315946|NCT06516705|560592327|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
155315947|NCT02485938|560592329|FG000|Overall Study|Withdrawal of consent|2|||
155315948|NCT02485938|560592330|FG001|Overall Study|Withdrawal of consent|0|||
155315949|NCT03241745|560592331|FG000|Overall Study|Adverse Event|7|||
155315950|NCT03241745|560592331|FG000|Overall Study|Death|1|||
155315951|NCT03241745|560592331|FG000|Overall Study|Withdrawal by Subject|5|||
155315952|NCT03241745|560592331|FG000|Overall Study|Treatment delay >28 days|2|||
155315953|NCT03241745|560592331|FG000|Overall Study|Lack of Efficacy|14|||
155315954|NCT00470704|560592332|FG000|Overall Study|Withdrawal by Subject|4|||
155315955|NCT00470704|560592333|FG001|Overall Study|Withdrawal by Subject|3|||
155315956|NCT00470704|560592332|FG000|Overall Study|Relapse/Progression|37|||
155315957|NCT00470704|560592333|FG001|Overall Study|Relapse/Progression|42|||
155315958|NCT00470704|560592332|FG000|Overall Study|toxicity|0|||
155315959|NCT00470704|560592333|FG001|Overall Study|toxicity|1|||
155315960|NCT04802967|560592335|FG000|Part B|Withdrawal by Subject|0|||
155315961|NCT04802967|560592336|FG001|Part B|Withdrawal by Subject|0|||
155315962|NCT04802967|560592337|FG002|Part B|Withdrawal by Subject|0|||
155315963|NCT04802967|560592338|FG003|Part B|Withdrawal by Subject|0|||
155315964|NCT04802967|560592339|FG004|Part B|Withdrawal by Subject|0|||
155315965|NCT04802967|560592340|FG005|Part B|Withdrawal by Subject|1|||
155315966|NCT04802967|560592341|FG006|Part B|Withdrawal by Subject|0|||
155315967|NCT04802967|560592342|FG007|Part B|Withdrawal by Subject|0|||
155315968|NCT04802967|560592343|FG008|Part B|Withdrawal by Subject|0|||
155315969|NCT04802967|560592344|FG009|Part B|Withdrawal by Subject|0|||
155315970|NCT03339713|560592349|FG000|Overall Study|Lost to Follow-up|2|||
155315971|NCT03339713|560592350|FG001|Overall Study|Lost to Follow-up|1|||
155315972|NCT03339713|560592349|FG000|Overall Study|Protocol Violation|1|||
155315973|NCT03339713|560592350|FG001|Overall Study|Protocol Violation|0|||
155315974|NCT03339713|560592349|FG000|Overall Study|Withdrawal by Subject|1|||
155315975|NCT03339713|560592350|FG001|Overall Study|Withdrawal by Subject|1|||
155315976|NCT02268253|560592351|FG000|Stage 1|Withdrawal by Subject|1|||
155315977|NCT02268253|560592352|FG001|Stage 1|Withdrawal by Subject|0|||
155315978|NCT02268253|560592353|FG002|Stage 1|Withdrawal by Subject|0|||
155315979|NCT02268253|560592354|FG003|Stage 1|Withdrawal by Subject|0|||
155315980|NCT02268253|560592355|FG004|Stage 1|Withdrawal by Subject|0|||
155315981|NCT02268253|560592356|FG005|Stage 1|Withdrawal by Subject|0|||
155315982|NCT02268253|560592357|FG006|Stage 1|Withdrawal by Subject|0|||
155315983|NCT02268253|560592351|FG000|Stage 1|Death|0|||
155315984|NCT02268253|560592352|FG001|Stage 1|Death|2|||
155315985|NCT02268253|560592353|FG002|Stage 1|Death|2|||
155315986|NCT02268253|560592354|FG003|Stage 1|Death|2|||
155315987|NCT02268253|560592355|FG004|Stage 1|Death|1|||
155315988|NCT02268253|560592356|FG005|Stage 1|Death|1|||
155315989|NCT02268253|560592357|FG006|Stage 1|Death|0|||
155315990|NCT02268253|560592351|FG000|Stage 2|Disease Recurrence/ Progression|0|||
155315991|NCT02268253|560592352|FG001|Stage 2|Disease Recurrence/ Progression|0|||
155315992|NCT02268253|560592353|FG002|Stage 2|Disease Recurrence/ Progression|1|||
155315993|NCT02268253|560592354|FG003|Stage 2|Disease Recurrence/ Progression|0|||
155162382|NCT00960999|560029879|FG001|Overall Study|RT dose constraints not met|0|||
155162383|NCT03467750|560029880|FG000|Overall Study|Surgery canceled|1|||
155315994|NCT02268253|560592355|FG004|Stage 2|Disease Recurrence/ Progression|0|||
155315995|NCT02268253|560592356|FG005|Stage 2|Disease Recurrence/ Progression|0|||
155315996|NCT02268253|560592357|FG006|Stage 2|Disease Recurrence/ Progression|0|||
155315997|NCT02268253|560592351|FG000|Stage 2|Withdrawal by Subject|0|||
155315998|NCT02268253|560592352|FG001|Stage 2|Withdrawal by Subject|0|||
155315999|NCT02268253|560592353|FG002|Stage 2|Withdrawal by Subject|2|||
155316000|NCT02268253|560592354|FG003|Stage 2|Withdrawal by Subject|0|||
155316001|NCT02268253|560592355|FG004|Stage 2|Withdrawal by Subject|0|||
155316002|NCT02268253|560592356|FG005|Stage 2|Withdrawal by Subject|2|||
155316003|NCT02268253|560592357|FG006|Stage 2|Withdrawal by Subject|0|||
155316004|NCT02268253|560592351|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316005|NCT02268253|560592352|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316006|NCT02268253|560592353|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
155316007|NCT02268253|560592354|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316008|NCT02268253|560592355|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316009|NCT02268253|560592356|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
155316010|NCT02268253|560592357|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
155316011|NCT02268253|560592351|FG000|Stage 2|Death|0|||
155316012|NCT02268253|560592352|FG001|Stage 2|Death|0|||
155316013|NCT02268253|560592353|FG002|Stage 2|Death|19|||
155316014|NCT02268253|560592354|FG003|Stage 2|Death|0|||
155316015|NCT02268253|560592355|FG004|Stage 2|Death|0|||
155316016|NCT02268253|560592356|FG005|Stage 2|Death|20|||
155316017|NCT02268253|560592357|FG006|Stage 2|Death|1|||
155316018|NCT02268253|560592351|FG000|Stage 2|Lost to Follow-up|0|||
155316019|NCT02268253|560592352|FG001|Stage 2|Lost to Follow-up|0|||
155316020|NCT02268253|560592353|FG002|Stage 2|Lost to Follow-up|0|||
155316021|NCT02268253|560592354|FG003|Stage 2|Lost to Follow-up|0|||
155316022|NCT02268253|560592355|FG004|Stage 2|Lost to Follow-up|0|||
155316023|NCT02268253|560592356|FG005|Stage 2|Lost to Follow-up|4|||
155067019|NCT03329001|559676948|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155067020|NCT03329001|559676949|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155067021|NCT03329001|559676950|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155067022|NCT03329001|559676951|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
155067023|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155067024|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155067025|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155067026|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
155067027|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155316024|NCT02268253|560592357|FG006|Stage 2|Lost to Follow-up|0|||
155316025|NCT02268253|560592351|FG000|Stage 2|Transferred to Hospice|0|||
155316026|NCT02268253|560592352|FG001|Stage 2|Transferred to Hospice|0|||
155316027|NCT02268253|560592353|FG002|Stage 2|Transferred to Hospice|0|||
155067028|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155067029|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155067030|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
155067031|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067032|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067033|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067034|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
155067035|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067036|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067037|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067038|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
155067039|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155067040|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155067041|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155067042|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
155162384|NCT03467750|560029881|FG001|Overall Study|Surgery canceled|0|||
155316028|NCT02268253|560592354|FG003|Stage 2|Transferred to Hospice|0|||
155316029|NCT02268253|560592355|FG004|Stage 2|Transferred to Hospice|0|||
155316030|NCT02268253|560592356|FG005|Stage 2|Transferred to Hospice|2|||
155316031|NCT02268253|560592357|FG006|Stage 2|Transferred to Hospice|0|||
155316032|NCT02268253|560592351|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
155316033|NCT02268253|560592352|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
155316034|NCT02268253|560592353|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
155316035|NCT02268253|560592354|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
155316036|NCT02268253|560592355|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
155316037|NCT02268253|560592356|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
155316038|NCT02268253|560592357|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
155316039|NCT02268253|560592351|FG000|Stage 3A|Withdrawal by Subject|0|||
155316040|NCT02268253|560592352|FG001|Stage 3A|Withdrawal by Subject|0|||
155316041|NCT02268253|560592353|FG002|Stage 3A|Withdrawal by Subject|2|||
155316042|NCT02268253|560592354|FG003|Stage 3A|Withdrawal by Subject|0|||
155316043|NCT02268253|560592355|FG004|Stage 3A|Withdrawal by Subject|0|||
155316044|NCT02268253|560592356|FG005|Stage 3A|Withdrawal by Subject|0|||
155316045|NCT02268253|560592357|FG006|Stage 3A|Withdrawal by Subject|0|||
155316046|NCT02268253|560592351|FG000|Stage 3A|Physician Decision|0|||
155316047|NCT02268253|560592352|FG001|Stage 3A|Physician Decision|0|||
155316048|NCT02268253|560592353|FG002|Stage 3A|Physician Decision|2|||
155316049|NCT02268253|560592354|FG003|Stage 3A|Physician Decision|0|||
155316050|NCT02268253|560592355|FG004|Stage 3A|Physician Decision|0|||
155316051|NCT02268253|560592356|FG005|Stage 3A|Physician Decision|0|||
155316052|NCT02268253|560592357|FG006|Stage 3A|Physician Decision|0|||
155316053|NCT02268253|560592351|FG000|Stage 3A|Study Terminated by Sponsor|0|||
155316054|NCT02268253|560592352|FG001|Stage 3A|Study Terminated by Sponsor|0|||
155316055|NCT02268253|560592353|FG002|Stage 3A|Study Terminated by Sponsor|2|||
155316056|NCT02268253|560592354|FG003|Stage 3A|Study Terminated by Sponsor|0|||
155316057|NCT02268253|560592355|FG004|Stage 3A|Study Terminated by Sponsor|0|||
155316058|NCT02268253|560592356|FG005|Stage 3A|Study Terminated by Sponsor|0|||
155316059|NCT02268253|560592357|FG006|Stage 3A|Study Terminated by Sponsor|0|||
155316060|NCT02268253|560592351|FG000|Stage 3A|Lost to Follow-up|0|||
155316061|NCT02268253|560592352|FG001|Stage 3A|Lost to Follow-up|0|||
155316062|NCT02268253|560592353|FG002|Stage 3A|Lost to Follow-up|1|||
155316063|NCT02268253|560592354|FG003|Stage 3A|Lost to Follow-up|0|||
155316064|NCT02268253|560592355|FG004|Stage 3A|Lost to Follow-up|0|||
155316065|NCT02268253|560592356|FG005|Stage 3A|Lost to Follow-up|0|||
155316066|NCT02268253|560592357|FG006|Stage 3A|Lost to Follow-up|0|||
155316067|NCT02268253|560592351|FG000|Stage 3A|Death|0|||
155316068|NCT02268253|560592352|FG001|Stage 3A|Death|0|||
155316069|NCT02268253|560592353|FG002|Stage 3A|Death|5|||
155316070|NCT02268253|560592354|FG003|Stage 3A|Death|0|||
155316071|NCT02268253|560592355|FG004|Stage 3A|Death|0|||
155316072|NCT02268253|560592356|FG005|Stage 3A|Death|0|||
155316073|NCT02268253|560592357|FG006|Stage 3A|Death|0|||
155316074|NCT05714761|560592358|FG000|Overall Study|Lost to Follow-up|3|||
155316075|NCT05714761|560592358|FG000|Overall Study|Withdrawal by Subject|3|||
155316076|NCT05714761|560592358|FG000|Overall Study|unblinding of sensor data|1|||
155316077|NCT05714761|560592358|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
155316078|NCT05714761|560592358|FG000|Overall Study|did not return second CGM sensor|4|||
155316079|NCT05672069|560592359|FG000|Overall Study|Implant removal|1|||
155316080|NCT05672069|560592359|FG000|Overall Study|Lost to Follow-up|2|||
155316081|NCT03544281|560592362|FG000|Main Study Phase|Death|3|||
155316082|NCT03544281|560592363|FG001|Main Study Phase|Death|2|||
155316083|NCT03544281|560592364|FG002|Main Study Phase|Death|6|||
155316084|NCT03544281|560592365|FG003|Main Study Phase|Death|8|||
155316085|NCT03544281|560592366|FG004|Main Study Phase|Death|4|||
155316086|NCT03544281|560592367|FG005|Main Study Phase|Death|2|||
155316087|NCT03544281|560592368|FG006|Main Study Phase|Death|4|||
155316088|NCT03544281|560592369|FG007|Main Study Phase|Death|5|||
155316089|NCT03544281|560592370|FG008|Main Study Phase|Death|5|||
155316090|NCT03544281|560592371|FG009|Main Study Phase|Death|8|||
155316091|NCT03544281|560592372|FG010|Main Study Phase|Death|6|||
155316092|NCT03544281|560592373|FG011|Main Study Phase|Death|4|||
154959936|NCT00934050|559278642|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
155316093|NCT03544281|560592374|FG012|Main Study Phase|Death|0|||
155316094|NCT03544281|560592375|FG013|Main Study Phase|Death|0|||
155316095|NCT03544281|560592376|FG014|Main Study Phase|Death|0|||
154959937|NCT00934050|559278643|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
155316096|NCT03544281|560592377|FG015|Main Study Phase|Death|0|||
155316097|NCT03544281|560592378|FG016|Main Study Phase|Death|0|||
155316098|NCT03544281|560592379|FG017|Main Study Phase|Death|0|||
155316099|NCT03544281|560592380|FG018|Main Study Phase|Death|0|||
155316100|NCT03544281|560592381|FG019|Main Study Phase|Death|0|||
155316101|NCT03544281|560592382|FG020|Main Study Phase|Death|0|||
155316102|NCT03544281|560592383|FG021|Main Study Phase|Death|0|||
155316103|NCT03544281|560592362|FG000|Main Study Phase|Lost to Follow-up|0|||
155316104|NCT03544281|560592363|FG001|Main Study Phase|Lost to Follow-up|0|||
155316105|NCT03544281|560592364|FG002|Main Study Phase|Lost to Follow-up|0|||
155316106|NCT03544281|560592365|FG003|Main Study Phase|Lost to Follow-up|0|||
155316107|NCT03544281|560592366|FG004|Main Study Phase|Lost to Follow-up|0|||
155316108|NCT03544281|560592367|FG005|Main Study Phase|Lost to Follow-up|0|||
155316109|NCT03544281|560592368|FG006|Main Study Phase|Lost to Follow-up|0|||
155316110|NCT03544281|560592369|FG007|Main Study Phase|Lost to Follow-up|0|||
155316111|NCT03544281|560592370|FG008|Main Study Phase|Lost to Follow-up|0|||
155316112|NCT03544281|560592371|FG009|Main Study Phase|Lost to Follow-up|0|||
155316113|NCT03544281|560592372|FG010|Main Study Phase|Lost to Follow-up|1|||
155316114|NCT03544281|560592373|FG011|Main Study Phase|Lost to Follow-up|0|||
155316115|NCT03544281|560592374|FG012|Main Study Phase|Lost to Follow-up|0|||
155316116|NCT03544281|560592375|FG013|Main Study Phase|Lost to Follow-up|0|||
155316117|NCT03544281|560592376|FG014|Main Study Phase|Lost to Follow-up|0|||
155316118|NCT03544281|560592377|FG015|Main Study Phase|Lost to Follow-up|0|||
155316119|NCT03544281|560592378|FG016|Main Study Phase|Lost to Follow-up|0|||
155316120|NCT03544281|560592379|FG017|Main Study Phase|Lost to Follow-up|0|||
155316121|NCT03544281|560592380|FG018|Main Study Phase|Lost to Follow-up|0|||
155316122|NCT03544281|560592381|FG019|Main Study Phase|Lost to Follow-up|0|||
155316123|NCT03544281|560592382|FG020|Main Study Phase|Lost to Follow-up|0|||
155316124|NCT03544281|560592383|FG021|Main Study Phase|Lost to Follow-up|0|||
155316125|NCT03544281|560592362|FG000|Main Study Phase|Physician Decision|0|||
155316126|NCT03544281|560592363|FG001|Main Study Phase|Physician Decision|0|||
155316127|NCT03544281|560592364|FG002|Main Study Phase|Physician Decision|0|||
155316128|NCT03544281|560592365|FG003|Main Study Phase|Physician Decision|0|||
155316129|NCT03544281|560592366|FG004|Main Study Phase|Physician Decision|0|||
155316130|NCT03544281|560592367|FG005|Main Study Phase|Physician Decision|0|||
155316131|NCT03544281|560592368|FG006|Main Study Phase|Physician Decision|0|||
155316132|NCT03544281|560592369|FG007|Main Study Phase|Physician Decision|1|||
155316133|NCT03544281|560592370|FG008|Main Study Phase|Physician Decision|0|||
155316134|NCT03544281|560592371|FG009|Main Study Phase|Physician Decision|0|||
155316135|NCT03544281|560592372|FG010|Main Study Phase|Physician Decision|0|||
155316136|NCT03544281|560592373|FG011|Main Study Phase|Physician Decision|0|||
155316137|NCT03544281|560592374|FG012|Main Study Phase|Physician Decision|0|||
155316138|NCT03544281|560592375|FG013|Main Study Phase|Physician Decision|0|||
155316139|NCT03544281|560592376|FG014|Main Study Phase|Physician Decision|0|||
155316140|NCT03544281|560592377|FG015|Main Study Phase|Physician Decision|0|||
155316141|NCT03544281|560592378|FG016|Main Study Phase|Physician Decision|0|||
155316142|NCT03544281|560592379|FG017|Main Study Phase|Physician Decision|0|||
155316143|NCT03544281|560592380|FG018|Main Study Phase|Physician Decision|0|||
155316144|NCT03544281|560592381|FG019|Main Study Phase|Physician Decision|0|||
155316145|NCT03544281|560592382|FG020|Main Study Phase|Physician Decision|0|||
155316146|NCT03544281|560592383|FG021|Main Study Phase|Physician Decision|0|||
155316147|NCT03544281|560592362|FG000|Main Study Phase|Withdrawal by Subject|2|||
155316148|NCT03544281|560592363|FG001|Main Study Phase|Withdrawal by Subject|0|||
155316149|NCT03544281|560592364|FG002|Main Study Phase|Withdrawal by Subject|1|||
155316150|NCT03544281|560592365|FG003|Main Study Phase|Withdrawal by Subject|2|||
155316151|NCT03544281|560592366|FG004|Main Study Phase|Withdrawal by Subject|0|||
155316152|NCT03544281|560592367|FG005|Main Study Phase|Withdrawal by Subject|0|||
155316153|NCT03544281|560592368|FG006|Main Study Phase|Withdrawal by Subject|0|||
155316154|NCT03544281|560592369|FG007|Main Study Phase|Withdrawal by Subject|0|||
155316155|NCT03544281|560592370|FG008|Main Study Phase|Withdrawal by Subject|2|||
155316156|NCT03544281|560592371|FG009|Main Study Phase|Withdrawal by Subject|3|||
155316157|NCT03544281|560592372|FG010|Main Study Phase|Withdrawal by Subject|0|||
155316158|NCT03544281|560592373|FG011|Main Study Phase|Withdrawal by Subject|4|||
155316159|NCT03544281|560592374|FG012|Main Study Phase|Withdrawal by Subject|0|||
155316160|NCT03544281|560592375|FG013|Main Study Phase|Withdrawal by Subject|0|||
155316161|NCT03544281|560592376|FG014|Main Study Phase|Withdrawal by Subject|0|||
155316162|NCT03544281|560592377|FG015|Main Study Phase|Withdrawal by Subject|0|||
155316163|NCT03544281|560592378|FG016|Main Study Phase|Withdrawal by Subject|0|||
155316164|NCT03544281|560592379|FG017|Main Study Phase|Withdrawal by Subject|0|||
155316165|NCT03544281|560592380|FG018|Main Study Phase|Withdrawal by Subject|0|||
155316166|NCT03544281|560592381|FG019|Main Study Phase|Withdrawal by Subject|0|||
155316167|NCT03544281|560592382|FG020|Main Study Phase|Withdrawal by Subject|0|||
155316168|NCT03544281|560592383|FG021|Main Study Phase|Withdrawal by Subject|0|||
155316169|NCT03544281|560592362|FG000|Main Study Phase|Ongoing|3|||
155316170|NCT03544281|560592363|FG001|Main Study Phase|Ongoing|1|||
155316171|NCT03544281|560592364|FG002|Main Study Phase|Ongoing|2|||
155316172|NCT03544281|560592365|FG003|Main Study Phase|Ongoing|4|||
155316173|NCT03544281|560592366|FG004|Main Study Phase|Ongoing|2|||
155316174|NCT03544281|560592367|FG005|Main Study Phase|Ongoing|4|||
155316175|NCT03544281|560592368|FG006|Main Study Phase|Ongoing|4|||
155316176|NCT03544281|560592369|FG007|Main Study Phase|Ongoing|0|||
155316177|NCT03544281|560592370|FG008|Main Study Phase|Ongoing|2|||
155316178|NCT03544281|560592371|FG009|Main Study Phase|Ongoing|2|||
155316179|NCT03544281|560592372|FG010|Main Study Phase|Ongoing|1|||
155316180|NCT03544281|560592373|FG011|Main Study Phase|Ongoing|0|||
155316181|NCT03544281|560592374|FG012|Main Study Phase|Ongoing|0|||
155316182|NCT03544281|560592375|FG013|Main Study Phase|Ongoing|0|||
155316183|NCT03544281|560592376|FG014|Main Study Phase|Ongoing|0|||
155316184|NCT03544281|560592377|FG015|Main Study Phase|Ongoing|0|||
155316185|NCT03544281|560592378|FG016|Main Study Phase|Ongoing|0|||
155316186|NCT03544281|560592379|FG017|Main Study Phase|Ongoing|0|||
155316187|NCT03544281|560592380|FG018|Main Study Phase|Ongoing|0|||
155316188|NCT03544281|560592381|FG019|Main Study Phase|Ongoing|0|||
155316189|NCT03544281|560592382|FG020|Main Study Phase|Ongoing|0|||
155316190|NCT03544281|560592383|FG021|Main Study Phase|Ongoing|0|||
155316191|NCT03544281|560592362|FG000|Main Study Phase|Investigator Site Closed|0|||
155316192|NCT03544281|560592363|FG001|Main Study Phase|Investigator Site Closed|0|||
155067043|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155316193|NCT03544281|560592364|FG002|Main Study Phase|Investigator Site Closed|0|||
155316194|NCT03544281|560592365|FG003|Main Study Phase|Investigator Site Closed|0|||
155316195|NCT03544281|560592366|FG004|Main Study Phase|Investigator Site Closed|0|||
155316196|NCT03544281|560592367|FG005|Main Study Phase|Investigator Site Closed|0|||
155316197|NCT03544281|560592368|FG006|Main Study Phase|Investigator Site Closed|0|||
155316198|NCT03544281|560592369|FG007|Main Study Phase|Investigator Site Closed|0|||
155316199|NCT03544281|560592370|FG008|Main Study Phase|Investigator Site Closed|0|||
155316200|NCT03544281|560592371|FG009|Main Study Phase|Investigator Site Closed|1|||
155316201|NCT03544281|560592372|FG010|Main Study Phase|Investigator Site Closed|0|||
155316202|NCT03544281|560592373|FG011|Main Study Phase|Investigator Site Closed|0|||
155316203|NCT03544281|560592374|FG012|Main Study Phase|Investigator Site Closed|0|||
155316204|NCT03544281|560592375|FG013|Main Study Phase|Investigator Site Closed|0|||
155316205|NCT03544281|560592376|FG014|Main Study Phase|Investigator Site Closed|0|||
155316206|NCT03544281|560592377|FG015|Main Study Phase|Investigator Site Closed|0|||
155316207|NCT03544281|560592378|FG016|Main Study Phase|Investigator Site Closed|0|||
155316208|NCT03544281|560592379|FG017|Main Study Phase|Investigator Site Closed|0|||
155316209|NCT03544281|560592380|FG018|Main Study Phase|Investigator Site Closed|0|||
155316210|NCT03544281|560592381|FG019|Main Study Phase|Investigator Site Closed|0|||
155316211|NCT03544281|560592382|FG020|Main Study Phase|Investigator Site Closed|0|||
155316212|NCT03544281|560592383|FG021|Main Study Phase|Investigator Site Closed|0|||
155316213|NCT03544281|560592362|FG000|Main Study Phase|Did not receive study treatment|0|||
155316214|NCT03544281|560592363|FG001|Main Study Phase|Did not receive study treatment|0|||
155316215|NCT03544281|560592364|FG002|Main Study Phase|Did not receive study treatment|0|||
155316216|NCT03544281|560592365|FG003|Main Study Phase|Did not receive study treatment|0|||
155316217|NCT03544281|560592366|FG004|Main Study Phase|Did not receive study treatment|0|||
155316218|NCT03544281|560592367|FG005|Main Study Phase|Did not receive study treatment|0|||
155316219|NCT03544281|560592368|FG006|Main Study Phase|Did not receive study treatment|1|||
155316220|NCT03544281|560592369|FG007|Main Study Phase|Did not receive study treatment|0|||
155316221|NCT03544281|560592370|FG008|Main Study Phase|Did not receive study treatment|0|||
155316222|NCT03544281|560592371|FG009|Main Study Phase|Did not receive study treatment|0|||
155316223|NCT03544281|560592372|FG010|Main Study Phase|Did not receive study treatment|0|||
155316224|NCT03544281|560592373|FG011|Main Study Phase|Did not receive study treatment|0|||
155316225|NCT03544281|560592374|FG012|Main Study Phase|Did not receive study treatment|0|||
155316226|NCT03544281|560592375|FG013|Main Study Phase|Did not receive study treatment|0|||
155316227|NCT03544281|560592376|FG014|Main Study Phase|Did not receive study treatment|0|||
155316228|NCT03544281|560592377|FG015|Main Study Phase|Did not receive study treatment|0|||
155316229|NCT03544281|560592378|FG016|Main Study Phase|Did not receive study treatment|0|||
155316230|NCT03544281|560592379|FG017|Main Study Phase|Did not receive study treatment|0|||
155067044|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155067045|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155067046|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
155067047|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067048|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067049|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
155067050|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067051|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067052|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067053|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067054|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
155067055|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155067056|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155067057|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
155067058|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155162385|NCT03467750|560029880|FG000|Overall Study|Protocol Violation|1|||
155162386|NCT03467750|560029881|FG001|Overall Study|Protocol Violation|1|||
155316231|NCT03544281|560592380|FG018|Main Study Phase|Did not receive study treatment|0|||
155316232|NCT03544281|560592381|FG019|Main Study Phase|Did not receive study treatment|0|||
155316233|NCT03544281|560592382|FG020|Main Study Phase|Did not receive study treatment|0|||
155316234|NCT03544281|560592383|FG021|Main Study Phase|Did not receive study treatment|0|||
155316235|NCT03544281|560592362|FG000|PACT Phase|Adverse Event|0|||
155316236|NCT03544281|560592363|FG001|PACT Phase|Adverse Event|0|||
155316237|NCT03544281|560592364|FG002|PACT Phase|Adverse Event|0|||
155316238|NCT03544281|560592365|FG003|PACT Phase|Adverse Event|0|||
155316239|NCT03544281|560592366|FG004|PACT Phase|Adverse Event|0|||
155316240|NCT03544281|560592367|FG005|PACT Phase|Adverse Event|0|||
155316241|NCT03544281|560592368|FG006|PACT Phase|Adverse Event|0|||
155316242|NCT03544281|560592369|FG007|PACT Phase|Adverse Event|0|||
155316243|NCT03544281|560592370|FG008|PACT Phase|Adverse Event|0|||
155316244|NCT03544281|560592371|FG009|PACT Phase|Adverse Event|0|||
155316245|NCT03544281|560592372|FG010|PACT Phase|Adverse Event|0|||
155316246|NCT03544281|560592373|FG011|PACT Phase|Adverse Event|0|||
155316247|NCT03544281|560592374|FG012|PACT Phase|Adverse Event|1|||
155316248|NCT03544281|560592375|FG013|PACT Phase|Adverse Event|0|||
155316249|NCT03544281|560592376|FG014|PACT Phase|Adverse Event|0|||
155316250|NCT03544281|560592377|FG015|PACT Phase|Adverse Event|0|||
155316251|NCT03544281|560592378|FG016|PACT Phase|Adverse Event|0|||
155316252|NCT03544281|560592379|FG017|PACT Phase|Adverse Event|1|||
155316253|NCT03544281|560592380|FG018|PACT Phase|Adverse Event|1|||
155316254|NCT03544281|560592381|FG019|PACT Phase|Adverse Event|0|||
155316255|NCT03544281|560592382|FG020|PACT Phase|Adverse Event|0|||
155316256|NCT03544281|560592383|FG021|PACT Phase|Adverse Event|0|||
155316257|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
155316258|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
155316259|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
155316260|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
155316261|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
155316262|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
155316263|NCT02547233|560592384|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
155316264|NCT02547233|560592385|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
155316265|NCT02547233|560592384|FG000|12-month Follow-up|Withdrawal by Subject|10|||
155316266|NCT02547233|560592385|FG001|12-month Follow-up|Withdrawal by Subject|10|||
155316267|NCT02547233|560592384|FG000|12-month Follow-up|Lost to Follow-up|3|||
155316268|NCT02547233|560592385|FG001|12-month Follow-up|Lost to Follow-up|3|||
155316269|NCT02547233|560592384|FG000|12-month Follow-up|Lack of Efficacy|1|||
155316270|NCT02547233|560592385|FG001|12-month Follow-up|Lack of Efficacy|2|||
155316271|NCT02547233|560592384|FG000|12-month Follow-up|Protocol Violation|0|||
155316272|NCT02547233|560592385|FG001|12-month Follow-up|Protocol Violation|1|||
155316273|NCT02547233|560592384|FG000|12-month Follow-up|Other|0|||
155316274|NCT02547233|560592385|FG001|12-month Follow-up|Other|1|||
155316275|NCT06019559|560592387|FG000|Overall Study|Withdrawal by Subject|7|||
155316276|NCT06019559|560592388|FG001|Overall Study|Withdrawal by Subject|6|||
155316277|NCT06019559|560592389|FG002|Overall Study|Withdrawal by Subject|5|||
155316278|NCT06019559|560592387|FG000|Overall Study|Lost to Follow-up|2|||
155316279|NCT06019559|560592388|FG001|Overall Study|Lost to Follow-up|0|||
155316280|NCT06019559|560592389|FG002|Overall Study|Lost to Follow-up|3|||
155316281|NCT05949788|560592390|FG000|Overall Study|severe birth deformity|2|||
155316282|NCT05949788|560592391|FG001|Overall Study|severe birth deformity|7|||
155316283|NCT05949788|560592390|FG000|Overall Study|twin-twin transfusion syndrome|2|||
155316284|NCT05949788|560592391|FG001|Overall Study|twin-twin transfusion syndrome|7|||
155316285|NCT05949788|560592390|FG000|Overall Study|neonatal hemolytic disease|3|||
155316286|NCT05949788|560592391|FG001|Overall Study|neonatal hemolytic disease|8|||
155316287|NCT05949788|560592390|FG000|Overall Study|death within 14 days after birth|2|||
155316288|NCT05949788|560592391|FG001|Overall Study|death within 14 days after birth|6|||
155316289|NCT05949788|560592390|FG000|Overall Study|transfer to another hospital|2|||
155316290|NCT05949788|560592391|FG001|Overall Study|transfer to another hospital|6|||
155316291|NCT05213390|560592392|FG000|Overall Study|Withdrawal by Subject|2|||
155316292|NCT05213390|560592392|FG000|Overall Study|Lost to Follow-up|12|||
155316293|NCT05213390|560592392|FG000|Overall Study|Protocol Violation|9|||
155162387|NCT03467750|560029880|FG000|Overall Study|Withdrawal by Subject|0|||
155162388|NCT03467750|560029881|FG001|Overall Study|Withdrawal by Subject|1|||
155162389|NCT05673876|560029882|FG000|Overall Study|Death|3|||
155162390|NCT05673876|560029883|FG001|Overall Study|Death|1|||
155162391|NCT05673876|560029882|FG000|Overall Study|Study Terminated by Sponsor|0|||
155162392|NCT05673876|560029883|FG001|Overall Study|Study Terminated by Sponsor|1|||
155162393|NCT05673876|560029882|FG000|Overall Study|Physician Decision|0|||
155162394|NCT05673876|560029883|FG001|Overall Study|Physician Decision|1|||
155162395|NCT03529422|560029884|FG000|Overall Study|Withdrawal by Subject|1|||
155162396|NCT03529422|560029884|FG000|Overall Study|Protocol Violation|1|||
155162397|NCT03529422|560029884|FG000|Overall Study|Disease progression|2|||
155162398|NCT05006573|560029887|FG000|Double-blind Treatment Period|Physician Decision|2|||
155162399|NCT05006573|560029888|FG001|Double-blind Treatment Period|Physician Decision|0|||
155162400|NCT05006573|560029887|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
155162401|NCT05006573|560029888|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
155162402|NCT05006573|560029887|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
155162403|NCT05006573|560029888|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155162404|NCT05006573|560029887|FG000|Double-blind Treatment Period|Protocol Violation|2|||
155162405|NCT05006573|560029888|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155316294|NCT05362487|560592393|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
155316295|NCT03603600|560592397|FG000|Overall Study|Withdrawal by Subject|5|||
155316296|NCT03603600|560592398|FG001|Overall Study|Withdrawal by Subject|7|||
155316297|NCT03603600|560592397|FG000|Overall Study|Lost to Follow-up|2|||
155316298|NCT03603600|560592398|FG001|Overall Study|Lost to Follow-up|3|||
155316299|NCT03603600|560592397|FG000|Overall Study|Death|3|||
155316300|NCT03603600|560592398|FG001|Overall Study|Death|1|||
155316301|NCT03603600|560592397|FG000|Overall Study|Physician Decision|2|||
155316302|NCT03603600|560592398|FG001|Overall Study|Physician Decision|1|||
155316303|NCT03603600|560592397|FG000|Overall Study|Other reason|1|||
155316304|NCT03603600|560592398|FG001|Overall Study|Other reason|0|||
155316305|NCT02191618|560592408|FG000|Overall Study|Withdrawal by Subject|3|||
155162406|NCT05006573|560029887|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
155162407|NCT05006573|560029888|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
155162408|NCT05006573|560029887|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
155162409|NCT05006573|560029888|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
155316306|NCT02191618|560592408|FG000|Overall Study|Missed Visit|4|||
155316307|NCT03031470|560592410|FG000|Overall Study|Adverse Event|3|||
155316308|NCT03031470|560592411|FG001|Overall Study|Adverse Event|0|||
155316309|NCT03031470|560592410|FG000|Overall Study|Death|3|||
155316310|NCT03031470|560592411|FG001|Overall Study|Death|1|||
155316311|NCT03031470|560592410|FG000|Overall Study|Lost to Follow-up|1|||
155316312|NCT03031470|560592411|FG001|Overall Study|Lost to Follow-up|1|||
155316313|NCT03031470|560592410|FG000|Overall Study|Withdrawal by Subject|1|||
155316314|NCT03031470|560592411|FG001|Overall Study|Withdrawal by Subject|0|||
155316315|NCT03031470|560592410|FG000|Overall Study|Protocol entry criteria not met|0|||
155316316|NCT03031470|560592411|FG001|Overall Study|Protocol entry criteria not met|1|||
155316317|NCT03031470|560592410|FG000|Overall Study|Cancel the operation|0|||
155316318|NCT03031470|560592411|FG001|Overall Study|Cancel the operation|1|||
155316319|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
155316320|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
155316321|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
155316322|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
155316323|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
155316324|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
155316325|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
155316326|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
155316327|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
155316328|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
155316329|NCT03461276|560592412|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
155316330|NCT03461276|560592413|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
155316331|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
155316332|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
155316333|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
155316334|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
155316335|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
155316336|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
155316337|NCT03461276|560592412|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
155316338|NCT03461276|560592413|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
155316339|NCT02683447|560592418|FG000|Overall Study|Lost to Follow-up|2|||
155316340|NCT01943409|560592423|FG000|Overall Study|resumed oral/entral|24|||
155316341|NCT01943409|560592424|FG001|Overall Study|resumed oral/entral|20|||
155316342|NCT01943409|560592423|FG000|Overall Study|Protocol Violation|14|||
155316343|NCT01943409|560592424|FG001|Overall Study|Protocol Violation|24|||
155316344|NCT01943409|560592423|FG000|Overall Study|Death|3|||
155316345|NCT01943409|560592424|FG001|Overall Study|Death|1|||
155316346|NCT01943409|560592423|FG000|Overall Study|Withdrawal by Subject|4|||
155316347|NCT01943409|560592424|FG001|Overall Study|Withdrawal by Subject|3|||
155316348|NCT02489903|560592425|FG000|Screening|Screen Failure|24|||
155316349|NCT02489903|560592426|FG001|Screening|Screen Failure|0|||
155316350|NCT02489903|560592427|FG002|Screening|Screen Failure|0|||
155316351|NCT02489903|560592428|FG003|Screening|Screen Failure|8|||
155316352|NCT02489903|560592425|FG000|Randomized and Received Treatment|Protocol Violation|0|||
155316353|NCT02489903|560592426|FG001|Randomized and Received Treatment|Protocol Violation|1|||
155316354|NCT02489903|560592427|FG002|Randomized and Received Treatment|Protocol Violation|0|||
155316355|NCT02489903|560592428|FG003|Randomized and Received Treatment|Protocol Violation|0|||
155316356|NCT02489903|560592425|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
155316357|NCT02489903|560592426|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
155316358|NCT02489903|560592427|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
155316359|NCT02489903|560592428|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
155316360|NCT02489903|560592425|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
155316361|NCT02489903|560592426|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
155316362|NCT02489903|560592427|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
155316363|NCT02489903|560592428|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
155316364|NCT02489903|560592425|FG000|Randomized and Received Treatment|Death|10|||
155316365|NCT02489903|560592426|FG001|Randomized and Received Treatment|Death|1|||
155316366|NCT02489903|560592427|FG002|Randomized and Received Treatment|Death|0|||
155316367|NCT02489903|560592428|FG003|Randomized and Received Treatment|Death|0|||
155316368|NCT04542317|560592429|FG000|Overall Study|Care recipients passed away|18|||
155316369|NCT04542317|560592430|FG001|Overall Study|Care recipients passed away|13|||
155316370|NCT04542317|560592429|FG000|Overall Study|No longer a primary caregiver|5|||
155316371|NCT04542317|560592430|FG001|Overall Study|No longer a primary caregiver|1|||
155316372|NCT04542317|560592429|FG000|Overall Study|Withdrawal by Subject|4|||
155316373|NCT04542317|560592430|FG001|Overall Study|Withdrawal by Subject|2|||
155316374|NCT04542317|560592429|FG000|Overall Study|Caregivers passed away|0|||
155316375|NCT04542317|560592430|FG001|Overall Study|Caregivers passed away|2|||
155316376|NCT02310646|560592433|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
155316377|NCT02310646|560592434|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
155316378|NCT02310646|560592433|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
155316379|NCT02310646|560592434|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
155316380|NCT00613106|560592441|FG000|Overall Study|Adverse Event|3|||
155316381|NCT00613106|560592442|FG001|Overall Study|Adverse Event|1|||
155316382|NCT00613106|560592441|FG000|Overall Study|Withdrawal by Subject|6|||
155316383|NCT00613106|560592442|FG001|Overall Study|Withdrawal by Subject|3|||
155316384|NCT00613106|560592441|FG000|Overall Study|Lost to Follow-up|7|||
155316385|NCT00613106|560592442|FG001|Overall Study|Lost to Follow-up|2|||
155316386|NCT00613106|560592441|FG000|Overall Study|misc|4|||
155316387|NCT00613106|560592442|FG001|Overall Study|misc|3|||
155316388|NCT03496168|560592443|FG000|Overall Study|Other Reasons|1|||
155316389|NCT03496168|560592443|FG000|Overall Study|Adverse Event|1|||
155316390|NCT02043678|560592448|FG000|Overall Study|Never treated|11|||
155316391|NCT02043678|560592449|FG001|Overall Study|Never treated|9|||
155316392|NCT02043678|560592448|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
155316393|NCT02043678|560592449|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
155316394|NCT02043678|560592448|FG000|Overall Study|AE without clinical PD|54|||
155316395|NCT02043678|560592449|FG001|Overall Study|AE without clinical PD|36|||
155316396|NCT02043678|560592448|FG000|Overall Study|Lost to Follow-up|1|||
155316397|NCT02043678|560592449|FG001|Overall Study|Lost to Follow-up|1|||
155316398|NCT02043678|560592448|FG000|Overall Study|Other|10|||
155316399|NCT02043678|560592449|FG001|Overall Study|Other|14|||
155316400|NCT02043678|560592448|FG000|Overall Study|Clinical PD|114|||
155316401|NCT02043678|560592449|FG001|Overall Study|Clinical PD|148|||
155316402|NCT02043678|560592448|FG000|Overall Study|Radiological PD|100|||
155316403|NCT02043678|560592449|FG001|Overall Study|Radiological PD|90|||
155316404|NCT02043678|560592448|FG000|Overall Study|Protocol-driven decision point|59|||
155316405|NCT02043678|560592449|FG001|Overall Study|Protocol-driven decision point|58|||
155316406|NCT02043678|560592448|FG000|Overall Study|Withdrawal by Subject|16|||
155316407|NCT02043678|560592449|FG001|Overall Study|Withdrawal by Subject|20|||
155316408|NCT02043678|560592448|FG000|Overall Study|Protocol Violation|1|||
155316409|NCT02043678|560592449|FG001|Overall Study|Protocol Violation|0|||
155316410|NCT02043678|560592448|FG000|Overall Study|Deterioration of general conditions|1|||
155316411|NCT02043678|560592449|FG001|Overall Study|Deterioration of general conditions|1|||
155316412|NCT02043678|560592448|FG000|Overall Study|Logistical difficulties|2|||
155316413|NCT02043678|560592449|FG001|Overall Study|Logistical difficulties|0|||
155316414|NCT02043678|560592448|FG000|Overall Study|Non-compliance with study drug|3|||
155316415|NCT02043678|560592449|FG001|Overall Study|Non-compliance with study drug|1|||
155316416|NCT02043678|560592448|FG000|Overall Study|Physician Decision|4|||
155316417|NCT02043678|560592449|FG001|Overall Study|Physician Decision|3|||
155316418|NCT02043678|560592448|FG000|Overall Study|Subject decision|0|||
155316419|NCT02043678|560592449|FG001|Overall Study|Subject decision|1|||
155316420|NCT02043678|560592448|FG000|Overall Study|Switching to other therapy|3|||
155316421|NCT02043678|560592449|FG001|Overall Study|Switching to other therapy|2|||
155316422|NCT02043678|560592448|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
155316423|NCT02043678|560592449|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
155316424|NCT02043678|560592448|FG000|Overall Study|Missing|1|||
155316425|NCT02043678|560592449|FG001|Overall Study|Missing|0|||
155316426|NCT02043678|560592448|FG000|Overall Study|Adverse Event|0|||
155316427|NCT02043678|560592449|FG001|Overall Study|Adverse Event|1|||
155316428|NCT04137367|560592452|FG000|Overall Study|Lost to Follow-up|8|||
155316429|NCT04137367|560592453|FG001|Overall Study|Lost to Follow-up|6|||
155316430|NCT04137367|560592454|FG002|Overall Study|Lost to Follow-up|4|||
155316431|NCT01175356|560592455|FG000|Overall Study|Death|1|||
155316432|NCT01175356|560592455|FG000|Overall Study|Lack of Efficacy|12|||
155316433|NCT01175356|560592455|FG000|Overall Study|Lost to Follow-up|1|||
155316434|NCT01175356|560592455|FG000|Overall Study|Physician Decision|23|||
155316435|NCT01175356|560592455|FG000|Overall Study|Ineligible|1|||
155316436|NCT01175356|560592455|FG000|Overall Study|Treatment Slot Not Available|18|||
155316437|NCT01175356|560592455|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
155316438|NCT01175356|560592455|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
155316439|NCT01175356|560592455|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
155316440|NCT01175356|560592455|FG000|Overall Study|Inadequate stem cell for transplant|1|||
155316441|NCT01175356|560592455|FG000|Overall Study|Initiation other tx prior to completion|9|||
155316442|NCT05792085|560592456|FG000|Overall Study|Death|0|||
155316443|NCT05792085|560592457|FG001|Overall Study|Death|0|||
155316444|NCT05792085|560592458|FG002|Overall Study|Death|0|||
155316445|NCT05792085|560592459|FG003|Overall Study|Death|0|||
155316446|NCT05792085|560592460|FG004|Overall Study|Death|1|||
155316447|NCT04898673|560592463|FG000|Overall Study|Screenfail|1|||
155316448|NCT04898673|560592464|FG001|Overall Study|Screenfail|0|||
155316449|NCT04797897|560592465|FG000|Overall Study|Study Termination by Sponsor|1|||
155316450|NCT04797897|560592466|FG001|Overall Study|Study Termination by Sponsor|1|||
155316451|NCT05540665|560593953|FG000|Overall Study|Study terminated by sponsor|6|||
155316452|NCT05540665|560593954|FG001|Overall Study|Study terminated by sponsor|6|||
154959938|NCT00934050|559278644|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
154959939|NCT00934050|559278645|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
155316453|NCT05540665|560593955|FG002|Overall Study|Study terminated by sponsor|7|||
155316454|NCT03462030|560593956|FG000|Overall Study|Withdrawal by Subject|1|||
155316455|NCT03462030|560593957|FG001|Overall Study|Withdrawal by Subject|1|||
155316456|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
155316457|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316458|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316459|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316460|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316461|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316462|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
155316463|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316464|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316465|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
155316466|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316467|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316468|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316469|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
155316470|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
155316471|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
155316472|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
155316473|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316474|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316475|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316476|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
155316477|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316478|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
155316479|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316480|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316481|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316482|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316483|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155316484|NCT03628924|560593958|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
155316485|NCT03628924|560593959|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316486|NCT03628924|560593960|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
155316487|NCT03628924|560593961|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316488|NCT03628924|560593962|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316489|NCT03628924|560593963|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316490|NCT03628924|560593964|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
155316491|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
155316492|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
155316493|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
155316494|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
155316495|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
155316496|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
155316497|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
155316498|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316499|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316500|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316501|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
155316502|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
155316503|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
155316504|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
155316505|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316506|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316507|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316508|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
155316509|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
155316510|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
155316511|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
155316512|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
155316513|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
155316514|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
155316515|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
155316516|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
155316517|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
155316518|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
155316519|NCT03628924|560593958|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316520|NCT03628924|560593959|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316521|NCT03628924|560593960|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316522|NCT03628924|560593961|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
155316523|NCT03628924|560593962|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
155316524|NCT03628924|560593963|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
155316525|NCT03628924|560593964|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
155316526|NCT02276885|560593965|FG000|Overall Study|Withdrawal by Subject|2|||
155316527|NCT02276885|560593966|FG001|Overall Study|Withdrawal by Subject|0|||
155316528|NCT02276885|560593965|FG000|Overall Study|Lost to Follow-up|5|||
155316529|NCT02276885|560593966|FG001|Overall Study|Lost to Follow-up|2|||
155316530|NCT03768505|560593975|FG000|Overall Study|sponsor decision|76|||
155316531|NCT03768505|560593975|FG000|Overall Study|Death|35|||
155316532|NCT03768505|560593975|FG000|Overall Study|Other -Various|30|||
155316533|NCT03768505|560593975|FG000|Overall Study|Withdrawal by Subject|22|||
155316534|NCT03768505|560593975|FG000|Overall Study|Lost to Follow-up|6|||
155316535|NCT04948697|560593976|FG000|Overall Study|Progressive disease|27|||
155316536|NCT04948697|560593977|FG001|Overall Study|Progressive disease|18|||
155316537|NCT04948697|560593976|FG000|Overall Study|Adverse Event|14|||
155316538|NCT04948697|560593977|FG001|Overall Study|Adverse Event|4|||
155316539|NCT04948697|560593976|FG000|Overall Study|Participant moved to long term extension study|7|||
155316540|NCT04948697|560593977|FG001|Overall Study|Participant moved to long term extension study|4|||
155316541|NCT04948697|560593976|FG000|Overall Study|Withdrawal by Subject|10|||
155316542|NCT04948697|560593977|FG001|Overall Study|Withdrawal by Subject|0|||
155316543|NCT04948697|560593976|FG000|Overall Study|Closed by Sponsor|3|||
155316544|NCT04948697|560593977|FG001|Overall Study|Closed by Sponsor|2|||
155316545|NCT04948697|560593976|FG000|Overall Study|Physician Decision|0|||
155316546|NCT04948697|560593977|FG001|Overall Study|Physician Decision|2|||
155316547|NCT04948697|560593976|FG000|Overall Study|Lost to Follow-up|0|||
155316548|NCT04948697|560593977|FG001|Overall Study|Lost to Follow-up|1|||
155316549|NCT04948697|560593976|FG000|Overall Study|Other-Miscellaneous|1|||
155316550|NCT04948697|560593977|FG001|Overall Study|Other-Miscellaneous|0|||
155316551|NCT04948697|560593976|FG000|Overall Study|Randomized but not treated|0|||
155316552|NCT04948697|560593977|FG001|Overall Study|Randomized but not treated|1|||
154959940|NCT00934050|559278640|FG000|Enrolled After 15 Dec 2009|Death|0|||
155316553|NCT02815566|560593978|FG000|Overall Study|Adverse Event|1|||
155316554|NCT02815566|560593979|FG001|Overall Study|Adverse Event|1|||
155316555|NCT02815566|560593978|FG000|Overall Study|Withdrawal by Subject|1|||
155316556|NCT02815566|560593979|FG001|Overall Study|Withdrawal by Subject|0|||
155316557|NCT02815566|560593978|FG000|Overall Study|Lost to Follow-up|0|||
155316558|NCT02815566|560593979|FG001|Overall Study|Lost to Follow-up|1|||
155316559|NCT02861300|560593984|FG000|Overall Study|Death|0|||
155316560|NCT02861300|560593985|FG001|Overall Study|Death|0|||
155316561|NCT02861300|560593986|FG002|Overall Study|Death|0|||
155316562|NCT02861300|560593987|FG003|Overall Study|Death|0|||
155316563|NCT02861300|560593988|FG004|Overall Study|Death|0|||
155316564|NCT02861300|560593989|FG005|Overall Study|Death|0|||
155316565|NCT02861300|560593990|FG006|Overall Study|Death|24|||
155316566|NCT02861300|560593984|FG000|Overall Study|Delay in treatment|0|||
155316567|NCT02861300|560593985|FG001|Overall Study|Delay in treatment|0|||
155316568|NCT02861300|560593986|FG002|Overall Study|Delay in treatment|0|||
155316569|NCT02861300|560593987|FG003|Overall Study|Delay in treatment|0|||
155316570|NCT02861300|560593988|FG004|Overall Study|Delay in treatment|0|||
155316571|NCT02861300|560593989|FG005|Overall Study|Delay in treatment|1|||
155316572|NCT02861300|560593990|FG006|Overall Study|Delay in treatment|0|||
155316573|NCT02861300|560593984|FG000|Overall Study|Disease Progression|0|||
155316574|NCT02861300|560593985|FG001|Overall Study|Disease Progression|1|||
155316575|NCT02861300|560593986|FG002|Overall Study|Disease Progression|0|||
155316576|NCT02861300|560593987|FG003|Overall Study|Disease Progression|0|||
155316577|NCT02861300|560593988|FG004|Overall Study|Disease Progression|0|||
155316578|NCT02861300|560593989|FG005|Overall Study|Disease Progression|0|||
154959941|NCT00934050|559278641|FG001|Enrolled After 15 Dec 2009|Death|0|||
155316579|NCT02861300|560593990|FG006|Overall Study|Disease Progression|2|||
155316580|NCT02861300|560593984|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
155316581|NCT02861300|560593985|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
155316582|NCT02861300|560593986|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
155316583|NCT02861300|560593987|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
155316584|NCT02861300|560593988|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
155316585|NCT02861300|560593989|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
155316586|NCT02861300|560593990|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
155316587|NCT02861300|560593984|FG000|Overall Study|Clinical Complications|0|||
155316588|NCT02861300|560593985|FG001|Overall Study|Clinical Complications|0|||
155316589|NCT02861300|560593986|FG002|Overall Study|Clinical Complications|0|||
155316590|NCT02861300|560593987|FG003|Overall Study|Clinical Complications|0|||
155316591|NCT02861300|560593988|FG004|Overall Study|Clinical Complications|0|||
155316592|NCT02861300|560593989|FG005|Overall Study|Clinical Complications|0|||
155316593|NCT02861300|560593990|FG006|Overall Study|Clinical Complications|1|||
155316594|NCT05399459|560594000|FG000|Overall Study|Randomized but not treated|29|||
155316595|NCT05399459|560594001|FG001|Overall Study|Randomized but not treated|30|||
155316596|NCT05399459|560594002|FG002|Overall Study|Randomized but not treated|38|||
155316597|NCT05399459|560594000|FG000|Overall Study|Lost to Follow-up|1|||
155316598|NCT05399459|560594001|FG001|Overall Study|Lost to Follow-up|0|||
155316599|NCT05399459|560594002|FG002|Overall Study|Lost to Follow-up|0|||
155316600|NCT04992520|560594003|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
155316601|NCT04992520|560594004|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
155316602|NCT04992520|560594005|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
155316603|NCT04992520|560594006|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
155316604|NCT04992520|560594007|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
155316605|NCT04992520|560594008|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
155316606|NCT04992520|560594003|FG000|Part A: First Challenge|Non-compliance|0|||
155316607|NCT04992520|560594004|FG001|Part A: First Challenge|Non-compliance|0|||
155316608|NCT04992520|560594005|FG002|Part A: First Challenge|Non-compliance|0|||
155316609|NCT04992520|560594006|FG003|Part A: First Challenge|Non-compliance|1|||
155316610|NCT04992520|560594007|FG004|Part A: First Challenge|Non-compliance|0|||
155316611|NCT04992520|560594008|FG005|Part A: First Challenge|Non-compliance|0|||
155316612|NCT04992520|560594003|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316613|NCT04992520|560594004|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316614|NCT04992520|560594005|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
155316615|NCT04992520|560594006|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316616|NCT04992520|560594007|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
155316617|NCT04992520|560594008|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
155316618|NCT04992520|560594003|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316619|NCT04992520|560594004|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316620|NCT04992520|560594005|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
155316621|NCT04992520|560594006|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316622|NCT04992520|560594007|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316623|NCT04992520|560594008|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
155316624|NCT03020199|560594018|FG000|Treatment Period|Adverse Event|0|||
155316625|NCT03020199|560594019|FG001|Treatment Period|Adverse Event|2|||
155316626|NCT03020199|560594018|FG000|Treatment Period|Lack of Efficacy|1|||
155316627|NCT03020199|560594019|FG001|Treatment Period|Lack of Efficacy|6|||
155316628|NCT03020199|560594018|FG000|Treatment Period|Lost to Follow-up|1|||
155316629|NCT03020199|560594019|FG001|Treatment Period|Lost to Follow-up|6|||
155092649|NCT00854360|559773651|FG001|Overall Study|Withdrawal by Subject|0|||
155316630|NCT03020199|560594018|FG000|Treatment Period|Physician Decision|0|||
155316631|NCT03020199|560594019|FG001|Treatment Period|Physician Decision|1|||
155316632|NCT03020199|560594018|FG000|Treatment Period|Subject/guardian decision|8|||
155316633|NCT03020199|560594019|FG001|Treatment Period|Subject/guardian decision|15|||
155316634|NCT03020199|560594018|FG000|Treatment Period|Subjects not treated|3|||
155316635|NCT03020199|560594019|FG001|Treatment Period|Subjects not treated|4|||
155316636|NCT03020199|560594018|FG000|Follow-up Period|Disease relapse|32|||
155316637|NCT03020199|560594019|FG001|Follow-up Period|Disease relapse|7|||
154959942|NCT00934050|559278642|FG002|Enrolled After 15 Dec 2009|Death|0|||
154959943|NCT00934050|559278643|FG003|Enrolled After 15 Dec 2009|Death|0|||
155316638|NCT03020199|560594018|FG000|Follow-up Period|Lack of Efficacy|1|||
155316639|NCT03020199|560594019|FG001|Follow-up Period|Lack of Efficacy|2|||
155316640|NCT03020199|560594018|FG000|Follow-up Period|Lost to Follow-up|4|||
155316641|NCT03020199|560594019|FG001|Follow-up Period|Lost to Follow-up|6|||
155316642|NCT03020199|560594018|FG000|Follow-up Period|Physician Decision|2|||
155316643|NCT03020199|560594019|FG001|Follow-up Period|Physician Decision|2|||
154959944|NCT00934050|559278644|FG004|Enrolled After 15 Dec 2009|Death|0|||
155316644|NCT03020199|560594018|FG000|Follow-up Period|Protocol Violation|1|||
155316645|NCT03020199|560594019|FG001|Follow-up Period|Protocol Violation|2|||
155316646|NCT03020199|560594018|FG000|Follow-up Period|Study terminated by Sponsor|6|||
155316647|NCT03020199|560594019|FG001|Follow-up Period|Study terminated by Sponsor|3|||
155316648|NCT03020199|560594018|FG000|Follow-up Period|Subject/guardian decision|14|||
155316649|NCT03020199|560594019|FG001|Follow-up Period|Subject/guardian decision|9|||
155316650|NCT04313972|560594020|FG000|Overall Study|Withdrawal by Subject|0|||
155316651|NCT04313972|560594021|FG001|Overall Study|Withdrawal by Subject|1|||
155316652|NCT05201079|560594035|FG000|Overall Study|Adverse Event|7|||
155316653|NCT05201079|560594036|FG001|Overall Study|Adverse Event|11|||
155316654|NCT05201079|560594035|FG000|Overall Study|Death|1|||
155316655|NCT05201079|560594036|FG001|Overall Study|Death|1|||
155316656|NCT05201079|560594035|FG000|Overall Study|Lack of Efficacy|0|||
155316657|NCT05201079|560594036|FG001|Overall Study|Lack of Efficacy|2|||
155316658|NCT05201079|560594035|FG000|Overall Study|Lost to Follow-up|0|||
154959945|NCT00934050|559278645|FG005|Enrolled After 15 Dec 2009|Death|1|||
155316659|NCT05201079|560594036|FG001|Overall Study|Lost to Follow-up|1|||
155316660|NCT05201079|560594035|FG000|Overall Study|Physician Decision|1|||
155316661|NCT05201079|560594036|FG001|Overall Study|Physician Decision|1|||
155316662|NCT05201079|560594035|FG000|Overall Study|Protocol Violation|1|||
155316663|NCT05201079|560594036|FG001|Overall Study|Protocol Violation|0|||
155316664|NCT05201079|560594035|FG000|Overall Study|Withdrawal by Subject|1|||
155316665|NCT05201079|560594036|FG001|Overall Study|Withdrawal by Subject|0|||
155316666|NCT05201079|560594035|FG000|Overall Study|Forbidden medication|9|||
155316667|NCT05201079|560594036|FG001|Overall Study|Forbidden medication|5|||
155316668|NCT05201079|560594035|FG000|Overall Study|Transfer to another hospital|0|||
155316669|NCT05201079|560594036|FG001|Overall Study|Transfer to another hospital|1|||
155316670|NCT05201079|560594035|FG000|Overall Study|Clinical condition|1|||
155316671|NCT05201079|560594036|FG001|Overall Study|Clinical condition|0|||
155316672|NCT05201079|560594035|FG000|Overall Study|SAE and sepsis|1|||
155316673|NCT05201079|560594036|FG001|Overall Study|SAE and sepsis|0|||
155316674|NCT01210807|560594043|FG000|Overall Study|Lost to Follow-up|1|||
155316675|NCT01210807|560594044|FG001|Overall Study|Lost to Follow-up|2|||
155316676|NCT01210807|560594043|FG000|Overall Study|Not implanted bilaterally|2|||
155316677|NCT01210807|560594044|FG001|Overall Study|Not implanted bilaterally|1|||
155316678|NCT05281562|560594045|FG000|Overall Study|Ineligible patient|1|||
155316679|NCT05281562|560594046|FG001|Overall Study|Ineligible patient|0|||
155316680|NCT00324805|560594047|FG000|Overall Study|Adverse Event|62|||
155316681|NCT00324805|560594048|FG001|Overall Study|Adverse Event|203|||
155316682|NCT00324805|560594047|FG000|Overall Study|Progression|7|||
155316683|NCT00324805|560594048|FG001|Overall Study|Progression|35|||
155316684|NCT00324805|560594047|FG000|Overall Study|Withdrawal by Subject|51|||
155316685|NCT00324805|560594048|FG001|Overall Study|Withdrawal by Subject|174|||
155316686|NCT00324805|560594047|FG000|Overall Study|Death|6|||
155316687|NCT00324805|560594048|FG001|Overall Study|Death|9|||
155316688|NCT00324805|560594047|FG000|Overall Study|Alternative therapy|4|||
155316689|NCT00324805|560594048|FG001|Overall Study|Alternative therapy|8|||
155316690|NCT00324805|560594047|FG000|Overall Study|Other complicating disease|1|||
155316691|NCT00324805|560594048|FG001|Overall Study|Other complicating disease|9|||
155316692|NCT00324805|560594047|FG000|Overall Study|Other reasons|7|||
155316693|NCT00324805|560594048|FG001|Overall Study|Other reasons|26|||
155316694|NCT00324805|560594047|FG000|Overall Study|Other|0|||
155316695|NCT00324805|560594048|FG001|Overall Study|Other|2|||
155316696|NCT00324805|560594047|FG000|Overall Study|Did not start therapy|12|||
155316697|NCT00324805|560594048|FG001|Overall Study|Did not start therapy|17|||
155316698|NCT05526430|560594056|FG000|Overall Study|Withdrawal by Subject|0|||
155316699|NCT05526430|560594057|FG001|Overall Study|Withdrawal by Subject|2|||
155316700|NCT05526430|560594058|FG002|Overall Study|Withdrawal by Subject|0|||
155316701|NCT05526430|560594059|FG003|Overall Study|Withdrawal by Subject|0|||
155316702|NCT03085810|560594060|FG000|Main Study|Withdrawal by Subject|77|||
155316703|NCT03085810|560594061|FG001|Main Study|Withdrawal by Subject|0|||
155316704|NCT03085810|560594062|FG002|Main Study|Withdrawal by Subject|0|||
155316705|NCT03085810|560594060|FG000|Main Study|Terminated By Sponsor|14|||
155316706|NCT03085810|560594061|FG001|Main Study|Terminated By Sponsor|0|||
155316707|NCT03085810|560594062|FG002|Main Study|Terminated By Sponsor|0|||
155316708|NCT03085810|560594060|FG000|Main Study|Protocol Violation|15|||
155316709|NCT03085810|560594061|FG001|Main Study|Protocol Violation|0|||
155316710|NCT03085810|560594062|FG002|Main Study|Protocol Violation|0|||
155316711|NCT03085810|560594060|FG000|Main Study|Physician Decision|13|||
155316712|NCT03085810|560594061|FG001|Main Study|Physician Decision|0|||
155316713|NCT03085810|560594062|FG002|Main Study|Physician Decision|0|||
155316714|NCT03085810|560594060|FG000|Main Study|Lost to Follow-up|17|||
155316715|NCT03085810|560594061|FG001|Main Study|Lost to Follow-up|0|||
155316716|NCT03085810|560594062|FG002|Main Study|Lost to Follow-up|0|||
155316717|NCT03085810|560594060|FG000|Main Study|Adverse Event|25|||
155316718|NCT03085810|560594061|FG001|Main Study|Adverse Event|0|||
155316719|NCT03085810|560594062|FG002|Main Study|Adverse Event|0|||
155316720|NCT03085810|560594060|FG000|Main Study|Pregnancy|7|||
155316721|NCT03085810|560594061|FG001|Main Study|Pregnancy|0|||
155316722|NCT03085810|560594062|FG002|Main Study|Pregnancy|0|||
155316723|NCT03085810|560594060|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
155316724|NCT03085810|560594061|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
155316725|NCT03085810|560594062|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
155316726|NCT03085810|560594060|FG000|Main Study|Lack of Efficacy|10|||
155316727|NCT03085810|560594061|FG001|Main Study|Lack of Efficacy|0|||
155316728|NCT03085810|560594062|FG002|Main Study|Lack of Efficacy|0|||
155316729|NCT03085810|560594060|FG000|Main Study|Death|12|||
155316730|NCT03085810|560594061|FG001|Main Study|Death|0|||
155316731|NCT03085810|560594062|FG002|Main Study|Death|0|||
155316732|NCT03085810|560594060|FG000|Main Study|Disease progression|1|||
155316733|NCT03085810|560594061|FG001|Main Study|Disease progression|0|||
155316734|NCT03085810|560594062|FG002|Main Study|Disease progression|0|||
155316735|NCT03085810|560594060|FG000|Main Study|Site Closure|3|||
155316736|NCT03085810|560594061|FG001|Main Study|Site Closure|0|||
155316737|NCT03085810|560594062|FG002|Main Study|Site Closure|0|||
155316738|NCT03085810|560594060|FG000|Main Study|Planned pregnancy|17|||
155316739|NCT03085810|560594061|FG001|Main Study|Planned pregnancy|0|||
155316740|NCT03085810|560594062|FG002|Main Study|Planned pregnancy|0|||
155316741|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
155316742|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
155316743|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
155316744|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
155316745|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
155316746|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
155316747|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
155316748|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
155316749|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
155316750|NCT03085810|560594060|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
155316751|NCT03085810|560594061|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
155316752|NCT03085810|560594062|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
155316753|NCT02601313|560594063|FG000|Overall Study|Death|2|||
155316754|NCT02601313|560594064|FG001|Overall Study|Death|41|||
155316755|NCT02601313|560594065|FG002|Overall Study|Death|6|||
155316756|NCT02601313|560594063|FG000|Overall Study|Enrolled but never treated|0|||
155316757|NCT02601313|560594064|FG001|Overall Study|Enrolled but never treated|6|||
155316758|NCT02601313|560594065|FG002|Overall Study|Enrolled but never treated|3|||
155316759|NCT02601313|560594063|FG000|Overall Study|Enrolled, did not initiate AC|4|||
155316760|NCT02601313|560594064|FG001|Overall Study|Enrolled, did not initiate AC|0|||
155316761|NCT02601313|560594065|FG002|Overall Study|Enrolled, did not initiate AC|0|||
155316762|NCT02601313|560594063|FG000|Overall Study|Full consent withdrawal|0|||
155316763|NCT02601313|560594064|FG001|Overall Study|Full consent withdrawal|3|||
155316764|NCT02601313|560594065|FG002|Overall Study|Full consent withdrawal|2|||
155316765|NCT02601313|560594063|FG000|Overall Study|Lost to Follow-up|0|||
155316766|NCT02601313|560594064|FG001|Overall Study|Lost to Follow-up|1|||
155316767|NCT02601313|560594065|FG002|Overall Study|Lost to Follow-up|1|||
155316768|NCT03800654|560594066|FG000|Overall Study|Time constraints|3|||
155316769|NCT03800654|560594067|FG001|Overall Study|Time constraints|3|||
155316770|NCT03800654|560594068|FG002|Overall Study|Time constraints|3|||
155316771|NCT03800654|560594066|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
155316772|NCT03800654|560594067|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
155316773|NCT03800654|560594068|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
155316774|NCT03800654|560594066|FG000|Overall Study|Lost to Follow-up|2|||
155316775|NCT03800654|560594067|FG001|Overall Study|Lost to Follow-up|1|||
155316776|NCT03800654|560594068|FG002|Overall Study|Lost to Follow-up|6|||
155316777|NCT03800654|560594066|FG000|Overall Study|Medical Health Issue|0|||
155316778|NCT03800654|560594067|FG001|Overall Study|Medical Health Issue|0|||
155316779|NCT03800654|560594068|FG002|Overall Study|Medical Health Issue|1|||
155316780|NCT03800654|560594066|FG000|Overall Study|Personal Issues|0|||
155316781|NCT03800654|560594067|FG001|Overall Study|Personal Issues|2|||
155316782|NCT03800654|560594068|FG002|Overall Study|Personal Issues|0|||
155316783|NCT03800654|560594066|FG000|Overall Study|Protocol Violation|0|||
155316784|NCT03800654|560594067|FG001|Overall Study|Protocol Violation|1|||
155316785|NCT03800654|560594068|FG002|Overall Study|Protocol Violation|0|||
155316786|NCT03459729|560594069|FG000|Overall Study|Physician Decision|2|||
155316787|NCT02626533|560594071|FG000|Overall Study|Protocol Violation|14|||
155316788|NCT02626533|560594071|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
155316789|NCT02626533|560594071|FG000|Overall Study|Withdrawal by Subject|1|||
155316790|NCT03701763|560594072|FG000|Placebo-controlled Phase|Adverse Event|1|||
155316791|NCT03701763|560594073|FG001|Placebo-controlled Phase|Adverse Event|5|||
155316792|NCT03701763|560594074|FG002|Placebo-controlled Phase|Adverse Event|0|||
155316793|NCT03701763|560594075|FG003|Placebo-controlled Phase|Adverse Event|0|||
155316794|NCT03701763|560594072|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
155316795|NCT03701763|560594073|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
155316796|NCT03701763|560594074|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
155316797|NCT03701763|560594075|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
155316798|NCT03701763|560594072|FG000|Placebo-controlled Phase|Miscellaneous|2|||
155316799|NCT03701763|560594073|FG001|Placebo-controlled Phase|Miscellaneous|0|||
155316800|NCT03701763|560594074|FG002|Placebo-controlled Phase|Miscellaneous|0|||
155316801|NCT03701763|560594075|FG003|Placebo-controlled Phase|Miscellaneous|0|||
155316802|NCT03701763|560594072|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
155316803|NCT03701763|560594073|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
155316804|NCT03701763|560594074|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
155316805|NCT03701763|560594075|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
155316806|NCT03701763|560594072|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
155316807|NCT03701763|560594073|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
155316808|NCT03701763|560594074|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
155316809|NCT03701763|560594075|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
155316810|NCT03701763|560594072|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
155316811|NCT03701763|560594073|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
155316812|NCT03701763|560594074|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
155316813|NCT03701763|560594075|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
155316814|NCT03701763|560594072|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
155316815|NCT03701763|560594073|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
155316816|NCT03701763|560594074|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
155316817|NCT03701763|560594075|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
155316818|NCT03701763|560594072|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
155316819|NCT03701763|560594073|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
155316820|NCT03701763|560594074|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
155316821|NCT03701763|560594075|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
155316822|NCT03701763|560594072|FG000|Apremilast Extension Phase|Adverse Event|0|||
155316823|NCT03701763|560594073|FG001|Apremilast Extension Phase|Adverse Event|0|||
155316824|NCT03701763|560594074|FG002|Apremilast Extension Phase|Adverse Event|3|||
155316825|NCT03701763|560594075|FG003|Apremilast Extension Phase|Adverse Event|1|||
155316826|NCT03701763|560594072|FG000|Apremilast Extension Phase|Miscellaneous|0|||
155316827|NCT03701763|560594073|FG001|Apremilast Extension Phase|Miscellaneous|0|||
155316828|NCT03701763|560594074|FG002|Apremilast Extension Phase|Miscellaneous|2|||
155316829|NCT03701763|560594075|FG003|Apremilast Extension Phase|Miscellaneous|1|||
155316830|NCT03701763|560594072|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
155316831|NCT03701763|560594073|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
155316832|NCT03701763|560594074|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
155316833|NCT03701763|560594075|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
155316834|NCT03701763|560594072|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
155316835|NCT03701763|560594073|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
155316836|NCT03701763|560594074|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
155316837|NCT03701763|560594075|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
155316838|NCT03701763|560594072|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
155316839|NCT03701763|560594073|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
155316840|NCT03701763|560594074|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
155316841|NCT03701763|560594075|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
155316842|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
155316843|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
155316844|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
155316845|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
155316846|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
155316847|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
155316848|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
155316849|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
155316850|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Other|0|||
155316851|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Other|0|||
155316852|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Other|1|||
155316853|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Other|0|||
155316854|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
155316855|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
155316856|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
155316857|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
155316858|NCT03701763|560594072|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
155316859|NCT03701763|560594073|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
155316860|NCT03701763|560594074|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
155316861|NCT03701763|560594075|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
155316862|NCT05576155|560594078|FG000|Overall Study|Withdrawal by Subject|1|||
155316863|NCT05576155|560594079|FG001|Overall Study|Withdrawal by Subject|1|||
155316864|NCT04515849|560594080|FG000|Overall Study|Adverse Event|0|||
155316865|NCT04515849|560594081|FG001|Overall Study|Adverse Event|0|||
155316866|NCT04515849|560594082|FG002|Overall Study|Adverse Event|0|||
155316867|NCT04515849|560594083|FG003|Overall Study|Adverse Event|1|||
155316868|NCT04515849|560594084|FG004|Overall Study|Adverse Event|2|||
155316869|NCT04515849|560594080|FG000|Overall Study|Death|2|||
155316870|NCT04515849|560594081|FG001|Overall Study|Death|0|||
155316871|NCT04515849|560594082|FG002|Overall Study|Death|0|||
155316872|NCT04515849|560594083|FG003|Overall Study|Death|0|||
155316873|NCT04515849|560594084|FG004|Overall Study|Death|0|||
155316874|NCT04515849|560594080|FG000|Overall Study|Other:family emergency|0|||
155316875|NCT04515849|560594081|FG001|Overall Study|Other:family emergency|0|||
155316876|NCT04515849|560594082|FG002|Overall Study|Other:family emergency|0|||
155316877|NCT04515849|560594083|FG003|Overall Study|Other:family emergency|1|||
155316878|NCT04515849|560594084|FG004|Overall Study|Other:family emergency|0|||
155316879|NCT04515849|560594080|FG000|Overall Study|Other:randomised by error|0|||
155316880|NCT04515849|560594081|FG001|Overall Study|Other:randomised by error|1|||
155316881|NCT04515849|560594082|FG002|Overall Study|Other:randomised by error|0|||
155316882|NCT04515849|560594083|FG003|Overall Study|Other:randomised by error|0|||
155316883|NCT04515849|560594084|FG004|Overall Study|Other:randomised by error|0|||
155316884|NCT04515849|560594080|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316885|NCT04515849|560594081|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316886|NCT04515849|560594082|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316887|NCT04515849|560594083|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
155316888|NCT04515849|560594084|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
155316889|NCT04515849|560594080|FG000|Overall Study|Physician Decision|0|||
155316890|NCT04515849|560594081|FG001|Overall Study|Physician Decision|1|||
155316891|NCT04515849|560594082|FG002|Overall Study|Physician Decision|0|||
155316892|NCT04515849|560594083|FG003|Overall Study|Physician Decision|0|||
155316893|NCT04515849|560594084|FG004|Overall Study|Physician Decision|0|||
155316894|NCT04515849|560594080|FG000|Overall Study|Withdrawal by Subject|1|||
155316895|NCT04515849|560594081|FG001|Overall Study|Withdrawal by Subject|2|||
155316896|NCT04515849|560594082|FG002|Overall Study|Withdrawal by Subject|1|||
155316897|NCT04515849|560594083|FG003|Overall Study|Withdrawal by Subject|0|||
155316898|NCT04515849|560594084|FG004|Overall Study|Withdrawal by Subject|0|||
155316899|NCT04049643|560594092|FG000|Overall Study|Lack of Efficacy|1|||
155316900|NCT04049643|560594093|FG001|Overall Study|Lack of Efficacy|1|||
155316901|NCT04049643|560594094|FG002|Overall Study|Lack of Efficacy|0|||
155316902|NCT04049643|560594092|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155316903|NCT04049643|560594093|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155316904|NCT04049643|560594094|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
155316905|NCT04081103|560594095|FG000|Overall Study|Adverse Event|1|||
155316906|NCT04081103|560594096|FG001|Overall Study|Adverse Event|1|||
155316907|NCT04081103|560594097|FG002|Overall Study|Adverse Event|1|||
155316908|NCT04081103|560594095|FG000|Overall Study|Physician Decision|0|||
155316909|NCT04081103|560594096|FG001|Overall Study|Physician Decision|0|||
155316910|NCT04081103|560594097|FG002|Overall Study|Physician Decision|1|||
155316911|NCT03365882|560594100|FG000|Randomization|Still Receiving Protocol Treatment|2|||
155316912|NCT03365882|560594101|FG001|Randomization|Still Receiving Protocol Treatment|0|||
155316913|NCT03365882|560594100|FG000|Randomization|Adverse Event|1|||
155316914|NCT03365882|560594101|FG001|Randomization|Adverse Event|2|||
155316915|NCT03365882|560594100|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
155316916|NCT03365882|560594101|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
155316917|NCT03365882|560594100|FG000|Randomization|Progression/Relapse|21|||
155316918|NCT03365882|560594101|FG001|Randomization|Progression/Relapse|3|||
155316919|NCT03365882|560594100|FG000|Randomization|Death|1|||
155316920|NCT03365882|560594101|FG001|Randomization|Death|0|||
155316921|NCT03365882|560594100|FG000|Randomization|Other - Not Protocol Specified|1|||
155316922|NCT03365882|560594101|FG001|Randomization|Other - Not Protocol Specified|1|||
155316923|NCT03365882|560594100|FG000|Randomization|Major Protocol Deviation|0|||
155316924|NCT03365882|560594101|FG001|Randomization|Major Protocol Deviation|1|||
155316925|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
155316926|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
155316927|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
155316928|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
155316929|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
155316930|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
155316931|NCT03365882|560594100|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
155316932|NCT03365882|560594101|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
155316933|NCT04437615|560594102|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
155316934|NCT04828005|560594103|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
155316935|NCT04828005|560594104|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
155316936|NCT04828005|560594105|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
155316937|NCT04828005|560594106|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
155316938|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
155316939|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
155316940|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
155316941|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
155316942|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
155316943|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
155316944|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
155316945|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
155316946|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
155316947|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
155316948|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
155316949|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
155316950|NCT04828005|560594103|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
155316951|NCT04828005|560594104|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
155316952|NCT04828005|560594105|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
155316953|NCT04828005|560594106|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
155316954|NCT04828005|560594103|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
155316955|NCT04828005|560594104|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
155316956|NCT04828005|560594105|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
155316957|NCT04828005|560594106|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
155316958|NCT04828005|560594103|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
155316959|NCT04828005|560594104|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
155316960|NCT04828005|560594105|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
155316961|NCT04828005|560594106|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
155316962|NCT04828005|560594103|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
155316963|NCT04828005|560594104|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
155316964|NCT04828005|560594105|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
155316965|NCT04828005|560594106|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
155316966|NCT04828005|560594103|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
155316967|NCT04828005|560594104|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
155316968|NCT04828005|560594105|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
155316969|NCT04828005|560594106|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
155316970|NCT05579899|560596106|FG000|Overall Study|Lost to Follow-up|3|||
155316971|NCT05579899|560596107|FG001|Overall Study|Lost to Follow-up|1|||
155316972|NCT05579899|560596106|FG000|Overall Study|Adverse Event|0|||
155316973|NCT05579899|560596107|FG001|Overall Study|Adverse Event|3|||
155316974|NCT05579899|560596106|FG000|Overall Study|Pregnancy|0|||
155316975|NCT05579899|560596107|FG001|Overall Study|Pregnancy|1|||
155316976|NCT05579899|560596106|FG000|Overall Study|Withdrawal by Subject|0|||
155316977|NCT05579899|560596107|FG001|Overall Study|Withdrawal by Subject|3|||
155316978|NCT03023410|560596108|FG000|Overall Study|study termination|0|||
155316979|NCT03023410|560596109|FG001|Overall Study|study termination|1|||
155316980|NCT04987320|560596115|FG000|Overall Study|Withdrawal by Subject|0|||
155316981|NCT04987320|560596116|FG001|Overall Study|Withdrawal by Subject|1|||
155316982|NCT00085735|560596117|FG000|Overall Study|Adverse Event|1|||
155316983|NCT00085735|560596118|FG001|Overall Study|Adverse Event|0|||
155316984|NCT00085735|560596119|FG002|Overall Study|Adverse Event|0|||
155316985|NCT00085735|560596120|FG003|Overall Study|Adverse Event|0|||
155316986|NCT00085735|560596121|FG004|Overall Study|Adverse Event|0|||
155316987|NCT00085735|560596122|FG005|Overall Study|Adverse Event|0|||
155316988|NCT00085735|560596117|FG000|Overall Study|Lack of Efficacy|2|||
155316989|NCT00085735|560596118|FG001|Overall Study|Lack of Efficacy|4|||
155316990|NCT00085735|560596119|FG002|Overall Study|Lack of Efficacy|6|||
155316991|NCT00085735|560596120|FG003|Overall Study|Lack of Efficacy|3|||
155316992|NCT00085735|560596121|FG004|Overall Study|Lack of Efficacy|4|||
155316993|NCT00085735|560596122|FG005|Overall Study|Lack of Efficacy|3|||
155316994|NCT00085735|560596117|FG000|Overall Study|Lost to Follow-up|0|||
155316995|NCT00085735|560596118|FG001|Overall Study|Lost to Follow-up|1|||
155316996|NCT00085735|560596119|FG002|Overall Study|Lost to Follow-up|0|||
155316997|NCT00085735|560596120|FG003|Overall Study|Lost to Follow-up|0|||
155316998|NCT00085735|560596121|FG004|Overall Study|Lost to Follow-up|1|||
155316999|NCT00085735|560596122|FG005|Overall Study|Lost to Follow-up|0|||
155317000|NCT00085735|560596117|FG000|Overall Study|Physician Decision|2|||
155317001|NCT00085735|560596118|FG001|Overall Study|Physician Decision|3|||
155317002|NCT00085735|560596119|FG002|Overall Study|Physician Decision|2|||
155317003|NCT00085735|560596120|FG003|Overall Study|Physician Decision|3|||
155317004|NCT00085735|560596121|FG004|Overall Study|Physician Decision|11|||
155317005|NCT00085735|560596122|FG005|Overall Study|Physician Decision|8|||
155317006|NCT00085735|560596117|FG000|Overall Study|Protocol Violation|1|||
155317007|NCT00085735|560596118|FG001|Overall Study|Protocol Violation|0|||
155317008|NCT00085735|560596119|FG002|Overall Study|Protocol Violation|0|||
155317009|NCT00085735|560596120|FG003|Overall Study|Protocol Violation|0|||
155317010|NCT00085735|560596121|FG004|Overall Study|Protocol Violation|0|||
155317011|NCT00085735|560596122|FG005|Overall Study|Protocol Violation|0|||
155317012|NCT00085735|560596117|FG000|Overall Study|Withdrawal by Subject|1|||
155317013|NCT00085735|560596118|FG001|Overall Study|Withdrawal by Subject|0|||
155317014|NCT00085735|560596119|FG002|Overall Study|Withdrawal by Subject|4|||
155317015|NCT00085735|560596120|FG003|Overall Study|Withdrawal by Subject|5|||
155317016|NCT00085735|560596121|FG004|Overall Study|Withdrawal by Subject|7|||
155317017|NCT00085735|560596122|FG005|Overall Study|Withdrawal by Subject|8|||
155317018|NCT00085735|560596117|FG000|Overall Study|Patient ineligible|1|||
155317019|NCT00085735|560596118|FG001|Overall Study|Patient ineligible|0|||
155317020|NCT00085735|560596119|FG002|Overall Study|Patient ineligible|3|||
155317021|NCT00085735|560596120|FG003|Overall Study|Patient ineligible|7|||
155317022|NCT00085735|560596121|FG004|Overall Study|Patient ineligible|17|||
155317023|NCT00085735|560596122|FG005|Overall Study|Patient ineligible|8|||
155317024|NCT00085735|560596117|FG000|Overall Study|Excess residual disease|2|||
155317025|NCT00085735|560596118|FG001|Overall Study|Excess residual disease|2|||
155317026|NCT00085735|560596119|FG002|Overall Study|Excess residual disease|1|||
155317027|NCT00085735|560596120|FG003|Overall Study|Excess residual disease|1|||
155317028|NCT00085735|560596121|FG004|Overall Study|Excess residual disease|1|||
155317029|NCT00085735|560596122|FG005|Overall Study|Excess residual disease|4|||
155317030|NCT00085735|560596117|FG000|Overall Study|Reason not documented|1|||
155317031|NCT00085735|560596118|FG001|Overall Study|Reason not documented|0|||
155317032|NCT00085735|560596119|FG002|Overall Study|Reason not documented|1|||
155317033|NCT00085735|560596120|FG003|Overall Study|Reason not documented|0|||
155317034|NCT00085735|560596121|FG004|Overall Study|Reason not documented|1|||
155317035|NCT00085735|560596122|FG005|Overall Study|Reason not documented|0|||
155317036|NCT00085735|560596117|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
155317037|NCT00085735|560596118|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
155317038|NCT00085735|560596119|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
155317039|NCT00085735|560596120|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
155317040|NCT00085735|560596121|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
155317041|NCT00085735|560596122|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
155317042|NCT01824875|560596123|FG000|Overall Study|Disease progression|22|||
155317043|NCT01824875|560596124|FG001|Overall Study|Disease progression|15|||
155317044|NCT01824875|560596123|FG000|Overall Study|Withdrawal by Subject|5|||
155317045|NCT01824875|560596124|FG001|Overall Study|Withdrawal by Subject|4|||
155317046|NCT01824875|560596123|FG000|Overall Study|Adverse Event|4|||
155317047|NCT01824875|560596124|FG001|Overall Study|Adverse Event|10|||
155317048|NCT01824875|560596123|FG000|Overall Study|Alternative therapy|3|||
155317049|NCT01824875|560596124|FG001|Overall Study|Alternative therapy|0|||
155317050|NCT01824875|560596123|FG000|Overall Study|Complicating disease|1|||
155317051|NCT01824875|560596124|FG001|Overall Study|Complicating disease|0|||
155317052|NCT01824875|560596123|FG000|Overall Study|Physician Decision|0|||
155317053|NCT01824875|560596124|FG001|Overall Study|Physician Decision|1|||
155317054|NCT01824875|560596123|FG000|Overall Study|Non-compliance|1|||
155317055|NCT01824875|560596124|FG001|Overall Study|Non-compliance|1|||
155317056|NCT01824875|560596123|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
155317057|NCT01824875|560596124|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
155317058|NCT01824875|560596123|FG000|Overall Study|Administrative issues|0|||
155317059|NCT01824875|560596124|FG001|Overall Study|Administrative issues|2|||
155317060|NCT01824875|560596123|FG000|Overall Study|Ineligible or never started treatment|9|||
155317061|NCT01824875|560596124|FG001|Overall Study|Ineligible or never started treatment|5|||
155317062|NCT01824875|560596123|FG000|Overall Study|Other|0|||
155317063|NCT01824875|560596124|FG001|Overall Study|Other|2|||
155317064|NCT00433329|560596127|FG000|Overall Study|Adverse Event|9|||
155317065|NCT00433329|560596127|FG000|Overall Study|Death|4|||
155317066|NCT00433329|560596127|FG000|Overall Study|Withdrew consent|3|||
155317067|NCT00433329|560596127|FG000|Overall Study|Discontinued sildenafil|2|||
155317068|NCT00433329|560596127|FG000|Overall Study|Moved out of state|1|||
155317069|NCT00433329|560596127|FG000|Overall Study|Lost to Follow-up|1|||
155317070|NCT00433329|560596127|FG000|Overall Study|Physician Decision|1|||
155317071|NCT04195698|560596128|FG000|Overall Study|Adverse Event|4|||
155317072|NCT04195698|560596129|FG001|Overall Study|Adverse Event|11|||
155317073|NCT04195698|560596128|FG000|Overall Study|Withdrawal by Subject|9|||
155317074|NCT04195698|560596129|FG001|Overall Study|Withdrawal by Subject|10|||
155317075|NCT04195698|560596128|FG000|Overall Study|Lost to Follow-up|5|||
155317076|NCT04195698|560596129|FG001|Overall Study|Lost to Follow-up|4|||
155317077|NCT04195698|560596128|FG000|Overall Study|Lack of Efficacy|2|||
155317078|NCT04195698|560596129|FG001|Overall Study|Lack of Efficacy|10|||
155317079|NCT04195698|560596128|FG000|Overall Study|Other|5|||
155317080|NCT04195698|560596129|FG001|Overall Study|Other|4|||
155317081|NCT05459688|560596130|FG000|Overall Study|Lost to Follow-up|6|||
155317082|NCT05459688|560596130|FG000|Overall Study|Physician Decision|1|||
155317083|NCT05459688|560596130|FG000|Overall Study|Withdrawal by Subject|19|||
155317084|NCT05459688|560596130|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
155317085|NCT02675751|560596131|FG000|Overall Study|Lost to Follow-up|16|||
155317086|NCT03371381|560596132|FG000|Overall Study|Death|5|||
155317087|NCT03371381|560596132|FG000|Overall Study|Study terminated by sponsor|3|||
155317088|NCT03371381|560596132|FG000|Overall Study|Other|4|||
155317089|NCT01593917|560596135|FG000|Overall Study|Death|67|||
155317090|NCT01593917|560596135|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
155317091|NCT01593917|560596135|FG000|Overall Study|Withdrawal by Subject|23|||
155317092|NCT01593917|560596135|FG000|Overall Study|Lost to Follow-up|12|||
155162410|NCT03278249|560029891|FG000|Overall Study|Withdrawal by Subject|2|||
155317093|NCT01593917|560596135|FG000|Overall Study|Protocol Violation|5|||
155317094|NCT01593917|560596135|FG000|Overall Study|Physician Decision|3|||
155317095|NCT04663737|560596136|FG000|Overall Study|Withdrawal by Subject|2|||
155317096|NCT04663737|560596137|FG001|Overall Study|Withdrawal by Subject|0|||
155317097|NCT04016662|560596138|FG000|Run-In Phase|Death|1|||
155317098|NCT04016662|560596138|FG000|Run-In Phase|Withdrawal by Subject|11|||
155317099|NCT04016662|560596138|FG000|Run-In Phase|Not meeting screening eligibility|9|||
155317100|NCT04016662|560596138|FG000|Run-In Phase|Physician Decision|3|||
155317101|NCT04016662|560596138|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
155317102|NCT04016662|560596138|FG000|PLGS (12 Weeks)|Death|1|||
155317103|NCT04016662|560596138|FG000|SAP (12 Weeks)|Death|1|||
155317104|NCT03216057|560596139|FG000|Overall Study|Lost to Follow-up|2|||
155317105|NCT03216057|560596140|FG001|Overall Study|Lost to Follow-up|2|||
155317106|NCT05126433|560596141|FG000|Overall Study|Withdrawal by Subject|3|||
155317107|NCT05126433|560596142|FG001|Overall Study|Withdrawal by Subject|0|||
155317108|NCT05126433|560596143|FG002|Overall Study|Withdrawal by Subject|4|||
155317109|NCT05126433|560596141|FG000|Overall Study|Death|9|||
155317110|NCT05126433|560596142|FG001|Overall Study|Death|3|||
155317111|NCT05126433|560596143|FG002|Overall Study|Death|5|||
155317112|NCT05126433|560596141|FG000|Overall Study|Study Terminated by sponsor|0|||
155317113|NCT05126433|560596142|FG001|Overall Study|Study Terminated by sponsor|1|||
155317114|NCT05126433|560596143|FG002|Overall Study|Study Terminated by sponsor|2|||
155317115|NCT05126433|560596141|FG000|Overall Study|Progressive Disease|1|||
155317116|NCT05126433|560596142|FG001|Overall Study|Progressive Disease|4|||
155317117|NCT05126433|560596143|FG002|Overall Study|Progressive Disease|3|||
155317118|NCT05126433|560596141|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
155317119|NCT05126433|560596142|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
155317120|NCT05126433|560596143|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
155317121|NCT04599062|560596147|FG000|Overall Study|Physician Decision|1|||
155317122|NCT04599062|560596148|FG001|Overall Study|Physician Decision|0|||
155317123|NCT04032704|560596149|FG000|Part A|Withdrawal by Subject|0|||
155317124|NCT04032704|560596150|FG001|Part A|Withdrawal by Subject|0|||
155317125|NCT04032704|560596151|FG002|Part A|Withdrawal by Subject|3|||
155317126|NCT04032704|560596152|FG003|Part A|Withdrawal by Subject|0|||
155317127|NCT04032704|560596153|FG004|Part A|Withdrawal by Subject|1|||
155317128|NCT04032704|560596154|FG005|Part A|Withdrawal by Subject|7|||
155317129|NCT04032704|560596155|FG006|Part A|Withdrawal by Subject|0|||
155317130|NCT04032704|560596156|FG007|Part A|Withdrawal by Subject|0|||
155317131|NCT04032704|560596157|FG008|Part A|Withdrawal by Subject|0|||
155317132|NCT04032704|560596158|FG009|Part A|Withdrawal by Subject|0|||
155317133|NCT04032704|560596159|FG010|Part A|Withdrawal by Subject|0|||
155317134|NCT04032704|560596160|FG011|Part A|Withdrawal by Subject|0|||
155317135|NCT04032704|560596161|FG012|Part A|Withdrawal by Subject|0|||
155317136|NCT04032704|560596162|FG013|Part A|Withdrawal by Subject|0|||
155162411|NCT03278249|560029891|FG000|Overall Study|Lost to Follow-up|1|||
155317137|NCT04032704|560596163|FG014|Part A|Withdrawal by Subject|0|||
155317138|NCT04032704|560596164|FG015|Part A|Withdrawal by Subject|0|||
155317139|NCT04032704|560596165|FG016|Part A|Withdrawal by Subject|0|||
155317140|NCT04032704|560596166|FG017|Part A|Withdrawal by Subject|0|||
155317141|NCT04032704|560596149|FG000|Part A|Lost to Follow-up|1|||
155317142|NCT04032704|560596150|FG001|Part A|Lost to Follow-up|0|||
155317143|NCT04032704|560596151|FG002|Part A|Lost to Follow-up|0|||
155317144|NCT04032704|560596152|FG003|Part A|Lost to Follow-up|0|||
155317145|NCT04032704|560596153|FG004|Part A|Lost to Follow-up|0|||
155317146|NCT04032704|560596154|FG005|Part A|Lost to Follow-up|0|||
155317147|NCT04032704|560596155|FG006|Part A|Lost to Follow-up|0|||
155317148|NCT04032704|560596156|FG007|Part A|Lost to Follow-up|0|||
155317149|NCT04032704|560596157|FG008|Part A|Lost to Follow-up|0|||
155317150|NCT04032704|560596158|FG009|Part A|Lost to Follow-up|0|||
155317151|NCT04032704|560596159|FG010|Part A|Lost to Follow-up|0|||
155317152|NCT04032704|560596160|FG011|Part A|Lost to Follow-up|0|||
155317153|NCT04032704|560596161|FG012|Part A|Lost to Follow-up|0|||
155317154|NCT04032704|560596162|FG013|Part A|Lost to Follow-up|0|||
155317155|NCT04032704|560596163|FG014|Part A|Lost to Follow-up|0|||
155317156|NCT04032704|560596164|FG015|Part A|Lost to Follow-up|0|||
155317157|NCT04032704|560596165|FG016|Part A|Lost to Follow-up|0|||
155317158|NCT04032704|560596166|FG017|Part A|Lost to Follow-up|0|||
155317159|NCT04032704|560596149|FG000|Part A|Death|9|||
155317160|NCT04032704|560596150|FG001|Part A|Death|2|||
155317161|NCT04032704|560596151|FG002|Part A|Death|10|||
155317162|NCT04032704|560596152|FG003|Part A|Death|7|||
155317163|NCT04032704|560596153|FG004|Part A|Death|4|||
155317164|NCT04032704|560596154|FG005|Part A|Death|5|||
155317165|NCT04032704|560596155|FG006|Part A|Death|0|||
155317166|NCT04032704|560596156|FG007|Part A|Death|0|||
155317167|NCT04032704|560596157|FG008|Part A|Death|0|||
155317168|NCT04032704|560596158|FG009|Part A|Death|0|||
155317169|NCT04032704|560596159|FG010|Part A|Death|0|||
155317170|NCT04032704|560596160|FG011|Part A|Death|0|||
155317171|NCT04032704|560596161|FG012|Part A|Death|0|||
155317172|NCT04032704|560596162|FG013|Part A|Death|0|||
155317173|NCT04032704|560596163|FG014|Part A|Death|0|||
155317174|NCT04032704|560596164|FG015|Part A|Death|0|||
155317175|NCT04032704|560596165|FG016|Part A|Death|0|||
155317176|NCT04032704|560596166|FG017|Part A|Death|0|||
155317177|NCT04032704|560596149|FG000|Part B|Other|0|||
155317178|NCT04032704|560596150|FG001|Part B|Other|0|||
155317179|NCT04032704|560596151|FG002|Part B|Other|0|||
155317180|NCT04032704|560596152|FG003|Part B|Other|0|||
155317181|NCT04032704|560596153|FG004|Part B|Other|0|||
155317182|NCT04032704|560596154|FG005|Part B|Other|0|||
155317183|NCT04032704|560596155|FG006|Part B|Other|0|||
155317184|NCT04032704|560596156|FG007|Part B|Other|1|||
155317185|NCT04032704|560596157|FG008|Part B|Other|2|||
155317186|NCT04032704|560596158|FG009|Part B|Other|1|||
155317187|NCT04032704|560596159|FG010|Part B|Other|1|||
155317188|NCT04032704|560596160|FG011|Part B|Other|1|||
155317189|NCT04032704|560596161|FG012|Part B|Other|5|||
155317190|NCT04032704|560596162|FG013|Part B|Other|13|||
155317191|NCT04032704|560596163|FG014|Part B|Other|0|||
155317192|NCT04032704|560596164|FG015|Part B|Other|0|||
155317193|NCT04032704|560596165|FG016|Part B|Other|0|||
155317194|NCT04032704|560596166|FG017|Part B|Other|0|||
155317195|NCT04032704|560596149|FG000|Part B|Study termination by Sponsor|0|||
155317196|NCT04032704|560596150|FG001|Part B|Study termination by Sponsor|0|||
155317197|NCT04032704|560596151|FG002|Part B|Study termination by Sponsor|0|||
155317198|NCT04032704|560596152|FG003|Part B|Study termination by Sponsor|0|||
155317199|NCT04032704|560596153|FG004|Part B|Study termination by Sponsor|0|||
155317200|NCT04032704|560596154|FG005|Part B|Study termination by Sponsor|0|||
155317201|NCT04032704|560596155|FG006|Part B|Study termination by Sponsor|0|||
155317202|NCT04032704|560596156|FG007|Part B|Study termination by Sponsor|0|||
155317203|NCT04032704|560596157|FG008|Part B|Study termination by Sponsor|1|||
155317204|NCT04032704|560596158|FG009|Part B|Study termination by Sponsor|0|||
155317205|NCT04032704|560596159|FG010|Part B|Study termination by Sponsor|0|||
155317206|NCT04032704|560596160|FG011|Part B|Study termination by Sponsor|0|||
155317207|NCT04032704|560596161|FG012|Part B|Study termination by Sponsor|0|||
155317208|NCT04032704|560596162|FG013|Part B|Study termination by Sponsor|0|||
155317209|NCT04032704|560596163|FG014|Part B|Study termination by Sponsor|0|||
155317210|NCT04032704|560596164|FG015|Part B|Study termination by Sponsor|0|||
155317211|NCT04032704|560596165|FG016|Part B|Study termination by Sponsor|0|||
155317212|NCT04032704|560596166|FG017|Part B|Study termination by Sponsor|0|||
155317213|NCT04032704|560596149|FG000|Part B|Withdrawal by Subject|0|||
155317214|NCT04032704|560596150|FG001|Part B|Withdrawal by Subject|0|||
155317215|NCT04032704|560596151|FG002|Part B|Withdrawal by Subject|0|||
155317216|NCT04032704|560596152|FG003|Part B|Withdrawal by Subject|0|||
155317217|NCT04032704|560596153|FG004|Part B|Withdrawal by Subject|0|||
155317218|NCT04032704|560596154|FG005|Part B|Withdrawal by Subject|0|||
155317219|NCT04032704|560596155|FG006|Part B|Withdrawal by Subject|3|||
155317220|NCT04032704|560596156|FG007|Part B|Withdrawal by Subject|2|||
155317221|NCT04032704|560596157|FG008|Part B|Withdrawal by Subject|2|||
155317222|NCT04032704|560596158|FG009|Part B|Withdrawal by Subject|1|||
155317223|NCT04032704|560596159|FG010|Part B|Withdrawal by Subject|4|||
155317224|NCT04032704|560596160|FG011|Part B|Withdrawal by Subject|6|||
155317225|NCT04032704|560596161|FG012|Part B|Withdrawal by Subject|2|||
155317226|NCT04032704|560596162|FG013|Part B|Withdrawal by Subject|1|||
155317227|NCT04032704|560596163|FG014|Part B|Withdrawal by Subject|0|||
155317228|NCT04032704|560596164|FG015|Part B|Withdrawal by Subject|1|||
155317229|NCT04032704|560596165|FG016|Part B|Withdrawal by Subject|0|||
155317230|NCT04032704|560596166|FG017|Part B|Withdrawal by Subject|0|||
155067059|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155067060|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155067061|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155317231|NCT04032704|560596149|FG000|Part B|Lost to Follow-up|0|||
155317232|NCT04032704|560596150|FG001|Part B|Lost to Follow-up|0|||
155317233|NCT04032704|560596151|FG002|Part B|Lost to Follow-up|0|||
155317234|NCT04032704|560596152|FG003|Part B|Lost to Follow-up|0|||
155317235|NCT04032704|560596153|FG004|Part B|Lost to Follow-up|0|||
155317236|NCT04032704|560596154|FG005|Part B|Lost to Follow-up|0|||
155317237|NCT04032704|560596155|FG006|Part B|Lost to Follow-up|0|||
155317238|NCT04032704|560596156|FG007|Part B|Lost to Follow-up|0|||
155317239|NCT04032704|560596157|FG008|Part B|Lost to Follow-up|0|||
155317240|NCT04032704|560596158|FG009|Part B|Lost to Follow-up|0|||
155317241|NCT04032704|560596159|FG010|Part B|Lost to Follow-up|0|||
155317242|NCT04032704|560596160|FG011|Part B|Lost to Follow-up|1|||
155317243|NCT04032704|560596161|FG012|Part B|Lost to Follow-up|0|||
155317244|NCT04032704|560596162|FG013|Part B|Lost to Follow-up|0|||
155317245|NCT04032704|560596163|FG014|Part B|Lost to Follow-up|0|||
155317246|NCT04032704|560596164|FG015|Part B|Lost to Follow-up|0|||
155317247|NCT04032704|560596165|FG016|Part B|Lost to Follow-up|0|||
155317248|NCT04032704|560596166|FG017|Part B|Lost to Follow-up|0|||
155317249|NCT04032704|560596149|FG000|Part B|Death|0|||
155317250|NCT04032704|560596150|FG001|Part B|Death|0|||
155317251|NCT04032704|560596151|FG002|Part B|Death|0|||
155317252|NCT04032704|560596152|FG003|Part B|Death|0|||
155317253|NCT04032704|560596153|FG004|Part B|Death|0|||
155317254|NCT04032704|560596154|FG005|Part B|Death|0|||
155317255|NCT04032704|560596155|FG006|Part B|Death|13|||
155317256|NCT04032704|560596156|FG007|Part B|Death|13|||
155317257|NCT04032704|560596157|FG008|Part B|Death|14|||
155317258|NCT04032704|560596158|FG009|Part B|Death|12|||
155317259|NCT04032704|560596159|FG010|Part B|Death|12|||
155317260|NCT04032704|560596160|FG011|Part B|Death|13|||
155317261|NCT04032704|560596161|FG012|Part B|Death|7|||
155317262|NCT04032704|560596162|FG013|Part B|Death|17|||
155317263|NCT04032704|560596163|FG014|Part B|Death|2|||
155317264|NCT04032704|560596164|FG015|Part B|Death|1|||
155317265|NCT04032704|560596165|FG016|Part B|Death|2|||
155317266|NCT04032704|560596166|FG017|Part B|Death|2|||
155317267|NCT03133546|560596168|FG000|Overall Study|Death|46|||
155317268|NCT03133546|560596169|FG001|Overall Study|Death|43|||
155317269|NCT03133546|560596168|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
155317270|NCT03133546|560596169|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
155317271|NCT05034328|560596170|FG000|Overall Study|Protocol Violation|1|||
155317272|NCT05034328|560596171|FG001|Overall Study|Protocol Violation|0|||
155317273|NCT05034328|560596170|FG000|Overall Study|Lost to Follow-up|0|||
155317274|NCT05034328|560596171|FG001|Overall Study|Lost to Follow-up|10|||
155317275|NCT02993159|560596172|FG000|Overall Study|Withdrawal by Subject|1|||
155317276|NCT02993159|560596173|FG001|Overall Study|Withdrawal by Subject|3|||
155317277|NCT02993159|560596172|FG000|Overall Study|Protocol Violation|1|||
155317278|NCT02993159|560596173|FG001|Overall Study|Protocol Violation|0|||
155317279|NCT02993159|560596172|FG000|Overall Study|Opted out of surgery|2|||
155317280|NCT02993159|560596173|FG001|Overall Study|Opted out of surgery|0|||
155317281|NCT02993159|560596172|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
155317282|NCT02993159|560596173|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
155317283|NCT02993159|560596172|FG000|Overall Study|Physician Decision|0|||
155317284|NCT02993159|560596173|FG001|Overall Study|Physician Decision|1|||
155317285|NCT02231164|560596174|FG000|Overall Study|Adverse Event|1|||
155317286|NCT02231164|560596175|FG001|Overall Study|Adverse Event|1|||
155317287|NCT02231164|560596174|FG000|Overall Study|Lack of Efficacy|4|||
155317288|NCT02231164|560596175|FG001|Overall Study|Lack of Efficacy|3|||
155317289|NCT02231164|560596174|FG000|Overall Study|Withdrawal by Subject|1|||
155317290|NCT02231164|560596175|FG001|Overall Study|Withdrawal by Subject|2|||
155317291|NCT02969707|560596176|FG000|Overall Study|Withdrawal by Subject|6|||
155317292|NCT02969707|560596177|FG001|Overall Study|Withdrawal by Subject|5|||
155317293|NCT02969707|560596176|FG000|Overall Study|Severe anxiety|0|||
155317294|NCT02969707|560596177|FG001|Overall Study|Severe anxiety|1|||
155317295|NCT02969707|560596176|FG000|Overall Study|Positive toxicology screen|0|||
155317296|NCT02969707|560596177|FG001|Overall Study|Positive toxicology screen|2|||
155317297|NCT02969707|560596176|FG000|Overall Study|Claustrophobia|2|||
155317298|NCT02969707|560596177|FG001|Overall Study|Claustrophobia|2|||
155317299|NCT02969707|560596176|FG000|Overall Study|Non-compliance|1|||
155317300|NCT02969707|560596177|FG001|Overall Study|Non-compliance|2|||
155317301|NCT05583578|560596184|FG000|Overall Study|Withdrawal by Subject|2|||
155317302|NCT05583578|560596185|FG001|Overall Study|Withdrawal by Subject|0|||
155317303|NCT00248287|560596186|FG000|Overall Study|Adverse Event|11|||
155317304|NCT00248287|560596187|FG001|Overall Study|Adverse Event|10|||
155317305|NCT00248287|560596186|FG000|Overall Study|Death|1|||
155317306|NCT00248287|560596187|FG001|Overall Study|Death|0|||
155317307|NCT00248287|560596186|FG000|Overall Study|Lost to Follow-up|0|||
155317308|NCT00248287|560596187|FG001|Overall Study|Lost to Follow-up|1|||
155317309|NCT00248287|560596186|FG000|Overall Study|Investigator Request|4|||
155317310|NCT00248287|560596187|FG001|Overall Study|Investigator Request|3|||
155317311|NCT00248287|560596186|FG000|Overall Study|Patient Request|5|||
155317312|NCT00248287|560596187|FG001|Overall Study|Patient Request|3|||
155317313|NCT00248287|560596186|FG000|Overall Study|Other|3|||
155317314|NCT00248287|560596187|FG001|Overall Study|Other|2|||
155317315|NCT02714257|560596188|FG000|Overall Study|Withdrawal by Subject|6|||
155317316|NCT02714257|560596189|FG001|Overall Study|Withdrawal by Subject|11|||
155067062|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
155317317|NCT02714257|560596188|FG000|Overall Study|Death|3|||
155317318|NCT02714257|560596189|FG001|Overall Study|Death|4|||
155317319|NCT02714257|560596188|FG000|Overall Study|Lost to Follow-up|1|||
155317320|NCT02714257|560596189|FG001|Overall Study|Lost to Follow-up|6|||
155317321|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
155317322|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
155317323|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
155317324|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
155317325|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
155317326|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
155317327|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
155317328|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
155317329|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
155317330|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
155317331|NCT04103580|560596190|FG000|Phase 1 Active Caregiving|Other|3|||
155317332|NCT04103580|560596191|FG001|Phase 1 Active Caregiving|Other|3|||
155317333|NCT04103580|560596190|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
155317334|NCT04103580|560596191|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
155317335|NCT04103580|560596190|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
155317336|NCT04103580|560596191|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
155317337|NCT04103580|560596190|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
155317338|NCT04103580|560596191|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
155317339|NCT04103580|560596190|FG000|Phase 2 Bereavement|Other|8|||
155317340|NCT04103580|560596191|FG001|Phase 2 Bereavement|Other|6|||
155317341|NCT05808257|560596194|FG000|Overall Study|Lost to Follow-up|8|||
155317342|NCT05808257|560596195|FG001|Overall Study|Lost to Follow-up|8|||
155317343|NCT04568486|560596196|FG000|Overall Study|Withdrawal by Subject|26|||
155317344|NCT04568486|560596196|FG000|Overall Study|Lost to Follow-up|7|||
155317345|NCT04042233|560596197|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
155317346|NCT04042233|560596198|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
155317347|NCT04042233|560596197|FG000|Overall Study|Protocol Violation|0|||
155317348|NCT04042233|560596198|FG001|Overall Study|Protocol Violation|2|||
155317349|NCT04248725|560596212|FG000|Post-Treatment|Lost to Follow-up|6|||
155317350|NCT04248725|560596213|FG001|Post-Treatment|Lost to Follow-up|5|||
155317351|NCT04248725|560596212|FG000|6-Month Follow Up|Lost to Follow-up|9|||
155317352|NCT04248725|560596213|FG001|6-Month Follow Up|Lost to Follow-up|8|||
155317353|NCT04436276|560596216|FG000|Overall Study|Adverse Event|0|||
155317354|NCT04436276|560596217|FG001|Overall Study|Adverse Event|0|||
155317355|NCT04436276|560596218|FG002|Overall Study|Adverse Event|0|||
155317356|NCT04436276|560596219|FG003|Overall Study|Adverse Event|0|||
155317357|NCT04436276|560596220|FG004|Overall Study|Adverse Event|0|||
155317358|NCT04436276|560596221|FG005|Overall Study|Adverse Event|0|||
155317359|NCT04436276|560596222|FG006|Overall Study|Adverse Event|0|||
155317360|NCT04436276|560596223|FG007|Overall Study|Adverse Event|0|||
155317361|NCT04436276|560596224|FG008|Overall Study|Adverse Event|0|||
155317362|NCT04436276|560596225|FG009|Overall Study|Adverse Event|0|||
155317363|NCT04436276|560596226|FG010|Overall Study|Adverse Event|0|||
155317364|NCT04436276|560596227|FG011|Overall Study|Adverse Event|0|||
155317365|NCT04436276|560596228|FG012|Overall Study|Adverse Event|0|||
155317366|NCT04436276|560596229|FG013|Overall Study|Adverse Event|0|||
155317367|NCT04436276|560596230|FG014|Overall Study|Adverse Event|0|||
155317368|NCT04436276|560596231|FG015|Overall Study|Adverse Event|0|||
155317369|NCT04436276|560596232|FG016|Overall Study|Adverse Event|1|||
155317370|NCT04436276|560596233|FG017|Overall Study|Adverse Event|0|||
155317371|NCT04436276|560596234|FG018|Overall Study|Adverse Event|0|||
155317372|NCT04436276|560596235|FG019|Overall Study|Adverse Event|0|||
155317373|NCT04436276|560596236|FG020|Overall Study|Adverse Event|0|||
155317374|NCT04436276|560596237|FG021|Overall Study|Adverse Event|0|||
155317375|NCT04436276|560596238|FG022|Overall Study|Adverse Event|0|||
155317376|NCT04436276|560596216|FG000|Overall Study|Death|0|||
155317377|NCT04436276|560596217|FG001|Overall Study|Death|0|||
155317378|NCT04436276|560596218|FG002|Overall Study|Death|0|||
155317379|NCT04436276|560596219|FG003|Overall Study|Death|0|||
155317380|NCT04436276|560596220|FG004|Overall Study|Death|0|||
155317381|NCT04436276|560596221|FG005|Overall Study|Death|0|||
155317382|NCT04436276|560596222|FG006|Overall Study|Death|0|||
155317383|NCT04436276|560596223|FG007|Overall Study|Death|0|||
155317384|NCT04436276|560596224|FG008|Overall Study|Death|0|||
155317385|NCT04436276|560596225|FG009|Overall Study|Death|0|||
155317386|NCT04436276|560596226|FG010|Overall Study|Death|0|||
155317387|NCT04436276|560596227|FG011|Overall Study|Death|0|||
155317388|NCT04436276|560596228|FG012|Overall Study|Death|1|||
155317389|NCT04436276|560596229|FG013|Overall Study|Death|0|||
155317390|NCT04436276|560596230|FG014|Overall Study|Death|1|||
155317391|NCT04436276|560596231|FG015|Overall Study|Death|0|||
155317392|NCT04436276|560596232|FG016|Overall Study|Death|0|||
155317393|NCT04436276|560596233|FG017|Overall Study|Death|0|||
155317394|NCT04436276|560596234|FG018|Overall Study|Death|0|||
155317395|NCT04436276|560596235|FG019|Overall Study|Death|2|||
155317396|NCT04436276|560596236|FG020|Overall Study|Death|0|||
155317397|NCT04436276|560596237|FG021|Overall Study|Death|1|||
155317398|NCT04436276|560596238|FG022|Overall Study|Death|0|||
155317399|NCT04436276|560596216|FG000|Overall Study|Lost to Follow-up|0|||
155317400|NCT04436276|560596217|FG001|Overall Study|Lost to Follow-up|2|||
155317401|NCT04436276|560596218|FG002|Overall Study|Lost to Follow-up|2|||
155317402|NCT04436276|560596219|FG003|Overall Study|Lost to Follow-up|1|||
155317403|NCT04436276|560596220|FG004|Overall Study|Lost to Follow-up|4|||
155317404|NCT04436276|560596221|FG005|Overall Study|Lost to Follow-up|1|||
155317405|NCT04436276|560596222|FG006|Overall Study|Lost to Follow-up|0|||
155317406|NCT04436276|560596223|FG007|Overall Study|Lost to Follow-up|0|||
155317407|NCT04436276|560596224|FG008|Overall Study|Lost to Follow-up|1|||
155317408|NCT04436276|560596225|FG009|Overall Study|Lost to Follow-up|0|||
155317409|NCT04436276|560596226|FG010|Overall Study|Lost to Follow-up|5|||
155317410|NCT04436276|560596227|FG011|Overall Study|Lost to Follow-up|5|||
155317411|NCT04436276|560596228|FG012|Overall Study|Lost to Follow-up|4|||
155317412|NCT04436276|560596229|FG013|Overall Study|Lost to Follow-up|1|||
155317413|NCT04436276|560596230|FG014|Overall Study|Lost to Follow-up|7|||
155317414|NCT04436276|560596231|FG015|Overall Study|Lost to Follow-up|7|||
155317415|NCT04436276|560596232|FG016|Overall Study|Lost to Follow-up|1|||
155317416|NCT04436276|560596233|FG017|Overall Study|Lost to Follow-up|0|||
155317417|NCT04436276|560596234|FG018|Overall Study|Lost to Follow-up|1|||
155317418|NCT04436276|560596235|FG019|Overall Study|Lost to Follow-up|1|||
155317419|NCT04436276|560596236|FG020|Overall Study|Lost to Follow-up|2|||
155317420|NCT04436276|560596237|FG021|Overall Study|Lost to Follow-up|1|||
155317421|NCT04436276|560596238|FG022|Overall Study|Lost to Follow-up|1|||
155317422|NCT04436276|560596216|FG000|Overall Study|Physician Decision|1|||
155317423|NCT04436276|560596217|FG001|Overall Study|Physician Decision|0|||
155317424|NCT04436276|560596218|FG002|Overall Study|Physician Decision|2|||
155317425|NCT04436276|560596219|FG003|Overall Study|Physician Decision|1|||
155162412|NCT01177397|560031606|FG000|Overall Study|Protocol Violation|0|||
155162413|NCT01177397|560031607|FG001|Overall Study|Protocol Violation|0|||
155317426|NCT04436276|560596220|FG004|Overall Study|Physician Decision|0|||
155317427|NCT04436276|560596221|FG005|Overall Study|Physician Decision|0|||
155317428|NCT04436276|560596222|FG006|Overall Study|Physician Decision|0|||
155317429|NCT04436276|560596223|FG007|Overall Study|Physician Decision|0|||
155162414|NCT01177397|560031608|FG002|Overall Study|Protocol Violation|0|||
155317430|NCT04436276|560596224|FG008|Overall Study|Physician Decision|0|||
155317431|NCT04436276|560596225|FG009|Overall Study|Physician Decision|0|||
155317432|NCT04436276|560596226|FG010|Overall Study|Physician Decision|0|||
155317433|NCT04436276|560596227|FG011|Overall Study|Physician Decision|1|||
155317434|NCT04436276|560596228|FG012|Overall Study|Physician Decision|2|||
155317435|NCT04436276|560596229|FG013|Overall Study|Physician Decision|0|||
155317436|NCT04436276|560596230|FG014|Overall Study|Physician Decision|0|||
155317437|NCT04436276|560596231|FG015|Overall Study|Physician Decision|0|||
155317438|NCT04436276|560596232|FG016|Overall Study|Physician Decision|0|||
155317439|NCT04436276|560596233|FG017|Overall Study|Physician Decision|0|||
155317440|NCT04436276|560596234|FG018|Overall Study|Physician Decision|0|||
155317441|NCT04436276|560596235|FG019|Overall Study|Physician Decision|0|||
155317442|NCT04436276|560596236|FG020|Overall Study|Physician Decision|1|||
155317443|NCT04436276|560596237|FG021|Overall Study|Physician Decision|2|||
155317444|NCT04436276|560596238|FG022|Overall Study|Physician Decision|0|||
155317445|NCT04436276|560596216|FG000|Overall Study|Protocol Violation|0|||
155317446|NCT04436276|560596217|FG001|Overall Study|Protocol Violation|0|||
155317447|NCT04436276|560596218|FG002|Overall Study|Protocol Violation|0|||
155317448|NCT04436276|560596219|FG003|Overall Study|Protocol Violation|0|||
155317449|NCT04436276|560596220|FG004|Overall Study|Protocol Violation|0|||
155317450|NCT04436276|560596221|FG005|Overall Study|Protocol Violation|0|||
155317451|NCT04436276|560596222|FG006|Overall Study|Protocol Violation|0|||
155317452|NCT04436276|560596223|FG007|Overall Study|Protocol Violation|0|||
155317453|NCT04436276|560596224|FG008|Overall Study|Protocol Violation|0|||
155317454|NCT04436276|560596225|FG009|Overall Study|Protocol Violation|0|||
155317455|NCT04436276|560596226|FG010|Overall Study|Protocol Violation|0|||
155317456|NCT04436276|560596227|FG011|Overall Study|Protocol Violation|0|||
155317457|NCT04436276|560596228|FG012|Overall Study|Protocol Violation|0|||
155317458|NCT04436276|560596229|FG013|Overall Study|Protocol Violation|1|||
155317459|NCT04436276|560596230|FG014|Overall Study|Protocol Violation|0|||
155317460|NCT04436276|560596231|FG015|Overall Study|Protocol Violation|1|||
155317461|NCT04436276|560596232|FG016|Overall Study|Protocol Violation|0|||
155317462|NCT04436276|560596233|FG017|Overall Study|Protocol Violation|0|||
155317463|NCT04436276|560596234|FG018|Overall Study|Protocol Violation|0|||
155317464|NCT04436276|560596235|FG019|Overall Study|Protocol Violation|0|||
155317465|NCT04436276|560596236|FG020|Overall Study|Protocol Violation|0|||
155317466|NCT04436276|560596237|FG021|Overall Study|Protocol Violation|0|||
155317467|NCT04436276|560596238|FG022|Overall Study|Protocol Violation|0|||
155317468|NCT04436276|560596216|FG000|Overall Study|Withdrawal by Subject|25|||
155317469|NCT04436276|560596217|FG001|Overall Study|Withdrawal by Subject|22|||
155317470|NCT04436276|560596218|FG002|Overall Study|Withdrawal by Subject|24|||
155317471|NCT04436276|560596219|FG003|Overall Study|Withdrawal by Subject|23|||
155317472|NCT04436276|560596220|FG004|Overall Study|Withdrawal by Subject|14|||
155317473|NCT04436276|560596221|FG005|Overall Study|Withdrawal by Subject|0|||
155317474|NCT04436276|560596222|FG006|Overall Study|Withdrawal by Subject|0|||
155317475|NCT04436276|560596223|FG007|Overall Study|Withdrawal by Subject|1|||
155317476|NCT04436276|560596224|FG008|Overall Study|Withdrawal by Subject|0|||
155317477|NCT04436276|560596225|FG009|Overall Study|Withdrawal by Subject|1|||
155317478|NCT04436276|560596226|FG010|Overall Study|Withdrawal by Subject|17|||
155317479|NCT04436276|560596227|FG011|Overall Study|Withdrawal by Subject|7|||
155317480|NCT04436276|560596228|FG012|Overall Study|Withdrawal by Subject|10|||
155317481|NCT04436276|560596229|FG013|Overall Study|Withdrawal by Subject|6|||
155317482|NCT04436276|560596230|FG014|Overall Study|Withdrawal by Subject|20|||
155317483|NCT04436276|560596231|FG015|Overall Study|Withdrawal by Subject|6|||
155317484|NCT04436276|560596232|FG016|Overall Study|Withdrawal by Subject|11|||
155317485|NCT04436276|560596233|FG017|Overall Study|Withdrawal by Subject|4|||
155317486|NCT04436276|560596234|FG018|Overall Study|Withdrawal by Subject|14|||
155317487|NCT04436276|560596235|FG019|Overall Study|Withdrawal by Subject|24|||
155317488|NCT04436276|560596236|FG020|Overall Study|Withdrawal by Subject|24|||
155317489|NCT04436276|560596237|FG021|Overall Study|Withdrawal by Subject|16|||
155317490|NCT04436276|560596238|FG022|Overall Study|Withdrawal by Subject|14|||
155317491|NCT04436276|560596216|FG000|Overall Study|Other|3|||
155317492|NCT04436276|560596217|FG001|Overall Study|Other|2|||
155317493|NCT04436276|560596218|FG002|Overall Study|Other|5|||
155317494|NCT04436276|560596219|FG003|Overall Study|Other|9|||
155317495|NCT04436276|560596220|FG004|Overall Study|Other|23|||
155317496|NCT04436276|560596221|FG005|Overall Study|Other|1|||
155317497|NCT04436276|560596222|FG006|Overall Study|Other|0|||
155317498|NCT04436276|560596223|FG007|Overall Study|Other|0|||
155317499|NCT04436276|560596224|FG008|Overall Study|Other|0|||
155317500|NCT04436276|560596225|FG009|Overall Study|Other|0|||
155317501|NCT04436276|560596226|FG010|Overall Study|Other|3|||
155317502|NCT04436276|560596227|FG011|Overall Study|Other|1|||
155317503|NCT04436276|560596228|FG012|Overall Study|Other|1|||
155317504|NCT04436276|560596229|FG013|Overall Study|Other|2|||
155317505|NCT04436276|560596230|FG014|Overall Study|Other|3|||
155317506|NCT04436276|560596231|FG015|Overall Study|Other|0|||
155317507|NCT04436276|560596232|FG016|Overall Study|Other|0|||
155317508|NCT04436276|560596233|FG017|Overall Study|Other|6|||
155317509|NCT04436276|560596234|FG018|Overall Study|Other|1|||
155317510|NCT04436276|560596235|FG019|Overall Study|Other|0|||
155317511|NCT04436276|560596236|FG020|Overall Study|Other|2|||
155317512|NCT04436276|560596237|FG021|Overall Study|Other|2|||
155317513|NCT04436276|560596238|FG022|Overall Study|Other|60|||
155317514|NCT05977530|560596252|FG000|Overall Study|Withdrawal by Subject|1|||
155317515|NCT05977530|560596252|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
155317516|NCT04524442|560596253|FG000|Overall Study|Subject Decision|1|||
155317517|NCT03819153|560596256|FG000|Overall Study|Withdrawal by Subject|20|||
155317518|NCT03819153|560596257|FG001|Overall Study|Withdrawal by Subject|28|||
155317519|NCT03819153|560596256|FG000|Overall Study|Lost to Follow-up|23|||
155317520|NCT03819153|560596257|FG001|Overall Study|Lost to Follow-up|30|||
155317521|NCT03974178|560596263|FG000|Overall Study|Death|0|||
155317522|NCT03974178|560596264|FG001|Overall Study|Death|1|||
155317523|NCT04880863|560596268|FG000|Overall Study|Adverse Event|1|||
155317524|NCT04880863|560596268|FG000|Overall Study|Patient decision|2|||
155317525|NCT04880863|560596268|FG000|Overall Study|Confirmed Disease Progression|15|||
155317526|NCT04880863|560596268|FG000|Overall Study|Death|3|||
155317527|NCT04880863|560596268|FG000|Overall Study|Physician Decision|4|||
155317528|NCT04880863|560596268|FG000|Overall Study|Unconfirmed Disease Progression|4|||
155317529|NCT04880863|560596268|FG000|Overall Study|Withdrawal by Subject|2|||
155317530|NCT04880863|560596268|FG000|Overall Study|Study discontinuation by the sponsor|4|||
155317531|NCT04880863|560596268|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
155317532|NCT04880863|560596268|FG000|Overall Study|Not received study drug NAP|2|||
155317533|NCT03899259|560596269|FG000|Overall Study|Adverse Event|5|||
155317534|NCT03899259|560596270|FG001|Overall Study|Adverse Event|4|||
155317535|NCT03899259|560596271|FG002|Overall Study|Adverse Event|6|||
155317536|NCT03899259|560596269|FG000|Overall Study|Lack of Efficacy|5|||
155317537|NCT03899259|560596270|FG001|Overall Study|Lack of Efficacy|0|||
155317538|NCT03899259|560596271|FG002|Overall Study|Lack of Efficacy|2|||
155317539|NCT03899259|560596269|FG000|Overall Study|Pregnancy|3|||
155317540|NCT03899259|560596270|FG001|Overall Study|Pregnancy|0|||
155317541|NCT03899259|560596271|FG002|Overall Study|Pregnancy|1|||
155317542|NCT03899259|560596269|FG000|Overall Study|Physician Decision|0|||
155317543|NCT03899259|560596270|FG001|Overall Study|Physician Decision|1|||
155317544|NCT03899259|560596271|FG002|Overall Study|Physician Decision|0|||
155317545|NCT03899259|560596269|FG000|Overall Study|Protocol Deviation|1|||
155317546|NCT03899259|560596270|FG001|Overall Study|Protocol Deviation|1|||
155317547|NCT03899259|560596271|FG002|Overall Study|Protocol Deviation|1|||
155317548|NCT03899259|560596269|FG000|Overall Study|Withdrawal by Subject|8|||
155317549|NCT03899259|560596270|FG001|Overall Study|Withdrawal by Subject|10|||
155317550|NCT03899259|560596271|FG002|Overall Study|Withdrawal by Subject|12|||
155317551|NCT03899259|560596269|FG000|Overall Study|Lost to Follow-up|5|||
155317552|NCT03899259|560596270|FG001|Overall Study|Lost to Follow-up|6|||
155317553|NCT03899259|560596271|FG002|Overall Study|Lost to Follow-up|2|||
155317554|NCT03899259|560596269|FG000|Overall Study|Lack of Adherence|1|||
155317555|NCT03899259|560596270|FG001|Overall Study|Lack of Adherence|0|||
155317556|NCT03899259|560596271|FG002|Overall Study|Lack of Adherence|0|||
155317557|NCT03899259|560596269|FG000|Overall Study|Screen Failure|1|||
155317558|NCT03899259|560596270|FG001|Overall Study|Screen Failure|0|||
155317559|NCT03899259|560596271|FG002|Overall Study|Screen Failure|0|||
155317560|NCT03899259|560596269|FG000|Overall Study|Ongoing Study Participation|127|||
155317561|NCT03899259|560596270|FG001|Overall Study|Ongoing Study Participation|134|||
154959946|NCT00934050|559278640|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
154959947|NCT00934050|559278641|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155317562|NCT03899259|560596271|FG002|Overall Study|Ongoing Study Participation|210|||
155317563|NCT04508309|560596272|FG000|Overall Study|Death|0|||
155317564|NCT04508309|560596273|FG001|Overall Study|Death|0|||
155317565|NCT04508309|560596274|FG002|Overall Study|Death|0|||
155317566|NCT04508309|560596275|FG003|Overall Study|Death|0|||
155317567|NCT04508309|560596276|FG004|Overall Study|Death|1|||
155317568|NCT04508309|560596272|FG000|Overall Study|Lost to Follow-up|0|||
155317569|NCT04508309|560596273|FG001|Overall Study|Lost to Follow-up|0|||
155317570|NCT04508309|560596274|FG002|Overall Study|Lost to Follow-up|1|||
155317571|NCT04508309|560596275|FG003|Overall Study|Lost to Follow-up|1|||
155317572|NCT04508309|560596276|FG004|Overall Study|Lost to Follow-up|0|||
155317573|NCT04508309|560596272|FG000|Overall Study|Withdrawal by Subject|0|||
155317574|NCT04508309|560596273|FG001|Overall Study|Withdrawal by Subject|0|||
155317575|NCT04508309|560596274|FG002|Overall Study|Withdrawal by Subject|0|||
154959948|NCT00934050|559278642|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
154959949|NCT00934050|559278643|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
154959950|NCT00934050|559278644|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
155317576|NCT04508309|560596275|FG003|Overall Study|Withdrawal by Subject|0|||
155317577|NCT04508309|560596276|FG004|Overall Study|Withdrawal by Subject|1|||
155317578|NCT03058289|560596277|FG000|Overall Study|Radiographic Deterioration|0|||
155317579|NCT03058289|560596278|FG001|Overall Study|Radiographic Deterioration|3|||
155317580|NCT03058289|560596279|FG002|Overall Study|Radiographic Deterioration|1|||
155317581|NCT03058289|560596280|FG003|Overall Study|Radiographic Deterioration|2|||
155317582|NCT03058289|560596281|FG004|Overall Study|Radiographic Deterioration|6|||
155317583|NCT03058289|560596282|FG005|Overall Study|Radiographic Deterioration|3|||
155317584|NCT03058289|560596283|FG006|Overall Study|Radiographic Deterioration|0|||
155317585|NCT03058289|560596284|FG007|Overall Study|Radiographic Deterioration|4|||
155317586|NCT03058289|560596285|FG008|Overall Study|Radiographic Deterioration|2|||
155317587|NCT03058289|560596277|FG000|Overall Study|Adverse Event|2|||
155317588|NCT03058289|560596278|FG001|Overall Study|Adverse Event|0|||
155317589|NCT03058289|560596279|FG002|Overall Study|Adverse Event|1|||
155317590|NCT03058289|560596280|FG003|Overall Study|Adverse Event|3|||
155317591|NCT03058289|560596281|FG004|Overall Study|Adverse Event|1|||
155317592|NCT03058289|560596282|FG005|Overall Study|Adverse Event|0|||
155317593|NCT03058289|560596283|FG006|Overall Study|Adverse Event|1|||
155317594|NCT03058289|560596284|FG007|Overall Study|Adverse Event|3|||
155317595|NCT03058289|560596285|FG008|Overall Study|Adverse Event|0|||
155317596|NCT03058289|560596277|FG000|Overall Study|Withdrawal by Subject|0|||
155317597|NCT03058289|560596278|FG001|Overall Study|Withdrawal by Subject|0|||
155317598|NCT03058289|560596279|FG002|Overall Study|Withdrawal by Subject|0|||
155317599|NCT03058289|560596280|FG003|Overall Study|Withdrawal by Subject|2|||
155317600|NCT03058289|560596281|FG004|Overall Study|Withdrawal by Subject|0|||
155317601|NCT03058289|560596282|FG005|Overall Study|Withdrawal by Subject|2|||
155317602|NCT03058289|560596283|FG006|Overall Study|Withdrawal by Subject|0|||
155317603|NCT03058289|560596284|FG007|Overall Study|Withdrawal by Subject|4|||
155317604|NCT03058289|560596285|FG008|Overall Study|Withdrawal by Subject|1|||
155317605|NCT03058289|560596277|FG000|Overall Study|Physician Decision|1|||
155317606|NCT03058289|560596278|FG001|Overall Study|Physician Decision|0|||
155317607|NCT03058289|560596279|FG002|Overall Study|Physician Decision|0|||
155317608|NCT03058289|560596280|FG003|Overall Study|Physician Decision|2|||
155317609|NCT03058289|560596281|FG004|Overall Study|Physician Decision|1|||
155317610|NCT03058289|560596282|FG005|Overall Study|Physician Decision|0|||
155317611|NCT03058289|560596283|FG006|Overall Study|Physician Decision|2|||
155317612|NCT03058289|560596284|FG007|Overall Study|Physician Decision|3|||
155317613|NCT03058289|560596285|FG008|Overall Study|Physician Decision|0|||
155317614|NCT03058289|560596277|FG000|Overall Study|Clinical Deterioration|2|||
155317615|NCT03058289|560596278|FG001|Overall Study|Clinical Deterioration|0|||
155317616|NCT03058289|560596279|FG002|Overall Study|Clinical Deterioration|0|||
155317617|NCT03058289|560596280|FG003|Overall Study|Clinical Deterioration|2|||
155317618|NCT03058289|560596281|FG004|Overall Study|Clinical Deterioration|1|||
155317619|NCT03058289|560596282|FG005|Overall Study|Clinical Deterioration|1|||
155317620|NCT03058289|560596283|FG006|Overall Study|Clinical Deterioration|0|||
155317621|NCT03058289|560596284|FG007|Overall Study|Clinical Deterioration|3|||
155317622|NCT03058289|560596285|FG008|Overall Study|Clinical Deterioration|2|||
155317623|NCT03058289|560596277|FG000|Overall Study|Lost to Follow-up|0|||
155317624|NCT03058289|560596278|FG001|Overall Study|Lost to Follow-up|0|||
155317625|NCT03058289|560596279|FG002|Overall Study|Lost to Follow-up|0|||
155317626|NCT03058289|560596280|FG003|Overall Study|Lost to Follow-up|0|||
155317627|NCT03058289|560596281|FG004|Overall Study|Lost to Follow-up|1|||
155317628|NCT03058289|560596282|FG005|Overall Study|Lost to Follow-up|0|||
155317629|NCT03058289|560596283|FG006|Overall Study|Lost to Follow-up|0|||
155317630|NCT03058289|560596284|FG007|Overall Study|Lost to Follow-up|0|||
155317631|NCT03058289|560596285|FG008|Overall Study|Lost to Follow-up|0|||
155317632|NCT03058289|560596277|FG000|Overall Study|Refused Further Treatment|0|||
155317633|NCT03058289|560596278|FG001|Overall Study|Refused Further Treatment|0|||
155317634|NCT03058289|560596279|FG002|Overall Study|Refused Further Treatment|1|||
155317635|NCT03058289|560596280|FG003|Overall Study|Refused Further Treatment|0|||
155317636|NCT03058289|560596281|FG004|Overall Study|Refused Further Treatment|1|||
155317637|NCT03058289|560596282|FG005|Overall Study|Refused Further Treatment|0|||
155317638|NCT03058289|560596283|FG006|Overall Study|Refused Further Treatment|0|||
155317639|NCT03058289|560596284|FG007|Overall Study|Refused Further Treatment|0|||
155317640|NCT03058289|560596285|FG008|Overall Study|Refused Further Treatment|0|||
155317641|NCT03058289|560596277|FG000|Overall Study|Rapid Progression of Disease|0|||
155317642|NCT03058289|560596278|FG001|Overall Study|Rapid Progression of Disease|0|||
155317643|NCT03058289|560596279|FG002|Overall Study|Rapid Progression of Disease|0|||
155317644|NCT03058289|560596280|FG003|Overall Study|Rapid Progression of Disease|1|||
155317645|NCT03058289|560596281|FG004|Overall Study|Rapid Progression of Disease|0|||
155317646|NCT03058289|560596282|FG005|Overall Study|Rapid Progression of Disease|0|||
155162415|NCT01177397|560031609|FG003|Overall Study|Protocol Violation|0|||
155317647|NCT03058289|560596283|FG006|Overall Study|Rapid Progression of Disease|0|||
155317648|NCT03058289|560596284|FG007|Overall Study|Rapid Progression of Disease|0|||
155317649|NCT03058289|560596285|FG008|Overall Study|Rapid Progression of Disease|0|||
155317650|NCT05239455|560596291|FG000|Overall Study|Adverse Event|1|||
155317651|NCT05239455|560596291|FG000|Overall Study|Sponsor Decision|5|||
155317652|NCT05239455|560596291|FG000|Overall Study|Incomplete Blood Collection|1|||
155317653|NCT06182033|560596292|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
155317654|NCT06182033|560596293|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
155317655|NCT06182033|560596292|FG000|Overall Study|Target child relocation|1|||
155317656|NCT06182033|560596293|FG001|Overall Study|Target child relocation|1|||
155317657|NCT06182033|560596292|FG000|Overall Study|Withdrawal by Subject|1|||
155317658|NCT06182033|560596293|FG001|Overall Study|Withdrawal by Subject|0|||
155317659|NCT05623228|560596298|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
155317660|NCT05623228|560596299|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317661|NCT05623228|560596300|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317662|NCT05623228|560596301|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317663|NCT05623228|560596302|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317664|NCT05623228|560596303|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317665|NCT05623228|560596304|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317666|NCT05623228|560596305|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
155317667|NCT05623228|560596298|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
155317668|NCT05623228|560596299|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317669|NCT05623228|560596300|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
155317670|NCT05623228|560596301|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
155317671|NCT05623228|560596302|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317672|NCT05623228|560596303|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317673|NCT05623228|560596304|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317674|NCT05623228|560596305|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
155317675|NCT01129102|560597770|FG000|Overall Study|No study drug treatment|2|||
155317676|NCT01129102|560597771|FG001|Overall Study|No study drug treatment|3|||
155317677|NCT01129102|560597772|FG002|Overall Study|No study drug treatment|1|||
155317678|NCT01129102|560597770|FG000|Overall Study|Withdrawal by Subject|2|||
155317679|NCT01129102|560597771|FG001|Overall Study|Withdrawal by Subject|0|||
155317680|NCT01129102|560597772|FG002|Overall Study|Withdrawal by Subject|3|||
155317681|NCT01129102|560597770|FG000|Overall Study|Protocol Violation|0|||
155317682|NCT01129102|560597771|FG001|Overall Study|Protocol Violation|1|||
155317683|NCT01129102|560597772|FG002|Overall Study|Protocol Violation|1|||
155317684|NCT01129102|560597770|FG000|Overall Study|Pregnancy|0|||
155317685|NCT01129102|560597771|FG001|Overall Study|Pregnancy|0|||
155317686|NCT01129102|560597772|FG002|Overall Study|Pregnancy|1|||
155317687|NCT01129102|560597770|FG000|Overall Study|Adverse Event|2|||
155317688|NCT01129102|560597771|FG001|Overall Study|Adverse Event|2|||
155317689|NCT01129102|560597772|FG002|Overall Study|Adverse Event|1|||
155317690|NCT01129102|560597770|FG000|Overall Study|Lost to Follow-up|2|||
155317691|NCT01129102|560597771|FG001|Overall Study|Lost to Follow-up|0|||
155317692|NCT01129102|560597772|FG002|Overall Study|Lost to Follow-up|0|||
155317693|NCT03379675|560597775|FG000|Overall Study|Lost to Follow-up|0|||
155317694|NCT03379675|560597776|FG001|Overall Study|Lost to Follow-up|1|||
155317695|NCT03379675|560597777|FG002|Overall Study|Lost to Follow-up|0|||
155317696|NCT03379675|560597775|FG000|Overall Study|Adverse Event|2|||
155317697|NCT03379675|560597776|FG001|Overall Study|Adverse Event|0|||
155317698|NCT03379675|560597777|FG002|Overall Study|Adverse Event|0|||
155317699|NCT03379675|560597775|FG000|Overall Study|Withdrawal by Subject|2|||
155317700|NCT03379675|560597776|FG001|Overall Study|Withdrawal by Subject|1|||
155317701|NCT03379675|560597777|FG002|Overall Study|Withdrawal by Subject|2|||
155317702|NCT02817776|560597778|FG000|Overall Study|Excluded|33|||
155317703|NCT02817776|560597778|FG000|Overall Study|Lost to Follow-up|20|||
155317704|NCT02817776|560597778|FG000|Overall Study|Withdrawal by Subject|33|||
155317705|NCT02817776|560597778|FG000|Overall Study|Death|2|||
155317706|NCT03381196|560597783|FG000|Overall Study|Withdrawal by Subject|7|||
155317707|NCT03381196|560597784|FG001|Overall Study|Withdrawal by Subject|7|||
155317708|NCT03381196|560597783|FG000|Overall Study|Other|0|||
155317709|NCT03381196|560597784|FG001|Overall Study|Other|1|||
155317710|NCT03381196|560597783|FG000|Overall Study|Lost to Follow-up|5|||
155317711|NCT03381196|560597784|FG001|Overall Study|Lost to Follow-up|4|||
155317712|NCT03381196|560597783|FG000|Overall Study|Death|0|||
155317713|NCT03381196|560597784|FG001|Overall Study|Death|1|||
155317714|NCT03381196|560597783|FG000|Overall Study|Adverse Event|1|||
155317715|NCT03381196|560597784|FG001|Overall Study|Adverse Event|0|||
155317716|NCT03381196|560597783|FG000|Overall Study|Randomized, not treated|3|||
155317717|NCT03381196|560597784|FG001|Overall Study|Randomized, not treated|6|||
155317718|NCT02359890|560597786|FG000|Overall Study|Not meeting eligibility|4|||
155317719|NCT02359890|560597786|FG000|Overall Study|Never treated with study catheter|6|||
155317720|NCT01574274|560597791|FG000|Overall Study|Ineligible|0|||
155317721|NCT01574274|560597792|FG001|Overall Study|Ineligible|1|||
155317722|NCT01574274|560597791|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
155317723|NCT01574274|560597792|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
155317724|NCT01574274|560597791|FG000|Overall Study|Ph+ B-ALL|3|||
155317725|NCT01574274|560597792|FG001|Overall Study|Ph+ B-ALL|4|||
155317726|NCT01574274|560597791|FG000|Overall Study|Induction Death|2|||
155317727|NCT01574274|560597792|FG001|Overall Study|Induction Death|0|||
155317728|NCT01574274|560597791|FG000|Overall Study|Induction Failure|4|||
155317729|NCT01574274|560597792|FG001|Overall Study|Induction Failure|1|||
155317730|NCT01574274|560597791|FG000|Overall Study|Adverse Event|16|||
155317731|NCT01574274|560597792|FG001|Overall Study|Adverse Event|13|||
155317732|NCT01574274|560597791|FG000|Overall Study|Remission Death|1|||
155317733|NCT01574274|560597792|FG001|Overall Study|Remission Death|0|||
155317734|NCT01574274|560597791|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
155317735|NCT01574274|560597792|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
155317736|NCT01574274|560597791|FG000|Overall Study|Other, unknown|3|||
155317737|NCT01574274|560597792|FG001|Overall Study|Other, unknown|2|||
155317738|NCT03907878|560597803|FG000|Treatment Period|Withdrawal by Subject|5|||
155317739|NCT03907878|560597803|FG000|Treatment Period|Adverse Event|4|||
155317740|NCT03907878|560597803|FG000|Treatment Period|Lack of Efficacy|1|||
155317741|NCT03907878|560597803|FG000|Treatment Period|Protocol Violation|1|||
155317742|NCT03907878|560597803|FG000|Follow-up Period|Adverse Event|3|||
155317743|NCT03907878|560597803|FG000|Follow-up Period|Withdrawal by Subject|3|||
155317744|NCT03904147|560597808|FG000|Overall Study|Death|15|||
155317745|NCT03904147|560597809|FG001|Overall Study|Death|13|||
155317746|NCT03904147|560597810|FG002|Overall Study|Death|15|||
155317747|NCT03904147|560597808|FG000|Overall Study|Withdrawal by Subject|7|||
155317748|NCT03904147|560597809|FG001|Overall Study|Withdrawal by Subject|12|||
155317749|NCT03904147|560597810|FG002|Overall Study|Withdrawal by Subject|1|||
155317750|NCT03904147|560597808|FG000|Overall Study|1Y visit completed after 365 days|1|||
155317751|NCT03904147|560597809|FG001|Overall Study|1Y visit completed after 365 days|1|||
155317752|NCT03904147|560597810|FG002|Overall Study|1Y visit completed after 365 days|0|||
155317753|NCT03625167|560597812|FG000|Overall Study|Protocol Violation|5|||
155317754|NCT06103188|560597813|FG000|Overall Study|Lost to Follow-up|1|||
155317755|NCT06103188|560597814|FG001|Overall Study|Lost to Follow-up|6|||
155317756|NCT06103188|560597815|FG002|Overall Study|Lost to Follow-up|4|||
155317757|NCT04145440|560597818|FG000|Overall Study|Physician Decision|3|||
155317758|NCT04145440|560597819|FG001|Overall Study|Physician Decision|0|||
155317759|NCT04145440|560597818|FG000|Overall Study|Use of prohibited therapy|2|||
155317760|NCT04145440|560597819|FG001|Overall Study|Use of prohibited therapy|3|||
155317761|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
155317762|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
155317763|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
155317764|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
155317765|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
155317766|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
155317767|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
155317768|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
155317769|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
155317770|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
155067063|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155067064|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155317771|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
155317772|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
155317773|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
155317774|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
155317775|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
155317776|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
155317777|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
155317778|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
155317779|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
155317780|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
155317781|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317782|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
155317783|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317784|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317785|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
155317786|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
155317787|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
155317788|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
155317789|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
155317790|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
155317791|NCT03852472|560597825|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
155317792|NCT03852472|560597826|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
155317793|NCT03852472|560597827|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
155317794|NCT03852472|560597828|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
155317795|NCT03852472|560597829|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
155067065|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
155067066|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155067067|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155067068|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155067069|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155067070|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
155067071|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155067072|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155067073|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
155067074|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155067075|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155317796|NCT03852472|560597825|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
155317797|NCT03852472|560597826|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
155317798|NCT03852472|560597827|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
155317799|NCT03852472|560597828|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
155317800|NCT03852472|560597829|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
155317801|NCT03852472|560597825|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
155317802|NCT03852472|560597826|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
155317803|NCT03852472|560597827|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
155317804|NCT03852472|560597828|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
155317805|NCT03852472|560597829|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
155317806|NCT03852472|560597825|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
155317807|NCT03852472|560597826|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
155317808|NCT03852472|560597827|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
155317809|NCT03852472|560597828|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
155317810|NCT03852472|560597829|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
155317811|NCT03852472|560597825|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
155317812|NCT03852472|560597826|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
155317813|NCT03852472|560597827|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
155317814|NCT03852472|560597828|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
155317815|NCT03852472|560597829|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
155317816|NCT03852472|560597825|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
155317817|NCT03852472|560597826|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
155317818|NCT03852472|560597827|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
155317819|NCT03852472|560597828|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
155317820|NCT03852472|560597829|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
155317821|NCT03852472|560597825|FG000|Period 2 - Week 44|Adverse Event|0|||
155317822|NCT03852472|560597826|FG001|Period 2 - Week 44|Adverse Event|3|||
155317823|NCT03852472|560597827|FG002|Period 2 - Week 44|Adverse Event|1|||
155317824|NCT03852472|560597828|FG003|Period 2 - Week 44|Adverse Event|2|||
155317825|NCT03852472|560597829|FG004|Period 2 - Week 44|Adverse Event|2|||
155317826|NCT03852472|560597825|FG000|Period 2 - Week 44|COVID-19 Related|0|||
155317827|NCT03852472|560597826|FG001|Period 2 - Week 44|COVID-19 Related|0|||
155317828|NCT03852472|560597827|FG002|Period 2 - Week 44|COVID-19 Related|0|||
155317829|NCT03852472|560597828|FG003|Period 2 - Week 44|COVID-19 Related|1|||
155317830|NCT03852472|560597829|FG004|Period 2 - Week 44|COVID-19 Related|0|||
155317831|NCT03852472|560597825|FG000|Period 2 - Week 44|Reason not stated|0|||
155317832|NCT03852472|560597826|FG001|Period 2 - Week 44|Reason not stated|0|||
155317833|NCT03852472|560597827|FG002|Period 2 - Week 44|Reason not stated|0|||
155317834|NCT03852472|560597828|FG003|Period 2 - Week 44|Reason not stated|0|||
155317835|NCT03852472|560597829|FG004|Period 2 - Week 44|Reason not stated|1|||
155317836|NCT01919554|560597830|FG000|Overall Study|Withdrawal by Subject|0|||
155317837|NCT01919554|560597831|FG001|Overall Study|Withdrawal by Subject|0|||
155317838|NCT01919554|560597832|FG002|Overall Study|Withdrawal by Subject|1|||
155317839|NCT01919554|560597833|FG003|Overall Study|Withdrawal by Subject|1|||
155317840|NCT06457802|560597834|FG000|Overall Study|Early termination of study prior to participant completion|2|||
155317841|NCT06457802|560597835|FG001|Overall Study|Early termination of study prior to participant completion|2|||
155317842|NCT05496231|560597836|FG000|Overall Study|Adverse Event|1|||
155317843|NCT05496231|560597837|FG001|Overall Study|Adverse Event|1|||
155317844|NCT05496231|560597838|FG002|Overall Study|Adverse Event|0|||
155162416|NCT01177397|560031610|FG004|Overall Study|Protocol Violation|0|||
155317845|NCT05496231|560597839|FG003|Overall Study|Adverse Event|4|||
155317846|NCT05496231|560597836|FG000|Overall Study|Withdrawal by Subject|5|||
155317847|NCT05496231|560597837|FG001|Overall Study|Withdrawal by Subject|5|||
155317848|NCT05496231|560597838|FG002|Overall Study|Withdrawal by Subject|4|||
155317849|NCT05496231|560597839|FG003|Overall Study|Withdrawal by Subject|11|||
155317850|NCT05496231|560597836|FG000|Overall Study|Migrated/moved from the study area|3|||
155317851|NCT05496231|560597837|FG001|Overall Study|Migrated/moved from the study area|5|||
155317852|NCT05496231|560597838|FG002|Overall Study|Migrated/moved from the study area|3|||
155317853|NCT05496231|560597839|FG003|Overall Study|Migrated/moved from the study area|3|||
155317854|NCT05496231|560597836|FG000|Overall Study|Lost to Follow-up|13|||
155317855|NCT05496231|560597837|FG001|Overall Study|Lost to Follow-up|6|||
155317856|NCT05496231|560597838|FG002|Overall Study|Lost to Follow-up|11|||
155317857|NCT05496231|560597839|FG003|Overall Study|Lost to Follow-up|6|||
155317858|NCT05496231|560597836|FG000|Overall Study|Other|9|||
155317859|NCT05496231|560597837|FG001|Overall Study|Other|7|||
155317860|NCT05496231|560597838|FG002|Overall Study|Other|7|||
155317861|NCT05496231|560597839|FG003|Overall Study|Other|8|||
155317862|NCT01152450|560597842|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
155317863|NCT01152450|560597843|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
155317864|NCT01152450|560597844|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
155317865|NCT01152450|560597845|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
155317866|NCT01152450|560597846|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
155317867|NCT01152450|560597847|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
155317868|NCT01152450|560597842|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
155317869|NCT01152450|560597843|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
155317870|NCT01152450|560597844|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
155317871|NCT01152450|560597845|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
155317872|NCT01152450|560597846|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
155317873|NCT01152450|560597847|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
155317874|NCT01152450|560597842|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317875|NCT01152450|560597843|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
155317876|NCT01152450|560597844|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
155317877|NCT01152450|560597845|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317878|NCT01152450|560597846|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317879|NCT01152450|560597847|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
155317880|NCT05670587|560597848|FG000|Overall Study|Withdrawal by Subject|3|||
155317881|NCT01544114|560597852|FG000|Overall Study|Withdrawal by Subject|0|||
155317882|NCT01544114|560597853|FG001|Overall Study|Withdrawal by Subject|0|||
155317883|NCT01544114|560597854|FG002|Overall Study|Withdrawal by Subject|3|||
155317884|NCT01544114|560597852|FG000|Overall Study|Lost to Follow-up|0|||
155317885|NCT01544114|560597853|FG001|Overall Study|Lost to Follow-up|2|||
155317886|NCT01544114|560597854|FG002|Overall Study|Lost to Follow-up|0|||
155317887|NCT01544114|560597852|FG000|Overall Study|Adverse Event|1|||
155317888|NCT01544114|560597853|FG001|Overall Study|Adverse Event|1|||
155317889|NCT01544114|560597854|FG002|Overall Study|Adverse Event|2|||
155317890|NCT01544114|560597852|FG000|Overall Study|Protocol Violation|0|||
155317891|NCT01544114|560597853|FG001|Overall Study|Protocol Violation|1|||
155317892|NCT01544114|560597854|FG002|Overall Study|Protocol Violation|0|||
155317893|NCT01733316|560597859|FG000|RP103 Phase|Non-compliance|1|||
155317894|NCT01733316|560597859|FG000|Long Term Extension Phase|Adverse Event|1|||
155317895|NCT01733316|560597859|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
155317896|NCT01733316|560597859|FG000|Long Term Extension Phase|Sponsor Decision|2|||
155317897|NCT05940194|560597866|FG000|Overall Study|Adverse Event|0|||
155317898|NCT05940194|560597867|FG001|Overall Study|Adverse Event|1|||
155317899|NCT05940194|560597868|FG002|Overall Study|Adverse Event|0|||
155317900|NCT05940194|560597866|FG000|Overall Study|Migrated/Moved from the study area|2|||
155317901|NCT05940194|560597867|FG001|Overall Study|Migrated/Moved from the study area|2|||
155317902|NCT05940194|560597868|FG002|Overall Study|Migrated/Moved from the study area|4|||
155317903|NCT04625465|560597869|FG000|Overall Study|Lost to Follow-up|2|||
155317904|NCT04625465|560597870|FG001|Overall Study|Lost to Follow-up|2|||
155317905|NCT04625465|560597871|FG002|Overall Study|Lost to Follow-up|1|||
155317906|NCT04625465|560597872|FG003|Overall Study|Lost to Follow-up|0|||
155317907|NCT04625465|560597873|FG004|Overall Study|Lost to Follow-up|0|||
155317908|NCT04625465|560597874|FG005|Overall Study|Lost to Follow-up|2|||
155317909|NCT04625465|560597875|FG006|Overall Study|Lost to Follow-up|0|||
155317910|NCT04625465|560597876|FG007|Overall Study|Lost to Follow-up|0|||
155317911|NCT04625465|560597869|FG000|Overall Study|Death|1|||
155317912|NCT04625465|560597870|FG001|Overall Study|Death|0|||
155317913|NCT04625465|560597871|FG002|Overall Study|Death|0|||
155317914|NCT04625465|560597872|FG003|Overall Study|Death|0|||
155317915|NCT04625465|560597873|FG004|Overall Study|Death|0|||
155317916|NCT04625465|560597874|FG005|Overall Study|Death|0|||
155317917|NCT04625465|560597875|FG006|Overall Study|Death|0|||
155317918|NCT04625465|560597876|FG007|Overall Study|Death|0|||
155317919|NCT04625465|560597869|FG000|Overall Study|Withdrawal by Subject|1|||
155317920|NCT04625465|560597870|FG001|Overall Study|Withdrawal by Subject|0|||
155317921|NCT04625465|560597871|FG002|Overall Study|Withdrawal by Subject|4|||
155317922|NCT04625465|560597872|FG003|Overall Study|Withdrawal by Subject|4|||
155317923|NCT04625465|560597873|FG004|Overall Study|Withdrawal by Subject|4|||
155317924|NCT04625465|560597874|FG005|Overall Study|Withdrawal by Subject|0|||
155317925|NCT04625465|560597875|FG006|Overall Study|Withdrawal by Subject|0|||
155317926|NCT04625465|560597876|FG007|Overall Study|Withdrawal by Subject|0|||
155317927|NCT04753697|560597879|FG000|Induction Phase|Withdrawal by Subject|12|||
155317928|NCT04753697|560597880|FG001|Induction Phase|Withdrawal by Subject|5|||
155317929|NCT04753697|560597881|FG002|Induction Phase|Withdrawal by Subject|6|||
155317930|NCT04753697|560597879|FG000|Induction Phase|Physician Decision|1|||
155317931|NCT04753697|560597880|FG001|Induction Phase|Physician Decision|0|||
155317932|NCT04753697|560597881|FG002|Induction Phase|Physician Decision|0|||
155317933|NCT04753697|560597879|FG000|Induction Phase|Lost to Follow-up|2|||
155317934|NCT04753697|560597880|FG001|Induction Phase|Lost to Follow-up|2|||
155317935|NCT04753697|560597881|FG002|Induction Phase|Lost to Follow-up|1|||
155317936|NCT04753697|560597879|FG000|Induction Phase|Lack of Efficacy|1|||
155317937|NCT04753697|560597880|FG001|Induction Phase|Lack of Efficacy|0|||
155317938|NCT04753697|560597881|FG002|Induction Phase|Lack of Efficacy|0|||
155317939|NCT04753697|560597879|FG000|Maintenance Phase|Physician Decision|0|||
155317940|NCT04753697|560597880|FG001|Maintenance Phase|Physician Decision|0|||
155317941|NCT04753697|560597881|FG002|Maintenance Phase|Physician Decision|1|||
155317942|NCT04753697|560597879|FG000|Maintenance Phase|Withdrawal by Subject|3|||
155317943|NCT04753697|560597880|FG001|Maintenance Phase|Withdrawal by Subject|4|||
155317944|NCT04753697|560597881|FG002|Maintenance Phase|Withdrawal by Subject|6|||
155317945|NCT04753697|560597879|FG000|Maintenance Phase|Lost to Follow-up|2|||
155317946|NCT04753697|560597880|FG001|Maintenance Phase|Lost to Follow-up|2|||
155317947|NCT04753697|560597881|FG002|Maintenance Phase|Lost to Follow-up|0|||
155317948|NCT04753697|560597879|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
155317949|NCT04753697|560597880|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
155317950|NCT04753697|560597881|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
155317951|NCT04753697|560597879|FG000|Maintenance Phase|Adverse Event|0|||
155317952|NCT04753697|560597880|FG001|Maintenance Phase|Adverse Event|1|||
155317953|NCT04753697|560597881|FG002|Maintenance Phase|Adverse Event|1|||
155317954|NCT04753697|560597879|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
154959951|NCT00934050|559278645|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
155317955|NCT04753697|560597880|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
155317956|NCT04753697|560597881|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
155317957|NCT02151981|560597882|FG000|Overall Study|Death|184|||
155317958|NCT02151981|560597883|FG001|Overall Study|Death|88|||
155317959|NCT02151981|560597882|FG000|Overall Study|Lost to Follow-up|7|||
155317960|NCT02151981|560597883|FG001|Overall Study|Lost to Follow-up|1|||
155317961|NCT02151981|560597882|FG000|Overall Study|Withdrawal by Subject|27|||
155317962|NCT02151981|560597883|FG001|Overall Study|Withdrawal by Subject|21|||
154959952|NCT00934050|559278640|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
155317963|NCT02151981|560597882|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155317964|NCT02151981|560597883|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155317965|NCT02151981|560597882|FG000|Overall Study|Other reasons|1|||
155317966|NCT02151981|560597883|FG001|Overall Study|Other reasons|2|||
155317967|NCT05446168|560597884|FG000|Overall Study|Physician Decision|0|||
155317968|NCT05446168|560597885|FG001|Overall Study|Physician Decision|1|||
155317969|NCT03854227|560600526|FG000|Overall Study|Adverse Event|0|||
155317970|NCT03854227|560600527|FG001|Overall Study|Adverse Event|0|||
155317971|NCT03854227|560600528|FG002|Overall Study|Adverse Event|0|||
155317972|NCT03854227|560600529|FG003|Overall Study|Adverse Event|1|||
155317973|NCT03854227|560600530|FG004|Overall Study|Adverse Event|0|||
155317974|NCT03854227|560600531|FG005|Overall Study|Adverse Event|0|||
155317975|NCT03854227|560600532|FG006|Overall Study|Adverse Event|1|||
155317976|NCT03854227|560600533|FG007|Overall Study|Adverse Event|0|||
155317977|NCT03854227|560600534|FG008|Overall Study|Adverse Event|0|||
155317978|NCT03854227|560600535|FG009|Overall Study|Adverse Event|3|||
155317979|NCT03854227|560600536|FG010|Overall Study|Adverse Event|0|||
155317980|NCT03854227|560600537|FG011|Overall Study|Adverse Event|1|||
155317981|NCT03854227|560600526|FG000|Overall Study|Death|0|||
155317982|NCT03854227|560600527|FG001|Overall Study|Death|0|||
154959953|NCT00934050|559278641|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
154959954|NCT00934050|559278642|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
154959955|NCT00934050|559278643|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
154959956|NCT00934050|559278644|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
154959957|NCT00934050|559278645|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
154959958|NCT00835991|559278646|FG000|First Intervention|Adverse Event|0|||
154959959|NCT00835991|559278647|FG001|First Intervention|Adverse Event|1|||
154959960|NCT00835991|559278646|FG000|Washout|Protocol Violation|0|||
154959961|NCT00835991|559278647|FG001|Washout|Protocol Violation|2|||
154959962|NCT00835991|559278646|FG000|Washout|Withdrawal by Subject|3|||
154959963|NCT00835991|559278647|FG001|Washout|Withdrawal by Subject|1|||
154959964|NCT02146105|559278648|FG000|Overall Study|Adverse Event|1|||
154959965|NCT02146105|559278648|FG000|Overall Study|Withdrawal by Subject|5|||
154959966|NCT02718326|559278651|FG000|Overall Study|Adverse Event|4|||
154959967|NCT02718326|559278652|FG001|Overall Study|Adverse Event|9|||
154959968|NCT02718326|559278653|FG002|Overall Study|Adverse Event|0|||
154959969|NCT02718326|559278651|FG000|Overall Study|Death|8|||
154959970|NCT02718326|559278652|FG001|Overall Study|Death|1|||
155317983|NCT03854227|560600528|FG002|Overall Study|Death|0|||
155067076|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155067077|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155067078|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
155067079|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155067080|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155067081|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
155067082|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
155067083|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155067084|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155067085|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155067086|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
155067087|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155067088|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155067089|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
155067090|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155067091|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155067092|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155067093|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155067094|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
155162417|NCT01177397|560031611|FG005|Overall Study|Protocol Violation|1|||
155317984|NCT03854227|560600529|FG003|Overall Study|Death|0|||
155317985|NCT03854227|560600530|FG004|Overall Study|Death|0|||
155317986|NCT03854227|560600531|FG005|Overall Study|Death|1|||
155317987|NCT03854227|560600532|FG006|Overall Study|Death|0|||
155317988|NCT03854227|560600533|FG007|Overall Study|Death|0|||
155317989|NCT03854227|560600534|FG008|Overall Study|Death|0|||
155317990|NCT03854227|560600535|FG009|Overall Study|Death|1|||
155317991|NCT03854227|560600536|FG010|Overall Study|Death|0|||
155317992|NCT03854227|560600537|FG011|Overall Study|Death|1|||
154959971|NCT02718326|559278653|FG002|Overall Study|Death|2|||
154959972|NCT02718326|559278651|FG000|Overall Study|Withdrawal by Subject|4|||
154959973|NCT02718326|559278652|FG001|Overall Study|Withdrawal by Subject|9|||
155317993|NCT03854227|560600526|FG000|Overall Study|Physician Decision|0|||
155317994|NCT03854227|560600527|FG001|Overall Study|Physician Decision|0|||
155317995|NCT03854227|560600528|FG002|Overall Study|Physician Decision|0|||
155317996|NCT03854227|560600529|FG003|Overall Study|Physician Decision|0|||
155317997|NCT03854227|560600530|FG004|Overall Study|Physician Decision|0|||
155317998|NCT03854227|560600531|FG005|Overall Study|Physician Decision|1|||
155317999|NCT03854227|560600532|FG006|Overall Study|Physician Decision|0|||
155318000|NCT03854227|560600533|FG007|Overall Study|Physician Decision|0|||
155318001|NCT03854227|560600534|FG008|Overall Study|Physician Decision|1|||
155318002|NCT03854227|560600535|FG009|Overall Study|Physician Decision|1|||
155318003|NCT03854227|560600536|FG010|Overall Study|Physician Decision|0|||
155318004|NCT03854227|560600537|FG011|Overall Study|Physician Decision|1|||
155318005|NCT03854227|560600526|FG000|Overall Study|Progressive disease|1|||
155318006|NCT03854227|560600527|FG001|Overall Study|Progressive disease|1|||
155318007|NCT03854227|560600528|FG002|Overall Study|Progressive disease|1|||
155318008|NCT03854227|560600529|FG003|Overall Study|Progressive disease|2|||
155318009|NCT03854227|560600530|FG004|Overall Study|Progressive disease|3|||
155318010|NCT03854227|560600531|FG005|Overall Study|Progressive disease|1|||
155318011|NCT03854227|560600532|FG006|Overall Study|Progressive disease|2|||
155318012|NCT03854227|560600533|FG007|Overall Study|Progressive disease|5|||
155318013|NCT03854227|560600534|FG008|Overall Study|Progressive disease|2|||
155318014|NCT03854227|560600535|FG009|Overall Study|Progressive disease|5|||
155318015|NCT03854227|560600536|FG010|Overall Study|Progressive disease|1|||
155318016|NCT03854227|560600537|FG011|Overall Study|Progressive disease|6|||
155318017|NCT03854227|560600526|FG000|Overall Study|Study terminated by sponsor|0|||
155318018|NCT03854227|560600527|FG001|Overall Study|Study terminated by sponsor|0|||
155318019|NCT03854227|560600528|FG002|Overall Study|Study terminated by sponsor|0|||
155318020|NCT03854227|560600529|FG003|Overall Study|Study terminated by sponsor|0|||
155318021|NCT03854227|560600530|FG004|Overall Study|Study terminated by sponsor|0|||
155318022|NCT03854227|560600531|FG005|Overall Study|Study terminated by sponsor|0|||
155318023|NCT03854227|560600532|FG006|Overall Study|Study terminated by sponsor|0|||
155318024|NCT03854227|560600533|FG007|Overall Study|Study terminated by sponsor|0|||
155318025|NCT03854227|560600534|FG008|Overall Study|Study terminated by sponsor|0|||
155318026|NCT03854227|560600535|FG009|Overall Study|Study terminated by sponsor|1|||
155318027|NCT03854227|560600536|FG010|Overall Study|Study terminated by sponsor|0|||
155318028|NCT03854227|560600537|FG011|Overall Study|Study terminated by sponsor|0|||
155318029|NCT03854227|560600526|FG000|Overall Study|Withdrawal by Subject|0|||
155318030|NCT03854227|560600527|FG001|Overall Study|Withdrawal by Subject|0|||
155318031|NCT03854227|560600528|FG002|Overall Study|Withdrawal by Subject|1|||
155318032|NCT03854227|560600529|FG003|Overall Study|Withdrawal by Subject|0|||
155318033|NCT03854227|560600530|FG004|Overall Study|Withdrawal by Subject|0|||
155318034|NCT03854227|560600531|FG005|Overall Study|Withdrawal by Subject|0|||
155318035|NCT03854227|560600532|FG006|Overall Study|Withdrawal by Subject|0|||
155318036|NCT03854227|560600533|FG007|Overall Study|Withdrawal by Subject|0|||
155318037|NCT03854227|560600534|FG008|Overall Study|Withdrawal by Subject|0|||
155318038|NCT03854227|560600535|FG009|Overall Study|Withdrawal by Subject|1|||
155318039|NCT03854227|560600536|FG010|Overall Study|Withdrawal by Subject|1|||
155318040|NCT03854227|560600537|FG011|Overall Study|Withdrawal by Subject|0|||
155318041|NCT03854227|560600526|FG000|Overall Study|Disease relapse|0|||
155318042|NCT03854227|560600527|FG001|Overall Study|Disease relapse|0|||
155318043|NCT03854227|560600528|FG002|Overall Study|Disease relapse|0|||
155318044|NCT03854227|560600529|FG003|Overall Study|Disease relapse|0|||
155318045|NCT03854227|560600530|FG004|Overall Study|Disease relapse|0|||
155318046|NCT03854227|560600531|FG005|Overall Study|Disease relapse|0|||
155318047|NCT03854227|560600532|FG006|Overall Study|Disease relapse|0|||
155318048|NCT03854227|560600533|FG007|Overall Study|Disease relapse|0|||
155318049|NCT03854227|560600534|FG008|Overall Study|Disease relapse|1|||
155318050|NCT03854227|560600535|FG009|Overall Study|Disease relapse|0|||
155318051|NCT03854227|560600536|FG010|Overall Study|Disease relapse|0|||
155318052|NCT03854227|560600537|FG011|Overall Study|Disease relapse|0|||
155318053|NCT03854227|560600526|FG000|Overall Study|Global deterioration of health status|0|||
155318054|NCT03854227|560600527|FG001|Overall Study|Global deterioration of health status|0|||
155318055|NCT03854227|560600528|FG002|Overall Study|Global deterioration of health status|0|||
155318056|NCT03854227|560600529|FG003|Overall Study|Global deterioration of health status|0|||
155318057|NCT03854227|560600530|FG004|Overall Study|Global deterioration of health status|0|||
155318058|NCT03854227|560600531|FG005|Overall Study|Global deterioration of health status|1|||
155318059|NCT03854227|560600532|FG006|Overall Study|Global deterioration of health status|0|||
155318060|NCT03854227|560600533|FG007|Overall Study|Global deterioration of health status|1|||
155318061|NCT03854227|560600534|FG008|Overall Study|Global deterioration of health status|0|||
155318062|NCT03854227|560600535|FG009|Overall Study|Global deterioration of health status|0|||
155318063|NCT03854227|560600536|FG010|Overall Study|Global deterioration of health status|0|||
155318064|NCT03854227|560600537|FG011|Overall Study|Global deterioration of health status|0|||
155318065|NCT03854227|560600526|FG000|Overall Study|Refused further treatment|0|||
155318066|NCT03854227|560600527|FG001|Overall Study|Refused further treatment|0|||
155318067|NCT03854227|560600528|FG002|Overall Study|Refused further treatment|0|||
155318068|NCT03854227|560600529|FG003|Overall Study|Refused further treatment|0|||
155162418|NCT01177397|560031612|FG006|Overall Study|Protocol Violation|0|||
155162419|NCT01177397|560031613|FG007|Overall Study|Protocol Violation|0|||
155162420|NCT01177397|560031614|FG008|Overall Study|Protocol Violation|0|||
155162421|NCT01177397|560031615|FG009|Overall Study|Protocol Violation|0|||
155162422|NCT01177397|560031616|FG010|Overall Study|Protocol Violation|0|||
155318069|NCT03854227|560600530|FG004|Overall Study|Refused further treatment|0|||
155318070|NCT03854227|560600531|FG005|Overall Study|Refused further treatment|0|||
155318071|NCT03854227|560600532|FG006|Overall Study|Refused further treatment|0|||
155318072|NCT03854227|560600533|FG007|Overall Study|Refused further treatment|0|||
155318073|NCT03854227|560600534|FG008|Overall Study|Refused further treatment|0|||
155318074|NCT03854227|560600535|FG009|Overall Study|Refused further treatment|1|||
155318075|NCT03854227|560600536|FG010|Overall Study|Refused further treatment|0|||
155318076|NCT03854227|560600537|FG011|Overall Study|Refused further treatment|1|||
155318077|NCT03854227|560600526|FG000|Overall Study|Other|0|||
155318078|NCT03854227|560600527|FG001|Overall Study|Other|0|||
155318079|NCT03854227|560600528|FG002|Overall Study|Other|0|||
155318080|NCT03854227|560600529|FG003|Overall Study|Other|0|||
155318081|NCT03854227|560600530|FG004|Overall Study|Other|0|||
155318082|NCT03854227|560600531|FG005|Overall Study|Other|0|||
155318083|NCT03854227|560600532|FG006|Overall Study|Other|0|||
155318084|NCT03854227|560600533|FG007|Overall Study|Other|0|||
155318085|NCT03854227|560600534|FG008|Overall Study|Other|1|||
155318086|NCT03854227|560600535|FG009|Overall Study|Other|1|||
155318087|NCT03854227|560600536|FG010|Overall Study|Other|0|||
155318088|NCT03854227|560600537|FG011|Overall Study|Other|0|||
155318089|NCT04676763|560600538|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
155318090|NCT04676763|560600539|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
155318091|NCT04676763|560600540|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
155318092|NCT04676763|560600538|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
155318093|NCT04676763|560600539|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
155318094|NCT04676763|560600540|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
155318095|NCT04676763|560600538|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
155318096|NCT04676763|560600539|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
155318097|NCT04676763|560600540|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
155318098|NCT04119843|560600543|FG000|Overall Study|Adverse Event|3|||
155318099|NCT04119843|560600543|FG000|Overall Study|Death|1|||
155318100|NCT04499924|560600544|FG000|Overall Study|Study termination by sponsor|4|||
155318101|NCT04499924|560600545|FG001|Overall Study|Study termination by sponsor|6|||
155318102|NCT04499924|560600544|FG000|Overall Study|Withdrawal by Subject|1|||
155162423|NCT01177397|560031617|FG011|Overall Study|Protocol Violation|0|||
155318103|NCT04499924|560600545|FG001|Overall Study|Withdrawal by Subject|3|||
155318104|NCT04225273|560600546|FG000|Overall Study|Lost to Follow-up|3|||
155318105|NCT03652389|560600547|FG000|Overall Study|Lost to Follow-up|1|||
155318106|NCT03652389|560600548|FG001|Overall Study|Lost to Follow-up|5|||
155318107|NCT03652389|560600547|FG000|Overall Study|Withdrawal by Subject|5|||
155318108|NCT03652389|560600548|FG001|Overall Study|Withdrawal by Subject|1|||
155318109|NCT03652389|560600547|FG000|Overall Study|New diagnosis|2|||
155318110|NCT03652389|560600548|FG001|Overall Study|New diagnosis|0|||
155318111|NCT04413708|560600549|FG000|Overall Study|Lost to Follow-up|1|||
155318112|NCT04413708|560600550|FG001|Overall Study|Lost to Follow-up|2|||
155318113|NCT04231149|560600551|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318114|NCT04231149|560600552|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
155318115|NCT04231149|560600553|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318116|NCT04231149|560600554|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318117|NCT04231149|560600555|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
155318118|NCT01501955|560600558|FG000|Overall Study|Withdrawal by Subject|1|||
155318119|NCT01501955|560600559|FG001|Overall Study|Withdrawal by Subject|0|||
155318120|NCT01501955|560600558|FG000|Overall Study|Adverse Event|1|||
155318121|NCT01501955|560600559|FG001|Overall Study|Adverse Event|3|||
155318122|NCT05877976|560600560|FG000|Overall Study|Lost to Follow-up|31|||
155318123|NCT04314713|560600561|FG000|Overall Study|Lost to Follow-up|0|||
155318124|NCT04314713|560600562|FG001|Overall Study|Lost to Follow-up|0|||
155318125|NCT04314713|560600563|FG002|Overall Study|Lost to Follow-up|0|||
155318126|NCT04314713|560600564|FG003|Overall Study|Lost to Follow-up|1|||
155318127|NCT04314713|560600565|FG004|Overall Study|Lost to Follow-up|0|||
155318128|NCT04314713|560600566|FG005|Overall Study|Lost to Follow-up|0|||
155318129|NCT04907851|560600567|FG000|Overall Study|Consent withdrawn|1|||
155318130|NCT04907851|560600568|FG001|Overall Study|Consent withdrawn|2|||
155318131|NCT04907851|560600569|FG002|Overall Study|Consent withdrawn|0|||
155318132|NCT04907851|560600567|FG000|Overall Study|Death|5|||
155318133|NCT04907851|560600568|FG001|Overall Study|Death|15|||
155318134|NCT04907851|560600569|FG002|Overall Study|Death|10|||
155318135|NCT03656510|560600580|FG000|Overall Study|Lost to Follow-up|1|||
155318136|NCT03656510|560600581|FG001|Overall Study|Lost to Follow-up|0|||
155318137|NCT03656510|560600582|FG002|Overall Study|Lost to Follow-up|0|||
155318138|NCT03656510|560600583|FG003|Overall Study|Lost to Follow-up|0|||
155318139|NCT03656510|560600584|FG004|Overall Study|Lost to Follow-up|0|||
155318140|NCT03656510|560600585|FG005|Overall Study|Lost to Follow-up|0|||
155318141|NCT03656510|560600580|FG000|Overall Study|Withdrawal by Subject|1|||
155318142|NCT03656510|560600581|FG001|Overall Study|Withdrawal by Subject|1|||
155318143|NCT03656510|560600582|FG002|Overall Study|Withdrawal by Subject|0|||
155318144|NCT03656510|560600583|FG003|Overall Study|Withdrawal by Subject|1|||
155318145|NCT03656510|560600584|FG004|Overall Study|Withdrawal by Subject|0|||
155318146|NCT03656510|560600585|FG005|Overall Study|Withdrawal by Subject|0|||
155318147|NCT05477186|560600588|FG000|Overall Study|Vaccine not administered|0|||
155318148|NCT05477186|560600589|FG001|Overall Study|Vaccine not administered|2|||
155318149|NCT05477186|560600590|FG002|Overall Study|Vaccine not administered|1|||
155318150|NCT05477186|560600591|FG003|Overall Study|Vaccine not administered|0|||
155318151|NCT05477186|560600592|FG004|Overall Study|Vaccine not administered|1|||
155318152|NCT05477186|560600593|FG005|Overall Study|Vaccine not administered|0|||
155318153|NCT05477186|560600594|FG006|Overall Study|Vaccine not administered|0|||
155318154|NCT05477186|560600588|FG000|Overall Study|Withdrawal by Subject|1|||
155318155|NCT05477186|560600589|FG001|Overall Study|Withdrawal by Subject|0|||
155318156|NCT05477186|560600590|FG002|Overall Study|Withdrawal by Subject|0|||
155318157|NCT05477186|560600591|FG003|Overall Study|Withdrawal by Subject|0|||
155318158|NCT05477186|560600592|FG004|Overall Study|Withdrawal by Subject|0|||
155318159|NCT05477186|560600593|FG005|Overall Study|Withdrawal by Subject|1|||
155318160|NCT05477186|560600594|FG006|Overall Study|Withdrawal by Subject|0|||
155318161|NCT05477186|560600588|FG000|Overall Study|Lost to Follow-up|1|||
155318162|NCT05477186|560600589|FG001|Overall Study|Lost to Follow-up|0|||
155318163|NCT05477186|560600590|FG002|Overall Study|Lost to Follow-up|2|||
155318164|NCT05477186|560600591|FG003|Overall Study|Lost to Follow-up|1|||
155318165|NCT05477186|560600592|FG004|Overall Study|Lost to Follow-up|1|||
155318166|NCT05477186|560600593|FG005|Overall Study|Lost to Follow-up|0|||
155318167|NCT05477186|560600594|FG006|Overall Study|Lost to Follow-up|2|||
155318168|NCT02305888|560600600|FG000|Overall Study|Lost to Follow-up|0|||
155318169|NCT02305888|560600601|FG001|Overall Study|Lost to Follow-up|0|||
155092650|NCT00854360|559773652|FG002|Overall Study|Withdrawal by Subject|0|||
155318170|NCT02305888|560600602|FG002|Overall Study|Lost to Follow-up|1|||
155318171|NCT02305888|560600600|FG000|Overall Study|Adverse Event|0|||
155318172|NCT02305888|560600601|FG001|Overall Study|Adverse Event|1|||
155318173|NCT02305888|560600602|FG002|Overall Study|Adverse Event|0|||
155318174|NCT05139810|560600603|FG000|Overall Study|Voluntary Withdrawal|2|||
155318175|NCT05139810|560600604|FG001|Overall Study|Voluntary Withdrawal|1|||
155318176|NCT05139810|560600605|FG002|Overall Study|Voluntary Withdrawal|0|||
155318177|NCT05139810|560600603|FG000|Overall Study|Pregnancy|1|||
155318178|NCT05139810|560600604|FG001|Overall Study|Pregnancy|0|||
155318179|NCT05139810|560600605|FG002|Overall Study|Pregnancy|0|||
155318180|NCT05139810|560600603|FG000|Overall Study|Roll Over to CS7|19|||
155318181|NCT05139810|560600604|FG001|Overall Study|Roll Over to CS7|44|||
155318182|NCT05139810|560600605|FG002|Overall Study|Roll Over to CS7|20|||
155318183|NCT04914676|560600610|FG000|Overall Study|Study termination|3|||
155318184|NCT04914676|560600611|FG001|Overall Study|Study termination|0|||
155318185|NCT03024437|560600612|FG000|Overall Study|Adverse Event|0|||
155067095|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155067096|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155067097|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
155067098|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
155318186|NCT03024437|560600613|FG001|Overall Study|Adverse Event|1|||
155318187|NCT03024437|560600614|FG002|Overall Study|Adverse Event|3|||
155318188|NCT03024437|560600615|FG003|Overall Study|Adverse Event|5|||
155318189|NCT03024437|560600616|FG004|Overall Study|Adverse Event|0|||
155318190|NCT03024437|560600612|FG000|Overall Study|Physician Decision|1|||
155318191|NCT03024437|560600613|FG001|Overall Study|Physician Decision|0|||
155318192|NCT03024437|560600614|FG002|Overall Study|Physician Decision|0|||
155318193|NCT03024437|560600615|FG003|Overall Study|Physician Decision|1|||
155318194|NCT03024437|560600616|FG004|Overall Study|Physician Decision|0|||
155318195|NCT03024437|560600612|FG000|Overall Study|Disease progression, relapse|1|||
155318196|NCT03024437|560600613|FG001|Overall Study|Disease progression, relapse|0|||
155318197|NCT03024437|560600614|FG002|Overall Study|Disease progression, relapse|0|||
155318198|NCT03024437|560600615|FG003|Overall Study|Disease progression, relapse|3|||
155318199|NCT03024437|560600616|FG004|Overall Study|Disease progression, relapse|0|||
155318200|NCT03024437|560600612|FG000|Overall Study|Disease progression, refractory disease|4|||
155318201|NCT03024437|560600613|FG001|Overall Study|Disease progression, refractory disease|4|||
155318202|NCT03024437|560600614|FG002|Overall Study|Disease progression, refractory disease|2|||
155318203|NCT03024437|560600615|FG003|Overall Study|Disease progression, refractory disease|2|||
155318204|NCT03024437|560600616|FG004|Overall Study|Disease progression, refractory disease|1|||
155318205|NCT03024437|560600612|FG000|Overall Study|Newly diagnosed cancer|0|||
155318206|NCT03024437|560600613|FG001|Overall Study|Newly diagnosed cancer|0|||
155318207|NCT03024437|560600614|FG002|Overall Study|Newly diagnosed cancer|0|||
155318208|NCT03024437|560600615|FG003|Overall Study|Newly diagnosed cancer|1|||
155318209|NCT03024437|560600616|FG004|Overall Study|Newly diagnosed cancer|0|||
155318210|NCT03024437|560600612|FG000|Overall Study|Moved out of state|0|||
155318211|NCT03024437|560600613|FG001|Overall Study|Moved out of state|1|||
155318212|NCT03024437|560600614|FG002|Overall Study|Moved out of state|0|||
155318213|NCT03024437|560600615|FG003|Overall Study|Moved out of state|0|||
155318214|NCT03024437|560600616|FG004|Overall Study|Moved out of state|0|||
155318215|NCT03024437|560600612|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318216|NCT03024437|560600613|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318217|NCT03024437|560600614|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
155318218|NCT03024437|560600615|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318219|NCT03024437|560600616|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
155318220|NCT03240016|560600619|FG000|Overall Study|Adverse Event|9|||
155318221|NCT03240016|560600619|FG000|Overall Study|Withdrawal by Subject|7|||
155318222|NCT03240016|560600619|FG000|Overall Study|Death|1|||
155318223|NCT03240016|560600619|FG000|Overall Study|Physician Decision|2|||
155318224|NCT05200403|560600620|FG000|Overall Study|Withdrawal by Subject|4|||
155318225|NCT05200403|560600621|FG001|Overall Study|Withdrawal by Subject|2|||
155318226|NCT05200403|560600622|FG002|Overall Study|Withdrawal by Subject|6|||
155318227|NCT05546411|560600623|FG000|Overall Study|Progressive Disease|1|||
155318228|NCT05546411|560600624|FG001|Overall Study|Progressive Disease|0|||
155318229|NCT05546411|560600623|FG000|Overall Study|Adverse Event|0|||
155318230|NCT05546411|560600624|FG001|Overall Study|Adverse Event|1|||
155318231|NCT05546411|560600623|FG000|Overall Study|Metastatic disease|1|||
155318232|NCT05546411|560600624|FG001|Overall Study|Metastatic disease|0|||
155318233|NCT02606422|560600625|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
155318234|NCT02606422|560600626|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
155318235|NCT02606422|560600625|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
155318236|NCT02606422|560600626|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
155318237|NCT02606422|560600625|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
155318238|NCT02606422|560600626|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
155318239|NCT02606422|560600625|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
155318240|NCT02606422|560600626|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
155318241|NCT05566639|560600628|FG000|Overall Study|Adverse Event|1|||
155318242|NCT05566639|560600629|FG001|Overall Study|Adverse Event|1|||
155318243|NCT05566639|560600628|FG000|Overall Study|Serious Adverse Event|1|||
155318244|NCT05566639|560600629|FG001|Overall Study|Serious Adverse Event|3|||
155318245|NCT05566639|560600628|FG000|Overall Study|Death|44|||
155318246|NCT05566639|560600629|FG001|Overall Study|Death|45|||
155318247|NCT05566639|560600628|FG000|Overall Study|Lost to Follow-up|467|||
155318248|NCT05566639|560600629|FG001|Overall Study|Lost to Follow-up|461|||
155318249|NCT05566639|560600628|FG000|Overall Study|Physician Decision|45|||
155318250|NCT05566639|560600629|FG001|Overall Study|Physician Decision|44|||
154959974|NCT02718326|559278653|FG002|Overall Study|Withdrawal by Subject|6|||
154959975|NCT02718326|559278651|FG000|Overall Study|Lost to Follow-up|18|||
154959976|NCT02718326|559278652|FG001|Overall Study|Lost to Follow-up|5|||
154959977|NCT02718326|559278653|FG002|Overall Study|Lost to Follow-up|14|||
154959978|NCT02718326|559278651|FG000|Overall Study|Protocol Deviation|1|||
154959979|NCT02718326|559278652|FG001|Overall Study|Protocol Deviation|0|||
154959980|NCT02718326|559278653|FG002|Overall Study|Protocol Deviation|0|||
154959981|NCT02718326|559278651|FG000|Overall Study|Pregnancy|1|||
154959982|NCT02718326|559278652|FG001|Overall Study|Pregnancy|0|||
154959983|NCT02718326|559278653|FG002|Overall Study|Pregnancy|0|||
154959984|NCT00455312|559278655|FG000|Overall Study|Death|0|||
154959985|NCT00455312|559278656|FG001|Overall Study|Death|1|||
154959986|NCT03868891|559278657|FG000|Overall Study|Adverse Event|1|||
154959987|NCT03868891|559278658|FG001|Overall Study|Adverse Event|0|||
154959988|NCT03868891|559278657|FG000|Overall Study|Lost to Follow-up|2|||
154959989|NCT03868891|559278658|FG001|Overall Study|Lost to Follow-up|1|||
154959990|NCT03868891|559278657|FG000|Overall Study|COVID-19 Restrictions|1|||
154959991|NCT03868891|559278658|FG001|Overall Study|COVID-19 Restrictions|2|||
154959992|NCT00777023|559278659|FG000|Overall Study|Adverse Event|15|||
154959993|NCT00777023|559278660|FG001|Overall Study|Adverse Event|21|||
154959994|NCT00777023|559278661|FG002|Overall Study|Adverse Event|8|||
154959995|NCT00777023|559278659|FG000|Overall Study|Lack of Efficacy|1|||
154959996|NCT00777023|559278660|FG001|Overall Study|Lack of Efficacy|0|||
154959997|NCT00777023|559278661|FG002|Overall Study|Lack of Efficacy|14|||
154959998|NCT00777023|559278659|FG000|Overall Study|Protocol Violation|2|||
154959999|NCT00777023|559278660|FG001|Overall Study|Protocol Violation|1|||
154960000|NCT00777023|559278661|FG002|Overall Study|Protocol Violation|1|||
154960001|NCT00777023|559278659|FG000|Overall Study|Lost to Follow-up|2|||
154960002|NCT00777023|559278660|FG001|Overall Study|Lost to Follow-up|3|||
154960003|NCT00777023|559278661|FG002|Overall Study|Lost to Follow-up|3|||
154960004|NCT00777023|559278659|FG000|Overall Study|Death|0|||
154960005|NCT00777023|559278660|FG001|Overall Study|Death|1|||
154960006|NCT00777023|559278661|FG002|Overall Study|Death|0|||
154960007|NCT00777023|559278659|FG000|Overall Study|Withdrawal by Subject|7|||
154960008|NCT00777023|559278660|FG001|Overall Study|Withdrawal by Subject|7|||
154960009|NCT00777023|559278661|FG002|Overall Study|Withdrawal by Subject|8|||
154960010|NCT00777023|559278659|FG000|Overall Study|Missing data|1|||
154960011|NCT00777023|559278660|FG001|Overall Study|Missing data|1|||
154960012|NCT00777023|559278661|FG002|Overall Study|Missing data|0|||
154960013|NCT00777023|559278659|FG000|Overall Study|Reasons not specified|4|||
154960014|NCT00777023|559278660|FG001|Overall Study|Reasons not specified|4|||
154960015|NCT00777023|559278661|FG002|Overall Study|Reasons not specified|2|||
154960016|NCT00777023|559278659|FG000|Overall Study|Last dose date unknown|3|||
154960017|NCT00777023|559278660|FG001|Overall Study|Last dose date unknown|3|||
154960018|NCT00777023|559278661|FG002|Overall Study|Last dose date unknown|1|||
154960019|NCT02659150|559278662|FG000|Subject Enrollment|Physician Decision|3|||
154960020|NCT02659150|559278662|FG000|Subject Enrollment|Withdrawal by Subject|2|||
154960021|NCT02659150|559278662|FG000|Baseline Imaging|Withdrawal by Subject|1|||
154960022|NCT02659150|559278662|FG000|Baseline Imaging|Physician Decision|1|||
154960023|NCT02659150|559278662|FG000|Study Drug Dosing|Adverse Event|1|||
154960024|NCT02246920|559278663|FG000|Overall Study|Adverse Event|3|||
154960025|NCT02246920|559278664|FG001|Overall Study|Adverse Event|1|||
154960026|NCT02246920|559278665|FG002|Overall Study|Adverse Event|1|||
154960027|NCT02246920|559278663|FG000|Overall Study|Lost to Follow-up|2|||
154960028|NCT02246920|559278664|FG001|Overall Study|Lost to Follow-up|1|||
154960029|NCT02246920|559278665|FG002|Overall Study|Lost to Follow-up|0|||
154960030|NCT02246920|559278663|FG000|Overall Study|Protocol Violation|2|||
154960031|NCT02246920|559278664|FG001|Overall Study|Protocol Violation|5|||
154960032|NCT02246920|559278665|FG002|Overall Study|Protocol Violation|1|||
155162424|NCT01177397|560031606|FG000|Overall Study|Lost to Follow-up|0|||
155318251|NCT05566639|560600628|FG000|Overall Study|Protocol Deviation|4|||
155318252|NCT05566639|560600629|FG001|Overall Study|Protocol Deviation|4|||
154960033|NCT02246920|559278663|FG000|Overall Study|Withdrawal by Subject|0|||
154960034|NCT02246920|559278664|FG001|Overall Study|Withdrawal by Subject|0|||
154960035|NCT02246920|559278665|FG002|Overall Study|Withdrawal by Subject|1|||
154960036|NCT02678286|559278666|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
154960037|NCT02678286|559278667|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
154960038|NCT02678286|559278666|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
154960039|NCT02678286|559278667|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
154960040|NCT02678286|559278666|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
154960041|NCT02678286|559278667|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
154960042|NCT02678286|559278666|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
154960043|NCT02678286|559278667|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
154960044|NCT02678286|559278666|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
154960045|NCT02678286|559278667|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
154960046|NCT02909907|559278674|FG000|Overall Study|Withdrawal by Subject|0|||
154960047|NCT02909907|559278675|FG001|Overall Study|Withdrawal by Subject|1|||
154960048|NCT02902211|559278676|FG000|First Three Months|Withdrawal by Subject|7|||
154960049|NCT02902211|559278677|FG001|First Three Months|Withdrawal by Subject|3|||
154960050|NCT02576938|559278682|FG000|Overall Study|Adverse Event|5|||
154960051|NCT02576938|559278683|FG001|Overall Study|Adverse Event|3|||
154960052|NCT02576938|559278684|FG002|Overall Study|Adverse Event|6|||
154960053|NCT02576938|559278682|FG000|Overall Study|Protocol Violation|1|||
154960054|NCT02576938|559278683|FG001|Overall Study|Protocol Violation|1|||
154960055|NCT02576938|559278684|FG002|Overall Study|Protocol Violation|1|||
154960056|NCT02576938|559278682|FG000|Overall Study|Withdrawal by Subject|3|||
154960057|NCT02576938|559278683|FG001|Overall Study|Withdrawal by Subject|2|||
154960058|NCT02576938|559278684|FG002|Overall Study|Withdrawal by Subject|4|||
154960059|NCT02576938|559278682|FG000|Overall Study|Lack of Efficacy|9|||
154960060|NCT02576938|559278683|FG001|Overall Study|Lack of Efficacy|4|||
154960061|NCT02576938|559278684|FG002|Overall Study|Lack of Efficacy|0|||
154960062|NCT02576938|559278682|FG000|Overall Study|Lost to Follow-up|2|||
154960063|NCT02576938|559278683|FG001|Overall Study|Lost to Follow-up|0|||
154960064|NCT02576938|559278684|FG002|Overall Study|Lost to Follow-up|1|||
154960065|NCT02576938|559278682|FG000|Overall Study|Physician Decision|0|||
154960066|NCT02576938|559278683|FG001|Overall Study|Physician Decision|1|||
154960067|NCT02576938|559278684|FG002|Overall Study|Physician Decision|0|||
154960068|NCT02576938|559278682|FG000|Overall Study|Met Exclusion Criteria|0|||
154960069|NCT02576938|559278683|FG001|Overall Study|Met Exclusion Criteria|1|||
154960070|NCT02576938|559278684|FG002|Overall Study|Met Exclusion Criteria|0|||
154960071|NCT03500341|559278685|FG000|Overall Study|Withdrawn prior to Completion|2|||
154960072|NCT00838630|559278688|FG000|First Intervention|Adverse Event|1|||
154960073|NCT00838630|559278689|FG001|First Intervention|Adverse Event|0|||
154960074|NCT00838630|559278688|FG000|Washout: 7 Days|Protocol Violation|1|||
154960075|NCT00838630|559278689|FG001|Washout: 7 Days|Protocol Violation|0|||
155318253|NCT05566639|560600628|FG000|Overall Study|Withdrawal by Subject|277|||
155318254|NCT05566639|560600629|FG001|Overall Study|Withdrawal by Subject|271|||
155318255|NCT05566639|560600628|FG000|Overall Study|Other Than Specified|52|||
155318256|NCT05566639|560600629|FG001|Overall Study|Other Than Specified|64|||
155318257|NCT04054193|560600637|FG000|Cycle 1|Physician Decision|1|||
155318258|NCT04054193|560600637|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
155318259|NCT04054193|560600637|FG000|Cycle 1|Allocated but not treated|3|||
155318260|NCT04054193|560600637|FG000|Cycles 2-3|Physician Decision|2|||
155318261|NCT04054193|560600637|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
155318262|NCT04054193|560600637|FG000|Cycles 2-3|Various reasons|17|||
155318263|NCT02966873|560600638|FG000|Overall Study|Lost to Follow-up|16|||
154960076|NCT02699866|559278690|FG000|Overall Study|Withdrawal by Subject|3|||
154960077|NCT02699866|559278690|FG000|Overall Study|Physician Decision|2|||
154960078|NCT02699866|559278690|FG000|Overall Study|Adverse Event|3|||
154960079|NCT03098394|559278694|FG000|Overall Study|Pregnancy|0|||
155318264|NCT02966873|560600639|FG001|Overall Study|Lost to Follow-up|15|||
155318265|NCT03235544|560600648|FG000|Overall Study|Death|11|||
155318266|NCT03235544|560600649|FG001|Overall Study|Death|31|||
155318267|NCT03235544|560600650|FG002|Overall Study|Death|19|||
155318268|NCT03235544|560600651|FG003|Overall Study|Death|34|||
155318269|NCT03235544|560600648|FG000|Overall Study|Lost to Follow-up|0|||
155318270|NCT03235544|560600649|FG001|Overall Study|Lost to Follow-up|1|||
155318271|NCT03235544|560600650|FG002|Overall Study|Lost to Follow-up|1|||
155318272|NCT03235544|560600651|FG003|Overall Study|Lost to Follow-up|1|||
154960080|NCT03098394|559278695|FG001|Overall Study|Pregnancy|1|||
154960081|NCT01518972|559278698|FG000|Overall Study|Lost to Follow-up|2|||
154960082|NCT01518972|559278699|FG001|Overall Study|Lost to Follow-up|1|||
155318273|NCT03235544|560600648|FG000|Overall Study|Withdrawal by Subject|0|||
155318274|NCT03235544|560600649|FG001|Overall Study|Withdrawal by Subject|3|||
154960083|NCT01518972|559278698|FG000|Overall Study|Withdrawal by Subject|1|||
155318275|NCT03235544|560600650|FG002|Overall Study|Withdrawal by Subject|1|||
155318276|NCT03235544|560600651|FG003|Overall Study|Withdrawal by Subject|5|||
155318277|NCT03235544|560600648|FG000|Overall Study|Disease Progression|0|||
155318278|NCT03235544|560600649|FG001|Overall Study|Disease Progression|1|||
155318279|NCT03235544|560600650|FG002|Overall Study|Disease Progression|0|||
155318280|NCT03235544|560600651|FG003|Overall Study|Disease Progression|2|||
155318281|NCT03235544|560600648|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
154960084|NCT01518972|559278699|FG001|Overall Study|Withdrawal by Subject|0|||
154960085|NCT01518972|559278698|FG000|Overall Study|Moved from area|1|||
154960086|NCT01518972|559278699|FG001|Overall Study|Moved from area|0|||
154960087|NCT01518972|559278698|FG000|Overall Study|Transportation problems|1|||
154960088|NCT01518972|559278699|FG001|Overall Study|Transportation problems|0|||
154960089|NCT01518972|559278698|FG000|Overall Study|Exclusionary medical condition|1|||
154960090|NCT01518972|559278699|FG001|Overall Study|Exclusionary medical condition|0|||
154960091|NCT01518972|559278698|FG000|Overall Study|Missed safety visits|0|||
154960092|NCT01518972|559278699|FG001|Overall Study|Missed safety visits|1|||
155318282|NCT03235544|560600649|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
155318283|NCT03235544|560600650|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
155318284|NCT03235544|560600651|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
155318285|NCT03235544|560600648|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
155318286|NCT03235544|560600649|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
155318287|NCT03235544|560600650|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
155318288|NCT03235544|560600651|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
155318289|NCT00950742|560600652|FG000|Overall Study|Other Adverse Event|1|||
155318290|NCT00950742|560600653|FG001|Overall Study|Other Adverse Event|0|||
155318291|NCT00950742|560600652|FG000|Overall Study|Withdrawal by Subject|3|||
155318292|NCT00950742|560600653|FG001|Overall Study|Withdrawal by Subject|0|||
155318293|NCT00950742|560600652|FG000|Overall Study|Progressive Disease|6|||
155318294|NCT00950742|560600653|FG001|Overall Study|Progressive Disease|2|||
155318295|NCT00950742|560600652|FG000|Overall Study|Dose limiting toxicity|6|||
155318296|NCT00950742|560600653|FG001|Overall Study|Dose limiting toxicity|0|||
155318297|NCT05436262|560600655|FG000|Pre-Randomization|Withdrawal by Subject|1|||
155162425|NCT01177397|560031607|FG001|Overall Study|Lost to Follow-up|0|||
155318298|NCT05436262|560600656|FG001|Pre-Randomization|Withdrawal by Subject|0|||
155318299|NCT05436262|560600657|FG002|Pre-Randomization|Withdrawal by Subject|0|||
155318300|NCT05436262|560600655|FG000|Randomization|Withdrawal by Subject|0|||
155318301|NCT05436262|560600656|FG001|Randomization|Withdrawal by Subject|1|||
155318302|NCT05436262|560600657|FG002|Randomization|Withdrawal by Subject|0|||
155318303|NCT01456949|560600658|FG000|Enrollment|PI death- incomplete data|6|||
155318304|NCT01456949|560600658|FG000|Enrollment|Death|1|||
155318305|NCT01456949|560600658|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
155318306|NCT01456949|560600658|FG000|Enrollment|Physician Decision|10|||
155318307|NCT01456949|560600658|FG000|Enrollment|Withdrawal by Subject|7|||
155318308|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
155318309|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
155318310|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
155318311|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
155318312|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
155318313|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
155318314|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
155318315|NCT01456949|560600658|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
155318316|NCT04200456|560600661|FG000|Overall Study|Physician Decision|0|||
155318317|NCT04200456|560600662|FG001|Overall Study|Physician Decision|1|||
155318318|NCT04200456|560600661|FG000|Overall Study|Withdrawal by Subject|2|||
155318319|NCT04200456|560600662|FG001|Overall Study|Withdrawal by Subject|2|||
155318320|NCT04200456|560600661|FG000|Overall Study|Lack of Efficacy|1|||
155318321|NCT04200456|560600662|FG001|Overall Study|Lack of Efficacy|1|||
155318322|NCT04200456|560600661|FG000|Overall Study|Adverse event, non-fatal|0|||
155318323|NCT04200456|560600662|FG001|Overall Study|Adverse event, non-fatal|1|||
155318324|NCT04200456|560600661|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
155318325|NCT04200456|560600662|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
155318326|NCT05002088|560600664|FG000|Overall Study|Withdrawal by Subject|9|||
155318327|NCT05002088|560600665|FG001|Overall Study|Withdrawal by Subject|0|||
155318328|NCT05002088|560600664|FG000|Overall Study|Lost to Follow-up|0|||
155318329|NCT05002088|560600665|FG001|Overall Study|Lost to Follow-up|1|||
155318330|NCT05002088|560600664|FG000|Overall Study|Death|16|||
155318331|NCT05002088|560600665|FG001|Overall Study|Death|2|||
155318332|NCT05002088|560600664|FG000|Overall Study|Protocol Violation|25|||
155318333|NCT05002088|560600665|FG001|Overall Study|Protocol Violation|7|||
155318334|NCT04068181|560600666|FG000|Overall Study|Death|17|||
155318335|NCT04068181|560600667|FG001|Overall Study|Death|12|||
155318336|NCT04068181|560600668|FG002|Overall Study|Death|4|||
155318337|NCT04068181|560600669|FG003|Overall Study|Death|7|||
155318338|NCT04068181|560600666|FG000|Overall Study|Lost to Follow-up|1|||
155318339|NCT04068181|560600667|FG001|Overall Study|Lost to Follow-up|0|||
155318340|NCT04068181|560600668|FG002|Overall Study|Lost to Follow-up|0|||
155318341|NCT04068181|560600669|FG003|Overall Study|Lost to Follow-up|0|||
155318342|NCT04068181|560600666|FG000|Overall Study|Withdrawal of consent from study|3|||
155162426|NCT01177397|560031608|FG002|Overall Study|Lost to Follow-up|0|||
155318343|NCT04068181|560600667|FG001|Overall Study|Withdrawal of consent from study|0|||
155318344|NCT04068181|560600668|FG002|Overall Study|Withdrawal of consent from study|0|||
155318345|NCT04068181|560600669|FG003|Overall Study|Withdrawal of consent from study|0|||
155318346|NCT03785964|560600672|FG000|Overall Study|Adverse Event|14|||
155318347|NCT03785964|560600673|FG001|Overall Study|Adverse Event|1|||
155318348|NCT03785964|560600672|FG000|Overall Study|Unqualified Clinical Progression|1|||
155318349|NCT03785964|560600673|FG001|Overall Study|Unqualified Clinical Progression|1|||
155318350|NCT03785964|560600672|FG000|Overall Study|Participant non-compliance|1|||
155318351|NCT03785964|560600673|FG001|Overall Study|Participant non-compliance|1|||
155318352|NCT03785964|560600672|FG000|Overall Study|Not treated|1|||
155318353|NCT03785964|560600673|FG001|Overall Study|Not treated|0|||
155318354|NCT03785964|560600672|FG000|Overall Study|Other reason|5|||
155318355|NCT03785964|560600673|FG001|Overall Study|Other reason|11|||
155318356|NCT03785964|560600672|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
155318357|NCT03785964|560600673|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
155318358|NCT05070728|560600674|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
155318359|NCT05070728|560600675|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
155318360|NCT03924635|560600692|FG000|Overall Study|Withdrawal by Subject|2|||
155318361|NCT03924635|560600693|FG001|Overall Study|Withdrawal by Subject|4|||
155318362|NCT04568434|560600696|FG000|Overall Study|Voluntary Withdrawal|0|||
155318363|NCT04568434|560600697|FG001|Overall Study|Voluntary Withdrawal|1|||
155318364|NCT04568434|560600698|FG002|Overall Study|Voluntary Withdrawal|1|||
155318365|NCT04568434|560600696|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
155318366|NCT04568434|560600697|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
155318367|NCT04568434|560600698|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
155318368|NCT04568434|560600696|FG000|Overall Study|Investigator Judgement|1|||
155318369|NCT04568434|560600697|FG001|Overall Study|Investigator Judgement|0|||
155318370|NCT04568434|560600698|FG002|Overall Study|Investigator Judgement|0|||
155318371|NCT05469464|560600699|FG000|Overall Study|Withdrawal by Subject|8|||
155318372|NCT05469464|560600700|FG001|Overall Study|Withdrawal by Subject|7|||
155318373|NCT05469464|560600701|FG002|Overall Study|Withdrawal by Subject|4|||
155318374|NCT05469464|560600702|FG003|Overall Study|Withdrawal by Subject|5|||
155318375|NCT05469464|560600699|FG000|Overall Study|Adverse Event|8|||
155318376|NCT05469464|560600700|FG001|Overall Study|Adverse Event|14|||
155318377|NCT05469464|560600701|FG002|Overall Study|Adverse Event|13|||
155318378|NCT05469464|560600702|FG003|Overall Study|Adverse Event|2|||
155318379|NCT05469464|560600699|FG000|Overall Study|Lost to Follow-up|2|||
155318380|NCT05469464|560600700|FG001|Overall Study|Lost to Follow-up|5|||
155318381|NCT05469464|560600701|FG002|Overall Study|Lost to Follow-up|3|||
155318382|NCT05469464|560600702|FG003|Overall Study|Lost to Follow-up|3|||
155318383|NCT05469464|560600699|FG000|Overall Study|Lack of Efficacy|4|||
155318384|NCT05469464|560600700|FG001|Overall Study|Lack of Efficacy|1|||
155318385|NCT05469464|560600701|FG002|Overall Study|Lack of Efficacy|2|||
155318386|NCT05469464|560600702|FG003|Overall Study|Lack of Efficacy|2|||
155318387|NCT05469464|560600699|FG000|Overall Study|Physician Decision|0|||
155318388|NCT05469464|560600700|FG001|Overall Study|Physician Decision|0|||
155318389|NCT05469464|560600701|FG002|Overall Study|Physician Decision|0|||
155318390|NCT05469464|560600702|FG003|Overall Study|Physician Decision|1|||
155318391|NCT05374798|560600705|FG000|Overall Study|Lost to Follow-up|2|||
155318392|NCT05374798|560600705|FG000|Overall Study|Withdrawal by Subject|2|||
155318393|NCT05374798|560600705|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
155318394|NCT03463044|560600706|FG000|Overall Study|Lost to Follow-up|0|||
155318395|NCT03463044|560600707|FG001|Overall Study|Lost to Follow-up|0|||
155318396|NCT03463044|560600708|FG002|Overall Study|Lost to Follow-up|0|||
155318397|NCT03463044|560600709|FG003|Overall Study|Lost to Follow-up|0|||
155318398|NCT03463044|560600710|FG004|Overall Study|Lost to Follow-up|0|||
155318399|NCT03463044|560600711|FG005|Overall Study|Lost to Follow-up|0|||
155318400|NCT03463044|560600712|FG006|Overall Study|Lost to Follow-up|0|||
155318401|NCT03463044|560600713|FG007|Overall Study|Lost to Follow-up|1|||
155318402|NCT03463044|560600714|FG008|Overall Study|Lost to Follow-up|0|||
155318403|NCT04471246|560600715|FG000|Overall Study|Lost to Follow-up|2|||
155318404|NCT04471246|560600716|FG001|Overall Study|Lost to Follow-up|2|||
155318405|NCT04079218|560600721|FG000|Overall Study|Death|1|||
155318406|NCT04079218|560600722|FG001|Overall Study|Death|0|||
155318407|NCT04079218|560600721|FG000|Overall Study|Withdrawal by Subject|3|||
155318408|NCT04079218|560600722|FG001|Overall Study|Withdrawal by Subject|0|||
155318409|NCT04079218|560600721|FG000|Overall Study|Physician Decision|4|||
155318410|NCT04079218|560600722|FG001|Overall Study|Physician Decision|0|||
155318411|NCT04079218|560600721|FG000|Overall Study|Lost to Follow-up|0|||
155318412|NCT04079218|560600722|FG001|Overall Study|Lost to Follow-up|1|||
155318413|NCT05093842|560600728|FG000|Overall Study|Pregnancy loss|1|||
155318414|NCT05093842|560600729|FG001|Overall Study|Pregnancy loss|1|||
155318415|NCT05093842|560600728|FG000|Overall Study|Lost to Follow-up|6|||
155318416|NCT05093842|560600729|FG001|Overall Study|Lost to Follow-up|0|||
155318417|NCT05093842|560600728|FG000|Overall Study|Physician Decision|0|||
155318418|NCT05093842|560600729|FG001|Overall Study|Physician Decision|1|||
155318419|NCT03910478|560600735|FG000|Overall Study|Death|13|||
155318420|NCT03910478|560600736|FG001|Overall Study|Death|6|||
155318421|NCT03910478|560600735|FG000|Overall Study|Withdrawal by Subject|23|||
155318422|NCT03910478|560600736|FG001|Overall Study|Withdrawal by Subject|2|||
155318423|NCT03910478|560600735|FG000|Overall Study|Physician Decision|5|||
155318424|NCT03910478|560600736|FG001|Overall Study|Physician Decision|0|||
155318425|NCT03910478|560600735|FG000|Overall Study|Protocol Violation|1|||
155318426|NCT03910478|560600736|FG001|Overall Study|Protocol Violation|0|||
155318427|NCT03910478|560600735|FG000|Overall Study|Failure to meet continuation criteria|2|||
155318428|NCT03910478|560600736|FG001|Overall Study|Failure to meet continuation criteria|0|||
155318429|NCT03910478|560600735|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
155067099|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155067100|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155067101|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155318430|NCT03910478|560600736|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
155318431|NCT03478956|560600738|FG000|Randomized Treatment Period|Adverse Event|1|||
155318432|NCT03478956|560600739|FG001|Randomized Treatment Period|Adverse Event|0|||
155318433|NCT03478956|560600740|FG002|Randomized Treatment Period|Adverse Event|0|||
155318434|NCT03478956|560600741|FG003|Randomized Treatment Period|Adverse Event|0|||
155318435|NCT03478956|560600738|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
155318436|NCT03478956|560600739|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
155318437|NCT03478956|560600740|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
155318438|NCT03478956|560600741|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
155318439|NCT03478956|560600738|FG000|Open Label Extension Period|Adverse Event|0|||
155318440|NCT03478956|560600739|FG001|Open Label Extension Period|Adverse Event|0|||
155318441|NCT03478956|560600740|FG002|Open Label Extension Period|Adverse Event|4|||
155318442|NCT03478956|560600741|FG003|Open Label Extension Period|Adverse Event|0|||
155318443|NCT03478956|560600738|FG000|Open Label Extension Period|Lack of Efficacy|0|||
155318444|NCT03478956|560600739|FG001|Open Label Extension Period|Lack of Efficacy|0|||
155318445|NCT03478956|560600740|FG002|Open Label Extension Period|Lack of Efficacy|8|||
155318446|NCT03478956|560600741|FG003|Open Label Extension Period|Lack of Efficacy|0|||
155318447|NCT03478956|560600738|FG000|Open Label Extension Period|Reason Not Provided|0|||
155318448|NCT03478956|560600739|FG001|Open Label Extension Period|Reason Not Provided|0|||
155318449|NCT03478956|560600740|FG002|Open Label Extension Period|Reason Not Provided|1|||
155318450|NCT03478956|560600741|FG003|Open Label Extension Period|Reason Not Provided|0|||
155318451|NCT03478956|560600738|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
155318452|NCT03478956|560600739|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
155318453|NCT03478956|560600740|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
155318454|NCT03478956|560600741|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
155318455|NCT03478956|560600738|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
155318456|NCT03478956|560600739|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
155318457|NCT03478956|560600740|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
155318458|NCT03478956|560600741|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
155318459|NCT03478956|560600738|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155318460|NCT03478956|560600739|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155318461|NCT03478956|560600740|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
155318462|NCT03478956|560600741|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
155318463|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
155318464|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
155318465|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
155318466|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
155318467|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
155318468|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
155318469|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
155318470|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
155318471|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
155318472|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
155318473|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
155318474|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
155318475|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
155318476|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
155318477|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
155318478|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
155318479|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
155318480|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
155318481|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
155318482|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
155318483|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
155318484|NCT04800211|560600744|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
155318485|NCT04800211|560600745|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
155318486|NCT04800211|560600746|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
155318487|NCT04800211|560600744|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
155318488|NCT04800211|560600745|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
155318489|NCT04800211|560600746|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
155318490|NCT04800211|560600744|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
155318491|NCT04800211|560600745|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
155318492|NCT04800211|560600746|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
155318493|NCT04800211|560600744|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
155318494|NCT04800211|560600745|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
155318495|NCT04800211|560600746|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
155318496|NCT04032847|560600756|FG000|Overall Study|Study termination by sponsor|8|||
155318497|NCT04032847|560600757|FG001|Overall Study|Study termination by sponsor|0|||
155318498|NCT04032847|560600758|FG002|Overall Study|Study termination by sponsor|4|||
155318499|NCT04032847|560600756|FG000|Overall Study|Death|12|||
155318500|NCT04032847|560600757|FG001|Overall Study|Death|0|||
155318501|NCT04032847|560600758|FG002|Overall Study|Death|0|||
155318502|NCT04032847|560600756|FG000|Overall Study|Progressive disease|2|||
155318503|NCT04032847|560600757|FG001|Overall Study|Progressive disease|0|||
155318504|NCT04032847|560600758|FG002|Overall Study|Progressive disease|1|||
155318505|NCT03056573|560600759|FG000|Overall Study|Death|2|||
155318506|NCT03056573|560600760|FG001|Overall Study|Death|4|||
155318507|NCT03056573|560600759|FG000|Overall Study|Withdrawal by Subject|2|||
155318508|NCT03056573|560600760|FG001|Overall Study|Withdrawal by Subject|0|||
155318509|NCT03056573|560600759|FG000|Overall Study|Lost to Follow-up|1|||
155318510|NCT03056573|560600760|FG001|Overall Study|Lost to Follow-up|1|||
155318511|NCT03668236|560602974|FG000|90-day Follow-up|Withdrawal by Subject|3|||
155318512|NCT03668236|560602975|FG001|90-day Follow-up|Withdrawal by Subject|2|||
155318513|NCT03668236|560602974|FG000|90-day Follow-up|Lost to Follow-up|3|||
155318514|NCT03668236|560602975|FG001|90-day Follow-up|Lost to Follow-up|1|||
155318515|NCT03668236|560602974|FG000|Baseline Characteristics|Lost to Follow-up|9|||
155318516|NCT03668236|560602975|FG001|Baseline Characteristics|Lost to Follow-up|5|||
155318517|NCT03668236|560602974|FG000|1-year Follow-up|Withdrawal by Subject|17|||
155318518|NCT03668236|560602975|FG001|1-year Follow-up|Withdrawal by Subject|15|||
155318519|NCT06132282|560602976|FG000|Overall Study|Lost to Follow-up|31|||
155318520|NCT03748953|560602980|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
155318521|NCT03748953|560602981|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
155318522|NCT03748953|560602980|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
155318523|NCT03748953|560602981|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
155318524|NCT03748953|560602980|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
155318525|NCT03748953|560602981|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
155318526|NCT03748953|560602980|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
155318527|NCT03748953|560602981|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
155318528|NCT03748953|560602980|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
155318529|NCT03748953|560602981|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
155318530|NCT04858451|560602982|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
155318531|NCT04858451|560602983|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318532|NCT04858451|560602984|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318533|NCT04858451|560602985|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318534|NCT04858451|560602986|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318535|NCT04858451|560602987|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318536|NCT04858451|560602988|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318537|NCT04858451|560602989|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318538|NCT04858451|560602990|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
155318539|NCT04858451|560602982|FG000|Part 2|Discontinued|0|||
155318540|NCT04858451|560602983|FG001|Part 2|Discontinued|0|||
155318541|NCT04858451|560602984|FG002|Part 2|Discontinued|0|||
155318542|NCT04858451|560602985|FG003|Part 2|Discontinued|0|||
155318543|NCT04858451|560602986|FG004|Part 2|Discontinued|0|||
155318544|NCT04858451|560602987|FG005|Part 2|Discontinued|0|||
155318545|NCT04858451|560602988|FG006|Part 2|Discontinued|0|||
155318546|NCT04858451|560602989|FG007|Part 2|Discontinued|0|||
155318547|NCT04858451|560602990|FG008|Part 2|Discontinued|63|||
155318548|NCT03314454|560602991|FG000|Overall Study|Protocol Violation|1|||
155318549|NCT02841579|560603000|FG000|Overall Study|Death|1|||
155318550|NCT02841579|560603000|FG000|Overall Study|Adverse Event|1|||
155318551|NCT02841579|560603000|FG000|Overall Study|Lack of Efficacy|9|||
155318552|NCT03011333|560603003|FG000|Overall Study|Lost to Follow-up|0|||
155318553|NCT03011333|560603004|FG001|Overall Study|Lost to Follow-up|1|||
155318554|NCT03011333|560603005|FG002|Overall Study|Lost to Follow-up|0|||
155318555|NCT03011333|560603006|FG003|Overall Study|Lost to Follow-up|1|||
155318556|NCT03011333|560603007|FG004|Overall Study|Lost to Follow-up|4|||
155318557|NCT03011333|560603008|FG005|Overall Study|Lost to Follow-up|4|||
155318558|NCT03011333|560603009|FG006|Overall Study|Lost to Follow-up|5|||
155318559|NCT04233216|560603010|FG000|Overall Study|Lost to Follow-up|1|||
155318560|NCT04233216|560603011|FG001|Overall Study|Lost to Follow-up|0|||
155318561|NCT04233216|560603012|FG002|Overall Study|Lost to Follow-up|2|||
155318562|NCT04233216|560603013|FG003|Overall Study|Lost to Follow-up|0|||
155318563|NCT04233216|560603010|FG000|Overall Study|Physician Decision|0|||
155318564|NCT04233216|560603011|FG001|Overall Study|Physician Decision|3|||
155318565|NCT04233216|560603012|FG002|Overall Study|Physician Decision|0|||
155318566|NCT04233216|560603013|FG003|Overall Study|Physician Decision|2|||
155318567|NCT04233216|560603010|FG000|Overall Study|Withdrawal by Subject|0|||
155318568|NCT04233216|560603011|FG001|Overall Study|Withdrawal by Subject|2|||
155318569|NCT04233216|560603012|FG002|Overall Study|Withdrawal by Subject|1|||
155318570|NCT04233216|560603013|FG003|Overall Study|Withdrawal by Subject|0|||
155318571|NCT02998268|560603014|FG000|Overall Study|Adverse Event|0|||
155318572|NCT02998268|560603015|FG001|Overall Study|Adverse Event|2|||
155318573|NCT02998268|560603014|FG000|Overall Study|Withdrawal by Subject|0|||
155318574|NCT02998268|560603015|FG001|Overall Study|Withdrawal by Subject|1|||
155318575|NCT03252847|560603016|FG000|Overall Study|Withdrawal by Subject|0|||
155318576|NCT03252847|560603017|FG001|Overall Study|Withdrawal by Subject|0|||
155318577|NCT03252847|560603018|FG002|Overall Study|Withdrawal by Subject|1|||
155318578|NCT03252847|560603019|FG003|Overall Study|Withdrawal by Subject|0|||
155318579|NCT03252847|560603020|FG004|Overall Study|Withdrawal by Subject|0|||
155318580|NCT03252847|560603021|FG005|Overall Study|Withdrawal by Subject|0|||
155318581|NCT03252847|560603022|FG006|Overall Study|Withdrawal by Subject|0|||
155318582|NCT03252847|560603016|FG000|Overall Study|Other: Patient decision|0|||
155318583|NCT03252847|560603017|FG001|Overall Study|Other: Patient decision|0|||
155318584|NCT03252847|560603018|FG002|Overall Study|Other: Patient decision|0|||
155318585|NCT03252847|560603019|FG003|Overall Study|Other: Patient decision|0|||
155318586|NCT03252847|560603020|FG004|Overall Study|Other: Patient decision|1|||
155318587|NCT03252847|560603021|FG005|Overall Study|Other: Patient decision|0|||
155318588|NCT03252847|560603022|FG006|Overall Study|Other: Patient decision|0|||
155318589|NCT04298983|560603025|FG000|Overall Study|Adverse Event|4|||
155318590|NCT04298983|560603025|FG000|Overall Study|Lack of Efficacy|3|||
155318591|NCT02723591|560603028|FG000|Overall Study|Adverse Event|48|||
155318592|NCT02723591|560603029|FG001|Overall Study|Adverse Event|40|||
155318593|NCT02723591|560603028|FG000|Overall Study|Death|2|||
155318594|NCT02723591|560603029|FG001|Overall Study|Death|2|||
155318595|NCT02723591|560603028|FG000|Overall Study|Lack of Efficacy|4|||
155318596|NCT02723591|560603029|FG001|Overall Study|Lack of Efficacy|3|||
155318597|NCT02723591|560603028|FG000|Overall Study|Lost to Follow-up|1|||
155318598|NCT02723591|560603029|FG001|Overall Study|Lost to Follow-up|7|||
155318599|NCT02723591|560603028|FG000|Overall Study|Protocol Violation|20|||
155318600|NCT02723591|560603029|FG001|Overall Study|Protocol Violation|23|||
155318601|NCT02723591|560603028|FG000|Overall Study|Withdrawal by Subject|4|||
155318602|NCT02723591|560603029|FG001|Overall Study|Withdrawal by Subject|8|||
155318603|NCT02723591|560603028|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
155318604|NCT02723591|560603029|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
155318605|NCT02723591|560603028|FG000|Overall Study|Miscellaneous|5|||
155318606|NCT02723591|560603029|FG001|Overall Study|Miscellaneous|6|||
155318607|NCT04770402|560603030|FG000|Overall Study|Lost to Follow-up|1|||
155318608|NCT04770402|560603031|FG001|Overall Study|Lost to Follow-up|2|||
155318609|NCT04770402|560603030|FG000|Overall Study|Non-compliance|1|||
155318610|NCT04770402|560603031|FG001|Overall Study|Non-compliance|0|||
155318611|NCT04770402|560603030|FG000|Overall Study|Withdrawal by Subject|0|||
155318612|NCT04770402|560603031|FG001|Overall Study|Withdrawal by Subject|1|||
155318613|NCT02589795|560603032|FG000|Overall Study|Lost to Follow-up|1|||
155318614|NCT02589795|560603033|FG001|Overall Study|Lost to Follow-up|0|||
155318615|NCT02589795|560603034|FG002|Overall Study|Lost to Follow-up|0|||
155318616|NCT02589795|560603032|FG000|Overall Study|Withdrawal by Subject|0|||
155318617|NCT02589795|560603033|FG001|Overall Study|Withdrawal by Subject|0|||
155318618|NCT02589795|560603034|FG002|Overall Study|Withdrawal by Subject|2|||
155318619|NCT02589795|560603032|FG000|Overall Study|Protocol Violation|0|||
155318620|NCT02589795|560603033|FG001|Overall Study|Protocol Violation|0|||
155318621|NCT02589795|560603034|FG002|Overall Study|Protocol Violation|1|||
155318622|NCT03599661|560603036|FG000|Overall Study|Lost to Follow-up|9|||
155318623|NCT04811040|560603037|FG000|Overall Study|Lost to Follow-up|2|||
155318624|NCT04811040|560603038|FG001|Overall Study|Lost to Follow-up|0|||
155318625|NCT04811040|560603039|FG002|Overall Study|Lost to Follow-up|0|||
155318626|NCT04811040|560603040|FG003|Overall Study|Lost to Follow-up|0|||
155318627|NCT04811040|560603037|FG000|Overall Study|Withdrew consent|1|||
155318628|NCT04811040|560603038|FG001|Overall Study|Withdrew consent|1|||
155318629|NCT04811040|560603039|FG002|Overall Study|Withdrew consent|0|||
155318630|NCT04811040|560603040|FG003|Overall Study|Withdrew consent|0|||
155318631|NCT01828099|560603041|FG000|Treatment Period|Adverse Event|24|||
155318632|NCT01828099|560603042|FG001|Treatment Period|Adverse Event|23|||
155318633|NCT01828099|560603041|FG000|Treatment Period|Death|10|||
155318634|NCT01828099|560603042|FG001|Treatment Period|Death|12|||
155318635|NCT01828099|560603041|FG000|Treatment Period|Lost to Follow-up|2|||
155318636|NCT01828099|560603042|FG001|Treatment Period|Lost to Follow-up|1|||
155318637|NCT01828099|560603041|FG000|Treatment Period|Non-compliance with study treatment|1|||
155318638|NCT01828099|560603042|FG001|Treatment Period|Non-compliance with study treatment|0|||
155318639|NCT01828099|560603041|FG000|Treatment Period|Physician Decision|17|||
155318640|NCT01828099|560603042|FG001|Treatment Period|Physician Decision|16|||
155318641|NCT01828099|560603041|FG000|Treatment Period|Progressive disease|99|||
155318642|NCT01828099|560603042|FG001|Treatment Period|Progressive disease|107|||
155318643|NCT01828099|560603041|FG000|Treatment Period|Subject/guardian decision|22|||
155318644|NCT01828099|560603042|FG001|Treatment Period|Subject/guardian decision|26|||
155318645|NCT01828099|560603041|FG000|Treatment Period|Study terminated by Sponsor|13|||
155318646|NCT01828099|560603042|FG001|Treatment Period|Study terminated by Sponsor|1|||
155318647|NCT01828099|560603041|FG000|Treatment Period|Protocol deviation|1|||
155318648|NCT01828099|560603042|FG001|Treatment Period|Protocol deviation|0|||
155318649|NCT01828099|560603041|FG000|Treatment Period|No longer requires treatment|0|||
155318650|NCT01828099|560603042|FG001|Treatment Period|No longer requires treatment|1|||
155318651|NCT01828099|560603041|FG000|Extension-treatment Phase|Adverse Event|0|||
155318652|NCT01828099|560603042|FG001|Extension-treatment Phase|Adverse Event|17|||
155318653|NCT01828099|560603041|FG000|Extension-treatment Phase|Death|0|||
155318654|NCT01828099|560603042|FG001|Extension-treatment Phase|Death|11|||
155318655|NCT01828099|560603041|FG000|Extension-treatment Phase|Physician Decision|0|||
155318656|NCT01828099|560603042|FG001|Extension-treatment Phase|Physician Decision|5|||
155318657|NCT01828099|560603041|FG000|Extension-treatment Phase|Progressive disease|0|||
155318658|NCT01828099|560603042|FG001|Extension-treatment Phase|Progressive disease|54|||
155318659|NCT01828099|560603041|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
155318660|NCT01828099|560603042|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
155318661|NCT01828099|560603041|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
155318662|NCT01828099|560603042|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
155318663|NCT05934942|560603044|FG000|Run-in Period|Not treated|1|||
155318664|NCT05934942|560603044|FG000|Run-in Period|Withdrawal by Subject|1|||
155318665|NCT05645757|560603045|FG000|Overall Study|Enrolled but treatment not administered|0|||
155318666|NCT05645757|560603046|FG001|Overall Study|Enrolled but treatment not administered|0|||
155318667|NCT05645757|560603047|FG002|Overall Study|Enrolled but treatment not administered|0|||
155318668|NCT05645757|560603048|FG003|Overall Study|Enrolled but treatment not administered|0|||
155318669|NCT05645757|560603049|FG004|Overall Study|Enrolled but treatment not administered|1|||
155162427|NCT01177397|560031609|FG003|Overall Study|Lost to Follow-up|0|||
155162428|NCT01177397|560031610|FG004|Overall Study|Lost to Follow-up|1|||
155162429|NCT01177397|560031611|FG005|Overall Study|Lost to Follow-up|0|||
155162430|NCT01177397|560031612|FG006|Overall Study|Lost to Follow-up|0|||
155318670|NCT05645757|560603050|FG005|Overall Study|Enrolled but treatment not administered|1|||
155162431|NCT01177397|560031613|FG007|Overall Study|Lost to Follow-up|2|||
155162432|NCT01177397|560031614|FG008|Overall Study|Lost to Follow-up|0|||
155318671|NCT05645757|560603051|FG006|Overall Study|Enrolled but treatment not administered|0|||
155318672|NCT05645757|560603052|FG007|Overall Study|Enrolled but treatment not administered|0|||
155318673|NCT03905798|560603053|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
155318674|NCT04826471|560603054|FG000|Overall Study|Lost to Follow-up|2|||
155318675|NCT04826471|560603054|FG000|Overall Study|Protocol Violation|3|||
155318676|NCT04826471|560603054|FG000|Overall Study|Withdrawal by Subject|1|||
155318677|NCT05764525|560603055|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
155318678|NCT05764525|560603056|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
155318679|NCT05764525|560603055|FG000|Overall Study|Withdrawal by Subject|4|||
155318680|NCT05764525|560603056|FG001|Overall Study|Withdrawal by Subject|8|||
155318681|NCT05764525|560603055|FG000|Overall Study|Physician Decision|1|||
155318682|NCT05764525|560603056|FG001|Overall Study|Physician Decision|0|||
155318683|NCT03334630|560603057|FG000|Overall Study|Withdrawal by Subject|7|||
155318684|NCT03334630|560603058|FG001|Overall Study|Withdrawal by Subject|7|||
155318685|NCT03334630|560603057|FG000|Overall Study|Lost to Follow-up|3|||
155318686|NCT03334630|560603058|FG001|Overall Study|Lost to Follow-up|1|||
155318687|NCT03334630|560603057|FG000|Overall Study|Adverse Event|0|||
155318688|NCT03334630|560603058|FG001|Overall Study|Adverse Event|1|||
155318689|NCT03334630|560603057|FG000|Overall Study|Physician Decision|1|||
155318690|NCT03334630|560603058|FG001|Overall Study|Physician Decision|1|||
155318691|NCT03334630|560603057|FG000|Overall Study|Enrollment closed|2|||
155162433|NCT01177397|560031615|FG009|Overall Study|Lost to Follow-up|0|||
155318692|NCT03334630|560603058|FG001|Overall Study|Enrollment closed|1|||
155318693|NCT03334630|560603057|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
155318694|NCT03334630|560603058|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
155318695|NCT03334630|560603057|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
155318696|NCT03334630|560603058|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
155318697|NCT05907174|560603059|FG000|3-Month Assessment|Withdrawal by Subject|0|||
155318698|NCT05907174|560603060|FG001|3-Month Assessment|Withdrawal by Subject|0|||
155318699|NCT05907174|560603061|FG002|3-Month Assessment|Withdrawal by Subject|0|||
155318700|NCT05907174|560603062|FG003|3-Month Assessment|Withdrawal by Subject|1|||
155318701|NCT05907174|560603059|FG000|3-Month Assessment|Lost to Follow-up|1|||
155318702|NCT05907174|560603060|FG001|3-Month Assessment|Lost to Follow-up|1|||
155318703|NCT05907174|560603061|FG002|3-Month Assessment|Lost to Follow-up|1|||
155318704|NCT05907174|560603062|FG003|3-Month Assessment|Lost to Follow-up|1|||
155318705|NCT05907174|560603059|FG000|6-Month Assessment|Death|0|||
155318706|NCT05907174|560603060|FG001|6-Month Assessment|Death|0|||
155318707|NCT05907174|560603061|FG002|6-Month Assessment|Death|3|||
155318708|NCT05907174|560603062|FG003|6-Month Assessment|Death|0|||
155318709|NCT05907174|560603059|FG000|6-Month Assessment|Withdrawal by Subject|0|||
155318710|NCT05907174|560603060|FG001|6-Month Assessment|Withdrawal by Subject|0|||
155318711|NCT05907174|560603061|FG002|6-Month Assessment|Withdrawal by Subject|1|||
155318712|NCT05907174|560603062|FG003|6-Month Assessment|Withdrawal by Subject|1|||
155318713|NCT05907174|560603059|FG000|6-Month Assessment|Lost to Follow-up|0|||
155318714|NCT05907174|560603060|FG001|6-Month Assessment|Lost to Follow-up|1|||
155318715|NCT05907174|560603061|FG002|6-Month Assessment|Lost to Follow-up|1|||
155318716|NCT05907174|560603062|FG003|6-Month Assessment|Lost to Follow-up|1|||
155318717|NCT04498390|560603063|FG000|Overall Study|Adverse Event|0|||
155318718|NCT04498390|560603064|FG001|Overall Study|Adverse Event|0|||
155318719|NCT04498390|560603065|FG002|Overall Study|Adverse Event|1|||
155318720|NCT04498390|560603066|FG003|Overall Study|Adverse Event|0|||
155318721|NCT04498390|560603067|FG004|Overall Study|Adverse Event|0|||
155318722|NCT04498390|560603063|FG000|Overall Study|Withdrawal by Subject|0|||
155318723|NCT04498390|560603064|FG001|Overall Study|Withdrawal by Subject|0|||
155318724|NCT04498390|560603065|FG002|Overall Study|Withdrawal by Subject|0|||
155318725|NCT04498390|560603066|FG003|Overall Study|Withdrawal by Subject|1|||
155318726|NCT04498390|560603067|FG004|Overall Study|Withdrawal by Subject|0|||
155318727|NCT01275677|560603077|FG000|Overall Study|Not at risk for recurrence.|1|||
155318728|NCT01275677|560603078|FG001|Overall Study|Not at risk for recurrence.|1|||
155318729|NCT01275677|560603077|FG000|Overall Study|No follow-up|26|||
155318730|NCT01275677|560603078|FG001|Overall Study|No follow-up|37|||
155318731|NCT01275677|560603077|FG000|Overall Study|No clinical follow up.|1|||
155318732|NCT01275677|560603078|FG001|Overall Study|No clinical follow up.|4|||
155318733|NCT03734679|560603086|FG000|Overall Study|Missed Visit|1|||
155318734|NCT02733159|560603091|FG000|Overall Study|Adverse Event|1|||
155318735|NCT02733159|560603091|FG000|Overall Study|Lack of disease progression|1|||
155318736|NCT03088878|560603101|FG000|Overall Study|Adverse Event|0|||
155318737|NCT03088878|560603102|FG001|Overall Study|Adverse Event|0|||
155318738|NCT03088878|560603103|FG002|Overall Study|Adverse Event|0|||
155318739|NCT03088878|560603104|FG003|Overall Study|Adverse Event|0|||
155318740|NCT03088878|560603105|FG004|Overall Study|Adverse Event|4|||
155318741|NCT03088878|560603106|FG005|Overall Study|Adverse Event|2|||
154960093|NCT01518972|559278698|FG000|Overall Study|Exclusionary medication|0|||
154960094|NCT01518972|559278699|FG001|Overall Study|Exclusionary medication|1|||
154960095|NCT01518972|559278698|FG000|Overall Study|Declined medication starting on day 12|0|||
154960096|NCT01518972|559278699|FG001|Overall Study|Declined medication starting on day 12|1|||
155318742|NCT03088878|560603107|FG006|Overall Study|Adverse Event|1|||
155318743|NCT03088878|560603108|FG007|Overall Study|Adverse Event|0|||
155318744|NCT03088878|560603109|FG008|Overall Study|Adverse Event|0|||
155318745|NCT03088878|560603110|FG009|Overall Study|Adverse Event|0|||
155318746|NCT03088878|560603111|FG010|Overall Study|Adverse Event|0|||
155318747|NCT03088878|560603112|FG011|Overall Study|Adverse Event|0|||
155318748|NCT03088878|560603113|FG012|Overall Study|Adverse Event|5|||
155318749|NCT03088878|560603114|FG013|Overall Study|Adverse Event|3|||
154960097|NCT01294917|559278702|FG000|Overall Study|Relocation|5|||
154960098|NCT01294917|559278702|FG000|Overall Study|Inconvenience|1|||
154960099|NCT02159950|559278706|FG000|Overall Study|Adverse Event|0|||
154960100|NCT02159950|559278707|FG001|Overall Study|Adverse Event|1|||
154960101|NCT02159950|559278706|FG000|Overall Study|Progression|0|||
154960102|NCT02159950|559278707|FG001|Overall Study|Progression|1|||
155318750|NCT03088878|560603101|FG000|Overall Study|Clinical Progression|0|||
155318751|NCT03088878|560603102|FG001|Overall Study|Clinical Progression|0|||
155318752|NCT03088878|560603103|FG002|Overall Study|Clinical Progression|0|||
155318753|NCT03088878|560603104|FG003|Overall Study|Clinical Progression|0|||
155318754|NCT03088878|560603105|FG004|Overall Study|Clinical Progression|2|||
155318755|NCT03088878|560603106|FG005|Overall Study|Clinical Progression|0|||
155318756|NCT03088878|560603107|FG006|Overall Study|Clinical Progression|0|||
155318757|NCT03088878|560603108|FG007|Overall Study|Clinical Progression|0|||
155318758|NCT03088878|560603109|FG008|Overall Study|Clinical Progression|0|||
155318759|NCT03088878|560603110|FG009|Overall Study|Clinical Progression|0|||
155318760|NCT03088878|560603111|FG010|Overall Study|Clinical Progression|0|||
155318761|NCT03088878|560603112|FG011|Overall Study|Clinical Progression|0|||
155318762|NCT03088878|560603113|FG012|Overall Study|Clinical Progression|0|||
155318763|NCT03088878|560603114|FG013|Overall Study|Clinical Progression|0|||
155318764|NCT03088878|560603101|FG000|Overall Study|Death|0|||
155318765|NCT03088878|560603102|FG001|Overall Study|Death|0|||
155318766|NCT03088878|560603103|FG002|Overall Study|Death|0|||
155318767|NCT03088878|560603104|FG003|Overall Study|Death|0|||
155318768|NCT03088878|560603105|FG004|Overall Study|Death|2|||
155318769|NCT03088878|560603106|FG005|Overall Study|Death|0|||
155318770|NCT03088878|560603107|FG006|Overall Study|Death|0|||
155318771|NCT03088878|560603108|FG007|Overall Study|Death|0|||
155318772|NCT03088878|560603109|FG008|Overall Study|Death|0|||
155318773|NCT03088878|560603110|FG009|Overall Study|Death|0|||
155318774|NCT03088878|560603111|FG010|Overall Study|Death|0|||
155318775|NCT03088878|560603112|FG011|Overall Study|Death|1|||
155318776|NCT03088878|560603113|FG012|Overall Study|Death|0|||
155318777|NCT03088878|560603114|FG013|Overall Study|Death|0|||
155318778|NCT03088878|560603101|FG000|Overall Study|Disease Progression|1|||
155318779|NCT03088878|560603102|FG001|Overall Study|Disease Progression|2|||
155318780|NCT03088878|560603103|FG002|Overall Study|Disease Progression|3|||
155318781|NCT03088878|560603104|FG003|Overall Study|Disease Progression|0|||
155318782|NCT03088878|560603105|FG004|Overall Study|Disease Progression|3|||
155318783|NCT03088878|560603106|FG005|Overall Study|Disease Progression|0|||
155318784|NCT03088878|560603107|FG006|Overall Study|Disease Progression|0|||
155318785|NCT03088878|560603108|FG007|Overall Study|Disease Progression|0|||
155318786|NCT03088878|560603109|FG008|Overall Study|Disease Progression|0|||
155318787|NCT03088878|560603110|FG009|Overall Study|Disease Progression|0|||
155318788|NCT03088878|560603111|FG010|Overall Study|Disease Progression|0|||
155318789|NCT03088878|560603112|FG011|Overall Study|Disease Progression|0|||
155318790|NCT03088878|560603113|FG012|Overall Study|Disease Progression|1|||
155318791|NCT03088878|560603114|FG013|Overall Study|Disease Progression|1|||
155318792|NCT03088878|560603101|FG000|Overall Study|Initiation of Alternative Treatment|0|||
155318793|NCT03088878|560603102|FG001|Overall Study|Initiation of Alternative Treatment|0|||
155318794|NCT03088878|560603103|FG002|Overall Study|Initiation of Alternative Treatment|0|||
155318795|NCT03088878|560603104|FG003|Overall Study|Initiation of Alternative Treatment|1|||
155318796|NCT03088878|560603105|FG004|Overall Study|Initiation of Alternative Treatment|0|||
155318797|NCT03088878|560603106|FG005|Overall Study|Initiation of Alternative Treatment|0|||
155318798|NCT03088878|560603107|FG006|Overall Study|Initiation of Alternative Treatment|0|||
154960103|NCT03285594|559278711|FG000|Overall Study|At the Participant's Own Request|10|||
154960104|NCT03285594|559278712|FG001|Overall Study|At the Participant's Own Request|5|||
154960105|NCT03285594|559278713|FG002|Overall Study|At the Participant's Own Request|21|||
154960106|NCT03285594|559278711|FG000|Overall Study|Adverse Event|2|||
154960107|NCT03285594|559278712|FG001|Overall Study|Adverse Event|2|||
154960108|NCT03285594|559278713|FG002|Overall Study|Adverse Event|6|||
154960109|NCT03285594|559278711|FG000|Overall Study|Poor Compliance to Protocol|0|||
154960110|NCT03285594|559278712|FG001|Overall Study|Poor Compliance to Protocol|0|||
155318799|NCT03088878|560603108|FG007|Overall Study|Initiation of Alternative Treatment|1|||
155318800|NCT03088878|560603109|FG008|Overall Study|Initiation of Alternative Treatment|1|||
155318801|NCT03088878|560603110|FG009|Overall Study|Initiation of Alternative Treatment|0|||
155318802|NCT03088878|560603111|FG010|Overall Study|Initiation of Alternative Treatment|0|||
154960111|NCT03285594|559278713|FG002|Overall Study|Poor Compliance to Protocol|1|||
154960112|NCT03285594|559278711|FG000|Overall Study|Lost to Follow-up|0|||
154960113|NCT03285594|559278712|FG001|Overall Study|Lost to Follow-up|0|||
154960114|NCT03285594|559278713|FG002|Overall Study|Lost to Follow-up|1|||
155318803|NCT03088878|560603112|FG011|Overall Study|Initiation of Alternative Treatment|0|||
155318804|NCT03088878|560603113|FG012|Overall Study|Initiation of Alternative Treatment|0|||
155318805|NCT03088878|560603114|FG013|Overall Study|Initiation of Alternative Treatment|0|||
155318806|NCT03088878|560603101|FG000|Overall Study|Withdrawal by Subject|0|||
155318807|NCT03088878|560603102|FG001|Overall Study|Withdrawal by Subject|0|||
155318808|NCT03088878|560603103|FG002|Overall Study|Withdrawal by Subject|0|||
155318809|NCT03088878|560603104|FG003|Overall Study|Withdrawal by Subject|1|||
155318810|NCT03088878|560603105|FG004|Overall Study|Withdrawal by Subject|4|||
155318811|NCT03088878|560603106|FG005|Overall Study|Withdrawal by Subject|1|||
155318812|NCT03088878|560603107|FG006|Overall Study|Withdrawal by Subject|1|||
155318813|NCT03088878|560603108|FG007|Overall Study|Withdrawal by Subject|0|||
155318814|NCT03088878|560603109|FG008|Overall Study|Withdrawal by Subject|1|||
155318815|NCT03088878|560603110|FG009|Overall Study|Withdrawal by Subject|2|||
155318816|NCT03088878|560603111|FG010|Overall Study|Withdrawal by Subject|0|||
155318817|NCT03088878|560603112|FG011|Overall Study|Withdrawal by Subject|2|||
155318818|NCT03088878|560603113|FG012|Overall Study|Withdrawal by Subject|1|||
155318819|NCT03088878|560603114|FG013|Overall Study|Withdrawal by Subject|0|||
155318820|NCT03088878|560603101|FG000|Overall Study|Terminated by Sponsor|2|||
155318821|NCT03088878|560603102|FG001|Overall Study|Terminated by Sponsor|1|||
155318822|NCT03088878|560603103|FG002|Overall Study|Terminated by Sponsor|0|||
155318823|NCT03088878|560603104|FG003|Overall Study|Terminated by Sponsor|1|||
155318824|NCT03088878|560603105|FG004|Overall Study|Terminated by Sponsor|6|||
155318825|NCT03088878|560603106|FG005|Overall Study|Terminated by Sponsor|0|||
155318826|NCT03088878|560603107|FG006|Overall Study|Terminated by Sponsor|0|||
155318827|NCT03088878|560603108|FG007|Overall Study|Terminated by Sponsor|0|||
155318828|NCT03088878|560603109|FG008|Overall Study|Terminated by Sponsor|0|||
155318829|NCT03088878|560603110|FG009|Overall Study|Terminated by Sponsor|0|||
155318830|NCT03088878|560603111|FG010|Overall Study|Terminated by Sponsor|3|||
155318831|NCT03088878|560603112|FG011|Overall Study|Terminated by Sponsor|13|||
155318832|NCT03088878|560603113|FG012|Overall Study|Terminated by Sponsor|2|||
155318833|NCT03088878|560603114|FG013|Overall Study|Terminated by Sponsor|1|||
155318834|NCT03088878|560603101|FG000|Overall Study|Completed 2 years of Treatment|0|||
155318835|NCT03088878|560603102|FG001|Overall Study|Completed 2 years of Treatment|0|||
155318836|NCT03088878|560603103|FG002|Overall Study|Completed 2 years of Treatment|0|||
155318837|NCT03088878|560603104|FG003|Overall Study|Completed 2 years of Treatment|0|||
155318838|NCT03088878|560603105|FG004|Overall Study|Completed 2 years of Treatment|0|||
155318839|NCT03088878|560603106|FG005|Overall Study|Completed 2 years of Treatment|0|||
155318840|NCT03088878|560603107|FG006|Overall Study|Completed 2 years of Treatment|1|||
155318841|NCT03088878|560603108|FG007|Overall Study|Completed 2 years of Treatment|0|||
155318842|NCT03088878|560603109|FG008|Overall Study|Completed 2 years of Treatment|0|||
155318843|NCT03088878|560603110|FG009|Overall Study|Completed 2 years of Treatment|1|||
155318844|NCT03088878|560603111|FG010|Overall Study|Completed 2 years of Treatment|0|||
155318845|NCT03088878|560603112|FG011|Overall Study|Completed 2 years of Treatment|0|||
155318846|NCT03088878|560603113|FG012|Overall Study|Completed 2 years of Treatment|8|||
155318847|NCT03088878|560603114|FG013|Overall Study|Completed 2 years of Treatment|3|||
155318848|NCT03088878|560603101|FG000|Overall Study|Physician Decision|0|||
155318849|NCT03088878|560603102|FG001|Overall Study|Physician Decision|0|||
155318850|NCT03088878|560603103|FG002|Overall Study|Physician Decision|0|||
155318851|NCT03088878|560603104|FG003|Overall Study|Physician Decision|0|||
155318852|NCT03088878|560603105|FG004|Overall Study|Physician Decision|0|||
155318853|NCT03088878|560603106|FG005|Overall Study|Physician Decision|0|||
155318854|NCT03088878|560603107|FG006|Overall Study|Physician Decision|0|||
155318855|NCT03088878|560603108|FG007|Overall Study|Physician Decision|2|||
155318856|NCT03088878|560603109|FG008|Overall Study|Physician Decision|1|||
155318857|NCT03088878|560603110|FG009|Overall Study|Physician Decision|0|||
155318858|NCT03088878|560603111|FG010|Overall Study|Physician Decision|0|||
155318859|NCT03088878|560603112|FG011|Overall Study|Physician Decision|0|||
155318860|NCT03088878|560603113|FG012|Overall Study|Physician Decision|0|||
155318861|NCT03088878|560603114|FG013|Overall Study|Physician Decision|1|||
155318862|NCT03088878|560603101|FG000|Overall Study|COVID Related noncompliance|0|||
155318863|NCT03088878|560603102|FG001|Overall Study|COVID Related noncompliance|0|||
155318864|NCT03088878|560603103|FG002|Overall Study|COVID Related noncompliance|0|||
155318865|NCT03088878|560603104|FG003|Overall Study|COVID Related noncompliance|0|||
155318866|NCT03088878|560603105|FG004|Overall Study|COVID Related noncompliance|0|||
155318867|NCT03088878|560603106|FG005|Overall Study|COVID Related noncompliance|0|||
155318868|NCT03088878|560603107|FG006|Overall Study|COVID Related noncompliance|0|||
155318869|NCT03088878|560603108|FG007|Overall Study|COVID Related noncompliance|0|||
155318870|NCT03088878|560603109|FG008|Overall Study|COVID Related noncompliance|0|||
155318871|NCT03088878|560603110|FG009|Overall Study|COVID Related noncompliance|0|||
155318872|NCT03088878|560603111|FG010|Overall Study|COVID Related noncompliance|0|||
155318873|NCT03088878|560603112|FG011|Overall Study|COVID Related noncompliance|0|||
155318874|NCT03088878|560603113|FG012|Overall Study|COVID Related noncompliance|0|||
155318875|NCT03088878|560603114|FG013|Overall Study|COVID Related noncompliance|1|||
155318876|NCT03088878|560603101|FG000|Overall Study|Drug or Study Noncompliance|0|||
155318877|NCT03088878|560603102|FG001|Overall Study|Drug or Study Noncompliance|0|||
155318878|NCT03088878|560603103|FG002|Overall Study|Drug or Study Noncompliance|0|||
155318879|NCT03088878|560603104|FG003|Overall Study|Drug or Study Noncompliance|0|||
155318880|NCT03088878|560603105|FG004|Overall Study|Drug or Study Noncompliance|0|||
155318881|NCT03088878|560603106|FG005|Overall Study|Drug or Study Noncompliance|0|||
155318882|NCT03088878|560603107|FG006|Overall Study|Drug or Study Noncompliance|0|||
155318883|NCT03088878|560603108|FG007|Overall Study|Drug or Study Noncompliance|0|||
155318884|NCT03088878|560603109|FG008|Overall Study|Drug or Study Noncompliance|0|||
155318885|NCT03088878|560603110|FG009|Overall Study|Drug or Study Noncompliance|0|||
155318886|NCT03088878|560603111|FG010|Overall Study|Drug or Study Noncompliance|0|||
155318887|NCT03088878|560603112|FG011|Overall Study|Drug or Study Noncompliance|0|||
155318888|NCT03088878|560603113|FG012|Overall Study|Drug or Study Noncompliance|1|||
155318889|NCT03088878|560603114|FG013|Overall Study|Drug or Study Noncompliance|0|||
155318890|NCT04690582|560603115|FG000|Overall Study|Withdrawal by Subject|6|||
155318891|NCT04690582|560603116|FG001|Overall Study|Withdrawal by Subject|4|||
155318892|NCT05104463|560603117|FG000|Overall Study|Adverse Event|1|||
155318893|NCT05104463|560603118|FG001|Overall Study|Adverse Event|1|||
155318894|NCT05104463|560603117|FG000|Overall Study|Lost to Follow-up|1|||
155318895|NCT05104463|560603118|FG001|Overall Study|Lost to Follow-up|1|||
155318896|NCT05104463|560603117|FG000|Overall Study|Physician Decision|1|||
155318897|NCT05104463|560603118|FG001|Overall Study|Physician Decision|0|||
154960115|NCT03285594|559278711|FG000|Overall Study|Reason Not Specified|3|||
154960116|NCT03285594|559278712|FG001|Overall Study|Reason Not Specified|4|||
154960117|NCT03285594|559278713|FG002|Overall Study|Reason Not Specified|8|||
154960118|NCT03733444|559278717|FG000|Overall Study|Adverse Event|8|||
155318898|NCT05104463|560603117|FG000|Overall Study|Protocol Violation|0|||
155318899|NCT05104463|560603118|FG001|Overall Study|Protocol Violation|2|||
155318900|NCT05104463|560603117|FG000|Overall Study|Withdrawal by Subject|1|||
155318901|NCT05104463|560603118|FG001|Overall Study|Withdrawal by Subject|1|||
155318902|NCT05267470|560603119|FG000|Overall Study|Decision by sponsor|0|||
155318903|NCT05267470|560603120|FG001|Overall Study|Decision by sponsor|3|||
154960119|NCT03733444|559278718|FG001|Overall Study|Adverse Event|10|||
154960120|NCT03733444|559278719|FG002|Overall Study|Adverse Event|5|||
154960121|NCT03733444|559278717|FG000|Overall Study|Death|20|||
154960122|NCT03733444|559278718|FG001|Overall Study|Death|19|||
154960123|NCT03733444|559278719|FG002|Overall Study|Death|11|||
154960124|NCT03733444|559278717|FG000|Overall Study|Lost to Follow-up|3|||
154960125|NCT03733444|559278718|FG001|Overall Study|Lost to Follow-up|0|||
154960126|NCT03733444|559278719|FG002|Overall Study|Lost to Follow-up|1|||
154960127|NCT03733444|559278717|FG000|Overall Study|Lack of Efficacy|0|||
154960128|NCT03733444|559278718|FG001|Overall Study|Lack of Efficacy|1|||
154960129|NCT03733444|559278719|FG002|Overall Study|Lack of Efficacy|1|||
154960130|NCT03733444|559278717|FG000|Overall Study|Physician Decision|2|||
154960131|NCT03733444|559278718|FG001|Overall Study|Physician Decision|1|||
154960132|NCT03733444|559278719|FG002|Overall Study|Physician Decision|0|||
154960133|NCT03733444|559278717|FG000|Overall Study|Protocol Violation|2|||
154960134|NCT03733444|559278718|FG001|Overall Study|Protocol Violation|1|||
154960135|NCT03733444|559278719|FG002|Overall Study|Protocol Violation|0|||
154960136|NCT03733444|559278717|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
154960137|NCT03733444|559278718|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
154960138|NCT03733444|559278719|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
154960139|NCT03733444|559278717|FG000|Overall Study|Study Terminated by Sponsor|203|||
154960140|NCT03733444|559278718|FG001|Overall Study|Study Terminated by Sponsor|209|||
154960141|NCT03733444|559278719|FG002|Overall Study|Study Terminated by Sponsor|221|||
155067102|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
155067103|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155067104|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155067105|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
155318904|NCT05267470|560603121|FG002|Overall Study|Decision by sponsor|19|||
155318905|NCT05267470|560603122|FG003|Overall Study|Decision by sponsor|7|||
155318906|NCT05267470|560603123|FG004|Overall Study|Decision by sponsor|3|||
155318907|NCT05267470|560603119|FG000|Overall Study|Withdrawal by Subject|1|||
155318908|NCT05267470|560603120|FG001|Overall Study|Withdrawal by Subject|1|||
155318909|NCT05267470|560603121|FG002|Overall Study|Withdrawal by Subject|2|||
155318910|NCT05267470|560603122|FG003|Overall Study|Withdrawal by Subject|2|||
155318911|NCT05267470|560603123|FG004|Overall Study|Withdrawal by Subject|0|||
155318912|NCT05267470|560603119|FG000|Overall Study|Death|3|||
154960142|NCT03733444|559278717|FG000|Overall Study|Withdrawal by Subject|19|||
154960143|NCT03733444|559278718|FG001|Overall Study|Withdrawal by Subject|18|||
154960144|NCT03733444|559278719|FG002|Overall Study|Withdrawal by Subject|16|||
154960145|NCT03733444|559278717|FG000|Overall Study|Miscellaneous|1|||
154960146|NCT03733444|559278718|FG001|Overall Study|Miscellaneous|0|||
154960147|NCT03733444|559278719|FG002|Overall Study|Miscellaneous|1|||
155318913|NCT05267470|560603120|FG001|Overall Study|Death|5|||
155318914|NCT05267470|560603121|FG002|Overall Study|Death|8|||
155318915|NCT05267470|560603122|FG003|Overall Study|Death|18|||
155318916|NCT05267470|560603123|FG004|Overall Study|Death|1|||
155318917|NCT05267470|560603119|FG000|Overall Study|Lost to Follow-up|0|||
155318918|NCT05267470|560603120|FG001|Overall Study|Lost to Follow-up|0|||
155318919|NCT05267470|560603121|FG002|Overall Study|Lost to Follow-up|0|||
155318920|NCT05267470|560603122|FG003|Overall Study|Lost to Follow-up|1|||
155318921|NCT05267470|560603123|FG004|Overall Study|Lost to Follow-up|0|||
155318922|NCT04428203|560603124|FG000|Overall Study|Adverse Event|1|||
155318923|NCT04428203|560603125|FG001|Overall Study|Adverse Event|0|||
155318924|NCT04428203|560603126|FG002|Overall Study|Adverse Event|0|||
155318925|NCT04428203|560603124|FG000|Overall Study|Withdrawal by Subject|1|||
155318926|NCT04428203|560603125|FG001|Overall Study|Withdrawal by Subject|0|||
155318927|NCT04428203|560603126|FG002|Overall Study|Withdrawal by Subject|1|||
155318928|NCT02823145|560603127|FG000|Enrollment|Other|1|||
155318929|NCT02823145|560603128|FG001|Enrollment|Other|0|||
155318930|NCT02823145|560603127|FG000|Treatment|Adverse Event|0|||
155318931|NCT02823145|560603128|FG001|Treatment|Adverse Event|11|||
155318932|NCT02823145|560603127|FG000|Treatment|Death|0|||
155318933|NCT02823145|560603128|FG001|Treatment|Death|3|||
155318934|NCT02823145|560603127|FG000|Treatment|Family Decision|0|||
155318935|NCT02823145|560603128|FG001|Treatment|Family Decision|1|||
155318936|NCT02823145|560603127|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
155318937|NCT02823145|560603128|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
155318938|NCT02823145|560603127|FG000|Treatment|Lack of Efficacy|0|||
155318939|NCT02823145|560603128|FG001|Treatment|Lack of Efficacy|48|||
155318940|NCT02823145|560603127|FG000|Treatment|Non-Compliance With E-Diary|0|||
155318941|NCT02823145|560603128|FG001|Treatment|Non-Compliance With E-Diary|1|||
155318942|NCT02823145|560603127|FG000|Treatment|Physician Decision|0|||
155318943|NCT02823145|560603128|FG001|Treatment|Physician Decision|2|||
155318944|NCT02823145|560603127|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
155318945|NCT02823145|560603128|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
155318946|NCT02823145|560603127|FG000|Treatment|Subject needed to take prohibited medication|0|||
155318947|NCT02823145|560603128|FG001|Treatment|Subject needed to take prohibited medication|1|||
155318948|NCT02823145|560603127|FG000|Treatment|Subject transferred to direct access programme|0|||
155318949|NCT02823145|560603128|FG001|Treatment|Subject transferred to direct access programme|1|||
155318950|NCT02823145|560603127|FG000|Treatment|Switching to commercially available drug|0|||
155318951|NCT02823145|560603128|FG001|Treatment|Switching to commercially available drug|11|||
155318952|NCT02823145|560603127|FG000|Treatment|Transitioned to commercial supply of medication|0|||
155318953|NCT02823145|560603128|FG001|Treatment|Transitioned to commercial supply of medication|1|||
155318954|NCT02823145|560603127|FG000|Treatment|Withdrawal By Caregiver|0|||
155318955|NCT02823145|560603128|FG001|Treatment|Withdrawal By Caregiver|1|||
155318956|NCT02823145|560603127|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
155318957|NCT02823145|560603128|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
155318958|NCT02823145|560603127|FG000|Treatment|Withdrawal by Subject|0|||
155318959|NCT02823145|560603128|FG001|Treatment|Withdrawal by Subject|16|||
155318960|NCT02823145|560603127|FG000|Treatment|Reason unknown|0|||
155318961|NCT02823145|560603128|FG001|Treatment|Reason unknown|1|||
155318962|NCT04741776|560603129|FG000|Overall Study|Withdrawal by Subject|7|||
155318963|NCT04741776|560603130|FG001|Overall Study|Withdrawal by Subject|10|||
155318964|NCT04741776|560603131|FG002|Overall Study|Withdrawal by Subject|10|||
155318965|NCT04741776|560603132|FG003|Overall Study|Withdrawal by Subject|17|||
155318966|NCT04741776|560603129|FG000|Overall Study|Death|0|||
155318967|NCT04741776|560603130|FG001|Overall Study|Death|0|||
155318968|NCT04741776|560603131|FG002|Overall Study|Death|1|||
155318969|NCT04741776|560603132|FG003|Overall Study|Death|0|||
155318970|NCT02852655|560603148|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
155318971|NCT02852655|560603149|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
155318972|NCT02852655|560603150|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
155318973|NCT02852655|560603148|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
155318974|NCT02852655|560603149|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
155318975|NCT02852655|560603150|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
155318976|NCT02852655|560603148|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
155318977|NCT02852655|560603149|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
155318978|NCT02852655|560603150|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
155318979|NCT02852655|560603148|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
155318980|NCT02852655|560603149|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
155318981|NCT02852655|560603150|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
155318982|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
155318983|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
155318984|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
155318985|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
155318986|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
155318987|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
155318988|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
155318989|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
155318990|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
155318991|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
155318992|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
155318993|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
155318994|NCT02852655|560603148|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
155318995|NCT02852655|560603149|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
155318996|NCT02852655|560603150|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
155318997|NCT03257410|560605348|FG000|Overall Study|Adverse Event|2|||
155318998|NCT03257410|560605349|FG001|Overall Study|Adverse Event|3|||
155318999|NCT03257410|560605348|FG000|Overall Study|Protocol Violation|1|||
155319000|NCT03257410|560605349|FG001|Overall Study|Protocol Violation|2|||
155319001|NCT03257410|560605348|FG000|Overall Study|Lost to Follow-up|1|||
155319002|NCT03257410|560605349|FG001|Overall Study|Lost to Follow-up|0|||
155319003|NCT03257410|560605348|FG000|Overall Study|Withdrawal by Subject|1|||
155319004|NCT03257410|560605349|FG001|Overall Study|Withdrawal by Subject|2|||
155319005|NCT03257410|560605348|FG000|Overall Study|Physician Decision|1|||
155319006|NCT03257410|560605349|FG001|Overall Study|Physician Decision|1|||
155319007|NCT03257410|560605348|FG000|Overall Study|Renal transplantation|2|||
155319008|NCT03257410|560605349|FG001|Overall Study|Renal transplantation|0|||
155319009|NCT03257410|560605348|FG000|Overall Study|Switch to peritoneal dialysis|1|||
155319010|NCT03257410|560605349|FG001|Overall Study|Switch to peritoneal dialysis|0|||
155319011|NCT03257410|560605348|FG000|Overall Study|Death|3|||
155319012|NCT03257410|560605349|FG001|Overall Study|Death|2|||
155319013|NCT03257410|560605348|FG000|Overall Study|Change to another dialysis center|2|||
155319014|NCT03257410|560605349|FG001|Overall Study|Change to another dialysis center|2|||
155319015|NCT03257410|560605348|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
155319016|NCT03257410|560605349|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
155319017|NCT03257410|560605348|FG000|Overall Study|Miscellaneous|2|||
155319018|NCT03257410|560605349|FG001|Overall Study|Miscellaneous|2|||
155319019|NCT03257410|560605348|FG000|Overall Study|Other|0|||
155319020|NCT03257410|560605349|FG001|Overall Study|Other|1|||
155319021|NCT02598388|560605350|FG000|Overall Study|Lost to Follow-up|1|||
155319022|NCT02598388|560605351|FG001|Overall Study|Lost to Follow-up|0|||
155319023|NCT02598388|560605352|FG002|Overall Study|Lost to Follow-up|1|||
155319024|NCT02598388|560605353|FG003|Overall Study|Lost to Follow-up|0|||
155319025|NCT02598388|560605354|FG004|Overall Study|Lost to Follow-up|5|||
155319026|NCT02598388|560605355|FG005|Overall Study|Lost to Follow-up|1|||
155319027|NCT02598388|560605356|FG006|Overall Study|Lost to Follow-up|2|||
155319028|NCT02598388|560605357|FG007|Overall Study|Lost to Follow-up|1|||
155319029|NCT02598388|560605358|FG008|Overall Study|Lost to Follow-up|0|||
155319030|NCT02598388|560605359|FG009|Overall Study|Lost to Follow-up|0|||
155319031|NCT02598388|560605360|FG010|Overall Study|Lost to Follow-up|1|||
155319032|NCT02598388|560605361|FG011|Overall Study|Lost to Follow-up|0|||
155319033|NCT02598388|560605350|FG000|Overall Study|Withdrawal by Subject|0|||
155319034|NCT02598388|560605351|FG001|Overall Study|Withdrawal by Subject|0|||
155319035|NCT02598388|560605352|FG002|Overall Study|Withdrawal by Subject|0|||
155319036|NCT02598388|560605353|FG003|Overall Study|Withdrawal by Subject|0|||
154960148|NCT03733444|559278717|FG000|Overall Study|Not Treated|1|||
154960149|NCT03733444|559278718|FG001|Overall Study|Not Treated|2|||
155319037|NCT02598388|560605354|FG004|Overall Study|Withdrawal by Subject|2|||
155319038|NCT02598388|560605355|FG005|Overall Study|Withdrawal by Subject|0|||
155319039|NCT02598388|560605356|FG006|Overall Study|Withdrawal by Subject|2|||
155319040|NCT02598388|560605357|FG007|Overall Study|Withdrawal by Subject|0|||
155319041|NCT02598388|560605358|FG008|Overall Study|Withdrawal by Subject|0|||
155319042|NCT02598388|560605359|FG009|Overall Study|Withdrawal by Subject|1|||
155319043|NCT02598388|560605360|FG010|Overall Study|Withdrawal by Subject|0|||
155319044|NCT02598388|560605361|FG011|Overall Study|Withdrawal by Subject|0|||
155319045|NCT02598388|560605350|FG000|Overall Study|Other|0|||
155319046|NCT02598388|560605351|FG001|Overall Study|Other|0|||
155319047|NCT02598388|560605352|FG002|Overall Study|Other|1|||
155319048|NCT02598388|560605353|FG003|Overall Study|Other|0|||
155319049|NCT02598388|560605354|FG004|Overall Study|Other|3|||
155319050|NCT02598388|560605355|FG005|Overall Study|Other|0|||
155319051|NCT02598388|560605356|FG006|Overall Study|Other|1|||
155319052|NCT02598388|560605357|FG007|Overall Study|Other|0|||
154960150|NCT03733444|559278719|FG002|Overall Study|Not Treated|1|||
154960151|NCT02648438|559278720|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155319053|NCT02598388|560605358|FG008|Overall Study|Other|0|||
155319054|NCT02598388|560605359|FG009|Overall Study|Other|0|||
155319055|NCT02598388|560605360|FG010|Overall Study|Other|0|||
155319056|NCT02598388|560605361|FG011|Overall Study|Other|0|||
155319057|NCT05256017|560605364|FG000|Treatment Period|Withdrawal by Subject|1|||
155319058|NCT05256017|560605365|FG001|Treatment Period|Withdrawal by Subject|1|||
155319059|NCT05256017|560605364|FG000|Follow-up|Lost to Follow-up|7|||
155319060|NCT05256017|560605365|FG001|Follow-up|Lost to Follow-up|1|||
155319061|NCT05256017|560605364|FG000|Follow-up|Withdrawal by Subject|1|||
155319062|NCT05256017|560605365|FG001|Follow-up|Withdrawal by Subject|0|||
155319063|NCT05256017|560605364|FG000|Follow-up|Death|0|||
155319064|NCT05256017|560605365|FG001|Follow-up|Death|1|||
155319065|NCT04171141|560605366|FG000|Overall Study|Adverse Event|0|||
155319066|NCT04171141|560605367|FG001|Overall Study|Adverse Event|0|||
155319067|NCT04171141|560605368|FG002|Overall Study|Adverse Event|2|||
155319068|NCT04171141|560605369|FG003|Overall Study|Adverse Event|0|||
155319069|NCT04171141|560605370|FG004|Overall Study|Adverse Event|0|||
155319070|NCT04171141|560605371|FG005|Overall Study|Adverse Event|0|||
155319071|NCT04171141|560605372|FG006|Overall Study|Adverse Event|0|||
155319072|NCT04171141|560605373|FG007|Overall Study|Adverse Event|0|||
155319073|NCT04171141|560605374|FG008|Overall Study|Adverse Event|0|||
155319074|NCT04171141|560605375|FG009|Overall Study|Adverse Event|0|||
155319075|NCT04171141|560605376|FG010|Overall Study|Adverse Event|0|||
155319076|NCT04171141|560605377|FG011|Overall Study|Adverse Event|0|||
155319077|NCT04171141|560605378|FG012|Overall Study|Adverse Event|0|||
155319078|NCT04171141|560605379|FG013|Overall Study|Adverse Event|2|||
155319079|NCT04171141|560605380|FG014|Overall Study|Adverse Event|0|||
155319080|NCT04171141|560605381|FG015|Overall Study|Adverse Event|0|||
155319081|NCT04171141|560605366|FG000|Overall Study|Physician Decision|0|||
155319082|NCT04171141|560605367|FG001|Overall Study|Physician Decision|0|||
155319083|NCT04171141|560605368|FG002|Overall Study|Physician Decision|0|||
155319084|NCT04171141|560605369|FG003|Overall Study|Physician Decision|0|||
155319085|NCT04171141|560605370|FG004|Overall Study|Physician Decision|1|||
155319086|NCT04171141|560605371|FG005|Overall Study|Physician Decision|0|||
155319087|NCT04171141|560605372|FG006|Overall Study|Physician Decision|0|||
155319088|NCT04171141|560605373|FG007|Overall Study|Physician Decision|0|||
155319089|NCT04171141|560605374|FG008|Overall Study|Physician Decision|0|||
155319090|NCT04171141|560605375|FG009|Overall Study|Physician Decision|0|||
155319091|NCT04171141|560605376|FG010|Overall Study|Physician Decision|0|||
155319092|NCT04171141|560605377|FG011|Overall Study|Physician Decision|0|||
155319093|NCT04171141|560605378|FG012|Overall Study|Physician Decision|0|||
155319094|NCT04171141|560605379|FG013|Overall Study|Physician Decision|0|||
155319095|NCT04171141|560605380|FG014|Overall Study|Physician Decision|0|||
155319096|NCT04171141|560605381|FG015|Overall Study|Physician Decision|1|||
155319097|NCT04171141|560605366|FG000|Overall Study|Progressive disease|2|||
155319098|NCT04171141|560605367|FG001|Overall Study|Progressive disease|3|||
155319099|NCT04171141|560605368|FG002|Overall Study|Progressive disease|4|||
155319100|NCT04171141|560605369|FG003|Overall Study|Progressive disease|7|||
155319101|NCT04171141|560605370|FG004|Overall Study|Progressive disease|1|||
155319102|NCT04171141|560605371|FG005|Overall Study|Progressive disease|8|||
155319103|NCT04171141|560605372|FG006|Overall Study|Progressive disease|4|||
155319104|NCT04171141|560605373|FG007|Overall Study|Progressive disease|6|||
155319105|NCT04171141|560605374|FG008|Overall Study|Progressive disease|7|||
155319106|NCT04171141|560605375|FG009|Overall Study|Progressive disease|3|||
155319107|NCT04171141|560605376|FG010|Overall Study|Progressive disease|4|||
155319108|NCT04171141|560605377|FG011|Overall Study|Progressive disease|3|||
155319109|NCT04171141|560605378|FG012|Overall Study|Progressive disease|4|||
155319110|NCT04171141|560605379|FG013|Overall Study|Progressive disease|2|||
155319111|NCT04171141|560605380|FG014|Overall Study|Progressive disease|4|||
155319112|NCT04171141|560605381|FG015|Overall Study|Progressive disease|1|||
155319113|NCT04171141|560605366|FG000|Overall Study|Withdrawal by Subject|0|||
155319114|NCT04171141|560605367|FG001|Overall Study|Withdrawal by Subject|0|||
155319115|NCT04171141|560605368|FG002|Overall Study|Withdrawal by Subject|0|||
155319116|NCT04171141|560605369|FG003|Overall Study|Withdrawal by Subject|1|||
155319117|NCT04171141|560605370|FG004|Overall Study|Withdrawal by Subject|0|||
155319118|NCT04171141|560605371|FG005|Overall Study|Withdrawal by Subject|0|||
155319119|NCT04171141|560605372|FG006|Overall Study|Withdrawal by Subject|1|||
155319120|NCT04171141|560605373|FG007|Overall Study|Withdrawal by Subject|0|||
155319121|NCT04171141|560605374|FG008|Overall Study|Withdrawal by Subject|0|||
155319122|NCT04171141|560605375|FG009|Overall Study|Withdrawal by Subject|1|||
155319123|NCT04171141|560605376|FG010|Overall Study|Withdrawal by Subject|0|||
155319124|NCT04171141|560605377|FG011|Overall Study|Withdrawal by Subject|0|||
155319125|NCT04171141|560605378|FG012|Overall Study|Withdrawal by Subject|0|||
155319126|NCT04171141|560605379|FG013|Overall Study|Withdrawal by Subject|0|||
155319127|NCT04171141|560605380|FG014|Overall Study|Withdrawal by Subject|0|||
155319128|NCT04171141|560605381|FG015|Overall Study|Withdrawal by Subject|0|||
155319129|NCT04171141|560605366|FG000|Overall Study|Global deterioration of health status|0|||
155319130|NCT04171141|560605367|FG001|Overall Study|Global deterioration of health status|0|||
155319131|NCT04171141|560605368|FG002|Overall Study|Global deterioration of health status|0|||
155319132|NCT04171141|560605369|FG003|Overall Study|Global deterioration of health status|1|||
155319133|NCT04171141|560605370|FG004|Overall Study|Global deterioration of health status|0|||
155319134|NCT04171141|560605371|FG005|Overall Study|Global deterioration of health status|2|||
155319135|NCT04171141|560605372|FG006|Overall Study|Global deterioration of health status|1|||
155319136|NCT04171141|560605373|FG007|Overall Study|Global deterioration of health status|0|||
155319137|NCT04171141|560605374|FG008|Overall Study|Global deterioration of health status|1|||
155319138|NCT04171141|560605375|FG009|Overall Study|Global deterioration of health status|0|||
155319139|NCT04171141|560605376|FG010|Overall Study|Global deterioration of health status|0|||
155319140|NCT04171141|560605377|FG011|Overall Study|Global deterioration of health status|0|||
155319141|NCT04171141|560605378|FG012|Overall Study|Global deterioration of health status|0|||
155319142|NCT04171141|560605379|FG013|Overall Study|Global deterioration of health status|0|||
155319143|NCT04171141|560605380|FG014|Overall Study|Global deterioration of health status|1|||
155319144|NCT04171141|560605381|FG015|Overall Study|Global deterioration of health status|1|||
155319145|NCT03663569|560605382|FG000|Overall Study|Discontinuation of study|11|||
155319146|NCT03663569|560605382|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
155319147|NCT03663569|560605382|FG000|Overall Study|Deceased patient|6|||
155319148|NCT03663569|560605382|FG000|Overall Study|Lost to Follow-up|18|||
155319149|NCT03663569|560605382|FG000|Overall Study|Withdrawal of consent|5|||
155319150|NCT03663569|560605382|FG000|Overall Study|Patient's request|11|||
155319151|NCT03663569|560605382|FG000|Overall Study|Adverse Event|4|||
155319152|NCT03663569|560605382|FG000|Overall Study|Not come to second visit|3|||
155319153|NCT03663569|560605382|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
155319154|NCT03663569|560605382|FG000|Overall Study|Serious adverse event|1|||
155319155|NCT04979442|560605383|FG000|Overall Study|Death|43|||
155319156|NCT04979442|560605384|FG001|Overall Study|Death|30|||
155319157|NCT04979442|560605383|FG000|Overall Study|Withdrawal by Subject|8|||
155319158|NCT04979442|560605384|FG001|Overall Study|Withdrawal by Subject|13|||
155319159|NCT04979442|560605383|FG000|Overall Study|Physician Decision|1|||
155319160|NCT04979442|560605384|FG001|Overall Study|Physician Decision|1|||
155319161|NCT04979442|560605383|FG000|Overall Study|Lost to Follow-up|0|||
155319162|NCT04979442|560605384|FG001|Overall Study|Lost to Follow-up|2|||
155319163|NCT04979442|560605383|FG000|Overall Study|do not want to continue|0|||
155319164|NCT04979442|560605384|FG001|Overall Study|do not want to continue|1|||
155319165|NCT04005794|560605386|FG000|Overall Study|Lost to Follow-up|0|||
155319166|NCT04005794|560605387|FG001|Overall Study|Lost to Follow-up|4|||
155319167|NCT04005794|560605388|FG002|Overall Study|Lost to Follow-up|0|||
155319168|NCT00104676|560605392|FG000|Overall Study|Death|3|||
155319169|NCT00104676|560605393|FG001|Overall Study|Death|2|||
155319170|NCT00104676|560605392|FG000|Overall Study|Withdrawal by Subject|0|||
155319171|NCT00104676|560605393|FG001|Overall Study|Withdrawal by Subject|2|||
155319172|NCT00104676|560605392|FG000|Overall Study|treatment interruption|4|||
155319173|NCT00104676|560605393|FG001|Overall Study|treatment interruption|10|||
155319174|NCT05622812|560605394|FG000|Overall Study|Withdrawal by Subject|1|||
155319175|NCT05622812|560605395|FG001|Overall Study|Withdrawal by Subject|4|||
155319176|NCT05622812|560605394|FG000|Overall Study|Lost to Follow-up|2|||
155319177|NCT05622812|560605395|FG001|Overall Study|Lost to Follow-up|1|||
155319178|NCT02116530|560605396|FG000|Overall Study|Withdrawal by Subject|1|||
155319179|NCT02116530|560605397|FG001|Overall Study|Withdrawal by Subject|2|||
155319180|NCT02116530|560605396|FG000|Overall Study|Adverse Event|4|||
155319181|NCT02116530|560605397|FG001|Overall Study|Adverse Event|0|||
155319182|NCT02116530|560605396|FG000|Overall Study|Physician Decision|1|||
155319183|NCT02116530|560605397|FG001|Overall Study|Physician Decision|0|||
155319184|NCT02116530|560605396|FG000|Overall Study|Lost to Follow-up|1|||
155319185|NCT02116530|560605397|FG001|Overall Study|Lost to Follow-up|0|||
155319186|NCT02116530|560605396|FG000|Overall Study|Other Medical Problems|2|||
155319187|NCT02116530|560605397|FG001|Overall Study|Other Medical Problems|2|||
155319188|NCT02927236|560605398|FG000|Characterization Phase|Physician Decision|0|||
155319189|NCT02927236|560605399|FG001|Characterization Phase|Physician Decision|3|||
155319190|NCT02927236|560605400|FG002|Characterization Phase|Physician Decision|0|||
155319191|NCT02927236|560605401|FG003|Characterization Phase|Physician Decision|2|||
155319192|NCT02927236|560605398|FG000|Characterization Phase|Lost to Follow-up|0|||
155319193|NCT02927236|560605399|FG001|Characterization Phase|Lost to Follow-up|0|||
155319194|NCT02927236|560605400|FG002|Characterization Phase|Lost to Follow-up|0|||
155319195|NCT02927236|560605401|FG003|Characterization Phase|Lost to Follow-up|3|||
155319196|NCT02927236|560605398|FG000|Characterization Phase|Withdrawal by Subject|1|||
155319197|NCT02927236|560605399|FG001|Characterization Phase|Withdrawal by Subject|0|||
155319198|NCT02927236|560605400|FG002|Characterization Phase|Withdrawal by Subject|0|||
155319199|NCT02927236|560605401|FG003|Characterization Phase|Withdrawal by Subject|1|||
155319200|NCT02927236|560605398|FG000|Treatment Phase|Adverse Event|1|||
155319201|NCT02927236|560605399|FG001|Treatment Phase|Adverse Event|0|||
155319202|NCT02927236|560605400|FG002|Treatment Phase|Adverse Event|1|||
155319203|NCT02927236|560605401|FG003|Treatment Phase|Adverse Event|1|||
155319204|NCT02927236|560605398|FG000|Treatment Phase|Protocol Violation|3|||
155319205|NCT02927236|560605399|FG001|Treatment Phase|Protocol Violation|0|||
155319206|NCT02927236|560605400|FG002|Treatment Phase|Protocol Violation|0|||
155319207|NCT02927236|560605401|FG003|Treatment Phase|Protocol Violation|1|||
155319208|NCT02927236|560605398|FG000|Treatment Phase|Lost to Follow-up|1|||
155319209|NCT02927236|560605399|FG001|Treatment Phase|Lost to Follow-up|0|||
155319210|NCT02927236|560605400|FG002|Treatment Phase|Lost to Follow-up|0|||
155319211|NCT02927236|560605401|FG003|Treatment Phase|Lost to Follow-up|0|||
155319212|NCT02927236|560605398|FG000|Follow-up Phase|Lost to Follow-up|1|||
155319213|NCT02927236|560605399|FG001|Follow-up Phase|Lost to Follow-up|0|||
155319214|NCT02927236|560605400|FG002|Follow-up Phase|Lost to Follow-up|1|||
155319215|NCT02927236|560605401|FG003|Follow-up Phase|Lost to Follow-up|0|||
155319216|NCT05297565|560605402|FG000|Overall Study|Other Reasons|0|||
155319217|NCT05297565|560605403|FG001|Overall Study|Other Reasons|1|||
155319218|NCT05297565|560605402|FG000|Overall Study|Physician Decision|0|||
155319219|NCT05297565|560605403|FG001|Overall Study|Physician Decision|1|||
155319220|NCT05297565|560605402|FG000|Overall Study|Disease recurrence|1|||
155319221|NCT05297565|560605403|FG001|Overall Study|Disease recurrence|0|||
155319222|NCT01959607|560605404|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
155319223|NCT01959607|560605405|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
155319224|NCT01959607|560605406|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155319225|NCT01959607|560605407|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
155319226|NCT03913442|560605408|FG000|Overall Study|Adverse Event|0|||
155319227|NCT03913442|560605409|FG001|Overall Study|Adverse Event|3|||
154960152|NCT02648438|559278721|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
155319228|NCT03913442|560605408|FG000|Overall Study|Withdrawal by Subject|5|||
155319229|NCT03913442|560605409|FG001|Overall Study|Withdrawal by Subject|5|||
155319230|NCT03913442|560605408|FG000|Overall Study|Terminations|2|||
155319231|NCT03913442|560605409|FG001|Overall Study|Terminations|1|||
155319232|NCT03913442|560605408|FG000|Overall Study|Lost to Follow-up|2|||
155319233|NCT03913442|560605409|FG001|Overall Study|Lost to Follow-up|2|||
155319234|NCT02433379|560605413|FG000|Overall Study|Screen Failures|55|||
155319235|NCT02433379|560605413|FG000|Overall Study|Death|57|||
155319236|NCT02433379|560605413|FG000|Overall Study|Total Withdrawals|209|||
155319237|NCT03952338|560605414|FG000|Overall Study|Lost to Follow-up|11|||
155319238|NCT03952338|560605415|FG001|Overall Study|Lost to Follow-up|17|||
155319239|NCT03952338|560605414|FG000|Overall Study|Withdrawal by Subject|1|||
155319240|NCT03952338|560605415|FG001|Overall Study|Withdrawal by Subject|1|||
155319241|NCT03952338|560605414|FG000|Overall Study|Protocol Violation|1|||
154960153|NCT02648438|559278722|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155319242|NCT03952338|560605415|FG001|Overall Study|Protocol Violation|0|||
154960154|NCT02648438|559278720|FG000|Overall Study|Protocol Violation|2|||
154960155|NCT02648438|559278721|FG001|Overall Study|Protocol Violation|0|||
154960156|NCT02648438|559278722|FG002|Overall Study|Protocol Violation|0|||
154960157|NCT02648438|559278720|FG000|Overall Study|Withdrawal by Subject|1|||
154960158|NCT02648438|559278721|FG001|Overall Study|Withdrawal by Subject|1|||
154960159|NCT02648438|559278722|FG002|Overall Study|Withdrawal by Subject|0|||
154960160|NCT03138967|559278723|FG000|Overall Study|Death|0|||
154960161|NCT03138967|559278724|FG001|Overall Study|Death|1|||
154960162|NCT03138967|559278723|FG000|Overall Study|Physician Decision|1|||
154960163|NCT03138967|559278724|FG001|Overall Study|Physician Decision|3|||
154960164|NCT04604275|559278727|FG000|Washout-1 Week|Withdrawal by Subject|1|||
154960165|NCT04604275|559278728|FG001|Washout-1 Week|Withdrawal by Subject|0|||
154960166|NCT02258074|559278729|FG000|Overall Study|Withdrawal by Subject|1|||
154960167|NCT02258074|559278730|FG001|Overall Study|Withdrawal by Subject|0|||
154960168|NCT02258074|559278731|FG002|Overall Study|Withdrawal by Subject|0|||
154960169|NCT02258074|559278732|FG003|Overall Study|Withdrawal by Subject|0|||
154960170|NCT05446870|559278733|FG000|Overall Study|Death|6|||
154960171|NCT05446870|559278734|FG001|Overall Study|Death|5|||
154960172|NCT05446870|559278733|FG000|Overall Study|Lost to Follow-up|0|||
154960173|NCT05446870|559278734|FG001|Overall Study|Lost to Follow-up|1|||
154960174|NCT05446870|559278733|FG000|Overall Study|Physician Decision|52|||
154960175|NCT05446870|559278734|FG001|Overall Study|Physician Decision|53|||
154960176|NCT05446870|559278733|FG000|Overall Study|Withdrawal by Subject|3|||
154960177|NCT05446870|559278734|FG001|Overall Study|Withdrawal by Subject|3|||
155067106|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
155067107|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
154960178|NCT01208337|559278740|FG000|Overall Study|Death|3|||
154960179|NCT00984126|559278741|FG000|Overall Study|Protocol Violation|0|||
154960180|NCT00984126|559278742|FG001|Overall Study|Protocol Violation|0|||
154960181|NCT00984126|559278743|FG002|Overall Study|Protocol Violation|1|||
154960182|NCT00984126|559278744|FG003|Overall Study|Protocol Violation|2|||
154960183|NCT00984126|559278741|FG000|Overall Study|Adverse Event|0|||
154960184|NCT00984126|559278742|FG001|Overall Study|Adverse Event|0|||
155067108|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155067109|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155067110|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
155319243|NCT03710603|560605416|FG000|Overall Study|Adverse Event|1|||
155319244|NCT03710603|560605417|FG001|Overall Study|Adverse Event|0|||
155319245|NCT03710603|560605416|FG000|Overall Study|Death|44|||
155319246|NCT03710603|560605417|FG001|Overall Study|Death|34|||
155319247|NCT03710603|560605416|FG000|Overall Study|Lost to Follow-up|3|||
155319248|NCT03710603|560605417|FG001|Overall Study|Lost to Follow-up|5|||
155319249|NCT03710603|560605416|FG000|Overall Study|Withdrawal by Subject|11|||
155319250|NCT03710603|560605417|FG001|Overall Study|Withdrawal by Subject|10|||
155319251|NCT03691935|560605418|FG000|Overall Study|Physician Decision|2|||
155319252|NCT03691935|560605419|FG001|Overall Study|Physician Decision|1|||
155319253|NCT03691935|560605418|FG000|Overall Study|Adverse Event|3|||
155319254|NCT03691935|560605419|FG001|Overall Study|Adverse Event|0|||
155319255|NCT01946789|560605425|FG000|Overall Study|Death|0|||
155319256|NCT01946789|560605426|FG001|Overall Study|Death|2|||
155319257|NCT01946789|560605427|FG002|Overall Study|Death|1|||
155319258|NCT01946789|560605428|FG003|Overall Study|Death|1|||
155319259|NCT01946789|560605429|FG004|Overall Study|Death|1|||
155319260|NCT01946789|560605430|FG005|Overall Study|Death|1|||
155319261|NCT01946789|560605431|FG006|Overall Study|Death|3|||
155319262|NCT01946789|560605432|FG007|Overall Study|Death|1|||
155319263|NCT01946789|560605433|FG008|Overall Study|Death|2|||
155319264|NCT01946789|560605425|FG000|Overall Study|Progressive Disease|0|||
155319265|NCT01946789|560605426|FG001|Overall Study|Progressive Disease|0|||
155319266|NCT01946789|560605427|FG002|Overall Study|Progressive Disease|1|||
155319267|NCT01946789|560605428|FG003|Overall Study|Progressive Disease|0|||
155319268|NCT01946789|560605429|FG004|Overall Study|Progressive Disease|0|||
155319269|NCT01946789|560605430|FG005|Overall Study|Progressive Disease|2|||
155319270|NCT01946789|560605431|FG006|Overall Study|Progressive Disease|0|||
155319271|NCT01946789|560605432|FG007|Overall Study|Progressive Disease|0|||
155319272|NCT01946789|560605433|FG008|Overall Study|Progressive Disease|0|||
155319273|NCT01946789|560605425|FG000|Overall Study|Withdrawal by Subject|0|||
155319274|NCT01946789|560605426|FG001|Overall Study|Withdrawal by Subject|0|||
155319275|NCT01946789|560605427|FG002|Overall Study|Withdrawal by Subject|0|||
155319276|NCT01946789|560605428|FG003|Overall Study|Withdrawal by Subject|2|||
155319277|NCT01946789|560605429|FG004|Overall Study|Withdrawal by Subject|1|||
155319278|NCT01946789|560605430|FG005|Overall Study|Withdrawal by Subject|0|||
155319279|NCT01946789|560605431|FG006|Overall Study|Withdrawal by Subject|1|||
155319280|NCT01946789|560605432|FG007|Overall Study|Withdrawal by Subject|0|||
155319281|NCT01946789|560605433|FG008|Overall Study|Withdrawal by Subject|0|||
155319282|NCT04707625|560605434|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
155319283|NCT00321048|560605435|FG000|Overall Study|Withdrawal by Subject|6|||
155319284|NCT00321048|560605436|FG001|Overall Study|Withdrawal by Subject|8|||
155319285|NCT06473662|560605437|FG000|Overall Study|Withdrawal by Subject|1|||
155319286|NCT06473662|560605438|FG001|Overall Study|Withdrawal by Subject|6|||
155319287|NCT06473662|560605439|FG002|Overall Study|Withdrawal by Subject|5|||
155319288|NCT06473662|560605437|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
155319289|NCT06473662|560605438|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
155319290|NCT06473662|560605439|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
155319291|NCT06473662|560605437|FG000|Overall Study|Starting HbA1c below 7%|0|||
155319292|NCT06473662|560605438|FG001|Overall Study|Starting HbA1c below 7%|1|||
155319293|NCT06473662|560605439|FG002|Overall Study|Starting HbA1c below 7%|1|||
155319294|NCT06473662|560605437|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
155319295|NCT06473662|560605438|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
155319296|NCT06473662|560605439|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
155319297|NCT06473662|560605437|FG000|Overall Study|Did not take medication|2|||
155319298|NCT06473662|560605438|FG001|Overall Study|Did not take medication|3|||
155319299|NCT06473662|560605439|FG002|Overall Study|Did not take medication|2|||
155319300|NCT05485779|560605442|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319301|NCT05485779|560605443|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319302|NCT05485779|560605444|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319303|NCT05485779|560605445|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319304|NCT05485779|560605446|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319305|NCT05485779|560605447|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319306|NCT05485779|560605448|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319307|NCT05485779|560605449|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
155319308|NCT05485779|560605450|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
155319309|NCT05485779|560605451|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319310|NCT05485779|560605452|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
155319311|NCT05485779|560605442|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319312|NCT05485779|560605443|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319313|NCT05485779|560605444|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319314|NCT05485779|560605445|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319315|NCT05485779|560605446|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319316|NCT05485779|560605447|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319317|NCT05485779|560605448|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319318|NCT05485779|560605449|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319319|NCT05485779|560605450|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319320|NCT05485779|560605451|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
155319321|NCT05485779|560605452|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
155319322|NCT05485779|560605442|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319323|NCT05485779|560605443|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319324|NCT05485779|560605444|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319325|NCT05485779|560605445|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
155319326|NCT05485779|560605446|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319327|NCT05485779|560605447|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319328|NCT05485779|560605448|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319329|NCT05485779|560605449|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319330|NCT05485779|560605450|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319331|NCT05485779|560605451|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319332|NCT05485779|560605452|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
155319333|NCT02038777|560605453|FG000|Overall Study|Death|0|||
155319334|NCT02038777|560605454|FG001|Overall Study|Death|2|||
155319335|NCT02038777|560605455|FG002|Overall Study|Death|0|||
154960185|NCT00984126|559278743|FG002|Overall Study|Adverse Event|0|||
154960186|NCT00984126|559278744|FG003|Overall Study|Adverse Event|2|||
154960187|NCT00984126|559278741|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
155319336|NCT02038777|560605456|FG003|Overall Study|Death|1|||
155319337|NCT02038777|560605457|FG004|Overall Study|Death|2|||
155319338|NCT02038777|560605458|FG005|Overall Study|Death|4|||
155319339|NCT02038777|560605459|FG006|Overall Study|Death|0|||
155319340|NCT02038777|560605460|FG007|Overall Study|Death|11|||
155319341|NCT02038777|560605453|FG000|Overall Study|Lost to Follow-up|0|||
155319342|NCT02038777|560605454|FG001|Overall Study|Lost to Follow-up|0|||
155319343|NCT02038777|560605455|FG002|Overall Study|Lost to Follow-up|0|||
155319344|NCT02038777|560605456|FG003|Overall Study|Lost to Follow-up|1|||
155319345|NCT02038777|560605457|FG004|Overall Study|Lost to Follow-up|0|||
155319346|NCT02038777|560605458|FG005|Overall Study|Lost to Follow-up|0|||
155319347|NCT02038777|560605459|FG006|Overall Study|Lost to Follow-up|0|||
155319348|NCT02038777|560605460|FG007|Overall Study|Lost to Follow-up|0|||
155319349|NCT02038777|560605453|FG000|Overall Study|Other|0|||
155319350|NCT02038777|560605454|FG001|Overall Study|Other|1|||
155319351|NCT02038777|560605455|FG002|Overall Study|Other|0|||
155319352|NCT02038777|560605456|FG003|Overall Study|Other|2|||
155319353|NCT02038777|560605457|FG004|Overall Study|Other|1|||
155319354|NCT02038777|560605458|FG005|Overall Study|Other|0|||
155319355|NCT02038777|560605459|FG006|Overall Study|Other|0|||
155319356|NCT02038777|560605460|FG007|Overall Study|Other|0|||
155319357|NCT02038777|560605453|FG000|Overall Study|Randomized but not treated|0|||
155319358|NCT02038777|560605454|FG001|Overall Study|Randomized but not treated|1|||
155319359|NCT02038777|560605455|FG002|Overall Study|Randomized but not treated|0|||
155319360|NCT02038777|560605456|FG003|Overall Study|Randomized but not treated|0|||
155319361|NCT02038777|560605457|FG004|Overall Study|Randomized but not treated|0|||
155319362|NCT02038777|560605458|FG005|Overall Study|Randomized but not treated|0|||
155319363|NCT02038777|560605459|FG006|Overall Study|Randomized but not treated|0|||
155319364|NCT02038777|560605460|FG007|Overall Study|Randomized but not treated|0|||
155319365|NCT02038777|560605453|FG000|Overall Study|Started Chemotherapy|1|||
155319366|NCT02038777|560605454|FG001|Overall Study|Started Chemotherapy|0|||
155319367|NCT02038777|560605455|FG002|Overall Study|Started Chemotherapy|3|||
155319368|NCT02038777|560605456|FG003|Overall Study|Started Chemotherapy|0|||
155319369|NCT02038777|560605457|FG004|Overall Study|Started Chemotherapy|0|||
155319370|NCT02038777|560605458|FG005|Overall Study|Started Chemotherapy|0|||
155319371|NCT02038777|560605459|FG006|Overall Study|Started Chemotherapy|0|||
155319372|NCT02038777|560605460|FG007|Overall Study|Started Chemotherapy|0|||
155319373|NCT02038777|560605453|FG000|Overall Study|participation terminated by sponsor|0|||
155319374|NCT02038777|560605454|FG001|Overall Study|participation terminated by sponsor|0|||
155319375|NCT02038777|560605455|FG002|Overall Study|participation terminated by sponsor|0|||
155319376|NCT02038777|560605456|FG003|Overall Study|participation terminated by sponsor|0|||
155319377|NCT02038777|560605457|FG004|Overall Study|participation terminated by sponsor|0|||
155319378|NCT02038777|560605458|FG005|Overall Study|participation terminated by sponsor|0|||
155319379|NCT02038777|560605459|FG006|Overall Study|participation terminated by sponsor|1|||
155319380|NCT02038777|560605460|FG007|Overall Study|participation terminated by sponsor|1|||
155319381|NCT04299464|560605461|FG000|Overall Study|Adverse Event|1|||
155319382|NCT04299464|560605462|FG001|Overall Study|Adverse Event|0|||
155319383|NCT04299464|560605463|FG002|Overall Study|Adverse Event|2|||
155319384|NCT04299464|560605461|FG000|Overall Study|Non-compliance with Study Drug|1|||
155319385|NCT04299464|560605462|FG001|Overall Study|Non-compliance with Study Drug|0|||
155067111|NCT03329001|559676944|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155067112|NCT03329001|559676945|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155067113|NCT03329001|559676946|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
155067114|NCT03329001|559676947|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
155067115|NCT03329001|559676948|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155067116|NCT03329001|559676949|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155067117|NCT03329001|559676950|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155067118|NCT03329001|559676951|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
155067119|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067120|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067121|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067122|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
155067123|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067124|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067125|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067126|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
155067127|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067128|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067129|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067130|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
155067131|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067132|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067133|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067134|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
155067135|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067136|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067137|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
155067138|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067139|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067140|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067141|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067142|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
155067143|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155067144|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155067145|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
155067146|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
155067147|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155067148|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155067149|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155067150|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
155067151|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067152|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067153|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
155067154|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067155|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067156|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067157|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067158|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
155067159|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155067160|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155067161|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
155067162|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155067163|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155162434|NCT01177397|560031616|FG010|Overall Study|Lost to Follow-up|0|||
155162435|NCT01177397|560031617|FG011|Overall Study|Lost to Follow-up|0|||
155162436|NCT01177397|560031606|FG000|Overall Study|Death|0|||
155162437|NCT01177397|560031607|FG001|Overall Study|Death|0|||
155162438|NCT01177397|560031608|FG002|Overall Study|Death|1|||
155162439|NCT01177397|560031609|FG003|Overall Study|Death|1|||
155162440|NCT01177397|560031610|FG004|Overall Study|Death|0|||
155162441|NCT01177397|560031611|FG005|Overall Study|Death|0|||
155067164|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155067165|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
154960188|NCT00984126|559278742|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
154960189|NCT00984126|559278743|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
154960190|NCT00984126|559278744|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
154960191|NCT00984126|559278741|FG000|Overall Study|Withdrawal criteria|0|||
154960192|NCT00984126|559278742|FG001|Overall Study|Withdrawal criteria|1|||
154960193|NCT00984126|559278743|FG002|Overall Study|Withdrawal criteria|3|||
154960194|NCT00984126|559278744|FG003|Overall Study|Withdrawal criteria|9|||
154960195|NCT01029340|559278745|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
154960196|NCT01029340|559278746|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
154960197|NCT01029340|559278747|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
154960198|NCT01029340|559278748|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
154960199|NCT01029340|559278749|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
154960200|NCT01029340|559278750|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
154960201|NCT01029340|559278745|FG000|Part B Treatment Period|Protocol Violation|0|||
154960202|NCT01029340|559278746|FG001|Part B Treatment Period|Protocol Violation|0|||
154960203|NCT01029340|559278747|FG002|Part B Treatment Period|Protocol Violation|1|||
154960204|NCT01029340|559278748|FG003|Part B Treatment Period|Protocol Violation|0|||
154960205|NCT01029340|559278749|FG004|Part B Treatment Period|Protocol Violation|0|||
154960206|NCT01029340|559278750|FG005|Part B Treatment Period|Protocol Violation|0|||
154960207|NCT01029340|559278745|FG000|Extension Period|Adverse Event|0|||
154960208|NCT01029340|559278746|FG001|Extension Period|Adverse Event|0|||
154960209|NCT01029340|559278747|FG002|Extension Period|Adverse Event|0|||
154960210|NCT01029340|559278748|FG003|Extension Period|Adverse Event|0|||
154960211|NCT01029340|559278749|FG004|Extension Period|Adverse Event|0|||
154960212|NCT01029340|559278750|FG005|Extension Period|Adverse Event|1|||
154960213|NCT01029340|559278745|FG000|Extension Period|starting another study|0|||
154960214|NCT01029340|559278746|FG001|Extension Period|starting another study|0|||
154960215|NCT01029340|559278747|FG002|Extension Period|starting another study|0|||
154960216|NCT01029340|559278748|FG003|Extension Period|starting another study|0|||
154960217|NCT01029340|559278749|FG004|Extension Period|starting another study|0|||
154960218|NCT01029340|559278750|FG005|Extension Period|starting another study|8|||
154960219|NCT01029340|559278745|FG000|Extension Period|non-compliance|0|||
154960220|NCT01029340|559278746|FG001|Extension Period|non-compliance|0|||
154960221|NCT01029340|559278747|FG002|Extension Period|non-compliance|0|||
154960222|NCT01029340|559278748|FG003|Extension Period|non-compliance|0|||
154960223|NCT01029340|559278749|FG004|Extension Period|non-compliance|0|||
154960224|NCT01029340|559278750|FG005|Extension Period|non-compliance|1|||
154960225|NCT01029340|559278745|FG000|Extension Period|Withdrawal by Subject|0|||
154960226|NCT01029340|559278746|FG001|Extension Period|Withdrawal by Subject|0|||
154960227|NCT01029340|559278747|FG002|Extension Period|Withdrawal by Subject|0|||
154960228|NCT01029340|559278748|FG003|Extension Period|Withdrawal by Subject|0|||
154960229|NCT01029340|559278749|FG004|Extension Period|Withdrawal by Subject|0|||
154960230|NCT01029340|559278750|FG005|Extension Period|Withdrawal by Subject|1|||
154960231|NCT01029340|559278745|FG000|Extension Period|Physician Decision|0|||
154960232|NCT01029340|559278746|FG001|Extension Period|Physician Decision|0|||
154960233|NCT01029340|559278747|FG002|Extension Period|Physician Decision|0|||
154960234|NCT01029340|559278748|FG003|Extension Period|Physician Decision|0|||
154960235|NCT01029340|559278749|FG004|Extension Period|Physician Decision|0|||
154960236|NCT01029340|559278750|FG005|Extension Period|Physician Decision|1|||
154960237|NCT02648347|559278754|FG000|Overall Study|Death|174|||
154960238|NCT02648347|559278755|FG001|Overall Study|Death|167|||
154960239|NCT02648347|559278754|FG000|Overall Study|Withdrawal by Subject|16|||
154960240|NCT02648347|559278755|FG001|Overall Study|Withdrawal by Subject|9|||
154960241|NCT02648347|559278754|FG000|Overall Study|Lost to Follow-up|18|||
154960242|NCT02648347|559278755|FG001|Overall Study|Lost to Follow-up|21|||
154960243|NCT02648347|559278754|FG000|Overall Study|Missing|1|||
154960244|NCT02648347|559278755|FG001|Overall Study|Missing|0|||
154960245|NCT02196675|559278759|FG000|Overall Study|Withdrawal by Subject|1|||
154960246|NCT02196675|559278760|FG001|Overall Study|Withdrawal by Subject|0|||
154960247|NCT02196675|559278761|FG002|Overall Study|Withdrawal by Subject|0|||
154960248|NCT02196675|559278759|FG000|Overall Study|Intra-operative surgical exclusion|1|||
154960249|NCT02196675|559278760|FG001|Overall Study|Intra-operative surgical exclusion|1|||
154960250|NCT02196675|559278761|FG002|Overall Study|Intra-operative surgical exclusion|0|||
154960251|NCT02196675|559278759|FG000|Overall Study|Protocol Violation|0|||
154960252|NCT02196675|559278760|FG001|Overall Study|Protocol Violation|1|||
154960253|NCT02196675|559278761|FG002|Overall Study|Protocol Violation|0|||
154960254|NCT02196675|559278759|FG000|Overall Study|Death|0|||
154960255|NCT02196675|559278760|FG001|Overall Study|Death|0|||
154960256|NCT02196675|559278761|FG002|Overall Study|Death|1|||
154960257|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
154960258|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
154960259|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
154960260|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
154960261|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
154960262|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
154960263|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
154960264|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
154960265|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
154960266|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
154960267|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
154960268|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
154960269|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
154960270|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
154960271|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
154960272|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
154960273|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
154960274|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
154960275|NCT02009163|559278762|FG000|Open-label Period (Non-randomized)|Other|13|||
154960276|NCT02009163|559278763|FG001|Open-label Period (Non-randomized)|Other|0|||
154960277|NCT02009163|559278764|FG002|Open-label Period (Non-randomized)|Other|0|||
154960278|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
154960279|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
154960280|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
154960281|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
154960282|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
154960283|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
154960284|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Adverse Event|0|||
154960285|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Adverse Event|0|||
154960286|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Adverse Event|6|||
154960287|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
155067166|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
155067167|NCT03329001|559676944|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067168|NCT03329001|559676945|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067169|NCT03329001|559676946|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067170|NCT03329001|559676947|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
155067171|NCT03329001|559676948|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067172|NCT03329001|559676949|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067173|NCT03329001|559676950|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067174|NCT03329001|559676951|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
155067175|NCT03329001|559676944|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067176|NCT03329001|559676945|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067177|NCT03329001|559676946|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067178|NCT03329001|559676947|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067179|NCT03329001|559676948|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067180|NCT03329001|559676949|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
155067181|NCT03329001|559676950|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067182|NCT03329001|559676951|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
155067183|NCT03329001|559676944|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067184|NCT03329001|559676945|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067185|NCT03329001|559676946|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067186|NCT03329001|559676947|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067187|NCT03329001|559676948|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
155067188|NCT03329001|559676949|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067189|NCT03329001|559676950|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067190|NCT03329001|559676951|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
155067191|NCT03329001|559676944|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155319386|NCT04299464|560605463|FG002|Overall Study|Non-compliance with Study Drug|0|||
155319387|NCT04299464|560605461|FG000|Overall Study|Reason not Specified|0|||
155319388|NCT04299464|560605462|FG001|Overall Study|Reason not Specified|1|||
155319389|NCT04299464|560605463|FG002|Overall Study|Reason not Specified|3|||
155319390|NCT04299464|560605461|FG000|Overall Study|Physician Decision|0|||
155319391|NCT04299464|560605462|FG001|Overall Study|Physician Decision|1|||
155319392|NCT04299464|560605463|FG002|Overall Study|Physician Decision|1|||
155319393|NCT04299464|560605461|FG000|Overall Study|Withdrawal by Subject|0|||
155319394|NCT04299464|560605462|FG001|Overall Study|Withdrawal by Subject|2|||
155319395|NCT04299464|560605463|FG002|Overall Study|Withdrawal by Subject|1|||
155319396|NCT03030261|560605466|FG000|Overall Study|Still receiving continuation therapy|5|||
155319397|NCT05293171|560605473|FG000|Washout 5 to 7 Days|Adverse Event|1|||
155319398|NCT05293171|560605474|FG001|Washout 5 to 7 Days|Adverse Event|1|||
155319399|NCT05293171|560605475|FG002|Washout 5 to 7 Days|Adverse Event|0|||
155319400|NCT05293171|560605476|FG003|Washout 5 to 7 Days|Adverse Event|0|||
155319401|NCT05293171|560605477|FG004|Washout 5 to 7 Days|Adverse Event|0|||
155067192|NCT03329001|559676945|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155067193|NCT03329001|559676946|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155067194|NCT03329001|559676947|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155067195|NCT03329001|559676948|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
155067196|NCT03329001|559676949|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
155067197|NCT03329001|559676950|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155067198|NCT03329001|559676951|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
155067199|NCT03329001|559676944|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067200|NCT03329001|559676945|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067201|NCT03329001|559676946|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067202|NCT03329001|559676947|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067203|NCT03329001|559676948|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
155067204|NCT03329001|559676949|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067205|NCT03329001|559676950|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067206|NCT03329001|559676951|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
155067207|NCT03329001|559676944|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155067208|NCT03329001|559676945|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155067209|NCT03329001|559676946|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155067210|NCT03329001|559676947|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155067211|NCT03329001|559676948|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
155067212|NCT03329001|559676949|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
155067213|NCT03329001|559676950|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155067214|NCT03329001|559676951|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
155067215|NCT03329001|559676944|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155067216|NCT03329001|559676945|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155067217|NCT03329001|559676946|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155067218|NCT03329001|559676947|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155067219|NCT03329001|559676948|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155067220|NCT03329001|559676949|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
155067221|NCT03329001|559676950|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
155067222|NCT03329001|559676951|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
155067223|NCT03329001|559676944|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067224|NCT03329001|559676945|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067225|NCT03329001|559676946|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067226|NCT03329001|559676947|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067227|NCT03329001|559676948|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067228|NCT03329001|559676949|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067229|NCT03329001|559676950|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
155067230|NCT03329001|559676951|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
155067231|NCT03329001|559676944|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155067232|NCT03329001|559676945|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155067233|NCT03329001|559676946|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155067234|NCT03329001|559676947|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155067235|NCT03329001|559676948|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155067236|NCT03329001|559676949|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
155067237|NCT03329001|559676950|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
155067238|NCT03329001|559676951|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
155067239|NCT03329001|559676944|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155067240|NCT03329001|559676945|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155067241|NCT03329001|559676946|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155067242|NCT03329001|559676947|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155067243|NCT03329001|559676948|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155067244|NCT03329001|559676949|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
155067245|NCT03329001|559676950|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
155067246|NCT03329001|559676951|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
155067247|NCT01138046|559676952|FG000|Overall Study|Withdrawal due to death|6|||
155067248|NCT02178956|559676955|FG000|Overall Study|Lost to Follow-up|4|||
155067249|NCT02178956|559676956|FG001|Overall Study|Lost to Follow-up|4|||
155067250|NCT02178956|559676955|FG000|Overall Study|Sponsor terminated study|49|||
155067251|NCT02178956|559676956|FG001|Overall Study|Sponsor terminated study|58|||
155067252|NCT02178956|559676955|FG000|Overall Study|Withdrawal by Subject|15|||
155067253|NCT02178956|559676956|FG001|Overall Study|Withdrawal by Subject|11|||
155067254|NCT02178956|559676955|FG000|Overall Study|Various Reasons|3|||
155067255|NCT02178956|559676956|FG001|Overall Study|Various Reasons|5|||
155067256|NCT00963235|559676960|FG000|Overall Study|Withdrawal by Subject|22|||
155067257|NCT00963235|559676960|FG000|Overall Study|Lost to Follow-up|14|||
155067258|NCT00963235|559676960|FG000|Overall Study|Failed to return|9|||
155067259|NCT00963235|559676960|FG000|Overall Study|Protocol Violation|7|||
155067260|NCT00963235|559676960|FG000|Overall Study|Adverse Event|5|||
155067261|NCT00963235|559676960|FG000|Overall Study|Physician Decision|2|||
155067262|NCT00963235|559676960|FG000|Overall Study|Other|1|||
155067263|NCT01136915|559676963|FG000|Overall Study|Lost to Follow-up|2|||
155067264|NCT01136915|559676964|FG001|Overall Study|Lost to Follow-up|0|||
155067265|NCT01136915|559676963|FG000|Overall Study|Exclusion criterion met|0|||
155067266|NCT01136915|559676964|FG001|Overall Study|Exclusion criterion met|1|||
155067267|NCT02452190|559676969|FG000|Overall Study|Withdrawal by Sponsor|1|||
155067268|NCT02452190|559676970|FG001|Overall Study|Withdrawal by Sponsor|3|||
155067269|NCT02452190|559676969|FG000|Overall Study|Pregnancy|1|||
155067270|NCT02452190|559676970|FG001|Overall Study|Pregnancy|0|||
155067271|NCT02452190|559676969|FG000|Overall Study|Investigator's Decision|2|||
155067272|NCT02452190|559676970|FG001|Overall Study|Investigator's Decision|0|||
155067273|NCT02452190|559676969|FG000|Overall Study|Lack of Efficacy|3|||
155067274|NCT02452190|559676970|FG001|Overall Study|Lack of Efficacy|1|||
155067275|NCT02452190|559676969|FG000|Overall Study|Lost to Follow-up|4|||
155067276|NCT02452190|559676970|FG001|Overall Study|Lost to Follow-up|3|||
155067277|NCT02452190|559676969|FG000|Overall Study|Adverse Event|2|||
155067278|NCT02452190|559676970|FG001|Overall Study|Adverse Event|5|||
155067279|NCT02452190|559676969|FG000|Overall Study|Withdrawal by Subject|20|||
155067280|NCT02452190|559676970|FG001|Overall Study|Withdrawal by Subject|11|||
155067281|NCT02452190|559676969|FG000|Overall Study|Noncompliance with study drug|1|||
155067282|NCT02452190|559676970|FG001|Overall Study|Noncompliance with study drug|0|||
155067283|NCT02452190|559676969|FG000|Overall Study|Participant traveled abroad|1|||
155067284|NCT02452190|559676970|FG001|Overall Study|Participant traveled abroad|0|||
155067285|NCT02452190|559676969|FG000|Overall Study|Death|0|||
155067286|NCT02452190|559676970|FG001|Overall Study|Death|1|||
155067287|NCT06001866|559676977|FG000|Overall Study|Withdrawal by Subject|0|||
155067288|NCT06001866|559676978|FG001|Overall Study|Withdrawal by Subject|2|||
155067289|NCT06001866|559676977|FG000|Overall Study|Protocol Violation|0|||
155067290|NCT06001866|559676978|FG001|Overall Study|Protocol Violation|2|||
155067291|NCT04221490|559676979|FG000|At 30 Days Follow-up|Death|7|||
155067292|NCT04221490|559676979|FG000|At 30 Days Follow-up|Missed Visit|4|||
155067293|NCT04221490|559676979|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
155067294|NCT04221490|559676979|FG000|At 6 Months Follow-up|Death|9|||
155067295|NCT04221490|559676979|FG000|At 6 Months Follow-up|Physician Decision|1|||
155067296|NCT04221490|559676979|FG000|At 6 Months Follow-up|Missed Visit|8|||
155067297|NCT04221490|559676979|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
155162442|NCT01177397|560031612|FG006|Overall Study|Death|0|||
155162443|NCT01177397|560031613|FG007|Overall Study|Death|5|||
155067298|NCT04537299|559676984|FG000|Overall Study|Withdrawal by Subject|2|||
155067299|NCT04537299|559676985|FG001|Overall Study|Withdrawal by Subject|0|||
155067300|NCT04537299|559676984|FG000|Overall Study|Protocol Violation|1|||
155067301|NCT04537299|559676985|FG001|Overall Study|Protocol Violation|1|||
155067302|NCT00314145|559676988|FG000|Overall Study|Withdrawal by Subject|8|||
155067303|NCT00314145|559676989|FG001|Overall Study|Withdrawal by Subject|10|||
155067304|NCT00314145|559676988|FG000|Overall Study|Lost to Follow-up|5|||
155067305|NCT00314145|559676989|FG001|Overall Study|Lost to Follow-up|12|||
155162444|NCT01177397|560031614|FG008|Overall Study|Death|2|||
155067306|NCT00314145|559676988|FG000|Overall Study|Physician Decision|3|||
155067307|NCT00314145|559676989|FG001|Overall Study|Physician Decision|4|||
155162445|NCT01177397|560031615|FG009|Overall Study|Death|1|||
155067308|NCT00314145|559676988|FG000|Overall Study|Adverse Event|0|||
155067309|NCT00314145|559676989|FG001|Overall Study|Adverse Event|3|||
155067310|NCT00314145|559676988|FG000|Overall Study|Protocol Violation|3|||
155067311|NCT00314145|559676989|FG001|Overall Study|Protocol Violation|0|||
155067312|NCT00314145|559676988|FG000|Overall Study|Sponsor Decision|2|||
155067313|NCT00314145|559676989|FG001|Overall Study|Sponsor Decision|0|||
155067314|NCT03314935|559676990|FG000|Phase 1|Death|4|||
155067315|NCT03314935|559676991|FG001|Phase 1|Death|2|||
155067316|NCT03314935|559676992|FG002|Phase 1|Death|5|||
155067317|NCT03314935|559676993|FG003|Phase 1|Death|4|||
155067318|NCT03314935|559676994|FG004|Phase 1|Death|3|||
155067319|NCT03314935|559676995|FG005|Phase 1|Death|4|||
155067320|NCT03314935|559676996|FG006|Phase 1|Death|5|||
155067321|NCT03314935|559676997|FG007|Phase 1|Death|4|||
155067322|NCT03314935|559676998|FG008|Phase 1|Death|3|||
155067323|NCT03314935|559676999|FG009|Phase 1|Death|0|||
155067324|NCT03314935|559677000|FG010|Phase 1|Death|0|||
155067325|NCT03314935|559677001|FG011|Phase 1|Death|0|||
155067326|NCT03314935|559677002|FG012|Phase 1|Death|0|||
155067327|NCT03314935|559677003|FG013|Phase 1|Death|0|||
155067328|NCT03314935|559677004|FG014|Phase 1|Death|0|||
155067329|NCT03314935|559676990|FG000|Phase 1|Withdrawal by Subject|2|||
155067330|NCT03314935|559676991|FG001|Phase 1|Withdrawal by Subject|1|||
155067331|NCT03314935|559676992|FG002|Phase 1|Withdrawal by Subject|1|||
155067332|NCT03314935|559676993|FG003|Phase 1|Withdrawal by Subject|2|||
155067333|NCT03314935|559676994|FG004|Phase 1|Withdrawal by Subject|1|||
155067334|NCT03314935|559676995|FG005|Phase 1|Withdrawal by Subject|0|||
155067335|NCT03314935|559676996|FG006|Phase 1|Withdrawal by Subject|1|||
155067336|NCT03314935|559676997|FG007|Phase 1|Withdrawal by Subject|0|||
155067337|NCT03314935|559676998|FG008|Phase 1|Withdrawal by Subject|1|||
155067338|NCT03314935|559676999|FG009|Phase 1|Withdrawal by Subject|0|||
155067339|NCT03314935|559677000|FG010|Phase 1|Withdrawal by Subject|0|||
155067340|NCT03314935|559677001|FG011|Phase 1|Withdrawal by Subject|0|||
155067341|NCT03314935|559677002|FG012|Phase 1|Withdrawal by Subject|0|||
155067342|NCT03314935|559677003|FG013|Phase 1|Withdrawal by Subject|0|||
155067343|NCT03314935|559677004|FG014|Phase 1|Withdrawal by Subject|0|||
155067344|NCT03314935|559676990|FG000|Phase 1|Progressive Disease|2|||
155067345|NCT03314935|559676991|FG001|Phase 1|Progressive Disease|0|||
155067346|NCT03314935|559676992|FG002|Phase 1|Progressive Disease|0|||
155067347|NCT03314935|559676993|FG003|Phase 1|Progressive Disease|1|||
155067348|NCT03314935|559676994|FG004|Phase 1|Progressive Disease|0|||
155067349|NCT03314935|559676995|FG005|Phase 1|Progressive Disease|0|||
155067350|NCT03314935|559676996|FG006|Phase 1|Progressive Disease|0|||
155067351|NCT03314935|559676997|FG007|Phase 1|Progressive Disease|0|||
155067352|NCT03314935|559676998|FG008|Phase 1|Progressive Disease|0|||
155067353|NCT03314935|559676999|FG009|Phase 1|Progressive Disease|0|||
155067354|NCT03314935|559677000|FG010|Phase 1|Progressive Disease|0|||
155067355|NCT03314935|559677001|FG011|Phase 1|Progressive Disease|0|||
155067356|NCT03314935|559677002|FG012|Phase 1|Progressive Disease|0|||
155067357|NCT03314935|559677003|FG013|Phase 1|Progressive Disease|0|||
155067358|NCT03314935|559677004|FG014|Phase 1|Progressive Disease|0|||
155067359|NCT03314935|559676990|FG000|Phase 1|Study Terminated by Sponsor|0|||
155067360|NCT03314935|559676991|FG001|Phase 1|Study Terminated by Sponsor|1|||
155067361|NCT03314935|559676992|FG002|Phase 1|Study Terminated by Sponsor|0|||
155067362|NCT03314935|559676993|FG003|Phase 1|Study Terminated by Sponsor|0|||
155067363|NCT03314935|559676994|FG004|Phase 1|Study Terminated by Sponsor|0|||
155067364|NCT03314935|559676995|FG005|Phase 1|Study Terminated by Sponsor|0|||
155067365|NCT03314935|559676996|FG006|Phase 1|Study Terminated by Sponsor|0|||
155067366|NCT03314935|559676997|FG007|Phase 1|Study Terminated by Sponsor|0|||
155162446|NCT01177397|560031616|FG010|Overall Study|Death|0|||
155067367|NCT03314935|559676998|FG008|Phase 1|Study Terminated by Sponsor|1|||
155067368|NCT03314935|559676999|FG009|Phase 1|Study Terminated by Sponsor|0|||
155067369|NCT03314935|559677000|FG010|Phase 1|Study Terminated by Sponsor|0|||
155067370|NCT03314935|559677001|FG011|Phase 1|Study Terminated by Sponsor|0|||
155067371|NCT03314935|559677002|FG012|Phase 1|Study Terminated by Sponsor|0|||
155067372|NCT03314935|559677003|FG013|Phase 1|Study Terminated by Sponsor|0|||
155067373|NCT03314935|559677004|FG014|Phase 1|Study Terminated by Sponsor|0|||
155067374|NCT03314935|559676990|FG000|Phase 1|"Captured as Other in Database"|0|||
155067375|NCT03314935|559676991|FG001|Phase 1|"Captured as Other in Database"|2|||
155067376|NCT03314935|559676992|FG002|Phase 1|"Captured as Other in Database"|0|||
155067377|NCT03314935|559676993|FG003|Phase 1|"Captured as Other in Database"|0|||
155067378|NCT03314935|559676994|FG004|Phase 1|"Captured as Other in Database"|0|||
155067379|NCT03314935|559676995|FG005|Phase 1|"Captured as Other in Database"|0|||
155067380|NCT03314935|559676996|FG006|Phase 1|"Captured as Other in Database"|1|||
155067381|NCT03314935|559676997|FG007|Phase 1|"Captured as Other in Database"|1|||
155067382|NCT03314935|559676998|FG008|Phase 1|"Captured as Other in Database"|1|||
155067383|NCT03314935|559676999|FG009|Phase 1|"Captured as Other in Database"|0|||
155067384|NCT03314935|559677000|FG010|Phase 1|"Captured as Other in Database"|0|||
155067385|NCT03314935|559677001|FG011|Phase 1|"Captured as Other in Database"|0|||
155067386|NCT03314935|559677002|FG012|Phase 1|"Captured as Other in Database"|0|||
155162447|NCT01177397|560031617|FG011|Overall Study|Death|0|||
155162448|NCT01177397|560031606|FG000|Overall Study|Withdrawal by Subject|0|||
155162449|NCT01177397|560031607|FG001|Overall Study|Withdrawal by Subject|0|||
155162450|NCT01177397|560031608|FG002|Overall Study|Withdrawal by Subject|1|||
155162451|NCT01177397|560031609|FG003|Overall Study|Withdrawal by Subject|1|||
155162452|NCT01177397|560031610|FG004|Overall Study|Withdrawal by Subject|1|||
155162453|NCT01177397|560031611|FG005|Overall Study|Withdrawal by Subject|2|||
155162454|NCT01177397|560031612|FG006|Overall Study|Withdrawal by Subject|0|||
155067387|NCT03314935|559677003|FG013|Phase 1|"Captured as Other in Database"|0|||
155067388|NCT03314935|559677004|FG014|Phase 1|"Captured as Other in Database"|0|||
155067389|NCT03314935|559676990|FG000|Phase 1|Lost to Follow-up|0|||
155067390|NCT03314935|559676991|FG001|Phase 1|Lost to Follow-up|0|||
155067391|NCT03314935|559676992|FG002|Phase 1|Lost to Follow-up|0|||
155067392|NCT03314935|559676993|FG003|Phase 1|Lost to Follow-up|0|||
155067393|NCT03314935|559676994|FG004|Phase 1|Lost to Follow-up|0|||
155067394|NCT03314935|559676995|FG005|Phase 1|Lost to Follow-up|0|||
155067395|NCT03314935|559676996|FG006|Phase 1|Lost to Follow-up|0|||
155067396|NCT03314935|559676997|FG007|Phase 1|Lost to Follow-up|0|||
155067397|NCT03314935|559676998|FG008|Phase 1|Lost to Follow-up|1|||
155067398|NCT03314935|559676999|FG009|Phase 1|Lost to Follow-up|0|||
155067399|NCT03314935|559677000|FG010|Phase 1|Lost to Follow-up|0|||
155162455|NCT01177397|560031613|FG007|Overall Study|Withdrawal by Subject|5|||
155162456|NCT01177397|560031614|FG008|Overall Study|Withdrawal by Subject|9|||
155067400|NCT03314935|559677001|FG011|Phase 1|Lost to Follow-up|0|||
155067401|NCT03314935|559677002|FG012|Phase 1|Lost to Follow-up|0|||
155067402|NCT03314935|559677003|FG013|Phase 1|Lost to Follow-up|0|||
155067403|NCT03314935|559677004|FG014|Phase 1|Lost to Follow-up|0|||
155067404|NCT03314935|559676990|FG000|Phase 2|Death|0|||
155067405|NCT03314935|559676991|FG001|Phase 2|Death|0|||
155162457|NCT01177397|560031615|FG009|Overall Study|Withdrawal by Subject|1|||
155162458|NCT01177397|560031616|FG010|Overall Study|Withdrawal by Subject|1|||
155162459|NCT01177397|560031617|FG011|Overall Study|Withdrawal by Subject|0|||
155067406|NCT03314935|559676992|FG002|Phase 2|Death|0|||
155162460|NCT01177397|560031606|FG000|Overall Study|Adverse Event|0|||
155162461|NCT01177397|560031607|FG001|Overall Study|Adverse Event|0|||
155162462|NCT01177397|560031608|FG002|Overall Study|Adverse Event|1|||
155162463|NCT01177397|560031609|FG003|Overall Study|Adverse Event|2|||
155067407|NCT03314935|559676993|FG003|Phase 2|Death|0|||
155067408|NCT03314935|559676994|FG004|Phase 2|Death|0|||
155067409|NCT03314935|559676995|FG005|Phase 2|Death|0|||
155067410|NCT03314935|559676996|FG006|Phase 2|Death|0|||
155067411|NCT03314935|559676997|FG007|Phase 2|Death|0|||
155067412|NCT03314935|559676998|FG008|Phase 2|Death|0|||
155162464|NCT01177397|560031610|FG004|Overall Study|Adverse Event|0|||
155162465|NCT01177397|560031611|FG005|Overall Study|Adverse Event|12|||
155162466|NCT01177397|560031612|FG006|Overall Study|Adverse Event|1|||
155162467|NCT01177397|560031613|FG007|Overall Study|Adverse Event|14|||
155162468|NCT01177397|560031614|FG008|Overall Study|Adverse Event|8|||
155162469|NCT01177397|560031615|FG009|Overall Study|Adverse Event|6|||
155162470|NCT01177397|560031616|FG010|Overall Study|Adverse Event|3|||
155162471|NCT01177397|560031617|FG011|Overall Study|Adverse Event|7|||
155162472|NCT01177397|560031606|FG000|Overall Study|Disease progression|1|||
155162473|NCT01177397|560031607|FG001|Overall Study|Disease progression|2|||
155162474|NCT01177397|560031608|FG002|Overall Study|Disease progression|5|||
155162475|NCT01177397|560031609|FG003|Overall Study|Disease progression|5|||
155162476|NCT01177397|560031610|FG004|Overall Study|Disease progression|4|||
155162477|NCT01177397|560031611|FG005|Overall Study|Disease progression|10|||
155162478|NCT01177397|560031612|FG006|Overall Study|Disease progression|10|||
155162479|NCT01177397|560031613|FG007|Overall Study|Disease progression|21|||
155162480|NCT01177397|560031614|FG008|Overall Study|Disease progression|18|||
155162481|NCT01177397|560031615|FG009|Overall Study|Disease progression|12|||
155162482|NCT01177397|560031616|FG010|Overall Study|Disease progression|10|||
155162483|NCT01177397|560031617|FG011|Overall Study|Disease progression|8|||
155162484|NCT01177397|560031606|FG000|Overall Study|Other reasons|0|||
155162485|NCT01177397|560031607|FG001|Overall Study|Other reasons|0|||
155067413|NCT03314935|559676999|FG009|Phase 2|Death|5|||
155067414|NCT03314935|559677000|FG010|Phase 2|Death|20|||
155067415|NCT03314935|559677001|FG011|Phase 2|Death|6|||
155067416|NCT03314935|559677002|FG012|Phase 2|Death|7|||
155067417|NCT03314935|559677003|FG013|Phase 2|Death|6|||
155162486|NCT01177397|560031608|FG002|Overall Study|Other reasons|1|||
155067418|NCT03314935|559677004|FG014|Phase 2|Death|17|||
155067419|NCT03314935|559676990|FG000|Phase 2|Withdrawal by Subject|0|||
155067420|NCT03314935|559676991|FG001|Phase 2|Withdrawal by Subject|0|||
155067421|NCT03314935|559676992|FG002|Phase 2|Withdrawal by Subject|0|||
155319402|NCT05293171|560605478|FG005|Washout 5 to 7 Days|Adverse Event|0|||
155319403|NCT05293171|560605479|FG006|Washout 5 to 7 Days|Adverse Event|0|||
155319404|NCT05293171|560605480|FG007|Washout 5 to 7 Days|Adverse Event|0|||
155319405|NCT05293171|560605481|FG008|Washout 5 to 7 Days|Adverse Event|0|||
155319406|NCT05293171|560605482|FG009|Washout 5 to 7 Days|Adverse Event|0|||
155067422|NCT03314935|559676993|FG003|Phase 2|Withdrawal by Subject|0|||
155067423|NCT03314935|559676994|FG004|Phase 2|Withdrawal by Subject|0|||
155067424|NCT03314935|559676995|FG005|Phase 2|Withdrawal by Subject|0|||
155067425|NCT03314935|559676996|FG006|Phase 2|Withdrawal by Subject|0|||
155067426|NCT03314935|559676997|FG007|Phase 2|Withdrawal by Subject|0|||
155067427|NCT03314935|559676998|FG008|Phase 2|Withdrawal by Subject|0|||
155067428|NCT03314935|559676999|FG009|Phase 2|Withdrawal by Subject|1|||
155067429|NCT03314935|559677000|FG010|Phase 2|Withdrawal by Subject|4|||
155067430|NCT03314935|559677001|FG011|Phase 2|Withdrawal by Subject|0|||
155067431|NCT03314935|559677002|FG012|Phase 2|Withdrawal by Subject|1|||
155067432|NCT03314935|559677003|FG013|Phase 2|Withdrawal by Subject|0|||
155067433|NCT03314935|559677004|FG014|Phase 2|Withdrawal by Subject|1|||
155067434|NCT03314935|559676990|FG000|Phase 2|Progressive Disease|0|||
155067435|NCT03314935|559676991|FG001|Phase 2|Progressive Disease|0|||
155067436|NCT03314935|559676992|FG002|Phase 2|Progressive Disease|0|||
155067437|NCT03314935|559676993|FG003|Phase 2|Progressive Disease|0|||
155067438|NCT03314935|559676994|FG004|Phase 2|Progressive Disease|0|||
155067439|NCT03314935|559676995|FG005|Phase 2|Progressive Disease|0|||
155067440|NCT03314935|559676996|FG006|Phase 2|Progressive Disease|0|||
155067441|NCT03314935|559676997|FG007|Phase 2|Progressive Disease|0|||
155067442|NCT03314935|559676998|FG008|Phase 2|Progressive Disease|0|||
155067443|NCT03314935|559676999|FG009|Phase 2|Progressive Disease|1|||
155067444|NCT03314935|559677000|FG010|Phase 2|Progressive Disease|1|||
155067445|NCT03314935|559677001|FG011|Phase 2|Progressive Disease|1|||
155067446|NCT03314935|559677002|FG012|Phase 2|Progressive Disease|2|||
155067447|NCT03314935|559677003|FG013|Phase 2|Progressive Disease|0|||
155067448|NCT03314935|559677004|FG014|Phase 2|Progressive Disease|1|||
155067449|NCT03314935|559676990|FG000|Phase 2|Study Terminated by Sponsor|0|||
155319407|NCT05293171|560605483|FG010|Washout 5 to 7 Days|Adverse Event|0|||
155319408|NCT05293171|560605484|FG011|Washout 5 to 7 Days|Adverse Event|0|||
155319409|NCT05293171|560605473|FG000|Washout 5 to 7 Days|Adverse Event|0|||
155067450|NCT03314935|559676991|FG001|Phase 2|Study Terminated by Sponsor|0|||
155067451|NCT03314935|559676992|FG002|Phase 2|Study Terminated by Sponsor|0|||
155067452|NCT03314935|559676993|FG003|Phase 2|Study Terminated by Sponsor|0|||
155067453|NCT03314935|559676994|FG004|Phase 2|Study Terminated by Sponsor|0|||
155067454|NCT03314935|559676995|FG005|Phase 2|Study Terminated by Sponsor|0|||
155067455|NCT03314935|559676996|FG006|Phase 2|Study Terminated by Sponsor|0|||
155162487|NCT01177397|560031609|FG003|Overall Study|Other reasons|0|||
155067456|NCT03314935|559676997|FG007|Phase 2|Study Terminated by Sponsor|0|||
155067457|NCT03314935|559676998|FG008|Phase 2|Study Terminated by Sponsor|0|||
155067458|NCT03314935|559676999|FG009|Phase 2|Study Terminated by Sponsor|0|||
155067459|NCT03314935|559677000|FG010|Phase 2|Study Terminated by Sponsor|7|||
155067460|NCT03314935|559677001|FG011|Phase 2|Study Terminated by Sponsor|2|||
155067461|NCT03314935|559677002|FG012|Phase 2|Study Terminated by Sponsor|1|||
155067462|NCT03314935|559677003|FG013|Phase 2|Study Terminated by Sponsor|4|||
155067463|NCT03314935|559677004|FG014|Phase 2|Study Terminated by Sponsor|4|||
155067464|NCT03314935|559676990|FG000|Phase 2|Lost to Follow-up|0|||
155067465|NCT03314935|559676991|FG001|Phase 2|Lost to Follow-up|0|||
155067466|NCT03314935|559676992|FG002|Phase 2|Lost to Follow-up|0|||
155067467|NCT03314935|559676993|FG003|Phase 2|Lost to Follow-up|0|||
155067468|NCT03314935|559676994|FG004|Phase 2|Lost to Follow-up|0|||
155067469|NCT03314935|559676995|FG005|Phase 2|Lost to Follow-up|0|||
155067470|NCT03314935|559676996|FG006|Phase 2|Lost to Follow-up|0|||
155067471|NCT03314935|559676997|FG007|Phase 2|Lost to Follow-up|0|||
155067472|NCT03314935|559676998|FG008|Phase 2|Lost to Follow-up|0|||
155067473|NCT03314935|559676999|FG009|Phase 2|Lost to Follow-up|1|||
155067474|NCT03314935|559677000|FG010|Phase 2|Lost to Follow-up|0|||
155067475|NCT03314935|559677001|FG011|Phase 2|Lost to Follow-up|0|||
155067476|NCT03314935|559677002|FG012|Phase 2|Lost to Follow-up|0|||
155067477|NCT03314935|559677003|FG013|Phase 2|Lost to Follow-up|0|||
155067478|NCT03314935|559677004|FG014|Phase 2|Lost to Follow-up|1|||
155067479|NCT03314935|559676990|FG000|Phase 2|Physician Decision|0|||
155067480|NCT03314935|559676991|FG001|Phase 2|Physician Decision|0|||
155067481|NCT03314935|559676992|FG002|Phase 2|Physician Decision|0|||
155067482|NCT03314935|559676993|FG003|Phase 2|Physician Decision|0|||
155067483|NCT03314935|559676994|FG004|Phase 2|Physician Decision|0|||
155067484|NCT03314935|559676995|FG005|Phase 2|Physician Decision|0|||
155067485|NCT03314935|559676996|FG006|Phase 2|Physician Decision|0|||
155067486|NCT03314935|559676997|FG007|Phase 2|Physician Decision|0|||
155067487|NCT03314935|559676998|FG008|Phase 2|Physician Decision|0|||
155067488|NCT03314935|559676999|FG009|Phase 2|Physician Decision|0|||
155067489|NCT03314935|559677000|FG010|Phase 2|Physician Decision|1|||
155067490|NCT03314935|559677001|FG011|Phase 2|Physician Decision|0|||
155067491|NCT03314935|559677002|FG012|Phase 2|Physician Decision|0|||
155067492|NCT03314935|559677003|FG013|Phase 2|Physician Decision|0|||
155067493|NCT03314935|559677004|FG014|Phase 2|Physician Decision|0|||
155067494|NCT04478266|559677005|FG000|Overall Study|Adverse Event|20|||
155067495|NCT04478266|559677006|FG001|Overall Study|Adverse Event|21|||
155067496|NCT04478266|559677005|FG000|Overall Study|Progressive disease|146|||
155067497|NCT04478266|559677006|FG001|Overall Study|Progressive disease|168|||
155067498|NCT04478266|559677005|FG000|Overall Study|Poor compliance to protocol|1|||
155067499|NCT04478266|559677006|FG001|Overall Study|Poor compliance to protocol|0|||
155067500|NCT04478266|559677005|FG000|Overall Study|Withdrawal by Subject|19|||
155067501|NCT04478266|559677006|FG001|Overall Study|Withdrawal by Subject|16|||
155067502|NCT04478266|559677005|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
155067503|NCT04478266|559677006|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
155067504|NCT04478266|559677005|FG000|Overall Study|Study terminated by sponsor|33|||
155067505|NCT04478266|559677006|FG001|Overall Study|Study terminated by sponsor|35|||
155067506|NCT04478266|559677005|FG000|Overall Study|Other: unspecified|5|||
155067507|NCT04478266|559677006|FG001|Overall Study|Other: unspecified|7|||
155067508|NCT04478266|559677005|FG000|Overall Study|Randomized but not treated|1|||
155067509|NCT04478266|559677006|FG001|Overall Study|Randomized but not treated|1|||
155067510|NCT01192178|559677007|FG000|Overall Study|Withdrawal by Subject|6|||
155067511|NCT01192178|559677008|FG001|Overall Study|Withdrawal by Subject|10|||
155067512|NCT01192178|559677007|FG000|Overall Study|Protocol Violation|10|||
155067513|NCT01192178|559677008|FG001|Overall Study|Protocol Violation|3|||
155067514|NCT01192178|559677007|FG000|Overall Study|Physician Decision|2|||
155067515|NCT01192178|559677008|FG001|Overall Study|Physician Decision|4|||
155067516|NCT01192178|559677007|FG000|Overall Study|Lost to Follow-up|3|||
155067517|NCT01192178|559677008|FG001|Overall Study|Lost to Follow-up|3|||
155067518|NCT01192178|559677007|FG000|Overall Study|Adverse Event|2|||
155067519|NCT01192178|559677008|FG001|Overall Study|Adverse Event|1|||
155067520|NCT01192178|559677007|FG000|Overall Study|Lack of Efficacy|1|||
155067521|NCT01192178|559677008|FG001|Overall Study|Lack of Efficacy|2|||
155067522|NCT02164916|559677009|FG000|Overall Study|Adverse Event|3|||
155067523|NCT02164916|559677010|FG001|Overall Study|Adverse Event|8|||
155067524|NCT02164916|559677009|FG000|Overall Study|Death|1|||
155067525|NCT02164916|559677010|FG001|Overall Study|Death|1|||
155067526|NCT02164916|559677009|FG000|Overall Study|Refusal unrelated to adverse event|3|||
155067527|NCT02164916|559677010|FG001|Overall Study|Refusal unrelated to adverse event|7|||
155319410|NCT05293171|560605474|FG001|Washout 5 to 7 Days|Adverse Event|0|||
155067528|NCT02164916|559677009|FG000|Overall Study|Progression|37|||
155067529|NCT02164916|559677010|FG001|Overall Study|Progression|26|||
155067530|NCT02164916|559677009|FG000|Overall Study|Not protocol specified|5|||
155067531|NCT02164916|559677010|FG001|Overall Study|Not protocol specified|1|||
155067532|NCT02164916|559677009|FG000|Overall Study|Reason under review|1|||
155067533|NCT02164916|559677010|FG001|Overall Study|Reason under review|6|||
155067534|NCT02164916|559677009|FG000|Overall Study|Not eligible|2|||
155319411|NCT05293171|560605475|FG002|Washout 5 to 7 Days|Adverse Event|0|||
155319412|NCT05293171|560605476|FG003|Washout 5 to 7 Days|Adverse Event|0|||
155319413|NCT05293171|560605477|FG004|Washout 5 to 7 Days|Adverse Event|0|||
155319414|NCT05293171|560605478|FG005|Washout 5 to 7 Days|Adverse Event|1|||
155319415|NCT05293171|560605479|FG006|Washout 5 to 7 Days|Adverse Event|0|||
155319416|NCT05293171|560605480|FG007|Washout 5 to 7 Days|Adverse Event|0|||
155319417|NCT05293171|560605481|FG008|Washout 5 to 7 Days|Adverse Event|0|||
155319418|NCT05293171|560605482|FG009|Washout 5 to 7 Days|Adverse Event|0|||
155319419|NCT05293171|560605483|FG010|Washout 5 to 7 Days|Adverse Event|0|||
155319420|NCT05293171|560605484|FG011|Washout 5 to 7 Days|Adverse Event|0|||
155319421|NCT04066205|560605485|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
155319422|NCT04066205|560605486|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
154960288|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
154960289|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
154960290|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
154960291|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
154960292|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
154960293|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Pregnancy|0|||
154960294|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Pregnancy|0|||
154960295|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Pregnancy|2|||
154960296|NCT02009163|559278762|FG000|Randomized-withdrawal Period|Other|0|||
154960297|NCT02009163|559278763|FG001|Randomized-withdrawal Period|Other|9|||
154960298|NCT02009163|559278764|FG002|Randomized-withdrawal Period|Other|5|||
154960299|NCT00359281|559278765|FG000|Overall Study|Adverse Event|1|||
154960300|NCT00359281|559278766|FG001|Overall Study|Adverse Event|0|||
154960301|NCT00359281|559278767|FG002|Overall Study|Adverse Event|0|||
154960302|NCT00359281|559278768|FG003|Overall Study|Adverse Event|0|||
154960303|NCT00359281|559278769|FG004|Overall Study|Adverse Event|0|||
154960304|NCT00359281|559278770|FG005|Overall Study|Adverse Event|0|||
154960305|NCT00359281|559278771|FG006|Overall Study|Adverse Event|1|||
154960306|NCT00359281|559278772|FG007|Overall Study|Adverse Event|0|||
154960307|NCT00359281|559278773|FG008|Overall Study|Adverse Event|0|||
154960308|NCT00359281|559278765|FG000|Overall Study|Withdrawal by Subject|0|||
154960309|NCT00359281|559278766|FG001|Overall Study|Withdrawal by Subject|0|||
154960310|NCT00359281|559278767|FG002|Overall Study|Withdrawal by Subject|0|||
154960311|NCT00359281|559278768|FG003|Overall Study|Withdrawal by Subject|0|||
154960312|NCT00359281|559278769|FG004|Overall Study|Withdrawal by Subject|0|||
154960313|NCT00359281|559278770|FG005|Overall Study|Withdrawal by Subject|0|||
154960314|NCT00359281|559278771|FG006|Overall Study|Withdrawal by Subject|1|||
154960315|NCT00359281|559278772|FG007|Overall Study|Withdrawal by Subject|0|||
154960316|NCT00359281|559278773|FG008|Overall Study|Withdrawal by Subject|0|||
154960317|NCT01415986|559278774|FG000|Overall Study|Lost to Follow-up|1|||
154960318|NCT04419311|559278775|FG000|Overall Study|Lost to Follow-up|1|||
154960319|NCT04419311|559278776|FG001|Overall Study|Lost to Follow-up|0|||
154960320|NCT03122457|559278782|FG000|Overall Study|Withdrawal by Subject|6|||
154960321|NCT03686033|559278783|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
154960322|NCT03686033|559278784|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
154960323|NCT03686033|559278785|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
154960324|NCT03686033|559278786|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
154960325|NCT03686033|559278787|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
154960326|NCT03686033|559278788|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
154960327|NCT01302548|559278790|FG000|Overall Study|Lost to Follow-up|2|||
154960328|NCT01302548|559278791|FG001|Overall Study|Lost to Follow-up|1|||
155319423|NCT04066205|560605485|FG000|T2 Immediate Post-Intervention|did not respond|5|||
155319424|NCT04066205|560605486|FG001|T2 Immediate Post-Intervention|did not respond|3|||
154960329|NCT02089997|559278794|FG000|Overall Study|Case report forms uncollected|99|||
154960330|NCT02089997|559278794|FG000|Overall Study|Protocol Violation|147|||
154960331|NCT02335658|559278797|FG000|Overall Study|Adverse Event|18|||
154960332|NCT02335658|559278798|FG001|Overall Study|Adverse Event|12|||
154960333|NCT02335658|559278797|FG000|Overall Study|Lack of Efficacy|4|||
154960334|NCT02335658|559278798|FG001|Overall Study|Lack of Efficacy|5|||
154960335|NCT02335658|559278797|FG000|Overall Study|Pregnancy|1|||
154960336|NCT02335658|559278798|FG001|Overall Study|Pregnancy|0|||
154960337|NCT02335658|559278797|FG000|Overall Study|Withdrawal by Subject|13|||
154960338|NCT02335658|559278798|FG001|Overall Study|Withdrawal by Subject|21|||
154960339|NCT02335658|559278797|FG000|Overall Study|non-compliance|2|||
154960340|NCT02335658|559278798|FG001|Overall Study|non-compliance|3|||
154960341|NCT02335658|559278797|FG000|Overall Study|other reason|2|||
155162488|NCT01177397|560031610|FG004|Overall Study|Other reasons|1|||
155162489|NCT01177397|560031611|FG005|Overall Study|Other reasons|1|||
155319425|NCT02052882|560605487|FG000|Overall Study|Not treated|11|||
155319426|NCT02052882|560605487|FG000|Overall Study|Protocol Violation|1|||
155319427|NCT02052882|560605487|FG000|Overall Study|Inadequate testing|1|||
155319428|NCT03987022|560605491|FG000|Overall Study|Lost to Follow-up|2|||
155319429|NCT03987022|560605492|FG001|Overall Study|Lost to Follow-up|2|||
155319430|NCT03987022|560605491|FG000|Overall Study|Withdrawal by Subject|1|||
155319431|NCT03987022|560605492|FG001|Overall Study|Withdrawal by Subject|0|||
155319432|NCT05170841|560605494|FG000|Single Dose Phase|Adverse Event|1|||
155319433|NCT05170841|560605495|FG001|Single Dose Phase|Adverse Event|2|||
155319434|NCT05170841|560605496|FG002|Single Dose Phase|Adverse Event|0|||
155319435|NCT05170841|560605497|FG003|Single Dose Phase|Adverse Event|2|||
155319436|NCT05170841|560605494|FG000|Multiple Dose Phase|Adverse Event|1|||
155319437|NCT05170841|560605495|FG001|Multiple Dose Phase|Adverse Event|2|||
155319438|NCT05170841|560605496|FG002|Multiple Dose Phase|Adverse Event|1|||
154960342|NCT02335658|559278798|FG001|Overall Study|other reason|3|||
154960343|NCT02032888|559278799|FG000|Treatment Period|Poor compliance/noncompliance|1|||
154960344|NCT02032888|559278800|FG001|Treatment Period|Poor compliance/noncompliance|1|||
154960345|NCT02032888|559278801|FG002|Treatment Period|Poor compliance/noncompliance|0|||
154960346|NCT02032888|559278799|FG000|Treatment Period|Other|1|||
154960347|NCT02032888|559278800|FG001|Treatment Period|Other|1|||
154960348|NCT02032888|559278801|FG002|Treatment Period|Other|0|||
154960349|NCT02032888|559278799|FG000|Follow-up Period|Lost to Follow-up|1|||
154960350|NCT02032888|559278800|FG001|Follow-up Period|Lost to Follow-up|1|||
154960351|NCT02032888|559278801|FG002|Follow-up Period|Lost to Follow-up|0|||
154960352|NCT02032888|559278799|FG000|Follow-up Period|Death|1|||
154960353|NCT02032888|559278800|FG001|Follow-up Period|Death|1|||
154960354|NCT02032888|559278801|FG002|Follow-up Period|Death|0|||
154960355|NCT02032888|559278799|FG000|Follow-up Period|Other|1|||
154960356|NCT02032888|559278800|FG001|Follow-up Period|Other|0|||
154960357|NCT02032888|559278801|FG002|Follow-up Period|Other|0|||
154960358|NCT01754597|559278804|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
154960359|NCT01754597|559278805|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
154960360|NCT00819741|559278806|FG000|Overall Study|Adverse Event|5|||
154960361|NCT00819741|559278807|FG001|Overall Study|Adverse Event|2|||
154960362|NCT00819741|559278806|FG000|Overall Study|Lack of Efficacy|0|||
154960363|NCT00819741|559278807|FG001|Overall Study|Lack of Efficacy|2|||
154960364|NCT00819741|559278806|FG000|Overall Study|Lost to Follow-up|3|||
154960365|NCT00819741|559278807|FG001|Overall Study|Lost to Follow-up|1|||
154960366|NCT00819741|559278806|FG000|Overall Study|Protocol Violation|3|||
154960367|NCT00819741|559278807|FG001|Overall Study|Protocol Violation|4|||
154960368|NCT00819741|559278806|FG000|Overall Study|Withdrawal by Subject|2|||
154960369|NCT00819741|559278807|FG001|Overall Study|Withdrawal by Subject|2|||
154960370|NCT00819741|559278806|FG000|Overall Study|Unclassified|6|||
154960371|NCT00819741|559278807|FG001|Overall Study|Unclassified|0|||
154960372|NCT00819741|559278806|FG000|Overall Study|Reasons unknown|3|||
154960373|NCT00819741|559278807|FG001|Overall Study|Reasons unknown|3|||
154960374|NCT04115293|559280277|FG000|Overall Study|Adverse Event|0|||
154960375|NCT04115293|559280278|FG001|Overall Study|Adverse Event|2|||
154960376|NCT04115293|559280277|FG000|Overall Study|Withdrawal by Subject|2|||
154960377|NCT04115293|559280278|FG001|Overall Study|Withdrawal by Subject|1|||
154960378|NCT04115293|559280277|FG000|Overall Study|Physician Decision|1|||
154960379|NCT04115293|559280278|FG001|Overall Study|Physician Decision|0|||
154960380|NCT04115293|559280277|FG000|Overall Study|Death|1|||
154960381|NCT04115293|559280278|FG001|Overall Study|Death|1|||
154960382|NCT03071575|559280279|FG000|Overall Study|Death|0|||
154960383|NCT03071575|559280280|FG001|Overall Study|Death|1|||
154960384|NCT03071575|559280279|FG000|Overall Study|Lost to Follow-up|5|||
154960385|NCT03071575|559280280|FG001|Overall Study|Lost to Follow-up|11|||
154960386|NCT03071575|559280279|FG000|Overall Study|Withdrawal by Subject|4|||
154960387|NCT03071575|559280280|FG001|Overall Study|Withdrawal by Subject|2|||
154960388|NCT00462345|559280284|FG000|Overall Study|Withdrawal by Subject|2|||
154960389|NCT00462345|559280284|FG000|Overall Study|Did not complete second course|1|||
154960390|NCT02267187|559280285|FG000|Overall Study|Physician Decision|2|||
154960391|NCT02267187|559280285|FG000|Overall Study|Screen fail|3|||
154960392|NCT00508651|559280286|FG000|Overall Study|Lost to Follow-up|3|||
154960393|NCT00508651|559280287|FG001|Overall Study|Lost to Follow-up|1|||
154960394|NCT00508651|559280286|FG000|Overall Study|Withdrawal by Subject|1|||
154960395|NCT00508651|559280287|FG001|Overall Study|Withdrawal by Subject|1|||
154960396|NCT03570749|559280290|FG000|Overall Study|Ongoing|26|||
154960397|NCT03570749|559280291|FG001|Overall Study|Ongoing|25|||
155162490|NCT01177397|560031612|FG006|Overall Study|Other reasons|2|||
154960398|NCT03570749|559280292|FG002|Overall Study|Ongoing|25|||
154960399|NCT03570749|559280293|FG003|Overall Study|Ongoing|26|||
154960400|NCT03570749|559280294|FG004|Overall Study|Ongoing|140|||
154960401|NCT03570749|559280295|FG005|Overall Study|Ongoing|142|||
154960402|NCT03570749|559280296|FG006|Overall Study|Ongoing|220|||
154960403|NCT03570749|559280290|FG000|Overall Study|Adverse Event|0|||
155319439|NCT05170841|560605497|FG003|Multiple Dose Phase|Adverse Event|4|||
155067535|NCT02164916|559677010|FG001|Overall Study|Not eligible|5|||
155067536|NCT00964782|559677013|FG000|Overall Study|Lost to Follow-up|1|||
155067537|NCT00964782|559677014|FG001|Overall Study|Lost to Follow-up|0|||
155067538|NCT00862992|559677021|FG000|Overall Study|Adverse Event|2|||
155067539|NCT00862992|559677022|FG001|Overall Study|Adverse Event|1|||
155067540|NCT00862992|559677023|FG002|Overall Study|Adverse Event|1|||
155067541|NCT00862992|559677021|FG000|Overall Study|Physician Decision|1|||
155067542|NCT00862992|559677022|FG001|Overall Study|Physician Decision|0|||
155067543|NCT00862992|559677023|FG002|Overall Study|Physician Decision|0|||
155067544|NCT00862992|559677021|FG000|Overall Study|Withdrawal by Subject|0|||
155067545|NCT00862992|559677022|FG001|Overall Study|Withdrawal by Subject|0|||
155067546|NCT00862992|559677023|FG002|Overall Study|Withdrawal by Subject|2|||
155067547|NCT00720759|559677024|FG000|Overall Study|Lost to Follow-up|0|||
155067548|NCT00720759|559677025|FG001|Overall Study|Lost to Follow-up|1|||
155067549|NCT00720759|559677026|FG002|Overall Study|Lost to Follow-up|1|||
155067550|NCT00720759|559677027|FG003|Overall Study|Lost to Follow-up|0|||
155067551|NCT02318940|559677028|FG000|Overall Study|lost the record|1|||
155067552|NCT02318940|559677029|FG001|Overall Study|lost the record|0|||
155067553|NCT01157845|559677038|FG000|Overall Study|Lost to Follow-up|5|||
155067554|NCT01157845|559677038|FG000|Overall Study|Withdrawal by Subject|12|||
155067555|NCT01157845|559677038|FG000|Overall Study|Physician Decision|3|||
155067556|NCT01157845|559677038|FG000|Overall Study|Protocol Violation|13|||
155067557|NCT01157845|559677038|FG000|Overall Study|Study was ended|1|||
155067558|NCT01157845|559677038|FG000|Overall Study|Device malfunction|1|||
155067559|NCT03311555|559677039|FG000|Overall Study|Adverse Event|1|||
155067560|NCT01240746|559678831|FG000|Overall Study|Adverse Event|2|||
155067561|NCT01240746|559678832|FG001|Overall Study|Adverse Event|0|||
155067562|NCT01240746|559678833|FG002|Overall Study|Adverse Event|10|||
155067563|NCT01240746|559678831|FG000|Overall Study|Lost to Follow-up|23|||
155319440|NCT05170841|560605494|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
155319441|NCT05170841|560605495|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
155319442|NCT05170841|560605496|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
155319443|NCT05170841|560605497|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
155319444|NCT05123586|560605500|FG000|Overall Study|Physician Decision|1|||
155319445|NCT05123586|560605501|FG001|Overall Study|Physician Decision|1|||
155319446|NCT05123586|560605500|FG000|Overall Study|Withdrawal by Subject|0|||
155319447|NCT05123586|560605501|FG001|Overall Study|Withdrawal by Subject|3|||
155319448|NCT06122194|560605517|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
155319449|NCT06122194|560605518|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
155319450|NCT06122194|560605519|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
155319451|NCT06122194|560605520|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
155319452|NCT05218096|560605521|FG000|Primary Evaluation|Withdrawal by Subject|0|||
155319453|NCT05218096|560605522|FG001|Primary Evaluation|Withdrawal by Subject|0|||
155319454|NCT05218096|560605523|FG002|Primary Evaluation|Withdrawal by Subject|2|||
155319455|NCT05218096|560605524|FG003|Primary Evaluation|Withdrawal by Subject|0|||
155319456|NCT05218096|560605525|FG004|Primary Evaluation|Withdrawal by Subject|0|||
155319457|NCT05218096|560605521|FG000|Primary Evaluation|Physician Decision|1|||
155319458|NCT05218096|560605522|FG001|Primary Evaluation|Physician Decision|0|||
155319459|NCT05218096|560605523|FG002|Primary Evaluation|Physician Decision|0|||
155319460|NCT05218096|560605524|FG003|Primary Evaluation|Physician Decision|0|||
155319461|NCT05218096|560605525|FG004|Primary Evaluation|Physician Decision|0|||
155319462|NCT05218096|560605521|FG000|Extended Treatment|Clinical Deterioration|1|||
155319463|NCT05218096|560605522|FG001|Extended Treatment|Clinical Deterioration|1|||
155319464|NCT05218096|560605523|FG002|Extended Treatment|Clinical Deterioration|0|||
155319465|NCT05218096|560605524|FG003|Extended Treatment|Clinical Deterioration|0|||
155319466|NCT05218096|560605525|FG004|Extended Treatment|Clinical Deterioration|0|||
155319467|NCT05218096|560605521|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
155319468|NCT05218096|560605522|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
155319469|NCT05218096|560605523|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
155319470|NCT05218096|560605524|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
155067564|NCT01240746|559678832|FG001|Overall Study|Lost to Follow-up|20|||
155067565|NCT01240746|559678833|FG002|Overall Study|Lost to Follow-up|102|||
155067566|NCT01240746|559678831|FG000|Overall Study|Protocol Violation|24|||
155067567|NCT01240746|559678832|FG001|Overall Study|Protocol Violation|15|||
155067568|NCT01240746|559678833|FG002|Overall Study|Protocol Violation|72|||
155319471|NCT05218096|560605525|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
155319472|NCT05218096|560605521|FG000|Extended Treatment|Withdrawal by Subject|1|||
155067569|NCT01240746|559678831|FG000|Overall Study|Withdrawal by Subject|10|||
155067570|NCT01240746|559678832|FG001|Overall Study|Withdrawal by Subject|13|||
155067571|NCT01240746|559678833|FG002|Overall Study|Withdrawal by Subject|59|||
155067572|NCT01137786|559678836|FG000|Overall Study|Lost to Follow-up|0|||
155067573|NCT01137786|559678837|FG001|Overall Study|Lost to Follow-up|2|||
155067574|NCT01137786|559678836|FG000|Overall Study|Withdrawal by Subject|1|||
155067575|NCT01137786|559678837|FG001|Overall Study|Withdrawal by Subject|1|||
155067576|NCT02239328|559678838|FG000|Overall Study|Benign disease noted at time of surgery|6|||
155067577|NCT02239328|559678838|FG000|Overall Study|Equipment or website malfunction|2|||
155067578|NCT00460798|559678840|FG000|Overall Study|Death|59|||
155067579|NCT00460798|559678840|FG000|Overall Study|Adverse Event|27|||
155067580|NCT00460798|559678840|FG000|Overall Study|Lost to Follow-up|19|||
155067581|NCT00460798|559678840|FG000|Overall Study|Progressive Disease|99|||
155067582|NCT00460798|559678840|FG000|Overall Study|Other|27|||
155067583|NCT00460798|559678840|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
155067584|NCT00460798|559678840|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
155067585|NCT03881371|559678845|FG000|Overall Study|Adverse Event|8|||
155067586|NCT03881371|559678846|FG001|Overall Study|Adverse Event|9|||
155067587|NCT03881371|559678845|FG000|Overall Study|Death|1|||
155067588|NCT03881371|559678846|FG001|Overall Study|Death|0|||
155067589|NCT03881371|559678845|FG000|Overall Study|Lost to Follow-up|1|||
155067590|NCT03881371|559678846|FG001|Overall Study|Lost to Follow-up|0|||
155067591|NCT03881371|559678845|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155067592|NCT03881371|559678846|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155067593|NCT03881371|559678845|FG000|Overall Study|Physician Decision|3|||
155067594|NCT03881371|559678846|FG001|Overall Study|Physician Decision|3|||
155067595|NCT03881371|559678845|FG000|Overall Study|Withdrawal by Subject|2|||
155067596|NCT03881371|559678846|FG001|Overall Study|Withdrawal by Subject|10|||
155067597|NCT03881371|559678845|FG000|Overall Study|Discontinuation from Study|1|||
155067598|NCT03881371|559678846|FG001|Overall Study|Discontinuation from Study|0|||
155067599|NCT01104766|559678847|FG000|Overall Study|Did not meet inc/exc criteria|1|||
155067600|NCT01104766|559678848|FG001|Overall Study|Did not meet inc/exc criteria|0|||
155067601|NCT01104766|559678849|FG002|Overall Study|Did not meet inc/exc criteria|0|||
155067602|NCT01104766|559678850|FG003|Overall Study|Did not meet inc/exc criteria|0|||
155067603|NCT01104766|559678847|FG000|Overall Study|Adverse Event|17|||
155067604|NCT01104766|559678848|FG001|Overall Study|Adverse Event|15|||
155067605|NCT01104766|559678849|FG002|Overall Study|Adverse Event|20|||
155067606|NCT01104766|559678850|FG003|Overall Study|Adverse Event|14|||
155067607|NCT01104766|559678847|FG000|Overall Study|Lack of Efficacy|20|||
155067608|NCT01104766|559678848|FG001|Overall Study|Lack of Efficacy|15|||
155067609|NCT01104766|559678849|FG002|Overall Study|Lack of Efficacy|14|||
155067610|NCT01104766|559678850|FG003|Overall Study|Lack of Efficacy|8|||
155067611|NCT01104766|559678847|FG000|Overall Study|Protocol Violation|2|||
155067612|NCT01104766|559678848|FG001|Overall Study|Protocol Violation|0|||
155067613|NCT01104766|559678849|FG002|Overall Study|Protocol Violation|0|||
155067614|NCT01104766|559678850|FG003|Overall Study|Protocol Violation|0|||
155067615|NCT01104766|559678847|FG000|Overall Study|Withdrawal by Subject|17|||
155067616|NCT01104766|559678848|FG001|Overall Study|Withdrawal by Subject|19|||
155067617|NCT01104766|559678849|FG002|Overall Study|Withdrawal by Subject|25|||
155067618|NCT01104766|559678850|FG003|Overall Study|Withdrawal by Subject|15|||
155067619|NCT01104766|559678847|FG000|Overall Study|Lost to Follow-up|1|||
155067620|NCT01104766|559678848|FG001|Overall Study|Lost to Follow-up|2|||
155067621|NCT01104766|559678849|FG002|Overall Study|Lost to Follow-up|1|||
155067622|NCT01104766|559678850|FG003|Overall Study|Lost to Follow-up|1|||
155067623|NCT01756235|559678851|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
155067624|NCT05376358|559678852|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
155067625|NCT05376358|559678853|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
155067626|NCT05376358|559678852|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
155067627|NCT05376358|559678853|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
155067628|NCT05376358|559678852|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
155067629|NCT05376358|559678853|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
155067630|NCT05376358|559678852|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
155067631|NCT05376358|559678853|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
155067632|NCT05376358|559678852|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
155067633|NCT05376358|559678853|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
155067634|NCT05376358|559678852|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
155067635|NCT05376358|559678853|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
155067636|NCT04225832|559678854|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
155067637|NCT04225832|559678855|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
155067638|NCT04225832|559678854|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
155067639|NCT04225832|559678855|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
155067640|NCT00311168|559678856|FG000|First Intervention|Withdrawal by Subject|2|||
155067641|NCT00311168|559678857|FG001|First Intervention|Withdrawal by Subject|2|||
155067642|NCT00311168|559678856|FG000|First Intervention|Lost to Follow-up|1|||
155067643|NCT00311168|559678857|FG001|First Intervention|Lost to Follow-up|1|||
155067644|NCT00311168|559678856|FG000|First Intervention|Protocol Violation|1|||
155067645|NCT00311168|559678857|FG001|First Intervention|Protocol Violation|1|||
155067646|NCT00311168|559678856|FG000|First Intervention|Adverse Event|1|||
155067647|NCT00311168|559678857|FG001|First Intervention|Adverse Event|0|||
155067648|NCT00311168|559678856|FG000|First Intervention|Other|2|||
155067649|NCT00311168|559678857|FG001|First Intervention|Other|2|||
155067650|NCT00311168|559678856|FG000|Second Intervention|Lost to Follow-up|9|||
155067651|NCT00311168|559678857|FG001|Second Intervention|Lost to Follow-up|2|||
155067652|NCT00311168|559678856|FG000|Second Intervention|Withdrawal by Subject|0|||
155067653|NCT00311168|559678857|FG001|Second Intervention|Withdrawal by Subject|1|||
155067654|NCT00311168|559678856|FG000|Second Intervention|Other|1|||
155067655|NCT00311168|559678857|FG001|Second Intervention|Other|1|||
155067656|NCT03965923|559678860|FG000|Overall Study|Withdrawal by Subject|1|||
155067657|NCT03965923|559678861|FG001|Overall Study|Withdrawal by Subject|2|||
155067658|NCT03965923|559678862|FG002|Overall Study|Withdrawal by Subject|3|||
155067659|NCT03965923|559678863|FG003|Overall Study|Withdrawal by Subject|1|||
155067660|NCT03965923|559678864|FG004|Overall Study|Withdrawal by Subject|2|||
155067661|NCT03965923|559678865|FG005|Overall Study|Withdrawal by Subject|0|||
155067662|NCT03965923|559678866|FG006|Overall Study|Withdrawal by Subject|4|||
155067663|NCT03965923|559678867|FG007|Overall Study|Withdrawal by Subject|3|||
155067664|NCT03965923|559678868|FG008|Overall Study|Withdrawal by Subject|4|||
155067665|NCT03965923|559678869|FG009|Overall Study|Withdrawal by Subject|0|||
154960404|NCT03570749|559280291|FG001|Overall Study|Adverse Event|0|||
154960405|NCT03570749|559280292|FG002|Overall Study|Adverse Event|0|||
154960406|NCT03570749|559280293|FG003|Overall Study|Adverse Event|0|||
154960407|NCT03570749|559280294|FG004|Overall Study|Adverse Event|2|||
154960408|NCT03570749|559280295|FG005|Overall Study|Adverse Event|3|||
154960409|NCT03570749|559280296|FG006|Overall Study|Adverse Event|6|||
154960410|NCT03570749|559280290|FG000|Overall Study|Lack of Efficacy|0|||
154960411|NCT03570749|559280291|FG001|Overall Study|Lack of Efficacy|0|||
154960412|NCT03570749|559280292|FG002|Overall Study|Lack of Efficacy|0|||
154960413|NCT03570749|559280293|FG003|Overall Study|Lack of Efficacy|0|||
154960414|NCT03570749|559280294|FG004|Overall Study|Lack of Efficacy|8|||
154960415|NCT03570749|559280295|FG005|Overall Study|Lack of Efficacy|2|||
154960416|NCT03570749|559280296|FG006|Overall Study|Lack of Efficacy|7|||
154960417|NCT03570749|559280290|FG000|Overall Study|Lost to Follow-up|0|||
154960418|NCT03570749|559280291|FG001|Overall Study|Lost to Follow-up|0|||
154960419|NCT03570749|559280292|FG002|Overall Study|Lost to Follow-up|0|||
154960420|NCT03570749|559280293|FG003|Overall Study|Lost to Follow-up|0|||
154960421|NCT03570749|559280294|FG004|Overall Study|Lost to Follow-up|5|||
154960422|NCT03570749|559280295|FG005|Overall Study|Lost to Follow-up|10|||
154960423|NCT03570749|559280296|FG006|Overall Study|Lost to Follow-up|10|||
154960424|NCT03570749|559280290|FG000|Overall Study|Pregnancy|0|||
154960425|NCT03570749|559280291|FG001|Overall Study|Pregnancy|0|||
154960426|NCT03570749|559280292|FG002|Overall Study|Pregnancy|0|||
154960427|NCT03570749|559280293|FG003|Overall Study|Pregnancy|0|||
154960428|NCT03570749|559280294|FG004|Overall Study|Pregnancy|0|||
154960429|NCT03570749|559280295|FG005|Overall Study|Pregnancy|1|||
154960430|NCT03570749|559280296|FG006|Overall Study|Pregnancy|1|||
154960431|NCT03570749|559280290|FG000|Overall Study|Screen Fail|0|||
154960432|NCT03570749|559280291|FG001|Overall Study|Screen Fail|0|||
155067666|NCT03965923|559678870|FG010|Overall Study|Withdrawal by Subject|2|||
155067667|NCT03965923|559678871|FG011|Overall Study|Withdrawal by Subject|0|||
155067668|NCT03965923|559678860|FG000|Overall Study|Lost to Follow-up|2|||
155067669|NCT03965923|559678861|FG001|Overall Study|Lost to Follow-up|1|||
155067670|NCT03965923|559678862|FG002|Overall Study|Lost to Follow-up|1|||
155067671|NCT03965923|559678863|FG003|Overall Study|Lost to Follow-up|0|||
154960433|NCT03570749|559280292|FG002|Overall Study|Screen Fail|0|||
154960434|NCT03570749|559280293|FG003|Overall Study|Screen Fail|0|||
154960435|NCT03570749|559280294|FG004|Overall Study|Screen Fail|0|||
155319473|NCT05218096|560605522|FG001|Extended Treatment|Withdrawal by Subject|3|||
155319474|NCT05218096|560605523|FG002|Extended Treatment|Withdrawal by Subject|0|||
155319475|NCT05218096|560605524|FG003|Extended Treatment|Withdrawal by Subject|2|||
155319476|NCT05218096|560605525|FG004|Extended Treatment|Withdrawal by Subject|2|||
155319477|NCT05218096|560605521|FG000|Extended Treatment|Lack of Efficacy|3|||
155319478|NCT05218096|560605522|FG001|Extended Treatment|Lack of Efficacy|0|||
155319479|NCT05218096|560605523|FG002|Extended Treatment|Lack of Efficacy|0|||
155319480|NCT05218096|560605524|FG003|Extended Treatment|Lack of Efficacy|0|||
155319481|NCT05218096|560605525|FG004|Extended Treatment|Lack of Efficacy|0|||
155319482|NCT05218096|560605521|FG000|Extended Treatment|Physician Decision|0|||
155319483|NCT05218096|560605522|FG001|Extended Treatment|Physician Decision|1|||
155319484|NCT05218096|560605523|FG002|Extended Treatment|Physician Decision|0|||
155319485|NCT05218096|560605524|FG003|Extended Treatment|Physician Decision|0|||
155319486|NCT05218096|560605525|FG004|Extended Treatment|Physician Decision|0|||
155319487|NCT05218096|560605521|FG000|Open-label Extension|Adverse Event|1|||
155319488|NCT05218096|560605522|FG001|Open-label Extension|Adverse Event|0|||
155319489|NCT05218096|560605523|FG002|Open-label Extension|Adverse Event|0|||
155319490|NCT05218096|560605524|FG003|Open-label Extension|Adverse Event|0|||
155319491|NCT05218096|560605525|FG004|Open-label Extension|Adverse Event|1|||
155319492|NCT05218096|560605521|FG000|Open-label Extension|Pregnancy|0|||
155319493|NCT05218096|560605522|FG001|Open-label Extension|Pregnancy|0|||
155319494|NCT05218096|560605523|FG002|Open-label Extension|Pregnancy|0|||
155319495|NCT05218096|560605524|FG003|Open-label Extension|Pregnancy|0|||
155319496|NCT05218096|560605525|FG004|Open-label Extension|Pregnancy|1|||
155319497|NCT05218096|560605521|FG000|Open-label Extension|Lack of Efficacy|1|||
155067672|NCT03965923|559678864|FG004|Overall Study|Lost to Follow-up|2|||
155067673|NCT03965923|559678865|FG005|Overall Study|Lost to Follow-up|1|||
155067674|NCT03965923|559678866|FG006|Overall Study|Lost to Follow-up|2|||
155067675|NCT03965923|559678867|FG007|Overall Study|Lost to Follow-up|1|||
155067676|NCT03965923|559678868|FG008|Overall Study|Lost to Follow-up|0|||
155067677|NCT03965923|559678869|FG009|Overall Study|Lost to Follow-up|2|||
155067678|NCT03965923|559678870|FG010|Overall Study|Lost to Follow-up|0|||
155067679|NCT03965923|559678871|FG011|Overall Study|Lost to Follow-up|0|||
155067680|NCT03965923|559678860|FG000|Overall Study|Death|0|||
155067681|NCT03965923|559678861|FG001|Overall Study|Death|0|||
155067682|NCT03965923|559678862|FG002|Overall Study|Death|0|||
155067683|NCT03965923|559678863|FG003|Overall Study|Death|0|||
155067684|NCT03965923|559678864|FG004|Overall Study|Death|0|||
155067685|NCT03965923|559678865|FG005|Overall Study|Death|0|||
155067686|NCT03965923|559678866|FG006|Overall Study|Death|0|||
155067687|NCT03965923|559678867|FG007|Overall Study|Death|1|||
155319498|NCT05218096|560605522|FG001|Open-label Extension|Lack of Efficacy|2|||
154960436|NCT03570749|559280295|FG005|Overall Study|Screen Fail|0|||
154960437|NCT03570749|559280296|FG006|Overall Study|Screen Fail|1|||
154960438|NCT03570749|559280290|FG000|Overall Study|Withdrawal by Subject|2|||
154960439|NCT03570749|559280291|FG001|Overall Study|Withdrawal by Subject|3|||
154960440|NCT03570749|559280292|FG002|Overall Study|Withdrawal by Subject|2|||
154960441|NCT03570749|559280293|FG003|Overall Study|Withdrawal by Subject|1|||
154960442|NCT03570749|559280294|FG004|Overall Study|Withdrawal by Subject|17|||
154960443|NCT03570749|559280295|FG005|Overall Study|Withdrawal by Subject|12|||
154960444|NCT03570749|559280296|FG006|Overall Study|Withdrawal by Subject|15|||
154960445|NCT03570749|559280290|FG000|Overall Study|Other|0|||
154960446|NCT03570749|559280291|FG001|Overall Study|Other|0|||
154960447|NCT03570749|559280292|FG002|Overall Study|Other|0|||
154960448|NCT03570749|559280293|FG003|Overall Study|Other|0|||
154960449|NCT03570749|559280294|FG004|Overall Study|Other|17|||
154960450|NCT03570749|559280295|FG005|Overall Study|Other|14|||
154960451|NCT03570749|559280296|FG006|Overall Study|Other|21|||
154960452|NCT00583453|559280299|FG000|Overall Study|discontinued intervention|0|||
155319499|NCT05218096|560605523|FG002|Open-label Extension|Lack of Efficacy|0|||
155319500|NCT05218096|560605524|FG003|Open-label Extension|Lack of Efficacy|0|||
155319501|NCT05218096|560605525|FG004|Open-label Extension|Lack of Efficacy|0|||
155319502|NCT05218096|560605521|FG000|Open-label Extension|Lost to Follow-up|1|||
155319503|NCT05218096|560605522|FG001|Open-label Extension|Lost to Follow-up|0|||
154960453|NCT00583453|559280300|FG001|Overall Study|discontinued intervention|2|||
154960454|NCT00905606|559280301|FG000|Period 1|Adverse Event|0|||
154960455|NCT00905606|559280302|FG001|Period 1|Adverse Event|1|||
155067688|NCT03965923|559678868|FG008|Overall Study|Death|4|||
155067689|NCT03965923|559678869|FG009|Overall Study|Death|0|||
155067690|NCT03965923|559678870|FG010|Overall Study|Death|4|||
155319504|NCT05218096|560605523|FG002|Open-label Extension|Lost to Follow-up|0|||
155319505|NCT05218096|560605524|FG003|Open-label Extension|Lost to Follow-up|0|||
155319506|NCT05218096|560605525|FG004|Open-label Extension|Lost to Follow-up|0|||
155319507|NCT05218096|560605521|FG000|Open-label Extension|Death|0|||
155319508|NCT05218096|560605522|FG001|Open-label Extension|Death|0|||
155319509|NCT05218096|560605523|FG002|Open-label Extension|Death|0|||
155319510|NCT05218096|560605524|FG003|Open-label Extension|Death|1|||
155319511|NCT05218096|560605525|FG004|Open-label Extension|Death|0|||
155319512|NCT05218096|560605521|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
155319513|NCT05218096|560605522|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
155319514|NCT05218096|560605523|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
155319515|NCT05218096|560605524|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
155319516|NCT05218096|560605525|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
155319517|NCT05863156|560605533|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
155319518|NCT05863156|560605534|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
154960456|NCT00905606|559280301|FG000|Washout|Withdrawal by Subject|1|||
154960457|NCT00905606|559280302|FG001|Washout|Withdrawal by Subject|0|||
154960458|NCT01558635|559280303|FG000|Overall Study|Death|1|||
154960459|NCT01558635|559280303|FG000|Overall Study|Withdrawal by Subject|2|||
154960460|NCT01558635|559280303|FG000|Overall Study|Physician Decision|1|||
154960461|NCT01558635|559280303|FG000|Overall Study|Subject received other treatment|1|||
154960462|NCT01558635|559280303|FG000|Overall Study|Reveal XT was explanted|1|||
154960463|NCT03247972|559280307|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
154960464|NCT03247972|559280307|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
154960465|NCT00968812|559280308|FG000|Overall Study|Adverse Event|30|||
154960466|NCT00968812|559280309|FG001|Overall Study|Adverse Event|46|||
154960467|NCT00968812|559280310|FG002|Overall Study|Adverse Event|33|||
154960468|NCT00968812|559280308|FG000|Overall Study|Death|2|||
154960469|NCT00968812|559280309|FG001|Overall Study|Death|2|||
154960470|NCT00968812|559280310|FG002|Overall Study|Death|1|||
154960471|NCT00968812|559280308|FG000|Overall Study|Lack of Efficacy|9|||
154960472|NCT00968812|559280309|FG001|Overall Study|Lack of Efficacy|7|||
154960473|NCT00968812|559280310|FG002|Overall Study|Lack of Efficacy|16|||
155319519|NCT05863156|560605535|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
155319520|NCT03362476|560605536|FG000|Overall Study|Withdrawal by Subject|0|||
154960474|NCT00968812|559280308|FG000|Overall Study|Lost to Follow-up|17|||
154960475|NCT00968812|559280309|FG001|Overall Study|Lost to Follow-up|12|||
155067691|NCT03965923|559678871|FG011|Overall Study|Death|0|||
155067692|NCT03965923|559678860|FG000|Overall Study|Other reason|0|||
155067693|NCT03965923|559678861|FG001|Overall Study|Other reason|0|||
155067694|NCT03965923|559678862|FG002|Overall Study|Other reason|0|||
155067695|NCT03965923|559678863|FG003|Overall Study|Other reason|1|||
155067696|NCT03965923|559678864|FG004|Overall Study|Other reason|0|||
155067697|NCT03965923|559678865|FG005|Overall Study|Other reason|0|||
155067698|NCT03965923|559678866|FG006|Overall Study|Other reason|0|||
155067699|NCT03965923|559678867|FG007|Overall Study|Other reason|0|||
155067700|NCT03965923|559678868|FG008|Overall Study|Other reason|0|||
155067701|NCT03965923|559678869|FG009|Overall Study|Other reason|0|||
155067702|NCT03965923|559678870|FG010|Overall Study|Other reason|2|||
155067703|NCT03965923|559678871|FG011|Overall Study|Other reason|0|||
155067704|NCT02327078|559678874|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
155067705|NCT02327078|559678875|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
155067706|NCT02327078|559678876|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
155067707|NCT02327078|559678877|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
155067708|NCT02327078|559678878|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
155067709|NCT02327078|559678879|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
155067710|NCT02327078|559678880|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
155067711|NCT02327078|559678881|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
155067712|NCT02327078|559678882|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
155067713|NCT02327078|559678874|FG000|Overall Study|Death|2|||
155067714|NCT02327078|559678875|FG001|Overall Study|Death|4|||
155067715|NCT02327078|559678876|FG002|Overall Study|Death|10|||
155067716|NCT02327078|559678877|FG003|Overall Study|Death|6|||
155067717|NCT02327078|559678878|FG004|Overall Study|Death|4|||
155067718|NCT02327078|559678879|FG005|Overall Study|Death|3|||
155067719|NCT02327078|559678880|FG006|Overall Study|Death|2|||
155067720|NCT02327078|559678881|FG007|Overall Study|Death|51|||
155067721|NCT02327078|559678882|FG008|Overall Study|Death|97|||
155067722|NCT02327078|559678874|FG000|Overall Study|Lost to Follow-up|0|||
155067723|NCT02327078|559678875|FG001|Overall Study|Lost to Follow-up|1|||
155067724|NCT02327078|559678876|FG002|Overall Study|Lost to Follow-up|1|||
155067725|NCT02327078|559678877|FG003|Overall Study|Lost to Follow-up|0|||
155067726|NCT02327078|559678878|FG004|Overall Study|Lost to Follow-up|0|||
155067727|NCT02327078|559678879|FG005|Overall Study|Lost to Follow-up|0|||
155067728|NCT02327078|559678880|FG006|Overall Study|Lost to Follow-up|0|||
155067729|NCT02327078|559678881|FG007|Overall Study|Lost to Follow-up|2|||
155067730|NCT02327078|559678882|FG008|Overall Study|Lost to Follow-up|5|||
155067731|NCT02327078|559678874|FG000|Overall Study|Site Terminated by Sponsor|1|||
155067732|NCT02327078|559678875|FG001|Overall Study|Site Terminated by Sponsor|0|||
155067733|NCT02327078|559678876|FG002|Overall Study|Site Terminated by Sponsor|1|||
155067734|NCT02327078|559678877|FG003|Overall Study|Site Terminated by Sponsor|4|||
155067735|NCT02327078|559678878|FG004|Overall Study|Site Terminated by Sponsor|0|||
155067736|NCT02327078|559678879|FG005|Overall Study|Site Terminated by Sponsor|0|||
155067737|NCT02327078|559678880|FG006|Overall Study|Site Terminated by Sponsor|0|||
155067738|NCT02327078|559678881|FG007|Overall Study|Site Terminated by Sponsor|11|||
155067739|NCT02327078|559678882|FG008|Overall Study|Site Terminated by Sponsor|25|||
155067740|NCT02327078|559678874|FG000|Overall Study|Physician Decision|0|||
155067741|NCT02327078|559678875|FG001|Overall Study|Physician Decision|0|||
155067742|NCT02327078|559678876|FG002|Overall Study|Physician Decision|0|||
155067743|NCT02327078|559678877|FG003|Overall Study|Physician Decision|1|||
155067744|NCT02327078|559678878|FG004|Overall Study|Physician Decision|0|||
155067745|NCT02327078|559678879|FG005|Overall Study|Physician Decision|0|||
155067746|NCT02327078|559678880|FG006|Overall Study|Physician Decision|0|||
155067747|NCT02327078|559678881|FG007|Overall Study|Physician Decision|0|||
155067748|NCT02327078|559678882|FG008|Overall Study|Physician Decision|1|||
155067749|NCT02327078|559678874|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155067750|NCT02327078|559678875|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155067751|NCT02327078|559678876|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155067752|NCT02327078|559678877|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
155067753|NCT02327078|559678878|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
155067754|NCT02327078|559678879|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
155067755|NCT02327078|559678880|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
155067756|NCT02327078|559678881|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
155067757|NCT02327078|559678882|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
155162491|NCT01177397|560031613|FG007|Overall Study|Other reasons|6|||
155319521|NCT03362476|560605537|FG001|Overall Study|Withdrawal by Subject|1|||
155319522|NCT05216406|560605538|FG000|Overall Study|Lost to Follow-up|8|||
155319523|NCT05216406|560605539|FG001|Overall Study|Lost to Follow-up|9|||
155319524|NCT04270942|560605542|FG000|Overall Study|Death|1|||
155319525|NCT01236781|560605550|FG000|Overall Study|Ineligible|2|||
155319526|NCT01236781|560605551|FG001|Overall Study|Ineligible|1|||
155319527|NCT01236781|560605550|FG000|Overall Study|Did not complete study imaging|5|||
155319528|NCT01236781|560605551|FG001|Overall Study|Did not complete study imaging|0|||
155319529|NCT02709161|560605552|FG000|Overall Study|Withdrawal by Subject|1|||
155319530|NCT02709161|560605553|FG001|Overall Study|Withdrawal by Subject|0|||
155319531|NCT05167864|560605554|FG000|Overall Study|Lost to Follow-up|7|||
155319532|NCT05167864|560605555|FG001|Overall Study|Lost to Follow-up|6|||
155319533|NCT05167864|560605556|FG002|Overall Study|Lost to Follow-up|7|||
155319534|NCT05167864|560605557|FG003|Overall Study|Lost to Follow-up|9|||
155319535|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
155319536|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
155319537|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
155319538|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
155319539|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
155319540|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
155319541|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
155319542|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
155319543|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
155319544|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
155319545|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
155319546|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
155319547|NCT04059185|560605560|FG000|Longitudinal Assessment-Adults Only|Death|4|||
155319548|NCT04059185|560605561|FG001|Longitudinal Assessment-Adults Only|Death|4|||
155319549|NCT04059185|560605562|FG002|Longitudinal Assessment-Adults Only|Death|3|||
155319550|NCT03916185|560607283|FG000|Overall Study|Lost to Follow-up|0|||
155319551|NCT03916185|560607284|FG001|Overall Study|Lost to Follow-up|1|||
155319552|NCT03916185|560607285|FG002|Overall Study|Lost to Follow-up|0|||
155319553|NCT03916185|560607286|FG003|Overall Study|Lost to Follow-up|0|||
155319554|NCT03916185|560607283|FG000|Overall Study|Moved|1|||
155319555|NCT03916185|560607284|FG001|Overall Study|Moved|0|||
155319556|NCT03916185|560607285|FG002|Overall Study|Moved|0|||
155319557|NCT03916185|560607286|FG003|Overall Study|Moved|1|||
155319558|NCT03916185|560607283|FG000|Overall Study|Not Able to Get to Clinic|1|||
155319559|NCT03916185|560607284|FG001|Overall Study|Not Able to Get to Clinic|0|||
155319560|NCT03916185|560607285|FG002|Overall Study|Not Able to Get to Clinic|0|||
155319561|NCT03916185|560607286|FG003|Overall Study|Not Able to Get to Clinic|0|||
155319562|NCT03766685|560607287|FG000|Overall Study|Lost to Follow-up|1|||
155319563|NCT03766685|560607288|FG001|Overall Study|Lost to Follow-up|1|||
155319564|NCT03766685|560607289|FG002|Overall Study|Lost to Follow-up|0|||
155319565|NCT03766685|560607290|FG003|Overall Study|Lost to Follow-up|0|||
155319566|NCT03766685|560607287|FG000|Overall Study|Adverse Event, not fatal|0|||
155319567|NCT03766685|560607288|FG001|Overall Study|Adverse Event, not fatal|1|||
155319568|NCT03766685|560607289|FG002|Overall Study|Adverse Event, not fatal|0|||
155319569|NCT03766685|560607290|FG003|Overall Study|Adverse Event, not fatal|1|||
155319570|NCT03766685|560607287|FG000|Overall Study|Withdrawal by Subject|0|||
155319571|NCT03766685|560607288|FG001|Overall Study|Withdrawal by Subject|2|||
155319572|NCT03766685|560607289|FG002|Overall Study|Withdrawal by Subject|0|||
155319573|NCT03766685|560607290|FG003|Overall Study|Withdrawal by Subject|0|||
155319574|NCT03766685|560607287|FG000|Overall Study|Protocol Violation|0|||
155319575|NCT03766685|560607288|FG001|Overall Study|Protocol Violation|1|||
155319576|NCT03766685|560607289|FG002|Overall Study|Protocol Violation|0|||
155319577|NCT03766685|560607290|FG003|Overall Study|Protocol Violation|0|||
155319578|NCT03766685|560607287|FG000|Overall Study|Non-compliance|0|||
155319579|NCT03766685|560607288|FG001|Overall Study|Non-compliance|2|||
155319580|NCT03766685|560607289|FG002|Overall Study|Non-compliance|0|||
155319581|NCT03766685|560607290|FG003|Overall Study|Non-compliance|0|||
155319582|NCT02844465|560607296|FG000|Overall Study|Screen Failure|36|||
155319583|NCT02844465|560607296|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
155319584|NCT02844465|560607296|FG000|Overall Study|Withdrawal by Subject|5|||
155319585|NCT02844465|560607296|FG000|Overall Study|Lost to Follow-up|1|||
155319586|NCT02844465|560607296|FG000|Overall Study|Retreatment|1|||
155319587|NCT05029622|560607298|FG000|Overall Study|Lost to Follow-up|1|||
155319588|NCT06232590|560607299|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
155319589|NCT06232590|560607300|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
155319590|NCT05299723|560607301|FG000|Overall Study|Withdrawal by Subject|0|||
155319591|NCT05299723|560607302|FG001|Overall Study|Withdrawal by Subject|2|||
155319592|NCT05299723|560607303|FG002|Overall Study|Withdrawal by Subject|0|||
155319593|NCT02460458|560607304|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
155319594|NCT02460458|560607304|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
155319595|NCT02460458|560607304|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
155319596|NCT02460458|560607304|FG000|First Prospective Phase|Lost to Follow-up|84|||
155319597|NCT02460458|560607304|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
155319598|NCT05299073|560607305|FG000|Overall Study|Withdrawal by Subject|0|||
155319599|NCT05299073|560607306|FG001|Overall Study|Withdrawal by Subject|0|||
155319600|NCT05299073|560607307|FG002|Overall Study|Withdrawal by Subject|1|||
155319601|NCT05299073|560607305|FG000|Overall Study|Adverse Event|0|||
155319602|NCT05299073|560607306|FG001|Overall Study|Adverse Event|1|||
155319603|NCT05299073|560607307|FG002|Overall Study|Adverse Event|0|||
155319604|NCT05299073|560607305|FG000|Overall Study|Lost to Follow-up|0|||
155319605|NCT05299073|560607306|FG001|Overall Study|Lost to Follow-up|1|||
155319606|NCT05299073|560607307|FG002|Overall Study|Lost to Follow-up|0|||
155319607|NCT00592852|560607308|FG000|Overall Study|Non-compliance|1|||
155319608|NCT00592852|560607308|FG000|Overall Study|Adverse Event|3|||
155319609|NCT00592852|560607308|FG000|Overall Study|Found ineligible|1|||
155319610|NCT00592852|560607308|FG000|Overall Study|Withdrawal by Subject|1|||
155319611|NCT02505984|560607312|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
155319612|NCT02505984|560607313|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
155319613|NCT02505984|560607312|FG000|Overall Study|Unreliable self-report data|1|||
155319614|NCT02505984|560607313|FG001|Overall Study|Unreliable self-report data|0|||
155319615|NCT02505984|560607312|FG000|Overall Study|Study blind opened during assessment|0|||
155319616|NCT02505984|560607313|FG001|Overall Study|Study blind opened during assessment|1|||
155319617|NCT02505984|560607312|FG000|Overall Study|Noncompliance with study protocol|0|||
155319618|NCT02505984|560607313|FG001|Overall Study|Noncompliance with study protocol|1|||
155319619|NCT03511664|560607324|FG000|Overall Study|Death|457|||
155319620|NCT03511664|560607325|FG001|Overall Study|Death|201|||
155319621|NCT03511664|560607326|FG002|Overall Study|Death|21|||
155319622|NCT03511664|560607324|FG000|Overall Study|Withdrew consent|40|||
155319623|NCT03511664|560607325|FG001|Overall Study|Withdrew consent|63|||
155319624|NCT03511664|560607326|FG002|Overall Study|Withdrew consent|3|||
155319625|NCT03511664|560607324|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
155319626|NCT03511664|560607325|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
155319627|NCT03511664|560607326|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
155319628|NCT03511664|560607324|FG000|Overall Study|Lost to Follow-up|8|||
155319629|NCT03511664|560607325|FG001|Overall Study|Lost to Follow-up|5|||
155319630|NCT03511664|560607326|FG002|Overall Study|Lost to Follow-up|0|||
155319631|NCT03511664|560607324|FG000|Overall Study|Physician Decision|2|||
155319632|NCT03511664|560607325|FG001|Overall Study|Physician Decision|1|||
155319633|NCT03511664|560607326|FG002|Overall Study|Physician Decision|0|||
155319634|NCT03511664|560607324|FG000|Overall Study|Patient non-compliance|1|||
155319635|NCT03511664|560607325|FG001|Overall Study|Patient non-compliance|0|||
155067758|NCT02327078|559678874|FG000|Overall Study|Reason not Specified|0|||
155067759|NCT02327078|559678875|FG001|Overall Study|Reason not Specified|0|||
155067760|NCT02327078|559678876|FG002|Overall Study|Reason not Specified|0|||
155067761|NCT02327078|559678877|FG003|Overall Study|Reason not Specified|0|||
155067762|NCT02327078|559678878|FG004|Overall Study|Reason not Specified|0|||
155067763|NCT02327078|559678879|FG005|Overall Study|Reason not Specified|0|||
155067764|NCT02327078|559678880|FG006|Overall Study|Reason not Specified|0|||
155319636|NCT03511664|560607326|FG002|Overall Study|Patient non-compliance|0|||
155319637|NCT04362254|560607330|FG000|Overall Study|Adverse Event|1|||
155319638|NCT04362254|560607330|FG000|Overall Study|Protocol Violation|1|||
155319639|NCT04362254|560607330|FG000|Overall Study|Due to early termination of the trial|10|||
155319640|NCT04076618|560607331|FG000|Overall Study|Lost to Follow-up|2|||
155319641|NCT04076618|560607332|FG001|Overall Study|Lost to Follow-up|1|||
155319642|NCT04076618|560607333|FG002|Overall Study|Lost to Follow-up|3|||
155319643|NCT04076618|560607331|FG000|Overall Study|Withdrawal by Subject|3|||
155319644|NCT04076618|560607332|FG001|Overall Study|Withdrawal by Subject|1|||
155319645|NCT04076618|560607333|FG002|Overall Study|Withdrawal by Subject|2|||
155319646|NCT04076618|560607331|FG000|Overall Study|Relocated out of state|0|||
155319647|NCT04076618|560607332|FG001|Overall Study|Relocated out of state|2|||
155319648|NCT04076618|560607333|FG002|Overall Study|Relocated out of state|0|||
155319649|NCT04076618|560607331|FG000|Overall Study|COVID concerns|0|||
155319650|NCT04076618|560607332|FG001|Overall Study|COVID concerns|1|||
155319651|NCT04076618|560607333|FG002|Overall Study|COVID concerns|0|||
155319652|NCT04076618|560607331|FG000|Overall Study|Adverse Event|0|||
155319653|NCT04076618|560607332|FG001|Overall Study|Adverse Event|0|||
155319654|NCT04076618|560607333|FG002|Overall Study|Adverse Event|2|||
155319655|NCT01928394|560607334|FG000|Treatment Period|Disease progression|17|||
155319656|NCT01928394|560607335|FG001|Treatment Period|Disease progression|2|||
155319657|NCT01928394|560607336|FG002|Treatment Period|Disease progression|12|||
155319658|NCT01928394|560607337|FG003|Treatment Period|Disease progression|48|||
155319659|NCT01928394|560607338|FG004|Treatment Period|Disease progression|3|||
155319660|NCT01928394|560607339|FG005|Treatment Period|Disease progression|25|||
155319661|NCT01928394|560607340|FG006|Treatment Period|Disease progression|38|||
155319662|NCT01928394|560607341|FG007|Treatment Period|Disease progression|16|||
155319663|NCT01928394|560607342|FG008|Treatment Period|Disease progression|3|||
155319664|NCT01928394|560607343|FG009|Treatment Period|Disease progression|11|||
155319665|NCT01928394|560607344|FG010|Treatment Period|Disease progression|22|||
155319666|NCT01928394|560607345|FG011|Treatment Period|Disease progression|73|||
155319667|NCT01928394|560607346|FG012|Treatment Period|Disease progression|38|||
155319668|NCT01928394|560607347|FG013|Treatment Period|Disease progression|118|||
155319669|NCT01928394|560607348|FG014|Treatment Period|Disease progression|59|||
155319670|NCT01928394|560607349|FG015|Treatment Period|Disease progression|1|||
155319671|NCT01928394|560607350|FG016|Treatment Period|Disease progression|43|||
155319672|NCT01928394|560607351|FG017|Treatment Period|Disease progression|56|||
155319673|NCT01928394|560607352|FG018|Treatment Period|Disease progression|50|||
155319674|NCT01928394|560607353|FG019|Treatment Period|Disease progression|71|||
155319675|NCT01928394|560607354|FG020|Treatment Period|Disease progression|30|||
155319676|NCT01928394|560607355|FG021|Treatment Period|Disease progression|31|||
155319677|NCT01928394|560607356|FG022|Treatment Period|Disease progression|31|||
155319678|NCT01928394|560607334|FG000|Treatment Period|Study drug toxicity|1|||
155319679|NCT01928394|560607335|FG001|Treatment Period|Study drug toxicity|1|||
155319680|NCT01928394|560607336|FG002|Treatment Period|Study drug toxicity|3|||
155319681|NCT01928394|560607337|FG003|Treatment Period|Study drug toxicity|3|||
155319682|NCT01928394|560607338|FG004|Treatment Period|Study drug toxicity|0|||
155319683|NCT01928394|560607339|FG005|Treatment Period|Study drug toxicity|9|||
155319684|NCT01928394|560607340|FG006|Treatment Period|Study drug toxicity|7|||
155319685|NCT01928394|560607341|FG007|Treatment Period|Study drug toxicity|1|||
155319686|NCT01928394|560607342|FG008|Treatment Period|Study drug toxicity|0|||
155319687|NCT01928394|560607343|FG009|Treatment Period|Study drug toxicity|5|||
155319688|NCT01928394|560607344|FG010|Treatment Period|Study drug toxicity|2|||
155319689|NCT01928394|560607345|FG011|Treatment Period|Study drug toxicity|3|||
155319690|NCT01928394|560607346|FG012|Treatment Period|Study drug toxicity|7|||
155319691|NCT01928394|560607347|FG013|Treatment Period|Study drug toxicity|5|||
155319692|NCT01928394|560607348|FG014|Treatment Period|Study drug toxicity|12|||
155319693|NCT01928394|560607349|FG015|Treatment Period|Study drug toxicity|0|||
154960476|NCT00968812|559280310|FG002|Overall Study|Lost to Follow-up|11|||
154960477|NCT00968812|559280308|FG000|Overall Study|Physician Decision|8|||
154960478|NCT00968812|559280309|FG001|Overall Study|Physician Decision|5|||
154960479|NCT00968812|559280310|FG002|Overall Study|Physician Decision|9|||
154960480|NCT00968812|559280308|FG000|Overall Study|Protocol Violation|7|||
154960481|NCT00968812|559280309|FG001|Overall Study|Protocol Violation|4|||
154960482|NCT00968812|559280310|FG002|Overall Study|Protocol Violation|3|||
154960483|NCT00968812|559280308|FG000|Overall Study|Withdrawal by Subject|17|||
154960484|NCT00968812|559280309|FG001|Overall Study|Withdrawal by Subject|23|||
154960485|NCT00968812|559280310|FG002|Overall Study|Withdrawal by Subject|25|||
154960486|NCT00968812|559280308|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
154960487|NCT00968812|559280309|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
154960488|NCT00968812|559280310|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
154960489|NCT00968812|559280308|FG000|Overall Study|Noncompliance with study drug|4|||
154960490|NCT00968812|559280309|FG001|Overall Study|Noncompliance with study drug|1|||
154960491|NCT00968812|559280310|FG002|Overall Study|Noncompliance with study drug|6|||
154960492|NCT00968812|559280308|FG000|Overall Study|Unable to take rescue therapy|12|||
154960493|NCT00968812|559280309|FG001|Overall Study|Unable to take rescue therapy|12|||
154960494|NCT00968812|559280310|FG002|Overall Study|Unable to take rescue therapy|17|||
154960495|NCT00968812|559280308|FG000|Overall Study|Other|25|||
154960496|NCT00968812|559280309|FG001|Overall Study|Other|37|||
154960497|NCT00968812|559280310|FG002|Overall Study|Other|40|||
154960498|NCT00609674|559280311|FG000|Overall Study|Adverse Event|1|||
155319694|NCT01928394|560607350|FG016|Treatment Period|Study drug toxicity|3|||
155319695|NCT01928394|560607351|FG017|Treatment Period|Study drug toxicity|3|||
155319696|NCT01928394|560607352|FG018|Treatment Period|Study drug toxicity|12|||
155319697|NCT01928394|560607353|FG019|Treatment Period|Study drug toxicity|15|||
155319698|NCT01928394|560607354|FG020|Treatment Period|Study drug toxicity|4|||
155319699|NCT01928394|560607355|FG021|Treatment Period|Study drug toxicity|7|||
155319700|NCT01928394|560607356|FG022|Treatment Period|Study drug toxicity|4|||
155319701|NCT01928394|560607334|FG000|Treatment Period|AE unrelated to study drug|0|||
155319702|NCT01928394|560607335|FG001|Treatment Period|AE unrelated to study drug|0|||
155319703|NCT01928394|560607336|FG002|Treatment Period|AE unrelated to study drug|2|||
155319704|NCT01928394|560607337|FG003|Treatment Period|AE unrelated to study drug|3|||
155319705|NCT01928394|560607338|FG004|Treatment Period|AE unrelated to study drug|0|||
155319706|NCT01928394|560607339|FG005|Treatment Period|AE unrelated to study drug|5|||
155319707|NCT01928394|560607340|FG006|Treatment Period|AE unrelated to study drug|1|||
155319708|NCT01928394|560607341|FG007|Treatment Period|AE unrelated to study drug|0|||
155319709|NCT01928394|560607342|FG008|Treatment Period|AE unrelated to study drug|0|||
155319710|NCT01928394|560607343|FG009|Treatment Period|AE unrelated to study drug|2|||
155319711|NCT01928394|560607344|FG010|Treatment Period|AE unrelated to study drug|0|||
155319712|NCT01928394|560607345|FG011|Treatment Period|AE unrelated to study drug|12|||
155319713|NCT01928394|560607346|FG012|Treatment Period|AE unrelated to study drug|6|||
155319714|NCT01928394|560607347|FG013|Treatment Period|AE unrelated to study drug|13|||
155319715|NCT01928394|560607348|FG014|Treatment Period|AE unrelated to study drug|6|||
155319716|NCT01928394|560607349|FG015|Treatment Period|AE unrelated to study drug|1|||
155319717|NCT01928394|560607350|FG016|Treatment Period|AE unrelated to study drug|1|||
155319718|NCT01928394|560607351|FG017|Treatment Period|AE unrelated to study drug|6|||
155319719|NCT01928394|560607352|FG018|Treatment Period|AE unrelated to study drug|3|||
155319720|NCT01928394|560607353|FG019|Treatment Period|AE unrelated to study drug|5|||
155319721|NCT01928394|560607354|FG020|Treatment Period|AE unrelated to study drug|1|||
155319722|NCT01928394|560607355|FG021|Treatment Period|AE unrelated to study drug|1|||
155319723|NCT01928394|560607356|FG022|Treatment Period|AE unrelated to study drug|0|||
155319724|NCT01928394|560607334|FG000|Treatment Period|Participant request to stop therapy|0|||
155319725|NCT01928394|560607335|FG001|Treatment Period|Participant request to stop therapy|0|||
155319726|NCT01928394|560607336|FG002|Treatment Period|Participant request to stop therapy|0|||
155319727|NCT01928394|560607337|FG003|Treatment Period|Participant request to stop therapy|0|||
155319728|NCT01928394|560607338|FG004|Treatment Period|Participant request to stop therapy|0|||
155319729|NCT01928394|560607339|FG005|Treatment Period|Participant request to stop therapy|3|||
155319730|NCT01928394|560607340|FG006|Treatment Period|Participant request to stop therapy|3|||
155319731|NCT01928394|560607341|FG007|Treatment Period|Participant request to stop therapy|0|||
155319732|NCT01928394|560607342|FG008|Treatment Period|Participant request to stop therapy|0|||
155319733|NCT01928394|560607343|FG009|Treatment Period|Participant request to stop therapy|0|||
155319734|NCT01928394|560607344|FG010|Treatment Period|Participant request to stop therapy|3|||
155319735|NCT01928394|560607345|FG011|Treatment Period|Participant request to stop therapy|2|||
154960499|NCT00609674|559280312|FG001|Overall Study|Adverse Event|1|||
154960500|NCT00609674|559280311|FG000|Overall Study|Protocol Violation|3|||
154960501|NCT00609674|559280312|FG001|Overall Study|Protocol Violation|5|||
154960502|NCT00609674|559280311|FG000|Overall Study|Lost to Follow-up|1|||
154960503|NCT00609674|559280312|FG001|Overall Study|Lost to Follow-up|0|||
154960504|NCT00609674|559280311|FG000|Overall Study|Withdrew consent|2|||
154960505|NCT00609674|559280312|FG001|Overall Study|Withdrew consent|1|||
154960506|NCT00571064|559280313|FG000|Overall Study|Adverse Event|13|||
154960507|NCT00571064|559280313|FG000|Overall Study|Protocol Violation|4|||
154960508|NCT00571064|559280313|FG000|Overall Study|Withdrawal by Subject|2|||
154960509|NCT00571064|559280313|FG000|Overall Study|Other|2|||
154960510|NCT03872128|559280324|FG000|Overall Study|Dropped out before treatment|1|||
154960511|NCT03872128|559280325|FG001|Overall Study|Dropped out before treatment|0|||
154960512|NCT03872128|559280326|FG002|Overall Study|Dropped out before treatment|4|||
154960513|NCT03872128|559280324|FG000|Overall Study|Lost to Follow-up|2|||
154960514|NCT03872128|559280325|FG001|Overall Study|Lost to Follow-up|5|||
154960515|NCT03872128|559280326|FG002|Overall Study|Lost to Follow-up|8|||
154960516|NCT00834431|559280334|FG000|First Intervention|Adverse Event|0|||
154960517|NCT00834431|559280335|FG001|First Intervention|Adverse Event|1|||
154960518|NCT00834431|559280334|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
154960519|NCT00834431|559280335|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
154960520|NCT03637764|559280338|FG000|Overall Study|Adverse Event|2|||
154960521|NCT03637764|559280339|FG001|Overall Study|Adverse Event|0|||
154960522|NCT03637764|559280340|FG002|Overall Study|Adverse Event|0|||
154960523|NCT03637764|559280341|FG003|Overall Study|Adverse Event|1|||
154960524|NCT03637764|559280338|FG000|Overall Study|Progressive Disease|23|||
154960525|NCT03637764|559280339|FG001|Overall Study|Progressive Disease|23|||
154960526|NCT03637764|559280340|FG002|Overall Study|Progressive Disease|18|||
154960527|NCT03637764|559280341|FG003|Overall Study|Progressive Disease|31|||
154960528|NCT03637764|559280338|FG000|Overall Study|Withdrawal by Subject|1|||
154960529|NCT03637764|559280339|FG001|Overall Study|Withdrawal by Subject|3|||
155319736|NCT01928394|560607346|FG012|Treatment Period|Participant request to stop therapy|1|||
155319737|NCT01928394|560607347|FG013|Treatment Period|Participant request to stop therapy|2|||
155319738|NCT01928394|560607348|FG014|Treatment Period|Participant request to stop therapy|4|||
155319739|NCT01928394|560607349|FG015|Treatment Period|Participant request to stop therapy|0|||
155319740|NCT01928394|560607350|FG016|Treatment Period|Participant request to stop therapy|1|||
155319741|NCT01928394|560607351|FG017|Treatment Period|Participant request to stop therapy|3|||
155319742|NCT01928394|560607352|FG018|Treatment Period|Participant request to stop therapy|1|||
155319743|NCT01928394|560607353|FG019|Treatment Period|Participant request to stop therapy|1|||
155319744|NCT01928394|560607354|FG020|Treatment Period|Participant request to stop therapy|3|||
155319745|NCT01928394|560607355|FG021|Treatment Period|Participant request to stop therapy|1|||
155319746|NCT01928394|560607356|FG022|Treatment Period|Participant request to stop therapy|3|||
155319747|NCT01928394|560607334|FG000|Treatment Period|Participant withdrew consent|0|||
155319748|NCT01928394|560607335|FG001|Treatment Period|Participant withdrew consent|0|||
155319749|NCT01928394|560607336|FG002|Treatment Period|Participant withdrew consent|1|||
155319750|NCT01928394|560607337|FG003|Treatment Period|Participant withdrew consent|1|||
155067765|NCT02327078|559678881|FG007|Overall Study|Reason not Specified|5|||
155067766|NCT02327078|559678882|FG008|Overall Study|Reason not Specified|12|||
155067767|NCT06001021|559678883|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
155067768|NCT06001021|559678884|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
155067769|NCT06001021|559678885|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
155067770|NCT06001021|559678886|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
155067771|NCT06001021|559678887|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
155067772|NCT06001021|559678888|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
155067773|NCT06001021|559678889|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
155067774|NCT06001021|559678883|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
155067775|NCT06001021|559678884|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155067776|NCT06001021|559678885|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155067777|NCT06001021|559678886|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
155067778|NCT06001021|559678887|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
155067779|NCT06001021|559678888|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155067780|NCT06001021|559678889|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
155067781|NCT03112603|559678893|FG000|End of Randomization Period|Lost to Follow-up|3|||
155067782|NCT03112603|559678894|FG001|End of Randomization Period|Lost to Follow-up|0|||
155067783|NCT03112603|559678895|FG002|End of Randomization Period|Lost to Follow-up|0|||
155067784|NCT03112603|559678893|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
155067785|NCT03112603|559678894|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
155067786|NCT03112603|559678895|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
155067787|NCT03112603|559678893|FG000|End of Randomization Period|Physician Decision|43|||
155067788|NCT03112603|559678894|FG001|End of Randomization Period|Physician Decision|18|||
155067789|NCT03112603|559678895|FG002|End of Randomization Period|Physician Decision|0|||
155067790|NCT03112603|559678893|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
155067791|NCT03112603|559678894|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
155067792|NCT03112603|559678895|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
155067793|NCT03112603|559678893|FG000|End of Randomization Period|Death|10|||
155067794|NCT03112603|559678894|FG001|End of Randomization Period|Death|7|||
155067795|NCT03112603|559678895|FG002|End of Randomization Period|Death|0|||
155067796|NCT03112603|559678893|FG000|End of Randomization Period|Disease Relapse|12|||
155067797|NCT03112603|559678894|FG001|End of Randomization Period|Disease Relapse|7|||
155067798|NCT03112603|559678895|FG002|End of Randomization Period|Disease Relapse|0|||
155067799|NCT03112603|559678893|FG000|End of Randomization Period|Lack of Efficacy|25|||
155067800|NCT03112603|559678894|FG001|End of Randomization Period|Lack of Efficacy|77|||
155067801|NCT03112603|559678895|FG002|End of Randomization Period|Lack of Efficacy|0|||
155067802|NCT03112603|559678893|FG000|End of Randomization Period|Adverse Event|32|||
155067803|NCT03112603|559678894|FG001|End of Randomization Period|Adverse Event|12|||
155067804|NCT03112603|559678895|FG002|End of Randomization Period|Adverse Event|0|||
155067805|NCT03112603|559678893|FG000|End of Cross Over Period|Death|0|||
155067806|NCT03112603|559678894|FG001|End of Cross Over Period|Death|0|||
155067807|NCT03112603|559678895|FG002|End of Cross Over Period|Death|2|||
155067808|NCT03112603|559678893|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
155067809|NCT03112603|559678894|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
155067810|NCT03112603|559678895|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
155067811|NCT03112603|559678893|FG000|End of Cross Over Period|Physician Decision|0|||
155319751|NCT01928394|560607338|FG004|Treatment Period|Participant withdrew consent|0|||
155319752|NCT01928394|560607339|FG005|Treatment Period|Participant withdrew consent|1|||
155319753|NCT01928394|560607340|FG006|Treatment Period|Participant withdrew consent|0|||
155319754|NCT01928394|560607341|FG007|Treatment Period|Participant withdrew consent|1|||
155319755|NCT01928394|560607342|FG008|Treatment Period|Participant withdrew consent|0|||
155319756|NCT01928394|560607343|FG009|Treatment Period|Participant withdrew consent|0|||
155067812|NCT03112603|559678894|FG001|End of Cross Over Period|Physician Decision|0|||
155067813|NCT03112603|559678895|FG002|End of Cross Over Period|Physician Decision|29|||
155067814|NCT03112603|559678893|FG000|End of Cross Over Period|Lack of Efficacy|0|||
155067815|NCT03112603|559678894|FG001|End of Cross Over Period|Lack of Efficacy|0|||
155067816|NCT03112603|559678895|FG002|End of Cross Over Period|Lack of Efficacy|8|||
155067817|NCT03112603|559678893|FG000|End of Cross Over Period|Adverse Event|0|||
155067818|NCT03112603|559678894|FG001|End of Cross Over Period|Adverse Event|0|||
155067819|NCT03112603|559678895|FG002|End of Cross Over Period|Adverse Event|6|||
155067820|NCT03112603|559678893|FG000|End of Cross Over Period|Disease Relapse|0|||
155067821|NCT03112603|559678894|FG001|End of Cross Over Period|Disease Relapse|0|||
155067822|NCT03112603|559678895|FG002|End of Cross Over Period|Disease Relapse|2|||
155067823|NCT04725188|559678896|FG000|Overall Study|Death|72|||
155067824|NCT04725188|559678897|FG001|Overall Study|Death|69|||
155067825|NCT04725188|559678898|FG002|Overall Study|Death|76|||
155067826|NCT04725188|559678896|FG000|Overall Study|Lost to Follow-up|1|||
155067827|NCT04725188|559678897|FG001|Overall Study|Lost to Follow-up|0|||
155067828|NCT04725188|559678898|FG002|Overall Study|Lost to Follow-up|1|||
155067829|NCT04725188|559678896|FG000|Overall Study|Withdrawal by Subject|2|||
155067830|NCT04725188|559678897|FG001|Overall Study|Withdrawal by Subject|2|||
155067831|NCT04725188|559678898|FG002|Overall Study|Withdrawal by Subject|1|||
155067832|NCT04725188|559678896|FG000|Overall Study|Sponsor Decision|12|||
155067833|NCT04725188|559678897|FG001|Overall Study|Sponsor Decision|12|||
155067834|NCT04725188|559678898|FG002|Overall Study|Sponsor Decision|7|||
155067835|NCT00390013|559678900|FG000|Phase 1|tired|0|||
155319757|NCT01928394|560607344|FG010|Treatment Period|Participant withdrew consent|1|||
155319758|NCT01928394|560607345|FG011|Treatment Period|Participant withdrew consent|1|||
155319759|NCT01928394|560607346|FG012|Treatment Period|Participant withdrew consent|1|||
155319760|NCT01928394|560607347|FG013|Treatment Period|Participant withdrew consent|0|||
155319761|NCT01928394|560607348|FG014|Treatment Period|Participant withdrew consent|2|||
155319762|NCT01928394|560607349|FG015|Treatment Period|Participant withdrew consent|0|||
155319763|NCT01928394|560607350|FG016|Treatment Period|Participant withdrew consent|2|||
155319764|NCT01928394|560607351|FG017|Treatment Period|Participant withdrew consent|1|||
155319765|NCT01928394|560607352|FG018|Treatment Period|Participant withdrew consent|1|||
155319766|NCT01928394|560607353|FG019|Treatment Period|Participant withdrew consent|1|||
155319767|NCT01928394|560607354|FG020|Treatment Period|Participant withdrew consent|0|||
155319768|NCT01928394|560607355|FG021|Treatment Period|Participant withdrew consent|2|||
155319769|NCT01928394|560607356|FG022|Treatment Period|Participant withdrew consent|0|||
155319770|NCT01928394|560607334|FG000|Treatment Period|Poor/non-compliance|0|||
155319771|NCT01928394|560607335|FG001|Treatment Period|Poor/non-compliance|0|||
155319772|NCT01928394|560607336|FG002|Treatment Period|Poor/non-compliance|0|||
155319773|NCT01928394|560607337|FG003|Treatment Period|Poor/non-compliance|1|||
155319774|NCT01928394|560607338|FG004|Treatment Period|Poor/non-compliance|0|||
155319775|NCT01928394|560607339|FG005|Treatment Period|Poor/non-compliance|0|||
155319776|NCT01928394|560607340|FG006|Treatment Period|Poor/non-compliance|0|||
155319777|NCT01928394|560607341|FG007|Treatment Period|Poor/non-compliance|0|||
155319778|NCT01928394|560607342|FG008|Treatment Period|Poor/non-compliance|0|||
155319779|NCT01928394|560607343|FG009|Treatment Period|Poor/non-compliance|0|||
155319780|NCT01928394|560607344|FG010|Treatment Period|Poor/non-compliance|0|||
155319781|NCT01928394|560607345|FG011|Treatment Period|Poor/non-compliance|0|||
155319782|NCT01928394|560607346|FG012|Treatment Period|Poor/non-compliance|1|||
155319783|NCT01928394|560607347|FG013|Treatment Period|Poor/non-compliance|0|||
155319784|NCT01928394|560607348|FG014|Treatment Period|Poor/non-compliance|1|||
155319785|NCT01928394|560607349|FG015|Treatment Period|Poor/non-compliance|0|||
155319786|NCT01928394|560607350|FG016|Treatment Period|Poor/non-compliance|0|||
155319787|NCT01928394|560607351|FG017|Treatment Period|Poor/non-compliance|1|||
155319788|NCT01928394|560607352|FG018|Treatment Period|Poor/non-compliance|0|||
155319789|NCT01928394|560607353|FG019|Treatment Period|Poor/non-compliance|1|||
155319790|NCT01928394|560607354|FG020|Treatment Period|Poor/non-compliance|0|||
155067836|NCT00390013|559678901|FG001|Phase 1|tired|0|||
155319791|NCT01928394|560607355|FG021|Treatment Period|Poor/non-compliance|0|||
155319792|NCT01928394|560607356|FG022|Treatment Period|Poor/non-compliance|0|||
155319793|NCT01928394|560607334|FG000|Treatment Period|other reason|0|||
155067837|NCT00390013|559678902|FG002|Phase 1|tired|0|||
155067838|NCT00390013|559678903|FG003|Phase 1|tired|1|||
155067839|NCT00390013|559678900|FG000|Phase 2 First Treatment|tired|1|||
155067840|NCT00390013|559678901|FG001|Phase 2 First Treatment|tired|0|||
155067841|NCT00390013|559678902|FG002|Phase 2 First Treatment|tired|0|||
155067842|NCT00390013|559678903|FG003|Phase 2 First Treatment|tired|0|||
155067843|NCT00390013|559678900|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
155319794|NCT01928394|560607335|FG001|Treatment Period|other reason|0|||
155067844|NCT00390013|559678901|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
155067845|NCT00390013|559678902|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
155067846|NCT00390013|559678903|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
155319795|NCT01928394|560607336|FG002|Treatment Period|other reason|0|||
155319796|NCT01928394|560607337|FG003|Treatment Period|other reason|0|||
155319797|NCT01928394|560607338|FG004|Treatment Period|other reason|0|||
155319798|NCT01928394|560607339|FG005|Treatment Period|other reason|0|||
155319799|NCT01928394|560607340|FG006|Treatment Period|other reason|0|||
155319800|NCT01928394|560607341|FG007|Treatment Period|other reason|0|||
155319801|NCT01928394|560607342|FG008|Treatment Period|other reason|0|||
155319802|NCT01928394|560607343|FG009|Treatment Period|other reason|0|||
155319803|NCT01928394|560607344|FG010|Treatment Period|other reason|1|||
155319804|NCT01928394|560607345|FG011|Treatment Period|other reason|1|||
155319805|NCT01928394|560607346|FG012|Treatment Period|other reason|1|||
155319806|NCT01928394|560607347|FG013|Treatment Period|other reason|0|||
155319807|NCT01928394|560607348|FG014|Treatment Period|other reason|1|||
155319808|NCT01928394|560607349|FG015|Treatment Period|other reason|0|||
155319809|NCT01928394|560607350|FG016|Treatment Period|other reason|0|||
155319810|NCT01928394|560607351|FG017|Treatment Period|other reason|0|||
155319811|NCT01928394|560607352|FG018|Treatment Period|other reason|2|||
155319812|NCT01928394|560607353|FG019|Treatment Period|other reason|2|||
155319813|NCT01928394|560607354|FG020|Treatment Period|other reason|0|||
155319814|NCT01928394|560607355|FG021|Treatment Period|other reason|0|||
155319815|NCT01928394|560607356|FG022|Treatment Period|other reason|0|||
155319816|NCT01928394|560607334|FG000|Treatment Period|Maximum clinical benefit|0|||
155319817|NCT01928394|560607335|FG001|Treatment Period|Maximum clinical benefit|0|||
155319818|NCT01928394|560607336|FG002|Treatment Period|Maximum clinical benefit|0|||
155319819|NCT01928394|560607337|FG003|Treatment Period|Maximum clinical benefit|0|||
155319820|NCT01928394|560607338|FG004|Treatment Period|Maximum clinical benefit|0|||
155319821|NCT01928394|560607339|FG005|Treatment Period|Maximum clinical benefit|0|||
155319822|NCT01928394|560607340|FG006|Treatment Period|Maximum clinical benefit|0|||
155319823|NCT01928394|560607341|FG007|Treatment Period|Maximum clinical benefit|0|||
155319824|NCT01928394|560607342|FG008|Treatment Period|Maximum clinical benefit|0|||
155319825|NCT01928394|560607343|FG009|Treatment Period|Maximum clinical benefit|0|||
155319826|NCT01928394|560607344|FG010|Treatment Period|Maximum clinical benefit|1|||
155319827|NCT01928394|560607345|FG011|Treatment Period|Maximum clinical benefit|1|||
155319828|NCT01928394|560607346|FG012|Treatment Period|Maximum clinical benefit|0|||
155319829|NCT01928394|560607347|FG013|Treatment Period|Maximum clinical benefit|0|||
155319830|NCT01928394|560607348|FG014|Treatment Period|Maximum clinical benefit|1|||
155319831|NCT01928394|560607349|FG015|Treatment Period|Maximum clinical benefit|0|||
155319832|NCT01928394|560607350|FG016|Treatment Period|Maximum clinical benefit|0|||
155319833|NCT01928394|560607351|FG017|Treatment Period|Maximum clinical benefit|1|||
155319834|NCT01928394|560607352|FG018|Treatment Period|Maximum clinical benefit|1|||
155319835|NCT01928394|560607353|FG019|Treatment Period|Maximum clinical benefit|0|||
155319836|NCT01928394|560607354|FG020|Treatment Period|Maximum clinical benefit|2|||
155319837|NCT01928394|560607355|FG021|Treatment Period|Maximum clinical benefit|0|||
155319838|NCT01928394|560607356|FG022|Treatment Period|Maximum clinical benefit|0|||
155319839|NCT01928394|560607334|FG000|Treatment Period|Lost to Follow-up|0|||
155319840|NCT01928394|560607335|FG001|Treatment Period|Lost to Follow-up|0|||
155319841|NCT01928394|560607336|FG002|Treatment Period|Lost to Follow-up|0|||
155319842|NCT01928394|560607337|FG003|Treatment Period|Lost to Follow-up|0|||
155319843|NCT01928394|560607338|FG004|Treatment Period|Lost to Follow-up|0|||
155319844|NCT01928394|560607339|FG005|Treatment Period|Lost to Follow-up|0|||
155319845|NCT01928394|560607340|FG006|Treatment Period|Lost to Follow-up|0|||
155319846|NCT01928394|560607341|FG007|Treatment Period|Lost to Follow-up|0|||
155319847|NCT01928394|560607342|FG008|Treatment Period|Lost to Follow-up|0|||
155319848|NCT01928394|560607343|FG009|Treatment Period|Lost to Follow-up|0|||
155319849|NCT01928394|560607344|FG010|Treatment Period|Lost to Follow-up|0|||
155319850|NCT01928394|560607345|FG011|Treatment Period|Lost to Follow-up|0|||
155162492|NCT01177397|560031614|FG008|Overall Study|Other reasons|10|||
155319851|NCT01928394|560607346|FG012|Treatment Period|Lost to Follow-up|0|||
155319852|NCT01928394|560607347|FG013|Treatment Period|Lost to Follow-up|0|||
155319853|NCT01928394|560607348|FG014|Treatment Period|Lost to Follow-up|0|||
155319854|NCT01928394|560607349|FG015|Treatment Period|Lost to Follow-up|0|||
155319855|NCT01928394|560607350|FG016|Treatment Period|Lost to Follow-up|0|||
155319856|NCT01928394|560607351|FG017|Treatment Period|Lost to Follow-up|0|||
155319857|NCT01928394|560607352|FG018|Treatment Period|Lost to Follow-up|0|||
155319858|NCT01928394|560607353|FG019|Treatment Period|Lost to Follow-up|0|||
155319859|NCT01928394|560607354|FG020|Treatment Period|Lost to Follow-up|0|||
155319860|NCT01928394|560607355|FG021|Treatment Period|Lost to Follow-up|0|||
155319861|NCT01928394|560607356|FG022|Treatment Period|Lost to Follow-up|1|||
155319862|NCT01928394|560607334|FG000|Treatment Period|Death|0|||
155067847|NCT03839641|559678904|FG000|Overall Study|Withdrawal by Subject|1|||
155067848|NCT03839641|559678905|FG001|Overall Study|Withdrawal by Subject|1|||
155067849|NCT02802228|559678916|FG000|Overall Study|Withdrawal by Subject|2|||
155067850|NCT02802228|559678917|FG001|Overall Study|Withdrawal by Subject|0|||
155067851|NCT02802228|559678916|FG000|Overall Study|Lost to Follow-up|1|||
155067852|NCT02802228|559678917|FG001|Overall Study|Lost to Follow-up|0|||
155067853|NCT02802228|559678916|FG000|Overall Study|Adverse Event|1|||
155067854|NCT02802228|559678917|FG001|Overall Study|Adverse Event|0|||
155067855|NCT02802228|559678916|FG000|Overall Study|Physician Decision|1|||
155067856|NCT02802228|559678917|FG001|Overall Study|Physician Decision|0|||
155067857|NCT00924898|559678918|FG000|Overall Study|Withdrawal by Subject|2|||
155067858|NCT05291689|559678921|FG000|Overall Study|Adverse Event|3|||
155067859|NCT05291689|559678921|FG000|Overall Study|Lack of Efficacy|10|||
155067860|NCT05291689|559678921|FG000|Overall Study|Withdrawal by Subject|4|||
155067861|NCT01901562|559678922|FG000|Overall Study|Protocol Violation|5|||
155067862|NCT01901562|559678922|FG000|Overall Study|Excluded intraoperatively|4|||
155067863|NCT01925794|559678923|FG000|180 Days|Death|2|||
155067864|NCT01925794|559678923|FG000|180 Days|Withdrawal by Subject|2|||
155067865|NCT01925794|559678923|FG000|270 Days|Death|2|||
155067866|NCT01925794|559678923|FG000|270 Days|Protocol Violation|3|||
155067867|NCT02612155|559678924|FG000|Overall Study|Death|1|||
155067868|NCT02612155|559678925|FG001|Overall Study|Death|1|||
155067869|NCT02612155|559678924|FG000|Overall Study|Lost to Follow-up|2|||
155067870|NCT02612155|559678925|FG001|Overall Study|Lost to Follow-up|2|||
155067871|NCT01564407|559678932|FG000|Overall Study|Lost to Follow-up|0|||
155067872|NCT01564407|559678933|FG001|Overall Study|Lost to Follow-up|1|||
155067873|NCT01564407|559678934|FG002|Overall Study|Lost to Follow-up|0|||
155067874|NCT01564407|559678935|FG003|Overall Study|Lost to Follow-up|0|||
155067875|NCT01564407|559678936|FG004|Overall Study|Lost to Follow-up|0|||
155067876|NCT01564407|559678932|FG000|Overall Study|Withdrawal by Subject|0|||
155067877|NCT01564407|559678933|FG001|Overall Study|Withdrawal by Subject|1|||
155067878|NCT01564407|559678934|FG002|Overall Study|Withdrawal by Subject|0|||
155319863|NCT01928394|560607335|FG001|Treatment Period|Death|0|||
155067879|NCT01564407|559678935|FG003|Overall Study|Withdrawal by Subject|0|||
155067880|NCT01564407|559678936|FG004|Overall Study|Withdrawal by Subject|0|||
155067881|NCT01564407|559678932|FG000|Overall Study|funding lost, study ended|0|||
155067882|NCT01564407|559678933|FG001|Overall Study|funding lost, study ended|0|||
155067883|NCT01564407|559678934|FG002|Overall Study|funding lost, study ended|0|||
155067884|NCT01564407|559678935|FG003|Overall Study|funding lost, study ended|1|||
155067885|NCT01564407|559678936|FG004|Overall Study|funding lost, study ended|0|||
155319864|NCT01928394|560607336|FG002|Treatment Period|Death|0|||
155067886|NCT04235374|559678939|FG000|Overall Study|Death|91|||
155067887|NCT04235374|559678940|FG001|Overall Study|Death|91|||
155067888|NCT04235374|559678939|FG000|Overall Study|Refused|2|||
155067889|NCT04235374|559678940|FG001|Overall Study|Refused|2|||
155067890|NCT04235374|559678939|FG000|Overall Study|Unavailable|12|||
155067891|NCT04235374|559678940|FG001|Overall Study|Unavailable|3|||
155067892|NCT04235374|559678939|FG000|Overall Study|Withdrawal by Subject|0|||
155067893|NCT04235374|559678940|FG001|Overall Study|Withdrawal by Subject|1|||
155067894|NCT04235374|559678939|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
155067895|NCT04235374|559678940|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
155067896|NCT00294658|559678941|FG000|Overall Study|Death|0|||
155067897|NCT00294658|559678942|FG001|Overall Study|Death|1|||
155067898|NCT00294658|559678941|FG000|Overall Study|Lost to Follow-up|4|||
155067899|NCT00294658|559678942|FG001|Overall Study|Lost to Follow-up|0|||
155067900|NCT00294658|559678941|FG000|Overall Study|Physician Decision|1|||
155067901|NCT00294658|559678942|FG001|Overall Study|Physician Decision|2|||
155067902|NCT00294658|559678941|FG000|Overall Study|Pregnancy|0|||
155067903|NCT00294658|559678942|FG001|Overall Study|Pregnancy|1|||
155067904|NCT00294658|559678941|FG000|Overall Study|Withdrawal by Subject|0|||
155067905|NCT00294658|559678942|FG001|Overall Study|Withdrawal by Subject|4|||
155067906|NCT00294658|559678941|FG000|Overall Study|Found to have invasive thymoma|1|||
155067907|NCT00294658|559678942|FG001|Overall Study|Found to have invasive thymoma|0|||
155067908|NCT00294658|559678941|FG000|Overall Study|Patient and family were not satisfied|0|||
155067909|NCT00294658|559678942|FG001|Overall Study|Patient and family were not satisfied|1|||
155067910|NCT05049122|559678945|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
155067911|NCT05049122|559678945|FG000|Overall Study|Participant moved|1|||
155067912|NCT05049122|559678945|FG000|Overall Study|At the direction of the doctor|1|||
155067913|NCT01910441|559678946|FG000|Overall Study|Sponsor decision|0|||
155067914|NCT01910441|559678947|FG001|Overall Study|Sponsor decision|2|||
155067915|NCT01910441|559678946|FG000|Overall Study|Lost to Follow-up|6|||
155067916|NCT01910441|559678947|FG001|Overall Study|Lost to Follow-up|5|||
155067917|NCT01910441|559678946|FG000|Overall Study|Withdrawal by Subject|0|||
155067918|NCT01910441|559678947|FG001|Overall Study|Withdrawal by Subject|1|||
155067919|NCT01910441|559678946|FG000|Overall Study|Non-compliance|0|||
155067920|NCT01910441|559678947|FG001|Overall Study|Non-compliance|1|||
155067921|NCT01910441|559678946|FG000|Overall Study|Adverse Event|1|||
155067922|NCT01910441|559678947|FG001|Overall Study|Adverse Event|0|||
155067923|NCT01910441|559678946|FG000|Overall Study|Physician Decision|0|||
155067924|NCT01910441|559678947|FG001|Overall Study|Physician Decision|1|||
155067925|NCT05168800|559678948|FG000|Time 1 Survey|Did not start T1 survey|182|||
155067926|NCT05168800|559678949|FG001|Time 1 Survey|Did not start T1 survey|150|||
155067927|NCT05168800|559678950|FG002|Time 1 Survey|Did not start T1 survey|140|||
155067928|NCT05168800|559678948|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
155067929|NCT05168800|559678949|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
155067930|NCT05168800|559678950|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
155067931|NCT05168800|559678948|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
155067932|NCT05168800|559678949|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
155067933|NCT05168800|559678950|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
155067934|NCT05168800|559678948|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
155067935|NCT05168800|559678949|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
155067936|NCT05168800|559678950|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
155067937|NCT05168800|559678948|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
155067938|NCT05168800|559678949|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
155067939|NCT05168800|559678950|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
155067940|NCT05168800|559678948|FG000|Time 1 Survey|Withdrawal by Subject|6|||
155067941|NCT05168800|559678949|FG001|Time 1 Survey|Withdrawal by Subject|3|||
154960530|NCT03637764|559280340|FG002|Overall Study|Withdrawal by Subject|0|||
154960531|NCT03637764|559280341|FG003|Overall Study|Withdrawal by Subject|1|||
154960532|NCT02689505|559280342|FG000|Overall Study|Progressive disease|2|||
154960533|NCT02689505|559280343|FG001|Overall Study|Progressive disease|2|||
154960534|NCT02689505|559280344|FG002|Overall Study|Progressive disease|3|||
154960535|NCT02689505|559280345|FG003|Overall Study|Progressive disease|9|||
154960536|NCT02689505|559280346|FG004|Overall Study|Progressive disease|1|||
154960537|NCT02689505|559280342|FG000|Overall Study|Dose Limiting Toxicity|0|||
154960538|NCT02689505|559280343|FG001|Overall Study|Dose Limiting Toxicity|1|||
154960539|NCT02689505|559280344|FG002|Overall Study|Dose Limiting Toxicity|0|||
154960540|NCT02689505|559280345|FG003|Overall Study|Dose Limiting Toxicity|0|||
154960541|NCT02689505|559280346|FG004|Overall Study|Dose Limiting Toxicity|2|||
154960542|NCT02689505|559280342|FG000|Overall Study|Other AE or clinical progression|0|||
154960543|NCT02689505|559280343|FG001|Overall Study|Other AE or clinical progression|2|||
154960544|NCT02689505|559280344|FG002|Overall Study|Other AE or clinical progression|0|||
154960545|NCT02689505|559280345|FG003|Overall Study|Other AE or clinical progression|2|||
154960546|NCT02689505|559280346|FG004|Overall Study|Other AE or clinical progression|0|||
154960547|NCT04108858|559280347|FG000|Overall Study|Adverse Event|1|||
154960548|NCT03663179|559280350|FG000|Overall Study|Withdrawal by Subject|2|||
154960549|NCT03663179|559280351|FG001|Overall Study|Withdrawal by Subject|0|||
154960550|NCT03663179|559280350|FG000|Overall Study|Lost to Follow-up|1|||
154960551|NCT03663179|559280351|FG001|Overall Study|Lost to Follow-up|1|||
154960552|NCT03663179|559280350|FG000|Overall Study|Revealed exclusionary condition|1|||
154960553|NCT03663179|559280351|FG001|Overall Study|Revealed exclusionary condition|0|||
154960554|NCT01615198|559280352|FG000|Overall Study|Withdrawal by Subject|5|||
154960555|NCT01615198|559280353|FG001|Overall Study|Withdrawal by Subject|5|||
154960556|NCT01615198|559280352|FG000|Overall Study|Protocol deviation|1|||
154960557|NCT01615198|559280353|FG001|Overall Study|Protocol deviation|1|||
154960558|NCT01615198|559280352|FG000|Overall Study|Physician Decision|5|||
154960559|NCT01615198|559280353|FG001|Overall Study|Physician Decision|1|||
154960560|NCT01615198|559280352|FG000|Overall Study|Lost to Follow-up|1|||
154960561|NCT01615198|559280353|FG001|Overall Study|Lost to Follow-up|1|||
154960562|NCT01615198|559280352|FG000|Overall Study|Lack of Efficacy|1|||
154960563|NCT01615198|559280353|FG001|Overall Study|Lack of Efficacy|6|||
154960564|NCT01615198|559280352|FG000|Overall Study|Adverse Event|11|||
154960565|NCT01615198|559280353|FG001|Overall Study|Adverse Event|5|||
154960566|NCT01686438|559280354|FG000|Overall Study|Lost to Follow-up|8|||
154960567|NCT01686438|559280355|FG001|Overall Study|Lost to Follow-up|9|||
154960568|NCT01686438|559280356|FG002|Overall Study|Lost to Follow-up|10|||
154960569|NCT01686438|559280354|FG000|Overall Study|Adverse Event|0|||
154960570|NCT01686438|559280355|FG001|Overall Study|Adverse Event|0|||
154960571|NCT01686438|559280356|FG002|Overall Study|Adverse Event|1|||
154960572|NCT01686438|559280354|FG000|Overall Study|Protocol Violation|0|||
154960573|NCT01686438|559280355|FG001|Overall Study|Protocol Violation|0|||
154960574|NCT01686438|559280356|FG002|Overall Study|Protocol Violation|1|||
154960575|NCT01686438|559280354|FG000|Overall Study|Withdrawal by Subject|0|||
154960576|NCT01686438|559280355|FG001|Overall Study|Withdrawal by Subject|0|||
154960577|NCT01686438|559280356|FG002|Overall Study|Withdrawal by Subject|1|||
154960578|NCT01864174|559280359|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
154960579|NCT01864174|559280360|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
154960580|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
154960581|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
154960582|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
154960583|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
154960584|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
154960585|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
154960586|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Death|1|||
154960587|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Death|0|||
154960588|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
154960589|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
154960590|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
154960591|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
154960592|NCT01864174|559280359|FG000|Double Blind - Compliant Randomized|Other|6|||
154960593|NCT01864174|559280360|FG001|Double Blind - Compliant Randomized|Other|10|||
154960594|NCT01864174|559280359|FG000|Off Treatment Follow-Up|Other|2|||
154960595|NCT01864174|559280360|FG001|Off Treatment Follow-Up|Other|0|||
154960596|NCT01864174|559280359|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
154960597|NCT01864174|559280360|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
155067942|NCT05168800|559678950|FG002|Time 1 Survey|Withdrawal by Subject|2|||
155067943|NCT05168800|559678948|FG000|Time 2 Survey|Already excluded at Time 1|228|||
155067944|NCT05168800|559678949|FG001|Time 2 Survey|Already excluded at Time 1|202|||
155067945|NCT05168800|559678950|FG002|Time 2 Survey|Already excluded at Time 1|173|||
155067946|NCT05168800|559678948|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
155067947|NCT05168800|559678949|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
155067948|NCT05168800|559678950|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
155067949|NCT05168800|559678948|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
155067950|NCT05168800|559678949|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
155067951|NCT05168800|559678950|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
155067952|NCT05168800|559678948|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
155067953|NCT05168800|559678949|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
155067954|NCT05168800|559678950|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
155067955|NCT05168800|559678948|FG000|Time 2 Survey|Withdrawal by Subject|1|||
155067956|NCT05168800|559678949|FG001|Time 2 Survey|Withdrawal by Subject|0|||
155067957|NCT05168800|559678950|FG002|Time 2 Survey|Withdrawal by Subject|1|||
155067958|NCT05168800|559678948|FG000|Time 3 Survey|Already excluded at Time 1|228|||
155067959|NCT05168800|559678949|FG001|Time 3 Survey|Already excluded at Time 1|200|||
155067960|NCT05168800|559678950|FG002|Time 3 Survey|Already excluded at Time 1|173|||
155067961|NCT05168800|559678948|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
155067962|NCT05168800|559678949|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
155067963|NCT05168800|559678950|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
155067964|NCT05168800|559678948|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
155067965|NCT05168800|559678949|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
155067966|NCT05168800|559678950|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
155067967|NCT05168800|559678948|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
155067968|NCT05168800|559678949|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
155067969|NCT05168800|559678950|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
155067970|NCT05252702|559678951|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
155067971|NCT05252702|559678951|FG000|Overall Study|Death|16|||
155067972|NCT05252702|559678951|FG000|Overall Study|System explant|5|||
155319865|NCT01928394|560607337|FG003|Treatment Period|Death|0|||
155319866|NCT01928394|560607338|FG004|Treatment Period|Death|0|||
155319867|NCT01928394|560607339|FG005|Treatment Period|Death|0|||
155319868|NCT01928394|560607340|FG006|Treatment Period|Death|0|||
155319869|NCT01928394|560607341|FG007|Treatment Period|Death|0|||
155319870|NCT01928394|560607342|FG008|Treatment Period|Death|0|||
155319871|NCT01928394|560607343|FG009|Treatment Period|Death|0|||
155319872|NCT01928394|560607344|FG010|Treatment Period|Death|0|||
155067973|NCT05252702|559678951|FG000|Overall Study|Lost to Follow-up|1|||
155067974|NCT05252702|559678951|FG000|Overall Study|Withdrawn by investigator|1|||
155067975|NCT05252702|559678951|FG000|Overall Study|Visit not due|306|||
155067976|NCT05252702|559678951|FG000|Overall Study|Visit within window but not completed|92|||
155067977|NCT05252702|559678951|FG000|Overall Study|Unsuccessful implant|1|||
155067978|NCT04153864|559678952|FG000|Overall Study|Withdrawal by Subject|21|||
155067979|NCT04153864|559678953|FG001|Overall Study|Withdrawal by Subject|7|||
155067980|NCT04153864|559678954|FG002|Overall Study|Withdrawal by Subject|23|||
155067981|NCT04153864|559678955|FG003|Overall Study|Withdrawal by Subject|2|||
155067982|NCT04153864|559678952|FG000|Overall Study|Lost to Follow-up|4|||
155067983|NCT04153864|559678953|FG001|Overall Study|Lost to Follow-up|0|||
155067984|NCT04153864|559678954|FG002|Overall Study|Lost to Follow-up|3|||
155067985|NCT04153864|559678955|FG003|Overall Study|Lost to Follow-up|0|||
155067986|NCT04153864|559678952|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
155067987|NCT04153864|559678953|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
155067988|NCT04153864|559678954|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
155067989|NCT04153864|559678955|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
155067990|NCT04279522|559678957|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
155067991|NCT04279522|559678958|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
155067992|NCT04279522|559678957|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
155067993|NCT04279522|559678958|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
155319873|NCT01928394|560607345|FG011|Treatment Period|Death|0|||
155319874|NCT01928394|560607346|FG012|Treatment Period|Death|0|||
155319875|NCT01928394|560607347|FG013|Treatment Period|Death|1|||
155319876|NCT01928394|560607348|FG014|Treatment Period|Death|2|||
155319877|NCT01928394|560607349|FG015|Treatment Period|Death|0|||
155067994|NCT04279522|559678957|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
155319878|NCT01928394|560607350|FG016|Treatment Period|Death|0|||
155319879|NCT01928394|560607351|FG017|Treatment Period|Death|0|||
155319880|NCT01928394|560607352|FG018|Treatment Period|Death|0|||
155319881|NCT01928394|560607353|FG019|Treatment Period|Death|0|||
155319882|NCT01928394|560607354|FG020|Treatment Period|Death|0|||
155067995|NCT04279522|559678958|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
155067996|NCT04279522|559678957|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
155067997|NCT04279522|559678958|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
155067998|NCT04279522|559678957|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
155067999|NCT04279522|559678958|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
155068000|NCT04279522|559678957|FG000|Period 2: Open Label Phase|Physician Decision|0|||
155068001|NCT04279522|559678958|FG001|Period 2: Open Label Phase|Physician Decision|3|||
155068002|NCT04279522|559678957|FG000|Period 2: Open Label Phase|Adverse Event|0|||
155068003|NCT04279522|559678958|FG001|Period 2: Open Label Phase|Adverse Event|1|||
155068004|NCT04279522|559678957|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
155068005|NCT04279522|559678958|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
155068006|NCT01654276|559678960|FG000|Overall Study|Lack of Efficacy|1|||
155068007|NCT01654276|559678960|FG000|Overall Study|Lost to Follow-up|4|||
155068008|NCT01654276|559678960|FG000|Overall Study|Withdrawal by Subject|1|||
155068009|NCT01977846|559678967|FG000|Total Study - Prospective|Death|0|||
155068010|NCT01977846|559678968|FG001|Total Study - Prospective|Death|1|||
155068011|NCT01977846|559678967|FG000|Total Study - Prospective|Lost to Follow-up|0|||
155068012|NCT01977846|559678968|FG001|Total Study - Prospective|Lost to Follow-up|8|||
155068013|NCT01977846|559678967|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
155068014|NCT01977846|559678968|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
155068015|NCT01977846|559678967|FG000|Total Study - Prospective|Not available at time of visit|0|||
155068016|NCT01977846|559678968|FG001|Total Study - Prospective|Not available at time of visit|5|||
155068017|NCT01977846|559678967|FG000|Total Study - Prospective|No show|0|||
155068018|NCT01977846|559678968|FG001|Total Study - Prospective|No show|1|||
155068019|NCT01977846|559678967|FG000|Total Study - Prospective|Protocol Violation|0|||
155068020|NCT01977846|559678968|FG001|Total Study - Prospective|Protocol Violation|1|||
155068021|NCT01101178|559678969|FG000|Period 1|Withdrawal by Subject|1|||
155068022|NCT01101178|559678970|FG001|Period 1|Withdrawal by Subject|2|||
155068023|NCT01101178|559678969|FG000|Period 1|Positive drug screen|1|||
155068024|NCT01101178|559678970|FG001|Period 1|Positive drug screen|1|||
155068025|NCT01101178|559678969|FG000|Period 1|Adverse Event|2|||
155068026|NCT01101178|559678970|FG001|Period 1|Adverse Event|1|||
155068027|NCT01101178|559678969|FG000|Period 2|Withdrawal by Subject|0|||
155068028|NCT01101178|559678970|FG001|Period 2|Withdrawal by Subject|1|||
155068029|NCT00127803|559678971|FG000|Overall Study|Adverse Event|2|||
155068030|NCT00127803|559678972|FG001|Overall Study|Adverse Event|0|||
155068031|NCT00127803|559678973|FG002|Overall Study|Adverse Event|0|||
155068032|NCT00127803|559678974|FG003|Overall Study|Adverse Event|0|||
155068033|NCT00127803|559678971|FG000|Overall Study|Withdrawal by Subject|1|||
155068034|NCT00127803|559678972|FG001|Overall Study|Withdrawal by Subject|0|||
155068035|NCT00127803|559678973|FG002|Overall Study|Withdrawal by Subject|0|||
155068036|NCT00127803|559678974|FG003|Overall Study|Withdrawal by Subject|0|||
155068037|NCT00127803|559678971|FG000|Overall Study|Lost to Follow-up|0|||
155068038|NCT00127803|559678972|FG001|Overall Study|Lost to Follow-up|0|||
155068039|NCT00127803|559678973|FG002|Overall Study|Lost to Follow-up|0|||
155068040|NCT00127803|559678974|FG003|Overall Study|Lost to Follow-up|1|||
155068041|NCT00858988|559678977|FG000|Analysis|Lactulose unable to be detected in urine|2|||
155068042|NCT00858988|559678978|FG001|Analysis|Lactulose unable to be detected in urine|1|||
155068043|NCT01020123|559678979|FG000|Main Period|Withdrawal by Subject|6|||
155068044|NCT01020123|559678980|FG001|Main Period|Withdrawal by Subject|5|||
155068045|NCT01020123|559678981|FG002|Main Period|Withdrawal by Subject|3|||
155068046|NCT01020123|559678982|FG003|Main Period|Withdrawal by Subject|1|||
155068047|NCT01020123|559678983|FG004|Main Period|Withdrawal by Subject|6|||
155068048|NCT01020123|559678984|FG005|Main Period|Withdrawal by Subject|3|||
155068049|NCT01020123|559678985|FG006|Main Period|Withdrawal by Subject|2|||
155068050|NCT01020123|559678979|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
155068051|NCT01020123|559678980|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
155068052|NCT01020123|559678981|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
155068053|NCT01020123|559678982|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
155068054|NCT01020123|559678983|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
155068055|NCT01020123|559678984|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
155068056|NCT01020123|559678985|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
155068057|NCT01020123|559678979|FG000|Main Period|Adverse Event|5|||
155068058|NCT01020123|559678980|FG001|Main Period|Adverse Event|2|||
155068059|NCT01020123|559678981|FG002|Main Period|Adverse Event|2|||
155068060|NCT01020123|559678982|FG003|Main Period|Adverse Event|1|||
155068061|NCT01020123|559678983|FG004|Main Period|Adverse Event|1|||
155068062|NCT01020123|559678984|FG005|Main Period|Adverse Event|2|||
155068063|NCT01020123|559678985|FG006|Main Period|Adverse Event|1|||
155068064|NCT01020123|559678979|FG000|Main Period|Protocol Violation|4|||
155068065|NCT01020123|559678980|FG001|Main Period|Protocol Violation|4|||
155068066|NCT01020123|559678981|FG002|Main Period|Protocol Violation|2|||
155068067|NCT01020123|559678982|FG003|Main Period|Protocol Violation|5|||
155068068|NCT01020123|559678983|FG004|Main Period|Protocol Violation|2|||
155068069|NCT01020123|559678984|FG005|Main Period|Protocol Violation|3|||
155068070|NCT01020123|559678985|FG006|Main Period|Protocol Violation|2|||
155068071|NCT01020123|559678979|FG000|Main Period|Lost to Follow-up|0|||
155068072|NCT01020123|559678980|FG001|Main Period|Lost to Follow-up|2|||
155068073|NCT01020123|559678981|FG002|Main Period|Lost to Follow-up|0|||
155068074|NCT01020123|559678982|FG003|Main Period|Lost to Follow-up|0|||
155068075|NCT01020123|559678983|FG004|Main Period|Lost to Follow-up|0|||
155068076|NCT01020123|559678984|FG005|Main Period|Lost to Follow-up|0|||
155068077|NCT01020123|559678985|FG006|Main Period|Lost to Follow-up|0|||
155068078|NCT01020123|559678979|FG000|Main Period|Unclasified|2|||
155068079|NCT01020123|559678980|FG001|Main Period|Unclasified|0|||
155068080|NCT01020123|559678981|FG002|Main Period|Unclasified|1|||
155068081|NCT01020123|559678982|FG003|Main Period|Unclasified|0|||
155068082|NCT01020123|559678983|FG004|Main Period|Unclasified|1|||
155068083|NCT01020123|559678984|FG005|Main Period|Unclasified|3|||
155068084|NCT01020123|559678985|FG006|Main Period|Unclasified|6|||
155068085|NCT01020123|559678979|FG000|Extention Period|Withdrawal by Subject|2|||
155068086|NCT01020123|559678980|FG001|Extention Period|Withdrawal by Subject|1|||
155068087|NCT01020123|559678981|FG002|Extention Period|Withdrawal by Subject|1|||
155068088|NCT01020123|559678982|FG003|Extention Period|Withdrawal by Subject|0|||
155068089|NCT01020123|559678983|FG004|Extention Period|Withdrawal by Subject|0|||
155068090|NCT01020123|559678984|FG005|Extention Period|Withdrawal by Subject|0|||
155068091|NCT01020123|559678985|FG006|Extention Period|Withdrawal by Subject|0|||
155068092|NCT01020123|559678979|FG000|Extention Period|Adverse Event|0|||
155068093|NCT01020123|559678980|FG001|Extention Period|Adverse Event|0|||
155068094|NCT01020123|559678981|FG002|Extention Period|Adverse Event|0|||
155068095|NCT01020123|559678982|FG003|Extention Period|Adverse Event|1|||
155068096|NCT01020123|559678983|FG004|Extention Period|Adverse Event|0|||
155068097|NCT01020123|559678984|FG005|Extention Period|Adverse Event|0|||
155068098|NCT01020123|559678985|FG006|Extention Period|Adverse Event|0|||
155068099|NCT01020123|559678979|FG000|Extention Period|Protocol Violation|1|||
155068100|NCT01020123|559678980|FG001|Extention Period|Protocol Violation|1|||
155068101|NCT01020123|559678981|FG002|Extention Period|Protocol Violation|1|||
155068102|NCT01020123|559678982|FG003|Extention Period|Protocol Violation|0|||
155068103|NCT01020123|559678983|FG004|Extention Period|Protocol Violation|0|||
155068104|NCT01020123|559678984|FG005|Extention Period|Protocol Violation|0|||
155068105|NCT01020123|559678985|FG006|Extention Period|Protocol Violation|1|||
155068106|NCT01020123|559678979|FG000|Extention Period|Lost to Follow-up|0|||
155068107|NCT01020123|559678980|FG001|Extention Period|Lost to Follow-up|0|||
155068108|NCT01020123|559678981|FG002|Extention Period|Lost to Follow-up|0|||
155068109|NCT01020123|559678982|FG003|Extention Period|Lost to Follow-up|0|||
155068110|NCT01020123|559678983|FG004|Extention Period|Lost to Follow-up|0|||
155068111|NCT01020123|559678984|FG005|Extention Period|Lost to Follow-up|2|||
155068112|NCT01020123|559678985|FG006|Extention Period|Lost to Follow-up|0|||
155068113|NCT01349595|559678986|FG000|Overall Study|Lack of funding|2|||
155068114|NCT01349595|559678987|FG001|Overall Study|Lack of funding|2|||
155068115|NCT03479905|559678988|FG000|Overall Study|Other airway method used|4|||
155068116|NCT03479905|559678989|FG001|Overall Study|Other airway method used|5|||
155068117|NCT03479905|559678990|FG002|Overall Study|Other airway method used|5|||
155068118|NCT01047319|559678991|FG000|Overall Study|Teva requested participant withdrawal|3|||
155068119|NCT01047319|559678992|FG001|Overall Study|Teva requested participant withdrawal|0|||
155068120|NCT01047319|559678993|FG002|Overall Study|Teva requested participant withdrawal|1|||
155068121|NCT01047319|559678991|FG000|Overall Study|Protocol Violation|3|||
155068122|NCT01047319|559678992|FG001|Overall Study|Protocol Violation|2|||
155068123|NCT01047319|559678993|FG002|Overall Study|Protocol Violation|4|||
155068124|NCT01047319|559678991|FG000|Overall Study|Lack of Efficacy|4|||
155068125|NCT01047319|559678992|FG001|Overall Study|Lack of Efficacy|3|||
155068126|NCT01047319|559678993|FG002|Overall Study|Lack of Efficacy|3|||
155068127|NCT01047319|559678991|FG000|Overall Study|Death|5|||
155068128|NCT01047319|559678992|FG001|Overall Study|Death|1|||
155068129|NCT01047319|559678993|FG002|Overall Study|Death|5|||
155068130|NCT01047319|559678991|FG000|Overall Study|Pregnancy|13|||
155068131|NCT01047319|559678992|FG001|Overall Study|Pregnancy|8|||
155319883|NCT01928394|560607355|FG021|Treatment Period|Death|0|||
155319884|NCT01928394|560607356|FG022|Treatment Period|Death|0|||
155319885|NCT01928394|560607334|FG000|Follow-up Period|Participant withdrew consent|3|||
155319886|NCT01928394|560607335|FG001|Follow-up Period|Participant withdrew consent|0|||
155319887|NCT01928394|560607336|FG002|Follow-up Period|Participant withdrew consent|1|||
155319888|NCT01928394|560607337|FG003|Follow-up Period|Participant withdrew consent|4|||
155319889|NCT01928394|560607338|FG004|Follow-up Period|Participant withdrew consent|0|||
155319890|NCT01928394|560607339|FG005|Follow-up Period|Participant withdrew consent|2|||
155319891|NCT01928394|560607340|FG006|Follow-up Period|Participant withdrew consent|5|||
155319892|NCT01928394|560607341|FG007|Follow-up Period|Participant withdrew consent|1|||
155319893|NCT01928394|560607342|FG008|Follow-up Period|Participant withdrew consent|0|||
155319894|NCT01928394|560607343|FG009|Follow-up Period|Participant withdrew consent|0|||
155068132|NCT01047319|559678993|FG002|Overall Study|Pregnancy|8|||
155068133|NCT01047319|559678991|FG000|Overall Study|Physician Decision|12|||
155068134|NCT01047319|559678992|FG001|Overall Study|Physician Decision|9|||
155068135|NCT01047319|559678993|FG002|Overall Study|Physician Decision|10|||
155319895|NCT01928394|560607344|FG010|Follow-up Period|Participant withdrew consent|5|||
155068136|NCT01047319|559678991|FG000|Overall Study|Lost to Follow-up|14|||
155068137|NCT01047319|559678992|FG001|Overall Study|Lost to Follow-up|10|||
155068138|NCT01047319|559678993|FG002|Overall Study|Lost to Follow-up|10|||
155068139|NCT01047319|559678991|FG000|Overall Study|Adverse Event|16|||
155068140|NCT01047319|559678992|FG001|Overall Study|Adverse Event|27|||
155068141|NCT01047319|559678993|FG002|Overall Study|Adverse Event|21|||
155068142|NCT01047319|559678991|FG000|Overall Study|Withdrawal by Subject|77|||
155068143|NCT01047319|559678992|FG001|Overall Study|Withdrawal by Subject|75|||
155068144|NCT01047319|559678993|FG002|Overall Study|Withdrawal by Subject|87|||
155068145|NCT01047319|559678991|FG000|Overall Study|Study terminated by Sponsor|198|||
155068146|NCT01047319|559678992|FG001|Overall Study|Study terminated by Sponsor|215|||
155068147|NCT01047319|559678993|FG002|Overall Study|Study terminated by Sponsor|203|||
155068148|NCT01706328|559678994|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
155068149|NCT01706328|559678995|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155068150|NCT01706328|559678996|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155068151|NCT01706328|559678994|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
155068152|NCT01706328|559678995|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155068153|NCT01706328|559678996|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155068154|NCT01706328|559678994|FG000|2-week Run-in Period|Physician Decision|4|||
155068155|NCT01706328|559678995|FG001|2-week Run-in Period|Physician Decision|0|||
155068156|NCT01706328|559678996|FG002|2-week Run-in Period|Physician Decision|0|||
155068157|NCT01706328|559678994|FG000|2-week Run-in Period|Adverse Event|4|||
155068158|NCT01706328|559678995|FG001|2-week Run-in Period|Adverse Event|0|||
155068159|NCT01706328|559678996|FG002|2-week Run-in Period|Adverse Event|0|||
155068160|NCT01706328|559678994|FG000|2-week Run-in Period|Lost to Follow-up|2|||
155068161|NCT01706328|559678995|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155068162|NCT01706328|559678996|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155068163|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
155068164|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
155068165|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
155068166|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
155068167|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
155068168|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
155068169|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
155068170|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
155068171|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
155068172|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
155068173|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
155068174|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
155068175|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
155068176|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
155068177|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
155068178|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
155068179|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
155068180|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
155068181|NCT01706328|559678994|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155068182|NCT01706328|559678995|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
155068183|NCT01706328|559678996|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
155068184|NCT06481579|559678997|FG000|Overall Study|Death|1|||
155068185|NCT06481579|559678998|FG001|Overall Study|Death|0|||
155068186|NCT06481579|559678997|FG000|Overall Study|Withdrawal by Subject|3|||
155068187|NCT06481579|559678998|FG001|Overall Study|Withdrawal by Subject|0|||
155068188|NCT06481579|559678997|FG000|Overall Study|Other|1|||
155068189|NCT06481579|559678998|FG001|Overall Study|Other|1|||
155068190|NCT00770809|559680927|FG000|Overall Study|Adverse Event|9|||
155068191|NCT00770809|559680928|FG001|Overall Study|Adverse Event|1|||
155068192|NCT00770809|559680929|FG002|Overall Study|Adverse Event|12|||
155319896|NCT01928394|560607345|FG011|Follow-up Period|Participant withdrew consent|8|||
155319897|NCT01928394|560607346|FG012|Follow-up Period|Participant withdrew consent|2|||
155319898|NCT01928394|560607347|FG013|Follow-up Period|Participant withdrew consent|12|||
155319899|NCT01928394|560607348|FG014|Follow-up Period|Participant withdrew consent|7|||
155319900|NCT01928394|560607349|FG015|Follow-up Period|Participant withdrew consent|0|||
155319901|NCT01928394|560607350|FG016|Follow-up Period|Participant withdrew consent|5|||
155319902|NCT01928394|560607351|FG017|Follow-up Period|Participant withdrew consent|3|||
155319903|NCT01928394|560607352|FG018|Follow-up Period|Participant withdrew consent|2|||
155319904|NCT01928394|560607353|FG019|Follow-up Period|Participant withdrew consent|7|||
155319905|NCT01928394|560607354|FG020|Follow-up Period|Participant withdrew consent|4|||
155319906|NCT01928394|560607355|FG021|Follow-up Period|Participant withdrew consent|6|||
155319907|NCT01928394|560607356|FG022|Follow-up Period|Participant withdrew consent|2|||
155319908|NCT01928394|560607334|FG000|Follow-up Period|Death|0|||
155319909|NCT01928394|560607335|FG001|Follow-up Period|Death|0|||
155319910|NCT01928394|560607336|FG002|Follow-up Period|Death|2|||
155319911|NCT01928394|560607337|FG003|Follow-up Period|Death|6|||
155068193|NCT00770809|559680927|FG000|Overall Study|Death|1|||
155068194|NCT00770809|559680928|FG001|Overall Study|Death|0|||
155068195|NCT00770809|559680929|FG002|Overall Study|Death|0|||
155319912|NCT01928394|560607338|FG004|Follow-up Period|Death|0|||
155319913|NCT01928394|560607339|FG005|Follow-up Period|Death|6|||
155319914|NCT01928394|560607340|FG006|Follow-up Period|Death|6|||
155319915|NCT01928394|560607341|FG007|Follow-up Period|Death|2|||
155319916|NCT01928394|560607342|FG008|Follow-up Period|Death|1|||
155319917|NCT01928394|560607343|FG009|Follow-up Period|Death|2|||
155319918|NCT01928394|560607344|FG010|Follow-up Period|Death|4|||
155319919|NCT01928394|560607345|FG011|Follow-up Period|Death|12|||
155319920|NCT01928394|560607346|FG012|Follow-up Period|Death|11|||
155319921|NCT01928394|560607347|FG013|Follow-up Period|Death|25|||
155319922|NCT01928394|560607348|FG014|Follow-up Period|Death|18|||
155319923|NCT01928394|560607349|FG015|Follow-up Period|Death|0|||
155319924|NCT01928394|560607350|FG016|Follow-up Period|Death|6|||
155319925|NCT01928394|560607351|FG017|Follow-up Period|Death|5|||
155319926|NCT01928394|560607352|FG018|Follow-up Period|Death|13|||
155319927|NCT01928394|560607353|FG019|Follow-up Period|Death|13|||
155319928|NCT01928394|560607354|FG020|Follow-up Period|Death|5|||
155319929|NCT01928394|560607355|FG021|Follow-up Period|Death|3|||
155319930|NCT01928394|560607356|FG022|Follow-up Period|Death|2|||
155068196|NCT00770809|559680927|FG000|Overall Study|Withdrawal by Subject|3|||
155068197|NCT00770809|559680928|FG001|Overall Study|Withdrawal by Subject|3|||
155068198|NCT00770809|559680929|FG002|Overall Study|Withdrawal by Subject|7|||
155068199|NCT00770809|559680927|FG000|Overall Study|Progression|2|||
155068200|NCT00770809|559680928|FG001|Overall Study|Progression|2|||
155068201|NCT00770809|559680929|FG002|Overall Study|Progression|0|||
155068202|NCT00770809|559680927|FG000|Overall Study|Complicating illness|0|||
155068203|NCT00770809|559680928|FG001|Overall Study|Complicating illness|0|||
155068204|NCT00770809|559680929|FG002|Overall Study|Complicating illness|1|||
155068205|NCT00770809|559680927|FG000|Overall Study|Other Medical Reasons|2|||
155068206|NCT00770809|559680928|FG001|Overall Study|Other Medical Reasons|4|||
155068207|NCT00770809|559680929|FG002|Overall Study|Other Medical Reasons|3|||
155068208|NCT05028569|559680930|FG000|Double-Blind Phase|Death|0|||
155068209|NCT05028569|559680931|FG001|Double-Blind Phase|Death|0|||
155068210|NCT05028569|559680932|FG002|Double-Blind Phase|Death|0|||
155068211|NCT05028569|559680933|FG003|Double-Blind Phase|Death|1|||
155068212|NCT05028569|559680934|FG004|Double-Blind Phase|Death|0|||
155319931|NCT01928394|560607334|FG000|Follow-up Period|other reason|0|||
155319932|NCT01928394|560607335|FG001|Follow-up Period|other reason|0|||
155319933|NCT01928394|560607336|FG002|Follow-up Period|other reason|0|||
155319934|NCT01928394|560607337|FG003|Follow-up Period|other reason|0|||
155068213|NCT05028569|559680935|FG005|Double-Blind Phase|Death|0|||
155068214|NCT05028569|559680936|FG006|Double-Blind Phase|Death|0|||
155319935|NCT01928394|560607338|FG004|Follow-up Period|other reason|0|||
155068215|NCT05028569|559680930|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155068216|NCT05028569|559680931|FG001|Double-Blind Phase|Lost to Follow-up|6|||
155068217|NCT05028569|559680932|FG002|Double-Blind Phase|Lost to Follow-up|3|||
155319936|NCT01928394|560607339|FG005|Follow-up Period|other reason|0|||
155319937|NCT01928394|560607340|FG006|Follow-up Period|other reason|1|||
155319938|NCT01928394|560607341|FG007|Follow-up Period|other reason|3|||
155319939|NCT01928394|560607342|FG008|Follow-up Period|other reason|0|||
155319940|NCT01928394|560607343|FG009|Follow-up Period|other reason|0|||
155319941|NCT01928394|560607344|FG010|Follow-up Period|other reason|2|||
154960598|NCT00468286|559280361|FG000|Overall Study|Adverse Event|1|||
154960599|NCT00468286|559280362|FG001|Overall Study|Adverse Event|6|||
154960600|NCT00468286|559280361|FG000|Overall Study|Protocol Violation|2|||
154960601|NCT00468286|559280362|FG001|Overall Study|Protocol Violation|2|||
154960602|NCT00468286|559280361|FG000|Overall Study|Withdrawal by Subject|4|||
154960603|NCT00468286|559280362|FG001|Overall Study|Withdrawal by Subject|3|||
154960604|NCT00468286|559280361|FG000|Overall Study|Physician Decision|0|||
154960605|NCT00468286|559280362|FG001|Overall Study|Physician Decision|1|||
154960606|NCT02453386|559280366|FG000|Overall Study|Adverse Event|22|||
154960607|NCT02453386|559280367|FG001|Overall Study|Adverse Event|30|||
154960608|NCT02453386|559280368|FG002|Overall Study|Adverse Event|15|||
154960609|NCT02453386|559280366|FG000|Overall Study|Protocol Violation|1|||
154960610|NCT02453386|559280367|FG001|Overall Study|Protocol Violation|0|||
154960611|NCT02453386|559280368|FG002|Overall Study|Protocol Violation|1|||
154960612|NCT02453386|559280366|FG000|Overall Study|Withdrawal by Subject|10|||
154960613|NCT02453386|559280367|FG001|Overall Study|Withdrawal by Subject|9|||
154960614|NCT02453386|559280368|FG002|Overall Study|Withdrawal by Subject|9|||
154960615|NCT02453386|559280366|FG000|Overall Study|Sponsor Terminated Study|14|||
154960616|NCT02453386|559280367|FG001|Overall Study|Sponsor Terminated Study|8|||
154960617|NCT02453386|559280368|FG002|Overall Study|Sponsor Terminated Study|11|||
154960618|NCT02453386|559280366|FG000|Overall Study|Subject Terminated by Sponsor|1|||
154960619|NCT02453386|559280367|FG001|Overall Study|Subject Terminated by Sponsor|1|||
154960620|NCT02453386|559280368|FG002|Overall Study|Subject Terminated by Sponsor|1|||
154960621|NCT02453386|559280366|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
154960622|NCT02453386|559280367|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
154960623|NCT02453386|559280368|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
154960624|NCT02453386|559280366|FG000|Overall Study|Lost to Follow-up|0|||
154960625|NCT02453386|559280367|FG001|Overall Study|Lost to Follow-up|0|||
154960626|NCT02453386|559280368|FG002|Overall Study|Lost to Follow-up|1|||
154960627|NCT02453386|559280366|FG000|Overall Study|Other|1|||
154960628|NCT02453386|559280367|FG001|Overall Study|Other|0|||
154960629|NCT02453386|559280368|FG002|Overall Study|Other|1|||
154960630|NCT02601625|559280369|FG000|Overall Study|Lost to Follow-up|0|||
154960631|NCT02601625|559280370|FG001|Overall Study|Lost to Follow-up|0|||
154960632|NCT02601625|559280371|FG002|Overall Study|Lost to Follow-up|1|||
154960633|NCT02601625|559280372|FG003|Overall Study|Lost to Follow-up|1|||
154960634|NCT01289262|559280375|FG000|Overall Study|Lost to Follow-up|29|||
154960635|NCT01289262|559280376|FG001|Overall Study|Lost to Follow-up|16|||
154960636|NCT01289262|559280375|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
154960637|NCT01289262|559280376|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
154960638|NCT00838279|559280379|FG000|Washout|Protocol Violation|1|||
154960639|NCT00838279|559280380|FG001|Washout|Protocol Violation|0|||
154960640|NCT00838279|559280379|FG000|Washout|Withdrawal by Subject|0|||
154960641|NCT00838279|559280380|FG001|Washout|Withdrawal by Subject|1|||
154960642|NCT04608188|559280381|FG000|Overall Study|Withdrawal by Subject|4|||
154960643|NCT04608188|559280382|FG001|Overall Study|Withdrawal by Subject|8|||
154960644|NCT01474551|559280386|FG000|Overall Study|Death|1|||
154960645|NCT01921062|559280387|FG000|Overall Study|Withdrawal by Subject|0|||
154960646|NCT01921062|559280388|FG001|Overall Study|Withdrawal by Subject|7|||
154960647|NCT01921062|559280387|FG000|Overall Study|Adverse Event|5|||
154960648|NCT01921062|559280388|FG001|Overall Study|Adverse Event|6|||
154960649|NCT01921062|559280387|FG000|Overall Study|Protocol Violation|0|||
154960650|NCT01921062|559280388|FG001|Overall Study|Protocol Violation|1|||
154960651|NCT01921062|559280387|FG000|Overall Study|VMIQ score > 72|4|||
154960652|NCT01921062|559280388|FG001|Overall Study|VMIQ score > 72|1|||
154960653|NCT01921062|559280387|FG000|Overall Study|Logistic error|0|||
154960654|NCT01921062|559280388|FG001|Overall Study|Logistic error|1|||
154960655|NCT01854047|559280389|FG000|Overall Study|Lack of Efficacy|1|||
154960656|NCT01854047|559280390|FG001|Overall Study|Lack of Efficacy|0|||
155068218|NCT05028569|559680933|FG003|Double-Blind Phase|Lost to Follow-up|9|||
155068219|NCT05028569|559680934|FG004|Double-Blind Phase|Lost to Follow-up|0|||
155068220|NCT05028569|559680935|FG005|Double-Blind Phase|Lost to Follow-up|0|||
155068221|NCT05028569|559680936|FG006|Double-Blind Phase|Lost to Follow-up|0|||
155068222|NCT05028569|559680930|FG000|Double-Blind Phase|Protocol Deviation|0|||
155068223|NCT05028569|559680931|FG001|Double-Blind Phase|Protocol Deviation|2|||
155068224|NCT05028569|559680932|FG002|Double-Blind Phase|Protocol Deviation|0|||
155068225|NCT05028569|559680933|FG003|Double-Blind Phase|Protocol Deviation|0|||
155068226|NCT05028569|559680934|FG004|Double-Blind Phase|Protocol Deviation|0|||
155068227|NCT05028569|559680935|FG005|Double-Blind Phase|Protocol Deviation|0|||
155068228|NCT05028569|559680936|FG006|Double-Blind Phase|Protocol Deviation|0|||
155068229|NCT05028569|559680930|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155068230|NCT05028569|559680931|FG001|Double-Blind Phase|Withdrawal by Subject|27|||
155068231|NCT05028569|559680932|FG002|Double-Blind Phase|Withdrawal by Subject|20|||
155068232|NCT05028569|559680933|FG003|Double-Blind Phase|Withdrawal by Subject|22|||
155068233|NCT05028569|559680934|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155068234|NCT05028569|559680935|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
155068235|NCT05028569|559680936|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
155068236|NCT05028569|559680930|FG000|Double-Blind Phase|Other, not specified|0|||
155068237|NCT05028569|559680931|FG001|Double-Blind Phase|Other, not specified|5|||
155068238|NCT05028569|559680932|FG002|Double-Blind Phase|Other, not specified|4|||
155068239|NCT05028569|559680933|FG003|Double-Blind Phase|Other, not specified|6|||
155068240|NCT05028569|559680934|FG004|Double-Blind Phase|Other, not specified|0|||
155068241|NCT05028569|559680935|FG005|Double-Blind Phase|Other, not specified|0|||
155068242|NCT05028569|559680936|FG006|Double-Blind Phase|Other, not specified|0|||
155068243|NCT05028569|559680930|FG000|Open-Label Phase|Death|0|||
155068244|NCT05028569|559680931|FG001|Open-Label Phase|Death|0|||
155068245|NCT05028569|559680932|FG002|Open-Label Phase|Death|0|||
155068246|NCT05028569|559680933|FG003|Open-Label Phase|Death|0|||
155068247|NCT05028569|559680934|FG004|Open-Label Phase|Death|0|||
155068248|NCT05028569|559680935|FG005|Open-Label Phase|Death|0|||
155068249|NCT05028569|559680936|FG006|Open-Label Phase|Death|1|||
155068250|NCT05028569|559680930|FG000|Open-Label Phase|Lost to Follow-up|0|||
155068251|NCT05028569|559680931|FG001|Open-Label Phase|Lost to Follow-up|0|||
155068252|NCT05028569|559680932|FG002|Open-Label Phase|Lost to Follow-up|0|||
155068253|NCT05028569|559680933|FG003|Open-Label Phase|Lost to Follow-up|0|||
155068254|NCT05028569|559680934|FG004|Open-Label Phase|Lost to Follow-up|5|||
155068255|NCT05028569|559680935|FG005|Open-Label Phase|Lost to Follow-up|5|||
155068256|NCT05028569|559680936|FG006|Open-Label Phase|Lost to Follow-up|4|||
155068257|NCT05028569|559680930|FG000|Open-Label Phase|Protocol Deviation|0|||
155068258|NCT05028569|559680931|FG001|Open-Label Phase|Protocol Deviation|0|||
155068259|NCT05028569|559680932|FG002|Open-Label Phase|Protocol Deviation|0|||
155068260|NCT05028569|559680933|FG003|Open-Label Phase|Protocol Deviation|0|||
155068261|NCT05028569|559680934|FG004|Open-Label Phase|Protocol Deviation|1|||
155068262|NCT05028569|559680935|FG005|Open-Label Phase|Protocol Deviation|0|||
155068263|NCT05028569|559680936|FG006|Open-Label Phase|Protocol Deviation|0|||
155068264|NCT05028569|559680930|FG000|Open-Label Phase|Pregnancy|0|||
155068265|NCT05028569|559680931|FG001|Open-Label Phase|Pregnancy|0|||
155319942|NCT01928394|560607345|FG011|Follow-up Period|other reason|1|||
155068266|NCT05028569|559680932|FG002|Open-Label Phase|Pregnancy|0|||
155068267|NCT05028569|559680933|FG003|Open-Label Phase|Pregnancy|0|||
155319943|NCT01928394|560607346|FG012|Follow-up Period|other reason|0|||
155319944|NCT01928394|560607347|FG013|Follow-up Period|other reason|1|||
155319945|NCT01928394|560607348|FG014|Follow-up Period|other reason|4|||
155319946|NCT01928394|560607349|FG015|Follow-up Period|other reason|0|||
155319947|NCT01928394|560607350|FG016|Follow-up Period|other reason|2|||
155319948|NCT01928394|560607351|FG017|Follow-up Period|other reason|0|||
155319949|NCT01928394|560607352|FG018|Follow-up Period|other reason|1|||
155319950|NCT01928394|560607353|FG019|Follow-up Period|other reason|1|||
155319951|NCT01928394|560607354|FG020|Follow-up Period|other reason|0|||
155319952|NCT01928394|560607355|FG021|Follow-up Period|other reason|0|||
155319953|NCT01928394|560607356|FG022|Follow-up Period|other reason|1|||
155319954|NCT01928394|560607334|FG000|Follow-up Period|Lost to Follow-up|0|||
155068268|NCT05028569|559680934|FG004|Open-Label Phase|Pregnancy|0|||
155068269|NCT05028569|559680935|FG005|Open-Label Phase|Pregnancy|1|||
155068270|NCT05028569|559680936|FG006|Open-Label Phase|Pregnancy|0|||
155068271|NCT05028569|559680930|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155068272|NCT05028569|559680931|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155068273|NCT05028569|559680932|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155068274|NCT05028569|559680933|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155319955|NCT01928394|560607335|FG001|Follow-up Period|Lost to Follow-up|0|||
155319956|NCT01928394|560607336|FG002|Follow-up Period|Lost to Follow-up|0|||
155319957|NCT01928394|560607337|FG003|Follow-up Period|Lost to Follow-up|0|||
155319958|NCT01928394|560607338|FG004|Follow-up Period|Lost to Follow-up|0|||
155319959|NCT01928394|560607339|FG005|Follow-up Period|Lost to Follow-up|0|||
155319960|NCT01928394|560607340|FG006|Follow-up Period|Lost to Follow-up|0|||
155319961|NCT01928394|560607341|FG007|Follow-up Period|Lost to Follow-up|0|||
155319962|NCT01928394|560607342|FG008|Follow-up Period|Lost to Follow-up|0|||
155319963|NCT01928394|560607343|FG009|Follow-up Period|Lost to Follow-up|0|||
155319964|NCT01928394|560607344|FG010|Follow-up Period|Lost to Follow-up|0|||
155319965|NCT01928394|560607345|FG011|Follow-up Period|Lost to Follow-up|1|||
155319966|NCT01928394|560607346|FG012|Follow-up Period|Lost to Follow-up|1|||
155319967|NCT01928394|560607347|FG013|Follow-up Period|Lost to Follow-up|0|||
155319968|NCT01928394|560607348|FG014|Follow-up Period|Lost to Follow-up|1|||
155319969|NCT01928394|560607349|FG015|Follow-up Period|Lost to Follow-up|0|||
155319970|NCT01928394|560607350|FG016|Follow-up Period|Lost to Follow-up|1|||
155319971|NCT01928394|560607351|FG017|Follow-up Period|Lost to Follow-up|0|||
155319972|NCT01928394|560607352|FG018|Follow-up Period|Lost to Follow-up|0|||
155319973|NCT01928394|560607353|FG019|Follow-up Period|Lost to Follow-up|0|||
155319974|NCT01928394|560607354|FG020|Follow-up Period|Lost to Follow-up|0|||
155068275|NCT05028569|559680934|FG004|Open-Label Phase|Withdrawal by Subject|15|||
155068276|NCT05028569|559680935|FG005|Open-Label Phase|Withdrawal by Subject|8|||
155068277|NCT05028569|559680936|FG006|Open-Label Phase|Withdrawal by Subject|13|||
155068278|NCT05028569|559680930|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
155068279|NCT05028569|559680931|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
155068280|NCT05028569|559680932|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
155068281|NCT05028569|559680933|FG003|Open-Label Phase|Study Terminated by Sponsor|0|||
155068282|NCT05028569|559680934|FG004|Open-Label Phase|Study Terminated by Sponsor|4|||
155068283|NCT05028569|559680935|FG005|Open-Label Phase|Study Terminated by Sponsor|10|||
155068284|NCT05028569|559680936|FG006|Open-Label Phase|Study Terminated by Sponsor|5|||
155068285|NCT05028569|559680930|FG000|Open-Label Phase|Other, not specified|0|||
155068286|NCT05028569|559680931|FG001|Open-Label Phase|Other, not specified|0|||
155068287|NCT05028569|559680932|FG002|Open-Label Phase|Other, not specified|0|||
155068288|NCT05028569|559680933|FG003|Open-Label Phase|Other, not specified|0|||
155068289|NCT05028569|559680934|FG004|Open-Label Phase|Other, not specified|6|||
155068290|NCT05028569|559680935|FG005|Open-Label Phase|Other, not specified|5|||
155068291|NCT05028569|559680936|FG006|Open-Label Phase|Other, not specified|7|||
155068292|NCT05028569|559680930|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155068293|NCT05028569|559680931|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155068294|NCT05028569|559680932|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155068295|NCT05028569|559680933|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155068296|NCT05028569|559680934|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155068297|NCT05028569|559680935|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|2|||
155068298|NCT05028569|559680936|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew from study|0|||
155068299|NCT05028569|559680930|FG000|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155068300|NCT05028569|559680931|FG001|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155068301|NCT05028569|559680932|FG002|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155068302|NCT05028569|559680933|FG003|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155068303|NCT05028569|559680934|FG004|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155068304|NCT05028569|559680935|FG005|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|0|||
155068305|NCT05028569|559680936|FG006|Open-Label Phase|Completed Double-Blind Phase and then withdrew due to pregnancy|1|||
155068306|NCT04609553|559680937|FG000|Overall Study|Lost to Follow-up|27|||
155319975|NCT01928394|560607355|FG021|Follow-up Period|Lost to Follow-up|0|||
155319976|NCT01928394|560607356|FG022|Follow-up Period|Lost to Follow-up|1|||
155319977|NCT03209973|560607360|FG000|Overall Study|Withdrawal by Subject|7|||
155319978|NCT03209973|560607360|FG000|Overall Study|Lost to Follow-up|2|||
155319979|NCT03209973|560607360|FG000|Overall Study|Death|8|||
155068307|NCT04609553|559680938|FG001|Overall Study|Lost to Follow-up|31|||
155068308|NCT04609553|559680939|FG002|Overall Study|Lost to Follow-up|24|||
155068309|NCT04609553|559680937|FG000|Overall Study|Discontinued|12|||
155068310|NCT04609553|559680938|FG001|Overall Study|Discontinued|10|||
155068311|NCT04609553|559680939|FG002|Overall Study|Discontinued|9|||
155068312|NCT01838876|559680945|FG000|Overall Study|Adverse Event|49|||
155068313|NCT01838876|559680945|FG000|Overall Study|Insufficient Therapeutic Response|10|||
155068314|NCT01838876|559680945|FG000|Overall Study|Protocol Violation|34|||
155068315|NCT01838876|559680945|FG000|Overall Study|Withdrawal of Consent|33|||
155068316|NCT01838876|559680945|FG000|Overall Study|Lost to Follow-up|21|||
155068317|NCT01838876|559680945|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
155068318|NCT01838876|559680945|FG000|Overall Study|Reason not Specified|7|||
155068319|NCT01838876|559680945|FG000|Overall Study|Did not meet eligibility criteria|78|||
155068320|NCT00689936|559680946|FG000|Active Treatment Phase|Adverse Event|68|||
155068321|NCT00689936|559680947|FG001|Active Treatment Phase|Adverse Event|71|||
155068322|NCT00689936|559680948|FG002|Active Treatment Phase|Adverse Event|76|||
155162493|NCT01177397|560031615|FG009|Overall Study|Other reasons|8|||
155319980|NCT03209973|560607360|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
155319981|NCT03209973|560607360|FG000|Overall Study|Sponsor Decision|18|||
155319982|NCT03209973|560607360|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
155319983|NCT03209973|560607360|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
155162494|NCT01177397|560031616|FG010|Overall Study|Other reasons|0|||
155162495|NCT01177397|560031617|FG011|Overall Study|Other reasons|2|||
155319984|NCT02240238|560607372|FG000|Phase 1|Adverse Event|0|||
155319985|NCT02240238|560607373|FG001|Phase 1|Adverse Event|0|||
155319986|NCT02240238|560607374|FG002|Phase 1|Adverse Event|0|||
155319987|NCT02240238|560607375|FG003|Phase 1|Adverse Event|0|||
155319988|NCT02240238|560607376|FG004|Phase 1|Adverse Event|0|||
155319989|NCT02240238|560607377|FG005|Phase 1|Adverse Event|0|||
155319990|NCT02240238|560607378|FG006|Phase 1|Adverse Event|3|||
155319991|NCT02240238|560607379|FG007|Phase 1|Adverse Event|1|||
155319992|NCT02240238|560607380|FG008|Phase 1|Adverse Event|0|||
155319993|NCT02240238|560607381|FG009|Phase 1|Adverse Event|0|||
155319994|NCT02240238|560607382|FG010|Phase 1|Adverse Event|0|||
155319995|NCT02240238|560607383|FG011|Phase 1|Adverse Event|0|||
155319996|NCT02240238|560607372|FG000|Phase 1|Death|0|||
155319997|NCT02240238|560607373|FG001|Phase 1|Death|0|||
155319998|NCT02240238|560607374|FG002|Phase 1|Death|0|||
155319999|NCT02240238|560607375|FG003|Phase 1|Death|0|||
155320000|NCT02240238|560607376|FG004|Phase 1|Death|0|||
155320001|NCT02240238|560607377|FG005|Phase 1|Death|1|||
155320002|NCT02240238|560607378|FG006|Phase 1|Death|0|||
155320003|NCT02240238|560607379|FG007|Phase 1|Death|0|||
155320004|NCT02240238|560607380|FG008|Phase 1|Death|0|||
155320005|NCT02240238|560607381|FG009|Phase 1|Death|0|||
155320006|NCT02240238|560607382|FG010|Phase 1|Death|0|||
155320007|NCT02240238|560607383|FG011|Phase 1|Death|0|||
155320008|NCT02240238|560607372|FG000|Phase 1|Sponsor termination|0|||
155320009|NCT02240238|560607373|FG001|Phase 1|Sponsor termination|0|||
155320010|NCT02240238|560607374|FG002|Phase 1|Sponsor termination|0|||
155320011|NCT02240238|560607375|FG003|Phase 1|Sponsor termination|0|||
154960657|NCT01854047|559280391|FG002|Overall Study|Lack of Efficacy|0|||
154960658|NCT01854047|559280392|FG003|Overall Study|Lack of Efficacy|0|||
154960659|NCT01854047|559280393|FG004|Overall Study|Lack of Efficacy|0|||
154960660|NCT01854047|559280389|FG000|Overall Study|Poor compliance to protocol|3|||
154960661|NCT01854047|559280390|FG001|Overall Study|Poor compliance to protocol|0|||
154960662|NCT01854047|559280391|FG002|Overall Study|Poor compliance to protocol|2|||
154960663|NCT01854047|559280392|FG003|Overall Study|Poor compliance to protocol|0|||
154960664|NCT01854047|559280393|FG004|Overall Study|Poor compliance to protocol|0|||
154960665|NCT01854047|559280389|FG000|Overall Study|Adverse Event|5|||
154960666|NCT01854047|559280390|FG001|Overall Study|Adverse Event|4|||
154960667|NCT01854047|559280391|FG002|Overall Study|Adverse Event|6|||
154960668|NCT01854047|559280392|FG003|Overall Study|Adverse Event|10|||
154960669|NCT01854047|559280393|FG004|Overall Study|Adverse Event|7|||
154960670|NCT01854047|559280389|FG000|Overall Study|Randomized but not treated|0|||
154960671|NCT01854047|559280390|FG001|Overall Study|Randomized but not treated|1|||
154960672|NCT01854047|559280391|FG002|Overall Study|Randomized but not treated|2|||
154960673|NCT01854047|559280392|FG003|Overall Study|Randomized but not treated|0|||
154960674|NCT01854047|559280393|FG004|Overall Study|Randomized but not treated|4|||
154960675|NCT01854047|559280389|FG000|Overall Study|Other than specified above|3|||
154960676|NCT01854047|559280390|FG001|Overall Study|Other than specified above|3|||
154960677|NCT01854047|559280391|FG002|Overall Study|Other than specified above|3|||
154960678|NCT01854047|559280392|FG003|Overall Study|Other than specified above|5|||
154960679|NCT01854047|559280393|FG004|Overall Study|Other than specified above|8|||
154960680|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
154960681|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
154960682|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
154960683|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
154960684|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
154960685|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
154960686|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
154960687|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
154960688|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
154960689|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
154960690|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
154960691|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
154960692|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
154960693|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
154960694|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
154960695|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
154960696|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
154960697|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
154960698|NCT01045161|559280394|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
155320012|NCT02240238|560607376|FG004|Phase 1|Sponsor termination|0|||
155320013|NCT02240238|560607377|FG005|Phase 1|Sponsor termination|1|||
155320014|NCT02240238|560607378|FG006|Phase 1|Sponsor termination|0|||
155320015|NCT02240238|560607379|FG007|Phase 1|Sponsor termination|0|||
155320016|NCT02240238|560607380|FG008|Phase 1|Sponsor termination|0|||
155320017|NCT02240238|560607381|FG009|Phase 1|Sponsor termination|0|||
155320018|NCT02240238|560607382|FG010|Phase 1|Sponsor termination|0|||
155320019|NCT02240238|560607383|FG011|Phase 1|Sponsor termination|0|||
155320020|NCT02240238|560607372|FG000|Phase 1|Withdrawal by Subject|0|||
155320021|NCT02240238|560607373|FG001|Phase 1|Withdrawal by Subject|0|||
155320022|NCT02240238|560607374|FG002|Phase 1|Withdrawal by Subject|0|||
155320023|NCT02240238|560607375|FG003|Phase 1|Withdrawal by Subject|0|||
155320024|NCT02240238|560607376|FG004|Phase 1|Withdrawal by Subject|0|||
155320025|NCT02240238|560607377|FG005|Phase 1|Withdrawal by Subject|2|||
155320026|NCT02240238|560607378|FG006|Phase 1|Withdrawal by Subject|0|||
155320027|NCT02240238|560607379|FG007|Phase 1|Withdrawal by Subject|0|||
155320028|NCT02240238|560607380|FG008|Phase 1|Withdrawal by Subject|0|||
155320029|NCT02240238|560607381|FG009|Phase 1|Withdrawal by Subject|0|||
155320030|NCT02240238|560607382|FG010|Phase 1|Withdrawal by Subject|0|||
155320031|NCT02240238|560607383|FG011|Phase 1|Withdrawal by Subject|0|||
155320032|NCT02240238|560607372|FG000|Phase 1|Physician Decision|0|||
155320033|NCT02240238|560607373|FG001|Phase 1|Physician Decision|0|||
155320034|NCT02240238|560607374|FG002|Phase 1|Physician Decision|0|||
155320035|NCT02240238|560607375|FG003|Phase 1|Physician Decision|0|||
155320036|NCT02240238|560607376|FG004|Phase 1|Physician Decision|0|||
155320037|NCT02240238|560607377|FG005|Phase 1|Physician Decision|2|||
155320038|NCT02240238|560607378|FG006|Phase 1|Physician Decision|0|||
155320039|NCT02240238|560607379|FG007|Phase 1|Physician Decision|0|||
155320040|NCT02240238|560607380|FG008|Phase 1|Physician Decision|0|||
155320041|NCT02240238|560607381|FG009|Phase 1|Physician Decision|0|||
155320042|NCT02240238|560607382|FG010|Phase 1|Physician Decision|0|||
155068323|NCT00689936|559680946|FG000|Active Treatment Phase|Disease Progression|273|||
155068324|NCT00689936|559680947|FG001|Active Treatment Phase|Disease Progression|362|||
155068325|NCT00689936|559680948|FG002|Active Treatment Phase|Disease Progression|339|||
155068326|NCT00689936|559680946|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
155068327|NCT00689936|559680947|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
155068328|NCT00689936|559680948|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
155068329|NCT00689936|559680946|FG000|Active Treatment Phase|Death|60|||
155068330|NCT00689936|559680947|FG001|Active Treatment Phase|Death|28|||
155068331|NCT00689936|559680948|FG002|Active Treatment Phase|Death|37|||
155068332|NCT00689936|559680946|FG000|Active Treatment Phase|Lost to Follow-up|0|||
155068333|NCT00689936|559680947|FG001|Active Treatment Phase|Lost to Follow-up|2|||
155068334|NCT00689936|559680948|FG002|Active Treatment Phase|Lost to Follow-up|2|||
155068335|NCT00689936|559680946|FG000|Active Treatment Phase|Protocol Violation|2|||
155068336|NCT00689936|559680947|FG001|Active Treatment Phase|Protocol Violation|2|||
155068337|NCT00689936|559680948|FG002|Active Treatment Phase|Protocol Violation|4|||
155068338|NCT00689936|559680946|FG000|Active Treatment Phase|Study Close Out|64|||
155068339|NCT00689936|559680947|FG001|Active Treatment Phase|Study Close Out|26|||
155068340|NCT00689936|559680948|FG002|Active Treatment Phase|Study Close Out|21|||
155068341|NCT00689936|559680946|FG000|Active Treatment Phase|Miscellaneous|52|||
155068342|NCT00689936|559680947|FG001|Active Treatment Phase|Miscellaneous|34|||
155068343|NCT00689936|559680948|FG002|Active Treatment Phase|Miscellaneous|47|||
155068344|NCT00689936|559680946|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
155068345|NCT00689936|559680947|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
155068346|NCT00689936|559680948|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
155068347|NCT01682031|559680949|FG000|Overall Study|Withdrawal by Subject|0|||
155068348|NCT01682031|559680950|FG001|Overall Study|Withdrawal by Subject|1|||
155068349|NCT01682031|559680949|FG000|Overall Study|Adverse Event|0|||
155068350|NCT01682031|559680950|FG001|Overall Study|Adverse Event|2|||
155068351|NCT01682031|559680949|FG000|Overall Study|MRI results indicate increased nodul|0|||
155068352|NCT01682031|559680950|FG001|Overall Study|MRI results indicate increased nodul|1|||
155068353|NCT01682031|559680949|FG000|Overall Study|Patient could not swallow tablets|1|||
155068354|NCT01682031|559680950|FG001|Overall Study|Patient could not swallow tablets|0|||
155068355|NCT01682031|559680949|FG000|Overall Study|Patient stopped selenium on his own|0|||
155068356|NCT01682031|559680950|FG001|Overall Study|Patient stopped selenium on his own|1|||
155068357|NCT00933933|559680956|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
155068358|NCT00933933|559680957|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
155068359|NCT00933933|559680958|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
155068360|NCT00933933|559680956|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
155068361|NCT00933933|559680957|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
155162496|NCT02446899|560031622|FG000|Overall Study|Adverse Event|4|||
155162497|NCT02446899|560031623|FG001|Overall Study|Adverse Event|7|||
155068362|NCT00933933|559680958|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
155068363|NCT04703192|559680959|FG000|Overall Study|Withdrawal by Subject|2|||
155320043|NCT02240238|560607383|FG011|Phase 1|Physician Decision|0|||
155068364|NCT04703192|559680960|FG001|Overall Study|Withdrawal by Subject|0|||
155068365|NCT04703192|559680959|FG000|Overall Study|Death|3|||
155320044|NCT02240238|560607372|FG000|Phase 2|Adverse Event|0|||
155320045|NCT02240238|560607373|FG001|Phase 2|Adverse Event|0|||
155320046|NCT02240238|560607374|FG002|Phase 2|Adverse Event|0|||
155320047|NCT02240238|560607375|FG003|Phase 2|Adverse Event|0|||
155320048|NCT02240238|560607376|FG004|Phase 2|Adverse Event|0|||
155320049|NCT02240238|560607377|FG005|Phase 2|Adverse Event|0|||
155320050|NCT02240238|560607378|FG006|Phase 2|Adverse Event|0|||
155320051|NCT02240238|560607379|FG007|Phase 2|Adverse Event|0|||
155320052|NCT02240238|560607380|FG008|Phase 2|Adverse Event|0|||
155320053|NCT02240238|560607381|FG009|Phase 2|Adverse Event|7|||
155320054|NCT02240238|560607382|FG010|Phase 2|Adverse Event|14|||
155320055|NCT02240238|560607383|FG011|Phase 2|Adverse Event|2|||
155320056|NCT02240238|560607372|FG000|Phase 2|Death|0|||
155320057|NCT02240238|560607373|FG001|Phase 2|Death|0|||
155320058|NCT02240238|560607374|FG002|Phase 2|Death|0|||
155320059|NCT02240238|560607375|FG003|Phase 2|Death|0|||
155320060|NCT02240238|560607376|FG004|Phase 2|Death|0|||
155320061|NCT02240238|560607377|FG005|Phase 2|Death|0|||
155320062|NCT02240238|560607378|FG006|Phase 2|Death|0|||
155320063|NCT02240238|560607379|FG007|Phase 2|Death|0|||
155320064|NCT02240238|560607380|FG008|Phase 2|Death|0|||
155320065|NCT02240238|560607381|FG009|Phase 2|Death|3|||
155320066|NCT02240238|560607382|FG010|Phase 2|Death|2|||
155320067|NCT02240238|560607383|FG011|Phase 2|Death|1|||
155320068|NCT02240238|560607372|FG000|Phase 2|Disease progression|0|||
155320069|NCT02240238|560607373|FG001|Phase 2|Disease progression|0|||
155320070|NCT02240238|560607374|FG002|Phase 2|Disease progression|0|||
155320071|NCT02240238|560607375|FG003|Phase 2|Disease progression|0|||
155320072|NCT02240238|560607376|FG004|Phase 2|Disease progression|0|||
155320073|NCT02240238|560607377|FG005|Phase 2|Disease progression|0|||
155320074|NCT02240238|560607378|FG006|Phase 2|Disease progression|0|||
155320075|NCT02240238|560607379|FG007|Phase 2|Disease progression|0|||
155320076|NCT02240238|560607380|FG008|Phase 2|Disease progression|0|||
155320077|NCT02240238|560607381|FG009|Phase 2|Disease progression|5|||
155320078|NCT02240238|560607382|FG010|Phase 2|Disease progression|11|||
155320079|NCT02240238|560607383|FG011|Phase 2|Disease progression|1|||
155320080|NCT02240238|560607372|FG000|Phase 2|Withdrawal by Subject|0|||
155320081|NCT02240238|560607373|FG001|Phase 2|Withdrawal by Subject|0|||
155320082|NCT02240238|560607374|FG002|Phase 2|Withdrawal by Subject|0|||
155320083|NCT02240238|560607375|FG003|Phase 2|Withdrawal by Subject|0|||
155320084|NCT02240238|560607376|FG004|Phase 2|Withdrawal by Subject|0|||
155320085|NCT02240238|560607377|FG005|Phase 2|Withdrawal by Subject|0|||
155320086|NCT02240238|560607378|FG006|Phase 2|Withdrawal by Subject|0|||
155320087|NCT02240238|560607379|FG007|Phase 2|Withdrawal by Subject|0|||
155320088|NCT02240238|560607380|FG008|Phase 2|Withdrawal by Subject|0|||
155320089|NCT02240238|560607381|FG009|Phase 2|Withdrawal by Subject|1|||
155320090|NCT02240238|560607382|FG010|Phase 2|Withdrawal by Subject|1|||
155320091|NCT02240238|560607383|FG011|Phase 2|Withdrawal by Subject|0|||
155320092|NCT02240238|560607372|FG000|Phase 2|Physician Decision|0|||
155320093|NCT02240238|560607373|FG001|Phase 2|Physician Decision|0|||
155320094|NCT02240238|560607374|FG002|Phase 2|Physician Decision|0|||
155320095|NCT02240238|560607375|FG003|Phase 2|Physician Decision|0|||
155320096|NCT02240238|560607376|FG004|Phase 2|Physician Decision|0|||
155320097|NCT02240238|560607377|FG005|Phase 2|Physician Decision|0|||
155320098|NCT02240238|560607378|FG006|Phase 2|Physician Decision|0|||
155320099|NCT02240238|560607379|FG007|Phase 2|Physician Decision|0|||
155320100|NCT02240238|560607380|FG008|Phase 2|Physician Decision|0|||
155320101|NCT02240238|560607381|FG009|Phase 2|Physician Decision|1|||
155320102|NCT02240238|560607382|FG010|Phase 2|Physician Decision|3|||
155320103|NCT02240238|560607383|FG011|Phase 2|Physician Decision|0|||
155320104|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320105|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320106|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320107|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320108|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320109|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320110|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320111|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320112|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320113|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
155320114|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320115|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
155320116|NCT02240238|560607372|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320117|NCT02240238|560607373|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320118|NCT02240238|560607374|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320119|NCT02240238|560607375|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320120|NCT02240238|560607376|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320121|NCT02240238|560607377|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320122|NCT02240238|560607378|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320123|NCT02240238|560607379|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320124|NCT02240238|560607380|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320125|NCT02240238|560607381|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
155320126|NCT02240238|560607382|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320127|NCT02240238|560607383|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
155320128|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320129|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320130|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320131|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320132|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320133|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320134|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320135|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320136|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320137|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320138|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
155320139|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
155320140|NCT02240238|560607372|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320141|NCT02240238|560607373|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155068366|NCT04703192|559680960|FG001|Overall Study|Death|1|||
155068367|NCT04703192|559680959|FG000|Overall Study|Adverse Event|13|||
155068368|NCT04703192|559680960|FG001|Overall Study|Adverse Event|2|||
155068369|NCT04703192|559680959|FG000|Overall Study|Progressive or Relapsed Disease|46|||
155320142|NCT02240238|560607374|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320143|NCT02240238|560607375|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320144|NCT02240238|560607376|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320145|NCT02240238|560607377|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320146|NCT02240238|560607378|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320147|NCT02240238|560607379|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320148|NCT02240238|560607380|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320149|NCT02240238|560607381|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320150|NCT02240238|560607382|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
155320151|NCT02240238|560607383|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
155320152|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320153|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320154|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320155|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320156|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320157|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320158|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320159|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320160|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320161|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155320162|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
155320163|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
155068370|NCT04703192|559680960|FG001|Overall Study|Progressive or Relapsed Disease|7|||
155068371|NCT04703192|559680959|FG000|Overall Study|Clinical Progression|19|||
155068372|NCT04703192|559680960|FG001|Overall Study|Clinical Progression|8|||
155068373|NCT04703192|559680959|FG000|Overall Study|Lost to Follow-up|1|||
155068374|NCT04703192|559680960|FG001|Overall Study|Lost to Follow-up|0|||
155068375|NCT04703192|559680959|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
155068376|NCT04703192|559680960|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
155162498|NCT02446899|560031622|FG000|Overall Study|Condition Under Investigation Worsened|1|||
155162499|NCT02446899|560031623|FG001|Overall Study|Condition Under Investigation Worsened|4|||
155162500|NCT02446899|560031622|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
155162501|NCT02446899|560031623|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
155162502|NCT02446899|560031622|FG000|Overall Study|Lack of Efficacy|2|||
155162503|NCT02446899|560031623|FG001|Overall Study|Lack of Efficacy|8|||
155068377|NCT04703192|559680959|FG000|Overall Study|Other|5|||
155068378|NCT04703192|559680960|FG001|Overall Study|Other|1|||
155068379|NCT00876343|559680965|FG000|Overall Study|Adverse Event|7|||
155068380|NCT00876343|559680966|FG001|Overall Study|Adverse Event|8|||
155068381|NCT00876343|559680967|FG002|Overall Study|Adverse Event|2|||
155068382|NCT00876343|559680965|FG000|Overall Study|Withdrawal by Subject|4|||
155068383|NCT00876343|559680966|FG001|Overall Study|Withdrawal by Subject|4|||
155068384|NCT00876343|559680967|FG002|Overall Study|Withdrawal by Subject|3|||
155068385|NCT00876343|559680965|FG000|Overall Study|Lack of Efficacy|0|||
155068386|NCT00876343|559680966|FG001|Overall Study|Lack of Efficacy|0|||
155068387|NCT00876343|559680967|FG002|Overall Study|Lack of Efficacy|1|||
155068388|NCT00876343|559680965|FG000|Overall Study|Protocol Violation|4|||
155068389|NCT00876343|559680966|FG001|Overall Study|Protocol Violation|1|||
155068390|NCT00876343|559680967|FG002|Overall Study|Protocol Violation|1|||
155068391|NCT00876343|559680965|FG000|Overall Study|Physician Decision|0|||
155068392|NCT00876343|559680966|FG001|Overall Study|Physician Decision|1|||
155068393|NCT00876343|559680967|FG002|Overall Study|Physician Decision|1|||
155068394|NCT00876343|559680965|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
155068395|NCT00876343|559680966|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
155068396|NCT00876343|559680967|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
155068397|NCT00876343|559680965|FG000|Overall Study|Change of residence or other commitments|2|||
155068398|NCT00876343|559680966|FG001|Overall Study|Change of residence or other commitments|2|||
155068399|NCT00876343|559680967|FG002|Overall Study|Change of residence or other commitments|3|||
155068400|NCT00695019|559680970|FG000|Overall Study|Withdrawal by Subject|8|||
155068401|NCT00695019|559680971|FG001|Overall Study|Withdrawal by Subject|6|||
155068402|NCT00695019|559680972|FG002|Overall Study|Withdrawal by Subject|4|||
155068403|NCT00695019|559680970|FG000|Overall Study|Protocol Violation|1|||
155068404|NCT00695019|559680971|FG001|Overall Study|Protocol Violation|3|||
155068405|NCT00695019|559680972|FG002|Overall Study|Protocol Violation|1|||
155068406|NCT00695019|559680970|FG000|Overall Study|Lack of Efficacy|0|||
155068407|NCT00695019|559680971|FG001|Overall Study|Lack of Efficacy|0|||
155068408|NCT00695019|559680972|FG002|Overall Study|Lack of Efficacy|1|||
155068409|NCT00695019|559680970|FG000|Overall Study|Various|4|||
155068410|NCT00695019|559680971|FG001|Overall Study|Various|5|||
155068411|NCT00695019|559680972|FG002|Overall Study|Various|4|||
155068412|NCT04896385|559680973|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
155068413|NCT04896385|559680974|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
155068414|NCT04896385|559680975|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
155068415|NCT04896385|559680976|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
155068416|NCT04896385|559680973|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
155068417|NCT04896385|559680974|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
155068418|NCT04896385|559680975|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155068419|NCT04896385|559680976|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155068420|NCT04896385|559680973|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155068421|NCT04896385|559680974|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155068422|NCT04896385|559680975|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
155068423|NCT04896385|559680976|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
155068424|NCT04896385|559680973|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155068425|NCT04896385|559680974|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155068426|NCT04896385|559680975|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
155068427|NCT04896385|559680976|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
155068428|NCT04896385|559680973|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
155068429|NCT04896385|559680974|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
155162504|NCT02446899|560031622|FG000|Overall Study|Lost to Follow-up|1|||
155162505|NCT02446899|560031623|FG001|Overall Study|Lost to Follow-up|3|||
155162506|NCT02446899|560031622|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
155162507|NCT02446899|560031623|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
155162508|NCT02446899|560031622|FG000|Overall Study|Withdrawal by Subject|11|||
155162509|NCT02446899|560031623|FG001|Overall Study|Withdrawal by Subject|19|||
155162510|NCT02446899|560031622|FG000|Overall Study|Miscellaneous|5|||
155162511|NCT02446899|560031623|FG001|Overall Study|Miscellaneous|4|||
155162512|NCT02446899|560031622|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155162513|NCT02446899|560031623|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
155162514|NCT00742235|560031624|FG000|Overall Study|Lost to Follow-up|0|||
155162515|NCT00742235|560031625|FG001|Overall Study|Lost to Follow-up|31|||
155162516|NCT00433004|560031626|FG000|Overall Study|Lost to Follow-up|5|||
155162517|NCT00433004|560031627|FG001|Overall Study|Lost to Follow-up|7|||
155162518|NCT05661409|560031629|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
155162519|NCT05661409|560031630|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
155162520|NCT05661409|560031631|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
155162521|NCT05661409|560031632|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
155162522|NCT05661409|560031633|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
155162523|NCT05661409|560031634|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
155162524|NCT05661409|560031629|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
155162525|NCT05661409|560031630|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
155162526|NCT05661409|560031631|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
155162527|NCT05661409|560031632|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
155162528|NCT05661409|560031633|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
155162529|NCT05661409|560031634|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
155162530|NCT05661409|560031629|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
155162531|NCT05661409|560031630|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
155162532|NCT05661409|560031631|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
155162533|NCT05661409|560031632|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
155162534|NCT05661409|560031633|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
155162535|NCT05661409|560031634|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
155162536|NCT05661409|560031629|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
155162537|NCT05661409|560031630|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
155162538|NCT05661409|560031631|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
155162539|NCT05661409|560031632|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
155162540|NCT05661409|560031633|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
155162541|NCT05661409|560031634|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
155162542|NCT05661409|560031629|FG000|Overall Study|Miscommu-nication about administration|0|||
155162543|NCT05661409|560031630|FG001|Overall Study|Miscommu-nication about administration|0|||
155162544|NCT05661409|560031631|FG002|Overall Study|Miscommu-nication about administration|0|||
155162545|NCT05661409|560031632|FG003|Overall Study|Miscommu-nication about administration|0|||
155162546|NCT05661409|560031633|FG004|Overall Study|Miscommu-nication about administration|0|||
155162547|NCT05661409|560031634|FG005|Overall Study|Miscommu-nication about administration|1|||
155162548|NCT04730271|560031635|FG000|Overall Study|Adverse Event|0|||
155162549|NCT04730271|560031636|FG001|Overall Study|Adverse Event|2|||
155162550|NCT04730271|560031635|FG000|Overall Study|Withdrawal by Subject|1|||
155162551|NCT04730271|560031636|FG001|Overall Study|Withdrawal by Subject|1|||
155162552|NCT04730271|560031635|FG000|Overall Study|Protocol Violation|7|||
155162553|NCT04730271|560031636|FG001|Overall Study|Protocol Violation|13|||
155162554|NCT04730271|560031635|FG000|Overall Study|Lost to Follow-up|3|||
155162555|NCT04730271|560031636|FG001|Overall Study|Lost to Follow-up|3|||
155162556|NCT04730271|560031635|FG000|Overall Study|Death|1|||
155162557|NCT04730271|560031636|FG001|Overall Study|Death|0|||
155162558|NCT00998296|560031637|FG000|Overall Study|Progressive disease|0|||
155162559|NCT00998296|560031638|FG001|Overall Study|Progressive disease|1|||
155162560|NCT00998296|560031639|FG002|Overall Study|Progressive disease|0|||
155162561|NCT00998296|560031640|FG003|Overall Study|Progressive disease|0|||
155162562|NCT00998296|560031641|FG004|Overall Study|Progressive disease|0|||
155068430|NCT04896385|559680975|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
155068431|NCT04896385|559680976|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
155162563|NCT00998296|560031642|FG005|Overall Study|Progressive disease|0|||
155320164|NCT02240238|560607372|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320165|NCT02240238|560607373|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320166|NCT02240238|560607374|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320167|NCT02240238|560607375|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320168|NCT02240238|560607376|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320169|NCT02240238|560607377|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320170|NCT02240238|560607378|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320171|NCT02240238|560607379|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320172|NCT02240238|560607380|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320173|NCT02240238|560607381|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320174|NCT02240238|560607382|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
155320175|NCT02240238|560607383|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
155320176|NCT02240238|560607372|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320177|NCT02240238|560607373|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320178|NCT02240238|560607374|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320179|NCT02240238|560607375|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320180|NCT02240238|560607376|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320181|NCT02240238|560607377|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320182|NCT02240238|560607378|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320183|NCT02240238|560607379|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320184|NCT02240238|560607380|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320185|NCT02240238|560607381|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320186|NCT02240238|560607382|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
155320187|NCT02240238|560607383|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
155320188|NCT02240238|560607372|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320189|NCT02240238|560607373|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320190|NCT02240238|560607374|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320191|NCT02240238|560607375|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320192|NCT02240238|560607376|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320193|NCT02240238|560607377|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320194|NCT02240238|560607378|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320195|NCT02240238|560607379|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320196|NCT02240238|560607380|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320197|NCT02240238|560607381|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320198|NCT02240238|560607382|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
155320199|NCT02240238|560607383|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
155320200|NCT02724969|560607395|FG000|Overall Study|Lost to Follow-up|12|||
155320201|NCT02724969|560607396|FG001|Overall Study|Lost to Follow-up|6|||
155320202|NCT02724969|560607395|FG000|Overall Study|Withdrawal by Subject|3|||
155320203|NCT02724969|560607396|FG001|Overall Study|Withdrawal by Subject|3|||
155320204|NCT02724969|560607395|FG000|Overall Study|Infant demise|0|||
155320205|NCT02724969|560607396|FG001|Overall Study|Infant demise|2|||
155320206|NCT01346540|560607397|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
155320207|NCT01346540|560607398|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
155320208|NCT01346540|560607397|FG000|Overall Study|Adverse Event|0|||
155320209|NCT01346540|560607398|FG001|Overall Study|Adverse Event|4|||
155320210|NCT04797195|560607402|FG000|Overall Study|Death|8|||
155320211|NCT04797195|560607403|FG001|Overall Study|Death|15|||
155320212|NCT04797195|560607402|FG000|Overall Study|Change from PD|15|||
155320213|NCT04797195|560607403|FG001|Overall Study|Change from PD|15|||
155320214|NCT04797195|560607402|FG000|Overall Study|Withdrawal by Subject|3|||
155320215|NCT04797195|560607403|FG001|Overall Study|Withdrawal by Subject|2|||
155320216|NCT04577963|560607405|FG000|Part 2|Death|0|||
155320217|NCT04577963|560607406|FG001|Part 2|Death|1|||
155320218|NCT04577963|560607407|FG002|Part 2|Death|8|||
155320219|NCT04577963|560607408|FG003|Part 2|Death|0|||
155320220|NCT04577963|560607409|FG004|Part 2|Death|20|||
155320221|NCT04577963|560607405|FG000|Part 2|Lost to Follow-up|0|||
155320222|NCT04577963|560607406|FG001|Part 2|Lost to Follow-up|0|||
155320223|NCT04577963|560607407|FG002|Part 2|Lost to Follow-up|0|||
155320224|NCT04577963|560607408|FG003|Part 2|Lost to Follow-up|0|||
155320225|NCT04577963|560607409|FG004|Part 2|Lost to Follow-up|2|||
155320226|NCT04577963|560607405|FG000|Part 2|Withdrawal by Subject|0|||
155320227|NCT04577963|560607406|FG001|Part 2|Withdrawal by Subject|0|||
155320228|NCT04577963|560607407|FG002|Part 2|Withdrawal by Subject|0|||
155320229|NCT04577963|560607408|FG003|Part 2|Withdrawal by Subject|0|||
155320230|NCT04577963|560607409|FG004|Part 2|Withdrawal by Subject|10|||
155320231|NCT04577963|560607405|FG000|Part 2|Progressive disease|0|||
155320232|NCT04577963|560607406|FG001|Part 2|Progressive disease|0|||
155320233|NCT04577963|560607407|FG002|Part 2|Progressive disease|0|||
155320234|NCT04577963|560607408|FG003|Part 2|Progressive disease|0|||
155320235|NCT04577963|560607409|FG004|Part 2|Progressive disease|2|||
155320236|NCT04577963|560607405|FG000|Part 2|Investigator decision|0|||
155320237|NCT04577963|560607406|FG001|Part 2|Investigator decision|0|||
155320238|NCT04577963|560607407|FG002|Part 2|Investigator decision|0|||
155320239|NCT04577963|560607408|FG003|Part 2|Investigator decision|0|||
155320240|NCT04577963|560607409|FG004|Part 2|Investigator decision|1|||
155320241|NCT04577963|560607405|FG000|Part 2|Sponsor terminated study|0|||
155320242|NCT04577963|560607406|FG001|Part 2|Sponsor terminated study|0|||
155320243|NCT04577963|560607407|FG002|Part 2|Sponsor terminated study|3|||
155320244|NCT04577963|560607408|FG003|Part 2|Sponsor terminated study|1|||
155320245|NCT04577963|560607409|FG004|Part 2|Sponsor terminated study|4|||
155320246|NCT04862416|560607416|FG000|Overall Study|Withdrawal by Subject|0|||
155320247|NCT04862416|560607417|FG001|Overall Study|Withdrawal by Subject|1|||
155320248|NCT04862416|560607418|FG002|Overall Study|Withdrawal by Subject|0|||
155320249|NCT04862416|560607419|FG003|Overall Study|Withdrawal by Subject|1|||
155320250|NCT04862416|560607420|FG004|Overall Study|Withdrawal by Subject|0|||
155320251|NCT04862416|560607421|FG005|Overall Study|Withdrawal by Subject|0|||
155320252|NCT04862416|560607422|FG006|Overall Study|Withdrawal by Subject|0|||
155320253|NCT04862416|560607423|FG007|Overall Study|Withdrawal by Subject|0|||
155320254|NCT00746096|560607424|FG000|Overall Study|Adverse Event|1|||
155320255|NCT00746096|560607425|FG001|Overall Study|Adverse Event|0|||
155320256|NCT00746096|560607424|FG000|Overall Study|Withdrawal by Subject|5|||
155320257|NCT00746096|560607425|FG001|Overall Study|Withdrawal by Subject|1|||
155320258|NCT00746096|560607424|FG000|Overall Study|Lost to Follow-up|2|||
155320259|NCT00746096|560607425|FG001|Overall Study|Lost to Follow-up|1|||
155320260|NCT00746096|560607424|FG000|Overall Study|Protocol Violation|1|||
155320261|NCT00746096|560607425|FG001|Overall Study|Protocol Violation|0|||
155320262|NCT00746096|560607424|FG000|Overall Study|No study drug treatment|1|||
155320263|NCT00746096|560607425|FG001|Overall Study|No study drug treatment|1|||
155320264|NCT04295512|560607428|FG000|Overall Study|Lack of family response to schedule assessment|0|||
155320265|NCT04295512|560607429|FG001|Overall Study|Lack of family response to schedule assessment|0|||
155068432|NCT04896385|559680973|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
155068433|NCT04896385|559680974|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
155320266|NCT04295512|560607430|FG002|Overall Study|Lack of family response to schedule assessment|0|||
155320267|NCT04295512|560607431|FG003|Overall Study|Lack of family response to schedule assessment|2|||
155320268|NCT04295512|560607428|FG000|Overall Study|Therapist did not refer eligible family|7|||
155320269|NCT04295512|560607429|FG001|Overall Study|Therapist did not refer eligible family|7|||
155320270|NCT04295512|560607430|FG002|Overall Study|Therapist did not refer eligible family|0|||
155320271|NCT04295512|560607431|FG003|Overall Study|Therapist did not refer eligible family|0|||
155320272|NCT05207956|560607436|FG000|Overall Study|Lost to follow up|1|||
155320273|NCT05207956|560607437|FG001|Overall Study|Lost to follow up|2|||
155320274|NCT01009788|560607440|FG000|Overall Study|Withdrawal by Subject|1|||
155320275|NCT01009788|560607441|FG001|Overall Study|Withdrawal by Subject|0|||
155320276|NCT04587453|560607442|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
155320277|NCT04587453|560607443|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
155320278|NCT03571581|560607444|FG000|Overall Study|Death|2|||
155320279|NCT03571581|560607444|FG000|Overall Study|Withdrawal by Subject|2|||
155320280|NCT04737330|560607447|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
155320281|NCT04737330|560607448|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
155320282|NCT04737330|560607447|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
155320283|NCT04737330|560607448|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
155320284|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
155320285|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
155320286|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
155320287|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
155320288|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
155320289|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
155320290|NCT04737330|560607447|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
155320291|NCT04737330|560607448|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
155320292|NCT03295721|560607452|FG000|Overall Study|Adverse Event|1|||
155320293|NCT03295721|560607453|FG001|Overall Study|Adverse Event|0|||
155320294|NCT03295721|560607454|FG002|Overall Study|Adverse Event|0|||
155320295|NCT03295721|560607452|FG000|Overall Study|Lost to Follow-up|1|||
155320296|NCT03295721|560607453|FG001|Overall Study|Lost to Follow-up|1|||
155320297|NCT03295721|560607454|FG002|Overall Study|Lost to Follow-up|1|||
155320298|NCT03295721|560607452|FG000|Overall Study|Withdrawal by Subject|1|||
155320299|NCT03295721|560607453|FG001|Overall Study|Withdrawal by Subject|0|||
155320300|NCT03295721|560607454|FG002|Overall Study|Withdrawal by Subject|1|||
155320301|NCT03295721|560607452|FG000|Overall Study|Death|0|||
155320302|NCT03295721|560607453|FG001|Overall Study|Death|0|||
155320303|NCT03295721|560607454|FG002|Overall Study|Death|1|||
155320304|NCT01651403|560607456|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
155320305|NCT01651403|560607457|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
155320306|NCT01651403|560607456|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
155320307|NCT01651403|560607457|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
155320308|NCT01651403|560607456|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
155320309|NCT01651403|560607457|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
155320310|NCT01651403|560607456|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
155320311|NCT01651403|560607457|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
155320312|NCT01651403|560607456|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
155320313|NCT01651403|560607457|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
155320314|NCT01651403|560607456|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
155320315|NCT01651403|560607457|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
155320316|NCT05090683|560607458|FG000|Overall Study|Lost to Follow-up|10|||
155320317|NCT05090683|560607459|FG001|Overall Study|Lost to Follow-up|2|||
155320318|NCT05090683|560607458|FG000|Overall Study|Withdrawal by Subject|15|||
155320319|NCT05090683|560607459|FG001|Overall Study|Withdrawal by Subject|0|||
155320320|NCT03325985|560607460|FG000|Overall Study|Lost to Follow-up|122|||
155320321|NCT03325985|560607461|FG001|Overall Study|Lost to Follow-up|26|||
155320322|NCT03325985|560607462|FG002|Overall Study|Lost to Follow-up|141|||
155320323|NCT03325985|560607463|FG003|Overall Study|Lost to Follow-up|28|||
155320324|NCT03325985|560607460|FG000|Overall Study|Death|99|||
155320325|NCT03325985|560607461|FG001|Overall Study|Death|36|||
155320326|NCT03325985|560607462|FG002|Overall Study|Death|94|||
155320327|NCT03325985|560607463|FG003|Overall Study|Death|32|||
155320328|NCT03213665|560607464|FG000|Overall Study|Adverse Event|1|||
155320329|NCT03213665|560607464|FG000|Overall Study|Physician Decision|2|||
155320330|NCT03213665|560607464|FG000|Overall Study|Withdrawal by Subject|3|||
155320331|NCT03213665|560607464|FG000|Overall Study|Progressive Disease|13|||
155320332|NCT03034356|560607465|FG000|Baseline|Lost to Follow-up|2|||
155320333|NCT03034356|560607466|FG001|Baseline|Lost to Follow-up|4|||
155320334|NCT03034356|560607465|FG000|Baseline|Withdrawal by Subject|2|||
155320335|NCT03034356|560607466|FG001|Baseline|Withdrawal by Subject|0|||
155320336|NCT03034356|560607465|FG000|Baseline|Physician Decision|0|||
155320337|NCT03034356|560607466|FG001|Baseline|Physician Decision|1|||
155320338|NCT03034356|560607465|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
155320339|NCT03034356|560607466|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
155320340|NCT03034356|560607465|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
155320341|NCT03034356|560607466|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
155320342|NCT03034356|560607465|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
155320343|NCT03034356|560607466|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
155320344|NCT03034356|560607465|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
155320345|NCT03034356|560607466|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
155320346|NCT02684227|560607467|FG000|Overall Study|Adverse Event|1|||
155320347|NCT02684227|560607468|FG001|Overall Study|Adverse Event|7|||
155320348|NCT02684227|560607467|FG000|Overall Study|Death|0|||
155320349|NCT02684227|560607468|FG001|Overall Study|Death|2|||
155320350|NCT02684227|560607467|FG000|Overall Study|Withdrawal by Subject|0|||
155320351|NCT02684227|560607468|FG001|Overall Study|Withdrawal by Subject|1|||
155320352|NCT02684227|560607467|FG000|Overall Study|Progressive Disease|0|||
155320353|NCT02684227|560607468|FG001|Overall Study|Progressive Disease|2|||
154960699|NCT01045161|559280395|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
154960700|NCT01045161|559280396|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
155320354|NCT05292391|560607471|FG000|Overall Study|Lost to Follow-up|0|||
155320355|NCT05292391|560607472|FG001|Overall Study|Lost to Follow-up|0|||
155320356|NCT05292391|560607473|FG002|Overall Study|Lost to Follow-up|0|||
155320357|NCT05292391|560607474|FG003|Overall Study|Lost to Follow-up|1|||
155320358|NCT05292391|560607475|FG004|Overall Study|Lost to Follow-up|0|||
155320359|NCT03221426|560607478|FG000|Overall Study|Ongoing in study|212|||
155320360|NCT03221426|560607479|FG001|Overall Study|Ongoing in study|193|||
155320361|NCT03221426|560607480|FG002|Overall Study|Ongoing in study|61|||
155320362|NCT03221426|560607481|FG003|Overall Study|Ongoing in study|55|||
155320363|NCT03221426|560607478|FG000|Overall Study|Withdrawal by Subject|12|||
155320364|NCT03221426|560607479|FG001|Overall Study|Withdrawal by Subject|4|||
155320365|NCT03221426|560607480|FG002|Overall Study|Withdrawal by Subject|2|||
155320366|NCT03221426|560607481|FG003|Overall Study|Withdrawal by Subject|3|||
155320367|NCT03221426|560607478|FG000|Overall Study|Lost to Follow-up|4|||
155320368|NCT03221426|560607479|FG001|Overall Study|Lost to Follow-up|1|||
155320369|NCT03221426|560607480|FG002|Overall Study|Lost to Follow-up|1|||
155320370|NCT03221426|560607481|FG003|Overall Study|Lost to Follow-up|0|||
155320371|NCT03221426|560607478|FG000|Overall Study|Death|174|||
155320372|NCT03221426|560607479|FG001|Overall Study|Death|204|||
155320373|NCT03221426|560607480|FG002|Overall Study|Death|36|||
155320374|NCT03221426|560607481|FG003|Overall Study|Death|45|||
155320375|NCT05671653|560609057|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
155320376|NCT05671653|560609058|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
155320377|NCT05671653|560609059|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
155320378|NCT05671653|560609060|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
155320379|NCT05671653|560609061|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
155320380|NCT05671653|560609062|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
155320381|NCT05671653|560609063|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
155320382|NCT05671653|560609064|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
155320383|NCT05671653|560609065|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
155320384|NCT05671653|560609066|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
155320385|NCT05671653|560609067|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
155320386|NCT05671653|560609068|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
155320387|NCT05671653|560609069|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
155320388|NCT05671653|560609057|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320389|NCT05671653|560609058|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320390|NCT05671653|560609059|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320391|NCT05671653|560609060|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320392|NCT05671653|560609061|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320393|NCT05671653|560609062|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
155320394|NCT05671653|560609063|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320395|NCT05671653|560609064|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320396|NCT05671653|560609065|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320397|NCT05671653|560609066|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320398|NCT05671653|560609067|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320399|NCT05671653|560609068|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320400|NCT05671653|560609069|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
155320401|NCT05671653|560609057|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320402|NCT05671653|560609058|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320403|NCT05671653|560609059|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320404|NCT05671653|560609060|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320405|NCT05671653|560609061|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320406|NCT05671653|560609062|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
155320407|NCT05671653|560609063|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320408|NCT05671653|560609064|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320409|NCT05671653|560609065|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320410|NCT05671653|560609066|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320411|NCT05671653|560609067|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
154960701|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
154960702|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
154960703|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
154960704|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
154960705|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
154960706|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
155162564|NCT00998296|560031643|FG006|Overall Study|Progressive disease|1|||
155320412|NCT05671653|560609068|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320413|NCT05671653|560609069|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
155320414|NCT05671653|560609057|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320415|NCT05671653|560609058|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320416|NCT05671653|560609059|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320417|NCT05671653|560609060|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320418|NCT05671653|560609061|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320419|NCT05671653|560609062|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320420|NCT05671653|560609063|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320421|NCT05671653|560609064|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320422|NCT05671653|560609065|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
155320423|NCT05671653|560609066|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320424|NCT05671653|560609067|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320425|NCT05671653|560609068|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320426|NCT05671653|560609069|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
155320427|NCT05671653|560609057|FG000|Cohort 2 Period 2|Adverse Event|0|||
155320428|NCT05671653|560609058|FG001|Cohort 2 Period 2|Adverse Event|0|||
155320429|NCT05671653|560609059|FG002|Cohort 2 Period 2|Adverse Event|0|||
155320430|NCT05671653|560609060|FG003|Cohort 2 Period 2|Adverse Event|0|||
155320431|NCT05671653|560609061|FG004|Cohort 2 Period 2|Adverse Event|0|||
155320432|NCT05671653|560609062|FG005|Cohort 2 Period 2|Adverse Event|0|||
155320433|NCT05671653|560609063|FG006|Cohort 2 Period 2|Adverse Event|0|||
155320434|NCT05671653|560609064|FG007|Cohort 2 Period 2|Adverse Event|0|||
155320435|NCT05671653|560609065|FG008|Cohort 2 Period 2|Adverse Event|0|||
155320436|NCT05671653|560609066|FG009|Cohort 2 Period 2|Adverse Event|0|||
155320437|NCT05671653|560609067|FG010|Cohort 2 Period 2|Adverse Event|1|||
155320438|NCT05671653|560609068|FG011|Cohort 2 Period 2|Adverse Event|0|||
155320439|NCT05671653|560609069|FG012|Cohort 2 Period 2|Adverse Event|0|||
155320440|NCT05671653|560609057|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
155320441|NCT05671653|560609058|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
155320442|NCT05671653|560609059|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
155320443|NCT05671653|560609060|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
155320444|NCT05671653|560609061|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
155320445|NCT05671653|560609062|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
155320446|NCT05671653|560609063|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
155320447|NCT05671653|560609064|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
155320448|NCT05671653|560609065|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
155320449|NCT05671653|560609066|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
155320450|NCT05671653|560609067|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
155320451|NCT05671653|560609068|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
155320452|NCT05671653|560609069|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
155320453|NCT05671653|560609057|FG000|Cohort 2 Period 2|Pregnancy|0|||
155320454|NCT05671653|560609058|FG001|Cohort 2 Period 2|Pregnancy|0|||
155320455|NCT05671653|560609059|FG002|Cohort 2 Period 2|Pregnancy|0|||
155320456|NCT05671653|560609060|FG003|Cohort 2 Period 2|Pregnancy|0|||
155320457|NCT05671653|560609061|FG004|Cohort 2 Period 2|Pregnancy|0|||
155320458|NCT05671653|560609062|FG005|Cohort 2 Period 2|Pregnancy|0|||
155320459|NCT05671653|560609063|FG006|Cohort 2 Period 2|Pregnancy|0|||
155320460|NCT05671653|560609064|FG007|Cohort 2 Period 2|Pregnancy|0|||
155320461|NCT05671653|560609065|FG008|Cohort 2 Period 2|Pregnancy|0|||
155320462|NCT05671653|560609066|FG009|Cohort 2 Period 2|Pregnancy|0|||
155320463|NCT05671653|560609067|FG010|Cohort 2 Period 2|Pregnancy|1|||
155320464|NCT05671653|560609068|FG011|Cohort 2 Period 2|Pregnancy|0|||
155320465|NCT05671653|560609069|FG012|Cohort 2 Period 2|Pregnancy|0|||
155320466|NCT05671653|560609057|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320467|NCT05671653|560609058|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320468|NCT05671653|560609059|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320469|NCT05671653|560609060|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320470|NCT05671653|560609061|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320471|NCT05671653|560609062|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
155068434|NCT04896385|559680975|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
155068435|NCT04896385|559680976|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
155068436|NCT01931098|559680980|FG000|Overall Study|Withdrawal by Subject|0|||
155068437|NCT01931098|559680981|FG001|Overall Study|Withdrawal by Subject|1|||
155320472|NCT05671653|560609063|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320473|NCT05671653|560609064|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320474|NCT05671653|560609065|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320475|NCT05671653|560609066|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320476|NCT05671653|560609067|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
155320477|NCT05671653|560609068|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320478|NCT05671653|560609069|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
155320479|NCT05671653|560609057|FG000|Cohort 2 Period 2|Other|0|||
155320480|NCT05671653|560609058|FG001|Cohort 2 Period 2|Other|0|||
155320481|NCT05671653|560609059|FG002|Cohort 2 Period 2|Other|0|||
155320482|NCT05671653|560609060|FG003|Cohort 2 Period 2|Other|0|||
155320483|NCT05671653|560609061|FG004|Cohort 2 Period 2|Other|0|||
155068438|NCT01931098|559680980|FG000|Overall Study|Enrolled in different protocol|0|||
155320484|NCT05671653|560609062|FG005|Cohort 2 Period 2|Other|0|||
155320485|NCT05671653|560609063|FG006|Cohort 2 Period 2|Other|0|||
155320486|NCT05671653|560609064|FG007|Cohort 2 Period 2|Other|0|||
155320487|NCT05671653|560609065|FG008|Cohort 2 Period 2|Other|0|||
155320488|NCT05671653|560609066|FG009|Cohort 2 Period 2|Other|0|||
155320489|NCT05671653|560609067|FG010|Cohort 2 Period 2|Other|1|||
155320490|NCT05671653|560609068|FG011|Cohort 2 Period 2|Other|0|||
155320491|NCT05671653|560609069|FG012|Cohort 2 Period 2|Other|0|||
155320492|NCT05671653|560609057|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320493|NCT05671653|560609058|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320494|NCT05671653|560609059|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320495|NCT05671653|560609060|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320496|NCT05671653|560609061|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320497|NCT05671653|560609062|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320498|NCT05671653|560609063|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320499|NCT05671653|560609064|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320500|NCT05671653|560609065|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320501|NCT05671653|560609066|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320502|NCT05671653|560609067|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320503|NCT05671653|560609068|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
155320504|NCT05671653|560609069|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
155320505|NCT01197378|560609073|FG000|Overall Study|Adverse Event|3|||
155320506|NCT01197378|560609073|FG000|Overall Study|Withdrawal by Subject|1|||
155320507|NCT01197378|560609073|FG000|Overall Study|Physician Decision|1|||
155320508|NCT01197378|560609073|FG000|Overall Study|Other|2|||
155320509|NCT05274074|560609091|FG000|Overall Study|Lost to Follow-up|2|||
155320510|NCT05274074|560609092|FG001|Overall Study|Lost to Follow-up|3|||
155320511|NCT05274074|560609091|FG000|Overall Study|Withdrawal by Subject|1|||
155320512|NCT05274074|560609092|FG001|Overall Study|Withdrawal by Subject|2|||
155320513|NCT04117347|560609093|FG000|Overall Study|Adverse Event|0|||
155320514|NCT04117347|560609094|FG001|Overall Study|Adverse Event|0|||
155320515|NCT04117347|560609095|FG002|Overall Study|Adverse Event|1|||
155320516|NCT04117347|560609093|FG000|Overall Study|No time for study|0|||
155320517|NCT04117347|560609094|FG001|Overall Study|No time for study|2|||
155320518|NCT04117347|560609095|FG002|Overall Study|No time for study|0|||
155320519|NCT04117347|560609093|FG000|Overall Study|Family emergency|1|||
155320520|NCT04117347|560609094|FG001|Overall Study|Family emergency|0|||
155320521|NCT04117347|560609095|FG002|Overall Study|Family emergency|0|||
155320522|NCT03687086|560609096|FG000|Overall Study|Withdrawal by Subject|3|||
155320523|NCT03687086|560609097|FG001|Overall Study|Withdrawal by Subject|4|||
155320524|NCT03687086|560609096|FG000|Overall Study|Lost to Follow-up|1|||
155320525|NCT03687086|560609097|FG001|Overall Study|Lost to Follow-up|1|||
155320526|NCT03687086|560609096|FG000|Overall Study|Death|1|||
155320527|NCT03687086|560609097|FG001|Overall Study|Death|0|||
155320528|NCT03687086|560609096|FG000|Overall Study|Incomplete assessment|0|||
155320529|NCT03687086|560609097|FG001|Overall Study|Incomplete assessment|2|||
155320530|NCT05194956|560609098|FG000|Washout Period|Withdrawal by Subject|0|||
155320531|NCT05194956|560609099|FG001|Washout Period|Withdrawal by Subject|2|||
155320532|NCT02593773|560609100|FG000|Overall Study|Voluntary Withdrawal|3|||
155320533|NCT02593773|560609100|FG000|Overall Study|Study Terminated by Sponsor|31|||
155320534|NCT02593773|560609100|FG000|Overall Study|Death|1|||
155320535|NCT04294641|560609101|FG000|Overall Study|Screen failure|4|||
155320536|NCT01627574|560609102|FG000|Overall Study|Withdrawal by Subject|8|||
155320537|NCT01627574|560609103|FG001|Overall Study|Withdrawal by Subject|5|||
155320538|NCT01627574|560609102|FG000|Overall Study|Lost to Follow-up|13|||
155320539|NCT01627574|560609103|FG001|Overall Study|Lost to Follow-up|13|||
155320540|NCT03249090|560609111|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
155320541|NCT03249090|560609112|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
155320542|NCT03249090|560609111|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
155320543|NCT03249090|560609112|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
155320544|NCT03249090|560609111|FG000|3 Month Time Point|Voluntary withdrawal|6|||
155320545|NCT03249090|560609112|FG001|3 Month Time Point|Voluntary withdrawal|3|||
155320546|NCT03249090|560609111|FG000|3 Month Time Point|Changed oncology practice|4|||
155320547|NCT03249090|560609112|FG001|3 Month Time Point|Changed oncology practice|2|||
155320548|NCT03249090|560609111|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
155320549|NCT03249090|560609112|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
155320550|NCT03249090|560609111|FG000|12 Month Time Point|Voluntary withdrawal|35|||
155320551|NCT03249090|560609112|FG001|12 Month Time Point|Voluntary withdrawal|4|||
155162565|NCT00998296|560031644|FG007|Overall Study|Progressive disease|0|||
155320552|NCT03249090|560609111|FG000|12 Month Time Point|Changed oncology practice|20|||
155320553|NCT03249090|560609112|FG001|12 Month Time Point|Changed oncology practice|9|||
155320554|NCT04314778|560609117|FG000|Overall Study|Lost to Follow-up|5|||
155320555|NCT04314778|560609118|FG001|Overall Study|Lost to Follow-up|3|||
155068439|NCT01931098|559680981|FG001|Overall Study|Enrolled in different protocol|1|||
155068440|NCT01931098|559680980|FG000|Overall Study|Unable to begin trmt:active infection|0|||
155068441|NCT01931098|559680981|FG001|Overall Study|Unable to begin trmt:active infection|1|||
155068442|NCT01931098|559680980|FG000|Overall Study|Refused further treatment|0|||
155068443|NCT01931098|559680981|FG001|Overall Study|Refused further treatment|1|||
155068444|NCT02278354|559680985|FG000|Overall Study|Lost to Follow-up|2|||
155068445|NCT02278354|559680986|FG001|Overall Study|Lost to Follow-up|2|||
155068446|NCT02278354|559680985|FG000|Overall Study|Withdrawal by Subject|0|||
155068447|NCT02278354|559680986|FG001|Overall Study|Withdrawal by Subject|1|||
155068448|NCT02278354|559680985|FG000|Overall Study|<10 professional fights|2|||
155068449|NCT02278354|559680986|FG001|Overall Study|<10 professional fights|0|||
155068450|NCT02879695|559680994|FG000|Overall Study|Did not start study treatment|2|||
155068451|NCT02879695|559680995|FG001|Overall Study|Did not start study treatment|0|||
155068452|NCT02879695|559680996|FG002|Overall Study|Did not start study treatment|3|||
155068453|NCT02879695|559680997|FG003|Overall Study|Did not start study treatment|0|||
155320556|NCT05646355|560609119|FG000|Overall Study|Lost to Follow-up|1|||
155320557|NCT05646355|560609120|FG001|Overall Study|Lost to Follow-up|0|||
155320558|NCT05646355|560609119|FG000|Overall Study|translated materials not available for pilot|2|||
155320559|NCT05646355|560609120|FG001|Overall Study|translated materials not available for pilot|0|||
155320560|NCT05646355|560609119|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
155320561|NCT05646355|560609120|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
155320562|NCT03523572|560609121|FG000|Dose Escalation|Progressive disease|1|||
155320563|NCT03523572|560609122|FG001|Dose Escalation|Progressive disease|0|||
155320564|NCT03523572|560609123|FG002|Dose Escalation|Progressive disease|0|||
155320565|NCT03523572|560609124|FG003|Dose Escalation|Progressive disease|0|||
155162566|NCT00998296|560031645|FG008|Overall Study|Progressive disease|0|||
155162567|NCT00998296|560031646|FG009|Overall Study|Progressive disease|14|||
155320566|NCT03523572|560609125|FG004|Dose Escalation|Progressive disease|0|||
155320567|NCT03523572|560609126|FG005|Dose Escalation|Progressive disease|0|||
155320568|NCT03523572|560609121|FG000|Dose Escalation|Clinical Progression|0|||
155320569|NCT03523572|560609122|FG001|Dose Escalation|Clinical Progression|1|||
155320570|NCT03523572|560609123|FG002|Dose Escalation|Clinical Progression|0|||
155320571|NCT03523572|560609124|FG003|Dose Escalation|Clinical Progression|0|||
155320572|NCT03523572|560609125|FG004|Dose Escalation|Clinical Progression|0|||
155320573|NCT03523572|560609126|FG005|Dose Escalation|Clinical Progression|0|||
155320574|NCT03523572|560609121|FG000|Dose Escalation|Adverse Event|2|||
155320575|NCT03523572|560609122|FG001|Dose Escalation|Adverse Event|0|||
155320576|NCT03523572|560609123|FG002|Dose Escalation|Adverse Event|0|||
155320577|NCT03523572|560609124|FG003|Dose Escalation|Adverse Event|0|||
155320578|NCT03523572|560609125|FG004|Dose Escalation|Adverse Event|0|||
155320579|NCT03523572|560609126|FG005|Dose Escalation|Adverse Event|0|||
155320580|NCT03523572|560609121|FG000|Dose Escalation|Physician Decision|1|||
155320581|NCT03523572|560609122|FG001|Dose Escalation|Physician Decision|1|||
155320582|NCT03523572|560609123|FG002|Dose Escalation|Physician Decision|0|||
155320583|NCT03523572|560609124|FG003|Dose Escalation|Physician Decision|0|||
155320584|NCT03523572|560609125|FG004|Dose Escalation|Physician Decision|0|||
155320585|NCT03523572|560609126|FG005|Dose Escalation|Physician Decision|0|||
155320586|NCT03523572|560609121|FG000|Dose Expansion|Progressive Disease|0|||
155320587|NCT03523572|560609122|FG001|Dose Expansion|Progressive Disease|0|||
155320588|NCT03523572|560609123|FG002|Dose Expansion|Progressive Disease|9|||
155320589|NCT03523572|560609124|FG003|Dose Expansion|Progressive Disease|11|||
155320590|NCT03523572|560609125|FG004|Dose Expansion|Progressive Disease|15|||
155320591|NCT03523572|560609126|FG005|Dose Expansion|Progressive Disease|2|||
155320592|NCT03523572|560609121|FG000|Dose Expansion|Clinical Progression|0|||
155320593|NCT03523572|560609122|FG001|Dose Expansion|Clinical Progression|0|||
155320594|NCT03523572|560609123|FG002|Dose Expansion|Clinical Progression|2|||
155320595|NCT03523572|560609124|FG003|Dose Expansion|Clinical Progression|2|||
155320596|NCT03523572|560609125|FG004|Dose Expansion|Clinical Progression|2|||
155320597|NCT03523572|560609126|FG005|Dose Expansion|Clinical Progression|0|||
155320598|NCT03523572|560609121|FG000|Dose Expansion|Adverse Event|0|||
155320599|NCT03523572|560609122|FG001|Dose Expansion|Adverse Event|0|||
155320600|NCT03523572|560609123|FG002|Dose Expansion|Adverse Event|10|||
155320601|NCT03523572|560609124|FG003|Dose Expansion|Adverse Event|1|||
155320602|NCT03523572|560609125|FG004|Dose Expansion|Adverse Event|5|||
155320603|NCT03523572|560609126|FG005|Dose Expansion|Adverse Event|2|||
155320604|NCT03523572|560609121|FG000|Dose Expansion|Withdrawal by Subject|0|||
155320605|NCT03523572|560609122|FG001|Dose Expansion|Withdrawal by Subject|0|||
155320606|NCT03523572|560609123|FG002|Dose Expansion|Withdrawal by Subject|1|||
155320607|NCT03523572|560609124|FG003|Dose Expansion|Withdrawal by Subject|1|||
155320608|NCT03523572|560609125|FG004|Dose Expansion|Withdrawal by Subject|0|||
155068454|NCT03126110|559680999|FG000|Phase 1|Death|2|||
155068455|NCT03126110|559681000|FG001|Phase 1|Death|2|||
155068456|NCT03126110|559681001|FG002|Phase 1|Death|4|||
155068457|NCT03126110|559681002|FG003|Phase 1|Death|3|||
155068458|NCT03126110|559681003|FG004|Phase 1|Death|4|||
155068459|NCT03126110|559681004|FG005|Phase 1|Death|4|||
155320609|NCT03523572|560609126|FG005|Dose Expansion|Withdrawal by Subject|0|||
155320610|NCT03523572|560609121|FG000|Dose Expansion|Physician Decision|0|||
155320611|NCT03523572|560609122|FG001|Dose Expansion|Physician Decision|0|||
155320612|NCT03523572|560609123|FG002|Dose Expansion|Physician Decision|1|||
155320613|NCT03523572|560609124|FG003|Dose Expansion|Physician Decision|0|||
155320614|NCT03523572|560609125|FG004|Dose Expansion|Physician Decision|1|||
155320615|NCT03523572|560609126|FG005|Dose Expansion|Physician Decision|0|||
155320616|NCT03523572|560609121|FG000|Dose Expansion|Miscellaneous|0|||
155320617|NCT03523572|560609122|FG001|Dose Expansion|Miscellaneous|0|||
155320618|NCT03523572|560609123|FG002|Dose Expansion|Miscellaneous|0|||
155320619|NCT03523572|560609124|FG003|Dose Expansion|Miscellaneous|0|||
155320620|NCT03523572|560609125|FG004|Dose Expansion|Miscellaneous|3|||
155320621|NCT03523572|560609126|FG005|Dose Expansion|Miscellaneous|0|||
155320622|NCT04685135|560609127|FG000|Overall Study|Death|126|||
155320623|NCT04685135|560609128|FG001|Overall Study|Death|53|||
155320624|NCT04685135|560609127|FG000|Overall Study|Withdrawal by Subject|12|||
155320625|NCT04685135|560609128|FG001|Overall Study|Withdrawal by Subject|16|||
155320626|NCT03672916|560609132|FG000|Overall Study|Death|6|||
155320627|NCT03672916|560609132|FG000|Overall Study|Lost to Follow-up|29|||
155320628|NCT03672916|560609132|FG000|Overall Study|Adverse Event|6|||
155320629|NCT03672916|560609132|FG000|Overall Study|Withdrawal by Subject|11|||
155320630|NCT05868382|560609133|FG000|Overall Study|Lost to Follow-up|5|||
155320631|NCT05868382|560609134|FG001|Overall Study|Lost to Follow-up|0|||
155320632|NCT05868382|560609135|FG002|Overall Study|Lost to Follow-up|6|||
155320633|NCT05868382|560609136|FG003|Overall Study|Lost to Follow-up|4|||
155320634|NCT05868382|560609137|FG004|Overall Study|Lost to Follow-up|2|||
155320635|NCT05868382|560609138|FG005|Overall Study|Lost to Follow-up|6|||
155320636|NCT05868382|560609133|FG000|Overall Study|Withdrawal by Subject|1|||
155320637|NCT05868382|560609134|FG001|Overall Study|Withdrawal by Subject|0|||
155320638|NCT05868382|560609135|FG002|Overall Study|Withdrawal by Subject|0|||
155320639|NCT05868382|560609136|FG003|Overall Study|Withdrawal by Subject|0|||
155320640|NCT05868382|560609137|FG004|Overall Study|Withdrawal by Subject|1|||
155320641|NCT05868382|560609138|FG005|Overall Study|Withdrawal by Subject|0|||
155320642|NCT03513302|560609141|FG000|First Intervention (14 Days)|Screen failure|15|||
155320643|NCT03513302|560609142|FG001|First Intervention (14 Days)|Screen failure|16|||
155320644|NCT05256654|560609143|FG000|Overall Study|Adverse Event|0|||
155320645|NCT05256654|560609144|FG001|Overall Study|Adverse Event|0|||
155320646|NCT05256654|560609145|FG002|Overall Study|Adverse Event|1|||
155320647|NCT05256654|560609146|FG003|Overall Study|Adverse Event|0|||
155320648|NCT05256654|560609143|FG000|Overall Study|Lost to Follow-up|0|||
155320649|NCT05256654|560609144|FG001|Overall Study|Lost to Follow-up|0|||
155320650|NCT05256654|560609145|FG002|Overall Study|Lost to Follow-up|0|||
155320651|NCT05256654|560609146|FG003|Overall Study|Lost to Follow-up|1|||
155320652|NCT05256654|560609143|FG000|Overall Study|Withdrawal by Subject|1|||
155320653|NCT05256654|560609144|FG001|Overall Study|Withdrawal by Subject|2|||
155320654|NCT05256654|560609145|FG002|Overall Study|Withdrawal by Subject|1|||
155320655|NCT05256654|560609146|FG003|Overall Study|Withdrawal by Subject|3|||
155320656|NCT05256654|560609143|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
155320657|NCT05256654|560609144|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
155320658|NCT05256654|560609145|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
155320659|NCT05256654|560609146|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
155320660|NCT05256654|560609143|FG000|Overall Study|Other|0|||
155320661|NCT05256654|560609144|FG001|Overall Study|Other|0|||
155320662|NCT05256654|560609145|FG002|Overall Study|Other|0|||
155320663|NCT05256654|560609146|FG003|Overall Study|Other|1|||
155320664|NCT01309672|560609152|FG000|Overall Study|Lack of Efficacy|20|||
155320665|NCT01309672|560609152|FG000|Overall Study|Other|9|||
155320666|NCT01309672|560609152|FG000|Overall Study|Adverse Event|5|||
155320667|NCT01309672|560609152|FG000|Overall Study|Withdrawal by Subject|3|||
155320668|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
155320669|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
155320670|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
155320671|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
155320672|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
155320673|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
155320674|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
155320675|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
155320676|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
155320677|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
155320678|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
155320679|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
155320680|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
155320681|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
155320682|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
154960707|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
154960708|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
154960709|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
154960710|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
154960711|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
154960712|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
154960713|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
154960714|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
154960715|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
154960716|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
154960717|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
154960718|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
154960719|NCT01045161|559280394|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
154960720|NCT01045161|559280395|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
154960721|NCT01045161|559280396|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
154960722|NCT00773253|559280397|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
154960723|NCT00773253|559280398|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
154960724|NCT03173547|559280402|FG000|Overall Study|Adverse Event|2|||
154960725|NCT03173547|559280403|FG001|Overall Study|Adverse Event|0|||
154960726|NCT03173547|559280402|FG000|Overall Study|Withdrawal by Subject|2|||
154960727|NCT03173547|559280403|FG001|Overall Study|Withdrawal by Subject|2|||
154960728|NCT00657553|559280404|FG000|Overall Study|low accrual, no analysis run|5|||
154960729|NCT00657553|559280405|FG001|Overall Study|low accrual, no analysis run|5|||
154960730|NCT01169558|559280406|FG000|Overall Study|Disease progression|98|||
154960731|NCT01169558|559280406|FG000|Overall Study|Adverse Event|25|||
154960732|NCT01169558|559280406|FG000|Overall Study|Withdrawal of Consent|8|||
154960733|NCT01169558|559280406|FG000|Overall Study|Medical Decision|7|||
154960734|NCT01169558|559280406|FG000|Overall Study|Stable Disease|4|||
154960735|NCT01169558|559280406|FG000|Overall Study|Lost to Follow-up|4|||
154960736|NCT01169558|559280406|FG000|Overall Study|Need for Surgery|4|||
154960737|NCT01169558|559280406|FG000|Overall Study|Non-compliance|2|||
154960738|NCT01169558|559280406|FG000|Overall Study|Protocol Violation|2|||
154960739|NCT01169558|559280406|FG000|Overall Study|Partial response|2|||
154960740|NCT02911701|559280407|FG000|Overall Study|Withdrawal by Subject|2|||
154960741|NCT02911701|559280408|FG001|Overall Study|Withdrawal by Subject|4|||
154960742|NCT02911701|559280407|FG000|Overall Study|Adverse Event|1|||
154960743|NCT02911701|559280408|FG001|Overall Study|Adverse Event|0|||
154960744|NCT02409355|559280411|FG000|Overall Study|Withdrawal by Subject|1|||
154960745|NCT02409355|559280412|FG001|Overall Study|Withdrawal by Subject|0|||
154960746|NCT02409355|559280411|FG000|Overall Study|Death|1|||
154960747|NCT02409355|559280412|FG001|Overall Study|Death|1|||
154960748|NCT02409355|559280411|FG000|Overall Study|Study terminated by Sponsor|2|||
154960749|NCT02409355|559280412|FG001|Overall Study|Study terminated by Sponsor|3|||
154960750|NCT03134222|559280413|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
154960751|NCT03134222|559280414|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
154960752|NCT03134222|559280415|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
154960753|NCT03134222|559280416|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
154960754|NCT03134222|559280417|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
154960755|NCT03134222|559280413|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
155320683|NCT01254864|560609155|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
155320684|NCT01254864|560609156|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
155320685|NCT01254864|560609157|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
155320686|NCT01254864|560609155|FG000|Randomization Phase|Adverse Event|0|||
154960756|NCT03134222|559280414|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
154960757|NCT03134222|559280415|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
154960758|NCT03134222|559280416|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
154960759|NCT03134222|559280417|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
155162568|NCT00998296|560031647|FG010|Overall Study|Progressive disease|5|||
155162569|NCT00998296|560031637|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
155162570|NCT00998296|560031638|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
154960760|NCT03134222|559280413|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
154960761|NCT03134222|559280414|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
154960762|NCT03134222|559280415|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
154960763|NCT03134222|559280416|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
154960764|NCT03134222|559280417|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
154960765|NCT03134222|559280413|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
154960766|NCT03134222|559280414|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
154960767|NCT03134222|559280415|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
154960768|NCT03134222|559280416|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
154960769|NCT03134222|559280417|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
154960770|NCT03134222|559280413|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
154960771|NCT03134222|559280414|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
154960772|NCT03134222|559280415|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
154960773|NCT03134222|559280416|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
154960774|NCT03134222|559280417|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
154960775|NCT03134222|559280413|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
154960776|NCT03134222|559280414|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
154960777|NCT03134222|559280415|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
154960778|NCT03134222|559280416|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
154960779|NCT03134222|559280417|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
154960780|NCT03134222|559280413|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
154960781|NCT03134222|559280414|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
154960782|NCT03134222|559280415|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
154960783|NCT03134222|559280416|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
154960784|NCT03134222|559280417|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
154960785|NCT03134222|559280413|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
154960786|NCT03134222|559280414|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
154960787|NCT03134222|559280415|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
154960788|NCT03134222|559280416|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
154960789|NCT03134222|559280417|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
154960790|NCT03482882|559280418|FG000|Overall Study|Adverse Event|3|||
154960791|NCT03482882|559280418|FG000|Overall Study|Lost to Follow-up|1|||
154960792|NCT03482882|559280418|FG000|Overall Study|Protocol Violation|2|||
154960793|NCT03482882|559280418|FG000|Overall Study|Not further specified|1|||
154960794|NCT01110005|559280421|FG000|Overall Study|ineligible|1|||
154960795|NCT01110005|559280422|FG001|Overall Study|ineligible|2|||
154960796|NCT01110005|559280421|FG000|Overall Study|missing consent|3|||
154960797|NCT01110005|559280422|FG001|Overall Study|missing consent|2|||
154960798|NCT01110005|559280421|FG000|Overall Study|Withdrawal by Subject|0|||
154960799|NCT01110005|559280422|FG001|Overall Study|Withdrawal by Subject|1|||
154960800|NCT02957942|559280423|FG000|Overall Study|Withdrawal by Subject|0|||
154960801|NCT02957942|559280424|FG001|Overall Study|Withdrawal by Subject|1|||
154960802|NCT02957942|559280423|FG000|Overall Study|Practicing experiment protocol|0|||
154960803|NCT02957942|559280424|FG001|Overall Study|Practicing experiment protocol|6|||
155162571|NCT00998296|560031639|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
155162572|NCT00998296|560031640|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
155162573|NCT00998296|560031641|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
155162574|NCT00998296|560031642|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
155162575|NCT00998296|560031643|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
155162576|NCT00998296|560031644|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
155162577|NCT00998296|560031645|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
154960804|NCT04611789|559280427|FG000|Overall Study|Lost to Follow-up|1|||
154960805|NCT04611789|559280428|FG001|Overall Study|Lost to Follow-up|0|||
154960806|NCT04611789|559280429|FG002|Overall Study|Lost to Follow-up|0|||
154960807|NCT02820350|559280432|FG000|Overall Study|Withdrawal by Subject|3|||
154960808|NCT02820350|559280432|FG000|Overall Study|Death|4|||
154960809|NCT03801707|559280433|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
154960810|NCT05265624|559282101|FG000|Overall Study|Lost to Follow-up|3|||
154960811|NCT05265624|559282102|FG001|Overall Study|Lost to Follow-up|0|||
154960812|NCT05265624|559282101|FG000|Overall Study|Withdrawal by Subject|1|||
154960813|NCT05265624|559282102|FG001|Overall Study|Withdrawal by Subject|0|||
154960814|NCT00001703|559282103|FG000|Overall Study|progressed disease|2|||
154960815|NCT00001703|559282103|FG000|Overall Study|No evidence of disease|1|||
154960816|NCT00001703|559282103|FG000|Overall Study|recurrent disease|2|||
154960817|NCT02286739|559282108|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
154960818|NCT02286739|559282109|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
154960819|NCT02286739|559282108|FG000|Overall Study|No Verasense type documented|0|||
154960820|NCT02286739|559282109|FG001|Overall Study|No Verasense type documented|23|||
155320687|NCT01254864|560609156|FG001|Randomization Phase|Adverse Event|5|||
155320688|NCT01254864|560609157|FG002|Randomization Phase|Adverse Event|17|||
155320689|NCT01254864|560609155|FG000|Randomization Phase|Death|0|||
155320690|NCT01254864|560609156|FG001|Randomization Phase|Death|1|||
155320691|NCT01254864|560609157|FG002|Randomization Phase|Death|0|||
155320692|NCT01254864|560609155|FG000|Randomization Phase|Lost to Follow-up|0|||
155320693|NCT01254864|560609156|FG001|Randomization Phase|Lost to Follow-up|0|||
155320694|NCT01254864|560609157|FG002|Randomization Phase|Lost to Follow-up|1|||
155320695|NCT01254864|560609155|FG000|Randomization Phase|Physician Decision|0|||
155320696|NCT01254864|560609156|FG001|Randomization Phase|Physician Decision|20|||
155320697|NCT01254864|560609157|FG002|Randomization Phase|Physician Decision|25|||
155320698|NCT01254864|560609155|FG000|Randomization Phase|Withdrawal by Subject|0|||
155320699|NCT01254864|560609156|FG001|Randomization Phase|Withdrawal by Subject|4|||
155320700|NCT01254864|560609157|FG002|Randomization Phase|Withdrawal by Subject|2|||
155320701|NCT01254864|560609155|FG000|Randomization Phase|Non-Compliance|0|||
155320702|NCT01254864|560609156|FG001|Randomization Phase|Non-Compliance|1|||
155320703|NCT01254864|560609157|FG002|Randomization Phase|Non-Compliance|0|||
155320704|NCT01254864|560609155|FG000|Randomization Phase|Comorbidities|0|||
155320705|NCT01254864|560609156|FG001|Randomization Phase|Comorbidities|2|||
155320706|NCT01254864|560609157|FG002|Randomization Phase|Comorbidities|1|||
155320707|NCT04141891|560609158|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
155320708|NCT04141891|560609159|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
155320709|NCT04141891|560609158|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
155320710|NCT04141891|560609159|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
155068460|NCT03126110|559681005|FG006|Phase 1|Death|3|||
155068461|NCT03126110|559681006|FG007|Phase 1|Death|4|||
155068462|NCT03126110|559681007|FG008|Phase 1|Death|5|||
155068463|NCT03126110|559681008|FG009|Phase 1|Death|2|||
155068464|NCT03126110|559681009|FG010|Phase 1|Death|6|||
155068465|NCT03126110|559681010|FG011|Phase 1|Death|0|||
155068466|NCT03126110|559681011|FG012|Phase 1|Death|0|||
155320711|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
155320712|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
155320713|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
155320714|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
155320715|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
155320716|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
155320717|NCT04141891|560609158|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
155320718|NCT04141891|560609159|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
155320719|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
155320720|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
155320721|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
155320722|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
155320723|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
155320724|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
155320725|NCT04141891|560609158|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
155320726|NCT04141891|560609159|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
155320727|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
155320728|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
155320729|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
155320730|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
155320731|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
155320732|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
155320733|NCT04141891|560609158|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
155320734|NCT04141891|560609159|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
155320735|NCT01828112|560609162|FG000|Treatment Phase|Adverse Event|7|||
155320736|NCT01828112|560609163|FG001|Treatment Phase|Adverse Event|8|||
155320737|NCT01828112|560609164|FG002|Treatment Phase|Adverse Event|0|||
155320738|NCT01828112|560609162|FG000|Treatment Phase|Death|9|||
155320739|NCT01828112|560609163|FG001|Treatment Phase|Death|5|||
155320740|NCT01828112|560609164|FG002|Treatment Phase|Death|0|||
155320741|NCT01828112|560609162|FG000|Treatment Phase|No longer required treatment|0|||
155320742|NCT01828112|560609163|FG001|Treatment Phase|No longer required treatment|1|||
155320743|NCT01828112|560609164|FG002|Treatment Phase|No longer required treatment|0|||
155320744|NCT01828112|560609162|FG000|Treatment Phase|Physician Decision|6|||
155320745|NCT01828112|560609163|FG001|Treatment Phase|Physician Decision|7|||
155068467|NCT03126110|559681012|FG013|Phase 1|Death|0|||
155068468|NCT03126110|559681013|FG014|Phase 1|Death|0|||
155068469|NCT03126110|559681014|FG015|Phase 1|Death|0|||
155068470|NCT03126110|559681015|FG016|Phase 1|Death|0|||
155320746|NCT01828112|560609164|FG002|Treatment Phase|Physician Decision|0|||
155320747|NCT01828112|560609162|FG000|Treatment Phase|Pregnancy|1|||
155320748|NCT01828112|560609163|FG001|Treatment Phase|Pregnancy|0|||
155320749|NCT01828112|560609164|FG002|Treatment Phase|Pregnancy|0|||
155320750|NCT01828112|560609162|FG000|Treatment Phase|Progressive disease|79|||
155320751|NCT01828112|560609163|FG001|Treatment Phase|Progressive disease|87|||
155320752|NCT01828112|560609164|FG002|Treatment Phase|Progressive disease|0|||
155320753|NCT01828112|560609162|FG000|Treatment Phase|Study terminated by sponsor|1|||
155320754|NCT01828112|560609163|FG001|Treatment Phase|Study terminated by sponsor|0|||
155320755|NCT01828112|560609164|FG002|Treatment Phase|Study terminated by sponsor|0|||
155320756|NCT01828112|560609162|FG000|Treatment Phase|Subject/guardian decision|12|||
155320757|NCT01828112|560609163|FG001|Treatment Phase|Subject/guardian decision|8|||
155320758|NCT01828112|560609164|FG002|Treatment Phase|Subject/guardian decision|0|||
155320759|NCT01828112|560609162|FG000|Extension Treatment Phase|Adverse Event|0|||
155320760|NCT01828112|560609163|FG001|Extension Treatment Phase|Adverse Event|0|||
155320761|NCT01828112|560609164|FG002|Extension Treatment Phase|Adverse Event|6|||
155320762|NCT01828112|560609162|FG000|Extension Treatment Phase|Death|0|||
155320763|NCT01828112|560609163|FG001|Extension Treatment Phase|Death|0|||
155320764|NCT01828112|560609164|FG002|Extension Treatment Phase|Death|17|||
155320765|NCT01828112|560609162|FG000|Extension Treatment Phase|Physician Decision|0|||
155320766|NCT01828112|560609163|FG001|Extension Treatment Phase|Physician Decision|0|||
155320767|NCT01828112|560609164|FG002|Extension Treatment Phase|Physician Decision|5|||
155320768|NCT01828112|560609162|FG000|Extension Treatment Phase|Progressive disease|0|||
155320769|NCT01828112|560609163|FG001|Extension Treatment Phase|Progressive disease|0|||
155320770|NCT01828112|560609164|FG002|Extension Treatment Phase|Progressive disease|46|||
155320771|NCT01828112|560609162|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
155320772|NCT01828112|560609163|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
155320773|NCT01828112|560609164|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
155320774|NCT01828112|560609162|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
155320775|NCT01828112|560609163|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
155320776|NCT01828112|560609164|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
155320777|NCT04308681|560609165|FG000|Pre-Treatment|Not reported|1|||
155320778|NCT04308681|560609166|FG001|Pre-Treatment|Not reported|1|||
155320779|NCT04308681|560609167|FG002|Pre-Treatment|Not reported|0|||
155320780|NCT04308681|560609168|FG003|Pre-Treatment|Not reported|0|||
155320781|NCT04308681|560609169|FG004|Pre-Treatment|Not reported|0|||
155320782|NCT04308681|560609170|FG005|Pre-Treatment|Not reported|2|||
155320783|NCT04308681|560609171|FG006|Pre-Treatment|Not reported|0|||
155320784|NCT04308681|560609172|FG007|Pre-Treatment|Not reported|0|||
155320785|NCT04308681|560609165|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
155320786|NCT04308681|560609166|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
155320787|NCT04308681|560609167|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
155320788|NCT04308681|560609168|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
155320789|NCT04308681|560609169|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
155320790|NCT04308681|560609170|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
155320791|NCT04308681|560609171|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
155320792|NCT04308681|560609172|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
155320793|NCT04308681|560609165|FG000|Treatment up to Week 26|Other reasons|2|||
155320794|NCT04308681|560609166|FG001|Treatment up to Week 26|Other reasons|0|||
155320795|NCT04308681|560609167|FG002|Treatment up to Week 26|Other reasons|0|||
155320796|NCT04308681|560609168|FG003|Treatment up to Week 26|Other reasons|0|||
155320797|NCT04308681|560609169|FG004|Treatment up to Week 26|Other reasons|1|||
155320798|NCT04308681|560609170|FG005|Treatment up to Week 26|Other reasons|1|||
155320799|NCT04308681|560609171|FG006|Treatment up to Week 26|Other reasons|0|||
155320800|NCT04308681|560609172|FG007|Treatment up to Week 26|Other reasons|0|||
155320801|NCT04308681|560609165|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320802|NCT04308681|560609166|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
155320803|NCT04308681|560609167|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
155320804|NCT04308681|560609168|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320805|NCT04308681|560609169|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
155320806|NCT04308681|560609170|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320807|NCT04308681|560609171|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
155320808|NCT04308681|560609172|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
155320809|NCT04308681|560609165|FG000|Treatment up to Week 26|Adverse Event|6|||
155320810|NCT04308681|560609166|FG001|Treatment up to Week 26|Adverse Event|5|||
155320811|NCT04308681|560609167|FG002|Treatment up to Week 26|Adverse Event|5|||
155320812|NCT04308681|560609168|FG003|Treatment up to Week 26|Adverse Event|0|||
155320813|NCT04308681|560609169|FG004|Treatment up to Week 26|Adverse Event|6|||
155320814|NCT04308681|560609170|FG005|Treatment up to Week 26|Adverse Event|1|||
155320815|NCT04308681|560609171|FG006|Treatment up to Week 26|Adverse Event|0|||
154960821|NCT02286739|559282108|FG000|Overall Study|Adverse Event|1|||
154960822|NCT02286739|559282109|FG001|Overall Study|Adverse Event|2|||
154960823|NCT02286739|559282108|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
154960824|NCT02286739|559282109|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
154960825|NCT00834795|559282110|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
154960826|NCT00834795|559282111|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
154960827|NCT00834795|559282110|FG000|Second Intervention|Adverse Event|1|||
154960828|NCT00834795|559282111|FG001|Second Intervention|Adverse Event|0|||
154960829|NCT03447353|559282119|FG000|Overall Study|Failure at Screening Visit|2|||
154960830|NCT03447353|559282119|FG000|Overall Study|Lost to Follow-up|4|||
154960831|NCT03447353|559282119|FG000|Overall Study|Scheduling Conflicts|3|||
154960832|NCT03447353|559282119|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
154960833|NCT02175095|559282120|FG000|Overall Study|Withdrawal by Subject|3|||
154960834|NCT02635750|559282121|FG000|Part 1, Period 2|Adverse Event|1|||
154960835|NCT02635750|559282122|FG001|Part 1, Period 2|Adverse Event|0|||
154960836|NCT02635750|559282123|FG002|Part 1, Period 2|Adverse Event|0|||
154960837|NCT02642653|559282127|FG000|Overall Study|Adverse Event|2|||
154960838|NCT02642653|559282128|FG001|Overall Study|Adverse Event|0|||
155320816|NCT04308681|560609172|FG007|Treatment up to Week 26|Adverse Event|0|||
155320817|NCT04308681|560609165|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320818|NCT04308681|560609166|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
155320819|NCT04308681|560609167|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
155320820|NCT04308681|560609168|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320821|NCT04308681|560609169|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320822|NCT04308681|560609170|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320823|NCT04308681|560609171|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320824|NCT04308681|560609172|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
155320825|NCT04308681|560609165|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
155320826|NCT04308681|560609166|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
155320827|NCT04308681|560609167|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
155320828|NCT04308681|560609168|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
155320829|NCT04308681|560609169|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
155320830|NCT04308681|560609170|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
155320831|NCT04308681|560609171|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
155320832|NCT04308681|560609172|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
155320833|NCT04308681|560609165|FG000|OTE - 26 Weeks|Death|0|||
155320834|NCT04308681|560609166|FG001|OTE - 26 Weeks|Death|1|||
155320835|NCT04308681|560609167|FG002|OTE - 26 Weeks|Death|0|||
155320836|NCT04308681|560609168|FG003|OTE - 26 Weeks|Death|0|||
155320837|NCT04308681|560609169|FG004|OTE - 26 Weeks|Death|0|||
155320838|NCT04308681|560609170|FG005|OTE - 26 Weeks|Death|0|||
155320839|NCT04308681|560609171|FG006|OTE - 26 Weeks|Death|1|||
155320840|NCT04308681|560609172|FG007|OTE - 26 Weeks|Death|0|||
155320841|NCT04308681|560609165|FG000|OTE - 26 Weeks|Adverse Event|0|||
155320842|NCT04308681|560609166|FG001|OTE - 26 Weeks|Adverse Event|2|||
155320843|NCT04308681|560609167|FG002|OTE - 26 Weeks|Adverse Event|8|||
155320844|NCT04308681|560609168|FG003|OTE - 26 Weeks|Adverse Event|3|||
155320845|NCT04308681|560609169|FG004|OTE - 26 Weeks|Adverse Event|0|||
155320846|NCT04308681|560609170|FG005|OTE - 26 Weeks|Adverse Event|1|||
155320847|NCT04308681|560609171|FG006|OTE - 26 Weeks|Adverse Event|2|||
155320848|NCT04308681|560609172|FG007|OTE - 26 Weeks|Adverse Event|0|||
155320849|NCT04308681|560609165|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320850|NCT04308681|560609166|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
155320851|NCT04308681|560609167|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
155320852|NCT04308681|560609168|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320853|NCT04308681|560609169|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320854|NCT04308681|560609170|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
155320855|NCT04308681|560609171|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320856|NCT04308681|560609172|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
155320857|NCT04571619|560609177|FG000|Phase 1|Death|22|||
155320858|NCT04571619|560609178|FG001|Phase 1|Death|18|||
155320859|NCT04571619|560609177|FG000|Phase 1|Withdrawal by Subject|7|||
155320860|NCT04571619|560609178|FG001|Phase 1|Withdrawal by Subject|2|||
154960839|NCT02057835|559282129|FG000|Overall Study|Withdrawal by Subject|0|||
154960840|NCT02057835|559282130|FG001|Overall Study|Withdrawal by Subject|2|||
154960841|NCT02057835|559282131|FG002|Overall Study|Withdrawal by Subject|0|||
154960842|NCT02057835|559282132|FG003|Overall Study|Withdrawal by Subject|0|||
154960843|NCT02057835|559282133|FG004|Overall Study|Withdrawal by Subject|0|||
154960844|NCT02057835|559282134|FG005|Overall Study|Withdrawal by Subject|0|||
154960845|NCT02057835|559282135|FG006|Overall Study|Withdrawal by Subject|0|||
155320861|NCT04571619|560609177|FG000|Phase 2|Death|13|||
155320862|NCT04571619|560609178|FG001|Phase 2|Death|16|||
155320863|NCT04571619|560609177|FG000|Phase 2|Withdrawal by Subject|6|||
155320864|NCT04571619|560609178|FG001|Phase 2|Withdrawal by Subject|4|||
155320865|NCT05309291|560609183|FG000|Overall Study|Adverse Event|0|||
155320866|NCT05309291|560609184|FG001|Overall Study|Adverse Event|1|||
155320867|NCT05209152|560609185|FG000|Overall Study|Sponsor decision|1|||
155320868|NCT05209152|560609186|FG001|Overall Study|Sponsor decision|2|||
155320869|NCT05209152|560609185|FG000|Overall Study|Death|3|||
155320870|NCT05209152|560609186|FG001|Overall Study|Death|1|||
155320871|NCT04857723|560609190|FG000|Overall Study|Withdrawal by Subject|2|||
155320874|NCT00696111|560610713|FG000|Overall Study|Withdrawal by Subject|17|||
155320875|NCT04850898|560610714|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
155320876|NCT04850898|560610715|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
155320877|NCT04550221|560610716|FG000|Overall Study|Lost to Follow-up|0|||
155320878|NCT04550221|560610717|FG001|Overall Study|Lost to Follow-up|4|||
155320879|NCT04550221|560610716|FG000|Overall Study|Withdrawn|3|||
155320880|NCT04550221|560610717|FG001|Overall Study|Withdrawn|0|||
155320881|NCT04550221|560610716|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
155320882|NCT04550221|560610717|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
155320883|NCT03676192|560610719|FG000|Induction Study Period|Adverse Event|21|||
155320884|NCT03676192|560610720|FG001|Induction Study Period|Adverse Event|20|||
155320885|NCT03676192|560610719|FG000|Induction Study Period|Death|23|||
155320886|NCT03676192|560610720|FG001|Induction Study Period|Death|20|||
155320887|NCT03676192|560610719|FG000|Induction Study Period|Lost to Follow-up|3|||
155320888|NCT03676192|560610720|FG001|Induction Study Period|Lost to Follow-up|3|||
155320889|NCT03676192|560610719|FG000|Induction Study Period|Physician Decision|6|||
155320890|NCT03676192|560610720|FG001|Induction Study Period|Physician Decision|3|||
155068471|NCT03126110|559680999|FG000|Phase 1|Lost to Follow-up|0|||
155068472|NCT03126110|559681000|FG001|Phase 1|Lost to Follow-up|1|||
155068473|NCT03126110|559681001|FG002|Phase 1|Lost to Follow-up|0|||
155068474|NCT03126110|559681002|FG003|Phase 1|Lost to Follow-up|0|||
155068475|NCT03126110|559681003|FG004|Phase 1|Lost to Follow-up|0|||
155068476|NCT03126110|559681004|FG005|Phase 1|Lost to Follow-up|0|||
155068477|NCT03126110|559681005|FG006|Phase 1|Lost to Follow-up|0|||
155068478|NCT03126110|559681006|FG007|Phase 1|Lost to Follow-up|0|||
155068479|NCT03126110|559681007|FG008|Phase 1|Lost to Follow-up|1|||
155068480|NCT03126110|559681008|FG009|Phase 1|Lost to Follow-up|0|||
155068481|NCT03126110|559681009|FG010|Phase 1|Lost to Follow-up|0|||
155068482|NCT03126110|559681010|FG011|Phase 1|Lost to Follow-up|0|||
155068483|NCT03126110|559681011|FG012|Phase 1|Lost to Follow-up|0|||
155068484|NCT03126110|559681012|FG013|Phase 1|Lost to Follow-up|0|||
155068485|NCT03126110|559681013|FG014|Phase 1|Lost to Follow-up|0|||
155068486|NCT03126110|559681014|FG015|Phase 1|Lost to Follow-up|0|||
155068487|NCT03126110|559681015|FG016|Phase 1|Lost to Follow-up|0|||
155068488|NCT03126110|559680999|FG000|Phase 1|Withdrawal by Subject|1|||
155068489|NCT03126110|559681000|FG001|Phase 1|Withdrawal by Subject|0|||
155068490|NCT03126110|559681001|FG002|Phase 1|Withdrawal by Subject|0|||
155068491|NCT03126110|559681002|FG003|Phase 1|Withdrawal by Subject|1|||
155068492|NCT03126110|559681003|FG004|Phase 1|Withdrawal by Subject|1|||
155068493|NCT03126110|559681004|FG005|Phase 1|Withdrawal by Subject|0|||
155068494|NCT03126110|559681005|FG006|Phase 1|Withdrawal by Subject|0|||
155068495|NCT03126110|559681006|FG007|Phase 1|Withdrawal by Subject|0|||
155068496|NCT03126110|559681007|FG008|Phase 1|Withdrawal by Subject|2|||
155068497|NCT03126110|559681008|FG009|Phase 1|Withdrawal by Subject|1|||
155068498|NCT03126110|559681009|FG010|Phase 1|Withdrawal by Subject|0|||
155068499|NCT03126110|559681010|FG011|Phase 1|Withdrawal by Subject|0|||
155068500|NCT03126110|559681011|FG012|Phase 1|Withdrawal by Subject|0|||
155068501|NCT03126110|559681012|FG013|Phase 1|Withdrawal by Subject|0|||
155068502|NCT03126110|559681013|FG014|Phase 1|Withdrawal by Subject|0|||
155068503|NCT03126110|559681014|FG015|Phase 1|Withdrawal by Subject|0|||
155068504|NCT03126110|559681015|FG016|Phase 1|Withdrawal by Subject|0|||
155068505|NCT03126110|559680999|FG000|Phase 1|Safety follow-up no longer necessary|1|||
155068506|NCT03126110|559681000|FG001|Phase 1|Safety follow-up no longer necessary|0|||
155068507|NCT03126110|559681001|FG002|Phase 1|Safety follow-up no longer necessary|0|||
155068508|NCT03126110|559681002|FG003|Phase 1|Safety follow-up no longer necessary|0|||
155068509|NCT03126110|559681003|FG004|Phase 1|Safety follow-up no longer necessary|0|||
155068510|NCT03126110|559681004|FG005|Phase 1|Safety follow-up no longer necessary|0|||
155068511|NCT03126110|559681005|FG006|Phase 1|Safety follow-up no longer necessary|0|||
155068512|NCT03126110|559681006|FG007|Phase 1|Safety follow-up no longer necessary|0|||
155068513|NCT03126110|559681007|FG008|Phase 1|Safety follow-up no longer necessary|0|||
155068514|NCT03126110|559681008|FG009|Phase 1|Safety follow-up no longer necessary|0|||
155068515|NCT03126110|559681009|FG010|Phase 1|Safety follow-up no longer necessary|0|||
155068516|NCT03126110|559681010|FG011|Phase 1|Safety follow-up no longer necessary|0|||
155068517|NCT03126110|559681011|FG012|Phase 1|Safety follow-up no longer necessary|0|||
155320891|NCT03676192|560610719|FG000|Induction Study Period|Progressive Disease|32|||
155320892|NCT03676192|560610720|FG001|Induction Study Period|Progressive Disease|21|||
155320893|NCT03676192|560610719|FG000|Induction Study Period|Protocol Violation|1|||
155320894|NCT03676192|560610720|FG001|Induction Study Period|Protocol Violation|2|||
155320895|NCT03676192|560610719|FG000|Induction Study Period|Withdrawal by Subject|20|||
155320896|NCT03676192|560610720|FG001|Induction Study Period|Withdrawal by Subject|15|||
155320897|NCT03386578|560610722|FG000|PK Component|Lost to Follow-up|0|||
155320898|NCT03386578|560610723|FG001|PK Component|Lost to Follow-up|1|||
155320899|NCT03386578|560610724|FG002|PK Component|Lost to Follow-up|0|||
155320900|NCT03386578|560610725|FG003|PK Component|Lost to Follow-up|0|||
155320901|NCT03386578|560610726|FG004|PK Component|Lost to Follow-up|0|||
155320902|NCT03386578|560610727|FG005|PK Component|Lost to Follow-up|0|||
155320903|NCT03386578|560610728|FG006|PK Component|Lost to Follow-up|1|||
155320904|NCT03386578|560610729|FG007|PK Component|Lost to Follow-up|0|||
155320905|NCT03386578|560610730|FG008|PK Component|Lost to Follow-up|0|||
155320906|NCT03386578|560610731|FG009|PK Component|Lost to Follow-up|0|||
155320907|NCT03386578|560610722|FG000|PK Component|Stillbirth/Abortion|0|||
155320908|NCT03386578|560610723|FG001|PK Component|Stillbirth/Abortion|0|||
155320909|NCT03386578|560610724|FG002|PK Component|Stillbirth/Abortion|0|||
155320910|NCT03386578|560610725|FG003|PK Component|Stillbirth/Abortion|0|||
155320911|NCT03386578|560610726|FG004|PK Component|Stillbirth/Abortion|0|||
155320912|NCT03386578|560610727|FG005|PK Component|Stillbirth/Abortion|2|||
155320913|NCT03386578|560610728|FG006|PK Component|Stillbirth/Abortion|0|||
155320914|NCT03386578|560610729|FG007|PK Component|Stillbirth/Abortion|0|||
155320915|NCT03386578|560610730|FG008|PK Component|Stillbirth/Abortion|0|||
155320916|NCT03386578|560610731|FG009|PK Component|Stillbirth/Abortion|0|||
155320917|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320918|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320919|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
155320920|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
155320921|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320922|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320923|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320924|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
155320925|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
155320926|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
155320927|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320928|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320929|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
155320930|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
155320931|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320932|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320933|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320934|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
155320935|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
155320936|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
155320937|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Death|0|||
155320938|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Death|0|||
155320939|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Death|1|||
155320940|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Death|0|||
155320941|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Death|0|||
155320942|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Death|0|||
155320943|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Death|0|||
155320944|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Death|9|||
155320945|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Death|5|||
155320946|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Death|0|||
155320947|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320948|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320949|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320950|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
155320951|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320952|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320953|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320954|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320955|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
155320956|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
155320957|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320958|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320959|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320960|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320961|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320962|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320963|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320964|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
155320965|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
155320966|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
155320967|NCT03386578|560610722|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320968|NCT03386578|560610723|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320969|NCT03386578|560610724|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320970|NCT03386578|560610725|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320971|NCT03386578|560610726|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320972|NCT03386578|560610727|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320973|NCT03386578|560610728|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320974|NCT03386578|560610729|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
155320975|NCT03386578|560610730|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
155320976|NCT03386578|560610731|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
155320977|NCT02694822|560610734|FG000|Phase 1|Death|2|||
155320978|NCT02694822|560610735|FG001|Phase 1|Death|1|||
155320979|NCT02694822|560610736|FG002|Phase 1|Death|6|||
155320980|NCT02694822|560610737|FG003|Phase 1|Death|6|||
155320981|NCT02694822|560610738|FG004|Phase 1|Death|3|||
155320982|NCT02694822|560610739|FG005|Phase 1|Death|0|||
155320983|NCT02694822|560610734|FG000|Phase 1|Withdrawal by Subject|2|||
155320984|NCT02694822|560610735|FG001|Phase 1|Withdrawal by Subject|2|||
155320985|NCT02694822|560610736|FG002|Phase 1|Withdrawal by Subject|4|||
155320986|NCT02694822|560610737|FG003|Phase 1|Withdrawal by Subject|8|||
155320987|NCT02694822|560610738|FG004|Phase 1|Withdrawal by Subject|1|||
155320988|NCT02694822|560610739|FG005|Phase 1|Withdrawal by Subject|0|||
155320989|NCT02694822|560610734|FG000|Phase 2|Death|0|||
155320990|NCT02694822|560610735|FG001|Phase 2|Death|0|||
155320991|NCT02694822|560610736|FG002|Phase 2|Death|0|||
155320992|NCT02694822|560610737|FG003|Phase 2|Death|0|||
155320993|NCT02694822|560610738|FG004|Phase 2|Death|0|||
155320994|NCT02694822|560610739|FG005|Phase 2|Death|26|||
155320995|NCT02694822|560610734|FG000|Phase 2|Withdrawal by Subject|0|||
155320996|NCT02694822|560610735|FG001|Phase 2|Withdrawal by Subject|0|||
155320997|NCT02694822|560610736|FG002|Phase 2|Withdrawal by Subject|0|||
155320998|NCT02694822|560610737|FG003|Phase 2|Withdrawal by Subject|0|||
155320999|NCT02694822|560610738|FG004|Phase 2|Withdrawal by Subject|0|||
155321000|NCT02694822|560610739|FG005|Phase 2|Withdrawal by Subject|13|||
155321001|NCT02694822|560610734|FG000|Phase 2|Administrative Study Closure|0|||
155321002|NCT02694822|560610735|FG001|Phase 2|Administrative Study Closure|0|||
155321003|NCT02694822|560610736|FG002|Phase 2|Administrative Study Closure|0|||
155321004|NCT02694822|560610737|FG003|Phase 2|Administrative Study Closure|0|||
155321005|NCT02694822|560610738|FG004|Phase 2|Administrative Study Closure|0|||
155321006|NCT02694822|560610739|FG005|Phase 2|Administrative Study Closure|2|||
155321007|NCT02694822|560610734|FG000|Phase 2|Lost to Follow-up|0|||
155321008|NCT02694822|560610735|FG001|Phase 2|Lost to Follow-up|0|||
155321009|NCT02694822|560610736|FG002|Phase 2|Lost to Follow-up|0|||
155321010|NCT02694822|560610737|FG003|Phase 2|Lost to Follow-up|0|||
155321011|NCT02694822|560610738|FG004|Phase 2|Lost to Follow-up|0|||
155321012|NCT02694822|560610739|FG005|Phase 2|Lost to Follow-up|1|||
155321013|NCT02694822|560610734|FG000|Phase 2|Participant Transferred to Another Site|0|||
155321014|NCT02694822|560610735|FG001|Phase 2|Participant Transferred to Another Site|0|||
155321015|NCT02694822|560610736|FG002|Phase 2|Participant Transferred to Another Site|0|||
155321016|NCT02694822|560610737|FG003|Phase 2|Participant Transferred to Another Site|0|||
155321017|NCT02694822|560610738|FG004|Phase 2|Participant Transferred to Another Site|0|||
155321018|NCT02694822|560610739|FG005|Phase 2|Participant Transferred to Another Site|1|||
155321019|NCT01868997|560610740|FG000|Overall Study|Adverse Event|2|||
155321020|NCT01868997|560610741|FG001|Overall Study|Adverse Event|5|||
155321021|NCT01868997|560610740|FG000|Overall Study|Lack of Efficacy|2|||
155321022|NCT01868997|560610741|FG001|Overall Study|Lack of Efficacy|0|||
155321023|NCT01868997|560610740|FG000|Overall Study|Other|3|||
155321024|NCT01868997|560610741|FG001|Overall Study|Other|1|||
155321025|NCT05370040|560610742|FG000|Overall Study|Lost to Follow-up|0|||
155321026|NCT05370040|560610743|FG001|Overall Study|Lost to Follow-up|0|||
155321027|NCT05370040|560610744|FG002|Overall Study|Lost to Follow-up|1|||
155321028|NCT05370040|560610745|FG003|Overall Study|Lost to Follow-up|0|||
155321029|NCT05370040|560610746|FG004|Overall Study|Lost to Follow-up|1|||
155321030|NCT05370040|560610747|FG005|Overall Study|Lost to Follow-up|0|||
155321031|NCT04971109|560610748|FG000|Overall Study|Adverse Event|4|||
155321032|NCT04971109|560610749|FG001|Overall Study|Adverse Event|3|||
155321033|NCT04971109|560610748|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
155321034|NCT04971109|560610749|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
155321035|NCT04971109|560610748|FG000|Overall Study|Lost to Follow-up|8|||
155321036|NCT04971109|560610749|FG001|Overall Study|Lost to Follow-up|2|||
155321037|NCT04971109|560610748|FG000|Overall Study|Physician Decision|5|||
155321038|NCT04971109|560610749|FG001|Overall Study|Physician Decision|0|||
155321039|NCT04971109|560610748|FG000|Overall Study|Protocol Violation|0|||
155068518|NCT03126110|559681012|FG013|Phase 1|Safety follow-up no longer necessary|0|||
155068519|NCT03126110|559681013|FG014|Phase 1|Safety follow-up no longer necessary|0|||
155068520|NCT03126110|559681014|FG015|Phase 1|Safety follow-up no longer necessary|0|||
155068521|NCT03126110|559681015|FG016|Phase 1|Safety follow-up no longer necessary|0|||
155068522|NCT03126110|559680999|FG000|Phase 1|Survival follow-up no longer necessary|0|||
155068523|NCT03126110|559681000|FG001|Phase 1|Survival follow-up no longer necessary|0|||
155068524|NCT03126110|559681001|FG002|Phase 1|Survival follow-up no longer necessary|1|||
155068525|NCT03126110|559681002|FG003|Phase 1|Survival follow-up no longer necessary|0|||
155068526|NCT03126110|559681003|FG004|Phase 1|Survival follow-up no longer necessary|0|||
155068527|NCT03126110|559681004|FG005|Phase 1|Survival follow-up no longer necessary|0|||
155068528|NCT03126110|559681005|FG006|Phase 1|Survival follow-up no longer necessary|0|||
155068529|NCT03126110|559681006|FG007|Phase 1|Survival follow-up no longer necessary|0|||
155068530|NCT03126110|559681007|FG008|Phase 1|Survival follow-up no longer necessary|0|||
155068531|NCT03126110|559681008|FG009|Phase 1|Survival follow-up no longer necessary|0|||
155068532|NCT03126110|559681009|FG010|Phase 1|Survival follow-up no longer necessary|0|||
155068533|NCT03126110|559681010|FG011|Phase 1|Survival follow-up no longer necessary|0|||
155068534|NCT03126110|559681011|FG012|Phase 1|Survival follow-up no longer necessary|0|||
155068535|NCT03126110|559681012|FG013|Phase 1|Survival follow-up no longer necessary|0|||
155068536|NCT03126110|559681013|FG014|Phase 1|Survival follow-up no longer necessary|0|||
155068537|NCT03126110|559681014|FG015|Phase 1|Survival follow-up no longer necessary|0|||
155068538|NCT03126110|559681015|FG016|Phase 1|Survival follow-up no longer necessary|0|||
155068539|NCT03126110|559680999|FG000|Phase 2|Study terminated by the sponsor|0|||
155068540|NCT03126110|559681000|FG001|Phase 2|Study terminated by the sponsor|0|||
155068541|NCT03126110|559681001|FG002|Phase 2|Study terminated by the sponsor|0|||
155068542|NCT03126110|559681002|FG003|Phase 2|Study terminated by the sponsor|0|||
155068543|NCT03126110|559681003|FG004|Phase 2|Study terminated by the sponsor|0|||
155162578|NCT00998296|560031646|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
155162579|NCT00998296|560031647|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
155321040|NCT04971109|560610749|FG001|Overall Study|Protocol Violation|1|||
155321041|NCT04971109|560610748|FG000|Overall Study|Withdrawal by Subject|18|||
155321042|NCT04971109|560610749|FG001|Overall Study|Withdrawal by Subject|3|||
155321043|NCT04971109|560610748|FG000|Overall Study|Subject was randomized in error|1|||
155321044|NCT04971109|560610749|FG001|Overall Study|Subject was randomized in error|0|||
155321045|NCT04778397|560610752|FG000|Overall Study|Death|59|||
155321046|NCT04778397|560610753|FG001|Overall Study|Death|54|||
155321047|NCT04778397|560610754|FG002|Overall Study|Death|11|||
155321048|NCT04778397|560610755|FG003|Overall Study|Death|9|||
155321049|NCT04778397|560610752|FG000|Overall Study|Study Terminated by Sponsor|34|||
155321050|NCT04778397|560610753|FG001|Overall Study|Study Terminated by Sponsor|42|||
155321051|NCT04778397|560610754|FG002|Overall Study|Study Terminated by Sponsor|15|||
155321052|NCT04778397|560610755|FG003|Overall Study|Study Terminated by Sponsor|12|||
155321053|NCT04778397|560610752|FG000|Overall Study|Withdrew Consent|5|||
155321054|NCT04778397|560610753|FG001|Overall Study|Withdrew Consent|4|||
155321055|NCT04778397|560610754|FG002|Overall Study|Withdrew Consent|1|||
155068544|NCT03126110|559681004|FG005|Phase 2|Study terminated by the sponsor|0|||
155068545|NCT03126110|559681005|FG006|Phase 2|Study terminated by the sponsor|0|||
155068546|NCT03126110|559681006|FG007|Phase 2|Study terminated by the sponsor|0|||
155068547|NCT03126110|559681007|FG008|Phase 2|Study terminated by the sponsor|0|||
155068548|NCT03126110|559681008|FG009|Phase 2|Study terminated by the sponsor|0|||
155321056|NCT04778397|560610755|FG003|Overall Study|Withdrew Consent|1|||
155321057|NCT04778397|560610752|FG000|Overall Study|Reason Not Specified|1|||
155321058|NCT04778397|560610753|FG001|Overall Study|Reason Not Specified|3|||
155321059|NCT04778397|560610754|FG002|Overall Study|Reason Not Specified|0|||
155321060|NCT04778397|560610755|FG003|Overall Study|Reason Not Specified|2|||
155321061|NCT04778397|560610752|FG000|Overall Study|Lost to Follow-up|2|||
155321062|NCT04778397|560610753|FG001|Overall Study|Lost to Follow-up|1|||
155321063|NCT04778397|560610754|FG002|Overall Study|Lost to Follow-up|0|||
155321064|NCT04778397|560610755|FG003|Overall Study|Lost to Follow-up|1|||
155321065|NCT05906784|560610757|FG000|Overall Study|Lost to Follow-up|2|||
155321066|NCT05906784|560610758|FG001|Overall Study|Lost to Follow-up|1|||
155321067|NCT05906784|560610759|FG002|Overall Study|Lost to Follow-up|1|||
155321068|NCT05906784|560610760|FG003|Overall Study|Lost to Follow-up|1|||
155321069|NCT04730739|560610764|FG000|Overall Study|Death|1|||
155321070|NCT03308877|560610765|FG000|Overall Study|Lost to Follow-up|32|||
155321071|NCT03308877|560610766|FG001|Overall Study|Lost to Follow-up|28|||
155321072|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321073|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321074|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321075|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
155321076|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
155321077|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321078|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
155321079|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
155321080|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
155321081|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
155321082|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
155321083|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
155321084|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
155321085|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
155321086|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
155321087|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
155321088|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321089|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321090|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321091|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321092|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321093|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
155321094|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
155321095|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
155321096|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321097|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321098|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321099|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321100|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321101|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321102|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
155321103|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
155321104|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
155321105|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
155321106|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
155321107|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
155321108|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
155321109|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
155321110|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
155321111|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
155321112|NCT02315703|560610773|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
155321113|NCT02315703|560610774|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
155321114|NCT02315703|560610775|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
155321115|NCT02315703|560610776|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
155321116|NCT02315703|560610777|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
155321117|NCT02315703|560610778|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
155321118|NCT02315703|560610779|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
155321119|NCT02315703|560610780|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
155321120|NCT02315703|560610773|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
155321121|NCT02315703|560610774|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
155321122|NCT02315703|560610775|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321123|NCT02315703|560610776|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321124|NCT02315703|560610777|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321125|NCT02315703|560610778|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321126|NCT02315703|560610779|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321127|NCT02315703|560610780|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
155321128|NCT02315703|560610773|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321129|NCT02315703|560610774|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
155321130|NCT02315703|560610775|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321131|NCT02315703|560610776|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321132|NCT02315703|560610777|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321133|NCT02315703|560610778|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321134|NCT02315703|560610779|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321135|NCT02315703|560610780|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
155321136|NCT02315703|560610773|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
155321137|NCT02315703|560610774|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
155321138|NCT02315703|560610775|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
155321139|NCT02315703|560610776|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
155321140|NCT02315703|560610777|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
155321141|NCT02315703|560610778|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
155321142|NCT02315703|560610779|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
155321143|NCT02315703|560610780|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
155321144|NCT03625115|560610781|FG000|Overall Study|Withdrawal by Subject|4|||
155321145|NCT03625115|560610782|FG001|Overall Study|Withdrawal by Subject|7|||
155321146|NCT03625115|560610781|FG000|Overall Study|Lost to Follow-up|17|||
155321147|NCT03625115|560610782|FG001|Overall Study|Lost to Follow-up|24|||
155321148|NCT04197336|560610783|FG000|Overall Study|Withdrawal by Subject|1|||
155321149|NCT03852550|560610793|FG000|Overall Study|Lost to Follow-up|4|||
155321150|NCT03852550|560610794|FG001|Overall Study|Lost to Follow-up|3|||
155321151|NCT03852550|560610793|FG000|Overall Study|Only parent outcomes completed|0|||
155321152|NCT03852550|560610794|FG001|Overall Study|Only parent outcomes completed|1|||
155321153|NCT03852550|560610793|FG000|Overall Study|Withdrawal by Subject|1|||
155321154|NCT03852550|560610794|FG001|Overall Study|Withdrawal by Subject|0|||
155321155|NCT05204654|560610795|FG000|Overall Study|Study terminated due to time restraint|2|||
155321156|NCT05204654|560610796|FG001|Overall Study|Study terminated due to time restraint|2|||
155321157|NCT01221948|560610797|FG000|Overall Study|Physician Decision|5|||
155321158|NCT01221948|560610797|FG000|Overall Study|Withdrawal by Subject|2|||
155321159|NCT01221948|560610797|FG000|Overall Study|not disclosed|2|||
155321160|NCT01221948|560610797|FG000|Overall Study|Death|1|||
155321161|NCT01221948|560610797|FG000|Overall Study|Protocol Violation|4|||
155321162|NCT03756662|560610798|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
155321163|NCT03626220|560610799|FG000|Overall Study|Withdrawal by Subject|2|||
155321164|NCT03626220|560610800|FG001|Overall Study|Withdrawal by Subject|0|||
155321165|NCT05565820|560610807|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
155321166|NCT05565820|560610808|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
155321167|NCT05565820|560610807|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
155321168|NCT05565820|560610808|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
155321169|NCT05828017|560610809|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
155321170|NCT05012163|560610813|FG000|Overall Study|Protocol Violation|0|||
155321171|NCT05012163|560610814|FG001|Overall Study|Protocol Violation|0|||
155321172|NCT05012163|560610815|FG002|Overall Study|Protocol Violation|1|||
155321173|NCT05012163|560610816|FG003|Overall Study|Protocol Violation|1|||
155321174|NCT04132518|560610817|FG000|Overall Study|Prematurely withdrawn from the study|0|||
155321175|NCT04132518|560610818|FG001|Overall Study|Prematurely withdrawn from the study|9|||
155321176|NCT04132518|560610819|FG002|Overall Study|Prematurely withdrawn from the study|1|||
155321177|NCT05425420|560610821|FG000|Overall Study|Physician Decision|1|||
155321178|NCT05425420|560610821|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
155321179|NCT03673501|560610822|FG000|Overall Study|Participants ongoing.|36|||
155321180|NCT03673501|560610823|FG001|Overall Study|Participants ongoing.|24|||
155321181|NCT04599634|560610824|FG000|Overall Study|Dose limiting toxicity|0|||
155321182|NCT04599634|560610825|FG001|Overall Study|Dose limiting toxicity|0|||
155321183|NCT04599634|560610826|FG002|Overall Study|Dose limiting toxicity|2|||
155321184|NCT04599634|560610827|FG003|Overall Study|Dose limiting toxicity|0|||
155321185|NCT03714815|560610828|FG000|Overall Study|Physician Decision|2|||
155321186|NCT03714815|560610828|FG000|Overall Study|Withdrawal by Subject|2|||
155321187|NCT03714815|560610828|FG000|Overall Study|Death|11|||
155321188|NCT03733925|560610831|FG000|Overall Study|Lost to Follow-up|1|||
155321189|NCT03733925|560610831|FG000|Overall Study|Withdrawal by Subject|2|||
155321190|NCT03733925|560610831|FG000|Overall Study|Adverse Event|2|||
155321191|NCT03733925|560610831|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155321192|NCT02631746|560610837|FG000|Overall Study|Lack of Efficacy|3|||
155321193|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
155321194|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
155321195|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
155321196|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
155321197|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
155321198|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
155321199|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
155321200|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
155321201|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
155321202|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
155321203|NCT02361216|560610838|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
155321204|NCT02361216|560610839|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
155321205|NCT00323856|560610840|FG000|Overall Study|Withdrawal by Subject|1|||
155321206|NCT00323856|560610840|FG000|Overall Study|Was uncooperative and noncompliant|1|||
155321207|NCT00323856|560610840|FG000|Overall Study|Reason not specified|1|||
155321208|NCT00323856|560610840|FG000|Overall Study|Missing|2|||
155321209|NCT04086121|560610841|FG000|Overall Study|Other than listed|8|||
155321210|NCT04086121|560610841|FG000|Overall Study|Withdrawal by Subject|3|||
155321211|NCT04086121|560610841|FG000|Overall Study|Lost to Follow-up|2|||
155321212|NCT04086121|560610841|FG000|Overall Study|Adverse Event|1|||
155321213|NCT04167553|560610846|FG000|Overall Study|Withdrawal by Subject|1|||
155321214|NCT04167553|560610847|FG001|Overall Study|Withdrawal by Subject|0|||
154960846|NCT02057835|559282136|FG007|Overall Study|Withdrawal by Subject|0|||
154960847|NCT02057835|559282137|FG008|Overall Study|Withdrawal by Subject|0|||
154960848|NCT02057835|559282138|FG009|Overall Study|Withdrawal by Subject|0|||
154966782|NCT00902538|559301138|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
155068549|NCT03126110|559681009|FG010|Phase 2|Study terminated by the sponsor|0|||
155068550|NCT03126110|559681010|FG011|Phase 2|Study terminated by the sponsor|0|||
155068551|NCT03126110|559681011|FG012|Phase 2|Study terminated by the sponsor|0|||
155068552|NCT03126110|559681012|FG013|Phase 2|Study terminated by the sponsor|4|||
155068553|NCT03126110|559681013|FG014|Phase 2|Study terminated by the sponsor|0|||
155068554|NCT03126110|559681014|FG015|Phase 2|Study terminated by the sponsor|0|||
155068555|NCT03126110|559681015|FG016|Phase 2|Study terminated by the sponsor|0|||
155068556|NCT03126110|559680999|FG000|Phase 2|Withdrawal by Subject|0|||
155068557|NCT03126110|559681000|FG001|Phase 2|Withdrawal by Subject|0|||
155162580|NCT00998296|560031637|FG000|Overall Study|Other adverse event|0|||
155162581|NCT00998296|560031638|FG001|Overall Study|Other adverse event|0|||
155162582|NCT00998296|560031639|FG002|Overall Study|Other adverse event|0|||
155162583|NCT00998296|560031640|FG003|Overall Study|Other adverse event|0|||
155162584|NCT00998296|560031641|FG004|Overall Study|Other adverse event|1|||
155162585|NCT00998296|560031642|FG005|Overall Study|Other adverse event|0|||
155162586|NCT00998296|560031643|FG006|Overall Study|Other adverse event|0|||
155162587|NCT00998296|560031644|FG007|Overall Study|Other adverse event|0|||
154960849|NCT02875392|559282139|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
155162588|NCT00998296|560031645|FG008|Overall Study|Other adverse event|0|||
155162589|NCT00998296|560031646|FG009|Overall Study|Other adverse event|1|||
155162590|NCT00998296|560031647|FG010|Overall Study|Other adverse event|2|||
154960850|NCT02875392|559282140|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
154960851|NCT00834717|559282146|FG000|First Intervention|Adverse Event|1|||
154960852|NCT00834717|559282147|FG001|First Intervention|Adverse Event|0|||
154960853|NCT00834717|559282146|FG000|First Intervention|Withdrawal by Subject|0|||
154960854|NCT00834717|559282147|FG001|First Intervention|Withdrawal by Subject|1|||
154960855|NCT02222818|559282148|FG000|Period 1|Eligibility criteria not met|0|||
154960856|NCT02222818|559282149|FG001|Period 1|Eligibility criteria not met|3|||
154960857|NCT01660243|559282150|FG000|Overall Study|Adverse Event|1|||
154960858|NCT01660243|559282151|FG001|Overall Study|Adverse Event|0|||
155321215|NCT04167553|560610848|FG002|Overall Study|Withdrawal by Subject|1|||
155321216|NCT04167553|560610849|FG003|Overall Study|Withdrawal by Subject|2|||
155321217|NCT04167553|560610850|FG004|Overall Study|Withdrawal by Subject|1|||
155321218|NCT04167553|560610851|FG005|Overall Study|Withdrawal by Subject|0|||
155321219|NCT04167553|560610852|FG006|Overall Study|Withdrawal by Subject|0|||
155321220|NCT04167553|560610846|FG000|Overall Study|Physician Decision|0|||
155321221|NCT04167553|560610847|FG001|Overall Study|Physician Decision|0|||
155321222|NCT04167553|560610848|FG002|Overall Study|Physician Decision|0|||
155321223|NCT04167553|560610849|FG003|Overall Study|Physician Decision|0|||
155321224|NCT04167553|560610850|FG004|Overall Study|Physician Decision|2|||
155321225|NCT04167553|560610851|FG005|Overall Study|Physician Decision|2|||
155321226|NCT04167553|560610852|FG006|Overall Study|Physician Decision|0|||
155321227|NCT04167553|560610846|FG000|Overall Study|Lost to Follow-up|0|||
155321228|NCT04167553|560610847|FG001|Overall Study|Lost to Follow-up|0|||
155321229|NCT04167553|560610848|FG002|Overall Study|Lost to Follow-up|2|||
155321230|NCT04167553|560610849|FG003|Overall Study|Lost to Follow-up|0|||
155321231|NCT04167553|560610850|FG004|Overall Study|Lost to Follow-up|0|||
155321232|NCT04167553|560610851|FG005|Overall Study|Lost to Follow-up|0|||
154960859|NCT01660243|559282152|FG002|Overall Study|Adverse Event|1|||
155321233|NCT04167553|560610852|FG006|Overall Study|Lost to Follow-up|0|||
155321234|NCT02828358|560610853|FG000|Overall Study|Physician Decision|7|||
155321235|NCT02828358|560610854|FG001|Overall Study|Physician Decision|1|||
155321236|NCT02828358|560610853|FG000|Overall Study|Treatment Failure|6|||
155321237|NCT02828358|560610854|FG001|Overall Study|Treatment Failure|0|||
155321238|NCT02828358|560610853|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
155321239|NCT02828358|560610854|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
155321240|NCT02828358|560610853|FG000|Overall Study|Refusal of further protocol therapy|2|||
155321241|NCT02828358|560610854|FG001|Overall Study|Refusal of further protocol therapy|0|||
155321242|NCT02828358|560610853|FG000|Overall Study|Relapse|25|||
155321243|NCT02828358|560610854|FG001|Overall Study|Relapse|0|||
155321244|NCT02828358|560610853|FG000|Overall Study|Still on therapy|5|||
155321245|NCT02828358|560610854|FG001|Overall Study|Still on therapy|0|||
155321246|NCT05285137|560610867|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
154960860|NCT01660243|559282153|FG003|Overall Study|Adverse Event|0|||
155321247|NCT05285137|560610868|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155321248|NCT05285137|560610869|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
155321249|NCT05285137|560610870|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
154960861|NCT01660243|559282150|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
154960862|NCT01660243|559282151|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
154960863|NCT01660243|559282152|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
155321250|NCT05285137|560610871|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
155321251|NCT05285137|560610872|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
155321252|NCT05285137|560610873|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
155321253|NCT05285137|560610874|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
155321254|NCT05285137|560610875|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
155321255|NCT05285137|560610867|FG000|Overall Study|Lost to Follow-up|0|||
155321256|NCT05285137|560610868|FG001|Overall Study|Lost to Follow-up|0|||
155321257|NCT05285137|560610869|FG002|Overall Study|Lost to Follow-up|1|||
155321258|NCT05285137|560610870|FG003|Overall Study|Lost to Follow-up|3|||
155321259|NCT05285137|560610871|FG004|Overall Study|Lost to Follow-up|0|||
155321260|NCT05285137|560610872|FG005|Overall Study|Lost to Follow-up|0|||
155321261|NCT05285137|560610873|FG006|Overall Study|Lost to Follow-up|1|||
155321262|NCT05285137|560610874|FG007|Overall Study|Lost to Follow-up|0|||
155321263|NCT05285137|560610875|FG008|Overall Study|Lost to Follow-up|0|||
155321264|NCT05285137|560610867|FG000|Overall Study|Physician Decision|0|||
155321265|NCT05285137|560610868|FG001|Overall Study|Physician Decision|1|||
155321266|NCT05285137|560610869|FG002|Overall Study|Physician Decision|0|||
155321267|NCT05285137|560610870|FG003|Overall Study|Physician Decision|0|||
155321268|NCT05285137|560610871|FG004|Overall Study|Physician Decision|0|||
155321269|NCT05285137|560610872|FG005|Overall Study|Physician Decision|0|||
155321270|NCT05285137|560610873|FG006|Overall Study|Physician Decision|0|||
155321271|NCT05285137|560610874|FG007|Overall Study|Physician Decision|0|||
155321272|NCT05285137|560610875|FG008|Overall Study|Physician Decision|0|||
155321273|NCT05285137|560610867|FG000|Overall Study|Pregnancy|0|||
155321274|NCT05285137|560610868|FG001|Overall Study|Pregnancy|0|||
155321275|NCT05285137|560610869|FG002|Overall Study|Pregnancy|0|||
155321276|NCT05285137|560610870|FG003|Overall Study|Pregnancy|0|||
155321277|NCT05285137|560610871|FG004|Overall Study|Pregnancy|0|||
155321278|NCT05285137|560610872|FG005|Overall Study|Pregnancy|0|||
155321279|NCT05285137|560610873|FG006|Overall Study|Pregnancy|1|||
155321280|NCT05285137|560610874|FG007|Overall Study|Pregnancy|0|||
155321281|NCT05285137|560610875|FG008|Overall Study|Pregnancy|0|||
155321282|NCT05285137|560610867|FG000|Overall Study|Withdrawal by Subject|0|||
154960864|NCT01660243|559282153|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
154960865|NCT01660243|559282150|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
154960866|NCT01660243|559282151|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
154960867|NCT01660243|559282152|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
154966783|NCT00902538|559301139|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
155321283|NCT05285137|560610868|FG001|Overall Study|Withdrawal by Subject|1|||
155321284|NCT05285137|560610869|FG002|Overall Study|Withdrawal by Subject|2|||
155321285|NCT05285137|560610870|FG003|Overall Study|Withdrawal by Subject|1|||
155321286|NCT05285137|560610871|FG004|Overall Study|Withdrawal by Subject|0|||
155321287|NCT05285137|560610872|FG005|Overall Study|Withdrawal by Subject|0|||
155321288|NCT05285137|560610873|FG006|Overall Study|Withdrawal by Subject|0|||
155321289|NCT05285137|560610874|FG007|Overall Study|Withdrawal by Subject|0|||
155321290|NCT05285137|560610875|FG008|Overall Study|Withdrawal by Subject|1|||
155321291|NCT04479761|560610876|FG000|Overall Study|could not perform the balance tasks|1|||
155321292|NCT04479761|560610877|FG001|Overall Study|could not perform the balance tasks|0|||
155321293|NCT04479761|560610878|FG002|Overall Study|could not perform the balance tasks|0|||
155321294|NCT04479761|560610876|FG000|Overall Study|Adverse Event|1|||
155321295|NCT04479761|560610877|FG001|Overall Study|Adverse Event|0|||
155321296|NCT04479761|560610878|FG002|Overall Study|Adverse Event|0|||
155321297|NCT04479761|560610876|FG000|Overall Study|one control did not meet screening criteria|0|||
155321298|NCT04479761|560610877|FG001|Overall Study|one control did not meet screening criteria|0|||
155321299|NCT04479761|560610878|FG002|Overall Study|one control did not meet screening criteria|1|||
155321300|NCT04479761|560610876|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
155321301|NCT04479761|560610877|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
155321302|NCT04479761|560610878|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
155321303|NCT05809453|560612268|FG000|Overall Study|Withdrawal by Subject|1|||
155321304|NCT05809453|560612269|FG001|Overall Study|Withdrawal by Subject|0|||
155321305|NCT05809453|560612270|FG002|Overall Study|Withdrawal by Subject|0|||
155321306|NCT05809453|560612271|FG003|Overall Study|Withdrawal by Subject|0|||
155321307|NCT04183283|560612273|FG000|Period 1|Withdrawal by Subject|0|||
155321308|NCT04183283|560612274|FG001|Period 1|Withdrawal by Subject|1|||
155321309|NCT04183283|560612275|FG002|Period 1|Withdrawal by Subject|0|||
155321310|NCT04183283|560612276|FG003|Period 1|Withdrawal by Subject|0|||
155321311|NCT04183283|560612273|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
155321312|NCT04183283|560612274|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
155321313|NCT04183283|560612275|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
155321314|NCT04183283|560612276|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
155321315|NCT04909801|560612278|FG000|Overall Study|Lack of Efficacy|2|||
155321316|NCT04909801|560612279|FG001|Overall Study|Lack of Efficacy|1|||
155321317|NCT04909801|560612278|FG000|Overall Study|Adverse Event|1|||
155321318|NCT04909801|560612279|FG001|Overall Study|Adverse Event|2|||
155321319|NCT04909801|560612278|FG000|Overall Study|Participant request to discontinue study treatment|1|||
155321320|NCT04909801|560612279|FG001|Overall Study|Participant request to discontinue study treatment|2|||
155321321|NCT04909801|560612278|FG000|Overall Study|Withdrawal by Subject|2|||
155321322|NCT04909801|560612279|FG001|Overall Study|Withdrawal by Subject|1|||
155321323|NCT04909801|560612278|FG000|Overall Study|other reasons|1|||
155321324|NCT04909801|560612279|FG001|Overall Study|other reasons|1|||
155321325|NCT04447040|560612280|FG000|Overall Study|Lost to Follow-up|2|||
155321326|NCT04447040|560612281|FG001|Overall Study|Lost to Follow-up|1|||
155321327|NCT04447040|560612282|FG002|Overall Study|Lost to Follow-up|3|||
155321328|NCT04447040|560612283|FG003|Overall Study|Lost to Follow-up|3|||
155321329|NCT04447040|560612284|FG004|Overall Study|Lost to Follow-up|1|||
155321330|NCT04447040|560612285|FG005|Overall Study|Lost to Follow-up|3|||
155321331|NCT04447040|560612280|FG000|Overall Study|Withdrawal by Subject|0|||
155321332|NCT04447040|560612281|FG001|Overall Study|Withdrawal by Subject|1|||
155321333|NCT04447040|560612282|FG002|Overall Study|Withdrawal by Subject|1|||
155321334|NCT04447040|560612283|FG003|Overall Study|Withdrawal by Subject|1|||
155321335|NCT04447040|560612284|FG004|Overall Study|Withdrawal by Subject|0|||
155321336|NCT04447040|560612285|FG005|Overall Study|Withdrawal by Subject|0|||
155321337|NCT01208662|560612286|FG000|Induction and Consolidation|Disease Progression|23|||
155321338|NCT01208662|560612287|FG001|Induction and Consolidation|Disease Progression|13|||
155321339|NCT01208662|560612288|FG002|Induction and Consolidation|Disease Progression|0|||
155321340|NCT01208662|560612286|FG000|Induction and Consolidation|Adverse Event|16|||
155321341|NCT01208662|560612287|FG001|Induction and Consolidation|Adverse Event|18|||
155321342|NCT01208662|560612288|FG002|Induction and Consolidation|Adverse Event|2|||
155321343|NCT01208662|560612286|FG000|Induction and Consolidation|MD or Participant Decision|16|||
155321344|NCT01208662|560612287|FG001|Induction and Consolidation|MD or Participant Decision|34|||
155321345|NCT01208662|560612288|FG002|Induction and Consolidation|MD or Participant Decision|4|||
155321346|NCT01208662|560612286|FG000|Induction and Consolidation|Death|1|||
155321347|NCT01208662|560612287|FG001|Induction and Consolidation|Death|3|||
155321348|NCT01208662|560612288|FG002|Induction and Consolidation|Death|1|||
155321349|NCT01208662|560612286|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
155321350|NCT01208662|560612287|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
155321351|NCT01208662|560612288|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
155321352|NCT01208662|560612286|FG000|Maintenance|Disease Progression|156|||
155321353|NCT01208662|560612287|FG001|Maintenance|Disease Progression|102|||
155321354|NCT01208662|560612288|FG002|Maintenance|Disease Progression|0|||
155321355|NCT01208662|560612286|FG000|Maintenance|Adverse Event|12|||
155321356|NCT01208662|560612287|FG001|Maintenance|Adverse Event|28|||
155321357|NCT01208662|560612288|FG002|Maintenance|Adverse Event|0|||
155321358|NCT01208662|560612286|FG000|Maintenance|MD or Participant Decision|24|||
155068558|NCT03126110|559681001|FG002|Phase 2|Withdrawal by Subject|0|||
155321359|NCT01208662|560612287|FG001|Maintenance|MD or Participant Decision|36|||
155068559|NCT03126110|559681002|FG003|Phase 2|Withdrawal by Subject|0|||
155321360|NCT01208662|560612288|FG002|Maintenance|MD or Participant Decision|0|||
155321361|NCT01208662|560612286|FG000|Maintenance|Death|0|||
155321362|NCT01208662|560612287|FG001|Maintenance|Death|3|||
155321363|NCT01208662|560612288|FG002|Maintenance|Death|0|||
155321364|NCT01208662|560612286|FG000|Maintenance|Discontinued for other reasons|21|||
155321365|NCT01208662|560612287|FG001|Maintenance|Discontinued for other reasons|31|||
155321366|NCT01208662|560612288|FG002|Maintenance|Discontinued for other reasons|0|||
155321367|NCT01208662|560612286|FG000|Maintenance|Still on Treatment|78|||
155321368|NCT01208662|560612287|FG001|Maintenance|Still on Treatment|89|||
155321369|NCT01208662|560612288|FG002|Maintenance|Still on Treatment|0|||
155321370|NCT05147116|560612291|FG000|Overall Study|Withdrawal by Subject|0|||
155321371|NCT05147116|560612292|FG001|Overall Study|Withdrawal by Subject|1|||
155321372|NCT04101357|560612293|FG000|Overall Study|Death|1|||
155321373|NCT04101357|560612294|FG001|Overall Study|Death|1|||
155321374|NCT04101357|560612295|FG002|Overall Study|Death|1|||
155321375|NCT04101357|560612296|FG003|Overall Study|Death|2|||
155321376|NCT04101357|560612297|FG004|Overall Study|Death|4|||
155321377|NCT04101357|560612298|FG005|Overall Study|Death|11|||
155321378|NCT04101357|560612299|FG006|Overall Study|Death|4|||
155321379|NCT04101357|560612300|FG007|Overall Study|Death|4|||
155321380|NCT04101357|560612301|FG008|Overall Study|Death|5|||
155321381|NCT04101357|560612302|FG009|Overall Study|Death|2|||
155321382|NCT04101357|560612303|FG010|Overall Study|Death|3|||
155321383|NCT04101357|560612293|FG000|Overall Study|Trial closure|0|||
155321384|NCT04101357|560612294|FG001|Overall Study|Trial closure|0|||
155321385|NCT04101357|560612295|FG002|Overall Study|Trial closure|0|||
155321386|NCT04101357|560612296|FG003|Overall Study|Trial closure|0|||
155321387|NCT04101357|560612297|FG004|Overall Study|Trial closure|0|||
155321388|NCT04101357|560612298|FG005|Overall Study|Trial closure|2|||
155321389|NCT04101357|560612299|FG006|Overall Study|Trial closure|2|||
155321390|NCT04101357|560612300|FG007|Overall Study|Trial closure|0|||
155321391|NCT04101357|560612301|FG008|Overall Study|Trial closure|0|||
155321392|NCT04101357|560612302|FG009|Overall Study|Trial closure|0|||
155321393|NCT04101357|560612303|FG010|Overall Study|Trial closure|1|||
155321394|NCT04101357|560612293|FG000|Overall Study|Lost to Follow-up|0|||
155321395|NCT04101357|560612294|FG001|Overall Study|Lost to Follow-up|0|||
155321396|NCT04101357|560612295|FG002|Overall Study|Lost to Follow-up|0|||
155321397|NCT04101357|560612296|FG003|Overall Study|Lost to Follow-up|1|||
155321398|NCT04101357|560612297|FG004|Overall Study|Lost to Follow-up|0|||
155321399|NCT04101357|560612298|FG005|Overall Study|Lost to Follow-up|0|||
155321400|NCT04101357|560612299|FG006|Overall Study|Lost to Follow-up|0|||
155321401|NCT04101357|560612300|FG007|Overall Study|Lost to Follow-up|1|||
155321402|NCT04101357|560612301|FG008|Overall Study|Lost to Follow-up|0|||
155321403|NCT04101357|560612302|FG009|Overall Study|Lost to Follow-up|0|||
155321404|NCT04101357|560612303|FG010|Overall Study|Lost to Follow-up|0|||
155321405|NCT04101357|560612293|FG000|Overall Study|Withdrawal by Subject|1|||
155321406|NCT04101357|560612294|FG001|Overall Study|Withdrawal by Subject|0|||
155321407|NCT04101357|560612295|FG002|Overall Study|Withdrawal by Subject|0|||
155321408|NCT04101357|560612296|FG003|Overall Study|Withdrawal by Subject|0|||
155321409|NCT04101357|560612297|FG004|Overall Study|Withdrawal by Subject|0|||
155321410|NCT04101357|560612298|FG005|Overall Study|Withdrawal by Subject|0|||
155321411|NCT04101357|560612299|FG006|Overall Study|Withdrawal by Subject|0|||
155321412|NCT04101357|560612300|FG007|Overall Study|Withdrawal by Subject|0|||
155321413|NCT04101357|560612301|FG008|Overall Study|Withdrawal by Subject|1|||
155321414|NCT04101357|560612302|FG009|Overall Study|Withdrawal by Subject|1|||
155321415|NCT04101357|560612303|FG010|Overall Study|Withdrawal by Subject|0|||
155321416|NCT04101357|560612293|FG000|Overall Study|Other|0|||
155321417|NCT04101357|560612294|FG001|Overall Study|Other|0|||
155321418|NCT04101357|560612295|FG002|Overall Study|Other|0|||
155321419|NCT04101357|560612296|FG003|Overall Study|Other|0|||
155321420|NCT04101357|560612297|FG004|Overall Study|Other|0|||
155321421|NCT04101357|560612298|FG005|Overall Study|Other|1|||
155321422|NCT04101357|560612299|FG006|Overall Study|Other|2|||
155321423|NCT04101357|560612300|FG007|Overall Study|Other|1|||
155321424|NCT04101357|560612301|FG008|Overall Study|Other|0|||
155321425|NCT04101357|560612302|FG009|Overall Study|Other|0|||
155321426|NCT04101357|560612303|FG010|Overall Study|Other|0|||
155321427|NCT04101357|560612293|FG000|Overall Study|Enrolled but not treated|0|||
155321428|NCT04101357|560612294|FG001|Overall Study|Enrolled but not treated|0|||
155321429|NCT04101357|560612295|FG002|Overall Study|Enrolled but not treated|0|||
155321430|NCT04101357|560612296|FG003|Overall Study|Enrolled but not treated|0|||
155321431|NCT04101357|560612297|FG004|Overall Study|Enrolled but not treated|0|||
155321432|NCT04101357|560612298|FG005|Overall Study|Enrolled but not treated|1|||
155321433|NCT04101357|560612299|FG006|Overall Study|Enrolled but not treated|1|||
155321434|NCT04101357|560612300|FG007|Overall Study|Enrolled but not treated|0|||
155321435|NCT04101357|560612301|FG008|Overall Study|Enrolled but not treated|0|||
155321436|NCT04101357|560612302|FG009|Overall Study|Enrolled but not treated|0|||
155321437|NCT04101357|560612303|FG010|Overall Study|Enrolled but not treated|0|||
155321438|NCT03655028|560612304|FG000|12-weeks Follow up|Death|1|||
155321439|NCT03655028|560612305|FG001|12-weeks Follow up|Death|0|||
155162591|NCT00998296|560031637|FG000|Overall Study|Refused to continue taking trial med.|0|||
155162592|NCT00998296|560031638|FG001|Overall Study|Refused to continue taking trial med.|0|||
155162593|NCT00998296|560031639|FG002|Overall Study|Refused to continue taking trial med.|0|||
155162594|NCT00998296|560031640|FG003|Overall Study|Refused to continue taking trial med.|0|||
155162595|NCT00998296|560031641|FG004|Overall Study|Refused to continue taking trial med.|0|||
155162596|NCT00998296|560031642|FG005|Overall Study|Refused to continue taking trial med.|0|||
155162597|NCT00998296|560031643|FG006|Overall Study|Refused to continue taking trial med.|0|||
155162598|NCT00998296|560031644|FG007|Overall Study|Refused to continue taking trial med.|0|||
155162599|NCT00998296|560031645|FG008|Overall Study|Refused to continue taking trial med.|0|||
155162600|NCT00998296|560031646|FG009|Overall Study|Refused to continue taking trial med.|2|||
155162601|NCT00998296|560031647|FG010|Overall Study|Refused to continue taking trial med.|0|||
155162602|NCT00998296|560031637|FG000|Overall Study|Reason other than those specified above|0|||
155162603|NCT00998296|560031638|FG001|Overall Study|Reason other than those specified above|0|||
155162604|NCT00998296|560031639|FG002|Overall Study|Reason other than those specified above|0|||
155162605|NCT00998296|560031640|FG003|Overall Study|Reason other than those specified above|0|||
155162606|NCT00998296|560031641|FG004|Overall Study|Reason other than those specified above|0|||
155162607|NCT00998296|560031642|FG005|Overall Study|Reason other than those specified above|0|||
155162608|NCT00998296|560031643|FG006|Overall Study|Reason other than those specified above|0|||
155162609|NCT00998296|560031644|FG007|Overall Study|Reason other than those specified above|0|||
155162610|NCT00998296|560031645|FG008|Overall Study|Reason other than those specified above|0|||
155162611|NCT00998296|560031646|FG009|Overall Study|Reason other than those specified above|1|||
155162612|NCT00998296|560031647|FG010|Overall Study|Reason other than those specified above|0|||
155162613|NCT04396639|560031648|FG000|Overall Study|Withdrawal by Subject|1|||
155162614|NCT04396639|560031648|FG000|Overall Study|Other|1|||
155162615|NCT01544335|560031649|FG000|Overall Study|Lost to Follow-up|27|||
155162616|NCT01544335|560031649|FG000|Overall Study|Death|4|||
155162617|NCT01544335|560031649|FG000|Overall Study|Disease progression|3|||
155162618|NCT01544335|560031649|FG000|Overall Study|Baseline Measurements not Available|19|||
155162619|NCT03198507|560031650|FG000|Overall Study|Withdrawal by Subject|1|||
155162620|NCT03198507|560031651|FG001|Overall Study|Withdrawal by Subject|0|||
155162621|NCT03809104|560031658|FG000|Overall Study|Withdrawal by Subject|3|||
155162622|NCT00241839|560031659|FG000|Overall Study|Withdrawal by Subject|18|||
155162623|NCT00241839|560031660|FG001|Overall Study|Withdrawal by Subject|17|||
155162624|NCT00241839|560031659|FG000|Overall Study|Adverse Event|1|||
155162625|NCT00241839|560031660|FG001|Overall Study|Adverse Event|1|||
155162626|NCT05021978|560031661|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
155162627|NCT05021978|560031662|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
155162628|NCT05021978|560031663|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
155162629|NCT05021978|560031664|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
155162630|NCT05021978|560031661|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
155162631|NCT05021978|560031662|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
155162632|NCT05021978|560031663|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
155162633|NCT05021978|560031664|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
155162634|NCT00196313|560031665|FG000|Overall Study|Protocol Violation|2|||
155162635|NCT00196313|560031666|FG001|Overall Study|Protocol Violation|3|||
155162636|NCT00196313|560031665|FG000|Overall Study|Withdrawal by Subject|3|||
155162637|NCT00196313|560031666|FG001|Overall Study|Withdrawal by Subject|1|||
155162638|NCT00196313|560031665|FG000|Overall Study|Adverse Event|3|||
155162639|NCT00196313|560031666|FG001|Overall Study|Adverse Event|1|||
155162640|NCT00196313|560031665|FG000|Overall Study|Subject Pregnant|1|||
155162641|NCT00196313|560031666|FG001|Overall Study|Subject Pregnant|1|||
155162642|NCT00196313|560031665|FG000|Overall Study|Lost to Follow-up|2|||
155162643|NCT00196313|560031666|FG001|Overall Study|Lost to Follow-up|2|||
155162644|NCT00043979|560031667|FG000|Period 1|recipient with progressive disease|7|||
155162645|NCT00043979|560031668|FG001|Period 1|recipient with progressive disease|4|||
155162646|NCT00043979|560031669|FG002|Period 1|recipient with progressive disease|3|||
155162647|NCT03096288|560031671|FG000|Overall Study|Withdrawal by Subject|0|||
155162648|NCT03096288|560031672|FG001|Overall Study|Withdrawal by Subject|1|||
155162649|NCT03096288|560031673|FG002|Overall Study|Withdrawal by Subject|0|||
155162650|NCT03096288|560031674|FG003|Overall Study|Withdrawal by Subject|1|||
155162651|NCT01411891|560031680|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
155162652|NCT01411891|560031681|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
155162653|NCT00414596|560031682|FG000|Overall Study|Protocol Violation|2|||
155162654|NCT04639258|560031684|FG000|Overall Study|Screen failure|5|||
155162655|NCT04639258|560031684|FG000|Overall Study|Physician Decision|2|||
155162656|NCT04639258|560031684|FG000|Overall Study|Early study termination|3|||
155162657|NCT04639258|560031684|FG000|Overall Study|Withdrawal by Subject|1|||
155162658|NCT04614974|560031685|FG000|Overall Study|Lost to Follow-up|14|||
155321440|NCT03655028|560612304|FG000|12-weeks Follow up|Physician Decision|3|||
155321441|NCT03655028|560612305|FG001|12-weeks Follow up|Physician Decision|3|||
155321442|NCT03655028|560612304|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
155321443|NCT03655028|560612305|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
155321444|NCT03655028|560612304|FG000|12-weeks Follow up|Lost to Follow-up|4|||
155321445|NCT03655028|560612305|FG001|12-weeks Follow up|Lost to Follow-up|4|||
155321446|NCT03655028|560612304|FG000|24-weeks|Lost to Follow-up|1|||
155321447|NCT03655028|560612305|FG001|24-weeks|Lost to Follow-up|1|||
155321448|NCT03655028|560612304|FG000|24-weeks|Death|0|||
155321449|NCT03655028|560612305|FG001|24-weeks|Death|1|||
155321450|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
155321451|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321452|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321453|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321454|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321455|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
155321456|NCT04625725|560612309|FG000|Provent Main Study|Withdrawal by Subject|242|||
155321457|NCT04625725|560612310|FG001|Provent Main Study|Withdrawal by Subject|144|||
155321458|NCT04625725|560612311|FG002|Provent Main Study|Withdrawal by Subject|0|||
155321459|NCT04625725|560612312|FG003|Provent Main Study|Withdrawal by Subject|0|||
155321460|NCT04625725|560612313|FG004|Provent Main Study|Withdrawal by Subject|0|||
155321461|NCT04625725|560612314|FG005|Provent Main Study|Withdrawal by Subject|0|||
155321462|NCT04625725|560612309|FG000|Provent Main Study|Physician Decision|5|||
155321463|NCT04625725|560612310|FG001|Provent Main Study|Physician Decision|0|||
155321464|NCT04625725|560612311|FG002|Provent Main Study|Physician Decision|0|||
155321465|NCT04625725|560612312|FG003|Provent Main Study|Physician Decision|0|||
155321466|NCT04625725|560612313|FG004|Provent Main Study|Physician Decision|0|||
155321467|NCT04625725|560612314|FG005|Provent Main Study|Physician Decision|0|||
155321468|NCT04625725|560612309|FG000|Provent Main Study|Protocol Violation|1|||
155321469|NCT04625725|560612310|FG001|Provent Main Study|Protocol Violation|0|||
154960868|NCT01660243|559282153|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
154960869|NCT01660243|559282150|FG000|Overall Study|Randomization error|0|||
155321470|NCT04625725|560612311|FG002|Provent Main Study|Protocol Violation|0|||
155162659|NCT04614974|560031686|FG001|Overall Study|Lost to Follow-up|11|||
155162660|NCT01635153|560031687|FG000|Overall Study|Lost to Follow-up|40|||
155321471|NCT04625725|560612312|FG003|Provent Main Study|Protocol Violation|0|||
155321472|NCT04625725|560612313|FG004|Provent Main Study|Protocol Violation|0|||
155321473|NCT04625725|560612314|FG005|Provent Main Study|Protocol Violation|0|||
155321474|NCT04625725|560612309|FG000|Provent Main Study|Lost to Follow-up|357|||
155321475|NCT04625725|560612310|FG001|Provent Main Study|Lost to Follow-up|200|||
155321476|NCT04625725|560612311|FG002|Provent Main Study|Lost to Follow-up|0|||
155321477|NCT04625725|560612312|FG003|Provent Main Study|Lost to Follow-up|0|||
155321478|NCT04625725|560612313|FG004|Provent Main Study|Lost to Follow-up|0|||
155321479|NCT04625725|560612314|FG005|Provent Main Study|Lost to Follow-up|0|||
155321480|NCT04625725|560612309|FG000|Provent Main Study|Death|22|||
155321481|NCT04625725|560612310|FG001|Provent Main Study|Death|10|||
155321482|NCT04625725|560612311|FG002|Provent Main Study|Death|0|||
155321483|NCT04625725|560612312|FG003|Provent Main Study|Death|0|||
155321484|NCT04625725|560612313|FG004|Provent Main Study|Death|0|||
155321485|NCT04625725|560612314|FG005|Provent Main Study|Death|0|||
155321486|NCT04625725|560612309|FG000|Provent Main Study|Adverse Event|2|||
155321487|NCT04625725|560612310|FG001|Provent Main Study|Adverse Event|1|||
155321488|NCT04625725|560612311|FG002|Provent Main Study|Adverse Event|0|||
155321489|NCT04625725|560612312|FG003|Provent Main Study|Adverse Event|0|||
155321490|NCT04625725|560612313|FG004|Provent Main Study|Adverse Event|0|||
155321491|NCT04625725|560612314|FG005|Provent Main Study|Adverse Event|0|||
155321492|NCT04625725|560612309|FG000|Provent Main Study|Participants dosed in sub-study|310|||
155321493|NCT04625725|560612310|FG001|Provent Main Study|Participants dosed in sub-study|193|||
155321494|NCT04625725|560612311|FG002|Provent Main Study|Participants dosed in sub-study|0|||
155321495|NCT04625725|560612312|FG003|Provent Main Study|Participants dosed in sub-study|0|||
155321496|NCT04625725|560612313|FG004|Provent Main Study|Participants dosed in sub-study|0|||
155321497|NCT04625725|560612314|FG005|Provent Main Study|Participants dosed in sub-study|0|||
155321498|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
155321499|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
155321500|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321501|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321502|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321503|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
155321504|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
155321505|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
155321506|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321507|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321508|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321509|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
155321510|NCT04625725|560612309|FG000|Provent Main Study|INCARCERATION|3|||
155321511|NCT04625725|560612310|FG001|Provent Main Study|INCARCERATION|0|||
155321512|NCT04625725|560612311|FG002|Provent Main Study|INCARCERATION|0|||
155321513|NCT04625725|560612312|FG003|Provent Main Study|INCARCERATION|0|||
155321514|NCT04625725|560612313|FG004|Provent Main Study|INCARCERATION|0|||
155321515|NCT04625725|560612314|FG005|Provent Main Study|INCARCERATION|0|||
155321516|NCT04625725|560612309|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
155321517|NCT04625725|560612310|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
155321518|NCT04625725|560612311|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321519|NCT04625725|560612312|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321520|NCT04625725|560612313|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321521|NCT04625725|560612314|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
155321522|NCT04625725|560612309|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
155321523|NCT04625725|560612310|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
155321524|NCT04625725|560612311|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155321525|NCT04625725|560612312|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155321526|NCT04625725|560612313|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
155321527|NCT04625725|560612314|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
154960870|NCT01660243|559282151|FG001|Overall Study|Randomization error|0|||
154960871|NCT01660243|559282152|FG002|Overall Study|Randomization error|0|||
154960872|NCT01660243|559282153|FG003|Overall Study|Randomization error|1|||
154960873|NCT04299087|559282154|FG000|Overall Study|Lost to Follow-up|2|||
154960874|NCT04299087|559282155|FG001|Overall Study|Lost to Follow-up|1|||
154960875|NCT03025087|559282156|FG000|Overall Study|Physician Decision|3|||
155321528|NCT04625725|560612309|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
155321529|NCT04625725|560612310|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
155321530|NCT04625725|560612311|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321531|NCT04625725|560612312|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321532|NCT04625725|560612313|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321533|NCT04625725|560612314|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
155321534|NCT04625725|560612309|FG000|Provent Main Study|MISSING REASON|0|||
155321535|NCT04625725|560612310|FG001|Provent Main Study|MISSING REASON|1|||
155321536|NCT04625725|560612311|FG002|Provent Main Study|MISSING REASON|0|||
155321537|NCT04625725|560612312|FG003|Provent Main Study|MISSING REASON|0|||
155321538|NCT04625725|560612313|FG004|Provent Main Study|MISSING REASON|0|||
155321539|NCT04625725|560612314|FG005|Provent Main Study|MISSING REASON|0|||
155321540|NCT04625725|560612309|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321541|NCT04625725|560612310|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321542|NCT04625725|560612311|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321543|NCT04625725|560612312|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
155321544|NCT04625725|560612313|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321545|NCT04625725|560612314|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
155321546|NCT04625725|560612309|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321547|NCT04625725|560612310|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321548|NCT04625725|560612311|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
155321549|NCT04625725|560612312|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321550|NCT04625725|560612313|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321551|NCT04625725|560612314|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
155321552|NCT04625725|560612309|FG000|Provent Sub Study|Lost to Follow-up|0|||
155321553|NCT04625725|560612310|FG001|Provent Sub Study|Lost to Follow-up|0|||
155321554|NCT04625725|560612311|FG002|Provent Sub Study|Lost to Follow-up|20|||
155321555|NCT04625725|560612312|FG003|Provent Sub Study|Lost to Follow-up|10|||
155321556|NCT04625725|560612313|FG004|Provent Sub Study|Lost to Follow-up|6|||
155321557|NCT04625725|560612314|FG005|Provent Sub Study|Lost to Follow-up|4|||
155321558|NCT04625725|560612309|FG000|Provent Sub Study|Death|0|||
155321559|NCT04625725|560612310|FG001|Provent Sub Study|Death|0|||
155321560|NCT04625725|560612311|FG002|Provent Sub Study|Death|8|||
155321561|NCT04625725|560612312|FG003|Provent Sub Study|Death|5|||
155321562|NCT04625725|560612313|FG004|Provent Sub Study|Death|0|||
155321563|NCT04625725|560612314|FG005|Provent Sub Study|Death|1|||
155321564|NCT04625725|560612309|FG000|Provent Sub Study|Adverse Event|0|||
155321565|NCT04625725|560612310|FG001|Provent Sub Study|Adverse Event|0|||
155321566|NCT04625725|560612311|FG002|Provent Sub Study|Adverse Event|0|||
155321567|NCT04625725|560612312|FG003|Provent Sub Study|Adverse Event|0|||
155321568|NCT04625725|560612313|FG004|Provent Sub Study|Adverse Event|0|||
155321569|NCT04625725|560612314|FG005|Provent Sub Study|Adverse Event|1|||
155321570|NCT04625725|560612309|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321571|NCT04625725|560612310|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321572|NCT04625725|560612311|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321573|NCT04625725|560612312|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321574|NCT04625725|560612313|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
155321575|NCT04625725|560612314|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
155321576|NCT04625725|560612309|FG000|Provent Sub Study|Withdrawal by Subject|0|||
155321577|NCT04625725|560612310|FG001|Provent Sub Study|Withdrawal by Subject|0|||
155321578|NCT04625725|560612311|FG002|Provent Sub Study|Withdrawal by Subject|11|||
155321579|NCT04625725|560612312|FG003|Provent Sub Study|Withdrawal by Subject|13|||
155321580|NCT04625725|560612313|FG004|Provent Sub Study|Withdrawal by Subject|5|||
155321581|NCT04625725|560612314|FG005|Provent Sub Study|Withdrawal by Subject|6|||
155321582|NCT04625725|560612309|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321583|NCT04625725|560612310|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321584|NCT04625725|560612311|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321585|NCT04625725|560612312|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321586|NCT04625725|560612313|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
155321587|NCT04625725|560612314|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
155321588|NCT00429364|560612328|FG000|Overall Study|Withdrawal by Subject|11|||
155321589|NCT00429364|560612329|FG001|Overall Study|Withdrawal by Subject|5|||
155321590|NCT00429364|560612328|FG000|Overall Study|Physician Decision|4|||
155321591|NCT00429364|560612329|FG001|Overall Study|Physician Decision|2|||
155321592|NCT00429364|560612328|FG000|Overall Study|Lost to Follow-up|7|||
155321593|NCT00429364|560612329|FG001|Overall Study|Lost to Follow-up|6|||
155321594|NCT00429364|560612328|FG000|Overall Study|Death|0|||
155321595|NCT00429364|560612329|FG001|Overall Study|Death|1|||
155321596|NCT00429364|560612328|FG000|Overall Study|Underwent aortic root surgery|10|||
155321597|NCT00429364|560612329|FG001|Overall Study|Underwent aortic root surgery|18|||
155321598|NCT00429364|560612328|FG000|Overall Study|Pregnancy|0|||
155321599|NCT00429364|560612329|FG001|Overall Study|Pregnancy|1|||
155321600|NCT04871529|560612330|FG000|Overall Study|Withdrawal by Subject|0|||
155321601|NCT04871529|560612331|FG001|Overall Study|Withdrawal by Subject|1|||
155321602|NCT04871529|560612330|FG000|Overall Study|Death|0|||
155321603|NCT04871529|560612331|FG001|Overall Study|Death|1|||
155068560|NCT03126110|559681003|FG004|Phase 2|Withdrawal by Subject|0|||
155321604|NCT04871529|560612330|FG000|Overall Study|Not protocol specified|0|||
155321605|NCT04871529|560612331|FG001|Overall Study|Not protocol specified|1|||
155321606|NCT05184452|560612332|FG000|Overall Study|Lost to Follow-up|0|||
155321607|NCT05184452|560612333|FG001|Overall Study|Lost to Follow-up|0|||
155321608|NCT05184452|560612334|FG002|Overall Study|Lost to Follow-up|0|||
155321609|NCT05184452|560612335|FG003|Overall Study|Lost to Follow-up|0|||
155321610|NCT05184452|560612336|FG004|Overall Study|Lost to Follow-up|0|||
155321611|NCT05184452|560612337|FG005|Overall Study|Lost to Follow-up|2|||
155321612|NCT05184452|560612338|FG006|Overall Study|Lost to Follow-up|0|||
155321613|NCT05184452|560612339|FG007|Overall Study|Lost to Follow-up|0|||
155321614|NCT05184452|560612340|FG008|Overall Study|Lost to Follow-up|0|||
155321615|NCT05184452|560612341|FG009|Overall Study|Lost to Follow-up|1|||
155321616|NCT05184452|560612332|FG000|Overall Study|Withdrawal by Subject|0|||
155321617|NCT05184452|560612333|FG001|Overall Study|Withdrawal by Subject|0|||
155321618|NCT05184452|560612334|FG002|Overall Study|Withdrawal by Subject|0|||
155321619|NCT05184452|560612335|FG003|Overall Study|Withdrawal by Subject|0|||
155321620|NCT05184452|560612336|FG004|Overall Study|Withdrawal by Subject|0|||
155321621|NCT05184452|560612337|FG005|Overall Study|Withdrawal by Subject|1|||
155321622|NCT05184452|560612338|FG006|Overall Study|Withdrawal by Subject|0|||
155321623|NCT05184452|560612339|FG007|Overall Study|Withdrawal by Subject|0|||
155321624|NCT05184452|560612340|FG008|Overall Study|Withdrawal by Subject|0|||
155321625|NCT05184452|560612341|FG009|Overall Study|Withdrawal by Subject|1|||
155321626|NCT05586490|560612342|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321627|NCT05586490|560612343|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321628|NCT05586490|560612344|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
155321629|NCT05586490|560612345|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321630|NCT05586490|560612346|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
155321631|NCT05586490|560612342|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
155321632|NCT05586490|560612343|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321633|NCT05586490|560612344|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321634|NCT05586490|560612345|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321635|NCT05586490|560612346|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
155321636|NCT05586490|560612342|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
155321637|NCT05586490|560612343|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321638|NCT05586490|560612344|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321639|NCT05586490|560612345|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321640|NCT05586490|560612346|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
155321641|NCT05873556|560612347|FG000|Overall Study|Lost to Follow-up|4|||
155321642|NCT05873556|560612348|FG001|Overall Study|Lost to Follow-up|1|||
155321643|NCT03606408|560612350|FG000|Overall Study|Adverse Event|13|||
155321644|NCT03606408|560612350|FG000|Overall Study|Withdrawal by Subject|7|||
155321645|NCT03606408|560612350|FG000|Overall Study|Physician Decision|4|||
155321646|NCT03606408|560612350|FG000|Overall Study|Lack of Efficacy|2|||
155321647|NCT03606408|560612350|FG000|Overall Study|Death|1|||
155321648|NCT03606408|560612350|FG000|Overall Study|new therapy for study indication|1|||
155321649|NCT04689256|560612351|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
155321650|NCT04689256|560612352|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
155321651|NCT03556293|560612353|FG000|Overall Study|Ineligible for analysis|1904|||
155321652|NCT03556293|560612354|FG001|Overall Study|Ineligible for analysis|1471|||
155321653|NCT03556293|560612355|FG002|Overall Study|Ineligible for analysis|1091|||
155321654|NCT03556293|560612356|FG003|Overall Study|Ineligible for analysis|1269|||
155321655|NCT02224144|560612382|FG000|Overall Study|Lost to Follow-up|3|||
155321656|NCT02224144|560612383|FG001|Overall Study|Lost to Follow-up|1|||
155321657|NCT02224144|560612382|FG000|Overall Study|Death|2|||
155321658|NCT02224144|560612383|FG001|Overall Study|Death|0|||
155321659|NCT02224144|560612382|FG000|Overall Study|Withdrawal by Subject|0|||
155321660|NCT02224144|560612383|FG001|Overall Study|Withdrawal by Subject|1|||
155321661|NCT03505008|560612384|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
155068561|NCT03126110|559681004|FG005|Phase 2|Withdrawal by Subject|0|||
155068562|NCT03126110|559681005|FG006|Phase 2|Withdrawal by Subject|0|||
155068563|NCT03126110|559681006|FG007|Phase 2|Withdrawal by Subject|0|||
155068564|NCT03126110|559681007|FG008|Phase 2|Withdrawal by Subject|0|||
155068565|NCT03126110|559681008|FG009|Phase 2|Withdrawal by Subject|0|||
155321662|NCT03505008|560612385|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
155321663|NCT03505008|560612386|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
155068566|NCT03126110|559681009|FG010|Phase 2|Withdrawal by Subject|0|||
155068567|NCT03126110|559681010|FG011|Phase 2|Withdrawal by Subject|1|||
155321664|NCT03505008|560612387|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
155068568|NCT03126110|559681011|FG012|Phase 2|Withdrawal by Subject|3|||
155068569|NCT03126110|559681012|FG013|Phase 2|Withdrawal by Subject|3|||
155321665|NCT03505008|560612384|FG000|Before Week 24 Randomization|Adverse Event|10|||
155321666|NCT03505008|560612385|FG001|Before Week 24 Randomization|Adverse Event|0|||
154960876|NCT03025087|559282157|FG001|Overall Study|Physician Decision|3|||
154960877|NCT03025087|559282158|FG002|Overall Study|Physician Decision|0|||
155321667|NCT03505008|560612386|FG002|Before Week 24 Randomization|Adverse Event|0|||
155321668|NCT03505008|560612387|FG003|Before Week 24 Randomization|Adverse Event|0|||
155321669|NCT03505008|560612384|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
155321670|NCT03505008|560612385|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
155321671|NCT03505008|560612386|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
155321672|NCT03505008|560612387|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
155321673|NCT03505008|560612384|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
155321674|NCT03505008|560612385|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
155321675|NCT03505008|560612386|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
155321676|NCT03505008|560612387|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
155321677|NCT03505008|560612384|FG000|Before Week 24 Randomization|Physician Decision|2|||
155321678|NCT03505008|560612385|FG001|Before Week 24 Randomization|Physician Decision|0|||
155321679|NCT03505008|560612386|FG002|Before Week 24 Randomization|Physician Decision|0|||
155321680|NCT03505008|560612387|FG003|Before Week 24 Randomization|Physician Decision|0|||
155321681|NCT03505008|560612384|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
155321682|NCT03505008|560612385|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
155321683|NCT03505008|560612386|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
155321684|NCT03505008|560612387|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
155321685|NCT03505008|560612384|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
155321686|NCT03505008|560612385|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
155321687|NCT03505008|560612386|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
155321688|NCT03505008|560612387|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
155321689|NCT03505008|560612384|FG000|Before Week 24 Randomization|Complication|1|||
155321690|NCT03505008|560612385|FG001|Before Week 24 Randomization|Complication|0|||
155321691|NCT03505008|560612386|FG002|Before Week 24 Randomization|Complication|0|||
155321692|NCT03505008|560612387|FG003|Before Week 24 Randomization|Complication|0|||
155321693|NCT03505008|560612384|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
155321694|NCT03505008|560612385|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
155321695|NCT03505008|560612386|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
155321696|NCT03505008|560612387|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
155321697|NCT03505008|560612384|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
155321698|NCT03505008|560612385|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
155321699|NCT03505008|560612386|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
155321700|NCT03505008|560612387|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
155321701|NCT03505008|560612384|FG000|After Week 24 Randomization|Adverse Event|0|||
155321702|NCT03505008|560612385|FG001|After Week 24 Randomization|Adverse Event|1|||
155321703|NCT03505008|560612386|FG002|After Week 24 Randomization|Adverse Event|2|||
155321704|NCT03505008|560612387|FG003|After Week 24 Randomization|Adverse Event|2|||
155321705|NCT03505008|560612384|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
155321706|NCT03505008|560612385|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
155321707|NCT03505008|560612386|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
155321708|NCT03505008|560612387|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
155321709|NCT03505008|560612384|FG000|After Week 24 Randomization|Protocol Violation|0|||
155321710|NCT03505008|560612385|FG001|After Week 24 Randomization|Protocol Violation|0|||
155321711|NCT03505008|560612386|FG002|After Week 24 Randomization|Protocol Violation|1|||
155321712|NCT03505008|560612387|FG003|After Week 24 Randomization|Protocol Violation|0|||
155321713|NCT02962076|560612388|FG000|Overall Study|MHED tracer not available|5|||
155321714|NCT02962076|560612388|FG000|Overall Study|Protocol Violation|1|||
155321715|NCT02962076|560612388|FG000|Overall Study|Physician Decision|1|||
155321716|NCT02780700|560612389|FG000|Overall Study|Progressive disease|1|||
155321717|NCT04580914|560612393|FG000|Overall Study|Withdrawal by Subject|6|||
155321718|NCT04580914|560612393|FG000|Overall Study|Lost to Follow-up|2|||
155321719|NCT02998528|560612395|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
155321720|NCT02998528|560612396|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
155321721|NCT02998528|560612397|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
155321722|NCT02998528|560612395|FG000|Randomization Period|Participant withdrew consent|0|||
155321723|NCT02998528|560612396|FG001|Randomization Period|Participant withdrew consent|3|||
155321724|NCT02998528|560612397|FG002|Randomization Period|Participant withdrew consent|0|||
155321725|NCT02998528|560612395|FG000|Randomization Period|Participant no longer meets study criteria|1|||
155321726|NCT02998528|560612396|FG001|Randomization Period|Participant no longer meets study criteria|3|||
154960878|NCT03025087|559282159|FG003|Overall Study|Physician Decision|0|||
154960879|NCT03025087|559282160|FG004|Overall Study|Physician Decision|0|||
154960880|NCT03025087|559282156|FG000|Overall Study|Withdrawal by Subject|1|||
154960881|NCT03025087|559282157|FG001|Overall Study|Withdrawal by Subject|1|||
154960882|NCT03025087|559282158|FG002|Overall Study|Withdrawal by Subject|0|||
155068570|NCT03126110|559681013|FG014|Phase 2|Withdrawal by Subject|2|||
155321727|NCT02998528|560612397|FG002|Randomization Period|Participant no longer meets study criteria|2|||
155321728|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
155321729|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
155321730|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
155321731|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
155321732|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
155321733|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
155321734|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
155321735|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
155321736|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
155321737|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
155321738|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
155321739|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
155321740|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
155321741|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
155321742|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
155321743|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Death|1|||
155321744|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Death|0|||
155321745|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Death|0|||
155321746|NCT02998528|560612395|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
155321747|NCT02998528|560612396|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
155321748|NCT02998528|560612397|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
155321749|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
155321750|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
155321751|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
155321752|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
155321753|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
155321754|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
155321755|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
155321756|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
155321757|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
155321758|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
155321759|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
155321760|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
155321761|NCT02998528|560612395|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
155321762|NCT02998528|560612396|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
155321763|NCT02998528|560612397|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
155321764|NCT05035654|560612400|FG000|Overall Study|Physician Decision|0|||
155321765|NCT05035654|560612401|FG001|Overall Study|Physician Decision|1|||
154960883|NCT03025087|559282159|FG003|Overall Study|Withdrawal by Subject|0|||
154960884|NCT03025087|559282160|FG004|Overall Study|Withdrawal by Subject|0|||
154960885|NCT03025087|559282156|FG000|Overall Study|Unable to complete MRI|2|||
154960886|NCT03025087|559282157|FG001|Overall Study|Unable to complete MRI|2|||
154960887|NCT03025087|559282158|FG002|Overall Study|Unable to complete MRI|0|||
154960888|NCT03025087|559282159|FG003|Overall Study|Unable to complete MRI|0|||
155068571|NCT03126110|559681014|FG015|Phase 2|Withdrawal by Subject|1|||
155068572|NCT03126110|559681015|FG016|Phase 2|Withdrawal by Subject|0|||
155068573|NCT03126110|559680999|FG000|Phase 2|Lost to Follow-up|0|||
155321766|NCT05035654|560612402|FG002|Overall Study|Physician Decision|0|||
155321767|NCT05035654|560612400|FG000|Overall Study|Adverse Event|0|||
155321768|NCT05035654|560612401|FG001|Overall Study|Adverse Event|1|||
155321769|NCT05035654|560612402|FG002|Overall Study|Adverse Event|0|||
155321770|NCT05035654|560612400|FG000|Overall Study|Withdrawal by Subject|0|||
155321771|NCT05035654|560612401|FG001|Overall Study|Withdrawal by Subject|0|||
155321772|NCT05035654|560612402|FG002|Overall Study|Withdrawal by Subject|4|||
155321773|NCT05035654|560612400|FG000|Overall Study|Bilateral Dislodgement|1|||
155321774|NCT05035654|560612401|FG001|Overall Study|Bilateral Dislodgement|0|||
155321775|NCT05035654|560612402|FG002|Overall Study|Bilateral Dislodgement|0|||
155321776|NCT01199133|560612413|FG000|Year 1|Adverse Event|16|||
155321777|NCT01199133|560612414|FG001|Year 1|Adverse Event|4|||
155321778|NCT01199133|560612413|FG000|Year 1|Withdrawal by Subject|8|||
154960889|NCT03025087|559282160|FG004|Overall Study|Unable to complete MRI|0|||
154960890|NCT00594035|559282161|FG000|Overall Study|Lost to Follow-up|1|||
154960891|NCT00594035|559282162|FG001|Overall Study|Lost to Follow-up|1|||
155068574|NCT03126110|559681000|FG001|Phase 2|Lost to Follow-up|0|||
155068575|NCT03126110|559681001|FG002|Phase 2|Lost to Follow-up|0|||
155068576|NCT03126110|559681002|FG003|Phase 2|Lost to Follow-up|0|||
155068577|NCT03126110|559681003|FG004|Phase 2|Lost to Follow-up|0|||
155321779|NCT01199133|560612414|FG001|Year 1|Withdrawal by Subject|4|||
155321780|NCT01199133|560612413|FG000|Year 1|Any other reason not above-mentioned|6|||
155321781|NCT01199133|560612414|FG001|Year 1|Any other reason not above-mentioned|7|||
155321782|NCT01199133|560612413|FG000|Year 2|Adverse Event|1|||
155321783|NCT01199133|560612414|FG001|Year 2|Adverse Event|0|||
155321784|NCT01199133|560612413|FG000|Year 2|Withdrawal by Subject|1|||
155321785|NCT01199133|560612414|FG001|Year 2|Withdrawal by Subject|1|||
155321786|NCT01199133|560612413|FG000|Year 2|Any other reason not above-mentioned|1|||
155321787|NCT01199133|560612414|FG001|Year 2|Any other reason not above-mentioned|2|||
155321788|NCT02575950|560612415|FG000|Overall Study|Withdrawal by Subject|0|||
155321789|NCT02575950|560612416|FG001|Overall Study|Withdrawal by Subject|0|||
155321790|NCT02575950|560612417|FG002|Overall Study|Withdrawal by Subject|0|||
155321791|NCT02575950|560612418|FG003|Overall Study|Withdrawal by Subject|2|||
155321792|NCT02575950|560612415|FG000|Overall Study|Lost to Follow-up|0|||
155321793|NCT02575950|560612416|FG001|Overall Study|Lost to Follow-up|1|||
155321794|NCT02575950|560612417|FG002|Overall Study|Lost to Follow-up|0|||
155321795|NCT02575950|560612418|FG003|Overall Study|Lost to Follow-up|3|||
155321796|NCT03993392|560612421|FG000|Overall Study|Withdrawal by Subject|3|||
155321797|NCT03993392|560612421|FG000|Overall Study|Lost to Follow-up|2|||
155321798|NCT03993392|560612421|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
155321799|NCT03106740|560614194|FG000|Overall Study|Lost to Follow-up|2|||
155321800|NCT03106740|560614195|FG001|Overall Study|Lost to Follow-up|2|||
155321801|NCT03106740|560614194|FG000|Overall Study|Withdrawal by Subject|2|||
155321802|NCT03106740|560614195|FG001|Overall Study|Withdrawal by Subject|4|||
155321803|NCT03106740|560614194|FG000|Overall Study|Physician Decision|0|||
155321804|NCT03106740|560614195|FG001|Overall Study|Physician Decision|1|||
155321805|NCT03106740|560614194|FG000|Overall Study|Partial data|1|||
155321806|NCT03106740|560614195|FG001|Overall Study|Partial data|0|||
155321807|NCT06262477|560614196|FG000|Overall Study|Withdrawal by Subject|1|||
155321808|NCT06262477|560614197|FG001|Overall Study|Withdrawal by Subject|0|||
155321809|NCT06262477|560614196|FG000|Overall Study|Adverse Event|0|||
155321810|NCT06262477|560614197|FG001|Overall Study|Adverse Event|1|||
155321811|NCT06262477|560614196|FG000|Overall Study|Lost to Follow-up|0|||
155321812|NCT06262477|560614197|FG001|Overall Study|Lost to Follow-up|1|||
155321813|NCT03220035|560614201|FG000|Overall Study|Adverse Event|1|||
155321814|NCT03220035|560614201|FG000|Overall Study|Protocol Violation|1|||
155321815|NCT03220035|560614201|FG000|Overall Study|Progressive Disease|2|||
155321816|NCT05452460|560614202|FG000|Overall Study|Lost to Follow-up|3|||
155321817|NCT05452460|560614203|FG001|Overall Study|Lost to Follow-up|3|||
155321818|NCT05452460|560614202|FG000|Overall Study|Did not receive intervention|1|||
155321819|NCT05452460|560614203|FG001|Overall Study|Did not receive intervention|0|||
155321820|NCT04433208|560614204|FG000|Overall Study|Withdrawal by Subject|0|||
155321821|NCT04433208|560614205|FG001|Overall Study|Withdrawal by Subject|1|||
155321822|NCT04433208|560614206|FG002|Overall Study|Withdrawal by Subject|1|||
155321823|NCT04433208|560614207|FG003|Overall Study|Withdrawal by Subject|0|||
155321824|NCT04433208|560614208|FG004|Overall Study|Withdrawal by Subject|2|||
155321825|NCT04433208|560614209|FG005|Overall Study|Withdrawal by Subject|1|||
155321826|NCT04433208|560614204|FG000|Overall Study|Lost to Follow-up|0|||
155321827|NCT04433208|560614205|FG001|Overall Study|Lost to Follow-up|0|||
155321828|NCT04433208|560614206|FG002|Overall Study|Lost to Follow-up|0|||
155321829|NCT04433208|560614207|FG003|Overall Study|Lost to Follow-up|0|||
155321830|NCT04433208|560614208|FG004|Overall Study|Lost to Follow-up|0|||
155321831|NCT04433208|560614209|FG005|Overall Study|Lost to Follow-up|1|||
155321832|NCT02424617|560614212|FG000|Overall Study|Adverse Event|0|||
155321833|NCT02424617|560614213|FG001|Overall Study|Adverse Event|1|||
155068578|NCT03126110|559681004|FG005|Phase 2|Lost to Follow-up|0|||
155068579|NCT03126110|559681005|FG006|Phase 2|Lost to Follow-up|0|||
155068580|NCT03126110|559681006|FG007|Phase 2|Lost to Follow-up|0|||
155068581|NCT03126110|559681007|FG008|Phase 2|Lost to Follow-up|0|||
155068582|NCT03126110|559681008|FG009|Phase 2|Lost to Follow-up|0|||
155068583|NCT03126110|559681009|FG010|Phase 2|Lost to Follow-up|0|||
155321834|NCT02424617|560614214|FG002|Overall Study|Adverse Event|0|||
155321835|NCT02424617|560614215|FG003|Overall Study|Adverse Event|0|||
155321836|NCT02424617|560614212|FG000|Overall Study|Investigator Decision|0|||
155321837|NCT02424617|560614213|FG001|Overall Study|Investigator Decision|0|||
155321838|NCT02424617|560614214|FG002|Overall Study|Investigator Decision|0|||
155068584|NCT03126110|559681010|FG011|Phase 2|Lost to Follow-up|1|||
155068585|NCT03126110|559681011|FG012|Phase 2|Lost to Follow-up|1|||
155068586|NCT03126110|559681012|FG013|Phase 2|Lost to Follow-up|1|||
155321839|NCT02424617|560614215|FG003|Overall Study|Investigator Decision|1|||
155321840|NCT02424617|560614212|FG000|Overall Study|Withdrawal by Subject|1|||
155321841|NCT02424617|560614213|FG001|Overall Study|Withdrawal by Subject|1|||
155321842|NCT02424617|560614214|FG002|Overall Study|Withdrawal by Subject|0|||
155321843|NCT02424617|560614215|FG003|Overall Study|Withdrawal by Subject|1|||
155321844|NCT02424617|560614212|FG000|Overall Study|Progressive Disease|7|||
155321845|NCT02424617|560614213|FG001|Overall Study|Progressive Disease|6|||
155321846|NCT02424617|560614214|FG002|Overall Study|Progressive Disease|11|||
155321847|NCT02424617|560614215|FG003|Overall Study|Progressive Disease|10|||
155321848|NCT02424617|560614212|FG000|Overall Study|Other|0|||
155321849|NCT02424617|560614213|FG001|Overall Study|Other|0|||
155321850|NCT02424617|560614214|FG002|Overall Study|Other|0|||
155321851|NCT02424617|560614215|FG003|Overall Study|Other|1|||
155321852|NCT04359654|560614217|FG000|Overall Study|Withdrawal by Subject|1|||
155162661|NCT01635153|560031688|FG001|Overall Study|Lost to Follow-up|43|||
155162662|NCT00658359|560031690|FG000|Overall Study|Death|3|||
155162663|NCT00658359|560031691|FG001|Overall Study|Death|1|||
155162664|NCT00658359|560031692|FG002|Overall Study|Death|2|||
155162665|NCT00658359|560031690|FG000|Overall Study|Adverse Event|13|||
155162666|NCT00658359|560031691|FG001|Overall Study|Adverse Event|6|||
155162667|NCT00658359|560031692|FG002|Overall Study|Adverse Event|9|||
155162668|NCT00658359|560031690|FG000|Overall Study|Protocol Violation|1|||
155162669|NCT00658359|560031691|FG001|Overall Study|Protocol Violation|0|||
155162670|NCT00658359|560031692|FG002|Overall Study|Protocol Violation|0|||
155162671|NCT00658359|560031690|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
155162672|NCT00658359|560031691|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
155162673|NCT00658359|560031692|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
155162674|NCT00658359|560031690|FG000|Overall Study|Withdrawal by Subject|7|||
155162675|NCT00658359|560031691|FG001|Overall Study|Withdrawal by Subject|4|||
155162676|NCT00658359|560031692|FG002|Overall Study|Withdrawal by Subject|2|||
155162677|NCT00658359|560031690|FG000|Overall Study|Lost to Follow-up|2|||
155162678|NCT00658359|560031691|FG001|Overall Study|Lost to Follow-up|2|||
155162679|NCT00658359|560031692|FG002|Overall Study|Lost to Follow-up|4|||
155162680|NCT00658359|560031690|FG000|Overall Study|Lack of Efficacy|0|||
155162681|NCT00658359|560031691|FG001|Overall Study|Lack of Efficacy|1|||
155162682|NCT00658359|560031692|FG002|Overall Study|Lack of Efficacy|0|||
155162683|NCT02558296|560031693|FG000|Completed the Study Through Week 24|Adverse Event|9|||
155162684|NCT02558296|560031694|FG001|Completed the Study Through Week 24|Adverse Event|3|||
155162685|NCT02558296|560031693|FG000|Completed the Study Through Week 24|Death|7|||
155162686|NCT02558296|560031694|FG001|Completed the Study Through Week 24|Death|7|||
155162687|NCT02558296|560031693|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
155162688|NCT02558296|560031694|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
155162689|NCT02558296|560031693|FG000|Completed the Study Through Week 24|Physician Decision|1|||
155162690|NCT02558296|560031694|FG001|Completed the Study Through Week 24|Physician Decision|0|||
155162691|NCT02558296|560031693|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
155162692|NCT02558296|560031694|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
155162693|NCT02558296|560031693|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
155162694|NCT02558296|560031694|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
155162695|NCT02558296|560031693|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
155162696|NCT02558296|560031694|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
155162697|NCT02558296|560031693|FG000|Completed the Study|Adverse Event|14|||
155162698|NCT02558296|560031694|FG001|Completed the Study|Adverse Event|5|||
155162699|NCT02558296|560031693|FG000|Completed the Study|Death|39|||
155162700|NCT02558296|560031694|FG001|Completed the Study|Death|25|||
155162701|NCT02558296|560031693|FG000|Completed the Study|Lost to Follow-up|31|||
155162702|NCT02558296|560031694|FG001|Completed the Study|Lost to Follow-up|23|||
155162703|NCT02558296|560031693|FG000|Completed the Study|Physician Decision|6|||
155162704|NCT02558296|560031694|FG001|Completed the Study|Physician Decision|0|||
155162705|NCT02558296|560031693|FG000|Completed the Study|Protocol Violation|2|||
155162706|NCT02558296|560031694|FG001|Completed the Study|Protocol Violation|1|||
155162707|NCT02558296|560031693|FG000|Completed the Study|Withdrawal by Subject|53|||
155162708|NCT02558296|560031694|FG001|Completed the Study|Withdrawal by Subject|31|||
155162709|NCT02558296|560031693|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
155162710|NCT02558296|560031694|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
155162711|NCT02919995|560031697|FG000|Overall Study|Adverse Event|0|||
155162712|NCT02919995|560031698|FG001|Overall Study|Adverse Event|0|||
155162713|NCT02919995|560031699|FG002|Overall Study|Adverse Event|0|||
155162714|NCT02919995|560031700|FG003|Overall Study|Adverse Event|0|||
155162715|NCT02919995|560031701|FG004|Overall Study|Adverse Event|0|||
155162716|NCT02919995|560031702|FG005|Overall Study|Adverse Event|1|||
155162717|NCT00275509|560031703|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
155162718|NCT00275509|560031704|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
155162719|NCT03388164|560031709|FG000|Overall Study|Withdrawal by Subject|3|||
155162720|NCT03388164|560031710|FG001|Overall Study|Withdrawal by Subject|1|||
155162721|NCT00345358|560031711|FG000|Primary Vaccination Phase|Other|0|||
155162722|NCT00345358|560031712|FG001|Primary Vaccination Phase|Other|1|||
155162723|NCT00345358|560031713|FG002|Primary Vaccination Phase|Other|1|||
155162724|NCT00345358|560031714|FG003|Primary Vaccination Phase|Other|0|||
155162725|NCT00345358|560031711|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
155162726|NCT00345358|560031712|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
155162727|NCT00345358|560031713|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
155162728|NCT00345358|560031714|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
155162729|NCT00345358|560031711|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
155162730|NCT00345358|560031712|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
155162731|NCT00345358|560031713|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
155321853|NCT04359654|560614218|FG001|Overall Study|Withdrawal by Subject|0|||
155321854|NCT04359654|560614217|FG000|Overall Study|Adverse Event|0|||
155321855|NCT04359654|560614218|FG001|Overall Study|Adverse Event|1|||
155321856|NCT04024020|560614219|FG000|Overall Study|Withdrawal by Subject|2|||
155321857|NCT04024020|560614220|FG001|Overall Study|Withdrawal by Subject|2|||
155321858|NCT05269966|560614223|FG000|Overall Study|Adverse Event|4|||
155321859|NCT05269966|560614223|FG000|Overall Study|Withdrawal by Subject|1|||
155321860|NCT05269966|560614223|FG000|Overall Study|Lost to Follow-up|4|||
155321861|NCT05269966|560614223|FG000|Overall Study|Physician Decision|1|||
155321862|NCT03476343|560614226|FG000|Overall Study|Clinical exam moved to another scanner|7|||
155321863|NCT03476343|560614226|FG000|Overall Study|Clinical order cancelled|4|||
155321864|NCT03476343|560614226|FG000|Overall Study|Neonate did not settle down for the scan|1|||
155321865|NCT05974501|560614227|FG000|Overall Study|Physician Decision|0|||
155321866|NCT05974501|560614228|FG001|Overall Study|Physician Decision|1|||
155321867|NCT04304144|560614229|FG000|DLT Observation Period|Physician Decision|0|||
155321868|NCT04304144|560614230|FG001|DLT Observation Period|Physician Decision|1|||
155321869|NCT04304144|560614231|FG002|DLT Observation Period|Physician Decision|0|||
155321870|NCT04304144|560614232|FG003|DLT Observation Period|Physician Decision|0|||
155321871|NCT04304144|560614229|FG000|Continued Treatment Period|Adverse Event|0|||
155321872|NCT04304144|560614230|FG001|Continued Treatment Period|Adverse Event|1|||
155321873|NCT04304144|560614231|FG002|Continued Treatment Period|Adverse Event|0|||
155321874|NCT04304144|560614232|FG003|Continued Treatment Period|Adverse Event|0|||
155321875|NCT04304144|560614229|FG000|Continued Treatment Period|Death|0|||
155321876|NCT04304144|560614230|FG001|Continued Treatment Period|Death|0|||
155321877|NCT04304144|560614231|FG002|Continued Treatment Period|Death|1|||
155321878|NCT04304144|560614232|FG003|Continued Treatment Period|Death|2|||
155321879|NCT04304144|560614229|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
155321880|NCT04304144|560614230|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
155321881|NCT04304144|560614231|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
155321882|NCT04304144|560614232|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
155321883|NCT04304144|560614229|FG000|Continued Treatment Period|Other than specified|2|||
155321884|NCT04304144|560614230|FG001|Continued Treatment Period|Other than specified|0|||
155321885|NCT04304144|560614231|FG002|Continued Treatment Period|Other than specified|1|||
155321886|NCT04304144|560614232|FG003|Continued Treatment Period|Other than specified|1|||
155321887|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
155321888|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
155321889|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
155321890|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
155321891|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
155321892|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
155321893|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
155321894|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Death|0|||
155321895|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Death|1|||
155321896|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Death|0|||
155321897|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Death|0|||
155321898|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Death|0|||
155321899|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Death|0|||
155321900|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Death|0|||
155321901|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
155321902|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321903|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321904|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321905|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321906|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321907|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
155321908|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321909|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
155321910|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321911|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321912|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155068587|NCT03126110|559681013|FG014|Phase 2|Lost to Follow-up|2|||
155068588|NCT03126110|559681014|FG015|Phase 2|Lost to Follow-up|0|||
155068589|NCT03126110|559681015|FG016|Phase 2|Lost to Follow-up|0|||
155068590|NCT03126110|559680999|FG000|Phase 2|Death|0|||
155321913|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321914|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
155321915|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Other|1|||
155321916|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Other|0|||
155321917|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Other|0|||
155321918|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Other|0|||
155321919|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Other|0|||
155321920|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Other|0|||
155068591|NCT03126110|559681000|FG001|Phase 2|Death|0|||
155068592|NCT03126110|559681001|FG002|Phase 2|Death|0|||
155068593|NCT03126110|559681002|FG003|Phase 2|Death|0|||
155068594|NCT03126110|559681003|FG004|Phase 2|Death|0|||
155068595|NCT03126110|559681004|FG005|Phase 2|Death|0|||
155068596|NCT03126110|559681005|FG006|Phase 2|Death|0|||
155068597|NCT03126110|559681006|FG007|Phase 2|Death|0|||
155068598|NCT03126110|559681007|FG008|Phase 2|Death|0|||
155068599|NCT03126110|559681008|FG009|Phase 2|Death|0|||
155068600|NCT03126110|559681009|FG010|Phase 2|Death|0|||
155068601|NCT03126110|559681010|FG011|Phase 2|Death|6|||
155068602|NCT03126110|559681011|FG012|Phase 2|Death|12|||
155068603|NCT03126110|559681012|FG013|Phase 2|Death|25|||
155068604|NCT03126110|559681013|FG014|Phase 2|Death|11|||
155068605|NCT03126110|559681014|FG015|Phase 2|Death|3|||
155068606|NCT03126110|559681015|FG016|Phase 2|Death|2|||
155068607|NCT03126110|559680999|FG000|Phase 2|Progressive Disease|0|||
155068608|NCT03126110|559681000|FG001|Phase 2|Progressive Disease|0|||
155068609|NCT03126110|559681001|FG002|Phase 2|Progressive Disease|0|||
155068610|NCT03126110|559681002|FG003|Phase 2|Progressive Disease|0|||
155068611|NCT03126110|559681003|FG004|Phase 2|Progressive Disease|0|||
155068612|NCT03126110|559681004|FG005|Phase 2|Progressive Disease|0|||
155068613|NCT03126110|559681005|FG006|Phase 2|Progressive Disease|0|||
155068614|NCT03126110|559681006|FG007|Phase 2|Progressive Disease|0|||
155068615|NCT03126110|559681007|FG008|Phase 2|Progressive Disease|0|||
155068616|NCT03126110|559681008|FG009|Phase 2|Progressive Disease|0|||
155068617|NCT03126110|559681009|FG010|Phase 2|Progressive Disease|0|||
155068618|NCT03126110|559681010|FG011|Phase 2|Progressive Disease|0|||
155068619|NCT03126110|559681011|FG012|Phase 2|Progressive Disease|0|||
155068620|NCT03126110|559681012|FG013|Phase 2|Progressive Disease|1|||
155068621|NCT03126110|559681013|FG014|Phase 2|Progressive Disease|0|||
155068622|NCT03126110|559681014|FG015|Phase 2|Progressive Disease|0|||
155068623|NCT03126110|559681015|FG016|Phase 2|Progressive Disease|0|||
155068624|NCT03126110|559680999|FG000|Phase 2|Started new treatment|0|||
155068625|NCT03126110|559681000|FG001|Phase 2|Started new treatment|0|||
155068626|NCT03126110|559681001|FG002|Phase 2|Started new treatment|0|||
155068627|NCT03126110|559681002|FG003|Phase 2|Started new treatment|0|||
155068628|NCT03126110|559681003|FG004|Phase 2|Started new treatment|0|||
155068629|NCT03126110|559681004|FG005|Phase 2|Started new treatment|0|||
155068630|NCT03126110|559681005|FG006|Phase 2|Started new treatment|0|||
155068631|NCT03126110|559681006|FG007|Phase 2|Started new treatment|0|||
155068632|NCT03126110|559681007|FG008|Phase 2|Started new treatment|0|||
155068633|NCT03126110|559681008|FG009|Phase 2|Started new treatment|0|||
155068634|NCT03126110|559681009|FG010|Phase 2|Started new treatment|0|||
155068635|NCT03126110|559681010|FG011|Phase 2|Started new treatment|0|||
155068636|NCT03126110|559681011|FG012|Phase 2|Started new treatment|0|||
155068637|NCT03126110|559681012|FG013|Phase 2|Started new treatment|0|||
155068638|NCT03126110|559681013|FG014|Phase 2|Started new treatment|1|||
155068639|NCT03126110|559681014|FG015|Phase 2|Started new treatment|0|||
155068640|NCT03126110|559681015|FG016|Phase 2|Started new treatment|0|||
155068641|NCT04435626|559681018|FG000|Overall Study|Lost to Follow-up|1|||
155068642|NCT04435626|559681019|FG001|Overall Study|Lost to Follow-up|5|||
155321921|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Other|0|||
155321922|NCT04585815|560614233|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
155321923|NCT04585815|560614234|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
155321924|NCT04585815|560614235|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321925|NCT04585815|560614236|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321926|NCT04585815|560614237|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321927|NCT04585815|560614238|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321928|NCT04585815|560614239|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
155321929|NCT04585815|560614233|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155068643|NCT04435626|559681018|FG000|Overall Study|Withdrawal by Subject|6|||
155068644|NCT04435626|559681019|FG001|Overall Study|Withdrawal by Subject|7|||
155068645|NCT04435626|559681018|FG000|Overall Study|major GCP violations|8|||
155068646|NCT04435626|559681019|FG001|Overall Study|major GCP violations|7|||
155068647|NCT05845619|559681023|FG000|Overall Study|duplicate enrollment|2|||
155068648|NCT05845619|559681024|FG001|Overall Study|duplicate enrollment|2|||
155068649|NCT05845619|559681025|FG002|Overall Study|duplicate enrollment|1|||
155068650|NCT03621592|559681026|FG000|Overall Study|Lost to Follow-up|1|||
155068651|NCT03621592|559681027|FG001|Overall Study|Lost to Follow-up|0|||
155068652|NCT03621592|559681026|FG000|Overall Study|Lack of Improvement|1|||
155068653|NCT03621592|559681027|FG001|Overall Study|Lack of Improvement|0|||
155068654|NCT03621592|559681026|FG000|Overall Study|Preference to receive wound care closer to home|1|||
155068655|NCT03621592|559681027|FG001|Overall Study|Preference to receive wound care closer to home|0|||
155068656|NCT03621592|559681026|FG000|Overall Study|Lack of healing|0|||
155068657|NCT03621592|559681027|FG001|Overall Study|Lack of healing|2|||
155068658|NCT04967222|559681028|FG000|Randomized|Lost to Follow-up|0|||
155321930|NCT04585815|560614234|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
155321931|NCT04585815|560614235|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321932|NCT04585815|560614236|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321933|NCT04585815|560614237|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321934|NCT04585815|560614238|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321935|NCT04585815|560614239|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
155321936|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
155321937|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
155321938|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
155321939|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
155321940|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
155321941|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
155321942|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
155321943|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Death|0|||
155321944|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Death|0|||
155321945|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Death|0|||
155321946|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Death|1|||
155321947|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Death|0|||
155321948|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Death|0|||
155321949|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Death|0|||
155321950|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321951|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321952|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321953|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
155321954|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321955|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
155321956|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
155321957|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321958|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321959|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321960|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
155321961|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321962|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321963|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
155321964|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321965|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321966|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321967|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321968|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321969|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
155321970|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
155321971|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
155321972|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
155321973|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
155321974|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
155321975|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
155321976|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
155321977|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
155321978|NCT04585815|560614233|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
155321979|NCT04585815|560614234|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
155321980|NCT04585815|560614235|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
155321981|NCT04585815|560614236|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
155321982|NCT04585815|560614237|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
155321983|NCT04585815|560614238|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
155321984|NCT04585815|560614239|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
155321985|NCT04585815|560614233|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321986|NCT04585815|560614234|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321987|NCT04585815|560614235|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321988|NCT04585815|560614236|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
155321989|NCT04585815|560614237|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
155321990|NCT04585815|560614238|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
155321991|NCT04585815|560614239|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
155068659|NCT04967222|559681029|FG001|Randomized|Lost to Follow-up|1|||
155321992|NCT04585815|560614233|FG000|Sub-study B- Follow-up Phase|Death|0|||
155321993|NCT04585815|560614234|FG001|Sub-study B- Follow-up Phase|Death|0|||
155321994|NCT04585815|560614235|FG002|Sub-study B- Follow-up Phase|Death|1|||
155321995|NCT04585815|560614236|FG003|Sub-study B- Follow-up Phase|Death|3|||
155321996|NCT04585815|560614237|FG004|Sub-study B- Follow-up Phase|Death|0|||
155321997|NCT04585815|560614238|FG005|Sub-study B- Follow-up Phase|Death|0|||
155321998|NCT04585815|560614239|FG006|Sub-study B- Follow-up Phase|Death|1|||
155162732|NCT00345358|560031714|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
155162733|NCT00345358|560031711|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
155162734|NCT00345358|560031712|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
155162735|NCT00345358|560031713|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
155162736|NCT00345358|560031714|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
155162737|NCT00345358|560031711|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
155162738|NCT00345358|560031712|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155162739|NCT00345358|560031713|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
155162740|NCT00345358|560031714|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
155162741|NCT00345358|560031711|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
155162742|NCT00345358|560031712|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
155162743|NCT00345358|560031713|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
155162744|NCT00345358|560031714|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
155162745|NCT00346697|560031716|FG000|Overall Study|Lost to Follow-up|0|||
155162746|NCT00346697|560031717|FG001|Overall Study|Lost to Follow-up|1|||
155162747|NCT00499083|560031718|FG000|Overall Study|Not evaluable|3|||
155162748|NCT00686686|560031719|FG000|Overall Study|Non-compliance|1|||
155162749|NCT00686686|560031719|FG000|Overall Study|Adverse Event|2|||
155162750|NCT00686686|560031719|FG000|Overall Study|Lost to Follow-up|3|||
155162751|NCT01012440|560031720|FG000|Overall Study|Withdrawal by Subject|2|||
155162752|NCT00477386|560031724|FG000|Overall Study|Adverse Event|4|||
155162753|NCT00477386|560031725|FG001|Overall Study|Adverse Event|8|||
155162754|NCT00477386|560031724|FG000|Overall Study|Disease progression, relapse|3|||
155162755|NCT00477386|560031725|FG001|Overall Study|Disease progression, relapse|4|||
155162756|NCT00477386|560031724|FG000|Overall Study|Disease progression, refractory|1|||
155162757|NCT00477386|560031725|FG001|Overall Study|Disease progression, refractory|3|||
155162758|NCT00477386|560031724|FG000|Overall Study|Other|1|||
155321999|NCT02497950|560614242|FG000|Overall Study|Death|209|||
155322000|NCT02497950|560614242|FG000|Overall Study|Transplanted|85|||
155322001|NCT02497950|560614242|FG000|Overall Study|Explanted|8|||
155322002|NCT02497950|560614242|FG000|Overall Study|Device Permanently Deactivated|4|||
155322003|NCT02497950|560614242|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
155322004|NCT02497950|560614242|FG000|Overall Study|Lost to Follow-up|6|||
155322005|NCT02497950|560614242|FG000|Overall Study|Withdrawal by Subject|2|||
155322006|NCT02497950|560614242|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
155322007|NCT02497950|560614242|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
155322008|NCT04660539|560614243|FG000|Overall Study|Adverse Event|10|||
155322009|NCT04660539|560614243|FG000|Overall Study|Lack of Efficacy|4|||
155322010|NCT04660539|560614243|FG000|Overall Study|Lost to Follow-up|5|||
155322011|NCT04660539|560614243|FG000|Overall Study|Non-Compliance With Study Drug|3|||
155322012|NCT04660539|560614243|FG000|Overall Study|Reason not Specified|12|||
155322013|NCT04660539|560614243|FG000|Overall Study|Pregnancy|2|||
155322014|NCT04660539|560614243|FG000|Overall Study|Protocol Violation|2|||
155322015|NCT04660539|560614243|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
155322016|NCT04660539|560614243|FG000|Overall Study|Withdrawal by Subject|21|||
155322017|NCT04862234|560614246|FG000|Overall Study|Surgery cancellation|1|||
155322018|NCT04862234|560614247|FG001|Overall Study|Surgery cancellation|2|||
155322019|NCT04862234|560614246|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
155322020|NCT04862234|560614247|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
155322021|NCT04862234|560614246|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
155322022|NCT04862234|560614247|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
155322023|NCT03292484|560614248|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
155322024|NCT03292484|560614248|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
155322025|NCT03292484|560614248|FG000|Overall Study|Protocol Violation|2|||
155322026|NCT03292484|560614248|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
155322027|NCT03292484|560614248|FG000|Overall Study|Sponsor decision|349|||
155322028|NCT03292484|560614248|FG000|Overall Study|Lost to Follow-up|7|||
155162759|NCT00477386|560031725|FG001|Overall Study|Other|2|||
155162760|NCT00477386|560031724|FG000|Overall Study|Physician Decision|1|||
155162761|NCT00477386|560031725|FG001|Overall Study|Physician Decision|0|||
155162762|NCT00477386|560031724|FG000|Overall Study|Withdrawal by Subject|1|||
155162763|NCT00477386|560031725|FG001|Overall Study|Withdrawal by Subject|0|||
155162764|NCT01254422|560031726|FG000|Overall Study|Protocol Violation|1|||
155162765|NCT01254422|560031727|FG001|Overall Study|Protocol Violation|0|||
155322029|NCT03292484|560614248|FG000|Overall Study|Coronavirus Disease 2019|1|||
155322030|NCT03292484|560614248|FG000|Overall Study|Other|20|||
155322031|NCT05290493|560614251|FG000|Overall Study|Withdrawal by Subject|2|||
155322032|NCT05290493|560614252|FG001|Overall Study|Withdrawal by Subject|2|||
155322033|NCT05290493|560614251|FG000|Overall Study|Adverse Event|1|||
155322034|NCT05290493|560614252|FG001|Overall Study|Adverse Event|0|||
155322035|NCT05524402|560614253|FG000|Overall Study|Withdrawal by Subject|3|||
155322036|NCT05524402|560614254|FG001|Overall Study|Withdrawal by Subject|1|||
155322037|NCT05524402|560614253|FG000|Overall Study|Lost to Follow-up|2|||
154960892|NCT00594035|559282161|FG000|Overall Study|Withdrawal by Subject|1|||
154960893|NCT00594035|559282162|FG001|Overall Study|Withdrawal by Subject|0|||
155162766|NCT01254422|560031726|FG000|Overall Study|Adverse Event|1|||
155322038|NCT05524402|560614254|FG001|Overall Study|Lost to Follow-up|1|||
155162767|NCT01254422|560031727|FG001|Overall Study|Adverse Event|0|||
155322039|NCT05976334|560614255|FG000|Part B|Death|0|||
155322040|NCT05976334|560614256|FG001|Part B|Death|1|||
155322041|NCT05976334|560614255|FG000|Part B|Study Terminated by Sponsor|0|||
155322042|NCT05976334|560614256|FG001|Part B|Study Terminated by Sponsor|1|||
155322043|NCT05976334|560614255|FG000|Part B|Reason Not Specified|0|||
155322044|NCT05976334|560614256|FG001|Part B|Reason Not Specified|1|||
155322045|NCT03381586|560614257|FG000|Overall Study|Adverse Event|1|||
155322046|NCT03381586|560614258|FG001|Overall Study|Adverse Event|1|||
155322047|NCT03381586|560614257|FG000|Overall Study|Protocol Violation|1|||
155322048|NCT03381586|560614258|FG001|Overall Study|Protocol Violation|0|||
155322049|NCT03381586|560614257|FG000|Overall Study|Withdrawal by Subject|1|||
155322050|NCT03381586|560614258|FG001|Overall Study|Withdrawal by Subject|2|||
155322051|NCT05280574|560614259|FG000|Overall Study|Withdrawal by Subject|0|||
155322052|NCT05280574|560614260|FG001|Overall Study|Withdrawal by Subject|2|||
155322053|NCT05280574|560614261|FG002|Overall Study|Withdrawal by Subject|0|||
155322054|NCT05363163|560614262|FG000|Overall Study|Withdrawal by Subject|13|||
155322055|NCT05838027|560614266|FG000|Overall Study|Lost to Follow-up|5|||
155322056|NCT05838027|560614267|FG001|Overall Study|Lost to Follow-up|1|||
155322057|NCT05838027|560614266|FG000|Overall Study|Withdrawal by Subject|1|||
155322058|NCT05838027|560614267|FG001|Overall Study|Withdrawal by Subject|0|||
155322059|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
155322060|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
155322061|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
155322062|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
155322063|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
155322064|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
155322065|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
155322066|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
155322067|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
155322068|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
155322069|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
155322070|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
155322071|NCT05237284|560614268|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
155322072|NCT05237284|560614269|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
155322073|NCT05237284|560614270|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
155322074|NCT05237284|560614271|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
155322075|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
155322076|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
155322077|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
155322078|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
155322079|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
155322080|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
155322081|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
155322082|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
155322083|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
155322084|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
155322085|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
155322086|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
155322087|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
155322088|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
155322089|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
155322090|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
155322091|NCT05237284|560614268|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
155322092|NCT05237284|560614269|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
155322093|NCT05237284|560614270|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
155322094|NCT05237284|560614271|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
155322095|NCT04999111|560614272|FG000|Overall Study|Lost to Follow-up|21|||
155322096|NCT04999111|560614273|FG001|Overall Study|Lost to Follow-up|16|||
155322097|NCT04999111|560614274|FG002|Overall Study|Lost to Follow-up|2|||
155322098|NCT04999111|560614275|FG003|Overall Study|Lost to Follow-up|26|||
155322099|NCT04999111|560614276|FG004|Overall Study|Lost to Follow-up|30|||
155322100|NCT04999111|560614277|FG005|Overall Study|Lost to Follow-up|6|||
155322101|NCT04999111|560614272|FG000|Overall Study|Physician Decision|1|||
155322102|NCT04999111|560614273|FG001|Overall Study|Physician Decision|3|||
155322103|NCT04999111|560614274|FG002|Overall Study|Physician Decision|0|||
155322104|NCT04999111|560614275|FG003|Overall Study|Physician Decision|1|||
155322105|NCT04999111|560614276|FG004|Overall Study|Physician Decision|2|||
155322106|NCT04999111|560614277|FG005|Overall Study|Physician Decision|0|||
155322107|NCT04999111|560614272|FG000|Overall Study|Withdrawal by Subject|23|||
155068660|NCT04967222|559681030|FG002|Randomized|Lost to Follow-up|1|||
155322108|NCT04999111|560614273|FG001|Overall Study|Withdrawal by Subject|29|||
155322109|NCT04999111|560614274|FG002|Overall Study|Withdrawal by Subject|15|||
155322110|NCT04999111|560614275|FG003|Overall Study|Withdrawal by Subject|30|||
155322111|NCT04999111|560614276|FG004|Overall Study|Withdrawal by Subject|35|||
155322112|NCT04999111|560614277|FG005|Overall Study|Withdrawal by Subject|10|||
155322113|NCT04999111|560614272|FG000|Overall Study|Other|6|||
155322114|NCT04999111|560614273|FG001|Overall Study|Other|6|||
155322115|NCT04999111|560614274|FG002|Overall Study|Other|3|||
155322116|NCT04999111|560614275|FG003|Overall Study|Other|8|||
155322117|NCT04999111|560614276|FG004|Overall Study|Other|8|||
155322118|NCT04999111|560614277|FG005|Overall Study|Other|5|||
155322119|NCT04999111|560614272|FG000|Overall Study|Non-compliance with study schedule|1|||
155322120|NCT04999111|560614273|FG001|Overall Study|Non-compliance with study schedule|0|||
155322121|NCT04999111|560614274|FG002|Overall Study|Non-compliance with study schedule|0|||
155322122|NCT04999111|560614275|FG003|Overall Study|Non-compliance with study schedule|1|||
155322123|NCT04999111|560614276|FG004|Overall Study|Non-compliance with study schedule|1|||
155322124|NCT04999111|560614277|FG005|Overall Study|Non-compliance with study schedule|1|||
155322125|NCT04999111|560614272|FG000|Overall Study|Randomized but not vaccinated|1|||
155322126|NCT04999111|560614273|FG001|Overall Study|Randomized but not vaccinated|2|||
155322127|NCT04999111|560614274|FG002|Overall Study|Randomized but not vaccinated|0|||
155322128|NCT04999111|560614275|FG003|Overall Study|Randomized but not vaccinated|3|||
155322129|NCT04999111|560614276|FG004|Overall Study|Randomized but not vaccinated|3|||
155322130|NCT04999111|560614277|FG005|Overall Study|Randomized but not vaccinated|0|||
155322131|NCT04999111|560614272|FG000|Overall Study|Adverse Event|1|||
155322132|NCT04999111|560614273|FG001|Overall Study|Adverse Event|1|||
155322133|NCT04999111|560614274|FG002|Overall Study|Adverse Event|0|||
155322134|NCT04999111|560614275|FG003|Overall Study|Adverse Event|0|||
155322135|NCT04999111|560614276|FG004|Overall Study|Adverse Event|0|||
155322136|NCT04999111|560614277|FG005|Overall Study|Adverse Event|0|||
155322137|NCT04999111|560614272|FG000|Overall Study|Initiated prohibited medication|0|||
155322138|NCT04999111|560614273|FG001|Overall Study|Initiated prohibited medication|0|||
155068661|NCT04967222|559681028|FG000|Randomized|Physician Decision|0|||
155068662|NCT04967222|559681029|FG001|Randomized|Physician Decision|0|||
155068663|NCT04967222|559681030|FG002|Randomized|Physician Decision|1|||
155068664|NCT04967222|559681028|FG000|Randomized|Withdrawal by Subject|0|||
155068665|NCT04967222|559681029|FG001|Randomized|Withdrawal by Subject|0|||
155068666|NCT04967222|559681030|FG002|Randomized|Withdrawal by Subject|2|||
155068667|NCT04967222|559681028|FG000|Randomized|abnormal finding in MRI|0|||
155162768|NCT01254422|560031726|FG000|Overall Study|Serious adverse event|0|||
155068668|NCT04967222|559681029|FG001|Randomized|abnormal finding in MRI|2|||
155068669|NCT04967222|559681030|FG002|Randomized|abnormal finding in MRI|0|||
155322139|NCT04999111|560614274|FG002|Overall Study|Initiated prohibited medication|0|||
155322140|NCT04999111|560614275|FG003|Overall Study|Initiated prohibited medication|0|||
155322141|NCT04999111|560614276|FG004|Overall Study|Initiated prohibited medication|1|||
155322142|NCT04999111|560614277|FG005|Overall Study|Initiated prohibited medication|0|||
155322143|NCT04056611|560614284|FG000|Overall Study|Physician Decision|1|||
155322144|NCT03213873|560614285|FG000|Overall Study|Withdrawal by Subject|8|||
155322145|NCT03213873|560614286|FG001|Overall Study|Withdrawal by Subject|9|||
155322146|NCT03213873|560614285|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
155322147|NCT03213873|560614286|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
155322148|NCT03213873|560614285|FG000|Overall Study|Lost to Follow-up|0|||
155322149|NCT03213873|560614286|FG001|Overall Study|Lost to Follow-up|2|||
155322150|NCT04709419|560614288|FG000|Overall Study|Physician Decision|1|||
155322151|NCT04709419|560614289|FG001|Overall Study|Physician Decision|0|||
155322152|NCT05683340|560614290|FG000|Overall Study|Adverse Event|1|||
155322153|NCT05683340|560614291|FG001|Overall Study|Adverse Event|1|||
155322154|NCT05683340|560614290|FG000|Overall Study|Protocol Violation|1|||
155322155|NCT05683340|560614291|FG001|Overall Study|Protocol Violation|0|||
155322156|NCT05683340|560614290|FG000|Overall Study|Withdrawal by Subject|0|||
155322157|NCT05683340|560614291|FG001|Overall Study|Withdrawal by Subject|2|||
155322158|NCT02437136|560614292|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
155322159|NCT02437136|560614293|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322160|NCT02437136|560614294|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322161|NCT02437136|560614295|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322162|NCT02437136|560614296|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322163|NCT02437136|560614297|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322164|NCT02437136|560614298|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
155322165|NCT02437136|560614292|FG000|Expansion (Phase 2)|Death|0|||
155322166|NCT02437136|560614293|FG001|Expansion (Phase 2)|Death|0|||
155322167|NCT02437136|560614294|FG002|Expansion (Phase 2)|Death|0|||
155322168|NCT02437136|560614295|FG003|Expansion (Phase 2)|Death|6|||
155322169|NCT02437136|560614296|FG004|Expansion (Phase 2)|Death|37|||
155322170|NCT02437136|560614297|FG005|Expansion (Phase 2)|Death|29|||
155322171|NCT02437136|560614298|FG006|Expansion (Phase 2)|Death|24|||
155322172|NCT02437136|560614292|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
155322173|NCT02437136|560614293|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
155322174|NCT02437136|560614294|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
155322175|NCT02437136|560614295|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
155322176|NCT02437136|560614296|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
155322177|NCT02437136|560614297|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
155322178|NCT02437136|560614298|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
155322179|NCT02437136|560614292|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
155322180|NCT02437136|560614293|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
155322181|NCT02437136|560614294|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
155322182|NCT02437136|560614295|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
155322183|NCT02437136|560614296|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
155322184|NCT02437136|560614297|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
155068670|NCT04958707|559681038|FG000|Post Intervention|Withdrawal by Subject|1|||
155068671|NCT04958707|559681039|FG001|Post Intervention|Withdrawal by Subject|0|||
155068672|NCT04958707|559681040|FG002|Post Intervention|Withdrawal by Subject|0|||
155068673|NCT04958707|559681038|FG000|3 Months Follow- up|Lost to Follow-up|0|||
155068674|NCT04958707|559681039|FG001|3 Months Follow- up|Lost to Follow-up|3|||
155068675|NCT04958707|559681040|FG002|3 Months Follow- up|Lost to Follow-up|0|||
155068676|NCT04958707|559681038|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
155068677|NCT04958707|559681039|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
155068678|NCT04958707|559681040|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
155068679|NCT02629159|559681043|FG000|Overall Study|Adverse Event|17|||
155068680|NCT02629159|559681044|FG001|Overall Study|Adverse Event|20|||
155068681|NCT02629159|559681045|FG002|Overall Study|Adverse Event|22|||
155068682|NCT02629159|559681043|FG000|Overall Study|Withdrawal by Subject|22|||
155068683|NCT02629159|559681044|FG001|Overall Study|Withdrawal by Subject|11|||
155068684|NCT02629159|559681045|FG002|Overall Study|Withdrawal by Subject|15|||
155068685|NCT02629159|559681043|FG000|Overall Study|Lost to Follow-up|7|||
155068686|NCT02629159|559681044|FG001|Overall Study|Lost to Follow-up|4|||
155068687|NCT02629159|559681045|FG002|Overall Study|Lost to Follow-up|5|||
155068688|NCT02629159|559681043|FG000|Overall Study|Lack of Efficacy|4|||
155068689|NCT02629159|559681044|FG001|Overall Study|Lack of Efficacy|0|||
155068690|NCT02629159|559681045|FG002|Overall Study|Lack of Efficacy|1|||
155068691|NCT02629159|559681043|FG000|Overall Study|Other|6|||
155068692|NCT02629159|559681044|FG001|Overall Study|Other|4|||
155068693|NCT02629159|559681045|FG002|Overall Study|Other|8|||
155068694|NCT04717557|559681054|FG000|Overall Study|Withdrawal by Subject|2|||
155068695|NCT04717557|559681055|FG001|Overall Study|Withdrawal by Subject|0|||
155068696|NCT04717557|559681054|FG000|Overall Study|Death|1|||
155068697|NCT04717557|559681055|FG001|Overall Study|Death|0|||
155068698|NCT06354257|559681060|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155322185|NCT02437136|560614298|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
155322186|NCT02056834|560614299|FG000|Overall Study|Lost to Follow-up|7|||
155322187|NCT03276676|560614306|FG000|Overall Study|Withdrawal by Subject|2|||
155322188|NCT03276676|560614307|FG001|Overall Study|Withdrawal by Subject|1|||
155322189|NCT03926130|560614316|FG000|Overall Study|Adverse Event|9|||
155322190|NCT03926130|560614317|FG001|Overall Study|Adverse Event|11|||
155322191|NCT03926130|560614318|FG002|Overall Study|Adverse Event|2|||
155322192|NCT03926130|560614319|FG003|Overall Study|Adverse Event|0|||
155322193|NCT03926130|560614316|FG000|Overall Study|Death|2|||
155322194|NCT03926130|560614317|FG001|Overall Study|Death|0|||
155322195|NCT03926130|560614318|FG002|Overall Study|Death|1|||
155322196|NCT03926130|560614319|FG003|Overall Study|Death|0|||
155322197|NCT03926130|560614316|FG000|Overall Study|Lack of Efficacy|14|||
155322198|NCT03926130|560614317|FG001|Overall Study|Lack of Efficacy|11|||
155322199|NCT03926130|560614318|FG002|Overall Study|Lack of Efficacy|7|||
155322200|NCT03926130|560614319|FG003|Overall Study|Lack of Efficacy|1|||
155322201|NCT03926130|560614316|FG000|Overall Study|Lost to Follow-up|0|||
155322202|NCT03926130|560614317|FG001|Overall Study|Lost to Follow-up|7|||
155322203|NCT03926130|560614318|FG002|Overall Study|Lost to Follow-up|1|||
155322204|NCT03926130|560614319|FG003|Overall Study|Lost to Follow-up|0|||
155322205|NCT03926130|560614316|FG000|Overall Study|As Reported by Investigator|2|||
155322206|NCT03926130|560614317|FG001|Overall Study|As Reported by Investigator|6|||
155322207|NCT03926130|560614318|FG002|Overall Study|As Reported by Investigator|6|||
155322208|NCT03926130|560614319|FG003|Overall Study|As Reported by Investigator|0|||
155322209|NCT03926130|560614316|FG000|Overall Study|Physician Decision|3|||
155322210|NCT03926130|560614317|FG001|Overall Study|Physician Decision|2|||
155322211|NCT03926130|560614318|FG002|Overall Study|Physician Decision|1|||
155322212|NCT03926130|560614319|FG003|Overall Study|Physician Decision|0|||
155322213|NCT03926130|560614316|FG000|Overall Study|Pregnancy|2|||
155322214|NCT03926130|560614317|FG001|Overall Study|Pregnancy|2|||
155322215|NCT03926130|560614318|FG002|Overall Study|Pregnancy|1|||
155322216|NCT03926130|560614319|FG003|Overall Study|Pregnancy|0|||
155322217|NCT03926130|560614316|FG000|Overall Study|Withdrawal by Subject|20|||
155322218|NCT03926130|560614317|FG001|Overall Study|Withdrawal by Subject|28|||
155322219|NCT03926130|560614318|FG002|Overall Study|Withdrawal by Subject|18|||
155322220|NCT03926130|560614319|FG003|Overall Study|Withdrawal by Subject|1|||
155322221|NCT03926130|560614316|FG000|Overall Study|Non-Compliance|1|||
155322222|NCT03926130|560614317|FG001|Overall Study|Non-Compliance|1|||
155322223|NCT03926130|560614318|FG002|Overall Study|Non-Compliance|0|||
155322224|NCT03926130|560614319|FG003|Overall Study|Non-Compliance|0|||
155322225|NCT03926130|560614316|FG000|Overall Study|Disposition Not Captured|0|||
155322226|NCT03926130|560614317|FG001|Overall Study|Disposition Not Captured|2|||
155322227|NCT03926130|560614318|FG002|Overall Study|Disposition Not Captured|1|||
155322228|NCT03926130|560614319|FG003|Overall Study|Disposition Not Captured|0|||
155322229|NCT03583333|560614320|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
155322230|NCT03583333|560614321|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
155322231|NCT03583333|560614320|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
155068699|NCT06354257|559681060|FG000|Treatment Period 2|Adverse Event|1|||
155068700|NCT02685735|559681061|FG000|Overall Study|Surgery Cancelled|4|||
155068701|NCT02685735|559681062|FG001|Overall Study|Surgery Cancelled|9|||
155068702|NCT02685735|559681061|FG000|Overall Study|Adverse Event|10|||
155068703|NCT02685735|559681062|FG001|Overall Study|Adverse Event|3|||
155068704|NCT02685735|559681061|FG000|Overall Study|Preop testing found to be incomplete|2|||
155068705|NCT02685735|559681062|FG001|Overall Study|Preop testing found to be incomplete|2|||
155068706|NCT02685735|559681061|FG000|Overall Study|Withdrawal by Subject|1|||
155068707|NCT02685735|559681062|FG001|Overall Study|Withdrawal by Subject|2|||
155068708|NCT02685735|559681061|FG000|Overall Study|Death|1|||
155068709|NCT02685735|559681062|FG001|Overall Study|Death|0|||
155068710|NCT05523297|559681063|FG000|Overall Study|Death|7|||
155068711|NCT05523297|559681064|FG001|Overall Study|Death|8|||
155068712|NCT05523297|559681063|FG000|Overall Study|Lost to Follow-up|2|||
155068713|NCT05523297|559681064|FG001|Overall Study|Lost to Follow-up|1|||
155322232|NCT03583333|560614321|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
155322233|NCT03583333|560614320|FG000|Overall Study|Withdrawal by Subject|9|||
155322234|NCT03583333|560614321|FG001|Overall Study|Withdrawal by Subject|5|||
155322235|NCT03583333|560614320|FG000|Overall Study|Physician Decision|3|||
155322236|NCT03583333|560614321|FG001|Overall Study|Physician Decision|2|||
155068714|NCT02401230|559681065|FG000|Overall Study|Adverse Event|3|||
155068715|NCT02401230|559681066|FG001|Overall Study|Adverse Event|2|||
155068716|NCT02401230|559681067|FG002|Overall Study|Adverse Event|0|||
155068717|NCT02401230|559681065|FG000|Overall Study|Withdrawal by Subject|2|||
155068718|NCT02401230|559681066|FG001|Overall Study|Withdrawal by Subject|1|||
155322237|NCT03583333|560614320|FG000|Overall Study|Death|12|||
155322238|NCT03583333|560614321|FG001|Overall Study|Death|7|||
155322239|NCT03824366|560614337|FG000|Overall Study|Death|1|||
155322240|NCT03824366|560614337|FG000|Overall Study|Previously unidentified metal artifact|1|||
155322241|NCT03824366|560614337|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
155322242|NCT03824366|560614337|FG000|Overall Study|Withdrawal by Subject|1|||
155322243|NCT05069896|560614340|FG000|Overall Study|Adverse Event|0|||
155322244|NCT05069896|560614341|FG001|Overall Study|Adverse Event|1|||
155322245|NCT05069896|560614342|FG002|Overall Study|Adverse Event|1|||
155322246|NCT05069896|560614343|FG003|Overall Study|Adverse Event|0|||
155322247|NCT05069896|560614344|FG004|Overall Study|Adverse Event|0|||
155322248|NCT05069896|560614345|FG005|Overall Study|Adverse Event|0|||
155322249|NCT05069896|560614340|FG000|Overall Study|Lost to Follow-up|0|||
155322250|NCT05069896|560614341|FG001|Overall Study|Lost to Follow-up|0|||
155322251|NCT05069896|560614342|FG002|Overall Study|Lost to Follow-up|1|||
155322252|NCT05069896|560614343|FG003|Overall Study|Lost to Follow-up|0|||
155322253|NCT05069896|560614344|FG004|Overall Study|Lost to Follow-up|1|||
155322254|NCT05069896|560614345|FG005|Overall Study|Lost to Follow-up|2|||
155322255|NCT04068831|560614346|FG000|Overall Study|Disease Progression|10|||
155322256|NCT04068831|560614347|FG001|Overall Study|Disease Progression|8|||
155322257|NCT05715528|560614351|FG000|Overall Study|Randomized but never treated|11|||
155322258|NCT05715528|560614352|FG001|Overall Study|Randomized but never treated|13|||
155322259|NCT05715528|560614351|FG000|Overall Study|Withdrew consent|7|||
155322260|NCT05715528|560614352|FG001|Overall Study|Withdrew consent|15|||
155322261|NCT05715528|560614351|FG000|Overall Study|Lost to Follow-up|5|||
155322262|NCT05715528|560614352|FG001|Overall Study|Lost to Follow-up|13|||
155322263|NCT05715528|560614351|FG000|Overall Study|Investigator's discretion|3|||
155322264|NCT05715528|560614352|FG001|Overall Study|Investigator's discretion|1|||
155322265|NCT05715528|560614351|FG000|Overall Study|Protocol Violation|2|||
155322266|NCT05715528|560614352|FG001|Overall Study|Protocol Violation|0|||
155322267|NCT05715528|560614351|FG000|Overall Study|Non-compliance with study drug|0|||
155322268|NCT05715528|560614352|FG001|Overall Study|Non-compliance with study drug|1|||
155322269|NCT03118518|560614353|FG000|Overall Study|Early Exit after treatment|2|||
155322270|NCT03118518|560614354|FG001|Overall Study|Early Exit after treatment|8|||
155322271|NCT03118518|560614353|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
155322272|NCT03118518|560614354|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
155322273|NCT04565990|560615757|FG000|Overall Study|Death|5|||
155322274|NCT04565990|560615757|FG000|Overall Study|Lost to Follow-up|1|||
155322275|NCT04565990|560615757|FG000|Overall Study|Withdrawal by Subject|1|||
155322276|NCT04797858|560615758|FG000|Overall Study|Withdrawal by Subject|0|||
155322277|NCT04797858|560615759|FG001|Overall Study|Withdrawal by Subject|1|||
155322278|NCT04797858|560615758|FG000|Overall Study|Excluded due to administrative error|7|||
155322279|NCT04797858|560615759|FG001|Overall Study|Excluded due to administrative error|8|||
155322280|NCT01960452|560615763|FG000|Overall Study|Withdrawal by Subject|2|||
155322281|NCT01960452|560615764|FG001|Overall Study|Withdrawal by Subject|1|||
155322282|NCT01960452|560615763|FG000|Overall Study|Sleep apnea in Night 1|1|||
155322283|NCT01960452|560615764|FG001|Overall Study|Sleep apnea in Night 1|0|||
155322284|NCT01960452|560615763|FG000|Overall Study|Poor Sleep in Night 1|0|||
155322285|NCT01960452|560615764|FG001|Overall Study|Poor Sleep in Night 1|2|||
155322286|NCT01960452|560615763|FG000|Overall Study|No Sex/Age Match Night 1|1|||
155322287|NCT01960452|560615764|FG001|Overall Study|No Sex/Age Match Night 1|0|||
154960894|NCT00594035|559282161|FG000|Overall Study|Subject transferred to nursing home|0|||
155322288|NCT01960452|560615763|FG000|Overall Study|No Sex/Age Match Night 2|0|||
155322289|NCT01960452|560615764|FG001|Overall Study|No Sex/Age Match Night 2|2|||
155322290|NCT01960452|560615763|FG000|Overall Study|Technical Difficulties Night 2|2|||
155322291|NCT01960452|560615764|FG001|Overall Study|Technical Difficulties Night 2|0|||
155322292|NCT04766892|560615765|FG000|Overall Study|Withdrawal by Subject|1|||
155322293|NCT04766892|560615765|FG000|Overall Study|Lost to Follow-up|1|||
155322294|NCT04766892|560615765|FG000|Overall Study|Adverse Event|3|||
155322295|NCT04766892|560615765|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
155322296|NCT02668692|560615766|FG000|Overall Study|Adverse Event|1|||
155322297|NCT02668692|560615767|FG001|Overall Study|Adverse Event|0|||
155322298|NCT03981926|560615768|FG000|Overall Study|Lost to Follow-up|5|||
155322299|NCT03981926|560615769|FG001|Overall Study|Lost to Follow-up|9|||
155322300|NCT06262347|560615772|FG000|Overall Study|Lost to Follow-up|4|||
155322301|NCT06262347|560615773|FG001|Overall Study|Lost to Follow-up|3|||
155322302|NCT06262347|560615772|FG000|Overall Study|Withdrawal by Subject|0|||
155322303|NCT06262347|560615773|FG001|Overall Study|Withdrawal by Subject|1|||
155322304|NCT03711474|560615787|FG000|Overall Study|Physician Decision|2|||
155322305|NCT03711474|560615788|FG001|Overall Study|Physician Decision|0|||
155322306|NCT05618587|560615789|FG000|Overall Study|Lost to Follow-up|2|||
155322307|NCT05618587|560615790|FG001|Overall Study|Lost to Follow-up|0|||
155322308|NCT03442309|560615791|FG000|Overall Study|Lost to Follow-up|1676|||
155322309|NCT03442309|560615792|FG001|Overall Study|Lost to Follow-up|1642|||
155322310|NCT02446236|560615795|FG000|Overall Study|Screen Failure|1|||
155322311|NCT02446236|560615796|FG001|Overall Study|Screen Failure|0|||
155322312|NCT02446236|560615797|FG002|Overall Study|Screen Failure|1|||
155322313|NCT02446236|560615795|FG000|Overall Study|Actively Receiving Therapy|0|||
155322314|NCT02446236|560615796|FG001|Overall Study|Actively Receiving Therapy|0|||
155322315|NCT02446236|560615797|FG002|Overall Study|Actively Receiving Therapy|1|||
155322316|NCT04136912|560615802|FG000|Overall Study|Operational reasons|0|||
155322317|NCT04136912|560615803|FG001|Overall Study|Operational reasons|0|||
155322318|NCT04136912|560615804|FG002|Overall Study|Operational reasons|2|||
155322319|NCT04003246|560615815|FG000|Overall Study|Death|9|||
155322320|NCT02834390|560615821|FG000|Induction Phase|Progressive disease|0|||
155322321|NCT02834390|560615822|FG001|Induction Phase|Progressive disease|1|||
155322322|NCT02834390|560615821|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
155322323|NCT02834390|560615822|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
155322324|NCT02834390|560615821|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
155322325|NCT02834390|560615822|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
155322326|NCT02834390|560615821|FG000|Consolidation Phase|Physician Decision|1|||
155322327|NCT02834390|560615822|FG001|Consolidation Phase|Physician Decision|1|||
155322328|NCT05533190|560615830|FG000|Overall Study|Lost to Follow-up|19|||
155322329|NCT05533190|560615831|FG001|Overall Study|Lost to Follow-up|7|||
155322330|NCT05533190|560615830|FG000|Overall Study|Failed to download app|1|||
155322331|NCT05533190|560615831|FG001|Overall Study|Failed to download app|0|||
155322332|NCT05533190|560615830|FG000|Overall Study|Thought app was a scam|1|||
155322333|NCT05533190|560615831|FG001|Overall Study|Thought app was a scam|0|||
155322334|NCT05533190|560615830|FG000|Overall Study|Withdrawal by Subject|2|||
155322335|NCT05533190|560615831|FG001|Overall Study|Withdrawal by Subject|0|||
154960895|NCT00594035|559282162|FG001|Overall Study|Subject transferred to nursing home|1|||
154960896|NCT00594035|559282161|FG000|Overall Study|Subject couldn't return due to job|0|||
155162769|NCT01254422|560031727|FG001|Overall Study|Serious adverse event|1|||
155322336|NCT05856435|560615832|FG000|Overall Study|Lost to Follow-up|6|||
155322337|NCT05660434|560615833|FG000|Overall Study|Never obtained study materials|2|||
155322338|NCT05660434|560615834|FG001|Overall Study|Never obtained study materials|1|||
154960897|NCT00594035|559282162|FG001|Overall Study|Subject couldn't return due to job|1|||
154960898|NCT00795821|559282163|FG000|Acute Treatment Phase|Adverse Event|23|||
154960899|NCT00795821|559282164|FG001|Acute Treatment Phase|Adverse Event|4|||
154960900|NCT00795821|559282163|FG000|Acute Treatment Phase|Death|1|||
154960901|NCT00795821|559282164|FG001|Acute Treatment Phase|Death|0|||
154960902|NCT00795821|559282163|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
154960903|NCT00795821|559282164|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
154960904|NCT00795821|559282163|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
154960905|NCT00795821|559282164|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
154960906|NCT00795821|559282163|FG000|Acute Treatment Phase|Physician Decision|1|||
155322339|NCT03213678|560615837|FG000|Overall Study|Death|1|||
155322340|NCT03213678|560615837|FG000|Overall Study|Physician Decision|1|||
155322341|NCT03213678|560615837|FG000|Overall Study|Progressive disease|16|||
155322342|NCT02413489|560615840|FG000|Overall Study|Death|11|||
155322343|NCT02413489|560615841|FG001|Overall Study|Death|3|||
155322344|NCT02413489|560615842|FG002|Overall Study|Death|4|||
155322345|NCT02413489|560615840|FG000|Overall Study|Withdrawal by Subject|2|||
155322346|NCT02413489|560615841|FG001|Overall Study|Withdrawal by Subject|0|||
155322347|NCT02413489|560615842|FG002|Overall Study|Withdrawal by Subject|0|||
155322348|NCT02413489|560615840|FG000|Overall Study|Study Terminated By Sponsor|2|||
155322349|NCT02413489|560615841|FG001|Overall Study|Study Terminated By Sponsor|13|||
155322350|NCT02413489|560615842|FG002|Overall Study|Study Terminated By Sponsor|1|||
155322351|NCT04456296|560615843|FG000|Overall Study|Withdrawal by Subject|14|||
155322352|NCT04456296|560615844|FG001|Overall Study|Withdrawal by Subject|21|||
155322353|NCT04456296|560615845|FG002|Overall Study|Withdrawal by Subject|21|||
155322354|NCT04456296|560615843|FG000|Overall Study|Adverse Event|2|||
155322355|NCT04456296|560615844|FG001|Overall Study|Adverse Event|2|||
155322356|NCT04456296|560615845|FG002|Overall Study|Adverse Event|2|||
155322357|NCT04456296|560615843|FG000|Overall Study|Death|1|||
155322358|NCT04456296|560615844|FG001|Overall Study|Death|0|||
155322359|NCT04456296|560615845|FG002|Overall Study|Death|0|||
155322360|NCT04456296|560615843|FG000|Overall Study|Lost to Follow-up|3|||
155322361|NCT04456296|560615844|FG001|Overall Study|Lost to Follow-up|5|||
155322362|NCT04456296|560615845|FG002|Overall Study|Lost to Follow-up|6|||
155322363|NCT04456296|560615843|FG000|Overall Study|Other than specified|0|||
155322364|NCT04456296|560615844|FG001|Overall Study|Other than specified|1|||
155068719|NCT02401230|559681067|FG002|Overall Study|Withdrawal by Subject|1|||
155322365|NCT04456296|560615845|FG002|Overall Study|Other than specified|4|||
155322366|NCT04456296|560615843|FG000|Overall Study|Randomized, not treated|2|||
155322367|NCT04456296|560615844|FG001|Overall Study|Randomized, not treated|1|||
155322368|NCT04456296|560615845|FG002|Overall Study|Randomized, not treated|0|||
155322369|NCT05736458|560615846|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
155322370|NCT05736458|560615847|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
155322371|NCT05736458|560615848|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
155322372|NCT05736458|560615846|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
155322373|NCT05736458|560615847|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
155322374|NCT05736458|560615848|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
155322375|NCT05736458|560615846|FG000|TMS/fMRI #1|Physician Decision|0|||
155068720|NCT02401230|559681065|FG000|Overall Study|Lost to Follow-up|1|||
155068721|NCT02401230|559681066|FG001|Overall Study|Lost to Follow-up|3|||
155068722|NCT02401230|559681067|FG002|Overall Study|Lost to Follow-up|3|||
155322376|NCT05736458|560615847|FG001|TMS/fMRI #1|Physician Decision|0|||
155322377|NCT05736458|560615848|FG002|TMS/fMRI #1|Physician Decision|2|||
155322378|NCT05736458|560615846|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
155322379|NCT05736458|560615847|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
155322380|NCT05736458|560615848|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
155068723|NCT00831844|559681073|FG000|Overall Study|Adverse Event|2|||
155068724|NCT00831844|559681074|FG001|Overall Study|Adverse Event|0|||
155068725|NCT00831844|559681075|FG002|Overall Study|Adverse Event|0|||
155068726|NCT00831844|559681076|FG003|Overall Study|Adverse Event|0|||
155068727|NCT00831844|559681077|FG004|Overall Study|Adverse Event|1|||
154960907|NCT00795821|559282164|FG001|Acute Treatment Phase|Physician Decision|1|||
154960908|NCT00795821|559282163|FG000|Acute Treatment Phase|Protocol Violation|1|||
154960909|NCT00795821|559282164|FG001|Acute Treatment Phase|Protocol Violation|2|||
154960910|NCT00795821|559282163|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
154960911|NCT00795821|559282164|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
154960912|NCT00795821|559282163|FG000|Long-term Extension Phase|Adverse Event|25|||
154960913|NCT00795821|559282164|FG001|Long-term Extension Phase|Adverse Event|32|||
154960914|NCT00795821|559282163|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
154960915|NCT00795821|559282164|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
154960916|NCT00795821|559282163|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
154960917|NCT00795821|559282164|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
154960918|NCT00795821|559282163|FG000|Long-term Extension Phase|Physician Decision|1|||
154960919|NCT00795821|559282164|FG001|Long-term Extension Phase|Physician Decision|2|||
154960920|NCT00795821|559282163|FG000|Long-term Extension Phase|Protocol Violation|3|||
154960921|NCT00795821|559282164|FG001|Long-term Extension Phase|Protocol Violation|5|||
155068728|NCT00831844|559681078|FG005|Overall Study|Adverse Event|1|||
155322381|NCT05100628|560615853|FG000|Overall Study|Progressive Disease|1|||
155322382|NCT05100628|560615854|FG001|Overall Study|Progressive Disease|0|||
155322383|NCT05100628|560615855|FG002|Overall Study|Progressive Disease|0|||
155322384|NCT05100628|560615856|FG003|Overall Study|Progressive Disease|0|||
155322385|NCT05100628|560615853|FG000|Overall Study|Study Terminated by Sponsor|0|||
155162770|NCT01254422|560031726|FG000|Overall Study|Lost to Follow-up|1|||
155162771|NCT01254422|560031727|FG001|Overall Study|Lost to Follow-up|0|||
155162772|NCT00643162|560031728|FG000|Overall Study|Withdrawal by Subject|1|||
155162773|NCT00643162|560031729|FG001|Overall Study|Withdrawal by Subject|1|||
155162774|NCT02691507|560031735|FG000|Overall Study|Missed Visit 3|0|||
155162775|NCT02691507|560031736|FG001|Overall Study|Missed Visit 3|1|||
155162776|NCT02557139|560031737|FG000|Overall Study|Significant liver elevation|1|||
155162777|NCT02557139|560031738|FG001|Overall Study|Significant liver elevation|0|||
155162778|NCT02557139|560031739|FG002|Overall Study|Significant liver elevation|1|||
155162779|NCT02557139|560031737|FG000|Overall Study|Withdrawal by Subject|1|||
155162780|NCT02557139|560031738|FG001|Overall Study|Withdrawal by Subject|0|||
155162781|NCT02557139|560031739|FG002|Overall Study|Withdrawal by Subject|0|||
155162782|NCT02557139|560031737|FG000|Overall Study|Illness of prohibited medication|0|||
155162783|NCT02557139|560031738|FG001|Overall Study|Illness of prohibited medication|0|||
155162784|NCT02557139|560031739|FG002|Overall Study|Illness of prohibited medication|1|||
155162785|NCT03023397|560031741|FG000|Run-In|Failed screening allergen challenge|1|||
155162786|NCT03023397|560031742|FG001|Run-In|Failed screening allergen challenge|0|||
155162787|NCT03023397|560031743|FG002|Run-In|Failed screening allergen challenge|0|||
155162788|NCT03023397|560031741|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
155162789|NCT03023397|560031742|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
155162790|NCT03023397|560031743|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
155162791|NCT01146795|560031747|FG000|Overall Study|Withdrawal by Subject|4|||
155162792|NCT01146795|560031747|FG000|Overall Study|Adverse Event|6|||
155162793|NCT01146795|560031747|FG000|Overall Study|Still in treatment at study closure|10|||
155162794|NCT05375760|560031748|FG000|Overall Study|Adverse Event|1|||
155162795|NCT05375760|560031749|FG001|Overall Study|Adverse Event|0|||
155162796|NCT05375760|560031748|FG000|Overall Study|Death|0|||
155162797|NCT05375760|560031749|FG001|Overall Study|Death|1|||
155162798|NCT05375760|560031748|FG000|Overall Study|Lost to Follow-up|6|||
155162799|NCT05375760|560031749|FG001|Overall Study|Lost to Follow-up|6|||
155162800|NCT05375760|560031748|FG000|Overall Study|Withdrawal by Subject|17|||
155162801|NCT05375760|560031749|FG001|Overall Study|Withdrawal by Subject|19|||
155162802|NCT05375760|560031748|FG000|Overall Study|Dosing halted by FDA|96|||
155162803|NCT05375760|560031749|FG001|Overall Study|Dosing halted by FDA|100|||
155162804|NCT05375760|560031748|FG000|Overall Study|Not compliant with study visit|2|||
155162805|NCT05375760|560031749|FG001|Overall Study|Not compliant with study visit|0|||
155162806|NCT05375760|560031748|FG000|Overall Study|Physician Decision|1|||
155162807|NCT05375760|560031749|FG001|Overall Study|Physician Decision|0|||
155162808|NCT05375760|560031748|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
155162809|NCT05375760|560031749|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
155162810|NCT05375760|560031748|FG000|Overall Study|Participant moved|1|||
155162811|NCT05375760|560031749|FG001|Overall Study|Participant moved|0|||
155162812|NCT03853109|560031750|FG000|Overall Study|Withdrawal by Subject|0|||
155162813|NCT03853109|560031751|FG001|Overall Study|Withdrawal by Subject|0|||
155162814|NCT03853109|560031752|FG002|Overall Study|Withdrawal by Subject|1|||
155162815|NCT03853109|560031753|FG003|Overall Study|Withdrawal by Subject|2|||
155162816|NCT03853109|560031754|FG004|Overall Study|Withdrawal by Subject|1|||
155162817|NCT03853109|560031755|FG005|Overall Study|Withdrawal by Subject|4|||
155162818|NCT03853109|560031756|FG006|Overall Study|Withdrawal by Subject|5|||
155162819|NCT03853109|560031757|FG007|Overall Study|Withdrawal by Subject|3|||
155162820|NCT03853109|560031750|FG000|Overall Study|Decision by Sponsor|0|||
155162821|NCT03853109|560031751|FG001|Overall Study|Decision by Sponsor|0|||
155162822|NCT03853109|560031752|FG002|Overall Study|Decision by Sponsor|1|||
155162823|NCT03853109|560031753|FG003|Overall Study|Decision by Sponsor|0|||
155162824|NCT03853109|560031754|FG004|Overall Study|Decision by Sponsor|1|||
155162825|NCT03853109|560031755|FG005|Overall Study|Decision by Sponsor|1|||
155162826|NCT03853109|560031756|FG006|Overall Study|Decision by Sponsor|10|||
155162827|NCT03853109|560031757|FG007|Overall Study|Decision by Sponsor|2|||
155162828|NCT03853109|560031750|FG000|Overall Study|Lost to Follow-up|0|||
155162829|NCT03853109|560031751|FG001|Overall Study|Lost to Follow-up|0|||
155162830|NCT03853109|560031752|FG002|Overall Study|Lost to Follow-up|0|||
155162831|NCT03853109|560031753|FG003|Overall Study|Lost to Follow-up|0|||
155162832|NCT03853109|560031754|FG004|Overall Study|Lost to Follow-up|1|||
155162833|NCT03853109|560031755|FG005|Overall Study|Lost to Follow-up|3|||
155162834|NCT03853109|560031756|FG006|Overall Study|Lost to Follow-up|0|||
155162835|NCT03853109|560031757|FG007|Overall Study|Lost to Follow-up|0|||
155162836|NCT03853109|560031750|FG000|Overall Study|Death|2|||
155322386|NCT05100628|560615854|FG001|Overall Study|Study Terminated by Sponsor|0|||
155322387|NCT05100628|560615855|FG002|Overall Study|Study Terminated by Sponsor|3|||
155322388|NCT05100628|560615856|FG003|Overall Study|Study Terminated by Sponsor|0|||
155322389|NCT05100628|560615853|FG000|Overall Study|unkown|0|||
155322390|NCT05100628|560615854|FG001|Overall Study|unkown|1|||
155322391|NCT05100628|560615855|FG002|Overall Study|unkown|0|||
155322392|NCT05100628|560615856|FG003|Overall Study|unkown|0|||
155322393|NCT05900154|560615861|FG000|Follow-Up Period|Lost to Follow-up|1|||
155322394|NCT05900154|560615862|FG001|Follow-Up Period|Lost to Follow-up|2|||
155322395|NCT05900154|560615863|FG002|Follow-Up Period|Lost to Follow-up|1|||
155322396|NCT05900154|560615864|FG003|Follow-Up Period|Lost to Follow-up|0|||
155322397|NCT05900154|560615865|FG004|Follow-Up Period|Lost to Follow-up|1|||
155322398|NCT05900154|560615866|FG005|Follow-Up Period|Lost to Follow-up|1|||
155322399|NCT01570361|560615867|FG000|Overall Study|Subject discontinued|1|||
155322400|NCT01570361|560615868|FG001|Overall Study|Subject discontinued|2|||
155322401|NCT01570361|560615867|FG000|Overall Study|Sponsor closing the study|51|||
155322402|NCT01570361|560615868|FG001|Overall Study|Sponsor closing the study|50|||
155322403|NCT01570361|560615867|FG000|Overall Study|Subject excluded|5|||
155322404|NCT01570361|560615868|FG001|Overall Study|Subject excluded|3|||
155322405|NCT01570361|560615867|FG000|Overall Study|Subject withdrew consent|14|||
155322406|NCT01570361|560615868|FG001|Overall Study|Subject withdrew consent|9|||
155322407|NCT01570361|560615867|FG000|Overall Study|Adverse Event|2|||
155322408|NCT01570361|560615868|FG001|Overall Study|Adverse Event|1|||
155322409|NCT01570361|560615867|FG000|Overall Study|Lost to Follow-up|4|||
155322410|NCT01570361|560615868|FG001|Overall Study|Lost to Follow-up|4|||
155322411|NCT01570361|560615867|FG000|Overall Study|Death|5|||
155322412|NCT01570361|560615868|FG001|Overall Study|Death|4|||
155322413|NCT01570361|560615867|FG000|Overall Study|Other|0|||
155322414|NCT01570361|560615868|FG001|Overall Study|Other|2|||
155322415|NCT04129554|560615869|FG000|Overall Study|Withdrawal by Subject|4|||
155322416|NCT04129554|560615870|FG001|Overall Study|Withdrawal by Subject|3|||
155322417|NCT04129554|560615869|FG000|Overall Study|Other|0|||
155322418|NCT04129554|560615870|FG001|Overall Study|Other|2|||
155322419|NCT05158504|560615873|FG000|Overall Study|Lost to Follow-up|2|||
155322420|NCT05158504|560615874|FG001|Overall Study|Lost to Follow-up|3|||
155322421|NCT03606512|560615875|FG000|Overall Study|Lost to Follow-up|0|||
155322422|NCT03606512|560615876|FG001|Overall Study|Lost to Follow-up|1|||
155322423|NCT03606512|560615875|FG000|Overall Study|'moved from study area|0|||
155322424|NCT03606512|560615876|FG001|Overall Study|'moved from study area|1|||
155322425|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
155322426|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
155322427|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
155322428|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
155322429|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
155322430|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
155322431|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
155322432|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
155322433|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
155322434|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
155162837|NCT03853109|560031751|FG001|Overall Study|Death|5|||
155162838|NCT03853109|560031752|FG002|Overall Study|Death|8|||
155322435|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
155322436|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
155322437|NCT05513937|560615877|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
155322438|NCT05513937|560615878|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
155322439|NCT05513937|560615879|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
155322440|NCT05513937|560615880|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
155322441|NCT05513937|560615877|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
155322442|NCT05513937|560615878|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
155322443|NCT05513937|560615879|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
155322444|NCT05513937|560615880|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
155322445|NCT05513937|560615877|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
155322446|NCT05513937|560615878|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
155322447|NCT05513937|560615879|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
155162839|NCT03853109|560031753|FG003|Overall Study|Death|10|||
155162840|NCT03853109|560031754|FG004|Overall Study|Death|3|||
155322448|NCT05513937|560615880|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
155322449|NCT02846545|560615881|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
155322450|NCT02846545|560615882|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
155322451|NCT02846545|560615881|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
155322452|NCT02846545|560615882|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
155322453|NCT02846545|560615881|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
155322454|NCT02846545|560615882|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
155322455|NCT02846545|560615881|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
155322456|NCT02846545|560615882|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
155322457|NCT02846545|560615881|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
155322458|NCT02846545|560615882|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
155322459|NCT05654662|560615885|FG000|Overall Study|Withdrawal by Subject|1|||
155322460|NCT05654662|560615886|FG001|Overall Study|Withdrawal by Subject|0|||
155322461|NCT05654662|560615885|FG000|Overall Study|A death in the family|1|||
155322462|NCT05654662|560615886|FG001|Overall Study|A death in the family|0|||
155322463|NCT04230681|560615887|FG000|Overall Study|Physician Decision|2|||
155322464|NCT04230681|560615888|FG001|Overall Study|Physician Decision|3|||
155322465|NCT04230681|560615887|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
155068729|NCT00831844|559681079|FG006|Overall Study|Adverse Event|2|||
155322466|NCT04230681|560615888|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
155322467|NCT04230681|560615887|FG000|Overall Study|IV inadvertently removed|0|||
155322468|NCT04230681|560615888|FG001|Overall Study|IV inadvertently removed|1|||
155322469|NCT01064440|560617324|FG000|Overall Study|Lost to Follow-up|1|||
155322470|NCT01064440|560617325|FG001|Overall Study|Lost to Follow-up|1|||
155322471|NCT01064440|560617326|FG002|Overall Study|Lost to Follow-up|1|||
155322472|NCT01064440|560617324|FG000|Overall Study|Non-compliance|0|||
155322473|NCT01064440|560617325|FG001|Overall Study|Non-compliance|1|||
155322474|NCT01064440|560617326|FG002|Overall Study|Non-compliance|0|||
155322475|NCT01064440|560617324|FG000|Overall Study|Death|1|||
155322476|NCT01064440|560617325|FG001|Overall Study|Death|0|||
155322477|NCT01064440|560617326|FG002|Overall Study|Death|1|||
155322478|NCT01064440|560617324|FG000|Overall Study|Withdrawal by Subject|0|||
155322479|NCT01064440|560617325|FG001|Overall Study|Withdrawal by Subject|1|||
155322480|NCT01064440|560617326|FG002|Overall Study|Withdrawal by Subject|1|||
155322481|NCT01064440|560617324|FG000|Overall Study|Other: amputation|1|||
155322482|NCT01064440|560617325|FG001|Overall Study|Other: amputation|0|||
155322483|NCT01064440|560617326|FG002|Overall Study|Other: amputation|0|||
155322484|NCT05507333|560617327|FG000|Overall Study|Protocol Violation|1|||
155322485|NCT01880515|560617328|FG000|Overall Study|Lost to Follow-up|3|||
155322486|NCT01880515|560617329|FG001|Overall Study|Lost to Follow-up|2|||
155322487|NCT01880515|560617328|FG000|Overall Study|Disease Progression|5|||
155322488|NCT01880515|560617329|FG001|Overall Study|Disease Progression|7|||
155322489|NCT05247034|560617330|FG000|Overall Study|Lost to Follow-up|3|||
155322490|NCT05247034|560617331|FG001|Overall Study|Lost to Follow-up|2|||
155322491|NCT05247034|560617330|FG000|Overall Study|Organizational problems when attending appointments|1|||
155322492|NCT05247034|560617331|FG001|Overall Study|Organizational problems when attending appointments|0|||
155322493|NCT03505710|560617334|FG000|Overall Study|Progressive Disease|24|||
155322494|NCT03505710|560617335|FG001|Overall Study|Progressive Disease|17|||
155322495|NCT03505710|560617336|FG002|Overall Study|Progressive Disease|43|||
155322496|NCT03505710|560617334|FG000|Overall Study|Clinical Progression|6|||
155322497|NCT03505710|560617335|FG001|Overall Study|Clinical Progression|8|||
155322498|NCT03505710|560617336|FG002|Overall Study|Clinical Progression|3|||
155322499|NCT03505710|560617334|FG000|Overall Study|Adverse Event|12|||
154960922|NCT00795821|559282163|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
154960923|NCT00795821|559282164|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
154960924|NCT00795821|559282163|FG000|Taper Phase|Adverse Event|2|||
154960925|NCT00795821|559282164|FG001|Taper Phase|Adverse Event|0|||
155322500|NCT03505710|560617335|FG001|Overall Study|Adverse Event|6|||
154960926|NCT00795821|559282163|FG000|Taper Phase|Lost to Follow-up|1|||
155322501|NCT03505710|560617336|FG002|Overall Study|Adverse Event|28|||
155322502|NCT03505710|560617334|FG000|Overall Study|Withdrawal by Subject|1|||
155322503|NCT03505710|560617335|FG001|Overall Study|Withdrawal by Subject|3|||
155322504|NCT03505710|560617336|FG002|Overall Study|Withdrawal by Subject|7|||
155322505|NCT03505710|560617334|FG000|Overall Study|Physician Decision|1|||
155322506|NCT03505710|560617335|FG001|Overall Study|Physician Decision|1|||
155322507|NCT03505710|560617336|FG002|Overall Study|Physician Decision|2|||
155322508|NCT03505710|560617334|FG000|Overall Study|Death|4|||
155322509|NCT03505710|560617335|FG001|Overall Study|Death|5|||
155322510|NCT03505710|560617336|FG002|Overall Study|Death|6|||
154960927|NCT00795821|559282164|FG001|Taper Phase|Lost to Follow-up|0|||
154960928|NCT00795821|559282163|FG000|Taper Phase|Physician Decision|2|||
154960929|NCT00795821|559282164|FG001|Taper Phase|Physician Decision|0|||
154960930|NCT00795821|559282163|FG000|Taper Phase|Withdrawal by Subject|4|||
154960931|NCT00795821|559282164|FG001|Taper Phase|Withdrawal by Subject|0|||
154960932|NCT00712959|559282171|FG000|Overall Study|Protocol Violation|3|||
154960933|NCT00712959|559282172|FG001|Overall Study|Protocol Violation|1|||
154960934|NCT00712959|559282171|FG000|Overall Study|Lost to Follow-up|13|||
154960935|NCT00712959|559282172|FG001|Overall Study|Lost to Follow-up|2|||
154960936|NCT00712959|559282171|FG000|Overall Study|Withdrawal by Subject|3|||
154960937|NCT00712959|559282172|FG001|Overall Study|Withdrawal by Subject|0|||
154960938|NCT06284525|559282174|FG000|Overall Study|Withdrawal by Subject|1|||
154960939|NCT02149420|559282175|FG000|Core Study|Administrative problems|0|||
154960940|NCT02149420|559282176|FG001|Core Study|Administrative problems|1|||
154960941|NCT02149420|559282177|FG002|Core Study|Administrative problems|2|||
154960942|NCT02149420|559282175|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
154960943|NCT02149420|559282176|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
154960944|NCT02149420|559282177|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
155068730|NCT00831844|559681080|FG007|Overall Study|Adverse Event|0|||
155068731|NCT00831844|559681081|FG008|Overall Study|Adverse Event|0|||
155068732|NCT00831844|559681082|FG009|Overall Study|Adverse Event|0|||
155068733|NCT00831844|559681073|FG000|Overall Study|Death|0|||
155068734|NCT00831844|559681074|FG001|Overall Study|Death|0|||
155322511|NCT03505710|560617334|FG000|Overall Study|Other Reasons|1|||
155322512|NCT03505710|560617335|FG001|Overall Study|Other Reasons|1|||
155322513|NCT03505710|560617336|FG002|Overall Study|Other Reasons|1|||
155322514|NCT03505710|560617334|FG000|Overall Study|Study Terminated by Sponsor|0|||
155322515|NCT03505710|560617335|FG001|Overall Study|Study Terminated by Sponsor|0|||
155322516|NCT03505710|560617336|FG002|Overall Study|Study Terminated by Sponsor|1|||
155322517|NCT04414722|560617339|FG000|Overall Study|Lost to Follow-up|3|||
155322518|NCT04414722|560617340|FG001|Overall Study|Lost to Follow-up|4|||
155322519|NCT04414722|560617341|FG002|Overall Study|Lost to Follow-up|3|||
154960945|NCT00834067|559282180|FG000|Washout of 21 Days|Protocol Violation|0|||
154960946|NCT00834067|559282181|FG001|Washout of 21 Days|Protocol Violation|1|||
154960947|NCT00440518|559282182|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
154960948|NCT00440518|559282183|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
155322520|NCT04414722|560617342|FG003|Overall Study|Lost to Follow-up|2|||
155322521|NCT04414722|560617343|FG004|Overall Study|Lost to Follow-up|3|||
154960949|NCT00440518|559282184|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
154960950|NCT00440518|559282182|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
154960951|NCT00440518|559282183|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
154960952|NCT00440518|559282184|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
154960953|NCT00440518|559282182|FG000|Randomized /Titration Period|Protocol Deviation|1|||
154960954|NCT00440518|559282183|FG001|Randomized /Titration Period|Protocol Deviation|0|||
154960955|NCT00440518|559282184|FG002|Randomized /Titration Period|Protocol Deviation|0|||
154960956|NCT00440518|559282182|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
154960957|NCT00440518|559282183|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
155322522|NCT04414722|560617339|FG000|Overall Study|Withdrawal by Subject|6|||
154960958|NCT00440518|559282184|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
154960959|NCT00440518|559282182|FG000|Randomized /Titration Period|Other|1|||
155322523|NCT04414722|560617340|FG001|Overall Study|Withdrawal by Subject|3|||
154960960|NCT00440518|559282183|FG001|Randomized /Titration Period|Other|0|||
155068735|NCT00831844|559681075|FG002|Overall Study|Death|0|||
155322524|NCT04414722|560617341|FG002|Overall Study|Withdrawal by Subject|1|||
154960961|NCT00440518|559282184|FG002|Randomized /Titration Period|Other|0|||
155068736|NCT00831844|559681076|FG003|Overall Study|Death|1|||
155068737|NCT00831844|559681077|FG004|Overall Study|Death|0|||
155322525|NCT04414722|560617342|FG003|Overall Study|Withdrawal by Subject|5|||
155322526|NCT04414722|560617343|FG004|Overall Study|Withdrawal by Subject|1|||
155322527|NCT04414722|560617339|FG000|Overall Study|Physician Decision|0|||
155322528|NCT04414722|560617340|FG001|Overall Study|Physician Decision|1|||
155322529|NCT04414722|560617341|FG002|Overall Study|Physician Decision|2|||
155322530|NCT04414722|560617342|FG003|Overall Study|Physician Decision|0|||
155322531|NCT04414722|560617343|FG004|Overall Study|Physician Decision|0|||
155322532|NCT04414722|560617339|FG000|Overall Study|Non-participatory|0|||
155322533|NCT04414722|560617340|FG001|Overall Study|Non-participatory|1|||
155322534|NCT04414722|560617341|FG002|Overall Study|Non-participatory|1|||
155322535|NCT04414722|560617342|FG003|Overall Study|Non-participatory|0|||
155322536|NCT04414722|560617343|FG004|Overall Study|Non-participatory|0|||
155322537|NCT05464069|560617344|FG000|Overall Study|Protocol Violation|3|||
155322538|NCT05464069|560617345|FG001|Overall Study|Protocol Violation|2|||
155322539|NCT04615273|560617349|FG000|Overall Study|Withdrawal by Subject|3|||
155322540|NCT04615273|560617350|FG001|Overall Study|Withdrawal by Subject|1|||
155322541|NCT04615273|560617351|FG002|Overall Study|Withdrawal by Subject|2|||
155322542|NCT04615273|560617349|FG000|Overall Study|Adverse Event|1|||
155322543|NCT04615273|560617350|FG001|Overall Study|Adverse Event|0|||
155322544|NCT04615273|560617351|FG002|Overall Study|Adverse Event|1|||
155322545|NCT04615273|560617349|FG000|Overall Study|Lost to Follow-up|0|||
155322546|NCT04615273|560617350|FG001|Overall Study|Lost to Follow-up|1|||
155322547|NCT04615273|560617351|FG002|Overall Study|Lost to Follow-up|0|||
155322548|NCT04615273|560617349|FG000|Overall Study|Physician Decision|0|||
155322549|NCT04615273|560617350|FG001|Overall Study|Physician Decision|0|||
155322550|NCT04615273|560617351|FG002|Overall Study|Physician Decision|1|||
155322551|NCT04615273|560617349|FG000|Overall Study|Other|0|||
155322552|NCT04615273|560617350|FG001|Overall Study|Other|1|||
155322553|NCT04615273|560617351|FG002|Overall Study|Other|0|||
155322554|NCT04615273|560617349|FG000|Overall Study|Randomized but not treated|1|||
155322555|NCT04615273|560617350|FG001|Overall Study|Randomized but not treated|3|||
155322556|NCT04615273|560617351|FG002|Overall Study|Randomized but not treated|1|||
155322557|NCT03677141|560617352|FG000|Overall Study|Death|2|||
155322558|NCT03677141|560617353|FG001|Overall Study|Death|1|||
155322559|NCT03677141|560617354|FG002|Overall Study|Death|6|||
155322560|NCT03677141|560617355|FG003|Overall Study|Death|9|||
155322561|NCT03677141|560617356|FG004|Overall Study|Death|5|||
155322562|NCT03677141|560617357|FG005|Overall Study|Death|3|||
155322563|NCT03677141|560617352|FG000|Overall Study|Lost to Follow-up|0|||
155322564|NCT03677141|560617353|FG001|Overall Study|Lost to Follow-up|0|||
155322565|NCT03677141|560617354|FG002|Overall Study|Lost to Follow-up|0|||
155322566|NCT03677141|560617355|FG003|Overall Study|Lost to Follow-up|2|||
155322567|NCT03677141|560617356|FG004|Overall Study|Lost to Follow-up|0|||
155322568|NCT03677141|560617357|FG005|Overall Study|Lost to Follow-up|0|||
155322569|NCT03677141|560617352|FG000|Overall Study|Screen failure or enrolled in error|0|||
155322570|NCT03677141|560617353|FG001|Overall Study|Screen failure or enrolled in error|0|||
155322571|NCT03677141|560617354|FG002|Overall Study|Screen failure or enrolled in error|0|||
155322572|NCT03677141|560617355|FG003|Overall Study|Screen failure or enrolled in error|0|||
155322573|NCT03677141|560617356|FG004|Overall Study|Screen failure or enrolled in error|2|||
155322574|NCT03677141|560617357|FG005|Overall Study|Screen failure or enrolled in error|0|||
155322575|NCT03677141|560617352|FG000|Overall Study|Physician Decision|0|||
155322576|NCT03677141|560617353|FG001|Overall Study|Physician Decision|0|||
155322577|NCT03677141|560617354|FG002|Overall Study|Physician Decision|0|||
155322578|NCT03677141|560617355|FG003|Overall Study|Physician Decision|0|||
155322579|NCT03677141|560617356|FG004|Overall Study|Physician Decision|1|||
155322580|NCT03677141|560617357|FG005|Overall Study|Physician Decision|0|||
155322581|NCT03677141|560617352|FG000|Overall Study|Withdrawal by Subject|0|||
155322582|NCT03677141|560617353|FG001|Overall Study|Withdrawal by Subject|0|||
155322583|NCT03677141|560617354|FG002|Overall Study|Withdrawal by Subject|1|||
155322584|NCT03677141|560617355|FG003|Overall Study|Withdrawal by Subject|1|||
155322585|NCT03677141|560617356|FG004|Overall Study|Withdrawal by Subject|1|||
155322586|NCT03677141|560617357|FG005|Overall Study|Withdrawal by Subject|0|||
155322587|NCT01314105|560617361|FG000|Overall Study|Progressive Disease|6|||
155322588|NCT01314105|560617362|FG001|Overall Study|Progressive Disease|10|||
155322589|NCT01314105|560617361|FG000|Overall Study|Refused to continue taking medication|0|||
155322590|NCT01314105|560617362|FG001|Overall Study|Refused to continue taking medication|1|||
155322591|NCT01314105|560617361|FG000|Overall Study|Other Adverse Event|1|||
155322592|NCT01314105|560617362|FG001|Overall Study|Other Adverse Event|1|||
155322593|NCT04526886|560617363|FG000|Overall Study|Physician Decision|4|||
155322594|NCT04820322|560617369|FG000|Overall Study|Adverse Event|1|||
155322595|NCT04820322|560617370|FG001|Overall Study|Adverse Event|0|||
155322596|NCT03156465|560617376|FG000|Overall Study|Withdrawal by Subject|2|||
155322597|NCT03640286|560617377|FG000|Overall Study|Adverse Event|6|||
155322598|NCT03640286|560617378|FG001|Overall Study|Adverse Event|6|||
155322599|NCT03640286|560617377|FG000|Overall Study|Lost to Follow-up|3|||
155322600|NCT03640286|560617378|FG001|Overall Study|Lost to Follow-up|6|||
155322601|NCT03640286|560617377|FG000|Overall Study|Pregnancy|1|||
155322602|NCT03640286|560617378|FG001|Overall Study|Pregnancy|0|||
155322603|NCT03640286|560617377|FG000|Overall Study|Withdrawal by Subject|10|||
155322604|NCT03640286|560617378|FG001|Overall Study|Withdrawal by Subject|10|||
155322605|NCT03640286|560617377|FG000|Overall Study|Non-compliance|4|||
155322606|NCT03640286|560617378|FG001|Overall Study|Non-compliance|10|||
155322607|NCT03640286|560617377|FG000|Overall Study|Medication change|1|||
155322608|NCT03640286|560617378|FG001|Overall Study|Medication change|0|||
155322609|NCT03640286|560617377|FG000|Overall Study|Other|1|||
155322610|NCT03640286|560617378|FG001|Overall Study|Other|2|||
155322611|NCT03640286|560617377|FG000|Overall Study|Joined another lifestyle program|0|||
155322612|NCT03640286|560617378|FG001|Overall Study|Joined another lifestyle program|1|||
155322613|NCT03580356|560617379|FG000|Treatment Period|Withdrawal by Subject|13|||
155322614|NCT03580356|560617380|FG001|Treatment Period|Withdrawal by Subject|0|||
155322615|NCT03580356|560617381|FG002|Treatment Period|Withdrawal by Subject|13|||
155322616|NCT03580356|560617382|FG003|Treatment Period|Withdrawal by Subject|1|||
155322617|NCT03580356|560617383|FG004|Treatment Period|Withdrawal by Subject|17|||
155322618|NCT03580356|560617384|FG005|Treatment Period|Withdrawal by Subject|0|||
155322619|NCT03580356|560617385|FG006|Treatment Period|Withdrawal by Subject|5|||
155322620|NCT03580356|560617386|FG007|Treatment Period|Withdrawal by Subject|0|||
155322621|NCT03580356|560617379|FG000|Treatment Period|Adverse Event|10|||
155322622|NCT03580356|560617380|FG001|Treatment Period|Adverse Event|0|||
155322623|NCT03580356|560617381|FG002|Treatment Period|Adverse Event|13|||
155322624|NCT03580356|560617382|FG003|Treatment Period|Adverse Event|0|||
155322625|NCT03580356|560617383|FG004|Treatment Period|Adverse Event|5|||
155322626|NCT03580356|560617384|FG005|Treatment Period|Adverse Event|0|||
155322627|NCT03580356|560617385|FG006|Treatment Period|Adverse Event|8|||
155322628|NCT03580356|560617386|FG007|Treatment Period|Adverse Event|0|||
155322629|NCT03580356|560617379|FG000|Treatment Period|Protocol Violation|5|||
155322630|NCT03580356|560617380|FG001|Treatment Period|Protocol Violation|0|||
155322631|NCT03580356|560617381|FG002|Treatment Period|Protocol Violation|6|||
155322632|NCT03580356|560617382|FG003|Treatment Period|Protocol Violation|1|||
155322633|NCT03580356|560617383|FG004|Treatment Period|Protocol Violation|9|||
155322634|NCT03580356|560617384|FG005|Treatment Period|Protocol Violation|1|||
155322635|NCT03580356|560617385|FG006|Treatment Period|Protocol Violation|1|||
155322636|NCT03580356|560617386|FG007|Treatment Period|Protocol Violation|0|||
155322637|NCT03580356|560617379|FG000|Treatment Period|Lack of Efficacy|6|||
155322638|NCT03580356|560617380|FG001|Treatment Period|Lack of Efficacy|0|||
155322639|NCT03580356|560617381|FG002|Treatment Period|Lack of Efficacy|2|||
155322640|NCT03580356|560617382|FG003|Treatment Period|Lack of Efficacy|0|||
155162841|NCT03853109|560031755|FG005|Overall Study|Death|20|||
155162842|NCT03853109|560031756|FG006|Overall Study|Death|10|||
155162843|NCT03853109|560031757|FG007|Overall Study|Death|5|||
155162844|NCT04032093|560031758|FG000|Overall Study|Lost to Follow-up|7|||
155162845|NCT04032093|560031759|FG001|Overall Study|Lost to Follow-up|7|||
155162846|NCT04032093|560031760|FG002|Overall Study|Lost to Follow-up|6|||
155162847|NCT04032093|560031761|FG003|Overall Study|Lost to Follow-up|10|||
155162848|NCT04032093|560031762|FG004|Overall Study|Lost to Follow-up|13|||
155162849|NCT04032093|560031763|FG005|Overall Study|Lost to Follow-up|7|||
155162850|NCT04032093|560031764|FG006|Overall Study|Lost to Follow-up|7|||
155322641|NCT03580356|560617383|FG004|Treatment Period|Lack of Efficacy|3|||
155322642|NCT03580356|560617384|FG005|Treatment Period|Lack of Efficacy|0|||
155322643|NCT03580356|560617385|FG006|Treatment Period|Lack of Efficacy|3|||
155322644|NCT03580356|560617386|FG007|Treatment Period|Lack of Efficacy|0|||
155322645|NCT03580356|560617379|FG000|Treatment Period|Pregnancy|1|||
155322646|NCT03580356|560617380|FG001|Treatment Period|Pregnancy|0|||
155322647|NCT03580356|560617381|FG002|Treatment Period|Pregnancy|7|||
155322648|NCT03580356|560617382|FG003|Treatment Period|Pregnancy|0|||
155322649|NCT03580356|560617383|FG004|Treatment Period|Pregnancy|2|||
155322650|NCT03580356|560617384|FG005|Treatment Period|Pregnancy|0|||
155322651|NCT03580356|560617385|FG006|Treatment Period|Pregnancy|1|||
155322652|NCT03580356|560617386|FG007|Treatment Period|Pregnancy|0|||
155322653|NCT03580356|560617379|FG000|Treatment Period|Physician Decision|2|||
155322654|NCT03580356|560617380|FG001|Treatment Period|Physician Decision|0|||
155322655|NCT03580356|560617381|FG002|Treatment Period|Physician Decision|1|||
155322656|NCT03580356|560617382|FG003|Treatment Period|Physician Decision|0|||
155322657|NCT03580356|560617383|FG004|Treatment Period|Physician Decision|4|||
155322658|NCT03580356|560617384|FG005|Treatment Period|Physician Decision|0|||
155322659|NCT03580356|560617385|FG006|Treatment Period|Physician Decision|2|||
155322660|NCT03580356|560617386|FG007|Treatment Period|Physician Decision|0|||
155322661|NCT03580356|560617379|FG000|Treatment Period|Lost to Follow-up|1|||
155322662|NCT03580356|560617380|FG001|Treatment Period|Lost to Follow-up|1|||
155322663|NCT03580356|560617381|FG002|Treatment Period|Lost to Follow-up|1|||
155322664|NCT03580356|560617382|FG003|Treatment Period|Lost to Follow-up|0|||
155322665|NCT03580356|560617383|FG004|Treatment Period|Lost to Follow-up|3|||
155162851|NCT04032093|560031765|FG007|Overall Study|Lost to Follow-up|5|||
155322666|NCT03580356|560617384|FG005|Treatment Period|Lost to Follow-up|0|||
155322667|NCT03580356|560617385|FG006|Treatment Period|Lost to Follow-up|1|||
155322668|NCT03580356|560617386|FG007|Treatment Period|Lost to Follow-up|0|||
155322669|NCT03580356|560617379|FG000|Treatment Period|Death|0|||
155322670|NCT03580356|560617380|FG001|Treatment Period|Death|0|||
155322671|NCT03580356|560617381|FG002|Treatment Period|Death|1|||
155322672|NCT03580356|560617382|FG003|Treatment Period|Death|0|||
155322673|NCT03580356|560617383|FG004|Treatment Period|Death|0|||
155322674|NCT03580356|560617384|FG005|Treatment Period|Death|0|||
155322675|NCT03580356|560617385|FG006|Treatment Period|Death|0|||
155322676|NCT03580356|560617386|FG007|Treatment Period|Death|0|||
155322677|NCT03580356|560617379|FG000|Treatment Period|Technical problems|0|||
155322678|NCT03580356|560617380|FG001|Treatment Period|Technical problems|0|||
155322679|NCT03580356|560617381|FG002|Treatment Period|Technical problems|0|||
155322680|NCT03580356|560617382|FG003|Treatment Period|Technical problems|0|||
155322681|NCT03580356|560617383|FG004|Treatment Period|Technical problems|1|||
155322682|NCT03580356|560617384|FG005|Treatment Period|Technical problems|0|||
155322683|NCT03580356|560617385|FG006|Treatment Period|Technical problems|0|||
155322684|NCT03580356|560617386|FG007|Treatment Period|Technical problems|0|||
155322685|NCT03580356|560617379|FG000|Treatment Period|Misrandomized, no treatment|0|||
155322686|NCT03580356|560617380|FG001|Treatment Period|Misrandomized, no treatment|0|||
155322687|NCT03580356|560617381|FG002|Treatment Period|Misrandomized, no treatment|1|||
155322688|NCT03580356|560617382|FG003|Treatment Period|Misrandomized, no treatment|0|||
155322689|NCT03580356|560617383|FG004|Treatment Period|Misrandomized, no treatment|2|||
155322690|NCT03580356|560617384|FG005|Treatment Period|Misrandomized, no treatment|0|||
155322691|NCT03580356|560617385|FG006|Treatment Period|Misrandomized, no treatment|0|||
155322692|NCT03580356|560617386|FG007|Treatment Period|Misrandomized, no treatment|0|||
155322693|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
155322694|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
155322695|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
155322696|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
155322697|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
155322698|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
155322699|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
155322700|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
155322701|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
155322702|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322703|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
155322704|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322705|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
155322706|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322707|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322708|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
155322709|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
155322710|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
155322711|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
155322712|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
155322713|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
155322714|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
155322715|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
155322716|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
155322717|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322718|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322719|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
155322720|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
154960962|NCT00440518|559282182|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
154960963|NCT00440518|559282183|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
154960964|NCT00440518|559282184|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
154960965|NCT00440518|559282182|FG000|Randomized /Titration Period|Adverse Event|2|||
154960966|NCT00440518|559282183|FG001|Randomized /Titration Period|Adverse Event|3|||
154960967|NCT00440518|559282184|FG002|Randomized /Titration Period|Adverse Event|0|||
154960968|NCT00440518|559282182|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
154960969|NCT00440518|559282183|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
154960970|NCT00440518|559282184|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
154960971|NCT00440518|559282182|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
154960972|NCT00440518|559282183|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
154960973|NCT00440518|559282184|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
154960974|NCT00440518|559282182|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
154960975|NCT00440518|559282183|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
155322721|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
155322722|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322723|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322724|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
155322725|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
155322726|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
155322727|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
155322728|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
155322729|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
155322730|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
155322731|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
155322732|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
155322733|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
155322734|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
155322735|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
155322736|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
155322737|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
155322738|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
155322739|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
155322740|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
155322741|NCT03580356|560617379|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
155322742|NCT03580356|560617380|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
155322743|NCT03580356|560617381|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
155322744|NCT03580356|560617382|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
155322745|NCT03580356|560617383|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
155322746|NCT03580356|560617384|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
155322747|NCT03580356|560617385|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
155322748|NCT03580356|560617386|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
155322749|NCT02839265|560617398|FG000|Overall Study|Screen Failure|2|||
155322750|NCT02839265|560617398|FG000|Overall Study|Death|1|||
155322751|NCT02839265|560617398|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
155322752|NCT05552508|560617399|FG000|Overall Study|Adverse Event|3|||
155322753|NCT04311632|560617401|FG000|Overall Study|Withdrawal by Subject|0|||
155322754|NCT04311632|560617402|FG001|Overall Study|Withdrawal by Subject|0|||
155322755|NCT04311632|560617403|FG002|Overall Study|Withdrawal by Subject|1|||
155322756|NCT04632225|560617404|FG000|Overall Study|Withdrawal by Subject|2|||
155162852|NCT04032093|560031766|FG008|Overall Study|Lost to Follow-up|9|||
155162853|NCT04032093|560031767|FG009|Overall Study|Lost to Follow-up|12|||
155162854|NCT04032093|560031758|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155162855|NCT04032093|560031759|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155162856|NCT04032093|560031760|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155162857|NCT04032093|560031761|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
155162858|NCT04032093|560031762|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
155162859|NCT04032093|560031763|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155162860|NCT04032093|560031764|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
155162861|NCT04032093|560031765|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155162862|NCT04032093|560031766|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
155162863|NCT04032093|560031767|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
155162864|NCT04032093|560031758|FG000|Overall Study|Other|1|||
155162865|NCT04032093|560031759|FG001|Overall Study|Other|0|||
155162866|NCT04032093|560031760|FG002|Overall Study|Other|0|||
155162867|NCT04032093|560031761|FG003|Overall Study|Other|1|||
155162868|NCT04032093|560031762|FG004|Overall Study|Other|1|||
155162869|NCT04032093|560031763|FG005|Overall Study|Other|0|||
155162870|NCT04032093|560031764|FG006|Overall Study|Other|0|||
155162871|NCT04032093|560031765|FG007|Overall Study|Other|0|||
155162872|NCT04032093|560031766|FG008|Overall Study|Other|0|||
155162873|NCT04032093|560031767|FG009|Overall Study|Other|1|||
155162874|NCT04032093|560031758|FG000|Overall Study|Withdrawal by Subject|1|||
155162875|NCT04032093|560031759|FG001|Overall Study|Withdrawal by Subject|3|||
155322757|NCT04632225|560617405|FG001|Overall Study|Withdrawal by Subject|2|||
155322758|NCT02323880|560617406|FG000|Overall Study|Adverse Event|2|||
155322759|NCT02323880|560617407|FG001|Overall Study|Adverse Event|0|||
155322760|NCT02323880|560617408|FG002|Overall Study|Adverse Event|1|||
155322761|NCT02323880|560617409|FG003|Overall Study|Adverse Event|1|||
154960976|NCT00440518|559282184|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
155162876|NCT04032093|560031760|FG002|Overall Study|Withdrawal by Subject|2|||
155162877|NCT04032093|560031761|FG003|Overall Study|Withdrawal by Subject|2|||
155162878|NCT04032093|560031762|FG004|Overall Study|Withdrawal by Subject|3|||
155162879|NCT04032093|560031763|FG005|Overall Study|Withdrawal by Subject|0|||
155322762|NCT02323880|560617410|FG004|Overall Study|Adverse Event|1|||
155322763|NCT02323880|560617411|FG005|Overall Study|Adverse Event|0|||
155322764|NCT02323880|560617412|FG006|Overall Study|Adverse Event|1|||
155322765|NCT02323880|560617413|FG007|Overall Study|Adverse Event|0|||
155322766|NCT02323880|560617406|FG000|Overall Study|Death|0|||
155322767|NCT02323880|560617407|FG001|Overall Study|Death|0|||
155322768|NCT02323880|560617408|FG002|Overall Study|Death|0|||
155322769|NCT02323880|560617409|FG003|Overall Study|Death|0|||
155322770|NCT02323880|560617410|FG004|Overall Study|Death|0|||
155322771|NCT02323880|560617411|FG005|Overall Study|Death|1|||
155322772|NCT02323880|560617412|FG006|Overall Study|Death|0|||
155322773|NCT02323880|560617413|FG007|Overall Study|Death|0|||
155322774|NCT02323880|560617406|FG000|Overall Study|Lack of Efficacy|4|||
155322775|NCT02323880|560617407|FG001|Overall Study|Lack of Efficacy|11|||
155322776|NCT02323880|560617408|FG002|Overall Study|Lack of Efficacy|5|||
155322777|NCT02323880|560617409|FG003|Overall Study|Lack of Efficacy|5|||
155322778|NCT02323880|560617410|FG004|Overall Study|Lack of Efficacy|4|||
155322779|NCT02323880|560617411|FG005|Overall Study|Lack of Efficacy|8|||
155322780|NCT02323880|560617412|FG006|Overall Study|Lack of Efficacy|4|||
155322781|NCT02323880|560617413|FG007|Overall Study|Lack of Efficacy|6|||
155322782|NCT02323880|560617406|FG000|Overall Study|Physician Decision|0|||
155322783|NCT02323880|560617407|FG001|Overall Study|Physician Decision|0|||
155322784|NCT02323880|560617408|FG002|Overall Study|Physician Decision|0|||
155322785|NCT02323880|560617409|FG003|Overall Study|Physician Decision|0|||
155322786|NCT02323880|560617410|FG004|Overall Study|Physician Decision|1|||
155322787|NCT02323880|560617411|FG005|Overall Study|Physician Decision|1|||
155322788|NCT02323880|560617412|FG006|Overall Study|Physician Decision|1|||
155322789|NCT02323880|560617413|FG007|Overall Study|Physician Decision|0|||
155322790|NCT02323880|560617406|FG000|Overall Study|Withdrawal by Subject|0|||
155322791|NCT02323880|560617407|FG001|Overall Study|Withdrawal by Subject|2|||
155322792|NCT02323880|560617408|FG002|Overall Study|Withdrawal by Subject|0|||
155322793|NCT02323880|560617409|FG003|Overall Study|Withdrawal by Subject|0|||
155322794|NCT02323880|560617410|FG004|Overall Study|Withdrawal by Subject|0|||
155322795|NCT02323880|560617411|FG005|Overall Study|Withdrawal by Subject|0|||
155322796|NCT02323880|560617412|FG006|Overall Study|Withdrawal by Subject|0|||
155322797|NCT02323880|560617413|FG007|Overall Study|Withdrawal by Subject|0|||
155322798|NCT04934072|560617414|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
155322799|NCT04934072|560617415|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
155322800|NCT04934072|560617416|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
155322801|NCT04934072|560617417|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
155322802|NCT04934072|560617418|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
155322803|NCT04934072|560617414|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
155322804|NCT04934072|560617415|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
155322805|NCT04934072|560617416|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
155322806|NCT04934072|560617417|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
155322807|NCT04934072|560617418|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
155322808|NCT04934072|560617414|FG000|Day 0 to Week 52|Other|3|||
155322809|NCT04934072|560617415|FG001|Day 0 to Week 52|Other|1|||
155322810|NCT04934072|560617416|FG002|Day 0 to Week 52|Other|0|||
155322811|NCT04934072|560617417|FG003|Day 0 to Week 52|Other|0|||
155322812|NCT04934072|560617418|FG004|Day 0 to Week 52|Other|0|||
155322813|NCT04934072|560617414|FG000|Day 0 to Week 52|Adverse Event|1|||
155322814|NCT04934072|560617415|FG001|Day 0 to Week 52|Adverse Event|3|||
155322815|NCT04934072|560617416|FG002|Day 0 to Week 52|Adverse Event|0|||
155322816|NCT04934072|560617417|FG003|Day 0 to Week 52|Adverse Event|0|||
155322817|NCT04934072|560617418|FG004|Day 0 to Week 52|Adverse Event|0|||
155322818|NCT04934072|560617414|FG000|Week 52 to Week 78|Adverse Event|0|||
155322819|NCT04934072|560617415|FG001|Week 52 to Week 78|Adverse Event|0|||
155322820|NCT04934072|560617416|FG002|Week 52 to Week 78|Adverse Event|0|||
155322821|NCT04934072|560617417|FG003|Week 52 to Week 78|Adverse Event|1|||
155322822|NCT04934072|560617418|FG004|Week 52 to Week 78|Adverse Event|1|||
155322823|NCT04934072|560617414|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
155322824|NCT04934072|560617415|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
155322825|NCT04934072|560617416|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
155322826|NCT04934072|560617417|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
155322827|NCT04934072|560617418|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
155322828|NCT04934072|560617414|FG000|Week 52 to Week 78|Other|0|||
155322829|NCT04934072|560617415|FG001|Week 52 to Week 78|Other|0|||
155322830|NCT04934072|560617416|FG002|Week 52 to Week 78|Other|1|||
155322831|NCT04934072|560617417|FG003|Week 52 to Week 78|Other|0|||
155322832|NCT04934072|560617418|FG004|Week 52 to Week 78|Other|0|||
155322833|NCT00844415|560617422|FG000|Overall Study|Withdrawal by Subject|1|||
155322834|NCT03174275|560617423|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
155322835|NCT03174275|560617423|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
155322836|NCT03174275|560617423|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
155322837|NCT03174275|560617423|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
155322838|NCT03174275|560617423|FG000|Adjuvant Chemotherapy|Progression|1|||
155322839|NCT03174275|560617423|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
155322840|NCT03174275|560617423|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
155322841|NCT03174275|560617423|FG000|Adjuvant Durvalumab|Progression|1|||
155322842|NCT03174275|560617423|FG000|Adjuvant Durvalumab|Adverse Event|3|||
155322843|NCT03174275|560617423|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
155322844|NCT03174275|560617423|FG000|Adjuvant Radiotherapy|Progression|1|||
155322845|NCT03174275|560617423|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
155322846|NCT03717935|560617424|FG000|Overall Study|Withdrawal by Subject|0|||
155322847|NCT03717935|560617425|FG001|Overall Study|Withdrawal by Subject|2|||
155322848|NCT03015532|560617430|FG000|Overall Study|Adverse Event|0|||
155322849|NCT03015532|560617431|FG001|Overall Study|Adverse Event|0|||
155322850|NCT03015532|560617432|FG002|Overall Study|Adverse Event|0|||
155322851|NCT03015532|560617433|FG003|Overall Study|Adverse Event|0|||
155322852|NCT03015532|560617434|FG004|Overall Study|Adverse Event|0|||
155322853|NCT03015532|560617435|FG005|Overall Study|Adverse Event|2|||
155322854|NCT03015532|560617436|FG006|Overall Study|Adverse Event|1|||
155322855|NCT03015532|560617437|FG007|Overall Study|Adverse Event|0|||
155322856|NCT03015532|560617430|FG000|Overall Study|Withdrawal by Subject|0|||
155322857|NCT03015532|560617431|FG001|Overall Study|Withdrawal by Subject|0|||
155322858|NCT03015532|560617432|FG002|Overall Study|Withdrawal by Subject|0|||
155322859|NCT03015532|560617433|FG003|Overall Study|Withdrawal by Subject|0|||
155322860|NCT03015532|560617434|FG004|Overall Study|Withdrawal by Subject|0|||
155322861|NCT03015532|560617435|FG005|Overall Study|Withdrawal by Subject|0|||
155322862|NCT03015532|560617436|FG006|Overall Study|Withdrawal by Subject|1|||
155322863|NCT03015532|560617437|FG007|Overall Study|Withdrawal by Subject|0|||
155322864|NCT02990338|560617438|FG000|Overall Study|Randomized and not treated|4|||
155322865|NCT02990338|560617439|FG001|Overall Study|Randomized and not treated|2|||
155322866|NCT02990338|560617438|FG000|Overall Study|Adverse Event|23|||
155322867|NCT02990338|560617439|FG001|Overall Study|Adverse Event|22|||
155322868|NCT02990338|560617438|FG000|Overall Study|Progressive disease|118|||
155322869|NCT02990338|560617439|FG001|Overall Study|Progressive disease|107|||
155322870|NCT02990338|560617438|FG000|Overall Study|Poor compliance to protocol|0|||
155322871|NCT02990338|560617439|FG001|Overall Study|Poor compliance to protocol|1|||
155322872|NCT02990338|560617438|FG000|Overall Study|Withdrawal by Subject|6|||
155322873|NCT02990338|560617439|FG001|Overall Study|Withdrawal by Subject|8|||
155322874|NCT02990338|560617438|FG000|Overall Study|Physician's decision|2|||
155322875|NCT02990338|560617439|FG001|Overall Study|Physician's decision|6|||
155322876|NCT02990338|560617438|FG000|Overall Study|Treatment extension study|0|||
155322877|NCT02990338|560617439|FG001|Overall Study|Treatment extension study|6|||
155322878|NCT02990338|560617438|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
155322879|NCT02990338|560617439|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
155322880|NCT02990338|560617438|FG000|Overall Study|Continue with therapy available commercially|0|||
155162880|NCT04032093|560031764|FG006|Overall Study|Withdrawal by Subject|0|||
155162881|NCT04032093|560031765|FG007|Overall Study|Withdrawal by Subject|0|||
155162882|NCT04032093|560031766|FG008|Overall Study|Withdrawal by Subject|0|||
155162883|NCT04032093|560031767|FG009|Overall Study|Withdrawal by Subject|0|||
155162884|NCT04032093|560031758|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155162885|NCT04032093|560031759|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155162886|NCT04032093|560031760|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155162887|NCT04032093|560031761|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155162888|NCT04032093|560031762|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155162889|NCT04032093|560031763|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155162890|NCT04032093|560031764|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
155162891|NCT04032093|560031765|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
155162892|NCT04032093|560031766|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
155162893|NCT04032093|560031767|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
155162894|NCT04032093|560031758|FG000|Overall Study|Adverse Event|0|||
155162895|NCT04032093|560031759|FG001|Overall Study|Adverse Event|0|||
155162896|NCT04032093|560031760|FG002|Overall Study|Adverse Event|0|||
155162897|NCT04032093|560031761|FG003|Overall Study|Adverse Event|0|||
155162898|NCT04032093|560031762|FG004|Overall Study|Adverse Event|0|||
155162899|NCT04032093|560031763|FG005|Overall Study|Adverse Event|0|||
155162900|NCT04032093|560031764|FG006|Overall Study|Adverse Event|0|||
155322881|NCT02990338|560617439|FG001|Overall Study|Continue with therapy available commercially|1|||
155322882|NCT02641730|560617442|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
155322883|NCT02641730|560617443|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155322884|NCT02641730|560617444|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
155322885|NCT02641730|560617445|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
155322886|NCT02641730|560617446|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
155322887|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155322888|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
155322889|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
155162901|NCT04032093|560031765|FG007|Overall Study|Adverse Event|0|||
155322890|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
155162902|NCT04032093|560031766|FG008|Overall Study|Adverse Event|0|||
155162903|NCT04032093|560031767|FG009|Overall Study|Adverse Event|1|||
155322891|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
155322892|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
155322893|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
155322894|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
155322895|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
155322896|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
155322897|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155322898|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155322899|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155322900|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
155322901|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
155322902|NCT02641730|560617442|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
155322903|NCT02641730|560617443|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
155322904|NCT02641730|560617444|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
155322905|NCT02641730|560617445|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
155322906|NCT02641730|560617446|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
155322907|NCT02641730|560617442|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
155322908|NCT02641730|560617443|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
155322909|NCT02641730|560617444|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
155322910|NCT02641730|560617445|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
155322911|NCT02641730|560617446|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
155322912|NCT05460871|560617447|FG000|Overall Study|Withdrawal by Subject|1|||
155322913|NCT05460871|560617448|FG001|Overall Study|Withdrawal by Subject|2|||
155322914|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
155322915|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
155322916|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
155322917|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
155322918|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
155322919|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
155322920|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
155322921|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
155322922|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
155322923|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
155322924|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
155322925|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
155322926|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
155322927|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
155322928|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
155322929|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
155322930|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
155322931|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
155322932|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
155322933|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
155322934|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
155322935|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
155322936|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
155322937|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
155322938|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
155322939|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
155322940|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
155322941|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
155322942|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
155322943|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
155322944|NCT04614948|560617450|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
155322945|NCT04614948|560617451|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
155322946|NCT04614948|560617452|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
155322947|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
155322948|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
155322949|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
155322950|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
155322951|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
155322952|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
155322953|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
155322954|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
155322955|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
155322956|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
155322957|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
155322958|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
155322959|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
155322960|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
155322961|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
155322962|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
155322963|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
155322964|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
155322965|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
155322966|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
155322967|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
155322968|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
155322969|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
155322970|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
155322971|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
155322972|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
155322973|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
155322974|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
155322975|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
155322976|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
155322977|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
155322978|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
155322979|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
155322980|NCT04614948|560617450|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
155322981|NCT04614948|560617451|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
155322982|NCT04614948|560617452|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
155322983|NCT04271046|560617453|FG000|Overall Study|Death|0|||
155322984|NCT04271046|560617454|FG001|Overall Study|Death|2|||
155322985|NCT04271046|560617455|FG002|Overall Study|Death|0|||
155322986|NCT04271046|560617456|FG003|Overall Study|Death|2|||
155322987|NCT04271046|560617453|FG000|Overall Study|Lost to Follow-up|12|||
155322988|NCT04271046|560617454|FG001|Overall Study|Lost to Follow-up|12|||
155322989|NCT04271046|560617455|FG002|Overall Study|Lost to Follow-up|11|||
155322990|NCT04271046|560617456|FG003|Overall Study|Lost to Follow-up|11|||
155322991|NCT04271046|560617453|FG000|Overall Study|Patient with Dementia Died|2|||
155322992|NCT04271046|560617454|FG001|Overall Study|Patient with Dementia Died|0|||
155322993|NCT04271046|560617455|FG002|Overall Study|Patient with Dementia Died|2|||
155322994|NCT04271046|560617456|FG003|Overall Study|Patient with Dementia Died|0|||
155322995|NCT04271046|560617453|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
155322996|NCT04271046|560617454|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
155322997|NCT04271046|560617455|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
155322998|NCT04271046|560617456|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
155322999|NCT03663205|560617457|FG000|Overall Study|Death|144|||
155323000|NCT03663205|560617458|FG001|Overall Study|Death|69|||
155323001|NCT03663205|560617457|FG000|Overall Study|Sponsor decision|53|||
155323002|NCT03663205|560617458|FG001|Overall Study|Sponsor decision|19|||
155323003|NCT03663205|560617457|FG000|Overall Study|Withdrawal by Subject|8|||
155323004|NCT03663205|560617458|FG001|Overall Study|Withdrawal by Subject|11|||
155323005|NCT03663205|560617457|FG000|Overall Study|Lost to Follow-up|7|||
155323006|NCT03663205|560617458|FG001|Overall Study|Lost to Follow-up|9|||
155323007|NCT03663205|560617457|FG000|Overall Study|Transferred to long term extension study|11|||
155323008|NCT03663205|560617458|FG001|Overall Study|Transferred to long term extension study|3|||
155323009|NCT05962814|560617459|FG000|Overall Study|failed eligibility|1|||
155323010|NCT03057054|560617462|FG000|Overall Study|Death|4|||
155323011|NCT03057054|560617463|FG001|Overall Study|Death|4|||
155323012|NCT03057054|560617462|FG000|Overall Study|Withdrawal by Subject|6|||
155323013|NCT03057054|560617463|FG001|Overall Study|Withdrawal by Subject|3|||
155323014|NCT03057054|560617462|FG000|Overall Study|Ineligible|1|||
155323015|NCT03057054|560617463|FG001|Overall Study|Ineligible|1|||
155323016|NCT03972150|560618571|FG000|Overall Study|Adverse Event|0|||
155323017|NCT03972150|560618572|FG001|Overall Study|Adverse Event|1|||
155323018|NCT03972150|560618573|FG002|Overall Study|Adverse Event|1|||
155323019|NCT03972150|560618574|FG003|Overall Study|Adverse Event|0|||
155323020|NCT03972150|560618575|FG004|Overall Study|Adverse Event|0|||
155323021|NCT03972150|560618571|FG000|Overall Study|Progressive disease|3|||
155323022|NCT03972150|560618572|FG001|Overall Study|Progressive disease|5|||
155323023|NCT03972150|560618573|FG002|Overall Study|Progressive disease|2|||
155323024|NCT03972150|560618574|FG003|Overall Study|Progressive disease|2|||
155323025|NCT03972150|560618575|FG004|Overall Study|Progressive disease|3|||
155323026|NCT03181516|560618577|FG000|Overall Study|Withdrawal by Subject|14|||
155323027|NCT03181516|560618578|FG001|Overall Study|Withdrawal by Subject|7|||
155323028|NCT03181516|560618577|FG000|Overall Study|Lost to Follow-up|2|||
155323029|NCT03181516|560618578|FG001|Overall Study|Lost to Follow-up|2|||
155323030|NCT04544007|560618581|FG000|Overall Study|Withdrawal by Subject|1|||
155323031|NCT04544007|560618581|FG000|Overall Study|Confirmed Progressive Disease|1|||
155323032|NCT03485729|560618582|FG000|Overall Study|Withdrawal by Subject|0|||
155323033|NCT03485729|560618583|FG001|Overall Study|Withdrawal by Subject|0|||
155323034|NCT03485729|560618584|FG002|Overall Study|Withdrawal by Subject|1|||
155323035|NCT03485729|560618582|FG000|Overall Study|Disease progression|8|||
155323036|NCT03485729|560618583|FG001|Overall Study|Disease progression|13|||
155323037|NCT03485729|560618584|FG002|Overall Study|Disease progression|1|||
155323038|NCT03485729|560618582|FG000|Overall Study|Hospice care|1|||
155323039|NCT03485729|560618583|FG001|Overall Study|Hospice care|0|||
155323040|NCT03485729|560618584|FG002|Overall Study|Hospice care|0|||
155323041|NCT03485729|560618582|FG000|Overall Study|Poor performance status|1|||
155323042|NCT03485729|560618583|FG001|Overall Study|Poor performance status|0|||
155323043|NCT03485729|560618584|FG002|Overall Study|Poor performance status|0|||
155323044|NCT03485729|560618582|FG000|Overall Study|Illness|0|||
155323045|NCT03485729|560618583|FG001|Overall Study|Illness|1|||
155323046|NCT03485729|560618584|FG002|Overall Study|Illness|0|||
155323047|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
155323048|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
155323049|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
155323050|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
155323051|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
155323052|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
155323053|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
155323054|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
155323055|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
155323056|NCT04880733|560618585|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
155323057|NCT04880733|560618586|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
155323058|NCT04880733|560618587|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
155323059|NCT04880733|560618585|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
155323060|NCT04880733|560618586|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
155323061|NCT04880733|560618587|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
155323062|NCT04451772|560618602|FG000|Overall Study|Adverse Event|1|||
155323063|NCT04451772|560618603|FG001|Overall Study|Adverse Event|0|||
155323064|NCT04451772|560618604|FG002|Overall Study|Adverse Event|1|||
155323065|NCT04451772|560618605|FG003|Overall Study|Adverse Event|1|||
155323066|NCT04451772|560618606|FG004|Overall Study|Adverse Event|0|||
155323067|NCT04451772|560618607|FG005|Overall Study|Adverse Event|3|||
155323068|NCT04451772|560618602|FG000|Overall Study|Withdrawal by Subject|2|||
155323069|NCT04451772|560618603|FG001|Overall Study|Withdrawal by Subject|7|||
155323070|NCT04451772|560618604|FG002|Overall Study|Withdrawal by Subject|2|||
155323071|NCT04451772|560618605|FG003|Overall Study|Withdrawal by Subject|1|||
155323072|NCT04451772|560618606|FG004|Overall Study|Withdrawal by Subject|1|||
155323073|NCT04451772|560618607|FG005|Overall Study|Withdrawal by Subject|0|||
155323074|NCT04451772|560618602|FG000|Overall Study|Other, not specified|1|||
155323075|NCT04451772|560618603|FG001|Overall Study|Other, not specified|2|||
155323076|NCT04451772|560618604|FG002|Overall Study|Other, not specified|1|||
155323077|NCT04451772|560618605|FG003|Overall Study|Other, not specified|0|||
155323078|NCT04451772|560618606|FG004|Overall Study|Other, not specified|0|||
155323079|NCT04451772|560618607|FG005|Overall Study|Other, not specified|1|||
155323080|NCT04451772|560618602|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
155323081|NCT04451772|560618603|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
155323082|NCT04451772|560618604|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
155323083|NCT04451772|560618605|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
155323084|NCT04451772|560618606|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
155323085|NCT04451772|560618607|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
155323086|NCT04605159|560618608|FG000|Overall Study|Adverse Event|6|||
155323087|NCT04605159|560618609|FG001|Overall Study|Adverse Event|3|||
155323088|NCT04605159|560618610|FG002|Overall Study|Adverse Event|21|||
155323089|NCT04605159|560618611|FG003|Overall Study|Adverse Event|4|||
155323090|NCT04605159|560618608|FG000|Overall Study|Lost to Follow-up|74|||
155323091|NCT04605159|560618609|FG001|Overall Study|Lost to Follow-up|45|||
155323092|NCT04605159|560618610|FG002|Overall Study|Lost to Follow-up|119|||
155323093|NCT04605159|560618611|FG003|Overall Study|Lost to Follow-up|80|||
155323094|NCT04605159|560618608|FG000|Overall Study|Protocol Violation|4|||
155323095|NCT04605159|560618609|FG001|Overall Study|Protocol Violation|5|||
155323096|NCT04605159|560618610|FG002|Overall Study|Protocol Violation|2|||
155323097|NCT04605159|560618611|FG003|Overall Study|Protocol Violation|0|||
155323098|NCT04605159|560618608|FG000|Overall Study|Withdrawal by Subject|66|||
155323099|NCT04605159|560618609|FG001|Overall Study|Withdrawal by Subject|37|||
155323100|NCT04605159|560618610|FG002|Overall Study|Withdrawal by Subject|68|||
155323101|NCT04605159|560618611|FG003|Overall Study|Withdrawal by Subject|50|||
155323102|NCT04605159|560618608|FG000|Overall Study|Migrated / moved from the study area|32|||
155323103|NCT04605159|560618609|FG001|Overall Study|Migrated / moved from the study area|22|||
155323104|NCT04605159|560618610|FG002|Overall Study|Migrated / moved from the study area|41|||
155323105|NCT04605159|560618611|FG003|Overall Study|Migrated / moved from the study area|21|||
155323106|NCT04605159|560618608|FG000|Overall Study|Other|1|||
155323107|NCT04605159|560618609|FG001|Overall Study|Other|2|||
155323108|NCT04605159|560618610|FG002|Overall Study|Other|7|||
155323109|NCT04605159|560618611|FG003|Overall Study|Other|3|||
155323110|NCT04218851|560618615|FG000|Overall Study|Death|1|||
155323111|NCT04218851|560618616|FG001|Overall Study|Death|3|||
155323112|NCT01820611|560618617|FG000|Overall Study|Death|8|||
155323113|NCT01820611|560618617|FG000|Overall Study|Adverse Event|1|||
155323114|NCT01820611|560618617|FG000|Overall Study|Withdrawal by Subject|9|||
155323115|NCT03484819|560618618|FG000|Overall Study|Death|2|||
155323116|NCT03484819|560618618|FG000|Overall Study|Adverse Event|2|||
155323117|NCT03484819|560618618|FG000|Overall Study|Physician Decision|1|||
155323118|NCT03484819|560618618|FG000|Overall Study|Withdrawal by Subject|2|||
155323119|NCT03484819|560618618|FG000|Overall Study|Disease Progression|4|||
155323120|NCT03484819|560618618|FG000|Overall Study|Complicating Condition|1|||
155323121|NCT05970861|560618619|FG000|Overall Study|Physician Decision|4|||
155323122|NCT05970861|560618620|FG001|Overall Study|Physician Decision|4|||
155323123|NCT05970861|560618619|FG000|Overall Study|Lost to Follow-up|4|||
155323124|NCT05970861|560618620|FG001|Overall Study|Lost to Follow-up|3|||
155323125|NCT04186819|560618622|FG000|Overall Study|Adverse Event|1|||
155323126|NCT04186819|560618622|FG000|Overall Study|Lost to Follow-up|1|||
155323127|NCT04186819|560618622|FG000|Overall Study|Opted for EBRT|1|||
155323128|NCT04186819|560618622|FG000|Overall Study|Opted SBRT|1|||
155323129|NCT04186819|560618622|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
155323130|NCT04186819|560618622|FG000|Overall Study|Physician Decision|1|||
155323131|NCT04186819|560618622|FG000|Overall Study|RP Delayed|1|||
155323132|NCT04186819|560618622|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
155323133|NCT04186819|560618622|FG000|Overall Study|Subject declined for financial reasons|1|||
155323134|NCT04186819|560618622|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
155323135|NCT04186819|560618622|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
155323136|NCT04186819|560618622|FG000|Overall Study|The subject opted for other treatment option|2|||
155323137|NCT04186819|560618622|FG000|Overall Study|The subject opted for other treatment options|1|||
155323138|NCT04186819|560618622|FG000|Overall Study|Withdrawal by Subject|3|||
155323139|NCT04186819|560618622|FG000|Overall Study|Reason not specified|1|||
155323140|NCT03988621|560618627|FG000|Overall Study|Lost to Follow-up|16|||
155323141|NCT03988621|560618628|FG001|Overall Study|Lost to Follow-up|17|||
155323142|NCT03988621|560618627|FG000|Overall Study|Withdrawal by Subject|14|||
155323143|NCT03988621|560618628|FG001|Overall Study|Withdrawal by Subject|7|||
155323144|NCT03988621|560618627|FG000|Overall Study|Patient Lost to Follow Up|15|||
155323145|NCT03988621|560618628|FG001|Overall Study|Patient Lost to Follow Up|15|||
155323146|NCT03988621|560618627|FG000|Overall Study|Patient death|1|||
155323147|NCT03988621|560618628|FG001|Overall Study|Patient death|5|||
155323148|NCT05013385|560618629|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
155323149|NCT01447719|560618634|FG000|Overall Study|Image acquisition failure|2|||
155323150|NCT01447719|560618634|FG000|Overall Study|Invalid image or not imaged|3|||
155323151|NCT01447719|560618634|FG000|Overall Study|Subject still living at end of study|79|||
155323152|NCT01447719|560618634|FG000|Overall Study|Withdrawal by Subject|2|||
155323153|NCT01447719|560618634|FG000|Overall Study|Family withdrew autopsy consent|7|||
155323154|NCT03914469|560618635|FG000|Overall Study|Lost to Follow-up|1|||
155323155|NCT03914469|560618636|FG001|Overall Study|Lost to Follow-up|4|||
155323156|NCT03252288|560618637|FG000|Overall Study|Death|1|||
155323157|NCT03252288|560618638|FG001|Overall Study|Death|0|||
155323158|NCT03252288|560618639|FG002|Overall Study|Death|0|||
155323159|NCT03252288|560618637|FG000|Overall Study|Death|11|||
155323160|NCT03252288|560618638|FG001|Overall Study|Death|0|||
155323161|NCT03252288|560618639|FG002|Overall Study|Death|0|||
155323162|NCT03252288|560618637|FG000|Overall Study|Withdrawal by Subject|2|||
155323163|NCT03252288|560618638|FG001|Overall Study|Withdrawal by Subject|0|||
155323164|NCT03252288|560618639|FG002|Overall Study|Withdrawal by Subject|0|||
155323165|NCT03252288|560618637|FG000|Overall Study|Lost to Follow-up|79|||
155323166|NCT03252288|560618638|FG001|Overall Study|Lost to Follow-up|0|||
155323167|NCT03252288|560618639|FG002|Overall Study|Lost to Follow-up|0|||
155323168|NCT03252288|560618637|FG000|Overall Study|Loss of baseline data on tablets|6|||
155323169|NCT03252288|560618638|FG001|Overall Study|Loss of baseline data on tablets|0|||
155323170|NCT03252288|560618639|FG002|Overall Study|Loss of baseline data on tablets|0|||
155323171|NCT00677365|560618640|FG000|Overall Study|Adverse Event|2|||
155323172|NCT00677365|560618641|FG001|Overall Study|Adverse Event|1|||
155323173|NCT00677365|560618642|FG002|Overall Study|Adverse Event|1|||
155323174|NCT00677365|560618643|FG003|Overall Study|Adverse Event|2|||
155323175|NCT00677365|560618640|FG000|Overall Study|Withdrawal by Subject|0|||
155323176|NCT00677365|560618641|FG001|Overall Study|Withdrawal by Subject|0|||
155323177|NCT00677365|560618642|FG002|Overall Study|Withdrawal by Subject|1|||
155323178|NCT00677365|560618643|FG003|Overall Study|Withdrawal by Subject|0|||
155323179|NCT00677365|560618640|FG000|Overall Study|Other reason|0|||
155323180|NCT00677365|560618641|FG001|Overall Study|Other reason|0|||
155323181|NCT00677365|560618642|FG002|Overall Study|Other reason|0|||
155323182|NCT00677365|560618643|FG003|Overall Study|Other reason|1|||
154960977|NCT00440518|559282182|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
154960978|NCT00440518|559282183|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
154960979|NCT00440518|559282184|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
154960980|NCT00440518|559282182|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
155323183|NCT02944968|560618644|FG000|Overall Study|Subject excluded before study procedure|1|||
155323184|NCT02944968|560618644|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
155323185|NCT02905331|560618645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
155323186|NCT02905331|560618646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
154960981|NCT00440518|559282183|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
154960982|NCT00440518|559282184|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
154960983|NCT00440518|559282182|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
154960984|NCT00440518|559282183|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
154960985|NCT00440518|559282184|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
154960986|NCT02436005|559282185|FG000|Second Intervention|Adverse Event|0|||
154960987|NCT02436005|559282186|FG001|Second Intervention|Adverse Event|1|||
154960988|NCT00804856|559282189|FG000|Overall Study|Progressive Disease|3|||
154960989|NCT00804856|559282190|FG001|Overall Study|Progressive Disease|2|||
154960990|NCT00804856|559282191|FG002|Overall Study|Progressive Disease|4|||
154960991|NCT00804856|559282192|FG003|Overall Study|Progressive Disease|6|||
154960992|NCT00804856|559282193|FG004|Overall Study|Progressive Disease|4|||
154960993|NCT00804856|559282194|FG005|Overall Study|Progressive Disease|1|||
154960994|NCT00804856|559282195|FG006|Overall Study|Progressive Disease|8|||
154960995|NCT00804856|559282196|FG007|Overall Study|Progressive Disease|2|||
154960996|NCT00804856|559282197|FG008|Overall Study|Progressive Disease|4|||
154960997|NCT00804856|559282198|FG009|Overall Study|Progressive Disease|5|||
154960998|NCT00804856|559282199|FG010|Overall Study|Progressive Disease|12|||
154960999|NCT00804856|559282200|FG011|Overall Study|Progressive Disease|2|||
154961000|NCT00804856|559282201|FG012|Overall Study|Progressive Disease|2|||
154961001|NCT00804856|559282202|FG013|Overall Study|Progressive Disease|26|||
154961002|NCT00804856|559282203|FG014|Overall Study|Progressive Disease|20|||
154961003|NCT00804856|559282189|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961004|NCT00804856|559282190|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961005|NCT00804856|559282191|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961006|NCT00804856|559282192|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961007|NCT00804856|559282193|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
154961008|NCT00804856|559282194|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961009|NCT00804856|559282195|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961010|NCT00804856|559282196|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961011|NCT00804856|559282197|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961012|NCT00804856|559282198|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961013|NCT00804856|559282199|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961014|NCT00804856|559282200|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961015|NCT00804856|559282201|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961016|NCT00804856|559282202|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154961017|NCT00804856|559282203|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155068738|NCT00831844|559681078|FG005|Overall Study|Death|0|||
155323187|NCT02905331|560618647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
155323188|NCT02905331|560618645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
155323189|NCT02905331|560618646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
155068739|NCT00831844|559681079|FG006|Overall Study|Death|0|||
155068740|NCT00831844|559681080|FG007|Overall Study|Death|0|||
155068741|NCT00831844|559681081|FG008|Overall Study|Death|0|||
155323190|NCT02905331|560618647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
155323191|NCT02905331|560618645|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
154961018|NCT00804856|559282189|FG000|Overall Study|Other Adverse Event|1|||
154961019|NCT00804856|559282190|FG001|Overall Study|Other Adverse Event|1|||
154961020|NCT00804856|559282191|FG002|Overall Study|Other Adverse Event|1|||
155068742|NCT00831844|559681082|FG009|Overall Study|Death|0|||
155068743|NCT00831844|559681073|FG000|Overall Study|Lack of Efficacy|8|||
155323192|NCT02905331|560618646|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
155323193|NCT02905331|560618647|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
155323194|NCT02905331|560618645|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
155323195|NCT02905331|560618646|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
155323196|NCT02905331|560618647|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
155323197|NCT02905331|560618645|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
155323198|NCT02905331|560618646|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
155323199|NCT02905331|560618647|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
155323200|NCT04102111|560618655|FG000|Overall Study|Withdrawal by Subject|2|||
155323201|NCT04102111|560618656|FG001|Overall Study|Withdrawal by Subject|3|||
155323202|NCT04102111|560618655|FG000|Overall Study|Adverse Event|1|||
155323203|NCT04102111|560618656|FG001|Overall Study|Adverse Event|1|||
155323204|NCT04102111|560618655|FG000|Overall Study|Study terminated by sponsor|1|||
155323205|NCT04102111|560618656|FG001|Overall Study|Study terminated by sponsor|3|||
155323206|NCT03334695|560618657|FG000|Overall Study|Lost to Follow-up|3|||
155323207|NCT03334695|560618658|FG001|Overall Study|Lost to Follow-up|3|||
155323208|NCT03334695|560618657|FG000|Overall Study|Physician Decision|1|||
155323209|NCT03334695|560618658|FG001|Overall Study|Physician Decision|2|||
155323210|NCT03334695|560618657|FG000|Overall Study|Protocol Violation|0|||
155068744|NCT00831844|559681074|FG001|Overall Study|Lack of Efficacy|10|||
155068745|NCT00831844|559681075|FG002|Overall Study|Lack of Efficacy|15|||
155068746|NCT00831844|559681076|FG003|Overall Study|Lack of Efficacy|8|||
155068747|NCT00831844|559681077|FG004|Overall Study|Lack of Efficacy|11|||
155068748|NCT00831844|559681078|FG005|Overall Study|Lack of Efficacy|17|||
155323211|NCT03334695|560618658|FG001|Overall Study|Protocol Violation|1|||
155323212|NCT02542631|560618659|FG000|Overall Study|Adverse Event|1|||
155323213|NCT02542631|560618660|FG001|Overall Study|Adverse Event|1|||
155068749|NCT00831844|559681079|FG006|Overall Study|Lack of Efficacy|8|||
155323214|NCT02542631|560618659|FG000|Overall Study|Sponsor Termination|1|||
155323215|NCT02542631|560618660|FG001|Overall Study|Sponsor Termination|0|||
155323216|NCT02542631|560618659|FG000|Overall Study|Withdrawal by Subject|11|||
155323217|NCT02542631|560618660|FG001|Overall Study|Withdrawal by Subject|16|||
155323218|NCT02542631|560618659|FG000|Overall Study|Protocol Violation|1|||
155323219|NCT02542631|560618660|FG001|Overall Study|Protocol Violation|1|||
155323220|NCT02542631|560618659|FG000|Overall Study|Physician Decision|6|||
155323221|NCT02542631|560618660|FG001|Overall Study|Physician Decision|4|||
155068750|NCT00831844|559681080|FG007|Overall Study|Lack of Efficacy|9|||
154961021|NCT00804856|559282192|FG003|Overall Study|Other Adverse Event|2|||
154961022|NCT00804856|559282193|FG004|Overall Study|Other Adverse Event|2|||
154961023|NCT00804856|559282194|FG005|Overall Study|Other Adverse Event|1|||
154961024|NCT00804856|559282195|FG006|Overall Study|Other Adverse Event|3|||
154961025|NCT00804856|559282196|FG007|Overall Study|Other Adverse Event|0|||
154961026|NCT00804856|559282197|FG008|Overall Study|Other Adverse Event|0|||
154961027|NCT00804856|559282198|FG009|Overall Study|Other Adverse Event|1|||
154961028|NCT00804856|559282199|FG010|Overall Study|Other Adverse Event|5|||
154961029|NCT00804856|559282200|FG011|Overall Study|Other Adverse Event|2|||
154961030|NCT00804856|559282201|FG012|Overall Study|Other Adverse Event|0|||
155068751|NCT00831844|559681081|FG008|Overall Study|Lack of Efficacy|7|||
155068752|NCT00831844|559681082|FG009|Overall Study|Lack of Efficacy|0|||
155323222|NCT02542631|560618659|FG000|Overall Study|Lost to Follow-up|6|||
155323223|NCT02542631|560618660|FG001|Overall Study|Lost to Follow-up|5|||
155323224|NCT02542631|560618659|FG000|Overall Study|Death|1|||
155323225|NCT02542631|560618660|FG001|Overall Study|Death|2|||
155323226|NCT02542631|560618659|FG000|Overall Study|Other|2|||
155323227|NCT02542631|560618660|FG001|Overall Study|Other|1|||
155323228|NCT02542631|560618659|FG000|Overall Study|Used Prohibited Medication|2|||
155323229|NCT02542631|560618660|FG001|Overall Study|Used Prohibited Medication|1|||
155323230|NCT02938923|560618661|FG000|Overall Study|Death|1|||
155323231|NCT02938923|560618662|FG001|Overall Study|Death|0|||
155323232|NCT02938923|560618663|FG002|Overall Study|Death|0|||
155323233|NCT02938923|560618661|FG000|Overall Study|Physician Decision|0|||
155323234|NCT02938923|560618662|FG001|Overall Study|Physician Decision|2|||
155323235|NCT02938923|560618663|FG002|Overall Study|Physician Decision|0|||
155323236|NCT02938923|560618661|FG000|Overall Study|Withdrawal by Subject|0|||
155323237|NCT02938923|560618662|FG001|Overall Study|Withdrawal by Subject|1|||
155323238|NCT02938923|560618663|FG002|Overall Study|Withdrawal by Subject|1|||
155323239|NCT00721149|560618664|FG000|Overall Study|Physician Decision|1|||
155323240|NCT06010836|560618672|FG000|Overall Study|Lost to Follow-up|2|||
155323241|NCT06010836|560618673|FG001|Overall Study|Lost to Follow-up|2|||
155323242|NCT06010836|560618672|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
155323243|NCT06010836|560618673|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
155323244|NCT06010836|560618672|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
155323245|NCT06010836|560618673|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
155323246|NCT06010836|560618672|FG000|Overall Study|Did not receive intervention discussion|0|||
155323247|NCT06010836|560618673|FG001|Overall Study|Did not receive intervention discussion|4|||
155323248|NCT05890105|560618677|FG000|Overall Study|Adverse Event|1|||
155323249|NCT05890105|560618678|FG001|Overall Study|Adverse Event|0|||
155323250|NCT05890105|560618679|FG002|Overall Study|Adverse Event|0|||
155323251|NCT05890105|560618677|FG000|Overall Study|Other|1|||
155323252|NCT05890105|560618678|FG001|Overall Study|Other|2|||
155323253|NCT05890105|560618679|FG002|Overall Study|Other|0|||
155323254|NCT04206787|560618680|FG000|Overall Study|Other than listed|2|||
155323255|NCT04206787|560618680|FG000|Overall Study|Investigator decision|1|||
155323256|NCT04206787|560618680|FG000|Overall Study|Death|25|||
155323257|NCT04206787|560618680|FG000|Overall Study|Lost to Follow-up|9|||
155323258|NCT04206787|560618680|FG000|Overall Study|Withdrawal of consent|9|||
155323259|NCT04505410|560618682|FG000|Overall Study|Adverse Event|2|||
155323260|NCT04505410|560618683|FG001|Overall Study|Adverse Event|0|||
155323261|NCT04505410|560618682|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
155323262|NCT04505410|560618683|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
155323263|NCT04505410|560618682|FG000|Overall Study|did not want to follow diet|1|||
155323264|NCT04505410|560618683|FG001|Overall Study|did not want to follow diet|0|||
155323265|NCT04505410|560618682|FG000|Overall Study|flare up of ulcerative colitis|0|||
155323266|NCT04505410|560618683|FG001|Overall Study|flare up of ulcerative colitis|1|||
155323267|NCT04505410|560618682|FG000|Overall Study|Lost to Follow-up|0|||
155323268|NCT04505410|560618683|FG001|Overall Study|Lost to Follow-up|2|||
155323269|NCT04505410|560618682|FG000|Overall Study|Lost to Follow-up|1|||
155323270|NCT04505410|560618683|FG001|Overall Study|Lost to Follow-up|0|||
154961031|NCT00804856|559282202|FG013|Overall Study|Other Adverse Event|6|||
155068753|NCT00831844|559681073|FG000|Overall Study|Physician Decision|0|||
155068754|NCT00831844|559681074|FG001|Overall Study|Physician Decision|1|||
155068755|NCT00831844|559681075|FG002|Overall Study|Physician Decision|3|||
155323271|NCT04505410|560618682|FG000|Overall Study|initiated another diet on their own|0|||
155068756|NCT00831844|559681076|FG003|Overall Study|Physician Decision|1|||
155323272|NCT04505410|560618683|FG001|Overall Study|initiated another diet on their own|2|||
155323273|NCT03533257|560618692|FG000|Overall Study|Adverse Event|4|||
155323274|NCT03533257|560618693|FG001|Overall Study|Adverse Event|2|||
155323275|NCT03533257|560618692|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
155323276|NCT03533257|560618693|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
155323277|NCT04108130|560619875|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
154961032|NCT00804856|559282203|FG014|Overall Study|Other Adverse Event|13|||
154961033|NCT00804856|559282189|FG000|Overall Study|Non compliance with protocol|0|||
155068757|NCT00831844|559681077|FG004|Overall Study|Physician Decision|1|||
155068758|NCT00831844|559681078|FG005|Overall Study|Physician Decision|1|||
155323278|NCT04108130|560619876|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
155323279|NCT04108130|560619875|FG000|Overall Study|Consent Withdrawn|9|||
155323280|NCT04108130|560619876|FG001|Overall Study|Consent Withdrawn|6|||
155323281|NCT04108130|560619875|FG000|Overall Study|Surgery Cancelled|4|||
155323282|NCT04108130|560619876|FG001|Overall Study|Surgery Cancelled|4|||
155323283|NCT04108130|560619875|FG000|Overall Study|Found Ineligible for Study|4|||
155323284|NCT04108130|560619876|FG001|Overall Study|Found Ineligible for Study|3|||
155323285|NCT04108130|560619875|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
155323286|NCT04108130|560619876|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
155323287|NCT04108130|560619875|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
155323288|NCT04108130|560619876|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
155323289|NCT01130883|560619877|FG000|Overall Study|Patient Noncompliance|6|||
155323290|NCT01130883|560619877|FG000|Overall Study|Reason Unknown|1|||
155323291|NCT01130883|560619877|FG000|Overall Study|Adverse Event|3|||
155323292|NCT05311176|560619880|FG000|Overall Study|Death|6|||
155323293|NCT05311176|560619880|FG000|Overall Study|Sponsor discontinued the study|1|||
155323294|NCT06106022|560619885|FG000|Overall Study|Lost to Follow-up|1|||
155323295|NCT06106022|560619886|FG001|Overall Study|Lost to Follow-up|0|||
155323296|NCT06106022|560619885|FG000|Overall Study|Voluntary Withdrawal|0|||
155323297|NCT06106022|560619886|FG001|Overall Study|Voluntary Withdrawal|2|||
155323298|NCT05405985|560619887|FG000|Overall Study|Withdrawal by Subject|1|||
155323299|NCT05405985|560619888|FG001|Overall Study|Withdrawal by Subject|0|||
155323300|NCT05424380|560619891|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
155323301|NCT05424380|560619892|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323302|NCT05424380|560619893|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323303|NCT05424380|560619894|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323304|NCT05424380|560619895|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323305|NCT05424380|560619896|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
155323306|NCT05424380|560619891|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
155323307|NCT05424380|560619892|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323308|NCT05424380|560619893|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323309|NCT05424380|560619894|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323310|NCT05424380|560619895|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323311|NCT05424380|560619896|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
155323312|NCT05424380|560619891|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
155323313|NCT05424380|560619892|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323314|NCT05424380|560619893|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323315|NCT05424380|560619894|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323316|NCT05424380|560619895|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323317|NCT05424380|560619896|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
155323318|NCT05424380|560619891|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323319|NCT05424380|560619892|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
155323320|NCT05424380|560619893|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323321|NCT05424380|560619894|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323322|NCT05424380|560619895|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323323|NCT05424380|560619896|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
155323324|NCT05424380|560619891|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323325|NCT05424380|560619892|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
155323326|NCT05424380|560619893|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323327|NCT05424380|560619894|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323328|NCT05424380|560619895|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323329|NCT05424380|560619896|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
155323330|NCT05424380|560619891|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155068759|NCT00831844|559681079|FG006|Overall Study|Physician Decision|0|||
155323331|NCT05424380|560619892|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155323332|NCT05424380|560619893|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
155323333|NCT05424380|560619894|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155068760|NCT00831844|559681080|FG007|Overall Study|Physician Decision|0|||
155068761|NCT00831844|559681081|FG008|Overall Study|Physician Decision|1|||
155068762|NCT00831844|559681082|FG009|Overall Study|Physician Decision|0|||
155068763|NCT00831844|559681073|FG000|Overall Study|Withdrawal by Subject|0|||
155068764|NCT00831844|559681074|FG001|Overall Study|Withdrawal by Subject|0|||
155068765|NCT00831844|559681075|FG002|Overall Study|Withdrawal by Subject|1|||
155068766|NCT00831844|559681076|FG003|Overall Study|Withdrawal by Subject|0|||
155068767|NCT00831844|559681077|FG004|Overall Study|Withdrawal by Subject|0|||
155323334|NCT05424380|560619895|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155323335|NCT05424380|560619896|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
155068768|NCT00831844|559681078|FG005|Overall Study|Withdrawal by Subject|0|||
155068769|NCT00831844|559681079|FG006|Overall Study|Withdrawal by Subject|0|||
155068770|NCT00831844|559681080|FG007|Overall Study|Withdrawal by Subject|1|||
155323336|NCT05424380|560619891|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323337|NCT05424380|560619892|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323338|NCT05424380|560619893|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
155323339|NCT05424380|560619894|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323340|NCT05424380|560619895|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323341|NCT05424380|560619896|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
155323342|NCT05424380|560619891|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323343|NCT05424380|560619892|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323344|NCT05424380|560619893|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
155323345|NCT05424380|560619894|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323346|NCT05424380|560619895|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323347|NCT05424380|560619896|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
155323348|NCT05424380|560619891|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323349|NCT05424380|560619892|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323350|NCT05424380|560619893|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323351|NCT05424380|560619894|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
155323352|NCT05424380|560619895|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323353|NCT05424380|560619896|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323354|NCT05424380|560619891|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323355|NCT05424380|560619892|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323356|NCT05424380|560619893|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323357|NCT05424380|560619894|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
155068771|NCT00831844|559681081|FG008|Overall Study|Withdrawal by Subject|1|||
155068772|NCT00831844|559681082|FG009|Overall Study|Withdrawal by Subject|0|||
155068773|NCT00831844|559681073|FG000|Overall Study|Ineligible|0|||
155068774|NCT00831844|559681074|FG001|Overall Study|Ineligible|1|||
155068775|NCT00831844|559681075|FG002|Overall Study|Ineligible|1|||
155068776|NCT00831844|559681076|FG003|Overall Study|Ineligible|0|||
155068777|NCT00831844|559681077|FG004|Overall Study|Ineligible|1|||
155068778|NCT00831844|559681078|FG005|Overall Study|Ineligible|0|||
155068779|NCT00831844|559681079|FG006|Overall Study|Ineligible|0|||
155068780|NCT00831844|559681080|FG007|Overall Study|Ineligible|0|||
155068781|NCT00831844|559681081|FG008|Overall Study|Ineligible|0|||
155068782|NCT00831844|559681082|FG009|Overall Study|Ineligible|0|||
155068783|NCT00315445|559681085|FG000|Overall Study|Adverse Event|7|||
155323358|NCT05424380|560619895|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323359|NCT05424380|560619896|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
155323360|NCT05424380|560619891|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155068784|NCT00315445|559681086|FG001|Overall Study|Adverse Event|12|||
155068785|NCT00315445|559681087|FG002|Overall Study|Adverse Event|15|||
155068786|NCT00315445|559681085|FG000|Overall Study|Lack of Efficacy|16|||
155068787|NCT00315445|559681086|FG001|Overall Study|Lack of Efficacy|1|||
155068788|NCT00315445|559681087|FG002|Overall Study|Lack of Efficacy|7|||
155068789|NCT00315445|559681085|FG000|Overall Study|Lost to Follow-up|1|||
155068790|NCT00315445|559681086|FG001|Overall Study|Lost to Follow-up|0|||
155068791|NCT00315445|559681087|FG002|Overall Study|Lost to Follow-up|1|||
155068792|NCT00315445|559681085|FG000|Overall Study|Protocol Violation|2|||
155068793|NCT00315445|559681086|FG001|Overall Study|Protocol Violation|0|||
155068794|NCT00315445|559681087|FG002|Overall Study|Protocol Violation|1|||
155068795|NCT00315445|559681085|FG000|Overall Study|Other|1|||
155068796|NCT00315445|559681086|FG001|Overall Study|Other|3|||
155068797|NCT00315445|559681087|FG002|Overall Study|Other|0|||
155068798|NCT03980223|559681088|FG000|Overall Study|Lost to Follow-up|3|||
155068799|NCT03980223|559681089|FG001|Overall Study|Lost to Follow-up|7|||
155068800|NCT03980223|559681090|FG002|Overall Study|Lost to Follow-up|10|||
155068801|NCT03980223|559681091|FG003|Overall Study|Lost to Follow-up|8|||
155068802|NCT03980223|559681088|FG000|Overall Study|Withdrawal by Subject|0|||
155068803|NCT03980223|559681089|FG001|Overall Study|Withdrawal by Subject|0|||
155068804|NCT03980223|559681090|FG002|Overall Study|Withdrawal by Subject|1|||
155068805|NCT03980223|559681091|FG003|Overall Study|Withdrawal by Subject|2|||
155068806|NCT03980223|559681088|FG000|Overall Study|Physician Decision|0|||
155068807|NCT03980223|559681089|FG001|Overall Study|Physician Decision|0|||
155068808|NCT03980223|559681090|FG002|Overall Study|Physician Decision|1|||
155068809|NCT03980223|559681091|FG003|Overall Study|Physician Decision|0|||
155068810|NCT03980223|559681088|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
155068811|NCT03980223|559681089|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
155068812|NCT03980223|559681090|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
155068813|NCT03980223|559681091|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
155162904|NCT04032093|560031758|FG000|Overall Study|Physician Decision|0|||
155068814|NCT02460289|559681095|FG000|Overall Study|Adverse Event|1|||
155068815|NCT02460289|559681095|FG000|Overall Study|Withdrawal by Subject|8|||
155162905|NCT04032093|560031759|FG001|Overall Study|Physician Decision|0|||
155323361|NCT05424380|560619892|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323362|NCT05424380|560619893|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323363|NCT05424380|560619894|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
155323364|NCT05424380|560619895|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323365|NCT05424380|560619896|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
155323366|NCT05424380|560619891|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323367|NCT05424380|560619892|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323368|NCT05424380|560619893|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323369|NCT05424380|560619894|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323370|NCT05424380|560619895|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
154961034|NCT00804856|559282190|FG001|Overall Study|Non compliance with protocol|0|||
154961035|NCT00804856|559282191|FG002|Overall Study|Non compliance with protocol|0|||
154961036|NCT00804856|559282192|FG003|Overall Study|Non compliance with protocol|0|||
154961037|NCT00804856|559282193|FG004|Overall Study|Non compliance with protocol|0|||
154961038|NCT00804856|559282194|FG005|Overall Study|Non compliance with protocol|0|||
154961039|NCT00804856|559282195|FG006|Overall Study|Non compliance with protocol|0|||
155068816|NCT02460289|559681095|FG000|Overall Study|Lost to Follow-up|1|||
155068817|NCT01155570|559681096|FG000|Overall Study|Adverse Event|39|||
155323371|NCT05424380|560619896|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
155323372|NCT05424380|560619891|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323373|NCT05424380|560619892|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
154961040|NCT00804856|559282196|FG007|Overall Study|Non compliance with protocol|0|||
154961041|NCT00804856|559282197|FG008|Overall Study|Non compliance with protocol|0|||
154961042|NCT00804856|559282198|FG009|Overall Study|Non compliance with protocol|0|||
154961043|NCT00804856|559282199|FG010|Overall Study|Non compliance with protocol|0|||
154961044|NCT00804856|559282200|FG011|Overall Study|Non compliance with protocol|0|||
154961045|NCT00804856|559282201|FG012|Overall Study|Non compliance with protocol|0|||
154961046|NCT00804856|559282202|FG013|Overall Study|Non compliance with protocol|2|||
154961047|NCT00804856|559282203|FG014|Overall Study|Non compliance with protocol|0|||
154961048|NCT00804856|559282189|FG000|Overall Study|Refused to continue medication|0|||
154961049|NCT00804856|559282190|FG001|Overall Study|Refused to continue medication|0|||
154961050|NCT00804856|559282191|FG002|Overall Study|Refused to continue medication|0|||
154961051|NCT00804856|559282192|FG003|Overall Study|Refused to continue medication|1|||
154961052|NCT00804856|559282193|FG004|Overall Study|Refused to continue medication|1|||
155068818|NCT01155570|559681096|FG000|Overall Study|Lack of Efficacy|46|||
155068819|NCT01155570|559681096|FG000|Overall Study|Participant's Economic Reasons|17|||
155068820|NCT01155570|559681096|FG000|Overall Study|No Hospital Visits|7|||
155068821|NCT01155570|559681096|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
155068822|NCT01155570|559681096|FG000|Overall Study|Adverse Event + Other Reasons|7|||
155068823|NCT01155570|559681096|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
155068824|NCT01155570|559681096|FG000|Overall Study|Other Reasons|23|||
155068825|NCT02916927|559681097|FG000|Overall Study|Discharged prior to study drug receipt|0|||
155068826|NCT02916927|559681098|FG001|Overall Study|Discharged prior to study drug receipt|2|||
155068827|NCT02916927|559681097|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
155068828|NCT02916927|559681098|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
155068829|NCT02916927|559681097|FG000|Overall Study|Withdrawal before first time point|1|||
155068830|NCT02916927|559681098|FG001|Overall Study|Withdrawal before first time point|0|||
155068831|NCT00724945|559681099|FG000|Period 1|non-compliance|1|||
155068832|NCT00724945|559681100|FG001|Period 1|non-compliance|0|||
155068833|NCT00724945|559681099|FG000|Period 1|Adverse Event|1|||
155068834|NCT00724945|559681100|FG001|Period 1|Adverse Event|1|||
155068835|NCT00724945|559681099|FG000|Period 1|Lost to Follow-up|1|||
155068836|NCT00724945|559681100|FG001|Period 1|Lost to Follow-up|0|||
155068837|NCT00724945|559681099|FG000|Period 2|lens comfort issue|3|||
155068838|NCT00724945|559681100|FG001|Period 2|lens comfort issue|0|||
155068839|NCT00724945|559681099|FG000|Period 2|lens physiology issue|1|||
155068840|NCT00724945|559681100|FG001|Period 2|lens physiology issue|0|||
155068841|NCT05166876|559681101|FG000|Overall Study|Withdrawal by Subject|1|||
155068842|NCT05166876|559681102|FG001|Overall Study|Withdrawal by Subject|0|||
155068843|NCT05166876|559681103|FG002|Overall Study|Withdrawal by Subject|0|||
155068844|NCT04611126|559681110|FG000|Overall Study|TIL expansion unsuccessful|1|||
155068845|NCT04611126|559681111|FG001|Overall Study|TIL expansion unsuccessful|0|||
155068846|NCT04338581|559682679|FG000|Overall Study|Lack of Efficacy|1|||
155068847|NCT04338581|559682680|FG001|Overall Study|Lack of Efficacy|0|||
155068848|NCT04338581|559682679|FG000|Overall Study|Withdrawal by Subject|4|||
155068849|NCT04338581|559682680|FG001|Overall Study|Withdrawal by Subject|4|||
155068850|NCT04338581|559682679|FG000|Overall Study|Prohibited Medication|1|||
155068851|NCT04338581|559682680|FG001|Overall Study|Prohibited Medication|0|||
155068852|NCT01136954|559682681|FG000|Overall Study|Adverse Event|3|||
155068853|NCT01136954|559682682|FG001|Overall Study|Adverse Event|2|||
155068854|NCT01136954|559682681|FG000|Overall Study|Withdrawal by Subject|6|||
155068855|NCT01136954|559682682|FG001|Overall Study|Withdrawal by Subject|2|||
155068856|NCT01136954|559682681|FG000|Overall Study|Lack of Efficacy|14|||
155068857|NCT01136954|559682682|FG001|Overall Study|Lack of Efficacy|13|||
155068858|NCT01136954|559682681|FG000|Overall Study|Physician Decision|0|||
155068859|NCT01136954|559682682|FG001|Overall Study|Physician Decision|1|||
155068860|NCT01136954|559682681|FG000|Overall Study|Other|1|||
155068861|NCT01136954|559682682|FG001|Overall Study|Other|3|||
155068862|NCT04190225|559682689|FG000|Overall Study|Lost to Follow-up|2|||
155068863|NCT04190225|559682690|FG001|Overall Study|Lost to Follow-up|3|||
155068864|NCT04190225|559682689|FG000|Overall Study|Withdrawal by Subject|3|||
155068865|NCT04190225|559682690|FG001|Overall Study|Withdrawal by Subject|2|||
155068866|NCT04190225|559682689|FG000|Overall Study|Unrelated health condition|2|||
155068867|NCT04190225|559682690|FG001|Overall Study|Unrelated health condition|0|||
155068868|NCT02362451|559682691|FG000|Overall Study|Withdrawal by Subject|0|||
155068869|NCT02362451|559682692|FG001|Overall Study|Withdrawal by Subject|1|||
155068870|NCT02362451|559682691|FG000|Overall Study|Lack of Efficacy|2|||
155068871|NCT02362451|559682692|FG001|Overall Study|Lack of Efficacy|0|||
155068872|NCT02362451|559682691|FG000|Overall Study|Progression|1|||
155068873|NCT02362451|559682692|FG001|Overall Study|Progression|0|||
155068874|NCT02362451|559682691|FG000|Overall Study|Participant chose other therapy.|1|||
155068875|NCT02362451|559682692|FG001|Overall Study|Participant chose other therapy.|0|||
155068876|NCT01732783|559682695|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
155068877|NCT01732783|559682696|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
155068878|NCT01732783|559682697|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
155068879|NCT01732783|559682695|FG000|Overall Study|Death|13|||
155068880|NCT01732783|559682696|FG001|Overall Study|Death|4|||
155068881|NCT01732783|559682697|FG002|Overall Study|Death|1|||
155068882|NCT01732783|559682695|FG000|Overall Study|Lost to Follow-up|7|||
155068883|NCT01732783|559682696|FG001|Overall Study|Lost to Follow-up|1|||
155068884|NCT01732783|559682697|FG002|Overall Study|Lost to Follow-up|1|||
155068885|NCT01732783|559682695|FG000|Overall Study|Administrative Decision|8|||
155068886|NCT01732783|559682696|FG001|Overall Study|Administrative Decision|2|||
155068887|NCT01732783|559682697|FG002|Overall Study|Administrative Decision|1|||
155068888|NCT01732783|559682695|FG000|Overall Study|Withdrawal by Subject|1|||
155068889|NCT01732783|559682696|FG001|Overall Study|Withdrawal by Subject|0|||
155068890|NCT01732783|559682697|FG002|Overall Study|Withdrawal by Subject|0|||
155068891|NCT04429971|559682698|FG000|Overall Study|Lost to Follow-up|7|||
155068892|NCT04429971|559682699|FG001|Overall Study|Lost to Follow-up|8|||
155068893|NCT04044690|559682705|FG000|Period 1|Lack of Efficacy|1|||
155068894|NCT04044690|559682706|FG001|Period 1|Lack of Efficacy|1|||
155068895|NCT04044690|559682705|FG000|Period 1|Adverse Event|4|||
155323374|NCT05424380|560619893|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323375|NCT05424380|560619894|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323376|NCT05424380|560619895|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
155323377|NCT05424380|560619896|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
155323378|NCT05424380|560619891|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323379|NCT05424380|560619892|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323380|NCT05424380|560619893|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155068896|NCT04044690|559682706|FG001|Period 1|Adverse Event|2|||
155323381|NCT05424380|560619894|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323382|NCT05424380|560619895|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
155323383|NCT05424380|560619896|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
155323384|NCT02473445|560619901|FG000|Overall Study|Withdrawal by Subject|2|||
155323385|NCT02473445|560619901|FG000|Overall Study|Sponsor Decision|20|||
155323386|NCT04247802|560619902|FG000|Overall Study|Withdrawal by Subject|1|||
155323387|NCT04247802|560619903|FG001|Overall Study|Withdrawal by Subject|3|||
155323388|NCT04247802|560619902|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
155323389|NCT04247802|560619903|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
155323390|NCT04778410|560619908|FG000|Safety Run-in Period|Death|5|||
155068897|NCT04044690|559682705|FG000|Period 1|Physician Decision|0|||
155068898|NCT04044690|559682706|FG001|Period 1|Physician Decision|1|||
155068899|NCT04044690|559682705|FG000|Period 1|Withdrawal by Subject|2|||
155068900|NCT04044690|559682706|FG001|Period 1|Withdrawal by Subject|5|||
155068901|NCT04044690|559682705|FG000|Period 1|Protocol Deviation|2|||
155068902|NCT04044690|559682706|FG001|Period 1|Protocol Deviation|0|||
155068903|NCT04044690|559682705|FG000|Period 1|Site Terminated by Sponsor|0|||
155068904|NCT04044690|559682706|FG001|Period 1|Site Terminated by Sponsor|1|||
155068905|NCT04044690|559682705|FG000|Period 1|Study Terminated by Sponsor|0|||
155068906|NCT04044690|559682706|FG001|Period 1|Study Terminated by Sponsor|1|||
155068907|NCT04044690|559682705|FG000|Period 1|Death|1|||
155068908|NCT04044690|559682706|FG001|Period 1|Death|1|||
155068909|NCT04044690|559682705|FG000|Period 1|Other: Unspecified|1|||
155068910|NCT04044690|559682706|FG001|Period 1|Other: Unspecified|0|||
155068911|NCT04044690|559682705|FG000|Period 2|Lack of Efficacy|0|||
155068912|NCT04044690|559682706|FG001|Period 2|Lack of Efficacy|1|||
155068913|NCT04044690|559682705|FG000|Period 2|Adverse Event|0|||
155068914|NCT04044690|559682706|FG001|Period 2|Adverse Event|1|||
155068915|NCT04044690|559682705|FG000|Period 2|Physician Decision|0|||
155068916|NCT04044690|559682706|FG001|Period 2|Physician Decision|2|||
155068917|NCT04044690|559682705|FG000|Period 2|Withdrawal by Subject|5|||
155068918|NCT04044690|559682706|FG001|Period 2|Withdrawal by Subject|5|||
155068919|NCT04044690|559682705|FG000|Period 2|Lost to Follow-up|0|||
155068920|NCT04044690|559682706|FG001|Period 2|Lost to Follow-up|1|||
155068921|NCT04044690|559682705|FG000|Period 2|Site Terminated by Sponsor|1|||
155068922|NCT04044690|559682706|FG001|Period 2|Site Terminated by Sponsor|3|||
155068923|NCT04044690|559682705|FG000|Period 2|Study Terminated by Sponsor|8|||
155068924|NCT04044690|559682706|FG001|Period 2|Study Terminated by Sponsor|3|||
155068925|NCT04044690|559682705|FG000|Period 2|Death|1|||
155068926|NCT04044690|559682706|FG001|Period 2|Death|0|||
155068927|NCT04044690|559682705|FG000|Period 2|Other: Unspecified|1|||
155068928|NCT04044690|559682706|FG001|Period 2|Other: Unspecified|1|||
155068929|NCT04044690|559682705|FG000|Period 3|Site Terminated by Sponsor|1|||
155068930|NCT04044690|559682706|FG001|Period 3|Site Terminated by Sponsor|2|||
155068931|NCT04044690|559682705|FG000|Period 3|Study Terminated by Sponsor|24|||
155068932|NCT04044690|559682706|FG001|Period 3|Study Terminated by Sponsor|18|||
155068933|NCT04044690|559682705|FG000|Period 3|Missing|0|||
155068934|NCT04044690|559682706|FG001|Period 3|Missing|2|||
155068935|NCT01582451|559682707|FG000|Overall Study|Adverse Event|1|||
155068936|NCT01582451|559682708|FG001|Overall Study|Adverse Event|3|||
155068937|NCT01582451|559682707|FG000|Overall Study|Death|3|||
155068938|NCT01582451|559682708|FG001|Overall Study|Death|3|||
155068939|NCT01582451|559682707|FG000|Overall Study|Lost to Follow-up|0|||
155068940|NCT01582451|559682708|FG001|Overall Study|Lost to Follow-up|2|||
155068941|NCT01582451|559682707|FG000|Overall Study|Protocol Violation|11|||
155068942|NCT01582451|559682708|FG001|Overall Study|Protocol Violation|3|||
155068943|NCT01582451|559682707|FG000|Overall Study|Withdrawal by Subject|13|||
155068944|NCT01582451|559682708|FG001|Overall Study|Withdrawal by Subject|9|||
155068945|NCT01582451|559682707|FG000|Overall Study|Physician Decision|3|||
155068946|NCT01582451|559682708|FG001|Overall Study|Physician Decision|0|||
155068947|NCT01582451|559682707|FG000|Overall Study|Sponsor Decision|1|||
155068948|NCT01582451|559682708|FG001|Overall Study|Sponsor Decision|0|||
155068949|NCT05472142|559682711|FG000|Total Participants|Lost to Follow-up|312|||
155068950|NCT05472142|559682712|FG001|Total Participants|Lost to Follow-up|0|||
155068951|NCT05472142|559682711|FG000|Clinic Patients|Lost to Follow-up|312|||
155068952|NCT05472142|559682712|FG001|Clinic Patients|Lost to Follow-up|0|||
155323391|NCT04778410|560619909|FG001|Safety Run-in Period|Death|6|||
155323392|NCT04778410|560619910|FG002|Safety Run-in Period|Death|0|||
155068953|NCT03330197|559682713|FG000|Overall Study|Adverse Event|0|||
155068954|NCT03330197|559682714|FG001|Overall Study|Adverse Event|1|||
155068955|NCT03330197|559682713|FG000|Overall Study|Withdrawal by Subject|0|||
155068956|NCT03330197|559682714|FG001|Overall Study|Withdrawal by Subject|1|||
155068957|NCT02550795|559682718|FG000|Overall Study|Physician Decision|0|||
155068958|NCT02550795|559682719|FG001|Overall Study|Physician Decision|1|||
155068959|NCT02550795|559682720|FG002|Overall Study|Physician Decision|0|||
155068960|NCT02225587|559682721|FG000|Overall Study|Adverse Event|5|||
155068961|NCT02225587|559682722|FG001|Overall Study|Adverse Event|5|||
155068962|NCT02225587|559682721|FG000|Overall Study|Lost to Follow-up|5|||
155068963|NCT02225587|559682722|FG001|Overall Study|Lost to Follow-up|5|||
155323393|NCT04778410|560619911|FG003|Safety Run-in Period|Death|0|||
155323394|NCT04778410|560619912|FG004|Safety Run-in Period|Death|0|||
155323395|NCT04778410|560619913|FG005|Safety Run-in Period|Death|0|||
155323396|NCT04778410|560619908|FG000|Phase 2 Period|Death|0|||
155323397|NCT04778410|560619909|FG001|Phase 2 Period|Death|0|||
155323398|NCT04778410|560619910|FG002|Phase 2 Period|Death|0|||
155323399|NCT04778410|560619911|FG003|Phase 2 Period|Death|5|||
155323400|NCT04778410|560619912|FG004|Phase 2 Period|Death|18|||
155323401|NCT04778410|560619913|FG005|Phase 2 Period|Death|0|||
155323402|NCT04778410|560619908|FG000|Phase 2 Period|Lost to Follow-up|0|||
155323403|NCT04778410|560619909|FG001|Phase 2 Period|Lost to Follow-up|0|||
155323404|NCT04778410|560619910|FG002|Phase 2 Period|Lost to Follow-up|0|||
155323405|NCT04778410|560619911|FG003|Phase 2 Period|Lost to Follow-up|1|||
155323406|NCT04778410|560619912|FG004|Phase 2 Period|Lost to Follow-up|1|||
155323407|NCT04778410|560619913|FG005|Phase 2 Period|Lost to Follow-up|0|||
155323408|NCT04778410|560619908|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
155323409|NCT04778410|560619909|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
155323410|NCT04778410|560619910|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
155323411|NCT04778410|560619911|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
155323412|NCT04778410|560619912|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
155323413|NCT04778410|560619913|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
155323414|NCT04778410|560619908|FG000|Phase 2 Period|Withdrew Consent|0|||
155323415|NCT04778410|560619909|FG001|Phase 2 Period|Withdrew Consent|0|||
155323416|NCT04778410|560619910|FG002|Phase 2 Period|Withdrew Consent|0|||
155323417|NCT04778410|560619911|FG003|Phase 2 Period|Withdrew Consent|0|||
155323418|NCT04778410|560619912|FG004|Phase 2 Period|Withdrew Consent|2|||
155068964|NCT02225587|559682721|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155323419|NCT04778410|560619913|FG005|Phase 2 Period|Withdrew Consent|0|||
155323420|NCT05422885|560619918|FG000|Overall Study|Lost to Follow-up|1|||
155323421|NCT05422885|560619918|FG000|Overall Study|Withdrawal by Subject|2|||
155323422|NCT03691298|560619921|FG000|Overall Study|Lost to Follow-up|8|||
155323423|NCT03691298|560619921|FG000|Overall Study|Sponsor terminated study|2|||
155323424|NCT04214834|560619928|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
155323425|NCT04214834|560619929|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
155323426|NCT04924400|560619930|FG000|Overall Study|Lost to Follow-up|3|||
155323427|NCT04924400|560619931|FG001|Overall Study|Lost to Follow-up|0|||
155323428|NCT04424316|560619932|FG000|Overall Study|Adverse Event|0|||
155323429|NCT04424316|560619933|FG001|Overall Study|Adverse Event|1|||
155323430|NCT04424316|560619934|FG002|Overall Study|Adverse Event|0|||
155323431|NCT04424316|560619935|FG003|Overall Study|Adverse Event|0|||
155323432|NCT04424316|560619932|FG000|Overall Study|Death|1|||
155068965|NCT02225587|559682722|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155068966|NCT02225587|559682721|FG000|Overall Study|Physician Decision|2|||
155323433|NCT04424316|560619933|FG001|Overall Study|Death|0|||
155323434|NCT04424316|560619934|FG002|Overall Study|Death|8|||
155323435|NCT04424316|560619935|FG003|Overall Study|Death|14|||
155323436|NCT04424316|560619932|FG000|Overall Study|Lost to Follow-up|93|||
155323437|NCT04424316|560619933|FG001|Overall Study|Lost to Follow-up|88|||
155323438|NCT04424316|560619934|FG002|Overall Study|Lost to Follow-up|224|||
155323439|NCT04424316|560619935|FG003|Overall Study|Lost to Follow-up|211|||
155323440|NCT04424316|560619932|FG000|Overall Study|No longer met eligibility criteria|1|||
155323441|NCT04424316|560619933|FG001|Overall Study|No longer met eligibility criteria|0|||
155323442|NCT04424316|560619934|FG002|Overall Study|No longer met eligibility criteria|0|||
155323443|NCT04424316|560619935|FG003|Overall Study|No longer met eligibility criteria|0|||
155323444|NCT04424316|560619932|FG000|Overall Study|Other|15|||
155323445|NCT04424316|560619933|FG001|Overall Study|Other|11|||
155323446|NCT04424316|560619934|FG002|Overall Study|Other|34|||
155323447|NCT04424316|560619935|FG003|Overall Study|Other|45|||
155323448|NCT04424316|560619932|FG000|Overall Study|Physician Decision|1|||
155323449|NCT04424316|560619933|FG001|Overall Study|Physician Decision|0|||
155323450|NCT04424316|560619934|FG002|Overall Study|Physician Decision|1|||
155323451|NCT04424316|560619935|FG003|Overall Study|Physician Decision|1|||
155068967|NCT02225587|559682722|FG001|Overall Study|Physician Decision|0|||
155323452|NCT04424316|560619932|FG000|Overall Study|Protocol Violation|0|||
155323453|NCT04424316|560619933|FG001|Overall Study|Protocol Violation|1|||
155323454|NCT04424316|560619934|FG002|Overall Study|Protocol Violation|0|||
155323455|NCT04424316|560619935|FG003|Overall Study|Protocol Violation|0|||
155323456|NCT04424316|560619932|FG000|Overall Study|Withdrawal by Subject|71|||
155323457|NCT04424316|560619933|FG001|Overall Study|Withdrawal by Subject|77|||
155323458|NCT04424316|560619934|FG002|Overall Study|Withdrawal by Subject|0|||
155323459|NCT04424316|560619935|FG003|Overall Study|Withdrawal by Subject|0|||
155323460|NCT04424316|560619932|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155323461|NCT04424316|560619933|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155323462|NCT04424316|560619934|FG002|Overall Study|Withdrawal by parent/guardian|74|||
155323463|NCT04424316|560619935|FG003|Overall Study|Withdrawal by parent/guardian|81|||
155323464|NCT04424316|560619932|FG000|Overall Study|Randomized but not vaccinated|13|||
155068968|NCT02225587|559682721|FG000|Overall Study|Protocol Violation|1|||
155068969|NCT02225587|559682722|FG001|Overall Study|Protocol Violation|0|||
155323465|NCT04424316|560619933|FG001|Overall Study|Randomized but not vaccinated|21|||
155323466|NCT04424316|560619934|FG002|Overall Study|Randomized but not vaccinated|0|||
155323467|NCT04424316|560619935|FG003|Overall Study|Randomized but not vaccinated|0|||
155323468|NCT04424316|560619932|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
155323469|NCT04424316|560619933|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
155323470|NCT04424316|560619934|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
155323471|NCT04424316|560619935|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
155068970|NCT02225587|559682721|FG000|Overall Study|Participant Moved|1|||
155068971|NCT02225587|559682722|FG001|Overall Study|Participant Moved|0|||
155068972|NCT02225587|559682721|FG000|Overall Study|Withdrawal by Subject|13|||
155068973|NCT02225587|559682722|FG001|Overall Study|Withdrawal by Subject|28|||
155068974|NCT02572167|559682723|FG000|Overall Study|Withdrawal by Subject|0|||
155068975|NCT02572167|559682724|FG001|Overall Study|Withdrawal by Subject|3|||
155068976|NCT02572167|559682725|FG002|Overall Study|Withdrawal by Subject|0|||
155068977|NCT02572167|559682723|FG000|Overall Study|Lost to Follow-up|2|||
155068978|NCT02572167|559682724|FG001|Overall Study|Lost to Follow-up|5|||
155068979|NCT02572167|559682725|FG002|Overall Study|Lost to Follow-up|3|||
155068980|NCT02572167|559682723|FG000|Overall Study|Death|0|||
155068981|NCT02572167|559682724|FG001|Overall Study|Death|8|||
155068982|NCT02572167|559682725|FG002|Overall Study|Death|3|||
155068983|NCT02572167|559682723|FG000|Overall Study|Did not meet inclusion criteria|0|||
155068984|NCT02572167|559682724|FG001|Overall Study|Did not meet inclusion criteria|0|||
155162906|NCT04032093|560031760|FG002|Overall Study|Physician Decision|0|||
155162907|NCT04032093|560031761|FG003|Overall Study|Physician Decision|0|||
155162908|NCT04032093|560031762|FG004|Overall Study|Physician Decision|0|||
155162909|NCT04032093|560031763|FG005|Overall Study|Physician Decision|1|||
155162910|NCT04032093|560031764|FG006|Overall Study|Physician Decision|0|||
155162911|NCT04032093|560031765|FG007|Overall Study|Physician Decision|0|||
155162912|NCT04032093|560031766|FG008|Overall Study|Physician Decision|0|||
155162913|NCT04032093|560031767|FG009|Overall Study|Physician Decision|0|||
155323472|NCT04633538|560619936|FG000|Overall Study|Death|1|||
155323473|NCT04633538|560619936|FG000|Overall Study|Lost to Follow-up|3|||
155323474|NCT04633538|560619936|FG000|Overall Study|Withdrawal by Subject|1|||
155068985|NCT02572167|559682725|FG002|Overall Study|Did not meet inclusion criteria|1|||
155068986|NCT02572167|559682723|FG000|Overall Study|Study closure by Sponsor|4|||
155068987|NCT02572167|559682724|FG001|Overall Study|Study closure by Sponsor|40|||
155068988|NCT02572167|559682725|FG002|Overall Study|Study closure by Sponsor|24|||
155068989|NCT00580840|559682728|FG000|Run-in|Adverse Event|17|||
155068990|NCT00580840|559682729|FG001|Run-in|Adverse Event|0|||
155068991|NCT00580840|559682730|FG002|Run-in|Adverse Event|0|||
155068992|NCT00580840|559682731|FG003|Run-in|Adverse Event|0|||
155068993|NCT00580840|559682728|FG000|Run-in|Lack of Efficacy|93|||
155162914|NCT02447003|560031768|FG000|Overall Study|Other|0|||
155323475|NCT05070741|560619937|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
155323476|NCT03245840|560619938|FG000|Overall Study|Adverse Event|6|||
155323477|NCT03245840|560619939|FG001|Overall Study|Adverse Event|0|||
155323478|NCT03245840|560619938|FG000|Overall Study|Death|2|||
155323479|NCT03245840|560619939|FG001|Overall Study|Death|0|||
155323480|NCT03245840|560619938|FG000|Overall Study|Withdrawal by Subject|31|||
155323481|NCT03245840|560619939|FG001|Overall Study|Withdrawal by Subject|1|||
155323482|NCT03245840|560619938|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155323483|NCT03245840|560619939|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155323484|NCT03245840|560619938|FG000|Overall Study|Physician Decision|4|||
155323485|NCT03245840|560619939|FG001|Overall Study|Physician Decision|1|||
155323486|NCT03245840|560619938|FG000|Overall Study|Study Terminated by Sponsor|56|||
155323487|NCT03245840|560619939|FG001|Overall Study|Study Terminated by Sponsor|6|||
155323488|NCT03245840|560619938|FG000|Overall Study|Site Terminated by Sponsor|4|||
155323489|NCT03245840|560619939|FG001|Overall Study|Site Terminated by Sponsor|0|||
155323490|NCT03245840|560619938|FG000|Overall Study|Lost to Follow-up|12|||
155323491|NCT03245840|560619939|FG001|Overall Study|Lost to Follow-up|2|||
155323492|NCT03245840|560619938|FG000|Overall Study|Pregnancy|2|||
155323493|NCT03245840|560619939|FG001|Overall Study|Pregnancy|0|||
155323494|NCT03245840|560619938|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155323495|NCT03245840|560619939|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155323496|NCT03245840|560619938|FG000|Overall Study|Not treated|1|||
155323497|NCT03245840|560619939|FG001|Overall Study|Not treated|1|||
155323498|NCT03582033|560619946|FG000|Part A|Other|0|||
155323499|NCT03582033|560619947|FG001|Part A|Other|0|||
155323500|NCT03582033|560619948|FG002|Part A|Other|0|||
155323501|NCT03582033|560619949|FG003|Part A|Other|0|||
155323502|NCT03582033|560619950|FG004|Part A|Other|2|||
155323503|NCT03582033|560619951|FG005|Part A|Other|0|||
155323504|NCT03582033|560619952|FG006|Part A|Other|0|||
155323505|NCT03582033|560619953|FG007|Part A|Other|0|||
155323506|NCT03582033|560619954|FG008|Part A|Other|0|||
155323507|NCT03582033|560619955|FG009|Part A|Other|0|||
155323508|NCT03582033|560619946|FG000|Part A|Death|1|||
155323509|NCT03582033|560619947|FG001|Part A|Death|1|||
155323510|NCT03582033|560619948|FG002|Part A|Death|2|||
155323511|NCT03582033|560619949|FG003|Part A|Death|4|||
155323512|NCT03582033|560619950|FG004|Part A|Death|11|||
155323513|NCT03582033|560619951|FG005|Part A|Death|0|||
155323514|NCT03582033|560619952|FG006|Part A|Death|0|||
155323515|NCT03582033|560619953|FG007|Part A|Death|0|||
155323516|NCT03582033|560619954|FG008|Part A|Death|0|||
155323517|NCT03582033|560619955|FG009|Part A|Death|0|||
155323518|NCT03582033|560619946|FG000|Part A|Lost to Follow-up|0|||
155323519|NCT03582033|560619947|FG001|Part A|Lost to Follow-up|0|||
155323520|NCT03582033|560619948|FG002|Part A|Lost to Follow-up|0|||
155323521|NCT03582033|560619949|FG003|Part A|Lost to Follow-up|0|||
155323522|NCT03582033|560619950|FG004|Part A|Lost to Follow-up|1|||
155323523|NCT03582033|560619951|FG005|Part A|Lost to Follow-up|0|||
155323524|NCT03582033|560619952|FG006|Part A|Lost to Follow-up|0|||
155323525|NCT03582033|560619953|FG007|Part A|Lost to Follow-up|0|||
155323526|NCT03582033|560619954|FG008|Part A|Lost to Follow-up|0|||
155323527|NCT03582033|560619955|FG009|Part A|Lost to Follow-up|0|||
155323528|NCT03582033|560619946|FG000|Part A|Study terminated by sponsor|0|||
155323529|NCT03582033|560619947|FG001|Part A|Study terminated by sponsor|0|||
155323530|NCT03582033|560619948|FG002|Part A|Study terminated by sponsor|0|||
155323531|NCT03582033|560619949|FG003|Part A|Study terminated by sponsor|2|||
155323532|NCT03582033|560619950|FG004|Part A|Study terminated by sponsor|1|||
155162915|NCT02447003|560031769|FG001|Overall Study|Other|4|||
155162916|NCT02447003|560031768|FG000|Overall Study|Site discontinued|0|||
155323533|NCT03582033|560619951|FG005|Part A|Study terminated by sponsor|0|||
155323534|NCT03582033|560619952|FG006|Part A|Study terminated by sponsor|0|||
155323535|NCT03582033|560619953|FG007|Part A|Study terminated by sponsor|0|||
155323536|NCT03582033|560619954|FG008|Part A|Study terminated by sponsor|0|||
155323537|NCT03582033|560619955|FG009|Part A|Study terminated by sponsor|0|||
155323538|NCT03582033|560619946|FG000|Part A|Withdrawal by Subject|1|||
155323539|NCT03582033|560619947|FG001|Part A|Withdrawal by Subject|1|||
155323540|NCT03582033|560619948|FG002|Part A|Withdrawal by Subject|0|||
155323541|NCT03582033|560619949|FG003|Part A|Withdrawal by Subject|1|||
155323542|NCT03582033|560619950|FG004|Part A|Withdrawal by Subject|7|||
155323543|NCT03582033|560619951|FG005|Part A|Withdrawal by Subject|0|||
155323544|NCT03582033|560619952|FG006|Part A|Withdrawal by Subject|0|||
155323545|NCT03582033|560619953|FG007|Part A|Withdrawal by Subject|0|||
155323546|NCT03582033|560619954|FG008|Part A|Withdrawal by Subject|0|||
155323547|NCT03582033|560619955|FG009|Part A|Withdrawal by Subject|0|||
155323548|NCT03582033|560619946|FG000|Part B|Death|0|||
155323549|NCT03582033|560619947|FG001|Part B|Death|0|||
155323550|NCT03582033|560619948|FG002|Part B|Death|0|||
155323551|NCT03582033|560619949|FG003|Part B|Death|0|||
155323552|NCT03582033|560619950|FG004|Part B|Death|0|||
155323553|NCT03582033|560619951|FG005|Part B|Death|2|||
155323554|NCT03582033|560619952|FG006|Part B|Death|0|||
155323555|NCT03582033|560619953|FG007|Part B|Death|0|||
155323556|NCT03582033|560619954|FG008|Part B|Death|0|||
155323557|NCT03582033|560619955|FG009|Part B|Death|0|||
155323558|NCT03582033|560619946|FG000|Part B|Study terminated by sponsor|0|||
155323559|NCT03582033|560619947|FG001|Part B|Study terminated by sponsor|0|||
155323560|NCT03582033|560619948|FG002|Part B|Study terminated by sponsor|0|||
155323561|NCT03582033|560619949|FG003|Part B|Study terminated by sponsor|0|||
155323562|NCT03582033|560619950|FG004|Part B|Study terminated by sponsor|0|||
155323563|NCT03582033|560619951|FG005|Part B|Study terminated by sponsor|12|||
155323564|NCT03582033|560619952|FG006|Part B|Study terminated by sponsor|0|||
155323565|NCT03582033|560619953|FG007|Part B|Study terminated by sponsor|0|||
155323566|NCT03582033|560619954|FG008|Part B|Study terminated by sponsor|0|||
155323567|NCT03582033|560619955|FG009|Part B|Study terminated by sponsor|0|||
155323568|NCT03582033|560619946|FG000|Part B|Withdrawal by Subject|0|||
155323569|NCT03582033|560619947|FG001|Part B|Withdrawal by Subject|0|||
155323570|NCT03582033|560619948|FG002|Part B|Withdrawal by Subject|0|||
155323571|NCT03582033|560619949|FG003|Part B|Withdrawal by Subject|0|||
155323572|NCT03582033|560619950|FG004|Part B|Withdrawal by Subject|0|||
155323573|NCT03582033|560619951|FG005|Part B|Withdrawal by Subject|6|||
155323574|NCT03582033|560619952|FG006|Part B|Withdrawal by Subject|0|||
155323575|NCT03582033|560619953|FG007|Part B|Withdrawal by Subject|0|||
155323576|NCT03582033|560619954|FG008|Part B|Withdrawal by Subject|0|||
155323577|NCT03582033|560619955|FG009|Part B|Withdrawal by Subject|0|||
155323578|NCT03582033|560619946|FG000|Part C|Other|0|||
155323579|NCT03582033|560619947|FG001|Part C|Other|0|||
155323580|NCT03582033|560619948|FG002|Part C|Other|0|||
155323581|NCT03582033|560619949|FG003|Part C|Other|0|||
155323582|NCT03582033|560619950|FG004|Part C|Other|0|||
155323583|NCT03582033|560619951|FG005|Part C|Other|0|||
155323584|NCT03582033|560619952|FG006|Part C|Other|2|||
155323585|NCT03582033|560619953|FG007|Part C|Other|0|||
155323586|NCT03582033|560619954|FG008|Part C|Other|0|||
155323587|NCT03582033|560619955|FG009|Part C|Other|0|||
155323588|NCT03582033|560619946|FG000|Part C|Death|0|||
155323589|NCT03582033|560619947|FG001|Part C|Death|0|||
155323590|NCT03582033|560619948|FG002|Part C|Death|0|||
155323591|NCT03582033|560619949|FG003|Part C|Death|0|||
155323592|NCT03582033|560619950|FG004|Part C|Death|0|||
155323593|NCT03582033|560619951|FG005|Part C|Death|0|||
155323594|NCT03582033|560619952|FG006|Part C|Death|6|||
155323595|NCT03582033|560619953|FG007|Part C|Death|1|||
155323596|NCT03582033|560619954|FG008|Part C|Death|2|||
155323597|NCT03582033|560619955|FG009|Part C|Death|0|||
155323598|NCT03582033|560619946|FG000|Part C|Study terminated by sponsor|0|||
155323599|NCT03582033|560619947|FG001|Part C|Study terminated by sponsor|0|||
155323600|NCT03582033|560619948|FG002|Part C|Study terminated by sponsor|0|||
154961053|NCT00804856|559282194|FG005|Overall Study|Refused to continue medication|0|||
154961054|NCT00804856|559282195|FG006|Overall Study|Refused to continue medication|0|||
154961055|NCT00804856|559282196|FG007|Overall Study|Refused to continue medication|0|||
154961056|NCT00804856|559282197|FG008|Overall Study|Refused to continue medication|0|||
154961057|NCT00804856|559282198|FG009|Overall Study|Refused to continue medication|0|||
154961058|NCT00804856|559282199|FG010|Overall Study|Refused to continue medication|3|||
154961059|NCT00804856|559282200|FG011|Overall Study|Refused to continue medication|0|||
154961060|NCT00804856|559282201|FG012|Overall Study|Refused to continue medication|1|||
154961061|NCT00804856|559282202|FG013|Overall Study|Refused to continue medication|1|||
154961062|NCT00804856|559282203|FG014|Overall Study|Refused to continue medication|5|||
154961063|NCT00804856|559282189|FG000|Overall Study|Other reason than listed above|0|||
154961064|NCT00804856|559282190|FG001|Overall Study|Other reason than listed above|0|||
154961065|NCT00804856|559282191|FG002|Overall Study|Other reason than listed above|0|||
154961066|NCT00804856|559282192|FG003|Overall Study|Other reason than listed above|0|||
155162917|NCT02447003|560031769|FG001|Overall Study|Site discontinued|2|||
155162918|NCT02447003|560031768|FG000|Overall Study|Physician Decision|0|||
155323601|NCT03582033|560619949|FG003|Part C|Study terminated by sponsor|0|||
155323602|NCT03582033|560619950|FG004|Part C|Study terminated by sponsor|0|||
155323603|NCT03582033|560619951|FG005|Part C|Study terminated by sponsor|0|||
155323604|NCT03582033|560619952|FG006|Part C|Study terminated by sponsor|3|||
155323605|NCT03582033|560619953|FG007|Part C|Study terminated by sponsor|3|||
155323606|NCT03582033|560619954|FG008|Part C|Study terminated by sponsor|2|||
155323607|NCT03582033|560619955|FG009|Part C|Study terminated by sponsor|0|||
155323608|NCT03582033|560619946|FG000|Part C|Withdrawal by Subject|0|||
155323609|NCT03582033|560619947|FG001|Part C|Withdrawal by Subject|0|||
155323610|NCT03582033|560619948|FG002|Part C|Withdrawal by Subject|0|||
155323611|NCT03582033|560619949|FG003|Part C|Withdrawal by Subject|0|||
155323612|NCT03582033|560619950|FG004|Part C|Withdrawal by Subject|0|||
155323613|NCT03582033|560619951|FG005|Part C|Withdrawal by Subject|0|||
155323614|NCT03582033|560619952|FG006|Part C|Withdrawal by Subject|1|||
155323615|NCT03582033|560619953|FG007|Part C|Withdrawal by Subject|2|||
155323616|NCT03582033|560619954|FG008|Part C|Withdrawal by Subject|1|||
155323617|NCT03582033|560619955|FG009|Part C|Withdrawal by Subject|0|||
155323618|NCT03582033|560619946|FG000|Part D|Death|0|||
155323619|NCT03582033|560619947|FG001|Part D|Death|0|||
155323620|NCT03582033|560619948|FG002|Part D|Death|0|||
155323621|NCT03582033|560619949|FG003|Part D|Death|0|||
155323622|NCT03582033|560619950|FG004|Part D|Death|0|||
155323623|NCT03582033|560619951|FG005|Part D|Death|0|||
155323624|NCT03582033|560619952|FG006|Part D|Death|0|||
155323625|NCT03582033|560619953|FG007|Part D|Death|0|||
155323626|NCT03582033|560619954|FG008|Part D|Death|0|||
155323627|NCT03582033|560619955|FG009|Part D|Death|1|||
155323628|NCT03582033|560619946|FG000|Part D|Study terminated by sponsor|0|||
155323629|NCT03582033|560619947|FG001|Part D|Study terminated by sponsor|0|||
155323630|NCT03582033|560619948|FG002|Part D|Study terminated by sponsor|0|||
155323631|NCT03582033|560619949|FG003|Part D|Study terminated by sponsor|0|||
155323632|NCT03582033|560619950|FG004|Part D|Study terminated by sponsor|0|||
155323633|NCT03582033|560619951|FG005|Part D|Study terminated by sponsor|0|||
155323634|NCT03582033|560619952|FG006|Part D|Study terminated by sponsor|0|||
155323635|NCT03582033|560619953|FG007|Part D|Study terminated by sponsor|0|||
155323636|NCT03582033|560619954|FG008|Part D|Study terminated by sponsor|0|||
155323637|NCT03582033|560619955|FG009|Part D|Study terminated by sponsor|4|||
155323638|NCT05741294|560619956|FG000|Overall Study|Lost to Follow-up|3|||
155323639|NCT05741294|560619956|FG000|Overall Study|Protocol deviation|3|||
155323640|NCT05741294|560619956|FG000|Overall Study|Withdrawal by Subject|1|||
155323641|NCT04707768|560619967|FG000|Overall Study|Adverse Event|9|||
155323642|NCT04707768|560619968|FG001|Overall Study|Adverse Event|18|||
155323643|NCT04707768|560619969|FG002|Overall Study|Adverse Event|3|||
155323644|NCT04707768|560619967|FG000|Overall Study|Investigator's Discretion|8|||
155323645|NCT04707768|560619968|FG001|Overall Study|Investigator's Discretion|4|||
155323646|NCT04707768|560619969|FG002|Overall Study|Investigator's Discretion|3|||
155323647|NCT04707768|560619967|FG000|Overall Study|Withdrawal by Subject|6|||
155323648|NCT04707768|560619968|FG001|Overall Study|Withdrawal by Subject|8|||
155323649|NCT04707768|560619969|FG002|Overall Study|Withdrawal by Subject|2|||
155323650|NCT04707768|560619967|FG000|Overall Study|Lack of Efficacy|1|||
155323651|NCT04707768|560619968|FG001|Overall Study|Lack of Efficacy|3|||
155323652|NCT04707768|560619969|FG002|Overall Study|Lack of Efficacy|0|||
155323653|NCT04707768|560619967|FG000|Overall Study|Lost to Follow-up|0|||
155323654|NCT04707768|560619968|FG001|Overall Study|Lost to Follow-up|0|||
155323655|NCT04707768|560619969|FG002|Overall Study|Lost to Follow-up|3|||
155323656|NCT04707768|560619967|FG000|Overall Study|Death|13|||
155323657|NCT04707768|560619968|FG001|Overall Study|Death|11|||
155323658|NCT04707768|560619969|FG002|Overall Study|Death|13|||
155323659|NCT04707768|560619967|FG000|Overall Study|Protocol Violation|2|||
155323660|NCT04707768|560619968|FG001|Overall Study|Protocol Violation|1|||
154961067|NCT00804856|559282193|FG004|Overall Study|Other reason than listed above|0|||
154961068|NCT00804856|559282194|FG005|Overall Study|Other reason than listed above|1|||
155323661|NCT04707768|560619969|FG002|Overall Study|Protocol Violation|0|||
155323662|NCT04707768|560619967|FG000|Overall Study|Non Compliance with Study Drug|1|||
155323663|NCT04707768|560619968|FG001|Overall Study|Non Compliance with Study Drug|0|||
155323664|NCT04707768|560619969|FG002|Overall Study|Non Compliance with Study Drug|0|||
155323665|NCT04707768|560619967|FG000|Overall Study|Transplant|4|||
155323666|NCT04707768|560619968|FG001|Overall Study|Transplant|4|||
155323667|NCT04707768|560619969|FG002|Overall Study|Transplant|8|||
155323668|NCT04707768|560619967|FG000|Overall Study|Other|9|||
155323669|NCT04707768|560619968|FG001|Overall Study|Other|5|||
155323670|NCT04707768|560619969|FG002|Overall Study|Other|2|||
155323671|NCT02518048|560619970|FG000|Overall Study|Withdrawal by Subject|1|||
155323672|NCT05123027|560619975|FG000|Overall Study|Lost to Follow-up|17|||
155323673|NCT05123027|560619976|FG001|Overall Study|Lost to Follow-up|22|||
155323674|NCT05123027|560619975|FG000|Overall Study|Incarceration|3|||
155323675|NCT05123027|560619976|FG001|Overall Study|Incarceration|4|||
155323676|NCT05123027|560619975|FG000|Overall Study|Death|2|||
155323677|NCT05123027|560619976|FG001|Overall Study|Death|2|||
155323678|NCT05123027|560619975|FG000|Overall Study|Other|2|||
155323679|NCT05123027|560619976|FG001|Overall Study|Other|0|||
155323680|NCT03735979|560619977|FG000|Overall Study|Lost to Follow-up|1|||
155323681|NCT03735979|560619978|FG001|Overall Study|Lost to Follow-up|12|||
155323682|NCT03735979|560619979|FG002|Overall Study|Lost to Follow-up|14|||
155323683|NCT03735979|560619977|FG000|Overall Study|Withdrawal by Subject|1|||
155323684|NCT03735979|560619978|FG001|Overall Study|Withdrawal by Subject|5|||
155323685|NCT03735979|560619979|FG002|Overall Study|Withdrawal by Subject|2|||
155323686|NCT03735979|560619977|FG000|Overall Study|Not due to the above reasons|1|||
155323687|NCT03735979|560619978|FG001|Overall Study|Not due to the above reasons|0|||
155323688|NCT03735979|560619979|FG002|Overall Study|Not due to the above reasons|0|||
155323689|NCT00319111|560619982|FG000|Overall Study|Adverse Event|20|||
155323690|NCT00319111|560619982|FG000|Overall Study|Withdrawal of consent|11|||
155323691|NCT00319111|560619982|FG000|Overall Study|Death|9|||
155323692|NCT00319111|560619982|FG000|Overall Study|Lack of clinical improvement|4|||
155323693|NCT00319111|560619982|FG000|Overall Study|Administrative|2|||
155323694|NCT00319111|560619982|FG000|Overall Study|Treatment failure|1|||
155323695|NCT04330040|560619983|FG000|Overall Study|Other: Adverse event|5|||
155323696|NCT04330040|560619984|FG001|Overall Study|Other: Adverse event|0|||
155323697|NCT04330040|560619985|FG002|Overall Study|Other: Adverse event|0|||
155323698|NCT04330040|560619983|FG000|Overall Study|Disease progression|38|||
155323699|NCT04330040|560619984|FG001|Overall Study|Disease progression|10|||
155323700|NCT04330040|560619985|FG002|Overall Study|Disease progression|0|||
155323701|NCT04330040|560619983|FG000|Overall Study|Physician Decision|5|||
155323702|NCT04330040|560619984|FG001|Overall Study|Physician Decision|3|||
155323703|NCT04330040|560619985|FG002|Overall Study|Physician Decision|0|||
155323704|NCT04330040|560619983|FG000|Overall Study|Lost to Follow-up|1|||
155323705|NCT04330040|560619984|FG001|Overall Study|Lost to Follow-up|1|||
155323706|NCT04330040|560619985|FG002|Overall Study|Lost to Follow-up|0|||
155323707|NCT04330040|560619983|FG000|Overall Study|Death|2|||
155323708|NCT04330040|560619984|FG001|Overall Study|Death|1|||
155323709|NCT04330040|560619985|FG002|Overall Study|Death|0|||
155323710|NCT04330040|560619983|FG000|Overall Study|Withdrawal by Subject|3|||
155323711|NCT04330040|560619984|FG001|Overall Study|Withdrawal by Subject|3|||
155323712|NCT04330040|560619985|FG002|Overall Study|Withdrawal by Subject|0|||
155323713|NCT04330040|560619983|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
155323714|NCT04330040|560619984|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
155323715|NCT04330040|560619985|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
155323716|NCT04330040|560619983|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
155323717|NCT04330040|560619984|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
155323718|NCT04330040|560619985|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
155323719|NCT04330040|560619983|FG000|Overall Study|Other: Disease progression|1|||
155323720|NCT04330040|560619984|FG001|Overall Study|Other: Disease progression|0|||
155323721|NCT04330040|560619985|FG002|Overall Study|Other: Disease progression|0|||
155323722|NCT04330040|560619983|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
155323723|NCT04330040|560619984|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
155323724|NCT04330040|560619985|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
155323725|NCT04330040|560619983|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
155323726|NCT04330040|560619984|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
155323727|NCT04330040|560619985|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
155323728|NCT04330040|560619983|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
155323729|NCT04330040|560619984|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
155323730|NCT04330040|560619985|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
155323731|NCT05525104|560619986|FG000|Overall Study|Failed caudal analgesia|1|||
155323732|NCT05525104|560619987|FG001|Overall Study|Failed caudal analgesia|3|||
155323733|NCT05525104|560619986|FG000|Overall Study|Premedication needed|0|||
155323734|NCT05525104|560619987|FG001|Overall Study|Premedication needed|1|||
155323735|NCT05525104|560619986|FG000|Overall Study|Protocol Violation|10|||
155323736|NCT05525104|560619987|FG001|Overall Study|Protocol Violation|0|||
155323737|NCT05525104|560619986|FG000|Overall Study|Cancelled operation|1|||
155323738|NCT05525104|560619987|FG001|Overall Study|Cancelled operation|0|||
155323739|NCT02039401|560619988|FG000|Overall Study|Adverse Event|0|||
155323740|NCT02039401|560619989|FG001|Overall Study|Adverse Event|1|||
155323741|NCT02585323|560621884|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
155323742|NCT02585323|560621885|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
155323743|NCT02585323|560621884|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
155323744|NCT02585323|560621885|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
155323745|NCT02585323|560621884|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
155323746|NCT02585323|560621885|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
155323747|NCT02585323|560621884|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
155323748|NCT02585323|560621885|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
155323749|NCT05524116|560621901|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
155323750|NCT05524116|560621902|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
155323751|NCT05524116|560621901|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
155323752|NCT05524116|560621902|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
155323753|NCT05524116|560621901|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
155323754|NCT05524116|560621902|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
155323755|NCT05524116|560621901|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
155323756|NCT05524116|560621902|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
155323757|NCT05524116|560621901|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
155323758|NCT05524116|560621902|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
155323759|NCT04389957|560621903|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
155323760|NCT04389957|560621904|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
155323761|NCT04389957|560621905|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
155323762|NCT04389957|560621906|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
155323763|NCT04389957|560621907|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
155323764|NCT04084574|560621914|FG000|Overall Study|Lost to Follow-up|1|||
155323765|NCT04084574|560621915|FG001|Overall Study|Lost to Follow-up|0|||
155323766|NCT04084574|560621914|FG000|Overall Study|Physician Decision|1|||
155323767|NCT04084574|560621915|FG001|Overall Study|Physician Decision|0|||
155323768|NCT04084574|560621914|FG000|Overall Study|Relocated out of state|1|||
155323769|NCT04084574|560621915|FG001|Overall Study|Relocated out of state|0|||
155323770|NCT01121588|560621916|FG000|Overall Study|Death|5|||
155323771|NCT01121588|560621917|FG001|Overall Study|Death|3|||
155323772|NCT01121588|560621918|FG002|Overall Study|Death|13|||
155323773|NCT01121588|560621916|FG000|Overall Study|Study Terminated by Sponsor|1|||
155323774|NCT01121588|560621917|FG001|Overall Study|Study Terminated by Sponsor|1|||
155323775|NCT01121588|560621918|FG002|Overall Study|Study Terminated by Sponsor|0|||
155323776|NCT01121588|560621916|FG000|Overall Study|Participant Refused Further Followup|2|||
155323777|NCT01121588|560621917|FG001|Overall Study|Participant Refused Further Followup|0|||
155323778|NCT01121588|560621918|FG002|Overall Study|Participant Refused Further Followup|2|||
155323779|NCT01121588|560621916|FG000|Overall Study|Lost to Follow-up|0|||
155323780|NCT01121588|560621917|FG001|Overall Study|Lost to Follow-up|1|||
155323781|NCT01121588|560621918|FG002|Overall Study|Lost to Follow-up|1|||
155323782|NCT01121588|560621916|FG000|Overall Study|Non-Specified Reasons|9|||
155323783|NCT01121588|560621917|FG001|Overall Study|Non-Specified Reasons|4|||
155323784|NCT01121588|560621918|FG002|Overall Study|Non-Specified Reasons|2|||
155323785|NCT00942877|560621919|FG000|Overall Study|Refused further treatment|1|||
155323786|NCT00942877|560621920|FG001|Overall Study|Refused further treatment|1|||
155323787|NCT00942877|560621919|FG000|Overall Study|Patient was not treated|1|||
155323788|NCT00942877|560621920|FG001|Overall Study|Patient was not treated|0|||
155323789|NCT00942877|560621919|FG000|Overall Study|Adverse Event|1|||
155323790|NCT00942877|560621920|FG001|Overall Study|Adverse Event|0|||
155323791|NCT00942877|560621919|FG000|Overall Study|Progressive disease|42|||
155323792|NCT00942877|560621920|FG001|Overall Study|Progressive disease|3|||
155323793|NCT01385202|560621923|FG000|Overall Study|Lost to Follow-up|6|||
155323794|NCT01385202|560621923|FG000|Overall Study|Not Eligible|11|||
155323795|NCT01385202|560621923|FG000|Overall Study|Withdrawn|1|||
155323796|NCT03681262|560621924|FG000|Overall Study|Continuing on study|3|||
155323797|NCT03681262|560621925|FG001|Overall Study|Continuing on study|3|||
155323798|NCT03681262|560621924|FG000|Overall Study|Lost to Follow-up|1|||
155323799|NCT03681262|560621925|FG001|Overall Study|Lost to Follow-up|0|||
155323800|NCT02095691|560621926|FG000|Overall Study|Physician Decision|1|||
155323801|NCT04583280|560621927|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
155323802|NCT04583280|560621928|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
155323803|NCT00964392|560621929|FG000|Overall Study|Withdrawal by Subject|4|||
155323804|NCT00964392|560621930|FG001|Overall Study|Withdrawal by Subject|6|||
155323805|NCT00964392|560621929|FG000|Overall Study|Lost to Follow-up|4|||
155323806|NCT00964392|560621930|FG001|Overall Study|Lost to Follow-up|10|||
155323807|NCT00964392|560621929|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
155323808|NCT00964392|560621930|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
154961069|NCT00804856|559282195|FG006|Overall Study|Other reason than listed above|0|||
154961070|NCT00804856|559282196|FG007|Overall Study|Other reason than listed above|0|||
154961071|NCT00804856|559282197|FG008|Overall Study|Other reason than listed above|1|||
154961072|NCT00804856|559282198|FG009|Overall Study|Other reason than listed above|0|||
154961073|NCT00804856|559282199|FG010|Overall Study|Other reason than listed above|3|||
154961074|NCT00804856|559282200|FG011|Overall Study|Other reason than listed above|1|||
154961075|NCT00804856|559282201|FG012|Overall Study|Other reason than listed above|1|||
154961076|NCT00804856|559282202|FG013|Overall Study|Other reason than listed above|10|||
154961077|NCT00804856|559282203|FG014|Overall Study|Other reason than listed above|3|||
154961078|NCT01158118|559282204|FG000|Overall Study|Screen failure|1|||
154961079|NCT01158118|559282205|FG001|Overall Study|Screen failure|0|||
154961080|NCT01158118|559282204|FG000|Overall Study|Donor match was a screen failure|0|||
154961081|NCT01158118|559282205|FG001|Overall Study|Donor match was a screen failure|1|||
154961082|NCT01158118|559282204|FG000|Overall Study|Suffered stroke prior to transplant|0|||
154961083|NCT01158118|559282205|FG001|Overall Study|Suffered stroke prior to transplant|1|||
154961084|NCT01158118|559282204|FG000|Overall Study|Death|0|||
154961085|NCT01158118|559282205|FG001|Overall Study|Death|1|||
154961086|NCT01175018|559282206|FG000|Overall Study|Adverse Event|3|||
154961087|NCT01175018|559282207|FG001|Overall Study|Adverse Event|1|||
154961088|NCT02558491|559282208|FG000|First Invention|Withdrawal by Subject|3|||
154961089|NCT02558491|559282209|FG001|First Invention|Withdrawal by Subject|1|||
154961090|NCT02558491|559282208|FG000|First Invention|Data collection issues|1|||
154961091|NCT02558491|559282209|FG001|First Invention|Data collection issues|0|||
154961092|NCT02558491|559282208|FG000|First Invention|Stopping criteria|0|||
155323809|NCT00964392|560621929|FG000|Overall Study|Not completed|44|||
154961093|NCT02558491|559282209|FG001|First Invention|Stopping criteria|1|||
154961094|NCT02558491|559282208|FG000|First Invention|Changed parameters during trial|1|||
155323810|NCT00964392|560621930|FG001|Overall Study|Not completed|168|||
155323811|NCT03652272|560621935|FG000|3 Month|Withdrawal by Subject|1|||
155323812|NCT03652272|560621936|FG001|3 Month|Withdrawal by Subject|1|||
155323813|NCT03652272|560621935|FG000|3 Month|Lost to Follow-up|16|||
155323814|NCT03652272|560621936|FG001|3 Month|Lost to Follow-up|14|||
155323815|NCT02326974|560621937|FG000|Overall Study|Withdrawal by Subject|2|||
155323816|NCT02326974|560621937|FG000|Overall Study|failed heterogenity evaluation|5|||
155323817|NCT02577354|560621938|FG000|Overall Study|Lack of Efficacy|4|||
155323818|NCT02577354|560621939|FG001|Overall Study|Lack of Efficacy|4|||
155323819|NCT02577354|560621938|FG000|Overall Study|Lost to Follow-up|3|||
155323820|NCT02577354|560621939|FG001|Overall Study|Lost to Follow-up|1|||
155323821|NCT02577354|560621938|FG000|Overall Study|Missed Visit|4|||
155323822|NCT02577354|560621939|FG001|Overall Study|Missed Visit|3|||
155323823|NCT02577354|560621938|FG000|Overall Study|Adverse Event|4|||
155323824|NCT02577354|560621939|FG001|Overall Study|Adverse Event|5|||
155323825|NCT02938520|560621942|FG000|Overall Study|On-going at the time of analysis|258|||
155323826|NCT02938520|560621943|FG001|Overall Study|On-going at the time of analysis|261|||
155323827|NCT02938520|560621942|FG000|Overall Study|Physician Decision|2|||
155323828|NCT02938520|560621943|FG001|Overall Study|Physician Decision|5|||
155323829|NCT02938520|560621942|FG000|Overall Study|Lost to Follow-up|2|||
155323830|NCT02938520|560621943|FG001|Overall Study|Lost to Follow-up|2|||
155323831|NCT02938520|560621942|FG000|Overall Study|Withdrawal by Subject|7|||
155323832|NCT02938520|560621943|FG001|Overall Study|Withdrawal by Subject|7|||
155323833|NCT02938520|560621942|FG000|Overall Study|Protocol Violation|0|||
155323834|NCT02938520|560621943|FG001|Overall Study|Protocol Violation|1|||
155323835|NCT02938520|560621942|FG000|Overall Study|Lack of Efficacy|5|||
155323836|NCT02938520|560621943|FG001|Overall Study|Lack of Efficacy|3|||
155323837|NCT02938520|560621942|FG000|Overall Study|Adverse Event|9|||
155323838|NCT02938520|560621943|FG001|Overall Study|Adverse Event|4|||
155323839|NCT03812614|560621946|FG000|Intervention|Withdrawal by Subject|7|||
155323840|NCT03812614|560621947|FG001|Intervention|Withdrawal by Subject|2|||
155323841|NCT03812614|560621948|FG002|Intervention|Withdrawal by Subject|7|||
155323842|NCT03812614|560621949|FG003|Intervention|Withdrawal by Subject|2|||
155323843|NCT03812614|560621946|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
155323844|NCT03812614|560621947|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
155323845|NCT03812614|560621948|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
155323846|NCT03812614|560621949|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
155323847|NCT03812614|560621946|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
155323848|NCT03812614|560621947|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
155323849|NCT03812614|560621948|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
155323850|NCT03812614|560621949|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
155323851|NCT03812614|560621946|FG000|6-month Follow-up|Lost to Follow-up|0|||
155323852|NCT03812614|560621947|FG001|6-month Follow-up|Lost to Follow-up|0|||
155323853|NCT03812614|560621948|FG002|6-month Follow-up|Lost to Follow-up|12|||
155323854|NCT03812614|560621949|FG003|6-month Follow-up|Lost to Follow-up|8|||
155068994|NCT00580840|559682729|FG001|Run-in|Lack of Efficacy|0|||
155068995|NCT00580840|559682730|FG002|Run-in|Lack of Efficacy|0|||
155068996|NCT00580840|559682731|FG003|Run-in|Lack of Efficacy|0|||
155068997|NCT00580840|559682728|FG000|Run-in|Loss of Efficacy|1|||
155068998|NCT00580840|559682729|FG001|Run-in|Loss of Efficacy|0|||
155068999|NCT00580840|559682730|FG002|Run-in|Loss of Efficacy|0|||
155069000|NCT00580840|559682731|FG003|Run-in|Loss of Efficacy|0|||
155069001|NCT00580840|559682728|FG000|Run-in|Lost to Follow-up|4|||
155069002|NCT00580840|559682729|FG001|Run-in|Lost to Follow-up|0|||
155069003|NCT00580840|559682730|FG002|Run-in|Lost to Follow-up|0|||
155069004|NCT00580840|559682731|FG003|Run-in|Lost to Follow-up|0|||
155069005|NCT00580840|559682728|FG000|Run-in|Withdrawal by Subject|5|||
155069006|NCT00580840|559682729|FG001|Run-in|Withdrawal by Subject|0|||
155069007|NCT00580840|559682730|FG002|Run-in|Withdrawal by Subject|0|||
155069008|NCT00580840|559682731|FG003|Run-in|Withdrawal by Subject|0|||
155069009|NCT00580840|559682728|FG000|Run-in|Other: Per Sponsor Request|2|||
155069010|NCT00580840|559682729|FG001|Run-in|Other: Per Sponsor Request|0|||
155069011|NCT00580840|559682730|FG002|Run-in|Other: Per Sponsor Request|0|||
155069012|NCT00580840|559682731|FG003|Run-in|Other: Per Sponsor Request|0|||
155069013|NCT00580840|559682728|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
155069014|NCT00580840|559682729|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
155069015|NCT00580840|559682730|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
155069016|NCT00580840|559682731|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
155069017|NCT00580840|559682728|FG000|Run-in|Other: Exclusionary Lab Value|1|||
155069018|NCT00580840|559682729|FG001|Run-in|Other: Exclusionary Lab Value|0|||
155069019|NCT00580840|559682730|FG002|Run-in|Other: Exclusionary Lab Value|0|||
155069020|NCT00580840|559682731|FG003|Run-in|Other: Exclusionary Lab Value|0|||
155069021|NCT00580840|559682728|FG000|Double-Blind|Adverse Event|0|||
155069022|NCT00580840|559682729|FG001|Double-Blind|Adverse Event|3|||
155069023|NCT00580840|559682730|FG002|Double-Blind|Adverse Event|4|||
155069024|NCT00580840|559682731|FG003|Double-Blind|Adverse Event|1|||
155069025|NCT00580840|559682728|FG000|Double-Blind|Loss of Efficacy|0|||
155069026|NCT00580840|559682729|FG001|Double-Blind|Loss of Efficacy|1|||
155069027|NCT00580840|559682730|FG002|Double-Blind|Loss of Efficacy|2|||
155069028|NCT00580840|559682731|FG003|Double-Blind|Loss of Efficacy|10|||
155069029|NCT00580840|559682728|FG000|Double-Blind|Lost to Follow-up|0|||
155069030|NCT00580840|559682729|FG001|Double-Blind|Lost to Follow-up|1|||
155069031|NCT00580840|559682730|FG002|Double-Blind|Lost to Follow-up|0|||
155069032|NCT00580840|559682731|FG003|Double-Blind|Lost to Follow-up|2|||
155069033|NCT00580840|559682728|FG000|Double-Blind|Withdrawal by Subject|0|||
155069034|NCT00580840|559682729|FG001|Double-Blind|Withdrawal by Subject|1|||
155069035|NCT00580840|559682730|FG002|Double-Blind|Withdrawal by Subject|2|||
155069036|NCT00580840|559682731|FG003|Double-Blind|Withdrawal by Subject|2|||
155069037|NCT00580840|559682728|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
155069038|NCT00580840|559682729|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
155069039|NCT00580840|559682730|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
155069040|NCT00580840|559682731|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
155323855|NCT03812614|560621946|FG000|12-month Follow-up|Lost to Follow-up|18|||
155323856|NCT03812614|560621947|FG001|12-month Follow-up|Lost to Follow-up|17|||
155323857|NCT03812614|560621948|FG002|12-month Follow-up|Lost to Follow-up|5|||
155323858|NCT03812614|560621949|FG003|12-month Follow-up|Lost to Follow-up|2|||
155323859|NCT05652010|560621950|FG000|First Intervention|Withdrawal by Subject|0|||
155323860|NCT05652010|560621951|FG001|First Intervention|Withdrawal by Subject|1|||
155323861|NCT05652010|560621950|FG000|Second Intervention|Withdrawal by Subject|1|||
155323862|NCT05652010|560621951|FG001|Second Intervention|Withdrawal by Subject|0|||
155323863|NCT05451693|560621952|FG000|Overall Study|Withdrawal by Subject|1|||
155323864|NCT05451693|560621953|FG001|Overall Study|Withdrawal by Subject|1|||
155323865|NCT04490109|560621960|FG000|Overall Study|Lost to Follow-up|3|||
155323866|NCT04490109|560621961|FG001|Overall Study|Lost to Follow-up|10|||
155323867|NCT04490109|560621962|FG002|Overall Study|Lost to Follow-up|4|||
155323868|NCT04490109|560621960|FG000|Overall Study|Withdrawal by Subject|8|||
155323869|NCT04490109|560621961|FG001|Overall Study|Withdrawal by Subject|6|||
155323870|NCT04490109|560621962|FG002|Overall Study|Withdrawal by Subject|9|||
155069041|NCT00580840|559682728|FG000|Double-Blind|Other: Forbidden Medication|0|||
155323871|NCT04490109|560621960|FG000|Overall Study|Physician Decision|0|||
155323872|NCT04490109|560621961|FG001|Overall Study|Physician Decision|2|||
155323873|NCT04490109|560621962|FG002|Overall Study|Physician Decision|3|||
155323874|NCT04490109|560621960|FG000|Overall Study|Adverse Event|2|||
155323875|NCT04490109|560621961|FG001|Overall Study|Adverse Event|1|||
155323876|NCT04490109|560621962|FG002|Overall Study|Adverse Event|0|||
155069042|NCT00580840|559682729|FG001|Double-Blind|Other: Forbidden Medication|0|||
155323877|NCT04490109|560621960|FG000|Overall Study|Significant Non-Compliance|2|||
155323878|NCT04490109|560621961|FG001|Overall Study|Significant Non-Compliance|4|||
155323879|NCT04490109|560621962|FG002|Overall Study|Significant Non-Compliance|4|||
155323880|NCT04490109|560621960|FG000|Overall Study|Significant Clinical Event|0|||
155323881|NCT04490109|560621961|FG001|Overall Study|Significant Clinical Event|1|||
155323882|NCT04490109|560621962|FG002|Overall Study|Significant Clinical Event|0|||
155323883|NCT04490109|560621960|FG000|Overall Study|Other Reason|4|||
155323884|NCT04490109|560621961|FG001|Overall Study|Other Reason|1|||
155323885|NCT04490109|560621962|FG002|Overall Study|Other Reason|1|||
155323886|NCT03372057|560621963|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
155323887|NCT03372057|560621964|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
155323888|NCT03372057|560621965|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
155323889|NCT03372057|560621963|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
155323890|NCT03372057|560621964|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
155323891|NCT03372057|560621965|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
155323892|NCT03372057|560621963|FG000|Dose Optimization Phase|Death|16|||
155323893|NCT03372057|560621964|FG001|Dose Optimization Phase|Death|11|||
155323894|NCT03372057|560621965|FG002|Dose Optimization Phase|Death|0|||
155323895|NCT03372057|560621963|FG000|Expansion Phase|Withdrawal by Subject|0|||
155323896|NCT03372057|560621964|FG001|Expansion Phase|Withdrawal by Subject|0|||
155323897|NCT03372057|560621965|FG002|Expansion Phase|Withdrawal by Subject|4|||
155323898|NCT03372057|560621963|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
155323899|NCT03372057|560621964|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
155323900|NCT03372057|560621965|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
155323901|NCT03372057|560621963|FG000|Expansion Phase|Death|0|||
155323902|NCT03372057|560621964|FG001|Expansion Phase|Death|0|||
155323903|NCT03372057|560621965|FG002|Expansion Phase|Death|78|||
155323904|NCT03372057|560621963|FG000|Expansion Phase|Progressive Disease|0|||
155323905|NCT03372057|560621964|FG001|Expansion Phase|Progressive Disease|0|||
155323906|NCT03372057|560621965|FG002|Expansion Phase|Progressive Disease|1|||
155323907|NCT03372057|560621963|FG000|Expansion Phase|Adverse Event|0|||
155323908|NCT03372057|560621964|FG001|Expansion Phase|Adverse Event|0|||
155323909|NCT03372057|560621965|FG002|Expansion Phase|Adverse Event|1|||
155323910|NCT05953740|560621966|FG000|Period 1|Physician Decision|0|||
155323911|NCT05953740|560621967|FG001|Period 1|Physician Decision|1|||
155323912|NCT05953740|560621968|FG002|Period 1|Physician Decision|0|||
155323913|NCT05953740|560621969|FG003|Period 1|Physician Decision|0|||
155323914|NCT05953740|560621970|FG004|Period 1|Physician Decision|0|||
155323915|NCT05953740|560621971|FG005|Period 1|Physician Decision|0|||
155323916|NCT05953740|560621972|FG006|Period 1|Physician Decision|0|||
155323917|NCT05953740|560621973|FG007|Period 1|Physician Decision|0|||
155323918|NCT05953740|560621966|FG000|Period 2|Withdrawal by Subject|0|||
155323919|NCT05953740|560621967|FG001|Period 2|Withdrawal by Subject|1|||
155323920|NCT05953740|560621968|FG002|Period 2|Withdrawal by Subject|1|||
155323921|NCT05953740|560621969|FG003|Period 2|Withdrawal by Subject|0|||
155323922|NCT05953740|560621970|FG004|Period 2|Withdrawal by Subject|0|||
155323923|NCT05953740|560621971|FG005|Period 2|Withdrawal by Subject|0|||
155323924|NCT05953740|560621972|FG006|Period 2|Withdrawal by Subject|0|||
155323925|NCT05953740|560621973|FG007|Period 2|Withdrawal by Subject|0|||
155323926|NCT03880955|560621974|FG000|Overall Study|Adverse Event|1|||
155323927|NCT03880955|560621974|FG000|Overall Study|Death|1|||
155323928|NCT03880955|560621974|FG000|Overall Study|Lost to Follow-up|12|||
155323929|NCT03880955|560621974|FG000|Overall Study|Withdrawal by Subject|4|||
155323930|NCT03880955|560621974|FG000|Overall Study|Missing- Study Site Closed|27|||
155323931|NCT05112900|560621975|FG000|Overall Study|Withdrawal by Subject|960|||
155323932|NCT05112900|560621976|FG001|Overall Study|Withdrawal by Subject|921|||
155323933|NCT05112900|560621977|FG002|Overall Study|Withdrawal by Subject|968|||
155323934|NCT04761198|560621980|FG000|Overall Study|Progressive Disease|1|||
155323935|NCT04761198|560621981|FG001|Overall Study|Progressive Disease|0|||
155323936|NCT04761198|560621982|FG002|Overall Study|Progressive Disease|0|||
155323937|NCT04761198|560621983|FG003|Overall Study|Progressive Disease|1|||
155323938|NCT04761198|560621984|FG004|Overall Study|Progressive Disease|4|||
155323939|NCT04761198|560621985|FG005|Overall Study|Progressive Disease|1|||
155323940|NCT04761198|560621986|FG006|Overall Study|Progressive Disease|2|||
155323941|NCT04761198|560621980|FG000|Overall Study|Protocol Violation|0|||
155323942|NCT04761198|560621981|FG001|Overall Study|Protocol Violation|0|||
155323943|NCT04761198|560621982|FG002|Overall Study|Protocol Violation|0|||
155323944|NCT04761198|560621983|FG003|Overall Study|Protocol Violation|0|||
155323945|NCT04761198|560621984|FG004|Overall Study|Protocol Violation|1|||
155323946|NCT04761198|560621985|FG005|Overall Study|Protocol Violation|0|||
155323947|NCT04761198|560621986|FG006|Overall Study|Protocol Violation|0|||
155323948|NCT04761198|560621980|FG000|Overall Study|Death|2|||
155323949|NCT04761198|560621981|FG001|Overall Study|Death|1|||
155323950|NCT04761198|560621982|FG002|Overall Study|Death|2|||
155323951|NCT04761198|560621983|FG003|Overall Study|Death|5|||
155323952|NCT04761198|560621984|FG004|Overall Study|Death|14|||
155323953|NCT04761198|560621985|FG005|Overall Study|Death|2|||
155323954|NCT04761198|560621986|FG006|Overall Study|Death|5|||
155323955|NCT04761198|560621980|FG000|Overall Study|Lost to Follow-up|0|||
155323956|NCT04761198|560621981|FG001|Overall Study|Lost to Follow-up|0|||
155323957|NCT04761198|560621982|FG002|Overall Study|Lost to Follow-up|0|||
155323958|NCT04761198|560621983|FG003|Overall Study|Lost to Follow-up|0|||
155323959|NCT04761198|560621984|FG004|Overall Study|Lost to Follow-up|1|||
155323960|NCT04761198|560621985|FG005|Overall Study|Lost to Follow-up|0|||
155323961|NCT04761198|560621986|FG006|Overall Study|Lost to Follow-up|0|||
155323962|NCT04761198|560621980|FG000|Overall Study|Withdrawal by Subject|2|||
155323963|NCT04761198|560621981|FG001|Overall Study|Withdrawal by Subject|0|||
155323964|NCT04761198|560621982|FG002|Overall Study|Withdrawal by Subject|1|||
155323965|NCT04761198|560621983|FG003|Overall Study|Withdrawal by Subject|0|||
155323966|NCT04761198|560621984|FG004|Overall Study|Withdrawal by Subject|2|||
155323967|NCT04761198|560621985|FG005|Overall Study|Withdrawal by Subject|0|||
155323968|NCT04761198|560621986|FG006|Overall Study|Withdrawal by Subject|1|||
155323969|NCT04761198|560621980|FG000|Overall Study|Study Terminated by Sponsor|6|||
155323970|NCT04761198|560621981|FG001|Overall Study|Study Terminated by Sponsor|0|||
155323971|NCT04761198|560621982|FG002|Overall Study|Study Terminated by Sponsor|5|||
155323972|NCT04761198|560621983|FG003|Overall Study|Study Terminated by Sponsor|3|||
155323973|NCT04761198|560621984|FG004|Overall Study|Study Terminated by Sponsor|10|||
155323974|NCT04761198|560621985|FG005|Overall Study|Study Terminated by Sponsor|1|||
155323975|NCT04761198|560621986|FG006|Overall Study|Study Terminated by Sponsor|2|||
155323976|NCT02994927|560621987|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155323977|NCT02994927|560621988|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155323978|NCT02994927|560621987|FG000|Overall Study|Did not meet eligibility criteria|0|||
155323979|NCT02994927|560621988|FG001|Overall Study|Did not meet eligibility criteria|1|||
155323980|NCT02994927|560621987|FG000|Overall Study|Physician Decision|4|||
155323981|NCT02994927|560621988|FG001|Overall Study|Physician Decision|3|||
155323982|NCT02994927|560621987|FG000|Overall Study|Death|4|||
155323983|NCT02994927|560621988|FG001|Overall Study|Death|2|||
155323984|NCT02994927|560621987|FG000|Overall Study|Adverse Event|2|||
155323985|NCT02994927|560621988|FG001|Overall Study|Adverse Event|1|||
155323986|NCT02994927|560621987|FG000|Overall Study|Withdrawal by Subject|3|||
155323987|NCT02994927|560621988|FG001|Overall Study|Withdrawal by Subject|6|||
155323988|NCT02994927|560621987|FG000|Overall Study|Lost to Follow-up|2|||
155323989|NCT02994927|560621988|FG001|Overall Study|Lost to Follow-up|1|||
155323990|NCT02865538|560621990|FG000|Overall Study|Withdrawal by Subject|0|||
155323991|NCT02865538|560621991|FG001|Overall Study|Withdrawal by Subject|0|||
155323992|NCT02865538|560621992|FG002|Overall Study|Withdrawal by Subject|1|||
155323993|NCT02865538|560621993|FG003|Overall Study|Withdrawal by Subject|0|||
155323994|NCT02865538|560621994|FG004|Overall Study|Withdrawal by Subject|0|||
155323995|NCT02865538|560621990|FG000|Overall Study|Lost to Follow-up|1|||
155323996|NCT02865538|560621991|FG001|Overall Study|Lost to Follow-up|0|||
155323997|NCT02865538|560621992|FG002|Overall Study|Lost to Follow-up|0|||
155323998|NCT02865538|560621993|FG003|Overall Study|Lost to Follow-up|0|||
154961095|NCT02558491|559282209|FG001|First Invention|Changed parameters during trial|0|||
154961096|NCT02558491|559282208|FG000|Second Intervention|Withdrawal by Subject|1|||
155323999|NCT02865538|560621994|FG004|Overall Study|Lost to Follow-up|0|||
155324000|NCT04427007|560623514|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
155324001|NCT04427007|560623515|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
155324002|NCT04165213|560623524|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
155324003|NCT04165213|560623525|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
155324004|NCT04165213|560623524|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
155324005|NCT04165213|560623525|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
155324006|NCT04165213|560623524|FG000|Clinician Enrollment|Termination from site|0|||
155324007|NCT04165213|560623525|FG001|Clinician Enrollment|Termination from site|1|||
155324008|NCT04165213|560623524|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
155324009|NCT04165213|560623525|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
155324010|NCT04165213|560623524|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
155324011|NCT04165213|560623525|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
155324012|NCT04165213|560623524|FG000|Caregiver Enrollment|Physician Decision|1|||
155324013|NCT04165213|560623525|FG001|Caregiver Enrollment|Physician Decision|0|||
155324014|NCT04165213|560623524|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
155324015|NCT04165213|560623525|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
155324016|NCT04165213|560623524|FG000|Caregiver Enrollment|PLWD death|2|||
155324017|NCT04165213|560623525|FG001|Caregiver Enrollment|PLWD death|0|||
155324018|NCT04165213|560623524|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
155324019|NCT04165213|560623525|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
155324020|NCT04165213|560623524|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
155324021|NCT04165213|560623525|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
155324022|NCT04165213|560623524|FG000|PLWD Enrollment|Lost to Follow-up|1|||
155324023|NCT04165213|560623525|FG001|PLWD Enrollment|Lost to Follow-up|1|||
155324024|NCT04165213|560623524|FG000|PLWD Enrollment|Physician Decision|1|||
155324025|NCT04165213|560623525|FG001|PLWD Enrollment|Physician Decision|0|||
155324026|NCT04165213|560623524|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
155324027|NCT04165213|560623525|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
155324028|NCT04165213|560623524|FG000|PLWD Enrollment|Death|2|||
155324029|NCT04165213|560623525|FG001|PLWD Enrollment|Death|0|||
155324030|NCT04165213|560623524|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
155324031|NCT04165213|560623525|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
155324032|NCT04464564|560623526|FG000|Period A (Placebo lead-in)|Other|5|||
155324033|NCT04464564|560623527|FG001|Period A (Placebo lead-in)|Other|0|||
155324034|NCT04464564|560623528|FG002|Period A (Placebo lead-in)|Other|0|||
155324035|NCT04464564|560623529|FG003|Period A (Placebo lead-in)|Other|0|||
155324036|NCT04464564|560623526|FG000|Period B (Randomization Period)|Adverse Event|0|||
155324037|NCT04464564|560623527|FG001|Period B (Randomization Period)|Adverse Event|1|||
155324038|NCT04464564|560623528|FG002|Period B (Randomization Period)|Adverse Event|2|||
155324039|NCT04464564|560623529|FG003|Period B (Randomization Period)|Adverse Event|8|||
155324040|NCT04464564|560623526|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
155324041|NCT04464564|560623527|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
155324042|NCT04464564|560623528|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
155324043|NCT04464564|560623529|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
155324044|NCT04464564|560623526|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
155324045|NCT04464564|560623527|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
155324046|NCT04464564|560623528|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
155324047|NCT04464564|560623529|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
155324048|NCT04464564|560623526|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
155324049|NCT04464564|560623527|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
155324050|NCT04464564|560623528|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
155324051|NCT04464564|560623529|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
155324052|NCT04464564|560623526|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
155324053|NCT04464564|560623527|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
155324054|NCT04464564|560623528|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
155324055|NCT04464564|560623529|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
155324056|NCT04464564|560623526|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
155324057|NCT04464564|560623527|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
155324058|NCT04464564|560623528|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
155324059|NCT04464564|560623529|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
155324060|NCT04464564|560623526|FG000|Period B (Randomization Period)|Reason not Specified|0|||
155324061|NCT04464564|560623527|FG001|Period B (Randomization Period)|Reason not Specified|3|||
155324062|NCT04464564|560623528|FG002|Period B (Randomization Period)|Reason not Specified|3|||
155324063|NCT04464564|560623529|FG003|Period B (Randomization Period)|Reason not Specified|3|||
155324064|NCT04089865|560623538|FG000|Overall Study|Withdrawal by Subject|2|||
155324065|NCT04089865|560623539|FG001|Overall Study|Withdrawal by Subject|2|||
155069043|NCT00580840|559682730|FG002|Double-Blind|Other: Forbidden Medication|1|||
155324066|NCT04089865|560623540|FG002|Overall Study|Withdrawal by Subject|7|||
155324067|NCT04089865|560623541|FG003|Overall Study|Withdrawal by Subject|2|||
155324068|NCT04282980|560623544|FG000|Overall Study|Remained on treatment|6|||
155324069|NCT04282980|560623544|FG000|Overall Study|Survival follow-up|11|||
155324070|NCT04282980|560623544|FG000|Overall Study|Withdrawal of informed consent|1|||
155324071|NCT04282980|560623544|FG000|Overall Study|Lost to Follow-up|1|||
155324072|NCT01917084|560623546|FG000|Overall Study|Withdrawal by Subject|1|||
155324073|NCT03571386|560623547|FG000|Overall Study|scheduling conflict|4|||
155324074|NCT03571386|560623548|FG001|Overall Study|scheduling conflict|0|||
155324075|NCT03571386|560623547|FG000|Overall Study|Withdrawal by Subject|15|||
155324076|NCT03571386|560623548|FG001|Overall Study|Withdrawal by Subject|5|||
155324077|NCT02909686|560623556|FG000|Overall Study|Physician Decision|3|||
155324078|NCT02909686|560623556|FG000|Overall Study|Withdrawal by Subject|2|||
155324079|NCT03858517|560623557|FG000|Overall Study|Adverse Event|1|||
155324080|NCT03858517|560623557|FG000|Overall Study|Lost to Follow-up|1|||
155324081|NCT03858517|560623557|FG000|Overall Study|removed for being incarcerated|1|||
155324082|NCT03858517|560623557|FG000|Overall Study|Sponsor Closure|48|||
155324083|NCT00887198|560623559|FG000|Randomized Period|Ongoing|42|||
155324084|NCT00887198|560623560|FG001|Randomized Period|Ongoing|0|||
155324085|NCT00887198|560623561|FG002|Randomized Period|Ongoing|0|||
155324086|NCT00887198|560623559|FG000|Randomized Period|Adverse Event|50|||
155324087|NCT00887198|560623560|FG001|Randomized Period|Adverse Event|33|||
155324088|NCT00887198|560623561|FG002|Randomized Period|Adverse Event|0|||
155324089|NCT00887198|560623559|FG000|Randomized Period|Lost to Follow-up|1|||
155324090|NCT00887198|560623560|FG001|Randomized Period|Lost to Follow-up|0|||
155324091|NCT00887198|560623561|FG002|Randomized Period|Lost to Follow-up|0|||
155324092|NCT00887198|560623559|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
155324093|NCT00887198|560623560|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
155324094|NCT00887198|560623561|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
155324095|NCT00887198|560623559|FG000|Randomized Period|Withdrawal by Subject|41|||
155324096|NCT00887198|560623560|FG001|Randomized Period|Withdrawal by Subject|56|||
155324097|NCT00887198|560623561|FG002|Randomized Period|Withdrawal by Subject|0|||
155324098|NCT00887198|560623559|FG000|Randomized Period|Progressive disease|366|||
155324099|NCT00887198|560623560|FG001|Randomized Period|Progressive disease|370|||
155324100|NCT00887198|560623561|FG002|Randomized Period|Progressive disease|0|||
155324101|NCT00887198|560623559|FG000|Randomized Period|Other|42|||
155324102|NCT00887198|560623560|FG001|Randomized Period|Other|30|||
155324103|NCT00887198|560623561|FG002|Randomized Period|Other|0|||
155324104|NCT00887198|560623559|FG000|Randomized Period|Randomized, Not treated|4|||
155324105|NCT00887198|560623560|FG001|Randomized Period|Randomized, Not treated|2|||
155324106|NCT00887198|560623561|FG002|Randomized Period|Randomized, Not treated|0|||
155324107|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
155324108|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
155324109|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
155324110|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
155324111|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
155324112|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
155324113|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
155324114|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
155324115|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
155324116|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
155324117|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
155324118|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
155324119|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
155324120|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
155324121|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
155324122|NCT00887198|560623559|FG000|Cross Over (Placebo to AA)|Other|0|||
155324123|NCT00887198|560623560|FG001|Cross Over (Placebo to AA)|Other|0|||
155324124|NCT00887198|560623561|FG002|Cross Over (Placebo to AA)|Other|19|||
155324125|NCT02782676|560623562|FG000|Overall Study|Lost to Follow-up|0|||
155324126|NCT02782676|560623563|FG001|Overall Study|Lost to Follow-up|1|||
155324127|NCT05007080|560623564|FG000|Overall Study|Lost to Follow-up|0|||
155324128|NCT05007080|560623565|FG001|Overall Study|Lost to Follow-up|1|||
155324129|NCT05007080|560623566|FG002|Overall Study|Lost to Follow-up|0|||
155324130|NCT05007080|560623567|FG003|Overall Study|Lost to Follow-up|1|||
155324131|NCT05007080|560623568|FG004|Overall Study|Lost to Follow-up|1|||
155324132|NCT05007080|560623569|FG005|Overall Study|Lost to Follow-up|1|||
155324133|NCT05007080|560623564|FG000|Overall Study|Death|0|||
155324134|NCT05007080|560623565|FG001|Overall Study|Death|1|||
155324135|NCT05007080|560623566|FG002|Overall Study|Death|0|||
155324136|NCT05007080|560623567|FG003|Overall Study|Death|0|||
155324137|NCT05007080|560623568|FG004|Overall Study|Death|0|||
155324138|NCT05007080|560623569|FG005|Overall Study|Death|0|||
155324139|NCT05007080|560623564|FG000|Overall Study|Withdrawal by Subject|1|||
155324140|NCT05007080|560623565|FG001|Overall Study|Withdrawal by Subject|2|||
155324141|NCT05007080|560623566|FG002|Overall Study|Withdrawal by Subject|0|||
155324142|NCT05007080|560623567|FG003|Overall Study|Withdrawal by Subject|2|||
155324143|NCT05007080|560623568|FG004|Overall Study|Withdrawal by Subject|1|||
155324144|NCT05007080|560623569|FG005|Overall Study|Withdrawal by Subject|1|||
155324145|NCT05007080|560623564|FG000|Overall Study|Other|1|||
155324146|NCT05007080|560623565|FG001|Overall Study|Other|0|||
155324147|NCT05007080|560623566|FG002|Overall Study|Other|1|||
155324148|NCT05007080|560623567|FG003|Overall Study|Other|1|||
155324149|NCT05007080|560623568|FG004|Overall Study|Other|0|||
155324150|NCT05007080|560623569|FG005|Overall Study|Other|2|||
155324151|NCT05007080|560623564|FG000|Overall Study|Randomized not vaccinated|0|||
155324152|NCT05007080|560623565|FG001|Overall Study|Randomized not vaccinated|0|||
155324153|NCT05007080|560623566|FG002|Overall Study|Randomized not vaccinated|0|||
155324154|NCT05007080|560623567|FG003|Overall Study|Randomized not vaccinated|0|||
155324155|NCT05007080|560623568|FG004|Overall Study|Randomized not vaccinated|0|||
155324156|NCT05007080|560623569|FG005|Overall Study|Randomized not vaccinated|1|||
155324157|NCT02874742|560623571|FG000|Overall Study|Death|0|||
155324158|NCT02874742|560623572|FG001|Overall Study|Death|1|||
155324159|NCT02874742|560623573|FG002|Overall Study|Death|0|||
155324160|NCT02874742|560623571|FG000|Overall Study|Lost to Follow-up|5|||
155324161|NCT02874742|560623572|FG001|Overall Study|Lost to Follow-up|4|||
155324162|NCT02874742|560623573|FG002|Overall Study|Lost to Follow-up|1|||
155324163|NCT02874742|560623571|FG000|Overall Study|Withdrawal by Subject|17|||
155324164|NCT02874742|560623572|FG001|Overall Study|Withdrawal by Subject|8|||
155324165|NCT02874742|560623573|FG002|Overall Study|Withdrawal by Subject|0|||
155324166|NCT02874742|560623571|FG000|Overall Study|Other|4|||
155324167|NCT02874742|560623572|FG001|Overall Study|Other|1|||
155324168|NCT02874742|560623573|FG002|Overall Study|Other|0|||
155324169|NCT02874742|560623571|FG000|Overall Study|Progressive Disease|1|||
155324170|NCT02874742|560623572|FG001|Overall Study|Progressive Disease|0|||
155324171|NCT02874742|560623573|FG002|Overall Study|Progressive Disease|0|||
155324172|NCT02874742|560623571|FG000|Overall Study|Screen Failure|0|||
155324173|NCT02874742|560623572|FG001|Overall Study|Screen Failure|2|||
155324174|NCT02874742|560623573|FG002|Overall Study|Screen Failure|0|||
155324175|NCT00631475|560623579|FG000|Overall Study|Death|18|||
155324176|NCT00631475|560623579|FG000|Overall Study|Adverse Event|14|||
155324177|NCT00631475|560623579|FG000|Overall Study|Withdrew consent|5|||
155324178|NCT00631475|560623579|FG000|Overall Study|Preparation for lung transplant|8|||
155324179|NCT00303459|560623580|FG000|Overall Study|Death|33|||
155324180|NCT00303459|560623581|FG001|Overall Study|Death|44|||
155324181|NCT00303459|560623580|FG000|Overall Study|Withdrawal of consent|32|||
155324182|NCT00303459|560623581|FG001|Overall Study|Withdrawal of consent|26|||
155324183|NCT00303459|560623580|FG000|Overall Study|Lost to Follow-up|5|||
155324184|NCT00303459|560623581|FG001|Overall Study|Lost to Follow-up|4|||
155324185|NCT00303459|560623580|FG000|Overall Study|Administrative reason|7|||
155324186|NCT00303459|560623581|FG001|Overall Study|Administrative reason|7|||
155324187|NCT00303459|560623580|FG000|Overall Study|Decision by the investigator|5|||
155324188|NCT00303459|560623581|FG001|Overall Study|Decision by the investigator|7|||
155324189|NCT00303459|560623580|FG000|Overall Study|Lung transplantation|1|||
155324190|NCT00303459|560623581|FG001|Overall Study|Lung transplantation|1|||
155324191|NCT02492711|560623584|FG000|Overall Study|Adverse Event|9|||
155324192|NCT02492711|560623585|FG001|Overall Study|Adverse Event|9|||
155324193|NCT02492711|560623586|FG002|Overall Study|Adverse Event|2|||
155324194|NCT02492711|560623584|FG000|Overall Study|Death|3|||
155324195|NCT02492711|560623585|FG001|Overall Study|Death|3|||
155324196|NCT02492711|560623586|FG002|Overall Study|Death|0|||
155324197|NCT02492711|560623584|FG000|Overall Study|Withdrawal by Subject|10|||
155324198|NCT02492711|560623585|FG001|Overall Study|Withdrawal by Subject|16|||
155324199|NCT02492711|560623586|FG002|Overall Study|Withdrawal by Subject|5|||
155324200|NCT02492711|560623584|FG000|Overall Study|Physician Decision|10|||
155324201|NCT02492711|560623585|FG001|Overall Study|Physician Decision|6|||
155324202|NCT02492711|560623586|FG002|Overall Study|Physician Decision|4|||
155324203|NCT02492711|560623584|FG000|Overall Study|Lost to Follow-up|0|||
155324204|NCT02492711|560623585|FG001|Overall Study|Lost to Follow-up|0|||
155324205|NCT02492711|560623586|FG002|Overall Study|Lost to Follow-up|1|||
155324206|NCT02492711|560623584|FG000|Overall Study|study treatment delay|2|||
155324207|NCT02492711|560623585|FG001|Overall Study|study treatment delay|1|||
155324208|NCT02492711|560623586|FG002|Overall Study|study treatment delay|0|||
155324209|NCT02492711|560623584|FG000|Overall Study|change in chemotherapy|0|||
155324210|NCT02492711|560623585|FG001|Overall Study|change in chemotherapy|1|||
155324211|NCT02492711|560623586|FG002|Overall Study|change in chemotherapy|0|||
155324212|NCT02492711|560623584|FG000|Overall Study|never treated|2|||
155324213|NCT02492711|560623585|FG001|Overall Study|never treated|4|||
155324214|NCT02492711|560623586|FG002|Overall Study|never treated|0|||
155324215|NCT02492711|560623584|FG000|Overall Study|Other|0|||
155324216|NCT02492711|560623585|FG001|Overall Study|Other|0|||
155324217|NCT02492711|560623586|FG002|Overall Study|Other|1|||
155324218|NCT05830799|560623591|FG000|Overall Study|Withdrawal by Subject|1|||
155324219|NCT04109066|560623603|FG000|Pre-treatment|Participant withdrew consent|2|||
155324220|NCT04109066|560623604|FG001|Pre-treatment|Participant withdrew consent|0|||
155324221|NCT04109066|560623603|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
155324222|NCT04109066|560623604|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
155324223|NCT04109066|560623603|FG000|Treatment|Lack of Efficacy|2|||
155324224|NCT04109066|560623604|FG001|Treatment|Lack of Efficacy|4|||
155324225|NCT04109066|560623603|FG000|Treatment|Adverse Event|23|||
155324226|NCT04109066|560623604|FG001|Treatment|Adverse Event|7|||
155324227|NCT04109066|560623603|FG000|Treatment|Participant request to discontinue Study treatment|15|||
155324228|NCT04109066|560623604|FG001|Treatment|Participant request to discontinue Study treatment|14|||
155324229|NCT04109066|560623603|FG000|Treatment|Withdrawal by Subject|8|||
155324230|NCT04109066|560623604|FG001|Treatment|Withdrawal by Subject|8|||
155324231|NCT04109066|560623603|FG000|Treatment|Death|3|||
155324232|NCT04109066|560623604|FG001|Treatment|Death|0|||
155324233|NCT04109066|560623603|FG000|Treatment|Participant no longer meets study criteria|2|||
155324234|NCT04109066|560623604|FG001|Treatment|Participant no longer meets study criteria|2|||
155324235|NCT04109066|560623603|FG000|Treatment|Administrative reasons by sponsor|2|||
155324236|NCT04109066|560623604|FG001|Treatment|Administrative reasons by sponsor|3|||
155324237|NCT04109066|560623603|FG000|Treatment|Other reasons|17|||
155324238|NCT04109066|560623604|FG001|Treatment|Other reasons|23|||
155324239|NCT04109066|560623603|FG000|Treatment|Disease Progression|4|||
155324240|NCT04109066|560623604|FG001|Treatment|Disease Progression|7|||
155324241|NCT04109066|560623603|FG000|Treatment|Study drug toxicity|12|||
155324242|NCT04109066|560623604|FG001|Treatment|Study drug toxicity|5|||
155324243|NCT04109066|560623603|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
155324244|NCT04109066|560623604|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
155324245|NCT04109066|560623603|FG000|Treatment|Disease Recurrence|0|||
155324246|NCT04109066|560623604|FG001|Treatment|Disease Recurrence|2|||
155324247|NCT04109066|560623603|FG000|Treatment|Not reported|4|||
155324248|NCT04109066|560623604|FG001|Treatment|Not reported|8|||
155324249|NCT05205161|560623605|FG000|Overall Study|Study terminated by sponsor|3|||
155324250|NCT05205161|560623606|FG001|Overall Study|Study terminated by sponsor|3|||
154961097|NCT02558491|559282209|FG001|Second Intervention|Withdrawal by Subject|0|||
154961098|NCT02558491|559282208|FG000|Second Intervention|Stopping Criteria|1|||
154961099|NCT02558491|559282209|FG001|Second Intervention|Stopping Criteria|0|||
154961100|NCT03792477|559282213|FG000|Overall Study|Adverse Event|0|||
154961101|NCT03792477|559282214|FG001|Overall Study|Adverse Event|0|||
154961102|NCT03792477|559282215|FG002|Overall Study|Adverse Event|0|||
154961103|NCT03792477|559282216|FG003|Overall Study|Adverse Event|1|||
154961104|NCT03792477|559282217|FG004|Overall Study|Adverse Event|0|||
154961105|NCT03792477|559282213|FG000|Overall Study|Lost to Follow-up|0|||
154961106|NCT03792477|559282214|FG001|Overall Study|Lost to Follow-up|0|||
154961107|NCT03792477|559282215|FG002|Overall Study|Lost to Follow-up|2|||
154961108|NCT03792477|559282216|FG003|Overall Study|Lost to Follow-up|0|||
154961109|NCT03792477|559282217|FG004|Overall Study|Lost to Follow-up|0|||
154961110|NCT03792477|559282213|FG000|Overall Study|Other|0|||
154961111|NCT03792477|559282214|FG001|Overall Study|Other|0|||
154961112|NCT03792477|559282215|FG002|Overall Study|Other|0|||
154961113|NCT03792477|559282216|FG003|Overall Study|Other|0|||
154961114|NCT03792477|559282217|FG004|Overall Study|Other|1|||
154961115|NCT00840411|559282219|FG000|First Intervention|Adverse Event|1|||
155324251|NCT05205161|560623607|FG002|Overall Study|Study terminated by sponsor|1|||
155324252|NCT04369911|560623609|FG000|Overall Study|Lost to Follow-up|3|||
155324253|NCT04369911|560623610|FG001|Overall Study|Lost to Follow-up|3|||
155324254|NCT04369911|560623609|FG000|Overall Study|Withdrawal by Subject|1|||
154961116|NCT00840411|559282220|FG001|First Intervention|Adverse Event|0|||
154961117|NCT00840411|559282219|FG000|Washout|Withdrawal by Subject|1|||
154961118|NCT00840411|559282220|FG001|Washout|Withdrawal by Subject|0|||
154961119|NCT01576042|559282223|FG000|Overall Study|Physician Decision|2|||
154961120|NCT01576042|559282224|FG001|Overall Study|Physician Decision|0|||
154961121|NCT03233724|559282225|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
154961122|NCT03233724|559282226|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
154961123|NCT03233724|559282227|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
154961124|NCT03233724|559282228|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
154961125|NCT03233724|559282229|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
154961126|NCT03233724|559282225|FG000|Phase I Dose Escalation|Best interest of participant|1|||
154961127|NCT03233724|559282226|FG001|Phase I Dose Escalation|Best interest of participant|1|||
154961128|NCT03233724|559282227|FG002|Phase I Dose Escalation|Best interest of participant|1|||
154961129|NCT03233724|559282228|FG003|Phase I Dose Escalation|Best interest of participant|0|||
154961130|NCT03233724|559282229|FG004|Phase I Dose Escalation|Best interest of participant|0|||
154961131|NCT03233724|559282225|FG000|Phase I Dose Escalation|Physician Decision|0|||
154961132|NCT03233724|559282226|FG001|Phase I Dose Escalation|Physician Decision|0|||
155324255|NCT04369911|560623610|FG001|Overall Study|Withdrawal by Subject|2|||
155324256|NCT04163991|560623613|FG000|Overall Study|Adverse Event|0|||
155324257|NCT04163991|560623614|FG001|Overall Study|Adverse Event|0|||
155324258|NCT04163991|560623615|FG002|Overall Study|Adverse Event|0|||
155324259|NCT04163991|560623616|FG003|Overall Study|Adverse Event|1|||
155324260|NCT04163991|560623617|FG004|Overall Study|Adverse Event|0|||
155324261|NCT04163991|560623613|FG000|Overall Study|Death|0|||
155324262|NCT04163991|560623614|FG001|Overall Study|Death|0|||
155324263|NCT04163991|560623615|FG002|Overall Study|Death|1|||
155324264|NCT04163991|560623616|FG003|Overall Study|Death|0|||
155324265|NCT04163991|560623617|FG004|Overall Study|Death|0|||
155324266|NCT04163991|560623613|FG000|Overall Study|Lost to Follow-up|0|||
155324267|NCT04163991|560623614|FG001|Overall Study|Lost to Follow-up|1|||
155324268|NCT04163991|560623615|FG002|Overall Study|Lost to Follow-up|0|||
155324269|NCT04163991|560623616|FG003|Overall Study|Lost to Follow-up|0|||
155324270|NCT04163991|560623617|FG004|Overall Study|Lost to Follow-up|0|||
155324271|NCT04163991|560623613|FG000|Overall Study|Withdrawal by Subject|1|||
155324272|NCT04163991|560623614|FG001|Overall Study|Withdrawal by Subject|1|||
155324273|NCT04163991|560623615|FG002|Overall Study|Withdrawal by Subject|3|||
155324274|NCT04163991|560623616|FG003|Overall Study|Withdrawal by Subject|1|||
155324275|NCT04163991|560623617|FG004|Overall Study|Withdrawal by Subject|1|||
155324276|NCT04163991|560623613|FG000|Overall Study|Other, Not Specified|0|||
155324277|NCT04163991|560623614|FG001|Overall Study|Other, Not Specified|1|||
155324278|NCT04163991|560623615|FG002|Overall Study|Other, Not Specified|1|||
155324279|NCT04163991|560623616|FG003|Overall Study|Other, Not Specified|1|||
155324280|NCT04163991|560623617|FG004|Overall Study|Other, Not Specified|0|||
155324281|NCT02510235|560623619|FG000|Overall Study|Withdrawal by Subject|1|||
155324282|NCT02510235|560623620|FG001|Overall Study|Withdrawal by Subject|0|||
155324283|NCT00450216|560623621|FG000|Overall Study|Adverse Event|38|||
155324284|NCT00450216|560623622|FG001|Overall Study|Adverse Event|23|||
155324285|NCT00450216|560623621|FG000|Overall Study|Withdrawal by Subject|48|||
155324286|NCT00450216|560623622|FG001|Overall Study|Withdrawal by Subject|26|||
155324287|NCT00450216|560623621|FG000|Overall Study|Lost to Follow-up|16|||
155324288|NCT00450216|560623622|FG001|Overall Study|Lost to Follow-up|9|||
155324289|NCT00450216|560623621|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
155324290|NCT00450216|560623622|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
155324291|NCT00450216|560623621|FG000|Overall Study|misc|21|||
155324292|NCT00450216|560623622|FG001|Overall Study|misc|20|||
155324293|NCT05008055|560623623|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
155324294|NCT05008055|560623624|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
155324295|NCT05008055|560623625|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
155324296|NCT03011034|560623633|FG000|Overall Study|Adverse Event|1|||
155324297|NCT03011034|560623634|FG001|Overall Study|Adverse Event|0|||
155324298|NCT02461134|560623640|FG000|Overall Study|Adverse Event|1|||
155324299|NCT03165955|560623641|FG000|Treatment|Withdrawal by Subject|3|||
155324300|NCT03165955|560623641|FG000|Treatment|Death|1|||
155324301|NCT03165955|560623641|FG000|Treatment|Adverse Event|1|||
155324302|NCT03165955|560623641|FG000|Treatment|Progressive disease|3|||
155324303|NCT00626795|560623642|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
155324304|NCT00626795|560623643|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
155324305|NCT00626795|560623644|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
155324306|NCT00626795|560623642|FG000|Blinded Treatment|Lack of Efficacy|2|||
155324307|NCT00626795|560623643|FG001|Blinded Treatment|Lack of Efficacy|0|||
155324308|NCT00626795|560623644|FG002|Blinded Treatment|Lack of Efficacy|0|||
155324309|NCT00626795|560623642|FG000|Blinded Treatment|Unacceptable adverse event|0|||
155324310|NCT00626795|560623643|FG001|Blinded Treatment|Unacceptable adverse event|0|||
155324311|NCT00626795|560623644|FG002|Blinded Treatment|Unacceptable adverse event|1|||
155324312|NCT00626795|560623642|FG000|Blinded Treatment|Protocol Violation|0|||
155324313|NCT00626795|560623643|FG001|Blinded Treatment|Protocol Violation|1|||
155324314|NCT00626795|560623644|FG002|Blinded Treatment|Protocol Violation|1|||
155324315|NCT00626795|560623642|FG000|Blinded Treatment|Withdrawal by Subject|1|||
155324316|NCT00626795|560623643|FG001|Blinded Treatment|Withdrawal by Subject|1|||
155324317|NCT00626795|560623644|FG002|Blinded Treatment|Withdrawal by Subject|0|||
155324318|NCT00626795|560623642|FG000|Blinded Treatment|Other reasons|2|||
155324319|NCT00626795|560623643|FG001|Blinded Treatment|Other reasons|0|||
155162919|NCT02447003|560031769|FG001|Overall Study|Physician Decision|1|||
154961133|NCT03233724|559282227|FG002|Phase I Dose Escalation|Physician Decision|1|||
154961134|NCT03233724|559282228|FG003|Phase I Dose Escalation|Physician Decision|0|||
154961135|NCT03233724|559282229|FG004|Phase I Dose Escalation|Physician Decision|0|||
154961136|NCT03233724|559282225|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
154961137|NCT03233724|559282226|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155324320|NCT00626795|560623644|FG002|Blinded Treatment|Other reasons|2|||
155324321|NCT00626795|560623642|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
155324322|NCT00626795|560623643|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
155324323|NCT00626795|560623644|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
155324324|NCT03493542|560623645|FG000|Base Study|Withdrawal by Subject|0|||
155324325|NCT03493542|560623646|FG001|Base Study|Withdrawal by Subject|4|||
155324326|NCT03493542|560623647|FG002|Base Study|Withdrawal by Subject|0|||
155324327|NCT03493542|560623645|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
155324328|NCT03493542|560623646|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
155324329|NCT03493542|560623647|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
155324330|NCT03493542|560623645|FG000|Extension Study|Withdrawal by Subject|0|||
154961138|NCT03233724|559282227|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
154961139|NCT03233724|559282228|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155162920|NCT02447003|560031768|FG000|Overall Study|Withdrawal by Subject|4|||
155324331|NCT03493542|560623646|FG001|Extension Study|Withdrawal by Subject|0|||
155324332|NCT03493542|560623647|FG002|Extension Study|Withdrawal by Subject|25|||
155324333|NCT04499521|560623648|FG000|Overall Study|Disease Progression|1|||
155324334|NCT04499521|560623649|FG001|Overall Study|Disease Progression|0|||
155324335|NCT04244175|560624368|FG000|Overall Study|Adverse Event|3|||
155324336|NCT04244175|560624369|FG001|Overall Study|Adverse Event|2|||
155324337|NCT04244175|560624370|FG002|Overall Study|Adverse Event|5|||
155324338|NCT04244175|560624368|FG000|Overall Study|Lack of Efficacy|1|||
155324339|NCT04244175|560624369|FG001|Overall Study|Lack of Efficacy|0|||
155324340|NCT04244175|560624370|FG002|Overall Study|Lack of Efficacy|1|||
155324341|NCT04244175|560624368|FG000|Overall Study|Lost to Follow-up|1|||
155324342|NCT04244175|560624369|FG001|Overall Study|Lost to Follow-up|0|||
155324343|NCT04244175|560624370|FG002|Overall Study|Lost to Follow-up|0|||
155324344|NCT04244175|560624368|FG000|Overall Study|Non-compliance with study drug|1|||
155324345|NCT04244175|560624369|FG001|Overall Study|Non-compliance with study drug|0|||
155324346|NCT04244175|560624370|FG002|Overall Study|Non-compliance with study drug|1|||
155324347|NCT04244175|560624368|FG000|Overall Study|Protocol deviation|0|||
155324348|NCT04244175|560624369|FG001|Overall Study|Protocol deviation|1|||
155324349|NCT04244175|560624370|FG002|Overall Study|Protocol deviation|0|||
155324350|NCT04244175|560624368|FG000|Overall Study|Withdrawal by Subject|1|||
155324351|NCT04244175|560624369|FG001|Overall Study|Withdrawal by Subject|3|||
155324352|NCT04244175|560624370|FG002|Overall Study|Withdrawal by Subject|1|||
155324353|NCT04244175|560624368|FG000|Overall Study|Other, not specified|0|||
155324354|NCT04244175|560624369|FG001|Overall Study|Other, not specified|1|||
155324355|NCT04244175|560624370|FG002|Overall Study|Other, not specified|2|||
155324356|NCT03417284|560624371|FG000|Overall Study|Inadequate supply on study drug|1|||
155324357|NCT03417284|560624372|FG001|Overall Study|Inadequate supply on study drug|0|||
155324358|NCT03417284|560624373|FG002|Overall Study|Inadequate supply on study drug|0|||
155324359|NCT03417284|560624374|FG003|Overall Study|Inadequate supply on study drug|0|||
155324360|NCT03417284|560624371|FG000|Overall Study|Disease Progression|0|||
154961140|NCT03233724|559282229|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
155324361|NCT03417284|560624372|FG001|Overall Study|Disease Progression|0|||
155324362|NCT03417284|560624373|FG002|Overall Study|Disease Progression|1|||
155324363|NCT03417284|560624374|FG003|Overall Study|Disease Progression|0|||
155324364|NCT03636490|560624375|FG000|Overall Study|Dropped out or incomplete data|141|||
155324365|NCT02278211|560624378|FG000|Overall Study|Unable to analyse PET scan|2|||
155324366|NCT06037668|560624381|FG000|Overall Study|Lost to Follow-up|1|||
155324367|NCT06037668|560624382|FG001|Overall Study|Lost to Follow-up|1|||
155324368|NCT06037668|560624381|FG000|Overall Study|Protocol Violation|1|||
155324369|NCT06037668|560624382|FG001|Overall Study|Protocol Violation|0|||
155324370|NCT06037668|560624381|FG000|Overall Study|Withdrawal by Subject|1|||
155324371|NCT06037668|560624382|FG001|Overall Study|Withdrawal by Subject|0|||
155324372|NCT06037668|560624381|FG000|Overall Study|Other Study Discontinuation Reason|1|||
155324373|NCT06037668|560624382|FG001|Overall Study|Other Study Discontinuation Reason|0|||
155324374|NCT04804540|560624383|FG000|Overall Study|Adverse Event|26|||
155324375|NCT04804540|560624384|FG001|Overall Study|Adverse Event|13|||
155324376|NCT05172232|560624385|FG000|Overall Study|Lost to Follow-up|3|||
155324377|NCT04881461|560624386|FG000|Overall Study|Adverse Event|2|||
155324378|NCT04881461|560624387|FG001|Overall Study|Adverse Event|4|||
155324379|NCT04881461|560624386|FG000|Overall Study|Withdrawal by Subject|19|||
155324380|NCT04881461|560624387|FG001|Overall Study|Withdrawal by Subject|19|||
155324381|NCT04881461|560624386|FG000|Overall Study|Lost to Follow-up|4|||
155324382|NCT04881461|560624387|FG001|Overall Study|Lost to Follow-up|4|||
155324383|NCT04881461|560624386|FG000|Overall Study|Lack of Efficacy|1|||
155324384|NCT04881461|560624387|FG001|Overall Study|Lack of Efficacy|0|||
155324385|NCT04881461|560624386|FG000|Overall Study|"Reason stated as other in CRF"|1|||
155324386|NCT04881461|560624387|FG001|Overall Study|"Reason stated as other in CRF"|2|||
155324387|NCT02997202|560624388|FG000|Overall Study|Miscellaneous|2|||
155324388|NCT02997202|560624389|FG001|Overall Study|Miscellaneous|2|||
155324389|NCT02997202|560624388|FG000|Overall Study|Withdrawal by Subject|8|||
155324390|NCT02997202|560624389|FG001|Overall Study|Withdrawal by Subject|12|||
155324391|NCT02997202|560624388|FG000|Overall Study|Lost to Follow-up|5|||
155324392|NCT02997202|560624389|FG001|Overall Study|Lost to Follow-up|3|||
155324393|NCT02997202|560624388|FG000|Overall Study|Death|41|||
155324394|NCT02997202|560624389|FG001|Overall Study|Death|45|||
155324395|NCT04629339|560624393|FG000|Overall Study|Death|1|||
155324396|NCT04629339|560624394|FG001|Overall Study|Death|0|||
155324397|NCT04629339|560624395|FG002|Overall Study|Death|2|||
155324398|NCT04629339|560624396|FG003|Overall Study|Death|2|||
155324399|NCT04629339|560624397|FG004|Overall Study|Death|0|||
155324400|NCT04629339|560624393|FG000|Overall Study|Disease Progression|0|||
155324401|NCT04629339|560624394|FG001|Overall Study|Disease Progression|0|||
155324402|NCT04629339|560624395|FG002|Overall Study|Disease Progression|1|||
155324403|NCT04629339|560624396|FG003|Overall Study|Disease Progression|1|||
155324404|NCT04629339|560624397|FG004|Overall Study|Disease Progression|0|||
155324405|NCT04629339|560624393|FG000|Overall Study|Lost to Follow-up|0|||
154961141|NCT00651820|559282232|FG000|Overall Study|Lost to Follow-up|2|||
154961142|NCT02388191|559282233|FG000|Overall Study|Patient did not receive IUD|1|||
154961143|NCT02388191|559282234|FG001|Overall Study|Patient did not receive IUD|0|||
154961144|NCT01911676|559282235|FG000|Period 1 of Study|Withdrawal by Subject|4|||
154961145|NCT01911676|559282236|FG001|Period 1 of Study|Withdrawal by Subject|2|||
155324406|NCT04629339|560624394|FG001|Overall Study|Lost to Follow-up|0|||
155324407|NCT04629339|560624395|FG002|Overall Study|Lost to Follow-up|0|||
155324408|NCT04629339|560624396|FG003|Overall Study|Lost to Follow-up|1|||
155324409|NCT04629339|560624397|FG004|Overall Study|Lost to Follow-up|0|||
155324410|NCT04629339|560624393|FG000|Overall Study|Physician Decision|0|||
155324411|NCT04629339|560624394|FG001|Overall Study|Physician Decision|1|||
155324412|NCT04629339|560624395|FG002|Overall Study|Physician Decision|0|||
155324413|NCT04629339|560624396|FG003|Overall Study|Physician Decision|0|||
155324414|NCT04629339|560624397|FG004|Overall Study|Physician Decision|0|||
155324415|NCT04629339|560624393|FG000|Overall Study|Study Terminated by Sponsor|0|||
155324416|NCT04629339|560624394|FG001|Overall Study|Study Terminated by Sponsor|0|||
155324417|NCT04629339|560624395|FG002|Overall Study|Study Terminated by Sponsor|0|||
155324418|NCT04629339|560624396|FG003|Overall Study|Study Terminated by Sponsor|1|||
154961146|NCT01911676|559282237|FG002|Period 1 of Study|Withdrawal by Subject|1|||
154961147|NCT01911676|559282238|FG003|Period 1 of Study|Withdrawal by Subject|2|||
154961148|NCT01911676|559282235|FG000|Period 1 of Study|Physician Decision|2|||
155324419|NCT04629339|560624397|FG004|Overall Study|Study Terminated by Sponsor|0|||
155324420|NCT04629339|560624393|FG000|Overall Study|Withdrawal by Subject|0|||
155324421|NCT04629339|560624394|FG001|Overall Study|Withdrawal by Subject|0|||
154961149|NCT01911676|559282236|FG001|Period 1 of Study|Physician Decision|0|||
154961150|NCT01911676|559282237|FG002|Period 1 of Study|Physician Decision|0|||
154961151|NCT01911676|559282238|FG003|Period 1 of Study|Physician Decision|1|||
155324422|NCT04629339|560624395|FG002|Overall Study|Withdrawal by Subject|2|||
155324423|NCT04629339|560624396|FG003|Overall Study|Withdrawal by Subject|2|||
155324424|NCT04629339|560624397|FG004|Overall Study|Withdrawal by Subject|0|||
154961152|NCT01911676|559282235|FG000|Period 2 of Study|Physician Decision|2|||
155162921|NCT02447003|560031769|FG001|Overall Study|Withdrawal by Subject|3|||
155324425|NCT04158739|560624398|FG000|Overall Study|Adverse Event|1|||
155324426|NCT04158739|560624399|FG001|Overall Study|Adverse Event|0|||
155324427|NCT04158739|560624398|FG000|Overall Study|Death|0|||
155324428|NCT04158739|560624399|FG001|Overall Study|Death|1|||
155324429|NCT04158739|560624398|FG000|Overall Study|Lack of Efficacy|3|||
155162922|NCT02447003|560031768|FG000|Overall Study|Sponsor Decision|6|||
155324430|NCT04158739|560624399|FG001|Overall Study|Lack of Efficacy|7|||
155324431|NCT04158739|560624398|FG000|Overall Study|Physician Decision|0|||
155324432|NCT04158739|560624399|FG001|Overall Study|Physician Decision|1|||
155324433|NCT04158739|560624398|FG000|Overall Study|Withdrawal by Subject|3|||
155324434|NCT04158739|560624399|FG001|Overall Study|Withdrawal by Subject|0|||
155324435|NCT04055012|560624406|FG000|Overall Study|Withdrawal by Subject|1|||
155324436|NCT04055012|560624407|FG001|Overall Study|Withdrawal by Subject|3|||
155324437|NCT04055012|560624408|FG002|Overall Study|Withdrawal by Subject|1|||
155324438|NCT04055012|560624409|FG003|Overall Study|Withdrawal by Subject|0|||
155324439|NCT04055012|560624406|FG000|Overall Study|Metformin Recall|1|||
155324440|NCT04055012|560624407|FG001|Overall Study|Metformin Recall|1|||
155324441|NCT04055012|560624408|FG002|Overall Study|Metformin Recall|1|||
155324442|NCT04055012|560624409|FG003|Overall Study|Metformin Recall|0|||
155324443|NCT04173247|560624410|FG000|Overall Study|Withdrawal by Subject|0|||
155324444|NCT04173247|560624411|FG001|Overall Study|Withdrawal by Subject|2|||
155324445|NCT04173247|560624410|FG000|Overall Study|Death|1|||
155324446|NCT04173247|560624411|FG001|Overall Study|Death|0|||
155324447|NCT04173247|560624410|FG000|Overall Study|Physician Decision|1|||
155324448|NCT04173247|560624411|FG001|Overall Study|Physician Decision|0|||
155324449|NCT03418740|560624417|FG000|Overall Study|Lost to Follow-up|13|||
155324450|NCT03418740|560624417|FG000|Overall Study|Scheduling Issues|7|||
155324451|NCT03418740|560624417|FG000|Overall Study|Withdrawal by Subject|2|||
155324452|NCT03418740|560624417|FG000|Overall Study|Unable to Continue Consent|1|||
155324453|NCT01475786|560624418|FG000|Overall Study|Adverse Event|0|||
155324454|NCT01475786|560624419|FG001|Overall Study|Adverse Event|1|||
155324455|NCT01475786|560624420|FG002|Overall Study|Adverse Event|0|||
155324456|NCT01475786|560624418|FG000|Overall Study|Lost to Follow-up|1|||
155324457|NCT01475786|560624419|FG001|Overall Study|Lost to Follow-up|2|||
155324458|NCT01475786|560624420|FG002|Overall Study|Lost to Follow-up|1|||
155324459|NCT01475786|560624418|FG000|Overall Study|Withdrawal by Subject|0|||
155324460|NCT01475786|560624419|FG001|Overall Study|Withdrawal by Subject|1|||
155324461|NCT01475786|560624420|FG002|Overall Study|Withdrawal by Subject|1|||
155324462|NCT01475786|560624418|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
155324463|NCT01475786|560624419|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
155324464|NCT01475786|560624420|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
155324465|NCT04678856|560624429|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
155324466|NCT04678856|560624430|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
155324467|NCT04678856|560624429|FG000|Overall Study|Withdrawal by Subject|5|||
155324468|NCT04678856|560624430|FG001|Overall Study|Withdrawal by Subject|1|||
155324469|NCT01828021|560624871|FG000|Overall Study|Adverse Event|5|||
155324470|NCT01828021|560624871|FG000|Overall Study|Lack of Efficacy|17|||
155324471|NCT01828021|560624871|FG000|Overall Study|Withdrawal by Subject|2|||
155324472|NCT01828021|560624871|FG000|Overall Study|Ileal obstruction, unrelated|1|||
155324473|NCT02163694|560624881|FG000|Overall Study|Adverse event- related to progression|4|||
155324474|NCT02163694|560624882|FG001|Overall Study|Adverse event- related to progression|10|||
155069044|NCT00580840|559682731|FG003|Double-Blind|Other: Forbidden Medication|0|||
155069045|NCT00976027|559682733|FG000|Overall Study|Serious Adverse Event|36|||
155069046|NCT00976027|559682734|FG001|Overall Study|Serious Adverse Event|17|||
155069047|NCT00976027|559682733|FG000|Overall Study|Adverse Event|0|||
155324475|NCT02163694|560624881|FG000|Overall Study|Adverse event- not related to progression|7|||
155324476|NCT02163694|560624882|FG001|Overall Study|Adverse event- not related to progression|22|||
155324477|NCT02163694|560624881|FG000|Overall Study|Withdrew consent|13|||
155324478|NCT02163694|560624882|FG001|Overall Study|Withdrew consent|28|||
155324479|NCT02163694|560624881|FG000|Overall Study|Lost to Follow-up|2|||
155324480|NCT02163694|560624882|FG001|Overall Study|Lost to Follow-up|2|||
155324481|NCT02163694|560624881|FG000|Overall Study|Sponsor discontinued study|3|||
155324482|NCT02163694|560624882|FG001|Overall Study|Sponsor discontinued study|29|||
155324483|NCT02163694|560624881|FG000|Overall Study|Progressive disease per protocol|125|||
155324484|NCT02163694|560624882|FG001|Overall Study|Progressive disease per protocol|224|||
155324485|NCT02163694|560624881|FG000|Overall Study|Other, not specified|17|||
155324486|NCT02163694|560624882|FG001|Overall Study|Other, not specified|22|||
155069048|NCT00976027|559682734|FG001|Overall Study|Adverse Event|2|||
155324487|NCT02163694|560624881|FG000|Overall Study|Randomized but Not Treated|1|||
155324488|NCT02163694|560624882|FG001|Overall Study|Randomized but Not Treated|0|||
155324489|NCT02163694|560624881|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
155324490|NCT02163694|560624882|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
155324491|NCT04967599|560624889|FG000|Overall Study|Lost to Follow-up|35|||
155324492|NCT04967599|560624890|FG001|Overall Study|Lost to Follow-up|19|||
155069049|NCT00976027|559682733|FG000|Overall Study|Protocol Violation|60|||
155069050|NCT00976027|559682734|FG001|Overall Study|Protocol Violation|27|||
154961153|NCT01911676|559282236|FG001|Period 2 of Study|Physician Decision|0|||
154961154|NCT01911676|559282237|FG002|Period 2 of Study|Physician Decision|0|||
154961155|NCT01911676|559282238|FG003|Period 2 of Study|Physician Decision|1|||
154961156|NCT01911676|559282235|FG000|Period 2 of Study|Lost to Follow-up|0|||
155324493|NCT04967599|560624891|FG002|Overall Study|Lost to Follow-up|23|||
155324494|NCT03817983|560624892|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
155324495|NCT03817983|560624893|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
154961157|NCT01911676|559282236|FG001|Period 2 of Study|Lost to Follow-up|0|||
154961158|NCT01911676|559282237|FG002|Period 2 of Study|Lost to Follow-up|0|||
154961159|NCT01911676|559282238|FG003|Period 2 of Study|Lost to Follow-up|1|||
154961160|NCT01566721|559282239|FG000|Treatment Period|Withdrawal by Subject|35|||
154961161|NCT01566721|559282240|FG001|Treatment Period|Withdrawal by Subject|9|||
154961162|NCT01566721|559282239|FG000|Treatment Period|Disease Progression/Recurrence|37|||
154961163|NCT01566721|559282240|FG001|Treatment Period|Disease Progression/Recurrence|13|||
154961164|NCT01566721|559282239|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
154961165|NCT01566721|559282240|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
154961166|NCT01566721|559282239|FG000|Treatment Period|Other|13|||
154961167|NCT01566721|559282240|FG001|Treatment Period|Other|2|||
154961168|NCT01566721|559282239|FG000|Treatment Period|Lack of Compliance|5|||
154961169|NCT01566721|559282240|FG001|Treatment Period|Lack of Compliance|1|||
154961170|NCT01566721|559282239|FG000|Treatment Period|Adverse Event|100|||
154961171|NCT01566721|559282240|FG001|Treatment Period|Adverse Event|30|||
155324496|NCT03817983|560624894|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
155324497|NCT03744676|560624895|FG000|Pre-Treatment Phase|Disease related complications|2|||
155324498|NCT03744676|560624895|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
155324499|NCT03744676|560624895|FG000|Pre-Treatment Phase|Death|7|||
155324500|NCT03744676|560624895|FG000|Pre-Treatment Phase|Other Reasons|7|||
155324501|NCT03744676|560624895|FG000|Treatment Phase|Participant withdrew consent|8|||
154961172|NCT01566721|559282239|FG000|Treatment Period|Pregnancy|1|||
154961173|NCT01566721|559282240|FG001|Treatment Period|Pregnancy|0|||
154961174|NCT01566721|559282239|FG000|Safety Follow-up|Physician Decision|6|||
154961175|NCT01566721|559282240|FG001|Safety Follow-up|Physician Decision|4|||
154961176|NCT01566721|559282239|FG000|Safety Follow-up|Lost to Follow-up|101|||
154961177|NCT01566721|559282240|FG001|Safety Follow-up|Lost to Follow-up|48|||
154961178|NCT01566721|559282239|FG000|Safety Follow-up|Withdrawal by Subject|155|||
154961179|NCT01566721|559282240|FG001|Safety Follow-up|Withdrawal by Subject|49|||
154961180|NCT01566721|559282239|FG000|Safety Follow-up|Death|28|||
154961181|NCT01566721|559282240|FG001|Safety Follow-up|Death|4|||
154961182|NCT01566721|559282239|FG000|Safety Follow-up|Non-compliance|7|||
154961183|NCT01566721|559282240|FG001|Safety Follow-up|Non-compliance|3|||
154961184|NCT01566721|559282239|FG000|Safety Follow-up|Protocol Violation|7|||
154961185|NCT01566721|559282240|FG001|Safety Follow-up|Protocol Violation|0|||
154961186|NCT01566721|559282239|FG000|Safety Follow-up|Site closure|2|||
154961187|NCT01566721|559282240|FG001|Safety Follow-up|Site closure|3|||
154961188|NCT01566721|559282239|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
154961189|NCT01566721|559282240|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
154961190|NCT01566721|559282239|FG000|Safety Follow-up|Missing|7|||
154961191|NCT01566721|559282240|FG001|Safety Follow-up|Missing|2|||
154961192|NCT01566721|559282239|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
154961193|NCT01566721|559282240|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
154961194|NCT01566721|559282239|FG000|Safety Follow-up|Sponsor decision|1|||
154961195|NCT01566721|559282240|FG001|Safety Follow-up|Sponsor decision|0|||
154961196|NCT01566721|559282239|FG000|Safety Follow-up|Adverse Event|8|||
154961197|NCT01566721|559282240|FG001|Safety Follow-up|Adverse Event|4|||
154961198|NCT00446563|559282241|FG000|Overall Study|Adverse Event|4|||
154961199|NCT00446563|559282242|FG001|Overall Study|Adverse Event|3|||
154961200|NCT00446563|559282241|FG000|Overall Study|Abnormal laboratory value(s)|0|||
154961201|NCT00446563|559282242|FG001|Overall Study|Abnormal laboratory value(s)|1|||
154961202|NCT00446563|559282241|FG000|Overall Study|Abnormal test procedure result(s)|1|||
154961203|NCT00446563|559282242|FG001|Overall Study|Abnormal test procedure result(s)|0|||
154961204|NCT00446563|559282241|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
154961205|NCT00446563|559282242|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
154961206|NCT00446563|559282241|FG000|Overall Study|Withdrawal by Subject|2|||
154961207|NCT00446563|559282242|FG001|Overall Study|Withdrawal by Subject|1|||
154961208|NCT00446563|559282241|FG000|Overall Study|Administrative problems|0|||
154961209|NCT00446563|559282242|FG001|Overall Study|Administrative problems|1|||
154961210|NCT03769025|559282243|FG000|Overall Study|Withdrawal by Subject|1|||
154961211|NCT03769025|559282244|FG001|Overall Study|Withdrawal by Subject|1|||
154961212|NCT03769025|559282243|FG000|Overall Study|Lost to Follow-up|4|||
154961213|NCT03769025|559282244|FG001|Overall Study|Lost to Follow-up|3|||
154961214|NCT04659603|559282255|FG000|Overall Study|Study terminated by sponsor|0|||
154961215|NCT04659603|559282256|FG001|Overall Study|Study terminated by sponsor|0|||
154961216|NCT04659603|559282257|FG002|Overall Study|Study terminated by sponsor|2|||
154961217|NCT04659603|559282255|FG000|Overall Study|Withdrawal by Subject|0|||
154961218|NCT04659603|559282256|FG001|Overall Study|Withdrawal by Subject|5|||
154961219|NCT04659603|559282257|FG002|Overall Study|Withdrawal by Subject|0|||
155324502|NCT03744676|560624895|FG000|Treatment Phase|Death|33|||
155324503|NCT03744676|560624895|FG000|Treatment Phase|other reasons|6|||
155324504|NCT05541484|560624898|FG000|Overall Study|Withdrawal by Subject|1|||
155324505|NCT05541484|560624899|FG001|Overall Study|Withdrawal by Subject|0|||
155324506|NCT01438853|560624900|FG000|Overall Study|Death|0|||
155069051|NCT00976027|559682733|FG000|Overall Study|Lost to Follow-up|208|||
155069052|NCT00976027|559682734|FG001|Overall Study|Lost to Follow-up|103|||
155069053|NCT00976027|559682733|FG000|Overall Study|Withdrawal by Subject|107|||
155069054|NCT00976027|559682734|FG001|Overall Study|Withdrawal by Subject|66|||
155069055|NCT01771107|559682740|FG000|Overall Study|Adverse Event|1|||
155069056|NCT01771107|559682741|FG001|Overall Study|Adverse Event|3|||
155069057|NCT01771107|559682740|FG000|Overall Study|Withdrawal by Subject|0|||
155069058|NCT01771107|559682741|FG001|Overall Study|Withdrawal by Subject|2|||
155069059|NCT01771107|559682740|FG000|Overall Study|Lost to Follow-up|0|||
155069060|NCT01771107|559682741|FG001|Overall Study|Lost to Follow-up|1|||
155069061|NCT01771107|559682740|FG000|Overall Study|participant moved|0|||
155069062|NCT01771107|559682741|FG001|Overall Study|participant moved|1|||
155069063|NCT01771107|559682740|FG000|Overall Study|Other|0|||
155069064|NCT01771107|559682741|FG001|Overall Study|Other|1|||
155069065|NCT05248386|559682742|FG000|Overall Study|Technical problems|0|||
155069066|NCT05248386|559682743|FG001|Overall Study|Technical problems|1|||
155069067|NCT05248386|559682742|FG000|Overall Study|Withdrawal by Subject|15|||
155069068|NCT05248386|559682743|FG001|Overall Study|Withdrawal by Subject|10|||
155069069|NCT05248386|559682742|FG000|Overall Study|Physician Decision|0|||
155069070|NCT05248386|559682743|FG001|Overall Study|Physician Decision|1|||
155069071|NCT05248386|559682742|FG000|Overall Study|Adverse Event|2|||
155069072|NCT05248386|559682743|FG001|Overall Study|Adverse Event|4|||
155069073|NCT05248386|559682742|FG000|Overall Study|Other|1|||
155069074|NCT05248386|559682743|FG001|Overall Study|Other|0|||
155069075|NCT05248386|559682742|FG000|Overall Study|Lack of Efficacy|14|||
155069076|NCT05248386|559682743|FG001|Overall Study|Lack of Efficacy|12|||
155069077|NCT01723774|559682744|FG000|Neoadjuvant|Ki67 > 10%|4|||
155069078|NCT01723774|559682745|FG001|Neoadjuvant|Ki67 > 10%|0|||
155069079|NCT01723774|559682746|FG002|Neoadjuvant|Ki67 > 10%|10|||
155324507|NCT01438853|560624901|FG001|Overall Study|Death|0|||
155324508|NCT01438853|560624902|FG002|Overall Study|Death|0|||
155324509|NCT01438853|560624903|FG003|Overall Study|Death|1|||
155324510|NCT01438853|560624900|FG000|Overall Study|Withdrawal by Subject|0|||
155069080|NCT01723774|559682747|FG003|Neoadjuvant|Ki67 > 10%|0|||
155069081|NCT01723774|559682744|FG000|Neoadjuvant|Withdrawal by Subject|3|||
155069082|NCT01723774|559682745|FG001|Neoadjuvant|Withdrawal by Subject|1|||
155069083|NCT01723774|559682746|FG002|Neoadjuvant|Withdrawal by Subject|0|||
155324511|NCT01438853|560624901|FG001|Overall Study|Withdrawal by Subject|0|||
155324512|NCT01438853|560624902|FG002|Overall Study|Withdrawal by Subject|1|||
155324513|NCT01438853|560624903|FG003|Overall Study|Withdrawal by Subject|0|||
155324514|NCT02919917|560624904|FG000|Overall Study|Withdrawal by Subject|4|||
155324515|NCT02919917|560624905|FG001|Overall Study|Withdrawal by Subject|8|||
155324516|NCT04743973|560624909|FG000|Overall Study|Withdrawal by Subject|5|||
155324517|NCT04159519|560624910|FG000|Overall Study|Adverse Event|1|||
155324518|NCT04159519|560624911|FG001|Overall Study|Adverse Event|1|||
155324519|NCT04159519|560624910|FG000|Overall Study|Lack of Efficacy|1|||
154961220|NCT04659603|559282255|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
154961221|NCT04659603|559282256|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
154961222|NCT04659603|559282257|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
154961223|NCT04646213|559282258|FG000|Overall Study|Physician Decision|3|||
155324520|NCT04159519|560624911|FG001|Overall Study|Lack of Efficacy|0|||
155324521|NCT04159519|560624910|FG000|Overall Study|Discontinued from study|1|||
155324522|NCT04159519|560624911|FG001|Overall Study|Discontinued from study|0|||
155324523|NCT04159519|560624910|FG000|Overall Study|Protocol Violation|1|||
155324524|NCT04159519|560624911|FG001|Overall Study|Protocol Violation|1|||
155324525|NCT04159519|560624910|FG000|Overall Study|Withdrawal by Subject|4|||
155324526|NCT04159519|560624911|FG001|Overall Study|Withdrawal by Subject|4|||
155324527|NCT04780581|560624915|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
154961224|NCT04646213|559282258|FG000|Overall Study|Withdrawal by Subject|2|||
154961225|NCT02441309|559282261|FG000|Overall Study|Disease progression|2|||
154961226|NCT02441309|559282262|FG001|Overall Study|Disease progression|1|||
154961227|NCT02441309|559282263|FG002|Overall Study|Disease progression|2|||
155324528|NCT04780581|560624916|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
155324529|NCT04780581|560624915|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
155324530|NCT04780581|560624916|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
155324531|NCT01756300|560624917|FG000|Overall Study|Death|1|||
155324532|NCT01756300|560624917|FG000|Overall Study|Withdrawal by Subject|1|||
154961228|NCT02441309|559282261|FG000|Overall Study|Adverse Event|0|||
155069084|NCT01723774|559682747|FG003|Neoadjuvant|Withdrawal by Subject|0|||
155069085|NCT01723774|559682744|FG000|Neoadjuvant|Disease progression|0|||
155069086|NCT01723774|559682745|FG001|Neoadjuvant|Disease progression|1|||
155069087|NCT01723774|559682746|FG002|Neoadjuvant|Disease progression|1|||
155069088|NCT01723774|559682747|FG003|Neoadjuvant|Disease progression|0|||
155069089|NCT01723774|559682744|FG000|Neoadjuvant|Adverse Event|0|||
155069090|NCT01723774|559682745|FG001|Neoadjuvant|Adverse Event|1|||
155069091|NCT01723774|559682746|FG002|Neoadjuvant|Adverse Event|2|||
155069092|NCT01723774|559682747|FG003|Neoadjuvant|Adverse Event|0|||
154961229|NCT02441309|559282262|FG001|Overall Study|Adverse Event|1|||
154961230|NCT02441309|559282263|FG002|Overall Study|Adverse Event|0|||
155069093|NCT01723774|559682744|FG000|Neoadjuvant|High estradiol|0|||
155069094|NCT01723774|559682745|FG001|Neoadjuvant|High estradiol|1|||
155324533|NCT04595331|560625504|FG000|Overall Study|Withdrawal by Subject|0|||
155324534|NCT04595331|560625505|FG001|Overall Study|Withdrawal by Subject|1|||
155324535|NCT04595331|560625504|FG000|Overall Study|Lost to Follow-up|0|||
155324536|NCT04595331|560625505|FG001|Overall Study|Lost to Follow-up|5|||
155069095|NCT01723774|559682746|FG002|Neoadjuvant|High estradiol|0|||
155069096|NCT01723774|559682747|FG003|Neoadjuvant|High estradiol|0|||
155069097|NCT02964182|559682748|FG000|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155069098|NCT02964182|559682749|FG001|Phase 2 (Weeks 2-4)|Lost to Follow-up|7|||
155069099|NCT02964182|559682750|FG002|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155069100|NCT02964182|559682751|FG003|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155069101|NCT02964182|559682752|FG004|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155069102|NCT02964182|559682753|FG005|Phase 2 (Weeks 2-4)|Lost to Follow-up|2|||
155069103|NCT02964182|559682754|FG006|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155069104|NCT02964182|559682755|FG007|Phase 2 (Weeks 2-4)|Lost to Follow-up|0|||
155069105|NCT02964182|559682748|FG000|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069106|NCT02964182|559682749|FG001|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069107|NCT02964182|559682750|FG002|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069108|NCT02964182|559682751|FG003|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069109|NCT02964182|559682752|FG004|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069110|NCT02964182|559682753|FG005|Phase 2 (Weeks 2-4)|Physician Decision|12|||
155069111|NCT02964182|559682754|FG006|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069112|NCT02964182|559682755|FG007|Phase 2 (Weeks 2-4)|Physician Decision|0|||
155069113|NCT02964182|559682748|FG000|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155069114|NCT02964182|559682749|FG001|Phase 2 (Weeks 2-4)|Withdrawal by Subject|11|||
155069115|NCT02964182|559682750|FG002|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155069116|NCT02964182|559682751|FG003|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155069117|NCT02964182|559682752|FG004|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155069118|NCT02964182|559682753|FG005|Phase 2 (Weeks 2-4)|Withdrawal by Subject|1|||
155069119|NCT02964182|559682754|FG006|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155069120|NCT02964182|559682755|FG007|Phase 2 (Weeks 2-4)|Withdrawal by Subject|0|||
155324537|NCT04595331|560625504|FG000|Overall Study|Medical reason|0|||
155324538|NCT04595331|560625505|FG001|Overall Study|Medical reason|1|||
155324539|NCT02246127|560625506|FG000|First Course Treatment|Adverse Event|9|||
155324540|NCT02246127|560625507|FG001|First Course Treatment|Adverse Event|7|||
155069121|NCT02964182|559682748|FG000|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155069122|NCT02964182|559682749|FG001|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155069123|NCT02964182|559682750|FG002|Phase 3 (Weeks 5-7)|Lost to Follow-up|3|||
155069124|NCT02964182|559682751|FG003|Phase 3 (Weeks 5-7)|Lost to Follow-up|2|||
155069125|NCT02964182|559682752|FG004|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155324541|NCT02246127|560625506|FG000|First Course Treatment|Withdrawal by Subject|6|||
155324542|NCT02246127|560625507|FG001|First Course Treatment|Withdrawal by Subject|7|||
155324543|NCT02246127|560625506|FG000|First Course Treatment|Physician Decision|9|||
155324544|NCT02246127|560625507|FG001|First Course Treatment|Physician Decision|9|||
155324545|NCT02246127|560625506|FG000|First Course Treatment|Death|3|||
155324546|NCT02246127|560625507|FG001|First Course Treatment|Death|3|||
155324547|NCT02246127|560625506|FG000|First Course Treatment|Not reported reasons|6|||
155324548|NCT02246127|560625507|FG001|First Course Treatment|Not reported reasons|7|||
155324549|NCT02246127|560625506|FG000|First Course Treatment|Not treated|3|||
155324550|NCT02246127|560625507|FG001|First Course Treatment|Not treated|3|||
155324551|NCT03635567|560625508|FG000|Overall Study|Lost to Follow-up|4|||
155324552|NCT03635567|560625509|FG001|Overall Study|Lost to Follow-up|1|||
155324553|NCT03635567|560625508|FG000|Overall Study|Withdrawal by Subject|11|||
155069126|NCT02964182|559682753|FG005|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155069127|NCT02964182|559682754|FG006|Phase 3 (Weeks 5-7)|Lost to Follow-up|1|||
155069128|NCT02964182|559682755|FG007|Phase 3 (Weeks 5-7)|Lost to Follow-up|0|||
155069129|NCT02964182|559682748|FG000|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155069130|NCT02964182|559682749|FG001|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155069131|NCT02964182|559682750|FG002|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
155069132|NCT02964182|559682751|FG003|Phase 3 (Weeks 5-7)|Withdrawal by Subject|5|||
155069133|NCT02964182|559682752|FG004|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155069134|NCT02964182|559682753|FG005|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155324554|NCT03635567|560625509|FG001|Overall Study|Withdrawal by Subject|16|||
155324555|NCT03635567|560625508|FG000|Overall Study|Sponsor Decision|99|||
155324556|NCT03635567|560625509|FG001|Overall Study|Sponsor Decision|57|||
155324557|NCT03635567|560625508|FG000|Overall Study|Death|194|||
155324558|NCT03635567|560625509|FG001|Overall Study|Death|235|||
155324559|NCT00739908|560625510|FG000|Overall Study|Adverse Event|5|||
155324560|NCT00739908|560625511|FG001|Overall Study|Adverse Event|6|||
155324561|NCT00739908|560625510|FG000|Overall Study|Withdrawal by Subject|4|||
155324562|NCT00739908|560625511|FG001|Overall Study|Withdrawal by Subject|2|||
155324563|NCT00739908|560625510|FG000|Overall Study|Lost to Follow-up|14|||
155324564|NCT00739908|560625511|FG001|Overall Study|Lost to Follow-up|9|||
155324565|NCT00739908|560625510|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
155324566|NCT00739908|560625511|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
155324567|NCT00739908|560625510|FG000|Overall Study|Non-Compliance With Study Medication|0|||
155324568|NCT00739908|560625511|FG001|Overall Study|Non-Compliance With Study Medication|3|||
155324569|NCT00739908|560625510|FG000|Overall Study|Lack of Efficacy|0|||
155324570|NCT00739908|560625511|FG001|Overall Study|Lack of Efficacy|1|||
155324571|NCT00739908|560625510|FG000|Overall Study|Relocation|0|||
155324572|NCT00739908|560625511|FG001|Overall Study|Relocation|1|||
155324573|NCT05157841|560625512|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
155324574|NCT05157841|560625513|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
155324575|NCT05157841|560625514|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
155324576|NCT05157841|560625512|FG000|Part A (14 Days)|Adverse Event|1|||
155324577|NCT05157841|560625513|FG001|Part A (14 Days)|Adverse Event|0|||
155324578|NCT05157841|560625514|FG002|Part A (14 Days)|Adverse Event|0|||
155324579|NCT05157841|560625512|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
155324580|NCT05157841|560625513|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
155324581|NCT05157841|560625514|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
155324582|NCT03884101|560625517|FG000|Overall Study|Participant Ongoing in Study|202|||
155324583|NCT03884101|560625518|FG001|Overall Study|Participant Ongoing in Study|186|||
155162923|NCT02447003|560031769|FG001|Overall Study|Sponsor Decision|11|||
155162924|NCT02447003|560031768|FG000|Overall Study|Progressive Disease|1|||
155324584|NCT03884101|560625517|FG000|Overall Study|Death|212|||
155162925|NCT02447003|560031769|FG001|Overall Study|Progressive Disease|0|||
155162926|NCT02447003|560031768|FG000|Overall Study|Lost to Follow-up|5|||
155162927|NCT02447003|560031769|FG001|Overall Study|Lost to Follow-up|0|||
155324585|NCT03884101|560625518|FG001|Overall Study|Death|224|||
155324586|NCT03884101|560625517|FG000|Overall Study|Lost to Follow-up|0|||
155324587|NCT03884101|560625518|FG001|Overall Study|Lost to Follow-up|1|||
155324588|NCT03884101|560625517|FG000|Overall Study|Withdrawal by Subject|6|||
155324589|NCT03884101|560625518|FG001|Overall Study|Withdrawal by Subject|11|||
155324590|NCT04560179|560625519|FG000|Overall Study|Physician Decision|1|||
155324591|NCT04560179|560625520|FG001|Overall Study|Physician Decision|0|||
155324592|NCT04560179|560625521|FG002|Overall Study|Physician Decision|0|||
155324593|NCT04560179|560625522|FG003|Overall Study|Physician Decision|0|||
155324594|NCT04560179|560625523|FG004|Overall Study|Physician Decision|0|||
155324595|NCT04560179|560625519|FG000|Overall Study|Adverse Event|0|||
155324596|NCT04560179|560625520|FG001|Overall Study|Adverse Event|0|||
155324597|NCT04560179|560625521|FG002|Overall Study|Adverse Event|0|||
155324598|NCT04560179|560625522|FG003|Overall Study|Adverse Event|1|||
155324599|NCT04560179|560625523|FG004|Overall Study|Adverse Event|0|||
155324600|NCT04631016|560625524|FG000|Overall Study|Adverse Event|3|||
155324601|NCT04631016|560625525|FG001|Overall Study|Adverse Event|0|||
155324602|NCT04631016|560625524|FG000|Overall Study|Withdrawal by Subject|5|||
155324603|NCT04631016|560625525|FG001|Overall Study|Withdrawal by Subject|4|||
155324604|NCT04631016|560625524|FG000|Overall Study|Reason unspecified|1|||
155324605|NCT04631016|560625525|FG001|Overall Study|Reason unspecified|0|||
155324606|NCT04631016|560625524|FG000|Overall Study|Failure to meet randomization criteria|2|||
155324607|NCT04631016|560625525|FG001|Overall Study|Failure to meet randomization criteria|1|||
155324608|NCT05454514|560625531|FG000|Overall Study|Withdrawal by Subject|4|||
155324609|NCT02624050|560625537|FG000|Overall Study|Physician Decision|4|||
155324610|NCT02624050|560625538|FG001|Overall Study|Physician Decision|0|||
155324611|NCT02624050|560625537|FG000|Overall Study|Protocol Violation|2|||
155324612|NCT02624050|560625538|FG001|Overall Study|Protocol Violation|0|||
155324613|NCT04795245|560625539|FG000|Overall Study|Unkown reason|7|||
155324614|NCT04795245|560625539|FG000|Overall Study|Death|17|||
155324615|NCT04795245|560625539|FG000|Overall Study|Other than listed|19|||
155324616|NCT04795245|560625539|FG000|Overall Study|Adverse Event|143|||
155324617|NCT04795245|560625539|FG000|Overall Study|Progressive disease|512|||
155324618|NCT04795245|560625539|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
155324619|NCT03904576|560625540|FG000|Washout Period|Protocol Violation|1|||
155324620|NCT03904576|560625541|FG001|Washout Period|Protocol Violation|1|||
155324621|NCT01897441|560625544|FG000|Overall Study|Lost to Follow-up|0|||
155324622|NCT01897441|560625545|FG001|Overall Study|Lost to Follow-up|0|||
155324623|NCT01897441|560625546|FG002|Overall Study|Lost to Follow-up|1|||
155324624|NCT01897441|560625547|FG003|Overall Study|Lost to Follow-up|0|||
155324625|NCT01897441|560625548|FG004|Overall Study|Lost to Follow-up|0|||
155324626|NCT01897441|560625549|FG005|Overall Study|Lost to Follow-up|0|||
155324627|NCT01897441|560625544|FG000|Overall Study|Withdrawal by Subject|0|||
155324628|NCT01897441|560625545|FG001|Overall Study|Withdrawal by Subject|0|||
155324629|NCT01897441|560625546|FG002|Overall Study|Withdrawal by Subject|0|||
155324630|NCT01897441|560625547|FG003|Overall Study|Withdrawal by Subject|0|||
155324631|NCT01897441|560625548|FG004|Overall Study|Withdrawal by Subject|1|||
155324632|NCT01897441|560625549|FG005|Overall Study|Withdrawal by Subject|0|||
155324633|NCT01897441|560625544|FG000|Overall Study|Withdrawn by Provider|0|||
155324634|NCT01897441|560625545|FG001|Overall Study|Withdrawn by Provider|2|||
155324635|NCT01897441|560625546|FG002|Overall Study|Withdrawn by Provider|0|||
155324636|NCT01897441|560625547|FG003|Overall Study|Withdrawn by Provider|0|||
155324637|NCT01897441|560625548|FG004|Overall Study|Withdrawn by Provider|0|||
155324638|NCT01897441|560625549|FG005|Overall Study|Withdrawn by Provider|0|||
155324639|NCT03279978|560625550|FG000|Overall Study|Withdrawal by Subject|0|||
155324640|NCT03279978|560625551|FG001|Overall Study|Withdrawal by Subject|1|||
155324641|NCT03279978|560625552|FG002|Overall Study|Withdrawal by Subject|0|||
155324642|NCT03279978|560625553|FG003|Overall Study|Withdrawal by Subject|0|||
155324643|NCT03279978|560625554|FG004|Overall Study|Withdrawal by Subject|0|||
155162928|NCT02447003|560031768|FG000|Overall Study|Death|154|||
155324644|NCT03279978|560625555|FG005|Overall Study|Withdrawal by Subject|0|||
155324645|NCT03279978|560625556|FG006|Overall Study|Withdrawal by Subject|0|||
155324646|NCT03279978|560625557|FG007|Overall Study|Withdrawal by Subject|0|||
155324647|NCT03279978|560625558|FG008|Overall Study|Withdrawal by Subject|0|||
155324648|NCT03279978|560625559|FG009|Overall Study|Withdrawal by Subject|1|||
155324649|NCT03279978|560625550|FG000|Overall Study|Lost to Follow-up|1|||
155324650|NCT03279978|560625551|FG001|Overall Study|Lost to Follow-up|0|||
155162929|NCT02447003|560031769|FG001|Overall Study|Death|63|||
155324651|NCT03279978|560625552|FG002|Overall Study|Lost to Follow-up|1|||
155324652|NCT03279978|560625553|FG003|Overall Study|Lost to Follow-up|0|||
155162930|NCT03848728|560031770|FG000|Overall Study|Death|16|||
155324653|NCT03279978|560625554|FG004|Overall Study|Lost to Follow-up|0|||
155324654|NCT03279978|560625555|FG005|Overall Study|Lost to Follow-up|0|||
155324655|NCT03279978|560625556|FG006|Overall Study|Lost to Follow-up|0|||
155324656|NCT03279978|560625557|FG007|Overall Study|Lost to Follow-up|0|||
155324657|NCT03279978|560625558|FG008|Overall Study|Lost to Follow-up|0|||
155324658|NCT03279978|560625559|FG009|Overall Study|Lost to Follow-up|0|||
155324659|NCT03279978|560625550|FG000|Overall Study|Other than stated above|0|||
155324660|NCT03279978|560625551|FG001|Overall Study|Other than stated above|0|||
155324661|NCT03279978|560625552|FG002|Overall Study|Other than stated above|0|||
155324662|NCT03279978|560625553|FG003|Overall Study|Other than stated above|0|||
155324663|NCT03279978|560625554|FG004|Overall Study|Other than stated above|0|||
155324664|NCT03279978|560625555|FG005|Overall Study|Other than stated above|0|||
155324665|NCT03279978|560625556|FG006|Overall Study|Other than stated above|1|||
155324666|NCT03279978|560625557|FG007|Overall Study|Other than stated above|0|||
155324667|NCT03279978|560625558|FG008|Overall Study|Other than stated above|0|||
155324668|NCT03279978|560625559|FG009|Overall Study|Other than stated above|0|||
155324669|NCT01651000|560625560|FG000|Overall Study|Adverse Event|2|||
155324670|NCT01651000|560625561|FG001|Overall Study|Adverse Event|8|||
155324671|NCT01651000|560625560|FG000|Overall Study|Lost to Follow-up|3|||
155324672|NCT01651000|560625561|FG001|Overall Study|Lost to Follow-up|2|||
155324673|NCT01651000|560625560|FG000|Overall Study|Protocol Violation|0|||
155324674|NCT01651000|560625561|FG001|Overall Study|Protocol Violation|3|||
155324675|NCT01651000|560625560|FG000|Overall Study|Withdrawal by Subject|2|||
155324676|NCT01651000|560625561|FG001|Overall Study|Withdrawal by Subject|10|||
155324677|NCT01651000|560625560|FG000|Overall Study|Subject noncompliance|0|||
155324678|NCT01651000|560625561|FG001|Overall Study|Subject noncompliance|3|||
155324679|NCT01651000|560625560|FG000|Overall Study|Lack of Efficacy|1|||
155324680|NCT01651000|560625561|FG001|Overall Study|Lack of Efficacy|1|||
155324681|NCT01651000|560625560|FG000|Overall Study|Physician Decision|1|||
155324682|NCT01651000|560625561|FG001|Overall Study|Physician Decision|0|||
155324683|NCT01651000|560625560|FG000|Overall Study|Administrative reason|1|||
155324684|NCT01651000|560625561|FG001|Overall Study|Administrative reason|0|||
155324685|NCT01651000|560625560|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
155324686|NCT01651000|560625561|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
155324687|NCT02765412|560625562|FG000|Overall Study|Death|482|||
155324688|NCT02765412|560625563|FG001|Overall Study|Death|855|||
155324689|NCT03990883|560625564|FG000|Blinded Treatment Phase|Adverse Event|1|||
155324690|NCT03990883|560625565|FG001|Blinded Treatment Phase|Adverse Event|1|||
155324691|NCT03990883|560625566|FG002|Blinded Treatment Phase|Adverse Event|0|||
155324692|NCT03990883|560625564|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
155324693|NCT03990883|560625565|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
155324694|NCT03990883|560625566|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
155324695|NCT03990883|560625564|FG000|Blinded Treatment Phase|Physician Decision|1|||
155324696|NCT03990883|560625565|FG001|Blinded Treatment Phase|Physician Decision|0|||
155324697|NCT03990883|560625566|FG002|Blinded Treatment Phase|Physician Decision|0|||
155324698|NCT03990883|560625564|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
155324699|NCT03990883|560625565|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
155324700|NCT03990883|560625566|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
155324701|NCT03990883|560625564|FG000|Blinded Treatment Phase|COVID-19|3|||
155324702|NCT03990883|560625565|FG001|Blinded Treatment Phase|COVID-19|2|||
155324703|NCT03990883|560625566|FG002|Blinded Treatment Phase|COVID-19|0|||
155324704|NCT03990883|560625564|FG000|Blinded Treatment Phase|Personal Reasons|6|||
155324705|NCT03990883|560625565|FG001|Blinded Treatment Phase|Personal Reasons|3|||
155324706|NCT03990883|560625566|FG002|Blinded Treatment Phase|Personal Reasons|0|||
155324707|NCT03990883|560625564|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
155324708|NCT03990883|560625565|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
155324709|NCT03990883|560625566|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
155324710|NCT03990883|560625564|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
155324711|NCT03990883|560625565|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
155324712|NCT03990883|560625566|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
155324713|NCT03990883|560625564|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
155324714|NCT03990883|560625565|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
155324715|NCT03990883|560625566|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
155324716|NCT03734029|560625567|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
155324717|NCT03734029|560625568|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
155324718|NCT03734029|560625567|FG000|Overall Study|Adverse Event|60|||
155324719|NCT03734029|560625568|FG001|Overall Study|Adverse Event|14|||
155324720|NCT03734029|560625567|FG000|Overall Study|Withdrawal by Subject|12|||
155162931|NCT03848728|560031771|FG001|Overall Study|Death|13|||
155324721|NCT03734029|560625568|FG001|Overall Study|Withdrawal by Subject|11|||
155324722|NCT03734029|560625567|FG000|Overall Study|Clinical progression by investigator|10|||
155324723|NCT03734029|560625568|FG001|Overall Study|Clinical progression by investigator|8|||
155324724|NCT03734029|560625567|FG000|Overall Study|Death|5|||
155162932|NCT03848728|560031770|FG000|Overall Study|Outmigrated to non-study community|98|||
155162933|NCT03848728|560031771|FG001|Overall Study|Outmigrated to non-study community|106|||
155162934|NCT03848728|560031770|FG000|Overall Study|Transfered to non-study clinic|32|||
155162935|NCT03848728|560031771|FG001|Overall Study|Transfered to non-study clinic|48|||
155324725|NCT03734029|560625568|FG001|Overall Study|Death|2|||
155324726|NCT03734029|560625567|FG000|Overall Study|Physician Decision|4|||
155324727|NCT03734029|560625568|FG001|Overall Study|Physician Decision|3|||
155324728|NCT03734029|560625567|FG000|Overall Study|Other|2|||
155324729|NCT03734029|560625568|FG001|Overall Study|Other|0|||
155324730|NCT03734029|560625567|FG000|Overall Study|Lost to Follow-up|0|||
155324731|NCT03734029|560625568|FG001|Overall Study|Lost to Follow-up|1|||
155324732|NCT03734029|560625567|FG000|Overall Study|Randomized, but not treated|2|||
155324733|NCT03734029|560625568|FG001|Overall Study|Randomized, but not treated|12|||
155324734|NCT05412004|560626551|FG000|Overall Study|Adverse Event|0|||
155324735|NCT05412004|560626552|FG001|Overall Study|Adverse Event|2|||
155324736|NCT05412004|560626553|FG002|Overall Study|Adverse Event|1|||
155324737|NCT05412004|560626554|FG003|Overall Study|Adverse Event|5|||
155324738|NCT05412004|560626551|FG000|Overall Study|Assigned Treatment by Mistake|5|||
155324739|NCT05412004|560626552|FG001|Overall Study|Assigned Treatment by Mistake|10|||
155324740|NCT05412004|560626553|FG002|Overall Study|Assigned Treatment by Mistake|2|||
155324741|NCT05412004|560626554|FG003|Overall Study|Assigned Treatment by Mistake|5|||
155324742|NCT05412004|560626551|FG000|Overall Study|Lost to Follow-up|3|||
155324743|NCT05412004|560626552|FG001|Overall Study|Lost to Follow-up|0|||
155324744|NCT05412004|560626553|FG002|Overall Study|Lost to Follow-up|0|||
155324745|NCT05412004|560626554|FG003|Overall Study|Lost to Follow-up|0|||
155324746|NCT05412004|560626551|FG000|Overall Study|Patient could not travel to site|0|||
155324747|NCT05412004|560626552|FG001|Overall Study|Patient could not travel to site|1|||
155324748|NCT05412004|560626553|FG002|Overall Study|Patient could not travel to site|0|||
155162936|NCT03848728|560031770|FG000|Overall Study|Withdrawal by Subject|1|||
155324749|NCT05412004|560626554|FG003|Overall Study|Patient could not travel to site|0|||
155324750|NCT05412004|560626551|FG000|Overall Study|Physician Decision|0|||
155324751|NCT05412004|560626552|FG001|Overall Study|Physician Decision|1|||
155324752|NCT05412004|560626553|FG002|Overall Study|Physician Decision|0|||
155324753|NCT05412004|560626554|FG003|Overall Study|Physician Decision|0|||
155324754|NCT05412004|560626551|FG000|Overall Study|Pregnancy|0|||
155324755|NCT05412004|560626552|FG001|Overall Study|Pregnancy|1|||
155324756|NCT05412004|560626553|FG002|Overall Study|Pregnancy|0|||
155324757|NCT05412004|560626554|FG003|Overall Study|Pregnancy|0|||
155324758|NCT05412004|560626551|FG000|Overall Study|Protocol Violation|1|||
155324759|NCT05412004|560626552|FG001|Overall Study|Protocol Violation|0|||
155324760|NCT05412004|560626553|FG002|Overall Study|Protocol Violation|0|||
155324761|NCT05412004|560626554|FG003|Overall Study|Protocol Violation|0|||
155324762|NCT05412004|560626551|FG000|Overall Study|Withdrawal by Subject|4|||
155324763|NCT05412004|560626552|FG001|Overall Study|Withdrawal by Subject|19|||
155324764|NCT05412004|560626553|FG002|Overall Study|Withdrawal by Subject|4|||
155324765|NCT05412004|560626554|FG003|Overall Study|Withdrawal by Subject|14|||
155324766|NCT05412004|560626551|FG000|Overall Study|Screen Failure|0|||
155324767|NCT05412004|560626552|FG001|Overall Study|Screen Failure|0|||
155324768|NCT05412004|560626553|FG002|Overall Study|Screen Failure|0|||
155324769|NCT05412004|560626554|FG003|Overall Study|Screen Failure|1|||
155324770|NCT05412004|560626551|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
155324771|NCT05412004|560626552|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
155324772|NCT05412004|560626553|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
155324773|NCT05412004|560626554|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
155324774|NCT03781089|560626555|FG000|Overall Study|Constipation|1|||
155324775|NCT03781089|560626556|FG001|Overall Study|Constipation|0|||
155324776|NCT03781089|560626555|FG000|Overall Study|Positive pregnancy test|0|||
155324777|NCT03781089|560626556|FG001|Overall Study|Positive pregnancy test|1|||
155324778|NCT04644029|560626557|FG000|Overall Study|Death|1|||
155324779|NCT04644029|560626558|FG001|Overall Study|Death|0|||
155324780|NCT04644029|560626557|FG000|Overall Study|Physician Decision|1|||
155324781|NCT04644029|560626558|FG001|Overall Study|Physician Decision|2|||
155324782|NCT04644029|560626557|FG000|Overall Study|Withdrawal by Subject|21|||
155324783|NCT04644029|560626558|FG001|Overall Study|Withdrawal by Subject|19|||
155324784|NCT04644029|560626557|FG000|Overall Study|Lost to Follow-up|31|||
155324785|NCT04644029|560626558|FG001|Overall Study|Lost to Follow-up|34|||
155324786|NCT04644029|560626557|FG000|Overall Study|Study Terminated by Sponsor|308|||
155324787|NCT04644029|560626558|FG001|Overall Study|Study Terminated by Sponsor|309|||
155324788|NCT04644029|560626557|FG000|Overall Study|Randomized in Error|2|||
155324789|NCT04644029|560626558|FG001|Overall Study|Randomized in Error|1|||
155324790|NCT04644029|560626557|FG000|Overall Study|Other|0|||
155324791|NCT04644029|560626558|FG001|Overall Study|Other|1|||
155324792|NCT05132400|560626559|FG000|Overall Study|Withdrawal by Subject|14|||
155324793|NCT05132400|560626560|FG001|Overall Study|Withdrawal by Subject|8|||
155324794|NCT05132400|560626559|FG000|Overall Study|Lost to Follow-up|132|||
155324795|NCT05132400|560626560|FG001|Overall Study|Lost to Follow-up|121|||
155324796|NCT03934931|560626561|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
155324797|NCT03934931|560626562|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
155324798|NCT03934931|560626563|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
155324799|NCT02076009|560626566|FG000|Overall Study|Death|172|||
155324800|NCT02076009|560626567|FG001|Overall Study|Death|153|||
155324801|NCT02076009|560626566|FG000|Overall Study|Withdrawal by Subject|16|||
155324802|NCT02076009|560626567|FG001|Overall Study|Withdrawal by Subject|12|||
155324803|NCT02076009|560626566|FG000|Overall Study|Lost to Follow-up|4|||
155324804|NCT02076009|560626567|FG001|Overall Study|Lost to Follow-up|2|||
155324805|NCT02076009|560626566|FG000|Overall Study|Progressive Disease|1|||
155324806|NCT02076009|560626567|FG001|Overall Study|Progressive Disease|0|||
155324807|NCT02076009|560626566|FG000|Overall Study|Physician Decision|0|||
155324808|NCT02076009|560626567|FG001|Overall Study|Physician Decision|1|||
155324809|NCT02076009|560626566|FG000|Overall Study|End of data collection|90|||
155324810|NCT02076009|560626567|FG001|Overall Study|End of data collection|118|||
155324811|NCT03786926|560626570|FG000|Overall Study|Adverse Event|0|||
155324812|NCT03786926|560626571|FG001|Overall Study|Adverse Event|0|||
155324813|NCT03786926|560626572|FG002|Overall Study|Adverse Event|0|||
155324814|NCT03786926|560626573|FG003|Overall Study|Adverse Event|0|||
155324815|NCT03786926|560626574|FG004|Overall Study|Adverse Event|0|||
155324816|NCT03786926|560626575|FG005|Overall Study|Adverse Event|0|||
155324817|NCT03786926|560626576|FG006|Overall Study|Adverse Event|0|||
155324818|NCT03786926|560626577|FG007|Overall Study|Adverse Event|1|||
155324819|NCT03786926|560626578|FG008|Overall Study|Adverse Event|1|||
155324820|NCT03786926|560626579|FG009|Overall Study|Adverse Event|0|||
155324821|NCT03786926|560626580|FG010|Overall Study|Adverse Event|1|||
155324822|NCT03786926|560626570|FG000|Overall Study|Progressive disease|3|||
155324823|NCT03786926|560626571|FG001|Overall Study|Progressive disease|0|||
155324824|NCT03786926|560626572|FG002|Overall Study|Progressive disease|3|||
155324825|NCT03786926|560626573|FG003|Overall Study|Progressive disease|1|||
155324826|NCT03786926|560626574|FG004|Overall Study|Progressive disease|2|||
155324827|NCT03786926|560626575|FG005|Overall Study|Progressive disease|2|||
155324828|NCT03786926|560626576|FG006|Overall Study|Progressive disease|1|||
155324829|NCT03786926|560626577|FG007|Overall Study|Progressive disease|6|||
155324830|NCT03786926|560626578|FG008|Overall Study|Progressive disease|1|||
155324831|NCT03786926|560626579|FG009|Overall Study|Progressive disease|1|||
155324832|NCT03786926|560626580|FG010|Overall Study|Progressive disease|1|||
155324833|NCT03786926|560626570|FG000|Overall Study|Death|0|||
155324834|NCT03786926|560626571|FG001|Overall Study|Death|1|||
155324835|NCT03786926|560626572|FG002|Overall Study|Death|1|||
155324836|NCT03786926|560626573|FG003|Overall Study|Death|0|||
155162937|NCT03848728|560031771|FG001|Overall Study|Withdrawal by Subject|0|||
155162938|NCT00536744|560031774|FG000|Overall Study|Adverse Event|13|||
155324837|NCT03786926|560626574|FG004|Overall Study|Death|0|||
155324838|NCT03786926|560626575|FG005|Overall Study|Death|0|||
155324839|NCT03786926|560626576|FG006|Overall Study|Death|0|||
155324840|NCT03786926|560626577|FG007|Overall Study|Death|0|||
155324841|NCT03786926|560626578|FG008|Overall Study|Death|0|||
155324842|NCT03786926|560626579|FG009|Overall Study|Death|1|||
155324843|NCT03786926|560626580|FG010|Overall Study|Death|2|||
155324844|NCT03786926|560626570|FG000|Overall Study|Physician Decision|0|||
155324845|NCT03786926|560626571|FG001|Overall Study|Physician Decision|1|||
155324846|NCT03786926|560626572|FG002|Overall Study|Physician Decision|0|||
155324847|NCT03786926|560626573|FG003|Overall Study|Physician Decision|1|||
155324848|NCT03786926|560626574|FG004|Overall Study|Physician Decision|2|||
155324849|NCT03786926|560626575|FG005|Overall Study|Physician Decision|0|||
155324850|NCT03786926|560626576|FG006|Overall Study|Physician Decision|0|||
155324851|NCT03786926|560626577|FG007|Overall Study|Physician Decision|2|||
155324852|NCT03786926|560626578|FG008|Overall Study|Physician Decision|1|||
155324853|NCT03786926|560626579|FG009|Overall Study|Physician Decision|1|||
155324854|NCT03786926|560626580|FG010|Overall Study|Physician Decision|0|||
155324855|NCT03786926|560626570|FG000|Overall Study|Withdrawal by Subject|0|||
155324856|NCT03786926|560626571|FG001|Overall Study|Withdrawal by Subject|1|||
155324857|NCT03786926|560626572|FG002|Overall Study|Withdrawal by Subject|1|||
155324858|NCT03786926|560626573|FG003|Overall Study|Withdrawal by Subject|0|||
155324859|NCT03786926|560626574|FG004|Overall Study|Withdrawal by Subject|0|||
155162939|NCT00536744|560031775|FG001|Overall Study|Adverse Event|10|||
155324860|NCT03786926|560626575|FG005|Overall Study|Withdrawal by Subject|0|||
155324861|NCT03786926|560626576|FG006|Overall Study|Withdrawal by Subject|1|||
155324862|NCT03786926|560626577|FG007|Overall Study|Withdrawal by Subject|0|||
155324863|NCT03786926|560626578|FG008|Overall Study|Withdrawal by Subject|1|||
155324864|NCT03786926|560626579|FG009|Overall Study|Withdrawal by Subject|0|||
155324865|NCT03786926|560626580|FG010|Overall Study|Withdrawal by Subject|1|||
155324866|NCT03786926|560626570|FG000|Overall Study|Study terminated by Sponsor|0|||
155324867|NCT03786926|560626571|FG001|Overall Study|Study terminated by Sponsor|0|||
155324868|NCT03786926|560626572|FG002|Overall Study|Study terminated by Sponsor|0|||
155324869|NCT03786926|560626573|FG003|Overall Study|Study terminated by Sponsor|0|||
155324870|NCT03786926|560626574|FG004|Overall Study|Study terminated by Sponsor|1|||
155324871|NCT03786926|560626575|FG005|Overall Study|Study terminated by Sponsor|0|||
155324872|NCT03786926|560626576|FG006|Overall Study|Study terminated by Sponsor|0|||
155324873|NCT03786926|560626577|FG007|Overall Study|Study terminated by Sponsor|4|||
155324874|NCT03786926|560626578|FG008|Overall Study|Study terminated by Sponsor|0|||
155324875|NCT03786926|560626579|FG009|Overall Study|Study terminated by Sponsor|0|||
155324876|NCT03786926|560626580|FG010|Overall Study|Study terminated by Sponsor|0|||
155324877|NCT03786926|560626570|FG000|Overall Study|Anti-neoplasm treatment|0|||
155324878|NCT03786926|560626571|FG001|Overall Study|Anti-neoplasm treatment|0|||
155324879|NCT03786926|560626572|FG002|Overall Study|Anti-neoplasm treatment|0|||
155324880|NCT03786926|560626573|FG003|Overall Study|Anti-neoplasm treatment|0|||
155324881|NCT03786926|560626574|FG004|Overall Study|Anti-neoplasm treatment|1|||
155324882|NCT03786926|560626575|FG005|Overall Study|Anti-neoplasm treatment|0|||
155324883|NCT03786926|560626576|FG006|Overall Study|Anti-neoplasm treatment|1|||
155324884|NCT03786926|560626577|FG007|Overall Study|Anti-neoplasm treatment|0|||
155324885|NCT03786926|560626578|FG008|Overall Study|Anti-neoplasm treatment|0|||
155324886|NCT03786926|560626579|FG009|Overall Study|Anti-neoplasm treatment|0|||
155324887|NCT03786926|560626580|FG010|Overall Study|Anti-neoplasm treatment|0|||
155324888|NCT03786926|560626570|FG000|Overall Study|Other|0|||
155324889|NCT03786926|560626571|FG001|Overall Study|Other|0|||
155324890|NCT03786926|560626572|FG002|Overall Study|Other|0|||
155324891|NCT03786926|560626573|FG003|Overall Study|Other|1|||
155324892|NCT03786926|560626574|FG004|Overall Study|Other|0|||
155324893|NCT03786926|560626575|FG005|Overall Study|Other|1|||
155324894|NCT03786926|560626576|FG006|Overall Study|Other|0|||
155324895|NCT03786926|560626577|FG007|Overall Study|Other|0|||
155324896|NCT03786926|560626578|FG008|Overall Study|Other|2|||
155324897|NCT03786926|560626579|FG009|Overall Study|Other|0|||
155324898|NCT03786926|560626580|FG010|Overall Study|Other|0|||
155324899|NCT05988398|560626586|FG000|Overall Study|Lack of time|21|||
155324900|NCT05988398|560626587|FG001|Overall Study|Lack of time|0|||
155324901|NCT05988398|560626586|FG000|Overall Study|Absent from school|0|||
155324902|NCT05988398|560626587|FG001|Overall Study|Absent from school|38|||
155324903|NCT05988398|560626586|FG000|Overall Study|Chose not to participate|0|||
155324904|NCT05988398|560626587|FG001|Overall Study|Chose not to participate|42|||
155324905|NCT05988398|560626586|FG000|Overall Study|Other commitments (e.g., sports)|0|||
155324906|NCT05988398|560626587|FG001|Overall Study|Other commitments (e.g., sports)|25|||
155324907|NCT00942734|560626589|FG000|Overall Study|Adverse Event|2|||
155324908|NCT00942734|560626589|FG000|Overall Study|Protocol Violation|3|||
155324909|NCT00942734|560626589|FG000|Overall Study|Disease Progression|2|||
155324910|NCT00942734|560626589|FG000|Overall Study|Physician Decision|1|||
155324911|NCT00319046|560626590|FG000|Overall Study|withdrawal of subject's consent|7|||
155324912|NCT00319046|560626590|FG000|Overall Study|administrative reason|1|||
155324913|NCT05147584|560626591|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
155324914|NCT03370913|560626597|FG000|Overall Study|Death|1|||
155324915|NCT03370913|560626597|FG000|Overall Study|Lost to Follow-up|1|||
155324916|NCT04496752|560626602|FG000|Second Assessment|Lost to Follow-up|3|||
155324917|NCT04496752|560626603|FG001|Second Assessment|Lost to Follow-up|3|||
155324918|NCT04496752|560626602|FG000|Second Assessment|Adverse Event|2|||
155324919|NCT04496752|560626603|FG001|Second Assessment|Adverse Event|0|||
155324920|NCT04078152|560626604|FG000|Overall Study|Other|83|||
155324921|NCT04078152|560626605|FG001|Overall Study|Other|22|||
155324922|NCT04078152|560626606|FG002|Overall Study|Other|25|||
155324923|NCT04078152|560626604|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
155324924|NCT04078152|560626605|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
155324925|NCT04078152|560626606|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
155324926|NCT04078152|560626604|FG000|Overall Study|Withdrawal by Subject|5|||
155324927|NCT04078152|560626605|FG001|Overall Study|Withdrawal by Subject|0|||
155324928|NCT04078152|560626606|FG002|Overall Study|Withdrawal by Subject|1|||
155324929|NCT04078152|560626604|FG000|Overall Study|Death|10|||
155324930|NCT04078152|560626605|FG001|Overall Study|Death|2|||
155324931|NCT04078152|560626606|FG002|Overall Study|Death|12|||
155324932|NCT04078152|560626604|FG000|Overall Study|Adverse Event|1|||
155324933|NCT04078152|560626605|FG001|Overall Study|Adverse Event|0|||
155324934|NCT04078152|560626606|FG002|Overall Study|Adverse Event|0|||
155324935|NCT04679389|560626607|FG000|Overall Study|Adverse Event|1|||
155324936|NCT04679389|560626608|FG001|Overall Study|Adverse Event|0|||
155324937|NCT04679389|560626607|FG000|Overall Study|Protocol Violation|2|||
155324938|NCT04679389|560626608|FG001|Overall Study|Protocol Violation|0|||
155324939|NCT04679389|560626607|FG000|Overall Study|Physician Decision|3|||
155324940|NCT04679389|560626608|FG001|Overall Study|Physician Decision|5|||
155069135|NCT02964182|559682754|FG006|Phase 3 (Weeks 5-7)|Withdrawal by Subject|0|||
155324941|NCT04679389|560626607|FG000|Overall Study|Withdrawal by Subject|5|||
155324942|NCT04679389|560626608|FG001|Overall Study|Withdrawal by Subject|7|||
155324943|NCT03522298|560626620|FG000|Overall Study|Adverse Event|1|||
155324944|NCT03522298|560626621|FG001|Overall Study|Adverse Event|0|||
155324945|NCT03522298|560626622|FG002|Overall Study|Adverse Event|0|||
155324946|NCT03522298|560626623|FG003|Overall Study|Adverse Event|1|||
155324947|NCT03522298|560626620|FG000|Overall Study|Death|2|||
155324948|NCT03522298|560626621|FG001|Overall Study|Death|4|||
155324949|NCT03522298|560626622|FG002|Overall Study|Death|8|||
155324950|NCT03522298|560626623|FG003|Overall Study|Death|8|||
155324951|NCT03522298|560626620|FG000|Overall Study|Patient decision|0|||
155324952|NCT03522298|560626621|FG001|Overall Study|Patient decision|2|||
155324953|NCT03522298|560626622|FG002|Overall Study|Patient decision|2|||
155324954|NCT03522298|560626623|FG003|Overall Study|Patient decision|2|||
155324955|NCT05718687|560626626|FG000|Overall Study|Withdrawal by Subject|3|||
155324956|NCT03250676|560626631|FG000|Overall Study|Adverse Event|0|||
155324957|NCT03250676|560626632|FG001|Overall Study|Adverse Event|0|||
155324958|NCT03250676|560626633|FG002|Overall Study|Adverse Event|0|||
155324959|NCT03250676|560626634|FG003|Overall Study|Adverse Event|1|||
155324960|NCT03250676|560626635|FG004|Overall Study|Adverse Event|2|||
155324961|NCT03250676|560626636|FG005|Overall Study|Adverse Event|9|||
155324962|NCT03250676|560626631|FG000|Overall Study|Withdrawal by Subject|1|||
155324963|NCT03250676|560626632|FG001|Overall Study|Withdrawal by Subject|0|||
155324964|NCT03250676|560626633|FG002|Overall Study|Withdrawal by Subject|0|||
155324965|NCT03250676|560626634|FG003|Overall Study|Withdrawal by Subject|1|||
155324966|NCT03250676|560626635|FG004|Overall Study|Withdrawal by Subject|1|||
155324967|NCT03250676|560626636|FG005|Overall Study|Withdrawal by Subject|2|||
155324968|NCT03250676|560626631|FG000|Overall Study|Physician Decision|0|||
155324969|NCT03250676|560626632|FG001|Overall Study|Physician Decision|0|||
155324970|NCT03250676|560626633|FG002|Overall Study|Physician Decision|0|||
155324971|NCT03250676|560626634|FG003|Overall Study|Physician Decision|2|||
155324972|NCT03250676|560626635|FG004|Overall Study|Physician Decision|0|||
155324973|NCT03250676|560626636|FG005|Overall Study|Physician Decision|3|||
155324974|NCT03250676|560626631|FG000|Overall Study|Withdrawal of consent|0|||
155324975|NCT03250676|560626632|FG001|Overall Study|Withdrawal of consent|0|||
155324976|NCT03250676|560626633|FG002|Overall Study|Withdrawal of consent|2|||
155324977|NCT03250676|560626634|FG003|Overall Study|Withdrawal of consent|0|||
155324978|NCT03250676|560626635|FG004|Overall Study|Withdrawal of consent|0|||
155324979|NCT03250676|560626636|FG005|Overall Study|Withdrawal of consent|2|||
155324980|NCT03250676|560626631|FG000|Overall Study|Other|1|||
155324981|NCT03250676|560626632|FG001|Overall Study|Other|0|||
155324982|NCT03250676|560626633|FG002|Overall Study|Other|0|||
155324983|NCT03250676|560626634|FG003|Overall Study|Other|0|||
155069136|NCT02964182|559682755|FG007|Phase 3 (Weeks 5-7)|Withdrawal by Subject|3|||
155324984|NCT03250676|560626635|FG004|Overall Study|Other|0|||
155324985|NCT03250676|560626636|FG005|Overall Study|Other|0|||
155324986|NCT03250676|560626631|FG000|Overall Study|Disease progression|4|||
155069137|NCT02964182|559682748|FG000|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155324987|NCT03250676|560626632|FG001|Overall Study|Disease progression|12|||
155324988|NCT03250676|560626633|FG002|Overall Study|Disease progression|9|||
155324989|NCT03250676|560626634|FG003|Overall Study|Disease progression|7|||
155324990|NCT03250676|560626635|FG004|Overall Study|Disease progression|4|||
155324991|NCT03250676|560626636|FG005|Overall Study|Disease progression|88|||
155324992|NCT05020353|560627738|FG000|Overall Study|Protocol Violation|7|||
155324993|NCT05020353|560627738|FG000|Overall Study|Withdrawal by Subject|33|||
155324994|NCT04633278|560627742|FG000|Overall Study|Adverse Event|1|||
155324995|NCT04633278|560627743|FG001|Overall Study|Adverse Event|0|||
155324996|NCT04633278|560627742|FG000|Overall Study|Withdrawal by Subject|1|||
155324997|NCT04633278|560627743|FG001|Overall Study|Withdrawal by Subject|0|||
155324998|NCT04633278|560627742|FG000|Overall Study|Death|11|||
155324999|NCT04633278|560627743|FG001|Overall Study|Death|7|||
155325000|NCT04633278|560627742|FG000|Overall Study|Sponsor Decision|3|||
155325001|NCT04633278|560627743|FG001|Overall Study|Sponsor Decision|0|||
155325002|NCT04633278|560627742|FG000|Overall Study|Not Listed|1|||
155325003|NCT04633278|560627743|FG001|Overall Study|Not Listed|0|||
155325004|NCT02611687|560627744|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
155325005|NCT02611687|560627745|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
155325006|NCT02075554|560627749|FG000|Overall Study|Lost to Follow-up|7|||
155325007|NCT02075554|560627749|FG000|Overall Study|Withdrawal by Subject|5|||
155325008|NCT02075554|560627749|FG000|Overall Study|Physician Decision|3|||
155325009|NCT04933474|560627755|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
155325010|NCT04933474|560627756|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
155325011|NCT04933474|560627755|FG000|Overall Study|Lost to Follow-up|19|||
155325012|NCT04933474|560627756|FG001|Overall Study|Lost to Follow-up|9|||
155325013|NCT04933474|560627755|FG000|Overall Study|Life Burden - unable to participate|6|||
155325014|NCT04933474|560627756|FG001|Overall Study|Life Burden - unable to participate|2|||
155325015|NCT04933474|560627755|FG000|Overall Study|Disease Burden - unable to participate|4|||
155325016|NCT04933474|560627756|FG001|Overall Study|Disease Burden - unable to participate|1|||
155325017|NCT04933474|560627755|FG000|Overall Study|Surgery/Hospitalization|1|||
155325018|NCT04933474|560627756|FG001|Overall Study|Surgery/Hospitalization|2|||
155325019|NCT04933474|560627755|FG000|Overall Study|Dissatisfied with Intervention|1|||
155325020|NCT04933474|560627756|FG001|Overall Study|Dissatisfied with Intervention|1|||
155325021|NCT04933474|560627755|FG000|Overall Study|Withdrew interest in participation|1|||
155325022|NCT04933474|560627756|FG001|Overall Study|Withdrew interest in participation|0|||
155325023|NCT04933474|560627755|FG000|Overall Study|Had previously enrolled in the study|0|||
155325024|NCT04933474|560627756|FG001|Overall Study|Had previously enrolled in the study|1|||
155325025|NCT04757753|560627761|FG000|Overall Study|Lost to Follow-up|7|||
155325026|NCT04757753|560627762|FG001|Overall Study|Lost to Follow-up|7|||
154961231|NCT02441309|559282261|FG000|Overall Study|Withdrawal by Subject|1|||
154961232|NCT02441309|559282262|FG001|Overall Study|Withdrawal by Subject|0|||
155325027|NCT04757753|560627761|FG000|Overall Study|Withdrawal by Subject|0|||
155325028|NCT04757753|560627762|FG001|Overall Study|Withdrawal by Subject|3|||
155325029|NCT04757753|560627761|FG000|Overall Study|Endodontic treatment failure|1|||
155325030|NCT04757753|560627762|FG001|Overall Study|Endodontic treatment failure|2|||
155325031|NCT04757753|560627761|FG000|Overall Study|Tooth fracture/extraction|3|||
155325032|NCT04757753|560627762|FG001|Overall Study|Tooth fracture/extraction|0|||
155325033|NCT06655818|560627767|FG000|Overall Study|Withdrawal by Subject|1|||
155325034|NCT03816397|560627772|FG000|Overall Study|Censored at interim analysis date.|13|||
155325035|NCT03816397|560627773|FG001|Overall Study|Censored at interim analysis date.|6|||
155325036|NCT03816397|560627772|FG000|Overall Study|Withdrawal by Subject|1|||
155325037|NCT03816397|560627773|FG001|Overall Study|Withdrawal by Subject|1|||
155325038|NCT04908930|560627776|FG000|Overall Study|Lost to Follow-up|1|||
155325039|NCT04908930|560627777|FG001|Overall Study|Lost to Follow-up|1|||
155325040|NCT04908930|560627778|FG002|Overall Study|Lost to Follow-up|0|||
155325041|NCT04908930|560627779|FG003|Overall Study|Lost to Follow-up|0|||
155325042|NCT04908930|560627780|FG004|Overall Study|Lost to Follow-up|0|||
155325043|NCT04908930|560627776|FG000|Overall Study|hardware in mouth|1|||
155325044|NCT04908930|560627777|FG001|Overall Study|hardware in mouth|1|||
155325045|NCT04908930|560627778|FG002|Overall Study|hardware in mouth|0|||
155325046|NCT04908930|560627779|FG003|Overall Study|hardware in mouth|0|||
155325047|NCT04908930|560627780|FG004|Overall Study|hardware in mouth|0|||
155325048|NCT04908930|560627776|FG000|Overall Study|wrong team|1|||
155325049|NCT04908930|560627777|FG001|Overall Study|wrong team|0|||
155325050|NCT04908930|560627778|FG002|Overall Study|wrong team|0|||
155325051|NCT04908930|560627779|FG003|Overall Study|wrong team|0|||
155325052|NCT04908930|560627780|FG004|Overall Study|wrong team|0|||
155325053|NCT04908930|560627776|FG000|Overall Study|quit team|2|||
155325054|NCT04908930|560627777|FG001|Overall Study|quit team|4|||
155325055|NCT04908930|560627778|FG002|Overall Study|quit team|0|||
155325056|NCT04908930|560627779|FG003|Overall Study|quit team|0|||
155325057|NCT04908930|560627780|FG004|Overall Study|quit team|0|||
154961233|NCT02441309|559282263|FG002|Overall Study|Withdrawal by Subject|1|||
155325058|NCT04908930|560627776|FG000|Overall Study|Withdrawal by Subject|1|||
155325059|NCT04908930|560627777|FG001|Overall Study|Withdrawal by Subject|2|||
155325060|NCT04908930|560627778|FG002|Overall Study|Withdrawal by Subject|0|||
155325061|NCT04908930|560627779|FG003|Overall Study|Withdrawal by Subject|0|||
155325062|NCT04908930|560627780|FG004|Overall Study|Withdrawal by Subject|0|||
155325063|NCT04908930|560627776|FG000|Overall Study|parent not liking program|0|||
155325064|NCT04908930|560627777|FG001|Overall Study|parent not liking program|1|||
155325065|NCT04908930|560627778|FG002|Overall Study|parent not liking program|0|||
155325066|NCT04908930|560627779|FG003|Overall Study|parent not liking program|0|||
155325067|NCT04908930|560627780|FG004|Overall Study|parent not liking program|0|||
155325068|NCT03248479|560627781|FG000|Overall Study|Death|12|||
155325069|NCT03248479|560627782|FG001|Overall Study|Death|44|||
155325070|NCT03248479|560627783|FG002|Overall Study|Death|1|||
155325071|NCT03248479|560627784|FG003|Overall Study|Death|72|||
155325072|NCT03248479|560627785|FG004|Overall Study|Death|17|||
155325073|NCT03248479|560627786|FG005|Overall Study|Death|6|||
155325074|NCT03248479|560627787|FG006|Overall Study|Death|1|||
155325075|NCT03248479|560627788|FG007|Overall Study|Death|14|||
155325076|NCT03248479|560627789|FG008|Overall Study|Death|3|||
155325077|NCT03248479|560627790|FG009|Overall Study|Death|7|||
155325078|NCT03248479|560627791|FG010|Overall Study|Death|3|||
155325079|NCT03248479|560627792|FG011|Overall Study|Death|1|||
155325080|NCT03248479|560627793|FG012|Overall Study|Death|1|||
155325081|NCT03248479|560627781|FG000|Overall Study|Study terminated by sponsor|12|||
155325082|NCT03248479|560627782|FG001|Overall Study|Study terminated by sponsor|15|||
155325083|NCT03248479|560627783|FG002|Overall Study|Study terminated by sponsor|0|||
155325084|NCT03248479|560627784|FG003|Overall Study|Study terminated by sponsor|5|||
155325085|NCT03248479|560627785|FG004|Overall Study|Study terminated by sponsor|0|||
155325086|NCT03248479|560627786|FG005|Overall Study|Study terminated by sponsor|0|||
155325087|NCT03248479|560627787|FG006|Overall Study|Study terminated by sponsor|0|||
155325088|NCT03248479|560627788|FG007|Overall Study|Study terminated by sponsor|1|||
155325089|NCT03248479|560627789|FG008|Overall Study|Study terminated by sponsor|1|||
155325090|NCT03248479|560627790|FG009|Overall Study|Study terminated by sponsor|0|||
155325091|NCT03248479|560627791|FG010|Overall Study|Study terminated by sponsor|5|||
155325092|NCT03248479|560627792|FG011|Overall Study|Study terminated by sponsor|4|||
155325093|NCT03248479|560627793|FG012|Overall Study|Study terminated by sponsor|0|||
155325094|NCT03248479|560627781|FG000|Overall Study|Consent withdrawn|6|||
155325095|NCT03248479|560627782|FG001|Overall Study|Consent withdrawn|3|||
155325096|NCT03248479|560627783|FG002|Overall Study|Consent withdrawn|0|||
155325097|NCT03248479|560627784|FG003|Overall Study|Consent withdrawn|9|||
155325098|NCT03248479|560627785|FG004|Overall Study|Consent withdrawn|1|||
155325099|NCT03248479|560627786|FG005|Overall Study|Consent withdrawn|0|||
155325100|NCT03248479|560627787|FG006|Overall Study|Consent withdrawn|0|||
155325101|NCT03248479|560627788|FG007|Overall Study|Consent withdrawn|1|||
155325102|NCT03248479|560627789|FG008|Overall Study|Consent withdrawn|0|||
155325103|NCT03248479|560627790|FG009|Overall Study|Consent withdrawn|3|||
155325104|NCT03248479|560627791|FG010|Overall Study|Consent withdrawn|1|||
155325105|NCT03248479|560627792|FG011|Overall Study|Consent withdrawn|0|||
155325106|NCT03248479|560627793|FG012|Overall Study|Consent withdrawn|1|||
155325107|NCT03248479|560627781|FG000|Overall Study|Lost to Follow-up|2|||
155325108|NCT03248479|560627782|FG001|Overall Study|Lost to Follow-up|1|||
155325109|NCT03248479|560627783|FG002|Overall Study|Lost to Follow-up|0|||
155325110|NCT03248479|560627784|FG003|Overall Study|Lost to Follow-up|0|||
155325111|NCT03248479|560627785|FG004|Overall Study|Lost to Follow-up|0|||
155325112|NCT03248479|560627786|FG005|Overall Study|Lost to Follow-up|0|||
155325113|NCT03248479|560627787|FG006|Overall Study|Lost to Follow-up|0|||
155325114|NCT03248479|560627788|FG007|Overall Study|Lost to Follow-up|0|||
155325115|NCT03248479|560627789|FG008|Overall Study|Lost to Follow-up|0|||
155325116|NCT03248479|560627790|FG009|Overall Study|Lost to Follow-up|0|||
155325117|NCT03248479|560627791|FG010|Overall Study|Lost to Follow-up|0|||
155325118|NCT03248479|560627792|FG011|Overall Study|Lost to Follow-up|0|||
155325119|NCT03248479|560627793|FG012|Overall Study|Lost to Follow-up|1|||
155325120|NCT03248479|560627781|FG000|Overall Study|Not reported|0|||
155325121|NCT03248479|560627782|FG001|Overall Study|Not reported|0|||
155325122|NCT03248479|560627783|FG002|Overall Study|Not reported|0|||
155325123|NCT03248479|560627784|FG003|Overall Study|Not reported|1|||
155325124|NCT03248479|560627785|FG004|Overall Study|Not reported|1|||
155325125|NCT03248479|560627786|FG005|Overall Study|Not reported|0|||
155325126|NCT03248479|560627787|FG006|Overall Study|Not reported|0|||
155325127|NCT03248479|560627788|FG007|Overall Study|Not reported|1|||
155325128|NCT03248479|560627789|FG008|Overall Study|Not reported|1|||
155325129|NCT03248479|560627790|FG009|Overall Study|Not reported|0|||
155325130|NCT03248479|560627791|FG010|Overall Study|Not reported|0|||
155325131|NCT03248479|560627792|FG011|Overall Study|Not reported|0|||
155325132|NCT03248479|560627793|FG012|Overall Study|Not reported|0|||
155325133|NCT02777593|560627794|FG000|Overall Study|Still in study|1|||
155325134|NCT02777593|560627795|FG001|Overall Study|Still in study|32|||
155325135|NCT02777593|560627796|FG002|Overall Study|Still in study|3|||
155325136|NCT02777593|560627797|FG003|Overall Study|Still in study|6|||
155325137|NCT02777593|560627798|FG004|Overall Study|Still in study|5|||
155325138|NCT02777593|560627794|FG000|Overall Study|Death|21|||
155325139|NCT02777593|560627795|FG001|Overall Study|Death|28|||
155325140|NCT02777593|560627796|FG002|Overall Study|Death|0|||
155325141|NCT02777593|560627797|FG003|Overall Study|Death|5|||
155325142|NCT02777593|560627798|FG004|Overall Study|Death|0|||
155325143|NCT02777593|560627794|FG000|Overall Study|Withdrawal by Subject|8|||
155325144|NCT02777593|560627795|FG001|Overall Study|Withdrawal by Subject|4|||
155325145|NCT02777593|560627796|FG002|Overall Study|Withdrawal by Subject|1|||
155325146|NCT02777593|560627797|FG003|Overall Study|Withdrawal by Subject|1|||
155325147|NCT02777593|560627798|FG004|Overall Study|Withdrawal by Subject|0|||
155325148|NCT02777593|560627794|FG000|Overall Study|Lost to Follow-up|8|||
155325149|NCT02777593|560627795|FG001|Overall Study|Lost to Follow-up|16|||
155325150|NCT02777593|560627796|FG002|Overall Study|Lost to Follow-up|5|||
155325151|NCT02777593|560627797|FG003|Overall Study|Lost to Follow-up|0|||
155325152|NCT02777593|560627798|FG004|Overall Study|Lost to Follow-up|1|||
155325153|NCT02777593|560627794|FG000|Overall Study|Physician Decision|2|||
155325154|NCT02777593|560627795|FG001|Overall Study|Physician Decision|2|||
155325155|NCT02777593|560627796|FG002|Overall Study|Physician Decision|0|||
155325156|NCT02777593|560627797|FG003|Overall Study|Physician Decision|0|||
155325157|NCT02777593|560627798|FG004|Overall Study|Physician Decision|0|||
155325158|NCT02777593|560627794|FG000|Overall Study|Discontinued due to Other|1|||
155325159|NCT02777593|560627795|FG001|Overall Study|Discontinued due to Other|0|||
155325160|NCT02777593|560627796|FG002|Overall Study|Discontinued due to Other|0|||
155325161|NCT02777593|560627797|FG003|Overall Study|Discontinued due to Other|0|||
155325162|NCT02777593|560627798|FG004|Overall Study|Discontinued due to Other|0|||
155325163|NCT05785130|560627802|FG000|Overall Study|Withdrawal by Subject|1|||
155325164|NCT05785130|560627803|FG001|Overall Study|Withdrawal by Subject|0|||
155325165|NCT05785130|560627802|FG000|Overall Study|Lack of Efficacy|0|||
155325166|NCT05785130|560627803|FG001|Overall Study|Lack of Efficacy|1|||
155325167|NCT03547271|560627804|FG000|Overall Study|Adverse Event|1|||
155325168|NCT03547271|560627805|FG001|Overall Study|Adverse Event|1|||
155325169|NCT03547271|560627806|FG002|Overall Study|Adverse Event|0|||
155325170|NCT03547271|560627807|FG003|Overall Study|Adverse Event|0|||
155325171|NCT03547271|560627804|FG000|Overall Study|Protocol deviation|5|||
155325172|NCT03547271|560627805|FG001|Overall Study|Protocol deviation|7|||
155325173|NCT03547271|560627806|FG002|Overall Study|Protocol deviation|3|||
155325174|NCT03547271|560627807|FG003|Overall Study|Protocol deviation|0|||
155325175|NCT03547271|560627804|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
155325176|NCT03547271|560627805|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
155325177|NCT03547271|560627806|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155325178|NCT03547271|560627807|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
155325179|NCT03547271|560627804|FG000|Overall Study|Lost to Follow-up|3|||
155325180|NCT03547271|560627805|FG001|Overall Study|Lost to Follow-up|3|||
155325181|NCT03547271|560627806|FG002|Overall Study|Lost to Follow-up|1|||
155325182|NCT03547271|560627807|FG003|Overall Study|Lost to Follow-up|0|||
155325183|NCT06065735|560627808|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
155325184|NCT06065735|560627809|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
155325185|NCT06065735|560627810|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
155325186|NCT06065735|560627808|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
155325187|NCT06065735|560627809|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
155325188|NCT06065735|560627810|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
155325189|NCT06065735|560627808|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
155325190|NCT06065735|560627809|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
155325191|NCT06065735|560627810|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
155325192|NCT06065735|560627808|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
155325193|NCT06065735|560627809|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
155325194|NCT06065735|560627810|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
155325195|NCT06065735|560627808|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
155325196|NCT06065735|560627809|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
155325197|NCT06065735|560627810|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
155325198|NCT03982186|560627811|FG000|Overall Study|Lost to Follow-up|0|||
155325199|NCT03982186|560627812|FG001|Overall Study|Lost to Follow-up|1|||
155325200|NCT03982186|560627813|FG002|Overall Study|Lost to Follow-up|2|||
155325201|NCT03982186|560627814|FG003|Overall Study|Lost to Follow-up|1|||
155325202|NCT03982186|560627815|FG004|Overall Study|Lost to Follow-up|1|||
155325203|NCT03982186|560627816|FG005|Overall Study|Lost to Follow-up|0|||
155325204|NCT03982186|560627811|FG000|Overall Study|Physician Decision|0|||
155325205|NCT03982186|560627812|FG001|Overall Study|Physician Decision|1|||
155325206|NCT03982186|560627813|FG002|Overall Study|Physician Decision|0|||
155325207|NCT03982186|560627814|FG003|Overall Study|Physician Decision|0|||
155325208|NCT03982186|560627815|FG004|Overall Study|Physician Decision|0|||
155325209|NCT03982186|560627816|FG005|Overall Study|Physician Decision|0|||
155069138|NCT02964182|559682749|FG001|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155069139|NCT02964182|559682750|FG002|Phase 4 (Weeks 8-10)|Lost to Follow-up|1|||
155069140|NCT02964182|559682751|FG003|Phase 4 (Weeks 8-10)|Lost to Follow-up|2|||
155069141|NCT02964182|559682752|FG004|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155069142|NCT02964182|559682753|FG005|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155069143|NCT02964182|559682754|FG006|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155069144|NCT02964182|559682755|FG007|Phase 4 (Weeks 8-10)|Lost to Follow-up|0|||
155069145|NCT02964182|559682748|FG000|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155069146|NCT02964182|559682749|FG001|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155069147|NCT02964182|559682750|FG002|Phase 4 (Weeks 8-10)|Withdrawal by Subject|3|||
155069148|NCT02964182|559682751|FG003|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
155069149|NCT02964182|559682752|FG004|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155069150|NCT02964182|559682753|FG005|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155069151|NCT02964182|559682754|FG006|Phase 4 (Weeks 8-10)|Withdrawal by Subject|1|||
155069152|NCT02964182|559682755|FG007|Phase 4 (Weeks 8-10)|Withdrawal by Subject|0|||
155162940|NCT00536744|560031774|FG000|Overall Study|Death|2|||
155325210|NCT03982186|560627811|FG000|Overall Study|Withdrawal by Subject|3|||
155325211|NCT03982186|560627812|FG001|Overall Study|Withdrawal by Subject|4|||
155325212|NCT03982186|560627813|FG002|Overall Study|Withdrawal by Subject|1|||
155325213|NCT03982186|560627814|FG003|Overall Study|Withdrawal by Subject|7|||
155325214|NCT03982186|560627815|FG004|Overall Study|Withdrawal by Subject|2|||
155325215|NCT03982186|560627816|FG005|Overall Study|Withdrawal by Subject|0|||
155325216|NCT03982186|560627811|FG000|Overall Study|Randomized and not treated|0|||
155325217|NCT03982186|560627812|FG001|Overall Study|Randomized and not treated|0|||
155325218|NCT03982186|560627813|FG002|Overall Study|Randomized and not treated|0|||
155325219|NCT03982186|560627814|FG003|Overall Study|Randomized and not treated|1|||
155325220|NCT03982186|560627815|FG004|Overall Study|Randomized and not treated|0|||
155325221|NCT03982186|560627816|FG005|Overall Study|Randomized and not treated|0|||
155325222|NCT02325154|560627817|FG000|Overall Study|Physician Decision|1|||
155325223|NCT01265537|560627818|FG000|Overall Study|Adverse Event|2|||
155325224|NCT01265537|560627819|FG001|Overall Study|Adverse Event|1|||
155325225|NCT01265537|560627818|FG000|Overall Study|Physician Decision|0|||
155325226|NCT01265537|560627819|FG001|Overall Study|Physician Decision|1|||
155325227|NCT03512301|560628507|FG000|Overall Study|Protocol Violation|2|||
155325228|NCT03512301|560628507|FG000|Overall Study|Did Not Qualify|3|||
155325229|NCT03512301|560628507|FG000|Overall Study|Age-ineligible|1|||
155325230|NCT03512301|560628507|FG000|Overall Study|Inadequate fluency with the English language|3|||
155325231|NCT02720068|560628511|FG000|Overall Study|Adverse Event|0|||
155325232|NCT02720068|560628512|FG001|Overall Study|Adverse Event|0|||
155325233|NCT02720068|560628513|FG002|Overall Study|Adverse Event|0|||
155325234|NCT02720068|560628514|FG003|Overall Study|Adverse Event|0|||
155325235|NCT02720068|560628515|FG004|Overall Study|Adverse Event|0|||
155325236|NCT02720068|560628516|FG005|Overall Study|Adverse Event|0|||
155325237|NCT02720068|560628517|FG006|Overall Study|Adverse Event|0|||
155325238|NCT02720068|560628518|FG007|Overall Study|Adverse Event|0|||
155069153|NCT03636477|559682759|FG000|Overall Study|Adverse Event|0|||
155325239|NCT02720068|560628519|FG008|Overall Study|Adverse Event|0|||
155325240|NCT02720068|560628520|FG009|Overall Study|Adverse Event|0|||
155325241|NCT02720068|560628521|FG010|Overall Study|Adverse Event|0|||
155325242|NCT02720068|560628522|FG011|Overall Study|Adverse Event|1|||
155325243|NCT02720068|560628523|FG012|Overall Study|Adverse Event|0|||
154961234|NCT03290781|559282269|FG000|Overall Study|Adverse Event|5|||
154961235|NCT03290781|559282270|FG001|Overall Study|Adverse Event|7|||
154961236|NCT03290781|559282271|FG002|Overall Study|Adverse Event|4|||
154961237|NCT03290781|559282272|FG003|Overall Study|Adverse Event|1|||
154961238|NCT03290781|559282273|FG004|Overall Study|Adverse Event|0|||
154961239|NCT03290781|559282274|FG005|Overall Study|Adverse Event|0|||
154961240|NCT03290781|559282275|FG006|Overall Study|Adverse Event|0|||
154961241|NCT03290781|559282269|FG000|Overall Study|Death|0|||
154961242|NCT03290781|559282270|FG001|Overall Study|Death|0|||
154961243|NCT03290781|559282271|FG002|Overall Study|Death|1|||
154961244|NCT03290781|559282272|FG003|Overall Study|Death|0|||
154961245|NCT03290781|559282273|FG004|Overall Study|Death|1|||
154961246|NCT03290781|559282274|FG005|Overall Study|Death|0|||
154961247|NCT03290781|559282275|FG006|Overall Study|Death|0|||
154961248|NCT03290781|559282269|FG000|Overall Study|Withdrawal by Subject|6|||
154961249|NCT03290781|559282270|FG001|Overall Study|Withdrawal by Subject|5|||
154961250|NCT03290781|559282271|FG002|Overall Study|Withdrawal by Subject|9|||
154961251|NCT03290781|559282272|FG003|Overall Study|Withdrawal by Subject|10|||
154961252|NCT03290781|559282273|FG004|Overall Study|Withdrawal by Subject|1|||
154961253|NCT03290781|559282274|FG005|Overall Study|Withdrawal by Subject|2|||
154961254|NCT03290781|559282275|FG006|Overall Study|Withdrawal by Subject|0|||
154961255|NCT03290781|559282269|FG000|Overall Study|Physician Decision|0|||
154961256|NCT03290781|559282270|FG001|Overall Study|Physician Decision|1|||
154961257|NCT03290781|559282271|FG002|Overall Study|Physician Decision|0|||
154961258|NCT03290781|559282272|FG003|Overall Study|Physician Decision|0|||
154961259|NCT03290781|559282273|FG004|Overall Study|Physician Decision|0|||
154961260|NCT03290781|559282274|FG005|Overall Study|Physician Decision|0|||
154961261|NCT03290781|559282275|FG006|Overall Study|Physician Decision|0|||
154961262|NCT03290781|559282269|FG000|Overall Study|Site Terminated by Sponsor|1|||
154961263|NCT03290781|559282270|FG001|Overall Study|Site Terminated by Sponsor|0|||
154961264|NCT03290781|559282271|FG002|Overall Study|Site Terminated by Sponsor|2|||
154961265|NCT03290781|559282272|FG003|Overall Study|Site Terminated by Sponsor|1|||
154961266|NCT03290781|559282273|FG004|Overall Study|Site Terminated by Sponsor|0|||
154961267|NCT03290781|559282274|FG005|Overall Study|Site Terminated by Sponsor|0|||
154961268|NCT03290781|559282275|FG006|Overall Study|Site Terminated by Sponsor|0|||
154961269|NCT03290781|559282269|FG000|Overall Study|Lost to Follow-up|0|||
154961270|NCT03290781|559282270|FG001|Overall Study|Lost to Follow-up|0|||
154961271|NCT03290781|559282271|FG002|Overall Study|Lost to Follow-up|0|||
154961272|NCT03290781|559282272|FG003|Overall Study|Lost to Follow-up|1|||
154961273|NCT03290781|559282273|FG004|Overall Study|Lost to Follow-up|0|||
154961274|NCT03290781|559282274|FG005|Overall Study|Lost to Follow-up|0|||
154961275|NCT03290781|559282275|FG006|Overall Study|Lost to Follow-up|0|||
154961276|NCT03290781|559282269|FG000|Overall Study|Protocol Deviation|2|||
154961277|NCT03290781|559282270|FG001|Overall Study|Protocol Deviation|0|||
154961278|NCT03290781|559282271|FG002|Overall Study|Protocol Deviation|0|||
154961279|NCT03290781|559282272|FG003|Overall Study|Protocol Deviation|1|||
154961280|NCT03290781|559282273|FG004|Overall Study|Protocol Deviation|0|||
154961281|NCT03290781|559282274|FG005|Overall Study|Protocol Deviation|0|||
154961282|NCT03290781|559282275|FG006|Overall Study|Protocol Deviation|0|||
154961283|NCT03290781|559282269|FG000|Overall Study|Disease Relapse|32|||
154961284|NCT03290781|559282270|FG001|Overall Study|Disease Relapse|5|||
154961285|NCT03290781|559282271|FG002|Overall Study|Disease Relapse|38|||
154961286|NCT03290781|559282272|FG003|Overall Study|Disease Relapse|7|||
154961287|NCT03290781|559282273|FG004|Overall Study|Disease Relapse|3|||
154961288|NCT03290781|559282274|FG005|Overall Study|Disease Relapse|1|||
154961289|NCT03290781|559282275|FG006|Overall Study|Disease Relapse|4|||
154961290|NCT03290781|559282269|FG000|Overall Study|Other|3|||
154961291|NCT03290781|559282270|FG001|Overall Study|Other|0|||
154961292|NCT03290781|559282271|FG002|Overall Study|Other|2|||
154961293|NCT03290781|559282272|FG003|Overall Study|Other|2|||
154961294|NCT03290781|559282273|FG004|Overall Study|Other|0|||
154961295|NCT03290781|559282274|FG005|Overall Study|Other|0|||
154961296|NCT03290781|559282275|FG006|Overall Study|Other|0|||
154961297|NCT00811655|559282293|FG000|Overall Study|Physician Decision|1|||
154961298|NCT00119015|559282301|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
154961299|NCT00119015|559282302|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
154961300|NCT00119015|559282303|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
154961301|NCT02255149|559283909|FG000|Overall Study|Lost to Follow-up|2|||
155325244|NCT02720068|560628524|FG013|Overall Study|Adverse Event|0|||
155325245|NCT02720068|560628525|FG014|Overall Study|Adverse Event|0|||
155325246|NCT02720068|560628526|FG015|Overall Study|Adverse Event|0|||
155325247|NCT02720068|560628527|FG016|Overall Study|Adverse Event|0|||
155325248|NCT02720068|560628528|FG017|Overall Study|Adverse Event|0|||
155325249|NCT02720068|560628511|FG000|Overall Study|Death|1|||
155325250|NCT02720068|560628512|FG001|Overall Study|Death|3|||
155325251|NCT02720068|560628513|FG002|Overall Study|Death|2|||
155325252|NCT02720068|560628514|FG003|Overall Study|Death|1|||
155325253|NCT02720068|560628515|FG004|Overall Study|Death|2|||
155325254|NCT02720068|560628516|FG005|Overall Study|Death|1|||
155069154|NCT03636477|559682760|FG001|Overall Study|Adverse Event|0|||
155069155|NCT03636477|559682761|FG002|Overall Study|Adverse Event|1|||
155325255|NCT02720068|560628517|FG006|Overall Study|Death|2|||
155325256|NCT02720068|560628518|FG007|Overall Study|Death|2|||
155325257|NCT02720068|560628519|FG008|Overall Study|Death|3|||
155069156|NCT02382380|559682763|FG000|Overall Study|Withdrawal by Subject|2|||
155069157|NCT02382380|559682764|FG001|Overall Study|Withdrawal by Subject|2|||
155069158|NCT02382380|559682763|FG000|Overall Study|Lost to Follow-up|0|||
155069159|NCT02382380|559682764|FG001|Overall Study|Lost to Follow-up|1|||
155069160|NCT01295944|559682765|FG000|Overall Study|Switched to alternative treatment|1|||
155069161|NCT01295944|559682765|FG000|Overall Study|Ineligible|9|||
155069162|NCT01295944|559682765|FG000|Overall Study|Withdrawal by Subject|1|||
155325258|NCT02720068|560628520|FG009|Overall Study|Death|1|||
155325259|NCT02720068|560628521|FG010|Overall Study|Death|20|||
155325260|NCT02720068|560628522|FG011|Overall Study|Death|166|||
155325261|NCT02720068|560628523|FG012|Overall Study|Death|34|||
155325262|NCT02720068|560628524|FG013|Overall Study|Death|30|||
155325263|NCT02720068|560628525|FG014|Overall Study|Death|45|||
155325264|NCT02720068|560628526|FG015|Overall Study|Death|16|||
155325265|NCT02720068|560628527|FG016|Overall Study|Death|20|||
155325266|NCT02720068|560628528|FG017|Overall Study|Death|28|||
155325267|NCT02720068|560628511|FG000|Overall Study|Lost to Follow-up|0|||
155325268|NCT02720068|560628512|FG001|Overall Study|Lost to Follow-up|0|||
155325269|NCT02720068|560628513|FG002|Overall Study|Lost to Follow-up|0|||
154961302|NCT02255149|559283909|FG000|Overall Study|Withdrawal by Subject|1|||
154961303|NCT02255149|559283909|FG000|Overall Study|Withdrawal by PI|1|||
154961304|NCT02255149|559283909|FG000|Overall Study|Implant Failure|1|||
154961305|NCT05604170|559283911|FG000|Overall Study|Lack of Efficacy|5|||
154961306|NCT05604170|559283911|FG000|Overall Study|Adverse Event|6|||
154961307|NCT05604170|559283911|FG000|Overall Study|Physician Decision|6|||
154961308|NCT05604170|559283911|FG000|Overall Study|Lost to Follow-up|6|||
154961309|NCT05604170|559283911|FG000|Overall Study|Withdrawal by Subject|11|||
154961310|NCT05604170|559283911|FG000|Overall Study|Early study termination by sponsor|77|||
154961311|NCT05604170|559283911|FG000|Overall Study|Other|6|||
154961312|NCT03697109|559283916|FG000|Open-label (OL) Phase|Adverse Event|24|||
154961313|NCT03697109|559283917|FG001|Open-label (OL) Phase|Adverse Event|0|||
154961314|NCT03697109|559283918|FG002|Open-label (OL) Phase|Adverse Event|0|||
154961315|NCT03697109|559283916|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
154961316|NCT03697109|559283917|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
154961317|NCT03697109|559283918|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
154961318|NCT03697109|559283916|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
154961319|NCT03697109|559283917|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
154961320|NCT03697109|559283918|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
154961321|NCT03697109|559283916|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
154961322|NCT03697109|559283917|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
154961323|NCT03697109|559283918|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
154961324|NCT03697109|559283916|FG000|Open-label (OL) Phase|Physician Decision|2|||
154961325|NCT03697109|559283917|FG001|Open-label (OL) Phase|Physician Decision|0|||
154961326|NCT03697109|559283918|FG002|Open-label (OL) Phase|Physician Decision|0|||
154961327|NCT03697109|559283916|FG000|Open-label (OL) Phase|Death|2|||
154961328|NCT03697109|559283917|FG001|Open-label (OL) Phase|Death|0|||
154961329|NCT03697109|559283918|FG002|Open-label (OL) Phase|Death|0|||
154961330|NCT03697109|559283916|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
155325270|NCT02720068|560628514|FG003|Overall Study|Lost to Follow-up|0|||
155325271|NCT02720068|560628515|FG004|Overall Study|Lost to Follow-up|0|||
155325272|NCT02720068|560628516|FG005|Overall Study|Lost to Follow-up|0|||
155325273|NCT02720068|560628517|FG006|Overall Study|Lost to Follow-up|0|||
154961331|NCT03697109|559283917|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
154961332|NCT03697109|559283918|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
155325274|NCT02720068|560628518|FG007|Overall Study|Lost to Follow-up|0|||
154961333|NCT03697109|559283916|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
154961334|NCT03697109|559283917|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
154961335|NCT03697109|559283918|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
154961336|NCT03697109|559283916|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
155069163|NCT01295944|559682765|FG000|Overall Study|Participant chose to be treated in Peru|1|||
155069164|NCT01295944|559682765|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
155069165|NCT01295944|559682765|FG000|Overall Study|Physician Decision|1|||
155162941|NCT00536744|560031775|FG001|Overall Study|Death|1|||
155325275|NCT02720068|560628519|FG008|Overall Study|Lost to Follow-up|0|||
155325276|NCT02720068|560628520|FG009|Overall Study|Lost to Follow-up|0|||
155325277|NCT02720068|560628521|FG010|Overall Study|Lost to Follow-up|0|||
155325278|NCT02720068|560628522|FG011|Overall Study|Lost to Follow-up|1|||
155325279|NCT02720068|560628523|FG012|Overall Study|Lost to Follow-up|0|||
155325280|NCT02720068|560628524|FG013|Overall Study|Lost to Follow-up|1|||
155325281|NCT02720068|560628525|FG014|Overall Study|Lost to Follow-up|2|||
155325282|NCT02720068|560628526|FG015|Overall Study|Lost to Follow-up|0|||
155325283|NCT02720068|560628527|FG016|Overall Study|Lost to Follow-up|0|||
155325284|NCT02720068|560628528|FG017|Overall Study|Lost to Follow-up|1|||
155325285|NCT02720068|560628511|FG000|Overall Study|Physician Decision|0|||
155325286|NCT02720068|560628512|FG001|Overall Study|Physician Decision|0|||
155325287|NCT02720068|560628513|FG002|Overall Study|Physician Decision|0|||
155325288|NCT02720068|560628514|FG003|Overall Study|Physician Decision|1|||
155325289|NCT02720068|560628515|FG004|Overall Study|Physician Decision|0|||
155325290|NCT02720068|560628516|FG005|Overall Study|Physician Decision|0|||
155325291|NCT02720068|560628517|FG006|Overall Study|Physician Decision|0|||
155325292|NCT02720068|560628518|FG007|Overall Study|Physician Decision|0|||
155325293|NCT02720068|560628519|FG008|Overall Study|Physician Decision|0|||
155325294|NCT02720068|560628520|FG009|Overall Study|Physician Decision|0|||
155325295|NCT02720068|560628521|FG010|Overall Study|Physician Decision|0|||
155325296|NCT02720068|560628522|FG011|Overall Study|Physician Decision|1|||
155325297|NCT02720068|560628523|FG012|Overall Study|Physician Decision|0|||
155325298|NCT02720068|560628524|FG013|Overall Study|Physician Decision|0|||
155325299|NCT02720068|560628525|FG014|Overall Study|Physician Decision|0|||
155325300|NCT02720068|560628526|FG015|Overall Study|Physician Decision|0|||
155325301|NCT02720068|560628527|FG016|Overall Study|Physician Decision|0|||
155325302|NCT02720068|560628528|FG017|Overall Study|Physician Decision|1|||
155325303|NCT02720068|560628511|FG000|Overall Study|Progressive Disease|2|||
155325304|NCT02720068|560628512|FG001|Overall Study|Progressive Disease|3|||
155325305|NCT02720068|560628513|FG002|Overall Study|Progressive Disease|1|||
155325306|NCT02720068|560628514|FG003|Overall Study|Progressive Disease|1|||
155325307|NCT02720068|560628515|FG004|Overall Study|Progressive Disease|1|||
155325308|NCT02720068|560628516|FG005|Overall Study|Progressive Disease|2|||
155325309|NCT02720068|560628517|FG006|Overall Study|Progressive Disease|1|||
155325310|NCT02720068|560628518|FG007|Overall Study|Progressive Disease|1|||
155325311|NCT02720068|560628519|FG008|Overall Study|Progressive Disease|0|||
155325312|NCT02720068|560628520|FG009|Overall Study|Progressive Disease|1|||
155325313|NCT02720068|560628521|FG010|Overall Study|Progressive Disease|0|||
155325314|NCT02720068|560628522|FG011|Overall Study|Progressive Disease|4|||
155325315|NCT02720068|560628523|FG012|Overall Study|Progressive Disease|1|||
155325316|NCT02720068|560628524|FG013|Overall Study|Progressive Disease|0|||
155325317|NCT02720068|560628525|FG014|Overall Study|Progressive Disease|0|||
155325318|NCT02720068|560628526|FG015|Overall Study|Progressive Disease|0|||
155325319|NCT02720068|560628527|FG016|Overall Study|Progressive Disease|0|||
155325320|NCT02720068|560628528|FG017|Overall Study|Progressive Disease|0|||
155325321|NCT02720068|560628511|FG000|Overall Study|Sponsor Decision|0|||
155325322|NCT02720068|560628512|FG001|Overall Study|Sponsor Decision|0|||
155325323|NCT02720068|560628513|FG002|Overall Study|Sponsor Decision|0|||
155325324|NCT02720068|560628514|FG003|Overall Study|Sponsor Decision|0|||
155325325|NCT02720068|560628515|FG004|Overall Study|Sponsor Decision|0|||
155325326|NCT02720068|560628516|FG005|Overall Study|Sponsor Decision|0|||
155325327|NCT02720068|560628517|FG006|Overall Study|Sponsor Decision|0|||
155325328|NCT02720068|560628518|FG007|Overall Study|Sponsor Decision|0|||
155162942|NCT00536744|560031774|FG000|Overall Study|Physician Decision|3|||
155325329|NCT02720068|560628519|FG008|Overall Study|Sponsor Decision|0|||
155325330|NCT02720068|560628520|FG009|Overall Study|Sponsor Decision|0|||
155325331|NCT02720068|560628521|FG010|Overall Study|Sponsor Decision|0|||
155325332|NCT02720068|560628522|FG011|Overall Study|Sponsor Decision|6|||
155325333|NCT02720068|560628523|FG012|Overall Study|Sponsor Decision|3|||
155325334|NCT02720068|560628524|FG013|Overall Study|Sponsor Decision|2|||
155325335|NCT02720068|560628525|FG014|Overall Study|Sponsor Decision|4|||
155325336|NCT02720068|560628526|FG015|Overall Study|Sponsor Decision|4|||
155325337|NCT02720068|560628527|FG016|Overall Study|Sponsor Decision|0|||
155325338|NCT02720068|560628528|FG017|Overall Study|Sponsor Decision|8|||
155325339|NCT02720068|560628511|FG000|Overall Study|Withdrawal by Subject|0|||
155325340|NCT02720068|560628512|FG001|Overall Study|Withdrawal by Subject|0|||
155325341|NCT02720068|560628513|FG002|Overall Study|Withdrawal by Subject|0|||
155325342|NCT02720068|560628514|FG003|Overall Study|Withdrawal by Subject|0|||
155325343|NCT02720068|560628515|FG004|Overall Study|Withdrawal by Subject|0|||
155325344|NCT02720068|560628516|FG005|Overall Study|Withdrawal by Subject|0|||
155325345|NCT02720068|560628517|FG006|Overall Study|Withdrawal by Subject|0|||
155325346|NCT02720068|560628518|FG007|Overall Study|Withdrawal by Subject|0|||
155325347|NCT02720068|560628519|FG008|Overall Study|Withdrawal by Subject|0|||
155325348|NCT02720068|560628520|FG009|Overall Study|Withdrawal by Subject|1|||
155325349|NCT02720068|560628521|FG010|Overall Study|Withdrawal by Subject|0|||
155325350|NCT02720068|560628522|FG011|Overall Study|Withdrawal by Subject|27|||
155325351|NCT02720068|560628523|FG012|Overall Study|Withdrawal by Subject|2|||
155325352|NCT02720068|560628524|FG013|Overall Study|Withdrawal by Subject|8|||
155325353|NCT02720068|560628525|FG014|Overall Study|Withdrawal by Subject|7|||
155325354|NCT02720068|560628526|FG015|Overall Study|Withdrawal by Subject|0|||
155325355|NCT02720068|560628527|FG016|Overall Study|Withdrawal by Subject|0|||
155325356|NCT02720068|560628528|FG017|Overall Study|Withdrawal by Subject|2|||
155325357|NCT02720068|560628511|FG000|Overall Study|Protocol Violation|0|||
155325358|NCT02720068|560628512|FG001|Overall Study|Protocol Violation|0|||
155325359|NCT02720068|560628513|FG002|Overall Study|Protocol Violation|0|||
155325360|NCT02720068|560628514|FG003|Overall Study|Protocol Violation|0|||
155325361|NCT02720068|560628515|FG004|Overall Study|Protocol Violation|0|||
155325362|NCT02720068|560628516|FG005|Overall Study|Protocol Violation|0|||
155325363|NCT02720068|560628517|FG006|Overall Study|Protocol Violation|0|||
155325364|NCT02720068|560628518|FG007|Overall Study|Protocol Violation|0|||
155325365|NCT02720068|560628519|FG008|Overall Study|Protocol Violation|0|||
155325366|NCT02720068|560628520|FG009|Overall Study|Protocol Violation|0|||
155325367|NCT02720068|560628521|FG010|Overall Study|Protocol Violation|1|||
155325368|NCT02720068|560628522|FG011|Overall Study|Protocol Violation|0|||
155325369|NCT02720068|560628523|FG012|Overall Study|Protocol Violation|0|||
155325370|NCT02720068|560628524|FG013|Overall Study|Protocol Violation|0|||
155325371|NCT02720068|560628525|FG014|Overall Study|Protocol Violation|1|||
155325372|NCT02720068|560628526|FG015|Overall Study|Protocol Violation|0|||
155325373|NCT02720068|560628527|FG016|Overall Study|Protocol Violation|1|||
155325374|NCT02720068|560628528|FG017|Overall Study|Protocol Violation|0|||
155325375|NCT01773993|560628532|FG000|Overall Study|No Visit After Treatment|35|||
155325376|NCT04993677|560628536|FG000|Overall Study|Lost to Follow-up|1|||
155325377|NCT04993677|560628537|FG001|Overall Study|Lost to Follow-up|0|||
155325378|NCT04993677|560628538|FG002|Overall Study|Lost to Follow-up|0|||
155325379|NCT04993677|560628539|FG003|Overall Study|Lost to Follow-up|0|||
155325380|NCT04993677|560628536|FG000|Overall Study|Death|11|||
155325381|NCT04993677|560628537|FG001|Overall Study|Death|8|||
155325382|NCT04993677|560628538|FG002|Overall Study|Death|3|||
155325383|NCT04993677|560628539|FG003|Overall Study|Death|1|||
155325384|NCT04993677|560628536|FG000|Overall Study|Subject withdrawal of consent|4|||
155325385|NCT04993677|560628537|FG001|Overall Study|Subject withdrawal of consent|3|||
155325386|NCT04993677|560628538|FG002|Overall Study|Subject withdrawal of consent|0|||
155325387|NCT04993677|560628539|FG003|Overall Study|Subject withdrawal of consent|2|||
155325388|NCT04993677|560628536|FG000|Overall Study|Study termination by sponsor|3|||
155325389|NCT04993677|560628537|FG001|Overall Study|Study termination by sponsor|25|||
155325390|NCT04993677|560628538|FG002|Overall Study|Study termination by sponsor|3|||
155325391|NCT04993677|560628539|FG003|Overall Study|Study termination by sponsor|3|||
155325392|NCT04993677|560628536|FG000|Overall Study|Other|2|||
155325393|NCT04993677|560628537|FG001|Overall Study|Other|3|||
155325394|NCT04993677|560628538|FG002|Overall Study|Other|3|||
155325395|NCT04993677|560628539|FG003|Overall Study|Other|2|||
155325396|NCT04408755|560628552|FG000|Period A (Placebo lead-in)|Other|11|||
155325397|NCT04408755|560628553|FG001|Period A (Placebo lead-in)|Other|0|||
155325398|NCT04408755|560628554|FG002|Period A (Placebo lead-in)|Other|0|||
155325399|NCT04408755|560628555|FG003|Period A (Placebo lead-in)|Other|0|||
155325400|NCT04408755|560628552|FG000|Period B (Randomization Period)|Adverse Event|0|||
155325401|NCT04408755|560628553|FG001|Period B (Randomization Period)|Adverse Event|3|||
155325402|NCT04408755|560628554|FG002|Period B (Randomization Period)|Adverse Event|0|||
155325403|NCT04408755|560628555|FG003|Period B (Randomization Period)|Adverse Event|1|||
155325404|NCT04408755|560628552|FG000|Period B (Randomization Period)|Death|0|||
155325405|NCT04408755|560628553|FG001|Period B (Randomization Period)|Death|0|||
155325406|NCT04408755|560628554|FG002|Period B (Randomization Period)|Death|1|||
155325407|NCT04408755|560628555|FG003|Period B (Randomization Period)|Death|0|||
155325408|NCT04408755|560628552|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
155325409|NCT04408755|560628553|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
155325410|NCT04408755|560628554|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
155325411|NCT04408755|560628555|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
155325412|NCT04408755|560628552|FG000|Period B (Randomization Period)|Physician Decision|0|||
155325413|NCT04408755|560628553|FG001|Period B (Randomization Period)|Physician Decision|0|||
155325414|NCT04408755|560628554|FG002|Period B (Randomization Period)|Physician Decision|1|||
155325415|NCT04408755|560628555|FG003|Period B (Randomization Period)|Physician Decision|0|||
155325416|NCT04408755|560628552|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
155325417|NCT04408755|560628553|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
155325418|NCT04408755|560628554|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
155325419|NCT04408755|560628555|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
155325420|NCT04408755|560628552|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
155325421|NCT04408755|560628553|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
155325422|NCT04408755|560628554|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
155325423|NCT04408755|560628555|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
155325424|NCT04408755|560628552|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
155325425|NCT04408755|560628553|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
155325426|NCT04408755|560628554|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
155325427|NCT04408755|560628555|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
155325428|NCT04408755|560628552|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
155325429|NCT04408755|560628553|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
155325430|NCT04408755|560628554|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
155325431|NCT04408755|560628555|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
155325432|NCT04408755|560628552|FG000|Period B (Randomization Period)|Reason not Specified|0|||
155325433|NCT04408755|560628553|FG001|Period B (Randomization Period)|Reason not Specified|1|||
155325434|NCT04408755|560628554|FG002|Period B (Randomization Period)|Reason not Specified|0|||
155325435|NCT04408755|560628555|FG003|Period B (Randomization Period)|Reason not Specified|2|||
155325436|NCT03733626|560628556|FG000|Overall Study|Physician Decision|4|||
155325437|NCT03733626|560628557|FG001|Overall Study|Physician Decision|4|||
155325438|NCT00412607|560628560|FG000|Overall Study|Withdrawal by Subject|9|||
155325439|NCT00412607|560628560|FG000|Overall Study|Lost to Follow-up|19|||
155325440|NCT00412607|560628560|FG000|Overall Study|Death|61|||
155325441|NCT00412607|560628560|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
155325442|NCT03662022|560628561|FG000|Year 1 2019|prevalent case|83|||
155325443|NCT03662022|560628562|FG001|Year 1 2019|prevalent case|116|||
155325444|NCT03662022|560628563|FG002|Year 1 2019|prevalent case|158|||
155325445|NCT03662022|560628564|FG003|Year 1 2019|prevalent case|99|||
155325446|NCT03662022|560628561|FG000|Year 2 2020|incident case|18|||
155325447|NCT03662022|560628562|FG001|Year 2 2020|incident case|18|||
155325448|NCT03662022|560628563|FG002|Year 2 2020|incident case|16|||
155325449|NCT03662022|560628564|FG003|Year 2 2020|incident case|26|||
155325450|NCT03662022|560628561|FG000|Year 2 2020|other case|18|||
155325451|NCT03662022|560628562|FG001|Year 2 2020|other case|16|||
155325452|NCT03662022|560628563|FG002|Year 2 2020|other case|16|||
155325453|NCT03662022|560628564|FG003|Year 2 2020|other case|24|||
155325454|NCT03662022|560628561|FG000|Year 2 2020|Lost to Follow-up|1633|||
155325455|NCT03662022|560628562|FG001|Year 2 2020|Lost to Follow-up|1183|||
155325456|NCT03662022|560628563|FG002|Year 2 2020|Lost to Follow-up|1381|||
155325457|NCT03662022|560628564|FG003|Year 2 2020|Lost to Follow-up|2858|||
155325458|NCT03662022|560628561|FG000|Year 3 2021|incident case|24|||
155325459|NCT03662022|560628562|FG001|Year 3 2021|incident case|27|||
155325460|NCT03662022|560628563|FG002|Year 3 2021|incident case|24|||
155325461|NCT03662022|560628564|FG003|Year 3 2021|incident case|11|||
155325462|NCT03662022|560628561|FG000|Year 3 2021|other case|4|||
155069166|NCT01295944|559682765|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
155069167|NCT01295944|559682765|FG000|Overall Study|Disease progression|4|||
155069168|NCT01295944|559682765|FG000|Overall Study|Transferred care before starting new treatment|1|||
155069169|NCT02783274|559682772|FG000|Overall Study|Withdrawal by Subject|16|||
155069170|NCT02783274|559682772|FG000|Overall Study|Physician Decision|6|||
155325463|NCT03662022|560628562|FG001|Year 3 2021|other case|15|||
155325464|NCT03662022|560628563|FG002|Year 3 2021|other case|10|||
155325465|NCT03662022|560628564|FG003|Year 3 2021|other case|14|||
155325466|NCT03662022|560628561|FG000|Year 3 2021|Lost to Follow-up|179|||
155325467|NCT03662022|560628562|FG001|Year 3 2021|Lost to Follow-up|244|||
155325468|NCT03662022|560628563|FG002|Year 3 2021|Lost to Follow-up|480|||
155325469|NCT03662022|560628564|FG003|Year 3 2021|Lost to Follow-up|477|||
155325470|NCT03662022|560628561|FG000|Year 4 2022|incident case|25|||
155325471|NCT03662022|560628562|FG001|Year 4 2022|incident case|41|||
155325472|NCT03662022|560628563|FG002|Year 4 2022|incident case|28|||
155325473|NCT03662022|560628564|FG003|Year 4 2022|incident case|7|||
155325474|NCT03662022|560628561|FG000|Year 4 2022|other case|8|||
155325475|NCT03662022|560628562|FG001|Year 4 2022|other case|19|||
155325476|NCT03662022|560628563|FG002|Year 4 2022|other case|13|||
155325477|NCT03662022|560628564|FG003|Year 4 2022|other case|7|||
155325478|NCT03662022|560628561|FG000|Year 4 2022|Lost to Follow-up|986|||
155325479|NCT03662022|560628562|FG001|Year 4 2022|Lost to Follow-up|1079|||
155325480|NCT03662022|560628563|FG002|Year 4 2022|Lost to Follow-up|1236|||
155325481|NCT03662022|560628564|FG003|Year 4 2022|Lost to Follow-up|1826|||
155325482|NCT03884439|560628574|FG000|Overall Study|No informed consent for publication of study results|38|||
155325483|NCT03884439|560628574|FG000|Overall Study|Contract violation/deficiency|7|||
155325484|NCT05215054|560628575|FG000|Overall Study|Lost to Follow-up|1|||
155325485|NCT05215054|560628576|FG001|Overall Study|Lost to Follow-up|1|||
155325486|NCT05215054|560628575|FG000|Overall Study|Protocol Violation|1|||
155325487|NCT05215054|560628576|FG001|Overall Study|Protocol Violation|1|||
155325488|NCT05215054|560628575|FG000|Overall Study|Withdrawal by Subject|4|||
155325489|NCT05215054|560628576|FG001|Overall Study|Withdrawal by Subject|4|||
155325490|NCT02933489|560628577|FG000|Overall Study|Ineligible|3|||
155325491|NCT02933489|560628578|FG001|Overall Study|Ineligible|3|||
155325492|NCT02933489|560628577|FG000|Overall Study|Withdrawal by Subject|27|||
155325493|NCT02933489|560628578|FG001|Overall Study|Withdrawal by Subject|18|||
155325494|NCT02933489|560628577|FG000|Overall Study|Unable to complete exams (other)|14|||
155325495|NCT02933489|560628578|FG001|Overall Study|Unable to complete exams (other)|7|||
155325496|NCT05485935|560628579|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
155325497|NCT05485935|560628580|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
155325498|NCT05485935|560628579|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
155325499|NCT05485935|560628580|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
155325500|NCT05485935|560628579|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
155325501|NCT05485935|560628580|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
155325502|NCT05485935|560628579|FG000|Period 2 (T2 and V3)|loss of contact|0|||
155325503|NCT05485935|560628580|FG001|Period 2 (T2 and V3)|loss of contact|1|||
155325504|NCT02806726|560628581|FG000|Overall Study|Lost to Follow-up|1|||
155325505|NCT01499368|560628582|FG000|Overall Study|Did not meet I/E criteria|8|||
155325506|NCT01499368|560628583|FG001|Overall Study|Did not meet I/E criteria|4|||
155325507|NCT01499368|560628584|FG002|Overall Study|Did not meet I/E criteria|4|||
155325508|NCT01499368|560628582|FG000|Overall Study|Prohibited Concomitant medication|1|||
155325509|NCT01499368|560628583|FG001|Overall Study|Prohibited Concomitant medication|1|||
155325510|NCT01499368|560628584|FG002|Overall Study|Prohibited Concomitant medication|0|||
155325511|NCT01499368|560628582|FG000|Overall Study|Withdrawal by Subject|11|||
155325512|NCT01499368|560628583|FG001|Overall Study|Withdrawal by Subject|10|||
155325513|NCT01499368|560628584|FG002|Overall Study|Withdrawal by Subject|8|||
155069171|NCT02783274|559682772|FG000|Overall Study|Death|9|||
155325514|NCT01499368|560628582|FG000|Overall Study|Lost to Follow-up|3|||
155325515|NCT01499368|560628583|FG001|Overall Study|Lost to Follow-up|2|||
155325516|NCT01499368|560628584|FG002|Overall Study|Lost to Follow-up|5|||
155069172|NCT02783274|559682772|FG000|Overall Study|Lost to Follow-up|22|||
155325517|NCT01499368|560628582|FG000|Overall Study|Adverse Event|4|||
155325518|NCT01499368|560628583|FG001|Overall Study|Adverse Event|0|||
155325519|NCT01499368|560628584|FG002|Overall Study|Adverse Event|2|||
155325520|NCT01499368|560628582|FG000|Overall Study|Physician Decision|0|||
155325521|NCT01499368|560628583|FG001|Overall Study|Physician Decision|1|||
155325522|NCT01499368|560628584|FG002|Overall Study|Physician Decision|0|||
155325523|NCT01499368|560628582|FG000|Overall Study|Deviation from visit window|0|||
155325524|NCT01499368|560628583|FG001|Overall Study|Deviation from visit window|0|||
155325525|NCT01499368|560628584|FG002|Overall Study|Deviation from visit window|1|||
155325526|NCT01499368|560628582|FG000|Overall Study|Error of Prescriptions|0|||
155325527|NCT01499368|560628583|FG001|Overall Study|Error of Prescriptions|0|||
155069173|NCT02783274|559682772|FG000|Overall Study|Other|22|||
155069174|NCT05722015|559682774|FG000|Overall Study|Death|57|||
155069175|NCT05722015|559682775|FG001|Overall Study|Death|37|||
155069176|NCT05722015|559682774|FG000|Overall Study|Lost to Follow-up|1|||
155069177|NCT05722015|559682775|FG001|Overall Study|Lost to Follow-up|0|||
155069178|NCT05722015|559682774|FG000|Overall Study|Withdrawal by Subject|5|||
155069179|NCT05722015|559682775|FG001|Overall Study|Withdrawal by Subject|1|||
155069180|NCT05722015|559682774|FG000|Overall Study|Participants Ongoing|188|||
155069181|NCT05722015|559682775|FG001|Overall Study|Participants Ongoing|88|||
155069182|NCT01802281|559682776|FG000|Overall Study|Death|1|||
155325528|NCT01499368|560628584|FG002|Overall Study|Error of Prescriptions|1|||
155325529|NCT03092674|560628585|FG000|Overall Study|Adverse Event or Side Effects|1|||
155325530|NCT03092674|560628586|FG001|Overall Study|Adverse Event or Side Effects|4|||
155325531|NCT03092674|560628587|FG002|Overall Study|Adverse Event or Side Effects|4|||
155325532|NCT03092674|560628585|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
155325533|NCT03092674|560628586|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
155325534|NCT03092674|560628587|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
155325535|NCT03092674|560628585|FG000|Overall Study|Progression/Relapse|5|||
155325536|NCT03092674|560628586|FG001|Overall Study|Progression/Relapse|4|||
155325537|NCT03092674|560628587|FG002|Overall Study|Progression/Relapse|8|||
155325538|NCT03092674|560628585|FG000|Overall Study|Death|4|||
155325539|NCT03092674|560628586|FG001|Overall Study|Death|8|||
155325540|NCT03092674|560628587|FG002|Overall Study|Death|2|||
155325541|NCT03092674|560628585|FG000|Overall Study|Other - Not Protocol Specified|11|||
155325542|NCT03092674|560628586|FG001|Overall Study|Other - Not Protocol Specified|8|||
155325543|NCT03092674|560628587|FG002|Overall Study|Other - Not Protocol Specified|8|||
155325544|NCT04626427|560628588|FG000|Overall Study|Death|1|||
155325545|NCT04626427|560628588|FG000|Overall Study|Withdrawal by Subject|1|||
155325546|NCT04626427|560628588|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
155325547|NCT04626427|560628588|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
155325548|NCT04518943|560629355|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
155325549|NCT04518943|560629356|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
155069183|NCT01802281|559682777|FG001|Overall Study|Death|2|||
155069184|NCT01802281|559682776|FG000|Overall Study|Withdrawal by Subject|2|||
155325550|NCT04518943|560629357|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
155325551|NCT04518943|560629358|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
155325552|NCT04518943|560629359|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
155325553|NCT04518943|560629360|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
155069185|NCT01802281|559682777|FG001|Overall Study|Withdrawal by Subject|1|||
155069186|NCT01802281|559682776|FG000|Overall Study|Ineligible|5|||
155069187|NCT01802281|559682777|FG001|Overall Study|Ineligible|3|||
155325554|NCT04518943|560629361|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
155069188|NCT04133909|559682778|FG000|Overall Study|Death|11|||
155069189|NCT04133909|559682779|FG001|Overall Study|Death|11|||
155325555|NCT04518943|560629362|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
155325556|NCT04518943|560629363|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
155325557|NCT04518943|560629364|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
155325558|NCT04518943|560629365|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
155325559|NCT04518943|560629366|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
155325560|NCT04518943|560629367|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
155325561|NCT04518943|560629368|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
155325562|NCT04518943|560629369|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
155325563|NCT04518943|560629370|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
155325564|NCT03705793|560629374|FG000|Overall Study|Lost to Follow-up|3|||
155325565|NCT03705793|560629375|FG001|Overall Study|Lost to Follow-up|4|||
155325566|NCT03705793|560629374|FG000|Overall Study|Withdrawal by Subject|2|||
155325567|NCT03705793|560629375|FG001|Overall Study|Withdrawal by Subject|1|||
155325568|NCT04174170|560629376|FG000|Placebo Run-in Period|Not Randomized|38|||
155325569|NCT04174170|560629377|FG001|Placebo Run-in Period|Not Randomized|0|||
155325570|NCT04174170|560629378|FG002|Placebo Run-in Period|Not Randomized|0|||
155325571|NCT04174170|560629379|FG003|Placebo Run-in Period|Not Randomized|0|||
155325572|NCT04174170|560629376|FG000|Double Blind Treatment Period|Adverse Event|0|||
155325573|NCT04174170|560629377|FG001|Double Blind Treatment Period|Adverse Event|9|||
154961337|NCT03697109|559283917|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
154961338|NCT03697109|559283918|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
154961339|NCT03032172|559283919|FG000|Treatment Period|Adverse Event|0|||
155325574|NCT04174170|560629378|FG002|Double Blind Treatment Period|Adverse Event|9|||
155325575|NCT04174170|560629379|FG003|Double Blind Treatment Period|Adverse Event|8|||
155325576|NCT04174170|560629376|FG000|Double Blind Treatment Period|Death|0|||
155325577|NCT04174170|560629377|FG001|Double Blind Treatment Period|Death|1|||
155325578|NCT04174170|560629378|FG002|Double Blind Treatment Period|Death|0|||
155325579|NCT04174170|560629379|FG003|Double Blind Treatment Period|Death|0|||
155325580|NCT04174170|560629376|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155325581|NCT04174170|560629377|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
155325582|NCT04174170|560629378|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
155325583|NCT04174170|560629379|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
155325584|NCT04174170|560629376|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
155325585|NCT04174170|560629377|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
155325586|NCT04174170|560629378|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
155325587|NCT04174170|560629379|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
155325588|NCT04174170|560629376|FG000|Double Blind Treatment Period|Physician Decision|0|||
155325589|NCT04174170|560629377|FG001|Double Blind Treatment Period|Physician Decision|1|||
155325590|NCT04174170|560629378|FG002|Double Blind Treatment Period|Physician Decision|0|||
155325591|NCT04174170|560629379|FG003|Double Blind Treatment Period|Physician Decision|1|||
155325592|NCT04174170|560629376|FG000|Double Blind Treatment Period|Pregnancy|0|||
155325593|NCT04174170|560629377|FG001|Double Blind Treatment Period|Pregnancy|1|||
155325594|NCT04174170|560629378|FG002|Double Blind Treatment Period|Pregnancy|0|||
155325595|NCT04174170|560629379|FG003|Double Blind Treatment Period|Pregnancy|1|||
155325596|NCT04174170|560629376|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
155325597|NCT04174170|560629377|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
155325598|NCT04174170|560629378|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
155325599|NCT04174170|560629379|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
155325600|NCT04174170|560629376|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155325601|NCT04174170|560629377|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
155325602|NCT04174170|560629378|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
155325603|NCT04174170|560629379|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
155325604|NCT04174170|560629376|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
155325605|NCT04174170|560629377|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
155325606|NCT04174170|560629378|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
155325607|NCT04174170|560629379|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
154961340|NCT03032172|559283920|FG001|Treatment Period|Adverse Event|1|||
154961341|NCT03032172|559283921|FG002|Treatment Period|Adverse Event|0|||
154961342|NCT03032172|559283922|FG003|Treatment Period|Adverse Event|0|||
154961343|NCT03032172|559283923|FG004|Treatment Period|Adverse Event|0|||
155069190|NCT04133909|559682778|FG000|Overall Study|Adverse Event|4|||
154961344|NCT03032172|559283924|FG005|Treatment Period|Adverse Event|0|||
154961345|NCT03032172|559283925|FG006|Treatment Period|Adverse Event|0|||
155325608|NCT04664881|560629380|FG000|Overall Study|Withdrawal by Subject|1|||
155325609|NCT04664881|560629381|FG001|Overall Study|Withdrawal by Subject|8|||
155325610|NCT04664881|560629380|FG000|Overall Study|Physician Decision|0|||
155325611|NCT04664881|560629381|FG001|Overall Study|Physician Decision|5|||
155325612|NCT04664881|560629380|FG000|Overall Study|Lost to Follow-up|1|||
155325613|NCT04664881|560629381|FG001|Overall Study|Lost to Follow-up|0|||
155325614|NCT04772534|560629390|FG000|Overall Study|Physician Decision|1|||
155325615|NCT04772534|560629391|FG001|Overall Study|Physician Decision|0|||
155325616|NCT04772534|560629392|FG002|Overall Study|Physician Decision|0|||
155325617|NCT04772534|560629390|FG000|Overall Study|Withdrawal by Subject|3|||
155325618|NCT04772534|560629391|FG001|Overall Study|Withdrawal by Subject|0|||
155325619|NCT04772534|560629392|FG002|Overall Study|Withdrawal by Subject|1|||
155325620|NCT04194450|560629393|FG000|Overall Study|not eligible|1|||
155325621|NCT04194450|560629394|FG001|Overall Study|not eligible|0|||
155325622|NCT05875701|560629401|FG000|Overall Study|Lost to Follow-up|2|||
155325623|NCT05875701|560629402|FG001|Overall Study|Lost to Follow-up|0|||
155325624|NCT05875701|560629401|FG000|Overall Study|Withdrawal by Subject|1|||
155325625|NCT05875701|560629402|FG001|Overall Study|Withdrawal by Subject|1|||
155325626|NCT00308997|560629410|FG000|Overall Study|Subject feigned clinical data|0|||
155325627|NCT00308997|560629411|FG001|Overall Study|Subject feigned clinical data|1|||
155325628|NCT00308997|560629410|FG000|Overall Study|Unable to tolerate intervention|1|||
155325629|NCT00308997|560629411|FG001|Overall Study|Unable to tolerate intervention|0|||
155325630|NCT04490356|560629413|FG000|Overall Study|Lost to Follow-up|1|||
155325631|NCT04214418|560629427|FG000|Overall Study|Withdrawal by Subject|1|||
155325632|NCT04214418|560629428|FG001|Overall Study|Withdrawal by Subject|0|||
155325633|NCT04214418|560629429|FG002|Overall Study|Withdrawal by Subject|0|||
155325634|NCT04214418|560629430|FG003|Overall Study|Withdrawal by Subject|0|||
155325635|NCT04214418|560629431|FG004|Overall Study|Withdrawal by Subject|0|||
155325636|NCT04214418|560629432|FG005|Overall Study|Withdrawal by Subject|0|||
155325637|NCT04214418|560629427|FG000|Overall Study|Adverse Event|0|||
155325638|NCT04214418|560629428|FG001|Overall Study|Adverse Event|2|||
155325639|NCT04214418|560629429|FG002|Overall Study|Adverse Event|0|||
155325640|NCT04214418|560629430|FG003|Overall Study|Adverse Event|0|||
155325641|NCT04214418|560629431|FG004|Overall Study|Adverse Event|0|||
155325642|NCT04214418|560629432|FG005|Overall Study|Adverse Event|0|||
155325643|NCT04214418|560629427|FG000|Overall Study|Death|1|||
155325644|NCT04214418|560629428|FG001|Overall Study|Death|0|||
155325645|NCT04214418|560629429|FG002|Overall Study|Death|0|||
155325646|NCT04214418|560629430|FG003|Overall Study|Death|0|||
155325647|NCT04214418|560629431|FG004|Overall Study|Death|0|||
155325648|NCT04214418|560629432|FG005|Overall Study|Death|0|||
155325649|NCT05836012|560629435|FG000|Overall Study|Lost to Follow-up|1|||
155325650|NCT05836012|560629436|FG001|Overall Study|Lost to Follow-up|0|||
154961346|NCT03032172|559283926|FG007|Treatment Period|Adverse Event|0|||
155325651|NCT05836012|560629435|FG000|Overall Study|Withdrawal by Subject|1|||
155325652|NCT05836012|560629436|FG001|Overall Study|Withdrawal by Subject|3|||
155325653|NCT05836012|560629435|FG000|Overall Study|Reason not included in pre-specified categories|2|||
155325654|NCT05836012|560629436|FG001|Overall Study|Reason not included in pre-specified categories|1|||
155325655|NCT04093869|560629440|FG000|Overall Study|Death|0|||
155325656|NCT04093869|560629441|FG001|Overall Study|Death|1|||
155325657|NCT04093869|560629440|FG000|Overall Study|Withdrawal by Subject|1|||
155325658|NCT04093869|560629441|FG001|Overall Study|Withdrawal by Subject|0|||
155325659|NCT05129501|560629442|FG000|Overall Study|Lost to Follow-up|54|||
155325660|NCT05129501|560629443|FG001|Overall Study|Lost to Follow-up|41|||
155325661|NCT01527188|560629446|FG000|Overall Study|Adverse Event|5|||
155325662|NCT01527188|560629447|FG001|Overall Study|Adverse Event|5|||
155325663|NCT01527188|560629448|FG002|Overall Study|Adverse Event|11|||
155325664|NCT01527188|560629449|FG003|Overall Study|Adverse Event|0|||
155325665|NCT01527188|560629446|FG000|Overall Study|Withdrawal by Subject|3|||
155325666|NCT01527188|560629447|FG001|Overall Study|Withdrawal by Subject|6|||
155325667|NCT01527188|560629448|FG002|Overall Study|Withdrawal by Subject|4|||
155325668|NCT01527188|560629449|FG003|Overall Study|Withdrawal by Subject|4|||
155325669|NCT01527188|560629446|FG000|Overall Study|Any other reason not above-mentioned|6|||
155325670|NCT01527188|560629447|FG001|Overall Study|Any other reason not above-mentioned|7|||
155325671|NCT01527188|560629448|FG002|Overall Study|Any other reason not above-mentioned|8|||
155325672|NCT01527188|560629449|FG003|Overall Study|Any other reason not above-mentioned|8|||
155325673|NCT05162586|560630069|FG000|Overall Study|Other|0|||
155325674|NCT05162586|560630070|FG001|Overall Study|Other|0|||
155325675|NCT05162586|560630071|FG002|Overall Study|Other|0|||
155325676|NCT05162586|560630072|FG003|Overall Study|Other|0|||
155325677|NCT05162586|560630073|FG004|Overall Study|Other|1|||
155325678|NCT05162586|560630074|FG005|Overall Study|Other|0|||
155325679|NCT05162586|560630075|FG006|Overall Study|Other|2|||
155325680|NCT05162586|560630076|FG007|Overall Study|Other|2|||
155325681|NCT05162586|560630069|FG000|Overall Study|Lack of Efficacy|0|||
155325682|NCT05162586|560630070|FG001|Overall Study|Lack of Efficacy|0|||
155325683|NCT05162586|560630071|FG002|Overall Study|Lack of Efficacy|0|||
155325684|NCT05162586|560630072|FG003|Overall Study|Lack of Efficacy|0|||
155325685|NCT05162586|560630073|FG004|Overall Study|Lack of Efficacy|1|||
155325686|NCT05162586|560630074|FG005|Overall Study|Lack of Efficacy|0|||
155325687|NCT05162586|560630075|FG006|Overall Study|Lack of Efficacy|0|||
155325688|NCT05162586|560630076|FG007|Overall Study|Lack of Efficacy|1|||
155325689|NCT05162586|560630069|FG000|Overall Study|Lost to Follow-up|0|||
155325690|NCT05162586|560630070|FG001|Overall Study|Lost to Follow-up|0|||
155325691|NCT05162586|560630071|FG002|Overall Study|Lost to Follow-up|0|||
155325692|NCT05162586|560630072|FG003|Overall Study|Lost to Follow-up|0|||
155325693|NCT05162586|560630073|FG004|Overall Study|Lost to Follow-up|2|||
155325694|NCT05162586|560630074|FG005|Overall Study|Lost to Follow-up|0|||
155325695|NCT05162586|560630075|FG006|Overall Study|Lost to Follow-up|0|||
155325696|NCT05162586|560630076|FG007|Overall Study|Lost to Follow-up|2|||
155325697|NCT05162586|560630069|FG000|Overall Study|Non-Compliance|0|||
155325698|NCT05162586|560630070|FG001|Overall Study|Non-Compliance|1|||
155325699|NCT05162586|560630071|FG002|Overall Study|Non-Compliance|0|||
155325700|NCT05162586|560630072|FG003|Overall Study|Non-Compliance|0|||
155325701|NCT05162586|560630073|FG004|Overall Study|Non-Compliance|1|||
155325702|NCT05162586|560630074|FG005|Overall Study|Non-Compliance|0|||
155325703|NCT05162586|560630075|FG006|Overall Study|Non-Compliance|0|||
155325704|NCT05162586|560630076|FG007|Overall Study|Non-Compliance|1|||
155325705|NCT05162586|560630069|FG000|Overall Study|Withdrawal by Subject|2|||
155325706|NCT05162586|560630070|FG001|Overall Study|Withdrawal by Subject|0|||
155325707|NCT05162586|560630071|FG002|Overall Study|Withdrawal by Subject|0|||
155325708|NCT05162586|560630072|FG003|Overall Study|Withdrawal by Subject|0|||
155325709|NCT05162586|560630073|FG004|Overall Study|Withdrawal by Subject|7|||
155325710|NCT05162586|560630074|FG005|Overall Study|Withdrawal by Subject|6|||
155325711|NCT05162586|560630075|FG006|Overall Study|Withdrawal by Subject|2|||
155325712|NCT05162586|560630076|FG007|Overall Study|Withdrawal by Subject|2|||
155325713|NCT05162586|560630069|FG000|Overall Study|Adverse Event|2|||
155325714|NCT05162586|560630070|FG001|Overall Study|Adverse Event|0|||
155325715|NCT05162586|560630071|FG002|Overall Study|Adverse Event|1|||
155325716|NCT05162586|560630072|FG003|Overall Study|Adverse Event|2|||
155325717|NCT05162586|560630073|FG004|Overall Study|Adverse Event|4|||
155325718|NCT05162586|560630074|FG005|Overall Study|Adverse Event|1|||
155325719|NCT05162586|560630075|FG006|Overall Study|Adverse Event|5|||
155325720|NCT05162586|560630076|FG007|Overall Study|Adverse Event|2|||
155325721|NCT02656706|560630078|FG000|Overall Study|Insurance Denial|1|||
155325722|NCT04675034|560630081|FG000|Overall Study|Lost to Follow-up|1|||
155325723|NCT04675034|560630082|FG001|Overall Study|Lost to Follow-up|1|||
155325724|NCT04675034|560630083|FG002|Overall Study|Lost to Follow-up|0|||
155325725|NCT04675034|560630084|FG003|Overall Study|Lost to Follow-up|2|||
155325726|NCT04675034|560630085|FG004|Overall Study|Lost to Follow-up|0|||
155325727|NCT04675034|560630081|FG000|Overall Study|Protocol Violation|1|||
155325728|NCT04675034|560630082|FG001|Overall Study|Protocol Violation|0|||
155325729|NCT04675034|560630083|FG002|Overall Study|Protocol Violation|0|||
155325730|NCT04675034|560630084|FG003|Overall Study|Protocol Violation|1|||
155325731|NCT04675034|560630085|FG004|Overall Study|Protocol Violation|3|||
155325732|NCT04675034|560630081|FG000|Overall Study|Withdrawal by Subject|9|||
155325733|NCT04675034|560630082|FG001|Overall Study|Withdrawal by Subject|3|||
155325734|NCT04675034|560630083|FG002|Overall Study|Withdrawal by Subject|4|||
155325735|NCT04675034|560630084|FG003|Overall Study|Withdrawal by Subject|8|||
155325736|NCT04675034|560630085|FG004|Overall Study|Withdrawal by Subject|6|||
155325737|NCT03201939|560630086|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
155325738|NCT03201939|560630087|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
155325739|NCT02532621|560630090|FG000|Overall Study|Death|3|||
155325740|NCT02532621|560630090|FG000|Overall Study|Lost to Follow-up|3|||
155325741|NCT02532621|560630090|FG000|Overall Study|Withdrawal by Subject|6|||
155069191|NCT04133909|559682779|FG001|Overall Study|Adverse Event|5|||
155069192|NCT04133909|559682778|FG000|Overall Study|Lost to Follow-up|3|||
155069193|NCT04133909|559682779|FG001|Overall Study|Lost to Follow-up|5|||
155069194|NCT04133909|559682778|FG000|Overall Study|Physician Decision|4|||
155069195|NCT04133909|559682779|FG001|Overall Study|Physician Decision|7|||
155069196|NCT04133909|559682778|FG000|Overall Study|Withdrawal by Subject|40|||
155069197|NCT04133909|559682779|FG001|Overall Study|Withdrawal by Subject|35|||
155069198|NCT04133909|559682778|FG000|Overall Study|Lack of Efficacy|2|||
155069199|NCT04133909|559682779|FG001|Overall Study|Lack of Efficacy|7|||
155069200|NCT04133909|559682778|FG000|Overall Study|Randomized in error|1|||
155069201|NCT04133909|559682779|FG001|Overall Study|Randomized in error|1|||
155069202|NCT05020743|559682780|FG000|Overall Study|Enrollment in Interventional Study|2|||
155069203|NCT05020743|559682781|FG001|Overall Study|Enrollment in Interventional Study|9|||
155069204|NCT05020743|559682782|FG002|Overall Study|Enrollment in Interventional Study|0|||
155069205|NCT05020743|559682780|FG000|Overall Study|Withdrawal by Subject|0|||
155069206|NCT05020743|559682781|FG001|Overall Study|Withdrawal by Subject|3|||
155069207|NCT05020743|559682782|FG002|Overall Study|Withdrawal by Subject|1|||
155069208|NCT05020743|559682780|FG000|Overall Study|Lost to Follow-up|1|||
155069209|NCT05020743|559682781|FG001|Overall Study|Lost to Follow-up|0|||
155069210|NCT05020743|559682782|FG002|Overall Study|Lost to Follow-up|0|||
155069211|NCT05020743|559682780|FG000|Overall Study|Study Termination by Sponsor|10|||
155069212|NCT05020743|559682781|FG001|Overall Study|Study Termination by Sponsor|11|||
155069213|NCT05020743|559682782|FG002|Overall Study|Study Termination by Sponsor|10|||
155069214|NCT03488524|559682783|FG000|Overall Study|Withdrawal by Subject|51|||
155325742|NCT02532621|560630090|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
155325743|NCT02532621|560630090|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
155325744|NCT04281498|560630097|FG000|Overall Study|Progression of disease|1|||
155325745|NCT04281498|560630097|FG000|Overall Study|Planned SCT|1|||
155325746|NCT04281498|560630097|FG000|Overall Study|Alternative Treatment|1|||
155069215|NCT03488524|559682783|FG000|Overall Study|Death|19|||
155069216|NCT03488524|559682783|FG000|Overall Study|Study Sponsor|11|||
155069217|NCT03488524|559682783|FG000|Overall Study|Physician Decision|4|||
155069218|NCT03488524|559682783|FG000|Overall Study|Lost to Follow-up|3|||
155325747|NCT03142009|560630098|FG000|Overall Study|Lost to Follow-up|45|||
155069219|NCT00830765|559682784|FG000|Overall Study|Protocol Violation|3|||
155069220|NCT00830765|559682785|FG001|Overall Study|Protocol Violation|2|||
155069221|NCT02390284|559682786|FG000|Overall Study|Physician Decision|0|||
155069222|NCT02390284|559682787|FG001|Overall Study|Physician Decision|0|||
155069223|NCT02390284|559682788|FG002|Overall Study|Physician Decision|9|||
155325748|NCT03142009|560630099|FG001|Overall Study|Lost to Follow-up|30|||
155325749|NCT03587805|560630100|FG000|Overall Study|Adverse Event|72|||
155325750|NCT03587805|560630100|FG000|Overall Study|Death|1|||
155325751|NCT03587805|560630100|FG000|Overall Study|Lost to Follow-up|78|||
155325752|NCT03587805|560630100|FG000|Overall Study|Withdrawal by Subject|105|||
155325753|NCT03587805|560630100|FG000|Overall Study|Lack of Efficacy|119|||
155325754|NCT03587805|560630100|FG000|Overall Study|Reason unknown|26|||
155325755|NCT03587805|560630100|FG000|Overall Study|COVID_19 pandemic|4|||
155325756|NCT03587805|560630100|FG000|Overall Study|Various reasons|121|||
155325757|NCT03587805|560630100|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155325758|NCT01553149|560630101|FG000|Overall Study|Adverse Event|0|||
155325759|NCT01553149|560630102|FG001|Overall Study|Adverse Event|9|||
155162943|NCT00536744|560031775|FG001|Overall Study|Physician Decision|1|||
155325760|NCT01553149|560630101|FG000|Overall Study|Physician Decision|5|||
155325761|NCT01553149|560630102|FG001|Overall Study|Physician Decision|10|||
155325762|NCT01553149|560630101|FG000|Overall Study|Ineligible|0|||
155325763|NCT01553149|560630102|FG001|Overall Study|Ineligible|1|||
155325764|NCT03008382|560630103|FG000|Overall Study|Withdrawal by Subject|2|||
155325765|NCT03008382|560630104|FG001|Overall Study|Withdrawal by Subject|5|||
155325766|NCT03008382|560630105|FG002|Overall Study|Withdrawal by Subject|2|||
155325767|NCT03008382|560630106|FG003|Overall Study|Withdrawal by Subject|0|||
155325768|NCT03008382|560630103|FG000|Overall Study|Protocol Violation|1|||
155325769|NCT03008382|560630104|FG001|Overall Study|Protocol Violation|0|||
155325770|NCT03008382|560630105|FG002|Overall Study|Protocol Violation|0|||
155325771|NCT03008382|560630106|FG003|Overall Study|Protocol Violation|0|||
155325772|NCT03008382|560630103|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
155325773|NCT03008382|560630104|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
155325774|NCT03008382|560630105|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
155325775|NCT03008382|560630106|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
155325776|NCT03008382|560630103|FG000|Overall Study|Lost to Follow-up|0|||
155325777|NCT03008382|560630104|FG001|Overall Study|Lost to Follow-up|0|||
155325778|NCT03008382|560630105|FG002|Overall Study|Lost to Follow-up|1|||
155325779|NCT03008382|560630106|FG003|Overall Study|Lost to Follow-up|0|||
155325780|NCT03008382|560630103|FG000|Overall Study|Screenfail|0|||
155325781|NCT03008382|560630104|FG001|Overall Study|Screenfail|0|||
155325782|NCT03008382|560630105|FG002|Overall Study|Screenfail|2|||
155325783|NCT03008382|560630106|FG003|Overall Study|Screenfail|0|||
155325784|NCT05267639|560630794|FG000|Overall Study|Withdrawal by Subject|1|||
155325785|NCT05267639|560630795|FG001|Overall Study|Withdrawal by Subject|0|||
155325786|NCT04732871|560630796|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
155325787|NCT04732871|560630797|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
155325788|NCT04732871|560630798|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
155069224|NCT01299909|559682789|FG000|Overall Study|Lost to Follow-up|22|||
155069225|NCT01299909|559682790|FG001|Overall Study|Lost to Follow-up|18|||
155069226|NCT01299909|559682791|FG002|Overall Study|Lost to Follow-up|17|||
155069227|NCT01811238|559682792|FG000|Overall Study|Withdrawal by Subject|42|||
155069228|NCT01811238|559682792|FG000|Overall Study|Adverse Event|25|||
155069229|NCT01811238|559682792|FG000|Overall Study|Protocol Violation|4|||
155162944|NCT00536744|560031774|FG000|Overall Study|Lost to Follow-up|3|||
155162945|NCT00536744|560031775|FG001|Overall Study|Lost to Follow-up|5|||
155325789|NCT04732871|560630796|FG000|Overall Study|Lost to Follow-up|7|||
155325790|NCT04732871|560630797|FG001|Overall Study|Lost to Follow-up|4|||
155325791|NCT04732871|560630798|FG002|Overall Study|Lost to Follow-up|3|||
155325792|NCT04732871|560630796|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
155325793|NCT04732871|560630797|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
155325794|NCT04732871|560630798|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
155325795|NCT04732871|560630796|FG000|Overall Study|Migrated / moved from the study area|5|||
155325796|NCT04732871|560630797|FG001|Overall Study|Migrated / moved from the study area|0|||
155325797|NCT04732871|560630798|FG002|Overall Study|Migrated / moved from the study area|0|||
155325798|NCT04732871|560630796|FG000|Overall Study|Other|1|||
155069230|NCT01811238|559682792|FG000|Overall Study|Lack of Efficacy|4|||
155069231|NCT01811238|559682792|FG000|Overall Study|subject refused study medication|6|||
155069232|NCT01922934|559682796|FG000|Eligible Patients|Death|0|||
155069233|NCT01922934|559682797|FG001|Eligible Patients|Death|7|||
155069234|NCT01922934|559682796|FG000|Eligible Patients|Physician Decision|17|||
155069235|NCT01922934|559682797|FG001|Eligible Patients|Physician Decision|0|||
155069236|NCT01922934|559682796|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
155069237|NCT01922934|559682797|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
155069238|NCT01922934|559682796|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
155069239|NCT01922934|559682797|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
155069240|NCT01922934|559682796|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
155069241|NCT01922934|559682797|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
155069242|NCT01922934|559682796|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
155069243|NCT01922934|559682797|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
155069244|NCT02774889|559682811|FG000|Overall Study|Lost to Follow-up|2|||
155069245|NCT02774889|559682812|FG001|Overall Study|Lost to Follow-up|1|||
155069246|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
155325799|NCT04732871|560630797|FG001|Overall Study|Other|0|||
155325800|NCT04732871|560630798|FG002|Overall Study|Other|1|||
155325801|NCT04732871|560630796|FG000|Overall Study|Ongoing|6|||
155325802|NCT04732871|560630797|FG001|Overall Study|Ongoing|0|||
155325803|NCT04732871|560630798|FG002|Overall Study|Ongoing|1|||
155325804|NCT04732871|560630796|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
155325805|NCT04732871|560630797|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
155325806|NCT04732871|560630798|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
155325807|NCT05180539|560630808|FG000|Overall Study|Lost to Follow-up|27|||
155325808|NCT05180539|560630809|FG001|Overall Study|Lost to Follow-up|30|||
155325809|NCT00968149|560630813|FG000|Overall Study|Adverse Event|5|||
155325810|NCT00968149|560630814|FG001|Overall Study|Adverse Event|1|||
155325811|NCT00968149|560630813|FG000|Overall Study|Lack of Efficacy|0|||
155325812|NCT00968149|560630814|FG001|Overall Study|Lack of Efficacy|4|||
155325813|NCT00968149|560630813|FG000|Overall Study|Lost to Follow-up|0|||
155325814|NCT00968149|560630814|FG001|Overall Study|Lost to Follow-up|1|||
155069247|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
155069248|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
155325815|NCT00968149|560630813|FG000|Overall Study|Protocol Violation|4|||
155325816|NCT00968149|560630814|FG001|Overall Study|Protocol Violation|0|||
155325817|NCT00968149|560630813|FG000|Overall Study|Withdrawal by Subject|2|||
155325818|NCT00968149|560630814|FG001|Overall Study|Withdrawal by Subject|0|||
155325819|NCT00447980|560630815|FG000|Overall Study|Withdrawal by Subject|1|||
155325820|NCT00447980|560630816|FG001|Overall Study|Withdrawal by Subject|1|||
155325821|NCT00447980|560630817|FG002|Overall Study|Withdrawal by Subject|4|||
155325822|NCT00447980|560630818|FG003|Overall Study|Withdrawal by Subject|4|||
155325823|NCT00447980|560630815|FG000|Overall Study|Lost to Follow-up|1|||
155325824|NCT00447980|560630816|FG001|Overall Study|Lost to Follow-up|1|||
155325825|NCT00447980|560630817|FG002|Overall Study|Lost to Follow-up|0|||
155325826|NCT00447980|560630818|FG003|Overall Study|Lost to Follow-up|0|||
155325827|NCT00447980|560630815|FG000|Overall Study|Did not proceed with surgery|3|||
155325828|NCT00447980|560630816|FG001|Overall Study|Did not proceed with surgery|3|||
155325829|NCT00447980|560630817|FG002|Overall Study|Did not proceed with surgery|2|||
155325830|NCT00447980|560630818|FG003|Overall Study|Did not proceed with surgery|2|||
155325831|NCT02467270|560630819|FG000|Overall Study|Participants Never Treated|0|||
155325832|NCT02467270|560630820|FG001|Overall Study|Participants Never Treated|1|||
155325833|NCT02467270|560630821|FG002|Overall Study|Participants Never Treated|0|||
155325834|NCT02467270|560630819|FG000|Overall Study|Ongoing|50|||
155325835|NCT02467270|560630820|FG001|Overall Study|Ongoing|41|||
155325836|NCT02467270|560630821|FG002|Overall Study|Ongoing|43|||
155325837|NCT02467270|560630819|FG000|Overall Study|Adverse Event|16|||
155069249|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
155069250|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
155069251|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
155069252|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
155069253|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
155069254|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
155069255|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
155325838|NCT02467270|560630820|FG001|Overall Study|Adverse Event|15|||
155325839|NCT02467270|560630821|FG002|Overall Study|Adverse Event|14|||
155325840|NCT02467270|560630819|FG000|Overall Study|Progressive Disease|7|||
155325841|NCT02467270|560630820|FG001|Overall Study|Progressive Disease|7|||
155325842|NCT02467270|560630821|FG002|Overall Study|Progressive Disease|4|||
155325843|NCT02467270|560630819|FG000|Overall Study|Death|2|||
155325844|NCT02467270|560630820|FG001|Overall Study|Death|0|||
155325845|NCT02467270|560630821|FG002|Overall Study|Death|2|||
155325846|NCT02467270|560630819|FG000|Overall Study|Lack of Efficacy|12|||
155325847|NCT02467270|560630820|FG001|Overall Study|Lack of Efficacy|18|||
155325848|NCT02467270|560630821|FG002|Overall Study|Lack of Efficacy|23|||
155325849|NCT02467270|560630819|FG000|Overall Study|Non-compliance With Study Drug|0|||
155325850|NCT02467270|560630820|FG001|Overall Study|Non-compliance With Study Drug|2|||
155325851|NCT02467270|560630821|FG002|Overall Study|Non-compliance With Study Drug|1|||
155325852|NCT02467270|560630819|FG000|Overall Study|Lost to Follow-up|2|||
155325853|NCT02467270|560630820|FG001|Overall Study|Lost to Follow-up|1|||
155325854|NCT02467270|560630821|FG002|Overall Study|Lost to Follow-up|0|||
155325855|NCT02467270|560630819|FG000|Overall Study|Pregnancy|0|||
155325856|NCT02467270|560630820|FG001|Overall Study|Pregnancy|1|||
155325857|NCT02467270|560630821|FG002|Overall Study|Pregnancy|0|||
155325858|NCT02467270|560630819|FG000|Overall Study|Physician Decision|0|||
155325859|NCT02467270|560630820|FG001|Overall Study|Physician Decision|4|||
155325860|NCT02467270|560630821|FG002|Overall Study|Physician Decision|1|||
155325861|NCT02467270|560630819|FG000|Overall Study|Withdrawal by Subject|4|||
155325862|NCT02467270|560630820|FG001|Overall Study|Withdrawal by Subject|3|||
155325863|NCT02467270|560630821|FG002|Overall Study|Withdrawal by Subject|5|||
155325864|NCT02467270|560630819|FG000|Overall Study|Reason not Specified|1|||
155325865|NCT02467270|560630820|FG001|Overall Study|Reason not Specified|2|||
155325866|NCT02467270|560630821|FG002|Overall Study|Reason not Specified|1|||
155325867|NCT06408870|560630822|FG000|Washout period|Withdrawal by Subject|1|||
155325868|NCT06408870|560630823|FG001|Washout period|Withdrawal by Subject|0|||
155325869|NCT06408870|560630822|FG000|Washout period|Adverse Event|2|||
155325870|NCT06408870|560630823|FG001|Washout period|Adverse Event|0|||
155325871|NCT00495677|560630824|FG000|Stage 1 (25 Days)|Adverse Event|0|||
155325872|NCT00495677|560630825|FG001|Stage 1 (25 Days)|Adverse Event|0|||
155325873|NCT00495677|560630826|FG002|Stage 1 (25 Days)|Adverse Event|1|||
155325874|NCT00495677|560630827|FG003|Stage 1 (25 Days)|Adverse Event|0|||
155325875|NCT00495677|560630828|FG004|Stage 1 (25 Days)|Adverse Event|0|||
155325876|NCT00495677|560630829|FG005|Stage 1 (25 Days)|Adverse Event|0|||
155325877|NCT00495677|560630830|FG006|Stage 1 (25 Days)|Adverse Event|0|||
155325878|NCT02567435|560630834|FG000|Overall Study|Death|1|||
155325879|NCT02567435|560630835|FG001|Overall Study|Death|1|||
155325880|NCT02567435|560630836|FG002|Overall Study|Death|0|||
155325881|NCT02567435|560630837|FG003|Overall Study|Death|0|||
155325882|NCT02567435|560630834|FG000|Overall Study|Ineligible|1|||
155325883|NCT02567435|560630835|FG001|Overall Study|Ineligible|3|||
155325884|NCT02567435|560630836|FG002|Overall Study|Ineligible|0|||
155325885|NCT02567435|560630837|FG003|Overall Study|Ineligible|0|||
155325886|NCT02567435|560630834|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
155325887|NCT02567435|560630835|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
155325888|NCT02567435|560630836|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
155325889|NCT02567435|560630837|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
155325890|NCT05771467|560630838|FG000|Overall Study|Lost to Follow-up|6|||
155325891|NCT05771467|560630839|FG001|Overall Study|Lost to Follow-up|3|||
155325892|NCT01220531|560630842|FG000|Overall Study|Death|7|||
155325893|NCT01220531|560630842|FG000|Overall Study|Lost to Follow-up|1|||
155325894|NCT05866926|560630846|FG000|Overall Study|Death|16|||
155325895|NCT05866926|560630847|FG001|Overall Study|Death|9|||
155325896|NCT05866926|560630846|FG000|Overall Study|Lost to Follow-up|0|||
155325897|NCT05866926|560630847|FG001|Overall Study|Lost to Follow-up|1|||
155325898|NCT05866926|560630846|FG000|Overall Study|Adverse Event|1|||
155325899|NCT05866926|560630847|FG001|Overall Study|Adverse Event|0|||
155325900|NCT05866926|560630846|FG000|Overall Study|Withdrawal by Subject|5|||
155325901|NCT05866926|560630847|FG001|Overall Study|Withdrawal by Subject|1|||
154961347|NCT03032172|559283919|FG000|Treatment Period|Lack of Efficacy|0|||
154961348|NCT03032172|559283920|FG001|Treatment Period|Lack of Efficacy|1|||
154961349|NCT03032172|559283921|FG002|Treatment Period|Lack of Efficacy|0|||
154961350|NCT03032172|559283922|FG003|Treatment Period|Lack of Efficacy|0|||
154961351|NCT03032172|559283923|FG004|Treatment Period|Lack of Efficacy|0|||
154961352|NCT03032172|559283924|FG005|Treatment Period|Lack of Efficacy|0|||
154961353|NCT03032172|559283925|FG006|Treatment Period|Lack of Efficacy|0|||
154961354|NCT03032172|559283926|FG007|Treatment Period|Lack of Efficacy|0|||
154961355|NCT03032172|559283919|FG000|Treatment Period|Non-compliance With Study Drug|0|||
154961356|NCT03032172|559283920|FG001|Treatment Period|Non-compliance With Study Drug|1|||
154961357|NCT03032172|559283921|FG002|Treatment Period|Non-compliance With Study Drug|0|||
154961358|NCT03032172|559283922|FG003|Treatment Period|Non-compliance With Study Drug|0|||
154961359|NCT03032172|559283923|FG004|Treatment Period|Non-compliance With Study Drug|0|||
155325902|NCT05866926|560630846|FG000|Overall Study|Disease progression|1|||
155325903|NCT05866926|560630847|FG001|Overall Study|Disease progression|0|||
155325904|NCT05866926|560630846|FG000|Overall Study|other causes|2|||
155325905|NCT05866926|560630847|FG001|Overall Study|other causes|1|||
155325906|NCT00709956|560630848|FG000|Overall Study|Withdrawal by Subject|1|||
155325907|NCT00709956|560630849|FG001|Overall Study|Withdrawal by Subject|1|||
155325908|NCT00709956|560630848|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
155325909|NCT00709956|560630849|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
155325910|NCT01105091|560630850|FG000|Overall Study|Death|2|||
155325911|NCT01105091|560630851|FG001|Overall Study|Death|0|||
155325912|NCT02206828|560630854|FG000|Overall Study|Lost to Follow-up|7|||
155325913|NCT04039113|560630859|FG000|Overall Study|Withdrawal by Subject|8|||
155325914|NCT04039113|560630860|FG001|Overall Study|Withdrawal by Subject|11|||
155325915|NCT04039113|560630859|FG000|Overall Study|Lost to Follow-up|1|||
155325916|NCT04039113|560630860|FG001|Overall Study|Lost to Follow-up|1|||
155325917|NCT04039113|560630859|FG000|Overall Study|Adverse Event|2|||
155325918|NCT04039113|560630860|FG001|Overall Study|Adverse Event|2|||
155325919|NCT04039113|560630859|FG000|Overall Study|Death|2|||
155325920|NCT04039113|560630860|FG001|Overall Study|Death|4|||
155325921|NCT04039113|560630859|FG000|Overall Study|Site Closure|6|||
155325922|NCT04039113|560630860|FG001|Overall Study|Site Closure|0|||
155325923|NCT04039113|560630859|FG000|Overall Study|Failure to meet randomisation criteria|4|||
155069256|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
155325924|NCT04039113|560630860|FG001|Overall Study|Failure to meet randomisation criteria|0|||
155325925|NCT00353496|560630861|FG000|Overall Study|Adverse Event|1|||
155325926|NCT00353496|560630862|FG001|Overall Study|Adverse Event|0|||
155325927|NCT00353496|560630861|FG000|Overall Study|Protocol Violation|2|||
155325928|NCT00353496|560630862|FG001|Overall Study|Protocol Violation|2|||
155325929|NCT00353496|560630861|FG000|Overall Study|Withdrawal by Subject|3|||
155325930|NCT00353496|560630862|FG001|Overall Study|Withdrawal by Subject|4|||
155325931|NCT00353496|560630861|FG000|Overall Study|Physician Decision|6|||
155325932|NCT00353496|560630862|FG001|Overall Study|Physician Decision|9|||
155325933|NCT00353496|560630861|FG000|Overall Study|Not otherwise specified|4|||
155325934|NCT00353496|560630862|FG001|Overall Study|Not otherwise specified|2|||
154961360|NCT03032172|559283924|FG005|Treatment Period|Non-compliance With Study Drug|0|||
155069257|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
155069258|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
155162946|NCT00536744|560031774|FG000|Overall Study|Withdrawal by Subject|7|||
155162947|NCT00536744|560031775|FG001|Overall Study|Withdrawal by Subject|8|||
155162948|NCT00536744|560031774|FG000|Overall Study|PI tried alternative treatment|1|||
155162949|NCT00536744|560031775|FG001|Overall Study|PI tried alternative treatment|3|||
155162950|NCT02581410|560031776|FG000|Vaccination Phase|Adverse Event|2|||
155162951|NCT02581410|560031777|FG001|Vaccination Phase|Adverse Event|1|||
155162952|NCT02581410|560031776|FG000|Vaccination Phase|Withdrawal by Subject|0|||
155162953|NCT02581410|560031777|FG001|Vaccination Phase|Withdrawal by Subject|1|||
155162954|NCT02581410|560031776|FG000|Vaccination Phase|Migrated/moved from study area|0|||
155162955|NCT02581410|560031777|FG001|Vaccination Phase|Migrated/moved from study area|1|||
155162956|NCT02581410|560031776|FG000|End of Study Phase|Adverse Event|4|||
155162957|NCT02581410|560031777|FG001|End of Study Phase|Adverse Event|3|||
155162958|NCT02581410|560031776|FG000|End of Study Phase|Withdrawal by Subject|1|||
155162959|NCT02581410|560031777|FG001|End of Study Phase|Withdrawal by Subject|2|||
155069259|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
155069260|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
155069261|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
155069262|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
155069263|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
155069264|NCT01069939|559682813|FG000|Randomised and Included in the Analyses|Removal|1|||
155069265|NCT01069939|559682814|FG001|Randomised and Included in the Analyses|Removal|0|||
155069266|NCT00658528|559682815|FG000|Overall Study|Adverse Event|5|||
155069267|NCT00658528|559682816|FG001|Overall Study|Adverse Event|7|||
155069268|NCT00658528|559682815|FG000|Overall Study|Lost to Follow-up|14|||
155069269|NCT00658528|559682816|FG001|Overall Study|Lost to Follow-up|22|||
155069270|NCT00658528|559682815|FG000|Overall Study|Withdrawal by Subject|8|||
155069271|NCT00658528|559682816|FG001|Overall Study|Withdrawal by Subject|6|||
155069272|NCT00658528|559682815|FG000|Overall Study|Withdrawal of consent|5|||
155069273|NCT00658528|559682816|FG001|Overall Study|Withdrawal of consent|6|||
155069274|NCT00658528|559682815|FG000|Overall Study|Other|8|||
155069275|NCT00658528|559682816|FG001|Overall Study|Other|4|||
155162960|NCT02581410|560031776|FG000|End of Study Phase|Migrated/moved from study area|0|||
155162961|NCT02581410|560031777|FG001|End of Study Phase|Migrated/moved from study area|3|||
155162962|NCT02581410|560031776|FG000|End of Study Phase|Lost to Follow-up|0|||
155162963|NCT02581410|560031777|FG001|End of Study Phase|Lost to Follow-up|2|||
155162964|NCT02581410|560031776|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
155325935|NCT00945724|560630863|FG000|Overall Study|Withdrawal by Subject|2|||
154961361|NCT03032172|559283925|FG006|Treatment Period|Non-compliance With Study Drug|0|||
154961362|NCT03032172|559283926|FG007|Treatment Period|Non-compliance With Study Drug|0|||
154961363|NCT03032172|559283919|FG000|Treatment Period|Reason Not Specified|0|||
154961364|NCT03032172|559283920|FG001|Treatment Period|Reason Not Specified|4|||
154961365|NCT03032172|559283921|FG002|Treatment Period|Reason Not Specified|1|||
154961366|NCT03032172|559283922|FG003|Treatment Period|Reason Not Specified|0|||
154961367|NCT03032172|559283923|FG004|Treatment Period|Reason Not Specified|0|||
154961368|NCT03032172|559283924|FG005|Treatment Period|Reason Not Specified|0|||
155162965|NCT02581410|560031777|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
155325936|NCT00945724|560630863|FG000|Overall Study|Physician Decision|1|||
155325937|NCT00945724|560630863|FG000|Overall Study|Adverse Event|5|||
155162966|NCT00670748|560031779|FG000|Overall Study|Death during treatment|1|||
155162967|NCT00670748|560031780|FG001|Overall Study|Death during treatment|1|||
155162968|NCT00670748|560031781|FG002|Overall Study|Death during treatment|1|||
155162969|NCT00670748|560031782|FG003|Overall Study|Death during treatment|0|||
155162970|NCT00670748|560031779|FG000|Overall Study|Not off study|2|||
155162971|NCT00670748|560031780|FG001|Overall Study|Not off study|1|||
155162972|NCT00670748|560031781|FG002|Overall Study|Not off study|1|||
155162973|NCT00670748|560031782|FG003|Overall Study|Not off study|1|||
155162974|NCT02876601|560031783|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
155162975|NCT02876601|560031784|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
155162976|NCT02876601|560031785|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
155162977|NCT02876601|560031786|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
155162978|NCT03863080|560031787|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
155162979|NCT03863080|560031788|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
155162980|NCT03863080|560031789|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
155162981|NCT03863080|560031790|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
155162982|NCT03863080|560031787|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
155162983|NCT03863080|560031788|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
155162984|NCT03863080|560031789|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
155162985|NCT03863080|560031790|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
155162986|NCT03863080|560031787|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
155162987|NCT03863080|560031788|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
155162988|NCT03863080|560031789|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
155162989|NCT03863080|560031790|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
155162990|NCT02000115|560031799|FG000|Overall Study|Death|56|||
155162991|NCT02000115|560031800|FG001|Overall Study|Death|45|||
155162992|NCT02000115|560031801|FG002|Overall Study|Death|0|||
155162993|NCT02000115|560031802|FG003|Overall Study|Death|0|||
155162994|NCT02000115|560031799|FG000|Overall Study|Missed Visit|6|||
155162995|NCT02000115|560031800|FG001|Overall Study|Missed Visit|8|||
155162996|NCT02000115|560031801|FG002|Overall Study|Missed Visit|1|||
155162997|NCT02000115|560031802|FG003|Overall Study|Missed Visit|0|||
155162998|NCT02000115|560031799|FG000|Overall Study|Protocol Violation|2|||
155162999|NCT02000115|560031800|FG001|Overall Study|Protocol Violation|1|||
155163000|NCT02000115|560031801|FG002|Overall Study|Protocol Violation|0|||
155163001|NCT02000115|560031802|FG003|Overall Study|Protocol Violation|0|||
155163002|NCT02000115|560031799|FG000|Overall Study|Physician Decision|2|||
155163003|NCT02000115|560031800|FG001|Overall Study|Physician Decision|0|||
155163004|NCT02000115|560031801|FG002|Overall Study|Physician Decision|0|||
155163005|NCT02000115|560031802|FG003|Overall Study|Physician Decision|0|||
155163006|NCT02000115|560031799|FG000|Overall Study|Withdrawal by Subject|11|||
155163007|NCT02000115|560031800|FG001|Overall Study|Withdrawal by Subject|11|||
155163008|NCT02000115|560031801|FG002|Overall Study|Withdrawal by Subject|0|||
155163009|NCT02000115|560031802|FG003|Overall Study|Withdrawal by Subject|0|||
155163010|NCT02000115|560031799|FG000|Overall Study|Lost to Follow-up|0|||
155163011|NCT02000115|560031800|FG001|Overall Study|Lost to Follow-up|1|||
155163012|NCT02000115|560031801|FG002|Overall Study|Lost to Follow-up|0|||
155163013|NCT02000115|560031802|FG003|Overall Study|Lost to Follow-up|0|||
155163014|NCT02000115|560031799|FG000|Overall Study|Non-compliance|2|||
155163015|NCT02000115|560031800|FG001|Overall Study|Non-compliance|1|||
155163016|NCT02000115|560031801|FG002|Overall Study|Non-compliance|0|||
155163017|NCT02000115|560031802|FG003|Overall Study|Non-compliance|0|||
155163018|NCT02000115|560031799|FG000|Overall Study|Withdrawn on day of randomization|0|||
155163019|NCT02000115|560031800|FG001|Overall Study|Withdrawn on day of randomization|1|||
155163020|NCT02000115|560031801|FG002|Overall Study|Withdrawn on day of randomization|0|||
155163021|NCT02000115|560031802|FG003|Overall Study|Withdrawn on day of randomization|0|||
155163022|NCT02000115|560031799|FG000|Overall Study|Still on Study|0|||
155163023|NCT02000115|560031800|FG001|Overall Study|Still on Study|0|||
155163024|NCT02000115|560031801|FG002|Overall Study|Still on Study|0|||
155163025|NCT02000115|560031802|FG003|Overall Study|Still on Study|53|||
155163026|NCT02484391|560031805|FG000|Overall Study|Lack of Efficacy|15|||
155163027|NCT02484391|560031806|FG001|Overall Study|Lack of Efficacy|14|||
155163028|NCT02484391|560031807|FG002|Overall Study|Lack of Efficacy|3|||
155163029|NCT02484391|560031805|FG000|Overall Study|Lost to Follow-up|0|||
155163030|NCT02484391|560031806|FG001|Overall Study|Lost to Follow-up|0|||
155163031|NCT02484391|560031807|FG002|Overall Study|Lost to Follow-up|2|||
155163032|NCT02484391|560031805|FG000|Overall Study|Physician Decision|1|||
155163033|NCT02484391|560031806|FG001|Overall Study|Physician Decision|3|||
155163034|NCT02484391|560031807|FG002|Overall Study|Physician Decision|0|||
155163035|NCT02484391|560031805|FG000|Overall Study|Went to Transplant|5|||
155163036|NCT02484391|560031806|FG001|Overall Study|Went to Transplant|3|||
155163037|NCT02484391|560031807|FG002|Overall Study|Went to Transplant|2|||
155163038|NCT02605122|560033150|FG000|Overall Study|Withdrawal by Subject|4|||
155163039|NCT02605122|560033151|FG001|Overall Study|Withdrawal by Subject|1|||
155163040|NCT02605122|560033150|FG000|Overall Study|Lost to Follow-up|1|||
155163041|NCT02605122|560033151|FG001|Overall Study|Lost to Follow-up|1|||
155069276|NCT01147458|559682817|FG000|First Intervention|Study terminated by sponsor|8|||
155069277|NCT01147458|559682818|FG001|First Intervention|Study terminated by sponsor|8|||
155069278|NCT01147458|559682819|FG002|First Intervention|Study terminated by sponsor|7|||
155069279|NCT01147458|559682820|FG003|First Intervention|Study terminated by sponsor|8|||
155069280|NCT01147458|559682817|FG000|First Intervention|Protocol Violation|2|||
155069281|NCT01147458|559682818|FG001|First Intervention|Protocol Violation|3|||
155069282|NCT01147458|559682819|FG002|First Intervention|Protocol Violation|2|||
155069283|NCT01147458|559682820|FG003|First Intervention|Protocol Violation|3|||
155069284|NCT01147458|559682817|FG000|First Intervention|Withdrawal by Subject|3|||
155069285|NCT01147458|559682818|FG001|First Intervention|Withdrawal by Subject|0|||
155069286|NCT01147458|559682819|FG002|First Intervention|Withdrawal by Subject|1|||
155069287|NCT01147458|559682820|FG003|First Intervention|Withdrawal by Subject|0|||
155069288|NCT01147458|559682817|FG000|First Intervention|Adverse Event|0|||
155069289|NCT01147458|559682818|FG001|First Intervention|Adverse Event|3|||
155069290|NCT01147458|559682819|FG002|First Intervention|Adverse Event|2|||
155069291|NCT01147458|559682820|FG003|First Intervention|Adverse Event|3|||
155069292|NCT01147458|559682817|FG000|First Intervention|Other|1|||
155069293|NCT01147458|559682818|FG001|First Intervention|Other|2|||
155069294|NCT01147458|559682819|FG002|First Intervention|Other|0|||
155069295|NCT01147458|559682820|FG003|First Intervention|Other|0|||
155069296|NCT01147458|559682817|FG000|Second Intervention|Study terminated by sponsor|7|||
155069297|NCT01147458|559682818|FG001|Second Intervention|Study terminated by sponsor|5|||
155069298|NCT01147458|559682819|FG002|Second Intervention|Study terminated by sponsor|5|||
155069299|NCT01147458|559682820|FG003|Second Intervention|Study terminated by sponsor|3|||
155069300|NCT01147458|559682817|FG000|Second Intervention|Protocol Violation|0|||
155069301|NCT01147458|559682818|FG001|Second Intervention|Protocol Violation|1|||
155069302|NCT01147458|559682819|FG002|Second Intervention|Protocol Violation|1|||
155069303|NCT01147458|559682820|FG003|Second Intervention|Protocol Violation|0|||
155069304|NCT01147458|559682817|FG000|Second Intervention|Withdrawal by Subject|0|||
155069305|NCT01147458|559682818|FG001|Second Intervention|Withdrawal by Subject|1|||
155069306|NCT01147458|559682819|FG002|Second Intervention|Withdrawal by Subject|0|||
155069307|NCT01147458|559682820|FG003|Second Intervention|Withdrawal by Subject|0|||
155069308|NCT01147458|559682817|FG000|Second Intervention|Adverse Event|2|||
155069309|NCT01147458|559682818|FG001|Second Intervention|Adverse Event|0|||
155069310|NCT01147458|559682819|FG002|Second Intervention|Adverse Event|1|||
155069311|NCT01147458|559682820|FG003|Second Intervention|Adverse Event|1|||
155069312|NCT01147458|559682817|FG000|Second Intervention|Other|0|||
155069313|NCT01147458|559682818|FG001|Second Intervention|Other|0|||
155069314|NCT01147458|559682819|FG002|Second Intervention|Other|1|||
155069315|NCT01147458|559682820|FG003|Second Intervention|Other|0|||
155069316|NCT02811159|559682825|FG000|Treatment Course 1|Lost to Follow-up|1|||
155069317|NCT05759338|559682827|FG000|Overall Study|Withdrawal by Subject|3|||
155069318|NCT04409002|559682828|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
155069319|NCT02328014|559683960|FG000|Overall Study|Adverse Event|1|||
155069320|NCT02328014|559683961|FG001|Overall Study|Adverse Event|0|||
155069321|NCT02328014|559683962|FG002|Overall Study|Adverse Event|0|||
155069322|NCT02328014|559683963|FG003|Overall Study|Adverse Event|1|||
155069323|NCT02328014|559683960|FG000|Overall Study|Death|0|||
155069324|NCT02328014|559683961|FG001|Overall Study|Death|0|||
155069325|NCT02328014|559683962|FG002|Overall Study|Death|0|||
155069326|NCT02328014|559683963|FG003|Overall Study|Death|4|||
155069327|NCT02328014|559683960|FG000|Overall Study|Physician Decision|0|||
155069328|NCT02328014|559683961|FG001|Overall Study|Physician Decision|0|||
155069329|NCT02328014|559683962|FG002|Overall Study|Physician Decision|0|||
155069330|NCT02328014|559683963|FG003|Overall Study|Physician Decision|1|||
155069331|NCT02328014|559683960|FG000|Overall Study|Disease Progression|1|||
155069332|NCT02328014|559683961|FG001|Overall Study|Disease Progression|0|||
155069333|NCT02328014|559683962|FG002|Overall Study|Disease Progression|1|||
155069334|NCT02328014|559683963|FG003|Overall Study|Disease Progression|3|||
155069335|NCT02328014|559683960|FG000|Overall Study|Study Terminated by Sponsor|4|||
155069336|NCT02328014|559683961|FG001|Overall Study|Study Terminated by Sponsor|1|||
155069337|NCT02328014|559683962|FG002|Overall Study|Study Terminated by Sponsor|1|||
155069338|NCT02328014|559683963|FG003|Overall Study|Study Terminated by Sponsor|0|||
155069339|NCT02328014|559683960|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
155069340|NCT02328014|559683961|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
155069341|NCT02328014|559683962|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
155069342|NCT02328014|559683963|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
155069343|NCT02328014|559683960|FG000|Overall Study|Withdrawal by Subject|0|||
155069344|NCT02328014|559683961|FG001|Overall Study|Withdrawal by Subject|0|||
155069345|NCT02328014|559683962|FG002|Overall Study|Withdrawal by Subject|0|||
155069346|NCT02328014|559683963|FG003|Overall Study|Withdrawal by Subject|1|||
155069347|NCT00177671|559683966|FG000|Overall Study|Withdrawal by Subject|5|||
155069348|NCT00177671|559683967|FG001|Overall Study|Withdrawal by Subject|6|||
155069349|NCT00177671|559683966|FG000|Overall Study|medical complications|2|||
155069350|NCT00177671|559683967|FG001|Overall Study|medical complications|0|||
155069351|NCT00177671|559683966|FG000|Overall Study|Adverse Event|6|||
155069352|NCT00177671|559683967|FG001|Overall Study|Adverse Event|0|||
155069353|NCT00177671|559683966|FG000|Overall Study|Physician Decision|12|||
155069354|NCT00177671|559683967|FG001|Overall Study|Physician Decision|8|||
155069355|NCT05522751|559683974|FG000|Overall Study|Adverse Event|1|||
155069356|NCT04092777|559683981|FG000|Overall Study|Lost to Follow-up|28|||
155069357|NCT04092777|559683982|FG001|Overall Study|Lost to Follow-up|46|||
155069358|NCT04092777|559683981|FG000|Overall Study|Withdrawal by Subject|8|||
155069359|NCT04092777|559683982|FG001|Overall Study|Withdrawal by Subject|5|||
155069360|NCT03765073|559683983|FG000|Stage 1|Lost to Follow-up|1|||
155069361|NCT03765073|559683984|FG001|Stage 1|Lost to Follow-up|0|||
155069362|NCT03765073|559683985|FG002|Stage 1|Lost to Follow-up|0|||
155069363|NCT03765073|559683986|FG003|Stage 1|Lost to Follow-up|0|||
155069364|NCT03765073|559683987|FG004|Stage 1|Lost to Follow-up|0|||
155069365|NCT03765073|559683988|FG005|Stage 1|Lost to Follow-up|0|||
155069366|NCT03765073|559683989|FG006|Stage 1|Lost to Follow-up|0|||
155069367|NCT03765073|559683990|FG007|Stage 1|Lost to Follow-up|0|||
155069368|NCT03765073|559683991|FG008|Stage 1|Lost to Follow-up|0|||
155069369|NCT03765073|559683992|FG009|Stage 1|Lost to Follow-up|0|||
155069370|NCT03765073|559683993|FG010|Stage 1|Lost to Follow-up|0|||
155069371|NCT03765073|559683994|FG011|Stage 1|Lost to Follow-up|0|||
155069372|NCT03765073|559683995|FG012|Stage 1|Lost to Follow-up|0|||
155069373|NCT03765073|559683996|FG013|Stage 1|Lost to Follow-up|0|||
155069374|NCT03765073|559683997|FG014|Stage 1|Lost to Follow-up|0|||
155069375|NCT03765073|559683998|FG015|Stage 1|Lost to Follow-up|0|||
155069376|NCT03765073|559683999|FG016|Stage 1|Lost to Follow-up|0|||
155069377|NCT03765073|559684000|FG017|Stage 1|Lost to Follow-up|0|||
155069378|NCT03765073|559684001|FG018|Stage 1|Lost to Follow-up|0|||
155069379|NCT03765073|559684002|FG019|Stage 1|Lost to Follow-up|0|||
155069380|NCT03765073|559684003|FG020|Stage 1|Lost to Follow-up|0|||
155069381|NCT03765073|559683983|FG000|Stage 1|Withdrawal by participant|0|||
155069382|NCT03765073|559683984|FG001|Stage 1|Withdrawal by participant|1|||
155069383|NCT03765073|559683985|FG002|Stage 1|Withdrawal by participant|0|||
155069384|NCT03765073|559683986|FG003|Stage 1|Withdrawal by participant|0|||
155069385|NCT03765073|559683987|FG004|Stage 1|Withdrawal by participant|0|||
155069386|NCT03765073|559683988|FG005|Stage 1|Withdrawal by participant|0|||
155069387|NCT03765073|559683989|FG006|Stage 1|Withdrawal by participant|0|||
155069388|NCT03765073|559683990|FG007|Stage 1|Withdrawal by participant|0|||
155069389|NCT03765073|559683991|FG008|Stage 1|Withdrawal by participant|0|||
155069390|NCT03765073|559683992|FG009|Stage 1|Withdrawal by participant|0|||
155069391|NCT03765073|559683993|FG010|Stage 1|Withdrawal by participant|0|||
155069392|NCT03765073|559683994|FG011|Stage 1|Withdrawal by participant|0|||
155069393|NCT03765073|559683995|FG012|Stage 1|Withdrawal by participant|0|||
155069394|NCT03765073|559683996|FG013|Stage 1|Withdrawal by participant|0|||
155069395|NCT03765073|559683997|FG014|Stage 1|Withdrawal by participant|0|||
155069396|NCT03765073|559683998|FG015|Stage 1|Withdrawal by participant|0|||
155069397|NCT03765073|559683999|FG016|Stage 1|Withdrawal by participant|0|||
155069398|NCT03765073|559684000|FG017|Stage 1|Withdrawal by participant|0|||
155069399|NCT03765073|559684001|FG018|Stage 1|Withdrawal by participant|0|||
155069400|NCT03765073|559684002|FG019|Stage 1|Withdrawal by participant|0|||
155069401|NCT03765073|559684003|FG020|Stage 1|Withdrawal by participant|0|||
155069402|NCT03765073|559683983|FG000|Stage 2|Death|0|||
155069403|NCT03765073|559683984|FG001|Stage 2|Death|0|||
155069404|NCT03765073|559683985|FG002|Stage 2|Death|0|||
155069405|NCT03765073|559683986|FG003|Stage 2|Death|0|||
155069406|NCT03765073|559683987|FG004|Stage 2|Death|0|||
155069407|NCT03765073|559683988|FG005|Stage 2|Death|0|||
155069408|NCT03765073|559683989|FG006|Stage 2|Death|0|||
155069409|NCT03765073|559683990|FG007|Stage 2|Death|0|||
155069410|NCT03765073|559683991|FG008|Stage 2|Death|0|||
155069411|NCT03765073|559683992|FG009|Stage 2|Death|1|||
155069412|NCT03765073|559683993|FG010|Stage 2|Death|0|||
155325938|NCT00945724|560630863|FG000|Overall Study|Second malignancy|1|||
155325939|NCT02502266|560631485|FG000|Overall Study|Adverse Event|0|||
155069413|NCT03765073|559683994|FG011|Stage 2|Death|1|||
155069414|NCT03765073|559683995|FG012|Stage 2|Death|0|||
155069415|NCT03765073|559683996|FG013|Stage 2|Death|0|||
155069416|NCT03765073|559683997|FG014|Stage 2|Death|0|||
155069417|NCT03765073|559683998|FG015|Stage 2|Death|0|||
155069418|NCT03765073|559683999|FG016|Stage 2|Death|2|||
155069419|NCT03765073|559684000|FG017|Stage 2|Death|0|||
155069420|NCT03765073|559684001|FG018|Stage 2|Death|0|||
155069421|NCT03765073|559684002|FG019|Stage 2|Death|0|||
155069422|NCT03765073|559684003|FG020|Stage 2|Death|0|||
155069423|NCT03765073|559683983|FG000|Stage 2|Lost to Follow-up|0|||
155325940|NCT02502266|560631486|FG001|Overall Study|Adverse Event|0|||
155069424|NCT03765073|559683984|FG001|Stage 2|Lost to Follow-up|0|||
155069425|NCT03765073|559683985|FG002|Stage 2|Lost to Follow-up|0|||
155069426|NCT03765073|559683986|FG003|Stage 2|Lost to Follow-up|5|||
155069427|NCT03765073|559683987|FG004|Stage 2|Lost to Follow-up|1|||
155069428|NCT03765073|559683988|FG005|Stage 2|Lost to Follow-up|0|||
155069429|NCT03765073|559683989|FG006|Stage 2|Lost to Follow-up|3|||
155069430|NCT03765073|559683990|FG007|Stage 2|Lost to Follow-up|3|||
155069431|NCT03765073|559683991|FG008|Stage 2|Lost to Follow-up|1|||
155069432|NCT03765073|559683992|FG009|Stage 2|Lost to Follow-up|6|||
155069433|NCT03765073|559683993|FG010|Stage 2|Lost to Follow-up|5|||
155069434|NCT03765073|559683994|FG011|Stage 2|Lost to Follow-up|1|||
155069435|NCT03765073|559683995|FG012|Stage 2|Lost to Follow-up|1|||
155069436|NCT03765073|559683996|FG013|Stage 2|Lost to Follow-up|3|||
155325941|NCT02502266|560631487|FG002|Overall Study|Adverse Event|0|||
155325942|NCT02502266|560631488|FG003|Overall Study|Adverse Event|0|||
155325943|NCT02502266|560631489|FG004|Overall Study|Adverse Event|1|||
155325944|NCT02502266|560631490|FG005|Overall Study|Adverse Event|1|||
155325945|NCT02502266|560631491|FG006|Overall Study|Adverse Event|1|||
155325946|NCT02502266|560631485|FG000|Overall Study|Withdrawal by Subject|30|||
155325947|NCT02502266|560631486|FG001|Overall Study|Withdrawal by Subject|15|||
155325948|NCT02502266|560631487|FG002|Overall Study|Withdrawal by Subject|16|||
155325949|NCT02502266|560631488|FG003|Overall Study|Withdrawal by Subject|0|||
155325950|NCT02502266|560631489|FG004|Overall Study|Withdrawal by Subject|0|||
155325951|NCT02502266|560631490|FG005|Overall Study|Withdrawal by Subject|0|||
155325952|NCT02502266|560631491|FG006|Overall Study|Withdrawal by Subject|0|||
155325953|NCT02502266|560631485|FG000|Overall Study|Still on Treatment|0|||
155325954|NCT02502266|560631486|FG001|Overall Study|Still on Treatment|0|||
155325955|NCT02502266|560631487|FG002|Overall Study|Still on Treatment|1|||
155325956|NCT02502266|560631488|FG003|Overall Study|Still on Treatment|0|||
155325957|NCT02502266|560631489|FG004|Overall Study|Still on Treatment|0|||
155325958|NCT02502266|560631490|FG005|Overall Study|Still on Treatment|0|||
155325959|NCT02502266|560631491|FG006|Overall Study|Still on Treatment|0|||
155325960|NCT02502266|560631485|FG000|Overall Study|Other Reasons|19|||
155325961|NCT02502266|560631486|FG001|Overall Study|Other Reasons|6|||
155325962|NCT02502266|560631487|FG002|Overall Study|Other Reasons|14|||
155325963|NCT02502266|560631488|FG003|Overall Study|Other Reasons|0|||
155325964|NCT02502266|560631489|FG004|Overall Study|Other Reasons|1|||
155325965|NCT02502266|560631490|FG005|Overall Study|Other Reasons|1|||
155325966|NCT02502266|560631491|FG006|Overall Study|Other Reasons|0|||
155325967|NCT02502266|560631485|FG000|Overall Study|Arm 4 Discontinued|0|||
155325968|NCT02502266|560631486|FG001|Overall Study|Arm 4 Discontinued|0|||
155325969|NCT02502266|560631487|FG002|Overall Study|Arm 4 Discontinued|0|||
155325970|NCT02502266|560631488|FG003|Overall Study|Arm 4 Discontinued|52|||
155325971|NCT02502266|560631489|FG004|Overall Study|Arm 4 Discontinued|0|||
155325972|NCT02502266|560631490|FG005|Overall Study|Arm 4 Discontinued|0|||
155325973|NCT02502266|560631491|FG006|Overall Study|Arm 4 Discontinued|0|||
155325974|NCT02502266|560631485|FG000|Overall Study|Never treated|0|||
155325975|NCT02502266|560631486|FG001|Overall Study|Never treated|0|||
155325976|NCT02502266|560631487|FG002|Overall Study|Never treated|0|||
155325977|NCT02502266|560631488|FG003|Overall Study|Never treated|0|||
155325978|NCT02502266|560631489|FG004|Overall Study|Never treated|0|||
155325979|NCT02502266|560631490|FG005|Overall Study|Never treated|1|||
155069437|NCT03765073|559683997|FG014|Stage 2|Lost to Follow-up|3|||
155069438|NCT03765073|559683998|FG015|Stage 2|Lost to Follow-up|1|||
155069439|NCT03765073|559683999|FG016|Stage 2|Lost to Follow-up|6|||
155069440|NCT03765073|559684000|FG017|Stage 2|Lost to Follow-up|0|||
155069441|NCT03765073|559684001|FG018|Stage 2|Lost to Follow-up|0|||
155069442|NCT03765073|559684002|FG019|Stage 2|Lost to Follow-up|0|||
155069443|NCT03765073|559684003|FG020|Stage 2|Lost to Follow-up|0|||
155069444|NCT03765073|559683983|FG000|Stage 2|Other|0|||
155069445|NCT03765073|559683984|FG001|Stage 2|Other|0|||
155069446|NCT03765073|559683985|FG002|Stage 2|Other|0|||
155069447|NCT03765073|559683986|FG003|Stage 2|Other|0|||
155069448|NCT03765073|559683987|FG004|Stage 2|Other|0|||
155069449|NCT03765073|559683988|FG005|Stage 2|Other|0|||
155069450|NCT03765073|559683989|FG006|Stage 2|Other|0|||
155069451|NCT03765073|559683990|FG007|Stage 2|Other|1|||
155069452|NCT03765073|559683991|FG008|Stage 2|Other|1|||
155325980|NCT02502266|560631491|FG006|Overall Study|Never treated|0|||
155069453|NCT03765073|559683992|FG009|Stage 2|Other|3|||
155069454|NCT03765073|559683993|FG010|Stage 2|Other|0|||
155069455|NCT03765073|559683994|FG011|Stage 2|Other|0|||
155163042|NCT00476008|560033157|FG000|Overall Study|Adverse Event|4|||
155163043|NCT00476008|560033158|FG001|Overall Study|Adverse Event|4|||
155325981|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Other|0|||
155069456|NCT03765073|559683995|FG012|Stage 2|Other|0|||
155069457|NCT03765073|559683996|FG013|Stage 2|Other|0|||
155069458|NCT03765073|559683997|FG014|Stage 2|Other|0|||
155069459|NCT03765073|559683998|FG015|Stage 2|Other|1|||
155069460|NCT03765073|559683999|FG016|Stage 2|Other|2|||
155069461|NCT03765073|559684000|FG017|Stage 2|Other|0|||
155069462|NCT03765073|559684001|FG018|Stage 2|Other|0|||
155069463|NCT03765073|559684002|FG019|Stage 2|Other|0|||
155069464|NCT03765073|559684003|FG020|Stage 2|Other|0|||
155069465|NCT03765073|559683983|FG000|Stage 2|Withdrawal by parent/guardian|0|||
155325982|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Other|2|||
155325983|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Other|1|||
155325984|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Other|2|||
155325985|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Other|2|||
155325986|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Other|0|||
155325987|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Other|0|||
155325988|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Other|0|||
155325989|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Other|0|||
155069466|NCT03765073|559683984|FG001|Stage 2|Withdrawal by parent/guardian|0|||
155069467|NCT03765073|559683985|FG002|Stage 2|Withdrawal by parent/guardian|0|||
155069468|NCT03765073|559683986|FG003|Stage 2|Withdrawal by parent/guardian|0|||
155069469|NCT03765073|559683987|FG004|Stage 2|Withdrawal by parent/guardian|0|||
155069470|NCT03765073|559683988|FG005|Stage 2|Withdrawal by parent/guardian|0|||
155069471|NCT03765073|559683989|FG006|Stage 2|Withdrawal by parent/guardian|0|||
155069472|NCT03765073|559683990|FG007|Stage 2|Withdrawal by parent/guardian|0|||
155069473|NCT03765073|559683991|FG008|Stage 2|Withdrawal by parent/guardian|0|||
155069474|NCT03765073|559683992|FG009|Stage 2|Withdrawal by parent/guardian|0|||
155069475|NCT03765073|559683993|FG010|Stage 2|Withdrawal by parent/guardian|3|||
155069476|NCT03765073|559683994|FG011|Stage 2|Withdrawal by parent/guardian|3|||
155069477|NCT03765073|559683995|FG012|Stage 2|Withdrawal by parent/guardian|3|||
155069478|NCT03765073|559683996|FG013|Stage 2|Withdrawal by parent/guardian|1|||
155069479|NCT03765073|559683997|FG014|Stage 2|Withdrawal by parent/guardian|1|||
155069480|NCT03765073|559683998|FG015|Stage 2|Withdrawal by parent/guardian|0|||
155069481|NCT03765073|559683999|FG016|Stage 2|Withdrawal by parent/guardian|3|||
155069482|NCT03765073|559684000|FG017|Stage 2|Withdrawal by parent/guardian|0|||
155069483|NCT03765073|559684001|FG018|Stage 2|Withdrawal by parent/guardian|0|||
155069484|NCT03765073|559684002|FG019|Stage 2|Withdrawal by parent/guardian|0|||
155069485|NCT03765073|559684003|FG020|Stage 2|Withdrawal by parent/guardian|0|||
155069486|NCT03765073|559683983|FG000|Stage 2|Withdrawal by Subject|0|||
155069487|NCT03765073|559683984|FG001|Stage 2|Withdrawal by Subject|0|||
155069488|NCT03765073|559683985|FG002|Stage 2|Withdrawal by Subject|0|||
155069489|NCT03765073|559683986|FG003|Stage 2|Withdrawal by Subject|3|||
155069490|NCT03765073|559683987|FG004|Stage 2|Withdrawal by Subject|3|||
155069491|NCT03765073|559683988|FG005|Stage 2|Withdrawal by Subject|3|||
155069492|NCT03765073|559683989|FG006|Stage 2|Withdrawal by Subject|0|||
155069493|NCT03765073|559683990|FG007|Stage 2|Withdrawal by Subject|1|||
155069494|NCT03765073|559683991|FG008|Stage 2|Withdrawal by Subject|0|||
155069495|NCT03765073|559683992|FG009|Stage 2|Withdrawal by Subject|5|||
155163044|NCT00476008|560033157|FG000|Overall Study|Placebo concerns|2|||
155163045|NCT00476008|560033158|FG001|Overall Study|Placebo concerns|2|||
155325990|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Other|0|||
155325991|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Other|0|||
155325992|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Other|0|||
155325993|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Other|0|||
155325994|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Other|0|||
155325995|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Other|0|||
155325996|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Other|0|||
155325997|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Other|0|||
155325998|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
155325999|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
155326000|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
155326001|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
155326002|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
155326003|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
155163046|NCT00476008|560033157|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
155326004|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326005|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155069496|NCT03765073|559683993|FG010|Stage 2|Withdrawal by Subject|0|||
155069497|NCT03765073|559683994|FG011|Stage 2|Withdrawal by Subject|0|||
155069498|NCT03765073|559683995|FG012|Stage 2|Withdrawal by Subject|0|||
155069499|NCT03765073|559683996|FG013|Stage 2|Withdrawal by Subject|0|||
155069500|NCT03765073|559683997|FG014|Stage 2|Withdrawal by Subject|0|||
155069501|NCT03765073|559683998|FG015|Stage 2|Withdrawal by Subject|0|||
155069502|NCT03765073|559683999|FG016|Stage 2|Withdrawal by Subject|0|||
155069503|NCT03765073|559684000|FG017|Stage 2|Withdrawal by Subject|0|||
155069504|NCT03765073|559684001|FG018|Stage 2|Withdrawal by Subject|0|||
155069505|NCT03765073|559684002|FG019|Stage 2|Withdrawal by Subject|0|||
155069506|NCT03765073|559684003|FG020|Stage 2|Withdrawal by Subject|0|||
155069507|NCT03765073|559683983|FG000|Stage 3|Adverse Event|0|||
155069508|NCT03765073|559683984|FG001|Stage 3|Adverse Event|0|||
155069509|NCT03765073|559683985|FG002|Stage 3|Adverse Event|0|||
155069510|NCT03765073|559683986|FG003|Stage 3|Adverse Event|0|||
155069511|NCT03765073|559683987|FG004|Stage 3|Adverse Event|0|||
155069512|NCT03765073|559683988|FG005|Stage 3|Adverse Event|0|||
155069513|NCT03765073|559683989|FG006|Stage 3|Adverse Event|0|||
155069514|NCT03765073|559683990|FG007|Stage 3|Adverse Event|0|||
155069515|NCT03765073|559683991|FG008|Stage 3|Adverse Event|0|||
155069516|NCT03765073|559683992|FG009|Stage 3|Adverse Event|0|||
155069517|NCT03765073|559683993|FG010|Stage 3|Adverse Event|0|||
155069518|NCT03765073|559683994|FG011|Stage 3|Adverse Event|0|||
155069519|NCT03765073|559683995|FG012|Stage 3|Adverse Event|0|||
155069520|NCT03765073|559683996|FG013|Stage 3|Adverse Event|0|||
155069521|NCT03765073|559683997|FG014|Stage 3|Adverse Event|0|||
155326006|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326007|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326008|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326009|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326010|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326011|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326012|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326013|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326014|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
155326015|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326016|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
155326017|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
155326018|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326019|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
155326020|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
155326021|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326022|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326023|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326024|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326025|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326026|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326027|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326028|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326029|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326030|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326031|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
155326032|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Death|2|||
155326033|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Death|1|||
155326034|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Death|1|||
155326035|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Death|0|||
155326036|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Death|0|||
155326037|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Death|0|||
155326038|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Death|0|||
155326039|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Death|0|||
155326040|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Death|0|||
155326041|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Death|0|||
155326042|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Death|0|||
155326043|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Death|0|||
155326044|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Death|0|||
155326045|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Death|0|||
154961369|NCT03032172|559283925|FG006|Treatment Period|Reason Not Specified|0|||
154961370|NCT03032172|559283926|FG007|Treatment Period|Reason Not Specified|0|||
155326046|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Death|0|||
155326047|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Death|0|||
155326048|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Death|0|||
155326049|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326050|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
155326051|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326052|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326053|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
155326054|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
155326055|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326056|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326057|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326058|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326059|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326060|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326061|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326062|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326063|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326064|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326065|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
155326066|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326067|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326068|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
154961371|NCT03032172|559283919|FG000|Treatment Period|Physician Decision|0|||
154961372|NCT03032172|559283920|FG001|Treatment Period|Physician Decision|2|||
155326069|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326070|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
155326071|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
155326072|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
154961373|NCT03032172|559283921|FG002|Treatment Period|Physician Decision|1|||
155326073|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326074|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326075|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326076|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326077|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326078|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326079|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326080|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326081|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326082|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
155326083|NCT02719574|560631492|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326084|NCT02719574|560631493|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326085|NCT02719574|560631494|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
155326086|NCT02719574|560631495|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326087|NCT02719574|560631496|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326088|NCT02719574|560631497|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326089|NCT02719574|560631498|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326090|NCT02719574|560631499|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326091|NCT02719574|560631500|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326092|NCT02719574|560631501|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326093|NCT02719574|560631502|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326094|NCT02719574|560631503|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326095|NCT02719574|560631504|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326096|NCT02719574|560631505|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326097|NCT02719574|560631506|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326098|NCT02719574|560631507|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326099|NCT02719574|560631508|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
155326100|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326101|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326102|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326103|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326104|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326105|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326106|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
155326107|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
155326108|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
155326109|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326110|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326111|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326112|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326113|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155069522|NCT03765073|559683998|FG015|Stage 3|Adverse Event|0|||
155069523|NCT03765073|559683999|FG016|Stage 3|Adverse Event|0|||
155326114|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326115|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326116|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
155326117|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326118|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155069524|NCT03765073|559684000|FG017|Stage 3|Adverse Event|0|||
155069525|NCT03765073|559684001|FG018|Stage 3|Adverse Event|1|||
155069526|NCT03765073|559684002|FG019|Stage 3|Adverse Event|0|||
154961374|NCT03032172|559283922|FG003|Treatment Period|Physician Decision|0|||
154961375|NCT03032172|559283923|FG004|Treatment Period|Physician Decision|0|||
154961376|NCT03032172|559283924|FG005|Treatment Period|Physician Decision|0|||
154961377|NCT03032172|559283925|FG006|Treatment Period|Physician Decision|0|||
154961378|NCT03032172|559283926|FG007|Treatment Period|Physician Decision|0|||
154961379|NCT03032172|559283919|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
154961380|NCT03032172|559283920|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
154961381|NCT03032172|559283921|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
154961382|NCT03032172|559283922|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
154961383|NCT03032172|559283923|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
154961384|NCT03032172|559283924|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
154961385|NCT03032172|559283925|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
154961386|NCT03032172|559283926|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
154961387|NCT03032172|559283919|FG000|Treatment Period|Withdrawal by Subject|2|||
154961388|NCT03032172|559283920|FG001|Treatment Period|Withdrawal by Subject|0|||
154961389|NCT03032172|559283921|FG002|Treatment Period|Withdrawal by Subject|3|||
154961390|NCT03032172|559283922|FG003|Treatment Period|Withdrawal by Subject|0|||
154961391|NCT03032172|559283923|FG004|Treatment Period|Withdrawal by Subject|0|||
154961392|NCT03032172|559283924|FG005|Treatment Period|Withdrawal by Subject|0|||
154961393|NCT03032172|559283925|FG006|Treatment Period|Withdrawal by Subject|0|||
154961394|NCT03032172|559283926|FG007|Treatment Period|Withdrawal by Subject|0|||
154961395|NCT03032172|559283919|FG000|Open-label Extension Period|Death|0|||
154961396|NCT03032172|559283920|FG001|Open-label Extension Period|Death|0|||
154961397|NCT03032172|559283921|FG002|Open-label Extension Period|Death|0|||
154961398|NCT03032172|559283922|FG003|Open-label Extension Period|Death|0|||
154961399|NCT03032172|559283923|FG004|Open-label Extension Period|Death|0|||
154961400|NCT03032172|559283924|FG005|Open-label Extension Period|Death|0|||
154961401|NCT03032172|559283925|FG006|Open-label Extension Period|Death|0|||
154961402|NCT03032172|559283926|FG007|Open-label Extension Period|Death|2|||
154961403|NCT03032172|559283919|FG000|Open-label Extension Period|Reason Not Specified|0|||
154961404|NCT03032172|559283920|FG001|Open-label Extension Period|Reason Not Specified|0|||
154961405|NCT03032172|559283921|FG002|Open-label Extension Period|Reason Not Specified|0|||
154961406|NCT03032172|559283922|FG003|Open-label Extension Period|Reason Not Specified|0|||
154961407|NCT03032172|559283923|FG004|Open-label Extension Period|Reason Not Specified|0|||
154961408|NCT03032172|559283924|FG005|Open-label Extension Period|Reason Not Specified|5|||
154961409|NCT03032172|559283925|FG006|Open-label Extension Period|Reason Not Specified|3|||
154961410|NCT03032172|559283926|FG007|Open-label Extension Period|Reason Not Specified|0|||
154961411|NCT03032172|559283919|FG000|Open-label Extension Period|Pregnancy|0|||
154961412|NCT03032172|559283920|FG001|Open-label Extension Period|Pregnancy|0|||
154961413|NCT03032172|559283921|FG002|Open-label Extension Period|Pregnancy|0|||
154961414|NCT03032172|559283922|FG003|Open-label Extension Period|Pregnancy|0|||
154961415|NCT03032172|559283923|FG004|Open-label Extension Period|Pregnancy|0|||
154961416|NCT03032172|559283924|FG005|Open-label Extension Period|Pregnancy|0|||
154961417|NCT03032172|559283925|FG006|Open-label Extension Period|Pregnancy|1|||
154961418|NCT03032172|559283926|FG007|Open-label Extension Period|Pregnancy|0|||
154961419|NCT03032172|559283919|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
154961420|NCT03032172|559283920|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
154961421|NCT03032172|559283921|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
154961422|NCT03032172|559283922|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
154961423|NCT03032172|559283923|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
154961424|NCT03032172|559283924|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
154961425|NCT03032172|559283925|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
154961426|NCT03032172|559283926|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
154961427|NCT04516967|559283928|FG000|Core Phase|Adverse Event|2|||
154961428|NCT04516967|559283929|FG001|Core Phase|Adverse Event|1|||
154961429|NCT04516967|559283930|FG002|Core Phase|Adverse Event|0|||
154961430|NCT04516967|559283928|FG000|Core Phase|Physician Decision|1|||
154961431|NCT04516967|559283929|FG001|Core Phase|Physician Decision|1|||
154961432|NCT04516967|559283930|FG002|Core Phase|Physician Decision|0|||
154961433|NCT04516967|559283928|FG000|Core Phase|Lack of Efficacy|7|||
154961434|NCT04516967|559283929|FG001|Core Phase|Lack of Efficacy|18|||
154961435|NCT04516967|559283930|FG002|Core Phase|Lack of Efficacy|0|||
154961436|NCT03165994|559283931|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
154961437|NCT03165994|559283931|FG000|Overall Study|Death|2|||
154961438|NCT03165994|559283931|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
154961439|NCT03165994|559283931|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
154961440|NCT03165994|559283931|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
155163047|NCT00476008|560033158|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
155163048|NCT00476008|560033157|FG000|Overall Study|Withdrawal by Subject|0|||
155163049|NCT00476008|560033158|FG001|Overall Study|Withdrawal by Subject|1|||
155326119|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326120|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326121|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326122|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326123|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
155326124|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
155326125|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326126|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326127|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326128|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326129|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326130|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326131|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326132|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326133|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
155326134|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Death|0|||
155326135|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Death|0|||
155326136|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Death|0|||
155326137|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Death|0|||
155326138|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Death|0|||
155326139|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Death|0|||
155326140|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Death|1|||
155326141|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Death|6|||
155326142|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Death|0|||
155326143|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Death|0|||
155326144|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Death|0|||
155326145|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Death|0|||
155326146|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Death|0|||
155326147|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Death|0|||
155326148|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Death|0|||
155326149|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Death|0|||
155326150|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Death|0|||
155326151|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326152|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326153|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326154|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326155|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326156|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326157|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
154961441|NCT03165994|559283931|FG000|Overall Study|Miscellaneous|1|||
154961442|NCT00519194|559283932|FG000|Overall Study|Withdrawal by Subject|9|||
155163050|NCT00476008|560033157|FG000|Overall Study|Death|1|||
155163051|NCT00476008|560033158|FG001|Overall Study|Death|0|||
155163052|NCT01227018|560033159|FG000|Overall Study|Disease progression|9|||
155163053|NCT01227018|560033159|FG000|Overall Study|Toxicity|2|||
155326158|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
155326159|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326160|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326161|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326162|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326163|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326164|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326165|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326166|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326167|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
155326168|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326169|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326170|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
154961443|NCT00519194|559283932|FG000|Overall Study|Death|9|||
154961444|NCT00519194|559283932|FG000|Overall Study|Lost to Follow-up|3|||
154961445|NCT02301975|559283935|FG000|Overall Study|Adverse Event|8|||
154961446|NCT02301975|559283936|FG001|Overall Study|Adverse Event|3|||
154961447|NCT02301975|559283937|FG002|Overall Study|Adverse Event|2|||
154961448|NCT02301975|559283935|FG000|Overall Study|Lack of Efficacy|1|||
154961449|NCT02301975|559283936|FG001|Overall Study|Lack of Efficacy|1|||
154961450|NCT02301975|559283937|FG002|Overall Study|Lack of Efficacy|1|||
154961451|NCT02301975|559283935|FG000|Overall Study|Protocol Violation|3|||
154961452|NCT02301975|559283936|FG001|Overall Study|Protocol Violation|5|||
154961453|NCT02301975|559283937|FG002|Overall Study|Protocol Violation|3|||
154961454|NCT02301975|559283935|FG000|Overall Study|Lost to Follow-up|0|||
154961455|NCT02301975|559283936|FG001|Overall Study|Lost to Follow-up|2|||
154961456|NCT02301975|559283937|FG002|Overall Study|Lost to Follow-up|2|||
155326171|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326172|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326173|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326174|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
155326175|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
155326176|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326177|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326178|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326179|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326180|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326181|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326182|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326183|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326184|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
155326185|NCT02719574|560631492|FG000|Phase 1 (Dose Expansion)|Other|0|||
155326186|NCT02719574|560631493|FG001|Phase 1 (Dose Expansion)|Other|0|||
155326187|NCT02719574|560631494|FG002|Phase 1 (Dose Expansion)|Other|0|||
155326188|NCT02719574|560631495|FG003|Phase 1 (Dose Expansion)|Other|0|||
155326189|NCT02719574|560631496|FG004|Phase 1 (Dose Expansion)|Other|0|||
155326190|NCT02719574|560631497|FG005|Phase 1 (Dose Expansion)|Other|0|||
155326191|NCT02719574|560631498|FG006|Phase 1 (Dose Expansion)|Other|1|||
155326192|NCT02719574|560631499|FG007|Phase 1 (Dose Expansion)|Other|7|||
155326193|NCT02719574|560631500|FG008|Phase 1 (Dose Expansion)|Other|0|||
155326194|NCT02719574|560631501|FG009|Phase 1 (Dose Expansion)|Other|0|||
155326195|NCT02719574|560631502|FG010|Phase 1 (Dose Expansion)|Other|0|||
155326196|NCT02719574|560631503|FG011|Phase 1 (Dose Expansion)|Other|0|||
155326197|NCT02719574|560631504|FG012|Phase 1 (Dose Expansion)|Other|0|||
155326198|NCT02719574|560631505|FG013|Phase 1 (Dose Expansion)|Other|0|||
155326199|NCT02719574|560631506|FG014|Phase 1 (Dose Expansion)|Other|0|||
155326200|NCT02719574|560631507|FG015|Phase 1 (Dose Expansion)|Other|0|||
155326201|NCT02719574|560631508|FG016|Phase 1 (Dose Expansion)|Other|0|||
155326202|NCT02719574|560631492|FG000|Phase 2|Protocol Defined Disease Progression|0|||
155326203|NCT02719574|560631493|FG001|Phase 2|Protocol Defined Disease Progression|0|||
155326204|NCT02719574|560631494|FG002|Phase 2|Protocol Defined Disease Progression|0|||
155326205|NCT02719574|560631495|FG003|Phase 2|Protocol Defined Disease Progression|0|||
155326206|NCT02719574|560631496|FG004|Phase 2|Protocol Defined Disease Progression|0|||
155326207|NCT02719574|560631497|FG005|Phase 2|Protocol Defined Disease Progression|0|||
155326208|NCT02719574|560631498|FG006|Phase 2|Protocol Defined Disease Progression|0|||
155326209|NCT02719574|560631499|FG007|Phase 2|Protocol Defined Disease Progression|0|||
155326210|NCT02719574|560631500|FG008|Phase 2|Protocol Defined Disease Progression|0|||
155326211|NCT02719574|560631501|FG009|Phase 2|Protocol Defined Disease Progression|65|||
155326212|NCT02719574|560631502|FG010|Phase 2|Protocol Defined Disease Progression|8|||
155326213|NCT02719574|560631503|FG011|Phase 2|Protocol Defined Disease Progression|2|||
155326214|NCT02719574|560631504|FG012|Phase 2|Protocol Defined Disease Progression|4|||
155326215|NCT02719574|560631505|FG013|Phase 2|Protocol Defined Disease Progression|9|||
155326216|NCT02719574|560631506|FG014|Phase 2|Protocol Defined Disease Progression|11|||
155326217|NCT02719574|560631507|FG015|Phase 2|Protocol Defined Disease Progression|3|||
155326218|NCT02719574|560631508|FG016|Phase 2|Protocol Defined Disease Progression|4|||
155326219|NCT02719574|560631492|FG000|Phase 2|Adverse Event|0|||
155326220|NCT02719574|560631493|FG001|Phase 2|Adverse Event|0|||
155326221|NCT02719574|560631494|FG002|Phase 2|Adverse Event|0|||
155326222|NCT02719574|560631495|FG003|Phase 2|Adverse Event|0|||
155069527|NCT03765073|559684003|FG020|Stage 3|Adverse Event|0|||
155326223|NCT02719574|560631496|FG004|Phase 2|Adverse Event|0|||
155326224|NCT02719574|560631497|FG005|Phase 2|Adverse Event|0|||
155326225|NCT02719574|560631498|FG006|Phase 2|Adverse Event|0|||
155326226|NCT02719574|560631499|FG007|Phase 2|Adverse Event|0|||
155326227|NCT02719574|560631500|FG008|Phase 2|Adverse Event|0|||
155326228|NCT02719574|560631501|FG009|Phase 2|Adverse Event|27|||
155326229|NCT02719574|560631502|FG010|Phase 2|Adverse Event|0|||
155326230|NCT02719574|560631503|FG011|Phase 2|Adverse Event|1|||
155326231|NCT02719574|560631504|FG012|Phase 2|Adverse Event|1|||
155326232|NCT02719574|560631505|FG013|Phase 2|Adverse Event|1|||
155326233|NCT02719574|560631506|FG014|Phase 2|Adverse Event|2|||
155326234|NCT02719574|560631507|FG015|Phase 2|Adverse Event|2|||
155326235|NCT02719574|560631508|FG016|Phase 2|Adverse Event|3|||
155326236|NCT02719574|560631492|FG000|Phase 2|Other|0|||
155326237|NCT02719574|560631493|FG001|Phase 2|Other|0|||
155326238|NCT02719574|560631494|FG002|Phase 2|Other|0|||
155326239|NCT02719574|560631495|FG003|Phase 2|Other|0|||
155326240|NCT02719574|560631496|FG004|Phase 2|Other|0|||
155326241|NCT02719574|560631497|FG005|Phase 2|Other|0|||
155326242|NCT02719574|560631498|FG006|Phase 2|Other|0|||
155326243|NCT02719574|560631499|FG007|Phase 2|Other|0|||
155326244|NCT02719574|560631500|FG008|Phase 2|Other|0|||
155326245|NCT02719574|560631501|FG009|Phase 2|Other|20|||
155326246|NCT02719574|560631502|FG010|Phase 2|Other|7|||
155069528|NCT03765073|559683983|FG000|Stage 3|Death|0|||
155326247|NCT02719574|560631503|FG011|Phase 2|Other|0|||
155326248|NCT02719574|560631504|FG012|Phase 2|Other|5|||
155326249|NCT02719574|560631505|FG013|Phase 2|Other|7|||
155326250|NCT02719574|560631506|FG014|Phase 2|Other|0|||
155326251|NCT02719574|560631507|FG015|Phase 2|Other|1|||
155326252|NCT02719574|560631508|FG016|Phase 2|Other|4|||
155326253|NCT02719574|560631492|FG000|Phase 2|Transplant|0|||
155326254|NCT02719574|560631493|FG001|Phase 2|Transplant|0|||
155326255|NCT02719574|560631494|FG002|Phase 2|Transplant|0|||
155326256|NCT02719574|560631495|FG003|Phase 2|Transplant|0|||
155326257|NCT02719574|560631496|FG004|Phase 2|Transplant|0|||
155326258|NCT02719574|560631497|FG005|Phase 2|Transplant|0|||
155326259|NCT02719574|560631498|FG006|Phase 2|Transplant|0|||
155326260|NCT02719574|560631499|FG007|Phase 2|Transplant|0|||
155326261|NCT02719574|560631500|FG008|Phase 2|Transplant|0|||
155326262|NCT02719574|560631501|FG009|Phase 2|Transplant|15|||
155326263|NCT02719574|560631502|FG010|Phase 2|Transplant|2|||
155326264|NCT02719574|560631503|FG011|Phase 2|Transplant|0|||
155326265|NCT02719574|560631504|FG012|Phase 2|Transplant|6|||
155326266|NCT02719574|560631505|FG013|Phase 2|Transplant|1|||
155326267|NCT02719574|560631506|FG014|Phase 2|Transplant|1|||
155326268|NCT02719574|560631507|FG015|Phase 2|Transplant|0|||
155069529|NCT03765073|559683984|FG001|Stage 3|Death|0|||
155069530|NCT03765073|559683985|FG002|Stage 3|Death|0|||
155069531|NCT03765073|559683986|FG003|Stage 3|Death|0|||
155069532|NCT03765073|559683987|FG004|Stage 3|Death|0|||
155069533|NCT03765073|559683988|FG005|Stage 3|Death|0|||
155326269|NCT02719574|560631508|FG016|Phase 2|Transplant|0|||
155326270|NCT02719574|560631492|FG000|Phase 2|Death|0|||
155326271|NCT02719574|560631493|FG001|Phase 2|Death|0|||
155326272|NCT02719574|560631494|FG002|Phase 2|Death|0|||
155326273|NCT02719574|560631495|FG003|Phase 2|Death|0|||
155326274|NCT02719574|560631496|FG004|Phase 2|Death|0|||
155326275|NCT02719574|560631497|FG005|Phase 2|Death|0|||
155326276|NCT02719574|560631498|FG006|Phase 2|Death|0|||
155326277|NCT02719574|560631499|FG007|Phase 2|Death|0|||
155326278|NCT02719574|560631500|FG008|Phase 2|Death|0|||
155326279|NCT02719574|560631501|FG009|Phase 2|Death|14|||
155326280|NCT02719574|560631502|FG010|Phase 2|Death|0|||
155326281|NCT02719574|560631503|FG011|Phase 2|Death|0|||
155326282|NCT02719574|560631504|FG012|Phase 2|Death|1|||
155326283|NCT02719574|560631505|FG013|Phase 2|Death|1|||
155326284|NCT02719574|560631506|FG014|Phase 2|Death|2|||
155326285|NCT02719574|560631507|FG015|Phase 2|Death|0|||
155326286|NCT02719574|560631508|FG016|Phase 2|Death|0|||
155326287|NCT02719574|560631492|FG000|Phase 2|Investigator Decision|0|||
155326288|NCT02719574|560631493|FG001|Phase 2|Investigator Decision|0|||
155326289|NCT02719574|560631494|FG002|Phase 2|Investigator Decision|0|||
155326290|NCT02719574|560631495|FG003|Phase 2|Investigator Decision|0|||
155326291|NCT02719574|560631496|FG004|Phase 2|Investigator Decision|0|||
155326292|NCT02719574|560631497|FG005|Phase 2|Investigator Decision|0|||
155326293|NCT02719574|560631498|FG006|Phase 2|Investigator Decision|0|||
155326294|NCT02719574|560631499|FG007|Phase 2|Investigator Decision|0|||
155326295|NCT02719574|560631500|FG008|Phase 2|Investigator Decision|0|||
155326296|NCT02719574|560631501|FG009|Phase 2|Investigator Decision|6|||
155326297|NCT02719574|560631502|FG010|Phase 2|Investigator Decision|1|||
155326298|NCT02719574|560631503|FG011|Phase 2|Investigator Decision|2|||
155326299|NCT02719574|560631504|FG012|Phase 2|Investigator Decision|3|||
155326300|NCT02719574|560631505|FG013|Phase 2|Investigator Decision|1|||
155069534|NCT03765073|559683989|FG006|Stage 3|Death|0|||
155069535|NCT03765073|559683990|FG007|Stage 3|Death|0|||
155069536|NCT03765073|559683991|FG008|Stage 3|Death|0|||
155069537|NCT03765073|559683992|FG009|Stage 3|Death|0|||
155069538|NCT03765073|559683993|FG010|Stage 3|Death|0|||
155326301|NCT02719574|560631506|FG014|Phase 2|Investigator Decision|3|||
155326302|NCT02719574|560631507|FG015|Phase 2|Investigator Decision|2|||
155326303|NCT02719574|560631508|FG016|Phase 2|Investigator Decision|0|||
155326304|NCT02719574|560631492|FG000|Phase 2|Withdrawal by Subject|0|||
155326305|NCT02719574|560631493|FG001|Phase 2|Withdrawal by Subject|0|||
155326306|NCT02719574|560631494|FG002|Phase 2|Withdrawal by Subject|0|||
155326307|NCT02719574|560631495|FG003|Phase 2|Withdrawal by Subject|0|||
155326308|NCT02719574|560631496|FG004|Phase 2|Withdrawal by Subject|0|||
155326309|NCT02719574|560631497|FG005|Phase 2|Withdrawal by Subject|0|||
155069539|NCT03765073|559683994|FG011|Stage 3|Death|0|||
155326310|NCT02719574|560631498|FG006|Phase 2|Withdrawal by Subject|0|||
155326311|NCT02719574|560631499|FG007|Phase 2|Withdrawal by Subject|0|||
155326312|NCT02719574|560631500|FG008|Phase 2|Withdrawal by Subject|0|||
155326313|NCT02719574|560631501|FG009|Phase 2|Withdrawal by Subject|5|||
155326314|NCT02719574|560631502|FG010|Phase 2|Withdrawal by Subject|0|||
155326315|NCT02719574|560631503|FG011|Phase 2|Withdrawal by Subject|0|||
155326316|NCT02719574|560631504|FG012|Phase 2|Withdrawal by Subject|0|||
155326317|NCT02719574|560631505|FG013|Phase 2|Withdrawal by Subject|1|||
155326318|NCT02719574|560631506|FG014|Phase 2|Withdrawal by Subject|1|||
155326319|NCT02719574|560631507|FG015|Phase 2|Withdrawal by Subject|2|||
155326320|NCT02719574|560631508|FG016|Phase 2|Withdrawal by Subject|0|||
155326321|NCT02719574|560631492|FG000|Phase 2|Protocol Violation|0|||
155326322|NCT02719574|560631493|FG001|Phase 2|Protocol Violation|0|||
155326323|NCT02719574|560631494|FG002|Phase 2|Protocol Violation|0|||
155326324|NCT02719574|560631495|FG003|Phase 2|Protocol Violation|0|||
155326325|NCT02719574|560631496|FG004|Phase 2|Protocol Violation|0|||
155326326|NCT02719574|560631497|FG005|Phase 2|Protocol Violation|0|||
155326327|NCT02719574|560631498|FG006|Phase 2|Protocol Violation|0|||
155326328|NCT02719574|560631499|FG007|Phase 2|Protocol Violation|0|||
155326329|NCT02719574|560631500|FG008|Phase 2|Protocol Violation|0|||
155326330|NCT02719574|560631501|FG009|Phase 2|Protocol Violation|1|||
155326331|NCT02719574|560631502|FG010|Phase 2|Protocol Violation|0|||
155326332|NCT02719574|560631503|FG011|Phase 2|Protocol Violation|0|||
155326333|NCT02719574|560631504|FG012|Phase 2|Protocol Violation|0|||
155163054|NCT01227018|560033159|FG000|Overall Study|Withdrew after beginning treatment|4|||
155163055|NCT02873702|560033162|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
155163056|NCT02873702|560033163|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
155163057|NCT02873702|560033164|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
155326334|NCT02719574|560631505|FG013|Phase 2|Protocol Violation|0|||
155326335|NCT02719574|560631506|FG014|Phase 2|Protocol Violation|0|||
155326336|NCT02719574|560631507|FG015|Phase 2|Protocol Violation|0|||
155326337|NCT02719574|560631508|FG016|Phase 2|Protocol Violation|0|||
155326338|NCT00113360|560631510|FG000|Overall Study|Adverse Event|3|||
155326339|NCT00113360|560631510|FG000|Overall Study|Subject required surgery|1|||
155326340|NCT00113360|560631510|FG000|Overall Study|Did not meet eligibility criteria|3|||
155326341|NCT01976936|560631523|FG000|Overall Study|Did not receive at least 9 doses|9|||
155326342|NCT01976936|560631524|FG001|Overall Study|Did not receive at least 9 doses|4|||
155326343|NCT02231749|560631528|FG000|Overall Study|Disease progression|229|||
155326344|NCT02231749|560631529|FG001|Overall Study|Disease progression|297|||
155326345|NCT02231749|560631528|FG000|Overall Study|Study Drug Toxicity|134|||
155326346|NCT02231749|560631529|FG001|Overall Study|Study Drug Toxicity|63|||
155326347|NCT02231749|560631528|FG000|Overall Study|Death|1|||
155326348|NCT02231749|560631529|FG001|Overall Study|Death|1|||
155326349|NCT02231749|560631528|FG000|Overall Study|AE unrelated to Study drug|32|||
155326350|NCT02231749|560631529|FG001|Overall Study|AE unrelated to Study drug|31|||
155326351|NCT02231749|560631528|FG000|Overall Study|Participant's request to discontinue|10|||
155326352|NCT02231749|560631529|FG001|Overall Study|Participant's request to discontinue|21|||
155326353|NCT02231749|560631528|FG000|Overall Study|Participant withdrew Consent|8|||
155326354|NCT02231749|560631529|FG001|Overall Study|Participant withdrew Consent|15|||
155326355|NCT02231749|560631528|FG000|Overall Study|Lost to Follow-up|1|||
155326356|NCT02231749|560631529|FG001|Overall Study|Lost to Follow-up|2|||
155326357|NCT02231749|560631528|FG000|Overall Study|Maximum Clinical Benefit|5|||
155326358|NCT02231749|560631529|FG001|Overall Study|Maximum Clinical Benefit|8|||
155326359|NCT02231749|560631528|FG000|Overall Study|Poor/Non-Compliance|0|||
155326360|NCT02231749|560631529|FG001|Overall Study|Poor/Non-Compliance|3|||
155326361|NCT02231749|560631528|FG000|Overall Study|Pregnancy|1|||
155326362|NCT02231749|560631529|FG001|Overall Study|Pregnancy|0|||
155326363|NCT02231749|560631528|FG000|Overall Study|other|0|||
155326364|NCT02231749|560631529|FG001|Overall Study|other|8|||
155326365|NCT02231749|560631528|FG000|Overall Study|No longer meets Study Criteria|1|||
155069540|NCT03765073|559683995|FG012|Stage 3|Death|0|||
155069541|NCT03765073|559683996|FG013|Stage 3|Death|0|||
155069542|NCT03765073|559683997|FG014|Stage 3|Death|0|||
155069543|NCT03765073|559683998|FG015|Stage 3|Death|0|||
155069544|NCT03765073|559683999|FG016|Stage 3|Death|0|||
155069545|NCT03765073|559684000|FG017|Stage 3|Death|0|||
155069546|NCT03765073|559684001|FG018|Stage 3|Death|0|||
155069547|NCT03765073|559684002|FG019|Stage 3|Death|3|||
155069548|NCT03765073|559684003|FG020|Stage 3|Death|2|||
155069549|NCT03765073|559683983|FG000|Stage 3|Lost to Follow-up|0|||
155069550|NCT03765073|559683984|FG001|Stage 3|Lost to Follow-up|0|||
155069551|NCT03765073|559683985|FG002|Stage 3|Lost to Follow-up|0|||
155069552|NCT03765073|559683986|FG003|Stage 3|Lost to Follow-up|0|||
155069553|NCT03765073|559683987|FG004|Stage 3|Lost to Follow-up|0|||
155069554|NCT03765073|559683988|FG005|Stage 3|Lost to Follow-up|0|||
155069555|NCT03765073|559683989|FG006|Stage 3|Lost to Follow-up|0|||
155069556|NCT03765073|559683990|FG007|Stage 3|Lost to Follow-up|0|||
155069557|NCT03765073|559683991|FG008|Stage 3|Lost to Follow-up|0|||
154961457|NCT02301975|559283935|FG000|Overall Study|Physician Decision|4|||
154961458|NCT02301975|559283936|FG001|Overall Study|Physician Decision|2|||
154961459|NCT02301975|559283937|FG002|Overall Study|Physician Decision|3|||
154961460|NCT02301975|559283935|FG000|Overall Study|Withdrawal by Subject|15|||
154961461|NCT02301975|559283936|FG001|Overall Study|Withdrawal by Subject|12|||
154961462|NCT02301975|559283937|FG002|Overall Study|Withdrawal by Subject|11|||
154961463|NCT01111461|559283938|FG000|Overall Study|Adverse Event|32|||
154961464|NCT01111461|559283938|FG000|Overall Study|Participant choice|11|||
154961465|NCT01111461|559283938|FG000|Overall Study|Lost to Follow-up|1|||
154961466|NCT01111461|559283938|FG000|Overall Study|Withdrawal by Subject|1|||
155326366|NCT02231749|560631529|FG001|Overall Study|No longer meets Study Criteria|0|||
155326367|NCT02989662|560631536|FG000|Overall Study|Lost to Follow-up|0|||
155326368|NCT02989662|560631537|FG001|Overall Study|Lost to Follow-up|0|||
155326369|NCT02989662|560631538|FG002|Overall Study|Lost to Follow-up|0|||
155326370|NCT02989662|560631539|FG003|Overall Study|Lost to Follow-up|2|||
155326371|NCT02989662|560631536|FG000|Overall Study|Physician Decision|3|||
154961467|NCT01111461|559283938|FG000|Overall Study|Other|6|||
154961468|NCT00561015|559283940|FG000|Overall Study|Adverse Event|0|||
155326372|NCT02989662|560631537|FG001|Overall Study|Physician Decision|0|||
155326373|NCT02989662|560631538|FG002|Overall Study|Physician Decision|0|||
155326374|NCT02989662|560631539|FG003|Overall Study|Physician Decision|0|||
155326375|NCT02989662|560631536|FG000|Overall Study|Withdrawal by Subject|1|||
155326376|NCT02989662|560631537|FG001|Overall Study|Withdrawal by Subject|0|||
155326377|NCT02989662|560631538|FG002|Overall Study|Withdrawal by Subject|0|||
155326378|NCT02989662|560631539|FG003|Overall Study|Withdrawal by Subject|0|||
155326379|NCT00328783|560631540|FG000|Overall Study|Could not tolerate ABC|21|||
155326380|NCT00328783|560631540|FG000|Overall Study|No heart in RT field|4|||
155326381|NCT00328783|560631540|FG000|Overall Study|Withdrawal by Subject|1|||
155326382|NCT00357682|560631541|FG000|Overall Study|Did not receive allocated Treatment|10|||
155326383|NCT00357682|560631542|FG001|Overall Study|Did not receive allocated Treatment|9|||
155326384|NCT00357682|560631543|FG002|Overall Study|Did not receive allocated Treatment|9|||
155326385|NCT00357682|560631544|FG003|Overall Study|Did not receive allocated Treatment|10|||
155326386|NCT00357682|560631541|FG000|Overall Study|Withdrew consent|6|||
155326387|NCT00357682|560631542|FG001|Overall Study|Withdrew consent|6|||
155326388|NCT00357682|560631543|FG002|Overall Study|Withdrew consent|5|||
155326389|NCT00357682|560631544|FG003|Overall Study|Withdrew consent|5|||
155326390|NCT00357682|560631541|FG000|Overall Study|Lost to Follow-up|39|||
155326391|NCT00357682|560631542|FG001|Overall Study|Lost to Follow-up|33|||
155326392|NCT00357682|560631543|FG002|Overall Study|Lost to Follow-up|26|||
155326393|NCT00357682|560631544|FG003|Overall Study|Lost to Follow-up|35|||
155326394|NCT00357682|560631541|FG000|Overall Study|Adverse Event|24|||
155326395|NCT00357682|560631542|FG001|Overall Study|Adverse Event|32|||
155326396|NCT00357682|560631543|FG002|Overall Study|Adverse Event|22|||
155326397|NCT00357682|560631544|FG003|Overall Study|Adverse Event|27|||
155326398|NCT00357682|560631541|FG000|Overall Study|Physician Decision|32|||
155326399|NCT00357682|560631542|FG001|Overall Study|Physician Decision|20|||
155326400|NCT00357682|560631543|FG002|Overall Study|Physician Decision|24|||
155326401|NCT00357682|560631544|FG003|Overall Study|Physician Decision|30|||
155326402|NCT00357682|560631541|FG000|Overall Study|Patient decision|73|||
155326403|NCT00357682|560631542|FG001|Overall Study|Patient decision|80|||
155326404|NCT00357682|560631543|FG002|Overall Study|Patient decision|51|||
155326405|NCT00357682|560631544|FG003|Overall Study|Patient decision|59|||
155326406|NCT00357682|560631541|FG000|Overall Study|Other reason|157|||
155326407|NCT00357682|560631542|FG001|Overall Study|Other reason|130|||
155326408|NCT00357682|560631543|FG002|Overall Study|Other reason|114|||
155326409|NCT00357682|560631544|FG003|Overall Study|Other reason|99|||
155326410|NCT05424718|560631551|FG000|Overall Study|Lost to Follow-up|5|||
155326411|NCT05424718|560631552|FG001|Overall Study|Lost to Follow-up|4|||
155326412|NCT04046549|560631553|FG000|Overall Study|Adverse Event|1|||
155326413|NCT04046549|560631553|FG000|Overall Study|Physician Decision|1|||
155326414|NCT04046549|560631553|FG000|Overall Study|Withdrawal by Subject|3|||
155326415|NCT04046549|560631553|FG000|Overall Study|Other, Not Specified|5|||
155326416|NCT06059443|560631554|FG000|Overall Study|Withdrawal by Subject|2|||
155326417|NCT06059443|560631555|FG001|Overall Study|Withdrawal by Subject|0|||
155326418|NCT06059443|560631554|FG000|Overall Study|Lost to Follow-up|2|||
155326419|NCT06059443|560631555|FG001|Overall Study|Lost to Follow-up|2|||
155326420|NCT04479787|560631560|FG000|Through 6 Months|Withdrawal by Subject|16|||
155326421|NCT04479787|560631561|FG001|Through 6 Months|Withdrawal by Subject|14|||
155326422|NCT04479787|560631560|FG000|Through 6 Months|Unsuccessful Trial|17|||
155326423|NCT04479787|560631561|FG001|Through 6 Months|Unsuccessful Trial|0|||
155326424|NCT04479787|560631560|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
155326425|NCT04479787|560631561|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
155326426|NCT04479787|560631560|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
155326427|NCT04479787|560631561|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
155326428|NCT04479787|560631560|FG000|Through 6 Months|Lost to Follow-up|3|||
155326429|NCT04479787|560631561|FG001|Through 6 Months|Lost to Follow-up|2|||
155326430|NCT04479787|560631560|FG000|Through 6 Months|Death|3|||
155326431|NCT04479787|560631561|FG001|Through 6 Months|Death|0|||
155326432|NCT04479787|560631560|FG000|Through 6 Months|Inclusion/Exclusion|2|||
155326433|NCT04479787|560631561|FG001|Through 6 Months|Inclusion/Exclusion|1|||
155326434|NCT04479787|560631560|FG000|Through 6 Months|Subject Became Pregnant|1|||
155326435|NCT04479787|560631561|FG001|Through 6 Months|Subject Became Pregnant|1|||
155326436|NCT04479787|560631560|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
155326437|NCT04479787|560631561|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
155326438|NCT04479787|560631560|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
155326439|NCT04479787|560631561|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
155326440|NCT04479787|560631560|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
155326441|NCT04479787|560631561|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
155326442|NCT04479787|560631560|FG000|After 6 Months|Withdrawal by Subject|3|||
155326443|NCT04479787|560631561|FG001|After 6 Months|Withdrawal by Subject|13|||
155326444|NCT04479787|560631560|FG000|After 6 Months|Unsuccessful Trial|0|||
155069558|NCT03765073|559683992|FG009|Stage 3|Lost to Follow-up|0|||
155326445|NCT04479787|560631561|FG001|After 6 Months|Unsuccessful Trial|7|||
155326446|NCT04479787|560631560|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
155326447|NCT04479787|560631561|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
155326448|NCT04479787|560631560|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
155326449|NCT04479787|560631561|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
155326450|NCT04479787|560631560|FG000|After 6 Months|Death|2|||
155326451|NCT04479787|560631561|FG001|After 6 Months|Death|0|||
155326452|NCT04479787|560631560|FG000|After 6 Months|Lost to Follow-up|1|||
155326453|NCT04479787|560631561|FG001|After 6 Months|Lost to Follow-up|1|||
155326454|NCT04479787|560631560|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
155326455|NCT04479787|560631561|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
155326456|NCT04479787|560631560|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
155326457|NCT04479787|560631561|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
155069559|NCT03765073|559683993|FG010|Stage 3|Lost to Follow-up|0|||
155069560|NCT03765073|559683994|FG011|Stage 3|Lost to Follow-up|0|||
155069561|NCT03765073|559683995|FG012|Stage 3|Lost to Follow-up|0|||
155069562|NCT03765073|559683996|FG013|Stage 3|Lost to Follow-up|0|||
155069563|NCT03765073|559683997|FG014|Stage 3|Lost to Follow-up|0|||
155069564|NCT03765073|559683998|FG015|Stage 3|Lost to Follow-up|0|||
155069565|NCT03765073|559683999|FG016|Stage 3|Lost to Follow-up|0|||
155326458|NCT04479787|560631560|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
155326459|NCT04479787|560631561|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
155326460|NCT04479787|560631560|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
155326461|NCT04479787|560631561|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
155326462|NCT03983382|560632216|FG000|Overall Study|Death|1|||
155326463|NCT03983382|560632216|FG000|Overall Study|Lost to Follow-up|3|||
155326464|NCT03983382|560632216|FG000|Overall Study|Physician Decision|2|||
155326465|NCT03983382|560632216|FG000|Overall Study|Withdrawal by Subject|10|||
155326466|NCT03983382|560632216|FG000|Overall Study|Change in cancer treatment|2|||
155069566|NCT03765073|559684000|FG017|Stage 3|Lost to Follow-up|8|||
155069567|NCT03765073|559684001|FG018|Stage 3|Lost to Follow-up|5|||
155326467|NCT02166463|560632223|FG000|Overall Study|Lost to Follow-up|0|||
155326468|NCT02166463|560632224|FG001|Overall Study|Lost to Follow-up|1|||
155326469|NCT02166463|560632223|FG000|Overall Study|Physician Decision|10|||
155326470|NCT02166463|560632224|FG001|Overall Study|Physician Decision|10|||
155326471|NCT02166463|560632223|FG000|Overall Study|Ineligible|11|||
155326472|NCT02166463|560632224|FG001|Overall Study|Ineligible|2|||
155326473|NCT02166463|560632223|FG000|Overall Study|Progressive Disease|9|||
155326474|NCT02166463|560632224|FG001|Overall Study|Progressive Disease|6|||
155326475|NCT02166463|560632223|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
155326476|NCT02166463|560632224|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
155326477|NCT02166463|560632223|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
155326478|NCT02166463|560632224|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
155326479|NCT02166463|560632223|FG000|Overall Study|Refusal of further protocol therapy|5|||
155326480|NCT02166463|560632224|FG001|Overall Study|Refusal of further protocol therapy|6|||
155326481|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
155326482|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
155326483|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
155326484|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
155326485|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
155326486|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
155326487|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
155326488|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
155326489|NCT00982644|560632225|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
155326490|NCT00982644|560632226|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
155326491|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
155326492|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
155326493|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
155326494|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
155326495|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
155326496|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
155326497|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
155326498|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
155326499|NCT00982644|560632225|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
155326500|NCT00982644|560632226|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
155326501|NCT03767335|560632227|FG000|Overall Study|Physician Decision|1|||
155326502|NCT03767335|560632228|FG001|Overall Study|Physician Decision|1|||
155326503|NCT03767335|560632229|FG002|Overall Study|Physician Decision|0|||
155326504|NCT03767335|560632227|FG000|Overall Study|Withdrawal by Subject|0|||
155326505|NCT03767335|560632228|FG001|Overall Study|Withdrawal by Subject|0|||
155326506|NCT03767335|560632229|FG002|Overall Study|Withdrawal by Subject|6|||
155326507|NCT03767335|560632227|FG000|Overall Study|Participant excluded from efficacy population|0|||
155326508|NCT03767335|560632228|FG001|Overall Study|Participant excluded from efficacy population|0|||
155326509|NCT03767335|560632229|FG002|Overall Study|Participant excluded from efficacy population|1|||
155326510|NCT03767335|560632227|FG000|Overall Study|Death|0|||
155326511|NCT03767335|560632228|FG001|Overall Study|Death|0|||
155326512|NCT03767335|560632229|FG002|Overall Study|Death|2|||
155326513|NCT03767335|560632227|FG000|Overall Study|Progressive Disease|2|||
155326514|NCT03767335|560632228|FG001|Overall Study|Progressive Disease|2|||
155326515|NCT03767335|560632229|FG002|Overall Study|Progressive Disease|2|||
155326516|NCT03767335|560632227|FG000|Overall Study|Disease progression needing additional medication|0|||
155326517|NCT03767335|560632228|FG001|Overall Study|Disease progression needing additional medication|0|||
155326518|NCT03767335|560632229|FG002|Overall Study|Disease progression needing additional medication|17|||
155326519|NCT03767335|560632227|FG000|Overall Study|Sponsor decision|0|||
155326520|NCT03767335|560632228|FG001|Overall Study|Sponsor decision|0|||
155326521|NCT03767335|560632229|FG002|Overall Study|Sponsor decision|2|||
155326522|NCT03767335|560632227|FG000|Overall Study|Other Medical Reasons|0|||
155326523|NCT03767335|560632228|FG001|Overall Study|Other Medical Reasons|0|||
155326524|NCT03767335|560632229|FG002|Overall Study|Other Medical Reasons|3|||
155326525|NCT03660930|560632230|FG000|Overall Study|Adverse Event|0|||
155326526|NCT03660930|560632231|FG001|Overall Study|Adverse Event|0|||
155326527|NCT03660930|560632232|FG002|Overall Study|Adverse Event|0|||
155326528|NCT03660930|560632233|FG003|Overall Study|Adverse Event|2|||
155069568|NCT03765073|559684002|FG019|Stage 3|Lost to Follow-up|7|||
155069569|NCT03765073|559684003|FG020|Stage 3|Lost to Follow-up|4|||
155069570|NCT03765073|559683983|FG000|Stage 3|No longer meets eligibility criteria|0|||
155069571|NCT03765073|559683984|FG001|Stage 3|No longer meets eligibility criteria|0|||
155326529|NCT03660930|560632234|FG004|Overall Study|Adverse Event|0|||
155069572|NCT03765073|559683985|FG002|Stage 3|No longer meets eligibility criteria|0|||
155326530|NCT03660930|560632235|FG005|Overall Study|Adverse Event|1|||
155326531|NCT03660930|560632236|FG006|Overall Study|Adverse Event|0|||
155326532|NCT03660930|560632237|FG007|Overall Study|Adverse Event|0|||
155326533|NCT03660930|560632230|FG000|Overall Study|Withdrawal by Subject|0|||
155326534|NCT03660930|560632231|FG001|Overall Study|Withdrawal by Subject|0|||
155326535|NCT03660930|560632232|FG002|Overall Study|Withdrawal by Subject|0|||
155326536|NCT03660930|560632233|FG003|Overall Study|Withdrawal by Subject|0|||
155326537|NCT03660930|560632234|FG004|Overall Study|Withdrawal by Subject|0|||
155326538|NCT03660930|560632235|FG005|Overall Study|Withdrawal by Subject|1|||
155326539|NCT03660930|560632236|FG006|Overall Study|Withdrawal by Subject|0|||
155326540|NCT03660930|560632237|FG007|Overall Study|Withdrawal by Subject|0|||
155326541|NCT02726386|560632242|FG000|Overall Study|Adverse Event|17|||
155326542|NCT02726386|560632243|FG001|Overall Study|Adverse Event|20|||
155326543|NCT02726386|560632242|FG000|Overall Study|Withdrawal by Subject|14|||
155326544|NCT02726386|560632243|FG001|Overall Study|Withdrawal by Subject|28|||
155326545|NCT02726386|560632242|FG000|Overall Study|Other reasons|7|||
155326546|NCT02726386|560632243|FG001|Overall Study|Other reasons|8|||
155326547|NCT02112916|560632248|FG000|Overall Study|Adverse Event|6|||
155326548|NCT02112916|560632249|FG001|Overall Study|Adverse Event|9|||
155326549|NCT02112916|560632250|FG002|Overall Study|Adverse Event|3|||
155326550|NCT02112916|560632251|FG003|Overall Study|Adverse Event|2|||
155326551|NCT02112916|560632248|FG000|Overall Study|Death|9|||
155326552|NCT02112916|560632249|FG001|Overall Study|Death|9|||
155326553|NCT02112916|560632250|FG002|Overall Study|Death|3|||
155326554|NCT02112916|560632251|FG003|Overall Study|Death|4|||
155326555|NCT02112916|560632248|FG000|Overall Study|Lost to Follow-up|1|||
155326556|NCT02112916|560632249|FG001|Overall Study|Lost to Follow-up|0|||
155326557|NCT02112916|560632250|FG002|Overall Study|Lost to Follow-up|0|||
155326558|NCT02112916|560632251|FG003|Overall Study|Lost to Follow-up|0|||
155326559|NCT02112916|560632248|FG000|Overall Study|Physician Decision|94|||
155326560|NCT02112916|560632249|FG001|Overall Study|Physician Decision|72|||
155326561|NCT02112916|560632250|FG002|Overall Study|Physician Decision|24|||
155326562|NCT02112916|560632251|FG003|Overall Study|Physician Decision|15|||
155326563|NCT02112916|560632248|FG000|Overall Study|Withdrawal by Subject|5|||
155326564|NCT02112916|560632249|FG001|Overall Study|Withdrawal by Subject|3|||
155326565|NCT02112916|560632250|FG002|Overall Study|Withdrawal by Subject|1|||
155326566|NCT02112916|560632251|FG003|Overall Study|Withdrawal by Subject|1|||
155326567|NCT02112916|560632248|FG000|Overall Study|Ineligible|4|||
155326568|NCT02112916|560632249|FG001|Overall Study|Ineligible|8|||
155326569|NCT02112916|560632250|FG002|Overall Study|Ineligible|3|||
155326570|NCT02112916|560632251|FG003|Overall Study|Ineligible|8|||
155326571|NCT02112916|560632248|FG000|Overall Study|Inevaluable|6|||
155326572|NCT02112916|560632249|FG001|Overall Study|Inevaluable|4|||
155326573|NCT02112916|560632250|FG002|Overall Study|Inevaluable|5|||
155326574|NCT02112916|560632251|FG003|Overall Study|Inevaluable|5|||
155326575|NCT02112916|560632248|FG000|Overall Study|Refusal of further protocol therapy|19|||
155326576|NCT02112916|560632249|FG001|Overall Study|Refusal of further protocol therapy|16|||
155326577|NCT02112916|560632250|FG002|Overall Study|Refusal of further protocol therapy|1|||
155326578|NCT02112916|560632251|FG003|Overall Study|Refusal of further protocol therapy|7|||
155326579|NCT02112916|560632248|FG000|Overall Study|Development of SMN|1|||
155326580|NCT02112916|560632249|FG001|Overall Study|Development of SMN|0|||
155326581|NCT02112916|560632250|FG002|Overall Study|Development of SMN|0|||
155326582|NCT02112916|560632251|FG003|Overall Study|Development of SMN|1|||
155326583|NCT02112916|560632248|FG000|Overall Study|Relapse/Progression|10|||
155326584|NCT02112916|560632249|FG001|Overall Study|Relapse/Progression|18|||
155326585|NCT02112916|560632250|FG002|Overall Study|Relapse/Progression|15|||
155326586|NCT02112916|560632251|FG003|Overall Study|Relapse/Progression|2|||
155326587|NCT02112916|560632248|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
155326588|NCT02112916|560632249|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
155326589|NCT02112916|560632250|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
155326590|NCT02112916|560632251|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
155326591|NCT02112916|560632248|FG000|Overall Study|Still on Therapy|44|||
155326592|NCT02112916|560632249|FG001|Overall Study|Still on Therapy|47|||
155326593|NCT02112916|560632250|FG002|Overall Study|Still on Therapy|3|||
155326594|NCT02112916|560632251|FG003|Overall Study|Still on Therapy|2|||
155326595|NCT02112916|560632248|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
155326596|NCT02112916|560632249|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
155326597|NCT02112916|560632250|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
155326598|NCT02112916|560632251|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
155326599|NCT02112916|560632248|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
155326600|NCT02112916|560632249|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
155326601|NCT02112916|560632250|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
155326602|NCT02112916|560632251|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
155326603|NCT03333915|560632253|FG000|Overall Study|Lost to Follow-up|0|||
155326604|NCT03333915|560632254|FG001|Overall Study|Lost to Follow-up|0|||
155326605|NCT03333915|560632255|FG002|Overall Study|Lost to Follow-up|1|||
155326606|NCT03333915|560632256|FG003|Overall Study|Lost to Follow-up|0|||
155326607|NCT03333915|560632257|FG004|Overall Study|Lost to Follow-up|0|||
155326608|NCT03333915|560632253|FG000|Overall Study|Disease Progression|0|||
155326609|NCT03333915|560632254|FG001|Overall Study|Disease Progression|1|||
155326610|NCT03333915|560632255|FG002|Overall Study|Disease Progression|0|||
155326611|NCT03333915|560632256|FG003|Overall Study|Disease Progression|0|||
155326612|NCT03333915|560632257|FG004|Overall Study|Disease Progression|0|||
155326613|NCT03333915|560632253|FG000|Overall Study|Death|0|||
155326614|NCT03333915|560632254|FG001|Overall Study|Death|0|||
155326615|NCT03333915|560632255|FG002|Overall Study|Death|0|||
155326616|NCT03333915|560632256|FG003|Overall Study|Death|37|||
155326617|NCT03333915|560632257|FG004|Overall Study|Death|18|||
155326618|NCT03333915|560632253|FG000|Overall Study|Sponsor's Decision|0|||
155326619|NCT03333915|560632254|FG001|Overall Study|Sponsor's Decision|0|||
155326620|NCT03333915|560632255|FG002|Overall Study|Sponsor's Decision|0|||
155326621|NCT03333915|560632256|FG003|Overall Study|Sponsor's Decision|48|||
155326622|NCT03333915|560632257|FG004|Overall Study|Sponsor's Decision|4|||
155326623|NCT03333915|560632253|FG000|Overall Study|Withdrawal by Subject|0|||
155326624|NCT03333915|560632254|FG001|Overall Study|Withdrawal by Subject|0|||
155326625|NCT03333915|560632255|FG002|Overall Study|Withdrawal by Subject|0|||
155326626|NCT03333915|560632256|FG003|Overall Study|Withdrawal by Subject|5|||
155326627|NCT03333915|560632257|FG004|Overall Study|Withdrawal by Subject|1|||
155326628|NCT04174560|560632275|FG000|Overall Study|Lost to Follow-up|1|||
155326629|NCT04174560|560632276|FG001|Overall Study|Lost to Follow-up|0|||
155326630|NCT04174560|560632277|FG002|Overall Study|Lost to Follow-up|0|||
155326631|NCT04174560|560632278|FG003|Overall Study|Lost to Follow-up|0|||
155326632|NCT04174560|560632275|FG000|Overall Study|Withdrawal by Subject|0|||
155326633|NCT04174560|560632276|FG001|Overall Study|Withdrawal by Subject|0|||
155326634|NCT04174560|560632277|FG002|Overall Study|Withdrawal by Subject|2|||
155326635|NCT04174560|560632278|FG003|Overall Study|Withdrawal by Subject|0|||
155326636|NCT04940624|560632281|FG000|Overall Study|Adverse Event|4|||
155326637|NCT04940624|560632282|FG001|Overall Study|Adverse Event|11|||
155326638|NCT04940624|560632281|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155326639|NCT04940624|560632282|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155326640|NCT04940624|560632281|FG000|Overall Study|Physician Decision|1|||
155326641|NCT04940624|560632282|FG001|Overall Study|Physician Decision|0|||
155326642|NCT04940624|560632281|FG000|Overall Study|Lost to Follow-up|1|||
155326643|NCT04940624|560632282|FG001|Overall Study|Lost to Follow-up|0|||
155326644|NCT04940624|560632281|FG000|Overall Study|Reason Not Specified|1|||
155326645|NCT04940624|560632282|FG001|Overall Study|Reason Not Specified|0|||
155326646|NCT02890355|560632285|FG000|Overall Study|Adverse Event|5|||
155326647|NCT02890355|560632286|FG001|Overall Study|Adverse Event|5|||
155326648|NCT02890355|560632285|FG000|Overall Study|Refusal unrelated to adverse event|5|||
155326649|NCT02890355|560632286|FG001|Overall Study|Refusal unrelated to adverse event|10|||
155326650|NCT02890355|560632285|FG000|Overall Study|Progression/relapse|46|||
155326651|NCT02890355|560632286|FG001|Overall Study|Progression/relapse|39|||
155326652|NCT02890355|560632285|FG000|Overall Study|Not protocol specified|3|||
155326653|NCT02890355|560632286|FG001|Overall Study|Not protocol specified|4|||
155326654|NCT02180867|560632288|FG000|Overall Study|Adverse Event|3|||
155326655|NCT02180867|560632289|FG001|Overall Study|Adverse Event|4|||
155326656|NCT02180867|560632290|FG002|Overall Study|Adverse Event|1|||
155326657|NCT02180867|560632291|FG003|Overall Study|Adverse Event|5|||
155326658|NCT02180867|560632292|FG004|Overall Study|Adverse Event|0|||
155326659|NCT02180867|560632293|FG005|Overall Study|Adverse Event|0|||
155326660|NCT02180867|560632294|FG006|Overall Study|Adverse Event|0|||
155326661|NCT02180867|560632288|FG000|Overall Study|Death|0|||
155326662|NCT02180867|560632289|FG001|Overall Study|Death|0|||
155326663|NCT02180867|560632290|FG002|Overall Study|Death|0|||
155326664|NCT02180867|560632291|FG003|Overall Study|Death|0|||
155326665|NCT02180867|560632292|FG004|Overall Study|Death|1|||
155326666|NCT02180867|560632293|FG005|Overall Study|Death|0|||
155326667|NCT02180867|560632294|FG006|Overall Study|Death|0|||
155326668|NCT02180867|560632288|FG000|Overall Study|Lack of Efficacy|0|||
155326669|NCT02180867|560632289|FG001|Overall Study|Lack of Efficacy|2|||
155326670|NCT02180867|560632290|FG002|Overall Study|Lack of Efficacy|0|||
155326671|NCT02180867|560632291|FG003|Overall Study|Lack of Efficacy|1|||
155326672|NCT02180867|560632292|FG004|Overall Study|Lack of Efficacy|6|||
155326673|NCT02180867|560632293|FG005|Overall Study|Lack of Efficacy|0|||
155326674|NCT02180867|560632294|FG006|Overall Study|Lack of Efficacy|1|||
155326675|NCT02180867|560632288|FG000|Overall Study|Physician Decision|1|||
155326676|NCT02180867|560632289|FG001|Overall Study|Physician Decision|3|||
155326677|NCT02180867|560632290|FG002|Overall Study|Physician Decision|1|||
155326678|NCT02180867|560632291|FG003|Overall Study|Physician Decision|10|||
155326679|NCT02180867|560632292|FG004|Overall Study|Physician Decision|9|||
155326680|NCT02180867|560632293|FG005|Overall Study|Physician Decision|3|||
155326681|NCT02180867|560632294|FG006|Overall Study|Physician Decision|4|||
155326682|NCT02180867|560632288|FG000|Overall Study|Withdrawal by Subject|0|||
155326683|NCT02180867|560632289|FG001|Overall Study|Withdrawal by Subject|0|||
155326684|NCT02180867|560632290|FG002|Overall Study|Withdrawal by Subject|0|||
155326685|NCT02180867|560632291|FG003|Overall Study|Withdrawal by Subject|1|||
155326686|NCT02180867|560632292|FG004|Overall Study|Withdrawal by Subject|1|||
155326687|NCT02180867|560632293|FG005|Overall Study|Withdrawal by Subject|0|||
155326688|NCT02180867|560632294|FG006|Overall Study|Withdrawal by Subject|0|||
155326689|NCT02180867|560632288|FG000|Overall Study|Ineligible|1|||
155326690|NCT02180867|560632289|FG001|Overall Study|Ineligible|2|||
155326691|NCT02180867|560632290|FG002|Overall Study|Ineligible|0|||
155326692|NCT02180867|560632291|FG003|Overall Study|Ineligible|3|||
155326693|NCT02180867|560632292|FG004|Overall Study|Ineligible|5|||
155326694|NCT02180867|560632293|FG005|Overall Study|Ineligible|0|||
155326695|NCT02180867|560632294|FG006|Overall Study|Ineligible|0|||
155326696|NCT02180867|560632288|FG000|Overall Study|Repeat Eligibility Studies|0|||
155326697|NCT02180867|560632289|FG001|Overall Study|Repeat Eligibility Studies|0|||
155326698|NCT02180867|560632290|FG002|Overall Study|Repeat Eligibility Studies|0|||
155326699|NCT02180867|560632291|FG003|Overall Study|Repeat Eligibility Studies|0|||
155326700|NCT02180867|560632292|FG004|Overall Study|Repeat Eligibility Studies|1|||
155326701|NCT02180867|560632293|FG005|Overall Study|Repeat Eligibility Studies|0|||
155326702|NCT02180867|560632294|FG006|Overall Study|Repeat Eligibility Studies|0|||
155326703|NCT02180867|560632288|FG000|Overall Study|Refusal of further protocol therapy|1|||
155326704|NCT02180867|560632289|FG001|Overall Study|Refusal of further protocol therapy|0|||
155326705|NCT02180867|560632290|FG002|Overall Study|Refusal of further protocol therapy|2|||
155326706|NCT02180867|560632291|FG003|Overall Study|Refusal of further protocol therapy|6|||
155326707|NCT02180867|560632292|FG004|Overall Study|Refusal of further protocol therapy|4|||
155326708|NCT02180867|560632293|FG005|Overall Study|Refusal of further protocol therapy|0|||
155326709|NCT02180867|560632294|FG006|Overall Study|Refusal of further protocol therapy|0|||
155326710|NCT00994643|560632655|FG000|Overall Study|Withdrawal by Subject|1|||
155326711|NCT03653364|560632656|FG000|Overall Study|Withdrawal by Subject|1|||
155326712|NCT03653364|560632656|FG000|Overall Study|Enrolled in Error|1|||
155326713|NCT03653364|560632656|FG000|Overall Study|Death|1|||
155326714|NCT02306161|560632659|FG000|Overall Study|Death|1|||
155326715|NCT02306161|560632660|FG001|Overall Study|Death|3|||
155326716|NCT02306161|560632659|FG000|Overall Study|Lack of Efficacy|20|||
155326717|NCT02306161|560632660|FG001|Overall Study|Lack of Efficacy|43|||
155326718|NCT02306161|560632659|FG000|Overall Study|Physician Decision|30|||
155326719|NCT02306161|560632660|FG001|Overall Study|Physician Decision|18|||
155326720|NCT02306161|560632659|FG000|Overall Study|Withdrawal by Subject|4|||
155326721|NCT02306161|560632660|FG001|Overall Study|Withdrawal by Subject|0|||
155326722|NCT02306161|560632659|FG000|Overall Study|Ineligible|9|||
155326723|NCT02306161|560632660|FG001|Overall Study|Ineligible|5|||
155326724|NCT03705390|560632665|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
155326725|NCT03705390|560632665|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
155326726|NCT03047213|560632666|FG000|Overall Study|Withdrawal by Subject|2|||
155326727|NCT03047213|560632667|FG001|Overall Study|Withdrawal by Subject|0|||
155326728|NCT03047213|560632666|FG000|Overall Study|Adverse Event|2|||
155326729|NCT03047213|560632667|FG001|Overall Study|Adverse Event|0|||
155326730|NCT03725332|560632669|FG000|Overall Study|Adverse Event|5|||
155326731|NCT03725332|560632670|FG001|Overall Study|Adverse Event|10|||
155326732|NCT03725332|560632669|FG000|Overall Study|Death|1|||
155326733|NCT03725332|560632670|FG001|Overall Study|Death|3|||
155326734|NCT03725332|560632669|FG000|Overall Study|Lost to Follow-up|43|||
155326735|NCT03725332|560632670|FG001|Overall Study|Lost to Follow-up|122|||
155326736|NCT03725332|560632669|FG000|Overall Study|Withdrawal by Subject|0|||
155326737|NCT03725332|560632670|FG001|Overall Study|Withdrawal by Subject|1|||
155326738|NCT03725332|560632669|FG000|Overall Study|Duplicate enrollment|0|||
155326739|NCT03725332|560632670|FG001|Overall Study|Duplicate enrollment|1|||
155326740|NCT03725332|560632669|FG000|Overall Study|Did not consent|0|||
155326741|NCT03725332|560632670|FG001|Overall Study|Did not consent|1|||
155326742|NCT03242915|560632673|FG000|Overall Study|Adverse Event|5|||
155326743|NCT03242915|560632674|FG001|Overall Study|Adverse Event|1|||
155326744|NCT03242915|560632673|FG000|Overall Study|Withdrawal by Subject|0|||
155326745|NCT03242915|560632674|FG001|Overall Study|Withdrawal by Subject|2|||
155326746|NCT03242915|560632673|FG000|Overall Study|Physician Decision|4|||
155326747|NCT03242915|560632674|FG001|Overall Study|Physician Decision|1|||
155326748|NCT02754596|560632675|FG000|Overall Study|Withdrawal by Subject|3|||
155326749|NCT02754596|560632676|FG001|Overall Study|Withdrawal by Subject|4|||
155326750|NCT02754596|560632677|FG002|Overall Study|Withdrawal by Subject|0|||
155326751|NCT02754596|560632675|FG000|Overall Study|Physician Decision|1|||
155326752|NCT02754596|560632676|FG001|Overall Study|Physician Decision|1|||
155326753|NCT02754596|560632677|FG002|Overall Study|Physician Decision|1|||
155326754|NCT02754596|560632675|FG000|Overall Study|Lost to Follow-up|1|||
155326755|NCT02754596|560632676|FG001|Overall Study|Lost to Follow-up|1|||
155326756|NCT02754596|560632677|FG002|Overall Study|Lost to Follow-up|2|||
155326757|NCT02754596|560632675|FG000|Overall Study|Death|0|||
155326758|NCT02754596|560632676|FG001|Overall Study|Death|2|||
155326759|NCT02754596|560632677|FG002|Overall Study|Death|0|||
155326760|NCT02754596|560632675|FG000|Overall Study|Adverse Event|1|||
155326761|NCT02754596|560632676|FG001|Overall Study|Adverse Event|0|||
155326762|NCT02754596|560632677|FG002|Overall Study|Adverse Event|1|||
155326763|NCT02754596|560632675|FG000|Overall Study|Other|1|||
155326764|NCT02754596|560632676|FG001|Overall Study|Other|0|||
155326765|NCT02754596|560632677|FG002|Overall Study|Other|0|||
155326766|NCT03872466|560632678|FG000|Overall Study|Withdrawal by Subject|1|||
155326767|NCT03872466|560632679|FG001|Overall Study|Withdrawal by Subject|0|||
155326768|NCT03872466|560632678|FG000|Overall Study|Physician Decision|2|||
155326769|NCT03872466|560632679|FG001|Overall Study|Physician Decision|0|||
155326770|NCT01778686|560632680|FG000|Overall Study|Adverse Event|0|||
155326771|NCT01778686|560632681|FG001|Overall Study|Adverse Event|0|||
155326772|NCT01778686|560632682|FG002|Overall Study|Adverse Event|1|||
155326773|NCT04012567|560632683|FG000|Overall Study|Lost to Follow-up|0|||
155326774|NCT04012567|560632684|FG001|Overall Study|Lost to Follow-up|1|||
155326775|NCT04012567|560632683|FG000|Overall Study|Withdrawal by Subject|1|||
155326776|NCT04012567|560632684|FG001|Overall Study|Withdrawal by Subject|0|||
155326777|NCT03782116|560632687|FG000|Completed Intervetion|Lost to Follow-up|11|||
155326778|NCT03782116|560632688|FG001|Completed Intervetion|Lost to Follow-up|7|||
155326779|NCT03782116|560632687|FG000|Completed Intervetion|Withdrawal by Subject|6|||
155326780|NCT03782116|560632688|FG001|Completed Intervetion|Withdrawal by Subject|5|||
155326781|NCT03782116|560632687|FG000|Included in Analysis|Protocol Violation|5|||
155326782|NCT03782116|560632688|FG001|Included in Analysis|Protocol Violation|5|||
155326783|NCT05714059|560632691|FG000|Overall Study|Withdrawal by Subject|2|||
155326784|NCT05714059|560632692|FG001|Overall Study|Withdrawal by Subject|2|||
155326785|NCT05714059|560632691|FG000|Overall Study|Adverse Event|0|||
155326786|NCT05714059|560632692|FG001|Overall Study|Adverse Event|1|||
155326787|NCT05714059|560632691|FG000|Overall Study|Lost to Follow-up|0|||
155326788|NCT05714059|560632692|FG001|Overall Study|Lost to Follow-up|1|||
155326789|NCT05714059|560632691|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
155326790|NCT05714059|560632692|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
155326791|NCT05714059|560632691|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
155326792|NCT05714059|560632692|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
155326793|NCT04899674|560632693|FG000|Test|Adverse Event|1|||
155326794|NCT04129450|560632694|FG000|Overall Study|Lost to Follow-up|20|||
155326795|NCT04129450|560632695|FG001|Overall Study|Lost to Follow-up|10|||
155326796|NCT04129450|560632694|FG000|Overall Study|Withdrawal by Subject|9|||
155326797|NCT04129450|560632695|FG001|Overall Study|Withdrawal by Subject|5|||
155326798|NCT04129450|560632694|FG000|Overall Study|Work Family Obligations|2|||
155326799|NCT04129450|560632695|FG001|Overall Study|Work Family Obligations|0|||
155326800|NCT04129450|560632694|FG000|Overall Study|Other|3|||
155326801|NCT04129450|560632695|FG001|Overall Study|Other|0|||
155069573|NCT03765073|559683986|FG003|Stage 3|No longer meets eligibility criteria|0|||
155326802|NCT05039021|560633367|FG000|Overall Study|Death|1|||
155326803|NCT05039021|560633367|FG000|Overall Study|Lost to Follow-up|3|||
155326804|NCT02566889|560633368|FG000|Overall Study|Withdrawal by Subject|3|||
155326805|NCT02566889|560633369|FG001|Overall Study|Withdrawal by Subject|1|||
155326806|NCT02566889|560633368|FG000|Overall Study|Adverse Event|4|||
155326807|NCT02566889|560633369|FG001|Overall Study|Adverse Event|2|||
155326808|NCT02566889|560633368|FG000|Overall Study|Other|6|||
155326809|NCT02566889|560633369|FG001|Overall Study|Other|2|||
155326810|NCT04974047|560633371|FG000|Overall Study|Sponsor Ended Study|20|||
155326811|NCT04974047|560633372|FG001|Overall Study|Sponsor Ended Study|22|||
155326812|NCT04974047|560633371|FG000|Overall Study|Death|8|||
155326813|NCT04974047|560633372|FG001|Overall Study|Death|17|||
155326814|NCT04974047|560633371|FG000|Overall Study|Lost to Follow-up|2|||
155326815|NCT04974047|560633372|FG001|Overall Study|Lost to Follow-up|0|||
155326816|NCT04974047|560633371|FG000|Overall Study|Withdrawal by Subject|0|||
155326817|NCT04974047|560633372|FG001|Overall Study|Withdrawal by Subject|1|||
155326818|NCT00655499|560633373|FG000|Overall Study|not eligible|4|||
155326819|NCT03391466|560633374|FG000|Overall Study|Death|84|||
155326820|NCT03391466|560633375|FG001|Overall Study|Death|91|||
155326821|NCT03391466|560633374|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
155326822|NCT03391466|560633375|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
155069574|NCT03765073|559683987|FG004|Stage 3|No longer meets eligibility criteria|0|||
155326823|NCT03391466|560633374|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
155069575|NCT03765073|559683988|FG005|Stage 3|No longer meets eligibility criteria|0|||
155069576|NCT03765073|559683989|FG006|Stage 3|No longer meets eligibility criteria|0|||
155326824|NCT03391466|560633375|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
155326825|NCT03391466|560633374|FG000|Overall Study|Lost to Follow-up|9|||
155326826|NCT03391466|560633375|FG001|Overall Study|Lost to Follow-up|5|||
155326827|NCT03391466|560633374|FG000|Overall Study|Reason Not Specified|2|||
155069577|NCT03765073|559683990|FG007|Stage 3|No longer meets eligibility criteria|0|||
155069578|NCT03765073|559683991|FG008|Stage 3|No longer meets eligibility criteria|0|||
155326828|NCT03391466|560633375|FG001|Overall Study|Reason Not Specified|2|||
155326829|NCT03391466|560633374|FG000|Overall Study|Investigator Decision|0|||
155326830|NCT03391466|560633375|FG001|Overall Study|Investigator Decision|1|||
155326831|NCT03140670|560633376|FG000|Overall Study|Withdrawal by Subject|2|||
155326832|NCT03140670|560633376|FG000|Overall Study|Lost to Follow-up|1|||
155326833|NCT03140670|560633376|FG000|Overall Study|Physician Decision|1|||
155326834|NCT00220805|560633377|FG000|Overall Study|Adverse Event|1|||
155326835|NCT00220805|560633378|FG001|Overall Study|Adverse Event|3|||
155326836|NCT00220805|560633377|FG000|Overall Study|Withdrawal by Subject|3|||
155326837|NCT00220805|560633378|FG001|Overall Study|Withdrawal by Subject|0|||
155326838|NCT00220805|560633377|FG000|Overall Study|Lack of Efficacy|1|||
155326839|NCT00220805|560633378|FG001|Overall Study|Lack of Efficacy|0|||
155326840|NCT00220805|560633377|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
155326841|NCT00220805|560633378|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
155326842|NCT02325466|560633379|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
155326843|NCT02325466|560633380|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
155326844|NCT02325466|560633381|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
155326845|NCT02325466|560633379|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
155326846|NCT02325466|560633380|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
155326847|NCT02325466|560633381|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
155326848|NCT02325466|560633379|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
155326849|NCT02325466|560633380|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
155326850|NCT02325466|560633381|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
155326851|NCT02325466|560633379|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
155326852|NCT02325466|560633380|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
155326853|NCT02325466|560633381|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
155326854|NCT02325466|560633379|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
155326855|NCT02325466|560633380|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
155326856|NCT02325466|560633381|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
155326857|NCT02325466|560633379|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
155326858|NCT02325466|560633380|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
155326859|NCT02325466|560633381|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
155326860|NCT02325466|560633379|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
155326861|NCT02325466|560633380|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
155326862|NCT02325466|560633381|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
155326863|NCT02325466|560633379|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
155326864|NCT02325466|560633380|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
155326865|NCT02325466|560633381|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
155326866|NCT02325466|560633379|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
155326867|NCT02325466|560633380|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
155326868|NCT02325466|560633381|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
155326869|NCT03699163|560633382|FG000|Overall Study|Physician Decision|12|||
155326870|NCT03699163|560633383|FG001|Overall Study|Physician Decision|0|||
155326871|NCT03699163|560633382|FG000|Overall Study|failed QC measures|205|||
155326872|NCT03699163|560633383|FG001|Overall Study|failed QC measures|206|||
155326873|NCT01596972|560633384|FG000|Overall Study|Physician Decision|1|||
155326874|NCT01596972|560633385|FG001|Overall Study|Physician Decision|9|||
155326875|NCT01596972|560633384|FG000|Overall Study|Lost to Follow-up|0|||
155326876|NCT01596972|560633385|FG001|Overall Study|Lost to Follow-up|4|||
155326877|NCT01596972|560633384|FG000|Overall Study|Withdrawal by Subject|0|||
155326878|NCT01596972|560633385|FG001|Overall Study|Withdrawal by Subject|1|||
155326879|NCT01964300|560633387|FG000|Overall Study|Ineligible after enrollment|0|||
155326880|NCT01964300|560633388|FG001|Overall Study|Ineligible after enrollment|1|||
155326881|NCT01964300|560633387|FG000|Overall Study|Adverse Event|1|||
155326882|NCT01964300|560633388|FG001|Overall Study|Adverse Event|1|||
155326883|NCT01964300|560633387|FG000|Overall Study|Lack of Efficacy|3|||
155326884|NCT01964300|560633388|FG001|Overall Study|Lack of Efficacy|5|||
155069579|NCT03765073|559683992|FG009|Stage 3|No longer meets eligibility criteria|0|||
155069580|NCT03765073|559683993|FG010|Stage 3|No longer meets eligibility criteria|0|||
155069581|NCT03765073|559683994|FG011|Stage 3|No longer meets eligibility criteria|0|||
155069582|NCT03765073|559683995|FG012|Stage 3|No longer meets eligibility criteria|0|||
155069583|NCT03765073|559683996|FG013|Stage 3|No longer meets eligibility criteria|0|||
155069584|NCT03765073|559683997|FG014|Stage 3|No longer meets eligibility criteria|0|||
155069585|NCT03765073|559683998|FG015|Stage 3|No longer meets eligibility criteria|0|||
155069586|NCT03765073|559683999|FG016|Stage 3|No longer meets eligibility criteria|0|||
155069587|NCT03765073|559684000|FG017|Stage 3|No longer meets eligibility criteria|0|||
155326885|NCT01964300|560633387|FG000|Overall Study|Withdrawal by Subject|0|||
155326886|NCT01964300|560633388|FG001|Overall Study|Withdrawal by Subject|1|||
155326887|NCT01964300|560633387|FG000|Overall Study|To receive alternative therapy|1|||
155326888|NCT01964300|560633388|FG001|Overall Study|To receive alternative therapy|2|||
155069588|NCT03765073|559684001|FG018|Stage 3|No longer meets eligibility criteria|1|||
155069589|NCT03765073|559684002|FG019|Stage 3|No longer meets eligibility criteria|0|||
155069590|NCT03765073|559684003|FG020|Stage 3|No longer meets eligibility criteria|1|||
155069591|NCT03765073|559683983|FG000|Stage 3|Other|0|||
155069592|NCT03765073|559683984|FG001|Stage 3|Other|0|||
155069593|NCT03765073|559683985|FG002|Stage 3|Other|0|||
155069594|NCT03765073|559683986|FG003|Stage 3|Other|0|||
155069595|NCT03765073|559683987|FG004|Stage 3|Other|0|||
155069596|NCT03765073|559683988|FG005|Stage 3|Other|0|||
155069597|NCT03765073|559683989|FG006|Stage 3|Other|0|||
155069598|NCT03765073|559683990|FG007|Stage 3|Other|0|||
155069599|NCT03765073|559683991|FG008|Stage 3|Other|0|||
155069600|NCT03765073|559683992|FG009|Stage 3|Other|0|||
155069601|NCT03765073|559683993|FG010|Stage 3|Other|0|||
155069602|NCT03765073|559683994|FG011|Stage 3|Other|0|||
155069603|NCT03765073|559683995|FG012|Stage 3|Other|0|||
155069604|NCT03765073|559683996|FG013|Stage 3|Other|0|||
155069605|NCT03765073|559683997|FG014|Stage 3|Other|0|||
155069606|NCT03765073|559683998|FG015|Stage 3|Other|0|||
155069607|NCT03765073|559683999|FG016|Stage 3|Other|0|||
155069608|NCT03765073|559684000|FG017|Stage 3|Other|1|||
155069609|NCT03765073|559684001|FG018|Stage 3|Other|2|||
155069610|NCT03765073|559684002|FG019|Stage 3|Other|2|||
155069611|NCT03765073|559684003|FG020|Stage 3|Other|2|||
155069612|NCT03765073|559683983|FG000|Stage 3|Withdrawal by parent/guardian|0|||
155069613|NCT03765073|559683984|FG001|Stage 3|Withdrawal by parent/guardian|0|||
155069614|NCT03765073|559683985|FG002|Stage 3|Withdrawal by parent/guardian|0|||
155069615|NCT03765073|559683986|FG003|Stage 3|Withdrawal by parent/guardian|0|||
155069616|NCT03765073|559683987|FG004|Stage 3|Withdrawal by parent/guardian|0|||
155069617|NCT03765073|559683988|FG005|Stage 3|Withdrawal by parent/guardian|0|||
155069618|NCT03765073|559683989|FG006|Stage 3|Withdrawal by parent/guardian|0|||
155069619|NCT03765073|559683990|FG007|Stage 3|Withdrawal by parent/guardian|0|||
155069620|NCT03765073|559683991|FG008|Stage 3|Withdrawal by parent/guardian|0|||
155069621|NCT03765073|559683992|FG009|Stage 3|Withdrawal by parent/guardian|0|||
155069622|NCT03765073|559683993|FG010|Stage 3|Withdrawal by parent/guardian|0|||
155069623|NCT03765073|559683994|FG011|Stage 3|Withdrawal by parent/guardian|0|||
155069624|NCT03765073|559683995|FG012|Stage 3|Withdrawal by parent/guardian|0|||
155069625|NCT03765073|559683996|FG013|Stage 3|Withdrawal by parent/guardian|0|||
155069626|NCT03765073|559683997|FG014|Stage 3|Withdrawal by parent/guardian|0|||
155069627|NCT03765073|559683998|FG015|Stage 3|Withdrawal by parent/guardian|0|||
155069628|NCT03765073|559683999|FG016|Stage 3|Withdrawal by parent/guardian|0|||
155069629|NCT03765073|559684000|FG017|Stage 3|Withdrawal by parent/guardian|0|||
155069630|NCT03765073|559684001|FG018|Stage 3|Withdrawal by parent/guardian|0|||
155069631|NCT03765073|559684002|FG019|Stage 3|Withdrawal by parent/guardian|6|||
155069632|NCT03765073|559684003|FG020|Stage 3|Withdrawal by parent/guardian|9|||
155069633|NCT03765073|559683983|FG000|Stage 3|Withdrawal by Subject|0|||
155069634|NCT03765073|559683984|FG001|Stage 3|Withdrawal by Subject|0|||
155069635|NCT03765073|559683985|FG002|Stage 3|Withdrawal by Subject|0|||
155069636|NCT03765073|559683986|FG003|Stage 3|Withdrawal by Subject|0|||
155069637|NCT03765073|559683987|FG004|Stage 3|Withdrawal by Subject|0|||
155069638|NCT03765073|559683988|FG005|Stage 3|Withdrawal by Subject|0|||
155069639|NCT03765073|559683989|FG006|Stage 3|Withdrawal by Subject|0|||
155069640|NCT03765073|559683990|FG007|Stage 3|Withdrawal by Subject|0|||
155069641|NCT03765073|559683991|FG008|Stage 3|Withdrawal by Subject|0|||
155069642|NCT03765073|559683992|FG009|Stage 3|Withdrawal by Subject|0|||
155163058|NCT02873702|560033165|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
155163059|NCT02873702|560033162|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
155163060|NCT02873702|560033163|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
155163061|NCT02873702|560033164|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
155163062|NCT02873702|560033165|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
155163063|NCT02873702|560033162|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
155163064|NCT02873702|560033163|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
155163065|NCT02873702|560033164|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
155163066|NCT02873702|560033165|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
155163067|NCT02873702|560033162|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
155163068|NCT02873702|560033163|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
155163069|NCT02873702|560033164|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
155163070|NCT02873702|560033165|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
155163071|NCT02873702|560033162|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
155163072|NCT02873702|560033163|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
155069643|NCT03765073|559683993|FG010|Stage 3|Withdrawal by Subject|0|||
155069644|NCT03765073|559683994|FG011|Stage 3|Withdrawal by Subject|0|||
155069645|NCT03765073|559683995|FG012|Stage 3|Withdrawal by Subject|0|||
155069646|NCT03765073|559683996|FG013|Stage 3|Withdrawal by Subject|0|||
155069647|NCT03765073|559683997|FG014|Stage 3|Withdrawal by Subject|0|||
155069648|NCT03765073|559683998|FG015|Stage 3|Withdrawal by Subject|0|||
155069649|NCT03765073|559683999|FG016|Stage 3|Withdrawal by Subject|0|||
155326889|NCT01964300|560633387|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
155326890|NCT01964300|560633388|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
155069650|NCT03765073|559684000|FG017|Stage 3|Withdrawal by Subject|8|||
155326891|NCT01964300|560633387|FG000|Overall Study|Weight criteria not met|0|||
155326892|NCT01964300|560633388|FG001|Overall Study|Weight criteria not met|1|||
155326893|NCT00557492|560633389|FG000|Overall Study|Change in health insurance|1|||
155326894|NCT04129164|560633391|FG000|Overall Study|Non-compliance with procedures|0|||
155326895|NCT04129164|560633392|FG001|Overall Study|Non-compliance with procedures|0|||
155326896|NCT04129164|560633393|FG002|Overall Study|Non-compliance with procedures|2|||
155326897|NCT04129164|560633394|FG003|Overall Study|Non-compliance with procedures|0|||
155326898|NCT04129164|560633391|FG000|Overall Study|Adverse Event|0|||
155326899|NCT04129164|560633392|FG001|Overall Study|Adverse Event|0|||
155326900|NCT04129164|560633393|FG002|Overall Study|Adverse Event|2|||
155326901|NCT04129164|560633394|FG003|Overall Study|Adverse Event|0|||
155326902|NCT04129164|560633391|FG000|Overall Study|Pregnancy|0|||
155326903|NCT04129164|560633392|FG001|Overall Study|Pregnancy|0|||
155326904|NCT04129164|560633393|FG002|Overall Study|Pregnancy|0|||
155326905|NCT04129164|560633394|FG003|Overall Study|Pregnancy|1|||
155326906|NCT04129164|560633391|FG000|Overall Study|Withdrawal by Subject|3|||
155326907|NCT04129164|560633392|FG001|Overall Study|Withdrawal by Subject|2|||
155326908|NCT04129164|560633393|FG002|Overall Study|Withdrawal by Subject|4|||
155326909|NCT04129164|560633394|FG003|Overall Study|Withdrawal by Subject|6|||
155326910|NCT04129164|560633391|FG000|Overall Study|Death|0|||
155326911|NCT04129164|560633392|FG001|Overall Study|Death|1|||
155326912|NCT04129164|560633393|FG002|Overall Study|Death|0|||
155069651|NCT03765073|559684001|FG018|Stage 3|Withdrawal by Subject|11|||
155069652|NCT03765073|559684002|FG019|Stage 3|Withdrawal by Subject|0|||
155069653|NCT03765073|559684003|FG020|Stage 3|Withdrawal by Subject|0|||
155326913|NCT04129164|560633394|FG003|Overall Study|Death|0|||
155326914|NCT04129164|560633391|FG000|Overall Study|Lost to Follow-up|0|||
155326915|NCT04129164|560633392|FG001|Overall Study|Lost to Follow-up|1|||
155326916|NCT04129164|560633393|FG002|Overall Study|Lost to Follow-up|0|||
155326917|NCT04129164|560633394|FG003|Overall Study|Lost to Follow-up|0|||
155326918|NCT01260896|560633401|FG000|First Intervention|Withdrawn Due to Emesis|2|||
155326919|NCT01260896|560633402|FG001|First Intervention|Withdrawn Due to Emesis|0|||
155326920|NCT00003222|560633412|FG000|Overall Study|Physician Decision|0|||
155326921|NCT00003222|560633413|FG001|Overall Study|Physician Decision|1|||
155326922|NCT05030584|560633414|FG000|Overall Study|Adverse Event|17|||
155326923|NCT05030584|560633415|FG001|Overall Study|Adverse Event|2|||
155326924|NCT05030584|560633414|FG000|Overall Study|Lack of Efficacy|0|||
155326925|NCT05030584|560633415|FG001|Overall Study|Lack of Efficacy|6|||
155326926|NCT05030584|560633414|FG000|Overall Study|Lost to Follow-up|5|||
155326927|NCT05030584|560633415|FG001|Overall Study|Lost to Follow-up|2|||
155326928|NCT05030584|560633414|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155326929|NCT05030584|560633415|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155069654|NCT04063163|559684004|FG000|Overall Study|Death|281|||
155069655|NCT04063163|559684005|FG001|Overall Study|Death|166|||
155069656|NCT04063163|559684004|FG000|Overall Study|Lost to Follow-up|12|||
155069657|NCT04063163|559684005|FG001|Overall Study|Lost to Follow-up|8|||
155069658|NCT04063163|559684004|FG000|Overall Study|Withdrawal by Subject|19|||
155069659|NCT04063163|559684005|FG001|Overall Study|Withdrawal by Subject|10|||
155069660|NCT01160614|559684008|FG000|Overall Study|Withdrawal by Subject|0|||
155069661|NCT01160614|559684009|FG001|Overall Study|Withdrawal by Subject|2|||
155069662|NCT03805841|559684010|FG000|Overall Study|Clinical Progression|2|||
155069663|NCT03805841|559684011|FG001|Overall Study|Clinical Progression|0|||
155069664|NCT03805841|559684012|FG002|Overall Study|Clinical Progression|0|||
155069665|NCT03805841|559684010|FG000|Overall Study|Death|0|||
155069666|NCT03805841|559684011|FG001|Overall Study|Death|3|||
155069667|NCT03805841|559684012|FG002|Overall Study|Death|1|||
155069668|NCT03805841|559684010|FG000|Overall Study|Lost to Follow-up|0|||
155069669|NCT03805841|559684011|FG001|Overall Study|Lost to Follow-up|0|||
155163073|NCT02873702|560033164|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
155069670|NCT03805841|559684012|FG002|Overall Study|Lost to Follow-up|1|||
155069671|NCT03805841|559684010|FG000|Overall Study|Withdrawal by Subject|2|||
155163074|NCT02873702|560033165|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
155163075|NCT01229267|560033170|FG000|Overall Study|Adverse Event|4|||
155326930|NCT05030584|560633414|FG000|Overall Study|Other reason|4|||
155326931|NCT05030584|560633415|FG001|Overall Study|Other reason|3|||
155326932|NCT05030584|560633414|FG000|Overall Study|Physician Decision|1|||
155326933|NCT05030584|560633415|FG001|Overall Study|Physician Decision|4|||
155326934|NCT05030584|560633414|FG000|Overall Study|Protocol Violation|0|||
155326935|NCT05030584|560633415|FG001|Overall Study|Protocol Violation|2|||
155069672|NCT03805841|559684011|FG001|Overall Study|Withdrawal by Subject|3|||
155069673|NCT03805841|559684012|FG002|Overall Study|Withdrawal by Subject|0|||
155163076|NCT01229267|560033171|FG001|Overall Study|Adverse Event|6|||
155326936|NCT05030584|560633414|FG000|Overall Study|Randomized by Mistake|0|||
155326937|NCT05030584|560633415|FG001|Overall Study|Randomized by Mistake|2|||
155326938|NCT05030584|560633414|FG000|Overall Study|Withdrawal by Subject|21|||
155069674|NCT03805841|559684010|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
155069675|NCT03805841|559684011|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
155069676|NCT03805841|559684012|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
155069677|NCT03240874|559684013|FG000|Overall Study|Lost to Follow-up|0|||
155069678|NCT03240874|559684014|FG001|Overall Study|Lost to Follow-up|2|||
155069679|NCT03240874|559684015|FG002|Overall Study|Lost to Follow-up|4|||
155069680|NCT03240874|559684016|FG003|Overall Study|Lost to Follow-up|1|||
155069681|NCT01964404|559684017|FG000|Pre-Randomization - Scan 1|Screen Fail|49|||
155069682|NCT01964404|559684018|FG001|Pre-Randomization - Scan 1|Screen Fail|36|||
155069683|NCT01964404|559684019|FG002|Pre-Randomization - Scan 1|Screen Fail|12|||
155069684|NCT01964404|559684020|FG003|Pre-Randomization - Scan 1|Screen Fail|9|||
155069685|NCT01964404|559684021|FG004|Pre-Randomization - Scan 1|Screen Fail|0|||
155069686|NCT01964404|559684022|FG005|Pre-Randomization - Scan 1|Screen Fail|0|||
155069687|NCT01964404|559684023|FG006|Pre-Randomization - Scan 1|Screen Fail|0|||
155069688|NCT01964404|559684024|FG007|Pre-Randomization - Scan 1|Screen Fail|0|||
155069689|NCT01964404|559684025|FG008|Pre-Randomization - Scan 1|Screen Fail|0|||
155069690|NCT01964404|559684026|FG009|Pre-Randomization - Scan 1|Screen Fail|0|||
155069691|NCT01964404|559684017|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
155069692|NCT01964404|559684018|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|8|||
155069693|NCT01964404|559684019|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
155326939|NCT05030584|560633415|FG001|Overall Study|Withdrawal by Subject|28|||
155326940|NCT05030584|560633414|FG000|Overall Study|Technical Problems|0|||
155326941|NCT05030584|560633415|FG001|Overall Study|Technical Problems|1|||
155326942|NCT05030584|560633414|FG000|Overall Study|Completed post-treatment/FU visits|41|||
155326943|NCT05030584|560633415|FG001|Overall Study|Completed post-treatment/FU visits|31|||
155326944|NCT01313559|560633422|FG000|Overall Study|Withdrawal by Subject|1|||
155326945|NCT01313559|560633423|FG001|Overall Study|Withdrawal by Subject|2|||
155326946|NCT01313559|560633422|FG000|Overall Study|Disease progression|1|||
155326947|NCT01313559|560633423|FG001|Overall Study|Disease progression|0|||
155326948|NCT01313559|560633422|FG000|Overall Study|Rising PSA|2|||
155326949|NCT01313559|560633423|FG001|Overall Study|Rising PSA|0|||
155326950|NCT06393127|560633424|FG000|Washout period|Withdrawal by Subject|1|||
155326951|NCT06393127|560633425|FG001|Washout period|Withdrawal by Subject|0|||
155326952|NCT06393127|560633424|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
155326953|NCT06393127|560633425|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
155326954|NCT02446600|560633426|FG000|Overall Study|Never treated|20|||
155326955|NCT02446600|560633427|FG001|Overall Study|Never treated|2|||
155326956|NCT02446600|560633428|FG002|Overall Study|Never treated|6|||
155326957|NCT02446600|560633429|FG003|Overall Study|Never treated|0|||
155326958|NCT02446600|560633426|FG000|Overall Study|Withdrawal by Subject|19|||
155326959|NCT02446600|560633427|FG001|Overall Study|Withdrawal by Subject|5|||
155326960|NCT02446600|560633428|FG002|Overall Study|Withdrawal by Subject|17|||
155326961|NCT02446600|560633429|FG003|Overall Study|Withdrawal by Subject|0|||
155326962|NCT02446600|560633426|FG000|Overall Study|Ineligible|1|||
155326963|NCT02446600|560633427|FG001|Overall Study|Ineligible|4|||
155326964|NCT02446600|560633428|FG002|Overall Study|Ineligible|4|||
155326965|NCT02446600|560633429|FG003|Overall Study|Ineligible|1|||
155326966|NCT02446600|560633426|FG000|Overall Study|Duplicate Enrollment|0|||
155326967|NCT02446600|560633427|FG001|Overall Study|Duplicate Enrollment|1|||
155326968|NCT02446600|560633428|FG002|Overall Study|Duplicate Enrollment|0|||
155326969|NCT02446600|560633429|FG003|Overall Study|Duplicate Enrollment|0|||
155069694|NCT01964404|559684020|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
155069695|NCT01964404|559684021|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069696|NCT01964404|559684022|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069697|NCT01964404|559684023|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069698|NCT01964404|559684024|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069699|NCT01964404|559684025|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069700|NCT01964404|559684026|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069701|NCT01964404|559684017|FG000|Pre-Randomization - Scan 1|Withdrawal by Subject|3|||
155069702|NCT01964404|559684018|FG001|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
155069703|NCT01964404|559684019|FG002|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069704|NCT01964404|559684020|FG003|Pre-Randomization - Scan 1|Withdrawal by Subject|1|||
155069705|NCT01964404|559684021|FG004|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069706|NCT01964404|559684022|FG005|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155326970|NCT02466971|560633432|FG000|Overall Study|eligible and never treated|14|||
155326971|NCT02466971|560633433|FG001|Overall Study|eligible and never treated|20|||
155069707|NCT01964404|559684023|FG006|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155326972|NCT02466971|560633432|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
155326973|NCT02466971|560633433|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
155069708|NCT01964404|559684024|FG007|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069709|NCT01964404|559684025|FG008|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155326974|NCT02466971|560633432|FG000|Overall Study|ineligible and treated|1|||
155326975|NCT02466971|560633433|FG001|Overall Study|ineligible and treated|0|||
155163077|NCT01229267|560033172|FG002|Overall Study|Adverse Event|3|||
155326976|NCT02466971|560633432|FG000|Overall Study|ineligible and never treated|0|||
155326977|NCT02466971|560633433|FG001|Overall Study|ineligible and never treated|1|||
155326978|NCT02101853|560633434|FG000|Block 1 Induction|Adverse Event|11|||
155326979|NCT02101853|560633435|FG001|Block 1 Induction|Adverse Event|0|||
155326980|NCT02101853|560633436|FG002|Block 1 Induction|Adverse Event|0|||
155326981|NCT02101853|560633437|FG003|Block 1 Induction|Adverse Event|0|||
155326982|NCT02101853|560633438|FG004|Block 1 Induction|Adverse Event|0|||
155326983|NCT02101853|560633439|FG005|Block 1 Induction|Adverse Event|0|||
155326984|NCT02101853|560633434|FG000|Block 1 Induction|Death|20|||
155326985|NCT02101853|560633435|FG001|Block 1 Induction|Death|0|||
155326986|NCT02101853|560633436|FG002|Block 1 Induction|Death|0|||
155326987|NCT02101853|560633437|FG003|Block 1 Induction|Death|0|||
155326988|NCT02101853|560633438|FG004|Block 1 Induction|Death|0|||
155326989|NCT02101853|560633439|FG005|Block 1 Induction|Death|0|||
155326990|NCT02101853|560633434|FG000|Block 1 Induction|Lack of Efficacy|6|||
154961469|NCT00561015|559283941|FG001|Overall Study|Adverse Event|0|||
154961470|NCT00561015|559283942|FG002|Overall Study|Adverse Event|0|||
154961471|NCT00561015|559283943|FG003|Overall Study|Adverse Event|0|||
154961472|NCT00561015|559283944|FG004|Overall Study|Adverse Event|1|||
154961473|NCT00561015|559283945|FG005|Overall Study|Adverse Event|0|||
154961474|NCT00561015|559283940|FG000|Overall Study|Lost to Follow-up|2|||
154961475|NCT00561015|559283941|FG001|Overall Study|Lost to Follow-up|0|||
154961476|NCT00561015|559283942|FG002|Overall Study|Lost to Follow-up|0|||
154961477|NCT00561015|559283943|FG003|Overall Study|Lost to Follow-up|1|||
154961478|NCT00561015|559283944|FG004|Overall Study|Lost to Follow-up|0|||
154961479|NCT00561015|559283945|FG005|Overall Study|Lost to Follow-up|3|||
154961480|NCT00561015|559283940|FG000|Overall Study|Participant non-compliance|2|||
154961481|NCT00561015|559283941|FG001|Overall Study|Participant non-compliance|0|||
154961482|NCT00561015|559283942|FG002|Overall Study|Participant non-compliance|0|||
154961483|NCT00561015|559283943|FG003|Overall Study|Participant non-compliance|0|||
154961484|NCT00561015|559283944|FG004|Overall Study|Participant non-compliance|0|||
154961485|NCT00561015|559283945|FG005|Overall Study|Participant non-compliance|0|||
154961486|NCT03616535|559283946|FG000|Overall Study|Death|2|||
154961487|NCT03616535|559283947|FG001|Overall Study|Death|0|||
154961488|NCT03616535|559283948|FG002|Overall Study|Death|0|||
154961489|NCT03616535|559283949|FG003|Overall Study|Death|1|||
154961490|NCT03616535|559283946|FG000|Overall Study|Lost to Follow-up|2|||
154961491|NCT03616535|559283947|FG001|Overall Study|Lost to Follow-up|1|||
154961492|NCT03616535|559283948|FG002|Overall Study|Lost to Follow-up|0|||
154961493|NCT03616535|559283949|FG003|Overall Study|Lost to Follow-up|2|||
154961494|NCT03616535|559283946|FG000|Overall Study|Withdrawal by Subject|1|||
154961495|NCT03616535|559283947|FG001|Overall Study|Withdrawal by Subject|2|||
154961496|NCT03616535|559283948|FG002|Overall Study|Withdrawal by Subject|5|||
154961497|NCT03616535|559283949|FG003|Overall Study|Withdrawal by Subject|1|||
154961498|NCT03616535|559283946|FG000|Overall Study|Not specified or change in eligibility|2|||
154961499|NCT03616535|559283947|FG001|Overall Study|Not specified or change in eligibility|3|||
154961500|NCT03616535|559283948|FG002|Overall Study|Not specified or change in eligibility|3|||
154961501|NCT03616535|559283949|FG003|Overall Study|Not specified or change in eligibility|1|||
154961502|NCT00163657|559283950|FG000|Overall Study|Death|12|||
154961503|NCT00163657|559283951|FG001|Overall Study|Death|14|||
154961504|NCT00163657|559283952|FG002|Overall Study|Death|19|||
155326991|NCT02101853|560633435|FG001|Block 1 Induction|Lack of Efficacy|0|||
155326992|NCT02101853|560633436|FG002|Block 1 Induction|Lack of Efficacy|0|||
155326993|NCT02101853|560633437|FG003|Block 1 Induction|Lack of Efficacy|0|||
155326994|NCT02101853|560633438|FG004|Block 1 Induction|Lack of Efficacy|0|||
155326995|NCT02101853|560633439|FG005|Block 1 Induction|Lack of Efficacy|0|||
155326996|NCT02101853|560633434|FG000|Block 1 Induction|Physician Decision|61|||
155326997|NCT02101853|560633435|FG001|Block 1 Induction|Physician Decision|0|||
155326998|NCT02101853|560633436|FG002|Block 1 Induction|Physician Decision|0|||
155326999|NCT02101853|560633437|FG003|Block 1 Induction|Physician Decision|0|||
155327000|NCT02101853|560633438|FG004|Block 1 Induction|Physician Decision|0|||
155327001|NCT02101853|560633439|FG005|Block 1 Induction|Physician Decision|0|||
155327002|NCT02101853|560633434|FG000|Block 1 Induction|Protocol Violation|2|||
155327003|NCT02101853|560633435|FG001|Block 1 Induction|Protocol Violation|0|||
155163078|NCT01229267|560033173|FG003|Overall Study|Adverse Event|2|||
154961505|NCT00163657|559283950|FG000|Overall Study|graft loss|4|||
154961506|NCT00163657|559283951|FG001|Overall Study|graft loss|1|||
154961507|NCT00163657|559283952|FG002|Overall Study|graft loss|2|||
154961508|NCT00163657|559283950|FG000|Overall Study|Withdrawal by Subject|2|||
154961509|NCT00163657|559283951|FG001|Overall Study|Withdrawal by Subject|3|||
154961510|NCT00163657|559283952|FG002|Overall Study|Withdrawal by Subject|2|||
154961511|NCT00163657|559283950|FG000|Overall Study|Physician Decision|0|||
154961512|NCT00163657|559283951|FG001|Overall Study|Physician Decision|1|||
154961513|NCT00163657|559283952|FG002|Overall Study|Physician Decision|1|||
154961514|NCT00163657|559283950|FG000|Overall Study|Non Compliance|1|||
154961515|NCT00163657|559283951|FG001|Overall Study|Non Compliance|0|||
154961516|NCT00163657|559283952|FG002|Overall Study|Non Compliance|0|||
154961517|NCT00163657|559283950|FG000|Overall Study|Lost to Follow-up|1|||
154961518|NCT00163657|559283951|FG001|Overall Study|Lost to Follow-up|3|||
155327004|NCT02101853|560633436|FG002|Block 1 Induction|Protocol Violation|0|||
155327005|NCT02101853|560633437|FG003|Block 1 Induction|Protocol Violation|0|||
155327006|NCT02101853|560633438|FG004|Block 1 Induction|Protocol Violation|0|||
155327007|NCT02101853|560633439|FG005|Block 1 Induction|Protocol Violation|0|||
155327008|NCT02101853|560633434|FG000|Block 1 Induction|Withdrawal by Subject|65|||
155327009|NCT02101853|560633435|FG001|Block 1 Induction|Withdrawal by Subject|0|||
155327010|NCT02101853|560633436|FG002|Block 1 Induction|Withdrawal by Subject|0|||
155327011|NCT02101853|560633437|FG003|Block 1 Induction|Withdrawal by Subject|0|||
155327012|NCT02101853|560633438|FG004|Block 1 Induction|Withdrawal by Subject|0|||
155327013|NCT02101853|560633439|FG005|Block 1 Induction|Withdrawal by Subject|0|||
155327014|NCT02101853|560633434|FG000|Block 1 Induction|Ineligible|8|||
155327015|NCT02101853|560633435|FG001|Block 1 Induction|Ineligible|0|||
155327016|NCT02101853|560633436|FG002|Block 1 Induction|Ineligible|0|||
155327017|NCT02101853|560633437|FG003|Block 1 Induction|Ineligible|0|||
155327018|NCT02101853|560633438|FG004|Block 1 Induction|Ineligible|0|||
155327019|NCT02101853|560633439|FG005|Block 1 Induction|Ineligible|0|||
155327020|NCT02101853|560633434|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
155327021|NCT02101853|560633435|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327022|NCT02101853|560633436|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327023|NCT02101853|560633437|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327024|NCT02101853|560633438|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327025|NCT02101853|560633439|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
155327026|NCT02101853|560633434|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
155327027|NCT02101853|560633435|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327028|NCT02101853|560633436|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327029|NCT02101853|560633437|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327030|NCT02101853|560633438|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327031|NCT02101853|560633439|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327032|NCT02101853|560633434|FG000|Post Induction Randomization|Adverse Event|0|||
155327033|NCT02101853|560633435|FG001|Post Induction Randomization|Adverse Event|3|||
155327034|NCT02101853|560633436|FG002|Post Induction Randomization|Adverse Event|8|||
155327035|NCT02101853|560633437|FG003|Post Induction Randomization|Adverse Event|4|||
155327036|NCT02101853|560633438|FG004|Post Induction Randomization|Adverse Event|4|||
155327037|NCT02101853|560633439|FG005|Post Induction Randomization|Adverse Event|0|||
155327038|NCT02101853|560633434|FG000|Post Induction Randomization|Death|0|||
155327039|NCT02101853|560633435|FG001|Post Induction Randomization|Death|9|||
155327040|NCT02101853|560633436|FG002|Post Induction Randomization|Death|2|||
155327041|NCT02101853|560633437|FG003|Post Induction Randomization|Death|2|||
155327042|NCT02101853|560633438|FG004|Post Induction Randomization|Death|0|||
155327043|NCT02101853|560633439|FG005|Post Induction Randomization|Death|0|||
155327044|NCT02101853|560633434|FG000|Post Induction Randomization|Lack of Efficacy|0|||
155327045|NCT02101853|560633435|FG001|Post Induction Randomization|Lack of Efficacy|14|||
155327046|NCT02101853|560633436|FG002|Post Induction Randomization|Lack of Efficacy|23|||
155327047|NCT02101853|560633437|FG003|Post Induction Randomization|Lack of Efficacy|18|||
155327048|NCT02101853|560633438|FG004|Post Induction Randomization|Lack of Efficacy|21|||
155327049|NCT02101853|560633439|FG005|Post Induction Randomization|Lack of Efficacy|0|||
155327050|NCT02101853|560633434|FG000|Post Induction Randomization|Physician Decision|0|||
155327051|NCT02101853|560633435|FG001|Post Induction Randomization|Physician Decision|43|||
155327052|NCT02101853|560633436|FG002|Post Induction Randomization|Physician Decision|23|||
155327053|NCT02101853|560633437|FG003|Post Induction Randomization|Physician Decision|14|||
155327054|NCT02101853|560633438|FG004|Post Induction Randomization|Physician Decision|14|||
155327055|NCT02101853|560633439|FG005|Post Induction Randomization|Physician Decision|0|||
155327056|NCT02101853|560633434|FG000|Post Induction Randomization|Protocol Violation|0|||
155327057|NCT02101853|560633435|FG001|Post Induction Randomization|Protocol Violation|3|||
155327058|NCT02101853|560633436|FG002|Post Induction Randomization|Protocol Violation|0|||
155327059|NCT02101853|560633437|FG003|Post Induction Randomization|Protocol Violation|0|||
155327060|NCT02101853|560633438|FG004|Post Induction Randomization|Protocol Violation|0|||
155327061|NCT02101853|560633439|FG005|Post Induction Randomization|Protocol Violation|0|||
155327062|NCT02101853|560633434|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
155327063|NCT02101853|560633435|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
155327064|NCT02101853|560633436|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
155327065|NCT02101853|560633437|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
155327066|NCT02101853|560633438|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
155327067|NCT02101853|560633439|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
155327068|NCT02101853|560633434|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327069|NCT02101853|560633435|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327070|NCT02101853|560633436|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327071|NCT02101853|560633437|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
155327072|NCT02101853|560633438|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327073|NCT02101853|560633439|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
155327074|NCT02101853|560633434|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327075|NCT02101853|560633435|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
155327076|NCT02101853|560633436|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
155327077|NCT02101853|560633437|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327078|NCT02101853|560633438|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327079|NCT02101853|560633439|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
155327080|NCT02101853|560633434|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327081|NCT02101853|560633435|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
155327082|NCT02101853|560633436|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327083|NCT02101853|560633437|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327084|NCT02101853|560633438|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327085|NCT02101853|560633439|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
155327086|NCT02101853|560633434|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327087|NCT02101853|560633435|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327088|NCT02101853|560633436|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327089|NCT02101853|560633437|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
155327090|NCT02101853|560633438|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
155327091|NCT02101853|560633439|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
155327092|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Death|0|||
155327093|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Death|0|||
155327094|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Death|0|||
155327095|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Death|0|||
155327096|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Death|0|||
155327097|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Death|2|||
155327098|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327099|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327100|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327101|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327102|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
155327103|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
155327104|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327105|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327106|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327107|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327108|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
155327109|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
154961519|NCT00163657|559283952|FG002|Overall Study|Lost to Follow-up|10|||
155327110|NCT02101853|560633434|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327111|NCT02101853|560633435|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327112|NCT02101853|560633436|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327113|NCT02101853|560633437|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327114|NCT02101853|560633438|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
155327115|NCT02101853|560633439|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
155327116|NCT05707351|560633443|FG000|Overall Study|Withdrawal by Subject|2|||
155327117|NCT05707351|560633443|FG000|Overall Study|Reason Not Specified|1|||
155327118|NCT05934292|560633449|FG000|Overall Study|Lost to Follow-up|0|||
155327119|NCT05934292|560633450|FG001|Overall Study|Lost to Follow-up|0|||
155327120|NCT05934292|560633451|FG002|Overall Study|Lost to Follow-up|1|||
155327121|NCT05934292|560633452|FG003|Overall Study|Lost to Follow-up|0|||
155327122|NCT01639131|560634382|FG000|Overall Study|Disease Progression|6|||
155327123|NCT01637402|560634383|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
155327124|NCT01637402|560634384|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
155327125|NCT01637402|560634383|FG000|Standard Dose Regimen|Adverse Event|1|||
155327126|NCT01637402|560634384|FG001|Standard Dose Regimen|Adverse Event|0|||
155327127|NCT01637402|560634383|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
155327128|NCT01637402|560634384|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
155327129|NCT01637402|560634383|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
155327130|NCT01637402|560634384|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
155327131|NCT01637402|560634383|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
155327132|NCT01637402|560634384|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
155327133|NCT01637402|560634383|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
155327134|NCT01637402|560634384|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
155327135|NCT02285270|560634385|FG000|Overall Study|Lost to Follow-up|1|||
155327136|NCT02285270|560634385|FG000|Overall Study|Physician Decision|3|||
155327137|NCT02285270|560634385|FG000|Overall Study|Determined to be ineligible|1|||
155327138|NCT00439270|560634386|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
155327139|NCT00439270|560634387|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
155327140|NCT00439270|560634388|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
155327141|NCT00439270|560634389|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
155327142|NCT00439270|560634390|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
155327143|NCT00439270|560634386|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327144|NCT00439270|560634387|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
155327145|NCT00439270|560634388|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327146|NCT00439270|560634389|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327147|NCT00439270|560634390|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
155327148|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
155327149|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
155327150|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
155327151|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
155327152|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
155327153|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327154|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327155|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327156|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
155327157|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
155327158|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327159|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327160|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327161|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
155327162|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
155327163|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327164|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327165|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327166|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
155327167|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
155327168|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327169|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327170|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327171|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
155327172|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
155327173|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327174|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327175|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327176|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
155327177|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
155327178|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327179|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327180|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327181|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
155327182|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
155327183|NCT00439270|560634386|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327184|NCT00439270|560634387|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327185|NCT00439270|560634388|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327186|NCT00439270|560634389|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
155327187|NCT00439270|560634390|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
155327188|NCT01268306|560634391|FG000|Overall Study|Lost to Follow-up|1|||
155327189|NCT04334317|560634392|FG000|Overall Study|Adverse Event|1|||
155327190|NCT04334317|560634393|FG001|Overall Study|Adverse Event|2|||
155327191|NCT04334317|560634394|FG002|Overall Study|Adverse Event|0|||
155327192|NCT04334317|560634395|FG003|Overall Study|Adverse Event|0|||
155327193|NCT04334317|560634392|FG000|Overall Study|Protocol Deviation|0|||
155327194|NCT04334317|560634393|FG001|Overall Study|Protocol Deviation|1|||
155327195|NCT04334317|560634394|FG002|Overall Study|Protocol Deviation|0|||
155327196|NCT04334317|560634395|FG003|Overall Study|Protocol Deviation|0|||
155327197|NCT04334317|560634392|FG000|Overall Study|Withdrawal by Subject|2|||
155327198|NCT04334317|560634393|FG001|Overall Study|Withdrawal by Subject|2|||
155327199|NCT04334317|560634394|FG002|Overall Study|Withdrawal by Subject|0|||
155327200|NCT04334317|560634395|FG003|Overall Study|Withdrawal by Subject|0|||
155327201|NCT04121546|560634400|FG000|Overall Study|Lost to Follow-up|1|||
155327202|NCT04121546|560634401|FG001|Overall Study|Lost to Follow-up|3|||
155327203|NCT03286114|560634405|FG000|Overall Study|Adverse Event|6|||
155327204|NCT03286114|560634405|FG000|Overall Study|Death|3|||
155327205|NCT00943917|560634414|FG000|Stage I|Adverse Event|1|||
155327206|NCT00943917|560634415|FG001|Stage I|Adverse Event|2|||
155327207|NCT00943917|560634416|FG002|Stage I|Adverse Event|2|||
155327208|NCT00943917|560634417|FG003|Stage I|Adverse Event|0|||
155327209|NCT00943917|560634418|FG004|Stage I|Adverse Event|0|||
155327210|NCT00943917|560634419|FG005|Stage I|Adverse Event|0|||
155327211|NCT00943917|560634420|FG006|Stage I|Adverse Event|0|||
155327212|NCT00943917|560634421|FG007|Stage I|Adverse Event|0|||
155327213|NCT00943917|560634422|FG008|Stage I|Adverse Event|0|||
155327214|NCT00943917|560634423|FG009|Stage I|Adverse Event|0|||
155327215|NCT00943917|560634424|FG010|Stage I|Adverse Event|0|||
155327216|NCT00943917|560634425|FG011|Stage I|Adverse Event|0|||
155327217|NCT00943917|560634426|FG012|Stage I|Adverse Event|0|||
155327218|NCT00943917|560634427|FG013|Stage I|Adverse Event|0|||
155327219|NCT00943917|560634428|FG014|Stage I|Adverse Event|0|||
155327220|NCT00943917|560634414|FG000|Stage I|Lost to Follow-up|0|||
155327221|NCT00943917|560634415|FG001|Stage I|Lost to Follow-up|0|||
155327222|NCT00943917|560634416|FG002|Stage I|Lost to Follow-up|1|||
155327223|NCT00943917|560634417|FG003|Stage I|Lost to Follow-up|0|||
155327224|NCT00943917|560634418|FG004|Stage I|Lost to Follow-up|0|||
155327225|NCT00943917|560634419|FG005|Stage I|Lost to Follow-up|0|||
155327226|NCT00943917|560634420|FG006|Stage I|Lost to Follow-up|0|||
155327227|NCT00943917|560634421|FG007|Stage I|Lost to Follow-up|0|||
155327228|NCT00943917|560634422|FG008|Stage I|Lost to Follow-up|0|||
155327229|NCT00943917|560634423|FG009|Stage I|Lost to Follow-up|0|||
155327230|NCT00943917|560634424|FG010|Stage I|Lost to Follow-up|0|||
155327231|NCT00943917|560634425|FG011|Stage I|Lost to Follow-up|0|||
155327232|NCT00943917|560634426|FG012|Stage I|Lost to Follow-up|0|||
155327233|NCT00943917|560634427|FG013|Stage I|Lost to Follow-up|0|||
155327234|NCT00943917|560634428|FG014|Stage I|Lost to Follow-up|0|||
155327235|NCT00943917|560634414|FG000|Stage I|hyperglycemia|0|||
155327236|NCT00943917|560634415|FG001|Stage I|hyperglycemia|0|||
155327237|NCT00943917|560634416|FG002|Stage I|hyperglycemia|1|||
155327238|NCT00943917|560634417|FG003|Stage I|hyperglycemia|0|||
155327239|NCT00943917|560634418|FG004|Stage I|hyperglycemia|0|||
155327240|NCT00943917|560634419|FG005|Stage I|hyperglycemia|0|||
155327241|NCT00943917|560634420|FG006|Stage I|hyperglycemia|0|||
155327242|NCT00943917|560634421|FG007|Stage I|hyperglycemia|0|||
155327243|NCT00943917|560634422|FG008|Stage I|hyperglycemia|0|||
155327244|NCT00943917|560634423|FG009|Stage I|hyperglycemia|0|||
154961520|NCT00163657|559283950|FG000|Overall Study|Other reason|0|||
154961521|NCT00163657|559283951|FG001|Overall Study|Other reason|1|||
154961522|NCT00163657|559283952|FG002|Overall Study|Other reason|3|||
155327245|NCT00943917|560634424|FG010|Stage I|hyperglycemia|0|||
155327246|NCT00943917|560634425|FG011|Stage I|hyperglycemia|0|||
155327247|NCT00943917|560634426|FG012|Stage I|hyperglycemia|0|||
155327248|NCT00943917|560634427|FG013|Stage I|hyperglycemia|0|||
155327249|NCT00943917|560634428|FG014|Stage I|hyperglycemia|0|||
155327250|NCT00943917|560634414|FG000|Stage I|A1C elevation|1|||
155327251|NCT00943917|560634415|FG001|Stage I|A1C elevation|0|||
155327252|NCT00943917|560634416|FG002|Stage I|A1C elevation|0|||
155327253|NCT00943917|560634417|FG003|Stage I|A1C elevation|0|||
155327254|NCT00943917|560634418|FG004|Stage I|A1C elevation|0|||
155327255|NCT00943917|560634419|FG005|Stage I|A1C elevation|0|||
155327256|NCT00943917|560634420|FG006|Stage I|A1C elevation|0|||
155327257|NCT00943917|560634421|FG007|Stage I|A1C elevation|0|||
155069710|NCT01964404|559684026|FG009|Pre-Randomization - Scan 1|Withdrawal by Subject|0|||
155069711|NCT05528510|559684027|FG000|Overall Study|Death|1|||
155069712|NCT05528510|559684028|FG001|Overall Study|Death|0|||
155069713|NCT05528510|559684029|FG002|Overall Study|Death|0|||
155069714|NCT05528510|559684027|FG000|Overall Study|Lost to Follow-up|1|||
155069715|NCT05528510|559684028|FG001|Overall Study|Lost to Follow-up|0|||
155069716|NCT05528510|559684029|FG002|Overall Study|Lost to Follow-up|0|||
155069717|NCT05528510|559684027|FG000|Overall Study|Withdrawal by Subject|4|||
155069718|NCT05528510|559684028|FG001|Overall Study|Withdrawal by Subject|1|||
155069719|NCT05528510|559684029|FG002|Overall Study|Withdrawal by Subject|3|||
155069720|NCT05528510|559684027|FG000|Overall Study|Other|2|||
155069721|NCT05528510|559684028|FG001|Overall Study|Other|2|||
155069722|NCT05528510|559684029|FG002|Overall Study|Other|1|||
155069723|NCT03036254|559684030|FG000|Overall Study|Adverse Event|6|||
155069724|NCT03036254|559684031|FG001|Overall Study|Adverse Event|4|||
155069725|NCT03036254|559684030|FG000|Overall Study|Death|3|||
155069726|NCT03036254|559684031|FG001|Overall Study|Death|1|||
155069727|NCT03036254|559684030|FG000|Overall Study|Lack of Efficacy|5|||
155069728|NCT03036254|559684031|FG001|Overall Study|Lack of Efficacy|1|||
155069729|NCT03036254|559684030|FG000|Overall Study|Withdrawal by Subject|3|||
155069730|NCT03036254|559684031|FG001|Overall Study|Withdrawal by Subject|5|||
155069731|NCT05317546|559684037|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
155069732|NCT05317546|559684038|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
155069733|NCT05350202|559684039|FG000|Visit 1 - Baseline|Not-treated|18|||
155069734|NCT05350202|559684040|FG001|Visit 1 - Baseline|Not-treated|0|||
155069735|NCT05350202|559684039|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
155069736|NCT05350202|559684040|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
155069737|NCT05350202|559684039|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
155069738|NCT05350202|559684040|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
155069739|NCT05350202|559684039|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
155069740|NCT05350202|559684040|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
155069741|NCT05350202|559684039|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
155069742|NCT05350202|559684040|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
155069743|NCT05350202|559684039|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
155069744|NCT05350202|559684040|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
155069745|NCT05350202|559684039|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
155069746|NCT05350202|559684040|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
155069747|NCT04707469|559684041|FG000|Overall Study|Site closure|0|||
155069748|NCT04707469|559684042|FG001|Overall Study|Site closure|2|||
155069749|NCT04707469|559684043|FG002|Overall Study|Site closure|0|||
155069750|NCT04707469|559684041|FG000|Overall Study|Physician Decision|2|||
155069751|NCT04707469|559684042|FG001|Overall Study|Physician Decision|2|||
155069752|NCT04707469|559684043|FG002|Overall Study|Physician Decision|2|||
155069753|NCT04707469|559684041|FG000|Overall Study|Death|1|||
155069754|NCT04707469|559684042|FG001|Overall Study|Death|6|||
155069755|NCT04707469|559684043|FG002|Overall Study|Death|2|||
155069756|NCT04707469|559684041|FG000|Overall Study|Lost to Follow-up|9|||
155069757|NCT04707469|559684042|FG001|Overall Study|Lost to Follow-up|19|||
155069758|NCT04707469|559684043|FG002|Overall Study|Lost to Follow-up|14|||
155069759|NCT04707469|559684041|FG000|Overall Study|Withdrawal by Subject|17|||
155069760|NCT04707469|559684042|FG001|Overall Study|Withdrawal by Subject|16|||
155069761|NCT04707469|559684043|FG002|Overall Study|Withdrawal by Subject|12|||
155069762|NCT04603066|559684056|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
155069763|NCT04603066|559684057|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
155069764|NCT01525589|559684058|FG000|Overall Study|Non-treatment-related AE|1|||
155069765|NCT01525589|559684059|FG001|Overall Study|Non-treatment-related AE|0|||
155069766|NCT01525589|559684060|FG002|Overall Study|Non-treatment-related AE|0|||
155069767|NCT01525589|559684058|FG000|Overall Study|Progressive disease|48|||
155069768|NCT01525589|559684059|FG001|Overall Study|Progressive disease|15|||
155069769|NCT01525589|559684060|FG002|Overall Study|Progressive disease|29|||
155069770|NCT01525589|559684058|FG000|Overall Study|Never treated|2|||
155069771|NCT01525589|559684059|FG001|Overall Study|Never treated|0|||
155069772|NCT01525589|559684060|FG002|Overall Study|Never treated|0|||
155069773|NCT01525589|559684058|FG000|Overall Study|Physician Decision|4|||
155069774|NCT01525589|559684059|FG001|Overall Study|Physician Decision|2|||
155069775|NCT01525589|559684060|FG002|Overall Study|Physician Decision|2|||
155069776|NCT01525589|559684058|FG000|Overall Study|Death|0|||
155069777|NCT01525589|559684059|FG001|Overall Study|Death|0|||
155069778|NCT01525589|559684060|FG002|Overall Study|Death|2|||
155069779|NCT01525589|559684058|FG000|Overall Study|Treatment-related AE|1|||
155069780|NCT01525589|559684059|FG001|Overall Study|Treatment-related AE|1|||
155069781|NCT01525589|559684060|FG002|Overall Study|Treatment-related AE|2|||
155069782|NCT01525589|559684058|FG000|Overall Study|Other reasons|0|||
155069783|NCT01525589|559684059|FG001|Overall Study|Other reasons|1|||
155069784|NCT01525589|559684060|FG002|Overall Study|Other reasons|0|||
155069785|NCT01525589|559684058|FG000|Overall Study|Withdrawal by Subject|0|||
155069786|NCT01525589|559684059|FG001|Overall Study|Withdrawal by Subject|1|||
155069787|NCT01525589|559684060|FG002|Overall Study|Withdrawal by Subject|0|||
155069788|NCT02924376|559684061|FG000|Overall Study|Progressive Disease|4|||
155069789|NCT02924376|559684062|FG001|Overall Study|Progressive Disease|0|||
155069790|NCT02924376|559684063|FG002|Overall Study|Progressive Disease|1|||
155069791|NCT02924376|559684064|FG003|Overall Study|Progressive Disease|0|||
155069792|NCT02924376|559684061|FG000|Overall Study|Death|73|||
155069793|NCT02924376|559684062|FG001|Overall Study|Death|18|||
155069794|NCT02924376|559684063|FG002|Overall Study|Death|15|||
155069795|NCT02924376|559684064|FG003|Overall Study|Death|2|||
155069796|NCT02924376|559684061|FG000|Overall Study|Lost to Follow-up|3|||
155069797|NCT02924376|559684062|FG001|Overall Study|Lost to Follow-up|0|||
155069798|NCT02924376|559684063|FG002|Overall Study|Lost to Follow-up|0|||
155069799|NCT02924376|559684064|FG003|Overall Study|Lost to Follow-up|0|||
155069800|NCT02924376|559684061|FG000|Overall Study|Study Terminated by Sponsor|19|||
155069801|NCT02924376|559684062|FG001|Overall Study|Study Terminated by Sponsor|0|||
155069802|NCT02924376|559684063|FG002|Overall Study|Study Terminated by Sponsor|0|||
155069803|NCT02924376|559684064|FG003|Overall Study|Study Terminated by Sponsor|0|||
155069804|NCT02924376|559684061|FG000|Overall Study|Physician Decision|1|||
155069805|NCT02924376|559684062|FG001|Overall Study|Physician Decision|0|||
155069806|NCT02924376|559684063|FG002|Overall Study|Physician Decision|0|||
155069807|NCT02924376|559684064|FG003|Overall Study|Physician Decision|0|||
155069808|NCT02924376|559684061|FG000|Overall Study|Withdrawal by Subject|7|||
155069809|NCT02924376|559684062|FG001|Overall Study|Withdrawal by Subject|2|||
155327258|NCT00943917|560634422|FG008|Stage I|A1C elevation|0|||
155327259|NCT00943917|560634423|FG009|Stage I|A1C elevation|0|||
155327260|NCT00943917|560634424|FG010|Stage I|A1C elevation|0|||
155327261|NCT00943917|560634425|FG011|Stage I|A1C elevation|0|||
155327262|NCT00943917|560634426|FG012|Stage I|A1C elevation|0|||
155327263|NCT00943917|560634427|FG013|Stage I|A1C elevation|0|||
155327264|NCT00943917|560634428|FG014|Stage I|A1C elevation|0|||
155327265|NCT00943917|560634414|FG000|Stage I|Withdrawal by Subject|2|||
155327266|NCT00943917|560634415|FG001|Stage I|Withdrawal by Subject|1|||
155327267|NCT00943917|560634416|FG002|Stage I|Withdrawal by Subject|2|||
155327268|NCT00943917|560634417|FG003|Stage I|Withdrawal by Subject|0|||
154961523|NCT03086460|559283957|FG000|Study Participants|Lost to Follow-up|2|||
154961524|NCT03086460|559283957|FG000|Study Participants|Protocol Violation|1|||
154961525|NCT03086460|559283957|FG000|Study Participants|Withdrawal by Subject|6|||
154961526|NCT03086460|559283957|FG000|Treatment A|Lost to Follow-up|1|||
155327269|NCT00943917|560634418|FG004|Stage I|Withdrawal by Subject|0|||
155327270|NCT00943917|560634419|FG005|Stage I|Withdrawal by Subject|0|||
155327271|NCT00943917|560634420|FG006|Stage I|Withdrawal by Subject|0|||
155327272|NCT00943917|560634421|FG007|Stage I|Withdrawal by Subject|0|||
155327273|NCT00943917|560634422|FG008|Stage I|Withdrawal by Subject|0|||
155327274|NCT00943917|560634423|FG009|Stage I|Withdrawal by Subject|0|||
155327275|NCT00943917|560634424|FG010|Stage I|Withdrawal by Subject|0|||
155327276|NCT00943917|560634425|FG011|Stage I|Withdrawal by Subject|0|||
155327277|NCT00943917|560634426|FG012|Stage I|Withdrawal by Subject|0|||
155327278|NCT00943917|560634427|FG013|Stage I|Withdrawal by Subject|0|||
154961527|NCT03086460|559283957|FG000|Treatment A|Protocol Violation|1|||
154961528|NCT03086460|559283957|FG000|Treatment A|Withdrawal by Subject|2|||
154961529|NCT03086460|559283957|FG000|Treatment C|Withdrawal by Subject|2|||
155069810|NCT02924376|559684063|FG002|Overall Study|Withdrawal by Subject|1|||
155069811|NCT02924376|559684064|FG003|Overall Study|Withdrawal by Subject|0|||
155069812|NCT02924376|559684061|FG000|Overall Study|Rolled Over to Another Study|1|||
155069813|NCT02924376|559684062|FG001|Overall Study|Rolled Over to Another Study|0|||
155069814|NCT02924376|559684063|FG002|Overall Study|Rolled Over to Another Study|0|||
155069815|NCT02924376|559684064|FG003|Overall Study|Rolled Over to Another Study|0|||
155069816|NCT04835441|559684065|FG000|Overall Study|Physician Decision|4|||
155069817|NCT04835441|559684066|FG001|Overall Study|Physician Decision|4|||
155069818|NCT04835441|559684065|FG000|Overall Study|Other|1|||
155069819|NCT04835441|559684066|FG001|Overall Study|Other|1|||
155069820|NCT04835441|559684065|FG000|Overall Study|Lost to Follow-up|0|||
155069821|NCT04835441|559684066|FG001|Overall Study|Lost to Follow-up|1|||
155327279|NCT00943917|560634428|FG014|Stage I|Withdrawal by Subject|0|||
155327280|NCT00943917|560634414|FG000|Stage II|Adverse Event|0|||
154961530|NCT03086460|559283957|FG000|Treatment E|Lost to Follow-up|1|||
154961531|NCT03086460|559283957|FG000|Treatment E|Withdrawal by Subject|3|||
155069822|NCT02293499|559685008|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
155069823|NCT02293499|559685009|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
155069824|NCT02293499|559685010|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
155069825|NCT02293499|559685008|FG000|Intervention - Camp|Withdrawal by Subject|3|||
155069826|NCT02293499|559685009|FG001|Intervention - Camp|Withdrawal by Subject|6|||
155327281|NCT00943917|560634415|FG001|Stage II|Adverse Event|0|||
154961532|NCT06195579|559283958|FG000|Overall Study|Withdrawal by Subject|1|||
155327282|NCT00943917|560634416|FG002|Stage II|Adverse Event|0|||
155327283|NCT00943917|560634417|FG003|Stage II|Adverse Event|0|||
155327284|NCT00943917|560634418|FG004|Stage II|Adverse Event|0|||
155327285|NCT00943917|560634419|FG005|Stage II|Adverse Event|1|||
155327286|NCT00943917|560634420|FG006|Stage II|Adverse Event|3|||
155327287|NCT00943917|560634421|FG007|Stage II|Adverse Event|0|||
155327288|NCT00943917|560634422|FG008|Stage II|Adverse Event|1|||
155327289|NCT00943917|560634423|FG009|Stage II|Adverse Event|0|||
155327290|NCT00943917|560634424|FG010|Stage II|Adverse Event|0|||
155327291|NCT00943917|560634425|FG011|Stage II|Adverse Event|0|||
155327292|NCT00943917|560634426|FG012|Stage II|Adverse Event|0|||
155327293|NCT00943917|560634427|FG013|Stage II|Adverse Event|0|||
155327294|NCT00943917|560634428|FG014|Stage II|Adverse Event|0|||
155327295|NCT00943917|560634414|FG000|Stage II|Withdrawal by Subject|0|||
155327296|NCT00943917|560634415|FG001|Stage II|Withdrawal by Subject|0|||
155327297|NCT00943917|560634416|FG002|Stage II|Withdrawal by Subject|0|||
155327298|NCT00943917|560634417|FG003|Stage II|Withdrawal by Subject|0|||
155327299|NCT00943917|560634418|FG004|Stage II|Withdrawal by Subject|0|||
155327300|NCT00943917|560634419|FG005|Stage II|Withdrawal by Subject|1|||
155327301|NCT00943917|560634420|FG006|Stage II|Withdrawal by Subject|0|||
155327302|NCT00943917|560634421|FG007|Stage II|Withdrawal by Subject|0|||
155327303|NCT00943917|560634422|FG008|Stage II|Withdrawal by Subject|0|||
155327304|NCT00943917|560634423|FG009|Stage II|Withdrawal by Subject|0|||
155327305|NCT00943917|560634424|FG010|Stage II|Withdrawal by Subject|0|||
155327306|NCT00943917|560634425|FG011|Stage II|Withdrawal by Subject|0|||
155327307|NCT00943917|560634426|FG012|Stage II|Withdrawal by Subject|0|||
155327308|NCT00943917|560634427|FG013|Stage II|Withdrawal by Subject|0|||
155327309|NCT00943917|560634428|FG014|Stage II|Withdrawal by Subject|0|||
155327310|NCT00943917|560634414|FG000|Stage II|Pregnancy|0|||
155327311|NCT00943917|560634415|FG001|Stage II|Pregnancy|0|||
155327312|NCT00943917|560634416|FG002|Stage II|Pregnancy|0|||
155327313|NCT00943917|560634417|FG003|Stage II|Pregnancy|0|||
155327314|NCT00943917|560634418|FG004|Stage II|Pregnancy|0|||
155327315|NCT00943917|560634419|FG005|Stage II|Pregnancy|1|||
155327316|NCT00943917|560634420|FG006|Stage II|Pregnancy|0|||
155327317|NCT00943917|560634421|FG007|Stage II|Pregnancy|0|||
155327318|NCT00943917|560634422|FG008|Stage II|Pregnancy|0|||
155327319|NCT00943917|560634423|FG009|Stage II|Pregnancy|0|||
155327320|NCT00943917|560634424|FG010|Stage II|Pregnancy|0|||
155327321|NCT00943917|560634425|FG011|Stage II|Pregnancy|0|||
155327322|NCT00943917|560634426|FG012|Stage II|Pregnancy|0|||
155327323|NCT00943917|560634427|FG013|Stage II|Pregnancy|0|||
155327324|NCT00943917|560634428|FG014|Stage II|Pregnancy|0|||
155327325|NCT00943917|560634414|FG000|Stage II Continuation|Adverse Event|0|||
155327326|NCT00943917|560634415|FG001|Stage II Continuation|Adverse Event|0|||
155327327|NCT00943917|560634416|FG002|Stage II Continuation|Adverse Event|0|||
155327328|NCT00943917|560634417|FG003|Stage II Continuation|Adverse Event|0|||
155327329|NCT00943917|560634418|FG004|Stage II Continuation|Adverse Event|0|||
155327330|NCT00943917|560634419|FG005|Stage II Continuation|Adverse Event|0|||
155327331|NCT00943917|560634420|FG006|Stage II Continuation|Adverse Event|0|||
155327332|NCT00943917|560634421|FG007|Stage II Continuation|Adverse Event|0|||
155327333|NCT00943917|560634422|FG008|Stage II Continuation|Adverse Event|0|||
155327334|NCT00943917|560634423|FG009|Stage II Continuation|Adverse Event|0|||
155327335|NCT00943917|560634424|FG010|Stage II Continuation|Adverse Event|0|||
155327336|NCT00943917|560634425|FG011|Stage II Continuation|Adverse Event|1|||
155327337|NCT00943917|560634426|FG012|Stage II Continuation|Adverse Event|2|||
155327338|NCT00943917|560634427|FG013|Stage II Continuation|Adverse Event|1|||
155327339|NCT00943917|560634428|FG014|Stage II Continuation|Adverse Event|1|||
155327340|NCT00943917|560634414|FG000|Stage II Continuation|Withdrawal by Subject|0|||
155327341|NCT00943917|560634415|FG001|Stage II Continuation|Withdrawal by Subject|0|||
155327342|NCT00943917|560634416|FG002|Stage II Continuation|Withdrawal by Subject|0|||
155327343|NCT00943917|560634417|FG003|Stage II Continuation|Withdrawal by Subject|0|||
155327344|NCT00943917|560634418|FG004|Stage II Continuation|Withdrawal by Subject|0|||
155327345|NCT00943917|560634419|FG005|Stage II Continuation|Withdrawal by Subject|0|||
155327346|NCT00943917|560634420|FG006|Stage II Continuation|Withdrawal by Subject|0|||
155327347|NCT00943917|560634421|FG007|Stage II Continuation|Withdrawal by Subject|0|||
155327348|NCT00943917|560634422|FG008|Stage II Continuation|Withdrawal by Subject|0|||
155327349|NCT00943917|560634423|FG009|Stage II Continuation|Withdrawal by Subject|0|||
155327350|NCT00943917|560634424|FG010|Stage II Continuation|Withdrawal by Subject|0|||
155327351|NCT00943917|560634425|FG011|Stage II Continuation|Withdrawal by Subject|0|||
155327352|NCT00943917|560634426|FG012|Stage II Continuation|Withdrawal by Subject|0|||
155327353|NCT00943917|560634427|FG013|Stage II Continuation|Withdrawal by Subject|1|||
155327354|NCT00943917|560634428|FG014|Stage II Continuation|Withdrawal by Subject|3|||
155327355|NCT00943917|560634414|FG000|Stage II Continuation|Protocol Violation|0|||
155327356|NCT00943917|560634415|FG001|Stage II Continuation|Protocol Violation|0|||
155327357|NCT00943917|560634416|FG002|Stage II Continuation|Protocol Violation|0|||
155327358|NCT00943917|560634417|FG003|Stage II Continuation|Protocol Violation|0|||
155327359|NCT00943917|560634418|FG004|Stage II Continuation|Protocol Violation|0|||
155327360|NCT00943917|560634419|FG005|Stage II Continuation|Protocol Violation|0|||
155327361|NCT00943917|560634420|FG006|Stage II Continuation|Protocol Violation|0|||
155327362|NCT00943917|560634421|FG007|Stage II Continuation|Protocol Violation|0|||
155327363|NCT00943917|560634422|FG008|Stage II Continuation|Protocol Violation|0|||
155327364|NCT00943917|560634423|FG009|Stage II Continuation|Protocol Violation|1|||
155327365|NCT00943917|560634424|FG010|Stage II Continuation|Protocol Violation|0|||
155327366|NCT00943917|560634425|FG011|Stage II Continuation|Protocol Violation|1|||
155327367|NCT00943917|560634426|FG012|Stage II Continuation|Protocol Violation|0|||
155327368|NCT00943917|560634427|FG013|Stage II Continuation|Protocol Violation|0|||
155327369|NCT00943917|560634428|FG014|Stage II Continuation|Protocol Violation|0|||
155327370|NCT00943917|560634414|FG000|Stage II Continuation|hypoglycemia|0|||
155327371|NCT00943917|560634415|FG001|Stage II Continuation|hypoglycemia|0|||
155327372|NCT00943917|560634416|FG002|Stage II Continuation|hypoglycemia|0|||
155327373|NCT00943917|560634417|FG003|Stage II Continuation|hypoglycemia|0|||
155327374|NCT00943917|560634418|FG004|Stage II Continuation|hypoglycemia|0|||
155327375|NCT00943917|560634419|FG005|Stage II Continuation|hypoglycemia|0|||
155327376|NCT00943917|560634420|FG006|Stage II Continuation|hypoglycemia|0|||
155327377|NCT00943917|560634421|FG007|Stage II Continuation|hypoglycemia|0|||
155327378|NCT00943917|560634422|FG008|Stage II Continuation|hypoglycemia|0|||
155327379|NCT00943917|560634423|FG009|Stage II Continuation|hypoglycemia|0|||
155327380|NCT00943917|560634424|FG010|Stage II Continuation|hypoglycemia|0|||
155327381|NCT00943917|560634425|FG011|Stage II Continuation|hypoglycemia|0|||
155327382|NCT00943917|560634426|FG012|Stage II Continuation|hypoglycemia|1|||
155327383|NCT00943917|560634427|FG013|Stage II Continuation|hypoglycemia|0|||
155327384|NCT00943917|560634428|FG014|Stage II Continuation|hypoglycemia|0|||
155327385|NCT00943917|560634414|FG000|Stage II Continuation|A1C elevation|0|||
155327386|NCT00943917|560634415|FG001|Stage II Continuation|A1C elevation|0|||
155327387|NCT00943917|560634416|FG002|Stage II Continuation|A1C elevation|0|||
155327388|NCT00943917|560634417|FG003|Stage II Continuation|A1C elevation|0|||
155327389|NCT00943917|560634418|FG004|Stage II Continuation|A1C elevation|0|||
155327390|NCT00943917|560634419|FG005|Stage II Continuation|A1C elevation|0|||
155327391|NCT00943917|560634420|FG006|Stage II Continuation|A1C elevation|0|||
155327392|NCT00943917|560634421|FG007|Stage II Continuation|A1C elevation|0|||
155327393|NCT00943917|560634422|FG008|Stage II Continuation|A1C elevation|0|||
155327394|NCT00943917|560634423|FG009|Stage II Continuation|A1C elevation|0|||
155327395|NCT00943917|560634424|FG010|Stage II Continuation|A1C elevation|0|||
155327396|NCT00943917|560634425|FG011|Stage II Continuation|A1C elevation|0|||
155327397|NCT00943917|560634426|FG012|Stage II Continuation|A1C elevation|0|||
155327398|NCT00943917|560634427|FG013|Stage II Continuation|A1C elevation|1|||
155327399|NCT00943917|560634428|FG014|Stage II Continuation|A1C elevation|0|||
155327400|NCT01171976|560634429|FG000|Overall Study|Protocol Violation|0|||
155327401|NCT01171976|560634430|FG001|Overall Study|Protocol Violation|0|||
155327402|NCT01171976|560634431|FG002|Overall Study|Protocol Violation|1|||
155327403|NCT01171976|560634429|FG000|Overall Study|Death|2|||
155327404|NCT01171976|560634430|FG001|Overall Study|Death|4|||
155327405|NCT01171976|560634431|FG002|Overall Study|Death|1|||
155327406|NCT01171976|560634429|FG000|Overall Study|Lost to Follow-up|4|||
155327407|NCT01171976|560634430|FG001|Overall Study|Lost to Follow-up|0|||
155327408|NCT01171976|560634431|FG002|Overall Study|Lost to Follow-up|2|||
155327409|NCT01171976|560634429|FG000|Overall Study|Withdrawal by Subject|1|||
155327410|NCT01171976|560634430|FG001|Overall Study|Withdrawal by Subject|5|||
155327411|NCT01171976|560634431|FG002|Overall Study|Withdrawal by Subject|6|||
155327412|NCT01171976|560634429|FG000|Overall Study|Abnormal test result|1|||
155327413|NCT01171976|560634430|FG001|Overall Study|Abnormal test result|0|||
155327414|NCT01171976|560634431|FG002|Overall Study|Abnormal test result|0|||
155327415|NCT01171976|560634429|FG000|Overall Study|Adverse Event|6|||
155327416|NCT01171976|560634430|FG001|Overall Study|Adverse Event|2|||
155327417|NCT01171976|560634431|FG002|Overall Study|Adverse Event|5|||
155327418|NCT03248492|560634432|FG000|Overall Study|Progressive Disease|24|||
155327419|NCT03248492|560634433|FG001|Overall Study|Progressive Disease|23|||
155327420|NCT03248492|560634434|FG002|Overall Study|Progressive Disease|11|||
155327421|NCT03248492|560634435|FG003|Overall Study|Progressive Disease|66|||
155327422|NCT03248492|560634436|FG004|Overall Study|Progressive Disease|1|||
155069827|NCT02293499|559685010|FG002|Intervention - Camp|Withdrawal by Subject|2|||
155327423|NCT03248492|560634432|FG000|Overall Study|Adverse Event|14|||
155327424|NCT03248492|560634433|FG001|Overall Study|Adverse Event|13|||
155327425|NCT03248492|560634434|FG002|Overall Study|Adverse Event|9|||
154961533|NCT02545283|559283959|FG000|Overall Study|Lost to Follow-up|2|||
154961534|NCT02545283|559283960|FG001|Overall Study|Lost to Follow-up|4|||
154961535|NCT02545283|559283959|FG000|Overall Study|Withdrawal by Subject|5|||
154961536|NCT02545283|559283960|FG001|Overall Study|Withdrawal by Subject|9|||
154961537|NCT02545283|559283959|FG000|Overall Study|Death|109|||
154961538|NCT02545283|559283960|FG001|Overall Study|Death|211|||
154961539|NCT02545283|559283959|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
154961540|NCT02545283|559283960|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
154961541|NCT02545283|559283959|FG000|Overall Study|Study Terminated By Sponsor|33|||
154961542|NCT02545283|559283960|FG001|Overall Study|Study Terminated By Sponsor|71|||
155069828|NCT02293499|559685008|FG000|Intervention - Camp|these are those not showing up at camp|24|||
155327426|NCT03248492|560634435|FG003|Overall Study|Adverse Event|22|||
155327427|NCT03248492|560634436|FG004|Overall Study|Adverse Event|2|||
155327428|NCT03248492|560634432|FG000|Overall Study|Withdrawal by Subject|5|||
155327429|NCT03248492|560634433|FG001|Overall Study|Withdrawal by Subject|4|||
155327430|NCT03248492|560634434|FG002|Overall Study|Withdrawal by Subject|0|||
155327431|NCT03248492|560634435|FG003|Overall Study|Withdrawal by Subject|8|||
155327432|NCT03248492|560634436|FG004|Overall Study|Withdrawal by Subject|1|||
155327433|NCT03248492|560634432|FG000|Overall Study|Physician Decision|1|||
155327434|NCT03248492|560634433|FG001|Overall Study|Physician Decision|1|||
155327435|NCT03248492|560634434|FG002|Overall Study|Physician Decision|1|||
155327436|NCT03248492|560634435|FG003|Overall Study|Physician Decision|7|||
155327437|NCT03248492|560634436|FG004|Overall Study|Physician Decision|0|||
155327438|NCT03248492|560634432|FG000|Overall Study|Death|1|||
155327439|NCT03248492|560634433|FG001|Overall Study|Death|1|||
155327440|NCT03248492|560634434|FG002|Overall Study|Death|0|||
155327441|NCT03248492|560634435|FG003|Overall Study|Death|6|||
155327442|NCT03248492|560634436|FG004|Overall Study|Death|0|||
155327443|NCT03248492|560634432|FG000|Overall Study|Study Terminated by Sponsor|3|||
155327444|NCT03248492|560634433|FG001|Overall Study|Study Terminated by Sponsor|1|||
155327445|NCT03248492|560634434|FG002|Overall Study|Study Terminated by Sponsor|0|||
155327446|NCT03248492|560634435|FG003|Overall Study|Study Terminated by Sponsor|7|||
155327447|NCT03248492|560634436|FG004|Overall Study|Study Terminated by Sponsor|0|||
155327448|NCT03248492|560634432|FG000|Overall Study|Other|2|||
155327449|NCT03248492|560634433|FG001|Overall Study|Other|5|||
155327450|NCT03248492|560634434|FG002|Overall Study|Other|0|||
155327451|NCT03248492|560634435|FG003|Overall Study|Other|14|||
155327452|NCT03248492|560634436|FG004|Overall Study|Other|0|||
155327453|NCT04495621|560634439|FG000|Overall Study|Withdrawal by Subject|0|||
155327454|NCT04495621|560634440|FG001|Overall Study|Withdrawal by Subject|3|||
155327455|NCT04495621|560634439|FG000|Overall Study|Death|7|||
155327456|NCT04495621|560634440|FG001|Overall Study|Death|11|||
155327457|NCT04495621|560634439|FG000|Overall Study|Investigator Decision|0|||
155327458|NCT04495621|560634440|FG001|Overall Study|Investigator Decision|7|||
155327459|NCT04495621|560634439|FG000|Overall Study|Lost to Follow-up|0|||
155327460|NCT04495621|560634440|FG001|Overall Study|Lost to Follow-up|1|||
155327461|NCT04908514|560634447|FG000|Overall Study|Lost to Follow-up|2|||
155327462|NCT04908514|560634447|FG000|Overall Study|Withdrawal by Subject|1|||
155327463|NCT03774472|560634448|FG000|Overall Study|Physician Decision|1|||
155327464|NCT03774472|560634449|FG001|Overall Study|Physician Decision|0|||
155327465|NCT03774472|560634450|FG002|Overall Study|Physician Decision|0|||
155327466|NCT03774472|560634448|FG000|Overall Study|Progression prior to 4 weeks|0|||
155327467|NCT03774472|560634449|FG001|Overall Study|Progression prior to 4 weeks|1|||
155327468|NCT03774472|560634450|FG002|Overall Study|Progression prior to 4 weeks|0|||
155327469|NCT03774472|560634448|FG000|Overall Study|Withdrawal by Subject|0|||
155327470|NCT03774472|560634449|FG001|Overall Study|Withdrawal by Subject|1|||
155327471|NCT03774472|560634450|FG002|Overall Study|Withdrawal by Subject|0|||
155327472|NCT05155306|560634455|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
155327473|NCT05155306|560634456|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
155327474|NCT05155306|560634457|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
155327475|NCT05155306|560634458|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
155327476|NCT05155306|560634455|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
155327477|NCT05155306|560634456|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
155327478|NCT05155306|560634457|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
155327479|NCT05155306|560634458|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
155327480|NCT03150862|560634459|FG000|Overall Study|Death|2|||
155327481|NCT03150862|560634460|FG001|Overall Study|Death|7|||
155327482|NCT03150862|560634461|FG002|Overall Study|Death|8|||
155327483|NCT03150862|560634462|FG003|Overall Study|Death|27|||
155327484|NCT03150862|560634463|FG004|Overall Study|Death|4|||
155327485|NCT03150862|560634464|FG005|Overall Study|Death|8|||
155327486|NCT03150862|560634465|FG006|Overall Study|Death|6|||
155327487|NCT03150862|560634466|FG007|Overall Study|Death|21|||
155327488|NCT03150862|560634459|FG000|Overall Study|Withdrawal by Subject|1|||
155327489|NCT03150862|560634460|FG001|Overall Study|Withdrawal by Subject|1|||
154961543|NCT03343535|559283962|FG000|Overall Study|Lost to Follow-up|1|||
155327490|NCT03150862|560634461|FG002|Overall Study|Withdrawal by Subject|0|||
155327491|NCT03150862|560634462|FG003|Overall Study|Withdrawal by Subject|3|||
155327492|NCT03150862|560634463|FG004|Overall Study|Withdrawal by Subject|1|||
155327493|NCT03150862|560634464|FG005|Overall Study|Withdrawal by Subject|1|||
155327494|NCT03150862|560634465|FG006|Overall Study|Withdrawal by Subject|1|||
155327495|NCT03150862|560634466|FG007|Overall Study|Withdrawal by Subject|3|||
155327496|NCT03150862|560634459|FG000|Overall Study|Lost to Follow-up|0|||
155327497|NCT03150862|560634460|FG001|Overall Study|Lost to Follow-up|0|||
155327498|NCT03150862|560634461|FG002|Overall Study|Lost to Follow-up|1|||
155327499|NCT03150862|560634462|FG003|Overall Study|Lost to Follow-up|0|||
155327500|NCT03150862|560634463|FG004|Overall Study|Lost to Follow-up|0|||
155327501|NCT03150862|560634464|FG005|Overall Study|Lost to Follow-up|0|||
155327502|NCT03150862|560634465|FG006|Overall Study|Lost to Follow-up|0|||
155327503|NCT03150862|560634466|FG007|Overall Study|Lost to Follow-up|2|||
155327504|NCT03150862|560634459|FG000|Overall Study|Sponsor's decision|0|||
155327505|NCT03150862|560634460|FG001|Overall Study|Sponsor's decision|0|||
155327506|NCT03150862|560634461|FG002|Overall Study|Sponsor's decision|0|||
155327507|NCT03150862|560634462|FG003|Overall Study|Sponsor's decision|10|||
155327508|NCT03150862|560634463|FG004|Overall Study|Sponsor's decision|3|||
155327509|NCT03150862|560634464|FG005|Overall Study|Sponsor's decision|0|||
155327510|NCT03150862|560634465|FG006|Overall Study|Sponsor's decision|1|||
155327511|NCT03150862|560634466|FG007|Overall Study|Sponsor's decision|1|||
155327512|NCT03150862|560634459|FG000|Overall Study|Change in Methylation status|0|||
155327513|NCT03150862|560634460|FG001|Overall Study|Change in Methylation status|0|||
155327514|NCT03150862|560634461|FG002|Overall Study|Change in Methylation status|0|||
155327515|NCT03150862|560634462|FG003|Overall Study|Change in Methylation status|0|||
155327516|NCT03150862|560634463|FG004|Overall Study|Change in Methylation status|1|||
155327517|NCT03150862|560634464|FG005|Overall Study|Change in Methylation status|0|||
155327518|NCT03150862|560634465|FG006|Overall Study|Change in Methylation status|0|||
155327519|NCT03150862|560634466|FG007|Overall Study|Change in Methylation status|0|||
155327520|NCT03150862|560634459|FG000|Overall Study|Roll over in to Long Term Extension|0|||
155327521|NCT03150862|560634460|FG001|Overall Study|Roll over in to Long Term Extension|0|||
155327522|NCT03150862|560634461|FG002|Overall Study|Roll over in to Long Term Extension|0|||
155327523|NCT03150862|560634462|FG003|Overall Study|Roll over in to Long Term Extension|0|||
155327524|NCT03150862|560634463|FG004|Overall Study|Roll over in to Long Term Extension|0|||
155327525|NCT03150862|560634464|FG005|Overall Study|Roll over in to Long Term Extension|0|||
155327526|NCT03150862|560634465|FG006|Overall Study|Roll over in to Long Term Extension|0|||
155327527|NCT03150862|560634466|FG007|Overall Study|Roll over in to Long Term Extension|1|||
155327528|NCT03150862|560634459|FG000|Overall Study|Progressive Disease|0|||
155327529|NCT03150862|560634460|FG001|Overall Study|Progressive Disease|0|||
155327530|NCT03150862|560634461|FG002|Overall Study|Progressive Disease|0|||
155327531|NCT03150862|560634462|FG003|Overall Study|Progressive Disease|0|||
155327532|NCT03150862|560634463|FG004|Overall Study|Progressive Disease|0|||
155327533|NCT03150862|560634464|FG005|Overall Study|Progressive Disease|0|||
155327534|NCT03150862|560634465|FG006|Overall Study|Progressive Disease|0|||
155327535|NCT03150862|560634466|FG007|Overall Study|Progressive Disease|2|||
155327536|NCT04158141|560634467|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
155327537|NCT04158141|560634468|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
155069829|NCT02293499|559685009|FG001|Intervention - Camp|these are those not showing up at camp|28|||
155069830|NCT02293499|559685010|FG002|Intervention - Camp|these are those not showing up at camp|4|||
155069831|NCT02293499|559685008|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
155069832|NCT02293499|559685009|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
155069833|NCT02293499|559685010|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
155069834|NCT02293499|559685008|FG000|3 Month Follow Up|Lost to Follow-up|14|||
155069835|NCT02293499|559685009|FG001|3 Month Follow Up|Lost to Follow-up|15|||
155069836|NCT02293499|559685010|FG002|3 Month Follow Up|Lost to Follow-up|6|||
155069837|NCT02293499|559685008|FG000|6 Month Follow Up|Lost to Follow-up|17|||
155069838|NCT02293499|559685009|FG001|6 Month Follow Up|Lost to Follow-up|27|||
155069839|NCT02293499|559685010|FG002|6 Month Follow Up|Lost to Follow-up|6|||
155069840|NCT02293499|559685008|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
155069841|NCT02293499|559685009|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
155069842|NCT02293499|559685010|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
155069843|NCT02293499|559685008|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
155069844|NCT02293499|559685009|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
155069845|NCT02293499|559685010|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
155069846|NCT02293499|559685008|FG000|9 Month Follow Up|Lost to Follow-up|24|||
155069847|NCT02293499|559685009|FG001|9 Month Follow Up|Lost to Follow-up|28|||
155069848|NCT02293499|559685010|FG002|9 Month Follow Up|Lost to Follow-up|4|||
155069849|NCT02293499|559685008|FG000|12 Month Follow Up|Lost to Follow-up|26|||
155069850|NCT02293499|559685009|FG001|12 Month Follow Up|Lost to Follow-up|25|||
155069851|NCT02293499|559685010|FG002|12 Month Follow Up|Lost to Follow-up|6|||
155069852|NCT02293499|559685008|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
155069853|NCT02293499|559685009|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
155069854|NCT02293499|559685010|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
155069855|NCT02293499|559685008|FG000|15 Month Follow Up|Lost to Follow-up|22|||
155069856|NCT02293499|559685009|FG001|15 Month Follow Up|Lost to Follow-up|22|||
155069857|NCT02293499|559685010|FG002|15 Month Follow Up|Lost to Follow-up|7|||
155069858|NCT01787838|559685011|FG000|Overall Study|refused|1413|||
155069859|NCT00356590|559685018|FG000|Overall Study|Adverse Event|54|||
155069860|NCT00356590|559685018|FG000|Overall Study|Death|10|||
155069861|NCT00356590|559685018|FG000|Overall Study|Lost to Follow-up|35|||
155069862|NCT00356590|559685018|FG000|Overall Study|Physician Decision|46|||
155069863|NCT00356590|559685018|FG000|Overall Study|Withdrawal by Subject|41|||
155069864|NCT00356590|559685018|FG000|Overall Study|Completed month 12 only|2|||
155069865|NCT00356590|559685018|FG000|Overall Study|Protocol issues|6|||
155327538|NCT04158141|560634469|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
155327539|NCT04158141|560634467|FG000|Step 1: Registration|Adverse Event|1|||
155327540|NCT04158141|560634468|FG001|Step 1: Registration|Adverse Event|0|||
155327541|NCT04158141|560634469|FG002|Step 1: Registration|Adverse Event|0|||
155327542|NCT04158141|560634467|FG000|Step 1: Registration|Withdrawal by Subject|1|||
155327543|NCT04158141|560634468|FG001|Step 1: Registration|Withdrawal by Subject|0|||
155327544|NCT04158141|560634469|FG002|Step 1: Registration|Withdrawal by Subject|0|||
155327545|NCT04158141|560634467|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
155327546|NCT04158141|560634468|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
155327547|NCT04158141|560634469|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
155327548|NCT04121741|560634473|FG000|Overall Study|Protocol Violation|1|||
155327549|NCT04121741|560634474|FG001|Overall Study|Protocol Violation|0|||
155327550|NCT04121741|560634475|FG002|Overall Study|Protocol Violation|0|||
155327551|NCT04121741|560634476|FG003|Overall Study|Protocol Violation|0|||
155327552|NCT04121741|560634477|FG004|Overall Study|Protocol Violation|0|||
155327553|NCT04121741|560634478|FG005|Overall Study|Protocol Violation|0|||
155327554|NCT01084863|560634479|FG000|Main Study Treatment Period|Disease progression|11|||
155327555|NCT01084863|560634480|FG001|Main Study Treatment Period|Disease progression|7|||
155327556|NCT01084863|560634479|FG000|Main Study Treatment Period|Adverse Event|5|||
155327557|NCT01084863|560634480|FG001|Main Study Treatment Period|Adverse Event|3|||
155327558|NCT01084863|560634479|FG000|Main Study Treatment Period|Other Reason|0|||
155327559|NCT01084863|560634480|FG001|Main Study Treatment Period|Other Reason|1|||
155327560|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
155327561|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
155327562|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
155327563|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
155327564|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
155327565|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
155327566|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
155327567|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
155327568|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Other|0|||
155327569|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Other|1|||
155327570|NCT01084863|560634479|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
155327571|NCT01084863|560634480|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
155327572|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
155327573|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
155327574|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
155327575|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
155327576|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
155327577|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
155327578|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
155327579|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
155327580|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
155327581|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
155327582|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
155327583|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
155327584|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
155069866|NCT00356590|559685018|FG000|Overall Study|Response status|28|||
155069867|NCT00356590|559685018|FG000|Overall Study|Other|52|||
155069868|NCT02696616|559685019|FG000|Overall Study|Adverse Event|0|||
155069869|NCT02696616|559685020|FG001|Overall Study|Adverse Event|1|||
155069870|NCT02696616|559685021|FG002|Overall Study|Adverse Event|0|||
155069871|NCT02696616|559685022|FG003|Overall Study|Adverse Event|0|||
155327585|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
155327586|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
155327587|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
155327588|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
155327589|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
155327590|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
155327591|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
154961544|NCT03343535|559283962|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
154961545|NCT03343535|559283962|FG000|Overall Study|Death|12|||
154961546|NCT04994535|559283963|FG000|Overall Study|Lost to Follow-up|7|||
154961547|NCT04994535|559283964|FG001|Overall Study|Lost to Follow-up|7|||
154961548|NCT04994535|559283963|FG000|Overall Study|Withdrawal by Subject|10|||
154961549|NCT04994535|559283964|FG001|Overall Study|Withdrawal by Subject|7|||
154961550|NCT04994535|559283963|FG000|Overall Study|Other|1|||
154961551|NCT04994535|559283964|FG001|Overall Study|Other|1|||
154961552|NCT00604162|559283965|FG000|Overall Study|Physician Decision|3|||
154961553|NCT00604162|559283965|FG000|Overall Study|Withdrawal by Subject|1|||
154961554|NCT00736190|559283968|FG000|Overall Study|Pregnancy|1|||
154961555|NCT00736190|559283968|FG000|Overall Study|Withdrawal by Subject|1|||
154961556|NCT00736190|559283968|FG000|Overall Study|Adverse Event|1|||
154961557|NCT05014828|559283969|FG000|Overall Study|Study Completed by Sponsor|16|||
154961558|NCT05014828|559283970|FG001|Overall Study|Study Completed by Sponsor|16|||
155327592|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
155327593|NCT04505722|560634482|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
155327594|NCT04505722|560634483|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
155327595|NCT04505722|560634484|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
155327596|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
155327597|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
155327598|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
155327599|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
155327600|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
155327601|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
155327602|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
155327603|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
155069872|NCT02696616|559685023|FG004|Overall Study|Adverse Event|0|||
155069873|NCT02696616|559685024|FG005|Overall Study|Adverse Event|0|||
155069874|NCT02696616|559685025|FG006|Overall Study|Adverse Event|0|||
155069875|NCT01970371|559685026|FG000|Overall Study|Death|8|||
155069876|NCT01970371|559685027|FG001|Overall Study|Death|13|||
155069877|NCT01970371|559685028|FG002|Overall Study|Death|12|||
155069878|NCT01970371|559685026|FG000|Overall Study|Lost to Follow-up|0|||
155069879|NCT01970371|559685027|FG001|Overall Study|Lost to Follow-up|0|||
155069880|NCT01970371|559685028|FG002|Overall Study|Lost to Follow-up|1|||
155069881|NCT01481779|559685029|FG000|Overall Study|Adverse Event|23|||
155069882|NCT01481779|559685030|FG001|Overall Study|Adverse Event|5|||
155069883|NCT01481779|559685029|FG000|Overall Study|Lost to Follow-up|3|||
155069884|NCT01481779|559685030|FG001|Overall Study|Lost to Follow-up|2|||
155069885|NCT01481779|559685029|FG000|Overall Study|Protocol Violation|2|||
155069886|NCT01481779|559685030|FG001|Overall Study|Protocol Violation|3|||
155069887|NCT01481779|559685029|FG000|Overall Study|Withdrawal by Subject|26|||
155069888|NCT01481779|559685030|FG001|Overall Study|Withdrawal by Subject|13|||
155069889|NCT01481779|559685029|FG000|Overall Study|Physician Decision|13|||
155069890|NCT01481779|559685030|FG001|Overall Study|Physician Decision|4|||
155327604|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
155327605|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
155327606|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
155327607|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
155327608|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
155327609|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
155327610|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
155327611|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
155327612|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
155327613|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
155327614|NCT04505722|560634482|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
155327615|NCT04505722|560634483|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
155327616|NCT04505722|560634484|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
155327617|NCT03473223|560634485|FG000|Overall Study|Lost to Follow-up|1|||
155327618|NCT03473223|560634486|FG001|Overall Study|Lost to Follow-up|1|||
155327619|NCT03473223|560634485|FG000|Overall Study|Withdrawal by Subject|47|||
155327620|NCT03473223|560634486|FG001|Overall Study|Withdrawal by Subject|42|||
155327621|NCT03473223|560634485|FG000|Overall Study|Indirect contact|32|||
155327622|NCT03473223|560634486|FG001|Overall Study|Indirect contact|29|||
155327623|NCT03473223|560634485|FG000|Overall Study|Other (Not specified)|32|||
155327624|NCT03473223|560634486|FG001|Overall Study|Other (Not specified)|20|||
155327625|NCT04755595|560634487|FG000|Overall Study|Lost to Follow-up|1|||
155327626|NCT00319696|560634488|FG000|Overall Study|Adverse Event|36|||
155327627|NCT00319696|560634488|FG000|Overall Study|withdrawal of consent|14|||
155069891|NCT01481779|559685029|FG000|Overall Study|Sponsor Decision|3|||
155069892|NCT01481779|559685030|FG001|Overall Study|Sponsor Decision|1|||
155069893|NCT06420232|559685038|FG000|Overall Study|Withdrawal by Subject|3|||
155069894|NCT00487188|559685039|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
155069895|NCT00487188|559685040|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
155327628|NCT00319696|560634488|FG000|Overall Study|administrative|7|||
155069896|NCT00487188|559685041|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
155069897|NCT00487188|559685039|FG000|Induction Phase|Adverse Event|5|||
155069898|NCT00487188|559685040|FG001|Induction Phase|Adverse Event|0|||
155327629|NCT00319696|560634488|FG000|Overall Study|Lost to Follow-up|3|||
155327630|NCT04530487|560635214|FG000|Overall Study|Death|1|||
155327631|NCT00210106|560635215|FG000|Overall Study|Death|1|||
155327632|NCT00210106|560635215|FG000|Overall Study|Protocol Violation|13|||
155327633|NCT01288443|560635218|FG000|Overall Study|Adverse Event|0|||
155069899|NCT00487188|559685041|FG002|Induction Phase|Adverse Event|0|||
155069900|NCT00487188|559685039|FG000|Induction Phase|Lack of Efficacy|0|||
155069901|NCT00487188|559685040|FG001|Induction Phase|Lack of Efficacy|1|||
155069902|NCT00487188|559685041|FG002|Induction Phase|Lack of Efficacy|0|||
155327634|NCT01288443|560635219|FG001|Overall Study|Adverse Event|0|||
155327635|NCT01288443|560635220|FG002|Overall Study|Adverse Event|1|||
155327636|NCT01288443|560635221|FG003|Overall Study|Adverse Event|1|||
155327637|NCT01288443|560635222|FG004|Overall Study|Adverse Event|3|||
155327638|NCT01288443|560635223|FG005|Overall Study|Adverse Event|1|||
155327639|NCT01288443|560635218|FG000|Overall Study|Poor compliance to protocol|0|||
155327640|NCT01288443|560635219|FG001|Overall Study|Poor compliance to protocol|0|||
155327641|NCT01288443|560635220|FG002|Overall Study|Poor compliance to protocol|0|||
155069903|NCT00487188|559685039|FG000|Induction Phase|Protocol Violation|1|||
155069904|NCT00487188|559685040|FG001|Induction Phase|Protocol Violation|0|||
155327642|NCT01288443|560635221|FG003|Overall Study|Poor compliance to protocol|0|||
155069905|NCT00487188|559685041|FG002|Induction Phase|Protocol Violation|0|||
155069906|NCT00487188|559685039|FG000|Induction Phase|Refused Treatment|1|||
155327643|NCT01288443|560635222|FG004|Overall Study|Poor compliance to protocol|0|||
155327644|NCT01288443|560635223|FG005|Overall Study|Poor compliance to protocol|1|||
155327645|NCT01288443|560635218|FG000|Overall Study|Participant Moved|0|||
155327646|NCT01288443|560635219|FG001|Overall Study|Participant Moved|0|||
155327647|NCT01288443|560635220|FG002|Overall Study|Participant Moved|0|||
155327648|NCT01288443|560635221|FG003|Overall Study|Participant Moved|1|||
155327649|NCT01288443|560635222|FG004|Overall Study|Participant Moved|2|||
155327650|NCT01288443|560635223|FG005|Overall Study|Participant Moved|1|||
155327651|NCT01288443|560635218|FG000|Overall Study|Consent withdrawn by Participant|0|||
155327652|NCT01288443|560635219|FG001|Overall Study|Consent withdrawn by Participant|0|||
155327653|NCT01288443|560635220|FG002|Overall Study|Consent withdrawn by Participant|0|||
155327654|NCT01288443|560635221|FG003|Overall Study|Consent withdrawn by Participant|0|||
155327655|NCT01288443|560635222|FG004|Overall Study|Consent withdrawn by Participant|0|||
155327656|NCT01288443|560635223|FG005|Overall Study|Consent withdrawn by Participant|1|||
155327657|NCT01288443|560635218|FG000|Overall Study|Lost to Follow-up|0|||
155327658|NCT01288443|560635219|FG001|Overall Study|Lost to Follow-up|1|||
155327659|NCT01288443|560635220|FG002|Overall Study|Lost to Follow-up|0|||
155327660|NCT01288443|560635221|FG003|Overall Study|Lost to Follow-up|0|||
155327661|NCT01288443|560635222|FG004|Overall Study|Lost to Follow-up|0|||
155327662|NCT01288443|560635223|FG005|Overall Study|Lost to Follow-up|0|||
154961559|NCT05014828|559283971|FG002|Overall Study|Study Completed by Sponsor|3|||
154961560|NCT05014828|559283972|FG003|Overall Study|Study Completed by Sponsor|3|||
154961561|NCT05014828|559283969|FG000|Overall Study|Death|11|||
154961562|NCT05014828|559283970|FG001|Overall Study|Death|6|||
154961563|NCT05014828|559283971|FG002|Overall Study|Death|0|||
154961564|NCT05014828|559283972|FG003|Overall Study|Death|0|||
154961565|NCT05014828|559283969|FG000|Overall Study|Lost to Follow-up|0|||
154961566|NCT05014828|559283970|FG001|Overall Study|Lost to Follow-up|0|||
154961567|NCT05014828|559283971|FG002|Overall Study|Lost to Follow-up|2|||
154961568|NCT05014828|559283972|FG003|Overall Study|Lost to Follow-up|0|||
154961569|NCT05014828|559283969|FG000|Overall Study|Miscellaneous.|0|||
154961570|NCT05014828|559283970|FG001|Overall Study|Miscellaneous.|1|||
154961571|NCT05014828|559283971|FG002|Overall Study|Miscellaneous.|0|||
154961572|NCT05014828|559283972|FG003|Overall Study|Miscellaneous.|0|||
154961573|NCT01370317|559283976|FG000|Overall Study|Participant withdrew consent|1|||
154961574|NCT01370317|559283977|FG001|Overall Study|Participant withdrew consent|0|||
154961575|NCT01370317|559283976|FG000|Overall Study|Protocol deviation|0|||
154961576|NCT01370317|559283977|FG001|Overall Study|Protocol deviation|1|||
154961577|NCT00075478|559283978|FG000|Overall Study|not eligible|1|||
154961578|NCT00075478|559283979|FG001|Overall Study|not eligible|0|||
154961579|NCT00075478|559283978|FG000|Overall Study|Physician Decision|0|||
154961580|NCT00075478|559283979|FG001|Overall Study|Physician Decision|1|||
154961581|NCT00960297|559283981|FG000|Overall Study|Physician Decision|1|||
154961582|NCT00960297|559283981|FG000|Overall Study|Venous port infection|1|||
154961583|NCT00960297|559283981|FG000|Overall Study|Disease progression|1|||
154961584|NCT04238754|559283990|FG000|Washout - 1 Week|Lost to Follow-up|1|||
154961585|NCT04238754|559283991|FG001|Washout - 1 Week|Lost to Follow-up|0|||
154961586|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
154961587|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
154961588|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
154961589|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
154961590|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
154961591|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
154961592|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
154961593|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
154961594|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
154961595|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
154961596|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
154961597|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
155327663|NCT01288443|560635218|FG000|Overall Study|Study drug auto-injector administration|0|||
155327664|NCT01288443|560635219|FG001|Overall Study|Study drug auto-injector administration|0|||
155327665|NCT01288443|560635220|FG002|Overall Study|Study drug auto-injector administration|0|||
155069907|NCT00487188|559685040|FG001|Induction Phase|Refused Treatment|2|||
155069908|NCT00487188|559685041|FG002|Induction Phase|Refused Treatment|0|||
155327666|NCT01288443|560635221|FG003|Overall Study|Study drug auto-injector administration|0|||
155327667|NCT01288443|560635222|FG004|Overall Study|Study drug auto-injector administration|1|||
155327668|NCT01288443|560635223|FG005|Overall Study|Study drug auto-injector administration|1|||
155327669|NCT01288443|560635218|FG000|Overall Study|Other than above|0|||
155327670|NCT01288443|560635219|FG001|Overall Study|Other than above|0|||
155327671|NCT01288443|560635220|FG002|Overall Study|Other than above|0|||
155327672|NCT01288443|560635221|FG003|Overall Study|Other than above|2|||
155327673|NCT01288443|560635222|FG004|Overall Study|Other than above|1|||
155327674|NCT01288443|560635223|FG005|Overall Study|Other than above|0|||
155327675|NCT04876417|560635226|FG000|Overall Study|Lost to Follow-up|5|||
155327676|NCT04876417|560635227|FG001|Overall Study|Lost to Follow-up|8|||
155327677|NCT04876417|560635228|FG002|Overall Study|Lost to Follow-up|0|||
155327678|NCT04876417|560635229|FG003|Overall Study|Lost to Follow-up|0|||
155327679|NCT02111096|560635230|FG000|Overall Study|Adverse Event|4|||
155327680|NCT02111096|560635231|FG001|Overall Study|Adverse Event|1|||
155327681|NCT02111096|560635232|FG002|Overall Study|Adverse Event|2|||
155327682|NCT02111096|560635230|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155327683|NCT02111096|560635231|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155327684|NCT02111096|560635232|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155069909|NCT00487188|559685039|FG000|Induction Phase|Lost to Follow-up|2|||
155069910|NCT00487188|559685040|FG001|Induction Phase|Lost to Follow-up|2|||
155069911|NCT00487188|559685041|FG002|Induction Phase|Lost to Follow-up|0|||
155069912|NCT00487188|559685039|FG000|Induction Phase|Administrative|0|||
155069913|NCT00487188|559685040|FG001|Induction Phase|Administrative|1|||
155069914|NCT00487188|559685041|FG002|Induction Phase|Administrative|0|||
155069915|NCT00487188|559685039|FG000|Maintenance Phase|Adverse Event|1|||
155069916|NCT00487188|559685040|FG001|Maintenance Phase|Adverse Event|0|||
155069917|NCT00487188|559685041|FG002|Maintenance Phase|Adverse Event|0|||
155069918|NCT00487188|559685039|FG000|Maintenance Phase|Death|1|||
155069919|NCT00487188|559685040|FG001|Maintenance Phase|Death|0|||
155069920|NCT00487188|559685041|FG002|Maintenance Phase|Death|0|||
155069921|NCT00487188|559685039|FG000|Maintenance Phase|Lost to Follow-up|1|||
155069922|NCT00487188|559685040|FG001|Maintenance Phase|Lost to Follow-up|0|||
155069923|NCT00487188|559685041|FG002|Maintenance Phase|Lost to Follow-up|0|||
155069924|NCT00487188|559685039|FG000|Maintenance Phase|Administrative|0|||
155069925|NCT00487188|559685040|FG001|Maintenance Phase|Administrative|0|||
155069926|NCT00487188|559685041|FG002|Maintenance Phase|Administrative|1|||
155069927|NCT03483584|559685044|FG000|Overall Study|Lost to Follow-up|40|||
155069928|NCT03483584|559685045|FG001|Overall Study|Lost to Follow-up|7|||
155069929|NCT03483584|559685044|FG000|Overall Study|Withdrawal by Subject|4|||
155069930|NCT03483584|559685045|FG001|Overall Study|Withdrawal by Subject|1|||
155069931|NCT00005047|559685046|FG000|Overall Study|Withdrawal by Subject|12|||
155069932|NCT00005047|559685047|FG001|Overall Study|Withdrawal by Subject|0|||
155069933|NCT00005047|559685048|FG002|Overall Study|Withdrawal by Subject|0|||
155069934|NCT00005047|559685049|FG003|Overall Study|Withdrawal by Subject|0|||
155069935|NCT00005047|559685046|FG000|Overall Study|Adverse Event|5|||
155069936|NCT00005047|559685047|FG001|Overall Study|Adverse Event|0|||
155069937|NCT00005047|559685048|FG002|Overall Study|Adverse Event|0|||
155069938|NCT00005047|559685049|FG003|Overall Study|Adverse Event|0|||
155069939|NCT00005047|559685046|FG000|Overall Study|Lost to Follow-up|1|||
155069940|NCT00005047|559685047|FG001|Overall Study|Lost to Follow-up|0|||
155069941|NCT00005047|559685048|FG002|Overall Study|Lost to Follow-up|0|||
155069942|NCT00005047|559685049|FG003|Overall Study|Lost to Follow-up|0|||
155069943|NCT00005047|559685046|FG000|Overall Study|Lack of Efficacy|1|||
155069944|NCT00005047|559685047|FG001|Overall Study|Lack of Efficacy|0|||
155069945|NCT00005047|559685048|FG002|Overall Study|Lack of Efficacy|0|||
155069946|NCT00005047|559685049|FG003|Overall Study|Lack of Efficacy|0|||
155069947|NCT02296125|559685054|FG000|Overall Study|Withdrawal by Subject|18|||
155069948|NCT02296125|559685055|FG001|Overall Study|Withdrawal by Subject|8|||
155069949|NCT02296125|559685056|FG002|Overall Study|Withdrawal by Subject|6|||
155069950|NCT02296125|559685057|FG003|Overall Study|Withdrawal by Subject|2|||
155069951|NCT02296125|559685054|FG000|Overall Study|Adverse Event|41|||
155069952|NCT02296125|559685055|FG001|Overall Study|Adverse Event|52|||
155069953|NCT02296125|559685056|FG002|Overall Study|Adverse Event|9|||
155069954|NCT02296125|559685057|FG003|Overall Study|Adverse Event|4|||
155069955|NCT02296125|559685054|FG000|Overall Study|Severe non-compliance to protocol|0|||
155069956|NCT02296125|559685055|FG001|Overall Study|Severe non-compliance to protocol|1|||
155327685|NCT02111096|560635230|FG000|Overall Study|Lost to Follow Up|1|||
155327686|NCT02111096|560635231|FG001|Overall Study|Lost to Follow Up|1|||
155327687|NCT02111096|560635232|FG002|Overall Study|Lost to Follow Up|1|||
155069957|NCT02296125|559685056|FG002|Overall Study|Severe non-compliance to protocol|0|||
155069958|NCT02296125|559685057|FG003|Overall Study|Severe non-compliance to protocol|0|||
155069959|NCT02296125|559685054|FG000|Overall Study|Condition under investigation worsened|153|||
155069960|NCT02296125|559685055|FG001|Overall Study|Condition under investigation worsened|199|||
155163079|NCT01229267|560033174|FG004|Overall Study|Adverse Event|10|||
155327688|NCT02111096|560635230|FG000|Overall Study|Physician Decision|0|||
155327689|NCT02111096|560635231|FG001|Overall Study|Physician Decision|1|||
155327690|NCT02111096|560635232|FG002|Overall Study|Physician Decision|0|||
155163080|NCT01229267|560033170|FG000|Overall Study|Death|40|||
155163081|NCT01229267|560033171|FG001|Overall Study|Death|37|||
155163082|NCT01229267|560033172|FG002|Overall Study|Death|35|||
155163083|NCT01229267|560033173|FG003|Overall Study|Death|13|||
155163084|NCT01229267|560033174|FG004|Overall Study|Death|103|||
155163085|NCT01229267|560033170|FG000|Overall Study|Withdrawal by Subject|23|||
155163086|NCT01229267|560033171|FG001|Overall Study|Withdrawal by Subject|22|||
155163087|NCT01229267|560033172|FG002|Overall Study|Withdrawal by Subject|32|||
155163088|NCT01229267|560033173|FG003|Overall Study|Withdrawal by Subject|14|||
155163089|NCT01229267|560033174|FG004|Overall Study|Withdrawal by Subject|59|||
155163090|NCT01229267|560033170|FG000|Overall Study|Protocol Violation|0|||
155163091|NCT01229267|560033171|FG001|Overall Study|Protocol Violation|1|||
155163092|NCT01229267|560033172|FG002|Overall Study|Protocol Violation|0|||
155163093|NCT01229267|560033173|FG003|Overall Study|Protocol Violation|0|||
155163094|NCT01229267|560033174|FG004|Overall Study|Protocol Violation|0|||
155163095|NCT01229267|560033170|FG000|Overall Study|Progressive disease|0|||
155163096|NCT01229267|560033171|FG001|Overall Study|Progressive disease|0|||
155163097|NCT01229267|560033172|FG002|Overall Study|Progressive disease|0|||
155163098|NCT01229267|560033173|FG003|Overall Study|Progressive disease|0|||
155163099|NCT01229267|560033174|FG004|Overall Study|Progressive disease|1|||
155163100|NCT01229267|560033170|FG000|Overall Study|Physician Decision|8|||
155163101|NCT01229267|560033171|FG001|Overall Study|Physician Decision|11|||
155163102|NCT01229267|560033172|FG002|Overall Study|Physician Decision|8|||
155163103|NCT01229267|560033173|FG003|Overall Study|Physician Decision|3|||
155163104|NCT01229267|560033174|FG004|Overall Study|Physician Decision|25|||
155163105|NCT01229267|560033170|FG000|Overall Study|Lost to Follow-up|6|||
155163106|NCT01229267|560033171|FG001|Overall Study|Lost to Follow-up|5|||
155163107|NCT01229267|560033172|FG002|Overall Study|Lost to Follow-up|8|||
155163108|NCT01229267|560033173|FG003|Overall Study|Lost to Follow-up|3|||
155163109|NCT01229267|560033174|FG004|Overall Study|Lost to Follow-up|22|||
155163110|NCT03085797|560033177|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
155163111|NCT03085797|560033178|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
155163112|NCT03085797|560033177|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
155163113|NCT03085797|560033178|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
155163114|NCT03085797|560033177|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
155163115|NCT03085797|560033178|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
155163116|NCT02636595|560033179|FG000|Overall Study|Lost to Follow-up|1|||
155163117|NCT02636595|560033179|FG000|Overall Study|Other|1|||
155163118|NCT02004093|560033183|FG000|Overall Study|Death|2|||
155163119|NCT02004093|560033184|FG001|Overall Study|Death|1|||
155163120|NCT02004093|560033183|FG000|Overall Study|Lack of Efficacy|66|||
155163121|NCT02004093|560033184|FG001|Overall Study|Lack of Efficacy|62|||
155327691|NCT02111096|560635230|FG000|Overall Study|Protocol Violation|1|||
155327692|NCT02111096|560635231|FG001|Overall Study|Protocol Violation|0|||
155327693|NCT02111096|560635232|FG002|Overall Study|Protocol Violation|1|||
155327694|NCT02111096|560635230|FG000|Overall Study|Terminated by Sponsor|53|||
155327695|NCT02111096|560635231|FG001|Overall Study|Terminated by Sponsor|35|||
155327696|NCT02111096|560635232|FG002|Overall Study|Terminated by Sponsor|54|||
155327697|NCT02111096|560635230|FG000|Overall Study|Withdrawal by Subject|4|||
155327698|NCT02111096|560635231|FG001|Overall Study|Withdrawal by Subject|2|||
155327699|NCT02111096|560635232|FG002|Overall Study|Withdrawal by Subject|8|||
155327700|NCT03875313|560635237|FG000|Overall Study|Withdrawal by Subject|1|||
155327701|NCT03875313|560635238|FG001|Overall Study|Withdrawal by Subject|3|||
155327702|NCT03875313|560635239|FG002|Overall Study|Withdrawal by Subject|0|||
155327703|NCT03875313|560635240|FG003|Overall Study|Withdrawal by Subject|0|||
155327704|NCT03875313|560635241|FG004|Overall Study|Withdrawal by Subject|0|||
155327705|NCT03875313|560635237|FG000|Overall Study|Death|0|||
155327706|NCT03875313|560635238|FG001|Overall Study|Death|0|||
155327707|NCT03875313|560635239|FG002|Overall Study|Death|0|||
155327708|NCT03875313|560635240|FG003|Overall Study|Death|0|||
155327709|NCT03875313|560635241|FG004|Overall Study|Death|1|||
155163122|NCT02004093|560033183|FG000|Overall Study|Protocol Violation|0|||
155163123|NCT02004093|560033184|FG001|Overall Study|Protocol Violation|1|||
155163124|NCT02004093|560033183|FG000|Overall Study|Lost to Follow-up|0|||
155163125|NCT02004093|560033184|FG001|Overall Study|Lost to Follow-up|1|||
155163126|NCT02004093|560033183|FG000|Overall Study|Withdrawal by Subject|3|||
155163127|NCT02004093|560033184|FG001|Overall Study|Withdrawal by Subject|7|||
155163128|NCT02004093|560033183|FG000|Overall Study|Other|3|||
155163129|NCT02004093|560033184|FG001|Overall Study|Other|1|||
155163130|NCT04085289|560033185|FG000|Overall Study|Withdrawal by Subject|0|||
155163131|NCT04085289|560033186|FG001|Overall Study|Withdrawal by Subject|0|||
155163132|NCT04085289|560033187|FG002|Overall Study|Withdrawal by Subject|1|||
155163133|NCT01967576|560033198|FG000|Overall Study|Withdrawal by Subject|3|||
155327710|NCT03875313|560635237|FG000|Overall Study|Lost to Follow-up|0|||
155327711|NCT03875313|560635238|FG001|Overall Study|Lost to Follow-up|0|||
155327712|NCT03875313|560635239|FG002|Overall Study|Lost to Follow-up|0|||
155327713|NCT03875313|560635240|FG003|Overall Study|Lost to Follow-up|0|||
155327714|NCT03875313|560635241|FG004|Overall Study|Lost to Follow-up|1|||
155069961|NCT02296125|559685056|FG002|Overall Study|Condition under investigation worsened|39|||
155069962|NCT02296125|559685057|FG003|Overall Study|Condition under investigation worsened|56|||
155069963|NCT02296125|559685054|FG000|Overall Study|Any reason not specifically recorded|6|||
155069964|NCT02296125|559685055|FG001|Overall Study|Any reason not specifically recorded|4|||
155069965|NCT02296125|559685056|FG002|Overall Study|Any reason not specifically recorded|2|||
155069966|NCT02296125|559685057|FG003|Overall Study|Any reason not specifically recorded|0|||
155069967|NCT00984399|559685058|FG000|Overall Study|Adverse Event|0|||
155069968|NCT00984399|559685059|FG001|Overall Study|Adverse Event|1|||
155069969|NCT00984399|559685058|FG000|Overall Study|Physician Decision|1|||
155069970|NCT00984399|559685059|FG001|Overall Study|Physician Decision|0|||
155069971|NCT00984399|559685058|FG000|Overall Study|Withdrawal by Subject|1|||
155069972|NCT00984399|559685059|FG001|Overall Study|Withdrawal by Subject|1|||
155069973|NCT00984399|559685058|FG000|Overall Study|Protocol Violation|0|||
155069974|NCT00984399|559685059|FG001|Overall Study|Protocol Violation|1|||
155069975|NCT00984399|559685058|FG000|Overall Study|Pts did not start treatment|2|||
155069976|NCT00984399|559685059|FG001|Overall Study|Pts did not start treatment|2|||
155069977|NCT03785366|559685061|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
155069978|NCT03785366|559685062|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
155069979|NCT03785366|559685061|FG000|Overall Study|Lost to Follow-up|1|||
155069980|NCT03785366|559685062|FG001|Overall Study|Lost to Follow-up|0|||
155069981|NCT03785366|559685061|FG000|Overall Study|Partial IUD Expulsion|0|||
155069982|NCT03785366|559685062|FG001|Overall Study|Partial IUD Expulsion|2|||
155069983|NCT03785366|559685061|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
155069984|NCT03785366|559685062|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
155069985|NCT00927472|559685063|FG000|Overall Study|Withdrawal by Subject|10|||
155069986|NCT00927472|559685064|FG001|Overall Study|Withdrawal by Subject|11|||
155069987|NCT00927472|559685063|FG000|Overall Study|Lost to Follow-up|1|||
155069988|NCT00927472|559685064|FG001|Overall Study|Lost to Follow-up|6|||
155069989|NCT00927472|559685063|FG000|Overall Study|Protocol Violation|0|||
155069990|NCT00927472|559685064|FG001|Overall Study|Protocol Violation|1|||
155069991|NCT00927472|559685063|FG000|Overall Study|Post treatment Assessment out of window|0|||
155069992|NCT00927472|559685064|FG001|Overall Study|Post treatment Assessment out of window|4|||
155069993|NCT04364646|559685071|FG000|Overall Study|Lost to Follow-up|1|||
155327715|NCT03875313|560635237|FG000|Overall Study|Study Termination by Sponsor|0|||
155327716|NCT03875313|560635238|FG001|Overall Study|Study Termination by Sponsor|1|||
155327717|NCT03875313|560635239|FG002|Overall Study|Study Termination by Sponsor|1|||
155327718|NCT03875313|560635240|FG003|Overall Study|Study Termination by Sponsor|0|||
155327719|NCT03875313|560635241|FG004|Overall Study|Study Termination by Sponsor|1|||
155327720|NCT03875313|560635237|FG000|Overall Study|New Anticancer Treatment|0|||
155327721|NCT03875313|560635238|FG001|Overall Study|New Anticancer Treatment|1|||
155327722|NCT03875313|560635239|FG002|Overall Study|New Anticancer Treatment|2|||
155327723|NCT03875313|560635240|FG003|Overall Study|New Anticancer Treatment|1|||
155327724|NCT03875313|560635241|FG004|Overall Study|New Anticancer Treatment|0|||
155327725|NCT03875313|560635237|FG000|Overall Study|Other, Not Specified|2|||
155327726|NCT03875313|560635238|FG001|Overall Study|Other, Not Specified|11|||
155327727|NCT03875313|560635239|FG002|Overall Study|Other, Not Specified|3|||
155327728|NCT03875313|560635240|FG003|Overall Study|Other, Not Specified|3|||
155327729|NCT03875313|560635241|FG004|Overall Study|Other, Not Specified|1|||
155327730|NCT03213457|560635243|FG000|Screening Period|Withdrawal by Subject|0|||
155327731|NCT03213457|560635244|FG001|Screening Period|Withdrawal by Subject|1|||
155327732|NCT03213457|560635245|FG002|Screening Period|Withdrawal by Subject|0|||
155327733|NCT03213457|560635243|FG000|Screening Period|Other|1|||
155327734|NCT03213457|560635244|FG001|Screening Period|Other|0|||
155069994|NCT04364646|559685072|FG001|Overall Study|Lost to Follow-up|0|||
155069995|NCT04364646|559685071|FG000|Overall Study|Withdrawal by Subject|7|||
155069996|NCT04364646|559685072|FG001|Overall Study|Withdrawal by Subject|14|||
155069997|NCT04364646|559685071|FG000|Overall Study|Protocol Violation|4|||
155069998|NCT04364646|559685072|FG001|Overall Study|Protocol Violation|5|||
155069999|NCT00832975|559685074|FG000|Overall Study|Lost to Follow-up|7|||
155070000|NCT00832975|559685074|FG000|Overall Study|Protocol Violation|6|||
155070001|NCT00832975|559685074|FG000|Overall Study|Death|5|||
155070002|NCT00832975|559685074|FG000|Overall Study|Physician Decision|4|||
155070003|NCT00832975|559685074|FG000|Overall Study|Withdrawal by Subject|3|||
155070004|NCT00832975|559685074|FG000|Overall Study|Other reasons|14|||
155070005|NCT06081829|559685077|FG000|Overall Study|Participants still on-study|8|||
155327735|NCT03213457|560635245|FG002|Screening Period|Other|0|||
155070006|NCT06081829|559685077|FG000|Overall Study|Death|4|||
155070007|NCT05253807|559685078|FG000|Overall Study|Death|1|||
155070008|NCT05253807|559685079|FG001|Overall Study|Death|4|||
155070009|NCT05253807|559685078|FG000|Overall Study|Withdrawal by Subject|1|||
155327736|NCT03213457|560635243|FG000|Double-Blind Period|Adverse Event|3|||
155327737|NCT03213457|560635244|FG001|Double-Blind Period|Adverse Event|2|||
155327738|NCT03213457|560635245|FG002|Double-Blind Period|Adverse Event|7|||
155327739|NCT03213457|560635243|FG000|Double-Blind Period|Withdrawal by Subject|14|||
155327740|NCT03213457|560635244|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155327741|NCT03213457|560635245|FG002|Double-Blind Period|Withdrawal by Subject|14|||
155327742|NCT03213457|560635243|FG000|Double-Blind Period|Lost to Follow-up|2|||
155327743|NCT03213457|560635244|FG001|Double-Blind Period|Lost to Follow-up|3|||
155327744|NCT03213457|560635245|FG002|Double-Blind Period|Lost to Follow-up|9|||
155327745|NCT03213457|560635243|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
155327746|NCT03213457|560635244|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
155327747|NCT03213457|560635245|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
155070010|NCT05253807|559685079|FG001|Overall Study|Withdrawal by Subject|0|||
155070011|NCT05253807|559685078|FG000|Overall Study|Study Terminated by Sponsor|1|||
155070012|NCT05253807|559685079|FG001|Overall Study|Study Terminated by Sponsor|1|||
155070013|NCT02900976|559685080|FG000|Overall Study|Adverse Event|0|||
155070014|NCT02900976|559685081|FG001|Overall Study|Adverse Event|1|||
155070015|NCT02900976|559685080|FG000|Overall Study|Physician Decision|0|||
155070016|NCT02900976|559685081|FG001|Overall Study|Physician Decision|2|||
155070017|NCT02900976|559685080|FG000|Overall Study|Progressive disease|0|||
155070018|NCT02900976|559685081|FG001|Overall Study|Progressive disease|6|||
155070019|NCT03682848|559685089|FG000|Overall Study|Withdrawal by Subject|3|||
155070020|NCT03682848|559685089|FG000|Overall Study|Site closed|5|||
155070021|NCT03682848|559685089|FG000|Overall Study|Protocol Deviation|1|||
155070022|NCT03682848|559685089|FG000|Overall Study|Adverse Event|2|||
155070023|NCT03682848|559685089|FG000|Overall Study|Lack of Efficacy|1|||
155070024|NCT03069989|559685092|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
155070025|NCT03069989|559685093|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
155070026|NCT02145390|559685096|FG000|Overall Study|Withdrawal by Subject|1|||
155070027|NCT01991314|559686377|FG000|Overall Study|Adverse Event|5|||
155070028|NCT01991314|559686378|FG001|Overall Study|Adverse Event|1|||
155070029|NCT01991314|559686377|FG000|Overall Study|Lost to Follow-up|6|||
155070030|NCT01991314|559686378|FG001|Overall Study|Lost to Follow-up|10|||
155070031|NCT00970944|559686380|FG000|Overall Study|Death|1|||
155070032|NCT00970944|559686381|FG001|Overall Study|Death|0|||
155070033|NCT00970944|559686380|FG000|Overall Study|Physician Decision|0|||
155327748|NCT03213457|560635243|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
155327749|NCT03213457|560635244|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
155327750|NCT03213457|560635245|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
155327751|NCT03213457|560635243|FG000|Double-Blind Period|Pregnancy|5|||
155327752|NCT03213457|560635244|FG001|Double-Blind Period|Pregnancy|0|||
155327753|NCT03213457|560635245|FG002|Double-Blind Period|Pregnancy|0|||
155327754|NCT03213457|560635243|FG000|Double-Blind Period|Other|10|||
155327755|NCT03213457|560635244|FG001|Double-Blind Period|Other|3|||
155327756|NCT03213457|560635245|FG002|Double-Blind Period|Other|17|||
155327757|NCT03213457|560635243|FG000|Open-Label Period|Adverse Event|1|||
155327758|NCT03213457|560635244|FG001|Open-Label Period|Adverse Event|2|||
155327759|NCT03213457|560635245|FG002|Open-Label Period|Adverse Event|2|||
155327760|NCT03213457|560635243|FG000|Open-Label Period|Withdrawal by Subject|12|||
155327761|NCT03213457|560635244|FG001|Open-Label Period|Withdrawal by Subject|5|||
155327762|NCT03213457|560635245|FG002|Open-Label Period|Withdrawal by Subject|24|||
155327763|NCT03213457|560635243|FG000|Open-Label Period|Lost to Follow-up|1|||
155327764|NCT03213457|560635244|FG001|Open-Label Period|Lost to Follow-up|2|||
155327765|NCT03213457|560635245|FG002|Open-Label Period|Lost to Follow-up|8|||
155327766|NCT03213457|560635243|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
155327767|NCT03213457|560635244|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
155327768|NCT03213457|560635245|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
155327769|NCT03213457|560635243|FG000|Open-Label Period|Non-compliance with study procedures|1|||
155327770|NCT03213457|560635244|FG001|Open-Label Period|Non-compliance with study procedures|1|||
155327771|NCT03213457|560635245|FG002|Open-Label Period|Non-compliance with study procedures|2|||
155327772|NCT03213457|560635243|FG000|Open-Label Period|Exclusionary medications|0|||
155070034|NCT00970944|559686381|FG001|Overall Study|Physician Decision|2|||
155070035|NCT02008370|559686382|FG000|Overall Study|Lost to Follow-up|7|||
155070036|NCT00972738|559686383|FG000|Overall Study|Adverse Event|7|||
155327773|NCT03213457|560635244|FG001|Open-Label Period|Exclusionary medications|0|||
155327774|NCT03213457|560635245|FG002|Open-Label Period|Exclusionary medications|1|||
155327775|NCT03213457|560635243|FG000|Open-Label Period|Other|1|||
155327776|NCT03213457|560635244|FG001|Open-Label Period|Other|1|||
155327777|NCT03213457|560635245|FG002|Open-Label Period|Other|6|||
155327778|NCT03213457|560635243|FG000|Follow-Up Period|Adverse Event|16|||
155070037|NCT00972738|559686384|FG001|Overall Study|Adverse Event|1|||
155070038|NCT00972738|559686385|FG002|Overall Study|Adverse Event|8|||
155070039|NCT00972738|559686383|FG000|Overall Study|Protocol Violation|2|||
155070040|NCT00972738|559686384|FG001|Overall Study|Protocol Violation|1|||
155070041|NCT00972738|559686385|FG002|Overall Study|Protocol Violation|3|||
155070042|NCT00972738|559686383|FG000|Overall Study|Lost to Follow-up|1|||
155070043|NCT00972738|559686384|FG001|Overall Study|Lost to Follow-up|0|||
155070044|NCT00972738|559686385|FG002|Overall Study|Lost to Follow-up|1|||
155327779|NCT03213457|560635244|FG001|Follow-Up Period|Adverse Event|8|||
155327780|NCT03213457|560635245|FG002|Follow-Up Period|Adverse Event|37|||
155327781|NCT03213457|560635243|FG000|Follow-Up Period|Withdrawal by Subject|18|||
155327782|NCT03213457|560635244|FG001|Follow-Up Period|Withdrawal by Subject|11|||
155327783|NCT03213457|560635245|FG002|Follow-Up Period|Withdrawal by Subject|55|||
155327784|NCT03213457|560635243|FG000|Follow-Up Period|Lost to Follow-up|28|||
155327785|NCT03213457|560635244|FG001|Follow-Up Period|Lost to Follow-up|15|||
155327786|NCT03213457|560635245|FG002|Follow-Up Period|Lost to Follow-up|50|||
155327787|NCT03213457|560635243|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
155327788|NCT03213457|560635244|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
155327789|NCT03213457|560635245|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
155327790|NCT03213457|560635243|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
155327791|NCT03213457|560635244|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
155327792|NCT03213457|560635245|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
155327793|NCT03213457|560635243|FG000|Follow-Up Period|Pregnancy|7|||
155327794|NCT03213457|560635244|FG001|Follow-Up Period|Pregnancy|0|||
155327795|NCT03213457|560635245|FG002|Follow-Up Period|Pregnancy|18|||
155327796|NCT03213457|560635243|FG000|Follow-Up Period|Exclusionary medications|1|||
155327797|NCT03213457|560635244|FG001|Follow-Up Period|Exclusionary medications|1|||
155327798|NCT03213457|560635245|FG002|Follow-Up Period|Exclusionary medications|5|||
155327799|NCT03213457|560635243|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
155327800|NCT03213457|560635244|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
155327801|NCT03213457|560635245|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
155327802|NCT03213457|560635243|FG000|Follow-Up Period|Other|14|||
155327803|NCT03213457|560635244|FG001|Follow-Up Period|Other|10|||
155327804|NCT03213457|560635245|FG002|Follow-Up Period|Other|31|||
155327805|NCT02951052|560635246|FG000|Overall Study|Adverse Event|13|||
155327806|NCT02951052|560635247|FG001|Overall Study|Adverse Event|5|||
155327807|NCT02951052|560635246|FG000|Overall Study|Withdrawal by Subject|1|||
155327808|NCT02951052|560635247|FG001|Overall Study|Withdrawal by Subject|5|||
155327809|NCT02951052|560635246|FG000|Overall Study|Physician Decision|2|||
155327810|NCT02951052|560635247|FG001|Overall Study|Physician Decision|0|||
155327811|NCT02951052|560635246|FG000|Overall Study|Lost to Follow-up|1|||
155327812|NCT02951052|560635247|FG001|Overall Study|Lost to Follow-up|1|||
155327813|NCT02951052|560635246|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
155327814|NCT02951052|560635247|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
155327815|NCT02951052|560635246|FG000|Overall Study|Protocol Violation|5|||
155327816|NCT02951052|560635247|FG001|Overall Study|Protocol Violation|3|||
155327817|NCT02951052|560635246|FG000|Overall Study|Lack of Efficacy|3|||
155327818|NCT02951052|560635247|FG001|Overall Study|Lack of Efficacy|4|||
155327819|NCT02951052|560635246|FG000|Overall Study|Ongoing|1|||
155327820|NCT02951052|560635247|FG001|Overall Study|Ongoing|0|||
155327821|NCT04018495|560635252|FG000|Overall Study|Physician Decision|1|||
155327822|NCT04059406|560635261|FG000|Overall Study|Early Treatment Termination|5|||
155327823|NCT04059406|560635262|FG001|Overall Study|Early Treatment Termination|5|||
155327824|NCT04059406|560635263|FG002|Overall Study|Early Treatment Termination|15|||
155327825|NCT04305327|560635269|FG000|Overall Study|Study early termination|2|||
155327826|NCT04305327|560635270|FG001|Overall Study|Study early termination|5|||
155327827|NCT04305327|560635271|FG002|Overall Study|Study early termination|2|||
155327828|NCT04305327|560635272|FG003|Overall Study|Study early termination|2|||
155327829|NCT04305327|560635269|FG000|Overall Study|Withdrawal by Subject|0|||
155327830|NCT04305327|560635270|FG001|Overall Study|Withdrawal by Subject|1|||
155327831|NCT04305327|560635271|FG002|Overall Study|Withdrawal by Subject|0|||
155327832|NCT04305327|560635272|FG003|Overall Study|Withdrawal by Subject|0|||
154961598|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
154961599|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
154961600|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
154961601|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
154961602|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
154961603|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
155327833|NCT04977583|560636332|FG000|Overall Study|Lost to Follow-up|8|||
155327834|NCT04977583|560636333|FG001|Overall Study|Lost to Follow-up|4|||
155327835|NCT04977583|560636334|FG002|Overall Study|Lost to Follow-up|13|||
155070045|NCT00972738|559686383|FG000|Overall Study|Lack of Efficacy|5|||
155327836|NCT04977583|560636332|FG000|Overall Study|Withdrawal by Subject|3|||
155327837|NCT04977583|560636333|FG001|Overall Study|Withdrawal by Subject|2|||
155327838|NCT04977583|560636334|FG002|Overall Study|Withdrawal by Subject|1|||
155327839|NCT00786864|560636358|FG000|Overall Study|Lost to Follow-up|0|||
155327840|NCT00786864|560636359|FG001|Overall Study|Lost to Follow-up|1|||
155327841|NCT00786864|560636358|FG000|Overall Study|Sustained serious back injury|1|||
155327842|NCT00786864|560636359|FG001|Overall Study|Sustained serious back injury|0|||
155327843|NCT02422615|560636362|FG000|Treatment Period|Progressive disease|314|||
155070046|NCT00972738|559686384|FG001|Overall Study|Lack of Efficacy|1|||
155163134|NCT01967576|560033198|FG000|Overall Study|Progressed/Removed from treatment|1|||
155327844|NCT02422615|560636363|FG001|Treatment Period|Progressive disease|200|||
155327845|NCT02422615|560636362|FG000|Treatment Period|Adverse Event|51|||
155327846|NCT02422615|560636363|FG001|Treatment Period|Adverse Event|9|||
155327847|NCT02422615|560636362|FG000|Treatment Period|Physician Decision|32|||
155327848|NCT02422615|560636363|FG001|Treatment Period|Physician Decision|8|||
155327849|NCT02422615|560636362|FG000|Treatment Period|Subject/guardian decision|38|||
155327850|NCT02422615|560636363|FG001|Treatment Period|Subject/guardian decision|8|||
155327851|NCT02422615|560636362|FG000|Treatment Period|Death|2|||
155327852|NCT02422615|560636363|FG001|Treatment Period|Death|1|||
155327853|NCT02422615|560636362|FG000|Treatment Period|Technical problems|0|||
155327854|NCT02422615|560636363|FG001|Treatment Period|Technical problems|1|||
155327855|NCT02422615|560636362|FG000|Treatment Period|Protocol deviation|1|||
155327856|NCT02422615|560636363|FG001|Treatment Period|Protocol deviation|1|||
155327857|NCT02422615|560636362|FG000|Treatment Period|Study terminated as per protocol|46|||
155327858|NCT02422615|560636363|FG001|Treatment Period|Study terminated as per protocol|14|||
155327859|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155327860|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155327861|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Death|2|||
155327862|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Death|1|||
155327863|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155327864|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155327865|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
155327866|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
155327867|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
155327868|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
155327869|NCT02422615|560636362|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
155327870|NCT02422615|560636363|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
155327871|NCT01036724|560636364|FG000|Overall Study|Adverse Event|1|||
155327872|NCT01036724|560636365|FG001|Overall Study|Adverse Event|2|||
155327873|NCT01036724|560636364|FG000|Overall Study|Lack of Efficacy|1|||
155327874|NCT01036724|560636365|FG001|Overall Study|Lack of Efficacy|1|||
155327875|NCT01036724|560636364|FG000|Overall Study|Protocol Violation|4|||
155327876|NCT01036724|560636365|FG001|Overall Study|Protocol Violation|5|||
155327877|NCT02291913|560636370|FG000|Overall Study|Progressive Disease|32|||
155327878|NCT02291913|560636370|FG000|Overall Study|Adverse Event|11|||
155327879|NCT02291913|560636370|FG000|Overall Study|Death|2|||
155327880|NCT02291913|560636370|FG000|Overall Study|Physician Decision|1|||
155327881|NCT02291913|560636370|FG000|Overall Study|Withdrawal by Subject|1|||
155327882|NCT02291913|560636370|FG000|Overall Study|Protocol Violation|1|||
155327883|NCT03709706|560636371|FG000|Overall Study|Adverse Event|0|||
155327884|NCT03709706|560636372|FG001|Overall Study|Adverse Event|1|||
155327885|NCT03709706|560636371|FG000|Overall Study|Physician Decision|14|||
155327886|NCT03709706|560636372|FG001|Overall Study|Physician Decision|8|||
155327887|NCT03709706|560636371|FG000|Overall Study|Withdrawal by Subject|2|||
155327888|NCT03709706|560636372|FG001|Overall Study|Withdrawal by Subject|1|||
155327889|NCT03709706|560636371|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
155327890|NCT03709706|560636372|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
154961604|NCT01667679|559283994|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
154961605|NCT01667679|559283995|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
155327891|NCT01105975|560636373|FG000|Overall Study|Adverse Event|2|||
154961606|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
154961607|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
154961608|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
154961609|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
154961610|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
154961611|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
154961612|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
154961613|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
154961614|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
154961615|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
154961616|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
154961617|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
154961618|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
154961619|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
154961620|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
154961621|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
154961622|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
154961623|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
154961624|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
154961625|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
155327892|NCT01105975|560636374|FG001|Overall Study|Adverse Event|1|||
155327893|NCT01105975|560636375|FG002|Overall Study|Adverse Event|5|||
155327894|NCT01105975|560636376|FG003|Overall Study|Adverse Event|1|||
155327895|NCT01105975|560636377|FG004|Overall Study|Adverse Event|0|||
155327896|NCT01105975|560636378|FG005|Overall Study|Adverse Event|1|||
155327897|NCT01105975|560636379|FG006|Overall Study|Adverse Event|2|||
155163135|NCT01967576|560033198|FG000|Overall Study|Study closing at site|1|||
155163136|NCT01967576|560033198|FG000|Overall Study|Adverse Event|1|||
155163137|NCT01967576|560033198|FG000|Overall Study|Refused further treatment|1|||
155163138|NCT02892448|560033201|FG000|Overall Study|Screening failure|2|||
155163139|NCT02892448|560033202|FG001|Overall Study|Screening failure|2|||
155163140|NCT02892448|560033203|FG002|Overall Study|Screening failure|1|||
155163141|NCT00131248|560033204|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
155163142|NCT00131248|560033205|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
155163143|NCT02284243|560033206|FG000|Overall Study|Lack of Efficacy|3|||
155163144|NCT02284243|560033207|FG001|Overall Study|Lack of Efficacy|3|||
155163145|NCT02284243|560033206|FG000|Overall Study|Adverse Event|1|||
155163146|NCT02284243|560033207|FG001|Overall Study|Adverse Event|0|||
155163147|NCT04269889|560033209|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
155163148|NCT01654302|560033214|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
155163149|NCT01654302|560033215|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
155163150|NCT02699749|560033221|FG000|Overall Study|Other|0|||
155163151|NCT02699749|560033222|FG001|Overall Study|Other|0|||
155163152|NCT02699749|560033223|FG002|Overall Study|Other|2|||
155163153|NCT02699749|560033224|FG003|Overall Study|Other|0|||
155163154|NCT02699749|560033225|FG004|Overall Study|Other|0|||
155163155|NCT02699749|560033226|FG005|Overall Study|Other|1|||
155163156|NCT02699749|560033227|FG006|Overall Study|Other|1|||
155163157|NCT02699749|560033228|FG007|Overall Study|Other|0|||
155327898|NCT01105975|560636380|FG007|Overall Study|Adverse Event|4|||
155327899|NCT01105975|560636381|FG008|Overall Study|Adverse Event|1|||
155327900|NCT01105975|560636382|FG009|Overall Study|Adverse Event|4|||
155327901|NCT01105975|560636373|FG000|Overall Study|Withdrawal by Subject|2|||
155327902|NCT01105975|560636374|FG001|Overall Study|Withdrawal by Subject|2|||
155327903|NCT01105975|560636375|FG002|Overall Study|Withdrawal by Subject|2|||
155070047|NCT00972738|559686385|FG002|Overall Study|Lack of Efficacy|11|||
155070048|NCT00972738|559686383|FG000|Overall Study|Withdrawal by Subject|5|||
155070049|NCT00972738|559686384|FG001|Overall Study|Withdrawal by Subject|1|||
155070050|NCT00972738|559686385|FG002|Overall Study|Withdrawal by Subject|4|||
155070051|NCT00972738|559686383|FG000|Overall Study|Moved|0|||
155070052|NCT00972738|559686384|FG001|Overall Study|Moved|0|||
155070053|NCT00972738|559686385|FG002|Overall Study|Moved|1|||
155070054|NCT00972738|559686383|FG000|Overall Study|Other|1|||
155070055|NCT00972738|559686384|FG001|Overall Study|Other|2|||
155070056|NCT00972738|559686385|FG002|Overall Study|Other|1|||
155070057|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
155070058|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
155070059|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
155070060|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
155070061|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
155070062|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155070063|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
155070064|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155070065|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155070066|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
155070067|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Death|0|||
155070068|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Death|0|||
155070069|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Death|1|||
155070070|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Death|0|||
155070071|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Death|0|||
155070072|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
155070073|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
155070074|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
155070075|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
155070076|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
155070077|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Other|2|||
155070078|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Other|1|||
155070079|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Other|0|||
155070080|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Other|0|||
155070081|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Other|0|||
155070082|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155163158|NCT02699749|560033229|FG008|Overall Study|Other|0|||
155163159|NCT02699749|560033230|FG009|Overall Study|Other|0|||
155163160|NCT02699749|560033231|FG010|Overall Study|Other|1|||
155163161|NCT02699749|560033232|FG011|Overall Study|Other|0|||
155163162|NCT02699749|560033233|FG012|Overall Study|Other|0|||
155163163|NCT02699749|560033234|FG013|Overall Study|Other|0|||
155163164|NCT02699749|560033221|FG000|Overall Study|Progressive Disease|3|||
155327904|NCT01105975|560636376|FG003|Overall Study|Withdrawal by Subject|0|||
155327905|NCT01105975|560636377|FG004|Overall Study|Withdrawal by Subject|4|||
155327906|NCT01105975|560636378|FG005|Overall Study|Withdrawal by Subject|1|||
155327907|NCT01105975|560636379|FG006|Overall Study|Withdrawal by Subject|2|||
155327908|NCT01105975|560636380|FG007|Overall Study|Withdrawal by Subject|1|||
155327909|NCT01105975|560636381|FG008|Overall Study|Withdrawal by Subject|0|||
155327910|NCT01105975|560636382|FG009|Overall Study|Withdrawal by Subject|3|||
155327911|NCT01105975|560636373|FG000|Overall Study|Lost to Follow-up|1|||
155070083|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155070084|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
155070085|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155070086|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
155070087|NCT03317496|559686386|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
155070088|NCT03317496|559686387|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
155070089|NCT03317496|559686388|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
155070090|NCT03317496|559686389|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
155070091|NCT03317496|559686390|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
155070092|NCT03317496|559686386|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
155070093|NCT03317496|559686387|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
155070094|NCT03317496|559686388|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
155070095|NCT03317496|559686389|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
155070096|NCT03317496|559686390|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
155070097|NCT03317496|559686386|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
155070098|NCT03317496|559686387|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155070099|NCT03317496|559686388|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155070100|NCT03317496|559686389|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155070101|NCT03317496|559686390|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
155070102|NCT03317496|559686386|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155070103|NCT03317496|559686387|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155070104|NCT03317496|559686388|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
155327912|NCT01105975|560636374|FG001|Overall Study|Lost to Follow-up|0|||
155327913|NCT01105975|560636375|FG002|Overall Study|Lost to Follow-up|0|||
155070105|NCT03317496|559686389|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155070106|NCT03317496|559686390|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
155070107|NCT03317496|559686386|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
155070108|NCT03317496|559686387|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
155070109|NCT03317496|559686388|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
155070110|NCT03317496|559686389|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
155070111|NCT03317496|559686390|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
155070112|NCT03317496|559686386|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
155070113|NCT03317496|559686387|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
155070114|NCT03317496|559686388|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
155327914|NCT01105975|560636376|FG003|Overall Study|Lost to Follow-up|1|||
155327915|NCT01105975|560636377|FG004|Overall Study|Lost to Follow-up|1|||
155327916|NCT01105975|560636378|FG005|Overall Study|Lost to Follow-up|0|||
155327917|NCT01105975|560636379|FG006|Overall Study|Lost to Follow-up|0|||
155327918|NCT01105975|560636380|FG007|Overall Study|Lost to Follow-up|0|||
155327919|NCT01105975|560636381|FG008|Overall Study|Lost to Follow-up|1|||
155327920|NCT01105975|560636382|FG009|Overall Study|Lost to Follow-up|0|||
155327921|NCT01105975|560636373|FG000|Overall Study|Physician Decision|0|||
155327922|NCT01105975|560636374|FG001|Overall Study|Physician Decision|0|||
155327923|NCT01105975|560636375|FG002|Overall Study|Physician Decision|0|||
155327924|NCT01105975|560636376|FG003|Overall Study|Physician Decision|0|||
155327925|NCT01105975|560636377|FG004|Overall Study|Physician Decision|0|||
155327926|NCT01105975|560636378|FG005|Overall Study|Physician Decision|0|||
155327927|NCT01105975|560636379|FG006|Overall Study|Physician Decision|2|||
155327928|NCT01105975|560636380|FG007|Overall Study|Physician Decision|0|||
155327929|NCT01105975|560636381|FG008|Overall Study|Physician Decision|0|||
155327930|NCT01105975|560636382|FG009|Overall Study|Physician Decision|0|||
155327931|NCT01105975|560636373|FG000|Overall Study|Protocol Violation|0|||
155327932|NCT01105975|560636374|FG001|Overall Study|Protocol Violation|2|||
155327933|NCT01105975|560636375|FG002|Overall Study|Protocol Violation|2|||
155327934|NCT01105975|560636376|FG003|Overall Study|Protocol Violation|0|||
155327935|NCT01105975|560636377|FG004|Overall Study|Protocol Violation|1|||
155327936|NCT01105975|560636378|FG005|Overall Study|Protocol Violation|1|||
155327937|NCT01105975|560636379|FG006|Overall Study|Protocol Violation|1|||
155070115|NCT03317496|559686389|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
155327938|NCT01105975|560636380|FG007|Overall Study|Protocol Violation|1|||
155327939|NCT01105975|560636381|FG008|Overall Study|Protocol Violation|2|||
155327940|NCT01105975|560636382|FG009|Overall Study|Protocol Violation|2|||
155327941|NCT01105975|560636373|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327942|NCT01105975|560636374|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327943|NCT01105975|560636375|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155327944|NCT01105975|560636376|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327945|NCT01105975|560636377|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155070116|NCT03317496|559686390|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
155070117|NCT03317496|559686386|FG000|Phase 2: Treatment|Adverse Event|0|||
155070118|NCT03317496|559686387|FG001|Phase 2: Treatment|Adverse Event|0|||
155070119|NCT03317496|559686388|FG002|Phase 2: Treatment|Adverse Event|0|||
155070120|NCT03317496|559686389|FG003|Phase 2: Treatment|Adverse Event|0|||
155070121|NCT03317496|559686390|FG004|Phase 2: Treatment|Adverse Event|6|||
155070122|NCT03317496|559686386|FG000|Phase 2: Treatment|Progressive disease|0|||
155070123|NCT03317496|559686387|FG001|Phase 2: Treatment|Progressive disease|0|||
155070124|NCT03317496|559686388|FG002|Phase 2: Treatment|Progressive disease|0|||
155070125|NCT03317496|559686389|FG003|Phase 2: Treatment|Progressive disease|0|||
155070126|NCT03317496|559686390|FG004|Phase 2: Treatment|Progressive disease|22|||
155070127|NCT03317496|559686386|FG000|Phase 2: Treatment|Other|0|||
155327946|NCT01105975|560636378|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
155327947|NCT01105975|560636379|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155327948|NCT01105975|560636380|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155327949|NCT01105975|560636381|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
155327950|NCT01105975|560636382|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155327951|NCT04868617|560636383|FG000|Overall Study|Death|1|||
155327952|NCT04868617|560636384|FG001|Overall Study|Death|0|||
155327953|NCT04868617|560636383|FG000|Overall Study|Adverse Event|1|||
155327954|NCT04868617|560636384|FG001|Overall Study|Adverse Event|0|||
155327955|NCT04868617|560636383|FG000|Overall Study|Withdrawal by Subject|1|||
155327956|NCT04868617|560636384|FG001|Overall Study|Withdrawal by Subject|0|||
155327957|NCT04868617|560636383|FG000|Overall Study|Device deficiency|1|||
155327958|NCT04868617|560636384|FG001|Overall Study|Device deficiency|0|||
155327959|NCT02502526|560636385|FG000|Overall Study|Lost to Follow-up|2|||
155327960|NCT02502526|560636386|FG001|Overall Study|Lost to Follow-up|2|||
155327961|NCT02502526|560636387|FG002|Overall Study|Lost to Follow-up|3|||
155327962|NCT02502526|560636385|FG000|Overall Study|Withdrawal by Subject|0|||
155327963|NCT02502526|560636386|FG001|Overall Study|Withdrawal by Subject|1|||
155327964|NCT02502526|560636387|FG002|Overall Study|Withdrawal by Subject|1|||
155327965|NCT02502526|560636385|FG000|Overall Study|Disqualified due to cataract grading|0|||
155327966|NCT02502526|560636386|FG001|Overall Study|Disqualified due to cataract grading|0|||
155327967|NCT02502526|560636387|FG002|Overall Study|Disqualified due to cataract grading|1|||
155327968|NCT02502526|560636385|FG000|Overall Study|Enrollment suspension|4|||
155327969|NCT02502526|560636386|FG001|Overall Study|Enrollment suspension|1|||
155327970|NCT02502526|560636387|FG002|Overall Study|Enrollment suspension|1|||
155327971|NCT02964741|560636388|FG000|Overall Study|Protocol Violation|1|||
155327972|NCT02964741|560636389|FG001|Overall Study|Protocol Violation|0|||
155327973|NCT02964741|560636390|FG002|Overall Study|Protocol Violation|0|||
155070128|NCT03317496|559686387|FG001|Phase 2: Treatment|Other|0|||
155070129|NCT03317496|559686388|FG002|Phase 2: Treatment|Other|0|||
155070130|NCT03317496|559686389|FG003|Phase 2: Treatment|Other|0|||
155070131|NCT03317496|559686390|FG004|Phase 2: Treatment|Other|4|||
155070132|NCT03317496|559686386|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
155070133|NCT03317496|559686387|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
155070134|NCT03317496|559686388|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
155070135|NCT03317496|559686389|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
155070136|NCT03317496|559686390|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
155070137|NCT03317496|559686386|FG000|Phase 2: Treatment|Physician Decision|0|||
155070138|NCT03317496|559686387|FG001|Phase 2: Treatment|Physician Decision|0|||
155070139|NCT03317496|559686388|FG002|Phase 2: Treatment|Physician Decision|0|||
155070140|NCT03317496|559686389|FG003|Phase 2: Treatment|Physician Decision|0|||
155070141|NCT03317496|559686390|FG004|Phase 2: Treatment|Physician Decision|1|||
155163165|NCT02699749|560033222|FG001|Overall Study|Progressive Disease|3|||
155163166|NCT02699749|560033223|FG002|Overall Study|Progressive Disease|14|||
155163167|NCT02699749|560033224|FG003|Overall Study|Progressive Disease|3|||
155163168|NCT02699749|560033225|FG004|Overall Study|Progressive Disease|3|||
155163169|NCT02699749|560033226|FG005|Overall Study|Progressive Disease|7|||
155163170|NCT02699749|560033227|FG006|Overall Study|Progressive Disease|5|||
155163171|NCT02699749|560033228|FG007|Overall Study|Progressive Disease|5|||
155163172|NCT02699749|560033229|FG008|Overall Study|Progressive Disease|6|||
155163173|NCT02699749|560033230|FG009|Overall Study|Progressive Disease|6|||
155163174|NCT02699749|560033231|FG010|Overall Study|Progressive Disease|5|||
155163175|NCT02699749|560033232|FG011|Overall Study|Progressive Disease|4|||
155163176|NCT02699749|560033233|FG012|Overall Study|Progressive Disease|3|||
155163177|NCT02699749|560033234|FG013|Overall Study|Progressive Disease|5|||
155163178|NCT02699749|560033221|FG000|Overall Study|Death|0|||
155163179|NCT02699749|560033222|FG001|Overall Study|Death|0|||
155327974|NCT02964741|560636388|FG000|Overall Study|Withdrawal by Subject|0|||
155070142|NCT03317496|559686386|FG000|Phase 2: Treatment|Death|0|||
155070143|NCT03317496|559686387|FG001|Phase 2: Treatment|Death|0|||
155070144|NCT03317496|559686388|FG002|Phase 2: Treatment|Death|0|||
155070145|NCT03317496|559686389|FG003|Phase 2: Treatment|Death|0|||
155070146|NCT03317496|559686390|FG004|Phase 2: Treatment|Death|1|||
155163180|NCT02699749|560033223|FG002|Overall Study|Death|0|||
155163181|NCT02699749|560033224|FG003|Overall Study|Death|0|||
155163182|NCT02699749|560033225|FG004|Overall Study|Death|0|||
155327975|NCT02964741|560636389|FG001|Overall Study|Withdrawal by Subject|1|||
155327976|NCT02964741|560636390|FG002|Overall Study|Withdrawal by Subject|0|||
155327977|NCT02964741|560636388|FG000|Overall Study|claustrophobia|1|||
155327978|NCT02964741|560636389|FG001|Overall Study|claustrophobia|0|||
155327979|NCT02964741|560636390|FG002|Overall Study|claustrophobia|0|||
155327980|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
155327981|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
155070147|NCT03317496|559686386|FG000|Phase 2: Follow-up|Death|0|||
155327982|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
155327983|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
155327984|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
155327985|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
155327986|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
155327987|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
155327988|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
155327989|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
155327990|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
155327991|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
155327992|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
155327993|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
155070148|NCT03317496|559686387|FG001|Phase 2: Follow-up|Death|0|||
155070149|NCT03317496|559686388|FG002|Phase 2: Follow-up|Death|0|||
155070150|NCT03317496|559686389|FG003|Phase 2: Follow-up|Death|0|||
155070151|NCT03317496|559686390|FG004|Phase 2: Follow-up|Death|24|||
155070152|NCT03317496|559686386|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
155070153|NCT03317496|559686387|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
155070154|NCT03317496|559686388|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
155070155|NCT03317496|559686389|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
155070156|NCT03317496|559686390|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
155070157|NCT03317496|559686386|FG000|Phase 2: Follow-up|Other|0|||
155070158|NCT03317496|559686387|FG001|Phase 2: Follow-up|Other|0|||
155070159|NCT03317496|559686388|FG002|Phase 2: Follow-up|Other|0|||
155070160|NCT03317496|559686389|FG003|Phase 2: Follow-up|Other|0|||
155070161|NCT03317496|559686390|FG004|Phase 2: Follow-up|Other|1|||
155070162|NCT03317496|559686386|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
155070163|NCT03317496|559686387|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
155070164|NCT03317496|559686388|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
155070165|NCT03317496|559686389|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
155070166|NCT03317496|559686390|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
155070167|NCT01793935|559686393|FG000|Overall Study|Pregnancy|1|||
155070168|NCT01793935|559686394|FG001|Overall Study|Pregnancy|0|||
155070169|NCT01793935|559686393|FG000|Overall Study|Protocol Violation|2|||
155070170|NCT01793935|559686394|FG001|Overall Study|Protocol Violation|1|||
155070171|NCT01793935|559686393|FG000|Overall Study|Adverse Event|2|||
155070172|NCT01793935|559686394|FG001|Overall Study|Adverse Event|0|||
155070173|NCT01793935|559686393|FG000|Overall Study|Patient did not take study medication|1|||
155070174|NCT01793935|559686394|FG001|Overall Study|Patient did not take study medication|1|||
155070175|NCT01793935|559686393|FG000|Overall Study|Lost to Follow-up|0|||
155070176|NCT01793935|559686394|FG001|Overall Study|Lost to Follow-up|1|||
155070177|NCT01121926|559686395|FG000|First Intervention Period|Adverse Event|1|||
155070178|NCT01121926|559686396|FG001|First Intervention Period|Adverse Event|0|||
155070179|NCT01121926|559686395|FG000|Washout Period|Adverse Event|0|||
155070180|NCT01121926|559686396|FG001|Washout Period|Adverse Event|1|||
155163183|NCT02699749|560033226|FG005|Overall Study|Death|0|||
155070181|NCT01121926|559686395|FG000|Washout Period|Positive pregnancy test|0|||
155070182|NCT01121926|559686396|FG001|Washout Period|Positive pregnancy test|1|||
155163184|NCT02699749|560033227|FG006|Overall Study|Death|0|||
155070183|NCT02782468|559686397|FG000|Overall Study|Progressive Disease|2|||
155070184|NCT02782468|559686398|FG001|Overall Study|Progressive Disease|5|||
155070185|NCT02782468|559686399|FG002|Overall Study|Progressive Disease|0|||
155070186|NCT02782468|559686400|FG003|Overall Study|Progressive Disease|4|||
155070187|NCT02782468|559686397|FG000|Overall Study|Adverse Event|0|||
155070188|NCT02782468|559686398|FG001|Overall Study|Adverse Event|2|||
155070189|NCT02782468|559686399|FG002|Overall Study|Adverse Event|2|||
155070190|NCT02782468|559686400|FG003|Overall Study|Adverse Event|3|||
155327994|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
155327995|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
155327996|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
155327997|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
155327998|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
155327999|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
155328000|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
155328001|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
155328002|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
155328003|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
155328004|NCT01074294|560636394|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
155328005|NCT01074294|560636395|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
155328006|NCT01074294|560636396|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
155328007|NCT01074294|560636397|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
155328008|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
155328009|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
155328010|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
155328011|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
155328012|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
155328013|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
155328014|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
155328015|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
155328016|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
155328017|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
155328018|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
155328019|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
155328020|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
155328021|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
155328022|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
155328023|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
155070191|NCT02782468|559686397|FG000|Overall Study|Other|0|||
155070192|NCT02782468|559686398|FG001|Overall Study|Other|0|||
155070193|NCT02782468|559686399|FG002|Overall Study|Other|1|||
155070194|NCT02782468|559686400|FG003|Overall Study|Other|1|||
155070195|NCT02782468|559686397|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
155070196|NCT02782468|559686398|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
155070197|NCT02782468|559686399|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
155070198|NCT02782468|559686400|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
155070199|NCT02782468|559686397|FG000|Overall Study|Symptomatic Deterioration|0|||
155070200|NCT02782468|559686398|FG001|Overall Study|Symptomatic Deterioration|0|||
155070201|NCT02782468|559686399|FG002|Overall Study|Symptomatic Deterioration|0|||
155070202|NCT02782468|559686400|FG003|Overall Study|Symptomatic Deterioration|1|||
155070203|NCT02782468|559686397|FG000|Overall Study|Withdrawal by Subject|1|||
155070204|NCT02782468|559686398|FG001|Overall Study|Withdrawal by Subject|0|||
155070205|NCT02782468|559686399|FG002|Overall Study|Withdrawal by Subject|0|||
155070206|NCT02782468|559686400|FG003|Overall Study|Withdrawal by Subject|0|||
155070207|NCT04919161|559686401|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
155070208|NCT04919161|559686402|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
155070209|NCT04919161|559686401|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
155070210|NCT04919161|559686402|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
155070211|NCT04919161|559686401|FG000|Overall Study|Acute ankle sprain after session 1|0|||
155070212|NCT04919161|559686402|FG001|Overall Study|Acute ankle sprain after session 1|1|||
155328024|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
155328025|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
155328026|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
155328027|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
155328028|NCT01074294|560636394|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
155070213|NCT00712920|559686403|FG000|Overall Study|Adverse Event|3|||
155070214|NCT00712920|559686404|FG001|Overall Study|Adverse Event|4|||
155070215|NCT00712920|559686405|FG002|Overall Study|Adverse Event|7|||
155070216|NCT00712920|559686403|FG000|Overall Study|Withdrawal by Subject|4|||
155070217|NCT00712920|559686404|FG001|Overall Study|Withdrawal by Subject|2|||
155070218|NCT00712920|559686405|FG002|Overall Study|Withdrawal by Subject|1|||
155070219|NCT00712920|559686403|FG000|Overall Study|Lost to Follow-up|1|||
155070220|NCT00712920|559686404|FG001|Overall Study|Lost to Follow-up|4|||
155070221|NCT00712920|559686405|FG002|Overall Study|Lost to Follow-up|0|||
155070222|NCT00712920|559686403|FG000|Overall Study|Lack of Efficacy|1|||
155328029|NCT01074294|560636395|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
155328030|NCT01074294|560636396|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
155328031|NCT01074294|560636397|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
155328032|NCT00640159|560636398|FG000|Overall Study|Lost to Follow-up|2|||
155328033|NCT00112359|560636399|FG000|Overall Study|Unrelated adverse event|16|||
155328034|NCT00112359|560636400|FG001|Overall Study|Unrelated adverse event|8|||
155328035|NCT00112359|560636399|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
155328036|NCT00112359|560636400|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
155328037|NCT00112359|560636399|FG000|Overall Study|Related adverse event|5|||
155328038|NCT00112359|560636400|FG001|Overall Study|Related adverse event|3|||
155328039|NCT00112359|560636399|FG000|Overall Study|Lost to Follow-up|0|||
155328040|NCT00112359|560636400|FG001|Overall Study|Lost to Follow-up|1|||
155328041|NCT00112359|560636399|FG000|Overall Study|Personal/administrative|1|||
155328042|NCT00112359|560636400|FG001|Overall Study|Personal/administrative|1|||
155328043|NCT00112359|560636399|FG000|Overall Study|Other|3|||
155328044|NCT00112359|560636400|FG001|Overall Study|Other|0|||
155328045|NCT00312208|560636401|FG000|Overall Study|Adverse Event|97|||
155328046|NCT00312208|560636402|FG001|Overall Study|Adverse Event|61|||
155328047|NCT00312208|560636401|FG000|Overall Study|Protocol Violation|5|||
155328048|NCT00312208|560636402|FG001|Overall Study|Protocol Violation|3|||
155328049|NCT00312208|560636401|FG000|Overall Study|Death|2|||
155328050|NCT00312208|560636402|FG001|Overall Study|Death|1|||
155328051|NCT00312208|560636401|FG000|Overall Study|Lack of Efficacy|7|||
155328052|NCT00312208|560636402|FG001|Overall Study|Lack of Efficacy|4|||
155328053|NCT00312208|560636401|FG000|Overall Study|Lost to Follow-up|3|||
155328054|NCT00312208|560636402|FG001|Overall Study|Lost to Follow-up|5|||
155328055|NCT00312208|560636401|FG000|Overall Study|Withdrawal by Subject|53|||
155328056|NCT00312208|560636402|FG001|Overall Study|Withdrawal by Subject|42|||
155328057|NCT00312208|560636401|FG000|Overall Study|Other|5|||
155328058|NCT00312208|560636402|FG001|Overall Study|Other|7|||
155328059|NCT01315132|560636403|FG000|Overall Study|not treated due to disease progression|1|||
155328060|NCT03275285|560636411|FG000|Overall Study|Ongoing|45|||
155328061|NCT03275285|560636412|FG001|Overall Study|Ongoing|69|||
155328062|NCT00115934|560636413|FG000|Overall Study|Lost to Follow-up|1|||
155328063|NCT00115934|560636414|FG001|Overall Study|Lost to Follow-up|0|||
155328064|NCT00115934|560636413|FG000|Overall Study|Did not receive intervention|3|||
155328065|NCT00115934|560636414|FG001|Overall Study|Did not receive intervention|2|||
155328066|NCT00747565|560636415|FG000|Overall Study|Withdrawal by Subject|10|||
155328067|NCT00747565|560636416|FG001|Overall Study|Withdrawal by Subject|6|||
155328068|NCT00747565|560636415|FG000|Overall Study|Lost to Follow-up|4|||
155328069|NCT00747565|560636416|FG001|Overall Study|Lost to Follow-up|1|||
155328070|NCT03777657|560636417|FG000|Overall Study|Death|397|||
155328071|NCT03777657|560636418|FG001|Overall Study|Death|431|||
155328072|NCT03777657|560636417|FG000|Overall Study|Study Closed by Sponsor|77|||
155328073|NCT03777657|560636418|FG001|Overall Study|Study Closed by Sponsor|38|||
155328074|NCT03777657|560636417|FG000|Overall Study|Withdrawal by Subject|20|||
155328075|NCT03777657|560636418|FG001|Overall Study|Withdrawal by Subject|17|||
155328076|NCT03777657|560636417|FG000|Overall Study|Lost to Follow-up|6|||
155328077|NCT03777657|560636418|FG001|Overall Study|Lost to Follow-up|10|||
155328079|NCT00319020|560636426|FG000|Overall Study|Death|2|||
155328080|NCT00319020|560636427|FG001|Overall Study|Death|2|||
155328081|NCT00319020|560636426|FG000|Overall Study|Withdrawal by Subject|4|||
155328082|NCT00319020|560636427|FG001|Overall Study|Withdrawal by Subject|1|||
155328083|NCT00319020|560636426|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
155328084|NCT00319020|560636427|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
155328085|NCT00319020|560636426|FG000|Overall Study|Administrative reason|0|||
155328086|NCT00319020|560636427|FG001|Overall Study|Administrative reason|5|||
155328087|NCT00319020|560636426|FG000|Overall Study|Disease progression|0|||
155328088|NCT00319020|560636427|FG001|Overall Study|Disease progression|2|||
155328089|NCT00319020|560636426|FG000|Overall Study|Transplant|0|||
155328090|NCT00319020|560636427|FG001|Overall Study|Transplant|1|||
155328091|NCT00319020|560636426|FG000|Overall Study|Treatment failure|0|||
155328092|NCT00319020|560636427|FG001|Overall Study|Treatment failure|1|||
155328093|NCT00319020|560636426|FG000|Overall Study|Adverse Event|0|||
155328094|NCT00319020|560636427|FG001|Overall Study|Adverse Event|1|||
155328095|NCT02549352|560636430|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
155328096|NCT02549352|560636431|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
155328097|NCT02549352|560636430|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
155328098|NCT02549352|560636431|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
155328099|NCT02549352|560636430|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
155328100|NCT02549352|560636431|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
155328101|NCT02549352|560636430|FG000|12-month Follow-up|Withdrawal by Subject|4|||
155328102|NCT02549352|560636431|FG001|12-month Follow-up|Withdrawal by Subject|5|||
155328103|NCT02549352|560636430|FG000|12-month Follow-up|Lost to Follow-up|3|||
155328104|NCT02549352|560636431|FG001|12-month Follow-up|Lost to Follow-up|2|||
155328105|NCT02549352|560636430|FG000|12-month Follow-up|Death|0|||
155328106|NCT02549352|560636431|FG001|12-month Follow-up|Death|1|||
155328107|NCT02549352|560636430|FG000|12-month Follow-up|Protocol Violation|0|||
155328108|NCT02549352|560636431|FG001|12-month Follow-up|Protocol Violation|1|||
155328109|NCT02549352|560636430|FG000|12-month Follow-up|Other|1|||
155328110|NCT02549352|560636431|FG001|12-month Follow-up|Other|3|||
155328111|NCT04980300|560636432|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
155328112|NCT04980300|560636433|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
155328113|NCT04980300|560636432|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
155328114|NCT04980300|560636433|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
155328115|NCT04980300|560636432|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
155328116|NCT04980300|560636433|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
155328117|NCT04980300|560636432|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
155328118|NCT04980300|560636433|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
155328119|NCT05864209|560637455|FG000|Overall Study|Lost to Follow-up|2|||
155070223|NCT00712920|559686404|FG001|Overall Study|Lack of Efficacy|0|||
155070224|NCT00712920|559686405|FG002|Overall Study|Lack of Efficacy|1|||
155070225|NCT00712920|559686403|FG000|Overall Study|Other|5|||
155070226|NCT00712920|559686404|FG001|Overall Study|Other|7|||
155070227|NCT00712920|559686405|FG002|Overall Study|Other|3|||
155070228|NCT00712920|559686403|FG000|Overall Study|Non-compliance|3|||
155070229|NCT00712920|559686404|FG001|Overall Study|Non-compliance|0|||
155070230|NCT00712920|559686405|FG002|Overall Study|Non-compliance|0|||
155070231|NCT02489773|559686406|FG000|Overall Study|Lost to Follow-up|4|||
155070232|NCT02489773|559686407|FG001|Overall Study|Lost to Follow-up|1|||
155070233|NCT02489773|559686406|FG000|Overall Study|Physician Decision|1|||
155070234|NCT02489773|559686407|FG001|Overall Study|Physician Decision|0|||
155070235|NCT02489773|559686406|FG000|Overall Study|Withdrawal by Subject|1|||
155070236|NCT02489773|559686407|FG001|Overall Study|Withdrawal by Subject|0|||
155070237|NCT02489773|559686406|FG000|Overall Study|Leave the country or the state|1|||
155070238|NCT02489773|559686407|FG001|Overall Study|Leave the country or the state|1|||
155070239|NCT05696847|559686409|FG000|Overall Study|Withdrawal by Subject|1|||
155070240|NCT05696847|559686410|FG001|Overall Study|Withdrawal by Subject|0|||
155070241|NCT05696847|559686411|FG002|Overall Study|Withdrawal by Subject|0|||
155070242|NCT05696847|559686412|FG003|Overall Study|Withdrawal by Subject|0|||
155070243|NCT05696847|559686413|FG004|Overall Study|Withdrawal by Subject|0|||
155070244|NCT05696847|559686414|FG005|Overall Study|Withdrawal by Subject|0|||
155070245|NCT05696847|559686409|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155070246|NCT05696847|559686410|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155328120|NCT05864209|560637456|FG001|Overall Study|Lost to Follow-up|3|||
155328121|NCT02722434|560637459|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
155328122|NCT02722434|560637460|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
155328123|NCT02722434|560637459|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
155328124|NCT02722434|560637460|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
155328125|NCT04559698|560637461|FG000|Overall Study|Lost to Follow-up|14|||
155328126|NCT04559698|560637462|FG001|Overall Study|Lost to Follow-up|15|||
155328127|NCT04559698|560637461|FG000|Overall Study|Withdrawal by Subject|0|||
155328128|NCT04559698|560637462|FG001|Overall Study|Withdrawal by Subject|1|||
155328129|NCT03437733|560637463|FG000|Overall Study|Eligibility criteria not met|0|||
155328130|NCT03437733|560637464|FG001|Overall Study|Eligibility criteria not met|3|||
155328131|NCT01982682|560637465|FG000|Overall Study|Physician Decision|1|||
155328132|NCT02760654|560637466|FG000|Overall Study|Lost to Follow-up|3|||
155328133|NCT02760654|560637467|FG001|Overall Study|Lost to Follow-up|3|||
155328134|NCT02760654|560637466|FG000|Overall Study|Withdrawal by Subject|4|||
155328135|NCT02760654|560637467|FG001|Overall Study|Withdrawal by Subject|3|||
155328136|NCT00146172|560637468|FG000|Overall Study|Adverse Event|0|||
155328137|NCT00146172|560637469|FG001|Overall Study|Adverse Event|0|||
155328138|NCT00146172|560637470|FG002|Overall Study|Adverse Event|1|||
155328139|NCT00146172|560637471|FG003|Overall Study|Adverse Event|1|||
155328140|NCT00146172|560637472|FG004|Overall Study|Adverse Event|0|||
155328141|NCT00146172|560637473|FG005|Overall Study|Adverse Event|2|||
155328142|NCT00146172|560637474|FG006|Overall Study|Adverse Event|3|||
155070247|NCT05696847|559686411|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155070248|NCT05696847|559686412|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155070249|NCT05696847|559686413|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155163185|NCT02699749|560033228|FG007|Overall Study|Death|0|||
155328143|NCT00146172|560637475|FG007|Overall Study|Adverse Event|10|||
155328144|NCT00146172|560637468|FG000|Overall Study|Lost to Follow-up|0|||
155163186|NCT02699749|560033229|FG008|Overall Study|Death|0|||
155328145|NCT00146172|560637469|FG001|Overall Study|Lost to Follow-up|0|||
155328146|NCT00146172|560637470|FG002|Overall Study|Lost to Follow-up|0|||
155328147|NCT00146172|560637471|FG003|Overall Study|Lost to Follow-up|0|||
155328148|NCT00146172|560637472|FG004|Overall Study|Lost to Follow-up|0|||
155070250|NCT05696847|559686414|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155070251|NCT05696847|559686409|FG000|Overall Study|Adverse Event|0|||
155070252|NCT05696847|559686410|FG001|Overall Study|Adverse Event|0|||
155163187|NCT02699749|560033230|FG009|Overall Study|Death|0|||
155328149|NCT00146172|560637473|FG005|Overall Study|Lost to Follow-up|0|||
155328150|NCT00146172|560637474|FG006|Overall Study|Lost to Follow-up|0|||
155328151|NCT00146172|560637475|FG007|Overall Study|Lost to Follow-up|1|||
155328152|NCT00146172|560637468|FG000|Overall Study|Disease Progression|2|||
155328153|NCT00146172|560637469|FG001|Overall Study|Disease Progression|4|||
154961626|NCT01667679|559283994|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
155328154|NCT00146172|560637470|FG002|Overall Study|Disease Progression|2|||
155328155|NCT00146172|560637471|FG003|Overall Study|Disease Progression|5|||
155328156|NCT00146172|560637472|FG004|Overall Study|Disease Progression|2|||
155328157|NCT00146172|560637473|FG005|Overall Study|Disease Progression|2|||
155328158|NCT00146172|560637474|FG006|Overall Study|Disease Progression|1|||
155328159|NCT00146172|560637475|FG007|Overall Study|Disease Progression|22|||
155328160|NCT00146172|560637468|FG000|Overall Study|Death|0|||
155328161|NCT00146172|560637469|FG001|Overall Study|Death|0|||
155328162|NCT00146172|560637470|FG002|Overall Study|Death|0|||
155328163|NCT00146172|560637471|FG003|Overall Study|Death|0|||
155328164|NCT00146172|560637472|FG004|Overall Study|Death|0|||
154961627|NCT01667679|559283995|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
154961628|NCT01788423|559283997|FG000|Overall Study|See Comments in Completed (above)|0|||
154961629|NCT01788423|559283998|FG001|Overall Study|See Comments in Completed (above)|4|||
154961630|NCT01788423|559283999|FG002|Overall Study|See Comments in Completed (above)|5|||
154961631|NCT00835263|559284000|FG000|Second Intervention|Adverse Event|1|||
154961632|NCT00835263|559284001|FG001|Second Intervention|Adverse Event|0|||
154961633|NCT03987191|559284004|FG000|Overall Study|COVID-19 related research disruption|0|||
154961634|NCT03987191|559284005|FG001|Overall Study|COVID-19 related research disruption|2|||
154961635|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
154961636|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
154961637|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
154961638|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
154961639|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
154961640|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
154961641|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
154961642|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
154961643|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
154961644|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
154961645|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
154961646|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
154961647|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
154961648|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
154961649|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
154961650|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
154961651|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
154961652|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
154961653|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
154961654|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
154961655|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Death|0|||
154961656|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Death|1|||
154961657|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Death|0|||
154961658|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Death|0|||
155070253|NCT05696847|559686411|FG002|Overall Study|Adverse Event|0|||
155328165|NCT00146172|560637473|FG005|Overall Study|Death|0|||
155328166|NCT00146172|560637474|FG006|Overall Study|Death|1|||
155328167|NCT00146172|560637475|FG007|Overall Study|Death|0|||
155328168|NCT00146172|560637468|FG000|Overall Study|Physician Decision|0|||
155328169|NCT00146172|560637469|FG001|Overall Study|Physician Decision|0|||
155328170|NCT00146172|560637470|FG002|Overall Study|Physician Decision|0|||
155328171|NCT00146172|560637471|FG003|Overall Study|Physician Decision|0|||
155328172|NCT00146172|560637472|FG004|Overall Study|Physician Decision|0|||
155328173|NCT00146172|560637473|FG005|Overall Study|Physician Decision|0|||
155328174|NCT00146172|560637474|FG006|Overall Study|Physician Decision|0|||
155328175|NCT00146172|560637475|FG007|Overall Study|Physician Decision|1|||
155070254|NCT05696847|559686412|FG003|Overall Study|Adverse Event|0|||
155070255|NCT05696847|559686413|FG004|Overall Study|Adverse Event|0|||
155328176|NCT00146172|560637468|FG000|Overall Study|Withdrawal by Subject|0|||
155328177|NCT00146172|560637469|FG001|Overall Study|Withdrawal by Subject|0|||
155328178|NCT00146172|560637470|FG002|Overall Study|Withdrawal by Subject|0|||
155328179|NCT00146172|560637471|FG003|Overall Study|Withdrawal by Subject|0|||
155328180|NCT00146172|560637472|FG004|Overall Study|Withdrawal by Subject|0|||
155328181|NCT00146172|560637473|FG005|Overall Study|Withdrawal by Subject|1|||
155328182|NCT00146172|560637474|FG006|Overall Study|Withdrawal by Subject|1|||
155328183|NCT00146172|560637475|FG007|Overall Study|Withdrawal by Subject|4|||
155328184|NCT00146172|560637468|FG000|Overall Study|Symptomatic Deterioration|1|||
155328185|NCT00146172|560637469|FG001|Overall Study|Symptomatic Deterioration|0|||
155328186|NCT00146172|560637470|FG002|Overall Study|Symptomatic Deterioration|1|||
155328187|NCT00146172|560637471|FG003|Overall Study|Symptomatic Deterioration|0|||
155328188|NCT00146172|560637472|FG004|Overall Study|Symptomatic Deterioration|1|||
155328189|NCT00146172|560637473|FG005|Overall Study|Symptomatic Deterioration|2|||
155328190|NCT00146172|560637474|FG006|Overall Study|Symptomatic Deterioration|0|||
154961659|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
154961660|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
154961661|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
154961662|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
154961663|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
154961664|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
154961665|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
154961666|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
154961667|NCT01940341|559284013|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
154961668|NCT01940341|559284014|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
154961669|NCT01940341|559284015|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
154961670|NCT01940341|559284016|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
154961671|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
154961672|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
154961673|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
154961674|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
154961675|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
154961676|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
154961677|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
154961678|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
155070256|NCT05696847|559686414|FG005|Overall Study|Adverse Event|1|||
155070257|NCT05696847|559686409|FG000|Overall Study|Sponsor Decision|0|||
155070258|NCT05696847|559686410|FG001|Overall Study|Sponsor Decision|0|||
155070259|NCT05696847|559686411|FG002|Overall Study|Sponsor Decision|0|||
155328191|NCT00146172|560637475|FG007|Overall Study|Symptomatic Deterioration|2|||
155328192|NCT03876457|560637477|FG000|Overall Study|Lost to Follow-up|1|||
155328193|NCT03876457|560637478|FG001|Overall Study|Lost to Follow-up|3|||
155328194|NCT01574716|560637480|FG000|Part 1|Death|3|||
155328195|NCT01574716|560637481|FG001|Part 1|Death|1|||
155328196|NCT01574716|560637482|FG002|Part 1|Death|8|||
155328197|NCT01574716|560637483|FG003|Part 1|Death|0|||
155328198|NCT01574716|560637484|FG004|Part 1|Death|0|||
155328199|NCT01574716|560637480|FG000|Part 1|Discontinuation of study by sponsor|0|||
155328200|NCT01574716|560637481|FG001|Part 1|Discontinuation of study by sponsor|0|||
155328201|NCT01574716|560637482|FG002|Part 1|Discontinuation of study by sponsor|1|||
155328202|NCT01574716|560637483|FG003|Part 1|Discontinuation of study by sponsor|0|||
155328203|NCT01574716|560637484|FG004|Part 1|Discontinuation of study by sponsor|0|||
155328204|NCT01574716|560637480|FG000|Part 1|Withdrawal by Subject|0|||
155070260|NCT05696847|559686412|FG003|Overall Study|Sponsor Decision|1|||
155328205|NCT01574716|560637481|FG001|Part 1|Withdrawal by Subject|2|||
155328206|NCT01574716|560637482|FG002|Part 1|Withdrawal by Subject|0|||
155328207|NCT01574716|560637483|FG003|Part 1|Withdrawal by Subject|0|||
155328208|NCT01574716|560637484|FG004|Part 1|Withdrawal by Subject|0|||
155070261|NCT05696847|559686413|FG004|Overall Study|Sponsor Decision|0|||
155328209|NCT01574716|560637480|FG000|Part 1|Lost to Follow-up|0|||
155070262|NCT05696847|559686414|FG005|Overall Study|Sponsor Decision|0|||
155070263|NCT01697579|559686415|FG000|Base Study-Cycle 1|Adverse Event|1|||
155070264|NCT01697579|559686416|FG001|Base Study-Cycle 1|Adverse Event|0|||
155328210|NCT01574716|560637481|FG001|Part 1|Lost to Follow-up|1|||
155328211|NCT01574716|560637482|FG002|Part 1|Lost to Follow-up|0|||
155328212|NCT01574716|560637483|FG003|Part 1|Lost to Follow-up|0|||
155328213|NCT01574716|560637484|FG004|Part 1|Lost to Follow-up|0|||
155328214|NCT01574716|560637480|FG000|Part 2|Progressive disease|0|||
155328215|NCT01574716|560637481|FG001|Part 2|Progressive disease|0|||
155328216|NCT01574716|560637482|FG002|Part 2|Progressive disease|0|||
155328217|NCT01574716|560637483|FG003|Part 2|Progressive disease|1|||
155328218|NCT01574716|560637484|FG004|Part 2|Progressive disease|0|||
155328219|NCT01574716|560637480|FG000|Part 2|Death|0|||
155328220|NCT01574716|560637481|FG001|Part 2|Death|0|||
155328221|NCT01574716|560637482|FG002|Part 2|Death|0|||
155328222|NCT01574716|560637483|FG003|Part 2|Death|76|||
155328223|NCT01574716|560637484|FG004|Part 2|Death|35|||
155328224|NCT01574716|560637480|FG000|Part 2|Discontinuation of study by sponsor|0|||
155328225|NCT01574716|560637481|FG001|Part 2|Discontinuation of study by sponsor|0|||
155328226|NCT01574716|560637482|FG002|Part 2|Discontinuation of study by sponsor|0|||
155328227|NCT01574716|560637483|FG003|Part 2|Discontinuation of study by sponsor|51|||
155328228|NCT01574716|560637484|FG004|Part 2|Discontinuation of study by sponsor|31|||
155328229|NCT01574716|560637480|FG000|Part 2|Withdrawal by Subject|0|||
155328230|NCT01574716|560637481|FG001|Part 2|Withdrawal by Subject|0|||
155328231|NCT01574716|560637482|FG002|Part 2|Withdrawal by Subject|0|||
155328232|NCT01574716|560637483|FG003|Part 2|Withdrawal by Subject|5|||
155328233|NCT01574716|560637484|FG004|Part 2|Withdrawal by Subject|4|||
155328234|NCT01574716|560637480|FG000|Part 2|Brain metastases|0|||
155328235|NCT01574716|560637481|FG001|Part 2|Brain metastases|0|||
155328236|NCT01574716|560637482|FG002|Part 2|Brain metastases|0|||
155328237|NCT01574716|560637483|FG003|Part 2|Brain metastases|1|||
155328238|NCT01574716|560637484|FG004|Part 2|Brain metastases|0|||
155328239|NCT01574716|560637480|FG000|Part 2|Lost to Follow-up|0|||
155328240|NCT01574716|560637481|FG001|Part 2|Lost to Follow-up|0|||
155328241|NCT01574716|560637482|FG002|Part 2|Lost to Follow-up|0|||
155328242|NCT01574716|560637483|FG003|Part 2|Lost to Follow-up|3|||
155328243|NCT01574716|560637484|FG004|Part 2|Lost to Follow-up|0|||
155328244|NCT02438137|560637485|FG000|Overall Study|Lost to Follow-up|3|||
155328245|NCT02438137|560637486|FG001|Overall Study|Lost to Follow-up|2|||
155328246|NCT02438137|560637485|FG000|Overall Study|Adverse Event|1|||
155328247|NCT02438137|560637486|FG001|Overall Study|Adverse Event|0|||
155328248|NCT02438137|560637485|FG000|Overall Study|Withdrawal by Subject|4|||
155328249|NCT02438137|560637486|FG001|Overall Study|Withdrawal by Subject|3|||
155328250|NCT02438137|560637485|FG000|Overall Study|Physician Decision|0|||
155328251|NCT02438137|560637486|FG001|Overall Study|Physician Decision|1|||
155328252|NCT00945321|560637487|FG000|Period 1|Adverse Event|0|||
155328253|NCT00945321|560637488|FG001|Period 1|Adverse Event|0|||
155328254|NCT00945321|560637489|FG002|Period 1|Adverse Event|0|||
155328255|NCT00945321|560637490|FG003|Period 1|Adverse Event|0|||
155328256|NCT00945321|560637491|FG004|Period 1|Adverse Event|1|||
155328257|NCT00945321|560637492|FG005|Period 1|Adverse Event|0|||
155328258|NCT00945321|560637487|FG000|Period 4|Lost to Follow-up|0|||
155328259|NCT00945321|560637488|FG001|Period 4|Lost to Follow-up|0|||
155328260|NCT00945321|560637489|FG002|Period 4|Lost to Follow-up|0|||
155328261|NCT00945321|560637490|FG003|Period 4|Lost to Follow-up|0|||
155328262|NCT00945321|560637491|FG004|Period 4|Lost to Follow-up|0|||
155328263|NCT00945321|560637492|FG005|Period 4|Lost to Follow-up|1|||
155328264|NCT00692913|560637494|FG000|Overall Study|Adverse Event|8|||
155328265|NCT00692913|560637495|FG001|Overall Study|Adverse Event|4|||
155328266|NCT00692913|560637494|FG000|Overall Study|Lost to Follow-up|3|||
155328267|NCT00692913|560637495|FG001|Overall Study|Lost to Follow-up|5|||
155328268|NCT00692913|560637494|FG000|Overall Study|Physician Decision|2|||
155328269|NCT00692913|560637495|FG001|Overall Study|Physician Decision|0|||
155070265|NCT01697579|559686417|FG002|Base Study-Cycle 1|Adverse Event|0|||
155070266|NCT01697579|559686418|FG003|Base Study-Cycle 1|Adverse Event|0|||
155070267|NCT01697579|559686419|FG004|Base Study-Cycle 1|Adverse Event|0|||
155070268|NCT01697579|559686420|FG005|Base Study-Cycle 1|Adverse Event|0|||
155070269|NCT01697579|559686421|FG006|Base Study-Cycle 1|Adverse Event|0|||
155070270|NCT01697579|559686415|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
155328270|NCT00692913|560637494|FG000|Overall Study|Protocol Violation|1|||
155328271|NCT00692913|560637495|FG001|Overall Study|Protocol Violation|1|||
155328272|NCT00692913|560637494|FG000|Overall Study|Withdrawal by Subject|15|||
155328273|NCT00692913|560637495|FG001|Overall Study|Withdrawal by Subject|20|||
155328274|NCT03621735|560637496|FG000|Overall Study|Withdrawal by Subject|13|||
155328275|NCT03621735|560637497|FG001|Overall Study|Withdrawal by Subject|13|||
155328276|NCT00605306|560637500|FG000|Overall Study|Adverse Event|0|||
155328277|NCT00605306|560637501|FG001|Overall Study|Adverse Event|1|||
155070271|NCT01697579|559686416|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155328278|NCT01750684|560637502|FG000|Overall Study|Death|1|||
155328279|NCT01750684|560637503|FG001|Overall Study|Death|0|||
155328280|NCT01750684|560637502|FG000|Overall Study|Non-compliance with Study Drug|0|||
155328281|NCT01750684|560637503|FG001|Overall Study|Non-compliance with Study Drug|1|||
155328282|NCT01750684|560637502|FG000|Overall Study|Withdrawn by Sponsor|0|||
155328283|NCT01750684|560637503|FG001|Overall Study|Withdrawn by Sponsor|1|||
155070272|NCT01697579|559686417|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155070273|NCT01697579|559686418|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155070274|NCT01697579|559686419|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155070275|NCT01697579|559686420|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155070276|NCT01697579|559686421|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
155070277|NCT01697579|559686415|FG000|Base Study-Cycle 1|Protocol Violation|0|||
155070278|NCT01697579|559686416|FG001|Base Study-Cycle 1|Protocol Violation|0|||
155070279|NCT01697579|559686417|FG002|Base Study-Cycle 1|Protocol Violation|0|||
155070280|NCT01697579|559686418|FG003|Base Study-Cycle 1|Protocol Violation|0|||
155070281|NCT01697579|559686419|FG004|Base Study-Cycle 1|Protocol Violation|3|||
155070282|NCT01697579|559686420|FG005|Base Study-Cycle 1|Protocol Violation|0|||
155070283|NCT01697579|559686421|FG006|Base Study-Cycle 1|Protocol Violation|0|||
155070284|NCT01697579|559686415|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155070285|NCT01697579|559686416|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
155070286|NCT01697579|559686417|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155070287|NCT01697579|559686418|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155070288|NCT01697579|559686419|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155070289|NCT01697579|559686420|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155070290|NCT01697579|559686421|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
155070291|NCT01697579|559686415|FG000|Base Study-Cycle 1|Technical Problems|0|||
155070292|NCT01697579|559686416|FG001|Base Study-Cycle 1|Technical Problems|0|||
155070293|NCT01697579|559686417|FG002|Base Study-Cycle 1|Technical Problems|1|||
155070294|NCT01697579|559686418|FG003|Base Study-Cycle 1|Technical Problems|1|||
155070295|NCT01697579|559686419|FG004|Base Study-Cycle 1|Technical Problems|0|||
155070296|NCT01697579|559686420|FG005|Base Study-Cycle 1|Technical Problems|0|||
155070297|NCT01697579|559686421|FG006|Base Study-Cycle 1|Technical Problems|0|||
155070298|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Death|0|||
155070299|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Death|0|||
155070300|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Death|0|||
155070301|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Death|0|||
155070302|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Death|0|||
155070303|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Death|0|||
155070304|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Death|2|||
155070305|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155070306|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155328284|NCT01750684|560637502|FG000|Overall Study|Protocol Violation|1|||
155328285|NCT01750684|560637503|FG001|Overall Study|Protocol Violation|0|||
155328286|NCT02185794|560637505|FG000|Overall Study|Enrolled but Never Dosed|1|||
155328287|NCT02185794|560637506|FG001|Overall Study|Enrolled but Never Dosed|6|||
155328288|NCT02185794|560637507|FG002|Overall Study|Enrolled but Never Dosed|3|||
155328289|NCT02185794|560637508|FG003|Overall Study|Enrolled but Never Dosed|1|||
155328290|NCT02185794|560637509|FG004|Overall Study|Enrolled but Never Dosed|1|||
155328291|NCT02185794|560637510|FG005|Overall Study|Enrolled but Never Dosed|0|||
155328292|NCT02185794|560637505|FG000|Overall Study|Investigator's Discretion|1|||
155328293|NCT02185794|560637506|FG001|Overall Study|Investigator's Discretion|0|||
155328294|NCT02185794|560637507|FG002|Overall Study|Investigator's Discretion|1|||
155328295|NCT02185794|560637508|FG003|Overall Study|Investigator's Discretion|2|||
155328296|NCT02185794|560637509|FG004|Overall Study|Investigator's Discretion|2|||
155328297|NCT02185794|560637510|FG005|Overall Study|Investigator's Discretion|15|||
155328298|NCT02185794|560637505|FG000|Overall Study|Withdrew Consent|2|||
155328299|NCT02185794|560637506|FG001|Overall Study|Withdrew Consent|5|||
155328300|NCT02185794|560637507|FG002|Overall Study|Withdrew Consent|10|||
155328301|NCT02185794|560637508|FG003|Overall Study|Withdrew Consent|2|||
155328302|NCT02185794|560637509|FG004|Overall Study|Withdrew Consent|0|||
155328303|NCT02185794|560637510|FG005|Overall Study|Withdrew Consent|0|||
155328304|NCT02185794|560637505|FG000|Overall Study|Lost to Follow-up|1|||
155328305|NCT02185794|560637506|FG001|Overall Study|Lost to Follow-up|2|||
155328306|NCT02185794|560637507|FG002|Overall Study|Lost to Follow-up|2|||
155328307|NCT02185794|560637508|FG003|Overall Study|Lost to Follow-up|3|||
155328308|NCT02185794|560637509|FG004|Overall Study|Lost to Follow-up|0|||
155328309|NCT02185794|560637510|FG005|Overall Study|Lost to Follow-up|1|||
155328310|NCT00336505|560637511|FG000|Overall Study|Adverse Event|10|||
155328311|NCT00336505|560637512|FG001|Overall Study|Adverse Event|9|||
155328312|NCT00336505|560637511|FG000|Overall Study|Lack of Efficacy|8|||
155328313|NCT00336505|560637512|FG001|Overall Study|Lack of Efficacy|4|||
155328314|NCT00336505|560637511|FG000|Overall Study|Lost to Follow-up|7|||
155328315|NCT00336505|560637512|FG001|Overall Study|Lost to Follow-up|4|||
155328316|NCT00336505|560637511|FG000|Overall Study|Withdrawal by Subject|5|||
155328317|NCT00336505|560637512|FG001|Overall Study|Withdrawal by Subject|3|||
155070307|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155070308|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155070309|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155328318|NCT00336505|560637511|FG000|Overall Study|Other|7|||
155328319|NCT00336505|560637512|FG001|Overall Study|Other|7|||
155328320|NCT01092416|560637513|FG000|Enrollment|Atherectomy device not inserted|3|||
155328321|NCT01092416|560637513|FG000|30-Day Follow-up|Death|2|||
155328322|NCT01092416|560637513|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
155328323|NCT01092416|560637513|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
155328324|NCT01092416|560637513|FG000|12-Month Follow-up|Death|16|||
155328325|NCT01092416|560637513|FG000|12-Month Follow-up|Lost to Follow-up|4|||
155328326|NCT01092416|560637513|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
155328327|NCT01092416|560637513|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
155328328|NCT01092416|560637513|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
155328329|NCT00366249|560637514|FG000|Overall Study|Adverse Event|53|||
155328330|NCT00366249|560637515|FG001|Overall Study|Adverse Event|28|||
155328331|NCT00366249|560637514|FG000|Overall Study|Death|0|||
155328332|NCT00366249|560637515|FG001|Overall Study|Death|1|||
155328333|NCT00366249|560637514|FG000|Overall Study|Physician Decision|5|||
155328334|NCT00366249|560637515|FG001|Overall Study|Physician Decision|2|||
155328335|NCT00366249|560637514|FG000|Overall Study|Lost to Follow-up|2|||
155328336|NCT00366249|560637515|FG001|Overall Study|Lost to Follow-up|0|||
155328337|NCT00366249|560637514|FG000|Overall Study|Protocol Violation|1|||
155328338|NCT00366249|560637515|FG001|Overall Study|Protocol Violation|2|||
155328339|NCT00366249|560637514|FG000|Overall Study|Withdrawal by Subject|18|||
155328340|NCT00366249|560637515|FG001|Overall Study|Withdrawal by Subject|4|||
155328341|NCT00366249|560637514|FG000|Overall Study|Lack of Efficacy|21|||
155328342|NCT00366249|560637515|FG001|Overall Study|Lack of Efficacy|21|||
155328343|NCT00366249|560637514|FG000|Overall Study|Most due to osteomylitis status|31|||
155328344|NCT00366249|560637515|FG001|Overall Study|Most due to osteomylitis status|20|||
155328345|NCT00246805|560637516|FG000|Phase 1|Lost to Follow-up|1|||
155328346|NCT00246805|560637517|FG001|Phase 1|Lost to Follow-up|0|||
155328347|NCT03183050|560637518|FG000|Overall Study|Lost to Follow-up|23|||
155328348|NCT00686595|560637522|FG000|Overall Study|Adverse Event|3|||
155328349|NCT00686595|560637522|FG000|Overall Study|Protocol Violation|1|||
155328350|NCT00686595|560637522|FG000|Overall Study|Lost to Follow-up|1|||
155328351|NCT00686595|560637522|FG000|Overall Study|Lack of Efficacy|1|||
155328352|NCT00686595|560637522|FG000|Overall Study|Poor Compliance|1|||
155328353|NCT02797132|560637523|FG000|Part A (15 Days)|Adverse Event|1|||
155328354|NCT02797132|560637523|FG000|Part B (24 Weeks)|Adverse Event|3|||
155328355|NCT01342367|560637525|FG000|Overall Study|Death|1|||
155328356|NCT01342367|560637526|FG001|Overall Study|Death|0|||
155328357|NCT01342367|560637525|FG000|Overall Study|Withdrawal by Subject|1|||
155328358|NCT01342367|560637526|FG001|Overall Study|Withdrawal by Subject|2|||
155328359|NCT01961609|560637527|FG000|Initiation|Missing|3|||
155328360|NCT01961609|560637528|FG001|Initiation|Missing|2|||
155328361|NCT01961609|560637529|FG002|Initiation|Missing|0|||
155328362|NCT01961609|560637530|FG003|Initiation|Missing|0|||
155328363|NCT01961609|560637527|FG000|Initiation|Protocol deviation|1|||
155328364|NCT01961609|560637528|FG001|Initiation|Protocol deviation|0|||
155328365|NCT01961609|560637529|FG002|Initiation|Protocol deviation|0|||
155328366|NCT01961609|560637530|FG003|Initiation|Protocol deviation|0|||
155328367|NCT01961609|560637527|FG000|Initiation|Death|0|||
155328368|NCT01961609|560637528|FG001|Initiation|Death|1|||
155328369|NCT01961609|560637529|FG002|Initiation|Death|0|||
155328370|NCT01961609|560637530|FG003|Initiation|Death|0|||
155328371|NCT01961609|560637527|FG000|Initiation|Administrative problems|1|||
155328372|NCT01961609|560637528|FG001|Initiation|Administrative problems|0|||
155328373|NCT01961609|560637529|FG002|Initiation|Administrative problems|0|||
155328374|NCT01961609|560637530|FG003|Initiation|Administrative problems|0|||
155328375|NCT01961609|560637527|FG000|Initiation|Withdrawal by Subject|1|||
155328376|NCT01961609|560637528|FG001|Initiation|Withdrawal by Subject|2|||
155328377|NCT01961609|560637529|FG002|Initiation|Withdrawal by Subject|0|||
155328378|NCT01961609|560637530|FG003|Initiation|Withdrawal by Subject|0|||
155328379|NCT01961609|560637527|FG000|Initiation|Lack of Efficacy|2|||
155328380|NCT01961609|560637528|FG001|Initiation|Lack of Efficacy|1|||
155328381|NCT01961609|560637529|FG002|Initiation|Lack of Efficacy|0|||
155328382|NCT01961609|560637530|FG003|Initiation|Lack of Efficacy|0|||
155328383|NCT01961609|560637527|FG000|Initiation|Abnormal lab values|0|||
155328384|NCT01961609|560637528|FG001|Initiation|Abnormal lab values|1|||
155328385|NCT01961609|560637529|FG002|Initiation|Abnormal lab values|0|||
155328386|NCT01961609|560637530|FG003|Initiation|Abnormal lab values|0|||
155328387|NCT01961609|560637527|FG000|Initiation|Adverse Event|3|||
155328388|NCT01961609|560637528|FG001|Initiation|Adverse Event|5|||
155328389|NCT01961609|560637529|FG002|Initiation|Adverse Event|0|||
155328390|NCT01961609|560637530|FG003|Initiation|Adverse Event|0|||
155328391|NCT01961609|560637527|FG000|Initiation|Randomized but not treated|1|||
155328392|NCT01961609|560637528|FG001|Initiation|Randomized but not treated|1|||
155328393|NCT01961609|560637529|FG002|Initiation|Randomized but not treated|0|||
155328394|NCT01961609|560637530|FG003|Initiation|Randomized but not treated|0|||
155328395|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
155328396|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
155328397|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
155328398|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
155328399|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
154961679|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
154961680|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
155328400|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
155328401|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
155328402|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
155328403|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
155328404|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
155328405|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
155328406|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
155328407|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
155328408|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
155328409|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
155328410|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
155328411|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
155328412|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
155328413|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
155328414|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
155328415|NCT01961609|560637527|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
155328416|NCT01961609|560637528|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
155328417|NCT01961609|560637529|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
155328418|NCT01961609|560637530|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
155328419|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
155328420|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
155328421|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
155328422|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
155328423|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
155328424|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
154961681|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
154961682|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
154961683|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
155163188|NCT02699749|560033231|FG010|Overall Study|Death|0|||
155328425|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
155328426|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
155328427|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
155328428|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
155328429|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
155328430|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
155328431|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
155328432|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
155328433|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
155328434|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
155328435|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
155328436|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
155328437|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
155070310|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
155070311|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
155070312|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
155070313|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
155328438|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
155328439|NCT01961609|560637527|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
155328440|NCT01961609|560637528|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
155328441|NCT01961609|560637529|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
155328442|NCT01961609|560637530|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
155328443|NCT02284113|560637531|FG000|Overall Study|Adverse Event|1|||
155328444|NCT02284113|560637532|FG001|Overall Study|Adverse Event|0|||
155328445|NCT02284113|560637531|FG000|Overall Study|non-compliance|0|||
155328446|NCT02284113|560637532|FG001|Overall Study|non-compliance|1|||
155328447|NCT02284113|560637531|FG000|Overall Study|Withdrawal by Subject|0|||
155070314|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
155070315|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
155070316|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
155070317|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
155070318|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
155070319|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155328448|NCT02284113|560637532|FG001|Overall Study|Withdrawal by Subject|1|||
155328449|NCT02284113|560637531|FG000|Overall Study|not provided|0|||
155070320|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155070321|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155070322|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155070323|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155070324|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
155070325|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
155070326|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155070327|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155070328|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155070329|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155070330|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
155070331|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
155070332|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
155070333|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155070334|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155070335|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155070336|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155070337|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155070338|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
155070339|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
155070340|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155328450|NCT02284113|560637532|FG001|Overall Study|not provided|1|||
155328451|NCT02284113|560637531|FG000|Overall Study|surgery cancelled|2|||
155328452|NCT02284113|560637532|FG001|Overall Study|surgery cancelled|0|||
155328453|NCT04191824|560637533|FG000|Overall Study|Death|13|||
155328454|NCT04191824|560637534|FG001|Overall Study|Death|12|||
155328455|NCT04191824|560637533|FG000|Overall Study|Lost to Follow-up|456|||
155070341|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155328456|NCT04191824|560637534|FG001|Overall Study|Lost to Follow-up|435|||
155070342|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155328457|NCT04191824|560637533|FG000|Overall Study|Physician Decision|2|||
155328458|NCT04191824|560637534|FG001|Overall Study|Physician Decision|1|||
155328459|NCT04191824|560637533|FG000|Overall Study|Protocol Violation|0|||
155328460|NCT04191824|560637534|FG001|Overall Study|Protocol Violation|2|||
155328461|NCT04191824|560637533|FG000|Overall Study|Withdrawal by Subject|16|||
155328462|NCT04191824|560637534|FG001|Overall Study|Withdrawal by Subject|18|||
155328463|NCT04191824|560637533|FG000|Overall Study|Early site closure|24|||
155328464|NCT04191824|560637534|FG001|Overall Study|Early site closure|22|||
155328465|NCT01218009|560637537|FG000|Overall Study|Protocol Violation|2|||
155328466|NCT01218009|560637538|FG001|Overall Study|Protocol Violation|1|||
155328467|NCT01218009|560637537|FG000|Overall Study|Withdrawal by Subject|3|||
155328468|NCT01218009|560637538|FG001|Overall Study|Withdrawal by Subject|1|||
155328469|NCT01218009|560637537|FG000|Overall Study|Sponsor terminated study|161|||
155328470|NCT01218009|560637538|FG001|Overall Study|Sponsor terminated study|163|||
155328471|NCT01324310|560637539|FG000|Overall Study|Adverse Event|1|||
155328472|NCT01324310|560637539|FG000|Overall Study|Disease Progression|1|||
155328473|NCT03170882|560637540|FG000|Overall Study|Death|17|||
155328474|NCT03170882|560637541|FG001|Overall Study|Death|29|||
155328475|NCT03170882|560637540|FG000|Overall Study|Lost to Follow-up|0|||
155328476|NCT03170882|560637541|FG001|Overall Study|Lost to Follow-up|1|||
155328477|NCT03170882|560637540|FG000|Overall Study|Withdrawal by Subject|4|||
155328478|NCT03170882|560637541|FG001|Overall Study|Withdrawal by Subject|7|||
155328479|NCT03170882|560637540|FG000|Overall Study|Reason not Specified|28|||
155328480|NCT03170882|560637541|FG001|Overall Study|Reason not Specified|36|||
155328481|NCT01371994|560637545|FG000|Overall Study|Adverse Event|3|||
155328482|NCT01371994|560637546|FG001|Overall Study|Adverse Event|6|||
155328483|NCT01371994|560637545|FG000|Overall Study|Lack of Efficacy|3|||
155328484|NCT01371994|560637546|FG001|Overall Study|Lack of Efficacy|0|||
155328485|NCT01371994|560637545|FG000|Overall Study|Withdrawal by Subject|13|||
155328486|NCT01371994|560637546|FG001|Overall Study|Withdrawal by Subject|7|||
155328487|NCT01371994|560637545|FG000|Overall Study|Lost to Follow-up|1|||
155328488|NCT01371994|560637546|FG001|Overall Study|Lost to Follow-up|1|||
155328489|NCT01371994|560637545|FG000|Overall Study|Protocol Violation|24|||
155328490|NCT01371994|560637546|FG001|Overall Study|Protocol Violation|17|||
155328491|NCT01371994|560637545|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
155328492|NCT01371994|560637546|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
155328493|NCT01371994|560637545|FG000|Overall Study|Physician Decision|1|||
155328494|NCT01371994|560637546|FG001|Overall Study|Physician Decision|1|||
155328495|NCT01371994|560637545|FG000|Overall Study|Miscellaneous Reasons|6|||
155328496|NCT01371994|560637546|FG001|Overall Study|Miscellaneous Reasons|4|||
155328497|NCT00087685|560637547|FG000|Overall Study|Adverse Event|5|||
155328498|NCT00087685|560637547|FG000|Overall Study|Non-Compliance|1|||
155328499|NCT00087685|560637547|FG000|Overall Study|Progressive Disease|5|||
155328500|NCT00087685|560637547|FG000|Overall Study|Withdrawal by Subject|3|||
155328501|NCT03891758|560637549|FG000|Overall Study|Adverse Event|2|||
155328502|NCT03891758|560637550|FG001|Overall Study|Adverse Event|0|||
155328503|NCT03891758|560637549|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155328504|NCT03891758|560637550|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155328505|NCT01983683|560637551|FG000|Overall Study|Withdrawal by Subject|14|||
155328506|NCT01983683|560637552|FG001|Overall Study|Withdrawal by Subject|18|||
155328507|NCT01983683|560637551|FG000|Overall Study|Death|11|||
155328508|NCT01983683|560637552|FG001|Overall Study|Death|15|||
155328509|NCT01983683|560637551|FG000|Overall Study|Physician Decision|8|||
155328510|NCT01983683|560637552|FG001|Overall Study|Physician Decision|9|||
155328511|NCT01983683|560637551|FG000|Overall Study|Lost to Follow-up|4|||
155328512|NCT01983683|560637552|FG001|Overall Study|Lost to Follow-up|8|||
155328513|NCT01983683|560637551|FG000|Overall Study|Sponsor Decision|1|||
155328514|NCT01983683|560637552|FG001|Overall Study|Sponsor Decision|1|||
155328515|NCT00536120|560638186|FG000|Overall Study|Lost to Follow-up|1|||
155328516|NCT00536120|560638187|FG001|Overall Study|Lost to Follow-up|0|||
155328517|NCT00536120|560638186|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
155328518|NCT00536120|560638187|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
155328519|NCT00536120|560638186|FG000|Overall Study|Non-compliance|1|||
155328520|NCT00536120|560638187|FG001|Overall Study|Non-compliance|0|||
155328521|NCT00536120|560638186|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
155328522|NCT00536120|560638187|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
155328523|NCT00536120|560638186|FG000|Overall Study|Steroid Use|0|||
155328524|NCT00536120|560638187|FG001|Overall Study|Steroid Use|2|||
155328525|NCT00536120|560638186|FG000|Overall Study|Missed Study Visit|0|||
155328526|NCT00536120|560638187|FG001|Overall Study|Missed Study Visit|1|||
155328527|NCT04989816|560638188|FG000|Overall Study|Death|77|||
155328528|NCT04989816|560638188|FG000|Overall Study|Lost to Follow-up|3|||
155328529|NCT01184326|560638192|FG000|Overall Study|Adverse Event|1|||
155328530|NCT01184326|560638193|FG001|Overall Study|Adverse Event|2|||
155328531|NCT01184326|560638194|FG002|Overall Study|Adverse Event|0|||
155328532|NCT01184326|560638192|FG000|Overall Study|Death|0|||
155328533|NCT01184326|560638193|FG001|Overall Study|Death|0|||
155328534|NCT01184326|560638194|FG002|Overall Study|Death|1|||
155328535|NCT01184326|560638192|FG000|Overall Study|Withdrawal by Subject|0|||
155328536|NCT01184326|560638193|FG001|Overall Study|Withdrawal by Subject|0|||
155328537|NCT01184326|560638194|FG002|Overall Study|Withdrawal by Subject|1|||
155328538|NCT01184326|560638192|FG000|Overall Study|Physician Decision|1|||
155328539|NCT01184326|560638193|FG001|Overall Study|Physician Decision|1|||
155328540|NCT01184326|560638194|FG002|Overall Study|Physician Decision|0|||
155328541|NCT01184326|560638192|FG000|Overall Study|Disease Progression|1|||
155328542|NCT01184326|560638193|FG001|Overall Study|Disease Progression|3|||
155328543|NCT01184326|560638194|FG002|Overall Study|Disease Progression|12|||
155328544|NCT01084694|560638195|FG000|Overall Study|Withdrawal by Subject|2|||
155328545|NCT01084694|560638196|FG001|Overall Study|Withdrawal by Subject|1|||
155328546|NCT01084694|560638195|FG000|Overall Study|Death|2|||
155328547|NCT01084694|560638196|FG001|Overall Study|Death|12|||
155328548|NCT01084694|560638195|FG000|Overall Study|eligibility not maintained|2|||
155328549|NCT01084694|560638196|FG001|Overall Study|eligibility not maintained|7|||
155328550|NCT04017611|560638202|FG000|Overall Study|Withdrawn prior to completion|1|||
155328551|NCT00777049|560638213|FG000|Overall Study|Withdrawal by Subject|1|||
155328552|NCT00777049|560638214|FG001|Overall Study|Withdrawal by Subject|0|||
155328553|NCT00777049|560638213|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
155328554|NCT00777049|560638214|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
155328555|NCT00609869|560638215|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
155328556|NCT00609869|560638215|FG000|Overall Study|Severe hematologic toxicity|1|||
155328557|NCT00609869|560638215|FG000|Overall Study|Withdrawal by Subject|1|||
155328558|NCT00609869|560638215|FG000|Overall Study|Seizures|1|||
155328559|NCT00609869|560638215|FG000|Overall Study|Severe tumor flare reaction|1|||
155328560|NCT00609869|560638215|FG000|Overall Study|Hepatitis B infection|1|||
155328561|NCT00609869|560638215|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
155328562|NCT00609869|560638215|FG000|Overall Study|Mantle cell: not evaluable|4|||
155328563|NCT03478969|560638216|FG000|Overall Study|Withdrawal by Subject|4|||
155328564|NCT03478969|560638217|FG001|Overall Study|Withdrawal by Subject|7|||
155328565|NCT03478969|560638218|FG002|Overall Study|Withdrawal by Subject|6|||
155328566|NCT03478969|560638216|FG000|Overall Study|Adverse Event|2|||
155328567|NCT03478969|560638217|FG001|Overall Study|Adverse Event|0|||
155328568|NCT03478969|560638218|FG002|Overall Study|Adverse Event|1|||
155328569|NCT03478969|560638216|FG000|Overall Study|Pregnancy|1|||
155328570|NCT03478969|560638217|FG001|Overall Study|Pregnancy|0|||
155328571|NCT03478969|560638218|FG002|Overall Study|Pregnancy|0|||
155328572|NCT03478969|560638216|FG000|Overall Study|Personal Reasons|1|||
155328573|NCT03478969|560638217|FG001|Overall Study|Personal Reasons|0|||
155328574|NCT03478969|560638218|FG002|Overall Study|Personal Reasons|1|||
155328575|NCT03478969|560638216|FG000|Overall Study|Covid-19|1|||
155328576|NCT03478969|560638217|FG001|Overall Study|Covid-19|4|||
155328577|NCT03478969|560638218|FG002|Overall Study|Covid-19|3|||
155328578|NCT03478969|560638216|FG000|Overall Study|Multiple Reasons|0|||
155328579|NCT03478969|560638217|FG001|Overall Study|Multiple Reasons|1|||
155328580|NCT03478969|560638218|FG002|Overall Study|Multiple Reasons|1|||
155328581|NCT03478969|560638216|FG000|Overall Study|Eligibility Criteria|0|||
155328582|NCT03478969|560638217|FG001|Overall Study|Eligibility Criteria|0|||
155328583|NCT03478969|560638218|FG002|Overall Study|Eligibility Criteria|5|||
155328584|NCT03478969|560638216|FG000|Overall Study|Lost to Follow-up|0|||
155328585|NCT03478969|560638217|FG001|Overall Study|Lost to Follow-up|0|||
155328586|NCT03478969|560638218|FG002|Overall Study|Lost to Follow-up|1|||
155328587|NCT03885232|560638221|FG000|Overall Study|Lost to Follow-up|74|||
155328588|NCT03885232|560638222|FG001|Overall Study|Lost to Follow-up|32|||
155328589|NCT03885232|560638221|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
155328590|NCT03885232|560638222|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
155328591|NCT05139992|560638223|FG000|Overall Study|Withdrawal by Subject|12|||
155328592|NCT05139992|560638223|FG000|Overall Study|Lost to Follow-up|6|||
155328593|NCT05521516|560638224|FG000|Overall Study|Withdrawal by Subject|1|||
155328594|NCT05521516|560638225|FG001|Overall Study|Withdrawal by Subject|1|||
155328595|NCT02500576|560638227|FG000|Overall Study|Adverse Event|0|||
155328596|NCT02500576|560638228|FG001|Overall Study|Adverse Event|1|||
155328597|NCT02500576|560638227|FG000|Overall Study|Death|2|||
155328598|NCT02500576|560638228|FG001|Overall Study|Death|1|||
155328599|NCT02500576|560638227|FG000|Overall Study|Lack of Efficacy|5|||
155328600|NCT02500576|560638228|FG001|Overall Study|Lack of Efficacy|5|||
155328601|NCT02500576|560638227|FG000|Overall Study|Withdrawal by Subject|1|||
155328602|NCT02500576|560638228|FG001|Overall Study|Withdrawal by Subject|1|||
155328603|NCT04882917|560638237|FG000|Overall Study|Adverse Event|0|||
155328604|NCT04882917|560638238|FG001|Overall Study|Adverse Event|1|||
155328605|NCT04882917|560638239|FG002|Overall Study|Adverse Event|2|||
155328606|NCT04882917|560638240|FG003|Overall Study|Adverse Event|2|||
155328607|NCT04882917|560638237|FG000|Overall Study|Withdrawal by Subject|1|||
155328608|NCT04882917|560638238|FG001|Overall Study|Withdrawal by Subject|0|||
155328609|NCT04882917|560638239|FG002|Overall Study|Withdrawal by Subject|2|||
155328610|NCT04882917|560638240|FG003|Overall Study|Withdrawal by Subject|1|||
155328611|NCT04882917|560638237|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
155328612|NCT04882917|560638238|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
155328613|NCT04882917|560638239|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
155328614|NCT04882917|560638240|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
155328615|NCT00227266|560638241|FG000|Overall Study|Withdrawal by Subject|0|||
155328616|NCT00227266|560638242|FG001|Overall Study|Withdrawal by Subject|0|||
155328617|NCT00227266|560638243|FG002|Overall Study|Withdrawal by Subject|1|||
155328618|NCT00227266|560638241|FG000|Overall Study|Protocol Violation|1|||
155328619|NCT00227266|560638242|FG001|Overall Study|Protocol Violation|0|||
155328620|NCT00227266|560638243|FG002|Overall Study|Protocol Violation|1|||
155328621|NCT00227266|560638241|FG000|Overall Study|Excessive weight gain|0|||
155328622|NCT00227266|560638242|FG001|Overall Study|Excessive weight gain|0|||
155328623|NCT00227266|560638243|FG002|Overall Study|Excessive weight gain|2|||
155328624|NCT03959423|560638247|FG000|Overall Study|Withdrawal by Subject|2|||
155328625|NCT03959423|560638248|FG001|Overall Study|Withdrawal by Subject|3|||
155328626|NCT03959423|560638247|FG000|Overall Study|Physician Decision|0|||
155328627|NCT03959423|560638248|FG001|Overall Study|Physician Decision|1|||
155328628|NCT03959423|560638247|FG000|Overall Study|Lost to Follow-up|1|||
155328629|NCT03959423|560638248|FG001|Overall Study|Lost to Follow-up|0|||
155328630|NCT03959423|560638247|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
155328631|NCT03959423|560638248|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155328632|NCT04926740|560638249|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
155328633|NCT04926740|560638250|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
155328634|NCT04926740|560638249|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
155328635|NCT04926740|560638250|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
155328636|NCT01470144|560638253|FG000|Overall Study|Adverse Event|2|||
155328637|NCT01470144|560638253|FG000|Overall Study|Death|1|||
155328638|NCT01470144|560638253|FG000|Overall Study|Lung transplant|6|||
155328639|NCT01470144|560638253|FG000|Overall Study|Patient's and investigator's decision|1|||
155328640|NCT00593840|560638254|FG000|Overall Study|Withdrawal by Subject|1|||
155328641|NCT01128595|560639252|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155328642|NCT01128595|560639253|FG001|Treatment Period 3|Withdrawal by Subject|1|||
155328643|NCT01128595|560639254|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155328644|NCT01128595|560639255|FG003|Treatment Period 3|Withdrawal by Subject|0|||
155328645|NCT01561300|560639257|FG000|Run in on Placebo|Adverse Event|1|||
155328646|NCT01561300|560639258|FG001|Run in on Placebo|Adverse Event|0|||
155328647|NCT01185600|560639259|FG000|Overall Study|Adverse Event|1|||
155328648|NCT01185600|560639260|FG001|Overall Study|Adverse Event|1|||
155328649|NCT01185600|560639259|FG000|Overall Study|Death|0|||
155328650|NCT01185600|560639260|FG001|Overall Study|Death|1|||
155328651|NCT01185600|560639259|FG000|Overall Study|Lost to Follow-up|0|||
155328652|NCT01185600|560639260|FG001|Overall Study|Lost to Follow-up|5|||
155328653|NCT01185600|560639259|FG000|Overall Study|Physician Decision|29|||
155328654|NCT01185600|560639260|FG001|Overall Study|Physician Decision|35|||
155328655|NCT01185600|560639259|FG000|Overall Study|Withdrawal by Subject|1|||
155328656|NCT01185600|560639260|FG001|Overall Study|Withdrawal by Subject|1|||
155328657|NCT01185600|560639259|FG000|Overall Study|Hold by DSMB|1|||
155328658|NCT01185600|560639260|FG001|Overall Study|Hold by DSMB|2|||
155328659|NCT01436175|560639261|FG000|Overall Study|Adverse Event|111|||
155328660|NCT01436175|560639261|FG000|Overall Study|Protocol Violation|49|||
155328661|NCT01436175|560639261|FG000|Overall Study|Withdrawal by Subject|108|||
155328662|NCT01436175|560639261|FG000|Overall Study|Lost to Follow-up|89|||
155328663|NCT01436175|560639261|FG000|Overall Study|Lack of Efficacy|24|||
155328664|NCT01436175|560639261|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
155328665|NCT01436175|560639261|FG000|Overall Study|Other|826|||
155328666|NCT05405244|560639262|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
155328667|NCT05405244|560639263|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
155328668|NCT05405244|560639262|FG000|Washout (2 Weeks)|Adverse Event|2|||
155328669|NCT05405244|560639263|FG001|Washout (2 Weeks)|Adverse Event|0|||
155328670|NCT05405244|560639262|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
155328671|NCT05405244|560639263|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
155328672|NCT00739934|560639264|FG000|Voriconazole IV|Adverse Event|6|||
155328673|NCT00739934|560639264|FG000|Voriconazole Oral|Other|3|||
155328674|NCT04353492|560639270|FG000|Overall Study|Subject decision|24|||
155328675|NCT04353492|560639270|FG000|Overall Study|Physician Decision|5|||
155328676|NCT04353492|560639270|FG000|Overall Study|Adverse Event|3|||
155328677|NCT04353492|560639270|FG000|Overall Study|Pregnancy|3|||
155328678|NCT04353492|560639270|FG000|Overall Study|Lost to Follow-up|2|||
155328679|NCT04353492|560639270|FG000|Overall Study|Protocol deviation|1|||
155328680|NCT04353492|560639270|FG000|Overall Study|Technical problems|1|||
155328681|NCT04250194|560639271|FG000|Overall Study|Declined to schedule biopsy|6|||
155328682|NCT04250194|560639272|FG001|Overall Study|Declined to schedule biopsy|10|||
155328683|NCT04250194|560639271|FG000|Overall Study|Medically Unfit for Biopsy|2|||
155328684|NCT04250194|560639272|FG001|Overall Study|Medically Unfit for Biopsy|1|||
155328685|NCT04250194|560639271|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
155328686|NCT04250194|560639272|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
155328687|NCT04250194|560639271|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
155328688|NCT04250194|560639272|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
155328689|NCT04250194|560639271|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
155328690|NCT04250194|560639272|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
155328691|NCT00857766|560639273|FG000|Overall Study|Adverse Event|13|||
155328692|NCT00857766|560639274|FG001|Overall Study|Adverse Event|12|||
155328693|NCT00857766|560639273|FG000|Overall Study|Protocol Violation|11|||
155328694|NCT00857766|560639274|FG001|Overall Study|Protocol Violation|11|||
155328695|NCT00857766|560639273|FG000|Overall Study|Lost to Follow-up|1|||
155328696|NCT00857766|560639274|FG001|Overall Study|Lost to Follow-up|0|||
155328697|NCT00857766|560639273|FG000|Overall Study|Investigator Discretion|2|||
155328698|NCT00857766|560639274|FG001|Overall Study|Investigator Discretion|3|||
155328699|NCT00857766|560639273|FG000|Overall Study|Participant Withdrew Consent|4|||
155328700|NCT00857766|560639274|FG001|Overall Study|Participant Withdrew Consent|4|||
155328701|NCT01212744|560639277|FG000|Overall Study|Withdrawal by Subject|1|||
155328702|NCT02167451|560639279|FG000|Overall Study|Withdrawal by Subject|1|||
155328703|NCT00571649|560639280|FG000|Treatment Period|Adverse Event|438|||
155328704|NCT00571649|560639281|FG001|Treatment Period|Adverse Event|385|||
155328705|NCT00571649|560639280|FG000|Treatment Period|Clinical endpoint reached|50|||
155328706|NCT00571649|560639281|FG001|Treatment Period|Clinical endpoint reached|56|||
155328707|NCT00571649|560639280|FG000|Treatment Period|Withdrawal by Subject|285|||
155328708|NCT00571649|560639281|FG001|Treatment Period|Withdrawal by Subject|255|||
155328709|NCT00571649|560639280|FG000|Treatment Period|Death|76|||
155328710|NCT00571649|560639281|FG001|Treatment Period|Death|59|||
155328711|NCT00571649|560639280|FG000|Treatment Period|Physician Decision|8|||
155328712|NCT00571649|560639281|FG001|Treatment Period|Physician Decision|9|||
155328713|NCT00571649|560639280|FG000|Treatment Period|Lost to Follow-up|43|||
155328714|NCT00571649|560639281|FG001|Treatment Period|Lost to Follow-up|41|||
155328715|NCT00571649|560639280|FG000|Treatment Period|Non-compliant with study medication|88|||
155328716|NCT00571649|560639281|FG001|Treatment Period|Non-compliant with study medication|89|||
155328717|NCT00571649|560639280|FG000|Treatment Period|Patient convenience|11|||
155328718|NCT00571649|560639281|FG001|Treatment Period|Patient convenience|13|||
155328719|NCT00571649|560639280|FG000|Treatment Period|Protocol Violation|90|||
155328720|NCT00571649|560639281|FG001|Treatment Period|Protocol Violation|92|||
155328721|NCT00571649|560639280|FG000|Treatment Period|Technical problems|3|||
155328722|NCT00571649|560639281|FG001|Treatment Period|Technical problems|5|||
155328723|NCT00571649|560639280|FG000|Follow-up Period|Adverse Event|46|||
155328724|NCT00571649|560639281|FG001|Follow-up Period|Adverse Event|40|||
155328725|NCT00571649|560639280|FG000|Follow-up Period|Clinical endpoint reached|5|||
155328726|NCT00571649|560639281|FG001|Follow-up Period|Clinical endpoint reached|2|||
155328727|NCT00571649|560639280|FG000|Follow-up Period|Withdrawal by Subject|119|||
155328728|NCT00571649|560639281|FG001|Follow-up Period|Withdrawal by Subject|115|||
155070343|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155070344|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
155070345|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
155070346|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
155070347|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155070348|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155070349|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155070350|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155070351|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
155070352|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
155070353|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
155070354|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155070355|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155070356|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155070357|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155070358|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155070359|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
155070360|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
155070361|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
155328729|NCT00571649|560639280|FG000|Follow-up Period|Death|132|||
155328730|NCT00571649|560639281|FG001|Follow-up Period|Death|133|||
155328731|NCT00571649|560639280|FG000|Follow-up Period|Physician Decision|7|||
155328732|NCT00571649|560639281|FG001|Follow-up Period|Physician Decision|13|||
155328733|NCT00571649|560639280|FG000|Follow-up Period|Lost to Follow-up|95|||
155328734|NCT00571649|560639281|FG001|Follow-up Period|Lost to Follow-up|92|||
155328735|NCT00571649|560639280|FG000|Follow-up Period|Patient convenience|136|||
155328736|NCT00571649|560639281|FG001|Follow-up Period|Patient convenience|121|||
155328737|NCT00571649|560639280|FG000|Follow-up Period|Protocol Violation|5|||
155328738|NCT00571649|560639281|FG001|Follow-up Period|Protocol Violation|12|||
155163189|NCT02699749|560033232|FG011|Overall Study|Death|0|||
155163190|NCT02699749|560033233|FG012|Overall Study|Death|0|||
155163191|NCT02699749|560033234|FG013|Overall Study|Death|1|||
155163192|NCT02699749|560033221|FG000|Overall Study|Lost to Follow-up|0|||
155163193|NCT02699749|560033222|FG001|Overall Study|Lost to Follow-up|0|||
155163194|NCT02699749|560033223|FG002|Overall Study|Lost to Follow-up|0|||
155163195|NCT02699749|560033224|FG003|Overall Study|Lost to Follow-up|0|||
155163196|NCT02699749|560033225|FG004|Overall Study|Lost to Follow-up|0|||
155163197|NCT02699749|560033226|FG005|Overall Study|Lost to Follow-up|1|||
155163198|NCT02699749|560033227|FG006|Overall Study|Lost to Follow-up|0|||
155163199|NCT02699749|560033228|FG007|Overall Study|Lost to Follow-up|1|||
155163200|NCT02699749|560033229|FG008|Overall Study|Lost to Follow-up|0|||
155163201|NCT02699749|560033230|FG009|Overall Study|Lost to Follow-up|0|||
155163202|NCT02699749|560033231|FG010|Overall Study|Lost to Follow-up|0|||
155163203|NCT02699749|560033232|FG011|Overall Study|Lost to Follow-up|0|||
155163204|NCT02699749|560033233|FG012|Overall Study|Lost to Follow-up|0|||
155163205|NCT02699749|560033234|FG013|Overall Study|Lost to Follow-up|0|||
155163206|NCT02377817|560033235|FG000|Overall Study|Transportation/childcare barriers.|2|||
155163207|NCT02377817|560033236|FG001|Overall Study|Transportation/childcare barriers.|0|||
155163208|NCT02377817|560033235|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
155163209|NCT02377817|560033236|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
155163210|NCT04139018|560033237|FG000|Overall Study|Screen fail|1|||
155163211|NCT04139018|560033238|FG001|Overall Study|Screen fail|0|||
155163212|NCT04139018|560033237|FG000|Overall Study|Withdrawal by Subject|2|||
155163213|NCT04139018|560033238|FG001|Overall Study|Withdrawal by Subject|0|||
155163214|NCT04139018|560033237|FG000|Overall Study|Lost to Follow-up|0|||
155163215|NCT04139018|560033238|FG001|Overall Study|Lost to Follow-up|1|||
155163216|NCT02565108|560033239|FG000|Overall Study|Adverse Event|1|||
155163217|NCT02565108|560033240|FG001|Overall Study|Adverse Event|0|||
155163218|NCT02565108|560033239|FG000|Overall Study|Withdrew Consent|1|||
155163219|NCT02565108|560033240|FG001|Overall Study|Withdrew Consent|0|||
155163220|NCT01310075|560033257|FG000|Overall Study|Lost to Follow-up|1|||
155163221|NCT01310075|560033258|FG001|Overall Study|Lost to Follow-up|0|||
155163222|NCT01310075|560033257|FG000|Overall Study|Physician Decision|10|||
155328739|NCT01218659|560639282|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
155328740|NCT01218659|560639283|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
155328741|NCT01218659|560639284|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
155328742|NCT01218659|560639282|FG000|18-Month Randomized Period|Did not receive study drug|0|||
155328743|NCT01218659|560639283|FG001|18-Month Randomized Period|Did not receive study drug|3|||
155328744|NCT01218659|560639284|FG002|18-Month Randomized Period|Did not receive study drug|0|||
155328745|NCT01218659|560639282|FG000|12-Month OLE|Withdrawal by Subject|0|||
155328746|NCT01218659|560639283|FG001|12-Month OLE|Withdrawal by Subject|0|||
154961684|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
154961685|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
155163223|NCT01310075|560033258|FG001|Overall Study|Physician Decision|7|||
155163224|NCT01310075|560033257|FG000|Overall Study|Protocol Violation|2|||
155163225|NCT01310075|560033258|FG001|Overall Study|Protocol Violation|2|||
155163226|NCT01310075|560033257|FG000|Overall Study|Withdrawal by Subject|1|||
155163227|NCT01310075|560033258|FG001|Overall Study|Withdrawal by Subject|1|||
155163228|NCT01696188|560033260|FG000|Overall Study|Protocol Violation|1|||
155163229|NCT01696188|560033261|FG001|Overall Study|Protocol Violation|1|||
155163230|NCT02908672|560033262|FG000|Run-in Period|Death|12|||
155163231|NCT02908672|560033263|FG001|Run-in Period|Death|10|||
155163232|NCT02908672|560033264|FG002|Run-in Period|Death|0|||
155163233|NCT02908672|560033265|FG003|Run-in Period|Death|0|||
155163234|NCT02908672|560033262|FG000|Run-in Period|Lost to Follow-up|1|||
155163235|NCT02908672|560033263|FG001|Run-in Period|Lost to Follow-up|1|||
155163236|NCT02908672|560033264|FG002|Run-in Period|Lost to Follow-up|0|||
155163237|NCT02908672|560033265|FG003|Run-in Period|Lost to Follow-up|0|||
154961686|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
154961687|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
154961688|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
154961689|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
154961690|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
154961691|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
154961692|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
154961693|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
154961694|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
154961695|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
154961696|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
154961697|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
155163238|NCT02908672|560033262|FG000|Run-in Period|Reason Not Specified|2|||
155163239|NCT02908672|560033263|FG001|Run-in Period|Reason Not Specified|0|||
155163240|NCT02908672|560033264|FG002|Run-in Period|Reason Not Specified|0|||
155163241|NCT02908672|560033265|FG003|Run-in Period|Reason Not Specified|0|||
155070362|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
155070363|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
155070364|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
155070365|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
155070366|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
155070367|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
155070368|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
155070369|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
155070370|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
155070371|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
155070372|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
155070373|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
155070374|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
155070375|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155070376|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155070377|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155070378|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155163242|NCT02908672|560033262|FG000|Run-in Period|Protocol Violation|1|||
155328747|NCT01218659|560639284|FG002|12-Month OLE|Withdrawal by Subject|2|||
155328748|NCT01218659|560639282|FG000|12-Month OLE|Physician Decision|0|||
155328749|NCT01218659|560639283|FG001|12-Month OLE|Physician Decision|0|||
155328750|NCT01218659|560639284|FG002|12-Month OLE|Physician Decision|1|||
155328751|NCT01218659|560639282|FG000|12-Month OLE|Lost to Follow-up|0|||
155328752|NCT01218659|560639283|FG001|12-Month OLE|Lost to Follow-up|0|||
154961698|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
154961699|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
154961700|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
154961701|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
154961702|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
154961703|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
154961704|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
154961705|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
154961706|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
154961707|NCT01940341|559284013|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
154961708|NCT01940341|559284014|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
154961709|NCT01940341|559284015|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
154961710|NCT01940341|559284016|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
154961711|NCT03552393|559284017|FG000|Core Period|Kidney Transplant|1|||
154961712|NCT03552393|559284017|FG000|Core Period|Prohibited Medication|1|||
154961713|NCT03552393|559284017|FG000|Safety Extension Period|Kidney Transplant|4|||
154961714|NCT05646251|559284018|FG000|Overall Study|Physician Decision|1|||
154961715|NCT05646251|559284019|FG001|Overall Study|Physician Decision|0|||
154961716|NCT05646251|559284020|FG002|Overall Study|Physician Decision|2|||
154961717|NCT00465270|559284021|FG000|Overall Study|Death|7|||
154961718|NCT00465270|559284022|FG001|Overall Study|Death|11|||
154961719|NCT00465270|559284021|FG000|Overall Study|Withdrawal by Subject|34|||
154961720|NCT00465270|559284022|FG001|Overall Study|Withdrawal by Subject|78|||
154961721|NCT00465270|559284021|FG000|Overall Study|Lost to Follow-up|60|||
154961722|NCT00465270|559284022|FG001|Overall Study|Lost to Follow-up|67|||
154961723|NCT00465270|559284021|FG000|Overall Study|Investigator request|3|||
154961724|NCT00465270|559284022|FG001|Overall Study|Investigator request|4|||
154961725|NCT02605928|559284026|FG000|Overall Study|Model tuning phase|28|||
154961726|NCT02605928|559284026|FG000|Overall Study|Lack of Efficacy|5|||
154961727|NCT01231906|559284027|FG000|Overall Study|Lack of Efficacy|75|||
154961728|NCT01231906|559284028|FG001|Overall Study|Lack of Efficacy|68|||
154961729|NCT01231906|559284027|FG000|Overall Study|Lost to Follow-up|1|||
154961730|NCT01231906|559284028|FG001|Overall Study|Lost to Follow-up|0|||
154961731|NCT01231906|559284027|FG000|Overall Study|Physician Decision|34|||
154961732|NCT01231906|559284028|FG001|Overall Study|Physician Decision|24|||
154961733|NCT01231906|559284027|FG000|Overall Study|Withdrawal by Subject|0|||
154961734|NCT01231906|559284028|FG001|Overall Study|Withdrawal by Subject|4|||
154961735|NCT01231906|559284027|FG000|Overall Study|Ineligible|10|||
154961736|NCT01231906|559284028|FG001|Overall Study|Ineligible|3|||
154961737|NCT01231906|559284027|FG000|Overall Study|No treatment|1|||
154961738|NCT01231906|559284028|FG001|Overall Study|No treatment|2|||
154961739|NCT05341622|559284029|FG000|Overall Study|Death|0|||
154961740|NCT05341622|559284030|FG001|Overall Study|Death|0|||
154961741|NCT05341622|559284031|FG002|Overall Study|Death|0|||
154961742|NCT05341622|559284032|FG003|Overall Study|Death|0|||
154961743|NCT05341622|559284033|FG004|Overall Study|Death|1|||
154961744|NCT05341622|559284034|FG005|Overall Study|Death|0|||
154961745|NCT05341622|559284035|FG006|Overall Study|Death|0|||
154961746|NCT05341622|559284036|FG007|Overall Study|Death|1|||
154961747|NCT05341622|559284029|FG000|Overall Study|Invalid Address|0|||
155328753|NCT01218659|560639284|FG002|12-Month OLE|Lost to Follow-up|1|||
155328754|NCT01218659|560639282|FG000|12-Month OLE|Pregnancy|0|||
155328755|NCT01218659|560639283|FG001|12-Month OLE|Pregnancy|0|||
155328756|NCT01218659|560639284|FG002|12-Month OLE|Pregnancy|1|||
155328757|NCT01218659|560639282|FG000|12-Month OLE|Lack of Efficacy|0|||
155328758|NCT01218659|560639283|FG001|12-Month OLE|Lack of Efficacy|0|||
155328759|NCT01218659|560639284|FG002|12-Month OLE|Lack of Efficacy|1|||
155328760|NCT01218659|560639282|FG000|12-Month OLE|Declined to participate in the OLE|0|||
155328761|NCT01218659|560639283|FG001|12-Month OLE|Declined to participate in the OLE|0|||
155328762|NCT01218659|560639284|FG002|12-Month OLE|Declined to participate in the OLE|4|||
155328763|NCT03066609|560639291|FG000|INDUCTION|Pregnancy|0|||
155070379|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
155070380|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
155070381|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
155070382|NCT01697579|559686415|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155328764|NCT03066609|560639292|FG001|INDUCTION|Pregnancy|0|||
155328765|NCT03066609|560639293|FG002|INDUCTION|Pregnancy|1|||
155328766|NCT03066609|560639294|FG003|INDUCTION|Pregnancy|0|||
155328767|NCT03066609|560639291|FG000|INDUCTION|Lack of Efficacy|0|||
155328768|NCT03066609|560639292|FG001|INDUCTION|Lack of Efficacy|0|||
155328769|NCT03066609|560639293|FG002|INDUCTION|Lack of Efficacy|1|||
155328770|NCT03066609|560639294|FG003|INDUCTION|Lack of Efficacy|0|||
155328771|NCT03066609|560639291|FG000|INDUCTION|Adverse Event|2|||
155328772|NCT03066609|560639292|FG001|INDUCTION|Adverse Event|2|||
155328773|NCT03066609|560639293|FG002|INDUCTION|Adverse Event|0|||
155328774|NCT03066609|560639294|FG003|INDUCTION|Adverse Event|0|||
155070383|NCT01697579|559686416|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155070384|NCT01697579|559686417|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155070385|NCT01697579|559686418|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155163243|NCT02908672|560033263|FG001|Run-in Period|Protocol Violation|1|||
155163244|NCT02908672|560033264|FG002|Run-in Period|Protocol Violation|0|||
155163245|NCT02908672|560033265|FG003|Run-in Period|Protocol Violation|0|||
155163246|NCT02908672|560033262|FG000|Run-in Period|Study Ended by Sponsor|5|||
155163247|NCT02908672|560033263|FG001|Run-in Period|Study Ended by Sponsor|1|||
155163248|NCT02908672|560033264|FG002|Run-in Period|Study Ended by Sponsor|0|||
155163249|NCT02908672|560033265|FG003|Run-in Period|Study Ended by Sponsor|0|||
155163250|NCT02908672|560033262|FG000|Run-in Period|Withdrawal by Subject|3|||
155163251|NCT02908672|560033263|FG001|Run-in Period|Withdrawal by Subject|9|||
155163252|NCT02908672|560033264|FG002|Run-in Period|Withdrawal by Subject|0|||
155163253|NCT02908672|560033265|FG003|Run-in Period|Withdrawal by Subject|0|||
155163254|NCT02908672|560033262|FG000|Triple Combination Period|Death|0|||
155163255|NCT02908672|560033263|FG001|Triple Combination Period|Death|0|||
155163256|NCT02908672|560033264|FG002|Triple Combination Period|Death|150|||
155163257|NCT02908672|560033265|FG003|Triple Combination Period|Death|127|||
155163258|NCT02908672|560033262|FG000|Triple Combination Period|Lost to Follow-up|0|||
155163259|NCT02908672|560033263|FG001|Triple Combination Period|Lost to Follow-up|0|||
155163260|NCT02908672|560033264|FG002|Triple Combination Period|Lost to Follow-up|6|||
155163261|NCT02908672|560033265|FG003|Triple Combination Period|Lost to Follow-up|8|||
155163262|NCT02908672|560033262|FG000|Triple Combination Period|Reason Not Specified|0|||
155163263|NCT02908672|560033263|FG001|Triple Combination Period|Reason Not Specified|0|||
155163264|NCT02908672|560033264|FG002|Triple Combination Period|Reason Not Specified|0|||
155163265|NCT02908672|560033265|FG003|Triple Combination Period|Reason Not Specified|1|||
155163266|NCT02908672|560033262|FG000|Triple Combination Period|Physician Decision|0|||
155163267|NCT02908672|560033263|FG001|Triple Combination Period|Physician Decision|0|||
155163268|NCT02908672|560033264|FG002|Triple Combination Period|Physician Decision|1|||
155163269|NCT02908672|560033265|FG003|Triple Combination Period|Physician Decision|1|||
155163270|NCT02908672|560033262|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
155163271|NCT02908672|560033263|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
155163272|NCT02908672|560033264|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
155163273|NCT02908672|560033265|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
155163274|NCT02908672|560033262|FG000|Triple Combination Period|Withdrawal by Subject|0|||
155163275|NCT02908672|560033263|FG001|Triple Combination Period|Withdrawal by Subject|0|||
155163276|NCT02908672|560033264|FG002|Triple Combination Period|Withdrawal by Subject|13|||
155163277|NCT02908672|560033265|FG003|Triple Combination Period|Withdrawal by Subject|16|||
155163278|NCT01185080|560033269|FG000|Overall Study|Adverse Event|1|||
155163279|NCT01185080|560033270|FG001|Overall Study|Adverse Event|1|||
155163280|NCT01185080|560033271|FG002|Overall Study|Adverse Event|0|||
155163281|NCT01185080|560033269|FG000|Overall Study|Personal reasons|0|||
155163282|NCT01185080|560033270|FG001|Overall Study|Personal reasons|0|||
155328775|NCT03066609|560639291|FG000|MAINTENANCE|Adverse Event|0|||
155328776|NCT03066609|560639292|FG001|MAINTENANCE|Adverse Event|0|||
155328777|NCT03066609|560639293|FG002|MAINTENANCE|Adverse Event|0|||
155328778|NCT03066609|560639294|FG003|MAINTENANCE|Adverse Event|1|||
155328779|NCT03066609|560639291|FG000|MAINTENANCE|Withdrawal by Subject|4|||
155328780|NCT03066609|560639292|FG001|MAINTENANCE|Withdrawal by Subject|2|||
155328781|NCT03066609|560639293|FG002|MAINTENANCE|Withdrawal by Subject|1|||
155328782|NCT03066609|560639294|FG003|MAINTENANCE|Withdrawal by Subject|1|||
155328783|NCT03066609|560639291|FG000|MAINTENANCE|Lost to Follow-up|0|||
155328784|NCT03066609|560639292|FG001|MAINTENANCE|Lost to Follow-up|1|||
155328785|NCT03066609|560639293|FG002|MAINTENANCE|Lost to Follow-up|1|||
155328786|NCT03066609|560639294|FG003|MAINTENANCE|Lost to Follow-up|0|||
155328787|NCT03066609|560639291|FG000|MAINTENANCE|Pregnancy|1|||
155328788|NCT03066609|560639292|FG001|MAINTENANCE|Pregnancy|0|||
155328789|NCT03066609|560639293|FG002|MAINTENANCE|Pregnancy|0|||
155328790|NCT03066609|560639294|FG003|MAINTENANCE|Pregnancy|0|||
155163283|NCT01185080|560033271|FG002|Overall Study|Personal reasons|1|||
155163284|NCT06083506|560033273|FG000|Overall Study|Physician Decision|2|||
155163285|NCT06083506|560033273|FG000|Overall Study|Lack of Efficacy|1|||
155163286|NCT01648751|560033277|FG000|Overall Study|Withdrawal by Subject|2|||
155163287|NCT01648751|560033278|FG001|Overall Study|Withdrawal by Subject|3|||
155163288|NCT01967238|560033280|FG000|Overall Study|Adverse Event|1|||
155163289|NCT01967238|560033281|FG001|Overall Study|Adverse Event|1|||
155163290|NCT01967238|560033282|FG002|Overall Study|Adverse Event|0|||
155163291|NCT01967238|560033280|FG000|Overall Study|Lost to Follow-up|1|||
155163292|NCT01967238|560033281|FG001|Overall Study|Lost to Follow-up|0|||
155163293|NCT01967238|560033282|FG002|Overall Study|Lost to Follow-up|1|||
155163294|NCT01967238|560033280|FG000|Overall Study|Withdrawal by Subject|0|||
155163295|NCT01967238|560033281|FG001|Overall Study|Withdrawal by Subject|0|||
155163296|NCT01967238|560033282|FG002|Overall Study|Withdrawal by Subject|1|||
155163297|NCT04949490|560033286|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155163298|NCT04949490|560033287|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155163299|NCT04949490|560033288|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155163300|NCT04949490|560033289|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
155163301|NCT04949490|560033290|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155163302|NCT04949490|560033291|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
155328791|NCT03066609|560639291|FG000|MAINTENANCE|Lack of Efficacy|2|||
155328792|NCT03066609|560639292|FG001|MAINTENANCE|Lack of Efficacy|1|||
155328793|NCT03066609|560639293|FG002|MAINTENANCE|Lack of Efficacy|0|||
155328794|NCT03066609|560639294|FG003|MAINTENANCE|Lack of Efficacy|1|||
155328795|NCT03066609|560639291|FG000|OVERALL STUDY|Adverse Event|2|||
155328796|NCT03066609|560639292|FG001|OVERALL STUDY|Adverse Event|2|||
155328797|NCT03066609|560639293|FG002|OVERALL STUDY|Adverse Event|0|||
155328798|NCT03066609|560639294|FG003|OVERALL STUDY|Adverse Event|1|||
155328799|NCT03066609|560639291|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
155328800|NCT03066609|560639292|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
155328801|NCT03066609|560639293|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
155328802|NCT03066609|560639294|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
155328803|NCT03066609|560639291|FG000|OVERALL STUDY|Lost to Follow-up|1|||
155328804|NCT03066609|560639292|FG001|OVERALL STUDY|Lost to Follow-up|1|||
155328805|NCT03066609|560639293|FG002|OVERALL STUDY|Lost to Follow-up|1|||
155328806|NCT03066609|560639294|FG003|OVERALL STUDY|Lost to Follow-up|1|||
155328807|NCT03066609|560639291|FG000|OVERALL STUDY|Pregnancy|1|||
155328808|NCT03066609|560639292|FG001|OVERALL STUDY|Pregnancy|0|||
155328809|NCT03066609|560639293|FG002|OVERALL STUDY|Pregnancy|1|||
155328810|NCT03066609|560639294|FG003|OVERALL STUDY|Pregnancy|0|||
155328811|NCT03066609|560639291|FG000|OVERALL STUDY|Lack of Efficacy|2|||
155328812|NCT03066609|560639292|FG001|OVERALL STUDY|Lack of Efficacy|1|||
155328813|NCT03066609|560639293|FG002|OVERALL STUDY|Lack of Efficacy|1|||
155328814|NCT03066609|560639294|FG003|OVERALL STUDY|Lack of Efficacy|1|||
155328815|NCT03066609|560639291|FG000|OVERALL STUDY|discontinued follow up|0|||
155328816|NCT03066609|560639292|FG001|OVERALL STUDY|discontinued follow up|2|||
155328817|NCT03066609|560639293|FG002|OVERALL STUDY|discontinued follow up|0|||
155328818|NCT03066609|560639294|FG003|OVERALL STUDY|discontinued follow up|0|||
155328819|NCT03355573|560639295|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
155328820|NCT03355573|560639295|FG000|Overall Study|Sponsor's decision|1|||
155328821|NCT03355573|560639295|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
155328822|NCT03355573|560639295|FG000|Overall Study|PI's decision|2|||
155328823|NCT03355573|560639295|FG000|Overall Study|Withdrawal by Subject|23|||
155328824|NCT03355573|560639295|FG000|Overall Study|Lost to Follow-up|4|||
155163303|NCT04949490|560033286|FG000|Group A and Group B|Withdrawal by Subject|0|||
155163304|NCT04949490|560033287|FG001|Group A and Group B|Withdrawal by Subject|0|||
155163305|NCT04949490|560033288|FG002|Group A and Group B|Withdrawal by Subject|1|||
155163306|NCT04949490|560033289|FG003|Group A and Group B|Withdrawal by Subject|0|||
155328825|NCT03355573|560639295|FG000|Overall Study|Lack of Efficacy|2|||
155328826|NCT03355573|560639295|FG000|Overall Study|Adverse Event, non-fatal|17|||
155328827|NCT03355573|560639295|FG000|Overall Study|Adverse Event, serious fatal|2|||
155328828|NCT01566890|560639296|FG000|Overall Study|Adverse Event|1|||
155328829|NCT01566890|560639297|FG001|Overall Study|Adverse Event|0|||
155328830|NCT01566890|560639298|FG002|Overall Study|Adverse Event|0|||
155328831|NCT01566890|560639299|FG003|Overall Study|Adverse Event|0|||
155328832|NCT01566890|560639300|FG004|Overall Study|Adverse Event|0|||
155070386|NCT01697579|559686419|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155070387|NCT01697579|559686420|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
155070388|NCT01697579|559686421|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
155070389|NCT01044498|559686422|FG000|Overall Study|Withdrew consent|1|||
155070390|NCT01044498|559686423|FG001|Overall Study|Withdrew consent|1|||
155070391|NCT01044498|559686422|FG000|Overall Study|Adverse Event|1|||
155070392|NCT01044498|559686423|FG001|Overall Study|Adverse Event|1|||
155070393|NCT01044498|559686422|FG000|Overall Study|Other|1|||
155070394|NCT01044498|559686423|FG001|Overall Study|Other|0|||
155070395|NCT03487445|559686428|FG000|Randomization|Not treated for administrative reasons|1|||
155070396|NCT03487445|559686429|FG001|Randomization|Not treated for administrative reasons|0|||
155070397|NCT04225039|559686432|FG000|Overall Study|Withdrawal by Subject|1|||
155070398|NCT04225039|559686433|FG001|Overall Study|Withdrawal by Subject|0|||
155070399|NCT04225039|559686434|FG002|Overall Study|Withdrawal by Subject|0|||
155070400|NCT04225039|559686435|FG003|Overall Study|Withdrawal by Subject|1|||
155070401|NCT04225039|559686432|FG000|Overall Study|Currently active on study treatment|0|||
155070402|NCT04225039|559686433|FG001|Overall Study|Currently active on study treatment|1|||
155070403|NCT04225039|559686434|FG002|Overall Study|Currently active on study treatment|0|||
155070404|NCT04225039|559686435|FG003|Overall Study|Currently active on study treatment|0|||
155070405|NCT04225039|559686432|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
155070406|NCT04225039|559686433|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
155070407|NCT04225039|559686434|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
155070408|NCT04225039|559686435|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
155070409|NCT04225039|559686432|FG000|Overall Study|Ineligible for treatment|0|||
155070410|NCT04225039|559686433|FG001|Overall Study|Ineligible for treatment|0|||
155328833|NCT01566890|560639296|FG000|Overall Study|Withdrawal by Subject|3|||
155328834|NCT01566890|560639297|FG001|Overall Study|Withdrawal by Subject|1|||
155328835|NCT01566890|560639298|FG002|Overall Study|Withdrawal by Subject|1|||
155328836|NCT01566890|560639299|FG003|Overall Study|Withdrawal by Subject|1|||
155328837|NCT01566890|560639300|FG004|Overall Study|Withdrawal by Subject|0|||
155328838|NCT01566890|560639296|FG000|Overall Study|Screen failure|6|||
155328839|NCT01566890|560639297|FG001|Overall Study|Screen failure|0|||
155328840|NCT01566890|560639298|FG002|Overall Study|Screen failure|1|||
155328841|NCT01566890|560639299|FG003|Overall Study|Screen failure|1|||
155328842|NCT01566890|560639300|FG004|Overall Study|Screen failure|0|||
155070411|NCT04225039|559686434|FG002|Overall Study|Ineligible for treatment|0|||
155328843|NCT01566890|560639296|FG000|Overall Study|Incomplete CEU data|1|||
155328844|NCT01566890|560639297|FG001|Overall Study|Incomplete CEU data|3|||
155328845|NCT01566890|560639298|FG002|Overall Study|Incomplete CEU data|5|||
155328846|NCT01566890|560639299|FG003|Overall Study|Incomplete CEU data|8|||
155328847|NCT01566890|560639300|FG004|Overall Study|Incomplete CEU data|0|||
155328848|NCT01566890|560639296|FG000|Overall Study|Lost to Follow-up|0|||
155328849|NCT01566890|560639297|FG001|Overall Study|Lost to Follow-up|0|||
155328850|NCT01566890|560639298|FG002|Overall Study|Lost to Follow-up|4|||
155328851|NCT01566890|560639299|FG003|Overall Study|Lost to Follow-up|4|||
155328852|NCT01566890|560639300|FG004|Overall Study|Lost to Follow-up|0|||
155328853|NCT01566890|560639296|FG000|Overall Study|Other|0|||
155328854|NCT01566890|560639297|FG001|Overall Study|Other|0|||
155328855|NCT01566890|560639298|FG002|Overall Study|Other|0|||
155328856|NCT01566890|560639299|FG003|Overall Study|Other|0|||
155328857|NCT01566890|560639300|FG004|Overall Study|Other|7|||
155070412|NCT04225039|559686435|FG003|Overall Study|Ineligible for treatment|4|||
155070413|NCT00975923|559686440|FG000|Overall Study|Withdrawal by Subject|0|||
155070414|NCT00975923|559686441|FG001|Overall Study|Withdrawal by Subject|1|||
155070415|NCT05567172|559686442|FG000|Overall Study|Death|3|||
155070416|NCT04132050|559686443|FG000|Period I (Double-blind Period)|Adverse Event|3|||
155070417|NCT04132050|559686444|FG001|Period I (Double-blind Period)|Adverse Event|0|||
155070418|NCT04132050|559686443|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
155070419|NCT04132050|559686444|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
155070420|NCT04132050|559686443|FG000|R788 Treatment Period|Adverse Event|5|||
155070421|NCT04132050|559686444|FG001|R788 Treatment Period|Adverse Event|0|||
155070422|NCT04132050|559686443|FG000|R788 Treatment Period|Lack of Efficacy|5|||
155070423|NCT04132050|559686444|FG001|R788 Treatment Period|Lack of Efficacy|0|||
155328858|NCT00523419|560639306|FG000|Overall Study|Adverse Event|1|||
155328859|NCT00523419|560639306|FG000|Overall Study|Withdrawal by Subject|1|||
155328860|NCT00523419|560639306|FG000|Overall Study|Physician Decision|2|||
155070424|NCT04132050|559686443|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
155070425|NCT04132050|559686444|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
155070426|NCT03168672|559686447|FG000|Overall Study|Withdrawal by Subject|13|||
155070427|NCT03168672|559686447|FG000|Overall Study|Death|3|||
155328861|NCT00523419|560639306|FG000|Overall Study|Progressive Disease|22|||
155070428|NCT03168672|559686447|FG000|Overall Study|Investigator's Decision|137|||
155328862|NCT00523419|560639306|FG000|Overall Study|Death due to Study Disease|4|||
155328863|NCT00523419|560639306|FG000|Overall Study|Death due to Adverse Event|2|||
155328864|NCT00822120|560639307|FG000|Initial Registration|Adverse Event|1|||
155328865|NCT00822120|560639308|FG001|Initial Registration|Adverse Event|0|||
155328866|NCT00822120|560639309|FG002|Initial Registration|Adverse Event|0|||
155328867|NCT00822120|560639310|FG003|Initial Registration|Adverse Event|0|||
155328868|NCT00822120|560639311|FG004|Initial Registration|Adverse Event|0|||
155070429|NCT03168672|559686447|FG000|Overall Study|Adverse Event|1|||
155070430|NCT03168672|559686447|FG000|Overall Study|Other|2|||
155070431|NCT03168672|559686447|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
155328869|NCT00822120|560639312|FG005|Initial Registration|Adverse Event|0|||
155328870|NCT00822120|560639307|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
155328871|NCT00822120|560639308|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328872|NCT00822120|560639309|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328873|NCT00822120|560639310|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328874|NCT00822120|560639311|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155328875|NCT00822120|560639312|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
155070432|NCT00433537|559686448|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
155070433|NCT00433537|559686449|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
155070434|NCT00433537|559686450|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
155070435|NCT00433537|559686448|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
155070436|NCT00433537|559686449|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
155328876|NCT00822120|560639307|FG000|Initial Registration|Reasons not Protocol Specified|2|||
155070437|NCT00433537|559686450|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
155070438|NCT00433537|559686448|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
155070439|NCT00433537|559686449|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
155328877|NCT00822120|560639308|FG001|Initial Registration|Reasons not Protocol Specified|0|||
155328878|NCT00822120|560639309|FG002|Initial Registration|Reasons not Protocol Specified|0|||
155328879|NCT00822120|560639310|FG003|Initial Registration|Reasons not Protocol Specified|0|||
155328880|NCT00822120|560639311|FG004|Initial Registration|Reasons not Protocol Specified|0|||
155328881|NCT00822120|560639312|FG005|Initial Registration|Reasons not Protocol Specified|0|||
155328882|NCT00822120|560639307|FG000|Initial Registration|Ineligible|22|||
155328883|NCT00822120|560639308|FG001|Initial Registration|Ineligible|1|||
155328884|NCT00822120|560639309|FG002|Initial Registration|Ineligible|0|||
155328885|NCT00822120|560639310|FG003|Initial Registration|Ineligible|0|||
155328886|NCT00822120|560639311|FG004|Initial Registration|Ineligible|0|||
155328887|NCT00822120|560639312|FG005|Initial Registration|Ineligible|0|||
155328888|NCT00822120|560639307|FG000|PET-directed Therapy|Adverse Event|0|||
155328889|NCT00822120|560639308|FG001|PET-directed Therapy|Adverse Event|0|||
155328890|NCT00822120|560639309|FG002|PET-directed Therapy|Adverse Event|0|||
155328891|NCT00822120|560639310|FG003|PET-directed Therapy|Adverse Event|1|||
155328892|NCT00822120|560639311|FG004|PET-directed Therapy|Adverse Event|0|||
155328893|NCT00822120|560639312|FG005|PET-directed Therapy|Adverse Event|0|||
155328894|NCT00822120|560639307|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155070440|NCT00433537|559686450|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
155070441|NCT00433537|559686448|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
155070442|NCT00433537|559686449|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
155070443|NCT00433537|559686450|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
155070444|NCT00433537|559686448|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
155070445|NCT00433537|559686449|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
155070446|NCT00433537|559686450|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
155070447|NCT00433537|559686448|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
155070448|NCT00433537|559686449|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
155163307|NCT04949490|560033290|FG004|Group A and Group B|Withdrawal by Subject|0|||
155163308|NCT04949490|560033291|FG005|Group A and Group B|Withdrawal by Subject|0|||
155328895|NCT00822120|560639308|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328896|NCT00822120|560639309|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328897|NCT00822120|560639310|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
155328898|NCT00822120|560639311|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328899|NCT00822120|560639312|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
155328900|NCT00822120|560639307|FG000|PET-directed Therapy|Death|0|||
155328901|NCT00822120|560639308|FG001|PET-directed Therapy|Death|0|||
155328902|NCT00822120|560639309|FG002|PET-directed Therapy|Death|0|||
155328903|NCT00822120|560639310|FG003|PET-directed Therapy|Death|2|||
155328904|NCT00822120|560639311|FG004|PET-directed Therapy|Death|0|||
155328905|NCT00822120|560639312|FG005|PET-directed Therapy|Death|0|||
155328906|NCT00822120|560639307|FG000|PET-directed Therapy|Protocol Violation|0|||
155328907|NCT00822120|560639308|FG001|PET-directed Therapy|Protocol Violation|0|||
155328908|NCT00822120|560639309|FG002|PET-directed Therapy|Protocol Violation|0|||
155328909|NCT00822120|560639310|FG003|PET-directed Therapy|Protocol Violation|6|||
155328910|NCT00822120|560639311|FG004|PET-directed Therapy|Protocol Violation|0|||
155328911|NCT00822120|560639312|FG005|PET-directed Therapy|Protocol Violation|0|||
155328912|NCT01437319|560639314|FG000|Phase I|Lost to Follow-up|2|||
155163309|NCT04949490|560033286|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155070449|NCT00433537|559686450|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
155070450|NCT00433537|559686448|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
155070451|NCT00433537|559686449|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
155070452|NCT00433537|559686450|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
155070453|NCT00433537|559686448|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
155070454|NCT00433537|559686449|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
155070455|NCT00433537|559686450|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
155070456|NCT00433537|559686448|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
155070457|NCT00433537|559686449|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
155070458|NCT00433537|559686450|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
155070459|NCT04556097|559686451|FG000|Overall Study|Death|0|||
155070460|NCT04556097|559686452|FG001|Overall Study|Death|5|||
155070461|NCT04556097|559686453|FG002|Overall Study|Death|0|||
155070462|NCT04556097|559686454|FG003|Overall Study|Death|0|||
155070463|NCT04556097|559686451|FG000|Overall Study|No caregiver|43|||
155070464|NCT04556097|559686452|FG001|Overall Study|No caregiver|53|||
155070465|NCT04556097|559686453|FG002|Overall Study|No caregiver|0|||
155070466|NCT04556097|559686454|FG003|Overall Study|No caregiver|0|||
155070467|NCT04556097|559686451|FG000|Overall Study|Ineligible, SNF|2|||
155070468|NCT04556097|559686452|FG001|Overall Study|Ineligible, SNF|2|||
155070469|NCT04556097|559686453|FG002|Overall Study|Ineligible, SNF|0|||
155070470|NCT04556097|559686454|FG003|Overall Study|Ineligible, SNF|0|||
155070471|NCT04556097|559686451|FG000|Overall Study|Ineligible, health|3|||
155070472|NCT04556097|559686452|FG001|Overall Study|Ineligible, health|4|||
155070473|NCT04556097|559686453|FG002|Overall Study|Ineligible, health|0|||
155070474|NCT04556097|559686454|FG003|Overall Study|Ineligible, health|0|||
155070475|NCT04556097|559686451|FG000|Overall Study|Ineligible, language|0|||
155070476|NCT04556097|559686452|FG001|Overall Study|Ineligible, language|1|||
155070477|NCT04556097|559686453|FG002|Overall Study|Ineligible, language|0|||
155070478|NCT04556097|559686454|FG003|Overall Study|Ineligible, language|0|||
155070479|NCT04556097|559686451|FG000|Overall Study|Ineligible, no longer in care management|0|||
155070480|NCT04556097|559686452|FG001|Overall Study|Ineligible, no longer in care management|2|||
155070481|NCT04556097|559686453|FG002|Overall Study|Ineligible, no longer in care management|1|||
155070482|NCT04556097|559686454|FG003|Overall Study|Ineligible, no longer in care management|0|||
155070483|NCT04556097|559686451|FG000|Overall Study|No dementia|13|||
155070484|NCT04556097|559686452|FG001|Overall Study|No dementia|3|||
155070485|NCT04556097|559686453|FG002|Overall Study|No dementia|0|||
155070486|NCT04556097|559686454|FG003|Overall Study|No dementia|0|||
155070487|NCT04556097|559686451|FG000|Overall Study|Missing identifier|2|||
155070488|NCT04556097|559686452|FG001|Overall Study|Missing identifier|4|||
155070489|NCT04556097|559686453|FG002|Overall Study|Missing identifier|0|||
155070490|NCT04556097|559686454|FG003|Overall Study|Missing identifier|0|||
155070491|NCT04556097|559686451|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
155070492|NCT04556097|559686452|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
155070493|NCT04556097|559686453|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
155163310|NCT04949490|560033287|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155163311|NCT04949490|560033288|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155163312|NCT04949490|560033289|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155163313|NCT04949490|560033290|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
155163314|NCT04949490|560033291|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
155328913|NCT01437319|560639315|FG001|Phase I|Lost to Follow-up|0|||
155328914|NCT01437319|560639316|FG002|Phase I|Lost to Follow-up|0|||
155328915|NCT01437319|560639314|FG000|Phase I|Protocol Violation|1|||
155328916|NCT01437319|560639315|FG001|Phase I|Protocol Violation|0|||
155328917|NCT01437319|560639316|FG002|Phase I|Protocol Violation|0|||
155328918|NCT01437319|560639314|FG000|Phase I|Study related symptoms/complaints|27|||
155328919|NCT01437319|560639315|FG001|Phase I|Study related symptoms/complaints|0|||
155328920|NCT01437319|560639316|FG002|Phase I|Study related symptoms/complaints|0|||
155328921|NCT01437319|560639314|FG000|Phase I|Withdrawal by Subject|25|||
155328922|NCT01437319|560639315|FG001|Phase I|Withdrawal by Subject|0|||
155328923|NCT01437319|560639316|FG002|Phase I|Withdrawal by Subject|0|||
155328924|NCT01437319|560639314|FG000|Phase II|Withdrawal by Subject|0|||
155328925|NCT01437319|560639315|FG001|Phase II|Withdrawal by Subject|8|||
155070494|NCT04556097|559686454|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
155070495|NCT05436613|559686455|FG000|Overall Study|Lost to Follow-up|9|||
155070496|NCT05436613|559686455|FG000|Overall Study|Withdrawal by Subject|3|||
155070497|NCT04635423|559686468|FG000|Overall Study|Ongoing|493|||
155070498|NCT04635423|559686469|FG001|Overall Study|Ongoing|501|||
155070499|NCT04635423|559686468|FG000|Overall Study|Withdrawal by Subject|36|||
155070500|NCT04635423|559686469|FG001|Overall Study|Withdrawal by Subject|29|||
155070501|NCT05556057|559686470|FG000|Overall Study|Lost to Follow-up|5|||
155070502|NCT05556057|559686471|FG001|Overall Study|Lost to Follow-up|4|||
155070503|NCT05556057|559686470|FG000|Overall Study|Withdrawal by Subject|0|||
155070504|NCT05556057|559686471|FG001|Overall Study|Withdrawal by Subject|2|||
155070505|NCT02003924|559686472|FG000|Double-blind Phase|Lost to Follow-up|2|||
155070506|NCT02003924|559686473|FG001|Double-blind Phase|Lost to Follow-up|1|||
155070507|NCT02003924|559686474|FG002|Double-blind Phase|Lost to Follow-up|0|||
155070508|NCT02003924|559686472|FG000|Double-blind Phase|Protocol Violation|1|||
155070509|NCT02003924|559686473|FG001|Double-blind Phase|Protocol Violation|2|||
155070510|NCT02003924|559686474|FG002|Double-blind Phase|Protocol Violation|0|||
155070511|NCT02003924|559686472|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
155070512|NCT02003924|559686473|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
155070513|NCT02003924|559686474|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
155070514|NCT02003924|559686472|FG000|Double-blind Phase|Disease Progression|229|||
155070515|NCT02003924|559686473|FG001|Double-blind Phase|Disease Progression|247|||
155070516|NCT02003924|559686474|FG002|Double-blind Phase|Disease Progression|0|||
155070517|NCT02003924|559686472|FG000|Double-blind Phase|Adverse Event|120|||
155070518|NCT02003924|559686473|FG001|Double-blind Phase|Adverse Event|31|||
155070519|NCT02003924|559686474|FG002|Double-blind Phase|Adverse Event|0|||
155070520|NCT02003924|559686472|FG000|Double-blind Phase|Randomized But not Treated|3|||
155328926|NCT01437319|560639316|FG002|Phase II|Withdrawal by Subject|16|||
155328927|NCT01437319|560639314|FG000|Phase II|Lost to Follow-up|0|||
155328928|NCT01437319|560639315|FG001|Phase II|Lost to Follow-up|7|||
155328929|NCT01437319|560639316|FG002|Phase II|Lost to Follow-up|2|||
155328930|NCT01437319|560639314|FG000|Phase II|Study related symptoms/complaints|0|||
155328931|NCT01437319|560639315|FG001|Phase II|Study related symptoms/complaints|28|||
155328932|NCT01437319|560639316|FG002|Phase II|Study related symptoms/complaints|19|||
155328933|NCT01437319|560639314|FG000|Phase II|Protocol Violation|0|||
155328934|NCT01437319|560639315|FG001|Phase II|Protocol Violation|1|||
155328935|NCT01437319|560639316|FG002|Phase II|Protocol Violation|0|||
155328936|NCT00811941|560639317|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
155328937|NCT00811941|560639318|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
155328938|NCT00811941|560639317|FG000|All Treated Patients|Adverse Event|2|||
155328939|NCT00811941|560639318|FG001|All Treated Patients|Adverse Event|43|||
155328940|NCT00811941|560639317|FG000|All Treated Patients|Lack of Efficacy|2|||
155328941|NCT00811941|560639318|FG001|All Treated Patients|Lack of Efficacy|3|||
155328942|NCT00811941|560639317|FG000|All Treated Patients|Non-compliance|1|||
155328943|NCT00811941|560639318|FG001|All Treated Patients|Non-compliance|8|||
155328944|NCT00811941|560639317|FG000|All Treated Patients|Protocol Violation|5|||
155328945|NCT00811941|560639318|FG001|All Treated Patients|Protocol Violation|17|||
155328946|NCT00811941|560639317|FG000|All Treated Patients|Withdrawal by Subject|35|||
155328947|NCT00811941|560639318|FG001|All Treated Patients|Withdrawal by Subject|94|||
155328948|NCT00811941|560639317|FG000|All Treated Patients|Lost to Follow-up|3|||
155328949|NCT00811941|560639318|FG001|All Treated Patients|Lost to Follow-up|12|||
155328950|NCT00811941|560639317|FG000|All Treated Patients|Other Reason|4|||
155328951|NCT00811941|560639318|FG001|All Treated Patients|Other Reason|14|||
155328952|NCT00942266|560639326|FG000|Overall Study|Withdrawal by Subject|1|||
155328953|NCT00942266|560639327|FG001|Overall Study|Withdrawal by Subject|0|||
155328954|NCT00942266|560639326|FG000|Overall Study|Adverse Event|2|||
155328955|NCT00942266|560639327|FG001|Overall Study|Adverse Event|1|||
155328956|NCT00942266|560639326|FG000|Overall Study|Disease Progression|38|||
155328957|NCT00942266|560639327|FG001|Overall Study|Disease Progression|11|||
155328958|NCT00942266|560639326|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
155328959|NCT00942266|560639327|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
155328960|NCT00942266|560639326|FG000|Overall Study|Intercurrent illness|0|||
155328961|NCT00942266|560639327|FG001|Overall Study|Intercurrent illness|1|||
155328962|NCT00942266|560639326|FG000|Overall Study|Physician Decision|2|||
155328963|NCT00942266|560639327|FG001|Overall Study|Physician Decision|0|||
155328964|NCT00942266|560639326|FG000|Overall Study|medical deterioration (pneumonia)|0|||
155070521|NCT02003924|559686473|FG001|Double-blind Phase|Randomized But not Treated|3|||
155070522|NCT02003924|559686474|FG002|Double-blind Phase|Randomized But not Treated|0|||
155070523|NCT02003924|559686472|FG000|Double-blind Phase|Other|29|||
155328965|NCT00942266|560639327|FG001|Overall Study|medical deterioration (pneumonia)|1|||
155328966|NCT02397096|560639344|FG000|Day 1 to Week 24|Adverse Event|7|||
155328967|NCT02397096|560639345|FG001|Day 1 to Week 24|Adverse Event|1|||
155070524|NCT02003924|559686473|FG001|Double-blind Phase|Other|50|||
155328968|NCT02397096|560639344|FG000|Day 1 to Week 24|Death|1|||
155328969|NCT02397096|560639345|FG001|Day 1 to Week 24|Death|0|||
155328970|NCT02397096|560639344|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
155328971|NCT02397096|560639345|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
155328972|NCT02397096|560639344|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
155328973|NCT02397096|560639345|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
155328974|NCT02397096|560639344|FG000|Day 1 to Week 24|Physician Decision|2|||
155328975|NCT02397096|560639345|FG001|Day 1 to Week 24|Physician Decision|3|||
155070525|NCT02003924|559686474|FG002|Double-blind Phase|Other|0|||
155328976|NCT02397096|560639344|FG000|Day 1 to Week 24|Protocol Violation|1|||
155328977|NCT02397096|560639345|FG001|Day 1 to Week 24|Protocol Violation|4|||
155328978|NCT02397096|560639344|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
155328979|NCT02397096|560639345|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
155328980|NCT02397096|560639344|FG000|Day 1 to Week 24|Randomized, not treated|3|||
155328981|NCT02397096|560639345|FG001|Day 1 to Week 24|Randomized, not treated|0|||
155328982|NCT02397096|560639344|FG000|Week 24 to Week 48|Adverse Event|6|||
155328983|NCT02397096|560639345|FG001|Week 24 to Week 48|Adverse Event|2|||
155328984|NCT02397096|560639344|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
155328985|NCT02397096|560639345|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
155328986|NCT02397096|560639344|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
155328987|NCT02397096|560639345|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
155328988|NCT02397096|560639344|FG000|Week 24 to Week 48|Physician Decision|2|||
155328989|NCT02397096|560639345|FG001|Week 24 to Week 48|Physician Decision|1|||
155328990|NCT02397096|560639344|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
155328991|NCT02397096|560639345|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
155328992|NCT02397096|560639344|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
155328993|NCT02397096|560639345|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
155328994|NCT02397096|560639344|FG000|Study Extension 1|Adverse Event|7|||
155328995|NCT02397096|560639345|FG001|Study Extension 1|Adverse Event|5|||
155328996|NCT02397096|560639344|FG000|Study Extension 1|Death|1|||
155328997|NCT02397096|560639345|FG001|Study Extension 1|Death|0|||
155328998|NCT02397096|560639344|FG000|Study Extension 1|Lack of Efficacy|2|||
155328999|NCT02397096|560639345|FG001|Study Extension 1|Lack of Efficacy|5|||
155329000|NCT02397096|560639344|FG000|Study Extension 1|Lost to Follow-up|2|||
155329001|NCT02397096|560639345|FG001|Study Extension 1|Lost to Follow-up|3|||
155329002|NCT02397096|560639344|FG000|Study Extension 1|Non-compliance with study drug|3|||
155329003|NCT02397096|560639345|FG001|Study Extension 1|Non-compliance with study drug|0|||
155329004|NCT02397096|560639344|FG000|Study Extension 1|Physician Decision|4|||
155329005|NCT02397096|560639345|FG001|Study Extension 1|Physician Decision|2|||
155329006|NCT02397096|560639344|FG000|Study Extension 1|Pregnancy|1|||
155329007|NCT02397096|560639345|FG001|Study Extension 1|Pregnancy|0|||
155329008|NCT02397096|560639344|FG000|Study Extension 1|Protocol Violation|0|||
155329009|NCT02397096|560639345|FG001|Study Extension 1|Protocol Violation|1|||
155329010|NCT02397096|560639344|FG000|Study Extension 1|Withdrawal by Subject|21|||
155329011|NCT02397096|560639345|FG001|Study Extension 1|Withdrawal by Subject|7|||
155329012|NCT02397096|560639344|FG000|Study Extension 2|Adverse Event|3|||
155329013|NCT02397096|560639345|FG001|Study Extension 2|Adverse Event|3|||
155329014|NCT02397096|560639344|FG000|Study Extension 2|Availability of study medication locally|152|||
155329015|NCT02397096|560639345|FG001|Study Extension 2|Availability of study medication locally|64|||
155329016|NCT02397096|560639344|FG000|Study Extension 2|Death|2|||
155329017|NCT02397096|560639345|FG001|Study Extension 2|Death|0|||
155329018|NCT02397096|560639344|FG000|Study Extension 2|Lack of Efficacy|1|||
155329019|NCT02397096|560639345|FG001|Study Extension 2|Lack of Efficacy|0|||
155329020|NCT02397096|560639344|FG000|Study Extension 2|Lost to Follow-up|2|||
155329021|NCT02397096|560639345|FG001|Study Extension 2|Lost to Follow-up|1|||
155329022|NCT02397096|560639344|FG000|Study Extension 2|Non-compliance with study drug|1|||
155329023|NCT02397096|560639345|FG001|Study Extension 2|Non-compliance with study drug|0|||
155329024|NCT02397096|560639344|FG000|Study Extension 2|Physician Decision|2|||
155329025|NCT02397096|560639345|FG001|Study Extension 2|Physician Decision|5|||
155163315|NCT04949490|560033286|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155163316|NCT04949490|560033287|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155163317|NCT04949490|560033288|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155163318|NCT04949490|560033289|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155163319|NCT04949490|560033290|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
155163320|NCT04949490|560033291|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
155163321|NCT04721977|560033292|FG000|Overall Study|Death|15|||
155163322|NCT04721977|560033292|FG000|Overall Study|Ongoing|51|||
155163323|NCT02864394|560033293|FG000|Overall Study|Death|184|||
155163324|NCT02864394|560033294|FG001|Overall Study|Death|189|||
155163325|NCT02864394|560033293|FG000|Overall Study|Lost to Follow-up|0|||
155329026|NCT02397096|560639344|FG000|Study Extension 2|Pregnancy|1|||
155329027|NCT02397096|560639345|FG001|Study Extension 2|Pregnancy|0|||
155329028|NCT02397096|560639344|FG000|Study Extension 2|Withdrawal by Subject|10|||
155329029|NCT02397096|560639345|FG001|Study Extension 2|Withdrawal by Subject|3|||
155329030|NCT02397096|560639344|FG000|Study Extension 3|Adverse Event|1|||
155329031|NCT02397096|560639345|FG001|Study Extension 3|Adverse Event|0|||
155329032|NCT02397096|560639344|FG000|Study Extension 3|Availability of study medication locally|11|||
155329033|NCT02397096|560639345|FG001|Study Extension 3|Availability of study medication locally|3|||
155329034|NCT02397096|560639344|FG000|Study Extension 3|Lost to Follow-up|1|||
155329035|NCT02397096|560639345|FG001|Study Extension 3|Lost to Follow-up|0|||
154961748|NCT05341622|559284030|FG001|Overall Study|Invalid Address|1|||
155329036|NCT02397096|560639344|FG000|Study Extension 3|Withdrawal by Subject|2|||
155329037|NCT02397096|560639345|FG001|Study Extension 3|Withdrawal by Subject|1|||
155329038|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
155329039|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
155329040|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
155329041|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
155329042|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
155329043|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
155329044|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
155329045|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
155329046|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
155329047|NCT00918203|560639346|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
155329048|NCT00918203|560639347|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
155329049|NCT00918203|560639348|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
155329050|NCT03357952|560639351|FG000|Overall Study|Withdrawal by Subject|0|||
155329051|NCT03357952|560639352|FG001|Overall Study|Withdrawal by Subject|1|||
155329052|NCT03357952|560639351|FG000|Overall Study|Sponsor Decision|9|||
155329053|NCT03357952|560639352|FG001|Overall Study|Sponsor Decision|0|||
155329054|NCT05018143|560639353|FG000|Overall Study|Lost to Follow-up|5|||
155329055|NCT05018143|560639354|FG001|Overall Study|Lost to Follow-up|4|||
155329056|NCT05018143|560639353|FG000|Overall Study|Withdrawal by Subject|0|||
155329057|NCT05018143|560639354|FG001|Overall Study|Withdrawal by Subject|1|||
155329058|NCT01830595|560639355|FG000|First Period|Withdrawal by Subject|1|||
155329059|NCT01830595|560639356|FG001|First Period|Withdrawal by Subject|3|||
155329060|NCT01830595|560639355|FG000|Washout|Withdrawal by Subject|2|||
155329061|NCT01830595|560639356|FG001|Washout|Withdrawal by Subject|2|||
155329062|NCT06688357|560639357|FG000|Overall Study|Adverse Event|0|||
155329063|NCT06688357|560639358|FG001|Overall Study|Adverse Event|1|||
155329064|NCT05116774|560639359|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
155329065|NCT05116774|560639360|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
155329066|NCT05116774|560639359|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
155329067|NCT05116774|560639360|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
155329068|NCT05116774|560639359|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
155329069|NCT05116774|560639360|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
155329070|NCT05116774|560639359|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
155329071|NCT05116774|560639360|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
155329072|NCT03280030|560639361|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
155329073|NCT03280030|560639362|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
155329074|NCT03280030|560639363|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
155329075|NCT03280030|560639361|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
155329076|NCT03280030|560639362|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
155329077|NCT03280030|560639363|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
155329078|NCT03280030|560639361|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
155329079|NCT03280030|560639362|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
155329080|NCT03280030|560639363|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
155329081|NCT03280030|560639361|FG000|Part 2 - Efficacy|Adverse Event|0|||
155329082|NCT03280030|560639362|FG001|Part 2 - Efficacy|Adverse Event|4|||
155329083|NCT03280030|560639363|FG002|Part 2 - Efficacy|Adverse Event|6|||
155329084|NCT03280030|560639361|FG000|Part 2 - Efficacy|Death|0|||
155329085|NCT03280030|560639362|FG001|Part 2 - Efficacy|Death|3|||
155329086|NCT03280030|560639363|FG002|Part 2 - Efficacy|Death|0|||
155329087|NCT03280030|560639361|FG000|Part 2 - Efficacy|Physician Decision|0|||
155329088|NCT03280030|560639362|FG001|Part 2 - Efficacy|Physician Decision|10|||
155329089|NCT03280030|560639363|FG002|Part 2 - Efficacy|Physician Decision|16|||
155329090|NCT03280030|560639361|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
155329091|NCT03280030|560639362|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
155329092|NCT03280030|560639363|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
155329093|NCT03280030|560639361|FG000|Part 2 - Efficacy|Progressive disease|0|||
155329094|NCT03280030|560639362|FG001|Part 2 - Efficacy|Progressive disease|7|||
155329095|NCT03280030|560639363|FG002|Part 2 - Efficacy|Progressive disease|5|||
155329096|NCT05601882|560639364|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
155329097|NCT05601882|560639365|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
155329098|NCT05601882|560639366|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
154961749|NCT05341622|559284031|FG002|Overall Study|Invalid Address|0|||
155329099|NCT05601882|560639367|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
155329100|NCT05601882|560639364|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
155329101|NCT05601882|560639365|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
155329102|NCT05601882|560639366|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
155329103|NCT05601882|560639367|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
155329104|NCT05601882|560639364|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
155329105|NCT05601882|560639365|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
154961750|NCT05341622|559284032|FG003|Overall Study|Invalid Address|0|||
154961751|NCT05341622|559284033|FG004|Overall Study|Invalid Address|0|||
154961752|NCT05341622|559284034|FG005|Overall Study|Invalid Address|0|||
154961753|NCT05341622|559284035|FG006|Overall Study|Invalid Address|0|||
154961754|NCT05341622|559284036|FG007|Overall Study|Invalid Address|0|||
154961755|NCT05341622|559284029|FG000|Overall Study|Ineligible|26|||
154961756|NCT05341622|559284030|FG001|Overall Study|Ineligible|21|||
154961757|NCT05341622|559284031|FG002|Overall Study|Ineligible|28|||
154961758|NCT05341622|559284032|FG003|Overall Study|Ineligible|24|||
154961759|NCT05341622|559284033|FG004|Overall Study|Ineligible|29|||
154961760|NCT05341622|559284034|FG005|Overall Study|Ineligible|31|||
154961761|NCT05341622|559284035|FG006|Overall Study|Ineligible|28|||
154961762|NCT05341622|559284036|FG007|Overall Study|Ineligible|26|||
154961763|NCT02658084|559284037|FG000|Overall Study|Withdrawal by Subject|1|||
154961764|NCT02658084|559284038|FG001|Overall Study|Withdrawal by Subject|0|||
154961765|NCT02658084|559284037|FG000|Overall Study|Study Termination|1|||
154961766|NCT02658084|559284038|FG001|Overall Study|Study Termination|0|||
154961767|NCT01376037|559285624|FG000|Overall Study|Lost to Follow-up|0|||
154961768|NCT01376037|559285625|FG001|Overall Study|Lost to Follow-up|2|||
154961769|NCT02328040|559285626|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
154961770|NCT02328040|559285627|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
154961771|NCT04278560|559285629|FG000|Overall Study|Adverse Event|1|||
154961772|NCT04278560|559285630|FG001|Overall Study|Adverse Event|2|||
154961773|NCT04278560|559285629|FG000|Overall Study|Withdrawal by Subject|0|||
154961774|NCT04278560|559285630|FG001|Overall Study|Withdrawal by Subject|1|||
154961775|NCT01319383|559285631|FG000|Overall Study|No ex vivo or in vivo response|4|||
154961776|NCT01319383|559285632|FG001|Overall Study|No ex vivo or in vivo response|0|||
154961777|NCT01319383|559285631|FG000|Overall Study|Physician Decision|3|||
154961778|NCT01319383|559285632|FG001|Overall Study|Physician Decision|0|||
154961779|NCT01319383|559285631|FG000|Overall Study|Lack of Efficacy|5|||
154961780|NCT01319383|559285632|FG001|Overall Study|Lack of Efficacy|9|||
154961781|NCT01319383|559285631|FG000|Overall Study|No in vivo response to interval doses|0|||
154961782|NCT01319383|559285632|FG001|Overall Study|No in vivo response to interval doses|1|||
154961783|NCT01531894|559285633|FG000|Overall Study|Physician Decision|8|||
154961784|NCT01531894|559285633|FG000|Overall Study|Death|1|||
154961785|NCT03600805|559285634|FG000|Overall Study|Adverse Event|2|||
154961786|NCT03600805|559285635|FG001|Overall Study|Adverse Event|1|||
154961787|NCT03600805|559285636|FG002|Overall Study|Adverse Event|1|||
154961788|NCT03600805|559285637|FG003|Overall Study|Adverse Event|7|||
154961789|NCT03600805|559285634|FG000|Overall Study|Lack of Efficacy|2|||
154961790|NCT03600805|559285635|FG001|Overall Study|Lack of Efficacy|1|||
154961791|NCT03600805|559285636|FG002|Overall Study|Lack of Efficacy|0|||
154961792|NCT03600805|559285637|FG003|Overall Study|Lack of Efficacy|0|||
154961793|NCT03600805|559285634|FG000|Overall Study|Withdrawal by Subject|1|||
154961794|NCT03600805|559285635|FG001|Overall Study|Withdrawal by Subject|0|||
155070526|NCT02003924|559686472|FG000|Open-label Phase|Lost to Follow-up|0|||
155070527|NCT02003924|559686473|FG001|Open-label Phase|Lost to Follow-up|0|||
155070528|NCT02003924|559686474|FG002|Open-label Phase|Lost to Follow-up|1|||
155070529|NCT02003924|559686472|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
155070530|NCT02003924|559686473|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
155070531|NCT02003924|559686474|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
155163326|NCT02864394|560033294|FG001|Overall Study|Lost to Follow-up|2|||
155163327|NCT02864394|560033293|FG000|Overall Study|Sponsor Decision|26|||
155163328|NCT02864394|560033294|FG001|Overall Study|Sponsor Decision|11|||
155163329|NCT02864394|560033293|FG000|Overall Study|Withdrawal by Subject|3|||
155163330|NCT02864394|560033294|FG001|Overall Study|Withdrawal by Subject|10|||
155163331|NCT04774094|560033295|FG000|Overall Study|Other|2|||
155163332|NCT04774094|560033295|FG000|Overall Study|Withdrawal by Subject|9|||
155163333|NCT04774094|560033295|FG000|Overall Study|Lost to Follow-up|7|||
155163334|NCT04774094|560033295|FG000|Overall Study|Lack of Efficacy|5|||
155163335|NCT04774094|560033295|FG000|Overall Study|Death|17|||
155163336|NCT04774094|560033295|FG000|Overall Study|Adverse Event|4|||
155163337|NCT02273596|560034928|FG000|24-Week Treatment Period|Adverse Event|3|||
155163338|NCT02273596|560034928|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
155163339|NCT02273596|560034928|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
155163340|NCT02273596|560034928|FG000|24-Week Treatment Period|Physician Decision|1|||
155163341|NCT02273596|560034928|FG000|24-Week Treatment Period|Protocol Deviation|1|||
155163342|NCT02273596|560034928|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
155163343|NCT02273596|560034928|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
155163344|NCT02273596|560034928|FG000|Extension Period|Lost to Follow-up|1|||
155163345|NCT02273596|560034928|FG000|Extension Period|Protocol Deviation|1|||
155163346|NCT02741518|560034929|FG000|Overall Study|Withdrawal by Subject|1|||
155070532|NCT02003924|559686472|FG000|Open-label Phase|Disease Progression|59|||
155070533|NCT02003924|559686473|FG001|Open-label Phase|Disease Progression|0|||
155070534|NCT02003924|559686474|FG002|Open-label Phase|Disease Progression|5|||
155070535|NCT02003924|559686472|FG000|Open-label Phase|Adverse Event|25|||
155070536|NCT02003924|559686473|FG001|Open-label Phase|Adverse Event|0|||
155070537|NCT02003924|559686474|FG002|Open-label Phase|Adverse Event|10|||
155070538|NCT02003924|559686472|FG000|Open-label Phase|Other|7|||
155070539|NCT02003924|559686473|FG001|Open-label Phase|Other|0|||
155070540|NCT02003924|559686474|FG002|Open-label Phase|Other|0|||
155070541|NCT02003924|559686472|FG000|Long-term Follow-up Phase|Death|288|||
155070542|NCT02003924|559686473|FG001|Long-term Follow-up Phase|Death|174|||
155070543|NCT02003924|559686474|FG002|Long-term Follow-up Phase|Death|4|||
155070544|NCT02003924|559686472|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
155070545|NCT02003924|559686473|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
155070546|NCT02003924|559686474|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
155070547|NCT02003924|559686472|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
155070548|NCT02003924|559686473|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
155070549|NCT02003924|559686474|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
155070550|NCT02003924|559686472|FG000|Long-term Follow-up Phase|Other|5|||
155070551|NCT02003924|559686473|FG001|Long-term Follow-up Phase|Other|2|||
155070552|NCT02003924|559686474|FG002|Long-term Follow-up Phase|Other|1|||
155070553|NCT03608033|559686475|FG000|Treatment Period|Death|0|||
155070554|NCT03608033|559686476|FG001|Treatment Period|Death|1|||
155163347|NCT02741518|560034930|FG001|Overall Study|Withdrawal by Subject|1|||
155163348|NCT04050202|560034931|FG000|Overall Study|Lost to Follow-up|2|||
155163349|NCT00001213|560034932|FG000|Overall Study|Death|18|||
155163350|NCT05782179|560034933|FG000|Overall Study|Adverse Event|0|||
155163351|NCT05782179|560034934|FG001|Overall Study|Adverse Event|0|||
155329106|NCT05601882|560639366|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
155329107|NCT05601882|560639367|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
155163352|NCT05782179|560034935|FG002|Overall Study|Adverse Event|2|||
155329108|NCT05601882|560639364|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
155329109|NCT05601882|560639365|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
155070555|NCT03608033|559686475|FG000|Treatment Period|Adverse Event|1|||
155070556|NCT03608033|559686476|FG001|Treatment Period|Adverse Event|5|||
155070557|NCT03608033|559686475|FG000|Treatment Period|Lack of Efficacy|4|||
155070558|NCT03608033|559686476|FG001|Treatment Period|Lack of Efficacy|3|||
155070559|NCT03608033|559686475|FG000|Treatment Period|Lost to Follow-up|2|||
155070560|NCT03608033|559686476|FG001|Treatment Period|Lost to Follow-up|6|||
155070561|NCT03608033|559686475|FG000|Treatment Period|Physician Decision|6|||
155070562|NCT03608033|559686476|FG001|Treatment Period|Physician Decision|10|||
155070563|NCT03608033|559686475|FG000|Treatment Period|Pregnancy|1|||
155070564|NCT03608033|559686476|FG001|Treatment Period|Pregnancy|0|||
155070565|NCT03608033|559686475|FG000|Treatment Period|Protocol Violation|1|||
155070566|NCT03608033|559686476|FG001|Treatment Period|Protocol Violation|2|||
155070567|NCT03608033|559686475|FG000|Treatment Period|Withdrawal by Subject|46|||
155070568|NCT03608033|559686476|FG001|Treatment Period|Withdrawal by Subject|45|||
155163353|NCT05782179|560034936|FG003|Overall Study|Adverse Event|0|||
155163354|NCT05782179|560034937|FG004|Overall Study|Adverse Event|0|||
155163355|NCT05782179|560034938|FG005|Overall Study|Adverse Event|0|||
155163356|NCT06170242|560034939|FG000|Overall Study|Lost to Follow-up|0|||
155163357|NCT06170242|560034940|FG001|Overall Study|Lost to Follow-up|0|||
155163358|NCT06170242|560034941|FG002|Overall Study|Lost to Follow-up|1|||
155163359|NCT06170242|560034942|FG003|Overall Study|Lost to Follow-up|1|||
155163360|NCT02754440|560034943|FG000|Overall Study|Protocol Violation|3|||
155163361|NCT02754440|560034944|FG001|Overall Study|Protocol Violation|2|||
155163362|NCT02754440|560034945|FG002|Overall Study|Protocol Violation|2|||
155163363|NCT02754440|560034946|FG003|Overall Study|Protocol Violation|6|||
155163364|NCT02754440|560034943|FG000|Overall Study|Adverse Event|3|||
155163365|NCT02754440|560034944|FG001|Overall Study|Adverse Event|1|||
155163366|NCT02754440|560034945|FG002|Overall Study|Adverse Event|0|||
155163367|NCT02754440|560034946|FG003|Overall Study|Adverse Event|9|||
155163368|NCT02754440|560034943|FG000|Overall Study|Withdrawal by Subject|0|||
155163369|NCT02754440|560034944|FG001|Overall Study|Withdrawal by Subject|0|||
155163370|NCT02754440|560034945|FG002|Overall Study|Withdrawal by Subject|0|||
155163371|NCT02754440|560034946|FG003|Overall Study|Withdrawal by Subject|1|||
155163372|NCT02754440|560034943|FG000|Overall Study|Equipment failure|0|||
155163373|NCT02754440|560034944|FG001|Overall Study|Equipment failure|5|||
155163374|NCT02754440|560034945|FG002|Overall Study|Equipment failure|5|||
155163375|NCT02754440|560034946|FG003|Overall Study|Equipment failure|7|||
155163376|NCT02754440|560034943|FG000|Overall Study|Subject issues not resulting in AE|0|||
155163377|NCT02754440|560034944|FG001|Overall Study|Subject issues not resulting in AE|0|||
155163378|NCT02754440|560034945|FG002|Overall Study|Subject issues not resulting in AE|0|||
155163379|NCT02754440|560034946|FG003|Overall Study|Subject issues not resulting in AE|12|||
155163380|NCT02560558|560034947|FG000|Overall Study|Adverse Event|1|||
155163381|NCT02560558|560034948|FG001|Overall Study|Adverse Event|0|||
155163382|NCT02560558|560034947|FG000|Overall Study|Death|0|||
155163383|NCT02560558|560034948|FG001|Overall Study|Death|2|||
155163384|NCT02560558|560034947|FG000|Overall Study|Lost to Follow-up|0|||
155163385|NCT02560558|560034948|FG001|Overall Study|Lost to Follow-up|4|||
155329110|NCT05601882|560639366|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
155329111|NCT05601882|560639367|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
155329112|NCT05601882|560639364|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
155329113|NCT05601882|560639365|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
155329114|NCT05601882|560639366|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
155329115|NCT05601882|560639367|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
155329116|NCT05601882|560639364|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
155329117|NCT05601882|560639365|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
155329118|NCT05601882|560639366|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
155329119|NCT05601882|560639367|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
155329120|NCT03834740|560639368|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
155329121|NCT03834740|560639369|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
155329122|NCT03834740|560639370|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
155329123|NCT01208974|560639371|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
155329124|NCT01208974|560639372|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
155329125|NCT01208974|560639373|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
155329126|NCT01208974|560639374|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
155329127|NCT01208974|560639371|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
155329128|NCT01208974|560639372|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
155329129|NCT01208974|560639373|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
155329130|NCT01208974|560639374|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
155329131|NCT01208974|560639371|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
155329132|NCT01208974|560639372|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
155329133|NCT01208974|560639373|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
155329134|NCT01208974|560639374|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
155329135|NCT03691493|560639375|FG000|Overall Study|Withdrawal by Subject|1|||
155329136|NCT04213807|560640778|FG000|Overall Study|Physician Decision|0|||
155329137|NCT04213807|560640779|FG001|Overall Study|Physician Decision|0|||
155329138|NCT04213807|560640780|FG002|Overall Study|Physician Decision|1|||
155163386|NCT02560558|560034947|FG000|Overall Study|Protocol Violation|3|||
155163387|NCT02560558|560034948|FG001|Overall Study|Protocol Violation|0|||
155329139|NCT03442777|560640781|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
155329140|NCT03442777|560640782|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
154961795|NCT03600805|559285636|FG002|Overall Study|Withdrawal by Subject|0|||
155163388|NCT02560558|560034947|FG000|Overall Study|Withdrawal by Subject|3|||
155163389|NCT02560558|560034948|FG001|Overall Study|Withdrawal by Subject|0|||
155163390|NCT01263197|560034959|FG000|First Intervention (Period 1)|Adverse Event|0|||
155163391|NCT01263197|560034960|FG001|First Intervention (Period 1)|Adverse Event|0|||
155163392|NCT01263197|560034961|FG002|First Intervention (Period 1)|Adverse Event|0|||
155163393|NCT01263197|560034962|FG003|First Intervention (Period 1)|Adverse Event|0|||
155163394|NCT01263197|560034963|FG004|First Intervention (Period 1)|Adverse Event|0|||
155329141|NCT03442777|560640783|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
155329142|NCT02866942|560640784|FG000|Overall Study|Invalid consent|1|||
155329143|NCT03418922|560640786|FG000|Overall Study|Withdrawal by Subject|0|||
155329144|NCT03418922|560640787|FG001|Overall Study|Withdrawal by Subject|2|||
155329145|NCT03418922|560640786|FG000|Overall Study|Adverse Event|2|||
155329146|NCT03418922|560640787|FG001|Overall Study|Adverse Event|2|||
155329147|NCT03418922|560640786|FG000|Overall Study|Death|0|||
155329148|NCT03418922|560640787|FG001|Overall Study|Death|1|||
155329149|NCT03418922|560640786|FG000|Overall Study|Physician Decision|0|||
155329150|NCT03418922|560640787|FG001|Overall Study|Physician Decision|1|||
155329151|NCT03577106|560640788|FG000|Overall Study|Withdrawal by Subject|3|||
155329152|NCT00754065|560640791|FG000|Overall Study|Never received treatment|12|||
155329153|NCT00754065|560640792|FG001|Overall Study|Never received treatment|2|||
155329154|NCT00754065|560640791|FG000|Overall Study|Adverse Event|19|||
155329155|NCT00754065|560640792|FG001|Overall Study|Adverse Event|25|||
155329156|NCT00754065|560640791|FG000|Overall Study|Lost to Follow-up|7|||
155329157|NCT00754065|560640792|FG001|Overall Study|Lost to Follow-up|11|||
155329158|NCT00754065|560640791|FG000|Overall Study|Protocol Violation|12|||
155329159|NCT00754065|560640792|FG001|Overall Study|Protocol Violation|10|||
155329160|NCT00754065|560640791|FG000|Overall Study|Withdrawal by Subject|4|||
155329161|NCT00754065|560640792|FG001|Overall Study|Withdrawal by Subject|5|||
155329162|NCT00754065|560640791|FG000|Overall Study|Pregnancy|6|||
155329163|NCT00754065|560640792|FG001|Overall Study|Pregnancy|0|||
155329164|NCT00754065|560640791|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
155329165|NCT00754065|560640792|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
155329166|NCT01500200|560640795|FG000|Stage 1|Adverse Event|1|||
155329167|NCT01500200|560640796|FG001|Stage 1|Adverse Event|4|||
155329168|NCT01500200|560640797|FG002|Stage 1|Adverse Event|5|||
155329169|NCT01500200|560640798|FG003|Stage 1|Adverse Event|0|||
155329170|NCT01500200|560640799|FG004|Stage 1|Adverse Event|0|||
155329171|NCT01500200|560640800|FG005|Stage 1|Adverse Event|0|||
155329172|NCT01500200|560640795|FG000|Stage 1|Lost to Follow-up|2|||
155329173|NCT01500200|560640796|FG001|Stage 1|Lost to Follow-up|2|||
155329174|NCT01500200|560640797|FG002|Stage 1|Lost to Follow-up|1|||
155329175|NCT01500200|560640798|FG003|Stage 1|Lost to Follow-up|0|||
155329176|NCT01500200|560640799|FG004|Stage 1|Lost to Follow-up|0|||
155329177|NCT01500200|560640800|FG005|Stage 1|Lost to Follow-up|0|||
155329178|NCT01500200|560640795|FG000|Stage 1|Withdrawal by Subject|3|||
155329179|NCT01500200|560640796|FG001|Stage 1|Withdrawal by Subject|0|||
155329180|NCT01500200|560640797|FG002|Stage 1|Withdrawal by Subject|0|||
155329181|NCT01500200|560640798|FG003|Stage 1|Withdrawal by Subject|0|||
155329182|NCT01500200|560640799|FG004|Stage 1|Withdrawal by Subject|0|||
155329183|NCT01500200|560640800|FG005|Stage 1|Withdrawal by Subject|0|||
155329184|NCT01500200|560640795|FG000|Stage 1|Noncompliance with Study Drug|1|||
155329185|NCT01500200|560640796|FG001|Stage 1|Noncompliance with Study Drug|0|||
155329186|NCT01500200|560640797|FG002|Stage 1|Noncompliance with Study Drug|0|||
155329187|NCT01500200|560640798|FG003|Stage 1|Noncompliance with Study Drug|0|||
155329188|NCT01500200|560640799|FG004|Stage 1|Noncompliance with Study Drug|0|||
155329189|NCT01500200|560640800|FG005|Stage 1|Noncompliance with Study Drug|0|||
155329190|NCT01500200|560640795|FG000|Stage 1|Physician Decision|1|||
155070569|NCT03608033|559686475|FG000|Treatment Period|Study terminated by sponsor|82|||
155070570|NCT03608033|559686476|FG001|Treatment Period|Study terminated by sponsor|68|||
155070571|NCT03608033|559686475|FG000|Treatment Period|Site Terminated by Sponsor|1|||
155070572|NCT03608033|559686476|FG001|Treatment Period|Site Terminated by Sponsor|0|||
155070573|NCT03608033|559686475|FG000|Open-Label Period: OMS721|Adverse Event|1|||
155070574|NCT03608033|559686476|FG001|Open-Label Period: OMS721|Adverse Event|0|||
155070575|NCT03608033|559686475|FG000|Open-Label Period: OMS721|Lack of Efficacy|1|||
155070576|NCT03608033|559686476|FG001|Open-Label Period: OMS721|Lack of Efficacy|0|||
155070577|NCT03608033|559686475|FG000|Open-Label Period: OMS721|Lost to Follow-up|1|||
155070578|NCT03608033|559686476|FG001|Open-Label Period: OMS721|Lost to Follow-up|0|||
155070579|NCT03608033|559686475|FG000|Open-Label Period: OMS721|Study Terminated By Sponsor|11|||
155070580|NCT03608033|559686476|FG001|Open-Label Period: OMS721|Study Terminated By Sponsor|0|||
155070581|NCT03608033|559686475|FG000|Open-Label Period: OMS721|Withdrawal by Subject|5|||
155070582|NCT03608033|559686476|FG001|Open-Label Period: OMS721|Withdrawal by Subject|0|||
155070583|NCT03483012|559686477|FG000|Overall Study|Lack of Efficacy|6|||
155070584|NCT02360579|559686478|FG000|Initial|Death|16|||
155070585|NCT02360579|559686479|FG001|Initial|Death|49|||
155070586|NCT02360579|559686480|FG002|Initial|Death|0|||
155070587|NCT02360579|559686481|FG003|Initial|Death|71|||
155070588|NCT02360579|559686478|FG000|Initial|Lost to Follow-up|0|||
155070589|NCT02360579|559686479|FG001|Initial|Lost to Follow-up|4|||
155070590|NCT02360579|559686480|FG002|Initial|Lost to Follow-up|0|||
155070591|NCT02360579|559686481|FG003|Initial|Lost to Follow-up|1|||
155329191|NCT01500200|560640796|FG001|Stage 1|Physician Decision|0|||
155329192|NCT01500200|560640797|FG002|Stage 1|Physician Decision|0|||
155329193|NCT01500200|560640798|FG003|Stage 1|Physician Decision|0|||
155329194|NCT01500200|560640799|FG004|Stage 1|Physician Decision|0|||
155329195|NCT01500200|560640800|FG005|Stage 1|Physician Decision|0|||
155329196|NCT01500200|560640795|FG000|Stage 2|Adverse Event|0|||
155070592|NCT02360579|559686478|FG000|Initial|Withdrawal by Subject|0|||
155070593|NCT02360579|559686479|FG001|Initial|Withdrawal by Subject|0|||
155070594|NCT02360579|559686480|FG002|Initial|Withdrawal by Subject|0|||
155070595|NCT02360579|559686481|FG003|Initial|Withdrawal by Subject|3|||
155070596|NCT02360579|559686478|FG000|Initial|Other|7|||
155070597|NCT02360579|559686479|FG001|Initial|Other|0|||
155070598|NCT02360579|559686480|FG002|Initial|Other|0|||
155070599|NCT02360579|559686481|FG003|Initial|Other|0|||
155070600|NCT02360579|559686478|FG000|Initial|Did not receive TIL|8|||
155070601|NCT02360579|559686479|FG001|Initial|Did not receive TIL|11|||
155070602|NCT02360579|559686480|FG002|Initial|Did not receive TIL|0|||
155329197|NCT01500200|560640796|FG001|Stage 2|Adverse Event|0|||
155329198|NCT01500200|560640797|FG002|Stage 2|Adverse Event|0|||
155329199|NCT01500200|560640798|FG003|Stage 2|Adverse Event|0|||
155329200|NCT01500200|560640799|FG004|Stage 2|Adverse Event|5|||
155329201|NCT01500200|560640800|FG005|Stage 2|Adverse Event|4|||
155329202|NCT00623194|560640801|FG000|Overall Study|Lack of Efficacy|1|||
155329203|NCT00623194|560640801|FG000|Overall Study|Protocol Violation|3|||
155329204|NCT00623194|560640801|FG000|Overall Study|Unclassified|1|||
155329205|NCT01952366|560640802|FG000|Overall Study|Death|22|||
155329206|NCT01952366|560640802|FG000|Overall Study|Withdrawal by Subject|9|||
155329207|NCT04860505|560640803|FG000|Overall Study|Lost to Follow-up|2|||
155329208|NCT01988402|560640804|FG000|Overall Study|Adverse Event|1|||
155329209|NCT01988402|560640805|FG001|Overall Study|Adverse Event|2|||
155070603|NCT02360579|559686481|FG003|Initial|Did not receive TIL|22|||
155329210|NCT01988402|560640804|FG000|Overall Study|Withdrawal by Subject|1|||
155329211|NCT01988402|560640805|FG001|Overall Study|Withdrawal by Subject|0|||
155329212|NCT01759862|560640809|FG000|Overall Study|Physician Decision|3|||
155329213|NCT01759862|560640810|FG001|Overall Study|Physician Decision|1|||
155329214|NCT01759862|560640809|FG000|Overall Study|Adverse Event|0|||
155329215|NCT01759862|560640810|FG001|Overall Study|Adverse Event|1|||
155329216|NCT04060212|560640811|FG000|Overall Study|Withdrawal by Subject|7|||
155329217|NCT01499849|560640812|FG000|Overall Study|Adverse Event|28|||
155329218|NCT01499849|560640813|FG001|Overall Study|Adverse Event|32|||
155329219|NCT01499849|560640812|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
155329220|NCT01499849|560640813|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
155329221|NCT01499849|560640812|FG000|Overall Study|Withdrawal by Subject|43|||
155329222|NCT01499849|560640813|FG001|Overall Study|Withdrawal by Subject|43|||
155329223|NCT01499849|560640812|FG000|Overall Study|Death|5|||
155329224|NCT01499849|560640813|FG001|Overall Study|Death|7|||
155329225|NCT01499849|560640812|FG000|Overall Study|Disease Progression|11|||
155329226|NCT01499849|560640813|FG001|Overall Study|Disease Progression|10|||
155329227|NCT01499849|560640812|FG000|Overall Study|Protocol Violation|11|||
155329228|NCT01499849|560640813|FG001|Overall Study|Protocol Violation|11|||
155329229|NCT01499849|560640812|FG000|Overall Study|Physician Decision|20|||
155329230|NCT01499849|560640813|FG001|Overall Study|Physician Decision|19|||
155329231|NCT01499849|560640812|FG000|Overall Study|Lack of Efficacy|3|||
155329232|NCT01499849|560640813|FG001|Overall Study|Lack of Efficacy|4|||
155329233|NCT01499849|560640812|FG000|Overall Study|Lost to Follow-up|6|||
155329234|NCT01499849|560640813|FG001|Overall Study|Lost to Follow-up|3|||
155329235|NCT01499849|560640812|FG000|Overall Study|Other Reasons|27|||
155329236|NCT01499849|560640813|FG001|Overall Study|Other Reasons|30|||
155329237|NCT00622700|560640814|FG000|Core Treatment Period|Randomized but Not Treated|0|||
155329238|NCT00622700|560640815|FG001|Core Treatment Period|Randomized but Not Treated|2|||
155329239|NCT00622700|560640816|FG002|Core Treatment Period|Randomized but Not Treated|2|||
155329240|NCT00622700|560640817|FG003|Core Treatment Period|Randomized but Not Treated|0|||
155329241|NCT00622700|560640818|FG004|Core Treatment Period|Randomized but Not Treated|0|||
155329242|NCT00622700|560640819|FG005|Core Treatment Period|Randomized but Not Treated|0|||
155329243|NCT00622700|560640820|FG006|Core Treatment Period|Randomized but Not Treated|0|||
155329244|NCT00622700|560640814|FG000|Core Treatment Period|Adverse Event|18|||
155329245|NCT00622700|560640815|FG001|Core Treatment Period|Adverse Event|25|||
155329246|NCT00622700|560640816|FG002|Core Treatment Period|Adverse Event|18|||
155329247|NCT00622700|560640817|FG003|Core Treatment Period|Adverse Event|0|||
155329248|NCT00622700|560640818|FG004|Core Treatment Period|Adverse Event|0|||
155329249|NCT00622700|560640819|FG005|Core Treatment Period|Adverse Event|0|||
155329250|NCT00622700|560640820|FG006|Core Treatment Period|Adverse Event|0|||
155329251|NCT00622700|560640814|FG000|Core Treatment Period|Lack of Efficacy|19|||
155329252|NCT00622700|560640815|FG001|Core Treatment Period|Lack of Efficacy|6|||
155070604|NCT02360579|559686478|FG000|Retreatment|Death|0|||
155070605|NCT02360579|559686479|FG001|Retreatment|Death|0|||
155329253|NCT00622700|560640816|FG002|Core Treatment Period|Lack of Efficacy|12|||
155329254|NCT00622700|560640817|FG003|Core Treatment Period|Lack of Efficacy|0|||
155329255|NCT00622700|560640818|FG004|Core Treatment Period|Lack of Efficacy|0|||
155329256|NCT00622700|560640819|FG005|Core Treatment Period|Lack of Efficacy|0|||
155070606|NCT02360579|559686480|FG002|Retreatment|Death|11|||
155070607|NCT02360579|559686481|FG003|Retreatment|Death|0|||
155070608|NCT00143507|559688067|FG000|Overall Study|Death|572|||
155070609|NCT00143507|559688068|FG001|Overall Study|Death|547|||
155070610|NCT00143507|559688067|FG000|Overall Study|Withdrawal by Subject|114|||
155070611|NCT00143507|559688068|FG001|Overall Study|Withdrawal by Subject|102|||
155329257|NCT00622700|560640820|FG006|Core Treatment Period|Lack of Efficacy|0|||
155329258|NCT00622700|560640814|FG000|Core Treatment Period|Lost to Follow-up|1|||
155329259|NCT00622700|560640815|FG001|Core Treatment Period|Lost to Follow-up|1|||
155329260|NCT00622700|560640816|FG002|Core Treatment Period|Lost to Follow-up|1|||
155329261|NCT00622700|560640817|FG003|Core Treatment Period|Lost to Follow-up|0|||
155329262|NCT00622700|560640818|FG004|Core Treatment Period|Lost to Follow-up|0|||
155329263|NCT00622700|560640819|FG005|Core Treatment Period|Lost to Follow-up|0|||
155329264|NCT00622700|560640820|FG006|Core Treatment Period|Lost to Follow-up|0|||
155329265|NCT00622700|560640814|FG000|Core Treatment Period|Death|1|||
155329266|NCT00622700|560640815|FG001|Core Treatment Period|Death|0|||
155329267|NCT00622700|560640816|FG002|Core Treatment Period|Death|0|||
155329268|NCT00622700|560640817|FG003|Core Treatment Period|Death|0|||
155329269|NCT00622700|560640818|FG004|Core Treatment Period|Death|0|||
155329270|NCT00622700|560640819|FG005|Core Treatment Period|Death|0|||
155329271|NCT00622700|560640820|FG006|Core Treatment Period|Death|0|||
155329272|NCT00622700|560640814|FG000|Core Treatment Period|Progressive Disease|3|||
155329273|NCT00622700|560640815|FG001|Core Treatment Period|Progressive Disease|1|||
155329274|NCT00622700|560640816|FG002|Core Treatment Period|Progressive Disease|0|||
155329275|NCT00622700|560640817|FG003|Core Treatment Period|Progressive Disease|0|||
155329276|NCT00622700|560640818|FG004|Core Treatment Period|Progressive Disease|0|||
155329277|NCT00622700|560640819|FG005|Core Treatment Period|Progressive Disease|0|||
155329278|NCT00622700|560640820|FG006|Core Treatment Period|Progressive Disease|0|||
155329279|NCT00622700|560640814|FG000|Core Treatment Period|Withdrawal by Subject|12|||
155329280|NCT00622700|560640815|FG001|Core Treatment Period|Withdrawal by Subject|18|||
155329281|NCT00622700|560640816|FG002|Core Treatment Period|Withdrawal by Subject|15|||
155329282|NCT00622700|560640817|FG003|Core Treatment Period|Withdrawal by Subject|0|||
155329283|NCT00622700|560640818|FG004|Core Treatment Period|Withdrawal by Subject|0|||
155329284|NCT00622700|560640819|FG005|Core Treatment Period|Withdrawal by Subject|0|||
155329285|NCT00622700|560640820|FG006|Core Treatment Period|Withdrawal by Subject|0|||
155329286|NCT00622700|560640814|FG000|Core Treatment Period|Other than specified above|2|||
155329287|NCT00622700|560640815|FG001|Core Treatment Period|Other than specified above|2|||
155329288|NCT00622700|560640816|FG002|Core Treatment Period|Other than specified above|5|||
155329289|NCT00622700|560640817|FG003|Core Treatment Period|Other than specified above|0|||
155329290|NCT00622700|560640818|FG004|Core Treatment Period|Other than specified above|0|||
155329291|NCT00622700|560640819|FG005|Core Treatment Period|Other than specified above|0|||
155329292|NCT00622700|560640820|FG006|Core Treatment Period|Other than specified above|0|||
155329293|NCT00622700|560640814|FG000|Extension Treatment Period|Adverse Event|0|||
155329294|NCT00622700|560640815|FG001|Extension Treatment Period|Adverse Event|0|||
155329295|NCT00622700|560640816|FG002|Extension Treatment Period|Adverse Event|0|||
155329296|NCT00622700|560640817|FG003|Extension Treatment Period|Adverse Event|5|||
155329297|NCT00622700|560640818|FG004|Extension Treatment Period|Adverse Event|9|||
155329298|NCT00622700|560640819|FG005|Extension Treatment Period|Adverse Event|6|||
155329299|NCT00622700|560640820|FG006|Extension Treatment Period|Adverse Event|8|||
155329300|NCT00622700|560640814|FG000|Extension Treatment Period|Lack of Efficacy|0|||
155329301|NCT00622700|560640815|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155070612|NCT00143507|559688067|FG000|Overall Study|Lost to Follow-up|1|||
155070613|NCT00143507|559688068|FG001|Overall Study|Lost to Follow-up|0|||
155070614|NCT00143507|559688067|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
155070615|NCT00143507|559688068|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
155070616|NCT00690898|559688069|FG000|SCREENING|Screen failure|18|||
155070617|NCT00690898|559688069|FG000|TREATMENT|Adverse Event|3|||
155070618|NCT00690898|559688069|FG000|TREATMENT|Lack of Efficacy|18|||
155070619|NCT00690898|559688069|FG000|TREATMENT|Withdrawal by Subject|4|||
155070620|NCT00690898|559688069|FG000|TREATMENT|Other (not otherwise specified)|1|||
155070621|NCT05977868|559688070|FG000|Overall Study|Withdrawal by Subject|1|||
155070622|NCT05977868|559688071|FG001|Overall Study|Withdrawal by Subject|2|||
155329302|NCT00622700|560640816|FG002|Extension Treatment Period|Lack of Efficacy|0|||
155329303|NCT00622700|560640817|FG003|Extension Treatment Period|Lack of Efficacy|2|||
155329304|NCT00622700|560640818|FG004|Extension Treatment Period|Lack of Efficacy|8|||
155329305|NCT00622700|560640819|FG005|Extension Treatment Period|Lack of Efficacy|1|||
155329306|NCT00622700|560640820|FG006|Extension Treatment Period|Lack of Efficacy|9|||
155329307|NCT00622700|560640814|FG000|Extension Treatment Period|Protocol Violation|0|||
155329308|NCT00622700|560640815|FG001|Extension Treatment Period|Protocol Violation|0|||
155329309|NCT00622700|560640816|FG002|Extension Treatment Period|Protocol Violation|0|||
155329310|NCT00622700|560640817|FG003|Extension Treatment Period|Protocol Violation|0|||
155329311|NCT00622700|560640818|FG004|Extension Treatment Period|Protocol Violation|0|||
155070623|NCT05977868|559688070|FG000|Overall Study|Transitioned to comfort care|1|||
155070624|NCT05977868|559688071|FG001|Overall Study|Transitioned to comfort care|0|||
155070625|NCT00876395|559688072|FG000|Overall Study|Untreated|8|||
155329312|NCT00622700|560640819|FG005|Extension Treatment Period|Protocol Violation|2|||
155329313|NCT00622700|560640820|FG006|Extension Treatment Period|Protocol Violation|0|||
155070626|NCT00876395|559688073|FG001|Overall Study|Untreated|1|||
155070627|NCT00876395|559688072|FG000|Overall Study|Adverse Event|63|||
155070628|NCT00876395|559688073|FG001|Overall Study|Adverse Event|11|||
155070629|NCT00876395|559688072|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155070630|NCT00876395|559688073|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155070631|NCT00876395|559688072|FG000|Overall Study|Disease progression|259|||
155070632|NCT00876395|559688073|FG001|Overall Study|Disease progression|162|||
155070633|NCT00876395|559688072|FG000|Overall Study|New cancer therapy|25|||
155070634|NCT00876395|559688073|FG001|Overall Study|New cancer therapy|7|||
155070635|NCT00876395|559688072|FG000|Overall Study|Protocol Violation|5|||
155070636|NCT00876395|559688073|FG001|Overall Study|Protocol Violation|2|||
155070637|NCT00876395|559688072|FG000|Overall Study|Withdrawal by Subject|66|||
155070638|NCT00876395|559688073|FG001|Overall Study|Withdrawal by Subject|33|||
155070639|NCT00876395|559688072|FG000|Overall Study|Lost to Follow-up|2|||
155070640|NCT00876395|559688073|FG001|Overall Study|Lost to Follow-up|0|||
155070641|NCT00876395|559688072|FG000|Overall Study|Administrative problems|39|||
155070642|NCT00876395|559688073|FG001|Overall Study|Administrative problems|23|||
155070643|NCT00876395|559688072|FG000|Overall Study|Death|12|||
155070644|NCT00876395|559688073|FG001|Overall Study|Death|0|||
155070645|NCT00662259|559688078|FG000|Overall Study|Adverse Event|2|||
155070646|NCT00662259|559688079|FG001|Overall Study|Adverse Event|0|||
155070647|NCT03915067|559688081|FG000|Overall Study|Adverse Event|0|||
155070648|NCT03915067|559688082|FG001|Overall Study|Adverse Event|0|||
155070649|NCT03915067|559688083|FG002|Overall Study|Adverse Event|1|||
155070650|NCT03915067|559688081|FG000|Overall Study|Withdrawal by Subject|4|||
155070651|NCT03915067|559688082|FG001|Overall Study|Withdrawal by Subject|3|||
155070652|NCT03915067|559688083|FG002|Overall Study|Withdrawal by Subject|0|||
155070653|NCT03915067|559688081|FG000|Overall Study|Lost to Follow-up|3|||
155070654|NCT03915067|559688082|FG001|Overall Study|Lost to Follow-up|2|||
155070655|NCT03915067|559688083|FG002|Overall Study|Lost to Follow-up|0|||
155070656|NCT03915067|559688081|FG000|Overall Study|Protocol Deviation|0|||
155070657|NCT03915067|559688082|FG001|Overall Study|Protocol Deviation|0|||
155070658|NCT03915067|559688083|FG002|Overall Study|Protocol Deviation|1|||
155070659|NCT03915067|559688081|FG000|Overall Study|Covid-19 Related Issues|2|||
155163395|NCT01263197|560034964|FG005|First Intervention (Period 1)|Adverse Event|1|||
155070660|NCT03915067|559688082|FG001|Overall Study|Covid-19 Related Issues|4|||
155070661|NCT03915067|559688083|FG002|Overall Study|Covid-19 Related Issues|4|||
155070662|NCT03915067|559688081|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
155070663|NCT03915067|559688082|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
155070664|NCT03915067|559688083|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
155070665|NCT02693418|559688084|FG000|Overall Study|Lost to Follow-up|1|||
155070666|NCT02693418|559688085|FG001|Overall Study|Lost to Follow-up|2|||
155070667|NCT02693418|559688086|FG002|Overall Study|Lost to Follow-up|0|||
155070668|NCT02693418|559688087|FG003|Overall Study|Lost to Follow-up|0|||
155070669|NCT02693418|559688088|FG004|Overall Study|Lost to Follow-up|0|||
155163396|NCT01263197|560034959|FG000|Washout Period 1|Protocol Violation|0|||
155163397|NCT01263197|560034960|FG001|Washout Period 1|Protocol Violation|0|||
155163398|NCT01263197|560034961|FG002|Washout Period 1|Protocol Violation|0|||
155163399|NCT01263197|560034962|FG003|Washout Period 1|Protocol Violation|0|||
155163400|NCT01263197|560034963|FG004|Washout Period 1|Protocol Violation|1|||
155163401|NCT01263197|560034964|FG005|Washout Period 1|Protocol Violation|0|||
155163402|NCT01263197|560034959|FG000|Washout Period 2|Physician Decision|0|||
155163403|NCT01263197|560034960|FG001|Washout Period 2|Physician Decision|0|||
155163404|NCT01263197|560034961|FG002|Washout Period 2|Physician Decision|0|||
155163405|NCT01263197|560034962|FG003|Washout Period 2|Physician Decision|0|||
155163406|NCT01263197|560034963|FG004|Washout Period 2|Physician Decision|0|||
155163407|NCT01263197|560034964|FG005|Washout Period 2|Physician Decision|1|||
155163408|NCT01263197|560034959|FG000|Washout Period 2|Protocol Violation|0|||
155163409|NCT01263197|560034960|FG001|Washout Period 2|Protocol Violation|0|||
155163410|NCT01263197|560034961|FG002|Washout Period 2|Protocol Violation|0|||
155163411|NCT01263197|560034962|FG003|Washout Period 2|Protocol Violation|1|||
155163412|NCT01263197|560034963|FG004|Washout Period 2|Protocol Violation|0|||
155163413|NCT01263197|560034964|FG005|Washout Period 2|Protocol Violation|0|||
155163414|NCT01263197|560034959|FG000|Third Intervention (Period 3)|Adverse Event|0|||
155163415|NCT01263197|560034960|FG001|Third Intervention (Period 3)|Adverse Event|1|||
155163416|NCT01263197|560034961|FG002|Third Intervention (Period 3)|Adverse Event|0|||
155163417|NCT01263197|560034962|FG003|Third Intervention (Period 3)|Adverse Event|0|||
155163418|NCT01263197|560034963|FG004|Third Intervention (Period 3)|Adverse Event|0|||
155070670|NCT02693418|559688084|FG000|Overall Study|Menses during study period|0|||
155070671|NCT02693418|559688085|FG001|Overall Study|Menses during study period|0|||
155163419|NCT01263197|560034964|FG005|Third Intervention (Period 3)|Adverse Event|0|||
155329314|NCT00622700|560640814|FG000|Extension Treatment Period|Lost to Follow-up|0|||
155329315|NCT00622700|560640815|FG001|Extension Treatment Period|Lost to Follow-up|0|||
155329316|NCT00622700|560640816|FG002|Extension Treatment Period|Lost to Follow-up|0|||
155329317|NCT00622700|560640817|FG003|Extension Treatment Period|Lost to Follow-up|0|||
155329318|NCT00622700|560640818|FG004|Extension Treatment Period|Lost to Follow-up|1|||
155329319|NCT00622700|560640819|FG005|Extension Treatment Period|Lost to Follow-up|0|||
155329320|NCT00622700|560640820|FG006|Extension Treatment Period|Lost to Follow-up|0|||
155329321|NCT00622700|560640814|FG000|Extension Treatment Period|Progressive Disease|0|||
155329322|NCT00622700|560640815|FG001|Extension Treatment Period|Progressive Disease|0|||
155329323|NCT00622700|560640816|FG002|Extension Treatment Period|Progressive Disease|0|||
155329324|NCT00622700|560640817|FG003|Extension Treatment Period|Progressive Disease|1|||
155329325|NCT00622700|560640818|FG004|Extension Treatment Period|Progressive Disease|2|||
155329326|NCT00622700|560640819|FG005|Extension Treatment Period|Progressive Disease|0|||
155329327|NCT00622700|560640820|FG006|Extension Treatment Period|Progressive Disease|2|||
155329328|NCT00622700|560640814|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
155329329|NCT00622700|560640815|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155329330|NCT00622700|560640816|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155329331|NCT00622700|560640817|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
155329332|NCT00622700|560640818|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
155329333|NCT00622700|560640819|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
155329334|NCT00622700|560640820|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
155329335|NCT00622700|560640814|FG000|Extension Treatment Period|Missing|0|||
155329336|NCT00622700|560640815|FG001|Extension Treatment Period|Missing|0|||
155329337|NCT00622700|560640816|FG002|Extension Treatment Period|Missing|0|||
155329338|NCT00622700|560640817|FG003|Extension Treatment Period|Missing|2|||
155329339|NCT00622700|560640818|FG004|Extension Treatment Period|Missing|3|||
155329340|NCT00622700|560640819|FG005|Extension Treatment Period|Missing|1|||
155329341|NCT00622700|560640820|FG006|Extension Treatment Period|Missing|0|||
155329342|NCT00622700|560640814|FG000|Extension Treatment Period|Other than specified above|0|||
155329343|NCT00622700|560640815|FG001|Extension Treatment Period|Other than specified above|0|||
155329344|NCT00622700|560640816|FG002|Extension Treatment Period|Other than specified above|0|||
155329345|NCT00622700|560640817|FG003|Extension Treatment Period|Other than specified above|0|||
155329346|NCT00622700|560640818|FG004|Extension Treatment Period|Other than specified above|0|||
155329347|NCT00622700|560640819|FG005|Extension Treatment Period|Other than specified above|1|||
155329348|NCT00622700|560640820|FG006|Extension Treatment Period|Other than specified above|1|||
155329349|NCT02646618|560640823|FG000|Overall Study|Lost to Follow-up|10|||
155329350|NCT02646618|560640824|FG001|Overall Study|Lost to Follow-up|14|||
155329351|NCT04035447|560640825|FG000|Treatment Period|Lost to Follow-up|6|||
155329352|NCT04035447|560640826|FG001|Treatment Period|Lost to Follow-up|5|||
155329353|NCT04035447|560640825|FG000|Treatment Period|Physician Decision|0|||
155329354|NCT04035447|560640826|FG001|Treatment Period|Physician Decision|2|||
155329355|NCT00274261|560640827|FG000|Overall Study|Adverse Event|19|||
155163420|NCT01189032|560034965|FG000|Overall Study|Adverse Event|1|||
155329356|NCT00274261|560640828|FG001|Overall Study|Adverse Event|11|||
155329357|NCT00274261|560640827|FG000|Overall Study|Pregnancy|114|||
155329358|NCT00274261|560640828|FG001|Overall Study|Pregnancy|83|||
155329359|NCT00274261|560640827|FG000|Overall Study|Withdrawal by Subject|179|||
155329360|NCT00274261|560640828|FG001|Overall Study|Withdrawal by Subject|126|||
155329361|NCT00274261|560640827|FG000|Overall Study|Protocol Violation|71|||
155329362|NCT00274261|560640828|FG001|Overall Study|Protocol Violation|42|||
155329363|NCT00274261|560640827|FG000|Overall Study|Lost to Follow-up|106|||
155329364|NCT00274261|560640828|FG001|Overall Study|Lost to Follow-up|75|||
155329365|NCT03500549|560640829|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
155329366|NCT03500549|560640830|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
155329367|NCT03500549|560640829|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
155329368|NCT03500549|560640830|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
155329369|NCT05509816|560640831|FG000|Overall Study|Lost to Follow-up|1|||
155329370|NCT00589875|560640835|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
155329371|NCT00589875|560640835|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
155329372|NCT02016872|560640838|FG000|Overall Study|Withdrawal by Subject|10|||
155329373|NCT02016872|560640838|FG000|Overall Study|Death Progression|2|||
155329374|NCT02016872|560640838|FG000|Overall Study|No FMISO scan|1|||
155329375|NCT02016872|560640838|FG000|Overall Study|Ineligible|2|||
155329376|NCT03222609|560640841|FG000|Overall Study|Withdrew consent|2|||
155329377|NCT03222609|560640842|FG001|Overall Study|Withdrew consent|3|||
155329378|NCT03222609|560640843|FG002|Overall Study|Withdrew consent|4|||
155329379|NCT03222609|560640844|FG003|Overall Study|Withdrew consent|2|||
155329380|NCT03222609|560640841|FG000|Overall Study|Lost to Follow-up|1|||
155329381|NCT03222609|560640842|FG001|Overall Study|Lost to Follow-up|0|||
155329382|NCT03222609|560640843|FG002|Overall Study|Lost to Follow-up|0|||
155329383|NCT03222609|560640844|FG003|Overall Study|Lost to Follow-up|0|||
155329384|NCT03222609|560640841|FG000|Overall Study|Death|16|||
155329385|NCT03222609|560640842|FG001|Overall Study|Death|13|||
155329386|NCT03222609|560640843|FG002|Overall Study|Death|9|||
155329387|NCT03222609|560640844|FG003|Overall Study|Death|6|||
155329388|NCT03222609|560640841|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
155329389|NCT03222609|560640842|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
155329390|NCT03222609|560640843|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
155329391|NCT03222609|560640844|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
155329392|NCT03789110|560640845|FG000|Overall Study|Adverse Event|2|||
155329393|NCT03789110|560640845|FG000|Overall Study|Physician Decision|1|||
155329394|NCT03789110|560640845|FG000|Overall Study|Withdrawal by Subject|2|||
155329395|NCT03789110|560640845|FG000|Overall Study|Lack of Efficacy|22|||
155329396|NCT03789110|560640845|FG000|Overall Study|still on treatment|3|||
155329397|NCT00545545|560640846|FG000|Overall Study|Progressive Neoplastic Disease|1|||
155329398|NCT00545545|560640847|FG001|Overall Study|Progressive Neoplastic Disease|5|||
155329399|NCT00545545|560640848|FG002|Overall Study|Progressive Neoplastic Disease|0|||
155329400|NCT00545545|560640849|FG003|Overall Study|Progressive Neoplastic Disease|4|||
155329401|NCT00545545|560640850|FG004|Overall Study|Progressive Neoplastic Disease|8|||
155329402|NCT00545545|560640851|FG005|Overall Study|Progressive Neoplastic Disease|7|||
155329403|NCT00545545|560640846|FG000|Overall Study|Withdrawal by Subject|0|||
155329404|NCT00545545|560640847|FG001|Overall Study|Withdrawal by Subject|1|||
155329405|NCT00545545|560640848|FG002|Overall Study|Withdrawal by Subject|0|||
155329406|NCT00545545|560640849|FG003|Overall Study|Withdrawal by Subject|0|||
155329407|NCT00545545|560640850|FG004|Overall Study|Withdrawal by Subject|0|||
155329408|NCT00545545|560640851|FG005|Overall Study|Withdrawal by Subject|0|||
155329409|NCT00545545|560640846|FG000|Overall Study|Physician Decision|1|||
155329410|NCT00545545|560640847|FG001|Overall Study|Physician Decision|0|||
155329411|NCT00545545|560640848|FG002|Overall Study|Physician Decision|0|||
155329412|NCT00545545|560640849|FG003|Overall Study|Physician Decision|0|||
155329413|NCT00545545|560640850|FG004|Overall Study|Physician Decision|0|||
155329414|NCT00545545|560640851|FG005|Overall Study|Physician Decision|1|||
155329415|NCT00545545|560640846|FG000|Overall Study|Irinotecan intolerance|1|||
155329416|NCT00545545|560640847|FG001|Overall Study|Irinotecan intolerance|1|||
155329417|NCT00545545|560640848|FG002|Overall Study|Irinotecan intolerance|0|||
155329418|NCT00545545|560640849|FG003|Overall Study|Irinotecan intolerance|0|||
155329419|NCT00545545|560640850|FG004|Overall Study|Irinotecan intolerance|0|||
155329420|NCT00545545|560640851|FG005|Overall Study|Irinotecan intolerance|0|||
155329421|NCT00545545|560640846|FG000|Overall Study|No target lesions to track post surgery|0|||
155329422|NCT00545545|560640847|FG001|Overall Study|No target lesions to track post surgery|0|||
155329423|NCT00545545|560640848|FG002|Overall Study|No target lesions to track post surgery|0|||
155329424|NCT00545545|560640849|FG003|Overall Study|No target lesions to track post surgery|0|||
155329425|NCT00545545|560640850|FG004|Overall Study|No target lesions to track post surgery|1|||
155329426|NCT00545545|560640851|FG005|Overall Study|No target lesions to track post surgery|1|||
155329427|NCT05827068|560640861|FG000|Overall Study|Lost to Follow-up|1|||
155329428|NCT05827068|560640862|FG001|Overall Study|Lost to Follow-up|4|||
155329429|NCT05827068|560640863|FG002|Overall Study|Lost to Follow-up|1|||
155329430|NCT05827068|560640864|FG003|Overall Study|Lost to Follow-up|1|||
155329431|NCT05827068|560640865|FG004|Overall Study|Lost to Follow-up|2|||
155329432|NCT05827068|560640866|FG005|Overall Study|Lost to Follow-up|4|||
155329433|NCT05827068|560640867|FG006|Overall Study|Lost to Follow-up|1|||
155329434|NCT05827068|560640861|FG000|Overall Study|Withdrawal by Subject|4|||
155329435|NCT05827068|560640862|FG001|Overall Study|Withdrawal by Subject|0|||
155329436|NCT05827068|560640863|FG002|Overall Study|Withdrawal by Subject|1|||
155329437|NCT05827068|560640864|FG003|Overall Study|Withdrawal by Subject|2|||
155329438|NCT05827068|560640865|FG004|Overall Study|Withdrawal by Subject|3|||
155329439|NCT05827068|560640866|FG005|Overall Study|Withdrawal by Subject|0|||
155163421|NCT01189032|560034966|FG001|Overall Study|Adverse Event|3|||
155163422|NCT01189032|560034967|FG002|Overall Study|Adverse Event|4|||
155329440|NCT05827068|560640867|FG006|Overall Study|Withdrawal by Subject|1|||
155329441|NCT05827068|560640861|FG000|Overall Study|Physician Decision|0|||
155329442|NCT05827068|560640862|FG001|Overall Study|Physician Decision|0|||
155329443|NCT05827068|560640863|FG002|Overall Study|Physician Decision|0|||
155329444|NCT05827068|560640864|FG003|Overall Study|Physician Decision|0|||
155329445|NCT05827068|560640865|FG004|Overall Study|Physician Decision|1|||
155329446|NCT05827068|560640866|FG005|Overall Study|Physician Decision|0|||
155329447|NCT05827068|560640867|FG006|Overall Study|Physician Decision|1|||
155329448|NCT05827068|560640861|FG000|Overall Study|Other Than Specified|0|||
155329449|NCT05827068|560640862|FG001|Overall Study|Other Than Specified|1|||
155329450|NCT05827068|560640863|FG002|Overall Study|Other Than Specified|0|||
155329451|NCT05827068|560640864|FG003|Overall Study|Other Than Specified|0|||
155329452|NCT05827068|560640865|FG004|Overall Study|Other Than Specified|0|||
155329453|NCT05827068|560640866|FG005|Overall Study|Other Than Specified|0|||
155329454|NCT05827068|560640867|FG006|Overall Study|Other Than Specified|0|||
155329455|NCT05704725|560640874|FG000|Overall Study|Lost to Follow-up|0|||
155329456|NCT05704725|560640875|FG001|Overall Study|Lost to Follow-up|1|||
155329457|NCT05704725|560640874|FG000|Overall Study|Withdrawal by Subject|1|||
155329458|NCT05704725|560640875|FG001|Overall Study|Withdrawal by Subject|0|||
155329459|NCT00490139|560640876|FG000|Overall Study|Lost to Follow-up|249|||
155329460|NCT00490139|560640877|FG001|Overall Study|Lost to Follow-up|216|||
155329461|NCT00490139|560640878|FG002|Overall Study|Lost to Follow-up|205|||
155329462|NCT00490139|560640879|FG003|Overall Study|Lost to Follow-up|229|||
155329463|NCT00490139|560640876|FG000|Overall Study|Withdrawal by Subject|333|||
155329464|NCT00490139|560640877|FG001|Overall Study|Withdrawal by Subject|322|||
155329465|NCT00490139|560640878|FG002|Overall Study|Withdrawal by Subject|396|||
155329466|NCT00490139|560640879|FG003|Overall Study|Withdrawal by Subject|295|||
155329467|NCT00490139|560640876|FG000|Overall Study|Patient did not sign ICF 12|169|||
155329468|NCT00490139|560640877|FG001|Overall Study|Patient did not sign ICF 12|176|||
155329469|NCT00490139|560640878|FG002|Overall Study|Patient did not sign ICF 12|139|||
155329470|NCT00490139|560640879|FG003|Overall Study|Patient did not sign ICF 12|167|||
155329471|NCT00490139|560640876|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
155329472|NCT00490139|560640877|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
155329473|NCT00490139|560640878|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
155329474|NCT00490139|560640879|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
155329475|NCT00490139|560640876|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
155329476|NCT00490139|560640877|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
155329477|NCT00490139|560640878|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
155329478|NCT00490139|560640879|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
155329479|NCT00490139|560640876|FG000|Overall Study|Other reasons as defined per protocol|98|||
155329480|NCT00490139|560640877|FG001|Overall Study|Other reasons as defined per protocol|84|||
155329481|NCT00490139|560640878|FG002|Overall Study|Other reasons as defined per protocol|82|||
155329482|NCT00490139|560640879|FG003|Overall Study|Other reasons as defined per protocol|105|||
155329483|NCT03664804|560640881|FG000|Overall Study|Withdrawal by Subject|7|||
155329484|NCT05529992|560640882|FG000|Overall Study|Withdrawal by Subject|1|||
155329485|NCT06140290|560640883|FG000|Period 1|Adverse Event|1|||
155329486|NCT06140290|560640884|FG001|Period 1|Adverse Event|0|||
155329487|NCT06140290|560640883|FG000|Period 2|Assigned but not treated|0|||
155329488|NCT06140290|560640884|FG001|Period 2|Assigned but not treated|1|||
155329489|NCT06140290|560640883|FG000|Period 2|Withdrawal by Subject|0|||
155329490|NCT06140290|560640884|FG001|Period 2|Withdrawal by Subject|1|||
155329491|NCT02798471|560640887|FG000|Overall Study|Adverse Event|7|||
155329492|NCT02798471|560640888|FG001|Overall Study|Adverse Event|2|||
155329493|NCT02798471|560640887|FG000|Overall Study|Physician Decision|3|||
155329494|NCT02798471|560640888|FG001|Overall Study|Physician Decision|7|||
155329495|NCT02798471|560640887|FG000|Overall Study|Death|2|||
155329496|NCT02798471|560640888|FG001|Overall Study|Death|3|||
155329497|NCT02798471|560640887|FG000|Overall Study|Lost to Follow-up|0|||
155329498|NCT02798471|560640888|FG001|Overall Study|Lost to Follow-up|1|||
155329499|NCT02798471|560640887|FG000|Overall Study|Other|5|||
155329500|NCT02798471|560640888|FG001|Overall Study|Other|3|||
155070672|NCT02693418|559688086|FG002|Overall Study|Menses during study period|2|||
155070673|NCT02693418|559688087|FG003|Overall Study|Menses during study period|0|||
155070674|NCT02693418|559688088|FG004|Overall Study|Menses during study period|0|||
155070675|NCT01750346|559688091|FG000|Overall Study|Adverse Event|1|||
155329501|NCT02798471|560640887|FG000|Overall Study|Subject withdrew consent|0|||
155329502|NCT02798471|560640888|FG001|Overall Study|Subject withdrew consent|6|||
155329503|NCT02798471|560640887|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
155329504|NCT02798471|560640888|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
155329505|NCT02798471|560640887|FG000|Overall Study|Randomized, but not treated|0|||
155329506|NCT02798471|560640888|FG001|Overall Study|Randomized, but not treated|2|||
155329507|NCT04503681|560642177|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
155329508|NCT04503681|560642178|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
155329509|NCT03352713|560642181|FG000|Overall Study|Lost to Follow-up|8|||
155070676|NCT01750346|559688092|FG001|Overall Study|Adverse Event|0|||
155070677|NCT01750346|559688093|FG002|Overall Study|Adverse Event|0|||
155070678|NCT01001104|559688094|FG000|Overall Study|Adverse Event|2|||
155329510|NCT03352713|560642181|FG000|Overall Study|Withdrawn by investigator|5|||
155329511|NCT03352713|560642181|FG000|Overall Study|Completed 0 EMAs|8|||
155329512|NCT03352713|560642181|FG000|Overall Study|Device incompatible/stolen|5|||
155329513|NCT01812759|560642182|FG000|Overall Study|Physician Decision|0|||
155329514|NCT01812759|560642183|FG001|Overall Study|Physician Decision|0|||
155329515|NCT01812759|560642184|FG002|Overall Study|Physician Decision|1|||
155329516|NCT03758638|560642185|FG000|Overall Study|Pregnancy|17|||
155329517|NCT03758638|560642186|FG001|Overall Study|Pregnancy|25|||
155329518|NCT03758638|560642185|FG000|Overall Study|Lost to Follow-up|60|||
155329519|NCT03758638|560642186|FG001|Overall Study|Lost to Follow-up|54|||
155329520|NCT03758638|560642185|FG000|Overall Study|Protocol Violation|2|||
155329521|NCT03758638|560642186|FG001|Overall Study|Protocol Violation|0|||
155329522|NCT03758638|560642185|FG000|Overall Study|Withdrawal by Subject|8|||
155329523|NCT03758638|560642186|FG001|Overall Study|Withdrawal by Subject|2|||
155329524|NCT03758638|560642185|FG000|Overall Study|Providers not included in the primary outcome.|183|||
155329525|NCT03758638|560642186|FG001|Overall Study|Providers not included in the primary outcome.|128|||
155329526|NCT00372775|560642188|FG000|Overall Study|Adverse Event|8|||
155329527|NCT00372775|560642188|FG000|Overall Study|Death|15|||
155329528|NCT00372775|560642188|FG000|Overall Study|Objective progression or relapse|30|||
155329529|NCT00372775|560642188|FG000|Overall Study|Global deterioration of health status|6|||
155329530|NCT00372775|560642188|FG000|Overall Study|Withdrawal by Subject|1|||
155329531|NCT00372775|560642188|FG000|Overall Study|Other|1|||
155329532|NCT00372775|560642188|FG000|Overall Study|Not Treated|2|||
155329533|NCT00724126|560642189|FG000|Overall Study|Adverse Event|2|||
155329534|NCT00724126|560642190|FG001|Overall Study|Adverse Event|0|||
155329535|NCT00724126|560642189|FG000|Overall Study|Withdrawal by Subject|8|||
155329536|NCT00724126|560642190|FG001|Overall Study|Withdrawal by Subject|6|||
155329537|NCT00724126|560642189|FG000|Overall Study|Lost to Follow-up|6|||
155329538|NCT00724126|560642190|FG001|Overall Study|Lost to Follow-up|6|||
155329539|NCT00724126|560642189|FG000|Overall Study|Noncompliance|2|||
155329540|NCT00724126|560642190|FG001|Overall Study|Noncompliance|1|||
155329541|NCT00724126|560642189|FG000|Overall Study|Subject randomized although ineligible|1|||
155329542|NCT00724126|560642190|FG001|Overall Study|Subject randomized although ineligible|1|||
155329543|NCT00724126|560642189|FG000|Overall Study|Subject had to leave vicinity of site|0|||
155329544|NCT00724126|560642190|FG001|Overall Study|Subject had to leave vicinity of site|1|||
155329545|NCT01579318|560642191|FG000|Overall Study|Disease Progression|1|||
155329546|NCT03601715|560642194|FG000|Second Intervention|Lost to Follow-up|1|||
155329547|NCT03601715|560642195|FG001|Second Intervention|Lost to Follow-up|1|||
155329548|NCT03601715|560642196|FG002|Second Intervention|Lost to Follow-up|0|||
155329549|NCT02347332|560642197|FG000|Overall Study|Not treated|5|||
155329550|NCT02347332|560642198|FG001|Overall Study|Not treated|2|||
155329551|NCT02347332|560642197|FG000|Overall Study|Progressive disease|141|||
155329552|NCT02347332|560642198|FG001|Overall Study|Progressive disease|159|||
155329553|NCT02347332|560642197|FG000|Overall Study|Adverse Event|50|||
155329554|NCT02347332|560642198|FG001|Overall Study|Adverse Event|41|||
155329555|NCT02347332|560642197|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
155329556|NCT02347332|560642198|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
155329557|NCT02347332|560642197|FG000|Overall Study|Protocol Violation|1|||
155329558|NCT02347332|560642198|FG001|Overall Study|Protocol Violation|1|||
155329559|NCT02347332|560642197|FG000|Overall Study|Lost to Follow-up|2|||
155329560|NCT02347332|560642198|FG001|Overall Study|Lost to Follow-up|1|||
155329561|NCT02347332|560642197|FG000|Overall Study|Physician Decision|4|||
155329562|NCT02347332|560642198|FG001|Overall Study|Physician Decision|3|||
155329563|NCT02347332|560642197|FG000|Overall Study|Withdrawal by Subject|20|||
155329564|NCT02347332|560642198|FG001|Overall Study|Withdrawal by Subject|14|||
155329565|NCT02347332|560642197|FG000|Overall Study|Protocol requirement|1|||
155329566|NCT02347332|560642198|FG001|Overall Study|Protocol requirement|1|||
155329567|NCT02347332|560642197|FG000|Overall Study|Switch Post-Trial program|0|||
154961796|NCT03600805|559285637|FG003|Overall Study|Withdrawal by Subject|1|||
154961797|NCT03600805|559285634|FG000|Overall Study|Other unspecified|14|||
154961798|NCT03600805|559285635|FG001|Overall Study|Other unspecified|6|||
154961799|NCT03600805|559285636|FG002|Overall Study|Other unspecified|7|||
155163423|NCT01189032|560034965|FG000|Overall Study|Lack of Efficacy|2|||
155163424|NCT01189032|560034966|FG001|Overall Study|Lack of Efficacy|3|||
155329568|NCT02347332|560642198|FG001|Overall Study|Switch Post-Trial program|1|||
155329569|NCT01478594|560642199|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
155329570|NCT01478594|560642200|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
155329571|NCT01478594|560642199|FG000|Overall Study|Death|45|||
155329572|NCT01478594|560642200|FG001|Overall Study|Death|18|||
155329573|NCT01478594|560642199|FG000|Overall Study|Lost to Follow-up|3|||
155329574|NCT01478594|560642200|FG001|Overall Study|Lost to Follow-up|1|||
155329575|NCT01478594|560642199|FG000|Overall Study|Withdrawal by Subject|9|||
155329576|NCT01478594|560642200|FG001|Overall Study|Withdrawal by Subject|3|||
154961800|NCT03600805|559285637|FG003|Overall Study|Other unspecified|11|||
154961801|NCT03635320|559285638|FG000|Overall Study|not implanted the device|1|||
154961802|NCT03635320|559285639|FG001|Overall Study|not implanted the device|2|||
154961803|NCT03635320|559285638|FG000|Overall Study|Withdrawal by Subject|11|||
155163425|NCT01189032|560034967|FG002|Overall Study|Lack of Efficacy|0|||
155163426|NCT01189032|560034965|FG000|Overall Study|Withdrawal by Subject|1|||
155163427|NCT01189032|560034966|FG001|Overall Study|Withdrawal by Subject|0|||
155163428|NCT01189032|560034967|FG002|Overall Study|Withdrawal by Subject|1|||
155163429|NCT01189032|560034965|FG000|Overall Study|Protocol Violation|1|||
155163430|NCT01189032|560034966|FG001|Overall Study|Protocol Violation|1|||
155163431|NCT01189032|560034967|FG002|Overall Study|Protocol Violation|1|||
155163432|NCT01733680|560034968|FG000|Overall Study|Withdrawal by Subject|0|||
155163433|NCT01733680|560034969|FG001|Overall Study|Withdrawal by Subject|1|||
155163434|NCT01932437|560034970|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155163435|NCT01932437|560034971|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155163436|NCT01932437|560034972|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155163437|NCT01932437|560034973|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155163438|NCT01932437|560034974|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
155163439|NCT01932437|560034975|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
155163440|NCT01526733|560034977|FG000|Phase 1|Protocol Violation|1|||
155163441|NCT01526733|560034978|FG001|Phase 1|Protocol Violation|0|||
155163442|NCT01526733|560034977|FG000|Phase 1|Withdrawal by Subject|1|||
155163443|NCT01526733|560034978|FG001|Phase 1|Withdrawal by Subject|1|||
155163444|NCT02839200|560034979|FG000|Overall Study|Withdrawal by Subject|2|||
155163445|NCT02839200|560034980|FG001|Overall Study|Withdrawal by Subject|0|||
155163446|NCT02839200|560034981|FG002|Overall Study|Withdrawal by Subject|1|||
155163447|NCT02839200|560034982|FG003|Overall Study|Withdrawal by Subject|0|||
155163448|NCT02839200|560034983|FG004|Overall Study|Withdrawal by Subject|0|||
155163449|NCT02839200|560034984|FG005|Overall Study|Withdrawal by Subject|1|||
155163450|NCT02839200|560034979|FG000|Overall Study|Lost to Follow-up|2|||
155163451|NCT02839200|560034980|FG001|Overall Study|Lost to Follow-up|0|||
155163452|NCT02839200|560034981|FG002|Overall Study|Lost to Follow-up|0|||
155163453|NCT02839200|560034982|FG003|Overall Study|Lost to Follow-up|0|||
155163454|NCT02839200|560034983|FG004|Overall Study|Lost to Follow-up|1|||
155163455|NCT02839200|560034984|FG005|Overall Study|Lost to Follow-up|0|||
155163456|NCT02839200|560034979|FG000|Overall Study|Adverse Event|0|||
155163457|NCT02839200|560034980|FG001|Overall Study|Adverse Event|0|||
155163458|NCT02839200|560034981|FG002|Overall Study|Adverse Event|0|||
155163459|NCT02839200|560034982|FG003|Overall Study|Adverse Event|0|||
155163460|NCT02839200|560034983|FG004|Overall Study|Adverse Event|1|||
155163461|NCT02839200|560034984|FG005|Overall Study|Adverse Event|0|||
155163462|NCT02839200|560034979|FG000|Overall Study|Randomized in error|0|||
155163463|NCT02839200|560034980|FG001|Overall Study|Randomized in error|1|||
155163464|NCT02839200|560034981|FG002|Overall Study|Randomized in error|0|||
155163465|NCT02839200|560034982|FG003|Overall Study|Randomized in error|0|||
155163466|NCT02839200|560034983|FG004|Overall Study|Randomized in error|0|||
155163467|NCT02839200|560034984|FG005|Overall Study|Randomized in error|0|||
155163468|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
155163469|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
155163470|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
155163471|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
155163472|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
155163473|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
155329577|NCT01478594|560642199|FG000|Overall Study|Study Closed by Sponsor|8|||
155329578|NCT01478594|560642200|FG001|Overall Study|Study Closed by Sponsor|5|||
154961804|NCT03635320|559285639|FG001|Overall Study|Withdrawal by Subject|6|||
154961805|NCT03049748|559285640|FG000|Overall Study|Lost to Follow-up|1|||
154961806|NCT03049748|559285641|FG001|Overall Study|Lost to Follow-up|0|||
154961807|NCT03049748|559285640|FG000|Overall Study|Death|3|||
154961808|NCT03049748|559285641|FG001|Overall Study|Death|0|||
154961809|NCT03049748|559285640|FG000|Overall Study|Withdrawal by Subject|0|||
154961810|NCT03049748|559285641|FG001|Overall Study|Withdrawal by Subject|3|||
154961811|NCT03049748|559285640|FG000|Overall Study|Protocol Violation|0|||
154961812|NCT03049748|559285641|FG001|Overall Study|Protocol Violation|2|||
154961813|NCT03049748|559285640|FG000|Overall Study|Moved out of state (relocation)|0|||
154961814|NCT03049748|559285641|FG001|Overall Study|Moved out of state (relocation)|1|||
154961815|NCT01471353|559285642|FG000|Overall Study|remain on study|3|||
154961816|NCT03123094|559285643|FG000|Overall Study|Withdrawal by Subject|0|||
154961817|NCT03123094|559285644|FG001|Overall Study|Withdrawal by Subject|2|||
154961818|NCT03123094|559285645|FG002|Overall Study|Withdrawal by Subject|1|||
155163474|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
155163475|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
155163476|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
155163477|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
155163478|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
155329579|NCT01313884|560642201|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
155329580|NCT01970007|560642202|FG000|Overall Study|Death|5|||
155329581|NCT01970007|560642202|FG000|Overall Study|Withdrawal by Subject|23|||
155329582|NCT01970007|560642202|FG000|Overall Study|Lost to Follow-up|24|||
155329583|NCT01970007|560642202|FG000|Overall Study|"Other endpoint"|3|||
155329584|NCT00776009|560642203|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
155329585|NCT00776009|560642204|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
155329586|NCT00776009|560642205|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
155329587|NCT00776009|560642206|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
155329588|NCT00776009|560642207|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
155329589|NCT00776009|560642208|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
155329590|NCT00776009|560642203|FG000|Period 1: First Intervention|Protocol Violation|0|||
155329591|NCT00776009|560642204|FG001|Period 1: First Intervention|Protocol Violation|1|||
155329592|NCT00776009|560642205|FG002|Period 1: First Intervention|Protocol Violation|0|||
155329593|NCT00776009|560642206|FG003|Period 1: First Intervention|Protocol Violation|0|||
155329594|NCT00776009|560642207|FG004|Period 1: First Intervention|Protocol Violation|1|||
155329595|NCT00776009|560642208|FG005|Period 1: First Intervention|Protocol Violation|0|||
155329596|NCT00776009|560642203|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329597|NCT00776009|560642204|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329598|NCT00776009|560642205|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329599|NCT00776009|560642206|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329600|NCT00776009|560642207|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
155329601|NCT00776009|560642208|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
155329602|NCT00776009|560642203|FG000|Period 2: Second Intervention|Protocol Violation|1|||
155329603|NCT00776009|560642204|FG001|Period 2: Second Intervention|Protocol Violation|0|||
155329604|NCT00776009|560642205|FG002|Period 2: Second Intervention|Protocol Violation|1|||
155329605|NCT00776009|560642206|FG003|Period 2: Second Intervention|Protocol Violation|0|||
155329606|NCT00776009|560642207|FG004|Period 2: Second Intervention|Protocol Violation|0|||
155329607|NCT00776009|560642208|FG005|Period 2: Second Intervention|Protocol Violation|0|||
155329608|NCT00776009|560642203|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
155329609|NCT00776009|560642204|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329610|NCT00776009|560642205|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329611|NCT00776009|560642206|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329612|NCT00776009|560642207|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329613|NCT00776009|560642208|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
155329614|NCT01640951|560642209|FG000|Overall Study|Adverse Event|8|||
155329615|NCT01640951|560642210|FG001|Overall Study|Adverse Event|3|||
155329616|NCT01640951|560642211|FG002|Overall Study|Adverse Event|10|||
155329617|NCT01640951|560642212|FG003|Overall Study|Adverse Event|6|||
155329618|NCT01640951|560642213|FG004|Overall Study|Adverse Event|1|||
155329619|NCT01640951|560642214|FG005|Overall Study|Adverse Event|11|||
155329620|NCT01640951|560642215|FG006|Overall Study|Adverse Event|1|||
155329621|NCT01640951|560642216|FG007|Overall Study|Adverse Event|3|||
155329622|NCT01640951|560642209|FG000|Overall Study|Lack of Efficacy|20|||
155329623|NCT01640951|560642210|FG001|Overall Study|Lack of Efficacy|1|||
155329624|NCT01640951|560642211|FG002|Overall Study|Lack of Efficacy|7|||
155329625|NCT01640951|560642212|FG003|Overall Study|Lack of Efficacy|14|||
155329626|NCT01640951|560642213|FG004|Overall Study|Lack of Efficacy|0|||
155329627|NCT01640951|560642214|FG005|Overall Study|Lack of Efficacy|6|||
155329628|NCT01640951|560642215|FG006|Overall Study|Lack of Efficacy|5|||
155329629|NCT01640951|560642216|FG007|Overall Study|Lack of Efficacy|6|||
155329630|NCT01640951|560642209|FG000|Overall Study|Lost to Follow-up|1|||
155329631|NCT01640951|560642210|FG001|Overall Study|Lost to Follow-up|0|||
155329632|NCT01640951|560642211|FG002|Overall Study|Lost to Follow-up|6|||
155329633|NCT01640951|560642212|FG003|Overall Study|Lost to Follow-up|2|||
155070679|NCT01001104|559688095|FG001|Overall Study|Adverse Event|1|||
155070680|NCT01001104|559688096|FG002|Overall Study|Adverse Event|0|||
155070681|NCT01001104|559688097|FG003|Overall Study|Adverse Event|0|||
155070682|NCT01001104|559688094|FG000|Overall Study|Lost to Follow-up|0|||
155070683|NCT01001104|559688095|FG001|Overall Study|Lost to Follow-up|0|||
155329634|NCT01640951|560642213|FG004|Overall Study|Lost to Follow-up|2|||
155329635|NCT01640951|560642214|FG005|Overall Study|Lost to Follow-up|3|||
155329636|NCT01640951|560642215|FG006|Overall Study|Lost to Follow-up|1|||
155329637|NCT01640951|560642216|FG007|Overall Study|Lost to Follow-up|1|||
155329638|NCT01640951|560642209|FG000|Overall Study|Non-compliance with study treatment|0|||
155329639|NCT01640951|560642210|FG001|Overall Study|Non-compliance with study treatment|0|||
155329640|NCT01640951|560642211|FG002|Overall Study|Non-compliance with study treatment|1|||
155329641|NCT01640951|560642212|FG003|Overall Study|Non-compliance with study treatment|1|||
155329642|NCT01640951|560642213|FG004|Overall Study|Non-compliance with study treatment|1|||
155070684|NCT01001104|559688096|FG002|Overall Study|Lost to Follow-up|1|||
155070685|NCT01001104|559688097|FG003|Overall Study|Lost to Follow-up|0|||
155329643|NCT01640951|560642214|FG005|Overall Study|Non-compliance with study treatment|4|||
155329644|NCT01640951|560642215|FG006|Overall Study|Non-compliance with study treatment|1|||
155329645|NCT01640951|560642216|FG007|Overall Study|Non-compliance with study treatment|0|||
155329646|NCT01640951|560642209|FG000|Overall Study|Physician Decision|2|||
155329647|NCT01640951|560642210|FG001|Overall Study|Physician Decision|5|||
155329648|NCT01640951|560642211|FG002|Overall Study|Physician Decision|2|||
155329649|NCT01640951|560642212|FG003|Overall Study|Physician Decision|2|||
155329650|NCT01640951|560642213|FG004|Overall Study|Physician Decision|2|||
155329651|NCT01640951|560642214|FG005|Overall Study|Physician Decision|3|||
155329652|NCT01640951|560642215|FG006|Overall Study|Physician Decision|3|||
155329653|NCT01640951|560642216|FG007|Overall Study|Physician Decision|0|||
155329654|NCT01640951|560642209|FG000|Overall Study|Pregnancy|3|||
155329655|NCT01640951|560642210|FG001|Overall Study|Pregnancy|0|||
155329656|NCT01640951|560642211|FG002|Overall Study|Pregnancy|0|||
155329657|NCT01640951|560642212|FG003|Overall Study|Pregnancy|4|||
155329658|NCT01640951|560642213|FG004|Overall Study|Pregnancy|0|||
155329659|NCT01640951|560642214|FG005|Overall Study|Pregnancy|0|||
155329660|NCT01640951|560642215|FG006|Overall Study|Pregnancy|2|||
155329661|NCT01640951|560642216|FG007|Overall Study|Pregnancy|0|||
155329662|NCT01640951|560642209|FG000|Overall Study|Protocol Deviation|0|||
155329663|NCT01640951|560642210|FG001|Overall Study|Protocol Deviation|1|||
155329664|NCT01640951|560642211|FG002|Overall Study|Protocol Deviation|2|||
155329665|NCT01640951|560642212|FG003|Overall Study|Protocol Deviation|1|||
155329666|NCT01640951|560642213|FG004|Overall Study|Protocol Deviation|0|||
155329667|NCT01640951|560642214|FG005|Overall Study|Protocol Deviation|1|||
155329668|NCT01640951|560642215|FG006|Overall Study|Protocol Deviation|0|||
155329669|NCT01640951|560642216|FG007|Overall Study|Protocol Deviation|0|||
155329670|NCT01640951|560642209|FG000|Overall Study|Subject/Guardian decision|12|||
155329671|NCT01640951|560642210|FG001|Overall Study|Subject/Guardian decision|4|||
155329672|NCT01640951|560642211|FG002|Overall Study|Subject/Guardian decision|13|||
155329673|NCT01640951|560642212|FG003|Overall Study|Subject/Guardian decision|15|||
155329674|NCT01640951|560642213|FG004|Overall Study|Subject/Guardian decision|7|||
155329675|NCT01640951|560642214|FG005|Overall Study|Subject/Guardian decision|19|||
155329676|NCT01640951|560642215|FG006|Overall Study|Subject/Guardian decision|5|||
155329677|NCT01640951|560642216|FG007|Overall Study|Subject/Guardian decision|4|||
155329678|NCT01640951|560642209|FG000|Overall Study|Death|0|||
155329679|NCT01640951|560642210|FG001|Overall Study|Death|1|||
155329680|NCT01640951|560642211|FG002|Overall Study|Death|1|||
155329681|NCT01640951|560642212|FG003|Overall Study|Death|0|||
155329682|NCT01640951|560642213|FG004|Overall Study|Death|0|||
155329683|NCT01640951|560642214|FG005|Overall Study|Death|0|||
155329684|NCT01640951|560642215|FG006|Overall Study|Death|0|||
155329685|NCT01640951|560642216|FG007|Overall Study|Death|2|||
155329686|NCT00582972|560642217|FG000|Overall Study|Protocol Violation|2|||
155329687|NCT00293397|560642221|FG000|Overall Study|Death|2|||
155329688|NCT03304587|560642230|FG000|Overall Study|Headache after intervention|0|||
155329689|NCT03304587|560642231|FG001|Overall Study|Headache after intervention|1|||
155329690|NCT03304587|560642230|FG000|Overall Study|Withdrawal by Subject|1|||
155329691|NCT03304587|560642231|FG001|Overall Study|Withdrawal by Subject|0|||
155329692|NCT01458366|560642233|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
155329693|NCT01458366|560642234|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
155329694|NCT01458366|560642235|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
155329695|NCT01458366|560642236|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
155329696|NCT01458366|560642237|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
155329697|NCT01458366|560642233|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329698|NCT01458366|560642234|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329699|NCT01458366|560642235|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329700|NCT01458366|560642236|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
155329701|NCT01458366|560642237|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
155329702|NCT04647487|560642238|FG000|Overall Study|Protocol Deviation|0|||
155329703|NCT04647487|560642239|FG001|Overall Study|Protocol Deviation|0|||
155070686|NCT01001104|559688094|FG000|Overall Study|Entry Criteria Not Met|0|||
155070687|NCT01001104|559688095|FG001|Overall Study|Entry Criteria Not Met|0|||
155070688|NCT01001104|559688096|FG002|Overall Study|Entry Criteria Not Met|0|||
155070689|NCT01001104|559688097|FG003|Overall Study|Entry Criteria Not Met|1|||
155329704|NCT04647487|560642240|FG002|Overall Study|Protocol Deviation|1|||
155329705|NCT04647487|560642238|FG000|Overall Study|Withdrawal by Subject|1|||
155329706|NCT04647487|560642239|FG001|Overall Study|Withdrawal by Subject|0|||
155329707|NCT04647487|560642240|FG002|Overall Study|Withdrawal by Subject|2|||
155329708|NCT03840902|560642241|FG000|Overall Study|Randomized but not treated|1|||
155329709|NCT03840902|560642242|FG001|Overall Study|Randomized but not treated|1|||
155329710|NCT00174252|560642243|FG000|Overall Study|Protocol Violation|2|||
155329711|NCT02107261|560642250|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
155329712|NCT02107261|560642251|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
155329713|NCT02107261|560642250|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
155329714|NCT02107261|560642251|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
155329715|NCT04337931|560642253|FG000|Overall Study|Death|4|||
155329716|NCT04337931|560642254|FG001|Overall Study|Death|1|||
155329717|NCT04337931|560642255|FG002|Overall Study|Death|7|||
155329718|NCT04337931|560642253|FG000|Overall Study|Withdrawal by Subject|0|||
155329719|NCT04337931|560642254|FG001|Overall Study|Withdrawal by Subject|1|||
155329720|NCT04337931|560642255|FG002|Overall Study|Withdrawal by Subject|0|||
155329721|NCT04337931|560642253|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
155329722|NCT04337931|560642254|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
155329723|NCT04337931|560642255|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
155329724|NCT04337931|560642253|FG000|Overall Study|Study terminated by sponsor|3|||
155329725|NCT04337931|560642254|FG001|Overall Study|Study terminated by sponsor|6|||
155329726|NCT04337931|560642255|FG002|Overall Study|Study terminated by sponsor|2|||
155329727|NCT04337931|560642253|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
155329728|NCT04337931|560642254|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
155329729|NCT04337931|560642255|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
155329730|NCT04337931|560642253|FG000|Overall Study|Colorectal cancer treatment|1|||
155329731|NCT04337931|560642254|FG001|Overall Study|Colorectal cancer treatment|0|||
155329732|NCT04337931|560642255|FG002|Overall Study|Colorectal cancer treatment|0|||
155329733|NCT04337931|560642253|FG000|Overall Study|Participant decision|0|||
155329734|NCT04337931|560642254|FG001|Overall Study|Participant decision|1|||
155329735|NCT04337931|560642255|FG002|Overall Study|Participant decision|0|||
155329736|NCT01738438|560642256|FG000|Overall Study|Disease Progression|32|||
155329737|NCT01738438|560642256|FG000|Overall Study|Adverse Event|3|||
155329738|NCT02130557|560642258|FG000|Overall Study|Withdrawal by Subject|12|||
155329739|NCT02130557|560642259|FG001|Overall Study|Withdrawal by Subject|12|||
155329740|NCT02130557|560642258|FG000|Overall Study|Investigator Request|0|||
155329741|NCT02130557|560642259|FG001|Overall Study|Investigator Request|2|||
155329742|NCT02130557|560642258|FG000|Overall Study|Deceased|14|||
155329743|NCT02130557|560642259|FG001|Overall Study|Deceased|14|||
155329744|NCT02130557|560642258|FG000|Overall Study|Lost to Follow-up|6|||
155329745|NCT02130557|560642259|FG001|Overall Study|Lost to Follow-up|7|||
155329746|NCT02130557|560642258|FG000|Overall Study|Other|2|||
155329747|NCT02130557|560642259|FG001|Overall Study|Other|1|||
155329748|NCT02130557|560642258|FG000|Overall Study|Missing|2|||
155329749|NCT02130557|560642259|FG001|Overall Study|Missing|1|||
155329750|NCT01532999|560642260|FG000|Overall Study|Lost to Follow-up|14|||
155329751|NCT01532999|560642261|FG001|Overall Study|Lost to Follow-up|8|||
155329752|NCT01532999|560642260|FG000|Overall Study|Physician Decision|1|||
155329753|NCT01532999|560642261|FG001|Overall Study|Physician Decision|2|||
155329754|NCT01532999|560642260|FG000|Overall Study|Withdrawal by Subject|5|||
155329755|NCT01532999|560642261|FG001|Overall Study|Withdrawal by Subject|0|||
155329756|NCT01532999|560642260|FG000|Overall Study|Relocated|2|||
155329757|NCT01532999|560642261|FG001|Overall Study|Relocated|0|||
155329758|NCT01532999|560642260|FG000|Overall Study|should not have been randomized|1|||
155329759|NCT01532999|560642261|FG001|Overall Study|should not have been randomized|0|||
155329760|NCT01532999|560642260|FG000|Overall Study|substantial noncompliance|2|||
155329761|NCT01532999|560642261|FG001|Overall Study|substantial noncompliance|0|||
155329762|NCT01532999|560642260|FG000|Overall Study|no show for week 9 assessments|6|||
155329763|NCT01532999|560642261|FG001|Overall Study|no show for week 9 assessments|4|||
155329764|NCT01532999|560642260|FG000|Overall Study|Adverse Event|0|||
155329765|NCT01532999|560642261|FG001|Overall Study|Adverse Event|1|||
155329766|NCT01532999|560642260|FG000|Overall Study|incarcerated|0|||
155329767|NCT01532999|560642261|FG001|Overall Study|incarcerated|1|||
155329768|NCT01532999|560642260|FG000|Overall Study|New job|0|||
155329769|NCT01532999|560642261|FG001|Overall Study|New job|2|||
155329770|NCT02928172|560642262|FG000|Overall Study|Device did not record data|1|||
155329771|NCT02408887|560642263|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
155329772|NCT02408887|560642264|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
155329773|NCT02408887|560642263|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
155329774|NCT02408887|560642264|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
155329775|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155329776|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
155329777|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
154961819|NCT03123094|559285646|FG003|Overall Study|Withdrawal by Subject|0|||
155329778|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155329779|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155329780|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
155329781|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
155329782|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
155329783|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
155329784|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
155329785|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
155329786|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
155329787|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
155329788|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
155329789|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
155329790|NCT03333109|560642266|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
155329791|NCT03333109|560642267|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
155329792|NCT03333109|560642268|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
155329793|NCT03333109|560642266|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
155070690|NCT01001104|559688094|FG000|Overall Study|Withdrawal by Subject|0|||
155329794|NCT03333109|560642267|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
155329795|NCT03333109|560642268|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
155329796|NCT03333109|560642266|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
155329797|NCT03333109|560642267|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
155329798|NCT03333109|560642268|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
155070691|NCT01001104|559688095|FG001|Overall Study|Withdrawal by Subject|0|||
155070692|NCT01001104|559688096|FG002|Overall Study|Withdrawal by Subject|0|||
155070693|NCT01001104|559688097|FG003|Overall Study|Withdrawal by Subject|2|||
155070694|NCT02034591|559688098|FG000|Overall Study|Withdrawal by Subject|0|||
155070695|NCT02034591|559688099|FG001|Overall Study|Withdrawal by Subject|0|||
155070696|NCT02034591|559688100|FG002|Overall Study|Withdrawal by Subject|0|||
155070697|NCT02034591|559688101|FG003|Overall Study|Withdrawal by Subject|0|||
155070698|NCT02034591|559688102|FG004|Overall Study|Withdrawal by Subject|1|||
155070699|NCT02034591|559688103|FG005|Overall Study|Withdrawal by Subject|0|||
155070700|NCT00599313|559688104|FG000|Overall Study|Adverse Event|19|||
155070701|NCT00599313|559688104|FG000|Overall Study|Disease Progression|12|||
155070702|NCT00599313|559688104|FG000|Overall Study|Patient Request|4|||
155070703|NCT00599313|559688104|FG000|Overall Study|Ineligible|1|||
155070704|NCT00817063|559688111|FG000|Overall Study|Adverse Event|32|||
155070705|NCT00817063|559688112|FG001|Overall Study|Adverse Event|13|||
155070706|NCT00817063|559688111|FG000|Overall Study|Death|1|||
155070707|NCT00817063|559688112|FG001|Overall Study|Death|1|||
155070708|NCT00817063|559688111|FG000|Overall Study|Lack of Efficacy|33|||
155070709|NCT00817063|559688112|FG001|Overall Study|Lack of Efficacy|86|||
155070710|NCT00817063|559688111|FG000|Overall Study|Failure to Return|13|||
155070711|NCT00817063|559688112|FG001|Overall Study|Failure to Return|12|||
155070712|NCT00817063|559688111|FG000|Overall Study|Violation of Selection at Entry|7|||
155329799|NCT04066075|560642269|FG000|Overall Study|Lost to Follow-up|3|||
155329800|NCT04066075|560642270|FG001|Overall Study|Lost to Follow-up|3|||
155329801|NCT04066075|560642269|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
155329802|NCT04066075|560642270|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
155329803|NCT04066075|560642269|FG000|Overall Study|Withdrawal by Subject|2|||
155329804|NCT04066075|560642270|FG001|Overall Study|Withdrawal by Subject|2|||
155329805|NCT00309166|560642271|FG000|Overall Study|Adverse event, non-fatal|1|||
155329806|NCT00309166|560642272|FG001|Overall Study|Adverse event, non-fatal|0|||
155329807|NCT00309166|560642271|FG000|Overall Study|Withdrawal by Subject|4|||
155329808|NCT00309166|560642272|FG001|Overall Study|Withdrawal by Subject|3|||
155329809|NCT00701701|560642273|FG000|Overall Study|Withdrawal by Subject|0|||
155329810|NCT00701701|560642274|FG001|Overall Study|Withdrawal by Subject|1|||
155329811|NCT00701701|560642273|FG000|Overall Study|Adverse Event|0|||
155329812|NCT00701701|560642274|FG001|Overall Study|Adverse Event|1|||
155329813|NCT03593226|560642277|FG000|Overall Study|Disease progression|6|||
155329814|NCT03593226|560642278|FG001|Overall Study|Disease progression|13|||
155329815|NCT03593226|560642279|FG002|Overall Study|Disease progression|5|||
155329816|NCT03593226|560642280|FG003|Overall Study|Disease progression|6|||
155329817|NCT03593226|560642277|FG000|Overall Study|Adverse Event|0|||
155329818|NCT03593226|560642278|FG001|Overall Study|Adverse Event|1|||
155329819|NCT03593226|560642279|FG002|Overall Study|Adverse Event|0|||
155329820|NCT03593226|560642280|FG003|Overall Study|Adverse Event|0|||
155070713|NCT00817063|559688112|FG001|Overall Study|Violation of Selection at Entry|4|||
155070714|NCT00817063|559688111|FG000|Overall Study|Protocol Violation|3|||
155070715|NCT00817063|559688112|FG001|Overall Study|Protocol Violation|8|||
155070716|NCT00817063|559688111|FG000|Overall Study|Withdrawal by Subject|17|||
155163479|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
155329821|NCT03593226|560642277|FG000|Overall Study|Withdrawal by Subject|0|||
155329822|NCT03593226|560642278|FG001|Overall Study|Withdrawal by Subject|4|||
155329823|NCT03593226|560642279|FG002|Overall Study|Withdrawal by Subject|1|||
155329824|NCT03593226|560642280|FG003|Overall Study|Withdrawal by Subject|0|||
155329825|NCT03593226|560642277|FG000|Overall Study|Physician Decision|0|||
155329826|NCT03593226|560642278|FG001|Overall Study|Physician Decision|1|||
155070717|NCT00817063|559688112|FG001|Overall Study|Withdrawal by Subject|37|||
155329827|NCT03593226|560642279|FG002|Overall Study|Physician Decision|0|||
155070718|NCT00817063|559688111|FG000|Overall Study|Early Improvement|19|||
155070719|NCT00817063|559688112|FG001|Overall Study|Early Improvement|4|||
155070720|NCT00817063|559688111|FG000|Overall Study|Administrative|10|||
155070721|NCT00817063|559688112|FG001|Overall Study|Administrative|4|||
155163480|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
155163481|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
155163482|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
155163483|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
155163484|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
155163485|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
155163486|NCT02952820|560034985|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
155163487|NCT02952820|560034986|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
155163488|NCT02952820|560034987|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
155163489|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
155163490|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
155163491|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
155163492|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
155163493|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
155163494|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
155163495|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
155163496|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
155163497|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
155163498|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
155163499|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
155163500|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
155070722|NCT00817063|559688111|FG000|Overall Study|Abnormality of Laboratory Test|2|||
155070723|NCT00817063|559688112|FG001|Overall Study|Abnormality of Laboratory Test|1|||
155070724|NCT01496456|559688113|FG000|Overall Study|Protocol Violation|1|||
155070725|NCT01496456|559688113|FG000|Overall Study|Lost to Follow-up|7|||
155070726|NCT02175758|559688114|FG000|Treatment Phase|Lost to Follow-up|0|||
155070727|NCT02175758|559688115|FG001|Treatment Phase|Lost to Follow-up|1|||
155070728|NCT02175758|559688116|FG002|Treatment Phase|Lost to Follow-up|0|||
155070729|NCT02175758|559688117|FG003|Treatment Phase|Lost to Follow-up|0|||
155070730|NCT02175758|559688118|FG004|Treatment Phase|Lost to Follow-up|0|||
155070731|NCT02175758|559688119|FG005|Treatment Phase|Lost to Follow-up|0|||
155070732|NCT02175758|559688114|FG000|Treatment Phase|Adverse Event|0|||
155070733|NCT02175758|559688115|FG001|Treatment Phase|Adverse Event|0|||
155070734|NCT02175758|559688116|FG002|Treatment Phase|Adverse Event|0|||
155070735|NCT02175758|559688117|FG003|Treatment Phase|Adverse Event|0|||
155070736|NCT02175758|559688118|FG004|Treatment Phase|Adverse Event|1|||
155070737|NCT02175758|559688119|FG005|Treatment Phase|Adverse Event|0|||
155070738|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
155070739|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
155070740|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
155070741|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
155070742|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
155070743|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
155070744|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155070745|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155070746|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
155070747|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
155070748|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
155070749|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
155070750|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
155070751|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
155070752|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
155070753|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
155070754|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155070755|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
155070756|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155070757|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
155329828|NCT03593226|560642280|FG003|Overall Study|Physician Decision|0|||
155329829|NCT03593226|560642277|FG000|Overall Study|Clinical disease progression|0|||
155070758|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
155070759|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
155070760|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
155070761|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
155329830|NCT03593226|560642278|FG001|Overall Study|Clinical disease progression|0|||
155329831|NCT03593226|560642279|FG002|Overall Study|Clinical disease progression|1|||
155070762|NCT00620542|559688122|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
155329832|NCT03593226|560642280|FG003|Overall Study|Clinical disease progression|0|||
155070763|NCT00620542|559688123|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
155070764|NCT00620542|559688124|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
155070765|NCT00620542|559688125|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
155163501|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
155329833|NCT04517435|560642297|FG000|Overall Study|Withdrawal by Subject|0|||
155329834|NCT04517435|560642298|FG001|Overall Study|Withdrawal by Subject|0|||
155329835|NCT04517435|560642299|FG002|Overall Study|Withdrawal by Subject|1|||
155329836|NCT04517435|560642297|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
155329837|NCT04517435|560642298|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
155329838|NCT04517435|560642299|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
155329839|NCT06191679|560642300|FG000|Baseline|Lost to Follow-up|1|||
155329840|NCT06191679|560642301|FG001|Baseline|Lost to Follow-up|0|||
155329841|NCT06191679|560642302|FG002|Baseline|Lost to Follow-up|1|||
155329842|NCT06191679|560642303|FG003|Baseline|Lost to Follow-up|0|||
155329843|NCT06191679|560642300|FG000|Allocation to Group|Withdrawal by Subject|0|||
155329844|NCT06191679|560642301|FG001|Allocation to Group|Withdrawal by Subject|1|||
155329845|NCT06191679|560642302|FG002|Allocation to Group|Withdrawal by Subject|2|||
155329846|NCT06191679|560642303|FG003|Allocation to Group|Withdrawal by Subject|0|||
155329847|NCT06191679|560642300|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
155329848|NCT06191679|560642301|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
155329849|NCT06191679|560642302|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
155329850|NCT06191679|560642303|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
155329851|NCT06191679|560642300|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
155329852|NCT06191679|560642301|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
155070766|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
155070767|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
155070768|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
155070769|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
155070770|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
155070771|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
155070772|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
155070773|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
155070774|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
155070775|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
155070776|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
155070777|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
155070778|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
155070779|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
155070780|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
155070781|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
155070782|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
155070783|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
155070784|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
155070785|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
155070786|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
155070787|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
155070788|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
155070789|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
155070790|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
155070791|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
155070792|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
155070793|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
155070794|NCT00620542|559688122|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
155070795|NCT00620542|559688123|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
155070796|NCT00620542|559688124|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
155070797|NCT00620542|559688125|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
155070798|NCT01500083|559688126|FG000|Overall Study|Adverse Event|4|||
155070799|NCT01500083|559688127|FG001|Overall Study|Adverse Event|17|||
155070800|NCT01500083|559688126|FG000|Overall Study|Death|0|||
155070801|NCT01500083|559688127|FG001|Overall Study|Death|2|||
155070802|NCT01500083|559688126|FG000|Overall Study|Lost to Follow-up|1|||
155070803|NCT01500083|559688127|FG001|Overall Study|Lost to Follow-up|0|||
155070804|NCT01500083|559688126|FG000|Overall Study|Withdrawal of Consent|0|||
155070805|NCT01500083|559688127|FG001|Overall Study|Withdrawal of Consent|1|||
155070806|NCT01500083|559688126|FG000|Overall Study|Disease Progression|2|||
155070807|NCT01500083|559688127|FG001|Overall Study|Disease Progression|10|||
155329853|NCT06191679|560642302|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
155329854|NCT06191679|560642303|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
155329855|NCT06191679|560642300|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
155329856|NCT06191679|560642301|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
155329857|NCT06191679|560642302|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
155070808|NCT01500083|559688126|FG000|Overall Study|Investigator Discretion|3|||
155070809|NCT01500083|559688127|FG001|Overall Study|Investigator Discretion|8|||
155070810|NCT01500083|559688126|FG000|Overall Study|Other Reasons|2|||
155070811|NCT01500083|559688127|FG001|Overall Study|Other Reasons|5|||
155070812|NCT00741611|559688128|FG000|Overall Study|Death|0|||
155070813|NCT00741611|559688129|FG001|Overall Study|Death|0|||
155070814|NCT00741611|559688130|FG002|Overall Study|Death|1|||
155070815|NCT00741611|559688128|FG000|Overall Study|Withdrawal by Subject|0|||
155070816|NCT00741611|559688129|FG001|Overall Study|Withdrawal by Subject|2|||
155070817|NCT00741611|559688130|FG002|Overall Study|Withdrawal by Subject|2|||
155163502|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
155163503|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
155163504|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
155163505|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
155163506|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
155163507|NCT02952820|560034985|FG000|Active Treatment Period (6 Months)|Not treated|0|||
155163508|NCT02952820|560034986|FG001|Active Treatment Period (6 Months)|Not treated|0|||
155163509|NCT02952820|560034987|FG002|Active Treatment Period (6 Months)|Not treated|1|||
155163510|NCT03614156|560034988|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
155163511|NCT03614156|560034989|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
155163512|NCT03614156|560034990|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
155163513|NCT03614156|560034991|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
155163514|NCT03614156|560034988|FG000|Open-Label Treatment Period|Adverse Event|7|||
155163515|NCT03614156|560034989|FG001|Open-Label Treatment Period|Adverse Event|0|||
155163516|NCT03614156|560034990|FG002|Open-Label Treatment Period|Adverse Event|0|||
155163517|NCT03614156|560034991|FG003|Open-Label Treatment Period|Adverse Event|0|||
155163518|NCT03614156|560034988|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
155163519|NCT03614156|560034989|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155163520|NCT03614156|560034990|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
155163521|NCT03614156|560034991|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
155163522|NCT03614156|560034988|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
155163523|NCT03614156|560034989|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
155163524|NCT03614156|560034990|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
155163525|NCT03614156|560034991|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
155163526|NCT03614156|560034988|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
155163527|NCT03614156|560034989|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
155163528|NCT03614156|560034990|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
155163529|NCT03614156|560034991|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
155163530|NCT03614156|560034988|FG000|Open-Label Treatment Period|Protocol Violation|2|||
155163531|NCT03614156|560034989|FG001|Open-Label Treatment Period|Protocol Violation|0|||
155163532|NCT03614156|560034990|FG002|Open-Label Treatment Period|Protocol Violation|0|||
155163533|NCT03614156|560034991|FG003|Open-Label Treatment Period|Protocol Violation|0|||
155163534|NCT03614156|560034988|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
155163535|NCT03614156|560034989|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
155163536|NCT03614156|560034990|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
155163537|NCT03614156|560034991|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
155163538|NCT03614156|560034988|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
155163539|NCT03614156|560034989|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
155163540|NCT03614156|560034990|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
155163541|NCT03614156|560034991|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
155163542|NCT03614156|560034988|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
155163543|NCT03614156|560034989|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
155163544|NCT03614156|560034990|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
155163545|NCT03614156|560034991|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
155163546|NCT03614156|560034988|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155163547|NCT03614156|560034989|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
155163548|NCT03614156|560034990|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155163549|NCT03614156|560034991|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
155163550|NCT03614156|560034988|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155163551|NCT03614156|560034989|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
155163552|NCT03614156|560034990|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
155163553|NCT03614156|560034991|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
155163554|NCT03614156|560034988|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
155163555|NCT03614156|560034989|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
155163556|NCT03614156|560034990|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
155163557|NCT03614156|560034991|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
155329858|NCT06191679|560642303|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
155070818|NCT01555931|559688133|FG000|Overall Study|Lost to Follow-up|2|||
155070819|NCT01555931|559688134|FG001|Overall Study|Lost to Follow-up|5|||
155163558|NCT03614156|560034988|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
155163559|NCT03614156|560034989|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
155329859|NCT05464732|560642304|FG000|Overall Study|Lost to Follow-up|0|||
155329860|NCT05464732|560642305|FG001|Overall Study|Lost to Follow-up|1|||
155329861|NCT05464732|560642304|FG000|Overall Study|Adverse Event|1|||
155329862|NCT05464732|560642305|FG001|Overall Study|Adverse Event|0|||
155329863|NCT02678689|560642307|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
155329864|NCT02678689|560642308|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
155329865|NCT02761187|560642309|FG000|Overall Study|Too ill to Participate|13|||
155329866|NCT02761187|560642310|FG001|Overall Study|Too ill to Participate|8|||
155329867|NCT02761187|560642309|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
155329868|NCT02761187|560642310|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
155329869|NCT02761187|560642309|FG000|Overall Study|Patient withdrew consent|64|||
155329870|NCT02761187|560642310|FG001|Overall Study|Patient withdrew consent|58|||
155329871|NCT02761187|560642309|FG000|Overall Study|Physician discretion|4|||
155329872|NCT02761187|560642310|FG001|Overall Study|Physician discretion|8|||
155329873|NCT02761187|560642309|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
155329874|NCT02761187|560642310|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
155329875|NCT02761187|560642309|FG000|Overall Study|On Hospice|20|||
155329876|NCT02761187|560642310|FG001|Overall Study|On Hospice|26|||
155329877|NCT02761187|560642309|FG000|Overall Study|Deceased|474|||
155329878|NCT02761187|560642310|FG001|Overall Study|Deceased|642|||
155329879|NCT02761187|560642309|FG000|Overall Study|Lost to Follow-up|73|||
155329880|NCT02761187|560642310|FG001|Overall Study|Lost to Follow-up|63|||
155329881|NCT02761187|560642309|FG000|Overall Study|Due to study discontinued at site|100|||
155329882|NCT02761187|560642310|FG001|Overall Study|Due to study discontinued at site|85|||
155329883|NCT02761187|560642309|FG000|Overall Study|Reason not Specified|1484|||
155329884|NCT02761187|560642310|FG001|Overall Study|Reason not Specified|937|||
155329885|NCT05786612|560642311|FG000|Overall Study|Adverse Event|1|||
155329886|NCT05786612|560642312|FG001|Overall Study|Adverse Event|2|||
155329887|NCT05786612|560642311|FG000|Overall Study|one screening failure|0|||
155329888|NCT05786612|560642312|FG001|Overall Study|one screening failure|2|||
155329889|NCT05630833|560642317|FG000|Overall Study|Adverse Event|3|||
155329890|NCT05630833|560642318|FG001|Overall Study|Adverse Event|0|||
155329891|NCT05630833|560642317|FG000|Overall Study|Lack of Efficacy|0|||
155329892|NCT05630833|560642318|FG001|Overall Study|Lack of Efficacy|1|||
155329893|NCT05630833|560642317|FG000|Overall Study|Lost to Follow-up|1|||
155329894|NCT05630833|560642318|FG001|Overall Study|Lost to Follow-up|0|||
155329895|NCT05630833|560642317|FG000|Overall Study|Withdrawal by Subject|3|||
155329896|NCT05630833|560642318|FG001|Overall Study|Withdrawal by Subject|1|||
155329897|NCT03459196|560643539|FG000|Overall Study|Subject didn't receive study catheter|2|||
155329898|NCT00092534|560643542|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
155329899|NCT00092534|560643543|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
155329900|NCT00092534|560643544|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155329901|NCT00092534|560643545|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155329902|NCT00092534|560643546|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155329903|NCT00092534|560643542|FG000|Base Study Vaccination Period|Adverse Event|3|||
155329904|NCT00092534|560643543|FG001|Base Study Vaccination Period|Adverse Event|1|||
155070820|NCT01922011|559688135|FG000|Overall Study|Protocol Violation|0|||
155070821|NCT01922011|559688136|FG001|Overall Study|Protocol Violation|1|||
155070822|NCT01922011|559688135|FG000|Overall Study|Physician Decision|0|||
155070823|NCT01922011|559688136|FG001|Overall Study|Physician Decision|1|||
155070824|NCT01922011|559688135|FG000|Overall Study|Parent/Guardian Decision|3|||
155070825|NCT01922011|559688136|FG001|Overall Study|Parent/Guardian Decision|0|||
155070826|NCT01922011|559688135|FG000|Overall Study|Lost to Follow-up|0|||
155070827|NCT01922011|559688136|FG001|Overall Study|Lost to Follow-up|1|||
155070828|NCT01922011|559688135|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
155070829|NCT01922011|559688136|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
155070830|NCT01922011|559688135|FG000|Overall Study|Not Treated|1|||
155070831|NCT01922011|559688136|FG001|Overall Study|Not Treated|0|||
155070832|NCT01922011|559688135|FG000|Overall Study|Lack of willing home health agency|1|||
155070833|NCT01922011|559688136|FG001|Overall Study|Lack of willing home health agency|0|||
155070834|NCT01922011|559688135|FG000|Overall Study|Randomized in error|1|||
155329905|NCT00092534|560643544|FG002|Base Study Vaccination Period|Adverse Event|0|||
155329906|NCT00092534|560643545|FG003|Base Study Vaccination Period|Adverse Event|0|||
155329907|NCT00092534|560643546|FG004|Base Study Vaccination Period|Adverse Event|0|||
155070835|NCT01922011|559688136|FG001|Overall Study|Randomized in error|0|||
155329908|NCT00092534|560643542|FG000|Base Study Vaccination Period|Death|5|||
155329909|NCT00092534|560643543|FG001|Base Study Vaccination Period|Death|4|||
155329910|NCT00092534|560643544|FG002|Base Study Vaccination Period|Death|0|||
155329911|NCT00092534|560643545|FG003|Base Study Vaccination Period|Death|0|||
155329912|NCT00092534|560643546|FG004|Base Study Vaccination Period|Death|0|||
155329913|NCT00092534|560643542|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
155329914|NCT00092534|560643543|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
155070836|NCT01510756|559688137|FG000|Overall Study|Death|1|||
155070837|NCT01510756|559688137|FG000|Overall Study|Lack of Efficacy|2|||
155329915|NCT00092534|560643544|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
155329916|NCT00092534|560643545|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
155329917|NCT00092534|560643546|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155329918|NCT00092534|560643542|FG000|Base Study Vaccination Period|Physician Decision|1|||
155329919|NCT00092534|560643543|FG001|Base Study Vaccination Period|Physician Decision|0|||
155329920|NCT00092534|560643544|FG002|Base Study Vaccination Period|Physician Decision|0|||
155329921|NCT00092534|560643545|FG003|Base Study Vaccination Period|Physician Decision|0|||
155329922|NCT00092534|560643546|FG004|Base Study Vaccination Period|Physician Decision|0|||
155329923|NCT00092534|560643542|FG000|Base Study Vaccination Period|Pregnancy|9|||
155329924|NCT00092534|560643543|FG001|Base Study Vaccination Period|Pregnancy|7|||
155329925|NCT00092534|560643544|FG002|Base Study Vaccination Period|Pregnancy|0|||
155329926|NCT00092534|560643545|FG003|Base Study Vaccination Period|Pregnancy|0|||
155329927|NCT00092534|560643546|FG004|Base Study Vaccination Period|Pregnancy|0|||
155329928|NCT00092534|560643542|FG000|Base Study Vaccination Period|Protocol Violation|2|||
155329929|NCT00092534|560643543|FG001|Base Study Vaccination Period|Protocol Violation|1|||
155329930|NCT00092534|560643544|FG002|Base Study Vaccination Period|Protocol Violation|0|||
155329931|NCT00092534|560643545|FG003|Base Study Vaccination Period|Protocol Violation|0|||
155329932|NCT00092534|560643546|FG004|Base Study Vaccination Period|Protocol Violation|0|||
155329933|NCT00092534|560643542|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
155329934|NCT00092534|560643543|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
155329935|NCT00092534|560643544|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
155329936|NCT00092534|560643545|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
155329937|NCT00092534|560643546|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155329938|NCT00092534|560643542|FG000|Base Study Vaccination Period|Moved|14|||
155329939|NCT00092534|560643543|FG001|Base Study Vaccination Period|Moved|12|||
155329940|NCT00092534|560643544|FG002|Base Study Vaccination Period|Moved|0|||
155329941|NCT00092534|560643545|FG003|Base Study Vaccination Period|Moved|0|||
155329942|NCT00092534|560643546|FG004|Base Study Vaccination Period|Moved|0|||
155329943|NCT00092534|560643542|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
155329944|NCT00092534|560643543|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329945|NCT00092534|560643544|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329946|NCT00092534|560643545|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329947|NCT00092534|560643546|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
155329948|NCT00092534|560643542|FG000|Base Study Vaccination Period|Travel|1|||
155329949|NCT00092534|560643543|FG001|Base Study Vaccination Period|Travel|0|||
155329950|NCT00092534|560643544|FG002|Base Study Vaccination Period|Travel|0|||
155329951|NCT00092534|560643545|FG003|Base Study Vaccination Period|Travel|0|||
155329952|NCT00092534|560643546|FG004|Base Study Vaccination Period|Travel|0|||
155329953|NCT00092534|560643542|FG000|Base Study Vaccination Period|Site Closed|0|||
155329954|NCT00092534|560643543|FG001|Base Study Vaccination Period|Site Closed|1|||
155329955|NCT00092534|560643544|FG002|Base Study Vaccination Period|Site Closed|0|||
155329956|NCT00092534|560643545|FG003|Base Study Vaccination Period|Site Closed|0|||
155329957|NCT00092534|560643546|FG004|Base Study Vaccination Period|Site Closed|0|||
155329958|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Adverse Event|2|||
155329959|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Adverse Event|4|||
155329960|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Adverse Event|0|||
155329961|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Adverse Event|0|||
155329962|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Adverse Event|0|||
155329963|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Death|2|||
155329964|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Death|1|||
155329965|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Death|0|||
155329966|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Death|0|||
155329967|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Death|0|||
155329968|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
155329969|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
155329970|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
155329971|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
155329972|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
155329973|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Pregnancy|6|||
155329974|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Pregnancy|10|||
155329975|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Pregnancy|0|||
155329976|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Pregnancy|0|||
155329977|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Pregnancy|0|||
155329978|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
155329979|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
155329980|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
155329981|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
155329982|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
155329983|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
155329984|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
155329985|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
155329986|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
155329987|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
155329988|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Moved|62|||
155329989|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Moved|58|||
155329990|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Moved|0|||
155329991|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Moved|0|||
155329992|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Moved|0|||
155329993|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Travel|10|||
155329994|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Travel|7|||
155329995|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Travel|0|||
155329996|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Travel|0|||
155329997|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Travel|0|||
155329998|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Site Closed|0|||
155329999|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Site Closed|2|||
155330000|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Site Closed|0|||
155330001|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Site Closed|0|||
155330002|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Site Closed|0|||
155330003|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
155330004|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
155330005|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
155330006|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
155330007|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
155330008|NCT00092534|560643542|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
155330009|NCT00092534|560643543|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
155330010|NCT00092534|560643544|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
155330011|NCT00092534|560643545|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
155330012|NCT00092534|560643546|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
155330013|NCT00092534|560643542|FG000|Base Study EXT|Lost to Follow-up|0|||
155330014|NCT00092534|560643543|FG001|Base Study EXT|Lost to Follow-up|0|||
155330015|NCT00092534|560643544|FG002|Base Study EXT|Lost to Follow-up|41|||
155330016|NCT00092534|560643545|FG003|Base Study EXT|Lost to Follow-up|0|||
155330017|NCT00092534|560643546|FG004|Base Study EXT|Lost to Follow-up|0|||
155330018|NCT00092534|560643542|FG000|Base Study EXT|Physician Decision|0|||
155330019|NCT00092534|560643543|FG001|Base Study EXT|Physician Decision|0|||
155330020|NCT00092534|560643544|FG002|Base Study EXT|Physician Decision|1|||
155330021|NCT00092534|560643545|FG003|Base Study EXT|Physician Decision|0|||
155330022|NCT00092534|560643546|FG004|Base Study EXT|Physician Decision|0|||
155330023|NCT00092534|560643542|FG000|Base Study EXT|Pregnancy|0|||
155330024|NCT00092534|560643543|FG001|Base Study EXT|Pregnancy|0|||
155330025|NCT00092534|560643544|FG002|Base Study EXT|Pregnancy|12|||
155330026|NCT00092534|560643545|FG003|Base Study EXT|Pregnancy|0|||
155330027|NCT00092534|560643546|FG004|Base Study EXT|Pregnancy|0|||
155330028|NCT00092534|560643542|FG000|Base Study EXT|Withdrawal by Subject|0|||
155330029|NCT00092534|560643543|FG001|Base Study EXT|Withdrawal by Subject|0|||
155330030|NCT00092534|560643544|FG002|Base Study EXT|Withdrawal by Subject|18|||
155330031|NCT00092534|560643545|FG003|Base Study EXT|Withdrawal by Subject|0|||
155330032|NCT00092534|560643546|FG004|Base Study EXT|Withdrawal by Subject|0|||
155330033|NCT00092534|560643542|FG000|Base Study EXT|Participant moved|0|||
155330034|NCT00092534|560643543|FG001|Base Study EXT|Participant moved|0|||
155330035|NCT00092534|560643544|FG002|Base Study EXT|Participant moved|6|||
155330036|NCT00092534|560643545|FG003|Base Study EXT|Participant moved|0|||
155330037|NCT00092534|560643546|FG004|Base Study EXT|Participant moved|0|||
155330038|NCT00092534|560643542|FG000|Base Study EXT|Travel|0|||
155330039|NCT00092534|560643543|FG001|Base Study EXT|Travel|0|||
155330040|NCT00092534|560643544|FG002|Base Study EXT|Travel|2|||
155330041|NCT00092534|560643545|FG003|Base Study EXT|Travel|0|||
155330042|NCT00092534|560643546|FG004|Base Study EXT|Travel|0|||
155330043|NCT00092534|560643542|FG000|Base Study EXT|Site closed|0|||
155330044|NCT00092534|560643543|FG001|Base Study EXT|Site closed|0|||
155330045|NCT00092534|560643544|FG002|Base Study EXT|Site closed|21|||
155330046|NCT00092534|560643545|FG003|Base Study EXT|Site closed|0|||
155330047|NCT00092534|560643546|FG004|Base Study EXT|Site closed|0|||
154961820|NCT03123094|559285647|FG004|Overall Study|Withdrawal by Subject|1|||
154961821|NCT01735994|559285648|FG000|Overall Study|Withdrawal by Subject|6|||
155330048|NCT00092534|560643542|FG000|Base Study EXT|Study ended|0|||
155330049|NCT00092534|560643543|FG001|Base Study EXT|Study ended|0|||
155330050|NCT00092534|560643544|FG002|Base Study EXT|Study ended|29|||
155330051|NCT00092534|560643545|FG003|Base Study EXT|Study ended|0|||
155330052|NCT00092534|560643546|FG004|Base Study EXT|Study ended|0|||
155330053|NCT00092534|560643542|FG000|Base Study EXT|Protocol Violation|0|||
155330054|NCT00092534|560643543|FG001|Base Study EXT|Protocol Violation|0|||
155330055|NCT00092534|560643544|FG002|Base Study EXT|Protocol Violation|15|||
155330056|NCT00092534|560643545|FG003|Base Study EXT|Protocol Violation|0|||
155330057|NCT00092534|560643546|FG004|Base Study EXT|Protocol Violation|0|||
155330058|NCT00092534|560643542|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330059|NCT00092534|560643543|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330060|NCT00092534|560643544|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330061|NCT00092534|560643545|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
155330062|NCT00092534|560643546|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
155330063|NCT03083366|560643547|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
155330064|NCT03083366|560643548|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
155330065|NCT03083366|560643547|FG000|Enrollment Period|Lack of Efficacy|1|||
155330066|NCT03083366|560643548|FG001|Enrollment Period|Lack of Efficacy|0|||
155330067|NCT06056310|560643553|FG000|Overall Study|Other Reasons|2|||
155330068|NCT06056310|560643553|FG000|Overall Study|Sponsor Request|16|||
155330069|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330070|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330071|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
155330072|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
155330073|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330074|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
155330075|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
155330076|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
155330077|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
155330078|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
155330079|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Death|0|||
155330080|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Death|0|||
155330081|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Death|0|||
155330082|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Death|0|||
155330083|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Death|0|||
155330084|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Death|0|||
155330085|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Death|0|||
155330086|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Death|0|||
155330087|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Death|1|||
155330088|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Death|0|||
155330089|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
155330090|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330091|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
155070838|NCT01510756|559688137|FG000|Overall Study|Physician Decision|1|||
155070839|NCT02299167|559688140|FG000|Overall Study|patients were excluded from the study|11|||
155070840|NCT05513950|559688147|FG000|Overall Study|Not treated due to technical reasons|0|||
155070841|NCT05513950|559688148|FG001|Overall Study|Not treated due to technical reasons|0|||
155070842|NCT05513950|559688149|FG002|Overall Study|Not treated due to technical reasons|1|||
155070843|NCT05513950|559688150|FG003|Overall Study|Not treated due to technical reasons|0|||
155070844|NCT02903914|559688151|FG000|Overall Study|Adverse Event|0|||
155070845|NCT02903914|559688152|FG001|Overall Study|Adverse Event|0|||
155070846|NCT02903914|559688153|FG002|Overall Study|Adverse Event|1|||
155070847|NCT02903914|559688154|FG003|Overall Study|Adverse Event|0|||
155070848|NCT02903914|559688155|FG004|Overall Study|Adverse Event|0|||
155070849|NCT02903914|559688156|FG005|Overall Study|Adverse Event|0|||
155070850|NCT02903914|559688157|FG006|Overall Study|Adverse Event|2|||
155070851|NCT02903914|559688158|FG007|Overall Study|Adverse Event|0|||
155070852|NCT02903914|559688151|FG000|Overall Study|Withdrawal by Subject|3|||
155070853|NCT02903914|559688152|FG001|Overall Study|Withdrawal by Subject|1|||
155070854|NCT02903914|559688153|FG002|Overall Study|Withdrawal by Subject|28|||
155070855|NCT02903914|559688154|FG003|Overall Study|Withdrawal by Subject|0|||
155070856|NCT02903914|559688155|FG004|Overall Study|Withdrawal by Subject|1|||
155330092|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330093|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330094|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330095|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330096|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330097|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
155330098|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
155330099|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330100|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330101|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330102|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330103|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
155330104|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330105|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330106|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
155330107|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
155330108|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
155330109|NCT02036970|560643555|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330110|NCT02036970|560643556|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330111|NCT02036970|560643557|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330112|NCT02036970|560643558|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
155330113|NCT02036970|560643559|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330114|NCT02036970|560643560|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330115|NCT02036970|560643561|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330116|NCT02036970|560643562|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330117|NCT02036970|560643563|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330118|NCT02036970|560643564|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
155330119|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
155330120|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
155330121|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
155330122|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
155330123|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
155330124|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
155330125|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
155330126|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
155330127|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
155330128|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
155330129|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330130|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330131|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330132|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330133|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330134|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330135|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330136|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
155330137|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330138|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
155330139|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330140|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
155330141|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
155330142|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330143|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330144|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330145|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330146|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330147|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
155330148|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
155330149|NCT02036970|560643555|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330150|NCT02036970|560643556|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
155330151|NCT02036970|560643557|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
155330152|NCT02036970|560643558|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
155330153|NCT02036970|560643559|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330154|NCT02036970|560643560|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330155|NCT02036970|560643561|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330156|NCT02036970|560643562|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330157|NCT02036970|560643563|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
155330158|NCT02036970|560643564|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
155330159|NCT02702843|560643565|FG000|Overall Study|Insufficient data to analyze|15|||
155330160|NCT02702843|560643566|FG001|Overall Study|Insufficient data to analyze|23|||
155330161|NCT05802173|560643567|FG000|Overall Study|Withdrawal by Subject|2|||
155330162|NCT05802173|560643568|FG001|Overall Study|Withdrawal by Subject|0|||
155330163|NCT05802173|560643569|FG002|Overall Study|Withdrawal by Subject|0|||
155330164|NCT05802173|560643567|FG000|Overall Study|Protocol Violation|1|||
155330165|NCT05802173|560643568|FG001|Overall Study|Protocol Violation|0|||
155330166|NCT05802173|560643569|FG002|Overall Study|Protocol Violation|0|||
155330167|NCT05802173|560643567|FG000|Overall Study|Lost to Follow-up|0|||
155330168|NCT05802173|560643568|FG001|Overall Study|Lost to Follow-up|6|||
155330169|NCT05802173|560643569|FG002|Overall Study|Lost to Follow-up|4|||
155330170|NCT05802173|560643567|FG000|Overall Study|non-compliance|0|||
155330171|NCT05802173|560643568|FG001|Overall Study|non-compliance|1|||
155330172|NCT05802173|560643569|FG002|Overall Study|non-compliance|0|||
155330173|NCT03752684|560643571|FG000|Overall Study|Lost to Follow-up|4|||
155330174|NCT00360269|560643574|FG000|Overall Study|Lost to Follow-up|7|||
155330175|NCT00360269|560643575|FG001|Overall Study|Lost to Follow-up|9|||
155330176|NCT00360269|560643574|FG000|Overall Study|Physician Decision|1|||
155330177|NCT00360269|560643575|FG001|Overall Study|Physician Decision|2|||
155330178|NCT00360269|560643574|FG000|Overall Study|Adverse Event|1|||
155330179|NCT00360269|560643575|FG001|Overall Study|Adverse Event|0|||
155330180|NCT00360269|560643574|FG000|Overall Study|Withdrawal by Subject|1|||
155330181|NCT00360269|560643575|FG001|Overall Study|Withdrawal by Subject|1|||
155330182|NCT00048932|560643578|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
155330183|NCT00048932|560643579|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
155330184|NCT00048932|560643580|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
155330185|NCT00048932|560643578|FG000|Double Blind Period (DB)|Adverse Event|51|||
155330186|NCT00048932|560643579|FG001|Double Blind Period (DB)|Adverse Event|19|||
155330187|NCT00048932|560643580|FG002|Double Blind Period (DB)|Adverse Event|0|||
155330188|NCT00048932|560643578|FG000|Double Blind Period (DB)|Death|5|||
155330189|NCT00048932|560643579|FG001|Double Blind Period (DB)|Death|3|||
155330190|NCT00048932|560643580|FG002|Double Blind Period (DB)|Death|0|||
155330191|NCT00048932|560643578|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
155330192|NCT00048932|560643579|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
155330193|NCT00048932|560643580|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
155330194|NCT00048932|560643578|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
155330195|NCT00048932|560643579|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
155330196|NCT00048932|560643580|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
155330197|NCT00048932|560643578|FG000|Double Blind Period (DB)|Relocation|1|||
155330198|NCT00048932|560643579|FG001|Double Blind Period (DB)|Relocation|0|||
155330199|NCT00048932|560643580|FG002|Double Blind Period (DB)|Relocation|0|||
155330200|NCT00048932|560643578|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
155330201|NCT00048932|560643579|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
155330202|NCT00048932|560643580|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
155330203|NCT00048932|560643578|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
155330204|NCT00048932|560643579|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
154961822|NCT01735994|559285649|FG001|Overall Study|Withdrawal by Subject|4|||
154961823|NCT01735994|559285648|FG000|Overall Study|Injury|2|||
154961824|NCT01735994|559285649|FG001|Overall Study|Injury|0|||
154961825|NCT01735994|559285648|FG000|Overall Study|Kicked off team|5|||
154961826|NCT01735994|559285649|FG001|Overall Study|Kicked off team|0|||
155330205|NCT00048932|560643580|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
155330206|NCT00048932|560643578|FG000|Double Blind Period (DB)|Pregnancy|1|||
155330207|NCT00048932|560643579|FG001|Double Blind Period (DB)|Pregnancy|0|||
155330208|NCT00048932|560643580|FG002|Double Blind Period (DB)|Pregnancy|0|||
155330209|NCT00048932|560643578|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
155330210|NCT00048932|560643579|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
155330211|NCT00048932|560643580|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
155330212|NCT00048932|560643578|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
155330213|NCT00048932|560643579|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
155330214|NCT00048932|560643580|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
155330215|NCT00048932|560643578|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
155330216|NCT00048932|560643579|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
155330217|NCT00048932|560643580|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
154961827|NCT01735994|559285648|FG000|Overall Study|Lost to Follow-up|50|||
154961828|NCT01735994|559285649|FG001|Overall Study|Lost to Follow-up|62|||
155330218|NCT00048932|560643578|FG000|Open Label Period (OL)|Death|0|||
155330219|NCT00048932|560643579|FG001|Open Label Period (OL)|Death|0|||
155330220|NCT00048932|560643580|FG002|Open Label Period (OL)|Death|25|||
155330221|NCT00048932|560643578|FG000|Open Label Period (OL)|Adverse Event|0|||
155330222|NCT00048932|560643579|FG001|Open Label Period (OL)|Adverse Event|0|||
155330223|NCT00048932|560643580|FG002|Open Label Period (OL)|Adverse Event|103|||
155330224|NCT00048932|560643578|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
155330225|NCT00048932|560643579|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
155330226|NCT00048932|560643580|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
155330227|NCT00048932|560643578|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
155330228|NCT00048932|560643579|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
155330229|NCT00048932|560643580|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
155330230|NCT00048932|560643578|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
155330231|NCT00048932|560643579|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
155330232|NCT00048932|560643580|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
155330233|NCT00048932|560643578|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
155330234|NCT00048932|560643579|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
155330235|NCT00048932|560643580|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
155330236|NCT00048932|560643578|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
155330237|NCT00048932|560643579|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
155330238|NCT00048932|560643580|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
155330239|NCT00048932|560643578|FG000|Open Label Period (OL)|Pregnancy|0|||
155070857|NCT02903914|559688156|FG005|Overall Study|Withdrawal by Subject|2|||
155070858|NCT02903914|559688157|FG006|Overall Study|Withdrawal by Subject|12|||
155070859|NCT02903914|559688158|FG007|Overall Study|Withdrawal by Subject|0|||
155070860|NCT02903914|559688151|FG000|Overall Study|Progressive Disease|1|||
155070861|NCT02903914|559688152|FG001|Overall Study|Progressive Disease|0|||
155070862|NCT02903914|559688153|FG002|Overall Study|Progressive Disease|4|||
155070863|NCT02903914|559688154|FG003|Overall Study|Progressive Disease|0|||
155070864|NCT02903914|559688155|FG004|Overall Study|Progressive Disease|0|||
155070865|NCT02903914|559688156|FG005|Overall Study|Progressive Disease|0|||
155070866|NCT02903914|559688157|FG006|Overall Study|Progressive Disease|2|||
155070867|NCT02903914|559688158|FG007|Overall Study|Progressive Disease|0|||
155070868|NCT02903914|559688151|FG000|Overall Study|Death|0|||
155070869|NCT02903914|559688152|FG001|Overall Study|Death|0|||
155070870|NCT02903914|559688153|FG002|Overall Study|Death|9|||
155070871|NCT02903914|559688154|FG003|Overall Study|Death|0|||
155070872|NCT02903914|559688155|FG004|Overall Study|Death|1|||
155070873|NCT02903914|559688156|FG005|Overall Study|Death|3|||
155070874|NCT02903914|559688157|FG006|Overall Study|Death|24|||
155070875|NCT02903914|559688158|FG007|Overall Study|Death|2|||
155070876|NCT02903914|559688151|FG000|Overall Study|Lost to Follow-up|0|||
155070877|NCT02903914|559688152|FG001|Overall Study|Lost to Follow-up|1|||
155070878|NCT02903914|559688153|FG002|Overall Study|Lost to Follow-up|0|||
155070879|NCT02903914|559688154|FG003|Overall Study|Lost to Follow-up|0|||
155070880|NCT02903914|559688155|FG004|Overall Study|Lost to Follow-up|2|||
155070881|NCT02903914|559688156|FG005|Overall Study|Lost to Follow-up|0|||
155070882|NCT02903914|559688157|FG006|Overall Study|Lost to Follow-up|1|||
155070883|NCT02903914|559688158|FG007|Overall Study|Lost to Follow-up|0|||
155070884|NCT02903914|559688151|FG000|Overall Study|Physician Decision|0|||
155070885|NCT02903914|559688152|FG001|Overall Study|Physician Decision|0|||
155070886|NCT02903914|559688153|FG002|Overall Study|Physician Decision|1|||
155070887|NCT02903914|559688154|FG003|Overall Study|Physician Decision|0|||
155070888|NCT02903914|559688155|FG004|Overall Study|Physician Decision|0|||
155070889|NCT02903914|559688156|FG005|Overall Study|Physician Decision|0|||
155070890|NCT02903914|559688157|FG006|Overall Study|Physician Decision|1|||
155070891|NCT02903914|559688158|FG007|Overall Study|Physician Decision|0|||
155070892|NCT02903914|559688151|FG000|Overall Study|Symptomatic Deterioration|0|||
155070893|NCT02903914|559688152|FG001|Overall Study|Symptomatic Deterioration|0|||
155070894|NCT02903914|559688153|FG002|Overall Study|Symptomatic Deterioration|1|||
155070895|NCT02903914|559688154|FG003|Overall Study|Symptomatic Deterioration|0|||
155070896|NCT02903914|559688155|FG004|Overall Study|Symptomatic Deterioration|0|||
155330240|NCT00048932|560643579|FG001|Open Label Period (OL)|Pregnancy|0|||
155330241|NCT00048932|560643580|FG002|Open Label Period (OL)|Pregnancy|6|||
155330242|NCT00048932|560643578|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
155330243|NCT00048932|560643579|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
155330244|NCT00048932|560643580|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
155330245|NCT00048932|560643578|FG000|Open Label Period (OL)|Investigator Retiring|0|||
155330246|NCT00048932|560643579|FG001|Open Label Period (OL)|Investigator Retiring|0|||
155330247|NCT00048932|560643580|FG002|Open Label Period (OL)|Investigator Retiring|2|||
155070897|NCT02903914|559688156|FG005|Overall Study|Symptomatic Deterioration|0|||
155330248|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
155070898|NCT02903914|559688157|FG006|Overall Study|Symptomatic Deterioration|0|||
155070899|NCT02903914|559688158|FG007|Overall Study|Symptomatic Deterioration|0|||
155330249|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
155330250|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
155070900|NCT02903914|559688151|FG000|Overall Study|New Cancer Therapy|2|||
155070901|NCT02903914|559688152|FG001|Overall Study|New Cancer Therapy|2|||
155070902|NCT02903914|559688153|FG002|Overall Study|New Cancer Therapy|21|||
155070903|NCT02903914|559688154|FG003|Overall Study|New Cancer Therapy|4|||
155070904|NCT02903914|559688155|FG004|Overall Study|New Cancer Therapy|3|||
155070905|NCT02903914|559688156|FG005|Overall Study|New Cancer Therapy|6|||
155070906|NCT02903914|559688157|FG006|Overall Study|New Cancer Therapy|56|||
155070907|NCT02903914|559688158|FG007|Overall Study|New Cancer Therapy|3|||
155070908|NCT02903914|559688151|FG000|Overall Study|Didn't Return to Site|1|||
155070909|NCT02903914|559688152|FG001|Overall Study|Didn't Return to Site|0|||
155070910|NCT02903914|559688153|FG002|Overall Study|Didn't Return to Site|1|||
155070911|NCT02903914|559688154|FG003|Overall Study|Didn't Return to Site|1|||
155070912|NCT02903914|559688155|FG004|Overall Study|Didn't Return to Site|0|||
155070913|NCT02903914|559688156|FG005|Overall Study|Didn't Return to Site|0|||
155070914|NCT02903914|559688157|FG006|Overall Study|Didn't Return to Site|2|||
155070915|NCT02903914|559688158|FG007|Overall Study|Didn't Return to Site|0|||
155163560|NCT03614156|560034990|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
155163561|NCT03614156|560034991|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
155163562|NCT03614156|560034988|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
155163563|NCT03614156|560034989|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
155163564|NCT03614156|560034990|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
155163565|NCT03614156|560034991|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
155163566|NCT03614156|560034988|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
155163567|NCT03614156|560034989|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
155163568|NCT03614156|560034990|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
155163569|NCT03614156|560034991|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
155163570|NCT03614156|560034988|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
155163571|NCT03614156|560034989|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
155163572|NCT03614156|560034990|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
155163573|NCT03614156|560034991|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
155163574|NCT03614156|560034988|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
155163575|NCT03614156|560034989|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
155163576|NCT03614156|560034990|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
155163577|NCT03614156|560034991|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
155163578|NCT03857867|560034992|FG000|Overall Study|Physician Decision|1|||
155163579|NCT03070964|560034993|FG000|Overall Study|Progressive disease|8|||
155163580|NCT03070964|560034993|FG000|Overall Study|Treatment-unrelated adverse event|2|||
155163581|NCT03070964|560034993|FG000|Overall Study|Never treated|1|||
155163582|NCT03070964|560034993|FG000|Overall Study|Physician Decision|1|||
155163583|NCT03070964|560034993|FG000|Overall Study|Withdrawal by Subject|1|||
155163584|NCT03070964|560034993|FG000|Overall Study|Adverse Event|1|||
155163585|NCT01094119|560034994|FG000|Overall Study|Lack of Efficacy|2|||
155163586|NCT01094119|560034995|FG001|Overall Study|Lack of Efficacy|4|||
155163587|NCT01626872|560034996|FG000|Overall Study|Physician Decision|13|||
155163588|NCT01626872|560034997|FG001|Overall Study|Physician Decision|9|||
155163589|NCT01626872|560034998|FG002|Overall Study|Physician Decision|6|||
155163590|NCT01626872|560034996|FG000|Overall Study|Withdrawal by Subject|19|||
155163591|NCT01626872|560034997|FG001|Overall Study|Withdrawal by Subject|27|||
155163592|NCT01626872|560034998|FG002|Overall Study|Withdrawal by Subject|8|||
155163593|NCT01626872|560034996|FG000|Overall Study|Adverse Event (including Death)|20|||
155330251|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Relocated|0|||
155330252|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Relocated|0|||
155330253|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Relocated|6|||
155330254|NCT00048932|560643578|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
155330255|NCT00048932|560643579|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
155330256|NCT00048932|560643580|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
155330257|NCT00048932|560643578|FG000|Open Label Period (OL)|Site Closure|0|||
155330258|NCT00048932|560643579|FG001|Open Label Period (OL)|Site Closure|0|||
155330259|NCT00048932|560643580|FG002|Open Label Period (OL)|Site Closure|3|||
155330260|NCT00048932|560643578|FG000|Open Label Period (OL)|Trial Terminated|0|||
155330261|NCT00048932|560643579|FG001|Open Label Period (OL)|Trial Terminated|0|||
155330262|NCT00048932|560643580|FG002|Open Label Period (OL)|Trial Terminated|1|||
155330263|NCT00048932|560643578|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
155330264|NCT00048932|560643579|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
155330265|NCT00048932|560643580|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
155330266|NCT00048932|560643578|FG000|Open Label Period (OL)|Patient Decision|0|||
155330267|NCT00048932|560643579|FG001|Open Label Period (OL)|Patient Decision|0|||
155330268|NCT00048932|560643580|FG002|Open Label Period (OL)|Patient Decision|4|||
155330269|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
155330270|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
155330271|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
155330272|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
155330273|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
155330274|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
155330275|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
155330276|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
155330277|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
155330278|NCT00048932|560643578|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
155330279|NCT00048932|560643579|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
155330280|NCT00048932|560643580|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
155330281|NCT00048932|560643578|FG000|Open Label Period (OL)|Investigator Decision|0|||
155330282|NCT00048932|560643579|FG001|Open Label Period (OL)|Investigator Decision|0|||
155330283|NCT00048932|560643580|FG002|Open Label Period (OL)|Investigator Decision|4|||
155330284|NCT00048932|560643578|FG000|Open Label Period (OL)|Site Staff Issues|0|||
155330285|NCT00048932|560643579|FG001|Open Label Period (OL)|Site Staff Issues|0|||
155330286|NCT00048932|560643580|FG002|Open Label Period (OL)|Site Staff Issues|2|||
155330287|NCT00048932|560643578|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
155330288|NCT00048932|560643579|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
155330289|NCT00048932|560643580|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
155330290|NCT00048932|560643578|FG000|Open Label Period (OL)|Participant Surgery|0|||
155330291|NCT00048932|560643579|FG001|Open Label Period (OL)|Participant Surgery|0|||
155330292|NCT00048932|560643580|FG002|Open Label Period (OL)|Participant Surgery|1|||
155330293|NCT02568215|560643585|FG000|Overall Study|Death|1|||
155330294|NCT02568215|560643586|FG001|Overall Study|Death|2|||
155330295|NCT02568215|560643587|FG002|Overall Study|Death|0|||
155330296|NCT02568215|560643585|FG000|Overall Study|Physician Decision|2|||
155330297|NCT02568215|560643586|FG001|Overall Study|Physician Decision|2|||
155330298|NCT02568215|560643587|FG002|Overall Study|Physician Decision|2|||
155330299|NCT02568215|560643585|FG000|Overall Study|Lost to Follow-up|29|||
155330300|NCT02568215|560643586|FG001|Overall Study|Lost to Follow-up|32|||
155330301|NCT02568215|560643587|FG002|Overall Study|Lost to Follow-up|41|||
155330302|NCT02568215|560643585|FG000|Overall Study|Withdrawal by Subject|21|||
155330303|NCT02568215|560643586|FG001|Overall Study|Withdrawal by Subject|19|||
155330304|NCT02568215|560643587|FG002|Overall Study|Withdrawal by Subject|22|||
155330305|NCT02568215|560643585|FG000|Overall Study|Protocol Violation|1|||
155330306|NCT02568215|560643586|FG001|Overall Study|Protocol Violation|1|||
155330307|NCT02568215|560643587|FG002|Overall Study|Protocol Violation|0|||
155330308|NCT02568215|560643585|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
155330309|NCT02568215|560643586|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
155330310|NCT02568215|560643587|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
155330311|NCT02568215|560643585|FG000|Overall Study|Other|0|||
155330312|NCT02568215|560643586|FG001|Overall Study|Other|1|||
155330313|NCT02568215|560643587|FG002|Overall Study|Other|4|||
155330314|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
155330315|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
155330316|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
155330317|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Death|0|||
155330318|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Death|2|||
155330319|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Death|1|||
155330320|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
155330321|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
155330322|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
155330323|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
155330324|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
155330325|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
155330326|NCT00790569|560643588|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
155330327|NCT00790569|560643589|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
155330328|NCT00790569|560643590|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
155330329|NCT00790569|560643588|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
155330330|NCT00790569|560643589|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
155330331|NCT00790569|560643590|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
155330332|NCT01627561|560643591|FG000|Overall Study|Lost to Follow-up|1|||
155330333|NCT01627561|560643592|FG001|Overall Study|Lost to Follow-up|0|||
155330334|NCT01627561|560643591|FG000|Overall Study|Withdrawal by Subject|0|||
155330335|NCT01627561|560643592|FG001|Overall Study|Withdrawal by Subject|1|||
155330336|NCT01627561|560643591|FG000|Overall Study|Migrated/moved from study area|0|||
155330337|NCT01627561|560643592|FG001|Overall Study|Migrated/moved from study area|2|||
155330338|NCT03244800|560643593|FG000|Overall Study|Adverse Event|0|||
155330339|NCT03244800|560643594|FG001|Overall Study|Adverse Event|1|||
155330340|NCT03244800|560643595|FG002|Overall Study|Adverse Event|0|||
155330341|NCT03244800|560643596|FG003|Overall Study|Adverse Event|1|||
155070916|NCT02903914|559688151|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
155330342|NCT03244800|560643593|FG000|Overall Study|Withdrew treatment|0|||
155330343|NCT03244800|560643594|FG001|Overall Study|Withdrew treatment|0|||
155070917|NCT02903914|559688152|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
155070918|NCT02903914|559688153|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
155070919|NCT02903914|559688154|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
155070920|NCT02903914|559688155|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
155070921|NCT02903914|559688156|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
155070922|NCT02903914|559688157|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
155070923|NCT02903914|559688158|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
155070924|NCT02903914|559688151|FG000|Overall Study|Follow-up Did Not Occur|0|||
155070925|NCT02903914|559688152|FG001|Overall Study|Follow-up Did Not Occur|1|||
155070926|NCT02903914|559688153|FG002|Overall Study|Follow-up Did Not Occur|1|||
155070927|NCT02903914|559688154|FG003|Overall Study|Follow-up Did Not Occur|0|||
155070928|NCT02903914|559688155|FG004|Overall Study|Follow-up Did Not Occur|2|||
155070929|NCT02903914|559688156|FG005|Overall Study|Follow-up Did Not Occur|0|||
155070930|NCT02903914|559688157|FG006|Overall Study|Follow-up Did Not Occur|8|||
155070931|NCT02903914|559688158|FG007|Overall Study|Follow-up Did Not Occur|0|||
155070932|NCT02903914|559688151|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
155070933|NCT02903914|559688152|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
155070934|NCT02903914|559688153|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
155070935|NCT02903914|559688154|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
155070936|NCT02903914|559688155|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
155070937|NCT02903914|559688156|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
155070938|NCT02903914|559688157|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
155070939|NCT02903914|559688158|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
155070940|NCT02903914|559688151|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
155070941|NCT02903914|559688152|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
155070942|NCT02903914|559688153|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
155070943|NCT02903914|559688154|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
155070944|NCT02903914|559688155|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
155070945|NCT02903914|559688156|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
155070946|NCT02903914|559688157|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
155070947|NCT02903914|559688158|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
155070948|NCT02903914|559688151|FG000|Overall Study|Clinical Disease Progression|0|||
155070949|NCT02903914|559688152|FG001|Overall Study|Clinical Disease Progression|0|||
155163594|NCT01626872|560034997|FG001|Overall Study|Adverse Event (including Death)|28|||
155163595|NCT01626872|560034998|FG002|Overall Study|Adverse Event (including Death)|8|||
155163596|NCT01626872|560034996|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
155163597|NCT01626872|560034997|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
155163598|NCT01626872|560034998|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
155163599|NCT01587924|560034999|FG000|Overall Study|Adverse Event|0|||
155163600|NCT01587924|560035000|FG001|Overall Study|Adverse Event|2|||
155163601|NCT01587924|560035001|FG002|Overall Study|Adverse Event|0|||
155163602|NCT01587924|560035002|FG003|Overall Study|Adverse Event|0|||
155163603|NCT01587924|560034999|FG000|Overall Study|Protocol Violation|2|||
155163604|NCT01587924|560035000|FG001|Overall Study|Protocol Violation|1|||
155163605|NCT01587924|560035001|FG002|Overall Study|Protocol Violation|2|||
155163606|NCT01587924|560035002|FG003|Overall Study|Protocol Violation|1|||
155163607|NCT01587924|560034999|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
155163608|NCT01587924|560035000|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
155163609|NCT01587924|560035001|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
155163610|NCT01587924|560035002|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
155163611|NCT01587924|560034999|FG000|Overall Study|Withdrawal by Subject|0|||
155163612|NCT01587924|560035000|FG001|Overall Study|Withdrawal by Subject|1|||
155163613|NCT01587924|560035001|FG002|Overall Study|Withdrawal by Subject|1|||
155163614|NCT01587924|560035002|FG003|Overall Study|Withdrawal by Subject|0|||
155163615|NCT01578486|560035003|FG000|Overall Study|Physician Decision|3|||
155163616|NCT01578486|560035003|FG000|Overall Study|Withdrawal by Subject|2|||
155163617|NCT02425943|560035004|FG000|Overall Study|Adverse Event|3|||
155163618|NCT02425943|560035005|FG001|Overall Study|Adverse Event|1|||
155163619|NCT02425943|560035004|FG000|Overall Study|Lost to Follow-up|59|||
155163620|NCT02425943|560035005|FG001|Overall Study|Lost to Follow-up|37|||
155163621|NCT02425943|560035004|FG000|Overall Study|Protocol Violation|4|||
155163622|NCT02425943|560035005|FG001|Overall Study|Protocol Violation|1|||
155163623|NCT02425943|560035004|FG000|Overall Study|Withdrawal by Subject|64|||
155163624|NCT02425943|560035005|FG001|Overall Study|Withdrawal by Subject|31|||
155163625|NCT02425943|560035004|FG000|Overall Study|Other|6|||
155163626|NCT02425943|560035005|FG001|Overall Study|Other|0|||
155163627|NCT01106248|560035007|FG000|Overall Study|Adverse Event|1|||
155163628|NCT01106248|560035007|FG000|Overall Study|Administrative|2|||
155163629|NCT00357903|560035008|FG000|Overall Study|Adverse Event|87|||
155163630|NCT00357903|560035009|FG001|Overall Study|Adverse Event|4|||
155330344|NCT03244800|560643595|FG002|Overall Study|Withdrew treatment|0|||
155163631|NCT00357903|560035008|FG000|Overall Study|Death|33|||
155163632|NCT00357903|560035009|FG001|Overall Study|Death|0|||
155163633|NCT00357903|560035008|FG000|Overall Study|Lost to Follow-up|23|||
155330345|NCT03244800|560643596|FG003|Overall Study|Withdrew treatment|1|||
155330346|NCT00890591|560643604|FG000|Overall Study|Lack of Efficacy|20|||
155330347|NCT02941549|560643605|FG000|Overall Study|Adverse Event|1|||
155330348|NCT02941549|560643606|FG001|Overall Study|Adverse Event|0|||
155330349|NCT02941549|560643607|FG002|Overall Study|Adverse Event|0|||
155330350|NCT02941549|560643605|FG000|Overall Study|Withdrawal by Subject|2|||
155330351|NCT02941549|560643606|FG001|Overall Study|Withdrawal by Subject|1|||
155330352|NCT02941549|560643607|FG002|Overall Study|Withdrawal by Subject|2|||
155330353|NCT03451422|560643614|FG000|Overall Study|Lost to Follow-up|0|||
155330354|NCT03451422|560643615|FG001|Overall Study|Lost to Follow-up|0|||
155330355|NCT03451422|560643616|FG002|Overall Study|Lost to Follow-up|0|||
155330356|NCT03451422|560643617|FG003|Overall Study|Lost to Follow-up|0|||
155330357|NCT03451422|560643618|FG004|Overall Study|Lost to Follow-up|0|||
155330358|NCT03451422|560643619|FG005|Overall Study|Lost to Follow-up|1|||
155330359|NCT03451422|560643614|FG000|Overall Study|Decision by sponsor|1|||
155330360|NCT03451422|560643615|FG001|Overall Study|Decision by sponsor|0|||
155330361|NCT03451422|560643616|FG002|Overall Study|Decision by sponsor|1|||
155330362|NCT03451422|560643617|FG003|Overall Study|Decision by sponsor|0|||
155330363|NCT03451422|560643618|FG004|Overall Study|Decision by sponsor|0|||
155330364|NCT03451422|560643619|FG005|Overall Study|Decision by sponsor|0|||
155330365|NCT03451422|560643614|FG000|Overall Study|Withdrawal by Subject|0|||
155330366|NCT03451422|560643615|FG001|Overall Study|Withdrawal by Subject|0|||
155330367|NCT03451422|560643616|FG002|Overall Study|Withdrawal by Subject|2|||
155330368|NCT03451422|560643617|FG003|Overall Study|Withdrawal by Subject|3|||
155330369|NCT03451422|560643618|FG004|Overall Study|Withdrawal by Subject|2|||
155330370|NCT03451422|560643619|FG005|Overall Study|Withdrawal by Subject|1|||
155330371|NCT04545619|560643620|FG000|Overall Study|due to equipment challenges|1|||
155330372|NCT04384172|560643623|FG000|Overall Study|Lost to Follow-up|0|||
155330373|NCT04384172|560643624|FG001|Overall Study|Lost to Follow-up|2|||
155330374|NCT04384172|560643623|FG000|Overall Study|Pregnancy|1|||
155330375|NCT04384172|560643624|FG001|Overall Study|Pregnancy|0|||
155330376|NCT04384172|560643623|FG000|Overall Study|Withdrawal by Subject|0|||
155330377|NCT04384172|560643624|FG001|Overall Study|Withdrawal by Subject|1|||
155330378|NCT04949542|560643625|FG000|Overall Study|Lost to Follow-up|4|||
155330379|NCT04949542|560643626|FG001|Overall Study|Lost to Follow-up|1|||
155330380|NCT01536093|560643629|FG000|Overall Study|Death|1|||
155330381|NCT01536093|560643630|FG001|Overall Study|Death|2|||
155330382|NCT01536093|560643629|FG000|Overall Study|absence of maternal colostrum|2|||
155330383|NCT01536093|560643630|FG001|Overall Study|absence of maternal colostrum|0|||
155330384|NCT01536093|560643629|FG000|Overall Study|Withdrawal by Subject|0|||
155330385|NCT01536093|560643630|FG001|Overall Study|Withdrawal by Subject|1|||
155330386|NCT01211184|560643631|FG000|Overall Study|Withdrawal by Subject|0|||
155330387|NCT01211184|560643632|FG001|Overall Study|Withdrawal by Subject|2|||
155330388|NCT01211184|560643633|FG002|Overall Study|Withdrawal by Subject|1|||
155330389|NCT01421667|560643634|FG000|Overall Study|Withdrawal by Subject|0|||
155330390|NCT01421667|560643635|FG001|Overall Study|Withdrawal by Subject|1|||
155330391|NCT01421667|560643636|FG002|Overall Study|Withdrawal by Subject|2|||
155330392|NCT01421667|560643637|FG003|Overall Study|Withdrawal by Subject|1|||
155330393|NCT01421667|560643634|FG000|Overall Study|Lost to Follow-up|0|||
155330394|NCT01421667|560643635|FG001|Overall Study|Lost to Follow-up|1|||
155330395|NCT01421667|560643636|FG002|Overall Study|Lost to Follow-up|0|||
155330396|NCT01421667|560643637|FG003|Overall Study|Lost to Follow-up|0|||
155330397|NCT00503906|560643638|FG000|Overall Study|Withdrawal by Subject|1|||
155330398|NCT03631407|560643639|FG000|Overall Study|Withdrawal by Subject|3|||
155330399|NCT03631407|560643640|FG001|Overall Study|Withdrawal by Subject|2|||
155330400|NCT03631407|560643639|FG000|Overall Study|Sponsor Decision|0|||
155330401|NCT03631407|560643640|FG001|Overall Study|Sponsor Decision|2|||
155330402|NCT03631407|560643639|FG000|Overall Study|Death|16|||
155330403|NCT03631407|560643640|FG001|Overall Study|Death|16|||
155330404|NCT03631407|560643639|FG000|Overall Study|Randomized by mistake without study treatment|1|||
155330405|NCT03631407|560643640|FG001|Overall Study|Randomized by mistake without study treatment|0|||
155330406|NCT03802994|560643642|FG000|Overall Study|Lost to Follow-up|0|||
155330407|NCT03802994|560643643|FG001|Overall Study|Lost to Follow-up|2|||
155330408|NCT03802994|560643644|FG002|Overall Study|Lost to Follow-up|3|||
155330409|NCT03802994|560643645|FG003|Overall Study|Lost to Follow-up|2|||
155330410|NCT03802994|560643646|FG004|Overall Study|Lost to Follow-up|2|||
155330411|NCT00983294|560643647|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
155330412|NCT00983294|560643647|FG000|Colchicine With Azithromycin|Adverse Event|1|||
155330413|NCT00980954|560643648|FG000|Overall Study|Protocol Violation|9|||
155330414|NCT00980954|560643649|FG001|Overall Study|Protocol Violation|15|||
155330415|NCT02744066|560643653|FG000|Overall Study|Withdrawal by parent|0|||
155330416|NCT02744066|560643654|FG001|Overall Study|Withdrawal by parent|1|||
155330417|NCT02744066|560643653|FG000|Overall Study|Discharged from NICU prior to completion|0|||
155330418|NCT02744066|560643654|FG001|Overall Study|Discharged from NICU prior to completion|4|||
155330419|NCT02415127|560643655|FG000|Overall Study|Adverse Event|1|||
155330420|NCT02415127|560643656|FG001|Overall Study|Adverse Event|0|||
155330421|NCT04153890|560643659|FG000|Overall Study|Lost to Follow-up|9|||
155330422|NCT04153890|560643660|FG001|Overall Study|Lost to Follow-up|0|||
155330423|NCT04153890|560643661|FG002|Overall Study|Lost to Follow-up|9|||
155330424|NCT04153890|560643662|FG003|Overall Study|Lost to Follow-up|0|||
155330425|NCT04153890|560643659|FG000|Overall Study|Death|0|||
155330426|NCT04153890|560643660|FG001|Overall Study|Death|2|||
155330427|NCT04153890|560643661|FG002|Overall Study|Death|0|||
155330428|NCT04153890|560643662|FG003|Overall Study|Death|0|||
155330429|NCT04153890|560643659|FG000|Overall Study|Withdrawal by Subject|0|||
155330430|NCT04153890|560643660|FG001|Overall Study|Withdrawal by Subject|0|||
155330431|NCT04153890|560643661|FG002|Overall Study|Withdrawal by Subject|0|||
155330432|NCT04153890|560643662|FG003|Overall Study|Withdrawal by Subject|2|||
155330433|NCT03997474|560643665|FG000|Overall Study|Death|6|||
155330434|NCT03997474|560643666|FG001|Overall Study|Death|2|||
155330435|NCT03997474|560643667|FG002|Overall Study|Death|1|||
155330436|NCT03997474|560643665|FG000|Overall Study|Physician Decision|2|||
155330437|NCT03997474|560643666|FG001|Overall Study|Physician Decision|0|||
155330438|NCT03997474|560643667|FG002|Overall Study|Physician Decision|0|||
155330439|NCT03997474|560643665|FG000|Overall Study|study terminated by sponsor|1|||
155330440|NCT03997474|560643666|FG001|Overall Study|study terminated by sponsor|0|||
155330441|NCT03997474|560643667|FG002|Overall Study|study terminated by sponsor|1|||
155330442|NCT03277989|560643669|FG000|Overall Study|Lost to Follow-up|6|||
155330443|NCT03277989|560643669|FG000|Overall Study|Adverse Event|6|||
155330444|NCT03277989|560643669|FG000|Overall Study|Withdrawal by Subject|3|||
155330445|NCT03277989|560643669|FG000|Overall Study|Didn't Receive Study Device|7|||
155330446|NCT03277989|560643669|FG000|Overall Study|Site Closure|26|||
155330447|NCT03277989|560643669|FG000|Overall Study|Sponsor Closure|107|||
155330448|NCT05037513|560643673|FG000|Intervention Period|Lost to Follow-up|1|||
155330449|NCT05037513|560643674|FG001|Intervention Period|Lost to Follow-up|2|||
155330450|NCT05037513|560643673|FG000|Follow Up Period|Lost to Follow-up|16|||
155330451|NCT05037513|560643674|FG001|Follow Up Period|Lost to Follow-up|21|||
155330452|NCT05037513|560643673|FG000|Follow Up Period|Death|0|||
155330453|NCT05037513|560643674|FG001|Follow Up Period|Death|1|||
155330454|NCT05037513|560643673|FG000|Follow Up Period|Incarcerated|4|||
155330455|NCT05037513|560643674|FG001|Follow Up Period|Incarcerated|2|||
155330456|NCT02232737|560645452|FG000|Overall Study|Lost to Follow-up|18|||
155330457|NCT02232737|560645453|FG001|Overall Study|Lost to Follow-up|28|||
155330458|NCT02232737|560645454|FG002|Overall Study|Lost to Follow-up|33|||
155330459|NCT02232737|560645452|FG000|Overall Study|Personal reasons|7|||
155330460|NCT02232737|560645453|FG001|Overall Study|Personal reasons|8|||
155330461|NCT02232737|560645454|FG002|Overall Study|Personal reasons|14|||
155330462|NCT02232737|560645452|FG000|Overall Study|Adverse Event|6|||
155330463|NCT02232737|560645453|FG001|Overall Study|Adverse Event|3|||
155330464|NCT02232737|560645454|FG002|Overall Study|Adverse Event|8|||
155330465|NCT02232737|560645452|FG000|Overall Study|Incarcerated|2|||
155330466|NCT02232737|560645453|FG001|Overall Study|Incarcerated|1|||
155330467|NCT02232737|560645454|FG002|Overall Study|Incarcerated|2|||
155330468|NCT02232737|560645452|FG000|Overall Study|Withdrawal by Subject|0|||
155330469|NCT02232737|560645453|FG001|Overall Study|Withdrawal by Subject|1|||
155330470|NCT02232737|560645454|FG002|Overall Study|Withdrawal by Subject|2|||
155330471|NCT02232737|560645452|FG000|Overall Study|Death|0|||
155330472|NCT02232737|560645453|FG001|Overall Study|Death|1|||
155330473|NCT02232737|560645454|FG002|Overall Study|Death|1|||
155330474|NCT02232737|560645452|FG000|Overall Study|Physician Decision|1|||
155330475|NCT02232737|560645453|FG001|Overall Study|Physician Decision|3|||
155330476|NCT02232737|560645454|FG002|Overall Study|Physician Decision|1|||
155330477|NCT02232737|560645452|FG000|Overall Study|Protocol Violation|1|||
155330478|NCT02232737|560645453|FG001|Overall Study|Protocol Violation|0|||
155330479|NCT02232737|560645454|FG002|Overall Study|Protocol Violation|1|||
155330480|NCT02232737|560645452|FG000|Overall Study|Reason unknown|1|||
155070950|NCT02903914|559688153|FG002|Overall Study|Clinical Disease Progression|2|||
155070951|NCT02903914|559688154|FG003|Overall Study|Clinical Disease Progression|0|||
155070952|NCT02903914|559688155|FG004|Overall Study|Clinical Disease Progression|0|||
155070953|NCT02903914|559688156|FG005|Overall Study|Clinical Disease Progression|0|||
155330481|NCT02232737|560645453|FG001|Overall Study|Reason unknown|0|||
155330482|NCT02232737|560645454|FG002|Overall Study|Reason unknown|0|||
155330483|NCT00065182|560645463|FG000|Overall Study|Adverse Event|24|||
155330484|NCT00065182|560645464|FG001|Overall Study|Adverse Event|17|||
155330485|NCT00065182|560645463|FG000|Overall Study|Lost to Follow-up|0|||
155330486|NCT00065182|560645464|FG001|Overall Study|Lost to Follow-up|4|||
155330487|NCT00065182|560645463|FG000|Overall Study|Protocol Violation|3|||
155330488|NCT00065182|560645464|FG001|Overall Study|Protocol Violation|4|||
155330489|NCT00065182|560645463|FG000|Overall Study|Serious adverse events (SAE)|1|||
155330490|NCT00065182|560645464|FG001|Overall Study|Serious adverse events (SAE)|0|||
155330491|NCT00065182|560645463|FG000|Overall Study|Sponsor Decision|11|||
155070954|NCT02903914|559688157|FG006|Overall Study|Clinical Disease Progression|0|||
155330492|NCT00065182|560645464|FG001|Overall Study|Sponsor Decision|7|||
155330493|NCT00065182|560645463|FG000|Overall Study|Withdrawal by Subject|8|||
155330494|NCT00065182|560645464|FG001|Overall Study|Withdrawal by Subject|3|||
155330495|NCT00065182|560645463|FG000|Overall Study|No clinical benefit|1|||
155330496|NCT00065182|560645464|FG001|Overall Study|No clinical benefit|0|||
155330497|NCT00065182|560645463|FG000|Overall Study|Death|0|||
155330498|NCT00065182|560645464|FG001|Overall Study|Death|1|||
155330499|NCT00065182|560645463|FG000|Overall Study|Decline in Status|0|||
155330500|NCT00065182|560645464|FG001|Overall Study|Decline in Status|1|||
155330501|NCT03738228|560645465|FG000|Overall Study|Never received study treatment|2|||
155330502|NCT03738228|560645466|FG001|Overall Study|Never received study treatment|2|||
155330503|NCT01641900|560645467|FG000|Overall Study|Withdrawal by Subject|2|||
155330504|NCT01641900|560645468|FG001|Overall Study|Withdrawal by Subject|2|||
155330505|NCT02275611|560645472|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
155330506|NCT02275611|560645473|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
155330507|NCT02275611|560645474|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
155330508|NCT02275611|560645475|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
155330509|NCT02101775|560645476|FG000|Overall Study|Adverse Event|4|||
155330510|NCT02101775|560645477|FG001|Overall Study|Adverse Event|0|||
155330511|NCT02101775|560645478|FG002|Overall Study|Adverse Event|0|||
155330512|NCT02101775|560645476|FG000|Overall Study|Admission to Hospital|0|||
155330513|NCT02101775|560645477|FG001|Overall Study|Admission to Hospital|1|||
155330514|NCT02101775|560645478|FG002|Overall Study|Admission to Hospital|0|||
155330515|NCT03611556|560645479|FG000|Overall Study|Death|7|||
155330516|NCT03611556|560645480|FG001|Overall Study|Death|7|||
155330517|NCT03611556|560645481|FG002|Overall Study|Death|3|||
155330518|NCT03611556|560645482|FG003|Overall Study|Death|8|||
155330519|NCT03611556|560645483|FG004|Overall Study|Death|47|||
155330520|NCT03611556|560645484|FG005|Overall Study|Death|32|||
155330521|NCT03611556|560645485|FG006|Overall Study|Death|53|||
155330522|NCT03611556|560645479|FG000|Overall Study|Withdrawal by Subject|0|||
155330523|NCT03611556|560645480|FG001|Overall Study|Withdrawal by Subject|0|||
155330524|NCT03611556|560645481|FG002|Overall Study|Withdrawal by Subject|0|||
155330525|NCT03611556|560645482|FG003|Overall Study|Withdrawal by Subject|0|||
155330526|NCT03611556|560645483|FG004|Overall Study|Withdrawal by Subject|4|||
155330527|NCT03611556|560645484|FG005|Overall Study|Withdrawal by Subject|2|||
155330528|NCT03611556|560645485|FG006|Overall Study|Withdrawal by Subject|4|||
155330529|NCT03611556|560645479|FG000|Overall Study|Sponsor decision|0|||
155330530|NCT03611556|560645480|FG001|Overall Study|Sponsor decision|0|||
155330531|NCT03611556|560645481|FG002|Overall Study|Sponsor decision|0|||
155330532|NCT03611556|560645482|FG003|Overall Study|Sponsor decision|0|||
155330533|NCT03611556|560645483|FG004|Overall Study|Sponsor decision|9|||
155330534|NCT03611556|560645484|FG005|Overall Study|Sponsor decision|4|||
155330535|NCT03611556|560645485|FG006|Overall Study|Sponsor decision|12|||
155330536|NCT03611556|560645479|FG000|Overall Study|Reasons|0|||
155330537|NCT03611556|560645480|FG001|Overall Study|Reasons|0|||
155330538|NCT03611556|560645481|FG002|Overall Study|Reasons|0|||
155330539|NCT03611556|560645482|FG003|Overall Study|Reasons|0|||
155330540|NCT03611556|560645483|FG004|Overall Study|Reasons|2|||
155330541|NCT03611556|560645484|FG005|Overall Study|Reasons|0|||
155330542|NCT03611556|560645485|FG006|Overall Study|Reasons|1|||
155330543|NCT02844439|560645486|FG000|Overall Study|Withdrawal by Subject|1|||
155330544|NCT02844439|560645486|FG000|Overall Study|Lost to Follow-up|2|||
155330545|NCT02844439|560645486|FG000|Overall Study|Termination by Sponsor|4|||
155330546|NCT02844439|560645486|FG000|Overall Study|Death|28|||
155330547|NCT02844439|560645486|FG000|Overall Study|Other|5|||
155330548|NCT00390884|560645489|FG000|Overall Study|Withdrawal by Subject|2|||
155330549|NCT00390884|560645490|FG001|Overall Study|Withdrawal by Subject|2|||
155330550|NCT00756574|560645491|FG000|Overall Study|Withdrawal by Subject|9|||
155330551|NCT00756574|560645492|FG001|Overall Study|Withdrawal by Subject|7|||
155330552|NCT00756574|560645491|FG000|Overall Study|Lost to Follow-up|4|||
155330553|NCT00756574|560645492|FG001|Overall Study|Lost to Follow-up|4|||
155330554|NCT04622332|560645493|FG000|Overall Study|Withdrawal by Subject|4|||
155330555|NCT04622332|560645494|FG001|Overall Study|Withdrawal by Subject|2|||
155330556|NCT04622332|560645493|FG000|Overall Study|Physician Decision|1|||
155330557|NCT04622332|560645494|FG001|Overall Study|Physician Decision|1|||
155330558|NCT04622332|560645493|FG000|Overall Study|Adverse Event|0|||
155330559|NCT04622332|560645494|FG001|Overall Study|Adverse Event|2|||
155330560|NCT04622332|560645493|FG000|Overall Study|Protocol Violation|0|||
155330561|NCT04622332|560645494|FG001|Overall Study|Protocol Violation|1|||
155330562|NCT05966155|560645495|FG000|Overall Study|Death|1|||
155330563|NCT05966155|560645496|FG001|Overall Study|Death|2|||
155330564|NCT05966155|560645495|FG000|Overall Study|Lost to Follow-up|63|||
155330565|NCT05966155|560645496|FG001|Overall Study|Lost to Follow-up|67|||
155330566|NCT05966155|560645495|FG000|Overall Study|Protocol Violation|1|||
155330567|NCT05966155|560645496|FG001|Overall Study|Protocol Violation|0|||
155330568|NCT05966155|560645495|FG000|Overall Study|Withdrawal by Subject|8|||
155330569|NCT05966155|560645496|FG001|Overall Study|Withdrawal by Subject|9|||
155330570|NCT05966155|560645495|FG000|Overall Study|Enrolled Erroneously|0|||
155330571|NCT05966155|560645496|FG001|Overall Study|Enrolled Erroneously|1|||
155330572|NCT05966155|560645495|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
155330573|NCT05966155|560645496|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
155330574|NCT05036278|560645499|FG000|Overall Study|Withdrawal by Subject|1|||
155330575|NCT05036278|560645499|FG000|Overall Study|Adverse Event|1|||
155330576|NCT02787005|560645502|FG000|Overall Study|Adverse Event|24|||
155330577|NCT02787005|560645503|FG001|Overall Study|Adverse Event|9|||
155330578|NCT02787005|560645504|FG002|Overall Study|Adverse Event|9|||
155330579|NCT02787005|560645505|FG003|Overall Study|Adverse Event|7|||
155330580|NCT02787005|560645506|FG004|Overall Study|Adverse Event|2|||
155330581|NCT02787005|560645502|FG000|Overall Study|Death|100|||
155330582|NCT02787005|560645503|FG001|Overall Study|Death|53|||
155330583|NCT02787005|560645504|FG002|Overall Study|Death|48|||
155330584|NCT02787005|560645505|FG003|Overall Study|Death|69|||
155330585|NCT02787005|560645506|FG004|Overall Study|Death|38|||
155330586|NCT02787005|560645502|FG000|Overall Study|Sponsor Decision|7|||
155330587|NCT02787005|560645503|FG001|Overall Study|Sponsor Decision|4|||
155330588|NCT02787005|560645504|FG002|Overall Study|Sponsor Decision|0|||
155330589|NCT02787005|560645505|FG003|Overall Study|Sponsor Decision|4|||
155330590|NCT02787005|560645506|FG004|Overall Study|Sponsor Decision|5|||
155330591|NCT02787005|560645502|FG000|Overall Study|Withdrawal by Subject|2|||
155330592|NCT02787005|560645503|FG001|Overall Study|Withdrawal by Subject|1|||
155330593|NCT02787005|560645504|FG002|Overall Study|Withdrawal by Subject|1|||
155330594|NCT02787005|560645505|FG003|Overall Study|Withdrawal by Subject|0|||
155330595|NCT02787005|560645506|FG004|Overall Study|Withdrawal by Subject|1|||
155330596|NCT02787005|560645502|FG000|Overall Study|Screen Failure|0|||
155330597|NCT02787005|560645503|FG001|Overall Study|Screen Failure|2|||
155330598|NCT02787005|560645504|FG002|Overall Study|Screen Failure|0|||
155330599|NCT02787005|560645505|FG003|Overall Study|Screen Failure|0|||
155330600|NCT02787005|560645506|FG004|Overall Study|Screen Failure|1|||
155330601|NCT02787005|560645502|FG000|Overall Study|Lost to Follow-up|0|||
155330602|NCT02787005|560645503|FG001|Overall Study|Lost to Follow-up|0|||
155330603|NCT02787005|560645504|FG002|Overall Study|Lost to Follow-up|0|||
155330604|NCT02787005|560645505|FG003|Overall Study|Lost to Follow-up|1|||
155330605|NCT02787005|560645506|FG004|Overall Study|Lost to Follow-up|0|||
155330606|NCT05580003|560645512|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330607|NCT05580003|560645513|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330608|NCT05580003|560645514|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330609|NCT05580003|560645515|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330610|NCT05580003|560645516|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330611|NCT05580003|560645517|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330612|NCT05580003|560645518|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
155330613|NCT05580003|560645519|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330614|NCT05580003|560645520|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330615|NCT05580003|560645521|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330616|NCT05580003|560645522|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330617|NCT05580003|560645523|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330618|NCT05580003|560645524|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330619|NCT05580003|560645525|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330620|NCT05580003|560645526|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330621|NCT05580003|560645527|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330622|NCT05580003|560645528|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330623|NCT05580003|560645529|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330624|NCT05580003|560645530|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330625|NCT05580003|560645531|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330626|NCT05580003|560645532|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330627|NCT05580003|560645533|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330628|NCT05580003|560645534|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330629|NCT05580003|560645535|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330630|NCT05580003|560645536|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154961829|NCT02682238|559285655|FG000|Overall Study|Lost to Follow-up|0|||
155330631|NCT05580003|560645537|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330632|NCT05580003|560645538|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330633|NCT05580003|560645539|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
155330634|NCT05580003|560645512|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330635|NCT05580003|560645513|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330636|NCT05580003|560645514|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330637|NCT05580003|560645515|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330638|NCT05580003|560645516|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155070955|NCT02903914|559688158|FG007|Overall Study|Clinical Disease Progression|0|||
155070956|NCT02903914|559688151|FG000|Overall Study|Completed Follow-up Period|0|||
155070957|NCT02903914|559688152|FG001|Overall Study|Completed Follow-up Period|0|||
155330639|NCT05580003|560645517|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
155330640|NCT05580003|560645518|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330641|NCT05580003|560645519|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330642|NCT05580003|560645520|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330643|NCT05580003|560645521|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330644|NCT05580003|560645522|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330645|NCT05580003|560645523|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330646|NCT05580003|560645524|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330647|NCT05580003|560645525|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330648|NCT05580003|560645526|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330649|NCT05580003|560645527|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330650|NCT05580003|560645528|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330651|NCT05580003|560645529|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330652|NCT05580003|560645530|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330653|NCT05580003|560645531|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330654|NCT05580003|560645532|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330655|NCT05580003|560645533|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330656|NCT05580003|560645534|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330657|NCT05580003|560645535|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330658|NCT05580003|560645536|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330659|NCT05580003|560645537|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330660|NCT05580003|560645538|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330661|NCT05580003|560645539|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
155330662|NCT05580003|560645512|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330663|NCT05580003|560645513|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330664|NCT05580003|560645514|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330665|NCT05580003|560645515|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
155330666|NCT05580003|560645516|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330667|NCT05580003|560645517|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330668|NCT05580003|560645518|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330669|NCT05580003|560645519|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330670|NCT05580003|560645520|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330671|NCT05580003|560645521|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330672|NCT05580003|560645522|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330673|NCT05580003|560645523|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330674|NCT05580003|560645524|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330675|NCT05580003|560645525|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330676|NCT05580003|560645526|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330677|NCT05580003|560645527|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330678|NCT05580003|560645528|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330679|NCT05580003|560645529|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330680|NCT05580003|560645530|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330681|NCT05580003|560645531|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330682|NCT05580003|560645532|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330683|NCT05580003|560645533|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330684|NCT05580003|560645534|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330685|NCT05580003|560645535|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330686|NCT05580003|560645536|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330687|NCT05580003|560645537|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330688|NCT05580003|560645538|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330689|NCT05580003|560645539|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
155330690|NCT05580003|560645512|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330691|NCT05580003|560645513|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
155070958|NCT02903914|559688153|FG002|Overall Study|Completed Follow-up Period|6|||
155070959|NCT02903914|559688154|FG003|Overall Study|Completed Follow-up Period|2|||
155330692|NCT05580003|560645514|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330693|NCT05580003|560645515|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330694|NCT05580003|560645516|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330695|NCT05580003|560645517|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330696|NCT05580003|560645518|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330697|NCT05580003|560645519|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330698|NCT05580003|560645520|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330699|NCT05580003|560645521|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330700|NCT05580003|560645522|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330701|NCT05580003|560645523|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330702|NCT05580003|560645524|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330703|NCT05580003|560645525|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330704|NCT05580003|560645526|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330705|NCT05580003|560645527|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330706|NCT05580003|560645528|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330707|NCT05580003|560645529|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330708|NCT05580003|560645530|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330709|NCT05580003|560645531|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330710|NCT05580003|560645532|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330711|NCT05580003|560645533|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330712|NCT05580003|560645534|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330713|NCT05580003|560645535|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330714|NCT05580003|560645536|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330715|NCT05580003|560645537|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330716|NCT05580003|560645538|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330717|NCT05580003|560645539|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
155330718|NCT05580003|560645512|FG000|Part 2 (up to 10 Days)|Other|0|||
155330719|NCT05580003|560645513|FG001|Part 2 (up to 10 Days)|Other|0|||
155070960|NCT02903914|559688155|FG004|Overall Study|Completed Follow-up Period|1|||
155330720|NCT05580003|560645514|FG002|Part 2 (up to 10 Days)|Other|0|||
155330721|NCT05580003|560645515|FG003|Part 2 (up to 10 Days)|Other|0|||
155330722|NCT05580003|560645516|FG004|Part 2 (up to 10 Days)|Other|0|||
155330723|NCT05580003|560645517|FG005|Part 2 (up to 10 Days)|Other|0|||
155330724|NCT05580003|560645518|FG006|Part 2 (up to 10 Days)|Other|0|||
155330725|NCT05580003|560645519|FG007|Part 2 (up to 10 Days)|Other|0|||
155330726|NCT05580003|560645520|FG008|Part 2 (up to 10 Days)|Other|0|||
155330727|NCT05580003|560645521|FG009|Part 2 (up to 10 Days)|Other|1|||
155330728|NCT05580003|560645522|FG010|Part 2 (up to 10 Days)|Other|0|||
155070961|NCT02903914|559688156|FG005|Overall Study|Completed Follow-up Period|0|||
155070962|NCT02903914|559688157|FG006|Overall Study|Completed Follow-up Period|9|||
155070963|NCT02903914|559688158|FG007|Overall Study|Completed Follow-up Period|1|||
155070964|NCT02903914|559688151|FG000|Overall Study|Taken off Treatment per Protocol|0|||
155070965|NCT02903914|559688152|FG001|Overall Study|Taken off Treatment per Protocol|0|||
155070966|NCT02903914|559688153|FG002|Overall Study|Taken off Treatment per Protocol|0|||
155070967|NCT02903914|559688154|FG003|Overall Study|Taken off Treatment per Protocol|0|||
155070968|NCT02903914|559688155|FG004|Overall Study|Taken off Treatment per Protocol|0|||
155070969|NCT02903914|559688156|FG005|Overall Study|Taken off Treatment per Protocol|1|||
155070970|NCT02903914|559688157|FG006|Overall Study|Taken off Treatment per Protocol|0|||
155070971|NCT02903914|559688158|FG007|Overall Study|Taken off Treatment per Protocol|0|||
155070972|NCT02903914|559688151|FG000|Overall Study|Refused Further Treatment/Contact|0|||
155070973|NCT02903914|559688152|FG001|Overall Study|Refused Further Treatment/Contact|0|||
155070974|NCT02903914|559688153|FG002|Overall Study|Refused Further Treatment/Contact|0|||
155330729|NCT05580003|560645523|FG011|Part 2 (up to 10 Days)|Other|0|||
155330730|NCT05580003|560645524|FG012|Part 2 (up to 10 Days)|Other|0|||
155330731|NCT05580003|560645525|FG013|Part 2 (up to 10 Days)|Other|0|||
155330732|NCT05580003|560645526|FG014|Part 2 (up to 10 Days)|Other|0|||
155330733|NCT05580003|560645527|FG015|Part 2 (up to 10 Days)|Other|0|||
155070975|NCT02903914|559688154|FG003|Overall Study|Refused Further Treatment/Contact|0|||
155070976|NCT02903914|559688155|FG004|Overall Study|Refused Further Treatment/Contact|0|||
155070977|NCT02903914|559688156|FG005|Overall Study|Refused Further Treatment/Contact|0|||
155070978|NCT02903914|559688157|FG006|Overall Study|Refused Further Treatment/Contact|1|||
155070979|NCT02903914|559688158|FG007|Overall Study|Refused Further Treatment/Contact|0|||
155070980|NCT02903914|559688151|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155330734|NCT05580003|560645528|FG016|Part 2 (up to 10 Days)|Other|0|||
155330735|NCT05580003|560645529|FG017|Part 2 (up to 10 Days)|Other|0|||
155330736|NCT05580003|560645530|FG018|Part 2 (up to 10 Days)|Other|0|||
155330737|NCT05580003|560645531|FG019|Part 2 (up to 10 Days)|Other|0|||
155330738|NCT05580003|560645532|FG020|Part 2 (up to 10 Days)|Other|0|||
155330739|NCT05580003|560645533|FG021|Part 2 (up to 10 Days)|Other|0|||
155330740|NCT05580003|560645534|FG022|Part 2 (up to 10 Days)|Other|0|||
155330741|NCT05580003|560645535|FG023|Part 2 (up to 10 Days)|Other|0|||
155330742|NCT05580003|560645536|FG024|Part 2 (up to 10 Days)|Other|0|||
155330743|NCT05580003|560645537|FG025|Part 2 (up to 10 Days)|Other|0|||
155330744|NCT05580003|560645538|FG026|Part 2 (up to 10 Days)|Other|0|||
155070981|NCT02903914|559688152|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155070982|NCT02903914|559688153|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155070983|NCT02903914|559688154|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155070984|NCT02903914|559688155|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155070985|NCT02903914|559688156|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155330745|NCT05580003|560645539|FG027|Part 2 (up to 10 Days)|Other|0|||
155330746|NCT05580003|560645512|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155070986|NCT02903914|559688157|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
155070987|NCT02903914|559688158|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
155070988|NCT02246777|559688161|FG000|Overall Study|Adverse Event|2|||
155070989|NCT02246777|559688161|FG000|Overall Study|Change of residence|1|||
155070990|NCT01063114|559688167|FG000|Overall Study|Lost to Follow-up|1|||
155070991|NCT06239610|559688175|FG000|Overall Study|no usable migration data for minimum of one day|11|||
155070992|NCT02555878|559688176|FG000|Overall Study|Lost to Follow-up|2|||
155070993|NCT02555878|559688177|FG001|Overall Study|Lost to Follow-up|3|||
155163634|NCT00357903|560035009|FG001|Overall Study|Lost to Follow-up|4|||
155163635|NCT00357903|560035008|FG000|Overall Study|Physician Decision|39|||
155330747|NCT05580003|560645513|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330748|NCT05580003|560645514|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330749|NCT05580003|560645515|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330750|NCT05580003|560645516|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330751|NCT05580003|560645517|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330752|NCT05580003|560645518|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330753|NCT05580003|560645519|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330754|NCT05580003|560645520|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330755|NCT05580003|560645521|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330756|NCT05580003|560645522|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330757|NCT05580003|560645523|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330758|NCT05580003|560645524|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330759|NCT05580003|560645525|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330760|NCT05580003|560645526|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330761|NCT05580003|560645527|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330762|NCT05580003|560645528|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330763|NCT05580003|560645529|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330764|NCT05580003|560645530|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330765|NCT05580003|560645531|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
155330766|NCT05580003|560645532|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330767|NCT05580003|560645533|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330768|NCT05580003|560645534|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330769|NCT05580003|560645535|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330770|NCT05580003|560645536|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330771|NCT05580003|560645537|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155163636|NCT00357903|560035009|FG001|Overall Study|Physician Decision|5|||
155163637|NCT00357903|560035008|FG000|Overall Study|Withdrawal by Subject|57|||
155163638|NCT00357903|560035009|FG001|Overall Study|Withdrawal by Subject|7|||
155330772|NCT05580003|560645538|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330773|NCT05580003|560645539|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
155330774|NCT05580003|560645512|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155163639|NCT00357903|560035008|FG000|Overall Study|Completed month 12 only|0|||
155163640|NCT00357903|560035009|FG001|Overall Study|Completed month 12 only|1|||
155330775|NCT05580003|560645513|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330776|NCT05580003|560645514|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330777|NCT05580003|560645515|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330778|NCT05580003|560645516|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330779|NCT05580003|560645517|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330780|NCT05580003|560645518|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330781|NCT05580003|560645519|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330782|NCT05580003|560645520|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330783|NCT05580003|560645521|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155070994|NCT02555878|559688176|FG000|Overall Study|Withdrawal by Subject|48|||
155330784|NCT05580003|560645522|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155070995|NCT02555878|559688177|FG001|Overall Study|Withdrawal by Subject|48|||
155070996|NCT02555878|559688176|FG000|Overall Study|Adverse Event|12|||
155070997|NCT02555878|559688177|FG001|Overall Study|Adverse Event|8|||
155070998|NCT02555878|559688176|FG000|Overall Study|Death|74|||
155163641|NCT00357903|560035008|FG000|Overall Study|Protocol issues|14|||
155163642|NCT00357903|560035009|FG001|Overall Study|Protocol issues|3|||
155330785|NCT05580003|560645523|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330786|NCT05580003|560645524|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330787|NCT05580003|560645525|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330788|NCT05580003|560645526|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330789|NCT05580003|560645527|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330790|NCT05580003|560645528|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155070999|NCT02555878|559688177|FG001|Overall Study|Death|59|||
155330791|NCT05580003|560645529|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330792|NCT05580003|560645530|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330793|NCT05580003|560645531|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330794|NCT05580003|560645532|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
155330795|NCT05580003|560645533|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330796|NCT05580003|560645534|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330797|NCT05580003|560645535|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330798|NCT05580003|560645536|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330799|NCT05580003|560645537|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330800|NCT05580003|560645538|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330801|NCT05580003|560645539|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
155330802|NCT05580003|560645512|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330803|NCT05580003|560645513|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330804|NCT05580003|560645514|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330805|NCT05580003|560645515|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330806|NCT05580003|560645516|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330807|NCT05580003|560645517|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330808|NCT05580003|560645518|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330809|NCT05580003|560645519|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330810|NCT05580003|560645520|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330811|NCT05580003|560645521|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330812|NCT05580003|560645522|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330813|NCT05580003|560645523|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330814|NCT05580003|560645524|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155071000|NCT02555878|559688176|FG000|Overall Study|Protocol Violation|1|||
155071001|NCT02555878|559688177|FG001|Overall Study|Protocol Violation|2|||
155071002|NCT02555878|559688176|FG000|Overall Study|Physician Decision|12|||
155330815|NCT05580003|560645525|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330816|NCT05580003|560645526|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330817|NCT05580003|560645527|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330818|NCT05580003|560645528|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330819|NCT05580003|560645529|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330820|NCT05580003|560645530|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330821|NCT05580003|560645531|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330822|NCT05580003|560645532|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330823|NCT05580003|560645533|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
155330824|NCT05580003|560645534|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330825|NCT05580003|560645535|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330826|NCT05580003|560645536|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330827|NCT05580003|560645537|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330828|NCT05580003|560645538|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330829|NCT05580003|560645539|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
155330830|NCT05580003|560645512|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330831|NCT05580003|560645513|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330832|NCT05580003|560645514|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330833|NCT05580003|560645515|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330834|NCT05580003|560645516|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330835|NCT05580003|560645517|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330836|NCT05580003|560645518|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330837|NCT05580003|560645519|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330838|NCT05580003|560645520|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330839|NCT05580003|560645521|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330840|NCT05580003|560645522|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330841|NCT05580003|560645523|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155071003|NCT02555878|559688177|FG001|Overall Study|Physician Decision|13|||
155330842|NCT05580003|560645524|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330843|NCT05580003|560645525|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330844|NCT05580003|560645526|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330845|NCT05580003|560645527|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330846|NCT05580003|560645528|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330847|NCT05580003|560645529|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330848|NCT05580003|560645530|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330849|NCT05580003|560645531|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155071004|NCT02555878|559688176|FG000|Overall Study|Other|17|||
155071005|NCT02555878|559688177|FG001|Overall Study|Other|17|||
155071006|NCT00765076|559688178|FG000|Overall Study|Adverse Event|1|||
155330850|NCT05580003|560645532|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155071007|NCT00765076|559688179|FG001|Overall Study|Adverse Event|0|||
155330851|NCT05580003|560645533|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330852|NCT05580003|560645534|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330853|NCT05580003|560645535|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330854|NCT05580003|560645536|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330855|NCT05580003|560645537|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330856|NCT05580003|560645538|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
155330857|NCT05580003|560645539|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
155330858|NCT05580003|560645512|FG000|Part 6 Period 2 (Day 1)|Other|0|||
155330859|NCT05580003|560645513|FG001|Part 6 Period 2 (Day 1)|Other|0|||
155330860|NCT05580003|560645514|FG002|Part 6 Period 2 (Day 1)|Other|0|||
155330861|NCT05580003|560645515|FG003|Part 6 Period 2 (Day 1)|Other|0|||
155330862|NCT05580003|560645516|FG004|Part 6 Period 2 (Day 1)|Other|0|||
155330863|NCT05580003|560645517|FG005|Part 6 Period 2 (Day 1)|Other|0|||
155330864|NCT05580003|560645518|FG006|Part 6 Period 2 (Day 1)|Other|0|||
155330865|NCT05580003|560645519|FG007|Part 6 Period 2 (Day 1)|Other|0|||
155330866|NCT05580003|560645520|FG008|Part 6 Period 2 (Day 1)|Other|0|||
155330867|NCT05580003|560645521|FG009|Part 6 Period 2 (Day 1)|Other|0|||
155330868|NCT05580003|560645522|FG010|Part 6 Period 2 (Day 1)|Other|0|||
155330869|NCT05580003|560645523|FG011|Part 6 Period 2 (Day 1)|Other|0|||
155330870|NCT05580003|560645524|FG012|Part 6 Period 2 (Day 1)|Other|0|||
155330871|NCT05580003|560645525|FG013|Part 6 Period 2 (Day 1)|Other|0|||
155330872|NCT05580003|560645526|FG014|Part 6 Period 2 (Day 1)|Other|0|||
155330873|NCT05580003|560645527|FG015|Part 6 Period 2 (Day 1)|Other|0|||
155330874|NCT05580003|560645528|FG016|Part 6 Period 2 (Day 1)|Other|0|||
155330875|NCT05580003|560645529|FG017|Part 6 Period 2 (Day 1)|Other|0|||
155330876|NCT05580003|560645530|FG018|Part 6 Period 2 (Day 1)|Other|0|||
155330877|NCT05580003|560645531|FG019|Part 6 Period 2 (Day 1)|Other|0|||
155330878|NCT05580003|560645532|FG020|Part 6 Period 2 (Day 1)|Other|0|||
155330879|NCT05580003|560645533|FG021|Part 6 Period 2 (Day 1)|Other|0|||
155330880|NCT05580003|560645534|FG022|Part 6 Period 2 (Day 1)|Other|0|||
155330881|NCT05580003|560645535|FG023|Part 6 Period 2 (Day 1)|Other|0|||
155330882|NCT05580003|560645536|FG024|Part 6 Period 2 (Day 1)|Other|1|||
155330883|NCT05580003|560645537|FG025|Part 6 Period 2 (Day 1)|Other|0|||
155330884|NCT05580003|560645538|FG026|Part 6 Period 2 (Day 1)|Other|0|||
155330885|NCT05580003|560645539|FG027|Part 6 Period 2 (Day 1)|Other|0|||
155330886|NCT03516812|560645540|FG000|Overall Study|Adverse Event|4|||
155330887|NCT03516812|560645540|FG000|Overall Study|Lack of Efficacy|2|||
155330888|NCT04795167|560645541|FG000|Overall Study|Death|1|||
155330889|NCT04795167|560645542|FG001|Overall Study|Death|18|||
155330890|NCT04795167|560645543|FG002|Overall Study|Death|1|||
155330891|NCT04795167|560645541|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
155330892|NCT04795167|560645542|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
155330893|NCT04795167|560645543|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
155330894|NCT01753999|560645544|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
155330895|NCT01753999|560645545|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
155330896|NCT01753999|560645544|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
155330897|NCT01753999|560645545|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
155330898|NCT01753999|560645544|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
155330899|NCT01753999|560645545|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
155330900|NCT01753999|560645544|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
155330901|NCT01753999|560645545|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
155330902|NCT01753999|560645544|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
155330903|NCT01753999|560645545|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
155330904|NCT01753999|560645544|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
155330905|NCT01753999|560645545|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
155330906|NCT03890289|560645546|FG000|Overall Study|Adverse Event|1|||
155330907|NCT03890289|560645546|FG000|Overall Study|Physician Decision|1|||
155071008|NCT00765076|559688180|FG002|Overall Study|Adverse Event|0|||
155071009|NCT00765076|559688178|FG000|Overall Study|Withdrawal by Subject|0|||
155071010|NCT00765076|559688179|FG001|Overall Study|Withdrawal by Subject|0|||
155071011|NCT00765076|559688180|FG002|Overall Study|Withdrawal by Subject|1|||
155330908|NCT03890289|560645546|FG000|Overall Study|Lack of Efficacy|2|||
155330909|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155330910|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
155330911|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155330912|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
155330913|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155071012|NCT01164475|559688181|FG000|Overall Study|Lack of Efficacy|1|||
155071013|NCT01164475|559688182|FG001|Overall Study|Lack of Efficacy|0|||
155330914|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
155071014|NCT01164475|559688181|FG000|Overall Study|Other|0|||
155071015|NCT01164475|559688182|FG001|Overall Study|Other|1|||
155330915|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330916|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330917|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330918|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330919|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
155330920|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
155330921|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330922|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330923|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330924|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330925|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
155330926|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
155330927|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
155330928|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330929|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330930|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
155330931|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330932|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
155330933|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330934|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330935|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330936|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330937|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
155330938|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
155330939|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
155330940|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
155330941|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
155330942|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
155330943|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
155330944|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
155330945|NCT02392234|560645553|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330946|NCT02392234|560645554|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330947|NCT02392234|560645555|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
155330948|NCT02392234|560645556|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330949|NCT02392234|560645557|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
155330950|NCT02392234|560645558|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
155330951|NCT02392234|560645553|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
155330952|NCT02392234|560645554|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330953|NCT02392234|560645555|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330954|NCT02392234|560645556|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330955|NCT02392234|560645557|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
154961830|NCT02682238|559285656|FG001|Overall Study|Lost to Follow-up|2|||
154961831|NCT02682238|559285655|FG000|Overall Study|Withdrawal by Subject|1|||
155330956|NCT02392234|560645558|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
155330957|NCT02029235|560645563|FG000|Overall Study|Non-compliance with study meds or diary|4|||
155330958|NCT02029235|560645564|FG001|Overall Study|Non-compliance with study meds or diary|1|||
155330959|NCT01387516|560645565|FG000|Overall Study|Lost to Follow-up|4|||
155330960|NCT01387516|560645566|FG001|Overall Study|Lost to Follow-up|4|||
154961832|NCT02682238|559285656|FG001|Overall Study|Withdrawal by Subject|0|||
154961833|NCT02682238|559285655|FG000|Overall Study|Adverse Event|1|||
154961834|NCT02682238|559285656|FG001|Overall Study|Adverse Event|0|||
154961835|NCT02682238|559285655|FG000|Overall Study|Non-compliance with Study Drug|1|||
154961836|NCT02682238|559285656|FG001|Overall Study|Non-compliance with Study Drug|0|||
154961837|NCT02682238|559285655|FG000|Overall Study|Non-compliance with Protocol|0|||
154961838|NCT02682238|559285656|FG001|Overall Study|Non-compliance with Protocol|2|||
154961839|NCT00824291|559285661|FG000|Overall Study|Adverse Event|15|||
154961840|NCT00824291|559285662|FG001|Overall Study|Adverse Event|6|||
154961841|NCT00824291|559285661|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
154961842|NCT00824291|559285662|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
154961843|NCT00824291|559285661|FG000|Overall Study|Lost to Follow-up|11|||
154961844|NCT00824291|559285662|FG001|Overall Study|Lost to Follow-up|9|||
154961845|NCT00824291|559285661|FG000|Overall Study|Non-compliance|1|||
154961846|NCT00824291|559285662|FG001|Overall Study|Non-compliance|1|||
154961847|NCT00824291|559285661|FG000|Overall Study|Protocol Violation|4|||
154961848|NCT00824291|559285662|FG001|Overall Study|Protocol Violation|1|||
154961849|NCT00824291|559285661|FG000|Overall Study|Withdrawal by Subject|14|||
154961850|NCT00824291|559285662|FG001|Overall Study|Withdrawal by Subject|8|||
154961851|NCT00824291|559285661|FG000|Overall Study|Lack of Efficacy|7|||
154961852|NCT00824291|559285662|FG001|Overall Study|Lack of Efficacy|8|||
154961853|NCT00824291|559285661|FG000|Overall Study|Participant on prohibited medication|1|||
154961854|NCT00824291|559285662|FG001|Overall Study|Participant on prohibited medication|0|||
154961855|NCT02849457|559285666|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
154961856|NCT02849457|559285667|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
154961857|NCT02849457|559285668|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
155330961|NCT01387516|560645567|FG002|Overall Study|Lost to Follow-up|2|||
155330962|NCT01387516|560645568|FG003|Overall Study|Lost to Follow-up|3|||
155330963|NCT01387516|560645565|FG000|Overall Study|Withdrawal by Subject|1|||
155330964|NCT01387516|560645566|FG001|Overall Study|Withdrawal by Subject|1|||
155330965|NCT01387516|560645567|FG002|Overall Study|Withdrawal by Subject|2|||
155330966|NCT01387516|560645568|FG003|Overall Study|Withdrawal by Subject|0|||
155330967|NCT01387516|560645565|FG000|Overall Study|Death|0|||
155330968|NCT01387516|560645566|FG001|Overall Study|Death|0|||
155330969|NCT01387516|560645567|FG002|Overall Study|Death|0|||
155330970|NCT01387516|560645568|FG003|Overall Study|Death|1|||
155330971|NCT03582475|560645569|FG000|Treatment Period|Withdrawal by Subject|0|||
155330972|NCT03582475|560645570|FG001|Treatment Period|Withdrawal by Subject|1|||
155330973|NCT03582475|560645569|FG000|Follow-up Period|Withdrawal by Subject|0|||
155330974|NCT03582475|560645570|FG001|Follow-up Period|Withdrawal by Subject|1|||
155330975|NCT03170648|560645572|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
155330976|NCT03170648|560645572|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
155330977|NCT02052440|560645573|FG000|Overall Study|Withdrawal by Subject|0|||
155330978|NCT02052440|560645574|FG001|Overall Study|Withdrawal by Subject|1|||
155330979|NCT03509909|560645575|FG000|Overall Study|Withdrawal by Subject|16|||
155330980|NCT03509909|560645576|FG001|Overall Study|Withdrawal by Subject|9|||
155330981|NCT03509909|560645575|FG000|Overall Study|Lost to Follow-up|3|||
155330982|NCT03509909|560645576|FG001|Overall Study|Lost to Follow-up|4|||
155330983|NCT03509909|560645575|FG000|Overall Study|Adverse Event|2|||
155330984|NCT03509909|560645576|FG001|Overall Study|Adverse Event|0|||
155330985|NCT01400958|560645577|FG000|Overall Study|Physician Decision|0|||
155330986|NCT01400958|560645578|FG001|Overall Study|Physician Decision|1|||
155330987|NCT01400958|560645577|FG000|Overall Study|Withdrawal by Subject|0|||
155330988|NCT01400958|560645578|FG001|Overall Study|Withdrawal by Subject|1|||
155330989|NCT01400958|560645577|FG000|Overall Study|Adverse Event|1|||
155330990|NCT01400958|560645578|FG001|Overall Study|Adverse Event|0|||
155330991|NCT04436289|560645579|FG000|Overall Study|Death prior to hospital discharge|8|||
155330992|NCT04436289|560645580|FG001|Overall Study|Death prior to hospital discharge|5|||
155330993|NCT04436289|560645581|FG002|Overall Study|Death prior to hospital discharge|0|||
155330994|NCT04436289|560645582|FG003|Overall Study|Death prior to hospital discharge|1|||
155330995|NCT04436289|560645579|FG000|Overall Study|Withdrawal by Subject|0|||
155330996|NCT04436289|560645580|FG001|Overall Study|Withdrawal by Subject|1|||
155330997|NCT04436289|560645581|FG002|Overall Study|Withdrawal by Subject|4|||
155330998|NCT04436289|560645582|FG003|Overall Study|Withdrawal by Subject|0|||
155330999|NCT04436289|560645579|FG000|Overall Study|Extended hospital stay|0|||
155331000|NCT04436289|560645580|FG001|Overall Study|Extended hospital stay|1|||
155331001|NCT04436289|560645581|FG002|Overall Study|Extended hospital stay|0|||
155331002|NCT04436289|560645582|FG003|Overall Study|Extended hospital stay|0|||
155331003|NCT04436289|560645579|FG000|Overall Study|Lost to Follow-up|0|||
155331004|NCT04436289|560645580|FG001|Overall Study|Lost to Follow-up|4|||
155331005|NCT04436289|560645581|FG002|Overall Study|Lost to Follow-up|1|||
155331006|NCT04436289|560645582|FG003|Overall Study|Lost to Follow-up|3|||
155331007|NCT04801420|560645589|FG000|Overall Study|Other|1|||
155331008|NCT04801420|560645590|FG001|Overall Study|Other|2|||
155071016|NCT01164475|559688181|FG000|Overall Study|Progressive disease|0|||
155331009|NCT04801420|560645591|FG002|Overall Study|Other|1|||
155331010|NCT04801420|560645589|FG000|Overall Study|Lost to Follow-up|7|||
155331011|NCT04801420|560645590|FG001|Overall Study|Lost to Follow-up|9|||
155331012|NCT04801420|560645591|FG002|Overall Study|Lost to Follow-up|10|||
155331013|NCT04801420|560645589|FG000|Overall Study|Moved from study area|0|||
155331014|NCT04801420|560645590|FG001|Overall Study|Moved from study area|1|||
155331015|NCT04801420|560645591|FG002|Overall Study|Moved from study area|1|||
155331016|NCT04801420|560645589|FG000|Overall Study|Withdrawal by Subject|5|||
155331017|NCT04801420|560645590|FG001|Overall Study|Withdrawal by Subject|1|||
155331018|NCT04801420|560645591|FG002|Overall Study|Withdrawal by Subject|4|||
155071017|NCT01164475|559688182|FG001|Overall Study|Progressive disease|1|||
155071018|NCT01164475|559688181|FG000|Overall Study|Protocol Violation|1|||
155071019|NCT01164475|559688182|FG001|Overall Study|Protocol Violation|0|||
155071020|NCT02335944|559688183|FG000|Treatment Phase|Progressive Disease|2|||
155071021|NCT02335944|559688184|FG001|Treatment Phase|Progressive Disease|5|||
155071022|NCT02335944|559688185|FG002|Treatment Phase|Progressive Disease|2|||
155071023|NCT02335944|559688186|FG003|Treatment Phase|Progressive Disease|11|||
155331019|NCT04801420|560645589|FG000|Overall Study|Individual stopping criteria reached|0|||
155331020|NCT04801420|560645590|FG001|Overall Study|Individual stopping criteria reached|1|||
155331021|NCT04801420|560645591|FG002|Overall Study|Individual stopping criteria reached|0|||
155331022|NCT04801420|560645589|FG000|Overall Study|Ongoing in the study|195|||
155331023|NCT04801420|560645590|FG001|Overall Study|Ongoing in the study|195|||
155331024|NCT04801420|560645591|FG002|Overall Study|Ongoing in the study|192|||
155331025|NCT03598907|560645592|FG000|Overall Study|Physician Decision|14|||
155331026|NCT03598907|560645593|FG001|Overall Study|Physician Decision|19|||
155331027|NCT02078648|560645596|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
155331028|NCT02078648|560645597|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
155331029|NCT02078648|560645596|FG000|Overall Study|Adverse Event|0|||
155071024|NCT02335944|559688187|FG004|Treatment Phase|Progressive Disease|4|||
155071025|NCT02335944|559688188|FG005|Treatment Phase|Progressive Disease|25|||
155071026|NCT02335944|559688189|FG006|Treatment Phase|Progressive Disease|2|||
155071027|NCT02335944|559688190|FG007|Treatment Phase|Progressive Disease|30|||
155071028|NCT02335944|559688191|FG008|Treatment Phase|Progressive Disease|27|||
155071029|NCT02335944|559688192|FG009|Treatment Phase|Progressive Disease|0|||
155071030|NCT02335944|559688183|FG000|Treatment Phase|Adverse Event|2|||
155071031|NCT02335944|559688184|FG001|Treatment Phase|Adverse Event|0|||
155071032|NCT02335944|559688185|FG002|Treatment Phase|Adverse Event|0|||
155071033|NCT02335944|559688186|FG003|Treatment Phase|Adverse Event|2|||
155071034|NCT02335944|559688187|FG004|Treatment Phase|Adverse Event|1|||
155071035|NCT02335944|559688188|FG005|Treatment Phase|Adverse Event|15|||
155071036|NCT02335944|559688189|FG006|Treatment Phase|Adverse Event|0|||
155071037|NCT02335944|559688190|FG007|Treatment Phase|Adverse Event|5|||
155071038|NCT02335944|559688191|FG008|Treatment Phase|Adverse Event|7|||
155071039|NCT02335944|559688192|FG009|Treatment Phase|Adverse Event|0|||
155071040|NCT02335944|559688183|FG000|Treatment Phase|Physician Decision|0|||
155331030|NCT02078648|560645597|FG001|Overall Study|Adverse Event|1|||
155331031|NCT02078648|560645596|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
155331032|NCT02078648|560645597|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
155331033|NCT02078648|560645596|FG000|Overall Study|Withdrawal by Subject|3|||
155331034|NCT02078648|560645597|FG001|Overall Study|Withdrawal by Subject|1|||
155331035|NCT02078648|560645596|FG000|Overall Study|Investigator Decision|5|||
155071041|NCT02335944|559688184|FG001|Treatment Phase|Physician Decision|0|||
155331036|NCT02078648|560645597|FG001|Overall Study|Investigator Decision|7|||
155331037|NCT02078648|560645596|FG000|Overall Study|Death|1|||
155331038|NCT02078648|560645597|FG001|Overall Study|Death|1|||
155331039|NCT02078648|560645596|FG000|Overall Study|Undefined|0|||
155331040|NCT02078648|560645597|FG001|Overall Study|Undefined|1|||
155331041|NCT04088227|560645598|FG000|Overall Study|Withdrawal by Subject|1|||
155331042|NCT04088227|560645599|FG001|Overall Study|Withdrawal by Subject|0|||
155331043|NCT04088227|560645598|FG000|Overall Study|Surgery postponed >5weeks|1|||
155331044|NCT04088227|560645599|FG001|Overall Study|Surgery postponed >5weeks|0|||
155331045|NCT01675492|560645600|FG000|Overall Study|study completed early - product approval|42|||
155331046|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
155331047|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
155331048|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
155331049|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
155331050|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
155331051|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
155331052|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
155331053|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
155331054|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
155331055|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
155331056|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
155331057|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
155331058|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
155331059|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
155331060|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
155331061|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
155331062|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
155331063|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
155331064|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
155331065|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
155331066|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
155071042|NCT02335944|559688185|FG002|Treatment Phase|Physician Decision|0|||
155071043|NCT02335944|559688186|FG003|Treatment Phase|Physician Decision|1|||
155071044|NCT02335944|559688187|FG004|Treatment Phase|Physician Decision|0|||
155071045|NCT02335944|559688188|FG005|Treatment Phase|Physician Decision|6|||
155071046|NCT02335944|559688189|FG006|Treatment Phase|Physician Decision|1|||
155071047|NCT02335944|559688190|FG007|Treatment Phase|Physician Decision|2|||
155071048|NCT02335944|559688191|FG008|Treatment Phase|Physician Decision|1|||
155071049|NCT02335944|559688192|FG009|Treatment Phase|Physician Decision|0|||
155071050|NCT02335944|559688183|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
155331067|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155071051|NCT02335944|559688184|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
155071052|NCT02335944|559688185|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
155331068|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331069|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331070|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331071|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
155331072|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
155331073|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
155331074|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
155331075|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331076|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331077|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331078|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331079|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
155331080|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
155331081|NCT03656718|560645601|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331082|NCT03656718|560645602|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331083|NCT03656718|560645603|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331084|NCT03656718|560645604|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331085|NCT03656718|560645605|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
155331086|NCT03656718|560645606|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
155331087|NCT03656718|560645607|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
155331088|NCT03656718|560645601|FG000|Treatment Period Part C|Disease progression|0|||
155331089|NCT03656718|560645602|FG001|Treatment Period Part C|Disease progression|0|||
155331090|NCT03656718|560645603|FG002|Treatment Period Part C|Disease progression|0|||
155331091|NCT03656718|560645604|FG003|Treatment Period Part C|Disease progression|0|||
155331092|NCT03656718|560645605|FG004|Treatment Period Part C|Disease progression|12|||
155331093|NCT03656718|560645606|FG005|Treatment Period Part C|Disease progression|0|||
155331094|NCT03656718|560645607|FG006|Treatment Period Part C|Disease progression|0|||
155331095|NCT03656718|560645601|FG000|Treatment Period Part C|Death|0|||
155331096|NCT03656718|560645602|FG001|Treatment Period Part C|Death|0|||
155331097|NCT03656718|560645603|FG002|Treatment Period Part C|Death|0|||
155331098|NCT03656718|560645604|FG003|Treatment Period Part C|Death|0|||
155331099|NCT03656718|560645605|FG004|Treatment Period Part C|Death|1|||
155331100|NCT03656718|560645606|FG005|Treatment Period Part C|Death|0|||
155331101|NCT03656718|560645607|FG006|Treatment Period Part C|Death|0|||
155331102|NCT03656718|560645601|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331103|NCT03656718|560645602|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331104|NCT03656718|560645603|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331105|NCT03656718|560645604|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331106|NCT03656718|560645605|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
155331107|NCT03656718|560645606|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331108|NCT03656718|560645607|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
155331109|NCT03656718|560645601|FG000|Treatment Period Part C|Other reasons|0|||
155331110|NCT03656718|560645602|FG001|Treatment Period Part C|Other reasons|0|||
155331111|NCT03656718|560645603|FG002|Treatment Period Part C|Other reasons|0|||
155331112|NCT03656718|560645604|FG003|Treatment Period Part C|Other reasons|0|||
155331113|NCT03656718|560645605|FG004|Treatment Period Part C|Other reasons|1|||
155331114|NCT03656718|560645606|FG005|Treatment Period Part C|Other reasons|0|||
155331115|NCT03656718|560645607|FG006|Treatment Period Part C|Other reasons|0|||
155331116|NCT03656718|560645601|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
155331117|NCT03656718|560645602|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
155331118|NCT03656718|560645603|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
155331119|NCT03656718|560645604|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
155331120|NCT03656718|560645605|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
155331121|NCT03656718|560645606|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
155331122|NCT03656718|560645607|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
155331123|NCT03211247|560645608|FG000|Overall Study|Adverse Event|8|||
155331124|NCT03211247|560645609|FG001|Overall Study|Adverse Event|0|||
155331125|NCT03211247|560645610|FG002|Overall Study|Adverse Event|1|||
155331126|NCT03211247|560645611|FG003|Overall Study|Adverse Event|0|||
155331127|NCT03211247|560645612|FG004|Overall Study|Adverse Event|0|||
155331128|NCT03211247|560645608|FG000|Overall Study|Lost to Follow-up|2|||
155071053|NCT02335944|559688186|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
155331129|NCT03211247|560645609|FG001|Overall Study|Lost to Follow-up|1|||
155071054|NCT02335944|559688187|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
155331130|NCT03211247|560645610|FG002|Overall Study|Lost to Follow-up|0|||
155163643|NCT00357903|560035008|FG000|Overall Study|Response status|61|||
155331131|NCT03211247|560645611|FG003|Overall Study|Lost to Follow-up|0|||
155331132|NCT03211247|560645612|FG004|Overall Study|Lost to Follow-up|0|||
155331133|NCT03211247|560645608|FG000|Overall Study|Physician Decision|1|||
155331134|NCT03211247|560645609|FG001|Overall Study|Physician Decision|2|||
155331135|NCT03211247|560645610|FG002|Overall Study|Physician Decision|0|||
155331136|NCT03211247|560645611|FG003|Overall Study|Physician Decision|0|||
155331137|NCT03211247|560645612|FG004|Overall Study|Physician Decision|0|||
155331138|NCT03211247|560645608|FG000|Overall Study|Non-compliance with study drug|2|||
155331139|NCT03211247|560645609|FG001|Overall Study|Non-compliance with study drug|0|||
155331140|NCT03211247|560645610|FG002|Overall Study|Non-compliance with study drug|0|||
155331141|NCT03211247|560645611|FG003|Overall Study|Non-compliance with study drug|0|||
155331142|NCT03211247|560645612|FG004|Overall Study|Non-compliance with study drug|0|||
155331143|NCT03211247|560645608|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
155331144|NCT03211247|560645609|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
155331145|NCT03211247|560645610|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
155331146|NCT03211247|560645611|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
155331147|NCT03211247|560645612|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
155331148|NCT03211247|560645608|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
155331149|NCT03211247|560645609|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
155331150|NCT03211247|560645610|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
155331151|NCT03211247|560645611|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
155331152|NCT03211247|560645612|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
155331153|NCT03211247|560645608|FG000|Overall Study|Protocol Violation|0|||
155331154|NCT03211247|560645609|FG001|Overall Study|Protocol Violation|1|||
155331155|NCT03211247|560645610|FG002|Overall Study|Protocol Violation|0|||
155331156|NCT03211247|560645611|FG003|Overall Study|Protocol Violation|0|||
155331157|NCT03211247|560645612|FG004|Overall Study|Protocol Violation|0|||
155331158|NCT01855750|560645613|FG000|Overall Study|Death|78|||
155331159|NCT01855750|560645614|FG001|Overall Study|Death|78|||
155331160|NCT01855750|560645613|FG000|Overall Study|Lost to Follow-up|9|||
155331161|NCT01855750|560645614|FG001|Overall Study|Lost to Follow-up|23|||
155331162|NCT01855750|560645613|FG000|Overall Study|Withdrawal by Subject|35|||
155331163|NCT01855750|560645614|FG001|Overall Study|Withdrawal by Subject|28|||
155331164|NCT01855750|560645613|FG000|Overall Study|Sponsor ends the study|297|||
155331165|NCT01855750|560645614|FG001|Overall Study|Sponsor ends the study|290|||
155331166|NCT05379270|560645615|FG000|Overall Study|Withdrawal by Subject|1|||
155331167|NCT05379270|560645616|FG001|Overall Study|Withdrawal by Subject|1|||
155331168|NCT03160885|560645617|FG000|Initial Treatment Period|Not dosed|2|||
155331169|NCT03160885|560645618|FG001|Initial Treatment Period|Not dosed|0|||
155331170|NCT03160885|560645619|FG002|Initial Treatment Period|Not dosed|0|||
155331171|NCT03160885|560645620|FG003|Initial Treatment Period|Not dosed|0|||
155331172|NCT03160885|560645621|FG004|Initial Treatment Period|Not dosed|0|||
155331173|NCT03160885|560645622|FG005|Initial Treatment Period|Not dosed|0|||
155331174|NCT03160885|560645623|FG006|Initial Treatment Period|Not dosed|0|||
155331175|NCT03160885|560645617|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
155331176|NCT03160885|560645618|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
155331177|NCT03160885|560645619|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331178|NCT03160885|560645620|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331179|NCT03160885|560645621|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331180|NCT03160885|560645622|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331181|NCT03160885|560645623|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
155331182|NCT03160885|560645617|FG000|Open-label Treatment|Not dosed|0|||
155071055|NCT02335944|559688188|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
155071056|NCT02335944|559688189|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
155071057|NCT02335944|559688190|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
155071058|NCT02335944|559688191|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
155071059|NCT02335944|559688192|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
155071060|NCT02335944|559688183|FG000|Treatment Phase|Subject/Guardian Decision|0|||
155071061|NCT02335944|559688184|FG001|Treatment Phase|Subject/Guardian Decision|0|||
155071062|NCT02335944|559688185|FG002|Treatment Phase|Subject/Guardian Decision|1|||
155071063|NCT02335944|559688186|FG003|Treatment Phase|Subject/Guardian Decision|0|||
155071064|NCT02335944|559688187|FG004|Treatment Phase|Subject/Guardian Decision|0|||
155071065|NCT02335944|559688188|FG005|Treatment Phase|Subject/Guardian Decision|1|||
155071066|NCT02335944|559688189|FG006|Treatment Phase|Subject/Guardian Decision|0|||
155331183|NCT03160885|560645618|FG001|Open-label Treatment|Not dosed|0|||
155331184|NCT03160885|560645619|FG002|Open-label Treatment|Not dosed|0|||
155331185|NCT03160885|560645620|FG003|Open-label Treatment|Not dosed|0|||
155331186|NCT03160885|560645621|FG004|Open-label Treatment|Not dosed|0|||
155331187|NCT03160885|560645622|FG005|Open-label Treatment|Not dosed|0|||
155331188|NCT03160885|560645623|FG006|Open-label Treatment|Not dosed|2|||
155331189|NCT03160885|560645617|FG000|Open-label Treatment|Discontinued IMP|0|||
155331190|NCT03160885|560645618|FG001|Open-label Treatment|Discontinued IMP|0|||
155331191|NCT03160885|560645619|FG002|Open-label Treatment|Discontinued IMP|0|||
155331192|NCT03160885|560645620|FG003|Open-label Treatment|Discontinued IMP|0|||
155331193|NCT03160885|560645621|FG004|Open-label Treatment|Discontinued IMP|0|||
155331194|NCT03160885|560645622|FG005|Open-label Treatment|Discontinued IMP|0|||
155071067|NCT02335944|559688190|FG007|Treatment Phase|Subject/Guardian Decision|4|||
155331195|NCT03160885|560645623|FG006|Open-label Treatment|Discontinued IMP|131|||
155331196|NCT03160885|560645617|FG000|Open-label Treatment|Completed Week 50|0|||
155331197|NCT03160885|560645618|FG001|Open-label Treatment|Completed Week 50|0|||
155331198|NCT03160885|560645619|FG002|Open-label Treatment|Completed Week 50|0|||
155331199|NCT03160885|560645620|FG003|Open-label Treatment|Completed Week 50|0|||
155331200|NCT03160885|560645621|FG004|Open-label Treatment|Completed Week 50|0|||
155331201|NCT03160885|560645622|FG005|Open-label Treatment|Completed Week 50|0|||
155331202|NCT03160885|560645623|FG006|Open-label Treatment|Completed Week 50|4|||
155331203|NCT03160885|560645617|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331204|NCT03160885|560645618|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331205|NCT03160885|560645619|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331206|NCT03160885|560645620|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
155331207|NCT03160885|560645621|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331208|NCT03160885|560645622|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331209|NCT03160885|560645623|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
155331210|NCT03160885|560645617|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
155331211|NCT03160885|560645618|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
155331212|NCT03160885|560645619|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
155331213|NCT03160885|560645620|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
155331214|NCT03160885|560645621|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
155331215|NCT03160885|560645622|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
155331216|NCT03160885|560645623|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
155331217|NCT03160885|560645617|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155331218|NCT03160885|560645618|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155331219|NCT03160885|560645619|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
155331220|NCT03160885|560645620|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
155331221|NCT03160885|560645621|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
155331222|NCT03160885|560645622|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
155331223|NCT03160885|560645623|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
155331224|NCT03160885|560645617|FG000|Maintenance Treatment Period|Completed Week 50|0|||
155331225|NCT03160885|560645618|FG001|Maintenance Treatment Period|Completed Week 50|0|||
155331226|NCT03160885|560645619|FG002|Maintenance Treatment Period|Completed Week 50|1|||
155331227|NCT03160885|560645620|FG003|Maintenance Treatment Period|Completed Week 50|0|||
155331228|NCT03160885|560645621|FG004|Maintenance Treatment Period|Completed Week 50|0|||
155331229|NCT03160885|560645622|FG005|Maintenance Treatment Period|Completed Week 50|0|||
155331230|NCT03160885|560645623|FG006|Maintenance Treatment Period|Completed Week 50|0|||
155331231|NCT03610581|560645624|FG000|Overall Study|Study terminated by sponsor|2|||
155331232|NCT03610581|560645625|FG001|Overall Study|Study terminated by sponsor|0|||
155331233|NCT03610581|560645624|FG000|Overall Study|Other|0|||
155331234|NCT03610581|560645625|FG001|Overall Study|Other|1|||
155331235|NCT03610581|560645624|FG000|Overall Study|Withdrawal by Subject|1|||
155331236|NCT03610581|560645625|FG001|Overall Study|Withdrawal by Subject|0|||
155331237|NCT02307682|560645626|FG000|Overall Study|Adverse Event|9|||
155331238|NCT02307682|560645627|FG001|Overall Study|Adverse Event|8|||
155331239|NCT02307682|560645628|FG002|Overall Study|Adverse Event|12|||
155071068|NCT02335944|559688191|FG008|Treatment Phase|Subject/Guardian Decision|0|||
155071069|NCT02335944|559688192|FG009|Treatment Phase|Subject/Guardian Decision|0|||
155071070|NCT02335944|559688183|FG000|Post-treatment Follow-up|Progressive Disease|0|||
155071071|NCT02335944|559688184|FG001|Post-treatment Follow-up|Progressive Disease|0|||
155071072|NCT02335944|559688185|FG002|Post-treatment Follow-up|Progressive Disease|0|||
155071073|NCT02335944|559688186|FG003|Post-treatment Follow-up|Progressive Disease|1|||
155071074|NCT02335944|559688187|FG004|Post-treatment Follow-up|Progressive Disease|0|||
155071075|NCT02335944|559688188|FG005|Post-treatment Follow-up|Progressive Disease|9|||
155071076|NCT02335944|559688189|FG006|Post-treatment Follow-up|Progressive Disease|0|||
155071077|NCT02335944|559688190|FG007|Post-treatment Follow-up|Progressive Disease|2|||
155071078|NCT02335944|559688191|FG008|Post-treatment Follow-up|Progressive Disease|3|||
155071079|NCT02335944|559688192|FG009|Post-treatment Follow-up|Progressive Disease|0|||
155331240|NCT02307682|560645626|FG000|Overall Study|Lack of Efficacy|1|||
155071080|NCT02335944|559688183|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155331241|NCT02307682|560645627|FG001|Overall Study|Lack of Efficacy|0|||
155331242|NCT02307682|560645628|FG002|Overall Study|Lack of Efficacy|1|||
155331243|NCT02307682|560645626|FG000|Overall Study|Physician Decision|2|||
155331244|NCT02307682|560645627|FG001|Overall Study|Physician Decision|2|||
155331245|NCT02307682|560645628|FG002|Overall Study|Physician Decision|8|||
155331246|NCT02307682|560645626|FG000|Overall Study|Progressive Disease|1|||
155331247|NCT02307682|560645627|FG001|Overall Study|Progressive Disease|0|||
155331248|NCT02307682|560645628|FG002|Overall Study|Progressive Disease|0|||
155331249|NCT02307682|560645626|FG000|Overall Study|Withdrawal by Subject|26|||
155331250|NCT02307682|560645627|FG001|Overall Study|Withdrawal by Subject|34|||
155331251|NCT02307682|560645628|FG002|Overall Study|Withdrawal by Subject|23|||
155331252|NCT02307682|560645626|FG000|Overall Study|Death|9|||
155331253|NCT02307682|560645627|FG001|Overall Study|Death|7|||
155331254|NCT02307682|560645628|FG002|Overall Study|Death|12|||
155331255|NCT02307682|560645626|FG000|Overall Study|Lost to Follow-up|1|||
155331256|NCT02307682|560645627|FG001|Overall Study|Lost to Follow-up|5|||
154961858|NCT02849457|559285669|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
155331257|NCT02307682|560645628|FG002|Overall Study|Lost to Follow-up|6|||
155331258|NCT02307682|560645626|FG000|Overall Study|Protocol Deviation|0|||
155331259|NCT02307682|560645627|FG001|Overall Study|Protocol Deviation|0|||
155331260|NCT02307682|560645628|FG002|Overall Study|Protocol Deviation|2|||
155331261|NCT02307682|560645626|FG000|Overall Study|Other|1|||
155331262|NCT02307682|560645627|FG001|Overall Study|Other|1|||
155331263|NCT02307682|560645628|FG002|Overall Study|Other|0|||
155331264|NCT03367156|560646919|FG000|Overall Study|Lack of interest|3|||
155331265|NCT03367156|560646920|FG001|Overall Study|Lack of interest|1|||
155331266|NCT03367156|560646919|FG000|Overall Study|Death|2|||
155331267|NCT03367156|560646920|FG001|Overall Study|Death|0|||
155331268|NCT03367156|560646919|FG000|Overall Study|Lost to Follow-up|2|||
155331269|NCT03367156|560646920|FG001|Overall Study|Lost to Follow-up|1|||
155331270|NCT03367156|560646919|FG000|Overall Study|Became ineligible|1|||
155331271|NCT03367156|560646920|FG001|Overall Study|Became ineligible|2|||
155331272|NCT03367156|560646919|FG000|Overall Study|Hospitalization|1|||
155331273|NCT03367156|560646920|FG001|Overall Study|Hospitalization|0|||
155331274|NCT03367156|560646919|FG000|Overall Study|Concerned about Treatment|11|||
155331275|NCT03367156|560646920|FG001|Overall Study|Concerned about Treatment|3|||
155331276|NCT03367156|560646919|FG000|Overall Study|Started new treatment|4|||
155331277|NCT03367156|560646920|FG001|Overall Study|Started new treatment|1|||
155331278|NCT03762850|560646921|FG000|Overall Study|Death|0|||
155331279|NCT03762850|560646922|FG001|Overall Study|Death|1|||
155331280|NCT03762850|560646921|FG000|Overall Study|Lost to Follow-up|0|||
155331281|NCT03762850|560646922|FG001|Overall Study|Lost to Follow-up|1|||
155331282|NCT03762850|560646921|FG000|Overall Study|Physician Decision|0|||
155331283|NCT03762850|560646922|FG001|Overall Study|Physician Decision|1|||
155331284|NCT03762850|560646921|FG000|Overall Study|Withdrawal by Subject|4|||
155331285|NCT03762850|560646922|FG001|Overall Study|Withdrawal by Subject|9|||
155331286|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
155331287|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
155331288|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
155331289|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
155331290|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
155331291|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
155331292|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
155331293|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
155331294|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
155331295|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
155331296|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
155331297|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
155331298|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
155331299|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
155331300|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
155331301|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155331302|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
155331303|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155331304|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
155331305|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
154961859|NCT00392665|559285670|FG000|Overall Study|Death|16|||
154961860|NCT00392665|559285671|FG001|Overall Study|Death|14|||
154961861|NCT00392665|559285670|FG000|Overall Study|Lost to Follow-up|1|||
155331306|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
155331307|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
155331308|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
155331309|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
155331310|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
155331311|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other|1|||
155331312|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other|0|||
155331313|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other|0|||
155331314|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other|0|||
155331315|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other|0|||
155331316|NCT02386098|560646927|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
155331317|NCT02386098|560646928|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
155331318|NCT02386098|560646929|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
155331319|NCT02386098|560646930|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
155331320|NCT02386098|560646931|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
155331321|NCT03002194|560646932|FG000|Overall Study|Lost to Follow-up|6|||
155331322|NCT03002194|560646932|FG000|Overall Study|Adverse Event|1|||
155331323|NCT03002194|560646932|FG000|Overall Study|Lack of Efficacy|1|||
155331324|NCT03002194|560646932|FG000|Overall Study|Withdrawal by Subject|2|||
155331325|NCT02200705|560646933|FG000|Overall Study|Excluded|12|||
155331326|NCT02200705|560646933|FG000|Overall Study|Death|21|||
155331327|NCT02200705|560646933|FG000|Overall Study|Withdrawal by Subject|22|||
155331328|NCT02200705|560646933|FG000|Overall Study|Lost to Follow-up|13|||
155331329|NCT02200705|560646933|FG000|Overall Study|Physician Decision|5|||
155331330|NCT02200705|560646933|FG000|Overall Study|Adverse Event|2|||
155331331|NCT05250115|560646934|FG000|Overall Study|Premature study end|40|||
155331332|NCT05250115|560646934|FG000|Overall Study|Adverse Event|8|||
155331333|NCT05250115|560646934|FG000|Overall Study|Lost to Follow-up|7|||
155331334|NCT05250115|560646934|FG000|Overall Study|Withdrawal by Subject|6|||
155331335|NCT05250115|560646934|FG000|Overall Study|Withdrawal of informed consent|1|||
155331336|NCT05250115|560646934|FG000|Overall Study|Other|7|||
155331337|NCT02633215|560646938|FG000|Overall Study|Lost to Follow-up|2|||
155331338|NCT02633215|560646939|FG001|Overall Study|Lost to Follow-up|3|||
155331339|NCT00754325|560646940|FG000|Initial Treatment|Continuing Active Treatment|4|||
155331340|NCT00754325|560646941|FG001|Initial Treatment|Continuing Active Treatment|5|||
155331341|NCT00754325|560646940|FG000|Initial Treatment|Adverse Event|7|||
155331342|NCT00754325|560646941|FG001|Initial Treatment|Adverse Event|6|||
155331343|NCT00754325|560646940|FG000|Initial Treatment|Withdrawal by Subject|2|||
155331344|NCT00754325|560646941|FG001|Initial Treatment|Withdrawal by Subject|2|||
155331345|NCT00754325|560646940|FG000|Initial Treatment|Physician Decision|2|||
155331346|NCT00754325|560646941|FG001|Initial Treatment|Physician Decision|0|||
155331347|NCT00754325|560646940|FG000|Initial Treatment|Sponsor Request|0|||
155331348|NCT00754325|560646941|FG001|Initial Treatment|Sponsor Request|1|||
155331349|NCT00754325|560646940|FG000|Initial Treatment|Disease Progression|35|||
155331350|NCT00754325|560646941|FG001|Initial Treatment|Disease Progression|35|||
155331351|NCT03801148|560646942|FG000|Period 1 (2 Days)|Adverse Event|1|||
155331352|NCT03801148|560646943|FG001|Period 1 (2 Days)|Adverse Event|1|||
155331353|NCT03801148|560646944|FG002|Period 1 (2 Days)|Adverse Event|0|||
155331354|NCT03801148|560646945|FG003|Period 1 (2 Days)|Adverse Event|0|||
155331355|NCT03801148|560646942|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155331356|NCT03801148|560646943|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155331357|NCT03801148|560646944|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
155331358|NCT03801148|560646945|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
155331359|NCT03801148|560646942|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155331360|NCT03801148|560646943|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155331361|NCT03801148|560646944|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
155331362|NCT03801148|560646945|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
155331363|NCT03801148|560646942|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
155331364|NCT03801148|560646943|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
155331365|NCT03801148|560646944|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
155331366|NCT03801148|560646945|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
155331367|NCT06212752|560646946|FG000|Overall Study|Death|5|||
155331368|NCT06212752|560646947|FG001|Overall Study|Death|3|||
155331369|NCT06212752|560646946|FG000|Overall Study|Participants ongoing|23|||
155331370|NCT06212752|560646947|FG001|Overall Study|Participants ongoing|8|||
155331371|NCT04162210|560646948|FG000|Overall Study|Lost to Follow-up|4|||
155331372|NCT04162210|560646949|FG001|Overall Study|Lost to Follow-up|1|||
155331373|NCT04162210|560646948|FG000|Overall Study|Withdrawal by Subject|17|||
155331374|NCT04162210|560646949|FG001|Overall Study|Withdrawal by Subject|9|||
155331375|NCT04162210|560646948|FG000|Overall Study|Ongoing|113|||
155331376|NCT04162210|560646949|FG001|Overall Study|Ongoing|59|||
155331377|NCT00371345|560646950|FG000|Overall Study|Disease Progression|21|||
155331378|NCT00371345|560646951|FG001|Overall Study|Disease Progression|35|||
155331379|NCT00371345|560646950|FG000|Overall Study|Study Drug Toxicity|1|||
155331380|NCT00371345|560646951|FG001|Overall Study|Study Drug Toxicity|7|||
155331381|NCT00371345|560646950|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
155331382|NCT00371345|560646951|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
155331383|NCT00371345|560646950|FG000|Overall Study|Participant Request|1|||
155331384|NCT00371345|560646951|FG001|Overall Study|Participant Request|1|||
155331385|NCT00371345|560646950|FG000|Overall Study|Participant Withdrew Consent|0|||
155331386|NCT00371345|560646951|FG001|Overall Study|Participant Withdrew Consent|1|||
155331387|NCT00705406|560646952|FG000|Overall Study|Lost to Follow-up|3|||
155331388|NCT00705406|560646953|FG001|Overall Study|Lost to Follow-up|3|||
155331389|NCT00705406|560646952|FG000|Overall Study|Did not receive study drug|1|||
155331390|NCT00705406|560646953|FG001|Overall Study|Did not receive study drug|2|||
155331391|NCT01779700|560646954|FG000|Overall Study|Adverse Event|4|||
155331392|NCT01779700|560646955|FG001|Overall Study|Adverse Event|3|||
155331393|NCT01779700|560646954|FG000|Overall Study|Withdrawal by Subject|0|||
155331394|NCT01779700|560646955|FG001|Overall Study|Withdrawal by Subject|2|||
155331395|NCT00442104|560646956|FG000|Overall Study|Adverse Event|5|||
155331396|NCT00442104|560646956|FG000|Overall Study|Death|2|||
155331397|NCT00442104|560646956|FG000|Overall Study|Lost to Follow-up|3|||
155331398|NCT00442104|560646956|FG000|Overall Study|Withdrawal by Subject|5|||
155331399|NCT00442104|560646956|FG000|Overall Study|Insufficient Clinical Response|10|||
155331400|NCT00442104|560646956|FG000|Overall Study|Other|21|||
155331401|NCT00442104|560646956|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
155331402|NCT00918333|560646959|FG000|Overall Study|Drug not taken per protocol|1|||
155331403|NCT00918333|560646960|FG001|Overall Study|Drug not taken per protocol|0|||
155331404|NCT00918333|560646959|FG000|Overall Study|Inadequate amount of drugs provided|1|||
155331405|NCT00918333|560646960|FG001|Overall Study|Inadequate amount of drugs provided|4|||
155331406|NCT00918333|560646959|FG000|Overall Study|Ineligible|1|||
155331407|NCT00918333|560646960|FG001|Overall Study|Ineligible|0|||
155331408|NCT00918333|560646959|FG000|Overall Study|Withdrawal by Subject|0|||
155331409|NCT00918333|560646960|FG001|Overall Study|Withdrawal by Subject|1|||
155331410|NCT04497415|560646961|FG000|Overall Study|Lost to Follow-up|43|||
155331411|NCT04497415|560646962|FG001|Overall Study|Lost to Follow-up|27|||
155331412|NCT00263757|560646963|FG000|Overall Study|Withdrawal by Subject|5|||
155331413|NCT00263757|560646964|FG001|Overall Study|Withdrawal by Subject|4|||
155331414|NCT00263757|560646963|FG000|Overall Study|Screen failure|0|||
155331415|NCT00263757|560646964|FG001|Overall Study|Screen failure|1|||
155331416|NCT00263757|560646963|FG000|Overall Study|Adverse Event|3|||
155331417|NCT00263757|560646964|FG001|Overall Study|Adverse Event|3|||
155331418|NCT00713596|560646965|FG000|Overall Study|Study was terminated|2|||
155331419|NCT00713596|560646966|FG001|Overall Study|Study was terminated|3|||
155331420|NCT00713596|560646967|FG002|Overall Study|Study was terminated|2|||
155331421|NCT03712371|560646968|FG000|Overall Study|Lack of Efficacy|0|||
155331422|NCT03712371|560646969|FG001|Overall Study|Lack of Efficacy|0|||
155331423|NCT03712371|560646970|FG002|Overall Study|Lack of Efficacy|0|||
155331424|NCT03712371|560646971|FG003|Overall Study|Lack of Efficacy|1|||
155331425|NCT02463448|560646976|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
155331426|NCT02463448|560646976|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
155331427|NCT02463448|560646976|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
155331428|NCT02463448|560646976|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
155331429|NCT03021993|560646982|FG000|Overall Study|Withdrawal by Subject|4|||
155331430|NCT03021993|560646982|FG000|Overall Study|Physician Decision|1|||
155331431|NCT03021993|560646982|FG000|Overall Study|enrolled but were not treated|1|||
155331432|NCT03021993|560646982|FG000|Overall Study|Death|3|||
155331433|NCT02816398|560646995|FG000|Overall Study|Death|5|||
155331434|NCT02816398|560646995|FG000|Overall Study|Lack of Efficacy|8|||
155331435|NCT02816398|560646995|FG000|Overall Study|Lost to Follow-up|1|||
155331436|NCT02499328|560647001|FG000|Overall Study|Withdrawal by Subject|1|||
155331437|NCT02499328|560647002|FG001|Overall Study|Withdrawal by Subject|1|||
155331438|NCT02499328|560647003|FG002|Overall Study|Withdrawal by Subject|5|||
155331439|NCT02499328|560647004|FG003|Overall Study|Withdrawal by Subject|3|||
155331440|NCT02499328|560647005|FG004|Overall Study|Withdrawal by Subject|5|||
155331441|NCT02499328|560647006|FG005|Overall Study|Withdrawal by Subject|0|||
155331442|NCT02499328|560647007|FG006|Overall Study|Withdrawal by Subject|0|||
155331443|NCT02499328|560647008|FG007|Overall Study|Withdrawal by Subject|0|||
155331444|NCT02499328|560647009|FG008|Overall Study|Withdrawal by Subject|2|||
155331445|NCT02499328|560647010|FG009|Overall Study|Withdrawal by Subject|2|||
155331446|NCT02499328|560647011|FG010|Overall Study|Withdrawal by Subject|0|||
155331447|NCT02499328|560647012|FG011|Overall Study|Withdrawal by Subject|3|||
155331448|NCT02499328|560647013|FG012|Overall Study|Withdrawal by Subject|7|||
155331449|NCT02499328|560647014|FG013|Overall Study|Withdrawal by Subject|3|||
155331450|NCT02499328|560647015|FG014|Overall Study|Withdrawal by Subject|1|||
155331451|NCT02499328|560647016|FG015|Overall Study|Withdrawal by Subject|0|||
155331452|NCT02499328|560647017|FG016|Overall Study|Withdrawal by Subject|0|||
155331453|NCT02499328|560647018|FG017|Overall Study|Withdrawal by Subject|3|||
155331454|NCT02499328|560647019|FG018|Overall Study|Withdrawal by Subject|0|||
155331455|NCT02499328|560647001|FG000|Overall Study|Lost to Follow-up|0|||
155331456|NCT02499328|560647002|FG001|Overall Study|Lost to Follow-up|1|||
155331457|NCT02499328|560647003|FG002|Overall Study|Lost to Follow-up|1|||
155331458|NCT02499328|560647004|FG003|Overall Study|Lost to Follow-up|2|||
155331459|NCT02499328|560647005|FG004|Overall Study|Lost to Follow-up|0|||
154961862|NCT00392665|559285671|FG001|Overall Study|Lost to Follow-up|1|||
155331460|NCT02499328|560647006|FG005|Overall Study|Lost to Follow-up|0|||
155331461|NCT02499328|560647007|FG006|Overall Study|Lost to Follow-up|0|||
155331462|NCT02499328|560647008|FG007|Overall Study|Lost to Follow-up|2|||
155331463|NCT02499328|560647009|FG008|Overall Study|Lost to Follow-up|3|||
155331464|NCT02499328|560647010|FG009|Overall Study|Lost to Follow-up|0|||
155331465|NCT02499328|560647011|FG010|Overall Study|Lost to Follow-up|0|||
155331466|NCT02499328|560647012|FG011|Overall Study|Lost to Follow-up|0|||
155331467|NCT02499328|560647013|FG012|Overall Study|Lost to Follow-up|0|||
155331468|NCT02499328|560647014|FG013|Overall Study|Lost to Follow-up|0|||
155331469|NCT02499328|560647015|FG014|Overall Study|Lost to Follow-up|0|||
155331470|NCT02499328|560647016|FG015|Overall Study|Lost to Follow-up|0|||
155331471|NCT02499328|560647017|FG016|Overall Study|Lost to Follow-up|0|||
155331472|NCT02499328|560647018|FG017|Overall Study|Lost to Follow-up|0|||
155331473|NCT02499328|560647019|FG018|Overall Study|Lost to Follow-up|1|||
155331474|NCT02499328|560647001|FG000|Overall Study|Death|0|||
155331475|NCT02499328|560647002|FG001|Overall Study|Death|3|||
155331476|NCT02499328|560647003|FG002|Overall Study|Death|3|||
155331477|NCT02499328|560647004|FG003|Overall Study|Death|2|||
155331478|NCT02499328|560647005|FG004|Overall Study|Death|4|||
155331479|NCT02499328|560647006|FG005|Overall Study|Death|7|||
155331480|NCT02499328|560647007|FG006|Overall Study|Death|3|||
155331481|NCT02499328|560647008|FG007|Overall Study|Death|0|||
155331482|NCT02499328|560647009|FG008|Overall Study|Death|2|||
155331483|NCT02499328|560647010|FG009|Overall Study|Death|6|||
155331484|NCT02499328|560647011|FG010|Overall Study|Death|6|||
155331485|NCT02499328|560647012|FG011|Overall Study|Death|20|||
155331486|NCT02499328|560647013|FG012|Overall Study|Death|9|||
155331487|NCT02499328|560647014|FG013|Overall Study|Death|7|||
155331488|NCT02499328|560647015|FG014|Overall Study|Death|3|||
155331489|NCT02499328|560647016|FG015|Overall Study|Death|1|||
155331490|NCT02499328|560647017|FG016|Overall Study|Death|1|||
155331491|NCT02499328|560647018|FG017|Overall Study|Death|16|||
155331492|NCT02499328|560647019|FG018|Overall Study|Death|5|||
155331493|NCT02499328|560647001|FG000|Overall Study|"Other"|2|||
155331494|NCT02499328|560647002|FG001|Overall Study|"Other"|2|||
155331495|NCT02499328|560647003|FG002|Overall Study|"Other"|1|||
155331496|NCT02499328|560647004|FG003|Overall Study|"Other"|3|||
155331497|NCT02499328|560647005|FG004|Overall Study|"Other"|6|||
155331498|NCT02499328|560647006|FG005|Overall Study|"Other"|2|||
155331499|NCT02499328|560647007|FG006|Overall Study|"Other"|3|||
155331500|NCT02499328|560647008|FG007|Overall Study|"Other"|4|||
155331501|NCT02499328|560647009|FG008|Overall Study|"Other"|6|||
155331502|NCT02499328|560647010|FG009|Overall Study|"Other"|16|||
155331503|NCT02499328|560647011|FG010|Overall Study|"Other"|13|||
155331504|NCT02499328|560647012|FG011|Overall Study|"Other"|31|||
155331505|NCT02499328|560647013|FG012|Overall Study|"Other"|8|||
155331506|NCT02499328|560647014|FG013|Overall Study|"Other"|7|||
155331507|NCT02499328|560647015|FG014|Overall Study|"Other"|6|||
155331508|NCT02499328|560647016|FG015|Overall Study|"Other"|0|||
155331509|NCT02499328|560647017|FG016|Overall Study|"Other"|0|||
155331510|NCT02499328|560647018|FG017|Overall Study|"Other"|34|||
155331511|NCT02499328|560647019|FG018|Overall Study|"Other"|43|||
155331512|NCT02499328|560647001|FG000|Overall Study|Disease Progression|0|||
155331513|NCT02499328|560647002|FG001|Overall Study|Disease Progression|0|||
155331514|NCT02499328|560647003|FG002|Overall Study|Disease Progression|0|||
155331515|NCT02499328|560647004|FG003|Overall Study|Disease Progression|0|||
155331516|NCT02499328|560647005|FG004|Overall Study|Disease Progression|0|||
155331517|NCT02499328|560647006|FG005|Overall Study|Disease Progression|0|||
155331518|NCT02499328|560647007|FG006|Overall Study|Disease Progression|1|||
155331519|NCT02499328|560647008|FG007|Overall Study|Disease Progression|0|||
155331520|NCT02499328|560647009|FG008|Overall Study|Disease Progression|1|||
155331521|NCT02499328|560647010|FG009|Overall Study|Disease Progression|0|||
155331522|NCT02499328|560647011|FG010|Overall Study|Disease Progression|1|||
155331523|NCT02499328|560647012|FG011|Overall Study|Disease Progression|0|||
155331524|NCT02499328|560647013|FG012|Overall Study|Disease Progression|0|||
155331525|NCT02499328|560647014|FG013|Overall Study|Disease Progression|0|||
155331526|NCT02499328|560647015|FG014|Overall Study|Disease Progression|0|||
155331527|NCT02499328|560647016|FG015|Overall Study|Disease Progression|0|||
155331528|NCT02499328|560647017|FG016|Overall Study|Disease Progression|0|||
155331529|NCT02499328|560647018|FG017|Overall Study|Disease Progression|2|||
155331530|NCT02499328|560647019|FG018|Overall Study|Disease Progression|0|||
155331531|NCT02499328|560647001|FG000|Overall Study|Adverse Event|1|||
155331532|NCT02499328|560647002|FG001|Overall Study|Adverse Event|0|||
155331533|NCT02499328|560647003|FG002|Overall Study|Adverse Event|0|||
155331534|NCT02499328|560647004|FG003|Overall Study|Adverse Event|1|||
155331535|NCT02499328|560647005|FG004|Overall Study|Adverse Event|0|||
155331536|NCT02499328|560647006|FG005|Overall Study|Adverse Event|0|||
155331537|NCT02499328|560647007|FG006|Overall Study|Adverse Event|0|||
155331538|NCT02499328|560647008|FG007|Overall Study|Adverse Event|0|||
155331539|NCT02499328|560647009|FG008|Overall Study|Adverse Event|0|||
155331540|NCT02499328|560647010|FG009|Overall Study|Adverse Event|0|||
155331541|NCT02499328|560647011|FG010|Overall Study|Adverse Event|0|||
155331542|NCT02499328|560647012|FG011|Overall Study|Adverse Event|0|||
155331543|NCT02499328|560647013|FG012|Overall Study|Adverse Event|1|||
155331544|NCT02499328|560647014|FG013|Overall Study|Adverse Event|0|||
155331545|NCT02499328|560647015|FG014|Overall Study|Adverse Event|0|||
155331546|NCT02499328|560647016|FG015|Overall Study|Adverse Event|0|||
155331547|NCT02499328|560647017|FG016|Overall Study|Adverse Event|0|||
155331548|NCT02499328|560647018|FG017|Overall Study|Adverse Event|0|||
155331549|NCT02499328|560647019|FG018|Overall Study|Adverse Event|0|||
155331550|NCT03414684|560647020|FG000|First-course Treatment|Complete response|0|||
155331551|NCT03414684|560647021|FG001|First-course Treatment|Complete response|1|||
155331552|NCT03414684|560647020|FG000|First-course Treatment|Intercurrent illness|1|||
155331553|NCT03414684|560647021|FG001|First-course Treatment|Intercurrent illness|0|||
155331554|NCT03414684|560647020|FG000|First-course Treatment|Progressive Disease|31|||
155331555|NCT03414684|560647021|FG001|First-course Treatment|Progressive Disease|32|||
155331556|NCT03414684|560647020|FG000|First-course Treatment|Adverse Event|1|||
154961863|NCT03673670|559285675|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
154961864|NCT03673670|559285676|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155331557|NCT03414684|560647021|FG001|First-course Treatment|Adverse Event|2|||
155331558|NCT03414684|560647020|FG000|First-course Treatment|Physician Decision|0|||
155331559|NCT03414684|560647021|FG001|First-course Treatment|Physician Decision|1|||
155331560|NCT03414684|560647020|FG000|First-course Treatment|Withdrawal by Subject|0|||
155331561|NCT03414684|560647021|FG001|First-course Treatment|Withdrawal by Subject|1|||
155331562|NCT03414684|560647020|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
155331563|NCT03414684|560647021|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
155331564|NCT03414684|560647020|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
155331565|NCT03414684|560647021|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
155331566|NCT03414684|560647020|FG000|First-course Treatment|Still on treatment|3|||
155331567|NCT03414684|560647021|FG001|First-course Treatment|Still on treatment|0|||
155331568|NCT03414684|560647020|FG000|First-course Treatment|Never started protocol therapy|2|||
155331569|NCT03414684|560647021|FG001|First-course Treatment|Never started protocol therapy|1|||
155331570|NCT03414684|560647020|FG000|Crossover Treatment|Progressive disease|0|||
155331571|NCT03414684|560647021|FG001|Crossover Treatment|Progressive disease|12|||
155331572|NCT03414684|560647020|FG000|Crossover Treatment|Adverse Event|0|||
155331573|NCT03414684|560647021|FG001|Crossover Treatment|Adverse Event|3|||
155331574|NCT03414684|560647020|FG000|Crossover Treatment|Physician Decision|0|||
155331575|NCT03414684|560647021|FG001|Crossover Treatment|Physician Decision|1|||
155331576|NCT03414684|560647020|FG000|Crossover Treatment|Still on treatment|0|||
155331577|NCT03414684|560647021|FG001|Crossover Treatment|Still on treatment|2|||
155331578|NCT05525572|560647022|FG000|Overall Study|Lost to Follow-up|2|||
155331579|NCT05251363|560647023|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
155331580|NCT05251363|560647023|FG000|Overall Study After Implant Period|Death|9|||
155331581|NCT05251363|560647023|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
155331582|NCT05251363|560647023|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
155331583|NCT05251363|560647023|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
155331584|NCT05251363|560647023|FG000|Overall Study After Implant Period|Physician Decision|1|||
155331585|NCT05251363|560647023|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
155331586|NCT03425682|560647024|FG000|Overall Study|Lost to Follow-up|2|||
155331587|NCT03425682|560647025|FG001|Overall Study|Lost to Follow-up|4|||
155331588|NCT03425682|560647024|FG000|Overall Study|Withdrawal by Subject|0|||
155331589|NCT03425682|560647025|FG001|Overall Study|Withdrawal by Subject|3|||
155331590|NCT03425682|560647024|FG000|Overall Study|Subject did not meet I/E|4|||
155331591|NCT03425682|560647025|FG001|Overall Study|Subject did not meet I/E|10|||
155331592|NCT04306367|560647026|FG000|Overall Study|Progression of Disease|9|||
155331593|NCT04306367|560647026|FG000|Overall Study|Adverse Event|3|||
155331594|NCT04306367|560647026|FG000|Overall Study|Withdrawal by Subject|1|||
155331595|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
155331596|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
155331597|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
155331598|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
155331599|NCT03227861|560647027|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
155331600|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
155331601|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
155331602|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
155331603|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
155331604|NCT03227861|560647027|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
155331605|NCT02157116|560648489|FG000|Overall Study|Withdrawal by Subject|4|||
155331606|NCT02157116|560648489|FG000|Overall Study|Physician Decision|3|||
154961865|NCT03673670|559285677|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155331607|NCT02157116|560648489|FG000|Overall Study|Failed Screening|2|||
155331608|NCT00975585|560648490|FG000|Overall Study|Adverse Event|0|||
155331609|NCT00975585|560648491|FG001|Overall Study|Adverse Event|4|||
154961866|NCT03673670|559285678|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
155331610|NCT00975585|560648490|FG000|Overall Study|Lost to Follow-up|3|||
155331611|NCT00975585|560648491|FG001|Overall Study|Lost to Follow-up|5|||
155331612|NCT00975585|560648490|FG000|Overall Study|Withdrawal by Subject|2|||
154961867|NCT03673670|559285679|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
154961868|NCT03673670|559285680|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
154961869|NCT03673670|559285675|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
155331613|NCT00975585|560648491|FG001|Overall Study|Withdrawal by Subject|1|||
155331614|NCT00975585|560648490|FG000|Overall Study|Lens issue|2|||
155331615|NCT00975585|560648491|FG001|Overall Study|Lens issue|2|||
155331616|NCT01953224|560648492|FG000|Overall Study|Lost to Follow-up|1|||
155331617|NCT01953224|560648493|FG001|Overall Study|Lost to Follow-up|1|||
155331618|NCT01953224|560648492|FG000|Overall Study|Withdrawal by Subject|1|||
155331619|NCT01953224|560648493|FG001|Overall Study|Withdrawal by Subject|2|||
155331620|NCT00683800|560648494|FG000|Overall Study|Adverse Event|195|||
155331621|NCT00683800|560648495|FG001|Overall Study|Adverse Event|102|||
155331622|NCT00683800|560648494|FG000|Overall Study|Death|0|||
155331623|NCT00683800|560648495|FG001|Overall Study|Death|1|||
155331624|NCT00683800|560648494|FG000|Overall Study|Lost to Follow-up|57|||
155331625|NCT00683800|560648495|FG001|Overall Study|Lost to Follow-up|44|||
155331626|NCT00683800|560648494|FG000|Overall Study|Other|5|||
155331627|NCT00683800|560648495|FG001|Overall Study|Other|2|||
155163644|NCT00357903|560035009|FG001|Overall Study|Response status|9|||
155163645|NCT00357903|560035008|FG000|Overall Study|Other|49|||
155331628|NCT00683800|560648494|FG000|Overall Study|Protocol Violation|13|||
155331629|NCT00683800|560648495|FG001|Overall Study|Protocol Violation|16|||
155331630|NCT00683800|560648494|FG000|Overall Study|Withdrawal by Subject|66|||
155331631|NCT00683800|560648495|FG001|Overall Study|Withdrawal by Subject|64|||
155331632|NCT00683800|560648494|FG000|Overall Study|Lack of Efficacy|61|||
155331633|NCT00683800|560648495|FG001|Overall Study|Lack of Efficacy|104|||
155331634|NCT00683800|560648494|FG000|Overall Study|Randomized, not treated|35|||
155331635|NCT00683800|560648495|FG001|Overall Study|Randomized, not treated|33|||
155331636|NCT01359150|560648496|FG000|Overall Study|Lack of Efficacy|1|||
155331637|NCT01359150|560648497|FG001|Overall Study|Lack of Efficacy|1|||
155331638|NCT01359150|560648496|FG000|Overall Study|Withdrawal by Subject|1|||
155331639|NCT01359150|560648497|FG001|Overall Study|Withdrawal by Subject|1|||
155331640|NCT01359150|560648496|FG000|Overall Study|Adverse Event|4|||
155331641|NCT01359150|560648497|FG001|Overall Study|Adverse Event|3|||
155331642|NCT01359150|560648496|FG000|Overall Study|Other|1|||
155331643|NCT01359150|560648497|FG001|Overall Study|Other|0|||
155331644|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
155331645|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
155331646|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
155331647|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
155331648|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
155331649|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
155331650|NCT01619059|560648498|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
155331651|NCT01619059|560648499|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
155331652|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
155331653|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
155331654|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
155331655|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
155331656|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
155331657|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
155331658|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Death|1|||
155331659|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Death|0|||
155331660|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
155331661|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
155331662|NCT01619059|560648498|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
155331663|NCT01619059|560648499|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
155331664|NCT02406092|560648502|FG000|Overall Study|Screen failure|10|||
155331665|NCT02406092|560648503|FG001|Overall Study|Screen failure|7|||
155331666|NCT02406092|560648502|FG000|Overall Study|Death|22|||
155331667|NCT02406092|560648503|FG001|Overall Study|Death|5|||
155331668|NCT02406092|560648502|FG000|Overall Study|Lost to Follow-up|4|||
155331669|NCT02406092|560648503|FG001|Overall Study|Lost to Follow-up|1|||
155331670|NCT02406092|560648502|FG000|Overall Study|Adverse Event|1|||
155331671|NCT02406092|560648503|FG001|Overall Study|Adverse Event|0|||
155331672|NCT02406092|560648502|FG000|Overall Study|Withdrawal by Subject|1|||
155331673|NCT02406092|560648503|FG001|Overall Study|Withdrawal by Subject|0|||
155331674|NCT03041233|560648504|FG000|Overall Study|Death|5|||
155331675|NCT03041233|560648504|FG000|Overall Study|Physician Decision|1|||
155331676|NCT03041233|560648504|FG000|Overall Study|Lost to Follow-up|16|||
155331677|NCT03041233|560648504|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
155331678|NCT03041233|560648504|FG000|Overall Study|Sponsor Request|1|||
155331679|NCT03041233|560648504|FG000|Overall Study|Duplicate subject|1|||
155331680|NCT03041233|560648504|FG000|Overall Study|Re-ablation|1|||
155331681|NCT00853593|560648508|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
155331682|NCT00853593|560648508|FG000|Overall Study|Model 4396 lead not attempted|29|||
155331683|NCT00853593|560648508|FG000|Overall Study|Implant not attempted|4|||
155331684|NCT03362190|560648511|FG000|Overall Study|Adverse Event|0|||
155331685|NCT03362190|560648512|FG001|Overall Study|Adverse Event|0|||
155331686|NCT03362190|560648513|FG002|Overall Study|Adverse Event|0|||
155331687|NCT03362190|560648514|FG003|Overall Study|Adverse Event|1|||
155163646|NCT00357903|560035009|FG001|Overall Study|Other|10|||
155163647|NCT03181529|560035010|FG000|Overall Study|Withdrawal by Subject|1|||
155163648|NCT03181529|560035011|FG001|Overall Study|Withdrawal by Subject|1|||
155163649|NCT03181529|560035010|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
155163650|NCT03181529|560035011|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
155163651|NCT01209325|560035014|FG000|Overall Study|Lost to Follow-up|24|||
155163652|NCT01209325|560035014|FG000|Overall Study|Adverse Event|1|||
155163653|NCT01209325|560035014|FG000|Overall Study|Relocated|3|||
155163654|NCT01209325|560035014|FG000|Overall Study|Refusal after starting therapy|8|||
155163655|NCT01209325|560035014|FG000|Overall Study|Protocol Violation|4|||
155163656|NCT01209325|560035014|FG000|Overall Study|Refusal prior to therapy|1|||
155163657|NCT01209325|560035014|FG000|Overall Study|Incarceration|2|||
155163658|NCT00607373|560035015|FG000|Treatment Period|Adverse Event|0|||
155163659|NCT00607373|560035016|FG001|Treatment Period|Adverse Event|4|||
155163660|NCT00607373|560035015|FG000|Treatment Period|Physician Decision|0|||
155163661|NCT00607373|560035016|FG001|Treatment Period|Physician Decision|1|||
155163662|NCT00607373|560035015|FG000|Treatment Period|Withdrawal by Subject|0|||
155163663|NCT00607373|560035016|FG001|Treatment Period|Withdrawal by Subject|1|||
155163664|NCT00607373|560035015|FG000|Follow-up Period|Other|0|||
155163665|NCT00607373|560035016|FG001|Follow-up Period|Other|1|||
155163666|NCT00607373|560035015|FG000|Follow-up Period|Protocol Violation|0|||
155163667|NCT00607373|560035016|FG001|Follow-up Period|Protocol Violation|1|||
155163668|NCT00607373|560035015|FG000|Follow-up Period|Withdrawal by Subject|1|||
155163669|NCT00607373|560035016|FG001|Follow-up Period|Withdrawal by Subject|3|||
155163670|NCT01918306|560035017|FG000|Overall Study|progresive disease|4|||
155163671|NCT01918306|560035018|FG001|Overall Study|progresive disease|0|||
155163672|NCT01918306|560035019|FG002|Overall Study|progresive disease|1|||
155163673|NCT01918306|560035020|FG003|Overall Study|progresive disease|1|||
155163674|NCT01918306|560035017|FG000|Overall Study|Withdrawal by Subject|0|||
155163675|NCT01918306|560035018|FG001|Overall Study|Withdrawal by Subject|0|||
155163676|NCT01918306|560035019|FG002|Overall Study|Withdrawal by Subject|0|||
155163677|NCT01918306|560035020|FG003|Overall Study|Withdrawal by Subject|2|||
155163678|NCT01918306|560035017|FG000|Overall Study|neutropenia|1|||
155163679|NCT01918306|560035018|FG001|Overall Study|neutropenia|0|||
155163680|NCT01918306|560035019|FG002|Overall Study|neutropenia|0|||
155163681|NCT01918306|560035020|FG003|Overall Study|neutropenia|0|||
155163682|NCT01918306|560035017|FG000|Overall Study|Lack of Efficacy|1|||
155163683|NCT01918306|560035018|FG001|Overall Study|Lack of Efficacy|0|||
155163684|NCT01918306|560035019|FG002|Overall Study|Lack of Efficacy|0|||
155163685|NCT01918306|560035020|FG003|Overall Study|Lack of Efficacy|0|||
155163686|NCT01918306|560035017|FG000|Overall Study|progress disease, crossover|0|||
155163687|NCT01918306|560035018|FG001|Overall Study|progress disease, crossover|0|||
155331688|NCT03362190|560648511|FG000|Overall Study|Withdrawal by Subject|0|||
155331689|NCT03362190|560648512|FG001|Overall Study|Withdrawal by Subject|0|||
155331690|NCT03362190|560648513|FG002|Overall Study|Withdrawal by Subject|0|||
155331691|NCT03362190|560648514|FG003|Overall Study|Withdrawal by Subject|1|||
155331692|NCT01588951|560648516|FG000|Overall Study|Ineligible in retrospect|0|||
155331693|NCT01588951|560648517|FG001|Overall Study|Ineligible in retrospect|0|||
155331694|NCT01588951|560648518|FG002|Overall Study|Ineligible in retrospect|1|||
155331695|NCT03683576|560648519|FG000|Overall Study|Withdrawal by Subject|2|||
155331696|NCT03683576|560648520|FG001|Overall Study|Withdrawal by Subject|0|||
155331697|NCT03683576|560648521|FG002|Overall Study|Withdrawal by Subject|8|||
155331698|NCT03683576|560648522|FG003|Overall Study|Withdrawal by Subject|3|||
155331699|NCT03683576|560648519|FG000|Overall Study|Adverse Event|3|||
155331700|NCT03683576|560648520|FG001|Overall Study|Adverse Event|0|||
155331701|NCT03683576|560648521|FG002|Overall Study|Adverse Event|0|||
155331702|NCT03683576|560648522|FG003|Overall Study|Adverse Event|4|||
155331703|NCT03683576|560648519|FG000|Overall Study|Lack of Efficacy|1|||
154961870|NCT03673670|559285676|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
155331704|NCT03683576|560648520|FG001|Overall Study|Lack of Efficacy|0|||
155331705|NCT03683576|560648521|FG002|Overall Study|Lack of Efficacy|1|||
155163688|NCT01918306|560035019|FG002|Overall Study|progress disease, crossover|1|||
155163689|NCT01918306|560035020|FG003|Overall Study|progress disease, crossover|0|||
155163690|NCT01160822|560035025|FG000|Overall Study|Adverse Event|0|||
155163691|NCT01160822|560035026|FG001|Overall Study|Adverse Event|0|||
155163692|NCT01160822|560035027|FG002|Overall Study|Adverse Event|0|||
155163693|NCT01160822|560035028|FG003|Overall Study|Adverse Event|0|||
155163694|NCT01160822|560035029|FG004|Overall Study|Adverse Event|1|||
155163695|NCT01160822|560035030|FG005|Overall Study|Adverse Event|2|||
155163696|NCT01160822|560035031|FG006|Overall Study|Adverse Event|5|||
155163697|NCT01160822|560035025|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155163698|NCT01160822|560035026|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155331706|NCT03683576|560648522|FG003|Overall Study|Lack of Efficacy|1|||
155331707|NCT03683576|560648519|FG000|Overall Study|Lost to Follow-up|0|||
155331708|NCT03683576|560648520|FG001|Overall Study|Lost to Follow-up|1|||
155331709|NCT03683576|560648521|FG002|Overall Study|Lost to Follow-up|2|||
155331710|NCT03683576|560648522|FG003|Overall Study|Lost to Follow-up|0|||
155331711|NCT03683576|560648519|FG000|Overall Study|Other, Not Specified|0|||
155331712|NCT03683576|560648520|FG001|Overall Study|Other, Not Specified|2|||
155331713|NCT03683576|560648521|FG002|Overall Study|Other, Not Specified|0|||
155331714|NCT03683576|560648522|FG003|Overall Study|Other, Not Specified|0|||
155331715|NCT03683576|560648519|FG000|Overall Study|Protocol Violation|0|||
154961871|NCT03673670|559285677|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
155331716|NCT03683576|560648520|FG001|Overall Study|Protocol Violation|1|||
155331717|NCT03683576|560648521|FG002|Overall Study|Protocol Violation|1|||
155331718|NCT03683576|560648522|FG003|Overall Study|Protocol Violation|0|||
155331719|NCT03488719|560648523|FG000|Overall Study|Adverse Event|0|||
155331720|NCT03488719|560648524|FG001|Overall Study|Adverse Event|4|||
155331721|NCT03488719|560648525|FG002|Overall Study|Adverse Event|2|||
155331722|NCT03488719|560648523|FG000|Overall Study|Other|0|||
155331723|NCT03488719|560648524|FG001|Overall Study|Other|0|||
155331724|NCT03488719|560648525|FG002|Overall Study|Other|5|||
155331725|NCT04038580|560648529|FG000|Washout 1|Death|0|||
155331726|NCT04038580|560648530|FG001|Washout 1|Death|0|||
155331727|NCT04038580|560648531|FG002|Washout 1|Death|0|||
155331728|NCT04038580|560648532|FG003|Washout 1|Death|1|||
155331729|NCT04038580|560648533|FG004|Washout 1|Death|0|||
155331730|NCT04038580|560648534|FG005|Washout 1|Death|0|||
155331731|NCT04038580|560648529|FG000|Washout 1|Withdrawal by Subject|0|||
155331732|NCT04038580|560648530|FG001|Washout 1|Withdrawal by Subject|0|||
155331733|NCT04038580|560648531|FG002|Washout 1|Withdrawal by Subject|0|||
155331734|NCT04038580|560648532|FG003|Washout 1|Withdrawal by Subject|0|||
155331735|NCT04038580|560648533|FG004|Washout 1|Withdrawal by Subject|1|||
155331736|NCT04038580|560648534|FG005|Washout 1|Withdrawal by Subject|0|||
155331737|NCT04038580|560648529|FG000|Wash-out 2|Withdrawal by Subject|1|||
155331738|NCT04038580|560648530|FG001|Wash-out 2|Withdrawal by Subject|0|||
155331739|NCT04038580|560648531|FG002|Wash-out 2|Withdrawal by Subject|0|||
155331740|NCT04038580|560648532|FG003|Wash-out 2|Withdrawal by Subject|2|||
155331741|NCT04038580|560648533|FG004|Wash-out 2|Withdrawal by Subject|0|||
155331742|NCT04038580|560648534|FG005|Wash-out 2|Withdrawal by Subject|1|||
155331743|NCT04038580|560648529|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
155331744|NCT04038580|560648530|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
155331745|NCT04038580|560648531|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
155331746|NCT04038580|560648532|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
155331747|NCT04038580|560648533|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
155331748|NCT04038580|560648534|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
155331749|NCT04038580|560648529|FG000|Wash-out 3|Withdrawal by Subject|1|||
155331750|NCT04038580|560648530|FG001|Wash-out 3|Withdrawal by Subject|0|||
155331751|NCT04038580|560648531|FG002|Wash-out 3|Withdrawal by Subject|2|||
155331752|NCT04038580|560648532|FG003|Wash-out 3|Withdrawal by Subject|0|||
155331753|NCT04038580|560648533|FG004|Wash-out 3|Withdrawal by Subject|0|||
155331754|NCT04038580|560648534|FG005|Wash-out 3|Withdrawal by Subject|0|||
155331755|NCT03477175|560648535|FG000|Overall Study|Unable to travel due to COVID-19|0|||
155331756|NCT03477175|560648536|FG001|Overall Study|Unable to travel due to COVID-19|1|||
155331757|NCT03477175|560648535|FG000|Overall Study|Physician Decision|1|||
155331758|NCT03477175|560648536|FG001|Overall Study|Physician Decision|0|||
155331759|NCT03477175|560648535|FG000|Overall Study|Transitioned to commercial drug|6|||
155331760|NCT03477175|560648536|FG001|Overall Study|Transitioned to commercial drug|6|||
155331761|NCT03477175|560648535|FG000|Overall Study|Lost to Follow-up|1|||
155331762|NCT03477175|560648536|FG001|Overall Study|Lost to Follow-up|1|||
155331763|NCT03477175|560648535|FG000|Overall Study|Withdrawal by Subject|3|||
155331764|NCT03477175|560648536|FG001|Overall Study|Withdrawal by Subject|1|||
154961872|NCT03673670|559285678|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
154961873|NCT03673670|559285679|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
155331765|NCT03477175|560648535|FG000|Overall Study|Adverse Event|1|||
155331766|NCT03477175|560648536|FG001|Overall Study|Adverse Event|5|||
155331767|NCT03477175|560648535|FG000|Overall Study|Disease Progression|7|||
155331768|NCT03477175|560648536|FG001|Overall Study|Disease Progression|7|||
155331769|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331770|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
155331771|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331772|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331773|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331774|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
155331775|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
155331776|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331777|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331778|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331779|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331780|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
155331781|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331782|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331783|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
155331784|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331785|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331786|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
155331787|NCT04021862|560648537|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
155331788|NCT04021862|560648538|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
155331789|NCT04021862|560648539|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
155331790|NCT04021862|560648540|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
155331791|NCT04021862|560648541|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
155331792|NCT04021862|560648542|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
155331793|NCT04021862|560648537|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331794|NCT04021862|560648538|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331795|NCT04021862|560648539|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331796|NCT04021862|560648540|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
155331797|NCT04021862|560648541|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331798|NCT04021862|560648542|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
155331799|NCT03371017|560648543|FG000|Overall Study|Physician Decision|0|||
155331800|NCT03371017|560648544|FG001|Overall Study|Physician Decision|1|||
155331801|NCT03371017|560648543|FG000|Overall Study|Reason not Specified|0|||
155331802|NCT03371017|560648544|FG001|Overall Study|Reason not Specified|1|||
155331803|NCT03371017|560648543|FG000|Overall Study|Lost to Follow-up|13|||
155331804|NCT03371017|560648544|FG001|Overall Study|Lost to Follow-up|16|||
155331805|NCT03371017|560648543|FG000|Overall Study|Death|228|||
155331806|NCT03371017|560648544|FG001|Overall Study|Death|215|||
155331807|NCT03371017|560648543|FG000|Overall Study|Withdrawal by Subject|20|||
155331808|NCT03371017|560648544|FG001|Overall Study|Withdrawal by Subject|25|||
155331809|NCT03371017|560648543|FG000|Overall Study|Study Ended by Sponsor|37|||
155331810|NCT03371017|560648544|FG001|Overall Study|Study Ended by Sponsor|38|||
155331811|NCT03371017|560648543|FG000|Overall Study|Protocol Deviation|0|||
155331812|NCT03371017|560648544|FG001|Overall Study|Protocol Deviation|1|||
155331813|NCT00489307|560648547|FG000|Overall Study|Death|1|||
155331814|NCT00489307|560648548|FG001|Overall Study|Death|1|||
155331815|NCT00489307|560648547|FG000|Overall Study|Lost to Follow-up|2|||
155331816|NCT00489307|560648548|FG001|Overall Study|Lost to Follow-up|2|||
155331817|NCT00489307|560648547|FG000|Overall Study|Physician Decision|1|||
155331818|NCT00489307|560648548|FG001|Overall Study|Physician Decision|0|||
155331819|NCT00489307|560648547|FG000|Overall Study|Withdrawal by Subject|2|||
155331820|NCT00489307|560648548|FG001|Overall Study|Withdrawal by Subject|4|||
155331821|NCT00489307|560648547|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
155331822|NCT00489307|560648548|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
154961874|NCT03673670|559285680|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
154961875|NCT03673670|559285675|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
155331823|NCT00489307|560648547|FG000|Overall Study|Surgery after assignment|1|||
155331824|NCT00489307|560648548|FG001|Overall Study|Surgery after assignment|0|||
155331825|NCT00489307|560648547|FG000|Overall Study|Did not fill up the forms|2|||
154961876|NCT03673670|559285676|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
154961877|NCT03673670|559285677|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
154961878|NCT03673670|559285678|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
154961879|NCT03673670|559285679|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
154961880|NCT03673670|559285680|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
154961881|NCT03673670|559285675|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
154961882|NCT03673670|559285676|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
154961883|NCT03673670|559285677|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
154961884|NCT03673670|559285678|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
154961885|NCT03673670|559285679|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
154961886|NCT03673670|559285680|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
154961887|NCT03673670|559285675|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
154961888|NCT03673670|559285676|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
154961889|NCT03673670|559285677|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
154961890|NCT03673670|559285678|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
154961891|NCT03673670|559285679|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
154961892|NCT03673670|559285680|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
154961893|NCT03673670|559285675|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
154961894|NCT03673670|559285676|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
154961895|NCT03673670|559285677|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
154961896|NCT03673670|559285678|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
154961897|NCT03673670|559285679|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
154961898|NCT03673670|559285680|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
154961899|NCT03673670|559285675|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
154961900|NCT03673670|559285676|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
154961901|NCT03673670|559285677|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
154961902|NCT03673670|559285678|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
154961903|NCT03673670|559285679|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
154961904|NCT03673670|559285680|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
154961905|NCT04408794|559285681|FG000|Overall Study|Adverse Event|43|||
154961906|NCT04408794|559285681|FG000|Overall Study|Infrequent study drug usage|43|||
154961907|NCT04408794|559285681|FG000|Overall Study|Lack of Efficacy|61|||
154961908|NCT04408794|559285681|FG000|Overall Study|Lost to Follow-up|33|||
154961909|NCT04408794|559285681|FG000|Overall Study|Non-compliance|6|||
154961910|NCT04408794|559285681|FG000|Overall Study|Physician Decision|1|||
154961911|NCT04408794|559285681|FG000|Overall Study|Pregnancy|6|||
154961912|NCT04408794|559285681|FG000|Overall Study|Protocol Deviation|9|||
154961913|NCT04408794|559285681|FG000|Overall Study|Sheehan-STS Result|1|||
154961914|NCT04408794|559285681|FG000|Overall Study|Withdrawal by Subject|57|||
154961915|NCT04408794|559285681|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
154961916|NCT04408794|559285681|FG000|Overall Study|Never Treated Migraine|5|||
154961917|NCT03437265|559285684|FG000|Overall Study|Protocol Violation|6|||
154961918|NCT02294786|559285687|FG000|Overall Study|Withdrawal by Subject|0|||
154961919|NCT02294786|559285688|FG001|Overall Study|Withdrawal by Subject|1|||
154961920|NCT02294786|559285687|FG000|Overall Study|Physician Decision|6|||
154961921|NCT02294786|559285688|FG001|Overall Study|Physician Decision|7|||
154961922|NCT02294786|559285687|FG000|Overall Study|Lost to Follow-up|1|||
154961923|NCT02294786|559285688|FG001|Overall Study|Lost to Follow-up|2|||
154961924|NCT02294786|559285687|FG000|Overall Study|Protocol Violation|1|||
154961925|NCT02294786|559285688|FG001|Overall Study|Protocol Violation|0|||
154961926|NCT02294786|559285687|FG000|Overall Study|Adverse Event|1|||
154961927|NCT02294786|559285688|FG001|Overall Study|Adverse Event|1|||
154961928|NCT02294786|559285687|FG000|Overall Study|Death|2|||
154961929|NCT02294786|559285688|FG001|Overall Study|Death|3|||
154961930|NCT01778010|559285689|FG000|Overall Study|Withdrawal by Subject|2|||
154961931|NCT01778010|559285689|FG000|Overall Study|abnormal ECG before meds|1|||
154961932|NCT01778010|559285689|FG000|Overall Study|Arrested|1|||
154961933|NCT01778010|559285689|FG000|Overall Study|rash while on placebo|1|||
154961934|NCT00840073|559285696|FG000|Second Intervention|Missed 72 hour blood draw|1|||
154961935|NCT00840073|559285697|FG001|Second Intervention|Missed 72 hour blood draw|1|||
154961936|NCT00556322|559285698|FG000|Overall Study|Insufficient therapeutic response|158|||
154961937|NCT00556322|559285699|FG001|Overall Study|Insufficient therapeutic response|168|||
154961938|NCT00556322|559285698|FG000|Overall Study|Adverse Event|7|||
154961939|NCT00556322|559285699|FG001|Overall Study|Adverse Event|4|||
154961940|NCT00556322|559285698|FG000|Overall Study|Other|4|||
154961941|NCT00556322|559285699|FG001|Overall Study|Other|1|||
154961942|NCT00556322|559285698|FG000|Overall Study|Lost to Follow-up|5|||
154961943|NCT00556322|559285699|FG001|Overall Study|Lost to Follow-up|3|||
154961944|NCT00556322|559285698|FG000|Overall Study|Withdrawal by Subject|19|||
155331826|NCT00489307|560648548|FG001|Overall Study|Did not fill up the forms|1|||
155331827|NCT00489307|560648547|FG000|Overall Study|Patient or family refusal|5|||
155331828|NCT00489307|560648548|FG001|Overall Study|Patient or family refusal|9|||
155331829|NCT03835754|560648549|FG000|Overall Study|Death|4|||
155331830|NCT02751528|560648554|FG000|Overall Study|Withdrawal by Subject|1|||
155331831|NCT02751528|560648554|FG000|Overall Study|Adverse Event|1|||
155331832|NCT05485805|560648555|FG000|Overall Study|Withdrawal by Subject|1|||
155331833|NCT05485805|560648556|FG001|Overall Study|Withdrawal by Subject|2|||
155331834|NCT05485805|560648557|FG002|Overall Study|Withdrawal by Subject|2|||
155331835|NCT05485805|560648558|FG003|Overall Study|Withdrawal by Subject|0|||
155331836|NCT05485805|560648559|FG004|Overall Study|Withdrawal by Subject|2|||
155331837|NCT05485805|560648555|FG000|Overall Study|Adverse Event|0|||
155331838|NCT05485805|560648556|FG001|Overall Study|Adverse Event|1|||
155331839|NCT05485805|560648557|FG002|Overall Study|Adverse Event|0|||
155331840|NCT05485805|560648558|FG003|Overall Study|Adverse Event|0|||
155331841|NCT05485805|560648559|FG004|Overall Study|Adverse Event|0|||
155331842|NCT05485805|560648555|FG000|Overall Study|Lost to Follow-up|1|||
155331843|NCT05485805|560648556|FG001|Overall Study|Lost to Follow-up|1|||
155331844|NCT05485805|560648557|FG002|Overall Study|Lost to Follow-up|3|||
155331845|NCT05485805|560648558|FG003|Overall Study|Lost to Follow-up|1|||
155331846|NCT05485805|560648559|FG004|Overall Study|Lost to Follow-up|0|||
155331847|NCT04218357|560648560|FG000|1st Allocation|Withdrawal by Subject|1|||
155331848|NCT04218357|560648561|FG001|1st Allocation|Withdrawal by Subject|0|||
155331849|NCT05349838|560648562|FG000|Overall Study|Virological Failure|1|||
155331850|NCT05349838|560648563|FG001|Overall Study|Virological Failure|2|||
155331851|NCT05349838|560648562|FG000|Overall Study|Withdrawal by Subject|2|||
155331852|NCT05349838|560648563|FG001|Overall Study|Withdrawal by Subject|3|||
155331853|NCT05349838|560648562|FG000|Overall Study|Adverse Event|3|||
155331854|NCT05349838|560648563|FG001|Overall Study|Adverse Event|1|||
155331855|NCT05349838|560648562|FG000|Overall Study|Lost to Follow-up|1|||
155331856|NCT05349838|560648563|FG001|Overall Study|Lost to Follow-up|2|||
155331857|NCT05349838|560648562|FG000|Overall Study|Other reasons|5|||
155331858|NCT05349838|560648563|FG001|Overall Study|Other reasons|1|||
155331859|NCT05071430|560648565|FG000|Overall Study|Adverse Event|1|||
155331860|NCT05071430|560648566|FG001|Overall Study|Adverse Event|2|||
155331861|NCT05071430|560648565|FG000|Overall Study|Lost to Follow-up|4|||
155331862|NCT05071430|560648566|FG001|Overall Study|Lost to Follow-up|4|||
155331863|NCT05071430|560648565|FG000|Overall Study|Protocol Violation|1|||
155331864|NCT05071430|560648566|FG001|Overall Study|Protocol Violation|0|||
155331865|NCT05071430|560648565|FG000|Overall Study|Withdrawal by Subject|3|||
155331866|NCT05071430|560648566|FG001|Overall Study|Withdrawal by Subject|2|||
155331867|NCT05071430|560648565|FG000|Overall Study|Other|1|||
155331868|NCT05071430|560648566|FG001|Overall Study|Other|1|||
155331869|NCT01958021|560648567|FG000|Treatment|Progressive disease|206|||
155331870|NCT01958021|560648568|FG001|Treatment|Progressive disease|265|||
155331871|NCT01958021|560648567|FG000|Treatment|Adverse Event|38|||
155331872|NCT01958021|560648568|FG001|Treatment|Adverse Event|10|||
155331873|NCT01958021|560648567|FG000|Treatment|Subject/guardian decision|29|||
155331874|NCT01958021|560648568|FG001|Treatment|Subject/guardian decision|25|||
155331875|NCT01958021|560648567|FG000|Treatment|Physician Decision|28|||
155331876|NCT01958021|560648568|FG001|Treatment|Physician Decision|21|||
155331877|NCT01958021|560648567|FG000|Treatment|Death|6|||
155331878|NCT01958021|560648568|FG001|Treatment|Death|1|||
155331879|NCT01958021|560648567|FG000|Treatment|Protocol deviation|3|||
155331880|NCT01958021|560648568|FG001|Treatment|Protocol deviation|1|||
155331881|NCT01958021|560648567|FG000|Treatment|Sponsor decision|24|||
155331882|NCT01958021|560648568|FG001|Treatment|Sponsor decision|11|||
155331883|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155331884|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155331885|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Death|1|||
155331886|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Death|0|||
155331887|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
155331888|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155331889|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155331890|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155331891|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
155331892|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155331893|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
155331894|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
155331895|NCT01958021|560648567|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
155331896|NCT01958021|560648568|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
155331897|NCT05810285|560648572|FG000|Overall Study|Death|4|||
155331898|NCT05810285|560648573|FG001|Overall Study|Death|21|||
155331899|NCT05810285|560648572|FG000|Overall Study|Adverse Event|18|||
155331900|NCT05810285|560648573|FG001|Overall Study|Adverse Event|16|||
155331901|NCT04484623|560648574|FG000|Overall Study|Lost to Follow-up|0|||
155331902|NCT04484623|560648575|FG001|Overall Study|Lost to Follow-up|1|||
155331903|NCT04484623|560648574|FG000|Overall Study|Protocol Deviation|1|||
155331904|NCT04484623|560648575|FG001|Overall Study|Protocol Deviation|0|||
155331905|NCT04484623|560648574|FG000|Overall Study|Physician Decision|1|||
155331906|NCT04484623|560648575|FG001|Overall Study|Physician Decision|0|||
155331907|NCT04484623|560648574|FG000|Overall Study|Withdrawal by Subject|11|||
155331908|NCT04484623|560648575|FG001|Overall Study|Withdrawal by Subject|8|||
155331909|NCT04484623|560648574|FG000|Overall Study|Ongoing|94|||
155331910|NCT04484623|560648575|FG001|Overall Study|Ongoing|84|||
155331911|NCT05470114|560648576|FG000|Overall Study|Withdrawal by Subject|1|||
155331912|NCT05470114|560648577|FG001|Overall Study|Withdrawal by Subject|0|||
155331913|NCT05470114|560648576|FG000|Overall Study|Lost to Follow-up|1|||
155331914|NCT05470114|560648577|FG001|Overall Study|Lost to Follow-up|0|||
155331915|NCT04649047|560648582|FG000|Overall Study|Withdrawal by Subject|3|||
155331916|NCT02488408|560648583|FG000|Part A|Adverse Event|2|||
155331917|NCT02488408|560648584|FG001|Part A|Adverse Event|0|||
155331918|NCT02488408|560648585|FG002|Part A|Adverse Event|0|||
155331919|NCT02488408|560648586|FG003|Part A|Adverse Event|0|||
155331920|NCT02488408|560648587|FG004|Part A|Adverse Event|0|||
155331921|NCT02488408|560648588|FG005|Part A|Adverse Event|0|||
155331922|NCT02488408|560648589|FG006|Part A|Adverse Event|0|||
155331923|NCT02488408|560648590|FG007|Part A|Adverse Event|0|||
155331924|NCT02488408|560648591|FG008|Part A|Adverse Event|0|||
155331925|NCT02488408|560648592|FG009|Part A|Adverse Event|0|||
155331926|NCT02488408|560648583|FG000|Part A|Death|1|||
155331927|NCT02488408|560648584|FG001|Part A|Death|5|||
155331928|NCT02488408|560648585|FG002|Part A|Death|0|||
155331929|NCT02488408|560648586|FG003|Part A|Death|0|||
155331930|NCT02488408|560648587|FG004|Part A|Death|3|||
155331931|NCT02488408|560648588|FG005|Part A|Death|0|||
155331932|NCT02488408|560648589|FG006|Part A|Death|0|||
155331933|NCT02488408|560648590|FG007|Part A|Death|0|||
155331934|NCT02488408|560648591|FG008|Part A|Death|0|||
155331935|NCT02488408|560648592|FG009|Part A|Death|0|||
155331936|NCT02488408|560648583|FG000|Part A|Disease Progression|2|||
155331937|NCT02488408|560648584|FG001|Part A|Disease Progression|8|||
155331938|NCT02488408|560648585|FG002|Part A|Disease Progression|2|||
155331939|NCT02488408|560648586|FG003|Part A|Disease Progression|3|||
155331940|NCT02488408|560648587|FG004|Part A|Disease Progression|4|||
155331941|NCT02488408|560648588|FG005|Part A|Disease Progression|0|||
155331942|NCT02488408|560648589|FG006|Part A|Disease Progression|0|||
155331943|NCT02488408|560648590|FG007|Part A|Disease Progression|0|||
155331944|NCT02488408|560648591|FG008|Part A|Disease Progression|0|||
155331945|NCT02488408|560648592|FG009|Part A|Disease Progression|0|||
155331946|NCT02488408|560648583|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
155331947|NCT02488408|560648584|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
155331948|NCT02488408|560648585|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
155331949|NCT02488408|560648586|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
155331950|NCT02488408|560648587|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
155331951|NCT02488408|560648588|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
155331952|NCT02488408|560648589|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
155331953|NCT02488408|560648590|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
155331954|NCT02488408|560648591|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
155071081|NCT02335944|559688184|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155331955|NCT02488408|560648592|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
155331956|NCT02488408|560648583|FG000|Part A|Investigator Decision|0|||
155331957|NCT02488408|560648584|FG001|Part A|Investigator Decision|1|||
155331958|NCT02488408|560648585|FG002|Part A|Investigator Decision|1|||
155331959|NCT02488408|560648586|FG003|Part A|Investigator Decision|0|||
155331960|NCT02488408|560648587|FG004|Part A|Investigator Decision|0|||
155331961|NCT02488408|560648588|FG005|Part A|Investigator Decision|0|||
155331962|NCT02488408|560648589|FG006|Part A|Investigator Decision|0|||
155331963|NCT02488408|560648590|FG007|Part A|Investigator Decision|0|||
155331964|NCT02488408|560648591|FG008|Part A|Investigator Decision|0|||
155331965|NCT02488408|560648592|FG009|Part A|Investigator Decision|0|||
155331966|NCT02488408|560648583|FG000|Part A|Withdrawal by Subject|0|||
155331967|NCT02488408|560648584|FG001|Part A|Withdrawal by Subject|0|||
155331968|NCT02488408|560648585|FG002|Part A|Withdrawal by Subject|2|||
155331969|NCT02488408|560648586|FG003|Part A|Withdrawal by Subject|0|||
155331970|NCT02488408|560648587|FG004|Part A|Withdrawal by Subject|0|||
155331971|NCT02488408|560648588|FG005|Part A|Withdrawal by Subject|0|||
155331972|NCT02488408|560648589|FG006|Part A|Withdrawal by Subject|0|||
155071082|NCT02335944|559688185|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155071083|NCT02335944|559688186|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155071084|NCT02335944|559688187|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155071085|NCT02335944|559688188|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
155071086|NCT02335944|559688189|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155071087|NCT02335944|559688190|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155331973|NCT02488408|560648590|FG007|Part A|Withdrawal by Subject|0|||
155331974|NCT02488408|560648591|FG008|Part A|Withdrawal by Subject|0|||
155331975|NCT02488408|560648592|FG009|Part A|Withdrawal by Subject|0|||
155331976|NCT02488408|560648583|FG000|Part A|Other|1|||
155331977|NCT02488408|560648584|FG001|Part A|Other|0|||
155331978|NCT02488408|560648585|FG002|Part A|Other|0|||
155331979|NCT02488408|560648586|FG003|Part A|Other|0|||
155331980|NCT02488408|560648587|FG004|Part A|Other|0|||
155331981|NCT02488408|560648588|FG005|Part A|Other|0|||
155331982|NCT02488408|560648589|FG006|Part A|Other|0|||
155331983|NCT02488408|560648590|FG007|Part A|Other|0|||
155331984|NCT02488408|560648591|FG008|Part A|Other|0|||
155331985|NCT02488408|560648592|FG009|Part A|Other|0|||
155331986|NCT02488408|560648583|FG000|Part B|Adverse Event|0|||
155331987|NCT02488408|560648584|FG001|Part B|Adverse Event|0|||
155331988|NCT02488408|560648585|FG002|Part B|Adverse Event|0|||
155331989|NCT02488408|560648586|FG003|Part B|Adverse Event|0|||
155331990|NCT02488408|560648587|FG004|Part B|Adverse Event|0|||
155331991|NCT02488408|560648588|FG005|Part B|Adverse Event|2|||
155331992|NCT02488408|560648589|FG006|Part B|Adverse Event|2|||
155331993|NCT02488408|560648590|FG007|Part B|Adverse Event|7|||
155331994|NCT02488408|560648591|FG008|Part B|Adverse Event|2|||
155331995|NCT02488408|560648592|FG009|Part B|Adverse Event|2|||
155331996|NCT02488408|560648583|FG000|Part B|Death|0|||
155331997|NCT02488408|560648584|FG001|Part B|Death|0|||
155331998|NCT02488408|560648585|FG002|Part B|Death|0|||
155331999|NCT02488408|560648586|FG003|Part B|Death|0|||
155332000|NCT02488408|560648587|FG004|Part B|Death|0|||
155332001|NCT02488408|560648588|FG005|Part B|Death|3|||
155332002|NCT02488408|560648589|FG006|Part B|Death|1|||
155332003|NCT02488408|560648590|FG007|Part B|Death|2|||
155332004|NCT02488408|560648591|FG008|Part B|Death|2|||
155332005|NCT02488408|560648592|FG009|Part B|Death|2|||
155332006|NCT02488408|560648583|FG000|Part B|Death due to Disease Progression|0|||
155332007|NCT02488408|560648584|FG001|Part B|Death due to Disease Progression|0|||
155332008|NCT02488408|560648585|FG002|Part B|Death due to Disease Progression|0|||
155332009|NCT02488408|560648586|FG003|Part B|Death due to Disease Progression|0|||
155332010|NCT02488408|560648587|FG004|Part B|Death due to Disease Progression|0|||
155332011|NCT02488408|560648588|FG005|Part B|Death due to Disease Progression|2|||
155332012|NCT02488408|560648589|FG006|Part B|Death due to Disease Progression|2|||
155332013|NCT02488408|560648590|FG007|Part B|Death due to Disease Progression|1|||
155332014|NCT02488408|560648591|FG008|Part B|Death due to Disease Progression|1|||
155332015|NCT02488408|560648592|FG009|Part B|Death due to Disease Progression|1|||
155332016|NCT02488408|560648583|FG000|Part B|Disease Progression|0|||
155332017|NCT02488408|560648584|FG001|Part B|Disease Progression|0|||
155332018|NCT02488408|560648585|FG002|Part B|Disease Progression|0|||
155332019|NCT02488408|560648586|FG003|Part B|Disease Progression|0|||
155332020|NCT02488408|560648587|FG004|Part B|Disease Progression|0|||
155332021|NCT02488408|560648588|FG005|Part B|Disease Progression|6|||
155332022|NCT02488408|560648589|FG006|Part B|Disease Progression|9|||
155332023|NCT02488408|560648590|FG007|Part B|Disease Progression|7|||
155332024|NCT02488408|560648591|FG008|Part B|Disease Progression|9|||
155332025|NCT02488408|560648592|FG009|Part B|Disease Progression|11|||
155332026|NCT02488408|560648583|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
155332027|NCT02488408|560648584|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
155332028|NCT02488408|560648585|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
155332029|NCT02488408|560648586|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
155332030|NCT02488408|560648587|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
155332031|NCT02488408|560648588|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
155332032|NCT02488408|560648589|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
155332033|NCT02488408|560648590|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
155332034|NCT02488408|560648591|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
155332035|NCT02488408|560648592|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
155332036|NCT02488408|560648583|FG000|Part B|Investigator Decision|0|||
155332037|NCT02488408|560648584|FG001|Part B|Investigator Decision|0|||
155332038|NCT02488408|560648585|FG002|Part B|Investigator Decision|0|||
155332039|NCT02488408|560648586|FG003|Part B|Investigator Decision|0|||
155332040|NCT02488408|560648587|FG004|Part B|Investigator Decision|0|||
155332041|NCT02488408|560648588|FG005|Part B|Investigator Decision|0|||
155332042|NCT02488408|560648589|FG006|Part B|Investigator Decision|1|||
155332043|NCT02488408|560648590|FG007|Part B|Investigator Decision|0|||
155332044|NCT02488408|560648591|FG008|Part B|Investigator Decision|2|||
155332045|NCT02488408|560648592|FG009|Part B|Investigator Decision|1|||
155332046|NCT00719888|560648593|FG000|Overall Study|Death|24|||
155332047|NCT00719888|560648594|FG001|Overall Study|Death|9|||
155332048|NCT00719888|560648593|FG000|Overall Study|Relapse|8|||
155332049|NCT00719888|560648594|FG001|Overall Study|Relapse|3|||
155332050|NCT00719888|560648593|FG000|Overall Study|Physician Decision|1|||
155332051|NCT00719888|560648594|FG001|Overall Study|Physician Decision|0|||
155332052|NCT00719888|560648593|FG000|Overall Study|Withdrawal by Subject|1|||
154961945|NCT00556322|559285699|FG001|Overall Study|Withdrawal by Subject|7|||
155332053|NCT00719888|560648594|FG001|Overall Study|Withdrawal by Subject|0|||
155332054|NCT05886777|560648595|FG000|Overall Study|Lost to Follow-up|1|||
155332055|NCT05886777|560648596|FG001|Overall Study|Lost to Follow-up|0|||
155332056|NCT05886777|560648597|FG002|Overall Study|Lost to Follow-up|2|||
155332057|NCT05886777|560648598|FG003|Overall Study|Lost to Follow-up|1|||
155332058|NCT05886777|560648599|FG004|Overall Study|Lost to Follow-up|0|||
155332059|NCT05886777|560648600|FG005|Overall Study|Lost to Follow-up|2|||
155332060|NCT05886777|560648601|FG006|Overall Study|Lost to Follow-up|0|||
155332061|NCT05886777|560648595|FG000|Overall Study|Other|0|||
155332062|NCT05886777|560648596|FG001|Overall Study|Other|2|||
155332063|NCT05886777|560648597|FG002|Overall Study|Other|1|||
155332064|NCT05886777|560648598|FG003|Overall Study|Other|0|||
155332065|NCT05886777|560648599|FG004|Overall Study|Other|0|||
155332066|NCT05886777|560648600|FG005|Overall Study|Other|0|||
155332067|NCT05886777|560648601|FG006|Overall Study|Other|0|||
155332068|NCT05886777|560648595|FG000|Overall Study|Withdrawal by Subject|1|||
155332069|NCT05886777|560648596|FG001|Overall Study|Withdrawal by Subject|0|||
155332070|NCT05886777|560648597|FG002|Overall Study|Withdrawal by Subject|1|||
155332071|NCT05886777|560648598|FG003|Overall Study|Withdrawal by Subject|4|||
155332072|NCT05886777|560648599|FG004|Overall Study|Withdrawal by Subject|3|||
155332073|NCT05886777|560648600|FG005|Overall Study|Withdrawal by Subject|1|||
155332074|NCT05886777|560648601|FG006|Overall Study|Withdrawal by Subject|1|||
155332075|NCT05886777|560648595|FG000|Overall Study|Protocol Violation|0|||
155332076|NCT05886777|560648596|FG001|Overall Study|Protocol Violation|0|||
155332077|NCT05886777|560648597|FG002|Overall Study|Protocol Violation|1|||
155332078|NCT05886777|560648598|FG003|Overall Study|Protocol Violation|0|||
155332079|NCT05886777|560648599|FG004|Overall Study|Protocol Violation|0|||
155332080|NCT05886777|560648600|FG005|Overall Study|Protocol Violation|0|||
155332081|NCT05886777|560648601|FG006|Overall Study|Protocol Violation|0|||
155332082|NCT05886777|560648595|FG000|Overall Study|No longer met eligibility criteria|0|||
155332083|NCT05886777|560648596|FG001|Overall Study|No longer met eligibility criteria|1|||
154961946|NCT00556322|559285698|FG000|Overall Study|Protocol Violation|5|||
154961947|NCT00556322|559285699|FG001|Overall Study|Protocol Violation|1|||
154961948|NCT00556322|559285698|FG000|Overall Study|Ongoing at data cutoff|3|||
155332084|NCT05886777|560648597|FG002|Overall Study|No longer met eligibility criteria|0|||
155332085|NCT05886777|560648598|FG003|Overall Study|No longer met eligibility criteria|0|||
155332086|NCT05886777|560648599|FG004|Overall Study|No longer met eligibility criteria|0|||
155332087|NCT05886777|560648600|FG005|Overall Study|No longer met eligibility criteria|0|||
155332088|NCT05886777|560648601|FG006|Overall Study|No longer met eligibility criteria|0|||
155332089|NCT03773107|560648602|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
155332090|NCT03773107|560648603|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
155332091|NCT03773107|560648604|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
155332092|NCT03773107|560648605|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
155332093|NCT07204444|560648607|FG000|Overall Study|Medical/Hospitalization|6|||
155332094|NCT07204444|560648608|FG001|Overall Study|Medical/Hospitalization|9|||
155332095|NCT07204444|560648609|FG002|Overall Study|Medical/Hospitalization|6|||
155332096|NCT07204444|560648607|FG000|Overall Study|Treatment Provider Issue|1|||
155332097|NCT07204444|560648608|FG001|Overall Study|Treatment Provider Issue|3|||
155332098|NCT07204444|560648609|FG002|Overall Study|Treatment Provider Issue|0|||
155332099|NCT07204444|560648607|FG000|Overall Study|Withdrawal by Subject|11|||
155332100|NCT07204444|560648608|FG001|Overall Study|Withdrawal by Subject|5|||
155332101|NCT07204444|560648609|FG002|Overall Study|Withdrawal by Subject|5|||
155332102|NCT07204444|560648607|FG000|Overall Study|Death|3|||
155332103|NCT07204444|560648608|FG001|Overall Study|Death|6|||
155332104|NCT07204444|560648609|FG002|Overall Study|Death|1|||
155332105|NCT07204444|560648607|FG000|Overall Study|Unable To Reach|29|||
155332106|NCT07204444|560648608|FG001|Overall Study|Unable To Reach|26|||
155332107|NCT07204444|560648609|FG002|Overall Study|Unable To Reach|17|||
155332108|NCT07204444|560648607|FG000|Overall Study|Protocol Deviation|3|||
155332109|NCT07204444|560648608|FG001|Overall Study|Protocol Deviation|2|||
155332110|NCT07204444|560648609|FG002|Overall Study|Protocol Deviation|0|||
155332111|NCT05199571|560650131|FG000|Treatment Period|Participant decision|3|||
155332112|NCT05199571|560650131|FG000|Treatment Period|Physician Decision|1|||
155332113|NCT05199571|560650131|FG000|Post-treatment Follow up Period|Participant decision|3|||
155332114|NCT05029284|560650132|FG000|Overall Study|Lost to Follow-up|1|||
155332115|NCT02972034|560650133|FG000|Overall Study|Death|11|||
155332116|NCT02972034|560650134|FG001|Overall Study|Death|1|||
155332117|NCT02972034|560650135|FG002|Overall Study|Death|3|||
155332118|NCT02972034|560650136|FG003|Overall Study|Death|3|||
155332119|NCT02972034|560650137|FG004|Overall Study|Death|2|||
155332120|NCT02972034|560650138|FG005|Overall Study|Death|2|||
155332121|NCT02972034|560650139|FG006|Overall Study|Death|3|||
155332122|NCT02972034|560650140|FG007|Overall Study|Death|4|||
155332123|NCT02972034|560650141|FG008|Overall Study|Death|8|||
155332124|NCT02972034|560650142|FG009|Overall Study|Death|11|||
155332125|NCT02972034|560650143|FG010|Overall Study|Death|3|||
155332126|NCT02972034|560650144|FG011|Overall Study|Death|2|||
155332127|NCT02972034|560650145|FG012|Overall Study|Death|11|||
155332128|NCT02972034|560650146|FG013|Overall Study|Death|10|||
155332129|NCT02972034|560650147|FG014|Overall Study|Death|9|||
155332130|NCT02972034|560650133|FG000|Overall Study|Lost to Follow-up|0|||
155332131|NCT02972034|560650134|FG001|Overall Study|Lost to Follow-up|0|||
155332132|NCT02972034|560650135|FG002|Overall Study|Lost to Follow-up|0|||
155332133|NCT02972034|560650136|FG003|Overall Study|Lost to Follow-up|0|||
155332134|NCT02972034|560650137|FG004|Overall Study|Lost to Follow-up|1|||
155332135|NCT02972034|560650138|FG005|Overall Study|Lost to Follow-up|0|||
155332136|NCT02972034|560650139|FG006|Overall Study|Lost to Follow-up|0|||
155332137|NCT02972034|560650140|FG007|Overall Study|Lost to Follow-up|1|||
155332138|NCT02972034|560650141|FG008|Overall Study|Lost to Follow-up|0|||
155332139|NCT02972034|560650142|FG009|Overall Study|Lost to Follow-up|0|||
155332140|NCT02972034|560650143|FG010|Overall Study|Lost to Follow-up|0|||
155332141|NCT02972034|560650144|FG011|Overall Study|Lost to Follow-up|0|||
155332142|NCT02972034|560650145|FG012|Overall Study|Lost to Follow-up|0|||
155332143|NCT02972034|560650146|FG013|Overall Study|Lost to Follow-up|0|||
155332144|NCT02972034|560650147|FG014|Overall Study|Lost to Follow-up|1|||
155332145|NCT02972034|560650133|FG000|Overall Study|Physician Decision|0|||
155332146|NCT02972034|560650134|FG001|Overall Study|Physician Decision|0|||
155332147|NCT02972034|560650135|FG002|Overall Study|Physician Decision|0|||
155332148|NCT02972034|560650136|FG003|Overall Study|Physician Decision|0|||
155332149|NCT02972034|560650137|FG004|Overall Study|Physician Decision|0|||
155332150|NCT02972034|560650138|FG005|Overall Study|Physician Decision|0|||
155332151|NCT02972034|560650139|FG006|Overall Study|Physician Decision|0|||
155332152|NCT02972034|560650140|FG007|Overall Study|Physician Decision|1|||
155332153|NCT02972034|560650141|FG008|Overall Study|Physician Decision|0|||
155332154|NCT02972034|560650142|FG009|Overall Study|Physician Decision|0|||
155332155|NCT02972034|560650143|FG010|Overall Study|Physician Decision|1|||
155332156|NCT02972034|560650144|FG011|Overall Study|Physician Decision|0|||
155332157|NCT02972034|560650145|FG012|Overall Study|Physician Decision|0|||
155332158|NCT02972034|560650146|FG013|Overall Study|Physician Decision|0|||
155332159|NCT02972034|560650147|FG014|Overall Study|Physician Decision|0|||
155332160|NCT02972034|560650133|FG000|Overall Study|Sponsor Decision|0|||
155332161|NCT02972034|560650134|FG001|Overall Study|Sponsor Decision|0|||
155332162|NCT02972034|560650135|FG002|Overall Study|Sponsor Decision|0|||
155332163|NCT02972034|560650136|FG003|Overall Study|Sponsor Decision|1|||
155332164|NCT02972034|560650137|FG004|Overall Study|Sponsor Decision|0|||
155332165|NCT02972034|560650138|FG005|Overall Study|Sponsor Decision|0|||
155332166|NCT02972034|560650139|FG006|Overall Study|Sponsor Decision|1|||
155332167|NCT02972034|560650140|FG007|Overall Study|Sponsor Decision|1|||
155332168|NCT02972034|560650141|FG008|Overall Study|Sponsor Decision|1|||
155332169|NCT02972034|560650142|FG009|Overall Study|Sponsor Decision|2|||
155332170|NCT02972034|560650143|FG010|Overall Study|Sponsor Decision|2|||
155332171|NCT02972034|560650144|FG011|Overall Study|Sponsor Decision|0|||
155332172|NCT02972034|560650145|FG012|Overall Study|Sponsor Decision|1|||
155332173|NCT02972034|560650146|FG013|Overall Study|Sponsor Decision|0|||
155332174|NCT02972034|560650147|FG014|Overall Study|Sponsor Decision|1|||
155332175|NCT02972034|560650133|FG000|Overall Study|Withdrawal by Subject|3|||
155332176|NCT02972034|560650134|FG001|Overall Study|Withdrawal by Subject|0|||
155332177|NCT02972034|560650135|FG002|Overall Study|Withdrawal by Subject|0|||
155332178|NCT02972034|560650136|FG003|Overall Study|Withdrawal by Subject|0|||
155332179|NCT02972034|560650137|FG004|Overall Study|Withdrawal by Subject|1|||
155332180|NCT02972034|560650138|FG005|Overall Study|Withdrawal by Subject|1|||
155332181|NCT02972034|560650139|FG006|Overall Study|Withdrawal by Subject|0|||
155332182|NCT02972034|560650140|FG007|Overall Study|Withdrawal by Subject|0|||
155332183|NCT02972034|560650141|FG008|Overall Study|Withdrawal by Subject|1|||
155332184|NCT02972034|560650142|FG009|Overall Study|Withdrawal by Subject|1|||
155332185|NCT02972034|560650143|FG010|Overall Study|Withdrawal by Subject|2|||
155332186|NCT02972034|560650144|FG011|Overall Study|Withdrawal by Subject|1|||
155332187|NCT02972034|560650145|FG012|Overall Study|Withdrawal by Subject|1|||
155332188|NCT02972034|560650146|FG013|Overall Study|Withdrawal by Subject|1|||
155332189|NCT02972034|560650147|FG014|Overall Study|Withdrawal by Subject|0|||
155332190|NCT02972034|560650133|FG000|Overall Study|Screen Failure|0|||
155332191|NCT02972034|560650134|FG001|Overall Study|Screen Failure|0|||
155332192|NCT02972034|560650135|FG002|Overall Study|Screen Failure|0|||
155332193|NCT02972034|560650136|FG003|Overall Study|Screen Failure|0|||
155332194|NCT02972034|560650137|FG004|Overall Study|Screen Failure|0|||
155332195|NCT02972034|560650138|FG005|Overall Study|Screen Failure|0|||
155332196|NCT02972034|560650139|FG006|Overall Study|Screen Failure|0|||
155332197|NCT02972034|560650140|FG007|Overall Study|Screen Failure|0|||
155332198|NCT02972034|560650141|FG008|Overall Study|Screen Failure|0|||
155332199|NCT02972034|560650142|FG009|Overall Study|Screen Failure|0|||
155332200|NCT02972034|560650143|FG010|Overall Study|Screen Failure|0|||
155332201|NCT02972034|560650144|FG011|Overall Study|Screen Failure|0|||
155071088|NCT02335944|559688191|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155071089|NCT02335944|559688192|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
155332202|NCT02972034|560650145|FG012|Overall Study|Screen Failure|1|||
155332203|NCT02972034|560650146|FG013|Overall Study|Screen Failure|0|||
155332204|NCT02972034|560650147|FG014|Overall Study|Screen Failure|0|||
155332205|NCT03861052|560650148|FG000|Overall Study|Adverse Event|1|||
155332206|NCT03861052|560650149|FG001|Overall Study|Adverse Event|1|||
155332207|NCT03861052|560650150|FG002|Overall Study|Adverse Event|2|||
155332208|NCT03861052|560650151|FG003|Overall Study|Adverse Event|4|||
155332209|NCT03861052|560650148|FG000|Overall Study|Lost to Follow-up|0|||
155332210|NCT03861052|560650149|FG001|Overall Study|Lost to Follow-up|0|||
155332211|NCT03861052|560650150|FG002|Overall Study|Lost to Follow-up|0|||
155332212|NCT03861052|560650151|FG003|Overall Study|Lost to Follow-up|1|||
155332213|NCT03861052|560650148|FG000|Overall Study|Physician Decision|0|||
155332214|NCT03861052|560650149|FG001|Overall Study|Physician Decision|1|||
155332215|NCT03861052|560650150|FG002|Overall Study|Physician Decision|0|||
155332216|NCT03861052|560650151|FG003|Overall Study|Physician Decision|0|||
155332217|NCT03861052|560650148|FG000|Overall Study|Withdrawal by Subject|2|||
155332218|NCT03861052|560650149|FG001|Overall Study|Withdrawal by Subject|5|||
155332219|NCT03861052|560650150|FG002|Overall Study|Withdrawal by Subject|3|||
155332220|NCT03861052|560650151|FG003|Overall Study|Withdrawal by Subject|0|||
155332221|NCT03861052|560650148|FG000|Overall Study|Relocation to other city|1|||
155332222|NCT03861052|560650149|FG001|Overall Study|Relocation to other city|0|||
155332223|NCT03861052|560650150|FG002|Overall Study|Relocation to other city|0|||
155332224|NCT03861052|560650151|FG003|Overall Study|Relocation to other city|0|||
155332225|NCT03009344|560650152|FG000|Overall Study|Lack of Efficacy|5|||
155332226|NCT03009344|560650152|FG000|Overall Study|Withdrawal by Subject|1|||
155332227|NCT03009344|560650152|FG000|Overall Study|Adverse Event|1|||
155332228|NCT00454194|560650163|FG000|Overall Study|Adverse Event|7|||
155332229|NCT00454194|560650164|FG001|Overall Study|Adverse Event|2|||
155332230|NCT00454194|560650163|FG000|Overall Study|Withdrawal by Subject|12|||
155332231|NCT00454194|560650164|FG001|Overall Study|Withdrawal by Subject|8|||
155332232|NCT00454194|560650163|FG000|Overall Study|Other Medical Problems|1|||
155332233|NCT00454194|560650164|FG001|Overall Study|Other Medical Problems|2|||
155332234|NCT00454194|560650163|FG000|Overall Study|Other Unspecified Reason|2|||
155332235|NCT00454194|560650164|FG001|Overall Study|Other Unspecified Reason|2|||
155332236|NCT00229658|560650182|FG000|Overall Study|Administrative|2|||
155332237|NCT00229658|560650183|FG001|Overall Study|Administrative|1|||
155332238|NCT00229658|560650182|FG000|Overall Study|Investigator decision|13|||
155332239|NCT00229658|560650183|FG001|Overall Study|Investigator decision|10|||
155332240|NCT00229658|560650182|FG000|Overall Study|Other|80|||
154961949|NCT00556322|559285699|FG001|Overall Study|Ongoing at data cutoff|5|||
154961950|NCT00556322|559285698|FG000|Overall Study|Death|20|||
154961951|NCT00556322|559285699|FG001|Overall Study|Death|14|||
154961952|NCT03249454|559285700|FG000|Overall Study|Withdrawal by Subject|0|||
154961953|NCT03249454|559285701|FG001|Overall Study|Withdrawal by Subject|0|||
154961954|NCT03249454|559285702|FG002|Overall Study|Withdrawal by Subject|0|||
154961955|NCT03249454|559285703|FG003|Overall Study|Withdrawal by Subject|0|||
154961956|NCT03249454|559285704|FG004|Overall Study|Withdrawal by Subject|0|||
154961957|NCT03249454|559285705|FG005|Overall Study|Withdrawal by Subject|0|||
154961958|NCT03249454|559285706|FG006|Overall Study|Withdrawal by Subject|0|||
154961959|NCT03249454|559285707|FG007|Overall Study|Withdrawal by Subject|0|||
154961960|NCT03249454|559285708|FG008|Overall Study|Withdrawal by Subject|0|||
154961961|NCT03249454|559285709|FG009|Overall Study|Withdrawal by Subject|1|||
154961962|NCT03249454|559285710|FG010|Overall Study|Withdrawal by Subject|1|||
154961963|NCT01913405|559285711|FG000|Overall Study|Withdrawal by Subject|1|||
154961964|NCT01913405|559285711|FG000|Overall Study|Adverse Event|1|||
154961965|NCT01020474|559285712|FG000|Overall Study|Adverse Event|4|||
154961966|NCT01020474|559285713|FG001|Overall Study|Adverse Event|4|||
154961967|NCT01020474|559285712|FG000|Overall Study|Protocol Violation|0|||
154961968|NCT01020474|559285713|FG001|Overall Study|Protocol Violation|2|||
154961969|NCT01020474|559285712|FG000|Overall Study|Withdrawal by Subject|5|||
154961970|NCT01020474|559285713|FG001|Overall Study|Withdrawal by Subject|7|||
154961971|NCT01020474|559285712|FG000|Overall Study|Other Reasons|1|||
154961972|NCT01020474|559285713|FG001|Overall Study|Other Reasons|1|||
155332241|NCT00229658|560650183|FG001|Overall Study|Other|60|||
154961973|NCT01020474|559285712|FG000|Overall Study|Insufficient Clinical Response|0|||
155332242|NCT00229658|560650182|FG000|Overall Study|Lost to Follow-up|82|||
155332243|NCT00229658|560650183|FG001|Overall Study|Lost to Follow-up|55|||
155332244|NCT00229658|560650182|FG000|Overall Study|Serious Adverse Event|2|||
155332245|NCT00229658|560650183|FG001|Overall Study|Serious Adverse Event|2|||
155332246|NCT00229658|560650182|FG000|Overall Study|Withdrawal of consent|46|||
155332247|NCT00229658|560650183|FG001|Overall Study|Withdrawal of consent|39|||
155332248|NCT00205179|560650184|FG000|Overall Study|Death|0|||
155332249|NCT00205179|560650185|FG001|Overall Study|Death|2|||
155332250|NCT00205179|560650184|FG000|Overall Study|Physician Decision|1|||
155332251|NCT00205179|560650185|FG001|Overall Study|Physician Decision|1|||
155332252|NCT00205179|560650184|FG000|Overall Study|Adverse Event|1|||
155332253|NCT00205179|560650185|FG001|Overall Study|Adverse Event|1|||
155332254|NCT00463229|560650186|FG000|Overall Study|Lost to Follow-up|5|||
155332255|NCT00463229|560650187|FG001|Overall Study|Lost to Follow-up|7|||
155332256|NCT00463229|560650186|FG000|Overall Study|Death|4|||
155332257|NCT00463229|560650187|FG001|Overall Study|Death|3|||
155332258|NCT01700205|560650194|FG000|Overall Study|Withdrawal by Subject|13|||
155332259|NCT01700205|560650195|FG001|Overall Study|Withdrawal by Subject|13|||
155332260|NCT01700205|560650194|FG000|Overall Study|Protocol Violation|2|||
155332261|NCT01700205|560650195|FG001|Overall Study|Protocol Violation|2|||
155332262|NCT01728324|560650200|FG000|Termination of DBV|Adverse Event|14|||
155332263|NCT01728324|560650201|FG001|Termination of DBV|Adverse Event|13|||
155332264|NCT01728324|560650202|FG002|Termination of DBV|Adverse Event|4|||
155332265|NCT01728324|560650200|FG000|Termination of DBV|Lack of Efficacy|14|||
155332266|NCT01728324|560650201|FG001|Termination of DBV|Lack of Efficacy|12|||
155332267|NCT01728324|560650202|FG002|Termination of DBV|Lack of Efficacy|8|||
155332268|NCT01728324|560650200|FG000|Termination of DBV|Withdrawal by Subject|9|||
155332269|NCT01728324|560650201|FG001|Termination of DBV|Withdrawal by Subject|6|||
155332270|NCT01728324|560650202|FG002|Termination of DBV|Withdrawal by Subject|2|||
155332271|NCT01728324|560650200|FG000|Termination of DBV|Other than stated|1|||
155332272|NCT01728324|560650201|FG001|Termination of DBV|Other than stated|3|||
155332273|NCT01728324|560650202|FG002|Termination of DBV|Other than stated|0|||
155332274|NCT01728324|560650200|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
155332275|NCT01728324|560650201|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
155332276|NCT01728324|560650202|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
155332277|NCT01728324|560650200|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
155332278|NCT01728324|560650201|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
155332279|NCT01728324|560650202|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
155332280|NCT01728324|560650200|FG000|Termination of FDV|Adverse Event|14|||
155332281|NCT01728324|560650201|FG001|Termination of FDV|Adverse Event|13|||
155332282|NCT01728324|560650202|FG002|Termination of FDV|Adverse Event|4|||
155332283|NCT01728324|560650200|FG000|Termination of FDV|Lack of Efficacy|14|||
155332284|NCT01728324|560650201|FG001|Termination of FDV|Lack of Efficacy|12|||
155332285|NCT01728324|560650202|FG002|Termination of FDV|Lack of Efficacy|8|||
155332286|NCT01728324|560650200|FG000|Termination of FDV|Withdrawal by Subject|9|||
155332287|NCT01728324|560650201|FG001|Termination of FDV|Withdrawal by Subject|6|||
155332288|NCT01728324|560650202|FG002|Termination of FDV|Withdrawal by Subject|2|||
155332289|NCT01728324|560650200|FG000|Termination of FDV|Other than stated|1|||
155332290|NCT01728324|560650201|FG001|Termination of FDV|Other than stated|3|||
155332291|NCT01728324|560650202|FG002|Termination of FDV|Other than stated|0|||
155332292|NCT01728324|560650200|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
155332293|NCT01728324|560650201|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
155332294|NCT01728324|560650202|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
155332295|NCT01728324|560650200|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
155332296|NCT01728324|560650201|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
155332297|NCT01728324|560650202|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
155332298|NCT01728324|560650200|FG000|Termination of RBV|Adverse Event|15|||
155332299|NCT01728324|560650201|FG001|Termination of RBV|Adverse Event|16|||
155332300|NCT01728324|560650202|FG002|Termination of RBV|Adverse Event|5|||
155332301|NCT01728324|560650200|FG000|Termination of RBV|Lack of Efficacy|14|||
155332302|NCT01728324|560650201|FG001|Termination of RBV|Lack of Efficacy|11|||
155332303|NCT01728324|560650202|FG002|Termination of RBV|Lack of Efficacy|7|||
155332304|NCT01728324|560650200|FG000|Termination of RBV|Withdrawal by Subject|9|||
155332305|NCT01728324|560650201|FG001|Termination of RBV|Withdrawal by Subject|5|||
155332306|NCT01728324|560650202|FG002|Termination of RBV|Withdrawal by Subject|2|||
155332307|NCT01728324|560650200|FG000|Termination of RBV|Other than stated|1|||
155332308|NCT01728324|560650201|FG001|Termination of RBV|Other than stated|3|||
155332309|NCT01728324|560650202|FG002|Termination of RBV|Other than stated|1|||
155332310|NCT01728324|560650200|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
155332311|NCT01728324|560650201|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
155332312|NCT01728324|560650202|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
154961974|NCT01020474|559285713|FG001|Overall Study|Insufficient Clinical Response|3|||
155332313|NCT01728324|560650200|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
155332314|NCT01728324|560650201|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
155332315|NCT01728324|560650202|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
155332316|NCT01170208|560650203|FG000|Overall Study|Withdrawal by Subject|5|||
155332317|NCT01170208|560650204|FG001|Overall Study|Withdrawal by Subject|0|||
155332318|NCT01170208|560650205|FG002|Overall Study|Withdrawal by Subject|1|||
155332319|NCT01170208|560650203|FG000|Overall Study|Protocol Violation|1|||
155332320|NCT01170208|560650204|FG001|Overall Study|Protocol Violation|0|||
155332321|NCT01170208|560650205|FG002|Overall Study|Protocol Violation|1|||
155332322|NCT03113409|560650208|FG000|Overall Study|Withdrawal by Subject|5|||
155332323|NCT03113409|560650209|FG001|Overall Study|Withdrawal by Subject|0|||
155332324|NCT03113409|560650210|FG002|Overall Study|Withdrawal by Subject|0|||
155332325|NCT00388726|560650211|FG000|Overall Study|Adverse Event|50|||
155332326|NCT00388726|560650212|FG001|Overall Study|Adverse Event|24|||
155332327|NCT00388726|560650211|FG000|Overall Study|Progressive Disease|336|||
155332328|NCT00388726|560650212|FG001|Overall Study|Progressive Disease|153|||
155332329|NCT00388726|560650211|FG000|Overall Study|Clinical Progression|61|||
155332330|NCT00388726|560650212|FG001|Overall Study|Clinical Progression|36|||
155332331|NCT00388726|560650211|FG000|Overall Study|Withdrawal by Subject|10|||
155332332|NCT00388726|560650212|FG001|Overall Study|Withdrawal by Subject|7|||
155332333|NCT00388726|560650211|FG000|Overall Study|Administrative|6|||
155332334|NCT00388726|560650212|FG001|Overall Study|Administrative|9|||
155332335|NCT00388726|560650211|FG000|Overall Study|Physician Decision|18|||
155332336|NCT00388726|560650212|FG001|Overall Study|Physician Decision|13|||
155332337|NCT00388726|560650211|FG000|Overall Study|Death|3|||
155332338|NCT00388726|560650212|FG001|Overall Study|Death|2|||
155332339|NCT00641537|560650215|FG000|96-week Period|Adverse Event|0|||
155332340|NCT00641537|560650216|FG001|96-week Period|Adverse Event|1|||
155332341|NCT00641537|560650217|FG002|96-week Period|Adverse Event|3|||
155332342|NCT00641537|560650218|FG003|96-week Period|Adverse Event|0|||
155332343|NCT00641537|560650219|FG004|96-week Period|Adverse Event|2|||
155332344|NCT00641537|560650220|FG005|96-week Period|Adverse Event|0|||
155332345|NCT00641537|560650221|FG006|96-week Period|Adverse Event|0|||
155332346|NCT00641537|560650222|FG007|96-week Period|Adverse Event|0|||
155332347|NCT00641537|560650215|FG000|96-week Period|Lost to Follow-up|3|||
155332348|NCT00641537|560650216|FG001|96-week Period|Lost to Follow-up|1|||
155332349|NCT00641537|560650217|FG002|96-week Period|Lost to Follow-up|2|||
155332350|NCT00641537|560650218|FG003|96-week Period|Lost to Follow-up|2|||
155332351|NCT00641537|560650219|FG004|96-week Period|Lost to Follow-up|4|||
155332352|NCT00641537|560650220|FG005|96-week Period|Lost to Follow-up|0|||
155332353|NCT00641537|560650221|FG006|96-week Period|Lost to Follow-up|1|||
155332354|NCT00641537|560650222|FG007|96-week Period|Lost to Follow-up|0|||
155332355|NCT00641537|560650215|FG000|96-week Period|Protocol Violation|0|||
155332356|NCT00641537|560650216|FG001|96-week Period|Protocol Violation|1|||
155332357|NCT00641537|560650217|FG002|96-week Period|Protocol Violation|0|||
155332358|NCT00641537|560650218|FG003|96-week Period|Protocol Violation|1|||
155332359|NCT00641537|560650219|FG004|96-week Period|Protocol Violation|0|||
155332360|NCT00641537|560650220|FG005|96-week Period|Protocol Violation|1|||
155332361|NCT00641537|560650221|FG006|96-week Period|Protocol Violation|0|||
155332362|NCT00641537|560650222|FG007|96-week Period|Protocol Violation|0|||
155332363|NCT00641537|560650215|FG000|96-week Period|Death|2|||
155332364|NCT00641537|560650216|FG001|96-week Period|Death|0|||
155332365|NCT00641537|560650217|FG002|96-week Period|Death|1|||
155332366|NCT00641537|560650218|FG003|96-week Period|Death|0|||
155332367|NCT00641537|560650219|FG004|96-week Period|Death|0|||
155332368|NCT00641537|560650220|FG005|96-week Period|Death|0|||
155332369|NCT00641537|560650221|FG006|96-week Period|Death|0|||
155332370|NCT00641537|560650222|FG007|96-week Period|Death|0|||
155332371|NCT00641537|560650215|FG000|96-week Period|Other|4|||
155332372|NCT00641537|560650216|FG001|96-week Period|Other|7|||
155332373|NCT00641537|560650217|FG002|96-week Period|Other|14|||
155332374|NCT00641537|560650218|FG003|96-week Period|Other|9|||
155332375|NCT00641537|560650219|FG004|96-week Period|Other|11|||
155332376|NCT00641537|560650220|FG005|96-week Period|Other|6|||
155332377|NCT00641537|560650221|FG006|96-week Period|Other|4|||
155332378|NCT00641537|560650222|FG007|96-week Period|Other|6|||
155332379|NCT00641537|560650215|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
155332380|NCT00641537|560650216|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
155332381|NCT00641537|560650217|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
155332382|NCT00641537|560650218|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
155332383|NCT00641537|560650219|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
155332384|NCT00641537|560650220|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
155332385|NCT00641537|560650221|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
155332386|NCT00641537|560650222|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
155332387|NCT00641537|560650215|FG000|24-Week Supplemental Follow-up Period|Other|0|||
155332388|NCT00641537|560650216|FG001|24-Week Supplemental Follow-up Period|Other|2|||
155332389|NCT00641537|560650217|FG002|24-Week Supplemental Follow-up Period|Other|2|||
155332390|NCT00641537|560650218|FG003|24-Week Supplemental Follow-up Period|Other|1|||
155332391|NCT00641537|560650219|FG004|24-Week Supplemental Follow-up Period|Other|3|||
155332392|NCT00641537|560650220|FG005|24-Week Supplemental Follow-up Period|Other|0|||
155332393|NCT00641537|560650221|FG006|24-Week Supplemental Follow-up Period|Other|1|||
155332394|NCT00641537|560650222|FG007|24-Week Supplemental Follow-up Period|Other|1|||
155163699|NCT01160822|560035027|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155163700|NCT01160822|560035028|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155163701|NCT01160822|560035029|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
155163702|NCT01160822|560035030|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
155163703|NCT01160822|560035031|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
155163704|NCT01160822|560035025|FG000|Overall Study|Withdrawal by Subject|0|||
155163705|NCT01160822|560035026|FG001|Overall Study|Withdrawal by Subject|0|||
155163706|NCT01160822|560035027|FG002|Overall Study|Withdrawal by Subject|0|||
155163707|NCT01160822|560035028|FG003|Overall Study|Withdrawal by Subject|0|||
155163708|NCT01160822|560035029|FG004|Overall Study|Withdrawal by Subject|0|||
155163709|NCT01160822|560035030|FG005|Overall Study|Withdrawal by Subject|0|||
155163710|NCT01160822|560035031|FG006|Overall Study|Withdrawal by Subject|1|||
155163711|NCT01160822|560035025|FG000|Overall Study|Lost to Follow-up|0|||
155163712|NCT01160822|560035026|FG001|Overall Study|Lost to Follow-up|0|||
155163713|NCT01160822|560035027|FG002|Overall Study|Lost to Follow-up|0|||
155332395|NCT03229408|560650223|FG000|Overall Study|Withdrawal by Subject|4|||
155332396|NCT03229408|560650224|FG001|Overall Study|Withdrawal by Subject|1|||
155332397|NCT03229408|560650223|FG000|Overall Study|Adverse Event|2|||
155332398|NCT03229408|560650224|FG001|Overall Study|Adverse Event|0|||
155332399|NCT03229408|560650223|FG000|Overall Study|Pregnancy|0|||
155332400|NCT03229408|560650224|FG001|Overall Study|Pregnancy|1|||
155332401|NCT03229408|560650223|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
155332402|NCT03229408|560650224|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
155332403|NCT03745313|560650229|FG000|At 30 Days Follow-up|Death|2|||
155332404|NCT03745313|560650229|FG000|At 6 Months Follow-up|Death|1|||
155332405|NCT03745313|560650229|FG000|At 6 Months Follow-up|Missed Visit|1|||
155332406|NCT03745313|560650229|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
155332407|NCT03745313|560650229|FG000|At 1 Year Follow-up|Death|2|||
155332408|NCT03745313|560650229|FG000|At 1 Year Follow-up|Missed Visit|2|||
155332409|NCT03745313|560650229|FG000|At 2 Year Follow-up|Missed Visit|1|||
155332410|NCT01706159|560650230|FG000|Overall Study|Withdrawal Criteria|2|||
155332411|NCT01706159|560650231|FG001|Overall Study|Withdrawal Criteria|1|||
155332412|NCT01706159|560650230|FG000|Overall Study|Unclassified|6|||
155332413|NCT01706159|560650231|FG001|Overall Study|Unclassified|1|||
155332414|NCT02235298|560650239|FG000|Overall Study|Lost to Follow-up|6|||
155332415|NCT02235298|560650240|FG001|Overall Study|Lost to Follow-up|5|||
155332416|NCT02235298|560650239|FG000|Overall Study|Adverse Event|2|||
155332417|NCT02235298|560650240|FG001|Overall Study|Adverse Event|2|||
155332418|NCT02235298|560650239|FG000|Overall Study|Withdrawal by Subject|0|||
155332419|NCT02235298|560650240|FG001|Overall Study|Withdrawal by Subject|1|||
155332420|NCT02628626|560650245|FG000|Overall Study|Withdrawal by Subject|2|||
155332421|NCT02628626|560650246|FG001|Overall Study|Withdrawal by Subject|2|||
155163714|NCT01160822|560035028|FG003|Overall Study|Lost to Follow-up|0|||
155163715|NCT01160822|560035029|FG004|Overall Study|Lost to Follow-up|1|||
155332422|NCT01593020|560650247|FG000|Overall Study|Adverse Event|1|||
155332423|NCT01593020|560650248|FG001|Overall Study|Adverse Event|1|||
155332424|NCT01593020|560650247|FG000|Overall Study|Death|0|||
155332425|NCT01593020|560650248|FG001|Overall Study|Death|1|||
155332426|NCT01593020|560650247|FG000|Overall Study|Ineligible|1|||
155332427|NCT01593020|560650248|FG001|Overall Study|Ineligible|0|||
155332428|NCT02454959|560650249|FG000|Overall Study|Protocol-Specified Criteria|3|||
155332429|NCT02454959|560650249|FG000|Overall Study|Physician Decision|1|||
155332430|NCT02454959|560650249|FG000|Overall Study|Withdrawal by Subject|3|||
155332431|NCT02454959|560650249|FG000|Overall Study|Adverse Event|2|||
155332432|NCT02350634|560650250|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
154961975|NCT01103713|559285715|FG000|Overall Study|Lost to Follow-up|2|||
155163716|NCT01160822|560035030|FG005|Overall Study|Lost to Follow-up|0|||
155163717|NCT01160822|560035031|FG006|Overall Study|Lost to Follow-up|0|||
155163718|NCT01160822|560035025|FG000|Overall Study|Administrative problems|0|||
155163719|NCT01160822|560035026|FG001|Overall Study|Administrative problems|0|||
155163720|NCT01160822|560035027|FG002|Overall Study|Administrative problems|0|||
155163721|NCT01160822|560035028|FG003|Overall Study|Administrative problems|0|||
155163722|NCT01160822|560035029|FG004|Overall Study|Administrative problems|1|||
155163723|NCT01160822|560035030|FG005|Overall Study|Administrative problems|0|||
155332433|NCT03102034|560650261|FG000|Overall Study|Withdrawal by Subject|1|||
155332434|NCT03102034|560650262|FG001|Overall Study|Withdrawal by Subject|0|||
155332435|NCT03611075|560650266|FG000|Overall Study|Physician Decision|0|||
155332436|NCT03611075|560650267|FG001|Overall Study|Physician Decision|1|||
155332437|NCT03611075|560650268|FG002|Overall Study|Physician Decision|1|||
155332438|NCT03611075|560650269|FG003|Overall Study|Physician Decision|0|||
155332439|NCT03611075|560650270|FG004|Overall Study|Physician Decision|0|||
155332440|NCT03611075|560650271|FG005|Overall Study|Physician Decision|0|||
155332441|NCT03611075|560650272|FG006|Overall Study|Physician Decision|0|||
155332442|NCT03611075|560650273|FG007|Overall Study|Physician Decision|0|||
155332443|NCT03611075|560650274|FG008|Overall Study|Physician Decision|0|||
155332444|NCT03611075|560650266|FG000|Overall Study|Lost to Follow-up|1|||
155332445|NCT03611075|560650267|FG001|Overall Study|Lost to Follow-up|0|||
155332446|NCT03611075|560650268|FG002|Overall Study|Lost to Follow-up|0|||
155332447|NCT03611075|560650269|FG003|Overall Study|Lost to Follow-up|2|||
155332448|NCT03611075|560650270|FG004|Overall Study|Lost to Follow-up|0|||
155332449|NCT03611075|560650271|FG005|Overall Study|Lost to Follow-up|0|||
155332450|NCT03611075|560650272|FG006|Overall Study|Lost to Follow-up|0|||
155332451|NCT03611075|560650273|FG007|Overall Study|Lost to Follow-up|0|||
155332452|NCT03611075|560650274|FG008|Overall Study|Lost to Follow-up|0|||
155332453|NCT03611075|560650266|FG000|Overall Study|Withdrawal by Subject|0|||
155332454|NCT03611075|560650267|FG001|Overall Study|Withdrawal by Subject|1|||
155332455|NCT03611075|560650268|FG002|Overall Study|Withdrawal by Subject|1|||
155332456|NCT03611075|560650269|FG003|Overall Study|Withdrawal by Subject|1|||
155332457|NCT03611075|560650270|FG004|Overall Study|Withdrawal by Subject|0|||
155332458|NCT03611075|560650271|FG005|Overall Study|Withdrawal by Subject|0|||
155332459|NCT03611075|560650272|FG006|Overall Study|Withdrawal by Subject|1|||
155332460|NCT03611075|560650273|FG007|Overall Study|Withdrawal by Subject|0|||
155332461|NCT03611075|560650274|FG008|Overall Study|Withdrawal by Subject|0|||
155332462|NCT03611075|560650266|FG000|Overall Study|Reason unknown|0|||
155071090|NCT02335944|559688183|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071091|NCT02335944|559688184|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071092|NCT02335944|559688185|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071093|NCT02335944|559688186|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071094|NCT02335944|559688187|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071095|NCT02335944|559688188|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071096|NCT02335944|559688189|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071097|NCT02335944|559688190|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
155071098|NCT02335944|559688191|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071099|NCT02335944|559688192|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
155071100|NCT02335944|559688183|FG000|Post-treatment Follow-up|Adverse Event|0|||
155071101|NCT02335944|559688184|FG001|Post-treatment Follow-up|Adverse Event|0|||
155071102|NCT02335944|559688185|FG002|Post-treatment Follow-up|Adverse Event|0|||
155071103|NCT02335944|559688186|FG003|Post-treatment Follow-up|Adverse Event|0|||
155071104|NCT02335944|559688187|FG004|Post-treatment Follow-up|Adverse Event|0|||
155071105|NCT02335944|559688188|FG005|Post-treatment Follow-up|Adverse Event|1|||
155071106|NCT02335944|559688189|FG006|Post-treatment Follow-up|Adverse Event|0|||
155071107|NCT02335944|559688190|FG007|Post-treatment Follow-up|Adverse Event|0|||
155071108|NCT02335944|559688191|FG008|Post-treatment Follow-up|Adverse Event|0|||
155071109|NCT02335944|559688192|FG009|Post-treatment Follow-up|Adverse Event|0|||
155071110|NCT02335944|559688183|FG000|Post-treatment Follow-up|Death|0|||
155071111|NCT02335944|559688184|FG001|Post-treatment Follow-up|Death|0|||
155071112|NCT02335944|559688185|FG002|Post-treatment Follow-up|Death|0|||
155071113|NCT02335944|559688186|FG003|Post-treatment Follow-up|Death|1|||
155071114|NCT02335944|559688187|FG004|Post-treatment Follow-up|Death|0|||
155071115|NCT02335944|559688188|FG005|Post-treatment Follow-up|Death|1|||
155332463|NCT03611075|560650267|FG001|Overall Study|Reason unknown|0|||
155332464|NCT03611075|560650268|FG002|Overall Study|Reason unknown|0|||
155332465|NCT03611075|560650269|FG003|Overall Study|Reason unknown|1|||
155332466|NCT03611075|560650270|FG004|Overall Study|Reason unknown|0|||
155332467|NCT03611075|560650271|FG005|Overall Study|Reason unknown|0|||
155332468|NCT03611075|560650272|FG006|Overall Study|Reason unknown|1|||
155071116|NCT02335944|559688189|FG006|Post-treatment Follow-up|Death|0|||
155071117|NCT02335944|559688190|FG007|Post-treatment Follow-up|Death|0|||
155071118|NCT02335944|559688191|FG008|Post-treatment Follow-up|Death|0|||
155071119|NCT02335944|559688192|FG009|Post-treatment Follow-up|Death|0|||
155071120|NCT02335944|559688183|FG000|Post-treatment Follow-up|Physician Decision|1|||
155071121|NCT02335944|559688184|FG001|Post-treatment Follow-up|Physician Decision|0|||
155071122|NCT02335944|559688185|FG002|Post-treatment Follow-up|Physician Decision|0|||
155071123|NCT02335944|559688186|FG003|Post-treatment Follow-up|Physician Decision|0|||
155071124|NCT02335944|559688187|FG004|Post-treatment Follow-up|Physician Decision|0|||
155071125|NCT02335944|559688188|FG005|Post-treatment Follow-up|Physician Decision|0|||
155163724|NCT01160822|560035031|FG006|Overall Study|Administrative problems|0|||
155332469|NCT03611075|560650273|FG007|Overall Study|Reason unknown|0|||
155332470|NCT03611075|560650274|FG008|Overall Study|Reason unknown|0|||
155332471|NCT02063659|560650275|FG000|Double-Blind Treatment Period|Adverse Event|1|||
155071126|NCT02335944|559688189|FG006|Post-treatment Follow-up|Physician Decision|0|||
155071127|NCT02335944|559688190|FG007|Post-treatment Follow-up|Physician Decision|1|||
155071128|NCT02335944|559688191|FG008|Post-treatment Follow-up|Physician Decision|0|||
155071129|NCT02335944|559688192|FG009|Post-treatment Follow-up|Physician Decision|0|||
155071130|NCT03043573|559688201|FG000|Overall Study|Lost to Follow-up|3|||
155071131|NCT03043573|559688202|FG001|Overall Study|Lost to Follow-up|3|||
155071132|NCT03043573|559688201|FG000|Overall Study|Physician Decision|0|||
155071133|NCT03043573|559688202|FG001|Overall Study|Physician Decision|5|||
155071134|NCT03043573|559688201|FG000|Overall Study|Withdrawal by Subject|0|||
155071135|NCT03043573|559688202|FG001|Overall Study|Withdrawal by Subject|4|||
155071136|NCT03439514|559689626|FG000|Double-Blind Treatment Period|Other|4|||
155071137|NCT03439514|559689627|FG001|Double-Blind Treatment Period|Other|1|||
155071138|NCT03439514|559689626|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
155071139|NCT03439514|559689627|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155071140|NCT03439514|559689626|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
155071141|NCT03439514|559689627|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
155071142|NCT03439514|559689626|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
155071143|NCT03439514|559689627|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155071144|NCT03439514|559689626|FG000|Double-Blind Treatment Period|Death|1|||
155071145|NCT03439514|559689627|FG001|Double-Blind Treatment Period|Death|2|||
155071146|NCT04398134|559689628|FG000|Overall Study|Adverse Event|0|||
155071147|NCT04398134|559689629|FG001|Overall Study|Adverse Event|0|||
155071148|NCT04398134|559689630|FG002|Overall Study|Adverse Event|1|||
155071149|NCT04398134|559689631|FG003|Overall Study|Adverse Event|0|||
155071150|NCT04398134|559689628|FG000|Overall Study|Withdrawal by Subject|2|||
155071151|NCT04398134|559689629|FG001|Overall Study|Withdrawal by Subject|0|||
155071152|NCT04398134|559689630|FG002|Overall Study|Withdrawal by Subject|0|||
155071153|NCT04398134|559689631|FG003|Overall Study|Withdrawal by Subject|1|||
155071154|NCT04398134|559689628|FG000|Overall Study|Study Terminated by Sponsor|30|||
155071155|NCT04398134|559689629|FG001|Overall Study|Study Terminated by Sponsor|11|||
155071156|NCT04398134|559689630|FG002|Overall Study|Study Terminated by Sponsor|32|||
155071157|NCT04398134|559689631|FG003|Overall Study|Study Terminated by Sponsor|11|||
155071158|NCT02989389|559689635|FG000|Period 1|Lost to Follow-up|0|||
155071159|NCT02989389|559689636|FG001|Period 1|Lost to Follow-up|1|||
155071160|NCT02989389|559689637|FG002|Period 1|Lost to Follow-up|0|||
155071161|NCT02989389|559689638|FG003|Period 1|Lost to Follow-up|0|||
155071162|NCT02989389|559689639|FG004|Period 1|Lost to Follow-up|0|||
155071163|NCT02989389|559689640|FG005|Period 1|Lost to Follow-up|0|||
155071164|NCT02989389|559689641|FG006|Period 1|Lost to Follow-up|0|||
155071165|NCT02989389|559689642|FG007|Period 1|Lost to Follow-up|0|||
155071166|NCT02989389|559689643|FG008|Period 1|Lost to Follow-up|0|||
155071167|NCT02989389|559689644|FG009|Period 1|Lost to Follow-up|0|||
155071168|NCT02989389|559689635|FG000|Period 1|Physician Decision|0|||
155071169|NCT02989389|559689636|FG001|Period 1|Physician Decision|0|||
155071170|NCT02989389|559689637|FG002|Period 1|Physician Decision|0|||
155071171|NCT02989389|559689638|FG003|Period 1|Physician Decision|0|||
155071172|NCT02989389|559689639|FG004|Period 1|Physician Decision|0|||
155071173|NCT02989389|559689640|FG005|Period 1|Physician Decision|0|||
155071174|NCT02989389|559689641|FG006|Period 1|Physician Decision|0|||
155071175|NCT02989389|559689642|FG007|Period 1|Physician Decision|0|||
155071176|NCT02989389|559689643|FG008|Period 1|Physician Decision|1|||
155071177|NCT02989389|559689644|FG009|Period 1|Physician Decision|0|||
155071178|NCT01018979|559689645|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
155071179|NCT01018979|559689646|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
155071180|NCT01018979|559689645|FG000|Overall Study|Not received at least one dose|0|||
155071181|NCT01018979|559689646|FG001|Overall Study|Not received at least one dose|1|||
155071182|NCT03506477|559689652|FG000|Overall Study|Withdrawal by Subject|1|||
155071183|NCT03506477|559689653|FG001|Overall Study|Withdrawal by Subject|0|||
155071184|NCT03462680|559689654|FG000|Overall Study|Withdrawal by Subject|3|||
155071185|NCT03462680|559689655|FG001|Overall Study|Withdrawal by Subject|5|||
155071186|NCT01757847|559689656|FG000|Overall Study|Withdrawal by Subject|3|||
155071187|NCT01757847|559689657|FG001|Overall Study|Withdrawal by Subject|4|||
155071188|NCT02516241|559689658|FG000|Overall Study|Death|255|||
155071189|NCT02516241|559689659|FG001|Overall Study|Death|262|||
155071190|NCT02516241|559689660|FG002|Overall Study|Death|270|||
155332472|NCT02063659|560650276|FG001|Double-Blind Treatment Period|Adverse Event|2|||
155071191|NCT02516241|559689658|FG000|Overall Study|Lost to Follow-up|1|||
155071192|NCT02516241|559689659|FG001|Overall Study|Lost to Follow-up|1|||
155071193|NCT02516241|559689660|FG002|Overall Study|Lost to Follow-up|3|||
155071194|NCT02516241|559689658|FG000|Overall Study|Withdrawal by Subject|2|||
155071195|NCT02516241|559689659|FG001|Overall Study|Withdrawal by Subject|7|||
155071196|NCT02516241|559689660|FG002|Overall Study|Withdrawal by Subject|12|||
155071197|NCT02516241|559689658|FG000|Overall Study|participants ongoing at data cut-off|84|||
155071198|NCT02516241|559689659|FG001|Overall Study|participants ongoing at data cut-off|76|||
155071199|NCT02516241|559689660|FG002|Overall Study|participants ongoing at data cut-off|59|||
155332473|NCT02063659|560650277|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155332474|NCT02063659|560650278|FG003|Double-Blind Treatment Period|Adverse Event|0|||
155332475|NCT02063659|560650275|FG000|Double-Blind Treatment Period|Physician Decision|1|||
155332476|NCT02063659|560650276|FG001|Double-Blind Treatment Period|Physician Decision|0|||
155332477|NCT02063659|560650277|FG002|Double-Blind Treatment Period|Physician Decision|0|||
155332478|NCT02063659|560650278|FG003|Double-Blind Treatment Period|Physician Decision|0|||
155332479|NCT02063659|560650275|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
155332480|NCT02063659|560650276|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
155332481|NCT02063659|560650277|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
155332482|NCT02063659|560650278|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
155332483|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
155332484|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
155332485|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
155332486|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
155332487|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155332488|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155332489|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
155332490|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
155332491|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155332492|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155332493|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
155332494|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
155332495|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
155332496|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
155332497|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
155332498|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
155332499|NCT02063659|560650275|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155332500|NCT02063659|560650276|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155332501|NCT02063659|560650277|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
155332502|NCT02063659|560650278|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
155332503|NCT02972359|560650279|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
155332504|NCT02972359|560650279|FG000|Overall Study|Lack of Efficacy|1|||
155332505|NCT02972359|560650279|FG000|Overall Study|Adverse Event|4|||
155332506|NCT02972359|560650279|FG000|Overall Study|Death|1|||
155332507|NCT02972359|560650279|FG000|Overall Study|Withdrawal by Subject|30|||
155332508|NCT02972359|560650279|FG000|Overall Study|Protocol Violation|1|||
155332509|NCT02972359|560650279|FG000|Overall Study|Lost to Follow-up|26|||
155332510|NCT02972359|560650279|FG000|Overall Study|Other reasons|5|||
155332511|NCT02972359|560650279|FG000|Overall Study|Missing|1|||
155332512|NCT02830204|560650282|FG000|Overall Study|Death|9|||
155332513|NCT02830204|560650282|FG000|Overall Study|Withdrawal by Subject|1|||
155332514|NCT02517268|560650285|FG000|Overall Study|Withdrawal by Subject|1|||
155332515|NCT02517268|560650286|FG001|Overall Study|Withdrawal by Subject|0|||
155332516|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332517|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332518|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332519|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
155332520|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332521|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332522|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332523|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332524|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332525|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
155332526|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
155332527|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332528|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155071200|NCT01260948|559689666|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
155071201|NCT01260948|559689667|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
155071202|NCT01260948|559689666|FG000|Second Intervention|Emesis|0|||
155071203|NCT01260948|559689667|FG001|Second Intervention|Emesis|1|||
155071204|NCT00462462|559689668|FG000|Overall Study|Physician Decision|0|||
155332529|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
155332530|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332531|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332532|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332533|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332534|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332535|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
155332536|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Death|1|||
155332537|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Death|2|||
155332538|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Death|3|||
155332539|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Death|5|||
155332540|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Death|4|||
155332541|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Death|0|||
155332542|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Death|0|||
155332543|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Death|0|||
155332544|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Death|0|||
155332545|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Death|0|||
155332546|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332547|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
155332548|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332549|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332550|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
155332551|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332552|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332553|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332554|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332555|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
155332556|NCT02401815|560650289|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
155332557|NCT02401815|560650290|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332558|NCT02401815|560650291|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332559|NCT02401815|560650292|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332560|NCT02401815|560650293|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
155332561|NCT02401815|560650294|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332562|NCT02401815|560650295|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332563|NCT02401815|560650296|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332564|NCT02401815|560650297|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332565|NCT02401815|560650298|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
155332566|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332567|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332568|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332569|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332570|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332571|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
155332572|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332573|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332574|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332575|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
155332576|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332577|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332578|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332579|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332580|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332581|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332582|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
155071205|NCT00462462|559689669|FG001|Overall Study|Physician Decision|1|||
155332583|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155071206|NCT01163617|559689670|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155071207|NCT01163617|559689671|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
155071208|NCT01163617|559689672|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155071209|NCT01163617|559689673|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155071210|NCT01163617|559689674|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155332584|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332585|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332586|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332587|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332588|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332589|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332590|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332591|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
155332592|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
155332593|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332594|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332595|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
155332596|NCT02401815|560650289|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332597|NCT02401815|560650290|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332598|NCT02401815|560650291|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332599|NCT02401815|560650292|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332600|NCT02401815|560650293|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332601|NCT02401815|560650294|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
155332602|NCT02401815|560650295|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332603|NCT02401815|560650296|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332604|NCT02401815|560650297|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332605|NCT02401815|560650298|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
155332606|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332607|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332608|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332609|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332610|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332611|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332612|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
155332613|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
155332614|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
155332615|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
155332616|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332617|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332618|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332619|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332620|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332621|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332622|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332623|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
155332624|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
155332625|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
155332626|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332627|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332628|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332629|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155071211|NCT01163617|559689675|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155071212|NCT01163617|559689676|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155332630|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332631|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332632|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332633|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332634|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
155332635|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
155332636|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332637|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332638|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332639|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332640|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332641|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332642|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332643|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332644|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
155332645|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
155332646|NCT02401815|560650289|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332647|NCT02401815|560650290|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332648|NCT02401815|560650291|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332649|NCT02401815|560650292|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332650|NCT02401815|560650293|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332651|NCT02401815|560650294|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332652|NCT02401815|560650295|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332653|NCT02401815|560650296|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
155332654|NCT02401815|560650297|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
155332655|NCT02401815|560650298|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
155332656|NCT00378898|560651308|FG000|Overall Study|Withdrawal by Subject|10|||
155332657|NCT00378898|560651309|FG001|Overall Study|Withdrawal by Subject|5|||
155332658|NCT00378898|560651308|FG000|Overall Study|Protocol Violation|1|||
155332659|NCT00378898|560651309|FG001|Overall Study|Protocol Violation|1|||
155332660|NCT03116464|560651311|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
155332661|NCT00345046|560651314|FG000|Overall Study|Protocol Violation|1|||
155332662|NCT00345046|560651315|FG001|Overall Study|Protocol Violation|1|||
155332663|NCT00345046|560651316|FG002|Overall Study|Protocol Violation|2|||
155332664|NCT03689946|560651317|FG000|Overall Study|Withdrawal by Subject|3|||
155332665|NCT03689946|560651317|FG000|Overall Study|Lost to Follow-up|3|||
155332666|NCT03689946|560651317|FG000|Overall Study|Data corruption|2|||
155332667|NCT04608409|560651322|FG000|Overall Study|Physician Decision|1|||
155332668|NCT04608409|560651323|FG001|Overall Study|Physician Decision|1|||
155332669|NCT04608409|560651324|FG002|Overall Study|Physician Decision|2|||
155332670|NCT01787032|560651325|FG000|Overall Study|Protocol Violation|0|||
155332671|NCT01787032|560651326|FG001|Overall Study|Protocol Violation|0|||
155332672|NCT01787032|560651327|FG002|Overall Study|Protocol Violation|0|||
155332673|NCT01787032|560651328|FG003|Overall Study|Protocol Violation|0|||
155332674|NCT01787032|560651329|FG004|Overall Study|Protocol Violation|1|||
155332675|NCT01787032|560651330|FG005|Overall Study|Protocol Violation|1|||
155332676|NCT00687219|560651336|FG000|Overall Study|Adverse Event|8|||
155332677|NCT00687219|560651336|FG000|Overall Study|Discontinuance criteria met|7|||
155332678|NCT00687219|560651336|FG000|Overall Study|HCV-RNA positive conversion|34|||
155332679|NCT00687219|560651336|FG000|Overall Study|Withdrawal by Subject|1|||
155332680|NCT00687219|560651336|FG000|Overall Study|Lack of Efficacy|1|||
155332681|NCT04827732|560651348|FG000|Overall Study|Did not start treatment|0|||
155332682|NCT04827732|560651349|FG001|Overall Study|Did not start treatment|1|||
155332683|NCT04827732|560651350|FG002|Overall Study|Did not start treatment|0|||
155332684|NCT04827732|560651351|FG003|Overall Study|Did not start treatment|1|||
155332685|NCT04300023|560651354|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
155332686|NCT04300023|560651355|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
155332687|NCT05025384|560651362|FG000|Overall Study|Physician Decision|5|||
155332688|NCT05025384|560651363|FG001|Overall Study|Physician Decision|6|||
155332689|NCT04057131|560651364|FG000|Overall Study|Protocol Violation|24|||
155332690|NCT04686266|560651367|FG000|Overall Study|Withdrawal by Subject|0|||
155332691|NCT04686266|560651368|FG001|Overall Study|Withdrawal by Subject|1|||
155332692|NCT05613907|560651373|FG000|Overall Study|Lost to Follow-up|5|||
155332693|NCT05613907|560651373|FG000|Overall Study|Death|3|||
155332694|NCT05613907|560651373|FG000|Overall Study|Withdrawal by Subject|2|||
155332695|NCT00748709|560651383|FG000|Overall Study|Progressive disease|15|||
155332696|NCT00748709|560651383|FG000|Overall Study|Drug reducing Toxity|2|||
155071213|NCT01163617|559689677|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
155071214|NCT01163617|559689670|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155071215|NCT01163617|559689671|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
155071216|NCT01163617|559689672|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155071217|NCT01163617|559689673|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155332697|NCT00748709|560651383|FG000|Overall Study|Other Adverse Event|1|||
155071218|NCT01163617|559689674|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155163725|NCT01160822|560035025|FG000|Overall Study|Protocol deviation|0|||
155332698|NCT00748709|560651383|FG000|Overall Study|Withdrawal by Subject|1|||
155332699|NCT00748709|560651383|FG000|Overall Study|Other Reasons|1|||
155332700|NCT03789656|560651384|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
155332701|NCT03789656|560651385|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
155332702|NCT03789656|560651386|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
155332703|NCT03789656|560651387|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
155332704|NCT03789656|560651388|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
155332705|NCT03789656|560651384|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332706|NCT03789656|560651385|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332707|NCT03789656|560651386|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
155332708|NCT03789656|560651387|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332709|NCT03789656|560651388|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
155332710|NCT03789656|560651384|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
155071219|NCT01163617|559689675|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155071220|NCT01163617|559689676|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155332711|NCT03789656|560651385|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332712|NCT03789656|560651386|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332713|NCT03789656|560651387|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332714|NCT03789656|560651388|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
155332715|NCT03789656|560651384|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
155332716|NCT03789656|560651385|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332717|NCT03789656|560651386|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332718|NCT03789656|560651387|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332719|NCT03789656|560651388|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
155332720|NCT05325294|560651394|FG000|Overall Study|Adverse Event|3|||
155332721|NCT05325294|560651395|FG001|Overall Study|Adverse Event|3|||
155332722|NCT05325294|560651394|FG000|Overall Study|Physician Decision|0|||
155332723|NCT05325294|560651395|FG001|Overall Study|Physician Decision|1|||
155332724|NCT05325294|560651394|FG000|Overall Study|Withdrawal by Subject|0|||
155332725|NCT05325294|560651395|FG001|Overall Study|Withdrawal by Subject|3|||
155332726|NCT05325294|560651394|FG000|Overall Study|Lost to Follow-up|1|||
155332727|NCT05325294|560651395|FG001|Overall Study|Lost to Follow-up|0|||
155332728|NCT05325294|560651394|FG000|Overall Study|Sponsor Request|0|||
155332729|NCT05325294|560651395|FG001|Overall Study|Sponsor Request|2|||
155332730|NCT00491894|560651396|FG000|Overall Study|Adverse Event|14|||
155332731|NCT00491894|560651396|FG000|Overall Study|Withdrawal by Subject|5|||
155332732|NCT00491894|560651396|FG000|Overall Study|Death|3|||
155332733|NCT00491894|560651396|FG000|Overall Study|Lost to Follow-up|3|||
155071221|NCT01163617|559689677|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
155071222|NCT01163617|559689670|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155071223|NCT01163617|559689671|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155071224|NCT01163617|559689672|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
155071225|NCT01163617|559689673|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155071226|NCT01163617|559689674|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155071227|NCT01163617|559689675|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155071228|NCT01163617|559689676|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155163726|NCT01160822|560035026|FG001|Overall Study|Protocol deviation|0|||
155332734|NCT00491894|560651396|FG000|Overall Study|Lack of Efficacy|2|||
155332735|NCT00491894|560651396|FG000|Overall Study|Other-Failed to meet any criteria|2|||
155332736|NCT00491894|560651396|FG000|Overall Study|Physician Decision|2|||
155332737|NCT00491894|560651396|FG000|Overall Study|Protocol Violation|2|||
155332738|NCT00491894|560651396|FG000|Overall Study|Other-Intake of prohibited medication|1|||
155332739|NCT01563185|560651397|FG000|Overall Study|Withdrawal by Subject|1|||
155332740|NCT01563185|560651397|FG000|Overall Study|Non-Compliance with study drug|1|||
155332741|NCT04577651|560651398|FG000|Overall Study|Screen Failure|7|||
155332742|NCT04577651|560651398|FG000|Overall Study|Adverse Event|1|||
155332743|NCT04577651|560651398|FG000|Overall Study|Death|1|||
155332744|NCT04577651|560651398|FG000|Overall Study|Physician Decision|1|||
155332745|NCT04577651|560651398|FG000|Overall Study|Withdrawal by Subject|3|||
155332746|NCT05422339|560652642|FG000|Overall Study|Withdrawal by Subject|17|||
155332747|NCT05422339|560652643|FG001|Overall Study|Withdrawal by Subject|15|||
155332748|NCT04172675|560652644|FG000|Overall Study|Withdrawal by Subject|7|||
155071229|NCT01163617|559689677|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
155071230|NCT02875080|559689678|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
155071231|NCT02875080|559689679|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
155071232|NCT02875080|559689680|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
155071233|NCT02394756|559689681|FG000|Period 1|Lens Discomfort|0|||
155071234|NCT02394756|559689682|FG001|Period 1|Lens Discomfort|0|||
155071235|NCT02394756|559689683|FG002|Period 1|Lens Discomfort|0|||
155071236|NCT02394756|559689684|FG003|Period 1|Lens Discomfort|0|||
155071237|NCT02394756|559689685|FG004|Period 1|Lens Discomfort|0|||
155071238|NCT02394756|559689686|FG005|Period 1|Lens Discomfort|1|||
155071239|NCT02394756|559689681|FG000|Period 1|Withdrawal by Subject|0|||
155071240|NCT02394756|559689682|FG001|Period 1|Withdrawal by Subject|1|||
155071241|NCT02394756|559689683|FG002|Period 1|Withdrawal by Subject|1|||
155071242|NCT02394756|559689684|FG003|Period 1|Withdrawal by Subject|1|||
155071243|NCT02394756|559689685|FG004|Period 1|Withdrawal by Subject|0|||
155071244|NCT02394756|559689686|FG005|Period 1|Withdrawal by Subject|0|||
155071245|NCT02394756|559689681|FG000|Period 2|Unsatisfactory Visual Response|0|||
155071246|NCT02394756|559689682|FG001|Period 2|Unsatisfactory Visual Response|0|||
155071247|NCT02394756|559689683|FG002|Period 2|Unsatisfactory Visual Response|0|||
155071248|NCT02394756|559689684|FG003|Period 2|Unsatisfactory Visual Response|0|||
155071249|NCT02394756|559689685|FG004|Period 2|Unsatisfactory Visual Response|1|||
155071250|NCT02394756|559689686|FG005|Period 2|Unsatisfactory Visual Response|0|||
155071251|NCT02406612|559689687|FG000|Overall Study|Screening Failure|3|||
155071252|NCT02406612|559689688|FG001|Overall Study|Screening Failure|0|||
155071253|NCT02406612|559689687|FG000|Overall Study|Intra-procedural Exclusion|1|||
155332749|NCT04172675|560652645|FG001|Overall Study|Withdrawal by Subject|5|||
155332750|NCT04172675|560652646|FG002|Overall Study|Withdrawal by Subject|1|||
155332751|NCT04172675|560652647|FG003|Overall Study|Withdrawal by Subject|4|||
155332752|NCT03070392|560652648|FG000|Overall Study|Not Treated|7|||
155332753|NCT03070392|560652649|FG001|Overall Study|Not Treated|0|||
155332754|NCT03070392|560652650|FG002|Overall Study|Not Treated|3|||
155332755|NCT03070392|560652651|FG003|Overall Study|Not Treated|12|||
155332756|NCT03070392|560652648|FG000|Overall Study|Death|3|||
155332757|NCT03070392|560652649|FG001|Overall Study|Death|0|||
155332758|NCT03070392|560652650|FG002|Overall Study|Death|0|||
155332759|NCT03070392|560652651|FG003|Overall Study|Death|1|||
155332760|NCT03070392|560652648|FG000|Overall Study|Withdrawal by Subject|7|||
155332761|NCT03070392|560652649|FG001|Overall Study|Withdrawal by Subject|0|||
155332762|NCT03070392|560652650|FG002|Overall Study|Withdrawal by Subject|0|||
155332763|NCT03070392|560652651|FG003|Overall Study|Withdrawal by Subject|3|||
155332764|NCT03070392|560652648|FG000|Overall Study|Physician Decision|1|||
155332765|NCT03070392|560652649|FG001|Overall Study|Physician Decision|0|||
155332766|NCT03070392|560652650|FG002|Overall Study|Physician Decision|0|||
155332767|NCT03070392|560652651|FG003|Overall Study|Physician Decision|2|||
155332768|NCT03070392|560652648|FG000|Overall Study|Progressive Disease|154|||
155332769|NCT03070392|560652649|FG001|Overall Study|Progressive Disease|6|||
155332770|NCT03070392|560652650|FG002|Overall Study|Progressive Disease|2|||
155332771|NCT03070392|560652651|FG003|Overall Study|Progressive Disease|70|||
155332772|NCT03070392|560652648|FG000|Overall Study|Adverse Event|6|||
155332773|NCT03070392|560652649|FG001|Overall Study|Adverse Event|1|||
155332774|NCT03070392|560652650|FG002|Overall Study|Adverse Event|1|||
155332775|NCT03070392|560652651|FG003|Overall Study|Adverse Event|3|||
155332776|NCT03070392|560652648|FG000|Overall Study|Alternate anticancer treatment|1|||
155332777|NCT03070392|560652649|FG001|Overall Study|Alternate anticancer treatment|0|||
155332778|NCT03070392|560652650|FG002|Overall Study|Alternate anticancer treatment|0|||
155332779|NCT03070392|560652651|FG003|Overall Study|Alternate anticancer treatment|1|||
155332780|NCT03070392|560652648|FG000|Overall Study|Ongoing|73|||
155071254|NCT02406612|559689688|FG001|Overall Study|Intra-procedural Exclusion|3|||
155332781|NCT03070392|560652649|FG001|Overall Study|Ongoing|0|||
155071255|NCT02406612|559689687|FG000|Overall Study|Guidewire Failure|0|||
155071256|NCT02406612|559689688|FG001|Overall Study|Guidewire Failure|1|||
155071257|NCT02830087|559689693|FG000|Overall Study|No study staff to follow-up patients|4|||
155332782|NCT03070392|560652650|FG002|Overall Study|Ongoing|0|||
155071258|NCT02830087|559689694|FG001|Overall Study|No study staff to follow-up patients|4|||
155163727|NCT01160822|560035027|FG002|Overall Study|Protocol deviation|0|||
155071259|NCT02830087|559689695|FG002|Overall Study|No study staff to follow-up patients|4|||
155071260|NCT02830087|559689696|FG003|Overall Study|No study staff to follow-up patients|3|||
155071261|NCT02830087|559689697|FG004|Overall Study|No study staff to follow-up patients|3|||
155071262|NCT02830087|559689698|FG005|Overall Study|No study staff to follow-up patients|3|||
155163728|NCT01160822|560035028|FG003|Overall Study|Protocol deviation|0|||
155332783|NCT03070392|560652651|FG003|Overall Study|Ongoing|11|||
155332784|NCT02534233|560652657|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
155332785|NCT00925548|560652658|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
155332786|NCT00925548|560652659|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
155332787|NCT01278030|560652660|FG000|Overall Study|Withdrawal by Subject|8|||
155332788|NCT01278030|560652661|FG001|Overall Study|Withdrawal by Subject|4|||
155332789|NCT00458783|560652663|FG000|Overall Study|Protocol Violation|1228|||
155332790|NCT00458783|560652664|FG001|Overall Study|Protocol Violation|1220|||
155332791|NCT01737398|560652665|FG000|Overall Study|Adverse event or SAE|16|||
155332792|NCT01737398|560652666|FG001|Overall Study|Adverse event or SAE|1|||
155332793|NCT01737398|560652665|FG000|Overall Study|Stopping rule met|2|||
155332794|NCT01737398|560652666|FG001|Overall Study|Stopping rule met|1|||
155332795|NCT01737398|560652665|FG000|Overall Study|Voluntary withdrawal|2|||
155332796|NCT01737398|560652666|FG001|Overall Study|Voluntary withdrawal|3|||
155332797|NCT01737398|560652665|FG000|Overall Study|Ineligibility|1|||
155332798|NCT01737398|560652666|FG001|Overall Study|Ineligibility|0|||
155332799|NCT01737398|560652665|FG000|Overall Study|Liver transplant|1|||
155332800|NCT01737398|560652666|FG001|Overall Study|Liver transplant|0|||
155332801|NCT01737398|560652665|FG000|Overall Study|Disease progression|2|||
155332802|NCT01737398|560652666|FG001|Overall Study|Disease progression|3|||
155332803|NCT01737398|560652665|FG000|Overall Study|Sponsor's decision|2|||
155332804|NCT01737398|560652666|FG001|Overall Study|Sponsor's decision|0|||
155332805|NCT02372799|560652669|FG000|Treatment Period|Adverse Event|3|||
155332806|NCT02372799|560652670|FG001|Treatment Period|Adverse Event|10|||
155332807|NCT02372799|560652671|FG002|Treatment Period|Adverse Event|6|||
155332808|NCT02372799|560652669|FG000|Treatment Period|Insufficient therapeutic response|2|||
155332809|NCT02372799|560652670|FG001|Treatment Period|Insufficient therapeutic response|2|||
155332810|NCT02372799|560652671|FG002|Treatment Period|Insufficient therapeutic response|0|||
155332811|NCT02372799|560652669|FG000|Treatment Period|Withdrawal by Subject|10|||
155332812|NCT02372799|560652670|FG001|Treatment Period|Withdrawal by Subject|10|||
155332813|NCT02372799|560652671|FG002|Treatment Period|Withdrawal by Subject|2|||
155332814|NCT02372799|560652669|FG000|Treatment Period|Lost to Follow-up|11|||
155332815|NCT02372799|560652670|FG001|Treatment Period|Lost to Follow-up|5|||
155332816|NCT02372799|560652671|FG002|Treatment Period|Lost to Follow-up|3|||
155332817|NCT02372799|560652669|FG000|Treatment Period|Protocol Violation|3|||
155332818|NCT02372799|560652670|FG001|Treatment Period|Protocol Violation|0|||
155332819|NCT02372799|560652671|FG002|Treatment Period|Protocol Violation|0|||
155332820|NCT02372799|560652669|FG000|Treatment Period|Non-compliance with study drug|4|||
155332821|NCT02372799|560652670|FG001|Treatment Period|Non-compliance with study drug|4|||
155332822|NCT02372799|560652671|FG002|Treatment Period|Non-compliance with study drug|4|||
155332823|NCT02372799|560652669|FG000|Treatment Period|Miscellaneous Reasons|1|||
155332824|NCT02372799|560652670|FG001|Treatment Period|Miscellaneous Reasons|1|||
155332825|NCT02372799|560652671|FG002|Treatment Period|Miscellaneous Reasons|0|||
155332826|NCT02372799|560652669|FG000|Down-taper Period|Lost to Follow-up|1|||
155332827|NCT02372799|560652670|FG001|Down-taper Period|Lost to Follow-up|2|||
155332828|NCT02372799|560652671|FG002|Down-taper Period|Lost to Follow-up|2|||
155332829|NCT00089609|560652672|FG000|Overall Study|Withdrawal by Subject|3|||
155332830|NCT00089609|560652673|FG001|Overall Study|Withdrawal by Subject|1|||
155332831|NCT05815342|560652675|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
155332832|NCT05815342|560652675|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
155332833|NCT05815342|560652675|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
155332834|NCT05815342|560652675|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
155332835|NCT05815342|560652675|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
155332836|NCT01555138|560652680|FG000|Overall Study|Death|0|||
155332837|NCT01555138|560652681|FG001|Overall Study|Death|1|||
155332838|NCT01555138|560652680|FG000|Overall Study|Lost to Follow-up|1|||
155332839|NCT01555138|560652681|FG001|Overall Study|Lost to Follow-up|0|||
155332840|NCT01555138|560652680|FG000|Overall Study|Abnormal Lab reults|1|||
155332841|NCT01555138|560652681|FG001|Overall Study|Abnormal Lab reults|3|||
155332842|NCT01555138|560652680|FG000|Overall Study|Lack of Efficacy|2|||
155332843|NCT01555138|560652681|FG001|Overall Study|Lack of Efficacy|2|||
155332844|NCT01555138|560652680|FG000|Overall Study|Protocol Violation|5|||
155332845|NCT01555138|560652681|FG001|Overall Study|Protocol Violation|3|||
155332846|NCT01555138|560652680|FG000|Overall Study|Administrative problems|8|||
155332847|NCT01555138|560652681|FG001|Overall Study|Administrative problems|0|||
155332848|NCT01555138|560652680|FG000|Overall Study|Withdrawal by Subject|16|||
154961976|NCT01103713|559285715|FG000|Overall Study|Withdrawal by Subject|8|||
154961977|NCT01103713|559285715|FG000|Overall Study|Study terminated by sponsor|2|||
155332849|NCT01555138|560652681|FG001|Overall Study|Withdrawal by Subject|15|||
155332850|NCT01555138|560652680|FG000|Overall Study|Adverse Event|14|||
155332851|NCT01555138|560652681|FG001|Overall Study|Adverse Event|14|||
155332852|NCT03220724|560652683|FG000|Overall Study|Lost to Follow-up|2|||
154961978|NCT01103713|559285715|FG000|Overall Study|Other|1|||
154961979|NCT01218867|559285718|FG000|Overall Study|Death during treatment|0|||
154961980|NCT01218867|559285719|FG001|Overall Study|Death during treatment|0|||
154961981|NCT01218867|559285720|FG002|Overall Study|Death during treatment|0|||
154961982|NCT01218867|559285721|FG003|Overall Study|Death during treatment|0|||
154961983|NCT01218867|559285722|FG004|Overall Study|Death during treatment|0|||
154961984|NCT01218867|559285723|FG005|Overall Study|Death during treatment|0|||
154961985|NCT01218867|559285724|FG006|Overall Study|Death during treatment|1|||
155332853|NCT03220724|560652684|FG001|Overall Study|Lost to Follow-up|2|||
155332854|NCT03220724|560652685|FG002|Overall Study|Lost to Follow-up|0|||
155332855|NCT03220724|560652686|FG003|Overall Study|Lost to Follow-up|3|||
155332856|NCT03220724|560652687|FG004|Overall Study|Lost to Follow-up|1|||
155332857|NCT03220724|560652688|FG005|Overall Study|Lost to Follow-up|0|||
155332858|NCT03220724|560652689|FG006|Overall Study|Lost to Follow-up|2|||
155332859|NCT03220724|560652690|FG007|Overall Study|Lost to Follow-up|1|||
155332860|NCT03220724|560652691|FG008|Overall Study|Lost to Follow-up|0|||
155332861|NCT03220724|560652683|FG000|Overall Study|Withdrawal by Subject|1|||
155332862|NCT03220724|560652684|FG001|Overall Study|Withdrawal by Subject|0|||
155332863|NCT03220724|560652685|FG002|Overall Study|Withdrawal by Subject|1|||
155332864|NCT03220724|560652686|FG003|Overall Study|Withdrawal by Subject|0|||
155332865|NCT03220724|560652687|FG004|Overall Study|Withdrawal by Subject|0|||
155332866|NCT03220724|560652688|FG005|Overall Study|Withdrawal by Subject|0|||
155332867|NCT03220724|560652689|FG006|Overall Study|Withdrawal by Subject|0|||
155332868|NCT03220724|560652690|FG007|Overall Study|Withdrawal by Subject|0|||
155332869|NCT03220724|560652691|FG008|Overall Study|Withdrawal by Subject|0|||
155332870|NCT01613417|560652692|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
155332871|NCT01613417|560652693|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
155332872|NCT00512252|560652694|FG000|Overall Study|Lost to Follow-up|0|||
155332873|NCT00512252|560652695|FG001|Overall Study|Lost to Follow-up|0|||
155332874|NCT00512252|560652696|FG002|Overall Study|Lost to Follow-up|1|||
155332875|NCT00512252|560652694|FG000|Overall Study|Protocol Violation|0|||
155332876|NCT00512252|560652695|FG001|Overall Study|Protocol Violation|0|||
155332877|NCT00512252|560652696|FG002|Overall Study|Protocol Violation|1|||
155332878|NCT00512252|560652694|FG000|Overall Study|Death|0|||
155332879|NCT00512252|560652695|FG001|Overall Study|Death|0|||
155332880|NCT00512252|560652696|FG002|Overall Study|Death|1|||
155332881|NCT02357966|560652697|FG000|Overall Study|Death|0|||
155332882|NCT02357966|560652698|FG001|Overall Study|Death|0|||
155332883|NCT02357966|560652699|FG002|Overall Study|Death|1|||
155332884|NCT02357966|560652700|FG003|Overall Study|Death|0|||
155332885|NCT02357966|560652701|FG004|Overall Study|Death|2|||
155332886|NCT02357966|560652702|FG005|Overall Study|Death|0|||
155332887|NCT02357966|560652697|FG000|Overall Study|Physician Decision|1|||
155332888|NCT02357966|560652698|FG001|Overall Study|Physician Decision|0|||
155332889|NCT02357966|560652699|FG002|Overall Study|Physician Decision|0|||
155332890|NCT02357966|560652700|FG003|Overall Study|Physician Decision|0|||
155332891|NCT02357966|560652701|FG004|Overall Study|Physician Decision|1|||
155332892|NCT02357966|560652702|FG005|Overall Study|Physician Decision|0|||
155332893|NCT00047385|560652704|FG000|Overall Study|Death before any screening|2|||
155332894|NCT00047385|560652705|FG001|Overall Study|Death before any screening|5|||
155332895|NCT00047385|560652704|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
155332896|NCT00047385|560652705|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
155332897|NCT00047385|560652704|FG000|Overall Study|Eligible for screening but had no screen|260|||
155332898|NCT00047385|560652705|FG001|Overall Study|Eligible for screening but had no screen|492|||
155332899|NCT03392194|560652706|FG000|Overall Study|Withdrawal by Subject|1|||
155332900|NCT03392194|560652707|FG001|Overall Study|Withdrawal by Subject|2|||
155332901|NCT03392194|560652706|FG000|Overall Study|Conflicts with personal schedule|1|||
155332902|NCT03392194|560652707|FG001|Overall Study|Conflicts with personal schedule|0|||
155332903|NCT03865732|560652708|FG000|Overall Study|Adverse Event|0|||
155332904|NCT03865732|560652709|FG001|Overall Study|Adverse Event|1|||
155332905|NCT00620854|560652712|FG000|Washout 1|Withdrawal by Subject|0|||
155332906|NCT00620854|560652713|FG001|Washout 1|Withdrawal by Subject|0|||
155332907|NCT00620854|560652714|FG002|Washout 1|Withdrawal by Subject|1|||
155071263|NCT02916771|559689699|FG000|Overall Study|Withdrawal by Subject|9|||
155071264|NCT02916771|559689699|FG000|Overall Study|Physician Decision|1|||
155332908|NCT00620854|560652715|FG003|Washout 1|Withdrawal by Subject|1|||
155332909|NCT00620854|560652716|FG004|Washout 1|Withdrawal by Subject|0|||
155071265|NCT02916771|559689699|FG000|Overall Study|Began treatment for another active malignancy|1|||
155332910|NCT00620854|560652717|FG005|Washout 1|Withdrawal by Subject|0|||
155332911|NCT03345979|560652718|FG000|Overall Study|Withdrawal by Subject|20|||
155332912|NCT03345979|560652719|FG001|Overall Study|Withdrawal by Subject|31|||
155071266|NCT06455111|559689701|FG000|Overall Study|Withdrawal by Subject|11|||
155332913|NCT03345979|560652718|FG000|Overall Study|Adverse Event|10|||
155332914|NCT03345979|560652719|FG001|Overall Study|Adverse Event|11|||
155332915|NCT03345979|560652718|FG000|Overall Study|Lost to Follow-up|8|||
155332916|NCT03345979|560652719|FG001|Overall Study|Lost to Follow-up|9|||
155332917|NCT03345979|560652718|FG000|Overall Study|Lack of Efficacy|4|||
155332918|NCT03345979|560652719|FG001|Overall Study|Lack of Efficacy|2|||
155332919|NCT03345979|560652718|FG000|Overall Study|Protocol Violation|1|||
155332920|NCT03345979|560652719|FG001|Overall Study|Protocol Violation|3|||
155332921|NCT03345979|560652718|FG000|Overall Study|Physician Decision|0|||
155332922|NCT03345979|560652719|FG001|Overall Study|Physician Decision|2|||
155332923|NCT00734578|560652723|FG000|Overall Study|Adverse Event|4|||
155332924|NCT00734578|560652724|FG001|Overall Study|Adverse Event|6|||
155332925|NCT00734578|560652725|FG002|Overall Study|Adverse Event|1|||
155332926|NCT00734578|560652723|FG000|Overall Study|Protocol Violation|8|||
155332927|NCT00734578|560652724|FG001|Overall Study|Protocol Violation|6|||
155332928|NCT00734578|560652725|FG002|Overall Study|Protocol Violation|3|||
155332929|NCT00734578|560652723|FG000|Overall Study|Withdrawal by Subject|7|||
155332930|NCT00734578|560652724|FG001|Overall Study|Withdrawal by Subject|8|||
155332931|NCT00734578|560652725|FG002|Overall Study|Withdrawal by Subject|11|||
155332932|NCT00734578|560652723|FG000|Overall Study|Lost to Follow-up|9|||
155332933|NCT00734578|560652724|FG001|Overall Study|Lost to Follow-up|3|||
155332934|NCT00734578|560652725|FG002|Overall Study|Lost to Follow-up|5|||
155332935|NCT00734578|560652723|FG000|Overall Study|Lack of Efficacy|3|||
155332936|NCT00734578|560652724|FG001|Overall Study|Lack of Efficacy|2|||
155332937|NCT00734578|560652725|FG002|Overall Study|Lack of Efficacy|5|||
155332938|NCT00734578|560652723|FG000|Overall Study|Randomized in error|1|||
155332939|NCT00734578|560652724|FG001|Overall Study|Randomized in error|0|||
155332940|NCT00734578|560652725|FG002|Overall Study|Randomized in error|0|||
155332941|NCT00734578|560652723|FG000|Overall Study|Exclusion criteria|1|||
155332942|NCT00734578|560652724|FG001|Overall Study|Exclusion criteria|0|||
155332943|NCT00734578|560652725|FG002|Overall Study|Exclusion criteria|0|||
155332944|NCT00999596|560652726|FG000|Overall Study|Statistical population not required|101|||
155332945|NCT02095145|560652727|FG000|Overall Study|Withdrawal by Subject|1|||
155332946|NCT02095145|560652728|FG001|Overall Study|Withdrawal by Subject|0|||
155332947|NCT02085941|560652730|FG000|Overall Study|Lack of Efficacy|1|||
155332948|NCT02085941|560652731|FG001|Overall Study|Lack of Efficacy|0|||
155332949|NCT02085941|560652730|FG000|Overall Study|Death|6|||
155332950|NCT02085941|560652731|FG001|Overall Study|Death|1|||
155332951|NCT02085941|560652730|FG000|Overall Study|Lost to Follow-up|1|||
155332952|NCT02085941|560652731|FG001|Overall Study|Lost to Follow-up|0|||
155332953|NCT02085941|560652730|FG000|Overall Study|Physician Decision|0|||
155332954|NCT02085941|560652731|FG001|Overall Study|Physician Decision|2|||
155332955|NCT00093496|560652735|FG000|Overall Study|Protocol Violation|1|||
155332956|NCT00093496|560652736|FG001|Overall Study|Protocol Violation|3|||
155332957|NCT00586313|560652737|FG000|Overall Study|Lack of Efficacy|2|||
155332958|NCT01932970|560652741|FG000|Overall Study|Withdrawal by Subject|5|||
155332959|NCT01932970|560652741|FG000|Overall Study|Death|1|||
155332960|NCT01932970|560652741|FG000|Overall Study|Lost to Follow-up|2|||
155332961|NCT01932970|560652741|FG000|Overall Study|Protocol Specified Criteria|10|||
155332962|NCT03205566|560652743|FG000|Phase 1|Protocol Violation|1|||
155332963|NCT03205566|560652744|FG001|Phase 1|Protocol Violation|1|||
155332964|NCT03184987|560652745|FG000|Overall Study|Withdrawal by Subject|0|||
155332965|NCT03184987|560652746|FG001|Overall Study|Withdrawal by Subject|1|||
155332966|NCT03184987|560652747|FG002|Overall Study|Withdrawal by Subject|2|||
155332967|NCT03184987|560652745|FG000|Overall Study|Physician Decision|0|||
155332968|NCT03184987|560652746|FG001|Overall Study|Physician Decision|0|||
155332969|NCT03184987|560652747|FG002|Overall Study|Physician Decision|1|||
155332970|NCT03184987|560652745|FG000|Overall Study|Adverse Event|1|||
155332971|NCT03184987|560652746|FG001|Overall Study|Adverse Event|0|||
155332972|NCT03184987|560652747|FG002|Overall Study|Adverse Event|1|||
155332973|NCT00853580|560652748|FG000|Overall Study|Lost to Follow-up|3|||
155332974|NCT00853580|560652749|FG001|Overall Study|Lost to Follow-up|5|||
155332975|NCT00853580|560652748|FG000|Overall Study|Protocol Violation|2|||
155332976|NCT00853580|560652749|FG001|Overall Study|Protocol Violation|1|||
155332977|NCT00853580|560652748|FG000|Overall Study|Withdrawal by Subject|2|||
155332978|NCT00853580|560652749|FG001|Overall Study|Withdrawal by Subject|8|||
155332979|NCT00853580|560652748|FG000|Overall Study|Commenced contraindicated therapy|0|||
155332980|NCT00853580|560652749|FG001|Overall Study|Commenced contraindicated therapy|2|||
155332981|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
155332982|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
155332983|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
155332984|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
155332985|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
155332986|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
155332987|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
155071267|NCT06455111|559689702|FG001|Overall Study|Withdrawal by Subject|4|||
155071268|NCT03611946|559689708|FG000|Overall Study|Withdrawal by Subject|0|||
155332988|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
155332989|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
155332990|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
155332991|NCT01767467|560652750|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
155332992|NCT01767467|560652751|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
155332993|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
155332994|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
155332995|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
155332996|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
155332997|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
155071269|NCT03611946|559689709|FG001|Overall Study|Withdrawal by Subject|0|||
155332998|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
155163729|NCT01160822|560035029|FG004|Overall Study|Protocol deviation|2|||
155163730|NCT01160822|560035030|FG005|Overall Study|Protocol deviation|0|||
155163731|NCT01160822|560035031|FG006|Overall Study|Protocol deviation|0|||
155163732|NCT00314795|560035035|FG000|Overall Study|Adverse Event|8|||
155163733|NCT00314795|560035035|FG000|Overall Study|Death|4|||
155163734|NCT00314795|560035035|FG000|Overall Study|Reason not Specified|3|||
155163735|NCT00314795|560035035|FG000|Overall Study|Renal Transplant|3|||
155163736|NCT00314795|560035035|FG000|Overall Study|Participants Withdrew Consent|2|||
155332999|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
155333000|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
155333001|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
155163737|NCT02170077|560035040|FG000|Overall Study|Withdrawal by Subject|3|||
155333002|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
155333003|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
155333004|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
155333005|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
155333006|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
155333007|NCT01767467|560652750|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
155333008|NCT01767467|560652751|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
155333009|NCT02040870|560652754|FG000|Overall Study|Completed treatment phase|6|||
155333010|NCT02040870|560652754|FG000|Overall Study|Adverse Event|7|||
155333011|NCT02040870|560652754|FG000|Overall Study|Progressive disease|58|||
155333012|NCT02040870|560652754|FG000|Overall Study|Physician Decision|6|||
155333013|NCT02040870|560652754|FG000|Overall Study|Subject/guardian decision|10|||
155333014|NCT02040870|560652754|FG000|Overall Study|Lost to Follow-up|3|||
155333015|NCT02040870|560652754|FG000|Overall Study|Death|13|||
155333016|NCT04971733|560652757|FG000|Overall Study|Adverse Event|1|||
155333017|NCT04971733|560652758|FG001|Overall Study|Adverse Event|1|||
155333018|NCT04971733|560652757|FG000|Overall Study|Subject choice|2|||
155333019|NCT04971733|560652758|FG001|Overall Study|Subject choice|0|||
155333020|NCT04971733|560652757|FG000|Overall Study|Withdrawal by Subject|1|||
155333021|NCT04971733|560652758|FG001|Overall Study|Withdrawal by Subject|0|||
155333022|NCT04971733|560652757|FG000|Overall Study|Other|1|||
155333023|NCT04971733|560652758|FG001|Overall Study|Other|0|||
155333024|NCT00600353|560652759|FG000|Overall Study|history of malignancy within 5 years|1|||
155333025|NCT00600353|560652760|FG001|Overall Study|history of malignancy within 5 years|0|||
155333026|NCT00600353|560652759|FG000|Overall Study|History of prepartive regimen|0|||
155333027|NCT00600353|560652760|FG001|Overall Study|History of prepartive regimen|1|||
155333028|NCT04941482|560652761|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
155333029|NCT04941482|560652762|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
155333030|NCT04200664|560652763|FG000|Overall Study|Withdrawal by Subject|1|||
155333031|NCT04200664|560652764|FG001|Overall Study|Withdrawal by Subject|0|||
155333032|NCT04200664|560652765|FG002|Overall Study|Withdrawal by Subject|0|||
155333033|NCT01367236|560652769|FG000|Overall Study|Withdrawal by Subject|3|||
155333034|NCT01367236|560652770|FG001|Overall Study|Withdrawal by Subject|1|||
155333035|NCT05293717|560652776|FG000|Overall Study|Physician Decision|1|||
155333036|NCT00357994|560653793|FG000|Overall Study|Adverse Event|1|||
155333037|NCT00357994|560653794|FG001|Overall Study|Adverse Event|2|||
155333038|NCT00357994|560653793|FG000|Overall Study|Lack of Efficacy|0|||
155333039|NCT00357994|560653794|FG001|Overall Study|Lack of Efficacy|1|||
155333040|NCT00357994|560653793|FG000|Overall Study|Protocol Violation|1|||
155333041|NCT00357994|560653794|FG001|Overall Study|Protocol Violation|0|||
155333042|NCT00019604|560653798|FG000|Overall Study|Death|1|||
155333043|NCT00019604|560653798|FG000|Overall Study|Progressive disease|23|||
155333044|NCT00019604|560653798|FG000|Overall Study|Refused treatment|1|||
155333045|NCT00019604|560653798|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
155333046|NCT00019604|560653798|FG000|Overall Study|Going to have liver transplant|1|||
155163738|NCT02170077|560035041|FG001|Overall Study|Withdrawal by Subject|4|||
155163739|NCT02170077|560035042|FG002|Overall Study|Withdrawal by Subject|2|||
155163740|NCT02170077|560035040|FG000|Overall Study|Adverse Event|4|||
155163741|NCT02170077|560035041|FG001|Overall Study|Adverse Event|4|||
155333047|NCT00019604|560653798|FG000|Overall Study|Move to a different study|1|||
155333048|NCT00019604|560653798|FG000|Overall Study|Non compliant on systemic CH|1|||
155333049|NCT00019604|560653798|FG000|Overall Study|Non compliant|1|||
155333050|NCT00019604|560653798|FG000|Overall Study|Resectable disease|1|||
155333051|NCT00019604|560653798|FG000|Overall Study|Started new chemo regimen|1|||
155333052|NCT00019604|560653798|FG000|Overall Study|Pt going to immunotherapy study|1|||
155333053|NCT00019604|560653798|FG000|Overall Study|Too much disease|1|||
155333054|NCT00019604|560653798|FG000|Overall Study|Unable to evaluate|1|||
155333055|NCT00019604|560653798|FG000|Overall Study|Details for other not available|4|||
155333056|NCT02203799|560653822|FG000|Overall Study|Withdrawal by Subject|3|||
154961986|NCT01218867|559285725|FG007|Overall Study|Death during treatment|0|||
155333057|NCT03335488|560653823|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
155333058|NCT03335488|560653824|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
155333059|NCT03335488|560653823|FG000|Safety Extension Period|Adverse Event|1|||
155333060|NCT03335488|560653824|FG001|Safety Extension Period|Adverse Event|0|||
155333061|NCT03335488|560653823|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
155333062|NCT03335488|560653824|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
155333063|NCT01953692|560653825|FG000|Overall Study|Adverse Event|5|||
155333064|NCT01953692|560653826|FG001|Overall Study|Adverse Event|2|||
155333065|NCT01953692|560653827|FG002|Overall Study|Adverse Event|4|||
155333066|NCT01953692|560653828|FG003|Overall Study|Adverse Event|2|||
155333067|NCT01953692|560653829|FG004|Overall Study|Adverse Event|1|||
155333068|NCT01953692|560653830|FG005|Overall Study|Adverse Event|2|||
155333069|NCT01953692|560653831|FG006|Overall Study|Adverse Event|0|||
155333070|NCT01953692|560653832|FG007|Overall Study|Adverse Event|0|||
155333071|NCT01953692|560653833|FG008|Overall Study|Adverse Event|0|||
155333072|NCT01953692|560653825|FG000|Overall Study|Clinical Progression|0|||
155333073|NCT01953692|560653826|FG001|Overall Study|Clinical Progression|15|||
155333074|NCT01953692|560653827|FG002|Overall Study|Clinical Progression|7|||
155333075|NCT01953692|560653828|FG003|Overall Study|Clinical Progression|5|||
155333076|NCT01953692|560653829|FG004|Overall Study|Clinical Progression|0|||
155333077|NCT01953692|560653830|FG005|Overall Study|Clinical Progression|7|||
155333078|NCT01953692|560653831|FG006|Overall Study|Clinical Progression|20|||
155333079|NCT01953692|560653832|FG007|Overall Study|Clinical Progression|3|||
155333080|NCT01953692|560653833|FG008|Overall Study|Clinical Progression|3|||
155333081|NCT01953692|560653825|FG000|Overall Study|Death|5|||
155333082|NCT01953692|560653826|FG001|Overall Study|Death|0|||
155333083|NCT01953692|560653827|FG002|Overall Study|Death|2|||
155333084|NCT01953692|560653828|FG003|Overall Study|Death|2|||
155333085|NCT01953692|560653829|FG004|Overall Study|Death|1|||
155333086|NCT01953692|560653830|FG005|Overall Study|Death|3|||
155333087|NCT01953692|560653831|FG006|Overall Study|Death|6|||
155333088|NCT01953692|560653832|FG007|Overall Study|Death|2|||
155333089|NCT01953692|560653833|FG008|Overall Study|Death|1|||
155333090|NCT01953692|560653825|FG000|Overall Study|Excluded Medication|1|||
155333091|NCT01953692|560653826|FG001|Overall Study|Excluded Medication|0|||
155333092|NCT01953692|560653827|FG002|Overall Study|Excluded Medication|0|||
155333093|NCT01953692|560653828|FG003|Overall Study|Excluded Medication|0|||
155333094|NCT01953692|560653829|FG004|Overall Study|Excluded Medication|0|||
155333095|NCT01953692|560653830|FG005|Overall Study|Excluded Medication|0|||
155333096|NCT01953692|560653831|FG006|Overall Study|Excluded Medication|0|||
155333097|NCT01953692|560653832|FG007|Overall Study|Excluded Medication|0|||
155333098|NCT01953692|560653833|FG008|Overall Study|Excluded Medication|0|||
155333099|NCT01953692|560653825|FG000|Overall Study|Lost to Follow-up|1|||
155333100|NCT01953692|560653826|FG001|Overall Study|Lost to Follow-up|0|||
155333101|NCT01953692|560653827|FG002|Overall Study|Lost to Follow-up|3|||
155333102|NCT01953692|560653828|FG003|Overall Study|Lost to Follow-up|1|||
155333103|NCT01953692|560653829|FG004|Overall Study|Lost to Follow-up|0|||
155333104|NCT01953692|560653830|FG005|Overall Study|Lost to Follow-up|1|||
155333105|NCT01953692|560653831|FG006|Overall Study|Lost to Follow-up|0|||
155333106|NCT01953692|560653832|FG007|Overall Study|Lost to Follow-up|0|||
155333107|NCT01953692|560653833|FG008|Overall Study|Lost to Follow-up|0|||
155333108|NCT01953692|560653825|FG000|Overall Study|Physician Decision|11|||
155333109|NCT01953692|560653826|FG001|Overall Study|Physician Decision|4|||
155333110|NCT01953692|560653827|FG002|Overall Study|Physician Decision|2|||
155333111|NCT01953692|560653828|FG003|Overall Study|Physician Decision|2|||
155333112|NCT01953692|560653829|FG004|Overall Study|Physician Decision|1|||
155333113|NCT01953692|560653830|FG005|Overall Study|Physician Decision|2|||
155333114|NCT01953692|560653831|FG006|Overall Study|Physician Decision|4|||
155333115|NCT01953692|560653832|FG007|Overall Study|Physician Decision|1|||
155333116|NCT01953692|560653833|FG008|Overall Study|Physician Decision|0|||
154961987|NCT01218867|559285726|FG008|Overall Study|Death during treatment|0|||
154961988|NCT01218867|559285727|FG009|Overall Study|Death during treatment|0|||
154961989|NCT01218867|559285728|FG010|Overall Study|Death during treatment|0|||
154961990|NCT00251979|559285729|FG000|Overall Study|Protocol Violation|3|||
154961991|NCT00251979|559285730|FG001|Overall Study|Protocol Violation|5|||
154961992|NCT00251979|559285729|FG000|Overall Study|Adverse Event|11|||
155333117|NCT01953692|560653825|FG000|Overall Study|Protocol Violation|0|||
155333118|NCT01953692|560653826|FG001|Overall Study|Protocol Violation|2|||
155333119|NCT01953692|560653827|FG002|Overall Study|Protocol Violation|1|||
155333120|NCT01953692|560653828|FG003|Overall Study|Protocol Violation|0|||
155333121|NCT01953692|560653829|FG004|Overall Study|Protocol Violation|0|||
155333122|NCT01953692|560653830|FG005|Overall Study|Protocol Violation|0|||
155333123|NCT01953692|560653831|FG006|Overall Study|Protocol Violation|0|||
155333124|NCT01953692|560653832|FG007|Overall Study|Protocol Violation|1|||
155333125|NCT01953692|560653833|FG008|Overall Study|Protocol Violation|0|||
155333126|NCT01953692|560653825|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333127|NCT01953692|560653826|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333128|NCT01953692|560653827|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333129|NCT01953692|560653828|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333130|NCT01953692|560653829|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333131|NCT01953692|560653830|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333132|NCT01953692|560653831|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333133|NCT01953692|560653832|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
155333134|NCT01953692|560653833|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
155333135|NCT01953692|560653825|FG000|Overall Study|Withdrawal by Subject|4|||
155333136|NCT01953692|560653826|FG001|Overall Study|Withdrawal by Subject|2|||
155333137|NCT01953692|560653827|FG002|Overall Study|Withdrawal by Subject|1|||
155333138|NCT01953692|560653828|FG003|Overall Study|Withdrawal by Subject|2|||
155333139|NCT01953692|560653829|FG004|Overall Study|Withdrawal by Subject|0|||
155333140|NCT01953692|560653830|FG005|Overall Study|Withdrawal by Subject|3|||
155333141|NCT01953692|560653831|FG006|Overall Study|Withdrawal by Subject|2|||
155333142|NCT01953692|560653832|FG007|Overall Study|Withdrawal by Subject|1|||
155333143|NCT01953692|560653833|FG008|Overall Study|Withdrawal by Subject|1|||
155333144|NCT01160354|560653838|FG000|Overall Study|Death|0|||
155333145|NCT01160354|560653839|FG001|Overall Study|Death|1|||
155333146|NCT01160354|560653840|FG002|Overall Study|Death|1|||
155333147|NCT01801007|560653844|FG000|Overall Study|Adverse Event|2|||
155333148|NCT01801007|560653844|FG000|Overall Study|Lost to Follow-up|4|||
155333149|NCT01801007|560653844|FG000|Overall Study|Withdrawal by Subject|5|||
155333150|NCT02743819|560653845|FG000|Overall Study|Lack of Efficacy|5|||
155333151|NCT02743819|560653845|FG000|Overall Study|Death|2|||
155333152|NCT02743819|560653845|FG000|Overall Study|Adverse Event|1|||
155333153|NCT00145470|560653846|FG000|Overall Study|Adverse Event|19|||
155333154|NCT00145470|560653847|FG001|Overall Study|Adverse Event|25|||
155333155|NCT00145470|560653846|FG000|Overall Study|Lack of Efficacy|27|||
155333156|NCT00145470|560653847|FG001|Overall Study|Lack of Efficacy|13|||
155333157|NCT00145470|560653846|FG000|Overall Study|Withdrawal by Subject|36|||
155333158|NCT00145470|560653847|FG001|Overall Study|Withdrawal by Subject|34|||
155333159|NCT00145470|560653846|FG000|Overall Study|Lost to Follow-up|21|||
155333160|NCT00145470|560653847|FG001|Overall Study|Lost to Follow-up|17|||
155333161|NCT00145470|560653846|FG000|Overall Study|Reason Not Reported|9|||
155333162|NCT00145470|560653847|FG001|Overall Study|Reason Not Reported|9|||
155333163|NCT00914966|560653854|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
155333164|NCT00914966|560653854|FG000|Step 1: 1500 Units|Physician Decision|1|||
155333165|NCT00914966|560653854|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
155333166|NCT01701401|560653855|FG000|Overall Study|Randomized But Not Treated|3|||
155333167|NCT01701401|560653856|FG001|Overall Study|Randomized But Not Treated|1|||
155333168|NCT01701401|560653857|FG002|Overall Study|Randomized But Not Treated|0|||
155333169|NCT01701401|560653858|FG003|Overall Study|Randomized But Not Treated|1|||
155333170|NCT01701401|560653855|FG000|Overall Study|Lost to Follow-up|5|||
155333171|NCT01701401|560653856|FG001|Overall Study|Lost to Follow-up|5|||
155333172|NCT01701401|560653857|FG002|Overall Study|Lost to Follow-up|1|||
155333173|NCT01701401|560653858|FG003|Overall Study|Lost to Follow-up|3|||
155333174|NCT01701401|560653855|FG000|Overall Study|Withdrew Consent|0|||
155333175|NCT01701401|560653856|FG001|Overall Study|Withdrew Consent|3|||
155333176|NCT01701401|560653857|FG002|Overall Study|Withdrew Consent|1|||
155333177|NCT01701401|560653858|FG003|Overall Study|Withdrew Consent|2|||
155333178|NCT01701401|560653855|FG000|Overall Study|Lack of Efficacy|1|||
155333179|NCT01701401|560653856|FG001|Overall Study|Lack of Efficacy|0|||
155333180|NCT01701401|560653857|FG002|Overall Study|Lack of Efficacy|2|||
155333181|NCT01701401|560653858|FG003|Overall Study|Lack of Efficacy|0|||
155333182|NCT01701401|560653855|FG000|Overall Study|Adverse Event|1|||
155333183|NCT01701401|560653856|FG001|Overall Study|Adverse Event|0|||
155333184|NCT01701401|560653857|FG002|Overall Study|Adverse Event|0|||
155071270|NCT03611946|559689710|FG002|Overall Study|Withdrawal by Subject|1|||
155071271|NCT03611946|559689711|FG003|Overall Study|Withdrawal by Subject|0|||
155071272|NCT06717399|559689716|FG000|Overall Study|Death|1|||
155071273|NCT02337686|559689717|FG000|Overall Study|Adverse Event|1|||
155071274|NCT04333498|559690682|FG000|Overall Study|Lost to Follow-up|1|||
155333185|NCT01701401|560653858|FG003|Overall Study|Adverse Event|0|||
155071275|NCT04333498|559690683|FG001|Overall Study|Lost to Follow-up|0|||
155071276|NCT04333498|559690682|FG000|Overall Study|Lost to Follow-up|0|||
155071277|NCT04333498|559690683|FG001|Overall Study|Lost to Follow-up|1|||
155333186|NCT01701401|560653855|FG000|Overall Study|Protocol Violation|0|||
155333187|NCT01701401|560653856|FG001|Overall Study|Protocol Violation|0|||
155333188|NCT01701401|560653857|FG002|Overall Study|Protocol Violation|1|||
155333189|NCT01701401|560653858|FG003|Overall Study|Protocol Violation|0|||
155333190|NCT04762277|560653862|FG000|Overall Study|Withdrawal by Subject|0|||
155333191|NCT04762277|560653863|FG001|Overall Study|Withdrawal by Subject|2|||
155333192|NCT04762277|560653862|FG000|Overall Study|Protocol Violation|0|||
155333193|NCT04762277|560653863|FG001|Overall Study|Protocol Violation|1|||
155333194|NCT04762277|560653862|FG000|Overall Study|Adverse Event|1|||
155333195|NCT04762277|560653863|FG001|Overall Study|Adverse Event|0|||
155333196|NCT05824559|560653864|FG000|Overall Study|Adverse Event|2|||
155333197|NCT05824559|560653864|FG000|Overall Study|Physician Decision|2|||
155333198|NCT05824559|560653864|FG000|Overall Study|Progressive Disease|16|||
155333199|NCT05824559|560653864|FG000|Overall Study|Study Terminated by Sponsor|1|||
155333200|NCT05824559|560653864|FG000|Overall Study|Withdrawal by Subject|2|||
155333201|NCT01690624|560653865|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
155333202|NCT01690624|560653866|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
155333203|NCT01690624|560653867|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
155333204|NCT01690624|560653868|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
155333205|NCT01690624|560653865|FG000|Overall Study|Adverse event (other than DLT)|3|||
155333206|NCT01690624|560653866|FG001|Overall Study|Adverse event (other than DLT)|1|||
155333207|NCT01690624|560653867|FG002|Overall Study|Adverse event (other than DLT)|1|||
155333208|NCT01690624|560653868|FG003|Overall Study|Adverse event (other than DLT)|1|||
155333209|NCT01690624|560653865|FG000|Overall Study|Withdrawal by Subject|0|||
155333210|NCT01690624|560653866|FG001|Overall Study|Withdrawal by Subject|0|||
155333211|NCT01690624|560653867|FG002|Overall Study|Withdrawal by Subject|1|||
155333212|NCT01690624|560653868|FG003|Overall Study|Withdrawal by Subject|0|||
155333213|NCT01690624|560653865|FG000|Overall Study|Sponsor is ending trial|0|||
155333214|NCT01690624|560653866|FG001|Overall Study|Sponsor is ending trial|0|||
155333215|NCT01690624|560653867|FG002|Overall Study|Sponsor is ending trial|0|||
155333216|NCT01690624|560653868|FG003|Overall Study|Sponsor is ending trial|1|||
155333217|NCT01690624|560653865|FG000|Overall Study|Physician Decision|0|||
155333218|NCT01690624|560653866|FG001|Overall Study|Physician Decision|0|||
155333219|NCT01690624|560653867|FG002|Overall Study|Physician Decision|0|||
155333220|NCT01690624|560653868|FG003|Overall Study|Physician Decision|1|||
155333221|NCT01690624|560653865|FG000|Overall Study|Withdrawal by Subject|0|||
155333222|NCT01690624|560653866|FG001|Overall Study|Withdrawal by Subject|1|||
155333223|NCT01690624|560653867|FG002|Overall Study|Withdrawal by Subject|0|||
155333224|NCT01690624|560653868|FG003|Overall Study|Withdrawal by Subject|0|||
155333225|NCT01690624|560653865|FG000|Overall Study|Lack of Efficacy|1|||
155333226|NCT01690624|560653866|FG001|Overall Study|Lack of Efficacy|1|||
155333227|NCT01690624|560653867|FG002|Overall Study|Lack of Efficacy|3|||
155333228|NCT01690624|560653868|FG003|Overall Study|Lack of Efficacy|0|||
155333229|NCT04445831|560653869|FG000|Overall Study|Withdrawal by Subject|2|||
155333230|NCT04445831|560653870|FG001|Overall Study|Withdrawal by Subject|1|||
155333231|NCT04445831|560653871|FG002|Overall Study|Withdrawal by Subject|1|||
155333232|NCT04445831|560653872|FG003|Overall Study|Withdrawal by Subject|0|||
155333233|NCT04445831|560653873|FG004|Overall Study|Withdrawal by Subject|0|||
155333234|NCT04445831|560653874|FG005|Overall Study|Withdrawal by Subject|0|||
155333235|NCT04445831|560653875|FG006|Overall Study|Withdrawal by Subject|0|||
155333236|NCT04445831|560653869|FG000|Overall Study|Subject withdrawal by caregiver|0|||
155333237|NCT04445831|560653870|FG001|Overall Study|Subject withdrawal by caregiver|1|||
155333238|NCT04445831|560653871|FG002|Overall Study|Subject withdrawal by caregiver|0|||
155333239|NCT04445831|560653872|FG003|Overall Study|Subject withdrawal by caregiver|0|||
155333240|NCT04445831|560653873|FG004|Overall Study|Subject withdrawal by caregiver|0|||
155333241|NCT04445831|560653874|FG005|Overall Study|Subject withdrawal by caregiver|0|||
155333242|NCT04445831|560653875|FG006|Overall Study|Subject withdrawal by caregiver|0|||
155333243|NCT04701203|560653878|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
155333244|NCT04701203|560653879|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
155333245|NCT04701203|560653880|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
155333246|NCT04701203|560653878|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
155333247|NCT04701203|560653879|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
155333248|NCT04701203|560653880|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
155333249|NCT04701203|560653878|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
155333250|NCT04701203|560653879|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
155333251|NCT04701203|560653880|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
155333252|NCT04701203|560653878|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
155333253|NCT04701203|560653879|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
155333254|NCT04701203|560653880|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
155333255|NCT02434328|560653883|FG000|Overall Study|Adverse Event|9|||
155333256|NCT02434328|560653884|FG001|Overall Study|Adverse Event|4|||
155333257|NCT02434328|560653883|FG000|Overall Study|Lack of Efficacy|0|||
155333258|NCT02434328|560653884|FG001|Overall Study|Lack of Efficacy|2|||
155071278|NCT00484159|559690685|FG000|Overall Study|Lost to Follow-up|1|||
155333259|NCT02434328|560653883|FG000|Overall Study|Physician Decision|0|||
155333260|NCT02434328|560653884|FG001|Overall Study|Physician Decision|1|||
155333261|NCT02434328|560653883|FG000|Overall Study|Withdrawal by Subject|12|||
155333262|NCT02434328|560653884|FG001|Overall Study|Withdrawal by Subject|21|||
155333263|NCT02434328|560653883|FG000|Overall Study|Death|4|||
155333264|NCT02434328|560653884|FG001|Overall Study|Death|7|||
155333265|NCT02434328|560653883|FG000|Overall Study|Lost to Follow-up|1|||
155333266|NCT02434328|560653884|FG001|Overall Study|Lost to Follow-up|6|||
155333267|NCT02434328|560653883|FG000|Overall Study|Other|4|||
155333268|NCT02434328|560653884|FG001|Overall Study|Other|1|||
155333269|NCT03147287|560653885|FG000|Overall Study|Randomized Not Treated|2|||
155333270|NCT03147287|560653886|FG001|Overall Study|Randomized Not Treated|1|||
155333271|NCT03147287|560653887|FG002|Overall Study|Randomized Not Treated|1|||
155333272|NCT03147287|560653885|FG000|Overall Study|Progressive Disease RECIST|31|||
155333273|NCT03147287|560653886|FG001|Overall Study|Progressive Disease RECIST|72|||
155333274|NCT03147287|560653887|FG002|Overall Study|Progressive Disease RECIST|32|||
155071279|NCT00484159|559690686|FG001|Overall Study|Lost to Follow-up|1|||
155071280|NCT00484159|559690687|FG002|Overall Study|Lost to Follow-up|0|||
155071281|NCT04766333|559690688|FG000|Overall Study|Lost to Follow-up|40|||
155333275|NCT03147287|560653885|FG000|Overall Study|Progressive Disease not RECIST|13|||
155333276|NCT03147287|560653886|FG001|Overall Study|Progressive Disease not RECIST|21|||
155333277|NCT03147287|560653887|FG002|Overall Study|Progressive Disease not RECIST|13|||
155333278|NCT03147287|560653885|FG000|Overall Study|Physician Decision|1|||
155333279|NCT03147287|560653886|FG001|Overall Study|Physician Decision|2|||
155333280|NCT03147287|560653887|FG002|Overall Study|Physician Decision|1|||
155333281|NCT03147287|560653885|FG000|Overall Study|Intercurrent illness|0|||
155333282|NCT03147287|560653886|FG001|Overall Study|Intercurrent illness|1|||
155333283|NCT03147287|560653887|FG002|Overall Study|Intercurrent illness|0|||
155333284|NCT03147287|560653885|FG000|Overall Study|Withdrawal by Subject|2|||
155333285|NCT03147287|560653886|FG001|Overall Study|Withdrawal by Subject|3|||
155333286|NCT03147287|560653887|FG002|Overall Study|Withdrawal by Subject|2|||
155333287|NCT03147287|560653885|FG000|Overall Study|Patient Non-Compliance|0|||
155333288|NCT03147287|560653886|FG001|Overall Study|Patient Non-Compliance|2|||
155333289|NCT03147287|560653887|FG002|Overall Study|Patient Non-Compliance|0|||
155333290|NCT03147287|560653885|FG000|Overall Study|Patient moved|0|||
155333291|NCT03147287|560653886|FG001|Overall Study|Patient moved|1|||
155333292|NCT03147287|560653887|FG002|Overall Study|Patient moved|0|||
155333293|NCT03147287|560653885|FG000|Overall Study|Arm A crossover without PD|1|||
155333294|NCT03147287|560653886|FG001|Overall Study|Arm A crossover without PD|0|||
155333295|NCT03147287|560653887|FG002|Overall Study|Arm A crossover without PD|0|||
155333296|NCT03147287|560653885|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
155333297|NCT03147287|560653886|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
155333298|NCT03147287|560653887|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
155333299|NCT03678688|560655953|FG000|Overall Study|Reason not Specified|0|||
155333300|NCT03678688|560655954|FG001|Overall Study|Reason not Specified|0|||
155333301|NCT03678688|560655955|FG002|Overall Study|Reason not Specified|3|||
155333302|NCT03678688|560655956|FG003|Overall Study|Reason not Specified|0|||
155333303|NCT03678688|560655957|FG004|Overall Study|Reason not Specified|1|||
155333304|NCT03678688|560655958|FG005|Overall Study|Reason not Specified|0|||
155333305|NCT03678688|560655959|FG006|Overall Study|Reason not Specified|0|||
155333306|NCT03678688|560655960|FG007|Overall Study|Reason not Specified|0|||
155333307|NCT03678688|560655961|FG008|Overall Study|Reason not Specified|0|||
155333308|NCT03678688|560655953|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
155333309|NCT03678688|560655954|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
155333310|NCT03678688|560655955|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
155333311|NCT03678688|560655956|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
155333312|NCT03678688|560655957|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
155333313|NCT03678688|560655958|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
155333314|NCT03678688|560655959|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
155333315|NCT03678688|560655960|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
155333316|NCT03678688|560655961|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
155333317|NCT03678688|560655953|FG000|Overall Study|Covid Related Adverse Event|0|||
155071282|NCT04766333|559690689|FG001|Overall Study|Lost to Follow-up|826|||
155071283|NCT05177094|559690692|FG000|Overall Study|Adverse Event|5|||
155333318|NCT03678688|560655954|FG001|Overall Study|Covid Related Adverse Event|0|||
155333319|NCT03678688|560655955|FG002|Overall Study|Covid Related Adverse Event|0|||
155333320|NCT03678688|560655956|FG003|Overall Study|Covid Related Adverse Event|0|||
155333321|NCT03678688|560655957|FG004|Overall Study|Covid Related Adverse Event|0|||
155333322|NCT03678688|560655958|FG005|Overall Study|Covid Related Adverse Event|3|||
155333323|NCT03678688|560655959|FG006|Overall Study|Covid Related Adverse Event|1|||
155333324|NCT03678688|560655960|FG007|Overall Study|Covid Related Adverse Event|1|||
155333325|NCT03678688|560655961|FG008|Overall Study|Covid Related Adverse Event|0|||
155333326|NCT03678688|560655953|FG000|Overall Study|Physician Decision|0|||
155333327|NCT03678688|560655954|FG001|Overall Study|Physician Decision|0|||
155333328|NCT03678688|560655955|FG002|Overall Study|Physician Decision|0|||
155333329|NCT03678688|560655956|FG003|Overall Study|Physician Decision|0|||
155333330|NCT03678688|560655957|FG004|Overall Study|Physician Decision|0|||
155333331|NCT03678688|560655958|FG005|Overall Study|Physician Decision|1|||
155333332|NCT03678688|560655959|FG006|Overall Study|Physician Decision|0|||
155333333|NCT03678688|560655960|FG007|Overall Study|Physician Decision|0|||
155333334|NCT03678688|560655961|FG008|Overall Study|Physician Decision|0|||
155333335|NCT03678688|560655953|FG000|Overall Study|Withdrawal by Subject|0|||
155333336|NCT03678688|560655954|FG001|Overall Study|Withdrawal by Subject|0|||
155333337|NCT03678688|560655955|FG002|Overall Study|Withdrawal by Subject|0|||
155333338|NCT03678688|560655956|FG003|Overall Study|Withdrawal by Subject|0|||
155333339|NCT03678688|560655957|FG004|Overall Study|Withdrawal by Subject|0|||
155071284|NCT05177094|559690693|FG001|Overall Study|Adverse Event|5|||
155333340|NCT03678688|560655958|FG005|Overall Study|Withdrawal by Subject|0|||
155333341|NCT03678688|560655959|FG006|Overall Study|Withdrawal by Subject|2|||
155333342|NCT03678688|560655960|FG007|Overall Study|Withdrawal by Subject|1|||
155333343|NCT03678688|560655961|FG008|Overall Study|Withdrawal by Subject|0|||
155333344|NCT00551421|560655962|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
155333345|NCT03136159|560655963|FG000|Overall Study|chorioamnionitis|2|||
155333346|NCT03136159|560655964|FG001|Overall Study|chorioamnionitis|0|||
155333347|NCT03136159|560655963|FG000|Overall Study|vertical skin incision|1|||
155333348|NCT03136159|560655964|FG001|Overall Study|vertical skin incision|0|||
155333349|NCT03136159|560655963|FG000|Overall Study|additional dressing|1|||
155333350|NCT03136159|560655964|FG001|Overall Study|additional dressing|0|||
155333351|NCT03136159|560655963|FG000|Overall Study|never got dressing placed|1|||
155333352|NCT03136159|560655964|FG001|Overall Study|never got dressing placed|0|||
155333353|NCT03823703|560655965|FG000|Overall Study|Sponsor request|0|||
155333354|NCT03823703|560655966|FG001|Overall Study|Sponsor request|3|||
155333355|NCT03823703|560655967|FG002|Overall Study|Sponsor request|4|||
155333356|NCT03823703|560655965|FG000|Overall Study|Adverse Event|3|||
155333357|NCT03823703|560655966|FG001|Overall Study|Adverse Event|1|||
155333358|NCT03823703|560655967|FG002|Overall Study|Adverse Event|0|||
155333359|NCT03823703|560655965|FG000|Overall Study|Withdrawal by Subject|0|||
155333360|NCT03823703|560655966|FG001|Overall Study|Withdrawal by Subject|1|||
155333361|NCT03823703|560655967|FG002|Overall Study|Withdrawal by Subject|0|||
155333362|NCT04323800|560655968|FG000|Overall Study|Withdrawal by Subject|4|||
155333363|NCT04323800|560655969|FG001|Overall Study|Withdrawal by Subject|4|||
155333364|NCT04323800|560655968|FG000|Overall Study|Incomplete transfusion|1|||
155333365|NCT04323800|560655969|FG001|Overall Study|Incomplete transfusion|0|||
155333366|NCT04323800|560655968|FG000|Overall Study|Other|0|||
155333367|NCT04323800|560655969|FG001|Overall Study|Other|1|||
155333368|NCT04323800|560655968|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
155333369|NCT04323800|560655969|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
155333370|NCT00489554|560655970|FG000|Overall Study|Adverse Event|2|||
155333371|NCT00489554|560655970|FG000|Overall Study|Withdrawal by Subject|1|||
155333372|NCT00489554|560655970|FG000|Overall Study|Lost to Follow-up|1|||
155333373|NCT01732757|560655971|FG000|Overall Study|Lost to Follow-up|1|||
155333374|NCT01732757|560655972|FG001|Overall Study|Lost to Follow-up|0|||
155333375|NCT01732757|560655973|FG002|Overall Study|Lost to Follow-up|0|||
155333376|NCT00731692|560655974|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
155333377|NCT00731692|560655975|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
155333378|NCT00731692|560655976|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
155333379|NCT00731692|560655974|FG000|Core Study (36 Months)|Physician Decision|1|||
155333380|NCT00731692|560655975|FG001|Core Study (36 Months)|Physician Decision|0|||
155333381|NCT00731692|560655976|FG002|Core Study (36 Months)|Physician Decision|2|||
155333382|NCT00731692|560655974|FG000|Core Study (36 Months)|Death|2|||
155333383|NCT00731692|560655975|FG001|Core Study (36 Months)|Death|1|||
155333384|NCT00731692|560655976|FG002|Core Study (36 Months)|Death|2|||
155333385|NCT00731692|560655974|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
155333386|NCT00731692|560655975|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
155333387|NCT00731692|560655976|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
155333388|NCT00731692|560655974|FG000|Core Study (36 Months)|Administrative|2|||
155333389|NCT00731692|560655975|FG001|Core Study (36 Months)|Administrative|2|||
155333390|NCT00731692|560655976|FG002|Core Study (36 Months)|Administrative|6|||
155333391|NCT00731692|560655974|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
155333392|NCT00731692|560655975|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
155333393|NCT00731692|560655976|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
155333394|NCT00731692|560655974|FG000|Core Study (36 Months)|Protocol Violation|4|||
155333395|NCT00731692|560655975|FG001|Core Study (36 Months)|Protocol Violation|5|||
155333396|NCT00731692|560655976|FG002|Core Study (36 Months)|Protocol Violation|8|||
155333397|NCT00731692|560655974|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
155333398|NCT00731692|560655975|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
155333399|NCT00731692|560655976|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
155333400|NCT00731692|560655974|FG000|Core Study (36 Months)|Adverse Event|25|||
155333401|NCT00731692|560655975|FG001|Core Study (36 Months)|Adverse Event|28|||
155333402|NCT00731692|560655976|FG002|Core Study (36 Months)|Adverse Event|29|||
155333403|NCT00731692|560655974|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
155333404|NCT00731692|560655975|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
155333405|NCT00731692|560655976|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
155333406|NCT00731692|560655974|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
155333407|NCT00731692|560655975|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
155333408|NCT00731692|560655976|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
155333409|NCT00731692|560655974|FG000|Extension Phase|Abnormal test procedure|0|||
155333410|NCT00731692|560655975|FG001|Extension Phase|Abnormal test procedure|0|||
155333411|NCT00731692|560655976|FG002|Extension Phase|Abnormal test procedure|1|||
155333412|NCT00731692|560655974|FG000|Extension Phase|Abnormal lab values|0|||
155333413|NCT00731692|560655975|FG001|Extension Phase|Abnormal lab values|0|||
155333414|NCT00731692|560655976|FG002|Extension Phase|Abnormal lab values|1|||
155071285|NCT05177094|559690692|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
155163742|NCT02170077|560035042|FG002|Overall Study|Adverse Event|4|||
155333415|NCT00731692|560655974|FG000|Extension Phase|Lost to Follow-up|0|||
155333416|NCT00731692|560655975|FG001|Extension Phase|Lost to Follow-up|1|||
155333417|NCT00731692|560655976|FG002|Extension Phase|Lost to Follow-up|4|||
155333418|NCT00731692|560655974|FG000|Extension Phase|Withdrawal by Subject|4|||
155333419|NCT00731692|560655975|FG001|Extension Phase|Withdrawal by Subject|5|||
155333420|NCT00731692|560655976|FG002|Extension Phase|Withdrawal by Subject|3|||
155333421|NCT00731692|560655974|FG000|Extension Phase|Adverse Event|1|||
155333422|NCT00731692|560655975|FG001|Extension Phase|Adverse Event|1|||
155333423|NCT00731692|560655976|FG002|Extension Phase|Adverse Event|15|||
155333424|NCT00747006|560655977|FG000|Overall Study|Adverse Event|1|||
155333425|NCT00747006|560655978|FG001|Overall Study|Adverse Event|0|||
155333426|NCT00747006|560655979|FG002|Overall Study|Adverse Event|0|||
155333427|NCT00747006|560655977|FG000|Overall Study|Lost to Follow-up|0|||
155333428|NCT00747006|560655978|FG001|Overall Study|Lost to Follow-up|1|||
155333429|NCT00747006|560655979|FG002|Overall Study|Lost to Follow-up|0|||
155333430|NCT00747006|560655977|FG000|Overall Study|Physician Decision|2|||
155333431|NCT00747006|560655978|FG001|Overall Study|Physician Decision|0|||
155333432|NCT00747006|560655979|FG002|Overall Study|Physician Decision|1|||
155333433|NCT02132949|560655984|FG000|Overall Study|Death|7|||
155333434|NCT02132949|560655985|FG001|Overall Study|Death|13|||
155333435|NCT02132949|560655984|FG000|Overall Study|Lost to Follow-up|14|||
155333436|NCT02132949|560655985|FG001|Overall Study|Lost to Follow-up|4|||
155333437|NCT02132949|560655984|FG000|Overall Study|Withdrawal by Subject|6|||
155333438|NCT02132949|560655985|FG001|Overall Study|Withdrawal by Subject|5|||
155333439|NCT02132949|560655984|FG000|Overall Study|Noncompliance|5|||
155333440|NCT02132949|560655985|FG001|Overall Study|Noncompliance|1|||
155333441|NCT02132949|560655984|FG000|Overall Study|Physician Decision|3|||
155333442|NCT02132949|560655985|FG001|Overall Study|Physician Decision|1|||
155333443|NCT02132949|560655984|FG000|Overall Study|Disease Progression|3|||
155333444|NCT02132949|560655985|FG001|Overall Study|Disease Progression|0|||
155333445|NCT02132949|560655984|FG000|Overall Study|Adverse Event|2|||
155333446|NCT02132949|560655985|FG001|Overall Study|Adverse Event|1|||
155333447|NCT02132949|560655984|FG000|Overall Study|Withdrew Prior to Treatment|1|||
155333448|NCT02132949|560655985|FG001|Overall Study|Withdrew Prior to Treatment|2|||
155333449|NCT02132949|560655984|FG000|Overall Study|Reason Unspecified|0|||
155333450|NCT02132949|560655985|FG001|Overall Study|Reason Unspecified|1|||
155333451|NCT00745875|560655990|FG000|Overall Study|Continuing study treatment|4|||
155333452|NCT00745875|560655991|FG001|Overall Study|Continuing study treatment|4|||
155333453|NCT01583166|560655992|FG000|Overall Study|Withdrawal by Subject|4|||
155333454|NCT01583166|560655993|FG001|Overall Study|Withdrawal by Subject|6|||
155333455|NCT04652869|560655994|FG000|Overall Study|Withdrawal by Subject|0|||
155333456|NCT04652869|560655995|FG001|Overall Study|Withdrawal by Subject|2|||
155333457|NCT04652869|560655996|FG002|Overall Study|Withdrawal by Subject|0|||
155333458|NCT01372085|560655997|FG000|Washout Period 2|Physician Decision|0|||
155333459|NCT01372085|560655998|FG001|Washout Period 2|Physician Decision|0|||
155333460|NCT01372085|560655999|FG002|Washout Period 2|Physician Decision|0|||
155333461|NCT01372085|560656000|FG003|Washout Period 2|Physician Decision|0|||
155333462|NCT01372085|560656001|FG004|Washout Period 2|Physician Decision|1|||
155333463|NCT01372085|560656002|FG005|Washout Period 2|Physician Decision|0|||
155333464|NCT01372085|560656003|FG006|Washout Period 2|Physician Decision|0|||
155333465|NCT01372085|560656004|FG007|Washout Period 2|Physician Decision|0|||
155333466|NCT01372085|560656005|FG008|Washout Period 2|Physician Decision|0|||
155333467|NCT01372085|560656006|FG009|Washout Period 2|Physician Decision|0|||
155333468|NCT01372085|560655997|FG000|Washout Period 3|Withdrawal by Subject|0|||
155333469|NCT01372085|560655998|FG001|Washout Period 3|Withdrawal by Subject|0|||
155333470|NCT01372085|560655999|FG002|Washout Period 3|Withdrawal by Subject|0|||
155333471|NCT01372085|560656000|FG003|Washout Period 3|Withdrawal by Subject|0|||
155333472|NCT01372085|560656001|FG004|Washout Period 3|Withdrawal by Subject|0|||
155333473|NCT01372085|560656002|FG005|Washout Period 3|Withdrawal by Subject|2|||
155333474|NCT01372085|560656003|FG006|Washout Period 3|Withdrawal by Subject|0|||
155333475|NCT01372085|560656004|FG007|Washout Period 3|Withdrawal by Subject|0|||
155333476|NCT01372085|560656005|FG008|Washout Period 3|Withdrawal by Subject|0|||
155333477|NCT01372085|560656006|FG009|Washout Period 3|Withdrawal by Subject|0|||
155333478|NCT01833455|560656007|FG000|Overall Study|Withdrawal by Subject|1|||
155333479|NCT01833455|560656008|FG001|Overall Study|Withdrawal by Subject|0|||
155333480|NCT00562094|560656009|FG000|Overall Study|Lost to Follow-up|62|||
155333481|NCT02000752|560656014|FG000|Overall Study|Dystocic delivery|19|||
155333482|NCT02000752|560656015|FG001|Overall Study|Dystocic delivery|8|||
155333483|NCT02000752|560656014|FG000|Overall Study|Shift Changes|12|||
155333484|NCT02000752|560656015|FG001|Overall Study|Shift Changes|5|||
155333485|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
155333486|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
155333487|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
155333488|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
155333489|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
155333490|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
155333491|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
155333492|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
155333493|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155333494|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
155333495|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
155333496|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
155333497|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155333498|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155333499|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
155333500|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
155333501|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
155333502|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
155333503|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
155333504|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
155333505|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
155333506|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
155333507|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
155333508|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
155333509|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
155333510|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
155333511|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
155333512|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
155333513|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
155333514|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
155333515|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333516|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333517|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333518|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333519|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
155333520|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333521|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333522|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333523|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
155333524|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155333525|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155333526|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
155333527|NCT03732807|560656020|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333528|NCT03732807|560656021|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333529|NCT03732807|560656022|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333530|NCT03732807|560656023|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333531|NCT03732807|560656024|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333532|NCT03732807|560656025|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
155333533|NCT03732807|560656026|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155333534|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
155333535|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
155333536|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
155333537|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
155333538|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
155333539|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
155333540|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
155333541|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
155333542|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
155333543|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
155333544|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
155333545|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
155333546|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
155333547|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
155333548|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
155333549|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
154961993|NCT00251979|559285730|FG001|Overall Study|Adverse Event|17|||
155333550|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
155333551|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
155333552|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
155333553|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
154961994|NCT00251979|559285729|FG000|Overall Study|Withdrawal by Subject|13|||
154961995|NCT00251979|559285730|FG001|Overall Study|Withdrawal by Subject|7|||
155333554|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
155333555|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333556|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
155333557|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333558|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333559|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333560|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333561|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
155333562|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333563|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
155333564|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333565|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
155333566|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
155333567|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333568|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
155333569|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
155333570|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
155333571|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333572|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333573|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
155333574|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333575|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
155333576|NCT03732807|560656020|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
155333577|NCT03732807|560656021|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
155333578|NCT03732807|560656022|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
155333579|NCT03732807|560656023|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
155333580|NCT03732807|560656024|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
155333581|NCT03732807|560656025|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
155333582|NCT03732807|560656026|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
155333583|NCT00599196|560656031|FG000|Overall Study|Lack of Efficacy|22|||
155333584|NCT00599196|560656031|FG000|Overall Study|Adverse Event|93|||
155333585|NCT00599196|560656031|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
155333586|NCT00599196|560656031|FG000|Overall Study|Subject withdrew consent|43|||
155333587|NCT00599196|560656031|FG000|Overall Study|Study ended per sponsor|197|||
155333588|NCT00599196|560656031|FG000|Overall Study|Lost to Follow-up|17|||
155333589|NCT00599196|560656031|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
155333590|NCT00599196|560656031|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
155333591|NCT00599196|560656031|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
155333592|NCT00599196|560656031|FG000|Overall Study|Other: Pt Moved To Australia|1|||
155333593|NCT00599196|560656031|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
155333594|NCT00599196|560656031|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
155333595|NCT01009645|560656032|FG000|Overall Study|Lost to Follow-up|2|||
155333596|NCT01009645|560656033|FG001|Overall Study|Lost to Follow-up|8|||
155333597|NCT01009645|560656034|FG002|Overall Study|Lost to Follow-up|4|||
155333598|NCT01009645|560656035|FG003|Overall Study|Lost to Follow-up|5|||
155333599|NCT01079806|560656036|FG000|Day 1 to Week 96|Adverse Event|0|||
155333600|NCT01079806|560656037|FG001|Day 1 to Week 96|Adverse Event|3|||
155333601|NCT01079806|560656036|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
155333602|NCT01079806|560656037|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
155333603|NCT01079806|560656036|FG000|Day 1 to Week 96|Pregnancy|0|||
155333604|NCT01079806|560656037|FG001|Day 1 to Week 96|Pregnancy|1|||
155333605|NCT01079806|560656036|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
155333606|NCT01079806|560656037|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
155333607|NCT01079806|560656036|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
155333608|NCT01079806|560656037|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
155333609|NCT01079806|560656036|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
155333610|NCT01079806|560656037|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
155333611|NCT01079806|560656036|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
155333612|NCT01079806|560656037|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
155333613|NCT01079806|560656036|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
155333614|NCT01079806|560656037|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
155333615|NCT01079806|560656036|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
155333616|NCT01079806|560656037|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
155333617|NCT01079806|560656036|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
155333618|NCT01079806|560656037|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
155071286|NCT05177094|559690693|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
155071287|NCT05177094|559690692|FG000|Overall Study|Protocol Deviation|3|||
155071288|NCT05177094|559690693|FG001|Overall Study|Protocol Deviation|0|||
155071289|NCT05177094|559690692|FG000|Overall Study|Withdrawal by Subject|6|||
155071290|NCT05177094|559690693|FG001|Overall Study|Withdrawal by Subject|3|||
155071291|NCT05177094|559690692|FG000|Overall Study|Participant could not tolerate long study visits|1|||
155071292|NCT05177094|559690693|FG001|Overall Study|Participant could not tolerate long study visits|0|||
155071293|NCT02260986|559690694|FG000|Overall Study|Adverse Event|24|||
155071294|NCT02260986|559690695|FG001|Overall Study|Adverse Event|0|||
155071295|NCT02260986|559690696|FG002|Overall Study|Adverse Event|11|||
155071296|NCT02260986|559690694|FG000|Overall Study|Lack of Efficacy|27|||
155071297|NCT02260986|559690695|FG001|Overall Study|Lack of Efficacy|3|||
155071298|NCT02260986|559690696|FG002|Overall Study|Lack of Efficacy|0|||
155071299|NCT02260986|559690694|FG000|Overall Study|Protocol Violation|14|||
155071300|NCT02260986|559690695|FG001|Overall Study|Protocol Violation|5|||
155071301|NCT02260986|559690696|FG002|Overall Study|Protocol Violation|16|||
155071302|NCT02260986|559690694|FG000|Overall Study|Car accident|0|||
155071303|NCT02260986|559690695|FG001|Overall Study|Car accident|0|||
155071304|NCT02260986|559690696|FG002|Overall Study|Car accident|1|||
155071305|NCT02260986|559690694|FG000|Overall Study|Withdrawal by Subject|17|||
155071306|NCT02260986|559690695|FG001|Overall Study|Withdrawal by Subject|4|||
155071307|NCT02260986|559690696|FG002|Overall Study|Withdrawal by Subject|9|||
155071308|NCT02260986|559690694|FG000|Overall Study|Incorrect randomization|0|||
155071309|NCT02260986|559690695|FG001|Overall Study|Incorrect randomization|1|||
155071310|NCT02260986|559690696|FG002|Overall Study|Incorrect randomization|0|||
155071311|NCT02260986|559690694|FG000|Overall Study|Lack of investigation product supply|2|||
155071312|NCT02260986|559690695|FG001|Overall Study|Lack of investigation product supply|0|||
155071313|NCT02260986|559690696|FG002|Overall Study|Lack of investigation product supply|1|||
155071314|NCT02260986|559690694|FG000|Overall Study|Lost to Follow-up|4|||
155071315|NCT02260986|559690695|FG001|Overall Study|Lost to Follow-up|0|||
155071316|NCT02260986|559690696|FG002|Overall Study|Lost to Follow-up|3|||
155071317|NCT02260986|559690694|FG000|Overall Study|Pregnancy|2|||
155071318|NCT02260986|559690695|FG001|Overall Study|Pregnancy|0|||
155071319|NCT02260986|559690696|FG002|Overall Study|Pregnancy|0|||
155071320|NCT00313170|559690698|FG000|Overall Study|Death|2|||
155071321|NCT00313170|559690699|FG001|Overall Study|Death|4|||
155071322|NCT00313170|559690700|FG002|Overall Study|Death|2|||
155071323|NCT00313170|559690698|FG000|Overall Study|Adverse Event|1|||
155071324|NCT00313170|559690699|FG001|Overall Study|Adverse Event|2|||
155071325|NCT00313170|559690700|FG002|Overall Study|Adverse Event|0|||
155071326|NCT00313170|559690698|FG000|Overall Study|Disease progression|31|||
155071327|NCT00313170|559690699|FG001|Overall Study|Disease progression|26|||
155071328|NCT00313170|559690700|FG002|Overall Study|Disease progression|27|||
155071329|NCT00313170|559690698|FG000|Overall Study|Withdrawal by Subject|1|||
155071330|NCT00313170|559690699|FG001|Overall Study|Withdrawal by Subject|0|||
155071331|NCT00313170|559690700|FG002|Overall Study|Withdrawal by Subject|1|||
155071332|NCT00313170|559690698|FG000|Overall Study|Incorrect enrollment|0|||
155071333|NCT00313170|559690699|FG001|Overall Study|Incorrect enrollment|2|||
155071334|NCT00313170|559690700|FG002|Overall Study|Incorrect enrollment|1|||
155071335|NCT00313170|559690698|FG000|Overall Study|Lost to Follow-up|0|||
155071336|NCT00313170|559690699|FG001|Overall Study|Lost to Follow-up|0|||
155071337|NCT00313170|559690700|FG002|Overall Study|Lost to Follow-up|1|||
155071338|NCT00313170|559690698|FG000|Overall Study|Progression (investigators opinion)|1|||
155071339|NCT00313170|559690699|FG001|Overall Study|Progression (investigators opinion)|0|||
155071340|NCT00313170|559690700|FG002|Overall Study|Progression (investigators opinion)|0|||
155071341|NCT02827708|559690701|FG000|Overall Study|Lost to Follow-up|3|||
155071342|NCT02827708|559690702|FG001|Overall Study|Lost to Follow-up|1|||
155071343|NCT02827708|559690701|FG000|Overall Study|Withdrawal by Subject|1|||
155071344|NCT02827708|559690702|FG001|Overall Study|Withdrawal by Subject|2|||
155071345|NCT02827708|559690701|FG000|Overall Study|Death|1|||
155071346|NCT02827708|559690702|FG001|Overall Study|Death|2|||
155071347|NCT00898807|559690704|FG000|Overall Study|Withdrawal by Subject|5|||
155071348|NCT00898807|559690705|FG001|Overall Study|Withdrawal by Subject|3|||
155071349|NCT00898807|559690704|FG000|Overall Study|Family pressure to discontinue|2|||
155071350|NCT00898807|559690705|FG001|Overall Study|Family pressure to discontinue|2|||
155071351|NCT00898807|559690704|FG000|Overall Study|Lost to Follow-up|1|||
155071352|NCT00898807|559690705|FG001|Overall Study|Lost to Follow-up|3|||
155071353|NCT00898807|559690704|FG000|Overall Study|Death|0|||
155071354|NCT00898807|559690705|FG001|Overall Study|Death|1|||
155071355|NCT00407511|559690706|FG000|Overall Study|Adverse Event|9|||
155071356|NCT00407511|559690706|FG000|Overall Study|Lost to Follow-up|4|||
155071357|NCT00407511|559690706|FG000|Overall Study|Other|5|||
155071358|NCT00407511|559690706|FG000|Overall Study|Withdrawal by Subject|4|||
155071359|NCT00529035|559690707|FG000|Overall Study|Withdrawal by Subject|1|||
155071360|NCT01521364|559690708|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
155071361|NCT01521364|559690708|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
155071362|NCT02636283|559690709|FG000|Overall Study|Adverse Event|2|||
155071363|NCT02636283|559690710|FG001|Overall Study|Adverse Event|0|||
155071364|NCT02636283|559690709|FG000|Overall Study|Trial Terminated Prematurely|0|||
155071365|NCT02636283|559690710|FG001|Overall Study|Trial Terminated Prematurely|3|||
155333619|NCT02788981|560656038|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
155333620|NCT02788981|560656039|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
155333621|NCT00795184|560656041|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
155333622|NCT00795184|560656042|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
155333623|NCT03781375|560656043|FG000|Double-blind Phase|Adverse Event|0|||
155333624|NCT03781375|560656044|FG001|Double-blind Phase|Adverse Event|1|||
155333625|NCT03781375|560656043|FG000|Double-blind Phase|Lack of Response|6|||
155333626|NCT03781375|560656044|FG001|Double-blind Phase|Lack of Response|2|||
155333627|NCT03781375|560656043|FG000|Double-blind Phase|Other|1|||
155333628|NCT03781375|560656044|FG001|Double-blind Phase|Other|3|||
155333629|NCT03781375|560656043|FG000|Open-label Phase|Protocol Issues|0|||
155333630|NCT03781375|560656044|FG001|Open-label Phase|Protocol Issues|1|||
155333631|NCT03781375|560656043|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
155333632|NCT03781375|560656044|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
155333633|NCT03781375|560656043|FG000|Open-label Phase|Other|2|||
155333634|NCT03781375|560656044|FG001|Open-label Phase|Other|2|||
155333635|NCT03489369|560656067|FG000|Overall Study|Documented Progressive Disease|3|||
155333636|NCT03489369|560656068|FG001|Overall Study|Documented Progressive Disease|2|||
155333637|NCT03489369|560656069|FG002|Overall Study|Documented Progressive Disease|3|||
155333638|NCT03489369|560656070|FG003|Overall Study|Documented Progressive Disease|6|||
155333639|NCT03489369|560656067|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
155333640|NCT03489369|560656068|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
155333641|NCT03489369|560656069|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
155333642|NCT03489369|560656070|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
155333643|NCT02106884|560656073|FG000|Overall Study|Change of diagnosis/exclusion|0|||
155333644|NCT02106884|560656074|FG001|Overall Study|Change of diagnosis/exclusion|1|||
155333645|NCT02384382|560656075|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
155333646|NCT02384382|560656075|FG000|Overall Study|Death|1|||
155333647|NCT02384382|560656075|FG000|Overall Study|Adverse Event|1|||
155333648|NCT02384382|560656075|FG000|Overall Study|Disease progression|16|||
155333649|NCT01822756|560656078|FG000|Overall Study|Adverse Event|0|||
155333650|NCT01822756|560656079|FG001|Overall Study|Adverse Event|0|||
155333651|NCT01822756|560656080|FG002|Overall Study|Adverse Event|0|||
155333652|NCT01822756|560656081|FG003|Overall Study|Adverse Event|2|||
155333653|NCT01822756|560656082|FG004|Overall Study|Adverse Event|0|||
155333654|NCT01822756|560656078|FG000|Overall Study|Disease progression|11|||
155333655|NCT01822756|560656079|FG001|Overall Study|Disease progression|1|||
155333656|NCT01822756|560656080|FG002|Overall Study|Disease progression|7|||
155333657|NCT01822756|560656081|FG003|Overall Study|Disease progression|2|||
155333658|NCT01822756|560656082|FG004|Overall Study|Disease progression|6|||
155333659|NCT01822756|560656078|FG000|Overall Study|Death|2|||
155333660|NCT01822756|560656079|FG001|Overall Study|Death|2|||
155333661|NCT01822756|560656080|FG002|Overall Study|Death|1|||
155333662|NCT01822756|560656081|FG003|Overall Study|Death|0|||
155333663|NCT01822756|560656082|FG004|Overall Study|Death|0|||
155333664|NCT01822756|560656078|FG000|Overall Study|Lost to Follow-up|1|||
155333665|NCT01822756|560656079|FG001|Overall Study|Lost to Follow-up|0|||
155333666|NCT01822756|560656080|FG002|Overall Study|Lost to Follow-up|1|||
155333667|NCT01822756|560656081|FG003|Overall Study|Lost to Follow-up|0|||
155333668|NCT01822756|560656082|FG004|Overall Study|Lost to Follow-up|1|||
155333669|NCT01822756|560656078|FG000|Overall Study|Physician Decision|0|||
155333670|NCT01822756|560656079|FG001|Overall Study|Physician Decision|1|||
155333671|NCT01822756|560656080|FG002|Overall Study|Physician Decision|0|||
155333672|NCT01822756|560656081|FG003|Overall Study|Physician Decision|0|||
155333673|NCT01822756|560656082|FG004|Overall Study|Physician Decision|0|||
155333674|NCT01822756|560656078|FG000|Overall Study|disease progression & patient preference|2|||
155333675|NCT01822756|560656079|FG001|Overall Study|disease progression & patient preference|0|||
155333676|NCT01822756|560656080|FG002|Overall Study|disease progression & patient preference|1|||
155333677|NCT01822756|560656081|FG003|Overall Study|disease progression & patient preference|0|||
155333678|NCT01822756|560656082|FG004|Overall Study|disease progression & patient preference|0|||
155333679|NCT02091752|560656083|FG000|Overall Study|Study terminated by Sponsor|2|||
155333680|NCT02091752|560656083|FG000|Overall Study|Adverse Event|1|||
155333681|NCT00665392|560656090|FG000|Overall Study|not treated|1|||
155333682|NCT03389802|560656100|FG000|Overall Study|Lack of Efficacy|3|||
155333683|NCT03389802|560656101|FG001|Overall Study|Lack of Efficacy|3|||
155333684|NCT03389802|560656102|FG002|Overall Study|Lack of Efficacy|13|||
155333685|NCT03389802|560656103|FG003|Overall Study|Lack of Efficacy|6|||
155333686|NCT03389802|560656104|FG004|Overall Study|Lack of Efficacy|1|||
155333687|NCT03389802|560656100|FG000|Overall Study|Adverse Event|0|||
155333688|NCT03389802|560656101|FG001|Overall Study|Adverse Event|0|||
155333689|NCT03389802|560656102|FG002|Overall Study|Adverse Event|1|||
155333690|NCT03389802|560656103|FG003|Overall Study|Adverse Event|0|||
155333691|NCT03389802|560656104|FG004|Overall Study|Adverse Event|4|||
155333692|NCT03389802|560656100|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
155333693|NCT03389802|560656101|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
155333694|NCT03389802|560656102|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
155333695|NCT03389802|560656103|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
155333696|NCT03389802|560656104|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
155333697|NCT02426138|560656105|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155333698|NCT02426138|560656106|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155333699|NCT04677738|560656107|FG000|Overall Study|Withdrawal by Subject|4|||
155333700|NCT04677738|560656108|FG001|Overall Study|Withdrawal by Subject|2|||
155333701|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333702|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333703|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
155333704|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333705|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
155333706|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
155333707|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
155333708|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
155333709|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
155333710|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
155333711|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333712|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
155333713|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333714|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333715|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
155333716|NCT01683409|560656113|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
155333717|NCT01683409|560656114|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
155333718|NCT01683409|560656115|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
155333719|NCT01683409|560656116|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
155333720|NCT01683409|560656117|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
155333721|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333722|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333723|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
155333724|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333725|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
155333726|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
155333727|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
155333728|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
155333729|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
155333730|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
155333731|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
155333732|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
155333733|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
155333734|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
155333735|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
155333736|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
155333737|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333738|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333739|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333740|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
155333741|NCT01683409|560656113|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
155333742|NCT01683409|560656114|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
155333743|NCT01683409|560656115|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
155333744|NCT01683409|560656116|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
155333745|NCT01683409|560656117|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
155333746|NCT01683409|560656113|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333747|NCT01683409|560656114|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333748|NCT01683409|560656115|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333749|NCT01683409|560656116|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
155333750|NCT01683409|560656117|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
155333751|NCT01683409|560656113|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333752|NCT01683409|560656114|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333753|NCT01683409|560656115|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
155333754|NCT01683409|560656116|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333755|NCT01683409|560656117|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
155333756|NCT00553332|560656119|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
155333757|NCT03520036|560656123|FG000|Overall Study|Adverse Event|1|||
155333758|NCT03520036|560656124|FG001|Overall Study|Adverse Event|2|||
155333759|NCT03520036|560656125|FG002|Overall Study|Adverse Event|0|||
155333760|NCT03520036|560656123|FG000|Overall Study|Protocol Violation|1|||
155333761|NCT03520036|560656124|FG001|Overall Study|Protocol Violation|0|||
155333762|NCT03520036|560656125|FG002|Overall Study|Protocol Violation|0|||
155333763|NCT03520036|560656123|FG000|Overall Study|Withdrawal by Subject|0|||
155333764|NCT03520036|560656124|FG001|Overall Study|Withdrawal by Subject|1|||
155333765|NCT03520036|560656125|FG002|Overall Study|Withdrawal by Subject|4|||
155333766|NCT03520036|560656123|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
155333767|NCT03520036|560656124|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
155333768|NCT03520036|560656125|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
155333769|NCT00467272|560656129|FG000|Overall Study|Pneumonia|2|||
155333770|NCT00467272|560656129|FG000|Overall Study|Thrombophlebitis|1|||
155333771|NCT04745676|560656132|FG000|Overall Study|Death|1|||
155333772|NCT04745676|560656133|FG001|Overall Study|Death|0|||
155333773|NCT04745676|560656134|FG002|Overall Study|Death|0|||
155333774|NCT00676091|560656135|FG000|Infant Series|Parent or legal guardian request|10|||
155333775|NCT00676091|560656136|FG001|Infant Series|Parent or legal guardian request|8|||
155333776|NCT00676091|560656135|FG000|Infant Series|Protocol Violation|6|||
155333777|NCT00676091|560656136|FG001|Infant Series|Protocol Violation|3|||
155333778|NCT00676091|560656135|FG000|Infant Series|Adverse Event|2|||
155333779|NCT00676091|560656136|FG001|Infant Series|Adverse Event|3|||
155333780|NCT00676091|560656135|FG000|Infant Series|Failed to return|1|||
155333781|NCT00676091|560656136|FG001|Infant Series|Failed to return|3|||
155333782|NCT00676091|560656135|FG000|Infant Series|Lost to Follow-up|1|||
155333783|NCT00676091|560656136|FG001|Infant Series|Lost to Follow-up|0|||
155333784|NCT00676091|560656135|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
155333785|NCT00676091|560656136|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
155333786|NCT00676091|560656135|FG000|After Infant Series|Adverse Event|0|||
155333787|NCT00676091|560656136|FG001|After Infant Series|Adverse Event|1|||
155333788|NCT00676091|560656135|FG000|After Infant Series|Protocol Violation|0|||
155333789|NCT00676091|560656136|FG001|After Infant Series|Protocol Violation|1|||
155333790|NCT00676091|560656135|FG000|After Infant Series|Failed to return|1|||
155333791|NCT00676091|560656136|FG001|After Infant Series|Failed to return|1|||
155333792|NCT00676091|560656135|FG000|Toddler Dose|Failed to return|2|||
155333793|NCT00676091|560656136|FG001|Toddler Dose|Failed to return|0|||
155333794|NCT00676091|560656135|FG000|Toddler Dose|Parent or legal guardian request|1|||
155333795|NCT00676091|560656136|FG001|Toddler Dose|Parent or legal guardian request|0|||
155333796|NCT00989196|560656137|FG000|Treatment Period|Lost to Follow-up|1|||
155333797|NCT00989196|560656138|FG001|Treatment Period|Lost to Follow-up|0|||
155333798|NCT04912856|560656144|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
155333799|NCT04912856|560656145|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
155333800|NCT04912856|560656144|FG000|Overall Study|Not reported in synoptic CSR.|0|||
155333801|NCT04912856|560656145|FG001|Overall Study|Not reported in synoptic CSR.|1|||
155333802|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
155071366|NCT03418675|559690711|FG000|Overall Study|Lost to Follow-up|13|||
155071367|NCT03418675|559690712|FG001|Overall Study|Lost to Follow-up|10|||
155071368|NCT03418675|559690711|FG000|Overall Study|Adverse Event|2|||
155333803|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
155333804|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
155333805|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
155333806|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
155333807|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
155333808|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
155163743|NCT02170077|560035040|FG000|Overall Study|Lost to Follow-up|0|||
155163744|NCT02170077|560035041|FG001|Overall Study|Lost to Follow-up|1|||
155163745|NCT02170077|560035042|FG002|Overall Study|Lost to Follow-up|0|||
155163746|NCT02170077|560035040|FG000|Overall Study|Exclusion criteria|2|||
154961996|NCT00251979|559285729|FG000|Overall Study|Lost to Follow-up|8|||
155163747|NCT02170077|560035041|FG001|Overall Study|Exclusion criteria|2|||
155163748|NCT02170077|560035042|FG002|Overall Study|Exclusion criteria|5|||
155163749|NCT02170077|560035040|FG000|Overall Study|Exacerbation of seizures|0|||
155163750|NCT02170077|560035041|FG001|Overall Study|Exacerbation of seizures|2|||
155163751|NCT02170077|560035042|FG002|Overall Study|Exacerbation of seizures|1|||
155163752|NCT01780974|560035047|FG000|Overall Study|Death|1|||
155163753|NCT01780974|560035048|FG001|Overall Study|Death|0|||
155163754|NCT01780974|560035047|FG000|Overall Study|Adverse Event|1|||
155163755|NCT01780974|560035048|FG001|Overall Study|Adverse Event|3|||
155163756|NCT00525161|560035049|FG000|Overall Study|Adverse Event|1|||
155163757|NCT01076361|560035053|FG000|Overall Study|22 leads were excluded from analysis|21|||
155163758|NCT00750438|560035058|FG000|Overall Study|Protocol Violation|4|||
155163759|NCT00750438|560035059|FG001|Overall Study|Protocol Violation|1|||
155163760|NCT00750438|560035058|FG000|Overall Study|Physician Decision|2|||
155163761|NCT00750438|560035059|FG001|Overall Study|Physician Decision|2|||
155163762|NCT00750438|560035058|FG000|Overall Study|Withdrawal by Subject|1|||
155163763|NCT00750438|560035059|FG001|Overall Study|Withdrawal by Subject|1|||
155163764|NCT00787644|560035060|FG000|Overall Study|Lost to Follow-up|1|||
155163765|NCT00787644|560035061|FG001|Overall Study|Lost to Follow-up|1|||
155163766|NCT00787644|560035060|FG000|Overall Study|Withdrawal by Subject|1|||
155163767|NCT00787644|560035061|FG001|Overall Study|Withdrawal by Subject|1|||
155163768|NCT01108185|560035069|FG000|Overall Study|Non-compliance|15|||
155163769|NCT01108185|560035069|FG000|Overall Study|Lost to Follow-up|12|||
154961997|NCT00251979|559285730|FG001|Overall Study|Lost to Follow-up|6|||
154961998|NCT00251979|559285729|FG000|Overall Study|Death|3|||
154961999|NCT00251979|559285730|FG001|Overall Study|Death|5|||
154962000|NCT02530905|559285738|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
154962001|NCT02530905|559285739|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
154962002|NCT02530905|559285740|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
154962003|NCT00415363|559285746|FG000|Overall Study|Withdrawal by Subject|4|||
154962004|NCT00415363|559285747|FG001|Overall Study|Withdrawal by Subject|4|||
154962005|NCT00415363|559285746|FG000|Overall Study|Adverse Event|4|||
154962006|NCT00415363|559285747|FG001|Overall Study|Adverse Event|4|||
154962007|NCT00415363|559285746|FG000|Overall Study|Lost to Follow-up|2|||
154962008|NCT00415363|559285747|FG001|Overall Study|Lost to Follow-up|1|||
154962009|NCT00415363|559285746|FG000|Overall Study|Physician Decision|3|||
154962010|NCT00415363|559285747|FG001|Overall Study|Physician Decision|1|||
154962011|NCT00415363|559285746|FG000|Overall Study|Death|16|||
154962012|NCT00415363|559285747|FG001|Overall Study|Death|12|||
154962013|NCT00415363|559285746|FG000|Overall Study|Progressive disease|26|||
154962014|NCT00415363|559285747|FG001|Overall Study|Progressive disease|32|||
154962015|NCT03123471|559285750|FG000|Placebo-controlled Phase|Adverse Event|3|||
154962016|NCT03123471|559285751|FG001|Placebo-controlled Phase|Adverse Event|8|||
154962017|NCT03123471|559285750|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
154962018|NCT03123471|559285751|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
154962019|NCT03123471|559285750|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
154962020|NCT03123471|559285751|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
155071369|NCT03418675|559690712|FG001|Overall Study|Adverse Event|0|||
155071370|NCT01879852|559690713|FG000|Overall Study|Withdrawal by Subject|2|||
155071371|NCT01879852|559690714|FG001|Overall Study|Withdrawal by Subject|0|||
155071372|NCT02115386|559690715|FG000|Overall Study|Protocol Violation|1|||
155071373|NCT02115386|559690715|FG000|Overall Study|Administrative - trial was terminated|6|||
155071374|NCT02493855|559690716|FG000|Overall Study|Non-compliance|1|||
155071375|NCT02493855|559690717|FG001|Overall Study|Non-compliance|0|||
155071376|NCT02493855|559690718|FG002|Overall Study|Non-compliance|0|||
155071377|NCT02493855|559690716|FG000|Overall Study|Adverse Event|0|||
155071378|NCT02493855|559690717|FG001|Overall Study|Adverse Event|1|||
155071379|NCT02493855|559690718|FG002|Overall Study|Adverse Event|0|||
155071380|NCT02493855|559690716|FG000|Overall Study|Withdrawal by Subject|1|||
155071381|NCT02493855|559690717|FG001|Overall Study|Withdrawal by Subject|0|||
155071382|NCT02493855|559690718|FG002|Overall Study|Withdrawal by Subject|0|||
155071383|NCT05059080|559690722|FG000|Overall Study|Withdrawal by Subject|3|||
155071384|NCT05059080|559690722|FG000|Overall Study|Study Terminated by Sponsor|64|||
155071385|NCT03600428|559690725|FG000|Overall Study|Not eligible|0|||
155071386|NCT03600428|559690726|FG001|Overall Study|Not eligible|1|||
155071387|NCT03600428|559690725|FG000|Overall Study|Lost to Follow-up|5|||
155071388|NCT03600428|559690726|FG001|Overall Study|Lost to Follow-up|4|||
155071389|NCT00770484|559690727|FG000|Overall Study|Withdrawal by Subject|1|||
155071390|NCT00770484|559690728|FG001|Overall Study|Withdrawal by Subject|0|||
155071391|NCT00221104|559690734|FG000|Overall Study|Adverse Event|1|||
155071392|NCT00221104|559690735|FG001|Overall Study|Adverse Event|0|||
155071393|NCT00221104|559690734|FG000|Overall Study|Physician Decision|1|||
154962021|NCT03123471|559285750|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
154962022|NCT03123471|559285751|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
155071394|NCT00221104|559690735|FG001|Overall Study|Physician Decision|0|||
155071395|NCT00221104|559690734|FG000|Overall Study|Protocol Violation|2|||
155071396|NCT00221104|559690735|FG001|Overall Study|Protocol Violation|0|||
155163770|NCT05615922|560035072|FG000|Overall Study|Lost to Follow-up|1|||
155163771|NCT04500158|560035073|FG000|Overall Study|Physician Decision|17|||
155163772|NCT04500158|560035074|FG001|Overall Study|Physician Decision|11|||
155163773|NCT02374450|560035079|FG000|Overall Study|Protocol Violation|0|||
155163774|NCT02374450|560035080|FG001|Overall Study|Protocol Violation|1|||
155163775|NCT02374450|560035081|FG002|Overall Study|Protocol Violation|0|||
155163776|NCT02374450|560035079|FG000|Overall Study|Withdrawal by Subject|91|||
155163777|NCT02374450|560035080|FG001|Overall Study|Withdrawal by Subject|110|||
155163778|NCT02374450|560035081|FG002|Overall Study|Withdrawal by Subject|4|||
155163779|NCT02374450|560035079|FG000|Overall Study|Lost to Follow-up|168|||
154962023|NCT03123471|559285750|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
155071397|NCT00221104|559690734|FG000|Overall Study|Withdrawal by Subject|42|||
155071398|NCT00221104|559690735|FG001|Overall Study|Withdrawal by Subject|29|||
155071399|NCT00221104|559690734|FG000|Overall Study|Others|37|||
155071400|NCT00221104|559690735|FG001|Overall Study|Others|47|||
155071401|NCT01666652|559690736|FG000|Overall Study|Serious Adverse Event|0|||
155071402|NCT01666652|559690737|FG001|Overall Study|Serious Adverse Event|0|||
155071403|NCT01666652|559690738|FG002|Overall Study|Serious Adverse Event|0|||
155071404|NCT01666652|559690739|FG003|Overall Study|Serious Adverse Event|1|||
155071405|NCT01666652|559690740|FG004|Overall Study|Serious Adverse Event|0|||
155071406|NCT01666652|559690736|FG000|Overall Study|Withdrawal by Subject|0|||
155071407|NCT01666652|559690737|FG001|Overall Study|Withdrawal by Subject|0|||
155071408|NCT01666652|559690738|FG002|Overall Study|Withdrawal by Subject|0|||
155071409|NCT01666652|559690739|FG003|Overall Study|Withdrawal by Subject|0|||
155071410|NCT01666652|559690740|FG004|Overall Study|Withdrawal by Subject|1|||
155071411|NCT01666652|559690736|FG000|Overall Study|Moved from study area|1|||
155071412|NCT01666652|559690737|FG001|Overall Study|Moved from study area|0|||
155071413|NCT01666652|559690738|FG002|Overall Study|Moved from study area|0|||
155071414|NCT01666652|559690739|FG003|Overall Study|Moved from study area|2|||
155071415|NCT01666652|559690740|FG004|Overall Study|Moved from study area|0|||
155071416|NCT01666652|559690736|FG000|Overall Study|Lost to Follow-up|1|||
155071417|NCT01666652|559690737|FG001|Overall Study|Lost to Follow-up|1|||
155071418|NCT01666652|559690738|FG002|Overall Study|Lost to Follow-up|1|||
155071419|NCT01666652|559690739|FG003|Overall Study|Lost to Follow-up|1|||
155071420|NCT01666652|559690740|FG004|Overall Study|Lost to Follow-up|0|||
155071421|NCT00088153|559690741|FG000|Overall Study|Physician Decision|3|||
155163780|NCT02374450|560035080|FG001|Overall Study|Lost to Follow-up|194|||
154962024|NCT03123471|559285751|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
154962025|NCT03123471|559285750|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
154962026|NCT03123471|559285751|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
154962027|NCT03123471|559285750|FG000|Placebo-controlled Phase|Miscellaneous|0|||
154962028|NCT03123471|559285751|FG001|Placebo-controlled Phase|Miscellaneous|1|||
154962029|NCT03123471|559285750|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
154962030|NCT03123471|559285751|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
154962031|NCT03123471|559285750|FG000|Apremilast Extension Phase|Adverse Event|1|||
154962032|NCT03123471|559285751|FG001|Apremilast Extension Phase|Adverse Event|5|||
154962033|NCT03123471|559285750|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
154962034|NCT03123471|559285751|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
154962035|NCT03123471|559285750|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
154962036|NCT03123471|559285751|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
154962037|NCT01136174|559285753|FG000|Overall Study|Adverse Event|0|||
154962038|NCT01136174|559285754|FG001|Overall Study|Adverse Event|0|||
154962039|NCT01136174|559285755|FG002|Overall Study|Adverse Event|0|||
154962040|NCT01136174|559285756|FG003|Overall Study|Adverse Event|4|||
154962041|NCT01249651|559285760|FG000|Overall Study|Withdrawal by Subject|4|||
154962042|NCT01249651|559285760|FG000|Overall Study|Adverse Event|1|||
154962043|NCT01249651|559285760|FG000|Overall Study|Protocol Violation|1|||
154962044|NCT01249651|559285760|FG000|Overall Study|Sponsor Decision|1|||
154962045|NCT01588236|559285769|FG000|Overall Study|Adverse Event|5|||
154962046|NCT01588236|559285770|FG001|Overall Study|Adverse Event|4|||
155071422|NCT00088153|559690742|FG001|Overall Study|Physician Decision|3|||
155071423|NCT00088153|559690741|FG000|Overall Study|Withdrawal by Subject|10|||
155163781|NCT02374450|560035081|FG002|Overall Study|Lost to Follow-up|138|||
155163782|NCT02374450|560035079|FG000|Overall Study|Death|173|||
155071424|NCT00088153|559690742|FG001|Overall Study|Withdrawal by Subject|10|||
155071425|NCT00088153|559690741|FG000|Overall Study|Lost to Follow-up|11|||
155071426|NCT00088153|559690742|FG001|Overall Study|Lost to Follow-up|12|||
155071427|NCT01078662|559690743|FG000|Overall Study|Death|41|||
155071428|NCT01078662|559690744|FG001|Overall Study|Death|103|||
155071429|NCT01078662|559690745|FG002|Overall Study|Death|18|||
155333809|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
155333810|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
155333811|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
155333812|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
155333813|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333814|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333815|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333816|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
155333817|NCT00302211|560656146|FG000|Double Blind Period (New Patients)|Disease progression|0|||
155333818|NCT00302211|560656147|FG001|Double Blind Period (New Patients)|Disease progression|1|||
155333819|NCT00302211|560656148|FG002|Double Blind Period (New Patients)|Disease progression|1|||
155333820|NCT00302211|560656149|FG003|Double Blind Period (New Patients)|Disease progression|0|||
155333821|NCT00302211|560656150|FG004|Double Blind Period (New Patients)|Disease progression|0|||
155333822|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
155333823|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
155333824|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
155333825|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
155333826|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
155333827|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333828|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333829|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333830|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
155333831|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
155333832|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333833|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333834|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333835|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
155333836|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
155333837|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
155333838|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
155333839|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
155333840|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
155333841|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
155333842|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Death|0|||
155333843|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Death|0|||
155333844|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Death|0|||
155333845|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Death|1|||
155333846|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Death|1|||
155333847|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333848|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333849|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333850|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
155333851|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
155333852|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333853|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333854|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333855|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
155333856|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
155333857|NCT00302211|560656146|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333858|NCT00302211|560656147|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333859|NCT00302211|560656148|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333860|NCT00302211|560656149|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
155333861|NCT00302211|560656150|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
155333862|NCT02556918|560657803|FG000|Overall Study|Protocol Violation|5|||
155071430|NCT01078662|559690746|FG003|Overall Study|Death|5|||
155163783|NCT02374450|560035080|FG001|Overall Study|Death|185|||
155071431|NCT01078662|559690747|FG004|Overall Study|Death|8|||
155071432|NCT01078662|559690743|FG000|Overall Study|Patients reached data cut-off|12|||
155163784|NCT02374450|560035081|FG002|Overall Study|Death|81|||
155163785|NCT02374450|560035079|FG000|Overall Study|Migrated from the study area|538|||
155333863|NCT02556918|560657804|FG001|Overall Study|Protocol Violation|6|||
155333864|NCT02556918|560657803|FG000|Overall Study|Withdrawal by Subject|4|||
155333865|NCT02556918|560657804|FG001|Overall Study|Withdrawal by Subject|4|||
155333866|NCT04511702|560657814|FG000|Overall Study|Lost to Follow-up|3|||
155333867|NCT04511702|560657815|FG001|Overall Study|Lost to Follow-up|0|||
155333868|NCT04511702|560657816|FG002|Overall Study|Lost to Follow-up|4|||
155333869|NCT04511702|560657814|FG000|Overall Study|Withdrawal by Subject|17|||
155333870|NCT04511702|560657815|FG001|Overall Study|Withdrawal by Subject|1|||
155333871|NCT04511702|560657816|FG002|Overall Study|Withdrawal by Subject|8|||
155333872|NCT05349721|560657817|FG000|Part A (24 Weeks)|Adverse Event|9|||
155333873|NCT05349721|560657818|FG001|Part A (24 Weeks)|Adverse Event|2|||
155333874|NCT05349721|560657817|FG000|Part A (24 Weeks)|Death|8|||
155333875|NCT05349721|560657818|FG001|Part A (24 Weeks)|Death|3|||
155333876|NCT05349721|560657817|FG000|Part A (24 Weeks)|Disease Progression|1|||
155333877|NCT05349721|560657818|FG001|Part A (24 Weeks)|Disease Progression|1|||
155333878|NCT05349721|560657817|FG000|Part A (24 Weeks)|Screen Failure|2|||
155333879|NCT05349721|560657818|FG001|Part A (24 Weeks)|Screen Failure|0|||
155333880|NCT05349721|560657817|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
155333881|NCT05349721|560657818|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
155333882|NCT05349721|560657817|FG000|Part A (24 Weeks)|Other Than Specified|5|||
155333883|NCT05349721|560657818|FG001|Part A (24 Weeks)|Other Than Specified|1|||
155333884|NCT05349721|560657817|FG000|Part B (28 Weeks)|Adverse Event|3|||
155333885|NCT05349721|560657818|FG001|Part B (28 Weeks)|Adverse Event|0|||
155333886|NCT05349721|560657817|FG000|Part B (28 Weeks)|Death|21|||
155333887|NCT05349721|560657818|FG001|Part B (28 Weeks)|Death|11|||
155333888|NCT05349721|560657817|FG000|Part B (28 Weeks)|Disease Progression|2|||
155333889|NCT05349721|560657818|FG001|Part B (28 Weeks)|Disease Progression|1|||
155333890|NCT05349721|560657817|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
155333891|NCT05349721|560657818|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
155333892|NCT05349721|560657817|FG000|Part B (28 Weeks)|Physician Decision|1|||
155333893|NCT05349721|560657818|FG001|Part B (28 Weeks)|Physician Decision|0|||
155333894|NCT05349721|560657817|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
155333895|NCT05349721|560657818|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
155333896|NCT05349721|560657817|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
155333897|NCT05349721|560657818|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
155333898|NCT05349721|560657817|FG000|Part B (28 Weeks)|Other Than Specified|4|||
155333899|NCT05349721|560657818|FG001|Part B (28 Weeks)|Other Than Specified|2|||
155333900|NCT05349721|560657817|FG000|Part C (108 Weeks)|Death|0|||
155333901|NCT05349721|560657818|FG001|Part C (108 Weeks)|Death|1|||
155333902|NCT05349721|560657817|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
155333903|NCT05349721|560657818|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
155333904|NCT05349721|560657817|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
155333905|NCT05349721|560657818|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
155333906|NCT05349721|560657817|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
155333907|NCT05349721|560657818|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
155333908|NCT00799409|560657821|FG000|Overall Study|Withdrawal by Subject|1|||
155333909|NCT00799409|560657822|FG001|Overall Study|Withdrawal by Subject|0|||
155333910|NCT00799409|560657823|FG002|Overall Study|Withdrawal by Subject|0|||
155333911|NCT00799409|560657821|FG000|Overall Study|Lost to Follow-up|1|||
155333912|NCT00799409|560657822|FG001|Overall Study|Lost to Follow-up|0|||
155333913|NCT00799409|560657823|FG002|Overall Study|Lost to Follow-up|0|||
155333914|NCT00799409|560657821|FG000|Overall Study|Optimal Dose Not Achieved|2|||
155333915|NCT00799409|560657822|FG001|Overall Study|Optimal Dose Not Achieved|0|||
155333916|NCT00799409|560657823|FG002|Overall Study|Optimal Dose Not Achieved|0|||
155333917|NCT00799409|560657821|FG000|Overall Study|Failure to follow study protocol)|1|||
155333918|NCT00799409|560657822|FG001|Overall Study|Failure to follow study protocol)|0|||
155333919|NCT00799409|560657823|FG002|Overall Study|Failure to follow study protocol)|0|||
155333920|NCT00799409|560657821|FG000|Overall Study|Did not attend lab school day 1|1|||
155333921|NCT00799409|560657822|FG001|Overall Study|Did not attend lab school day 1|0|||
155333922|NCT00799409|560657823|FG002|Overall Study|Did not attend lab school day 1|0|||
155333923|NCT00799409|560657821|FG000|Overall Study|medication compliance|1|||
155333924|NCT00799409|560657822|FG001|Overall Study|medication compliance|0|||
155333925|NCT00799409|560657823|FG002|Overall Study|medication compliance|0|||
155333926|NCT03137459|560657824|FG000|2-month Assessment|Withdrawal by Subject|13|||
155333927|NCT03137459|560657825|FG001|2-month Assessment|Withdrawal by Subject|3|||
155333928|NCT03137459|560657824|FG000|2-month Assessment|Unable to reach|42|||
155333929|NCT03137459|560657825|FG001|2-month Assessment|Unable to reach|32|||
155333930|NCT03137459|560657824|FG000|2-month Assessment|Refused assessment|7|||
155333931|NCT03137459|560657825|FG001|2-month Assessment|Refused assessment|5|||
155333932|NCT03137459|560657824|FG000|2-month Assessment|Acutely ill|6|||
155333933|NCT03137459|560657825|FG001|2-month Assessment|Acutely ill|2|||
155333934|NCT03137459|560657824|FG000|4-month Assessment|Death|4|||
155333935|NCT03137459|560657825|FG001|4-month Assessment|Death|2|||
155333936|NCT03137459|560657824|FG000|4-month Assessment|Withdrawal by Subject|4|||
155333937|NCT03137459|560657825|FG001|4-month Assessment|Withdrawal by Subject|2|||
155333938|NCT03137459|560657824|FG000|4-month Assessment|Unable to reach|44|||
155333939|NCT03137459|560657825|FG001|4-month Assessment|Unable to reach|29|||
155333940|NCT03137459|560657824|FG000|4-month Assessment|Refused assessment|24|||
155333941|NCT03137459|560657825|FG001|4-month Assessment|Refused assessment|10|||
155333942|NCT03137459|560657824|FG000|4-month Assessment|Acutely ill|2|||
155333943|NCT03137459|560657825|FG001|4-month Assessment|Acutely ill|3|||
155333944|NCT03137459|560657824|FG000|6-months|Lost to Follow-up|14|||
155333945|NCT03137459|560657825|FG001|6-months|Lost to Follow-up|11|||
155333946|NCT03137459|560657824|FG000|6-months|Death|0|||
155333947|NCT03137459|560657825|FG001|6-months|Death|2|||
155333948|NCT03137459|560657824|FG000|6-months|Refused assessment|6|||
155333949|NCT03137459|560657825|FG001|6-months|Refused assessment|3|||
155333950|NCT03137459|560657824|FG000|6-months|Acutely ill|1|||
155333951|NCT03137459|560657825|FG001|6-months|Acutely ill|1|||
155333952|NCT04921358|560657827|FG000|Overall Study|Withdrawal by Subject|6|||
155333953|NCT04921358|560657828|FG001|Overall Study|Withdrawal by Subject|13|||
155333954|NCT04921358|560657827|FG000|Overall Study|Lost to Follow-up|3|||
155333955|NCT04921358|560657828|FG001|Overall Study|Lost to Follow-up|6|||
155333956|NCT04921358|560657827|FG000|Overall Study|Study Terminated by Sponsor|86|||
155333957|NCT04921358|560657828|FG001|Overall Study|Study Terminated by Sponsor|89|||
155333958|NCT04921358|560657827|FG000|Overall Study|Death|92|||
155333959|NCT04921358|560657828|FG001|Overall Study|Death|82|||
155333960|NCT02278796|560657829|FG000|Overall Study|Death|2|||
155333961|NCT02278796|560657830|FG001|Overall Study|Death|3|||
155333962|NCT04926857|560657831|FG000|Overall Study|Withdrawal by Subject|40|||
155333963|NCT04926857|560657831|FG000|Overall Study|Death|9|||
155333964|NCT04926857|560657831|FG000|Overall Study|Study product no longer in use|44|||
155333965|NCT04926857|560657831|FG000|Overall Study|Inadequate data to address primary objective|16|||
155333966|NCT02310581|560657832|FG000|Overall Study|Adverse Event|1|||
155333967|NCT02310581|560657833|FG001|Overall Study|Adverse Event|1|||
155333968|NCT02310581|560657834|FG002|Overall Study|Adverse Event|1|||
155333969|NCT02310581|560657835|FG003|Overall Study|Adverse Event|0|||
155333970|NCT02310581|560657832|FG000|Overall Study|Withdrawal by Subject|2|||
155333971|NCT02310581|560657833|FG001|Overall Study|Withdrawal by Subject|1|||
155333972|NCT02310581|560657834|FG002|Overall Study|Withdrawal by Subject|0|||
155333973|NCT02310581|560657835|FG003|Overall Study|Withdrawal by Subject|1|||
155333974|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
155333975|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
155333976|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
155333977|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
155333978|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
155333979|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
155333980|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
155333981|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
155333982|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
155333983|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
155333984|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
155333985|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
155333986|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Other|1|||
155333987|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Other|0|||
155333988|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Other|0|||
155333989|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
155333990|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
155333991|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
155333992|NCT00887224|560657836|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
155333993|NCT00887224|560657837|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
155333994|NCT00887224|560657838|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
155333995|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
155333996|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
155333997|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
155071433|NCT01078662|559690744|FG001|Overall Study|Patients reached data cut-off|53|||
155071434|NCT01078662|559690745|FG002|Overall Study|Patients reached data cut-off|2|||
155071435|NCT01078662|559690746|FG003|Overall Study|Patients reached data cut-off|2|||
155071436|NCT01078662|559690747|FG004|Overall Study|Patients reached data cut-off|3|||
155071437|NCT01078662|559690743|FG000|Overall Study|Withdrawal by Subject|4|||
155071438|NCT01078662|559690744|FG001|Overall Study|Withdrawal by Subject|11|||
155333998|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
155333999|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
155334000|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
155334001|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
155334002|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
155334003|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
155334004|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
155334005|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
155334006|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
155334007|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Other|1|||
155334008|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Other|0|||
155334009|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Other|0|||
155334010|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
155334011|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
155334012|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
155334013|NCT00887224|560657836|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
155334014|NCT00887224|560657837|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
155334015|NCT00887224|560657838|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
155334016|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
155334017|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
155071439|NCT01078662|559690745|FG002|Overall Study|Withdrawal by Subject|1|||
155071440|NCT01078662|559690746|FG003|Overall Study|Withdrawal by Subject|0|||
155334018|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
155334019|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
155334020|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
155334021|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
155334022|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
155334023|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
155334024|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
155334025|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
155334026|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
155334027|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
155334028|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Other|30|||
155334029|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Other|0|||
155334030|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Other|0|||
155334031|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
155334032|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
155334033|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
155334034|NCT00887224|560657836|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
155334035|NCT00887224|560657837|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
155334036|NCT00887224|560657838|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
155334037|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Adverse Event|0|||
155334038|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Adverse Event|7|||
155334039|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Adverse Event|2|||
155334040|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Failed to return|0|||
155334041|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Failed to return|2|||
154962047|NCT01588236|559285771|FG002|Overall Study|Adverse Event|1|||
154962048|NCT01588236|559285769|FG000|Overall Study|Lost to Follow-up|8|||
154962049|NCT01588236|559285770|FG001|Overall Study|Lost to Follow-up|13|||
154962050|NCT01588236|559285771|FG002|Overall Study|Lost to Follow-up|6|||
154962051|NCT01588236|559285769|FG000|Overall Study|Physician Decision|1|||
154962052|NCT01588236|559285770|FG001|Overall Study|Physician Decision|2|||
154962053|NCT01588236|559285771|FG002|Overall Study|Physician Decision|0|||
155334042|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Failed to return|2|||
155334043|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
155334044|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
155334045|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
155334046|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
155334047|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
155334048|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
155334049|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Other|0|||
155334050|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Other|2|||
155334051|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Other|0|||
155334052|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
155334053|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
155334054|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
155334055|NCT00887224|560657836|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
155334056|NCT00887224|560657837|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
155334057|NCT00887224|560657838|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
155334058|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
155334059|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
155334060|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
155334061|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
155334062|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
155334063|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
155334064|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
155334065|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
155334066|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
155334067|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
155334068|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
155334069|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
155334070|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
155334071|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
155334072|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
155334073|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
155334074|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
155334075|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
155334076|NCT00887224|560657836|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
155334077|NCT00887224|560657837|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
155334078|NCT00887224|560657838|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
155334079|NCT03883828|560657839|FG000|Overall Study|Did not start radiotherapy|1|||
155334080|NCT03883828|560657840|FG001|Overall Study|Did not start radiotherapy|2|||
155334081|NCT03960645|560657841|FG000|Overall Study|Protocol Violation|1|||
155334082|NCT03960645|560657842|FG001|Overall Study|Protocol Violation|0|||
155334083|NCT04938453|560657843|FG000|Washout Period 1|Adverse Event|1|||
155071441|NCT01078662|559690747|FG004|Overall Study|Withdrawal by Subject|0|||
155071442|NCT01078662|559690743|FG000|Overall Study|Protocol Violation|0|||
155071443|NCT01078662|559690744|FG001|Overall Study|Protocol Violation|1|||
155071444|NCT01078662|559690745|FG002|Overall Study|Protocol Violation|0|||
155334084|NCT04938453|560657844|FG001|Washout Period 1|Adverse Event|0|||
155334085|NCT04938453|560657843|FG000|Washout Period 1|Physician Decision|0|||
155334086|NCT04938453|560657844|FG001|Washout Period 1|Physician Decision|1|||
155334087|NCT03737110|560657845|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
155334088|NCT03737110|560657846|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
155334089|NCT03737110|560657847|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
155334090|NCT03737110|560657848|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
155334091|NCT03737110|560657849|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
155334092|NCT03737110|560657850|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
155071445|NCT01078662|559690746|FG003|Overall Study|Protocol Violation|0|||
155071446|NCT01078662|559690747|FG004|Overall Study|Protocol Violation|0|||
155071447|NCT01078662|559690743|FG000|Overall Study|Lost to Follow-up|1|||
155071448|NCT01078662|559690744|FG001|Overall Study|Lost to Follow-up|0|||
155071449|NCT01078662|559690745|FG002|Overall Study|Lost to Follow-up|0|||
155334093|NCT03737110|560657845|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
155334094|NCT03737110|560657846|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334095|NCT03737110|560657847|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334096|NCT03737110|560657848|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334097|NCT03737110|560657849|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334098|NCT03737110|560657850|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
155334099|NCT03737110|560657845|FG000|Run-in (RI) Period|Adverse Event|4|||
155334100|NCT03737110|560657846|FG001|Run-in (RI) Period|Adverse Event|0|||
155334101|NCT03737110|560657847|FG002|Run-in (RI) Period|Adverse Event|0|||
155334102|NCT03737110|560657848|FG003|Run-in (RI) Period|Adverse Event|0|||
155334103|NCT03737110|560657849|FG004|Run-in (RI) Period|Adverse Event|0|||
155334104|NCT03737110|560657850|FG005|Run-in (RI) Period|Adverse Event|0|||
155334105|NCT03737110|560657845|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334106|NCT03737110|560657846|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
155334107|NCT03737110|560657847|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334108|NCT03737110|560657848|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334109|NCT03737110|560657849|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334110|NCT03737110|560657850|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
155334111|NCT03737110|560657845|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334112|NCT03737110|560657846|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334113|NCT03737110|560657847|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
155334114|NCT03737110|560657848|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334115|NCT03737110|560657849|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334116|NCT03737110|560657850|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
155334117|NCT03737110|560657845|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334118|NCT03737110|560657846|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334119|NCT03737110|560657847|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334120|NCT03737110|560657848|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
155334121|NCT03737110|560657849|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334122|NCT03737110|560657850|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
155334123|NCT03737110|560657845|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334124|NCT03737110|560657846|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334125|NCT03737110|560657847|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334126|NCT03737110|560657848|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
155334127|NCT03737110|560657849|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
155334128|NCT03737110|560657850|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
155334129|NCT03737110|560657845|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334130|NCT03737110|560657846|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334131|NCT03737110|560657847|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334132|NCT03737110|560657848|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334133|NCT03737110|560657849|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
155334134|NCT03737110|560657850|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
155334135|NCT05553366|560657859|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
155334136|NCT05553366|560657860|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
155334137|NCT05553366|560657861|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
155334138|NCT05553366|560657859|FG000|Overall Study|Lost to Follow-up|3|||
155334139|NCT05553366|560657860|FG001|Overall Study|Lost to Follow-up|3|||
155334140|NCT05553366|560657861|FG002|Overall Study|Lost to Follow-up|3|||
155334141|NCT05553366|560657859|FG000|Overall Study|Other non-compliance|1|||
155334142|NCT05553366|560657860|FG001|Overall Study|Other non-compliance|1|||
155071450|NCT01078662|559690746|FG003|Overall Study|Lost to Follow-up|0|||
155071451|NCT01078662|559690747|FG004|Overall Study|Lost to Follow-up|0|||
155071452|NCT00325416|559690748|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
155071453|NCT00325416|559690749|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
155071454|NCT00325416|559690748|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
155071455|NCT00325416|559690749|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
155071456|NCT00325416|559690748|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
155071457|NCT00325416|559690749|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
155071458|NCT00325416|559690748|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
155071459|NCT00325416|559690749|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
155071460|NCT00325416|559690748|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
155071461|NCT00325416|559690749|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
155334143|NCT05553366|560657861|FG002|Overall Study|Other non-compliance|0|||
155334144|NCT05553366|560657859|FG000|Overall Study|Randomized but not dosed|0|||
155334145|NCT05553366|560657860|FG001|Overall Study|Randomized but not dosed|0|||
155334146|NCT05553366|560657861|FG002|Overall Study|Randomized but not dosed|2|||
155334147|NCT00249769|560657862|FG000|Overall Study|Withdrawal by Subject|1|||
155334148|NCT00249769|560657863|FG001|Overall Study|Withdrawal by Subject|10|||
155334149|NCT00249769|560657864|FG002|Overall Study|Withdrawal by Subject|6|||
155334150|NCT00249769|560657862|FG000|Overall Study|Migration from Study Area|1|||
155334151|NCT00249769|560657863|FG001|Overall Study|Migration from Study Area|3|||
155334152|NCT00249769|560657864|FG002|Overall Study|Migration from Study Area|14|||
155071462|NCT00325416|559690748|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
155071463|NCT00325416|559690749|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
155071464|NCT01937299|559690750|FG000|Overall Study|Adverse Event|13|||
155071465|NCT01937299|559690751|FG001|Overall Study|Adverse Event|0|||
155334153|NCT00249769|560657862|FG000|Overall Study|Miscellaneous|0|||
155334154|NCT00249769|560657863|FG001|Overall Study|Miscellaneous|2|||
155334155|NCT00249769|560657864|FG002|Overall Study|Miscellaneous|2|||
155334156|NCT00249769|560657862|FG000|Overall Study|Adverse Event|0|||
155334157|NCT00249769|560657863|FG001|Overall Study|Adverse Event|0|||
155334158|NCT00249769|560657864|FG002|Overall Study|Adverse Event|1|||
155334159|NCT00249769|560657862|FG000|Overall Study|Physician Decision|0|||
155334160|NCT00249769|560657863|FG001|Overall Study|Physician Decision|0|||
155334161|NCT00249769|560657864|FG002|Overall Study|Physician Decision|2|||
155334162|NCT00249769|560657862|FG000|Overall Study|Lost to Follow-up|0|||
155334163|NCT00249769|560657863|FG001|Overall Study|Lost to Follow-up|0|||
155334164|NCT00249769|560657864|FG002|Overall Study|Lost to Follow-up|3|||
155334165|NCT02022657|560657869|FG000|Overall Study|Withdrawal by Subject|2|||
155334166|NCT02022657|560657870|FG001|Overall Study|Withdrawal by Subject|0|||
155334167|NCT02022657|560657871|FG002|Overall Study|Withdrawal by Subject|1|||
155334168|NCT02022657|560657872|FG003|Overall Study|Withdrawal by Subject|0|||
155334169|NCT02022657|560657873|FG004|Overall Study|Withdrawal by Subject|0|||
155334170|NCT02022657|560657874|FG005|Overall Study|Withdrawal by Subject|0|||
155334171|NCT02022657|560657869|FG000|Overall Study|Physician Decision|0|||
155071466|NCT01937299|559690750|FG000|Overall Study|Lack of Efficacy|0|||
155071467|NCT01937299|559690751|FG001|Overall Study|Lack of Efficacy|4|||
155071468|NCT01937299|559690750|FG000|Overall Study|Withdrawal by Subject|1|||
155071469|NCT01937299|559690751|FG001|Overall Study|Withdrawal by Subject|0|||
155071470|NCT00700635|559690752|FG000|Overall Study|Adverse Event|1|||
155071471|NCT00700635|559690753|FG001|Overall Study|Adverse Event|0|||
155071472|NCT00700635|559690754|FG002|Overall Study|Adverse Event|0|||
155071473|NCT00700635|559690752|FG000|Overall Study|Lost to Follow-up|1|||
155071474|NCT00700635|559690753|FG001|Overall Study|Lost to Follow-up|3|||
155071475|NCT00700635|559690754|FG002|Overall Study|Lost to Follow-up|0|||
155334172|NCT02022657|560657870|FG001|Overall Study|Physician Decision|0|||
155334173|NCT02022657|560657871|FG002|Overall Study|Physician Decision|0|||
155071476|NCT00700635|559690752|FG000|Overall Study|Protocol Violation|2|||
155334174|NCT02022657|560657872|FG003|Overall Study|Physician Decision|0|||
155334175|NCT02022657|560657873|FG004|Overall Study|Physician Decision|0|||
155334176|NCT02022657|560657874|FG005|Overall Study|Physician Decision|1|||
155334177|NCT03274076|560657875|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
155334178|NCT03274076|560657876|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
155334179|NCT03274076|560657877|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
155334180|NCT03274076|560657878|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
155334181|NCT03274076|560657875|FG000|24 Weeks Open Label|Adverse Event|0|||
155334182|NCT03274076|560657876|FG001|24 Weeks Open Label|Adverse Event|0|||
155334183|NCT03274076|560657877|FG002|24 Weeks Open Label|Adverse Event|2|||
155334184|NCT03274076|560657878|FG003|24 Weeks Open Label|Adverse Event|0|||
155334185|NCT03274076|560657875|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
155334186|NCT03274076|560657876|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
155334187|NCT03274076|560657877|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
155334188|NCT03274076|560657878|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
155334189|NCT01629589|560657879|FG000|Overall Study|Protocol Violation|4|||
155334190|NCT01629589|560657880|FG001|Overall Study|Protocol Violation|2|||
155334191|NCT01629589|560657879|FG000|Overall Study|Lost to Follow-up|2|||
155334192|NCT01629589|560657880|FG001|Overall Study|Lost to Follow-up|1|||
155334193|NCT01629589|560657879|FG000|Overall Study|Withdrawal by Subject|2|||
155334194|NCT01629589|560657880|FG001|Overall Study|Withdrawal by Subject|3|||
155334195|NCT01629589|560657879|FG000|Overall Study|Did not receive study vaccine|0|||
155334196|NCT01629589|560657880|FG001|Overall Study|Did not receive study vaccine|1|||
155334197|NCT01530334|560657881|FG000|Overall Study|Adverse Event|3|||
155334198|NCT01530334|560657881|FG000|Overall Study|unknown reason|1|||
155334199|NCT01530334|560657881|FG000|Overall Study|Progressive disease|47|||
155334200|NCT02079649|560657883|FG000|Overall Study|Lost to Follow-up|0|||
155334201|NCT02079649|560657884|FG001|Overall Study|Lost to Follow-up|0|||
155334202|NCT02079649|560657885|FG002|Overall Study|Lost to Follow-up|0|||
155071477|NCT00700635|559690753|FG001|Overall Study|Protocol Violation|2|||
155071478|NCT00700635|559690754|FG002|Overall Study|Protocol Violation|0|||
155071479|NCT00700635|559690752|FG000|Overall Study|Withdrawal by Subject|7|||
155071480|NCT00700635|559690753|FG001|Overall Study|Withdrawal by Subject|3|||
155071481|NCT00700635|559690754|FG002|Overall Study|Withdrawal by Subject|1|||
155071482|NCT00768053|559690756|FG000|Overall Study|Adverse Event|10|||
155071483|NCT00768053|559690756|FG000|Overall Study|Lost to Follow-up|1|||
155071484|NCT03018938|559690757|FG000|Overall Study|Death|0|||
155071485|NCT03018938|559690758|FG001|Overall Study|Death|1|||
155071486|NCT03018938|559690757|FG000|Overall Study|Lost to Follow-up|21|||
155071487|NCT03018938|559690758|FG001|Overall Study|Lost to Follow-up|32|||
155334203|NCT02079649|560657886|FG003|Overall Study|Lost to Follow-up|1|||
155071488|NCT03018938|559690757|FG000|Overall Study|Withdrawal by Subject|38|||
155071489|NCT03018938|559690758|FG001|Overall Study|Withdrawal by Subject|45|||
155071490|NCT03018938|559690757|FG000|Overall Study|Physician Decision|3|||
155071491|NCT03018938|559690758|FG001|Overall Study|Physician Decision|2|||
155071492|NCT03018938|559690757|FG000|Overall Study|Sponsor Decision|0|||
155071493|NCT03018938|559690758|FG001|Overall Study|Sponsor Decision|1|||
155071494|NCT03018938|559690757|FG000|Overall Study|Screen failure-After randomization|4|||
155071495|NCT03018938|559690758|FG001|Overall Study|Screen failure-After randomization|2|||
155071496|NCT03018938|559690757|FG000|Overall Study|Not recorded|0|||
155071497|NCT03018938|559690758|FG001|Overall Study|Not recorded|2|||
155071498|NCT01202591|559690759|FG000|Overall Study|Adverse Event|2|||
155071499|NCT01202591|559690760|FG001|Overall Study|Adverse Event|1|||
155071500|NCT01202591|559690761|FG002|Overall Study|Adverse Event|4|||
155071501|NCT01202591|559690762|FG003|Overall Study|Adverse Event|4|||
155071502|NCT01202591|559690763|FG004|Overall Study|Adverse Event|0|||
155071503|NCT01202591|559690764|FG005|Overall Study|Adverse Event|0|||
155334204|NCT02079649|560657883|FG000|Overall Study|Withdrawal by Subject|0|||
155334205|NCT02079649|560657884|FG001|Overall Study|Withdrawal by Subject|0|||
155334206|NCT02079649|560657885|FG002|Overall Study|Withdrawal by Subject|0|||
155334207|NCT02079649|560657886|FG003|Overall Study|Withdrawal by Subject|1|||
155334208|NCT02079649|560657883|FG000|Overall Study|Randomization error (prior to treatment)|1|||
155334209|NCT02079649|560657884|FG001|Overall Study|Randomization error (prior to treatment)|0|||
155334210|NCT02079649|560657885|FG002|Overall Study|Randomization error (prior to treatment)|1|||
155334211|NCT02079649|560657886|FG003|Overall Study|Randomization error (prior to treatment)|0|||
155334212|NCT03739866|560657889|FG000|Overall Study|Lost to Follow-up|0|||
155334213|NCT03739866|560657890|FG001|Overall Study|Lost to Follow-up|0|||
155071504|NCT01202591|559690759|FG000|Overall Study|Other reason as per investigator|3|||
155334214|NCT03739866|560657891|FG002|Overall Study|Lost to Follow-up|0|||
155071505|NCT01202591|559690760|FG001|Overall Study|Other reason as per investigator|4|||
155071506|NCT01202591|559690761|FG002|Overall Study|Other reason as per investigator|7|||
155071507|NCT01202591|559690762|FG003|Overall Study|Other reason as per investigator|3|||
155071508|NCT01202591|559690763|FG004|Overall Study|Other reason as per investigator|1|||
155071509|NCT01202591|559690764|FG005|Overall Study|Other reason as per investigator|3|||
155334215|NCT03739866|560657892|FG003|Overall Study|Lost to Follow-up|1|||
155334216|NCT03739866|560657893|FG004|Overall Study|Lost to Follow-up|0|||
155334217|NCT03739866|560657894|FG005|Overall Study|Lost to Follow-up|0|||
155334218|NCT03739866|560657895|FG006|Overall Study|Lost to Follow-up|0|||
155334219|NCT03739866|560657896|FG007|Overall Study|Lost to Follow-up|0|||
155334220|NCT03739866|560657889|FG000|Overall Study|Enrolled but not treated|0|||
155334221|NCT03739866|560657890|FG001|Overall Study|Enrolled but not treated|0|||
155071510|NCT01202591|559690759|FG000|Overall Study|Withdrawal by Subject|0|||
155334222|NCT03739866|560657891|FG002|Overall Study|Enrolled but not treated|1|||
155334223|NCT03739866|560657892|FG003|Overall Study|Enrolled but not treated|0|||
155334224|NCT03739866|560657893|FG004|Overall Study|Enrolled but not treated|1|||
155334225|NCT03739866|560657894|FG005|Overall Study|Enrolled but not treated|0|||
155334226|NCT03739866|560657895|FG006|Overall Study|Enrolled but not treated|0|||
155334227|NCT03739866|560657896|FG007|Overall Study|Enrolled but not treated|0|||
155334228|NCT01034306|560657897|FG000|Overall Study|Adverse Event|1|||
155334229|NCT01034306|560657898|FG001|Overall Study|Adverse Event|0|||
155334230|NCT01034306|560657897|FG000|Overall Study|Lost to Follow-up|0|||
155334231|NCT01034306|560657898|FG001|Overall Study|Lost to Follow-up|1|||
155334232|NCT01034306|560657897|FG000|Overall Study|Withdrawal by Subject|2|||
155334233|NCT01034306|560657898|FG001|Overall Study|Withdrawal by Subject|2|||
155334234|NCT01034306|560657897|FG000|Overall Study|hospitalized and decided to stop|1|||
155334235|NCT01034306|560657898|FG001|Overall Study|hospitalized and decided to stop|0|||
155334236|NCT01034306|560657897|FG000|Overall Study|Noncomplience|1|||
155334237|NCT01034306|560657898|FG001|Overall Study|Noncomplience|0|||
155334238|NCT00836498|560657899|FG000|Overall Study|Adverse Event|1|||
155334239|NCT00836498|560657900|FG001|Overall Study|Adverse Event|0|||
155334240|NCT00836498|560657899|FG000|Overall Study|Lost to Follow-up|1|||
155334241|NCT00836498|560657900|FG001|Overall Study|Lost to Follow-up|0|||
155334242|NCT00836498|560657899|FG000|Overall Study|Withdrawal by Subject|2|||
155334243|NCT00836498|560657900|FG001|Overall Study|Withdrawal by Subject|1|||
155334244|NCT01968967|560657901|FG000|Treatment Period|Other|22|||
155334245|NCT01968967|560657902|FG001|Treatment Period|Other|22|||
155334246|NCT01968967|560657903|FG002|Treatment Period|Other|0|||
155334247|NCT01968967|560657904|FG003|Treatment Period|Other|0|||
155334248|NCT01968967|560657905|FG004|Treatment Period|Other|0|||
155334249|NCT01968967|560657901|FG000|Treatment Period|Withdrawal by Subject|71|||
155334250|NCT01968967|560657902|FG001|Treatment Period|Withdrawal by Subject|61|||
155334251|NCT01968967|560657903|FG002|Treatment Period|Withdrawal by Subject|0|||
155334252|NCT01968967|560657904|FG003|Treatment Period|Withdrawal by Subject|0|||
155334253|NCT01968967|560657905|FG004|Treatment Period|Withdrawal by Subject|0|||
155071511|NCT01202591|559690760|FG001|Overall Study|Withdrawal by Subject|0|||
155334254|NCT01968967|560657901|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
155334255|NCT01968967|560657902|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
155334256|NCT01968967|560657903|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
155334257|NCT01968967|560657904|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
155334258|NCT01968967|560657905|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
155334259|NCT01968967|560657901|FG000|Treatment Period|Lost to Follow-up|26|||
155334260|NCT01968967|560657902|FG001|Treatment Period|Lost to Follow-up|31|||
155334261|NCT01968967|560657903|FG002|Treatment Period|Lost to Follow-up|0|||
155334262|NCT01968967|560657904|FG003|Treatment Period|Lost to Follow-up|0|||
155334263|NCT01968967|560657905|FG004|Treatment Period|Lost to Follow-up|0|||
155334264|NCT01968967|560657901|FG000|Treatment Period|Protocol Violation|1|||
155334265|NCT01968967|560657902|FG001|Treatment Period|Protocol Violation|2|||
155334266|NCT01968967|560657903|FG002|Treatment Period|Protocol Violation|0|||
155334267|NCT01968967|560657904|FG003|Treatment Period|Protocol Violation|0|||
155334268|NCT01968967|560657905|FG004|Treatment Period|Protocol Violation|0|||
155334269|NCT01968967|560657901|FG000|Treatment Period|Adverse Event|9|||
155334270|NCT01968967|560657902|FG001|Treatment Period|Adverse Event|8|||
155334271|NCT01968967|560657903|FG002|Treatment Period|Adverse Event|0|||
155334272|NCT01968967|560657904|FG003|Treatment Period|Adverse Event|0|||
155334273|NCT01968967|560657905|FG004|Treatment Period|Adverse Event|0|||
155334274|NCT01968967|560657901|FG000|Treatment Period|Death|9|||
155334275|NCT01968967|560657902|FG001|Treatment Period|Death|2|||
155334276|NCT01968967|560657903|FG002|Treatment Period|Death|0|||
155334277|NCT01968967|560657904|FG003|Treatment Period|Death|0|||
155334278|NCT01968967|560657905|FG004|Treatment Period|Death|0|||
155334279|NCT01968967|560657901|FG000|Treatment Period|Randomized Not Treated|6|||
155334280|NCT01968967|560657902|FG001|Treatment Period|Randomized Not Treated|5|||
155334281|NCT01968967|560657903|FG002|Treatment Period|Randomized Not Treated|0|||
155334282|NCT01968967|560657904|FG003|Treatment Period|Randomized Not Treated|0|||
155334283|NCT01968967|560657905|FG004|Treatment Period|Randomized Not Treated|0|||
155334284|NCT01968967|560657901|FG000|Extension Period|Withdrew Consent|0|||
155334285|NCT01968967|560657902|FG001|Extension Period|Withdrew Consent|0|||
155334286|NCT01968967|560657903|FG002|Extension Period|Withdrew Consent|2|||
155334287|NCT01968967|560657904|FG003|Extension Period|Withdrew Consent|0|||
155334288|NCT01968967|560657905|FG004|Extension Period|Withdrew Consent|5|||
155334289|NCT00701415|560657910|FG000|Overall Study|Adverse Event|0|||
155334290|NCT00701415|560657911|FG001|Overall Study|Adverse Event|1|||
155334291|NCT00701415|560657910|FG000|Overall Study|Social/family issues and needle phobia|1|||
155334292|NCT00701415|560657911|FG001|Overall Study|Social/family issues and needle phobia|0|||
155334293|NCT00109031|560657912|FG000|Overall Study|Adverse Event|0|||
155334294|NCT00109031|560657913|FG001|Overall Study|Adverse Event|0|||
155334295|NCT00109031|560657914|FG002|Overall Study|Adverse Event|1|||
155334296|NCT00109031|560657915|FG003|Overall Study|Adverse Event|0|||
155334297|NCT00109031|560657912|FG000|Overall Study|Withdrawal by Subject|0|||
155334298|NCT00109031|560657913|FG001|Overall Study|Withdrawal by Subject|1|||
155334299|NCT00109031|560657914|FG002|Overall Study|Withdrawal by Subject|0|||
155334300|NCT00109031|560657915|FG003|Overall Study|Withdrawal by Subject|0|||
155334301|NCT00109031|560657912|FG000|Overall Study|Physician Decision|0|||
155334302|NCT00109031|560657913|FG001|Overall Study|Physician Decision|1|||
155334303|NCT00109031|560657914|FG002|Overall Study|Physician Decision|0|||
155334304|NCT00109031|560657915|FG003|Overall Study|Physician Decision|0|||
155334305|NCT00109031|560657912|FG000|Overall Study|Protocol Violation|0|||
155334306|NCT00109031|560657913|FG001|Overall Study|Protocol Violation|0|||
155334307|NCT00109031|560657914|FG002|Overall Study|Protocol Violation|1|||
155334308|NCT00109031|560657915|FG003|Overall Study|Protocol Violation|0|||
155334309|NCT04029090|560657916|FG000|Overall Study|Protocol Violation|1|||
155334310|NCT04029090|560657917|FG001|Overall Study|Protocol Violation|0|||
155334311|NCT04029090|560657918|FG002|Overall Study|Protocol Violation|0|||
155334312|NCT04029090|560657916|FG000|Overall Study|Withdrawal by Subject|0|||
155334313|NCT04029090|560657917|FG001|Overall Study|Withdrawal by Subject|1|||
155334314|NCT04029090|560657918|FG002|Overall Study|Withdrawal by Subject|0|||
155334315|NCT01065779|560657919|FG000|Overall Study|Duplicate Investigation|1|||
155334316|NCT01065779|560657919|FG000|Overall Study|Investigation Before Contract Date|37|||
155334317|NCT01065779|560657919|FG000|Overall Study|Non-enrollment Period Administration|10|||
155334318|NCT01065779|560657919|FG000|Overall Study|Not Administered With Study Drug|17|||
155334319|NCT01065779|560657919|FG000|Overall Study|Failed to Follow-up|10|||
155334320|NCT01065779|560657919|FG000|Overall Study|Inclusion Criteria Violation|7|||
155334321|NCT02157948|560657920|FG000|Overall Study|Withdrawal by Subject|4|||
155334322|NCT02157948|560657921|FG001|Overall Study|Withdrawal by Subject|5|||
155334323|NCT02157948|560657920|FG000|Overall Study|Lost to Follow-up|3|||
155334324|NCT02157948|560657921|FG001|Overall Study|Lost to Follow-up|2|||
155334325|NCT02157948|560657920|FG000|Overall Study|Protocol Specified Criteria|2|||
155334326|NCT02157948|560657921|FG001|Overall Study|Protocol Specified Criteria|1|||
155334327|NCT02157948|560657920|FG000|Overall Study|Decision by Sponsor|0|||
155334328|NCT02157948|560657921|FG001|Overall Study|Decision by Sponsor|1|||
155334329|NCT01604824|560657923|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334330|NCT01604824|560657924|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334331|NCT01604824|560657925|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334332|NCT01604824|560657926|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334333|NCT01604824|560657927|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
155334334|NCT01604824|560657928|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
155334335|NCT01604824|560657923|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334336|NCT01604824|560657924|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334337|NCT01604824|560657925|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334338|NCT01604824|560657926|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334339|NCT01604824|560657927|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
155334340|NCT01604824|560657928|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
155334341|NCT02630966|560657929|FG000|Overall Study|Adverse Event|1|||
155334342|NCT02630966|560657930|FG001|Overall Study|Adverse Event|3|||
155334343|NCT02630966|560657929|FG000|Overall Study|Significant Protocol Deviation|0|||
155334344|NCT02630966|560657930|FG001|Overall Study|Significant Protocol Deviation|2|||
155334345|NCT02630966|560657929|FG000|Overall Study|Voluntary Withdrawal|1|||
155334346|NCT02630966|560657930|FG001|Overall Study|Voluntary Withdrawal|1|||
155334347|NCT02630966|560657929|FG000|Overall Study|Lack of Efficacy|0|||
155334348|NCT02630966|560657930|FG001|Overall Study|Lack of Efficacy|2|||
155334349|NCT04218864|560657945|FG000|Overall Study|Lost to Follow-up|8|||
155071512|NCT01202591|559690761|FG002|Overall Study|Withdrawal by Subject|0|||
155334350|NCT04218864|560657946|FG001|Overall Study|Lost to Follow-up|4|||
155334351|NCT04218864|560657945|FG000|Overall Study|Withdrawal by Subject|1|||
155334352|NCT04218864|560657946|FG001|Overall Study|Withdrawal by Subject|3|||
155334353|NCT00933270|560657947|FG000|Overall Study|Withdrawal by Subject|26|||
155334354|NCT00933270|560657947|FG000|Overall Study|Insufficient Follow-up|10|||
155071513|NCT01202591|559690762|FG003|Overall Study|Withdrawal by Subject|0|||
155071514|NCT01202591|559690763|FG004|Overall Study|Withdrawal by Subject|2|||
155071515|NCT01202591|559690764|FG005|Overall Study|Withdrawal by Subject|1|||
155071516|NCT01202591|559690759|FG000|Overall Study|Objective Disease Progression|0|||
155334355|NCT00933270|560657947|FG000|Overall Study|Lost to Follow-up|14|||
155334356|NCT00933270|560657947|FG000|Overall Study|Adverse Event|1|||
155334357|NCT00933270|560657947|FG000|Overall Study|Missed Visit|2|||
155334358|NCT00933270|560657947|FG000|Overall Study|Death|24|||
155334359|NCT00933270|560657947|FG000|Overall Study|Moved or would not return|10|||
155334360|NCT02409680|560657948|FG000|Overall Study|Lost to Follow-up|15|||
155334361|NCT02409680|560657949|FG001|Overall Study|Lost to Follow-up|30|||
155334362|NCT05366751|560657950|FG000|Overall Study|Adverse Event|25|||
155334363|NCT05366751|560657950|FG000|Overall Study|Physician Decision|3|||
155334364|NCT05366751|560657950|FG000|Overall Study|Lost to Follow-up|2|||
155334365|NCT05366751|560657950|FG000|Overall Study|Withdrawal by Subject|14|||
155334366|NCT05366751|560657950|FG000|Overall Study|Study Terminated by Sponsor|50|||
155334367|NCT05366751|560657950|FG000|Overall Study|Site Terminated by Sponsor|3|||
155334368|NCT00108355|560660071|FG000|Overall Study|Peritonitis at index paracentesis|1|||
155334369|NCT00108355|560660072|FG001|Overall Study|Peritonitis at index paracentesis|1|||
155334370|NCT00108355|560660071|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
155334371|NCT00108355|560660072|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
155334372|NCT03214081|560660073|FG000|Overall Study|Case Report Forms Uncollected|9|||
155334373|NCT03214081|560660073|FG000|Overall Study|Protocol Deviation|54|||
155334374|NCT02962284|560660074|FG000|Overall Study|Death|2|||
155334375|NCT02962284|560660075|FG001|Overall Study|Death|0|||
155334376|NCT02962284|560660074|FG000|Overall Study|Progressive disease|2|||
155334377|NCT02962284|560660075|FG001|Overall Study|Progressive disease|3|||
155334378|NCT02962284|560660074|FG000|Overall Study|Withdrawal by Subject|1|||
155071517|NCT01202591|559690760|FG001|Overall Study|Objective Disease Progression|0|||
155071518|NCT01202591|559690761|FG002|Overall Study|Objective Disease Progression|0|||
155334379|NCT02962284|560660075|FG001|Overall Study|Withdrawal by Subject|0|||
155334380|NCT02637063|560660076|FG000|Overall Study|Lost to Follow-up|3|||
155334381|NCT02637063|560660077|FG001|Overall Study|Lost to Follow-up|2|||
155334382|NCT02637063|560660078|FG002|Overall Study|Lost to Follow-up|3|||
155334383|NCT02637063|560660076|FG000|Overall Study|Withdrawal by Subject|2|||
155334384|NCT02637063|560660077|FG001|Overall Study|Withdrawal by Subject|2|||
155334385|NCT02637063|560660078|FG002|Overall Study|Withdrawal by Subject|3|||
155334386|NCT02634307|560660079|FG000|Overall Study|Adverse Event|50|||
155334387|NCT02634307|560660080|FG001|Overall Study|Adverse Event|24|||
155334388|NCT02634307|560660081|FG002|Overall Study|Adverse Event|14|||
155334389|NCT02634307|560660079|FG000|Overall Study|Lost to Follow-up|21|||
155334390|NCT02634307|560660080|FG001|Overall Study|Lost to Follow-up|5|||
155334391|NCT02634307|560660081|FG002|Overall Study|Lost to Follow-up|6|||
155334392|NCT02634307|560660079|FG000|Overall Study|Pregnancy|5|||
155334393|NCT02634307|560660080|FG001|Overall Study|Pregnancy|1|||
155334394|NCT02634307|560660081|FG002|Overall Study|Pregnancy|3|||
155334395|NCT02634307|560660079|FG000|Overall Study|Withdrawal by Subject|38|||
155334396|NCT02634307|560660080|FG001|Overall Study|Withdrawal by Subject|24|||
155334397|NCT02634307|560660081|FG002|Overall Study|Withdrawal by Subject|18|||
155334398|NCT02634307|560660079|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155334399|NCT02634307|560660080|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155334400|NCT02634307|560660081|FG002|Overall Study|Non-Compliance with Study Drug|2|||
155334401|NCT02634307|560660079|FG000|Overall Study|Lack of Efficacy|1|||
155334402|NCT02634307|560660080|FG001|Overall Study|Lack of Efficacy|5|||
155334403|NCT02634307|560660081|FG002|Overall Study|Lack of Efficacy|3|||
155334404|NCT02634307|560660079|FG000|Overall Study|Physician Decision|7|||
155334405|NCT02634307|560660080|FG001|Overall Study|Physician Decision|5|||
155334406|NCT02634307|560660081|FG002|Overall Study|Physician Decision|5|||
155334407|NCT02634307|560660079|FG000|Overall Study|Reason not Specified|3|||
155334408|NCT02634307|560660080|FG001|Overall Study|Reason not Specified|5|||
155334409|NCT02634307|560660081|FG002|Overall Study|Reason not Specified|10|||
155334410|NCT01532648|560660087|FG000|Overall Study|Lost to Follow-up|3|||
155334411|NCT01532648|560660088|FG001|Overall Study|Lost to Follow-up|4|||
155334412|NCT01532648|560660087|FG000|Overall Study|Lack of Efficacy|4|||
155334413|NCT01532648|560660088|FG001|Overall Study|Lack of Efficacy|1|||
155334414|NCT01532648|560660087|FG000|Overall Study|Protocol Violation|1|||
155334415|NCT01532648|560660088|FG001|Overall Study|Protocol Violation|1|||
155334416|NCT01532648|560660087|FG000|Overall Study|Adverse Event|12|||
155334417|NCT01532648|560660088|FG001|Overall Study|Adverse Event|9|||
155334418|NCT01532648|560660087|FG000|Overall Study|Withdrawal by Subject|16|||
155334419|NCT01532648|560660088|FG001|Overall Study|Withdrawal by Subject|2|||
155334420|NCT02824198|560660089|FG000|Overall Study|Non-compliance with the protocol|5|||
155334421|NCT02824198|560660090|FG001|Overall Study|Non-compliance with the protocol|1|||
155334422|NCT02824198|560660089|FG000|Overall Study|Lost to Follow-up|5|||
155334423|NCT02824198|560660090|FG001|Overall Study|Lost to Follow-up|2|||
155334424|NCT02824198|560660089|FG000|Overall Study|Withdrawal by Subject|5|||
155334425|NCT02824198|560660090|FG001|Overall Study|Withdrawal by Subject|0|||
155334426|NCT01256359|560660091|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
155334427|NCT01256359|560660092|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
155334428|NCT01256359|560660091|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
155334429|NCT01256359|560660092|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
155334430|NCT03292406|560660093|FG000|Overall Study|Progressive Disease|6|||
155334431|NCT03292406|560660094|FG001|Overall Study|Progressive Disease|3|||
155334432|NCT03292406|560660095|FG002|Overall Study|Progressive Disease|4|||
155334433|NCT03292406|560660093|FG000|Overall Study|Adverse Event|7|||
155334434|NCT03292406|560660094|FG001|Overall Study|Adverse Event|1|||
155334435|NCT03292406|560660095|FG002|Overall Study|Adverse Event|4|||
155334436|NCT03292406|560660093|FG000|Overall Study|Withdrawal by Subject|0|||
155334437|NCT03292406|560660094|FG001|Overall Study|Withdrawal by Subject|7|||
155334438|NCT03292406|560660095|FG002|Overall Study|Withdrawal by Subject|2|||
155334439|NCT03292406|560660093|FG000|Overall Study|Protocol Violation|0|||
155334440|NCT03292406|560660094|FG001|Overall Study|Protocol Violation|1|||
155334441|NCT03292406|560660095|FG002|Overall Study|Protocol Violation|1|||
155334442|NCT03292406|560660093|FG000|Overall Study|Other|0|||
155334443|NCT03292406|560660094|FG001|Overall Study|Other|1|||
155334444|NCT03292406|560660095|FG002|Overall Study|Other|2|||
155334445|NCT02575365|560660096|FG000|Overall Study|Lost to Follow-up|4|||
155334446|NCT00487240|560660098|FG000|Overall Study|Withdrawal by Subject|12|||
155334447|NCT00487240|560660099|FG001|Overall Study|Withdrawal by Subject|6|||
155334448|NCT00487240|560660098|FG000|Overall Study|Lost to Follow-up|7|||
155334449|NCT00487240|560660099|FG001|Overall Study|Lost to Follow-up|6|||
155334450|NCT00487240|560660098|FG000|Overall Study|Adverse Event|0|||
155334451|NCT00487240|560660099|FG001|Overall Study|Adverse Event|4|||
155334452|NCT00487240|560660098|FG000|Overall Study|Protocol Violation|5|||
155334453|NCT00487240|560660099|FG001|Overall Study|Protocol Violation|5|||
155334454|NCT00487240|560660098|FG000|Overall Study|Entry Criteria Not Met|3|||
155334455|NCT00487240|560660099|FG001|Overall Study|Entry Criteria Not Met|4|||
155334456|NCT00487240|560660098|FG000|Overall Study|Sponsor Decision|2|||
155334457|NCT00487240|560660099|FG001|Overall Study|Sponsor Decision|1|||
155334458|NCT00487240|560660098|FG000|Overall Study|Physician Decision|2|||
155334459|NCT00487240|560660099|FG001|Overall Study|Physician Decision|0|||
155334460|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
155334461|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
155334462|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Death|2|||
155334463|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
155334464|NCT01698918|560660100|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
155334465|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
155334466|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
155334467|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Death|1|||
155334468|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
155334469|NCT01698918|560660100|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
155334470|NCT03176407|560660101|FG000|Overall Study|Protocol Violation|1|||
155334471|NCT03176407|560660101|FG000|Overall Study|human failure|1|||
155334472|NCT03176407|560660101|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
155334473|NCT01428583|560660104|FG000|Overall Study|Adverse Event|75|||
155334474|NCT01428583|560660104|FG000|Overall Study|Withdrawal by Subject|51|||
155334475|NCT01428583|560660104|FG000|Overall Study|Lack of Efficacy|37|||
155334476|NCT01428583|560660104|FG000|Overall Study|Lost to Follow-up|17|||
155334477|NCT01428583|560660104|FG000|Overall Study|Death|1|||
155334478|NCT01428583|560660104|FG000|Overall Study|Pregnancy|1|||
155334479|NCT01428583|560660104|FG000|Overall Study|Protocol Violation|1|||
155334480|NCT01428583|560660104|FG000|Overall Study|Physician Decision|12|||
155334481|NCT01428583|560660104|FG000|Overall Study|Non-compliant|25|||
155334482|NCT01428583|560660104|FG000|Overall Study|Confirmed positive urine drug test|8|||
155334483|NCT01428583|560660104|FG000|Overall Study|Sponsor's request|3|||
155334484|NCT01428583|560660104|FG000|Overall Study|Other|6|||
155334485|NCT00768755|560660107|FG000|Phase 1|Death|6|||
155334486|NCT00768755|560660108|FG001|Phase 1|Death|0|||
155334487|NCT00768755|560660109|FG002|Phase 1|Death|0|||
155334488|NCT00768755|560660110|FG003|Phase 1|Death|0|||
155334489|NCT00768755|560660107|FG000|Phase 1|Other|4|||
155334490|NCT00768755|560660108|FG001|Phase 1|Other|0|||
155334491|NCT00768755|560660109|FG002|Phase 1|Other|0|||
155334492|NCT00768755|560660110|FG003|Phase 1|Other|0|||
155334493|NCT00768755|560660107|FG000|Phase 2|Death|0|||
155334494|NCT00768755|560660108|FG001|Phase 2|Death|37|||
155334495|NCT00768755|560660109|FG002|Phase 2|Death|48|||
155334496|NCT00768755|560660110|FG003|Phase 2|Death|31|||
155334497|NCT00768755|560660107|FG000|Phase 2|Protocol Violation|0|||
155334498|NCT00768755|560660108|FG001|Phase 2|Protocol Violation|2|||
155334499|NCT00768755|560660109|FG002|Phase 2|Protocol Violation|0|||
155334500|NCT00768755|560660110|FG003|Phase 2|Protocol Violation|1|||
155334501|NCT00768755|560660107|FG000|Phase 2|Lost to Follow-up|0|||
155334502|NCT00768755|560660108|FG001|Phase 2|Lost to Follow-up|1|||
155334503|NCT00768755|560660109|FG002|Phase 2|Lost to Follow-up|1|||
155334504|NCT00768755|560660110|FG003|Phase 2|Lost to Follow-up|4|||
155334505|NCT00768755|560660107|FG000|Phase 2|Withdrawal by Subject|0|||
155334506|NCT00768755|560660108|FG001|Phase 2|Withdrawal by Subject|1|||
155334507|NCT00768755|560660109|FG002|Phase 2|Withdrawal by Subject|0|||
155334508|NCT00768755|560660110|FG003|Phase 2|Withdrawal by Subject|1|||
155334509|NCT00768755|560660107|FG000|Phase 2|Other|0|||
155334510|NCT00768755|560660108|FG001|Phase 2|Other|1|||
155334511|NCT00768755|560660109|FG002|Phase 2|Other|2|||
155334512|NCT00768755|560660110|FG003|Phase 2|Other|4|||
155334513|NCT00768755|560660107|FG000|Phase 2|Study Terminated by Sponsor|0|||
155334514|NCT00768755|560660108|FG001|Phase 2|Study Terminated by Sponsor|13|||
155334515|NCT00768755|560660109|FG002|Phase 2|Study Terminated by Sponsor|7|||
155334516|NCT00768755|560660110|FG003|Phase 2|Study Terminated by Sponsor|14|||
155334517|NCT00768755|560660107|FG000|Phase 2|Randomized but not treated|0|||
155334518|NCT00768755|560660108|FG001|Phase 2|Randomized but not treated|0|||
155334519|NCT00768755|560660109|FG002|Phase 2|Randomized but not treated|0|||
155334520|NCT00768755|560660110|FG003|Phase 2|Randomized but not treated|2|||
155334521|NCT00670488|560660111|FG000|Overall Study|Adverse Event|0|||
155334522|NCT00670488|560660112|FG001|Overall Study|Adverse Event|7|||
155334523|NCT00670488|560660113|FG002|Overall Study|Adverse Event|0|||
155334524|NCT00670488|560660114|FG003|Overall Study|Adverse Event|3|||
155334525|NCT00670488|560660115|FG004|Overall Study|Adverse Event|1|||
155334526|NCT00670488|560660116|FG005|Overall Study|Adverse Event|1|||
155334527|NCT00670488|560660117|FG006|Overall Study|Adverse Event|5|||
155334528|NCT00670488|560660118|FG007|Overall Study|Adverse Event|1|||
155334529|NCT00670488|560660119|FG008|Overall Study|Adverse Event|0|||
155334530|NCT00670488|560660120|FG009|Overall Study|Adverse Event|1|||
155334531|NCT00670488|560660111|FG000|Overall Study|Physician Decision|1|||
155334532|NCT00670488|560660112|FG001|Overall Study|Physician Decision|9|||
155334533|NCT00670488|560660113|FG002|Overall Study|Physician Decision|0|||
155334534|NCT00670488|560660114|FG003|Overall Study|Physician Decision|1|||
155334535|NCT00670488|560660115|FG004|Overall Study|Physician Decision|0|||
155334536|NCT00670488|560660116|FG005|Overall Study|Physician Decision|0|||
155334537|NCT00670488|560660117|FG006|Overall Study|Physician Decision|0|||
155334538|NCT00670488|560660118|FG007|Overall Study|Physician Decision|0|||
155334539|NCT00670488|560660119|FG008|Overall Study|Physician Decision|0|||
155334540|NCT00670488|560660120|FG009|Overall Study|Physician Decision|0|||
155334541|NCT00670488|560660111|FG000|Overall Study|Progressive Disease|2|||
155334542|NCT00670488|560660112|FG001|Overall Study|Progressive Disease|41|||
155334543|NCT00670488|560660113|FG002|Overall Study|Progressive Disease|3|||
155334544|NCT00670488|560660114|FG003|Overall Study|Progressive Disease|2|||
155334545|NCT00670488|560660115|FG004|Overall Study|Progressive Disease|2|||
155334546|NCT00670488|560660116|FG005|Overall Study|Progressive Disease|4|||
155334547|NCT00670488|560660117|FG006|Overall Study|Progressive Disease|11|||
155334548|NCT00670488|560660118|FG007|Overall Study|Progressive Disease|2|||
155334549|NCT00670488|560660119|FG008|Overall Study|Progressive Disease|2|||
154962054|NCT01588236|559285769|FG000|Overall Study|Protocol Violation|0|||
154962055|NCT01588236|559285770|FG001|Overall Study|Protocol Violation|1|||
154962056|NCT01588236|559285771|FG002|Overall Study|Protocol Violation|1|||
155334550|NCT00670488|560660120|FG009|Overall Study|Progressive Disease|1|||
155334551|NCT00670488|560660111|FG000|Overall Study|Withdrawal by Subject|0|||
155334552|NCT00670488|560660112|FG001|Overall Study|Withdrawal by Subject|1|||
155334553|NCT00670488|560660113|FG002|Overall Study|Withdrawal by Subject|0|||
155334554|NCT00670488|560660114|FG003|Overall Study|Withdrawal by Subject|1|||
155334555|NCT00670488|560660115|FG004|Overall Study|Withdrawal by Subject|0|||
155334556|NCT00670488|560660116|FG005|Overall Study|Withdrawal by Subject|0|||
155334557|NCT00670488|560660117|FG006|Overall Study|Withdrawal by Subject|1|||
155334558|NCT00670488|560660118|FG007|Overall Study|Withdrawal by Subject|0|||
155334559|NCT00670488|560660119|FG008|Overall Study|Withdrawal by Subject|1|||
155334560|NCT00670488|560660120|FG009|Overall Study|Withdrawal by Subject|0|||
155334561|NCT00878189|560660121|FG000|Overall Study|Death|0|||
155334562|NCT00878189|560660122|FG001|Overall Study|Death|1|||
155334563|NCT00878189|560660123|FG002|Overall Study|Death|0|||
155334564|NCT00878189|560660124|FG003|Overall Study|Death|1|||
155334565|NCT00878189|560660125|FG004|Overall Study|Death|0|||
155334566|NCT00878189|560660126|FG005|Overall Study|Death|0|||
155334567|NCT00878189|560660127|FG006|Overall Study|Death|0|||
155334568|NCT00878189|560660128|FG007|Overall Study|Death|0|||
155334569|NCT00878189|560660129|FG008|Overall Study|Death|1|||
155334570|NCT00878189|560660121|FG000|Overall Study|Participant Refused to Follow-up|0|||
155334571|NCT00878189|560660122|FG001|Overall Study|Participant Refused to Follow-up|0|||
155334572|NCT00878189|560660123|FG002|Overall Study|Participant Refused to Follow-up|0|||
155334573|NCT00878189|560660124|FG003|Overall Study|Participant Refused to Follow-up|0|||
155334574|NCT00878189|560660125|FG004|Overall Study|Participant Refused to Follow-up|0|||
155334575|NCT00878189|560660126|FG005|Overall Study|Participant Refused to Follow-up|4|||
155334576|NCT00878189|560660127|FG006|Overall Study|Participant Refused to Follow-up|0|||
155334577|NCT00878189|560660128|FG007|Overall Study|Participant Refused to Follow-up|0|||
155334578|NCT00878189|560660129|FG008|Overall Study|Participant Refused to Follow-up|0|||
155334579|NCT00878189|560660121|FG000|Overall Study|Other|3|||
155334580|NCT00878189|560660122|FG001|Overall Study|Other|2|||
155334581|NCT00878189|560660123|FG002|Overall Study|Other|4|||
155334582|NCT00878189|560660124|FG003|Overall Study|Other|7|||
155334583|NCT00878189|560660125|FG004|Overall Study|Other|4|||
154962057|NCT01588236|559285769|FG000|Overall Study|Withdrawal by Subject|14|||
154962058|NCT01588236|559285770|FG001|Overall Study|Withdrawal by Subject|16|||
155334584|NCT00878189|560660126|FG005|Overall Study|Other|18|||
155334585|NCT00878189|560660127|FG006|Overall Study|Other|15|||
155334586|NCT00878189|560660128|FG007|Overall Study|Other|3|||
155334587|NCT00878189|560660129|FG008|Overall Study|Other|4|||
155334588|NCT00878189|560660121|FG000|Overall Study|Lost to Follow-up|0|||
155334589|NCT00878189|560660122|FG001|Overall Study|Lost to Follow-up|0|||
155334590|NCT00878189|560660123|FG002|Overall Study|Lost to Follow-up|0|||
155334591|NCT00878189|560660124|FG003|Overall Study|Lost to Follow-up|0|||
155334592|NCT00878189|560660125|FG004|Overall Study|Lost to Follow-up|0|||
155334593|NCT00878189|560660126|FG005|Overall Study|Lost to Follow-up|1|||
155334594|NCT00878189|560660127|FG006|Overall Study|Lost to Follow-up|1|||
155334595|NCT00878189|560660128|FG007|Overall Study|Lost to Follow-up|0|||
155334596|NCT00878189|560660129|FG008|Overall Study|Lost to Follow-up|0|||
155334597|NCT00878189|560660121|FG000|Overall Study|Objection Progression or Relapse|0|||
155334598|NCT00878189|560660122|FG001|Overall Study|Objection Progression or Relapse|0|||
155334599|NCT00878189|560660123|FG002|Overall Study|Objection Progression or Relapse|0|||
155334600|NCT00878189|560660124|FG003|Overall Study|Objection Progression or Relapse|0|||
155334601|NCT00878189|560660125|FG004|Overall Study|Objection Progression or Relapse|0|||
155334602|NCT00878189|560660126|FG005|Overall Study|Objection Progression or Relapse|0|||
155334603|NCT00878189|560660127|FG006|Overall Study|Objection Progression or Relapse|0|||
155334604|NCT00878189|560660128|FG007|Overall Study|Objection Progression or Relapse|0|||
155334605|NCT00878189|560660129|FG008|Overall Study|Objection Progression or Relapse|3|||
155334606|NCT04693637|560660130|FG000|Overall Study|Death|4|||
155334607|NCT04693637|560660130|FG000|Overall Study|Withdrawal by Subject|3|||
155334608|NCT04693637|560660130|FG000|Overall Study|Physician Decision|2|||
155334609|NCT04693637|560660130|FG000|Overall Study|Lost to Follow-up|1|||
155334610|NCT04237792|560660131|FG000|Treatment (Day 1)|Adverse Event|1|||
155334611|NCT04237792|560660132|FG001|Treatment (Day 1)|Adverse Event|0|||
155334612|NCT04237792|560660133|FG002|Treatment (Day 1)|Adverse Event|0|||
155334613|NCT04237792|560660134|FG003|Treatment (Day 1)|Adverse Event|0|||
155334614|NCT04237792|560660135|FG004|Treatment (Day 1)|Adverse Event|1|||
155334615|NCT04237792|560660136|FG005|Treatment (Day 1)|Adverse Event|1|||
155334616|NCT04237792|560660131|FG000|Treatment (Day 1)|Other|0|||
155334617|NCT04237792|560660132|FG001|Treatment (Day 1)|Other|0|||
155334618|NCT04237792|560660133|FG002|Treatment (Day 1)|Other|1|||
155334619|NCT04237792|560660134|FG003|Treatment (Day 1)|Other|0|||
155334620|NCT04237792|560660135|FG004|Treatment (Day 1)|Other|0|||
155334621|NCT04237792|560660136|FG005|Treatment (Day 1)|Other|1|||
155334622|NCT04237792|560660131|FG000|Treatment (Day 1)|Not treated|1|||
155334623|NCT04237792|560660132|FG001|Treatment (Day 1)|Not treated|1|||
155334624|NCT04237792|560660133|FG002|Treatment (Day 1)|Not treated|2|||
155334625|NCT04237792|560660134|FG003|Treatment (Day 1)|Not treated|1|||
155334626|NCT04237792|560660135|FG004|Treatment (Day 1)|Not treated|0|||
155334627|NCT04237792|560660136|FG005|Treatment (Day 1)|Not treated|1|||
155334628|NCT04885998|560660137|FG000|Overall Study|Withdrawal by Subject|0|||
155334629|NCT04885998|560660138|FG001|Overall Study|Withdrawal by Subject|2|||
155334630|NCT04885998|560660139|FG002|Overall Study|Withdrawal by Subject|0|||
155334631|NCT04885998|560660140|FG003|Overall Study|Withdrawal by Subject|3|||
155334632|NCT04885998|560660137|FG000|Overall Study|Lost to Follow-up|1|||
155334633|NCT04885998|560660138|FG001|Overall Study|Lost to Follow-up|1|||
155334634|NCT04885998|560660139|FG002|Overall Study|Lost to Follow-up|0|||
155334635|NCT04885998|560660140|FG003|Overall Study|Lost to Follow-up|0|||
155334636|NCT04885998|560660137|FG000|Overall Study|Death|2|||
155334637|NCT04885998|560660138|FG001|Overall Study|Death|1|||
155334638|NCT04885998|560660139|FG002|Overall Study|Death|2|||
155334639|NCT04885998|560660140|FG003|Overall Study|Death|2|||
155334640|NCT04885998|560660137|FG000|Overall Study|Decision by sponsor|1|||
155334641|NCT04885998|560660138|FG001|Overall Study|Decision by sponsor|1|||
155334642|NCT04885998|560660139|FG002|Overall Study|Decision by sponsor|0|||
154962059|NCT01588236|559285771|FG002|Overall Study|Withdrawal by Subject|18|||
155334643|NCT04885998|560660140|FG003|Overall Study|Decision by sponsor|0|||
155334644|NCT05260437|560660141|FG000|Overall Study|Lost to Follow-up|5|||
155334645|NCT05260437|560660142|FG001|Overall Study|Lost to Follow-up|2|||
155334646|NCT05260437|560660143|FG002|Overall Study|Lost to Follow-up|1|||
155334647|NCT05260437|560660144|FG003|Overall Study|Lost to Follow-up|2|||
155334648|NCT05260437|560660145|FG004|Overall Study|Lost to Follow-up|2|||
155334649|NCT05260437|560660141|FG000|Overall Study|Withdrawal by Subject|3|||
155334650|NCT05260437|560660142|FG001|Overall Study|Withdrawal by Subject|0|||
155334651|NCT05260437|560660143|FG002|Overall Study|Withdrawal by Subject|4|||
155334652|NCT05260437|560660144|FG003|Overall Study|Withdrawal by Subject|5|||
155334653|NCT05260437|560660145|FG004|Overall Study|Withdrawal by Subject|0|||
155334654|NCT05260437|560660141|FG000|Overall Study|Vaccine Not Administered|0|||
155334655|NCT05260437|560660142|FG001|Overall Study|Vaccine Not Administered|1|||
155334656|NCT05260437|560660143|FG002|Overall Study|Vaccine Not Administered|0|||
155334657|NCT05260437|560660144|FG003|Overall Study|Vaccine Not Administered|0|||
155334658|NCT05260437|560660145|FG004|Overall Study|Vaccine Not Administered|0|||
155334659|NCT00910962|560660146|FG000|Overall Study|Adverse Event|5|||
155334660|NCT00910962|560660147|FG001|Overall Study|Adverse Event|20|||
155071519|NCT01202591|559690762|FG003|Overall Study|Objective Disease Progression|0|||
155071520|NCT01202591|559690763|FG004|Overall Study|Objective Disease Progression|2|||
155071521|NCT01202591|559690764|FG005|Overall Study|Objective Disease Progression|0|||
155071522|NCT00191100|559690765|FG000|Overall Study|Adverse Event|18|||
155071523|NCT00191100|559690766|FG001|Overall Study|Adverse Event|1|||
155071524|NCT00191100|559690765|FG000|Overall Study|Lost to Follow-up|2|||
155071525|NCT00191100|559690766|FG001|Overall Study|Lost to Follow-up|0|||
155071526|NCT00191100|559690765|FG000|Overall Study|Patient Moved|0|||
155071527|NCT00191100|559690766|FG001|Overall Study|Patient Moved|1|||
155071528|NCT00191100|559690765|FG000|Overall Study|Withdrawal by Subject|9|||
155071529|NCT00191100|559690766|FG001|Overall Study|Withdrawal by Subject|3|||
155071530|NCT00191100|559690765|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
155071531|NCT00191100|559690766|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
155071532|NCT00191100|559690765|FG000|Overall Study|Clinical Relapse|2|||
155071533|NCT00191100|559690766|FG001|Overall Study|Clinical Relapse|1|||
155071534|NCT00191100|559690765|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
155071535|NCT00191100|559690766|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
155071536|NCT00191100|559690765|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
155071537|NCT00191100|559690766|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
155071538|NCT00191100|559690765|FG000|Overall Study|Physician Decision|3|||
155071539|NCT00191100|559690766|FG001|Overall Study|Physician Decision|1|||
155071540|NCT00191100|559690765|FG000|Overall Study|Death from Study Drug Toxicity|2|||
155071541|NCT00191100|559690766|FG001|Overall Study|Death from Study Drug Toxicity|0|||
155071542|NCT00191100|559690765|FG000|Overall Study|Protocol Violation|1|||
155071543|NCT00191100|559690766|FG001|Overall Study|Protocol Violation|1|||
155071544|NCT00191100|559690765|FG000|Overall Study|Death from Other Cause|1|||
155071545|NCT00191100|559690766|FG001|Overall Study|Death from Other Cause|0|||
155071546|NCT00191100|559690765|FG000|Overall Study|Reason Not Specified|0|||
155071547|NCT00191100|559690766|FG001|Overall Study|Reason Not Specified|1|||
155071548|NCT02872714|559690771|FG000|Overall Study|Progressive Disease|1|||
155071549|NCT02872714|559690772|FG001|Overall Study|Progressive Disease|2|||
155071550|NCT02872714|559690773|FG002|Overall Study|Progressive Disease|0|||
155071551|NCT02872714|559690774|FG003|Overall Study|Progressive Disease|0|||
155071552|NCT02872714|559690775|FG004|Overall Study|Progressive Disease|0|||
155071553|NCT02872714|559690771|FG000|Overall Study|Death|87|||
155071554|NCT02872714|559690772|FG001|Overall Study|Death|36|||
155071555|NCT02872714|559690773|FG002|Overall Study|Death|8|||
155071556|NCT02872714|559690774|FG003|Overall Study|Death|81|||
155071557|NCT02872714|559690775|FG004|Overall Study|Death|2|||
155071558|NCT02872714|559690771|FG000|Overall Study|Lost to Follow-up|2|||
155071559|NCT02872714|559690772|FG001|Overall Study|Lost to Follow-up|1|||
155071560|NCT02872714|559690773|FG002|Overall Study|Lost to Follow-up|0|||
155071561|NCT02872714|559690774|FG003|Overall Study|Lost to Follow-up|3|||
155071562|NCT02872714|559690775|FG004|Overall Study|Lost to Follow-up|0|||
155071563|NCT02872714|559690771|FG000|Overall Study|Physician Decision|0|||
155071564|NCT02872714|559690772|FG001|Overall Study|Physician Decision|0|||
155071565|NCT02872714|559690773|FG002|Overall Study|Physician Decision|0|||
155334661|NCT00910962|560660148|FG002|Overall Study|Adverse Event|17|||
155334662|NCT00910962|560660146|FG000|Overall Study|Protocol Violation|1|||
155334663|NCT00910962|560660147|FG001|Overall Study|Protocol Violation|3|||
155334664|NCT00910962|560660148|FG002|Overall Study|Protocol Violation|3|||
155334665|NCT00910962|560660146|FG000|Overall Study|Lost to Follow-up|0|||
155334666|NCT00910962|560660147|FG001|Overall Study|Lost to Follow-up|3|||
155071566|NCT02872714|559690774|FG003|Overall Study|Physician Decision|1|||
155071567|NCT02872714|559690775|FG004|Overall Study|Physician Decision|0|||
155071568|NCT02872714|559690771|FG000|Overall Study|Withdrawal by Subject|1|||
155071569|NCT02872714|559690772|FG001|Overall Study|Withdrawal by Subject|3|||
155071570|NCT02872714|559690773|FG002|Overall Study|Withdrawal by Subject|0|||
155334667|NCT00910962|560660148|FG002|Overall Study|Lost to Follow-up|1|||
155334668|NCT00910962|560660146|FG000|Overall Study|Physician Decision|0|||
155071571|NCT02872714|559690774|FG003|Overall Study|Withdrawal by Subject|2|||
155071572|NCT02872714|559690775|FG004|Overall Study|Withdrawal by Subject|0|||
155334669|NCT00910962|560660147|FG001|Overall Study|Physician Decision|6|||
155334670|NCT00910962|560660148|FG002|Overall Study|Physician Decision|6|||
155071573|NCT02872714|559690771|FG000|Overall Study|Captured as Other|2|||
155071574|NCT02872714|559690772|FG001|Overall Study|Captured as Other|0|||
155071575|NCT02872714|559690773|FG002|Overall Study|Captured as Other|0|||
155071576|NCT02872714|559690774|FG003|Overall Study|Captured as Other|1|||
155071577|NCT02872714|559690775|FG004|Overall Study|Captured as Other|0|||
155071578|NCT00479232|559691859|FG000|Overall Study|Adverse Event|0|||
155071579|NCT00479232|559691860|FG001|Overall Study|Adverse Event|0|||
155071580|NCT00479232|559691861|FG002|Overall Study|Adverse Event|5|||
155071581|NCT00479232|559691862|FG003|Overall Study|Adverse Event|0|||
155071582|NCT00479232|559691863|FG004|Overall Study|Adverse Event|0|||
155071583|NCT00479232|559691864|FG005|Overall Study|Adverse Event|10|||
155071584|NCT00479232|559691859|FG000|Overall Study|Deviation from Protocol|0|||
155071585|NCT00479232|559691860|FG001|Overall Study|Deviation from Protocol|0|||
155071586|NCT00479232|559691861|FG002|Overall Study|Deviation from Protocol|1|||
155071587|NCT00479232|559691862|FG003|Overall Study|Deviation from Protocol|0|||
155071588|NCT00479232|559691863|FG004|Overall Study|Deviation from Protocol|0|||
155071589|NCT00479232|559691864|FG005|Overall Study|Deviation from Protocol|0|||
155071590|NCT00479232|559691859|FG000|Overall Study|Lack of Efficacy|0|||
155334671|NCT00910962|560660146|FG000|Overall Study|Withdrawal by Subject|25|||
155334672|NCT00910962|560660147|FG001|Overall Study|Withdrawal by Subject|32|||
155334673|NCT00910962|560660148|FG002|Overall Study|Withdrawal by Subject|32|||
155334674|NCT00910962|560660146|FG000|Overall Study|Reached defined stopping criteria|12|||
155334675|NCT00910962|560660147|FG001|Overall Study|Reached defined stopping criteria|14|||
155334676|NCT00910962|560660148|FG002|Overall Study|Reached defined stopping criteria|17|||
155334677|NCT00195819|560660149|FG000|Double-Blind|Withdrawal by Subject|1|||
155334678|NCT00195819|560660150|FG001|Double-Blind|Withdrawal by Subject|0|||
155334679|NCT00195819|560660149|FG000|Double-Blind|Moved|1|||
155334680|NCT00195819|560660150|FG001|Double-Blind|Moved|0|||
155334681|NCT00195819|560660149|FG000|Open-label|Adverse Event|0|||
155071591|NCT00479232|559691860|FG001|Overall Study|Lack of Efficacy|0|||
155163786|NCT02374450|560035080|FG001|Overall Study|Migrated from the study area|648|||
155334682|NCT00195819|560660150|FG001|Open-label|Adverse Event|9|||
155334683|NCT00195819|560660149|FG000|Open-label|Lack of Efficacy|0|||
155334684|NCT00195819|560660150|FG001|Open-label|Lack of Efficacy|2|||
155334685|NCT00195819|560660149|FG000|Open-label|Pregnancy|0|||
155071592|NCT00479232|559691861|FG002|Overall Study|Lack of Efficacy|2|||
155071593|NCT00479232|559691862|FG003|Overall Study|Lack of Efficacy|0|||
155334686|NCT00195819|560660150|FG001|Open-label|Pregnancy|1|||
155334687|NCT00195819|560660149|FG000|Open-label|Protocol Violation|0|||
155334688|NCT00195819|560660150|FG001|Open-label|Protocol Violation|2|||
155334689|NCT00195819|560660149|FG000|Open-label|Moved|0|||
155334690|NCT00195819|560660150|FG001|Open-label|Moved|1|||
155334691|NCT00195819|560660149|FG000|Open-label|Withdrawal by Subject|0|||
155334692|NCT00195819|560660150|FG001|Open-label|Withdrawal by Subject|5|||
155334693|NCT00787176|560660151|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
155334694|NCT00787176|560660152|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
155334695|NCT00787176|560660153|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
155334696|NCT00787176|560660154|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
155334697|NCT01124045|560660155|FG000|Overall Study|Lost to Follow-up|0|||
155334698|NCT01124045|560660156|FG001|Overall Study|Lost to Follow-up|1|||
155334699|NCT01124045|560660155|FG000|Overall Study|Physician Decision|0|||
155334700|NCT01124045|560660156|FG001|Overall Study|Physician Decision|2|||
155334701|NCT03057600|560660160|FG000|Overall Study|Adverse Event|0|||
155334702|NCT03057600|560660161|FG001|Overall Study|Adverse Event|0|||
155334703|NCT03057600|560660162|FG002|Overall Study|Adverse Event|4|||
155334704|NCT03057600|560660163|FG003|Overall Study|Adverse Event|0|||
155334705|NCT03057600|560660160|FG000|Overall Study|Radiologic Disease Progression|8|||
155334706|NCT03057600|560660161|FG001|Overall Study|Radiologic Disease Progression|7|||
155334707|NCT03057600|560660162|FG002|Overall Study|Radiologic Disease Progression|13|||
155334708|NCT03057600|560660163|FG003|Overall Study|Radiologic Disease Progression|10|||
155334709|NCT03057600|560660160|FG000|Overall Study|Symptomatic Deterioration|0|||
155071594|NCT00479232|559691863|FG004|Overall Study|Lack of Efficacy|0|||
155334710|NCT03057600|560660161|FG001|Overall Study|Symptomatic Deterioration|1|||
155334711|NCT03057600|560660162|FG002|Overall Study|Symptomatic Deterioration|1|||
155334712|NCT03057600|560660163|FG003|Overall Study|Symptomatic Deterioration|0|||
155334713|NCT03057600|560660160|FG000|Overall Study|Investigator Decision|0|||
155334714|NCT03057600|560660161|FG001|Overall Study|Investigator Decision|0|||
155334715|NCT03057600|560660162|FG002|Overall Study|Investigator Decision|1|||
155334716|NCT03057600|560660163|FG003|Overall Study|Investigator Decision|0|||
155334717|NCT03057600|560660160|FG000|Overall Study|Study Termination by Sponsor|0|||
155334718|NCT03057600|560660161|FG001|Overall Study|Study Termination by Sponsor|0|||
155334719|NCT03057600|560660162|FG002|Overall Study|Study Termination by Sponsor|0|||
155334720|NCT03057600|560660163|FG003|Overall Study|Study Termination by Sponsor|2|||
155334721|NCT03057600|560660160|FG000|Overall Study|Withdrawal by Subject|0|||
155334722|NCT03057600|560660161|FG001|Overall Study|Withdrawal by Subject|1|||
155334723|NCT03057600|560660162|FG002|Overall Study|Withdrawal by Subject|0|||
155334724|NCT03057600|560660163|FG003|Overall Study|Withdrawal by Subject|0|||
155334725|NCT03057600|560660160|FG000|Overall Study|Other, Not Specified|1|||
155334726|NCT03057600|560660161|FG001|Overall Study|Other, Not Specified|1|||
155334727|NCT03057600|560660162|FG002|Overall Study|Other, Not Specified|1|||
155334728|NCT03057600|560660163|FG003|Overall Study|Other, Not Specified|1|||
155334729|NCT02022670|560660168|FG000|Overall Study|Adverse Event|1|||
155334730|NCT02022670|560660169|FG001|Overall Study|Adverse Event|0|||
155334731|NCT02022670|560660170|FG002|Overall Study|Adverse Event|1|||
155334732|NCT02113449|560660171|FG000|Overall Study|Adverse Event|4|||
155334733|NCT04638816|560660172|FG000|Overall Study|Withdrawal by Subject|0|||
155334734|NCT04638816|560660173|FG001|Overall Study|Withdrawal by Subject|1|||
155334735|NCT04638816|560660172|FG000|Overall Study|Lost to Follow-up|0|||
155334736|NCT04638816|560660173|FG001|Overall Study|Lost to Follow-up|1|||
155334737|NCT01328496|560660176|FG000|Overall Study|Significant Change in Health Status|1|||
155334738|NCT01328496|560660177|FG001|Overall Study|Significant Change in Health Status|0|||
155334739|NCT02208843|560660180|FG000|Overall Study|Clinical symptoms of progression|2|||
155334740|NCT02208843|560660180|FG000|Overall Study|Progression disease according to RECIST|24|||
155334741|NCT02208843|560660180|FG000|Overall Study|Adverse Event|12|||
155334742|NCT02208843|560660180|FG000|Overall Study|Protocol Violation|1|||
155334743|NCT02208843|560660180|FG000|Overall Study|Withdrawal by Subject|1|||
155334744|NCT02208843|560660180|FG000|Overall Study|Switched to commercial afatinib|20|||
155334745|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
155071595|NCT00479232|559691864|FG005|Overall Study|Lack of Efficacy|4|||
155071596|NCT00479232|559691859|FG000|Overall Study|Physician Decision|0|||
155071597|NCT00479232|559691860|FG001|Overall Study|Physician Decision|0|||
155071598|NCT00479232|559691861|FG002|Overall Study|Physician Decision|2|||
155071599|NCT00479232|559691862|FG003|Overall Study|Physician Decision|0|||
155334746|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
155334747|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
155334748|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
155334749|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
155334750|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
155334751|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
155334752|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
155071600|NCT00479232|559691863|FG004|Overall Study|Physician Decision|0|||
155071601|NCT00479232|559691864|FG005|Overall Study|Physician Decision|1|||
155334753|NCT03822832|560660185|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
155334754|NCT03822832|560660186|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
155334755|NCT03822832|560660185|FG000|Re-allocation|Not re-allocated to open label period|2|||
155334756|NCT03822832|560660186|FG001|Re-allocation|Not re-allocated to open label period|6|||
155334757|NCT03822832|560660185|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
155334758|NCT03822832|560660186|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
155334759|NCT03822832|560660185|FG000|Period 2 - Open Label Period|Adverse Event|0|||
155334760|NCT03822832|560660186|FG001|Period 2 - Open Label Period|Adverse Event|3|||
155334761|NCT00243867|560660187|FG000|Overall Study|Adverse Event|24|||
155071602|NCT00479232|559691859|FG000|Overall Study|Progressive Disease|3|||
155071603|NCT00479232|559691860|FG001|Overall Study|Progressive Disease|1|||
155071604|NCT00479232|559691861|FG002|Overall Study|Progressive Disease|12|||
155071605|NCT00479232|559691862|FG003|Overall Study|Progressive Disease|3|||
155071606|NCT00479232|559691863|FG004|Overall Study|Progressive Disease|3|||
155071607|NCT00479232|559691864|FG005|Overall Study|Progressive Disease|12|||
155071608|NCT00479232|559691859|FG000|Overall Study|Withdrew Consent|0|||
155071609|NCT00479232|559691860|FG001|Overall Study|Withdrew Consent|2|||
155071610|NCT00479232|559691861|FG002|Overall Study|Withdrew Consent|6|||
155071611|NCT00479232|559691862|FG003|Overall Study|Withdrew Consent|0|||
155071612|NCT00479232|559691863|FG004|Overall Study|Withdrew Consent|1|||
155071613|NCT00479232|559691864|FG005|Overall Study|Withdrew Consent|3|||
155071614|NCT05399771|559691865|FG000|Overall Study|Physician Decision|3|||
155071615|NCT05399771|559691865|FG000|Overall Study|Adverse Event|1|||
155071616|NCT00541229|559691870|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
155071617|NCT00541229|559691871|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
155071618|NCT00541229|559691872|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
155071619|NCT00541229|559691873|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
155071620|NCT00541229|559691874|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
155071621|NCT00541229|559691875|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
155071622|NCT00541229|559691870|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155071623|NCT00541229|559691871|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155071624|NCT00541229|559691872|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155071625|NCT00541229|559691873|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155071626|NCT00541229|559691874|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
155071627|NCT00541229|559691875|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
155071628|NCT00541229|559691870|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155071629|NCT00541229|559691871|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155071630|NCT00541229|559691872|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155071631|NCT00541229|559691873|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155071632|NCT00541229|559691874|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
155071633|NCT00541229|559691875|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
155071634|NCT00541229|559691870|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
155071635|NCT00541229|559691871|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
155071636|NCT00541229|559691872|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
155071637|NCT00541229|559691873|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
155163787|NCT02374450|560035081|FG002|Overall Study|Migrated from the study area|181|||
155071638|NCT00541229|559691874|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
155071639|NCT00541229|559691875|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
155071640|NCT00541229|559691870|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
155071641|NCT00541229|559691871|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
155071642|NCT00541229|559691872|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
155071643|NCT00541229|559691873|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
155334762|NCT00243867|560660188|FG001|Overall Study|Adverse Event|34|||
155071644|NCT00541229|559691874|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
155071645|NCT00541229|559691875|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
155071646|NCT00541229|559691870|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
155071647|NCT00541229|559691871|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
155071648|NCT00541229|559691872|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
155071649|NCT00541229|559691873|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
155071650|NCT00541229|559691874|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
155071651|NCT00541229|559691875|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
155071652|NCT00541229|559691870|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
155071653|NCT00541229|559691871|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
155071654|NCT00541229|559691872|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
155071655|NCT00541229|559691873|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
155071656|NCT00541229|559691874|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
155071657|NCT00541229|559691875|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
155071658|NCT00541229|559691870|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
155071659|NCT00541229|559691871|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
154962060|NCT01588236|559285769|FG000|Overall Study|Exclusion Criteria met during study|2|||
154962061|NCT01588236|559285770|FG001|Overall Study|Exclusion Criteria met during study|1|||
154962062|NCT01588236|559285771|FG002|Overall Study|Exclusion Criteria met during study|0|||
154962063|NCT01588236|559285769|FG000|Overall Study|sponsor decision|1|||
154962064|NCT01588236|559285770|FG001|Overall Study|sponsor decision|6|||
154962065|NCT01588236|559285771|FG002|Overall Study|sponsor decision|2|||
154962066|NCT03873272|559285772|FG000|Overall Study|Withdrawal by Subject|2|||
154962067|NCT03873272|559285773|FG001|Overall Study|Withdrawal by Subject|0|||
154962068|NCT03873272|559285774|FG002|Overall Study|Withdrawal by Subject|1|||
154962069|NCT03873272|559285772|FG000|Overall Study|Death|0|||
154962070|NCT03873272|559285773|FG001|Overall Study|Death|2|||
154962071|NCT03873272|559285774|FG002|Overall Study|Death|1|||
154962072|NCT00787254|559285775|FG000|Overall Study|Adverse Event|24|||
154962073|NCT00787254|559285776|FG001|Overall Study|Adverse Event|23|||
154962074|NCT00787254|559285775|FG000|Overall Study|Protocol Violation|26|||
154962075|NCT00787254|559285776|FG001|Overall Study|Protocol Violation|23|||
154962076|NCT00787254|559285775|FG000|Overall Study|Withdrawal by Subject|16|||
154962077|NCT00787254|559285776|FG001|Overall Study|Withdrawal by Subject|11|||
154962078|NCT00787254|559285775|FG000|Overall Study|Lack of Efficacy|4|||
154962079|NCT00787254|559285776|FG001|Overall Study|Lack of Efficacy|15|||
154962080|NCT00787254|559285775|FG000|Overall Study|NSAIDs discontinuation|1|||
154962081|NCT00787254|559285776|FG001|Overall Study|NSAIDs discontinuation|2|||
154962082|NCT00787254|559285775|FG000|Overall Study|Institution closed|1|||
154962083|NCT00787254|559285776|FG001|Overall Study|Institution closed|0|||
154962084|NCT00787254|559285775|FG000|Overall Study|Physician Decision|4|||
154962085|NCT00787254|559285776|FG001|Overall Study|Physician Decision|8|||
154962086|NCT03761173|559285781|FG000|Overall Study|Lost to Follow-up|93|||
154962087|NCT03761173|559285781|FG000|Overall Study|Withdrawal by Subject|74|||
154962088|NCT03761173|559285781|FG000|Overall Study|Death|45|||
154962089|NCT03761173|559285781|FG000|Overall Study|Withdrawal for Other Reasons|29|||
154962090|NCT03761173|559285781|FG000|Overall Study|Protocol Violation|1|||
154962091|NCT00316186|559285782|FG000|Overall Study|Adverse Event|6|||
154962092|NCT00316186|559285782|FG000|Overall Study|Disease Progression|4|||
154962093|NCT00316186|559285782|FG000|Overall Study|Lost to Follow-up|1|||
154962094|NCT00316186|559285782|FG000|Overall Study|Other|1|||
154962095|NCT00859430|559285784|FG000|First Intervention|Withdrawal by Subject|0|||
154962096|NCT00859430|559285785|FG001|First Intervention|Withdrawal by Subject|1|||
154962097|NCT00834522|559287846|FG000|Washout|Adverse Event|1|||
154962098|NCT00834522|559287847|FG001|Washout|Adverse Event|0|||
154962099|NCT00834522|559287846|FG000|Washout|Withdrawal by Subject|2|||
154962100|NCT00834522|559287847|FG001|Washout|Withdrawal by Subject|1|||
154962101|NCT03128723|559287858|FG000|Overall Study|Withdrawal by Subject|2|||
155071660|NCT00541229|559691872|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
155071661|NCT00541229|559691873|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
155334763|NCT00243867|560660187|FG000|Overall Study|Lack of Efficacy|115|||
155334764|NCT00243867|560660188|FG001|Overall Study|Lack of Efficacy|78|||
155334765|NCT00243867|560660187|FG000|Overall Study|Withdrawal by Subject|11|||
155334766|NCT00243867|560660188|FG001|Overall Study|Withdrawal by Subject|23|||
155334767|NCT00243867|560660187|FG000|Overall Study|Lost to Follow-up|2|||
155334768|NCT00243867|560660188|FG001|Overall Study|Lost to Follow-up|1|||
155334769|NCT00243867|560660187|FG000|Overall Study|Physician Decision|2|||
155334770|NCT00243867|560660188|FG001|Overall Study|Physician Decision|7|||
155334771|NCT00243867|560660187|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
155334772|NCT00243867|560660188|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
155071662|NCT00541229|559691874|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
155071663|NCT00541229|559691875|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
155071664|NCT00541229|559691870|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
155071665|NCT00541229|559691871|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
155071666|NCT00541229|559691872|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
155071667|NCT00541229|559691873|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
155071668|NCT00541229|559691874|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
155071669|NCT00541229|559691875|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
155071670|NCT00541229|559691870|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
154962102|NCT00673660|559287860|FG000|Overall Study|Lost to Follow-up|107|||
154962103|NCT00123734|559287861|FG000|Overall Study|Death|3|||
154962104|NCT00123734|559287861|FG000|Overall Study|Lost to Follow-up|3|||
154962105|NCT00123734|559287861|FG000|Overall Study|Dropout|1|||
154962106|NCT00123734|559287861|FG000|Overall Study|Withdrawal by Subject|1|||
154962107|NCT00113386|559287862|FG000|Overall Study|Withdrawal by Subject|1|||
154962108|NCT00113386|559287863|FG001|Overall Study|Withdrawal by Subject|0|||
154962109|NCT00113386|559287862|FG000|Overall Study|Physician Decision|0|||
154962110|NCT00113386|559287863|FG001|Overall Study|Physician Decision|1|||
154962111|NCT00113386|559287862|FG000|Overall Study|Toxicity|3|||
154962112|NCT00113386|559287863|FG001|Overall Study|Toxicity|0|||
155071671|NCT00541229|559691871|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155071672|NCT00541229|559691872|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155071673|NCT00541229|559691873|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155071674|NCT00541229|559691874|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
155334773|NCT04248803|560660199|FG000|Overall Study|Lost to Follow-up|7|||
155334774|NCT04248803|560660200|FG001|Overall Study|Lost to Follow-up|7|||
155334775|NCT04248803|560660201|FG002|Overall Study|Lost to Follow-up|7|||
155334776|NCT04248803|560660202|FG003|Overall Study|Lost to Follow-up|7|||
155334777|NCT04248803|560660203|FG004|Overall Study|Lost to Follow-up|7|||
155334778|NCT04248803|560660204|FG005|Overall Study|Lost to Follow-up|7|||
155334779|NCT05352230|560660205|FG000|First Intervention (3 Months)|study terminated|2|||
155334780|NCT05352230|560660206|FG001|First Intervention (3 Months)|study terminated|2|||
155334781|NCT04399837|560660207|FG000|Overall Study|Other than listed|0|||
155334782|NCT04399837|560660208|FG001|Overall Study|Other than listed|2|||
155334783|NCT04399837|560660209|FG002|Overall Study|Other than listed|2|||
155334784|NCT04399837|560660210|FG003|Overall Study|Other than listed|3|||
155334785|NCT04399837|560660207|FG000|Overall Study|Withdrawal by Subject|1|||
155334786|NCT04399837|560660208|FG001|Overall Study|Withdrawal by Subject|2|||
155334787|NCT04399837|560660209|FG002|Overall Study|Withdrawal by Subject|1|||
155334788|NCT04399837|560660210|FG003|Overall Study|Withdrawal by Subject|1|||
155334789|NCT02060487|560660211|FG000|Overall Study|Other|1|||
155334790|NCT02060487|560660212|FG001|Overall Study|Other|2|||
155334791|NCT02060487|560660213|FG002|Overall Study|Other|1|||
155334792|NCT02060487|560660211|FG000|Overall Study|Lack of Efficacy|0|||
155334793|NCT02060487|560660212|FG001|Overall Study|Lack of Efficacy|1|||
155334794|NCT02060487|560660213|FG002|Overall Study|Lack of Efficacy|0|||
155334795|NCT02060487|560660211|FG000|Overall Study|Withdrawal by Subject|3|||
155334796|NCT02060487|560660212|FG001|Overall Study|Withdrawal by Subject|10|||
155334797|NCT02060487|560660213|FG002|Overall Study|Withdrawal by Subject|4|||
155334798|NCT02060487|560660211|FG000|Overall Study|Study Terminated By Sponsor|87|||
155334799|NCT02060487|560660212|FG001|Overall Study|Study Terminated By Sponsor|89|||
155334800|NCT02060487|560660213|FG002|Overall Study|Study Terminated By Sponsor|100|||
155334801|NCT02060487|560660211|FG000|Overall Study|Randomized in error|1|||
155334802|NCT02060487|560660212|FG001|Overall Study|Randomized in error|0|||
155334803|NCT02060487|560660213|FG002|Overall Study|Randomized in error|0|||
155334804|NCT02060487|560660211|FG000|Overall Study|Protocol Violation|0|||
155334805|NCT02060487|560660212|FG001|Overall Study|Protocol Violation|1|||
155334806|NCT02060487|560660213|FG002|Overall Study|Protocol Violation|1|||
155334807|NCT02060487|560660211|FG000|Overall Study|Lost to Follow-up|3|||
155334808|NCT02060487|560660212|FG001|Overall Study|Lost to Follow-up|0|||
155334809|NCT02060487|560660213|FG002|Overall Study|Lost to Follow-up|2|||
155334810|NCT02060487|560660211|FG000|Overall Study|Death|34|||
155334811|NCT02060487|560660212|FG001|Overall Study|Death|25|||
155334812|NCT02060487|560660213|FG002|Overall Study|Death|19|||
155334813|NCT02060487|560660211|FG000|Overall Study|Adverse Event|0|||
155334814|NCT02060487|560660212|FG001|Overall Study|Adverse Event|0|||
155334815|NCT02060487|560660213|FG002|Overall Study|Adverse Event|1|||
155334816|NCT03697603|560660214|FG000|Overall Study|Adverse Event|3|||
155334817|NCT03697603|560660215|FG001|Overall Study|Adverse Event|18|||
155334818|NCT03697603|560660216|FG002|Overall Study|Adverse Event|3|||
155334819|NCT03697603|560660214|FG000|Overall Study|Physician Decision|1|||
155334820|NCT03697603|560660215|FG001|Overall Study|Physician Decision|0|||
155334821|NCT03697603|560660216|FG002|Overall Study|Physician Decision|2|||
155334822|NCT03697603|560660214|FG000|Overall Study|Protocol Violation|3|||
155334823|NCT03697603|560660215|FG001|Overall Study|Protocol Violation|8|||
155334824|NCT03697603|560660216|FG002|Overall Study|Protocol Violation|5|||
155334825|NCT03697603|560660214|FG000|Overall Study|Withdrawal by Subject|5|||
155334826|NCT03697603|560660215|FG001|Overall Study|Withdrawal by Subject|1|||
155334827|NCT03697603|560660216|FG002|Overall Study|Withdrawal by Subject|1|||
155334828|NCT03697603|560660214|FG000|Overall Study|Protocol Violation|0|||
155334829|NCT03697603|560660215|FG001|Overall Study|Protocol Violation|0|||
155334830|NCT03697603|560660216|FG002|Overall Study|Protocol Violation|1|||
155071675|NCT00541229|559691875|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
155334831|NCT05182606|560660217|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
155334832|NCT02309294|560660218|FG000|Overall Study|Withdrawal by Subject|2|||
155334833|NCT03683030|560660221|FG000|Overall Study|Enrolled but screen failures|12|||
155334834|NCT03683030|560660222|FG001|Overall Study|Enrolled but screen failures|7|||
155071676|NCT00541229|559691870|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
155334835|NCT03683030|560660221|FG000|Overall Study|Enrolled but no catheter inserted|11|||
155334836|NCT03683030|560660222|FG001|Overall Study|Enrolled but no catheter inserted|13|||
155334837|NCT03683030|560660221|FG000|Overall Study|Withdrawal by Subject|0|||
155334838|NCT03683030|560660222|FG001|Overall Study|Withdrawal by Subject|2|||
155334839|NCT03683030|560660221|FG000|Overall Study|Early termination by subject|1|||
155334840|NCT03683030|560660222|FG001|Overall Study|Early termination by subject|0|||
155334841|NCT03683030|560660221|FG000|Overall Study|Lost to Follow-up|0|||
155334842|NCT03683030|560660222|FG001|Overall Study|Lost to Follow-up|6|||
155334843|NCT03683030|560660221|FG000|Overall Study|Death|0|||
155334844|NCT03683030|560660222|FG001|Overall Study|Death|2|||
155334845|NCT03683030|560660221|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
155334846|NCT03683030|560660222|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
155334847|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
155334848|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
155334849|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
155334850|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
155334851|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
155334852|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
155334853|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
155334854|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
155334855|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
155334856|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
155334857|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
155334858|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
155334859|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
155334860|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
155334861|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
155334862|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
155334863|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
155334864|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
155334865|NCT02222493|560660225|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
155334866|NCT02222493|560660226|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
155334867|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
155334868|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
155334869|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
155334870|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
154962113|NCT00113386|559287862|FG000|Overall Study|Ineligible|1|||
155334871|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
155334872|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
155334873|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
155334874|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
155334875|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
155334876|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
155334877|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
155334878|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
155334879|NCT02222493|560660225|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
155334880|NCT02222493|560660226|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
155334881|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
155334882|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
155334883|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
155334884|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
155334885|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
155334886|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
155334887|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
155334888|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
155334889|NCT02222493|560660225|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
155334890|NCT02222493|560660226|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
155334891|NCT02542943|560660229|FG000|Overall Study|Lost to Follow-up|1|||
155334892|NCT02542943|560660230|FG001|Overall Study|Lost to Follow-up|0|||
155334893|NCT02542943|560660231|FG002|Overall Study|Lost to Follow-up|0|||
155334894|NCT02542943|560660229|FG000|Overall Study|Withdrawal by Subject|0|||
155334895|NCT02542943|560660230|FG001|Overall Study|Withdrawal by Subject|1|||
155334896|NCT02542943|560660231|FG002|Overall Study|Withdrawal by Subject|0|||
155334897|NCT03476798|560660235|FG000|Overall Study|Death|1|||
155334898|NCT03476798|560660235|FG000|Overall Study|Withdrawal by Subject|2|||
155334899|NCT03476798|560660235|FG000|Overall Study|Protocol Violation|2|||
155334900|NCT06269003|560660236|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
155334901|NCT06269003|560660237|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
155334902|NCT06269003|560660238|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
155334903|NCT06269003|560660239|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
155334904|NCT00647387|560660243|FG000|Overall Study|Lost to Follow-up|6|||
155334905|NCT00647387|560660243|FG000|Overall Study|Unsuccessful implant|5|||
155334906|NCT00647387|560660243|FG000|Overall Study|Device explanted|3|||
155334907|NCT00647387|560660243|FG000|Overall Study|Other Reason|3|||
155334908|NCT00647387|560660243|FG000|Overall Study|Death|2|||
154962114|NCT00113386|559287863|FG001|Overall Study|Ineligible|2|||
154962115|NCT00113386|559287862|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
155071677|NCT00541229|559691871|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
155071678|NCT00541229|559691872|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
155071679|NCT00541229|559691873|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
154962116|NCT00113386|559287863|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
154962117|NCT00834340|559287864|FG000|Washout|Adverse Event|1|||
154962118|NCT00834340|559287865|FG001|Washout|Adverse Event|0|||
154962119|NCT00834340|559287864|FG000|Washout|Withdrawal by Subject|1|||
154962120|NCT00834340|559287865|FG001|Washout|Withdrawal by Subject|0|||
154962121|NCT00395694|559287868|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
154962122|NCT00395694|559287869|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
154962123|NCT00395694|559287868|FG000|Continuation Phase|Adverse Event|1|||
154962124|NCT00395694|559287869|FG001|Continuation Phase|Adverse Event|0|||
154962125|NCT00395694|559287868|FG000|Continuation Phase|Lack of Efficacy|12|||
154962126|NCT00395694|559287869|FG001|Continuation Phase|Lack of Efficacy|11|||
154962127|NCT00395694|559287868|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
154962128|NCT00395694|559287869|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
154962129|NCT00395694|559287868|FG000|Continuation Phase|Poor Compliance|1|||
154962130|NCT00395694|559287869|FG001|Continuation Phase|Poor Compliance|0|||
154962131|NCT00395694|559287868|FG000|Continuation Phase|Withdrawal by Subject|0|||
154962132|NCT00395694|559287869|FG001|Continuation Phase|Withdrawal by Subject|2|||
154962133|NCT02159183|559287872|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
154962134|NCT02159183|559287873|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
154962135|NCT02159183|559287872|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
154962136|NCT02159183|559287873|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
154962137|NCT02159183|559287872|FG000|Analysis After the 36 Months Follow-up|Death|0|||
154962138|NCT02159183|559287873|FG001|Analysis After the 36 Months Follow-up|Death|1|||
154962139|NCT02159183|559287872|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
154962140|NCT02159183|559287873|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
154962141|NCT02159183|559287872|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
154962142|NCT02159183|559287873|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
154962143|NCT01444378|559287879|FG000|Overall Study|Lost to Follow-up|1|||
154962144|NCT01444378|559287879|FG000|Overall Study|Withdrawal by Subject|1|||
154962145|NCT01444378|559287879|FG000|Overall Study|Death|3|||
154962146|NCT01444378|559287879|FG000|Overall Study|Administrative Closure Of The Study|2|||
154962147|NCT01444378|559287879|FG000|Overall Study|Missed Visits|10|||
154962148|NCT01244620|559287880|FG000|Overall Study|Study terminated|4|||
154962149|NCT01244620|559287881|FG001|Overall Study|Study terminated|4|||
155334909|NCT00985088|560661668|FG000|Overall Study|Serious Adverse Event|1|||
155334910|NCT00985088|560661669|FG001|Overall Study|Serious Adverse Event|1|||
155334911|NCT00985088|560661670|FG002|Overall Study|Serious Adverse Event|0|||
155334912|NCT00985088|560661671|FG003|Overall Study|Serious Adverse Event|0|||
154962150|NCT01244620|559287882|FG002|Overall Study|Study terminated|4|||
155334913|NCT00985088|560661672|FG004|Overall Study|Serious Adverse Event|0|||
154962151|NCT01244620|559287883|FG003|Overall Study|Study terminated|4|||
154962152|NCT01663233|559287884|FG000|Overall Study|Withdrawal by Subject|3|||
154962153|NCT01663233|559287885|FG001|Overall Study|Withdrawal by Subject|2|||
154962154|NCT01663233|559287884|FG000|Overall Study|Protocol Deviation|1|||
155334914|NCT00985088|560661673|FG005|Overall Study|Serious Adverse Event|0|||
154962155|NCT01663233|559287885|FG001|Overall Study|Protocol Deviation|4|||
154962156|NCT01663233|559287884|FG000|Overall Study|Lost to Follow-up|0|||
154962157|NCT01663233|559287885|FG001|Overall Study|Lost to Follow-up|1|||
155334915|NCT00985088|560661674|FG006|Overall Study|Serious Adverse Event|0|||
155334916|NCT00985088|560661675|FG007|Overall Study|Serious Adverse Event|1|||
155334917|NCT00985088|560661668|FG000|Overall Study|Adverse Event|0|||
155334918|NCT00985088|560661669|FG001|Overall Study|Adverse Event|0|||
154962158|NCT02321098|559287886|FG000|12 Weeks Treament|Lost to Follow-up|1|||
154962159|NCT02321098|559287887|FG001|12 Weeks Treament|Lost to Follow-up|1|||
154962160|NCT02321098|559287888|FG002|12 Weeks Treament|Lost to Follow-up|0|||
154962161|NCT02321098|559287886|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
154962162|NCT02321098|559287887|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
154962163|NCT02321098|559287888|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
154962164|NCT02321098|559287886|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
154962165|NCT02321098|559287887|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
154962166|NCT02321098|559287888|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
154962167|NCT02321098|559287886|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
154962168|NCT02321098|559287887|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
154962169|NCT02321098|559287888|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
154962170|NCT00796328|559287891|FG000|Overall Study|experienced hypotension requiring tx|6|||
154962171|NCT03261167|559287892|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
154962172|NCT03261167|559287893|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
154962173|NCT03261167|559287892|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
154962174|NCT03261167|559287893|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
154962175|NCT03261167|559287892|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
154962176|NCT03261167|559287893|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
154962177|NCT03261167|559287892|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
154962178|NCT03261167|559287893|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
154962179|NCT03261167|559287892|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
154962180|NCT03261167|559287893|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
154962181|NCT03669861|559287896|FG000|Overall Study|Disease Flare|5|||
154962182|NCT03669861|559287896|FG000|Overall Study|Lack of Efficacy|2|||
154962183|NCT02760927|559287901|FG000|Overall Study|Tube Slippage from Device|1|||
155334919|NCT00985088|560661670|FG002|Overall Study|Adverse Event|1|||
155071680|NCT00541229|559691874|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
155071681|NCT00541229|559691875|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
155071682|NCT00541229|559691870|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155071683|NCT00541229|559691871|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155071684|NCT00541229|559691872|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155071685|NCT00541229|559691873|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155071686|NCT00541229|559691874|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
155071687|NCT00541229|559691875|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
155071688|NCT00541229|559691870|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
155071689|NCT00541229|559691871|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
155071690|NCT00541229|559691872|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
155071691|NCT00541229|559691873|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
155071692|NCT00541229|559691874|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
155071693|NCT00541229|559691875|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
155071694|NCT00541229|559691870|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
155071695|NCT00541229|559691871|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
155071696|NCT00541229|559691872|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
155071697|NCT00541229|559691873|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
155334920|NCT00985088|560661671|FG003|Overall Study|Adverse Event|0|||
155334921|NCT00985088|560661672|FG004|Overall Study|Adverse Event|0|||
155334922|NCT00985088|560661673|FG005|Overall Study|Adverse Event|0|||
155334923|NCT00985088|560661674|FG006|Overall Study|Adverse Event|0|||
155334924|NCT00985088|560661675|FG007|Overall Study|Adverse Event|0|||
155334925|NCT00985088|560661668|FG000|Overall Study|Withdrawal by Subject|4|||
155334926|NCT00985088|560661669|FG001|Overall Study|Withdrawal by Subject|0|||
155334927|NCT00985088|560661670|FG002|Overall Study|Withdrawal by Subject|0|||
155334928|NCT00985088|560661671|FG003|Overall Study|Withdrawal by Subject|1|||
155334929|NCT00985088|560661672|FG004|Overall Study|Withdrawal by Subject|3|||
155334930|NCT00985088|560661673|FG005|Overall Study|Withdrawal by Subject|2|||
155334931|NCT00985088|560661674|FG006|Overall Study|Withdrawal by Subject|1|||
155334932|NCT00985088|560661675|FG007|Overall Study|Withdrawal by Subject|2|||
155334933|NCT00985088|560661668|FG000|Overall Study|Migrated/moved from study area|0|||
155334934|NCT00985088|560661669|FG001|Overall Study|Migrated/moved from study area|0|||
155334935|NCT00985088|560661670|FG002|Overall Study|Migrated/moved from study area|1|||
155334936|NCT00985088|560661671|FG003|Overall Study|Migrated/moved from study area|0|||
155334937|NCT00985088|560661672|FG004|Overall Study|Migrated/moved from study area|0|||
155334938|NCT00985088|560661673|FG005|Overall Study|Migrated/moved from study area|0|||
155334939|NCT00985088|560661674|FG006|Overall Study|Migrated/moved from study area|0|||
155334940|NCT00985088|560661675|FG007|Overall Study|Migrated/moved from study area|1|||
155334941|NCT00985088|560661668|FG000|Overall Study|Lost to Follow-up|6|||
155334942|NCT00985088|560661669|FG001|Overall Study|Lost to Follow-up|1|||
155334943|NCT00985088|560661670|FG002|Overall Study|Lost to Follow-up|2|||
155334944|NCT00985088|560661671|FG003|Overall Study|Lost to Follow-up|6|||
155334945|NCT00985088|560661672|FG004|Overall Study|Lost to Follow-up|6|||
155334946|NCT00985088|560661673|FG005|Overall Study|Lost to Follow-up|5|||
155334947|NCT00985088|560661674|FG006|Overall Study|Lost to Follow-up|3|||
155334948|NCT00985088|560661675|FG007|Overall Study|Lost to Follow-up|2|||
155334949|NCT01970878|560661676|FG000|Overall Study|Withdrawal by Subject|11|||
155334950|NCT01970878|560661677|FG001|Overall Study|Withdrawal by Subject|10|||
155334951|NCT01970878|560661678|FG002|Overall Study|Withdrawal by Subject|14|||
155334952|NCT01970878|560661679|FG003|Overall Study|Withdrawal by Subject|7|||
155334953|NCT01970878|560661676|FG000|Overall Study|Lost to Follow-up|1|||
155334954|NCT01970878|560661677|FG001|Overall Study|Lost to Follow-up|3|||
155334955|NCT01970878|560661678|FG002|Overall Study|Lost to Follow-up|2|||
155334956|NCT01970878|560661679|FG003|Overall Study|Lost to Follow-up|4|||
155334957|NCT01970878|560661676|FG000|Overall Study|Administrative Reasons|1|||
155334958|NCT01970878|560661677|FG001|Overall Study|Administrative Reasons|0|||
155334959|NCT01970878|560661678|FG002|Overall Study|Administrative Reasons|0|||
155334960|NCT01970878|560661679|FG003|Overall Study|Administrative Reasons|4|||
155334961|NCT01970878|560661676|FG000|Overall Study|Lack of Efficacy|2|||
155334962|NCT01970878|560661677|FG001|Overall Study|Lack of Efficacy|1|||
155334963|NCT01970878|560661678|FG002|Overall Study|Lack of Efficacy|2|||
155334964|NCT01970878|560661679|FG003|Overall Study|Lack of Efficacy|0|||
155334965|NCT01970878|560661676|FG000|Overall Study|Adverse Event|12|||
155334966|NCT01970878|560661677|FG001|Overall Study|Adverse Event|7|||
155334967|NCT01970878|560661678|FG002|Overall Study|Adverse Event|4|||
155071698|NCT00541229|559691874|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
155334968|NCT01970878|560661679|FG003|Overall Study|Adverse Event|3|||
155334969|NCT01970878|560661676|FG000|Overall Study|Protocol Specified Criteria|10|||
155334970|NCT01970878|560661677|FG001|Overall Study|Protocol Specified Criteria|4|||
155334971|NCT01970878|560661678|FG002|Overall Study|Protocol Specified Criteria|3|||
155334972|NCT01970878|560661679|FG003|Overall Study|Protocol Specified Criteria|6|||
155334973|NCT01970878|560661676|FG000|Overall Study|Physician Decision|0|||
155334974|NCT01970878|560661677|FG001|Overall Study|Physician Decision|1|||
155334975|NCT01970878|560661678|FG002|Overall Study|Physician Decision|1|||
155334976|NCT01970878|560661679|FG003|Overall Study|Physician Decision|0|||
155334977|NCT01970878|560661676|FG000|Overall Study|No Completion Status|0|||
155334978|NCT01970878|560661677|FG001|Overall Study|No Completion Status|1|||
155334979|NCT01970878|560661678|FG002|Overall Study|No Completion Status|0|||
155334980|NCT01970878|560661679|FG003|Overall Study|No Completion Status|0|||
155334981|NCT06571695|560661684|FG000|Overall Study|Lost to Follow-up|1|||
155334982|NCT06571695|560661685|FG001|Overall Study|Lost to Follow-up|6|||
155334983|NCT00491400|560661686|FG000|Overall Study|Withdrawal by Subject|5|||
155334984|NCT00491400|560661687|FG001|Overall Study|Withdrawal by Subject|4|||
155334985|NCT00597376|560661688|FG000|Overall Study|Withdrawal by Subject|4|||
155334986|NCT00597376|560661689|FG001|Overall Study|Withdrawal by Subject|3|||
155334987|NCT00597376|560661688|FG000|Overall Study|Adverse Event|4|||
155334988|NCT00597376|560661689|FG001|Overall Study|Adverse Event|1|||
155334989|NCT02698475|560661690|FG000|Main Study Period|Lack of Efficacy|1|||
155334990|NCT02698475|560661690|FG000|Main Study Period|Protocol Violation|2|||
155334991|NCT02698475|560661690|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
155334992|NCT02698475|560661690|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
155334993|NCT02698475|560661690|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
155334994|NCT02698475|560661690|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
155334995|NCT02698475|560661690|FG000|Long-Term Extension Period|Other|1|||
155334996|NCT01214200|560661695|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
155334997|NCT01214200|560661695|FG000|Overall Study|Withdrawal by Subject|2|||
155334998|NCT02736188|560661700|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
155334999|NCT02736188|560661700|FG000|Overall Study|Adverse Event|1|||
155335000|NCT02736188|560661700|FG000|Overall Study|Withdrawal by Subject|1|||
155335001|NCT02736188|560661700|FG000|Overall Study|Other|6|||
155335002|NCT02708498|560661701|FG000|Overall Study|Death|20|||
155335003|NCT02708498|560661702|FG001|Overall Study|Death|19|||
155335004|NCT02708498|560661703|FG002|Overall Study|Death|0|||
155335005|NCT02708498|560661704|FG003|Overall Study|Death|0|||
155335006|NCT02708498|560661705|FG004|Overall Study|Death|1|||
155335007|NCT02708498|560661706|FG005|Overall Study|Death|0|||
155335008|NCT02708498|560661707|FG006|Overall Study|Death|0|||
155335009|NCT02708498|560661708|FG007|Overall Study|Death|0|||
155335010|NCT02708498|560661701|FG000|Overall Study|Unknown reason, missing data|0|||
155335011|NCT02708498|560661702|FG001|Overall Study|Unknown reason, missing data|0|||
155335012|NCT02708498|560661703|FG002|Overall Study|Unknown reason, missing data|62|||
155335013|NCT02708498|560661704|FG003|Overall Study|Unknown reason, missing data|51|||
155335014|NCT02708498|560661705|FG004|Overall Study|Unknown reason, missing data|195|||
155335015|NCT02708498|560661706|FG005|Overall Study|Unknown reason, missing data|132|||
155335016|NCT02708498|560661707|FG006|Overall Study|Unknown reason, missing data|0|||
155335017|NCT02708498|560661708|FG007|Overall Study|Unknown reason, missing data|0|||
155335018|NCT03052517|560661709|FG000|Overall Study|Study Terminated By Sponsor|928|||
155335019|NCT03052517|560661710|FG001|Overall Study|Study Terminated By Sponsor|938|||
155335020|NCT03052517|560661711|FG002|Overall Study|Study Terminated By Sponsor|296|||
155335021|NCT03052517|560661709|FG000|Overall Study|Subject/Guardian Decision|50|||
155335022|NCT03052517|560661710|FG001|Overall Study|Subject/Guardian Decision|45|||
155335023|NCT03052517|560661711|FG002|Overall Study|Subject/Guardian Decision|22|||
155335024|NCT03052517|560661709|FG000|Overall Study|Lack of Efficacy|23|||
155335025|NCT03052517|560661710|FG001|Overall Study|Lack of Efficacy|14|||
155335026|NCT03052517|560661711|FG002|Overall Study|Lack of Efficacy|7|||
155335027|NCT03052517|560661709|FG000|Overall Study|Adverse Event|6|||
155335028|NCT03052517|560661710|FG001|Overall Study|Adverse Event|5|||
155335029|NCT03052517|560661711|FG002|Overall Study|Adverse Event|0|||
155335030|NCT03052517|560661709|FG000|Overall Study|Physician Decision|4|||
155335031|NCT03052517|560661710|FG001|Overall Study|Physician Decision|5|||
155335032|NCT03052517|560661711|FG002|Overall Study|Physician Decision|1|||
155335033|NCT03052517|560661709|FG000|Overall Study|Death|3|||
155335034|NCT03052517|560661710|FG001|Overall Study|Death|0|||
155335035|NCT03052517|560661711|FG002|Overall Study|Death|1|||
155335036|NCT03052517|560661709|FG000|Overall Study|Lost to Follow-up|2|||
155335037|NCT03052517|560661710|FG001|Overall Study|Lost to Follow-up|4|||
155335038|NCT03052517|560661711|FG002|Overall Study|Lost to Follow-up|0|||
155335039|NCT03052517|560661709|FG000|Overall Study|Pregnancy|1|||
155335040|NCT03052517|560661710|FG001|Overall Study|Pregnancy|0|||
155335041|NCT03052517|560661711|FG002|Overall Study|Pregnancy|1|||
155335042|NCT03052517|560661709|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
155335043|NCT03052517|560661710|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
155335044|NCT03052517|560661711|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
155335045|NCT03052517|560661709|FG000|Overall Study|Technical Problems|0|||
155335046|NCT03052517|560661710|FG001|Overall Study|Technical Problems|1|||
155335047|NCT03052517|560661711|FG002|Overall Study|Technical Problems|0|||
155335048|NCT01858688|560661712|FG000|Overall Study|Withdrawal by Subject|8|||
155335049|NCT01858688|560661712|FG000|Overall Study|Participant began another therapy|3|||
155335050|NCT01858688|560661712|FG000|Overall Study|Physician Decision|2|||
155071699|NCT00541229|559691875|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
155071700|NCT00541229|559691870|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155071701|NCT00541229|559691871|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155071702|NCT00541229|559691872|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155071703|NCT00541229|559691873|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155071704|NCT00541229|559691874|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
155071705|NCT00541229|559691875|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
155335051|NCT01858688|560661712|FG000|Overall Study|Progressive Disease|2|||
155335052|NCT01858688|560661712|FG000|Overall Study|Reason not reproted|5|||
155071706|NCT00541229|559691870|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155071707|NCT00541229|559691871|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155071708|NCT00541229|559691872|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
155071709|NCT00541229|559691873|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155071710|NCT00541229|559691874|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155071711|NCT00541229|559691875|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
155071712|NCT03807843|559691876|FG000|Overall Study|Lost to Follow-up|1|||
155071713|NCT03807843|559691877|FG001|Overall Study|Lost to Follow-up|0|||
155071714|NCT01312129|559691878|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
155071715|NCT01312129|559691879|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
155071716|NCT01239680|559691882|FG000|Overall Study|Withdrawal by Subject|2|||
155071717|NCT01239680|559691883|FG001|Overall Study|Withdrawal by Subject|0|||
155071718|NCT01033942|559691884|FG000|Overall Study|Withdrawal by Subject|1|||
155071719|NCT01033942|559691885|FG001|Overall Study|Withdrawal by Subject|1|||
155071720|NCT01033942|559691886|FG002|Overall Study|Withdrawal by Subject|1|||
155071721|NCT01033942|559691884|FG000|Overall Study|Lost to Follow-up|1|||
155071722|NCT01033942|559691885|FG001|Overall Study|Lost to Follow-up|0|||
155071723|NCT01033942|559691886|FG002|Overall Study|Lost to Follow-up|0|||
155071724|NCT01033942|559691884|FG000|Overall Study|Enrolled in Extension Study|0|||
155071725|NCT01033942|559691885|FG001|Overall Study|Enrolled in Extension Study|3|||
155071726|NCT01033942|559691886|FG002|Overall Study|Enrolled in Extension Study|0|||
155071727|NCT02737618|559691887|FG000|Overall Study|Withdrawal by Subject|9|||
155071728|NCT01178411|559691892|FG000|Overall Study|Adverse Event|5|||
155071729|NCT01178411|559691892|FG000|Overall Study|Withdrawal by Subject|4|||
155071730|NCT01178411|559691892|FG000|Overall Study|Protocol Violation|1|||
155071731|NCT01178411|559691892|FG000|Overall Study|Progressive disease per RECIST|32|||
155071732|NCT01178411|559691892|FG000|Overall Study|Progressive disease per clinician|9|||
155071733|NCT01178411|559691892|FG000|Overall Study|Physician Decision|6|||
155071734|NCT01178411|559691892|FG000|Overall Study|Death|1|||
155071735|NCT01178411|559691892|FG000|Overall Study|No reason provided|1|||
155071736|NCT01178411|559691892|FG000|Overall Study|Drug manufacturing ended|1|||
155071737|NCT02453048|559691893|FG000|Overall Study|Only part of initial 6 mo. study|0|||
155071738|NCT02453048|559691894|FG001|Overall Study|Only part of initial 6 mo. study|0|||
155071739|NCT02453048|559691895|FG002|Overall Study|Only part of initial 6 mo. study|0|||
155071740|NCT02453048|559691896|FG003|Overall Study|Only part of initial 6 mo. study|0|||
155071741|NCT02453048|559691897|FG004|Overall Study|Only part of initial 6 mo. study|6|||
155071742|NCT02453048|559691893|FG000|Overall Study|Lost to Follow-up|0|||
155071743|NCT02453048|559691894|FG001|Overall Study|Lost to Follow-up|1|||
155071744|NCT02453048|559691895|FG002|Overall Study|Lost to Follow-up|2|||
155071745|NCT02453048|559691896|FG003|Overall Study|Lost to Follow-up|0|||
155071746|NCT02453048|559691897|FG004|Overall Study|Lost to Follow-up|0|||
155071747|NCT01482221|559691901|FG000|Overall Study|Lack of Efficacy|1|||
155335053|NCT03298087|560661715|FG000|Overall Study|Withdrawal by Subject|4|||
155335054|NCT01303510|560661716|FG000|Overall Study|Lost to Follow-up|1|||
155335055|NCT01303510|560661717|FG001|Overall Study|Lost to Follow-up|0|||
155335056|NCT00822900|560661721|FG000|Overall Study|Withdrawal by Subject|14|||
155335057|NCT00822900|560661722|FG001|Overall Study|Withdrawal by Subject|14|||
155335058|NCT00822900|560661721|FG000|Overall Study|Lost to Follow-up|9|||
155335059|NCT00822900|560661722|FG001|Overall Study|Lost to Follow-up|9|||
155335060|NCT00822900|560661721|FG000|Overall Study|Death|83|||
155335061|NCT00822900|560661722|FG001|Overall Study|Death|69|||
155335062|NCT00822900|560661721|FG000|Overall Study|Became a ward of the state|2|||
155335063|NCT00822900|560661722|FG001|Overall Study|Became a ward of the state|1|||
155335064|NCT00659373|560661734|FG000|Overall Study|Withdrawal by Subject|3|||
155335065|NCT00659373|560661735|FG001|Overall Study|Withdrawal by Subject|5|||
155335066|NCT00659373|560661734|FG000|Overall Study|Assessment Missed|2|||
155335067|NCT00659373|560661735|FG001|Overall Study|Assessment Missed|2|||
155335068|NCT03042767|560661738|FG000|Overall Study|Lost to Follow-up|1|||
155335069|NCT03042767|560661739|FG001|Overall Study|Lost to Follow-up|2|||
154962184|NCT03406156|559287911|FG000|Overall Study|Death|9|||
154962185|NCT03406156|559287912|FG001|Overall Study|Death|3|||
154962186|NCT03406156|559287911|FG000|Overall Study|Withdrawal by Subject|1|||
154962187|NCT03406156|559287912|FG001|Overall Study|Withdrawal by Subject|2|||
154962188|NCT03406156|559287911|FG000|Overall Study|COVID-19 infection|1|||
154962189|NCT03406156|559287912|FG001|Overall Study|COVID-19 infection|0|||
154962190|NCT03406156|559287911|FG000|Overall Study|Non-compliance with study procedures|1|||
154962191|NCT03406156|559287912|FG001|Overall Study|Non-compliance with study procedures|1|||
154962192|NCT03406156|559287911|FG000|Overall Study|Lost to Follow-up|0|||
154962193|NCT03406156|559287912|FG001|Overall Study|Lost to Follow-up|2|||
154962194|NCT03406156|559287911|FG000|Overall Study|Other, not specified|72|||
154962195|NCT03406156|559287912|FG001|Overall Study|Other, not specified|28|||
154962196|NCT02838420|559287914|FG000|Overall Study|Ongoing in Study|113|||
154962197|NCT02838420|559287915|FG001|Overall Study|Ongoing in Study|45|||
154962198|NCT02838420|559287914|FG000|Overall Study|Lost to Follow-up|1|||
154962199|NCT02838420|559287915|FG001|Overall Study|Lost to Follow-up|0|||
155071748|NCT01482221|559691902|FG001|Overall Study|Lack of Efficacy|0|||
155071749|NCT01482221|559691903|FG002|Overall Study|Lack of Efficacy|1|||
155071750|NCT01482221|559691901|FG000|Overall Study|Lost to Follow-up|3|||
155071751|NCT01482221|559691902|FG001|Overall Study|Lost to Follow-up|2|||
155071752|NCT01482221|559691903|FG002|Overall Study|Lost to Follow-up|1|||
155071753|NCT01482221|559691901|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
155071754|NCT01482221|559691902|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
155071755|NCT01482221|559691903|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
155071756|NCT01482221|559691901|FG000|Overall Study|Condition under Investigation Worsened|3|||
155071757|NCT01482221|559691902|FG001|Overall Study|Condition under Investigation Worsened|2|||
155071758|NCT01482221|559691903|FG002|Overall Study|Condition under Investigation Worsened|4|||
155071759|NCT01482221|559691901|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
155071760|NCT01482221|559691902|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
155071761|NCT01482221|559691903|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
155071762|NCT01482221|559691901|FG000|Overall Study|Adverse Event|1|||
155071763|NCT01482221|559691902|FG001|Overall Study|Adverse Event|7|||
155071764|NCT01482221|559691903|FG002|Overall Study|Adverse Event|3|||
155071765|NCT01482221|559691901|FG000|Overall Study|Withdrawal by Subject|10|||
155071766|NCT01482221|559691902|FG001|Overall Study|Withdrawal by Subject|7|||
155071767|NCT01482221|559691903|FG002|Overall Study|Withdrawal by Subject|12|||
155071768|NCT01482221|559691901|FG000|Overall Study|Incorrect randomization|0|||
155071769|NCT01482221|559691902|FG001|Overall Study|Incorrect randomization|1|||
155071770|NCT01482221|559691903|FG002|Overall Study|Incorrect randomization|0|||
155071771|NCT01482221|559691901|FG000|Overall Study|Physician Decision|0|||
155071772|NCT01482221|559691902|FG001|Overall Study|Physician Decision|1|||
155071773|NCT01482221|559691903|FG002|Overall Study|Physician Decision|0|||
155071774|NCT03086343|559691904|FG000|Period 1|Adverse Event|7|||
155071775|NCT03086343|559691905|FG001|Period 1|Adverse Event|7|||
155071776|NCT03086343|559691906|FG002|Period 1|Adverse Event|0|||
155071777|NCT03086343|559691907|FG003|Period 1|Adverse Event|1|||
155071778|NCT03086343|559691904|FG000|Period 1|Withdrawal by Subject|6|||
155071779|NCT03086343|559691905|FG001|Period 1|Withdrawal by Subject|10|||
155071780|NCT03086343|559691906|FG002|Period 1|Withdrawal by Subject|0|||
155071781|NCT03086343|559691907|FG003|Period 1|Withdrawal by Subject|0|||
155071782|NCT03086343|559691904|FG000|Period 1|Lost to Follow-up|1|||
155071783|NCT03086343|559691905|FG001|Period 1|Lost to Follow-up|3|||
155071784|NCT03086343|559691906|FG002|Period 1|Lost to Follow-up|1|||
155071785|NCT03086343|559691907|FG003|Period 1|Lost to Follow-up|0|||
155071786|NCT03086343|559691904|FG000|Period 1|Other, Not Specified|10|||
155071787|NCT03086343|559691905|FG001|Period 1|Other, Not Specified|12|||
155071788|NCT03086343|559691906|FG002|Period 1|Other, Not Specified|2|||
155071789|NCT03086343|559691907|FG003|Period 1|Other, Not Specified|1|||
155071790|NCT03086343|559691904|FG000|Period 1|Missing|1|||
155071791|NCT03086343|559691905|FG001|Period 1|Missing|0|||
155071792|NCT03086343|559691906|FG002|Period 1|Missing|0|||
155071793|NCT03086343|559691907|FG003|Period 1|Missing|0|||
155071794|NCT03086343|559691904|FG000|Period 2|Adverse Event|20|||
155071795|NCT03086343|559691905|FG001|Period 2|Adverse Event|11|||
155071796|NCT03086343|559691906|FG002|Period 2|Adverse Event|1|||
155071797|NCT03086343|559691907|FG003|Period 2|Adverse Event|2|||
155071798|NCT03086343|559691904|FG000|Period 2|Withdrawal by Subject|15|||
155071799|NCT03086343|559691905|FG001|Period 2|Withdrawal by Subject|25|||
155071800|NCT03086343|559691906|FG002|Period 2|Withdrawal by Subject|2|||
155071801|NCT03086343|559691907|FG003|Period 2|Withdrawal by Subject|2|||
155071802|NCT03086343|559691904|FG000|Period 2|Lost to Follow-up|6|||
155071803|NCT03086343|559691905|FG001|Period 2|Lost to Follow-up|11|||
155071804|NCT03086343|559691906|FG002|Period 2|Lost to Follow-up|1|||
155071805|NCT03086343|559691907|FG003|Period 2|Lost to Follow-up|0|||
155071806|NCT03086343|559691904|FG000|Period 2|COVID-19 Infection|5|||
155071807|NCT03086343|559691905|FG001|Period 2|COVID-19 Infection|0|||
155071808|NCT03086343|559691906|FG002|Period 2|COVID-19 Infection|0|||
155071809|NCT03086343|559691907|FG003|Period 2|COVID-19 Infection|0|||
155071810|NCT03086343|559691904|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
155163788|NCT02374450|560035079|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
155071811|NCT03086343|559691905|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
155071812|NCT03086343|559691906|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
155071813|NCT03086343|559691907|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
155163789|NCT02374450|560035080|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
155163790|NCT02374450|560035081|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
155071814|NCT03086343|559691904|FG000|Period 2|Other, Not Specified|23|||
155071815|NCT03086343|559691905|FG001|Period 2|Other, Not Specified|22|||
155071816|NCT03086343|559691906|FG002|Period 2|Other, Not Specified|2|||
155071817|NCT03086343|559691907|FG003|Period 2|Other, Not Specified|4|||
155335070|NCT02686658|560661746|FG000|Overall Study|Adverse Event|0|||
155071818|NCT04900272|559691908|FG000|Overall Study|Lost to Follow-up|2|||
155071819|NCT04900272|559691908|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
155071820|NCT04900272|559691908|FG000|Overall Study|Withdrawal by Subject|1|||
155071821|NCT01625182|559691910|FG000|Overall Study|Administrative problems|1|||
155071822|NCT01625182|559691911|FG001|Overall Study|Administrative problems|0|||
155071823|NCT01625182|559691910|FG000|Overall Study|Protocol deviation|0|||
154962200|NCT02838420|559287914|FG000|Overall Study|Withdrawal by Subject|3|||
155335071|NCT02686658|560661747|FG001|Overall Study|Adverse Event|0|||
155335072|NCT02686658|560661748|FG002|Overall Study|Adverse Event|1|||
155335073|NCT02686658|560661749|FG003|Overall Study|Adverse Event|1|||
155335074|NCT02686658|560661750|FG004|Overall Study|Adverse Event|2|||
155335075|NCT02686658|560661751|FG005|Overall Study|Adverse Event|1|||
155335076|NCT02686658|560661746|FG000|Overall Study|Investigator decision|0|||
155335077|NCT02686658|560661747|FG001|Overall Study|Investigator decision|0|||
155335078|NCT02686658|560661748|FG002|Overall Study|Investigator decision|0|||
155335079|NCT02686658|560661749|FG003|Overall Study|Investigator decision|1|||
155335080|NCT02686658|560661750|FG004|Overall Study|Investigator decision|2|||
155335081|NCT02686658|560661751|FG005|Overall Study|Investigator decision|1|||
155335082|NCT02686658|560661746|FG000|Overall Study|Sponsor decision|1|||
155335083|NCT02686658|560661747|FG001|Overall Study|Sponsor decision|2|||
155335084|NCT02686658|560661748|FG002|Overall Study|Sponsor decision|1|||
155335085|NCT02686658|560661749|FG003|Overall Study|Sponsor decision|5|||
155335086|NCT02686658|560661750|FG004|Overall Study|Sponsor decision|13|||
155335087|NCT02686658|560661751|FG005|Overall Study|Sponsor decision|2|||
155335088|NCT02686658|560661746|FG000|Overall Study|Lost to Follow-up|0|||
155335089|NCT02686658|560661747|FG001|Overall Study|Lost to Follow-up|0|||
155335090|NCT02686658|560661748|FG002|Overall Study|Lost to Follow-up|2|||
155335091|NCT02686658|560661749|FG003|Overall Study|Lost to Follow-up|0|||
155335092|NCT02686658|560661750|FG004|Overall Study|Lost to Follow-up|0|||
155335093|NCT02686658|560661751|FG005|Overall Study|Lost to Follow-up|1|||
155335094|NCT02686658|560661746|FG000|Overall Study|Death|1|||
155335095|NCT02686658|560661747|FG001|Overall Study|Death|0|||
155335096|NCT02686658|560661748|FG002|Overall Study|Death|0|||
155335097|NCT02686658|560661749|FG003|Overall Study|Death|1|||
155335098|NCT02686658|560661750|FG004|Overall Study|Death|1|||
155335099|NCT02686658|560661751|FG005|Overall Study|Death|1|||
155335100|NCT02686658|560661746|FG000|Overall Study|Withdrawal by Subject|2|||
155335101|NCT02686658|560661747|FG001|Overall Study|Withdrawal by Subject|5|||
155335102|NCT02686658|560661748|FG002|Overall Study|Withdrawal by Subject|4|||
155335103|NCT02686658|560661749|FG003|Overall Study|Withdrawal by Subject|4|||
155335104|NCT02686658|560661750|FG004|Overall Study|Withdrawal by Subject|17|||
155335105|NCT02686658|560661751|FG005|Overall Study|Withdrawal by Subject|8|||
155335106|NCT02686658|560661746|FG000|Overall Study|Placed in hospice care|0|||
155071824|NCT01625182|559691911|FG001|Overall Study|Protocol deviation|2|||
155071825|NCT01625182|559691910|FG000|Overall Study|Adverse Event|2|||
155071826|NCT01625182|559691911|FG001|Overall Study|Adverse Event|0|||
155071827|NCT01625182|559691910|FG000|Overall Study|Withdrawal by Subject|5|||
155071828|NCT01625182|559691911|FG001|Overall Study|Withdrawal by Subject|1|||
155071829|NCT01625182|559691910|FG000|Overall Study|Lack of Efficacy|12|||
155071830|NCT01625182|559691911|FG001|Overall Study|Lack of Efficacy|8|||
155071831|NCT00263562|559691912|FG000|Overall Study|Protocol Violation|3|||
155071832|NCT00263562|559691913|FG001|Overall Study|Protocol Violation|0|||
155071833|NCT01047501|559691914|FG000|Overall Study|Adverse Event|7|||
155071834|NCT01047501|559691915|FG001|Overall Study|Adverse Event|8|||
155071835|NCT01047501|559691916|FG002|Overall Study|Adverse Event|5|||
155071836|NCT01047501|559691914|FG000|Overall Study|Withdrew Consent|6|||
155071837|NCT01047501|559691915|FG001|Overall Study|Withdrew Consent|2|||
155071838|NCT01047501|559691916|FG002|Overall Study|Withdrew Consent|4|||
155071839|NCT01047501|559691914|FG000|Overall Study|Lost to Follow-up|0|||
155071840|NCT01047501|559691915|FG001|Overall Study|Lost to Follow-up|1|||
155071841|NCT01047501|559691916|FG002|Overall Study|Lost to Follow-up|1|||
155071842|NCT01047501|559691914|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
155071843|NCT01047501|559691915|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
155071844|NCT01047501|559691916|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
155071845|NCT01047501|559691914|FG000|Overall Study|Death|1|||
155071846|NCT01047501|559691915|FG001|Overall Study|Death|0|||
155071847|NCT01047501|559691916|FG002|Overall Study|Death|0|||
155071848|NCT01047501|559691914|FG000|Overall Study|Other discontinuation|1|||
155071849|NCT01047501|559691915|FG001|Overall Study|Other discontinuation|0|||
155071850|NCT01047501|559691916|FG002|Overall Study|Other discontinuation|1|||
155071851|NCT01047501|559691914|FG000|Overall Study|Investigator judgement|0|||
155071852|NCT01047501|559691915|FG001|Overall Study|Investigator judgement|0|||
155071853|NCT01047501|559691916|FG002|Overall Study|Investigator judgement|1|||
155071854|NCT02447029|559691917|FG000|Overall Study|Withdrawal by Subject|3|||
155071855|NCT02447029|559691918|FG001|Overall Study|Withdrawal by Subject|2|||
155071856|NCT01257542|559691919|FG000|Overall Study|Protocol Violation|3|||
155071857|NCT01257542|559691920|FG001|Overall Study|Protocol Violation|5|||
155071858|NCT01257542|559691919|FG000|Overall Study|Withdrawal by Subject|0|||
155071859|NCT01257542|559691920|FG001|Overall Study|Withdrawal by Subject|2|||
155071860|NCT00549328|559691925|FG000|Overall Study|Adverse Event|2|||
155071861|NCT00549328|559691925|FG000|Overall Study|Disease Progression|10|||
155071862|NCT00549328|559691925|FG000|Overall Study|Death|1|||
155071863|NCT00549328|559691925|FG000|Overall Study|Use of Prohibited Medication|1|||
155071864|NCT00153920|559691926|FG000|Overall Study|Adverse Event|9|||
155071865|NCT00153920|559691926|FG000|Overall Study|Progressive Disease|9|||
155071866|NCT00153920|559691926|FG000|Overall Study|Physician Decision|3|||
155071867|NCT00153920|559691926|FG000|Overall Study|Lack of Response|3|||
155071868|NCT00153920|559691926|FG000|Overall Study|Death|2|||
155071869|NCT00153920|559691926|FG000|Overall Study|Withdrawal by Subject|1|||
155071870|NCT00153920|559691926|FG000|Overall Study|Non-Protocol Therapy|1|||
155071871|NCT00153920|559691926|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
155071872|NCT00153920|559691926|FG000|Overall Study|Progressive Disease before Trt|1|||
155071873|NCT05630755|559691927|FG000|Overall Study|Lost to Follow-up|7|||
155071874|NCT05630755|559691928|FG001|Overall Study|Lost to Follow-up|0|||
155071875|NCT05630755|559691927|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
155071876|NCT05630755|559691928|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
155163791|NCT02374450|560035079|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
155163792|NCT02374450|560035080|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
155071877|NCT05630755|559691927|FG000|Overall Study|Withdrawal by Subject|9|||
155071878|NCT05630755|559691928|FG001|Overall Study|Withdrawal by Subject|3|||
155071879|NCT05630755|559691927|FG000|Overall Study|Participant moved away from trial site|0|||
155071880|NCT05630755|559691928|FG001|Overall Study|Participant moved away from trial site|1|||
155071881|NCT05630755|559691927|FG000|Overall Study|Status not Recorded|316|||
155071882|NCT05630755|559691928|FG001|Overall Study|Status not Recorded|161|||
155071883|NCT04868682|559691929|FG000|Post-treatment|Lost to Follow-up|1|||
155071884|NCT04868682|559691930|FG001|Post-treatment|Lost to Follow-up|1|||
155071885|NCT04868682|559691929|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
155071886|NCT04868682|559691930|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
155071887|NCT04868682|559691929|FG000|Six-month Assessment|Lost to Follow-up|1|||
155071888|NCT04868682|559691930|FG001|Six-month Assessment|Lost to Follow-up|0|||
155071889|NCT04868682|559691929|FG000|Six-month Assessment|Death|1|||
155071890|NCT04868682|559691930|FG001|Six-month Assessment|Death|0|||
155071891|NCT04868682|559691929|FG000|Six-month Assessment|Refused|0|||
155071892|NCT04868682|559691930|FG001|Six-month Assessment|Refused|1|||
155071893|NCT04868682|559691929|FG000|12-month Assessment|Lost to Follow-up|2|||
155071894|NCT04868682|559691930|FG001|12-month Assessment|Lost to Follow-up|1|||
155163793|NCT02374450|560035081|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
155163794|NCT02374450|560035079|FG000|Overall Study|Other|0|||
155335107|NCT02686658|560661747|FG001|Overall Study|Placed in hospice care|0|||
155335108|NCT02686658|560661748|FG002|Overall Study|Placed in hospice care|1|||
155335109|NCT02686658|560661749|FG003|Overall Study|Placed in hospice care|0|||
155335110|NCT02686658|560661750|FG004|Overall Study|Placed in hospice care|0|||
155335111|NCT02686658|560661751|FG005|Overall Study|Placed in hospice care|0|||
155335112|NCT02686658|560661746|FG000|Overall Study|Participant non-compliance|0|||
155335113|NCT02686658|560661747|FG001|Overall Study|Participant non-compliance|0|||
155335114|NCT02686658|560661748|FG002|Overall Study|Participant non-compliance|0|||
155335115|NCT02686658|560661749|FG003|Overall Study|Participant non-compliance|0|||
155335116|NCT02686658|560661750|FG004|Overall Study|Participant non-compliance|0|||
155335117|NCT02686658|560661751|FG005|Overall Study|Participant non-compliance|1|||
155335118|NCT02686658|560661746|FG000|Overall Study|Concern over coronavirus disease care|0|||
155335119|NCT02686658|560661747|FG001|Overall Study|Concern over coronavirus disease care|0|||
155335120|NCT02686658|560661748|FG002|Overall Study|Concern over coronavirus disease care|0|||
155335121|NCT02686658|560661749|FG003|Overall Study|Concern over coronavirus disease care|0|||
155335122|NCT02686658|560661750|FG004|Overall Study|Concern over coronavirus disease care|2|||
155335123|NCT02686658|560661751|FG005|Overall Study|Concern over coronavirus disease care|1|||
155335124|NCT01227421|560661754|FG000|Overall Study|Lost to Follow-up|6|||
155335125|NCT01227421|560661755|FG001|Overall Study|Lost to Follow-up|7|||
155335126|NCT01227421|560661756|FG002|Overall Study|Lost to Follow-up|5|||
155335127|NCT01227421|560661754|FG000|Overall Study|Adverse Event|2|||
155335128|NCT01227421|560661755|FG001|Overall Study|Adverse Event|7|||
155335129|NCT01227421|560661756|FG002|Overall Study|Adverse Event|2|||
155335130|NCT01227421|560661754|FG000|Overall Study|Withdrawal by Subject|1|||
155335131|NCT01227421|560661755|FG001|Overall Study|Withdrawal by Subject|2|||
155335132|NCT01227421|560661756|FG002|Overall Study|Withdrawal by Subject|1|||
155335133|NCT01227421|560661754|FG000|Overall Study|Protocol Violation|1|||
155335134|NCT01227421|560661755|FG001|Overall Study|Protocol Violation|1|||
155335135|NCT01227421|560661756|FG002|Overall Study|Protocol Violation|2|||
155335136|NCT01227421|560661754|FG000|Overall Study|Randomized in error|1|||
155335137|NCT01227421|560661755|FG001|Overall Study|Randomized in error|1|||
155335138|NCT01227421|560661756|FG002|Overall Study|Randomized in error|0|||
155335139|NCT01827839|560661759|FG000|Overall Study|Adverse Event|1|||
155335140|NCT01827839|560661759|FG000|Overall Study|Consent Withdrawal|2|||
155335141|NCT00614614|560661760|FG000|Primary Vaccination Phase|Adverse Event|6|||
155071895|NCT04868682|559691929|FG000|12-month Assessment|Death|0|||
155163795|NCT02374450|560035080|FG001|Overall Study|Other|21|||
155335142|NCT00614614|560661761|FG001|Primary Vaccination Phase|Adverse Event|0|||
155335143|NCT00614614|560661762|FG002|Primary Vaccination Phase|Adverse Event|0|||
155335144|NCT00614614|560661763|FG003|Primary Vaccination Phase|Adverse Event|0|||
155335145|NCT00614614|560661764|FG004|Primary Vaccination Phase|Adverse Event|0|||
155335146|NCT00614614|560661760|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
155335147|NCT00614614|560661761|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
155335148|NCT00614614|560661762|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
155335149|NCT00614614|560661763|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
155335150|NCT00614614|560661764|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
155335151|NCT00614614|560661760|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
155335152|NCT00614614|560661761|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
155335153|NCT00614614|560661762|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
155335154|NCT00614614|560661763|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
155335155|NCT00614614|560661764|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
155335156|NCT00614614|560661760|FG000|Primary Vaccination Phase|Protocol Violation|9|||
155335157|NCT00614614|560661761|FG001|Primary Vaccination Phase|Protocol Violation|3|||
155335158|NCT00614614|560661762|FG002|Primary Vaccination Phase|Protocol Violation|0|||
155335159|NCT00614614|560661763|FG003|Primary Vaccination Phase|Protocol Violation|0|||
155335160|NCT00614614|560661764|FG004|Primary Vaccination Phase|Protocol Violation|0|||
155335161|NCT00614614|560661760|FG000|Primary Vaccination Phase|Other|4|||
155335162|NCT00614614|560661761|FG001|Primary Vaccination Phase|Other|0|||
155335163|NCT00614614|560661762|FG002|Primary Vaccination Phase|Other|0|||
155335164|NCT00614614|560661763|FG003|Primary Vaccination Phase|Other|0|||
155335165|NCT00614614|560661764|FG004|Primary Vaccination Phase|Other|0|||
155335166|NCT00614614|560661760|FG000|Booster Vaccination Phase|Adverse Event|0|||
155335167|NCT00614614|560661761|FG001|Booster Vaccination Phase|Adverse Event|0|||
155335168|NCT00614614|560661762|FG002|Booster Vaccination Phase|Adverse Event|1|||
155335169|NCT00614614|560661763|FG003|Booster Vaccination Phase|Adverse Event|1|||
155335170|NCT00614614|560661764|FG004|Booster Vaccination Phase|Adverse Event|0|||
155335171|NCT00614614|560661760|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
155335172|NCT00614614|560661761|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
155335173|NCT00614614|560661762|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
155335174|NCT00614614|560661763|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
155335175|NCT00614614|560661764|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
155335176|NCT00614614|560661760|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
155335177|NCT00614614|560661761|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
155335178|NCT00614614|560661762|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
155335179|NCT00614614|560661763|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
155335180|NCT00614614|560661764|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
155335181|NCT00614614|560661760|FG000|Booster Vaccination Phase|Protocol Violation|0|||
155335182|NCT00614614|560661761|FG001|Booster Vaccination Phase|Protocol Violation|0|||
155335183|NCT00614614|560661762|FG002|Booster Vaccination Phase|Protocol Violation|2|||
155335184|NCT00614614|560661763|FG003|Booster Vaccination Phase|Protocol Violation|3|||
155335185|NCT00614614|560661764|FG004|Booster Vaccination Phase|Protocol Violation|0|||
155335186|NCT00614614|560661760|FG000|Booster Vaccination Phase|Other|0|||
154962201|NCT02838420|559287915|FG001|Overall Study|Withdrawal by Subject|4|||
154962202|NCT02838420|559287914|FG000|Overall Study|Death|8|||
154962203|NCT02838420|559287915|FG001|Overall Study|Death|13|||
154962204|NCT05479058|559287916|FG000|Overall Study|Withdrawal by Subject|1|||
154962205|NCT05479058|559287917|FG001|Overall Study|Withdrawal by Subject|1|||
154962206|NCT05479058|559287916|FG000|Overall Study|Study terminated by sponsor|10|||
154962207|NCT05479058|559287917|FG001|Overall Study|Study terminated by sponsor|10|||
154962208|NCT05630885|559287918|FG000|Study Completion|Took prohibited medications|2|||
154962209|NCT05630885|559287919|FG001|Study Completion|Took prohibited medications|0|||
154962210|NCT05630885|559287918|FG000|Study Completion|Non-compliance with study drug|1|||
154962211|NCT05630885|559287919|FG001|Study Completion|Non-compliance with study drug|0|||
154962212|NCT05630885|559287918|FG000|Study Completion|Adverse Event|1|||
154962213|NCT05630885|559287919|FG001|Study Completion|Adverse Event|0|||
154962214|NCT05630885|559287918|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
154962215|NCT05630885|559287919|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
154962216|NCT05630885|559287918|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
154962217|NCT05630885|559287919|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
154962218|NCT02645409|559287920|FG000|Overall Study|Withdrawal by Subject|3|||
154962219|NCT02645409|559287921|FG001|Overall Study|Withdrawal by Subject|0|||
154962220|NCT02645409|559287920|FG000|Overall Study|Physician Decision|1|||
154962221|NCT02645409|559287921|FG001|Overall Study|Physician Decision|0|||
154962222|NCT03419403|559287922|FG000|Overall Study|Withdrawal by Subject|5|||
154962223|NCT03419403|559287923|FG001|Overall Study|Withdrawal by Subject|2|||
154962224|NCT03419403|559287924|FG002|Overall Study|Withdrawal by Subject|5|||
154962225|NCT03419403|559287925|FG003|Overall Study|Withdrawal by Subject|1|||
155071896|NCT04868682|559691930|FG001|12-month Assessment|Death|1|||
155071897|NCT03384966|559691931|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
155335187|NCT00614614|560661761|FG001|Booster Vaccination Phase|Other|1|||
155335188|NCT00614614|560661762|FG002|Booster Vaccination Phase|Other|3|||
155335189|NCT00614614|560661763|FG003|Booster Vaccination Phase|Other|2|||
155335190|NCT00614614|560661764|FG004|Booster Vaccination Phase|Other|1|||
155335191|NCT05426109|560661765|FG000|Overall Study|Withdrawal by Subject|0|||
155335192|NCT05426109|560661766|FG001|Overall Study|Withdrawal by Subject|1|||
155335193|NCT05212285|560661767|FG000|Overall Study|Lack of Efficacy|12|||
155335194|NCT05212285|560661768|FG001|Overall Study|Lack of Efficacy|8|||
155071898|NCT03384966|559691932|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
155335195|NCT05212285|560661767|FG000|Overall Study|Withdrawal by Subject|8|||
155335196|NCT05212285|560661768|FG001|Overall Study|Withdrawal by Subject|1|||
155335197|NCT05212285|560661767|FG000|Overall Study|Lost to Follow-up|13|||
155335198|NCT05212285|560661768|FG001|Overall Study|Lost to Follow-up|1|||
155335199|NCT05212285|560661767|FG000|Overall Study|miss data|21|||
155335200|NCT05212285|560661768|FG001|Overall Study|miss data|2|||
155335201|NCT01000805|560661770|FG000|Overall Study|Adverse Event|21|||
155335202|NCT01000805|560661771|FG001|Overall Study|Adverse Event|9|||
155335203|NCT01000805|560661770|FG000|Overall Study|Lack of Efficacy|5|||
155335204|NCT01000805|560661771|FG001|Overall Study|Lack of Efficacy|16|||
155335205|NCT01000805|560661770|FG000|Overall Study|Lost to Follow-up|16|||
155335206|NCT01000805|560661771|FG001|Overall Study|Lost to Follow-up|21|||
155335207|NCT01000805|560661770|FG000|Overall Study|Physician Decision|0|||
155335208|NCT01000805|560661771|FG001|Overall Study|Physician Decision|1|||
155335209|NCT01000805|560661770|FG000|Overall Study|Protocol Violation|12|||
155335210|NCT01000805|560661771|FG001|Overall Study|Protocol Violation|8|||
155335211|NCT01000805|560661770|FG000|Overall Study|Withdrawal by Subject|16|||
155335212|NCT01000805|560661771|FG001|Overall Study|Withdrawal by Subject|6|||
155335213|NCT01000805|560661770|FG000|Overall Study|Sponsor Decision|0|||
155335214|NCT01000805|560661771|FG001|Overall Study|Sponsor Decision|1|||
155335215|NCT03343704|560661774|FG000|Overall Study|Refused to complete follow up|0|||
155335216|NCT03343704|560661775|FG001|Overall Study|Refused to complete follow up|1|||
155335217|NCT03343704|560661774|FG000|Overall Study|Death|0|||
155335218|NCT03343704|560661775|FG001|Overall Study|Death|1|||
155335219|NCT03343704|560661774|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
155335220|NCT03343704|560661775|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
154962226|NCT03419403|559287922|FG000|Overall Study|Progressive disease (per protocol)|0|||
154962227|NCT03419403|559287923|FG001|Overall Study|Progressive disease (per protocol)|2|||
155071899|NCT03384966|559691933|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
155335221|NCT05432986|560661780|FG000|Overall Study|Withdrawal by Subject|2|||
155335222|NCT05432986|560661780|FG000|Overall Study|incomplete measurement|7|||
155335223|NCT00949117|560663034|FG000|Overall Study|Lack of Efficacy|2|||
155335224|NCT00949117|560663035|FG001|Overall Study|Lack of Efficacy|3|||
155335225|NCT00949117|560663034|FG000|Overall Study|Protocol Violation|1|||
155335226|NCT00949117|560663035|FG001|Overall Study|Protocol Violation|1|||
155335227|NCT00949117|560663034|FG000|Overall Study|Adverse Event|0|||
155335228|NCT00949117|560663035|FG001|Overall Study|Adverse Event|1|||
155335229|NCT03964974|560663036|FG000|Overall Study|Lost to Follow-up|3|||
155335230|NCT03964974|560663037|FG001|Overall Study|Lost to Follow-up|2|||
155071900|NCT03384966|559691931|FG000|Follow-up Period|Adverse Event|1|||
155335231|NCT03964974|560663036|FG000|Overall Study|Withdrawal by Subject|0|||
155335232|NCT03964974|560663037|FG001|Overall Study|Withdrawal by Subject|3|||
155335233|NCT02014402|560663038|FG000|Overall Study|Adverse Event|1|||
155335234|NCT02014402|560663039|FG001|Overall Study|Adverse Event|0|||
155335235|NCT02014402|560663040|FG002|Overall Study|Adverse Event|0|||
155335236|NCT02014402|560663041|FG003|Overall Study|Adverse Event|0|||
155335237|NCT02014402|560663038|FG000|Overall Study|Withdrawal by Subject|1|||
155335238|NCT02014402|560663039|FG001|Overall Study|Withdrawal by Subject|2|||
155335239|NCT02014402|560663040|FG002|Overall Study|Withdrawal by Subject|2|||
155335240|NCT02014402|560663041|FG003|Overall Study|Withdrawal by Subject|1|||
155335241|NCT02014402|560663038|FG000|Overall Study|Subject did not have transportation|0|||
155335242|NCT02014402|560663039|FG001|Overall Study|Subject did not have transportation|1|||
155335243|NCT02014402|560663040|FG002|Overall Study|Subject did not have transportation|0|||
155335244|NCT02014402|560663041|FG003|Overall Study|Subject did not have transportation|0|||
155335245|NCT02014402|560663038|FG000|Overall Study|Lost to Follow-up|0|||
155335246|NCT02014402|560663039|FG001|Overall Study|Lost to Follow-up|0|||
155335247|NCT02014402|560663040|FG002|Overall Study|Lost to Follow-up|1|||
155335248|NCT02014402|560663041|FG003|Overall Study|Lost to Follow-up|2|||
155335249|NCT01364597|560663043|FG000|Overall Study|Adverse Event|4|||
155335250|NCT01364597|560663044|FG001|Overall Study|Adverse Event|5|||
155335251|NCT01364597|560663045|FG002|Overall Study|Adverse Event|16|||
155335252|NCT01364597|560663046|FG003|Overall Study|Adverse Event|7|||
155335253|NCT01364597|560663043|FG000|Overall Study|Lack of Efficacy|4|||
155335254|NCT01364597|560663044|FG001|Overall Study|Lack of Efficacy|4|||
155335255|NCT01364597|560663045|FG002|Overall Study|Lack of Efficacy|23|||
155335256|NCT01364597|560663046|FG003|Overall Study|Lack of Efficacy|8|||
155335257|NCT01364597|560663043|FG000|Overall Study|Protocol Violation|0|||
155335258|NCT01364597|560663044|FG001|Overall Study|Protocol Violation|0|||
155335259|NCT01364597|560663045|FG002|Overall Study|Protocol Violation|2|||
155071901|NCT03384966|559691932|FG001|Follow-up Period|Adverse Event|0|||
155071902|NCT03384966|559691933|FG002|Follow-up Period|Adverse Event|0|||
155071903|NCT03880565|559691934|FG000|Overall Study|Withdrawal by Subject|1|||
155071904|NCT03880565|559691935|FG001|Overall Study|Withdrawal by Subject|0|||
155071905|NCT02202616|559691936|FG000|Overall Study|Screen failed|24|||
155071906|NCT02202616|559691936|FG000|Overall Study|Adverse Event|32|||
155071907|NCT02202616|559691936|FG000|Overall Study|Protocol deviation|18|||
155071908|NCT02202616|559691936|FG000|Overall Study|Patient withdrew consent|12|||
155071909|NCT02202616|559691936|FG000|Overall Study|Lost to Follow-up|6|||
155071910|NCT02202616|559691936|FG000|Overall Study|Administrative problems|6|||
155071911|NCT02202616|559691936|FG000|Overall Study|Abnormal test procedure result|1|||
155071912|NCT02202616|559691936|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155071913|NCT00367458|559691937|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
155071914|NCT00367458|559691938|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
155071915|NCT04470427|559691939|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
155071916|NCT04470427|559691940|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
155071917|NCT04470427|559691941|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
155071918|NCT04470427|559691942|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
155071919|NCT04470427|559691943|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
155071920|NCT04470427|559691944|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
155071921|NCT04470427|559691939|FG000|Part B :Open-label|Other than specified|0|||
155071922|NCT04470427|559691940|FG001|Part B :Open-label|Other than specified|0|||
155071923|NCT04470427|559691941|FG002|Part B :Open-label|Other than specified|788|||
155071924|NCT04470427|559691942|FG003|Part B :Open-label|Other than specified|0|||
155071925|NCT04470427|559691943|FG004|Part B :Open-label|Other than specified|523|||
155071926|NCT04470427|559691944|FG005|Part B :Open-label|Other than specified|0|||
155071927|NCT04470427|559691939|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
155071928|NCT04470427|559691940|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
155071929|NCT04470427|559691941|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
155071930|NCT04470427|559691942|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
155071931|NCT04470427|559691943|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
155071932|NCT04470427|559691944|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
155071933|NCT04470427|559691939|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
155071934|NCT04470427|559691940|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
155335260|NCT01364597|560663046|FG003|Overall Study|Protocol Violation|0|||
155335261|NCT01364597|560663043|FG000|Overall Study|Lost to Follow-up|0|||
155335262|NCT01364597|560663044|FG001|Overall Study|Lost to Follow-up|0|||
155071935|NCT04470427|559691941|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
155071936|NCT04470427|559691942|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
155335263|NCT01364597|560663045|FG002|Overall Study|Lost to Follow-up|5|||
155335264|NCT01364597|560663046|FG003|Overall Study|Lost to Follow-up|3|||
155335265|NCT01364597|560663043|FG000|Overall Study|Withdrawal by Subject|4|||
155071937|NCT04470427|559691943|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
155071938|NCT04470427|559691944|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
155071939|NCT01695746|559691945|FG000|Overall Study|Adverse Event|1|||
155071940|NCT01695746|559691945|FG000|Overall Study|Non-compliance by the participant|3|||
155335266|NCT01364597|560663044|FG001|Overall Study|Withdrawal by Subject|1|||
155335267|NCT01364597|560663045|FG002|Overall Study|Withdrawal by Subject|18|||
155335268|NCT01364597|560663046|FG003|Overall Study|Withdrawal by Subject|6|||
155335269|NCT01364597|560663043|FG000|Overall Study|Non compliance|1|||
155335270|NCT01364597|560663044|FG001|Overall Study|Non compliance|0|||
155335271|NCT01364597|560663045|FG002|Overall Study|Non compliance|1|||
155335272|NCT01364597|560663046|FG003|Overall Study|Non compliance|0|||
155335273|NCT01364597|560663043|FG000|Overall Study|Lack of compliance|1|||
155335274|NCT01364597|560663044|FG001|Overall Study|Lack of compliance|0|||
155335275|NCT01364597|560663045|FG002|Overall Study|Lack of compliance|0|||
155335276|NCT01364597|560663046|FG003|Overall Study|Lack of compliance|0|||
155335277|NCT01364597|560663043|FG000|Overall Study|End of treatment epilepsy|1|||
155335278|NCT01364597|560663044|FG001|Overall Study|End of treatment epilepsy|0|||
155335279|NCT01364597|560663045|FG002|Overall Study|End of treatment epilepsy|0|||
155335280|NCT01364597|560663046|FG003|Overall Study|End of treatment epilepsy|0|||
155335281|NCT01364597|560663043|FG000|Overall Study|No Seizures|1|||
155335282|NCT01364597|560663044|FG001|Overall Study|No Seizures|0|||
155335283|NCT01364597|560663045|FG002|Overall Study|No Seizures|0|||
155335284|NCT01364597|560663046|FG003|Overall Study|No Seizures|0|||
155335285|NCT01364597|560663043|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
155335286|NCT01364597|560663044|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
155335287|NCT01364597|560663045|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
155335288|NCT01364597|560663046|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
155335289|NCT01364597|560663043|FG000|Overall Study|Cure|1|||
155335290|NCT01364597|560663044|FG001|Overall Study|Cure|0|||
155335291|NCT01364597|560663045|FG002|Overall Study|Cure|0|||
155335292|NCT01364597|560663046|FG003|Overall Study|Cure|0|||
155335293|NCT01364597|560663043|FG000|Overall Study|Patient was moving|0|||
155335294|NCT01364597|560663044|FG001|Overall Study|Patient was moving|1|||
155335295|NCT01364597|560663045|FG002|Overall Study|Patient was moving|0|||
155335296|NCT01364597|560663046|FG003|Overall Study|Patient was moving|0|||
155335297|NCT01364597|560663043|FG000|Overall Study|Seizures resolved|0|||
155335298|NCT01364597|560663044|FG001|Overall Study|Seizures resolved|0|||
155335299|NCT01364597|560663045|FG002|Overall Study|Seizures resolved|1|||
155335300|NCT01364597|560663046|FG003|Overall Study|Seizures resolved|0|||
155335301|NCT01364597|560663043|FG000|Overall Study|Patient became seizure-free after surgery|0|||
155335302|NCT01364597|560663044|FG001|Overall Study|Patient became seizure-free after surgery|0|||
155335303|NCT01364597|560663045|FG002|Overall Study|Patient became seizure-free after surgery|1|||
155335304|NCT01364597|560663046|FG003|Overall Study|Patient became seizure-free after surgery|0|||
155071941|NCT01695746|559691945|FG000|Overall Study|Protocol Violation|5|||
155071942|NCT01695746|559691945|FG000|Overall Study|Participant not willing to participate|3|||
155335305|NCT01364597|560663043|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
155335306|NCT01364597|560663044|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
155335307|NCT01364597|560663045|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
155335308|NCT01364597|560663046|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
155335309|NCT01364597|560663043|FG000|Overall Study|Patient cured from Epilepsy|0|||
155335310|NCT01364597|560663044|FG001|Overall Study|Patient cured from Epilepsy|0|||
155335311|NCT01364597|560663045|FG002|Overall Study|Patient cured from Epilepsy|1|||
155335312|NCT01364597|560663046|FG003|Overall Study|Patient cured from Epilepsy|0|||
155335313|NCT01364597|560663043|FG000|Overall Study|Investigator decision|0|||
155335314|NCT01364597|560663044|FG001|Overall Study|Investigator decision|0|||
155335315|NCT01364597|560663045|FG002|Overall Study|Investigator decision|1|||
155335316|NCT01364597|560663046|FG003|Overall Study|Investigator decision|0|||
155335317|NCT01364597|560663043|FG000|Overall Study|Sponsor recommended discontinuation|0|||
155335318|NCT01364597|560663044|FG001|Overall Study|Sponsor recommended discontinuation|0|||
155335319|NCT01364597|560663045|FG002|Overall Study|Sponsor recommended discontinuation|0|||
155071943|NCT02324153|559691947|FG000|Overall Study|Withdrawal by Subject|4|||
155335320|NCT01364597|560663046|FG003|Overall Study|Sponsor recommended discontinuation|1|||
155335321|NCT01364597|560663043|FG000|Overall Study|Parents went abroad with the patient|0|||
155335322|NCT01364597|560663044|FG001|Overall Study|Parents went abroad with the patient|0|||
155335323|NCT01364597|560663045|FG002|Overall Study|Parents went abroad with the patient|1|||
155335324|NCT01364597|560663046|FG003|Overall Study|Parents went abroad with the patient|0|||
155335325|NCT01364597|560663043|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
155335326|NCT01364597|560663044|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
155335327|NCT01364597|560663045|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
155335328|NCT01364597|560663046|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
155335329|NCT01364597|560663043|FG000|Overall Study|BRV administration dropout|0|||
155335330|NCT01364597|560663044|FG001|Overall Study|BRV administration dropout|0|||
155335331|NCT01364597|560663045|FG002|Overall Study|BRV administration dropout|1|||
155335332|NCT01364597|560663046|FG003|Overall Study|BRV administration dropout|0|||
155335333|NCT01364597|560663043|FG000|Overall Study|Dropout|0|||
155335334|NCT01364597|560663044|FG001|Overall Study|Dropout|0|||
155335335|NCT01364597|560663045|FG002|Overall Study|Dropout|3|||
155335336|NCT01364597|560663046|FG003|Overall Study|Dropout|1|||
155335337|NCT01364597|560663043|FG000|Overall Study|Unreliable subject|0|||
155335338|NCT01364597|560663044|FG001|Overall Study|Unreliable subject|0|||
155335339|NCT01364597|560663045|FG002|Overall Study|Unreliable subject|0|||
155335340|NCT01364597|560663046|FG003|Overall Study|Unreliable subject|1|||
155335341|NCT01364597|560663043|FG000|Overall Study|Other|0|||
155335342|NCT01364597|560663044|FG001|Overall Study|Other|0|||
155335343|NCT01364597|560663045|FG002|Overall Study|Other|0|||
155335344|NCT01364597|560663046|FG003|Overall Study|Other|1|||
155335345|NCT03493282|560663050|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
155335346|NCT03493282|560663051|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
155335347|NCT03493282|560663052|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
155335348|NCT03493282|560663050|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
155335349|NCT03493282|560663051|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
155335350|NCT03493282|560663052|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
155335351|NCT01380145|560663053|FG000|Overall Study|Progressive disease|4|||
155335352|NCT02038049|560663054|FG000|Overall Study|Lost to Follow-up|1|||
155335353|NCT02038049|560663055|FG001|Overall Study|Lost to Follow-up|0|||
155335354|NCT02660086|560663057|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
155335355|NCT02660086|560663058|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
155335356|NCT02660086|560663057|FG000|Overall Study- 12-month|Left full-time employment|12|||
155335357|NCT02660086|560663058|FG001|Overall Study- 12-month|Left full-time employment|20|||
155335358|NCT02660086|560663057|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
155335359|NCT02660086|560663058|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
155335360|NCT02660086|560663057|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
155335361|NCT02660086|560663058|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
155335362|NCT02660086|560663057|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
155335363|NCT02660086|560663058|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
155335364|NCT02660086|560663057|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
155335365|NCT02660086|560663058|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
155335366|NCT00587171|560663061|FG000|Overall Study|Lost to Follow-up|1|||
155335367|NCT00587171|560663062|FG001|Overall Study|Lost to Follow-up|1|||
155335368|NCT02148705|560663066|FG000|Overall Study|Death|2|||
155335369|NCT02148705|560663067|FG001|Overall Study|Death|0|||
155335370|NCT02148705|560663068|FG002|Overall Study|Death|0|||
155335371|NCT02148705|560663066|FG000|Overall Study|Lost to Follow-up|13|||
155335372|NCT02148705|560663067|FG001|Overall Study|Lost to Follow-up|4|||
155335373|NCT02148705|560663068|FG002|Overall Study|Lost to Follow-up|10|||
155335374|NCT02148705|560663066|FG000|Overall Study|Withdrawal by Subject|3|||
155335375|NCT02148705|560663067|FG001|Overall Study|Withdrawal by Subject|0|||
155335376|NCT02148705|560663068|FG002|Overall Study|Withdrawal by Subject|2|||
155163796|NCT02374450|560035081|FG002|Overall Study|Other|79|||
155163797|NCT05232682|560035082|FG000|Overall Study|Lost to Follow-up|2|||
155163798|NCT00905164|560035085|FG000|Period 1|Protocol Violation|0|||
155335377|NCT02148705|560663066|FG000|Overall Study|Not Treated|0|||
155335378|NCT02148705|560663067|FG001|Overall Study|Not Treated|1|||
155335379|NCT02148705|560663068|FG002|Overall Study|Not Treated|5|||
155335380|NCT01737021|560663069|FG000|Overall Study|Lost to Follow-up|5|||
155335381|NCT01737021|560663070|FG001|Overall Study|Lost to Follow-up|3|||
155335382|NCT01673594|560663071|FG000|Overall Study|Adverse Event|3|||
155335383|NCT01673594|560663072|FG001|Overall Study|Adverse Event|1|||
155335384|NCT01673594|560663071|FG000|Overall Study|Lost to Follow-up|1|||
155335385|NCT01673594|560663072|FG001|Overall Study|Lost to Follow-up|0|||
155335386|NCT01673594|560663071|FG000|Overall Study|Physician Decision|2|||
155335387|NCT01673594|560663072|FG001|Overall Study|Physician Decision|4|||
155335388|NCT01673594|560663071|FG000|Overall Study|Withdrawal by Subject|0|||
155335389|NCT01673594|560663072|FG001|Overall Study|Withdrawal by Subject|1|||
155335390|NCT02605174|560663076|FG000|Overall Study|Adverse Event|0|||
155335391|NCT02605174|560663077|FG001|Overall Study|Adverse Event|0|||
155335392|NCT02605174|560663078|FG002|Overall Study|Adverse Event|1|||
155335393|NCT02605174|560663079|FG003|Overall Study|Adverse Event|0|||
155335394|NCT02605174|560663080|FG004|Overall Study|Adverse Event|4|||
155335395|NCT02605174|560663081|FG005|Overall Study|Adverse Event|0|||
155335396|NCT02605174|560663082|FG006|Overall Study|Adverse Event|0|||
155335397|NCT02605174|560663076|FG000|Overall Study|Lost to Follow-up|20|||
155335398|NCT02605174|560663077|FG001|Overall Study|Lost to Follow-up|7|||
155335399|NCT02605174|560663078|FG002|Overall Study|Lost to Follow-up|27|||
155335400|NCT02605174|560663079|FG003|Overall Study|Lost to Follow-up|10|||
155335401|NCT02605174|560663080|FG004|Overall Study|Lost to Follow-up|20|||
155335402|NCT02605174|560663081|FG005|Overall Study|Lost to Follow-up|10|||
155335403|NCT02605174|560663082|FG006|Overall Study|Lost to Follow-up|29|||
155335404|NCT02605174|560663076|FG000|Overall Study|Protocol Violation|10|||
155335405|NCT02605174|560663077|FG001|Overall Study|Protocol Violation|4|||
155335406|NCT02605174|560663078|FG002|Overall Study|Protocol Violation|14|||
155335407|NCT02605174|560663079|FG003|Overall Study|Protocol Violation|6|||
155335408|NCT02605174|560663080|FG004|Overall Study|Protocol Violation|7|||
155335409|NCT02605174|560663081|FG005|Overall Study|Protocol Violation|7|||
155335410|NCT02605174|560663082|FG006|Overall Study|Protocol Violation|12|||
155335411|NCT02605174|560663076|FG000|Overall Study|Pregnancy|1|||
155335412|NCT02605174|560663077|FG001|Overall Study|Pregnancy|0|||
155335413|NCT02605174|560663078|FG002|Overall Study|Pregnancy|0|||
155335414|NCT02605174|560663079|FG003|Overall Study|Pregnancy|2|||
155335415|NCT02605174|560663080|FG004|Overall Study|Pregnancy|0|||
155335416|NCT02605174|560663081|FG005|Overall Study|Pregnancy|0|||
155335417|NCT02605174|560663082|FG006|Overall Study|Pregnancy|0|||
155335418|NCT02605174|560663076|FG000|Overall Study|Withdrawal by Subject|9|||
155335419|NCT02605174|560663077|FG001|Overall Study|Withdrawal by Subject|6|||
155335420|NCT02605174|560663078|FG002|Overall Study|Withdrawal by Subject|14|||
155335421|NCT02605174|560663079|FG003|Overall Study|Withdrawal by Subject|11|||
155335422|NCT02605174|560663080|FG004|Overall Study|Withdrawal by Subject|6|||
155335423|NCT02605174|560663081|FG005|Overall Study|Withdrawal by Subject|4|||
155335424|NCT02605174|560663082|FG006|Overall Study|Withdrawal by Subject|15|||
155335425|NCT02605174|560663076|FG000|Overall Study|Physician Decision|2|||
155335426|NCT02605174|560663077|FG001|Overall Study|Physician Decision|0|||
155335427|NCT02605174|560663078|FG002|Overall Study|Physician Decision|0|||
155335428|NCT02605174|560663079|FG003|Overall Study|Physician Decision|0|||
155335429|NCT02605174|560663080|FG004|Overall Study|Physician Decision|0|||
155335430|NCT02605174|560663081|FG005|Overall Study|Physician Decision|0|||
155335431|NCT02605174|560663082|FG006|Overall Study|Physician Decision|3|||
155335432|NCT02605174|560663076|FG000|Overall Study|Randomization Failure|22|||
155335433|NCT02605174|560663077|FG001|Overall Study|Randomization Failure|6|||
155335434|NCT02605174|560663078|FG002|Overall Study|Randomization Failure|20|||
155335435|NCT02605174|560663079|FG003|Overall Study|Randomization Failure|7|||
155335436|NCT02605174|560663080|FG004|Overall Study|Randomization Failure|16|||
155335437|NCT02605174|560663081|FG005|Overall Study|Randomization Failure|11|||
155335438|NCT02605174|560663082|FG006|Overall Study|Randomization Failure|30|||
155335439|NCT04250636|560663083|FG000|Overall Study|Lost to Follow-up|2|||
155335440|NCT05005247|560663088|FG000|Overall Study|Withdrawal by Subject|0|||
155335441|NCT05005247|560663089|FG001|Overall Study|Withdrawal by Subject|1|||
155335442|NCT05005247|560663090|FG002|Overall Study|Withdrawal by Subject|0|||
155335443|NCT02827201|560663097|FG000|Overall Study|Death|1|||
155335444|NCT02827201|560663098|FG001|Overall Study|Death|2|||
155335445|NCT02827201|560663097|FG000|Overall Study|Patients not treated|1|||
155335446|NCT02827201|560663098|FG001|Overall Study|Patients not treated|1|||
155335447|NCT02630186|560663099|FG000|Overall Study|Withdrawal by Subject|1|||
155335448|NCT00439218|560663100|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
155335449|NCT02128269|560663103|FG000|Treatment Period|Adverse Event|1|||
155335450|NCT02128269|560663103|FG000|Treatment Period|Physician Decision|1|||
155335451|NCT01021748|560663104|FG000|Overall Study|Adverse Event|2|||
155335452|NCT01021748|560663105|FG001|Overall Study|Adverse Event|1|||
155335453|NCT01021748|560663106|FG002|Overall Study|Adverse Event|2|||
155163799|NCT00905164|560035086|FG001|Period 1|Protocol Violation|1|||
155335454|NCT01021748|560663107|FG003|Overall Study|Adverse Event|0|||
155335455|NCT01021748|560663108|FG004|Overall Study|Adverse Event|2|||
155335456|NCT01021748|560663109|FG005|Overall Study|Adverse Event|0|||
155335457|NCT01021748|560663110|FG006|Overall Study|Adverse Event|1|||
155335458|NCT01021748|560663111|FG007|Overall Study|Adverse Event|0|||
155335459|NCT01021748|560663112|FG008|Overall Study|Adverse Event|7|||
155335460|NCT01021748|560663104|FG000|Overall Study|Physician Decision|1|||
155335461|NCT01021748|560663105|FG001|Overall Study|Physician Decision|0|||
155335462|NCT01021748|560663106|FG002|Overall Study|Physician Decision|1|||
155335463|NCT01021748|560663107|FG003|Overall Study|Physician Decision|1|||
155335464|NCT01021748|560663108|FG004|Overall Study|Physician Decision|0|||
155071944|NCT02324153|559691948|FG001|Overall Study|Withdrawal by Subject|1|||
155335465|NCT01021748|560663109|FG005|Overall Study|Physician Decision|0|||
155071945|NCT02324153|559691947|FG000|Overall Study|Surgery postponed after randomization|3|||
155071946|NCT02324153|559691948|FG001|Overall Study|Surgery postponed after randomization|0|||
155071947|NCT02324153|559691947|FG000|Overall Study|Developed delirium preoperatively|1|||
155071948|NCT02324153|559691948|FG001|Overall Study|Developed delirium preoperatively|0|||
155071949|NCT01913353|559691952|FG000|Overall Study|Adverse Event|2|||
155071950|NCT01913353|559691953|FG001|Overall Study|Adverse Event|0|||
155335466|NCT01021748|560663110|FG006|Overall Study|Physician Decision|1|||
155335467|NCT01021748|560663111|FG007|Overall Study|Physician Decision|1|||
155335468|NCT01021748|560663112|FG008|Overall Study|Physician Decision|2|||
155335469|NCT01021748|560663104|FG000|Overall Study|Progressive Disease|3|||
155335470|NCT01021748|560663105|FG001|Overall Study|Progressive Disease|3|||
155335471|NCT01021748|560663106|FG002|Overall Study|Progressive Disease|4|||
155335472|NCT01021748|560663107|FG003|Overall Study|Progressive Disease|6|||
155335473|NCT01021748|560663108|FG004|Overall Study|Progressive Disease|7|||
155335474|NCT01021748|560663109|FG005|Overall Study|Progressive Disease|3|||
155335475|NCT01021748|560663110|FG006|Overall Study|Progressive Disease|0|||
155335476|NCT01021748|560663111|FG007|Overall Study|Progressive Disease|5|||
155335477|NCT01021748|560663112|FG008|Overall Study|Progressive Disease|6|||
155335478|NCT01021748|560663104|FG000|Overall Study|Withdrawal by Subject|0|||
155335479|NCT01021748|560663105|FG001|Overall Study|Withdrawal by Subject|0|||
155335480|NCT01021748|560663106|FG002|Overall Study|Withdrawal by Subject|0|||
155335481|NCT01021748|560663107|FG003|Overall Study|Withdrawal by Subject|0|||
155335482|NCT01021748|560663108|FG004|Overall Study|Withdrawal by Subject|0|||
155335483|NCT01021748|560663109|FG005|Overall Study|Withdrawal by Subject|0|||
155335484|NCT01021748|560663110|FG006|Overall Study|Withdrawal by Subject|1|||
155335485|NCT01021748|560663111|FG007|Overall Study|Withdrawal by Subject|0|||
155335486|NCT01021748|560663112|FG008|Overall Study|Withdrawal by Subject|1|||
155335487|NCT01021748|560663104|FG000|Overall Study|Not Treated|0|||
155071951|NCT01913353|559691952|FG000|Overall Study|Physician Decision|0|||
155071952|NCT01913353|559691953|FG001|Overall Study|Physician Decision|2|||
155071953|NCT01913353|559691952|FG000|Overall Study|Withdrawal by Subject|20|||
155335488|NCT01021748|560663105|FG001|Overall Study|Not Treated|1|||
155335489|NCT01021748|560663106|FG002|Overall Study|Not Treated|0|||
155071954|NCT01913353|559691953|FG001|Overall Study|Withdrawal by Subject|6|||
155071955|NCT01913353|559691952|FG000|Overall Study|multiple reasons|10|||
155071956|NCT01913353|559691953|FG001|Overall Study|multiple reasons|7|||
155335490|NCT01021748|560663107|FG003|Overall Study|Not Treated|0|||
155335491|NCT01021748|560663108|FG004|Overall Study|Not Treated|0|||
155335492|NCT01021748|560663109|FG005|Overall Study|Not Treated|0|||
155335493|NCT01021748|560663110|FG006|Overall Study|Not Treated|0|||
155335494|NCT01021748|560663111|FG007|Overall Study|Not Treated|0|||
155335495|NCT01021748|560663112|FG008|Overall Study|Not Treated|0|||
155335496|NCT01829711|560663113|FG000|Overall Study|Lost to Follow-up|2|||
155335497|NCT01829711|560663113|FG000|Overall Study|Withdrawal by Subject|3|||
155335498|NCT01829711|560663113|FG000|Overall Study|Death|4|||
155335499|NCT01829711|560663113|FG000|Overall Study|Started new therapies|17|||
155335500|NCT01829711|560663113|FG000|Overall Study|Adverse Event|3|||
155335501|NCT01829711|560663113|FG000|Overall Study|Due to progression of disease|13|||
154962228|NCT03419403|559287924|FG002|Overall Study|Progressive disease (per protocol)|2|||
155335502|NCT01829711|560663113|FG000|Overall Study|Due to lack of response|1|||
155335503|NCT01480258|560663114|FG000|Infant Series|Protocol Violation|2|||
155335504|NCT01480258|560663115|FG001|Infant Series|Protocol Violation|0|||
154962229|NCT03419403|559287925|FG003|Overall Study|Progressive disease (per protocol)|0|||
154962230|NCT03419403|559287922|FG000|Overall Study|Other, not specified|6|||
154962231|NCT03419403|559287923|FG001|Overall Study|Other, not specified|4|||
154962232|NCT03419403|559287924|FG002|Overall Study|Other, not specified|5|||
154962233|NCT03419403|559287925|FG003|Overall Study|Other, not specified|1|||
154962234|NCT03419403|559287922|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
154962235|NCT03419403|559287923|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
154962236|NCT03419403|559287924|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
154962237|NCT03419403|559287925|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
154962238|NCT02089685|559287926|FG000|Overall Study|Adverse Event|1|||
155071957|NCT00385840|559691954|FG000|Overall Study|Adverse Event|1|||
155071958|NCT00385840|559691955|FG001|Overall Study|Adverse Event|1|||
155071959|NCT00385840|559691954|FG000|Overall Study|Lost to Follow-up|3|||
155071960|NCT00385840|559691955|FG001|Overall Study|Lost to Follow-up|13|||
155071961|NCT04017962|559691956|FG000|Overall Study|Death|2|||
155071962|NCT04017962|559691957|FG001|Overall Study|Death|0|||
155071963|NCT04017962|559691956|FG000|Overall Study|Lost to Follow-up|2|||
155071964|NCT04017962|559691957|FG001|Overall Study|Lost to Follow-up|0|||
155071965|NCT04017962|559691956|FG000|Overall Study|Physician Decision|1|||
155071966|NCT04017962|559691957|FG001|Overall Study|Physician Decision|0|||
155071967|NCT04017962|559691956|FG000|Overall Study|Discontinued LTV|5|||
155071968|NCT04017962|559691957|FG001|Overall Study|Discontinued LTV|0|||
155071969|NCT04633447|559692971|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
155071970|NCT04633447|559692972|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
155071971|NCT04633447|559692971|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
155071972|NCT04633447|559692972|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
155071973|NCT04633447|559692971|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
155071974|NCT04633447|559692972|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
155071975|NCT04633447|559692971|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
155071976|NCT04633447|559692972|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
155071977|NCT04633447|559692971|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
155071978|NCT04633447|559692972|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
155071979|NCT04633447|559692971|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
155071980|NCT04633447|559692972|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
155071981|NCT03641924|559692973|FG000|Overall Study|Withdrawal by Subject|26|||
155071982|NCT03641924|559692973|FG000|Overall Study|Lost to Follow-up|16|||
155071983|NCT03641924|559692973|FG000|Overall Study|Protocol Violation|10|||
155071984|NCT01565694|559692974|FG000|Dose-Titration Period|Adverse Event|4|||
155071985|NCT01565694|559692974|FG000|Dose-Titration Period|Protocol Violation|10|||
155071986|NCT01565694|559692974|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
155071987|NCT01373229|559692975|FG000|Overall Study|Death|3|||
155071988|NCT01373229|559692975|FG000|Overall Study|Physician Decision|3|||
155071989|NCT03033901|559692976|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
155071990|NCT03033901|559692976|FG000|Overall Study|Refused PSG|23|||
155335505|NCT01480258|560663114|FG000|Infant Series|Physician Decision|0|||
155335506|NCT01480258|560663115|FG001|Infant Series|Physician Decision|1|||
155335507|NCT01480258|560663114|FG000|Infant Series|Not Vaccinated|3|||
155335508|NCT01480258|560663115|FG001|Infant Series|Not Vaccinated|0|||
155335509|NCT01480258|560663114|FG000|Infant Series|Adverse Event|1|||
155335510|NCT01480258|560663115|FG001|Infant Series|Adverse Event|1|||
155071991|NCT03033901|559692976|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
155071992|NCT03033901|559692976|FG000|Overall Study|Missing Oximetry Data|3|||
155071993|NCT00729586|559692977|FG000|Overall Study|Ineligible|0|||
155071994|NCT00729586|559692978|FG001|Overall Study|Ineligible|1|||
155071995|NCT00729586|559692977|FG000|Overall Study|never treated|1|||
155071996|NCT00729586|559692978|FG001|Overall Study|never treated|0|||
155071997|NCT04602000|559692996|FG000|Overall Study|Withdrawal by Subject|3|||
155071998|NCT04602000|559692997|FG001|Overall Study|Withdrawal by Subject|6|||
155071999|NCT04602000|559692998|FG002|Overall Study|Withdrawal by Subject|3|||
155072000|NCT04602000|559692999|FG003|Overall Study|Withdrawal by Subject|27|||
155072001|NCT04602000|559693000|FG004|Overall Study|Withdrawal by Subject|39|||
155072002|NCT04602000|559692996|FG000|Overall Study|Physician Decision|1|||
155072003|NCT04602000|559692997|FG001|Overall Study|Physician Decision|0|||
155072004|NCT04602000|559692998|FG002|Overall Study|Physician Decision|0|||
155072005|NCT04602000|559692999|FG003|Overall Study|Physician Decision|2|||
155072006|NCT04602000|559693000|FG004|Overall Study|Physician Decision|2|||
155072007|NCT04602000|559692996|FG000|Overall Study|Death|0|||
155072008|NCT04602000|559692997|FG001|Overall Study|Death|1|||
155072009|NCT04602000|559692998|FG002|Overall Study|Death|0|||
155072010|NCT04602000|559692999|FG003|Overall Study|Death|1|||
155072011|NCT04602000|559693000|FG004|Overall Study|Death|2|||
155072012|NCT04602000|559692996|FG000|Overall Study|Lost to Follow-up|0|||
155072013|NCT04602000|559692997|FG001|Overall Study|Lost to Follow-up|0|||
155072014|NCT04602000|559692998|FG002|Overall Study|Lost to Follow-up|0|||
155072015|NCT04602000|559692999|FG003|Overall Study|Lost to Follow-up|3|||
155072016|NCT04602000|559693000|FG004|Overall Study|Lost to Follow-up|4|||
155072017|NCT04602000|559692996|FG000|Overall Study|Other|4|||
155072018|NCT04602000|559692997|FG001|Overall Study|Other|1|||
155072019|NCT04602000|559692998|FG002|Overall Study|Other|2|||
155072020|NCT04602000|559692999|FG003|Overall Study|Other|5|||
155072021|NCT04602000|559693000|FG004|Overall Study|Other|4|||
155072022|NCT04602000|559692996|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155072023|NCT04602000|559692997|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155072024|NCT04602000|559692998|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
155072025|NCT04602000|559692999|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155072026|NCT04602000|559693000|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
155072027|NCT04871113|559693007|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072028|NCT04871113|559693008|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072029|NCT04871113|559693009|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072030|NCT04871113|559693010|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072031|NCT04871113|559693011|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072032|NCT04871113|559693012|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
155072033|NCT04871113|559693013|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072034|NCT04871113|559693014|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072035|NCT04871113|559693015|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072036|NCT04871113|559693016|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
155072037|NCT04871113|559693007|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072038|NCT04871113|559693008|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072039|NCT04871113|559693009|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072040|NCT04871113|559693010|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072041|NCT04871113|559693011|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072042|NCT04871113|559693012|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072043|NCT04871113|559693013|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
155072044|NCT04871113|559693014|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
155072045|NCT04871113|559693015|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072046|NCT04871113|559693016|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
155072047|NCT03097315|559693021|FG000|Overall Study|Withdrawal by Subject|1|||
155072048|NCT01946802|559693022|FG000|Overall Study|Death|1|||
155072049|NCT01946802|559693022|FG000|Overall Study|Withdrawal by Subject|2|||
155072050|NCT01946802|559693022|FG000|Overall Study|Combined septic shock|1|||
155072051|NCT01946802|559693022|FG000|Overall Study|Protocol Violation|1|||
155072052|NCT00195429|559693023|FG000|Overall Study|Adverse Event|2|||
155072053|NCT00195429|559693024|FG001|Overall Study|Adverse Event|4|||
155072054|NCT00195429|559693023|FG000|Overall Study|Lack of Efficacy|2|||
155072055|NCT00195429|559693024|FG001|Overall Study|Lack of Efficacy|1|||
155072056|NCT00195429|559693023|FG000|Overall Study|Lost to Follow-up|1|||
155072057|NCT00195429|559693024|FG001|Overall Study|Lost to Follow-up|0|||
155072058|NCT04327271|559693029|FG000|Overall Study|Death|1|||
155072059|NCT04327271|559693030|FG001|Overall Study|Death|0|||
155072060|NCT04327271|559693029|FG000|Overall Study|Withdrawal by Subject|1|||
155072061|NCT04327271|559693030|FG001|Overall Study|Withdrawal by Subject|0|||
155072062|NCT04327271|559693029|FG000|Overall Study|randomization error (data capture)|4|||
155072063|NCT04327271|559693030|FG001|Overall Study|randomization error (data capture)|3|||
155072064|NCT04339972|559693031|FG000|Overall Study|Scheduling Issues|3|||
155072065|NCT04339972|559693032|FG001|Overall Study|Scheduling Issues|3|||
155072066|NCT04339972|559693031|FG000|Overall Study|dropout|1|||
155072067|NCT04339972|559693032|FG001|Overall Study|dropout|1|||
155072068|NCT04339972|559693031|FG000|Overall Study|Technical issues|1|||
155072069|NCT04339972|559693032|FG001|Overall Study|Technical issues|0|||
155072070|NCT04339972|559693031|FG000|Overall Study|Claustraphobia|0|||
155072071|NCT04339972|559693032|FG001|Overall Study|Claustraphobia|1|||
155072072|NCT01716156|559693033|FG000|Overall Study|Protocol Violation|1|||
155072073|NCT01716156|559693034|FG001|Overall Study|Protocol Violation|0|||
155072074|NCT01716156|559693035|FG002|Overall Study|Protocol Violation|0|||
155072075|NCT01716156|559693033|FG000|Overall Study|Withdrawal by Subject|0|||
155072076|NCT01716156|559693034|FG001|Overall Study|Withdrawal by Subject|1|||
155072077|NCT01716156|559693035|FG002|Overall Study|Withdrawal by Subject|2|||
155072078|NCT01716156|559693033|FG000|Overall Study|Lost to Follow-up|1|||
155072079|NCT01716156|559693034|FG001|Overall Study|Lost to Follow-up|0|||
155072080|NCT01716156|559693035|FG002|Overall Study|Lost to Follow-up|0|||
155072081|NCT05221866|559693038|FG000|Overall Study|Withdrawal by Subject|5|||
155072082|NCT05221866|559693039|FG001|Overall Study|Withdrawal by Subject|7|||
155072083|NCT05221866|559693040|FG002|Overall Study|Withdrawal by Subject|6|||
155072084|NCT05221866|559693041|FG003|Overall Study|Withdrawal by Subject|4|||
155072085|NCT05221866|559693038|FG000|Overall Study|Physician Decision|3|||
155072086|NCT05221866|559693039|FG001|Overall Study|Physician Decision|2|||
155072087|NCT05221866|559693040|FG002|Overall Study|Physician Decision|1|||
155072088|NCT05221866|559693041|FG003|Overall Study|Physician Decision|4|||
155072089|NCT05221866|559693038|FG000|Overall Study|Lost to Follow-up|12|||
155072090|NCT05221866|559693039|FG001|Overall Study|Lost to Follow-up|17|||
155072091|NCT05221866|559693040|FG002|Overall Study|Lost to Follow-up|14|||
155072092|NCT05221866|559693041|FG003|Overall Study|Lost to Follow-up|14|||
155072093|NCT05221866|559693038|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
155072094|NCT05221866|559693039|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
155072095|NCT05221866|559693040|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
155072096|NCT05221866|559693041|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
155335511|NCT01480258|560663114|FG000|Infant Series|Withdrawal by Subject|1|||
155335512|NCT01480258|560663115|FG001|Infant Series|Withdrawal by Subject|6|||
155335513|NCT01480258|560663114|FG000|Interim Period|Lost to Follow-up|0|||
155335514|NCT01480258|560663115|FG001|Interim Period|Lost to Follow-up|2|||
155335515|NCT01480258|560663114|FG000|Interim Period|Physician Decision|1|||
155335516|NCT01480258|560663115|FG001|Interim Period|Physician Decision|0|||
155335517|NCT01480258|560663114|FG000|Interim Period|Protocol Violation|0|||
155335518|NCT01480258|560663115|FG001|Interim Period|Protocol Violation|1|||
155335519|NCT01480258|560663114|FG000|Interim Period|Withdrawal by Subject|9|||
155335520|NCT01480258|560663115|FG001|Interim Period|Withdrawal by Subject|6|||
155335521|NCT01640288|560663118|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
155335522|NCT01640288|560663119|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
155335523|NCT01640288|560663118|FG000|Overall Study|Screen Failure|20|||
155072097|NCT04057365|559693042|FG000|Overall Study|Withdrawal by Subject|2|||
155072098|NCT04057365|559693043|FG001|Overall Study|Withdrawal by Subject|0|||
155072099|NCT04738487|559693044|FG000|Overall Study|Participant Ongoing in Study|298|||
155072100|NCT04738487|559693045|FG001|Overall Study|Participant Ongoing in Study|297|||
155072101|NCT04738487|559693044|FG000|Overall Study|Withdrawal by Subject|7|||
155072102|NCT04738487|559693045|FG001|Overall Study|Withdrawal by Subject|9|||
155072103|NCT04738487|559693044|FG000|Overall Study|Lost to Follow-up|2|||
155072104|NCT04738487|559693045|FG001|Overall Study|Lost to Follow-up|0|||
155072105|NCT04738487|559693044|FG000|Overall Study|Death|287|||
155072106|NCT04738487|559693045|FG001|Overall Study|Death|306|||
155072107|NCT02717611|559693046|FG000|Overall Study|Death|13|||
155072108|NCT02717611|559693046|FG000|Overall Study|Withdrawal by Subject|6|||
155072109|NCT02717611|559693046|FG000|Overall Study|Active, not recruiting|40|||
155072110|NCT02717611|559693046|FG000|Overall Study|Complicating disease|1|||
155072111|NCT04598828|559693047|FG000|Overall Study|Physician Decision|1|||
155072112|NCT04598828|559693048|FG001|Overall Study|Physician Decision|0|||
155072113|NCT04598828|559693047|FG000|Overall Study|Withdrawal by Subject|0|||
155072114|NCT04598828|559693048|FG001|Overall Study|Withdrawal by Subject|1|||
155072115|NCT04598828|559693047|FG000|Overall Study|Withdrawal by Subject|0|||
155072116|NCT04598828|559693048|FG001|Overall Study|Withdrawal by Subject|1|||
155163800|NCT04730804|560035087|FG000|Overall Study|Physician Decision|0|||
155163801|NCT04730804|560035088|FG001|Overall Study|Physician Decision|0|||
155163802|NCT04730804|560035089|FG002|Overall Study|Physician Decision|0|||
155163803|NCT04730804|560035090|FG003|Overall Study|Physician Decision|0|||
155163804|NCT04730804|560035091|FG004|Overall Study|Physician Decision|0|||
155163805|NCT04730804|560035092|FG005|Overall Study|Physician Decision|1|||
155163806|NCT04730804|560035087|FG000|Overall Study|Withdrawal by Subject|0|||
155163807|NCT04730804|560035088|FG001|Overall Study|Withdrawal by Subject|0|||
155163808|NCT04730804|560035089|FG002|Overall Study|Withdrawal by Subject|0|||
155163809|NCT04730804|560035090|FG003|Overall Study|Withdrawal by Subject|0|||
155335524|NCT01640288|560663119|FG001|Overall Study|Screen Failure|18|||
155335525|NCT01640288|560663118|FG000|Overall Study|Withdrawn by PI|5|||
155335526|NCT01640288|560663119|FG001|Overall Study|Withdrawn by PI|0|||
155335527|NCT01640288|560663118|FG000|Overall Study|Withdrawal by Subject|1|||
155335528|NCT01640288|560663119|FG001|Overall Study|Withdrawal by Subject|0|||
155335529|NCT01485887|560663123|FG000|Overall Study|Withdrawal by Subject|2|||
155335530|NCT01485887|560663123|FG000|Overall Study|Adverse Event|8|||
155163810|NCT04730804|560035091|FG004|Overall Study|Withdrawal by Subject|1|||
155163811|NCT04730804|560035092|FG005|Overall Study|Withdrawal by Subject|2|||
155163812|NCT01442103|560036711|FG000|Overall Study|Lost to Follow-up|2|||
155163813|NCT02102204|560036714|FG000|Overall Study|Withdrawal by Subject|137|||
155163814|NCT02102204|560036714|FG000|Overall Study|Death|92|||
155163815|NCT02102204|560036714|FG000|Overall Study|Lost to Follow-up|65|||
155163816|NCT02102204|560036714|FG000|Overall Study|Sponsor Decision|5|||
155163817|NCT02102204|560036714|FG000|Overall Study|Ongoing|5|||
155335531|NCT01485887|560663123|FG000|Overall Study|Deterioration of primary disease|1|||
155163818|NCT03751657|560036715|FG000|Overall Study|Physician Decision|0|||
155163819|NCT03751657|560036716|FG001|Overall Study|Physician Decision|1|||
155163820|NCT03751657|560036715|FG000|Overall Study|Withdrawal by Subject|1|||
155163821|NCT03751657|560036716|FG001|Overall Study|Withdrawal by Subject|1|||
155163822|NCT03751657|560036715|FG000|Overall Study|Lost to Follow-up|2|||
155163823|NCT03751657|560036716|FG001|Overall Study|Lost to Follow-up|1|||
155163824|NCT00807001|560036725|FG000|Overall Study|Non-compliance|0|||
155163825|NCT00807001|560036726|FG001|Overall Study|Non-compliance|1|||
155335532|NCT01485887|560663123|FG000|Overall Study|Primary disease markedly improved|1|||
155335533|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335534|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
155163826|NCT00807001|560036727|FG002|Overall Study|Non-compliance|0|||
155163827|NCT00807001|560036728|FG003|Overall Study|Non-compliance|0|||
155163828|NCT00807001|560036729|FG004|Overall Study|Non-compliance|0|||
155163829|NCT02269267|560036730|FG000|Overall Study|Death|5|||
155163830|NCT03773796|560036731|FG000|Overall Study|Adverse Event|1|||
155163831|NCT03773796|560036731|FG000|Overall Study|Withdrawal by Subject|1|||
155163832|NCT03773796|560036731|FG000|Overall Study|Lack of Efficacy|1|||
155163833|NCT03805659|560036732|FG000|Overall Study|Withdrawal by Subject|0|||
155163834|NCT03805659|560036733|FG001|Overall Study|Withdrawal by Subject|1|||
155163835|NCT02604160|560036736|FG000|Overall Study|Protocol Violation|0|||
155163836|NCT02604160|560036737|FG001|Overall Study|Protocol Violation|1|||
155163837|NCT02604160|560036736|FG000|Overall Study|Physician Decision|0|||
155163838|NCT02604160|560036737|FG001|Overall Study|Physician Decision|1|||
155163839|NCT02139592|560036738|FG000|Overall Study|Case Report Forms Uncollected|8|||
155163840|NCT01069900|560036742|FG000|Overall Study|Technical problems|0|||
155163841|NCT01069900|560036743|FG001|Overall Study|Technical problems|1|||
155163842|NCT01069900|560036742|FG000|Overall Study|Lost to Follow-up|7|||
155163843|NCT01069900|560036743|FG001|Overall Study|Lost to Follow-up|1|||
155163844|NCT01069900|560036742|FG000|Overall Study|Withdrawal by Subject|6|||
155163845|NCT01069900|560036743|FG001|Overall Study|Withdrawal by Subject|1|||
155163846|NCT01069900|560036742|FG000|Overall Study|Protocol Violation|4|||
155163847|NCT01069900|560036743|FG001|Overall Study|Protocol Violation|1|||
155163848|NCT01069900|560036742|FG000|Overall Study|Insufficient Therapeutic effect|1|||
155335535|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335536|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
155072117|NCT04818112|559693049|FG000|Overall Study|Withdrawal by Subject|54|||
155072118|NCT04818112|559693050|FG001|Overall Study|Withdrawal by Subject|12|||
155335537|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335538|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335539|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
155335540|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335541|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
155335542|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335543|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335544|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335545|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335546|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
155335547|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Death|1|||
155335548|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Death|2|||
155335549|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Death|0|||
155335550|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Death|1|||
155335551|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Death|0|||
155335552|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Death|0|||
155335553|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Death|0|||
155335554|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
155335555|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
155335556|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
155335557|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
155335558|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
155335559|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
155335560|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
155072119|NCT04818112|559693049|FG000|Overall Study|Lost to Follow-up|38|||
155072120|NCT04818112|559693050|FG001|Overall Study|Lost to Follow-up|10|||
155072121|NCT02676973|559693051|FG000|Overall Study|Withdrawal by Subject|9|||
155072122|NCT02676973|559693052|FG001|Overall Study|Withdrawal by Subject|8|||
155072123|NCT02676973|559693053|FG002|Overall Study|Withdrawal by Subject|11|||
155072124|NCT02676973|559693051|FG000|Overall Study|Lost to Follow-up|8|||
155072125|NCT02676973|559693052|FG001|Overall Study|Lost to Follow-up|12|||
155072126|NCT02676973|559693053|FG002|Overall Study|Lost to Follow-up|8|||
155072127|NCT02676973|559693051|FG000|Overall Study|Death|2|||
155072128|NCT02676973|559693052|FG001|Overall Study|Death|1|||
155072129|NCT02676973|559693053|FG002|Overall Study|Death|5|||
155072130|NCT05172570|559693054|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
155072131|NCT05172570|559693055|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
155072132|NCT05172570|559693056|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
155072133|NCT05172570|559693054|FG000|Overall Study|PI Decision due to equipment shortages|0|||
155072134|NCT05172570|559693055|FG001|Overall Study|PI Decision due to equipment shortages|0|||
155072135|NCT05172570|559693056|FG002|Overall Study|PI Decision due to equipment shortages|1|||
155072136|NCT06170827|559693063|FG000|Overall Study|Withdrawal by Subject|1|||
155072137|NCT06170827|559693064|FG001|Overall Study|Withdrawal by Subject|1|||
155072138|NCT00632359|559693065|FG000|Overall Study|Withdrawal by Subject|2|||
155072139|NCT03580928|559693068|FG000|Overall Study|Death|0|||
155072140|NCT03580928|559693069|FG001|Overall Study|Death|3|||
155072141|NCT03580928|559693068|FG000|Overall Study|Withdrawal by Subject|2|||
155072142|NCT03580928|559693069|FG001|Overall Study|Withdrawal by Subject|1|||
155072143|NCT03580928|559693068|FG000|Overall Study|Lost to Follow-up|2|||
155072144|NCT03580928|559693069|FG001|Overall Study|Lost to Follow-up|0|||
155072145|NCT03580928|559693068|FG000|Overall Study|Progressive Disease|0|||
155072146|NCT03580928|559693069|FG001|Overall Study|Progressive Disease|1|||
155072147|NCT01127061|559694060|FG000|Overall Study|Lost to Follow-up|7|||
155072148|NCT01127061|559694061|FG001|Overall Study|Lost to Follow-up|10|||
155072149|NCT01127061|559694060|FG000|Overall Study|Physician Decision|3|||
155072150|NCT01127061|559694061|FG001|Overall Study|Physician Decision|3|||
155072151|NCT03921541|559694064|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
155072152|NCT03921541|559694065|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
155072153|NCT00420407|559694066|FG000|Overall Study|Lost to Follow-up|0|||
155072154|NCT00420407|559694067|FG001|Overall Study|Lost to Follow-up|3|||
155072155|NCT00420407|559694066|FG000|Overall Study|Physician Decision|2|||
155072156|NCT00420407|559694067|FG001|Overall Study|Physician Decision|1|||
155072157|NCT00420407|559694066|FG000|Overall Study|subject identified as detainee|1|||
155072158|NCT00420407|559694067|FG001|Overall Study|subject identified as detainee|0|||
155072159|NCT00420407|559694066|FG000|Overall Study|subject identified as Jehovah's witness|1|||
155072160|NCT00420407|559694067|FG001|Overall Study|subject identified as Jehovah's witness|0|||
155072161|NCT00420407|559694066|FG000|Overall Study|Withdrawal by Subject|0|||
155072162|NCT00420407|559694067|FG001|Overall Study|Withdrawal by Subject|2|||
155072163|NCT03720847|559694069|FG000|Washout|Physician Decision|1|||
155072164|NCT03720847|559694070|FG001|Washout|Physician Decision|2|||
155072165|NCT00924651|559694073|FG000|Overall Study|Chemo started too soon|2|||
155072166|NCT00924651|559694074|FG001|Overall Study|Chemo started too soon|3|||
155072167|NCT00924651|559694073|FG000|Overall Study|No Reason|3|||
155072168|NCT00924651|559694074|FG001|Overall Study|No Reason|7|||
155072169|NCT00924651|559694073|FG000|Overall Study|Overwhelmed|6|||
155072170|NCT00924651|559694074|FG001|Overall Study|Overwhelmed|6|||
155072171|NCT00924651|559694073|FG000|Overall Study|Noncompliant|1|||
155072172|NCT00924651|559694074|FG001|Overall Study|Noncompliant|4|||
155072173|NCT00924651|559694073|FG000|Overall Study|Medical|1|||
155072174|NCT00924651|559694074|FG001|Overall Study|Medical|3|||
155072175|NCT00924651|559694073|FG000|Overall Study|Changed Mind|10|||
155072176|NCT00924651|559694074|FG001|Overall Study|Changed Mind|1|||
155072177|NCT00924651|559694073|FG000|Overall Study|Incomplete Form|2|||
155335561|NCT02234141|560663124|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335562|NCT02234141|560663125|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
155335563|NCT02234141|560663126|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335564|NCT02234141|560663127|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335565|NCT02234141|560663128|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335566|NCT02234141|560663129|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335567|NCT02234141|560663130|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
155335568|NCT02234141|560663124|FG000|Long-Term Treatment Period|Death|0|||
155335569|NCT02234141|560663125|FG001|Long-Term Treatment Period|Death|0|||
155072178|NCT00924651|559694074|FG001|Overall Study|Incomplete Form|1|||
155072179|NCT01797185|559694075|FG000|Overall Study|Adverse Event|5|||
155072180|NCT01797185|559694076|FG001|Overall Study|Adverse Event|15|||
155072181|NCT01797185|559694077|FG002|Overall Study|Adverse Event|6|||
155072182|NCT01797185|559694075|FG000|Overall Study|Withdrawal by Subject|6|||
155072183|NCT01797185|559694076|FG001|Overall Study|Withdrawal by Subject|9|||
155072184|NCT01797185|559694077|FG002|Overall Study|Withdrawal by Subject|5|||
155335570|NCT02234141|560663126|FG002|Long-Term Treatment Period|Death|0|||
155335571|NCT02234141|560663127|FG003|Long-Term Treatment Period|Death|0|||
155335572|NCT02234141|560663128|FG004|Long-Term Treatment Period|Death|0|||
155335573|NCT02234141|560663129|FG005|Long-Term Treatment Period|Death|1|||
155335574|NCT02234141|560663130|FG006|Long-Term Treatment Period|Death|0|||
155335575|NCT02234141|560663124|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
155335576|NCT02234141|560663125|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
155335577|NCT02234141|560663126|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
155072185|NCT01797185|559694075|FG000|Overall Study|Site terminated|8|||
155072186|NCT01797185|559694076|FG001|Overall Study|Site terminated|4|||
155072187|NCT01797185|559694077|FG002|Overall Study|Site terminated|0|||
155072188|NCT01797185|559694075|FG000|Overall Study|Lost to Follow-up|2|||
155072189|NCT01797185|559694076|FG001|Overall Study|Lost to Follow-up|6|||
155072190|NCT01797185|559694077|FG002|Overall Study|Lost to Follow-up|1|||
155072191|NCT01797185|559694075|FG000|Overall Study|Withdrawn per sponsor|5|||
155072192|NCT01797185|559694076|FG001|Overall Study|Withdrawn per sponsor|0|||
155072193|NCT01797185|559694077|FG002|Overall Study|Withdrawn per sponsor|0|||
155072194|NCT01797185|559694075|FG000|Overall Study|Physician Decision|1|||
155335578|NCT02234141|560663127|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
155335579|NCT02234141|560663128|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
155335580|NCT02234141|560663129|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
155335581|NCT02234141|560663130|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
155335582|NCT02234141|560663124|FG000|Long-Term Treatment Period|Adverse Event|4|||
155072195|NCT01797185|559694076|FG001|Overall Study|Physician Decision|3|||
155072196|NCT01797185|559694077|FG002|Overall Study|Physician Decision|0|||
155072197|NCT01797185|559694075|FG000|Overall Study|Protocol Violation|1|||
155072198|NCT01797185|559694076|FG001|Overall Study|Protocol Violation|1|||
155072199|NCT01797185|559694077|FG002|Overall Study|Protocol Violation|0|||
155072200|NCT01847209|559694078|FG000|Overall Study|Withdrawal by Subject|1|||
155072201|NCT01847209|559694078|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
155072202|NCT02513199|559694079|FG000|Treatment|Death|1|||
155072203|NCT02513199|559694079|FG000|Treatment|Lost to Follow-up|1|||
155072204|NCT02513199|559694079|FG000|Follow-Up|Death|11|||
155072205|NCT02397837|559694080|FG000|Overall Study|Withdrawal by Subject|6|||
155072206|NCT02397837|559694081|FG001|Overall Study|Withdrawal by Subject|5|||
155072207|NCT02397837|559694080|FG000|Overall Study|Physician Decision|1|||
155072208|NCT02397837|559694081|FG001|Overall Study|Physician Decision|1|||
155072209|NCT02536794|559694084|FG000|Reached 1st Response Assessment|Adverse Event|2|||
155072210|NCT02536794|559694084|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
155072211|NCT02536794|559694084|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
155072212|NCT02536794|559694084|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
155335583|NCT02234141|560663125|FG001|Long-Term Treatment Period|Adverse Event|0|||
155335584|NCT02234141|560663126|FG002|Long-Term Treatment Period|Adverse Event|5|||
155335585|NCT02234141|560663127|FG003|Long-Term Treatment Period|Adverse Event|0|||
155072213|NCT02536794|559694084|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
155072214|NCT02536794|559694084|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
155072215|NCT05276804|559694085|FG000|Overall Study|screen failure|23|||
155335586|NCT02234141|560663128|FG004|Long-Term Treatment Period|Adverse Event|1|||
155335587|NCT02234141|560663129|FG005|Long-Term Treatment Period|Adverse Event|1|||
155163849|NCT01069900|560036743|FG001|Overall Study|Insufficient Therapeutic effect|0|||
155163850|NCT00145158|560036744|FG000|Overall Study|premature withdrawal|2|||
155335588|NCT02234141|560663130|FG006|Long-Term Treatment Period|Adverse Event|1|||
155335589|NCT02234141|560663124|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
155335590|NCT02234141|560663125|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
155335591|NCT02234141|560663126|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
155335592|NCT02234141|560663127|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
155335593|NCT02234141|560663128|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
155335594|NCT02234141|560663129|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
155163851|NCT00145158|560036745|FG001|Overall Study|premature withdrawal|3|||
155163852|NCT02863419|560036750|FG000|Overall Study|Lost to Follow-up|0|||
155163853|NCT02863419|560036751|FG001|Overall Study|Lost to Follow-up|1|||
155163854|NCT02863419|560036752|FG002|Overall Study|Lost to Follow-up|4|||
155335595|NCT02234141|560663130|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
155335596|NCT02234141|560663124|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
155072216|NCT05276804|559694086|FG001|Overall Study|screen failure|0|||
155072217|NCT01410604|559694087|FG000|Overall Study|Adverse Event|2|||
155072218|NCT01410604|559694088|FG001|Overall Study|Adverse Event|1|||
155072219|NCT01410604|559694087|FG000|Overall Study|Lost to Follow-up|1|||
155072220|NCT01410604|559694088|FG001|Overall Study|Lost to Follow-up|0|||
155072221|NCT01410604|559694087|FG000|Overall Study|Physician Decision|0|||
155072222|NCT01410604|559694088|FG001|Overall Study|Physician Decision|1|||
155072223|NCT05607043|559694089|FG000|Overall Study|Lost to Follow-up|2|||
155072224|NCT05427916|559694090|FG000|Overall Study|Adverse Event|3|||
155072225|NCT05427916|559694091|FG001|Overall Study|Adverse Event|0|||
155072226|NCT05427916|559694090|FG000|Overall Study|Lack of Efficacy|6|||
155072227|NCT05427916|559694091|FG001|Overall Study|Lack of Efficacy|0|||
155072228|NCT05427916|559694090|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
155072229|NCT05427916|559694091|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
155072230|NCT00429299|559694094|FG000|Overall Study|Disease Progression|1|||
155072231|NCT00429299|559694095|FG001|Overall Study|Disease Progression|1|||
155072232|NCT00429299|559694096|FG002|Overall Study|Disease Progression|0|||
155072233|NCT00429299|559694094|FG000|Overall Study|Adverse Event|2|||
155072234|NCT00429299|559694095|FG001|Overall Study|Adverse Event|5|||
155072235|NCT00429299|559694096|FG002|Overall Study|Adverse Event|1|||
155072236|NCT00429299|559694094|FG000|Overall Study|Protocol Violation|1|||
155072237|NCT00429299|559694095|FG001|Overall Study|Protocol Violation|0|||
155072238|NCT00429299|559694096|FG002|Overall Study|Protocol Violation|0|||
155072239|NCT00429299|559694094|FG000|Overall Study|Withdrawal by Subject|0|||
155072240|NCT00429299|559694095|FG001|Overall Study|Withdrawal by Subject|1|||
155072241|NCT00429299|559694096|FG002|Overall Study|Withdrawal by Subject|3|||
155072242|NCT00081458|559694101|FG000|Overall Study|Adverse Event|1|||
155072243|NCT00081458|559694102|FG001|Overall Study|Adverse Event|5|||
155072244|NCT00081458|559694103|FG002|Overall Study|Adverse Event|2|||
155072245|NCT00081458|559694101|FG000|Overall Study|Withdrawal by Subject|0|||
155072246|NCT00081458|559694102|FG001|Overall Study|Withdrawal by Subject|3|||
155072247|NCT00081458|559694103|FG002|Overall Study|Withdrawal by Subject|1|||
155072248|NCT00081458|559694101|FG000|Overall Study|Randomized but not dosed|0|||
155072249|NCT00081458|559694102|FG001|Overall Study|Randomized but not dosed|0|||
155072250|NCT00081458|559694103|FG002|Overall Study|Randomized but not dosed|1|||
155072251|NCT01334515|559694104|FG000|Overall Study|Adverse Event|1|||
155072252|NCT01334515|559694105|FG001|Overall Study|Adverse Event|6|||
155072253|NCT01334515|559694104|FG000|Overall Study|Death|1|||
155072254|NCT01334515|559694105|FG001|Overall Study|Death|0|||
155163855|NCT02863419|560036750|FG000|Overall Study|Withdrawal by Subject|5|||
155163856|NCT02863419|560036751|FG001|Overall Study|Withdrawal by Subject|5|||
155163857|NCT02863419|560036752|FG002|Overall Study|Withdrawal by Subject|3|||
155163858|NCT02863419|560036750|FG000|Overall Study|Died|3|||
155335597|NCT02234141|560663125|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
155335598|NCT02234141|560663126|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
155335599|NCT02234141|560663127|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
155335600|NCT02234141|560663128|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
155072255|NCT01334515|559694104|FG000|Overall Study|Lack of Efficacy|8|||
155072256|NCT01334515|559694105|FG001|Overall Study|Lack of Efficacy|21|||
155072257|NCT01334515|559694104|FG000|Overall Study|Physician Decision|1|||
155072258|NCT01334515|559694105|FG001|Overall Study|Physician Decision|1|||
155072259|NCT01334515|559694104|FG000|Overall Study|Withdrawal by Subject|1|||
155072260|NCT01334515|559694105|FG001|Overall Study|Withdrawal by Subject|1|||
155072261|NCT00776997|559694108|FG000|Overall Study|Adverse Event|2|||
155072262|NCT02403271|559694112|FG000|Period 1|Other varied reasons|1|||
155072263|NCT02403271|559694113|FG001|Period 1|Other varied reasons|0|||
155072264|NCT02403271|559694112|FG000|Period 2|Withdrawal by Subject|0|||
155072265|NCT02403271|559694113|FG001|Period 2|Withdrawal by Subject|14|||
155163859|NCT02863419|560036751|FG001|Overall Study|Died|4|||
155335601|NCT02234141|560663129|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
155072266|NCT02403271|559694112|FG000|Period 2|Death|0|||
155072267|NCT02403271|559694113|FG001|Period 2|Death|84|||
155072268|NCT02403271|559694112|FG000|Period 2|Lost to Follow-up|0|||
155072269|NCT02403271|559694113|FG001|Period 2|Lost to Follow-up|2|||
155072270|NCT02403271|559694112|FG000|Period 2|Study Terminated by Sponsor|0|||
155072271|NCT02403271|559694113|FG001|Period 2|Study Terminated by Sponsor|14|||
155072272|NCT02403271|559694112|FG000|Period 2|Other varied reasons|0|||
155072273|NCT02403271|559694113|FG001|Period 2|Other varied reasons|10|||
155072274|NCT05561140|559694114|FG000|Randomized Treatment Period|Adverse Event|1|||
155072275|NCT05561140|559694115|FG001|Randomized Treatment Period|Adverse Event|0|||
155072276|NCT05561140|559694114|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
155072277|NCT05561140|559694115|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
155072278|NCT05561140|559694114|FG000|Open Label Treatment Period|Adverse Event|6|||
155072279|NCT05561140|559694115|FG001|Open Label Treatment Period|Adverse Event|4|||
155072280|NCT05561140|559694114|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
155072281|NCT05561140|559694115|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
155072282|NCT05561140|559694114|FG000|Open Label Treatment Period|Physician Decision|0|||
155072283|NCT05561140|559694115|FG001|Open Label Treatment Period|Physician Decision|1|||
155072284|NCT05561140|559694114|FG000|Open Label Treatment Period|Pregnancy|1|||
155072285|NCT05561140|559694115|FG001|Open Label Treatment Period|Pregnancy|0|||
155072286|NCT05561140|559694114|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
155072287|NCT05561140|559694115|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
155072288|NCT05561140|559694114|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
155072289|NCT05561140|559694115|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
155072290|NCT05561140|559694114|FG000|Open Label Treatment Period|Other|1|||
155072291|NCT05561140|559694115|FG001|Open Label Treatment Period|Other|0|||
155072292|NCT03301714|559694119|FG000|Overall Study|Lost to Follow-up|10|||
155072293|NCT03301714|559694120|FG001|Overall Study|Lost to Follow-up|4|||
155072294|NCT03301714|559694121|FG002|Overall Study|Lost to Follow-up|4|||
155072295|NCT03301714|559694119|FG000|Overall Study|Did not receive allocated intervention|0|||
155072296|NCT03301714|559694120|FG001|Overall Study|Did not receive allocated intervention|2|||
155072297|NCT03301714|559694121|FG002|Overall Study|Did not receive allocated intervention|3|||
155072298|NCT02112552|559694124|FG000|Overall Study|Withdrawal by Subject|1|||
155072299|NCT02112552|559694124|FG000|Overall Study|Adverse Event|1|||
155072300|NCT00825175|559694126|FG000|Overall Study|Withdrawal by Subject|0|||
155072301|NCT00825175|559694127|FG001|Overall Study|Withdrawal by Subject|5|||
155072302|NCT04822194|559694128|FG000|Overall Study|Withdrawal by Subject|5|||
155072303|NCT04822194|559694129|FG001|Overall Study|Withdrawal by Subject|4|||
155072304|NCT04822194|559694128|FG000|Overall Study|Technical issues with MR scanner|1|||
155072305|NCT04822194|559694129|FG001|Overall Study|Technical issues with MR scanner|0|||
155072306|NCT04822194|559694128|FG000|Overall Study|Lost to Follow-up|5|||
155072307|NCT04822194|559694129|FG001|Overall Study|Lost to Follow-up|7|||
155072308|NCT00118287|559694132|FG000|Overall Study|Intracranial haemorrhage|1|||
155072309|NCT00118287|559694132|FG000|Overall Study|Muscle pain|1|||
155072310|NCT03976375|559694133|FG000|Overall Study|Death|158|||
155072311|NCT03976375|559694134|FG001|Overall Study|Death|160|||
155072312|NCT03976375|559694135|FG002|Overall Study|Death|42|||
155072313|NCT03976375|559694133|FG000|Overall Study|Lost to Follow-up|2|||
155072314|NCT03976375|559694134|FG001|Overall Study|Lost to Follow-up|1|||
155072315|NCT03976375|559694135|FG002|Overall Study|Lost to Follow-up|1|||
155072316|NCT03976375|559694133|FG000|Overall Study|Withdrawal by Subject|5|||
155072317|NCT03976375|559694134|FG001|Overall Study|Withdrawal by Subject|9|||
155072318|NCT03976375|559694135|FG002|Overall Study|Withdrawal by Subject|4|||
155072319|NCT03976375|559694133|FG000|Overall Study|Sponsor decision|20|||
155072320|NCT03976375|559694134|FG001|Overall Study|Sponsor decision|19|||
155072321|NCT03976375|559694135|FG002|Overall Study|Sponsor decision|1|||
155072322|NCT03091439|559694136|FG000|Overall Study|Study Terminated by the Sponsor|1|||
155072323|NCT03091439|559694137|FG001|Overall Study|Study Terminated by the Sponsor|0|||
155072324|NCT03122106|559694138|FG000|Overall Study|Not enough tissue|1|||
155072325|NCT03122106|559694138|FG000|Overall Study|Disease progression during screening|2|||
155072326|NCT03122106|559694138|FG000|Overall Study|Poor RNA quality for vaccine|1|||
155072327|NCT00640289|559694139|FG000|Overall Study|Death|3|||
155072328|NCT00640289|559694139|FG000|Overall Study|Withdrawal by Subject|1|||
155163860|NCT02863419|560036752|FG002|Overall Study|Died|1|||
155163861|NCT03682770|560036753|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155072329|NCT00640289|559694139|FG000|Overall Study|Lost to Follow-up|1|||
155072330|NCT00640289|559694139|FG000|Overall Study|Data collected under different amendment|2|||
155072331|NCT00640289|559694139|FG000|Overall Study|Transferred to another center|1|||
155163862|NCT03682770|560036754|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
155072332|NCT00640289|559694139|FG000|Overall Study|Missing status|5|||
155072333|NCT03550209|559694140|FG000|Overall Study|Lost to Follow-up|1|||
155072334|NCT03550209|559694141|FG001|Overall Study|Lost to Follow-up|0|||
155072335|NCT03550209|559694142|FG002|Overall Study|Lost to Follow-up|1|||
155163863|NCT03682770|560036755|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155072336|NCT03550209|559694143|FG003|Overall Study|Lost to Follow-up|0|||
155072337|NCT03550209|559694140|FG000|Overall Study|Withdrawal by Subject|0|||
155163864|NCT03682770|560036756|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155163865|NCT03682770|560036757|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155163866|NCT03682770|560036758|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155163867|NCT03682770|560036759|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
155163868|NCT03682770|560036753|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
155163869|NCT03682770|560036754|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
154962239|NCT02089685|559287927|FG001|Overall Study|Adverse Event|0|||
154962240|NCT02089685|559287928|FG002|Overall Study|Adverse Event|0|||
154962241|NCT02089685|559287929|FG003|Overall Study|Adverse Event|0|||
154962242|NCT02089685|559287930|FG004|Overall Study|Adverse Event|1|||
154962243|NCT02089685|559287931|FG005|Overall Study|Adverse Event|0|||
154962244|NCT02089685|559287926|FG000|Overall Study|Clinical Progression|4|||
154962245|NCT02089685|559287927|FG001|Overall Study|Clinical Progression|0|||
154962246|NCT02089685|559287928|FG002|Overall Study|Clinical Progression|0|||
154962247|NCT02089685|559287929|FG003|Overall Study|Clinical Progression|5|||
155163870|NCT03682770|560036755|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155335602|NCT02234141|560663130|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
155335603|NCT00895245|560663131|FG000|Overall Study|Lack of Efficacy|6|||
155335604|NCT02095678|560663132|FG000|Overall Study|Withdrawal by Subject|0|||
155335605|NCT02095678|560663133|FG001|Overall Study|Withdrawal by Subject|1|||
155335606|NCT02095678|560663132|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
154962248|NCT02089685|559287930|FG004|Overall Study|Clinical Progression|1|||
154962249|NCT02089685|559287931|FG005|Overall Study|Clinical Progression|2|||
154962250|NCT02089685|559287926|FG000|Overall Study|Excluded Medication|1|||
154962251|NCT02089685|559287927|FG001|Overall Study|Excluded Medication|0|||
154962252|NCT02089685|559287928|FG002|Overall Study|Excluded Medication|0|||
154962253|NCT02089685|559287929|FG003|Overall Study|Excluded Medication|11|||
154962254|NCT02089685|559287930|FG004|Overall Study|Excluded Medication|2|||
154962255|NCT02089685|559287931|FG005|Overall Study|Excluded Medication|1|||
154962256|NCT02089685|559287926|FG000|Overall Study|Progressive disease|13|||
154962257|NCT02089685|559287927|FG001|Overall Study|Progressive disease|10|||
154962258|NCT02089685|559287928|FG002|Overall Study|Progressive disease|3|||
154962259|NCT02089685|559287929|FG003|Overall Study|Progressive disease|51|||
155335607|NCT02095678|560663133|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
155335608|NCT02095678|560663132|FG000|Overall Study|lesion impacted by previous treatment|1|||
155335609|NCT02095678|560663133|FG001|Overall Study|lesion impacted by previous treatment|1|||
155335610|NCT02095678|560663132|FG000|Overall Study|No Confirmed Diagnosis|0|||
155335611|NCT02095678|560663133|FG001|Overall Study|No Confirmed Diagnosis|3|||
155335612|NCT02095678|560663132|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
155335613|NCT02095678|560663133|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
155335614|NCT02095678|560663132|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
155335615|NCT02095678|560663133|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
155335616|NCT03418545|560663134|FG000|Overall Study|Withdrawal by Participant|2|||
155335617|NCT03418545|560663135|FG001|Overall Study|Withdrawal by Participant|4|||
155335618|NCT03418545|560663134|FG000|Overall Study|Lost to Follow-up|3|||
155335619|NCT03418545|560663135|FG001|Overall Study|Lost to Follow-up|5|||
155335620|NCT03418545|560663134|FG000|Overall Study|Reason Not Specified|0|||
155335621|NCT03418545|560663135|FG001|Overall Study|Reason Not Specified|1|||
155335622|NCT03418545|560663134|FG000|Overall Study|Missing Completion Status|0|||
155335623|NCT03418545|560663135|FG001|Overall Study|Missing Completion Status|1|||
154962260|NCT02089685|559287930|FG004|Overall Study|Progressive disease|17|||
154962261|NCT02089685|559287931|FG005|Overall Study|Progressive disease|12|||
154962262|NCT02089685|559287926|FG000|Overall Study|Follow up ended by sponsor|2|||
154962263|NCT02089685|559287927|FG001|Overall Study|Follow up ended by sponsor|2|||
154962264|NCT02089685|559287928|FG002|Overall Study|Follow up ended by sponsor|0|||
154962265|NCT02089685|559287929|FG003|Overall Study|Follow up ended by sponsor|70|||
154962266|NCT02089685|559287930|FG004|Overall Study|Follow up ended by sponsor|26|||
154962267|NCT02089685|559287931|FG005|Overall Study|Follow up ended by sponsor|26|||
154962268|NCT02089685|559287926|FG000|Overall Study|Withdrawal by Subject|0|||
154962269|NCT02089685|559287927|FG001|Overall Study|Withdrawal by Subject|2|||
154962270|NCT02089685|559287928|FG002|Overall Study|Withdrawal by Subject|0|||
154962271|NCT02089685|559287929|FG003|Overall Study|Withdrawal by Subject|8|||
154962272|NCT02089685|559287930|FG004|Overall Study|Withdrawal by Subject|1|||
154962273|NCT02089685|559287931|FG005|Overall Study|Withdrawal by Subject|1|||
154962274|NCT02089685|559287926|FG000|Overall Study|Status not recorded|1|||
154962275|NCT02089685|559287927|FG001|Overall Study|Status not recorded|0|||
155072338|NCT03550209|559694141|FG001|Overall Study|Withdrawal by Subject|3|||
155072339|NCT03550209|559694142|FG002|Overall Study|Withdrawal by Subject|1|||
155072340|NCT03550209|559694143|FG003|Overall Study|Withdrawal by Subject|2|||
155072341|NCT03550209|559694140|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
155072342|NCT03550209|559694141|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
155072343|NCT03550209|559694142|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
155072344|NCT03550209|559694143|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
155072345|NCT02347787|559694146|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
155072346|NCT02347787|559694147|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
155072347|NCT02347787|559694146|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
155072348|NCT02347787|559694147|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
155072349|NCT02347787|559694146|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
155072350|NCT02347787|559694147|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
155072351|NCT02347787|559694146|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
155072352|NCT02347787|559694147|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
155072353|NCT03244189|559694149|FG000|Overall Study|Death|0|||
155072354|NCT03244189|559694150|FG001|Overall Study|Death|2|||
155072355|NCT03244189|559694149|FG000|Overall Study|Lost to Follow-up|92|||
155072356|NCT03244189|559694150|FG001|Overall Study|Lost to Follow-up|107|||
155072357|NCT03244189|559694149|FG000|Overall Study|Physician Decision|4|||
155072358|NCT03244189|559694150|FG001|Overall Study|Physician Decision|2|||
155072359|NCT03244189|559694149|FG000|Overall Study|Pregnancy|7|||
155072360|NCT03244189|559694150|FG001|Overall Study|Pregnancy|5|||
155072361|NCT03244189|559694149|FG000|Overall Study|Protocol Violation|0|||
155072362|NCT03244189|559694150|FG001|Overall Study|Protocol Violation|2|||
155072363|NCT03244189|559694149|FG000|Overall Study|Withdrawal by Subject|45|||
155072364|NCT03244189|559694150|FG001|Overall Study|Withdrawal by Subject|23|||
155072365|NCT03244189|559694149|FG000|Overall Study|Technical Problems|2|||
155072366|NCT03244189|559694150|FG001|Overall Study|Technical Problems|0|||
155072367|NCT03599713|559694153|FG000|Overall Study|Death|38|||
155072368|NCT03599713|559694154|FG001|Overall Study|Death|3|||
155072369|NCT03599713|559694153|FG000|Overall Study|Withdrawal by Subject|17|||
155072370|NCT03599713|559694154|FG001|Overall Study|Withdrawal by Subject|0|||
155072371|NCT03599713|559694153|FG000|Overall Study|Lost to Follow-up|4|||
155072372|NCT03599713|559694154|FG001|Overall Study|Lost to Follow-up|0|||
155072373|NCT03599713|559694153|FG000|Overall Study|Discontinued Due to End of Study|42|||
155072374|NCT03599713|559694154|FG001|Overall Study|Discontinued Due to End of Study|3|||
155072375|NCT02850406|559694159|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
155072376|NCT02850406|559694160|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
155072377|NCT02850406|559694161|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
155072378|NCT02850406|559694162|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
155072379|NCT02850406|559694163|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
155072380|NCT02850406|559694164|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
155072381|NCT02850406|559694165|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
154962276|NCT02089685|559287928|FG002|Overall Study|Status not recorded|0|||
154962277|NCT02089685|559287929|FG003|Overall Study|Status not recorded|0|||
155072382|NCT02850406|559694166|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
155072383|NCT02850406|559694159|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155072384|NCT02850406|559694160|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
154962278|NCT02089685|559287930|FG004|Overall Study|Status not recorded|1|||
155072385|NCT02850406|559694161|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
155072386|NCT02850406|559694162|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
155072387|NCT02850406|559694163|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155072388|NCT02850406|559694164|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155072389|NCT02850406|559694165|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155072390|NCT02850406|559694166|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
155072391|NCT02850406|559694159|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155072392|NCT02850406|559694160|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155072393|NCT02850406|559694161|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
155072394|NCT02850406|559694162|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155163871|NCT03682770|560036756|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155163872|NCT03682770|560036757|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155163873|NCT03682770|560036758|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155163874|NCT03682770|560036759|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
155163875|NCT03682770|560036753|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155163876|NCT03682770|560036754|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155163877|NCT03682770|560036755|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
155163878|NCT03682770|560036756|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
155163879|NCT03682770|560036757|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155163880|NCT03682770|560036758|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155163881|NCT03682770|560036759|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
155163882|NCT03682770|560036753|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155163883|NCT03682770|560036754|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155163884|NCT03682770|560036755|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155163885|NCT03682770|560036756|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
155163886|NCT03682770|560036757|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155163887|NCT03682770|560036758|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155163888|NCT03682770|560036759|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
155163889|NCT03682770|560036753|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155163890|NCT03682770|560036754|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155163891|NCT03682770|560036755|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
155163892|NCT03682770|560036756|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
155163893|NCT03682770|560036757|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155163894|NCT03682770|560036758|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155163895|NCT03682770|560036759|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
155163896|NCT03682770|560036753|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155163897|NCT03682770|560036754|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155163898|NCT03682770|560036755|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
155163899|NCT03682770|560036756|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155163900|NCT03682770|560036757|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155163901|NCT03682770|560036758|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155163902|NCT03682770|560036759|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
155163903|NCT03682770|560036753|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155163904|NCT03682770|560036754|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155163905|NCT03682770|560036755|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
155072395|NCT02850406|559694163|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155072396|NCT02850406|559694164|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155072397|NCT02850406|559694165|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155072398|NCT02850406|559694166|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
155072399|NCT02850406|559694159|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
155072400|NCT02850406|559694160|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
155072401|NCT02850406|559694161|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
155072402|NCT02850406|559694162|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
155072403|NCT02850406|559694163|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
155163906|NCT03682770|560036756|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155163907|NCT03682770|560036757|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155163908|NCT03682770|560036758|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155072404|NCT02850406|559694164|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
155072405|NCT02850406|559694165|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
155072406|NCT02850406|559694166|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
155072407|NCT02850406|559694159|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
155072408|NCT02850406|559694160|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
155072409|NCT02850406|559694161|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
155072410|NCT02850406|559694162|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
155072411|NCT02850406|559694163|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
155072412|NCT02850406|559694164|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
155072413|NCT02850406|559694165|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
155072414|NCT02850406|559694166|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
155072415|NCT02850406|559694159|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072416|NCT02850406|559694160|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072417|NCT02850406|559694161|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072418|NCT02850406|559694162|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072419|NCT02850406|559694163|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
155072420|NCT02850406|559694164|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
155072421|NCT02850406|559694165|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072422|NCT02850406|559694166|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072423|NCT02850406|559694159|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
155072424|NCT02850406|559694160|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
155072425|NCT02850406|559694161|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
155072426|NCT02850406|559694162|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
155072427|NCT02850406|559694163|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
155072428|NCT02850406|559694164|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
155163909|NCT03682770|560036759|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
155163910|NCT03682770|560036753|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155163911|NCT03682770|560036754|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155072429|NCT02850406|559694165|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
155072430|NCT02850406|559694166|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
155072431|NCT02850406|559694159|FG000|Part C (Up to 52 Weeks)|Other|0|||
155072432|NCT02850406|559694160|FG001|Part C (Up to 52 Weeks)|Other|0|||
155072433|NCT02850406|559694161|FG002|Part C (Up to 52 Weeks)|Other|0|||
155072434|NCT02850406|559694162|FG003|Part C (Up to 52 Weeks)|Other|0|||
155163912|NCT03682770|560036755|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155163913|NCT03682770|560036756|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
155072435|NCT02850406|559694163|FG004|Part C (Up to 52 Weeks)|Other|1|||
155072436|NCT02850406|559694164|FG005|Part C (Up to 52 Weeks)|Other|3|||
155072437|NCT02850406|559694165|FG006|Part C (Up to 52 Weeks)|Other|0|||
155072438|NCT02850406|559694166|FG007|Part C (Up to 52 Weeks)|Other|0|||
155072439|NCT02850406|559694159|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072440|NCT02850406|559694160|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072441|NCT02850406|559694161|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072442|NCT02850406|559694162|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072443|NCT02850406|559694163|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072444|NCT02850406|559694164|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072445|NCT02850406|559694165|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
155072446|NCT02850406|559694166|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
155072447|NCT02850406|559694159|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072448|NCT02850406|559694160|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072449|NCT02850406|559694161|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072450|NCT02850406|559694162|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072451|NCT02850406|559694163|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072452|NCT02850406|559694164|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072453|NCT02850406|559694165|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
155072454|NCT02850406|559694166|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
155072455|NCT02850406|559694159|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
155072456|NCT02850406|559694160|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
155072457|NCT02850406|559694161|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
155072458|NCT02850406|559694162|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
155072459|NCT02850406|559694163|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
155072460|NCT02850406|559694164|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
155072461|NCT02850406|559694165|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
155072462|NCT02850406|559694166|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
155072463|NCT02850406|559694159|FG000|Part D (Up to 52 Weeks)|Other|0|||
155072464|NCT02850406|559694160|FG001|Part D (Up to 52 Weeks)|Other|0|||
155072465|NCT02850406|559694161|FG002|Part D (Up to 52 Weeks)|Other|0|||
155072466|NCT02850406|559694162|FG003|Part D (Up to 52 Weeks)|Other|0|||
155072467|NCT02850406|559694163|FG004|Part D (Up to 52 Weeks)|Other|0|||
155072468|NCT02850406|559694164|FG005|Part D (Up to 52 Weeks)|Other|0|||
155072469|NCT02850406|559694165|FG006|Part D (Up to 52 Weeks)|Other|0|||
155072470|NCT02850406|559694166|FG007|Part D (Up to 52 Weeks)|Other|1|||
155072471|NCT05578872|559694167|FG000|Overall Study|Withdrawal by Subject|2|||
155072472|NCT05578872|559694168|FG001|Overall Study|Withdrawal by Subject|1|||
155072473|NCT05578872|559694167|FG000|Overall Study|Adverse Event|1|||
155072474|NCT05578872|559694168|FG001|Overall Study|Adverse Event|1|||
155072475|NCT05578872|559694167|FG000|Overall Study|Physician Decision|1|||
155072476|NCT05578872|559694168|FG001|Overall Study|Physician Decision|2|||
155072477|NCT05578872|559694167|FG000|Overall Study|Progressive disease|10|||
155072478|NCT05578872|559694168|FG001|Overall Study|Progressive disease|9|||
155072479|NCT05578872|559694167|FG000|Overall Study|Sponsor decision|0|||
155072480|NCT05578872|559694168|FG001|Overall Study|Sponsor decision|1|||
155072481|NCT05578872|559694167|FG000|Overall Study|Toxicity and Patient's decision|0|||
155072482|NCT05578872|559694168|FG001|Overall Study|Toxicity and Patient's decision|1|||
155072483|NCT00182637|559694956|FG000|Overall Study|Adverse Event|2|||
155072484|NCT00182637|559694956|FG000|Overall Study|Disease Progression|1|||
155072485|NCT04941898|559694957|FG000|Overall Study|Protocol Violation|1|||
155072486|NCT00003456|559694958|FG000|Overall Study|Not evaluable|8|||
155072487|NCT00587457|559694961|FG000|Overall Study|Adverse Event|1|||
155072488|NCT00587457|559694962|FG001|Overall Study|Adverse Event|2|||
155072489|NCT00587457|559694963|FG002|Overall Study|Adverse Event|1|||
155072490|NCT00587457|559694961|FG000|Overall Study|Disease progression|2|||
155072491|NCT00587457|559694962|FG001|Overall Study|Disease progression|0|||
155072492|NCT00587457|559694963|FG002|Overall Study|Disease progression|2|||
155072493|NCT00587457|559694961|FG000|Overall Study|Initiation of alternative therapy|0|||
155072494|NCT00587457|559694962|FG001|Overall Study|Initiation of alternative therapy|1|||
155072495|NCT00587457|559694963|FG002|Overall Study|Initiation of alternative therapy|0|||
155072496|NCT00587457|559694961|FG000|Overall Study|Undefined|0|||
155072497|NCT00587457|559694962|FG001|Overall Study|Undefined|0|||
155072498|NCT00587457|559694963|FG002|Overall Study|Undefined|1|||
155072499|NCT00587457|559694961|FG000|Overall Study|Development of neutralizing Abs|0|||
155072500|NCT00587457|559694962|FG001|Overall Study|Development of neutralizing Abs|0|||
155072501|NCT00587457|559694963|FG002|Overall Study|Development of neutralizing Abs|1|||
155163914|NCT03682770|560036757|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155163915|NCT03682770|560036758|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155163916|NCT03682770|560036759|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
155335624|NCT04447027|560663136|FG000|Dose Escalation|Withdrawal by Subject|1|||
155335625|NCT04447027|560663137|FG001|Dose Escalation|Withdrawal by Subject|4|||
155335626|NCT04447027|560663138|FG002|Dose Escalation|Withdrawal by Subject|3|||
155335627|NCT04447027|560663139|FG003|Dose Escalation|Withdrawal by Subject|3|||
155335628|NCT04447027|560663140|FG004|Dose Escalation|Withdrawal by Subject|1|||
155335629|NCT04447027|560663141|FG005|Dose Escalation|Withdrawal by Subject|0|||
155335630|NCT04447027|560663142|FG006|Dose Escalation|Withdrawal by Subject|0|||
155335631|NCT04447027|560663143|FG007|Dose Escalation|Withdrawal by Subject|0|||
155335632|NCT04447027|560663144|FG008|Dose Escalation|Withdrawal by Subject|0|||
155335633|NCT04447027|560663136|FG000|Dose Escalation|Refused further treatment|0|||
155335634|NCT04447027|560663137|FG001|Dose Escalation|Refused further treatment|1|||
155335635|NCT04447027|560663138|FG002|Dose Escalation|Refused further treatment|1|||
155335636|NCT04447027|560663139|FG003|Dose Escalation|Refused further treatment|0|||
155335637|NCT04447027|560663140|FG004|Dose Escalation|Refused further treatment|0|||
155335638|NCT04447027|560663141|FG005|Dose Escalation|Refused further treatment|0|||
155335639|NCT04447027|560663142|FG006|Dose Escalation|Refused further treatment|0|||
155335640|NCT04447027|560663143|FG007|Dose Escalation|Refused further treatment|0|||
155335641|NCT04447027|560663144|FG008|Dose Escalation|Refused further treatment|0|||
155335642|NCT04447027|560663136|FG000|Dose Expansion|Withdrawal by Subject|0|||
155335643|NCT04447027|560663137|FG001|Dose Expansion|Withdrawal by Subject|0|||
155335644|NCT04447027|560663138|FG002|Dose Expansion|Withdrawal by Subject|0|||
155335645|NCT04447027|560663139|FG003|Dose Expansion|Withdrawal by Subject|0|||
155335646|NCT04447027|560663140|FG004|Dose Expansion|Withdrawal by Subject|0|||
155335647|NCT04447027|560663141|FG005|Dose Expansion|Withdrawal by Subject|2|||
155335648|NCT04447027|560663142|FG006|Dose Expansion|Withdrawal by Subject|0|||
155335649|NCT04447027|560663143|FG007|Dose Expansion|Withdrawal by Subject|2|||
155335650|NCT04447027|560663144|FG008|Dose Expansion|Withdrawal by Subject|0|||
155335651|NCT04224272|560663145|FG000|Part 1 - Dose Finding|Death|4|||
155335652|NCT04224272|560663145|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
154962279|NCT02089685|559287931|FG005|Overall Study|Status not recorded|0|||
154962280|NCT02089685|559287926|FG000|Overall Study|Death|0|||
154962281|NCT02089685|559287927|FG001|Overall Study|Death|0|||
154962282|NCT02089685|559287928|FG002|Overall Study|Death|0|||
154962283|NCT02089685|559287929|FG003|Overall Study|Death|7|||
154962284|NCT02089685|559287930|FG004|Overall Study|Death|2|||
154962285|NCT02089685|559287931|FG005|Overall Study|Death|5|||
154962286|NCT02089685|559287926|FG000|Overall Study|Lost to Follow-up|0|||
154962287|NCT02089685|559287927|FG001|Overall Study|Lost to Follow-up|0|||
154962288|NCT02089685|559287928|FG002|Overall Study|Lost to Follow-up|0|||
154962289|NCT02089685|559287929|FG003|Overall Study|Lost to Follow-up|1|||
154962290|NCT02089685|559287930|FG004|Overall Study|Lost to Follow-up|0|||
154962291|NCT02089685|559287931|FG005|Overall Study|Lost to Follow-up|0|||
154962292|NCT02089685|559287926|FG000|Overall Study|Physician Decision|0|||
154962293|NCT02089685|559287927|FG001|Overall Study|Physician Decision|0|||
154962294|NCT02089685|559287928|FG002|Overall Study|Physician Decision|0|||
154962295|NCT02089685|559287929|FG003|Overall Study|Physician Decision|0|||
154962296|NCT02089685|559287930|FG004|Overall Study|Physician Decision|0|||
154962297|NCT02089685|559287931|FG005|Overall Study|Physician Decision|4|||
154962298|NCT02089685|559287926|FG000|Overall Study|Screen failure|1|||
155335653|NCT04224272|560663145|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
155335654|NCT04224272|560663145|FG000|Part 2 - Dose Expansion|Death|10|||
155072502|NCT03234881|559694964|FG000|Overall Study|Lost to Follow-up|9|||
155072503|NCT03234881|559694965|FG001|Overall Study|Lost to Follow-up|3|||
155072504|NCT01500096|559694970|FG000|Overall Study|Lost to Follow-up|1|||
155072505|NCT01500096|559694971|FG001|Overall Study|Lost to Follow-up|0|||
155335655|NCT04224272|560663145|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
155335656|NCT02609048|560663146|FG000|Overall Study|Adverse Event|3|||
155335657|NCT02609048|560663147|FG001|Overall Study|Adverse Event|0|||
155335658|NCT02609048|560663148|FG002|Overall Study|Adverse Event|0|||
155335659|NCT02609048|560663146|FG000|Overall Study|Randomized but never treated|1|||
155335660|NCT02609048|560663147|FG001|Overall Study|Randomized but never treated|1|||
155335661|NCT02609048|560663148|FG002|Overall Study|Randomized but never treated|1|||
155335662|NCT02609048|560663146|FG000|Overall Study|Withdrawal of informed consent|1|||
155072506|NCT01500096|559694972|FG002|Overall Study|Lost to Follow-up|0|||
155072507|NCT01500096|559694973|FG003|Overall Study|Lost to Follow-up|2|||
155072508|NCT00639379|559694974|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
155072509|NCT00639379|559694975|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
155072510|NCT00639379|559694974|FG000|Period 1 - 2 Weeks|lens issue|3|||
155072511|NCT00639379|559694975|FG001|Period 1 - 2 Weeks|lens issue|0|||
155072512|NCT00723944|559694976|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
155072513|NCT00723944|559694977|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
155072514|NCT00723944|559694976|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
155072515|NCT00723944|559694977|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
155072516|NCT00723944|559694976|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
155072517|NCT00723944|559694977|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
155072518|NCT02506036|559694980|FG000|First Intervention (4-6 Weeks)|Death|1|||
155072519|NCT02506036|559694981|FG001|First Intervention (4-6 Weeks)|Death|0|||
155072520|NCT02506036|559694980|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
155072521|NCT02506036|559694981|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
155072522|NCT02506036|559694980|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
155072523|NCT02506036|559694981|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
155072524|NCT02383173|559694982|FG000|Overall Study|Palliative Care Team withdrew|0|||
155072525|NCT02383173|559694983|FG001|Overall Study|Palliative Care Team withdrew|2|||
155072526|NCT00800540|559694984|FG000|Period One: 6 Weeks|Noncompliance|1|||
155335663|NCT02609048|560663147|FG001|Overall Study|Withdrawal of informed consent|0|||
155335664|NCT02609048|560663148|FG002|Overall Study|Withdrawal of informed consent|0|||
155335665|NCT02609048|560663146|FG000|Overall Study|Reason not specified|6|||
155335666|NCT02609048|560663147|FG001|Overall Study|Reason not specified|9|||
155072527|NCT00800540|559694985|FG001|Period One: 6 Weeks|Noncompliance|0|||
155072528|NCT00800540|559694984|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
154962299|NCT02089685|559287927|FG001|Overall Study|Screen failure|0|||
154962300|NCT02089685|559287928|FG002|Overall Study|Screen failure|0|||
154962301|NCT02089685|559287929|FG003|Overall Study|Screen failure|0|||
155163917|NCT03682770|560036753|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155163918|NCT03682770|560036754|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155163919|NCT03682770|560036755|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155163920|NCT03682770|560036756|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
155163921|NCT03682770|560036757|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
155163922|NCT03682770|560036758|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
155163923|NCT03682770|560036759|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
155163924|NCT03682770|560036753|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155163925|NCT03682770|560036754|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155163926|NCT03682770|560036755|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155163927|NCT03682770|560036756|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155163928|NCT03682770|560036757|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
155163929|NCT03682770|560036758|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155163930|NCT03682770|560036759|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
155163931|NCT03682770|560036753|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155163932|NCT03682770|560036754|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155163933|NCT03682770|560036755|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155163934|NCT03682770|560036756|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155163935|NCT03682770|560036757|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155163936|NCT03682770|560036758|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
155163937|NCT03682770|560036759|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
155163938|NCT03682770|560036753|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155163939|NCT03682770|560036754|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155163940|NCT03682770|560036755|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155163941|NCT03682770|560036756|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155163942|NCT03682770|560036757|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
155163943|NCT03682770|560036758|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
155163944|NCT03682770|560036759|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
155163945|NCT02362282|560036760|FG000|Overall Study|Withdrawal by Subject|1|||
155163946|NCT02362282|560036761|FG001|Overall Study|Withdrawal by Subject|0|||
155163947|NCT01491607|560036764|FG000|Overall Study|Lost to Follow-up|7|||
155163948|NCT01491607|560036764|FG000|Overall Study|Withdrawal by Subject|3|||
155163949|NCT01317277|560036765|FG000|Overall Study|Lost to Follow-up|3|||
155163950|NCT01317277|560036766|FG001|Overall Study|Lost to Follow-up|1|||
155163951|NCT01317277|560036765|FG000|Overall Study|Lost MEMS|1|||
155163952|NCT01317277|560036766|FG001|Overall Study|Lost MEMS|1|||
155163953|NCT01317277|560036765|FG000|Overall Study|Unable to comply with intervention|1|||
155163954|NCT01317277|560036766|FG001|Overall Study|Unable to comply with intervention|0|||
155163955|NCT01317277|560036765|FG000|Overall Study|Withdrawal by Subject|1|||
155163956|NCT01317277|560036766|FG001|Overall Study|Withdrawal by Subject|0|||
155163957|NCT01317277|560036765|FG000|Overall Study|Adverse Event|1|||
155163958|NCT01317277|560036766|FG001|Overall Study|Adverse Event|0|||
155163959|NCT00774566|560036767|FG000|Overall Study|Protocol Violation|18|||
155163960|NCT00774566|560036768|FG001|Overall Study|Protocol Violation|15|||
155163961|NCT04896073|560036775|FG000|Overall Study|Screen failure|0|||
155163962|NCT04896073|560036776|FG001|Overall Study|Screen failure|2|||
155163963|NCT04896073|560036775|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
155163964|NCT04896073|560036776|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
155163965|NCT02454517|560036777|FG000|Overall Study|Withdrawal by Subject|3|||
155163966|NCT02454517|560036778|FG001|Overall Study|Withdrawal by Subject|0|||
155163967|NCT02454517|560036777|FG000|Overall Study|Lost to Follow-up|4|||
155163968|NCT02454517|560036778|FG001|Overall Study|Lost to Follow-up|7|||
155163969|NCT02454517|560036777|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
155163970|NCT02454517|560036778|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
155163971|NCT03565497|560036779|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
155163972|NCT03565497|560036780|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
155163973|NCT03565497|560036781|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
155163974|NCT03565497|560036779|FG000|Overall Study|Lost to Follow-up|1|||
155163975|NCT03565497|560036780|FG001|Overall Study|Lost to Follow-up|1|||
155163976|NCT03565497|560036781|FG002|Overall Study|Lost to Follow-up|2|||
155163977|NCT03565497|560036779|FG000|Overall Study|Withdrawal by Subject|1|||
155163978|NCT03565497|560036780|FG001|Overall Study|Withdrawal by Subject|1|||
155163979|NCT03565497|560036781|FG002|Overall Study|Withdrawal by Subject|1|||
155163980|NCT01470326|560036782|FG000|Overall Study|Protocol Violation|32|||
155163981|NCT01470326|560036782|FG000|Overall Study|No Drug Administration Information|2|||
155163982|NCT01470326|560036782|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
155163983|NCT02577718|560036783|FG000|Overall Study|Death|6|||
155163984|NCT02577718|560036783|FG000|Overall Study|Withdrawal by Subject|2|||
155163985|NCT01075685|560036784|FG000|Overall Study|Protocol Violation|9|||
155163986|NCT01075685|560036785|FG001|Overall Study|Protocol Violation|1|||
155163987|NCT01075685|560036784|FG000|Overall Study|Withdrawal by Subject|20|||
155163988|NCT01075685|560036785|FG001|Overall Study|Withdrawal by Subject|5|||
155163989|NCT01075685|560036784|FG000|Overall Study|Lost to Follow-up|563|||
155163990|NCT01075685|560036785|FG001|Overall Study|Lost to Follow-up|220|||
155163991|NCT02858362|560036788|FG000|Overall Study|Protocol Violation|0|||
155163992|NCT02858362|560036789|FG001|Overall Study|Protocol Violation|1|||
155163993|NCT02858362|560036790|FG002|Overall Study|Protocol Violation|0|||
155163994|NCT02858362|560036788|FG000|Overall Study|Withdrawal by Subject|1|||
155163995|NCT02858362|560036789|FG001|Overall Study|Withdrawal by Subject|0|||
155163996|NCT02858362|560036790|FG002|Overall Study|Withdrawal by Subject|0|||
155163997|NCT02858362|560036788|FG000|Overall Study|Early Study Termination|0|||
155163998|NCT02858362|560036789|FG001|Overall Study|Early Study Termination|0|||
155163999|NCT02858362|560036790|FG002|Overall Study|Early Study Termination|3|||
155164000|NCT02858362|560036788|FG000|Overall Study|Lost to Follow-up|1|||
155164001|NCT02858362|560036789|FG001|Overall Study|Lost to Follow-up|0|||
155164002|NCT02858362|560036790|FG002|Overall Study|Lost to Follow-up|0|||
155164003|NCT02194985|560036791|FG000|Overall Study|Adverse Event|1|||
155335667|NCT02609048|560663148|FG002|Overall Study|Reason not specified|9|||
155335668|NCT04118894|560663154|FG000|Overall Study|Lost to Follow-up|21|||
155335669|NCT04118894|560663154|FG000|Overall Study|Withdrawal by Subject|10|||
155164004|NCT02194985|560036791|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
155164005|NCT02194985|560036791|FG000|Overall Study|Physician Decision|4|||
155164006|NCT02194985|560036791|FG000|Overall Study|Lost to Follow-up|1|||
155164007|NCT02194985|560036791|FG000|Overall Study|Withdrawal by Subject|2|||
155164008|NCT02561832|560036801|FG000|Overall Study|Withdrawal by Subject|1|||
155164009|NCT02561832|560036802|FG001|Overall Study|Withdrawal by Subject|1|||
155164010|NCT02561832|560036801|FG000|Overall Study|Adverse Event|3|||
155164011|NCT02561832|560036802|FG001|Overall Study|Adverse Event|0|||
155164012|NCT02561832|560036801|FG000|Overall Study|Disease progression|3|||
155164013|NCT02561832|560036802|FG001|Overall Study|Disease progression|3|||
155164014|NCT00594815|560036803|FG000|Overall Study|Never Treated|3|||
155164015|NCT00594815|560036803|FG000|Overall Study|Withdrawal by Subject|2|||
155335670|NCT04118894|560663154|FG000|Overall Study|Adverse Event|4|||
155164016|NCT00594815|560036803|FG000|Overall Study|Toxicity|4|||
155164017|NCT02304367|560036804|FG000|Overall Study|Lack of Response to Bruosumab|1|||
155335671|NCT04992273|560664737|FG000|Overall Study|Lost to Follow-up|0|||
155335672|NCT04992273|560664738|FG001|Overall Study|Lost to Follow-up|1|||
155335673|NCT00670449|560664739|FG000|Overall Study|Adverse Event|6|||
155335674|NCT00670449|560664740|FG001|Overall Study|Adverse Event|2|||
155335675|NCT00670449|560664741|FG002|Overall Study|Adverse Event|8|||
155335676|NCT00670449|560664742|FG003|Overall Study|Adverse Event|5|||
155335677|NCT00670449|560664739|FG000|Overall Study|Protocol Deviation|1|||
155335678|NCT00670449|560664740|FG001|Overall Study|Protocol Deviation|2|||
155335679|NCT00670449|560664741|FG002|Overall Study|Protocol Deviation|0|||
155335680|NCT00670449|560664742|FG003|Overall Study|Protocol Deviation|1|||
155335681|NCT00670449|560664739|FG000|Overall Study|Administrative Problems|0|||
155335682|NCT00670449|560664740|FG001|Overall Study|Administrative Problems|2|||
155335683|NCT00670449|560664741|FG002|Overall Study|Administrative Problems|0|||
155335684|NCT00670449|560664742|FG003|Overall Study|Administrative Problems|1|||
155335685|NCT00670449|560664739|FG000|Overall Study|Subject Withdrew Consent|0|||
155335686|NCT00670449|560664740|FG001|Overall Study|Subject Withdrew Consent|2|||
155335687|NCT00670449|560664741|FG002|Overall Study|Subject Withdrew Consent|0|||
155335688|NCT00670449|560664742|FG003|Overall Study|Subject Withdrew Consent|1|||
155335689|NCT00670449|560664739|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
155335690|NCT00670449|560664740|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155335691|NCT00670449|560664741|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155335692|NCT00670449|560664742|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155335693|NCT00670449|560664739|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
155072529|NCT00800540|559694985|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
155072530|NCT00800540|559694984|FG000|Period 2: 6 Weeks|Adverse Event|0|||
155072531|NCT00800540|559694985|FG001|Period 2: 6 Weeks|Adverse Event|1|||
155072532|NCT01239745|559694986|FG000|Overall Study|Study terminated by sponsor|45|||
155072533|NCT01239745|559694986|FG000|Overall Study|Adverse Event|1|||
155072534|NCT00726557|559694987|FG000|Overall Study|Screening failure|4|||
155072535|NCT00726557|559694987|FG000|Overall Study|No end of treatment documentation|37|||
155072536|NCT00726557|559694987|FG000|Overall Study|No follow-up documentation available|55|||
155072537|NCT00726557|559694987|FG000|Overall Study|Treatment less than 3 months|17|||
155072538|NCT00726557|559694987|FG000|Overall Study|Inclusion criteria not met|15|||
155072539|NCT02143778|559694990|FG000|Overall Study|Withdrawal by Subject|2|||
155072540|NCT02143778|559694990|FG000|Overall Study|Device malfunction|1|||
155072541|NCT03637374|559694991|FG000|Overall Study|Death|2|||
155072542|NCT03637374|559694992|FG001|Overall Study|Death|0|||
155072543|NCT02836769|559694996|FG000|Overall Study|Lost to Follow-up|10|||
155072544|NCT02836769|559694996|FG000|Overall Study|Medical withdrawal|2|||
155072545|NCT02836769|559694996|FG000|Overall Study|Withdrawal by Subject|3|||
155072546|NCT03142750|559695001|FG000|Overall Study|Lost to Follow-up|4|||
155072547|NCT03142750|559695002|FG001|Overall Study|Lost to Follow-up|1|||
155072548|NCT02948400|559695004|FG000|Overall Study|Withdrawal by Subject|17|||
155072549|NCT02948400|559695005|FG001|Overall Study|Withdrawal by Subject|10|||
155072550|NCT02948400|559695004|FG000|Overall Study|failed to attend appointments|47|||
155072551|NCT02948400|559695005|FG001|Overall Study|failed to attend appointments|34|||
155072552|NCT02948400|559695004|FG000|Overall Study|COVID-related closure|6|||
155072553|NCT02948400|559695005|FG001|Overall Study|COVID-related closure|2|||
155072554|NCT02948400|559695004|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
155072555|NCT02948400|559695005|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
155072556|NCT02948400|559695004|FG000|Overall Study|motion sickness in virtual reality|2|||
155072557|NCT02948400|559695005|FG001|Overall Study|motion sickness in virtual reality|0|||
155072558|NCT03349515|559695006|FG000|Overall Study|Lack of Efficacy|2|||
155072559|NCT03349515|559695007|FG001|Overall Study|Lack of Efficacy|0|||
155072560|NCT03349515|559695006|FG000|Overall Study|Physician Decision|3|||
155072561|NCT03349515|559695007|FG001|Overall Study|Physician Decision|1|||
155164018|NCT02304367|560036804|FG000|Overall Study|Sponsor Decision|3|||
155335694|NCT00670449|560664740|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
155335695|NCT00670449|560664741|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155335696|NCT00670449|560664742|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
155335697|NCT02771366|560664743|FG000|Period 1|Withdrawal by Subject|0|||
155335698|NCT02771366|560664744|FG001|Period 1|Withdrawal by Subject|2|||
155335699|NCT02771366|560664743|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
155335700|NCT02771366|560664744|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
155335701|NCT01823224|560664745|FG000|Overall Study|Lost to Follow-up|5|||
155072562|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
155072563|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
155072564|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
155072565|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Death|1|||
155072566|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Death|0|||
155072567|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Death|0|||
155072568|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
155072569|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
155072570|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
155072571|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
155072572|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
155072573|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
155072574|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
155072575|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
155072576|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
155072577|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
155072578|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
155072579|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
155072580|NCT05073315|559695008|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
155072581|NCT05073315|559695009|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
155072582|NCT05073315|559695010|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
155072583|NCT05073315|559695008|FG000|Period 2|Adverse Event|0|||
155072584|NCT05073315|559695009|FG001|Period 2|Adverse Event|3|||
155335702|NCT01823224|560664746|FG001|Overall Study|Lost to Follow-up|6|||
155335703|NCT01823224|560664745|FG000|Overall Study|didn't qualify|1|||
155335704|NCT01823224|560664746|FG001|Overall Study|didn't qualify|2|||
155335705|NCT01823224|560664745|FG000|Overall Study|pharmacy error|0|||
155335706|NCT01823224|560664746|FG001|Overall Study|pharmacy error|1|||
155335707|NCT01823224|560664745|FG000|Overall Study|missed med dose|0|||
155335708|NCT01823224|560664746|FG001|Overall Study|missed med dose|1|||
155335709|NCT01823224|560664745|FG000|Overall Study|Withdrawal by Subject|0|||
155335710|NCT01823224|560664746|FG001|Overall Study|Withdrawal by Subject|1|||
155072585|NCT05073315|559695010|FG002|Period 2|Adverse Event|6|||
155164019|NCT02304367|560036804|FG000|Overall Study|Death|2|||
155335711|NCT01779050|560664749|FG000|Overall Study|Withdrawal by Subject|1|||
155335712|NCT01779050|560664750|FG001|Overall Study|Withdrawal by Subject|0|||
155335713|NCT00022672|560664751|FG000|Main Phase: 24 Months|Adverse Event|6|||
155335714|NCT00022672|560664752|FG001|Main Phase: 24 Months|Adverse Event|0|||
155335715|NCT00022672|560664751|FG000|Main Phase: 24 Months|Death|0|||
155335716|NCT00022672|560664752|FG001|Main Phase: 24 Months|Death|3|||
155335717|NCT00022672|560664751|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
155335718|NCT00022672|560664752|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
155335719|NCT00022672|560664751|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
155335720|NCT00022672|560664752|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
155335721|NCT00022672|560664751|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
155335722|NCT00022672|560664752|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
155335723|NCT00022672|560664751|FG000|Main Phase: 24 Months|Refused Treatment|3|||
155335724|NCT00022672|560664752|FG001|Main Phase: 24 Months|Refused Treatment|4|||
155335725|NCT00022672|560664751|FG000|Main Phase: 24 Months|Failure to Return|1|||
155335726|NCT00022672|560664752|FG001|Main Phase: 24 Months|Failure to Return|1|||
155335727|NCT00022672|560664751|FG000|Main Phase: 24 Months|Other|1|||
155335728|NCT00022672|560664752|FG001|Main Phase: 24 Months|Other|0|||
155335729|NCT00022672|560664751|FG000|Extension Phase|Adverse Event|1|||
155164020|NCT02304367|560036804|FG000|Overall Study|Physician Decision|1|||
155164021|NCT02304367|560036804|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
155164022|NCT03527732|560036805|FG000|Overall Study|Lost to Follow-up|21|||
155164023|NCT03527732|560036806|FG001|Overall Study|Lost to Follow-up|23|||
155164024|NCT03527732|560036807|FG002|Overall Study|Lost to Follow-up|80|||
155164025|NCT03527732|560036808|FG003|Overall Study|Lost to Follow-up|62|||
155164026|NCT03527732|560036809|FG004|Overall Study|Lost to Follow-up|12|||
155164027|NCT03527732|560036810|FG005|Overall Study|Lost to Follow-up|20|||
155164028|NCT03599089|560036811|FG000|Overall Study|Lost to Follow-up|1|||
155164029|NCT03599089|560036812|FG001|Overall Study|Lost to Follow-up|0|||
155164030|NCT03599089|560036813|FG002|Overall Study|Lost to Follow-up|0|||
155164031|NCT03599089|560036814|FG003|Overall Study|Lost to Follow-up|0|||
155164032|NCT03599089|560036811|FG000|Overall Study|Withdrawal by Subject|2|||
155164033|NCT03599089|560036812|FG001|Overall Study|Withdrawal by Subject|1|||
155164034|NCT03599089|560036813|FG002|Overall Study|Withdrawal by Subject|0|||
155164035|NCT03599089|560036814|FG003|Overall Study|Withdrawal by Subject|0|||
155164036|NCT03599089|560036811|FG000|Overall Study|Lack of Efficacy|0|||
155164037|NCT03599089|560036812|FG001|Overall Study|Lack of Efficacy|0|||
155164038|NCT03599089|560036813|FG002|Overall Study|Lack of Efficacy|1|||
155164039|NCT03599089|560036814|FG003|Overall Study|Lack of Efficacy|2|||
155164040|NCT02207088|560036815|FG000|Overall Study|Adverse Event|2|||
155164041|NCT00541385|560036823|FG000|Overall Study|Adverse Event|6|||
155164042|NCT00541385|560036824|FG001|Overall Study|Adverse Event|3|||
155164043|NCT00541385|560036823|FG000|Overall Study|Withdrawal by Subject|2|||
155164044|NCT00541385|560036824|FG001|Overall Study|Withdrawal by Subject|2|||
155164045|NCT00541385|560036823|FG000|Overall Study|Lost to Follow-up|6|||
155164046|NCT00541385|560036824|FG001|Overall Study|Lost to Follow-up|1|||
155164047|NCT00541385|560036823|FG000|Overall Study|Parasite reappearance/malaria|67|||
155164048|NCT00541385|560036824|FG001|Overall Study|Parasite reappearance/malaria|32|||
155164049|NCT03155841|560036825|FG000|Overall Study|Protocol Violation|3|||
155164050|NCT03155841|560036826|FG001|Overall Study|Protocol Violation|4|||
155164051|NCT04411667|560036827|FG000|Overall Study|Physician Decision|1|||
155164052|NCT04411667|560036828|FG001|Overall Study|Physician Decision|0|||
155164053|NCT00949702|560036829|FG000|Overall Study|Death|40|||
155164054|NCT00949702|560036829|FG000|Overall Study|Disease progression|7|||
155164055|NCT00949702|560036829|FG000|Overall Study|Withdrawal of consent|1|||
155164056|NCT03399552|560036830|FG000|Overall Study|No evidence of disease|1|||
155164057|NCT03399552|560036830|FG000|Overall Study|Unevaluable|1|||
155164058|NCT01286480|560036832|FG000|Overall Study|Withdrawal by Subject|5|||
155335730|NCT00022672|560664752|FG001|Extension Phase|Adverse Event|3|||
155335731|NCT00022672|560664751|FG000|Extension Phase|Death|0|||
154962302|NCT02089685|559287930|FG004|Overall Study|Screen failure|0|||
154962303|NCT02089685|559287931|FG005|Overall Study|Screen failure|0|||
155335732|NCT00022672|560664752|FG001|Extension Phase|Death|1|||
155335733|NCT00022672|560664751|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
155335734|NCT00022672|560664752|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
155335735|NCT00022672|560664751|FG000|Extension Phase|Refused Treatment|0|||
155335736|NCT00022672|560664752|FG001|Extension Phase|Refused Treatment|2|||
155335737|NCT00022672|560664751|FG000|Extension Phase|Other|1|||
155335738|NCT00022672|560664752|FG001|Extension Phase|Other|1|||
154962304|NCT00796653|559287934|FG000|Overall Study|Adverse Event|19|||
155164059|NCT01286480|560036833|FG001|Overall Study|Withdrawal by Subject|3|||
155164060|NCT00834093|560036834|FG000|Overall Study|Progressive Disease|3|||
155164061|NCT00834093|560036834|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
155164062|NCT00606593|560036835|FG000|Overall Study|Adverse Event|0|||
155164063|NCT00606593|560036836|FG001|Overall Study|Adverse Event|0|||
155164064|NCT00606593|560036837|FG002|Overall Study|Adverse Event|0|||
155164065|NCT00606593|560036838|FG003|Overall Study|Adverse Event|1|||
155164066|NCT00606593|560036839|FG004|Overall Study|Adverse Event|1|||
155164067|NCT00606593|560036840|FG005|Overall Study|Adverse Event|0|||
155164068|NCT00606593|560036841|FG006|Overall Study|Adverse Event|1|||
155335739|NCT03648541|560664753|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
155335740|NCT03648541|560664754|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
155335741|NCT03648541|560664753|FG000|Re-induction Period Only|Lack of Efficacy|7|||
155335742|NCT03648541|560664754|FG001|Re-induction Period Only|Lack of Efficacy|0|||
155335743|NCT03648541|560664753|FG000|Maintenance Period Only|Missing|0|||
155335744|NCT03648541|560664754|FG001|Maintenance Period Only|Missing|1|||
155335745|NCT03648541|560664753|FG000|Maintenance Period Only|Other not listed below|0|||
155335746|NCT03648541|560664754|FG001|Maintenance Period Only|Other not listed below|4|||
155335747|NCT03648541|560664753|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
155335748|NCT03648541|560664754|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
155335749|NCT03648541|560664753|FG000|Maintenance Period Only|Protocol Violation|0|||
155335750|NCT03648541|560664754|FG001|Maintenance Period Only|Protocol Violation|1|||
155335751|NCT03648541|560664753|FG000|Maintenance Period Only|Lack of Efficacy|0|||
155335752|NCT03648541|560664754|FG001|Maintenance Period Only|Lack of Efficacy|18|||
155335753|NCT03648541|560664753|FG000|Maintenance Period Only|Adverse Event|0|||
155335754|NCT03648541|560664754|FG001|Maintenance Period Only|Adverse Event|4|||
155335755|NCT03648541|560664753|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
154962305|NCT00796653|559287935|FG001|Overall Study|Adverse Event|16|||
154962306|NCT00796653|559287936|FG002|Overall Study|Adverse Event|16|||
154962307|NCT00796653|559287937|FG003|Overall Study|Adverse Event|16|||
154962308|NCT00796653|559287934|FG000|Overall Study|Lost to Follow-up|2|||
154962309|NCT00796653|559287935|FG001|Overall Study|Lost to Follow-up|1|||
154962310|NCT00796653|559287936|FG002|Overall Study|Lost to Follow-up|2|||
154962311|NCT00796653|559287937|FG003|Overall Study|Lost to Follow-up|3|||
154962312|NCT00796653|559287934|FG000|Overall Study|Withdrawal by Subject|16|||
154962313|NCT00796653|559287935|FG001|Overall Study|Withdrawal by Subject|8|||
154962314|NCT00796653|559287936|FG002|Overall Study|Withdrawal by Subject|8|||
154962315|NCT00796653|559287937|FG003|Overall Study|Withdrawal by Subject|13|||
154962316|NCT00796653|559287934|FG000|Overall Study|Lack of Efficacy|8|||
154962317|NCT00796653|559287935|FG001|Overall Study|Lack of Efficacy|1|||
154962318|NCT00796653|559287936|FG002|Overall Study|Lack of Efficacy|3|||
154962319|NCT00796653|559287937|FG003|Overall Study|Lack of Efficacy|2|||
154962320|NCT00796653|559287934|FG000|Overall Study|Non compliance with protocol|2|||
154962321|NCT00796653|559287935|FG001|Overall Study|Non compliance with protocol|2|||
154962322|NCT00796653|559287936|FG002|Overall Study|Non compliance with protocol|0|||
154962323|NCT00796653|559287937|FG003|Overall Study|Non compliance with protocol|2|||
154962324|NCT00796653|559287934|FG000|Overall Study|Other reason not described above|4|||
154962325|NCT00796653|559287935|FG001|Overall Study|Other reason not described above|9|||
154962326|NCT00796653|559287936|FG002|Overall Study|Other reason not described above|7|||
154962327|NCT00796653|559287937|FG003|Overall Study|Other reason not described above|4|||
154962328|NCT02414152|559287940|FG000|Overall Study|Withdrawal by Subject|1|||
154962329|NCT02414152|559287940|FG000|Overall Study|Lack of Efficacy|1|||
154962330|NCT04887415|559287944|FG000|Overall Study|Lost to Follow-up|2|||
154962331|NCT00841698|559287945|FG000|First Intervention|Withdrawal by Subject|1|||
154962332|NCT00841698|559287946|FG001|First Intervention|Withdrawal by Subject|0|||
154962333|NCT01250912|559287949|FG000|Overall Study|Lost to Follow-up|1|||
154962334|NCT00191815|559287950|FG000|Overall Study|Adverse Event|2|||
154962335|NCT00191815|559287950|FG000|Overall Study|Disease progression or relapse|24|||
154962336|NCT00191815|559287950|FG000|Overall Study|Death|2|||
154962337|NCT00191815|559287950|FG000|Overall Study|Protocol Violation|3|||
154962338|NCT00191815|559287950|FG000|Overall Study|Physician Decision|2|||
155335756|NCT03648541|560664754|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
155335757|NCT00273052|560664755|FG000|Overall Study|Withdrawal by Subject|16|||
155335758|NCT00273052|560664756|FG001|Overall Study|Withdrawal by Subject|19|||
155335759|NCT00273052|560664755|FG000|Overall Study|Adverse Event|21|||
155335760|NCT00273052|560664756|FG001|Overall Study|Adverse Event|19|||
155335761|NCT00273052|560664755|FG000|Overall Study|Protocol Violation|14|||
155335762|NCT00273052|560664756|FG001|Overall Study|Protocol Violation|18|||
155335763|NCT00273052|560664755|FG000|Overall Study|Lost to Follow-up|7|||
155072586|NCT05073315|559695008|FG000|Period 2|Lost to Follow-up|0|||
155072587|NCT05073315|559695009|FG001|Period 2|Lost to Follow-up|5|||
155072588|NCT05073315|559695010|FG002|Period 2|Lost to Follow-up|5|||
155072589|NCT05073315|559695008|FG000|Period 2|Withdrawal by Subject|0|||
155072590|NCT05073315|559695009|FG001|Period 2|Withdrawal by Subject|4|||
155072591|NCT05073315|559695010|FG002|Period 2|Withdrawal by Subject|9|||
155072592|NCT05073315|559695008|FG000|Period 2|Protocol Violation|0|||
155072593|NCT05073315|559695009|FG001|Period 2|Protocol Violation|0|||
155072594|NCT05073315|559695010|FG002|Period 2|Protocol Violation|1|||
155072595|NCT01529268|559695011|FG000|Overall Study|Lost to Follow-up|9|||
155072596|NCT01529268|559695012|FG001|Overall Study|Lost to Follow-up|3|||
155072597|NCT01529268|559695011|FG000|Overall Study|Moved|3|||
155072598|NCT01529268|559695012|FG001|Overall Study|Moved|0|||
155072599|NCT00303953|559695013|FG000|Overall Study|Ineligible|1|||
155072600|NCT00303953|559695013|FG000|Overall Study|Death|1|||
155072601|NCT00303953|559695013|FG000|Overall Study|Adverse Event|4|||
155072602|NCT00303953|559695013|FG000|Overall Study|Lack of Efficacy|12|||
155072603|NCT00303953|559695013|FG000|Overall Study|Physician Decision|1|||
155072604|NCT00021255|559695014|FG000|Overall Study|Death|1|||
155072605|NCT00021255|559695015|FG001|Overall Study|Death|0|||
155072606|NCT00021255|559695016|FG002|Overall Study|Death|2|||
155072607|NCT00021255|559695014|FG000|Overall Study|Breast cancer relapse|5|||
155072608|NCT00021255|559695015|FG001|Overall Study|Breast cancer relapse|18|||
155072609|NCT00021255|559695016|FG002|Overall Study|Breast cancer relapse|11|||
155072610|NCT00021255|559695014|FG000|Overall Study|Second primary malignancy|0|||
155072611|NCT00021255|559695015|FG001|Overall Study|Second primary malignancy|4|||
155072612|NCT00021255|559695016|FG002|Overall Study|Second primary malignancy|1|||
155072613|NCT00021255|559695014|FG000|Overall Study|Withdrawal by Subject|41|||
155072614|NCT00021255|559695015|FG001|Overall Study|Withdrawal by Subject|64|||
155072615|NCT00021255|559695016|FG002|Overall Study|Withdrawal by Subject|26|||
155072616|NCT00021255|559695014|FG000|Overall Study|Lost to Follow-up|0|||
155072617|NCT00021255|559695015|FG001|Overall Study|Lost to Follow-up|2|||
155072618|NCT00021255|559695016|FG002|Overall Study|Lost to Follow-up|3|||
155072619|NCT00021255|559695014|FG000|Overall Study|Cardiac toxicity|0|||
155072620|NCT00021255|559695015|FG001|Overall Study|Cardiac toxicity|61|||
155072621|NCT00021255|559695016|FG002|Overall Study|Cardiac toxicity|32|||
155072622|NCT00021255|559695014|FG000|Overall Study|Herceptin toxicity|0|||
155072623|NCT00021255|559695015|FG001|Overall Study|Herceptin toxicity|22|||
155072624|NCT00021255|559695016|FG002|Overall Study|Herceptin toxicity|6|||
155072625|NCT00021255|559695014|FG000|Overall Study|Adverse Event|46|||
155072626|NCT00021255|559695015|FG001|Overall Study|Adverse Event|30|||
155072627|NCT00021255|559695016|FG002|Overall Study|Adverse Event|18|||
155072628|NCT00021255|559695014|FG000|Overall Study|Protocol Violation|0|||
155072629|NCT00021255|559695015|FG001|Overall Study|Protocol Violation|2|||
155072630|NCT00021255|559695016|FG002|Overall Study|Protocol Violation|0|||
155072631|NCT00021255|559695014|FG000|Overall Study|Other than specified above|0|||
155072632|NCT00021255|559695015|FG001|Overall Study|Other than specified above|38|||
155072633|NCT00021255|559695016|FG002|Overall Study|Other than specified above|19|||
155072634|NCT00021255|559695014|FG000|Overall Study|Missing|0|||
155335764|NCT00273052|560664756|FG001|Overall Study|Lost to Follow-up|25|||
155335765|NCT00273052|560664755|FG000|Overall Study|Lack of Efficacy|6|||
155335766|NCT00273052|560664756|FG001|Overall Study|Lack of Efficacy|4|||
155335767|NCT00273052|560664755|FG000|Overall Study|Non-Compliance|3|||
155335768|NCT00273052|560664756|FG001|Overall Study|Non-Compliance|1|||
155072635|NCT00021255|559695015|FG001|Overall Study|Missing|27|||
155335769|NCT00273052|560664755|FG000|Overall Study|Other|2|||
155164069|NCT00606593|560036842|FG007|Overall Study|Adverse Event|2|||
155164070|NCT00606593|560036843|FG008|Overall Study|Adverse Event|1|||
155164071|NCT00606593|560036844|FG009|Overall Study|Adverse Event|0|||
154962339|NCT00191815|559287950|FG000|Overall Study|Withdrawal by Subject|7|||
154962340|NCT01348789|559287951|FG000|Overall Study|Protocol Violation|2|||
154962341|NCT01348789|559287951|FG000|Overall Study|Withdrawal by Subject|2|||
154962342|NCT01878292|559287952|FG000|Randomized|Protocol Violation|1|||
154962343|NCT01878292|559287953|FG001|Randomized|Protocol Violation|0|||
154962344|NCT01878292|559287954|FG002|Randomized|Protocol Violation|0|||
154962345|NCT01878292|559287952|FG000|Randomized|Lost to Follow-up|1|||
154962346|NCT01878292|559287953|FG001|Randomized|Lost to Follow-up|0|||
154962347|NCT01878292|559287954|FG002|Randomized|Lost to Follow-up|0|||
154962348|NCT01878292|559287952|FG000|Randomized|Adverse Event|1|||
154962349|NCT01878292|559287953|FG001|Randomized|Adverse Event|0|||
154962350|NCT01878292|559287954|FG002|Randomized|Adverse Event|0|||
154962351|NCT01878292|559287952|FG000|Double-blind Treatment Period|Other Reasons|2|||
154962352|NCT01878292|559287953|FG001|Double-blind Treatment Period|Other Reasons|0|||
154962353|NCT01878292|559287954|FG002|Double-blind Treatment Period|Other Reasons|0|||
154962354|NCT01878292|559287952|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
154962355|NCT01878292|559287953|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
155072636|NCT00021255|559695016|FG002|Overall Study|Missing|13|||
155072637|NCT00021255|559695014|FG000|Overall Study|Randomized but not treated|28|||
155335770|NCT00273052|560664756|FG001|Overall Study|Other|0|||
155335771|NCT00273052|560664755|FG000|Overall Study|Worsening serum lipid levels|0|||
155335772|NCT00273052|560664756|FG001|Overall Study|Worsening serum lipid levels|2|||
155335773|NCT01852045|560664757|FG000|Overall Study|Adverse Event|1|||
155335774|NCT01852045|560664758|FG001|Overall Study|Adverse Event|0|||
155335775|NCT01852045|560664759|FG002|Overall Study|Adverse Event|0|||
155335776|NCT01852045|560664757|FG000|Overall Study|Lack of Efficacy|3|||
155335777|NCT01852045|560664758|FG001|Overall Study|Lack of Efficacy|0|||
155335778|NCT01852045|560664759|FG002|Overall Study|Lack of Efficacy|0|||
155335779|NCT01852045|560664757|FG000|Overall Study|Lost to Follow-up|0|||
155335780|NCT01852045|560664758|FG001|Overall Study|Lost to Follow-up|1|||
155335781|NCT01852045|560664759|FG002|Overall Study|Lost to Follow-up|1|||
155072638|NCT00021255|559695015|FG001|Overall Study|Randomized but not treated|2|||
155072639|NCT00021255|559695016|FG002|Overall Study|Randomized but not treated|18|||
155072640|NCT01132755|559695019|FG000|Overall Study|Procedure not done due to medical reason|23|||
155072641|NCT01132755|559695019|FG000|Overall Study|Protocol Violation|15|||
155072642|NCT01132755|559695019|FG000|Overall Study|Withdrawal by Subject|4|||
155072643|NCT02232698|559695020|FG000|Overall Study|Pregnancy|1|||
155072644|NCT02232698|559695021|FG001|Overall Study|Pregnancy|1|||
155072645|NCT02232698|559695020|FG000|Overall Study|Met exclusion criteria|1|||
155072646|NCT02232698|559695021|FG001|Overall Study|Met exclusion criteria|1|||
155072647|NCT02232698|559695020|FG000|Overall Study|Had device-associated symptoms|7|||
155072648|NCT02232698|559695021|FG001|Overall Study|Had device-associated symptoms|0|||
155072649|NCT02232698|559695020|FG000|Overall Study|Non-compliance with study device|1|||
155072650|NCT02232698|559695021|FG001|Overall Study|Non-compliance with study device|4|||
155072651|NCT02232698|559695020|FG000|Overall Study|Allocated to control group|0|||
155072652|NCT02232698|559695021|FG001|Overall Study|Allocated to control group|3|||
155072653|NCT02232698|559695020|FG000|Overall Study|Withdrawal by Subject|0|||
155072654|NCT02232698|559695021|FG001|Overall Study|Withdrawal by Subject|11|||
155072655|NCT02393755|559695022|FG000|Overall Study|Withdrawal by Subject|0|||
155072656|NCT02393755|559695023|FG001|Overall Study|Withdrawal by Subject|3|||
155072657|NCT02393755|559695022|FG000|Overall Study|Adverse Event|0|||
155072658|NCT02393755|559695023|FG001|Overall Study|Adverse Event|2|||
155072659|NCT02393755|559695022|FG000|Overall Study|Physician Decision|0|||
155072660|NCT02393755|559695023|FG001|Overall Study|Physician Decision|2|||
155072661|NCT00812097|559695025|FG000|Overall Study|Death|3|||
155072662|NCT00812097|559695026|FG001|Overall Study|Death|10|||
155072663|NCT00812097|559695027|FG002|Overall Study|Death|3|||
155072664|NCT00812097|559695028|FG003|Overall Study|Death|3|||
155072665|NCT00812097|559695025|FG000|Overall Study|Withdrawal by Subject|14|||
155072666|NCT00812097|559695026|FG001|Overall Study|Withdrawal by Subject|12|||
155072667|NCT00812097|559695027|FG002|Overall Study|Withdrawal by Subject|8|||
155072668|NCT00812097|559695028|FG003|Overall Study|Withdrawal by Subject|2|||
155072669|NCT00812097|559695025|FG000|Overall Study|Lost to Follow-up|90|||
155072670|NCT00812097|559695026|FG001|Overall Study|Lost to Follow-up|14|||
155072671|NCT00812097|559695027|FG002|Overall Study|Lost to Follow-up|17|||
155072672|NCT00812097|559695028|FG003|Overall Study|Lost to Follow-up|5|||
155072673|NCT00812097|559695025|FG000|Overall Study|Explantation of study device(s)|27|||
155072674|NCT00812097|559695026|FG001|Overall Study|Explantation of study device(s)|29|||
155072675|NCT00812097|559695027|FG002|Overall Study|Explantation of study device(s)|14|||
155072676|NCT00812097|559695028|FG003|Overall Study|Explantation of study device(s)|20|||
155335782|NCT01852045|560664757|FG000|Overall Study|Withdrawal by Subject|1|||
155072677|NCT00812097|559695025|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
155072678|NCT00812097|559695026|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
155072679|NCT00812097|559695027|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
155072680|NCT00812097|559695028|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
155072681|NCT01786109|559695029|FG000|Overall Study|fail manometry barostat tube placement|1|||
155072682|NCT01786109|559695030|FG001|Overall Study|fail manometry barostat tube placement|0|||
155072683|NCT01786109|559695031|FG002|Overall Study|fail manometry barostat tube placement|0|||
155072684|NCT01786109|559695029|FG000|Overall Study|unrelated illness|0|||
155072685|NCT01786109|559695030|FG001|Overall Study|unrelated illness|0|||
155072686|NCT01786109|559695031|FG002|Overall Study|unrelated illness|1|||
155072687|NCT01786109|559695029|FG000|Overall Study|adverse effects colon preparation|0|||
155072688|NCT01786109|559695030|FG001|Overall Study|adverse effects colon preparation|0|||
155072689|NCT01786109|559695031|FG002|Overall Study|adverse effects colon preparation|1|||
155072690|NCT02949934|559695032|FG000|Natural Drinking Period|Adverse Event|1|||
155072691|NCT02949934|559695033|FG001|Natural Drinking Period|Adverse Event|0|||
155072692|NCT02949934|559695034|FG002|Natural Drinking Period|Adverse Event|0|||
155072693|NCT02949934|559695035|FG003|Natural Drinking Period|Adverse Event|1|||
155072694|NCT02949934|559695036|FG004|Natural Drinking Period|Adverse Event|0|||
155072695|NCT02949934|559695037|FG005|Natural Drinking Period|Adverse Event|0|||
155072696|NCT02949934|559695032|FG000|Natural Drinking Period|Lost to Follow-up|0|||
155072697|NCT02949934|559695033|FG001|Natural Drinking Period|Lost to Follow-up|0|||
155072698|NCT02949934|559695034|FG002|Natural Drinking Period|Lost to Follow-up|0|||
155072699|NCT02949934|559695035|FG003|Natural Drinking Period|Lost to Follow-up|0|||
155072700|NCT02949934|559695036|FG004|Natural Drinking Period|Lost to Follow-up|1|||
155072701|NCT02949934|559695037|FG005|Natural Drinking Period|Lost to Follow-up|0|||
155072702|NCT02949934|559695032|FG000|Neuroimaging|Protocol Violation|2|||
155072703|NCT02949934|559695033|FG001|Neuroimaging|Protocol Violation|0|||
155072704|NCT02949934|559695034|FG002|Neuroimaging|Protocol Violation|0|||
155072705|NCT02949934|559695035|FG003|Neuroimaging|Protocol Violation|0|||
155072706|NCT02949934|559695036|FG004|Neuroimaging|Protocol Violation|1|||
155335783|NCT01852045|560664758|FG001|Overall Study|Withdrawal by Subject|0|||
155335784|NCT01852045|560664759|FG002|Overall Study|Withdrawal by Subject|1|||
155335785|NCT01852045|560664757|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155335786|NCT01852045|560664758|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155335787|NCT01852045|560664759|FG002|Overall Study|Other Miscellaneous Reasons|2|||
155335788|NCT03142932|560664760|FG000|Overall Study|Lost to Follow-up|2|||
155072707|NCT02949934|559695037|FG005|Neuroimaging|Protocol Violation|0|||
155072708|NCT02949934|559695032|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
155335789|NCT03142932|560664761|FG001|Overall Study|Lost to Follow-up|11|||
155335790|NCT00703092|560664762|FG000|Overall Study|Withdrawal by Subject|2|||
155072709|NCT02949934|559695033|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
155164072|NCT00606593|560036835|FG000|Overall Study|Withdrawal of consent|1|||
155335791|NCT00681109|560664763|FG000|Overall Study|Lost to Follow-up|2|||
155335792|NCT00681109|560664764|FG001|Overall Study|Lost to Follow-up|6|||
155335793|NCT00681109|560664765|FG002|Overall Study|Lost to Follow-up|0|||
155335794|NCT04660799|560664766|FG000|Overall Study|Progressive Disease|1|||
155335795|NCT04660799|560664767|FG001|Overall Study|Progressive Disease|1|||
155335796|NCT04660799|560664766|FG000|Overall Study|Death|2|||
155335797|NCT04660799|560664767|FG001|Overall Study|Death|1|||
155335798|NCT04660799|560664766|FG000|Overall Study|Adverse Event|2|||
155335799|NCT04660799|560664767|FG001|Overall Study|Adverse Event|1|||
155335800|NCT04660799|560664766|FG000|Overall Study|Withdrawal by Subject|2|||
155335801|NCT04660799|560664767|FG001|Overall Study|Withdrawal by Subject|5|||
155335802|NCT02706483|560664768|FG000|Overall Study|Adverse Event|97|||
155335803|NCT02706483|560664768|FG000|Overall Study|Death|1|||
155335804|NCT02706483|560664768|FG000|Overall Study|Lack of Efficacy|39|||
155335805|NCT02706483|560664768|FG000|Overall Study|Lost to Follow-up|101|||
155335806|NCT02706483|560664768|FG000|Overall Study|Non-compliance with study drug|15|||
155335807|NCT02706483|560664768|FG000|Overall Study|Physician Decision|6|||
155335808|NCT02706483|560664768|FG000|Overall Study|Pregnancy|6|||
155335809|NCT02706483|560664768|FG000|Overall Study|Protocol Violation|18|||
155335810|NCT02706483|560664768|FG000|Overall Study|Withdrawal by Subject|136|||
155335811|NCT02706483|560664768|FG000|Overall Study|Non-compliance with visits|6|||
155335812|NCT02706483|560664768|FG000|Overall Study|Site closure|4|||
155335813|NCT02706483|560664768|FG000|Overall Study|Subject moved|1|||
155335814|NCT04248868|560664769|FG000|Overall Study|Death|1|||
155335815|NCT04248868|560664769|FG000|Overall Study|Lost to Follow-up|3|||
155335816|NCT04248868|560664769|FG000|Overall Study|Protocol Violation|2|||
155335817|NCT03131713|560664772|FG000|Overall Study|Lost to Follow-up|5|||
155335818|NCT03131713|560664773|FG001|Overall Study|Lost to Follow-up|0|||
155335819|NCT01972776|560664774|FG000|Part 1|Withdrawal by Subject|0|||
155335820|NCT01972776|560664775|FG001|Part 1|Withdrawal by Subject|0|||
155335821|NCT01972776|560664776|FG002|Part 1|Withdrawal by Subject|1|||
155335822|NCT01972776|560664777|FG003|Part 1|Withdrawal by Subject|0|||
155335823|NCT01972776|560664778|FG004|Part 1|Withdrawal by Subject|0|||
155335824|NCT01972776|560664779|FG005|Part 1|Withdrawal by Subject|0|||
155335825|NCT01972776|560664774|FG000|Part 1|Adverse Event|0|||
154962356|NCT01878292|559287954|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
154962357|NCT01878292|559287952|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
154962358|NCT01878292|559287953|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
155335826|NCT01972776|560664775|FG001|Part 1|Adverse Event|0|||
155335827|NCT01972776|560664776|FG002|Part 1|Adverse Event|1|||
155335828|NCT01972776|560664777|FG003|Part 1|Adverse Event|1|||
155335829|NCT01972776|560664778|FG004|Part 1|Adverse Event|0|||
155335830|NCT01972776|560664779|FG005|Part 1|Adverse Event|0|||
155335831|NCT01972776|560664774|FG000|Part 2|Adverse Event|0|||
155335832|NCT01972776|560664775|FG001|Part 2|Adverse Event|0|||
155335833|NCT01972776|560664776|FG002|Part 2|Adverse Event|0|||
155335834|NCT01972776|560664777|FG003|Part 2|Adverse Event|0|||
155335835|NCT01972776|560664778|FG004|Part 2|Adverse Event|3|||
155335836|NCT01972776|560664779|FG005|Part 2|Adverse Event|0|||
155335837|NCT01972776|560664774|FG000|Part 2|Administrative problems|0|||
155335838|NCT01972776|560664775|FG001|Part 2|Administrative problems|0|||
155335839|NCT01972776|560664776|FG002|Part 2|Administrative problems|0|||
155335840|NCT01972776|560664777|FG003|Part 2|Administrative problems|0|||
155335841|NCT01972776|560664778|FG004|Part 2|Administrative problems|10|||
155335842|NCT01972776|560664779|FG005|Part 2|Administrative problems|7|||
155335843|NCT01228734|560664783|FG000|Overall Study|Randomized, but not treated|0|||
155335844|NCT01228734|560664784|FG001|Overall Study|Randomized, but not treated|4|||
155335845|NCT02382640|560664792|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
155335846|NCT02382640|560664793|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
155335847|NCT02382640|560664794|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
155335848|NCT02382640|560664795|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
155335849|NCT01543204|560664796|FG000|Overall Study|Non-compliance|1|||
155335850|NCT01543204|560664796|FG000|Overall Study|Adverse Event|1|||
155335851|NCT01543204|560664796|FG000|Overall Study|Withdrawal by Subject|4|||
155335852|NCT01543204|560664796|FG000|Overall Study|Requirement for Alternative Therapy|1|||
155335853|NCT01543204|560664796|FG000|Overall Study|Lost to Follow-up|1|||
155335854|NCT01220999|560664797|FG000|Overall Study|Progressive disease|0|||
155335855|NCT01220999|560664798|FG001|Overall Study|Progressive disease|0|||
155335856|NCT01220999|560664799|FG002|Overall Study|Progressive disease|1|||
155335857|NCT01220999|560664800|FG003|Overall Study|Progressive disease|0|||
155335858|NCT01220999|560664801|FG004|Overall Study|Progressive disease|0|||
155335859|NCT01560429|560664805|FG000|Overall Study|Protocol Violation|3|||
155335860|NCT01560429|560664806|FG001|Overall Study|Protocol Violation|6|||
155335861|NCT02449902|560664807|FG000|Overall Study|Adverse Event|0|||
155335862|NCT02449902|560664808|FG001|Overall Study|Adverse Event|1|||
155335863|NCT02449902|560664807|FG000|Overall Study|Withdrawal by Subject|0|||
155335864|NCT02449902|560664808|FG001|Overall Study|Withdrawal by Subject|1|||
155335865|NCT01365546|560664809|FG000|Overall Study|Withdrawal by Subject|1|||
155335866|NCT01365546|560664809|FG000|Overall Study|Screen failure|9|||
155335867|NCT01365546|560664809|FG000|Overall Study|Study termination|1|||
155335868|NCT03326856|560664810|FG000|Overall Study|Lost to Follow-up|1|||
155335869|NCT03326856|560664811|FG001|Overall Study|Lost to Follow-up|1|||
155335870|NCT03326856|560664812|FG002|Overall Study|Lost to Follow-up|0|||
155335871|NCT03326856|560664813|FG003|Overall Study|Lost to Follow-up|0|||
155335872|NCT03326856|560664814|FG004|Overall Study|Lost to Follow-up|0|||
155335873|NCT02037568|560664815|FG000|Overall Study|Withdrawal by Subject|17|||
155335874|NCT02037568|560664816|FG001|Overall Study|Withdrawal by Subject|24|||
155335875|NCT02037568|560664815|FG000|Overall Study|Lost to Follow-up|16|||
155335876|NCT02037568|560664816|FG001|Overall Study|Lost to Follow-up|13|||
155335877|NCT02037568|560664815|FG000|Overall Study|Screen Failure|3|||
155335878|NCT02037568|560664816|FG001|Overall Study|Screen Failure|1|||
155335879|NCT02037568|560664815|FG000|Overall Study|Patient did not receive transplant|0|||
155335880|NCT02037568|560664816|FG001|Overall Study|Patient did not receive transplant|1|||
155335881|NCT00721734|560664819|FG000|Overall Study|Progressive Disease|3|||
155335882|NCT00721734|560664820|FG001|Overall Study|Progressive Disease|10|||
155335883|NCT00721734|560664821|FG002|Overall Study|Progressive Disease|4|||
155335884|NCT00721734|560664822|FG003|Overall Study|Progressive Disease|5|||
155335885|NCT00721734|560664823|FG004|Overall Study|Progressive Disease|2|||
155335886|NCT00721734|560664819|FG000|Overall Study|Adverse Event|3|||
155335887|NCT00721734|560664820|FG001|Overall Study|Adverse Event|1|||
155335888|NCT00721734|560664821|FG002|Overall Study|Adverse Event|4|||
155335889|NCT00721734|560664822|FG003|Overall Study|Adverse Event|0|||
155335890|NCT00721734|560664823|FG004|Overall Study|Adverse Event|3|||
155335891|NCT00721734|560664819|FG000|Overall Study|Withdrawal by Subject|2|||
155335892|NCT00721734|560664820|FG001|Overall Study|Withdrawal by Subject|1|||
155164073|NCT00606593|560036836|FG001|Overall Study|Withdrawal of consent|0|||
155164074|NCT00606593|560036837|FG002|Overall Study|Withdrawal of consent|1|||
155164075|NCT00606593|560036838|FG003|Overall Study|Withdrawal of consent|0|||
155164076|NCT00606593|560036839|FG004|Overall Study|Withdrawal of consent|0|||
155164077|NCT00606593|560036840|FG005|Overall Study|Withdrawal of consent|0|||
155164078|NCT00606593|560036841|FG006|Overall Study|Withdrawal of consent|0|||
155164079|NCT00606593|560036842|FG007|Overall Study|Withdrawal of consent|0|||
155164080|NCT00606593|560036843|FG008|Overall Study|Withdrawal of consent|0|||
155164081|NCT00606593|560036844|FG009|Overall Study|Withdrawal of consent|0|||
155164082|NCT00606593|560036835|FG000|Overall Study|Administrative/Other|0|||
155335893|NCT00721734|560664821|FG002|Overall Study|Withdrawal by Subject|0|||
155335894|NCT00721734|560664822|FG003|Overall Study|Withdrawal by Subject|0|||
154962359|NCT01878292|559287954|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
154962360|NCT01878292|559287952|FG000|Double-blind Treatment Period|Protocol Violation|3|||
154962361|NCT01878292|559287953|FG001|Double-blind Treatment Period|Protocol Violation|4|||
154962362|NCT01878292|559287954|FG002|Double-blind Treatment Period|Protocol Violation|2|||
154962363|NCT01878292|559287952|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
155164083|NCT00606593|560036836|FG001|Overall Study|Administrative/Other|0|||
155335895|NCT00721734|560664823|FG004|Overall Study|Withdrawal by Subject|1|||
155335896|NCT00721734|560664819|FG000|Overall Study|Other|0|||
155335897|NCT00721734|560664820|FG001|Overall Study|Other|0|||
155335898|NCT00721734|560664821|FG002|Overall Study|Other|0|||
155335899|NCT00721734|560664822|FG003|Overall Study|Other|1|||
155335900|NCT00721734|560664823|FG004|Overall Study|Other|0|||
155335901|NCT03162614|560664824|FG000|Overall Study|Lost to Follow-up|2|||
155335902|NCT03162614|560664825|FG001|Overall Study|Lost to Follow-up|1|||
155335903|NCT03162614|560664826|FG002|Overall Study|Lost to Follow-up|1|||
155335904|NCT03162614|560664827|FG003|Overall Study|Lost to Follow-up|1|||
155335905|NCT03162614|560664828|FG004|Overall Study|Lost to Follow-up|2|||
155335906|NCT03162614|560664829|FG005|Overall Study|Lost to Follow-up|0|||
155335907|NCT03162614|560664824|FG000|Overall Study|Protocol Violation|0|||
155335908|NCT03162614|560664825|FG001|Overall Study|Protocol Violation|1|||
155335909|NCT03162614|560664826|FG002|Overall Study|Protocol Violation|0|||
155335910|NCT03162614|560664827|FG003|Overall Study|Protocol Violation|1|||
155335911|NCT03162614|560664828|FG004|Overall Study|Protocol Violation|0|||
155335912|NCT03162614|560664829|FG005|Overall Study|Protocol Violation|0|||
155335913|NCT03162614|560664824|FG000|Overall Study|Withdrawal by Subject|2|||
155335914|NCT03162614|560664825|FG001|Overall Study|Withdrawal by Subject|1|||
155335915|NCT03162614|560664826|FG002|Overall Study|Withdrawal by Subject|1|||
155335916|NCT03162614|560664827|FG003|Overall Study|Withdrawal by Subject|1|||
155335917|NCT03162614|560664828|FG004|Overall Study|Withdrawal by Subject|0|||
155335918|NCT03162614|560664829|FG005|Overall Study|Withdrawal by Subject|0|||
155335919|NCT03162614|560664824|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
155335920|NCT03162614|560664825|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
155335921|NCT03162614|560664826|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
155335922|NCT03162614|560664827|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
155335923|NCT03162614|560664828|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
154962364|NCT01878292|559287953|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
154962365|NCT01878292|559287954|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
154962366|NCT01878292|559287952|FG000|Double-blind Treatment Period|Adverse Event|4|||
154962367|NCT01878292|559287953|FG001|Double-blind Treatment Period|Adverse Event|9|||
154962368|NCT01878292|559287954|FG002|Double-blind Treatment Period|Adverse Event|8|||
154962369|NCT01878292|559287952|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
154962370|NCT01878292|559287953|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
154962371|NCT01878292|559287954|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
154962372|NCT00323882|559287955|FG000|Overall Study|Adverse Event|2|||
154962373|NCT00323882|559287956|FG001|Overall Study|Adverse Event|1|||
154962374|NCT00323882|559287957|FG002|Overall Study|Adverse Event|1|||
154962375|NCT00323882|559287958|FG003|Overall Study|Adverse Event|1|||
154962376|NCT00323882|559287959|FG004|Overall Study|Adverse Event|3|||
154962377|NCT00323882|559287955|FG000|Overall Study|Disease Progression|6|||
154962378|NCT00323882|559287956|FG001|Overall Study|Disease Progression|4|||
154962379|NCT00323882|559287957|FG002|Overall Study|Disease Progression|10|||
154962380|NCT00323882|559287958|FG003|Overall Study|Disease Progression|5|||
155164084|NCT00606593|560036837|FG002|Overall Study|Administrative/Other|1|||
155335924|NCT03162614|560664829|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
155335925|NCT03861234|560664830|FG000|Overall Study|Not treated|0|||
155335926|NCT03861234|560664831|FG001|Overall Study|Not treated|0|||
155335927|NCT03861234|560664832|FG002|Overall Study|Not treated|0|||
155335928|NCT03861234|560664833|FG003|Overall Study|Not treated|0|||
155335929|NCT03861234|560664834|FG004|Overall Study|Not treated|0|||
155335930|NCT03861234|560664835|FG005|Overall Study|Not treated|1|||
154962381|NCT00323882|559287959|FG004|Overall Study|Disease Progression|22|||
155335931|NCT03861234|560664836|FG006|Overall Study|Not treated|0|||
155335932|NCT03861234|560664837|FG007|Overall Study|Not treated|0|||
155335933|NCT03861234|560664830|FG000|Overall Study|Adverse Event|0|||
155335934|NCT03861234|560664831|FG001|Overall Study|Adverse Event|0|||
155335935|NCT03861234|560664832|FG002|Overall Study|Adverse Event|0|||
155335936|NCT03861234|560664833|FG003|Overall Study|Adverse Event|0|||
155335937|NCT03861234|560664834|FG004|Overall Study|Adverse Event|0|||
155335938|NCT03861234|560664835|FG005|Overall Study|Adverse Event|1|||
155335939|NCT03861234|560664836|FG006|Overall Study|Adverse Event|0|||
155335940|NCT03861234|560664837|FG007|Overall Study|Adverse Event|0|||
155335941|NCT03861234|560664830|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
155335942|NCT03861234|560664831|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
155335943|NCT03861234|560664832|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
155335944|NCT03861234|560664833|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
155335945|NCT03861234|560664834|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
155335946|NCT03861234|560664835|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
155335947|NCT03861234|560664836|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
155335948|NCT03861234|560664837|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
155335949|NCT03861234|560664830|FG000|Overall Study|As per sponsor decision|0|||
155335950|NCT03861234|560664831|FG001|Overall Study|As per sponsor decision|0|||
155335951|NCT03861234|560664832|FG002|Overall Study|As per sponsor decision|0|||
155164085|NCT00606593|560036838|FG003|Overall Study|Administrative/Other|0|||
155335952|NCT03861234|560664833|FG003|Overall Study|As per sponsor decision|0|||
155335953|NCT03861234|560664834|FG004|Overall Study|As per sponsor decision|0|||
155335954|NCT03861234|560664835|FG005|Overall Study|As per sponsor decision|0|||
155335955|NCT03861234|560664836|FG006|Overall Study|As per sponsor decision|1|||
155335956|NCT03861234|560664837|FG007|Overall Study|As per sponsor decision|0|||
155335957|NCT03861234|560664830|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
155335958|NCT03861234|560664831|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
155335959|NCT03861234|560664832|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
155335960|NCT03861234|560664833|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
155335961|NCT03861234|560664834|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
155335962|NCT03861234|560664835|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
155335963|NCT03861234|560664836|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
155335964|NCT03861234|560664837|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
155335965|NCT00621842|560664838|FG000|Overall Study|Adverse Event|6|||
155335966|NCT00621842|560664838|FG000|Overall Study|Withdrawal by Subject|7|||
155335967|NCT00621842|560664838|FG000|Overall Study|Protocol Violation|4|||
155335968|NCT00621842|560664838|FG000|Overall Study|Lack of Efficacy|2|||
155335969|NCT02251652|560664841|FG000|Overall Study|Withdrawal by Subject|1|||
155335970|NCT01074242|560664844|FG000|Overall Study|Case report before date of contract|40|||
155335971|NCT01074242|560664844|FG000|Overall Study|Lost to Follow-up|1|||
155335972|NCT01074242|560664844|FG000|Overall Study|Case report unclear|6|||
155335973|NCT01074242|560664844|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
155335974|NCT01074242|560664844|FG000|Overall Study|Duplicate Case Report Form|5|||
155335975|NCT01957163|560664845|FG000|Overall Study|Adverse Event|5|||
155335976|NCT01957163|560664846|FG001|Overall Study|Adverse Event|2|||
155335977|NCT01957163|560664847|FG002|Overall Study|Adverse Event|4|||
155335978|NCT01957163|560664845|FG000|Overall Study|Lack of Efficacy|5|||
155335979|NCT01957163|560664846|FG001|Overall Study|Lack of Efficacy|4|||
155335980|NCT01957163|560664847|FG002|Overall Study|Lack of Efficacy|9|||
155335981|NCT01957163|560664845|FG000|Overall Study|Protocol Violation|1|||
155335982|NCT01957163|560664846|FG001|Overall Study|Protocol Violation|2|||
155335983|NCT01957163|560664847|FG002|Overall Study|Protocol Violation|0|||
155335984|NCT01957163|560664845|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
155335985|NCT01957163|560664846|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
155335986|NCT01957163|560664847|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
155335987|NCT01957163|560664845|FG000|Overall Study|Lost to Follow-up|0|||
155335988|NCT01957163|560664846|FG001|Overall Study|Lost to Follow-up|1|||
155335989|NCT01957163|560664847|FG002|Overall Study|Lost to Follow-up|0|||
155335990|NCT01957163|560664845|FG000|Overall Study|Withdrawal by Subject|4|||
155335991|NCT01957163|560664846|FG001|Overall Study|Withdrawal by Subject|2|||
155335992|NCT01957163|560664847|FG002|Overall Study|Withdrawal by Subject|4|||
155335993|NCT05169684|560664848|FG000|Overall Study|Adverse Event|1|||
155335994|NCT05169684|560664849|FG001|Overall Study|Adverse Event|3|||
155335995|NCT05169684|560664848|FG000|Overall Study|Physician Decision|0|||
155335996|NCT05169684|560664849|FG001|Overall Study|Physician Decision|1|||
155335997|NCT05169684|560664848|FG000|Overall Study|Progressive Disease|1|||
155335998|NCT05169684|560664849|FG001|Overall Study|Progressive Disease|1|||
155335999|NCT05169684|560664848|FG000|Overall Study|Participant request to discontinue treatment|0|||
155336000|NCT05169684|560664849|FG001|Overall Study|Participant request to discontinue treatment|1|||
155336001|NCT05169684|560664848|FG000|Overall Study|Other Reason|0|||
155336002|NCT05169684|560664849|FG001|Overall Study|Other Reason|1|||
155336003|NCT01668719|560664850|FG000|Phase I|On treatment|1|||
155336004|NCT01668719|560664851|FG001|Phase I|On treatment|0|||
155336005|NCT01668719|560664852|FG002|Phase I|On treatment|0|||
155336006|NCT01668719|560664850|FG000|Phase I|Adverse Event|2|||
155336007|NCT01668719|560664851|FG001|Phase I|Adverse Event|0|||
155336008|NCT01668719|560664852|FG002|Phase I|Adverse Event|0|||
155336009|NCT01668719|560664850|FG000|Phase I|Progression/relapse|1|||
155336010|NCT01668719|560664851|FG001|Phase I|Progression/relapse|0|||
155336011|NCT01668719|560664852|FG002|Phase I|Progression/relapse|0|||
155336012|NCT01668719|560664850|FG000|Phase I|not protocol specified|2|||
155336013|NCT01668719|560664851|FG001|Phase I|not protocol specified|0|||
155336014|NCT01668719|560664852|FG002|Phase I|not protocol specified|0|||
155336015|NCT01668719|560664850|FG000|Phase II|On treatment|0|||
155336016|NCT01668719|560664851|FG001|Phase II|On treatment|4|||
155336017|NCT01668719|560664852|FG002|Phase II|On treatment|3|||
155336018|NCT01668719|560664850|FG000|Phase II|Adverse Event|0|||
155336019|NCT01668719|560664851|FG001|Phase II|Adverse Event|18|||
155336020|NCT01668719|560664852|FG002|Phase II|Adverse Event|18|||
155336021|NCT01668719|560664850|FG000|Phase II|Refusal unrelated to adverse event|0|||
155336022|NCT01668719|560664851|FG001|Phase II|Refusal unrelated to adverse event|4|||
155336023|NCT01668719|560664852|FG002|Phase II|Refusal unrelated to adverse event|1|||
155336024|NCT01668719|560664850|FG000|Phase II|Progression/relapse|0|||
155336025|NCT01668719|560664851|FG001|Phase II|Progression/relapse|13|||
155336026|NCT01668719|560664852|FG002|Phase II|Progression/relapse|17|||
155336027|NCT01668719|560664850|FG000|Phase II|Death|0|||
155336028|NCT01668719|560664851|FG001|Phase II|Death|0|||
155336029|NCT01668719|560664852|FG002|Phase II|Death|2|||
155336030|NCT01668719|560664850|FG000|Phase II|not protocol specified|0|||
155336031|NCT01668719|560664851|FG001|Phase II|not protocol specified|13|||
155336032|NCT01668719|560664852|FG002|Phase II|not protocol specified|7|||
155336033|NCT03539055|560664853|FG000|Overall Study|Death|4|||
155336034|NCT03539055|560664853|FG000|Overall Study|Lost to Follow-up|1|||
155336035|NCT03539055|560664853|FG000|Overall Study|Withdrawal by Subject|2|||
155336036|NCT03539055|560664853|FG000|Overall Study|Screen Fail|7|||
155336037|NCT03539055|560664853|FG000|Overall Study|Drug Intolerance|2|||
155336038|NCT01321073|560664854|FG000|Overall Study|Did not attempt implant|4|||
155336039|NCT01321073|560664854|FG000|Overall Study|Death|3|||
155336040|NCT01638000|560664855|FG000|Overall Study|Randomized but Never Received Drug|7|||
155336041|NCT01638000|560664856|FG001|Overall Study|Randomized but Never Received Drug|10|||
155336042|NCT01638000|560664855|FG000|Overall Study|Adverse Event|14|||
155336043|NCT01638000|560664856|FG001|Overall Study|Adverse Event|16|||
155336044|NCT01638000|560664855|FG000|Overall Study|Lack of Efficacy|5|||
155336045|NCT01638000|560664856|FG001|Overall Study|Lack of Efficacy|6|||
155336046|NCT01638000|560664855|FG000|Overall Study|Protocol Violation|11|||
155336047|NCT01638000|560664856|FG001|Overall Study|Protocol Violation|13|||
155336048|NCT01638000|560664855|FG000|Overall Study|Withdrawal by Subject|21|||
155336049|NCT01638000|560664856|FG001|Overall Study|Withdrawal by Subject|24|||
155336050|NCT01638000|560664855|FG000|Overall Study|Miscellaneous|2|||
155336051|NCT01638000|560664856|FG001|Overall Study|Miscellaneous|2|||
155336052|NCT05484661|560664857|FG000|Overall Study|Withdrawal by Subject|1|||
155336053|NCT05484661|560664858|FG001|Overall Study|Withdrawal by Subject|0|||
155336054|NCT00875706|560664859|FG000|Overall Study|Withdrawal by Subject|1|||
155336055|NCT00875706|560664860|FG001|Overall Study|Withdrawal by Subject|0|||
155336056|NCT00875706|560664861|FG002|Overall Study|Withdrawal by Subject|0|||
155336057|NCT03775213|560664862|FG000|Overall Study|Withdrawal by Subject|51|||
155336058|NCT03775213|560664863|FG001|Overall Study|Withdrawal by Subject|53|||
155336059|NCT03775213|560664862|FG000|Overall Study|Incomplete Survey|7|||
155336060|NCT03775213|560664863|FG001|Overall Study|Incomplete Survey|7|||
155336061|NCT00786188|560664864|FG000|Overall Study|Adverse Event|3|||
155336062|NCT00786188|560664865|FG001|Overall Study|Adverse Event|1|||
155336063|NCT00786188|560664864|FG000|Overall Study|Withdrawal by Subject|2|||
155336064|NCT00786188|560664865|FG001|Overall Study|Withdrawal by Subject|0|||
155336065|NCT00326183|560664866|FG000|Overall Study|Lost to Follow-up|104|||
155336066|NCT00326183|560664867|FG001|Overall Study|Lost to Follow-up|56|||
155336067|NCT00326183|560664866|FG000|Overall Study|Protocol Violation|6|||
155336068|NCT00326183|560664867|FG001|Overall Study|Protocol Violation|3|||
155336069|NCT00326183|560664866|FG000|Overall Study|Withdrawal by Subject|35|||
155336070|NCT00326183|560664867|FG001|Overall Study|Withdrawal by Subject|7|||
155336071|NCT00326183|560664866|FG000|Overall Study|Subject Moved|7|||
155336072|NCT00326183|560664867|FG001|Overall Study|Subject Moved|4|||
155336073|NCT00326183|560664866|FG000|Overall Study|Other|47|||
155336074|NCT00326183|560664867|FG001|Overall Study|Other|13|||
155336075|NCT00326183|560664866|FG000|Overall Study|Adverse Event|1|||
155336076|NCT00326183|560664867|FG001|Overall Study|Adverse Event|0|||
155336077|NCT00570505|560664872|FG000|Overall Study|Adverse Event|7|||
155336078|NCT00570505|560664872|FG000|Overall Study|Withdrawal by Subject|7|||
155336079|NCT00570505|560664872|FG000|Overall Study|Lost to Follow-up|23|||
155336080|NCT00570505|560664872|FG000|Overall Study|Other loss to follow-up|4|||
155336081|NCT05865392|560664877|FG000|Overall Study|Withdrawal by Subject|4|||
155336082|NCT05865392|560664878|FG001|Overall Study|Withdrawal by Subject|0|||
155336083|NCT05865392|560664877|FG000|Overall Study|Didn't meet inclusion criteria|4|||
155336084|NCT05865392|560664878|FG001|Overall Study|Didn't meet inclusion criteria|0|||
155336085|NCT02159989|560664879|FG000|Overall Study|Adverse Event|1|||
155336086|NCT02159989|560664880|FG001|Overall Study|Adverse Event|0|||
155336087|NCT02159989|560664881|FG002|Overall Study|Adverse Event|0|||
155336088|NCT02159989|560664882|FG003|Overall Study|Adverse Event|0|||
155336089|NCT02159989|560664883|FG004|Overall Study|Adverse Event|1|||
155336090|NCT02159989|560664884|FG005|Overall Study|Adverse Event|0|||
155336091|NCT02159989|560664885|FG006|Overall Study|Adverse Event|1|||
155336092|NCT02159989|560664886|FG007|Overall Study|Adverse Event|2|||
155336093|NCT02159989|560664887|FG008|Overall Study|Adverse Event|0|||
155336094|NCT02159989|560664888|FG009|Overall Study|Adverse Event|2|||
155336095|NCT02159989|560664889|FG010|Overall Study|Adverse Event|1|||
155336096|NCT02159989|560664879|FG000|Overall Study|Death|0|||
155336097|NCT02159989|560664880|FG001|Overall Study|Death|0|||
155336098|NCT02159989|560664881|FG002|Overall Study|Death|0|||
155336099|NCT02159989|560664882|FG003|Overall Study|Death|0|||
155336100|NCT02159989|560664883|FG004|Overall Study|Death|0|||
155336101|NCT02159989|560664884|FG005|Overall Study|Death|0|||
155336102|NCT02159989|560664885|FG006|Overall Study|Death|0|||
155336103|NCT02159989|560664886|FG007|Overall Study|Death|0|||
155336104|NCT02159989|560664887|FG008|Overall Study|Death|0|||
155336105|NCT02159989|560664888|FG009|Overall Study|Death|0|||
155336106|NCT02159989|560664889|FG010|Overall Study|Death|1|||
155336107|NCT02159989|560664879|FG000|Overall Study|Lack of Efficacy|2|||
155336108|NCT02159989|560664880|FG001|Overall Study|Lack of Efficacy|3|||
155336109|NCT02159989|560664881|FG002|Overall Study|Lack of Efficacy|3|||
155336110|NCT02159989|560664882|FG003|Overall Study|Lack of Efficacy|0|||
155336111|NCT02159989|560664883|FG004|Overall Study|Lack of Efficacy|2|||
155336112|NCT02159989|560664884|FG005|Overall Study|Lack of Efficacy|3|||
155336113|NCT02159989|560664885|FG006|Overall Study|Lack of Efficacy|3|||
155336114|NCT02159989|560664886|FG007|Overall Study|Lack of Efficacy|1|||
155336115|NCT02159989|560664887|FG008|Overall Study|Lack of Efficacy|3|||
155336116|NCT02159989|560664888|FG009|Overall Study|Lack of Efficacy|6|||
155336117|NCT02159989|560664889|FG010|Overall Study|Lack of Efficacy|7|||
155336118|NCT02159989|560664879|FG000|Overall Study|Lost to Follow-up|0|||
155336119|NCT02159989|560664880|FG001|Overall Study|Lost to Follow-up|0|||
155336120|NCT02159989|560664881|FG002|Overall Study|Lost to Follow-up|0|||
155336121|NCT02159989|560664882|FG003|Overall Study|Lost to Follow-up|1|||
155336122|NCT02159989|560664883|FG004|Overall Study|Lost to Follow-up|0|||
155336123|NCT02159989|560664884|FG005|Overall Study|Lost to Follow-up|0|||
155336124|NCT02159989|560664885|FG006|Overall Study|Lost to Follow-up|0|||
155336125|NCT02159989|560664886|FG007|Overall Study|Lost to Follow-up|0|||
155336126|NCT02159989|560664887|FG008|Overall Study|Lost to Follow-up|0|||
155336127|NCT02159989|560664888|FG009|Overall Study|Lost to Follow-up|0|||
155336128|NCT02159989|560664889|FG010|Overall Study|Lost to Follow-up|1|||
155336129|NCT02159989|560664879|FG000|Overall Study|Withdrawal by Subject|2|||
155336130|NCT02159989|560664880|FG001|Overall Study|Withdrawal by Subject|0|||
155336131|NCT02159989|560664881|FG002|Overall Study|Withdrawal by Subject|0|||
155336132|NCT02159989|560664882|FG003|Overall Study|Withdrawal by Subject|2|||
155336133|NCT02159989|560664883|FG004|Overall Study|Withdrawal by Subject|1|||
155336134|NCT02159989|560664884|FG005|Overall Study|Withdrawal by Subject|0|||
155336135|NCT02159989|560664885|FG006|Overall Study|Withdrawal by Subject|3|||
155336136|NCT02159989|560664886|FG007|Overall Study|Withdrawal by Subject|1|||
155336137|NCT02159989|560664887|FG008|Overall Study|Withdrawal by Subject|0|||
155336138|NCT02159989|560664888|FG009|Overall Study|Withdrawal by Subject|0|||
155336139|NCT02159989|560664889|FG010|Overall Study|Withdrawal by Subject|0|||
155336140|NCT02159989|560664879|FG000|Overall Study|New treatment|0|||
155336141|NCT02159989|560664880|FG001|Overall Study|New treatment|1|||
155336142|NCT02159989|560664881|FG002|Overall Study|New treatment|0|||
155336143|NCT02159989|560664882|FG003|Overall Study|New treatment|0|||
155336144|NCT02159989|560664883|FG004|Overall Study|New treatment|0|||
155336145|NCT02159989|560664884|FG005|Overall Study|New treatment|0|||
155336146|NCT02159989|560664885|FG006|Overall Study|New treatment|0|||
155336147|NCT02159989|560664886|FG007|Overall Study|New treatment|0|||
155336148|NCT02159989|560664887|FG008|Overall Study|New treatment|0|||
155336149|NCT02159989|560664888|FG009|Overall Study|New treatment|0|||
155336150|NCT02159989|560664889|FG010|Overall Study|New treatment|0|||
155336151|NCT02159989|560664879|FG000|Overall Study|Insurance Issues|0|||
155336152|NCT02159989|560664880|FG001|Overall Study|Insurance Issues|0|||
155336153|NCT02159989|560664881|FG002|Overall Study|Insurance Issues|0|||
155336154|NCT02159989|560664882|FG003|Overall Study|Insurance Issues|0|||
155336155|NCT02159989|560664883|FG004|Overall Study|Insurance Issues|0|||
155336156|NCT02159989|560664884|FG005|Overall Study|Insurance Issues|0|||
155336157|NCT02159989|560664885|FG006|Overall Study|Insurance Issues|0|||
155336158|NCT02159989|560664886|FG007|Overall Study|Insurance Issues|0|||
155336159|NCT02159989|560664887|FG008|Overall Study|Insurance Issues|0|||
155336160|NCT02159989|560664888|FG009|Overall Study|Insurance Issues|1|||
155336161|NCT02159989|560664889|FG010|Overall Study|Insurance Issues|0|||
155336162|NCT02485925|560664897|FG000|Overall Study|Withdrawal by Subject|3|||
155336163|NCT02485925|560664897|FG000|Overall Study|Death|1|||
155336164|NCT02485925|560664897|FG000|Overall Study|Lost to Follow-up|11|||
155336165|NCT02969356|560664898|FG000|Overall Study|Adverse Event|7|||
155336166|NCT02969356|560664898|FG000|Overall Study|Consent withdrawn|2|||
155336167|NCT02969356|560664898|FG000|Overall Study|Lost to Follow-up|3|||
155336168|NCT02969356|560664898|FG000|Overall Study|Did not need to be reinjected|6|||
155336169|NCT02969356|560664898|FG000|Overall Study|Personal reasons|5|||
155336170|NCT04924608|560666186|FG000|Overall Study|Adverse Event|10|||
155336171|NCT04924608|560666187|FG001|Overall Study|Adverse Event|6|||
155336172|NCT04924608|560666186|FG000|Overall Study|Lost to Follow-up|1|||
155336173|NCT04924608|560666187|FG001|Overall Study|Lost to Follow-up|1|||
155336174|NCT04924608|560666186|FG000|Overall Study|Ongoing at the data cut-off date|54|||
155336175|NCT04924608|560666187|FG001|Overall Study|Ongoing at the data cut-off date|60|||
155336176|NCT04924608|560666186|FG000|Overall Study|Progressive Disease|2|||
155336177|NCT04924608|560666187|FG001|Overall Study|Progressive Disease|0|||
155336178|NCT04924608|560666186|FG000|Overall Study|Withdrawal by Subject|3|||
155336179|NCT04924608|560666187|FG001|Overall Study|Withdrawal by Subject|6|||
155336180|NCT04924608|560666186|FG000|Overall Study|Other reason|1|||
155336181|NCT04924608|560666187|FG001|Overall Study|Other reason|1|||
155336182|NCT04493424|560666188|FG000|Overall Study|Termination of the trial by the sponsor|89|||
155336183|NCT04493424|560666188|FG000|Overall Study|Withdrawal by Subject|9|||
155336184|NCT04493424|560666188|FG000|Overall Study|Lost to Follow-up|2|||
155336185|NCT04493424|560666188|FG000|Overall Study|Lack of Efficacy|3|||
155336186|NCT04493424|560666188|FG000|Overall Study|Adverse Event|5|||
155336187|NCT03769090|560666189|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
155336188|NCT03769090|560666190|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
155336189|NCT03769090|560666191|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
155336190|NCT03769090|560666189|FG000|Overall Study|Withdrawal by Subject|52|||
155336191|NCT03769090|560666190|FG001|Overall Study|Withdrawal by Subject|62|||
155336192|NCT03769090|560666191|FG002|Overall Study|Withdrawal by Subject|74|||
155336193|NCT03769090|560666189|FG000|Overall Study|Death|4|||
155336194|NCT03769090|560666190|FG001|Overall Study|Death|2|||
155336195|NCT03769090|560666191|FG002|Overall Study|Death|2|||
155336196|NCT03769090|560666189|FG000|Overall Study|Adverse Event|7|||
155336197|NCT03769090|560666190|FG001|Overall Study|Adverse Event|7|||
155336198|NCT03769090|560666191|FG002|Overall Study|Adverse Event|8|||
155336199|NCT03769090|560666189|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
155336200|NCT03769090|560666190|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
155336201|NCT03769090|560666191|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
155336202|NCT03769090|560666189|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
155336203|NCT03769090|560666190|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
155336204|NCT03769090|560666191|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
155336205|NCT03769090|560666189|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
155336206|NCT03769090|560666190|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
155336207|NCT03769090|560666191|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
155336208|NCT03769090|560666189|FG000|Overall Study|Protocol Violation|5|||
155336209|NCT03769090|560666190|FG001|Overall Study|Protocol Violation|6|||
155336210|NCT03769090|560666191|FG002|Overall Study|Protocol Violation|8|||
155336211|NCT03769090|560666189|FG000|Overall Study|Pregnancy|1|||
155336212|NCT03769090|560666190|FG001|Overall Study|Pregnancy|0|||
155336213|NCT03769090|560666191|FG002|Overall Study|Pregnancy|3|||
155336214|NCT03769090|560666189|FG000|Overall Study|Lost to Follow-up|19|||
155336215|NCT03769090|560666190|FG001|Overall Study|Lost to Follow-up|25|||
155336216|NCT03769090|560666191|FG002|Overall Study|Lost to Follow-up|21|||
155336217|NCT03769090|560666189|FG000|Overall Study|Condition under investigation worsened|2|||
155336218|NCT03769090|560666190|FG001|Overall Study|Condition under investigation worsened|0|||
155336219|NCT03769090|560666191|FG002|Overall Study|Condition under investigation worsened|1|||
155336220|NCT03769090|560666189|FG000|Overall Study|Lack of Efficacy|1|||
155336221|NCT03769090|560666190|FG001|Overall Study|Lack of Efficacy|2|||
155336222|NCT03769090|560666191|FG002|Overall Study|Lack of Efficacy|2|||
155336223|NCT03769090|560666189|FG000|Overall Study|Other reasons|8|||
155336224|NCT03769090|560666190|FG001|Overall Study|Other reasons|12|||
155336225|NCT03769090|560666191|FG002|Overall Study|Other reasons|15|||
155336226|NCT01190124|560666196|FG000|Overall Study|Death|3|||
155164086|NCT00606593|560036839|FG004|Overall Study|Administrative/Other|0|||
155336227|NCT01190124|560666197|FG001|Overall Study|Death|0|||
155336228|NCT01190124|560666198|FG002|Overall Study|Death|0|||
155336229|NCT01190124|560666196|FG000|Overall Study|Therapeutic Failure|12|||
155336230|NCT01190124|560666197|FG001|Overall Study|Therapeutic Failure|0|||
155336231|NCT01190124|560666198|FG002|Overall Study|Therapeutic Failure|1|||
155336232|NCT01190124|560666196|FG000|Overall Study|Lost to Follow-up|2|||
155336233|NCT01190124|560666197|FG001|Overall Study|Lost to Follow-up|0|||
155336234|NCT01190124|560666198|FG002|Overall Study|Lost to Follow-up|0|||
155336235|NCT02713594|560666199|FG000|Overall Study|Withdrawal by Subject|32|||
155336236|NCT02713594|560666200|FG001|Overall Study|Withdrawal by Subject|22|||
155336237|NCT02713594|560666199|FG000|Overall Study|Lost to Follow-up|358|||
155336238|NCT02713594|560666200|FG001|Overall Study|Lost to Follow-up|374|||
155336239|NCT00413283|560666201|FG000|Overall Study|Withdrawal by Subject|1|||
155336240|NCT00413283|560666202|FG001|Overall Study|Withdrawal by Subject|0|||
155336241|NCT00413283|560666203|FG002|Overall Study|Withdrawal by Subject|0|||
155336242|NCT00413283|560666204|FG003|Overall Study|Withdrawal by Subject|1|||
155336243|NCT00413283|560666201|FG000|Overall Study|Death|0|||
155336244|NCT00413283|560666202|FG001|Overall Study|Death|0|||
155336245|NCT00413283|560666203|FG002|Overall Study|Death|1|||
155336246|NCT00413283|560666204|FG003|Overall Study|Death|1|||
155336247|NCT00413283|560666201|FG000|Overall Study|Adverse Event|0|||
155336248|NCT00413283|560666202|FG001|Overall Study|Adverse Event|0|||
155336249|NCT00413283|560666203|FG002|Overall Study|Adverse Event|0|||
155336250|NCT00413283|560666204|FG003|Overall Study|Adverse Event|1|||
155336251|NCT00413283|560666201|FG000|Overall Study|Ineligibility determined|0|||
155336252|NCT00413283|560666202|FG001|Overall Study|Ineligibility determined|0|||
155336253|NCT00413283|560666203|FG002|Overall Study|Ineligibility determined|0|||
155336254|NCT00413283|560666204|FG003|Overall Study|Ineligibility determined|1|||
155336255|NCT00413283|560666201|FG000|Overall Study|Protocol deviation|0|||
155336256|NCT00413283|560666202|FG001|Overall Study|Protocol deviation|1|||
155336257|NCT00413283|560666203|FG002|Overall Study|Protocol deviation|0|||
155336258|NCT00413283|560666204|FG003|Overall Study|Protocol deviation|0|||
155336259|NCT00413283|560666201|FG000|Overall Study|Requirement for alternative therapy|0|||
155336260|NCT00413283|560666202|FG001|Overall Study|Requirement for alternative therapy|2|||
155336261|NCT00413283|560666203|FG002|Overall Study|Requirement for alternative therapy|0|||
155336262|NCT00413283|560666204|FG003|Overall Study|Requirement for alternative therapy|0|||
155336263|NCT00413283|560666201|FG000|Overall Study|Other|0|||
155336264|NCT00413283|560666202|FG001|Overall Study|Other|0|||
155336265|NCT00413283|560666203|FG002|Overall Study|Other|1|||
155336266|NCT00413283|560666204|FG003|Overall Study|Other|0|||
155336267|NCT00671853|560666206|FG000|Overall Study|Lack of Efficacy|3|||
155336268|NCT00671853|560666207|FG001|Overall Study|Lack of Efficacy|7|||
155336269|NCT00671853|560666206|FG000|Overall Study|Adverse Event|7|||
155336270|NCT00671853|560666207|FG001|Overall Study|Adverse Event|1|||
155336271|NCT00671853|560666206|FG000|Overall Study|Withdrawal by Subject|1|||
155336272|NCT00671853|560666207|FG001|Overall Study|Withdrawal by Subject|5|||
155336273|NCT00671853|560666206|FG000|Overall Study|Lost to Follow-up|8|||
155336274|NCT00671853|560666207|FG001|Overall Study|Lost to Follow-up|8|||
155336275|NCT00671853|560666206|FG000|Overall Study|Physician Decision|0|||
155336276|NCT00671853|560666207|FG001|Overall Study|Physician Decision|2|||
155336277|NCT00671853|560666206|FG000|Overall Study|Non-adherence with study procedures|1|||
155336278|NCT00671853|560666207|FG001|Overall Study|Non-adherence with study procedures|4|||
155336279|NCT01377844|560666208|FG000|Overall Study|Withdrawal by Subject|25|||
155336280|NCT01377844|560666209|FG001|Overall Study|Withdrawal by Subject|28|||
155336281|NCT01377844|560666208|FG000|Overall Study|Protocol Violation|2|||
155336282|NCT01377844|560666209|FG001|Overall Study|Protocol Violation|3|||
155336283|NCT01377844|560666208|FG000|Overall Study|Adverse Event|3|||
155336284|NCT01377844|560666209|FG001|Overall Study|Adverse Event|0|||
155336285|NCT01377844|560666208|FG000|Overall Study|Physician Decision|6|||
155336286|NCT01377844|560666209|FG001|Overall Study|Physician Decision|3|||
155336287|NCT01377844|560666208|FG000|Overall Study|Study terminated by Sponsor|0|||
155336288|NCT01377844|560666209|FG001|Overall Study|Study terminated by Sponsor|1|||
155336289|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
155336290|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155336291|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155336292|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155336293|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
155336294|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155336295|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155336296|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155336297|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
155336298|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155336299|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155336300|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155336301|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
155336302|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155336303|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155336304|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155336305|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
155336306|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155336307|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155336308|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155336309|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
155336310|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155336311|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155336312|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155336313|NCT01185340|560666213|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
155336314|NCT01185340|560666214|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155336315|NCT01185340|560666215|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155336316|NCT01185340|560666216|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155336317|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
155336318|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
155336319|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
155336320|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
155336321|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
155336322|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
155336323|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
155336324|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
155336325|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155336326|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
155336327|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
155336328|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
155336329|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155336330|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155336331|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155336332|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155336333|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
155336334|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
154962382|NCT00323882|559287955|FG000|Overall Study|Death|0|||
154962383|NCT00323882|559287956|FG001|Overall Study|Death|1|||
154962384|NCT00323882|559287957|FG002|Overall Study|Death|1|||
154962385|NCT00323882|559287958|FG003|Overall Study|Death|0|||
154962386|NCT00323882|559287959|FG004|Overall Study|Death|5|||
155336335|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
155336336|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155336337|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
155336338|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
154962387|NCT00323882|559287955|FG000|Overall Study|Lost to Follow-up|0|||
154962388|NCT00323882|559287956|FG001|Overall Study|Lost to Follow-up|0|||
155336339|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
155336340|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
155336341|NCT01185340|560666213|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155336342|NCT01185340|560666214|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155336343|NCT01185340|560666215|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
155336344|NCT01185340|560666216|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
155336345|NCT00667017|560666217|FG000|Overall Study|Withdrawal by Subject|1|||
155336346|NCT01848483|560666218|FG000|Overall Study|Death|2|||
155336347|NCT01848483|560666219|FG001|Overall Study|Death|1|||
155336348|NCT01848483|560666218|FG000|Overall Study|Lost to Follow-up|6|||
155336349|NCT01848483|560666219|FG001|Overall Study|Lost to Follow-up|8|||
155336350|NCT01848483|560666218|FG000|Overall Study|Withdrawal by Subject|1|||
155072710|NCT02949934|559695034|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
155072711|NCT02949934|559695035|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
155336351|NCT01848483|560666219|FG001|Overall Study|Withdrawal by Subject|0|||
155336352|NCT01848483|560666218|FG000|Overall Study|Incarceration|2|||
155336353|NCT01848483|560666219|FG001|Overall Study|Incarceration|2|||
155336354|NCT00246129|560666222|FG000|Overall Study|Lost to Follow-up|1|||
155336355|NCT00246129|560666223|FG001|Overall Study|Lost to Follow-up|0|||
155336356|NCT00246129|560666222|FG000|Overall Study|Death|2|||
155336357|NCT00246129|560666223|FG001|Overall Study|Death|1|||
155336358|NCT00246129|560666222|FG000|Overall Study|suffered primary non-function|1|||
155336359|NCT00246129|560666223|FG001|Overall Study|suffered primary non-function|0|||
155336360|NCT00246129|560666222|FG000|Overall Study|grafts failed|3|||
155336361|NCT00246129|560666223|FG001|Overall Study|grafts failed|1|||
155336362|NCT03469258|560666224|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
155336363|NCT03041090|560666230|FG000|Overall Study|technical error|0|||
155336364|NCT03041090|560666231|FG001|Overall Study|technical error|3|||
155336365|NCT02202317|560666232|FG000|Overall Study|Lost to Follow-up|1|||
155336366|NCT01353274|560666233|FG000|Overall Study|No case report form (CRF) collected|28|||
155336367|NCT02701296|560666234|FG000|Overall Study|Incomplete Data|0|||
155336368|NCT02701296|560666235|FG001|Overall Study|Incomplete Data|2|||
155336369|NCT01409837|560666238|FG000|Overall Study|Withdrawal by Subject|2|||
155336370|NCT01409837|560666239|FG001|Overall Study|Withdrawal by Subject|1|||
155336371|NCT01409837|560666238|FG000|Overall Study|Lost to Follow-up|1|||
155336372|NCT01409837|560666239|FG001|Overall Study|Lost to Follow-up|0|||
155336373|NCT01409837|560666238|FG000|Overall Study|Physician Decision|0|||
155336374|NCT01409837|560666239|FG001|Overall Study|Physician Decision|1|||
155336375|NCT00403494|560666241|FG000|Overall Study|Adverse Event|10|||
155336376|NCT00403494|560666242|FG001|Overall Study|Adverse Event|8|||
155336377|NCT00403494|560666241|FG000|Overall Study|Withdrew Consent|3|||
155336378|NCT00403494|560666242|FG001|Overall Study|Withdrew Consent|2|||
155336379|NCT00403494|560666241|FG000|Overall Study|Inappropriately enrolled|0|||
155336380|NCT00403494|560666242|FG001|Overall Study|Inappropriately enrolled|1|||
155336381|NCT00403494|560666241|FG000|Overall Study|Lost to Follow-up|0|||
155336382|NCT00403494|560666242|FG001|Overall Study|Lost to Follow-up|2|||
155336383|NCT00403494|560666241|FG000|Overall Study|Protocol noncompliance|0|||
155336384|NCT00403494|560666242|FG001|Overall Study|Protocol noncompliance|1|||
155336385|NCT00403494|560666241|FG000|Overall Study|Death|1|||
155336386|NCT00403494|560666242|FG001|Overall Study|Death|0|||
155336387|NCT00403494|560666241|FG000|Overall Study|Sponsor Request|1|||
155336388|NCT00403494|560666242|FG001|Overall Study|Sponsor Request|0|||
155336389|NCT03851094|560666244|FG000|Overall Study|Withdrawal by Subject|0|||
155336390|NCT03851094|560666245|FG001|Overall Study|Withdrawal by Subject|1|||
155336391|NCT03851094|560666244|FG000|Overall Study|Participant lost device|0|||
155336392|NCT03851094|560666245|FG001|Overall Study|Participant lost device|1|||
155336393|NCT03851094|560666244|FG000|Overall Study|Participant returned device|0|||
155336394|NCT03851094|560666245|FG001|Overall Study|Participant returned device|2|||
155336395|NCT04658784|560666246|FG000|6-month Follow-up|Lost to Follow-up|2|||
155336396|NCT04658784|560666247|FG001|6-month Follow-up|Lost to Follow-up|5|||
155336397|NCT03490032|560666248|FG000|Overall Study|family issue (child custody)|1|||
155336398|NCT03490032|560666249|FG001|Overall Study|family issue (child custody)|0|||
155336399|NCT03490032|560666250|FG002|Overall Study|family issue (child custody)|0|||
155336400|NCT02958553|560666251|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
155336401|NCT02958553|560666251|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
155336402|NCT00308308|560666253|FG000|Overall Study|Adverse Event|17|||
155336403|NCT00308308|560666254|FG001|Overall Study|Adverse Event|2|||
155336404|NCT00308308|560666253|FG000|Overall Study|Lost to Follow-up|5|||
155336405|NCT00308308|560666254|FG001|Overall Study|Lost to Follow-up|5|||
155336406|NCT00308308|560666253|FG000|Overall Study|Physician Decision|15|||
155336407|NCT00308308|560666254|FG001|Overall Study|Physician Decision|7|||
155336408|NCT00308308|560666253|FG000|Overall Study|Protocol Violation|3|||
155336409|NCT00308308|560666254|FG001|Overall Study|Protocol Violation|14|||
155336410|NCT00308308|560666253|FG000|Overall Study|Withdrawal by Subject|47|||
155336411|NCT00308308|560666254|FG001|Overall Study|Withdrawal by Subject|19|||
155336412|NCT00308308|560666253|FG000|Overall Study|Various|7|||
155336413|NCT00308308|560666254|FG001|Overall Study|Various|5|||
155336414|NCT00308308|560666253|FG000|Overall Study|Randomized but not dosed|8|||
155336415|NCT00308308|560666254|FG001|Overall Study|Randomized but not dosed|16|||
155336416|NCT00308308|560666253|FG000|Overall Study|Other|1|||
155336417|NCT00308308|560666254|FG001|Overall Study|Other|0|||
155336418|NCT02392507|560666261|FG000|Induction Regimen|Death|3|||
155336419|NCT02392507|560666261|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
155336420|NCT02392507|560666261|FG000|Induction Regimen|Physician Decision|1|||
155336421|NCT02392507|560666261|FG000|Induction Regimen|Withdrawal by Subject|2|||
155336422|NCT02392507|560666261|FG000|Maintenance Regimen|Death|1|||
155336423|NCT02392507|560666261|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
155336424|NCT01802333|560666266|FG000|Overall Study|Ineligible|2|||
155336425|NCT01802333|560666267|FG001|Overall Study|Ineligible|6|||
155336426|NCT01802333|560666268|FG002|Overall Study|Ineligible|8|||
155336427|NCT01802333|560666266|FG000|Overall Study|Adverse Event|1|||
155336428|NCT01802333|560666267|FG001|Overall Study|Adverse Event|8|||
155336429|NCT01802333|560666268|FG002|Overall Study|Adverse Event|8|||
155336430|NCT01802333|560666266|FG000|Overall Study|Withdrawal by Subject|6|||
155336431|NCT01802333|560666267|FG001|Overall Study|Withdrawal by Subject|6|||
155336432|NCT01802333|560666268|FG002|Overall Study|Withdrawal by Subject|5|||
155336433|NCT01802333|560666266|FG000|Overall Study|Progression/relapse|1|||
155336434|NCT01802333|560666267|FG001|Overall Study|Progression/relapse|3|||
155336435|NCT01802333|560666268|FG002|Overall Study|Progression/relapse|0|||
155336436|NCT01802333|560666266|FG000|Overall Study|Death|7|||
155336437|NCT01802333|560666267|FG001|Overall Study|Death|14|||
155336438|NCT01802333|560666268|FG002|Overall Study|Death|13|||
155336439|NCT01802333|560666266|FG000|Overall Study|Other - not protocol specified|32|||
155336440|NCT01802333|560666267|FG001|Overall Study|Other - not protocol specified|22|||
155336441|NCT01802333|560666268|FG002|Overall Study|Other - not protocol specified|24|||
155336442|NCT01802333|560666266|FG000|Overall Study|Did not start treatment|0|||
155336443|NCT01802333|560666267|FG001|Overall Study|Did not start treatment|2|||
155336444|NCT01802333|560666268|FG002|Overall Study|Did not start treatment|5|||
155336445|NCT02224755|560666269|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
155336446|NCT02224755|560666270|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
155336447|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Death|103|||
155336448|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Death|98|||
155336449|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
155336450|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
155336451|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
155336452|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
155336453|NCT02224755|560666269|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
155336454|NCT02224755|560666270|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
155336455|NCT01951703|560666271|FG000|First Intervention|Withdrawal by Subject|1|||
155336456|NCT01951703|560666272|FG001|First Intervention|Withdrawal by Subject|0|||
155336457|NCT01951703|560666271|FG000|First Intervention|Subject was not compliant|1|||
155336458|NCT01951703|560666272|FG001|First Intervention|Subject was not compliant|1|||
155336459|NCT01951703|560666271|FG000|First Intervention|Physician Decision|1|||
155336460|NCT01951703|560666272|FG001|First Intervention|Physician Decision|0|||
155336461|NCT01951703|560666271|FG000|Second Intervention|Protocol Violation|0|||
155336462|NCT01951703|560666272|FG001|Second Intervention|Protocol Violation|1|||
155336463|NCT01951703|560666271|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
155336464|NCT01951703|560666272|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
155336465|NCT00240994|560666275|FG000|Overall Study|Lost to Follow-up|1|||
155336466|NCT00240994|560666275|FG000|Overall Study|Protocol Violation|1|||
155336467|NCT00240994|560666275|FG000|Overall Study|Graft failure|1|||
155336468|NCT01019135|560666280|FG000|Overall Study|Did not receive allocated intervention|12|||
155336469|NCT01019135|560666281|FG001|Overall Study|Did not receive allocated intervention|6|||
155336470|NCT01019135|560666282|FG002|Overall Study|Did not receive allocated intervention|25|||
155336471|NCT01019135|560666280|FG000|Overall Study|Did not attend CR|8|||
155336472|NCT01019135|560666281|FG001|Overall Study|Did not attend CR|13|||
155336473|NCT01019135|560666282|FG002|Overall Study|Did not attend CR|6|||
155336474|NCT05124210|560666283|FG000|Overall Study|Lost to Follow-up|1|||
155336475|NCT05124210|560666284|FG001|Overall Study|Lost to Follow-up|0|||
155336476|NCT05124210|560666283|FG000|Overall Study|Withdrawal by Subject|1|||
155336477|NCT05124210|560666284|FG001|Overall Study|Withdrawal by Subject|0|||
155336478|NCT00638456|560666285|FG000|Overall Study|Withdrawal by Subject|6|||
155336479|NCT00638456|560666286|FG001|Overall Study|Withdrawal by Subject|2|||
155336480|NCT02007070|560666287|FG000|Overall Study|Adverse Event|4|||
155336481|NCT02007070|560666287|FG000|Overall Study|Clinical Progression|4|||
155336482|NCT02007070|560666287|FG000|Overall Study|Death|1|||
155336483|NCT02007070|560666287|FG000|Overall Study|Protocol Violation|2|||
155336484|NCT02007070|560666287|FG000|Overall Study|Physician Decision|1|||
155336485|NCT02007070|560666287|FG000|Overall Study|Progressive Disease|21|||
155336486|NCT03128099|560666288|FG000|Overall Study|High dose task was too long|0|||
155336487|NCT03128099|560666289|FG001|Overall Study|High dose task was too long|4|||
155336488|NCT03128099|560666290|FG002|Overall Study|High dose task was too long|0|||
154962389|NCT00323882|559287957|FG002|Overall Study|Lost to Follow-up|1|||
155336489|NCT03128099|560666288|FG000|Overall Study|Participant got a full time job.|1|||
154962390|NCT00323882|559287958|FG003|Overall Study|Lost to Follow-up|0|||
155336490|NCT03128099|560666289|FG001|Overall Study|Participant got a full time job.|0|||
155336491|NCT03128099|560666290|FG002|Overall Study|Participant got a full time job.|0|||
155336492|NCT03128099|560666288|FG000|Overall Study|Became homeless and lost contact|1|||
155336493|NCT03128099|560666289|FG001|Overall Study|Became homeless and lost contact|0|||
155336494|NCT03128099|560666290|FG002|Overall Study|Became homeless and lost contact|0|||
155336495|NCT03128099|560666288|FG000|Overall Study|Did not complete all the assessments|0|||
155336496|NCT03128099|560666289|FG001|Overall Study|Did not complete all the assessments|0|||
155336497|NCT03128099|560666290|FG002|Overall Study|Did not complete all the assessments|1|||
155336498|NCT02362789|560666296|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
155336499|NCT02362789|560666297|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
155336500|NCT02362789|560666298|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
155336501|NCT02362789|560666296|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
155336502|NCT02362789|560666297|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
155336503|NCT02362789|560666298|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
155336504|NCT02362789|560666296|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
155336505|NCT02362789|560666297|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
155336506|NCT02362789|560666298|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
155336507|NCT02362789|560666296|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
155336508|NCT02362789|560666297|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
155336509|NCT02362789|560666298|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
155336510|NCT02362789|560666296|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
155336511|NCT02362789|560666297|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
155336512|NCT02362789|560666298|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
155336513|NCT05270460|560666301|FG000|Overall Study|Adverse Event|0|||
155336514|NCT05270460|560666302|FG001|Overall Study|Adverse Event|1|||
155336515|NCT05270460|560666303|FG002|Overall Study|Adverse Event|0|||
155336516|NCT05270460|560666301|FG000|Overall Study|Early Termination|0|||
155336517|NCT05270460|560666302|FG001|Overall Study|Early Termination|1|||
155336518|NCT05270460|560666303|FG002|Overall Study|Early Termination|0|||
155336519|NCT00680771|560666306|FG000|Overall Study|Withdrawal by Subject|1|||
155336520|NCT00680771|560666307|FG001|Overall Study|Withdrawal by Subject|0|||
155336521|NCT00680771|560666306|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
155336522|NCT00680771|560666307|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
155336523|NCT00680771|560666306|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
155336524|NCT00680771|560666307|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
155336525|NCT03205488|560666319|FG000|Overall Study|Adverse Event|1|||
155336526|NCT03205488|560666320|FG001|Overall Study|Adverse Event|2|||
155336527|NCT03205488|560666321|FG002|Overall Study|Adverse Event|4|||
155336528|NCT03205488|560666319|FG000|Overall Study|Protocol Violation|0|||
155336529|NCT03205488|560666320|FG001|Overall Study|Protocol Violation|0|||
155336530|NCT03205488|560666321|FG002|Overall Study|Protocol Violation|1|||
155336531|NCT03652610|560666322|FG000|Overall Study|Lost to Follow-up|1|||
155336532|NCT03652610|560666323|FG001|Overall Study|Lost to Follow-up|0|||
155336533|NCT03652610|560666322|FG000|Overall Study|Withdrawal by Subject|3|||
155336534|NCT03652610|560666323|FG001|Overall Study|Withdrawal by Subject|5|||
155336535|NCT04748341|560666325|FG000|Overall Study|Lost to Follow-up|1|||
155336536|NCT04748341|560666326|FG001|Overall Study|Lost to Follow-up|1|||
155336537|NCT02334215|560666327|FG000|Overall Study|Death|1|||
155336538|NCT02334215|560666328|FG001|Overall Study|Death|1|||
155336539|NCT02334215|560666329|FG002|Overall Study|Death|0|||
154962391|NCT00323882|559287959|FG004|Overall Study|Lost to Follow-up|1|||
155336540|NCT02334215|560666327|FG000|Overall Study|Lost to Follow-up|1|||
155336541|NCT02334215|560666328|FG001|Overall Study|Lost to Follow-up|0|||
155336542|NCT02334215|560666329|FG002|Overall Study|Lost to Follow-up|4|||
155336543|NCT02334215|560666327|FG000|Overall Study|Withdrawal by Subject|2|||
155336544|NCT02334215|560666328|FG001|Overall Study|Withdrawal by Subject|2|||
155336545|NCT02334215|560666329|FG002|Overall Study|Withdrawal by Subject|1|||
155336546|NCT02334215|560666327|FG000|Overall Study|Not released from incarceration on time|3|||
155336547|NCT02334215|560666328|FG001|Overall Study|Not released from incarceration on time|3|||
155336548|NCT02334215|560666329|FG002|Overall Study|Not released from incarceration on time|3|||
155336549|NCT02334215|560666327|FG000|Overall Study|Incarcerated|0|||
155336550|NCT02334215|560666328|FG001|Overall Study|Incarcerated|0|||
155336551|NCT02334215|560666329|FG002|Overall Study|Incarcerated|7|||
155336552|NCT05615363|560666330|FG000|Overall Study|Adverse Event|0|||
155336553|NCT05615363|560666331|FG001|Overall Study|Adverse Event|4|||
154962392|NCT00323882|559287955|FG000|Overall Study|Other|0|||
155336554|NCT05615363|560666332|FG002|Overall Study|Adverse Event|4|||
155336555|NCT05615363|560666333|FG003|Overall Study|Adverse Event|3|||
155336556|NCT05615363|560666334|FG004|Overall Study|Adverse Event|1|||
155336557|NCT05615363|560666330|FG000|Overall Study|Physician Decision|2|||
155336558|NCT05615363|560666331|FG001|Overall Study|Physician Decision|0|||
155072712|NCT02949934|559695036|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
155072713|NCT02949934|559695037|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
155072714|NCT02949934|559695032|FG000|Neuroimaging|Not scanned|0|||
155072715|NCT02949934|559695033|FG001|Neuroimaging|Not scanned|0|||
155072716|NCT02949934|559695034|FG002|Neuroimaging|Not scanned|1|||
155072717|NCT02949934|559695035|FG003|Neuroimaging|Not scanned|0|||
155336559|NCT05615363|560666332|FG002|Overall Study|Physician Decision|4|||
155336560|NCT05615363|560666333|FG003|Overall Study|Physician Decision|1|||
155336561|NCT05615363|560666334|FG004|Overall Study|Physician Decision|3|||
155336562|NCT05615363|560666330|FG000|Overall Study|Protocol Violation|2|||
155336563|NCT05615363|560666331|FG001|Overall Study|Protocol Violation|0|||
155336564|NCT05615363|560666332|FG002|Overall Study|Protocol Violation|0|||
155336565|NCT05615363|560666333|FG003|Overall Study|Protocol Violation|0|||
155336566|NCT05615363|560666334|FG004|Overall Study|Protocol Violation|1|||
155336567|NCT05615363|560666330|FG000|Overall Study|Withdrawal by Subject|0|||
155336568|NCT05615363|560666331|FG001|Overall Study|Withdrawal by Subject|0|||
155072718|NCT02949934|559695036|FG004|Neuroimaging|Not scanned|0|||
155336569|NCT05615363|560666332|FG002|Overall Study|Withdrawal by Subject|1|||
155336570|NCT05615363|560666333|FG003|Overall Study|Withdrawal by Subject|0|||
155336571|NCT05615363|560666334|FG004|Overall Study|Withdrawal by Subject|0|||
155336572|NCT01276509|560668171|FG000|Overall Study|Adverse Event|9|||
155072719|NCT02949934|559695037|FG005|Neuroimaging|Not scanned|2|||
155336573|NCT01276509|560668172|FG001|Overall Study|Adverse Event|8|||
155336574|NCT01276509|560668173|FG002|Overall Study|Adverse Event|4|||
155072720|NCT02949934|559695032|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
155072721|NCT02949934|559695033|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
155072722|NCT02949934|559695034|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
155072723|NCT02949934|559695035|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
155072724|NCT02949934|559695036|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
155072725|NCT02949934|559695037|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
155072726|NCT02949934|559695032|FG000|Bar Laboratory|Adverse Event|1|||
155072727|NCT02949934|559695033|FG001|Bar Laboratory|Adverse Event|0|||
155072728|NCT02949934|559695034|FG002|Bar Laboratory|Adverse Event|2|||
155072729|NCT02949934|559695035|FG003|Bar Laboratory|Adverse Event|0|||
155072730|NCT02949934|559695036|FG004|Bar Laboratory|Adverse Event|1|||
155072731|NCT02949934|559695037|FG005|Bar Laboratory|Adverse Event|0|||
155072732|NCT02949934|559695032|FG000|Bar Laboratory|Protocol Violation|0|||
155072733|NCT02949934|559695033|FG001|Bar Laboratory|Protocol Violation|0|||
155072734|NCT02949934|559695034|FG002|Bar Laboratory|Protocol Violation|0|||
155072735|NCT02949934|559695035|FG003|Bar Laboratory|Protocol Violation|1|||
155072736|NCT02949934|559695036|FG004|Bar Laboratory|Protocol Violation|0|||
155072737|NCT02949934|559695037|FG005|Bar Laboratory|Protocol Violation|0|||
155072738|NCT04069520|559695041|FG000|Overall Study|Lost to Follow-up|0|||
155072739|NCT04069520|559695042|FG001|Overall Study|Lost to Follow-up|2|||
155072740|NCT04069520|559695041|FG000|Overall Study|Withdrawal by Subject|0|||
155072741|NCT04069520|559695042|FG001|Overall Study|Withdrawal by Subject|1|||
155072742|NCT04069520|559695041|FG000|Overall Study|Prior Injury|1|||
155072743|NCT04069520|559695042|FG001|Overall Study|Prior Injury|0|||
155336575|NCT01276509|560668174|FG003|Overall Study|Adverse Event|3|||
155336576|NCT01276509|560668171|FG000|Overall Study|Lack of Efficacy|2|||
155336577|NCT01276509|560668172|FG001|Overall Study|Lack of Efficacy|1|||
155336578|NCT01276509|560668173|FG002|Overall Study|Lack of Efficacy|1|||
155336579|NCT01276509|560668174|FG003|Overall Study|Lack of Efficacy|2|||
155336580|NCT01276509|560668171|FG000|Overall Study|Pregnancy|1|||
155336581|NCT01276509|560668172|FG001|Overall Study|Pregnancy|0|||
155336582|NCT01276509|560668173|FG002|Overall Study|Pregnancy|0|||
155336583|NCT01276509|560668174|FG003|Overall Study|Pregnancy|0|||
155336584|NCT01276509|560668171|FG000|Overall Study|Withdrawal by Subject|1|||
155336585|NCT01276509|560668172|FG001|Overall Study|Withdrawal by Subject|2|||
155336586|NCT01276509|560668173|FG002|Overall Study|Withdrawal by Subject|0|||
155336587|NCT01276509|560668174|FG003|Overall Study|Withdrawal by Subject|0|||
155336588|NCT01276509|560668171|FG000|Overall Study|Other|0|||
155336589|NCT01276509|560668172|FG001|Overall Study|Other|1|||
155336590|NCT01276509|560668173|FG002|Overall Study|Other|0|||
155336591|NCT01276509|560668174|FG003|Overall Study|Other|0|||
155336592|NCT03403036|560668178|FG000|Overall Study|Lack of Efficacy|5|||
155336593|NCT01128959|560668179|FG000|Lead in Period|Adverse Event|3|||
155336594|NCT01128959|560668179|FG000|Treatment Period|Adverse Event|3|||
155336595|NCT01128959|560668179|FG000|Treatment Period|Withdrawal by Subject|1|||
155336596|NCT02338999|560668180|FG000|First Intervention|Withdrawal by Subject|3|||
155336597|NCT02338999|560668181|FG001|First Intervention|Withdrawal by Subject|1|||
155336598|NCT02338999|560668180|FG000|Washout Period|Withdrawal by Subject|0|||
155336599|NCT02338999|560668181|FG001|Washout Period|Withdrawal by Subject|2|||
155336600|NCT02338999|560668180|FG000|Second Intervention|Withdrawal by Subject|0|||
155336601|NCT02338999|560668181|FG001|Second Intervention|Withdrawal by Subject|2|||
155072744|NCT04069520|559695041|FG000|Overall Study|Orthodontia|1|||
155072745|NCT04069520|559695042|FG001|Overall Study|Orthodontia|0|||
155072746|NCT04069520|559695041|FG000|Overall Study|Cut from team|0|||
155072747|NCT04069520|559695042|FG001|Overall Study|Cut from team|2|||
155336602|NCT01450007|560668183|FG000|Overall Study|Late exclusion before treatment|2|||
155336603|NCT01450007|560668184|FG001|Overall Study|Late exclusion before treatment|3|||
155072748|NCT00849472|559695043|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
155072749|NCT00849472|559695043|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
155072750|NCT00849472|559695043|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
155072751|NCT00849472|559695043|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
155072752|NCT00849472|559695043|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
155072753|NCT00849472|559695043|FG000|Weekly Paclitaxel|Disease Progression|1|||
155164087|NCT00606593|560036840|FG005|Overall Study|Administrative/Other|0|||
155336604|NCT01450007|560668185|FG002|Overall Study|Late exclusion before treatment|2|||
155164088|NCT00606593|560036841|FG006|Overall Study|Administrative/Other|0|||
155164089|NCT00606593|560036842|FG007|Overall Study|Administrative/Other|0|||
155336605|NCT01450007|560668183|FG000|Overall Study|Protocol Violation|0|||
155336606|NCT01450007|560668184|FG001|Overall Study|Protocol Violation|1|||
155336607|NCT01450007|560668185|FG002|Overall Study|Protocol Violation|1|||
155336608|NCT01450007|560668183|FG000|Overall Study|Adverse Event|0|||
155336609|NCT01450007|560668184|FG001|Overall Study|Adverse Event|1|||
155336610|NCT01450007|560668185|FG002|Overall Study|Adverse Event|0|||
155336611|NCT00484198|560668186|FG000|Overall Study|Participant Withdrew Consent|12|||
155336612|NCT00484198|560668187|FG001|Overall Study|Participant Withdrew Consent|21|||
155072754|NCT00849472|559695043|FG000|Weekly Paclitaxel|Adverse Event|11|||
155336613|NCT00484198|560668188|FG002|Overall Study|Participant Withdrew Consent|47|||
155336614|NCT00484198|560668189|FG003|Overall Study|Participant Withdrew Consent|59|||
155336615|NCT00484198|560668186|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
155336616|NCT00484198|560668187|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
155336617|NCT00484198|560668188|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
155336618|NCT00484198|560668189|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
155336619|NCT00484198|560668186|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
155336620|NCT00484198|560668187|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
155336621|NCT00484198|560668188|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
155336622|NCT00484198|560668189|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
155336623|NCT00484198|560668186|FG000|Overall Study|Adverse Event|3|||
155336624|NCT00484198|560668187|FG001|Overall Study|Adverse Event|11|||
155336625|NCT00484198|560668188|FG002|Overall Study|Adverse Event|32|||
154962393|NCT00323882|559287956|FG001|Overall Study|Other|0|||
154962394|NCT00323882|559287957|FG002|Overall Study|Other|0|||
154962395|NCT00323882|559287958|FG003|Overall Study|Other|1|||
155336626|NCT00484198|560668189|FG003|Overall Study|Adverse Event|31|||
155336627|NCT00484198|560668186|FG000|Overall Study|Protocol Violation|0|||
154962396|NCT00323882|559287959|FG004|Overall Study|Other|1|||
154962397|NCT00813592|559287960|FG000|Overall Study|Disease assessment was not completed per|2|||
155336628|NCT00484198|560668187|FG001|Overall Study|Protocol Violation|5|||
155336629|NCT00484198|560668188|FG002|Overall Study|Protocol Violation|6|||
155336630|NCT00484198|560668189|FG003|Overall Study|Protocol Violation|8|||
155336631|NCT00484198|560668186|FG000|Overall Study|Other|7|||
155336632|NCT00484198|560668187|FG001|Overall Study|Other|10|||
155336633|NCT00484198|560668188|FG002|Overall Study|Other|31|||
155336634|NCT00484198|560668189|FG003|Overall Study|Other|28|||
155336635|NCT01536704|560668190|FG000|Washout Period 1|Withdrawal by Subject|1|||
155336636|NCT01536704|560668191|FG001|Washout Period 1|Withdrawal by Subject|2|||
155336637|NCT01536704|560668192|FG002|Washout Period 1|Withdrawal by Subject|0|||
155336638|NCT01536704|560668193|FG003|Washout Period 1|Withdrawal by Subject|0|||
155336639|NCT01536704|560668190|FG000|Washout Period 2|Adverse Event|1|||
155336640|NCT01536704|560668191|FG001|Washout Period 2|Adverse Event|0|||
154962398|NCT04544410|559287961|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
154962399|NCT04544410|559287962|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
154962400|NCT04544410|559287961|FG000|Double-blind Treatment Period|Adverse Event|1|||
154962401|NCT04544410|559287962|FG001|Double-blind Treatment Period|Adverse Event|0|||
154962402|NCT04544410|559287961|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
154962403|NCT04544410|559287962|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
154962404|NCT04544410|559287961|FG000|Double-blind Treatment Period|Protocol Violation|1|||
154962405|NCT04544410|559287962|FG001|Double-blind Treatment Period|Protocol Violation|0|||
154962406|NCT04544410|559287961|FG000|Open-Label Treatment Period|Study Terminated|15|||
154962407|NCT04544410|559287962|FG001|Open-Label Treatment Period|Study Terminated|19|||
154962408|NCT04544410|559287961|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
154962409|NCT04544410|559287962|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
154962410|NCT04544410|559287961|FG000|Open-Label Treatment Period|Adverse Event|0|||
154962411|NCT04544410|559287962|FG001|Open-Label Treatment Period|Adverse Event|1|||
154962412|NCT04544410|559287961|FG000|Open-Label Treatment Period|Physician Decision|1|||
154962413|NCT04544410|559287962|FG001|Open-Label Treatment Period|Physician Decision|0|||
155336641|NCT01536704|560668192|FG002|Washout Period 2|Adverse Event|0|||
155336642|NCT01536704|560668193|FG003|Washout Period 2|Adverse Event|0|||
155336643|NCT01536704|560668190|FG000|Washout Period 2|Withdrawal by Subject|0|||
155336644|NCT01536704|560668191|FG001|Washout Period 2|Withdrawal by Subject|0|||
155336645|NCT01536704|560668192|FG002|Washout Period 2|Withdrawal by Subject|0|||
155336646|NCT01536704|560668193|FG003|Washout Period 2|Withdrawal by Subject|1|||
154962414|NCT04544410|559287961|FG000|Open-Label Treatment Period|Other|0|||
154962415|NCT04544410|559287962|FG001|Open-Label Treatment Period|Other|1|||
155336647|NCT01536704|560668190|FG000|Period 3|Adverse Event|0|||
155336648|NCT01536704|560668191|FG001|Period 3|Adverse Event|0|||
155336649|NCT01536704|560668192|FG002|Period 3|Adverse Event|0|||
155336650|NCT01536704|560668193|FG003|Period 3|Adverse Event|1|||
155336651|NCT01536704|560668190|FG000|Washout Period 3|Adverse Event|0|||
155336652|NCT01536704|560668191|FG001|Washout Period 3|Adverse Event|0|||
155336653|NCT01536704|560668192|FG002|Washout Period 3|Adverse Event|1|||
155336654|NCT01536704|560668193|FG003|Washout Period 3|Adverse Event|0|||
155336655|NCT01947491|560668194|FG000|Overall Study|Lost to Follow-up|5|||
155336656|NCT01947491|560668195|FG001|Overall Study|Lost to Follow-up|3|||
155336657|NCT01947491|560668196|FG002|Overall Study|Lost to Follow-up|1|||
154962416|NCT01030133|559287963|FG000|Overall Study|failed to experience pain at level 7/10|2|||
154962417|NCT01030133|559287964|FG001|Overall Study|failed to experience pain at level 7/10|2|||
155336658|NCT01947491|560668197|FG003|Overall Study|Lost to Follow-up|2|||
155072755|NCT00849472|559695043|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
155336659|NCT01947491|560668194|FG000|Overall Study|Lack of Efficacy|1|||
155336660|NCT01947491|560668195|FG001|Overall Study|Lack of Efficacy|0|||
155336661|NCT01947491|560668196|FG002|Overall Study|Lack of Efficacy|0|||
155336662|NCT01947491|560668197|FG003|Overall Study|Lack of Efficacy|1|||
155336663|NCT01947491|560668194|FG000|Overall Study|Protocol Violation|1|||
155336664|NCT01947491|560668195|FG001|Overall Study|Protocol Violation|0|||
155336665|NCT01947491|560668196|FG002|Overall Study|Protocol Violation|0|||
155336666|NCT01947491|560668197|FG003|Overall Study|Protocol Violation|0|||
155336667|NCT01947491|560668194|FG000|Overall Study|Withdrawal by Subject|1|||
155336668|NCT01947491|560668195|FG001|Overall Study|Withdrawal by Subject|1|||
155336669|NCT01947491|560668196|FG002|Overall Study|Withdrawal by Subject|1|||
155336670|NCT01947491|560668197|FG003|Overall Study|Withdrawal by Subject|0|||
155336671|NCT01947491|560668194|FG000|Overall Study|Worsening of condition|0|||
155336672|NCT01947491|560668195|FG001|Overall Study|Worsening of condition|1|||
155336673|NCT01947491|560668196|FG002|Overall Study|Worsening of condition|0|||
155336674|NCT01947491|560668197|FG003|Overall Study|Worsening of condition|0|||
155336675|NCT01947491|560668194|FG000|Overall Study|Adverse Event|0|||
155336676|NCT01947491|560668195|FG001|Overall Study|Adverse Event|1|||
155336677|NCT01947491|560668196|FG002|Overall Study|Adverse Event|0|||
155336678|NCT01947491|560668197|FG003|Overall Study|Adverse Event|2|||
155336679|NCT02067663|560668199|FG000|Overall Study|Lost to Follow-up|13|||
155336680|NCT02067663|560668200|FG001|Overall Study|Lost to Follow-up|14|||
155336681|NCT00704340|560668201|FG000|Overall Study|Lost to Follow-up|2|||
155336682|NCT00704340|560668202|FG001|Overall Study|Lost to Follow-up|1|||
155336683|NCT00704340|560668201|FG000|Overall Study|Death|0|||
155336684|NCT00704340|560668202|FG001|Overall Study|Death|1|||
155336685|NCT03236779|560668204|FG000|Overall Study|Lost to Follow-up|13|||
155336686|NCT03236779|560668205|FG001|Overall Study|Lost to Follow-up|21|||
155336687|NCT00403845|560668210|FG000|Treatment Period 1|Subject withdrew consent|1|||
155336688|NCT00403845|560668211|FG001|Treatment Period 1|Subject withdrew consent|0|||
155336689|NCT00403845|560668212|FG002|Treatment Period 1|Subject withdrew consent|0|||
155336690|NCT00403845|560668213|FG003|Treatment Period 1|Subject withdrew consent|0|||
155336691|NCT00403845|560668210|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
155336692|NCT00403845|560668211|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
155336693|NCT00403845|560668212|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
155336694|NCT00403845|560668213|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
155336695|NCT00403845|560668210|FG000|Treatment Period 2|Subject withdrew consent|1|||
155336696|NCT00403845|560668211|FG001|Treatment Period 2|Subject withdrew consent|0|||
155336697|NCT00403845|560668212|FG002|Treatment Period 2|Subject withdrew consent|0|||
155336698|NCT00403845|560668213|FG003|Treatment Period 2|Subject withdrew consent|0|||
155336699|NCT00403845|560668210|FG000|Treatment Period 3|Subject withdrew consent|0|||
155336700|NCT00403845|560668211|FG001|Treatment Period 3|Subject withdrew consent|0|||
155336701|NCT00403845|560668212|FG002|Treatment Period 3|Subject withdrew consent|0|||
155336702|NCT00403845|560668213|FG003|Treatment Period 3|Subject withdrew consent|1|||
155336703|NCT00403845|560668210|FG000|Treatment Period 3|Adverse Event|0|||
155336704|NCT00403845|560668211|FG001|Treatment Period 3|Adverse Event|0|||
155336705|NCT00403845|560668212|FG002|Treatment Period 3|Adverse Event|0|||
155336706|NCT00403845|560668213|FG003|Treatment Period 3|Adverse Event|1|||
155336707|NCT01836523|560668214|FG000|Overall Study|Adverse Event|15|||
155336708|NCT01836523|560668215|FG001|Overall Study|Adverse Event|41|||
155336709|NCT01836523|560668216|FG002|Overall Study|Adverse Event|49|||
155336710|NCT01836523|560668217|FG003|Overall Study|Adverse Event|14|||
155336711|NCT01836523|560668214|FG000|Overall Study|Protocol Violation|6|||
155336712|NCT01836523|560668215|FG001|Overall Study|Protocol Violation|3|||
155336713|NCT01836523|560668216|FG002|Overall Study|Protocol Violation|2|||
155336714|NCT01836523|560668217|FG003|Overall Study|Protocol Violation|4|||
155336715|NCT01836523|560668214|FG000|Overall Study|Met Withdrawal Criteria|13|||
155336716|NCT01836523|560668215|FG001|Overall Study|Met Withdrawal Criteria|13|||
155336717|NCT01836523|560668216|FG002|Overall Study|Met Withdrawal Criteria|21|||
155336718|NCT01836523|560668217|FG003|Overall Study|Met Withdrawal Criteria|27|||
155336719|NCT01836523|560668214|FG000|Overall Study|Unclassified|17|||
155072756|NCT00849472|559695043|FG000|Weekly Paclitaxel|Physician Decision|3|||
155336720|NCT01836523|560668215|FG001|Overall Study|Unclassified|28|||
155336721|NCT01836523|560668216|FG002|Overall Study|Unclassified|19|||
155336722|NCT01836523|560668217|FG003|Overall Study|Unclassified|29|||
155336723|NCT00624377|560668220|FG000|Overall Study|Lost to Follow-up|355|||
155336724|NCT00624377|560668220|FG000|Overall Study|Withdrawal by Subject|100|||
155336725|NCT00624377|560668220|FG000|Overall Study|Adverse Event|14|||
155336726|NCT00624377|560668220|FG000|Overall Study|Other|91|||
155336727|NCT00624377|560668220|FG000|Overall Study|Non-evaluable population|84|||
155336728|NCT00089791|560668224|FG000|Overall Study|Physician Decision|6|||
155336729|NCT00089791|560668225|FG001|Overall Study|Physician Decision|3|||
155336730|NCT00089791|560668224|FG000|Overall Study|Adverse Event|81|||
155336731|NCT00089791|560668225|FG001|Overall Study|Adverse Event|93|||
155336732|NCT00089791|560668224|FG000|Overall Study|Withdrawal by Subject|403|||
155336733|NCT00089791|560668225|FG001|Overall Study|Withdrawal by Subject|344|||
155336734|NCT00089791|560668224|FG000|Overall Study|Death|78|||
155336735|NCT00089791|560668225|FG001|Overall Study|Death|62|||
154962418|NCT04493684|559287966|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
154962419|NCT04493684|559287967|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962420|NCT04493684|559287968|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
154962421|NCT04493684|559287969|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962422|NCT04493684|559287970|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155336736|NCT00089791|560668224|FG000|Overall Study|Disease progression|7|||
155336737|NCT00089791|560668225|FG001|Overall Study|Disease progression|3|||
155336738|NCT00089791|560668224|FG000|Overall Study|Ineligibility determined|12|||
155336739|NCT00089791|560668225|FG001|Overall Study|Ineligibility determined|9|||
155336740|NCT00089791|560668224|FG000|Overall Study|Lost to Follow-up|57|||
154962423|NCT04493684|559287971|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
154962424|NCT04493684|559287972|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155336741|NCT00089791|560668225|FG001|Overall Study|Lost to Follow-up|57|||
155336742|NCT00089791|560668224|FG000|Overall Study|Noncompliance|17|||
155336743|NCT00089791|560668225|FG001|Overall Study|Noncompliance|13|||
155336744|NCT00089791|560668224|FG000|Overall Study|Other|20|||
155336745|NCT00089791|560668225|FG001|Overall Study|Other|32|||
155336746|NCT00089791|560668224|FG000|Overall Study|Protocol deviation|12|||
155336747|NCT00089791|560668225|FG001|Overall Study|Protocol deviation|10|||
155336748|NCT00089791|560668224|FG000|Overall Study|Requirement for alternative therapy|7|||
155336749|NCT00089791|560668225|FG001|Overall Study|Requirement for alternative therapy|4|||
155336750|NCT00148122|560668226|FG000|Overall Study|Withdrawal by Subject|2|||
155336751|NCT05074433|560668229|FG000|Overall Study|Adverse Event|0|||
155336752|NCT05074433|560668230|FG001|Overall Study|Adverse Event|2|||
155336753|NCT05074433|560668231|FG002|Overall Study|Adverse Event|0|||
155336754|NCT05074433|560668232|FG003|Overall Study|Adverse Event|1|||
155336755|NCT05074433|560668229|FG000|Overall Study|Sponsor Request|0|||
155336756|NCT05074433|560668230|FG001|Overall Study|Sponsor Request|1|||
155336757|NCT05074433|560668231|FG002|Overall Study|Sponsor Request|1|||
155336758|NCT05074433|560668232|FG003|Overall Study|Sponsor Request|0|||
155336759|NCT05074433|560668229|FG000|Overall Study|Death|1|||
155336760|NCT05074433|560668230|FG001|Overall Study|Death|0|||
155336761|NCT05074433|560668231|FG002|Overall Study|Death|0|||
155336762|NCT05074433|560668232|FG003|Overall Study|Death|0|||
155336763|NCT05074433|560668229|FG000|Overall Study|Lost to Follow-up|0|||
155336764|NCT05074433|560668230|FG001|Overall Study|Lost to Follow-up|0|||
155336765|NCT05074433|560668231|FG002|Overall Study|Lost to Follow-up|2|||
154962425|NCT04493684|559287973|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962426|NCT04493684|559287974|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
155336766|NCT05074433|560668232|FG003|Overall Study|Lost to Follow-up|0|||
155336767|NCT05074433|560668229|FG000|Overall Study|Subject Decision|8|||
155336768|NCT05074433|560668230|FG001|Overall Study|Subject Decision|6|||
155336769|NCT05074433|560668231|FG002|Overall Study|Subject Decision|4|||
155336770|NCT05074433|560668232|FG003|Overall Study|Subject Decision|5|||
155336771|NCT04397263|560668233|FG000|Overall Study|Withdrawal by Subject|2|||
155336772|NCT01989689|560668234|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
155336773|NCT01989689|560668235|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
155336774|NCT01989689|560668234|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
155336775|NCT01989689|560668235|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
155336776|NCT04492475|560668236|FG000|Overall Study|Enrolled but not treated|8|||
155336777|NCT04492475|560668237|FG001|Overall Study|Enrolled but not treated|8|||
155336778|NCT04492475|560668236|FG000|Overall Study|Withdrawal by Subject|4|||
155336779|NCT04492475|560668237|FG001|Overall Study|Withdrawal by Subject|0|||
155336780|NCT04492475|560668236|FG000|Overall Study|Became ineligible after enrollment|2|||
155336781|NCT04492475|560668237|FG001|Overall Study|Became ineligible after enrollment|0|||
155336782|NCT02066636|560668238|FG000|Overall Study|Disease progression|51|||
155336783|NCT02066636|560668239|FG001|Overall Study|Disease progression|60|||
155336784|NCT02066636|560668240|FG002|Overall Study|Disease progression|700|||
155336785|NCT02066636|560668238|FG000|Overall Study|Study drug toxicity|13|||
155336786|NCT02066636|560668239|FG001|Overall Study|Study drug toxicity|2|||
155336787|NCT02066636|560668240|FG002|Overall Study|Study drug toxicity|58|||
155336788|NCT02066636|560668238|FG000|Overall Study|Death|4|||
155336789|NCT02066636|560668239|FG001|Overall Study|Death|2|||
155336790|NCT02066636|560668240|FG002|Overall Study|Death|158|||
155336791|NCT02066636|560668238|FG000|Overall Study|Adverse event unrelated to study drug|6|||
155336792|NCT02066636|560668239|FG001|Overall Study|Adverse event unrelated to study drug|4|||
155336793|NCT02066636|560668240|FG002|Overall Study|Adverse event unrelated to study drug|45|||
155336794|NCT02066636|560668238|FG000|Overall Study|Participant request to discontinue treatment|12|||
155336795|NCT02066636|560668239|FG001|Overall Study|Participant request to discontinue treatment|12|||
155336796|NCT02066636|560668240|FG002|Overall Study|Participant request to discontinue treatment|70|||
155336797|NCT02066636|560668238|FG000|Overall Study|Participant withdrew consent|10|||
155336798|NCT02066636|560668239|FG001|Overall Study|Participant withdrew consent|18|||
155336799|NCT02066636|560668240|FG002|Overall Study|Participant withdrew consent|61|||
155336800|NCT02066636|560668238|FG000|Overall Study|Lost to Follow-up|0|||
155336801|NCT02066636|560668239|FG001|Overall Study|Lost to Follow-up|2|||
155336802|NCT02066636|560668240|FG002|Overall Study|Lost to Follow-up|2|||
155336803|NCT02066636|560668238|FG000|Overall Study|Maximum clinical benefit|2|||
155336804|NCT02066636|560668239|FG001|Overall Study|Maximum clinical benefit|2|||
155336805|NCT02066636|560668240|FG002|Overall Study|Maximum clinical benefit|3|||
155336806|NCT02066636|560668238|FG000|Overall Study|Poor/non-compliance|2|||
155336807|NCT02066636|560668239|FG001|Overall Study|Poor/non-compliance|1|||
155336808|NCT02066636|560668240|FG002|Overall Study|Poor/non-compliance|1|||
155336809|NCT02066636|560668238|FG000|Overall Study|Participant no loner meets study criteria|3|||
155336810|NCT02066636|560668239|FG001|Overall Study|Participant no loner meets study criteria|2|||
155336811|NCT02066636|560668240|FG002|Overall Study|Participant no loner meets study criteria|28|||
155336812|NCT02066636|560668238|FG000|Overall Study|Administrative reasons by sponsor|8|||
155336813|NCT02066636|560668239|FG001|Overall Study|Administrative reasons by sponsor|5|||
155072757|NCT00849472|559695043|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
155072758|NCT00849472|559695043|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
155072759|NCT00849472|559695043|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
155072760|NCT00849472|559695043|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
155072761|NCT00849472|559695043|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
155072762|NCT00849472|559695043|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
155072763|NCT00849472|559695043|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
155336814|NCT02066636|560668240|FG002|Overall Study|Administrative reasons by sponsor|0|||
155336815|NCT02066636|560668238|FG000|Overall Study|Other reasons|16|||
155336816|NCT02066636|560668239|FG001|Overall Study|Other reasons|15|||
155336817|NCT02066636|560668240|FG002|Overall Study|Other reasons|50|||
155336818|NCT00391170|560668241|FG000|Overall Study|Withdrawal by Subject|1|||
155336819|NCT00391170|560668242|FG001|Overall Study|Withdrawal by Subject|0|||
155336820|NCT00391170|560668241|FG000|Overall Study|Adverse Event|3|||
155336821|NCT00391170|560668242|FG001|Overall Study|Adverse Event|2|||
155336822|NCT00391170|560668241|FG000|Overall Study|Physician Decision|2|||
155336823|NCT00391170|560668242|FG001|Overall Study|Physician Decision|2|||
155336824|NCT03567616|560668247|FG000|Overall Study|Disease progression|4|||
155336825|NCT03567616|560668247|FG000|Overall Study|Withdrawal by Subject|1|||
155336826|NCT03567616|560668247|FG000|Overall Study|Physician Decision|1|||
155336827|NCT03567616|560668247|FG000|Overall Study|Death|1|||
155336828|NCT03567616|560668247|FG000|Overall Study|Adverse Event|1|||
155336829|NCT03200574|560668260|FG000|Overall Study|Death|4|||
155336830|NCT03200574|560668260|FG000|Overall Study|Withdrawal by Subject|8|||
155336831|NCT03200574|560668260|FG000|Overall Study|Long-Term need for anticoagulation|1|||
155336832|NCT03200574|560668260|FG000|Overall Study|Relocation|2|||
155336833|NCT03200574|560668260|FG000|Overall Study|Lost to Follow-up|2|||
155336834|NCT00705159|560668261|FG000|Overall Study|Withdrawal by Subject|0|||
155336835|NCT00705159|560668262|FG001|Overall Study|Withdrawal by Subject|1|||
155336836|NCT00705159|560668263|FG002|Overall Study|Withdrawal by Subject|1|||
155336837|NCT00705159|560668264|FG003|Overall Study|Withdrawal by Subject|1|||
155336838|NCT00705159|560668261|FG000|Overall Study|Protocol Violation|0|||
155336839|NCT00705159|560668262|FG001|Overall Study|Protocol Violation|1|||
155336840|NCT00705159|560668263|FG002|Overall Study|Protocol Violation|0|||
155336841|NCT00705159|560668264|FG003|Overall Study|Protocol Violation|0|||
155336842|NCT00705159|560668261|FG000|Overall Study|Adverse Event|0|||
155336843|NCT00705159|560668262|FG001|Overall Study|Adverse Event|0|||
155336844|NCT00705159|560668263|FG002|Overall Study|Adverse Event|1|||
155336845|NCT00705159|560668264|FG003|Overall Study|Adverse Event|0|||
155336846|NCT00705159|560668261|FG000|Overall Study|Lost to Follow-up|0|||
155336847|NCT00705159|560668262|FG001|Overall Study|Lost to Follow-up|0|||
155336848|NCT00705159|560668263|FG002|Overall Study|Lost to Follow-up|3|||
155336849|NCT00705159|560668264|FG003|Overall Study|Lost to Follow-up|2|||
155336850|NCT00705159|560668261|FG000|Overall Study|Screen Failure|0|||
155336851|NCT00705159|560668262|FG001|Overall Study|Screen Failure|0|||
155336852|NCT00705159|560668263|FG002|Overall Study|Screen Failure|0|||
155336853|NCT00705159|560668264|FG003|Overall Study|Screen Failure|1|||
155336854|NCT00526994|560668265|FG000|Overall Study|Lost to Follow-up|98|||
155336855|NCT00526994|560668266|FG001|Overall Study|Lost to Follow-up|108|||
155336856|NCT00526994|560668267|FG002|Overall Study|Lost to Follow-up|96|||
155336857|NCT00526994|560668265|FG000|Overall Study|Death|4|||
155336858|NCT00526994|560668266|FG001|Overall Study|Death|3|||
155336859|NCT00526994|560668267|FG002|Overall Study|Death|3|||
155336860|NCT00526994|560668265|FG000|Overall Study|Withdrawal by Subject|2|||
155336861|NCT00526994|560668266|FG001|Overall Study|Withdrawal by Subject|7|||
155336862|NCT00526994|560668267|FG002|Overall Study|Withdrawal by Subject|5|||
155336863|NCT00526994|560668265|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
155336864|NCT00526994|560668266|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
155336865|NCT00526994|560668267|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
155336866|NCT03026166|560668268|FG000|Overall Study|Death|22|||
155336867|NCT03026166|560668269|FG001|Overall Study|Death|7|||
155336868|NCT03026166|560668268|FG000|Overall Study|Physician Decision|2|||
155336869|NCT03026166|560668269|FG001|Overall Study|Physician Decision|0|||
155336870|NCT03026166|560668268|FG000|Overall Study|Withdrawal by Subject|1|||
155336871|NCT03026166|560668269|FG001|Overall Study|Withdrawal by Subject|2|||
155336872|NCT03026166|560668268|FG000|Overall Study|Lost to Follow-up|1|||
155336873|NCT03026166|560668269|FG001|Overall Study|Lost to Follow-up|0|||
155336874|NCT03026166|560668268|FG000|Overall Study|Study Terminated by Sponsor|3|||
155336875|NCT03026166|560668269|FG001|Overall Study|Study Terminated by Sponsor|3|||
155336876|NCT03026166|560668268|FG000|Overall Study|Other|1|||
155336877|NCT03026166|560668269|FG001|Overall Study|Other|0|||
155336878|NCT03035942|560668270|FG000|Overall Study|Adverse Event|8|||
155336879|NCT03035942|560668271|FG001|Overall Study|Adverse Event|4|||
155336880|NCT03035942|560668272|FG002|Overall Study|Adverse Event|5|||
155336881|NCT00380250|560668273|FG000|Overall Study|Withdrawal by Subject|39|||
155336882|NCT00380250|560668274|FG001|Overall Study|Withdrawal by Subject|28|||
155336883|NCT00380250|560668273|FG000|Overall Study|Adverse Event|20|||
155336884|NCT00380250|560668274|FG001|Overall Study|Adverse Event|9|||
155336885|NCT00380250|560668273|FG000|Overall Study|Lack of Efficacy|10|||
155336886|NCT00380250|560668274|FG001|Overall Study|Lack of Efficacy|8|||
155336887|NCT00380250|560668273|FG000|Overall Study|Protocol Violation|15|||
155336888|NCT00380250|560668274|FG001|Overall Study|Protocol Violation|5|||
155336889|NCT00380250|560668273|FG000|Overall Study|Lost to Follow-up|14|||
155336890|NCT00380250|560668274|FG001|Overall Study|Lost to Follow-up|5|||
155336891|NCT00380250|560668273|FG000|Overall Study|Physician Decision|1|||
155336892|NCT00380250|560668274|FG001|Overall Study|Physician Decision|0|||
155336893|NCT01989104|560668275|FG000|Overall Study|Withdrawal by Subject|3|||
155336894|NCT01989104|560668276|FG001|Overall Study|Withdrawal by Subject|0|||
155336895|NCT01989104|560668277|FG002|Overall Study|Withdrawal by Subject|0|||
155336896|NCT01989104|560668278|FG003|Overall Study|Withdrawal by Subject|0|||
155336897|NCT01989104|560668279|FG004|Overall Study|Withdrawal by Subject|0|||
155336898|NCT02833948|560668280|FG000|Overall Study|Death|2|||
155336899|NCT02833948|560668281|FG001|Overall Study|Death|3|||
155336900|NCT02833948|560668280|FG000|Overall Study|were not scanned|8|||
155336901|NCT02833948|560668281|FG001|Overall Study|were not scanned|13|||
155336902|NCT02833948|560668280|FG000|Overall Study|scans could not be evaluated|5|||
155336903|NCT02833948|560668281|FG001|Overall Study|scans could not be evaluated|2|||
155336904|NCT02691702|560668285|FG000|Overall Study|Adverse Event|1|||
155336905|NCT02691702|560668286|FG001|Overall Study|Adverse Event|0|||
155336906|NCT02691702|560668287|FG002|Overall Study|Adverse Event|0|||
155336907|NCT02691702|560668288|FG003|Overall Study|Adverse Event|0|||
155336908|NCT02691702|560668289|FG004|Overall Study|Adverse Event|0|||
155336909|NCT02691702|560668290|FG005|Overall Study|Adverse Event|0|||
155336910|NCT02691702|560668291|FG006|Overall Study|Adverse Event|0|||
155336911|NCT02691702|560668292|FG007|Overall Study|Adverse Event|0|||
155336912|NCT02691702|560668293|FG008|Overall Study|Adverse Event|1|||
155336913|NCT02691702|560668294|FG009|Overall Study|Adverse Event|0|||
155336914|NCT02691702|560668295|FG010|Overall Study|Adverse Event|1|||
155336915|NCT02691702|560668285|FG000|Overall Study|Lost to Follow-up|0|||
155336916|NCT02691702|560668286|FG001|Overall Study|Lost to Follow-up|0|||
155336917|NCT02691702|560668287|FG002|Overall Study|Lost to Follow-up|1|||
155336918|NCT02691702|560668288|FG003|Overall Study|Lost to Follow-up|0|||
155336919|NCT02691702|560668289|FG004|Overall Study|Lost to Follow-up|0|||
155336920|NCT02691702|560668290|FG005|Overall Study|Lost to Follow-up|2|||
155336921|NCT02691702|560668291|FG006|Overall Study|Lost to Follow-up|0|||
155336922|NCT02691702|560668292|FG007|Overall Study|Lost to Follow-up|0|||
155336923|NCT02691702|560668293|FG008|Overall Study|Lost to Follow-up|0|||
155336924|NCT02691702|560668294|FG009|Overall Study|Lost to Follow-up|0|||
155336925|NCT02691702|560668295|FG010|Overall Study|Lost to Follow-up|1|||
155336926|NCT02691702|560668285|FG000|Overall Study|Withdrawal by Subject|1|||
155336927|NCT02691702|560668286|FG001|Overall Study|Withdrawal by Subject|1|||
155336928|NCT02691702|560668287|FG002|Overall Study|Withdrawal by Subject|0|||
155336929|NCT02691702|560668288|FG003|Overall Study|Withdrawal by Subject|0|||
155336930|NCT02691702|560668289|FG004|Overall Study|Withdrawal by Subject|0|||
155336931|NCT02691702|560668290|FG005|Overall Study|Withdrawal by Subject|1|||
155336932|NCT02691702|560668291|FG006|Overall Study|Withdrawal by Subject|2|||
155336933|NCT02691702|560668292|FG007|Overall Study|Withdrawal by Subject|0|||
155336934|NCT02691702|560668293|FG008|Overall Study|Withdrawal by Subject|0|||
155336935|NCT02691702|560668294|FG009|Overall Study|Withdrawal by Subject|0|||
155336936|NCT02691702|560668295|FG010|Overall Study|Withdrawal by Subject|0|||
155336937|NCT02691702|560668285|FG000|Overall Study|Other|0|||
155336938|NCT02691702|560668286|FG001|Overall Study|Other|0|||
155336939|NCT02691702|560668287|FG002|Overall Study|Other|0|||
155336940|NCT02691702|560668288|FG003|Overall Study|Other|0|||
155336941|NCT02691702|560668289|FG004|Overall Study|Other|0|||
155336942|NCT02691702|560668290|FG005|Overall Study|Other|0|||
155336943|NCT02691702|560668291|FG006|Overall Study|Other|1|||
155336944|NCT02691702|560668292|FG007|Overall Study|Other|0|||
155336945|NCT02691702|560668293|FG008|Overall Study|Other|1|||
155336946|NCT02691702|560668294|FG009|Overall Study|Other|0|||
155336947|NCT02691702|560668295|FG010|Overall Study|Other|0|||
155336948|NCT02691702|560668285|FG000|Overall Study|Protocol Violation|0|||
155336949|NCT02691702|560668286|FG001|Overall Study|Protocol Violation|0|||
155336950|NCT02691702|560668287|FG002|Overall Study|Protocol Violation|0|||
155336951|NCT02691702|560668288|FG003|Overall Study|Protocol Violation|0|||
155336952|NCT02691702|560668289|FG004|Overall Study|Protocol Violation|0|||
155336953|NCT02691702|560668290|FG005|Overall Study|Protocol Violation|0|||
155336954|NCT02691702|560668291|FG006|Overall Study|Protocol Violation|0|||
155336955|NCT02691702|560668292|FG007|Overall Study|Protocol Violation|0|||
155336956|NCT02691702|560668293|FG008|Overall Study|Protocol Violation|0|||
155336957|NCT02691702|560668294|FG009|Overall Study|Protocol Violation|2|||
155336958|NCT02691702|560668295|FG010|Overall Study|Protocol Violation|0|||
155336959|NCT05613088|560668296|FG000|Treatment|Ongoing Study Treatment|9|||
155336960|NCT05613088|560668297|FG001|Treatment|Ongoing Study Treatment|2|||
155336961|NCT05613088|560668296|FG000|Treatment|Adverse Event|3|||
155336962|NCT05613088|560668297|FG001|Treatment|Adverse Event|1|||
155336963|NCT05613088|560668296|FG000|Treatment|Other Reasons|0|||
155072764|NCT00849472|559695043|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
155072765|NCT04615507|559695044|FG000|Period 1|Covid-19 exposure|2|||
155336964|NCT05613088|560668297|FG001|Treatment|Other Reasons|1|||
155336965|NCT05613088|560668296|FG000|Treatment|Progressive Disease|58|||
155072766|NCT04615507|559695045|FG001|Period 1|Covid-19 exposure|1|||
155072767|NCT04615507|559695044|FG000|Period 2|Covid-19 exposure|0|||
155072768|NCT04615507|559695045|FG001|Period 2|Covid-19 exposure|1|||
155072769|NCT04615507|559695044|FG000|Period 2|Protocol Violation|1|||
155072770|NCT04615507|559695045|FG001|Period 2|Protocol Violation|0|||
155072771|NCT04615507|559695044|FG000|Period 2|Withdrawal by Subject|1|||
155072772|NCT04615507|559695045|FG001|Period 2|Withdrawal by Subject|0|||
155072773|NCT04615507|559695044|FG000|Period 2|Adverse Event|0|||
155072774|NCT04615507|559695045|FG001|Period 2|Adverse Event|1|||
155072775|NCT04615507|559695044|FG000|Period 3|Covid-19 exposure|0|||
155072776|NCT04615507|559695045|FG001|Period 3|Covid-19 exposure|1|||
155336966|NCT05613088|560668297|FG001|Treatment|Progressive Disease|26|||
155336967|NCT05613088|560668296|FG000|Treatment|Withdrawal by Subject|0|||
155336968|NCT05613088|560668297|FG001|Treatment|Withdrawal by Subject|4|||
155336969|NCT05163353|560668300|FG000|Overall Study|Adverse Event|1|||
155336970|NCT05163353|560668301|FG001|Overall Study|Adverse Event|0|||
155336971|NCT05163353|560668300|FG000|Overall Study|Withdrawal by Subject|21|||
155336972|NCT05163353|560668301|FG001|Overall Study|Withdrawal by Subject|6|||
155336973|NCT05163353|560668300|FG000|Overall Study|Protocol Violation|0|||
155336974|NCT05163353|560668301|FG001|Overall Study|Protocol Violation|1|||
155336975|NCT05163353|560668300|FG000|Overall Study|Lost to Follow-up|13|||
155336976|NCT05163353|560668301|FG001|Overall Study|Lost to Follow-up|2|||
155336977|NCT06086028|560668303|FG000|Overall Study|Withdrawal by Subject|1|||
155336978|NCT06086028|560668304|FG001|Overall Study|Withdrawal by Subject|1|||
155336979|NCT06086028|560668303|FG000|Overall Study|Lost to Follow-up|2|||
155336980|NCT06086028|560668304|FG001|Overall Study|Lost to Follow-up|3|||
155336981|NCT00824408|560668305|FG000|Run-in Phase|Progressive disease|4|||
155336982|NCT00824408|560668306|FG001|Run-in Phase|Progressive disease|4|||
155336983|NCT00824408|560668307|FG002|Run-in Phase|Progressive disease|0|||
155336984|NCT00824408|560668308|FG003|Run-in Phase|Progressive disease|0|||
155336985|NCT00824408|560668309|FG004|Run-in Phase|Progressive disease|0|||
155336986|NCT00824408|560668305|FG000|Run-in Phase|Adverse Event|1|||
155336987|NCT00824408|560668306|FG001|Run-in Phase|Adverse Event|1|||
155336988|NCT00824408|560668307|FG002|Run-in Phase|Adverse Event|0|||
155336989|NCT00824408|560668308|FG003|Run-in Phase|Adverse Event|0|||
155336990|NCT00824408|560668309|FG004|Run-in Phase|Adverse Event|0|||
155336991|NCT00824408|560668305|FG000|Run-in Phase|Refused to continue medication|1|||
155336992|NCT00824408|560668306|FG001|Run-in Phase|Refused to continue medication|0|||
155336993|NCT00824408|560668307|FG002|Run-in Phase|Refused to continue medication|0|||
155336994|NCT00824408|560668308|FG003|Run-in Phase|Refused to continue medication|0|||
155336995|NCT00824408|560668309|FG004|Run-in Phase|Refused to continue medication|0|||
155072777|NCT00308685|559695048|FG000|Overall Study|Lost to Follow-up|1|||
155336996|NCT00824408|560668305|FG000|Run-in Phase|Other reason not defined above|0|||
155336997|NCT00824408|560668306|FG001|Run-in Phase|Other reason not defined above|1|||
155336998|NCT00824408|560668307|FG002|Run-in Phase|Other reason not defined above|0|||
155336999|NCT00824408|560668308|FG003|Run-in Phase|Other reason not defined above|0|||
155072778|NCT00308685|559695049|FG001|Overall Study|Lost to Follow-up|0|||
155072779|NCT00308685|559695048|FG000|Overall Study|Need to administer prohibited medication|1|||
154962427|NCT04493684|559287975|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962428|NCT04493684|559287976|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962429|NCT04493684|559287977|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962430|NCT04493684|559287978|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962431|NCT04493684|559287979|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962432|NCT04493684|559287980|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962433|NCT04493684|559287981|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962434|NCT04493684|559287982|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
154962435|NCT04493684|559287966|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
154962436|NCT04493684|559287967|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962437|NCT04493684|559287968|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962438|NCT04493684|559287969|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962439|NCT04493684|559287970|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962440|NCT04493684|559287971|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962441|NCT04493684|559287972|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962442|NCT04493684|559287973|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962443|NCT04493684|559287974|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962444|NCT04493684|559287975|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962445|NCT04493684|559287976|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962446|NCT04493684|559287977|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962447|NCT04493684|559287978|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962448|NCT04493684|559287979|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962449|NCT04493684|559287980|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
155072780|NCT00308685|559695049|FG001|Overall Study|Need to administer prohibited medication|2|||
155072781|NCT00308685|559695048|FG000|Overall Study|Other than specified|1|||
155072782|NCT00308685|559695049|FG001|Overall Study|Other than specified|3|||
155072783|NCT04937387|559695050|FG000|Overall Study|Adverse Event|1|||
155072784|NCT04937387|559695051|FG001|Overall Study|Adverse Event|0|||
154962450|NCT04493684|559287981|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962451|NCT04493684|559287982|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
154962452|NCT04493684|559287966|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962453|NCT04493684|559287967|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962454|NCT04493684|559287968|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962455|NCT04493684|559287969|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962456|NCT04493684|559287970|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155072785|NCT04937387|559695052|FG002|Overall Study|Adverse Event|2|||
155072786|NCT04937387|559695053|FG003|Overall Study|Adverse Event|0|||
155072787|NCT04937387|559695050|FG000|Overall Study|Lack of Efficacy|1|||
155072788|NCT04937387|559695051|FG001|Overall Study|Lack of Efficacy|0|||
154962457|NCT04493684|559287971|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962458|NCT04493684|559287972|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
155337000|NCT00824408|560668309|FG004|Run-in Phase|Other reason not defined above|0|||
155337001|NCT00824408|560668305|FG000|Randomized Phase|Not treated|0|||
155337002|NCT00824408|560668306|FG001|Randomized Phase|Not treated|0|||
155337003|NCT00824408|560668307|FG002|Randomized Phase|Not treated|1|||
155072789|NCT04937387|559695052|FG002|Overall Study|Lack of Efficacy|0|||
155337004|NCT00824408|560668308|FG003|Randomized Phase|Not treated|1|||
155337005|NCT00824408|560668309|FG004|Randomized Phase|Not treated|1|||
155337006|NCT00824408|560668305|FG000|Randomized Phase|Progressive disease|0|||
155337007|NCT00824408|560668306|FG001|Randomized Phase|Progressive disease|0|||
155337008|NCT00824408|560668307|FG002|Randomized Phase|Progressive disease|25|||
155337009|NCT00824408|560668308|FG003|Randomized Phase|Progressive disease|36|||
155337010|NCT00824408|560668309|FG004|Randomized Phase|Progressive disease|34|||
155337011|NCT00824408|560668305|FG000|Randomized Phase|Adverse Event|0|||
155337012|NCT00824408|560668306|FG001|Randomized Phase|Adverse Event|0|||
155337013|NCT00824408|560668307|FG002|Randomized Phase|Adverse Event|4|||
155337014|NCT00824408|560668308|FG003|Randomized Phase|Adverse Event|5|||
155337015|NCT00824408|560668309|FG004|Randomized Phase|Adverse Event|5|||
155337016|NCT00824408|560668305|FG000|Randomized Phase|Refused to continue medication|0|||
155337017|NCT00824408|560668306|FG001|Randomized Phase|Refused to continue medication|0|||
155337018|NCT00824408|560668307|FG002|Randomized Phase|Refused to continue medication|2|||
155337019|NCT00824408|560668308|FG003|Randomized Phase|Refused to continue medication|2|||
155337020|NCT00824408|560668309|FG004|Randomized Phase|Refused to continue medication|2|||
155337021|NCT00824408|560668305|FG000|Randomized Phase|Other reason not defined above|0|||
155337022|NCT00824408|560668306|FG001|Randomized Phase|Other reason not defined above|0|||
155337023|NCT00824408|560668307|FG002|Randomized Phase|Other reason not defined above|4|||
155337024|NCT00824408|560668308|FG003|Randomized Phase|Other reason not defined above|2|||
155337025|NCT00824408|560668309|FG004|Randomized Phase|Other reason not defined above|4|||
155337026|NCT01218594|560668312|FG000|Overall Study|Death|1|||
155337027|NCT01218594|560668312|FG000|Overall Study|Withdrawal by Subject|3|||
155337028|NCT01218594|560668312|FG000|Overall Study|Adverse Event|2|||
155337029|NCT01218594|560668312|FG000|Overall Study|Physician Decision|6|||
155337030|NCT04602728|560668315|FG000|Overall Study|Lost to Follow-up|4|||
155337031|NCT04602728|560668316|FG001|Overall Study|Lost to Follow-up|4|||
155337032|NCT04181788|560668317|FG000|TREATMENT|Adverse Event|0|||
155337033|NCT04181788|560668318|FG001|TREATMENT|Adverse Event|2|||
155337034|NCT04181788|560668319|FG002|TREATMENT|Adverse Event|1|||
155337035|NCT04181788|560668320|FG003|TREATMENT|Adverse Event|0|||
155337036|NCT04181788|560668321|FG004|TREATMENT|Adverse Event|1|||
155337037|NCT04181788|560668322|FG005|TREATMENT|Adverse Event|3|||
155337038|NCT04181788|560668317|FG000|TREATMENT|Death|0|||
155337039|NCT04181788|560668318|FG001|TREATMENT|Death|0|||
155337040|NCT04181788|560668319|FG002|TREATMENT|Death|0|||
155337041|NCT04181788|560668320|FG003|TREATMENT|Death|0|||
155337042|NCT04181788|560668321|FG004|TREATMENT|Death|8|||
155337043|NCT04181788|560668322|FG005|TREATMENT|Death|8|||
155337044|NCT04181788|560668317|FG000|TREATMENT|Physician Decision|0|||
155337045|NCT04181788|560668318|FG001|TREATMENT|Physician Decision|0|||
155337046|NCT04181788|560668319|FG002|TREATMENT|Physician Decision|0|||
155337047|NCT04181788|560668320|FG003|TREATMENT|Physician Decision|0|||
155337048|NCT04181788|560668321|FG004|TREATMENT|Physician Decision|0|||
155337049|NCT04181788|560668322|FG005|TREATMENT|Physician Decision|1|||
155337050|NCT04181788|560668317|FG000|TREATMENT|Progressive disease|3|||
155337051|NCT04181788|560668318|FG001|TREATMENT|Progressive disease|3|||
155337052|NCT04181788|560668319|FG002|TREATMENT|Progressive disease|5|||
155337053|NCT04181788|560668320|FG003|TREATMENT|Progressive disease|7|||
155337054|NCT04181788|560668321|FG004|TREATMENT|Progressive disease|20|||
155337055|NCT04181788|560668322|FG005|TREATMENT|Progressive disease|38|||
154962459|NCT04493684|559287973|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962460|NCT04493684|559287974|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962461|NCT04493684|559287975|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155337056|NCT04181788|560668317|FG000|TREATMENT|Global deterioration of health status|0|||
155337057|NCT04181788|560668318|FG001|TREATMENT|Global deterioration of health status|2|||
155337058|NCT04181788|560668319|FG002|TREATMENT|Global deterioration of health status|0|||
155337059|NCT04181788|560668320|FG003|TREATMENT|Global deterioration of health status|0|||
155337060|NCT04181788|560668321|FG004|TREATMENT|Global deterioration of health status|2|||
155337061|NCT04181788|560668322|FG005|TREATMENT|Global deterioration of health status|8|||
154962462|NCT04493684|559287976|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962463|NCT04493684|559287977|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962464|NCT04493684|559287978|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962465|NCT04493684|559287979|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962466|NCT04493684|559287980|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155337062|NCT04181788|560668317|FG000|TREATMENT|Withdrawal by Subject|1|||
155337063|NCT04181788|560668318|FG001|TREATMENT|Withdrawal by Subject|2|||
155337064|NCT04181788|560668319|FG002|TREATMENT|Withdrawal by Subject|0|||
155337065|NCT04181788|560668320|FG003|TREATMENT|Withdrawal by Subject|0|||
155337066|NCT04181788|560668321|FG004|TREATMENT|Withdrawal by Subject|3|||
155337067|NCT04181788|560668322|FG005|TREATMENT|Withdrawal by Subject|5|||
155337068|NCT04181788|560668317|FG000|TREATMENT|Other unspecified|0|||
155337069|NCT04181788|560668318|FG001|TREATMENT|Other unspecified|0|||
155337070|NCT04181788|560668319|FG002|TREATMENT|Other unspecified|0|||
155337071|NCT04181788|560668320|FG003|TREATMENT|Other unspecified|0|||
155337072|NCT04181788|560668321|FG004|TREATMENT|Other unspecified|0|||
155337073|NCT04181788|560668322|FG005|TREATMENT|Other unspecified|2|||
155337074|NCT04181788|560668317|FG000|TREATMENT|Ongoing|0|||
155337075|NCT04181788|560668318|FG001|TREATMENT|Ongoing|3|||
155337076|NCT04181788|560668319|FG002|TREATMENT|Ongoing|0|||
155337077|NCT04181788|560668320|FG003|TREATMENT|Ongoing|5|||
155337078|NCT04181788|560668321|FG004|TREATMENT|Ongoing|7|||
155337079|NCT04181788|560668322|FG005|TREATMENT|Ongoing|15|||
155337080|NCT04181788|560668317|FG000|FOLLOW-UP|Death|0|||
155337081|NCT04181788|560668318|FG001|FOLLOW-UP|Death|0|||
155337082|NCT04181788|560668319|FG002|FOLLOW-UP|Death|1|||
155337083|NCT04181788|560668320|FG003|FOLLOW-UP|Death|2|||
155337084|NCT04181788|560668321|FG004|FOLLOW-UP|Death|8|||
155337085|NCT04181788|560668322|FG005|FOLLOW-UP|Death|20|||
155337086|NCT04181788|560668317|FG000|FOLLOW-UP|Lost to Follow-up|0|||
155337087|NCT04181788|560668318|FG001|FOLLOW-UP|Lost to Follow-up|0|||
155337088|NCT04181788|560668319|FG002|FOLLOW-UP|Lost to Follow-up|0|||
155337089|NCT04181788|560668320|FG003|FOLLOW-UP|Lost to Follow-up|0|||
155337090|NCT04181788|560668321|FG004|FOLLOW-UP|Lost to Follow-up|0|||
155337091|NCT04181788|560668322|FG005|FOLLOW-UP|Lost to Follow-up|2|||
155337092|NCT04181788|560668317|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
155337093|NCT04181788|560668318|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
155337094|NCT04181788|560668319|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
155337095|NCT04181788|560668320|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
155337096|NCT04181788|560668321|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
155337097|NCT04181788|560668322|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
155337098|NCT04181788|560668317|FG000|FOLLOW-UP|Other unspecified|0|||
155337099|NCT04181788|560668318|FG001|FOLLOW-UP|Other unspecified|1|||
155337100|NCT04181788|560668319|FG002|FOLLOW-UP|Other unspecified|0|||
155337101|NCT04181788|560668320|FG003|FOLLOW-UP|Other unspecified|0|||
155337102|NCT04181788|560668321|FG004|FOLLOW-UP|Other unspecified|0|||
155337103|NCT04181788|560668322|FG005|FOLLOW-UP|Other unspecified|3|||
155337104|NCT04181788|560668317|FG000|FOLLOW-UP|Ongoing|0|||
155337105|NCT04181788|560668318|FG001|FOLLOW-UP|Ongoing|0|||
155337106|NCT04181788|560668319|FG002|FOLLOW-UP|Ongoing|1|||
155337107|NCT04181788|560668320|FG003|FOLLOW-UP|Ongoing|3|||
155337108|NCT04181788|560668321|FG004|FOLLOW-UP|Ongoing|2|||
155337109|NCT04181788|560668322|FG005|FOLLOW-UP|Ongoing|2|||
155337110|NCT04535414|560668323|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
155337111|NCT04535414|560668324|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
155337112|NCT04535414|560668323|FG000|Overall Study|Cancelled appointment|1|||
155337113|NCT04535414|560668324|FG001|Overall Study|Cancelled appointment|0|||
155337114|NCT04535414|560668323|FG000|Overall Study|cancelled - food in stomach|2|||
155337115|NCT04535414|560668324|FG001|Overall Study|cancelled - food in stomach|0|||
155337116|NCT04535414|560668323|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
155337117|NCT04535414|560668324|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
155337118|NCT04535414|560668323|FG000|Overall Study|Withdrawal by Subject|0|||
155337119|NCT04535414|560668324|FG001|Overall Study|Withdrawal by Subject|1|||
155337120|NCT04186247|560668325|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
155337121|NCT04186247|560668326|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337122|NCT04186247|560668327|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337123|NCT04186247|560668328|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337124|NCT04186247|560668329|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
155337125|NCT03662659|560668330|FG000|Pre-treatment|Participant no longer met study criteria|1|||
155337126|NCT03662659|560668331|FG001|Pre-treatment|Participant no longer met study criteria|1|||
155337127|NCT03662659|560668330|FG000|Pre-treatment|Other reasons|1|||
155337128|NCT03662659|560668331|FG001|Pre-treatment|Other reasons|0|||
155337129|NCT03662659|560668330|FG000|Treatment|Completed Treatment|0|||
155337130|NCT03662659|560668331|FG001|Treatment|Completed Treatment|2|||
155337131|NCT03662659|560668330|FG000|Treatment|Disease Progression|85|||
155337132|NCT03662659|560668331|FG001|Treatment|Disease Progression|97|||
155337133|NCT03662659|560668330|FG000|Treatment|Study Drug Toxicity|19|||
155337134|NCT03662659|560668331|FG001|Treatment|Study Drug Toxicity|9|||
155337135|NCT03662659|560668330|FG000|Treatment|Death|11|||
155337136|NCT03662659|560668331|FG001|Treatment|Death|9|||
155337137|NCT03662659|560668330|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
155337138|NCT03662659|560668331|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
155337139|NCT03662659|560668330|FG000|Treatment|Withdrawal by Subject|1|||
155337140|NCT03662659|560668331|FG001|Treatment|Withdrawal by Subject|1|||
155337141|NCT03662659|560668330|FG000|Treatment|Poor/Non-compliance|1|||
155337142|NCT03662659|560668331|FG001|Treatment|Poor/Non-compliance|0|||
155337143|NCT03662659|560668330|FG000|Treatment|Participant no longer meets study criteria|1|||
155337144|NCT03662659|560668331|FG001|Treatment|Participant no longer meets study criteria|0|||
155337145|NCT03662659|560668330|FG000|Treatment|Other reasons|10|||
155337146|NCT03662659|560668331|FG001|Treatment|Other reasons|8|||
155337147|NCT03662659|560668330|FG000|Treatment|Administrative reasons by sponsor|1|||
155337148|NCT03662659|560668331|FG001|Treatment|Administrative reasons by sponsor|0|||
155337149|NCT03662659|560668330|FG000|Treatment|maximum clinical benefit|0|||
155337150|NCT03662659|560668331|FG001|Treatment|maximum clinical benefit|2|||
155337151|NCT04369664|560670642|FG000|Overall Study|Physician Decision|1|||
155337152|NCT04369664|560670643|FG001|Overall Study|Physician Decision|0|||
155337153|NCT01668355|560670646|FG000|Overall Study|Death|3|||
155337154|NCT01668355|560670647|FG001|Overall Study|Death|1|||
155337155|NCT01668355|560670646|FG000|Overall Study|Withdrawal by Subject|6|||
155337156|NCT01668355|560670647|FG001|Overall Study|Withdrawal by Subject|1|||
155337157|NCT00535626|560670648|FG000|Overall Study|Death|15|||
155337158|NCT00535626|560670648|FG000|Overall Study|Lost to Follow-up|29|||
155337159|NCT00535626|560670648|FG000|Overall Study|Withdrawal by Subject|20|||
155337160|NCT00535626|560670648|FG000|Overall Study|Removal/revision of study component|8|||
155337161|NCT00535626|560670648|FG000|Overall Study|Subject terminated|31|||
155337162|NCT00535626|560670648|FG000|Overall Study|Unable to return|2|||
155337163|NCT02830893|560670649|FG000|Overall Study|Relocation to out of the country|1|||
155337164|NCT02830893|560670650|FG001|Overall Study|Relocation to out of the country|0|||
155337165|NCT02830893|560670649|FG000|Overall Study|Lost to Follow-up|0|||
155337166|NCT02830893|560670650|FG001|Overall Study|Lost to Follow-up|2|||
155337167|NCT02830893|560670649|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
155337168|NCT02830893|560670650|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
155337169|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
155337170|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
155337171|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
155337172|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
155337173|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
155337174|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
155337175|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
155337176|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
155337177|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
155337178|NCT01277302|560670651|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
155337179|NCT01277302|560670652|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
155337180|NCT01277302|560670653|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
155337181|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
155337182|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
155337183|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
155337184|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
155337185|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
155337186|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
155337187|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
155337188|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
155337189|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
155337190|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
155337191|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
155337192|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
155337193|NCT01277302|560670651|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
155337194|NCT01277302|560670652|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
155337195|NCT01277302|560670653|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
155337196|NCT02710669|560670654|FG000|Overall Study|Physician Decision|2|||
155337197|NCT02710669|560670655|FG001|Overall Study|Physician Decision|1|||
155337198|NCT02710669|560670656|FG002|Overall Study|Physician Decision|0|||
155337199|NCT02710669|560670654|FG000|Overall Study|Institutional delays (including COVID)|2|||
155337200|NCT02710669|560670655|FG001|Overall Study|Institutional delays (including COVID)|2|||
155337201|NCT02710669|560670656|FG002|Overall Study|Institutional delays (including COVID)|0|||
155337202|NCT02710669|560670654|FG000|Overall Study|arrived in afib/aflutter|10|||
155337203|NCT02710669|560670655|FG001|Overall Study|arrived in afib/aflutter|8|||
155337204|NCT02710669|560670656|FG002|Overall Study|arrived in afib/aflutter|2|||
155337205|NCT01567852|560670659|FG000|Overall Study|Withdrawal by Subject|3|||
155337206|NCT01567852|560670660|FG001|Overall Study|Withdrawal by Subject|6|||
155337207|NCT01567852|560670659|FG000|Overall Study|ECT discontinued|1|||
155337208|NCT01567852|560670660|FG001|Overall Study|ECT discontinued|1|||
155337209|NCT03332589|560670661|FG000|Overall Study|Lack of Efficacy|2|||
155337210|NCT03332589|560670662|FG001|Overall Study|Lack of Efficacy|0|||
155337211|NCT03332589|560670663|FG002|Overall Study|Lack of Efficacy|0|||
155337212|NCT03332589|560670661|FG000|Overall Study|Adverse Event|1|||
155337213|NCT03332589|560670662|FG001|Overall Study|Adverse Event|0|||
155337214|NCT03332589|560670663|FG002|Overall Study|Adverse Event|0|||
155337215|NCT03332589|560670661|FG000|Overall Study|Death|1|||
155337216|NCT03332589|560670662|FG001|Overall Study|Death|0|||
154962467|NCT04493684|559287981|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
155072790|NCT04937387|559695053|FG003|Overall Study|Lack of Efficacy|1|||
155337217|NCT03332589|560670663|FG002|Overall Study|Death|0|||
155337218|NCT04633200|560670664|FG000|Overall Study|Lost to Follow-up|3|||
155337219|NCT04633200|560670665|FG001|Overall Study|Lost to Follow-up|5|||
155337220|NCT03690219|560670666|FG000|Overall Study|no injuries|9|||
155337221|NCT03690219|560670667|FG001|Overall Study|no injuries|20|||
155337222|NCT03690219|560670666|FG000|Overall Study|missing information|7|||
155337223|NCT03690219|560670667|FG001|Overall Study|missing information|7|||
155337224|NCT01523392|560670668|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155337225|NCT01523392|560670669|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155337226|NCT01523392|560670668|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
155337227|NCT01523392|560670669|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
155337228|NCT01523392|560670668|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
155337229|NCT01523392|560670669|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
155337230|NCT04809623|560670670|FG000|Overall Study|Study Terminated by Sponsor|1|||
155337231|NCT04809623|560670671|FG001|Overall Study|Study Terminated by Sponsor|0|||
155337232|NCT02002689|560670672|FG000|Overall Study|Disease Progression|7|||
155337233|NCT02002689|560670672|FG000|Overall Study|Adverse Event|3|||
155337234|NCT02354417|560670673|FG000|Overall Study|Physician Decision|1|||
155337235|NCT02092285|560670674|FG000|Induction Phase|Adverse Event|7|||
155337236|NCT02092285|560670674|FG000|Induction Phase|Physician Decision|4|||
155337237|NCT02092285|560670674|FG000|Induction Phase|Pregnancy|1|||
155337238|NCT02092285|560670674|FG000|Induction Phase|Relapse/Recurrence|7|||
155337239|NCT02092285|560670674|FG000|Induction Phase|Withdrawal by Subject|2|||
155337240|NCT02092285|560670674|FG000|Induction Phase|Lack of Efficacy|14|||
155337241|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
155337242|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
155337243|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
155337244|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
155337245|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
155337246|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
155337247|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
155337248|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
155337249|NCT02092285|560670674|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
155337250|NCT00087516|560670675|FG000|Overall Study|Adverse Event|10|||
155337251|NCT00087516|560670676|FG001|Overall Study|Adverse Event|10|||
155337252|NCT00087516|560670677|FG002|Overall Study|Adverse Event|3|||
155337253|NCT00087516|560670678|FG003|Overall Study|Adverse Event|6|||
155337254|NCT00087516|560670675|FG000|Overall Study|Lack of Efficacy|82|||
155337255|NCT00087516|560670676|FG001|Overall Study|Lack of Efficacy|80|||
155337256|NCT00087516|560670677|FG002|Overall Study|Lack of Efficacy|39|||
155337257|NCT00087516|560670678|FG003|Overall Study|Lack of Efficacy|29|||
155337258|NCT00087516|560670675|FG000|Overall Study|Lost to Follow-up|8|||
155337259|NCT00087516|560670676|FG001|Overall Study|Lost to Follow-up|6|||
155337260|NCT00087516|560670677|FG002|Overall Study|Lost to Follow-up|5|||
155337261|NCT00087516|560670678|FG003|Overall Study|Lost to Follow-up|5|||
155337262|NCT00087516|560670675|FG000|Overall Study|Protocol Violation|4|||
155337263|NCT00087516|560670676|FG001|Overall Study|Protocol Violation|8|||
155337264|NCT00087516|560670677|FG002|Overall Study|Protocol Violation|3|||
155337265|NCT00087516|560670678|FG003|Overall Study|Protocol Violation|6|||
155337266|NCT00087516|560670675|FG000|Overall Study|Withdrawal by Subject|16|||
155337267|NCT00087516|560670676|FG001|Overall Study|Withdrawal by Subject|27|||
155337268|NCT00087516|560670677|FG002|Overall Study|Withdrawal by Subject|11|||
155337269|NCT00087516|560670678|FG003|Overall Study|Withdrawal by Subject|12|||
155337270|NCT00087516|560670675|FG000|Overall Study|Site terminated|0|||
155337271|NCT00087516|560670676|FG001|Overall Study|Site terminated|2|||
155337272|NCT00087516|560670677|FG002|Overall Study|Site terminated|1|||
155337273|NCT00087516|560670678|FG003|Overall Study|Site terminated|0|||
155337274|NCT00087516|560670675|FG000|Overall Study|Protocol specified discontinuation|35|||
155337275|NCT00087516|560670676|FG001|Overall Study|Protocol specified discontinuation|33|||
155337276|NCT00087516|560670677|FG002|Overall Study|Protocol specified discontinuation|33|||
155337277|NCT00087516|560670678|FG003|Overall Study|Protocol specified discontinuation|26|||
155337278|NCT00087516|560670675|FG000|Overall Study|Patient moved|3|||
155337279|NCT00087516|560670676|FG001|Overall Study|Patient moved|2|||
155337280|NCT00087516|560670677|FG002|Overall Study|Patient moved|1|||
155337281|NCT00087516|560670678|FG003|Overall Study|Patient moved|0|||
155337282|NCT00087516|560670675|FG000|Overall Study|Patient was non-compliant|3|||
155337283|NCT00087516|560670676|FG001|Overall Study|Patient was non-compliant|1|||
155337284|NCT00087516|560670677|FG002|Overall Study|Patient was non-compliant|0|||
155337285|NCT00087516|560670678|FG003|Overall Study|Patient was non-compliant|0|||
155337286|NCT00087516|560670675|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
155337287|NCT00087516|560670676|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
155337288|NCT00087516|560670677|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
154962468|NCT04493684|559287982|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
154962469|NCT04493684|559287966|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
154962470|NCT04493684|559287967|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962471|NCT04493684|559287968|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155337289|NCT00087516|560670678|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
155337290|NCT00087516|560670675|FG000|Overall Study|Other|0|||
155337291|NCT00087516|560670676|FG001|Overall Study|Other|0|||
155337292|NCT00087516|560670677|FG002|Overall Study|Other|1|||
155337293|NCT00087516|560670678|FG003|Overall Study|Other|0|||
155337294|NCT01719172|560670679|FG000|Overall Study|Lost to Follow-up|1|||
155337295|NCT01719172|560670679|FG000|Overall Study|Death|1|||
155337296|NCT02236611|560670682|FG000|Overall Study|Adverse Event|10|||
155337297|NCT02236611|560670683|FG001|Overall Study|Adverse Event|16|||
155337298|NCT02236611|560670682|FG000|Overall Study|Lack of Efficacy|4|||
155337299|NCT02236611|560670683|FG001|Overall Study|Lack of Efficacy|7|||
155337300|NCT02236611|560670682|FG000|Overall Study|Lost to Follow-up|0|||
155337301|NCT02236611|560670683|FG001|Overall Study|Lost to Follow-up|2|||
155337302|NCT02236611|560670682|FG000|Overall Study|Protocol deviation|3|||
155337303|NCT02236611|560670683|FG001|Overall Study|Protocol deviation|5|||
155337304|NCT02236611|560670682|FG000|Overall Study|Withdrew consent|9|||
155337305|NCT02236611|560670683|FG001|Overall Study|Withdrew consent|4|||
155337306|NCT01332266|560670684|FG000|Phase 1b|Death|3|||
155337307|NCT01332266|560670685|FG001|Phase 1b|Death|3|||
155337308|NCT01332266|560670686|FG002|Phase 1b|Death|2|||
155337309|NCT01332266|560670687|FG003|Phase 1b|Death|0|||
155337310|NCT01332266|560670688|FG004|Phase 1b|Death|0|||
155337311|NCT01332266|560670684|FG000|Phase 1b|Lost to Follow-up|0|||
155337312|NCT01332266|560670685|FG001|Phase 1b|Lost to Follow-up|1|||
155337313|NCT01332266|560670686|FG002|Phase 1b|Lost to Follow-up|0|||
155337314|NCT01332266|560670687|FG003|Phase 1b|Lost to Follow-up|0|||
155337315|NCT01332266|560670688|FG004|Phase 1b|Lost to Follow-up|0|||
155337316|NCT01332266|560670684|FG000|Phase 1b|Withdrawal by Subject|1|||
155337317|NCT01332266|560670685|FG001|Phase 1b|Withdrawal by Subject|1|||
155337318|NCT01332266|560670686|FG002|Phase 1b|Withdrawal by Subject|1|||
155337319|NCT01332266|560670687|FG003|Phase 1b|Withdrawal by Subject|0|||
155337320|NCT01332266|560670688|FG004|Phase 1b|Withdrawal by Subject|0|||
155337321|NCT01332266|560670684|FG000|Phase 2|Death|0|||
155337322|NCT01332266|560670685|FG001|Phase 2|Death|0|||
155337323|NCT01332266|560670686|FG002|Phase 2|Death|0|||
155337324|NCT01332266|560670687|FG003|Phase 2|Death|33|||
155337325|NCT01332266|560670688|FG004|Phase 2|Death|36|||
155337326|NCT01332266|560670684|FG000|Phase 2|Lost to Follow-up|0|||
155337327|NCT01332266|560670685|FG001|Phase 2|Lost to Follow-up|0|||
155337328|NCT01332266|560670686|FG002|Phase 2|Lost to Follow-up|0|||
155337329|NCT01332266|560670687|FG003|Phase 2|Lost to Follow-up|2|||
154962472|NCT04493684|559287969|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962473|NCT04493684|559287970|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962474|NCT04493684|559287971|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962475|NCT04493684|559287972|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155337330|NCT01332266|560670688|FG004|Phase 2|Lost to Follow-up|0|||
155337331|NCT01332266|560670684|FG000|Phase 2|Physician Decision|0|||
155337332|NCT01332266|560670685|FG001|Phase 2|Physician Decision|0|||
155337333|NCT01332266|560670686|FG002|Phase 2|Physician Decision|0|||
155337334|NCT01332266|560670687|FG003|Phase 2|Physician Decision|3|||
155337335|NCT01332266|560670688|FG004|Phase 2|Physician Decision|1|||
155337336|NCT01332266|560670684|FG000|Phase 2|Symptomatic deterioration|0|||
155337337|NCT01332266|560670685|FG001|Phase 2|Symptomatic deterioration|0|||
155337338|NCT01332266|560670686|FG002|Phase 2|Symptomatic deterioration|0|||
155337339|NCT01332266|560670687|FG003|Phase 2|Symptomatic deterioration|0|||
155337340|NCT01332266|560670688|FG004|Phase 2|Symptomatic deterioration|1|||
155337341|NCT01332266|560670684|FG000|Phase 2|Progression Disease|0|||
155337342|NCT01332266|560670685|FG001|Phase 2|Progression Disease|0|||
155337343|NCT01332266|560670686|FG002|Phase 2|Progression Disease|0|||
155337344|NCT01332266|560670687|FG003|Phase 2|Progression Disease|2|||
155337345|NCT01332266|560670688|FG004|Phase 2|Progression Disease|1|||
155337346|NCT01332266|560670684|FG000|Phase 2|Withdrawal by Subject|0|||
155337347|NCT01332266|560670685|FG001|Phase 2|Withdrawal by Subject|0|||
155337348|NCT01332266|560670686|FG002|Phase 2|Withdrawal by Subject|0|||
155337349|NCT01332266|560670687|FG003|Phase 2|Withdrawal by Subject|2|||
155337350|NCT01332266|560670688|FG004|Phase 2|Withdrawal by Subject|2|||
155337351|NCT00486954|560670691|FG000|Pilot Part|Adverse Event|4|||
155337352|NCT00486954|560670692|FG001|Pilot Part|Adverse Event|0|||
155337353|NCT00486954|560670693|FG002|Pilot Part|Adverse Event|5|||
155337354|NCT00486954|560670694|FG003|Pilot Part|Adverse Event|0|||
155337355|NCT00486954|560670695|FG004|Pilot Part|Adverse Event|0|||
155337356|NCT00486954|560670691|FG000|Pilot Part|Disease Progression|2|||
155337357|NCT00486954|560670692|FG001|Pilot Part|Disease Progression|0|||
155337358|NCT00486954|560670693|FG002|Pilot Part|Disease Progression|1|||
155337359|NCT00486954|560670694|FG003|Pilot Part|Disease Progression|0|||
155337360|NCT00486954|560670695|FG004|Pilot Part|Disease Progression|0|||
155337361|NCT00486954|560670691|FG000|Randomized Part|Lost to Follow-up|0|||
155337362|NCT00486954|560670692|FG001|Randomized Part|Lost to Follow-up|0|||
155337363|NCT00486954|560670693|FG002|Randomized Part|Lost to Follow-up|0|||
155337364|NCT00486954|560670694|FG003|Randomized Part|Lost to Follow-up|0|||
155337365|NCT00486954|560670695|FG004|Randomized Part|Lost to Follow-up|1|||
155337366|NCT00486954|560670691|FG000|Randomized Part|Withdrawal by Subject|0|||
155337367|NCT00486954|560670692|FG001|Randomized Part|Withdrawal by Subject|0|||
155337368|NCT00486954|560670693|FG002|Randomized Part|Withdrawal by Subject|0|||
155337369|NCT00486954|560670694|FG003|Randomized Part|Withdrawal by Subject|1|||
155337370|NCT00486954|560670695|FG004|Randomized Part|Withdrawal by Subject|0|||
155337371|NCT00486954|560670691|FG000|Randomized Part|Sponsor Terminated Study|0|||
155337372|NCT00486954|560670692|FG001|Randomized Part|Sponsor Terminated Study|0|||
155337373|NCT00486954|560670693|FG002|Randomized Part|Sponsor Terminated Study|0|||
155337374|NCT00486954|560670694|FG003|Randomized Part|Sponsor Terminated Study|19|||
155337375|NCT00486954|560670695|FG004|Randomized Part|Sponsor Terminated Study|13|||
155337376|NCT03316170|560670698|FG000|Overall Study|Death|1|||
155337377|NCT03316170|560670699|FG001|Overall Study|Death|0|||
155337378|NCT03316170|560670698|FG000|Overall Study|Lost to Follow-up|6|||
155337379|NCT03316170|560670699|FG001|Overall Study|Lost to Follow-up|7|||
155337380|NCT02935673|560670700|FG000|Overall Study|Adverse Event|0|||
155337381|NCT02935673|560670701|FG001|Overall Study|Adverse Event|1|||
155337382|NCT02935673|560670702|FG002|Overall Study|Adverse Event|0|||
155337383|NCT02935673|560670700|FG000|Overall Study|Withdrawal by Subject|1|||
155337384|NCT02935673|560670701|FG001|Overall Study|Withdrawal by Subject|2|||
155337385|NCT02935673|560670702|FG002|Overall Study|Withdrawal by Subject|0|||
155337386|NCT01102426|560670706|FG000|Overall Study|Randomized but not treated|4|||
155337387|NCT01102426|560670707|FG001|Overall Study|Randomized but not treated|1|||
155337388|NCT01102426|560670706|FG000|Overall Study|Adverse Events (treatment-related)|15|||
155337389|NCT01102426|560670707|FG001|Overall Study|Adverse Events (treatment-related)|8|||
155337390|NCT01102426|560670706|FG000|Overall Study|Physician Decision|9|||
155337391|NCT01102426|560670707|FG001|Overall Study|Physician Decision|6|||
155337392|NCT01102426|560670706|FG000|Overall Study|Progressive Disease|85|||
155337393|NCT01102426|560670707|FG001|Overall Study|Progressive Disease|44|||
155337394|NCT01102426|560670706|FG000|Overall Study|Adverse Events (unrelated to|9|||
155337395|NCT01102426|560670707|FG001|Overall Study|Adverse Events (unrelated to|1|||
155337396|NCT01102426|560670706|FG000|Overall Study|Patient Refusal|24|||
155337397|NCT01102426|560670707|FG001|Overall Study|Patient Refusal|12|||
155337398|NCT01102426|560670706|FG000|Overall Study|Death (due to adverse events|0|||
155337399|NCT01102426|560670707|FG001|Overall Study|Death (due to adverse events|1|||
155337400|NCT01102426|560670706|FG000|Overall Study|Death (non-related to the study|19|||
155337401|NCT01102426|560670707|FG001|Overall Study|Death (non-related to the study|8|||
155337402|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
155337403|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
155337404|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
155337405|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
155337406|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
155337407|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
155337408|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Adverse Event|6|||
155337409|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Adverse Event|4|||
155337410|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Adverse Event|8|||
155337411|NCT01262456|560670719|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
155337412|NCT01262456|560670720|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
155337413|NCT01262456|560670721|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
155337414|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
155337415|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
155337416|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
155337417|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
155337418|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
155337419|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
155337420|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
155337421|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
155337422|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
155337423|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
155337424|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
155337425|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
155337426|NCT01262456|560670719|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
155337427|NCT01262456|560670720|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
155337428|NCT01262456|560670721|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
155337429|NCT03938272|560670722|FG000|Overall Study|Withdrawal by Subject|1|||
155337430|NCT03938272|560670723|FG001|Overall Study|Withdrawal by Subject|0|||
155337431|NCT03938272|560670722|FG000|Overall Study|Physician Decision|0|||
155337432|NCT03938272|560670723|FG001|Overall Study|Physician Decision|2|||
155337433|NCT03938272|560670722|FG000|Overall Study|Study termination by sponsor|10|||
155337434|NCT03938272|560670723|FG001|Overall Study|Study termination by sponsor|8|||
155337435|NCT04821271|560670731|FG000|Period 1|Withdrawal by Subject|2|||
155337436|NCT04821271|560670732|FG001|Period 1|Withdrawal by Subject|0|||
155337437|NCT02521493|560670736|FG000|Overall Study|Death|3|||
155337438|NCT02521493|560670737|FG001|Overall Study|Death|4|||
155337439|NCT02521493|560670738|FG002|Overall Study|Death|1|||
155337440|NCT02521493|560670736|FG000|Overall Study|Physician Decision|19|||
155337441|NCT02521493|560670737|FG001|Overall Study|Physician Decision|1|||
155337442|NCT02521493|560670738|FG002|Overall Study|Physician Decision|2|||
155337443|NCT02521493|560670736|FG000|Overall Study|Withdrawal by Subject|3|||
155337444|NCT02521493|560670737|FG001|Overall Study|Withdrawal by Subject|0|||
155164090|NCT00606593|560036843|FG008|Overall Study|Administrative/Other|0|||
155164091|NCT00606593|560036844|FG009|Overall Study|Administrative/Other|0|||
155337445|NCT02521493|560670738|FG002|Overall Study|Withdrawal by Subject|0|||
155337446|NCT02521493|560670736|FG000|Overall Study|Ineligible|0|||
155337447|NCT02521493|560670737|FG001|Overall Study|Ineligible|1|||
155337448|NCT02521493|560670738|FG002|Overall Study|Ineligible|0|||
155337449|NCT02521493|560670736|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
155337450|NCT02521493|560670737|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
155337451|NCT02521493|560670738|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
155337452|NCT02521493|560670736|FG000|Overall Study|No MRD result|0|||
155337453|NCT02521493|560670737|FG001|Overall Study|No MRD result|0|||
155337454|NCT02521493|560670738|FG002|Overall Study|No MRD result|4|||
155337455|NCT04083781|560670739|FG000|Main Part|Physician Decision|0|||
155337456|NCT04083781|560670740|FG001|Main Part|Physician Decision|1|||
155337457|NCT04083781|560670741|FG002|Main Part|Physician Decision|2|||
155337458|NCT04083781|560670742|FG003|Main Part|Physician Decision|0|||
155337459|NCT04083781|560670739|FG000|Main Part|Death|1|||
155337460|NCT04083781|560670740|FG001|Main Part|Death|3|||
155337461|NCT04083781|560670741|FG002|Main Part|Death|1|||
155337462|NCT04083781|560670742|FG003|Main Part|Death|0|||
155337463|NCT04083781|560670739|FG000|Main Part|Withdrawal by Subject|5|||
155337464|NCT04083781|560670740|FG001|Main Part|Withdrawal by Subject|2|||
155337465|NCT04083781|560670741|FG002|Main Part|Withdrawal by Subject|3|||
155337466|NCT04083781|560670742|FG003|Main Part|Withdrawal by Subject|7|||
155337467|NCT04083781|560670739|FG000|Extension Part|Physician Decision|0|||
155337468|NCT04083781|560670740|FG001|Extension Part|Physician Decision|0|||
155337469|NCT04083781|560670741|FG002|Extension Part|Physician Decision|0|||
155337470|NCT04083781|560670742|FG003|Extension Part|Physician Decision|1|||
155337471|NCT04083781|560670739|FG000|Extension Part|Death|0|||
155337472|NCT04083781|560670740|FG001|Extension Part|Death|1|||
155337473|NCT04083781|560670741|FG002|Extension Part|Death|0|||
155337474|NCT04083781|560670742|FG003|Extension Part|Death|1|||
155337475|NCT04083781|560670739|FG000|Extension Part|Withdrawal by Subject|0|||
155337476|NCT04083781|560670740|FG001|Extension Part|Withdrawal by Subject|1|||
155337477|NCT04083781|560670741|FG002|Extension Part|Withdrawal by Subject|0|||
155337478|NCT04083781|560670742|FG003|Extension Part|Withdrawal by Subject|0|||
155337479|NCT04083781|560670739|FG000|Extension Part|Ongoing|13|||
155337480|NCT04083781|560670740|FG001|Extension Part|Ongoing|25|||
155337481|NCT04083781|560670741|FG002|Extension Part|Ongoing|15|||
155337482|NCT04083781|560670742|FG003|Extension Part|Ongoing|51|||
155337483|NCT01263496|560670743|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
155337484|NCT01263496|560670744|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337485|NCT01263496|560670745|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
154962476|NCT04493684|559287973|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155337486|NCT01263496|560670746|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337487|NCT01263496|560670747|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337488|NCT01263496|560670748|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337489|NCT01263496|560670749|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337490|NCT01263496|560670750|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337491|NCT01263496|560670751|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
155337492|NCT01263496|560670743|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337493|NCT01263496|560670744|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337494|NCT01263496|560670745|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337495|NCT01263496|560670746|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
155337496|NCT01263496|560670747|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
155337497|NCT01263496|560670748|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337498|NCT01263496|560670749|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337499|NCT01263496|560670750|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337500|NCT01263496|560670751|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155337501|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
155337502|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
155337503|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
155337504|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
155337505|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
155337506|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
155337507|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
155337508|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
155337509|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
155337510|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337511|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
155337512|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337513|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337514|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337515|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337516|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337517|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337518|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
155337519|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337520|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155337521|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155337522|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155337523|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
155337524|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337525|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337526|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155337527|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155337528|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
155337529|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
155337530|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
155337531|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155337532|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
155337533|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155337534|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
154962477|NCT04493684|559287974|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
155337535|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155337536|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155337537|NCT01263496|560670743|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337538|NCT01263496|560670744|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337539|NCT01263496|560670745|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337540|NCT01263496|560670746|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337541|NCT01263496|560670747|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337542|NCT01263496|560670748|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337543|NCT01263496|560670749|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337544|NCT01263496|560670750|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
155337545|NCT01263496|560670751|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155337546|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
155337547|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
155337548|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
155337549|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
155337550|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
155337551|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
155337552|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
155337553|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
155337554|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
155337555|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
155337556|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
155337557|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
155337558|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
155337559|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
155337560|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
155337561|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
155337562|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
155337563|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
155337564|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
155337565|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
155337566|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
155337567|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
155337568|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
155337569|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
155337570|NCT02203032|560670753|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
155337571|NCT02203032|560670754|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
155337572|NCT02203032|560670755|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
155337573|NCT02203032|560670756|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
155337574|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
155337575|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
155337576|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
155337577|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
155337578|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
155337579|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
155337580|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
155337581|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
155337582|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
155337583|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
155337584|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
155337585|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
155337586|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
155337587|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
155337588|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
155337589|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
155337590|NCT02203032|560670753|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
155337591|NCT02203032|560670754|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
155337592|NCT02203032|560670755|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
155337593|NCT02203032|560670756|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
155337594|NCT02241785|560670757|FG000|Overall Study|Sponsor Termination|43|||
155337595|NCT02241785|560670757|FG000|Overall Study|Withdrawal by Subject|1|||
155337596|NCT02241785|560670757|FG000|Overall Study|Lost to Follow-up|2|||
155337597|NCT02241785|560670757|FG000|Overall Study|Adverse Event|1|||
155337598|NCT03905642|560670760|FG000|Overall Study|Withdrawal by Subject|3|||
155337599|NCT03905642|560670760|FG000|Overall Study|Pregnancy|1|||
155337600|NCT03905642|560670760|FG000|Overall Study|Adverse Event|1|||
155337601|NCT03905642|560670760|FG000|Overall Study|Lack of Efficacy|1|||
155072791|NCT04937387|559695050|FG000|Overall Study|Withdrawal by Subject|1|||
155072792|NCT04937387|559695051|FG001|Overall Study|Withdrawal by Subject|0|||
155072793|NCT04937387|559695052|FG002|Overall Study|Withdrawal by Subject|1|||
155072794|NCT04937387|559695053|FG003|Overall Study|Withdrawal by Subject|1|||
155072795|NCT04937387|559695050|FG000|Overall Study|Randomized in error|0|||
155072796|NCT04937387|559695051|FG001|Overall Study|Randomized in error|0|||
155072797|NCT04937387|559695052|FG002|Overall Study|Randomized in error|0|||
155072798|NCT04937387|559695053|FG003|Overall Study|Randomized in error|1|||
155072799|NCT03439839|559696824|FG000|Overall Study|Death|3|||
155072800|NCT03439839|559696825|FG001|Overall Study|Death|0|||
155072801|NCT03298061|559696826|FG000|Overall Study|Adverse Event|3|||
155072802|NCT03298061|559696826|FG000|Overall Study|Lack of Efficacy|6|||
155072803|NCT03298061|559696826|FG000|Overall Study|Protocol Violation|1|||
155072804|NCT03298061|559696826|FG000|Overall Study|Physician Decision|7|||
155072805|NCT03298061|559696826|FG000|Overall Study|Withdrawal by Subject|10|||
155072806|NCT04307394|559696829|FG000|Overall Study|Lost to Follow-up|3|||
155072807|NCT04307394|559696829|FG000|Overall Study|Withdrawal by Subject|2|||
155072808|NCT00416949|559696831|FG000|Overall Study|Patients refused to participate|5|||
155072809|NCT01471574|559696836|FG000|Treatment Period|Lack of Efficacy|12|||
155072810|NCT01471574|559696837|FG001|Treatment Period|Lack of Efficacy|4|||
155072811|NCT01471574|559696838|FG002|Treatment Period|Lack of Efficacy|14|||
155072812|NCT01471574|559696839|FG003|Treatment Period|Lack of Efficacy|1|||
155072813|NCT01471574|559696836|FG000|Treatment Period|Adverse Event|7|||
155072814|NCT01471574|559696837|FG001|Treatment Period|Adverse Event|3|||
155072815|NCT01471574|559696838|FG002|Treatment Period|Adverse Event|6|||
155072816|NCT01471574|559696839|FG003|Treatment Period|Adverse Event|1|||
155072817|NCT01471574|559696836|FG000|Treatment Period|Withdrawal by Subject|5|||
155072818|NCT01471574|559696837|FG001|Treatment Period|Withdrawal by Subject|1|||
155072819|NCT01471574|559696838|FG002|Treatment Period|Withdrawal by Subject|1|||
155072820|NCT01471574|559696839|FG003|Treatment Period|Withdrawal by Subject|0|||
155072821|NCT01471574|559696836|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
155072822|NCT01471574|559696837|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
155072823|NCT01471574|559696838|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
155072824|NCT01471574|559696839|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
155072825|NCT01471574|559696836|FG000|Treatment Period|Lost to Follow-up|1|||
155072826|NCT01471574|559696837|FG001|Treatment Period|Lost to Follow-up|2|||
155072827|NCT01471574|559696838|FG002|Treatment Period|Lost to Follow-up|2|||
155072828|NCT01471574|559696839|FG003|Treatment Period|Lost to Follow-up|0|||
155072829|NCT01471574|559696836|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
155072830|NCT01471574|559696837|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
155072831|NCT01471574|559696838|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
155072832|NCT01471574|559696839|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
155072833|NCT01471574|559696836|FG000|Treatment Period|Other|1|||
155072834|NCT01471574|559696837|FG001|Treatment Period|Other|0|||
155072835|NCT01471574|559696838|FG002|Treatment Period|Other|0|||
155072836|NCT01471574|559696839|FG003|Treatment Period|Other|0|||
155072837|NCT01471574|559696836|FG000|Follow-up Period|Withdrawal by Subject|3|||
155072838|NCT01471574|559696837|FG001|Follow-up Period|Withdrawal by Subject|0|||
155072839|NCT01471574|559696838|FG002|Follow-up Period|Withdrawal by Subject|3|||
155337602|NCT03905642|560670760|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
155337603|NCT05289037|560670763|FG000|Overall Study|Withdrawal by Subject|7|||
155072840|NCT01471574|559696839|FG003|Follow-up Period|Withdrawal by Subject|1|||
155072841|NCT01471574|559696836|FG000|Follow-up Period|Lost to Follow-up|4|||
155072842|NCT01471574|559696837|FG001|Follow-up Period|Lost to Follow-up|1|||
155072843|NCT01471574|559696838|FG002|Follow-up Period|Lost to Follow-up|3|||
155337604|NCT05289037|560670764|FG001|Overall Study|Withdrawal by Subject|0|||
155337605|NCT05289037|560670765|FG002|Overall Study|Withdrawal by Subject|3|||
155337606|NCT05289037|560670766|FG003|Overall Study|Withdrawal by Subject|3|||
155337607|NCT05289037|560670767|FG004|Overall Study|Withdrawal by Subject|1|||
155337608|NCT05289037|560670768|FG005|Overall Study|Withdrawal by Subject|5|||
155337609|NCT05289037|560670769|FG006|Overall Study|Withdrawal by Subject|2|||
155337610|NCT05289037|560670770|FG007|Overall Study|Withdrawal by Subject|1|||
155337611|NCT05289037|560670771|FG008|Overall Study|Withdrawal by Subject|2|||
155337612|NCT05289037|560670772|FG009|Overall Study|Withdrawal by Subject|2|||
155337613|NCT05289037|560670773|FG010|Overall Study|Withdrawal by Subject|1|||
155337614|NCT05289037|560670774|FG011|Overall Study|Withdrawal by Subject|0|||
155337615|NCT05289037|560670775|FG012|Overall Study|Withdrawal by Subject|1|||
155337616|NCT05289037|560670776|FG013|Overall Study|Withdrawal by Subject|2|||
155337617|NCT05289037|560670777|FG014|Overall Study|Withdrawal by Subject|0|||
155337618|NCT05289037|560670778|FG015|Overall Study|Withdrawal by Subject|3|||
155337619|NCT05289037|560670779|FG016|Overall Study|Withdrawal by Subject|3|||
155337620|NCT05289037|560670763|FG000|Overall Study|Lost to Follow-up|1|||
155337621|NCT05289037|560670764|FG001|Overall Study|Lost to Follow-up|4|||
155337622|NCT05289037|560670765|FG002|Overall Study|Lost to Follow-up|3|||
155337623|NCT05289037|560670766|FG003|Overall Study|Lost to Follow-up|3|||
155337624|NCT05289037|560670767|FG004|Overall Study|Lost to Follow-up|3|||
155337625|NCT05289037|560670768|FG005|Overall Study|Lost to Follow-up|2|||
155337626|NCT05289037|560670769|FG006|Overall Study|Lost to Follow-up|3|||
155337627|NCT05289037|560670770|FG007|Overall Study|Lost to Follow-up|2|||
155337628|NCT05289037|560670771|FG008|Overall Study|Lost to Follow-up|2|||
155337629|NCT05289037|560670772|FG009|Overall Study|Lost to Follow-up|1|||
155337630|NCT05289037|560670773|FG010|Overall Study|Lost to Follow-up|3|||
155337631|NCT05289037|560670774|FG011|Overall Study|Lost to Follow-up|4|||
155337632|NCT05289037|560670775|FG012|Overall Study|Lost to Follow-up|2|||
155337633|NCT05289037|560670776|FG013|Overall Study|Lost to Follow-up|7|||
155337634|NCT05289037|560670777|FG014|Overall Study|Lost to Follow-up|4|||
155337635|NCT05289037|560670778|FG015|Overall Study|Lost to Follow-up|6|||
155337636|NCT05289037|560670779|FG016|Overall Study|Lost to Follow-up|4|||
155337637|NCT05289037|560670763|FG000|Overall Study|Death|0|||
155337638|NCT05289037|560670764|FG001|Overall Study|Death|0|||
155337639|NCT05289037|560670765|FG002|Overall Study|Death|0|||
155337640|NCT05289037|560670766|FG003|Overall Study|Death|0|||
155337641|NCT05289037|560670767|FG004|Overall Study|Death|0|||
155337642|NCT05289037|560670768|FG005|Overall Study|Death|1|||
155337643|NCT05289037|560670769|FG006|Overall Study|Death|0|||
155337644|NCT05289037|560670770|FG007|Overall Study|Death|0|||
155337645|NCT05289037|560670771|FG008|Overall Study|Death|0|||
155337646|NCT05289037|560670772|FG009|Overall Study|Death|0|||
155337647|NCT05289037|560670773|FG010|Overall Study|Death|0|||
155337648|NCT05289037|560670774|FG011|Overall Study|Death|0|||
155337649|NCT05289037|560670775|FG012|Overall Study|Death|0|||
155337650|NCT05289037|560670776|FG013|Overall Study|Death|0|||
155337651|NCT05289037|560670777|FG014|Overall Study|Death|1|||
155337652|NCT05289037|560670778|FG015|Overall Study|Death|0|||
155337653|NCT05289037|560670779|FG016|Overall Study|Death|0|||
155337654|NCT05289037|560670763|FG000|Overall Study|Did not receive vaccine|0|||
155337655|NCT05289037|560670764|FG001|Overall Study|Did not receive vaccine|3|||
155072844|NCT01471574|559696839|FG003|Follow-up Period|Lost to Follow-up|2|||
155072845|NCT01471574|559696836|FG000|Follow-up Period|Death|0|||
155072846|NCT01471574|559696837|FG001|Follow-up Period|Death|0|||
155072847|NCT01471574|559696838|FG002|Follow-up Period|Death|1|||
155072848|NCT01471574|559696839|FG003|Follow-up Period|Death|0|||
155072849|NCT01471574|559696836|FG000|Follow-up Period|Follow-up no longer required|0|||
155072850|NCT01471574|559696837|FG001|Follow-up Period|Follow-up no longer required|1|||
155072851|NCT01471574|559696838|FG002|Follow-up Period|Follow-up no longer required|0|||
155072852|NCT01471574|559696839|FG003|Follow-up Period|Follow-up no longer required|0|||
155072853|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
155072854|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
155072855|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
155072856|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
155072857|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
155072858|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
155072859|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
155072860|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
155072861|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
155072862|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
155072863|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
155072864|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
155337656|NCT05289037|560670765|FG002|Overall Study|Did not receive vaccine|0|||
155337657|NCT05289037|560670766|FG003|Overall Study|Did not receive vaccine|0|||
155337658|NCT05289037|560670767|FG004|Overall Study|Did not receive vaccine|1|||
155337659|NCT05289037|560670768|FG005|Overall Study|Did not receive vaccine|1|||
155337660|NCT05289037|560670769|FG006|Overall Study|Did not receive vaccine|1|||
155337661|NCT05289037|560670770|FG007|Overall Study|Did not receive vaccine|0|||
155337662|NCT05289037|560670771|FG008|Overall Study|Did not receive vaccine|0|||
155337663|NCT05289037|560670772|FG009|Overall Study|Did not receive vaccine|0|||
155337664|NCT05289037|560670773|FG010|Overall Study|Did not receive vaccine|0|||
155337665|NCT05289037|560670774|FG011|Overall Study|Did not receive vaccine|0|||
155337666|NCT05289037|560670775|FG012|Overall Study|Did not receive vaccine|0|||
155072865|NCT00447278|559696842|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
155072866|NCT00447278|559696843|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
155072867|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
155072868|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
155337667|NCT05289037|560670776|FG013|Overall Study|Did not receive vaccine|0|||
155337668|NCT05289037|560670777|FG014|Overall Study|Did not receive vaccine|1|||
155337669|NCT05289037|560670778|FG015|Overall Study|Did not receive vaccine|0|||
155337670|NCT05289037|560670779|FG016|Overall Study|Did not receive vaccine|0|||
155337671|NCT05289037|560670763|FG000|Overall Study|Unable to make last visit|0|||
155337672|NCT05289037|560670764|FG001|Overall Study|Unable to make last visit|0|||
155072869|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
155072870|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
155072871|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
155072872|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
155072873|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
155072874|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
155072875|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
155072876|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
155072877|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
155072878|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
155072879|NCT00447278|559696842|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
155337673|NCT05289037|560670765|FG002|Overall Study|Unable to make last visit|1|||
155337674|NCT05289037|560670766|FG003|Overall Study|Unable to make last visit|0|||
155337675|NCT05289037|560670767|FG004|Overall Study|Unable to make last visit|0|||
155337676|NCT05289037|560670768|FG005|Overall Study|Unable to make last visit|0|||
155337677|NCT05289037|560670769|FG006|Overall Study|Unable to make last visit|0|||
155337678|NCT05289037|560670770|FG007|Overall Study|Unable to make last visit|0|||
155337679|NCT05289037|560670771|FG008|Overall Study|Unable to make last visit|0|||
155337680|NCT05289037|560670772|FG009|Overall Study|Unable to make last visit|0|||
155337681|NCT05289037|560670773|FG010|Overall Study|Unable to make last visit|0|||
155337682|NCT05289037|560670774|FG011|Overall Study|Unable to make last visit|0|||
155337683|NCT05289037|560670775|FG012|Overall Study|Unable to make last visit|0|||
155337684|NCT05289037|560670776|FG013|Overall Study|Unable to make last visit|0|||
155337685|NCT05289037|560670777|FG014|Overall Study|Unable to make last visit|0|||
155337686|NCT05289037|560670778|FG015|Overall Study|Unable to make last visit|0|||
155337687|NCT05289037|560670779|FG016|Overall Study|Unable to make last visit|0|||
155337688|NCT05289037|560670763|FG000|Overall Study|Protocol deviation|0|||
155337689|NCT05289037|560670764|FG001|Overall Study|Protocol deviation|0|||
155337690|NCT05289037|560670765|FG002|Overall Study|Protocol deviation|0|||
155072880|NCT00447278|559696843|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
155072881|NCT03927157|559696845|FG000|Overall Study|Adverse Event|1|||
155072882|NCT03927157|559696846|FG001|Overall Study|Adverse Event|3|||
155072883|NCT03927157|559696845|FG000|Overall Study|Protocol Violation|1|||
155072884|NCT03927157|559696846|FG001|Overall Study|Protocol Violation|2|||
155072885|NCT03927157|559696845|FG000|Overall Study|Withdrawal by Subject|8|||
155072886|NCT03927157|559696846|FG001|Overall Study|Withdrawal by Subject|21|||
155072887|NCT03927157|559696845|FG000|Overall Study|Due to COVID-19 pandemic|5|||
155072888|NCT03927157|559696846|FG001|Overall Study|Due to COVID-19 pandemic|2|||
155337691|NCT05289037|560670766|FG003|Overall Study|Protocol deviation|0|||
155337692|NCT05289037|560670767|FG004|Overall Study|Protocol deviation|0|||
155337693|NCT05289037|560670768|FG005|Overall Study|Protocol deviation|0|||
155337694|NCT05289037|560670769|FG006|Overall Study|Protocol deviation|0|||
155072889|NCT03927157|559696845|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
155072890|NCT03927157|559696846|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
155072891|NCT03927157|559696845|FG000|Overall Study|Other than above|0|||
155072892|NCT03927157|559696846|FG001|Overall Study|Other than above|1|||
155072893|NCT06262607|559696847|FG000|Overall Study|Physician Decision|0|||
155072894|NCT06262607|559696848|FG001|Overall Study|Physician Decision|1|||
155072895|NCT06262607|559696847|FG000|Overall Study|Withdrawal by Subject|2|||
155337695|NCT05289037|560670770|FG007|Overall Study|Protocol deviation|0|||
155337696|NCT05289037|560670771|FG008|Overall Study|Protocol deviation|0|||
155337697|NCT05289037|560670772|FG009|Overall Study|Protocol deviation|0|||
155337698|NCT05289037|560670773|FG010|Overall Study|Protocol deviation|0|||
155337699|NCT05289037|560670774|FG011|Overall Study|Protocol deviation|0|||
155337700|NCT05289037|560670775|FG012|Overall Study|Protocol deviation|0|||
155337701|NCT05289037|560670776|FG013|Overall Study|Protocol deviation|0|||
155337702|NCT05289037|560670777|FG014|Overall Study|Protocol deviation|0|||
155337703|NCT05289037|560670778|FG015|Overall Study|Protocol deviation|1|||
155337704|NCT05289037|560670779|FG016|Overall Study|Protocol deviation|0|||
155337705|NCT05995977|560670780|FG000|Overall Study|Withdrawal by Subject|1|||
155337706|NCT05995977|560670781|FG001|Overall Study|Withdrawal by Subject|4|||
155337707|NCT05995977|560670780|FG000|Overall Study|Lost to Follow-up|2|||
155337708|NCT05995977|560670781|FG001|Overall Study|Lost to Follow-up|0|||
155337709|NCT04937504|560670782|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
155337710|NCT04937504|560670783|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
155337711|NCT04937504|560670782|FG000|9 Months Assessment|Lost to Follow-up|3|||
155337712|NCT04937504|560670783|FG001|9 Months Assessment|Lost to Follow-up|2|||
155337713|NCT04852978|560670787|FG000|Overall Study|Physician Decision|0|||
155337714|NCT04852978|560670788|FG001|Overall Study|Physician Decision|1|||
155337715|NCT04852978|560670789|FG002|Overall Study|Physician Decision|0|||
155337716|NCT04852978|560670790|FG003|Overall Study|Physician Decision|0|||
155337717|NCT04852978|560670791|FG004|Overall Study|Physician Decision|0|||
155337718|NCT04852978|560670792|FG005|Overall Study|Physician Decision|0|||
155337719|NCT04852978|560670793|FG006|Overall Study|Physician Decision|0|||
155337720|NCT04852978|560670794|FG007|Overall Study|Physician Decision|2|||
155337721|NCT04852978|560670795|FG008|Overall Study|Physician Decision|0|||
155337722|NCT04852978|560670787|FG000|Overall Study|Sponsor request|0|||
155337723|NCT04852978|560670788|FG001|Overall Study|Sponsor request|0|||
155337724|NCT04852978|560670789|FG002|Overall Study|Sponsor request|1|||
155337725|NCT04852978|560670790|FG003|Overall Study|Sponsor request|0|||
155337726|NCT04852978|560670791|FG004|Overall Study|Sponsor request|0|||
155337727|NCT04852978|560670792|FG005|Overall Study|Sponsor request|0|||
155337728|NCT04852978|560670793|FG006|Overall Study|Sponsor request|0|||
155337729|NCT04852978|560670794|FG007|Overall Study|Sponsor request|0|||
155337730|NCT04852978|560670795|FG008|Overall Study|Sponsor request|0|||
155337731|NCT04852978|560670787|FG000|Overall Study|Death|0|||
155337732|NCT04852978|560670788|FG001|Overall Study|Death|0|||
155337733|NCT04852978|560670789|FG002|Overall Study|Death|0|||
155337734|NCT04852978|560670790|FG003|Overall Study|Death|0|||
155337735|NCT04852978|560670791|FG004|Overall Study|Death|0|||
155337736|NCT04852978|560670792|FG005|Overall Study|Death|0|||
155337737|NCT04852978|560670793|FG006|Overall Study|Death|1|||
155337738|NCT04852978|560670794|FG007|Overall Study|Death|0|||
155337739|NCT04852978|560670795|FG008|Overall Study|Death|0|||
155337740|NCT04852978|560670787|FG000|Overall Study|Lost to Follow-up|3|||
155337741|NCT04852978|560670788|FG001|Overall Study|Lost to Follow-up|2|||
155337742|NCT04852978|560670789|FG002|Overall Study|Lost to Follow-up|2|||
155337743|NCT04852978|560670790|FG003|Overall Study|Lost to Follow-up|0|||
155337744|NCT04852978|560670791|FG004|Overall Study|Lost to Follow-up|2|||
155337745|NCT04852978|560670792|FG005|Overall Study|Lost to Follow-up|4|||
155337746|NCT04852978|560670793|FG006|Overall Study|Lost to Follow-up|1|||
155337747|NCT04852978|560670794|FG007|Overall Study|Lost to Follow-up|2|||
155337748|NCT04852978|560670795|FG008|Overall Study|Lost to Follow-up|2|||
155337749|NCT04852978|560670787|FG000|Overall Study|Withdrawal by Subject|4|||
155337750|NCT04852978|560670788|FG001|Overall Study|Withdrawal by Subject|2|||
155337751|NCT04852978|560670789|FG002|Overall Study|Withdrawal by Subject|2|||
155337752|NCT04852978|560670790|FG003|Overall Study|Withdrawal by Subject|1|||
155337753|NCT04852978|560670791|FG004|Overall Study|Withdrawal by Subject|5|||
155072896|NCT06262607|559696848|FG001|Overall Study|Withdrawal by Subject|0|||
155072897|NCT05950906|559696850|FG000|Overall Study|Adverse Event|0|||
155072898|NCT05950906|559696851|FG001|Overall Study|Adverse Event|0|||
155072899|NCT05950906|559696852|FG002|Overall Study|Adverse Event|0|||
155072900|NCT05950906|559696853|FG003|Overall Study|Adverse Event|0|||
155072901|NCT05950906|559696854|FG004|Overall Study|Adverse Event|0|||
155072902|NCT05950906|559696855|FG005|Overall Study|Adverse Event|0|||
155072903|NCT05950906|559696856|FG006|Overall Study|Adverse Event|0|||
155164092|NCT01724346|560036845|FG000|Overall Study|Death|42|||
155164093|NCT01724346|560036846|FG001|Overall Study|Death|42|||
155164094|NCT01724346|560036845|FG000|Overall Study|Lost to Follow-up|5|||
155164095|NCT01724346|560036846|FG001|Overall Study|Lost to Follow-up|1|||
155164096|NCT01724346|560036845|FG000|Overall Study|Withdrawal by Subject|27|||
155164097|NCT01724346|560036846|FG001|Overall Study|Withdrawal by Subject|19|||
155164098|NCT01724346|560036845|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
155164099|NCT01724346|560036846|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
155164100|NCT01642589|560036847|FG000|Overall Study|Withdrawal by Subject|1|||
155164101|NCT01642589|560036848|FG001|Overall Study|Withdrawal by Subject|1|||
155164102|NCT00759941|560036853|FG000|Overall Study|Use of medication|1|||
155164103|NCT00759941|560036854|FG001|Overall Study|Use of medication|0|||
155164104|NCT00759941|560036853|FG000|Overall Study|Adverse Event|1|||
155164105|NCT00759941|560036854|FG001|Overall Study|Adverse Event|0|||
155164106|NCT00759941|560036853|FG000|Overall Study|Exited in error by site|1|||
155164107|NCT00759941|560036854|FG001|Overall Study|Exited in error by site|1|||
155164108|NCT02736578|560036855|FG000|Overall Study|Adverse Event|1|||
155164109|NCT02736578|560036856|FG001|Overall Study|Adverse Event|0|||
155164110|NCT00802945|560036857|FG000|Overall Study|Death|27|||
155164111|NCT00802945|560036858|FG001|Overall Study|Death|23|||
155164112|NCT00802945|560036857|FG000|Overall Study|Terminated by sponsor|8|||
155164113|NCT00802945|560036858|FG001|Overall Study|Terminated by sponsor|12|||
155164114|NCT05307692|560036859|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
155164115|NCT05307692|560036860|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
155164116|NCT05307692|560036861|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
155164117|NCT05307692|560036862|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
155164118|NCT05307692|560036859|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
155164119|NCT05307692|560036860|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
155164120|NCT05307692|560036861|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
155164121|NCT05307692|560036862|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
155164122|NCT05307692|560036859|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
155164123|NCT05307692|560036860|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
155164124|NCT05307692|560036861|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
155164125|NCT05307692|560036862|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
155164126|NCT05307692|560036859|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
155072904|NCT05950906|559696857|FG007|Overall Study|Adverse Event|0|||
155072905|NCT05950906|559696858|FG008|Overall Study|Adverse Event|0|||
155164127|NCT05307692|560036860|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
155164128|NCT05307692|560036861|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
155164129|NCT05307692|560036862|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
155164130|NCT05307692|560036859|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
155164131|NCT05307692|560036860|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
155164132|NCT05307692|560036861|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
155164133|NCT05307692|560036862|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
155164134|NCT05307692|560036859|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
155164135|NCT05307692|560036860|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
155164136|NCT05307692|560036861|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
155164137|NCT05307692|560036862|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
155164138|NCT05307692|560036859|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
155337754|NCT04852978|560670792|FG005|Overall Study|Withdrawal by Subject|3|||
155337755|NCT04852978|560670793|FG006|Overall Study|Withdrawal by Subject|2|||
155337756|NCT04852978|560670794|FG007|Overall Study|Withdrawal by Subject|2|||
155337757|NCT04852978|560670795|FG008|Overall Study|Withdrawal by Subject|1|||
155337758|NCT00070707|560672463|FG000|Overall Study|Adverse Event|1|||
155164139|NCT05307692|560036860|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
155164140|NCT05307692|560036861|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
155337759|NCT00070707|560672464|FG001|Overall Study|Adverse Event|2|||
155337760|NCT00070707|560672463|FG000|Overall Study|Lack of Efficacy|4|||
155337761|NCT00070707|560672464|FG001|Overall Study|Lack of Efficacy|1|||
155337762|NCT00070707|560672463|FG000|Overall Study|Protocol Violation|8|||
155337763|NCT00070707|560672464|FG001|Overall Study|Protocol Violation|4|||
155337764|NCT00070707|560672463|FG000|Overall Study|Unrelated to Study Medication|1|||
155337765|NCT00070707|560672464|FG001|Overall Study|Unrelated to Study Medication|0|||
155337766|NCT01808534|560672465|FG000|Overall Study|Disease progression|3|||
155337767|NCT01808534|560672465|FG000|Overall Study|Physician Decision|1|||
155337768|NCT00278395|560672468|FG000|Overall Study|Adverse Event|2|||
155337769|NCT00278395|560672468|FG000|Overall Study|Nonevaluable|1|||
155337770|NCT01148017|560672469|FG000|Overall Study|Withdrawal by Subject|31|||
155337771|NCT01148017|560672470|FG001|Overall Study|Withdrawal by Subject|14|||
155337772|NCT01148017|560672471|FG002|Overall Study|Withdrawal by Subject|0|||
155337773|NCT01148017|560672472|FG003|Overall Study|Withdrawal by Subject|0|||
155337774|NCT01148017|560672469|FG000|Overall Study|Lost to Follow-up|23|||
155337775|NCT01148017|560672470|FG001|Overall Study|Lost to Follow-up|10|||
155337776|NCT01148017|560672471|FG002|Overall Study|Lost to Follow-up|0|||
155337777|NCT01148017|560672472|FG003|Overall Study|Lost to Follow-up|0|||
155337778|NCT01148017|560672469|FG000|Overall Study|Inappropriate enrollment|1|||
155337779|NCT01148017|560672470|FG001|Overall Study|Inappropriate enrollment|0|||
155337780|NCT01148017|560672471|FG002|Overall Study|Inappropriate enrollment|0|||
155337781|NCT01148017|560672472|FG003|Overall Study|Inappropriate enrollment|0|||
155337782|NCT01148017|560672469|FG000|Overall Study|Administrative reason|22|||
155337783|NCT01148017|560672470|FG001|Overall Study|Administrative reason|9|||
155337784|NCT01148017|560672471|FG002|Overall Study|Administrative reason|0|||
155337785|NCT01148017|560672472|FG003|Overall Study|Administrative reason|0|||
155337786|NCT01148017|560672469|FG000|Overall Study|Unable to classify|3|||
155337787|NCT01148017|560672470|FG001|Overall Study|Unable to classify|1|||
155337788|NCT01148017|560672471|FG002|Overall Study|Unable to classify|0|||
155337789|NCT01148017|560672472|FG003|Overall Study|Unable to classify|0|||
155337790|NCT03740737|560672473|FG000|Overall Study|Protocol deviation|13|||
155337791|NCT03740737|560672474|FG001|Overall Study|Protocol deviation|0|||
155337792|NCT03740737|560672473|FG000|Overall Study|Adverse Event|2|||
155337793|NCT03740737|560672474|FG001|Overall Study|Adverse Event|0|||
155337794|NCT03740737|560672473|FG000|Overall Study|Lost to Follow-up|1|||
155337795|NCT03740737|560672474|FG001|Overall Study|Lost to Follow-up|0|||
154962478|NCT04493684|559287975|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962479|NCT04493684|559287976|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962480|NCT04493684|559287977|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962481|NCT04493684|559287978|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962482|NCT04493684|559287979|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962483|NCT04493684|559287980|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962484|NCT04493684|559287981|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962485|NCT04493684|559287982|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
154962486|NCT04493684|559287966|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962487|NCT04493684|559287967|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962488|NCT04493684|559287968|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962489|NCT04493684|559287969|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155337796|NCT03740737|560672473|FG000|Overall Study|Randomization failure|1|||
155164141|NCT05307692|560036862|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
155164142|NCT05307692|560036859|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
155164143|NCT05307692|560036860|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
155164144|NCT05307692|560036861|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
155337797|NCT03740737|560672474|FG001|Overall Study|Randomization failure|0|||
155337798|NCT03740737|560672473|FG000|Overall Study|Participant withdrew consent|1|||
155337799|NCT03740737|560672474|FG001|Overall Study|Participant withdrew consent|0|||
155337800|NCT03740737|560672473|FG000|Overall Study|Participant withdrew from trial|2|||
155337801|NCT03740737|560672474|FG001|Overall Study|Participant withdrew from trial|1|||
155337802|NCT00569166|560672476|FG000|Overall Study|Withdrawal by Subject|7|||
155337803|NCT00569166|560672477|FG001|Overall Study|Withdrawal by Subject|5|||
155337804|NCT00569166|560672478|FG002|Overall Study|Withdrawal by Subject|3|||
155337805|NCT00569166|560672476|FG000|Overall Study|Lost to Follow-up|2|||
155337806|NCT00569166|560672477|FG001|Overall Study|Lost to Follow-up|1|||
155337807|NCT00569166|560672478|FG002|Overall Study|Lost to Follow-up|1|||
155337808|NCT01686152|560672479|FG000|Overall Study|Withdrawal by Subject|11|||
155337809|NCT01686152|560672480|FG001|Overall Study|Withdrawal by Subject|11|||
155337810|NCT01686152|560672481|FG002|Overall Study|Withdrawal by Subject|3|||
155337811|NCT01686152|560672479|FG000|Overall Study|Drug Code Unblinded|0|||
155337812|NCT01686152|560672480|FG001|Overall Study|Drug Code Unblinded|1|||
155337813|NCT01686152|560672481|FG002|Overall Study|Drug Code Unblinded|0|||
155337814|NCT01686152|560672479|FG000|Overall Study|Protocol Violation|6|||
155337815|NCT01686152|560672480|FG001|Overall Study|Protocol Violation|1|||
155337816|NCT01686152|560672481|FG002|Overall Study|Protocol Violation|0|||
155337817|NCT01686152|560672479|FG000|Overall Study|Adverse Event|12|||
155337818|NCT01686152|560672480|FG001|Overall Study|Adverse Event|11|||
155337819|NCT01686152|560672481|FG002|Overall Study|Adverse Event|0|||
155337820|NCT01686152|560672479|FG000|Overall Study|Lack of Efficacy|0|||
155337821|NCT01686152|560672480|FG001|Overall Study|Lack of Efficacy|0|||
155337822|NCT01686152|560672481|FG002|Overall Study|Lack of Efficacy|1|||
155337823|NCT01686152|560672479|FG000|Overall Study|IP Non-compliance|5|||
155337824|NCT01686152|560672480|FG001|Overall Study|IP Non-compliance|5|||
155337825|NCT01686152|560672481|FG002|Overall Study|IP Non-compliance|0|||
155337826|NCT01686152|560672479|FG000|Overall Study|Lost to Follow-up|7|||
155337827|NCT01686152|560672480|FG001|Overall Study|Lost to Follow-up|6|||
155337828|NCT01686152|560672481|FG002|Overall Study|Lost to Follow-up|5|||
155337829|NCT01853384|560672482|FG000|Randomized|Adverse Event|5|||
155337830|NCT01853384|560672483|FG001|Randomized|Adverse Event|3|||
155337831|NCT01853384|560672482|FG000|Randomized|Death|1|||
155337832|NCT01853384|560672483|FG001|Randomized|Death|2|||
155337833|NCT01853384|560672482|FG000|Randomized|Lost to Follow-up|1|||
155337834|NCT01853384|560672483|FG001|Randomized|Lost to Follow-up|1|||
155337835|NCT01853384|560672482|FG000|Randomized|Withdrawal by Subject|5|||
155337836|NCT01853384|560672483|FG001|Randomized|Withdrawal by Subject|3|||
155337837|NCT01853384|560672482|FG000|Randomized|Sponsor Decision|47|||
155337838|NCT01853384|560672483|FG001|Randomized|Sponsor Decision|34|||
155337839|NCT01853384|560672482|FG000|Randomized|Other|3|||
155337840|NCT01853384|560672483|FG001|Randomized|Other|3|||
155337841|NCT01853384|560672482|FG000|Completed Follow up Visit 1|Early Termination|13|||
155337842|NCT01853384|560672483|FG001|Completed Follow up Visit 1|Early Termination|9|||
155337843|NCT01853384|560672482|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
155337844|NCT01853384|560672483|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
155337845|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Adverse Event|1|||
155337846|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Adverse Event|0|||
155337847|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
155337848|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
155337849|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Death|1|||
154962490|NCT04493684|559287970|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962491|NCT04493684|559287971|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
155337850|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Death|0|||
155337851|NCT01853384|560672482|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
155337852|NCT01853384|560672483|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
155337853|NCT00929526|560672484|FG000|Overall Study|Withdrawal by Subject|1|||
155337854|NCT00929526|560672485|FG001|Overall Study|Withdrawal by Subject|11|||
155337855|NCT00929526|560672484|FG000|Overall Study|Lost to Follow-up|8|||
155337856|NCT00929526|560672485|FG001|Overall Study|Lost to Follow-up|12|||
155337857|NCT00929526|560672484|FG000|Overall Study|Other|8|||
155337858|NCT00929526|560672485|FG001|Overall Study|Other|6|||
155337859|NCT02169414|560672488|FG000|Overall Study|Withdrawal by Subject|1|||
155337860|NCT02169414|560672489|FG001|Overall Study|Withdrawal by Subject|0|||
155337861|NCT02169414|560672490|FG002|Overall Study|Withdrawal by Subject|0|||
155337862|NCT02169414|560672491|FG003|Overall Study|Withdrawal by Subject|0|||
155337863|NCT02169414|560672488|FG000|Overall Study|Adverse Event|0|||
155337864|NCT02169414|560672489|FG001|Overall Study|Adverse Event|1|||
155337865|NCT02169414|560672490|FG002|Overall Study|Adverse Event|0|||
155337866|NCT02169414|560672491|FG003|Overall Study|Adverse Event|0|||
155337867|NCT03374254|560672494|FG000|Overall Study|Death|5|||
155337868|NCT03374254|560672495|FG001|Overall Study|Death|16|||
155337869|NCT03374254|560672496|FG002|Overall Study|Death|13|||
155337870|NCT03374254|560672497|FG003|Overall Study|Death|11|||
155337871|NCT03374254|560672498|FG004|Overall Study|Death|9|||
155337872|NCT03374254|560672499|FG005|Overall Study|Death|12|||
155337873|NCT03374254|560672500|FG006|Overall Study|Death|11|||
155337874|NCT03374254|560672501|FG007|Overall Study|Death|6|||
155337875|NCT03374254|560672502|FG008|Overall Study|Death|7|||
155337876|NCT03374254|560672494|FG000|Overall Study|Lost to Follow-up|0|||
155337877|NCT03374254|560672495|FG001|Overall Study|Lost to Follow-up|0|||
155337878|NCT03374254|560672496|FG002|Overall Study|Lost to Follow-up|0|||
155337879|NCT03374254|560672497|FG003|Overall Study|Lost to Follow-up|0|||
155337880|NCT03374254|560672498|FG004|Overall Study|Lost to Follow-up|0|||
155337881|NCT03374254|560672499|FG005|Overall Study|Lost to Follow-up|0|||
155337882|NCT03374254|560672500|FG006|Overall Study|Lost to Follow-up|2|||
155337883|NCT03374254|560672501|FG007|Overall Study|Lost to Follow-up|0|||
155337884|NCT03374254|560672502|FG008|Overall Study|Lost to Follow-up|0|||
155337885|NCT03374254|560672494|FG000|Overall Study|Sponsor Decision|1|||
155337886|NCT03374254|560672495|FG001|Overall Study|Sponsor Decision|0|||
155337887|NCT03374254|560672496|FG002|Overall Study|Sponsor Decision|2|||
155337888|NCT03374254|560672497|FG003|Overall Study|Sponsor Decision|3|||
155337889|NCT03374254|560672498|FG004|Overall Study|Sponsor Decision|2|||
155337890|NCT03374254|560672499|FG005|Overall Study|Sponsor Decision|3|||
155337891|NCT03374254|560672500|FG006|Overall Study|Sponsor Decision|3|||
155337892|NCT03374254|560672501|FG007|Overall Study|Sponsor Decision|3|||
155337893|NCT03374254|560672502|FG008|Overall Study|Sponsor Decision|4|||
155337894|NCT03374254|560672494|FG000|Overall Study|Withdrawal by Subject|0|||
155337895|NCT03374254|560672495|FG001|Overall Study|Withdrawal by Subject|0|||
155337896|NCT03374254|560672496|FG002|Overall Study|Withdrawal by Subject|0|||
155337897|NCT03374254|560672497|FG003|Overall Study|Withdrawal by Subject|2|||
155337898|NCT03374254|560672498|FG004|Overall Study|Withdrawal by Subject|0|||
155337899|NCT03374254|560672499|FG005|Overall Study|Withdrawal by Subject|1|||
155337900|NCT03374254|560672500|FG006|Overall Study|Withdrawal by Subject|0|||
155337901|NCT03374254|560672501|FG007|Overall Study|Withdrawal by Subject|0|||
155337902|NCT03374254|560672502|FG008|Overall Study|Withdrawal by Subject|0|||
155337903|NCT04070105|560672503|FG000|Overall Study|Lost to Follow-up|0|||
155337904|NCT04070105|560672504|FG001|Overall Study|Lost to Follow-up|0|||
155337905|NCT04070105|560672505|FG002|Overall Study|Lost to Follow-up|0|||
155337906|NCT04070105|560672506|FG003|Overall Study|Lost to Follow-up|0|||
155337907|NCT04070105|560672507|FG004|Overall Study|Lost to Follow-up|0|||
155337908|NCT04070105|560672508|FG005|Overall Study|Lost to Follow-up|1|||
155337909|NCT00749944|560672511|FG000|Overall Study|Lost to Follow-up|2|||
155337910|NCT00749944|560672512|FG001|Overall Study|Lost to Follow-up|1|||
155337911|NCT00749944|560672511|FG000|Overall Study|Other|1|||
155337912|NCT00749944|560672512|FG001|Overall Study|Other|0|||
155164145|NCT05307692|560036862|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
155164146|NCT03894813|560038811|FG000|Overall Study|Adverse Event|1|||
155337913|NCT00749944|560672511|FG000|Overall Study|Withdrawal by Subject|2|||
155337914|NCT00749944|560672512|FG001|Overall Study|Withdrawal by Subject|0|||
155337915|NCT02547974|560672513|FG000|Overall Study|Withdrawal by Subject|1|||
155337916|NCT02547974|560672514|FG001|Overall Study|Withdrawal by Subject|0|||
155337917|NCT02547974|560672515|FG002|Overall Study|Withdrawal by Subject|0|||
155337918|NCT02547974|560672516|FG003|Overall Study|Withdrawal by Subject|0|||
155337919|NCT00923078|560672517|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
155337920|NCT00923078|560672518|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
155337921|NCT00923078|560672519|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
155337922|NCT00923078|560672517|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
155337923|NCT00923078|560672518|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
155337924|NCT00923078|560672519|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
155337925|NCT01072149|560672523|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337926|NCT01072149|560672524|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337927|NCT01072149|560672525|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155337928|NCT01072149|560672526|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337929|NCT01072149|560672527|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337930|NCT01072149|560672528|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337931|NCT01072149|560672529|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337932|NCT01072149|560672530|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337933|NCT01072149|560672531|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337934|NCT01072149|560672532|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337935|NCT01072149|560672533|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337936|NCT01072149|560672534|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337937|NCT01072149|560672535|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337938|NCT01072149|560672536|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337939|NCT01072149|560672537|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337940|NCT01072149|560672538|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337941|NCT01072149|560672539|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337942|NCT01072149|560672540|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155337943|NCT01072149|560672523|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337944|NCT01072149|560672524|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337945|NCT01072149|560672525|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337946|NCT01072149|560672526|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337947|NCT01072149|560672527|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337948|NCT01072149|560672528|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337949|NCT01072149|560672529|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337950|NCT01072149|560672530|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337951|NCT01072149|560672531|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337952|NCT01072149|560672532|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337953|NCT01072149|560672533|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337954|NCT01072149|560672534|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337955|NCT01072149|560672535|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337956|NCT01072149|560672536|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337957|NCT01072149|560672537|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337958|NCT01072149|560672538|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337959|NCT01072149|560672539|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
155337960|NCT01072149|560672540|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
155337961|NCT01072149|560672523|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337962|NCT01072149|560672524|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337963|NCT01072149|560672525|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337964|NCT01072149|560672526|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337965|NCT01072149|560672527|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337966|NCT01072149|560672528|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337967|NCT01072149|560672529|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337968|NCT01072149|560672530|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337969|NCT01072149|560672531|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337970|NCT01072149|560672532|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337971|NCT01072149|560672533|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
155337972|NCT01072149|560672534|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337973|NCT01072149|560672535|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337974|NCT01072149|560672536|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337975|NCT01072149|560672537|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337976|NCT01072149|560672538|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337977|NCT01072149|560672539|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337978|NCT01072149|560672540|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
155337979|NCT01072149|560672523|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337980|NCT01072149|560672524|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
155337981|NCT01072149|560672525|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337982|NCT01072149|560672526|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337983|NCT01072149|560672527|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155164147|NCT03894813|560038812|FG001|Overall Study|Adverse Event|1|||
154962492|NCT04493684|559287972|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155072906|NCT05950906|559696859|FG009|Overall Study|Adverse Event|0|||
155072907|NCT05950906|559696860|FG010|Overall Study|Adverse Event|0|||
155072908|NCT05950906|559696861|FG011|Overall Study|Adverse Event|0|||
155072909|NCT05950906|559696862|FG012|Overall Study|Adverse Event|1|||
155072910|NCT05950906|559696863|FG013|Overall Study|Adverse Event|0|||
155072911|NCT05950906|559696850|FG000|Overall Study|Physician Decision|0|||
155072912|NCT05950906|559696851|FG001|Overall Study|Physician Decision|0|||
155072913|NCT05950906|559696852|FG002|Overall Study|Physician Decision|0|||
155072914|NCT05950906|559696853|FG003|Overall Study|Physician Decision|0|||
155072915|NCT05950906|559696854|FG004|Overall Study|Physician Decision|0|||
155072916|NCT05950906|559696855|FG005|Overall Study|Physician Decision|0|||
155072917|NCT05950906|559696856|FG006|Overall Study|Physician Decision|0|||
155072918|NCT05950906|559696857|FG007|Overall Study|Physician Decision|0|||
155072919|NCT05950906|559696858|FG008|Overall Study|Physician Decision|0|||
155072920|NCT05950906|559696859|FG009|Overall Study|Physician Decision|0|||
155337984|NCT01072149|560672528|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337985|NCT01072149|560672529|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337986|NCT01072149|560672530|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337987|NCT01072149|560672531|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337988|NCT01072149|560672532|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337989|NCT01072149|560672533|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155072921|NCT05950906|559696860|FG010|Overall Study|Physician Decision|0|||
155072922|NCT05950906|559696861|FG011|Overall Study|Physician Decision|0|||
155337990|NCT01072149|560672534|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337991|NCT01072149|560672535|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337992|NCT01072149|560672536|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337993|NCT01072149|560672537|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337994|NCT01072149|560672538|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337995|NCT01072149|560672539|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337996|NCT01072149|560672540|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
155337997|NCT01072149|560672523|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155337998|NCT01072149|560672524|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155337999|NCT01072149|560672525|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
155338000|NCT01072149|560672526|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338001|NCT01072149|560672527|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338002|NCT01072149|560672528|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338003|NCT01072149|560672529|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338004|NCT01072149|560672530|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338005|NCT01072149|560672531|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338006|NCT01072149|560672532|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338007|NCT01072149|560672533|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338008|NCT01072149|560672534|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338009|NCT01072149|560672535|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338010|NCT01072149|560672536|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338011|NCT01072149|560672537|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338012|NCT01072149|560672538|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338013|NCT01072149|560672539|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338014|NCT01072149|560672540|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
155338015|NCT01072149|560672523|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338016|NCT01072149|560672524|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338017|NCT01072149|560672525|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338018|NCT01072149|560672526|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338019|NCT01072149|560672527|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338020|NCT01072149|560672528|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338021|NCT01072149|560672529|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338022|NCT01072149|560672530|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
155338023|NCT01072149|560672531|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338024|NCT01072149|560672532|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338025|NCT01072149|560672533|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338026|NCT01072149|560672534|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338027|NCT01072149|560672535|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338028|NCT01072149|560672536|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338029|NCT01072149|560672537|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338030|NCT01072149|560672538|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
155072923|NCT05950906|559696862|FG012|Overall Study|Physician Decision|1|||
155072924|NCT05950906|559696863|FG013|Overall Study|Physician Decision|0|||
155072925|NCT02969018|559696868|FG000|Overall Study|Adverse Event|2|||
155072926|NCT02969018|559696869|FG001|Overall Study|Adverse Event|4|||
155072927|NCT02969018|559696870|FG002|Overall Study|Adverse Event|1|||
155072928|NCT02969018|559696871|FG003|Overall Study|Adverse Event|2|||
155072929|NCT02969018|559696872|FG004|Overall Study|Adverse Event|0|||
155072930|NCT02969018|559696873|FG005|Overall Study|Adverse Event|1|||
155338031|NCT01072149|560672539|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338032|NCT01072149|560672540|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
155338033|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
155338034|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
155338035|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
155338036|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
155338037|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
155338038|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
155338039|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
155338040|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
155338041|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
155338042|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
155338043|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
155338044|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
155338045|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
155338046|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
155338047|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
155338048|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
155338049|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
155338050|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
155338051|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338052|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338053|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338054|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338055|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338056|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338057|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338058|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338059|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338060|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338061|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338062|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338063|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338064|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338065|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338066|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
155338067|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338068|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
155338069|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
155338070|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
155338071|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
155338072|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
155338073|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
155338074|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
155338075|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
155338076|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
155072931|NCT02969018|559696874|FG006|Overall Study|Adverse Event|2|||
155072932|NCT02969018|559696875|FG007|Overall Study|Adverse Event|0|||
155072933|NCT02969018|559696868|FG000|Overall Study|Lack of Efficacy|0|||
155072934|NCT02969018|559696869|FG001|Overall Study|Lack of Efficacy|1|||
155072935|NCT02969018|559696870|FG002|Overall Study|Lack of Efficacy|0|||
155072936|NCT02969018|559696871|FG003|Overall Study|Lack of Efficacy|0|||
155072937|NCT02969018|559696872|FG004|Overall Study|Lack of Efficacy|1|||
155072938|NCT02969018|559696873|FG005|Overall Study|Lack of Efficacy|1|||
155072939|NCT02969018|559696874|FG006|Overall Study|Lack of Efficacy|1|||
155072940|NCT02969018|559696875|FG007|Overall Study|Lack of Efficacy|1|||
155072941|NCT02969018|559696868|FG000|Overall Study|Lost to Follow-up|1|||
155072942|NCT02969018|559696869|FG001|Overall Study|Lost to Follow-up|2|||
155072943|NCT02969018|559696870|FG002|Overall Study|Lost to Follow-up|2|||
155338077|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
155338078|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
155338079|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
155072944|NCT02969018|559696871|FG003|Overall Study|Lost to Follow-up|0|||
155338080|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
155072945|NCT02969018|559696872|FG004|Overall Study|Lost to Follow-up|1|||
155072946|NCT02969018|559696873|FG005|Overall Study|Lost to Follow-up|1|||
155072947|NCT02969018|559696874|FG006|Overall Study|Lost to Follow-up|0|||
155338081|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
155072948|NCT02969018|559696875|FG007|Overall Study|Lost to Follow-up|1|||
155072949|NCT02969018|559696868|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072950|NCT02969018|559696869|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072951|NCT02969018|559696870|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072952|NCT02969018|559696871|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072953|NCT02969018|559696872|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072954|NCT02969018|559696873|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072955|NCT02969018|559696874|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
155072956|NCT02969018|559696875|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155072957|NCT02969018|559696868|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155072958|NCT02969018|559696869|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155072959|NCT02969018|559696870|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155072960|NCT02969018|559696871|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155072961|NCT02969018|559696872|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155072962|NCT02969018|559696873|FG005|Overall Study|Non-Compliance With Study Drug|0|||
155072963|NCT02969018|559696874|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155072964|NCT02969018|559696875|FG007|Overall Study|Non-Compliance With Study Drug|0|||
155072965|NCT02969018|559696868|FG000|Overall Study|Other|0|||
155072966|NCT02969018|559696869|FG001|Overall Study|Other|0|||
155072967|NCT02969018|559696870|FG002|Overall Study|Other|0|||
155072968|NCT02969018|559696871|FG003|Overall Study|Other|1|||
155072969|NCT02969018|559696872|FG004|Overall Study|Other|0|||
155072970|NCT02969018|559696873|FG005|Overall Study|Other|0|||
155072971|NCT02969018|559696874|FG006|Overall Study|Other|0|||
155072972|NCT02969018|559696875|FG007|Overall Study|Other|2|||
155072973|NCT02969018|559696868|FG000|Overall Study|Pregnancy|0|||
155072974|NCT02969018|559696869|FG001|Overall Study|Pregnancy|0|||
155072975|NCT02969018|559696870|FG002|Overall Study|Pregnancy|0|||
155072976|NCT02969018|559696871|FG003|Overall Study|Pregnancy|0|||
155072977|NCT02969018|559696872|FG004|Overall Study|Pregnancy|0|||
155072978|NCT02969018|559696873|FG005|Overall Study|Pregnancy|1|||
155072979|NCT02969018|559696874|FG006|Overall Study|Pregnancy|0|||
155072980|NCT02969018|559696875|FG007|Overall Study|Pregnancy|0|||
155072981|NCT02969018|559696868|FG000|Overall Study|Protocol Violation|0|||
155072982|NCT02969018|559696869|FG001|Overall Study|Protocol Violation|0|||
155072983|NCT02969018|559696870|FG002|Overall Study|Protocol Violation|1|||
155072984|NCT02969018|559696871|FG003|Overall Study|Protocol Violation|1|||
155072985|NCT02969018|559696872|FG004|Overall Study|Protocol Violation|0|||
155072986|NCT02969018|559696873|FG005|Overall Study|Protocol Violation|0|||
155072987|NCT02969018|559696874|FG006|Overall Study|Protocol Violation|0|||
155072988|NCT02969018|559696875|FG007|Overall Study|Protocol Violation|0|||
155072989|NCT02969018|559696868|FG000|Overall Study|Withdrawal by Subject|0|||
155072990|NCT02969018|559696869|FG001|Overall Study|Withdrawal by Subject|1|||
155072991|NCT02969018|559696870|FG002|Overall Study|Withdrawal by Subject|2|||
155072992|NCT02969018|559696871|FG003|Overall Study|Withdrawal by Subject|1|||
155072993|NCT02969018|559696872|FG004|Overall Study|Withdrawal by Subject|0|||
155072994|NCT02969018|559696873|FG005|Overall Study|Withdrawal by Subject|4|||
155072995|NCT02969018|559696874|FG006|Overall Study|Withdrawal by Subject|4|||
155072996|NCT02969018|559696875|FG007|Overall Study|Withdrawal by Subject|3|||
155072997|NCT04795323|559696877|FG000|Overall Study|Did not interact with TARA|1|||
155072998|NCT04795323|559696878|FG001|Overall Study|Did not interact with TARA|0|||
155072999|NCT01479530|559696879|FG000|Overall Study|Adverse Event|5|||
155338082|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
155338083|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
155338084|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
155338085|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
155073000|NCT01479530|559696880|FG001|Overall Study|Adverse Event|6|||
155338086|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
155338087|NCT01072149|560672523|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338088|NCT01072149|560672524|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338089|NCT01072149|560672525|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338090|NCT01072149|560672526|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338091|NCT01072149|560672527|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338092|NCT01072149|560672528|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338093|NCT01072149|560672529|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338094|NCT01072149|560672530|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155073001|NCT01479530|559696879|FG000|Overall Study|Lack of Efficacy|0|||
155073002|NCT01479530|559696880|FG001|Overall Study|Lack of Efficacy|1|||
155073003|NCT01479530|559696879|FG000|Overall Study|Protocol Violation|2|||
155073004|NCT01479530|559696880|FG001|Overall Study|Protocol Violation|3|||
155073005|NCT01479530|559696879|FG000|Overall Study|Withdrawal of Consent|3|||
155073006|NCT01479530|559696880|FG001|Overall Study|Withdrawal of Consent|2|||
155073007|NCT00303628|559696885|FG000|Overall Study|Disease progression|0|||
155073008|NCT00303628|559696886|FG001|Overall Study|Disease progression|1|||
155073009|NCT00303628|559696885|FG000|Overall Study|Adverse Event|26|||
155338095|NCT01072149|560672531|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155073010|NCT00303628|559696886|FG001|Overall Study|Adverse Event|36|||
155338096|NCT01072149|560672532|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338097|NCT01072149|560672533|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338098|NCT01072149|560672534|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338099|NCT01072149|560672535|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
155338100|NCT01072149|560672536|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338101|NCT01072149|560672537|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338102|NCT01072149|560672538|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338103|NCT01072149|560672539|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338104|NCT01072149|560672540|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
155338105|NCT01072149|560672523|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338106|NCT01072149|560672524|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338107|NCT01072149|560672525|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
155338108|NCT01072149|560672526|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338109|NCT01072149|560672527|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338110|NCT01072149|560672528|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338111|NCT01072149|560672529|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338112|NCT01072149|560672530|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338113|NCT01072149|560672531|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338114|NCT01072149|560672532|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338115|NCT01072149|560672533|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338116|NCT01072149|560672534|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338117|NCT01072149|560672535|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338118|NCT01072149|560672536|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
155338119|NCT01072149|560672537|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338120|NCT01072149|560672538|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338121|NCT01072149|560672539|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338122|NCT01072149|560672540|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
155338123|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
155338124|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
155338125|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
155338126|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
155338127|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Adverse Event|7|||
155338128|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Adverse Event|8|||
155338129|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Adverse Event|8|||
155338130|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Adverse Event|9|||
155338131|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
155338132|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
155338133|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
155338134|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
155338135|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
155338136|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
155338137|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
155338138|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
155338139|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Pregnancy|0|||
155338140|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Pregnancy|2|||
155338141|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Pregnancy|2|||
155073011|NCT00303628|559696885|FG000|Overall Study|Death|0|||
155073012|NCT00303628|559696886|FG001|Overall Study|Death|1|||
155073013|NCT00303628|559696885|FG000|Overall Study|Withdrawal by Subject|11|||
155073014|NCT00303628|559696886|FG001|Overall Study|Withdrawal by Subject|20|||
155073015|NCT00303628|559696885|FG000|Overall Study|Alternative therapy|2|||
155338142|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Pregnancy|0|||
155338143|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Non-compliance|1|||
155338144|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Non-compliance|0|||
155338145|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Non-compliance|0|||
155338146|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Non-compliance|3|||
155338147|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Other|3|||
155338148|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Other|0|||
155338149|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Other|3|||
155073016|NCT00303628|559696886|FG001|Overall Study|Alternative therapy|0|||
155338150|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Other|2|||
155338151|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
155338152|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
155338153|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
155073017|NCT00303628|559696885|FG000|Overall Study|Other complicating disease|0|||
155073018|NCT00303628|559696886|FG001|Overall Study|Other complicating disease|1|||
155073019|NCT00303628|559696885|FG000|Overall Study|Not start protocol therapy|3|||
155338154|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
155338155|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
155338156|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
155338157|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
155338158|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
155338159|NCT02143713|560672541|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
155338160|NCT02143713|560672542|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
155338161|NCT02143713|560672543|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
155338162|NCT02143713|560672544|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
155338163|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
155338164|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
155338165|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
155338166|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
155338167|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
155338168|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
155338169|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
155338170|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
155338171|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
155338172|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
155338173|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
155338174|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
155338175|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
155338176|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
155338177|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
155338178|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
155338179|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
155338180|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
155338181|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
155338182|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
155338183|NCT02143713|560672541|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
155338184|NCT02143713|560672542|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
155338185|NCT02143713|560672543|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
155338186|NCT02143713|560672544|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
155338187|NCT01768572|560672545|FG000|Overall Study|Adverse Event|7|||
155338188|NCT01768572|560672546|FG001|Overall Study|Adverse Event|8|||
155338189|NCT01768572|560672547|FG002|Overall Study|Adverse Event|4|||
155338190|NCT01768572|560672545|FG000|Overall Study|Lack of Efficacy|1|||
155338191|NCT01768572|560672546|FG001|Overall Study|Lack of Efficacy|3|||
155338192|NCT01768572|560672547|FG002|Overall Study|Lack of Efficacy|1|||
155338193|NCT01768572|560672545|FG000|Overall Study|Other, Not due to an adverse event|1|||
155338194|NCT01768572|560672546|FG001|Overall Study|Other, Not due to an adverse event|1|||
155338195|NCT01768572|560672547|FG002|Overall Study|Other, Not due to an adverse event|1|||
155338196|NCT02245620|560672550|FG000|Overall Study|Physician Decision|1|||
155338197|NCT02245620|560672551|FG001|Overall Study|Physician Decision|1|||
155338198|NCT01999335|560672552|FG000|Overall Study|Discontinued before receiving treatment|0|||
155338199|NCT01999335|560672553|FG001|Overall Study|Discontinued before receiving treatment|0|||
154962493|NCT04493684|559287973|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155338200|NCT01999335|560672554|FG002|Overall Study|Discontinued before receiving treatment|0|||
155338201|NCT01999335|560672555|FG003|Overall Study|Discontinued before receiving treatment|0|||
155338202|NCT01999335|560672556|FG004|Overall Study|Discontinued before receiving treatment|2|||
155338203|NCT04766996|560672557|FG000|Overall Study|Withdrawal by Subject|1|||
155338204|NCT04766996|560672558|FG001|Overall Study|Withdrawal by Subject|0|||
155338205|NCT04766996|560672559|FG002|Overall Study|Withdrawal by Subject|13|||
155338206|NCT00080119|560672560|FG000|Overall Study|Discontinued because of study closure|0|||
155338207|NCT00080119|560672561|FG001|Overall Study|Discontinued because of study closure|0|||
155338208|NCT00080119|560672562|FG002|Overall Study|Discontinued because of study closure|130|||
155338209|NCT00080119|560672563|FG003|Overall Study|Discontinued because of study closure|141|||
154962494|NCT04493684|559287974|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962495|NCT04493684|559287975|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962496|NCT04493684|559287976|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155338210|NCT00080119|560672560|FG000|Overall Study|Unable to get to clinic|24|||
155338211|NCT00080119|560672561|FG001|Overall Study|Unable to get to clinic|24|||
155338212|NCT00080119|560672562|FG002|Overall Study|Unable to get to clinic|7|||
155338213|NCT00080119|560672563|FG003|Overall Study|Unable to get to clinic|1|||
155338214|NCT00080119|560672560|FG000|Overall Study|Consent withdrawn|13|||
155338215|NCT00080119|560672561|FG001|Overall Study|Consent withdrawn|17|||
155338216|NCT00080119|560672562|FG002|Overall Study|Consent withdrawn|4|||
155338217|NCT00080119|560672563|FG003|Overall Study|Consent withdrawn|6|||
154962497|NCT04493684|559287977|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962498|NCT04493684|559287978|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962499|NCT04493684|559287979|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
155338218|NCT00080119|560672560|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
155338219|NCT00080119|560672561|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
155338220|NCT00080119|560672562|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
155338221|NCT00080119|560672563|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
155338222|NCT00080119|560672560|FG000|Overall Study|Lost to Follow-up|16|||
155338223|NCT00080119|560672561|FG001|Overall Study|Lost to Follow-up|19|||
155338224|NCT00080119|560672562|FG002|Overall Study|Lost to Follow-up|19|||
155338225|NCT00080119|560672563|FG003|Overall Study|Lost to Follow-up|14|||
155338226|NCT01322386|560672564|FG000|Overall Study|Protocol Violation|0|||
155338227|NCT01322386|560672565|FG001|Overall Study|Protocol Violation|1|||
155338228|NCT01322386|560672564|FG000|Overall Study|Physician Decision|0|||
155338229|NCT01322386|560672565|FG001|Overall Study|Physician Decision|1|||
155338230|NCT00871494|560672576|FG000|Overall Study|Protocol Violation|5|||
155338231|NCT00871494|560672576|FG000|Overall Study|Lack of Efficacy|4|||
155338232|NCT00871494|560672576|FG000|Overall Study|Adverse Event|4|||
155338233|NCT00871494|560672576|FG000|Overall Study|Lost to Follow-up|1|||
155338234|NCT00889863|560672580|FG000|Part I: Open Label|Death|1|||
155338235|NCT00889863|560672581|FG001|Part I: Open Label|Death|0|||
155338236|NCT00889863|560672580|FG000|Part I: Open Label|Adverse Event|4|||
155338237|NCT00889863|560672581|FG001|Part I: Open Label|Adverse Event|0|||
155338238|NCT00889863|560672580|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
155338239|NCT00889863|560672581|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
155338240|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
155338241|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
155338242|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
155338243|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
155338244|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
155338245|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
155338246|NCT00889863|560672580|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
155338247|NCT00889863|560672581|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
155338248|NCT04410445|560672590|FG000|Overall Study|Lost to Follow-up|3|||
155338249|NCT04410445|560672591|FG001|Overall Study|Lost to Follow-up|9|||
155338250|NCT04410445|560672590|FG000|Overall Study|Withdrawal by Subject|27|||
155338251|NCT04410445|560672591|FG001|Overall Study|Withdrawal by Subject|15|||
155338252|NCT03547154|560672597|FG000|Overall Study|Disease Progression/Recurrence|6|||
155338253|NCT03547154|560672598|FG001|Overall Study|Disease Progression/Recurrence|14|||
155338254|NCT03547154|560672597|FG000|Overall Study|Adverse Event|26|||
155073020|NCT00303628|559696886|FG001|Overall Study|Not start protocol therapy|5|||
155073021|NCT00303628|559696885|FG000|Overall Study|Other|8|||
155073022|NCT00303628|559696886|FG001|Overall Study|Other|9|||
155073023|NCT04925934|559696887|FG000|Overall Study|Adverse Event|1|||
155073024|NCT04925934|559696888|FG001|Overall Study|Adverse Event|0|||
155073025|NCT04925934|559696889|FG002|Overall Study|Adverse Event|0|||
155073026|NCT04925934|559696887|FG000|Overall Study|Lost to Follow-up|2|||
155073027|NCT04925934|559696888|FG001|Overall Study|Lost to Follow-up|0|||
155073028|NCT04925934|559696889|FG002|Overall Study|Lost to Follow-up|1|||
155073029|NCT04925934|559696887|FG000|Overall Study|Death|0|||
155073030|NCT04925934|559696888|FG001|Overall Study|Death|1|||
155073031|NCT04925934|559696889|FG002|Overall Study|Death|0|||
155073032|NCT04925934|559696887|FG000|Overall Study|Withdrawal by Subject|8|||
155073033|NCT04925934|559696888|FG001|Overall Study|Withdrawal by Subject|5|||
155073034|NCT04925934|559696889|FG002|Overall Study|Withdrawal by Subject|9|||
155073035|NCT04925934|559696887|FG000|Overall Study|Other|2|||
155073036|NCT04925934|559696888|FG001|Overall Study|Other|2|||
155073037|NCT04925934|559696889|FG002|Overall Study|Other|2|||
155073038|NCT04925934|559696887|FG000|Overall Study|Eastern European Conflict|7|||
155073039|NCT04925934|559696888|FG001|Overall Study|Eastern European Conflict|3|||
155073040|NCT04925934|559696889|FG002|Overall Study|Eastern European Conflict|2|||
155073041|NCT03158688|559696890|FG000|Overall Study|Withdrawal by Subject|14|||
155073042|NCT03158688|559696891|FG001|Overall Study|Withdrawal by Subject|28|||
155073043|NCT03158688|559696890|FG000|Overall Study|Decision by sponsor|13|||
155073044|NCT03158688|559696891|FG001|Overall Study|Decision by sponsor|37|||
155073045|NCT03158688|559696890|FG000|Overall Study|Lost to Follow-up|4|||
155073046|NCT03158688|559696891|FG001|Overall Study|Lost to Follow-up|3|||
155073047|NCT03158688|559696890|FG000|Overall Study|Death|74|||
155073048|NCT03158688|559696891|FG001|Overall Study|Death|142|||
155073049|NCT00933166|559696893|FG000|Overall Study|Lost to Follow-up|4|||
155073050|NCT00933166|559696893|FG000|Overall Study|Lack of Efficacy|9|||
155073051|NCT00933166|559696893|FG000|Overall Study|Unavailable|4|||
155073052|NCT00933166|559696893|FG000|Overall Study|Withdrawal by Subject|1|||
155073053|NCT03925220|559696894|FG000|Overall Study|Withdrawal by Subject|4|||
155073054|NCT03925220|559696895|FG001|Overall Study|Withdrawal by Subject|4|||
155073055|NCT03925220|559696896|FG002|Overall Study|Withdrawal by Subject|4|||
155073056|NCT03925220|559696897|FG003|Overall Study|Withdrawal by Subject|4|||
155073057|NCT03925220|559696894|FG000|Overall Study|Lost to Follow-up|40|||
155073058|NCT03925220|559696895|FG001|Overall Study|Lost to Follow-up|46|||
155073059|NCT03925220|559696896|FG002|Overall Study|Lost to Follow-up|37|||
155073060|NCT03925220|559696897|FG003|Overall Study|Lost to Follow-up|38|||
155073061|NCT05774977|559696898|FG000|Overall Study|Withdrawal by Subject|2|||
155073062|NCT02503865|559696905|FG000|Overall Study|Moved out of area|1|||
155073063|NCT02503865|559696906|FG001|Overall Study|Moved out of area|8|||
155073064|NCT02503865|559696907|FG002|Overall Study|Moved out of area|0|||
155073065|NCT02503865|559696905|FG000|Overall Study|Refused treatment|4|||
155073066|NCT02503865|559696906|FG001|Overall Study|Refused treatment|39|||
155073067|NCT02503865|559696907|FG002|Overall Study|Refused treatment|2|||
155073068|NCT01131585|559696908|FG000|Overall Study|Adverse Event|0|||
155073069|NCT01131585|559696909|FG001|Overall Study|Adverse Event|2|||
155073070|NCT01131585|559696908|FG000|Overall Study|Abnormal laboratory value|1|||
155073071|NCT01131585|559696909|FG001|Overall Study|Abnormal laboratory value|0|||
155073072|NCT01131585|559696908|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155073073|NCT01131585|559696909|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155073074|NCT01131585|559696908|FG000|Overall Study|Protocol Violation|2|||
155073075|NCT01131585|559696909|FG001|Overall Study|Protocol Violation|1|||
155073076|NCT01131585|559696908|FG000|Overall Study|Withdrawal by Subject|3|||
155073077|NCT01131585|559696909|FG001|Overall Study|Withdrawal by Subject|3|||
155073078|NCT01131585|559696908|FG000|Overall Study|Lost to Follow-up|0|||
155073079|NCT01131585|559696909|FG001|Overall Study|Lost to Follow-up|1|||
155073080|NCT01131585|559696908|FG000|Overall Study|Administrative problems|1|||
155073081|NCT01131585|559696909|FG001|Overall Study|Administrative problems|1|||
155073082|NCT01131585|559696908|FG000|Overall Study|Study termination|78|||
155073083|NCT01131585|559696909|FG001|Overall Study|Study termination|32|||
155073084|NCT00927082|559696910|FG000|Overall Study|Lost to Follow-up|9|||
155073085|NCT00927082|559696911|FG001|Overall Study|Lost to Follow-up|8|||
155073086|NCT00927082|559696912|FG002|Overall Study|Lost to Follow-up|12|||
155073087|NCT00927082|559696913|FG003|Overall Study|Lost to Follow-up|16|||
155164148|NCT03894813|560038811|FG000|Overall Study|Lack of Efficacy|3|||
155164149|NCT03894813|560038812|FG001|Overall Study|Lack of Efficacy|3|||
155164150|NCT03894813|560038811|FG000|Overall Study|Lost to Follow-up|1|||
155164151|NCT03894813|560038812|FG001|Overall Study|Lost to Follow-up|0|||
155338255|NCT03547154|560672598|FG001|Overall Study|Adverse Event|31|||
155073088|NCT00927082|559696910|FG000|Overall Study|Withdrawal by Subject|3|||
155073089|NCT00927082|559696911|FG001|Overall Study|Withdrawal by Subject|2|||
155073090|NCT00927082|559696912|FG002|Overall Study|Withdrawal by Subject|7|||
155073091|NCT00927082|559696913|FG003|Overall Study|Withdrawal by Subject|2|||
155073092|NCT00927082|559696910|FG000|Overall Study|Death|0|||
155073093|NCT00927082|559696911|FG001|Overall Study|Death|0|||
155073094|NCT00927082|559696912|FG002|Overall Study|Death|1|||
155073095|NCT00927082|559696913|FG003|Overall Study|Death|0|||
155073096|NCT00927082|559696910|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
155073097|NCT00927082|559696911|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
155073098|NCT00927082|559696912|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
155073099|NCT00927082|559696913|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
155073100|NCT03998462|559696924|FG000|Overall Study|Withdrawal by Subject|10|||
155164152|NCT03894813|560038811|FG000|Overall Study|Pregnancy|2|||
155338256|NCT03547154|560672597|FG000|Overall Study|Protocol Violation|6|||
155338257|NCT03547154|560672598|FG001|Overall Study|Protocol Violation|1|||
155338258|NCT03547154|560672597|FG000|Overall Study|Physician Decision|4|||
155338259|NCT03547154|560672598|FG001|Overall Study|Physician Decision|3|||
155338260|NCT03547154|560672597|FG000|Overall Study|Insufficient Therapeutic Response|13|||
155073101|NCT03998462|559696925|FG001|Overall Study|Withdrawal by Subject|4|||
155073102|NCT03998462|559696924|FG000|Overall Study|Lost to Follow-up|1|||
155073103|NCT03998462|559696925|FG001|Overall Study|Lost to Follow-up|0|||
155073104|NCT03998462|559696924|FG000|Overall Study|Technical Difficulties|1|||
155073105|NCT03998462|559696925|FG001|Overall Study|Technical Difficulties|2|||
155073106|NCT05710224|559696926|FG000|Overall Study|Death|1|||
155073107|NCT05710224|559696927|FG001|Overall Study|Death|0|||
155073108|NCT05710224|559696926|FG000|Overall Study|Lost to Follow-up|16|||
155073109|NCT05710224|559696927|FG001|Overall Study|Lost to Follow-up|7|||
155073110|NCT05710224|559696926|FG000|Overall Study|Withdrawal by Subject|4|||
155073111|NCT05710224|559696927|FG001|Overall Study|Withdrawal by Subject|6|||
155073112|NCT05710224|559696926|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155073113|NCT05710224|559696927|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155073114|NCT05710224|559696926|FG000|Overall Study|Participants Left The City|0|||
155073115|NCT05710224|559696927|FG001|Overall Study|Participants Left The City|2|||
155073116|NCT03369223|559696930|FG000|Overall Study|Lost to Follow-up|0|||
155073117|NCT03369223|559696931|FG001|Overall Study|Lost to Follow-up|0|||
155073118|NCT03369223|559696932|FG002|Overall Study|Lost to Follow-up|0|||
155073119|NCT03369223|559696933|FG003|Overall Study|Lost to Follow-up|0|||
155073120|NCT03369223|559696934|FG004|Overall Study|Lost to Follow-up|0|||
155073121|NCT03369223|559696935|FG005|Overall Study|Lost to Follow-up|0|||
155073122|NCT03369223|559696936|FG006|Overall Study|Lost to Follow-up|0|||
155073123|NCT03369223|559696937|FG007|Overall Study|Lost to Follow-up|0|||
155073124|NCT03369223|559696938|FG008|Overall Study|Lost to Follow-up|0|||
155073125|NCT03369223|559696939|FG009|Overall Study|Lost to Follow-up|0|||
155073126|NCT03369223|559696940|FG010|Overall Study|Lost to Follow-up|0|||
155073127|NCT03369223|559696941|FG011|Overall Study|Lost to Follow-up|0|||
155073128|NCT03369223|559696942|FG012|Overall Study|Lost to Follow-up|0|||
155073129|NCT03369223|559696943|FG013|Overall Study|Lost to Follow-up|0|||
155073130|NCT03369223|559696944|FG014|Overall Study|Lost to Follow-up|0|||
155073131|NCT03369223|559696945|FG015|Overall Study|Lost to Follow-up|0|||
155073132|NCT03369223|559696946|FG016|Overall Study|Lost to Follow-up|0|||
155073133|NCT03369223|559696947|FG017|Overall Study|Lost to Follow-up|0|||
155073134|NCT03369223|559696948|FG018|Overall Study|Lost to Follow-up|2|||
155073135|NCT03369223|559696949|FG019|Overall Study|Lost to Follow-up|1|||
155073136|NCT03369223|559696930|FG000|Overall Study|Participant no longer meets study criteria|0|||
155073137|NCT03369223|559696931|FG001|Overall Study|Participant no longer meets study criteria|0|||
155073138|NCT03369223|559696932|FG002|Overall Study|Participant no longer meets study criteria|0|||
155073139|NCT03369223|559696933|FG003|Overall Study|Participant no longer meets study criteria|0|||
155073140|NCT03369223|559696934|FG004|Overall Study|Participant no longer meets study criteria|0|||
155073141|NCT03369223|559696935|FG005|Overall Study|Participant no longer meets study criteria|0|||
155073142|NCT03369223|559696936|FG006|Overall Study|Participant no longer meets study criteria|0|||
155073143|NCT03369223|559696937|FG007|Overall Study|Participant no longer meets study criteria|0|||
155073144|NCT03369223|559696938|FG008|Overall Study|Participant no longer meets study criteria|0|||
155073145|NCT03369223|559696939|FG009|Overall Study|Participant no longer meets study criteria|0|||
155073146|NCT03369223|559696940|FG010|Overall Study|Participant no longer meets study criteria|0|||
155073147|NCT03369223|559696941|FG011|Overall Study|Participant no longer meets study criteria|0|||
155073148|NCT03369223|559696942|FG012|Overall Study|Participant no longer meets study criteria|0|||
155073149|NCT03369223|559696943|FG013|Overall Study|Participant no longer meets study criteria|0|||
155073150|NCT03369223|559696944|FG014|Overall Study|Participant no longer meets study criteria|2|||
155073151|NCT03369223|559696945|FG015|Overall Study|Participant no longer meets study criteria|0|||
155073152|NCT03369223|559696946|FG016|Overall Study|Participant no longer meets study criteria|2|||
155073153|NCT03369223|559696947|FG017|Overall Study|Participant no longer meets study criteria|0|||
155073154|NCT03369223|559696948|FG018|Overall Study|Participant no longer meets study criteria|0|||
155073155|NCT03369223|559696949|FG019|Overall Study|Participant no longer meets study criteria|0|||
155073156|NCT03369223|559696930|FG000|Overall Study|Other reasons|0|||
155073157|NCT03369223|559696931|FG001|Overall Study|Other reasons|0|||
155073158|NCT03369223|559696932|FG002|Overall Study|Other reasons|0|||
155073159|NCT03369223|559696933|FG003|Overall Study|Other reasons|0|||
155338261|NCT03547154|560672598|FG001|Overall Study|Insufficient Therapeutic Response|10|||
155338262|NCT03547154|560672597|FG000|Overall Study|Withdrawal by Subject|10|||
155338263|NCT03547154|560672598|FG001|Overall Study|Withdrawal by Subject|6|||
155338264|NCT03547154|560672597|FG000|Overall Study|Not Selected|0|||
155073160|NCT03369223|559696934|FG004|Overall Study|Other reasons|0|||
155073161|NCT03369223|559696935|FG005|Overall Study|Other reasons|0|||
155073162|NCT03369223|559696936|FG006|Overall Study|Other reasons|0|||
155073163|NCT03369223|559696937|FG007|Overall Study|Other reasons|0|||
155073164|NCT03369223|559696938|FG008|Overall Study|Other reasons|0|||
155073165|NCT03369223|559696939|FG009|Overall Study|Other reasons|0|||
155073166|NCT03369223|559696940|FG010|Overall Study|Other reasons|0|||
155073167|NCT03369223|559696941|FG011|Overall Study|Other reasons|0|||
155073168|NCT03369223|559696942|FG012|Overall Study|Other reasons|0|||
155073169|NCT03369223|559696943|FG013|Overall Study|Other reasons|1|||
155073170|NCT03369223|559696944|FG014|Overall Study|Other reasons|2|||
155073171|NCT03369223|559696945|FG015|Overall Study|Other reasons|0|||
155073172|NCT03369223|559696946|FG016|Overall Study|Other reasons|1|||
155073173|NCT03369223|559696947|FG017|Overall Study|Other reasons|0|||
155073174|NCT03369223|559696948|FG018|Overall Study|Other reasons|0|||
155073175|NCT03369223|559696949|FG019|Overall Study|Other reasons|2|||
155073176|NCT03369223|559696930|FG000|Overall Study|Death|0|||
155073177|NCT03369223|559696931|FG001|Overall Study|Death|0|||
155073178|NCT03369223|559696932|FG002|Overall Study|Death|0|||
155073179|NCT03369223|559696933|FG003|Overall Study|Death|0|||
155338265|NCT03547154|560672598|FG001|Overall Study|Not Selected|1|||
155073180|NCT03369223|559696934|FG004|Overall Study|Death|0|||
155073181|NCT03369223|559696935|FG005|Overall Study|Death|0|||
155073182|NCT03369223|559696936|FG006|Overall Study|Death|0|||
155338266|NCT03547154|560672597|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
155073183|NCT03369223|559696937|FG007|Overall Study|Death|0|||
155338267|NCT03547154|560672598|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
155338268|NCT02988713|560672599|FG000|Overall Study|Withdrawal by Subject|1|||
155338269|NCT02988713|560672599|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
155338270|NCT03265132|560672600|FG000|Overall Study|Adverse Event|0|||
155338271|NCT03265132|560672601|FG001|Overall Study|Adverse Event|1|||
155338272|NCT03265132|560672600|FG000|Overall Study|Lack of Efficacy|0|||
155338273|NCT03265132|560672601|FG001|Overall Study|Lack of Efficacy|2|||
155338274|NCT03265132|560672600|FG000|Overall Study|Progressive disease|0|||
155338275|NCT03265132|560672601|FG001|Overall Study|Progressive disease|2|||
155338276|NCT03265132|560672600|FG000|Overall Study|Withdrawal by Subject|0|||
155338277|NCT03265132|560672601|FG001|Overall Study|Withdrawal by Subject|1|||
155338278|NCT00666705|560672607|FG000|Overall Study|Withdrawal by Subject|1|||
155338279|NCT03259568|560672610|FG000|Overall Study|Participant performance was low|3|||
155338280|NCT01976507|560672611|FG000|Overall Study|Adverse Event|6|||
155338281|NCT01976507|560672611|FG000|Overall Study|ablation not done, drug not given|1|||
155338282|NCT01029704|560672613|FG000|Overall Study|Adverse Event|0|||
155338283|NCT01029704|560672614|FG001|Overall Study|Adverse Event|0|||
155338284|NCT01029704|560672615|FG002|Overall Study|Adverse Event|0|||
155338285|NCT01029704|560672616|FG003|Overall Study|Adverse Event|0|||
155338286|NCT01029704|560672617|FG004|Overall Study|Adverse Event|0|||
155338287|NCT01029704|560672618|FG005|Overall Study|Adverse Event|0|||
155338288|NCT01029704|560672619|FG006|Overall Study|Adverse Event|1|||
155338289|NCT01029704|560672620|FG007|Overall Study|Adverse Event|1|||
155338290|NCT01029704|560672621|FG008|Overall Study|Adverse Event|0|||
155338291|NCT01029704|560672613|FG000|Overall Study|Withdrawal by Subject|0|||
155338292|NCT01029704|560672614|FG001|Overall Study|Withdrawal by Subject|0|||
155338293|NCT01029704|560672615|FG002|Overall Study|Withdrawal by Subject|0|||
155338294|NCT01029704|560672616|FG003|Overall Study|Withdrawal by Subject|0|||
155338295|NCT01029704|560672617|FG004|Overall Study|Withdrawal by Subject|2|||
155338296|NCT01029704|560672618|FG005|Overall Study|Withdrawal by Subject|1|||
155338297|NCT01029704|560672619|FG006|Overall Study|Withdrawal by Subject|1|||
155338298|NCT01029704|560672620|FG007|Overall Study|Withdrawal by Subject|1|||
155338299|NCT01029704|560672621|FG008|Overall Study|Withdrawal by Subject|0|||
155338300|NCT01029704|560672613|FG000|Overall Study|Lost to Follow-up|0|||
155338301|NCT01029704|560672614|FG001|Overall Study|Lost to Follow-up|0|||
155338302|NCT01029704|560672615|FG002|Overall Study|Lost to Follow-up|0|||
155338303|NCT01029704|560672616|FG003|Overall Study|Lost to Follow-up|0|||
155338304|NCT01029704|560672617|FG004|Overall Study|Lost to Follow-up|0|||
155338305|NCT01029704|560672618|FG005|Overall Study|Lost to Follow-up|0|||
155338306|NCT01029704|560672619|FG006|Overall Study|Lost to Follow-up|1|||
155338307|NCT01029704|560672620|FG007|Overall Study|Lost to Follow-up|1|||
155338308|NCT01029704|560672621|FG008|Overall Study|Lost to Follow-up|1|||
155338309|NCT01029704|560672613|FG000|Overall Study|Lack of Efficacy|0|||
155338310|NCT01029704|560672614|FG001|Overall Study|Lack of Efficacy|0|||
155338311|NCT01029704|560672615|FG002|Overall Study|Lack of Efficacy|0|||
155338312|NCT01029704|560672616|FG003|Overall Study|Lack of Efficacy|0|||
155338313|NCT01029704|560672617|FG004|Overall Study|Lack of Efficacy|2|||
155338314|NCT01029704|560672618|FG005|Overall Study|Lack of Efficacy|3|||
155338315|NCT01029704|560672619|FG006|Overall Study|Lack of Efficacy|1|||
155338316|NCT01029704|560672620|FG007|Overall Study|Lack of Efficacy|2|||
155338317|NCT01029704|560672621|FG008|Overall Study|Lack of Efficacy|0|||
155338318|NCT01029704|560672613|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
155338319|NCT01029704|560672614|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
155338320|NCT01029704|560672615|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
155338321|NCT01029704|560672616|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
155338322|NCT01029704|560672617|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
155338323|NCT01029704|560672618|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
155338324|NCT01029704|560672619|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
155338325|NCT01029704|560672620|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
155338326|NCT01029704|560672621|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
155338327|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
155338328|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
155338329|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
155338330|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
155338331|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Death|0|||
155338332|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Death|0|||
155338333|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Death|1|||
155338334|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Death|0|||
155338335|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
155338336|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
155338337|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
155338338|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
155073184|NCT03369223|559696938|FG008|Overall Study|Death|0|||
155073185|NCT03369223|559696939|FG009|Overall Study|Death|0|||
155338339|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155338340|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
155338341|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
155338342|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
155338343|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
155338344|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
155338345|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
155338346|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
155338347|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
155338348|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
155338349|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
155338350|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
155338351|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
155338352|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
155338353|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
155338354|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
155338355|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Other|2|||
155338356|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Other|0|||
155338357|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Other|0|||
155338358|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Other|0|||
155338359|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
155338360|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
155338361|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
155338362|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
155338363|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
155338364|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
155338365|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
155338366|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
155338367|NCT03845517|560672622|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
155338368|NCT03845517|560672623|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
155338369|NCT03845517|560672624|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
155338370|NCT03845517|560672625|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
155338371|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
155338372|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
155338373|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
155338374|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
155338375|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Death|0|||
155338376|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Death|0|||
155338377|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Death|1|||
155338378|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Death|1|||
155338379|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
155338380|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
155338381|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
155338382|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
155338383|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
155338384|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
155338385|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
155338386|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
155338387|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
155338388|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
155338389|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
155338390|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
155338391|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Other|1|||
155338392|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Other|0|||
155338393|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Other|1|||
155338394|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Other|0|||
155338395|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
155338396|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
155338397|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
155073186|NCT03369223|559696940|FG010|Overall Study|Death|0|||
155338398|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
155338399|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
155338400|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
155338401|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
155073187|NCT03369223|559696941|FG011|Overall Study|Death|0|||
155338402|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
155338403|NCT03845517|560672622|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
155338404|NCT03845517|560672623|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
155073188|NCT03369223|559696942|FG012|Overall Study|Death|0|||
155073189|NCT03369223|559696943|FG013|Overall Study|Death|1|||
155073190|NCT03369223|559696944|FG014|Overall Study|Death|0|||
155338405|NCT03845517|560672624|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
155338406|NCT03845517|560672625|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
155338407|NCT01109979|560672626|FG000|Overall Study|Physician Decision|2|||
155338408|NCT01109979|560672627|FG001|Overall Study|Physician Decision|0|||
155338409|NCT01109979|560672626|FG000|Overall Study|Withdrawal by Subject|0|||
155338410|NCT01109979|560672627|FG001|Overall Study|Withdrawal by Subject|1|||
155338411|NCT02161458|560672628|FG000|Overall Study|Withdrawal by Subject|0|||
155338412|NCT02161458|560672629|FG001|Overall Study|Withdrawal by Subject|4|||
155338413|NCT02161458|560672630|FG002|Overall Study|Withdrawal by Subject|4|||
155338414|NCT02161458|560672631|FG003|Overall Study|Withdrawal by Subject|0|||
155338415|NCT02161458|560672628|FG000|Overall Study|Lost to Follow-up|0|||
155338416|NCT02161458|560672629|FG001|Overall Study|Lost to Follow-up|2|||
155338417|NCT02161458|560672630|FG002|Overall Study|Lost to Follow-up|1|||
155338418|NCT02161458|560672631|FG003|Overall Study|Lost to Follow-up|0|||
155338419|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
155338420|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
155338421|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338422|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338423|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338424|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338425|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
155338426|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
155338427|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
155338428|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338429|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338430|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338431|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338432|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
155338433|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
155338434|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
155338435|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338436|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338437|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338438|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338439|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
155338440|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338441|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
155338442|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338443|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338444|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338445|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338446|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
155338447|NCT03136861|560672633|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
155338448|NCT03136861|560672634|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
155338449|NCT03136861|560672635|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338450|NCT03136861|560672636|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338451|NCT03136861|560672637|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338452|NCT03136861|560672638|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338453|NCT03136861|560672639|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
155338454|NCT03136861|560672633|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338455|NCT03136861|560672634|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338456|NCT03136861|560672635|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338457|NCT03136861|560672636|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
155338458|NCT03136861|560672637|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
155338459|NCT03136861|560672638|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
155338460|NCT03136861|560672639|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
155338461|NCT03136861|560672633|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155073191|NCT03369223|559696945|FG015|Overall Study|Death|0|||
155073192|NCT03369223|559696946|FG016|Overall Study|Death|0|||
155073193|NCT03369223|559696947|FG017|Overall Study|Death|0|||
155073194|NCT03369223|559696948|FG018|Overall Study|Death|1|||
155338462|NCT03136861|560672634|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155073195|NCT03369223|559696949|FG019|Overall Study|Death|0|||
155164153|NCT03894813|560038812|FG001|Overall Study|Pregnancy|1|||
155338463|NCT03136861|560672635|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
155338464|NCT03136861|560672636|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338465|NCT03136861|560672637|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338466|NCT03136861|560672638|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338467|NCT03136861|560672639|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
155338468|NCT03136861|560672633|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338469|NCT03136861|560672634|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338470|NCT03136861|560672635|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
155338471|NCT03136861|560672636|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338472|NCT03136861|560672637|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338473|NCT03136861|560672638|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338474|NCT03136861|560672639|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
155338475|NCT03390166|560672640|FG000|Overall Study|Death|0|||
155338476|NCT03390166|560672641|FG001|Overall Study|Death|1|||
155338477|NCT03390166|560672640|FG000|Overall Study|Lost to Follow-up|6|||
155338478|NCT03390166|560672641|FG001|Overall Study|Lost to Follow-up|4|||
155338479|NCT03390166|560672640|FG000|Overall Study|Physician Decision|2|||
155338480|NCT03390166|560672641|FG001|Overall Study|Physician Decision|1|||
155338481|NCT03390166|560672640|FG000|Overall Study|Move from study area|3|||
155338482|NCT03390166|560672641|FG001|Overall Study|Move from study area|2|||
155338483|NCT03390166|560672640|FG000|Overall Study|To militarycamp for conscript|1|||
155338484|NCT03390166|560672641|FG001|Overall Study|To militarycamp for conscript|0|||
155338485|NCT03390166|560672640|FG000|Overall Study|To drug therapy course|0|||
155338486|NCT03390166|560672641|FG001|Overall Study|To drug therapy course|1|||
155338487|NCT03390166|560672640|FG000|Overall Study|Move to work oversea|0|||
155338488|NCT03390166|560672641|FG001|Overall Study|Move to work oversea|1|||
155338489|NCT00274287|560672644|FG000|Overall Study|Withdrawal by Subject|1|||
155338490|NCT00274287|560672644|FG000|Overall Study|subject non-compliance|1|||
155338491|NCT01880736|560672648|FG000|Overall Study|Adverse Event|0|||
155338492|NCT01880736|560672649|FG001|Overall Study|Adverse Event|0|||
155338493|NCT01880736|560672650|FG002|Overall Study|Adverse Event|0|||
155338494|NCT01880736|560672651|FG003|Overall Study|Adverse Event|1|||
155338495|NCT01880736|560672648|FG000|Overall Study|Withdrawal Criteria|1|||
155338496|NCT01880736|560672649|FG001|Overall Study|Withdrawal Criteria|2|||
155338497|NCT01880736|560672650|FG002|Overall Study|Withdrawal Criteria|1|||
155338498|NCT01880736|560672651|FG003|Overall Study|Withdrawal Criteria|5|||
155338499|NCT00747149|560674019|FG000|Overall Study|Adverse Event|0|||
155338500|NCT00747149|560674020|FG001|Overall Study|Adverse Event|15|||
155338501|NCT00747149|560674019|FG000|Overall Study|Lost to Follow-up|0|||
155338502|NCT00747149|560674020|FG001|Overall Study|Lost to Follow-up|10|||
155338503|NCT00747149|560674019|FG000|Overall Study|Withdrawal by Subject|0|||
155338504|NCT00747149|560674020|FG001|Overall Study|Withdrawal by Subject|6|||
155338505|NCT00747149|560674019|FG000|Overall Study|Did not receive treatment|0|||
155338506|NCT00747149|560674020|FG001|Overall Study|Did not receive treatment|1|||
155338507|NCT00747149|560674019|FG000|Overall Study|Incorrect enrollment|0|||
155338508|NCT00747149|560674020|FG001|Overall Study|Incorrect enrollment|6|||
155338509|NCT00747149|560674019|FG000|Overall Study|Severe non-compliance to protocol|0|||
155338510|NCT00747149|560674020|FG001|Overall Study|Severe non-compliance to protocol|1|||
155338511|NCT00747149|560674019|FG000|Overall Study|Not reported|1|||
155338512|NCT00747149|560674020|FG001|Overall Study|Not reported|4|||
155338513|NCT03840200|560674021|FG000|Overall Study|Death|6|||
155338514|NCT03840200|560674022|FG001|Overall Study|Death|3|||
155338515|NCT03840200|560674023|FG002|Overall Study|Death|6|||
155338516|NCT03840200|560674024|FG003|Overall Study|Death|10|||
155338517|NCT03840200|560674021|FG000|Overall Study|Reason Not Specified|2|||
155338518|NCT03840200|560674022|FG001|Overall Study|Reason Not Specified|2|||
155338519|NCT03840200|560674023|FG002|Overall Study|Reason Not Specified|1|||
155338520|NCT03840200|560674024|FG003|Overall Study|Reason Not Specified|15|||
155338521|NCT03840200|560674021|FG000|Overall Study|Physician Decision|0|||
155338522|NCT03840200|560674022|FG001|Overall Study|Physician Decision|0|||
155338523|NCT03840200|560674023|FG002|Overall Study|Physician Decision|0|||
155338524|NCT03840200|560674024|FG003|Overall Study|Physician Decision|2|||
155338525|NCT03840200|560674021|FG000|Overall Study|Progressive Disease|0|||
155338526|NCT03840200|560674022|FG001|Overall Study|Progressive Disease|0|||
155338527|NCT03840200|560674023|FG002|Overall Study|Progressive Disease|0|||
155338528|NCT03840200|560674024|FG003|Overall Study|Progressive Disease|1|||
155338529|NCT03840200|560674021|FG000|Overall Study|Withdrawal by Subject|0|||
155338530|NCT03840200|560674022|FG001|Overall Study|Withdrawal by Subject|1|||
155338531|NCT03840200|560674023|FG002|Overall Study|Withdrawal by Subject|0|||
155338532|NCT03840200|560674024|FG003|Overall Study|Withdrawal by Subject|2|||
155338533|NCT02196259|560674027|FG000|Overall Study|Researcher choice|0|||
155073196|NCT03369223|559696930|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155073197|NCT03369223|559696931|FG001|Overall Study|Adverse event unrelated to study drug|0|||
155073198|NCT03369223|559696932|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155073199|NCT03369223|559696933|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155073200|NCT03369223|559696934|FG004|Overall Study|Adverse event unrelated to study drug|0|||
155073201|NCT03369223|559696935|FG005|Overall Study|Adverse event unrelated to study drug|0|||
155073202|NCT03369223|559696936|FG006|Overall Study|Adverse event unrelated to study drug|1|||
155073203|NCT03369223|559696937|FG007|Overall Study|Adverse event unrelated to study drug|0|||
155073204|NCT03369223|559696938|FG008|Overall Study|Adverse event unrelated to study drug|0|||
155073205|NCT03369223|559696939|FG009|Overall Study|Adverse event unrelated to study drug|1|||
155073206|NCT03369223|559696940|FG010|Overall Study|Adverse event unrelated to study drug|0|||
155073207|NCT03369223|559696941|FG011|Overall Study|Adverse event unrelated to study drug|0|||
155073208|NCT03369223|559696942|FG012|Overall Study|Adverse event unrelated to study drug|0|||
155073209|NCT03369223|559696943|FG013|Overall Study|Adverse event unrelated to study drug|4|||
155073210|NCT03369223|559696944|FG014|Overall Study|Adverse event unrelated to study drug|2|||
155073211|NCT03369223|559696945|FG015|Overall Study|Adverse event unrelated to study drug|0|||
155073212|NCT03369223|559696946|FG016|Overall Study|Adverse event unrelated to study drug|2|||
155073213|NCT03369223|559696947|FG017|Overall Study|Adverse event unrelated to study drug|1|||
155073214|NCT03369223|559696948|FG018|Overall Study|Adverse event unrelated to study drug|3|||
155073215|NCT03369223|559696949|FG019|Overall Study|Adverse event unrelated to study drug|2|||
155073216|NCT03369223|559696930|FG000|Overall Study|Disease progression|6|||
155073217|NCT03369223|559696931|FG001|Overall Study|Disease progression|8|||
155073218|NCT03369223|559696932|FG002|Overall Study|Disease progression|5|||
155073219|NCT03369223|559696933|FG003|Overall Study|Disease progression|1|||
155073220|NCT03369223|559696934|FG004|Overall Study|Disease progression|9|||
155073221|NCT03369223|559696935|FG005|Overall Study|Disease progression|9|||
155073222|NCT03369223|559696936|FG006|Overall Study|Disease progression|4|||
155073223|NCT03369223|559696937|FG007|Overall Study|Disease progression|6|||
155073224|NCT03369223|559696938|FG008|Overall Study|Disease progression|10|||
155073225|NCT03369223|559696939|FG009|Overall Study|Disease progression|7|||
155073226|NCT03369223|559696940|FG010|Overall Study|Disease progression|4|||
155073227|NCT03369223|559696941|FG011|Overall Study|Disease progression|1|||
155073228|NCT03369223|559696942|FG012|Overall Study|Disease progression|1|||
155073229|NCT03369223|559696943|FG013|Overall Study|Disease progression|25|||
155073230|NCT03369223|559696944|FG014|Overall Study|Disease progression|22|||
155073231|NCT03369223|559696945|FG015|Overall Study|Disease progression|2|||
155073232|NCT03369223|559696946|FG016|Overall Study|Disease progression|10|||
155073233|NCT03369223|559696947|FG017|Overall Study|Disease progression|1|||
155073234|NCT03369223|559696948|FG018|Overall Study|Disease progression|18|||
155073235|NCT03369223|559696949|FG019|Overall Study|Disease progression|28|||
155073236|NCT03369223|559696930|FG000|Overall Study|Study drug toxicity|0|||
155073237|NCT03369223|559696931|FG001|Overall Study|Study drug toxicity|1|||
155073238|NCT03369223|559696932|FG002|Overall Study|Study drug toxicity|4|||
155073239|NCT03369223|559696933|FG003|Overall Study|Study drug toxicity|0|||
155073240|NCT03369223|559696934|FG004|Overall Study|Study drug toxicity|1|||
155073241|NCT03369223|559696935|FG005|Overall Study|Study drug toxicity|2|||
155073242|NCT03369223|559696936|FG006|Overall Study|Study drug toxicity|4|||
155073243|NCT03369223|559696937|FG007|Overall Study|Study drug toxicity|2|||
155073244|NCT03369223|559696938|FG008|Overall Study|Study drug toxicity|2|||
155073245|NCT03369223|559696939|FG009|Overall Study|Study drug toxicity|0|||
155073246|NCT03369223|559696940|FG010|Overall Study|Study drug toxicity|6|||
155073247|NCT03369223|559696941|FG011|Overall Study|Study drug toxicity|1|||
155073248|NCT03369223|559696942|FG012|Overall Study|Study drug toxicity|2|||
155073249|NCT03369223|559696943|FG013|Overall Study|Study drug toxicity|19|||
155073250|NCT03369223|559696944|FG014|Overall Study|Study drug toxicity|19|||
155073251|NCT03369223|559696945|FG015|Overall Study|Study drug toxicity|0|||
155073252|NCT03369223|559696946|FG016|Overall Study|Study drug toxicity|18|||
155073253|NCT03369223|559696947|FG017|Overall Study|Study drug toxicity|3|||
155073254|NCT03369223|559696948|FG018|Overall Study|Study drug toxicity|11|||
155338534|NCT02196259|560674028|FG001|Overall Study|Researcher choice|0|||
155338535|NCT02196259|560674029|FG002|Overall Study|Researcher choice|1|||
155073255|NCT03369223|559696949|FG019|Overall Study|Study drug toxicity|7|||
155073256|NCT03369223|559696930|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155073257|NCT03369223|559696931|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155073258|NCT03369223|559696932|FG002|Overall Study|Participant request to discontinue study treatment|0|||
155164154|NCT03894813|560038811|FG000|Overall Study|Protocol Violation|3|||
155073259|NCT03369223|559696933|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155073260|NCT03369223|559696934|FG004|Overall Study|Participant request to discontinue study treatment|1|||
155073261|NCT03369223|559696935|FG005|Overall Study|Participant request to discontinue study treatment|1|||
155073262|NCT03369223|559696936|FG006|Overall Study|Participant request to discontinue study treatment|1|||
155338536|NCT02196259|560674027|FG000|Overall Study|Partial data analysis|0|||
155164155|NCT03894813|560038812|FG001|Overall Study|Protocol Violation|7|||
155164156|NCT03894813|560038811|FG000|Overall Study|Withdrawal by Subject|1|||
155164157|NCT03894813|560038812|FG001|Overall Study|Withdrawal by Subject|3|||
155164158|NCT03894813|560038811|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
155164159|NCT03894813|560038812|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
155164160|NCT02656693|560038826|FG000|Overall Study|Pregnancy|1|||
155164161|NCT02656693|560038827|FG001|Overall Study|Pregnancy|1|||
155164162|NCT02656693|560038828|FG002|Overall Study|Pregnancy|1|||
155164163|NCT02656693|560038826|FG000|Overall Study|Bariatric surgery|0|||
155164164|NCT02656693|560038827|FG001|Overall Study|Bariatric surgery|1|||
155164165|NCT02656693|560038828|FG002|Overall Study|Bariatric surgery|2|||
155164166|NCT01596062|560038829|FG000|Overall Study|Adverse Event|1|||
155338537|NCT02196259|560674028|FG001|Overall Study|Partial data analysis|3|||
155338538|NCT02196259|560674029|FG002|Overall Study|Partial data analysis|0|||
155338539|NCT00443820|560674030|FG000|Overall Study|Adverse Event|1|||
155338540|NCT00443820|560674031|FG001|Overall Study|Adverse Event|1|||
155338541|NCT00443820|560674032|FG002|Overall Study|Adverse Event|0|||
155338542|NCT00443820|560674033|FG003|Overall Study|Adverse Event|0|||
155338543|NCT00443820|560674030|FG000|Overall Study|Lack of Efficacy|3|||
155338544|NCT00443820|560674031|FG001|Overall Study|Lack of Efficacy|2|||
155338545|NCT00443820|560674032|FG002|Overall Study|Lack of Efficacy|1|||
155338546|NCT00443820|560674033|FG003|Overall Study|Lack of Efficacy|1|||
155338547|NCT00443820|560674030|FG000|Overall Study|Protocol Violation|2|||
155338548|NCT00443820|560674031|FG001|Overall Study|Protocol Violation|1|||
155338549|NCT00443820|560674032|FG002|Overall Study|Protocol Violation|2|||
155338550|NCT00443820|560674033|FG003|Overall Study|Protocol Violation|1|||
155338551|NCT00443820|560674030|FG000|Overall Study|Withdrawal by Subject|6|||
155338552|NCT00443820|560674031|FG001|Overall Study|Withdrawal by Subject|7|||
155338553|NCT00443820|560674032|FG002|Overall Study|Withdrawal by Subject|8|||
155338554|NCT00443820|560674033|FG003|Overall Study|Withdrawal by Subject|9|||
155338555|NCT00443820|560674030|FG000|Overall Study|Lost to Follow-up|9|||
155073263|NCT03369223|559696937|FG007|Overall Study|Participant request to discontinue study treatment|0|||
155073264|NCT03369223|559696938|FG008|Overall Study|Participant request to discontinue study treatment|0|||
155073265|NCT03369223|559696939|FG009|Overall Study|Participant request to discontinue study treatment|0|||
155073266|NCT03369223|559696940|FG010|Overall Study|Participant request to discontinue study treatment|0|||
155073267|NCT03369223|559696941|FG011|Overall Study|Participant request to discontinue study treatment|0|||
155073268|NCT03369223|559696942|FG012|Overall Study|Participant request to discontinue study treatment|0|||
155073269|NCT03369223|559696943|FG013|Overall Study|Participant request to discontinue study treatment|1|||
155073270|NCT03369223|559696944|FG014|Overall Study|Participant request to discontinue study treatment|1|||
155073271|NCT03369223|559696945|FG015|Overall Study|Participant request to discontinue study treatment|0|||
155073272|NCT03369223|559696946|FG016|Overall Study|Participant request to discontinue study treatment|0|||
155073273|NCT03369223|559696947|FG017|Overall Study|Participant request to discontinue study treatment|0|||
155073274|NCT03369223|559696948|FG018|Overall Study|Participant request to discontinue study treatment|1|||
155073275|NCT03369223|559696949|FG019|Overall Study|Participant request to discontinue study treatment|0|||
155073276|NCT03369223|559696930|FG000|Overall Study|Participant withdrew consent|0|||
155073277|NCT03369223|559696931|FG001|Overall Study|Participant withdrew consent|1|||
155164167|NCT01596062|560038830|FG001|Overall Study|Adverse Event|0|||
155164168|NCT01596062|560038831|FG002|Overall Study|Adverse Event|2|||
155338556|NCT00443820|560674031|FG001|Overall Study|Lost to Follow-up|8|||
155338557|NCT00443820|560674032|FG002|Overall Study|Lost to Follow-up|6|||
155338558|NCT00443820|560674033|FG003|Overall Study|Lost to Follow-up|5|||
155338559|NCT00443820|560674030|FG000|Overall Study|Administrative problems|0|||
155338560|NCT00443820|560674031|FG001|Overall Study|Administrative problems|0|||
155338561|NCT00443820|560674032|FG002|Overall Study|Administrative problems|0|||
155338562|NCT00443820|560674033|FG003|Overall Study|Administrative problems|1|||
155338563|NCT00443820|560674030|FG000|Overall Study|Death|0|||
155338564|NCT00443820|560674031|FG001|Overall Study|Death|0|||
155338565|NCT00443820|560674032|FG002|Overall Study|Death|1|||
155338566|NCT00443820|560674033|FG003|Overall Study|Death|0|||
155338567|NCT02507297|560674034|FG000|Overall Study|Withdrawal by Subject|1|||
155338568|NCT02507297|560674035|FG001|Overall Study|Withdrawal by Subject|0|||
155164169|NCT01596062|560038829|FG000|Overall Study|Lack of Efficacy|0|||
155338569|NCT02507297|560674034|FG000|Overall Study|Lost to Follow-up|0|||
155338570|NCT02507297|560674035|FG001|Overall Study|Lost to Follow-up|1|||
155338571|NCT02489799|560674036|FG000|Overall Study|Lost to Follow-up|4|||
155338572|NCT02489799|560674037|FG001|Overall Study|Lost to Follow-up|1|||
155338573|NCT02489799|560674036|FG000|Overall Study|Failure to Maintain Eligibility|4|||
155338574|NCT02489799|560674037|FG001|Overall Study|Failure to Maintain Eligibility|6|||
155338575|NCT02489799|560674036|FG000|Overall Study|Withdrawal by Subject|1|||
155338576|NCT02489799|560674037|FG001|Overall Study|Withdrawal by Subject|1|||
155338577|NCT02489799|560674036|FG000|Overall Study|Death|0|||
155338578|NCT02489799|560674037|FG001|Overall Study|Death|1|||
155338579|NCT01304940|560674047|FG000|Overall Study|not meet symptom severity requirement|3|||
155338580|NCT01304940|560674048|FG001|Overall Study|not meet symptom severity requirement|0|||
155338581|NCT04311983|560674052|FG000|Overall Study|Lost to Follow-up|421|||
155338582|NCT04311983|560674053|FG001|Overall Study|Lost to Follow-up|456|||
155338583|NCT04311983|560674052|FG000|Overall Study|Incomplete survey|7|||
155338584|NCT04311983|560674053|FG001|Overall Study|Incomplete survey|9|||
155338585|NCT04311983|560674052|FG000|Overall Study|Death|1|||
155338586|NCT04311983|560674053|FG001|Overall Study|Death|0|||
155338587|NCT01205126|560674054|FG000|Titration Phase|Adverse Event|5|||
155338588|NCT01205126|560674055|FG001|Titration Phase|Adverse Event|3|||
155338589|NCT01205126|560674054|FG000|Titration Phase|Withdrawal by Subject|5|||
155338590|NCT01205126|560674055|FG001|Titration Phase|Withdrawal by Subject|5|||
155338591|NCT01205126|560674054|FG000|Titration Phase|Lost to Follow-up|2|||
155338592|NCT01205126|560674055|FG001|Titration Phase|Lost to Follow-up|2|||
155338593|NCT01205126|560674054|FG000|Titration Phase|No stable titration dose|1|||
155338594|NCT01205126|560674055|FG001|Titration Phase|No stable titration dose|0|||
155338595|NCT01205126|560674054|FG000|Titration Phase|More than maximum dosage required|2|||
155338596|NCT01205126|560674055|FG001|Titration Phase|More than maximum dosage required|3|||
155338597|NCT01205126|560674054|FG000|Titration Phase|Other|8|||
155338598|NCT01205126|560674055|FG001|Titration Phase|Other|6|||
155338599|NCT01205126|560674054|FG000|Between Titration & Maintenance Phase|Other|0|||
155338600|NCT01205126|560674055|FG001|Between Titration & Maintenance Phase|Other|4|||
155338601|NCT01205126|560674054|FG000|Maintenance Phase|Adverse Event|3|||
155338602|NCT01205126|560674055|FG001|Maintenance Phase|Adverse Event|7|||
155338603|NCT01205126|560674054|FG000|Maintenance Phase|Death|4|||
155338604|NCT01205126|560674055|FG001|Maintenance Phase|Death|4|||
155338605|NCT01205126|560674054|FG000|Maintenance Phase|More than the maximum dosage required|5|||
155338606|NCT01205126|560674055|FG001|Maintenance Phase|More than the maximum dosage required|5|||
155338607|NCT01205126|560674054|FG000|Maintenance Phase|Prohibited drugs used|1|||
155338608|NCT01205126|560674055|FG001|Maintenance Phase|Prohibited drugs used|0|||
155338609|NCT01205126|560674054|FG000|Maintenance Phase|Other|11|||
155338610|NCT01205126|560674055|FG001|Maintenance Phase|Other|8|||
155338611|NCT01205126|560674054|FG000|Maintenance Phase|Lost to Follow-up|5|||
155338612|NCT01205126|560674055|FG001|Maintenance Phase|Lost to Follow-up|5|||
155338613|NCT01205126|560674054|FG000|Maintenance Phase|Withdrawal by Subject|8|||
155338614|NCT01205126|560674055|FG001|Maintenance Phase|Withdrawal by Subject|11|||
155073278|NCT03369223|559696932|FG002|Overall Study|Participant withdrew consent|1|||
155073279|NCT03369223|559696933|FG003|Overall Study|Participant withdrew consent|0|||
155073280|NCT03369223|559696934|FG004|Overall Study|Participant withdrew consent|0|||
155073281|NCT03369223|559696935|FG005|Overall Study|Participant withdrew consent|0|||
155073282|NCT03369223|559696936|FG006|Overall Study|Participant withdrew consent|1|||
155073283|NCT03369223|559696937|FG007|Overall Study|Participant withdrew consent|1|||
155073284|NCT03369223|559696938|FG008|Overall Study|Participant withdrew consent|1|||
155073285|NCT03369223|559696939|FG009|Overall Study|Participant withdrew consent|0|||
155338615|NCT00578344|560674056|FG000|Overall Study|Insurance problems|1|||
155338616|NCT00578344|560674056|FG000|Overall Study|Graft failure|1|||
155338617|NCT04803734|560674057|FG000|Overall Study|Withdrawal by Subject|0|||
155338618|NCT04803734|560674058|FG001|Overall Study|Withdrawal by Subject|1|||
155338619|NCT04803734|560674057|FG000|Overall Study|Protocol Violation|0|||
155338620|NCT04803734|560674058|FG001|Overall Study|Protocol Violation|1|||
155338621|NCT02309515|560674060|FG000|Overall Study|Withdrawal by Subject|0|||
154962500|NCT04493684|559287980|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962501|NCT04493684|559287981|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962502|NCT04493684|559287982|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
154962503|NCT04493684|559287966|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962504|NCT04493684|559287967|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962505|NCT04493684|559287968|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962506|NCT04493684|559287969|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962507|NCT04493684|559287970|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962508|NCT04493684|559287971|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962509|NCT04493684|559287972|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962510|NCT04493684|559287973|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962511|NCT04493684|559287974|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155164170|NCT01596062|560038830|FG001|Overall Study|Lack of Efficacy|0|||
155338622|NCT02309515|560674061|FG001|Overall Study|Withdrawal by Subject|1|||
155338623|NCT02784834|560674073|FG000|Overall Study|Lack of Efficacy|1|||
155338624|NCT01090739|560674078|FG000|Enrollment|Withdrawal by Subject|24|||
155338625|NCT01090739|560674078|FG000|Enrollment|Protocol Violation|14|||
155338626|NCT01090739|560674078|FG000|Enrollment|Lost to Follow-up|5|||
155338627|NCT01090739|560674078|FG000|Enrollment|Physician Decision|5|||
155338628|NCT01090739|560674078|FG000|Enrollment|Sponsor termination of site|4|||
155338629|NCT01090739|560674078|FG000|Enrollment|Study implant limit reached|2|||
155338630|NCT01090739|560674078|FG000|Enrollment|Adverse Event|1|||
155338631|NCT01090739|560674078|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
155338632|NCT01090739|560674078|FG000|12 Month Follow-up|Lost to Follow-up|1|||
155338633|NCT01090739|560674078|FG000|12 Month Follow-up|Physician Decision|1|||
155338634|NCT01090739|560674078|FG000|12 Month Follow-up|Death|1|||
155338635|NCT01090739|560674078|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
155338636|NCT01090739|560674078|FG000|24 Month Follow-up|Lost to Follow-up|1|||
155338637|NCT01090739|560674078|FG000|24 Month Follow-up|Death|1|||
155338638|NCT01090739|560674078|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
155338639|NCT01090739|560674078|FG000|36 Month Follow-up|Visit still pending|17|||
155338640|NCT00441168|560674079|FG000|Treatment Period|Death|3|||
155338641|NCT00441168|560674080|FG001|Treatment Period|Death|0|||
155338642|NCT00441168|560674079|FG000|Treatment Period|Adverse Event|1|||
155338643|NCT00441168|560674080|FG001|Treatment Period|Adverse Event|2|||
155338644|NCT00441168|560674079|FG000|Treatment Period|Progressive Disease|0|||
155338645|NCT00441168|560674080|FG001|Treatment Period|Progressive Disease|2|||
155338646|NCT00441168|560674079|FG000|Treatment Period|Protocol Violation|0|||
155338647|NCT00441168|560674080|FG001|Treatment Period|Protocol Violation|1|||
155338648|NCT00441168|560674079|FG000|Treatment Period|Lost to Follow-up|0|||
155338649|NCT00441168|560674080|FG001|Treatment Period|Lost to Follow-up|1|||
155338650|NCT00441168|560674079|FG000|Treatment Period|Withdrawal by Subject|3|||
155338651|NCT00441168|560674080|FG001|Treatment Period|Withdrawal by Subject|0|||
155338652|NCT00441168|560674079|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
155338653|NCT00441168|560674080|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
155338654|NCT00441168|560674079|FG000|Treatment Period|refractory disease|1|||
155338655|NCT00441168|560674080|FG001|Treatment Period|refractory disease|0|||
155338656|NCT00441168|560674079|FG000|Follow-up Period|Death|3|||
155338657|NCT00441168|560674080|FG001|Follow-up Period|Death|0|||
155338658|NCT00441168|560674079|FG000|Follow-up Period|Lost to Follow-up|5|||
155338659|NCT00441168|560674080|FG001|Follow-up Period|Lost to Follow-up|6|||
155338660|NCT00441168|560674079|FG000|Follow-up Period|Withdrawal by Subject|3|||
155338661|NCT00441168|560674080|FG001|Follow-up Period|Withdrawal by Subject|0|||
155338662|NCT00441168|560674079|FG000|Follow-up Period|Other|1|||
155338663|NCT00441168|560674080|FG001|Follow-up Period|Other|3|||
155338664|NCT02404441|560674082|FG000|Phase 1 Part|Adverse Event|1|||
155338665|NCT02404441|560674083|FG001|Phase 1 Part|Adverse Event|0|||
155338666|NCT02404441|560674084|FG002|Phase 1 Part|Adverse Event|0|||
155338667|NCT02404441|560674085|FG003|Phase 1 Part|Adverse Event|0|||
155338668|NCT02404441|560674086|FG004|Phase 1 Part|Adverse Event|0|||
155338669|NCT02404441|560674087|FG005|Phase 1 Part|Adverse Event|0|||
155338670|NCT02404441|560674088|FG006|Phase 1 Part|Adverse Event|0|||
155338671|NCT02404441|560674089|FG007|Phase 1 Part|Adverse Event|0|||
155338672|NCT02404441|560674090|FG008|Phase 1 Part|Adverse Event|0|||
155338673|NCT02404441|560674091|FG009|Phase 1 Part|Adverse Event|0|||
155338674|NCT02404441|560674082|FG000|Phase 1 Part|Physician Decision|0|||
155338675|NCT02404441|560674083|FG001|Phase 1 Part|Physician Decision|1|||
155338676|NCT02404441|560674084|FG002|Phase 1 Part|Physician Decision|0|||
155338677|NCT02404441|560674085|FG003|Phase 1 Part|Physician Decision|0|||
155338678|NCT02404441|560674086|FG004|Phase 1 Part|Physician Decision|0|||
155338679|NCT02404441|560674087|FG005|Phase 1 Part|Physician Decision|0|||
155338680|NCT02404441|560674088|FG006|Phase 1 Part|Physician Decision|0|||
155338681|NCT02404441|560674089|FG007|Phase 1 Part|Physician Decision|0|||
155338682|NCT02404441|560674090|FG008|Phase 1 Part|Physician Decision|0|||
155338683|NCT02404441|560674091|FG009|Phase 1 Part|Physician Decision|0|||
155338684|NCT02404441|560674082|FG000|Phase 1 Part|Progressive Disease|14|||
155338685|NCT02404441|560674083|FG001|Phase 1 Part|Progressive Disease|11|||
155338686|NCT02404441|560674084|FG002|Phase 1 Part|Progressive Disease|7|||
155338687|NCT02404441|560674085|FG003|Phase 1 Part|Progressive Disease|6|||
155338688|NCT02404441|560674086|FG004|Phase 1 Part|Progressive Disease|9|||
155338689|NCT02404441|560674087|FG005|Phase 1 Part|Progressive Disease|0|||
155338690|NCT02404441|560674088|FG006|Phase 1 Part|Progressive Disease|0|||
155338691|NCT02404441|560674089|FG007|Phase 1 Part|Progressive Disease|0|||
155338692|NCT02404441|560674090|FG008|Phase 1 Part|Progressive Disease|0|||
155338693|NCT02404441|560674091|FG009|Phase 1 Part|Progressive Disease|0|||
155338694|NCT02404441|560674082|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
155338695|NCT02404441|560674083|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
155338696|NCT02404441|560674084|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
155338697|NCT02404441|560674085|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
155338698|NCT02404441|560674086|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
155338699|NCT02404441|560674087|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
155338700|NCT02404441|560674088|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
155338701|NCT02404441|560674089|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
155338702|NCT02404441|560674090|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
155338703|NCT02404441|560674091|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
155338704|NCT02404441|560674082|FG000|Phase 1 Part|Death|1|||
155338705|NCT02404441|560674083|FG001|Phase 1 Part|Death|1|||
155338706|NCT02404441|560674084|FG002|Phase 1 Part|Death|1|||
155338707|NCT02404441|560674085|FG003|Phase 1 Part|Death|0|||
155338708|NCT02404441|560674086|FG004|Phase 1 Part|Death|1|||
155338709|NCT02404441|560674087|FG005|Phase 1 Part|Death|0|||
155338710|NCT02404441|560674088|FG006|Phase 1 Part|Death|0|||
155338711|NCT02404441|560674089|FG007|Phase 1 Part|Death|0|||
155338712|NCT02404441|560674090|FG008|Phase 1 Part|Death|0|||
155338713|NCT02404441|560674091|FG009|Phase 1 Part|Death|0|||
155338714|NCT02404441|560674082|FG000|Phase 2 Part|Adverse Event|0|||
155338715|NCT02404441|560674083|FG001|Phase 2 Part|Adverse Event|0|||
155338716|NCT02404441|560674084|FG002|Phase 2 Part|Adverse Event|0|||
155338717|NCT02404441|560674085|FG003|Phase 2 Part|Adverse Event|0|||
155338718|NCT02404441|560674086|FG004|Phase 2 Part|Adverse Event|0|||
155338719|NCT02404441|560674087|FG005|Phase 2 Part|Adverse Event|2|||
155338720|NCT02404441|560674088|FG006|Phase 2 Part|Adverse Event|3|||
155338721|NCT02404441|560674089|FG007|Phase 2 Part|Adverse Event|3|||
155338722|NCT02404441|560674090|FG008|Phase 2 Part|Adverse Event|6|||
155338723|NCT02404441|560674091|FG009|Phase 2 Part|Adverse Event|1|||
155338724|NCT02404441|560674082|FG000|Phase 2 Part|Physician Decision|0|||
155338725|NCT02404441|560674083|FG001|Phase 2 Part|Physician Decision|0|||
155338726|NCT02404441|560674084|FG002|Phase 2 Part|Physician Decision|0|||
155338727|NCT02404441|560674085|FG003|Phase 2 Part|Physician Decision|0|||
155338728|NCT02404441|560674086|FG004|Phase 2 Part|Physician Decision|0|||
155338729|NCT02404441|560674087|FG005|Phase 2 Part|Physician Decision|7|||
155338730|NCT02404441|560674088|FG006|Phase 2 Part|Physician Decision|9|||
155338731|NCT02404441|560674089|FG007|Phase 2 Part|Physician Decision|2|||
155338732|NCT02404441|560674090|FG008|Phase 2 Part|Physician Decision|1|||
155338733|NCT02404441|560674091|FG009|Phase 2 Part|Physician Decision|3|||
155338734|NCT02404441|560674082|FG000|Phase 2 Part|Progressive disease|0|||
155338735|NCT02404441|560674083|FG001|Phase 2 Part|Progressive disease|0|||
155338736|NCT02404441|560674084|FG002|Phase 2 Part|Progressive disease|0|||
155338737|NCT02404441|560674085|FG003|Phase 2 Part|Progressive disease|0|||
155338738|NCT02404441|560674086|FG004|Phase 2 Part|Progressive disease|0|||
155338739|NCT02404441|560674087|FG005|Phase 2 Part|Progressive disease|43|||
155338740|NCT02404441|560674088|FG006|Phase 2 Part|Progressive disease|32|||
155338741|NCT02404441|560674089|FG007|Phase 2 Part|Progressive disease|31|||
155338742|NCT02404441|560674090|FG008|Phase 2 Part|Progressive disease|39|||
155338743|NCT02404441|560674091|FG009|Phase 2 Part|Progressive disease|27|||
155338744|NCT02404441|560674082|FG000|Phase 2 Part|Subject/guardian decision|0|||
155338745|NCT02404441|560674083|FG001|Phase 2 Part|Subject/guardian decision|0|||
155338746|NCT02404441|560674084|FG002|Phase 2 Part|Subject/guardian decision|0|||
155338747|NCT02404441|560674085|FG003|Phase 2 Part|Subject/guardian decision|0|||
155338748|NCT02404441|560674086|FG004|Phase 2 Part|Subject/guardian decision|0|||
155338749|NCT02404441|560674087|FG005|Phase 2 Part|Subject/guardian decision|3|||
155338750|NCT02404441|560674088|FG006|Phase 2 Part|Subject/guardian decision|9|||
155338751|NCT02404441|560674089|FG007|Phase 2 Part|Subject/guardian decision|0|||
155338752|NCT02404441|560674090|FG008|Phase 2 Part|Subject/guardian decision|3|||
155338753|NCT02404441|560674091|FG009|Phase 2 Part|Subject/guardian decision|2|||
155338754|NCT02404441|560674082|FG000|Phase 2 Part|Death|0|||
155338755|NCT02404441|560674083|FG001|Phase 2 Part|Death|0|||
155338756|NCT02404441|560674084|FG002|Phase 2 Part|Death|0|||
155338757|NCT02404441|560674085|FG003|Phase 2 Part|Death|0|||
155338758|NCT02404441|560674086|FG004|Phase 2 Part|Death|0|||
155338759|NCT02404441|560674087|FG005|Phase 2 Part|Death|4|||
155338760|NCT02404441|560674088|FG006|Phase 2 Part|Death|8|||
155338761|NCT02404441|560674089|FG007|Phase 2 Part|Death|4|||
155338762|NCT02404441|560674090|FG008|Phase 2 Part|Death|10|||
155164171|NCT01596062|560038831|FG002|Overall Study|Lack of Efficacy|1|||
155164172|NCT02255435|560038832|FG000|Overall Study|Patient's Limited Time Availability|0|||
155164173|NCT02255435|560038833|FG001|Overall Study|Patient's Limited Time Availability|0|||
155164174|NCT02255435|560038834|FG002|Overall Study|Patient's Limited Time Availability|0|||
155164175|NCT02255435|560038835|FG003|Overall Study|Patient's Limited Time Availability|0|||
155164176|NCT02255435|560038836|FG004|Overall Study|Patient's Limited Time Availability|0|||
155164177|NCT02255435|560038837|FG005|Overall Study|Patient's Limited Time Availability|0|||
155164178|NCT02255435|560038838|FG006|Overall Study|Patient's Limited Time Availability|0|||
155164179|NCT02255435|560038839|FG007|Overall Study|Patient's Limited Time Availability|1|||
155164180|NCT02255435|560038840|FG008|Overall Study|Patient's Limited Time Availability|0|||
155164181|NCT02255435|560038841|FG009|Overall Study|Patient's Limited Time Availability|0|||
155164182|NCT02255435|560038832|FG000|Overall Study|Withdrawal by Subject|0|||
155164183|NCT02255435|560038833|FG001|Overall Study|Withdrawal by Subject|0|||
155164184|NCT02255435|560038834|FG002|Overall Study|Withdrawal by Subject|0|||
155164185|NCT02255435|560038835|FG003|Overall Study|Withdrawal by Subject|0|||
155164186|NCT02255435|560038836|FG004|Overall Study|Withdrawal by Subject|0|||
155164187|NCT02255435|560038837|FG005|Overall Study|Withdrawal by Subject|0|||
155164188|NCT02255435|560038838|FG006|Overall Study|Withdrawal by Subject|0|||
155164189|NCT02255435|560038839|FG007|Overall Study|Withdrawal by Subject|0|||
155164190|NCT02255435|560038840|FG008|Overall Study|Withdrawal by Subject|1|||
155164191|NCT02255435|560038841|FG009|Overall Study|Withdrawal by Subject|4|||
155164192|NCT02255435|560038832|FG000|Overall Study|Administrative reasons|0|||
155164193|NCT02255435|560038833|FG001|Overall Study|Administrative reasons|0|||
155164194|NCT02255435|560038834|FG002|Overall Study|Administrative reasons|0|||
155164195|NCT02255435|560038835|FG003|Overall Study|Administrative reasons|0|||
155164196|NCT02255435|560038836|FG004|Overall Study|Administrative reasons|0|||
155164197|NCT02255435|560038837|FG005|Overall Study|Administrative reasons|0|||
155164198|NCT02255435|560038838|FG006|Overall Study|Administrative reasons|0|||
155164199|NCT02255435|560038839|FG007|Overall Study|Administrative reasons|0|||
155164200|NCT02255435|560038840|FG008|Overall Study|Administrative reasons|0|||
155164201|NCT02255435|560038841|FG009|Overall Study|Administrative reasons|2|||
155164202|NCT02948634|560038845|FG000|Overall Study|Lack of efficacy and study suspended|10|||
155164203|NCT02948634|560038846|FG001|Overall Study|Lack of efficacy and study suspended|2|||
155164204|NCT00499616|560038849|FG000|Overall Study|Death|1|||
155164205|NCT00499616|560038850|FG001|Overall Study|Death|5|||
155164206|NCT00499616|560038851|FG002|Overall Study|Death|3|||
155164207|NCT00499616|560038852|FG003|Overall Study|Death|1|||
155164208|NCT00499616|560038849|FG000|Overall Study|Lack of Efficacy|5|||
155164209|NCT00499616|560038850|FG001|Overall Study|Lack of Efficacy|0|||
155164210|NCT00499616|560038851|FG002|Overall Study|Lack of Efficacy|19|||
155164211|NCT00499616|560038852|FG003|Overall Study|Lack of Efficacy|0|||
155164212|NCT00499616|560038849|FG000|Overall Study|Lost to Follow-up|0|||
155338763|NCT02404441|560674091|FG009|Phase 2 Part|Death|9|||
155338764|NCT01918033|560674092|FG000|Overall Study|Adverse Event|1|||
155338765|NCT01918033|560674093|FG001|Overall Study|Adverse Event|0|||
155338766|NCT01918033|560674094|FG002|Overall Study|Adverse Event|2|||
155338767|NCT01918033|560674092|FG000|Overall Study|Lost to Follow-up|0|||
155338768|NCT01918033|560674093|FG001|Overall Study|Lost to Follow-up|1|||
155338769|NCT01918033|560674094|FG002|Overall Study|Lost to Follow-up|0|||
155338770|NCT01918033|560674092|FG000|Overall Study|Protocol Violation|2|||
155338771|NCT01918033|560674093|FG001|Overall Study|Protocol Violation|0|||
155338772|NCT01918033|560674094|FG002|Overall Study|Protocol Violation|1|||
155338773|NCT01918033|560674092|FG000|Overall Study|Withdrawal by Subject|2|||
155338774|NCT01918033|560674093|FG001|Overall Study|Withdrawal by Subject|1|||
155338775|NCT01918033|560674094|FG002|Overall Study|Withdrawal by Subject|0|||
155338776|NCT03909100|560674100|FG000|Overall Study|Protocol Deviation|2|||
155338777|NCT03909100|560674100|FG000|Overall Study|Technical Problems|4|||
155338778|NCT03909100|560674100|FG000|Overall Study|Withdrawal by Subject|4|||
155338779|NCT03909100|560674100|FG000|Overall Study|Lost to Follow-up|1|||
155338780|NCT03909100|560674100|FG000|Overall Study|Reason not Specified|4|||
155338781|NCT00088166|560674101|FG000|Overall Study|Adverse Event|11|||
155338782|NCT00088166|560674102|FG001|Overall Study|Adverse Event|9|||
155338783|NCT00088166|560674101|FG000|Overall Study|Death|3|||
155338784|NCT00088166|560674102|FG001|Overall Study|Death|1|||
155164213|NCT00499616|560038850|FG001|Overall Study|Lost to Follow-up|0|||
155164214|NCT00499616|560038851|FG002|Overall Study|Lost to Follow-up|1|||
155338785|NCT00088166|560674101|FG000|Overall Study|Lost to Follow-up|0|||
155338786|NCT00088166|560674102|FG001|Overall Study|Lost to Follow-up|1|||
155338787|NCT00088166|560674101|FG000|Overall Study|Physician Decision|4|||
155338788|NCT00088166|560674102|FG001|Overall Study|Physician Decision|1|||
155338789|NCT00088166|560674101|FG000|Overall Study|Protocol Violation|1|||
155338790|NCT00088166|560674102|FG001|Overall Study|Protocol Violation|5|||
155338791|NCT00088166|560674101|FG000|Overall Study|Patient deterioration|29|||
155338792|NCT00088166|560674102|FG001|Overall Study|Patient deterioration|39|||
155164215|NCT00499616|560038852|FG003|Overall Study|Lost to Follow-up|0|||
155164216|NCT00499616|560038849|FG000|Overall Study|Physician Decision|6|||
155338793|NCT00088166|560674101|FG000|Overall Study|Withdrawal by Subject|5|||
155338794|NCT00088166|560674102|FG001|Overall Study|Withdrawal by Subject|5|||
155338795|NCT02671266|560674103|FG000|Overall Study|Withdrawal by Subject|1|||
155338796|NCT02671266|560674104|FG001|Overall Study|Withdrawal by Subject|1|||
155338797|NCT02538094|560674105|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
155338798|NCT02538094|560674106|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
155338799|NCT02538094|560674105|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
155338800|NCT02538094|560674106|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
155338801|NCT03803475|560674107|FG000|Overall Study|Physician Decision|1|||
155338802|NCT02807857|560674110|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
155338803|NCT02807857|560674110|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
155338804|NCT02807857|560674110|FG000|Follow-Up Set|Withdrawal by Subject|8|||
155338805|NCT02807857|560674110|FG000|Follow-Up Set|Lost to Follow-up|7|||
155338806|NCT02807857|560674110|FG000|Follow-Up Set|Physician Decision|6|||
155338807|NCT02807857|560674110|FG000|Follow-Up Set|Adverse Event|3|||
155338808|NCT02807857|560674110|FG000|Follow-Up Set|Death|27|||
155338809|NCT02807857|560674110|FG000|Follow-Up Set|Relocation|2|||
155338810|NCT00513071|560674112|FG000|Overall Study|Adverse Event|1|||
155338811|NCT00513071|560674112|FG000|Overall Study|Withdrawal by Subject|1|||
155338812|NCT00513071|560674112|FG000|Overall Study|Physician Decision|3|||
155338813|NCT00667732|560674114|FG000|Run -In (8 Weeks)|Adverse Event|4|||
155338814|NCT00667732|560674115|FG001|Run -In (8 Weeks)|Adverse Event|0|||
155338815|NCT00667732|560674116|FG002|Run -In (8 Weeks)|Adverse Event|0|||
155338816|NCT00667732|560674114|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
155338817|NCT00667732|560674115|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
155338818|NCT00667732|560674116|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
155338819|NCT00667732|560674114|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
155338820|NCT00667732|560674115|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
155338821|NCT00667732|560674116|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
155338822|NCT02106325|560674119|FG000|Phase 1|Lost to Follow-up|2|||
155338823|NCT02106325|560674120|FG001|Phase 1|Lost to Follow-up|2|||
155338824|NCT02106325|560674119|FG000|Phase 2|Lost to Follow-up|2|||
155338825|NCT02106325|560674120|FG001|Phase 2|Lost to Follow-up|3|||
155338826|NCT02106325|560674119|FG000|Phase 3|Lost to Follow-up|2|||
155338827|NCT02106325|560674120|FG001|Phase 3|Lost to Follow-up|1|||
155338828|NCT00452114|560674122|FG000|Overall Study|Physician Decision|3|||
155338829|NCT00452114|560674123|FG001|Overall Study|Physician Decision|3|||
155338830|NCT04197713|560674124|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
155338831|NCT04197713|560674125|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
155338832|NCT03242863|560674126|FG000|Study Week 1|Withdrawal by Subject|0|||
155338833|NCT03242863|560674127|FG001|Study Week 1|Withdrawal by Subject|1|||
155338834|NCT03242863|560674128|FG002|Study Week 1|Withdrawal by Subject|0|||
155338835|NCT03242863|560674129|FG003|Study Week 1|Withdrawal by Subject|0|||
155338836|NCT03242863|560674130|FG004|Study Week 1|Withdrawal by Subject|3|||
155338837|NCT03242863|560674131|FG005|Study Week 1|Withdrawal by Subject|0|||
155338838|NCT05338476|560674144|FG000|Period 2|Adverse Event|0|||
155338839|NCT05338476|560674145|FG001|Period 2|Adverse Event|1|||
155338840|NCT02831049|560674148|FG000|Overall Study|Lost to Follow-up|0|||
155338841|NCT02831049|560674149|FG001|Overall Study|Lost to Follow-up|0|||
155338842|NCT02831049|560674150|FG002|Overall Study|Lost to Follow-up|1|||
155338843|NCT02831049|560674148|FG000|Overall Study|Withdrawal by Subject|0|||
155338844|NCT02831049|560674149|FG001|Overall Study|Withdrawal by Subject|1|||
155338845|NCT02831049|560674150|FG002|Overall Study|Withdrawal by Subject|1|||
155073286|NCT03369223|559696940|FG010|Overall Study|Participant withdrew consent|0|||
155338846|NCT02831049|560674148|FG000|Overall Study|Pandemic shutdown|1|||
155338847|NCT02831049|560674149|FG001|Overall Study|Pandemic shutdown|0|||
155073287|NCT03369223|559696941|FG011|Overall Study|Participant withdrew consent|1|||
155073288|NCT03369223|559696942|FG012|Overall Study|Participant withdrew consent|0|||
155073289|NCT03369223|559696943|FG013|Overall Study|Participant withdrew consent|0|||
155338848|NCT02831049|560674150|FG002|Overall Study|Pandemic shutdown|0|||
155338849|NCT03786471|560674151|FG000|Overall Study|Death|254|||
155338850|NCT03786471|560674152|FG001|Overall Study|Death|223|||
155073290|NCT03369223|559696944|FG014|Overall Study|Participant withdrew consent|3|||
155073291|NCT03369223|559696945|FG015|Overall Study|Participant withdrew consent|0|||
155338851|NCT03786471|560674153|FG002|Overall Study|Death|37|||
155338852|NCT03786471|560674151|FG000|Overall Study|Lost to Follow-up|63|||
155338853|NCT03786471|560674152|FG001|Overall Study|Lost to Follow-up|50|||
155338854|NCT03786471|560674153|FG002|Overall Study|Lost to Follow-up|15|||
155338855|NCT03786471|560674151|FG000|Overall Study|Withdrawal by Subject|99|||
155338856|NCT03786471|560674152|FG001|Overall Study|Withdrawal by Subject|81|||
155338857|NCT03786471|560674153|FG002|Overall Study|Withdrawal by Subject|11|||
155338858|NCT00215943|560675625|FG000|Overall Study|Disease Progression|3|||
155338859|NCT00215943|560675626|FG001|Overall Study|Disease Progression|5|||
155338860|NCT00215943|560675625|FG000|Overall Study|Alternate therapy|0|||
155338861|NCT00215943|560675626|FG001|Overall Study|Alternate therapy|1|||
155338862|NCT00215943|560675625|FG000|Overall Study|Adverse Event|3|||
155073292|NCT03369223|559696946|FG016|Overall Study|Participant withdrew consent|1|||
155073293|NCT03369223|559696947|FG017|Overall Study|Participant withdrew consent|0|||
155073294|NCT03369223|559696948|FG018|Overall Study|Participant withdrew consent|4|||
155073295|NCT03369223|559696949|FG019|Overall Study|Participant withdrew consent|2|||
155073296|NCT03369223|559696930|FG000|Overall Study|Randomized but not treated|0|||
155073297|NCT03369223|559696931|FG001|Overall Study|Randomized but not treated|0|||
155073298|NCT03369223|559696932|FG002|Overall Study|Randomized but not treated|0|||
155073299|NCT03369223|559696933|FG003|Overall Study|Randomized but not treated|0|||
155073300|NCT03369223|559696934|FG004|Overall Study|Randomized but not treated|0|||
155073301|NCT03369223|559696935|FG005|Overall Study|Randomized but not treated|0|||
155073302|NCT03369223|559696936|FG006|Overall Study|Randomized but not treated|0|||
155073303|NCT03369223|559696937|FG007|Overall Study|Randomized but not treated|0|||
155073304|NCT03369223|559696938|FG008|Overall Study|Randomized but not treated|0|||
155073305|NCT03369223|559696939|FG009|Overall Study|Randomized but not treated|0|||
155073306|NCT03369223|559696940|FG010|Overall Study|Randomized but not treated|0|||
155073307|NCT03369223|559696941|FG011|Overall Study|Randomized but not treated|0|||
155073308|NCT03369223|559696942|FG012|Overall Study|Randomized but not treated|0|||
155073309|NCT03369223|559696943|FG013|Overall Study|Randomized but not treated|1|||
155073310|NCT03369223|559696944|FG014|Overall Study|Randomized but not treated|1|||
155073311|NCT03369223|559696945|FG015|Overall Study|Randomized but not treated|0|||
155073312|NCT03369223|559696946|FG016|Overall Study|Randomized but not treated|0|||
155073313|NCT03369223|559696947|FG017|Overall Study|Randomized but not treated|0|||
155073314|NCT03369223|559696948|FG018|Overall Study|Randomized but not treated|0|||
155073315|NCT03369223|559696949|FG019|Overall Study|Randomized but not treated|0|||
155073316|NCT02965833|559696951|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
155073317|NCT02965833|559696952|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
155073318|NCT02965833|559696951|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155073319|NCT02965833|559696952|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155073320|NCT02965833|559696951|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
155073321|NCT02965833|559696952|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
155073322|NCT02965833|559696951|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
155073323|NCT02965833|559696952|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
155073324|NCT02965833|559696951|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
155073325|NCT02965833|559696952|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
155073326|NCT03370302|559696953|FG000|Dose Escalation Phase|Other|0|||
155073327|NCT03370302|559696954|FG001|Dose Escalation Phase|Other|1|||
155073328|NCT03370302|559696955|FG002|Dose Escalation Phase|Other|1|||
155073329|NCT03370302|559696956|FG003|Dose Escalation Phase|Other|0|||
155073330|NCT03370302|559696957|FG004|Dose Escalation Phase|Other|0|||
155073331|NCT03370302|559696958|FG005|Dose Escalation Phase|Other|0|||
155073332|NCT03370302|559696953|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155073333|NCT03370302|559696954|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
155073334|NCT03370302|559696955|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
155073335|NCT03370302|559696956|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155073336|NCT03370302|559696957|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
155073337|NCT03370302|559696958|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
155073338|NCT03370302|559696953|FG000|Dose Escalation Phase|Adverse Event|1|||
155073339|NCT03370302|559696954|FG001|Dose Escalation Phase|Adverse Event|0|||
155073340|NCT03370302|559696955|FG002|Dose Escalation Phase|Adverse Event|2|||
155073341|NCT03370302|559696956|FG003|Dose Escalation Phase|Adverse Event|0|||
155073342|NCT03370302|559696957|FG004|Dose Escalation Phase|Adverse Event|0|||
155073343|NCT03370302|559696958|FG005|Dose Escalation Phase|Adverse Event|0|||
155073344|NCT03370302|559696953|FG000|Dose Escalation Phase|Progressive Disease|2|||
155073345|NCT03370302|559696954|FG001|Dose Escalation Phase|Progressive Disease|4|||
155073346|NCT03370302|559696955|FG002|Dose Escalation Phase|Progressive Disease|2|||
155073347|NCT03370302|559696956|FG003|Dose Escalation Phase|Progressive Disease|0|||
155073348|NCT03370302|559696957|FG004|Dose Escalation Phase|Progressive Disease|3|||
155073349|NCT03370302|559696958|FG005|Dose Escalation Phase|Progressive Disease|1|||
155073350|NCT03370302|559696953|FG000|Dose Expansion Phase|Progressive Disease|0|||
155073351|NCT03370302|559696954|FG001|Dose Expansion Phase|Progressive Disease|0|||
155073352|NCT03370302|559696955|FG002|Dose Expansion Phase|Progressive Disease|0|||
155073353|NCT03370302|559696956|FG003|Dose Expansion Phase|Progressive Disease|6|||
155073354|NCT03370302|559696957|FG004|Dose Expansion Phase|Progressive Disease|0|||
155073355|NCT03370302|559696958|FG005|Dose Expansion Phase|Progressive Disease|0|||
155073356|NCT03407482|559696959|FG000|Overall Study|Adverse Event|12|||
155073357|NCT03407482|559696959|FG000|Overall Study|Disease Relapse|1|||
155073358|NCT03407482|559696959|FG000|Overall Study|Lost to Follow-up|1|||
155338863|NCT00215943|560675626|FG001|Overall Study|Adverse Event|6|||
155338864|NCT00215943|560675625|FG000|Overall Study|Other disease|0|||
155338865|NCT00215943|560675626|FG001|Overall Study|Other disease|1|||
155338866|NCT00215943|560675625|FG000|Overall Study|Other complications|3|||
155338867|NCT00215943|560675626|FG001|Overall Study|Other complications|1|||
155338868|NCT03137784|560675629|FG000|Overall Study|Adverse Event|1|||
155338869|NCT03137784|560675630|FG001|Overall Study|Adverse Event|1|||
155338870|NCT03137784|560675631|FG002|Overall Study|Adverse Event|0|||
155338871|NCT03137784|560675632|FG003|Overall Study|Adverse Event|0|||
155338872|NCT03137784|560675633|FG004|Overall Study|Adverse Event|0|||
155338873|NCT03137784|560675634|FG005|Overall Study|Adverse Event|0|||
155338874|NCT03137784|560675629|FG000|Overall Study|Subject/guardian decision|1|||
155338875|NCT03137784|560675630|FG001|Overall Study|Subject/guardian decision|0|||
155338876|NCT03137784|560675631|FG002|Overall Study|Subject/guardian decision|0|||
155338877|NCT03137784|560675632|FG003|Overall Study|Subject/guardian decision|0|||
155338878|NCT03137784|560675633|FG004|Overall Study|Subject/guardian decision|0|||
155338879|NCT03137784|560675634|FG005|Overall Study|Subject/guardian decision|0|||
155338880|NCT03137784|560675629|FG000|Overall Study|Non-compliance with study treatment|0|||
155338881|NCT03137784|560675630|FG001|Overall Study|Non-compliance with study treatment|0|||
155338882|NCT03137784|560675631|FG002|Overall Study|Non-compliance with study treatment|0|||
155338883|NCT03137784|560675632|FG003|Overall Study|Non-compliance with study treatment|0|||
155338884|NCT03137784|560675633|FG004|Overall Study|Non-compliance with study treatment|1|||
155338885|NCT03137784|560675634|FG005|Overall Study|Non-compliance with study treatment|0|||
155338886|NCT00805792|560675635|FG000|Overall Study|Death|3|||
155338887|NCT00805792|560675635|FG000|Overall Study|Lost to Follow-up|2|||
155338888|NCT02165202|560675637|FG000|Oral Phase|Refused further participation|5|||
155338889|NCT02165202|560675638|FG001|Oral Phase|Refused further participation|1|||
155338890|NCT02165202|560675637|FG000|Oral Phase|Study product Related Toxicity|1|||
155338891|NCT02165202|560675638|FG001|Oral Phase|Study product Related Toxicity|0|||
155338892|NCT02165202|560675637|FG000|Oral Phase|Unable to contact Participant|1|||
155338893|NCT02165202|560675638|FG001|Oral Phase|Unable to contact Participant|1|||
155338894|NCT02165202|560675637|FG000|Oral Phase|Clinical reasons|1|||
155338895|NCT02165202|560675638|FG001|Oral Phase|Clinical reasons|0|||
155338896|NCT02165202|560675637|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
155338897|NCT02165202|560675638|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
155338898|NCT02165202|560675637|FG000|Oral Phase|CMC advised termination|1|||
155338899|NCT02165202|560675638|FG001|Oral Phase|CMC advised termination|0|||
155338900|NCT02165202|560675637|FG000|Oral Phase|Relocated, no follow-up planned|1|||
155338901|NCT02165202|560675638|FG001|Oral Phase|Relocated, no follow-up planned|0|||
155338902|NCT02165202|560675637|FG000|Oral Phase|Abnormal EKG|0|||
155073359|NCT03407482|559696959|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155073360|NCT03407482|559696959|FG000|Overall Study|Pregnancy|2|||
155073361|NCT03407482|559696959|FG000|Overall Study|Protocol Violation|1|||
155073362|NCT03407482|559696959|FG000|Overall Study|Study Terminated By Sponsor|106|||
155164217|NCT00499616|560038850|FG001|Overall Study|Physician Decision|16|||
155338903|NCT02165202|560675638|FG001|Oral Phase|Abnormal EKG|1|||
155338904|NCT02165202|560675637|FG000|Injection Phase|Abnormal Lab Value|5|||
155338905|NCT02165202|560675638|FG001|Injection Phase|Abnormal Lab Value|1|||
155338906|NCT02165202|560675637|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
155338907|NCT02165202|560675638|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
155338908|NCT02165202|560675637|FG000|Injection Phase|Unable to attend within Visit Window|1|||
155338909|NCT02165202|560675638|FG001|Injection Phase|Unable to attend within Visit Window|0|||
155338910|NCT02165202|560675637|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
155338911|NCT02165202|560675638|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
155338912|NCT02165202|560675637|FG000|Injection Phase|End of Study|2|||
155338913|NCT02165202|560675638|FG001|Injection Phase|End of Study|1|||
155073363|NCT03407482|559696959|FG000|Overall Study|Withdrawal by Subject|6|||
155073364|NCT03407482|559696959|FG000|Overall Study|Data Entry Error|1|||
155338914|NCT02165202|560675637|FG000|Injection Phase|Study Product related Toxicity|1|||
155338915|NCT02165202|560675638|FG001|Injection Phase|Study Product related Toxicity|0|||
155338916|NCT02165202|560675637|FG000|Injection Phase|No longer interested|0|||
155338917|NCT02165202|560675638|FG001|Injection Phase|No longer interested|1|||
155338918|NCT02165202|560675637|FG000|Injection Phase|Participant unwilling to comply|1|||
155338919|NCT02165202|560675638|FG001|Injection Phase|Participant unwilling to comply|0|||
155073365|NCT03442569|559696962|FG000|Overall Study|Subject was ineligible after enrollment|1|||
155073366|NCT03010501|559696965|FG000|Study Week 1|Withdrawal by Subject|2|||
155338920|NCT00990184|560675646|FG000|Overall Study|Physician Decision|1|||
155338921|NCT02753075|560675649|FG000|Overall Study|Adverse Event|2|||
155338922|NCT02753075|560675650|FG001|Overall Study|Adverse Event|1|||
155338923|NCT02753075|560675651|FG002|Overall Study|Adverse Event|0|||
155338924|NCT02753075|560675649|FG000|Overall Study|Lost to Follow-up|2|||
155338925|NCT02753075|560675650|FG001|Overall Study|Lost to Follow-up|0|||
155338926|NCT02753075|560675651|FG002|Overall Study|Lost to Follow-up|0|||
155338927|NCT02753075|560675649|FG000|Overall Study|Withdrawal of Consent|1|||
155338928|NCT02753075|560675650|FG001|Overall Study|Withdrawal of Consent|1|||
155338929|NCT02753075|560675651|FG002|Overall Study|Withdrawal of Consent|3|||
155338930|NCT02753075|560675649|FG000|Overall Study|Physician Decision|3|||
155338931|NCT02753075|560675650|FG001|Overall Study|Physician Decision|1|||
155338932|NCT02753075|560675651|FG002|Overall Study|Physician Decision|0|||
155338933|NCT02152384|560675652|FG000|Period 1|Withdrawal by Subject|0|||
155338934|NCT02152384|560675653|FG001|Period 1|Withdrawal by Subject|1|||
155073367|NCT03010501|559696966|FG001|Study Week 1|Withdrawal by Subject|1|||
155073368|NCT03010501|559696967|FG002|Study Week 1|Withdrawal by Subject|0|||
155073369|NCT03010501|559696968|FG003|Study Week 1|Withdrawal by Subject|2|||
155073370|NCT03010501|559696969|FG004|Study Week 1|Withdrawal by Subject|0|||
155073371|NCT03010501|559696970|FG005|Study Week 1|Withdrawal by Subject|0|||
155073372|NCT03010501|559696965|FG000|Study Week 3|Withdrawal by Subject|0|||
155073373|NCT03010501|559696966|FG001|Study Week 3|Withdrawal by Subject|0|||
155073374|NCT03010501|559696967|FG002|Study Week 3|Withdrawal by Subject|0|||
155338935|NCT02152384|560675652|FG000|Period 1|Adverse Event|1|||
155338936|NCT02152384|560675653|FG001|Period 1|Adverse Event|1|||
155073375|NCT03010501|559696968|FG003|Study Week 3|Withdrawal by Subject|1|||
155338937|NCT01215253|560675656|FG000|Overall Study|Withdrawal by Subject|57|||
155338938|NCT01215253|560675657|FG001|Overall Study|Withdrawal by Subject|35|||
155338939|NCT01215253|560675656|FG000|Overall Study|Physician Decision|9|||
155338940|NCT01215253|560675657|FG001|Overall Study|Physician Decision|12|||
155073376|NCT03010501|559696969|FG004|Study Week 3|Withdrawal by Subject|0|||
155073377|NCT03010501|559696970|FG005|Study Week 3|Withdrawal by Subject|0|||
155073378|NCT00544882|559696975|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
155073379|NCT00544882|559696976|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
155073380|NCT00544882|559696977|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
155073381|NCT00544882|559696975|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
155073382|NCT00544882|559696976|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
155338941|NCT01215253|560675656|FG000|Overall Study|Lost to Follow-up|6|||
155338942|NCT01215253|560675657|FG001|Overall Study|Lost to Follow-up|4|||
155338943|NCT01215253|560675656|FG000|Overall Study|Other|14|||
155338944|NCT01215253|560675657|FG001|Overall Study|Other|12|||
155338945|NCT01320683|560675658|FG000|Overall Study|Positive antibody response|1|||
155338946|NCT02291861|560675659|FG000|Overall Study|Adverse Event|2|||
155338947|NCT02291861|560675660|FG001|Overall Study|Adverse Event|4|||
155338948|NCT02291861|560675661|FG002|Overall Study|Adverse Event|1|||
155338949|NCT02291861|560675662|FG003|Overall Study|Adverse Event|2|||
155338950|NCT02291861|560675659|FG000|Overall Study|Death|0|||
155338951|NCT02291861|560675660|FG001|Overall Study|Death|0|||
155338952|NCT02291861|560675661|FG002|Overall Study|Death|1|||
155338953|NCT02291861|560675662|FG003|Overall Study|Death|1|||
155338954|NCT02291861|560675659|FG000|Overall Study|Protocol Violation|1|||
155338955|NCT02291861|560675660|FG001|Overall Study|Protocol Violation|0|||
155338956|NCT02291861|560675661|FG002|Overall Study|Protocol Violation|0|||
155338957|NCT02291861|560675662|FG003|Overall Study|Protocol Violation|1|||
155338958|NCT02291861|560675659|FG000|Overall Study|Withdrawal by Subject|1|||
155338959|NCT02291861|560675660|FG001|Overall Study|Withdrawal by Subject|2|||
155338960|NCT02291861|560675661|FG002|Overall Study|Withdrawal by Subject|1|||
155338961|NCT02291861|560675662|FG003|Overall Study|Withdrawal by Subject|4|||
155338962|NCT02291861|560675659|FG000|Overall Study|Noncompliance|1|||
155338963|NCT02291861|560675660|FG001|Overall Study|Noncompliance|1|||
155338964|NCT02291861|560675661|FG002|Overall Study|Noncompliance|2|||
155338965|NCT02291861|560675662|FG003|Overall Study|Noncompliance|1|||
155338966|NCT02291861|560675659|FG000|Overall Study|Lost to Follow-up|2|||
155338967|NCT02291861|560675660|FG001|Overall Study|Lost to Follow-up|1|||
155338968|NCT02291861|560675661|FG002|Overall Study|Lost to Follow-up|4|||
155338969|NCT02291861|560675662|FG003|Overall Study|Lost to Follow-up|0|||
155338970|NCT02291861|560675659|FG000|Overall Study|Other|0|||
155338971|NCT02291861|560675660|FG001|Overall Study|Other|0|||
155338972|NCT02291861|560675661|FG002|Overall Study|Other|0|||
155338973|NCT02291861|560675662|FG003|Overall Study|Other|1|||
155338974|NCT00267956|560675665|FG000|Controlled Period|Adverse Event|4|||
155073383|NCT00544882|559696977|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
155073384|NCT00544882|559696975|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
155073385|NCT00544882|559696976|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
155073386|NCT00544882|559696977|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
155073387|NCT00544882|559696975|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
155073388|NCT00544882|559696976|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
155073389|NCT00544882|559696977|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
155073390|NCT00544882|559696975|FG000|Cycle 3: Follow-up|Noncompliance|0|||
155073391|NCT00544882|559696976|FG001|Cycle 3: Follow-up|Noncompliance|1|||
155073392|NCT00544882|559696977|FG002|Cycle 3: Follow-up|Noncompliance|0|||
155073393|NCT00544882|559696975|FG000|Cycle 3: Follow-up|Pregnancy|0|||
155073394|NCT00544882|559696976|FG001|Cycle 3: Follow-up|Pregnancy|1|||
155073395|NCT00544882|559696977|FG002|Cycle 3: Follow-up|Pregnancy|0|||
155073396|NCT02583269|559696978|FG000|Overall Study|Patient hospitalized prior to start|1|||
155073397|NCT02583269|559696979|FG001|Overall Study|Patient hospitalized prior to start|0|||
155073398|NCT02583269|559696980|FG002|Overall Study|Patient hospitalized prior to start|0|||
155073399|NCT02583269|559696981|FG003|Overall Study|Patient hospitalized prior to start|0|||
155073400|NCT02583269|559696982|FG004|Overall Study|Patient hospitalized prior to start|0|||
155073401|NCT02369458|559696984|FG000|Overall Study|Determined to be not eligible|1|||
155073402|NCT02369458|559696985|FG001|Overall Study|Determined to be not eligible|0|||
155073403|NCT03853798|559696988|FG000|Overall Study|Death|0|||
155073404|NCT03853798|559696989|FG001|Overall Study|Death|0|||
155073405|NCT03853798|559696990|FG002|Overall Study|Death|0|||
155073406|NCT03853798|559696991|FG003|Overall Study|Death|0|||
155073407|NCT03853798|559696992|FG004|Overall Study|Death|0|||
155164218|NCT00499616|560038851|FG002|Overall Study|Physician Decision|9|||
155338975|NCT00267956|560675666|FG001|Controlled Period|Adverse Event|1|||
155338976|NCT00267956|560675667|FG002|Controlled Period|Adverse Event|0|||
155338977|NCT00267956|560675668|FG003|Controlled Period|Adverse Event|0|||
155338978|NCT00267956|560675665|FG000|Controlled Period|Lack of Efficacy|4|||
155338979|NCT00267956|560675666|FG001|Controlled Period|Lack of Efficacy|2|||
155164219|NCT00499616|560038852|FG003|Overall Study|Physician Decision|0|||
155338980|NCT00267956|560675667|FG002|Controlled Period|Lack of Efficacy|0|||
155338981|NCT00267956|560675668|FG003|Controlled Period|Lack of Efficacy|0|||
155338982|NCT00267956|560675665|FG000|Controlled Period|Lost to Follow-up|2|||
155338983|NCT00267956|560675666|FG001|Controlled Period|Lost to Follow-up|0|||
155338984|NCT00267956|560675667|FG002|Controlled Period|Lost to Follow-up|0|||
155338985|NCT00267956|560675668|FG003|Controlled Period|Lost to Follow-up|0|||
155338986|NCT00267956|560675665|FG000|Controlled Period|Withdrew consent|3|||
155338987|NCT00267956|560675666|FG001|Controlled Period|Withdrew consent|1|||
155338988|NCT00267956|560675667|FG002|Controlled Period|Withdrew consent|0|||
155338989|NCT00267956|560675668|FG003|Controlled Period|Withdrew consent|0|||
155338990|NCT00267956|560675665|FG000|After Controlled Period|Adverse Event|0|||
155338991|NCT00267956|560675666|FG001|After Controlled Period|Adverse Event|0|||
155338992|NCT00267956|560675667|FG002|After Controlled Period|Adverse Event|2|||
155338993|NCT00267956|560675668|FG003|After Controlled Period|Adverse Event|1|||
155338994|NCT00267956|560675665|FG000|After Controlled Period|Lack of Efficacy|0|||
155338995|NCT00267956|560675666|FG001|After Controlled Period|Lack of Efficacy|0|||
155338996|NCT00267956|560675667|FG002|After Controlled Period|Lack of Efficacy|1|||
155338997|NCT00267956|560675668|FG003|After Controlled Period|Lack of Efficacy|1|||
155338998|NCT00267956|560675665|FG000|After Controlled Period|Lost to Follow-up|0|||
155338999|NCT00267956|560675666|FG001|After Controlled Period|Lost to Follow-up|0|||
155339000|NCT00267956|560675667|FG002|After Controlled Period|Lost to Follow-up|1|||
155339001|NCT00267956|560675668|FG003|After Controlled Period|Lost to Follow-up|0|||
155339002|NCT00267956|560675665|FG000|After Controlled Period|Withdrew consent|0|||
155339003|NCT00267956|560675666|FG001|After Controlled Period|Withdrew consent|0|||
155339004|NCT00267956|560675667|FG002|After Controlled Period|Withdrew consent|1|||
155339005|NCT00267956|560675668|FG003|After Controlled Period|Withdrew consent|0|||
155339006|NCT01263223|560675669|FG000|Period 2|Withdrawal by Subject|0|||
155339007|NCT01263223|560675670|FG001|Period 2|Withdrawal by Subject|1|||
155339008|NCT01263223|560675669|FG000|7-day Follow-up|Withdrawal by Subject|0|||
155339009|NCT01263223|560675670|FG001|7-day Follow-up|Withdrawal by Subject|1|||
155339010|NCT01263223|560675669|FG000|7-day Follow-up|Lost to Follow-up|1|||
155339011|NCT01263223|560675670|FG001|7-day Follow-up|Lost to Follow-up|0|||
155339012|NCT02005484|560675673|FG000|Overall Study|Death|1|||
155339013|NCT02005484|560675673|FG000|Overall Study|Disease progression|1|||
155339014|NCT02005484|560675673|FG000|Overall Study|Changed to a Different Study|1|||
155339015|NCT02005484|560675673|FG000|Overall Study|Sponsor decision|1|||
155339016|NCT02246647|560675674|FG000|Overall Study|Withdrawal by Subject|1|||
155339017|NCT02246647|560675675|FG001|Overall Study|Withdrawal by Subject|1|||
155339018|NCT01393964|560675676|FG000|Overall Study|Disease Progression|4|||
155339019|NCT01393964|560675677|FG001|Overall Study|Disease Progression|3|||
155339020|NCT01393964|560675678|FG002|Overall Study|Disease Progression|5|||
155339021|NCT01393964|560675676|FG000|Overall Study|Study drug toxicity|1|||
155339022|NCT01393964|560675677|FG001|Overall Study|Study drug toxicity|0|||
155339023|NCT01393964|560675678|FG002|Overall Study|Study drug toxicity|0|||
155339024|NCT01393964|560675676|FG000|Overall Study|Withdrawal by Subject|0|||
155339025|NCT01393964|560675677|FG001|Overall Study|Withdrawal by Subject|0|||
155339026|NCT01393964|560675678|FG002|Overall Study|Withdrawal by Subject|1|||
155339027|NCT01393964|560675676|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155339028|NCT01393964|560675677|FG001|Overall Study|Adverse event unrelated to study drug|3|||
155339029|NCT01393964|560675678|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155339030|NCT01393964|560675676|FG000|Overall Study|Subject request stop study treatment|0|||
155339031|NCT01393964|560675677|FG001|Overall Study|Subject request stop study treatment|1|||
155073408|NCT03853798|559696993|FG005|Overall Study|Death|1|||
155339032|NCT01393964|560675678|FG002|Overall Study|Subject request stop study treatment|0|||
155339033|NCT01393964|560675676|FG000|Overall Study|Subject decided to move to transplant|1|||
155339034|NCT01393964|560675677|FG001|Overall Study|Subject decided to move to transplant|0|||
155339035|NCT01393964|560675678|FG002|Overall Study|Subject decided to move to transplant|0|||
155073409|NCT03853798|559696994|FG006|Overall Study|Death|0|||
155073410|NCT03853798|559696995|FG007|Overall Study|Death|0|||
155073411|NCT03853798|559696996|FG008|Overall Study|Death|0|||
155073412|NCT03853798|559696988|FG000|Overall Study|Adverse Event|0|||
155073413|NCT03853798|559696989|FG001|Overall Study|Adverse Event|0|||
155073414|NCT03853798|559696990|FG002|Overall Study|Adverse Event|2|||
155073415|NCT03853798|559696991|FG003|Overall Study|Adverse Event|0|||
155073416|NCT03853798|559696992|FG004|Overall Study|Adverse Event|0|||
155073417|NCT03853798|559696993|FG005|Overall Study|Adverse Event|0|||
155073418|NCT03853798|559696994|FG006|Overall Study|Adverse Event|0|||
155073419|NCT03853798|559696995|FG007|Overall Study|Adverse Event|0|||
155073420|NCT03853798|559696996|FG008|Overall Study|Adverse Event|0|||
155073421|NCT03853798|559696988|FG000|Overall Study|Withdrawal by Subject|0|||
155073422|NCT03853798|559696989|FG001|Overall Study|Withdrawal by Subject|1|||
155073423|NCT03853798|559696990|FG002|Overall Study|Withdrawal by Subject|4|||
155073424|NCT03853798|559696991|FG003|Overall Study|Withdrawal by Subject|0|||
155073425|NCT03853798|559696992|FG004|Overall Study|Withdrawal by Subject|0|||
155073426|NCT03853798|559696993|FG005|Overall Study|Withdrawal by Subject|5|||
155073427|NCT03853798|559696994|FG006|Overall Study|Withdrawal by Subject|0|||
155073428|NCT03853798|559696995|FG007|Overall Study|Withdrawal by Subject|0|||
155073429|NCT03853798|559696996|FG008|Overall Study|Withdrawal by Subject|4|||
155073430|NCT03853798|559696988|FG000|Overall Study|Physician Decision|1|||
155073431|NCT03853798|559696989|FG001|Overall Study|Physician Decision|0|||
155073432|NCT03853798|559696990|FG002|Overall Study|Physician Decision|0|||
155073433|NCT03853798|559696991|FG003|Overall Study|Physician Decision|0|||
155073434|NCT03853798|559696992|FG004|Overall Study|Physician Decision|0|||
155073435|NCT03853798|559696993|FG005|Overall Study|Physician Decision|0|||
155073436|NCT03853798|559696994|FG006|Overall Study|Physician Decision|0|||
155073437|NCT03853798|559696995|FG007|Overall Study|Physician Decision|0|||
155073438|NCT03853798|559696996|FG008|Overall Study|Physician Decision|1|||
155073439|NCT03853798|559696988|FG000|Overall Study|Lack of Efficacy|0|||
155073440|NCT03853798|559696989|FG001|Overall Study|Lack of Efficacy|0|||
155073441|NCT03853798|559696990|FG002|Overall Study|Lack of Efficacy|2|||
155073442|NCT03853798|559696991|FG003|Overall Study|Lack of Efficacy|0|||
155073443|NCT03853798|559696992|FG004|Overall Study|Lack of Efficacy|0|||
155073444|NCT03853798|559696993|FG005|Overall Study|Lack of Efficacy|0|||
155073445|NCT03853798|559696994|FG006|Overall Study|Lack of Efficacy|0|||
155073446|NCT03853798|559696995|FG007|Overall Study|Lack of Efficacy|0|||
155073447|NCT03853798|559696996|FG008|Overall Study|Lack of Efficacy|1|||
155073448|NCT03853798|559696988|FG000|Overall Study|Approved Drug Available for Indication|0|||
155073449|NCT03853798|559696989|FG001|Overall Study|Approved Drug Available for Indication|0|||
155073450|NCT03853798|559696990|FG002|Overall Study|Approved Drug Available for Indication|1|||
155073451|NCT03853798|559696991|FG003|Overall Study|Approved Drug Available for Indication|0|||
155073452|NCT03853798|559696992|FG004|Overall Study|Approved Drug Available for Indication|0|||
155073453|NCT03853798|559696993|FG005|Overall Study|Approved Drug Available for Indication|1|||
155073454|NCT03853798|559696994|FG006|Overall Study|Approved Drug Available for Indication|0|||
155073455|NCT03853798|559696995|FG007|Overall Study|Approved Drug Available for Indication|0|||
155073456|NCT03853798|559696996|FG008|Overall Study|Approved Drug Available for Indication|0|||
155073457|NCT03853798|559696988|FG000|Overall Study|Other un-specified|0|||
155073458|NCT03853798|559696989|FG001|Overall Study|Other un-specified|0|||
155073459|NCT03853798|559696990|FG002|Overall Study|Other un-specified|2|||
155073460|NCT03853798|559696991|FG003|Overall Study|Other un-specified|0|||
155073461|NCT03853798|559696992|FG004|Overall Study|Other un-specified|0|||
155073462|NCT03853798|559696993|FG005|Overall Study|Other un-specified|1|||
155073463|NCT03853798|559696994|FG006|Overall Study|Other un-specified|0|||
155073464|NCT03853798|559696995|FG007|Overall Study|Other un-specified|0|||
155073465|NCT03853798|559696996|FG008|Overall Study|Other un-specified|0|||
155073466|NCT02743494|559696997|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
155073467|NCT02743494|559696998|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
155073468|NCT02743494|559696997|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
155073469|NCT02743494|559696998|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
155073470|NCT02743494|559696997|FG000|Treatment Period|Disease recurrence|152|||
155339036|NCT01393964|560675676|FG000|Overall Study|Subject switched to commercial supply|1|||
155339037|NCT01393964|560675677|FG001|Overall Study|Subject switched to commercial supply|0|||
155339038|NCT01393964|560675678|FG002|Overall Study|Subject switched to commercial supply|2|||
155073471|NCT02743494|559696998|FG001|Treatment Period|Disease recurrence|115|||
155073472|NCT02743494|559696997|FG000|Treatment Period|Study drug toxicity|56|||
155073473|NCT02743494|559696998|FG001|Treatment Period|Study drug toxicity|8|||
155073474|NCT02743494|559696997|FG000|Treatment Period|Death|1|||
155073475|NCT02743494|559696998|FG001|Treatment Period|Death|1|||
155073476|NCT02743494|559696997|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
155073477|NCT02743494|559696998|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
155073478|NCT02743494|559696997|FG000|Treatment Period|Participant request to discontinue treatment|31|||
155073479|NCT02743494|559696998|FG001|Treatment Period|Participant request to discontinue treatment|5|||
155339039|NCT01393964|560675676|FG000|Overall Study|Subject plateaued in terms of effect|1|||
155339040|NCT01393964|560675677|FG001|Overall Study|Subject plateaued in terms of effect|0|||
155339041|NCT01393964|560675678|FG002|Overall Study|Subject plateaued in terms of effect|0|||
155339042|NCT01393964|560675676|FG000|Overall Study|Investigator removed subject from study|0|||
155339043|NCT01393964|560675677|FG001|Overall Study|Investigator removed subject from study|1|||
155339044|NCT01393964|560675678|FG002|Overall Study|Investigator removed subject from study|0|||
155339045|NCT01393964|560675676|FG000|Overall Study|Subject converted to roll-over study|0|||
155339046|NCT01393964|560675677|FG001|Overall Study|Subject converted to roll-over study|1|||
155339047|NCT01393964|560675678|FG002|Overall Study|Subject converted to roll-over study|0|||
155339048|NCT01393964|560675676|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
155339049|NCT01393964|560675677|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
155339050|NCT01393964|560675678|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
155339051|NCT01113541|560675679|FG000|Overall Study|Withdrawal by Subject|1|||
155339052|NCT01113541|560675679|FG000|Overall Study|Protocol Violation|1|||
155339053|NCT01113541|560675679|FG000|Overall Study|Study Terminated by Sponsor|7|||
155339054|NCT01113541|560675679|FG000|Overall Study|Adverse Event|4|||
155339055|NCT04679675|560675682|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
155339056|NCT04679675|560675683|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
155339057|NCT04679675|560675684|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
155339058|NCT04679675|560675685|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
155339059|NCT04679675|560675682|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
155339060|NCT04679675|560675683|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
155339061|NCT04679675|560675684|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
155339062|NCT04679675|560675685|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
155339063|NCT01794299|560675690|FG000|Overall Study|ATIR manufacturing not possible|1|||
155339064|NCT01794299|560675690|FG000|Overall Study|Death|14|||
155339065|NCT01794299|560675690|FG000|Overall Study|Graft failure|1|||
155339066|NCT01794299|560675690|FG000|Overall Study|ATIR batch rejected|2|||
155339067|NCT01794299|560675690|FG000|Overall Study|Relapse|2|||
155339068|NCT01794299|560675690|FG000|Overall Study|Discontinued from active follow-up|1|||
155339069|NCT01794299|560675690|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
155339070|NCT03006393|560675691|FG000|Overall Study|Withdrawal by Subject|1|||
155339071|NCT03006393|560675692|FG001|Overall Study|Withdrawal by Subject|1|||
155339072|NCT03006393|560675691|FG000|Overall Study|Pregnancy|0|||
155339073|NCT03006393|560675692|FG001|Overall Study|Pregnancy|1|||
155339074|NCT03006393|560675691|FG000|Overall Study|Lost to Follow-up|0|||
155339075|NCT03006393|560675692|FG001|Overall Study|Lost to Follow-up|1|||
155339076|NCT00807599|560675695|FG000|Overall Study|Not treated on protocol study|0|||
155339077|NCT00807599|560675696|FG001|Overall Study|Not treated on protocol study|0|||
155339078|NCT00807599|560675697|FG002|Overall Study|Not treated on protocol study|2|||
155339079|NCT00807599|560675695|FG000|Overall Study|Adverse Event|0|||
155339080|NCT00807599|560675696|FG001|Overall Study|Adverse Event|0|||
155339081|NCT00807599|560675697|FG002|Overall Study|Adverse Event|5|||
155339082|NCT00807599|560675695|FG000|Overall Study|Inadequate response to induction|0|||
155339083|NCT00807599|560675696|FG001|Overall Study|Inadequate response to induction|0|||
154962512|NCT04493684|559287975|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155339084|NCT00807599|560675697|FG002|Overall Study|Inadequate response to induction|9|||
155339085|NCT00807599|560675695|FG000|Overall Study|Withdrawal by Subject|0|||
154962513|NCT04493684|559287976|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155339086|NCT00807599|560675696|FG001|Overall Study|Withdrawal by Subject|0|||
155339087|NCT00807599|560675697|FG002|Overall Study|Withdrawal by Subject|1|||
155339088|NCT03695185|560675698|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
155339089|NCT03695185|560675698|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
155339090|NCT03695185|560675698|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
155339091|NCT03695185|560675698|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
155339092|NCT03695185|560675698|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
155339093|NCT03695185|560675698|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
155339094|NCT01328756|560675702|FG000|Overall Study|Protocol Violation|4|||
155339095|NCT01328756|560675702|FG000|Overall Study|Adverse Event|39|||
155339096|NCT01328756|560675702|FG000|Overall Study|Lack of Efficacy|5|||
155339097|NCT01328756|560675702|FG000|Overall Study|Withdrawal by Subject|41|||
155339098|NCT01328756|560675702|FG000|Overall Study|Lost to Follow-up|5|||
155339099|NCT01328756|560675702|FG000|Overall Study|Other|29|||
155339100|NCT04183491|560675708|FG000|Overall Study|Withdrawal by Subject|0|||
155339101|NCT04183491|560675709|FG001|Overall Study|Withdrawal by Subject|0|||
155339102|NCT04183491|560675710|FG002|Overall Study|Withdrawal by Subject|1|||
155339103|NCT04183491|560675711|FG003|Overall Study|Withdrawal by Subject|0|||
155339104|NCT04183491|560675712|FG004|Overall Study|Withdrawal by Subject|0|||
155339105|NCT04183491|560675713|FG005|Overall Study|Withdrawal by Subject|1|||
155339106|NCT04183491|560675714|FG006|Overall Study|Withdrawal by Subject|0|||
155339107|NCT03288506|560675715|FG000|Overall Study|Withdrawal by Subject|52|||
155339108|NCT03692871|560675716|FG000|Overall Study|Death|1|||
155339109|NCT03692871|560675717|FG001|Overall Study|Death|1|||
155339110|NCT03692871|560675716|FG000|Overall Study|Lost to Follow-up|24|||
155339111|NCT03692871|560675717|FG001|Overall Study|Lost to Follow-up|9|||
155339112|NCT03692871|560675716|FG000|Overall Study|Physician Decision|22|||
155339113|NCT03692871|560675717|FG001|Overall Study|Physician Decision|7|||
155339114|NCT03692871|560675716|FG000|Overall Study|Protocol Deviation|1|||
155339115|NCT03692871|560675717|FG001|Overall Study|Protocol Deviation|0|||
155339116|NCT03692871|560675716|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
155339117|NCT03692871|560675717|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
155339118|NCT02852824|560675720|FG000|Overall Study|Withdrawal by Subject|1|||
155339119|NCT02852824|560675721|FG001|Overall Study|Withdrawal by Subject|0|||
155339120|NCT02852824|560675722|FG002|Overall Study|Withdrawal by Subject|0|||
155339121|NCT02852824|560675723|FG003|Overall Study|Withdrawal by Subject|0|||
155339122|NCT02852824|560675724|FG004|Overall Study|Withdrawal by Subject|0|||
155339123|NCT02852824|560675725|FG005|Overall Study|Withdrawal by Subject|0|||
155339124|NCT02852824|560675726|FG006|Overall Study|Withdrawal by Subject|0|||
155339125|NCT02852824|560675720|FG000|Overall Study|Adverse Event|0|||
155339126|NCT02852824|560675721|FG001|Overall Study|Adverse Event|0|||
155339127|NCT02852824|560675722|FG002|Overall Study|Adverse Event|0|||
155339128|NCT02852824|560675723|FG003|Overall Study|Adverse Event|0|||
155339129|NCT02852824|560675724|FG004|Overall Study|Adverse Event|2|||
155339130|NCT02852824|560675725|FG005|Overall Study|Adverse Event|0|||
155339131|NCT02852824|560675726|FG006|Overall Study|Adverse Event|0|||
155339132|NCT01316913|560675727|FG000|Overall Study|Adverse Event|17|||
155339133|NCT01316913|560675728|FG001|Overall Study|Adverse Event|20|||
155339134|NCT01316913|560675729|FG002|Overall Study|Adverse Event|15|||
155339135|NCT01316913|560675730|FG003|Overall Study|Adverse Event|11|||
155339136|NCT01316913|560675727|FG000|Overall Study|Lack of Efficacy|22|||
155339137|NCT01316913|560675728|FG001|Overall Study|Lack of Efficacy|12|||
155339138|NCT01316913|560675729|FG002|Overall Study|Lack of Efficacy|9|||
155339139|NCT01316913|560675730|FG003|Overall Study|Lack of Efficacy|13|||
155339140|NCT01316913|560675727|FG000|Overall Study|Protocol Violation|1|||
155339141|NCT01316913|560675728|FG001|Overall Study|Protocol Violation|4|||
155339142|NCT01316913|560675729|FG002|Overall Study|Protocol Violation|4|||
155339143|NCT01316913|560675730|FG003|Overall Study|Protocol Violation|1|||
155339144|NCT01316913|560675727|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
155339145|NCT01316913|560675728|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
155164220|NCT00499616|560038849|FG000|Overall Study|Withdrawal by Subject|1|||
155339146|NCT01316913|560675729|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
155339147|NCT01316913|560675730|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
155339148|NCT01316913|560675727|FG000|Overall Study|Lost to Follow-up|0|||
155339149|NCT01316913|560675728|FG001|Overall Study|Lost to Follow-up|1|||
155339150|NCT01316913|560675729|FG002|Overall Study|Lost to Follow-up|0|||
155339151|NCT01316913|560675730|FG003|Overall Study|Lost to Follow-up|2|||
155339152|NCT01316913|560675727|FG000|Overall Study|Withdrawal by Subject|10|||
155339153|NCT01316913|560675728|FG001|Overall Study|Withdrawal by Subject|9|||
155339154|NCT01316913|560675729|FG002|Overall Study|Withdrawal by Subject|10|||
155339155|NCT01316913|560675730|FG003|Overall Study|Withdrawal by Subject|6|||
155339156|NCT01860079|560675731|FG000|Overall Study|Physician Decision|14|||
155339157|NCT01860079|560675732|FG001|Overall Study|Physician Decision|22|||
155339158|NCT04867382|560675733|FG000|Overall Study|Did not complete the survey|2|||
155339159|NCT04867382|560675734|FG001|Overall Study|Did not complete the survey|1|||
155339160|NCT02102724|560675735|FG000|Overall Study|Lost to Follow-up|1|||
155339161|NCT02102724|560675736|FG001|Overall Study|Lost to Follow-up|0|||
155339162|NCT02102724|560675735|FG000|Overall Study|surgery for brain aneurysm|1|||
155339163|NCT02102724|560675736|FG001|Overall Study|surgery for brain aneurysm|1|||
155339164|NCT05445557|560675737|FG000|Double Blind Part|Lost to Follow-up|1|||
155339165|NCT02008916|560675738|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
155339166|NCT02008916|560675739|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
155339167|NCT02008916|560675740|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
155339168|NCT02008916|560675738|FG000|Week 16 - 156|Adverse Event|4|||
155339169|NCT02008916|560675739|FG001|Week 16 - 156|Adverse Event|2|||
155339170|NCT02008916|560675740|FG002|Week 16 - 156|Adverse Event|3|||
155339171|NCT02008916|560675738|FG000|Week 16 - 156|Withdrawal by Subject|7|||
155339172|NCT02008916|560675739|FG001|Week 16 - 156|Withdrawal by Subject|3|||
155339173|NCT02008916|560675740|FG002|Week 16 - 156|Withdrawal by Subject|5|||
155339174|NCT02008916|560675738|FG000|Week 16 - 156|No longer requires treatment|0|||
155339175|NCT02008916|560675739|FG001|Week 16 - 156|No longer requires treatment|1|||
155339176|NCT02008916|560675740|FG002|Week 16 - 156|No longer requires treatment|0|||
155339177|NCT02008916|560675738|FG000|Week 16 - 156|Lost to Follow-up|5|||
155339178|NCT02008916|560675739|FG001|Week 16 - 156|Lost to Follow-up|0|||
155339179|NCT02008916|560675740|FG002|Week 16 - 156|Lost to Follow-up|0|||
155339180|NCT02008916|560675738|FG000|Week 16 - 156|Lack of Efficacy|3|||
155339181|NCT02008916|560675739|FG001|Week 16 - 156|Lack of Efficacy|5|||
155339182|NCT02008916|560675740|FG002|Week 16 - 156|Lack of Efficacy|2|||
155339183|NCT02008916|560675738|FG000|Week 16 - 156|Pregnancy|0|||
155339184|NCT02008916|560675739|FG001|Week 16 - 156|Pregnancy|1|||
155339185|NCT02008916|560675740|FG002|Week 16 - 156|Pregnancy|0|||
155339186|NCT02008916|560675738|FG000|Week 16 - 156|Physician Decision|0|||
155339187|NCT02008916|560675739|FG001|Week 16 - 156|Physician Decision|1|||
155339188|NCT02008916|560675740|FG002|Week 16 - 156|Physician Decision|0|||
155339189|NCT01323790|560675741|FG000|Overall Study|Other|3|||
155339190|NCT01323790|560675742|FG001|Overall Study|Other|2|||
155339191|NCT01323790|560675743|FG002|Overall Study|Other|1|||
155339192|NCT01323790|560675741|FG000|Overall Study|Lost to Follow-up|11|||
155339193|NCT01323790|560675742|FG001|Overall Study|Lost to Follow-up|9|||
155339194|NCT01323790|560675743|FG002|Overall Study|Lost to Follow-up|9|||
155339195|NCT01323790|560675741|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
155339196|NCT01323790|560675742|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
155339197|NCT01323790|560675743|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
155339198|NCT01323790|560675741|FG000|Overall Study|Lack of Efficacy|3|||
155339199|NCT01323790|560675742|FG001|Overall Study|Lack of Efficacy|0|||
155339200|NCT01323790|560675743|FG002|Overall Study|Lack of Efficacy|3|||
155339201|NCT01323790|560675741|FG000|Overall Study|Adverse Event|11|||
155339202|NCT01323790|560675742|FG001|Overall Study|Adverse Event|24|||
155339203|NCT01323790|560675743|FG002|Overall Study|Adverse Event|12|||
155339204|NCT01323790|560675741|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155339205|NCT01323790|560675742|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155339206|NCT01323790|560675743|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
155339207|NCT01323790|560675741|FG000|Overall Study|Withdrawal by Subject|23|||
155339208|NCT01323790|560675742|FG001|Overall Study|Withdrawal by Subject|20|||
155339209|NCT01323790|560675743|FG002|Overall Study|Withdrawal by Subject|13|||
155339210|NCT01323790|560675741|FG000|Overall Study|Did Not Receive Treatment|2|||
155339211|NCT01323790|560675742|FG001|Overall Study|Did Not Receive Treatment|0|||
155339212|NCT01323790|560675743|FG002|Overall Study|Did Not Receive Treatment|1|||
155339213|NCT01323790|560675741|FG000|Overall Study|Severe non-compliance with protocol|2|||
155339214|NCT01323790|560675742|FG001|Overall Study|Severe non-compliance with protocol|2|||
155339215|NCT01323790|560675743|FG002|Overall Study|Severe non-compliance with protocol|2|||
155339216|NCT00266656|560675750|FG000|Overall Study|Death|1|||
155339217|NCT00266656|560675751|FG001|Overall Study|Death|0|||
155339218|NCT00266656|560675750|FG000|Overall Study|Lost to Follow-up|4|||
155339219|NCT00266656|560675751|FG001|Overall Study|Lost to Follow-up|1|||
155339220|NCT00266656|560675750|FG000|Overall Study|Withdrawal by Subject|4|||
155339221|NCT00266656|560675751|FG001|Overall Study|Withdrawal by Subject|2|||
155339222|NCT00266656|560675750|FG000|Overall Study|Did Not Reach Final Height|4|||
155339223|NCT00266656|560675751|FG001|Overall Study|Did Not Reach Final Height|8|||
155339224|NCT00266656|560675750|FG000|Overall Study|Parent/Caregiver Decision|1|||
155339225|NCT00266656|560675751|FG001|Overall Study|Parent/Caregiver Decision|2|||
155339226|NCT02915783|560675753|FG000|Overall Study|Death|21|||
155339227|NCT02915783|560675753|FG000|Overall Study|Lost to Follow-up|1|||
155339228|NCT02915783|560675753|FG000|Overall Study|Withdrawal by Subject|2|||
155339229|NCT02950961|560675754|FG000|Overall Study|Study had to stop due to COVID.|7|||
155339230|NCT01915914|560675757|FG000|Acute Phase|Withdrawal by Subject|4|||
155339231|NCT01915914|560675758|FG001|Acute Phase|Withdrawal by Subject|0|||
155339232|NCT01915914|560675759|FG002|Acute Phase|Withdrawal by Subject|0|||
155339233|NCT01915914|560675760|FG003|Acute Phase|Withdrawal by Subject|0|||
155339234|NCT01915914|560675757|FG000|Acute Phase|Lost to Follow-up|4|||
155339235|NCT01915914|560675758|FG001|Acute Phase|Lost to Follow-up|0|||
155339236|NCT01915914|560675759|FG002|Acute Phase|Lost to Follow-up|0|||
155339237|NCT01915914|560675760|FG003|Acute Phase|Lost to Follow-up|0|||
155339238|NCT01915914|560675757|FG000|Acute Phase|Physician Decision|1|||
155339239|NCT01915914|560675758|FG001|Acute Phase|Physician Decision|0|||
155339240|NCT01915914|560675759|FG002|Acute Phase|Physician Decision|0|||
155339241|NCT01915914|560675760|FG003|Acute Phase|Physician Decision|0|||
155339242|NCT01915914|560675757|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
155339243|NCT01915914|560675758|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
155339244|NCT01915914|560675759|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
155339245|NCT01915914|560675760|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
155339246|NCT01915914|560675757|FG000|Acute Phase|"Not Achieved treatment success"|1|||
155339247|NCT01915914|560675758|FG001|Acute Phase|"Not Achieved treatment success"|0|||
155339248|NCT01915914|560675759|FG002|Acute Phase|"Not Achieved treatment success"|0|||
155339249|NCT01915914|560675760|FG003|Acute Phase|"Not Achieved treatment success"|0|||
155339250|NCT01915914|560675757|FG000|Acute Phase|Missing|1|||
155339251|NCT01915914|560675758|FG001|Acute Phase|Missing|0|||
155339252|NCT01915914|560675759|FG002|Acute Phase|Missing|0|||
155339253|NCT01915914|560675760|FG003|Acute Phase|Missing|0|||
155339254|NCT01915914|560675757|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155339255|NCT01915914|560675758|FG001|Maintenance Phase|Withdrawal by Subject|1|||
155339256|NCT01915914|560675759|FG002|Maintenance Phase|Withdrawal by Subject|1|||
155339257|NCT01915914|560675760|FG003|Maintenance Phase|Withdrawal by Subject|0|||
155339258|NCT01915914|560675757|FG000|Maintenance Phase|Lost to Follow-up|0|||
155339259|NCT01915914|560675758|FG001|Maintenance Phase|Lost to Follow-up|4|||
155339260|NCT01915914|560675759|FG002|Maintenance Phase|Lost to Follow-up|1|||
155339261|NCT01915914|560675760|FG003|Maintenance Phase|Lost to Follow-up|0|||
155339262|NCT01915914|560675757|FG000|Maintenance Phase|Missing|0|||
155339263|NCT01915914|560675758|FG001|Maintenance Phase|Missing|1|||
155339264|NCT01915914|560675759|FG002|Maintenance Phase|Missing|0|||
155339265|NCT01915914|560675760|FG003|Maintenance Phase|Missing|0|||
155339266|NCT01915914|560675757|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155339267|NCT01915914|560675758|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155339268|NCT01915914|560675759|FG002|Follow-up Phase|Withdrawal by Subject|0|||
155339269|NCT01915914|560675760|FG003|Follow-up Phase|Withdrawal by Subject|1|||
155339270|NCT01915914|560675757|FG000|Follow-up Phase|Physician Decision|0|||
155339271|NCT01915914|560675758|FG001|Follow-up Phase|Physician Decision|0|||
155339272|NCT01915914|560675759|FG002|Follow-up Phase|Physician Decision|0|||
155339273|NCT01915914|560675760|FG003|Follow-up Phase|Physician Decision|1|||
155339274|NCT00428714|560675762|FG000|Overall Study|Progressive Disease|28|||
155339275|NCT00428714|560675763|FG001|Overall Study|Progressive Disease|36|||
155339276|NCT00428714|560675762|FG000|Overall Study|Withdrawal by Subject|0|||
155339277|NCT00428714|560675763|FG001|Overall Study|Withdrawal by Subject|3|||
155339278|NCT00428714|560675762|FG000|Overall Study|Adverse Event|0|||
155339279|NCT00428714|560675763|FG001|Overall Study|Adverse Event|2|||
155339280|NCT00428714|560675762|FG000|Overall Study|Physician Decision|1|||
155339281|NCT00428714|560675763|FG001|Overall Study|Physician Decision|1|||
155339282|NCT00428714|560675762|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
155339283|NCT00428714|560675763|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
155339284|NCT00428714|560675762|FG000|Overall Study|Death due to other then PD|1|||
155339285|NCT00428714|560675763|FG001|Overall Study|Death due to other then PD|0|||
155339286|NCT02432274|560675764|FG000|Overall Study|Death|2|||
155339287|NCT02432274|560675765|FG001|Overall Study|Death|6|||
155073480|NCT02743494|559696997|FG000|Treatment Period|Participant withdrew consent|11|||
155073481|NCT02743494|559696998|FG001|Treatment Period|Participant withdrew consent|4|||
155339288|NCT02432274|560675766|FG002|Overall Study|Death|7|||
155339289|NCT02432274|560675767|FG003|Overall Study|Death|0|||
155339290|NCT02432274|560675768|FG004|Overall Study|Death|27|||
155339291|NCT02432274|560675769|FG005|Overall Study|Death|7|||
155339292|NCT02432274|560675770|FG006|Overall Study|Death|9|||
155339293|NCT02432274|560675771|FG007|Overall Study|Death|14|||
155339294|NCT02432274|560675764|FG000|Overall Study|Withdrawal of Consent|0|||
155339295|NCT02432274|560675765|FG001|Overall Study|Withdrawal of Consent|0|||
155339296|NCT02432274|560675766|FG002|Overall Study|Withdrawal of Consent|0|||
155339297|NCT02432274|560675767|FG003|Overall Study|Withdrawal of Consent|0|||
155339298|NCT02432274|560675768|FG004|Overall Study|Withdrawal of Consent|2|||
155339299|NCT02432274|560675769|FG005|Overall Study|Withdrawal of Consent|0|||
155339300|NCT02432274|560675770|FG006|Overall Study|Withdrawal of Consent|1|||
155339301|NCT02432274|560675771|FG007|Overall Study|Withdrawal of Consent|2|||
155339302|NCT01736475|560675772|FG000|Overall Study|Adverse Event|4|||
155339303|NCT01736475|560675773|FG001|Overall Study|Adverse Event|0|||
155339304|NCT01736475|560675772|FG000|Overall Study|Withdrawal by Subject|2|||
154962514|NCT04493684|559287977|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
154962515|NCT04493684|559287978|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155164221|NCT00499616|560038850|FG001|Overall Study|Withdrawal by Subject|0|||
155164222|NCT00499616|560038851|FG002|Overall Study|Withdrawal by Subject|1|||
155164223|NCT00499616|560038852|FG003|Overall Study|Withdrawal by Subject|0|||
155164224|NCT00499616|560038849|FG000|Overall Study|Ineligible|1|||
155164225|NCT00499616|560038850|FG001|Overall Study|Ineligible|2|||
155164226|NCT00499616|560038851|FG002|Overall Study|Ineligible|0|||
155164227|NCT00499616|560038852|FG003|Overall Study|Ineligible|15|||
155164228|NCT00499616|560038849|FG000|Overall Study|Not evaluable|0|||
155164229|NCT00499616|560038850|FG001|Overall Study|Not evaluable|0|||
155164230|NCT00499616|560038851|FG002|Overall Study|Not evaluable|0|||
155164231|NCT00499616|560038852|FG003|Overall Study|Not evaluable|41|||
155164232|NCT00499616|560038849|FG000|Overall Study|Patient/Parent Refusal|1|||
155164233|NCT00499616|560038850|FG001|Overall Study|Patient/Parent Refusal|5|||
155164234|NCT00499616|560038851|FG002|Overall Study|Patient/Parent Refusal|3|||
155164235|NCT00499616|560038852|FG003|Overall Study|Patient/Parent Refusal|0|||
155164236|NCT01255436|560038853|FG000|Overall Study|Lost to Follow-up|178|||
155164237|NCT01255436|560038854|FG001|Overall Study|Lost to Follow-up|191|||
155164238|NCT01255436|560038853|FG000|Overall Study|Death, stroke, or MI|4|||
155164239|NCT01255436|560038854|FG001|Overall Study|Death, stroke, or MI|3|||
155164240|NCT04816669|560038855|FG000|Part 1|Adverse Event|1|||
155164241|NCT04816669|560038856|FG001|Part 1|Adverse Event|1|||
155164242|NCT04816669|560038857|FG002|Part 1|Adverse Event|0|||
155164243|NCT04816669|560038858|FG003|Part 1|Adverse Event|0|||
155164244|NCT04816669|560038855|FG000|Part 1|Lost to Follow-up|2|||
155164245|NCT04816669|560038856|FG001|Part 1|Lost to Follow-up|2|||
155164246|NCT04816669|560038857|FG002|Part 1|Lost to Follow-up|0|||
155164247|NCT04816669|560038858|FG003|Part 1|Lost to Follow-up|0|||
155164248|NCT04816669|560038855|FG000|Part 1|Protocol Violation|0|||
155164249|NCT04816669|560038856|FG001|Part 1|Protocol Violation|1|||
154962516|NCT04493684|559287979|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962517|NCT04493684|559287980|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962518|NCT04493684|559287981|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
155164250|NCT04816669|560038857|FG002|Part 1|Protocol Violation|0|||
155164251|NCT04816669|560038858|FG003|Part 1|Protocol Violation|0|||
155164252|NCT04816669|560038855|FG000|Part 1|Withdrawal by Subject|1|||
155339305|NCT01736475|560675773|FG001|Overall Study|Withdrawal by Subject|0|||
155339306|NCT01736475|560675772|FG000|Overall Study|Protocol Violation|4|||
155339307|NCT01736475|560675773|FG001|Overall Study|Protocol Violation|0|||
155339308|NCT01736475|560675772|FG000|Overall Study|Other - Screen failure|1|||
155339309|NCT01736475|560675773|FG001|Overall Study|Other - Screen failure|0|||
155339310|NCT01736475|560675772|FG000|Overall Study|Other - Surgical procedure|1|||
155339311|NCT01736475|560675773|FG001|Overall Study|Other - Surgical procedure|0|||
155339312|NCT02114515|560675775|FG000|Overall Study|Lost to Follow-up|52|||
155339313|NCT02114515|560675776|FG001|Overall Study|Lost to Follow-up|55|||
155339314|NCT02114515|560675775|FG000|Overall Study|Death|12|||
155339315|NCT02114515|560675776|FG001|Overall Study|Death|12|||
155339316|NCT02114515|560675775|FG000|Overall Study|Withdrawal by Subject|4|||
155339317|NCT02114515|560675776|FG001|Overall Study|Withdrawal by Subject|22|||
155339318|NCT02114515|560675775|FG000|Overall Study|Other|65|||
155339319|NCT02114515|560675776|FG001|Overall Study|Other|61|||
155339320|NCT05522777|560677169|FG000|Overall Study|Lack of Efficacy|1|||
155339321|NCT05522777|560677169|FG000|Overall Study|Withdrawal by Subject|1|||
155164253|NCT04816669|560038856|FG001|Part 1|Withdrawal by Subject|2|||
155164254|NCT04816669|560038857|FG002|Part 1|Withdrawal by Subject|0|||
155164255|NCT04816669|560038858|FG003|Part 1|Withdrawal by Subject|0|||
155164256|NCT04816669|560038855|FG000|Part 2|Other|0|||
155164257|NCT04816669|560038856|FG001|Part 2|Other|0|||
155164258|NCT04816669|560038857|FG002|Part 2|Other|1|||
155164259|NCT04816669|560038858|FG003|Part 2|Other|0|||
155164260|NCT04816669|560038855|FG000|Part 2|Withdrawal by Subject|0|||
155164261|NCT04816669|560038856|FG001|Part 2|Withdrawal by Subject|0|||
155339322|NCT05487300|560677172|FG000|Overall Study|Withdrawal by Subject|1|||
155339323|NCT05487300|560677173|FG001|Overall Study|Withdrawal by Subject|0|||
155339324|NCT03141177|560677174|FG000|Overall Study|Death|62|||
155339325|NCT03141177|560677175|FG001|Overall Study|Death|13|||
155073482|NCT02743494|559696997|FG000|Treatment Period|Lost to Follow-up|0|||
155073483|NCT02743494|559696998|FG001|Treatment Period|Lost to Follow-up|1|||
155073484|NCT02743494|559696997|FG000|Treatment Period|Poor/Non-compliance|2|||
155073485|NCT02743494|559696998|FG001|Treatment Period|Poor/Non-compliance|0|||
155073486|NCT02743494|559696997|FG000|Treatment Period|Other reasons|4|||
155073487|NCT02743494|559696998|FG001|Treatment Period|Other reasons|1|||
155073488|NCT02207608|559696999|FG000|Overall Study|Adverse Event|1|||
155073489|NCT02207608|559697000|FG001|Overall Study|Adverse Event|0|||
155073490|NCT05800145|559697001|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
155073491|NCT05800145|559697002|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155164262|NCT04816669|560038857|FG002|Part 2|Withdrawal by Subject|0|||
155164263|NCT04816669|560038858|FG003|Part 2|Withdrawal by Subject|1|||
155164264|NCT04816669|560038855|FG000|Part 2|Lost to Follow-up|0|||
155164265|NCT04816669|560038856|FG001|Part 2|Lost to Follow-up|0|||
155164266|NCT04816669|560038857|FG002|Part 2|Lost to Follow-up|1|||
155164267|NCT04816669|560038858|FG003|Part 2|Lost to Follow-up|0|||
155164268|NCT00867815|560038864|FG000|Overall Study|Lost to Follow-up|1|||
155164269|NCT01499277|560038867|FG000|Overall Study|Adverse Event|3|||
155164270|NCT01499277|560038868|FG001|Overall Study|Adverse Event|6|||
155164271|NCT01499277|560038867|FG000|Overall Study|Death|3|||
155164272|NCT01499277|560038868|FG001|Overall Study|Death|2|||
155164273|NCT01499277|560038867|FG000|Overall Study|Lost to Follow-up|15|||
155164274|NCT01499277|560038868|FG001|Overall Study|Lost to Follow-up|8|||
155164275|NCT01499277|560038867|FG000|Overall Study|Protocol Violation|2|||
155164276|NCT01499277|560038868|FG001|Overall Study|Protocol Violation|3|||
155164277|NCT01499277|560038867|FG000|Overall Study|Withdrawal by Subject|16|||
155164278|NCT01499277|560038868|FG001|Overall Study|Withdrawal by Subject|6|||
155164279|NCT01499277|560038867|FG000|Overall Study|Lack of therapeutic response and other|8|||
155164280|NCT01499277|560038868|FG001|Overall Study|Lack of therapeutic response and other|7|||
155164281|NCT00790088|560038871|FG000|Overall Study|Protocol Violation|11|||
155164282|NCT00790088|560038871|FG000|Overall Study|Withdrawal by Subject|17|||
155164283|NCT00790088|560038871|FG000|Overall Study|Lost to Follow-up|7|||
155164284|NCT00790088|560038871|FG000|Overall Study|Physician Decision|4|||
155164285|NCT02015637|560038872|FG000|Overall Study|Lost to Follow-up|3|||
155164286|NCT02015637|560038873|FG001|Overall Study|Lost to Follow-up|5|||
155164287|NCT02015637|560038872|FG000|Overall Study|Adverse Event|3|||
155164288|NCT02015637|560038873|FG001|Overall Study|Adverse Event|0|||
155164289|NCT02015637|560038872|FG000|Overall Study|Did not take study drug|2|||
155164290|NCT02015637|560038873|FG001|Overall Study|Did not take study drug|0|||
155164291|NCT00297258|560038874|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
155164292|NCT00297258|560038874|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
155164293|NCT00297258|560038874|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
155164294|NCT00297258|560038874|FG000|Overall Study|Intercurrent Illness|3|||
155164295|NCT00297258|560038874|FG000|Overall Study|Intercurrent Death|2|||
155164296|NCT00297258|560038874|FG000|Overall Study|Deteriorization of General Condition|1|||
155164297|NCT00297258|560038874|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
155164298|NCT00297258|560038874|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
155164299|NCT00297258|560038874|FG000|Overall Study|Switch to Commercial Treatment|1|||
155164300|NCT00297258|560038874|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
155164301|NCT00473382|560038876|FG000|Core Study|Adverse Event|3|||
155164302|NCT00473382|560038877|FG001|Core Study|Adverse Event|1|||
155164303|NCT00473382|560038878|FG002|Core Study|Adverse Event|1|||
155164304|NCT00473382|560038876|FG000|Core Study|Death|3|||
155164305|NCT00473382|560038877|FG001|Core Study|Death|5|||
155164306|NCT00473382|560038878|FG002|Core Study|Death|10|||
155164307|NCT00473382|560038876|FG000|Core Study|Lost to Follow-up|3|||
155164308|NCT00473382|560038877|FG001|Core Study|Lost to Follow-up|3|||
155164309|NCT00473382|560038878|FG002|Core Study|Lost to Follow-up|3|||
155164310|NCT00473382|560038876|FG000|Core Study|Physician Decision|1|||
155164311|NCT00473382|560038877|FG001|Core Study|Physician Decision|2|||
155164312|NCT00473382|560038878|FG002|Core Study|Physician Decision|2|||
155164313|NCT00473382|560038876|FG000|Core Study|Subject non-compliance|5|||
155164314|NCT00473382|560038877|FG001|Core Study|Subject non-compliance|2|||
155164315|NCT00473382|560038878|FG002|Core Study|Subject non-compliance|1|||
155164316|NCT00473382|560038876|FG000|Core Study|Subject needed other treatment|1|||
155164317|NCT00473382|560038877|FG001|Core Study|Subject needed other treatment|3|||
155164318|NCT00473382|560038878|FG002|Core Study|Subject needed other treatment|2|||
155164319|NCT00473382|560038876|FG000|Core Study|Subject's decision|12|||
155073492|NCT05800145|559697003|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155073493|NCT05800145|559697004|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
155073494|NCT05800145|559697005|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155164320|NCT00473382|560038877|FG001|Core Study|Subject's decision|11|||
155164321|NCT00473382|560038878|FG002|Core Study|Subject's decision|10|||
155164322|NCT00473382|560038876|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
155164323|NCT00473382|560038877|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
155164324|NCT00473382|560038878|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
155339326|NCT03141177|560677176|FG002|Overall Study|Death|84|||
155073495|NCT05800145|559697006|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155073496|NCT05800145|559697001|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
155073497|NCT05800145|559697002|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155073498|NCT05800145|559697003|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155073499|NCT05800145|559697004|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
155073500|NCT05800145|559697005|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155073501|NCT05800145|559697006|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
155073502|NCT05800145|559697001|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
155073503|NCT05800145|559697002|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
155073504|NCT05800145|559697003|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
155073505|NCT05800145|559697004|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
155073506|NCT05800145|559697005|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
155073507|NCT05800145|559697006|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
155073508|NCT05643794|559698215|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
155073509|NCT05643794|559698216|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
155073510|NCT05643794|559698217|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155073511|NCT05643794|559698215|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155073512|NCT05643794|559698216|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155073513|NCT05643794|559698217|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155073514|NCT05643794|559698215|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155073515|NCT05643794|559698216|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
155073516|NCT05643794|559698217|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155073517|NCT05643794|559698215|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155073518|NCT05643794|559698216|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155073519|NCT05643794|559698217|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
155073520|NCT05643794|559698215|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
155073521|NCT05643794|559698216|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155073522|NCT05643794|559698217|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
155073523|NCT05643794|559698215|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
155073524|NCT05643794|559698216|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
155073525|NCT05643794|559698217|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
155073526|NCT04167670|559698220|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
155073527|NCT04167670|559698221|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
155073528|NCT04167670|559698222|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
155073529|NCT04167670|559698220|FG000|Overall Study|Significant protocol deviation|3|||
155073530|NCT04167670|559698221|FG001|Overall Study|Significant protocol deviation|1|||
155073531|NCT04167670|559698222|FG002|Overall Study|Significant protocol deviation|0|||
155073532|NCT04167670|559698220|FG000|Overall Study|Lost to Follow-up|0|||
155073533|NCT04167670|559698221|FG001|Overall Study|Lost to Follow-up|3|||
155073534|NCT04167670|559698222|FG002|Overall Study|Lost to Follow-up|3|||
155073535|NCT04167670|559698220|FG000|Overall Study|Voluntary Withdrawal|0|||
155073536|NCT04167670|559698221|FG001|Overall Study|Voluntary Withdrawal|1|||
155164325|NCT00473382|560038876|FG000|Open-label Extension Through Month 48|Death|1|||
155164326|NCT00473382|560038877|FG001|Open-label Extension Through Month 48|Death|3|||
155164327|NCT00473382|560038878|FG002|Open-label Extension Through Month 48|Death|3|||
155164328|NCT00473382|560038876|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
155164329|NCT00473382|560038877|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
155164330|NCT00473382|560038878|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
155164331|NCT00473382|560038876|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
155164332|NCT00473382|560038877|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
155164333|NCT00473382|560038878|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
155164334|NCT00473382|560038876|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
155164335|NCT00473382|560038877|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
155164336|NCT00473382|560038878|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
155164337|NCT00473382|560038876|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
155164338|NCT00473382|560038877|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
155164339|NCT00473382|560038878|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
155164340|NCT00473382|560038876|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
155164341|NCT00473382|560038877|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
155164342|NCT00473382|560038878|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
155164343|NCT00473382|560038876|FG000|Open-label Extension Through Month 60|Death|1|||
155164344|NCT00473382|560038877|FG001|Open-label Extension Through Month 60|Death|7|||
155164345|NCT00473382|560038878|FG002|Open-label Extension Through Month 60|Death|4|||
155164346|NCT00473382|560038876|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
155164347|NCT00473382|560038877|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
155164348|NCT00473382|560038878|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
155339327|NCT03141177|560677174|FG000|Overall Study|Participant withdrew consent|9|||
155339328|NCT03141177|560677175|FG001|Overall Study|Participant withdrew consent|2|||
155339329|NCT03141177|560677176|FG002|Overall Study|Participant withdrew consent|13|||
155339330|NCT03141177|560677174|FG000|Overall Study|Not reported|1|||
155339331|NCT03141177|560677175|FG001|Overall Study|Not reported|0|||
155339332|NCT03141177|560677176|FG002|Overall Study|Not reported|1|||
155339333|NCT03141177|560677174|FG000|Overall Study|Lost to Follow-up|2|||
155339334|NCT03141177|560677175|FG001|Overall Study|Lost to Follow-up|1|||
155339335|NCT03141177|560677176|FG002|Overall Study|Lost to Follow-up|1|||
155339336|NCT03141177|560677174|FG000|Overall Study|Other reasons|4|||
155339337|NCT03141177|560677175|FG001|Overall Study|Other reasons|0|||
155339338|NCT03141177|560677176|FG002|Overall Study|Other reasons|11|||
155339339|NCT03141177|560677174|FG000|Overall Study|Participants did not start treatment period|3|||
155339340|NCT03141177|560677175|FG001|Overall Study|Participants did not start treatment period|0|||
155339341|NCT03141177|560677176|FG002|Overall Study|Participants did not start treatment period|8|||
155339342|NCT05006703|560677177|FG000|Overall Study|Withdrawal by Subject|1|||
155339343|NCT05006703|560677178|FG001|Overall Study|Withdrawal by Subject|0|||
155339344|NCT05006703|560677177|FG000|Overall Study|Lost to Follow-up|13|||
155339345|NCT05006703|560677178|FG001|Overall Study|Lost to Follow-up|5|||
155339346|NCT00264576|560677183|FG000|Overall Study|Lost to Follow-up|1|||
155339347|NCT00264576|560677184|FG001|Overall Study|Lost to Follow-up|1|||
155339348|NCT02659059|560677185|FG000|Overall Study|Other reasons|6|||
155339349|NCT02659059|560677186|FG001|Overall Study|Other reasons|1|||
155339350|NCT02659059|560677185|FG000|Overall Study|Disease Progression|143|||
155339351|NCT02659059|560677186|FG001|Overall Study|Disease Progression|16|||
155339352|NCT02659059|560677185|FG000|Overall Study|Study Drug toxicity|56|||
155339353|NCT02659059|560677186|FG001|Overall Study|Study Drug toxicity|9|||
155339354|NCT02659059|560677185|FG000|Overall Study|Death|3|||
155339355|NCT02659059|560677186|FG001|Overall Study|Death|1|||
155339356|NCT02659059|560677185|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
155339357|NCT02659059|560677186|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
155339358|NCT02659059|560677185|FG000|Overall Study|Participant request to discontinue study treatment|5|||
155339359|NCT02659059|560677186|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155339360|NCT02659059|560677185|FG000|Overall Study|Participant withdrew consent|6|||
155339361|NCT02659059|560677186|FG001|Overall Study|Participant withdrew consent|1|||
155339362|NCT00092456|560677187|FG000|Overall Study|Adverse Event|0|||
155339363|NCT00092456|560677188|FG001|Overall Study|Adverse Event|0|||
155339364|NCT00092456|560677189|FG002|Overall Study|Adverse Event|1|||
155339365|NCT00092456|560677190|FG003|Overall Study|Adverse Event|1|||
155339366|NCT00092456|560677187|FG000|Overall Study|Lost to Follow-up|2|||
155339367|NCT00092456|560677188|FG001|Overall Study|Lost to Follow-up|2|||
155164349|NCT00473382|560038876|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
155164350|NCT00473382|560038877|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
155164351|NCT00473382|560038878|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
155164352|NCT00473382|560038876|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
155339368|NCT00092456|560677189|FG002|Overall Study|Lost to Follow-up|1|||
155339369|NCT00092456|560677190|FG003|Overall Study|Lost to Follow-up|2|||
155339370|NCT00092456|560677187|FG000|Overall Study|Protocol Violation|5|||
155339371|NCT00092456|560677188|FG001|Overall Study|Protocol Violation|7|||
155339372|NCT00092456|560677189|FG002|Overall Study|Protocol Violation|8|||
155339373|NCT00092456|560677190|FG003|Overall Study|Protocol Violation|6|||
155339374|NCT00092456|560677187|FG000|Overall Study|Withdrawal by Subject|13|||
155339375|NCT00092456|560677188|FG001|Overall Study|Withdrawal by Subject|5|||
155339376|NCT00092456|560677189|FG002|Overall Study|Withdrawal by Subject|16|||
155339377|NCT00092456|560677190|FG003|Overall Study|Withdrawal by Subject|6|||
155339378|NCT00092456|560677187|FG000|Overall Study|Moved|1|||
155339379|NCT00092456|560677188|FG001|Overall Study|Moved|1|||
155339380|NCT00092456|560677189|FG002|Overall Study|Moved|0|||
155339381|NCT00092456|560677190|FG003|Overall Study|Moved|1|||
155339382|NCT00092456|560677187|FG000|Overall Study|Other|4|||
155339383|NCT00092456|560677188|FG001|Overall Study|Other|2|||
155339384|NCT00092456|560677189|FG002|Overall Study|Other|3|||
155339385|NCT00092456|560677190|FG003|Overall Study|Other|0|||
155339386|NCT04783389|560677191|FG000|Overall Study|Withdrawal by Subject|2|||
155339387|NCT04783389|560677192|FG001|Overall Study|Withdrawal by Subject|0|||
155339388|NCT04783389|560677193|FG002|Overall Study|Withdrawal by Subject|0|||
155339389|NCT04783389|560677191|FG000|Overall Study|Termination of Study by Sponsor|10|||
155339390|NCT04783389|560677192|FG001|Overall Study|Termination of Study by Sponsor|12|||
155339391|NCT04783389|560677193|FG002|Overall Study|Termination of Study by Sponsor|14|||
155339392|NCT02121808|560677194|FG000|Overall Study|Technical problem|3|||
155339393|NCT00647699|560677195|FG000|Overall Study|Lost to Follow-up|5|||
155073537|NCT04167670|559698222|FG002|Overall Study|Voluntary Withdrawal|1|||
155073538|NCT04167670|559698220|FG000|Overall Study|Withdrawal of Consent|4|||
155073539|NCT04167670|559698221|FG001|Overall Study|Withdrawal of Consent|1|||
155073540|NCT04167670|559698222|FG002|Overall Study|Withdrawal of Consent|3|||
155073541|NCT04167670|559698220|FG000|Overall Study|Miscellaneous|7|||
155073542|NCT04167670|559698221|FG001|Overall Study|Miscellaneous|5|||
155073543|NCT04167670|559698222|FG002|Overall Study|Miscellaneous|3|||
155073544|NCT04827446|559698223|FG000|Overall Study|Lost to Follow-up|1|||
155073545|NCT04827446|559698224|FG001|Overall Study|Lost to Follow-up|1|||
155073546|NCT04827446|559698223|FG000|Overall Study|Death|2|||
155073547|NCT04827446|559698224|FG001|Overall Study|Death|0|||
155073548|NCT04827446|559698223|FG000|Overall Study|Withdrawal by Subject|2|||
155073549|NCT04827446|559698224|FG001|Overall Study|Withdrawal by Subject|2|||
155073550|NCT05399485|559698225|FG000|DBT Phase|Other|6|||
155073551|NCT05399485|559698226|FG001|DBT Phase|Other|5|||
155073552|NCT05399485|559698225|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
155073553|NCT05399485|559698226|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
155073554|NCT05399485|559698225|FG000|DBT Phase|Withdrawal by Subject|3|||
155073555|NCT05399485|559698226|FG001|DBT Phase|Withdrawal by Subject|2|||
155073556|NCT05399485|559698225|FG000|DBT Phase|Protocol Violation|2|||
155073557|NCT05399485|559698226|FG001|DBT Phase|Protocol Violation|1|||
155073558|NCT05399485|559698225|FG000|DBT Phase|Physician Decision|0|||
155073559|NCT05399485|559698226|FG001|DBT Phase|Physician Decision|1|||
155073560|NCT05399485|559698225|FG000|DBT Phase|Adverse Event|2|||
155073561|NCT05399485|559698226|FG001|DBT Phase|Adverse Event|1|||
155073562|NCT05399485|559698225|FG000|OLE Phase|Protocol deviation|1|||
155073563|NCT05399485|559698226|FG001|OLE Phase|Protocol deviation|0|||
155073564|NCT05399485|559698225|FG000|OLE Phase|Other|5|||
155073565|NCT05399485|559698226|FG001|OLE Phase|Other|5|||
155073566|NCT05399485|559698225|FG000|OLE Phase|Withdrawal by Subject|12|||
155073567|NCT05399485|559698226|FG001|OLE Phase|Withdrawal by Subject|7|||
155073568|NCT05399485|559698225|FG000|OLE Phase|Pregnancy|0|||
155073569|NCT05399485|559698226|FG001|OLE Phase|Pregnancy|2|||
155073570|NCT05399485|559698225|FG000|OLE Phase|Physician Decision|3|||
155073571|NCT05399485|559698226|FG001|OLE Phase|Physician Decision|0|||
155073572|NCT05399485|559698225|FG000|OLE Phase|Adverse Event|2|||
155073573|NCT05399485|559698226|FG001|OLE Phase|Adverse Event|2|||
155073574|NCT01363076|559698229|FG000|Overall Study|Withdrawal by Subject|0|||
155073575|NCT01363076|559698230|FG001|Overall Study|Withdrawal by Subject|1|||
155073576|NCT04706403|559698231|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
155073577|NCT04706403|559698232|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
155092651|NCT00854360|559773653|FG003|Overall Study|Withdrawal by Subject|1|||
155092652|NCT00854360|559773650|FG000|Overall Study|Pregnancy|0|||
155092653|NCT00854360|559773651|FG001|Overall Study|Pregnancy|1|||
154962519|NCT04493684|559287982|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
154962520|NCT04493684|559287966|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962521|NCT04493684|559287967|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962522|NCT04493684|559287968|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962523|NCT04493684|559287969|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962524|NCT04493684|559287970|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962525|NCT04493684|559287971|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962526|NCT04493684|559287972|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962527|NCT04493684|559287973|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962528|NCT04493684|559287974|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962529|NCT04493684|559287975|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962530|NCT04493684|559287976|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962531|NCT04493684|559287977|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962532|NCT04493684|559287978|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962533|NCT04493684|559287979|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962534|NCT04493684|559287980|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962535|NCT04493684|559287981|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
154962536|NCT04493684|559287982|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
154962537|NCT04493684|559287966|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962538|NCT04493684|559287967|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962539|NCT04493684|559287968|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962540|NCT04493684|559287969|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962541|NCT04493684|559287970|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962542|NCT04493684|559287971|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962543|NCT04493684|559287972|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962544|NCT04493684|559287973|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962545|NCT04493684|559287974|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962546|NCT04493684|559287975|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962547|NCT04493684|559287976|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962548|NCT04493684|559287977|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962549|NCT04493684|559287978|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962550|NCT04493684|559287979|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962551|NCT04493684|559287980|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
154962552|NCT04493684|559287981|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
154962553|NCT04493684|559287982|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
155073578|NCT04706403|559698233|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
155073579|NCT04706403|559698234|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
154962554|NCT05152576|559287989|FG000|Overall Study|Lost to Follow-up|3|||
154962555|NCT05152576|559287990|FG001|Overall Study|Lost to Follow-up|0|||
154962556|NCT05152576|559287991|FG002|Overall Study|Lost to Follow-up|0|||
155339394|NCT00647699|560677196|FG001|Overall Study|Lost to Follow-up|4|||
155339395|NCT00647699|560677195|FG000|Overall Study|Withdrawal by Subject|3|||
155339396|NCT00647699|560677196|FG001|Overall Study|Withdrawal by Subject|8|||
155339397|NCT04909593|560677197|FG000|Overall Study|Withdrawal by Subject|1|||
155339398|NCT01018992|560677198|FG000|Overall Study|Adverse Event|8|||
155339399|NCT01018992|560677199|FG001|Overall Study|Adverse Event|3|||
155339400|NCT01018992|560677198|FG000|Overall Study|Withdrawal by Subject|3|||
155339401|NCT01018992|560677199|FG001|Overall Study|Withdrawal by Subject|8|||
155339402|NCT01018992|560677198|FG000|Overall Study|Protocol Violation|0|||
155339403|NCT01018992|560677199|FG001|Overall Study|Protocol Violation|4|||
155339404|NCT01018992|560677198|FG000|Overall Study|Lost to Follow-up|5|||
155339405|NCT01018992|560677199|FG001|Overall Study|Lost to Follow-up|1|||
155339406|NCT01241448|560677200|FG000|Overall Study|Adverse Event|1|||
155339407|NCT01241448|560677201|FG001|Overall Study|Adverse Event|0|||
154962557|NCT05152576|559287992|FG003|Overall Study|Lost to Follow-up|1|||
154962558|NCT05152576|559287989|FG000|Overall Study|Withdrawal by Subject|0|||
155073580|NCT04706403|559698235|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
155073581|NCT02642679|559698236|FG000|Overall Study|Withdrawal by Subject|1|||
155073582|NCT02642679|559698236|FG000|Overall Study|Physician Decision|1|||
155073583|NCT02642679|559698236|FG000|Overall Study|Physician Decision|1|||
155073584|NCT01653262|559698237|FG000|Overall Study|Lack of Efficacy|1|||
155073585|NCT01653262|559698237|FG000|Overall Study|SAE, non-fatal|1|||
155339408|NCT01241448|560677202|FG002|Overall Study|Adverse Event|2|||
155339409|NCT01241448|560677203|FG003|Overall Study|Adverse Event|2|||
155339410|NCT01241448|560677200|FG000|Overall Study|Lost to Follow-up|2|||
155339411|NCT01241448|560677201|FG001|Overall Study|Lost to Follow-up|1|||
155339412|NCT01241448|560677202|FG002|Overall Study|Lost to Follow-up|1|||
155073586|NCT01653262|559698237|FG000|Overall Study|AE, non-serious non-fatal|1|||
155339413|NCT01241448|560677203|FG003|Overall Study|Lost to Follow-up|1|||
155339414|NCT01241448|560677200|FG000|Overall Study|Physician Decision|0|||
155339415|NCT01241448|560677201|FG001|Overall Study|Physician Decision|2|||
155339416|NCT01241448|560677202|FG002|Overall Study|Physician Decision|0|||
155339417|NCT01241448|560677203|FG003|Overall Study|Physician Decision|0|||
155339418|NCT01241448|560677200|FG000|Overall Study|Protocol Violation|10|||
155339419|NCT01241448|560677201|FG001|Overall Study|Protocol Violation|5|||
155339420|NCT01241448|560677202|FG002|Overall Study|Protocol Violation|3|||
155339421|NCT01241448|560677203|FG003|Overall Study|Protocol Violation|6|||
155339422|NCT01241448|560677200|FG000|Overall Study|Sponsor Decision|17|||
155339423|NCT01241448|560677201|FG001|Overall Study|Sponsor Decision|14|||
155339424|NCT01241448|560677202|FG002|Overall Study|Sponsor Decision|12|||
155339425|NCT01241448|560677203|FG003|Overall Study|Sponsor Decision|6|||
155339426|NCT01241448|560677200|FG000|Overall Study|Withdrawal by Subject|4|||
155339427|NCT01241448|560677201|FG001|Overall Study|Withdrawal by Subject|5|||
155339428|NCT01241448|560677202|FG002|Overall Study|Withdrawal by Subject|3|||
155339429|NCT01241448|560677203|FG003|Overall Study|Withdrawal by Subject|6|||
155339430|NCT01241448|560677200|FG000|Overall Study|Excluded due to data integrity issues|3|||
155339431|NCT01241448|560677201|FG001|Overall Study|Excluded due to data integrity issues|2|||
155339432|NCT01241448|560677202|FG002|Overall Study|Excluded due to data integrity issues|2|||
155339433|NCT01241448|560677203|FG003|Overall Study|Excluded due to data integrity issues|2|||
155339434|NCT04425252|560677204|FG000|Overall Study|Withdrawal by Subject|2|||
155339435|NCT04425252|560677205|FG001|Overall Study|Withdrawal by Subject|1|||
155339436|NCT04425252|560677204|FG000|Overall Study|Lost to Follow-up|1|||
155339437|NCT04425252|560677205|FG001|Overall Study|Lost to Follow-up|0|||
155339438|NCT04425252|560677204|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
155339439|NCT04425252|560677205|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
155339440|NCT00307489|560677206|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
155339441|NCT00307489|560677207|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
155339442|NCT00307489|560677206|FG000|Baseline Through Week 48|Physician Decision|1|||
155339443|NCT00307489|560677207|FG001|Baseline Through Week 48|Physician Decision|0|||
155339444|NCT00307489|560677206|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
155073587|NCT01112267|559698239|FG000|Overall Study|Adverse Event|24|||
155073588|NCT01112267|559698240|FG001|Overall Study|Adverse Event|6|||
155073589|NCT01112267|559698239|FG000|Overall Study|Withdrawal by Subject|3|||
155339445|NCT00307489|560677207|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
155339446|NCT00307489|560677206|FG000|Week 48 Through Week 168|Adverse Event|1|||
155339447|NCT00307489|560677207|FG001|Week 48 Through Week 168|Adverse Event|0|||
155339448|NCT00307489|560677206|FG000|Week 48 Through Week 168|Physician Decision|1|||
155339449|NCT00307489|560677207|FG001|Week 48 Through Week 168|Physician Decision|0|||
155339450|NCT00307489|560677206|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
155339451|NCT00307489|560677207|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
155339452|NCT00307489|560677206|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
155339453|NCT00307489|560677207|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
155339454|NCT00307489|560677206|FG000|Week 48 Through Week 168|Death|0|||
155339455|NCT00307489|560677207|FG001|Week 48 Through Week 168|Death|1|||
155339456|NCT00307489|560677206|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
155339457|NCT00307489|560677207|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
155339458|NCT00307489|560677206|FG000|Week 48 Through Week 168|Seroconversion|1|||
155339459|NCT00307489|560677207|FG001|Week 48 Through Week 168|Seroconversion|0|||
155339460|NCT01825785|560677208|FG000|Overall Study|Adverse Event|0|||
155339461|NCT01825785|560677209|FG001|Overall Study|Adverse Event|0|||
155339462|NCT01825785|560677210|FG002|Overall Study|Adverse Event|0|||
155339463|NCT01825785|560677211|FG003|Overall Study|Adverse Event|0|||
155339464|NCT01825785|560677212|FG004|Overall Study|Adverse Event|1|||
155339465|NCT01825785|560677213|FG005|Overall Study|Adverse Event|0|||
155339466|NCT01825785|560677214|FG006|Overall Study|Adverse Event|0|||
155339467|NCT01825785|560677208|FG000|Overall Study|Withdrawal by Subject|0|||
155339468|NCT01825785|560677209|FG001|Overall Study|Withdrawal by Subject|0|||
155339469|NCT01825785|560677210|FG002|Overall Study|Withdrawal by Subject|0|||
155339470|NCT01825785|560677211|FG003|Overall Study|Withdrawal by Subject|0|||
155339471|NCT01825785|560677212|FG004|Overall Study|Withdrawal by Subject|1|||
155339472|NCT01825785|560677213|FG005|Overall Study|Withdrawal by Subject|1|||
155339473|NCT01825785|560677214|FG006|Overall Study|Withdrawal by Subject|0|||
155339474|NCT00304278|560677217|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
155339475|NCT00304278|560677217|FG000|Overall Study|PT had medical condition preventing TX|1|||
155339476|NCT02065895|560677218|FG000|Overall Study|Protocol Violation|1|||
155339477|NCT02065895|560677219|FG001|Overall Study|Protocol Violation|0|||
155339478|NCT02065895|560677220|FG002|Overall Study|Protocol Violation|0|||
155339479|NCT02065895|560677221|FG003|Overall Study|Protocol Violation|1|||
155339480|NCT02065895|560677222|FG004|Overall Study|Protocol Violation|0|||
155339481|NCT02065895|560677223|FG005|Overall Study|Protocol Violation|0|||
155339482|NCT02065895|560677218|FG000|Overall Study|Scheduling conflicts|0|||
155339483|NCT02065895|560677219|FG001|Overall Study|Scheduling conflicts|1|||
155339484|NCT02065895|560677220|FG002|Overall Study|Scheduling conflicts|0|||
155339485|NCT02065895|560677221|FG003|Overall Study|Scheduling conflicts|0|||
155339486|NCT02065895|560677222|FG004|Overall Study|Scheduling conflicts|0|||
155339487|NCT02065895|560677223|FG005|Overall Study|Scheduling conflicts|0|||
155339488|NCT01381549|560677229|FG000|Overall Study|Ineligible: No organisms isolated|0|||
155339489|NCT01381549|560677230|FG001|Overall Study|Ineligible: No organisms isolated|0|||
155339490|NCT01381549|560677231|FG002|Overall Study|Ineligible: No organisms isolated|1|||
155073590|NCT01112267|559698240|FG001|Overall Study|Withdrawal by Subject|5|||
155073591|NCT01112267|559698239|FG000|Overall Study|Protocol Violation|5|||
155073592|NCT01112267|559698240|FG001|Overall Study|Protocol Violation|3|||
155073593|NCT01112267|559698239|FG000|Overall Study|Participants not compliant|1|||
155073594|NCT01112267|559698240|FG001|Overall Study|Participants not compliant|2|||
155073595|NCT01112267|559698239|FG000|Overall Study|Participants not receive any study drug|1|||
155073596|NCT01112267|559698240|FG001|Overall Study|Participants not receive any study drug|2|||
155073597|NCT02014103|559698241|FG000|Overall Study|Protocol Violation|7|||
155073598|NCT02014103|559698242|FG001|Overall Study|Protocol Violation|7|||
155073599|NCT02014103|559698241|FG000|Overall Study|Adverse Event|1|||
155073600|NCT02014103|559698242|FG001|Overall Study|Adverse Event|0|||
155073601|NCT02014103|559698241|FG000|Overall Study|Lost venous access|1|||
155073602|NCT02014103|559698242|FG001|Overall Study|Lost venous access|0|||
155073603|NCT02014103|559698241|FG000|Overall Study|Withdrawal by Subject|0|||
155073604|NCT02014103|559698242|FG001|Overall Study|Withdrawal by Subject|2|||
155073605|NCT05638737|559698243|FG000|Overall Study|Withdrawal by Subject|4|||
155073606|NCT05638737|559698244|FG001|Overall Study|Withdrawal by Subject|7|||
155073607|NCT02068794|559698245|FG000|Overall Study|Withdrawal by Subject|0|||
155073608|NCT02068794|559698246|FG001|Overall Study|Withdrawal by Subject|1|||
155073609|NCT02068794|559698247|FG002|Overall Study|Withdrawal by Subject|2|||
155073610|NCT02068794|559698245|FG000|Overall Study|Early Progression|1|||
155073611|NCT02068794|559698246|FG001|Overall Study|Early Progression|0|||
155073612|NCT02068794|559698247|FG002|Overall Study|Early Progression|1|||
155073613|NCT02068794|559698245|FG000|Overall Study|Ineligible|0|||
155073614|NCT02068794|559698246|FG001|Overall Study|Ineligible|0|||
155073615|NCT02068794|559698247|FG002|Overall Study|Ineligible|1|||
155073616|NCT04439175|559698250|FG000|Overall Study|Never started treatment|4|||
155073617|NCT04439175|559698250|FG000|Overall Study|Ineligible|5|||
155073618|NCT04439175|559698250|FG000|Overall Study|Adverse Event|6|||
155073619|NCT04439175|559698250|FG000|Overall Study|Death|4|||
155073620|NCT04439175|559698250|FG000|Overall Study|Disease progression|44|||
155073621|NCT04439175|559698250|FG000|Overall Study|Withdrawal by Subject|4|||
155073622|NCT04439175|559698250|FG000|Overall Study|Alternative Therapy|1|||
155073623|NCT04439175|559698250|FG000|Overall Study|Other|2|||
155073624|NCT01022580|559698251|FG000|Overall Study|Death|18|||
155073625|NCT01022580|559698252|FG001|Overall Study|Death|22|||
155073626|NCT02541903|559698263|FG000|Overall Study|Death|1|||
155073627|NCT00827242|559698264|FG000|Overall Study|Withdrawal by Subject|2|||
155073628|NCT00827242|559698265|FG001|Overall Study|Withdrawal by Subject|4|||
155073629|NCT00827242|559698264|FG000|Overall Study|Protocol Violation|1|||
155073630|NCT00827242|559698265|FG001|Overall Study|Protocol Violation|3|||
155339491|NCT02981953|560677232|FG000|Overall Study|Death|9|||
155339492|NCT02981953|560677232|FG000|Overall Study|Withdrawal by Subject|1|||
155339493|NCT02981953|560677232|FG000|Overall Study|Withdrawal to non-compliance|1|||
155339494|NCT01655498|560677241|FG000|Overall Study|Unrelated health issue|2|||
155073631|NCT00827242|559698264|FG000|Overall Study|Lost to Follow-up|0|||
155073632|NCT00827242|559698265|FG001|Overall Study|Lost to Follow-up|3|||
155073633|NCT00827242|559698264|FG000|Overall Study|Adverse Event Excluding Death|2|||
155073634|NCT00827242|559698265|FG001|Overall Study|Adverse Event Excluding Death|1|||
155073635|NCT00827242|559698264|FG000|Overall Study|Entry Criteria Not Met|4|||
155073636|NCT00827242|559698265|FG001|Overall Study|Entry Criteria Not Met|1|||
155339495|NCT01655498|560677241|FG000|Overall Study|Protocol Violation|2|||
155339496|NCT01655498|560677241|FG000|Overall Study|Withdrawal by Subject|1|||
155339497|NCT00603798|560677242|FG000|Overall Study|Adverse Event|4|||
155073637|NCT00827242|559698264|FG000|Overall Study|Physician Decision|2|||
155073638|NCT00827242|559698265|FG001|Overall Study|Physician Decision|0|||
155073639|NCT00827242|559698264|FG000|Overall Study|Death|1|||
155073640|NCT00827242|559698265|FG001|Overall Study|Death|0|||
155073641|NCT00827242|559698264|FG000|Overall Study|Lack of Efficacy|1|||
155073642|NCT00827242|559698265|FG001|Overall Study|Lack of Efficacy|0|||
155339498|NCT00603798|560677243|FG001|Overall Study|Adverse Event|2|||
155073643|NCT04790201|559698266|FG000|Overall Study|Lost to Follow-up|0|||
155073644|NCT04790201|559698267|FG001|Overall Study|Lost to Follow-up|0|||
155073645|NCT04790201|559698268|FG002|Overall Study|Lost to Follow-up|2|||
155073646|NCT04790201|559698266|FG000|Overall Study|Death|0|||
155073647|NCT04790201|559698267|FG001|Overall Study|Death|1|||
155073648|NCT04790201|559698268|FG002|Overall Study|Death|0|||
155339499|NCT00603798|560677244|FG002|Overall Study|Adverse Event|1|||
155339500|NCT00603798|560677242|FG000|Overall Study|Withdrawal by Subject|4|||
155339501|NCT00603798|560677243|FG001|Overall Study|Withdrawal by Subject|3|||
155339502|NCT00603798|560677244|FG002|Overall Study|Withdrawal by Subject|4|||
155339503|NCT00603798|560677242|FG000|Overall Study|Lost to Follow-up|1|||
155339504|NCT00603798|560677243|FG001|Overall Study|Lost to Follow-up|0|||
155339505|NCT00603798|560677244|FG002|Overall Study|Lost to Follow-up|1|||
155339506|NCT00603798|560677242|FG000|Overall Study|Non-compliance with study procedures|0|||
155339507|NCT00603798|560677243|FG001|Overall Study|Non-compliance with study procedures|1|||
155339508|NCT00603798|560677244|FG002|Overall Study|Non-compliance with study procedures|0|||
155339509|NCT00603798|560677242|FG000|Overall Study|Not due to AE|1|||
155339510|NCT00603798|560677243|FG001|Overall Study|Not due to AE|1|||
155339511|NCT00603798|560677244|FG002|Overall Study|Not due to AE|4|||
155339512|NCT00988429|560677247|FG000|Overall Study|Adverse Event|9|||
155339513|NCT00988429|560677248|FG001|Overall Study|Adverse Event|21|||
155339514|NCT00988429|560677249|FG002|Overall Study|Adverse Event|45|||
155339515|NCT00988429|560677247|FG000|Overall Study|Lack of Efficacy|0|||
155339516|NCT00988429|560677248|FG001|Overall Study|Lack of Efficacy|0|||
155339517|NCT00988429|560677249|FG002|Overall Study|Lack of Efficacy|1|||
155339518|NCT00988429|560677247|FG000|Overall Study|Non-Compliance with Study Drug|5|||
155339519|NCT00988429|560677248|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155339520|NCT00988429|560677249|FG002|Overall Study|Non-Compliance with Study Drug|3|||
155339521|NCT00988429|560677247|FG000|Overall Study|Physician Decision|1|||
155339522|NCT00988429|560677248|FG001|Overall Study|Physician Decision|0|||
155339523|NCT00988429|560677249|FG002|Overall Study|Physician Decision|3|||
155339524|NCT00988429|560677247|FG000|Overall Study|Pregnancy|2|||
155339525|NCT00988429|560677248|FG001|Overall Study|Pregnancy|1|||
155339526|NCT00988429|560677249|FG002|Overall Study|Pregnancy|0|||
155339527|NCT00988429|560677247|FG000|Overall Study|Protocol Violation|4|||
155339528|NCT00988429|560677248|FG001|Overall Study|Protocol Violation|3|||
155339529|NCT00988429|560677249|FG002|Overall Study|Protocol Violation|3|||
155339530|NCT00988429|560677247|FG000|Overall Study|Withdrawal by Subject|7|||
155339531|NCT00988429|560677248|FG001|Overall Study|Withdrawal by Subject|7|||
155339532|NCT00988429|560677249|FG002|Overall Study|Withdrawal by Subject|12|||
155339533|NCT00988429|560677247|FG000|Overall Study|Administrative Reasons|1|||
155339534|NCT00988429|560677248|FG001|Overall Study|Administrative Reasons|2|||
155339535|NCT00988429|560677249|FG002|Overall Study|Administrative Reasons|1|||
155339536|NCT00988429|560677247|FG000|Overall Study|other reasons|8|||
155339537|NCT00988429|560677248|FG001|Overall Study|other reasons|8|||
155339538|NCT00988429|560677249|FG002|Overall Study|other reasons|1|||
155339539|NCT02964234|560677250|FG000|Overall Study|Lost to Follow-up|22|||
155339540|NCT02964234|560677251|FG001|Overall Study|Lost to Follow-up|13|||
155339541|NCT01799993|560677252|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
155339542|NCT01799993|560677253|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
155339543|NCT01799993|560677252|FG000|Overall Study|Death|61|||
155339544|NCT01799993|560677253|FG001|Overall Study|Death|45|||
155339545|NCT01799993|560677252|FG000|Overall Study|Withdrawal by Subject|23|||
155339546|NCT01799993|560677253|FG001|Overall Study|Withdrawal by Subject|24|||
155339547|NCT01799993|560677252|FG000|Overall Study|Lost to Follow-up|5|||
155339548|NCT01799993|560677253|FG001|Overall Study|Lost to Follow-up|8|||
155339549|NCT01799993|560677252|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
155339550|NCT01799993|560677253|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
155073649|NCT04790201|559698266|FG000|Overall Study|Protocol Violation|1|||
155073650|NCT04790201|559698267|FG001|Overall Study|Protocol Violation|0|||
155164353|NCT00473382|560038877|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
155164354|NCT00473382|560038878|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
155164355|NCT00473382|560038876|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
155164356|NCT00473382|560038877|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
155339551|NCT01799993|560677252|FG000|Overall Study|Protocol driven decision point|0|||
155339552|NCT01799993|560677253|FG001|Overall Study|Protocol driven decision point|3|||
155339553|NCT01799993|560677252|FG000|Overall Study|Protocol Violation|1|||
155339554|NCT01799993|560677253|FG001|Overall Study|Protocol Violation|1|||
155339555|NCT01799993|560677252|FG000|Overall Study|Deterioration of general conditions|2|||
155339556|NCT01799993|560677253|FG001|Overall Study|Deterioration of general conditions|0|||
155339557|NCT01799993|560677252|FG000|Overall Study|Screen failure|0|||
155339558|NCT01799993|560677253|FG001|Overall Study|Screen failure|1|||
155339559|NCT01799993|560677252|FG000|Overall Study|Adverse Event|1|||
155339560|NCT01799993|560677253|FG001|Overall Study|Adverse Event|0|||
155073651|NCT04790201|559698268|FG002|Overall Study|Protocol Violation|1|||
155073652|NCT00376506|559698273|FG000|Overall Study|Death|0|||
155339561|NCT01799993|560677252|FG000|Overall Study|Lack of Efficacy|1|||
155339562|NCT01799993|560677253|FG001|Overall Study|Lack of Efficacy|0|||
155073653|NCT00376506|559698274|FG001|Overall Study|Death|2|||
155073654|NCT02942407|559698275|FG000|Overall Study|Lost to Follow-up|3|||
155073655|NCT02942407|559698276|FG001|Overall Study|Lost to Follow-up|2|||
155073656|NCT02942407|559698275|FG000|Overall Study|Withdrawal by Subject|7|||
155073657|NCT02942407|559698276|FG001|Overall Study|Withdrawal by Subject|9|||
155073658|NCT02942407|559698275|FG000|Overall Study|Death|16|||
155073659|NCT02942407|559698276|FG001|Overall Study|Death|13|||
155073660|NCT01944774|559698277|FG000|Overall Study|Withdrawal by Subject|2|||
155073661|NCT01944774|559698278|FG001|Overall Study|Withdrawal by Subject|3|||
155073662|NCT01944774|559698279|FG002|Overall Study|Withdrawal by Subject|3|||
155073663|NCT01944774|559698277|FG000|Overall Study|Adverse Event|3|||
155073664|NCT01944774|559698278|FG001|Overall Study|Adverse Event|2|||
155073665|NCT01944774|559698279|FG002|Overall Study|Adverse Event|3|||
155073666|NCT01944774|559698277|FG000|Overall Study|Lack of Efficacy|1|||
155073667|NCT01944774|559698278|FG001|Overall Study|Lack of Efficacy|2|||
155073668|NCT01944774|559698279|FG002|Overall Study|Lack of Efficacy|2|||
155170039|NCT00830869|560062406|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
155339563|NCT01799993|560677252|FG000|Overall Study|Recovery|0|||
155339564|NCT01799993|560677253|FG001|Overall Study|Recovery|1|||
155339565|NCT01799993|560677252|FG000|Overall Study|Logistical difficulties|1|||
155339566|NCT01799993|560677253|FG001|Overall Study|Logistical difficulties|0|||
155339567|NCT01799993|560677252|FG000|Overall Study|Protocol deviation|1|||
155339568|NCT01799993|560677253|FG001|Overall Study|Protocol deviation|0|||
155339569|NCT01799993|560677252|FG000|Overall Study|Non-compliance with medical device|1|||
155339570|NCT01799993|560677253|FG001|Overall Study|Non-compliance with medical device|0|||
155339571|NCT01799993|560677252|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155339572|NCT01799993|560677253|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155339573|NCT01799993|560677252|FG000|Overall Study|Other|1|||
155339574|NCT01799993|560677253|FG001|Overall Study|Other|0|||
155339575|NCT01799993|560677252|FG000|Overall Study|Subject didn't return for follow-up|0|||
155339576|NCT01799993|560677253|FG001|Overall Study|Subject didn't return for follow-up|1|||
155339577|NCT04361617|560677254|FG000|Overall Study|Withdrawal by Subject|0|||
155339578|NCT04361617|560677255|FG001|Overall Study|Withdrawal by Subject|1|||
155339579|NCT00687297|560677261|FG000|Randomization|Withdrawal by Subject|2|||
155339580|NCT00687297|560677262|FG001|Randomization|Withdrawal by Subject|0|||
155339581|NCT00687297|560677261|FG000|Randomization|Withdrew before treatment, ineligible|1|||
155339582|NCT00687297|560677262|FG001|Randomization|Withdrew before treatment, ineligible|1|||
155339583|NCT00687297|560677261|FG000|Induction|Withdrawal by Subject|4|||
155339584|NCT00687297|560677262|FG001|Induction|Withdrawal by Subject|4|||
155339585|NCT00687297|560677261|FG000|Induction|Adverse Event|16|||
155339586|NCT00687297|560677262|FG001|Induction|Adverse Event|15|||
155339587|NCT00687297|560677261|FG000|Induction|Death|7|||
155339588|NCT00687297|560677262|FG001|Induction|Death|11|||
155339589|NCT00687297|560677261|FG000|Induction|Lack of Efficacy|17|||
155339590|NCT00687297|560677262|FG001|Induction|Lack of Efficacy|21|||
155073669|NCT01944774|559698277|FG000|Overall Study|Lost to Follow-up|0|||
155339591|NCT00687297|560677261|FG000|Induction|Ineligible|0|||
155339592|NCT00687297|560677262|FG001|Induction|Ineligible|1|||
155339593|NCT00687297|560677261|FG000|Induction|Patient Noncompliance|1|||
155339594|NCT00687297|560677262|FG001|Induction|Patient Noncompliance|0|||
155073670|NCT01944774|559698278|FG001|Overall Study|Lost to Follow-up|1|||
155073671|NCT01944774|559698279|FG002|Overall Study|Lost to Follow-up|0|||
155073672|NCT00374868|559698280|FG000|Overall Study|Adverse Event|12|||
155339595|NCT00687297|560677261|FG000|Induction|Physician Decision|0|||
155339596|NCT00687297|560677262|FG001|Induction|Physician Decision|2|||
155339597|NCT00687297|560677261|FG000|Induction|Other|0|||
155339598|NCT00687297|560677262|FG001|Induction|Other|1|||
155339599|NCT04617847|560677267|FG000|Overall Study|Withdrawal by Subject|1|||
155339600|NCT04617847|560677268|FG001|Overall Study|Withdrawal by Subject|0|||
155339601|NCT04617847|560677267|FG000|Overall Study|Adverse Event|0|||
155339602|NCT04617847|560677268|FG001|Overall Study|Adverse Event|2|||
155339603|NCT04617847|560677267|FG000|Overall Study|Death|0|||
155339604|NCT04617847|560677268|FG001|Overall Study|Death|1|||
155339605|NCT04617847|560677267|FG000|Overall Study|Termination of Study by Sponsor|2|||
155339606|NCT04617847|560677268|FG001|Overall Study|Termination of Study by Sponsor|21|||
155339607|NCT00700999|560677269|FG000|Overall Study|Lost to Follow-up|7|||
155339608|NCT00700999|560677270|FG001|Overall Study|Lost to Follow-up|7|||
155339609|NCT00700999|560677269|FG000|Overall Study|Excluded - did not meet study criteria|0|||
155339610|NCT00700999|560677270|FG001|Overall Study|Excluded - did not meet study criteria|1|||
155339611|NCT00700999|560677269|FG000|Overall Study|Withdrawal by Subject|8|||
155339612|NCT00700999|560677270|FG001|Overall Study|Withdrawal by Subject|1|||
155339613|NCT00244751|560677271|FG000|Overall Study|Adverse Event|7|||
155339614|NCT00244751|560677272|FG001|Overall Study|Adverse Event|7|||
155339615|NCT00244751|560677273|FG002|Overall Study|Adverse Event|5|||
155339616|NCT00244751|560677271|FG000|Overall Study|Lost to Follow-up|0|||
155339617|NCT00244751|560677272|FG001|Overall Study|Lost to Follow-up|1|||
155339618|NCT00244751|560677273|FG002|Overall Study|Lost to Follow-up|0|||
155339619|NCT00244751|560677271|FG000|Overall Study|Protocol Violation|1|||
155339620|NCT00244751|560677272|FG001|Overall Study|Protocol Violation|0|||
155339621|NCT00244751|560677273|FG002|Overall Study|Protocol Violation|1|||
155339622|NCT00244751|560677271|FG000|Overall Study|Withdrawal by Subject|7|||
155339623|NCT00244751|560677272|FG001|Overall Study|Withdrawal by Subject|5|||
155339624|NCT00244751|560677273|FG002|Overall Study|Withdrawal by Subject|3|||
155339625|NCT00244751|560677271|FG000|Overall Study|Elevated liver enzymes|1|||
155339626|NCT00244751|560677272|FG001|Overall Study|Elevated liver enzymes|0|||
155339627|NCT00244751|560677273|FG002|Overall Study|Elevated liver enzymes|0|||
155339628|NCT00244751|560677271|FG000|Overall Study|Lack of compliance with protocol|0|||
155339629|NCT00244751|560677272|FG001|Overall Study|Lack of compliance with protocol|1|||
155339630|NCT00244751|560677273|FG002|Overall Study|Lack of compliance with protocol|0|||
155339631|NCT00244751|560677271|FG000|Overall Study|Safety reasons|0|||
155339632|NCT00244751|560677272|FG001|Overall Study|Safety reasons|1|||
155339633|NCT00244751|560677273|FG002|Overall Study|Safety reasons|0|||
155339634|NCT00244751|560677271|FG000|Overall Study|Participant randomized by mistake|0|||
155339635|NCT00244751|560677272|FG001|Overall Study|Participant randomized by mistake|0|||
155339636|NCT00244751|560677273|FG002|Overall Study|Participant randomized by mistake|1|||
155339637|NCT03031782|560677276|FG000|Treatment Period 1|Lack of Efficacy|3|||
155339638|NCT03031782|560677277|FG001|Treatment Period 1|Lack of Efficacy|0|||
155339639|NCT03031782|560677278|FG002|Treatment Period 1|Lack of Efficacy|0|||
155339640|NCT03031782|560677279|FG003|Treatment Period 1|Lack of Efficacy|0|||
155339641|NCT03031782|560677280|FG004|Treatment Period 1|Lack of Efficacy|0|||
155339642|NCT03031782|560677276|FG000|Treatment Period 2|Physician Decision|0|||
155339643|NCT03031782|560677277|FG001|Treatment Period 2|Physician Decision|1|||
155339644|NCT03031782|560677278|FG002|Treatment Period 2|Physician Decision|0|||
155339645|NCT03031782|560677279|FG003|Treatment Period 2|Physician Decision|0|||
155339646|NCT03031782|560677280|FG004|Treatment Period 2|Physician Decision|3|||
155339647|NCT03031782|560677276|FG000|Treatment Period 2|Lack of Efficacy|0|||
155339648|NCT03031782|560677277|FG001|Treatment Period 2|Lack of Efficacy|1|||
155339649|NCT03031782|560677278|FG002|Treatment Period 2|Lack of Efficacy|0|||
155339650|NCT03031782|560677279|FG003|Treatment Period 2|Lack of Efficacy|0|||
155339651|NCT03031782|560677280|FG004|Treatment Period 2|Lack of Efficacy|1|||
155339652|NCT03031782|560677276|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155339653|NCT03031782|560677277|FG001|Treatment Period 2|Withdrawal by Subject|3|||
155339654|NCT03031782|560677278|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155339655|NCT03031782|560677279|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155339656|NCT03031782|560677280|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155339657|NCT03031782|560677276|FG000|Treatment Period 2|Adverse Event|0|||
155339658|NCT03031782|560677277|FG001|Treatment Period 2|Adverse Event|1|||
155339659|NCT03031782|560677278|FG002|Treatment Period 2|Adverse Event|2|||
155339660|NCT03031782|560677279|FG003|Treatment Period 2|Adverse Event|0|||
155073673|NCT00374868|559698280|FG000|Overall Study|Progressive Disease|7|||
155339661|NCT03031782|560677280|FG004|Treatment Period 2|Adverse Event|0|||
155339662|NCT03031782|560677276|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155339663|NCT03031782|560677277|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155339664|NCT03031782|560677278|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155339665|NCT03031782|560677279|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155339666|NCT03031782|560677280|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155339667|NCT02699099|560677281|FG000|Overall Study|Adverse Event|1|||
155339668|NCT02699099|560677282|FG001|Overall Study|Adverse Event|0|||
155339669|NCT02699099|560677283|FG002|Overall Study|Adverse Event|2|||
155339670|NCT02699099|560677281|FG000|Overall Study|Lost to Follow-up|0|||
155339671|NCT02699099|560677282|FG001|Overall Study|Lost to Follow-up|1|||
155164357|NCT00473382|560038878|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
155164358|NCT02999672|560038879|FG000|Overall Study|Death|0|||
155164359|NCT02999672|560038880|FG001|Overall Study|Death|1|||
155164360|NCT02999672|560038879|FG000|Overall Study|Study Terminated by Sponsor|0|||
155164361|NCT02999672|560038880|FG001|Overall Study|Study Terminated by Sponsor|1|||
155164362|NCT02999672|560038879|FG000|Overall Study|Progressive Disease|9|||
155164363|NCT02999672|560038880|FG001|Overall Study|Progressive Disease|5|||
155164364|NCT02999672|560038879|FG000|Overall Study|Adverse Event|4|||
155073674|NCT00374868|559698280|FG000|Overall Study|Physician Decision|13|||
155073675|NCT00374868|559698280|FG000|Overall Study|Lost to Follow-up|1|||
155073676|NCT00374868|559698280|FG000|Overall Study|Death|2|||
155073677|NCT00374868|559698280|FG000|Overall Study|Other - Not Specified|1|||
155073678|NCT03188185|559698281|FG000|Stage 1|Adverse Event|4|||
155073679|NCT03188185|559698282|FG001|Stage 1|Adverse Event|12|||
155164365|NCT02999672|560038880|FG001|Overall Study|Adverse Event|0|||
155164366|NCT01166282|560038881|FG000|Open-label Period|Adverse Event|0|||
155164367|NCT01166282|560038882|FG001|Open-label Period|Adverse Event|0|||
155164368|NCT01166282|560038883|FG002|Open-label Period|Adverse Event|6|||
155164369|NCT01166282|560038881|FG000|Open-label Period|Withdrawal by Subject|0|||
155164370|NCT01166282|560038882|FG001|Open-label Period|Withdrawal by Subject|0|||
155164371|NCT01166282|560038883|FG002|Open-label Period|Withdrawal by Subject|4|||
155164372|NCT01166282|560038881|FG000|Open-label Period|Lack of Efficacy|0|||
155164373|NCT01166282|560038882|FG001|Open-label Period|Lack of Efficacy|0|||
155164374|NCT01166282|560038883|FG002|Open-label Period|Lack of Efficacy|2|||
155164375|NCT01166282|560038881|FG000|Open-label Period|Remission|0|||
155164376|NCT01166282|560038882|FG001|Open-label Period|Remission|0|||
155164377|NCT01166282|560038883|FG002|Open-label Period|Remission|4|||
155164378|NCT01166282|560038881|FG000|Open-label Period|Irregular Compliance|0|||
155164379|NCT01166282|560038882|FG001|Open-label Period|Irregular Compliance|0|||
155164380|NCT01166282|560038883|FG002|Open-label Period|Irregular Compliance|1|||
155164381|NCT03214666|560038884|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155164382|NCT03214666|560038885|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155164383|NCT03214666|560038886|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155164384|NCT03214666|560038887|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155073680|NCT03188185|559698283|FG002|Stage 1|Adverse Event|0|||
155073681|NCT03188185|559698284|FG003|Stage 1|Adverse Event|0|||
155073682|NCT03188185|559698281|FG000|Stage 1|Lack of Efficacy|0|||
155073683|NCT03188185|559698282|FG001|Stage 1|Lack of Efficacy|2|||
155073684|NCT03188185|559698283|FG002|Stage 1|Lack of Efficacy|0|||
155073685|NCT03188185|559698284|FG003|Stage 1|Lack of Efficacy|0|||
155073686|NCT03188185|559698281|FG000|Stage 1|Lost to Follow-up|6|||
155073687|NCT03188185|559698282|FG001|Stage 1|Lost to Follow-up|1|||
155073688|NCT03188185|559698283|FG002|Stage 1|Lost to Follow-up|0|||
155073689|NCT03188185|559698284|FG003|Stage 1|Lost to Follow-up|0|||
155073690|NCT03188185|559698281|FG000|Stage 1|Withdrawal by Subject|9|||
155073691|NCT03188185|559698282|FG001|Stage 1|Withdrawal by Subject|0|||
155073692|NCT03188185|559698283|FG002|Stage 1|Withdrawal by Subject|0|||
155073693|NCT03188185|559698284|FG003|Stage 1|Withdrawal by Subject|0|||
155073694|NCT03188185|559698281|FG000|Stage 1|Identified as a professional patient|0|||
155164385|NCT03214666|560038888|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
155164386|NCT03214666|560038889|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
155164387|NCT02500797|560038897|FG000|Overall Study|Cancel (rapid disease progression)|0|||
155164388|NCT02500797|560038898|FG001|Overall Study|Cancel (rapid disease progression)|0|||
155164389|NCT02500797|560038899|FG002|Overall Study|Cancel (rapid disease progression)|0|||
155073695|NCT03188185|559698282|FG001|Stage 1|Identified as a professional patient|1|||
155073696|NCT03188185|559698283|FG002|Stage 1|Identified as a professional patient|0|||
155073697|NCT03188185|559698284|FG003|Stage 1|Identified as a professional patient|0|||
155073698|NCT03188185|559698281|FG000|Stage 2|Adverse Event|0|||
155073699|NCT03188185|559698282|FG001|Stage 2|Adverse Event|0|||
155073700|NCT03188185|559698283|FG002|Stage 2|Adverse Event|2|||
155164390|NCT02500797|560038900|FG003|Overall Study|Cancel (rapid disease progression)|0|||
155339672|NCT02699099|560677283|FG002|Overall Study|Lost to Follow-up|0|||
155339673|NCT02699099|560677281|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
155339674|NCT02699099|560677282|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155339675|NCT02699099|560677283|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
155339676|NCT01240590|560677286|FG000|Phase I|Refused further treatment|0|||
155339677|NCT01240590|560677287|FG001|Phase I|Refused further treatment|0|||
155339678|NCT01240590|560677288|FG002|Phase I|Refused further treatment|3|||
155339679|NCT01240590|560677289|FG003|Phase I|Refused further treatment|0|||
155339680|NCT01240590|560677290|FG004|Phase I|Refused further treatment|0|||
155339681|NCT01240590|560677286|FG000|Phase II|Refused further treatment|0|||
155339682|NCT01240590|560677287|FG001|Phase II|Refused further treatment|0|||
155339683|NCT01240590|560677288|FG002|Phase II|Refused further treatment|0|||
155339684|NCT01240590|560677289|FG003|Phase II|Refused further treatment|2|||
155339685|NCT01240590|560677290|FG004|Phase II|Refused further treatment|1|||
155339686|NCT05184062|560677295|FG000|Overall Study|Lost to Follow-up|5|||
155339687|NCT05184062|560677296|FG001|Overall Study|Lost to Follow-up|1|||
155339688|NCT05184062|560677295|FG000|Overall Study|Withdrawal by Subject|1|||
155339689|NCT05184062|560677296|FG001|Overall Study|Withdrawal by Subject|0|||
155339690|NCT04620733|560678930|FG000|Overall Study|Adverse Event|4|||
155339691|NCT04620733|560678931|FG001|Overall Study|Adverse Event|3|||
155339692|NCT04620733|560678930|FG000|Overall Study|Withdrawal by Subject|2|||
155339693|NCT04620733|560678931|FG001|Overall Study|Withdrawal by Subject|5|||
155339694|NCT04620733|560678930|FG000|Overall Study|Lost to Follow-up|1|||
155339695|NCT04620733|560678931|FG001|Overall Study|Lost to Follow-up|1|||
155339696|NCT04620733|560678930|FG000|Overall Study|Protocol Deviation|1|||
155339697|NCT04620733|560678931|FG001|Overall Study|Protocol Deviation|1|||
155339698|NCT04620733|560678930|FG000|Overall Study|Reason Not Specified|0|||
155339699|NCT04620733|560678931|FG001|Overall Study|Reason Not Specified|1|||
155339700|NCT03976102|560678932|FG000|Overall Study|Withdrawal by Subject|4|||
155339701|NCT03976102|560678933|FG001|Overall Study|Withdrawal by Subject|4|||
155339702|NCT03976102|560678932|FG000|Overall Study|Adverse Event|2|||
155339703|NCT03976102|560678933|FG001|Overall Study|Adverse Event|4|||
155339704|NCT03976102|560678932|FG000|Overall Study|Not related to Covid-19|9|||
155339705|NCT03976102|560678933|FG001|Overall Study|Not related to Covid-19|13|||
155339706|NCT03976102|560678932|FG000|Overall Study|Lost to Follow-up|0|||
155339707|NCT03976102|560678933|FG001|Overall Study|Lost to Follow-up|2|||
155339708|NCT03976102|560678932|FG000|Overall Study|Death|3|||
155339709|NCT03976102|560678933|FG001|Overall Study|Death|2|||
155339710|NCT03976102|560678932|FG000|Overall Study|Physician Decision|1|||
155339711|NCT03976102|560678933|FG001|Overall Study|Physician Decision|1|||
155339712|NCT02164578|560678945|FG000|Treatment Period|Withdrawal by Subject|3|||
155339713|NCT02164578|560678946|FG001|Treatment Period|Withdrawal by Subject|3|||
155339714|NCT02164578|560678945|FG000|Treatment Period|Adverse Event|13|||
155339715|NCT02164578|560678946|FG001|Treatment Period|Adverse Event|6|||
155339716|NCT02164578|560678945|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
155339717|NCT02164578|560678946|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
155339718|NCT02164578|560678945|FG000|Treatment Period|Protocol Violation|0|||
155339719|NCT02164578|560678946|FG001|Treatment Period|Protocol Violation|2|||
155339720|NCT02164578|560678945|FG000|Extension Period|Withdrawal by Subject|2|||
155339721|NCT02164578|560678946|FG001|Extension Period|Withdrawal by Subject|0|||
155339722|NCT02164578|560678945|FG000|Extension Period|Adverse Event|4|||
155339723|NCT02164578|560678946|FG001|Extension Period|Adverse Event|0|||
155339724|NCT02164578|560678945|FG000|Extension Period|Expiry of study medication|1|||
155339725|NCT02164578|560678946|FG001|Extension Period|Expiry of study medication|0|||
155339726|NCT02164578|560678945|FG000|Extension Period|Protocol Violation|0|||
155339727|NCT02164578|560678946|FG001|Extension Period|Protocol Violation|1|||
155339728|NCT03924193|560678952|FG000|Overall Study|Adverse Event|10|||
155339729|NCT03924193|560678953|FG001|Overall Study|Adverse Event|0|||
155339730|NCT03924193|560678954|FG002|Overall Study|Adverse Event|10|||
155339731|NCT03924193|560678952|FG000|Overall Study|Withdrawal by Subject|5|||
155339732|NCT03924193|560678953|FG001|Overall Study|Withdrawal by Subject|10|||
155339733|NCT03924193|560678954|FG002|Overall Study|Withdrawal by Subject|2|||
155339734|NCT01562275|560678955|FG000|Stage 1|Adverse Event|0|||
155339735|NCT01562275|560678956|FG001|Stage 1|Adverse Event|0|||
155339736|NCT01562275|560678957|FG002|Stage 1|Adverse Event|0|||
155339737|NCT01562275|560678958|FG003|Stage 1|Adverse Event|1|||
155339738|NCT01562275|560678959|FG004|Stage 1|Adverse Event|1|||
155339739|NCT01562275|560678960|FG005|Stage 1|Adverse Event|0|||
155339740|NCT01562275|560678961|FG006|Stage 1|Adverse Event|0|||
155339741|NCT01562275|560678962|FG007|Stage 1|Adverse Event|0|||
155339742|NCT01562275|560678963|FG008|Stage 1|Adverse Event|0|||
155339743|NCT01562275|560678964|FG009|Stage 1|Adverse Event|1|||
155339744|NCT01562275|560678965|FG010|Stage 1|Adverse Event|0|||
155339745|NCT01562275|560678966|FG011|Stage 1|Adverse Event|0|||
155339746|NCT01562275|560678967|FG012|Stage 1|Adverse Event|0|||
155339747|NCT01562275|560678955|FG000|Stage 1|Death|1|||
155339748|NCT01562275|560678956|FG001|Stage 1|Death|0|||
154962559|NCT05152576|559287990|FG001|Overall Study|Withdrawal by Subject|1|||
154962560|NCT05152576|559287991|FG002|Overall Study|Withdrawal by Subject|0|||
155339749|NCT01562275|560678957|FG002|Stage 1|Death|0|||
155339750|NCT01562275|560678958|FG003|Stage 1|Death|0|||
155339751|NCT01562275|560678959|FG004|Stage 1|Death|0|||
155339752|NCT01562275|560678960|FG005|Stage 1|Death|0|||
155339753|NCT01562275|560678961|FG006|Stage 1|Death|0|||
155339754|NCT01562275|560678962|FG007|Stage 1|Death|0|||
155339755|NCT01562275|560678963|FG008|Stage 1|Death|0|||
155339756|NCT01562275|560678964|FG009|Stage 1|Death|0|||
155339757|NCT01562275|560678965|FG010|Stage 1|Death|0|||
155339758|NCT01562275|560678966|FG011|Stage 1|Death|0|||
155339759|NCT01562275|560678967|FG012|Stage 1|Death|0|||
155073701|NCT03188185|559698284|FG003|Stage 2|Adverse Event|4|||
155073702|NCT03188185|559698281|FG000|Stage 2|Lack of Efficacy|0|||
155073703|NCT03188185|559698282|FG001|Stage 2|Lack of Efficacy|0|||
155073704|NCT03188185|559698283|FG002|Stage 2|Lack of Efficacy|3|||
155073705|NCT03188185|559698284|FG003|Stage 2|Lack of Efficacy|0|||
155073706|NCT03188185|559698281|FG000|Stage 2|Lost to Follow-up|0|||
155073707|NCT03188185|559698282|FG001|Stage 2|Lost to Follow-up|0|||
155073708|NCT03188185|559698283|FG002|Stage 2|Lost to Follow-up|1|||
155073709|NCT03188185|559698284|FG003|Stage 2|Lost to Follow-up|0|||
155073710|NCT03188185|559698281|FG000|Stage 2|Physician Decision|0|||
155073711|NCT03188185|559698282|FG001|Stage 2|Physician Decision|0|||
155073712|NCT03188185|559698283|FG002|Stage 2|Physician Decision|0|||
155073713|NCT03188185|559698284|FG003|Stage 2|Physician Decision|1|||
155073714|NCT03188185|559698281|FG000|Stage 2|Withdrawal by Subject|0|||
155073715|NCT03188185|559698282|FG001|Stage 2|Withdrawal by Subject|0|||
155073716|NCT03188185|559698283|FG002|Stage 2|Withdrawal by Subject|3|||
155073717|NCT03188185|559698284|FG003|Stage 2|Withdrawal by Subject|1|||
155073718|NCT00774748|559698285|FG000|Overall Study|Lost to Follow-up|3|||
155073719|NCT02965456|559698290|FG000|Overall Study|Lost to Follow-up|40|||
155339760|NCT01562275|560678955|FG000|Stage 1|Non Compliance|0|||
155339761|NCT01562275|560678956|FG001|Stage 1|Non Compliance|0|||
155339762|NCT01562275|560678957|FG002|Stage 1|Non Compliance|1|||
155339763|NCT01562275|560678958|FG003|Stage 1|Non Compliance|0|||
155339764|NCT01562275|560678959|FG004|Stage 1|Non Compliance|0|||
155339765|NCT01562275|560678960|FG005|Stage 1|Non Compliance|0|||
155339766|NCT01562275|560678961|FG006|Stage 1|Non Compliance|0|||
155339767|NCT01562275|560678962|FG007|Stage 1|Non Compliance|0|||
155339768|NCT01562275|560678963|FG008|Stage 1|Non Compliance|0|||
155339769|NCT01562275|560678964|FG009|Stage 1|Non Compliance|0|||
155339770|NCT01562275|560678965|FG010|Stage 1|Non Compliance|0|||
155339771|NCT01562275|560678966|FG011|Stage 1|Non Compliance|0|||
155339772|NCT01562275|560678967|FG012|Stage 1|Non Compliance|0|||
155339773|NCT01562275|560678955|FG000|Stage 1|Physician Decision|0|||
155339774|NCT01562275|560678956|FG001|Stage 1|Physician Decision|0|||
155339775|NCT01562275|560678957|FG002|Stage 1|Physician Decision|0|||
155339776|NCT01562275|560678958|FG003|Stage 1|Physician Decision|0|||
155339777|NCT01562275|560678959|FG004|Stage 1|Physician Decision|1|||
155339778|NCT01562275|560678960|FG005|Stage 1|Physician Decision|0|||
155339779|NCT01562275|560678961|FG006|Stage 1|Physician Decision|1|||
155339780|NCT01562275|560678962|FG007|Stage 1|Physician Decision|0|||
155339781|NCT01562275|560678963|FG008|Stage 1|Physician Decision|1|||
155339782|NCT01562275|560678964|FG009|Stage 1|Physician Decision|0|||
155339783|NCT01562275|560678965|FG010|Stage 1|Physician Decision|0|||
155073720|NCT02965456|559698291|FG001|Overall Study|Lost to Follow-up|18|||
155073721|NCT02965456|559698290|FG000|Overall Study|Subject Request|22|||
155073722|NCT02965456|559698291|FG001|Overall Study|Subject Request|13|||
155073723|NCT02965456|559698290|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
155073724|NCT02965456|559698291|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
155073725|NCT02965456|559698290|FG000|Overall Study|Adverse Event|3|||
155073726|NCT02965456|559698291|FG001|Overall Study|Adverse Event|0|||
155073727|NCT02965456|559698290|FG000|Overall Study|Noncompliance with Study Drug|1|||
155164391|NCT02500797|560038901|FG004|Overall Study|Cancel (rapid disease progression)|1|||
155339784|NCT01562275|560678966|FG011|Stage 1|Physician Decision|0|||
155339785|NCT01562275|560678967|FG012|Stage 1|Physician Decision|0|||
155339786|NCT01562275|560678955|FG000|Stage 1|Progression of Disease|2|||
155339787|NCT01562275|560678956|FG001|Stage 1|Progression of Disease|6|||
155339788|NCT01562275|560678957|FG002|Stage 1|Progression of Disease|2|||
155339789|NCT01562275|560678958|FG003|Stage 1|Progression of Disease|1|||
155339790|NCT01562275|560678959|FG004|Stage 1|Progression of Disease|2|||
155339791|NCT01562275|560678960|FG005|Stage 1|Progression of Disease|4|||
155339792|NCT01562275|560678961|FG006|Stage 1|Progression of Disease|1|||
155339793|NCT01562275|560678962|FG007|Stage 1|Progression of Disease|7|||
155073728|NCT02965456|559698291|FG001|Overall Study|Noncompliance with Study Drug|1|||
155073729|NCT02965456|559698290|FG000|Overall Study|Worsening Condition|0|||
155073730|NCT02965456|559698291|FG001|Overall Study|Worsening Condition|2|||
155073731|NCT02965456|559698290|FG000|Overall Study|Lack of Efficacy|1|||
155073732|NCT02965456|559698291|FG001|Overall Study|Lack of Efficacy|0|||
155073733|NCT02965456|559698290|FG000|Overall Study|Physician Decision|0|||
155339794|NCT01562275|560678963|FG008|Stage 1|Progression of Disease|2|||
155339795|NCT01562275|560678964|FG009|Stage 1|Progression of Disease|5|||
155339796|NCT01562275|560678965|FG010|Stage 1|Progression of Disease|3|||
155339797|NCT01562275|560678966|FG011|Stage 1|Progression of Disease|0|||
155339798|NCT01562275|560678967|FG012|Stage 1|Progression of Disease|0|||
155339799|NCT01562275|560678955|FG000|Stage 1|Withdrawal by Subject|0|||
155339800|NCT01562275|560678956|FG001|Stage 1|Withdrawal by Subject|1|||
155339801|NCT01562275|560678957|FG002|Stage 1|Withdrawal by Subject|0|||
155339802|NCT01562275|560678958|FG003|Stage 1|Withdrawal by Subject|2|||
155339803|NCT01562275|560678959|FG004|Stage 1|Withdrawal by Subject|0|||
155339804|NCT01562275|560678960|FG005|Stage 1|Withdrawal by Subject|0|||
155339805|NCT01562275|560678961|FG006|Stage 1|Withdrawal by Subject|1|||
155339806|NCT01562275|560678962|FG007|Stage 1|Withdrawal by Subject|0|||
155339807|NCT01562275|560678963|FG008|Stage 1|Withdrawal by Subject|0|||
155339808|NCT01562275|560678964|FG009|Stage 1|Withdrawal by Subject|1|||
155339809|NCT01562275|560678965|FG010|Stage 1|Withdrawal by Subject|0|||
155339810|NCT01562275|560678966|FG011|Stage 1|Withdrawal by Subject|0|||
155339811|NCT01562275|560678967|FG012|Stage 1|Withdrawal by Subject|0|||
155339812|NCT01562275|560678955|FG000|Stage 2|Death|0|||
155339813|NCT01562275|560678956|FG001|Stage 2|Death|0|||
155339814|NCT01562275|560678957|FG002|Stage 2|Death|0|||
155339815|NCT01562275|560678958|FG003|Stage 2|Death|0|||
155073734|NCT02965456|559698291|FG001|Overall Study|Physician Decision|1|||
155073735|NCT02965456|559698290|FG000|Overall Study|Pregnancy|1|||
155073736|NCT02965456|559698291|FG001|Overall Study|Pregnancy|0|||
155073737|NCT02965456|559698290|FG000|Overall Study|Protocol Violation|0|||
155073738|NCT02965456|559698291|FG001|Overall Study|Protocol Violation|1|||
155073739|NCT02965456|559698290|FG000|Overall Study|Participant ran out of study drug|0|||
155073740|NCT02965456|559698291|FG001|Overall Study|Participant ran out of study drug|1|||
155073741|NCT04465955|559698292|FG000|Overall Study|Withdrew consent|6|||
155073742|NCT04465955|559698293|FG001|Overall Study|Withdrew consent|10|||
155073743|NCT04465955|559698294|FG002|Overall Study|Withdrew consent|7|||
155073744|NCT04465955|559698292|FG000|Overall Study|Adverse Event|6|||
155073745|NCT04465955|559698293|FG001|Overall Study|Adverse Event|5|||
155073746|NCT04465955|559698294|FG002|Overall Study|Adverse Event|1|||
155073747|NCT04465955|559698292|FG000|Overall Study|Lost to Follow-up|2|||
155073748|NCT04465955|559698293|FG001|Overall Study|Lost to Follow-up|0|||
155073749|NCT04465955|559698294|FG002|Overall Study|Lost to Follow-up|3|||
155073750|NCT04465955|559698292|FG000|Overall Study|Other|1|||
155073751|NCT04465955|559698293|FG001|Overall Study|Other|1|||
155339816|NCT01562275|560678959|FG004|Stage 2|Death|0|||
155339817|NCT01562275|560678960|FG005|Stage 2|Death|0|||
155339818|NCT01562275|560678961|FG006|Stage 2|Death|0|||
155339819|NCT01562275|560678962|FG007|Stage 2|Death|0|||
155339820|NCT01562275|560678963|FG008|Stage 2|Death|0|||
155339821|NCT01562275|560678964|FG009|Stage 2|Death|0|||
155339822|NCT01562275|560678965|FG010|Stage 2|Death|0|||
155073752|NCT04465955|559698294|FG002|Overall Study|Other|3|||
155073753|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
155073754|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
155073755|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
155339823|NCT01562275|560678966|FG011|Stage 2|Death|2|||
155339824|NCT01562275|560678967|FG012|Stage 2|Death|1|||
155339825|NCT01562275|560678955|FG000|Stage 2|Progression of Disease|0|||
155339826|NCT01562275|560678956|FG001|Stage 2|Progression of Disease|0|||
155339827|NCT01562275|560678957|FG002|Stage 2|Progression of Disease|0|||
155339828|NCT01562275|560678958|FG003|Stage 2|Progression of Disease|0|||
155339829|NCT01562275|560678959|FG004|Stage 2|Progression of Disease|0|||
155339830|NCT01562275|560678960|FG005|Stage 2|Progression of Disease|0|||
155339831|NCT01562275|560678961|FG006|Stage 2|Progression of Disease|0|||
155339832|NCT01562275|560678962|FG007|Stage 2|Progression of Disease|0|||
155339833|NCT01562275|560678963|FG008|Stage 2|Progression of Disease|0|||
155339834|NCT01562275|560678964|FG009|Stage 2|Progression of Disease|0|||
155339835|NCT01562275|560678965|FG010|Stage 2|Progression of Disease|0|||
155339836|NCT01562275|560678966|FG011|Stage 2|Progression of Disease|12|||
155339837|NCT01562275|560678967|FG012|Stage 2|Progression of Disease|4|||
155339838|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
155339839|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
155339840|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
155339841|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
155339842|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
155339843|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
155339844|NCT01863368|560678968|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
155339845|NCT01863368|560678969|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
155339846|NCT01863368|560678968|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
155339847|NCT01863368|560678969|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
155339848|NCT01863368|560678968|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
155339849|NCT01863368|560678969|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
155339850|NCT00515112|560678971|FG000|Overall Study|Death|0|||
155339851|NCT00515112|560678972|FG001|Overall Study|Death|1|||
155339852|NCT00515112|560678971|FG000|Overall Study|The study was terminated|3|||
155339853|NCT00515112|560678972|FG001|Overall Study|The study was terminated|2|||
155339854|NCT03029585|560678975|FG000|Overall Study|Death|1|||
155339855|NCT03029585|560678976|FG001|Overall Study|Death|1|||
155339856|NCT03029585|560678975|FG000|Overall Study|Withdrawal by Subject|1|||
155339857|NCT03029585|560678976|FG001|Overall Study|Withdrawal by Subject|0|||
155339858|NCT04025762|560678979|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
155339859|NCT04025762|560678980|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
155339860|NCT03340961|560678982|FG000|Overall Study|Adverse Event|1|||
155339861|NCT03340961|560678983|FG001|Overall Study|Adverse Event|3|||
155339862|NCT03340961|560678984|FG002|Overall Study|Adverse Event|2|||
155339863|NCT03340961|560678985|FG003|Overall Study|Adverse Event|4|||
155339864|NCT03340961|560678982|FG000|Overall Study|Lost to Follow-up|0|||
155339865|NCT03340961|560678983|FG001|Overall Study|Lost to Follow-up|1|||
155339866|NCT03340961|560678984|FG002|Overall Study|Lost to Follow-up|0|||
155339867|NCT03340961|560678985|FG003|Overall Study|Lost to Follow-up|1|||
155339868|NCT03340961|560678982|FG000|Overall Study|Withdrawal by Subject|3|||
155339869|NCT03340961|560678983|FG001|Overall Study|Withdrawal by Subject|2|||
155339870|NCT03340961|560678984|FG002|Overall Study|Withdrawal by Subject|4|||
155339871|NCT03340961|560678985|FG003|Overall Study|Withdrawal by Subject|7|||
155339872|NCT03340961|560678982|FG000|Overall Study|Use of prohibited treatment|0|||
155339873|NCT03340961|560678983|FG001|Overall Study|Use of prohibited treatment|3|||
155339874|NCT03340961|560678984|FG002|Overall Study|Use of prohibited treatment|2|||
155339875|NCT03340961|560678985|FG003|Overall Study|Use of prohibited treatment|4|||
155339876|NCT03340961|560678982|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
155073756|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
155073757|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
155339877|NCT03340961|560678983|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
155339878|NCT03340961|560678984|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
155339879|NCT03340961|560678985|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
155339880|NCT03340961|560678982|FG000|Overall Study|Subject developed an exclusion criterion|0|||
155339881|NCT03340961|560678983|FG001|Overall Study|Subject developed an exclusion criterion|1|||
155339882|NCT03340961|560678984|FG002|Overall Study|Subject developed an exclusion criterion|0|||
155339883|NCT03340961|560678985|FG003|Overall Study|Subject developed an exclusion criterion|0|||
155339884|NCT03340961|560678982|FG000|Overall Study|Protocol Violation|1|||
155339885|NCT03340961|560678983|FG001|Overall Study|Protocol Violation|0|||
155339886|NCT03340961|560678984|FG002|Overall Study|Protocol Violation|1|||
155092654|NCT00854360|559773652|FG002|Overall Study|Pregnancy|0|||
155073758|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
155339887|NCT03340961|560678985|FG003|Overall Study|Protocol Violation|0|||
155339888|NCT03340961|560678982|FG000|Overall Study|Adverse Event|1|||
155339889|NCT03340961|560678983|FG001|Overall Study|Adverse Event|1|||
155339890|NCT03340961|560678984|FG002|Overall Study|Adverse Event|0|||
155339891|NCT03340961|560678985|FG003|Overall Study|Adverse Event|0|||
155339892|NCT03340961|560678982|FG000|Overall Study|Lack of Efficacy|0|||
155073759|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
155073760|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
155073761|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
155073762|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
155073763|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
155073764|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
155073765|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
155073766|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
155339893|NCT03340961|560678983|FG001|Overall Study|Lack of Efficacy|0|||
155339894|NCT03340961|560678984|FG002|Overall Study|Lack of Efficacy|0|||
155339895|NCT03340961|560678985|FG003|Overall Study|Lack of Efficacy|1|||
155339896|NCT01286311|560678986|FG000|Overall Study|Physician did not want outreach sent|14|||
155339897|NCT01286311|560678987|FG001|Overall Study|Physician did not want outreach sent|0|||
155339898|NCT01437540|560678988|FG000|Overall Study|Not listed below|7|||
155339899|NCT01437540|560678989|FG001|Overall Study|Not listed below|6|||
155339900|NCT01437540|560678988|FG000|Overall Study|COPD exacerbation|13|||
155339901|NCT01437540|560678989|FG001|Overall Study|COPD exacerbation|3|||
155339902|NCT01437540|560678988|FG000|Overall Study|Lost to Follow-up|3|||
155339903|NCT01437540|560678989|FG001|Overall Study|Lost to Follow-up|5|||
155339904|NCT01437540|560678988|FG000|Overall Study|Lack of Efficacy|23|||
155339905|NCT01437540|560678989|FG001|Overall Study|Lack of Efficacy|11|||
155339906|NCT01437540|560678988|FG000|Overall Study|Protocol Violation|24|||
155339907|NCT01437540|560678989|FG001|Overall Study|Protocol Violation|12|||
155339908|NCT01437540|560678988|FG000|Overall Study|Adverse Event|26|||
155339909|NCT01437540|560678989|FG001|Overall Study|Adverse Event|13|||
155339910|NCT01437540|560678988|FG000|Overall Study|Withdrawal by Subject|31|||
155339911|NCT01437540|560678989|FG001|Overall Study|Withdrawal by Subject|15|||
155339912|NCT04328467|560678994|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
155339913|NCT04328467|560678995|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
155339914|NCT04328467|560678996|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
155339915|NCT01975701|560678997|FG000|Overall Study|Lost to Follow-up|1|||
155339916|NCT01975701|560678997|FG000|Overall Study|Death|23|||
155339917|NCT01975701|560678997|FG000|Overall Study|Physician Decision|1|||
155339918|NCT02446015|560679000|FG000|Overall Study|Adverse Event|0|||
155339919|NCT02446015|560679001|FG001|Overall Study|Adverse Event|1|||
155339920|NCT02446015|560679000|FG000|Overall Study|Withdrawal by Subject|1|||
155339921|NCT02446015|560679001|FG001|Overall Study|Withdrawal by Subject|0|||
155339922|NCT01393600|560679002|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
155339923|NCT01393600|560679003|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
155339924|NCT01393600|560679004|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
155339925|NCT01393600|560679005|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
155073767|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
155164392|NCT02500797|560038902|FG005|Overall Study|Cancel (rapid disease progression)|1|||
155164393|NCT02500797|560038903|FG006|Overall Study|Cancel (rapid disease progression)|0|||
155164394|NCT02500797|560038904|FG007|Overall Study|Cancel (rapid disease progression)|0|||
155339926|NCT01393600|560679002|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
155339927|NCT01393600|560679003|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
155339928|NCT01393600|560679004|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
155339929|NCT01393600|560679005|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
155339930|NCT01393600|560679002|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
155339931|NCT01393600|560679003|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
155339932|NCT01393600|560679004|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
155339933|NCT01393600|560679005|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
155339934|NCT01393600|560679002|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
155339935|NCT01393600|560679003|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
155339936|NCT01393600|560679004|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
155339937|NCT01393600|560679005|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
155339938|NCT01393600|560679002|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
155339939|NCT01393600|560679003|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
155339940|NCT01393600|560679004|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
155339941|NCT01393600|560679005|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
155339942|NCT01393600|560679002|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
155339943|NCT01393600|560679003|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
155339944|NCT01393600|560679004|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
155339945|NCT01393600|560679005|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
155339946|NCT01393600|560679002|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
155339947|NCT01393600|560679003|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
155339948|NCT01393600|560679004|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
155339949|NCT01393600|560679005|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
155339950|NCT01670877|560679006|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339951|NCT01670877|560679007|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
155339952|NCT01670877|560679008|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339953|NCT01670877|560679009|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339954|NCT01670877|560679010|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339955|NCT01670877|560679011|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
155339956|NCT01670877|560679006|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339957|NCT01670877|560679007|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339958|NCT01670877|560679008|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
155339959|NCT01670877|560679009|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339960|NCT01670877|560679010|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339961|NCT01670877|560679011|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
155339962|NCT01670877|560679006|FG000|Part I and Part 2|Grade 2 vomiting|0|||
155339963|NCT01670877|560679007|FG001|Part I and Part 2|Grade 2 vomiting|0|||
155339964|NCT01670877|560679008|FG002|Part I and Part 2|Grade 2 vomiting|0|||
155339965|NCT01670877|560679009|FG003|Part I and Part 2|Grade 2 vomiting|1|||
155339966|NCT01670877|560679010|FG004|Part I and Part 2|Grade 2 vomiting|0|||
155339967|NCT01670877|560679011|FG005|Part I and Part 2|Grade 2 vomiting|0|||
155339968|NCT01670877|560679006|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339969|NCT01670877|560679007|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339970|NCT01670877|560679008|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339971|NCT01670877|560679009|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
155339972|NCT01670877|560679010|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339973|NCT01670877|560679011|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
155339974|NCT01670877|560679006|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339975|NCT01670877|560679007|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339976|NCT01670877|560679008|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339977|NCT01670877|560679009|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
155339978|NCT01670877|560679010|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339979|NCT01670877|560679011|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
155339980|NCT02525744|560679012|FG000|Period 1|Physician Decision|0|||
155339981|NCT02525744|560679013|FG001|Period 1|Physician Decision|0|||
155339982|NCT02525744|560679014|FG002|Period 1|Physician Decision|1|||
155339983|NCT02525744|560679015|FG003|Period 1|Physician Decision|0|||
155339984|NCT02525744|560679012|FG000|Period 3|Adverse Event|0|||
155339985|NCT02525744|560679013|FG001|Period 3|Adverse Event|1|||
155339986|NCT02525744|560679014|FG002|Period 3|Adverse Event|0|||
155339987|NCT02525744|560679015|FG003|Period 3|Adverse Event|0|||
155339988|NCT02525744|560679012|FG000|Period 4|Withdrawal by Subject|1|||
155339989|NCT02525744|560679013|FG001|Period 4|Withdrawal by Subject|0|||
155339990|NCT02525744|560679014|FG002|Period 4|Withdrawal by Subject|0|||
155339991|NCT02525744|560679015|FG003|Period 4|Withdrawal by Subject|0|||
155339992|NCT02525744|560679012|FG000|Period 5|Physician Decision|1|||
155339993|NCT02525744|560679013|FG001|Period 5|Physician Decision|0|||
155339994|NCT02525744|560679014|FG002|Period 5|Physician Decision|0|||
155339995|NCT02525744|560679015|FG003|Period 5|Physician Decision|0|||
155339996|NCT01182285|560679016|FG000|First Intervention Week 1-10|Disease progression|1|||
155339997|NCT01182285|560679017|FG001|First Intervention Week 1-10|Disease progression|0|||
155339998|NCT01182285|560679018|FG002|First Intervention Week 1-10|Disease progression|0|||
155339999|NCT01182285|560679016|FG000|First Intervention Week 1-10|Adverse Event|1|||
155340000|NCT01182285|560679017|FG001|First Intervention Week 1-10|Adverse Event|0|||
155340001|NCT01182285|560679018|FG002|First Intervention Week 1-10|Adverse Event|0|||
155340002|NCT01182285|560679016|FG000|First Intervention Week 1-10|Non-compliance|1|||
155340003|NCT01182285|560679017|FG001|First Intervention Week 1-10|Non-compliance|0|||
155340004|NCT01182285|560679018|FG002|First Intervention Week 1-10|Non-compliance|0|||
155340005|NCT01182285|560679016|FG000|Third Intervention Week 11-52|Disease Progression|0|||
155340006|NCT01182285|560679017|FG001|Third Intervention Week 11-52|Disease Progression|0|||
155340007|NCT01182285|560679018|FG002|Third Intervention Week 11-52|Disease Progression|6|||
155340008|NCT01182285|560679016|FG000|Third Intervention Week 11-52|Other|0|||
155340009|NCT01182285|560679017|FG001|Third Intervention Week 11-52|Other|0|||
155340010|NCT01182285|560679018|FG002|Third Intervention Week 11-52|Other|2|||
155340011|NCT00472082|560679019|FG000|Overall Study|Study prematurely terminated|5|||
155340012|NCT03449979|560679020|FG000|Overall Study|Technical difficulty|0|||
155340013|NCT03449979|560679021|FG001|Overall Study|Technical difficulty|0|||
155340014|NCT03449979|560679022|FG002|Overall Study|Technical difficulty|0|||
155340015|NCT03449979|560679023|FG003|Overall Study|Technical difficulty|1|||
155340016|NCT02069379|560679024|FG000|Baseline Measurements|Lost to Follow-up|1|||
155340017|NCT02069379|560679025|FG001|Baseline Measurements|Lost to Follow-up|0|||
155340018|NCT02069379|560679026|FG002|Baseline Measurements|Lost to Follow-up|0|||
155340019|NCT02069379|560679027|FG003|Baseline Measurements|Lost to Follow-up|0|||
155340020|NCT02069379|560679024|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
155340021|NCT02069379|560679025|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
155340022|NCT02069379|560679026|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
155340023|NCT02069379|560679027|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
155340024|NCT02069379|560679024|FG000|First Treatment Arm|Lost to Follow-up|0|||
155340025|NCT02069379|560679025|FG001|First Treatment Arm|Lost to Follow-up|1|||
155340026|NCT02069379|560679026|FG002|First Treatment Arm|Lost to Follow-up|1|||
155340027|NCT02069379|560679027|FG003|First Treatment Arm|Lost to Follow-up|0|||
155340028|NCT02069379|560679024|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
155340029|NCT02069379|560679025|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
155340030|NCT02069379|560679026|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
155340031|NCT02069379|560679027|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
155340032|NCT02069379|560679024|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
155340033|NCT02069379|560679025|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
155340034|NCT02069379|560679026|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
155340035|NCT02069379|560679027|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
155340036|NCT02069379|560679024|FG000|Second Treatment Arm|Lost to Follow-up|0|||
155340037|NCT02069379|560679025|FG001|Second Treatment Arm|Lost to Follow-up|0|||
155340038|NCT02069379|560679026|FG002|Second Treatment Arm|Lost to Follow-up|1|||
155340039|NCT02069379|560679027|FG003|Second Treatment Arm|Lost to Follow-up|0|||
155340040|NCT01762345|560679028|FG000|Overall Study|Adverse Event|5|||
155340041|NCT01762345|560679028|FG000|Overall Study|Protocol Violation|2|||
155340042|NCT01525875|560679029|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
155340043|NCT01525875|560679030|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
155340044|NCT01525875|560679029|FG000|Open-label Period|Lost to Follow-up|0|||
155340045|NCT01525875|560679030|FG001|Open-label Period|Lost to Follow-up|2|||
155340046|NCT02379078|560679031|FG000|Overall Study|Lost to Follow-up|33|||
155340047|NCT02379078|560679032|FG001|Overall Study|Lost to Follow-up|30|||
155340048|NCT02379078|560679031|FG000|Overall Study|Withdrawal by Subject|6|||
155340049|NCT02379078|560679032|FG001|Overall Study|Withdrawal by Subject|5|||
155340050|NCT02206607|560679033|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
155340051|NCT02206607|560679034|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
155340052|NCT02206607|560679035|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
155340053|NCT02206607|560679036|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
155340054|NCT02206607|560679037|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
155340055|NCT02206607|560679033|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
155340056|NCT02206607|560679034|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
155340057|NCT02206607|560679035|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
155340058|NCT02206607|560679036|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
155340059|NCT02206607|560679037|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
155340060|NCT00761267|560679038|FG000|Overall Study|Death|1|||
155340061|NCT00761267|560679039|FG001|Overall Study|Death|2|||
155340062|NCT00761267|560679040|FG002|Overall Study|Death|5|||
155340063|NCT00761267|560679038|FG000|Overall Study|Lost to Follow-up|0|||
155340064|NCT00761267|560679039|FG001|Overall Study|Lost to Follow-up|0|||
155340065|NCT00761267|560679040|FG002|Overall Study|Lost to Follow-up|1|||
155340066|NCT00761267|560679038|FG000|Overall Study|Randomized but not treated|1|||
155340067|NCT00761267|560679039|FG001|Overall Study|Randomized but not treated|1|||
155340068|NCT00761267|560679040|FG002|Overall Study|Randomized but not treated|0|||
155340069|NCT00761267|560679038|FG000|Overall Study|Withdrawal by Subject|0|||
155340070|NCT00761267|560679039|FG001|Overall Study|Withdrawal by Subject|1|||
155340071|NCT00761267|560679040|FG002|Overall Study|Withdrawal by Subject|0|||
155340072|NCT01777932|560679045|FG000|Overall Study|Disease progression|136|||
155340073|NCT01777932|560679045|FG000|Overall Study|Death|3|||
155340074|NCT01777932|560679045|FG000|Overall Study|Adverse Event|34|||
155340075|NCT01777932|560679045|FG000|Overall Study|Lost to Follow-up|3|||
155340076|NCT01777932|560679045|FG000|Overall Study|Investigator decision|10|||
155340077|NCT01777932|560679045|FG000|Overall Study|Reimbursement limit|9|||
155340078|NCT01777932|560679045|FG000|Overall Study|Patient refused further treatment|10|||
155340079|NCT03989232|560679055|FG000|Overall Study|Lost to Follow-up|3|||
155340080|NCT03989232|560679056|FG001|Overall Study|Lost to Follow-up|10|||
155340081|NCT03989232|560679055|FG000|Overall Study|Withdrawal by Subject|6|||
155340082|NCT03989232|560679056|FG001|Overall Study|Withdrawal by Subject|6|||
155340083|NCT03989232|560679055|FG000|Overall Study|Death|1|||
155340084|NCT03989232|560679056|FG001|Overall Study|Death|2|||
155340085|NCT02644122|560679060|FG000|Overall Study|Withdrawal by Subject|1|||
155340086|NCT01930188|560679063|FG000|Overall Study|unclassified|4|||
155340087|NCT01930188|560679064|FG001|Overall Study|unclassified|5|||
155340088|NCT01930188|560679065|FG002|Overall Study|unclassified|3|||
155340089|NCT01930188|560679063|FG000|Overall Study|Missing follow-up information|2|||
155340090|NCT01930188|560679064|FG001|Overall Study|Missing follow-up information|2|||
155340091|NCT01930188|560679065|FG002|Overall Study|Missing follow-up information|3|||
155340092|NCT01930188|560679063|FG000|Overall Study|Lost to Follow-up|5|||
155340093|NCT01930188|560679064|FG001|Overall Study|Lost to Follow-up|2|||
155340094|NCT01930188|560679065|FG002|Overall Study|Lost to Follow-up|2|||
155340095|NCT01930188|560679063|FG000|Overall Study|Death|2|||
155340096|NCT01930188|560679064|FG001|Overall Study|Death|1|||
155340097|NCT01930188|560679065|FG002|Overall Study|Death|3|||
155340098|NCT01930188|560679063|FG000|Overall Study|Withdrawal by Subject|9|||
155340099|NCT01930188|560679064|FG001|Overall Study|Withdrawal by Subject|11|||
155340100|NCT01930188|560679065|FG002|Overall Study|Withdrawal by Subject|8|||
155340101|NCT02514824|560679066|FG000|Overall Study|Withdrawal by Subject|1|||
155340102|NCT02514824|560679067|FG001|Overall Study|Withdrawal by Subject|0|||
155340103|NCT02514824|560679068|FG002|Overall Study|Withdrawal by Subject|0|||
155340104|NCT02514824|560679069|FG003|Overall Study|Withdrawal by Subject|0|||
155340105|NCT02514824|560679066|FG000|Overall Study|Dose-Limiting Toxicity|0|||
155340106|NCT02514824|560679067|FG001|Overall Study|Dose-Limiting Toxicity|1|||
155340107|NCT02514824|560679068|FG002|Overall Study|Dose-Limiting Toxicity|0|||
155340108|NCT02514824|560679069|FG003|Overall Study|Dose-Limiting Toxicity|0|||
155340109|NCT02170207|560679072|FG000|Overall Study|Case report forms unavailable|5|||
155340110|NCT03122860|560679073|FG000|Overall Study|Discontinued Before Treatment|1|||
155340111|NCT03122860|560679074|FG001|Overall Study|Discontinued Before Treatment|1|||
155340112|NCT03122860|560679075|FG002|Overall Study|Discontinued Before Treatment|2|||
155340113|NCT03122860|560679076|FG003|Overall Study|Discontinued Before Treatment|0|||
155340114|NCT03122860|560679077|FG004|Overall Study|Discontinued Before Treatment|1|||
155340115|NCT03122860|560679078|FG005|Overall Study|Discontinued Before Treatment|0|||
155340116|NCT03122860|560679073|FG000|Overall Study|Adverse Event|1|||
155340117|NCT03122860|560679074|FG001|Overall Study|Adverse Event|0|||
155340118|NCT03122860|560679075|FG002|Overall Study|Adverse Event|1|||
155340119|NCT03122860|560679076|FG003|Overall Study|Adverse Event|1|||
155340120|NCT03122860|560679077|FG004|Overall Study|Adverse Event|0|||
155340121|NCT03122860|560679078|FG005|Overall Study|Adverse Event|0|||
155340122|NCT03122860|560679073|FG000|Overall Study|Lost to Follow-up|5|||
155340123|NCT03122860|560679074|FG001|Overall Study|Lost to Follow-up|2|||
155340124|NCT03122860|560679075|FG002|Overall Study|Lost to Follow-up|3|||
155340125|NCT03122860|560679076|FG003|Overall Study|Lost to Follow-up|3|||
155340126|NCT03122860|560679077|FG004|Overall Study|Lost to Follow-up|5|||
155340127|NCT03122860|560679078|FG005|Overall Study|Lost to Follow-up|4|||
155340128|NCT03122860|560679073|FG000|Overall Study|Subject Non-Compliance|0|||
155340129|NCT03122860|560679074|FG001|Overall Study|Subject Non-Compliance|0|||
155340130|NCT03122860|560679075|FG002|Overall Study|Subject Non-Compliance|1|||
155340131|NCT03122860|560679076|FG003|Overall Study|Subject Non-Compliance|0|||
155340132|NCT03122860|560679077|FG004|Overall Study|Subject Non-Compliance|0|||
155340133|NCT03122860|560679078|FG005|Overall Study|Subject Non-Compliance|0|||
155340134|NCT03122860|560679073|FG000|Overall Study|Withdrawal by Subject|3|||
155340135|NCT03122860|560679074|FG001|Overall Study|Withdrawal by Subject|2|||
155340136|NCT03122860|560679075|FG002|Overall Study|Withdrawal by Subject|5|||
155340137|NCT03122860|560679076|FG003|Overall Study|Withdrawal by Subject|7|||
155340138|NCT03122860|560679077|FG004|Overall Study|Withdrawal by Subject|9|||
155340139|NCT03122860|560679078|FG005|Overall Study|Withdrawal by Subject|8|||
155340140|NCT01138657|560679079|FG000|Overall Study|Adverse Event|3|||
155340141|NCT01138657|560679080|FG001|Overall Study|Adverse Event|10|||
155340142|NCT01138657|560679079|FG000|Overall Study|Lack of Efficacy|2|||
155340143|NCT01138657|560679080|FG001|Overall Study|Lack of Efficacy|1|||
155340144|NCT01138657|560679079|FG000|Overall Study|Lost to Follow-up|0|||
155340145|NCT01138657|560679080|FG001|Overall Study|Lost to Follow-up|3|||
155340146|NCT01138657|560679079|FG000|Overall Study|Miscellaneous Reasons|3|||
155340147|NCT01138657|560679080|FG001|Overall Study|Miscellaneous Reasons|4|||
155340148|NCT02399449|560679083|FG000|Overall Study|Withdrawal by Subject|3|||
155340149|NCT02399449|560679084|FG001|Overall Study|Withdrawal by Subject|9|||
155340150|NCT02399449|560679083|FG000|Overall Study|Physician Decision|0|||
155340151|NCT02399449|560679084|FG001|Overall Study|Physician Decision|1|||
155340152|NCT01020435|560679085|FG000|Overall Study|Lost to Follow-up|0|||
155340153|NCT01020435|560679086|FG001|Overall Study|Lost to Follow-up|1|||
155340154|NCT00337610|560679087|FG000|Overall Study|Adverse Event|2|||
155340155|NCT00337610|560679088|FG001|Overall Study|Adverse Event|2|||
155340156|NCT00337610|560679087|FG000|Overall Study|Death|0|||
155340157|NCT00337610|560679088|FG001|Overall Study|Death|1|||
155340158|NCT00337610|560679087|FG000|Overall Study|Lack of Efficacy|6|||
155340159|NCT00337610|560679088|FG001|Overall Study|Lack of Efficacy|3|||
155340160|NCT00337610|560679087|FG000|Overall Study|Lost to Follow-up|3|||
155340161|NCT00337610|560679088|FG001|Overall Study|Lost to Follow-up|3|||
155340162|NCT00337610|560679087|FG000|Overall Study|Withdrawal by Subject|6|||
155340163|NCT00337610|560679088|FG001|Overall Study|Withdrawal by Subject|5|||
155340164|NCT00346398|560679089|FG000|Overall Study|Lost to Follow-up|3|||
155340165|NCT00346398|560679090|FG001|Overall Study|Lost to Follow-up|0|||
155340166|NCT00346398|560679089|FG000|Overall Study|Withdrawal by Subject|0|||
155340167|NCT00346398|560679090|FG001|Overall Study|Withdrawal by Subject|2|||
155340168|NCT03979040|560679091|FG000|Overall Study|Withdrawal by Subject|24|||
155340169|NCT03979040|560679092|FG001|Overall Study|Withdrawal by Subject|32|||
155340170|NCT03979040|560679091|FG000|Overall Study|randomized but never started treatment|32|||
155340171|NCT03979040|560679092|FG001|Overall Study|randomized but never started treatment|39|||
155340172|NCT03979040|560679091|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
155340173|NCT03979040|560679092|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
155340174|NCT02607956|560679093|FG000|Double-Blinded Phase|Withdrew Consent|17|||
155340175|NCT02607956|560679094|FG001|Double-Blinded Phase|Withdrew Consent|19|||
155340176|NCT02607956|560679095|FG002|Double-Blinded Phase|Withdrew Consent|0|||
155340177|NCT02607956|560679096|FG003|Double-Blinded Phase|Withdrew Consent|0|||
155340178|NCT02607956|560679093|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
155340179|NCT02607956|560679094|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
155340180|NCT02607956|560679095|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
155340181|NCT02607956|560679096|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
155340182|NCT02607956|560679093|FG000|Double-Blinded Phase|Randomized but never treated|7|||
155340183|NCT02607956|560679094|FG001|Double-Blinded Phase|Randomized but never treated|5|||
155340184|NCT02607956|560679095|FG002|Double-Blinded Phase|Randomized but never treated|0|||
155340185|NCT02607956|560679096|FG003|Double-Blinded Phase|Randomized but never treated|0|||
155340186|NCT02607956|560679093|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
155340187|NCT02607956|560679094|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
155340188|NCT02607956|560679095|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
155340189|NCT02607956|560679096|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
155340190|NCT02607956|560679093|FG000|Double-Blinded Phase|Death|4|||
155340191|NCT02607956|560679094|FG001|Double-Blinded Phase|Death|4|||
155340192|NCT02607956|560679095|FG002|Double-Blinded Phase|Death|0|||
154962561|NCT05152576|559287992|FG003|Overall Study|Withdrawal by Subject|1|||
154962562|NCT05152576|559287989|FG000|Overall Study|Other|2|||
154962563|NCT05152576|559287990|FG001|Overall Study|Other|0|||
154962564|NCT05152576|559287991|FG002|Overall Study|Other|0|||
154962565|NCT05152576|559287992|FG003|Overall Study|Other|0|||
155340193|NCT02607956|560679096|FG003|Double-Blinded Phase|Death|0|||
155340194|NCT02607956|560679093|FG000|Double-Blinded Phase|Adverse Event|4|||
155340195|NCT02607956|560679094|FG001|Double-Blinded Phase|Adverse Event|3|||
155340196|NCT02607956|560679095|FG002|Double-Blinded Phase|Adverse Event|0|||
155340197|NCT02607956|560679096|FG003|Double-Blinded Phase|Adverse Event|0|||
155340198|NCT02607956|560679093|FG000|Double-Blinded Phase|Protocol Violation|3|||
155340199|NCT02607956|560679094|FG001|Double-Blinded Phase|Protocol Violation|1|||
154962566|NCT01952691|559289498|FG000|Overall Study|Lost to Follow-up|2|||
154962567|NCT00199901|559289499|FG000|Overall Study|Protocol Violation|2|||
154962568|NCT00199901|559289500|FG001|Overall Study|Protocol Violation|0|||
154962569|NCT00199901|559289499|FG000|Overall Study|Withdrawal by Subject|1|||
155340200|NCT02607956|560679095|FG002|Double-Blinded Phase|Protocol Violation|0|||
155340201|NCT02607956|560679096|FG003|Double-Blinded Phase|Protocol Violation|0|||
155340202|NCT02607956|560679093|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
155340203|NCT02607956|560679094|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
155340204|NCT02607956|560679095|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
155340205|NCT02607956|560679096|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
155340206|NCT02607956|560679093|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
155340207|NCT02607956|560679094|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
155340208|NCT02607956|560679095|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
155340209|NCT02607956|560679096|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
155340210|NCT02607956|560679093|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155340211|NCT02607956|560679094|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155340212|NCT02607956|560679095|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
155340213|NCT02607956|560679096|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
155340214|NCT02607956|560679093|FG000|Open-Label Extension Phase|Death|0|||
155340215|NCT02607956|560679094|FG001|Open-Label Extension Phase|Death|0|||
155340216|NCT02607956|560679095|FG002|Open-Label Extension Phase|Death|1|||
155340217|NCT02607956|560679096|FG003|Open-Label Extension Phase|Death|3|||
155340218|NCT02607956|560679093|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
155340219|NCT02607956|560679094|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
155340220|NCT02607956|560679095|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
155340221|NCT02607956|560679096|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
155340222|NCT02607956|560679093|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
155340223|NCT02607956|560679094|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
155340224|NCT02607956|560679095|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
155340225|NCT02607956|560679096|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
155340226|NCT02607956|560679093|FG000|Open-Label Extension Phase|Protocol Violation|0|||
155340227|NCT02607956|560679094|FG001|Open-Label Extension Phase|Protocol Violation|0|||
155340228|NCT02607956|560679095|FG002|Open-Label Extension Phase|Protocol Violation|0|||
155340229|NCT02607956|560679096|FG003|Open-Label Extension Phase|Protocol Violation|2|||
155340230|NCT02607956|560679093|FG000|Open-Label Extension Phase|Pregnancy|0|||
155340231|NCT02607956|560679094|FG001|Open-Label Extension Phase|Pregnancy|0|||
155340232|NCT02607956|560679095|FG002|Open-Label Extension Phase|Pregnancy|0|||
155340233|NCT02607956|560679096|FG003|Open-Label Extension Phase|Pregnancy|1|||
155340234|NCT02326220|560679102|FG000|Double-blind Treatment Period|Adverse Event|1|||
155340235|NCT02326220|560679103|FG001|Double-blind Treatment Period|Adverse Event|2|||
155340236|NCT02326220|560679104|FG002|Double-blind Treatment Period|Adverse Event|0|||
155340237|NCT02326220|560679102|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155340238|NCT02326220|560679103|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155340239|NCT02326220|560679104|FG002|Double-blind Treatment Period|Protocol Violation|0|||
155340240|NCT02326220|560679102|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155340241|NCT02326220|560679103|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155340242|NCT02326220|560679104|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155340243|NCT02326220|560679102|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
155340244|NCT02326220|560679103|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155340245|NCT02326220|560679104|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
155340246|NCT02326220|560679102|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155340247|NCT02326220|560679103|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155340248|NCT02326220|560679104|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
155340249|NCT00824850|560679105|FG000|Overall Study|Withdrawal by Subject|0|||
155340250|NCT00824850|560679106|FG001|Overall Study|Withdrawal by Subject|1|||
155340251|NCT01075152|560679108|FG000|Overall Study|Withdrawal by Subject|1|||
155340252|NCT01075152|560679109|FG001|Overall Study|Withdrawal by Subject|0|||
155340253|NCT04820491|560679110|FG000|Overall Study|Withdrawal by Subject|1|||
155340254|NCT04820491|560679111|FG001|Overall Study|Withdrawal by Subject|0|||
155340255|NCT01079949|560679114|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
155340256|NCT01079949|560679115|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
155340257|NCT01079949|560679114|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
155340258|NCT01079949|560679115|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
155340259|NCT01079949|560679114|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
155340260|NCT01079949|560679115|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
155340261|NCT01079949|560679114|FG000|Overall Study|Randomized but not treated|1|||
155340262|NCT01079949|560679115|FG001|Overall Study|Randomized but not treated|0|||
155340263|NCT02144285|560679116|FG000|Overall Study|Withdrawal by Subject|0|||
155340264|NCT02144285|560679117|FG001|Overall Study|Withdrawal by Subject|0|||
155340265|NCT02144285|560679118|FG002|Overall Study|Withdrawal by Subject|0|||
155340266|NCT02144285|560679119|FG003|Overall Study|Withdrawal by Subject|0|||
155340267|NCT02144285|560679120|FG004|Overall Study|Withdrawal by Subject|1|||
155340268|NCT02144285|560679121|FG005|Overall Study|Withdrawal by Subject|0|||
155340269|NCT02144285|560679122|FG006|Overall Study|Withdrawal by Subject|0|||
155340270|NCT02144285|560679123|FG007|Overall Study|Withdrawal by Subject|0|||
155340271|NCT02144285|560679124|FG008|Overall Study|Withdrawal by Subject|0|||
155340272|NCT02144285|560679125|FG009|Overall Study|Withdrawal by Subject|0|||
155340273|NCT01529632|560679126|FG000|Overall Study|Administrative problem|2|||
155340274|NCT01529632|560679127|FG001|Overall Study|Administrative problem|1|||
155340275|NCT01529632|560679126|FG000|Overall Study|Protocol Violation|0|||
155340276|NCT01529632|560679127|FG001|Overall Study|Protocol Violation|1|||
155340277|NCT01529632|560679126|FG000|Overall Study|Adverse Event|1|||
155340278|NCT01529632|560679127|FG001|Overall Study|Adverse Event|1|||
155340279|NCT03659136|560679133|FG000|Overall Study|Not treated|2|||
155340280|NCT03659136|560679134|FG001|Overall Study|Not treated|0|||
155340281|NCT03659136|560679133|FG000|Overall Study|Covid-19 related|1|||
155340282|NCT03659136|560679134|FG001|Overall Study|Covid-19 related|1|||
155340283|NCT03659136|560679133|FG000|Overall Study|Withdrawal by Subject|1|||
155340284|NCT03659136|560679134|FG001|Overall Study|Withdrawal by Subject|6|||
155340285|NCT03659136|560679133|FG000|Overall Study|Adverse Event|4|||
155340286|NCT03659136|560679134|FG001|Overall Study|Adverse Event|6|||
155340287|NCT03659136|560679133|FG000|Overall Study|Progressive disease|37|||
155340288|NCT03659136|560679134|FG001|Overall Study|Progressive disease|31|||
155340289|NCT03659136|560679133|FG000|Overall Study|Study closure|2|||
155340290|NCT03659136|560679134|FG001|Overall Study|Study closure|2|||
155340291|NCT03659136|560679133|FG000|Overall Study|Sponsor decision/recommendation|3|||
155340292|NCT03659136|560679134|FG001|Overall Study|Sponsor decision/recommendation|2|||
155340293|NCT03659136|560679133|FG000|Overall Study|Switched to other drug/therapy|2|||
155340294|NCT03659136|560679134|FG001|Overall Study|Switched to other drug/therapy|2|||
155340295|NCT03659136|560679133|FG000|Overall Study|Lack of clinical benefit|0|||
155340296|NCT03659136|560679134|FG001|Overall Study|Lack of clinical benefit|1|||
155340297|NCT04914897|560681211|FG000|Overall Study|Withdrawal by Subject|3|||
155340298|NCT04914897|560681212|FG001|Overall Study|Withdrawal by Subject|1|||
155340299|NCT04914897|560681213|FG002|Overall Study|Withdrawal by Subject|1|||
155340300|NCT04914897|560681214|FG003|Overall Study|Withdrawal by Subject|1|||
155340301|NCT04914897|560681211|FG000|Overall Study|Poor compliance to protocol|0|||
155340302|NCT04914897|560681212|FG001|Overall Study|Poor compliance to protocol|0|||
155340303|NCT04914897|560681213|FG002|Overall Study|Poor compliance to protocol|1|||
155340304|NCT04914897|560681214|FG003|Overall Study|Poor compliance to protocol|0|||
155340305|NCT04914897|560681211|FG000|Overall Study|Progressive disease|5|||
155340306|NCT04914897|560681212|FG001|Overall Study|Progressive disease|14|||
155340307|NCT04914897|560681213|FG002|Overall Study|Progressive disease|30|||
155340308|NCT04914897|560681214|FG003|Overall Study|Progressive disease|21|||
155340309|NCT04914897|560681211|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155340310|NCT04914897|560681212|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
155340311|NCT04914897|560681213|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
155340312|NCT04914897|560681214|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
155340313|NCT04914897|560681211|FG000|Overall Study|Other|1|||
155340314|NCT04914897|560681212|FG001|Overall Study|Other|0|||
155340315|NCT04914897|560681213|FG002|Overall Study|Other|0|||
155340316|NCT04914897|560681214|FG003|Overall Study|Other|1|||
155340317|NCT03020914|560681215|FG000|Overall Study|Surgery Cancelled|1|||
155340318|NCT03020914|560681216|FG001|Overall Study|Surgery Cancelled|0|||
155340319|NCT00451906|560681225|FG000|Overall Study|Adverse Event|515|||
155340320|NCT00451906|560681225|FG000|Overall Study|Lost to Follow-up|31|||
155340321|NCT00451906|560681225|FG000|Overall Study|Withdrawal by Subject|111|||
155340322|NCT00451906|560681225|FG000|Overall Study|Protocol Violation|21|||
155340323|NCT00451906|560681225|FG000|Overall Study|Progressive disease|1328|||
155340324|NCT00451906|560681225|FG000|Overall Study|Termination of the study|108|||
155340325|NCT00451906|560681225|FG000|Overall Study|Other Reasons|121|||
155340326|NCT00451906|560681225|FG000|Overall Study|Did not complete final visit|4|||
155340327|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
155340328|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
155340329|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
155340330|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
155340331|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
155340332|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
155340333|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
155340334|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
155340335|NCT05066230|560681227|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
155340336|NCT05066230|560681228|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
155340337|NCT05066230|560681227|FG000|After Week 48|Adverse Event|1|||
155340338|NCT05066230|560681228|FG001|After Week 48|Adverse Event|0|||
155340339|NCT05066230|560681227|FG000|After Week 48|Non-compliance with study schedule|1|||
155340340|NCT05066230|560681228|FG001|After Week 48|Non-compliance with study schedule|0|||
155340341|NCT05066230|560681227|FG000|After Week 48|Withdrawal by Subject|0|||
155340342|NCT05066230|560681228|FG001|After Week 48|Withdrawal by Subject|1|||
155340343|NCT05066230|560681227|FG000|After Week 48|Lost to Follow-up|3|||
155340344|NCT05066230|560681228|FG001|After Week 48|Lost to Follow-up|3|||
155340345|NCT05066230|560681227|FG000|After Week 48|Sponsor Request|115|||
155340346|NCT05066230|560681228|FG001|After Week 48|Sponsor Request|111|||
155340347|NCT03072238|560681229|FG000|Overall Study|Withdrawal by Subject|44|||
155340348|NCT03072238|560681230|FG001|Overall Study|Withdrawal by Subject|64|||
155340349|NCT03072238|560681229|FG000|Overall Study|Lost to Follow-up|14|||
155340350|NCT03072238|560681230|FG001|Overall Study|Lost to Follow-up|5|||
155340351|NCT03072238|560681229|FG000|Overall Study|Physician Decision|4|||
155340352|NCT03072238|560681230|FG001|Overall Study|Physician Decision|6|||
155340353|NCT03072238|560681229|FG000|Overall Study|Death|351|||
155340354|NCT03072238|560681230|FG001|Overall Study|Death|318|||
155340355|NCT03072238|560681229|FG000|Overall Study|Progressive Disease|3|||
155340356|NCT03072238|560681230|FG001|Overall Study|Progressive Disease|4|||
155340357|NCT03072238|560681229|FG000|Overall Study|Reason Not Specified|138|||
155340358|NCT03072238|560681230|FG001|Overall Study|Reason Not Specified|150|||
155340359|NCT02400749|560681231|FG000|Week 0 -16|Withdrawal by Subject|5|||
155340360|NCT02400749|560681232|FG001|Week 0 -16|Withdrawal by Subject|5|||
155340361|NCT02400749|560681231|FG000|Week 0 -16|Adverse Event|3|||
155340362|NCT02400749|560681232|FG001|Week 0 -16|Adverse Event|1|||
155340363|NCT02400749|560681231|FG000|Week 0 -16|Lost to Follow-up|2|||
155340364|NCT02400749|560681232|FG001|Week 0 -16|Lost to Follow-up|0|||
155340365|NCT02400749|560681231|FG000|Week 0 -16|Protocol Violation|1|||
155340366|NCT02400749|560681232|FG001|Week 0 -16|Protocol Violation|0|||
155340367|NCT02400749|560681231|FG000|Week 17 - 32|Withdrawal by Subject|3|||
155340368|NCT02400749|560681232|FG001|Week 17 - 32|Withdrawal by Subject|2|||
155340369|NCT02400749|560681231|FG000|Week 17 - 32|Adverse Event|2|||
155340370|NCT02400749|560681232|FG001|Week 17 - 32|Adverse Event|1|||
155340371|NCT00507429|560681233|FG000|Treatment Phase|Disease Progression|12|||
155340372|NCT00507429|560681234|FG001|Treatment Phase|Disease Progression|5|||
155340373|NCT00507429|560681233|FG000|Treatment Phase|Adverse Event|12|||
155340374|NCT00507429|560681234|FG001|Treatment Phase|Adverse Event|5|||
155340375|NCT00507429|560681233|FG000|Treatment Phase|Withdrawal by Subject|3|||
155340376|NCT00507429|560681234|FG001|Treatment Phase|Withdrawal by Subject|3|||
155340377|NCT00507429|560681233|FG000|Treatment Phase|Physician Decision|4|||
155340378|NCT00507429|560681234|FG001|Treatment Phase|Physician Decision|2|||
155340379|NCT00507429|560681233|FG000|Treatment Phase|Other|6|||
155340380|NCT00507429|560681234|FG001|Treatment Phase|Other|3|||
155340381|NCT00507429|560681233|FG000|Maintenance Phase|Progressive Disease|14|||
155340382|NCT00507429|560681234|FG001|Maintenance Phase|Progressive Disease|0|||
155340383|NCT02889900|560681235|FG000|Overall Study|Adverse Event|11|||
155340384|NCT02889900|560681235|FG000|Overall Study|Condition under investigation worsened|32|||
155340385|NCT02889900|560681235|FG000|Overall Study|Other|5|||
155340386|NCT02889900|560681235|FG000|Overall Study|Withdrawal by Subject|7|||
155340387|NCT02889900|560681235|FG000|Overall Study|Not treated|2|||
155340388|NCT00813709|560681236|FG000|Double Blind Period|Adverse Event|4|||
155340389|NCT00813709|560681237|FG001|Double Blind Period|Adverse Event|1|||
155340390|NCT00813709|560681238|FG002|Double Blind Period|Adverse Event|4|||
155340391|NCT00813709|560681239|FG003|Double Blind Period|Adverse Event|0|||
155340392|NCT00813709|560681240|FG004|Double Blind Period|Adverse Event|0|||
155340393|NCT00813709|560681241|FG005|Double Blind Period|Adverse Event|0|||
155340394|NCT00813709|560681236|FG000|Double Blind Period|Lost to Follow-up|3|||
155340395|NCT00813709|560681237|FG001|Double Blind Period|Lost to Follow-up|2|||
155340396|NCT00813709|560681238|FG002|Double Blind Period|Lost to Follow-up|2|||
155340397|NCT00813709|560681239|FG003|Double Blind Period|Lost to Follow-up|0|||
155340398|NCT00813709|560681240|FG004|Double Blind Period|Lost to Follow-up|0|||
155340399|NCT00813709|560681241|FG005|Double Blind Period|Lost to Follow-up|0|||
155340400|NCT00813709|560681236|FG000|Double Blind Period|Switched to open label phase|9|||
155340401|NCT00813709|560681237|FG001|Double Blind Period|Switched to open label phase|26|||
155340402|NCT00813709|560681238|FG002|Double Blind Period|Switched to open label phase|18|||
155340403|NCT00813709|560681239|FG003|Double Blind Period|Switched to open label phase|0|||
155340404|NCT00813709|560681240|FG004|Double Blind Period|Switched to open label phase|0|||
155340405|NCT00813709|560681241|FG005|Double Blind Period|Switched to open label phase|0|||
155340406|NCT00813709|560681236|FG000|Double Blind Period|Randomized but not treated|1|||
155340407|NCT00813709|560681237|FG001|Double Blind Period|Randomized but not treated|3|||
155340408|NCT00813709|560681238|FG002|Double Blind Period|Randomized but not treated|1|||
155340409|NCT00813709|560681239|FG003|Double Blind Period|Randomized but not treated|0|||
155340410|NCT00813709|560681240|FG004|Double Blind Period|Randomized but not treated|0|||
155340411|NCT00813709|560681241|FG005|Double Blind Period|Randomized but not treated|0|||
155340412|NCT00813709|560681236|FG000|Double Blind Period|Other|14|||
155340413|NCT00813709|560681237|FG001|Double Blind Period|Other|9|||
155340414|NCT00813709|560681238|FG002|Double Blind Period|Other|6|||
155340415|NCT00813709|560681239|FG003|Double Blind Period|Other|0|||
155073768|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
155340416|NCT00813709|560681240|FG004|Double Blind Period|Other|0|||
155340417|NCT00813709|560681241|FG005|Double Blind Period|Other|0|||
155340418|NCT00813709|560681236|FG000|Open Label Period|Adverse Event|0|||
155340419|NCT00813709|560681237|FG001|Open Label Period|Adverse Event|0|||
155340420|NCT00813709|560681238|FG002|Open Label Period|Adverse Event|0|||
155340421|NCT00813709|560681239|FG003|Open Label Period|Adverse Event|5|||
155340422|NCT00813709|560681240|FG004|Open Label Period|Adverse Event|4|||
155340423|NCT00813709|560681241|FG005|Open Label Period|Adverse Event|3|||
155340424|NCT00813709|560681236|FG000|Open Label Period|Lack of Efficacy|0|||
155340425|NCT00813709|560681237|FG001|Open Label Period|Lack of Efficacy|0|||
155340426|NCT00813709|560681238|FG002|Open Label Period|Lack of Efficacy|0|||
155340427|NCT00813709|560681239|FG003|Open Label Period|Lack of Efficacy|3|||
155340428|NCT00813709|560681240|FG004|Open Label Period|Lack of Efficacy|1|||
155340429|NCT00813709|560681241|FG005|Open Label Period|Lack of Efficacy|1|||
155340430|NCT00813709|560681236|FG000|Open Label Period|Randomized but not treated|0|||
155340431|NCT00813709|560681237|FG001|Open Label Period|Randomized but not treated|0|||
155340432|NCT00813709|560681238|FG002|Open Label Period|Randomized but not treated|0|||
155340433|NCT00813709|560681239|FG003|Open Label Period|Randomized but not treated|1|||
155340434|NCT00813709|560681240|FG004|Open Label Period|Randomized but not treated|0|||
155340435|NCT00813709|560681241|FG005|Open Label Period|Randomized but not treated|1|||
155340436|NCT00813709|560681236|FG000|Open Label Period|Other|0|||
155340437|NCT00813709|560681237|FG001|Open Label Period|Other|0|||
155340438|NCT00813709|560681238|FG002|Open Label Period|Other|0|||
155340439|NCT00813709|560681239|FG003|Open Label Period|Other|11|||
155340440|NCT00813709|560681240|FG004|Open Label Period|Other|5|||
155340441|NCT00813709|560681241|FG005|Open Label Period|Other|6|||
155340442|NCT03761849|560681244|FG000|Overall Study|transferred to OpenLabelExtension|35|||
155340443|NCT03761849|560681245|FG001|Overall Study|transferred to OpenLabelExtension|34|||
155340444|NCT03761849|560681246|FG002|Overall Study|transferred to OpenLabelExtension|36|||
155340445|NCT03761849|560681247|FG003|Overall Study|transferred to OpenLabelExtension|0|||
155340446|NCT03761849|560681248|FG004|Overall Study|transferred to OpenLabelExtension|0|||
155340447|NCT03761849|560681249|FG005|Overall Study|transferred to OpenLabelExtension|0|||
155340448|NCT03761849|560681244|FG000|Overall Study|Adverse Event|1|||
155340449|NCT03761849|560681245|FG001|Overall Study|Adverse Event|0|||
155340450|NCT03761849|560681246|FG002|Overall Study|Adverse Event|0|||
155340451|NCT03761849|560681247|FG003|Overall Study|Adverse Event|0|||
155340452|NCT03761849|560681248|FG004|Overall Study|Adverse Event|2|||
155340453|NCT03761849|560681249|FG005|Overall Study|Adverse Event|3|||
155340454|NCT03761849|560681244|FG000|Overall Study|Withdrawal by Subject|0|||
155073769|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
155073770|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
155073771|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
155340455|NCT03761849|560681245|FG001|Overall Study|Withdrawal by Subject|0|||
155340456|NCT03761849|560681246|FG002|Overall Study|Withdrawal by Subject|0|||
155340457|NCT03761849|560681247|FG003|Overall Study|Withdrawal by Subject|41|||
155073772|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
155073773|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
155073774|NCT02337946|559698297|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
155073775|NCT02337946|559698298|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
155073776|NCT02337946|559698299|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
155073777|NCT02337946|559698297|FG000|In-between Period|Without Informed Consent|1|||
155073778|NCT02337946|559698298|FG001|In-between Period|Without Informed Consent|0|||
155073779|NCT02337946|559698299|FG002|In-between Period|Without Informed Consent|0|||
155073780|NCT02337946|559698297|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
155073781|NCT02337946|559698298|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
155073782|NCT02337946|559698299|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
155073783|NCT02337946|559698297|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
155073784|NCT02337946|559698298|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
155073785|NCT02337946|559698299|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
155073786|NCT02337946|559698297|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
155073787|NCT02337946|559698298|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
155073788|NCT02337946|559698299|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
155073789|NCT02337946|559698297|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
155073790|NCT02337946|559698298|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
155073791|NCT02337946|559698299|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
155073792|NCT02337946|559698297|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
155073793|NCT02337946|559698298|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
155340458|NCT03761849|560681248|FG004|Overall Study|Withdrawal by Subject|43|||
155340459|NCT03761849|560681249|FG005|Overall Study|Withdrawal by Subject|35|||
155340460|NCT03761849|560681244|FG000|Overall Study|Lost to Follow-up|0|||
155340461|NCT03761849|560681245|FG001|Overall Study|Lost to Follow-up|1|||
155340462|NCT03761849|560681246|FG002|Overall Study|Lost to Follow-up|0|||
155340463|NCT03761849|560681247|FG003|Overall Study|Lost to Follow-up|2|||
155073794|NCT02337946|559698299|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
155073795|NCT02337946|559698297|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
155073796|NCT02337946|559698298|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
155073797|NCT02337946|559698299|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
155073798|NCT01327703|559698300|FG000|Second Treatment Period|Adverse Event|1|||
155073799|NCT01327703|559698301|FG001|Second Treatment Period|Adverse Event|1|||
155073800|NCT01327703|559698300|FG000|Second Treatment Period|Protocol Violation|0|||
155073801|NCT01327703|559698301|FG001|Second Treatment Period|Protocol Violation|1|||
155073802|NCT05324371|559698302|FG000|Overall Study|Withdrawal by Subject|1|||
155073803|NCT05324371|559698302|FG000|Overall Study|Death|1|||
155073804|NCT02513563|559698303|FG000|Overall Study|Death|4|||
155073805|NCT02513563|559698303|FG000|Overall Study|Withdrawal by Subject|4|||
155073806|NCT02513563|559698303|FG000|Overall Study|Physician Decision|1|||
155073807|NCT00317369|559698304|FG000|Overall Study|Adverse Event|2|||
155073808|NCT00317369|559698305|FG001|Overall Study|Adverse Event|1|||
155073809|NCT00317369|559698306|FG002|Overall Study|Adverse Event|0|||
155073810|NCT00317369|559698304|FG000|Overall Study|Lack of Efficacy|0|||
155073811|NCT00317369|559698305|FG001|Overall Study|Lack of Efficacy|1|||
155073812|NCT00317369|559698306|FG002|Overall Study|Lack of Efficacy|1|||
155073813|NCT00317369|559698304|FG000|Overall Study|Withdrawal by Subject|0|||
155073814|NCT00317369|559698305|FG001|Overall Study|Withdrawal by Subject|0|||
155073815|NCT00317369|559698306|FG002|Overall Study|Withdrawal by Subject|1|||
155164395|NCT02500797|560038897|FG000|Overall Study|Withdrawal by Subject|1|||
155164396|NCT02500797|560038898|FG001|Overall Study|Withdrawal by Subject|0|||
155164397|NCT02500797|560038899|FG002|Overall Study|Withdrawal by Subject|0|||
155164398|NCT02500797|560038900|FG003|Overall Study|Withdrawal by Subject|0|||
155164399|NCT02500797|560038901|FG004|Overall Study|Withdrawal by Subject|0|||
155164400|NCT02500797|560038902|FG005|Overall Study|Withdrawal by Subject|0|||
155164401|NCT02500797|560038903|FG006|Overall Study|Withdrawal by Subject|0|||
155164402|NCT02500797|560038904|FG007|Overall Study|Withdrawal by Subject|0|||
155164403|NCT01469377|560038911|FG000|Overall Study|Protocol Deviation|7|||
155164404|NCT01469377|560038912|FG001|Overall Study|Protocol Deviation|10|||
155164405|NCT01469377|560038913|FG002|Overall Study|Protocol Deviation|10|||
155164406|NCT01469377|560038911|FG000|Overall Study|Lost to Follow-up|3|||
155164407|NCT01469377|560038912|FG001|Overall Study|Lost to Follow-up|2|||
155164408|NCT01469377|560038913|FG002|Overall Study|Lost to Follow-up|5|||
155164409|NCT01469377|560038911|FG000|Overall Study|Withdrawal of Consent|12|||
155164410|NCT01469377|560038912|FG001|Overall Study|Withdrawal of Consent|14|||
155164411|NCT01469377|560038913|FG002|Overall Study|Withdrawal of Consent|15|||
155164412|NCT01469377|560038911|FG000|Overall Study|Adverse Event|8|||
155164413|NCT01469377|560038912|FG001|Overall Study|Adverse Event|18|||
155340464|NCT03761849|560681248|FG004|Overall Study|Lost to Follow-up|4|||
155073816|NCT01068912|559698309|FG000|Overall Study|Adverse Event|2|||
155073817|NCT01068912|559698310|FG001|Overall Study|Adverse Event|3|||
155073818|NCT01068912|559698311|FG002|Overall Study|Adverse Event|2|||
155073819|NCT01068912|559698309|FG000|Overall Study|Withdrawal by Subject|5|||
155073820|NCT01068912|559698310|FG001|Overall Study|Withdrawal by Subject|6|||
155073821|NCT01068912|559698311|FG002|Overall Study|Withdrawal by Subject|6|||
155073822|NCT01068912|559698309|FG000|Overall Study|Lost to Follow-up|3|||
155073823|NCT01068912|559698310|FG001|Overall Study|Lost to Follow-up|7|||
155073824|NCT01068912|559698311|FG002|Overall Study|Lost to Follow-up|3|||
155073825|NCT01068912|559698309|FG000|Overall Study|Protocol Violation|0|||
155073826|NCT01068912|559698310|FG001|Overall Study|Protocol Violation|2|||
155073827|NCT01068912|559698311|FG002|Overall Study|Protocol Violation|0|||
155073828|NCT01068912|559698309|FG000|Overall Study|aggravation influenza|1|||
155073829|NCT01068912|559698310|FG001|Overall Study|aggravation influenza|1|||
155073830|NCT01068912|559698311|FG002|Overall Study|aggravation influenza|1|||
155073831|NCT01068912|559698309|FG000|Overall Study|other underlying illness|0|||
155073832|NCT01068912|559698310|FG001|Overall Study|other underlying illness|3|||
155073833|NCT01068912|559698311|FG002|Overall Study|other underlying illness|3|||
155073834|NCT03770455|559698319|FG000|Overall Study|Screen failures|3|||
155073835|NCT01121575|559698320|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
155073836|NCT01121575|559698321|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
155073837|NCT01121575|559698322|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
155073838|NCT01121575|559698323|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
155073839|NCT01121575|559698324|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
155164414|NCT01469377|560038913|FG002|Overall Study|Adverse Event|36|||
155164415|NCT01469377|560038911|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155073840|NCT01121575|559698325|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
155073841|NCT01121575|559698320|FG000|Overall Study|Unspecified Reasons|8|||
155073842|NCT01121575|559698321|FG001|Overall Study|Unspecified Reasons|6|||
155164416|NCT01469377|560038912|FG001|Overall Study|Insufficient Therapeutic Response|4|||
155164417|NCT01469377|560038913|FG002|Overall Study|Insufficient Therapeutic Response|0|||
155164418|NCT01469377|560038911|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155164419|NCT01469377|560038912|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155164420|NCT01469377|560038913|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155164421|NCT00074490|560038914|FG000|Overall Study|Progressive malignancy|0|||
155164422|NCT00074490|560038915|FG001|Overall Study|Progressive malignancy|7|||
155164423|NCT00074490|560038916|FG002|Overall Study|Progressive malignancy|0|||
155164424|NCT00074490|560038917|FG003|Overall Study|Progressive malignancy|0|||
155164425|NCT00074490|560038918|FG004|Overall Study|Progressive malignancy|3|||
155164426|NCT00074490|560038919|FG005|Overall Study|Progressive malignancy|0|||
155164427|NCT04139798|560038922|FG000|Overall Study|Withdrawal by Subject|6|||
155164428|NCT04139798|560038923|FG001|Overall Study|Withdrawal by Subject|5|||
155164429|NCT04139798|560038922|FG000|Overall Study|Lost to Follow-up|2|||
155164430|NCT04139798|560038923|FG001|Overall Study|Lost to Follow-up|5|||
155164431|NCT04139798|560038922|FG000|Overall Study|Discontinued|4|||
155164432|NCT04139798|560038923|FG001|Overall Study|Discontinued|2|||
155164433|NCT04139798|560038922|FG000|Overall Study|Adverse Event|1|||
155164434|NCT04139798|560038923|FG001|Overall Study|Adverse Event|3|||
155164435|NCT04139798|560038922|FG000|Overall Study|Protocol Violation|1|||
155164436|NCT04139798|560038923|FG001|Overall Study|Protocol Violation|0|||
155164437|NCT04308291|560038924|FG000|Run-In Phase|Withdrawal by Subject|4|||
155164438|NCT04308291|560038924|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
155164439|NCT04308291|560038924|FG000|Study Phase 6-M|Physician Decision|2|||
155164440|NCT04308291|560038924|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
155164441|NCT04308291|560038924|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
155164442|NCT04308291|560038924|FG000|Study Phase 12-M|Physician Decision|2|||
155164443|NCT04308291|560038924|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
155164444|NCT02357368|560038928|FG000|Overall Study|Lost to Follow-up|0|||
155164445|NCT02357368|560038929|FG001|Overall Study|Lost to Follow-up|0|||
155340465|NCT03761849|560681249|FG005|Overall Study|Lost to Follow-up|5|||
155340466|NCT03761849|560681244|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
155340467|NCT03761849|560681245|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
155340468|NCT03761849|560681246|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
155340469|NCT03761849|560681247|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
155340470|NCT03761849|560681248|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
155340471|NCT03761849|560681249|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
155340472|NCT03761849|560681244|FG000|Overall Study|Physician Decision|0|||
155340473|NCT03761849|560681245|FG001|Overall Study|Physician Decision|0|||
155340474|NCT03761849|560681246|FG002|Overall Study|Physician Decision|0|||
155340475|NCT03761849|560681247|FG003|Overall Study|Physician Decision|1|||
155340476|NCT03761849|560681248|FG004|Overall Study|Physician Decision|4|||
155340477|NCT03761849|560681249|FG005|Overall Study|Physician Decision|4|||
155340478|NCT03761849|560681244|FG000|Overall Study|Death|0|||
155340479|NCT03761849|560681245|FG001|Overall Study|Death|0|||
155340480|NCT03761849|560681246|FG002|Overall Study|Death|0|||
155340481|NCT03761849|560681247|FG003|Overall Study|Death|1|||
155340482|NCT03761849|560681248|FG004|Overall Study|Death|1|||
155340483|NCT03761849|560681249|FG005|Overall Study|Death|3|||
155340484|NCT03761849|560681244|FG000|Overall Study|Protocol Violation|0|||
155340485|NCT03761849|560681245|FG001|Overall Study|Protocol Violation|0|||
155340486|NCT03761849|560681246|FG002|Overall Study|Protocol Violation|0|||
155340487|NCT03761849|560681247|FG003|Overall Study|Protocol Violation|2|||
155340488|NCT03761849|560681248|FG004|Overall Study|Protocol Violation|2|||
155340489|NCT03761849|560681249|FG005|Overall Study|Protocol Violation|1|||
155340490|NCT03761849|560681244|FG000|Overall Study|Participant could not come to site|0|||
155340491|NCT03761849|560681245|FG001|Overall Study|Participant could not come to site|0|||
155340492|NCT03761849|560681246|FG002|Overall Study|Participant could not come to site|0|||
155340493|NCT03761849|560681247|FG003|Overall Study|Participant could not come to site|0|||
155340494|NCT03761849|560681248|FG004|Overall Study|Participant could not come to site|1|||
155340495|NCT03761849|560681249|FG005|Overall Study|Participant could not come to site|0|||
155340496|NCT03761849|560681244|FG000|Overall Study|SF- safety Finding|0|||
155340497|NCT03761849|560681245|FG001|Overall Study|SF- safety Finding|0|||
155340498|NCT03761849|560681246|FG002|Overall Study|SF- safety Finding|0|||
155164446|NCT02357368|560038930|FG002|Overall Study|Lost to Follow-up|0|||
155340499|NCT03761849|560681247|FG003|Overall Study|SF- safety Finding|0|||
155340500|NCT03761849|560681248|FG004|Overall Study|SF- safety Finding|0|||
155340501|NCT03761849|560681249|FG005|Overall Study|SF- safety Finding|1|||
155340502|NCT03761849|560681244|FG000|Overall Study|Patient did not attend visit|0|||
155340503|NCT03761849|560681245|FG001|Overall Study|Patient did not attend visit|0|||
155164447|NCT02357368|560038931|FG003|Overall Study|Lost to Follow-up|1|||
155164448|NCT02357368|560038928|FG000|Overall Study|Pregnancy|3|||
155164449|NCT02357368|560038929|FG001|Overall Study|Pregnancy|2|||
155164450|NCT02357368|560038930|FG002|Overall Study|Pregnancy|0|||
155164451|NCT02357368|560038931|FG003|Overall Study|Pregnancy|0|||
155164452|NCT02357368|560038928|FG000|Overall Study|Withdrawal by Subject|3|||
155164453|NCT02357368|560038929|FG001|Overall Study|Withdrawal by Subject|1|||
155340504|NCT03761849|560681246|FG002|Overall Study|Patient did not attend visit|0|||
155340505|NCT03761849|560681247|FG003|Overall Study|Patient did not attend visit|0|||
155340506|NCT03761849|560681248|FG004|Overall Study|Patient did not attend visit|0|||
155340507|NCT03761849|560681249|FG005|Overall Study|Patient did not attend visit|1|||
155340508|NCT03840993|560681250|FG000|Overall Study|Adverse Event|1|||
155340509|NCT03840993|560681251|FG001|Overall Study|Adverse Event|0|||
155340510|NCT03840993|560681250|FG000|Overall Study|Lost to Follow-up|4|||
155340511|NCT03840993|560681251|FG001|Overall Study|Lost to Follow-up|0|||
155340512|NCT03840993|560681250|FG000|Overall Study|Physician Decision|0|||
155340513|NCT03840993|560681251|FG001|Overall Study|Physician Decision|1|||
155340514|NCT03840993|560681250|FG000|Overall Study|Pregnancy|0|||
155340515|NCT03840993|560681251|FG001|Overall Study|Pregnancy|1|||
155340516|NCT03840993|560681250|FG000|Overall Study|Withdrawal by Subject|1|||
155340517|NCT03840993|560681251|FG001|Overall Study|Withdrawal by Subject|3|||
155340518|NCT03840993|560681250|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
155340519|NCT03840993|560681251|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
155340520|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
155340521|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340522|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340523|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340524|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340525|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340526|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340527|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340528|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340529|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340530|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340531|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340532|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340533|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340534|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340535|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340536|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340537|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340538|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
155340539|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340540|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340541|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340542|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340543|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340544|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
155340545|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340546|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
155340547|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340548|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340549|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340550|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340551|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340552|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340553|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340554|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340555|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340556|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340557|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
155340558|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340559|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340560|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340561|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340562|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340563|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340564|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
155340565|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340566|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340567|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340568|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340569|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340570|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340571|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340572|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340573|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340574|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340575|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340576|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
155340577|NCT01587703|560681252|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
155340578|NCT01587703|560681253|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
155340579|NCT01587703|560681254|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
155340580|NCT01587703|560681255|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
155340581|NCT01587703|560681256|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
155340582|NCT01587703|560681257|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
155340583|NCT01587703|560681258|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
155340584|NCT01587703|560681259|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
155340585|NCT01587703|560681260|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340586|NCT01587703|560681261|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340587|NCT01587703|560681262|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340588|NCT01587703|560681263|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340589|NCT01587703|560681264|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340590|NCT01587703|560681265|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340591|NCT01587703|560681266|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340592|NCT01587703|560681267|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340593|NCT01587703|560681268|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340594|NCT01587703|560681269|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340595|NCT01587703|560681270|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
155340596|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340597|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340598|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340599|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340600|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340601|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340602|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340603|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340604|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
155340605|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
155340606|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
155340607|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340608|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340609|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340610|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340611|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340612|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340613|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155073843|NCT01121575|559698322|FG002|Overall Study|Unspecified Reasons|7|||
155073844|NCT01121575|559698323|FG003|Overall Study|Unspecified Reasons|5|||
155073845|NCT01121575|559698324|FG004|Overall Study|Unspecified Reasons|13|||
155073846|NCT01121575|559698325|FG005|Overall Study|Unspecified Reasons|10|||
155340614|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
155340615|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155073847|NCT01121575|559698320|FG000|Overall Study|Death|6|||
155340616|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340617|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340618|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340619|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340620|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340621|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340622|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340623|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
155340624|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340625|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
155340626|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340627|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340628|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340629|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340630|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340631|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340632|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340633|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
155340634|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340635|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340636|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340637|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340638|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340639|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340640|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340641|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340642|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340643|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
155340644|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
155340645|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340646|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340647|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340648|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340649|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340650|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340651|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340652|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
155340653|NCT01587703|560681252|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340654|NCT01587703|560681253|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340655|NCT01587703|560681254|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340656|NCT01587703|560681255|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340657|NCT01587703|560681256|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340658|NCT01587703|560681257|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340659|NCT01587703|560681258|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340660|NCT01587703|560681259|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340661|NCT01587703|560681260|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
155340662|NCT01587703|560681261|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340663|NCT01587703|560681262|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340664|NCT01587703|560681263|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340665|NCT01587703|560681264|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340666|NCT01587703|560681265|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340667|NCT01587703|560681266|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340668|NCT01587703|560681267|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340669|NCT01587703|560681268|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340670|NCT01587703|560681269|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340671|NCT01587703|560681270|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
155340672|NCT01587703|560681252|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340673|NCT01587703|560681253|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155073848|NCT01121575|559698321|FG001|Overall Study|Death|0|||
155340674|NCT01587703|560681254|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340675|NCT01587703|560681255|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340676|NCT01587703|560681256|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155073849|NCT01121575|559698322|FG002|Overall Study|Death|0|||
155340677|NCT01587703|560681257|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340678|NCT01587703|560681258|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340679|NCT01587703|560681259|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340680|NCT01587703|560681260|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340681|NCT01587703|560681261|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340682|NCT01587703|560681262|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340683|NCT01587703|560681263|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340684|NCT01587703|560681264|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340685|NCT01587703|560681265|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340686|NCT01587703|560681266|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340687|NCT01587703|560681267|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340688|NCT01587703|560681268|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340689|NCT01587703|560681269|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
155340690|NCT01587703|560681270|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
155340691|NCT01587703|560681252|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340692|NCT01587703|560681253|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340693|NCT01587703|560681254|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340694|NCT01587703|560681255|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340695|NCT01587703|560681256|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340696|NCT01587703|560681257|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340697|NCT01587703|560681258|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340698|NCT01587703|560681259|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340699|NCT01587703|560681260|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340700|NCT01587703|560681261|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340701|NCT01587703|560681262|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340702|NCT01587703|560681263|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340703|NCT01587703|560681264|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340704|NCT01587703|560681265|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340705|NCT01587703|560681266|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340706|NCT01587703|560681267|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340707|NCT01587703|560681268|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
155340708|NCT01587703|560681269|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
155340709|NCT01587703|560681270|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
155340710|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340711|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340712|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340713|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340714|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340715|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340716|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340717|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340718|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340719|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340720|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340721|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340722|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340723|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340724|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340725|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
155340726|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340727|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340728|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
155340729|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340730|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340731|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340732|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340733|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340734|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340735|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340736|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340737|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340738|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340739|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340740|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
155340741|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340742|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340743|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
155340744|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340745|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340746|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340747|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
155340748|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340749|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340750|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340751|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340752|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340753|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340754|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340755|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340756|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340757|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340758|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340759|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
155340760|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
155340761|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
155340762|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
155340763|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
155340764|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
155340765|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340766|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
155340767|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340768|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340769|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340770|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340771|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340772|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340773|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340774|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340775|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340776|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340777|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340778|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
155340779|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
155340780|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
155340781|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
155340782|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
155340783|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
155340784|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340785|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
155340786|NCT01587703|560681252|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340787|NCT01587703|560681253|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340788|NCT01587703|560681254|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340789|NCT01587703|560681255|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340790|NCT01587703|560681256|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
154962570|NCT00199901|559289500|FG001|Overall Study|Withdrawal by Subject|0|||
155340791|NCT01587703|560681257|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340792|NCT01587703|560681258|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340793|NCT01587703|560681259|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
154962571|NCT00199901|559289499|FG000|Overall Study|Progressive Disease|24|||
154962572|NCT00199901|559289500|FG001|Overall Study|Progressive Disease|24|||
155340794|NCT01587703|560681260|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340795|NCT01587703|560681261|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340796|NCT01587703|560681262|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340797|NCT01587703|560681263|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
155340798|NCT01587703|560681264|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340799|NCT01587703|560681265|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340800|NCT01587703|560681266|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340801|NCT01587703|560681267|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340802|NCT01587703|560681268|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340803|NCT01587703|560681269|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340804|NCT01587703|560681270|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
155340805|NCT04751929|560681271|FG000|Overall Study|Withdrawal by Subject|2|||
155340806|NCT04751929|560681272|FG001|Overall Study|Withdrawal by Subject|0|||
155340807|NCT04751929|560681273|FG002|Overall Study|Withdrawal by Subject|0|||
155340808|NCT04751929|560681274|FG003|Overall Study|Withdrawal by Subject|0|||
155340809|NCT04751929|560681271|FG000|Overall Study|Rising PSA|0|||
155340810|NCT04751929|560681272|FG001|Overall Study|Rising PSA|1|||
155340811|NCT04751929|560681273|FG002|Overall Study|Rising PSA|0|||
155340812|NCT04751929|560681274|FG003|Overall Study|Rising PSA|0|||
155340813|NCT04751929|560681271|FG000|Overall Study|Adverse Event|1|||
155340814|NCT04751929|560681272|FG001|Overall Study|Adverse Event|2|||
155340815|NCT04751929|560681273|FG002|Overall Study|Adverse Event|0|||
155340816|NCT04751929|560681274|FG003|Overall Study|Adverse Event|0|||
155340817|NCT04751929|560681271|FG000|Overall Study|Progressive Disease|3|||
155340818|NCT04751929|560681272|FG001|Overall Study|Progressive Disease|4|||
155340819|NCT04751929|560681273|FG002|Overall Study|Progressive Disease|4|||
155340820|NCT04751929|560681274|FG003|Overall Study|Progressive Disease|0|||
155340821|NCT04751929|560681271|FG000|Overall Study|Death|1|||
155340822|NCT04751929|560681272|FG001|Overall Study|Death|1|||
155340823|NCT04751929|560681273|FG002|Overall Study|Death|0|||
155340824|NCT04751929|560681274|FG003|Overall Study|Death|0|||
155340825|NCT01123356|560681275|FG000|Overall Study|Adverse Event|2|||
155340826|NCT01123356|560681275|FG000|Overall Study|Lack of Efficacy|4|||
155340827|NCT01123356|560681275|FG000|Overall Study|Withdrawal by Subject|1|||
155340828|NCT00376259|560681278|FG000|Overall Study|Sponsor request - study termination|21|||
155340829|NCT00376259|560681279|FG001|Overall Study|Sponsor request - study termination|21|||
155340830|NCT00376259|560681278|FG000|Overall Study|Patient request|1|||
155340831|NCT00376259|560681279|FG001|Overall Study|Patient request|0|||
155340832|NCT00759681|560681281|FG000|Overall Study|Death|2|||
155340833|NCT00759681|560681282|FG001|Overall Study|Death|5|||
155340834|NCT00759681|560681281|FG000|Overall Study|Lost to Follow-up|8|||
155340835|NCT00759681|560681282|FG001|Overall Study|Lost to Follow-up|5|||
155340836|NCT00930644|560681283|FG000|Overall Study|Withdrawal by Subject|4|||
155340837|NCT00930644|560681283|FG000|Overall Study|Physician Decision|2|||
155340838|NCT00930644|560681283|FG000|Overall Study|Death|1|||
155340839|NCT00930644|560681283|FG000|Overall Study|Adverse Event|16|||
155340840|NCT01877720|560681284|FG000|Overall Study|Adverse Event|1|||
155340841|NCT01877720|560681285|FG001|Overall Study|Adverse Event|0|||
155340842|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Adverse Event|0|||
155340843|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Adverse Event|0|||
155340844|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Adverse Event|0|||
155340845|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Adverse Event|5|||
155340846|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Adverse Event|0|||
155340847|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Death|0|||
155340848|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Death|0|||
155340849|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Death|0|||
155340850|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Death|1|||
155340851|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Death|0|||
155340852|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Disease Progression|1|||
155340853|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Disease Progression|1|||
155073850|NCT01121575|559698323|FG003|Overall Study|Death|1|||
155073851|NCT01121575|559698324|FG004|Overall Study|Death|7|||
155073852|NCT01121575|559698325|FG005|Overall Study|Death|1|||
155073853|NCT03735498|559699766|FG000|Overall Study|Withdrawal by Subject|3|||
155340854|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Disease Progression|0|||
155073854|NCT03735498|559699766|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
155340855|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Disease Progression|10|||
155340856|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Disease Progression|1|||
155340857|NCT00473512|560681288|FG000|Period 1 (Phase 1)|Other|0|||
155340858|NCT00473512|560681289|FG001|Period 1 (Phase 1)|Other|0|||
155340859|NCT00473512|560681290|FG002|Period 1 (Phase 1)|Other|0|||
155340860|NCT00473512|560681291|FG003|Period 1 (Phase 1)|Other|1|||
155340861|NCT00473512|560681292|FG004|Period 1 (Phase 1)|Other|0|||
155340862|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Adverse Event|0|||
155340863|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Adverse Event|0|||
155073855|NCT00160615|559699767|FG000|Overall Study|Adverse Event|5|||
155073856|NCT00160615|559699768|FG001|Overall Study|Adverse Event|12|||
155340864|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Adverse Event|0|||
155340865|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Adverse Event|1|||
155340866|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Adverse Event|0|||
155340867|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Death|0|||
155340868|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Death|0|||
155340869|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Death|0|||
155340870|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Death|1|||
155340871|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Death|1|||
155340872|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Disease Progression|0|||
155340873|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Disease Progression|2|||
155340874|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Disease Progression|2|||
155340875|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Disease Progression|17|||
155340876|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Disease Progression|1|||
155340877|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340878|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340879|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340880|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
155340881|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
155340882|NCT00473512|560681288|FG000|Period 2 (Phase 2)|Other|1|||
155340883|NCT00473512|560681289|FG001|Period 2 (Phase 2)|Other|0|||
155340884|NCT00473512|560681290|FG002|Period 2 (Phase 2)|Other|0|||
155340885|NCT00473512|560681291|FG003|Period 2 (Phase 2)|Other|3|||
155340886|NCT00473512|560681292|FG004|Period 2 (Phase 2)|Other|0|||
155340887|NCT01129011|560681293|FG000|Overall Study|Adverse Event|20|||
155340888|NCT01129011|560681294|FG001|Overall Study|Adverse Event|30|||
155340889|NCT01129011|560681293|FG000|Overall Study|Withdrawal by Subject|24|||
155340890|NCT01129011|560681294|FG001|Overall Study|Withdrawal by Subject|8|||
155340891|NCT01129011|560681293|FG000|Overall Study|Lost to Follow-up|6|||
155340892|NCT01129011|560681294|FG001|Overall Study|Lost to Follow-up|7|||
155340893|NCT01129011|560681293|FG000|Overall Study|Duodenal Ulcer|2|||
155340894|NCT01129011|560681294|FG001|Overall Study|Duodenal Ulcer|8|||
155340895|NCT01129011|560681293|FG000|Overall Study|misc|7|||
155340896|NCT01129011|560681294|FG001|Overall Study|misc|4|||
155340897|NCT01012999|560681298|FG000|Overall Study|Protocol Violation|1|||
155340898|NCT01369147|560681299|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
155340899|NCT01369147|560681300|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
155340900|NCT01369147|560681301|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
155340901|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
155340902|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
155340903|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
155340904|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
155340905|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
155340906|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
155340907|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
155340908|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
155340909|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
155340910|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
155340911|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
155340912|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
155340913|NCT01494467|560681306|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
155340914|NCT01494467|560681307|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
155340915|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
155340916|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
155340917|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
155340918|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
155340919|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
155340920|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
155340921|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
155340922|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
155340923|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
155340924|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
155340925|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
155340926|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
155340927|NCT01494467|560681306|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
155340928|NCT01494467|560681307|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
155340929|NCT02410278|560681310|FG000|Run-in Period|Adverse Event|5|||
155340930|NCT02410278|560681311|FG001|Run-in Period|Adverse Event|0|||
155340931|NCT02410278|560681312|FG002|Run-in Period|Adverse Event|0|||
155340932|NCT02410278|560681310|FG000|Run-in Period|GSRS Threshold Not Met|30|||
155340933|NCT02410278|560681311|FG001|Run-in Period|GSRS Threshold Not Met|0|||
155340934|NCT02410278|560681312|FG002|Run-in Period|GSRS Threshold Not Met|0|||
155340935|NCT02410278|560681310|FG000|Run-in Period|Lost to Follow-up|1|||
155340936|NCT02410278|560681311|FG001|Run-in Period|Lost to Follow-up|0|||
155340937|NCT02410278|560681312|FG002|Run-in Period|Lost to Follow-up|0|||
155340938|NCT02410278|560681310|FG000|Run-in Period|Withdrawal by Subject|1|||
155340939|NCT02410278|560681311|FG001|Run-in Period|Withdrawal by Subject|0|||
155340940|NCT02410278|560681312|FG002|Run-in Period|Withdrawal by Subject|0|||
155340941|NCT02410278|560681310|FG000|Run-in Period|Pregnancy|1|||
155340942|NCT02410278|560681311|FG001|Run-in Period|Pregnancy|0|||
155340943|NCT02410278|560681312|FG002|Run-in Period|Pregnancy|0|||
155340944|NCT02410278|560681310|FG000|Study Treatment Period|Adverse Event|0|||
155340945|NCT02410278|560681311|FG001|Study Treatment Period|Adverse Event|6|||
155340946|NCT02410278|560681312|FG002|Study Treatment Period|Adverse Event|3|||
155340947|NCT02410278|560681310|FG000|Study Treatment Period|Physician Decision|0|||
155340948|NCT02410278|560681311|FG001|Study Treatment Period|Physician Decision|0|||
155340949|NCT02410278|560681312|FG002|Study Treatment Period|Physician Decision|1|||
155340950|NCT02410278|560681310|FG000|Study Treatment Period|Withdrawal by Subject|0|||
155340951|NCT02410278|560681311|FG001|Study Treatment Period|Withdrawal by Subject|1|||
155340952|NCT02410278|560681312|FG002|Study Treatment Period|Withdrawal by Subject|0|||
155340953|NCT02410278|560681310|FG000|Study Treatment Period|Other|0|||
155340954|NCT02410278|560681311|FG001|Study Treatment Period|Other|3|||
155340955|NCT02410278|560681312|FG002|Study Treatment Period|Other|0|||
155340956|NCT02410278|560681310|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
155340957|NCT02410278|560681311|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
155340958|NCT02410278|560681312|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
155340959|NCT02584257|560681313|FG000|Period 1|Withdrawal by Subject|0|||
155340960|NCT02584257|560681314|FG001|Period 1|Withdrawal by Subject|0|||
155340961|NCT02584257|560681315|FG002|Period 1|Withdrawal by Subject|0|||
155340962|NCT02584257|560681316|FG003|Period 1|Withdrawal by Subject|0|||
155340963|NCT02584257|560681317|FG004|Period 1|Withdrawal by Subject|0|||
155340964|NCT02584257|560681318|FG005|Period 1|Withdrawal by Subject|0|||
155340965|NCT02584257|560681319|FG006|Period 1|Withdrawal by Subject|1|||
155340966|NCT02584257|560681320|FG007|Period 1|Withdrawal by Subject|0|||
155340967|NCT02584257|560681321|FG008|Period 1|Withdrawal by Subject|0|||
155340968|NCT02584257|560681313|FG000|Period 2|Physician Decision|1|||
155340969|NCT02584257|560681314|FG001|Period 2|Physician Decision|0|||
155340970|NCT02584257|560681315|FG002|Period 2|Physician Decision|0|||
155340971|NCT02584257|560681316|FG003|Period 2|Physician Decision|0|||
155340972|NCT02584257|560681317|FG004|Period 2|Physician Decision|0|||
155340973|NCT02584257|560681318|FG005|Period 2|Physician Decision|0|||
155340974|NCT02584257|560681319|FG006|Period 2|Physician Decision|0|||
155340975|NCT02584257|560681320|FG007|Period 2|Physician Decision|0|||
155340976|NCT02584257|560681321|FG008|Period 2|Physician Decision|0|||
155340977|NCT02584257|560681313|FG000|Period 2|Adverse Event|0|||
155340978|NCT02584257|560681314|FG001|Period 2|Adverse Event|1|||
155340979|NCT02584257|560681315|FG002|Period 2|Adverse Event|0|||
155340980|NCT02584257|560681316|FG003|Period 2|Adverse Event|0|||
155340981|NCT02584257|560681317|FG004|Period 2|Adverse Event|0|||
155340982|NCT02584257|560681318|FG005|Period 2|Adverse Event|0|||
155340983|NCT02584257|560681319|FG006|Period 2|Adverse Event|0|||
155340984|NCT02584257|560681320|FG007|Period 2|Adverse Event|0|||
155340985|NCT02584257|560681321|FG008|Period 2|Adverse Event|0|||
155340986|NCT05376397|560681324|FG000|Overall Study|Lost to Follow-up|1|||
155340987|NCT02721147|560681325|FG000|Overall Study|Lost to Follow-up|2|||
155340988|NCT02721147|560681326|FG001|Overall Study|Lost to Follow-up|0|||
155340989|NCT02721147|560681327|FG002|Overall Study|Lost to Follow-up|0|||
155340990|NCT01722097|560681328|FG000|Overall Study|Patient sheets not returned|6|||
155340991|NCT01722097|560681329|FG001|Overall Study|Patient sheets not returned|5|||
155340992|NCT01535261|560681331|FG000|Overall Study|Physician Decision|8|||
155340993|NCT01535261|560681331|FG000|Overall Study|Protocol Violation|3|||
155340994|NCT01535261|560681331|FG000|Overall Study|Death|5|||
155340995|NCT01535261|560681331|FG000|Overall Study|Lost to Follow-up|8|||
155340996|NCT01535261|560681331|FG000|Overall Study|Withdrawal by Subject|14|||
155340997|NCT01535261|560681331|FG000|Overall Study|Adverse Event|12|||
155340998|NCT01137682|560681332|FG000|Overall Study|Adverse Event-CORE|2|||
155340999|NCT01137682|560681333|FG001|Overall Study|Adverse Event-CORE|4|||
155341000|NCT01137682|560681334|FG002|Overall Study|Adverse Event-CORE|0|||
155341001|NCT01137682|560681332|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
155341002|NCT01137682|560681333|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
155341003|NCT01137682|560681334|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
155341004|NCT01137682|560681332|FG000|Overall Study|Administrative problems-CORE|2|||
155341005|NCT01137682|560681333|FG001|Overall Study|Administrative problems-CORE|1|||
155341006|NCT01137682|560681334|FG002|Overall Study|Administrative problems-CORE|0|||
155341007|NCT01137682|560681332|FG000|Overall Study|Protocol Violation-CORE|0|||
155341008|NCT01137682|560681333|FG001|Overall Study|Protocol Violation-CORE|1|||
155341009|NCT01137682|560681334|FG002|Overall Study|Protocol Violation-CORE|1|||
155164454|NCT02357368|560038930|FG002|Overall Study|Withdrawal by Subject|1|||
155341010|NCT01137682|560681332|FG000|Overall Study|Adverse Event-Extension|4|||
155341011|NCT01137682|560681333|FG001|Overall Study|Adverse Event-Extension|8|||
155341012|NCT01137682|560681334|FG002|Overall Study|Adverse Event-Extension|7|||
155341013|NCT01137682|560681332|FG000|Overall Study|Lack of Efficacy-Extension|15|||
155341014|NCT01137682|560681333|FG001|Overall Study|Lack of Efficacy-Extension|9|||
155341015|NCT01137682|560681334|FG002|Overall Study|Lack of Efficacy-Extension|13|||
155341016|NCT01137682|560681332|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
155341017|NCT01137682|560681333|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
155341018|NCT01137682|560681334|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
155341019|NCT01137682|560681332|FG000|Overall Study|Lost to Follow Up-Extension|0|||
155341020|NCT01137682|560681333|FG001|Overall Study|Lost to Follow Up-Extension|1|||
155341021|NCT01137682|560681334|FG002|Overall Study|Lost to Follow Up-Extension|0|||
155341022|NCT01137682|560681332|FG000|Overall Study|Administrative problems-Extension|0|||
155341023|NCT01137682|560681333|FG001|Overall Study|Administrative problems-Extension|2|||
155341024|NCT01137682|560681334|FG002|Overall Study|Administrative problems-Extension|0|||
155341025|NCT01137682|560681332|FG000|Overall Study|Death-Extension|2|||
155341026|NCT01137682|560681333|FG001|Overall Study|Death-Extension|0|||
155341027|NCT01137682|560681334|FG002|Overall Study|Death-Extension|0|||
155341028|NCT01137682|560681332|FG000|Overall Study|Protocol Violation-Extension|2|||
155341029|NCT01137682|560681333|FG001|Overall Study|Protocol Violation-Extension|1|||
155341030|NCT01137682|560681334|FG002|Overall Study|Protocol Violation-Extension|0|||
155341031|NCT01137682|560681332|FG000|Overall Study|Did not enter extension|2|||
155341032|NCT01137682|560681333|FG001|Overall Study|Did not enter extension|3|||
155341033|NCT01137682|560681334|FG002|Overall Study|Did not enter extension|2|||
155341034|NCT01137682|560681332|FG000|Overall Study|Did not receive treatment in extension|0|||
155341035|NCT01137682|560681333|FG001|Overall Study|Did not receive treatment in extension|0|||
155341036|NCT01137682|560681334|FG002|Overall Study|Did not receive treatment in extension|1|||
155341037|NCT02009332|560681337|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341038|NCT02009332|560681338|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
155341039|NCT02009332|560681339|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341040|NCT02009332|560681340|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341041|NCT02009332|560681341|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341042|NCT02009332|560681342|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
155341043|NCT02009332|560681337|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341044|NCT02009332|560681338|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341045|NCT02009332|560681339|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341046|NCT02009332|560681340|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341047|NCT02009332|560681341|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
155341048|NCT02009332|560681342|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
155341049|NCT02009332|560681337|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341050|NCT02009332|560681338|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341051|NCT02009332|560681339|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341052|NCT02009332|560681340|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341053|NCT02009332|560681341|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
155341054|NCT02009332|560681342|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
155341055|NCT01912599|560681343|FG000|Overall Study|Withdrawal by Subject|0|||
155341056|NCT01912599|560681344|FG001|Overall Study|Withdrawal by Subject|1|||
155341057|NCT01280721|560681348|FG000|Overall Study|Adverse Event|4|||
155341058|NCT01280721|560681348|FG000|Overall Study|Physician Decision|3|||
155341059|NCT01280721|560681348|FG000|Overall Study|Withdrawal by Subject|6|||
155341060|NCT01280721|560681348|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
155341061|NCT01280721|560681348|FG000|Overall Study|No tolerability for the lowest dose|2|||
155341062|NCT01180400|560681349|FG000|Overall Study|Withdrawal by Subject|5|||
155341063|NCT01180400|560681350|FG001|Overall Study|Withdrawal by Subject|6|||
155341064|NCT01180400|560681349|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155341065|NCT01180400|560681350|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
155341066|NCT01180400|560681349|FG000|Overall Study|Adverse Event|12|||
155341067|NCT01180400|560681350|FG001|Overall Study|Adverse Event|10|||
155341068|NCT01180400|560681349|FG000|Overall Study|Severe non-compliance to protocol|1|||
155341069|NCT01180400|560681350|FG001|Overall Study|Severe non-compliance to protocol|2|||
155341070|NCT01180400|560681349|FG000|Overall Study|Condition under investigation worsened|2|||
155341071|NCT01180400|560681350|FG001|Overall Study|Condition under investigation worsened|1|||
155341072|NCT01180400|560681349|FG000|Overall Study|Lack of Efficacy|2|||
155341073|NCT01180400|560681350|FG001|Overall Study|Lack of Efficacy|0|||
155341074|NCT01180400|560681349|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155341075|NCT01180400|560681350|FG001|Overall Study|Study-specific withdrawal criteria|2|||
155341076|NCT01180400|560681349|FG000|Overall Study|Lost to Follow-up|2|||
155341077|NCT01180400|560681350|FG001|Overall Study|Lost to Follow-up|3|||
155341078|NCT01180400|560681349|FG000|Overall Study|Other|0|||
155341079|NCT01180400|560681350|FG001|Overall Study|Other|1|||
155341080|NCT00042939|560681352|FG000|Overall Study|Adverse Event|6|||
155341081|NCT00042939|560681353|FG001|Overall Study|Adverse Event|7|||
155341082|NCT00042939|560681352|FG000|Overall Study|Death|3|||
155341083|NCT00042939|560681353|FG001|Overall Study|Death|2|||
155341084|NCT00042939|560681352|FG000|Overall Study|Withdrawal by Subject|3|||
155341085|NCT00042939|560681353|FG001|Overall Study|Withdrawal by Subject|4|||
155341086|NCT00042939|560681352|FG000|Overall Study|Other disease|1|||
155341087|NCT00042939|560681353|FG001|Overall Study|Other disease|0|||
155341088|NCT00042939|560681352|FG000|Overall Study|Ineligible|2|||
155341089|NCT00042939|560681353|FG001|Overall Study|Ineligible|2|||
155341090|NCT00042939|560681352|FG000|Overall Study|Deterioration of health|3|||
155341091|NCT00042939|560681353|FG001|Overall Study|Deterioration of health|4|||
155341092|NCT00042939|560681352|FG000|Overall Study|QOL diminished|1|||
155341093|NCT00042939|560681353|FG001|Overall Study|QOL diminished|0|||
155341094|NCT00042939|560681352|FG000|Overall Study|Rising ca 19-9|1|||
155341095|NCT00042939|560681353|FG001|Overall Study|Rising ca 19-9|0|||
155341096|NCT00042939|560681352|FG000|Overall Study|Patient non-compliance|1|||
155341097|NCT00042939|560681353|FG001|Overall Study|Patient non-compliance|0|||
155341098|NCT00042939|560681352|FG000|Overall Study|Still on treatment|1|||
155164455|NCT02357368|560038931|FG003|Overall Study|Withdrawal by Subject|2|||
155164456|NCT01931566|560038932|FG000|Overall Study|Randomized But Not Treated|6|||
155341099|NCT00042939|560681353|FG001|Overall Study|Still on treatment|0|||
155341100|NCT00042939|560681352|FG000|Overall Study|Treatment break > 4 weeks|0|||
155341101|NCT00042939|560681353|FG001|Overall Study|Treatment break > 4 weeks|1|||
155341102|NCT00042939|560681352|FG000|Overall Study|Did not start treatment|2|||
155341103|NCT00042939|560681353|FG001|Overall Study|Did not start treatment|1|||
154966784|NCT00902538|559301140|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
154966785|NCT00902538|559301141|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
154966786|NCT00902538|559301136|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
154966787|NCT00902538|559301137|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
154966788|NCT00902538|559301138|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
154966789|NCT00902538|559301139|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
154966790|NCT00902538|559301140|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
154966791|NCT00902538|559301141|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
154966792|NCT00902538|559301136|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
154966793|NCT00902538|559301137|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
154966794|NCT00902538|559301138|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
154966795|NCT00902538|559301139|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
154966796|NCT00902538|559301140|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
154966797|NCT00902538|559301141|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
154966798|NCT00902538|559301136|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
154966799|NCT00902538|559301137|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
154966800|NCT00902538|559301138|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
154966801|NCT00902538|559301139|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
154966802|NCT00902538|559301140|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
154966803|NCT00902538|559301141|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
154966804|NCT00902538|559301136|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
154966805|NCT00902538|559301137|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
154966806|NCT00902538|559301138|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
154966807|NCT00902538|559301139|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
154966808|NCT00902538|559301140|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
154966809|NCT00902538|559301141|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
154966810|NCT00902538|559301136|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
154966811|NCT00902538|559301137|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
154966812|NCT00902538|559301138|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
154966813|NCT00902538|559301139|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
154966814|NCT00902538|559301140|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
154966815|NCT00902538|559301141|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
154966816|NCT00902538|559301136|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
154966817|NCT00902538|559301137|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
155073857|NCT00160615|559699767|FG000|Overall Study|Withdrawal by Subject|0|||
155073858|NCT00160615|559699768|FG001|Overall Study|Withdrawal by Subject|2|||
155073859|NCT00160615|559699767|FG000|Overall Study|Lack of Efficacy|11|||
155073860|NCT00160615|559699768|FG001|Overall Study|Lack of Efficacy|23|||
155073861|NCT00160615|559699767|FG000|Overall Study|Patient decision|1|||
155073862|NCT00160615|559699768|FG001|Overall Study|Patient decision|2|||
155073863|NCT00160615|559699767|FG000|Overall Study|Investigator decision|1|||
155073864|NCT00160615|559699768|FG001|Overall Study|Investigator decision|1|||
155073865|NCT00160615|559699767|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
155073866|NCT00160615|559699768|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
155073867|NCT00160615|559699767|FG000|Overall Study|Switch to surgical treatment|0|||
155073868|NCT00160615|559699768|FG001|Overall Study|Switch to surgical treatment|2|||
155073869|NCT00160615|559699767|FG000|Overall Study|Non-compliance was suspected|0|||
155073870|NCT00160615|559699768|FG001|Overall Study|Non-compliance was suspected|1|||
155073871|NCT00160615|559699767|FG000|Overall Study|Poor compliance|0|||
155073872|NCT00160615|559699768|FG001|Overall Study|Poor compliance|1|||
155073873|NCT05417113|559699771|FG000|Overall Study|Lost to Follow-up|2|||
155073874|NCT05417113|559699772|FG001|Overall Study|Lost to Follow-up|2|||
155073875|NCT00134719|559699773|FG000|Primary Vaccination Phase|Adverse Event|4|||
155073876|NCT00134719|559699774|FG001|Primary Vaccination Phase|Adverse Event|0|||
155073877|NCT00134719|559699775|FG002|Primary Vaccination Phase|Adverse Event|0|||
155073878|NCT00134719|559699773|FG000|Primary Vaccination Phase|Protocol Violation|1|||
155073879|NCT00134719|559699774|FG001|Primary Vaccination Phase|Protocol Violation|0|||
155073880|NCT00134719|559699775|FG002|Primary Vaccination Phase|Protocol Violation|0|||
155073881|NCT00134719|559699773|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
155073882|NCT00134719|559699774|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
155073883|NCT00134719|559699775|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
155073884|NCT00134719|559699773|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
155073885|NCT00134719|559699774|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
155073886|NCT00134719|559699775|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
155073887|NCT00134719|559699773|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
155073888|NCT00134719|559699774|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
155073889|NCT00134719|559699775|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
155073890|NCT00134719|559699773|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
155073891|NCT00134719|559699774|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
155073892|NCT00134719|559699775|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
155073893|NCT01807520|559699776|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155073894|NCT01807520|559699777|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
155073895|NCT01807520|559699778|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
155073896|NCT01807520|559699779|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155073897|NCT01807520|559699780|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155073898|NCT01807520|559699781|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155073899|NCT01807520|559699782|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
155073900|NCT01807520|559699776|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
155073901|NCT01807520|559699777|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155073902|NCT01807520|559699778|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
155073903|NCT01807520|559699779|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155073904|NCT01807520|559699780|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155073905|NCT01807520|559699781|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155073906|NCT01807520|559699782|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
155073907|NCT01807520|559699776|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155073908|NCT01807520|559699777|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155073909|NCT01807520|559699778|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
155073910|NCT01807520|559699779|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155073911|NCT01807520|559699780|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155073912|NCT01807520|559699781|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155073913|NCT01807520|559699782|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
155073914|NCT01807520|559699776|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
155164457|NCT01931566|560038933|FG001|Overall Study|Randomized But Not Treated|9|||
155073915|NCT01807520|559699777|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155073916|NCT01807520|559699778|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155073917|NCT01807520|559699779|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155073918|NCT01807520|559699780|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155073919|NCT01807520|559699781|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155073920|NCT01807520|559699782|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
155073921|NCT01807520|559699776|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155073922|NCT01807520|559699777|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155073923|NCT01807520|559699778|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
155073924|NCT01807520|559699779|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155073925|NCT01807520|559699780|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155073926|NCT01807520|559699781|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155073927|NCT01807520|559699782|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
155073928|NCT01807520|559699776|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
155073929|NCT01807520|559699777|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155073930|NCT01807520|559699778|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155073931|NCT01807520|559699779|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155073932|NCT01807520|559699780|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155073933|NCT01807520|559699781|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155073934|NCT01807520|559699782|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
155073935|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
155073936|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
155073937|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155073938|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155073939|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
155073940|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155073941|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
155073942|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155073943|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155073944|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155073945|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
155073946|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155073947|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155073948|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
155073949|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
155073950|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155073951|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155073952|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155073953|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155073954|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155073955|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
155073956|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155073957|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
155073958|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155073959|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155073960|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155073961|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155073962|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
155073963|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
155073964|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155073965|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155073966|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
155073967|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155073968|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155073969|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
155073970|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
155073971|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
155073972|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155073973|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155073974|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
155341104|NCT03349476|560681354|FG000|Overall Study|Physician Decision|3|||
155341105|NCT00795639|560681355|FG000|Overall Study|Death|1|||
155341106|NCT00795639|560681356|FG001|Overall Study|Death|6|||
155341107|NCT00795639|560681355|FG000|Overall Study|Withdrawal by Subject|1|||
155341108|NCT00795639|560681356|FG001|Overall Study|Withdrawal by Subject|3|||
155341109|NCT00795639|560681355|FG000|Overall Study|Pregnancy|1|||
155341110|NCT00795639|560681356|FG001|Overall Study|Pregnancy|0|||
155073975|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155073976|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
155341111|NCT00795639|560681355|FG000|Overall Study|Adverse Event|5|||
155073977|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
155073978|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
155341112|NCT00795639|560681356|FG001|Overall Study|Adverse Event|2|||
155341113|NCT00795639|560681355|FG000|Overall Study|Other|0|||
155073979|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155073980|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
155073981|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155073982|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155073983|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
155073984|NCT01807520|559699776|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
155073985|NCT01807520|559699777|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
155073986|NCT01807520|559699778|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
155073987|NCT01807520|559699779|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
155073988|NCT01807520|559699780|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
155073989|NCT01807520|559699781|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
155073990|NCT01807520|559699782|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
155073991|NCT01807520|559699776|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155073992|NCT01807520|559699777|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155073993|NCT01807520|559699778|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155073994|NCT01807520|559699779|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155073995|NCT01807520|559699780|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155073996|NCT01807520|559699781|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
155073997|NCT01807520|559699782|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
155073998|NCT01807520|559699776|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155073999|NCT01807520|559699777|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155074000|NCT01807520|559699778|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155074001|NCT01807520|559699779|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155074002|NCT01807520|559699780|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155074003|NCT01807520|559699781|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
155074004|NCT01807520|559699782|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
155074005|NCT01807520|559699776|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155074006|NCT01807520|559699777|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155074007|NCT01807520|559699778|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155074008|NCT01807520|559699779|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155074009|NCT01807520|559699780|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
155074010|NCT01807520|559699781|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
155074011|NCT01807520|559699782|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
155074012|NCT01631188|559699783|FG000|Overall Study|Physician Decision|75|||
155074013|NCT00835978|559699786|FG000|Overall Study|Death|33|||
155074014|NCT00835978|559699787|FG001|Overall Study|Death|40|||
155074015|NCT00835978|559699788|FG002|Overall Study|Death|49|||
155074016|NCT00835978|559699789|FG003|Overall Study|Death|4|||
154962573|NCT05776901|559289503|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
154962574|NCT01958294|559289511|FG000|Overall Study|Clinical Circumstances|2|||
154962575|NCT00682461|559289513|FG000|Overall Study|Adverse Event|5|||
154962576|NCT00682461|559289514|FG001|Overall Study|Adverse Event|7|||
154962577|NCT00682461|559289513|FG000|Overall Study|Lost to Follow-up|8|||
154962578|NCT00682461|559289514|FG001|Overall Study|Lost to Follow-up|5|||
154962579|NCT00682461|559289513|FG000|Overall Study|Withdrawal by Subject|12|||
154962580|NCT00682461|559289514|FG001|Overall Study|Withdrawal by Subject|19|||
154962581|NCT00665925|559289515|FG000|Overall Study|Lack of Efficacy|10|||
154962582|NCT00665925|559289516|FG001|Overall Study|Lack of Efficacy|8|||
154962583|NCT00665925|559289517|FG002|Overall Study|Lack of Efficacy|9|||
154962584|NCT00665925|559289518|FG003|Overall Study|Lack of Efficacy|8|||
154962585|NCT00665925|559289515|FG000|Overall Study|Lost to Follow-up|1|||
154962586|NCT00665925|559289516|FG001|Overall Study|Lost to Follow-up|2|||
154962587|NCT00665925|559289517|FG002|Overall Study|Lost to Follow-up|2|||
155074017|NCT00835978|559699786|FG000|Overall Study|Lost to Follow-up|3|||
155341114|NCT00795639|560681356|FG001|Overall Study|Other|2|||
155341115|NCT00795639|560681355|FG000|Overall Study|Terminated by sponsor|13|||
155341116|NCT00795639|560681356|FG001|Overall Study|Terminated by sponsor|12|||
155341117|NCT00795639|560681355|FG000|Overall Study|Randomized and not treated|0|||
155341118|NCT00795639|560681356|FG001|Overall Study|Randomized and not treated|1|||
155341119|NCT00068107|560681357|FG000|Overall Study|end-stage renal disease|6|||
154962588|NCT00665925|559289518|FG003|Overall Study|Lost to Follow-up|2|||
155074018|NCT00835978|559699787|FG001|Overall Study|Lost to Follow-up|4|||
155074019|NCT00835978|559699788|FG002|Overall Study|Lost to Follow-up|2|||
155164458|NCT01931566|560038934|FG002|Overall Study|Randomized But Not Treated|14|||
155341120|NCT00068107|560681357|FG000|Overall Study|Death|2|||
155341121|NCT00068107|560681357|FG000|Overall Study|Withdrawal by Subject|1|||
155341122|NCT01419184|560681358|FG000|Overall Study|Site data not available|3|||
154962589|NCT00665925|559289515|FG000|Overall Study|Withdrawal by Subject|2|||
155074020|NCT00835978|559699789|FG003|Overall Study|Lost to Follow-up|1|||
155074021|NCT00835978|559699786|FG000|Overall Study|Other|5|||
155074022|NCT00835978|559699787|FG001|Overall Study|Other|1|||
155074023|NCT00835978|559699788|FG002|Overall Study|Other|8|||
155074024|NCT00835978|559699789|FG003|Overall Study|Other|0|||
155074025|NCT00835978|559699786|FG000|Overall Study|Objective progression or relapse|2|||
155074026|NCT00835978|559699787|FG001|Overall Study|Objective progression or relapse|0|||
155074027|NCT00835978|559699788|FG002|Overall Study|Objective progression or relapse|1|||
155074028|NCT00835978|559699789|FG003|Overall Study|Objective progression or relapse|0|||
155074029|NCT00835978|559699786|FG000|Overall Study|Adverse Event|1|||
155074030|NCT00835978|559699787|FG001|Overall Study|Adverse Event|0|||
155074031|NCT00835978|559699788|FG002|Overall Study|Adverse Event|1|||
155074032|NCT00835978|559699789|FG003|Overall Study|Adverse Event|0|||
155074033|NCT00835978|559699786|FG000|Overall Study|Withdrawal by Subject|0|||
155074034|NCT00835978|559699787|FG001|Overall Study|Withdrawal by Subject|3|||
155074035|NCT00835978|559699788|FG002|Overall Study|Withdrawal by Subject|0|||
155074036|NCT00835978|559699789|FG003|Overall Study|Withdrawal by Subject|5|||
155341123|NCT01419184|560681359|FG001|Overall Study|Site data not available|2|||
155341124|NCT01419184|560681358|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
155341125|NCT01419184|560681359|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
155074037|NCT00835978|559699786|FG000|Overall Study|Study terminated by sponsor|12|||
155074038|NCT00835978|559699787|FG001|Overall Study|Study terminated by sponsor|8|||
155074039|NCT00835978|559699788|FG002|Overall Study|Study terminated by sponsor|30|||
155341126|NCT01419184|560681358|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
155074040|NCT00835978|559699789|FG003|Overall Study|Study terminated by sponsor|0|||
155074041|NCT04575324|559699790|FG000|Overall Study|Lost to Follow-up|29|||
155074042|NCT04575324|559699791|FG001|Overall Study|Lost to Follow-up|25|||
155074043|NCT04575324|559699790|FG000|Overall Study|Death|1|||
155074044|NCT04575324|559699791|FG001|Overall Study|Death|2|||
155074045|NCT04575324|559699790|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
155074046|NCT04575324|559699791|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
155074047|NCT01105130|559699792|FG000|Overall Study|Withdrawal by Subject|4|||
155074048|NCT01105130|559699793|FG001|Overall Study|Withdrawal by Subject|6|||
155074049|NCT01105130|559699794|FG002|Overall Study|Withdrawal by Subject|2|||
155074050|NCT01105130|559699792|FG000|Overall Study|Never Started|2|||
155074051|NCT01105130|559699793|FG001|Overall Study|Never Started|2|||
155074052|NCT01105130|559699794|FG002|Overall Study|Never Started|4|||
155074053|NCT01105130|559699792|FG000|Overall Study|Toxicity|1|||
155074054|NCT01105130|559699793|FG001|Overall Study|Toxicity|3|||
155074055|NCT01105130|559699794|FG002|Overall Study|Toxicity|2|||
155074056|NCT01105130|559699792|FG000|Overall Study|Multiple Reasons|3|||
155074057|NCT01105130|559699793|FG001|Overall Study|Multiple Reasons|0|||
155074058|NCT01105130|559699794|FG002|Overall Study|Multiple Reasons|2|||
155074059|NCT02927145|559699796|FG000|Initial Recruitment|Withdrawal by Subject|0|||
155074060|NCT02927145|559699797|FG001|Initial Recruitment|Withdrawal by Subject|1|||
155074061|NCT02927145|559699798|FG002|Initial Recruitment|Withdrawal by Subject|1|||
155074062|NCT02927145|559699799|FG003|Initial Recruitment|Withdrawal by Subject|4|||
155074063|NCT02927145|559699800|FG004|Initial Recruitment|Withdrawal by Subject|1|||
155074064|NCT02927145|559699801|FG005|Initial Recruitment|Withdrawal by Subject|1|||
155074065|NCT02927145|559699802|FG006|Initial Recruitment|Withdrawal by Subject|0|||
155074066|NCT02927145|559699803|FG007|Initial Recruitment|Withdrawal by Subject|0|||
155074067|NCT02927145|559699804|FG008|Initial Recruitment|Withdrawal by Subject|2|||
155074068|NCT02927145|559699796|FG000|Initial Recruitment|Adverse Event|0|||
155074069|NCT02927145|559699797|FG001|Initial Recruitment|Adverse Event|0|||
155074070|NCT02927145|559699798|FG002|Initial Recruitment|Adverse Event|0|||
155074071|NCT02927145|559699799|FG003|Initial Recruitment|Adverse Event|0|||
155074072|NCT02927145|559699800|FG004|Initial Recruitment|Adverse Event|2|||
155074073|NCT02927145|559699801|FG005|Initial Recruitment|Adverse Event|0|||
155074074|NCT02927145|559699802|FG006|Initial Recruitment|Adverse Event|0|||
155074075|NCT02927145|559699803|FG007|Initial Recruitment|Adverse Event|0|||
155074076|NCT02927145|559699804|FG008|Initial Recruitment|Adverse Event|0|||
155074077|NCT02927145|559699796|FG000|Invitation for Additional Challenge|Pregnancy|0|||
155074078|NCT02927145|559699797|FG001|Invitation for Additional Challenge|Pregnancy|0|||
155074079|NCT02927145|559699798|FG002|Invitation for Additional Challenge|Pregnancy|0|||
155074080|NCT02927145|559699799|FG003|Invitation for Additional Challenge|Pregnancy|0|||
155074081|NCT02927145|559699800|FG004|Invitation for Additional Challenge|Pregnancy|0|||
155074082|NCT02927145|559699801|FG005|Invitation for Additional Challenge|Pregnancy|0|||
155074083|NCT02927145|559699802|FG006|Invitation for Additional Challenge|Pregnancy|1|||
155074084|NCT02927145|559699803|FG007|Invitation for Additional Challenge|Pregnancy|0|||
155074085|NCT02927145|559699804|FG008|Invitation for Additional Challenge|Pregnancy|0|||
155074086|NCT02582632|559699805|FG000|Overall Study|Other|1|||
155074087|NCT00327171|559699809|FG000|Overall Study|Did not receive study medication|3|||
155074088|NCT00327171|559699810|FG001|Overall Study|Did not receive study medication|0|||
155074089|NCT00327171|559699809|FG000|Overall Study|Adverse Event|23|||
155074090|NCT00327171|559699810|FG001|Overall Study|Adverse Event|23|||
155074091|NCT00327171|559699809|FG000|Overall Study|Disease progression/lack of efficacy|68|||
155074092|NCT00327171|559699810|FG001|Overall Study|Disease progression/lack of efficacy|69|||
155074093|NCT00327171|559699809|FG000|Overall Study|Investigator/participant request|1|||
155074094|NCT00327171|559699810|FG001|Overall Study|Investigator/participant request|8|||
155074095|NCT00327171|559699809|FG000|Overall Study|Clinical progression|12|||
155074096|NCT00327171|559699810|FG001|Overall Study|Clinical progression|8|||
155074097|NCT00327171|559699809|FG000|Overall Study|Undisclosed history of ischemia|0|||
155074098|NCT00327171|559699810|FG001|Overall Study|Undisclosed history of ischemia|1|||
155074099|NCT00327171|559699809|FG000|Overall Study|Other|1|||
155074100|NCT00327171|559699810|FG001|Overall Study|Other|0|||
155164459|NCT01931566|560038932|FG000|Overall Study|Adverse Event|37|||
155164460|NCT01931566|560038933|FG001|Overall Study|Adverse Event|167|||
155074101|NCT01771913|559699811|FG000|Overall Study|Withdrawal by Subject|1|||
155074102|NCT01771913|559699812|FG001|Overall Study|Withdrawal by Subject|0|||
155074103|NCT01363440|559699813|FG000|Overall Study|Adverse Event|5|||
155074104|NCT01363440|559699814|FG001|Overall Study|Adverse Event|4|||
155074105|NCT01363440|559699815|FG002|Overall Study|Adverse Event|4|||
155074106|NCT01363440|559699813|FG000|Overall Study|Death|3|||
155074107|NCT01363440|559699814|FG001|Overall Study|Death|7|||
155074108|NCT01363440|559699815|FG002|Overall Study|Death|5|||
155074109|NCT01363440|559699813|FG000|Overall Study|Withdrawal by Subject|9|||
155074110|NCT01363440|559699814|FG001|Overall Study|Withdrawal by Subject|11|||
155074111|NCT01363440|559699815|FG002|Overall Study|Withdrawal by Subject|11|||
155074112|NCT01363440|559699813|FG000|Overall Study|Lost to Follow-up|2|||
155074113|NCT01363440|559699814|FG001|Overall Study|Lost to Follow-up|4|||
155074114|NCT01363440|559699815|FG002|Overall Study|Lost to Follow-up|5|||
155074115|NCT01363440|559699813|FG000|Overall Study|Other|4|||
155074116|NCT01363440|559699814|FG001|Overall Study|Other|5|||
155074117|NCT01363440|559699815|FG002|Overall Study|Other|2|||
155074118|NCT00992836|559699816|FG000|Overall Study|Lost to Follow-up|1|||
155074119|NCT00992836|559699816|FG000|Overall Study|Withdrawal by Subject|2|||
155074120|NCT00992836|559699816|FG000|Overall Study|Protocol Violation|2|||
155074121|NCT00266812|559699817|FG000|Overall Study|Disease Progression|9|||
155074122|NCT00266812|559699818|FG001|Overall Study|Disease Progression|3|||
155074123|NCT00266812|559699817|FG000|Overall Study|Death|5|||
155074124|NCT00266812|559699818|FG001|Overall Study|Death|4|||
155074125|NCT00266812|559699817|FG000|Overall Study|Adverse Event|3|||
155074126|NCT00266812|559699818|FG001|Overall Study|Adverse Event|1|||
155074127|NCT00266812|559699817|FG000|Overall Study|Protocol Violation|0|||
155074128|NCT00266812|559699818|FG001|Overall Study|Protocol Violation|1|||
155164461|NCT01931566|560038934|FG002|Overall Study|Adverse Event|132|||
155164462|NCT01931566|560038932|FG000|Overall Study|Major Protocol Deviation|5|||
155164463|NCT01931566|560038933|FG001|Overall Study|Major Protocol Deviation|14|||
155164464|NCT01931566|560038934|FG002|Overall Study|Major Protocol Deviation|21|||
155164465|NCT01931566|560038932|FG000|Overall Study|Lost to Follow-up|3|||
155164466|NCT01931566|560038933|FG001|Overall Study|Lost to Follow-up|26|||
155164467|NCT01931566|560038934|FG002|Overall Study|Lost to Follow-up|23|||
155164468|NCT01931566|560038932|FG000|Overall Study|Voluntary Withdrawal|78|||
155164469|NCT01931566|560038933|FG001|Overall Study|Voluntary Withdrawal|245|||
155164470|NCT01931566|560038934|FG002|Overall Study|Voluntary Withdrawal|225|||
155164471|NCT01931566|560038932|FG000|Overall Study|Study Termination|289|||
155164472|NCT01931566|560038933|FG001|Overall Study|Study Termination|968|||
155164473|NCT01931566|560038934|FG002|Overall Study|Study Termination|1037|||
155164474|NCT01931566|560038932|FG000|Overall Study|Reason Not Specified|11|||
155341127|NCT01419184|560681359|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
155341128|NCT01419184|560681358|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
155341129|NCT01419184|560681359|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
155341130|NCT01419184|560681358|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
155341131|NCT01419184|560681359|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
155341132|NCT01419184|560681358|FG000|Overall Study|Participant randomized, not treated|1|||
155341133|NCT01419184|560681359|FG001|Overall Study|Participant randomized, not treated|0|||
155341134|NCT01441596|560681368|FG000|Overall Study|Other reason not defined below|0|||
155341135|NCT01441596|560681369|FG001|Overall Study|Other reason not defined below|2|||
155341136|NCT01441596|560681370|FG002|Overall Study|Other reason not defined below|1|||
155341137|NCT01441596|560681368|FG000|Overall Study|Withdrawal by Subject|4|||
155341138|NCT01441596|560681369|FG001|Overall Study|Withdrawal by Subject|0|||
155341139|NCT01441596|560681370|FG002|Overall Study|Withdrawal by Subject|2|||
155341140|NCT01441596|560681368|FG000|Overall Study|Not treated|0|||
155341141|NCT01441596|560681369|FG001|Overall Study|Not treated|1|||
155341142|NCT01441596|560681370|FG002|Overall Study|Not treated|1|||
155341143|NCT03055988|560681371|FG000|Period 1|Adverse Event|0|||
155341144|NCT03055988|560681372|FG001|Period 1|Adverse Event|1|||
155341145|NCT03055988|560681371|FG000|Period 1|Lost to Follow-up|1|||
155341146|NCT03055988|560681372|FG001|Period 1|Lost to Follow-up|0|||
155341147|NCT03055988|560681371|FG000|Period 1|Withdrawal by Subject|0|||
155341148|NCT03055988|560681372|FG001|Period 1|Withdrawal by Subject|4|||
155341149|NCT03055988|560681371|FG000|Period 2|Adverse Event|0|||
155341150|NCT03055988|560681372|FG001|Period 2|Adverse Event|1|||
155341151|NCT03055988|560681371|FG000|Period 2|Other than listed|1|||
155341152|NCT03055988|560681372|FG001|Period 2|Other than listed|1|||
155341153|NCT01528605|560681373|FG000|Overall Study|Lost to Follow-up|1|||
155341154|NCT01528605|560681374|FG001|Overall Study|Lost to Follow-up|0|||
155341155|NCT01528605|560681375|FG002|Overall Study|Lost to Follow-up|1|||
155341156|NCT01528605|560681376|FG003|Overall Study|Lost to Follow-up|1|||
155341157|NCT01528605|560681377|FG004|Overall Study|Lost to Follow-up|0|||
155341158|NCT01528605|560681378|FG005|Overall Study|Lost to Follow-up|0|||
155341159|NCT01528605|560681373|FG000|Overall Study|Death|1|||
155164475|NCT01931566|560038933|FG001|Overall Study|Reason Not Specified|47|||
155164476|NCT01931566|560038934|FG002|Overall Study|Reason Not Specified|53|||
155164477|NCT01931566|560038932|FG000|Overall Study|Missing|0|||
155341160|NCT01528605|560681374|FG001|Overall Study|Death|0|||
155341161|NCT01528605|560681375|FG002|Overall Study|Death|0|||
155341162|NCT01528605|560681376|FG003|Overall Study|Death|0|||
155341163|NCT01528605|560681377|FG004|Overall Study|Death|0|||
155341164|NCT01528605|560681378|FG005|Overall Study|Death|0|||
155074129|NCT00266812|559699817|FG000|Overall Study|Withdrawal by Subject|0|||
155074130|NCT00266812|559699818|FG001|Overall Study|Withdrawal by Subject|2|||
155074131|NCT00266812|559699817|FG000|Overall Study|Discontinued before starting study drug|4|||
155074132|NCT00266812|559699818|FG001|Overall Study|Discontinued before starting study drug|0|||
155341165|NCT01681511|560681379|FG000|Overall Study|No Treatment Received|1|||
155341166|NCT01681511|560681380|FG001|Overall Study|No Treatment Received|3|||
155341167|NCT01681511|560681379|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
155164478|NCT01931566|560038933|FG001|Overall Study|Missing|0|||
155164479|NCT01931566|560038934|FG002|Overall Study|Missing|1|||
155164480|NCT00760617|560038936|FG000|Overall Study|Adverse Event|5|||
155164481|NCT00760617|560038937|FG001|Overall Study|Adverse Event|2|||
154962590|NCT00665925|559289516|FG001|Overall Study|Withdrawal by Subject|2|||
154962591|NCT00665925|559289517|FG002|Overall Study|Withdrawal by Subject|3|||
154962592|NCT00665925|559289518|FG003|Overall Study|Withdrawal by Subject|2|||
154962593|NCT00665925|559289515|FG000|Overall Study|Physician Decision|0|||
154962594|NCT00665925|559289516|FG001|Overall Study|Physician Decision|0|||
154962595|NCT00665925|559289517|FG002|Overall Study|Physician Decision|1|||
154962596|NCT00665925|559289518|FG003|Overall Study|Physician Decision|2|||
154962597|NCT00665925|559289515|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
154962598|NCT00665925|559289516|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
154962599|NCT00665925|559289517|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
154962600|NCT00665925|559289518|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
154962601|NCT00665925|559289515|FG000|Overall Study|Adverse Event|1|||
154962602|NCT00665925|559289516|FG001|Overall Study|Adverse Event|5|||
154962603|NCT00665925|559289517|FG002|Overall Study|Adverse Event|10|||
154962604|NCT00665925|559289518|FG003|Overall Study|Adverse Event|5|||
154962605|NCT00665925|559289515|FG000|Overall Study|Enrolled by mistake|0|||
154962606|NCT00665925|559289516|FG001|Overall Study|Enrolled by mistake|0|||
154962607|NCT00665925|559289517|FG002|Overall Study|Enrolled by mistake|0|||
154962608|NCT00665925|559289518|FG003|Overall Study|Enrolled by mistake|1|||
154962609|NCT00665925|559289515|FG000|Overall Study|Due to exclusion criteria|1|||
154962610|NCT00665925|559289516|FG001|Overall Study|Due to exclusion criteria|0|||
154962611|NCT00665925|559289517|FG002|Overall Study|Due to exclusion criteria|0|||
154962612|NCT00665925|559289518|FG003|Overall Study|Due to exclusion criteria|0|||
154962613|NCT04035187|559289519|FG000|Overall Study|Withdrawal by Subject|2|||
154962614|NCT04035187|559289520|FG001|Overall Study|Withdrawal by Subject|1|||
154962615|NCT04035187|559289521|FG002|Overall Study|Withdrawal by Subject|0|||
154962616|NCT04035187|559289522|FG003|Overall Study|Withdrawal by Subject|0|||
154962617|NCT04035187|559289519|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
154962618|NCT04035187|559289520|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
154962619|NCT04035187|559289521|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
154962620|NCT04035187|559289522|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
154962621|NCT00373256|559289525|FG000|Overall Study|Adverse Event (AE)|1|||
154962622|NCT00373256|559289526|FG001|Overall Study|Adverse Event (AE)|5|||
154962623|NCT00373256|559289525|FG000|Overall Study|Lost to Follow-up|2|||
154962624|NCT00373256|559289526|FG001|Overall Study|Lost to Follow-up|1|||
154962625|NCT00373256|559289525|FG000|Overall Study|Death|9|||
154962626|NCT00373256|559289526|FG001|Overall Study|Death|8|||
154962627|NCT00373256|559289525|FG000|Overall Study|Objective Progression or Relapse|111|||
154962628|NCT00373256|559289526|FG001|Overall Study|Objective Progression or Relapse|104|||
154962629|NCT00373256|559289525|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
154962630|NCT00373256|559289526|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
154962631|NCT00373256|559289525|FG000|Overall Study|Other|73|||
154962632|NCT00373256|559289526|FG001|Overall Study|Other|107|||
154962633|NCT00373256|559289525|FG000|Overall Study|Protocol Violation|0|||
154962634|NCT00373256|559289526|FG001|Overall Study|Protocol Violation|2|||
154962635|NCT00373256|559289525|FG000|Overall Study|Study Terminated by Sponsor|41|||
154962636|NCT00373256|559289526|FG001|Overall Study|Study Terminated by Sponsor|13|||
154962637|NCT06144424|559289527|FG000|Overall Study|Withdrawal by Subject|2|||
154962638|NCT06144424|559289528|FG001|Overall Study|Withdrawal by Subject|0|||
154962639|NCT06144424|559289527|FG000|Overall Study|Incarceration|1|||
154962640|NCT06144424|559289528|FG001|Overall Study|Incarceration|0|||
155074133|NCT03695094|559699819|FG000|Overall Study|Adverse Event|1|||
155074134|NCT03695094|559699820|FG001|Overall Study|Adverse Event|1|||
155074135|NCT03695094|559699819|FG000|Overall Study|Withdrawal by Subject|1|||
155074136|NCT03695094|559699820|FG001|Overall Study|Withdrawal by Subject|0|||
155074137|NCT02323334|559699821|FG000|Period 3|Lost to Follow-up|0|||
155074138|NCT02323334|559699822|FG001|Period 3|Lost to Follow-up|0|||
155074139|NCT02323334|559699823|FG002|Period 3|Lost to Follow-up|1|||
155074140|NCT02323334|559699824|FG003|Period 3|Lost to Follow-up|0|||
155074141|NCT02323334|559699825|FG004|Period 3|Lost to Follow-up|0|||
155074142|NCT02323334|559699826|FG005|Period 3|Lost to Follow-up|0|||
155074143|NCT02323334|559699827|FG006|Period 3|Lost to Follow-up|0|||
155074144|NCT02323334|559699828|FG007|Period 3|Lost to Follow-up|0|||
155074145|NCT02323334|559699829|FG008|Period 3|Lost to Follow-up|0|||
155074146|NCT02323334|559699830|FG009|Period 3|Lost to Follow-up|0|||
155074147|NCT02323334|559699831|FG010|Period 3|Lost to Follow-up|0|||
155074148|NCT02323334|559699832|FG011|Period 3|Lost to Follow-up|0|||
155074149|NCT02323334|559699833|FG012|Period 3|Lost to Follow-up|0|||
155074150|NCT02323334|559699834|FG013|Period 3|Lost to Follow-up|0|||
155074151|NCT02323334|559699835|FG014|Period 3|Lost to Follow-up|0|||
155074152|NCT02323334|559699836|FG015|Period 3|Lost to Follow-up|0|||
155074153|NCT02323334|559699837|FG016|Period 3|Lost to Follow-up|0|||
155074154|NCT02323334|559699821|FG000|Period 3|Withdrawal by Subject|1|||
155074155|NCT02323334|559699822|FG001|Period 3|Withdrawal by Subject|0|||
155074156|NCT02323334|559699823|FG002|Period 3|Withdrawal by Subject|0|||
155074157|NCT02323334|559699824|FG003|Period 3|Withdrawal by Subject|0|||
155074158|NCT02323334|559699825|FG004|Period 3|Withdrawal by Subject|0|||
155074159|NCT02323334|559699826|FG005|Period 3|Withdrawal by Subject|0|||
155074160|NCT02323334|559699827|FG006|Period 3|Withdrawal by Subject|0|||
155074161|NCT02323334|559699828|FG007|Period 3|Withdrawal by Subject|0|||
155074162|NCT02323334|559699829|FG008|Period 3|Withdrawal by Subject|0|||
155074163|NCT02323334|559699830|FG009|Period 3|Withdrawal by Subject|0|||
155074164|NCT02323334|559699831|FG010|Period 3|Withdrawal by Subject|0|||
155074165|NCT02323334|559699832|FG011|Period 3|Withdrawal by Subject|0|||
155074166|NCT02323334|559699833|FG012|Period 3|Withdrawal by Subject|0|||
155074167|NCT02323334|559699834|FG013|Period 3|Withdrawal by Subject|0|||
155074168|NCT02323334|559699835|FG014|Period 3|Withdrawal by Subject|0|||
155074169|NCT02323334|559699836|FG015|Period 3|Withdrawal by Subject|0|||
155074170|NCT02323334|559699837|FG016|Period 3|Withdrawal by Subject|0|||
155074171|NCT01617967|559699838|FG000|Overall Study|Protocol Violation|0|||
155074172|NCT01617967|559699839|FG001|Overall Study|Protocol Violation|0|||
155074173|NCT01617967|559699840|FG002|Overall Study|Protocol Violation|0|||
155074174|NCT01617967|559699841|FG003|Overall Study|Protocol Violation|1|||
155074175|NCT01617967|559699842|FG004|Overall Study|Protocol Violation|0|||
155074176|NCT01617967|559699843|FG005|Overall Study|Protocol Violation|0|||
155074177|NCT01617967|559699838|FG000|Overall Study|Withdrawal by Subject|0|||
155074178|NCT01617967|559699839|FG001|Overall Study|Withdrawal by Subject|0|||
155074179|NCT01617967|559699840|FG002|Overall Study|Withdrawal by Subject|0|||
155074180|NCT01617967|559699841|FG003|Overall Study|Withdrawal by Subject|0|||
155074181|NCT01617967|559699842|FG004|Overall Study|Withdrawal by Subject|0|||
155074182|NCT01617967|559699843|FG005|Overall Study|Withdrawal by Subject|1|||
155074183|NCT01617967|559699838|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
155074184|NCT01617967|559699839|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
155074185|NCT01617967|559699840|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
155074186|NCT01617967|559699841|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
155074187|NCT01617967|559699842|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
155074188|NCT01617967|559699843|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
155074189|NCT00530075|559699844|FG000|Overall Study|Adverse Event|1|||
155074190|NCT00530075|559699844|FG000|Overall Study|Death|1|||
155074191|NCT00530075|559699844|FG000|Overall Study|Lack of Efficacy|3|||
155074192|NCT00530075|559699844|FG000|Overall Study|Protocol Violation|1|||
155341168|NCT01681511|560681380|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
155341169|NCT01681511|560681379|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
155341170|NCT01681511|560681380|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
155341171|NCT01681511|560681379|FG000|Overall Study|No Daily Urine Sample Collected|0|||
155341172|NCT01681511|560681380|FG001|Overall Study|No Daily Urine Sample Collected|1|||
155074193|NCT00530075|559699844|FG000|Overall Study|Withdrawal by Subject|1|||
155074194|NCT01166945|559699847|FG000|Randomized|diagnosed with Group A strep|4|||
155074195|NCT01166945|559699848|FG001|Randomized|diagnosed with Group A strep|4|||
155074196|NCT01166945|559699847|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
155074197|NCT01166945|559699848|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
155074198|NCT01166945|559699847|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
155074199|NCT01166945|559699848|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
155074200|NCT01166945|559699847|FG000|Day 30|Lost to Follow-up|4|||
155074201|NCT01166945|559699848|FG001|Day 30|Lost to Follow-up|3|||
155074202|NCT03520569|559699851|FG000|Overall Study|Withdrawal by Subject|1|||
155074203|NCT00784927|559699852|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
155074204|NCT00784927|559699852|FG000|Overall Study|Protocol Violation|1|||
155074205|NCT00784927|559699852|FG000|Overall Study|Ineligible|1|||
155074206|NCT01137812|559699857|FG000|Overall Study|Adverse Event|21|||
155074207|NCT01137812|559699858|FG001|Overall Study|Adverse Event|14|||
155074208|NCT01137812|559699857|FG000|Overall Study|Lost to Follow-up|6|||
155074209|NCT01137812|559699858|FG001|Overall Study|Lost to Follow-up|8|||
155074210|NCT01137812|559699857|FG000|Overall Study|Physician Decision|25|||
155074211|NCT01137812|559699858|FG001|Overall Study|Physician Decision|17|||
155074212|NCT01137812|559699857|FG000|Overall Study|Protocol Violation|5|||
155074213|NCT01137812|559699858|FG001|Overall Study|Protocol Violation|4|||
155074214|NCT01137812|559699857|FG000|Overall Study|Withdrawal by Subject|5|||
155074215|NCT01137812|559699858|FG001|Overall Study|Withdrawal by Subject|13|||
155074216|NCT01137812|559699857|FG000|Overall Study|Death|2|||
155074217|NCT01137812|559699858|FG001|Overall Study|Death|0|||
155074218|NCT01137812|559699857|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
155074219|NCT01137812|559699858|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
155074220|NCT01137812|559699857|FG000|Overall Study|Other|19|||
155074221|NCT01137812|559699858|FG001|Overall Study|Other|27|||
155074222|NCT03677401|559699860|FG000|Overall Study|Adverse Event|4|||
155074223|NCT03677401|559699861|FG001|Overall Study|Adverse Event|14|||
155074224|NCT03677401|559699860|FG000|Overall Study|Lack of Efficacy|3|||
155074225|NCT03677401|559699861|FG001|Overall Study|Lack of Efficacy|1|||
155074226|NCT03677401|559699860|FG000|Overall Study|Withdrawal by Subject|2|||
155074227|NCT03677401|559699861|FG001|Overall Study|Withdrawal by Subject|2|||
155074228|NCT03677401|559699860|FG000|Overall Study|Sponsor decision|0|||
155074229|NCT03677401|559699861|FG001|Overall Study|Sponsor decision|1|||
155074230|NCT03677401|559699860|FG000|Overall Study|Reason Unspecified|1|||
155074231|NCT03677401|559699861|FG001|Overall Study|Reason Unspecified|0|||
155074232|NCT01177410|559699864|FG000|Overall Study|Adverse Event|0|||
155074233|NCT01177410|559699865|FG001|Overall Study|Adverse Event|2|||
155074234|NCT01177410|559699866|FG002|Overall Study|Adverse Event|2|||
155074235|NCT01177410|559699864|FG000|Overall Study|Withdrawal by Subject|1|||
155074236|NCT01177410|559699865|FG001|Overall Study|Withdrawal by Subject|4|||
155074237|NCT01177410|559699866|FG002|Overall Study|Withdrawal by Subject|3|||
155074238|NCT01177410|559699864|FG000|Overall Study|Lost to Follow-up|0|||
155074239|NCT01177410|559699865|FG001|Overall Study|Lost to Follow-up|1|||
155074240|NCT01177410|559699866|FG002|Overall Study|Lost to Follow-up|0|||
155074241|NCT00471354|559699870|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
155074242|NCT00471354|559699870|FG000|Overall Study|Adverse Event|13|||
155074243|NCT00471354|559699870|FG000|Overall Study|Protocol Violation|12|||
155074244|NCT00471354|559699870|FG000|Overall Study|Withdrawal by Subject|1|||
155074245|NCT00471354|559699870|FG000|Overall Study|Physician Decision|4|||
155074246|NCT00471354|559699870|FG000|Overall Study|Sponsor Decision|1|||
155074247|NCT00471354|559699870|FG000|Overall Study|Lost to Follow-up|3|||
155074248|NCT00471354|559699870|FG000|Overall Study|Lack of Efficacy|5|||
155074249|NCT00471354|559699870|FG000|Overall Study|Patient/Caregiver Decision|12|||
155074250|NCT05558410|559699871|FG000|Overall Study|Adverse Event|1|||
155074251|NCT05558410|559699872|FG001|Overall Study|Adverse Event|2|||
155074252|NCT05558410|559699873|FG002|Overall Study|Adverse Event|0|||
155074253|NCT05558410|559699871|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
155074254|NCT05558410|559699872|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155074255|NCT05558410|559699873|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
155074256|NCT05558410|559699871|FG000|Overall Study|Lost to Follow-up|10|||
155074257|NCT05558410|559699872|FG001|Overall Study|Lost to Follow-up|17|||
155074258|NCT05558410|559699873|FG002|Overall Study|Lost to Follow-up|19|||
155074259|NCT05558410|559699871|FG000|Overall Study|Death|1|||
155074260|NCT05558410|559699872|FG001|Overall Study|Death|0|||
155074261|NCT05558410|559699873|FG002|Overall Study|Death|0|||
155164482|NCT00760617|560038938|FG002|Overall Study|Adverse Event|0|||
155074262|NCT05558410|559699871|FG000|Overall Study|Other non-compliance|0|||
155074263|NCT05558410|559699872|FG001|Overall Study|Other non-compliance|1|||
155074264|NCT05558410|559699873|FG002|Overall Study|Other non-compliance|2|||
155074265|NCT05558410|559699871|FG000|Overall Study|Sponsor Decision|1|||
155074266|NCT05558410|559699872|FG001|Overall Study|Sponsor Decision|0|||
155074267|NCT05558410|559699873|FG002|Overall Study|Sponsor Decision|0|||
155074268|NCT05558410|559699871|FG000|Overall Study|Other|1|||
155074269|NCT05558410|559699872|FG001|Overall Study|Other|0|||
155074270|NCT05558410|559699873|FG002|Overall Study|Other|1|||
155074271|NCT02265744|559699876|FG000|Overall Study|Poor/Non-compliance|1|||
155074272|NCT02265744|559699877|FG001|Overall Study|Poor/Non-compliance|1|||
155074273|NCT02265744|559699878|FG002|Overall Study|Poor/Non-compliance|0|||
155074274|NCT02265744|559699879|FG003|Overall Study|Poor/Non-compliance|0|||
155074275|NCT02265744|559699880|FG004|Overall Study|Poor/Non-compliance|2|||
155074276|NCT02265744|559699876|FG000|Overall Study|Lost to Follow-up|0|||
155074277|NCT02265744|559699877|FG001|Overall Study|Lost to Follow-up|0|||
155074278|NCT02265744|559699878|FG002|Overall Study|Lost to Follow-up|0|||
155074279|NCT02265744|559699879|FG003|Overall Study|Lost to Follow-up|1|||
155074280|NCT02265744|559699880|FG004|Overall Study|Lost to Follow-up|0|||
155074281|NCT02265744|559699876|FG000|Overall Study|Death|0|||
155074282|NCT02265744|559699877|FG001|Overall Study|Death|0|||
155074283|NCT02265744|559699878|FG002|Overall Study|Death|0|||
155074284|NCT02265744|559699879|FG003|Overall Study|Death|2|||
155074285|NCT02265744|559699880|FG004|Overall Study|Death|0|||
155074286|NCT02265744|559699876|FG000|Overall Study|Withdrawal by Subject|2|||
155074287|NCT02265744|559699877|FG001|Overall Study|Withdrawal by Subject|0|||
155074288|NCT02265744|559699878|FG002|Overall Study|Withdrawal by Subject|0|||
155074289|NCT02265744|559699879|FG003|Overall Study|Withdrawal by Subject|2|||
155074290|NCT02265744|559699880|FG004|Overall Study|Withdrawal by Subject|0|||
155074291|NCT02265744|559699876|FG000|Overall Study|Participant request to discontinue|2|||
155074292|NCT02265744|559699877|FG001|Overall Study|Participant request to discontinue|2|||
155074293|NCT02265744|559699878|FG002|Overall Study|Participant request to discontinue|2|||
155074294|NCT02265744|559699879|FG003|Overall Study|Participant request to discontinue|0|||
155074295|NCT02265744|559699880|FG004|Overall Study|Participant request to discontinue|0|||
155074296|NCT02265744|559699876|FG000|Overall Study|Adverse Event|8|||
155074297|NCT02265744|559699877|FG001|Overall Study|Adverse Event|4|||
155074298|NCT02265744|559699878|FG002|Overall Study|Adverse Event|9|||
155074299|NCT02265744|559699879|FG003|Overall Study|Adverse Event|8|||
155074300|NCT02265744|559699880|FG004|Overall Study|Adverse Event|2|||
155074301|NCT02265744|559699876|FG000|Overall Study|Lack of Efficacy|2|||
155074302|NCT02265744|559699877|FG001|Overall Study|Lack of Efficacy|4|||
155074303|NCT02265744|559699878|FG002|Overall Study|Lack of Efficacy|3|||
155074304|NCT02265744|559699879|FG003|Overall Study|Lack of Efficacy|4|||
155074305|NCT02265744|559699880|FG004|Overall Study|Lack of Efficacy|5|||
155074306|NCT02265744|559699876|FG000|Overall Study|Reason not provided by Investigator|1|||
155074307|NCT02265744|559699877|FG001|Overall Study|Reason not provided by Investigator|0|||
155074308|NCT02265744|559699878|FG002|Overall Study|Reason not provided by Investigator|0|||
155074309|NCT02265744|559699879|FG003|Overall Study|Reason not provided by Investigator|2|||
155074310|NCT02265744|559699880|FG004|Overall Study|Reason not provided by Investigator|0|||
155074311|NCT02265744|559699876|FG000|Overall Study|Administrative reason by sponsor|3|||
155074312|NCT02265744|559699877|FG001|Overall Study|Administrative reason by sponsor|2|||
155074313|NCT02265744|559699878|FG002|Overall Study|Administrative reason by sponsor|2|||
155074314|NCT02265744|559699879|FG003|Overall Study|Administrative reason by sponsor|3|||
155074315|NCT02265744|559699880|FG004|Overall Study|Administrative reason by sponsor|3|||
155074316|NCT02265744|559699876|FG000|Overall Study|Subject no longer meets study criteria|0|||
155074317|NCT02265744|559699877|FG001|Overall Study|Subject no longer meets study criteria|0|||
155074318|NCT02265744|559699878|FG002|Overall Study|Subject no longer meets study criteria|0|||
155074319|NCT02265744|559699879|FG003|Overall Study|Subject no longer meets study criteria|0|||
155074320|NCT02265744|559699880|FG004|Overall Study|Subject no longer meets study criteria|1|||
155074321|NCT02265744|559699876|FG000|Overall Study|Pregnancy|1|||
155074322|NCT02265744|559699877|FG001|Overall Study|Pregnancy|2|||
155074323|NCT02265744|559699878|FG002|Overall Study|Pregnancy|1|||
155074324|NCT02265744|559699879|FG003|Overall Study|Pregnancy|1|||
155074325|NCT02265744|559699880|FG004|Overall Study|Pregnancy|0|||
155074326|NCT00574951|559699881|FG000|Overall Study|Ineligible - improper prior treatment|1|||
155074327|NCT00923702|559699882|FG000|Overall Study|Ongoing enrollment|0|||
155074328|NCT00923702|559699883|FG001|Overall Study|Ongoing enrollment|0|||
155074329|NCT00923702|559699884|FG002|Overall Study|Ongoing enrollment|0|||
155074330|NCT00923702|559699885|FG003|Overall Study|Ongoing enrollment|0|||
155074331|NCT00923702|559699886|FG004|Overall Study|Ongoing enrollment|354|||
155074332|NCT05161936|559699887|FG000|Overall Study|Study terminated by Sponsor|1|||
155074333|NCT05161936|559699888|FG001|Overall Study|Study terminated by Sponsor|0|||
155074334|NCT05161936|559699889|FG002|Overall Study|Study terminated by Sponsor|0|||
155074335|NCT05161936|559699887|FG000|Overall Study|Withdrawal by Subject|0|||
155074336|NCT05161936|559699888|FG001|Overall Study|Withdrawal by Subject|0|||
155074337|NCT05161936|559699889|FG002|Overall Study|Withdrawal by Subject|1|||
155074338|NCT02448043|559699892|FG000|Overall Study|Withdrawal by Subject|2|||
155074339|NCT02448043|559699893|FG001|Overall Study|Withdrawal by Subject|2|||
155074340|NCT02448043|559699892|FG000|Overall Study|Protocol Violation|1|||
155074341|NCT02448043|559699893|FG001|Overall Study|Protocol Violation|2|||
155074342|NCT05762679|559699895|FG000|Overall Study|Withdrawal by Subject|1|||
155074343|NCT05762679|559699895|FG000|Overall Study|No analyzable imaging data|1|||
155074344|NCT04425018|559699896|FG000|Overall Study|Withdrawal by Subject|1|||
155074345|NCT04425018|559699897|FG001|Overall Study|Withdrawal by Subject|2|||
155074346|NCT02762604|559699898|FG000|Overall Study|Lost to Follow-up|2|||
155074347|NCT02762604|559699899|FG001|Overall Study|Lost to Follow-up|7|||
155074348|NCT02762604|559699898|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
155074349|NCT02762604|559699899|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
155074350|NCT05942040|559699901|FG000|Overall Study|No longer employed at study site.|0|||
155074351|NCT05942040|559699902|FG001|Overall Study|No longer employed at study site.|0|||
155074352|NCT05942040|559699903|FG002|Overall Study|No longer employed at study site.|3|||
155074353|NCT06061952|559699904|FG000|Overall Study|Withdrawal by Subject|1|||
155074354|NCT06061952|559699905|FG001|Overall Study|Withdrawal by Subject|2|||
155074355|NCT06061952|559699904|FG000|Overall Study|Lost to Follow-up|2|||
155074356|NCT06061952|559699905|FG001|Overall Study|Lost to Follow-up|2|||
155074357|NCT01685437|559699909|FG000|Overall Study|Withdrawal by Subject|22|||
155074358|NCT01685437|559699909|FG000|Overall Study|Lost to Follow-up|3|||
155074359|NCT01685437|559699909|FG000|Overall Study|Adverse Event|1|||
155074360|NCT01685437|559699909|FG000|Overall Study|Protocol Violation|4|||
155074361|NCT01685437|559699909|FG000|Overall Study|Unable to make visits due to work|1|||
155074362|NCT03860584|559699918|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
155074363|NCT03860584|559699919|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
155074364|NCT03860584|559699918|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155074365|NCT03860584|559699919|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155074366|NCT03860584|559699918|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
155074367|NCT03860584|559699919|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
155074368|NCT03860584|559699918|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
155074369|NCT03860584|559699919|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
155074374|NCT03971422|559701982|FG000|Overall Study|Lost to Follow-up|0|||
155074375|NCT03971422|559701983|FG001|Overall Study|Lost to Follow-up|1|||
155074376|NCT03971422|559701984|FG002|Overall Study|Lost to Follow-up|0|||
155074377|NCT03971422|559701982|FG000|Overall Study|Lack of Efficacy|5|||
155074378|NCT03971422|559701983|FG001|Overall Study|Lack of Efficacy|1|||
155074379|NCT03971422|559701984|FG002|Overall Study|Lack of Efficacy|1|||
155074380|NCT03971422|559701982|FG000|Overall Study|Adverse event, not fatal|2|||
155074381|NCT03971422|559701983|FG001|Overall Study|Adverse event, not fatal|2|||
155074382|NCT03971422|559701984|FG002|Overall Study|Adverse event, not fatal|5|||
155074383|NCT03971422|559701982|FG000|Overall Study|Worsening of MG Symptoms|1|||
155074384|NCT03971422|559701983|FG001|Overall Study|Worsening of MG Symptoms|4|||
155074385|NCT03971422|559701984|FG002|Overall Study|Worsening of MG Symptoms|2|||
154962641|NCT00835575|559289533|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
154962642|NCT00835575|559289534|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
154962643|NCT03415308|559289547|FG000|Overall Study|Lost to Follow-up|0|||
154962644|NCT03415308|559289548|FG001|Overall Study|Lost to Follow-up|0|||
154962645|NCT03415308|559289549|FG002|Overall Study|Lost to Follow-up|1|||
154962646|NCT03415308|559289547|FG000|Overall Study|Scheduling Conflicts|0|||
154962647|NCT03415308|559289548|FG001|Overall Study|Scheduling Conflicts|0|||
154962648|NCT03415308|559289549|FG002|Overall Study|Scheduling Conflicts|7|||
154962649|NCT00836472|559289550|FG000|Washout|Adverse Event|1|||
154962650|NCT00836472|559289551|FG001|Washout|Adverse Event|2|||
154962651|NCT00836472|559289550|FG000|Washout|Withdrawal by Subject|1|||
154962652|NCT00836472|559289551|FG001|Washout|Withdrawal by Subject|1|||
154962653|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
154962654|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
154962655|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
154962656|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
154962657|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962658|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962659|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962660|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962661|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962662|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962663|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155074386|NCT03971422|559701982|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
155074387|NCT03971422|559701983|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
155074388|NCT03971422|559701984|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
155074389|NCT03971422|559701982|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
155074390|NCT03971422|559701983|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
155074391|NCT03971422|559701984|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
155074392|NCT03971422|559701982|FG000|Overall Study|Due to COVID-19 pandemic|0|||
155074393|NCT03971422|559701983|FG001|Overall Study|Due to COVID-19 pandemic|1|||
155074394|NCT03971422|559701984|FG002|Overall Study|Due to COVID-19 pandemic|1|||
155074453|NCT01658878|559702014|FG000|Treatment Period|Disease Progression|1|||
155074454|NCT01658878|559702015|FG001|Treatment Period|Disease Progression|3|||
155074455|NCT01658878|559702016|FG002|Treatment Period|Disease Progression|2|||
155074456|NCT01658878|559702017|FG003|Treatment Period|Disease Progression|1|||
155074457|NCT01658878|559702018|FG004|Treatment Period|Disease Progression|13|||
155074458|NCT01658878|559702019|FG005|Treatment Period|Disease Progression|3|||
155074459|NCT01658878|559702020|FG006|Treatment Period|Disease Progression|4|||
155074460|NCT01658878|559702021|FG007|Treatment Period|Disease Progression|3|||
155074461|NCT01658878|559702022|FG008|Treatment Period|Disease Progression|5|||
155074462|NCT01658878|559702023|FG009|Treatment Period|Disease Progression|3|||
155074463|NCT01658878|559702024|FG010|Treatment Period|Disease Progression|3|||
155074464|NCT01658878|559702025|FG011|Treatment Period|Disease Progression|4|||
155074465|NCT01658878|559702026|FG012|Treatment Period|Disease Progression|43|||
155074466|NCT01658878|559702027|FG013|Treatment Period|Disease Progression|48|||
155074467|NCT01658878|559702028|FG014|Treatment Period|Disease Progression|33|||
155074468|NCT01658878|559702029|FG015|Treatment Period|Disease Progression|46|||
155074469|NCT01658878|559702030|FG016|Treatment Period|Disease Progression|41|||
155074470|NCT01658878|559702031|FG017|Treatment Period|Disease Progression|42|||
155074471|NCT01658878|559702032|FG018|Treatment Period|Disease Progression|28|||
155074472|NCT01658878|559702033|FG019|Treatment Period|Disease Progression|37|||
155074473|NCT01658878|559702034|FG020|Treatment Period|Disease Progression|37|||
155074474|NCT01658878|559702035|FG021|Treatment Period|Disease Progression|39|||
155074475|NCT01658878|559702036|FG022|Treatment Period|Disease Progression|27|||
155074476|NCT01658878|559702037|FG023|Treatment Period|Disease Progression|19|||
155074477|NCT01658878|559702014|FG000|Treatment Period|Study Drug Toxicity|0|||
155074478|NCT01658878|559702015|FG001|Treatment Period|Study Drug Toxicity|0|||
155074479|NCT01658878|559702016|FG002|Treatment Period|Study Drug Toxicity|0|||
155074480|NCT01658878|559702017|FG003|Treatment Period|Study Drug Toxicity|1|||
155074481|NCT01658878|559702018|FG004|Treatment Period|Study Drug Toxicity|0|||
155074482|NCT01658878|559702019|FG005|Treatment Period|Study Drug Toxicity|0|||
155074483|NCT01658878|559702020|FG006|Treatment Period|Study Drug Toxicity|0|||
155074484|NCT01658878|559702021|FG007|Treatment Period|Study Drug Toxicity|0|||
155074485|NCT01658878|559702022|FG008|Treatment Period|Study Drug Toxicity|0|||
155074486|NCT01658878|559702023|FG009|Treatment Period|Study Drug Toxicity|0|||
155074487|NCT01658878|559702024|FG010|Treatment Period|Study Drug Toxicity|0|||
155074488|NCT01658878|559702025|FG011|Treatment Period|Study Drug Toxicity|0|||
155074489|NCT01658878|559702026|FG012|Treatment Period|Study Drug Toxicity|7|||
155074490|NCT01658878|559702027|FG013|Treatment Period|Study Drug Toxicity|1|||
155074491|NCT01658878|559702028|FG014|Treatment Period|Study Drug Toxicity|5|||
155074492|NCT01658878|559702029|FG015|Treatment Period|Study Drug Toxicity|0|||
155074493|NCT01658878|559702030|FG016|Treatment Period|Study Drug Toxicity|5|||
155074494|NCT01658878|559702031|FG017|Treatment Period|Study Drug Toxicity|10|||
155074495|NCT01658878|559702032|FG018|Treatment Period|Study Drug Toxicity|12|||
155074496|NCT01658878|559702033|FG019|Treatment Period|Study Drug Toxicity|4|||
155074497|NCT01658878|559702034|FG020|Treatment Period|Study Drug Toxicity|2|||
155074498|NCT01658878|559702035|FG021|Treatment Period|Study Drug Toxicity|3|||
155074499|NCT01658878|559702036|FG022|Treatment Period|Study Drug Toxicity|2|||
155074500|NCT01658878|559702037|FG023|Treatment Period|Study Drug Toxicity|6|||
155074501|NCT01658878|559702014|FG000|Treatment Period|Maximum Clinical Benefit|0|||
155074502|NCT01658878|559702015|FG001|Treatment Period|Maximum Clinical Benefit|0|||
155074503|NCT01658878|559702016|FG002|Treatment Period|Maximum Clinical Benefit|1|||
155074504|NCT01658878|559702017|FG003|Treatment Period|Maximum Clinical Benefit|0|||
155074505|NCT01658878|559702018|FG004|Treatment Period|Maximum Clinical Benefit|0|||
155074506|NCT01658878|559702019|FG005|Treatment Period|Maximum Clinical Benefit|0|||
155074507|NCT01658878|559702020|FG006|Treatment Period|Maximum Clinical Benefit|0|||
155074508|NCT01658878|559702021|FG007|Treatment Period|Maximum Clinical Benefit|0|||
155074509|NCT01658878|559702022|FG008|Treatment Period|Maximum Clinical Benefit|0|||
155074510|NCT01658878|559702023|FG009|Treatment Period|Maximum Clinical Benefit|0|||
155074511|NCT01658878|559702024|FG010|Treatment Period|Maximum Clinical Benefit|0|||
155074512|NCT01658878|559702025|FG011|Treatment Period|Maximum Clinical Benefit|0|||
155074513|NCT01658878|559702026|FG012|Treatment Period|Maximum Clinical Benefit|0|||
155074514|NCT01658878|559702027|FG013|Treatment Period|Maximum Clinical Benefit|0|||
155074515|NCT01658878|559702028|FG014|Treatment Period|Maximum Clinical Benefit|0|||
155074516|NCT01658878|559702029|FG015|Treatment Period|Maximum Clinical Benefit|0|||
155074517|NCT01658878|559702030|FG016|Treatment Period|Maximum Clinical Benefit|0|||
155074518|NCT01658878|559702031|FG017|Treatment Period|Maximum Clinical Benefit|0|||
155074519|NCT01658878|559702032|FG018|Treatment Period|Maximum Clinical Benefit|1|||
155074520|NCT01658878|559702033|FG019|Treatment Period|Maximum Clinical Benefit|1|||
155074521|NCT01658878|559702034|FG020|Treatment Period|Maximum Clinical Benefit|0|||
155074522|NCT01658878|559702035|FG021|Treatment Period|Maximum Clinical Benefit|0|||
155074523|NCT01658878|559702036|FG022|Treatment Period|Maximum Clinical Benefit|0|||
155074524|NCT01658878|559702037|FG023|Treatment Period|Maximum Clinical Benefit|0|||
155074525|NCT01658878|559702014|FG000|Treatment Period|Other Reasons|0|||
155074526|NCT01658878|559702015|FG001|Treatment Period|Other Reasons|0|||
155074527|NCT01658878|559702016|FG002|Treatment Period|Other Reasons|0|||
155074528|NCT01658878|559702017|FG003|Treatment Period|Other Reasons|1|||
155074529|NCT01658878|559702018|FG004|Treatment Period|Other Reasons|0|||
155074530|NCT01658878|559702019|FG005|Treatment Period|Other Reasons|0|||
155074531|NCT01658878|559702020|FG006|Treatment Period|Other Reasons|0|||
155074532|NCT01658878|559702021|FG007|Treatment Period|Other Reasons|0|||
155074533|NCT01658878|559702022|FG008|Treatment Period|Other Reasons|0|||
155074534|NCT01658878|559702023|FG009|Treatment Period|Other Reasons|0|||
155074535|NCT01658878|559702024|FG010|Treatment Period|Other Reasons|0|||
155074536|NCT01658878|559702025|FG011|Treatment Period|Other Reasons|0|||
155074537|NCT01658878|559702026|FG012|Treatment Period|Other Reasons|2|||
155074538|NCT01658878|559702027|FG013|Treatment Period|Other Reasons|0|||
155074539|NCT01658878|559702028|FG014|Treatment Period|Other Reasons|0|||
155074540|NCT01658878|559702029|FG015|Treatment Period|Other Reasons|2|||
155074541|NCT01658878|559702030|FG016|Treatment Period|Other Reasons|1|||
155074542|NCT01658878|559702031|FG017|Treatment Period|Other Reasons|1|||
155074543|NCT01658878|559702032|FG018|Treatment Period|Other Reasons|3|||
155074544|NCT01658878|559702033|FG019|Treatment Period|Other Reasons|1|||
155074545|NCT01658878|559702034|FG020|Treatment Period|Other Reasons|4|||
154962664|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
155074546|NCT01658878|559702035|FG021|Treatment Period|Other Reasons|0|||
155074547|NCT01658878|559702036|FG022|Treatment Period|Other Reasons|0|||
155074548|NCT01658878|559702037|FG023|Treatment Period|Other Reasons|4|||
155074549|NCT01658878|559702014|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074550|NCT01658878|559702015|FG001|Treatment Period|Participant No Longer Meets Study Criteria|0|||
154962665|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962666|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
154962667|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
154962668|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
154962669|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
154962670|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
154962671|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962672|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962673|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962674|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962675|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962676|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962677|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962678|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962679|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962680|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
154962681|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
154962682|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962683|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
154962684|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962685|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962686|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962687|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962688|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962689|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962690|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962691|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962692|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962693|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
155074551|NCT01658878|559702016|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074552|NCT01658878|559702017|FG003|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074553|NCT01658878|559702018|FG004|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074554|NCT01658878|559702019|FG005|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074555|NCT01658878|559702020|FG006|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074556|NCT01658878|559702021|FG007|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074557|NCT01658878|559702022|FG008|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074558|NCT01658878|559702023|FG009|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074559|NCT01658878|559702024|FG010|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074560|NCT01658878|559702025|FG011|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074561|NCT01658878|559702026|FG012|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074562|NCT01658878|559702027|FG013|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074563|NCT01658878|559702028|FG014|Treatment Period|Participant No Longer Meets Study Criteria|1|||
155074564|NCT01658878|559702029|FG015|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074565|NCT01658878|559702030|FG016|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074566|NCT01658878|559702031|FG017|Treatment Period|Participant No Longer Meets Study Criteria|1|||
155074567|NCT01658878|559702032|FG018|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074568|NCT01658878|559702033|FG019|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074569|NCT01658878|559702034|FG020|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155092655|NCT00854360|559773653|FG003|Overall Study|Pregnancy|0|||
154962694|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
154962695|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
154962696|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155074570|NCT01658878|559702035|FG021|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074571|NCT01658878|559702036|FG022|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074572|NCT01658878|559702037|FG023|Treatment Period|Participant No Longer Meets Study Criteria|0|||
155074573|NCT01658878|559702014|FG000|Treatment Period|Poor/Non-compliance|0|||
155074574|NCT01658878|559702015|FG001|Treatment Period|Poor/Non-compliance|0|||
155074575|NCT01658878|559702016|FG002|Treatment Period|Poor/Non-compliance|0|||
155074576|NCT01658878|559702017|FG003|Treatment Period|Poor/Non-compliance|0|||
155074577|NCT01658878|559702018|FG004|Treatment Period|Poor/Non-compliance|0|||
155074578|NCT01658878|559702019|FG005|Treatment Period|Poor/Non-compliance|0|||
155074579|NCT01658878|559702020|FG006|Treatment Period|Poor/Non-compliance|0|||
155074580|NCT01658878|559702021|FG007|Treatment Period|Poor/Non-compliance|0|||
155074581|NCT01658878|559702022|FG008|Treatment Period|Poor/Non-compliance|0|||
155074582|NCT01658878|559702023|FG009|Treatment Period|Poor/Non-compliance|0|||
155074583|NCT01658878|559702024|FG010|Treatment Period|Poor/Non-compliance|0|||
155074584|NCT01658878|559702025|FG011|Treatment Period|Poor/Non-compliance|0|||
155074585|NCT01658878|559702026|FG012|Treatment Period|Poor/Non-compliance|0|||
155074586|NCT01658878|559702027|FG013|Treatment Period|Poor/Non-compliance|0|||
155074587|NCT01658878|559702028|FG014|Treatment Period|Poor/Non-compliance|0|||
155074588|NCT01658878|559702029|FG015|Treatment Period|Poor/Non-compliance|1|||
155074589|NCT01658878|559702030|FG016|Treatment Period|Poor/Non-compliance|0|||
155074590|NCT01658878|559702031|FG017|Treatment Period|Poor/Non-compliance|0|||
155074591|NCT01658878|559702032|FG018|Treatment Period|Poor/Non-compliance|0|||
155074592|NCT01658878|559702033|FG019|Treatment Period|Poor/Non-compliance|0|||
155074593|NCT01658878|559702034|FG020|Treatment Period|Poor/Non-compliance|0|||
155074594|NCT01658878|559702035|FG021|Treatment Period|Poor/Non-compliance|0|||
155074595|NCT01658878|559702036|FG022|Treatment Period|Poor/Non-compliance|0|||
155074596|NCT01658878|559702037|FG023|Treatment Period|Poor/Non-compliance|0|||
155074597|NCT01658878|559702014|FG000|Treatment Period|Participant Withdrew Consent|0|||
155074598|NCT01658878|559702015|FG001|Treatment Period|Participant Withdrew Consent|0|||
155074599|NCT01658878|559702016|FG002|Treatment Period|Participant Withdrew Consent|0|||
155074600|NCT01658878|559702017|FG003|Treatment Period|Participant Withdrew Consent|0|||
155074601|NCT01658878|559702018|FG004|Treatment Period|Participant Withdrew Consent|0|||
155074602|NCT01658878|559702019|FG005|Treatment Period|Participant Withdrew Consent|0|||
155074603|NCT01658878|559702020|FG006|Treatment Period|Participant Withdrew Consent|0|||
155074604|NCT01658878|559702021|FG007|Treatment Period|Participant Withdrew Consent|0|||
155074605|NCT01658878|559702022|FG008|Treatment Period|Participant Withdrew Consent|0|||
155074606|NCT01658878|559702023|FG009|Treatment Period|Participant Withdrew Consent|0|||
155074607|NCT01658878|559702024|FG010|Treatment Period|Participant Withdrew Consent|0|||
155074608|NCT01658878|559702025|FG011|Treatment Period|Participant Withdrew Consent|0|||
155074609|NCT01658878|559702026|FG012|Treatment Period|Participant Withdrew Consent|1|||
155074610|NCT01658878|559702027|FG013|Treatment Period|Participant Withdrew Consent|0|||
155074611|NCT01658878|559702028|FG014|Treatment Period|Participant Withdrew Consent|2|||
155074612|NCT01658878|559702029|FG015|Treatment Period|Participant Withdrew Consent|0|||
155074613|NCT01658878|559702030|FG016|Treatment Period|Participant Withdrew Consent|0|||
155074614|NCT01658878|559702031|FG017|Treatment Period|Participant Withdrew Consent|2|||
155074615|NCT01658878|559702032|FG018|Treatment Period|Participant Withdrew Consent|1|||
155074616|NCT01658878|559702033|FG019|Treatment Period|Participant Withdrew Consent|2|||
155074617|NCT01658878|559702034|FG020|Treatment Period|Participant Withdrew Consent|1|||
155074618|NCT01658878|559702035|FG021|Treatment Period|Participant Withdrew Consent|0|||
155074619|NCT01658878|559702036|FG022|Treatment Period|Participant Withdrew Consent|2|||
155074620|NCT01658878|559702037|FG023|Treatment Period|Participant Withdrew Consent|2|||
155074621|NCT01658878|559702014|FG000|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074622|NCT01658878|559702015|FG001|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074623|NCT01658878|559702016|FG002|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074624|NCT01658878|559702017|FG003|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074625|NCT01658878|559702018|FG004|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074626|NCT01658878|559702019|FG005|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074627|NCT01658878|559702020|FG006|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074628|NCT01658878|559702021|FG007|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074629|NCT01658878|559702022|FG008|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074630|NCT01658878|559702023|FG009|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074631|NCT01658878|559702024|FG010|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074632|NCT01658878|559702025|FG011|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074633|NCT01658878|559702026|FG012|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155074634|NCT01658878|559702027|FG013|Treatment Period|Participant Request to Discontinue Study Treatment|4|||
155074635|NCT01658878|559702028|FG014|Treatment Period|Participant Request to Discontinue Study Treatment|3|||
155074636|NCT01658878|559702029|FG015|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155074637|NCT01658878|559702030|FG016|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155074638|NCT01658878|559702031|FG017|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155074639|NCT01658878|559702032|FG018|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074640|NCT01658878|559702033|FG019|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155074641|NCT01658878|559702034|FG020|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155074642|NCT01658878|559702035|FG021|Treatment Period|Participant Request to Discontinue Study Treatment|2|||
155074643|NCT01658878|559702036|FG022|Treatment Period|Participant Request to Discontinue Study Treatment|0|||
155074644|NCT01658878|559702037|FG023|Treatment Period|Participant Request to Discontinue Study Treatment|1|||
155074645|NCT01658878|559702014|FG000|Treatment Period|Adverse Event Related to Study Drug|0|||
155074646|NCT01658878|559702015|FG001|Treatment Period|Adverse Event Related to Study Drug|0|||
155074647|NCT01658878|559702016|FG002|Treatment Period|Adverse Event Related to Study Drug|0|||
155074648|NCT01658878|559702017|FG003|Treatment Period|Adverse Event Related to Study Drug|0|||
155074649|NCT01658878|559702018|FG004|Treatment Period|Adverse Event Related to Study Drug|0|||
155074650|NCT01658878|559702019|FG005|Treatment Period|Adverse Event Related to Study Drug|0|||
155074651|NCT01658878|559702020|FG006|Treatment Period|Adverse Event Related to Study Drug|0|||
155074652|NCT01658878|559702021|FG007|Treatment Period|Adverse Event Related to Study Drug|0|||
155074653|NCT01658878|559702022|FG008|Treatment Period|Adverse Event Related to Study Drug|0|||
155074654|NCT01658878|559702023|FG009|Treatment Period|Adverse Event Related to Study Drug|0|||
155074655|NCT01658878|559702024|FG010|Treatment Period|Adverse Event Related to Study Drug|0|||
155074656|NCT01658878|559702025|FG011|Treatment Period|Adverse Event Related to Study Drug|0|||
155074657|NCT01658878|559702026|FG012|Treatment Period|Adverse Event Related to Study Drug|0|||
155074658|NCT01658878|559702027|FG013|Treatment Period|Adverse Event Related to Study Drug|4|||
155074659|NCT01658878|559702028|FG014|Treatment Period|Adverse Event Related to Study Drug|6|||
155074660|NCT01658878|559702029|FG015|Treatment Period|Adverse Event Related to Study Drug|0|||
155074661|NCT01658878|559702030|FG016|Treatment Period|Adverse Event Related to Study Drug|0|||
155074662|NCT01658878|559702031|FG017|Treatment Period|Adverse Event Related to Study Drug|0|||
155074663|NCT01658878|559702032|FG018|Treatment Period|Adverse Event Related to Study Drug|0|||
155074664|NCT01658878|559702033|FG019|Treatment Period|Adverse Event Related to Study Drug|0|||
155074665|NCT01658878|559702034|FG020|Treatment Period|Adverse Event Related to Study Drug|0|||
155074666|NCT01658878|559702035|FG021|Treatment Period|Adverse Event Related to Study Drug|0|||
155074667|NCT01658878|559702036|FG022|Treatment Period|Adverse Event Related to Study Drug|0|||
155074668|NCT01658878|559702037|FG023|Treatment Period|Adverse Event Related to Study Drug|0|||
155074669|NCT01658878|559702014|FG000|Treatment Period|Death|0|||
155074670|NCT01658878|559702015|FG001|Treatment Period|Death|0|||
155074671|NCT01658878|559702016|FG002|Treatment Period|Death|0|||
155074672|NCT01658878|559702017|FG003|Treatment Period|Death|0|||
155074673|NCT01658878|559702018|FG004|Treatment Period|Death|0|||
155074674|NCT01658878|559702019|FG005|Treatment Period|Death|0|||
155074675|NCT01658878|559702020|FG006|Treatment Period|Death|0|||
155074676|NCT01658878|559702021|FG007|Treatment Period|Death|0|||
155074677|NCT01658878|559702022|FG008|Treatment Period|Death|0|||
155074678|NCT01658878|559702023|FG009|Treatment Period|Death|0|||
155074679|NCT01658878|559702024|FG010|Treatment Period|Death|0|||
155074680|NCT01658878|559702025|FG011|Treatment Period|Death|0|||
155074681|NCT01658878|559702026|FG012|Treatment Period|Death|1|||
155074682|NCT01658878|559702027|FG013|Treatment Period|Death|0|||
155074683|NCT01658878|559702028|FG014|Treatment Period|Death|0|||
155074684|NCT01658878|559702029|FG015|Treatment Period|Death|0|||
155074685|NCT01658878|559702030|FG016|Treatment Period|Death|1|||
155074686|NCT01658878|559702031|FG017|Treatment Period|Death|1|||
155074687|NCT01658878|559702032|FG018|Treatment Period|Death|0|||
155074688|NCT01658878|559702033|FG019|Treatment Period|Death|0|||
155074689|NCT01658878|559702034|FG020|Treatment Period|Death|0|||
155074690|NCT01658878|559702035|FG021|Treatment Period|Death|2|||
155074691|NCT01658878|559702036|FG022|Treatment Period|Death|0|||
155074692|NCT01658878|559702037|FG023|Treatment Period|Death|0|||
155074693|NCT01658878|559702014|FG000|Treatment Period|Adverse Event|0|||
155074694|NCT01658878|559702015|FG001|Treatment Period|Adverse Event|0|||
155074695|NCT01658878|559702016|FG002|Treatment Period|Adverse Event|0|||
155074696|NCT01658878|559702017|FG003|Treatment Period|Adverse Event|0|||
155074697|NCT01658878|559702018|FG004|Treatment Period|Adverse Event|0|||
155074698|NCT01658878|559702019|FG005|Treatment Period|Adverse Event|0|||
155074699|NCT01658878|559702020|FG006|Treatment Period|Adverse Event|0|||
155074700|NCT01658878|559702021|FG007|Treatment Period|Adverse Event|0|||
155074701|NCT01658878|559702022|FG008|Treatment Period|Adverse Event|0|||
155074702|NCT01658878|559702023|FG009|Treatment Period|Adverse Event|0|||
155074703|NCT01658878|559702024|FG010|Treatment Period|Adverse Event|0|||
155074704|NCT01658878|559702025|FG011|Treatment Period|Adverse Event|0|||
155074705|NCT01658878|559702026|FG012|Treatment Period|Adverse Event|0|||
155074706|NCT01658878|559702027|FG013|Treatment Period|Adverse Event|0|||
155074707|NCT01658878|559702028|FG014|Treatment Period|Adverse Event|0|||
155074708|NCT01658878|559702029|FG015|Treatment Period|Adverse Event|0|||
155074709|NCT01658878|559702030|FG016|Treatment Period|Adverse Event|10|||
155074710|NCT01658878|559702031|FG017|Treatment Period|Adverse Event|3|||
155074711|NCT01658878|559702032|FG018|Treatment Period|Adverse Event|3|||
155074712|NCT01658878|559702033|FG019|Treatment Period|Adverse Event|2|||
155074713|NCT01658878|559702034|FG020|Treatment Period|Adverse Event|3|||
155074714|NCT01658878|559702035|FG021|Treatment Period|Adverse Event|3|||
155074715|NCT01658878|559702036|FG022|Treatment Period|Adverse Event|4|||
155074716|NCT01658878|559702037|FG023|Treatment Period|Adverse Event|3|||
155074717|NCT01658878|559702014|FG000|Treatment Period|Lost to Follow-up|0|||
155074718|NCT01658878|559702015|FG001|Treatment Period|Lost to Follow-up|0|||
155074719|NCT01658878|559702016|FG002|Treatment Period|Lost to Follow-up|0|||
155074720|NCT01658878|559702017|FG003|Treatment Period|Lost to Follow-up|0|||
155074721|NCT01658878|559702018|FG004|Treatment Period|Lost to Follow-up|0|||
155074722|NCT01658878|559702019|FG005|Treatment Period|Lost to Follow-up|0|||
155074723|NCT01658878|559702020|FG006|Treatment Period|Lost to Follow-up|0|||
155074724|NCT01658878|559702021|FG007|Treatment Period|Lost to Follow-up|0|||
155074725|NCT01658878|559702022|FG008|Treatment Period|Lost to Follow-up|0|||
155074726|NCT01658878|559702023|FG009|Treatment Period|Lost to Follow-up|0|||
155074727|NCT01658878|559702024|FG010|Treatment Period|Lost to Follow-up|0|||
155074728|NCT01658878|559702025|FG011|Treatment Period|Lost to Follow-up|0|||
155074729|NCT01658878|559702026|FG012|Treatment Period|Lost to Follow-up|0|||
155074730|NCT01658878|559702027|FG013|Treatment Period|Lost to Follow-up|0|||
155074731|NCT01658878|559702028|FG014|Treatment Period|Lost to Follow-up|0|||
155074732|NCT01658878|559702029|FG015|Treatment Period|Lost to Follow-up|0|||
155074733|NCT01658878|559702030|FG016|Treatment Period|Lost to Follow-up|1|||
155074734|NCT01658878|559702031|FG017|Treatment Period|Lost to Follow-up|0|||
155074735|NCT01658878|559702032|FG018|Treatment Period|Lost to Follow-up|1|||
155074736|NCT01658878|559702033|FG019|Treatment Period|Lost to Follow-up|1|||
155074737|NCT01658878|559702034|FG020|Treatment Period|Lost to Follow-up|0|||
155074738|NCT01658878|559702035|FG021|Treatment Period|Lost to Follow-up|0|||
155074739|NCT01658878|559702036|FG022|Treatment Period|Lost to Follow-up|1|||
155074740|NCT01658878|559702037|FG023|Treatment Period|Lost to Follow-up|0|||
155074741|NCT03928704|559702043|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155074742|NCT03928704|559702044|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
155074743|NCT03928704|559702045|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155074744|NCT03928704|559702046|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155074745|NCT03928704|559702047|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155074746|NCT03928704|559702048|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
155074747|NCT03928704|559702043|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
155074748|NCT03928704|559702044|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155074749|NCT03928704|559702045|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155074750|NCT03928704|559702046|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155074751|NCT03928704|559702047|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155074752|NCT03928704|559702048|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
155074753|NCT03928704|559702043|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
155074754|NCT03928704|559702044|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155074755|NCT03928704|559702045|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155074756|NCT03928704|559702046|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155074757|NCT03928704|559702047|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155074758|NCT03928704|559702048|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
155074759|NCT03928704|559702043|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
155074760|NCT03928704|559702044|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
155074761|NCT03928704|559702045|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155074762|NCT03928704|559702046|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155074763|NCT03928704|559702047|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155074764|NCT03928704|559702048|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
155074765|NCT03928704|559702043|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155074766|NCT03928704|559702044|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155074767|NCT03928704|559702045|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
155074768|NCT03928704|559702046|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155074769|NCT03928704|559702047|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155074770|NCT03928704|559702048|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
155074771|NCT03928704|559702043|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155074772|NCT03928704|559702044|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155074773|NCT03928704|559702045|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
155074774|NCT03928704|559702046|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155074775|NCT03928704|559702047|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155074776|NCT03928704|559702048|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
155074777|NCT03928704|559702043|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
155074778|NCT03928704|559702044|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
155074779|NCT03928704|559702045|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
155341173|NCT01681511|560681379|FG000|Overall Study|No post-catheter sample collected|11|||
155074780|NCT03928704|559702046|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
155074781|NCT03928704|559702047|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
155074782|NCT03928704|559702048|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
155074783|NCT03928704|559702043|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155074784|NCT03928704|559702044|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155074785|NCT03928704|559702045|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
155074786|NCT03928704|559702046|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155074787|NCT03928704|559702047|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155074788|NCT03928704|559702048|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
155074789|NCT03928704|559702043|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155074790|NCT03928704|559702044|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155074791|NCT03928704|559702045|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155074792|NCT03928704|559702046|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155074793|NCT03928704|559702047|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
155074794|NCT03928704|559702048|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
155074795|NCT03928704|559702043|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
155074796|NCT03928704|559702044|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
155074797|NCT03928704|559702045|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
155074798|NCT03928704|559702046|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
155164483|NCT00760617|560038936|FG000|Overall Study|Lost to Follow-up|0|||
155164484|NCT00760617|560038937|FG001|Overall Study|Lost to Follow-up|0|||
155164485|NCT00760617|560038938|FG002|Overall Study|Lost to Follow-up|5|||
155164486|NCT01147874|560038940|FG000|Overall Study|Adverse Event|5|||
155164487|NCT01147874|560038940|FG000|Overall Study|Investigator's Request|1|||
155164488|NCT01147874|560038940|FG000|Overall Study|Lost to Follow-up|25|||
155164489|NCT01147874|560038940|FG000|Overall Study|Other|5|||
155164490|NCT01147874|560038940|FG000|Overall Study|Protocol Violation|5|||
155164491|NCT01147874|560038940|FG000|Overall Study|Sponsor's Decision|2|||
155164492|NCT01147874|560038940|FG000|Overall Study|Withdrawal by Subject|24|||
155164493|NCT04625101|560038943|FG000|Overall Study|Withdrawal by Subject|0|||
155164494|NCT04625101|560038944|FG001|Overall Study|Withdrawal by Subject|1|||
155164495|NCT04625101|560038943|FG000|Overall Study|Protocol Deviation|1|||
155164496|NCT04625101|560038944|FG001|Overall Study|Protocol Deviation|0|||
155164497|NCT02991040|560038945|FG000|Overall Study|Withdrawal by Subject|2|||
155164498|NCT02991040|560038945|FG000|Overall Study|Lost to Follow-up|2|||
155164499|NCT04287517|560038946|FG000|Overall Study|Withdrawal by Subject|1|||
155164500|NCT04287517|560038947|FG001|Overall Study|Withdrawal by Subject|1|||
155164501|NCT01869764|560038954|FG000|Overall Study|Withdrawal by Subject|0|||
155164502|NCT01869764|560038955|FG001|Overall Study|Withdrawal by Subject|2|||
155164503|NCT02175030|560038956|FG000|Overall Study|Failed screen after consent|7|||
155164504|NCT02175030|560038957|FG001|Overall Study|Failed screen after consent|6|||
155164505|NCT02175030|560038956|FG000|Overall Study|Failed IUD Insertion|20|||
155164506|NCT02175030|560038957|FG001|Overall Study|Failed IUD Insertion|21|||
155164507|NCT02175030|560038956|FG000|Overall Study|Physician Decision|1|||
155164508|NCT02175030|560038957|FG001|Overall Study|Physician Decision|1|||
155164509|NCT02175030|560038956|FG000|Overall Study|Lost to Follow-up|6|||
155164510|NCT02175030|560038957|FG001|Overall Study|Lost to Follow-up|6|||
155164511|NCT02175030|560038956|FG000|Overall Study|Withdrawal by Subject|1|||
155164512|NCT02175030|560038957|FG001|Overall Study|Withdrawal by Subject|4|||
155164513|NCT02533453|560038958|FG000|Overall Study|Adverse Event|6|||
155164514|NCT02533453|560038958|FG000|Overall Study|Protocol Violation|1|||
155164515|NCT02533453|560038958|FG000|Overall Study|Withdrawal by Subject|2|||
155164516|NCT00885534|560038959|FG000|Overall Study|Patient deemed ineligible|1|||
155164517|NCT02453711|560038960|FG000|Overall Study|Withdrawal by Subject|5|||
155164518|NCT02453711|560038961|FG001|Overall Study|Withdrawal by Subject|4|||
155164519|NCT02453711|560038962|FG002|Overall Study|Withdrawal by Subject|6|||
155164520|NCT02453711|560038963|FG003|Overall Study|Withdrawal by Subject|4|||
155164521|NCT02453711|560038964|FG004|Overall Study|Withdrawal by Subject|1|||
155164522|NCT02453711|560038965|FG005|Overall Study|Withdrawal by Subject|1|||
155164523|NCT02453711|560038966|FG006|Overall Study|Withdrawal by Subject|0|||
155164524|NCT02453711|560038967|FG007|Overall Study|Withdrawal by Subject|1|||
155164525|NCT02453711|560038968|FG008|Overall Study|Withdrawal by Subject|7|||
155164526|NCT02453711|560038960|FG000|Overall Study|Lost to Follow-up|5|||
155164527|NCT02453711|560038961|FG001|Overall Study|Lost to Follow-up|3|||
155164528|NCT02453711|560038962|FG002|Overall Study|Lost to Follow-up|2|||
155164529|NCT02453711|560038963|FG003|Overall Study|Lost to Follow-up|3|||
155164530|NCT02453711|560038964|FG004|Overall Study|Lost to Follow-up|1|||
155164531|NCT02453711|560038965|FG005|Overall Study|Lost to Follow-up|5|||
155164532|NCT02453711|560038966|FG006|Overall Study|Lost to Follow-up|2|||
155164533|NCT02453711|560038967|FG007|Overall Study|Lost to Follow-up|6|||
155164534|NCT02453711|560038968|FG008|Overall Study|Lost to Follow-up|6|||
155164535|NCT02453711|560038960|FG000|Overall Study|Death|0|||
155164536|NCT02453711|560038961|FG001|Overall Study|Death|0|||
155164537|NCT02453711|560038962|FG002|Overall Study|Death|0|||
155164538|NCT02453711|560038963|FG003|Overall Study|Death|0|||
155074799|NCT03928704|559702047|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
155074800|NCT03928704|559702048|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
155074801|NCT05141357|559702050|FG000|Overall Study|Adverse Event|3|||
155074802|NCT05141357|559702050|FG000|Overall Study|Lack of Efficacy|2|||
155074807|NCT05887908|559702054|FG000|Overall Study|Adverse Event|6|||
155074808|NCT05887908|559702055|FG001|Overall Study|Adverse Event|1|||
155074809|NCT05887908|559702056|FG002|Overall Study|Adverse Event|1|||
155074810|NCT05887908|559702054|FG000|Overall Study|Physician Decision|4|||
155074811|NCT05887908|559702055|FG001|Overall Study|Physician Decision|1|||
155074812|NCT05887908|559702056|FG002|Overall Study|Physician Decision|0|||
155074813|NCT05887908|559702054|FG000|Overall Study|Withdrawal by Subject|3|||
155074814|NCT05887908|559702055|FG001|Overall Study|Withdrawal by Subject|2|||
155074815|NCT05887908|559702056|FG002|Overall Study|Withdrawal by Subject|3|||
155074816|NCT05887908|559702054|FG000|Overall Study|Ineligibility after the start of the study|4|||
155074817|NCT05887908|559702055|FG001|Overall Study|Ineligibility after the start of the study|1|||
155074818|NCT05887908|559702056|FG002|Overall Study|Ineligibility after the start of the study|0|||
155074819|NCT05887908|559702054|FG000|Overall Study|Subject non-compliance|4|||
155074820|NCT05887908|559702055|FG001|Overall Study|Subject non-compliance|0|||
155074821|NCT05887908|559702056|FG002|Overall Study|Subject non-compliance|4|||
155074822|NCT05887908|559702054|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
155074823|NCT05887908|559702055|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
155074824|NCT05887908|559702056|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
155074825|NCT05887908|559702054|FG000|Overall Study|Pregnancy|0|||
155074826|NCT05887908|559702055|FG001|Overall Study|Pregnancy|1|||
155074827|NCT05887908|559702056|FG002|Overall Study|Pregnancy|0|||
155074828|NCT05887908|559702054|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
155074829|NCT05887908|559702055|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
155074830|NCT05887908|559702056|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
155074831|NCT05887908|559702054|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
155074832|NCT05887908|559702055|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
155074833|NCT05887908|559702056|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
155074834|NCT05887908|559702054|FG000|Overall Study|Other Reason|3|||
155074835|NCT05887908|559702055|FG001|Overall Study|Other Reason|3|||
155074836|NCT05887908|559702056|FG002|Overall Study|Other Reason|3|||
155074837|NCT03928743|559702062|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
155074838|NCT03928743|559702063|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
155074839|NCT03928743|559702064|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
155074840|NCT03928743|559702062|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
155074841|NCT03928743|559702063|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
155074842|NCT03928743|559702064|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
155074843|NCT03928743|559702062|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
155074844|NCT03928743|559702063|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
155074845|NCT03928743|559702064|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
155074846|NCT03928743|559702062|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
155074847|NCT03928743|559702063|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
155074848|NCT03928743|559702064|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
155074849|NCT03928743|559702062|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
155074850|NCT03928743|559702063|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
155074851|NCT03928743|559702064|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
155074852|NCT03928743|559702062|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
155074853|NCT03928743|559702063|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
155074854|NCT03928743|559702064|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
155074855|NCT03928743|559702062|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
155074856|NCT03928743|559702063|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
155074857|NCT03928743|559702064|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
155074858|NCT03928743|559702062|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
155074859|NCT03928743|559702063|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
155074860|NCT03928743|559702064|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
155074861|NCT03928743|559702062|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
155074862|NCT03928743|559702063|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
155341174|NCT01681511|560681380|FG001|Overall Study|No post-catheter sample collected|4|||
155074863|NCT03928743|559702064|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
155341175|NCT01156675|560681381|FG000|Overall Study|Death|5|||
155341176|NCT01156675|560681382|FG001|Overall Study|Death|3|||
155074864|NCT03928743|559702062|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
155074865|NCT03928743|559702063|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
155074866|NCT03928743|559702064|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
155074867|NCT03928743|559702062|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
155074868|NCT03928743|559702063|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
155074869|NCT03928743|559702064|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
155074870|NCT04740567|559702067|FG000|Overall Study|Death|31|||
155074871|NCT04740567|559702068|FG001|Overall Study|Death|43|||
155074872|NCT04740567|559702067|FG000|Overall Study|Lost to Follow-up|2|||
155074873|NCT04740567|559702068|FG001|Overall Study|Lost to Follow-up|11|||
155074874|NCT04740567|559702067|FG000|Overall Study|Patient declined to participate|13|||
155074875|NCT04740567|559702068|FG001|Overall Study|Patient declined to participate|26|||
155074876|NCT04740567|559702067|FG000|Overall Study|Patient was physically incapable|1|||
155074877|NCT04740567|559702068|FG001|Overall Study|Patient was physically incapable|3|||
155074878|NCT04740567|559702067|FG000|Overall Study|Patient's spouse was had prolongued ICU stay|0|||
155074879|NCT04740567|559702068|FG001|Overall Study|Patient's spouse was had prolongued ICU stay|1|||
155074880|NCT06204887|559702071|FG000|Overall Study|Lost to Follow-up|3|||
155074881|NCT06204887|559702072|FG001|Overall Study|Lost to Follow-up|4|||
155074882|NCT06204887|559702073|FG002|Overall Study|Lost to Follow-up|1|||
155074883|NCT06204887|559702074|FG003|Overall Study|Lost to Follow-up|6|||
155074908|NCT06132386|559702079|FG000|Overall Study|ineligble laboratory|1|||
155074909|NCT06132386|559702080|FG001|Overall Study|ineligble laboratory|0|||
155074910|NCT06132386|559702081|FG002|Overall Study|ineligble laboratory|0|||
155074911|NCT06132386|559702082|FG003|Overall Study|ineligble laboratory|0|||
155074912|NCT06132386|559702083|FG004|Overall Study|ineligble laboratory|1|||
155074913|NCT06132386|559702084|FG005|Overall Study|ineligble laboratory|0|||
155074914|NCT06132386|559702079|FG000|Overall Study|ineligible vital signs|0|||
155074915|NCT06132386|559702080|FG001|Overall Study|ineligible vital signs|1|||
155074916|NCT06132386|559702081|FG002|Overall Study|ineligible vital signs|0|||
155074917|NCT06132386|559702082|FG003|Overall Study|ineligible vital signs|0|||
155074918|NCT06132386|559702083|FG004|Overall Study|ineligible vital signs|0|||
155074919|NCT06132386|559702084|FG005|Overall Study|ineligible vital signs|0|||
155074928|NCT03833167|559702087|FG000|Overall Study|Withdrawal by Subject|4|||
155074929|NCT03833167|559702088|FG001|Overall Study|Withdrawal by Subject|6|||
155074930|NCT03833167|559702087|FG000|Overall Study|Ongoing|186|||
155074931|NCT03833167|559702088|FG001|Overall Study|Ongoing|194|||
155074932|NCT03833167|559702087|FG000|Overall Study|Lost to Follow-up|1|||
155074933|NCT03833167|559702088|FG001|Overall Study|Lost to Follow-up|1|||
155074934|NCT03833167|559702087|FG000|Overall Study|Physician Decision|0|||
155074935|NCT03833167|559702088|FG001|Overall Study|Physician Decision|2|||
155074936|NCT03833167|559702087|FG000|Overall Study|Death|34|||
155074937|NCT03833167|559702088|FG001|Overall Study|Death|22|||
155074938|NCT05128942|559702091|FG000|Overall Study|Withdrawal by Subject|1|||
155074939|NCT05128942|559702092|FG001|Overall Study|Withdrawal by Subject|0|||
155074940|NCT05128942|559702093|FG002|Overall Study|Withdrawal by Subject|1|||
155074941|NCT05128942|559702094|FG003|Overall Study|Withdrawal by Subject|0|||
155074942|NCT05128942|559702095|FG004|Overall Study|Withdrawal by Subject|0|||
155074943|NCT05128942|559702096|FG005|Overall Study|Withdrawal by Subject|0|||
155074944|NCT05128942|559702097|FG006|Overall Study|Withdrawal by Subject|0|||
155074945|NCT05128942|559702098|FG007|Overall Study|Withdrawal by Subject|0|||
155074946|NCT05128942|559702099|FG008|Overall Study|Withdrawal by Subject|0|||
155074947|NCT05128942|559702091|FG000|Overall Study|Other|2|||
155074948|NCT05128942|559702092|FG001|Overall Study|Other|0|||
155074949|NCT05128942|559702093|FG002|Overall Study|Other|2|||
155074950|NCT05128942|559702094|FG003|Overall Study|Other|0|||
155074951|NCT05128942|559702095|FG004|Overall Study|Other|0|||
155074952|NCT05128942|559702096|FG005|Overall Study|Other|0|||
155074953|NCT05128942|559702097|FG006|Overall Study|Other|0|||
155074954|NCT05128942|559702098|FG007|Overall Study|Other|0|||
155074955|NCT05128942|559702099|FG008|Overall Study|Other|0|||
155074956|NCT05128942|559702091|FG000|Overall Study|Termination by Sponsor|2|||
155074957|NCT05128942|559702092|FG001|Overall Study|Termination by Sponsor|6|||
155074958|NCT05128942|559702093|FG002|Overall Study|Termination by Sponsor|14|||
155074959|NCT05128942|559702094|FG003|Overall Study|Termination by Sponsor|2|||
155074960|NCT05128942|559702095|FG004|Overall Study|Termination by Sponsor|4|||
155074961|NCT05128942|559702096|FG005|Overall Study|Termination by Sponsor|8|||
155074962|NCT05128942|559702097|FG006|Overall Study|Termination by Sponsor|11|||
155074963|NCT05128942|559702098|FG007|Overall Study|Termination by Sponsor|6|||
155074964|NCT05128942|559702099|FG008|Overall Study|Termination by Sponsor|0|||
155074965|NCT05128942|559702091|FG000|Overall Study|Adverse Event|0|||
155074966|NCT05128942|559702092|FG001|Overall Study|Adverse Event|0|||
155074967|NCT05128942|559702093|FG002|Overall Study|Adverse Event|0|||
155074968|NCT05128942|559702094|FG003|Overall Study|Adverse Event|0|||
155074969|NCT05128942|559702095|FG004|Overall Study|Adverse Event|0|||
155074970|NCT05128942|559702096|FG005|Overall Study|Adverse Event|0|||
155074971|NCT05128942|559702097|FG006|Overall Study|Adverse Event|1|||
155074972|NCT05128942|559702098|FG007|Overall Study|Adverse Event|1|||
155074973|NCT05128942|559702099|FG008|Overall Study|Adverse Event|0|||
155074974|NCT05128942|559702091|FG000|Overall Study|Lost to Follow-up|0|||
155074975|NCT05128942|559702092|FG001|Overall Study|Lost to Follow-up|0|||
155074976|NCT05128942|559702093|FG002|Overall Study|Lost to Follow-up|0|||
155074977|NCT05128942|559702094|FG003|Overall Study|Lost to Follow-up|0|||
155074978|NCT05128942|559702095|FG004|Overall Study|Lost to Follow-up|1|||
155074979|NCT05128942|559702096|FG005|Overall Study|Lost to Follow-up|0|||
155074980|NCT05128942|559702097|FG006|Overall Study|Lost to Follow-up|0|||
155074981|NCT05128942|559702098|FG007|Overall Study|Lost to Follow-up|0|||
155074982|NCT05128942|559702099|FG008|Overall Study|Lost to Follow-up|0|||
155341177|NCT01156675|560681383|FG002|Overall Study|Death|0|||
155341178|NCT01156675|560681381|FG000|Overall Study|No data|29|||
155341179|NCT01156675|560681382|FG001|Overall Study|No data|22|||
155341180|NCT01156675|560681383|FG002|Overall Study|No data|2|||
155075009|NCT05182125|559702110|FG000|Overall Study|Withdrawal by Subject|0|||
155075010|NCT05182125|559702111|FG001|Overall Study|Withdrawal by Subject|0|||
155075011|NCT05182125|559702112|FG002|Overall Study|Withdrawal by Subject|0|||
155075012|NCT05182125|559702113|FG003|Overall Study|Withdrawal by Subject|0|||
155075013|NCT05182125|559702114|FG004|Overall Study|Withdrawal by Subject|2|||
155092656|NCT00854360|559773650|FG000|Overall Study|Lack of Efficacy|2|||
155341181|NCT00090519|560681397|FG000|Overall Study|Adverse Event|5|||
155341182|NCT00090519|560681398|FG001|Overall Study|Adverse Event|4|||
155341183|NCT00090519|560681397|FG000|Overall Study|Death|9|||
154962697|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
154962698|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962699|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962700|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962701|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962702|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962703|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962704|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962705|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962706|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962707|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962708|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
154962709|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
154962710|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962711|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
154962712|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962713|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962714|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962715|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962716|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962717|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962718|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962719|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962720|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962721|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962722|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
154962723|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
154962724|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962725|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
154962726|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962727|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962728|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962729|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962730|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962731|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962732|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962733|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962734|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962735|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962736|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
154962737|NCT01695239|559289552|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
154962738|NCT01695239|559289553|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962739|NCT01695239|559289554|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962740|NCT01695239|559289555|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962741|NCT01695239|559289556|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962742|NCT01695239|559289557|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962743|NCT01695239|559289558|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962744|NCT01695239|559289559|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962745|NCT01695239|559289560|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962746|NCT01695239|559289561|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962747|NCT01695239|559289562|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962748|NCT01695239|559289563|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962749|NCT01695239|559289564|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962750|NCT01695239|559289565|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
154962751|NCT01695239|559289552|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962752|NCT01695239|559289553|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962753|NCT01695239|559289554|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962754|NCT01695239|559289555|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962755|NCT01695239|559289556|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962756|NCT01695239|559289557|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962757|NCT01695239|559289558|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
155341184|NCT00090519|560681398|FG001|Overall Study|Death|9|||
155341185|NCT00090519|560681397|FG000|Overall Study|Lost to Follow-up|26|||
155341186|NCT00090519|560681398|FG001|Overall Study|Lost to Follow-up|29|||
155341187|NCT00090519|560681397|FG000|Overall Study|Withdrawal by Subject|28|||
155341188|NCT00090519|560681398|FG001|Overall Study|Withdrawal by Subject|29|||
155341189|NCT00090519|560681397|FG000|Overall Study|Physician Decision|2|||
155341190|NCT00090519|560681398|FG001|Overall Study|Physician Decision|3|||
155341191|NCT00090519|560681397|FG000|Overall Study|Sponsor Decision|3|||
155341192|NCT00090519|560681398|FG001|Overall Study|Sponsor Decision|1|||
155341193|NCT00116649|560681399|FG000|Overall Study|Adverse Event|20|||
155341194|NCT00116649|560681399|FG000|Overall Study|Lack of Efficacy|1|||
155341195|NCT00116649|560681399|FG000|Overall Study|Lost to Follow-up|32|||
155341196|NCT00116649|560681399|FG000|Overall Study|Withdrawal by Subject|68|||
155341197|NCT00116649|560681399|FG000|Overall Study|Local Skin Reaction|9|||
154962758|NCT01695239|559289559|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
154962759|NCT01695239|559289560|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962760|NCT01695239|559289561|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962761|NCT01695239|559289562|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962762|NCT01695239|559289563|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962763|NCT01695239|559289564|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962764|NCT01695239|559289565|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
154962765|NCT01695239|559289552|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962766|NCT01695239|559289553|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962767|NCT01695239|559289554|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962768|NCT01695239|559289555|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962769|NCT01695239|559289556|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962770|NCT01695239|559289557|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962771|NCT01695239|559289558|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962772|NCT01695239|559289559|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
154962773|NCT01695239|559289560|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962774|NCT01695239|559289561|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962775|NCT01695239|559289562|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962776|NCT01695239|559289563|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962777|NCT01695239|559289564|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962778|NCT01695239|559289565|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
154962779|NCT01695239|559289552|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962780|NCT01695239|559289553|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962781|NCT01695239|559289554|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962782|NCT01695239|559289555|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962783|NCT01695239|559289556|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962784|NCT01695239|559289557|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962785|NCT01695239|559289558|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962786|NCT01695239|559289559|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
154962787|NCT01695239|559289560|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962788|NCT01695239|559289561|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962789|NCT01695239|559289562|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962790|NCT01695239|559289563|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962791|NCT01695239|559289564|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962792|NCT01695239|559289565|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
154962793|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962794|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962795|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962796|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962797|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962798|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962799|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962800|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962801|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
154962802|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
154962803|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962804|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962805|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962806|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
154962807|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
154962808|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
154962809|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
154962810|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
154962811|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
154962812|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
154962813|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
154962814|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
154962815|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
154962816|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
154962817|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
154962818|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
154962819|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
154962820|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
154962821|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962822|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962823|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962824|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962825|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962826|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962827|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962828|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962829|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
154962830|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
154962831|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962832|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962833|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962834|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
154962835|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
154962836|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
154962837|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
154962838|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
154962839|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
154962840|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
154962841|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
154962842|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
154962843|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
154962844|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
154962845|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
154962846|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
154962847|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
154962848|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
154962849|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962850|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962851|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962852|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962853|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962854|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962855|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962856|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962857|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
154962858|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
154962859|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962860|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962861|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
154962862|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
155341198|NCT00116649|560681399|FG000|Overall Study|Various Reasons|18|||
155075014|NCT05182125|559702115|FG005|Overall Study|Withdrawal by Subject|0|||
155075015|NCT05182125|559702110|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
155075016|NCT05182125|559702111|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
155075017|NCT05182125|559702112|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
155075018|NCT05182125|559702113|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
155075019|NCT05182125|559702114|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
155075020|NCT05182125|559702115|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
155075021|NCT05182125|559702110|FG000|Overall Study|Death|0|||
155075022|NCT05182125|559702111|FG001|Overall Study|Death|0|||
155075023|NCT05182125|559702112|FG002|Overall Study|Death|0|||
155075024|NCT05182125|559702113|FG003|Overall Study|Death|0|||
155075025|NCT05182125|559702114|FG004|Overall Study|Death|1|||
155075026|NCT05182125|559702115|FG005|Overall Study|Death|0|||
155075027|NCT03003962|559702116|FG000|Overall Study|Withdrawal by Subject|5|||
155075028|NCT03003962|559702117|FG001|Overall Study|Withdrawal by Subject|17|||
155075029|NCT03003962|559702116|FG000|Overall Study|Death|274|||
155075030|NCT03003962|559702117|FG001|Overall Study|Death|277|||
155075031|NCT03003962|559702116|FG000|Overall Study|Participants ongoing at DCO|55|||
155075032|NCT03003962|559702117|FG001|Overall Study|Participants ongoing at DCO|40|||
155075033|NCT05887401|559702118|FG000|Overall Study|Withdrawal by Subject|0|||
155075034|NCT05887401|559702119|FG001|Overall Study|Withdrawal by Subject|0|||
155075035|NCT05887401|559702120|FG002|Overall Study|Withdrawal by Subject|0|||
155075036|NCT05887401|559702121|FG003|Overall Study|Withdrawal by Subject|0|||
155075037|NCT05887401|559702122|FG004|Overall Study|Withdrawal by Subject|0|||
155075038|NCT05887401|559702123|FG005|Overall Study|Withdrawal by Subject|0|||
155075039|NCT05887401|559702124|FG006|Overall Study|Withdrawal by Subject|0|||
155075040|NCT05887401|559702125|FG007|Overall Study|Withdrawal by Subject|0|||
155075041|NCT05887401|559702126|FG008|Overall Study|Withdrawal by Subject|0|||
155075042|NCT05887401|559702127|FG009|Overall Study|Withdrawal by Subject|1|||
155075043|NCT05887401|559702128|FG010|Overall Study|Withdrawal by Subject|0|||
155075044|NCT05887401|559702129|FG011|Overall Study|Withdrawal by Subject|0|||
155075045|NCT05887401|559702130|FG012|Overall Study|Withdrawal by Subject|0|||
155075046|NCT05887401|559702131|FG013|Overall Study|Withdrawal by Subject|0|||
155075047|NCT05887401|559702132|FG014|Overall Study|Withdrawal by Subject|0|||
155075048|NCT05887401|559702133|FG015|Overall Study|Withdrawal by Subject|1|||
155075049|NCT05887401|559702118|FG000|Overall Study|Lost to Follow-up|0|||
155075050|NCT05887401|559702119|FG001|Overall Study|Lost to Follow-up|1|||
155075051|NCT05887401|559702120|FG002|Overall Study|Lost to Follow-up|1|||
155075052|NCT05887401|559702121|FG003|Overall Study|Lost to Follow-up|2|||
155075053|NCT05887401|559702122|FG004|Overall Study|Lost to Follow-up|0|||
155075054|NCT05887401|559702123|FG005|Overall Study|Lost to Follow-up|0|||
155075055|NCT05887401|559702124|FG006|Overall Study|Lost to Follow-up|0|||
155075056|NCT05887401|559702125|FG007|Overall Study|Lost to Follow-up|0|||
155075057|NCT05887401|559702126|FG008|Overall Study|Lost to Follow-up|1|||
155075058|NCT05887401|559702127|FG009|Overall Study|Lost to Follow-up|1|||
155075059|NCT05887401|559702128|FG010|Overall Study|Lost to Follow-up|2|||
155075060|NCT05887401|559702129|FG011|Overall Study|Lost to Follow-up|1|||
155075061|NCT05887401|559702130|FG012|Overall Study|Lost to Follow-up|0|||
155075062|NCT05887401|559702131|FG013|Overall Study|Lost to Follow-up|0|||
155075063|NCT05887401|559702132|FG014|Overall Study|Lost to Follow-up|0|||
155164539|NCT02453711|560038964|FG004|Overall Study|Death|0|||
155164540|NCT02453711|560038965|FG005|Overall Study|Death|0|||
155075064|NCT05887401|559702133|FG015|Overall Study|Lost to Follow-up|0|||
155075065|NCT04530526|559702134|FG000|Overall Study|Withdrawal by Subject|6|||
155075066|NCT05179603|559702135|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155075067|NCT05179603|559702135|FG000|Overall Study|Withdrawal by Subject|1|||
155075068|NCT05179603|559702135|FG000|Overall Study|Progressive disease|4|||
155075069|NCT05179603|559702135|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
155075070|NCT05937373|559702136|FG000|Overall Study|Out of Window|2|||
155075071|NCT05937373|559702137|FG001|Overall Study|Out of Window|0|||
155164541|NCT02453711|560038966|FG006|Overall Study|Death|1|||
154962863|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962864|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962865|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962866|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962867|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962868|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962869|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962870|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962871|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
154962872|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
154962873|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962874|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962875|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962876|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
154962877|NCT01695239|559289552|FG000|Extension Long-Term Extension Periods|Death|0|||
154962878|NCT01695239|559289553|FG001|Extension Long-Term Extension Periods|Death|0|||
154962879|NCT01695239|559289554|FG002|Extension Long-Term Extension Periods|Death|0|||
154962880|NCT01695239|559289555|FG003|Extension Long-Term Extension Periods|Death|0|||
154962881|NCT01695239|559289556|FG004|Extension Long-Term Extension Periods|Death|0|||
154962882|NCT01695239|559289557|FG005|Extension Long-Term Extension Periods|Death|0|||
154962883|NCT01695239|559289558|FG006|Extension Long-Term Extension Periods|Death|0|||
154962884|NCT01695239|559289559|FG007|Extension Long-Term Extension Periods|Death|0|||
154962885|NCT01695239|559289560|FG008|Extension Long-Term Extension Periods|Death|1|||
154962886|NCT01695239|559289561|FG009|Extension Long-Term Extension Periods|Death|0|||
154962887|NCT01695239|559289562|FG010|Extension Long-Term Extension Periods|Death|0|||
154962888|NCT01695239|559289563|FG011|Extension Long-Term Extension Periods|Death|0|||
154962889|NCT01695239|559289564|FG012|Extension Long-Term Extension Periods|Death|0|||
154962890|NCT01695239|559289565|FG013|Extension Long-Term Extension Periods|Death|0|||
154962891|NCT01695239|559289552|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962892|NCT01695239|559289553|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962893|NCT01695239|559289554|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962894|NCT01695239|559289555|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962895|NCT01695239|559289556|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962896|NCT01695239|559289557|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962897|NCT01695239|559289558|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962898|NCT01695239|559289559|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962899|NCT01695239|559289560|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962900|NCT01695239|559289561|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962901|NCT01695239|559289562|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154962902|NCT01695239|559289563|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
154962903|NCT01695239|559289564|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
154962904|NCT01695239|559289565|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
154962905|NCT01695239|559289552|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962906|NCT01695239|559289553|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962907|NCT01695239|559289554|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962908|NCT01695239|559289555|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962909|NCT01695239|559289556|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962910|NCT01695239|559289557|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962911|NCT01695239|559289558|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962912|NCT01695239|559289559|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962913|NCT01695239|559289560|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962914|NCT01695239|559289561|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962915|NCT01695239|559289562|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962916|NCT01695239|559289563|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154962917|NCT01695239|559289564|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
154962918|NCT01695239|559289565|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
154962919|NCT01695239|559289552|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962920|NCT01695239|559289553|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962921|NCT01695239|559289554|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962922|NCT01695239|559289555|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962923|NCT01695239|559289556|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962924|NCT01695239|559289557|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962925|NCT01695239|559289558|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962926|NCT01695239|559289559|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962927|NCT01695239|559289560|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
155075072|NCT05937373|559702136|FG000|Overall Study|Device fell off prior to date of surgery|0|||
155075073|NCT05937373|559702137|FG001|Overall Study|Device fell off prior to date of surgery|2|||
155075074|NCT06461455|559702138|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
155075075|NCT06461455|559702139|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
155075076|NCT06461455|559702138|FG000|First Wear Period (Approx 30 Days)|Screen failure|1|||
155075077|NCT06461455|559702139|FG001|First Wear Period (Approx 30 Days)|Screen failure|0|||
155075078|NCT06461455|559702138|FG000|Washout Period (Approx 2-4 Days)|Adverse Event|0|||
155075079|NCT06461455|559702139|FG001|Washout Period (Approx 2-4 Days)|Adverse Event|1|||
155075088|NCT06142383|559702145|FG000|Overall Study|Mis-randomized|0|||
155075089|NCT06142383|559702146|FG001|Overall Study|Mis-randomized|0|||
155075090|NCT06142383|559702147|FG002|Overall Study|Mis-randomized|1|||
155075091|NCT06142383|559702148|FG003|Overall Study|Mis-randomized|0|||
155075092|NCT06142383|559702149|FG004|Overall Study|Mis-randomized|0|||
155075093|NCT06142383|559702145|FG000|Overall Study|Adverse Event|0|||
155075094|NCT06142383|559702146|FG001|Overall Study|Adverse Event|1|||
155075095|NCT06142383|559702147|FG002|Overall Study|Adverse Event|1|||
155075096|NCT06142383|559702148|FG003|Overall Study|Adverse Event|0|||
155075097|NCT06142383|559702149|FG004|Overall Study|Adverse Event|0|||
155075098|NCT06142383|559702145|FG000|Overall Study|Death|0|||
155075099|NCT06142383|559702146|FG001|Overall Study|Death|1|||
155075100|NCT06142383|559702147|FG002|Overall Study|Death|3|||
155075101|NCT06142383|559702148|FG003|Overall Study|Death|0|||
155075102|NCT06142383|559702149|FG004|Overall Study|Death|1|||
155075103|NCT06142383|559702145|FG000|Overall Study|Study Terminated by Sponsor|20|||
155075104|NCT06142383|559702146|FG001|Overall Study|Study Terminated by Sponsor|17|||
155075105|NCT06142383|559702147|FG002|Overall Study|Study Terminated by Sponsor|33|||
155075106|NCT06142383|559702148|FG003|Overall Study|Study Terminated by Sponsor|0|||
155075107|NCT06142383|559702149|FG004|Overall Study|Study Terminated by Sponsor|21|||
155075108|NCT06142383|559702145|FG000|Overall Study|Subject Decision|0|||
155075109|NCT06142383|559702146|FG001|Overall Study|Subject Decision|1|||
155075110|NCT06142383|559702147|FG002|Overall Study|Subject Decision|2|||
155075111|NCT06142383|559702148|FG003|Overall Study|Subject Decision|0|||
155075112|NCT06142383|559702149|FG004|Overall Study|Subject Decision|0|||
155075113|NCT06991803|559702699|FG000|Overall Study|Lost to Follow-up|0|||
155075114|NCT06991803|559702700|FG001|Overall Study|Lost to Follow-up|4|||
155075115|NCT06991803|559702701|FG002|Overall Study|Lost to Follow-up|0|||
155075116|NCT06991803|559702702|FG003|Overall Study|Lost to Follow-up|3|||
155075117|NCT06991803|559702703|FG004|Overall Study|Lost to Follow-up|2|||
155075118|NCT06991803|559702704|FG005|Overall Study|Lost to Follow-up|5|||
155075121|NCT03514017|559702711|FG000|Overall Study|Death|1|||
155075122|NCT03514017|559702711|FG000|Overall Study|Adverse Event|1|||
155341199|NCT00116649|560681399|FG000|Overall Study|Protocol Specified|7|||
155341200|NCT02161146|560681400|FG000|Overall Study|Adverse Event|1|||
155341201|NCT02161146|560681401|FG001|Overall Study|Adverse Event|1|||
155075195|NCT06394323|559702716|FG000|Overall Study|Death|0|||
155075196|NCT06394323|559702717|FG001|Overall Study|Death|1|||
155075197|NCT06394323|559702718|FG002|Overall Study|Death|0|||
155075198|NCT06394323|559702719|FG003|Overall Study|Death|0|||
155075199|NCT06394323|559702716|FG000|Overall Study|Physician Decision|0|||
155075200|NCT06394323|559702717|FG001|Overall Study|Physician Decision|2|||
155075201|NCT06394323|559702718|FG002|Overall Study|Physician Decision|0|||
155075202|NCT06394323|559702719|FG003|Overall Study|Physician Decision|0|||
155075203|NCT06394323|559702716|FG000|Overall Study|Withdrawal by Subject|4|||
155075204|NCT06394323|559702717|FG001|Overall Study|Withdrawal by Subject|4|||
155075205|NCT06394323|559702718|FG002|Overall Study|Withdrawal by Subject|0|||
155075206|NCT06394323|559702719|FG003|Overall Study|Withdrawal by Subject|0|||
155092657|NCT00854360|559773651|FG001|Overall Study|Lack of Efficacy|1|||
155092658|NCT00854360|559773652|FG002|Overall Study|Lack of Efficacy|0|||
155092659|NCT00854360|559773653|FG003|Overall Study|Lack of Efficacy|0|||
155092660|NCT00854360|559773650|FG000|Overall Study|Other|0|||
155092661|NCT00854360|559773651|FG001|Overall Study|Other|0|||
155092662|NCT00854360|559773652|FG002|Overall Study|Other|0|||
155092663|NCT00854360|559773653|FG003|Overall Study|Other|3|||
155075207|NCT03600350|559703903|FG000|Overall Study|Death|1|||
155075208|NCT03600350|559703903|FG000|Overall Study|On Follow Up|18|||
155075209|NCT02400736|559703906|FG000|Overall Study|Lost to Follow-up|6|||
155075210|NCT02400736|559703907|FG001|Overall Study|Lost to Follow-up|6|||
155075211|NCT02400736|559703906|FG000|Overall Study|Withdrawal by Subject|2|||
155075212|NCT02400736|559703907|FG001|Overall Study|Withdrawal by Subject|1|||
155075213|NCT02400736|559703906|FG000|Overall Study|Moved from the area|3|||
155075214|NCT02400736|559703907|FG001|Overall Study|Moved from the area|1|||
155075215|NCT01002105|559703908|FG000|Overall Study|Lost to Follow-up|10|||
155075216|NCT01002105|559703909|FG001|Overall Study|Lost to Follow-up|16|||
155075217|NCT01002105|559703908|FG000|Overall Study|non compliance|5|||
155075218|NCT01002105|559703909|FG001|Overall Study|non compliance|3|||
155075219|NCT01002105|559703908|FG000|Overall Study|condition worsened|4|||
155075220|NCT01002105|559703909|FG001|Overall Study|condition worsened|2|||
155075221|NCT00552058|559703913|FG000|Overall Study|Adverse Event|8|||
155075222|NCT00552058|559703914|FG001|Overall Study|Adverse Event|7|||
155075223|NCT00552058|559703913|FG000|Overall Study|Lack of Efficacy|1|||
155075224|NCT00552058|559703914|FG001|Overall Study|Lack of Efficacy|5|||
155075225|NCT00552058|559703913|FG000|Overall Study|Lost to Follow-up|1|||
155075226|NCT00552058|559703914|FG001|Overall Study|Lost to Follow-up|0|||
155075227|NCT00552058|559703913|FG000|Overall Study|Withdrawal by Subject|4|||
155075228|NCT00552058|559703914|FG001|Overall Study|Withdrawal by Subject|4|||
155075229|NCT00552058|559703913|FG000|Overall Study|Other: Protocol Violation|0|||
155075230|NCT00552058|559703914|FG001|Overall Study|Other: Protocol Violation|1|||
155075231|NCT00552058|559703913|FG000|Overall Study|Other: Non Compliance|1|||
155075232|NCT00552058|559703914|FG001|Overall Study|Other: Non Compliance|2|||
155075233|NCT00552058|559703913|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
155075234|NCT00552058|559703914|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
155075235|NCT00552058|559703913|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
155075236|NCT00552058|559703914|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
155075237|NCT00552058|559703913|FG000|Overall Study|Other: Positive Stool Result|0|||
155075238|NCT00552058|559703914|FG001|Overall Study|Other: Positive Stool Result|1|||
155075239|NCT00552058|559703913|FG000|Overall Study|Other: Randomized in error|0|||
155075240|NCT00552058|559703914|FG001|Overall Study|Other: Randomized in error|1|||
155075241|NCT00552058|559703913|FG000|Overall Study|Other: Sponsors Decision|0|||
155075242|NCT00552058|559703914|FG001|Overall Study|Other: Sponsors Decision|1|||
155075243|NCT00552058|559703913|FG000|Overall Study|Other: Early Roll Over|1|||
155075244|NCT00552058|559703914|FG001|Overall Study|Other: Early Roll Over|0|||
155075245|NCT00422461|559703916|FG000|Overall Study|Adverse Event|1|||
155075246|NCT00422461|559703917|FG001|Overall Study|Adverse Event|2|||
155075247|NCT00422461|559703918|FG002|Overall Study|Adverse Event|1|||
155075248|NCT00422461|559703919|FG003|Overall Study|Adverse Event|1|||
155075249|NCT00422461|559703916|FG000|Overall Study|Other|0|||
155075250|NCT00422461|559703917|FG001|Overall Study|Other|0|||
155075251|NCT00422461|559703918|FG002|Overall Study|Other|0|||
155075252|NCT00422461|559703919|FG003|Overall Study|Other|2|||
155075253|NCT00422461|559703916|FG000|Overall Study|Participants no longer willing to participate in study|1|||
155075254|NCT00422461|559703917|FG001|Overall Study|Participants no longer willing to participate in study|0|||
155075255|NCT00422461|559703918|FG002|Overall Study|Participants no longer willing to participate in study|0|||
155075256|NCT00422461|559703919|FG003|Overall Study|Participants no longer willing to participate in study|0|||
155075257|NCT00422461|559703916|FG000|Overall Study|Randomized but not treated|1|||
155075258|NCT00422461|559703917|FG001|Overall Study|Randomized but not treated|1|||
155075259|NCT00422461|559703918|FG002|Overall Study|Randomized but not treated|0|||
155075260|NCT00422461|559703919|FG003|Overall Study|Randomized but not treated|0|||
155075261|NCT01795937|559703920|FG000|Overall Study|Withdrawal by Subject|1|||
155075262|NCT01795937|559703921|FG001|Overall Study|Withdrawal by Subject|0|||
154962928|NCT01695239|559289561|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962929|NCT01695239|559289562|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962930|NCT01695239|559289563|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962931|NCT01695239|559289564|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
154962932|NCT01695239|559289565|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
154962933|NCT01695239|559289552|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155075263|NCT01795937|559703922|FG002|Overall Study|Withdrawal by Subject|0|||
155075264|NCT01795937|559703920|FG000|Overall Study|Physician Decision|0|||
155075265|NCT01795937|559703921|FG001|Overall Study|Physician Decision|1|||
155075266|NCT01795937|559703922|FG002|Overall Study|Physician Decision|0|||
155075267|NCT01028053|559703923|FG000|Overall Study|Screen Failure|113|||
155075268|NCT01028053|559703923|FG000|Overall Study|Patient Request|11|||
155075269|NCT01028053|559703923|FG000|Overall Study|Protocol Violation|1|||
155075270|NCT01028053|559703923|FG000|Overall Study|Physician Decision|2|||
155075271|NCT01028053|559703923|FG000|Overall Study|Technical Problem|1|||
155075272|NCT01028053|559703923|FG000|Overall Study|Terminated by Sponsor|1|||
155075273|NCT01028053|559703923|FG000|Overall Study|Various reasons|4|||
155075274|NCT00845182|559703924|FG000|Overall Study|Lost to Follow-up|3|||
155075275|NCT00845182|559703925|FG001|Overall Study|Lost to Follow-up|3|||
155075276|NCT00845182|559703926|FG002|Overall Study|Lost to Follow-up|4|||
155075277|NCT00845182|559703924|FG000|Overall Study|Adverse Event|0|||
155075278|NCT00845182|559703925|FG001|Overall Study|Adverse Event|1|||
155075279|NCT00845182|559703926|FG002|Overall Study|Adverse Event|1|||
155075280|NCT00845182|559703924|FG000|Overall Study|Physician Decision|0|||
155075281|NCT00845182|559703925|FG001|Overall Study|Physician Decision|0|||
155075282|NCT00845182|559703926|FG002|Overall Study|Physician Decision|1|||
155075283|NCT04621760|559703927|FG000|Overall Study|Lost to Follow-up|2|||
155075284|NCT04621760|559703928|FG001|Overall Study|Lost to Follow-up|4|||
155075285|NCT04621760|559703927|FG000|Overall Study|Withdrawal by Subject|1|||
155075286|NCT04621760|559703928|FG001|Overall Study|Withdrawal by Subject|0|||
155075287|NCT02965716|559703930|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
155075288|NCT02965716|559703931|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
155075289|NCT02965716|559703930|FG000|Overall Study|Progression/Relapse|8|||
155075290|NCT02965716|559703931|FG001|Overall Study|Progression/Relapse|16|||
155075291|NCT02965716|559703930|FG000|Overall Study|Death|1|||
155075292|NCT02965716|559703931|FG001|Overall Study|Death|0|||
155075293|NCT02965716|559703930|FG000|Overall Study|Not Protocol Specified|1|||
155075294|NCT02965716|559703931|FG001|Overall Study|Not Protocol Specified|3|||
155075295|NCT01336972|559703932|FG000|Overall Study|Adverse Event|1|||
155075296|NCT01336972|559703933|FG001|Overall Study|Adverse Event|1|||
155075297|NCT01336972|559703934|FG002|Overall Study|Adverse Event|0|||
155164542|NCT02453711|560038967|FG007|Overall Study|Death|0|||
155164543|NCT02453711|560038968|FG008|Overall Study|Death|0|||
155164544|NCT02453711|560038960|FG000|Overall Study|Unclassified|1|||
155164545|NCT02453711|560038961|FG001|Overall Study|Unclassified|0|||
154962934|NCT01695239|559289553|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962935|NCT01695239|559289554|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
155075298|NCT02441114|559703939|FG000|Washout2|Withdrawal by Subject|4|||
155075299|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
155075300|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
155075301|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
155075302|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
155075303|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
155075304|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
155075305|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
155075306|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
155075307|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
155075308|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
155075309|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
155075310|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
155075311|NCT03446573|559703940|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
155075312|NCT03446573|559703941|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
155075313|NCT03446573|559703940|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
155164546|NCT02453711|560038962|FG002|Overall Study|Unclassified|1|||
155075314|NCT03446573|559703941|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
155075315|NCT03446573|559703940|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
155075316|NCT03446573|559703941|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
155075317|NCT03446573|559703940|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
155075318|NCT03446573|559703941|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
155075319|NCT03446573|559703940|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
155075320|NCT03446573|559703941|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
155075321|NCT03446573|559703940|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
155075322|NCT03446573|559703941|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
155075323|NCT03446573|559703940|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
155075324|NCT03446573|559703941|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
155075325|NCT02639559|559703946|FG000|Overall Study|Mobilization failure|0|||
155075326|NCT02639559|559703947|FG001|Overall Study|Mobilization failure|3|||
155075327|NCT02639559|559703946|FG000|Overall Study|Issues with vascular acess|1|||
155075328|NCT02639559|559703947|FG001|Overall Study|Issues with vascular acess|0|||
155075329|NCT04999020|559703948|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
155075330|NCT04999020|559703949|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
155075331|NCT04999020|559703950|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
155075332|NCT04999020|559703951|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
155075333|NCT04999020|559703948|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
155075334|NCT04999020|559703949|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
155075335|NCT04999020|559703950|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
155075336|NCT04999020|559703951|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
155075337|NCT04999020|559703948|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
155075338|NCT04999020|559703949|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
155075339|NCT04999020|559703950|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
155075340|NCT04999020|559703951|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
155075341|NCT04999020|559703948|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155075342|NCT04999020|559703949|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155075343|NCT04999020|559703950|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
155075344|NCT04999020|559703951|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
155075345|NCT04999020|559703948|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155075346|NCT04999020|559703949|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155075347|NCT04999020|559703950|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
155075348|NCT04999020|559703951|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
155075349|NCT04999020|559703948|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
155075350|NCT04999020|559703949|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
155075351|NCT04999020|559703950|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
155075352|NCT04999020|559703951|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
155075353|NCT04999020|559703948|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155075354|NCT04999020|559703949|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155075355|NCT04999020|559703950|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
155075356|NCT04999020|559703951|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155075357|NCT04999020|559703948|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
155075358|NCT04999020|559703949|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
155075359|NCT04999020|559703950|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
155075360|NCT04999020|559703951|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
155075361|NCT04828486|559703958|FG000|Overall Study|Adverse Event|2|||
155075362|NCT04828486|559703958|FG000|Overall Study|Death|1|||
155075363|NCT04828486|559703958|FG000|Overall Study|Disease Progression|8|||
155075364|NCT04828486|559703958|FG000|Overall Study|Other Complicating Disease|1|||
155075365|NCT04828486|559703958|FG000|Overall Study|Withdrawal by Subject|1|||
155075366|NCT03325439|559703959|FG000|Overall Study|Ineligibility|3|||
155075367|NCT00387127|559703961|FG000|Overall Study|Lost to Follow-up|0|||
155075368|NCT00387127|559703962|FG001|Overall Study|Lost to Follow-up|4|||
155075369|NCT00387127|559703961|FG000|Overall Study|Death|16|||
155075370|NCT00387127|559703962|FG001|Overall Study|Death|16|||
155075371|NCT00387127|559703961|FG000|Overall Study|Physician Decision|0|||
155075372|NCT00387127|559703962|FG001|Overall Study|Physician Decision|1|||
155075373|NCT00387127|559703961|FG000|Overall Study|Withdrawal by Subject|3|||
155075374|NCT00387127|559703962|FG001|Overall Study|Withdrawal by Subject|2|||
155075375|NCT00387127|559703961|FG000|Overall Study|Required by Protocol Amendment #4|12|||
155075376|NCT00387127|559703962|FG001|Overall Study|Required by Protocol Amendment #4|10|||
155075377|NCT00387127|559703961|FG000|Overall Study|Serious Adverse Event|1|||
154962936|NCT01695239|559289555|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962937|NCT01695239|559289556|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962938|NCT01695239|559289557|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962939|NCT01695239|559289558|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962940|NCT01695239|559289559|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962941|NCT01695239|559289560|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962942|NCT01695239|559289561|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962943|NCT01695239|559289562|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962944|NCT01695239|559289563|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962945|NCT01695239|559289564|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154962946|NCT01695239|559289565|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
154962947|NCT00933686|559289569|FG000|Overall Study|Protocol Violation|0|||
154962948|NCT00933686|559289570|FG001|Overall Study|Protocol Violation|1|||
154962949|NCT00933686|559289569|FG000|Overall Study|Lost to Follow-up|2|||
154962950|NCT00933686|559289570|FG001|Overall Study|Lost to Follow-up|2|||
154962951|NCT00933686|559289569|FG000|Overall Study|Withdrawal by Subject|6|||
154962952|NCT00933686|559289570|FG001|Overall Study|Withdrawal by Subject|5|||
154962953|NCT00933686|559289569|FG000|Overall Study|Adverse Event|1|||
154962954|NCT00933686|559289570|FG001|Overall Study|Adverse Event|1|||
154962955|NCT00933686|559289569|FG000|Overall Study|Physician Decision|1|||
154962956|NCT00933686|559289570|FG001|Overall Study|Physician Decision|0|||
154962957|NCT00933686|559289569|FG000|Overall Study|Failure to show up at endpoint visits|0|||
154962958|NCT00933686|559289570|FG001|Overall Study|Failure to show up at endpoint visits|2|||
154962959|NCT01058668|559289571|FG000|Double-blind Treatment Phase|Adverse Event|8|||
154962960|NCT01058668|559289572|FG001|Double-blind Treatment Phase|Adverse Event|15|||
154962961|NCT01058668|559289573|FG002|Double-blind Treatment Phase|Adverse Event|25|||
154962962|NCT01058668|559289571|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
154962963|NCT01058668|559289572|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
154962964|NCT01058668|559289573|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
154962965|NCT01058668|559289571|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
154962966|NCT01058668|559289572|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
154962967|NCT01058668|559289573|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
154962968|NCT01058668|559289571|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
154962969|NCT01058668|559289572|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
154962970|NCT01058668|559289573|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
155075378|NCT00387127|559703962|FG001|Overall Study|Serious Adverse Event|1|||
155075379|NCT00387127|559703961|FG000|Overall Study|Sponsor Unblinded|1|||
155075380|NCT00387127|559703962|FG001|Overall Study|Sponsor Unblinded|0|||
155075381|NCT03674411|559703969|FG000|Overall Study|Non-treatment|4|||
155075382|NCT06038643|559703971|FG000|Overall Study|Withdrawal by Subject|9|||
155075383|NCT06038643|559703972|FG001|Overall Study|Withdrawal by Subject|4|||
155075384|NCT06038643|559703971|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
154962971|NCT01058668|559289571|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
154962972|NCT01058668|559289572|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
154962973|NCT01058668|559289573|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
154962974|NCT01058668|559289571|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
155075385|NCT06038643|559703972|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
155075386|NCT02227199|559703973|FG000|Overall Study|Physician Decision|0|||
155075387|NCT02227199|559703974|FG001|Overall Study|Physician Decision|0|||
155075388|NCT02227199|559703975|FG002|Overall Study|Physician Decision|1|||
155075389|NCT02227199|559703973|FG000|Overall Study|Adverse Event|0|||
155075390|NCT02227199|559703974|FG001|Overall Study|Adverse Event|0|||
155075391|NCT02227199|559703975|FG002|Overall Study|Adverse Event|3|||
155075392|NCT03573882|559703976|FG000|Overall Study|Study Terminated by Sponsor|22|||
155075393|NCT03573882|559703977|FG001|Overall Study|Study Terminated by Sponsor|17|||
155075394|NCT03573882|559703978|FG002|Overall Study|Study Terminated by Sponsor|18|||
155075395|NCT03573882|559703976|FG000|Overall Study|Withdrawal by Subject|6|||
155075396|NCT03573882|559703977|FG001|Overall Study|Withdrawal by Subject|11|||
155075397|NCT03573882|559703978|FG002|Overall Study|Withdrawal by Subject|7|||
155075398|NCT03573882|559703976|FG000|Overall Study|Adverse Event|7|||
155075399|NCT03573882|559703977|FG001|Overall Study|Adverse Event|5|||
155075400|NCT03573882|559703978|FG002|Overall Study|Adverse Event|6|||
155075401|NCT03573882|559703976|FG000|Overall Study|Lost to Follow-up|2|||
155075402|NCT03573882|559703977|FG001|Overall Study|Lost to Follow-up|5|||
155075403|NCT03573882|559703978|FG002|Overall Study|Lost to Follow-up|3|||
155075404|NCT03573882|559703976|FG000|Overall Study|Physician Decision|4|||
155075405|NCT03573882|559703977|FG001|Overall Study|Physician Decision|3|||
155075406|NCT03573882|559703978|FG002|Overall Study|Physician Decision|2|||
155075407|NCT03573882|559703976|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
155075408|NCT03573882|559703977|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
155075409|NCT03573882|559703978|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
155075410|NCT03573882|559703976|FG000|Overall Study|Pregnancy|1|||
155075411|NCT03573882|559703977|FG001|Overall Study|Pregnancy|2|||
155075412|NCT03573882|559703978|FG002|Overall Study|Pregnancy|0|||
155075413|NCT03573882|559703976|FG000|Overall Study|Other|4|||
155075414|NCT03573882|559703977|FG001|Overall Study|Other|2|||
155075415|NCT03573882|559703978|FG002|Overall Study|Other|2|||
155075416|NCT02691572|559703979|FG000|Overall Study|Withdrawal by Subject|1|||
155075417|NCT02691572|559703980|FG001|Overall Study|Withdrawal by Subject|0|||
155075418|NCT02691572|559703979|FG000|Overall Study|Protocol Violation|0|||
155075419|NCT02691572|559703980|FG001|Overall Study|Protocol Violation|1|||
155075420|NCT06100250|559703984|FG000|Overall Study|Lost to Follow-up|5|||
155075421|NCT04337021|559703988|FG000|Overall Study|Lost to Follow-up|54|||
155075422|NCT04337021|559703989|FG001|Overall Study|Lost to Follow-up|66|||
155075423|NCT00424008|559703991|FG000|Overall Study|Adverse Event|8|||
155075424|NCT00424008|559703992|FG001|Overall Study|Adverse Event|6|||
155075425|NCT00424008|559703991|FG000|Overall Study|Lack of Efficacy|40|||
155075426|NCT00424008|559703992|FG001|Overall Study|Lack of Efficacy|34|||
155075427|NCT00424008|559703991|FG000|Overall Study|Lost to Follow-up|1|||
155075428|NCT00424008|559703992|FG001|Overall Study|Lost to Follow-up|2|||
155075429|NCT00424008|559703991|FG000|Overall Study|Withdrawal by Subject|5|||
155075430|NCT00424008|559703992|FG001|Overall Study|Withdrawal by Subject|8|||
155341202|NCT02161146|560681402|FG002|Overall Study|Adverse Event|0|||
155075431|NCT00424008|559703991|FG000|Overall Study|Noncompliance with protocol|13|||
155075432|NCT00424008|559703992|FG001|Overall Study|Noncompliance with protocol|7|||
155075433|NCT00424008|559703991|FG000|Overall Study|Did not meet protocol eligibility|16|||
155075434|NCT00424008|559703992|FG001|Overall Study|Did not meet protocol eligibility|21|||
155075435|NCT00424008|559703991|FG000|Overall Study|Administrative|266|||
155075436|NCT00424008|559703992|FG001|Overall Study|Administrative|257|||
155075437|NCT01405911|559703993|FG000|Overall Study|Pre-treatment lab AE|0|||
154962975|NCT01058668|559289572|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
154962976|NCT01058668|559289573|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
154962977|NCT02911792|559289574|FG000|Overall Study|Lost to Follow-up|3|||
154962978|NCT02911792|559289575|FG001|Overall Study|Lost to Follow-up|3|||
155341203|NCT02161146|560681403|FG003|Overall Study|Adverse Event|1|||
154962979|NCT02911792|559289576|FG002|Overall Study|Lost to Follow-up|3|||
154962980|NCT02911792|559289577|FG003|Overall Study|Lost to Follow-up|3|||
154962981|NCT00705666|559289578|FG000|Overall Study|No post-treatment questionnaire|279|||
154962982|NCT00705666|559289578|FG000|Overall Study|Withdrawal by Subject|21|||
154962983|NCT00705666|559289578|FG000|Overall Study|Physician Decision|7|||
154962984|NCT00705666|559289578|FG000|Overall Study|Lost to Follow-up|5|||
154962985|NCT00705666|559289578|FG000|Overall Study|Death|1|||
154962986|NCT00705666|559289578|FG000|Overall Study|Adverse Event|4|||
155075438|NCT01405911|559703994|FG001|Overall Study|Pre-treatment lab AE|1|||
155075439|NCT01405911|559703995|FG002|Overall Study|Pre-treatment lab AE|0|||
155075440|NCT01405911|559703993|FG000|Overall Study|Lost to Follow-up|0|||
155075441|NCT01405911|559703994|FG001|Overall Study|Lost to Follow-up|1|||
155075442|NCT01405911|559703995|FG002|Overall Study|Lost to Follow-up|0|||
155075443|NCT01405911|559703993|FG000|Overall Study|Protocol Violation|1|||
155075444|NCT01405911|559703994|FG001|Overall Study|Protocol Violation|0|||
155075445|NCT01405911|559703995|FG002|Overall Study|Protocol Violation|0|||
155075446|NCT01405911|559703993|FG000|Overall Study|Withdrawal by Subject|3|||
155075447|NCT01405911|559703994|FG001|Overall Study|Withdrawal by Subject|1|||
155075448|NCT01405911|559703995|FG002|Overall Study|Withdrawal by Subject|1|||
155075449|NCT06375655|559703996|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
155075450|NCT06375655|559703997|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
155075451|NCT02114684|559704009|FG000|Overall Study|Death|6|||
155075452|NCT02114684|559704010|FG001|Overall Study|Death|4|||
155075453|NCT02114684|559704009|FG000|Overall Study|Lost to Follow-up|1|||
155075454|NCT02114684|559704010|FG001|Overall Study|Lost to Follow-up|2|||
155075455|NCT02114684|559704009|FG000|Overall Study|Withdrawal by Subject|1|||
155075456|NCT02114684|559704010|FG001|Overall Study|Withdrawal by Subject|2|||
155075457|NCT02114684|559704009|FG000|Overall Study|Relocation|3|||
155075458|NCT02114684|559704010|FG001|Overall Study|Relocation|1|||
155075459|NCT02114684|559704009|FG000|Overall Study|Rifampicin resistant on culture|0|||
155075460|NCT02114684|559704010|FG001|Overall Study|Rifampicin resistant on culture|1|||
155075461|NCT02114684|559704009|FG000|Overall Study|Patient Incarcerated|1|||
155075462|NCT02114684|559704010|FG001|Overall Study|Patient Incarcerated|0|||
155075463|NCT02530242|559704011|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
155075464|NCT02530242|559704012|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
155075465|NCT00283959|559704013|FG000|Extension Period|Low Compliance|1|||
155075466|NCT01397747|559704022|FG000|Overall Study|Multitarget DNA test excluded|689|||
155075467|NCT01397747|559704022|FG000|Overall Study|Colonoscopy excluded|304|||
155075468|NCT01397747|559704022|FG000|Overall Study|FIT excluded|34|||
155075469|NCT03828383|559704023|FG000|Overall Study|Lost to Follow-up|3|||
155075470|NCT03828383|559704024|FG001|Overall Study|Lost to Follow-up|2|||
155075471|NCT03828383|559704023|FG000|Overall Study|Withdrawal by Subject|4|||
155075472|NCT03828383|559704024|FG001|Overall Study|Withdrawal by Subject|5|||
155075473|NCT00504309|559704025|FG000|Overall Study|Death|0|||
155075474|NCT00504309|559704026|FG001|Overall Study|Death|0|||
155075475|NCT00504309|559704027|FG002|Overall Study|Death|0|||
155075476|NCT00504309|559704028|FG003|Overall Study|Death|0|||
155075477|NCT00504309|559704029|FG004|Overall Study|Death|1|||
155075478|NCT00504309|559704030|FG005|Overall Study|Death|0|||
155075479|NCT00504309|559704025|FG000|Overall Study|Withdrawal by Subject|0|||
155075480|NCT00504309|559704026|FG001|Overall Study|Withdrawal by Subject|0|||
155075481|NCT00504309|559704027|FG002|Overall Study|Withdrawal by Subject|1|||
155075482|NCT00504309|559704028|FG003|Overall Study|Withdrawal by Subject|0|||
155075483|NCT00504309|559704029|FG004|Overall Study|Withdrawal by Subject|0|||
155075484|NCT00504309|559704030|FG005|Overall Study|Withdrawal by Subject|0|||
155075485|NCT02665455|559704032|FG000|Overall Study|Withdrawal by Subject|6|||
155075486|NCT02665455|559704032|FG000|Overall Study|Lost to Follow-up|1|||
155075487|NCT02665455|559704032|FG000|Overall Study|Adverse Event|1|||
155075488|NCT02665455|559704032|FG000|Overall Study|Protocol Violation|1|||
155075489|NCT01039675|559704036|FG000|Overall Study|Adverse Event|0|||
155075490|NCT01039675|559704037|FG001|Overall Study|Adverse Event|2|||
155075491|NCT01039675|559704036|FG000|Overall Study|Lack of Efficacy|0|||
155075492|NCT01039675|559704037|FG001|Overall Study|Lack of Efficacy|2|||
155075493|NCT01039675|559704036|FG000|Overall Study|Withdrawal by Subject|0|||
155075494|NCT01039675|559704037|FG001|Overall Study|Withdrawal by Subject|1|||
155075495|NCT01039675|559704036|FG000|Overall Study|Lost to Follow-up|0|||
155075496|NCT01039675|559704037|FG001|Overall Study|Lost to Follow-up|1|||
155075497|NCT01039675|559704036|FG000|Overall Study|Physician Decision|0|||
155341204|NCT02161146|560681404|FG004|Overall Study|Adverse Event|0|||
155341205|NCT02161146|560681400|FG000|Overall Study|Lost to Follow-up|0|||
155075498|NCT01039675|559704037|FG001|Overall Study|Physician Decision|1|||
155075499|NCT02564978|559704038|FG000|Overall Study|Adverse Event|8|||
155075500|NCT02564978|559704038|FG000|Overall Study|Death|1|||
155075501|NCT02564978|559704038|FG000|Overall Study|Lost to Follow-up|1|||
155075502|NCT02564978|559704038|FG000|Overall Study|Withdrawal by Subject|15|||
155075503|NCT02564978|559704038|FG000|Overall Study|Early Study Closure|2|||
155075504|NCT02564978|559704038|FG000|Overall Study|Other Reason|5|||
155075505|NCT03554473|559705044|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
155075506|NCT03554473|559705045|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
155075507|NCT03554473|559705046|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
155075508|NCT03554473|559705044|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
155075509|NCT03554473|559705045|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
155075510|NCT03554473|559705046|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
155341206|NCT02161146|560681401|FG001|Overall Study|Lost to Follow-up|1|||
155341207|NCT02161146|560681402|FG002|Overall Study|Lost to Follow-up|0|||
155341208|NCT02161146|560681403|FG003|Overall Study|Lost to Follow-up|0|||
155341209|NCT02161146|560681404|FG004|Overall Study|Lost to Follow-up|0|||
155341210|NCT02161146|560681400|FG000|Overall Study|Personal Reasons|0|||
155341211|NCT02161146|560681401|FG001|Overall Study|Personal Reasons|1|||
155092664|NCT02006927|559773654|FG000|Overall Study|Adverse Event|2|||
155341212|NCT02161146|560681402|FG002|Overall Study|Personal Reasons|0|||
155341213|NCT02161146|560681403|FG003|Overall Study|Personal Reasons|2|||
155341214|NCT02161146|560681404|FG004|Overall Study|Personal Reasons|1|||
155341215|NCT02161146|560681400|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155341216|NCT02161146|560681401|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155341217|NCT02161146|560681402|FG002|Overall Study|Other Miscellaneous Reasons|0|||
154962987|NCT00705666|559289578|FG000|Overall Study|Other|12|||
154962988|NCT00705666|559289578|FG000|Overall Study|Other|2|||
154962989|NCT00705666|559289578|FG000|Overall Study|Lack of data|3|||
154962990|NCT00705666|559289578|FG000|Overall Study|Untreated|5|||
154962991|NCT02105272|559289580|FG000|Overall Study|Adverse Event|1|||
154962992|NCT02105272|559289581|FG001|Overall Study|Adverse Event|2|||
154962993|NCT02105272|559289580|FG000|Overall Study|Physician Decision|0|||
154962994|NCT02105272|559289581|FG001|Overall Study|Physician Decision|1|||
154962995|NCT02105272|559289580|FG000|Overall Study|Protocol Violation|2|||
154962996|NCT02105272|559289581|FG001|Overall Study|Protocol Violation|0|||
154962997|NCT02105272|559289580|FG000|Overall Study|Withdrawal by Subject|2|||
154962998|NCT02105272|559289581|FG001|Overall Study|Withdrawal by Subject|0|||
154962999|NCT03256695|559289582|FG000|Overall Study|Adverse Event|8|||
154963000|NCT03256695|559289582|FG000|Overall Study|Death|2|||
154963001|NCT03256695|559289582|FG000|Overall Study|Withdrawal by Subject|14|||
154963002|NCT03256695|559289582|FG000|Overall Study|Non-compliance with study drug|1|||
154963003|NCT03256695|559289582|FG000|Overall Study|Lost to Follow-up|3|||
154963004|NCT03256695|559289582|FG000|Overall Study|Lack of Efficacy|3|||
154963005|NCT03256695|559289582|FG000|Overall Study|Protocol Violation|5|||
154963006|NCT03256695|559289582|FG000|Overall Study|Other than specified|3|||
154963007|NCT02964039|559289583|FG000|Overall Study|Medical reason unrelated to study participation|1|||
154963008|NCT02964039|559289584|FG001|Overall Study|Medical reason unrelated to study participation|0|||
154963009|NCT02964039|559289585|FG002|Overall Study|Medical reason unrelated to study participation|3|||
154963010|NCT02964039|559289583|FG000|Overall Study|Research shutdown due to pandemic|2|||
154963011|NCT02964039|559289584|FG001|Overall Study|Research shutdown due to pandemic|0|||
154963012|NCT02964039|559289585|FG002|Overall Study|Research shutdown due to pandemic|1|||
154963013|NCT02964039|559289583|FG000|Overall Study|Withdrawal by Subject|0|||
154963014|NCT02964039|559289584|FG001|Overall Study|Withdrawal by Subject|1|||
154963015|NCT02964039|559289585|FG002|Overall Study|Withdrawal by Subject|0|||
154963016|NCT02964039|559289583|FG000|Overall Study|Lost to Follow-up|1|||
154963017|NCT02964039|559289584|FG001|Overall Study|Lost to Follow-up|0|||
154963018|NCT02964039|559289585|FG002|Overall Study|Lost to Follow-up|1|||
154963019|NCT04078022|559289594|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
154963020|NCT04078022|559289595|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
154963021|NCT01929863|559289596|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
154963022|NCT01929863|559289597|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
154963023|NCT01929863|559289596|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
154963024|NCT01929863|559289597|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
154963025|NCT01929863|559289596|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
154963026|NCT01929863|559289597|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
154963027|NCT00429416|559289600|FG000|Overall Study|Death|1|||
154963028|NCT02152163|559289601|FG000|Overall Study|Physician Decision|12|||
154963029|NCT02152163|559289602|FG001|Overall Study|Physician Decision|13|||
154963030|NCT06999265|559289603|FG000|Overall Study|Lost to Follow-up|1|||
154963031|NCT06999265|559289604|FG001|Overall Study|Lost to Follow-up|1|||
154963032|NCT00730691|559289605|FG000|Overall Study|Adverse Event|4|||
154963033|NCT00730691|559289606|FG001|Overall Study|Adverse Event|8|||
154963034|NCT00730691|559289607|FG002|Overall Study|Adverse Event|11|||
154963035|NCT00730691|559289608|FG003|Overall Study|Adverse Event|11|||
154963036|NCT00730691|559289609|FG004|Overall Study|Adverse Event|23|||
154963037|NCT00730691|559289605|FG000|Overall Study|Lack of Efficacy|4|||
154963038|NCT00730691|559289606|FG001|Overall Study|Lack of Efficacy|4|||
154963039|NCT00730691|559289607|FG002|Overall Study|Lack of Efficacy|2|||
154963040|NCT00730691|559289608|FG003|Overall Study|Lack of Efficacy|1|||
154963041|NCT00730691|559289609|FG004|Overall Study|Lack of Efficacy|1|||
154963042|NCT00730691|559289605|FG000|Overall Study|Non-compliance with Study Drug|6|||
154963043|NCT00730691|559289606|FG001|Overall Study|Non-compliance with Study Drug|1|||
154963044|NCT00730691|559289607|FG002|Overall Study|Non-compliance with Study Drug|6|||
154963045|NCT00730691|559289608|FG003|Overall Study|Non-compliance with Study Drug|3|||
154963046|NCT00730691|559289609|FG004|Overall Study|Non-compliance with Study Drug|3|||
154963047|NCT00730691|559289605|FG000|Overall Study|Protocol Deviations|3|||
154963048|NCT00730691|559289606|FG001|Overall Study|Protocol Deviations|5|||
154963049|NCT00730691|559289607|FG002|Overall Study|Protocol Deviations|3|||
154963050|NCT00730691|559289608|FG003|Overall Study|Protocol Deviations|7|||
154963051|NCT00730691|559289609|FG004|Overall Study|Protocol Deviations|5|||
154963052|NCT00730691|559289605|FG000|Overall Study|Withdrawal of Consent|7|||
154963053|NCT00730691|559289606|FG001|Overall Study|Withdrawal of Consent|9|||
154963054|NCT00730691|559289607|FG002|Overall Study|Withdrawal of Consent|3|||
154963055|NCT00730691|559289608|FG003|Overall Study|Withdrawal of Consent|6|||
155075511|NCT03554473|559705044|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
155075512|NCT03554473|559705045|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
155075513|NCT03554473|559705046|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
155075514|NCT05206604|559705047|FG000|Overall Study|Non-compliance with study drug|0|||
155075515|NCT05206604|559705048|FG001|Overall Study|Non-compliance with study drug|0|||
155075516|NCT05206604|559705049|FG002|Overall Study|Non-compliance with study drug|0|||
155075517|NCT05206604|559705050|FG003|Overall Study|Non-compliance with study drug|0|||
155075518|NCT05206604|559705051|FG004|Overall Study|Non-compliance with study drug|0|||
155075519|NCT05206604|559705052|FG005|Overall Study|Non-compliance with study drug|1|||
155075520|NCT05206604|559705053|FG006|Overall Study|Non-compliance with study drug|0|||
155075521|NCT05206604|559705054|FG007|Overall Study|Non-compliance with study drug|0|||
155075522|NCT01778985|559705055|FG000|Overall Study|Lost to Follow-up|1|||
155075523|NCT01778985|559705056|FG001|Overall Study|Lost to Follow-up|0|||
155075524|NCT01778985|559705055|FG000|Overall Study|Physician Decision|2|||
155075525|NCT01778985|559705056|FG001|Overall Study|Physician Decision|2|||
155075526|NCT01778985|559705055|FG000|Overall Study|Protocol Violation|4|||
155075527|NCT01778985|559705056|FG001|Overall Study|Protocol Violation|1|||
155075528|NCT00504231|559705057|FG000|Overall Study|Discrepant chart documentation re route|0|||
155075529|NCT00504231|559705058|FG001|Overall Study|Discrepant chart documentation re route|0|||
155075530|NCT00504231|559705059|FG002|Overall Study|Discrepant chart documentation re route|1|||
155075531|NCT00504231|559705060|FG003|Overall Study|Discrepant chart documentation re route|0|||
155075532|NCT01028560|559705063|FG000|Overall Study|Lack of Efficacy|3|||
155075533|NCT01028560|559705064|FG001|Overall Study|Lack of Efficacy|6|||
155075534|NCT01028560|559705063|FG000|Overall Study|Withdrawal by Subject|7|||
155075535|NCT01028560|559705064|FG001|Overall Study|Withdrawal by Subject|12|||
155075536|NCT01060111|559705065|FG000|Overall Study|Adverse Event|9|||
155075537|NCT01060111|559705066|FG001|Overall Study|Adverse Event|5|||
155075538|NCT01060111|559705067|FG002|Overall Study|Adverse Event|18|||
155075539|NCT01060111|559705065|FG000|Overall Study|Lack of Efficacy|2|||
155075540|NCT01060111|559705066|FG001|Overall Study|Lack of Efficacy|1|||
155075541|NCT01060111|559705067|FG002|Overall Study|Lack of Efficacy|0|||
155075542|NCT01060111|559705065|FG000|Overall Study|Inappropriate participant|5|||
155075543|NCT01060111|559705066|FG001|Overall Study|Inappropriate participant|4|||
155075544|NCT01060111|559705067|FG002|Overall Study|Inappropriate participant|5|||
155075545|NCT01060111|559705065|FG000|Overall Study|Participants' evasion for hospital visit|0|||
155075546|NCT01060111|559705066|FG001|Overall Study|Participants' evasion for hospital visit|3|||
155075547|NCT01060111|559705067|FG002|Overall Study|Participants' evasion for hospital visit|2|||
155075548|NCT01060111|559705065|FG000|Overall Study|Participants' non-cooperation|8|||
155075549|NCT01060111|559705066|FG001|Overall Study|Participants' non-cooperation|6|||
155075550|NCT01060111|559705067|FG002|Overall Study|Participants' non-cooperation|6|||
155075551|NCT01060111|559705065|FG000|Overall Study|Adverse event and insufficient effect|0|||
155075552|NCT01060111|559705066|FG001|Overall Study|Adverse event and insufficient effect|1|||
155075553|NCT01060111|559705067|FG002|Overall Study|Adverse event and insufficient effect|0|||
155341218|NCT02161146|560681403|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155341219|NCT02161146|560681404|FG004|Overall Study|Other Miscellaneous Reasons|0|||
154963056|NCT00730691|559289609|FG004|Overall Study|Withdrawal of Consent|3|||
155075554|NCT01060111|559705065|FG000|Overall Study|Participants' non-cooperation|1|||
155075555|NCT01060111|559705066|FG001|Overall Study|Participants' non-cooperation|0|||
155075556|NCT01060111|559705067|FG002|Overall Study|Participants' non-cooperation|0|||
155075557|NCT01060111|559705065|FG000|Overall Study|Other|2|||
155075558|NCT01060111|559705066|FG001|Overall Study|Other|3|||
155075559|NCT01060111|559705067|FG002|Overall Study|Other|4|||
155075560|NCT05278065|559705068|FG000|Overall Study|Withdrawal by Subject|1|||
155075561|NCT05278065|559705069|FG001|Overall Study|Withdrawal by Subject|0|||
155075562|NCT02609633|559705075|FG000|Overall Study|Consent Withdrawn|0|||
155075563|NCT02609633|559705076|FG001|Overall Study|Consent Withdrawn|1|||
155075564|NCT02609633|559705075|FG000|Overall Study|Protocol Deviation|1|||
155075565|NCT02609633|559705076|FG001|Overall Study|Protocol Deviation|0|||
155075566|NCT02609633|559705075|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
155075567|NCT02609633|559705076|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
155075568|NCT02609633|559705075|FG000|Overall Study|Reason not Specified|2|||
155341220|NCT00845520|560681405|FG000|Overall Study|Death|1|||
154963057|NCT00730691|559289605|FG000|Overall Study|Lost to Follow-up|11|||
154963058|NCT00730691|559289606|FG001|Overall Study|Lost to Follow-up|8|||
154963059|NCT00730691|559289607|FG002|Overall Study|Lost to Follow-up|13|||
154963060|NCT00730691|559289608|FG003|Overall Study|Lost to Follow-up|15|||
154963061|NCT00730691|559289609|FG004|Overall Study|Lost to Follow-up|13|||
154963062|NCT00730691|559289605|FG000|Overall Study|Other|1|||
154963063|NCT00730691|559289606|FG001|Overall Study|Other|1|||
154963064|NCT00730691|559289607|FG002|Overall Study|Other|1|||
154963065|NCT00730691|559289608|FG003|Overall Study|Other|2|||
154963066|NCT00730691|559289609|FG004|Overall Study|Other|2|||
154963067|NCT02554890|559289610|FG000|Double-blind|Adverse Event|45|||
154963068|NCT02554890|559289611|FG001|Double-blind|Adverse Event|51|||
154963069|NCT02554890|559289610|FG000|Double-blind|Death|6|||
154963070|NCT02554890|559289611|FG001|Double-blind|Death|4|||
154963071|NCT02554890|559289610|FG000|Double-blind|Protocol Violation|1|||
154963072|NCT02554890|559289611|FG001|Double-blind|Protocol Violation|1|||
154963073|NCT02554890|559289610|FG000|Double-blind|Physician Decision|4|||
155075569|NCT02609633|559705076|FG001|Overall Study|Reason not Specified|1|||
155075570|NCT02691663|559705079|FG000|Overall Study|Screen failure after baseline|2|||
155075571|NCT02691663|559705080|FG001|Overall Study|Screen failure after baseline|2|||
155075572|NCT02691663|559705079|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
155075573|NCT02691663|559705080|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
155075574|NCT02691663|559705079|FG000|Overall Study|Withdrawn after Follow up 2|1|||
155075575|NCT02691663|559705080|FG001|Overall Study|Withdrawn after Follow up 2|1|||
155075576|NCT02691663|559705079|FG000|Overall Study|Lost to Follow-up|3|||
155075577|NCT02691663|559705080|FG001|Overall Study|Lost to Follow-up|2|||
155075578|NCT00471107|559705083|FG000|Overall Study|Technical problems/data loss|3|||
155075579|NCT00471107|559705084|FG001|Overall Study|Technical problems/data loss|1|||
155075580|NCT00471107|559705085|FG002|Overall Study|Technical problems/data loss|3|||
155075581|NCT00896233|559705086|FG000|Overall Study|Claustrophobia during MRI|1|||
155075582|NCT02068599|559705090|FG000|Overall Study|Adverse Event|4|||
155075583|NCT02068599|559705091|FG001|Overall Study|Adverse Event|1|||
155075584|NCT02068599|559705092|FG002|Overall Study|Adverse Event|1|||
155075585|NCT02068599|559705090|FG000|Overall Study|Withdrawal by Subject|2|||
155075586|NCT02068599|559705091|FG001|Overall Study|Withdrawal by Subject|7|||
155075587|NCT02068599|559705092|FG002|Overall Study|Withdrawal by Subject|5|||
155075588|NCT02068599|559705090|FG000|Overall Study|Protocol Violation|4|||
155075589|NCT02068599|559705091|FG001|Overall Study|Protocol Violation|2|||
155075590|NCT02068599|559705092|FG002|Overall Study|Protocol Violation|3|||
155075591|NCT02068599|559705090|FG000|Overall Study|Lost to Follow-up|1|||
155075592|NCT02068599|559705091|FG001|Overall Study|Lost to Follow-up|0|||
155075593|NCT02068599|559705092|FG002|Overall Study|Lost to Follow-up|0|||
155075594|NCT02068599|559705090|FG000|Overall Study|Lack of Efficacy|0|||
155075595|NCT02068599|559705091|FG001|Overall Study|Lack of Efficacy|0|||
155075596|NCT02068599|559705092|FG002|Overall Study|Lack of Efficacy|3|||
155075597|NCT02068599|559705090|FG000|Overall Study|Noncompliance|0|||
155075598|NCT02068599|559705091|FG001|Overall Study|Noncompliance|0|||
155075599|NCT02068599|559705092|FG002|Overall Study|Noncompliance|1|||
155075600|NCT01871727|559705093|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
155075601|NCT01871727|559705094|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
155341221|NCT00845520|560681406|FG001|Overall Study|Death|2|||
155341222|NCT00845520|560681407|FG002|Overall Study|Death|0|||
155341223|NCT00845520|560681405|FG000|Overall Study|Lost to Follow-up|1|||
154963074|NCT02554890|559289611|FG001|Double-blind|Physician Decision|3|||
154963075|NCT02554890|559289610|FG000|Double-blind|Subject/Guardian decision|21|||
154963076|NCT02554890|559289611|FG001|Double-blind|Subject/Guardian decision|16|||
154963077|NCT02554890|559289610|FG000|Double-blind|Lost to Follow-up|7|||
155075602|NCT01871727|559705095|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
155075603|NCT01871727|559705096|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
155075604|NCT01871727|559705097|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
155075605|NCT01871727|559705093|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
155075606|NCT01871727|559705094|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
155075607|NCT01871727|559705095|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
155075608|NCT01871727|559705096|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
155075609|NCT01871727|559705097|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
155075610|NCT01871727|559705093|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155075611|NCT01871727|559705094|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155075612|NCT01871727|559705095|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155075613|NCT01871727|559705096|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
155075614|NCT01871727|559705097|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
155075615|NCT01871727|559705093|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155075616|NCT01871727|559705094|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
154963078|NCT02554890|559289611|FG001|Double-blind|Lost to Follow-up|5|||
154963079|NCT02554890|559289610|FG000|Double-blind|Technical problems|1|||
155075617|NCT01871727|559705095|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155075618|NCT01871727|559705096|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
155075619|NCT01871727|559705097|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
155075620|NCT01871727|559705093|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155075621|NCT01871727|559705094|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155075622|NCT01871727|559705095|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155075623|NCT01871727|559705096|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
155075624|NCT01871727|559705097|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
155075625|NCT01871727|559705093|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155075626|NCT01871727|559705094|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155075627|NCT01871727|559705095|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155075628|NCT01871727|559705096|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
155075629|NCT01871727|559705097|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
155075630|NCT01871727|559705093|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
155075631|NCT01871727|559705094|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
155075632|NCT01871727|559705095|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
155075633|NCT01871727|559705096|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
155075634|NCT01871727|559705097|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
155075635|NCT01263028|559705098|FG000|Overall Study|Withdrawal by Subject|1|||
155075636|NCT01263028|559705098|FG000|Overall Study|Adverse Event|1|||
155075637|NCT01263028|559705098|FG000|Overall Study|Study terminated due to low enrollment.|4|||
155075638|NCT02958527|559705101|FG000|Overall Study|Not collected CRFs|12|||
155075639|NCT06042855|559705102|FG000|Overall Study|No Receipt of Study Drug|48|||
155075640|NCT06042855|559705103|FG001|Overall Study|No Receipt of Study Drug|57|||
155075641|NCT06042855|559705102|FG000|Overall Study|Administratively Withdrawn|59|||
155075642|NCT06042855|559705103|FG001|Overall Study|Administratively Withdrawn|59|||
155075643|NCT01947933|559705105|FG000|Overall Study|Withdrawal by Subject|0|||
155075644|NCT01947933|559705106|FG001|Overall Study|Withdrawal by Subject|0|||
155075645|NCT01947933|559705107|FG002|Overall Study|Withdrawal by Subject|1|||
155075646|NCT01947933|559705108|FG003|Overall Study|Withdrawal by Subject|0|||
155075647|NCT01947933|559705109|FG004|Overall Study|Withdrawal by Subject|0|||
155341224|NCT00845520|560681406|FG001|Overall Study|Lost to Follow-up|0|||
155341225|NCT00845520|560681407|FG002|Overall Study|Lost to Follow-up|0|||
155341226|NCT00845520|560681405|FG000|Overall Study|Adverse Event|0|||
155341227|NCT00845520|560681406|FG001|Overall Study|Adverse Event|0|||
155341228|NCT00845520|560681407|FG002|Overall Study|Adverse Event|1|||
155341229|NCT02613403|560681408|FG000|Overall Study|Lost to Follow-up|0|||
155341230|NCT02613403|560681409|FG001|Overall Study|Lost to Follow-up|1|||
155341231|NCT02613403|560681410|FG002|Overall Study|Lost to Follow-up|0|||
155341232|NCT02613403|560681411|FG003|Overall Study|Lost to Follow-up|0|||
155341233|NCT02613403|560681412|FG004|Overall Study|Lost to Follow-up|0|||
155341234|NCT02613403|560681408|FG000|Overall Study|Withdrawal by Subject|2|||
155341235|NCT02613403|560681409|FG001|Overall Study|Withdrawal by Subject|0|||
155341236|NCT02613403|560681410|FG002|Overall Study|Withdrawal by Subject|0|||
155341237|NCT02613403|560681411|FG003|Overall Study|Withdrawal by Subject|0|||
155341238|NCT02613403|560681412|FG004|Overall Study|Withdrawal by Subject|0|||
155341239|NCT00800176|560681413|FG000|Overall Study|Adverse Event|2|||
155341240|NCT00800176|560681414|FG001|Overall Study|Adverse Event|1|||
155341241|NCT00800176|560681415|FG002|Overall Study|Adverse Event|0|||
155341242|NCT00800176|560681416|FG003|Overall Study|Adverse Event|2|||
155341243|NCT00800176|560681417|FG004|Overall Study|Adverse Event|1|||
155341244|NCT00800176|560681418|FG005|Overall Study|Adverse Event|1|||
155341245|NCT00800176|560681413|FG000|Overall Study|Refused treatment|3|||
155075648|NCT01947933|559705110|FG005|Overall Study|Withdrawal by Subject|0|||
155075649|NCT01947933|559705111|FG006|Overall Study|Withdrawal by Subject|0|||
155075650|NCT01947933|559705112|FG007|Overall Study|Withdrawal by Subject|0|||
155075651|NCT01947933|559705113|FG008|Overall Study|Withdrawal by Subject|0|||
155075652|NCT01947933|559705105|FG000|Overall Study|Lost to Follow-up|0|||
155075653|NCT01947933|559705106|FG001|Overall Study|Lost to Follow-up|0|||
155075654|NCT01947933|559705107|FG002|Overall Study|Lost to Follow-up|0|||
155075655|NCT01947933|559705108|FG003|Overall Study|Lost to Follow-up|0|||
155075656|NCT01947933|559705109|FG004|Overall Study|Lost to Follow-up|0|||
155075657|NCT01947933|559705110|FG005|Overall Study|Lost to Follow-up|0|||
155075658|NCT01947933|559705111|FG006|Overall Study|Lost to Follow-up|0|||
155075659|NCT01947933|559705112|FG007|Overall Study|Lost to Follow-up|0|||
155075660|NCT01947933|559705113|FG008|Overall Study|Lost to Follow-up|1|||
155341246|NCT00800176|560681414|FG001|Overall Study|Refused treatment|2|||
155341247|NCT00800176|560681415|FG002|Overall Study|Refused treatment|0|||
155341248|NCT00800176|560681416|FG003|Overall Study|Refused treatment|0|||
155341249|NCT00800176|560681417|FG004|Overall Study|Refused treatment|1|||
155341250|NCT00800176|560681418|FG005|Overall Study|Refused treatment|4|||
155341251|NCT00800176|560681413|FG000|Overall Study|Failure to return|3|||
155341252|NCT00800176|560681414|FG001|Overall Study|Failure to return|3|||
155075661|NCT00294398|559705114|FG000|Overall Study|Lost to Follow-up|21|||
155075662|NCT00294398|559705115|FG001|Overall Study|Lost to Follow-up|26|||
155075663|NCT01428128|559705116|FG000|Overall Study|Withdrawal by Subject|4|||
155075664|NCT01428128|559705116|FG000|Overall Study|Screen failure by p53|10|||
155075665|NCT01428128|559705116|FG000|Overall Study|Received Neulasta in one cycle|2|||
155075666|NCT01428128|559705116|FG000|Overall Study|Adverse Event|1|||
155075667|NCT00250718|559705120|FG000|Overall Study|Death|1|||
155075668|NCT00250718|559705120|FG000|Overall Study|Adverse Event|1|||
155075669|NCT00250718|559705120|FG000|Overall Study|Withdrawal by Subject|1|||
155075670|NCT05259033|559705123|FG000|Overall Study|Withdrawal by Subject|10|||
155075671|NCT05259033|559705124|FG001|Overall Study|Withdrawal by Subject|5|||
155075672|NCT05259033|559705123|FG000|Overall Study|Lost to Follow-up|1|||
155075673|NCT05259033|559705124|FG001|Overall Study|Lost to Follow-up|0|||
155075674|NCT05259033|559705123|FG000|Overall Study|Death|2|||
155075675|NCT05259033|559705124|FG001|Overall Study|Death|0|||
155075676|NCT02593864|559705128|FG000|Overall Study|Withdrawal by Subject|3|||
155075677|NCT02593864|559705128|FG000|Overall Study|Lost to Follow-up|3|||
155075678|NCT03345095|559705135|FG000|Overall Study|Lack of Efficacy|184|||
155075679|NCT03345095|559705136|FG001|Overall Study|Lack of Efficacy|156|||
155075680|NCT03345095|559705135|FG000|Overall Study|Adverse Event|36|||
155075681|NCT03345095|559705136|FG001|Overall Study|Adverse Event|118|||
155075682|NCT03345095|559705135|FG000|Overall Study|Withdrawal by Subject|22|||
155075683|NCT03345095|559705136|FG001|Overall Study|Withdrawal by Subject|59|||
155075684|NCT03345095|559705135|FG000|Overall Study|Physician Decision|3|||
155075685|NCT03345095|559705136|FG001|Overall Study|Physician Decision|18|||
155075686|NCT03345095|559705135|FG000|Overall Study|Death|2|||
155075687|NCT03345095|559705136|FG001|Overall Study|Death|4|||
155075688|NCT03345095|559705135|FG000|Overall Study|Other reasons|2|||
155075689|NCT03345095|559705136|FG001|Overall Study|Other reasons|11|||
155075690|NCT03345095|559705135|FG000|Overall Study|Protocol Violation|0|||
155075691|NCT03345095|559705136|FG001|Overall Study|Protocol Violation|1|||
155075692|NCT05865886|559705137|FG000|Overall Study|Serious adverse event|0|||
155075693|NCT05865886|559705138|FG001|Overall Study|Serious adverse event|1|||
155075694|NCT01671059|559705139|FG000|Overall Study|Adverse Event|4|||
155075695|NCT01671059|559705139|FG000|Overall Study|Lack of Efficacy|1|||
155075696|NCT00567580|559706893|FG000|Overall Study|Protocol Violation|28|||
155075697|NCT00567580|559706894|FG001|Overall Study|Protocol Violation|24|||
155075698|NCT00567580|559706895|FG002|Overall Study|Protocol Violation|24|||
155075699|NCT04289298|559706899|FG000|Overall Study|Lost to Follow-up|5|||
155075700|NCT04289298|559706900|FG001|Overall Study|Lost to Follow-up|0|||
155075701|NCT04289298|559706899|FG000|Overall Study|Withdrawal by Subject|2|||
155075702|NCT04289298|559706900|FG001|Overall Study|Withdrawal by Subject|0|||
155075703|NCT01734928|559706901|FG000|Randomization|Physician Decision|0|||
155075704|NCT01734928|559706902|FG001|Randomization|Physician Decision|1|||
155075705|NCT01734928|559706901|FG000|Randomization|clinical progression|0|||
155075706|NCT01734928|559706902|FG001|Randomization|clinical progression|1|||
155075707|NCT01734928|559706901|FG000|Randomization|progressive disease|0|||
155075708|NCT01734928|559706902|FG001|Randomization|progressive disease|2|||
155075709|NCT01734928|559706901|FG000|Randomization|Withdrew informed consent|0|||
155075710|NCT01734928|559706902|FG001|Randomization|Withdrew informed consent|4|||
155075711|NCT01734928|559706901|FG000|Randomization|Death|1|||
155075712|NCT01734928|559706902|FG001|Randomization|Death|0|||
155075713|NCT01734928|559706901|FG000|Randomization|Randomization error|1|||
155075714|NCT01734928|559706902|FG001|Randomization|Randomization error|0|||
155075715|NCT01734928|559706901|FG000|Randomization|Lost to Follow-up|1|||
155075716|NCT01734928|559706902|FG001|Randomization|Lost to Follow-up|0|||
155075717|NCT01734928|559706901|FG000|Treatment Period|Lost to Follow-up|0|||
155075718|NCT01734928|559706902|FG001|Treatment Period|Lost to Follow-up|2|||
155075719|NCT01734928|559706901|FG000|Treatment Period|Progressive Disease|167|||
155075720|NCT01734928|559706902|FG001|Treatment Period|Progressive Disease|165|||
155075721|NCT01734928|559706901|FG000|Treatment Period|Adverse Event|39|||
155075722|NCT01734928|559706902|FG001|Treatment Period|Adverse Event|52|||
155075723|NCT01734928|559706901|FG000|Treatment Period|Withdrawal of Consent|25|||
155075724|NCT01734928|559706902|FG001|Treatment Period|Withdrawal of Consent|22|||
155075725|NCT01734928|559706901|FG000|Treatment Period|Death|20|||
155341253|NCT00800176|560681415|FG002|Overall Study|Failure to return|0|||
155341254|NCT00800176|560681416|FG003|Overall Study|Failure to return|2|||
155075726|NCT01734928|559706902|FG001|Treatment Period|Death|9|||
155075727|NCT01734928|559706901|FG000|Treatment Period|Other Reasons|27|||
155075728|NCT01734928|559706902|FG001|Treatment Period|Other Reasons|19|||
155075729|NCT01734928|559706901|FG000|Treatment Period|Pregnancy|0|||
155341255|NCT00800176|560681417|FG004|Overall Study|Failure to return|0|||
155164547|NCT02453711|560038963|FG003|Overall Study|Unclassified|0|||
155164548|NCT02453711|560038964|FG004|Overall Study|Unclassified|0|||
155164549|NCT02453711|560038965|FG005|Overall Study|Unclassified|0|||
155164550|NCT02453711|560038966|FG006|Overall Study|Unclassified|0|||
155164551|NCT02453711|560038967|FG007|Overall Study|Unclassified|0|||
155164552|NCT02453711|560038968|FG008|Overall Study|Unclassified|0|||
155164553|NCT03695367|560038971|FG000|Overall Study|Missed the Day 28 visit.|1|||
155164554|NCT03695367|560038972|FG001|Overall Study|Missed the Day 28 visit.|0|||
155164555|NCT03695367|560038971|FG000|Overall Study|Lost to Follow-up|0|||
155164556|NCT03695367|560038972|FG001|Overall Study|Lost to Follow-up|1|||
155164557|NCT03695367|560038971|FG000|Overall Study|Withdrawal by Subject|0|||
155164558|NCT03695367|560038972|FG001|Overall Study|Withdrawal by Subject|1|||
155164559|NCT03695367|560038971|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
155341256|NCT00800176|560681418|FG005|Overall Study|Failure to return|0|||
155341257|NCT00800176|560681413|FG000|Overall Study|Other|1|||
155341258|NCT00800176|560681414|FG001|Overall Study|Other|0|||
155341259|NCT00800176|560681415|FG002|Overall Study|Other|0|||
155341260|NCT00800176|560681416|FG003|Overall Study|Other|0|||
155341261|NCT00800176|560681417|FG004|Overall Study|Other|2|||
155341262|NCT00800176|560681418|FG005|Overall Study|Other|0|||
155341263|NCT02659540|560681421|FG000|Overall Study|Adverse Event|3|||
155341264|NCT02659540|560681422|FG001|Overall Study|Adverse Event|2|||
155341265|NCT02659540|560681421|FG000|Overall Study|Death|1|||
155341266|NCT02659540|560681422|FG001|Overall Study|Death|0|||
155341267|NCT02659540|560681421|FG000|Overall Study|Progressive disease|2|||
155341268|NCT02659540|560681422|FG001|Overall Study|Progressive disease|6|||
155341269|NCT00608959|560683134|FG000|Part 1|Did not meet eligibility criteria|1|||
155341270|NCT01416285|560683135|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
155341271|NCT01416285|560683136|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
155341272|NCT01005602|560683137|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
155341273|NCT01005602|560683138|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
155341274|NCT01248715|560683139|FG000|Overall Study|Not influenza positive|501|||
155341275|NCT01248715|560683140|FG001|Overall Study|Not influenza positive|510|||
155341276|NCT01919489|560683141|FG000|Overall Study|Rejected the need of injections|4|||
155341277|NCT01919489|560683142|FG001|Overall Study|Rejected the need of injections|7|||
155341278|NCT01919489|560683141|FG000|Overall Study|Adverse Event|10|||
155341279|NCT01919489|560683142|FG001|Overall Study|Adverse Event|0|||
155341280|NCT01919489|560683141|FG000|Overall Study|Hospital readmission|2|||
155341281|NCT01919489|560683142|FG001|Overall Study|Hospital readmission|9|||
155341282|NCT01919489|560683141|FG000|Overall Study|Death|2|||
155341283|NCT01919489|560683142|FG001|Overall Study|Death|1|||
155341284|NCT01919489|560683141|FG000|Overall Study|Lost to Follow-up|38|||
155341285|NCT01919489|560683142|FG001|Overall Study|Lost to Follow-up|27|||
155341286|NCT01131325|560683143|FG000|Overall Study|Adverse Event|1|||
155341287|NCT01131325|560683143|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
155341288|NCT03884478|560683144|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
155341289|NCT03884478|560683145|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
155341290|NCT03884478|560683146|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
155341291|NCT03884478|560683144|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
155341292|NCT03884478|560683145|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
155341293|NCT03884478|560683146|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
155341294|NCT03884478|560683144|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
155341295|NCT03884478|560683145|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
155341296|NCT03884478|560683146|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
155341297|NCT03884478|560683144|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
155341298|NCT03884478|560683145|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
155341299|NCT03884478|560683146|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
155341300|NCT01807234|560683147|FG000|Overall Study|Lost to Follow-up|2|||
155341301|NCT01807234|560683148|FG001|Overall Study|Lost to Follow-up|5|||
155164560|NCT03695367|560038972|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
155341302|NCT01807234|560683149|FG002|Overall Study|Lost to Follow-up|1|||
155341303|NCT01807234|560683150|FG003|Overall Study|Lost to Follow-up|1|||
155341304|NCT01807234|560683151|FG004|Overall Study|Lost to Follow-up|1|||
155164561|NCT01958164|560038973|FG000|Overall Study|Adverse Event|0|||
155164562|NCT01958164|560038974|FG001|Overall Study|Adverse Event|2|||
155341305|NCT01807234|560683152|FG005|Overall Study|Lost to Follow-up|2|||
155341306|NCT01807234|560683147|FG000|Overall Study|Withdrawal by Subject|3|||
155341307|NCT01807234|560683148|FG001|Overall Study|Withdrawal by Subject|1|||
155341308|NCT01807234|560683149|FG002|Overall Study|Withdrawal by Subject|1|||
155341309|NCT01807234|560683150|FG003|Overall Study|Withdrawal by Subject|1|||
155341310|NCT01807234|560683151|FG004|Overall Study|Withdrawal by Subject|2|||
155341311|NCT01807234|560683152|FG005|Overall Study|Withdrawal by Subject|1|||
155341312|NCT01807234|560683147|FG000|Overall Study|Lack of Efficacy|0|||
155341313|NCT01807234|560683148|FG001|Overall Study|Lack of Efficacy|0|||
155341314|NCT01807234|560683149|FG002|Overall Study|Lack of Efficacy|0|||
155341315|NCT01807234|560683150|FG003|Overall Study|Lack of Efficacy|0|||
155341316|NCT01807234|560683151|FG004|Overall Study|Lack of Efficacy|1|||
155341317|NCT01807234|560683152|FG005|Overall Study|Lack of Efficacy|1|||
155341318|NCT01540474|560683153|FG000|Vaccination Period|Lost to Follow-up|0|||
155341319|NCT01540474|560683154|FG001|Vaccination Period|Lost to Follow-up|1|||
155341320|NCT01540474|560683155|FG002|Vaccination Period|Lost to Follow-up|0|||
155341321|NCT01540474|560683156|FG003|Vaccination Period|Lost to Follow-up|0|||
155341322|NCT00857311|560683157|FG000|Overall Study|Lost to Follow-up|1|||
155341323|NCT00857311|560683158|FG001|Overall Study|Lost to Follow-up|0|||
155341324|NCT00857311|560683159|FG002|Overall Study|Lost to Follow-up|0|||
155341325|NCT00857311|560683160|FG003|Overall Study|Lost to Follow-up|0|||
155341326|NCT00828139|560683161|FG000|Overall Study|Adverse Event|8|||
155341327|NCT00828139|560683162|FG001|Overall Study|Adverse Event|1|||
155341328|NCT00828139|560683163|FG002|Overall Study|Adverse Event|10|||
155341329|NCT00828139|560683164|FG003|Overall Study|Adverse Event|5|||
155341330|NCT00828139|560683161|FG000|Overall Study|Death|2|||
155341331|NCT00828139|560683162|FG001|Overall Study|Death|1|||
155341332|NCT00828139|560683163|FG002|Overall Study|Death|0|||
155341333|NCT00828139|560683164|FG003|Overall Study|Death|2|||
155341334|NCT00828139|560683161|FG000|Overall Study|Refusal unrelated to toxicity|3|||
155341335|NCT00828139|560683162|FG001|Overall Study|Refusal unrelated to toxicity|4|||
155341336|NCT00828139|560683163|FG002|Overall Study|Refusal unrelated to toxicity|5|||
155341337|NCT00828139|560683164|FG003|Overall Study|Refusal unrelated to toxicity|3|||
155341338|NCT00828139|560683161|FG000|Overall Study|Disease Progression|24|||
155341339|NCT00828139|560683162|FG001|Overall Study|Disease Progression|33|||
155341340|NCT00828139|560683163|FG002|Overall Study|Disease Progression|35|||
155341341|NCT00828139|560683164|FG003|Overall Study|Disease Progression|39|||
155341342|NCT00828139|560683161|FG000|Overall Study|Other|4|||
155341343|NCT00828139|560683162|FG001|Overall Study|Other|2|||
155341344|NCT00828139|560683163|FG002|Overall Study|Other|5|||
155341345|NCT00828139|560683164|FG003|Overall Study|Other|2|||
155341346|NCT01714947|560683165|FG000|Part B|Progressive Disease|3|||
155341347|NCT04271254|560683169|FG000|Overall Study|Withdrawal by Subject|3|||
155341348|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
155341349|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
155341350|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
155341351|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
155341352|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
155341353|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
155341354|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
155341355|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
155341356|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
155341357|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
155341358|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
155341359|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
155341360|NCT01345253|560683170|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
155341361|NCT01345253|560683171|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
155341362|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
155341363|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
155341364|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
155341365|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
155341366|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
155341367|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
155341368|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
155341369|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
155341370|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
155341371|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
155341372|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
155341373|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
155341374|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
155341375|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
155341376|NCT01345253|560683170|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
155341377|NCT01345253|560683171|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
155341378|NCT02137785|560683176|FG000|Overall Study|Lost to Follow-up|1|||
155341379|NCT02137785|560683177|FG001|Overall Study|Lost to Follow-up|0|||
155341380|NCT02137785|560683176|FG000|Overall Study|Withdrawal by Subject|1|||
155341381|NCT02137785|560683177|FG001|Overall Study|Withdrawal by Subject|4|||
155341382|NCT02137785|560683176|FG000|Overall Study|subject moved out of state|1|||
155341383|NCT02137785|560683177|FG001|Overall Study|subject moved out of state|0|||
155341384|NCT00417885|560683178|FG000|Overall Study|Adverse Event|1|||
155341385|NCT00417885|560683178|FG000|Overall Study|Objective Progression or Relapse|3|||
155341386|NCT00417885|560683178|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
155341387|NCT02309892|560683179|FG000|Overall Study|Physician Decision|1|||
155341388|NCT02309892|560683180|FG001|Overall Study|Physician Decision|0|||
155341389|NCT02309892|560683181|FG002|Overall Study|Physician Decision|0|||
155341390|NCT02309892|560683182|FG003|Overall Study|Physician Decision|0|||
155341391|NCT02309892|560683183|FG004|Overall Study|Physician Decision|0|||
155341392|NCT02309892|560683184|FG005|Overall Study|Physician Decision|0|||
155341393|NCT02309892|560683185|FG006|Overall Study|Physician Decision|0|||
155341394|NCT02309892|560683179|FG000|Overall Study|Adverse Event|1|||
155341395|NCT02309892|560683180|FG001|Overall Study|Adverse Event|0|||
155341396|NCT02309892|560683181|FG002|Overall Study|Adverse Event|1|||
155341397|NCT02309892|560683182|FG003|Overall Study|Adverse Event|0|||
155341398|NCT02309892|560683183|FG004|Overall Study|Adverse Event|0|||
155341399|NCT02309892|560683184|FG005|Overall Study|Adverse Event|0|||
155341400|NCT02309892|560683185|FG006|Overall Study|Adverse Event|0|||
155341401|NCT02309892|560683179|FG000|Overall Study|Progressive Disease|0|||
155341402|NCT02309892|560683180|FG001|Overall Study|Progressive Disease|1|||
155341403|NCT02309892|560683181|FG002|Overall Study|Progressive Disease|0|||
155341404|NCT02309892|560683182|FG003|Overall Study|Progressive Disease|0|||
155341405|NCT02309892|560683183|FG004|Overall Study|Progressive Disease|1|||
155341406|NCT02309892|560683184|FG005|Overall Study|Progressive Disease|0|||
155341407|NCT02309892|560683185|FG006|Overall Study|Progressive Disease|0|||
155341408|NCT02309892|560683179|FG000|Overall Study|Death|0|||
155341409|NCT02309892|560683180|FG001|Overall Study|Death|0|||
155341410|NCT02309892|560683181|FG002|Overall Study|Death|0|||
155341411|NCT02309892|560683182|FG003|Overall Study|Death|0|||
155341412|NCT02309892|560683183|FG004|Overall Study|Death|0|||
155341413|NCT02309892|560683184|FG005|Overall Study|Death|1|||
155341414|NCT02309892|560683185|FG006|Overall Study|Death|0|||
155341415|NCT01584648|560683186|FG000|Overall Study|Death|136|||
155341416|NCT01584648|560683187|FG001|Overall Study|Death|146|||
155341417|NCT01584648|560683186|FG000|Overall Study|Lost to Follow-up|9|||
155341418|NCT01584648|560683187|FG001|Overall Study|Lost to Follow-up|9|||
155341419|NCT01584648|560683186|FG000|Overall Study|Investigator discretion|3|||
155341420|NCT01584648|560683187|FG001|Overall Study|Investigator discretion|2|||
155341421|NCT01584648|560683186|FG000|Overall Study|Withdrew consent|13|||
155341422|NCT01584648|560683187|FG001|Overall Study|Withdrew consent|4|||
155341423|NCT01584648|560683186|FG000|Overall Study|Study closed/terminated|50|||
155341424|NCT01584648|560683187|FG001|Overall Study|Study closed/terminated|23|||
155341425|NCT01584648|560683186|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
155341426|NCT01584648|560683187|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
155341427|NCT03146845|560683188|FG000|Overall Study|Reference ulcer healed|1|||
155341428|NCT03146845|560683189|FG001|Overall Study|Reference ulcer healed|0|||
155341429|NCT03146845|560683188|FG000|Overall Study|Physician Decision|1|||
155341430|NCT03146845|560683189|FG001|Overall Study|Physician Decision|0|||
155341431|NCT03146845|560683188|FG000|Overall Study|Adverse Event|1|||
155341432|NCT03146845|560683189|FG001|Overall Study|Adverse Event|0|||
155341433|NCT03146845|560683188|FG000|Overall Study|Withdrawal by Subject|2|||
155341434|NCT03146845|560683189|FG001|Overall Study|Withdrawal by Subject|0|||
155341435|NCT03146845|560683188|FG000|Overall Study|Noncompliance|0|||
155341436|NCT03146845|560683189|FG001|Overall Study|Noncompliance|1|||
155341437|NCT03146845|560683188|FG000|Overall Study|Protocol Violation|0|||
155341438|NCT03146845|560683189|FG001|Overall Study|Protocol Violation|2|||
155341439|NCT03146845|560683188|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
155341440|NCT03146845|560683189|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
155341441|NCT01757288|560683198|FG000|Overall Study|Consent withdrawal|0|||
155341442|NCT01757288|560683199|FG001|Overall Study|Consent withdrawal|4|||
155341443|NCT01757288|560683200|FG002|Overall Study|Consent withdrawal|4|||
155341444|NCT01757288|560683198|FG000|Overall Study|Patient off study, IRB hold.|0|||
155341445|NCT01757288|560683199|FG001|Overall Study|Patient off study, IRB hold.|0|||
155341446|NCT01757288|560683200|FG002|Overall Study|Patient off study, IRB hold.|1|||
155341447|NCT01757288|560683198|FG000|Overall Study|Patient death prior to starting treatment|0|||
155341448|NCT01757288|560683199|FG001|Overall Study|Patient death prior to starting treatment|0|||
155341449|NCT01757288|560683200|FG002|Overall Study|Patient death prior to starting treatment|1|||
155341450|NCT01757288|560683198|FG000|Overall Study|Wrong medication administered|0|||
155341451|NCT01757288|560683199|FG001|Overall Study|Wrong medication administered|1|||
155341452|NCT01757288|560683200|FG002|Overall Study|Wrong medication administered|0|||
155341453|NCT01757288|560683198|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
155341454|NCT01757288|560683199|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
155341455|NCT01757288|560683200|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
155341456|NCT01757288|560683198|FG000|Overall Study|Not meeting protocol constraints|0|||
155341457|NCT01757288|560683199|FG001|Overall Study|Not meeting protocol constraints|1|||
155341458|NCT01757288|560683200|FG002|Overall Study|Not meeting protocol constraints|1|||
155341459|NCT01757288|560683198|FG000|Overall Study|Multiple missed appointments|0|||
155341460|NCT01757288|560683199|FG001|Overall Study|Multiple missed appointments|1|||
155341461|NCT01757288|560683200|FG002|Overall Study|Multiple missed appointments|0|||
155341462|NCT01757288|560683198|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
155341463|NCT01757288|560683199|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
155341464|NCT01757288|560683200|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
155341465|NCT01757288|560683198|FG000|Overall Study|>2 weeks treatment break|0|||
155164563|NCT01958164|560038973|FG000|Overall Study|Lost to Follow-up|2|||
155164564|NCT01958164|560038974|FG001|Overall Study|Lost to Follow-up|3|||
155164565|NCT00354432|560038978|FG000|Overall Study|Adverse Event|3|||
155164566|NCT00354432|560038979|FG001|Overall Study|Adverse Event|1|||
155164567|NCT00354432|560038980|FG002|Overall Study|Adverse Event|5|||
155164568|NCT00354432|560038981|FG003|Overall Study|Adverse Event|5|||
155164569|NCT00354432|560038978|FG000|Overall Study|Off/Toxicity|3|||
155164570|NCT00354432|560038979|FG001|Overall Study|Off/Toxicity|7|||
155164571|NCT00354432|560038980|FG002|Overall Study|Off/Toxicity|5|||
155164572|NCT00354432|560038981|FG003|Overall Study|Off/Toxicity|5|||
155164573|NCT03843541|560038982|FG000|Overall Study|Adverse Event|4|||
155164574|NCT03843541|560038983|FG001|Overall Study|Adverse Event|2|||
155164575|NCT03843541|560038984|FG002|Overall Study|Adverse Event|3|||
155164576|NCT03843541|560038982|FG000|Overall Study|Death|1|||
155164577|NCT03843541|560038983|FG001|Overall Study|Death|0|||
155164578|NCT03843541|560038984|FG002|Overall Study|Death|0|||
155164579|NCT03843541|560038982|FG000|Overall Study|Lack of adherence to study medication|0|||
155164580|NCT03843541|560038983|FG001|Overall Study|Lack of adherence to study medication|0|||
155164581|NCT03843541|560038984|FG002|Overall Study|Lack of adherence to study medication|1|||
155164582|NCT03843541|560038982|FG000|Overall Study|Physician Decision|1|||
155164583|NCT03843541|560038983|FG001|Overall Study|Physician Decision|2|||
155164584|NCT03843541|560038984|FG002|Overall Study|Physician Decision|2|||
155164585|NCT03843541|560038982|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
155164586|NCT03843541|560038983|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
155164587|NCT03843541|560038984|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
155164588|NCT03843541|560038982|FG000|Overall Study|Withdrawal by Subject|6|||
155164589|NCT03843541|560038983|FG001|Overall Study|Withdrawal by Subject|9|||
155164590|NCT03843541|560038984|FG002|Overall Study|Withdrawal by Subject|7|||
155164591|NCT03843541|560038982|FG000|Overall Study|Administration of rescue mucolytic|0|||
155164592|NCT03843541|560038983|FG001|Overall Study|Administration of rescue mucolytic|0|||
155164593|NCT03843541|560038984|FG002|Overall Study|Administration of rescue mucolytic|1|||
155164594|NCT03843541|560038982|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
155341466|NCT01757288|560683199|FG001|Overall Study|>2 weeks treatment break|0|||
155341467|NCT01757288|560683200|FG002|Overall Study|>2 weeks treatment break|1|||
155341468|NCT02825550|560683202|FG000|Overall Study|Physician Decision|1|||
155341469|NCT03386344|560683203|FG000|Overall Study|Adverse Event|6|||
155341470|NCT03386344|560683204|FG001|Overall Study|Adverse Event|3|||
155341471|NCT03386344|560683205|FG002|Overall Study|Adverse Event|1|||
155341472|NCT03386344|560683203|FG000|Overall Study|Poor Compliance to Protocol|0|||
155341473|NCT03386344|560683204|FG001|Overall Study|Poor Compliance to Protocol|1|||
155341474|NCT03386344|560683205|FG002|Overall Study|Poor Compliance to Protocol|0|||
155164595|NCT03843541|560038983|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
155164596|NCT03843541|560038984|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
155341475|NCT03386344|560683203|FG000|Overall Study|Study Terminated by Sponsor|101|||
155341476|NCT03386344|560683204|FG001|Overall Study|Study Terminated by Sponsor|102|||
155341477|NCT03386344|560683205|FG002|Overall Study|Study Terminated by Sponsor|106|||
155341478|NCT03386344|560683203|FG000|Overall Study|Lost to Follow-up|3|||
155341479|NCT03386344|560683204|FG001|Overall Study|Lost to Follow-up|2|||
155341480|NCT03386344|560683205|FG002|Overall Study|Lost to Follow-up|1|||
155164597|NCT02930018|560038986|FG000|Overall Study|Lost to Follow-up|1|||
154963080|NCT02554890|559289611|FG001|Double-blind|Technical problems|0|||
155341481|NCT03386344|560683203|FG000|Overall Study|At the Participant's own Request|7|||
155341482|NCT03386344|560683204|FG001|Overall Study|At the Participant's own Request|7|||
155341483|NCT03386344|560683205|FG002|Overall Study|At the Participant's own Request|8|||
155341484|NCT03386344|560683203|FG000|Overall Study|Reason not Specified|0|||
155341485|NCT03386344|560683204|FG001|Overall Study|Reason not Specified|1|||
155341486|NCT03386344|560683205|FG002|Overall Study|Reason not Specified|0|||
155341487|NCT00248794|560683214|FG000|Overall Study|Lost to Follow-up|6|||
155341488|NCT00248794|560683215|FG001|Overall Study|Lost to Follow-up|8|||
155341489|NCT00248794|560683216|FG002|Overall Study|Lost to Follow-up|3|||
155341490|NCT04421456|560683217|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
155341491|NCT04421456|560683218|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
155341492|NCT04421456|560683219|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
155341493|NCT04421456|560683217|FG000|Randomized Treatment Period|Adverse Event|0|||
155341494|NCT04421456|560683218|FG001|Randomized Treatment Period|Adverse Event|1|||
155341495|NCT04421456|560683219|FG002|Randomized Treatment Period|Adverse Event|0|||
155341496|NCT04421456|560683217|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
155341497|NCT04421456|560683218|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
155341498|NCT04421456|560683219|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
155341499|NCT04421456|560683217|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
155341500|NCT04421456|560683218|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
155341501|NCT04421456|560683219|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
155341502|NCT04421456|560683217|FG000|Randomized Treatment Period|Participant non-compliance|1|||
155341503|NCT04421456|560683218|FG001|Randomized Treatment Period|Participant non-compliance|1|||
155341504|NCT04421456|560683219|FG002|Randomized Treatment Period|Participant non-compliance|2|||
155341505|NCT04421456|560683217|FG000|Randomized Treatment Period|Other|0|||
155341506|NCT04421456|560683218|FG001|Randomized Treatment Period|Other|1|||
155075730|NCT01734928|559706902|FG001|Treatment Period|Pregnancy|1|||
155341507|NCT04421456|560683219|FG002|Randomized Treatment Period|Other|3|||
155341508|NCT03209492|560683220|FG000|Overall Study|Case Report Forms Uncollected|5|||
155341509|NCT03481725|560683221|FG000|Overall Study|Withdrawal by Subject|1|||
155341510|NCT03481725|560683222|FG001|Overall Study|Withdrawal by Subject|0|||
155341511|NCT01894620|560683227|FG000|Overall Study|Withdrawal by Subject|0|||
155341512|NCT01894620|560683228|FG001|Overall Study|Withdrawal by Subject|1|||
155341513|NCT02877680|560683229|FG000|Overall Study|Lost to Follow-up|1|||
155341514|NCT02877680|560683230|FG001|Overall Study|Lost to Follow-up|1|||
155341515|NCT01133678|560683231|FG000|Overall Study|Death|1|||
155341516|NCT01133678|560683232|FG001|Overall Study|Death|1|||
155341517|NCT00879710|560683239|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
155341518|NCT00879710|560683240|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
155341519|NCT00879710|560683241|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
155341520|NCT00879710|560683242|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
155341521|NCT00879710|560683239|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
155341522|NCT00879710|560683240|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
155341523|NCT00879710|560683241|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
155341524|NCT00879710|560683242|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
155341525|NCT01864200|560683243|FG000|Overall Study|Lost to Follow-up|1|||
155341526|NCT01864200|560683244|FG001|Overall Study|Lost to Follow-up|3|||
155341527|NCT01864200|560683243|FG000|Overall Study|Protocol Violation|1|||
155075731|NCT01629563|559706904|FG000|Overall Study|Adverse Event|16|||
155075732|NCT01629563|559706905|FG001|Overall Study|Adverse Event|16|||
155075733|NCT01629563|559706904|FG000|Overall Study|Death|2|||
155075734|NCT01629563|559706905|FG001|Overall Study|Death|0|||
155075735|NCT01629563|559706904|FG000|Overall Study|Lack of Efficacy|2|||
155075736|NCT01629563|559706905|FG001|Overall Study|Lack of Efficacy|3|||
155075737|NCT01629563|559706904|FG000|Overall Study|Lost to Follow-up|1|||
155075738|NCT01629563|559706905|FG001|Overall Study|Lost to Follow-up|0|||
155075739|NCT01629563|559706904|FG000|Overall Study|Pregnancy|1|||
155075740|NCT01629563|559706905|FG001|Overall Study|Pregnancy|2|||
155075741|NCT01629563|559706904|FG000|Overall Study|Protocol Violation|0|||
155075742|NCT01629563|559706905|FG001|Overall Study|Protocol Violation|1|||
155075743|NCT01629563|559706904|FG000|Overall Study|Withdrawal by Subject|27|||
155075744|NCT01629563|559706905|FG001|Overall Study|Withdrawal by Subject|20|||
155075745|NCT01629563|559706904|FG000|Overall Study|surgery|0|||
155075746|NCT01629563|559706905|FG001|Overall Study|surgery|3|||
155075747|NCT01629563|559706904|FG000|Overall Study|Lack of return of menses|12|||
155075748|NCT01629563|559706905|FG001|Overall Study|Lack of return of menses|7|||
155075749|NCT01629563|559706904|FG000|Overall Study|Protocol Violation|0|||
155075750|NCT01629563|559706905|FG001|Overall Study|Protocol Violation|1|||
155075751|NCT00088881|559706907|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
155075752|NCT00088881|559706907|FG000|Step 1 - R-CHOP|Adverse Event|1|||
155075753|NCT00088881|559706907|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
155075754|NCT00088881|559706907|FG000|Step 1 - R-CHOP|Physician Decision|1|||
155075755|NCT00088881|559706907|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
155075756|NCT00088881|559706907|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
155075757|NCT00088881|559706907|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
155075758|NCT03684057|559706909|FG000|Overall Study|Withdrawal by Subject|4|||
155075759|NCT03684057|559706910|FG001|Overall Study|Withdrawal by Subject|5|||
155075760|NCT00456612|559706912|FG000|Overall Study|Withdrawal by Subject|3|||
155075761|NCT02316613|559706913|FG000|Overall Study|Death|63|||
155075762|NCT02316613|559706913|FG000|Overall Study|Lost to Follow-up|9|||
155075763|NCT02316613|559706913|FG000|Overall Study|Lymphoma transformation|2|||
155075764|NCT02316613|559706913|FG000|Overall Study|Participant moved/changed medical team|11|||
155075765|NCT02316613|559706913|FG000|Overall Study|No data and duplicate cases|5|||
155075766|NCT02316613|559706913|FG000|Overall Study|Did not met selection criteria|14|||
155075767|NCT03422718|559706923|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
155341528|NCT01864200|560683244|FG001|Overall Study|Protocol Violation|0|||
155341529|NCT02077374|560683245|FG000|Overall Study|Withdrawal by Subject|0|||
155341530|NCT02077374|560683246|FG001|Overall Study|Withdrawal by Subject|1|||
155341531|NCT02077374|560683245|FG000|Overall Study|Protocol Violation|0|||
155341532|NCT02077374|560683246|FG001|Overall Study|Protocol Violation|1|||
155341533|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
155341534|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341535|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341536|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341537|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
155341538|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Adverse Event|0|||
155341539|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Adverse Event|1|||
155341540|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Adverse Event|1|||
155341541|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Adverse Event|0|||
155341542|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Adverse Event|0|||
155341543|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
155341544|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341545|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341546|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341547|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
155341548|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Physician Decision|1|||
155341549|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Physician Decision|0|||
155341550|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Physician Decision|0|||
155341551|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Physician Decision|0|||
155341552|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Physician Decision|0|||
155341553|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
155341554|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
155341555|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
155341556|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
155341557|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
155341558|NCT00446095|560683247|FG000|Phase II (8 Weeks)|Ongoing|0|||
155341559|NCT00446095|560683248|FG001|Phase II (8 Weeks)|Ongoing|0|||
155341560|NCT00446095|560683249|FG002|Phase II (8 Weeks)|Ongoing|1|||
155341561|NCT00446095|560683250|FG003|Phase II (8 Weeks)|Ongoing|0|||
155341562|NCT00446095|560683251|FG004|Phase II (8 Weeks)|Ongoing|0|||
155341563|NCT00446095|560683247|FG000|Phase I (28 Days)|Adverse Event|0|||
155341564|NCT00446095|560683248|FG001|Phase I (28 Days)|Adverse Event|0|||
155341565|NCT00446095|560683249|FG002|Phase I (28 Days)|Adverse Event|0|||
155341566|NCT00446095|560683250|FG003|Phase I (28 Days)|Adverse Event|1|||
155341567|NCT00446095|560683251|FG004|Phase I (28 Days)|Adverse Event|0|||
155341568|NCT00446095|560683247|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
155341569|NCT00446095|560683248|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
155341570|NCT00446095|560683249|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
155341571|NCT00446095|560683250|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
155341572|NCT00446095|560683251|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
155341573|NCT00424476|560683252|FG000|Overall Study|Withdrawal by Subject|7|||
155341574|NCT00424476|560683253|FG001|Overall Study|Withdrawal by Subject|6|||
155341575|NCT00424476|560683254|FG002|Overall Study|Withdrawal by Subject|3|||
155341576|NCT00424476|560683252|FG000|Overall Study|Adverse Event|19|||
155341577|NCT00424476|560683253|FG001|Overall Study|Adverse Event|16|||
155341578|NCT00424476|560683254|FG002|Overall Study|Adverse Event|15|||
155341579|NCT00424476|560683252|FG000|Overall Study|Lack of Efficacy|16|||
155341580|NCT00424476|560683253|FG001|Overall Study|Lack of Efficacy|12|||
155341581|NCT00424476|560683254|FG002|Overall Study|Lack of Efficacy|12|||
155341582|NCT00424476|560683252|FG000|Overall Study|Lack of Compliance|1|||
155341583|NCT00424476|560683253|FG001|Overall Study|Lack of Compliance|1|||
155341584|NCT00424476|560683254|FG002|Overall Study|Lack of Compliance|1|||
155341585|NCT00424476|560683252|FG000|Overall Study|Lost to Follow-up|4|||
155341586|NCT00424476|560683253|FG001|Overall Study|Lost to Follow-up|6|||
155341587|NCT00424476|560683254|FG002|Overall Study|Lost to Follow-up|3|||
155341588|NCT00424476|560683252|FG000|Overall Study|Protocol Violation|7|||
155341589|NCT00424476|560683253|FG001|Overall Study|Protocol Violation|2|||
155341590|NCT00424476|560683254|FG002|Overall Study|Protocol Violation|3|||
155341591|NCT00424476|560683252|FG000|Overall Study|Physician Decision|3|||
155341592|NCT00424476|560683253|FG001|Overall Study|Physician Decision|2|||
155341593|NCT00424476|560683254|FG002|Overall Study|Physician Decision|3|||
155341594|NCT00424476|560683252|FG000|Overall Study|Other|4|||
155341595|NCT00424476|560683253|FG001|Overall Study|Other|3|||
155341596|NCT00424476|560683254|FG002|Overall Study|Other|9|||
155341597|NCT00886834|560683255|FG000|Overall Study|Protocol Violation|0|||
155341598|NCT00886834|560683256|FG001|Overall Study|Protocol Violation|3|||
154963081|NCT02554890|559289610|FG000|Double-blind|Withdrawal by Subject|5|||
154963082|NCT02554890|559289611|FG001|Double-blind|Withdrawal by Subject|6|||
154963083|NCT02554890|559289610|FG000|Double-blind|Noncompliance with study treatment|6|||
154963084|NCT02554890|559289611|FG001|Double-blind|Noncompliance with study treatment|5|||
154963085|NCT02554890|559289610|FG000|Open-label|Adverse Event|0|||
155341599|NCT00657709|560683257|FG000|Overall Study|AE or Death|7|||
155341600|NCT00657709|560683258|FG001|Overall Study|AE or Death|7|||
155341601|NCT00657709|560683259|FG002|Overall Study|AE or Death|6|||
155341602|NCT00657709|560683260|FG003|Overall Study|AE or Death|7|||
155341603|NCT00657709|560683261|FG004|Overall Study|AE or Death|1|||
155341604|NCT00657709|560683257|FG000|Overall Study|Withdrawal by Subject|7|||
155341605|NCT00657709|560683258|FG001|Overall Study|Withdrawal by Subject|15|||
155341606|NCT00657709|560683259|FG002|Overall Study|Withdrawal by Subject|15|||
155341607|NCT00657709|560683260|FG003|Overall Study|Withdrawal by Subject|5|||
155341608|NCT00657709|560683261|FG004|Overall Study|Withdrawal by Subject|9|||
155341609|NCT00657709|560683257|FG000|Overall Study|Lost to Follow-up|9|||
155341610|NCT00657709|560683258|FG001|Overall Study|Lost to Follow-up|9|||
155341611|NCT00657709|560683259|FG002|Overall Study|Lost to Follow-up|7|||
155341612|NCT00657709|560683260|FG003|Overall Study|Lost to Follow-up|1|||
155341613|NCT00657709|560683261|FG004|Overall Study|Lost to Follow-up|21|||
155341614|NCT00657709|560683257|FG000|Overall Study|Protocol Violation|0|||
155341615|NCT00657709|560683258|FG001|Overall Study|Protocol Violation|2|||
155341616|NCT00657709|560683259|FG002|Overall Study|Protocol Violation|0|||
155341617|NCT00657709|560683260|FG003|Overall Study|Protocol Violation|1|||
155341618|NCT00657709|560683261|FG004|Overall Study|Protocol Violation|2|||
155341619|NCT02574286|560683262|FG000|Overall Study|Adverse Event|3|||
155341620|NCT02574286|560683262|FG000|Overall Study|Withdrawal by Subject|2|||
155341621|NCT01029925|560683265|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
155341622|NCT01029925|560683265|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
155341623|NCT01029925|560683265|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
155341624|NCT02279732|560683266|FG000|Overall Study|Death|23|||
155341625|NCT02279732|560683267|FG001|Overall Study|Death|20|||
155341626|NCT02279732|560683266|FG000|Overall Study|Disease Progression|13|||
155341627|NCT02279732|560683267|FG001|Overall Study|Disease Progression|3|||
155341628|NCT02279732|560683266|FG000|Overall Study|Withdrawal by Subject|2|||
155341629|NCT02279732|560683267|FG001|Overall Study|Withdrawal by Subject|7|||
155341630|NCT02279732|560683266|FG000|Overall Study|Adverse Event|1|||
155341631|NCT02279732|560683267|FG001|Overall Study|Adverse Event|2|||
155341632|NCT02279732|560683266|FG000|Overall Study|Administrative Reason By Sponsor|0|||
155341633|NCT02279732|560683267|FG001|Overall Study|Administrative Reason By Sponsor|2|||
155341634|NCT02279732|560683266|FG000|Overall Study|Study Drug Toxicity|2|||
155341635|NCT02279732|560683267|FG001|Overall Study|Study Drug Toxicity|0|||
155341636|NCT02279732|560683266|FG000|Overall Study|Lost to Follow-up|0|||
155341637|NCT02279732|560683267|FG001|Overall Study|Lost to Follow-up|1|||
155341638|NCT02279732|560683266|FG000|Overall Study|Maximum Clinical Benefit|1|||
155341639|NCT02279732|560683267|FG001|Overall Study|Maximum Clinical Benefit|0|||
155341640|NCT02279732|560683266|FG000|Overall Study|Subject Requested to Discontinue|0|||
155341641|NCT02279732|560683267|FG001|Overall Study|Subject Requested to Discontinue|1|||
155341642|NCT02279732|560683266|FG000|Overall Study|Other|53|||
155341643|NCT02279732|560683267|FG001|Overall Study|Other|67|||
155341644|NCT02279732|560683266|FG000|Overall Study|Other|3|||
155341645|NCT02279732|560683267|FG001|Overall Study|Other|3|||
155341646|NCT02203513|560683268|FG000|Overall Study|Refused further treatment|2|||
155341647|NCT02203513|560683269|FG001|Overall Study|Refused further treatment|0|||
155341648|NCT02203513|560683270|FG002|Overall Study|Refused further treatment|1|||
155341649|NCT02203513|560683271|FG003|Overall Study|Refused further treatment|0|||
155341650|NCT02203513|560683272|FG004|Overall Study|Refused further treatment|0|||
155341651|NCT02203513|560683268|FG000|Overall Study|Switched to alternative treatment|3|||
155341652|NCT02203513|560683269|FG001|Overall Study|Switched to alternative treatment|4|||
155341653|NCT02203513|560683270|FG002|Overall Study|Switched to alternative treatment|0|||
155075768|NCT03422718|559706924|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
155075769|NCT03422718|559706925|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
155075770|NCT03422718|559706926|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
155341654|NCT02203513|560683271|FG003|Overall Study|Switched to alternative treatment|0|||
155341655|NCT02203513|560683272|FG004|Overall Study|Switched to alternative treatment|4|||
155341656|NCT02203513|560683268|FG000|Overall Study|Did not receive investigational product (IP)|0|||
155341657|NCT02203513|560683269|FG001|Overall Study|Did not receive investigational product (IP)|1|||
155341658|NCT02203513|560683270|FG002|Overall Study|Did not receive investigational product (IP)|0|||
155341659|NCT02203513|560683271|FG003|Overall Study|Did not receive investigational product (IP)|0|||
155341660|NCT02203513|560683272|FG004|Overall Study|Did not receive investigational product (IP)|0|||
155341661|NCT02203513|560683268|FG000|Overall Study|Death (unrelated to study therapy)|1|||
155341662|NCT02203513|560683269|FG001|Overall Study|Death (unrelated to study therapy)|3|||
155341663|NCT02203513|560683270|FG002|Overall Study|Death (unrelated to study therapy)|1|||
155341664|NCT02203513|560683271|FG003|Overall Study|Death (unrelated to study therapy)|0|||
155341665|NCT02203513|560683272|FG004|Overall Study|Death (unrelated to study therapy)|2|||
155341666|NCT02203513|560683268|FG000|Overall Study|Lost to Follow-up|0|||
155341667|NCT02203513|560683269|FG001|Overall Study|Lost to Follow-up|0|||
155341668|NCT02203513|560683270|FG002|Overall Study|Lost to Follow-up|1|||
155341669|NCT02203513|560683271|FG003|Overall Study|Lost to Follow-up|1|||
155341670|NCT02203513|560683272|FG004|Overall Study|Lost to Follow-up|0|||
155341671|NCT03060525|560683274|FG000|Overall Study|moved out of state|1|||
155341672|NCT03060525|560683275|FG001|Overall Study|moved out of state|1|||
155341673|NCT03060525|560683276|FG002|Overall Study|moved out of state|1|||
155341674|NCT03060525|560683277|FG003|Overall Study|moved out of state|1|||
155341675|NCT03060525|560683274|FG000|Overall Study|unable to meet time commitment required of study|2|||
155341676|NCT03060525|560683275|FG001|Overall Study|unable to meet time commitment required of study|3|||
155341677|NCT03060525|560683276|FG002|Overall Study|unable to meet time commitment required of study|3|||
155341678|NCT03060525|560683277|FG003|Overall Study|unable to meet time commitment required of study|1|||
155341679|NCT03060525|560683274|FG000|Overall Study|no longer interested in doing intervention|0|||
155341680|NCT03060525|560683275|FG001|Overall Study|no longer interested in doing intervention|0|||
155341681|NCT03060525|560683276|FG002|Overall Study|no longer interested in doing intervention|0|||
155341682|NCT03060525|560683277|FG003|Overall Study|no longer interested in doing intervention|1|||
155341683|NCT02978716|560683278|FG000|Overall Study|Death|25|||
155341684|NCT02978716|560683279|FG001|Overall Study|Death|13|||
155341685|NCT02978716|560683280|FG002|Overall Study|Death|20|||
155341686|NCT02978716|560683278|FG000|Overall Study|Lost to Follow-up|0|||
155341687|NCT02978716|560683279|FG001|Overall Study|Lost to Follow-up|0|||
155341688|NCT02978716|560683280|FG002|Overall Study|Lost to Follow-up|1|||
155341689|NCT02978716|560683278|FG000|Overall Study|Withdrawal by Subject|6|||
155341690|NCT02978716|560683279|FG001|Overall Study|Withdrawal by Subject|4|||
155341691|NCT02978716|560683280|FG002|Overall Study|Withdrawal by Subject|5|||
155341692|NCT02978716|560683278|FG000|Overall Study|Sponsor terminated|2|||
155341693|NCT02978716|560683279|FG001|Overall Study|Sponsor terminated|13|||
155341694|NCT02978716|560683280|FG002|Overall Study|Sponsor terminated|9|||
155341695|NCT02978716|560683278|FG000|Overall Study|Other|1|||
155341696|NCT02978716|560683279|FG001|Overall Study|Other|3|||
155341697|NCT02978716|560683280|FG002|Overall Study|Other|0|||
155341698|NCT00960206|560683281|FG000|Overall Study|Death|7|||
155341699|NCT00960206|560683282|FG001|Overall Study|Death|4|||
155341700|NCT00960206|560683283|FG002|Overall Study|Death|1|||
155341701|NCT00960206|560683281|FG000|Overall Study|Unwilling/Unable to return|1|||
155341702|NCT00960206|560683282|FG001|Overall Study|Unwilling/Unable to return|2|||
155341703|NCT00960206|560683283|FG002|Overall Study|Unwilling/Unable to return|0|||
155341704|NCT00960206|560683281|FG000|Overall Study|Lost to Follow-up|8|||
155341705|NCT00960206|560683282|FG001|Overall Study|Lost to Follow-up|14|||
155341706|NCT00960206|560683283|FG002|Overall Study|Lost to Follow-up|8|||
155341707|NCT00960206|560683281|FG000|Overall Study|Withdrawal by Subject|2|||
155341708|NCT00960206|560683282|FG001|Overall Study|Withdrawal by Subject|4|||
155341709|NCT00960206|560683283|FG002|Overall Study|Withdrawal by Subject|0|||
155341710|NCT00960206|560683281|FG000|Overall Study|Revision of study component|2|||
155341711|NCT00960206|560683282|FG001|Overall Study|Revision of study component|2|||
155164598|NCT02930018|560038987|FG001|Overall Study|Lost to Follow-up|1|||
155341712|NCT00960206|560683283|FG002|Overall Study|Revision of study component|2|||
155341713|NCT00960206|560683281|FG000|Overall Study|Missing 10 year data|20|||
155341714|NCT00960206|560683282|FG001|Overall Study|Missing 10 year data|1|||
155341715|NCT00960206|560683283|FG002|Overall Study|Missing 10 year data|1|||
155341716|NCT02612285|560683286|FG000|Overall Study|Withdrawal by Subject|1|||
155341717|NCT02548585|560683287|FG000|Overall Study|Withdrawal by Subject|0|||
155341718|NCT02548585|560683288|FG001|Overall Study|Withdrawal by Subject|0|||
155341719|NCT02548585|560683289|FG002|Overall Study|Withdrawal by Subject|0|||
155341720|NCT02548585|560683290|FG003|Overall Study|Withdrawal by Subject|0|||
155341721|NCT02548585|560683291|FG004|Overall Study|Withdrawal by Subject|0|||
155341722|NCT02548585|560683292|FG005|Overall Study|Withdrawal by Subject|1|||
155341723|NCT02548585|560683293|FG006|Overall Study|Withdrawal by Subject|0|||
155341724|NCT02548585|560683287|FG000|Overall Study|Lost to Follow-up|1|||
155341725|NCT02548585|560683288|FG001|Overall Study|Lost to Follow-up|0|||
155341726|NCT02548585|560683289|FG002|Overall Study|Lost to Follow-up|0|||
155341727|NCT02548585|560683290|FG003|Overall Study|Lost to Follow-up|0|||
155341728|NCT02548585|560683291|FG004|Overall Study|Lost to Follow-up|0|||
155341729|NCT02548585|560683292|FG005|Overall Study|Lost to Follow-up|0|||
155341730|NCT02548585|560683293|FG006|Overall Study|Lost to Follow-up|0|||
155341731|NCT02548585|560683287|FG000|Overall Study|Other|1|||
155341732|NCT02548585|560683288|FG001|Overall Study|Other|0|||
155341733|NCT02548585|560683289|FG002|Overall Study|Other|0|||
155341734|NCT02548585|560683290|FG003|Overall Study|Other|2|||
155341735|NCT02548585|560683291|FG004|Overall Study|Other|3|||
155341736|NCT02548585|560683292|FG005|Overall Study|Other|0|||
155341737|NCT02548585|560683293|FG006|Overall Study|Other|1|||
155341738|NCT02548585|560683287|FG000|Overall Study|Randomized but not treated|0|||
155341739|NCT02548585|560683288|FG001|Overall Study|Randomized but not treated|0|||
155341740|NCT02548585|560683289|FG002|Overall Study|Randomized but not treated|0|||
155341741|NCT02548585|560683290|FG003|Overall Study|Randomized but not treated|0|||
155341742|NCT02548585|560683291|FG004|Overall Study|Randomized but not treated|0|||
155341743|NCT02548585|560683292|FG005|Overall Study|Randomized but not treated|1|||
155341744|NCT02548585|560683293|FG006|Overall Study|Randomized but not treated|0|||
155341745|NCT00452452|560683296|FG000|Overall Study|Protocol Violation|0|||
155341746|NCT00452452|560683297|FG001|Overall Study|Protocol Violation|0|||
155341747|NCT00452452|560683298|FG002|Overall Study|Protocol Violation|1|||
155341748|NCT00452452|560683296|FG000|Overall Study|Withdrawal by Subject|1|||
155341749|NCT00452452|560683297|FG001|Overall Study|Withdrawal by Subject|0|||
155341750|NCT00452452|560683298|FG002|Overall Study|Withdrawal by Subject|0|||
155341751|NCT00452452|560683296|FG000|Overall Study|Lost to Follow-up|1|||
155341752|NCT00452452|560683297|FG001|Overall Study|Lost to Follow-up|0|||
155341753|NCT00452452|560683298|FG002|Overall Study|Lost to Follow-up|0|||
155341754|NCT00711555|560684994|FG000|Overall Study|Adverse Event|3|||
155341755|NCT02068352|560685000|FG000|Overall Study|Lost to Follow-up|0|||
155341756|NCT02068352|560685001|FG001|Overall Study|Lost to Follow-up|2|||
155341757|NCT02068352|560685002|FG002|Overall Study|Lost to Follow-up|0|||
155341758|NCT02068352|560685000|FG000|Overall Study|Adverse Event|4|||
155341759|NCT02068352|560685001|FG001|Overall Study|Adverse Event|2|||
155341760|NCT02068352|560685002|FG002|Overall Study|Adverse Event|7|||
155341761|NCT02068352|560685000|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
155341762|NCT02068352|560685001|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
155341763|NCT02068352|560685002|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
155341764|NCT02068352|560685000|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
155341765|NCT02068352|560685001|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
155341766|NCT02068352|560685002|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
155341767|NCT02068352|560685000|FG000|Overall Study|Protocol Deviation|0|||
155341768|NCT02068352|560685001|FG001|Overall Study|Protocol Deviation|0|||
155341769|NCT02068352|560685002|FG002|Overall Study|Protocol Deviation|1|||
155341770|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
155341771|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
155341772|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
155341773|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
155341774|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
155341775|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
155341776|NCT03557307|560685008|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
155075771|NCT03422718|559706927|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
155075772|NCT03422718|559706928|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
155075773|NCT03422718|559706929|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
155075774|NCT03422718|559706930|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
155075775|NCT03422718|559706923|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
155075776|NCT03422718|559706924|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
155075777|NCT03422718|559706925|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
155341777|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
155341778|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Death|3|||
155341779|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
155341780|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
155341781|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
155075778|NCT03422718|559706926|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
155075779|NCT03422718|559706927|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
155341782|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
155341783|NCT03557307|560685008|FG000|Period 2: Maintenance Phase|other|3|||
155341784|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
155341785|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
155341786|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341787|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341788|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341789|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341790|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155341791|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
155341792|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
155341793|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
155341794|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341795|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341796|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341797|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155341798|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
155341799|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341800|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
155341801|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341802|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341803|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341804|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155341805|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341806|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
155341807|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341808|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341809|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341810|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341811|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155341812|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
155341813|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
155341814|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
155341815|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341816|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341817|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341818|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155341819|NCT03745651|560685009|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
155341820|NCT03745651|560685010|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
155341821|NCT03745651|560685011|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
155341822|NCT03745651|560685012|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341823|NCT03745651|560685013|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341824|NCT03745651|560685014|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341825|NCT03745651|560685015|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
155341826|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341827|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341828|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341829|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341830|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341831|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
155341832|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155341833|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341834|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155075780|NCT03422718|559706928|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
155075781|NCT03422718|559706929|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
155075782|NCT03422718|559706930|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
155075783|NCT03422718|559706923|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
155075784|NCT03422718|559706924|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
155075785|NCT03422718|559706925|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
155075786|NCT03422718|559706926|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
155075787|NCT03422718|559706927|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
155075788|NCT03422718|559706928|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
155075789|NCT03422718|559706929|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
155075790|NCT03422718|559706930|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
155341835|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341836|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
155341837|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155341838|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
155341839|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
155341840|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155341841|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155341842|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155341843|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
155341844|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
155341845|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
155341846|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
155341847|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341848|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341849|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341850|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
155341851|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155341852|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
155341853|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
155341854|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341855|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341856|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341857|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
155341858|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341859|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
155341860|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
155341861|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341862|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341863|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341864|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341865|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341866|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
155341867|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155341868|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155341869|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155341870|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155341871|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
155341872|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
155341873|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
155341874|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
155341875|NCT03745651|560685009|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341876|NCT03745651|560685010|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341877|NCT03745651|560685011|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341878|NCT03745651|560685012|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
155341879|NCT03745651|560685013|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
155341880|NCT03745651|560685014|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
155341881|NCT03745651|560685015|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
155341882|NCT03456856|560685016|FG000|Overall Study|Lost to Follow-up|2|||
155341883|NCT03456856|560685016|FG000|Overall Study|Withdrawal by Subject|1|||
155341884|NCT01190436|560685017|FG000|Overall Study|Lost to Follow-up|35|||
155341885|NCT01190436|560685017|FG000|Overall Study|Other|4|||
155341886|NCT00113529|560685018|FG000|Overall Study|Adverse Event|4|||
155341887|NCT00113529|560685018|FG000|Overall Study|Lack of Efficacy|20|||
155341888|NCT00113529|560685018|FG000|Overall Study|Decision of sponsor|6|||
155341889|NCT00113529|560685018|FG000|Overall Study|Withdrawal by Subject|4|||
155341890|NCT01077284|560685019|FG000|Overall Study|Adverse Event|2|||
155341891|NCT01077284|560685020|FG001|Overall Study|Adverse Event|0|||
155341892|NCT01077284|560685021|FG002|Overall Study|Adverse Event|1|||
155341893|NCT01077284|560685019|FG000|Overall Study|Lost to Follow-up|1|||
155164599|NCT02930018|560038986|FG000|Overall Study|Withdrawal by Subject|5|||
155164600|NCT02930018|560038987|FG001|Overall Study|Withdrawal by Subject|2|||
155164601|NCT03493464|560038988|FG000|Overall Study|Surgery not performed|1|||
155164602|NCT02807402|560038989|FG000|Overall Study|Failure to Return|1|||
155164603|NCT02807402|560038989|FG000|Overall Study|Death|3|||
155164604|NCT02807402|560038989|FG000|Overall Study|Other|2|||
155164605|NCT00684060|560040486|FG000|Overall Study|Lost to Follow-up|1|||
155164606|NCT00684060|560040487|FG001|Overall Study|Lost to Follow-up|0|||
155164607|NCT00684060|560040486|FG000|Overall Study|New stenosis identified|1|||
155164608|NCT00684060|560040487|FG001|Overall Study|New stenosis identified|0|||
155164609|NCT00684060|560040486|FG000|Overall Study|Unable to collect MRI|1|||
155164610|NCT00684060|560040487|FG001|Overall Study|Unable to collect MRI|2|||
155164611|NCT00684060|560040486|FG000|Overall Study|Death|0|||
155164612|NCT00684060|560040487|FG001|Overall Study|Death|1|||
155164613|NCT00702715|560040488|FG000|Overall Study|Lost to Follow-up|1|||
155164614|NCT00702715|560040489|FG001|Overall Study|Lost to Follow-up|0|||
155164615|NCT01677377|560040490|FG000|Overall Study|Protocol Violation|1|||
155164616|NCT01677377|560040491|FG001|Overall Study|Protocol Violation|0|||
155164617|NCT01677377|560040492|FG002|Overall Study|Protocol Violation|0|||
155164618|NCT01677377|560040490|FG000|Overall Study|Lost to Follow-up|0|||
155164619|NCT01677377|560040491|FG001|Overall Study|Lost to Follow-up|1|||
155164620|NCT01677377|560040492|FG002|Overall Study|Lost to Follow-up|1|||
155164621|NCT01677377|560040490|FG000|Overall Study|Withdrawal by Subject|0|||
155164622|NCT01677377|560040491|FG001|Overall Study|Withdrawal by Subject|0|||
155164623|NCT01677377|560040492|FG002|Overall Study|Withdrawal by Subject|3|||
155164624|NCT01677377|560040490|FG000|Overall Study|Lack of Efficacy|0|||
155164625|NCT01677377|560040491|FG001|Overall Study|Lack of Efficacy|0|||
155164626|NCT01677377|560040492|FG002|Overall Study|Lack of Efficacy|1|||
155164627|NCT01677377|560040490|FG000|Overall Study|Pregnancy|0|||
155164628|NCT01677377|560040491|FG001|Overall Study|Pregnancy|0|||
155164629|NCT01677377|560040492|FG002|Overall Study|Pregnancy|1|||
155164630|NCT02260180|560040493|FG000|Overall Study|Adverse Event|2|||
155164631|NCT02260180|560040494|FG001|Overall Study|Adverse Event|0|||
155164632|NCT02260180|560040495|FG002|Overall Study|Adverse Event|1|||
155164633|NCT03180840|560040496|FG000|Overall Study|Withdrawal by Subject|1|||
155164634|NCT01788358|560040504|FG000|Overall Study|Other|11|||
155164635|NCT01788358|560040504|FG000|Overall Study|Logistical difficulties|1|||
155164636|NCT01788358|560040504|FG000|Overall Study|Lost to Follow-up|5|||
155164637|NCT01788358|560040504|FG000|Overall Study|Protocol Violation|3|||
155164638|NCT01788358|560040504|FG000|Overall Study|Withdrawal by Subject|26|||
155164639|NCT01788358|560040504|FG000|Overall Study|Lack of Efficacy|1|||
155164640|NCT01788358|560040504|FG000|Overall Study|Adverse Event|51|||
155164641|NCT01168219|560040505|FG000|Overall Study|off study before starting treatment|2|||
155164642|NCT01168219|560040505|FG000|Overall Study|withdrew before transplant|1|||
155164643|NCT01168219|560040505|FG000|Overall Study|ineligible due to CML|2|||
155341894|NCT01077284|560685020|FG001|Overall Study|Lost to Follow-up|2|||
155341895|NCT01077284|560685021|FG002|Overall Study|Lost to Follow-up|0|||
155341896|NCT01077284|560685019|FG000|Overall Study|Withdrawal by Subject|2|||
155341897|NCT01077284|560685020|FG001|Overall Study|Withdrawal by Subject|3|||
155341898|NCT01077284|560685021|FG002|Overall Study|Withdrawal by Subject|1|||
155341899|NCT01077284|560685019|FG000|Overall Study|Other|0|||
155341900|NCT01077284|560685020|FG001|Overall Study|Other|0|||
155341901|NCT01077284|560685021|FG002|Overall Study|Other|1|||
155341902|NCT04626128|560685022|FG000|Overall Study|Withdrawal by Subject|0|||
155341903|NCT04626128|560685023|FG001|Overall Study|Withdrawal by Subject|1|||
155341904|NCT04626128|560685024|FG002|Overall Study|Withdrawal by Subject|0|||
155341905|NCT04626128|560685025|FG003|Overall Study|Withdrawal by Subject|0|||
155341906|NCT00841321|560685026|FG000|Overall Study|Lost to Follow-up|1|||
155341907|NCT00841321|560685027|FG001|Overall Study|Lost to Follow-up|1|||
155341908|NCT00841321|560685026|FG000|Overall Study|Adverse Event|0|||
155164644|NCT01027273|560040507|FG000|Overall Study|Lost to Follow-up|57|||
155164645|NCT01027273|560040508|FG001|Overall Study|Lost to Follow-up|31|||
155164646|NCT01027273|560040507|FG000|Overall Study|Death|2|||
155164647|NCT01027273|560040508|FG001|Overall Study|Death|2|||
155164648|NCT01413204|560040511|FG000|Overall Study|Adverse Event|1|||
155164649|NCT01413204|560040512|FG001|Overall Study|Adverse Event|2|||
155164650|NCT01413204|560040513|FG002|Overall Study|Adverse Event|2|||
155164651|NCT01413204|560040511|FG000|Overall Study|Physician Decision|3|||
155164652|NCT01413204|560040512|FG001|Overall Study|Physician Decision|0|||
155164653|NCT01413204|560040513|FG002|Overall Study|Physician Decision|2|||
155164654|NCT01413204|560040511|FG000|Overall Study|Withdrawal by Subject|1|||
155341909|NCT00841321|560685027|FG001|Overall Study|Adverse Event|2|||
155341910|NCT02632747|560685028|FG000|Wash-out Period|Adverse Event|1|||
155164655|NCT01413204|560040512|FG001|Overall Study|Withdrawal by Subject|4|||
155341911|NCT02632747|560685029|FG001|Wash-out Period|Adverse Event|0|||
155341912|NCT04908488|560685030|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
155341913|NCT04908488|560685031|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
155341914|NCT04908488|560685030|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
155341915|NCT04908488|560685031|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
155341916|NCT03444155|560685032|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
155341917|NCT03444155|560685033|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
155341918|NCT01107912|560685034|FG000|Period 1|Adverse Event|0|||
155341919|NCT01107912|560685035|FG001|Period 1|Adverse Event|0|||
155341920|NCT01107912|560685036|FG002|Period 1|Adverse Event|0|||
155341921|NCT01107912|560685037|FG003|Period 1|Adverse Event|0|||
155341922|NCT01107912|560685038|FG004|Period 1|Adverse Event|2|||
155341923|NCT01107912|560685039|FG005|Period 1|Adverse Event|0|||
155341924|NCT01107912|560685034|FG000|Period 1|Physician Decision|0|||
155341925|NCT01107912|560685035|FG001|Period 1|Physician Decision|0|||
155341926|NCT01107912|560685036|FG002|Period 1|Physician Decision|0|||
155341927|NCT01107912|560685037|FG003|Period 1|Physician Decision|0|||
155341928|NCT01107912|560685038|FG004|Period 1|Physician Decision|1|||
155341929|NCT01107912|560685039|FG005|Period 1|Physician Decision|0|||
155341930|NCT01107912|560685034|FG000|Period 1|Withdrawal by Subject|1|||
155341931|NCT01107912|560685035|FG001|Period 1|Withdrawal by Subject|0|||
155341932|NCT01107912|560685036|FG002|Period 1|Withdrawal by Subject|0|||
155341933|NCT01107912|560685037|FG003|Period 1|Withdrawal by Subject|0|||
155341934|NCT01107912|560685038|FG004|Period 1|Withdrawal by Subject|0|||
155341935|NCT01107912|560685039|FG005|Period 1|Withdrawal by Subject|0|||
155341936|NCT01107912|560685034|FG000|Period 2|Physician Decision|0|||
155341937|NCT01107912|560685035|FG001|Period 2|Physician Decision|0|||
155341938|NCT01107912|560685036|FG002|Period 2|Physician Decision|1|||
155341939|NCT01107912|560685037|FG003|Period 2|Physician Decision|0|||
155341940|NCT01107912|560685038|FG004|Period 2|Physician Decision|0|||
155341941|NCT01107912|560685039|FG005|Period 2|Physician Decision|0|||
155341942|NCT01107912|560685034|FG000|Period 3|Adverse Event|0|||
155341943|NCT01107912|560685035|FG001|Period 3|Adverse Event|1|||
155341944|NCT01107912|560685036|FG002|Period 3|Adverse Event|1|||
155341945|NCT01107912|560685037|FG003|Period 3|Adverse Event|0|||
155341946|NCT01107912|560685038|FG004|Period 3|Adverse Event|0|||
155341947|NCT01107912|560685039|FG005|Period 3|Adverse Event|0|||
155341948|NCT01107912|560685034|FG000|Period 3|Withdrawal by Subject|0|||
155341949|NCT01107912|560685035|FG001|Period 3|Withdrawal by Subject|0|||
155341950|NCT01107912|560685036|FG002|Period 3|Withdrawal by Subject|0|||
155341951|NCT01107912|560685037|FG003|Period 3|Withdrawal by Subject|1|||
155341952|NCT01107912|560685038|FG004|Period 3|Withdrawal by Subject|0|||
155341953|NCT01107912|560685039|FG005|Period 3|Withdrawal by Subject|0|||
155341954|NCT01124916|560685044|FG000|Overall Study|Lost to Follow-up|3|||
155075791|NCT03422718|559706923|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155075792|NCT03422718|559706924|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
155075793|NCT03422718|559706925|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155075794|NCT03422718|559706926|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155075795|NCT03422718|559706927|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
155075796|NCT03422718|559706928|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
155075797|NCT03422718|559706929|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155075798|NCT03422718|559706930|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
155075799|NCT03422718|559706923|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
155075800|NCT03422718|559706924|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
155075801|NCT03422718|559706925|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
155075802|NCT03422718|559706926|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
155075803|NCT03422718|559706927|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
155075804|NCT03422718|559706928|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
155075805|NCT03422718|559706929|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
155075806|NCT03422718|559706930|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
155075807|NCT03422718|559706923|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
155075808|NCT03422718|559706924|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
155075809|NCT03422718|559706925|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
155075810|NCT03422718|559706926|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
155075811|NCT03422718|559706927|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
155075812|NCT03422718|559706928|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
155075813|NCT03422718|559706929|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
155075814|NCT03422718|559706930|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
155075815|NCT03309605|559706931|FG000|Overall Study|Adverse Event|0|||
155341955|NCT01124916|560685045|FG001|Overall Study|Lost to Follow-up|2|||
155341956|NCT00595959|560685046|FG000|Overall Study|Withdrawal by Subject|1|||
155341957|NCT00595959|560685046|FG000|Overall Study|Lost to Follow-up|1|||
155341958|NCT00963924|560685049|FG000|Overall Study|Adverse Event|1|||
155341959|NCT00963924|560685050|FG001|Overall Study|Adverse Event|0|||
155341960|NCT00963924|560685049|FG000|Overall Study|Withdrawal by Subject|0|||
155341961|NCT00963924|560685050|FG001|Overall Study|Withdrawal by Subject|1|||
155341962|NCT00963924|560685049|FG000|Overall Study|Changed antipsychotic|0|||
155341963|NCT00963924|560685050|FG001|Overall Study|Changed antipsychotic|1|||
155341964|NCT00963924|560685049|FG000|Overall Study|Lost to Follow-up|0|||
155341965|NCT00963924|560685050|FG001|Overall Study|Lost to Follow-up|1|||
155341966|NCT03875729|560685052|FG000|Overall Study|Adverse Event|0|||
155341967|NCT03875729|560685053|FG001|Overall Study|Adverse Event|5|||
155341968|NCT03875729|560685052|FG000|Overall Study|Withdrawal by Subject|8|||
155341969|NCT03875729|560685053|FG001|Overall Study|Withdrawal by Subject|11|||
155341970|NCT03875729|560685052|FG000|Overall Study|Pregnancy|0|||
155341971|NCT03875729|560685053|FG001|Overall Study|Pregnancy|1|||
155341972|NCT03875729|560685052|FG000|Overall Study|Lost to Follow-up|0|||
155341973|NCT03875729|560685053|FG001|Overall Study|Lost to Follow-up|5|||
155341974|NCT03875729|560685052|FG000|Overall Study|Personal reasons|2|||
155341975|NCT03875729|560685053|FG001|Overall Study|Personal reasons|0|||
155341976|NCT00753896|560685054|FG000|Overall Study|Adverse Event|4|||
155341977|NCT00753896|560685054|FG000|Overall Study|Death|1|||
155341978|NCT00753896|560685054|FG000|Overall Study|Lost to Follow-up|2|||
155341979|NCT00753896|560685054|FG000|Overall Study|Protocol Violation|1|||
155341980|NCT00753896|560685054|FG000|Overall Study|Withdrawal by Subject|4|||
155341981|NCT00753896|560685054|FG000|Overall Study|Entry Criteria Not Met|4|||
155341982|NCT01280656|560685055|FG000|Overall Study|Adverse Event|1|||
155341983|NCT01280656|560685056|FG001|Overall Study|Adverse Event|14|||
155341984|NCT01280656|560685057|FG002|Overall Study|Adverse Event|13|||
155341985|NCT01280656|560685055|FG000|Overall Study|Lack of Efficacy|1|||
155341986|NCT01280656|560685056|FG001|Overall Study|Lack of Efficacy|22|||
155341987|NCT01280656|560685057|FG002|Overall Study|Lack of Efficacy|38|||
155341988|NCT01280656|560685055|FG000|Overall Study|Treatment shortening (RGT)|0|||
155341989|NCT01280656|560685056|FG001|Overall Study|Treatment shortening (RGT)|4|||
155341990|NCT01280656|560685057|FG002|Overall Study|Treatment shortening (RGT)|5|||
155341991|NCT01280656|560685055|FG000|Overall Study|Other|1|||
155341992|NCT01280656|560685056|FG001|Overall Study|Other|7|||
155341993|NCT01280656|560685057|FG002|Overall Study|Other|7|||
155341994|NCT00952523|560685058|FG000|Overall Study|Withdrawal by Subject|7|||
155341995|NCT05265247|560685059|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
155341996|NCT05265247|560685060|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
155341997|NCT05265247|560685059|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
155341998|NCT05265247|560685060|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
155341999|NCT05265247|560685059|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
155342000|NCT05265247|560685060|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
155342001|NCT02159352|560685063|FG000|Overall Study|Adverse Event|3|||
155342002|NCT02159352|560685064|FG001|Overall Study|Adverse Event|1|||
155342003|NCT02159352|560685063|FG000|Overall Study|Withdrawal by Subject|0|||
155342004|NCT02159352|560685064|FG001|Overall Study|Withdrawal by Subject|1|||
155342005|NCT00529529|560685065|FG000|Overall Study|Adverse Event|12|||
155342006|NCT00529529|560685066|FG001|Overall Study|Adverse Event|17|||
155342007|NCT00529529|560685067|FG002|Overall Study|Adverse Event|8|||
155342008|NCT00529529|560685065|FG000|Overall Study|Subject withdrew consent|12|||
155342009|NCT00529529|560685066|FG001|Overall Study|Subject withdrew consent|9|||
155342010|NCT00529529|560685067|FG002|Overall Study|Subject withdrew consent|12|||
155342011|NCT00529529|560685065|FG000|Overall Study|Protocol deviation|8|||
155342012|NCT00529529|560685066|FG001|Overall Study|Protocol deviation|12|||
155342013|NCT00529529|560685067|FG002|Overall Study|Protocol deviation|5|||
155342014|NCT00529529|560685065|FG000|Overall Study|Lost to Follow-up|5|||
155342015|NCT00529529|560685066|FG001|Overall Study|Lost to Follow-up|3|||
155342016|NCT00529529|560685067|FG002|Overall Study|Lost to Follow-up|1|||
155342017|NCT00529529|560685065|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155342018|NCT00529529|560685066|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155342019|NCT00529529|560685067|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155342020|NCT00529529|560685065|FG000|Overall Study|Death|2|||
155342021|NCT00529529|560685066|FG001|Overall Study|Death|0|||
155342022|NCT00529529|560685067|FG002|Overall Study|Death|0|||
155342023|NCT00529529|560685065|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155342024|NCT00529529|560685066|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155342025|NCT00529529|560685067|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155342026|NCT00529529|560685065|FG000|Overall Study|Administrative problems|1|||
155342027|NCT00529529|560685066|FG001|Overall Study|Administrative problems|0|||
155342028|NCT00529529|560685067|FG002|Overall Study|Administrative problems|3|||
155342029|NCT04749797|560685072|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
155342030|NCT04749797|560685073|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
155342031|NCT04749797|560685074|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
155342032|NCT03072862|560685075|FG000|Overall Study|Withdrawal by Subject|4|||
155342033|NCT03072862|560685075|FG000|Overall Study|Lost to Follow-up|6|||
155342034|NCT03072862|560685075|FG000|Overall Study|Protocol Violation|4|||
155342035|NCT03072862|560685075|FG000|Overall Study|Physician Decision|2|||
155342036|NCT03072862|560685075|FG000|Overall Study|Death|1|||
155342037|NCT03072862|560685075|FG000|Overall Study|Adverse Event|1|||
155342038|NCT00632736|560685076|FG000|Overall Study|Adverse Event|104|||
155342039|NCT00632736|560685076|FG000|Overall Study|Lost to Follow-up|15|||
155342040|NCT00632736|560685076|FG000|Overall Study|Protocol Violation|14|||
155342041|NCT00632736|560685076|FG000|Overall Study|Withdrawal by Subject|99|||
155342042|NCT00632736|560685076|FG000|Overall Study|Lack of Efficacy|5|||
155342043|NCT00632736|560685076|FG000|Overall Study|Sponsor terminated study|5|||
155342044|NCT00632736|560685076|FG000|Overall Study|Non-compliance|10|||
155342045|NCT00632736|560685076|FG000|Overall Study|Other|16|||
155342046|NCT03347396|560685077|FG000|Part A (26 Weeks)|Adverse Event|1|||
155342047|NCT03347396|560685078|FG001|Part A (26 Weeks)|Adverse Event|0|||
155342048|NCT03347396|560685077|FG000|Part A (26 Weeks)|Death|0|||
155342049|NCT03347396|560685078|FG001|Part A (26 Weeks)|Death|1|||
155342050|NCT03347396|560685077|FG000|Part B (149 Weeks)|Adverse Event|1|||
155342051|NCT03347396|560685078|FG001|Part B (149 Weeks)|Adverse Event|1|||
155164656|NCT01413204|560040513|FG002|Overall Study|Withdrawal by Subject|4|||
155164657|NCT01413204|560040511|FG000|Overall Study|Clearly not eligible for the study|0|||
155164658|NCT01413204|560040512|FG001|Overall Study|Clearly not eligible for the study|0|||
155164659|NCT01413204|560040513|FG002|Overall Study|Clearly not eligible for the study|1|||
155164660|NCT01413204|560040511|FG000|Overall Study|Fasting plasma glucose level increased|1|||
155164661|NCT01413204|560040512|FG001|Overall Study|Fasting plasma glucose level increased|0|||
155342052|NCT03347396|560685077|FG000|Part B (149 Weeks)|Death|1|||
155342053|NCT03347396|560685078|FG001|Part B (149 Weeks)|Death|0|||
155342054|NCT00871715|560685079|FG000|Overall Study|Withdrawal by Subject|6|||
155342055|NCT00871715|560685080|FG001|Overall Study|Withdrawal by Subject|10|||
155342056|NCT00871715|560685081|FG002|Overall Study|Withdrawal by Subject|15|||
155342057|NCT00871715|560685079|FG000|Overall Study|Physician Decision|6|||
155342058|NCT00871715|560685080|FG001|Overall Study|Physician Decision|0|||
155342059|NCT00871715|560685081|FG002|Overall Study|Physician Decision|2|||
155342060|NCT00871715|560685079|FG000|Overall Study|Lost to Follow-up|3|||
155342061|NCT00871715|560685080|FG001|Overall Study|Lost to Follow-up|6|||
155342062|NCT00871715|560685081|FG002|Overall Study|Lost to Follow-up|9|||
155342063|NCT03015220|560685085|FG000|Overall Study|Withdrawal by Subject|3|||
155342064|NCT03015220|560685086|FG001|Overall Study|Withdrawal by Subject|2|||
155342065|NCT03015220|560685087|FG002|Overall Study|Withdrawal by Subject|2|||
155342066|NCT03015220|560685088|FG003|Overall Study|Withdrawal by Subject|2|||
155342067|NCT03015220|560685085|FG000|Overall Study|Lost to Follow-up|0|||
155342068|NCT03015220|560685086|FG001|Overall Study|Lost to Follow-up|0|||
155342069|NCT03015220|560685087|FG002|Overall Study|Lost to Follow-up|1|||
155342070|NCT03015220|560685088|FG003|Overall Study|Lost to Follow-up|0|||
155342071|NCT01670526|560685090|FG000|Overall Study|Withdrawal by Subject|3|||
155342072|NCT01670526|560685091|FG001|Overall Study|Withdrawal by Subject|1|||
155342073|NCT01670526|560685090|FG000|Overall Study|Lost to Follow-up|9|||
155342074|NCT01670526|560685091|FG001|Overall Study|Lost to Follow-up|5|||
155342075|NCT00392197|560685092|FG000|Overall Study|Adverse Event|4|||
155342076|NCT00392197|560685093|FG001|Overall Study|Adverse Event|12|||
155342077|NCT00392197|560685092|FG000|Overall Study|Lack of Efficacy|3|||
155342078|NCT00392197|560685093|FG001|Overall Study|Lack of Efficacy|4|||
155342079|NCT00392197|560685092|FG000|Overall Study|Lost to Follow-up|0|||
155342080|NCT00392197|560685093|FG001|Overall Study|Lost to Follow-up|1|||
155342081|NCT00392197|560685092|FG000|Overall Study|Physician Decision|3|||
155342082|NCT00392197|560685093|FG001|Overall Study|Physician Decision|2|||
155342083|NCT00392197|560685092|FG000|Overall Study|Protocol Violation|7|||
155342084|NCT00392197|560685093|FG001|Overall Study|Protocol Violation|5|||
155342085|NCT00392197|560685092|FG000|Overall Study|Withdrawal by Subject|4|||
155342086|NCT00392197|560685093|FG001|Overall Study|Withdrawal by Subject|6|||
155342087|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
155342088|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
155075816|NCT03309605|559706932|FG001|Overall Study|Adverse Event|0|||
155075817|NCT03309605|559706933|FG002|Overall Study|Adverse Event|0|||
155075818|NCT03309605|559706934|FG003|Overall Study|Adverse Event|1|||
155075819|NCT03309605|559706935|FG004|Overall Study|Adverse Event|0|||
155342089|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
155342090|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
155342091|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
155342092|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
155342093|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
155342094|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
155342095|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
155342096|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
155342097|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
155342098|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
155342099|NCT01794689|560685094|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
155342100|NCT01794689|560685095|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
155342101|NCT01794689|560685096|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
155342102|NCT01794689|560685097|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
155342103|NCT02312258|560685098|FG000|Overall Study|Lost to Follow-up|8|||
155342104|NCT02312258|560685099|FG001|Overall Study|Lost to Follow-up|8|||
155342105|NCT02312258|560685098|FG000|Overall Study|Withdrawal by Patient|49|||
155342106|NCT02312258|560685099|FG001|Overall Study|Withdrawal by Patient|76|||
155342107|NCT02312258|560685098|FG000|Overall Study|Reason not Specified|107|||
155342108|NCT02312258|560685099|FG001|Overall Study|Reason not Specified|159|||
155342109|NCT02312258|560685098|FG000|Overall Study|Missing|2|||
155342110|NCT02312258|560685099|FG001|Overall Study|Missing|1|||
155075820|NCT03309605|559706936|FG005|Overall Study|Adverse Event|0|||
155075821|NCT03309605|559706937|FG006|Overall Study|Adverse Event|2|||
155342111|NCT02312258|560685098|FG000|Overall Study|Death|115|||
155342112|NCT02312258|560685099|FG001|Overall Study|Death|181|||
155075822|NCT03309605|559706938|FG007|Overall Study|Adverse Event|1|||
155075823|NCT03309605|559706931|FG000|Overall Study|Withdrawal by Subject|0|||
155075824|NCT03309605|559706932|FG001|Overall Study|Withdrawal by Subject|0|||
155342113|NCT01970527|560685100|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
155342114|NCT01970527|560685101|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
155342115|NCT01970527|560685100|FG000|Treatment|Disease progression|0|||
155164662|NCT01413204|560040513|FG002|Overall Study|Fasting plasma glucose level increased|10|||
155164663|NCT00753649|560040514|FG000|Overall Study|Migrated/moved from study area|1|||
155164664|NCT00753649|560040515|FG001|Overall Study|Migrated/moved from study area|0|||
155342116|NCT01970527|560685101|FG001|Treatment|Disease progression|1|||
155342117|NCT01970527|560685100|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
155342118|NCT01970527|560685101|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
155342119|NCT01970527|560685100|FG000|Treatment|Death|0|||
155342120|NCT01970527|560685101|FG001|Treatment|Death|1|||
155342121|NCT01970527|560685100|FG000|Follow-up Clinic Visit|Disease progression|1|||
155342122|NCT01970527|560685101|FG001|Follow-up Clinic Visit|Disease progression|1|||
155342123|NCT01970527|560685100|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
155342124|NCT01970527|560685101|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
155342125|NCT01970527|560685100|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
155342126|NCT01970527|560685101|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
155342127|NCT01964547|560685102|FG000|Overall Study|Adverse Event|8|||
155342128|NCT01964547|560685103|FG001|Overall Study|Adverse Event|2|||
154963086|NCT02554890|559289611|FG001|Open-label|Adverse Event|30|||
154963087|NCT02554890|559289610|FG000|Open-label|Death|0|||
154963088|NCT02554890|559289611|FG001|Open-label|Death|1|||
154963089|NCT02554890|559289610|FG000|Open-label|Physician Decision|0|||
154963090|NCT02554890|559289611|FG001|Open-label|Physician Decision|1|||
154963091|NCT02554890|559289610|FG000|Open-label|Subject/Guardian decision|0|||
154963092|NCT02554890|559289611|FG001|Open-label|Subject/Guardian decision|11|||
154963093|NCT02554890|559289610|FG000|Open-label|Lost to Follow-up|0|||
154963094|NCT02554890|559289611|FG001|Open-label|Lost to Follow-up|7|||
154963095|NCT02554890|559289610|FG000|Open-label|Technical problems|0|||
154963096|NCT02554890|559289611|FG001|Open-label|Technical problems|1|||
154963097|NCT02554890|559289610|FG000|Open-label|Withdrawal by Subject|0|||
154963098|NCT02554890|559289611|FG001|Open-label|Withdrawal by Subject|1|||
154963099|NCT02430480|559289617|FG000|Overall Study|Death|1|||
154963100|NCT02430480|559289617|FG000|Overall Study|Anesthesia concerns|1|||
154963101|NCT02430480|559289617|FG000|Overall Study|Progressed on treatment|1|||
154963102|NCT01097577|559289625|FG000|Overall Study|Adverse Event|0|||
154963103|NCT01097577|559289626|FG001|Overall Study|Adverse Event|1|||
154963104|NCT01963728|559289629|FG000|Overall Study|Study terminated early|0|||
154963105|NCT01963728|559289630|FG001|Overall Study|Study terminated early|1|||
154963106|NCT01528696|559291083|FG000|Overall Study|See detailed description|18|||
154963107|NCT01528696|559291084|FG001|Overall Study|See detailed description|19|||
154963108|NCT01056484|559291085|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
154963109|NCT01056484|559291086|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
154963110|NCT01056484|559291085|FG000|Randomized Controlled Trial|Physician Decision|1|||
154963111|NCT01056484|559291086|FG001|Randomized Controlled Trial|Physician Decision|0|||
154963112|NCT01056484|559291085|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
154963113|NCT01056484|559291086|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
154963114|NCT00446966|559291087|FG000|Overall Study|Lost to Follow-up|10|||
154963115|NCT00446966|559291088|FG001|Overall Study|Lost to Follow-up|7|||
154963116|NCT01547286|559291089|FG000|Overall Study|Did not meet all eligibility criteria|1|||
154963117|NCT01547286|559291089|FG000|Overall Study|Physician Decision|1|||
154963118|NCT03502811|559291094|FG000|Overall Study|Death|157|||
154963119|NCT03502811|559291094|FG000|Overall Study|Withdrawal by Subject|105|||
154963120|NCT03502811|559291094|FG000|Overall Study|Lost to Follow-up|26|||
154963121|NCT03502811|559291094|FG000|Overall Study|No Visits (Missed)|31|||
154963122|NCT05239195|559291095|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
154963123|NCT05239195|559291096|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
154963124|NCT00081653|559291097|FG000|Overall Study|Adverse Event|23|||
154963125|NCT00081653|559291098|FG001|Overall Study|Adverse Event|17|||
154963126|NCT00081653|559291097|FG000|Overall Study|Lost to Follow-up|2|||
154963127|NCT00081653|559291098|FG001|Overall Study|Lost to Follow-up|4|||
155342129|NCT01964547|560685102|FG000|Overall Study|Withdrawal by Subject|4|||
155342130|NCT01964547|560685103|FG001|Overall Study|Withdrawal by Subject|7|||
155342131|NCT01964547|560685102|FG000|Overall Study|Lost to Follow-up|0|||
155342132|NCT01964547|560685103|FG001|Overall Study|Lost to Follow-up|1|||
155342133|NCT01964547|560685102|FG000|Overall Study|Withdrawal by Investigator|0|||
155342134|NCT01964547|560685103|FG001|Overall Study|Withdrawal by Investigator|1|||
155342135|NCT04447287|560685104|FG000|Period 1: Run-in Period|Adverse Event|3|||
155342136|NCT04447287|560685105|FG001|Period 1: Run-in Period|Adverse Event|0|||
155342137|NCT04447287|560685106|FG002|Period 1: Run-in Period|Adverse Event|0|||
155342138|NCT04447287|560685104|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
155342139|NCT04447287|560685105|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
155342140|NCT04447287|560685106|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
155342141|NCT04447287|560685104|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
155342142|NCT04447287|560685105|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
155342143|NCT04447287|560685106|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
155342144|NCT02147093|560685109|FG000|Period 1|Lost to Follow-up|0|||
155342145|NCT02147093|560685110|FG001|Period 1|Lost to Follow-up|1|||
155342146|NCT02147093|560685109|FG000|Period 2|Protocol Violation|2|||
155342147|NCT02147093|560685110|FG001|Period 2|Protocol Violation|0|||
155342148|NCT01229176|560685123|FG000|Overall Study|Withdrawal by Subject|0|||
155342149|NCT01229176|560685124|FG001|Overall Study|Withdrawal by Subject|0|||
155075825|NCT03309605|559706933|FG002|Overall Study|Withdrawal by Subject|0|||
155075826|NCT03309605|559706934|FG003|Overall Study|Withdrawal by Subject|0|||
155075827|NCT03309605|559706935|FG004|Overall Study|Withdrawal by Subject|1|||
155075828|NCT03309605|559706936|FG005|Overall Study|Withdrawal by Subject|0|||
155075829|NCT03309605|559706937|FG006|Overall Study|Withdrawal by Subject|1|||
155075830|NCT03309605|559706938|FG007|Overall Study|Withdrawal by Subject|1|||
155075831|NCT01129284|559706939|FG000|Overall Study|Adverse Event|2|||
155075832|NCT01129284|559706940|FG001|Overall Study|Adverse Event|0|||
155075833|NCT01129284|559706941|FG002|Overall Study|Adverse Event|1|||
155075834|NCT05788328|559706942|FG000|Treatment Period 4 (5 Days)|Other|1|||
155164665|NCT00753649|560040514|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
155164666|NCT00753649|560040515|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
155164667|NCT00753649|560040514|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
155164668|NCT00753649|560040515|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
155164669|NCT00753649|560040514|FG000|Overall Study|Protocol Violation|2|||
155164670|NCT00753649|560040515|FG001|Overall Study|Protocol Violation|0|||
155164671|NCT00372593|560040516|FG000|Overall Study|Adverse Event|43|||
155164672|NCT00372593|560040517|FG001|Overall Study|Adverse Event|45|||
155164673|NCT00372593|560040518|FG002|Overall Study|Adverse Event|0|||
155164674|NCT00372593|560040516|FG000|Overall Study|Death|16|||
155164675|NCT00372593|560040517|FG001|Overall Study|Death|20|||
155075835|NCT05788328|559706942|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
155075836|NCT02082483|559706943|FG000|Overall Study|Lost to Follow-up|1|||
155164676|NCT00372593|560040518|FG002|Overall Study|Death|1|||
155164677|NCT00372593|560040516|FG000|Overall Study|Lack of Efficacy|82|||
155342150|NCT01229176|560685125|FG002|Overall Study|Withdrawal by Subject|0|||
155342151|NCT01229176|560685126|FG003|Overall Study|Withdrawal by Subject|1|||
155342152|NCT01229176|560685127|FG004|Overall Study|Withdrawal by Subject|1|||
155342153|NCT01229176|560685128|FG005|Overall Study|Withdrawal by Subject|1|||
155342154|NCT01229176|560685129|FG006|Overall Study|Withdrawal by Subject|0|||
155342155|NCT01229176|560685130|FG007|Overall Study|Withdrawal by Subject|1|||
155342156|NCT01229176|560685123|FG000|Overall Study|Lost to Follow-up|0|||
155342157|NCT01229176|560685124|FG001|Overall Study|Lost to Follow-up|3|||
155342158|NCT01229176|560685125|FG002|Overall Study|Lost to Follow-up|0|||
155342159|NCT01229176|560685126|FG003|Overall Study|Lost to Follow-up|0|||
155342160|NCT01229176|560685127|FG004|Overall Study|Lost to Follow-up|1|||
155342161|NCT01229176|560685128|FG005|Overall Study|Lost to Follow-up|1|||
155342162|NCT01229176|560685129|FG006|Overall Study|Lost to Follow-up|0|||
155342163|NCT01229176|560685130|FG007|Overall Study|Lost to Follow-up|2|||
155342164|NCT03890484|560685131|FG000|Overall Study|Lost to Follow-up|1|||
155342165|NCT03890484|560685132|FG001|Overall Study|Lost to Follow-up|1|||
155342166|NCT00518206|560685133|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
155342167|NCT00518206|560685134|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
155342168|NCT00518206|560685133|FG000|Overall Study|Withdrawal by Subject|2|||
155342169|NCT00518206|560685134|FG001|Overall Study|Withdrawal by Subject|0|||
155342170|NCT00518206|560685133|FG000|Overall Study|Drug Supply Issue|1|||
155342171|NCT00518206|560685134|FG001|Overall Study|Drug Supply Issue|0|||
155342172|NCT00518206|560685133|FG000|Overall Study|Reason Unknown|1|||
155342173|NCT00518206|560685134|FG001|Overall Study|Reason Unknown|0|||
155342174|NCT00518206|560685133|FG000|Overall Study|Completion Status Unknown|1|||
155342175|NCT00518206|560685134|FG001|Overall Study|Completion Status Unknown|0|||
155342176|NCT03075878|560685135|FG000|Overall Study|Physician Decision|1|||
155342177|NCT02188459|560685136|FG000|Overall Study|Lost to Follow-up|3|||
155342178|NCT02188459|560685137|FG001|Overall Study|Lost to Follow-up|4|||
155342179|NCT02188459|560685136|FG000|Overall Study|Early Termination|0|||
155342180|NCT02188459|560685137|FG001|Overall Study|Early Termination|3|||
155342181|NCT00882050|560685142|FG000|Overall Study|Physician Decision|1|||
155342182|NCT00882050|560685143|FG001|Overall Study|Physician Decision|0|||
154963128|NCT00081653|559291097|FG000|Overall Study|Refused Treatment|18|||
154963129|NCT00081653|559291098|FG001|Overall Study|Refused Treatment|14|||
154963130|NCT00081653|559291097|FG000|Overall Study|Low bone mineral density|1|||
154963131|NCT00081653|559291098|FG001|Overall Study|Low bone mineral density|0|||
154963132|NCT00081653|559291097|FG000|Overall Study|Bone loss|2|||
154963133|NCT00081653|559291098|FG001|Overall Study|Bone loss|0|||
154963134|NCT00081653|559291097|FG000|Overall Study|Participant leaving country|1|||
154963135|NCT00081653|559291098|FG001|Overall Study|Participant leaving country|0|||
154963136|NCT00081653|559291097|FG000|Overall Study|Loss of bone mass|0|||
154963137|NCT00081653|559291098|FG001|Overall Study|Loss of bone mass|2|||
154963138|NCT02241551|559291099|FG000|Overall Study|Adverse Event|1|||
154963139|NCT02241551|559291100|FG001|Overall Study|Adverse Event|0|||
154963140|NCT03246503|559291103|FG000|Overall Study|Lost to Follow-up|23|||
154963141|NCT03246503|559291103|FG000|Overall Study|Withdrawal by Subject|20|||
154963142|NCT03246503|559291103|FG000|Overall Study|Physician Decision|5|||
154963143|NCT03246503|559291103|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
154963144|NCT02751424|559291111|FG000|Part 2|Adverse Event|0|||
154963145|NCT02751424|559291112|FG001|Part 2|Adverse Event|0|||
154963146|NCT02751424|559291113|FG002|Part 2|Adverse Event|0|||
154963147|NCT02751424|559291114|FG003|Part 2|Adverse Event|0|||
154963148|NCT02751424|559291115|FG004|Part 2|Adverse Event|0|||
154963149|NCT02751424|559291116|FG005|Part 2|Adverse Event|0|||
154963150|NCT02751424|559291117|FG006|Part 2|Adverse Event|0|||
154963151|NCT02751424|559291118|FG007|Part 2|Adverse Event|5|||
154963152|NCT02751424|559291119|FG008|Part 2|Adverse Event|0|||
154963153|NCT02197416|559291120|FG000|Overall Study|Other reasons|0|||
154963154|NCT02197416|559291121|FG001|Overall Study|Other reasons|2|||
154963155|NCT02197416|559291122|FG002|Overall Study|Other reasons|5|||
154963156|NCT02197416|559291120|FG000|Overall Study|Withdrawal by Subject|0|||
154963157|NCT02197416|559291121|FG001|Overall Study|Withdrawal by Subject|2|||
154963158|NCT02197416|559291122|FG002|Overall Study|Withdrawal by Subject|1|||
154963159|NCT02197416|559291120|FG000|Overall Study|Protocol Violation|1|||
154963160|NCT02197416|559291121|FG001|Overall Study|Protocol Violation|0|||
154963161|NCT02197416|559291122|FG002|Overall Study|Protocol Violation|1|||
154963162|NCT02197416|559291120|FG000|Overall Study|Adverse Event|0|||
154963163|NCT02197416|559291121|FG001|Overall Study|Adverse Event|0|||
154963164|NCT02197416|559291122|FG002|Overall Study|Adverse Event|1|||
154963165|NCT01492439|559291123|FG000|Overall Study|Withdrew from RTE|4|||
154963166|NCT01492439|559291124|FG001|Overall Study|Withdrew from RTE|9|||
154963167|NCT00716625|559291125|FG000|Overall Study|Safety was not Assessable|1|||
155075837|NCT02082483|559706944|FG001|Overall Study|Lost to Follow-up|1|||
155075838|NCT02082483|559706943|FG000|Overall Study|Withdrawal by Subject|2|||
155075839|NCT02082483|559706944|FG001|Overall Study|Withdrawal by Subject|1|||
155075840|NCT02082483|559706943|FG000|Overall Study|Physician Decision|1|||
155075841|NCT02082483|559706944|FG001|Overall Study|Physician Decision|1|||
155075842|NCT02082483|559706943|FG000|Overall Study|Death|2|||
155075843|NCT02082483|559706944|FG001|Overall Study|Death|3|||
155075844|NCT02181621|559706945|FG000|Overall Study|Adverse Event|1|||
155075845|NCT02181621|559706946|FG001|Overall Study|Adverse Event|0|||
155075846|NCT02181621|559706945|FG000|Overall Study|Previously Enrolled|0|||
155075847|NCT02181621|559706946|FG001|Overall Study|Previously Enrolled|1|||
155075848|NCT02181621|559706945|FG000|Overall Study|Enrollment Hold|1|||
155075849|NCT02181621|559706946|FG001|Overall Study|Enrollment Hold|1|||
155075850|NCT00145327|559706947|FG000|Overall Study|Withdrawal by Subject|77|||
155075851|NCT00145327|559706948|FG001|Overall Study|Withdrawal by Subject|72|||
155075852|NCT00145327|559706949|FG002|Overall Study|Withdrawal by Subject|164|||
155075853|NCT00145327|559706947|FG000|Overall Study|Death|26|||
155075854|NCT00145327|559706948|FG001|Overall Study|Death|18|||
155075855|NCT00145327|559706949|FG002|Overall Study|Death|30|||
155075856|NCT00145327|559706947|FG000|Overall Study|Adverse Event|14|||
155075857|NCT00145327|559706948|FG001|Overall Study|Adverse Event|11|||
155075858|NCT00145327|559706949|FG002|Overall Study|Adverse Event|22|||
155075859|NCT00145327|559706947|FG000|Overall Study|Lost to Follow-up|9|||
155075860|NCT00145327|559706948|FG001|Overall Study|Lost to Follow-up|14|||
155075861|NCT00145327|559706949|FG002|Overall Study|Lost to Follow-up|14|||
155075862|NCT00145327|559706947|FG000|Overall Study|Administrative problems|12|||
155075863|NCT00145327|559706948|FG001|Overall Study|Administrative problems|9|||
155075864|NCT00145327|559706949|FG002|Overall Study|Administrative problems|13|||
155075865|NCT00145327|559706947|FG000|Overall Study|Protocol Violation|2|||
155075866|NCT00145327|559706948|FG001|Overall Study|Protocol Violation|0|||
155075867|NCT00145327|559706949|FG002|Overall Study|Protocol Violation|2|||
155075868|NCT00145327|559706947|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155075869|NCT00145327|559706948|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155075870|NCT00145327|559706949|FG002|Overall Study|Abnormal laboratory value(s)|2|||
155075871|NCT00145327|559706947|FG000|Overall Study|Missing - not stated|1|||
155075872|NCT00145327|559706948|FG001|Overall Study|Missing - not stated|0|||
155342183|NCT00882050|560685144|FG002|Overall Study|Physician Decision|0|||
155342184|NCT00805441|560685145|FG000|Overall Study|Adverse Event|5|||
154963168|NCT01204294|559291126|FG000|Overall Study|Adverse Event|2|||
154963169|NCT01204294|559291127|FG001|Overall Study|Adverse Event|6|||
154963170|NCT01204294|559291128|FG002|Overall Study|Adverse Event|0|||
154963171|NCT01204294|559291129|FG003|Overall Study|Adverse Event|7|||
154963172|NCT01204294|559291130|FG004|Overall Study|Adverse Event|1|||
154963173|NCT01204294|559291131|FG005|Overall Study|Adverse Event|4|||
154963174|NCT01204294|559291132|FG006|Overall Study|Adverse Event|0|||
154963175|NCT01204294|559291126|FG000|Overall Study|Protocol Violation|1|||
154963176|NCT01204294|559291127|FG001|Overall Study|Protocol Violation|0|||
154963177|NCT01204294|559291128|FG002|Overall Study|Protocol Violation|2|||
154963178|NCT01204294|559291129|FG003|Overall Study|Protocol Violation|1|||
154963179|NCT01204294|559291130|FG004|Overall Study|Protocol Violation|0|||
154963180|NCT01204294|559291131|FG005|Overall Study|Protocol Violation|0|||
154963181|NCT01204294|559291132|FG006|Overall Study|Protocol Violation|0|||
154963182|NCT01204294|559291126|FG000|Overall Study|Withdrawal by Subject|0|||
154963183|NCT01204294|559291127|FG001|Overall Study|Withdrawal by Subject|2|||
154963184|NCT01204294|559291128|FG002|Overall Study|Withdrawal by Subject|2|||
154963185|NCT01204294|559291129|FG003|Overall Study|Withdrawal by Subject|1|||
154963186|NCT01204294|559291130|FG004|Overall Study|Withdrawal by Subject|1|||
154963187|NCT01204294|559291131|FG005|Overall Study|Withdrawal by Subject|1|||
154963188|NCT01204294|559291132|FG006|Overall Study|Withdrawal by Subject|2|||
154963189|NCT01204294|559291126|FG000|Overall Study|Lack of Efficacy|0|||
154963190|NCT01204294|559291127|FG001|Overall Study|Lack of Efficacy|0|||
154963191|NCT01204294|559291128|FG002|Overall Study|Lack of Efficacy|0|||
154963192|NCT01204294|559291129|FG003|Overall Study|Lack of Efficacy|2|||
154963193|NCT01204294|559291130|FG004|Overall Study|Lack of Efficacy|0|||
154963194|NCT01204294|559291131|FG005|Overall Study|Lack of Efficacy|0|||
154963195|NCT01204294|559291132|FG006|Overall Study|Lack of Efficacy|0|||
154963196|NCT01204294|559291126|FG000|Overall Study|Other (house moving)|0|||
154963197|NCT01204294|559291127|FG001|Overall Study|Other (house moving)|0|||
154963198|NCT01204294|559291128|FG002|Overall Study|Other (house moving)|1|||
154963199|NCT01204294|559291129|FG003|Overall Study|Other (house moving)|0|||
154963200|NCT01204294|559291130|FG004|Overall Study|Other (house moving)|0|||
154963201|NCT01204294|559291131|FG005|Overall Study|Other (house moving)|0|||
154963202|NCT01204294|559291132|FG006|Overall Study|Other (house moving)|0|||
154963203|NCT02075463|559291133|FG000|Overall Study|Adverse Event|3|||
154963204|NCT02075463|559291133|FG000|Overall Study|Par. reached stopping criteria|4|||
154963205|NCT02075463|559291133|FG000|Overall Study|Withdrawal by Subject|1|||
154963206|NCT01527006|559291134|FG000|Core Study|Adverse Event|0|||
154963207|NCT01527006|559291135|FG001|Core Study|Adverse Event|2|||
154963208|NCT01527006|559291134|FG000|Core Study|Lost to Follow-up|0|||
154963209|NCT01527006|559291135|FG001|Core Study|Lost to Follow-up|1|||
154963210|NCT01527006|559291134|FG000|Core Study|Subject Choice|1|||
154963211|NCT01527006|559291135|FG001|Core Study|Subject Choice|0|||
154963212|NCT01527006|559291134|FG000|Core Study|Inadequate Therapeutic Effect|1|||
154963213|NCT01527006|559291135|FG001|Core Study|Inadequate Therapeutic Effect|0|||
154963214|NCT01527006|559291134|FG000|Core Study|Withdrawal by Subject|0|||
154963215|NCT01527006|559291135|FG001|Core Study|Withdrawal by Subject|1|||
155342185|NCT00805441|560685146|FG001|Overall Study|Adverse Event|2|||
155342186|NCT00805441|560685145|FG000|Overall Study|Lack of Efficacy|0|||
155342187|NCT00805441|560685146|FG001|Overall Study|Lack of Efficacy|2|||
155342188|NCT00805441|560685145|FG000|Overall Study|Protocol Violation|4|||
155342189|NCT00805441|560685146|FG001|Overall Study|Protocol Violation|8|||
155342190|NCT00805441|560685145|FG000|Overall Study|Lost to Follow-up|10|||
155342191|NCT00805441|560685146|FG001|Overall Study|Lost to Follow-up|13|||
155342192|NCT00805441|560685145|FG000|Overall Study|Withdrawal by Subject|15|||
155342193|NCT00805441|560685146|FG001|Overall Study|Withdrawal by Subject|9|||
155342194|NCT00805441|560685145|FG000|Overall Study|Physician Decision|0|||
154963216|NCT01527006|559291134|FG000|Core Study|Other|0|||
154963217|NCT01527006|559291135|FG001|Core Study|Other|2|||
154963218|NCT01527006|559291134|FG000|Extension Phase|Adverse Event|4|||
154963219|NCT01527006|559291135|FG001|Extension Phase|Adverse Event|2|||
154963220|NCT01527006|559291134|FG000|Extension Phase|Lost to Follow-up|0|||
154963221|NCT01527006|559291135|FG001|Extension Phase|Lost to Follow-up|1|||
154963222|NCT01527006|559291134|FG000|Extension Phase|Subject Choice|1|||
154963223|NCT01527006|559291135|FG001|Extension Phase|Subject Choice|1|||
154963224|NCT01527006|559291134|FG000|Extension Phase|Inadequate therapeutic effect|1|||
155075873|NCT00145327|559706949|FG002|Overall Study|Missing - not stated|1|||
155075874|NCT00864513|559706951|FG000|Overall Study|Withdrawal by Subject|3|||
155075875|NCT00762788|559706952|FG000|Overall Study|Lost to Follow-up|26|||
155075876|NCT00762788|559706953|FG001|Overall Study|Lost to Follow-up|37|||
155075877|NCT00762788|559706954|FG002|Overall Study|Lost to Follow-up|21|||
155075878|NCT00762788|559706955|FG003|Overall Study|Lost to Follow-up|26|||
155075879|NCT00762788|559706956|FG004|Overall Study|Lost to Follow-up|13|||
155075880|NCT00762788|559706957|FG005|Overall Study|Lost to Follow-up|21|||
155075881|NCT05938010|559706958|FG000|Overall Study|Lost to Follow-up|2|||
155075882|NCT03073109|559706960|FG000|Overall Study|Adverse Event|0|||
155075883|NCT03073109|559706961|FG001|Overall Study|Adverse Event|1|||
155075884|NCT03073109|559706960|FG000|Overall Study|Other|2|||
155075885|NCT03073109|559706961|FG001|Overall Study|Other|0|||
155075886|NCT03073109|559706960|FG000|Overall Study|Lost to Follow-up|8|||
155075887|NCT03073109|559706961|FG001|Overall Study|Lost to Follow-up|1|||
155075888|NCT01158404|559706970|FG000|Overall Study|Withdrawal by Subject|0|||
155075889|NCT01158404|559706971|FG001|Overall Study|Withdrawal by Subject|1|||
155075890|NCT01158404|559706972|FG002|Overall Study|Withdrawal by Subject|0|||
155075891|NCT01158404|559706973|FG003|Overall Study|Withdrawal by Subject|0|||
155075892|NCT01158404|559706974|FG004|Overall Study|Withdrawal by Subject|3|||
155075893|NCT01158404|559706975|FG005|Overall Study|Withdrawal by Subject|1|||
155075894|NCT01158404|559706976|FG006|Overall Study|Withdrawal by Subject|0|||
155075895|NCT01158404|559706977|FG007|Overall Study|Withdrawal by Subject|1|||
155075896|NCT01158404|559706970|FG000|Overall Study|Physician Decision|0|||
154963225|NCT01527006|559291135|FG001|Extension Phase|Inadequate therapeutic effect|1|||
154963226|NCT01527006|559291134|FG000|Extension Phase|Other|0|||
154963227|NCT01527006|559291135|FG001|Extension Phase|Other|3|||
155075897|NCT01158404|559706971|FG001|Overall Study|Physician Decision|0|||
155075898|NCT01158404|559706972|FG002|Overall Study|Physician Decision|0|||
155075899|NCT01158404|559706973|FG003|Overall Study|Physician Decision|0|||
154963228|NCT01383486|559291136|FG000|Overall Study|Lost to Follow-up|10|||
154963229|NCT01383486|559291136|FG000|Overall Study|Incomplete information for analysis|2|||
154963230|NCT01383486|559291136|FG000|Overall Study|Did not take any product|6|||
155075900|NCT01158404|559706974|FG004|Overall Study|Physician Decision|0|||
155075901|NCT01158404|559706975|FG005|Overall Study|Physician Decision|0|||
155075902|NCT01158404|559706976|FG006|Overall Study|Physician Decision|0|||
155075903|NCT01158404|559706977|FG007|Overall Study|Physician Decision|1|||
155075904|NCT01158404|559706970|FG000|Overall Study|Progressive Disease|0|||
155075905|NCT01158404|559706971|FG001|Overall Study|Progressive Disease|0|||
155342195|NCT00805441|560685146|FG001|Overall Study|Physician Decision|1|||
155342196|NCT00805441|560685145|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
155342197|NCT00805441|560685146|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
154963231|NCT00245063|559291137|FG000|Overall Study|Adverse Event|6|||
155342198|NCT02935894|560685151|FG000|Overall Study|Subject dismissed|1|||
155342199|NCT00853957|560685152|FG000|Overall Study|Adverse Event|9|||
155342200|NCT00853957|560685153|FG001|Overall Study|Adverse Event|3|||
155342201|NCT00853957|560685152|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155342202|NCT00853957|560685153|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155342203|NCT00853957|560685152|FG000|Overall Study|Subject withdrew consent|4|||
155342204|NCT00853957|560685153|FG001|Overall Study|Subject withdrew consent|5|||
155342205|NCT00853957|560685152|FG000|Overall Study|Lost to Follow-up|1|||
155342206|NCT00853957|560685153|FG001|Overall Study|Lost to Follow-up|6|||
155342207|NCT00853957|560685152|FG000|Overall Study|Protocol deviation|0|||
155342208|NCT00853957|560685153|FG001|Overall Study|Protocol deviation|3|||
155342209|NCT02942771|560685154|FG000|Overall Study|Adverse Event|1|||
155342210|NCT02942771|560685155|FG001|Overall Study|Adverse Event|0|||
155342211|NCT02942771|560685156|FG002|Overall Study|Adverse Event|0|||
155342212|NCT02942771|560685157|FG003|Overall Study|Adverse Event|0|||
155342213|NCT02942771|560685158|FG004|Overall Study|Adverse Event|2|||
155342214|NCT02942771|560685154|FG000|Overall Study|Lost to Follow-up|1|||
155342215|NCT02942771|560685155|FG001|Overall Study|Lost to Follow-up|0|||
155342216|NCT02942771|560685156|FG002|Overall Study|Lost to Follow-up|0|||
155342217|NCT02942771|560685157|FG003|Overall Study|Lost to Follow-up|0|||
155342218|NCT02942771|560685158|FG004|Overall Study|Lost to Follow-up|0|||
155342219|NCT02942771|560685154|FG000|Overall Study|Withdrawal by Subject|1|||
155342220|NCT02942771|560685155|FG001|Overall Study|Withdrawal by Subject|0|||
155342221|NCT02942771|560685156|FG002|Overall Study|Withdrawal by Subject|0|||
155342222|NCT02942771|560685157|FG003|Overall Study|Withdrawal by Subject|0|||
155342223|NCT02942771|560685158|FG004|Overall Study|Withdrawal by Subject|2|||
155342224|NCT01186809|560685159|FG000|Overall Study|Death|30|||
155342225|NCT04895085|560685160|FG000|Overall Study|Death|1|||
155342226|NCT04895085|560685160|FG000|Overall Study|Withdrawal by Subject|1|||
155342227|NCT04895085|560685160|FG000|Overall Study|No longer eligible: Moved from area|1|||
155342228|NCT04919499|560685165|FG000|Overall Study|Adverse Event|0|||
155342229|NCT04919499|560685166|FG001|Overall Study|Adverse Event|0|||
154963232|NCT00245063|559291138|FG001|Overall Study|Adverse Event|5|||
154963233|NCT00245063|559291137|FG000|Overall Study|Death|1|||
155075906|NCT01158404|559706972|FG002|Overall Study|Progressive Disease|0|||
155342230|NCT04919499|560685167|FG002|Overall Study|Adverse Event|0|||
155342231|NCT04919499|560685168|FG003|Overall Study|Adverse Event|0|||
155342232|NCT04919499|560685169|FG004|Overall Study|Adverse Event|2|||
155342233|NCT04919499|560685165|FG000|Overall Study|Not treated|0|||
155342234|NCT04919499|560685166|FG001|Overall Study|Not treated|0|||
155342235|NCT04919499|560685167|FG002|Overall Study|Not treated|0|||
154963234|NCT00245063|559291138|FG001|Overall Study|Death|0|||
154963235|NCT01839279|559291141|FG000|Overall Study|Adverse Event|4|||
154963236|NCT01839279|559291142|FG001|Overall Study|Adverse Event|1|||
154963237|NCT01839279|559291143|FG002|Overall Study|Adverse Event|1|||
154963238|NCT01839279|559291141|FG000|Overall Study|Withdrawal by Subject|4|||
154963239|NCT01839279|559291142|FG001|Overall Study|Withdrawal by Subject|1|||
154963240|NCT01839279|559291143|FG002|Overall Study|Withdrawal by Subject|1|||
154963241|NCT01839279|559291141|FG000|Overall Study|Classified as 'Other'|5|||
154963242|NCT01839279|559291142|FG001|Overall Study|Classified as 'Other'|0|||
154963243|NCT01839279|559291143|FG002|Overall Study|Classified as 'Other'|0|||
154963244|NCT00466167|559291154|FG000|Overall Study|Adverse Event|8|||
154963245|NCT00466167|559291155|FG001|Overall Study|Adverse Event|8|||
154963246|NCT00466167|559291156|FG002|Overall Study|Adverse Event|7|||
154963247|NCT00466167|559291154|FG000|Overall Study|Lack of Efficacy|2|||
154963248|NCT00466167|559291155|FG001|Overall Study|Lack of Efficacy|0|||
154963249|NCT00466167|559291156|FG002|Overall Study|Lack of Efficacy|3|||
154963250|NCT00466167|559291154|FG000|Overall Study|Protocol Violation|1|||
154963251|NCT00466167|559291155|FG001|Overall Study|Protocol Violation|1|||
154963252|NCT00466167|559291156|FG002|Overall Study|Protocol Violation|2|||
154963253|NCT00466167|559291154|FG000|Overall Study|Lost to Follow-up|3|||
154963254|NCT00466167|559291155|FG001|Overall Study|Lost to Follow-up|2|||
154963255|NCT00466167|559291156|FG002|Overall Study|Lost to Follow-up|2|||
154963256|NCT00466167|559291154|FG000|Overall Study|Withdrawal by Subject|4|||
154963257|NCT00466167|559291155|FG001|Overall Study|Withdrawal by Subject|1|||
154963258|NCT00466167|559291156|FG002|Overall Study|Withdrawal by Subject|6|||
154963259|NCT00466167|559291154|FG000|Overall Study|patient did not meet inclusion criteria|1|||
154963260|NCT00466167|559291155|FG001|Overall Study|patient did not meet inclusion criteria|0|||
154963261|NCT00466167|559291156|FG002|Overall Study|patient did not meet inclusion criteria|1|||
154963262|NCT00466167|559291154|FG000|Overall Study|Not treated|1|||
154963263|NCT00466167|559291155|FG001|Overall Study|Not treated|0|||
154963264|NCT00466167|559291156|FG002|Overall Study|Not treated|0|||
154963265|NCT03199963|559291157|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
155164678|NCT00372593|560040517|FG001|Overall Study|Lack of Efficacy|71|||
155164679|NCT00372593|560040518|FG002|Overall Study|Lack of Efficacy|2|||
155164680|NCT00372593|560040516|FG000|Overall Study|Lost to Follow-up|1|||
155164681|NCT00372593|560040517|FG001|Overall Study|Lost to Follow-up|0|||
155164682|NCT00372593|560040518|FG002|Overall Study|Lost to Follow-up|0|||
155164683|NCT00372593|560040516|FG000|Overall Study|Physician Decision|42|||
155164684|NCT00372593|560040517|FG001|Overall Study|Physician Decision|41|||
155164685|NCT00372593|560040518|FG002|Overall Study|Physician Decision|0|||
155164686|NCT00372593|560040516|FG000|Overall Study|Ineligible|20|||
155164687|NCT00372593|560040517|FG001|Overall Study|Ineligible|21|||
155164688|NCT00372593|560040518|FG002|Overall Study|Ineligible|1|||
155164689|NCT02974543|560040519|FG000|Overall Study|Withdrawal by Subject|1|||
155164690|NCT02974543|560040520|FG001|Overall Study|Withdrawal by Subject|0|||
155164691|NCT03534180|560040521|FG000|Overall Study|Withdrawal by Subject|1|||
155164692|NCT00220636|560040522|FG000|Overall Study|Withdrawal by Subject|4|||
155164693|NCT01237899|560040525|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
155164694|NCT01237899|560040526|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
155164695|NCT01237899|560040527|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
155164696|NCT01237899|560040528|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
155164697|NCT01237899|560040529|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
155164698|NCT01237899|560040530|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
155164699|NCT01237899|560040531|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
155164700|NCT01237899|560040532|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
155164701|NCT01237899|560040533|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
155164702|NCT01237899|560040534|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
155164703|NCT01237899|560040535|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
155164704|NCT00859456|560040536|FG000|Overall Study|Adverse Event|3|||
155164705|NCT00859456|560040536|FG000|Overall Study|Progressive disease|2|||
155164706|NCT00859456|560040536|FG000|Overall Study|Non-compliance|3|||
155164707|NCT04269265|560040537|FG000|Overall Study|Physician Decision|1|||
155164708|NCT04269265|560040537|FG000|Overall Study|Withdrawal by Subject|1|||
155164709|NCT04269265|560040537|FG000|Overall Study|Overenrolled (sample size reached)|4|||
155164710|NCT04439136|560040538|FG000|Overall Study|Ineligible|1|||
155164711|NCT04439136|560040538|FG000|Overall Study|Never Started Treatment|2|||
155164712|NCT04439136|560040538|FG000|Overall Study|Adverse Event|4|||
155164713|NCT04439136|560040538|FG000|Overall Study|Death|3|||
155164714|NCT04439136|560040538|FG000|Overall Study|Disease Progression|27|||
155164715|NCT04439136|560040538|FG000|Overall Study|Alternative Therapy|1|||
155164716|NCT04439136|560040538|FG000|Overall Study|Increased Tumor Burden|1|||
155164717|NCT04439136|560040538|FG000|Overall Study|Symptomatic Detrioration|1|||
155164718|NCT04849559|560040542|FG000|Overall Study|Withdrawal by Subject|2|||
155164719|NCT04849559|560040543|FG001|Overall Study|Withdrawal by Subject|1|||
155164720|NCT02910986|560040544|FG000|Overall Study|non-Latina|14|||
155164721|NCT02910986|560040545|FG001|Overall Study|non-Latina|13|||
155164722|NCT02910986|560040546|FG002|Overall Study|non-Latina|12|||
155164723|NCT02910986|560040544|FG000|Overall Study|Failure to return T! survey|72|||
155164724|NCT02910986|560040545|FG001|Overall Study|Failure to return T! survey|84|||
155164725|NCT02910986|560040546|FG002|Overall Study|Failure to return T! survey|72|||
155164726|NCT02910986|560040544|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
155164727|NCT02910986|560040545|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
155164728|NCT02910986|560040546|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
155164729|NCT02910986|560040544|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
155164730|NCT02910986|560040545|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
155342236|NCT04919499|560685168|FG003|Overall Study|Not treated|1|||
155342237|NCT04919499|560685169|FG004|Overall Study|Not treated|0|||
155342238|NCT00476151|560686998|FG000|Overall Study|Adverse Event|0|||
155342239|NCT00476151|560686999|FG001|Overall Study|Adverse Event|2|||
155342240|NCT00476151|560686998|FG000|Overall Study|Protocol Violation|1|||
155342241|NCT00476151|560686999|FG001|Overall Study|Protocol Violation|3|||
155342242|NCT00476151|560686998|FG000|Overall Study|Withdrawal by Subject|2|||
155342243|NCT00476151|560686999|FG001|Overall Study|Withdrawal by Subject|0|||
155342244|NCT00476151|560686998|FG000|Overall Study|Physician Decision|0|||
155342245|NCT00476151|560686999|FG001|Overall Study|Physician Decision|2|||
155342246|NCT01767376|560687000|FG000|Overall Study|Lost to Follow-up|3|||
155342247|NCT01767376|560687001|FG001|Overall Study|Lost to Follow-up|2|||
155342248|NCT01767376|560687002|FG002|Overall Study|Lost to Follow-up|0|||
155342249|NCT01767376|560687000|FG000|Overall Study|Withdrawal by Subject|1|||
155342250|NCT01767376|560687001|FG001|Overall Study|Withdrawal by Subject|1|||
155342251|NCT01767376|560687002|FG002|Overall Study|Withdrawal by Subject|0|||
155342252|NCT04175834|560687003|FG000|Overall Study|Withdrawal by Subject|1|||
155342253|NCT04175834|560687004|FG001|Overall Study|Withdrawal by Subject|0|||
155342254|NCT00946088|560687005|FG000|Overall Study|Withdrawal by Subject|0|||
155342255|NCT00946088|560687006|FG001|Overall Study|Withdrawal by Subject|1|||
155342256|NCT04239911|560687010|FG000|Overall Study|Lost to Follow-up|2|||
155342257|NCT04239911|560687011|FG001|Overall Study|Lost to Follow-up|1|||
155342258|NCT03693989|560687013|FG000|Overall Study|Protocol Violation|3|||
155342259|NCT03693989|560687014|FG001|Overall Study|Protocol Violation|4|||
155342260|NCT01052272|560687015|FG000|Overall Study|Death|0|||
155342261|NCT01052272|560687016|FG001|Overall Study|Death|0|||
155342262|NCT01052272|560687017|FG002|Overall Study|Death|1|||
155342263|NCT01052272|560687018|FG003|Overall Study|Death|1|||
155342264|NCT01052272|560687015|FG000|Overall Study|Physician Decision|0|||
155342265|NCT01052272|560687016|FG001|Overall Study|Physician Decision|1|||
155342266|NCT01052272|560687017|FG002|Overall Study|Physician Decision|0|||
155342267|NCT01052272|560687018|FG003|Overall Study|Physician Decision|0|||
155342268|NCT01052272|560687015|FG000|Overall Study|patient refuses follow-up|5|||
155342269|NCT01052272|560687016|FG001|Overall Study|patient refuses follow-up|4|||
155342270|NCT01052272|560687017|FG002|Overall Study|patient refuses follow-up|2|||
155342271|NCT01052272|560687018|FG003|Overall Study|patient refuses follow-up|4|||
155342272|NCT01052272|560687015|FG000|Overall Study|Withdrawal by Subject|0|||
155342273|NCT01052272|560687016|FG001|Overall Study|Withdrawal by Subject|2|||
155342274|NCT01052272|560687017|FG002|Overall Study|Withdrawal by Subject|3|||
155342275|NCT01052272|560687018|FG003|Overall Study|Withdrawal by Subject|2|||
155075907|NCT01158404|559706973|FG003|Overall Study|Progressive Disease|0|||
155342276|NCT01052272|560687015|FG000|Overall Study|placed in long-term care|0|||
155342277|NCT01052272|560687016|FG001|Overall Study|placed in long-term care|0|||
155342278|NCT01052272|560687017|FG002|Overall Study|placed in long-term care|1|||
155342279|NCT01052272|560687018|FG003|Overall Study|placed in long-term care|0|||
155342280|NCT01052272|560687015|FG000|Overall Study|decline in health|0|||
155342281|NCT01052272|560687016|FG001|Overall Study|decline in health|0|||
155342282|NCT01052272|560687017|FG002|Overall Study|decline in health|1|||
155342283|NCT01052272|560687018|FG003|Overall Study|decline in health|0|||
155342284|NCT00648895|560687019|FG000|Overall Study|Lack of Efficacy|0|||
155342285|NCT00648895|560687020|FG001|Overall Study|Lack of Efficacy|1|||
155342286|NCT00096278|560687023|FG000|Overall Study|No follow-up data|15|||
155342287|NCT00096278|560687024|FG001|Overall Study|No follow-up data|18|||
155342288|NCT00096278|560687023|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
155342289|NCT00096278|560687024|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
155342290|NCT00379210|560687027|FG000|Overall Study|Withdrawal by Subject|10|||
155342291|NCT00379210|560687028|FG001|Overall Study|Withdrawal by Subject|7|||
155342292|NCT01358175|560687029|FG000|Overall Study|Death|1|||
155342293|NCT01358175|560687030|FG001|Overall Study|Death|0|||
155342294|NCT01358175|560687031|FG002|Overall Study|Death|1|||
155342295|NCT01358175|560687029|FG000|Overall Study|Withdrawal by Subject|9|||
155342296|NCT01358175|560687030|FG001|Overall Study|Withdrawal by Subject|5|||
155342297|NCT01358175|560687031|FG002|Overall Study|Withdrawal by Subject|10|||
155342298|NCT01358175|560687029|FG000|Overall Study|Technical issues|0|||
155342299|NCT01358175|560687030|FG001|Overall Study|Technical issues|1|||
155342300|NCT01358175|560687031|FG002|Overall Study|Technical issues|0|||
155342301|NCT01358175|560687029|FG000|Overall Study|Pregnancy|0|||
155342302|NCT01358175|560687030|FG001|Overall Study|Pregnancy|1|||
155342303|NCT01358175|560687031|FG002|Overall Study|Pregnancy|0|||
155342304|NCT01358175|560687029|FG000|Overall Study|Physician Decision|1|||
155342305|NCT01358175|560687030|FG001|Overall Study|Physician Decision|0|||
155342306|NCT01358175|560687031|FG002|Overall Study|Physician Decision|0|||
155075908|NCT01158404|559706974|FG004|Overall Study|Progressive Disease|0|||
155075909|NCT01158404|559706975|FG005|Overall Study|Progressive Disease|0|||
155075910|NCT01158404|559706976|FG006|Overall Study|Progressive Disease|1|||
155075911|NCT01158404|559706977|FG007|Overall Study|Progressive Disease|0|||
155075912|NCT02029443|559706980|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
155075913|NCT02029443|559706981|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
155075914|NCT02029443|559706982|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
155075915|NCT02029443|559706983|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
155075916|NCT02029443|559706984|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
155075917|NCT02029443|559706980|FG000|Overall Study|Death|13|||
155075918|NCT02029443|559706981|FG001|Overall Study|Death|2|||
155075919|NCT02029443|559706982|FG002|Overall Study|Death|2|||
155075920|NCT02029443|559706983|FG003|Overall Study|Death|11|||
155075921|NCT02029443|559706984|FG004|Overall Study|Death|2|||
155075922|NCT02029443|559706980|FG000|Overall Study|Lost to Follow-up|1|||
155075923|NCT02029443|559706981|FG001|Overall Study|Lost to Follow-up|0|||
155075924|NCT02029443|559706982|FG002|Overall Study|Lost to Follow-up|1|||
155075925|NCT02029443|559706983|FG003|Overall Study|Lost to Follow-up|1|||
155075926|NCT02029443|559706984|FG004|Overall Study|Lost to Follow-up|0|||
155075927|NCT02029443|559706980|FG000|Overall Study|Started other anti-cancer therapy|17|||
155075928|NCT02029443|559706981|FG001|Overall Study|Started other anti-cancer therapy|4|||
155075929|NCT02029443|559706982|FG002|Overall Study|Started other anti-cancer therapy|7|||
155075930|NCT02029443|559706983|FG003|Overall Study|Started other anti-cancer therapy|9|||
155075931|NCT02029443|559706984|FG004|Overall Study|Started other anti-cancer therapy|3|||
155075932|NCT02029443|559706980|FG000|Overall Study|Withdrawal by Subject|3|||
155075933|NCT02029443|559706981|FG001|Overall Study|Withdrawal by Subject|1|||
155075934|NCT02029443|559706982|FG002|Overall Study|Withdrawal by Subject|1|||
155075935|NCT02029443|559706983|FG003|Overall Study|Withdrawal by Subject|1|||
155075936|NCT02029443|559706984|FG004|Overall Study|Withdrawal by Subject|0|||
155075937|NCT02029443|559706980|FG000|Overall Study|Other|6|||
155075938|NCT02029443|559706981|FG001|Overall Study|Other|6|||
155075939|NCT02029443|559706982|FG002|Overall Study|Other|4|||
155075940|NCT02029443|559706983|FG003|Overall Study|Other|2|||
155075941|NCT02029443|559706984|FG004|Overall Study|Other|0|||
155075942|NCT02070991|559706986|FG000|Overall Study|Death|2|||
155075943|NCT02070991|559706987|FG001|Overall Study|Death|0|||
155075944|NCT02070991|559706986|FG000|Overall Study|Withdrawal by Subject|1|||
155342307|NCT01358175|560687029|FG000|Overall Study|Non Compliance with Study Treatment|0|||
155342308|NCT01358175|560687030|FG001|Overall Study|Non Compliance with Study Treatment|1|||
155342309|NCT01358175|560687031|FG002|Overall Study|Non Compliance with Study Treatment|1|||
155342310|NCT01358175|560687029|FG000|Overall Study|Lost to Follow-up|1|||
155342311|NCT01358175|560687030|FG001|Overall Study|Lost to Follow-up|1|||
155342312|NCT01358175|560687031|FG002|Overall Study|Lost to Follow-up|3|||
155342313|NCT01358175|560687029|FG000|Overall Study|Lack of Efficacy|3|||
155342314|NCT01358175|560687030|FG001|Overall Study|Lack of Efficacy|8|||
155342315|NCT01358175|560687031|FG002|Overall Study|Lack of Efficacy|6|||
155342316|NCT01358175|560687029|FG000|Overall Study|Adverse Event|6|||
155342317|NCT01358175|560687030|FG001|Overall Study|Adverse Event|11|||
155342318|NCT01358175|560687031|FG002|Overall Study|Adverse Event|11|||
155342319|NCT02991118|560687034|FG000|Overall Study|Death|3|||
155075945|NCT02070991|559706987|FG001|Overall Study|Withdrawal by Subject|0|||
155075946|NCT03670628|559706990|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
155075947|NCT03670628|559706991|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
155075948|NCT03670628|559706990|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
155342320|NCT02991118|560687035|FG001|Overall Study|Death|8|||
155075949|NCT03670628|559706991|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
155075950|NCT03123588|559706992|FG000|Overall Study|Study Terminated by Sponsor|2|||
155075951|NCT03123588|559706993|FG001|Overall Study|Study Terminated by Sponsor|5|||
155075952|NCT03123588|559706992|FG000|Overall Study|Withdrawal by Subject|1|||
155075953|NCT03123588|559706993|FG001|Overall Study|Withdrawal by Subject|0|||
155075954|NCT03123588|559706992|FG000|Overall Study|Adverse Event|1|||
155075955|NCT03123588|559706993|FG001|Overall Study|Adverse Event|0|||
155075956|NCT03123588|559706992|FG000|Overall Study|Physician Decision|2|||
155075957|NCT03123588|559706993|FG001|Overall Study|Physician Decision|1|||
155075958|NCT00997126|559706995|FG000|Overall Study|Physician Decision|7|||
155075959|NCT00997126|559706996|FG001|Overall Study|Physician Decision|11|||
155075960|NCT01769443|559706998|FG000|Overall Study|Study closure|1|||
155075961|NCT01769443|559706999|FG001|Overall Study|Study closure|0|||
155075962|NCT04149353|559707000|FG000|Overall Study|Study terminated|1|||
155075963|NCT03019588|559707001|FG000|Overall Study|Death|44|||
155075964|NCT03019588|559707002|FG001|Overall Study|Death|46|||
155075965|NCT03019588|559707001|FG000|Overall Study|Study terminated by Sponsor|3|||
155075966|NCT03019588|559707002|FG001|Overall Study|Study terminated by Sponsor|1|||
155075967|NCT00366535|559707003|FG000|First Phase: 12 Weeks|Adverse Event|1|||
155075968|NCT00366535|559707004|FG001|First Phase: 12 Weeks|Adverse Event|3|||
155075969|NCT00366535|559707003|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
155075970|NCT00366535|559707004|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
155075971|NCT00366535|559707003|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
155075972|NCT00366535|559707004|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
155075973|NCT00366535|559707003|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
155075974|NCT00366535|559707004|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
155075975|NCT00699751|559707009|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
155075976|NCT00699751|559707010|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
155075977|NCT00699751|559707009|FG000|Period 1: Without/Before Drug Switch|Death|28|||
155075978|NCT00699751|559707010|FG001|Period 1: Without/Before Drug Switch|Death|29|||
155075979|NCT00699751|559707009|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
155075980|NCT00699751|559707010|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
155075981|NCT00699751|559707009|FG000|Period 1: Without/Before Drug Switch|Other|30|||
155075982|NCT00699751|559707010|FG001|Period 1: Without/Before Drug Switch|Other|20|||
155075983|NCT00699751|559707009|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
155075984|NCT00699751|559707010|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
155075985|NCT00699751|559707009|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
155075986|NCT00699751|559707010|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
155075987|NCT00699751|559707009|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
155075988|NCT00699751|559707010|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
155075989|NCT00699751|559707009|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
155075990|NCT00699751|559707010|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
155075991|NCT02939781|559707011|FG000|Overall Study|Protocol Violation|8|||
155075992|NCT02939781|559707011|FG000|Overall Study|Withdrawal by Subject|1|||
155075993|NCT03753542|559707012|FG000|Overall Study|Lost to Follow-up|9|||
155075994|NCT03753542|559707013|FG001|Overall Study|Lost to Follow-up|14|||
155075995|NCT01068249|559707014|FG000|Overall Study|Death|1|||
155075996|NCT01068249|559707014|FG000|Overall Study|Withdrawal by Subject|3|||
155075997|NCT05537571|559707015|FG000|Overall Study|Withdrawal by Subject|1|||
155075998|NCT05537571|559707016|FG001|Overall Study|Withdrawal by Subject|1|||
155075999|NCT05537571|559707017|FG002|Overall Study|Withdrawal by Subject|0|||
155076000|NCT05537571|559707018|FG003|Overall Study|Withdrawal by Subject|0|||
155076001|NCT05537571|559707019|FG004|Overall Study|Withdrawal by Subject|0|||
155076002|NCT05537571|559707015|FG000|Overall Study|Adverse Event|2|||
155076003|NCT05537571|559707016|FG001|Overall Study|Adverse Event|0|||
155076004|NCT05537571|559707017|FG002|Overall Study|Adverse Event|0|||
155076005|NCT05537571|559707018|FG003|Overall Study|Adverse Event|0|||
155342321|NCT02991118|560687034|FG000|Overall Study|Protocol Violation|0|||
155342322|NCT02991118|560687035|FG001|Overall Study|Protocol Violation|3|||
155342323|NCT02991118|560687034|FG000|Overall Study|Physician Decision|0|||
155342324|NCT02991118|560687035|FG001|Overall Study|Physician Decision|1|||
155342325|NCT02991118|560687034|FG000|Overall Study|Moved out of the country|0|||
155342326|NCT02991118|560687035|FG001|Overall Study|Moved out of the country|1|||
155342327|NCT02991118|560687034|FG000|Overall Study|Adverse Event|2|||
155342328|NCT02991118|560687035|FG001|Overall Study|Adverse Event|2|||
155342329|NCT02991118|560687034|FG000|Overall Study|Withdrawal by Subject|1|||
155342330|NCT02991118|560687035|FG001|Overall Study|Withdrawal by Subject|7|||
155342331|NCT02991118|560687034|FG000|Overall Study|Could not attend study visits|0|||
155342332|NCT02991118|560687035|FG001|Overall Study|Could not attend study visits|1|||
155342333|NCT02991118|560687034|FG000|Overall Study|Lost to Follow-up|1|||
155342334|NCT02991118|560687035|FG001|Overall Study|Lost to Follow-up|9|||
155076006|NCT05537571|559707019|FG004|Overall Study|Adverse Event|0|||
155076007|NCT05537571|559707015|FG000|Overall Study|Hepatitis A screening result|2|||
155076008|NCT05537571|559707016|FG001|Overall Study|Hepatitis A screening result|0|||
155076009|NCT05537571|559707017|FG002|Overall Study|Hepatitis A screening result|0|||
155076010|NCT05537571|559707018|FG003|Overall Study|Hepatitis A screening result|0|||
155076011|NCT05537571|559707019|FG004|Overall Study|Hepatitis A screening result|0|||
155076012|NCT05537571|559707015|FG000|Overall Study|Lost to Follow-up|0|||
155076013|NCT05537571|559707016|FG001|Overall Study|Lost to Follow-up|0|||
155076014|NCT05537571|559707017|FG002|Overall Study|Lost to Follow-up|1|||
155076015|NCT05537571|559707018|FG003|Overall Study|Lost to Follow-up|0|||
155076016|NCT05537571|559707019|FG004|Overall Study|Lost to Follow-up|1|||
155076017|NCT04439123|559707022|FG000|Overall Study|Adverse Event|11|||
155076018|NCT04439123|559707022|FG000|Overall Study|Death|1|||
155076019|NCT04439123|559707022|FG000|Overall Study|Disease progression|19|||
155076020|NCT04439123|559707022|FG000|Overall Study|Withdrawal by Subject|2|||
155076021|NCT04439123|559707022|FG000|Overall Study|Still on treatment|2|||
155076022|NCT00002874|559707023|FG000|Overall Study|Withdrawal by Subject|1|||
155076023|NCT00002874|559707024|FG001|Overall Study|Withdrawal by Subject|1|||
155076024|NCT00002874|559707023|FG000|Overall Study|Protocol Violation|44|||
155076025|NCT00002874|559707024|FG001|Overall Study|Protocol Violation|34|||
155076026|NCT04971837|559709098|FG000|Overall Study|Long Term Illness|1|||
155076027|NCT04971837|559709098|FG000|Overall Study|BMI too low|9|||
155076028|NCT04971837|559709098|FG000|Overall Study|geographic location|1|||
155076029|NCT04971837|559709098|FG000|Overall Study|Discontinued scheduling conflict|1|||
155076030|NCT03787212|559709099|FG000|Period 1|Study Termination|2|||
155076031|NCT03787212|559709100|FG001|Period 1|Study Termination|2|||
155076032|NCT00884949|559709101|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
155076033|NCT00884949|559709101|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
155076034|NCT03022630|559709102|FG000|Overall Study|Death|9|||
155076035|NCT03022630|559709103|FG001|Overall Study|Death|7|||
155076036|NCT03022630|559709102|FG000|Overall Study|Withdrawal by Subject|0|||
155076037|NCT03022630|559709103|FG001|Overall Study|Withdrawal by Subject|5|||
155076038|NCT00382070|559709104|FG000|Overall Study|No follow up data mapped to Other|17|||
155076039|NCT00382070|559709105|FG001|Overall Study|No follow up data mapped to Other|19|||
155076040|NCT00382070|559709104|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
155076041|NCT00382070|559709105|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
155076042|NCT00382070|559709104|FG000|Overall Study|No clinical assessment|9|||
155076043|NCT00382070|559709105|FG001|Overall Study|No clinical assessment|11|||
155076044|NCT00620035|559709106|FG000|Overall Study|Adverse Event|106|||
155076045|NCT00620035|559709106|FG000|Overall Study|Withdrawal of Informed Consent|1|||
155076046|NCT00620035|559709106|FG000|Overall Study|Other Reason|38|||
155076047|NCT02370394|559709114|FG000|Overall Study|Lost to Follow-up|2|||
155076048|NCT02370394|559709115|FG001|Overall Study|Lost to Follow-up|1|||
155076049|NCT02370394|559709114|FG000|Overall Study|Withdrawal by Subject|0|||
155076050|NCT02370394|559709115|FG001|Overall Study|Withdrawal by Subject|1|||
155076051|NCT01108796|559709118|FG000|Overall Study|Adverse Event|0|||
155076052|NCT01108796|559709119|FG001|Overall Study|Adverse Event|1|||
155076053|NCT01108796|559709118|FG000|Overall Study|Lost to Follow-up|7|||
155076054|NCT01108796|559709119|FG001|Overall Study|Lost to Follow-up|6|||
155076055|NCT00758043|559709120|FG000|Overall Study|Adverse Event|1|||
155076056|NCT00758043|559709121|FG001|Overall Study|Adverse Event|20|||
155076057|NCT00758043|559709122|FG002|Overall Study|Adverse Event|12|||
155076058|NCT00758043|559709123|FG003|Overall Study|Adverse Event|62|||
155076059|NCT00758043|559709120|FG000|Overall Study|Lack of Efficacy|0|||
155076060|NCT00758043|559709121|FG001|Overall Study|Lack of Efficacy|6|||
155076061|NCT00758043|559709122|FG002|Overall Study|Lack of Efficacy|18|||
155076062|NCT00758043|559709123|FG003|Overall Study|Lack of Efficacy|12|||
155076063|NCT00758043|559709120|FG000|Overall Study|Refused Further Treatment|0|||
155076064|NCT00758043|559709121|FG001|Overall Study|Refused Further Treatment|11|||
155076065|NCT00758043|559709122|FG002|Overall Study|Refused Further Treatment|5|||
155076066|NCT00758043|559709123|FG003|Overall Study|Refused Further Treatment|8|||
155076067|NCT00758043|559709120|FG000|Overall Study|Lost to Follow-up|0|||
155076068|NCT00758043|559709121|FG001|Overall Study|Lost to Follow-up|2|||
155076069|NCT00758043|559709122|FG002|Overall Study|Lost to Follow-up|2|||
155076070|NCT00758043|559709123|FG003|Overall Study|Lost to Follow-up|5|||
155076071|NCT00758043|559709120|FG000|Overall Study|Withdrawal by Subject|0|||
155076072|NCT00758043|559709121|FG001|Overall Study|Withdrawal by Subject|1|||
155076073|NCT00758043|559709122|FG002|Overall Study|Withdrawal by Subject|1|||
155076074|NCT00758043|559709123|FG003|Overall Study|Withdrawal by Subject|4|||
155076075|NCT00758043|559709120|FG000|Overall Study|Required Prohibited Medication|0|||
155076076|NCT00758043|559709121|FG001|Overall Study|Required Prohibited Medication|0|||
155076077|NCT00758043|559709122|FG002|Overall Study|Required Prohibited Medication|1|||
155342335|NCT02764320|560687042|FG000|Overall Study|Withdrawal by Subject|35|||
155076078|NCT00758043|559709123|FG003|Overall Study|Required Prohibited Medication|3|||
155076079|NCT00758043|559709120|FG000|Overall Study|Non-Compliant With study Drug|0|||
155076080|NCT00758043|559709121|FG001|Overall Study|Non-Compliant With study Drug|0|||
155342336|NCT02764320|560687043|FG001|Overall Study|Withdrawal by Subject|38|||
155164731|NCT02910986|560040546|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
155076081|NCT00758043|559709122|FG002|Overall Study|Non-Compliant With study Drug|0|||
155164732|NCT00357006|560040559|FG000|Overall Study|Lost to Follow-up|1|||
155164733|NCT00357006|560040560|FG001|Overall Study|Lost to Follow-up|2|||
155164734|NCT00357006|560040561|FG002|Overall Study|Lost to Follow-up|1|||
155164735|NCT00357006|560040559|FG000|Overall Study|Withdrawal by Subject|1|||
155342337|NCT02764320|560687042|FG000|Overall Study|Protocol Violation|11|||
155342338|NCT02764320|560687043|FG001|Overall Study|Protocol Violation|6|||
155342339|NCT02764320|560687042|FG000|Overall Study|Adverse Event|2|||
155342340|NCT02764320|560687043|FG001|Overall Study|Adverse Event|0|||
155342341|NCT02764320|560687042|FG000|Overall Study|Health Issues unable to continue|2|||
155342342|NCT02764320|560687043|FG001|Overall Study|Health Issues unable to continue|0|||
155342343|NCT02764320|560687042|FG000|Overall Study|Did not meet inclusion criteria|1|||
155342344|NCT02764320|560687043|FG001|Overall Study|Did not meet inclusion criteria|0|||
155342345|NCT02764320|560687042|FG000|Overall Study|Subject moved|0|||
155342346|NCT02764320|560687043|FG001|Overall Study|Subject moved|2|||
155342347|NCT02764320|560687042|FG000|Overall Study|Overused medication unavailable|0|||
155342348|NCT02764320|560687043|FG001|Overall Study|Overused medication unavailable|1|||
155342349|NCT02764320|560687042|FG000|Overall Study|Seeking care outside site|0|||
155342350|NCT02764320|560687043|FG001|Overall Study|Seeking care outside site|1|||
155342351|NCT02764320|560687042|FG000|Overall Study|Technology barriers|0|||
155342352|NCT02764320|560687043|FG001|Overall Study|Technology barriers|1|||
155342353|NCT04085614|560687044|FG000|Overall Study|Protocol Violation|9|||
155342354|NCT04085614|560687045|FG001|Overall Study|Protocol Violation|6|||
155342355|NCT03529942|560687046|FG000|Overall Study|Withdrawal by Subject|13|||
155342356|NCT03529942|560687046|FG000|Overall Study|Physician Decision|1|||
155342357|NCT03529942|560687046|FG000|Overall Study|Lost to Follow-up|7|||
155342358|NCT03529942|560687046|FG000|Overall Study|Needle inserted but no drug administered|1|||
155342359|NCT03529942|560687046|FG000|Overall Study|Personal reasons|1|||
155342360|NCT00476957|560687047|FG000|Overall Study|Lost to Follow-up|176|||
155342361|NCT00476957|560687048|FG001|Overall Study|Lost to Follow-up|193|||
155342362|NCT02516202|560687053|FG000|Overall Study|Withdrawal by Subject|1|||
155342363|NCT02516202|560687054|FG001|Overall Study|Withdrawal by Subject|0|||
155342364|NCT02516202|560687055|FG002|Overall Study|Withdrawal by Subject|1|||
155342365|NCT02516202|560687053|FG000|Overall Study|Lost to Follow-up|1|||
155342366|NCT02516202|560687054|FG001|Overall Study|Lost to Follow-up|1|||
155342367|NCT02516202|560687055|FG002|Overall Study|Lost to Follow-up|1|||
155342368|NCT02516202|560687053|FG000|Overall Study|Stopped Follow-up|0|||
155342369|NCT02516202|560687054|FG001|Overall Study|Stopped Follow-up|0|||
155342370|NCT02516202|560687055|FG002|Overall Study|Stopped Follow-up|1|||
155342371|NCT00409747|560687060|FG000|Overall Study|Withdrawal by Subject|1|||
155342372|NCT01000649|560687063|FG000|Overall Study|Adverse Event|5|||
155342373|NCT01000649|560687064|FG001|Overall Study|Adverse Event|1|||
155342374|NCT01000649|560687065|FG002|Overall Study|Adverse Event|2|||
155342375|NCT01000649|560687066|FG003|Overall Study|Adverse Event|4|||
155342376|NCT01000649|560687063|FG000|Overall Study|Lost to Follow-up|0|||
155342377|NCT01000649|560687064|FG001|Overall Study|Lost to Follow-up|2|||
155342378|NCT01000649|560687065|FG002|Overall Study|Lost to Follow-up|0|||
155342379|NCT01000649|560687066|FG003|Overall Study|Lost to Follow-up|2|||
155342380|NCT01916109|560687067|FG000|Overall Study|Withdrawal by Subject|1|||
155342381|NCT00103857|560687068|FG000|54-Week Base Study|Adverse Event|12|||
155342382|NCT00103857|560687069|FG001|54-Week Base Study|Adverse Event|9|||
155342383|NCT00103857|560687070|FG002|54-Week Base Study|Adverse Event|11|||
155342384|NCT00103857|560687071|FG003|54-Week Base Study|Adverse Event|6|||
155342385|NCT00103857|560687072|FG004|54-Week Base Study|Adverse Event|5|||
155342386|NCT00103857|560687073|FG005|54-Week Base Study|Adverse Event|11|||
155342387|NCT00103857|560687074|FG006|54-Week Base Study|Adverse Event|3|||
154963266|NCT03199963|559291158|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
155342388|NCT00103857|560687068|FG000|54-Week Base Study|Death|0|||
155342389|NCT00103857|560687069|FG001|54-Week Base Study|Death|0|||
155342390|NCT00103857|560687070|FG002|54-Week Base Study|Death|0|||
155342391|NCT00103857|560687071|FG003|54-Week Base Study|Death|0|||
155342392|NCT00103857|560687072|FG004|54-Week Base Study|Death|1|||
155342393|NCT00103857|560687073|FG005|54-Week Base Study|Death|1|||
155342394|NCT00103857|560687074|FG006|54-Week Base Study|Death|0|||
155342395|NCT00103857|560687068|FG000|54-Week Base Study|Lack of Efficacy|11|||
155342396|NCT00103857|560687069|FG001|54-Week Base Study|Lack of Efficacy|14|||
155342397|NCT00103857|560687070|FG002|54-Week Base Study|Lack of Efficacy|8|||
155342398|NCT00103857|560687071|FG003|54-Week Base Study|Lack of Efficacy|4|||
155164736|NCT00357006|560040560|FG001|Overall Study|Withdrawal by Subject|3|||
155164737|NCT00357006|560040561|FG002|Overall Study|Withdrawal by Subject|2|||
155342399|NCT00103857|560687072|FG004|54-Week Base Study|Lack of Efficacy|3|||
155342400|NCT00103857|560687073|FG005|54-Week Base Study|Lack of Efficacy|14|||
155342401|NCT00103857|560687074|FG006|54-Week Base Study|Lack of Efficacy|19|||
155342402|NCT00103857|560687068|FG000|54-Week Base Study|Lost to Follow-up|5|||
155342403|NCT00103857|560687069|FG001|54-Week Base Study|Lost to Follow-up|4|||
155076082|NCT00758043|559709123|FG003|Overall Study|Non-Compliant With study Drug|1|||
155076083|NCT00758043|559709120|FG000|Overall Study|Other Reasons|0|||
155076084|NCT00758043|559709121|FG001|Overall Study|Other Reasons|1|||
155076085|NCT00758043|559709122|FG002|Overall Study|Other Reasons|0|||
155076086|NCT00758043|559709123|FG003|Overall Study|Other Reasons|5|||
155076087|NCT02545127|559709130|FG000|Overall Study|Lost to Follow-up|1|||
155076088|NCT02545127|559709131|FG001|Overall Study|Lost to Follow-up|0|||
155076089|NCT01875237|559709138|FG000|Overall Study|GVDH before DLI|1|||
155076090|NCT01875237|559709139|FG001|Overall Study|GVDH before DLI|0|||
155076091|NCT01875237|559709138|FG000|Overall Study|DLI cells could not be produced|1|||
155076092|NCT01875237|559709139|FG001|Overall Study|DLI cells could not be produced|0|||
155076093|NCT00983957|559709140|FG000|Overall Study|Adverse Event|1|||
155076094|NCT00983957|559709140|FG000|Overall Study|Personal Reasons|1|||
155076095|NCT03055195|559709141|FG000|Overall Study|Lack of Efficacy|1|||
155076096|NCT03055195|559709142|FG001|Overall Study|Lack of Efficacy|0|||
155076097|NCT03055195|559709141|FG000|Overall Study|Withdrawal by Subject|6|||
155076098|NCT03055195|559709142|FG001|Overall Study|Withdrawal by Subject|7|||
155076099|NCT03055195|559709141|FG000|Overall Study|Study Terminated by Sponsor|2|||
155076100|NCT03055195|559709142|FG001|Overall Study|Study Terminated by Sponsor|6|||
155076101|NCT03055195|559709141|FG000|Overall Study|Protocol Violation|2|||
155076102|NCT03055195|559709142|FG001|Overall Study|Protocol Violation|1|||
155076103|NCT03055195|559709141|FG000|Overall Study|Physician Decision|1|||
155076104|NCT03055195|559709142|FG001|Overall Study|Physician Decision|0|||
155076105|NCT00986232|559709143|FG000|Overall Study|Adverse Event|1|||
155076106|NCT00986232|559709144|FG001|Overall Study|Adverse Event|2|||
155076107|NCT00986232|559709145|FG002|Overall Study|Adverse Event|3|||
155076108|NCT00986232|559709146|FG003|Overall Study|Adverse Event|0|||
155076109|NCT00986232|559709143|FG000|Overall Study|Lost to Follow-up|19|||
155076110|NCT00986232|559709144|FG001|Overall Study|Lost to Follow-up|12|||
155164738|NCT03710161|560040562|FG000|Overall Study|Study halted due to COVID pandemic|3|||
155076111|NCT00986232|559709145|FG002|Overall Study|Lost to Follow-up|12|||
155076112|NCT00986232|559709146|FG003|Overall Study|Lost to Follow-up|7|||
155164739|NCT03710161|560040563|FG001|Overall Study|Study halted due to COVID pandemic|2|||
155164740|NCT02637037|560040566|FG000|Overall Study|Positive drug screen at admission|1|||
155164741|NCT02637037|560040567|FG001|Overall Study|Positive drug screen at admission|0|||
155076113|NCT00986232|559709143|FG000|Overall Study|Protocol Violation|2|||
155076114|NCT00986232|559709144|FG001|Overall Study|Protocol Violation|3|||
155076115|NCT00986232|559709145|FG002|Overall Study|Protocol Violation|0|||
155164742|NCT02637037|560040566|FG000|Overall Study|Withdrawal by Subject|2|||
155076116|NCT00986232|559709146|FG003|Overall Study|Protocol Violation|1|||
155164743|NCT02637037|560040567|FG001|Overall Study|Withdrawal by Subject|1|||
155164744|NCT02637037|560040566|FG000|Overall Study|Adverse Event|1|||
155164745|NCT02637037|560040567|FG001|Overall Study|Adverse Event|0|||
155164746|NCT03339219|560040568|FG000|Overall Study|Death|12|||
155164747|NCT03339219|560040568|FG000|Overall Study|Site Terminated by Sponsor|22|||
155164748|NCT03339219|560040568|FG000|Overall Study|Withdrawal by Subject|1|||
155164749|NCT02023697|560040570|FG000|Treatment Period|Radiological progression|13|||
155164750|NCT02023697|560040571|FG001|Treatment Period|Radiological progression|17|||
155164751|NCT02023697|560040572|FG002|Treatment Period|Radiological progression|26|||
155164752|NCT02023697|560040570|FG000|Treatment Period|Never Treated|5|||
155164753|NCT02023697|560040571|FG001|Treatment Period|Never Treated|6|||
155164754|NCT02023697|560040572|FG002|Treatment Period|Never Treated|10|||
155164755|NCT02023697|560040570|FG000|Treatment Period|Adverse Event|13|||
155164756|NCT02023697|560040571|FG001|Treatment Period|Adverse Event|25|||
155164757|NCT02023697|560040572|FG002|Treatment Period|Adverse Event|23|||
155164758|NCT02023697|560040570|FG000|Treatment Period|Logistical difficulties|1|||
155164759|NCT02023697|560040571|FG001|Treatment Period|Logistical difficulties|1|||
155164760|NCT02023697|560040572|FG002|Treatment Period|Logistical difficulties|1|||
155164761|NCT02023697|560040570|FG000|Treatment Period|Clinical progression|10|||
155164762|NCT02023697|560040571|FG001|Treatment Period|Clinical progression|8|||
155164763|NCT02023697|560040572|FG002|Treatment Period|Clinical progression|28|||
155164764|NCT02023697|560040570|FG000|Treatment Period|Withdrawal by Subject|4|||
155164765|NCT02023697|560040571|FG001|Treatment Period|Withdrawal by Subject|5|||
155164766|NCT02023697|560040572|FG002|Treatment Period|Withdrawal by Subject|13|||
155164767|NCT02023697|560040570|FG000|Treatment Period|Safety outcome reached|0|||
155164768|NCT02023697|560040571|FG001|Treatment Period|Safety outcome reached|1|||
155164769|NCT02023697|560040572|FG002|Treatment Period|Safety outcome reached|0|||
155164770|NCT02023697|560040570|FG000|Treatment Period|Physician Decision|0|||
155164771|NCT02023697|560040571|FG001|Treatment Period|Physician Decision|0|||
155164772|NCT02023697|560040572|FG002|Treatment Period|Physician Decision|1|||
155164773|NCT02023697|560040570|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
155164774|NCT02023697|560040571|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
155164775|NCT02023697|560040572|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
155164776|NCT02023697|560040570|FG000|Active Follow-up Period|Lost to Follow-up|1|||
155164777|NCT02023697|560040571|FG001|Active Follow-up Period|Lost to Follow-up|1|||
155164778|NCT02023697|560040572|FG002|Active Follow-up Period|Lost to Follow-up|1|||
155164779|NCT02023697|560040570|FG000|Active Follow-up Period|Deterioration of general condition|1|||
155164780|NCT02023697|560040571|FG001|Active Follow-up Period|Deterioration of general condition|1|||
155164781|NCT02023697|560040572|FG002|Active Follow-up Period|Deterioration of general condition|1|||
155164782|NCT02023697|560040570|FG000|Active Follow-up Period|Other unspecified|2|||
155164783|NCT02023697|560040571|FG001|Active Follow-up Period|Other unspecified|0|||
155164784|NCT02023697|560040572|FG002|Active Follow-up Period|Other unspecified|1|||
155164785|NCT02023697|560040570|FG000|Active Follow-up Period|Clinical progression|0|||
155164786|NCT02023697|560040571|FG001|Active Follow-up Period|Clinical progression|2|||
155164787|NCT02023697|560040572|FG002|Active Follow-up Period|Clinical progression|1|||
155164788|NCT02023697|560040570|FG000|Active Follow-up Period|Radiological progression|0|||
155164789|NCT02023697|560040571|FG001|Active Follow-up Period|Radiological progression|0|||
155164790|NCT02023697|560040572|FG002|Active Follow-up Period|Radiological progression|1|||
155164791|NCT02023697|560040570|FG000|Active Follow-up Period|Death|83|||
155164792|NCT02023697|560040571|FG001|Active Follow-up Period|Death|82|||
155164793|NCT02023697|560040572|FG002|Active Follow-up Period|Death|87|||
155164794|NCT02023697|560040570|FG000|Long-term Follow-up Period|Death|9|||
155164795|NCT02023697|560040571|FG001|Long-term Follow-up Period|Death|6|||
155342404|NCT00103857|560687070|FG002|54-Week Base Study|Lost to Follow-up|7|||
155342405|NCT00103857|560687071|FG003|54-Week Base Study|Lost to Follow-up|5|||
155342406|NCT00103857|560687072|FG004|54-Week Base Study|Lost to Follow-up|10|||
155342407|NCT00103857|560687073|FG005|54-Week Base Study|Lost to Follow-up|9|||
155342408|NCT00103857|560687074|FG006|54-Week Base Study|Lost to Follow-up|3|||
155342409|NCT00103857|560687068|FG000|54-Week Base Study|Physician Decision|1|||
155342410|NCT00103857|560687069|FG001|54-Week Base Study|Physician Decision|1|||
155164796|NCT02023697|560040572|FG002|Long-term Follow-up Period|Death|4|||
155164797|NCT02023697|560040570|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
155164798|NCT02023697|560040571|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
155164799|NCT02023697|560040572|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
155342411|NCT00103857|560687070|FG002|54-Week Base Study|Physician Decision|0|||
155342412|NCT00103857|560687071|FG003|54-Week Base Study|Physician Decision|0|||
155164800|NCT02023697|560040570|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
155342413|NCT00103857|560687072|FG004|54-Week Base Study|Physician Decision|1|||
155342414|NCT00103857|560687073|FG005|54-Week Base Study|Physician Decision|0|||
155342415|NCT00103857|560687074|FG006|54-Week Base Study|Physician Decision|0|||
155076117|NCT00986232|559709143|FG000|Overall Study|Withdrawal by Subject|13|||
155076118|NCT00986232|559709144|FG001|Overall Study|Withdrawal by Subject|16|||
155076119|NCT00986232|559709145|FG002|Overall Study|Withdrawal by Subject|12|||
155076120|NCT00986232|559709146|FG003|Overall Study|Withdrawal by Subject|3|||
155076121|NCT00986232|559709143|FG000|Overall Study|Missed one or more bleeds|13|||
155076122|NCT00986232|559709144|FG001|Overall Study|Missed one or more bleeds|10|||
155076123|NCT00986232|559709145|FG002|Overall Study|Missed one or more bleeds|6|||
155076124|NCT00986232|559709146|FG003|Overall Study|Missed one or more bleeds|7|||
155076125|NCT00986232|559709143|FG000|Overall Study|Incomplete safety follow-up|3|||
155076126|NCT00986232|559709144|FG001|Overall Study|Incomplete safety follow-up|7|||
155076127|NCT00986232|559709145|FG002|Overall Study|Incomplete safety follow-up|2|||
155076128|NCT00986232|559709146|FG003|Overall Study|Incomplete safety follow-up|2|||
155076129|NCT02568423|559709147|FG000|Overall Study|Lost to Follow-up|0|||
155076130|NCT02568423|559709148|FG001|Overall Study|Lost to Follow-up|2|||
155076131|NCT02568423|559709149|FG002|Overall Study|Lost to Follow-up|0|||
155076132|NCT02568423|559709150|FG003|Overall Study|Lost to Follow-up|0|||
155076133|NCT02568423|559709151|FG004|Overall Study|Lost to Follow-up|0|||
155076134|NCT02568423|559709152|FG005|Overall Study|Lost to Follow-up|0|||
155076135|NCT02568423|559709153|FG006|Overall Study|Lost to Follow-up|0|||
155076136|NCT02568423|559709154|FG007|Overall Study|Lost to Follow-up|0|||
155076137|NCT02568423|559709147|FG000|Overall Study|Physician Decision|0|||
155076138|NCT02568423|559709148|FG001|Overall Study|Physician Decision|0|||
155076139|NCT02568423|559709149|FG002|Overall Study|Physician Decision|0|||
155076140|NCT02568423|559709150|FG003|Overall Study|Physician Decision|0|||
155076141|NCT02568423|559709151|FG004|Overall Study|Physician Decision|0|||
155076142|NCT02568423|559709152|FG005|Overall Study|Physician Decision|1|||
155076143|NCT02568423|559709153|FG006|Overall Study|Physician Decision|0|||
155076144|NCT02568423|559709154|FG007|Overall Study|Physician Decision|0|||
155076145|NCT00790933|559709155|FG000|Overall Study|Adverse Event|94|||
155076146|NCT00790933|559709156|FG001|Overall Study|Adverse Event|119|||
155076147|NCT00790933|559709157|FG002|Overall Study|Adverse Event|65|||
154963267|NCT03199963|559291157|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
154963268|NCT03199963|559291158|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
154963269|NCT03199963|559291157|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
154963270|NCT03199963|559291158|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
154963271|NCT03199963|559291157|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
154963272|NCT03199963|559291158|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
154963273|NCT03199963|559291157|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
154963274|NCT03199963|559291158|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
154963275|NCT03199963|559291157|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
154963276|NCT03199963|559291158|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
154963277|NCT00107991|559291161|FG000|Eligibility Assessment|Disease not severe enough|7|||
154963278|NCT00107991|559291161|FG000|Eligibility Assessment|Unwilling to participate|7|||
154963279|NCT00107991|559291161|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
154963280|NCT00107991|559291161|FG000|Eligibility Assessment|Abnormal labs|2|||
154963281|NCT00107991|559291161|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
154963282|NCT00107991|559291161|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
154963283|NCT00107991|559291161|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
154963284|NCT00107991|559291161|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
154963285|NCT00107991|559291161|FG000|12 Week Treatment Period|Adverse Event|1|||
154963286|NCT00107991|559291161|FG000|12 Week Treatment Period|Protocol Violation|1|||
154963287|NCT00107991|559291161|FG000|12 Week Treatment Period|Incarcerated|1|||
154963288|NCT00107991|559291161|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
154963289|NCT03930732|559291162|FG000|Overall Study|Adverse Event|9|||
154963290|NCT03930732|559291163|FG001|Overall Study|Adverse Event|7|||
154963291|NCT03930732|559291162|FG000|Overall Study|Poor compliance to protocol|0|||
154963292|NCT03930732|559291163|FG001|Overall Study|Poor compliance to protocol|1|||
154963293|NCT03930732|559291162|FG000|Overall Study|Withdrawal by Subject|23|||
154963294|NCT03930732|559291163|FG001|Overall Study|Withdrawal by Subject|11|||
154963295|NCT03930732|559291162|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
154963296|NCT03930732|559291163|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
154963297|NCT03930732|559291162|FG000|Overall Study|Other reason not related to COVID-19|5|||
154963298|NCT03930732|559291163|FG001|Overall Study|Other reason not related to COVID-19|8|||
154963299|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Adverse Event|11|||
154963300|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Adverse Event|23|||
154963301|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Adverse Event|29|||
154963302|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Adverse Event|2|||
154963303|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Adverse Event|8|||
154963304|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
154963305|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
154963306|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
154963307|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
154963308|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
154963309|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
154963310|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
154963311|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
154963312|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
154963313|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
154963314|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
154963315|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
154963316|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
154963317|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
154963318|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
154963319|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
154963320|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
154963321|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
154963322|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
154963323|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
154963324|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
154963325|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
154963326|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
154963327|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
154963328|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
154963329|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
154963330|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
154963331|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
154963332|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
154963333|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
154963334|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Move|0|||
154963335|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Move|1|||
154963336|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Move|0|||
154963337|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Move|0|||
154963338|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Move|0|||
154963339|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
154963340|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
154963341|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
154963342|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
154963343|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
154963344|NCT00318461|559291170|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
154963345|NCT00318461|559291171|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
154963346|NCT00318461|559291172|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
154963347|NCT00318461|559291173|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
154963348|NCT00318461|559291174|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
154963349|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Work commitment|0|||
154963350|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Work commitment|0|||
154963351|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Work commitment|0|||
154963352|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Work commitment|0|||
154963353|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Work commitment|1|||
154963354|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Investigator decision|0|||
154963355|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Investigator decision|0|||
154963356|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Investigator decision|0|||
155076148|NCT00790933|559709158|FG003|Overall Study|Adverse Event|5|||
155076149|NCT00790933|559709159|FG004|Overall Study|Adverse Event|69|||
155076150|NCT00790933|559709155|FG000|Overall Study|Protocol Violation(s)|8|||
155076151|NCT00790933|559709156|FG001|Overall Study|Protocol Violation(s)|18|||
155076152|NCT00790933|559709157|FG002|Overall Study|Protocol Violation(s)|7|||
155076153|NCT00790933|559709158|FG003|Overall Study|Protocol Violation(s)|0|||
155076154|NCT00790933|559709159|FG004|Overall Study|Protocol Violation(s)|12|||
155076155|NCT00790933|559709155|FG000|Overall Study|Lack of Efficacy|192|||
155076156|NCT00790933|559709156|FG001|Overall Study|Lack of Efficacy|176|||
155076157|NCT00790933|559709157|FG002|Overall Study|Lack of Efficacy|130|||
155076158|NCT00790933|559709158|FG003|Overall Study|Lack of Efficacy|1|||
155076159|NCT00790933|559709159|FG004|Overall Study|Lack of Efficacy|121|||
155076160|NCT00790933|559709155|FG000|Overall Study|Study Terminated by Sponsor|0|||
155076161|NCT00790933|559709156|FG001|Overall Study|Study Terminated by Sponsor|0|||
155076162|NCT00790933|559709157|FG002|Overall Study|Study Terminated by Sponsor|1|||
155076163|NCT00790933|559709158|FG003|Overall Study|Study Terminated by Sponsor|0|||
155076164|NCT00790933|559709159|FG004|Overall Study|Study Terminated by Sponsor|0|||
155076165|NCT00790933|559709155|FG000|Overall Study|Withdrawal by Subject|123|||
155076166|NCT00790933|559709156|FG001|Overall Study|Withdrawal by Subject|120|||
155076167|NCT00790933|559709157|FG002|Overall Study|Withdrawal by Subject|52|||
155076168|NCT00790933|559709158|FG003|Overall Study|Withdrawal by Subject|6|||
155076169|NCT00790933|559709159|FG004|Overall Study|Withdrawal by Subject|50|||
155076170|NCT00790933|559709155|FG000|Overall Study|Lost to Follow-up|13|||
155076171|NCT00790933|559709156|FG001|Overall Study|Lost to Follow-up|31|||
155076172|NCT00790933|559709157|FG002|Overall Study|Lost to Follow-up|10|||
155076173|NCT00790933|559709158|FG003|Overall Study|Lost to Follow-up|1|||
155076174|NCT00790933|559709159|FG004|Overall Study|Lost to Follow-up|15|||
155076175|NCT00790933|559709155|FG000|Overall Study|Reason Not Specified|8|||
155076176|NCT00790933|559709156|FG001|Overall Study|Reason Not Specified|16|||
155076177|NCT00790933|559709157|FG002|Overall Study|Reason Not Specified|4|||
155076178|NCT00790933|559709158|FG003|Overall Study|Reason Not Specified|1|||
155076179|NCT00790933|559709159|FG004|Overall Study|Reason Not Specified|9|||
155076180|NCT00720083|559709162|FG000|Overall Study|Ineligible|1|||
155076181|NCT00720083|559709163|FG001|Overall Study|Ineligible|2|||
155076182|NCT01913470|559709167|FG000|Overall Study|Lost to Follow-up|0|||
155076183|NCT01913470|559709168|FG001|Overall Study|Lost to Follow-up|1|||
155076184|NCT01913470|559709167|FG000|Overall Study|Physician Decision|0|||
155076185|NCT01913470|559709168|FG001|Overall Study|Physician Decision|1|||
155076186|NCT01913470|559709167|FG000|Overall Study|Withdrawal by Subject|0|||
155076187|NCT01913470|559709168|FG001|Overall Study|Withdrawal by Subject|1|||
155076188|NCT01829165|559709173|FG000|Overall Study|Did not complete intervention|2|||
155076189|NCT01829165|559709174|FG001|Overall Study|Did not complete intervention|0|||
155076190|NCT02573467|559709175|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
155076191|NCT02573467|559709176|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
155076192|NCT02573467|559709177|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
155076193|NCT02573467|559709178|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
155076194|NCT02573467|559709175|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
155076195|NCT02573467|559709176|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
155076196|NCT02573467|559709177|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
155076197|NCT02573467|559709178|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
155076198|NCT02573467|559709175|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
155076199|NCT02573467|559709176|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
155076200|NCT02573467|559709177|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
155076201|NCT02573467|559709178|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
155076202|NCT02573467|559709175|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
155076203|NCT02573467|559709176|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
155076204|NCT02573467|559709177|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
155076205|NCT02573467|559709178|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
155076206|NCT02573467|559709175|FG000|Post-treatment Follow up Epoch|Death|1|||
155076207|NCT02573467|559709176|FG001|Post-treatment Follow up Epoch|Death|1|||
155076208|NCT02573467|559709177|FG002|Post-treatment Follow up Epoch|Death|0|||
155076209|NCT02573467|559709178|FG003|Post-treatment Follow up Epoch|Death|1|||
155076210|NCT02573467|559709175|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
155076211|NCT02573467|559709176|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
155076212|NCT02573467|559709177|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
155076213|NCT02573467|559709178|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
155076214|NCT02573467|559709175|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
155076215|NCT02573467|559709176|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
155076216|NCT02573467|559709177|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
155076217|NCT02573467|559709178|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
155076218|NCT01960842|559709182|FG000|Overall Study|Adverse Event|1|||
155076219|NCT01960842|559709182|FG000|Overall Study|Withdrawal by Subject|2|||
155076220|NCT02056288|559709187|FG000|In-Hospital Data|Surgery cancelled|1|||
155076221|NCT02056288|559709188|FG001|In-Hospital Data|Surgery cancelled|0|||
155076222|NCT02056288|559709187|FG000|In-Hospital Data|Protocol Violation|3|||
155076223|NCT02056288|559709188|FG001|In-Hospital Data|Protocol Violation|0|||
155076224|NCT02056288|559709187|FG000|In-Hospital Data|Physician Decision|1|||
155076225|NCT02056288|559709188|FG001|In-Hospital Data|Physician Decision|0|||
155076226|NCT02056288|559709187|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
155076227|NCT02056288|559709188|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
155076228|NCT02400580|559709191|FG000|Overall Study|Withdrawal by Subject|1|||
155076229|NCT02400580|559709192|FG001|Overall Study|Withdrawal by Subject|1|||
155076230|NCT02400580|559709191|FG000|Overall Study|Adverse Event|1|||
155076231|NCT02400580|559709192|FG001|Overall Study|Adverse Event|0|||
155076232|NCT02384460|559709193|FG000|Overall Study|Protocol Violation|0|||
155076233|NCT02384460|559709194|FG001|Overall Study|Protocol Violation|1|||
155076234|NCT02384460|559709193|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
155076235|NCT02384460|559709194|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
155076236|NCT02384460|559709193|FG000|Overall Study|Adverse Event|5|||
155076237|NCT02384460|559709194|FG001|Overall Study|Adverse Event|2|||
155076238|NCT02384460|559709193|FG000|Overall Study|Withdrawal by Subject|0|||
155076239|NCT02384460|559709194|FG001|Overall Study|Withdrawal by Subject|3|||
155076240|NCT02384460|559709193|FG000|Overall Study|Elective medical treatment|1|||
155076241|NCT02384460|559709194|FG001|Overall Study|Elective medical treatment|0|||
155076242|NCT02384460|559709193|FG000|Overall Study|Non-compliance|1|||
155076243|NCT02384460|559709194|FG001|Overall Study|Non-compliance|0|||
155076244|NCT04233580|559709195|FG000|Overall Study|Adverse Event|3|||
155076245|NCT04233580|559709196|FG001|Overall Study|Adverse Event|3|||
155076246|NCT04233580|559709195|FG000|Overall Study|Withdrawal by Subject|2|||
155076247|NCT04233580|559709196|FG001|Overall Study|Withdrawal by Subject|1|||
155076248|NCT00625378|559709197|FG000|Overall Study|Adverse Event|22|||
155076249|NCT00625378|559709198|FG001|Overall Study|Adverse Event|0|||
155076250|NCT00625378|559709197|FG000|Overall Study|Withdrawal by Subject|16|||
155076251|NCT00625378|559709198|FG001|Overall Study|Withdrawal by Subject|0|||
155076252|NCT00625378|559709197|FG000|Overall Study|Death|38|||
155076253|NCT00625378|559709198|FG001|Overall Study|Death|0|||
155076254|NCT00625378|559709197|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
155076255|NCT00625378|559709198|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
155076256|NCT00625378|559709197|FG000|Overall Study|Lost to Follow-up|17|||
155076257|NCT00625378|559709198|FG001|Overall Study|Lost to Follow-up|0|||
155076258|NCT00625378|559709197|FG000|Overall Study|Non-compliant with study medication|3|||
155076259|NCT00625378|559709198|FG001|Overall Study|Non-compliant with study medication|0|||
155076260|NCT00625378|559709197|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
155076261|NCT00625378|559709198|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
155076262|NCT00625378|559709197|FG000|Overall Study|Medical decision|1|||
155076263|NCT00625378|559709198|FG001|Overall Study|Medical decision|0|||
155076264|NCT00625378|559709197|FG000|Overall Study|Multiple toxicities|1|||
155076265|NCT00625378|559709198|FG001|Overall Study|Multiple toxicities|0|||
155076266|NCT00625378|559709197|FG000|Overall Study|New cancer|1|||
155076267|NCT00625378|559709198|FG001|Overall Study|New cancer|0|||
155076268|NCT00625378|559709197|FG000|Overall Study|PTA program|2|||
155076269|NCT00625378|559709198|FG001|Overall Study|PTA program|0|||
155076270|NCT00625378|559709197|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
155076271|NCT00625378|559709198|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
155076272|NCT00625378|559709197|FG000|Overall Study|Sponsor decision|1|||
155076273|NCT00625378|559709198|FG001|Overall Study|Sponsor decision|0|||
155076274|NCT00625378|559709197|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
155076275|NCT00625378|559709198|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
155076276|NCT00625378|559709197|FG000|Overall Study|Switch to commercial drug|6|||
155076277|NCT00625378|559709198|FG001|Overall Study|Switch to commercial drug|1|||
155076278|NCT00625378|559709197|FG000|Overall Study|Missing|2|||
155076279|NCT00625378|559709198|FG001|Overall Study|Missing|0|||
155076280|NCT00625378|559709197|FG000|Overall Study|End of treatment not available|2|||
155342416|NCT00103857|560687068|FG000|54-Week Base Study|Pregnancy|1|||
155342417|NCT00103857|560687069|FG001|54-Week Base Study|Pregnancy|0|||
155342418|NCT00103857|560687070|FG002|54-Week Base Study|Pregnancy|0|||
155342419|NCT00103857|560687071|FG003|54-Week Base Study|Pregnancy|0|||
155342420|NCT00103857|560687072|FG004|54-Week Base Study|Pregnancy|1|||
155342421|NCT00103857|560687073|FG005|54-Week Base Study|Pregnancy|0|||
155342422|NCT00103857|560687074|FG006|54-Week Base Study|Pregnancy|1|||
155342423|NCT00103857|560687068|FG000|54-Week Base Study|Protocol Violation|6|||
155342424|NCT00103857|560687069|FG001|54-Week Base Study|Protocol Violation|4|||
155342425|NCT00103857|560687070|FG002|54-Week Base Study|Protocol Violation|2|||
155342426|NCT00103857|560687071|FG003|54-Week Base Study|Protocol Violation|4|||
155342427|NCT00103857|560687072|FG004|54-Week Base Study|Protocol Violation|0|||
155342428|NCT00103857|560687073|FG005|54-Week Base Study|Protocol Violation|3|||
155342429|NCT00103857|560687074|FG006|54-Week Base Study|Protocol Violation|3|||
155342430|NCT00103857|560687068|FG000|54-Week Base Study|Withdrawal by Subject|17|||
155342431|NCT00103857|560687069|FG001|54-Week Base Study|Withdrawal by Subject|16|||
155342432|NCT00103857|560687070|FG002|54-Week Base Study|Withdrawal by Subject|16|||
155342433|NCT00103857|560687071|FG003|54-Week Base Study|Withdrawal by Subject|15|||
155342434|NCT00103857|560687072|FG004|54-Week Base Study|Withdrawal by Subject|10|||
155342435|NCT00103857|560687073|FG005|54-Week Base Study|Withdrawal by Subject|15|||
155342436|NCT00103857|560687074|FG006|54-Week Base Study|Withdrawal by Subject|4|||
155342437|NCT00103857|560687068|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
155342438|NCT00103857|560687069|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
155076281|NCT00625378|559709198|FG001|Overall Study|End of treatment not available|0|||
155076282|NCT00625378|559709197|FG000|Overall Study|Never treated|2|||
155076283|NCT00625378|559709198|FG001|Overall Study|Never treated|0|||
155076284|NCT01814332|559709199|FG000|Overall Study|Adverse Event|8|||
155076285|NCT01814332|559709200|FG001|Overall Study|Adverse Event|3|||
155076286|NCT01814332|559709199|FG000|Overall Study|Withdrawal by Subject|3|||
155076287|NCT01814332|559709200|FG001|Overall Study|Withdrawal by Subject|8|||
155076288|NCT01814332|559709199|FG000|Overall Study|Protocol Violation|0|||
155342439|NCT00103857|560687070|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
155342440|NCT00103857|560687071|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
155342441|NCT00103857|560687072|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
155342442|NCT00103857|560687073|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
155342443|NCT00103857|560687074|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
155342444|NCT00103857|560687068|FG000|54-Week Base Study|patient moved|0|||
155342445|NCT00103857|560687069|FG001|54-Week Base Study|patient moved|1|||
155342446|NCT00103857|560687070|FG002|54-Week Base Study|patient moved|1|||
155342447|NCT00103857|560687071|FG003|54-Week Base Study|patient moved|2|||
155342448|NCT00103857|560687072|FG004|54-Week Base Study|patient moved|3|||
154963357|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Investigator decision|0|||
155342449|NCT00103857|560687073|FG005|54-Week Base Study|patient moved|1|||
155342450|NCT00103857|560687074|FG006|54-Week Base Study|patient moved|0|||
155342451|NCT00103857|560687068|FG000|54-Week Base Study|non-compliance with study procedures|1|||
155342452|NCT00103857|560687069|FG001|54-Week Base Study|non-compliance with study procedures|2|||
155342453|NCT00103857|560687070|FG002|54-Week Base Study|non-compliance with study procedures|0|||
155342454|NCT00103857|560687071|FG003|54-Week Base Study|non-compliance with study procedures|0|||
155342455|NCT00103857|560687072|FG004|54-Week Base Study|non-compliance with study procedures|0|||
155342456|NCT00103857|560687073|FG005|54-Week Base Study|non-compliance with study procedures|2|||
155342457|NCT00103857|560687074|FG006|54-Week Base Study|non-compliance with study procedures|0|||
155342458|NCT00103857|560687068|FG000|54-Week Base Study|patient incarcerated|0|||
154963358|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Investigator decision|1|||
154963359|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Lack of time|1|||
154963360|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Lack of time|0|||
154963361|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Lack of time|0|||
154963362|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Lack of time|0|||
154963363|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Lack of time|0|||
154963364|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
154963365|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
154963366|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
154963367|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
154963368|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
154963369|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
154963370|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
154963371|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
154963372|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
154963373|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
154963374|NCT00318461|559291170|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
154963375|NCT00318461|559291171|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
154963376|NCT00318461|559291172|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
154963377|NCT00318461|559291173|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
154963378|NCT00318461|559291174|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
154963379|NCT00318461|559291170|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
154963380|NCT00318461|559291171|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
154963381|NCT00318461|559291172|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
154963382|NCT00318461|559291173|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
154963383|NCT00318461|559291174|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
154963384|NCT00318461|559291170|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
154963385|NCT00318461|559291171|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
154963386|NCT00318461|559291172|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
154963387|NCT00318461|559291173|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
154963388|NCT00318461|559291174|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
154963389|NCT00318461|559291170|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
154963390|NCT00318461|559291171|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
154963391|NCT00318461|559291172|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
154963392|NCT00318461|559291173|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
154963393|NCT00318461|559291174|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
154963394|NCT00318461|559291170|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
154963395|NCT00318461|559291171|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
154963396|NCT00318461|559291172|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
154963397|NCT00318461|559291173|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
154963398|NCT00318461|559291174|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
154963399|NCT00318461|559291170|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
154963400|NCT00318461|559291171|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
154963401|NCT00318461|559291172|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
154963402|NCT00318461|559291173|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
154963403|NCT00318461|559291174|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
154963404|NCT00505622|559291175|FG000|Overall Study|Adverse Event|5|||
154963405|NCT00505622|559291176|FG001|Overall Study|Adverse Event|6|||
154963406|NCT00505622|559291177|FG002|Overall Study|Adverse Event|4|||
154963407|NCT00505622|559291175|FG000|Overall Study|Protocol Violation|1|||
154963408|NCT00505622|559291176|FG001|Overall Study|Protocol Violation|1|||
155076289|NCT01814332|559709200|FG001|Overall Study|Protocol Violation|4|||
155076290|NCT01814332|559709199|FG000|Overall Study|Lost to Follow-up|5|||
155076291|NCT01814332|559709200|FG001|Overall Study|Lost to Follow-up|1|||
155076292|NCT02030418|559709202|FG000|Overall Study|Death|78|||
155076293|NCT02030418|559709202|FG000|Overall Study|Missed 12-Month Visit|9|||
155076294|NCT02030418|559709202|FG000|Overall Study|Withdrawn|57|||
155076295|NCT00866320|559709211|FG000|Overall Study|Withdrawal by Subject|4|||
155076296|NCT00866320|559709211|FG000|Overall Study|Death|2|||
155076297|NCT02063724|559709214|FG000|Overall Study|Disease progression|1|||
155076298|NCT02315625|559709215|FG000|First Intervention|Disease Progression|1|||
155076299|NCT02315625|559709216|FG001|First Intervention|Disease Progression|0|||
155076300|NCT02315625|559709215|FG000|Second Intervention|Physician Decision|2|||
155076301|NCT02315625|559709216|FG001|Second Intervention|Physician Decision|1|||
155076302|NCT02315625|559709215|FG000|Second Intervention|Study closure|1|||
155076303|NCT02315625|559709216|FG001|Second Intervention|Study closure|0|||
155076304|NCT02315625|559709215|FG000|Second Intervention|Disease Progression|1|||
155076305|NCT02315625|559709216|FG001|Second Intervention|Disease Progression|0|||
155076306|NCT02697422|559709217|FG000|Overall Study|Declined exit survey|9|||
155076307|NCT02697422|559709218|FG001|Overall Study|Declined exit survey|2|||
155076308|NCT02697422|559709217|FG000|Overall Study|Lost to Follow-up|13|||
155076309|NCT02697422|559709218|FG001|Overall Study|Lost to Follow-up|8|||
155076310|NCT02697422|559709217|FG000|Overall Study|Death|2|||
155076311|NCT02697422|559709218|FG001|Overall Study|Death|1|||
155342459|NCT00103857|560687069|FG001|54-Week Base Study|patient incarcerated|0|||
155342460|NCT00103857|560687070|FG002|54-Week Base Study|patient incarcerated|0|||
155076312|NCT02697422|559709217|FG000|Overall Study|Withdrawal by Subject|0|||
155076313|NCT02697422|559709218|FG001|Overall Study|Withdrawal by Subject|1|||
155076314|NCT02697422|559709217|FG000|Overall Study|Physician Decision|1|||
155076315|NCT02697422|559709218|FG001|Overall Study|Physician Decision|1|||
155076316|NCT02697422|559709217|FG000|Overall Study|Exit survey data lost|1|||
155076317|NCT02697422|559709218|FG001|Overall Study|Exit survey data lost|0|||
155076318|NCT03983109|559709220|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
155076319|NCT03983109|559709221|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
155076320|NCT00887588|559709222|FG000|Core Period|Death|1|||
155076321|NCT00887588|559709223|FG001|Core Period|Death|1|||
155076322|NCT00887588|559709222|FG000|Core Period|Lost to Follow-up|3|||
155076323|NCT00887588|559709223|FG001|Core Period|Lost to Follow-up|1|||
155076324|NCT00887588|559709222|FG000|Core Period|Withdrawal by Subject|6|||
155076325|NCT00887588|559709223|FG001|Core Period|Withdrawal by Subject|8|||
155076326|NCT00887588|559709222|FG000|Core Period|Adverse Event|9|||
155076327|NCT00887588|559709223|FG001|Core Period|Adverse Event|11|||
155076328|NCT00887588|559709222|FG000|Extension Period|Adverse Event|4|||
155076329|NCT00887588|559709223|FG001|Extension Period|Adverse Event|4|||
155076330|NCT00887588|559709222|FG000|Extension Period|Death|0|||
155076331|NCT00887588|559709223|FG001|Extension Period|Death|1|||
155076332|NCT00887588|559709222|FG000|Extension Period|Protocol deviation|1|||
155076333|NCT00887588|559709223|FG001|Extension Period|Protocol deviation|0|||
155076334|NCT00887588|559709222|FG000|Extension Period|Lost to Follow-up|1|||
155076335|NCT00887588|559709223|FG001|Extension Period|Lost to Follow-up|0|||
155076336|NCT04210375|559709228|FG000|Overall Study|Death|0|||
155076337|NCT04210375|559709229|FG001|Overall Study|Death|1|||
155076338|NCT04210375|559709230|FG002|Overall Study|Death|0|||
155076339|NCT04210375|559709231|FG003|Overall Study|Death|0|||
155076340|NCT05752487|559709232|FG000|Overall Study|Enrolled, not treated|9|||
155076341|NCT05752487|559709232|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
155076342|NCT05752487|559709232|FG000|Overall Study|Withdrawal by Subject|2|||
155076343|NCT04124965|559709234|FG000|Overall Study|Adverse event, non-fatal|3|||
155164801|NCT02023697|560040571|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
155342461|NCT00103857|560687071|FG003|54-Week Base Study|patient incarcerated|0|||
155342462|NCT00103857|560687072|FG004|54-Week Base Study|patient incarcerated|1|||
155342463|NCT00103857|560687073|FG005|54-Week Base Study|patient incarcerated|1|||
155342464|NCT00103857|560687074|FG006|54-Week Base Study|patient incarcerated|0|||
155342465|NCT00103857|560687068|FG000|54-Week Base Study|laboratory reporting error|0|||
155342466|NCT00103857|560687069|FG001|54-Week Base Study|laboratory reporting error|0|||
155342467|NCT00103857|560687070|FG002|54-Week Base Study|laboratory reporting error|0|||
155342468|NCT00103857|560687071|FG003|54-Week Base Study|laboratory reporting error|0|||
155342469|NCT00103857|560687072|FG004|54-Week Base Study|laboratory reporting error|1|||
155342470|NCT00103857|560687073|FG005|54-Week Base Study|laboratory reporting error|0|||
155342471|NCT00103857|560687074|FG006|54-Week Base Study|laboratory reporting error|0|||
155342472|NCT00103857|560687068|FG000|54-Week Base Study|site error|0|||
155076344|NCT04124965|559709235|FG001|Overall Study|Adverse event, non-fatal|1|||
155076345|NCT04124965|559709234|FG000|Overall Study|Withdrawal by Subject|1|||
155076346|NCT04124965|559709235|FG001|Overall Study|Withdrawal by Subject|1|||
155076347|NCT04124965|559709234|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
155164802|NCT02023697|560040572|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
155076348|NCT04124965|559709235|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
155076349|NCT04124965|559709234|FG000|Overall Study|Pregnancy|1|||
155076350|NCT04124965|559709235|FG001|Overall Study|Pregnancy|0|||
155076351|NCT04124965|559709234|FG000|Overall Study|Sponsor and participant decision|0|||
155076352|NCT04124965|559709235|FG001|Overall Study|Sponsor and participant decision|1|||
155076353|NCT04124965|559709234|FG000|Overall Study|Personal surgery|0|||
155076354|NCT04124965|559709235|FG001|Overall Study|Personal surgery|1|||
155076355|NCT04124965|559709234|FG000|Overall Study|Physician Decision|0|||
155076356|NCT04124965|559709235|FG001|Overall Study|Physician Decision|1|||
155076357|NCT02184156|559709236|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
155076358|NCT02184156|559709237|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
155076359|NCT02184156|559709236|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
155076360|NCT02184156|559709237|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
155076361|NCT01214720|559709239|FG000|Overall Study|Alive and still on treatment|34|||
155076362|NCT01214720|559709240|FG001|Overall Study|Alive and still on treatment|18|||
155076363|NCT01214720|559709239|FG000|Overall Study|Alive and in follow-up|45|||
155076364|NCT01214720|559709240|FG001|Overall Study|Alive and in follow-up|48|||
155076365|NCT01214720|559709239|FG000|Overall Study|Lost to Follow-up|6|||
155076366|NCT01214720|559709240|FG001|Overall Study|Lost to Follow-up|2|||
155076367|NCT05591755|559709241|FG000|Overall Study|Screen Failure|1|||
155076368|NCT05591755|559709242|FG001|Overall Study|Screen Failure|0|||
155076369|NCT05591755|559709243|FG002|Overall Study|Screen Failure|0|||
155076370|NCT05591755|559709244|FG003|Overall Study|Screen Failure|0|||
155076371|NCT05591755|559709241|FG000|Overall Study|Protocol Violation|0|||
155076372|NCT05591755|559709242|FG001|Overall Study|Protocol Violation|0|||
155076373|NCT05591755|559709243|FG002|Overall Study|Protocol Violation|2|||
155076374|NCT05591755|559709244|FG003|Overall Study|Protocol Violation|0|||
155076375|NCT05591755|559709241|FG000|Overall Study|Withdrawal by Subject|0|||
155076376|NCT05591755|559709242|FG001|Overall Study|Withdrawal by Subject|1|||
155076377|NCT05591755|559709243|FG002|Overall Study|Withdrawal by Subject|0|||
155076378|NCT05591755|559709244|FG003|Overall Study|Withdrawal by Subject|0|||
155076379|NCT03158311|559709247|FG000|Overall Study|Subject/Guardian Decision|10|||
155076380|NCT03158311|559709248|FG001|Overall Study|Subject/Guardian Decision|6|||
155076381|NCT03158311|559709249|FG002|Overall Study|Subject/Guardian Decision|11|||
155076382|NCT03158311|559709247|FG000|Overall Study|Adverse Event|5|||
155076383|NCT03158311|559709248|FG001|Overall Study|Adverse Event|3|||
155076384|NCT03158311|559709249|FG002|Overall Study|Adverse Event|3|||
155076385|NCT03158311|559709247|FG000|Overall Study|Techinical Problems|3|||
155076386|NCT03158311|559709248|FG001|Overall Study|Techinical Problems|1|||
155076387|NCT03158311|559709249|FG002|Overall Study|Techinical Problems|5|||
155076388|NCT03158311|559709247|FG000|Overall Study|Physician Decision|2|||
155076389|NCT03158311|559709248|FG001|Overall Study|Physician Decision|3|||
155076390|NCT03158311|559709249|FG002|Overall Study|Physician Decision|7|||
155076391|NCT03158311|559709247|FG000|Overall Study|Lost to Follow-up|1|||
155076392|NCT03158311|559709248|FG001|Overall Study|Lost to Follow-up|1|||
155076393|NCT03158311|559709249|FG002|Overall Study|Lost to Follow-up|1|||
155076394|NCT03158311|559709247|FG000|Overall Study|Sponsor decision|1|||
155076395|NCT03158311|559709248|FG001|Overall Study|Sponsor decision|0|||
155076396|NCT03158311|559709249|FG002|Overall Study|Sponsor decision|0|||
155076397|NCT03158311|559709247|FG000|Overall Study|Pregnancy|0|||
155076398|NCT03158311|559709248|FG001|Overall Study|Pregnancy|2|||
155076399|NCT03158311|559709249|FG002|Overall Study|Pregnancy|0|||
155164803|NCT02023697|560040570|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
155164804|NCT02023697|560040571|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
155342473|NCT00103857|560687069|FG001|54-Week Base Study|site error|0|||
155342474|NCT00103857|560687070|FG002|54-Week Base Study|site error|0|||
155342475|NCT00103857|560687071|FG003|54-Week Base Study|site error|0|||
155342476|NCT00103857|560687072|FG004|54-Week Base Study|site error|0|||
155342477|NCT00103857|560687073|FG005|54-Week Base Study|site error|1|||
155342478|NCT00103857|560687074|FG006|54-Week Base Study|site error|0|||
155342479|NCT00103857|560687068|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
155342480|NCT00103857|560687069|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342481|NCT00103857|560687070|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342482|NCT00103857|560687071|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342483|NCT00103857|560687072|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
155076400|NCT03158311|559709247|FG000|Overall Study|Randomized in error|0|||
155076401|NCT03158311|559709248|FG001|Overall Study|Randomized in error|0|||
155076402|NCT03158311|559709249|FG002|Overall Study|Randomized in error|1|||
155076403|NCT01033071|559709252|FG000|Overall Study|Adverse Event|28|||
155076404|NCT01033071|559709253|FG001|Overall Study|Adverse Event|51|||
155076405|NCT01033071|559709254|FG002|Overall Study|Adverse Event|26|||
155076406|NCT01033071|559709252|FG000|Overall Study|Protocol Violation|0|||
155076407|NCT01033071|559709253|FG001|Overall Study|Protocol Violation|2|||
155076408|NCT01033071|559709254|FG002|Overall Study|Protocol Violation|1|||
155076409|NCT01033071|559709252|FG000|Overall Study|Lost to Follow-up|4|||
155076410|NCT01033071|559709253|FG001|Overall Study|Lost to Follow-up|5|||
155076411|NCT01033071|559709254|FG002|Overall Study|Lost to Follow-up|5|||
155076412|NCT01033071|559709252|FG000|Overall Study|Withdrawal by Subject|17|||
155076413|NCT01033071|559709253|FG001|Overall Study|Withdrawal by Subject|14|||
155076414|NCT01033071|559709254|FG002|Overall Study|Withdrawal by Subject|11|||
155076415|NCT01033071|559709252|FG000|Overall Study|Lack of Efficacy|0|||
155076416|NCT01033071|559709253|FG001|Overall Study|Lack of Efficacy|1|||
155076417|NCT01033071|559709254|FG002|Overall Study|Lack of Efficacy|1|||
155076418|NCT01033071|559709252|FG000|Overall Study|Other|6|||
155076419|NCT01033071|559709253|FG001|Overall Study|Other|4|||
155076420|NCT01033071|559709254|FG002|Overall Study|Other|3|||
155076421|NCT03166631|559710986|FG000|Overall Study|Progressive disease|2|||
155076422|NCT03166631|559710987|FG001|Overall Study|Progressive disease|1|||
155076423|NCT03166631|559710988|FG002|Overall Study|Progressive disease|3|||
155342484|NCT00103857|560687073|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342485|NCT00103857|560687074|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
155342486|NCT00103857|560687068|FG000|50-Week Extension Study|Adverse Event|2|||
155342487|NCT00103857|560687069|FG001|50-Week Extension Study|Adverse Event|3|||
155342488|NCT00103857|560687070|FG002|50-Week Extension Study|Adverse Event|2|||
155342489|NCT00103857|560687071|FG003|50-Week Extension Study|Adverse Event|0|||
155342490|NCT00103857|560687072|FG004|50-Week Extension Study|Adverse Event|1|||
155342491|NCT00103857|560687073|FG005|50-Week Extension Study|Adverse Event|1|||
155342492|NCT00103857|560687074|FG006|50-Week Extension Study|Adverse Event|0|||
155342493|NCT00103857|560687068|FG000|50-Week Extension Study|Death|0|||
155342494|NCT00103857|560687069|FG001|50-Week Extension Study|Death|0|||
155342495|NCT00103857|560687070|FG002|50-Week Extension Study|Death|0|||
155342496|NCT00103857|560687071|FG003|50-Week Extension Study|Death|1|||
155342497|NCT00103857|560687072|FG004|50-Week Extension Study|Death|0|||
155342498|NCT00103857|560687073|FG005|50-Week Extension Study|Death|1|||
155342499|NCT00103857|560687074|FG006|50-Week Extension Study|Death|0|||
155342500|NCT00103857|560687068|FG000|50-Week Extension Study|Lack of Efficacy|26|||
155342501|NCT00103857|560687069|FG001|50-Week Extension Study|Lack of Efficacy|15|||
155342502|NCT00103857|560687070|FG002|50-Week Extension Study|Lack of Efficacy|13|||
155342503|NCT00103857|560687071|FG003|50-Week Extension Study|Lack of Efficacy|16|||
155342504|NCT00103857|560687072|FG004|50-Week Extension Study|Lack of Efficacy|8|||
155342505|NCT00103857|560687073|FG005|50-Week Extension Study|Lack of Efficacy|8|||
155342506|NCT00103857|560687074|FG006|50-Week Extension Study|Lack of Efficacy|0|||
155342507|NCT00103857|560687068|FG000|50-Week Extension Study|Lost to Follow-up|4|||
155342508|NCT00103857|560687069|FG001|50-Week Extension Study|Lost to Follow-up|0|||
155342509|NCT00103857|560687070|FG002|50-Week Extension Study|Lost to Follow-up|1|||
155342510|NCT00103857|560687071|FG003|50-Week Extension Study|Lost to Follow-up|4|||
155342511|NCT00103857|560687072|FG004|50-Week Extension Study|Lost to Follow-up|3|||
155342512|NCT00103857|560687073|FG005|50-Week Extension Study|Lost to Follow-up|3|||
155342513|NCT00103857|560687074|FG006|50-Week Extension Study|Lost to Follow-up|0|||
155342514|NCT00103857|560687068|FG000|50-Week Extension Study|Physician Decision|0|||
155076424|NCT03166631|559710989|FG003|Overall Study|Progressive disease|4|||
155076425|NCT03166631|559710990|FG004|Overall Study|Progressive disease|2|||
155076426|NCT03166631|559710991|FG005|Overall Study|Progressive disease|2|||
155076427|NCT03166631|559710992|FG006|Overall Study|Progressive disease|5|||
155076428|NCT03166631|559710993|FG007|Overall Study|Progressive disease|6|||
155076429|NCT03166631|559710994|FG008|Overall Study|Progressive disease|11|||
155076430|NCT03166631|559710995|FG009|Overall Study|Progressive disease|5|||
155076431|NCT03166631|559710996|FG010|Overall Study|Progressive disease|7|||
155076432|NCT03166631|559710986|FG000|Overall Study|Physician Decision|0|||
155076433|NCT03166631|559710987|FG001|Overall Study|Physician Decision|0|||
155076434|NCT03166631|559710988|FG002|Overall Study|Physician Decision|0|||
155076435|NCT03166631|559710989|FG003|Overall Study|Physician Decision|0|||
155076436|NCT03166631|559710990|FG004|Overall Study|Physician Decision|0|||
155164805|NCT02023697|560040572|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
155164806|NCT02023697|560040570|FG000|Long-term Follow-up Period|Technical problems|0|||
155164807|NCT02023697|560040571|FG001|Long-term Follow-up Period|Technical problems|0|||
155164808|NCT02023697|560040572|FG002|Long-term Follow-up Period|Technical problems|1|||
155164809|NCT02023697|560040570|FG000|Long-term Follow-up Period|Other unspecified|6|||
155164810|NCT02023697|560040571|FG001|Long-term Follow-up Period|Other unspecified|3|||
155164811|NCT02023697|560040572|FG002|Long-term Follow-up Period|Other unspecified|5|||
155164812|NCT04939415|560040575|FG000|Overall Study|Withdrawal by Subject|1|||
155164813|NCT04939415|560040576|FG001|Overall Study|Withdrawal by Subject|3|||
155164814|NCT04939415|560040575|FG000|Overall Study|Lost to Follow-up|0|||
155164815|NCT04939415|560040576|FG001|Overall Study|Lost to Follow-up|2|||
155164816|NCT00478023|560040582|FG000|Overall Study|Adverse Event|11|||
155164817|NCT00478023|560040583|FG001|Overall Study|Adverse Event|7|||
155164818|NCT00478023|560040584|FG002|Overall Study|Adverse Event|8|||
155164819|NCT00478023|560040585|FG003|Overall Study|Adverse Event|14|||
155164820|NCT00478023|560040586|FG004|Overall Study|Adverse Event|6|||
155164821|NCT00478023|560040582|FG000|Overall Study|Death|1|||
155164822|NCT00478023|560040583|FG001|Overall Study|Death|0|||
155164823|NCT00478023|560040584|FG002|Overall Study|Death|0|||
155164824|NCT00478023|560040585|FG003|Overall Study|Death|0|||
155164825|NCT00478023|560040586|FG004|Overall Study|Death|0|||
155164826|NCT00478023|560040582|FG000|Overall Study|Lack of Efficacy|11|||
155164827|NCT00478023|560040583|FG001|Overall Study|Lack of Efficacy|10|||
155164828|NCT00478023|560040584|FG002|Overall Study|Lack of Efficacy|4|||
155164829|NCT00478023|560040585|FG003|Overall Study|Lack of Efficacy|5|||
155164830|NCT00478023|560040586|FG004|Overall Study|Lack of Efficacy|41|||
155164831|NCT00478023|560040582|FG000|Overall Study|Lost to Follow-up|3|||
155164832|NCT00478023|560040583|FG001|Overall Study|Lost to Follow-up|1|||
155164833|NCT00478023|560040584|FG002|Overall Study|Lost to Follow-up|1|||
155164834|NCT00478023|560040585|FG003|Overall Study|Lost to Follow-up|1|||
155164835|NCT00478023|560040586|FG004|Overall Study|Lost to Follow-up|0|||
155164836|NCT00478023|560040582|FG000|Overall Study|Withdrawal by Subject|2|||
155164837|NCT00478023|560040583|FG001|Overall Study|Withdrawal by Subject|3|||
155164838|NCT00478023|560040584|FG002|Overall Study|Withdrawal by Subject|2|||
155164839|NCT00478023|560040585|FG003|Overall Study|Withdrawal by Subject|4|||
155164840|NCT00478023|560040586|FG004|Overall Study|Withdrawal by Subject|5|||
155164841|NCT00478023|560040582|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
155164842|NCT00478023|560040583|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
155164843|NCT00478023|560040584|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
155164844|NCT00478023|560040585|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
155164845|NCT00478023|560040586|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
155164846|NCT03895840|560040587|FG000|Overall Study|Withdrawal by Subject|21|||
155164847|NCT00611026|560040588|FG000|Randomized to Double-blind Treatment|Not treated|2|||
155164848|NCT00611026|560040589|FG001|Randomized to Double-blind Treatment|Not treated|1|||
155164849|NCT00611026|560040590|FG002|Randomized to Double-blind Treatment|Not treated|3|||
155164850|NCT00611026|560040588|FG000|Double-blind Treatment Period|Death|1|||
155164851|NCT00611026|560040589|FG001|Double-blind Treatment Period|Death|0|||
155164852|NCT00611026|560040590|FG002|Double-blind Treatment Period|Death|0|||
155164853|NCT00611026|560040588|FG000|Double-blind Treatment Period|Adverse Event|9|||
155164854|NCT00611026|560040589|FG001|Double-blind Treatment Period|Adverse Event|28|||
155164855|NCT00611026|560040590|FG002|Double-blind Treatment Period|Adverse Event|46|||
155164856|NCT00611026|560040588|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
155164857|NCT00611026|560040589|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
155164858|NCT00611026|560040590|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
155076437|NCT03166631|559710991|FG005|Overall Study|Physician Decision|0|||
155076438|NCT03166631|559710992|FG006|Overall Study|Physician Decision|1|||
155076439|NCT03166631|559710993|FG007|Overall Study|Physician Decision|0|||
155076440|NCT03166631|559710994|FG008|Overall Study|Physician Decision|1|||
155076441|NCT03166631|559710995|FG009|Overall Study|Physician Decision|0|||
155076442|NCT03166631|559710996|FG010|Overall Study|Physician Decision|1|||
155076443|NCT03166631|559710986|FG000|Overall Study|Death|0|||
155076444|NCT03166631|559710987|FG001|Overall Study|Death|0|||
155076445|NCT03166631|559710988|FG002|Overall Study|Death|0|||
155076446|NCT03166631|559710989|FG003|Overall Study|Death|0|||
155076447|NCT03166631|559710990|FG004|Overall Study|Death|1|||
155076448|NCT03166631|559710991|FG005|Overall Study|Death|0|||
155076449|NCT03166631|559710992|FG006|Overall Study|Death|1|||
155076450|NCT03166631|559710993|FG007|Overall Study|Death|0|||
155076451|NCT03166631|559710994|FG008|Overall Study|Death|0|||
155076452|NCT03166631|559710995|FG009|Overall Study|Death|0|||
155076453|NCT03166631|559710996|FG010|Overall Study|Death|0|||
155076454|NCT03166631|559710986|FG000|Overall Study|Adverse Event|1|||
155076455|NCT03166631|559710987|FG001|Overall Study|Adverse Event|0|||
155076456|NCT03166631|559710988|FG002|Overall Study|Adverse Event|0|||
155076457|NCT03166631|559710989|FG003|Overall Study|Adverse Event|0|||
155076458|NCT03166631|559710990|FG004|Overall Study|Adverse Event|0|||
155076459|NCT03166631|559710991|FG005|Overall Study|Adverse Event|1|||
155076460|NCT03166631|559710992|FG006|Overall Study|Adverse Event|1|||
155076461|NCT03166631|559710993|FG007|Overall Study|Adverse Event|0|||
155076462|NCT03166631|559710994|FG008|Overall Study|Adverse Event|1|||
155076463|NCT03166631|559710995|FG009|Overall Study|Adverse Event|2|||
155076464|NCT03166631|559710996|FG010|Overall Study|Adverse Event|1|||
155076465|NCT03166631|559710986|FG000|Overall Study|Withdrawal by Subject|0|||
155076466|NCT03166631|559710987|FG001|Overall Study|Withdrawal by Subject|0|||
155076467|NCT03166631|559710988|FG002|Overall Study|Withdrawal by Subject|0|||
155076468|NCT03166631|559710989|FG003|Overall Study|Withdrawal by Subject|0|||
155076469|NCT03166631|559710990|FG004|Overall Study|Withdrawal by Subject|0|||
155076470|NCT03166631|559710991|FG005|Overall Study|Withdrawal by Subject|0|||
155076471|NCT03166631|559710992|FG006|Overall Study|Withdrawal by Subject|0|||
155076472|NCT03166631|559710993|FG007|Overall Study|Withdrawal by Subject|0|||
155076473|NCT03166631|559710994|FG008|Overall Study|Withdrawal by Subject|1|||
155076474|NCT03166631|559710995|FG009|Overall Study|Withdrawal by Subject|1|||
155076475|NCT03166631|559710996|FG010|Overall Study|Withdrawal by Subject|0|||
155076476|NCT03197935|559710999|FG000|Overall Study|Death due to any cause|26|||
155076477|NCT03197935|559711000|FG001|Overall Study|Death due to any cause|15|||
155076478|NCT03197935|559710999|FG000|Overall Study|Lost to Follow-up|3|||
155076479|NCT03197935|559711000|FG001|Overall Study|Lost to Follow-up|5|||
155076480|NCT03197935|559710999|FG000|Overall Study|Physician Decision|2|||
155342515|NCT00103857|560687069|FG001|50-Week Extension Study|Physician Decision|1|||
155076481|NCT03197935|559711000|FG001|Overall Study|Physician Decision|1|||
155076482|NCT03197935|559710999|FG000|Overall Study|Withdrawal by Subject|16|||
155076483|NCT03197935|559711000|FG001|Overall Study|Withdrawal by Subject|8|||
155076484|NCT04027946|559711001|FG000|Overall Study|Screen failures|3|||
155076485|NCT03315689|559711002|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
155076486|NCT03315689|559711003|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
155076487|NCT03315689|559711002|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
155076488|NCT03315689|559711003|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
155076489|NCT03315689|559711002|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
155076490|NCT03315689|559711003|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
155076491|NCT00985192|559711004|FG000|Overall Study|Withdrawal by Subject|1|||
155076492|NCT00985192|559711004|FG000|Overall Study|Disease Progression|1|||
155076493|NCT00985192|559711004|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
155076494|NCT01348698|559711007|FG000|Overall Study|Does not meet lesion size criteria|1|||
155342516|NCT00103857|560687070|FG002|50-Week Extension Study|Physician Decision|1|||
155076495|NCT01348698|559711007|FG000|Overall Study|Death|3|||
155076496|NCT01348698|559711007|FG000|Overall Study|PI decision to close study|68|||
155076497|NCT01297244|559711008|FG000|Overall Study|Progressive disease|22|||
155076498|NCT01297244|559711009|FG001|Overall Study|Progressive disease|3|||
155076499|NCT01297244|559711008|FG000|Overall Study|Adverse Event|9|||
155076500|NCT01297244|559711009|FG001|Overall Study|Adverse Event|1|||
155076501|NCT01297244|559711008|FG000|Overall Study|Death|1|||
155076502|NCT01297244|559711009|FG001|Overall Study|Death|1|||
155076503|NCT01297244|559711008|FG000|Overall Study|Clinical progression|1|||
155076504|NCT01297244|559711009|FG001|Overall Study|Clinical progression|1|||
155076505|NCT01297244|559711008|FG000|Overall Study|Withdrawal by Subject|2|||
155076506|NCT01297244|559711009|FG001|Overall Study|Withdrawal by Subject|0|||
155076507|NCT02595749|559711010|FG000|Overall Study|Withdrawal by Subject|12|||
155076508|NCT02595749|559711011|FG001|Overall Study|Withdrawal by Subject|7|||
155076509|NCT00669331|559711012|FG000|Randomisation to First Dose|Adverse Event|1|||
155076510|NCT00669331|559711013|FG001|Randomisation to First Dose|Adverse Event|0|||
155342517|NCT00103857|560687071|FG003|50-Week Extension Study|Physician Decision|0|||
155342518|NCT00103857|560687072|FG004|50-Week Extension Study|Physician Decision|0|||
154963409|NCT00505622|559291177|FG002|Overall Study|Protocol Violation|0|||
154963410|NCT00505622|559291175|FG000|Overall Study|Withdrawal by Subject|0|||
154963411|NCT00505622|559291176|FG001|Overall Study|Withdrawal by Subject|3|||
154963412|NCT00505622|559291177|FG002|Overall Study|Withdrawal by Subject|2|||
155342519|NCT00103857|560687073|FG005|50-Week Extension Study|Physician Decision|0|||
155342520|NCT00103857|560687074|FG006|50-Week Extension Study|Physician Decision|0|||
155342521|NCT00103857|560687068|FG000|50-Week Extension Study|Pregnancy|0|||
155342522|NCT00103857|560687069|FG001|50-Week Extension Study|Pregnancy|0|||
155342523|NCT00103857|560687070|FG002|50-Week Extension Study|Pregnancy|1|||
155342524|NCT00103857|560687071|FG003|50-Week Extension Study|Pregnancy|0|||
155342525|NCT00103857|560687072|FG004|50-Week Extension Study|Pregnancy|1|||
155342526|NCT00103857|560687073|FG005|50-Week Extension Study|Pregnancy|0|||
155342527|NCT00103857|560687074|FG006|50-Week Extension Study|Pregnancy|0|||
155342528|NCT00103857|560687068|FG000|50-Week Extension Study|Protocol Violation|1|||
155342529|NCT00103857|560687069|FG001|50-Week Extension Study|Protocol Violation|1|||
155342530|NCT00103857|560687070|FG002|50-Week Extension Study|Protocol Violation|1|||
155342531|NCT00103857|560687071|FG003|50-Week Extension Study|Protocol Violation|2|||
155342532|NCT00103857|560687072|FG004|50-Week Extension Study|Protocol Violation|0|||
155342533|NCT00103857|560687073|FG005|50-Week Extension Study|Protocol Violation|1|||
155342534|NCT00103857|560687074|FG006|50-Week Extension Study|Protocol Violation|0|||
155342535|NCT00103857|560687068|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
155342536|NCT00103857|560687069|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
155342537|NCT00103857|560687070|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
155076511|NCT00669331|559711012|FG000|Randomisation to First Dose|Protocol Violation|1|||
155076512|NCT00669331|559711013|FG001|Randomisation to First Dose|Protocol Violation|0|||
155076513|NCT00669331|559711012|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
155342538|NCT00103857|560687071|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
155342539|NCT00103857|560687072|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
155342540|NCT00103857|560687073|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
155342541|NCT00103857|560687074|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
155342542|NCT00103857|560687068|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
155342543|NCT00103857|560687069|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
155342544|NCT00103857|560687070|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
155342545|NCT00103857|560687071|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
155342546|NCT00103857|560687072|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
155342547|NCT00103857|560687073|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
155342548|NCT00103857|560687074|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
155342549|NCT00103857|560687068|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
155342550|NCT00103857|560687069|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
155342551|NCT00103857|560687070|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
155342552|NCT00103857|560687071|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
155342553|NCT00103857|560687072|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
155342554|NCT00103857|560687073|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
155342555|NCT00103857|560687074|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
155342556|NCT00103857|560687068|FG000|50-Week Extension Study|patient moved|0|||
155342557|NCT00103857|560687069|FG001|50-Week Extension Study|patient moved|0|||
154963413|NCT00505622|559291175|FG000|Overall Study|Study termination by sponsor|115|||
154963414|NCT00505622|559291176|FG001|Overall Study|Study termination by sponsor|98|||
154963415|NCT00505622|559291177|FG002|Overall Study|Study termination by sponsor|90|||
154963416|NCT03084471|559291178|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
154963417|NCT03084471|559291178|FG000|Overall Study|Condition under investigation worsened|84|||
154963418|NCT03084471|559291178|FG000|Overall Study|Lack of therapeutic response|2|||
154963419|NCT03084471|559291178|FG000|Overall Study|Protocol Violation|1|||
154963420|NCT03084471|559291178|FG000|Overall Study|Adverse Event|73|||
154963421|NCT03084471|559291178|FG000|Overall Study|Withdrawal by Subject|12|||
154963422|NCT03084471|559291178|FG000|Overall Study|Disease relapse|181|||
154963423|NCT03084471|559291178|FG000|Overall Study|Subjective disease progression|359|||
154963424|NCT03084471|559291178|FG000|Overall Study|Other (as recorded)|33|||
154963425|NCT03084471|559291178|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
154963426|NCT01757392|559291189|FG000|Overall Study|Withdrawal by Subject|1|||
154963427|NCT01757392|559291189|FG000|Overall Study|Screen Fail|3|||
154963428|NCT00207090|559291192|FG000|Overall Study|Study drug toxicity|3|||
154963429|NCT00207090|559291192|FG000|Overall Study|Chest wall mass larger|1|||
154963430|NCT00207090|559291192|FG000|Overall Study|Disease progression/relapse|2|||
154963431|NCT00207090|559291192|FG000|Overall Study|Physician Decision|1|||
154963432|NCT00835692|559291193|FG000|First Intervention|Withdrawal by Subject|1|||
154963433|NCT00835692|559291194|FG001|First Intervention|Withdrawal by Subject|0|||
154963434|NCT03644550|559291199|FG000|Overall Study|Withdrawal by Subject|3|||
155076514|NCT00669331|559711013|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
155076515|NCT00669331|559711012|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
155076516|NCT00669331|559711013|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
155076517|NCT00669331|559711012|FG000|Randomisation to First Dose|Death|1|||
155076518|NCT00669331|559711013|FG001|Randomisation to First Dose|Death|0|||
155076519|NCT00669331|559711012|FG000|Randomisation to First Dose|Sponsor decision|0|||
155076520|NCT00669331|559711013|FG001|Randomisation to First Dose|Sponsor decision|1|||
155076521|NCT00669331|559711012|FG000|Randomisation to First Dose|Randomised in error|3|||
155076522|NCT00669331|559711013|FG001|Randomisation to First Dose|Randomised in error|10|||
155076523|NCT00669331|559711012|FG000|Blinded Treatment Period|Adverse Event|16|||
155076524|NCT00669331|559711013|FG001|Blinded Treatment Period|Adverse Event|10|||
155076525|NCT00669331|559711012|FG000|Blinded Treatment Period|Protocol Violation|1|||
155076526|NCT00669331|559711013|FG001|Blinded Treatment Period|Protocol Violation|1|||
155076527|NCT00669331|559711012|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
155076528|NCT00669331|559711013|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
155076529|NCT00669331|559711012|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
155076530|NCT00669331|559711013|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
155076531|NCT00669331|559711012|FG000|Blinded Treatment Period|Death|0|||
155076532|NCT00669331|559711013|FG001|Blinded Treatment Period|Death|2|||
155076533|NCT00669331|559711012|FG000|Blinded Treatment Period|Physician Decision|3|||
155076534|NCT00669331|559711013|FG001|Blinded Treatment Period|Physician Decision|3|||
155342558|NCT00103857|560687070|FG002|50-Week Extension Study|patient moved|1|||
155342559|NCT00103857|560687071|FG003|50-Week Extension Study|patient moved|2|||
155342560|NCT00103857|560687072|FG004|50-Week Extension Study|patient moved|0|||
155342561|NCT00103857|560687073|FG005|50-Week Extension Study|patient moved|0|||
155342562|NCT00103857|560687074|FG006|50-Week Extension Study|patient moved|0|||
155342563|NCT00103857|560687068|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342564|NCT00103857|560687069|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342565|NCT00103857|560687070|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
155342566|NCT00103857|560687071|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342567|NCT00103857|560687072|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342568|NCT00103857|560687073|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342569|NCT00103857|560687074|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
155342570|NCT00103857|560687068|FG000|50-Week Extension Study|reason unspecified|0|||
155342571|NCT00103857|560687069|FG001|50-Week Extension Study|reason unspecified|0|||
155342572|NCT00103857|560687070|FG002|50-Week Extension Study|reason unspecified|0|||
155342573|NCT00103857|560687071|FG003|50-Week Extension Study|reason unspecified|0|||
155342574|NCT00103857|560687072|FG004|50-Week Extension Study|reason unspecified|1|||
155342575|NCT00103857|560687073|FG005|50-Week Extension Study|reason unspecified|0|||
155076535|NCT00669331|559711012|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
155076536|NCT00669331|559711013|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
155076537|NCT01454063|559711014|FG000|Randomized|Adverse Event|1|||
155076538|NCT01454063|559711015|FG001|Randomized|Adverse Event|1|||
155076539|NCT01454063|559711014|FG000|Randomized|Protocol Violation|0|||
155076540|NCT01454063|559711015|FG001|Randomized|Protocol Violation|1|||
155076541|NCT01562444|559711016|FG000|Overall Study|Did not meet entry criteria|2|||
155076542|NCT01562444|559711017|FG001|Overall Study|Did not meet entry criteria|0|||
155076543|NCT01562444|559711018|FG002|Overall Study|Did not meet entry criteria|3|||
155076544|NCT01562444|559711016|FG000|Overall Study|Did not comply with blood draw schedule|1|||
155076545|NCT01562444|559711017|FG001|Overall Study|Did not comply with blood draw schedule|0|||
155076546|NCT01562444|559711018|FG002|Overall Study|Did not comply with blood draw schedule|1|||
155076547|NCT01562444|559711016|FG000|Overall Study|Unavailable serological results|0|||
155076548|NCT01562444|559711017|FG001|Overall Study|Unavailable serological results|2|||
155076549|NCT01562444|559711018|FG002|Overall Study|Unavailable serological results|2|||
155076550|NCT01562444|559711016|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
155076551|NCT01562444|559711017|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
155076552|NCT01562444|559711018|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
155076553|NCT01562444|559711016|FG000|Overall Study|Protocol forbidden medication|1|||
155164859|NCT00611026|560040588|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
155076554|NCT01562444|559711017|FG001|Overall Study|Protocol forbidden medication|0|||
155076555|NCT01562444|559711018|FG002|Overall Study|Protocol forbidden medication|0|||
155076556|NCT03387046|559711024|FG000|Overall Study|Adverse Event|1|||
155076557|NCT03387046|559711025|FG001|Overall Study|Adverse Event|1|||
155076558|NCT03558672|559711026|FG000|Overall Study|Study Early Termination|10|||
155076559|NCT00509600|559711027|FG000|Overall Study|Adverse Event|1|||
155076560|NCT03794544|559711032|FG000|Overall Study|Withdrawal by Subject|1|||
155076561|NCT03794544|559711033|FG001|Overall Study|Withdrawal by Subject|1|||
155342576|NCT00103857|560687074|FG006|50-Week Extension Study|reason unspecified|0|||
155076562|NCT03794544|559711034|FG002|Overall Study|Withdrawal by Subject|0|||
155164860|NCT00611026|560040589|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
155342577|NCT00636168|560687077|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
155076563|NCT03794544|559711035|FG003|Overall Study|Withdrawal by Subject|0|||
155076564|NCT03794544|559711032|FG000|Overall Study|Death|0|||
155076565|NCT03794544|559711033|FG001|Overall Study|Death|0|||
155076566|NCT03794544|559711034|FG002|Overall Study|Death|0|||
155076567|NCT03794544|559711035|FG003|Overall Study|Death|1|||
155076568|NCT03794544|559711032|FG000|Overall Study|Lost to Follow-up|0|||
155076569|NCT03794544|559711033|FG001|Overall Study|Lost to Follow-up|1|||
155076570|NCT03794544|559711034|FG002|Overall Study|Lost to Follow-up|1|||
155076571|NCT03794544|559711035|FG003|Overall Study|Lost to Follow-up|0|||
155076572|NCT03794544|559711032|FG000|Overall Study|Other|0|||
155076573|NCT03794544|559711033|FG001|Overall Study|Other|1|||
155076574|NCT03794544|559711034|FG002|Overall Study|Other|0|||
155076575|NCT03794544|559711035|FG003|Overall Study|Other|0|||
155076576|NCT01027416|559711036|FG000|Overall Study|Withdrawal by Subject|0|||
155076577|NCT01027416|559711037|FG001|Overall Study|Withdrawal by Subject|1|||
155076578|NCT01027416|559711036|FG000|Overall Study|Physician Decision|1|||
155076579|NCT01027416|559711037|FG001|Overall Study|Physician Decision|4|||
155076580|NCT00421733|559711038|FG000|Overall Study|Adverse Event|4|||
155076581|NCT00421733|559711039|FG001|Overall Study|Adverse Event|9|||
155076582|NCT00421733|559711040|FG002|Overall Study|Adverse Event|2|||
155076583|NCT00421733|559711038|FG000|Overall Study|Lost to Follow-up|1|||
155076584|NCT00421733|559711039|FG001|Overall Study|Lost to Follow-up|2|||
155076585|NCT00421733|559711040|FG002|Overall Study|Lost to Follow-up|4|||
155076586|NCT00421733|559711038|FG000|Overall Study|Withdrawal by Subject|1|||
155076587|NCT00421733|559711039|FG001|Overall Study|Withdrawal by Subject|2|||
155076588|NCT00421733|559711040|FG002|Overall Study|Withdrawal by Subject|7|||
155076589|NCT00421733|559711038|FG000|Overall Study|Death|0|||
155076590|NCT00421733|559711039|FG001|Overall Study|Death|3|||
155076591|NCT00421733|559711040|FG002|Overall Study|Death|0|||
155076592|NCT00421733|559711038|FG000|Overall Study|Required dialysis|1|||
155076593|NCT00421733|559711039|FG001|Overall Study|Required dialysis|0|||
155076594|NCT00421733|559711040|FG002|Overall Study|Required dialysis|0|||
155076595|NCT00421733|559711038|FG000|Overall Study|Administrative|2|||
155076596|NCT00421733|559711039|FG001|Overall Study|Administrative|0|||
155076597|NCT00421733|559711040|FG002|Overall Study|Administrative|0|||
155076598|NCT00421733|559711038|FG000|Overall Study|Did not satisfy entry criteria|1|||
155076599|NCT00421733|559711039|FG001|Overall Study|Did not satisfy entry criteria|3|||
155076600|NCT00421733|559711040|FG002|Overall Study|Did not satisfy entry criteria|2|||
155076601|NCT00421733|559711038|FG000|Overall Study|Sponsor request|1|||
155076602|NCT00421733|559711039|FG001|Overall Study|Sponsor request|0|||
155076603|NCT00421733|559711040|FG002|Overall Study|Sponsor request|3|||
155076604|NCT00421733|559711038|FG000|Overall Study|Protocol deviation|4|||
155076605|NCT00421733|559711039|FG001|Overall Study|Protocol deviation|7|||
155076606|NCT00421733|559711040|FG002|Overall Study|Protocol deviation|2|||
155164861|NCT00611026|560040590|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
155076607|NCT00875667|559711041|FG000|Overall Study|Adverse Event|29|||
155076608|NCT00875667|559711042|FG001|Overall Study|Adverse Event|10|||
155076609|NCT00875667|559711041|FG000|Overall Study|Withdrawal by Subject|17|||
155076610|NCT00875667|559711042|FG001|Overall Study|Withdrawal by Subject|5|||
155076611|NCT00875667|559711041|FG000|Overall Study|Death|7|||
155076612|NCT00875667|559711042|FG001|Overall Study|Death|2|||
155164862|NCT00611026|560040588|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
155076613|NCT00875667|559711041|FG000|Overall Study|Protocol Violation|2|||
155076614|NCT00875667|559711042|FG001|Overall Study|Protocol Violation|0|||
155076615|NCT00875667|559711041|FG000|Overall Study|Disease Progression|100|||
155076616|NCT00875667|559711042|FG001|Overall Study|Disease Progression|49|||
155076617|NCT00875667|559711041|FG000|Overall Study|Miscellaneous|12|||
155076618|NCT00875667|559711042|FG001|Overall Study|Miscellaneous|6|||
155076619|NCT00875667|559711041|FG000|Overall Study|Randomized but no Study Drug Given|3|||
155076620|NCT00875667|559711042|FG001|Overall Study|Randomized but no Study Drug Given|1|||
155076621|NCT00894647|559711043|FG000|Overall Study|Adverse Event|5|||
155076622|NCT00894647|559711044|FG001|Overall Study|Adverse Event|4|||
155076623|NCT00894647|559711043|FG000|Overall Study|Withdrawal by Subject|4|||
155076624|NCT00894647|559711044|FG001|Overall Study|Withdrawal by Subject|4|||
155076625|NCT00894647|559711043|FG000|Overall Study|Lost to Follow-up|0|||
155076626|NCT00894647|559711044|FG001|Overall Study|Lost to Follow-up|2|||
155076627|NCT00894647|559711043|FG000|Overall Study|Non-compliance with study procedures|0|||
155076628|NCT00894647|559711044|FG001|Overall Study|Non-compliance with study procedures|2|||
155076629|NCT00894647|559711043|FG000|Overall Study|Other, not due to AE|1|||
155076630|NCT00894647|559711044|FG001|Overall Study|Other, not due to AE|2|||
155076631|NCT01967277|559711048|FG000|Overall Study|Lost to Follow-up|1|||
155076632|NCT01967277|559711049|FG001|Overall Study|Lost to Follow-up|2|||
155076633|NCT01967277|559711048|FG000|Overall Study|Unrelated illness|0|||
155076634|NCT01967277|559711049|FG001|Overall Study|Unrelated illness|1|||
155076635|NCT00245570|559711050|FG000|Washout Between Periods III and IV|Adverse Event|0|||
155076636|NCT00245570|559711051|FG001|Washout Between Periods III and IV|Adverse Event|1|||
155076637|NCT00245570|559711052|FG002|Washout Between Periods III and IV|Adverse Event|0|||
155076638|NCT00245570|559711053|FG003|Washout Between Periods III and IV|Adverse Event|0|||
155076639|NCT00245570|559711054|FG004|Washout Between Periods III and IV|Adverse Event|0|||
155076640|NCT00245570|559711055|FG005|Washout Between Periods III and IV|Adverse Event|0|||
155076641|NCT01524705|559711056|FG000|Overall Study|Adverse Event|2|||
155076642|NCT01524705|559711057|FG001|Overall Study|Adverse Event|0|||
155076643|NCT01524705|559711056|FG000|Overall Study|Death|1|||
155076644|NCT01524705|559711057|FG001|Overall Study|Death|0|||
155076645|NCT01524705|559711056|FG000|Overall Study|Lost to Follow-up|0|||
155076646|NCT01524705|559711057|FG001|Overall Study|Lost to Follow-up|1|||
155076647|NCT01524705|559711056|FG000|Overall Study|Withdrawal by Subject|0|||
155076648|NCT01524705|559711057|FG001|Overall Study|Withdrawal by Subject|1|||
155076649|NCT01524705|559711056|FG000|Overall Study|Pancreatic Cancer|0|||
155076650|NCT01524705|559711057|FG001|Overall Study|Pancreatic Cancer|1|||
155076651|NCT00585585|559711060|FG000|Overall Study|Adverse Event|1|||
155076652|NCT00103506|559711061|FG000|Overall Study|Study closed by sponsor|34|||
155076653|NCT00103506|559711062|FG001|Overall Study|Study closed by sponsor|37|||
155076654|NCT00103506|559711061|FG000|Overall Study|Death|257|||
155076655|NCT00103506|559711062|FG001|Overall Study|Death|253|||
155076656|NCT00103506|559711061|FG000|Overall Study|Lost to Follow-up|13|||
155076657|NCT00103506|559711062|FG001|Overall Study|Lost to Follow-up|13|||
155076658|NCT00103506|559711061|FG000|Overall Study|Withdrawal by Subject|18|||
155076659|NCT00103506|559711062|FG001|Overall Study|Withdrawal by Subject|21|||
155076660|NCT00710970|559711065|FG000|Overall Study|Never took drug|3|||
155076661|NCT02153827|559711066|FG000|Overall Study|Lost to Follow-up|3|||
155076662|NCT02153827|559711067|FG001|Overall Study|Lost to Follow-up|9|||
155076663|NCT00397930|559711072|FG000|Overall Study|Personal reasons|14|||
155076664|NCT00397930|559711073|FG001|Overall Study|Personal reasons|8|||
155076665|NCT00397930|559711072|FG000|Overall Study|Other medical|9|||
155076666|NCT00397930|559711073|FG001|Overall Study|Other medical|4|||
155076667|NCT00397930|559711072|FG000|Overall Study|Unknown reasons|9|||
155076668|NCT00397930|559711073|FG001|Overall Study|Unknown reasons|14|||
155076669|NCT00397930|559711072|FG000|Overall Study|Noncompliant|3|||
155076670|NCT00397930|559711073|FG001|Overall Study|Noncompliant|2|||
155076671|NCT00397930|559711072|FG000|Overall Study|Too time-consuming|2|||
155076672|NCT00397930|559711073|FG001|Overall Study|Too time-consuming|9|||
155076673|NCT00397930|559711072|FG000|Overall Study|Started own yoga program|1|||
155076674|NCT00397930|559711073|FG001|Overall Study|Started own yoga program|1|||
155076675|NCT00397930|559711072|FG000|Overall Study|Did not want to be in control group|0|||
155076676|NCT00397930|559711073|FG001|Overall Study|Did not want to be in control group|1|||
155076677|NCT00397930|559711072|FG000|Overall Study|Withdrawal by Subject|0|||
155076678|NCT00397930|559711073|FG001|Overall Study|Withdrawal by Subject|8|||
155076679|NCT00397930|559711072|FG000|Overall Study|Missing data|0|||
155076680|NCT00397930|559711073|FG001|Overall Study|Missing data|4|||
155076681|NCT00965094|559711082|FG000|Overall Study|Adverse Event|5|||
155076682|NCT00965094|559711083|FG001|Overall Study|Adverse Event|0|||
155076683|NCT00965094|559711082|FG000|Overall Study|Lost to Follow-up|0|||
155076684|NCT00965094|559711083|FG001|Overall Study|Lost to Follow-up|1|||
155076685|NCT01433978|559711084|FG000|Core Study|Adverse Event, Non-Fatal|0|||
155076686|NCT01433978|559711085|FG001|Core Study|Adverse Event, Non-Fatal|1|||
155076687|NCT01433978|559711086|FG002|Core Study|Adverse Event, Non-Fatal|0|||
155076688|NCT01433978|559711084|FG000|Core Study|Lack of Efficacy|5|||
155076689|NCT01433978|559711085|FG001|Core Study|Lack of Efficacy|1|||
155076690|NCT01433978|559711086|FG002|Core Study|Lack of Efficacy|0|||
155076691|NCT01433978|559711084|FG000|Core Study|Study Terminated by Sponsor|6|||
155076692|NCT01433978|559711085|FG001|Core Study|Study Terminated by Sponsor|9|||
155076693|NCT01433978|559711086|FG002|Core Study|Study Terminated by Sponsor|0|||
155076694|NCT01433978|559711084|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
155076695|NCT01433978|559711085|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
155164863|NCT00611026|560040589|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
155164864|NCT00611026|560040590|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
155164865|NCT00611026|560040588|FG000|Double-blind Treatment Period|Other|13|||
155164866|NCT00611026|560040589|FG001|Double-blind Treatment Period|Other|20|||
155164867|NCT00611026|560040590|FG002|Double-blind Treatment Period|Other|18|||
155164868|NCT02395081|560040591|FG000|Overall Study|Withdrawal by Subject|1|||
155164869|NCT02395081|560040592|FG001|Overall Study|Withdrawal by Subject|1|||
155164870|NCT02395081|560040593|FG002|Overall Study|Withdrawal by Subject|0|||
155164871|NCT02395081|560040591|FG000|Overall Study|Moved where blood couldn't be collected|4|||
155164872|NCT02395081|560040592|FG001|Overall Study|Moved where blood couldn't be collected|1|||
155164873|NCT02395081|560040593|FG002|Overall Study|Moved where blood couldn't be collected|3|||
155164874|NCT02395081|560040591|FG000|Overall Study|Fetal Loss|2|||
155164875|NCT02395081|560040592|FG001|Overall Study|Fetal Loss|3|||
155164876|NCT02395081|560040593|FG002|Overall Study|Fetal Loss|1|||
155164877|NCT00068419|560040594|FG000|Overall Study|Adverse Event|3|||
155164878|NCT00068419|560040594|FG000|Overall Study|Lack of Efficacy|24|||
155164879|NCT00068419|560040594|FG000|Overall Study|Lost to Follow-up|1|||
155164880|NCT00068419|560040594|FG000|Overall Study|Physician Decision|7|||
155164881|NCT00068419|560040594|FG000|Overall Study|Withdrawal by Subject|14|||
155164882|NCT00068419|560040594|FG000|Overall Study|Ineligible|11|||
155164883|NCT02506244|560040602|FG000|Overall Study|Did not undergo active monitoring|458|||
155164884|NCT02506244|560040603|FG001|Overall Study|Did not undergo active monitoring|459|||
155164885|NCT02506244|560040604|FG002|Overall Study|Did not undergo active monitoring|0|||
155164886|NCT00740857|560040606|FG000|Overall Study|Withdrawal by Subject|1|||
155164887|NCT00740857|560040607|FG001|Overall Study|Withdrawal by Subject|0|||
155164888|NCT00740857|560040608|FG002|Overall Study|Withdrawal by Subject|0|||
155164889|NCT02963506|560040609|FG000|Double-Blind Period|Adverse Event|0|||
155164890|NCT02963506|560040610|FG001|Double-Blind Period|Adverse Event|0|||
155164891|NCT02963506|560040611|FG002|Double-Blind Period|Adverse Event|1|||
155164892|NCT02963506|560040612|FG003|Double-Blind Period|Adverse Event|0|||
155164893|NCT02963506|560040613|FG004|Double-Blind Period|Adverse Event|0|||
155164894|NCT02963506|560040614|FG005|Double-Blind Period|Adverse Event|0|||
155164895|NCT02963506|560040615|FG006|Double-Blind Period|Adverse Event|0|||
155164896|NCT02963506|560040616|FG007|Double-Blind Period|Adverse Event|0|||
155164897|NCT02963506|560040617|FG008|Double-Blind Period|Adverse Event|0|||
155164898|NCT02963506|560040618|FG009|Double-Blind Period|Adverse Event|0|||
155164899|NCT02963506|560040619|FG010|Double-Blind Period|Adverse Event|0|||
155164900|NCT02963506|560040620|FG011|Double-Blind Period|Adverse Event|0|||
155164901|NCT02963506|560040621|FG012|Double-Blind Period|Adverse Event|0|||
155164902|NCT02963506|560040609|FG000|Double-Blind Period|Death|0|||
155164903|NCT02963506|560040610|FG001|Double-Blind Period|Death|0|||
155164904|NCT02963506|560040611|FG002|Double-Blind Period|Death|0|||
155164905|NCT02963506|560040612|FG003|Double-Blind Period|Death|1|||
155164906|NCT02963506|560040613|FG004|Double-Blind Period|Death|0|||
155164907|NCT02963506|560040614|FG005|Double-Blind Period|Death|0|||
155164908|NCT02963506|560040615|FG006|Double-Blind Period|Death|0|||
155164909|NCT02963506|560040616|FG007|Double-Blind Period|Death|0|||
155076696|NCT01433978|559711086|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
155076697|NCT01433978|559711084|FG000|Extension Phase|Lack of Efficacy|0|||
155076698|NCT01433978|559711085|FG001|Extension Phase|Lack of Efficacy|0|||
155076699|NCT01433978|559711086|FG002|Extension Phase|Lack of Efficacy|1|||
155076700|NCT01433978|559711084|FG000|Extension Phase|Study Terminated by Sponsor|0|||
155076701|NCT01433978|559711085|FG001|Extension Phase|Study Terminated by Sponsor|0|||
155076702|NCT01433978|559711086|FG002|Extension Phase|Study Terminated by Sponsor|4|||
155076703|NCT01773889|559711087|FG000|Overall Study|lack of funding|2|||
155076704|NCT03954938|559711088|FG000|Overall Study|Withdrawal by Subject|2|||
155076705|NCT03954938|559711088|FG000|Overall Study|Adverse Event|1|||
155076706|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
155076707|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
155164910|NCT02963506|560040617|FG008|Double-Blind Period|Death|0|||
155164911|NCT02963506|560040618|FG009|Double-Blind Period|Death|0|||
155076708|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
155164912|NCT02963506|560040619|FG010|Double-Blind Period|Death|0|||
155164913|NCT02963506|560040620|FG011|Double-Blind Period|Death|0|||
155164914|NCT02963506|560040621|FG012|Double-Blind Period|Death|0|||
155164915|NCT02963506|560040609|FG000|Double-Blind Period|Lost to Follow-up|0|||
155164916|NCT02963506|560040610|FG001|Double-Blind Period|Lost to Follow-up|1|||
155164917|NCT02963506|560040611|FG002|Double-Blind Period|Lost to Follow-up|0|||
155164918|NCT02963506|560040612|FG003|Double-Blind Period|Lost to Follow-up|0|||
155164919|NCT02963506|560040613|FG004|Double-Blind Period|Lost to Follow-up|0|||
155164920|NCT02963506|560040614|FG005|Double-Blind Period|Lost to Follow-up|0|||
155164921|NCT02963506|560040615|FG006|Double-Blind Period|Lost to Follow-up|0|||
155164922|NCT02963506|560040616|FG007|Double-Blind Period|Lost to Follow-up|0|||
155076709|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
155076710|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
155076711|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
155076712|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
155076713|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
155076714|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
155076715|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
155076716|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
155076717|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
155076718|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
155076719|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
155076720|NCT00976391|559711089|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
155076721|NCT00976391|559711090|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
155076722|NCT00976391|559711089|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
155076723|NCT00976391|559711090|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
155076724|NCT00976391|559711089|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
155076725|NCT00976391|559711090|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
155076726|NCT00976391|559711089|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
155076727|NCT00976391|559711090|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
155076728|NCT00976391|559711089|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
155076729|NCT00976391|559711090|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
155076730|NCT00976391|559711089|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
155076731|NCT00976391|559711090|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
155076732|NCT00976391|559711089|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
155076733|NCT00976391|559711090|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
155076734|NCT02565186|559711091|FG000|Overall Study|Adverse Event|113|||
155076735|NCT02565186|559711092|FG001|Overall Study|Adverse Event|148|||
155076736|NCT02565186|559711091|FG000|Overall Study|Lost to Follow-up|102|||
155076737|NCT02565186|559711092|FG001|Overall Study|Lost to Follow-up|93|||
155076738|NCT02565186|559711091|FG000|Overall Study|Non-Compliance|57|||
155076739|NCT02565186|559711092|FG001|Overall Study|Non-Compliance|55|||
155076740|NCT02565186|559711091|FG000|Overall Study|Withdrawal by Subject|229|||
155076741|NCT02565186|559711092|FG001|Overall Study|Withdrawal by Subject|214|||
155076742|NCT02565186|559711091|FG000|Overall Study|Physician Decision|18|||
155076743|NCT02565186|559711092|FG001|Overall Study|Physician Decision|16|||
155076744|NCT02565186|559711091|FG000|Overall Study|Sponsor Request|5|||
155076745|NCT02565186|559711092|FG001|Overall Study|Sponsor Request|9|||
155076746|NCT02565186|559711091|FG000|Overall Study|Missing|1|||
155076747|NCT02565186|559711092|FG001|Overall Study|Missing|0|||
155076748|NCT02565186|559711091|FG000|Overall Study|Did Not Receive Study Drug|55|||
155076749|NCT02565186|559711092|FG001|Overall Study|Did Not Receive Study Drug|86|||
155076750|NCT01371565|559711093|FG000|Overall Study|Withdrawal by Subject|1|||
155076751|NCT01371565|559711093|FG000|Overall Study|Death|1|||
155076752|NCT01371565|559711093|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
155076753|NCT00617903|559711094|FG000|Overall Study|Withdrawal by Subject|2|||
155076754|NCT00617903|559711095|FG001|Overall Study|Withdrawal by Subject|3|||
155076755|NCT00617903|559711094|FG000|Overall Study|Lost to Follow-up|1|||
155076756|NCT00617903|559711095|FG001|Overall Study|Lost to Follow-up|1|||
155076757|NCT00617903|559711094|FG000|Overall Study|Lack of Efficacy|0|||
155076758|NCT00617903|559711095|FG001|Overall Study|Lack of Efficacy|1|||
155076759|NCT00617903|559711094|FG000|Overall Study|Adverse Event|0|||
155076760|NCT00617903|559711095|FG001|Overall Study|Adverse Event|1|||
155076761|NCT00617903|559711094|FG000|Overall Study|noncompliance|0|||
155076762|NCT00617903|559711095|FG001|Overall Study|noncompliance|1|||
155076763|NCT02217982|559711096|FG000|Overall Study|Trial discontinued|1|||
155076764|NCT02217982|559711097|FG001|Overall Study|Trial discontinued|0|||
155076765|NCT02217982|559711096|FG000|Overall Study|Adverse Event|0|||
155076766|NCT02217982|559711097|FG001|Overall Study|Adverse Event|1|||
155076767|NCT04676646|559711098|FG000|Open-label Run-in Phase|Adverse Event|3|||
155076768|NCT04676646|559711099|FG001|Open-label Run-in Phase|Adverse Event|0|||
155076769|NCT04676646|559711100|FG002|Open-label Run-in Phase|Adverse Event|0|||
155076770|NCT04676646|559711098|FG000|Open-label Run-in Phase|Death|3|||
155076771|NCT04676646|559711099|FG001|Open-label Run-in Phase|Death|0|||
155076772|NCT04676646|559711100|FG002|Open-label Run-in Phase|Death|0|||
155076773|NCT04676646|559711098|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
155076774|NCT04676646|559711099|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
155076775|NCT04676646|559711100|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
155076776|NCT04676646|559711098|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
155076777|NCT04676646|559711099|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
155076778|NCT04676646|559711100|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
155076779|NCT04676646|559711098|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
155076780|NCT04676646|559711099|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
155076781|NCT04676646|559711100|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
155076782|NCT04676646|559711098|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
155076783|NCT04676646|559711099|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
155076784|NCT04676646|559711100|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
155076785|NCT04676646|559711098|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
155076786|NCT04676646|559711099|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
155076787|NCT04676646|559711100|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
155076788|NCT04676646|559711098|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
155076789|NCT04676646|559711099|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
155076790|NCT04676646|559711100|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
155076791|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
155076792|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
155076793|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
155076794|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Death|0|||
155076795|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Death|1|||
155076796|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Death|2|||
155076797|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
155076798|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
155076799|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
155076800|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
155076801|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
155076802|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
155076803|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
155076804|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
155076805|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
155076806|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
155076807|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
155076808|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
155076809|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
155076810|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
155076811|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
155076812|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
155076813|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
155076814|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
155076815|NCT04676646|559711098|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
155076816|NCT04676646|559711099|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
155076817|NCT04676646|559711100|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
155076818|NCT04270760|559711101|FG000|Overall Study|Withdrawal by Subject|0|||
155076819|NCT04270760|559711102|FG001|Overall Study|Withdrawal by Subject|1|||
155076820|NCT04270760|559711103|FG002|Overall Study|Withdrawal by Subject|3|||
155076821|NCT04270760|559711104|FG003|Overall Study|Withdrawal by Subject|0|||
155076822|NCT04270760|559711105|FG004|Overall Study|Withdrawal by Subject|0|||
155076823|NCT04270760|559711101|FG000|Overall Study|Lost to Follow-up|1|||
155076824|NCT04270760|559711102|FG001|Overall Study|Lost to Follow-up|2|||
155076825|NCT04270760|559711103|FG002|Overall Study|Lost to Follow-up|1|||
155076826|NCT04270760|559711104|FG003|Overall Study|Lost to Follow-up|0|||
155076827|NCT04270760|559711105|FG004|Overall Study|Lost to Follow-up|0|||
155076828|NCT04270760|559711101|FG000|Overall Study|Death|0|||
155076829|NCT04270760|559711102|FG001|Overall Study|Death|0|||
155076830|NCT04270760|559711103|FG002|Overall Study|Death|0|||
155076831|NCT04270760|559711104|FG003|Overall Study|Death|0|||
155076832|NCT04270760|559711105|FG004|Overall Study|Death|1|||
155076833|NCT05156125|559711106|FG000|Overall Study|Lack of Efficacy|1|||
155076834|NCT05156125|559711107|FG001|Overall Study|Lack of Efficacy|1|||
155076835|NCT05156125|559711108|FG002|Overall Study|Lack of Efficacy|1|||
155076836|NCT05156125|559711106|FG000|Overall Study|Physician Decision|0|||
155076837|NCT05156125|559711107|FG001|Overall Study|Physician Decision|0|||
155076838|NCT05156125|559711108|FG002|Overall Study|Physician Decision|1|||
155076839|NCT05156125|559711106|FG000|Overall Study|Non-compliance|0|||
155076840|NCT05156125|559711107|FG001|Overall Study|Non-compliance|1|||
155076841|NCT05156125|559711108|FG002|Overall Study|Non-compliance|1|||
155076842|NCT05156125|559711106|FG000|Overall Study|Withdrawal by Subject|0|||
155076843|NCT05156125|559711107|FG001|Overall Study|Withdrawal by Subject|0|||
155076844|NCT05156125|559711108|FG002|Overall Study|Withdrawal by Subject|1|||
155076845|NCT05156125|559711106|FG000|Overall Study|Adverse Event|2|||
155076846|NCT05156125|559711107|FG001|Overall Study|Adverse Event|1|||
155076847|NCT05156125|559711108|FG002|Overall Study|Adverse Event|0|||
155076848|NCT01623752|559711111|FG000|Phase 1 (78 Weeks)|No Data|249|||
155076849|NCT01623752|559711112|FG001|Phase 1 (78 Weeks)|No Data|66|||
155076850|NCT01623752|559711113|FG002|Phase 1 (78 Weeks)|No Data|2|||
155076851|NCT01623752|559711111|FG000|Phase 1 (78 Weeks)|Other|33|||
155076852|NCT01623752|559711112|FG001|Phase 1 (78 Weeks)|Other|20|||
155076853|NCT01623752|559711113|FG002|Phase 1 (78 Weeks)|Other|0|||
155076854|NCT01623752|559711111|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
155076855|NCT01623752|559711112|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
155076856|NCT01623752|559711113|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
155076857|NCT01623752|559711111|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
155076858|NCT01623752|559711112|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
155076859|NCT01623752|559711113|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
155076860|NCT01623752|559711111|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
155076861|NCT01623752|559711112|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
155076862|NCT01623752|559711113|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
155076863|NCT01623752|559711111|FG000|Phase 2 (78 Weeks)|Other|5|||
155076864|NCT01623752|559711112|FG001|Phase 2 (78 Weeks)|Other|1|||
155076865|NCT01623752|559711113|FG002|Phase 2 (78 Weeks)|Other|0|||
155076866|NCT01623752|559711111|FG000|Phase 2 (78 Weeks)|No Data|43|||
155076867|NCT01623752|559711112|FG001|Phase 2 (78 Weeks)|No Data|11|||
155076868|NCT01623752|559711113|FG002|Phase 2 (78 Weeks)|No Data|0|||
155076869|NCT01623752|559711111|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
155076870|NCT01623752|559711112|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
155076871|NCT01623752|559711113|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
155076872|NCT01755637|559711114|FG000|Period 1|Adverse Event|0|||
155076873|NCT01755637|559711115|FG001|Period 1|Adverse Event|1|||
155076874|NCT04389671|559711116|FG000|Overall Study|Death|7|||
155076875|NCT03338023|559711117|FG000|Overall Study|Withdrawal by Subject|3|||
155076876|NCT03338023|559711118|FG001|Overall Study|Withdrawal by Subject|4|||
155076877|NCT03338023|559711117|FG000|Overall Study|Protocol Violation|3|||
155076878|NCT03338023|559711118|FG001|Overall Study|Protocol Violation|3|||
155076879|NCT03338023|559711117|FG000|Overall Study|Lost to Follow-up|2|||
155076880|NCT03338023|559711118|FG001|Overall Study|Lost to Follow-up|1|||
155076881|NCT03338023|559711117|FG000|Overall Study|Physician Decision|1|||
155076882|NCT03338023|559711118|FG001|Overall Study|Physician Decision|2|||
155076883|NCT04996264|559711119|FG000|Overall Study|Lost to Follow-up|0|||
155076884|NCT04996264|559711120|FG001|Overall Study|Lost to Follow-up|1|||
155076885|NCT04996264|559711119|FG000|Overall Study|Withdrawal by Subject|4|||
155076886|NCT04996264|559711120|FG001|Overall Study|Withdrawal by Subject|3|||
155076887|NCT04996264|559711119|FG000|Overall Study|1 left AMA|0|||
155076888|NCT04996264|559711120|FG001|Overall Study|1 left AMA|1|||
155076889|NCT04996264|559711119|FG000|Overall Study|Subject changed hospitals|0|||
155076890|NCT04996264|559711120|FG001|Overall Study|Subject changed hospitals|1|||
155076891|NCT04996264|559711119|FG000|Overall Study|unable to complete due to work|0|||
155076892|NCT04996264|559711120|FG001|Overall Study|unable to complete due to work|1|||
155076893|NCT00685698|559711121|FG000|Overall Study|Withdrawal by Subject|1|||
155076894|NCT00685698|559711121|FG000|Overall Study|Protocol Violation|6|||
155076895|NCT00685698|559711121|FG000|Overall Study|Adverse Event|3|||
155076896|NCT00685698|559711121|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
155076897|NCT00685698|559711121|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
155076898|NCT00685698|559711121|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
155076899|NCT03412890|559711124|FG000|Overall Study|Adverse Event|5|||
155076900|NCT03412890|559711125|FG001|Overall Study|Adverse Event|5|||
155076901|NCT03412890|559711126|FG002|Overall Study|Adverse Event|9|||
155076902|NCT03412890|559711124|FG000|Overall Study|Protocol deviation|2|||
155076903|NCT03412890|559711125|FG001|Overall Study|Protocol deviation|1|||
155076904|NCT03412890|559711126|FG002|Overall Study|Protocol deviation|2|||
155076905|NCT03412890|559711124|FG000|Overall Study|Lost to Follow-up|7|||
155076906|NCT03412890|559711125|FG001|Overall Study|Lost to Follow-up|10|||
155076907|NCT03412890|559711126|FG002|Overall Study|Lost to Follow-up|10|||
155076908|NCT03412890|559711124|FG000|Overall Study|Withdrawal by Subject|9|||
155076909|NCT03412890|559711125|FG001|Overall Study|Withdrawal by Subject|12|||
155076910|NCT03412890|559711126|FG002|Overall Study|Withdrawal by Subject|11|||
155076911|NCT03412890|559711124|FG000|Overall Study|Lack of Efficacy|2|||
155076912|NCT03412890|559711125|FG001|Overall Study|Lack of Efficacy|7|||
155076913|NCT03412890|559711126|FG002|Overall Study|Lack of Efficacy|5|||
155076914|NCT03412890|559711124|FG000|Overall Study|Other|5|||
155076915|NCT03412890|559711125|FG001|Overall Study|Other|6|||
155076916|NCT03412890|559711126|FG002|Overall Study|Other|5|||
155076917|NCT03412890|559711124|FG000|Overall Study|Participants who did not receive any study drug|0|||
155076918|NCT03412890|559711125|FG001|Overall Study|Participants who did not receive any study drug|1|||
155076919|NCT03412890|559711126|FG002|Overall Study|Participants who did not receive any study drug|0|||
155076920|NCT03767894|559711129|FG000|Overall Study|Withdrawal by Subject|1|||
155076921|NCT02547935|559711131|FG000|Overall Study|Other|0|||
155076922|NCT02547935|559711132|FG001|Overall Study|Other|1|||
155076923|NCT02547935|559711133|FG002|Overall Study|Other|0|||
155076924|NCT02547935|559711131|FG000|Overall Study|Withdrawal by Subject|2|||
155076925|NCT02547935|559711132|FG001|Overall Study|Withdrawal by Subject|3|||
155076926|NCT02547935|559711133|FG002|Overall Study|Withdrawal by Subject|4|||
155076927|NCT02547935|559711131|FG000|Overall Study|Screen Failure|2|||
155076928|NCT02547935|559711132|FG001|Overall Study|Screen Failure|0|||
155076929|NCT02547935|559711133|FG002|Overall Study|Screen Failure|0|||
155076930|NCT02547935|559711131|FG000|Overall Study|Physician Decision|0|||
155164923|NCT02963506|560040617|FG008|Double-Blind Period|Lost to Follow-up|0|||
155076931|NCT02547935|559711132|FG001|Overall Study|Physician Decision|1|||
155076932|NCT02547935|559711133|FG002|Overall Study|Physician Decision|0|||
155076933|NCT02547935|559711131|FG000|Overall Study|Lost to Follow-up|0|||
155076934|NCT02547935|559711132|FG001|Overall Study|Lost to Follow-up|2|||
155076935|NCT02547935|559711133|FG002|Overall Study|Lost to Follow-up|1|||
155076936|NCT02547935|559711131|FG000|Overall Study|Death|1|||
155076937|NCT02547935|559711132|FG001|Overall Study|Death|1|||
155076938|NCT02547935|559711133|FG002|Overall Study|Death|0|||
155076939|NCT00086307|559711134|FG000|Overall Study|Lack of Efficacy|1|||
155076940|NCT00086307|559711135|FG001|Overall Study|Lack of Efficacy|1|||
155076941|NCT00086307|559711136|FG002|Overall Study|Lack of Efficacy|2|||
155076942|NCT00086307|559711134|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
155076943|NCT00086307|559711135|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
155076944|NCT00086307|559711136|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
155076945|NCT00086307|559711134|FG000|Overall Study|Nausea and headaches|0|||
155076946|NCT00086307|559711135|FG001|Overall Study|Nausea and headaches|0|||
155076947|NCT00086307|559711136|FG002|Overall Study|Nausea and headaches|1|||
155076948|NCT00086307|559711134|FG000|Overall Study|Constipation and sleepiness|0|||
155076949|NCT00086307|559711135|FG001|Overall Study|Constipation and sleepiness|0|||
155076950|NCT00086307|559711136|FG002|Overall Study|Constipation and sleepiness|1|||
155076951|NCT00086307|559711134|FG000|Overall Study|Suicidal ideation|0|||
155076952|NCT00086307|559711135|FG001|Overall Study|Suicidal ideation|0|||
155076953|NCT00086307|559711136|FG002|Overall Study|Suicidal ideation|1|||
155076954|NCT00086307|559711134|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
155076955|NCT00086307|559711135|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
155076956|NCT00086307|559711136|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
155076957|NCT00086307|559711134|FG000|Overall Study|Withdrawal by Subject|0|||
155076958|NCT00086307|559711135|FG001|Overall Study|Withdrawal by Subject|0|||
155076959|NCT00086307|559711136|FG002|Overall Study|Withdrawal by Subject|2|||
155076960|NCT01018953|559711137|FG000|Overall Study|Adverse Event|2|||
155076961|NCT01018953|559711137|FG000|Overall Study|Withdrawal by Subject|1|||
155076962|NCT01018953|559711137|FG000|Overall Study|Study termination by sponsor|5|||
155076963|NCT00724503|559711138|FG000|Overall Study|Lost to Follow-up|4|||
155076964|NCT00724503|559711139|FG001|Overall Study|Lost to Follow-up|8|||
155076965|NCT00724503|559711138|FG000|Overall Study|Withdrawal by Subject|11|||
155076966|NCT00724503|559711139|FG001|Overall Study|Withdrawal by Subject|23|||
155076967|NCT00724503|559711138|FG000|Overall Study|Death|190|||
155076968|NCT00724503|559711139|FG001|Overall Study|Death|182|||
155076969|NCT00724503|559711138|FG000|Overall Study|Adverse Event|1|||
155076970|NCT00724503|559711139|FG001|Overall Study|Adverse Event|0|||
155076971|NCT00724503|559711138|FG000|Overall Study|Not otherwise specified|4|||
155076972|NCT00724503|559711139|FG001|Overall Study|Not otherwise specified|7|||
155076973|NCT01695772|559711147|FG000|Overall Study|Withdrawal by Subject|18|||
155076974|NCT01695772|559711147|FG000|Overall Study|Progressive Disease|8|||
155076975|NCT01695772|559711147|FG000|Overall Study|Investigator Decision|5|||
155076976|NCT01695772|559711147|FG000|Overall Study|Lost to Follow-up|4|||
155076977|NCT01695772|559711147|FG000|Overall Study|Protocol Violation|2|||
155076978|NCT01695772|559711147|FG000|Overall Study|Unspecified Reason|1|||
155076979|NCT04073407|559711150|FG000|Part 1|Withdrawal by Subject|1|||
155076980|NCT04073407|559711151|FG001|Part 1|Withdrawal by Subject|0|||
155076981|NCT04073407|559711150|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
155076982|NCT04073407|559711151|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
155076983|NCT04073407|559711150|FG000|Part 2|Withdrawal by Subject|0|||
155076984|NCT04073407|559711151|FG001|Part 2|Withdrawal by Subject|1|||
155076985|NCT00960856|559712751|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155076986|NCT00960856|559712752|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
155076987|NCT00960856|559712753|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
155076988|NCT00960856|559712754|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
155076989|NCT00960856|559712751|FG000|Washout Period of 7 Days|Adverse Event|0|||
155076990|NCT00960856|559712752|FG001|Washout Period of 7 Days|Adverse Event|0|||
155076991|NCT00960856|559712753|FG002|Washout Period of 7 Days|Adverse Event|1|||
155076992|NCT00960856|559712754|FG003|Washout Period of 7 Days|Adverse Event|0|||
155076993|NCT01428713|559712759|FG000|Overall Study|Non-compliance|2|||
155076994|NCT01428713|559712760|FG001|Overall Study|Non-compliance|2|||
155076995|NCT01428713|559712759|FG000|Overall Study|Withdrawal by Subject|1|||
155076996|NCT01428713|559712760|FG001|Overall Study|Withdrawal by Subject|1|||
155076997|NCT01428713|559712759|FG000|Overall Study|Adverse Event|0|||
155076998|NCT01428713|559712760|FG001|Overall Study|Adverse Event|2|||
155076999|NCT00120250|559712763|FG000|Overall Study|Lost to Follow-up|1|||
155077000|NCT00120250|559712764|FG001|Overall Study|Lost to Follow-up|1|||
155077001|NCT00120250|559712763|FG000|Overall Study|Protocol Violation|0|||
155077002|NCT00120250|559712764|FG001|Overall Study|Protocol Violation|1|||
155077003|NCT00585169|559712765|FG000|Overall Study|Withdrawal by Subject|1|||
155077004|NCT03055221|559712766|FG000|Overall Study|Adverse Event|2|||
155077005|NCT03055221|559712766|FG000|Overall Study|Withdrawal by Subject|4|||
155077006|NCT03055221|559712766|FG000|Overall Study|Death|6|||
155077007|NCT03055221|559712766|FG000|Overall Study|Physician Decision|1|||
155077008|NCT03055221|559712766|FG000|Overall Study|Study terminated by Sponsor|3|||
155077009|NCT03055221|559712766|FG000|Overall Study|Lost to Follow-up|4|||
155077010|NCT01964560|559712767|FG000|Overall Study|Adverse Event|23|||
155077011|NCT01964560|559712767|FG000|Overall Study|Lack of Efficacy|46|||
155077012|NCT01964560|559712767|FG000|Overall Study|Protocol deviation|2|||
155077013|NCT01964560|559712767|FG000|Overall Study|Lost to Follow-up|4|||
155077014|NCT01964560|559712767|FG000|Overall Study|Withdrawal by Subject|64|||
155077015|NCT01964560|559712767|FG000|Overall Study|Surgery-hemispherotomy|1|||
155077016|NCT01964560|559712767|FG000|Overall Study|Surgery|1|||
155077017|NCT01964560|559712767|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
155077018|NCT01964560|559712767|FG000|Overall Study|Patient and Investigator choice|1|||
155077019|NCT01964560|559712767|FG000|Overall Study|Patient was prescribed CBD|1|||
155077020|NCT01964560|559712767|FG000|Overall Study|Participant moved to another country|1|||
155077021|NCT02391584|559712768|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
155077022|NCT02391584|559712769|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
155077023|NCT02391584|559712768|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
155077024|NCT02391584|559712769|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
155077025|NCT02391584|559712768|FG000|3 Month|Lost to Follow-up|1|||
155077026|NCT02391584|559712769|FG001|3 Month|Lost to Follow-up|0|||
155077027|NCT02391584|559712768|FG000|6 Month|Withdrawal by Subject|1|||
155077028|NCT02391584|559712769|FG001|6 Month|Withdrawal by Subject|0|||
155077029|NCT02391584|559712768|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
155077030|NCT02391584|559712769|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
155077031|NCT01441414|559712782|FG000|Overall Study|Participant died|9|||
155077032|NCT01441414|559712782|FG000|Overall Study|Other reasons|3|||
155077033|NCT01441414|559712782|FG000|Overall Study|Study terminated by sponsor|2|||
155077034|NCT01441414|559712782|FG000|Overall Study|Subject refused further follow-up|1|||
155077035|NCT01058005|559712794|FG000|Overall Study|Adverse Event|0|||
155077036|NCT01058005|559712795|FG001|Overall Study|Adverse Event|2|||
155077037|NCT01058005|559712796|FG002|Overall Study|Adverse Event|1|||
155077038|NCT01058005|559712794|FG000|Overall Study|Physician Decision|2|||
155077039|NCT01058005|559712795|FG001|Overall Study|Physician Decision|2|||
155077040|NCT01058005|559712796|FG002|Overall Study|Physician Decision|0|||
155077041|NCT01058005|559712794|FG000|Overall Study|Withdrawal by Subject|4|||
155077042|NCT01058005|559712795|FG001|Overall Study|Withdrawal by Subject|5|||
155077043|NCT01058005|559712796|FG002|Overall Study|Withdrawal by Subject|11|||
155077044|NCT01058005|559712794|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
155077045|NCT01058005|559712795|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
155077046|NCT01058005|559712796|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
155077047|NCT01058005|559712794|FG000|Overall Study|Reason Missing|5|||
155077048|NCT01058005|559712795|FG001|Overall Study|Reason Missing|3|||
155077049|NCT01058005|559712796|FG002|Overall Study|Reason Missing|1|||
155077050|NCT01717859|559712797|FG000|Overall Study|Adverse Event|5|||
155077051|NCT01717859|559712797|FG000|Overall Study|Moved out of state|1|||
155077052|NCT01717859|559712797|FG000|Overall Study|Patient concerned about mental health|1|||
155077053|NCT01717859|559712797|FG000|Overall Study|Lost to Follow-up|1|||
155077054|NCT01717859|559712797|FG000|Overall Study|Withdrawal by Subject|2|||
155077055|NCT02287025|559712799|FG000|Overall Study|Not treated|2|||
155077056|NCT02287025|559712800|FG001|Overall Study|Not treated|0|||
155077057|NCT02287025|559712799|FG000|Overall Study|Progression of disease|3|||
155077058|NCT02287025|559712800|FG001|Overall Study|Progression of disease|2|||
155077059|NCT02287025|559712799|FG000|Overall Study|Adverse Event|2|||
155077060|NCT02287025|559712800|FG001|Overall Study|Adverse Event|4|||
155077061|NCT02287025|559712799|FG000|Overall Study|Withdrawal by Subject|2|||
155077062|NCT02287025|559712800|FG001|Overall Study|Withdrawal by Subject|2|||
155077063|NCT02287025|559712799|FG000|Overall Study|Screening failed|1|||
155077064|NCT02287025|559712800|FG001|Overall Study|Screening failed|1|||
155077065|NCT00899847|559712801|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
155077066|NCT05987540|559712802|FG000|Overall Study|Withdrawal by Subject|2|||
155077067|NCT05987540|559712802|FG000|Overall Study|Death|1|||
155077068|NCT05987540|559712802|FG000|Overall Study|Study Termination|1|||
155077069|NCT05987540|559712802|FG000|Overall Study|Adverse Event|2|||
155077070|NCT01421134|559712803|FG000|Overall Study|Adverse Event|3|||
155077071|NCT01421134|559712804|FG001|Overall Study|Adverse Event|5|||
155077072|NCT01421134|559712803|FG000|Overall Study|Lack of Efficacy|2|||
155077073|NCT01421134|559712804|FG001|Overall Study|Lack of Efficacy|4|||
155077074|NCT01421134|559712803|FG000|Overall Study|Protocol Violation|0|||
155077075|NCT01421134|559712804|FG001|Overall Study|Protocol Violation|3|||
155077076|NCT01421134|559712803|FG000|Overall Study|Withdrawal by Subject|1|||
155077077|NCT01421134|559712804|FG001|Overall Study|Withdrawal by Subject|1|||
155077078|NCT01421134|559712803|FG000|Overall Study|Administrative|0|||
155077079|NCT01421134|559712804|FG001|Overall Study|Administrative|1|||
155077080|NCT01421134|559712803|FG000|Overall Study|Lost to Follow-up|1|||
155077081|NCT01421134|559712804|FG001|Overall Study|Lost to Follow-up|1|||
155077082|NCT02959892|559712805|FG000|Overall Study|PET tracer synthesis failure|1|||
155077083|NCT02959892|559712806|FG001|Overall Study|PET tracer synthesis failure|0|||
155077084|NCT02959892|559712805|FG000|Overall Study|Study termination|0|||
155077085|NCT02959892|559712806|FG001|Overall Study|Study termination|1|||
155077086|NCT04433975|559712807|FG000|1-month Follow Up|Withdrawal by Subject|1|||
155077087|NCT04433975|559712808|FG001|1-month Follow Up|Withdrawal by Subject|1|||
155077088|NCT04433975|559712807|FG000|1-month Follow Up|Lost to Follow-up|21|||
155077089|NCT04433975|559712808|FG001|1-month Follow Up|Lost to Follow-up|25|||
155077090|NCT04433975|559712807|FG000|3-month Follow Up|Lost to Follow-up|20|||
155077091|NCT04433975|559712808|FG001|3-month Follow Up|Lost to Follow-up|24|||
155077092|NCT04433975|559712807|FG000|3-month Follow Up|Death|1|||
155077093|NCT04433975|559712808|FG001|3-month Follow Up|Death|0|||
155077094|NCT04433975|559712807|FG000|3-month Follow Up|Withdrawal by Subject|2|||
155077095|NCT04433975|559712808|FG001|3-month Follow Up|Withdrawal by Subject|0|||
155077096|NCT04433975|559712807|FG000|6-month Follow Up|Lost to Follow-up|23|||
155077097|NCT04433975|559712808|FG001|6-month Follow Up|Lost to Follow-up|28|||
155077098|NCT04433975|559712807|FG000|6-month Follow Up|Withdrawal by Subject|1|||
155077099|NCT04433975|559712808|FG001|6-month Follow Up|Withdrawal by Subject|1|||
155077100|NCT04433975|559712807|FG000|9-month Follow Up|Lost to Follow-up|27|||
155077101|NCT04433975|559712808|FG001|9-month Follow Up|Lost to Follow-up|36|||
155077102|NCT04433975|559712807|FG000|9-month Follow Up|Death|0|||
155077103|NCT04433975|559712808|FG001|9-month Follow Up|Death|1|||
155077104|NCT04433975|559712807|FG000|12-month Follow Up|Lost to Follow-up|27|||
155077105|NCT04433975|559712808|FG001|12-month Follow Up|Lost to Follow-up|31|||
155077106|NCT04392635|559712813|FG000|Overall Study|Lost to Follow-up|0|||
155077107|NCT04392635|559712814|FG001|Overall Study|Lost to Follow-up|1|||
155077108|NCT00724893|559712816|FG000|Overall Study|Adverse Event|76|||
155077109|NCT00724893|559712817|FG001|Overall Study|Adverse Event|142|||
155077110|NCT00724893|559712816|FG000|Overall Study|Withdrawal by Subject|0|||
155077111|NCT00724893|559712817|FG001|Overall Study|Withdrawal by Subject|1|||
155077112|NCT00724893|559712816|FG000|Overall Study|Lack of virologic response|94|||
155077113|NCT00724893|559712817|FG001|Overall Study|Lack of virologic response|202|||
155077114|NCT00724893|559712816|FG000|Overall Study|Reason not specified|193|||
155077115|NCT00724893|559712817|FG001|Overall Study|Reason not specified|7|||
155077116|NCT00724893|559712816|FG000|Overall Study|Patient choice|0|||
155077117|NCT00724893|559712817|FG001|Overall Study|Patient choice|26|||
155077118|NCT00724893|559712816|FG000|Overall Study|Geographic reasons|0|||
155077119|NCT00724893|559712817|FG001|Overall Study|Geographic reasons|11|||
155077120|NCT00724893|559712816|FG000|Overall Study|Incarceration|0|||
155077121|NCT00724893|559712817|FG001|Overall Study|Incarceration|9|||
155077122|NCT00724893|559712816|FG000|Overall Study|Substance abuse|0|||
155077123|NCT00724893|559712817|FG001|Overall Study|Substance abuse|3|||
155164924|NCT02963506|560040618|FG009|Double-Blind Period|Lost to Follow-up|0|||
155077124|NCT00724893|559712816|FG000|Overall Study|Financial reasons|0|||
155077125|NCT00724893|559712817|FG001|Overall Study|Financial reasons|2|||
155077126|NCT00724893|559712816|FG000|Overall Study|Assigned shorter treatment|0|||
155077127|NCT00724893|559712817|FG001|Overall Study|Assigned shorter treatment|2|||
155077128|NCT00724893|559712816|FG000|Overall Study|Lost to Follow-up|0|||
155077129|NCT00724893|559712817|FG001|Overall Study|Lost to Follow-up|52|||
155077130|NCT00724893|559712816|FG000|Overall Study|Unknown, missing data|1|||
155077131|NCT00724893|559712817|FG001|Overall Study|Unknown, missing data|1|||
155077132|NCT01290731|559712820|FG000|Overall Study|Withdrawal by Subject|1|||
154963435|NCT03644550|559291199|FG000|Overall Study|Progressive disease|15|||
154963436|NCT00835536|559291202|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
155077133|NCT01179516|559712822|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
155077134|NCT01179516|559712823|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
155077135|NCT01179516|559712824|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
155077136|NCT01179516|559712822|FG000|Overall Study|Lack of Efficacy|4|||
155077137|NCT01179516|559712823|FG001|Overall Study|Lack of Efficacy|2|||
155077138|NCT01179516|559712824|FG002|Overall Study|Lack of Efficacy|0|||
155077139|NCT01179516|559712822|FG000|Overall Study|Noncompliance with Study Drug|2|||
155077140|NCT01179516|559712823|FG001|Overall Study|Noncompliance with Study Drug|0|||
155077141|NCT01179516|559712824|FG002|Overall Study|Noncompliance with Study Drug|1|||
155077142|NCT01179516|559712822|FG000|Overall Study|Protocol Deviations|4|||
155077143|NCT01179516|559712823|FG001|Overall Study|Protocol Deviations|3|||
155077144|NCT01179516|559712824|FG002|Overall Study|Protocol Deviations|3|||
155077145|NCT01179516|559712822|FG000|Overall Study|Withdrawal of Consent|2|||
155077146|NCT01179516|559712823|FG001|Overall Study|Withdrawal of Consent|6|||
155077147|NCT01179516|559712824|FG002|Overall Study|Withdrawal of Consent|10|||
154963437|NCT00835536|559291203|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
154963438|NCT00830024|559291208|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
154963439|NCT00830024|559291209|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
154963440|NCT00950989|559291210|FG000|Overall Study|Death|0|||
154963441|NCT00950989|559291211|FG001|Overall Study|Death|0|||
154963442|NCT00950989|559291212|FG002|Overall Study|Death|1|||
154963443|NCT00950989|559291213|FG003|Overall Study|Death|0|||
154963444|NCT00950989|559291210|FG000|Overall Study|Administrative Decision|0|||
154963445|NCT00950989|559291211|FG001|Overall Study|Administrative Decision|1|||
154963446|NCT00950989|559291212|FG002|Overall Study|Administrative Decision|0|||
154963447|NCT00950989|559291213|FG003|Overall Study|Administrative Decision|0|||
154963448|NCT00950989|559291210|FG000|Overall Study|Disease Progression|0|||
154963449|NCT00950989|559291211|FG001|Overall Study|Disease Progression|0|||
154963450|NCT00950989|559291212|FG002|Overall Study|Disease Progression|1|||
154963451|NCT00950989|559291213|FG003|Overall Study|Disease Progression|0|||
154963452|NCT00950989|559291210|FG000|Overall Study|Withdrawal by Subject|2|||
154963453|NCT00950989|559291211|FG001|Overall Study|Withdrawal by Subject|1|||
154963454|NCT00950989|559291212|FG002|Overall Study|Withdrawal by Subject|0|||
154963455|NCT00950989|559291213|FG003|Overall Study|Withdrawal by Subject|0|||
154963456|NCT00950989|559291210|FG000|Overall Study|Adverse Event|2|||
154963457|NCT00950989|559291211|FG001|Overall Study|Adverse Event|1|||
154963458|NCT00950989|559291212|FG002|Overall Study|Adverse Event|1|||
154963459|NCT00950989|559291213|FG003|Overall Study|Adverse Event|0|||
154963460|NCT03804983|559291214|FG000|Overall Study|Adverse Event|0|||
154963461|NCT03804983|559291215|FG001|Overall Study|Adverse Event|1|||
154963462|NCT03804983|559291214|FG000|Overall Study|Family Obligation|1|||
154963463|NCT03804983|559291215|FG001|Overall Study|Family Obligation|0|||
154963464|NCT02358538|559291216|FG000|Through Week 26|Adverse Event|0|||
154963465|NCT02358538|559291217|FG001|Through Week 26|Adverse Event|1|||
154963466|NCT02358538|559291218|FG002|Through Week 26|Adverse Event|1|||
154963467|NCT02358538|559291219|FG003|Through Week 26|Adverse Event|2|||
154963468|NCT02358538|559291216|FG000|Through Week 26|Lack of Efficacy|1|||
154963469|NCT02358538|559291217|FG001|Through Week 26|Lack of Efficacy|1|||
154963470|NCT02358538|559291218|FG002|Through Week 26|Lack of Efficacy|3|||
154963471|NCT02358538|559291219|FG003|Through Week 26|Lack of Efficacy|3|||
155077148|NCT01179516|559712822|FG000|Overall Study|Lost to Follow-up|7|||
155077149|NCT01179516|559712823|FG001|Overall Study|Lost to Follow-up|7|||
155077150|NCT01179516|559712824|FG002|Overall Study|Lost to Follow-up|3|||
154963472|NCT02358538|559291216|FG000|Through Week 26|Withdrawal by Subject|1|||
154963473|NCT02358538|559291217|FG001|Through Week 26|Withdrawal by Subject|0|||
154963474|NCT02358538|559291218|FG002|Through Week 26|Withdrawal by Subject|0|||
154963475|NCT02358538|559291219|FG003|Through Week 26|Withdrawal by Subject|0|||
155077151|NCT01179516|559712822|FG000|Overall Study|Other|2|||
155077152|NCT01179516|559712823|FG001|Overall Study|Other|0|||
155077153|NCT01179516|559712824|FG002|Overall Study|Other|2|||
155077154|NCT00888849|559712827|FG000|Overall Study|Death|4|||
155077155|NCT00888849|559712828|FG001|Overall Study|Death|7|||
155077156|NCT00888849|559712827|FG000|Overall Study|Lost to Follow-up|1|||
154963476|NCT02358538|559291216|FG000|Through Week 26|Non-Compliance|0|||
155077157|NCT00888849|559712828|FG001|Overall Study|Lost to Follow-up|2|||
155077158|NCT05064800|559712829|FG000|Period 3|Withdrawal by Subject|0|||
154963477|NCT02358538|559291217|FG001|Through Week 26|Non-Compliance|0|||
155077159|NCT05064800|559712830|FG001|Period 3|Withdrawal by Subject|0|||
155077160|NCT05064800|559712831|FG002|Period 3|Withdrawal by Subject|0|||
154963478|NCT02358538|559291218|FG002|Through Week 26|Non-Compliance|1|||
154963479|NCT02358538|559291219|FG003|Through Week 26|Non-Compliance|0|||
155077161|NCT05064800|559712832|FG003|Period 3|Withdrawal by Subject|0|||
155077162|NCT05064800|559712833|FG004|Period 3|Withdrawal by Subject|1|||
155077163|NCT05064800|559712834|FG005|Period 3|Withdrawal by Subject|0|||
155077164|NCT00629239|559712835|FG000|Overall Study|Adverse Event|7|||
155077165|NCT00629239|559712836|FG001|Overall Study|Adverse Event|4|||
155077166|NCT00629239|559712835|FG000|Overall Study|Physician Decision|1|||
155077167|NCT00629239|559712836|FG001|Overall Study|Physician Decision|0|||
155077168|NCT01851369|559712837|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077169|NCT01851369|559712838|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077170|NCT01851369|559712839|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077171|NCT01851369|559712840|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077172|NCT01851369|559712841|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077173|NCT01851369|559712842|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
155077174|NCT01851369|559712843|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077175|NCT01851369|559712844|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077176|NCT01851369|559712845|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077177|NCT01851369|559712846|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077178|NCT01851369|559712847|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077179|NCT01851369|559712848|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077180|NCT01851369|559712849|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
155077181|NCT00183391|559712850|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
155077182|NCT00183391|559712851|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
155077183|NCT00183391|559712850|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
155077184|NCT00183391|559712851|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
155077185|NCT00395512|559712852|FG000|Overall Study|Adverse Event|3|||
155077186|NCT00395512|559712853|FG001|Overall Study|Adverse Event|8|||
155077187|NCT00395512|559712854|FG002|Overall Study|Adverse Event|6|||
155077188|NCT00395512|559712855|FG003|Overall Study|Adverse Event|6|||
155077189|NCT00395512|559712852|FG000|Overall Study|Protocol Violation|2|||
155077190|NCT00395512|559712853|FG001|Overall Study|Protocol Violation|3|||
155077191|NCT00395512|559712854|FG002|Overall Study|Protocol Violation|6|||
155077192|NCT00395512|559712855|FG003|Overall Study|Protocol Violation|7|||
155077193|NCT00395512|559712852|FG000|Overall Study|Lost to Follow-up|2|||
155077194|NCT00395512|559712853|FG001|Overall Study|Lost to Follow-up|6|||
155077195|NCT00395512|559712854|FG002|Overall Study|Lost to Follow-up|5|||
155077196|NCT00395512|559712855|FG003|Overall Study|Lost to Follow-up|5|||
155077197|NCT00395512|559712852|FG000|Overall Study|Withdrawal by Subject|6|||
155077198|NCT00395512|559712853|FG001|Overall Study|Withdrawal by Subject|5|||
155077199|NCT00395512|559712854|FG002|Overall Study|Withdrawal by Subject|5|||
155077200|NCT00395512|559712855|FG003|Overall Study|Withdrawal by Subject|12|||
155164925|NCT02963506|560040619|FG010|Double-Blind Period|Lost to Follow-up|0|||
154963480|NCT02358538|559291216|FG000|Through Week 26|Family did not see benefit from IP|1|||
154963481|NCT02358538|559291217|FG001|Through Week 26|Family did not see benefit from IP|0|||
154963482|NCT02358538|559291218|FG002|Through Week 26|Family did not see benefit from IP|0|||
154963483|NCT02358538|559291219|FG003|Through Week 26|Family did not see benefit from IP|0|||
154963484|NCT02358538|559291216|FG000|52 Week Extension Period|Lack of Efficacy|0|||
154963485|NCT02358538|559291217|FG001|52 Week Extension Period|Lack of Efficacy|0|||
154963486|NCT02358538|559291218|FG002|52 Week Extension Period|Lack of Efficacy|2|||
154963487|NCT02358538|559291219|FG003|52 Week Extension Period|Lack of Efficacy|4|||
154963488|NCT01686477|559291220|FG000|Feeding Intervention|Death|1|||
154963489|NCT01686477|559291221|FG001|Feeding Intervention|Death|0|||
154963490|NCT01686477|559291222|FG002|Feeding Intervention|Death|1|||
154963491|NCT01686477|559291220|FG000|Feeding Intervention|Withdrawal by Subject|0|||
154963492|NCT01686477|559291221|FG001|Feeding Intervention|Withdrawal by Subject|6|||
154963493|NCT01686477|559291222|FG002|Feeding Intervention|Withdrawal by Subject|0|||
154963494|NCT01686477|559291220|FG000|Feeding Intervention|Physician Decision|1|||
154963495|NCT01686477|559291221|FG001|Feeding Intervention|Physician Decision|2|||
154963496|NCT01686477|559291222|FG002|Feeding Intervention|Physician Decision|0|||
154963497|NCT01686477|559291220|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
154963498|NCT01686477|559291221|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
154963499|NCT01686477|559291222|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
154963500|NCT01686477|559291220|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
154963501|NCT01686477|559291221|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
154963502|NCT01686477|559291222|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
154963503|NCT01686477|559291220|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
154963504|NCT01686477|559291221|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
154963505|NCT01686477|559291222|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
154963506|NCT01686477|559291220|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
154963507|NCT01686477|559291221|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
154963508|NCT01686477|559291222|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
154963509|NCT01686477|559291220|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
154963510|NCT01686477|559291221|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
154963511|NCT01686477|559291222|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
154963512|NCT01686477|559291220|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
154963513|NCT01686477|559291221|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
154963514|NCT01686477|559291222|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
154963515|NCT01686477|559291220|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
154963516|NCT01686477|559291221|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
154963517|NCT01686477|559291222|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
154963518|NCT02178787|559291223|FG000|Overall Study|Lost to Follow-up|1|||
154963519|NCT02178787|559291224|FG001|Overall Study|Lost to Follow-up|0|||
154963520|NCT02178787|559291223|FG000|Overall Study|Withdrawal by Subject|0|||
154963521|NCT02178787|559291224|FG001|Overall Study|Withdrawal by Subject|2|||
154963522|NCT02178787|559291223|FG000|Overall Study|No TCD window|3|||
154963523|NCT02178787|559291224|FG001|Overall Study|No TCD window|7|||
154963524|NCT02178787|559291223|FG000|Overall Study|Physician Decision|1|||
154963525|NCT02178787|559291224|FG001|Overall Study|Physician Decision|0|||
154963526|NCT03649477|559291225|FG000|Overall Study|Adverse Event|2|||
154963527|NCT03649477|559291226|FG001|Overall Study|Adverse Event|0|||
154963528|NCT03649477|559291227|FG002|Overall Study|Adverse Event|0|||
154963529|NCT04825275|559292131|FG000|Overall Study|Withdrawal by Subject|1|||
154963530|NCT04825275|559292132|FG001|Overall Study|Withdrawal by Subject|0|||
154963531|NCT02566850|559292133|FG000|Overall Study|Protocol Violation|1|||
154963532|NCT06298396|559292134|FG000|Default MAP|Protocol Violation|1|||
154963533|NCT06137781|559292135|FG000|Baseline measurements|Lost to Follow-up|2|||
154963534|NCT06137781|559292135|FG000|Baseline measurements|Withdrawal by Subject|1|||
154963535|NCT06137781|559292135|FG000|Baseline measurements|Expedited surgery|1|||
154963536|NCT06137781|559292135|FG000|Intervention period|Lost to Follow-up|2|||
154963537|NCT06137781|559292135|FG000|Intervention period|Withdrawal by Subject|3|||
154963538|NCT06137781|559292135|FG000|Intervention period|Expedited surgery|1|||
154963539|NCT06137781|559292135|FG000|Intervention period|Adverse Event|1|||
154963540|NCT02591420|559292136|FG000|Overall Study|Lost to Follow-up|0|||
154963541|NCT02591420|559292137|FG001|Overall Study|Lost to Follow-up|1|||
154963542|NCT02591420|559292138|FG002|Overall Study|Lost to Follow-up|2|||
154963543|NCT03056755|559292139|FG000|Core Phase|Progressive disease|89|||
154963544|NCT03056755|559292140|FG001|Core Phase|Progressive disease|88|||
154963545|NCT03056755|559292141|FG002|Core Phase|Progressive disease|90|||
154963546|NCT03056755|559292139|FG000|Core Phase|Adverse Event|20|||
154963547|NCT03056755|559292140|FG001|Core Phase|Adverse Event|14|||
154963548|NCT03056755|559292141|FG002|Core Phase|Adverse Event|13|||
154963549|NCT03056755|559292139|FG000|Core Phase|Physician Decision|7|||
154963550|NCT03056755|559292140|FG001|Core Phase|Physician Decision|13|||
154963551|NCT03056755|559292141|FG002|Core Phase|Physician Decision|5|||
154963552|NCT03056755|559292139|FG000|Core Phase|Subject/guardian decision|5|||
155077201|NCT00395512|559712852|FG000|Overall Study|Physician Decision|6|||
154963553|NCT03056755|559292140|FG001|Core Phase|Subject/guardian decision|8|||
155077202|NCT00395512|559712853|FG001|Overall Study|Physician Decision|4|||
155077203|NCT00395512|559712854|FG002|Overall Study|Physician Decision|2|||
155077204|NCT00395512|559712855|FG003|Overall Study|Physician Decision|2|||
155077205|NCT00395512|559712852|FG000|Overall Study|Other|1|||
155077206|NCT00395512|559712853|FG001|Overall Study|Other|1|||
155077207|NCT00395512|559712854|FG002|Overall Study|Other|0|||
155077208|NCT00395512|559712855|FG003|Overall Study|Other|0|||
155077209|NCT00395512|559712852|FG000|Overall Study|Hyperglycemic Rescue|18|||
155077210|NCT00395512|559712853|FG001|Overall Study|Hyperglycemic Rescue|10|||
155077211|NCT00395512|559712854|FG002|Overall Study|Hyperglycemic Rescue|4|||
155077212|NCT00395512|559712855|FG003|Overall Study|Hyperglycemic Rescue|6|||
155077213|NCT04584554|559712858|FG000|Overall Study|Withdrawal by Subject|2|||
155077214|NCT04584554|559712859|FG001|Overall Study|Withdrawal by Subject|2|||
155077215|NCT02583477|559712864|FG000|Overall Study|Adverse Event|0|||
155077216|NCT02583477|559712865|FG001|Overall Study|Adverse Event|2|||
155077217|NCT02583477|559712864|FG000|Overall Study|Death|1|||
155077218|NCT02583477|559712865|FG001|Overall Study|Death|16|||
155077219|NCT02583477|559712864|FG000|Overall Study|Study terminated|2|||
155077220|NCT02583477|559712865|FG001|Overall Study|Study terminated|2|||
155077221|NCT05507450|559712866|FG000|Overall Study|Death|0|||
155077222|NCT05507450|559712867|FG001|Overall Study|Death|0|||
155077223|NCT05507450|559712868|FG002|Overall Study|Death|1|||
155077224|NCT05507450|559712869|FG003|Overall Study|Death|0|||
155077225|NCT05507450|559712866|FG000|Overall Study|Lost to Follow-up|22|||
155077226|NCT05507450|559712867|FG001|Overall Study|Lost to Follow-up|20|||
155077227|NCT05507450|559712868|FG002|Overall Study|Lost to Follow-up|20|||
155077228|NCT05507450|559712869|FG003|Overall Study|Lost to Follow-up|7|||
155077229|NCT05507450|559712866|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155077230|NCT05507450|559712867|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155077231|NCT05507450|559712868|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155077232|NCT05507450|559712869|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155077233|NCT05507450|559712866|FG000|Overall Study|Withdrawal by Subject|4|||
155077234|NCT05507450|559712867|FG001|Overall Study|Withdrawal by Subject|11|||
155077235|NCT05507450|559712868|FG002|Overall Study|Withdrawal by Subject|7|||
155077236|NCT05507450|559712869|FG003|Overall Study|Withdrawal by Subject|3|||
155077237|NCT05507450|559712866|FG000|Overall Study|Participant left the country|0|||
155077238|NCT05507450|559712867|FG001|Overall Study|Participant left the country|0|||
155077239|NCT05507450|559712868|FG002|Overall Study|Participant left the country|1|||
155077240|NCT05507450|559712869|FG003|Overall Study|Participant left the country|0|||
155077241|NCT05436288|559712871|FG000|Overall Study|Lost to Follow-up|1|||
155077242|NCT05436288|559712871|FG000|Overall Study|Adverse Event|1|||
155077243|NCT01436500|559712875|FG000|Overall Study|Death|1|||
155077244|NCT01436500|559712876|FG001|Overall Study|Death|0|||
155077245|NCT01436500|559712877|FG002|Overall Study|Death|0|||
155077246|NCT01436500|559712878|FG003|Overall Study|Death|0|||
155077247|NCT01436500|559712879|FG004|Overall Study|Death|0|||
155077248|NCT01436500|559712875|FG000|Overall Study|Adverse Event|0|||
155077249|NCT01436500|559712876|FG001|Overall Study|Adverse Event|2|||
155077250|NCT01436500|559712877|FG002|Overall Study|Adverse Event|2|||
155077251|NCT01436500|559712878|FG003|Overall Study|Adverse Event|0|||
155342578|NCT00636168|560687078|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
154963554|NCT03056755|559292141|FG002|Core Phase|Subject/guardian decision|4|||
154963555|NCT03056755|559292139|FG000|Core Phase|Death|3|||
154963556|NCT03056755|559292140|FG001|Core Phase|Death|2|||
154963557|NCT03056755|559292141|FG002|Core Phase|Death|4|||
154963558|NCT03056755|559292139|FG000|Core Phase|Protocol deviation|1|||
154963559|NCT03056755|559292140|FG001|Core Phase|Protocol deviation|1|||
155077252|NCT01436500|559712879|FG004|Overall Study|Adverse Event|1|||
155077253|NCT01436500|559712875|FG000|Overall Study|Withdrawal by Subject|0|||
155077254|NCT01436500|559712876|FG001|Overall Study|Withdrawal by Subject|0|||
155077255|NCT01436500|559712877|FG002|Overall Study|Withdrawal by Subject|2|||
155077256|NCT01436500|559712878|FG003|Overall Study|Withdrawal by Subject|0|||
155077257|NCT01436500|559712879|FG004|Overall Study|Withdrawal by Subject|2|||
155077258|NCT01436500|559712875|FG000|Overall Study|Physician Decision|0|||
155077259|NCT01436500|559712876|FG001|Overall Study|Physician Decision|0|||
155077260|NCT01436500|559712877|FG002|Overall Study|Physician Decision|1|||
155077261|NCT01436500|559712878|FG003|Overall Study|Physician Decision|0|||
155077262|NCT01436500|559712879|FG004|Overall Study|Physician Decision|0|||
155077263|NCT01436500|559712875|FG000|Overall Study|liver transplant|1|||
155077264|NCT01436500|559712876|FG001|Overall Study|liver transplant|0|||
155077265|NCT01436500|559712877|FG002|Overall Study|liver transplant|0|||
155164926|NCT02963506|560040620|FG011|Double-Blind Period|Lost to Follow-up|0|||
155077266|NCT01436500|559712878|FG003|Overall Study|liver transplant|0|||
154963560|NCT03056755|559292141|FG002|Core Phase|Protocol deviation|0|||
154963561|NCT03056755|559292139|FG000|Core Phase|Technical problems|1|||
154963562|NCT03056755|559292140|FG001|Core Phase|Technical problems|0|||
154963563|NCT03056755|559292141|FG002|Core Phase|Technical problems|0|||
154963564|NCT03056755|559292139|FG000|Extension Phase|Physician Decision|1|||
154963565|NCT03056755|559292140|FG001|Extension Phase|Physician Decision|0|||
154963566|NCT03056755|559292141|FG002|Extension Phase|Physician Decision|3|||
154963567|NCT03056755|559292139|FG000|Extension Phase|Adverse Event|0|||
154963568|NCT03056755|559292140|FG001|Extension Phase|Adverse Event|0|||
154963569|NCT03056755|559292141|FG002|Extension Phase|Adverse Event|1|||
154963570|NCT03056755|559292139|FG000|Extension Phase|Subject/guardian decision|0|||
155077267|NCT01436500|559712879|FG004|Overall Study|liver transplant|0|||
155077268|NCT01436500|559712875|FG000|Overall Study|initiation of dialysis|0|||
155077269|NCT01436500|559712876|FG001|Overall Study|initiation of dialysis|0|||
155077270|NCT01436500|559712877|FG002|Overall Study|initiation of dialysis|0|||
155077271|NCT01436500|559712878|FG003|Overall Study|initiation of dialysis|0|||
155077272|NCT01436500|559712879|FG004|Overall Study|initiation of dialysis|1|||
155077273|NCT01436500|559712875|FG000|Overall Study|discontinued study drug|1|||
155077274|NCT01436500|559712876|FG001|Overall Study|discontinued study drug|0|||
155077275|NCT01436500|559712877|FG002|Overall Study|discontinued study drug|0|||
155077276|NCT01436500|559712878|FG003|Overall Study|discontinued study drug|0|||
155077277|NCT01436500|559712879|FG004|Overall Study|discontinued study drug|0|||
155077278|NCT01436500|559712875|FG000|Overall Study|Other|0|||
155077279|NCT01436500|559712876|FG001|Overall Study|Other|1|||
155077280|NCT01436500|559712877|FG002|Overall Study|Other|0|||
155077281|NCT01436500|559712878|FG003|Overall Study|Other|1|||
155077282|NCT01436500|559712879|FG004|Overall Study|Other|0|||
155077283|NCT04625972|559712883|FG000|Overall Study|Death|3|||
155077284|NCT04625972|559712884|FG001|Overall Study|Death|2|||
155077285|NCT04625972|559712883|FG000|Overall Study|Lost to Follow-up|82|||
155077286|NCT04625972|559712884|FG001|Overall Study|Lost to Follow-up|38|||
155077287|NCT04625972|559712883|FG000|Overall Study|Physician Decision|2|||
155077288|NCT04625972|559712884|FG001|Overall Study|Physician Decision|0|||
155077289|NCT04625972|559712883|FG000|Overall Study|Protocol Violation|0|||
155077290|NCT04625972|559712884|FG001|Overall Study|Protocol Violation|1|||
155077291|NCT04625972|559712883|FG000|Overall Study|Withdrawal by Subject|37|||
155077292|NCT04625972|559712884|FG001|Overall Study|Withdrawal by Subject|24|||
155077293|NCT04625972|559712883|FG000|Overall Study|Not specified elsewhere|8|||
155077294|NCT04625972|559712884|FG001|Overall Study|Not specified elsewhere|6|||
155077295|NCT00433290|559712885|FG000|Overall Study|Adverse Event|24|||
155077296|NCT00433290|559712886|FG001|Overall Study|Adverse Event|7|||
155077297|NCT00433290|559712885|FG000|Overall Study|Lack of Efficacy|1|||
155077298|NCT00433290|559712886|FG001|Overall Study|Lack of Efficacy|5|||
155077299|NCT00433290|559712885|FG000|Overall Study|Withdrawal by Subject|4|||
155077300|NCT00433290|559712886|FG001|Overall Study|Withdrawal by Subject|2|||
155077301|NCT00433290|559712885|FG000|Overall Study|Protocol Violation|3|||
155077302|NCT00433290|559712886|FG001|Overall Study|Protocol Violation|2|||
155077303|NCT00433290|559712885|FG000|Overall Study|Physician Decision|2|||
155077304|NCT00433290|559712886|FG001|Overall Study|Physician Decision|0|||
155077305|NCT00433290|559712885|FG000|Overall Study|Entry Criteria Not Met|0|||
155077306|NCT00433290|559712886|FG001|Overall Study|Entry Criteria Not Met|1|||
155077307|NCT00433290|559712885|FG000|Overall Study|Lost to Follow-up|1|||
155077308|NCT00433290|559712886|FG001|Overall Study|Lost to Follow-up|0|||
155077309|NCT01483651|559712887|FG000|Overall Study|Withdrawal by Subject|0|||
155077310|NCT01483651|559712888|FG001|Overall Study|Withdrawal by Subject|1|||
155077311|NCT01483651|559712889|FG002|Overall Study|Withdrawal by Subject|1|||
155077312|NCT01483651|559712890|FG003|Overall Study|Withdrawal by Subject|0|||
155077313|NCT01483651|559712891|FG004|Overall Study|Withdrawal by Subject|0|||
155077314|NCT01483651|559712892|FG005|Overall Study|Withdrawal by Subject|1|||
155077315|NCT01184118|559712894|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
155077316|NCT01184118|559712894|FG000|Overall Study|No physiologic confirmation of asthma|8|||
155077317|NCT01184118|559712894|FG000|Overall Study|FEV1 <60% predicted|2|||
154963571|NCT03056755|559292140|FG001|Extension Phase|Subject/guardian decision|0|||
155077318|NCT01184118|559712894|FG000|Overall Study|Exclusionary medical condition|2|||
155077319|NCT01184118|559712894|FG000|Overall Study|Withdrawal by Subject|5|||
155077320|NCT01186419|559712895|FG000|Overall Study|Withdrawal by Subject|5|||
155077321|NCT01186419|559712896|FG001|Overall Study|Withdrawal by Subject|3|||
155077322|NCT01186419|559712895|FG000|Overall Study|Adverse Event|1|||
155077323|NCT01186419|559712896|FG001|Overall Study|Adverse Event|2|||
155077324|NCT01186419|559712895|FG000|Overall Study|Physician Decision|0|||
155077325|NCT01186419|559712896|FG001|Overall Study|Physician Decision|3|||
155077326|NCT01186419|559712895|FG000|Overall Study|Other|1|||
154963572|NCT03056755|559292141|FG002|Extension Phase|Subject/guardian decision|1|||
155077327|NCT01186419|559712896|FG001|Overall Study|Other|1|||
155077328|NCT01407367|559712898|FG000|Overall Study|Death|24|||
155077329|NCT01407367|559712899|FG001|Overall Study|Death|32|||
155077330|NCT01407367|559712898|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
155077331|NCT01407367|559712899|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
155077332|NCT01407367|559712898|FG000|Overall Study|Withdrawal by Subject|4|||
155077333|NCT01407367|559712899|FG001|Overall Study|Withdrawal by Subject|15|||
155077334|NCT01407367|559712898|FG000|Overall Study|Lost to Follow-up|0|||
155077335|NCT01407367|559712899|FG001|Overall Study|Lost to Follow-up|2|||
154963573|NCT05005442|559292142|FG000|Overall Study|Death|14|||
155077336|NCT01245062|559712900|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
155077337|NCT01245062|559712901|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
155077338|NCT01245062|559712902|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
155077339|NCT01245062|559712900|FG000|Randomization and Crossover Phase|Physician Decision|2|||
155077340|NCT01245062|559712901|FG001|Randomization and Crossover Phase|Physician Decision|4|||
155077341|NCT01245062|559712902|FG002|Randomization and Crossover Phase|Physician Decision|0|||
155077342|NCT01245062|559712900|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
155077343|NCT01245062|559712901|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
155077344|NCT01245062|559712902|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
155077345|NCT01245062|559712900|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
155077346|NCT01245062|559712901|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
155077347|NCT01245062|559712902|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
155077348|NCT01245062|559712900|FG000|Cross-over Phase|Lost to Follow-up|0|||
155077349|NCT01245062|559712901|FG001|Cross-over Phase|Lost to Follow-up|0|||
155077350|NCT01245062|559712902|FG002|Cross-over Phase|Lost to Follow-up|1|||
154963574|NCT05005442|559292143|FG001|Overall Study|Death|10|||
154963575|NCT05005442|559292144|FG002|Overall Study|Death|8|||
154963576|NCT05005442|559292145|FG003|Overall Study|Death|22|||
154963577|NCT05005442|559292146|FG004|Overall Study|Death|13|||
154963578|NCT05005442|559292147|FG005|Overall Study|Death|15|||
154963579|NCT05005442|559292142|FG000|Overall Study|Lost to Follow-up|0|||
154963580|NCT05005442|559292143|FG001|Overall Study|Lost to Follow-up|2|||
154963581|NCT05005442|559292144|FG002|Overall Study|Lost to Follow-up|0|||
154963582|NCT05005442|559292145|FG003|Overall Study|Lost to Follow-up|0|||
154963583|NCT05005442|559292146|FG004|Overall Study|Lost to Follow-up|1|||
154963584|NCT05005442|559292147|FG005|Overall Study|Lost to Follow-up|0|||
154963585|NCT05005442|559292142|FG000|Overall Study|Physician Decision|0|||
154963586|NCT05005442|559292143|FG001|Overall Study|Physician Decision|0|||
154963587|NCT05005442|559292144|FG002|Overall Study|Physician Decision|1|||
154963588|NCT05005442|559292145|FG003|Overall Study|Physician Decision|0|||
154963589|NCT05005442|559292146|FG004|Overall Study|Physician Decision|2|||
154963590|NCT05005442|559292147|FG005|Overall Study|Physician Decision|0|||
154963591|NCT05005442|559292142|FG000|Overall Study|Sponsor decision|26|||
154963592|NCT05005442|559292143|FG001|Overall Study|Sponsor decision|26|||
154963593|NCT05005442|559292144|FG002|Overall Study|Sponsor decision|10|||
154963594|NCT05005442|559292145|FG003|Overall Study|Sponsor decision|5|||
154963595|NCT05005442|559292146|FG004|Overall Study|Sponsor decision|9|||
154963596|NCT05005442|559292147|FG005|Overall Study|Sponsor decision|12|||
154963597|NCT05005442|559292142|FG000|Overall Study|Withdrawal by Subject|2|||
154963598|NCT05005442|559292143|FG001|Overall Study|Withdrawal by Subject|2|||
154963599|NCT05005442|559292144|FG002|Overall Study|Withdrawal by Subject|1|||
154963600|NCT05005442|559292145|FG003|Overall Study|Withdrawal by Subject|3|||
154963601|NCT05005442|559292146|FG004|Overall Study|Withdrawal by Subject|0|||
154963602|NCT05005442|559292147|FG005|Overall Study|Withdrawal by Subject|5|||
154963603|NCT05005442|559292142|FG000|Overall Study|Site terminated by sponsor|0|||
154963604|NCT05005442|559292143|FG001|Overall Study|Site terminated by sponsor|2|||
154963605|NCT05005442|559292144|FG002|Overall Study|Site terminated by sponsor|0|||
154963606|NCT05005442|559292145|FG003|Overall Study|Site terminated by sponsor|0|||
154963607|NCT05005442|559292146|FG004|Overall Study|Site terminated by sponsor|0|||
154963608|NCT05005442|559292147|FG005|Overall Study|Site terminated by sponsor|1|||
154963609|NCT03696160|559292154|FG000|Overall Study|Withdrew before IMP dosing|2|||
154963610|NCT03696160|559292155|FG001|Overall Study|Withdrew before IMP dosing|3|||
154963611|NCT04742491|559292158|FG000|Overall Study|Death|2|||
154963612|NCT04742491|559292159|FG001|Overall Study|Death|0|||
154963613|NCT04742491|559292158|FG000|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
154963614|NCT04742491|559292159|FG001|Overall Study|Participant unwilling or unable to comply with required study procedures|1|||
154963615|NCT04742491|559292158|FG000|Overall Study|Lost to Follow-up|6|||
155077351|NCT01245062|559712900|FG000|Cross-over Phase|Physician Decision|0|||
155077352|NCT01245062|559712901|FG001|Cross-over Phase|Physician Decision|0|||
155077353|NCT01245062|559712902|FG002|Cross-over Phase|Physician Decision|1|||
155077354|NCT01245062|559712900|FG000|Cross-over Phase|Withdrew Consent|0|||
155077355|NCT01245062|559712901|FG001|Cross-over Phase|Withdrew Consent|0|||
155077356|NCT01245062|559712902|FG002|Cross-over Phase|Withdrew Consent|4|||
155077357|NCT01245062|559712900|FG000|Cross-over Phase|Study closed/ terminated|0|||
154963616|NCT04742491|559292159|FG001|Overall Study|Lost to Follow-up|8|||
154963617|NCT04742491|559292158|FG000|Overall Study|Withdrawal by Subject|4|||
154963618|NCT04742491|559292159|FG001|Overall Study|Withdrawal by Subject|2|||
154963619|NCT04742491|559292158|FG000|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|2|||
154963620|NCT04742491|559292159|FG001|Overall Study|One or more reactive HIV test results or acute HIV infection suspected|1|||
154963621|NCT04742491|559292158|FG000|Overall Study|Participant refused further participation|2|||
154963622|NCT04742491|559292159|FG001|Overall Study|Participant refused further participation|7|||
155077358|NCT01245062|559712901|FG001|Cross-over Phase|Study closed/ terminated|0|||
155077359|NCT01245062|559712902|FG002|Cross-over Phase|Study closed/ terminated|11|||
155077360|NCT05762744|559712904|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
155077361|NCT05762744|559712905|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
155077362|NCT05762744|559712904|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
155077363|NCT05762744|559712905|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
155077364|NCT01560416|559712909|FG000|Randomized Phase|Crossover Participants|7|||
155077365|NCT01560416|559712910|FG001|Randomized Phase|Crossover Participants|0|||
155077366|NCT00004859|559712912|FG000|Overall Study|Lack of Efficacy|43|||
155077367|NCT00004859|559712913|FG001|Overall Study|Lack of Efficacy|113|||
155077368|NCT00004859|559712912|FG000|Overall Study|Adverse Event|31|||
155077369|NCT00004859|559712913|FG001|Overall Study|Adverse Event|93|||
155077370|NCT00004859|559712912|FG000|Overall Study|Death|5|||
155077371|NCT00004859|559712913|FG001|Overall Study|Death|5|||
155077372|NCT00004859|559712912|FG000|Overall Study|Withdrawal by Subject|7|||
155077373|NCT00004859|559712913|FG001|Overall Study|Withdrawal by Subject|33|||
155077374|NCT00004859|559712912|FG000|Overall Study|Protocol Violation|2|||
155077375|NCT00004859|559712913|FG001|Overall Study|Protocol Violation|2|||
155077376|NCT00004859|559712912|FG000|Overall Study|other disease|0|||
155077377|NCT00004859|559712913|FG001|Overall Study|other disease|3|||
155077378|NCT00004859|559712912|FG000|Overall Study|error|3|||
155077379|NCT00004859|559712913|FG001|Overall Study|error|1|||
155077380|NCT00004859|559712912|FG000|Overall Study|missing data|14|||
155077381|NCT00004859|559712913|FG001|Overall Study|missing data|11|||
155077382|NCT00004859|559712912|FG000|Overall Study|Other|13|||
155077383|NCT00004859|559712913|FG001|Overall Study|Other|21|||
155077384|NCT04535362|559714547|FG000|Overall Study|Lost to Follow-up|3|||
155077385|NCT04535362|559714548|FG001|Overall Study|Lost to Follow-up|1|||
155077386|NCT03791060|559714549|FG000|Overall Study|Withdrawal by Subject|1|||
155077387|NCT02018887|559714550|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
155077388|NCT02018887|559714551|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077389|NCT02018887|559714552|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077390|NCT02018887|559714553|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077391|NCT02018887|559714554|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077392|NCT02018887|559714555|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077393|NCT02018887|559714556|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077394|NCT02018887|559714557|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077395|NCT02018887|559714558|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077396|NCT02018887|559714559|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077397|NCT02018887|559714560|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
155077398|NCT02018887|559714550|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077399|NCT02018887|559714551|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077400|NCT02018887|559714552|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077401|NCT02018887|559714553|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077402|NCT02018887|559714554|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
155077403|NCT02018887|559714555|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077404|NCT02018887|559714556|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
155077405|NCT02018887|559714557|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
155077406|NCT02018887|559714558|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077407|NCT02018887|559714559|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077408|NCT02018887|559714560|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
155077409|NCT02018887|559714550|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
155077410|NCT02018887|559714551|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
155077411|NCT02018887|559714552|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
155077412|NCT02018887|559714553|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
155077413|NCT02018887|559714554|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
155077414|NCT02018887|559714555|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
155077415|NCT02018887|559714556|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
155077416|NCT02018887|559714557|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
155077417|NCT02018887|559714558|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
155077418|NCT02018887|559714559|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
155077419|NCT02018887|559714560|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
155077420|NCT02018887|559714550|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
155077421|NCT02018887|559714551|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
155077422|NCT02018887|559714552|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
155077423|NCT02018887|559714553|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
155077424|NCT02018887|559714554|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
155077425|NCT02018887|559714555|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
155077426|NCT02018887|559714556|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
155077427|NCT02018887|559714557|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
155077428|NCT02018887|559714558|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
155077429|NCT02018887|559714559|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
155077430|NCT02018887|559714560|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
155077431|NCT04053452|559714561|FG000|Overall Study|Withdrawal by Subject|1|||
155077432|NCT04053452|559714562|FG001|Overall Study|Withdrawal by Subject|0|||
155077433|NCT04053452|559714561|FG000|Overall Study|Time restraint due to inpatient needs|1|||
155077434|NCT04053452|559714562|FG001|Overall Study|Time restraint due to inpatient needs|2|||
155077435|NCT02061592|559714565|FG000|Period 1|Withdrawal by Subject|1|||
155077436|NCT02061592|559714566|FG001|Period 1|Withdrawal by Subject|0|||
155077437|NCT02061592|559714565|FG000|Period 1|Protocol Violation|1|||
155077438|NCT02061592|559714566|FG001|Period 1|Protocol Violation|0|||
155077439|NCT02061592|559714565|FG000|Period 2|Lost to Follow-up|0|||
155077440|NCT02061592|559714566|FG001|Period 2|Lost to Follow-up|1|||
155077441|NCT01279200|559714567|FG000|Overall Study|Withdrawal by Subject|1|||
155077442|NCT01279200|559714568|FG001|Overall Study|Withdrawal by Subject|3|||
155077443|NCT01279200|559714567|FG000|Overall Study|Patient withdrawal due to high cost|0|||
155077444|NCT01279200|559714568|FG001|Overall Study|Patient withdrawal due to high cost|1|||
155077445|NCT01279200|559714567|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
155077446|NCT01279200|559714568|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
155077447|NCT01279200|559714567|FG000|Overall Study|ultrasound screening failure|0|||
155077448|NCT01279200|559714568|FG001|Overall Study|ultrasound screening failure|1|||
155077449|NCT01279200|559714567|FG000|Overall Study|Lost to Follow-up|0|||
155077450|NCT01279200|559714568|FG001|Overall Study|Lost to Follow-up|1|||
155077451|NCT01279200|559714567|FG000|Overall Study|Adverse Event|1|||
155077452|NCT01279200|559714568|FG001|Overall Study|Adverse Event|0|||
155077453|NCT01399099|559714569|FG000|Overall Study|Lost to Follow-up|14|||
155077454|NCT01399099|559714569|FG000|Overall Study|Physician Decision|1|||
155077455|NCT01399099|559714569|FG000|Overall Study|Protocol Violation|1|||
155077456|NCT01399099|559714569|FG000|Overall Study|Skin Irritation|13|||
155077457|NCT01399099|559714569|FG000|Overall Study|Infection|1|||
155077458|NCT01399099|559714569|FG000|Overall Study|Miscellaneous|4|||
155077459|NCT01668537|559714570|FG000|Overall Study|Request to Discontinue Prematurely|1|||
155077460|NCT01668537|559714571|FG001|Overall Study|Request to Discontinue Prematurely|1|||
155077461|NCT01668537|559714570|FG000|Overall Study|Subject unwilling/unable to comply|5|||
155077462|NCT01668537|559714571|FG001|Overall Study|Subject unwilling/unable to comply|0|||
155077463|NCT01668537|559714570|FG000|Overall Study|Reason Precludes Participation|1|||
155077464|NCT01668537|559714571|FG001|Overall Study|Reason Precludes Participation|0|||
155077465|NCT01668537|559714570|FG000|Overall Study|Lost to Follow-up|13|||
155077466|NCT01668537|559714571|FG001|Overall Study|Lost to Follow-up|6|||
155077467|NCT01668537|559714570|FG000|Overall Study|Other|2|||
155077468|NCT01668537|559714571|FG001|Overall Study|Other|3|||
155077469|NCT01149538|559714574|FG000|Overall Study|Lost to Follow-up|0|||
155077470|NCT01149538|559714575|FG001|Overall Study|Lost to Follow-up|1|||
155077471|NCT01149538|559714574|FG000|Overall Study|Withdrawal by Subject|5|||
155077472|NCT01149538|559714575|FG001|Overall Study|Withdrawal by Subject|3|||
155077473|NCT00567112|559714582|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
155077474|NCT00567112|559714583|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
155077475|NCT00567112|559714584|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
155077476|NCT00567112|559714582|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
155077477|NCT00567112|559714583|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
155077478|NCT00567112|559714584|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
155077479|NCT00567112|559714582|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
155077480|NCT00567112|559714583|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
155077481|NCT00567112|559714584|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
155077482|NCT04689009|559714585|FG000|Overall Study|Adverse Event|1|||
155077483|NCT04689009|559714586|FG001|Overall Study|Adverse Event|0|||
155077484|NCT04689009|559714585|FG000|Overall Study|Lost to Follow-up|1|||
155077485|NCT04689009|559714586|FG001|Overall Study|Lost to Follow-up|2|||
155077486|NCT04689009|559714585|FG000|Overall Study|Withdrawal by Subject|4|||
155077487|NCT04689009|559714586|FG001|Overall Study|Withdrawal by Subject|3|||
155077488|NCT04689009|559714585|FG000|Overall Study|Protocol Violation|1|||
155077489|NCT04689009|559714586|FG001|Overall Study|Protocol Violation|0|||
155077490|NCT00985790|559714587|FG000|Overall Study|Withdrawal by Subject|1|||
155077491|NCT00985790|559714588|FG001|Overall Study|Withdrawal by Subject|1|||
155077492|NCT00985790|559714587|FG000|Overall Study|Lost to Follow-up|6|||
155077493|NCT00985790|559714588|FG001|Overall Study|Lost to Follow-up|7|||
155077494|NCT01666314|559714589|FG000|Overall Study|Adverse Event|3|||
155077495|NCT01666314|559714590|FG001|Overall Study|Adverse Event|13|||
155077496|NCT01666314|559714591|FG002|Overall Study|Adverse Event|7|||
155077497|NCT01666314|559714592|FG003|Overall Study|Adverse Event|7|||
155077498|NCT01666314|559714589|FG000|Overall Study|Progressive Disease|11|||
155077499|NCT01666314|559714590|FG001|Overall Study|Progressive Disease|9|||
155077500|NCT01666314|559714591|FG002|Overall Study|Progressive Disease|19|||
155077501|NCT01666314|559714592|FG003|Overall Study|Progressive Disease|20|||
155164927|NCT02963506|560040621|FG012|Double-Blind Period|Lost to Follow-up|0|||
155164928|NCT02963506|560040609|FG000|Double-Blind Period|Withdrawal by Subject|0|||
155164929|NCT02963506|560040610|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155164930|NCT02963506|560040611|FG002|Double-Blind Period|Withdrawal by Subject|1|||
155164931|NCT02963506|560040612|FG003|Double-Blind Period|Withdrawal by Subject|1|||
155164932|NCT02963506|560040613|FG004|Double-Blind Period|Withdrawal by Subject|0|||
155164933|NCT02963506|560040614|FG005|Double-Blind Period|Withdrawal by Subject|0|||
155164934|NCT02963506|560040615|FG006|Double-Blind Period|Withdrawal by Subject|0|||
155164935|NCT02963506|560040616|FG007|Double-Blind Period|Withdrawal by Subject|0|||
155164936|NCT02963506|560040617|FG008|Double-Blind Period|Withdrawal by Subject|0|||
155164937|NCT02963506|560040618|FG009|Double-Blind Period|Withdrawal by Subject|0|||
155164938|NCT02963506|560040619|FG010|Double-Blind Period|Withdrawal by Subject|0|||
155164939|NCT02963506|560040620|FG011|Double-Blind Period|Withdrawal by Subject|0|||
155164940|NCT02963506|560040621|FG012|Double-Blind Period|Withdrawal by Subject|0|||
155164941|NCT02963506|560040609|FG000|Double-Blind Period|No compliance|0|||
155164942|NCT02963506|560040610|FG001|Double-Blind Period|No compliance|1|||
155164943|NCT02963506|560040611|FG002|Double-Blind Period|No compliance|0|||
155164944|NCT02963506|560040612|FG003|Double-Blind Period|No compliance|0|||
155164945|NCT02963506|560040613|FG004|Double-Blind Period|No compliance|0|||
155164946|NCT02963506|560040614|FG005|Double-Blind Period|No compliance|0|||
154963623|NCT04742491|559292158|FG000|Overall Study|Participant unable to adhere to visit schedule|3|||
154963624|NCT04742491|559292159|FG001|Overall Study|Participant unable to adhere to visit schedule|4|||
154963625|NCT04742491|559292158|FG000|Overall Study|Other reasons|3|||
155164947|NCT02963506|560040615|FG006|Double-Blind Period|No compliance|0|||
155164948|NCT02963506|560040616|FG007|Double-Blind Period|No compliance|0|||
155164949|NCT02963506|560040617|FG008|Double-Blind Period|No compliance|0|||
155164950|NCT02963506|560040618|FG009|Double-Blind Period|No compliance|0|||
155164951|NCT02963506|560040619|FG010|Double-Blind Period|No compliance|0|||
155164952|NCT02963506|560040620|FG011|Double-Blind Period|No compliance|0|||
155164953|NCT02963506|560040621|FG012|Double-Blind Period|No compliance|0|||
155164954|NCT02963506|560040609|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164955|NCT02963506|560040610|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
155164956|NCT02963506|560040611|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164957|NCT02963506|560040612|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155077502|NCT01666314|559714589|FG000|Overall Study|Symptomatic Deterioration|1|||
155077503|NCT01666314|559714590|FG001|Overall Study|Symptomatic Deterioration|0|||
155077504|NCT01666314|559714591|FG002|Overall Study|Symptomatic Deterioration|2|||
155077505|NCT01666314|559714592|FG003|Overall Study|Symptomatic Deterioration|0|||
155077506|NCT01666314|559714589|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
155077507|NCT01666314|559714590|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
155077508|NCT01666314|559714591|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
155077509|NCT01666314|559714592|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
155077510|NCT01666314|559714589|FG000|Overall Study|Withdrawal by Subject|1|||
155077511|NCT01666314|559714590|FG001|Overall Study|Withdrawal by Subject|1|||
155077512|NCT01666314|559714591|FG002|Overall Study|Withdrawal by Subject|2|||
155077513|NCT01666314|559714592|FG003|Overall Study|Withdrawal by Subject|3|||
155077514|NCT01666314|559714589|FG000|Overall Study|Reason not Specified|10|||
155077515|NCT01666314|559714590|FG001|Overall Study|Reason not Specified|7|||
155077516|NCT01666314|559714591|FG002|Overall Study|Reason not Specified|5|||
155077517|NCT01666314|559714592|FG003|Overall Study|Reason not Specified|5|||
155077518|NCT05089357|559714599|FG000|Overall Study|Withdrawal by Subject|23|||
155077519|NCT05089357|559714599|FG000|Overall Study|Lost to Follow-up|6|||
155077520|NCT05089357|559714599|FG000|Overall Study|Medical reason|1|||
155077521|NCT05089357|559714599|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
155077522|NCT05089357|559714599|FG000|Overall Study|Pregnancy|2|||
155077523|NCT02021318|559714600|FG000|Overall Study|Adverse Event|2|||
155077524|NCT02021318|559714601|FG001|Overall Study|Adverse Event|1|||
155077525|NCT02021318|559714600|FG000|Overall Study|Death|33|||
155077526|NCT02021318|559714601|FG001|Overall Study|Death|34|||
155077527|NCT02021318|559714600|FG000|Overall Study|Lost to Follow-up|3|||
155077528|NCT02021318|559714601|FG001|Overall Study|Lost to Follow-up|3|||
155077529|NCT02021318|559714600|FG000|Overall Study|Progressive Disease|0|||
155077530|NCT02021318|559714601|FG001|Overall Study|Progressive Disease|1|||
154963626|NCT04742491|559292159|FG001|Overall Study|Other reasons|4|||
155164958|NCT02963506|560040613|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164959|NCT02963506|560040614|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164960|NCT02963506|560040615|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164961|NCT02963506|560040616|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164962|NCT02963506|560040617|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164963|NCT02963506|560040618|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155077531|NCT02021318|559714600|FG000|Overall Study|Withdrawal by Subject|30|||
155077532|NCT02021318|559714601|FG001|Overall Study|Withdrawal by Subject|18|||
155077533|NCT02021318|559714600|FG000|Overall Study|Physician Decision|3|||
155077534|NCT02021318|559714601|FG001|Overall Study|Physician Decision|3|||
155077535|NCT02021318|559714600|FG000|Overall Study|Miscellaneous|2|||
155077536|NCT02021318|559714601|FG001|Overall Study|Miscellaneous|3|||
155077537|NCT00689052|559714602|FG000|Overall Study|Adverse Event|4|||
155077538|NCT00689052|559714603|FG001|Overall Study|Adverse Event|6|||
155077539|NCT00689052|559714602|FG000|Overall Study|Protocol Violation|1|||
155077540|NCT00689052|559714603|FG001|Overall Study|Protocol Violation|0|||
155077541|NCT00689052|559714602|FG000|Overall Study|Lost to Follow-up|2|||
155077542|NCT00689052|559714603|FG001|Overall Study|Lost to Follow-up|0|||
155077543|NCT00689052|559714602|FG000|Overall Study|Withdrawal by Subject|2|||
155077544|NCT00689052|559714603|FG001|Overall Study|Withdrawal by Subject|0|||
155077545|NCT00689052|559714602|FG000|Overall Study|Early termination of the trial|22|||
155077546|NCT00689052|559714603|FG001|Overall Study|Early termination of the trial|24|||
155077547|NCT04180696|559714604|FG000|Overall Study|Death|5|||
155077548|NCT04180696|559714605|FG001|Overall Study|Death|6|||
155077549|NCT04180696|559714604|FG000|Overall Study|Lost to Follow-up|1|||
155077550|NCT04180696|559714605|FG001|Overall Study|Lost to Follow-up|0|||
155077551|NCT04180696|559714604|FG000|Overall Study|Withdrawal by Subject|0|||
155077552|NCT04180696|559714605|FG001|Overall Study|Withdrawal by Subject|1|||
155077553|NCT01740427|559714606|FG000|Overall Study|Objective Progression or Relapse|286|||
155077554|NCT01740427|559714607|FG001|Overall Study|Objective Progression or Relapse|172|||
155077555|NCT01740427|559714606|FG000|Overall Study|Adverse Event|32|||
155077556|NCT01740427|559714607|FG001|Overall Study|Adverse Event|9|||
155077557|NCT01740427|559714606|FG000|Overall Study|Global Deterioration of Health Status|28|||
155077558|NCT01740427|559714607|FG001|Overall Study|Global Deterioration of Health Status|12|||
155077559|NCT01740427|559714606|FG000|Overall Study|Participant Refused Continued Treatment|27|||
155077560|NCT01740427|559714607|FG001|Overall Study|Participant Refused Continued Treatment|15|||
155077561|NCT01740427|559714606|FG000|Overall Study|Unspecified reasons|52|||
155077562|NCT01740427|559714607|FG001|Overall Study|Unspecified reasons|8|||
155077563|NCT01740427|559714606|FG000|Overall Study|Death|10|||
155077564|NCT01740427|559714607|FG001|Overall Study|Death|3|||
155077565|NCT01740427|559714606|FG000|Overall Study|Protocol Violation|5|||
155077566|NCT01740427|559714607|FG001|Overall Study|Protocol Violation|3|||
155077567|NCT01740427|559714606|FG000|Overall Study|Lost to Follow-up|3|||
155077568|NCT01740427|559714607|FG001|Overall Study|Lost to Follow-up|0|||
155077569|NCT01740427|559714606|FG000|Overall Study|Site Terminated by Sponsor|1|||
155077570|NCT01740427|559714607|FG001|Overall Study|Site Terminated by Sponsor|0|||
155077571|NCT04796207|559714610|FG000|Overall Study|Lost to Follow-up|7|||
155077572|NCT04796207|559714611|FG001|Overall Study|Lost to Follow-up|2|||
155077573|NCT01860989|559714614|FG000|Overall Study|Unsatisfactory therapeutic|5|||
155077574|NCT04739709|559714617|FG000|Overall Study|Physician Decision|1|||
155077575|NCT04739709|559714618|FG001|Overall Study|Physician Decision|0|||
155077576|NCT03003468|559714619|FG000|Overall Study|Withdrawal by Subject|0|||
155077577|NCT03003468|559714620|FG001|Overall Study|Withdrawal by Subject|0|||
155077578|NCT03003468|559714621|FG002|Overall Study|Withdrawal by Subject|1|||
155077579|NCT03003468|559714619|FG000|Overall Study|No measurable lesions|0|||
155077580|NCT03003468|559714620|FG001|Overall Study|No measurable lesions|0|||
155077581|NCT03003468|559714621|FG002|Overall Study|No measurable lesions|1|||
155077582|NCT00421993|559714622|FG000|Overall Study|Withdrawal by Subject|22|||
155077583|NCT00421993|559714623|FG001|Overall Study|Withdrawal by Subject|23|||
155077584|NCT00421993|559714624|FG002|Overall Study|Withdrawal by Subject|23|||
155077585|NCT00421993|559714625|FG003|Overall Study|Withdrawal by Subject|24|||
155077586|NCT00421993|559714622|FG000|Overall Study|Lost to Follow-up|18|||
155077587|NCT00421993|559714623|FG001|Overall Study|Lost to Follow-up|19|||
155077588|NCT00421993|559714624|FG002|Overall Study|Lost to Follow-up|22|||
155077589|NCT00421993|559714625|FG003|Overall Study|Lost to Follow-up|20|||
155077590|NCT00421993|559714622|FG000|Overall Study|Adverse Event|11|||
155077591|NCT00421993|559714623|FG001|Overall Study|Adverse Event|1|||
155077592|NCT00421993|559714624|FG002|Overall Study|Adverse Event|6|||
155077593|NCT00421993|559714625|FG003|Overall Study|Adverse Event|4|||
155342579|NCT00636168|560687077|FG000|Randomized to Study Drug|Adverse Event|1|||
155342580|NCT00636168|560687078|FG001|Randomized to Study Drug|Adverse Event|0|||
155342581|NCT00636168|560687077|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
155077594|NCT00421993|559714622|FG000|Overall Study|Protocol Violation|2|||
155077595|NCT00421993|559714623|FG001|Overall Study|Protocol Violation|2|||
155077596|NCT00421993|559714624|FG002|Overall Study|Protocol Violation|0|||
155077597|NCT00421993|559714625|FG003|Overall Study|Protocol Violation|1|||
155077598|NCT00421993|559714622|FG000|Overall Study|Lack of Efficacy|0|||
155077599|NCT00421993|559714623|FG001|Overall Study|Lack of Efficacy|3|||
155077600|NCT00421993|559714624|FG002|Overall Study|Lack of Efficacy|0|||
155077601|NCT00421993|559714625|FG003|Overall Study|Lack of Efficacy|5|||
155077602|NCT00421993|559714622|FG000|Overall Study|Pregnancy|0|||
155077603|NCT00421993|559714623|FG001|Overall Study|Pregnancy|1|||
155077604|NCT00421993|559714624|FG002|Overall Study|Pregnancy|1|||
155077605|NCT00421993|559714625|FG003|Overall Study|Pregnancy|2|||
155077606|NCT00421993|559714622|FG000|Overall Study|Subject transportation issues|0|||
155077607|NCT00421993|559714623|FG001|Overall Study|Subject transportation issues|0|||
155077608|NCT00421993|559714624|FG002|Overall Study|Subject transportation issues|0|||
155077609|NCT00421993|559714625|FG003|Overall Study|Subject transportation issues|1|||
155077610|NCT02405962|559714626|FG000|Overall Study|Lost to Follow-up|1|||
155077611|NCT02405962|559714627|FG001|Overall Study|Lost to Follow-up|4|||
155077612|NCT02405962|559714626|FG000|Overall Study|A participant has moved to another place|0|||
155077613|NCT02405962|559714627|FG001|Overall Study|A participant has moved to another place|1|||
155077614|NCT01980888|559714628|FG000|Overall Study|Study Terminated by Sponsor|116|||
155077615|NCT01980888|559714629|FG001|Overall Study|Study Terminated by Sponsor|122|||
155077616|NCT01980888|559714628|FG000|Overall Study|Withdrew Consent|17|||
155077617|NCT01980888|559714629|FG001|Overall Study|Withdrew Consent|6|||
155077618|NCT01980888|559714628|FG000|Overall Study|Investigator's Discretion|8|||
155077619|NCT01980888|559714629|FG001|Overall Study|Investigator's Discretion|3|||
155077620|NCT01980888|559714628|FG000|Overall Study|Non-Compliance with Study Drug|3|||
155077621|NCT01980888|559714629|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155077622|NCT00165698|559714631|FG000|Overall Study|Adverse Event|2|||
155077623|NCT00165698|559714632|FG001|Overall Study|Adverse Event|10|||
155077624|NCT00165698|559714631|FG000|Overall Study|Lost to Follow-up|2|||
155077625|NCT00165698|559714632|FG001|Overall Study|Lost to Follow-up|2|||
155077626|NCT00165698|559714631|FG000|Overall Study|Withdrawal by Subject|2|||
155077627|NCT00165698|559714632|FG001|Overall Study|Withdrawal by Subject|1|||
155077628|NCT00165698|559714631|FG000|Overall Study|Protocol Violation|1|||
155077629|NCT00165698|559714632|FG001|Overall Study|Protocol Violation|0|||
155077630|NCT00165698|559714631|FG000|Overall Study|Not Taken/Lost the medicine|1|||
155077631|NCT00165698|559714632|FG001|Overall Study|Not Taken/Lost the medicine|2|||
155077632|NCT01727154|559714646|FG000|Overall Study|Death|17|||
155077633|NCT01727154|559714646|FG000|Overall Study|Withdrawal by Subject|14|||
155077634|NCT01727154|559714646|FG000|Overall Study|Subject Withdrew Consent|18|||
155077635|NCT01727154|559714646|FG000|Overall Study|Study Terminated|6|||
155077636|NCT01727154|559714646|FG000|Overall Study|No Discontinuation Documentation|4|||
155077637|NCT00003474|559714647|FG000|Overall Study|Not Evaluable|14|||
155077638|NCT03020888|559714648|FG000|Overall Study|Physician Decision|4|||
155077639|NCT03020888|559714648|FG000|Overall Study|Withdrawal by Subject|6|||
155077640|NCT03020888|559714648|FG000|Overall Study|Insurance coverage|2|||
155077641|NCT03020888|559714648|FG000|Overall Study|Lost to Follow-up|1|||
155077642|NCT01198548|559714653|FG000|Overall Study|Disease Progression|9|||
155077643|NCT01198548|559714653|FG000|Overall Study|Administrative Decision|1|||
155077644|NCT01928771|559714654|FG000|Overall Study|Adverse Event|6|||
155077645|NCT01928771|559714655|FG001|Overall Study|Adverse Event|5|||
155164964|NCT02963506|560040619|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164965|NCT02963506|560040620|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164966|NCT02963506|560040621|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
155164967|NCT02963506|560040609|FG000|Dose-Blind Period|Adverse Event|0|||
155164968|NCT02963506|560040610|FG001|Dose-Blind Period|Adverse Event|0|||
155164969|NCT02963506|560040611|FG002|Dose-Blind Period|Adverse Event|0|||
155164970|NCT02963506|560040612|FG003|Dose-Blind Period|Adverse Event|0|||
155164971|NCT02963506|560040613|FG004|Dose-Blind Period|Adverse Event|0|||
155164972|NCT02963506|560040614|FG005|Dose-Blind Period|Adverse Event|1|||
155164973|NCT02963506|560040615|FG006|Dose-Blind Period|Adverse Event|3|||
155164974|NCT02963506|560040616|FG007|Dose-Blind Period|Adverse Event|2|||
155164975|NCT02963506|560040617|FG008|Dose-Blind Period|Adverse Event|2|||
155164976|NCT02963506|560040618|FG009|Dose-Blind Period|Adverse Event|2|||
155164977|NCT02963506|560040619|FG010|Dose-Blind Period|Adverse Event|1|||
155164978|NCT02963506|560040620|FG011|Dose-Blind Period|Adverse Event|1|||
154963627|NCT03317899|559292163|FG000|Overall Study|Death|6|||
155077646|NCT01928771|559714656|FG002|Overall Study|Adverse Event|1|||
155164979|NCT02963506|560040621|FG012|Dose-Blind Period|Adverse Event|6|||
155164980|NCT02963506|560040609|FG000|Dose-Blind Period|Lack of Efficacy|0|||
155164981|NCT02963506|560040610|FG001|Dose-Blind Period|Lack of Efficacy|0|||
155164982|NCT02963506|560040611|FG002|Dose-Blind Period|Lack of Efficacy|0|||
155164983|NCT02963506|560040612|FG003|Dose-Blind Period|Lack of Efficacy|0|||
155164984|NCT02963506|560040613|FG004|Dose-Blind Period|Lack of Efficacy|0|||
155077647|NCT01928771|559714654|FG000|Overall Study|Death|2|||
155077648|NCT01928771|559714655|FG001|Overall Study|Death|2|||
155077649|NCT01928771|559714656|FG002|Overall Study|Death|2|||
155077650|NCT01928771|559714654|FG000|Overall Study|Lost to Follow-up|5|||
155077651|NCT01928771|559714655|FG001|Overall Study|Lost to Follow-up|6|||
155077652|NCT01928771|559714656|FG002|Overall Study|Lost to Follow-up|3|||
155077653|NCT01928771|559714654|FG000|Overall Study|Withdrawal by Subject|20|||
155077654|NCT01928771|559714655|FG001|Overall Study|Withdrawal by Subject|15|||
155077655|NCT01928771|559714656|FG002|Overall Study|Withdrawal by Subject|17|||
155077656|NCT01928771|559714654|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
155077657|NCT01928771|559714655|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155077658|NCT01928771|559714656|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
155077659|NCT01928771|559714654|FG000|Overall Study|Other Reasons|9|||
155164985|NCT02963506|560040614|FG005|Dose-Blind Period|Lack of Efficacy|0|||
155077660|NCT01928771|559714655|FG001|Overall Study|Other Reasons|9|||
155164986|NCT02963506|560040615|FG006|Dose-Blind Period|Lack of Efficacy|0|||
155164987|NCT02963506|560040616|FG007|Dose-Blind Period|Lack of Efficacy|1|||
155164988|NCT02963506|560040617|FG008|Dose-Blind Period|Lack of Efficacy|0|||
155164989|NCT02963506|560040618|FG009|Dose-Blind Period|Lack of Efficacy|1|||
155164990|NCT02963506|560040619|FG010|Dose-Blind Period|Lack of Efficacy|0|||
155164991|NCT02963506|560040620|FG011|Dose-Blind Period|Lack of Efficacy|0|||
155164992|NCT02963506|560040621|FG012|Dose-Blind Period|Lack of Efficacy|0|||
155164993|NCT02963506|560040609|FG000|Dose-Blind Period|Lost to Follow-up|0|||
155164994|NCT02963506|560040610|FG001|Dose-Blind Period|Lost to Follow-up|0|||
155164995|NCT02963506|560040611|FG002|Dose-Blind Period|Lost to Follow-up|0|||
155164996|NCT02963506|560040612|FG003|Dose-Blind Period|Lost to Follow-up|0|||
155164997|NCT02963506|560040613|FG004|Dose-Blind Period|Lost to Follow-up|0|||
155164998|NCT02963506|560040614|FG005|Dose-Blind Period|Lost to Follow-up|1|||
155164999|NCT02963506|560040615|FG006|Dose-Blind Period|Lost to Follow-up|0|||
155165000|NCT02963506|560040616|FG007|Dose-Blind Period|Lost to Follow-up|0|||
155165001|NCT02963506|560040617|FG008|Dose-Blind Period|Lost to Follow-up|1|||
155165002|NCT02963506|560040618|FG009|Dose-Blind Period|Lost to Follow-up|0|||
155077661|NCT01928771|559714656|FG002|Overall Study|Other Reasons|14|||
155077662|NCT01928771|559714654|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
155077663|NCT01928771|559714655|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
155077664|NCT01928771|559714656|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
155077665|NCT01937117|559714657|FG000|Overall Study|Disease Progression|7|||
155077666|NCT01937117|559714657|FG000|Overall Study|Physician Decision|4|||
155077667|NCT01937117|559714657|FG000|Overall Study|Adverse Event|2|||
155077668|NCT02186171|559714663|FG000|Overall Study|Withdrawal by Subject|1|||
155077669|NCT02186171|559714664|FG001|Overall Study|Withdrawal by Subject|9|||
155077670|NCT02186171|559714663|FG000|Overall Study|Lost to Follow-up|2|||
155077671|NCT02186171|559714664|FG001|Overall Study|Lost to Follow-up|2|||
155165003|NCT02963506|560040619|FG010|Dose-Blind Period|Lost to Follow-up|0|||
155165004|NCT02963506|560040620|FG011|Dose-Blind Period|Lost to Follow-up|1|||
155165005|NCT02963506|560040621|FG012|Dose-Blind Period|Lost to Follow-up|0|||
155165006|NCT02963506|560040609|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
155165007|NCT02963506|560040610|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
155165008|NCT02963506|560040611|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
155165009|NCT02963506|560040612|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
155165010|NCT02963506|560040613|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
155165011|NCT02963506|560040614|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
155165012|NCT02963506|560040615|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
155165013|NCT02963506|560040616|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
155165014|NCT02963506|560040617|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
155165015|NCT02963506|560040618|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
155165016|NCT02963506|560040619|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
155165017|NCT02963506|560040620|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
155165018|NCT02963506|560040621|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
155165019|NCT02963506|560040609|FG000|Dose-Blind Period|Sponsor decision|0|||
155165020|NCT02963506|560040610|FG001|Dose-Blind Period|Sponsor decision|0|||
155165021|NCT02963506|560040611|FG002|Dose-Blind Period|Sponsor decision|0|||
155165022|NCT02963506|560040612|FG003|Dose-Blind Period|Sponsor decision|0|||
155165023|NCT02963506|560040613|FG004|Dose-Blind Period|Sponsor decision|0|||
155165024|NCT02963506|560040614|FG005|Dose-Blind Period|Sponsor decision|1|||
155165025|NCT02963506|560040615|FG006|Dose-Blind Period|Sponsor decision|0|||
155165026|NCT02963506|560040616|FG007|Dose-Blind Period|Sponsor decision|0|||
155342582|NCT00636168|560687078|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
155342583|NCT00636168|560687077|FG000|Treated With Study Drug|Recurrence of disease|135|||
155342584|NCT00636168|560687078|FG001|Treated With Study Drug|Recurrence of disease|282|||
155342585|NCT00636168|560687077|FG000|Treated With Study Drug|Adverse Event|250|||
155342586|NCT00636168|560687078|FG001|Treated With Study Drug|Adverse Event|22|||
155342587|NCT00636168|560687077|FG000|Treated With Study Drug|Participant withdrew consent|16|||
155342588|NCT00636168|560687078|FG001|Treated With Study Drug|Participant withdrew consent|21|||
155342589|NCT00636168|560687077|FG000|Treated With Study Drug|Poor/non-compliance|1|||
155342590|NCT00636168|560687078|FG001|Treated With Study Drug|Poor/non-compliance|3|||
155342591|NCT00636168|560687077|FG000|Treated With Study Drug|Death|3|||
155077672|NCT02186171|559714663|FG000|Overall Study|Death|1|||
155077673|NCT02186171|559714664|FG001|Overall Study|Death|2|||
155077674|NCT02186171|559714663|FG000|Overall Study|Protocol-specified Criteria|0|||
155077675|NCT02186171|559714664|FG001|Overall Study|Protocol-specified Criteria|2|||
154963628|NCT03317899|559292164|FG001|Overall Study|Death|9|||
154963629|NCT04349267|559292167|FG000|Overall Study|Adverse Event|0|||
154963630|NCT04349267|559292168|FG001|Overall Study|Adverse Event|0|||
154963631|NCT04349267|559292169|FG002|Overall Study|Adverse Event|0|||
154963632|NCT04349267|559292170|FG003|Overall Study|Adverse Event|0|||
154963633|NCT04349267|559292171|FG004|Overall Study|Adverse Event|0|||
154963634|NCT04349267|559292172|FG005|Overall Study|Adverse Event|1|||
155077676|NCT02015104|559714665|FG000|Overall Study|Withdrew consent after first dose drug|1|||
155077677|NCT02015104|559714666|FG001|Overall Study|Withdrew consent after first dose drug|0|||
155077678|NCT02015104|559714665|FG000|Overall Study|Withdrew consent prior to treatment|0|||
155077679|NCT02015104|559714666|FG001|Overall Study|Withdrew consent prior to treatment|1|||
155077680|NCT06025695|559714667|FG000|Overall Study|Adverse Event|5|||
155077681|NCT06025695|559714668|FG001|Overall Study|Adverse Event|6|||
155077682|NCT06025695|559714667|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
155077683|NCT06025695|559714668|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
155077684|NCT06025695|559714667|FG000|Overall Study|Other|23|||
155077685|NCT06025695|559714668|FG001|Overall Study|Other|19|||
155077686|NCT06025695|559714667|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
155077687|NCT06025695|559714668|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
155077688|NCT01452347|559714669|FG000|Overall Study|Adverse Event|2|||
155077689|NCT01452347|559714670|FG001|Overall Study|Adverse Event|1|||
155077690|NCT01452347|559714669|FG000|Overall Study|Non compliance protocol|2|||
155077691|NCT01452347|559714670|FG001|Overall Study|Non compliance protocol|0|||
155077692|NCT01452347|559714669|FG000|Overall Study|Lost to Follow-up|2|||
155077693|NCT01452347|559714670|FG001|Overall Study|Lost to Follow-up|0|||
155077694|NCT01452347|559714669|FG000|Overall Study|Withdrawal by Subject|3|||
154963635|NCT04349267|559292173|FG006|Overall Study|Adverse Event|0|||
154963636|NCT04349267|559292167|FG000|Overall Study|Other reason|0|||
154963637|NCT04349267|559292168|FG001|Overall Study|Other reason|1|||
154963638|NCT04349267|559292169|FG002|Overall Study|Other reason|0|||
154963639|NCT04349267|559292170|FG003|Overall Study|Other reason|0|||
154963640|NCT04349267|559292171|FG004|Overall Study|Other reason|1|||
154963641|NCT04349267|559292172|FG005|Overall Study|Other reason|1|||
154963642|NCT04349267|559292173|FG006|Overall Study|Other reason|1|||
154963643|NCT04349267|559292167|FG000|Overall Study|Disease Progression|2|||
154963644|NCT04349267|559292168|FG001|Overall Study|Disease Progression|0|||
154963645|NCT04349267|559292169|FG002|Overall Study|Disease Progression|2|||
154963646|NCT04349267|559292170|FG003|Overall Study|Disease Progression|3|||
154963647|NCT04349267|559292171|FG004|Overall Study|Disease Progression|3|||
154963648|NCT04349267|559292172|FG005|Overall Study|Disease Progression|7|||
154963649|NCT04349267|559292173|FG006|Overall Study|Disease Progression|10|||
154963650|NCT04349267|559292167|FG000|Overall Study|Participant withdrew consent|0|||
154963651|NCT04349267|559292168|FG001|Overall Study|Participant withdrew consent|1|||
154963652|NCT04349267|559292169|FG002|Overall Study|Participant withdrew consent|0|||
154963653|NCT04349267|559292170|FG003|Overall Study|Participant withdrew consent|0|||
155077695|NCT01452347|559714670|FG001|Overall Study|Withdrawal by Subject|3|||
155077696|NCT01452347|559714669|FG000|Overall Study|Not treated|6|||
155077697|NCT01452347|559714670|FG001|Overall Study|Not treated|3|||
155077698|NCT01452347|559714669|FG000|Overall Study|Other reason not defined above|2|||
155077699|NCT01452347|559714670|FG001|Overall Study|Other reason not defined above|0|||
155077700|NCT01030900|559714671|FG000|Overall Study|Not treated due to congestive heart failure|1|||
155077701|NCT01030900|559714671|FG000|Overall Study|Not treated due to rapid disease|1|||
155077702|NCT00441896|559714672|FG000|Overall Study|Withdrawal by Subject|0|||
155077703|NCT00441896|559714673|FG001|Overall Study|Withdrawal by Subject|0|||
155077704|NCT00441896|559714674|FG002|Overall Study|Withdrawal by Subject|0|||
155077705|NCT00441896|559714675|FG003|Overall Study|Withdrawal by Subject|1|||
155077706|NCT00441896|559714676|FG004|Overall Study|Withdrawal by Subject|0|||
155077707|NCT00441896|559714677|FG005|Overall Study|Withdrawal by Subject|0|||
155077708|NCT00441896|559714678|FG006|Overall Study|Withdrawal by Subject|0|||
155077709|NCT00441896|559714679|FG007|Overall Study|Withdrawal by Subject|0|||
155077710|NCT00441896|559714680|FG008|Overall Study|Withdrawal by Subject|0|||
155077711|NCT00441896|559714681|FG009|Overall Study|Withdrawal by Subject|0|||
155077712|NCT00441896|559714672|FG000|Overall Study|Other|0|||
155077713|NCT00441896|559714673|FG001|Overall Study|Other|0|||
155077714|NCT00441896|559714674|FG002|Overall Study|Other|0|||
154963654|NCT04349267|559292171|FG004|Overall Study|Participant withdrew consent|0|||
154963655|NCT04349267|559292172|FG005|Overall Study|Participant withdrew consent|0|||
154963656|NCT04349267|559292173|FG006|Overall Study|Participant withdrew consent|1|||
154963657|NCT01648582|559292174|FG000|Overall Study|Adverse Event|6|||
155077715|NCT00441896|559714675|FG003|Overall Study|Other|0|||
155077716|NCT00441896|559714676|FG004|Overall Study|Other|1|||
155077717|NCT00441896|559714677|FG005|Overall Study|Other|0|||
155077718|NCT00441896|559714678|FG006|Overall Study|Other|0|||
154963658|NCT01648582|559292175|FG001|Overall Study|Adverse Event|11|||
155077719|NCT00441896|559714679|FG007|Overall Study|Other|0|||
155077720|NCT00441896|559714680|FG008|Overall Study|Other|0|||
155077721|NCT00441896|559714681|FG009|Overall Study|Other|0|||
155077722|NCT01301092|559714682|FG000|Overall Study|Lost to Follow-up|0|||
155165027|NCT02963506|560040617|FG008|Dose-Blind Period|Sponsor decision|0|||
155165028|NCT02963506|560040618|FG009|Dose-Blind Period|Sponsor decision|0|||
155165029|NCT02963506|560040619|FG010|Dose-Blind Period|Sponsor decision|0|||
155165030|NCT02963506|560040620|FG011|Dose-Blind Period|Sponsor decision|0|||
155165031|NCT02963506|560040621|FG012|Dose-Blind Period|Sponsor decision|0|||
155077723|NCT01301092|559714683|FG001|Overall Study|Lost to Follow-up|0|||
155077724|NCT01301092|559714684|FG002|Overall Study|Lost to Follow-up|1|||
155077725|NCT03334175|559714685|FG000|Overall Study|Lost to Follow-up|0|||
155077726|NCT03334175|559714686|FG001|Overall Study|Lost to Follow-up|1|||
155077727|NCT01350973|559714690|FG000|Overall Study|Adverse Event|4|||
155077728|NCT01350973|559714691|FG001|Overall Study|Adverse Event|7|||
155077729|NCT01350973|559714692|FG002|Overall Study|Adverse Event|7|||
155077730|NCT01350973|559714690|FG000|Overall Study|Voluntary Withdrawal|2|||
155077731|NCT01350973|559714691|FG001|Overall Study|Voluntary Withdrawal|1|||
155077732|NCT01350973|559714692|FG002|Overall Study|Voluntary Withdrawal|1|||
155077733|NCT00853047|559714693|FG000|Core Phase|Participant Request|0|||
155077734|NCT00853047|559714694|FG001|Core Phase|Participant Request|0|||
155077735|NCT00853047|559714695|FG002|Core Phase|Participant Request|0|||
155077736|NCT00853047|559714696|FG003|Core Phase|Participant Request|1|||
155077737|NCT00853047|559714697|FG004|Core Phase|Participant Request|0|||
155077738|NCT00853047|559714698|FG005|Core Phase|Participant Request|0|||
155077739|NCT00853047|559714693|FG000|Open-Label Extension Phase|Participant Request|0|||
155077740|NCT00853047|559714694|FG001|Open-Label Extension Phase|Participant Request|0|||
155077741|NCT00853047|559714695|FG002|Open-Label Extension Phase|Participant Request|0|||
155077742|NCT00853047|559714696|FG003|Open-Label Extension Phase|Participant Request|0|||
155077743|NCT00853047|559714697|FG004|Open-Label Extension Phase|Participant Request|0|||
155077744|NCT00853047|559714698|FG005|Open-Label Extension Phase|Participant Request|7|||
155077745|NCT00853047|559714693|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155077746|NCT00853047|559714694|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155077747|NCT00853047|559714695|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155077748|NCT00853047|559714696|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
155077749|NCT00853047|559714697|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
155077750|NCT00853047|559714698|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
155077751|NCT00853047|559714693|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155077752|NCT00853047|559714694|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155077753|NCT00853047|559714695|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155077754|NCT00853047|559714696|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155077755|NCT00853047|559714697|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
155077756|NCT00853047|559714698|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
155077757|NCT00853047|559714693|FG000|Open-Label Extension Phase|Investigator Decision|0|||
155077758|NCT00853047|559714694|FG001|Open-Label Extension Phase|Investigator Decision|0|||
155077759|NCT00853047|559714695|FG002|Open-Label Extension Phase|Investigator Decision|0|||
155077760|NCT00853047|559714696|FG003|Open-Label Extension Phase|Investigator Decision|0|||
155077761|NCT00853047|559714697|FG004|Open-Label Extension Phase|Investigator Decision|0|||
155077762|NCT00853047|559714698|FG005|Open-Label Extension Phase|Investigator Decision|1|||
155077763|NCT00853047|559714693|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
155077764|NCT00853047|559714694|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
155077765|NCT00853047|559714695|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
155077766|NCT00853047|559714696|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
155077767|NCT00853047|559714697|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
155077768|NCT00853047|559714698|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
155077769|NCT02638493|559714699|FG000|Overall Study|Inability to provide semen samples|2|||
155077770|NCT02638493|559714700|FG001|Overall Study|Inability to provide semen samples|0|||
155077771|NCT02638493|559714701|FG002|Overall Study|Inability to provide semen samples|0|||
155077772|NCT03882801|559716511|FG000|Period 1|Adverse Event|0|||
155077773|NCT03882801|559716512|FG001|Period 1|Adverse Event|1|||
155077774|NCT03882801|559716511|FG000|Period 1|Non-compliance with study drug|1|||
155077775|NCT03882801|559716512|FG001|Period 1|Non-compliance with study drug|1|||
155077776|NCT03882801|559716511|FG000|Period 1|Never treated with study drug|1|||
155077777|NCT03882801|559716512|FG001|Period 1|Never treated with study drug|0|||
155165032|NCT02963506|560040609|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165033|NCT02963506|560040610|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155077778|NCT03882801|559716511|FG000|Washout Period|Physician Decision|0|||
155165034|NCT02963506|560040611|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155077779|NCT03882801|559716512|FG001|Washout Period|Physician Decision|1|||
155165035|NCT02963506|560040612|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155077780|NCT03882801|559716511|FG000|Period 2|Non-compliance with study drug|0|||
155077781|NCT03882801|559716512|FG001|Period 2|Non-compliance with study drug|1|||
155077782|NCT01793129|559716513|FG000|Overall Study|Lost to Follow-up|3|||
155077783|NCT01793129|559716514|FG001|Overall Study|Lost to Follow-up|7|||
155077784|NCT01793129|559716513|FG000|Overall Study|Withdrawal by Subject|0|||
155077785|NCT01793129|559716514|FG001|Overall Study|Withdrawal by Subject|2|||
155077786|NCT04193176|559716517|FG000|Overall Study|Withdrawal by Subject|6|||
155077787|NCT04193176|559716518|FG001|Overall Study|Withdrawal by Subject|10|||
155077788|NCT00944645|559716519|FG000|Period 2|Adverse Event|1|||
155077789|NCT00944645|559716520|FG001|Period 2|Adverse Event|0|||
155077790|NCT00944645|559716519|FG000|Period 2|Lost to Follow-up|0|||
155077791|NCT00944645|559716520|FG001|Period 2|Lost to Follow-up|3|||
155077792|NCT00944645|559716519|FG000|Period 2|Withdrawal by Subject|7|||
155077793|NCT00944645|559716520|FG001|Period 2|Withdrawal by Subject|6|||
154963659|NCT01648582|559292176|FG002|Overall Study|Adverse Event|2|||
154963660|NCT01648582|559292174|FG000|Overall Study|Lost to Follow-up|9|||
154963661|NCT01648582|559292175|FG001|Overall Study|Lost to Follow-up|6|||
154963662|NCT01648582|559292176|FG002|Overall Study|Lost to Follow-up|8|||
154963663|NCT01648582|559292174|FG000|Overall Study|Protocol Violation|1|||
154963664|NCT01648582|559292175|FG001|Overall Study|Protocol Violation|2|||
154963665|NCT01648582|559292176|FG002|Overall Study|Protocol Violation|1|||
154963666|NCT01648582|559292174|FG000|Overall Study|Withdrawal by Subject|15|||
154963667|NCT01648582|559292175|FG001|Overall Study|Withdrawal by Subject|17|||
154963668|NCT01648582|559292176|FG002|Overall Study|Withdrawal by Subject|17|||
154963669|NCT01648582|559292174|FG000|Overall Study|Physician Decision|0|||
154963670|NCT01648582|559292175|FG001|Overall Study|Physician Decision|1|||
154963671|NCT01648582|559292176|FG002|Overall Study|Physician Decision|3|||
154963672|NCT01648582|559292174|FG000|Overall Study|Death|1|||
154963673|NCT01648582|559292175|FG001|Overall Study|Death|0|||
154963674|NCT01648582|559292176|FG002|Overall Study|Death|0|||
154963675|NCT01648582|559292174|FG000|Overall Study|Sponsor Decision|0|||
154963676|NCT01648582|559292175|FG001|Overall Study|Sponsor Decision|1|||
154963677|NCT01648582|559292176|FG002|Overall Study|Sponsor Decision|1|||
154963678|NCT06539676|559292181|FG000|Overall Study|Early study termination|1|||
154963679|NCT06539676|559292182|FG001|Overall Study|Early study termination|0|||
154963680|NCT06539676|559292183|FG002|Overall Study|Early study termination|6|||
154963681|NCT01154231|559292189|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
154963682|NCT01154231|559292189|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
154963683|NCT04970810|559292770|FG000|Overall Study|deemed ineligible after randomization|3|||
154963684|NCT04970810|559292771|FG001|Overall Study|deemed ineligible after randomization|0|||
154963685|NCT04970810|559292772|FG002|Overall Study|deemed ineligible after randomization|4|||
154963686|NCT01440803|559292775|FG000|Overall Study|Met study stopping rule|2|||
154963687|NCT01440803|559292776|FG001|Overall Study|Met study stopping rule|1|||
154963688|NCT01440803|559292775|FG000|Overall Study|Lost to Follow-up|0|||
154963689|NCT01440803|559292776|FG001|Overall Study|Lost to Follow-up|2|||
154963690|NCT01440803|559292775|FG000|Overall Study|Withdrawal by Subject|0|||
154963691|NCT01440803|559292776|FG001|Overall Study|Withdrawal by Subject|1|||
154963692|NCT03913377|559292777|FG000|Period 1|Test Article no longer available|0|||
154963693|NCT03913377|559292778|FG001|Period 1|Test Article no longer available|1|||
154963694|NCT03913377|559292779|FG002|Period 1|Test Article no longer available|0|||
154963695|NCT03913377|559292777|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
154963696|NCT03913377|559292778|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
154963697|NCT03913377|559292779|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
154963698|NCT03689400|559292780|FG000|Overall Study|Lost to Follow-up|4|||
154963699|NCT04618211|559292781|FG000|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
154963700|NCT04618211|559292782|FG001|Part I (Non-Attack, Safety)|Withdrawal by Subject|1|||
154963701|NCT04618211|559292783|FG002|Part I (Non-Attack, Safety)|Withdrawal by Subject|0|||
154963702|NCT04618211|559292781|FG000|Part II (Self-administration, Efficacy)|Withdrawal by Subject|2|||
154963703|NCT04618211|559292782|FG001|Part II (Self-administration, Efficacy)|Withdrawal by Subject|3|||
154963704|NCT04618211|559292783|FG002|Part II (Self-administration, Efficacy)|Withdrawal by Subject|5|||
154963705|NCT04618211|559292781|FG000|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|6|||
154963706|NCT04618211|559292782|FG001|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|9|||
154963707|NCT04618211|559292783|FG002|Part II (Self-administration, Efficacy)|Participants Met Primary Analysis Criteria|8|||
154963708|NCT03534193|559292786|FG000|Overall Study|Lost to Follow-up|1|||
154963709|NCT03534193|559292787|FG001|Overall Study|Lost to Follow-up|3|||
154963710|NCT04414930|559292788|FG000|Overall Study|Withdrawal by Subject|1|||
154963711|NCT04414930|559292789|FG001|Overall Study|Withdrawal by Subject|3|||
154963712|NCT05470699|559292790|FG000|Overall Study|Did not receive intervention|13|||
154963713|NCT05470699|559292790|FG000|Overall Study|Ineligible|1|||
154963714|NCT04128761|559292791|FG000|Overall Study|Lost to Follow-up|5|||
154963715|NCT04128761|559292792|FG001|Overall Study|Lost to Follow-up|6|||
154963716|NCT01848938|559292799|FG000|Overall Study|Lost to Follow-up|1|||
155342592|NCT00636168|560687078|FG001|Treated With Study Drug|Death|0|||
154963717|NCT01848938|559292800|FG001|Overall Study|Lost to Follow-up|1|||
154963718|NCT01983969|559292804|FG000|Overall Study|Disease Progression|0|||
155077794|NCT03537729|559716521|FG000|Overall Study|Death|2|||
155342593|NCT00636168|560687077|FG000|Treated With Study Drug|Pregnancy|1|||
154963719|NCT01983969|559292805|FG001|Overall Study|Disease Progression|1|||
154963720|NCT01983969|559292806|FG002|Overall Study|Disease Progression|0|||
154963721|NCT02619682|559292807|FG000|Overall Study|Withdrawal by Subject|3|||
154963722|NCT02619682|559292807|FG000|Overall Study|Lack of Efficacy|8|||
154963723|NCT02619682|559292807|FG000|Overall Study|new secondary cancer|1|||
155077795|NCT03537729|559716522|FG001|Overall Study|Death|2|||
155342594|NCT00636168|560687078|FG001|Treated With Study Drug|Pregnancy|0|||
155165036|NCT02963506|560040613|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165037|NCT02963506|560040614|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165038|NCT02963506|560040615|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165039|NCT02963506|560040616|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165040|NCT02963506|560040617|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165041|NCT02963506|560040618|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165042|NCT02963506|560040619|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165043|NCT02963506|560040620|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
155165044|NCT02963506|560040621|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
155165045|NCT00256997|560040624|FG000|Overall Study|Protocol Violation|1|||
155165046|NCT00256997|560040625|FG001|Overall Study|Protocol Violation|4|||
155165047|NCT00256997|560040624|FG000|Overall Study|Lack of Efficacy|1|||
155165048|NCT00256997|560040625|FG001|Overall Study|Lack of Efficacy|4|||
155165049|NCT00256997|560040624|FG000|Overall Study|Death|2|||
155165050|NCT00256997|560040625|FG001|Overall Study|Death|0|||
155165051|NCT00256997|560040624|FG000|Overall Study|Adverse Event|4|||
155165052|NCT00256997|560040625|FG001|Overall Study|Adverse Event|0|||
155165053|NCT00256997|560040624|FG000|Overall Study|Lost to Follow-up|3|||
155165054|NCT00256997|560040625|FG001|Overall Study|Lost to Follow-up|5|||
155165055|NCT00256997|560040624|FG000|Overall Study|Withdrawal by Subject|13|||
155165056|NCT00256997|560040625|FG001|Overall Study|Withdrawal by Subject|3|||
155165057|NCT00256997|560040624|FG000|Overall Study|Started but not treated|2|||
155165058|NCT00256997|560040625|FG001|Overall Study|Started but not treated|0|||
155165059|NCT00256997|560040624|FG000|Overall Study|Other|5|||
155165060|NCT00256997|560040625|FG001|Overall Study|Other|8|||
155165061|NCT00256997|560040624|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
155165062|NCT00256997|560040625|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
155165063|NCT00256997|560040624|FG000|Overall Study|Participant Non-compliant|3|||
155165064|NCT00256997|560040625|FG001|Overall Study|Participant Non-compliant|6|||
155165065|NCT00256997|560040624|FG000|Overall Study|Investigator Withdrew Participant|2|||
155165066|NCT00256997|560040625|FG001|Overall Study|Investigator Withdrew Participant|1|||
155165067|NCT01287741|560040626|FG000|Overall Study|Withdrawal by Subject|35|||
155165068|NCT01287741|560040627|FG001|Overall Study|Withdrawal by Subject|38|||
155165069|NCT01287741|560040626|FG000|Overall Study|Protocol Violation|2|||
155165070|NCT01287741|560040627|FG001|Overall Study|Protocol Violation|0|||
155165071|NCT01287741|560040626|FG000|Overall Study|Physician Decision|15|||
155165072|NCT01287741|560040627|FG001|Overall Study|Physician Decision|23|||
155165073|NCT01287741|560040626|FG000|Overall Study|Non-compliance|8|||
155165074|NCT01287741|560040627|FG001|Overall Study|Non-compliance|6|||
155165075|NCT01287741|560040626|FG000|Overall Study|Lost to Follow-up|10|||
155165076|NCT01287741|560040627|FG001|Overall Study|Lost to Follow-up|8|||
155165077|NCT01287741|560040626|FG000|Overall Study|Death|32|||
155165078|NCT01287741|560040627|FG001|Overall Study|Death|44|||
155165079|NCT01287741|560040626|FG000|Overall Study|Adverse Event|4|||
155165080|NCT01287741|560040627|FG001|Overall Study|Adverse Event|6|||
155165081|NCT01287741|560040626|FG000|Overall Study|Study terminated by Sponsor|307|||
155165082|NCT01287741|560040627|FG001|Overall Study|Study terminated by Sponsor|315|||
155165083|NCT01287741|560040626|FG000|Overall Study|Progressive disease|190|||
155165084|NCT01287741|560040627|FG001|Overall Study|Progressive disease|166|||
155165085|NCT01287741|560040626|FG000|Overall Study|Reason not specified|23|||
155165086|NCT01287741|560040627|FG001|Overall Study|Reason not specified|9|||
155165087|NCT04163016|560040629|FG000|Enrollment|Adverse Event|1|||
155165088|NCT04163016|560040630|FG001|Enrollment|Adverse Event|0|||
155165089|NCT04163016|560040631|FG002|Enrollment|Adverse Event|0|||
155165090|NCT04163016|560040632|FG003|Enrollment|Adverse Event|0|||
155165091|NCT04163016|560040629|FG000|Treatment|Adverse Event|0|||
155165092|NCT04163016|560040630|FG001|Treatment|Adverse Event|1|||
155165093|NCT04163016|560040631|FG002|Treatment|Adverse Event|0|||
155165094|NCT04163016|560040632|FG003|Treatment|Adverse Event|0|||
155165095|NCT04163016|560040629|FG000|Treatment|Withdrawal by Subject|0|||
155165096|NCT04163016|560040630|FG001|Treatment|Withdrawal by Subject|2|||
155165097|NCT04163016|560040631|FG002|Treatment|Withdrawal by Subject|0|||
155165098|NCT04163016|560040632|FG003|Treatment|Withdrawal by Subject|0|||
155165099|NCT04163016|560040629|FG000|Treatment|Indeterminate TB-test|0|||
155165100|NCT04163016|560040630|FG001|Treatment|Indeterminate TB-test|0|||
155077796|NCT03537729|559716523|FG002|Overall Study|Death|7|||
155077797|NCT03537729|559716521|FG000|Overall Study|Withdrawal by Subject|3|||
155077798|NCT03537729|559716522|FG001|Overall Study|Withdrawal by Subject|3|||
154963724|NCT02619682|559292807|FG000|Overall Study|post surgery complications|2|||
154963725|NCT00268203|559292808|FG000|Overall Study|Lost to Follow-up|92|||
154963726|NCT00268203|559292808|FG000|Overall Study|Withdrawal by Subject|9|||
154963727|NCT00268203|559292808|FG000|Overall Study|Received Other NHL Therapy|7|||
155077799|NCT03537729|559716523|FG002|Overall Study|Withdrawal by Subject|0|||
155077800|NCT03537729|559716521|FG000|Overall Study|Subject Moved|8|||
155077801|NCT03537729|559716522|FG001|Overall Study|Subject Moved|5|||
155077802|NCT03537729|559716523|FG002|Overall Study|Subject Moved|4|||
155077803|NCT03537729|559716521|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
155077804|NCT03537729|559716522|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
155077805|NCT03537729|559716523|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
155077806|NCT03537729|559716521|FG000|Overall Study|COVID-19 Site Restrictions|11|||
155077807|NCT03537729|559716522|FG001|Overall Study|COVID-19 Site Restrictions|15|||
155077808|NCT03537729|559716523|FG002|Overall Study|COVID-19 Site Restrictions|18|||
155077809|NCT03537729|559716521|FG000|Overall Study|Decline in Health|5|||
155077810|NCT03537729|559716522|FG001|Overall Study|Decline in Health|9|||
155077811|NCT03537729|559716523|FG002|Overall Study|Decline in Health|4|||
155077812|NCT03537729|559716521|FG000|Overall Study|Determined Ineligible|0|||
155077813|NCT03537729|559716522|FG001|Overall Study|Determined Ineligible|0|||
155077814|NCT03537729|559716523|FG002|Overall Study|Determined Ineligible|1|||
155077815|NCT00289978|559716526|FG000|Overall Study|Withdrawal by Subject|31|||
155077816|NCT00289978|559716527|FG001|Overall Study|Withdrawal by Subject|17|||
155077817|NCT00289978|559716528|FG002|Overall Study|Withdrawal by Subject|28|||
155077818|NCT00289978|559716526|FG000|Overall Study|Adverse Event|22|||
155077819|NCT00289978|559716527|FG001|Overall Study|Adverse Event|13|||
155077820|NCT00289978|559716528|FG002|Overall Study|Adverse Event|18|||
155077821|NCT00289978|559716526|FG000|Overall Study|Lack of Efficacy|13|||
155077822|NCT00289978|559716527|FG001|Overall Study|Lack of Efficacy|6|||
155077823|NCT00289978|559716528|FG002|Overall Study|Lack of Efficacy|25|||
155077824|NCT00289978|559716526|FG000|Overall Study|Abnormal laboratory value(s)|20|||
155077825|NCT00289978|559716527|FG001|Overall Study|Abnormal laboratory value(s)|9|||
155077826|NCT00289978|559716528|FG002|Overall Study|Abnormal laboratory value(s)|1|||
155077827|NCT00289978|559716526|FG000|Overall Study|Lost to Follow-up|3|||
155077828|NCT00289978|559716527|FG001|Overall Study|Lost to Follow-up|5|||
155077829|NCT00289978|559716528|FG002|Overall Study|Lost to Follow-up|7|||
155077830|NCT00289978|559716526|FG000|Overall Study|Protocol Violation|5|||
155077831|NCT00289978|559716527|FG001|Overall Study|Protocol Violation|5|||
155077832|NCT00289978|559716528|FG002|Overall Study|Protocol Violation|4|||
155077833|NCT00289978|559716526|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155077834|NCT00289978|559716527|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155077835|NCT00289978|559716528|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155077836|NCT00289978|559716526|FG000|Overall Study|Death|1|||
155077837|NCT00289978|559716527|FG001|Overall Study|Death|0|||
155077838|NCT00289978|559716528|FG002|Overall Study|Death|2|||
155077839|NCT00903344|559716529|FG000|Overall Study|Pregnancy|2|||
155077840|NCT00903344|559716530|FG001|Overall Study|Pregnancy|3|||
154963728|NCT00268203|559292808|FG000|Overall Study|Progressive Disease|359|||
154963729|NCT00268203|559292808|FG000|Overall Study|Death|84|||
154963730|NCT00268203|559292808|FG000|Overall Study|Reason Not Specified|34|||
154963731|NCT00268203|559292808|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
154963732|NCT04589650|559292809|FG000|Overall Study|Subject decision|6|||
154963733|NCT04589650|559292810|FG001|Overall Study|Subject decision|2|||
154963734|NCT04589650|559292811|FG002|Overall Study|Subject decision|2|||
154963735|NCT04589650|559292812|FG003|Overall Study|Subject decision|0|||
154963736|NCT04589650|559292813|FG004|Overall Study|Subject decision|0|||
154963737|NCT04589650|559292814|FG005|Overall Study|Subject decision|0|||
154963738|NCT04589650|559292809|FG000|Overall Study|Adverse Event|3|||
154963739|NCT04589650|559292810|FG001|Overall Study|Adverse Event|1|||
154963740|NCT04589650|559292811|FG002|Overall Study|Adverse Event|1|||
155077841|NCT00903344|559716529|FG000|Overall Study|Lost to Follow-up|3|||
155077842|NCT00903344|559716530|FG001|Overall Study|Lost to Follow-up|0|||
154963741|NCT04589650|559292812|FG003|Overall Study|Adverse Event|1|||
154963742|NCT04589650|559292813|FG004|Overall Study|Adverse Event|0|||
155077843|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
155077844|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
155077845|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
155077846|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
155077847|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
154963743|NCT04589650|559292814|FG005|Overall Study|Adverse Event|1|||
154963744|NCT04589650|559292809|FG000|Overall Study|Physician Decision|1|||
154963745|NCT04589650|559292810|FG001|Overall Study|Physician Decision|1|||
154963746|NCT04589650|559292811|FG002|Overall Study|Physician Decision|0|||
155077848|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
155077849|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
155077850|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
155077851|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
155077852|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
155077853|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
155077854|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
155077855|NCT01243424|559716533|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
155077856|NCT01243424|559716534|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
155077857|NCT01243424|559716533|FG000|Discontinuation From Treatment|Not treated|5|||
155077858|NCT01243424|559716534|FG001|Discontinuation From Treatment|Not treated|4|||
155077859|NCT01243424|559716533|FG000|Discontinuation From Treatment|Adverse Event|457|||
155077860|NCT01243424|559716534|FG001|Discontinuation From Treatment|Adverse Event|523|||
155077861|NCT01243424|559716533|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
155077862|NCT01243424|559716534|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
155077863|NCT01243424|559716533|FG000|Discontinuation From Treatment|Protocol Violation|46|||
155077864|NCT01243424|559716534|FG001|Discontinuation From Treatment|Protocol Violation|47|||
155077865|NCT01243424|559716533|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
155077866|NCT01243424|559716534|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
155077867|NCT01243424|559716533|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
155077868|NCT01243424|559716534|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
155077869|NCT01243424|559716533|FG000|Discontinuation From Treatment|Other than listed above|230|||
155077870|NCT01243424|559716534|FG001|Discontinuation From Treatment|Other than listed above|211|||
155077871|NCT01093885|559716552|FG000|Overall Study|Adverse Event|4|||
155077872|NCT01093885|559716552|FG000|Overall Study|Lost to Follow-up|1|||
155077873|NCT01301001|559716553|FG000|First Intervention|Lost to Follow-up|4|||
155077874|NCT01301001|559716554|FG001|First Intervention|Lost to Follow-up|4|||
155077875|NCT01301001|559716553|FG000|First Intervention|Withdrawal by Subject|1|||
155077876|NCT01301001|559716554|FG001|First Intervention|Withdrawal by Subject|4|||
155077877|NCT01301001|559716553|FG000|First Intervention|Adverse Event|5|||
155077878|NCT01301001|559716554|FG001|First Intervention|Adverse Event|0|||
155077879|NCT01301001|559716553|FG000|First Intervention|Protocol Violation|0|||
155077880|NCT01301001|559716554|FG001|First Intervention|Protocol Violation|1|||
155077881|NCT01301001|559716553|FG000|Second Intervention|Adverse Event|2|||
155077882|NCT01301001|559716554|FG001|Second Intervention|Adverse Event|0|||
155077883|NCT01301001|559716553|FG000|Second Intervention|Withdrawal by Subject|2|||
155077884|NCT01301001|559716554|FG001|Second Intervention|Withdrawal by Subject|0|||
155077885|NCT01560988|559716555|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
155077886|NCT01560988|559716556|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
155077887|NCT01560988|559716555|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
155077888|NCT01560988|559716556|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
155077889|NCT01560988|559716555|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
155077890|NCT01560988|559716556|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
155077891|NCT01160744|559716557|FG000|Overall Study|Withdrawal by Subject|11|||
155077892|NCT01160744|559716558|FG001|Overall Study|Withdrawal by Subject|5|||
155077893|NCT01160744|559716559|FG002|Overall Study|Withdrawal by Subject|6|||
155077894|NCT01160744|559716560|FG003|Overall Study|Withdrawal by Subject|4|||
155077895|NCT01160744|559716557|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
155077896|NCT01160744|559716558|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
155077897|NCT01160744|559716559|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
155077898|NCT01160744|559716560|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
155077899|NCT02301429|559716565|FG000|Overall Study|not acceptable vascular anatomy|3|||
155077900|NCT01502072|559716566|FG000|Overall Study|Withdrawal by Subject|1|||
155077901|NCT01502072|559716567|FG001|Overall Study|Withdrawal by Subject|0|||
155077902|NCT01502072|559716568|FG002|Overall Study|Withdrawal by Subject|0|||
155077903|NCT01502072|559716566|FG000|Overall Study|Death|0|||
155077904|NCT01502072|559716567|FG001|Overall Study|Death|1|||
155077905|NCT01502072|559716568|FG002|Overall Study|Death|0|||
155077906|NCT00500110|559716569|FG000|Overall Study|Withdrawal by Subject|3|||
155077907|NCT00605657|559716570|FG000|Overall Study|Adverse Event|1|||
155077908|NCT00605657|559716570|FG000|Overall Study|Protocol Violation|1|||
155077909|NCT04821245|559716571|FG000|Overall Study|Withdrawal by Subject|3|||
155077910|NCT04821245|559716571|FG000|Overall Study|Physician Decision|1|||
155077911|NCT04821245|559716571|FG000|Overall Study|Protocol Violation|5|||
155077912|NCT00397046|559716579|FG000|Overall Study|Disease Progression|3|||
155077913|NCT00397046|559716580|FG001|Overall Study|Disease Progression|3|||
155077914|NCT00397046|559716581|FG002|Overall Study|Disease Progression|10|||
155077915|NCT00397046|559716582|FG003|Overall Study|Disease Progression|5|||
155165101|NCT04163016|560040631|FG002|Treatment|Indeterminate TB-test|0|||
155077916|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
155077917|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
155077918|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
155077919|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
155077920|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
155077921|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
154963747|NCT04589650|559292812|FG003|Overall Study|Physician Decision|0|||
154963748|NCT04589650|559292813|FG004|Overall Study|Physician Decision|0|||
154963749|NCT04589650|559292814|FG005|Overall Study|Physician Decision|0|||
154963750|NCT04589650|559292809|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
154963751|NCT04589650|559292810|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154963752|NCT04589650|559292811|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
154963753|NCT04589650|559292812|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
154963754|NCT04589650|559292813|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
154963755|NCT04589650|559292814|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
154963756|NCT04589650|559292809|FG000|Overall Study|Death|0|||
154963757|NCT04589650|559292810|FG001|Overall Study|Death|0|||
154963758|NCT04589650|559292811|FG002|Overall Study|Death|0|||
154963759|NCT04589650|559292812|FG003|Overall Study|Death|1|||
154963760|NCT04589650|559292813|FG004|Overall Study|Death|0|||
154963761|NCT04589650|559292814|FG005|Overall Study|Death|0|||
155077922|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
155077923|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
155077924|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
154963762|NCT04589650|559292809|FG000|Overall Study|Guardian Decision|0|||
154963763|NCT04589650|559292810|FG001|Overall Study|Guardian Decision|0|||
154963764|NCT04589650|559292811|FG002|Overall Study|Guardian Decision|0|||
154963765|NCT04589650|559292812|FG003|Overall Study|Guardian Decision|1|||
154963766|NCT04589650|559292813|FG004|Overall Study|Guardian Decision|0|||
154963767|NCT04589650|559292814|FG005|Overall Study|Guardian Decision|0|||
154963768|NCT03600376|559292815|FG000|Overall Study|Adverse Event|1|||
154963769|NCT03600376|559292816|FG001|Overall Study|Adverse Event|1|||
154963770|NCT03600376|559292815|FG000|Overall Study|Transferred to other facility|1|||
154963771|NCT03600376|559292816|FG001|Overall Study|Transferred to other facility|0|||
154963772|NCT03600376|559292815|FG000|Overall Study|Investigator Decision|0|||
154963773|NCT03600376|559292816|FG001|Overall Study|Investigator Decision|4|||
154963774|NCT03600376|559292815|FG000|Overall Study|Determined to be ineligible for study|0|||
154963775|NCT03600376|559292816|FG001|Overall Study|Determined to be ineligible for study|1|||
154963776|NCT05655520|559292820|FG000|Overall Study|Adverse Event|2|||
154963777|NCT05655520|559292821|FG001|Overall Study|Adverse Event|3|||
154963778|NCT05655520|559292820|FG000|Overall Study|Physician Decision|2|||
154963779|NCT05655520|559292821|FG001|Overall Study|Physician Decision|0|||
154963780|NCT05655520|559292820|FG000|Overall Study|Non-Compliance with Study Drug|0|||
154963781|NCT05655520|559292821|FG001|Overall Study|Non-Compliance with Study Drug|2|||
154963782|NCT05655520|559292820|FG000|Overall Study|Lost to Follow-up|1|||
154963783|NCT05655520|559292821|FG001|Overall Study|Lost to Follow-up|0|||
154963784|NCT05655520|559292820|FG000|Overall Study|Withdrawal by Subject|4|||
154963785|NCT05655520|559292821|FG001|Overall Study|Withdrawal by Subject|4|||
154963786|NCT05655520|559292820|FG000|Overall Study|Study Terminated by Sponsor|61|||
154963787|NCT05655520|559292821|FG001|Overall Study|Study Terminated by Sponsor|68|||
154963788|NCT03114891|559292824|FG000|First Treatment Round|Lost to Follow-up|0|||
154963789|NCT03114891|559292825|FG001|First Treatment Round|Lost to Follow-up|1|||
154963790|NCT03114891|559292826|FG002|First Treatment Round|Lost to Follow-up|1|||
154963791|NCT03114891|559292827|FG003|First Treatment Round|Lost to Follow-up|0|||
154963792|NCT03114891|559292824|FG000|First Treatment Round|Withdrawal by Subject|0|||
154963793|NCT03114891|559292825|FG001|First Treatment Round|Withdrawal by Subject|2|||
154963794|NCT03114891|559292826|FG002|First Treatment Round|Withdrawal by Subject|0|||
154963795|NCT03114891|559292827|FG003|First Treatment Round|Withdrawal by Subject|1|||
154963796|NCT03114891|559292824|FG000|3 Week Break|Lost to Follow-up|1|||
154963797|NCT03114891|559292825|FG001|3 Week Break|Lost to Follow-up|0|||
155077925|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
155077926|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
155077927|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
155077928|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Other|6|||
154963798|NCT03114891|559292826|FG002|3 Week Break|Lost to Follow-up|0|||
154963799|NCT03114891|559292827|FG003|3 Week Break|Lost to Follow-up|1|||
154963800|NCT03114891|559292824|FG000|3 Week Break|Withdrawal by Subject|0|||
154963801|NCT03114891|559292825|FG001|3 Week Break|Withdrawal by Subject|1|||
154963802|NCT03114891|559292826|FG002|3 Week Break|Withdrawal by Subject|0|||
154963803|NCT03114891|559292827|FG003|3 Week Break|Withdrawal by Subject|0|||
154963804|NCT03114891|559292824|FG000|Second Treatment Round|Lost to Follow-up|1|||
154963805|NCT03114891|559292825|FG001|Second Treatment Round|Lost to Follow-up|0|||
154963806|NCT03114891|559292826|FG002|Second Treatment Round|Lost to Follow-up|0|||
154963807|NCT03114891|559292827|FG003|Second Treatment Round|Lost to Follow-up|0|||
155165102|NCT04163016|560040632|FG003|Treatment|Indeterminate TB-test|1|||
155342595|NCT00636168|560687077|FG000|Treated With Study Drug|No longer meets study criteria|1|||
155342596|NCT00636168|560687078|FG001|Treated With Study Drug|No longer meets study criteria|0|||
155342597|NCT00636168|560687077|FG000|Treated With Study Drug|Other reason|1|||
155342598|NCT00636168|560687078|FG001|Treated With Study Drug|Other reason|3|||
155077929|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Other|3|||
155077930|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Other|0|||
155077931|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
155077932|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155077933|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
155077934|NCT03636269|559716583|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
155077935|NCT03636269|559716584|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
155077936|NCT03636269|559716585|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
155077937|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Adverse Event|0|||
155077938|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Adverse Event|0|||
155077939|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Adverse Event|21|||
155077940|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
155077941|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
155077942|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
155077943|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
155077944|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
155077945|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
155077946|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
155077947|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
155077948|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
155077949|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Administrative|0|||
155077950|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Administrative|0|||
155077951|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Administrative|36|||
155077952|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Other|0|||
155077953|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Other|0|||
155077954|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Other|9|||
155077955|NCT03636269|559716583|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
155077956|NCT03636269|559716584|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
155077957|NCT03636269|559716585|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
155077958|NCT01975285|559716598|FG000|Overall Study|Failed Block and follow up|2|||
155077959|NCT01975285|559716599|FG001|Overall Study|Failed Block and follow up|2|||
155077960|NCT02852434|559716600|FG000|Overall Study|Withdrawal by Subject|0|||
155077961|NCT02852434|559716601|FG001|Overall Study|Withdrawal by Subject|1|||
155077962|NCT02852434|559716600|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
155077963|NCT02852434|559716601|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
155077964|NCT01145222|559716606|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
155077965|NCT01145222|559716607|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
155077966|NCT01145222|559716608|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
155077967|NCT01145222|559716609|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
155077968|NCT01145222|559716606|FG000|Overall Study|Poor bowel preparation|0|||
155077969|NCT01145222|559716607|FG001|Overall Study|Poor bowel preparation|0|||
155077970|NCT01145222|559716608|FG002|Overall Study|Poor bowel preparation|0|||
155077971|NCT01145222|559716609|FG003|Overall Study|Poor bowel preparation|1|||
155077972|NCT00604383|559716610|FG000|Overall Study|Withdrawal by Subject|33|||
155077973|NCT00604383|559716611|FG001|Overall Study|Withdrawal by Subject|31|||
155077974|NCT00604383|559716610|FG000|Overall Study|Lost to Follow-up|24|||
155077975|NCT00604383|559716611|FG001|Overall Study|Lost to Follow-up|19|||
155077976|NCT00604383|559716610|FG000|Overall Study|Death|14|||
155077977|NCT00604383|559716611|FG001|Overall Study|Death|22|||
155077978|NCT00604383|559716610|FG000|Overall Study|Adverse Event|16|||
155077979|NCT00604383|559716611|FG001|Overall Study|Adverse Event|9|||
155077980|NCT00604383|559716610|FG000|Overall Study|Physician Decision|0|||
155077981|NCT00604383|559716611|FG001|Overall Study|Physician Decision|3|||
155077982|NCT01698008|559716612|FG000|Overall Study|Withdrawal by Subject|1|||
155077983|NCT01698008|559716613|FG001|Overall Study|Withdrawal by Subject|2|||
155077984|NCT01011283|559716616|FG000|Overall Study|Adverse Event|4|||
155077985|NCT01011283|559716617|FG001|Overall Study|Adverse Event|2|||
155077986|NCT01011283|559716616|FG000|Overall Study|Progressive Disease|0|||
155077987|NCT01011283|559716617|FG001|Overall Study|Progressive Disease|2|||
155077988|NCT01011283|559716616|FG000|Overall Study|Terminated by Sponsor|5|||
155077989|NCT01011283|559716617|FG001|Overall Study|Terminated by Sponsor|5|||
155077990|NCT01011283|559716616|FG000|Overall Study|Other|2|||
155077991|NCT01011283|559716617|FG001|Overall Study|Other|2|||
155077992|NCT02619812|559716622|FG000|Overall Study|Withdrawal by Subject|0|||
155077993|NCT02619812|559716623|FG001|Overall Study|Withdrawal by Subject|0|||
155342599|NCT00636168|560687077|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
155077994|NCT02619812|559716624|FG002|Overall Study|Withdrawal by Subject|1|||
155077995|NCT02619812|559716625|FG003|Overall Study|Withdrawal by Subject|2|||
155077996|NCT00122187|559716626|FG000|Overall Study|Withdrew because of resource limitations|2|||
155077997|NCT00122187|559716627|FG001|Overall Study|Withdrew because of resource limitations|2|||
155077998|NCT02181738|559716636|FG000|Overall Study|Participant Withdrew Consent|2|||
155077999|NCT02181738|559716637|FG001|Overall Study|Participant Withdrew Consent|1|||
155078000|NCT02181738|559716638|FG002|Overall Study|Participant Withdrew Consent|1|||
155078001|NCT02181738|559716639|FG003|Overall Study|Participant Withdrew Consent|1|||
155078002|NCT02181738|559716636|FG000|Overall Study|Lost to Follow-up|1|||
155078003|NCT02181738|559716637|FG001|Overall Study|Lost to Follow-up|2|||
155078004|NCT02181738|559716638|FG002|Overall Study|Lost to Follow-up|1|||
155078005|NCT02181738|559716639|FG003|Overall Study|Lost to Follow-up|1|||
155078006|NCT02181738|559716636|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
155078007|NCT02181738|559716637|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
155342600|NCT00636168|560687078|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
155342601|NCT00636168|560687077|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
155342602|NCT00636168|560687078|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
155078008|NCT02181738|559716638|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
155078009|NCT02181738|559716639|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
155078010|NCT02181738|559716636|FG000|Overall Study|Poor/Non-Compliance|1|||
155078011|NCT02181738|559716637|FG001|Overall Study|Poor/Non-Compliance|0|||
155342603|NCT00636168|560687077|FG000|Long Term Follow-Up|Death|8|||
155342604|NCT00636168|560687078|FG001|Long Term Follow-Up|Death|9|||
155342605|NCT03541369|560687081|FG000|Overall Study|Death|0|||
155342606|NCT03541369|560687082|FG001|Overall Study|Death|0|||
155342607|NCT03541369|560687083|FG002|Overall Study|Death|0|||
155342608|NCT03541369|560687084|FG003|Overall Study|Death|0|||
155342609|NCT03541369|560687085|FG004|Overall Study|Death|1|||
155342610|NCT03541369|560687086|FG005|Overall Study|Death|1|||
155342611|NCT03541369|560687087|FG006|Overall Study|Death|0|||
155342612|NCT03541369|560687088|FG007|Overall Study|Death|2|||
155342613|NCT03541369|560687089|FG008|Overall Study|Death|1|||
155342614|NCT03541369|560687090|FG009|Overall Study|Death|2|||
155342615|NCT03541369|560687091|FG010|Overall Study|Death|1|||
155342616|NCT03541369|560687092|FG011|Overall Study|Death|0|||
155078012|NCT02181738|559716638|FG002|Overall Study|Poor/Non-Compliance|2|||
155078013|NCT02181738|559716639|FG003|Overall Study|Poor/Non-Compliance|1|||
155078014|NCT02181738|559716636|FG000|Overall Study|Disease Progression|28|||
155078015|NCT02181738|559716637|FG001|Overall Study|Disease Progression|35|||
155078016|NCT02181738|559716638|FG002|Overall Study|Disease Progression|40|||
155078017|NCT02181738|559716639|FG003|Overall Study|Disease Progression|0|||
155078018|NCT02181738|559716636|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
155078019|NCT02181738|559716637|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
155078020|NCT02181738|559716638|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
155078021|NCT02181738|559716639|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
155078022|NCT02181738|559716636|FG000|Overall Study|Study Drug Toxicity|6|||
155078023|NCT02181738|559716637|FG001|Overall Study|Study Drug Toxicity|11|||
155078024|NCT02181738|559716638|FG002|Overall Study|Study Drug Toxicity|8|||
155078025|NCT02181738|559716639|FG003|Overall Study|Study Drug Toxicity|1|||
155078026|NCT02181738|559716636|FG000|Overall Study|Other Reasons|14|||
155078027|NCT02181738|559716637|FG001|Overall Study|Other Reasons|16|||
155078028|NCT02181738|559716638|FG002|Overall Study|Other Reasons|28|||
155078029|NCT02181738|559716639|FG003|Overall Study|Other Reasons|0|||
155078030|NCT02181738|559716636|FG000|Overall Study|Maximum Clinical Benefit|3|||
155078031|NCT02181738|559716637|FG001|Overall Study|Maximum Clinical Benefit|0|||
155078032|NCT02181738|559716638|FG002|Overall Study|Maximum Clinical Benefit|1|||
155078033|NCT02181738|559716639|FG003|Overall Study|Maximum Clinical Benefit|0|||
155078034|NCT02181738|559716636|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155078035|NCT02181738|559716637|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
155078036|NCT02181738|559716638|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155078037|NCT02181738|559716639|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
155078038|NCT00191152|559716640|FG000|Initial Treatment|Adverse Event|43|||
155078039|NCT00191152|559716641|FG001|Initial Treatment|Adverse Event|67|||
155078040|NCT00191152|559716640|FG000|Initial Treatment|Physician Decision|40|||
155078041|NCT00191152|559716641|FG001|Initial Treatment|Physician Decision|31|||
155078042|NCT00191152|559716640|FG000|Initial Treatment|Withdrawal by Subject|40|||
155078043|NCT00191152|559716641|FG001|Initial Treatment|Withdrawal by Subject|28|||
154963808|NCT03114891|559292824|FG000|Second Treatment Round|Physician Decision|1|||
154963809|NCT03114891|559292825|FG001|Second Treatment Round|Physician Decision|0|||
154963810|NCT03114891|559292826|FG002|Second Treatment Round|Physician Decision|0|||
154963811|NCT03114891|559292827|FG003|Second Treatment Round|Physician Decision|0|||
154963812|NCT05710718|559293458|FG000|Overall Study|Withdrawal by Subject|5|||
154963813|NCT05710718|559293459|FG001|Overall Study|Withdrawal by Subject|1|||
154963814|NCT05710718|559293458|FG000|Overall Study|Lost to Follow-up|0|||
154963815|NCT05710718|559293459|FG001|Overall Study|Lost to Follow-up|1|||
154963816|NCT05710718|559293458|FG000|Overall Study|Death|0|||
154963817|NCT05710718|559293459|FG001|Overall Study|Death|1|||
154963818|NCT04372238|559293460|FG000|Overall Study|Duplicate|3|||
155078044|NCT00191152|559716640|FG000|Initial Treatment|Lost to Follow-up|0|||
155078045|NCT00191152|559716641|FG001|Initial Treatment|Lost to Follow-up|6|||
155078046|NCT00191152|559716640|FG000|Initial Treatment|Other|18|||
155078047|NCT00191152|559716641|FG001|Initial Treatment|Other|21|||
155078048|NCT00191152|559716640|FG000|Crossover Treatment|Adverse Event|8|||
155078049|NCT00191152|559716641|FG001|Crossover Treatment|Adverse Event|8|||
155078050|NCT00191152|559716640|FG000|Crossover Treatment|Physician Decision|7|||
154963819|NCT04372238|559293461|FG001|Overall Study|Duplicate|3|||
154963820|NCT04372238|559293460|FG000|Overall Study|Did not consent for data linkage|6|||
154963821|NCT04372238|559293461|FG001|Overall Study|Did not consent for data linkage|10|||
154963822|NCT04241458|559293462|FG000|Overall Study|Withdrawal by Subject|0|||
154963823|NCT04241458|559293463|FG001|Overall Study|Withdrawal by Subject|0|||
154963824|NCT04241458|559293464|FG002|Overall Study|Withdrawal by Subject|0|||
154963825|NCT04241458|559293465|FG003|Overall Study|Withdrawal by Subject|0|||
155078051|NCT00191152|559716641|FG001|Crossover Treatment|Physician Decision|7|||
155078052|NCT00191152|559716640|FG000|Crossover Treatment|Withdrawal by Subject|6|||
154963826|NCT04241458|559293466|FG004|Overall Study|Withdrawal by Subject|1|||
154963827|NCT00334815|559293467|FG000|Overall Study|Adverse Event|3|||
155078053|NCT00191152|559716641|FG001|Crossover Treatment|Withdrawal by Subject|9|||
155078054|NCT00191152|559716640|FG000|Crossover Treatment|Lost to Follow-up|2|||
155078055|NCT00191152|559716641|FG001|Crossover Treatment|Lost to Follow-up|1|||
154963828|NCT00334815|559293468|FG001|Overall Study|Adverse Event|2|||
155078056|NCT00191152|559716640|FG000|Crossover Treatment|Other|4|||
154963829|NCT00334815|559293467|FG000|Overall Study|Death|0|||
154963830|NCT00334815|559293468|FG001|Overall Study|Death|2|||
154963831|NCT00334815|559293467|FG000|Overall Study|Progression|1|||
155078057|NCT00191152|559716641|FG001|Crossover Treatment|Other|3|||
155078058|NCT00114777|559716645|FG000|Randomization to Month 36|Death|10|||
154963832|NCT00334815|559293468|FG001|Overall Study|Progression|0|||
155078059|NCT00114777|559716646|FG001|Randomization to Month 36|Death|4|||
155078060|NCT00114777|559716647|FG002|Randomization to Month 36|Death|3|||
155078061|NCT00114777|559716645|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
155078062|NCT00114777|559716646|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
155078063|NCT00114777|559716647|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
155078064|NCT00114777|559716645|FG000|Randomization to Month 36|Lack of Efficacy|19|||
155078065|NCT00114777|559716646|FG001|Randomization to Month 36|Lack of Efficacy|15|||
155078066|NCT00114777|559716647|FG002|Randomization to Month 36|Lack of Efficacy|17|||
155078067|NCT00114777|559716645|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
155078068|NCT00114777|559716646|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
155078069|NCT00114777|559716647|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
155078070|NCT00114777|559716645|FG000|Randomization to Month 36|Adverse Event|34|||
155078071|NCT00114777|559716646|FG001|Randomization to Month 36|Adverse Event|35|||
155078072|NCT00114777|559716647|FG002|Randomization to Month 36|Adverse Event|44|||
155078073|NCT00114777|559716645|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
155078074|NCT00114777|559716646|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
155078075|NCT00114777|559716647|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
155078076|NCT00114777|559716645|FG000|Randomization to Month 36|Other|9|||
155078077|NCT00114777|559716646|FG001|Randomization to Month 36|Other|3|||
155078078|NCT00114777|559716647|FG002|Randomization to Month 36|Other|12|||
155078079|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Death|8|||
155078080|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Death|13|||
155078081|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Death|7|||
155078082|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
155078083|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
155078084|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
155078085|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
155078086|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
155078087|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
155078088|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
155078089|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
155078090|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
155078091|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
155078092|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
155078093|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
155078094|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
155078095|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
155078096|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
155078097|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
155078098|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
155078099|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
155078100|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
155078101|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
155078102|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
155078103|NCT00114777|559716645|FG000|Long-Term Extension to Month 84|Other|2|||
155078104|NCT00114777|559716646|FG001|Long-Term Extension to Month 84|Other|0|||
155078105|NCT00114777|559716647|FG002|Long-Term Extension to Month 84|Other|2|||
155078106|NCT02280499|559716651|FG000|Overall Study|Death|14|||
155078107|NCT02280499|559716651|FG000|Overall Study|Lost to Follow-up|42|||
155078108|NCT02280499|559716651|FG000|Overall Study|Adverse Event|5|||
155078109|NCT03511066|559716661|FG000|Overall Study|Withdrawal by Subject|1|||
155078110|NCT03511066|559716662|FG001|Overall Study|Withdrawal by Subject|2|||
155078111|NCT03511066|559716663|FG002|Overall Study|Withdrawal by Subject|3|||
155078112|NCT03511066|559716661|FG000|Overall Study|Lost to Follow-up|2|||
155078113|NCT03511066|559716662|FG001|Overall Study|Lost to Follow-up|3|||
155078114|NCT03511066|559716663|FG002|Overall Study|Lost to Follow-up|0|||
155078115|NCT04560309|559716664|FG000|Overall Study|Meet drop out criteria|1|||
155078116|NCT04560309|559716665|FG001|Overall Study|Meet drop out criteria|1|||
155078117|NCT05085405|559716666|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155078118|NCT05085405|559716667|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155078119|NCT05085405|559716668|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
155078120|NCT05085405|559716669|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
155078121|NCT05085405|559716670|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155078122|NCT05085405|559716671|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
155078123|NCT05085405|559716666|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155078124|NCT05085405|559716667|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155078125|NCT05085405|559716668|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155078126|NCT05085405|559716669|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
155078127|NCT05085405|559716670|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155342617|NCT03541369|560687093|FG012|Overall Study|Death|2|||
155078128|NCT05085405|559716671|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
155078129|NCT04146909|559716672|FG000|Overall Study|Withdrawal by Subject|3|||
155078130|NCT04146909|559716672|FG000|Overall Study|Did not qualify after consented|1|||
155078131|NCT01860404|559716673|FG000|Overall Study|Lost to Follow-up|3|||
155078132|NCT01860404|559716674|FG001|Overall Study|Lost to Follow-up|4|||
155078133|NCT01860404|559716675|FG002|Overall Study|Lost to Follow-up|1|||
155078134|NCT01860404|559716676|FG003|Overall Study|Lost to Follow-up|6|||
155078135|NCT01860404|559716677|FG004|Overall Study|Lost to Follow-up|4|||
155078136|NCT01860404|559716673|FG000|Overall Study|Withdrawal by Subject|0|||
155078137|NCT01860404|559716674|FG001|Overall Study|Withdrawal by Subject|0|||
155078138|NCT01860404|559716675|FG002|Overall Study|Withdrawal by Subject|4|||
155078139|NCT01860404|559716676|FG003|Overall Study|Withdrawal by Subject|0|||
155078140|NCT01860404|559716677|FG004|Overall Study|Withdrawal by Subject|0|||
155078141|NCT00356421|559716679|FG000|Overall Study|Lack of Efficacy|3|||
155078142|NCT00356421|559716680|FG001|Overall Study|Lack of Efficacy|0|||
155078143|NCT00356421|559716679|FG000|Overall Study|Withdrawal by Subject|9|||
155078144|NCT00356421|559716680|FG001|Overall Study|Withdrawal by Subject|2|||
155078145|NCT00356421|559716679|FG000|Overall Study|Related to study drug|15|||
155078146|NCT00356421|559716680|FG001|Overall Study|Related to study drug|12|||
155078147|NCT00356421|559716679|FG000|Overall Study|Not related to study drug|5|||
155078148|NCT00356421|559716680|FG001|Overall Study|Not related to study drug|3|||
155078149|NCT00663351|559716681|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
155078150|NCT00663351|559716682|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
155078151|NCT00663351|559716681|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
155078152|NCT00663351|559716682|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
155078153|NCT00663351|559716681|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
155078154|NCT00663351|559716682|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
155078155|NCT00663351|559716681|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
155078156|NCT00663351|559716682|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
155078157|NCT00663351|559716681|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
155078158|NCT00663351|559716682|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
155078159|NCT00663351|559716681|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
155078160|NCT00663351|559716682|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
155078161|NCT03336866|559716683|FG000|Overall Study|Lost to Follow-up|2|||
155078162|NCT03336866|559716684|FG001|Overall Study|Lost to Follow-up|0|||
155078163|NCT03336866|559716685|FG002|Overall Study|Lost to Follow-up|3|||
155078164|NCT03336866|559716683|FG000|Overall Study|Withdrawal by Subject|1|||
155078165|NCT03336866|559716684|FG001|Overall Study|Withdrawal by Subject|1|||
155078166|NCT03336866|559716685|FG002|Overall Study|Withdrawal by Subject|0|||
155078167|NCT03336866|559716683|FG000|Overall Study|Noncompliance with clinic house rules|0|||
155078168|NCT03336866|559716684|FG001|Overall Study|Noncompliance with clinic house rules|0|||
155078169|NCT03336866|559716685|FG002|Overall Study|Noncompliance with clinic house rules|1|||
155078170|NCT03462563|559716686|FG000|Overall Study|Death|1|||
155078171|NCT03462563|559716687|FG001|Overall Study|Death|1|||
155078172|NCT03462563|559716686|FG000|Overall Study|Termination of study|2|||
155078173|NCT03462563|559716687|FG001|Overall Study|Termination of study|1|||
155078174|NCT03462563|559716686|FG000|Overall Study|Adverse Event|1|||
155078175|NCT03462563|559716687|FG001|Overall Study|Adverse Event|3|||
155078176|NCT03462563|559716686|FG000|Overall Study|Unspecified reason|10|||
155078177|NCT03462563|559716687|FG001|Overall Study|Unspecified reason|12|||
155078178|NCT03462563|559716686|FG000|Overall Study|Physician Decision|1|||
155078179|NCT03462563|559716687|FG001|Overall Study|Physician Decision|0|||
155078180|NCT03011372|559716690|FG000|Overall Study|Death|16|||
155078181|NCT03011372|559716690|FG000|Overall Study|Lost to Follow-up|2|||
155078182|NCT03011372|559716690|FG000|Overall Study|Sponsor Decision|17|||
155078183|NCT03011372|559716690|FG000|Overall Study|Withdrawal by Subject|7|||
155078184|NCT03011372|559716690|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
155078185|NCT03011372|559716690|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
155078186|NCT03011372|559716690|FG000|Overall Study|Sponsor's Decision|2|||
155078187|NCT03738215|559716691|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155078188|NCT03738215|559716692|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
155078189|NCT03738215|559716693|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155078190|NCT03738215|559716691|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
155342618|NCT03541369|560687094|FG013|Overall Study|Death|1|||
155342619|NCT03541369|560687095|FG014|Overall Study|Death|1|||
155342620|NCT03541369|560687096|FG015|Overall Study|Death|1|||
155342621|NCT03541369|560687097|FG016|Overall Study|Death|0|||
155342622|NCT03541369|560687098|FG017|Overall Study|Death|1|||
155342623|NCT03541369|560687081|FG000|Overall Study|Decision by sponsor|0|||
155342624|NCT03541369|560687082|FG001|Overall Study|Decision by sponsor|0|||
155342625|NCT03541369|560687083|FG002|Overall Study|Decision by sponsor|0|||
155342626|NCT03541369|560687084|FG003|Overall Study|Decision by sponsor|1|||
155342627|NCT03541369|560687085|FG004|Overall Study|Decision by sponsor|0|||
155342628|NCT03541369|560687086|FG005|Overall Study|Decision by sponsor|2|||
155078191|NCT03738215|559716692|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
155078192|NCT03738215|559716693|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155078193|NCT03738215|559716691|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
155078194|NCT03738215|559716692|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
155078195|NCT03738215|559716693|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
155078196|NCT03738215|559716691|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
155078197|NCT03738215|559716692|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
155078198|NCT03738215|559716693|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
155078199|NCT03738215|559716691|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
155078200|NCT03738215|559716692|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
155078201|NCT03738215|559716693|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
155078202|NCT03738215|559716691|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
155078203|NCT03738215|559716692|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
155078204|NCT03738215|559716693|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
155078205|NCT03738215|559716691|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
155078206|NCT03738215|559716692|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
155078207|NCT03738215|559716693|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
155078208|NCT03738215|559716691|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
155342629|NCT03541369|560687087|FG006|Overall Study|Decision by sponsor|0|||
154963833|NCT00334815|559293467|FG000|Overall Study|ineligible|1|||
155342630|NCT03541369|560687088|FG007|Overall Study|Decision by sponsor|1|||
155342631|NCT03541369|560687089|FG008|Overall Study|Decision by sponsor|2|||
155342632|NCT03541369|560687090|FG009|Overall Study|Decision by sponsor|0|||
155342633|NCT03541369|560687091|FG010|Overall Study|Decision by sponsor|0|||
155342634|NCT03541369|560687092|FG011|Overall Study|Decision by sponsor|0|||
155342635|NCT03541369|560687093|FG012|Overall Study|Decision by sponsor|2|||
155342636|NCT03541369|560687094|FG013|Overall Study|Decision by sponsor|2|||
155342637|NCT03541369|560687095|FG014|Overall Study|Decision by sponsor|0|||
155342638|NCT03541369|560687096|FG015|Overall Study|Decision by sponsor|1|||
155342639|NCT03541369|560687097|FG016|Overall Study|Decision by sponsor|1|||
155342640|NCT03541369|560687098|FG017|Overall Study|Decision by sponsor|1|||
155342641|NCT03541369|560687081|FG000|Overall Study|Withdrawal by Subject|0|||
155342642|NCT03541369|560687082|FG001|Overall Study|Withdrawal by Subject|0|||
155342643|NCT03541369|560687083|FG002|Overall Study|Withdrawal by Subject|0|||
155342644|NCT03541369|560687084|FG003|Overall Study|Withdrawal by Subject|0|||
155342645|NCT03541369|560687085|FG004|Overall Study|Withdrawal by Subject|0|||
155342646|NCT03541369|560687086|FG005|Overall Study|Withdrawal by Subject|0|||
155342647|NCT03541369|560687087|FG006|Overall Study|Withdrawal by Subject|1|||
155342648|NCT03541369|560687088|FG007|Overall Study|Withdrawal by Subject|0|||
155342649|NCT03541369|560687089|FG008|Overall Study|Withdrawal by Subject|0|||
155342650|NCT03541369|560687090|FG009|Overall Study|Withdrawal by Subject|0|||
155342651|NCT03541369|560687091|FG010|Overall Study|Withdrawal by Subject|0|||
155342652|NCT03541369|560687092|FG011|Overall Study|Withdrawal by Subject|1|||
155342653|NCT03541369|560687093|FG012|Overall Study|Withdrawal by Subject|0|||
155342654|NCT03541369|560687094|FG013|Overall Study|Withdrawal by Subject|0|||
155342655|NCT03541369|560687095|FG014|Overall Study|Withdrawal by Subject|3|||
155342656|NCT03541369|560687096|FG015|Overall Study|Withdrawal by Subject|0|||
155342657|NCT03541369|560687097|FG016|Overall Study|Withdrawal by Subject|4|||
155342658|NCT03541369|560687098|FG017|Overall Study|Withdrawal by Subject|2|||
155342659|NCT03541369|560687081|FG000|Overall Study|Lost to Follow-up|0|||
155342660|NCT03541369|560687082|FG001|Overall Study|Lost to Follow-up|0|||
155342661|NCT03541369|560687083|FG002|Overall Study|Lost to Follow-up|0|||
155342662|NCT03541369|560687084|FG003|Overall Study|Lost to Follow-up|0|||
155342663|NCT03541369|560687085|FG004|Overall Study|Lost to Follow-up|1|||
155342664|NCT03541369|560687086|FG005|Overall Study|Lost to Follow-up|0|||
155342665|NCT03541369|560687087|FG006|Overall Study|Lost to Follow-up|0|||
155342666|NCT03541369|560687088|FG007|Overall Study|Lost to Follow-up|0|||
155342667|NCT03541369|560687089|FG008|Overall Study|Lost to Follow-up|1|||
155342668|NCT03541369|560687090|FG009|Overall Study|Lost to Follow-up|0|||
155342669|NCT03541369|560687091|FG010|Overall Study|Lost to Follow-up|0|||
155342670|NCT03541369|560687092|FG011|Overall Study|Lost to Follow-up|0|||
155342671|NCT03541369|560687093|FG012|Overall Study|Lost to Follow-up|1|||
155342672|NCT03541369|560687094|FG013|Overall Study|Lost to Follow-up|0|||
155342673|NCT03541369|560687095|FG014|Overall Study|Lost to Follow-up|0|||
155342674|NCT03541369|560687096|FG015|Overall Study|Lost to Follow-up|0|||
155342675|NCT03541369|560687097|FG016|Overall Study|Lost to Follow-up|0|||
155342676|NCT03541369|560687098|FG017|Overall Study|Lost to Follow-up|0|||
155342677|NCT01856569|560687099|FG000|Overall Study|Other|1|||
155342678|NCT01856569|560687099|FG000|Overall Study|Changed Site/Structure|1|||
155342679|NCT01856569|560687099|FG000|Overall Study|Lost to Follow-up|3|||
155342680|NCT01856569|560687099|FG000|Overall Study|Did not met inclusion criteria|8|||
155342681|NCT02707952|560687100|FG000|Overall Study|Adverse Event|1|||
155342682|NCT02707952|560687101|FG001|Overall Study|Adverse Event|0|||
154963834|NCT00334815|559293468|FG001|Overall Study|ineligible|1|||
154963835|NCT00334815|559293467|FG000|Overall Study|patient refused treatment|0|||
154963836|NCT00334815|559293468|FG001|Overall Study|patient refused treatment|1|||
154963837|NCT00334815|559293467|FG000|Overall Study|Physician Decision|2|||
154963838|NCT00334815|559293468|FG001|Overall Study|Physician Decision|4|||
154963839|NCT05919823|559293469|FG000|Pre-Treatment Period|Screen failure|1|||
154963840|NCT05919823|559293470|FG001|Pre-Treatment Period|Screen failure|0|||
154963841|NCT05919823|559293471|FG002|Pre-Treatment Period|Screen failure|0|||
154963842|NCT05919823|559293472|FG003|Pre-Treatment Period|Screen failure|0|||
154963843|NCT05919823|559293469|FG000|Pre-Treatment Period|Protocol Violation|0|||
154963844|NCT05919823|559293470|FG001|Pre-Treatment Period|Protocol Violation|1|||
154963845|NCT05919823|559293471|FG002|Pre-Treatment Period|Protocol Violation|0|||
154963846|NCT05919823|559293472|FG003|Pre-Treatment Period|Protocol Violation|0|||
154963847|NCT05919823|559293469|FG000|Double-Blind Period|Adverse Event|8|||
154963848|NCT05919823|559293470|FG001|Double-Blind Period|Adverse Event|9|||
154963849|NCT05919823|559293471|FG002|Double-Blind Period|Adverse Event|0|||
154963850|NCT05919823|559293472|FG003|Double-Blind Period|Adverse Event|0|||
154963851|NCT05919823|559293469|FG000|Double-Blind Period|Protocol Violation|2|||
154963852|NCT05919823|559293470|FG001|Double-Blind Period|Protocol Violation|1|||
154963853|NCT05919823|559293471|FG002|Double-Blind Period|Protocol Violation|0|||
154963854|NCT05919823|559293472|FG003|Double-Blind Period|Protocol Violation|0|||
154963855|NCT05919823|559293469|FG000|Double-Blind Period|Participant withdrew consent|11|||
154963856|NCT05919823|559293470|FG001|Double-Blind Period|Participant withdrew consent|7|||
154963857|NCT05919823|559293471|FG002|Double-Blind Period|Participant withdrew consent|0|||
154963858|NCT05919823|559293472|FG003|Double-Blind Period|Participant withdrew consent|0|||
154963859|NCT05919823|559293469|FG000|Double-Blind Period|Other reasons|2|||
154963860|NCT05919823|559293470|FG001|Double-Blind Period|Other reasons|3|||
154963861|NCT05919823|559293471|FG002|Double-Blind Period|Other reasons|0|||
154963862|NCT05919823|559293472|FG003|Double-Blind Period|Other reasons|0|||
154963863|NCT05919823|559293469|FG000|Open Label Period|Adverse Event|0|||
154963864|NCT05919823|559293470|FG001|Open Label Period|Adverse Event|0|||
154963865|NCT05919823|559293471|FG002|Open Label Period|Adverse Event|2|||
154963866|NCT05919823|559293472|FG003|Open Label Period|Adverse Event|4|||
154963867|NCT05919823|559293469|FG000|Open Label Period|Lost to Follow-up|0|||
154963868|NCT05919823|559293470|FG001|Open Label Period|Lost to Follow-up|0|||
154963869|NCT05919823|559293471|FG002|Open Label Period|Lost to Follow-up|1|||
154963870|NCT05919823|559293472|FG003|Open Label Period|Lost to Follow-up|0|||
154963871|NCT05919823|559293469|FG000|Open Label Period|Protocol Violation|0|||
154963872|NCT05919823|559293470|FG001|Open Label Period|Protocol Violation|0|||
154963873|NCT05919823|559293471|FG002|Open Label Period|Protocol Violation|0|||
154963874|NCT05919823|559293472|FG003|Open Label Period|Protocol Violation|1|||
154963875|NCT05919823|559293469|FG000|Open Label Period|Participant withdrew consent|0|||
154963876|NCT05919823|559293470|FG001|Open Label Period|Participant withdrew consent|0|||
154963877|NCT05919823|559293471|FG002|Open Label Period|Participant withdrew consent|8|||
154963878|NCT05919823|559293472|FG003|Open Label Period|Participant withdrew consent|6|||
154963879|NCT05919823|559293469|FG000|Open Label Period|Death|0|||
154963880|NCT05919823|559293470|FG001|Open Label Period|Death|0|||
154963881|NCT05919823|559293471|FG002|Open Label Period|Death|0|||
154963882|NCT05919823|559293472|FG003|Open Label Period|Death|1|||
154963883|NCT05919823|559293469|FG000|Open Label Period|Other reasons|0|||
154963884|NCT05919823|559293470|FG001|Open Label Period|Other reasons|0|||
154963885|NCT05919823|559293471|FG002|Open Label Period|Other reasons|9|||
154963886|NCT05919823|559293472|FG003|Open Label Period|Other reasons|5|||
154963887|NCT02294981|559293477|FG000|Overall Study|Lost to Follow-up|1|||
154963888|NCT00909753|559293480|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
154963889|NCT00909753|559293481|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
154963890|NCT00909753|559293480|FG000|Period: Second Intervention|Protocol Violation|1|||
154963891|NCT00909753|559293481|FG001|Period: Second Intervention|Protocol Violation|0|||
154963892|NCT00424047|559293488|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
154963893|NCT00424047|559293489|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
154963894|NCT00424047|559293488|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
154963895|NCT00424047|559293489|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
154963896|NCT00424047|559293488|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
154963897|NCT00424047|559293489|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
154963898|NCT00424047|559293488|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
154963899|NCT00424047|559293489|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
154963900|NCT00424047|559293488|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
155078209|NCT03738215|559716692|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
155078210|NCT03738215|559716693|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
155078211|NCT03738215|559716691|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
155078212|NCT03738215|559716692|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
155078213|NCT03738215|559716693|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
155078214|NCT03738215|559716691|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
155078215|NCT03738215|559716692|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
155078216|NCT03738215|559716693|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
155078217|NCT01567085|559718452|FG000|Overall Study|Death|6|||
155078218|NCT01567085|559718452|FG000|Overall Study|Adverse Event|6|||
155165103|NCT04163016|560040629|FG000|Treatment|Participant did not want to continue in study|0|||
155165104|NCT04163016|560040630|FG001|Treatment|Participant did not want to continue in study|0|||
155165105|NCT04163016|560040631|FG002|Treatment|Participant did not want to continue in study|0|||
155165106|NCT04163016|560040632|FG003|Treatment|Participant did not want to continue in study|1|||
155165107|NCT04193189|560040633|FG000|Overall Study|Lost to Follow-up|9|||
155165108|NCT04193189|560040634|FG001|Overall Study|Lost to Follow-up|7|||
155165109|NCT04193189|560040635|FG002|Overall Study|Lost to Follow-up|9|||
155165110|NCT04193189|560040636|FG003|Overall Study|Lost to Follow-up|0|||
155165111|NCT04193189|560040633|FG000|Overall Study|Withdrawal by Subject|1|||
155165112|NCT04193189|560040634|FG001|Overall Study|Withdrawal by Subject|2|||
155165113|NCT04193189|560040635|FG002|Overall Study|Withdrawal by Subject|2|||
155165114|NCT04193189|560040636|FG003|Overall Study|Withdrawal by Subject|0|||
155078219|NCT01567085|559718452|FG000|Overall Study|Lost to Follow-up|3|||
155078220|NCT01567085|559718452|FG000|Overall Study|Graft loss|2|||
155078221|NCT01567085|559718452|FG000|Overall Study|Renal transplantectomy|1|||
155078222|NCT01567085|559718452|FG000|Overall Study|Returned to chronic dialysis|1|||
155078223|NCT01567085|559718452|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
155165115|NCT04193189|560040633|FG000|Overall Study|Death|1|||
155165116|NCT04193189|560040634|FG001|Overall Study|Death|1|||
155165117|NCT04193189|560040635|FG002|Overall Study|Death|0|||
155165118|NCT04193189|560040636|FG003|Overall Study|Death|0|||
155165119|NCT04193189|560040633|FG000|Overall Study|Protocol Violation|0|||
155165120|NCT04193189|560040634|FG001|Overall Study|Protocol Violation|0|||
155165121|NCT04193189|560040635|FG002|Overall Study|Protocol Violation|0|||
155165122|NCT04193189|560040636|FG003|Overall Study|Protocol Violation|1|||
155165123|NCT01006291|560041872|FG000|Overall Study|Adverse Event|2|||
155165124|NCT01006291|560041873|FG001|Overall Study|Adverse Event|1|||
155165125|NCT01006291|560041874|FG002|Overall Study|Adverse Event|2|||
155165126|NCT01006291|560041872|FG000|Overall Study|Lack of Efficacy|2|||
155165127|NCT01006291|560041873|FG001|Overall Study|Lack of Efficacy|2|||
155165128|NCT01006291|560041874|FG002|Overall Study|Lack of Efficacy|1|||
155165129|NCT01006291|560041872|FG000|Overall Study|Protocol Violation|3|||
155165130|NCT01006291|560041873|FG001|Overall Study|Protocol Violation|3|||
155165131|NCT01006291|560041874|FG002|Overall Study|Protocol Violation|3|||
155165132|NCT01006291|560041872|FG000|Overall Study|Withdrawal criteria|5|||
155165133|NCT01006291|560041873|FG001|Overall Study|Withdrawal criteria|4|||
155165134|NCT01006291|560041874|FG002|Overall Study|Withdrawal criteria|4|||
155165135|NCT01006291|560041872|FG000|Overall Study|Other|14|||
155165136|NCT01006291|560041873|FG001|Overall Study|Other|14|||
155165137|NCT01006291|560041874|FG002|Overall Study|Other|17|||
155165138|NCT03544333|560041881|FG000|Overall Study|Withdrawal by Subject|1|||
155165139|NCT03544333|560041882|FG001|Overall Study|Withdrawal by Subject|0|||
155165140|NCT00808080|560041886|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
155165141|NCT00423917|560041887|FG000|Overall Study|Cancel|2|||
155165142|NCT00423917|560041887|FG000|Overall Study|Ineligible|1|||
155078224|NCT00284934|559718465|FG000|Overall Study|Adverse Event|1|||
155078225|NCT00284934|559718466|FG001|Overall Study|Adverse Event|2|||
155078226|NCT00284934|559718465|FG000|Overall Study|Other reasons|3|||
155078227|NCT00284934|559718466|FG001|Overall Study|Other reasons|1|||
155078228|NCT00454142|559718467|FG000|Overall Study|Withdrawal by Subject|1|||
155078229|NCT01245751|559718471|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
155078230|NCT01245751|559718472|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
155078231|NCT01245751|559718473|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
155078232|NCT01245751|559718474|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
155078233|NCT01245751|559718471|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
155078234|NCT01245751|559718472|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
155078235|NCT01245751|559718473|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
155078236|NCT01245751|559718474|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
155165143|NCT01837823|560041888|FG000|Overall Study|Lost to Follow-up|6|||
155165144|NCT03052400|560041889|FG000|Overall Study|Lost to Follow-up|1|||
155165145|NCT03052400|560041890|FG001|Overall Study|Lost to Follow-up|0|||
155078237|NCT01245751|559718471|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
155078238|NCT01245751|559718472|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
155078239|NCT01245751|559718473|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
155078240|NCT01245751|559718474|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
155165146|NCT03052400|560041889|FG000|Overall Study|Withdrawal by Subject|0|||
155165147|NCT03052400|560041890|FG001|Overall Study|Withdrawal by Subject|1|||
155165148|NCT00555061|560041891|FG000|Overall Study|Adverse Event|3|||
155165149|NCT00555061|560041891|FG000|Overall Study|Protocol Violation|1|||
155165150|NCT00555061|560041891|FG000|Overall Study|Lost to Follow-up|2|||
155165151|NCT00555061|560041891|FG000|Overall Study|Withdrawal by Subject|2|||
155165152|NCT00555061|560041891|FG000|Overall Study|Participant enrolled, but never treated|1|||
155165153|NCT00475306|560041892|FG000|Overall Study|Protocol Violation|1|||
155078241|NCT01783015|559718477|FG000|Blinded Treatment|Adverse Event|0|||
155078242|NCT01783015|559718478|FG001|Blinded Treatment|Adverse Event|1|||
155078243|NCT01783015|559718479|FG002|Blinded Treatment|Adverse Event|0|||
155078244|NCT01783015|559718477|FG000|Blinded Treatment|Protocol Violation|0|||
155078245|NCT01783015|559718478|FG001|Blinded Treatment|Protocol Violation|1|||
155078246|NCT01783015|559718479|FG002|Blinded Treatment|Protocol Violation|0|||
155078247|NCT01783015|559718477|FG000|Blinded Treatment|Withdrawal by Subject|0|||
155078248|NCT01783015|559718478|FG001|Blinded Treatment|Withdrawal by Subject|1|||
155078249|NCT01783015|559718479|FG002|Blinded Treatment|Withdrawal by Subject|0|||
155078250|NCT01783015|559718477|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
155078251|NCT01783015|559718478|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
155078252|NCT01783015|559718479|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
155078253|NCT01783015|559718477|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
155078254|NCT01783015|559718478|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
155078255|NCT01783015|559718479|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
155078256|NCT00504556|559718480|FG000|Overall Study|Adverse Event|11|||
155078257|NCT00504556|559718481|FG001|Overall Study|Adverse Event|11|||
155078258|NCT00504556|559718482|FG002|Overall Study|Adverse Event|14|||
155078259|NCT00504556|559718483|FG003|Overall Study|Adverse Event|13|||
155078260|NCT00504556|559718484|FG004|Overall Study|Adverse Event|5|||
155078261|NCT00504556|559718480|FG000|Overall Study|Death|3|||
155078262|NCT00504556|559718481|FG001|Overall Study|Death|3|||
155078263|NCT00504556|559718482|FG002|Overall Study|Death|1|||
155078264|NCT00504556|559718483|FG003|Overall Study|Death|0|||
155078265|NCT00504556|559718484|FG004|Overall Study|Death|2|||
155078266|NCT00504556|559718480|FG000|Overall Study|Protocol Violation|1|||
155078267|NCT00504556|559718481|FG001|Overall Study|Protocol Violation|3|||
155078268|NCT00504556|559718482|FG002|Overall Study|Protocol Violation|2|||
155078269|NCT00504556|559718483|FG003|Overall Study|Protocol Violation|1|||
155078270|NCT00504556|559718484|FG004|Overall Study|Protocol Violation|2|||
155078271|NCT00504556|559718480|FG000|Overall Study|Lost to Follow-up|0|||
155078272|NCT00504556|559718481|FG001|Overall Study|Lost to Follow-up|0|||
155078273|NCT00504556|559718482|FG002|Overall Study|Lost to Follow-up|1|||
155078274|NCT00504556|559718483|FG003|Overall Study|Lost to Follow-up|1|||
155078275|NCT00504556|559718484|FG004|Overall Study|Lost to Follow-up|1|||
155078276|NCT00504556|559718480|FG000|Overall Study|Withdrawal by Subject|16|||
155078277|NCT00504556|559718481|FG001|Overall Study|Withdrawal by Subject|16|||
155078278|NCT00504556|559718482|FG002|Overall Study|Withdrawal by Subject|7|||
155078279|NCT00504556|559718483|FG003|Overall Study|Withdrawal by Subject|8|||
155078280|NCT00504556|559718484|FG004|Overall Study|Withdrawal by Subject|12|||
155078281|NCT00504556|559718480|FG000|Overall Study|administrative reasons|0|||
155078282|NCT00504556|559718481|FG001|Overall Study|administrative reasons|2|||
155078283|NCT00504556|559718482|FG002|Overall Study|administrative reasons|2|||
155078284|NCT00504556|559718483|FG003|Overall Study|administrative reasons|1|||
155078285|NCT00504556|559718484|FG004|Overall Study|administrative reasons|2|||
155078286|NCT00504556|559718480|FG000|Overall Study|did not meet entry criteria|2|||
155078287|NCT00504556|559718481|FG001|Overall Study|did not meet entry criteria|0|||
155078288|NCT00504556|559718482|FG002|Overall Study|did not meet entry criteria|1|||
155078289|NCT00504556|559718483|FG003|Overall Study|did not meet entry criteria|1|||
155078290|NCT00504556|559718484|FG004|Overall Study|did not meet entry criteria|0|||
155078291|NCT00504556|559718480|FG000|Overall Study|data monitor committee decision|0|||
155078292|NCT00504556|559718481|FG001|Overall Study|data monitor committee decision|0|||
155078293|NCT00504556|559718482|FG002|Overall Study|data monitor committee decision|0|||
155078294|NCT00504556|559718483|FG003|Overall Study|data monitor committee decision|100|||
155078295|NCT00504556|559718484|FG004|Overall Study|data monitor committee decision|0|||
155078296|NCT00504556|559718480|FG000|Overall Study|Other|2|||
155078297|NCT00504556|559718481|FG001|Overall Study|Other|2|||
155078298|NCT00504556|559718482|FG002|Overall Study|Other|2|||
155078299|NCT00504556|559718483|FG003|Overall Study|Other|3|||
155078300|NCT00504556|559718484|FG004|Overall Study|Other|0|||
155078301|NCT00504556|559718480|FG000|Overall Study|not in safety analysis set|0|||
155078302|NCT00504556|559718481|FG001|Overall Study|not in safety analysis set|1|||
155078303|NCT00504556|559718482|FG002|Overall Study|not in safety analysis set|1|||
155078304|NCT00504556|559718483|FG003|Overall Study|not in safety analysis set|0|||
155078305|NCT00504556|559718484|FG004|Overall Study|not in safety analysis set|1|||
155078306|NCT03607695|559718485|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
155078307|NCT03607695|559718485|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
155078308|NCT02741193|559718486|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
155078309|NCT02741193|559718486|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
155078310|NCT02502383|559718489|FG000|Overall Study|Lost to Follow-up|130|||
155078311|NCT02502383|559718490|FG001|Overall Study|Lost to Follow-up|131|||
155078312|NCT02502383|559718489|FG000|Overall Study|Withdrawal by Subject|31|||
155078313|NCT02502383|559718490|FG001|Overall Study|Withdrawal by Subject|24|||
155078314|NCT00676052|559718492|FG000|Overall Study|Adverse Event|0|||
155078315|NCT00676052|559718493|FG001|Overall Study|Adverse Event|1|||
155078316|NCT00676052|559718494|FG002|Overall Study|Adverse Event|1|||
155078317|NCT00676052|559718495|FG003|Overall Study|Adverse Event|2|||
155078318|NCT00676052|559718496|FG004|Overall Study|Adverse Event|2|||
155078319|NCT00676052|559718497|FG005|Overall Study|Adverse Event|2|||
155078320|NCT00676052|559718492|FG000|Overall Study|Lack of Efficacy|2|||
155078321|NCT00676052|559718493|FG001|Overall Study|Lack of Efficacy|2|||
155078322|NCT00676052|559718494|FG002|Overall Study|Lack of Efficacy|1|||
155078323|NCT00676052|559718495|FG003|Overall Study|Lack of Efficacy|1|||
155078324|NCT00676052|559718496|FG004|Overall Study|Lack of Efficacy|2|||
155078325|NCT00676052|559718497|FG005|Overall Study|Lack of Efficacy|1|||
155078326|NCT00676052|559718492|FG000|Overall Study|Protocol Violation|5|||
155078327|NCT00676052|559718493|FG001|Overall Study|Protocol Violation|3|||
155078328|NCT00676052|559718494|FG002|Overall Study|Protocol Violation|2|||
155078329|NCT00676052|559718495|FG003|Overall Study|Protocol Violation|2|||
155078330|NCT00676052|559718496|FG004|Overall Study|Protocol Violation|1|||
155078331|NCT00676052|559718497|FG005|Overall Study|Protocol Violation|2|||
155078332|NCT00676052|559718492|FG000|Overall Study|Lost to Follow-up|0|||
155078333|NCT00676052|559718493|FG001|Overall Study|Lost to Follow-up|0|||
155078334|NCT00676052|559718494|FG002|Overall Study|Lost to Follow-up|0|||
155078335|NCT00676052|559718495|FG003|Overall Study|Lost to Follow-up|0|||
155078336|NCT00676052|559718496|FG004|Overall Study|Lost to Follow-up|1|||
155078337|NCT00676052|559718497|FG005|Overall Study|Lost to Follow-up|0|||
155078338|NCT00676052|559718492|FG000|Overall Study|Physician Decision|1|||
155078339|NCT00676052|559718493|FG001|Overall Study|Physician Decision|1|||
155078340|NCT00676052|559718494|FG002|Overall Study|Physician Decision|1|||
155078341|NCT00676052|559718495|FG003|Overall Study|Physician Decision|0|||
155078342|NCT00676052|559718496|FG004|Overall Study|Physician Decision|0|||
155078343|NCT00676052|559718497|FG005|Overall Study|Physician Decision|1|||
155078344|NCT00676052|559718492|FG000|Overall Study|Withdrawal by Subject|1|||
155078345|NCT00676052|559718493|FG001|Overall Study|Withdrawal by Subject|0|||
155078346|NCT00676052|559718494|FG002|Overall Study|Withdrawal by Subject|1|||
155078347|NCT00676052|559718495|FG003|Overall Study|Withdrawal by Subject|0|||
155078348|NCT00676052|559718496|FG004|Overall Study|Withdrawal by Subject|0|||
155078349|NCT00676052|559718497|FG005|Overall Study|Withdrawal by Subject|0|||
155078350|NCT02930941|559718498|FG000|Overall Study|Lost to Follow-up|1|||
155078351|NCT02930941|559718499|FG001|Overall Study|Lost to Follow-up|2|||
155078352|NCT00527748|559718512|FG000|Overall Study|Other|3|||
155078353|NCT00710554|559718513|FG000|Overall Study|Adverse Event|24|||
155078354|NCT00710554|559718514|FG001|Overall Study|Adverse Event|7|||
155078355|NCT00710554|559718513|FG000|Overall Study|Withdrawal by Subject|7|||
155078356|NCT00710554|559718514|FG001|Overall Study|Withdrawal by Subject|3|||
155078357|NCT00710554|559718513|FG000|Overall Study|Lost to Follow-up|7|||
155078358|NCT00710554|559718514|FG001|Overall Study|Lost to Follow-up|1|||
155078359|NCT00710554|559718513|FG000|Overall Study|Lack of Efficacy|11|||
155078360|NCT00710554|559718514|FG001|Overall Study|Lack of Efficacy|12|||
155078361|NCT00710554|559718513|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
155078362|NCT00710554|559718514|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
155078363|NCT01346709|559718515|FG000|Overall Study|Protocol Violation|35|||
155078364|NCT01346709|559718515|FG000|Overall Study|Lost to Follow-up|31|||
155078365|NCT01346709|559718515|FG000|Overall Study|Missing data in candidate risk factor|285|||
155078366|NCT02421510|559718530|FG000|Overall Study|Other|4|||
155078367|NCT02421510|559718531|FG001|Overall Study|Other|2|||
155078368|NCT02421510|559718532|FG002|Overall Study|Other|3|||
155078369|NCT02421510|559718530|FG000|Overall Study|Protocol Violation|1|||
155078370|NCT02421510|559718531|FG001|Overall Study|Protocol Violation|2|||
155078371|NCT02421510|559718532|FG002|Overall Study|Protocol Violation|0|||
155078372|NCT02421510|559718530|FG000|Overall Study|Death|1|||
155078373|NCT02421510|559718531|FG001|Overall Study|Death|0|||
155078374|NCT02421510|559718532|FG002|Overall Study|Death|0|||
155078375|NCT02421510|559718530|FG000|Overall Study|Noncompliance with study drug|1|||
155078376|NCT02421510|559718531|FG001|Overall Study|Noncompliance with study drug|0|||
155078377|NCT02421510|559718532|FG002|Overall Study|Noncompliance with study drug|0|||
155078378|NCT02421510|559718530|FG000|Overall Study|Physician Decision|1|||
155078379|NCT02421510|559718531|FG001|Overall Study|Physician Decision|1|||
155078380|NCT02421510|559718532|FG002|Overall Study|Physician Decision|3|||
155078381|NCT02421510|559718530|FG000|Overall Study|Adverse Event|9|||
155078382|NCT02421510|559718531|FG001|Overall Study|Adverse Event|10|||
155078383|NCT02421510|559718532|FG002|Overall Study|Adverse Event|18|||
155078384|NCT02421510|559718530|FG000|Overall Study|Pregnancy|1|||
155078385|NCT02421510|559718531|FG001|Overall Study|Pregnancy|1|||
155078386|NCT02421510|559718532|FG002|Overall Study|Pregnancy|0|||
155078387|NCT02421510|559718530|FG000|Overall Study|Withdrawal by Subject|14|||
155078388|NCT02421510|559718531|FG001|Overall Study|Withdrawal by Subject|18|||
155078389|NCT02421510|559718532|FG002|Overall Study|Withdrawal by Subject|12|||
155078390|NCT02421510|559718530|FG000|Overall Study|Lost to Follow-up|1|||
155078391|NCT02421510|559718531|FG001|Overall Study|Lost to Follow-up|1|||
155078392|NCT02421510|559718532|FG002|Overall Study|Lost to Follow-up|0|||
155078393|NCT03528577|559718540|FG000|Sequence 1|Failed Spirometry|1|||
155078394|NCT03528577|559718540|FG000|Sequence 1|Restricted medication|1|||
155078395|NCT03528577|559718540|FG000|Sequence 2|Adverse Event|1|||
155078396|NCT03528577|559718540|FG000|Sequence 2|Withdrawal by Subject|1|||
155078397|NCT03528577|559718540|FG000|Sequence 2|Failed Spirometry|1|||
155078398|NCT03528577|559718540|FG000|Sequence 3|Failed Spirometry|1|||
155078399|NCT03528577|559718540|FG000|Sequence 4|Failed Spirometry|2|||
155078400|NCT03528577|559718540|FG000|Sequence 4|Adverse Event|1|||
155078401|NCT04882215|559718541|FG000|Overall Study|Withdrawal by Subject|5|||
155078402|NCT04882215|559718542|FG001|Overall Study|Withdrawal by Subject|0|||
155078403|NCT04098302|559718545|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
155078404|NCT04098302|559718546|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
155078405|NCT04098302|559718547|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
155078406|NCT04098302|559718548|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
155078407|NCT04098302|559718545|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
155078408|NCT04098302|559718546|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
155078409|NCT04098302|559718547|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
155078410|NCT04098302|559718548|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
155165154|NCT00475306|560041893|FG001|Overall Study|Protocol Violation|1|||
155165155|NCT00475306|560041894|FG002|Overall Study|Protocol Violation|0|||
155165156|NCT00475306|560041895|FG003|Overall Study|Protocol Violation|1|||
155165157|NCT02405442|560041897|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
155165158|NCT02405442|560041898|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
155165159|NCT02405442|560041899|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
155165160|NCT02405442|560041900|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
155165161|NCT02405442|560041897|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
155165162|NCT02405442|560041898|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
155165163|NCT02405442|560041899|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
155165164|NCT02405442|560041900|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
155165165|NCT02405442|560041897|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
155165166|NCT02405442|560041898|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
155165167|NCT02405442|560041899|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
155165168|NCT02405442|560041900|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
155165169|NCT02405442|560041897|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
155078411|NCT04098302|559718545|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
155078412|NCT04098302|559718546|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
155078413|NCT04098302|559718547|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
155078414|NCT04098302|559718548|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
155078415|NCT04098302|559718545|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
155078416|NCT04098302|559718546|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
155078417|NCT04098302|559718547|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
155078418|NCT04098302|559718548|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
155078419|NCT04098302|559718545|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
155078420|NCT04098302|559718546|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
155078421|NCT04098302|559718547|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
155078422|NCT04098302|559718548|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
155078423|NCT04098302|559718545|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
155078424|NCT04098302|559718546|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
155078425|NCT04098302|559718547|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
155078426|NCT04098302|559718548|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
155078427|NCT04098302|559718545|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
155078428|NCT04098302|559718546|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
155078429|NCT04098302|559718547|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
155078430|NCT04098302|559718548|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
155078431|NCT04098302|559718545|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
155078432|NCT04098302|559718546|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
155078433|NCT04098302|559718547|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
155078434|NCT04098302|559718548|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
155078435|NCT05061706|559718549|FG000|Overall Study|Adverse Event|29|||
155078436|NCT05061706|559718550|FG001|Overall Study|Adverse Event|1|||
155078437|NCT05061706|559718549|FG000|Overall Study|Lack of Efficacy|0|||
155078438|NCT05061706|559718550|FG001|Overall Study|Lack of Efficacy|1|||
155078439|NCT05061706|559718549|FG000|Overall Study|Lost to Follow-up|2|||
155078440|NCT05061706|559718550|FG001|Overall Study|Lost to Follow-up|2|||
155078441|NCT05061706|559718549|FG000|Overall Study|Protocol Violation|3|||
155078442|NCT05061706|559718550|FG001|Overall Study|Protocol Violation|1|||
155078443|NCT05061706|559718549|FG000|Overall Study|Withdrawal by Subject|3|||
155078444|NCT05061706|559718550|FG001|Overall Study|Withdrawal by Subject|9|||
155078445|NCT01181128|559718554|FG000|Overall Study|Withdrawal by Subject|2|||
155078446|NCT01181128|559718555|FG001|Overall Study|Withdrawal by Subject|2|||
155078447|NCT01181128|559718556|FG002|Overall Study|Withdrawal by Subject|0|||
155078448|NCT01181128|559718554|FG000|Overall Study|Death|1|||
155078449|NCT01181128|559718555|FG001|Overall Study|Death|0|||
155078450|NCT01181128|559718556|FG002|Overall Study|Death|0|||
155078451|NCT01181128|559718554|FG000|Overall Study|Physician Decision|2|||
155078452|NCT01181128|559718555|FG001|Overall Study|Physician Decision|0|||
155078453|NCT01181128|559718556|FG002|Overall Study|Physician Decision|0|||
155078454|NCT01181128|559718554|FG000|Overall Study|Adverse Event|0|||
155078455|NCT01181128|559718555|FG001|Overall Study|Adverse Event|2|||
155078456|NCT01181128|559718556|FG002|Overall Study|Adverse Event|0|||
155078457|NCT01181128|559718554|FG000|Overall Study|Other|1|||
155078458|NCT01181128|559718555|FG001|Overall Study|Other|1|||
155078459|NCT01181128|559718556|FG002|Overall Study|Other|1|||
155078460|NCT04477486|559718557|FG000|Overall Study|Death|2|||
155078461|NCT04477486|559718557|FG000|Overall Study|Ongoing at Time of Analysis|11|||
155078462|NCT02336503|559718559|FG000|Overall Study|Lost to Follow-up|0|||
155078463|NCT02336503|559718560|FG001|Overall Study|Lost to Follow-up|3|||
155078464|NCT02336503|559718561|FG002|Overall Study|Lost to Follow-up|0|||
155078465|NCT02336503|559718562|FG003|Overall Study|Lost to Follow-up|2|||
155078466|NCT02336503|559718559|FG000|Overall Study|Withdrawal by Subject|2|||
155078467|NCT02336503|559718560|FG001|Overall Study|Withdrawal by Subject|0|||
155078468|NCT02336503|559718561|FG002|Overall Study|Withdrawal by Subject|0|||
155078469|NCT02336503|559718562|FG003|Overall Study|Withdrawal by Subject|4|||
155078470|NCT02336503|559718559|FG000|Overall Study|Adverse Event|0|||
155078471|NCT02336503|559718560|FG001|Overall Study|Adverse Event|0|||
155078472|NCT02336503|559718561|FG002|Overall Study|Adverse Event|1|||
155078473|NCT02336503|559718562|FG003|Overall Study|Adverse Event|0|||
155078474|NCT01543503|559718563|FG000|Overall Study|Lost to Follow-up|32|||
155078475|NCT01543503|559718564|FG001|Overall Study|Lost to Follow-up|36|||
155078476|NCT01543503|559718563|FG000|Overall Study|Adverse Event|9|||
155078477|NCT01543503|559718564|FG001|Overall Study|Adverse Event|13|||
155078478|NCT01543503|559718563|FG000|Overall Study|Lack of Efficacy|4|||
155078479|NCT01543503|559718564|FG001|Overall Study|Lack of Efficacy|16|||
155078480|NCT01543503|559718563|FG000|Overall Study|Participant withdrew informed consent|8|||
155078481|NCT01543503|559718564|FG001|Overall Study|Participant withdrew informed consent|10|||
155078482|NCT01543503|559718563|FG000|Overall Study|Change of jobs|0|||
155078483|NCT01543503|559718564|FG001|Overall Study|Change of jobs|1|||
155078484|NCT01543503|559718563|FG000|Overall Study|Intolerance to the biologic treatment|0|||
155078485|NCT01543503|559718564|FG001|Overall Study|Intolerance to the biologic treatment|1|||
155078486|NCT01543503|559718563|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
155078487|NCT01543503|559718564|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
155078488|NCT01543503|559718563|FG000|Overall Study|Participant did not complete last visit|0|||
155078489|NCT01543503|559718564|FG001|Overall Study|Participant did not complete last visit|2|||
155078490|NCT01543503|559718563|FG000|Overall Study|Refused to continue treatment|7|||
155078491|NCT01543503|559718564|FG001|Overall Study|Refused to continue treatment|0|||
155078492|NCT01543503|559718563|FG000|Overall Study|Incorrect medication received|1|||
155078493|NCT01543503|559718564|FG001|Overall Study|Incorrect medication received|0|||
155078494|NCT01543503|559718563|FG000|Overall Study|Participant moved to another city|2|||
155078495|NCT01543503|559718564|FG001|Overall Study|Participant moved to another city|0|||
155078496|NCT01543503|559718563|FG000|Overall Study|Participant will not return for visits|0|||
155078497|NCT01543503|559718564|FG001|Overall Study|Participant will not return for visits|2|||
155078498|NCT01543503|559718563|FG000|Overall Study|Participant transferred to another city|1|||
155078499|NCT01543503|559718564|FG001|Overall Study|Participant transferred to another city|0|||
155078500|NCT01543503|559718563|FG000|Overall Study|Participant moved to Scotland|1|||
155078501|NCT01543503|559718564|FG001|Overall Study|Participant moved to Scotland|0|||
155078502|NCT01543503|559718563|FG000|Overall Study|Participant decision to stop treatment|1|||
155078503|NCT01543503|559718564|FG001|Overall Study|Participant decision to stop treatment|0|||
155078504|NCT01543503|559718563|FG000|Overall Study|Investigator did not wish to participate|1|||
155078505|NCT01543503|559718564|FG001|Overall Study|Investigator did not wish to participate|1|||
155078506|NCT01543503|559718563|FG000|Overall Study|Participant recruited after closing date|0|||
155078507|NCT01543503|559718564|FG001|Overall Study|Participant recruited after closing date|1|||
155078508|NCT01543503|559718563|FG000|Overall Study|Site stopped participation|5|||
155078509|NCT01543503|559718564|FG001|Overall Study|Site stopped participation|1|||
155078510|NCT01543503|559718563|FG000|Overall Study|Participant did not attend a visit|1|||
155078511|NCT01543503|559718564|FG001|Overall Study|Participant did not attend a visit|0|||
155078512|NCT01543503|559718563|FG000|Overall Study|Moved to other rheumatologic site|0|||
155078513|NCT01543503|559718564|FG001|Overall Study|Moved to other rheumatologic site|1|||
155078514|NCT01543503|559718563|FG000|Overall Study|Participant consented to another study|0|||
155078515|NCT01543503|559718564|FG001|Overall Study|Participant consented to another study|2|||
155078516|NCT01543503|559718563|FG000|Overall Study|Participant went to United States|1|||
155078517|NCT01543503|559718564|FG001|Overall Study|Participant went to United States|0|||
155078518|NCT01543503|559718563|FG000|Overall Study|Screen failure|1|||
155078519|NCT01543503|559718564|FG001|Overall Study|Screen failure|0|||
155078520|NCT02460380|559718565|FG000|Overall Study|Withdrawal by Subject|10|||
155078521|NCT02460380|559718566|FG001|Overall Study|Withdrawal by Subject|5|||
155078522|NCT01478087|559718569|FG000|Overall Study|due to sponsor closing study|1|||
155078523|NCT03566550|559718571|FG000|Overall Study|Withdrawal by Subject|0|||
155078524|NCT03566550|559718572|FG001|Overall Study|Withdrawal by Subject|1|||
155078525|NCT04576949|559718574|FG000|Overall Study|Adverse Event|1|||
155078526|NCT04576949|559718575|FG001|Overall Study|Adverse Event|3|||
155078527|NCT04576949|559718576|FG002|Overall Study|Adverse Event|2|||
155078528|NCT04576949|559718574|FG000|Overall Study|Withdrawal by Subject|41|||
155078529|NCT04576949|559718575|FG001|Overall Study|Withdrawal by Subject|26|||
155078530|NCT04576949|559718576|FG002|Overall Study|Withdrawal by Subject|18|||
155078531|NCT04576949|559718574|FG000|Overall Study|Physician Decision|3|||
155078532|NCT04576949|559718575|FG001|Overall Study|Physician Decision|0|||
155078533|NCT04576949|559718576|FG002|Overall Study|Physician Decision|0|||
155078534|NCT04576949|559718574|FG000|Overall Study|Death|0|||
155078535|NCT04576949|559718575|FG001|Overall Study|Death|1|||
155078536|NCT04576949|559718576|FG002|Overall Study|Death|0|||
155078537|NCT04576949|559718574|FG000|Overall Study|Lost to Follow-up|29|||
155078538|NCT04576949|559718575|FG001|Overall Study|Lost to Follow-up|37|||
155078539|NCT04576949|559718576|FG002|Overall Study|Lost to Follow-up|24|||
155078540|NCT04576949|559718574|FG000|Overall Study|Other, Not Specified|2|||
155078541|NCT04576949|559718575|FG001|Overall Study|Other, Not Specified|3|||
155078542|NCT04576949|559718576|FG002|Overall Study|Other, Not Specified|1|||
155078543|NCT04576949|559718574|FG000|Overall Study|Other|1|||
155078544|NCT04576949|559718575|FG001|Overall Study|Other|0|||
155078545|NCT04576949|559718576|FG002|Overall Study|Other|0|||
155078546|NCT00052715|559718580|FG000|Overall Study|wrong histology|1|||
155078547|NCT01936974|559718581|FG000|Overall Study|Physician Decision|2|||
155078548|NCT01936974|559718582|FG001|Overall Study|Physician Decision|5|||
155078549|NCT00063999|559718585|FG000|Overall Study|Withdrawal by Subject|1|||
155078550|NCT00063999|559718586|FG001|Overall Study|Withdrawal by Subject|0|||
155078551|NCT00063999|559718585|FG000|Overall Study|Ineligible|44|||
155078552|NCT00063999|559718586|FG001|Overall Study|Ineligible|24|||
154963901|NCT00424047|559293489|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
155078553|NCT01078545|559718590|FG000|Overall Study|Lost to Follow-up|13|||
155078554|NCT01078545|559718590|FG000|Overall Study|Physician Decision|6|||
155078555|NCT01078545|559718590|FG000|Overall Study|Withdrawal by Subject|3|||
155078556|NCT01078545|559718590|FG000|Overall Study|Death|3|||
155078557|NCT01078545|559718590|FG000|Overall Study|Participant moved to another physician|1|||
155078558|NCT02497755|559718591|FG000|Overall Study|Protocol Violation|1|||
155078559|NCT02497755|559718592|FG001|Overall Study|Protocol Violation|0|||
155078560|NCT01774370|559718595|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
155078561|NCT01774370|559718595|FG000|Overall Study|Administered prior to the contract date|4|||
155078562|NCT01774370|559718595|FG000|Overall Study|Subjects of contraindications|34|||
155078563|NCT01774370|559718595|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
155078564|NCT01774370|559718595|FG000|Overall Study|Follow-up failure|34|||
155078565|NCT00514917|559718598|FG000|Overall Study|Death|4|||
155078566|NCT00514917|559718599|FG001|Overall Study|Death|10|||
155078567|NCT00514917|559718598|FG000|Overall Study|Protocol Violation|1|||
155078568|NCT00514917|559718599|FG001|Overall Study|Protocol Violation|0|||
155078569|NCT00514917|559718598|FG000|Overall Study|Lost to Follow-up|4|||
155078570|NCT00514917|559718599|FG001|Overall Study|Lost to Follow-up|3|||
155078571|NCT00514917|559718598|FG000|Overall Study|Withdrawal by Subject|18|||
155078572|NCT00514917|559718599|FG001|Overall Study|Withdrawal by Subject|16|||
155078573|NCT00514917|559718598|FG000|Overall Study|Discontinued due to study closure|88|||
155078574|NCT00514917|559718599|FG001|Overall Study|Discontinued due to study closure|81|||
155078575|NCT00514917|559718598|FG000|Overall Study|Undefined|11|||
155078576|NCT00514917|559718599|FG001|Overall Study|Undefined|5|||
155078577|NCT04243837|559718603|FG000|Overall Study|Adverse Event|2|||
155078578|NCT04243837|559718604|FG001|Overall Study|Adverse Event|1|||
155165170|NCT02405442|560041898|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
155165171|NCT02405442|560041899|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
155165172|NCT02405442|560041900|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
155078579|NCT04243837|559718603|FG000|Overall Study|Withdrawal by Subject|4|||
155078580|NCT04243837|559718604|FG001|Overall Study|Withdrawal by Subject|2|||
155078581|NCT04243837|559718603|FG000|Overall Study|Covid-19 lock down|1|||
154963902|NCT00424047|559293488|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
155078582|NCT04243837|559718604|FG001|Overall Study|Covid-19 lock down|0|||
155078583|NCT04243837|559718603|FG000|Overall Study|Study Terminated by Sponsor|11|||
155078584|NCT04243837|559718604|FG001|Overall Study|Study Terminated by Sponsor|12|||
155078585|NCT03501277|559718608|FG000|Intervention Period 1 (4 Days)|Other|0|||
155078586|NCT03501277|559718609|FG001|Intervention Period 1 (4 Days)|Other|0|||
155078587|NCT03501277|559718610|FG002|Intervention Period 1 (4 Days)|Other|1|||
155078588|NCT03501277|559718611|FG003|Intervention Period 1 (4 Days)|Other|0|||
155078589|NCT03501277|559718608|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
155078590|NCT03501277|559718609|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
155078591|NCT03501277|559718610|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
155165173|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
155165174|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
155165175|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
155165176|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
155165177|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
155165178|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
155165179|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
155165180|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
155165181|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
155165182|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
155165183|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
155165184|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
155165185|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
155165186|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
155165187|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
155165188|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
155165189|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
155165190|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
155165191|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
154963903|NCT00424047|559293489|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
154963904|NCT00424047|559293488|FG000|On Study at Time of Unblinding|Adverse Event|22|||
154963905|NCT00424047|559293489|FG001|On Study at Time of Unblinding|Adverse Event|12|||
154963906|NCT00424047|559293488|FG000|On Study at Time of Unblinding|Progression of disease|92|||
154963907|NCT00424047|559293489|FG001|On Study at Time of Unblinding|Progression of disease|128|||
154963908|NCT00424047|559293488|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
154963909|NCT00424047|559293489|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
154963910|NCT00424047|559293488|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
155078592|NCT03501277|559718611|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
155078593|NCT03501277|559718608|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
155078594|NCT03501277|559718609|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
155078595|NCT03501277|559718610|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
155165192|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
155165193|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
155165194|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
155165195|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
155165196|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
155165197|NCT02405442|560041897|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
155165198|NCT02405442|560041898|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
155165199|NCT02405442|560041899|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
155165200|NCT02405442|560041900|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
155165201|NCT02405442|560041897|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
155165202|NCT02405442|560041898|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
155078596|NCT03501277|559718611|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
155165203|NCT02405442|560041899|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
155165204|NCT02405442|560041900|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
155165205|NCT02405442|560041897|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
155165206|NCT02405442|560041898|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
155165207|NCT02405442|560041899|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
155165208|NCT02405442|560041900|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
155165209|NCT02405442|560041897|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
155165210|NCT02405442|560041898|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
154963911|NCT00424047|559293489|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
155078597|NCT03501277|559718608|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
155078598|NCT03501277|559718609|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
155078599|NCT03501277|559718610|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
155078600|NCT03501277|559718611|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
155078601|NCT01873833|559718616|FG000|Overall Study|Withdrawal by Subject|1|||
155078602|NCT04193527|559718622|FG000|Overall Study|Other|1|||
155078603|NCT04193527|559718623|FG001|Overall Study|Other|1|||
154963912|NCT00424047|559293488|FG000|On Study at Time of Unblinding|Death|11|||
155078604|NCT04193527|559718624|FG002|Overall Study|Other|0|||
155078605|NCT03808909|559718625|FG000|Overall Study|Lost to Follow-up|3|||
155078606|NCT03808909|559718626|FG001|Overall Study|Lost to Follow-up|0|||
155078607|NCT01487161|559718629|FG000|Overall Study|Adverse Event|1|||
155078608|NCT01487161|559718630|FG001|Overall Study|Adverse Event|0|||
155078609|NCT01487161|559718631|FG002|Overall Study|Adverse Event|0|||
155078610|NCT01487161|559718632|FG003|Overall Study|Adverse Event|0|||
155078611|NCT01487161|559718629|FG000|Overall Study|Withdrawal by Subject|1|||
155078612|NCT01487161|559718630|FG001|Overall Study|Withdrawal by Subject|1|||
155078613|NCT01487161|559718631|FG002|Overall Study|Withdrawal by Subject|1|||
155078614|NCT01487161|559718632|FG003|Overall Study|Withdrawal by Subject|2|||
155078615|NCT01487161|559718629|FG000|Overall Study|missing data|0|||
155078616|NCT01487161|559718630|FG001|Overall Study|missing data|1|||
155078617|NCT01487161|559718631|FG002|Overall Study|missing data|0|||
155078618|NCT01487161|559718632|FG003|Overall Study|missing data|0|||
155078619|NCT03113136|559718633|FG000|Overall Study|Lost to Follow-up|22|||
155078620|NCT03113136|559718634|FG001|Overall Study|Lost to Follow-up|47|||
155078621|NCT03113136|559718635|FG002|Overall Study|Lost to Follow-up|54|||
155078622|NCT03113136|559718633|FG000|Overall Study|Withdrawal by Subject|4|||
155078623|NCT03113136|559718634|FG001|Overall Study|Withdrawal by Subject|13|||
155078624|NCT03113136|559718635|FG002|Overall Study|Withdrawal by Subject|14|||
155078625|NCT03113136|559718633|FG000|Overall Study|Ineligible|0|||
155078626|NCT03113136|559718634|FG001|Overall Study|Ineligible|2|||
155078627|NCT03113136|559718635|FG002|Overall Study|Ineligible|1|||
155078628|NCT03113136|559718633|FG000|Overall Study|Study Team Decision|1|||
155078629|NCT03113136|559718634|FG001|Overall Study|Study Team Decision|4|||
155078630|NCT03113136|559718635|FG002|Overall Study|Study Team Decision|0|||
155078631|NCT00977561|559718637|FG000|Overall Study|Death|3|||
155078632|NCT00977561|559718638|FG001|Overall Study|Death|2|||
155078633|NCT00977561|559718637|FG000|Overall Study|Study terminated|0|||
155078634|NCT00977561|559718638|FG001|Overall Study|Study terminated|2|||
155078635|NCT00977561|559718637|FG000|Overall Study|Other|2|||
155078636|NCT00977561|559718638|FG001|Overall Study|Other|0|||
155078637|NCT02187055|559718639|FG000|Overall Study|Lack of Efficacy|10|||
155078638|NCT02187055|559718640|FG001|Overall Study|Lack of Efficacy|3|||
155078639|NCT02187055|559718641|FG002|Overall Study|Lack of Efficacy|7|||
155078640|NCT02187055|559718639|FG000|Overall Study|Lost to Follow-up|2|||
155078641|NCT02187055|559718640|FG001|Overall Study|Lost to Follow-up|7|||
155078642|NCT02187055|559718641|FG002|Overall Study|Lost to Follow-up|3|||
155078643|NCT02187055|559718639|FG000|Overall Study|No longer meets eligibility criteria|0|||
155078644|NCT02187055|559718640|FG001|Overall Study|No longer meets eligibility criteria|2|||
155078645|NCT02187055|559718641|FG002|Overall Study|No longer meets eligibility criteria|0|||
155078646|NCT02187055|559718639|FG000|Overall Study|No longer willing to participate|6|||
155078647|NCT02187055|559718640|FG001|Overall Study|No longer willing to participate|8|||
155078648|NCT02187055|559718641|FG002|Overall Study|No longer willing to participate|10|||
155078649|NCT02187055|559718639|FG000|Overall Study|Other|5|||
155078650|NCT02187055|559718640|FG001|Overall Study|Other|6|||
155078651|NCT02187055|559718641|FG002|Overall Study|Other|3|||
155078652|NCT02187055|559718639|FG000|Overall Study|Protocol Violation|9|||
155078653|NCT02187055|559718640|FG001|Overall Study|Protocol Violation|9|||
155078654|NCT02187055|559718641|FG002|Overall Study|Protocol Violation|4|||
155078655|NCT02187055|559718639|FG000|Overall Study|Pregnancy|3|||
155078656|NCT02187055|559718640|FG001|Overall Study|Pregnancy|1|||
155078657|NCT02187055|559718641|FG002|Overall Study|Pregnancy|0|||
155078658|NCT02187055|559718639|FG000|Overall Study|Withdrawal by Subject|11|||
155078659|NCT02187055|559718640|FG001|Overall Study|Withdrawal by Subject|11|||
155078660|NCT02187055|559718641|FG002|Overall Study|Withdrawal by Subject|11|||
155078661|NCT02187055|559718639|FG000|Overall Study|Adverse Event|21|||
155078662|NCT02187055|559718640|FG001|Overall Study|Adverse Event|26|||
155078663|NCT02187055|559718641|FG002|Overall Study|Adverse Event|36|||
155342683|NCT02707952|560687102|FG002|Overall Study|Adverse Event|0|||
155342684|NCT02707952|560687103|FG003|Overall Study|Adverse Event|0|||
155078664|NCT02187055|559718639|FG000|Overall Study|Death|2|||
155078665|NCT02187055|559718640|FG001|Overall Study|Death|0|||
155078666|NCT02187055|559718641|FG002|Overall Study|Death|0|||
155078667|NCT03572218|559718644|FG000|Overall Study|Lost to Follow-up|3|||
155078668|NCT03572218|559718645|FG001|Overall Study|Lost to Follow-up|2|||
155078669|NCT03572218|559718644|FG000|Overall Study|No longer available for study visits|2|||
155078670|NCT03572218|559718645|FG001|Overall Study|No longer available for study visits|1|||
155078671|NCT03572218|559718644|FG000|Overall Study|No longer interested|1|||
155078672|NCT03572218|559718645|FG001|Overall Study|No longer interested|2|||
155078673|NCT02724644|559720768|FG000|Overall Study|Adverse Event|7|||
155078674|NCT02724644|559720769|FG001|Overall Study|Adverse Event|1|||
155078675|NCT02724644|559720768|FG000|Overall Study|Lost to Follow-up|6|||
155078676|NCT02724644|559720769|FG001|Overall Study|Lost to Follow-up|2|||
155078677|NCT02724644|559720768|FG000|Overall Study|Withdrawal by Subject|7|||
155078678|NCT02724644|559720769|FG001|Overall Study|Withdrawal by Subject|1|||
155078679|NCT02724644|559720768|FG000|Overall Study|Administrative|1|||
155078680|NCT02724644|559720769|FG001|Overall Study|Administrative|0|||
155342685|NCT02707952|560687100|FG000|Overall Study|Lost to Follow-up|1|||
155078681|NCT00520572|559720774|FG000|Overall Study|Adverse Event|9|||
155078682|NCT00520572|559720775|FG001|Overall Study|Adverse Event|3|||
155078683|NCT00520572|559720776|FG002|Overall Study|Adverse Event|6|||
155078684|NCT00520572|559720777|FG003|Overall Study|Adverse Event|9|||
155078685|NCT00520572|559720778|FG004|Overall Study|Adverse Event|7|||
155078686|NCT00520572|559720779|FG005|Overall Study|Adverse Event|2|||
155078687|NCT00520572|559720774|FG000|Overall Study|Withdrawal by Subject|0|||
155078688|NCT00520572|559720775|FG001|Overall Study|Withdrawal by Subject|9|||
155078689|NCT00520572|559720776|FG002|Overall Study|Withdrawal by Subject|5|||
155078690|NCT00520572|559720777|FG003|Overall Study|Withdrawal by Subject|2|||
155078691|NCT00520572|559720778|FG004|Overall Study|Withdrawal by Subject|2|||
155078692|NCT00520572|559720779|FG005|Overall Study|Withdrawal by Subject|0|||
155078693|NCT00520572|559720774|FG000|Overall Study|Protocol Violation|0|||
155078694|NCT00520572|559720775|FG001|Overall Study|Protocol Violation|0|||
155078695|NCT00520572|559720776|FG002|Overall Study|Protocol Violation|1|||
155078696|NCT00520572|559720777|FG003|Overall Study|Protocol Violation|0|||
155078697|NCT00520572|559720778|FG004|Overall Study|Protocol Violation|0|||
155078698|NCT00520572|559720779|FG005|Overall Study|Protocol Violation|0|||
155078699|NCT00520572|559720774|FG000|Overall Study|Lack of Efficacy|1|||
155078700|NCT00520572|559720775|FG001|Overall Study|Lack of Efficacy|1|||
155078701|NCT00520572|559720776|FG002|Overall Study|Lack of Efficacy|1|||
155078702|NCT00520572|559720777|FG003|Overall Study|Lack of Efficacy|2|||
155078703|NCT00520572|559720778|FG004|Overall Study|Lack of Efficacy|1|||
155078704|NCT00520572|559720779|FG005|Overall Study|Lack of Efficacy|0|||
155078705|NCT00520572|559720774|FG000|Overall Study|Lost to Follow-up|0|||
155078706|NCT00520572|559720775|FG001|Overall Study|Lost to Follow-up|0|||
155078707|NCT00520572|559720776|FG002|Overall Study|Lost to Follow-up|0|||
155078708|NCT00520572|559720777|FG003|Overall Study|Lost to Follow-up|0|||
155078709|NCT00520572|559720778|FG004|Overall Study|Lost to Follow-up|1|||
155078710|NCT00520572|559720779|FG005|Overall Study|Lost to Follow-up|0|||
155078711|NCT00520572|559720774|FG000|Overall Study|Incorrect enrollment|1|||
155078712|NCT00520572|559720775|FG001|Overall Study|Incorrect enrollment|0|||
155078713|NCT00520572|559720776|FG002|Overall Study|Incorrect enrollment|1|||
155078714|NCT00520572|559720777|FG003|Overall Study|Incorrect enrollment|0|||
155078715|NCT00520572|559720778|FG004|Overall Study|Incorrect enrollment|1|||
155078716|NCT00520572|559720779|FG005|Overall Study|Incorrect enrollment|0|||
155078717|NCT00520572|559720774|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
155078718|NCT00520572|559720775|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
155078719|NCT00520572|559720776|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
155078720|NCT00520572|559720777|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
155078721|NCT00520572|559720778|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
155078722|NCT00520572|559720779|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
155078723|NCT00520572|559720774|FG000|Overall Study|Long break in taking Medication|0|||
155078724|NCT00520572|559720775|FG001|Overall Study|Long break in taking Medication|0|||
155078725|NCT00520572|559720776|FG002|Overall Study|Long break in taking Medication|0|||
155078726|NCT00520572|559720777|FG003|Overall Study|Long break in taking Medication|1|||
155078727|NCT00520572|559720778|FG004|Overall Study|Long break in taking Medication|0|||
155078728|NCT00520572|559720779|FG005|Overall Study|Long break in taking Medication|0|||
155078729|NCT00520572|559720774|FG000|Overall Study|Did not receive Treatment|1|||
155078730|NCT00520572|559720775|FG001|Overall Study|Did not receive Treatment|0|||
155078731|NCT00520572|559720776|FG002|Overall Study|Did not receive Treatment|1|||
154963913|NCT00424047|559293489|FG001|On Study at Time of Unblinding|Death|11|||
154963914|NCT00424047|559293488|FG000|On Study at Time of Unblinding|Other|5|||
154963915|NCT00424047|559293489|FG001|On Study at Time of Unblinding|Other|4|||
154963916|NCT00424047|559293488|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
154963917|NCT00424047|559293489|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
154963918|NCT00424047|559293488|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
154963919|NCT00424047|559293489|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
154963920|NCT00424047|559293488|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
155078732|NCT00520572|559720777|FG003|Overall Study|Did not receive Treatment|0|||
155078733|NCT00520572|559720778|FG004|Overall Study|Did not receive Treatment|0|||
155078734|NCT00520572|559720779|FG005|Overall Study|Did not receive Treatment|0|||
155078735|NCT03548415|559720782|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155078736|NCT03548415|559720783|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155078737|NCT03548415|559720784|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
155078738|NCT03548415|559720785|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
155078739|NCT03548415|559720786|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
155078740|NCT04605588|559720788|FG000|Overall Study|Withdrawal by Subject|1|||
155078741|NCT04605588|559720789|FG001|Overall Study|Withdrawal by Subject|0|||
155078742|NCT01230814|559720790|FG000|Overall Study|Lost to Follow-up|11|||
155078743|NCT01230814|559720791|FG001|Overall Study|Lost to Follow-up|3|||
155078744|NCT01230814|559720790|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
155078745|NCT01230814|559720791|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
155078746|NCT01803737|559720794|FG000|Overall Study|Lack of Time|1|||
155078747|NCT01803737|559720795|FG001|Overall Study|Lack of Time|0|||
155078748|NCT01803737|559720794|FG000|Overall Study|Medical Reason|0|||
155078749|NCT01803737|559720795|FG001|Overall Study|Medical Reason|1|||
155078750|NCT01803737|559720794|FG000|Overall Study|Lost to Follow-up|0|||
155078751|NCT01803737|559720795|FG001|Overall Study|Lost to Follow-up|2|||
155078752|NCT01748552|559720796|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
155078753|NCT01748552|559720797|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
155078754|NCT01748552|559720798|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
155078755|NCT01748552|559720799|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
155078756|NCT01748552|559720800|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
155078757|NCT01748552|559720801|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
155078758|NCT01748552|559720802|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
155078759|NCT01748552|559720803|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
155078760|NCT01748552|559720804|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
155078761|NCT01748552|559720805|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
155078762|NCT01748552|559720806|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
155078763|NCT01748552|559720807|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
155078764|NCT01748552|559720796|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078765|NCT01748552|559720797|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078766|NCT01748552|559720798|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078767|NCT01748552|559720799|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078768|NCT01748552|559720800|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078769|NCT01748552|559720801|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078770|NCT01748552|559720802|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
155078771|NCT01748552|559720803|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
155078772|NCT01748552|559720804|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
155078773|NCT01748552|559720805|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078774|NCT01748552|559720806|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078775|NCT01748552|559720807|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
155078776|NCT00292370|559720810|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
155078777|NCT00292370|559720811|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
155078778|NCT00292370|559720812|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
155078779|NCT00292370|559720810|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
155078780|NCT00292370|559720811|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
155078781|NCT00292370|559720812|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
155078782|NCT00292370|559720810|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
155078783|NCT00292370|559720811|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
155078784|NCT00292370|559720812|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
155078785|NCT00292370|559720810|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
155078786|NCT00292370|559720811|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
155078787|NCT00292370|559720812|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
155078788|NCT00292370|559720810|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
155078789|NCT00292370|559720811|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
155078790|NCT00292370|559720812|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
155078791|NCT00292370|559720810|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
155078792|NCT00292370|559720811|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
155078793|NCT00292370|559720812|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
155078794|NCT02365064|559720816|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
155078795|NCT02365064|559720817|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
155078796|NCT02365064|559720816|FG000|Overall Study|Withdrawal by Subject|6|||
155078797|NCT02365064|559720817|FG001|Overall Study|Withdrawal by Subject|9|||
155078798|NCT02365064|559720816|FG000|Overall Study|Treatment intolerance|2|||
155078799|NCT02365064|559720817|FG001|Overall Study|Treatment intolerance|4|||
155078800|NCT02773537|559720818|FG000|Overall Study|Lost to Follow-up|0|||
155078801|NCT02773537|559720819|FG001|Overall Study|Lost to Follow-up|1|||
155078802|NCT02773537|559720820|FG002|Overall Study|Lost to Follow-up|4|||
155078803|NCT00662038|559720821|FG000|Overall Study|Reason not specified|3|||
155078804|NCT00662038|559720821|FG000|Overall Study|Withdrawn consent|22|||
155170040|NCT00830869|560062407|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
155078805|NCT00662038|559720821|FG000|Overall Study|Withdrawal by Subject|83|||
155078806|NCT00662038|559720821|FG000|Overall Study|Sponsor decision|1|||
155078807|NCT00662038|559720821|FG000|Overall Study|Physician Decision|19|||
155078808|NCT00662038|559720821|FG000|Overall Study|Lung transplantation|44|||
155078809|NCT00662038|559720821|FG000|Overall Study|Lost to Follow-up|1|||
155078810|NCT00662038|559720821|FG000|Overall Study|Death|95|||
155078811|NCT00662038|559720821|FG000|Overall Study|Adverse Event|358|||
155078812|NCT00662038|559720821|FG000|Overall Study|Continued treatment|5|||
155078813|NCT01840163|559720822|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
155078814|NCT01840163|559720823|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
155078815|NCT01840163|559720822|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
155078816|NCT01840163|559720823|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
155078817|NCT01840163|559720822|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
155078818|NCT01840163|559720823|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
155078819|NCT03774810|559720824|FG000|Phase 1|Lack of Efficacy|21|||
155078820|NCT03774810|559720825|FG001|Phase 1|Lack of Efficacy|0|||
155078821|NCT03774810|559720826|FG002|Phase 1|Lack of Efficacy|0|||
155078822|NCT03774810|559720827|FG003|Phase 1|Lack of Efficacy|0|||
155078823|NCT03774810|559720828|FG004|Phase 1|Lack of Efficacy|0|||
155078824|NCT03774810|559720824|FG000|Phase 1|Withdrawal by Subject|9|||
155078825|NCT03774810|559720825|FG001|Phase 1|Withdrawal by Subject|0|||
155078826|NCT03774810|559720826|FG002|Phase 1|Withdrawal by Subject|0|||
155078827|NCT03774810|559720827|FG003|Phase 1|Withdrawal by Subject|0|||
155078828|NCT03774810|559720828|FG004|Phase 1|Withdrawal by Subject|0|||
155078829|NCT03774810|559720824|FG000|Phase 1|Lost to Follow-up|2|||
155078830|NCT03774810|559720825|FG001|Phase 1|Lost to Follow-up|0|||
155078831|NCT03774810|559720826|FG002|Phase 1|Lost to Follow-up|0|||
155078832|NCT03774810|559720827|FG003|Phase 1|Lost to Follow-up|0|||
155078833|NCT03774810|559720828|FG004|Phase 1|Lost to Follow-up|0|||
155078834|NCT03774810|559720824|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
155078835|NCT03774810|559720825|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
155078836|NCT03774810|559720826|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
155078837|NCT03774810|559720827|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
155078838|NCT03774810|559720828|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
155078839|NCT03774810|559720824|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
155078840|NCT03774810|559720825|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
155078841|NCT03774810|559720826|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
155078842|NCT03774810|559720827|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
155078843|NCT03774810|559720828|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
155078844|NCT03774810|559720824|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
155078845|NCT03774810|559720825|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
155078846|NCT03774810|559720826|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
155078847|NCT03774810|559720827|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
155078848|NCT03774810|559720828|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
155078849|NCT03774810|559720824|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
155078850|NCT03774810|559720825|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
155078851|NCT03774810|559720826|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
155078852|NCT03774810|559720827|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
155078853|NCT03774810|559720828|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
155078854|NCT03774810|559720824|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
155078855|NCT03774810|559720825|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
155078856|NCT03774810|559720826|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
155078857|NCT03774810|559720827|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
155078858|NCT03774810|559720828|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
155078859|NCT03774810|559720824|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
155078860|NCT03774810|559720825|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
155078861|NCT03774810|559720826|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
155165211|NCT02405442|560041899|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
155165212|NCT02405442|560041900|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
155165213|NCT03830892|560041902|FG000|Overall Study|Physician Decision|2|||
155165214|NCT03830892|560041903|FG001|Overall Study|Physician Decision|3|||
155165215|NCT03830892|560041902|FG000|Overall Study|Study terminated due to COVID|4|||
155165216|NCT03830892|560041903|FG001|Overall Study|Study terminated due to COVID|0|||
155165217|NCT03830892|560041902|FG000|Overall Study|Protocol Violation|0|||
155165218|NCT03830892|560041903|FG001|Overall Study|Protocol Violation|1|||
155078862|NCT03774810|559720827|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
155078863|NCT03774810|559720828|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
155078864|NCT00927186|559720831|FG000|12 Months Primary Study|Adverse Event|5|||
155165219|NCT03830892|560041902|FG000|Overall Study|Withdrawal by Subject|0|||
155165220|NCT03830892|560041903|FG001|Overall Study|Withdrawal by Subject|2|||
155078865|NCT00927186|559720832|FG001|12 Months Primary Study|Adverse Event|2|||
155078866|NCT00927186|559720831|FG000|12 Months Primary Study|Lost to Follow-up|1|||
155078867|NCT00927186|559720832|FG001|12 Months Primary Study|Lost to Follow-up|0|||
155078868|NCT00927186|559720831|FG000|12 Months Primary Study|Protocol Violation|0|||
155078869|NCT00927186|559720832|FG001|12 Months Primary Study|Protocol Violation|1|||
155078870|NCT00927186|559720831|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
155078871|NCT00927186|559720832|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
155078872|NCT03994120|559720833|FG000|Overall Study|Lost to Follow-up|3|||
155078873|NCT03994120|559720834|FG001|Overall Study|Lost to Follow-up|1|||
155078874|NCT04914000|559720835|FG000|Overall Study|Lost to Follow-up|8|||
155078875|NCT04914000|559720835|FG000|Overall Study|Withdrawal by Subject|1|||
155078876|NCT00756444|559720836|FG000|Overall Study|Adverse Event|1|||
155078877|NCT00756444|559720837|FG001|Overall Study|Adverse Event|1|||
154963921|NCT00424047|559293489|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
154963922|NCT00424047|559293488|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
154963923|NCT00424047|559293489|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
155078878|NCT00756444|559720836|FG000|Overall Study|Withdrawal by Subject|6|||
155078879|NCT00756444|559720837|FG001|Overall Study|Withdrawal by Subject|8|||
155078880|NCT00756444|559720836|FG000|Overall Study|Lost to Follow-up|0|||
155078881|NCT00756444|559720837|FG001|Overall Study|Lost to Follow-up|1|||
155078882|NCT00756444|559720836|FG000|Overall Study|Death|5|||
155078883|NCT00756444|559720837|FG001|Overall Study|Death|4|||
155078884|NCT00756444|559720836|FG000|Overall Study|Disease Progression|2|||
155078885|NCT00756444|559720837|FG001|Overall Study|Disease Progression|7|||
155078886|NCT00756444|559720836|FG000|Overall Study|Ineligibility Determined|1|||
155078887|NCT00756444|559720837|FG001|Overall Study|Ineligibility Determined|0|||
155078888|NCT00564070|559720838|FG000|Overall Study|Lost to Follow-up|9|||
155078889|NCT00564070|559720839|FG001|Overall Study|Lost to Follow-up|7|||
155078890|NCT00564070|559720838|FG000|Overall Study|Worsening depression, referred to care|3|||
155078891|NCT00564070|559720839|FG001|Overall Study|Worsening depression, referred to care|0|||
155078892|NCT02264821|559720840|FG000|Overall Study|Protocol Violation|1|||
155078893|NCT02264821|559720841|FG001|Overall Study|Protocol Violation|3|||
155078894|NCT02264821|559720842|FG002|Overall Study|Protocol Violation|6|||
155078895|NCT03142334|559720844|FG000|Overall Study|Death|18|||
155078896|NCT03142334|559720845|FG001|Overall Study|Death|33|||
155078897|NCT03142334|559720844|FG000|Overall Study|Withdrawal by Subject|15|||
155078898|NCT03142334|559720845|FG001|Overall Study|Withdrawal by Subject|11|||
155078899|NCT03142334|559720844|FG000|Overall Study|Ongoing on trial follow up|463|||
155078900|NCT03142334|559720845|FG001|Overall Study|Ongoing on trial follow up|454|||
155078901|NCT02346370|559720846|FG000|Overall Study|Not treated|1|||
155078902|NCT02346370|559720847|FG001|Overall Study|Not treated|0|||
155078903|NCT02346370|559720848|FG002|Overall Study|Not treated|0|||
155078904|NCT02346370|559720846|FG000|Overall Study|Withdrawal of consent|1|||
155078905|NCT02346370|559720847|FG001|Overall Study|Withdrawal of consent|0|||
155078906|NCT02346370|559720848|FG002|Overall Study|Withdrawal of consent|0|||
155078907|NCT02346370|559720846|FG000|Overall Study|Death|1|||
155078908|NCT02346370|559720847|FG001|Overall Study|Death|3|||
155078909|NCT02346370|559720848|FG002|Overall Study|Death|1|||
155078910|NCT02346370|559720846|FG000|Overall Study|Sponsor discontinued study|5|||
155078911|NCT02346370|559720847|FG001|Overall Study|Sponsor discontinued study|0|||
155078912|NCT02346370|559720848|FG002|Overall Study|Sponsor discontinued study|2|||
155078913|NCT02346370|559720846|FG000|Overall Study|Radiologic progression|0|||
155078914|NCT02346370|559720847|FG001|Overall Study|Radiologic progression|0|||
155078915|NCT02346370|559720848|FG002|Overall Study|Radiologic progression|1|||
155078916|NCT02346370|559720846|FG000|Overall Study|Physician Decision|0|||
155078917|NCT02346370|559720847|FG001|Overall Study|Physician Decision|1|||
155078918|NCT02346370|559720848|FG002|Overall Study|Physician Decision|0|||
155342686|NCT02707952|560687101|FG001|Overall Study|Lost to Follow-up|0|||
155342687|NCT02707952|560687102|FG002|Overall Study|Lost to Follow-up|0|||
155342688|NCT02707952|560687103|FG003|Overall Study|Lost to Follow-up|0|||
155342689|NCT02707952|560687100|FG000|Overall Study|Withdrawal by Subject|0|||
155342690|NCT02707952|560687101|FG001|Overall Study|Withdrawal by Subject|1|||
155342691|NCT02707952|560687102|FG002|Overall Study|Withdrawal by Subject|2|||
155342692|NCT02707952|560687103|FG003|Overall Study|Withdrawal by Subject|0|||
155342693|NCT00696241|560687105|FG000|Overall Study|Adverse Event|11|||
155342694|NCT00696241|560687106|FG001|Overall Study|Adverse Event|3|||
155342695|NCT00696241|560687107|FG002|Overall Study|Adverse Event|6|||
155342696|NCT00696241|560687108|FG003|Overall Study|Adverse Event|4|||
155342697|NCT00696241|560687109|FG004|Overall Study|Adverse Event|5|||
155078919|NCT01217047|559720849|FG000|Overall Study|Lost to Follow-up|0|||
155078920|NCT01217047|559720850|FG001|Overall Study|Lost to Follow-up|1|||
155078921|NCT01217047|559720851|FG002|Overall Study|Lost to Follow-up|0|||
155078922|NCT04865978|559720852|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
155078923|NCT04865978|559720853|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
155078924|NCT05587998|559720854|FG000|Overall Study|Withdrawal by Subject|1|||
155078925|NCT05587998|559720855|FG001|Overall Study|Withdrawal by Subject|1|||
155078926|NCT05587998|559720854|FG000|Overall Study|Not treated|3|||
155078927|NCT05587998|559720855|FG001|Overall Study|Not treated|1|||
155078928|NCT05587998|559720854|FG000|Overall Study|Non-compliance with study procedures|0|||
155165221|NCT00975689|560041904|FG000|Overall Study|Adverse Event|0|||
155342698|NCT00696241|560687105|FG000|Overall Study|Protocol Violation|1|||
155342699|NCT00696241|560687106|FG001|Overall Study|Protocol Violation|1|||
155342700|NCT00696241|560687107|FG002|Overall Study|Protocol Violation|2|||
155342701|NCT00696241|560687108|FG003|Overall Study|Protocol Violation|0|||
155078929|NCT05587998|559720855|FG001|Overall Study|Non-compliance with study procedures|1|||
155078930|NCT03835117|559720856|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
155078931|NCT03835117|559720857|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
155078932|NCT04263532|559720858|FG000|Overall Study|Withdrawal by Subject|2|||
155078933|NCT04263532|559720859|FG001|Overall Study|Withdrawal by Subject|0|||
155078934|NCT06083493|559720860|FG000|Overall Study|Technical issues with the interventional device|2|||
155078935|NCT06083493|559720861|FG001|Overall Study|Technical issues with the interventional device|2|||
155078936|NCT06083493|559720860|FG000|Overall Study|Performed incorrect visual task|1|||
155078937|NCT06083493|559720861|FG001|Overall Study|Performed incorrect visual task|0|||
155078938|NCT06083493|559720860|FG000|Overall Study|Insufficient baseline performance|0|||
155078939|NCT06083493|559720861|FG001|Overall Study|Insufficient baseline performance|1|||
155078940|NCT03225989|559720865|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
155078941|NCT03225989|559720866|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
155078942|NCT03225989|559720867|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
155078943|NCT03225989|559720865|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
155078944|NCT03225989|559720866|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
155078945|NCT03225989|559720867|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
155078946|NCT03225989|559720865|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
155078947|NCT03225989|559720866|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
155078948|NCT03225989|559720867|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
155078949|NCT03225989|559720865|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
155078950|NCT03225989|559720866|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
155078951|NCT03225989|559720867|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
155078952|NCT03225989|559720865|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
155078953|NCT03225989|559720866|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
155078954|NCT03225989|559720867|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
155078955|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
155078956|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
155078957|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
155078958|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
155078959|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
155078960|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
155078961|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
155078962|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
155078963|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
155078964|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
155078965|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
155078966|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
155078967|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
155078968|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
155078969|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
155078970|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
155078971|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
155078972|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
155078973|NCT03225989|559720865|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
155078974|NCT03225989|559720866|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
155078975|NCT03225989|559720867|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
155078976|NCT03093870|559720868|FG000|Overall Study|Withdrawal by Subject|2|||
155078977|NCT03093870|559720869|FG001|Overall Study|Withdrawal by Subject|6|||
155078978|NCT03093870|559720870|FG002|Overall Study|Withdrawal by Subject|5|||
155078979|NCT03093870|559720868|FG000|Overall Study|Death|1|||
155078980|NCT03093870|559720869|FG001|Overall Study|Death|35|||
155078981|NCT03093870|559720870|FG002|Overall Study|Death|35|||
155078982|NCT03093870|559720868|FG000|Overall Study|Radiographic disease progression|10|||
155078983|NCT03093870|559720869|FG001|Overall Study|Radiographic disease progression|0|||
155078984|NCT03093870|559720870|FG002|Overall Study|Radiographic disease progression|0|||
155078985|NCT03093870|559720868|FG000|Overall Study|Clinical disease progression|1|||
155078986|NCT03093870|559720869|FG001|Overall Study|Clinical disease progression|0|||
155078987|NCT03093870|559720870|FG002|Overall Study|Clinical disease progression|0|||
155078988|NCT03093870|559720868|FG000|Overall Study|Physician Decision|2|||
155165222|NCT00975689|560041905|FG001|Overall Study|Adverse Event|3|||
154963924|NCT00424047|559293488|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
154963925|NCT00424047|559293489|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
154963926|NCT05248204|559293491|FG000|Overall Study|Lost to Follow-up|13|||
154963927|NCT05248204|559293492|FG001|Overall Study|Lost to Follow-up|13|||
155078989|NCT03093870|559720869|FG001|Overall Study|Physician Decision|0|||
155078990|NCT03093870|559720870|FG002|Overall Study|Physician Decision|0|||
155078991|NCT03093870|559720868|FG000|Overall Study|Adverse Event|7|||
155078992|NCT03093870|559720869|FG001|Overall Study|Adverse Event|0|||
155078993|NCT03093870|559720870|FG002|Overall Study|Adverse Event|0|||
155078994|NCT03093870|559720868|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
155078995|NCT03093870|559720869|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
155078996|NCT03093870|559720870|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
155078997|NCT03093870|559720868|FG000|Overall Study|Lost to Follow-up|0|||
155078998|NCT03093870|559720869|FG001|Overall Study|Lost to Follow-up|0|||
155078999|NCT03093870|559720870|FG002|Overall Study|Lost to Follow-up|1|||
155079000|NCT00601107|559720871|FG000|Overall Study|Adverse Event|0|||
155079001|NCT00601107|559720872|FG001|Overall Study|Adverse Event|1|||
155079002|NCT00601107|559720873|FG002|Overall Study|Adverse Event|3|||
155079003|NCT00601107|559720874|FG003|Overall Study|Adverse Event|0|||
155079004|NCT00601107|559720871|FG000|Overall Study|Withdrawal by Subject|5|||
155079005|NCT00601107|559720872|FG001|Overall Study|Withdrawal by Subject|4|||
155079006|NCT00601107|559720873|FG002|Overall Study|Withdrawal by Subject|7|||
155079007|NCT00601107|559720874|FG003|Overall Study|Withdrawal by Subject|4|||
155079008|NCT00601107|559720871|FG000|Overall Study|Lost to Follow-up|3|||
155079009|NCT00601107|559720872|FG001|Overall Study|Lost to Follow-up|3|||
155079010|NCT00601107|559720873|FG002|Overall Study|Lost to Follow-up|0|||
155079011|NCT00601107|559720874|FG003|Overall Study|Lost to Follow-up|3|||
155079012|NCT00601107|559720871|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
155079013|NCT00601107|559720872|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
155079014|NCT00601107|559720873|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
155079015|NCT00601107|559720874|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
155079016|NCT00601107|559720871|FG000|Overall Study|Worsening of Psoriasis|4|||
155079017|NCT00601107|559720872|FG001|Overall Study|Worsening of Psoriasis|1|||
155079018|NCT00601107|559720873|FG002|Overall Study|Worsening of Psoriasis|1|||
155079019|NCT00601107|559720874|FG003|Overall Study|Worsening of Psoriasis|4|||
155079020|NCT00601107|559720871|FG000|Overall Study|Undefined|1|||
155079021|NCT00601107|559720872|FG001|Overall Study|Undefined|0|||
155079022|NCT00601107|559720873|FG002|Overall Study|Undefined|1|||
155079023|NCT00601107|559720874|FG003|Overall Study|Undefined|0|||
155079024|NCT03892915|559720875|FG000|Overall Study|Lost to Follow-up|6|||
155079025|NCT03892915|559720876|FG001|Overall Study|Lost to Follow-up|12|||
155079026|NCT03892915|559720875|FG000|Overall Study|Death|0|||
155079027|NCT03892915|559720876|FG001|Overall Study|Death|2|||
155079028|NCT03892915|559720875|FG000|Overall Study|Withdrawal by Subject|1|||
155079029|NCT03892915|559720876|FG001|Overall Study|Withdrawal by Subject|1|||
155079030|NCT03892915|559720875|FG000|Overall Study|unsuccessful delivery|13|||
155079031|NCT03892915|559720876|FG001|Overall Study|unsuccessful delivery|18|||
155079032|NCT02318277|559720877|FG000|Overall Study|Physician Decision|0|||
155079033|NCT02318277|559720878|FG001|Overall Study|Physician Decision|0|||
155079034|NCT02318277|559720879|FG002|Overall Study|Physician Decision|0|||
155079035|NCT02318277|559720880|FG003|Overall Study|Physician Decision|0|||
155079036|NCT02318277|559720881|FG004|Overall Study|Physician Decision|0|||
155079037|NCT02318277|559720882|FG005|Overall Study|Physician Decision|0|||
155079038|NCT02318277|559720883|FG006|Overall Study|Physician Decision|0|||
155079039|NCT02318277|559720884|FG007|Overall Study|Physician Decision|1|||
155079040|NCT02318277|559720877|FG000|Overall Study|Other|0|||
155079041|NCT02318277|559720878|FG001|Overall Study|Other|0|||
155079042|NCT02318277|559720879|FG002|Overall Study|Other|0|||
155079043|NCT02318277|559720880|FG003|Overall Study|Other|0|||
155079044|NCT02318277|559720881|FG004|Overall Study|Other|0|||
155079045|NCT02318277|559720882|FG005|Overall Study|Other|0|||
155079046|NCT02318277|559720883|FG006|Overall Study|Other|1|||
155342702|NCT00696241|560687109|FG004|Overall Study|Protocol Violation|3|||
154963928|NCT05248204|559293491|FG000|Overall Study|Protocol Violation|1|||
155079047|NCT02318277|559720884|FG007|Overall Study|Other|0|||
155079048|NCT02318277|559720877|FG000|Overall Study|Withdrawal by Subject|0|||
155079049|NCT02318277|559720878|FG001|Overall Study|Withdrawal by Subject|0|||
155079050|NCT02318277|559720879|FG002|Overall Study|Withdrawal by Subject|1|||
155079051|NCT02318277|559720880|FG003|Overall Study|Withdrawal by Subject|0|||
155079052|NCT02318277|559720881|FG004|Overall Study|Withdrawal by Subject|1|||
155079053|NCT02318277|559720882|FG005|Overall Study|Withdrawal by Subject|1|||
155079054|NCT02318277|559720883|FG006|Overall Study|Withdrawal by Subject|6|||
155079055|NCT02318277|559720884|FG007|Overall Study|Withdrawal by Subject|14|||
155342703|NCT00696241|560687105|FG000|Overall Study|Lost to Follow-up|1|||
155079056|NCT02318277|559720877|FG000|Overall Study|Participant trial terminated by sponsor|0|||
155079057|NCT02318277|559720878|FG001|Overall Study|Participant trial terminated by sponsor|0|||
155079058|NCT02318277|559720879|FG002|Overall Study|Participant trial terminated by sponsor|1|||
155079059|NCT02318277|559720880|FG003|Overall Study|Participant trial terminated by sponsor|0|||
155079060|NCT02318277|559720881|FG004|Overall Study|Participant trial terminated by sponsor|1|||
155079061|NCT02318277|559720882|FG005|Overall Study|Participant trial terminated by sponsor|2|||
155079062|NCT02318277|559720883|FG006|Overall Study|Participant trial terminated by sponsor|5|||
155079063|NCT02318277|559720884|FG007|Overall Study|Participant trial terminated by sponsor|16|||
155079064|NCT02318277|559720877|FG000|Overall Study|Lost to Follow-up|1|||
155079065|NCT02318277|559720878|FG001|Overall Study|Lost to Follow-up|0|||
155079066|NCT02318277|559720879|FG002|Overall Study|Lost to Follow-up|1|||
155079067|NCT02318277|559720880|FG003|Overall Study|Lost to Follow-up|0|||
155079068|NCT02318277|559720881|FG004|Overall Study|Lost to Follow-up|0|||
155079069|NCT02318277|559720882|FG005|Overall Study|Lost to Follow-up|0|||
155079070|NCT02318277|559720883|FG006|Overall Study|Lost to Follow-up|3|||
155079071|NCT02318277|559720884|FG007|Overall Study|Lost to Follow-up|4|||
155079072|NCT02318277|559720877|FG000|Overall Study|Death|5|||
155079073|NCT02318277|559720878|FG001|Overall Study|Death|3|||
155079074|NCT02318277|559720879|FG002|Overall Study|Death|1|||
155079075|NCT02318277|559720880|FG003|Overall Study|Death|4|||
155079076|NCT02318277|559720881|FG004|Overall Study|Death|6|||
155079077|NCT02318277|559720882|FG005|Overall Study|Death|5|||
155079078|NCT02318277|559720883|FG006|Overall Study|Death|34|||
155079079|NCT02318277|559720884|FG007|Overall Study|Death|58|||
155079080|NCT02318277|559720877|FG000|Overall Study|Transitioned to Hospice|0|||
155079081|NCT02318277|559720878|FG001|Overall Study|Transitioned to Hospice|0|||
155079082|NCT02318277|559720879|FG002|Overall Study|Transitioned to Hospice|0|||
155079083|NCT02318277|559720880|FG003|Overall Study|Transitioned to Hospice|0|||
155079084|NCT02318277|559720881|FG004|Overall Study|Transitioned to Hospice|0|||
155079085|NCT02318277|559720882|FG005|Overall Study|Transitioned to Hospice|1|||
155079086|NCT02318277|559720883|FG006|Overall Study|Transitioned to Hospice|0|||
155079087|NCT02318277|559720884|FG007|Overall Study|Transitioned to Hospice|0|||
155079088|NCT03364686|559720885|FG000|Overall Study|Physician Decision|2|||
155079089|NCT01986751|559720891|FG000|Overall Study|improperly consented|10|||
155079090|NCT01986751|559720892|FG001|Overall Study|improperly consented|2|||
155079091|NCT01968785|559720894|FG000|Overall Study|Withdrawal by Subject|1|||
155079092|NCT01968785|559720895|FG001|Overall Study|Withdrawal by Subject|0|||
155079093|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Adverse Event|14|||
155079094|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Adverse Event|27|||
155079095|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Adverse Event|60|||
155079096|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Adverse Event|0|||
155079097|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Adverse Event|0|||
155079098|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Pregnancy|0|||
155079099|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Pregnancy|7|||
155079100|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Pregnancy|9|||
155079101|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Pregnancy|0|||
155079102|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Pregnancy|0|||
155079103|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
155079104|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
155079105|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
155079106|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
155079107|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
155342704|NCT00696241|560687106|FG001|Overall Study|Lost to Follow-up|4|||
155079108|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
155079109|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
155079110|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
155079111|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
155079112|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
155342705|NCT00696241|560687107|FG002|Overall Study|Lost to Follow-up|1|||
155342706|NCT00696241|560687108|FG003|Overall Study|Lost to Follow-up|2|||
155342707|NCT00696241|560687109|FG004|Overall Study|Lost to Follow-up|0|||
155342708|NCT00696241|560687105|FG000|Overall Study|Withdrawal by Subject|4|||
155342709|NCT00696241|560687106|FG001|Overall Study|Withdrawal by Subject|8|||
155342710|NCT00696241|560687107|FG002|Overall Study|Withdrawal by Subject|6|||
155342711|NCT00696241|560687108|FG003|Overall Study|Withdrawal by Subject|1|||
155342712|NCT00696241|560687109|FG004|Overall Study|Withdrawal by Subject|0|||
155079113|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Death|1|||
155079114|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Death|2|||
155079115|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Death|2|||
155079116|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Death|0|||
155079117|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Death|0|||
155342713|NCT00696241|560687105|FG000|Overall Study|Lack of Efficacy|1|||
155342714|NCT00696241|560687106|FG001|Overall Study|Lack of Efficacy|5|||
155079118|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
155079119|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
155079120|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
155079121|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
155079122|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
155079123|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
155079124|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
155079125|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
155079126|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
155079127|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
155079128|NCT00098293|559720896|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
155079129|NCT00098293|559720897|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
155079130|NCT00098293|559720898|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
155079131|NCT00098293|559720899|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
155079132|NCT00098293|559720900|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
155079133|NCT00098293|559720896|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155079134|NCT00098293|559720897|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155079135|NCT00098293|559720898|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
155079136|NCT00098293|559720899|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155079137|NCT00098293|559720900|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
155079138|NCT00098293|559720896|FG000|Open-label (OL) Phase|Adverse Event|0|||
155079139|NCT00098293|559720897|FG001|Open-label (OL) Phase|Adverse Event|3|||
155079140|NCT00098293|559720898|FG002|Open-label (OL) Phase|Adverse Event|7|||
155079141|NCT00098293|559720899|FG003|Open-label (OL) Phase|Adverse Event|6|||
155079142|NCT00098293|559720900|FG004|Open-label (OL) Phase|Adverse Event|0|||
155079143|NCT00098293|559720896|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
155079144|NCT00098293|559720897|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
155079145|NCT00098293|559720898|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
155079146|NCT00098293|559720899|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
155079147|NCT00098293|559720900|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
155079148|NCT00098293|559720896|FG000|Open-label (OL) Phase|Pregnancy|0|||
155079149|NCT00098293|559720897|FG001|Open-label (OL) Phase|Pregnancy|1|||
155079150|NCT00098293|559720898|FG002|Open-label (OL) Phase|Pregnancy|0|||
155079151|NCT00098293|559720899|FG003|Open-label (OL) Phase|Pregnancy|3|||
155079152|NCT00098293|559720900|FG004|Open-label (OL) Phase|Pregnancy|0|||
155079153|NCT00098293|559720896|FG000|Open-label (OL) Phase|Protocol Violation|0|||
155079154|NCT00098293|559720897|FG001|Open-label (OL) Phase|Protocol Violation|6|||
155079155|NCT00098293|559720898|FG002|Open-label (OL) Phase|Protocol Violation|13|||
155079156|NCT00098293|559720899|FG003|Open-label (OL) Phase|Protocol Violation|16|||
155079157|NCT00098293|559720900|FG004|Open-label (OL) Phase|Protocol Violation|0|||
155079158|NCT00098293|559720896|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
155079159|NCT00098293|559720897|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
155079160|NCT00098293|559720898|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
155079161|NCT00098293|559720899|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
155079162|NCT00098293|559720900|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
155079163|NCT00098293|559720896|FG000|Open-label (OL) Phase|Death|0|||
155079164|NCT00098293|559720897|FG001|Open-label (OL) Phase|Death|2|||
155079165|NCT00098293|559720898|FG002|Open-label (OL) Phase|Death|3|||
155079166|NCT00098293|559720899|FG003|Open-label (OL) Phase|Death|0|||
155079167|NCT00098293|559720900|FG004|Open-label (OL) Phase|Death|0|||
155079168|NCT00098293|559720896|FG000|Supplemental Phase (SP)|Death|0|||
155342715|NCT00696241|560687107|FG002|Overall Study|Lack of Efficacy|4|||
155342716|NCT00696241|560687108|FG003|Overall Study|Lack of Efficacy|5|||
155342717|NCT00696241|560687109|FG004|Overall Study|Lack of Efficacy|3|||
155342718|NCT00696241|560687105|FG000|Overall Study|Other|6|||
155342719|NCT00696241|560687106|FG001|Overall Study|Other|1|||
155342720|NCT00696241|560687107|FG002|Overall Study|Other|5|||
155342721|NCT00696241|560687108|FG003|Overall Study|Other|2|||
155342722|NCT00696241|560687109|FG004|Overall Study|Other|1|||
155342723|NCT01287832|560687110|FG000|Overall Study|Adverse Event|1|||
155342724|NCT01287832|560687111|FG001|Overall Study|Adverse Event|0|||
155342725|NCT01287832|560687110|FG000|Overall Study|Death|0|||
155342726|NCT01287832|560687111|FG001|Overall Study|Death|1|||
155342727|NCT03065400|560687115|FG000|Overall Study|Adverse Event|1|||
155342728|NCT03065400|560687115|FG000|Overall Study|Physician Decision|3|||
155342729|NCT03065400|560687115|FG000|Overall Study|Withdrawal by Subject|1|||
155079169|NCT00098293|559720897|FG001|Supplemental Phase (SP)|Death|0|||
155079170|NCT00098293|559720898|FG002|Supplemental Phase (SP)|Death|0|||
155079171|NCT00098293|559720899|FG003|Supplemental Phase (SP)|Death|0|||
155079172|NCT00098293|559720900|FG004|Supplemental Phase (SP)|Death|1|||
155079173|NCT00098293|559720896|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
155079174|NCT00098293|559720897|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
155079175|NCT00098293|559720898|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
155342730|NCT03065400|560687115|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
155342731|NCT02513667|560687116|FG000|Overall Study|Withdrawal by Subject|0|||
155079176|NCT00098293|559720899|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
155079177|NCT00098293|559720900|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
155079178|NCT00098293|559720896|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155079179|NCT00098293|559720897|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155079180|NCT00098293|559720898|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155079181|NCT00098293|559720899|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
155079182|NCT00098293|559720900|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
155079183|NCT00098293|559720896|FG000|Supplemental Phase (SP)|Other|0|||
155079184|NCT00098293|559720897|FG001|Supplemental Phase (SP)|Other|0|||
155079185|NCT00098293|559720898|FG002|Supplemental Phase (SP)|Other|0|||
155079186|NCT00098293|559720899|FG003|Supplemental Phase (SP)|Other|0|||
155079187|NCT00098293|559720900|FG004|Supplemental Phase (SP)|Other|22|||
155079188|NCT02829957|559720901|FG000|Overall Study|Lost to Follow-up|2|||
155079189|NCT02829957|559720902|FG001|Overall Study|Lost to Follow-up|1|||
155079190|NCT00676689|559720903|FG000|Overall Study|Screen Failure|2|||
155079191|NCT00676689|559720903|FG000|Overall Study|Death|2|||
155079192|NCT00676689|559720903|FG000|Overall Study|Lost to Follow-up|4|||
155079193|NCT00676689|559720903|FG000|Overall Study|Physician Decision|1|||
155079194|NCT00676689|559720903|FG000|Overall Study|Withdrawal by Subject|3|||
155079195|NCT00676689|559720903|FG000|Overall Study|Continuing FU|49|||
155079196|NCT01827943|559720904|FG000|Overall Study|Protocol Violation|8|||
155079197|NCT01827943|559720904|FG000|Overall Study|Never treated because of an rapid progression|1|||
155079198|NCT00501085|559720905|FG000|Overall Study|Lost to Follow-up|195|||
155079199|NCT00501085|559720905|FG000|Overall Study|Withdrawal by Subject|34|||
155079200|NCT00501085|559720905|FG000|Overall Study|Subject Decision|1|||
155079201|NCT00501085|559720905|FG000|Overall Study|Revision Surgery|7|||
155079202|NCT00501085|559720905|FG000|Overall Study|Explantation Surgery|26|||
155079203|NCT00501085|559720905|FG000|Overall Study|Adverse Event|4|||
155079204|NCT00501085|559720905|FG000|Overall Study|Non-Compliance|24|||
155079205|NCT00501085|559720905|FG000|Overall Study|Study closed by sponsor|109|||
155079206|NCT00501085|559720905|FG000|Overall Study|Other loss to follow-up|32|||
155079207|NCT02362412|559720909|FG000|Treatment Period III|Lost to Follow-up|0|||
155079208|NCT02362412|559720910|FG001|Treatment Period III|Lost to Follow-up|1|||
155079209|NCT00545948|559720911|FG000|Overall Study|Not Treated|1|||
155079210|NCT00545948|559720912|FG001|Overall Study|Not Treated|1|||
155079211|NCT00545948|559720913|FG002|Overall Study|Not Treated|7|||
155079212|NCT02975700|559720916|FG000|Overall Study|Adverse Event|1|||
155079213|NCT02975700|559720916|FG000|Overall Study|Progressive disease|3|||
155079214|NCT02975700|559720916|FG000|Overall Study|Failed screening criteria|2|||
155079215|NCT05737745|559720917|FG000|Overall Study|Withdrawal by Subject|0|||
155079216|NCT05737745|559720918|FG001|Overall Study|Withdrawal by Subject|6|||
155079217|NCT05737745|559720919|FG002|Overall Study|Withdrawal by Subject|1|||
155079218|NCT02569242|559720920|FG000|Overall Study|Death|1|||
155079219|NCT02569242|559720921|FG001|Overall Study|Death|0|||
155079220|NCT02569242|559720920|FG000|Overall Study|Withdrawal by Subject|0|||
155079221|NCT02569242|559720921|FG001|Overall Study|Withdrawal by Subject|1|||
155079222|NCT01125748|559720923|FG000|Overall Study|Adverse Event|0|||
155079223|NCT01125748|559720924|FG001|Overall Study|Adverse Event|2|||
155079224|NCT01125748|559720923|FG000|Overall Study|Lost to Follow-up|0|||
155079225|NCT01125748|559720924|FG001|Overall Study|Lost to Follow-up|1|||
155079226|NCT01125748|559720923|FG000|Overall Study|Physician Decision|8|||
155079227|NCT01125748|559720924|FG001|Overall Study|Physician Decision|7|||
155079228|NCT01125748|559720923|FG000|Overall Study|Patient Decision to Withdraw|2|||
155079229|NCT01125748|559720924|FG001|Overall Study|Patient Decision to Withdraw|4|||
155079230|NCT01751685|559720925|FG000|6-mo Followup|Missed study visit|1|||
155079231|NCT01751685|559720926|FG001|6-mo Followup|Missed study visit|0|||
155079232|NCT01751685|559720925|FG000|6-mo Followup|Withdrawal by Subject|2|||
155079233|NCT01751685|559720926|FG001|6-mo Followup|Withdrawal by Subject|2|||
155079234|NCT01751685|559720925|FG000|6-mo Followup|Lost to Follow-up|0|||
155079235|NCT01751685|559720926|FG001|6-mo Followup|Lost to Follow-up|1|||
155079236|NCT01751685|559720925|FG000|12-mo Followup|Lost to Follow-up|5|||
155165223|NCT00975689|560041904|FG000|Overall Study|Withdrawal by Subject|1|||
155165224|NCT00975689|560041905|FG001|Overall Study|Withdrawal by Subject|0|||
155079237|NCT01751685|559720926|FG001|12-mo Followup|Lost to Follow-up|0|||
155079238|NCT01028391|559720927|FG000|Overall Study|Adverse Event|4|||
155079239|NCT01028391|559720928|FG001|Overall Study|Adverse Event|0|||
155165225|NCT00975689|560041904|FG000|Overall Study|Physician Decision|1|||
155079240|NCT01028391|559720927|FG000|Overall Study|Lack of Efficacy|0|||
155079241|NCT01028391|559720928|FG001|Overall Study|Lack of Efficacy|2|||
155079242|NCT01028391|559720927|FG000|Overall Study|Lost to Follow-up|3|||
155079243|NCT01028391|559720928|FG001|Overall Study|Lost to Follow-up|4|||
155079244|NCT01028391|559720927|FG000|Overall Study|Physician Decision|0|||
155079245|NCT01028391|559720928|FG001|Overall Study|Physician Decision|1|||
155079246|NCT01028391|559720927|FG000|Overall Study|Withdrawal by Subject|6|||
155079247|NCT01028391|559720928|FG001|Overall Study|Withdrawal by Subject|3|||
155079248|NCT01028391|559720927|FG000|Overall Study|Needed excluded medication|1|||
155079249|NCT01028391|559720928|FG001|Overall Study|Needed excluded medication|1|||
155079250|NCT01107457|559720929|FG000|Part A|Adverse Event|1|||
155079251|NCT01107457|559720930|FG001|Part A|Adverse Event|2|||
155079252|NCT01107457|559720931|FG002|Part A|Adverse Event|1|||
155079253|NCT01107457|559720932|FG003|Part A|Adverse Event|0|||
155079254|NCT01107457|559720933|FG004|Part A|Adverse Event|0|||
155079255|NCT01107457|559720934|FG005|Part A|Adverse Event|0|||
155079256|NCT01107457|559720929|FG000|Part A|Withdrawal by Subject|3|||
155079257|NCT01107457|559720930|FG001|Part A|Withdrawal by Subject|3|||
155079258|NCT01107457|559720931|FG002|Part A|Withdrawal by Subject|0|||
155079259|NCT01107457|559720932|FG003|Part A|Withdrawal by Subject|3|||
155079260|NCT01107457|559720933|FG004|Part A|Withdrawal by Subject|1|||
155079261|NCT01107457|559720934|FG005|Part A|Withdrawal by Subject|0|||
155079262|NCT01107457|559720929|FG000|Part A|Lost to Follow-up|0|||
155079263|NCT01107457|559720930|FG001|Part A|Lost to Follow-up|1|||
155079264|NCT01107457|559720931|FG002|Part A|Lost to Follow-up|0|||
155079265|NCT01107457|559720932|FG003|Part A|Lost to Follow-up|0|||
155079266|NCT01107457|559720933|FG004|Part A|Lost to Follow-up|0|||
155079267|NCT01107457|559720934|FG005|Part A|Lost to Follow-up|0|||
155079268|NCT01107457|559720929|FG000|Part A|Lack of Efficacy|1|||
155079269|NCT01107457|559720930|FG001|Part A|Lack of Efficacy|0|||
155079270|NCT01107457|559720931|FG002|Part A|Lack of Efficacy|0|||
155079271|NCT01107457|559720932|FG003|Part A|Lack of Efficacy|0|||
155079272|NCT01107457|559720933|FG004|Part A|Lack of Efficacy|0|||
155079273|NCT01107457|559720934|FG005|Part A|Lack of Efficacy|0|||
155079274|NCT01107457|559720929|FG000|Part A|Protocol Violation|0|||
155079275|NCT01107457|559720930|FG001|Part A|Protocol Violation|1|||
155079276|NCT01107457|559720931|FG002|Part A|Protocol Violation|0|||
155079277|NCT01107457|559720932|FG003|Part A|Protocol Violation|0|||
155079278|NCT01107457|559720933|FG004|Part A|Protocol Violation|0|||
155079279|NCT01107457|559720934|FG005|Part A|Protocol Violation|0|||
155079280|NCT01107457|559720929|FG000|Part B and C|Adverse Event|0|||
155079281|NCT01107457|559720930|FG001|Part B and C|Adverse Event|0|||
155079282|NCT01107457|559720931|FG002|Part B and C|Adverse Event|0|||
155079283|NCT01107457|559720932|FG003|Part B and C|Adverse Event|0|||
155079284|NCT01107457|559720933|FG004|Part B and C|Adverse Event|0|||
155079285|NCT01107457|559720934|FG005|Part B and C|Adverse Event|12|||
155079286|NCT01107457|559720929|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155079287|NCT01107457|559720930|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155079288|NCT01107457|559720931|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155079289|NCT01107457|559720932|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155079290|NCT01107457|559720933|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
155079291|NCT01107457|559720934|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
155079292|NCT01107457|559720929|FG000|Part B and C|Physician Decision|0|||
155079293|NCT01107457|559720930|FG001|Part B and C|Physician Decision|0|||
155079294|NCT01107457|559720931|FG002|Part B and C|Physician Decision|0|||
155079295|NCT01107457|559720932|FG003|Part B and C|Physician Decision|0|||
155079296|NCT01107457|559720933|FG004|Part B and C|Physician Decision|0|||
155079297|NCT01107457|559720934|FG005|Part B and C|Physician Decision|3|||
155079298|NCT01107457|559720929|FG000|Part B and C|Lack of Efficacy|0|||
155079299|NCT01107457|559720930|FG001|Part B and C|Lack of Efficacy|0|||
155079300|NCT01107457|559720931|FG002|Part B and C|Lack of Efficacy|0|||
155079301|NCT01107457|559720932|FG003|Part B and C|Lack of Efficacy|0|||
155079302|NCT01107457|559720933|FG004|Part B and C|Lack of Efficacy|0|||
155079303|NCT01107457|559720934|FG005|Part B and C|Lack of Efficacy|7|||
155079304|NCT01107457|559720929|FG000|Part B and C|Lost to Follow-up|0|||
155079305|NCT01107457|559720930|FG001|Part B and C|Lost to Follow-up|0|||
155079306|NCT01107457|559720931|FG002|Part B and C|Lost to Follow-up|0|||
155079307|NCT01107457|559720932|FG003|Part B and C|Lost to Follow-up|0|||
155079308|NCT01107457|559720933|FG004|Part B and C|Lost to Follow-up|0|||
155079309|NCT01107457|559720934|FG005|Part B and C|Lost to Follow-up|10|||
155079310|NCT01107457|559720929|FG000|Part B and C|Protocol Violation|0|||
155079311|NCT01107457|559720930|FG001|Part B and C|Protocol Violation|0|||
155079312|NCT01107457|559720931|FG002|Part B and C|Protocol Violation|0|||
155079313|NCT01107457|559720932|FG003|Part B and C|Protocol Violation|0|||
155079314|NCT01107457|559720933|FG004|Part B and C|Protocol Violation|0|||
155079315|NCT01107457|559720934|FG005|Part B and C|Protocol Violation|1|||
155079316|NCT01107457|559720929|FG000|Part B and C|Sponsor Decision|0|||
155079317|NCT01107457|559720930|FG001|Part B and C|Sponsor Decision|0|||
155079318|NCT01107457|559720931|FG002|Part B and C|Sponsor Decision|0|||
155079319|NCT01107457|559720932|FG003|Part B and C|Sponsor Decision|0|||
155079320|NCT01107457|559720933|FG004|Part B and C|Sponsor Decision|0|||
155079321|NCT01107457|559720934|FG005|Part B and C|Sponsor Decision|66|||
155079322|NCT01107457|559720929|FG000|Part B and C|Withdrawal by Subject|0|||
155079323|NCT01107457|559720930|FG001|Part B and C|Withdrawal by Subject|0|||
155079324|NCT01107457|559720931|FG002|Part B and C|Withdrawal by Subject|0|||
155079325|NCT01107457|559720932|FG003|Part B and C|Withdrawal by Subject|0|||
155079326|NCT01107457|559720933|FG004|Part B and C|Withdrawal by Subject|0|||
155079327|NCT01107457|559720934|FG005|Part B and C|Withdrawal by Subject|16|||
155079328|NCT01107457|559720929|FG000|Part B and C|Clinical Relapse|0|||
155079329|NCT01107457|559720930|FG001|Part B and C|Clinical Relapse|0|||
155079330|NCT01107457|559720931|FG002|Part B and C|Clinical Relapse|0|||
155079331|NCT01107457|559720932|FG003|Part B and C|Clinical Relapse|0|||
155079332|NCT01107457|559720933|FG004|Part B and C|Clinical Relapse|0|||
155079333|NCT01107457|559720934|FG005|Part B and C|Clinical Relapse|4|||
155079334|NCT00694161|559720935|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
155079335|NCT00694161|559720935|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
155079336|NCT00694161|559720935|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
155079337|NCT03601052|559720936|FG000|Overall Study|Lost to Follow-up|2|||
155165226|NCT00975689|560041905|FG001|Overall Study|Physician Decision|0|||
155079338|NCT00837330|559720937|FG000|Overall Study|Lost to Follow-up|1|||
155079339|NCT00837330|559720938|FG001|Overall Study|Lost to Follow-up|3|||
155079340|NCT01227395|559720939|FG000|Overall Study|Protocol Violation|0|||
155079341|NCT01227395|559720940|FG001|Overall Study|Protocol Violation|1|||
155079342|NCT00694122|559720941|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
155079343|NCT00694122|559720942|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
155079344|NCT00694122|559720941|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
155079345|NCT00694122|559720942|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
155079346|NCT00694122|559720941|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
155079347|NCT00694122|559720942|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
155079348|NCT00105508|559720943|FG000|Overall Study|Prephase Dropout|1|||
155079349|NCT00105508|559720944|FG001|Overall Study|Prephase Dropout|0|||
155079350|NCT00105508|559720943|FG000|Overall Study|Adverse Event|16|||
155079351|NCT00105508|559720944|FG001|Overall Study|Adverse Event|19|||
155079352|NCT00105508|559720943|FG000|Overall Study|Insufficient Efficacy|1|||
155079353|NCT00105508|559720944|FG001|Overall Study|Insufficient Efficacy|0|||
155079354|NCT00105508|559720943|FG000|Overall Study|Withdrawal by Subject|10|||
155079355|NCT00105508|559720944|FG001|Overall Study|Withdrawal by Subject|6|||
155079356|NCT00105508|559720943|FG000|Overall Study|Lost to Follow-up|3|||
155079357|NCT00105508|559720944|FG001|Overall Study|Lost to Follow-up|0|||
155079358|NCT00105508|559720943|FG000|Overall Study|Protocol Violation|1|||
155079359|NCT00105508|559720944|FG001|Overall Study|Protocol Violation|2|||
155079360|NCT00105508|559720943|FG000|Overall Study|Other|8|||
155079361|NCT00105508|559720944|FG001|Overall Study|Other|9|||
155079362|NCT00683384|559720945|FG000|Overall Study|Death|1|||
155079363|NCT00683384|559720945|FG000|Overall Study|Adverse Event|1|||
155079364|NCT00120874|559720946|FG000|Overall Study|Death|0|||
155079365|NCT00120874|559720947|FG001|Overall Study|Death|1|||
155079366|NCT00300495|559720956|FG000|Overall Study|Protocol Violation|4|||
155079367|NCT00300495|559720957|FG001|Overall Study|Protocol Violation|1|||
155079368|NCT01348490|559720958|FG000|Overall Study|Death|1|||
155079369|NCT01348490|559720958|FG000|Overall Study|Adverse Event|3|||
155079370|NCT01348490|559720958|FG000|Overall Study|Consent withdrawn|7|||
155079371|NCT01348490|559720958|FG000|Overall Study|Disease progression|3|||
155079372|NCT01348490|559720958|FG000|Overall Study|Lost to Follow-up|1|||
155079373|NCT01348490|559720958|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
155165227|NCT00330967|560041906|FG000|Overall Study|Withdrawal by Subject|0|||
155342732|NCT02513667|560687117|FG001|Overall Study|Withdrawal by Subject|1|||
155342733|NCT02291549|560687120|FG000|Overall Study|Lost to Follow-up|1|||
155342734|NCT02291549|560687121|FG001|Overall Study|Lost to Follow-up|0|||
155342735|NCT02291549|560687120|FG000|Overall Study|Withdrawal by Subject|0|||
155342736|NCT02291549|560687121|FG001|Overall Study|Withdrawal by Subject|1|||
155342737|NCT00537914|560687122|FG000|Overall Study|Death|1|||
155342738|NCT00537914|560687122|FG000|Overall Study|Adverse Event|7|||
155342739|NCT00537914|560687122|FG000|Overall Study|Treatment failure|10|||
155342740|NCT00537914|560687122|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
155342741|NCT00537914|560687122|FG000|Overall Study|Lost to Follow-up|19|||
155342742|NCT00537914|560687122|FG000|Overall Study|Withdrawal of informed consent|59|||
155079374|NCT01348490|559720958|FG000|Overall Study|Other Unspecified|8|||
155079375|NCT03632720|559720959|FG000|Overall Study|Adverse Event|2|||
155079376|NCT03632720|559720960|FG001|Overall Study|Adverse Event|0|||
155079377|NCT03632720|559720961|FG002|Overall Study|Adverse Event|0|||
155079378|NCT03632720|559720959|FG000|Overall Study|Lost to Follow-up|0|||
155079379|NCT03632720|559720960|FG001|Overall Study|Lost to Follow-up|1|||
155079380|NCT03632720|559720961|FG002|Overall Study|Lost to Follow-up|0|||
155079381|NCT03632720|559720959|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
155079382|NCT03632720|559720960|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
155079383|NCT03632720|559720961|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
155079384|NCT03632720|559720959|FG000|Overall Study|Screen failure|0|||
155079385|NCT03632720|559720960|FG001|Overall Study|Screen failure|1|||
155079386|NCT03632720|559720961|FG002|Overall Study|Screen failure|0|||
155079387|NCT01179399|559720962|FG000|Overall Study|Adverse Event|1|||
155079388|NCT01179399|559720962|FG000|Overall Study|Lack of Efficacy|30|||
155079389|NCT01179399|559720962|FG000|Overall Study|Withdrawal by Subject|1|||
155079390|NCT03004183|559722910|FG000|Overall Study|Adverse Event|7|||
155079391|NCT03004183|559722910|FG000|Overall Study|Lost to Follow-up|1|||
155079392|NCT03004183|559722910|FG000|Overall Study|Physician Decision|40|||
155079393|NCT03004183|559722910|FG000|Overall Study|Withdrawal by Subject|1|||
155079394|NCT03004183|559722910|FG000|Overall Study|COVID-19|1|||
155079395|NCT03312114|559722913|FG000|Overall Study|All the five enrolled dropped out of the|5|||
155079396|NCT02469961|559722919|FG000|Overall Study|Physician Decision|4|||
155079397|NCT02469961|559722920|FG001|Overall Study|Physician Decision|1|||
155079398|NCT01386645|559722921|FG000|Overall Study|Physician Decision|0|||
155079399|NCT01386645|559722922|FG001|Overall Study|Physician Decision|0|||
155079400|NCT01386645|559722923|FG002|Overall Study|Physician Decision|1|||
155079401|NCT01386645|559722921|FG000|Overall Study|Withdrawal by Subject|0|||
155079402|NCT01386645|559722922|FG001|Overall Study|Withdrawal by Subject|1|||
155079403|NCT01386645|559722923|FG002|Overall Study|Withdrawal by Subject|1|||
155079404|NCT01530256|559722924|FG000|Overall Study|Death|2|||
155079405|NCT04621786|559722925|FG000|Overall Study|Lost to Follow-up|9|||
155079406|NCT04621786|559722925|FG000|Overall Study|Protocol Violation|3|||
155079407|NCT02533674|559722926|FG000|Dose Level I|Progressive disease|1|||
155079408|NCT02533674|559722927|FG001|Dose Level I|Progressive disease|0|||
155079409|NCT02533674|559722928|FG002|Dose Level I|Progressive disease|0|||
155079410|NCT02533674|559722929|FG003|Dose Level I|Progressive disease|0|||
155079411|NCT02533674|559722930|FG004|Dose Level I|Progressive disease|0|||
155079412|NCT02533674|559722931|FG005|Dose Level I|Progressive disease|0|||
155079413|NCT02533674|559722932|FG006|Dose Level I|Progressive disease|0|||
155079414|NCT02533674|559722933|FG007|Dose Level I|Progressive disease|0|||
155079415|NCT02533674|559722926|FG000|Dose Level I|Withdrawal by Subject|1|||
155079416|NCT02533674|559722927|FG001|Dose Level I|Withdrawal by Subject|0|||
155079417|NCT02533674|559722928|FG002|Dose Level I|Withdrawal by Subject|0|||
155079418|NCT02533674|559722929|FG003|Dose Level I|Withdrawal by Subject|0|||
155079419|NCT02533674|559722930|FG004|Dose Level I|Withdrawal by Subject|0|||
155079420|NCT02533674|559722931|FG005|Dose Level I|Withdrawal by Subject|0|||
155079421|NCT02533674|559722932|FG006|Dose Level I|Withdrawal by Subject|0|||
155079422|NCT02533674|559722933|FG007|Dose Level I|Withdrawal by Subject|0|||
155079423|NCT02533674|559722926|FG000|Dose Level I|Physician Decision|1|||
155079424|NCT02533674|559722927|FG001|Dose Level I|Physician Decision|0|||
155079425|NCT02533674|559722928|FG002|Dose Level I|Physician Decision|0|||
155079426|NCT02533674|559722929|FG003|Dose Level I|Physician Decision|0|||
155342743|NCT01697956|560687124|FG000|Overall Study|Protocol Violation|1|||
155342744|NCT01697956|560687125|FG001|Overall Study|Protocol Violation|1|||
155342745|NCT01115309|560687126|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
155342746|NCT01115309|560687126|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
155342747|NCT01115309|560687126|FG000|Long-term Follow-up|Lost to Follow-up|6|||
155342748|NCT05700851|560687127|FG000|Overall Study|Received a kidney transplant|1|||
155342749|NCT05700851|560687127|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
155342750|NCT05700851|560687127|FG000|Overall Study|Withdrawal by Subject|1|||
155342751|NCT03246724|560687128|FG000|Overall Study|Withdrawal by Subject|5|||
155342752|NCT03246724|560687129|FG001|Overall Study|Withdrawal by Subject|2|||
155342753|NCT03246724|560687130|FG002|Overall Study|Withdrawal by Subject|4|||
155342754|NCT03246724|560687131|FG003|Overall Study|Withdrawal by Subject|2|||
155342755|NCT03246724|560687128|FG000|Overall Study|Ineligible on day of surgery|7|||
155342756|NCT03246724|560687129|FG001|Overall Study|Ineligible on day of surgery|2|||
155342757|NCT03246724|560687130|FG002|Overall Study|Ineligible on day of surgery|0|||
155342758|NCT03246724|560687131|FG003|Overall Study|Ineligible on day of surgery|3|||
155342759|NCT03246724|560687128|FG000|Overall Study|Study completed before surgical date|2|||
155342760|NCT03246724|560687129|FG001|Overall Study|Study completed before surgical date|1|||
155342761|NCT03246724|560687130|FG002|Overall Study|Study completed before surgical date|8|||
155342762|NCT03246724|560687131|FG003|Overall Study|Study completed before surgical date|1|||
155342763|NCT03246724|560687128|FG000|Overall Study|Transferred to other arm|0|||
155342764|NCT03246724|560687129|FG001|Overall Study|Transferred to other arm|0|||
155342765|NCT03246724|560687130|FG002|Overall Study|Transferred to other arm|1|||
155342766|NCT03246724|560687131|FG003|Overall Study|Transferred to other arm|0|||
155079427|NCT02533674|559722930|FG004|Dose Level I|Physician Decision|0|||
155079428|NCT02533674|559722931|FG005|Dose Level I|Physician Decision|0|||
155079429|NCT02533674|559722932|FG006|Dose Level I|Physician Decision|0|||
155079430|NCT02533674|559722933|FG007|Dose Level I|Physician Decision|0|||
155079431|NCT02533674|559722926|FG000|Dose Level I|Death|1|||
155079432|NCT02533674|559722927|FG001|Dose Level I|Death|0|||
155079433|NCT02533674|559722928|FG002|Dose Level I|Death|0|||
155079434|NCT02533674|559722929|FG003|Dose Level I|Death|0|||
155079435|NCT02533674|559722930|FG004|Dose Level I|Death|0|||
155079436|NCT02533674|559722931|FG005|Dose Level I|Death|0|||
155079437|NCT02533674|559722932|FG006|Dose Level I|Death|0|||
155079438|NCT02533674|559722933|FG007|Dose Level I|Death|0|||
155079439|NCT02533674|559722926|FG000|Dose Level I|Never Treated|1|||
155079440|NCT02533674|559722927|FG001|Dose Level I|Never Treated|0|||
155079441|NCT02533674|559722928|FG002|Dose Level I|Never Treated|0|||
155079442|NCT02533674|559722929|FG003|Dose Level I|Never Treated|0|||
155079443|NCT02533674|559722930|FG004|Dose Level I|Never Treated|0|||
155079444|NCT02533674|559722931|FG005|Dose Level I|Never Treated|0|||
155079445|NCT02533674|559722932|FG006|Dose Level I|Never Treated|0|||
155079446|NCT02533674|559722933|FG007|Dose Level I|Never Treated|0|||
155079447|NCT02533674|559722926|FG000|Dose Level II|Progressive disease|0|||
155079448|NCT02533674|559722927|FG001|Dose Level II|Progressive disease|3|||
155079449|NCT02533674|559722928|FG002|Dose Level II|Progressive disease|0|||
155079450|NCT02533674|559722929|FG003|Dose Level II|Progressive disease|0|||
155079451|NCT02533674|559722930|FG004|Dose Level II|Progressive disease|0|||
155079452|NCT02533674|559722931|FG005|Dose Level II|Progressive disease|0|||
155079453|NCT02533674|559722932|FG006|Dose Level II|Progressive disease|0|||
155079454|NCT02533674|559722933|FG007|Dose Level II|Progressive disease|0|||
155079455|NCT02533674|559722926|FG000|Dose Level II|Withdrawal by Subject|0|||
155079456|NCT02533674|559722927|FG001|Dose Level II|Withdrawal by Subject|1|||
155079457|NCT02533674|559722928|FG002|Dose Level II|Withdrawal by Subject|0|||
155079458|NCT02533674|559722929|FG003|Dose Level II|Withdrawal by Subject|0|||
155079459|NCT02533674|559722930|FG004|Dose Level II|Withdrawal by Subject|0|||
155079460|NCT02533674|559722931|FG005|Dose Level II|Withdrawal by Subject|0|||
155079461|NCT02533674|559722932|FG006|Dose Level II|Withdrawal by Subject|0|||
155079462|NCT02533674|559722933|FG007|Dose Level II|Withdrawal by Subject|0|||
155079463|NCT02533674|559722926|FG000|Dose Level II|Treatment-related AE|0|||
155079464|NCT02533674|559722927|FG001|Dose Level II|Treatment-related AE|1|||
155079465|NCT02533674|559722928|FG002|Dose Level II|Treatment-related AE|0|||
155079466|NCT02533674|559722929|FG003|Dose Level II|Treatment-related AE|0|||
155079467|NCT02533674|559722930|FG004|Dose Level II|Treatment-related AE|0|||
155079468|NCT02533674|559722931|FG005|Dose Level II|Treatment-related AE|0|||
155079469|NCT02533674|559722932|FG006|Dose Level II|Treatment-related AE|0|||
155079470|NCT02533674|559722933|FG007|Dose Level II|Treatment-related AE|0|||
155079471|NCT02533674|559722926|FG000|Dose Level II|Physician Decision|0|||
155079472|NCT02533674|559722927|FG001|Dose Level II|Physician Decision|1|||
155079473|NCT02533674|559722928|FG002|Dose Level II|Physician Decision|0|||
155079474|NCT02533674|559722929|FG003|Dose Level II|Physician Decision|0|||
155079475|NCT02533674|559722930|FG004|Dose Level II|Physician Decision|0|||
155079476|NCT02533674|559722931|FG005|Dose Level II|Physician Decision|0|||
155079477|NCT02533674|559722932|FG006|Dose Level II|Physician Decision|0|||
155079478|NCT02533674|559722933|FG007|Dose Level II|Physician Decision|0|||
155079479|NCT02533674|559722926|FG000|Dose Level II|Non-treatment-related AE|0|||
155079480|NCT02533674|559722927|FG001|Dose Level II|Non-treatment-related AE|1|||
155079481|NCT02533674|559722928|FG002|Dose Level II|Non-treatment-related AE|0|||
155079482|NCT02533674|559722929|FG003|Dose Level II|Non-treatment-related AE|0|||
155079483|NCT02533674|559722930|FG004|Dose Level II|Non-treatment-related AE|0|||
155079484|NCT02533674|559722931|FG005|Dose Level II|Non-treatment-related AE|0|||
155079485|NCT02533674|559722932|FG006|Dose Level II|Non-treatment-related AE|0|||
155079486|NCT02533674|559722933|FG007|Dose Level II|Non-treatment-related AE|0|||
155079487|NCT02533674|559722926|FG000|Dose Level III|Progressive disease|0|||
155079488|NCT02533674|559722927|FG001|Dose Level III|Progressive disease|0|||
155079489|NCT02533674|559722928|FG002|Dose Level III|Progressive disease|2|||
155079490|NCT02533674|559722929|FG003|Dose Level III|Progressive disease|0|||
155079491|NCT02533674|559722930|FG004|Dose Level III|Progressive disease|0|||
155079492|NCT02533674|559722931|FG005|Dose Level III|Progressive disease|0|||
155079493|NCT02533674|559722932|FG006|Dose Level III|Progressive disease|0|||
155079494|NCT02533674|559722933|FG007|Dose Level III|Progressive disease|0|||
155079495|NCT02533674|559722926|FG000|Dose Level III|Withdrawal by Subject|0|||
155079496|NCT02533674|559722927|FG001|Dose Level III|Withdrawal by Subject|0|||
155079497|NCT02533674|559722928|FG002|Dose Level III|Withdrawal by Subject|1|||
155079498|NCT02533674|559722929|FG003|Dose Level III|Withdrawal by Subject|0|||
155079499|NCT02533674|559722930|FG004|Dose Level III|Withdrawal by Subject|0|||
155079500|NCT02533674|559722931|FG005|Dose Level III|Withdrawal by Subject|0|||
155079501|NCT02533674|559722932|FG006|Dose Level III|Withdrawal by Subject|0|||
155079502|NCT02533674|559722933|FG007|Dose Level III|Withdrawal by Subject|0|||
155079503|NCT02533674|559722926|FG000|Dose Level III|Treatment-related AE|0|||
155079504|NCT02533674|559722927|FG001|Dose Level III|Treatment-related AE|0|||
155079505|NCT02533674|559722928|FG002|Dose Level III|Treatment-related AE|1|||
155079506|NCT02533674|559722929|FG003|Dose Level III|Treatment-related AE|0|||
155079507|NCT02533674|559722930|FG004|Dose Level III|Treatment-related AE|0|||
154963929|NCT05248204|559293492|FG001|Overall Study|Protocol Violation|0|||
155079508|NCT02533674|559722931|FG005|Dose Level III|Treatment-related AE|0|||
155079509|NCT02533674|559722932|FG006|Dose Level III|Treatment-related AE|0|||
155079510|NCT02533674|559722933|FG007|Dose Level III|Treatment-related AE|0|||
155079511|NCT02533674|559722926|FG000|Dose Level IV|Progressive disease|0|||
155079512|NCT02533674|559722927|FG001|Dose Level IV|Progressive disease|0|||
155079513|NCT02533674|559722928|FG002|Dose Level IV|Progressive disease|0|||
155079514|NCT02533674|559722929|FG003|Dose Level IV|Progressive disease|3|||
155079515|NCT02533674|559722930|FG004|Dose Level IV|Progressive disease|0|||
155079516|NCT02533674|559722931|FG005|Dose Level IV|Progressive disease|0|||
155079517|NCT02533674|559722932|FG006|Dose Level IV|Progressive disease|0|||
155079518|NCT02533674|559722933|FG007|Dose Level IV|Progressive disease|0|||
155079519|NCT02533674|559722926|FG000|Dose Level IV|Withdrawal by Subject|0|||
155079520|NCT02533674|559722927|FG001|Dose Level IV|Withdrawal by Subject|0|||
155079521|NCT02533674|559722928|FG002|Dose Level IV|Withdrawal by Subject|0|||
155079522|NCT02533674|559722929|FG003|Dose Level IV|Withdrawal by Subject|1|||
155079523|NCT02533674|559722930|FG004|Dose Level IV|Withdrawal by Subject|0|||
155079524|NCT02533674|559722931|FG005|Dose Level IV|Withdrawal by Subject|0|||
155079525|NCT02533674|559722932|FG006|Dose Level IV|Withdrawal by Subject|0|||
155079526|NCT02533674|559722933|FG007|Dose Level IV|Withdrawal by Subject|0|||
155079527|NCT02533674|559722926|FG000|Dose Level IV|Physician Decision|0|||
155079528|NCT02533674|559722927|FG001|Dose Level IV|Physician Decision|0|||
155079529|NCT02533674|559722928|FG002|Dose Level IV|Physician Decision|0|||
155079530|NCT02533674|559722929|FG003|Dose Level IV|Physician Decision|1|||
155079531|NCT02533674|559722930|FG004|Dose Level IV|Physician Decision|0|||
155079532|NCT02533674|559722931|FG005|Dose Level IV|Physician Decision|0|||
155079533|NCT02533674|559722932|FG006|Dose Level IV|Physician Decision|0|||
155079534|NCT02533674|559722933|FG007|Dose Level IV|Physician Decision|0|||
155079535|NCT02533674|559722926|FG000|Dose Level V|Progressive disease|0|||
155079536|NCT02533674|559722927|FG001|Dose Level V|Progressive disease|0|||
155079537|NCT02533674|559722928|FG002|Dose Level V|Progressive disease|0|||
155079538|NCT02533674|559722929|FG003|Dose Level V|Progressive disease|0|||
155079539|NCT02533674|559722930|FG004|Dose Level V|Progressive disease|3|||
155079540|NCT02533674|559722931|FG005|Dose Level V|Progressive disease|0|||
155079541|NCT02533674|559722932|FG006|Dose Level V|Progressive disease|0|||
155079542|NCT02533674|559722933|FG007|Dose Level V|Progressive disease|0|||
155079543|NCT02533674|559722926|FG000|Dose Level V|Withdrawal by Subject|0|||
155079544|NCT02533674|559722927|FG001|Dose Level V|Withdrawal by Subject|0|||
155079545|NCT02533674|559722928|FG002|Dose Level V|Withdrawal by Subject|0|||
155079546|NCT02533674|559722929|FG003|Dose Level V|Withdrawal by Subject|0|||
155079547|NCT02533674|559722930|FG004|Dose Level V|Withdrawal by Subject|1|||
155079548|NCT02533674|559722931|FG005|Dose Level V|Withdrawal by Subject|0|||
155079549|NCT02533674|559722932|FG006|Dose Level V|Withdrawal by Subject|0|||
155079550|NCT02533674|559722933|FG007|Dose Level V|Withdrawal by Subject|0|||
155079551|NCT02533674|559722926|FG000|Dose Level V|Physician Decision|0|||
155079552|NCT02533674|559722927|FG001|Dose Level V|Physician Decision|0|||
155079553|NCT02533674|559722928|FG002|Dose Level V|Physician Decision|0|||
155079554|NCT02533674|559722929|FG003|Dose Level V|Physician Decision|0|||
155079555|NCT02533674|559722930|FG004|Dose Level V|Physician Decision|1|||
155079556|NCT02533674|559722931|FG005|Dose Level V|Physician Decision|0|||
155079557|NCT02533674|559722932|FG006|Dose Level V|Physician Decision|0|||
155079558|NCT02533674|559722933|FG007|Dose Level V|Physician Decision|0|||
155079559|NCT02533674|559722926|FG000|Dose Level VI|Progressive disease|0|||
155079560|NCT02533674|559722927|FG001|Dose Level VI|Progressive disease|0|||
155079561|NCT02533674|559722928|FG002|Dose Level VI|Progressive disease|0|||
155079562|NCT02533674|559722929|FG003|Dose Level VI|Progressive disease|0|||
155079563|NCT02533674|559722930|FG004|Dose Level VI|Progressive disease|0|||
155079564|NCT02533674|559722931|FG005|Dose Level VI|Progressive disease|7|||
155079565|NCT02533674|559722932|FG006|Dose Level VI|Progressive disease|0|||
155079566|NCT02533674|559722933|FG007|Dose Level VI|Progressive disease|0|||
155079567|NCT02533674|559722926|FG000|Dose Level VI|Withdrawal by Subject|0|||
155079568|NCT02533674|559722927|FG001|Dose Level VI|Withdrawal by Subject|0|||
155079569|NCT02533674|559722928|FG002|Dose Level VI|Withdrawal by Subject|0|||
155079570|NCT02533674|559722929|FG003|Dose Level VI|Withdrawal by Subject|0|||
155079571|NCT02533674|559722930|FG004|Dose Level VI|Withdrawal by Subject|0|||
155079572|NCT02533674|559722931|FG005|Dose Level VI|Withdrawal by Subject|1|||
155079573|NCT02533674|559722932|FG006|Dose Level VI|Withdrawal by Subject|0|||
155079574|NCT02533674|559722933|FG007|Dose Level VI|Withdrawal by Subject|0|||
155079575|NCT02533674|559722926|FG000|Dose Level VI|Treatment-related AE|0|||
155079576|NCT02533674|559722927|FG001|Dose Level VI|Treatment-related AE|0|||
155079577|NCT02533674|559722928|FG002|Dose Level VI|Treatment-related AE|0|||
155079578|NCT02533674|559722929|FG003|Dose Level VI|Treatment-related AE|0|||
155079579|NCT02533674|559722930|FG004|Dose Level VI|Treatment-related AE|0|||
155079580|NCT02533674|559722931|FG005|Dose Level VI|Treatment-related AE|1|||
155079581|NCT02533674|559722932|FG006|Dose Level VI|Treatment-related AE|0|||
155079582|NCT02533674|559722933|FG007|Dose Level VI|Treatment-related AE|0|||
155079583|NCT02533674|559722926|FG000|Dose Level VII|Progressive disease|0|||
155079584|NCT02533674|559722927|FG001|Dose Level VII|Progressive disease|0|||
155079585|NCT02533674|559722928|FG002|Dose Level VII|Progressive disease|0|||
155079586|NCT02533674|559722929|FG003|Dose Level VII|Progressive disease|0|||
155079587|NCT02533674|559722930|FG004|Dose Level VII|Progressive disease|0|||
155079588|NCT02533674|559722931|FG005|Dose Level VII|Progressive disease|0|||
155079589|NCT02533674|559722932|FG006|Dose Level VII|Progressive disease|10|||
155079590|NCT02533674|559722933|FG007|Dose Level VII|Progressive disease|0|||
155079591|NCT02533674|559722926|FG000|Dose Level VII|Withdrawal by Subject|0|||
155079592|NCT02533674|559722927|FG001|Dose Level VII|Withdrawal by Subject|0|||
155079593|NCT02533674|559722928|FG002|Dose Level VII|Withdrawal by Subject|0|||
155079594|NCT02533674|559722929|FG003|Dose Level VII|Withdrawal by Subject|0|||
155079595|NCT02533674|559722930|FG004|Dose Level VII|Withdrawal by Subject|0|||
155079596|NCT02533674|559722931|FG005|Dose Level VII|Withdrawal by Subject|0|||
155079597|NCT02533674|559722932|FG006|Dose Level VII|Withdrawal by Subject|3|||
155079598|NCT02533674|559722933|FG007|Dose Level VII|Withdrawal by Subject|0|||
155079599|NCT02533674|559722926|FG000|Dose Level VII|Treatment-related AE|0|||
155079600|NCT02533674|559722927|FG001|Dose Level VII|Treatment-related AE|0|||
155079601|NCT02533674|559722928|FG002|Dose Level VII|Treatment-related AE|0|||
155079602|NCT02533674|559722929|FG003|Dose Level VII|Treatment-related AE|0|||
155079603|NCT02533674|559722930|FG004|Dose Level VII|Treatment-related AE|0|||
155079604|NCT02533674|559722931|FG005|Dose Level VII|Treatment-related AE|0|||
155079605|NCT02533674|559722932|FG006|Dose Level VII|Treatment-related AE|1|||
155079606|NCT02533674|559722933|FG007|Dose Level VII|Treatment-related AE|0|||
155079607|NCT02533674|559722926|FG000|Dose Level VII|Death|0|||
155079608|NCT02533674|559722927|FG001|Dose Level VII|Death|0|||
155079609|NCT02533674|559722928|FG002|Dose Level VII|Death|0|||
155079610|NCT02533674|559722929|FG003|Dose Level VII|Death|0|||
155079611|NCT02533674|559722930|FG004|Dose Level VII|Death|0|||
155079612|NCT02533674|559722931|FG005|Dose Level VII|Death|0|||
155079613|NCT02533674|559722932|FG006|Dose Level VII|Death|2|||
155079614|NCT02533674|559722933|FG007|Dose Level VII|Death|0|||
155079615|NCT02533674|559722926|FG000|Dose Level VIII|Progressive disease|0|||
155079616|NCT02533674|559722927|FG001|Dose Level VIII|Progressive disease|0|||
155079617|NCT02533674|559722928|FG002|Dose Level VIII|Progressive disease|0|||
155079618|NCT02533674|559722929|FG003|Dose Level VIII|Progressive disease|0|||
155079619|NCT02533674|559722930|FG004|Dose Level VIII|Progressive disease|0|||
155079620|NCT02533674|559722931|FG005|Dose Level VIII|Progressive disease|0|||
155079621|NCT02533674|559722932|FG006|Dose Level VIII|Progressive disease|0|||
155079622|NCT02533674|559722933|FG007|Dose Level VIII|Progressive disease|3|||
155079623|NCT02533674|559722926|FG000|Dose Level VIII|Withdrawal by Subject|0|||
155079624|NCT02533674|559722927|FG001|Dose Level VIII|Withdrawal by Subject|0|||
155079625|NCT02533674|559722928|FG002|Dose Level VIII|Withdrawal by Subject|0|||
155079626|NCT02533674|559722929|FG003|Dose Level VIII|Withdrawal by Subject|0|||
155079627|NCT02533674|559722930|FG004|Dose Level VIII|Withdrawal by Subject|0|||
155079628|NCT02533674|559722931|FG005|Dose Level VIII|Withdrawal by Subject|0|||
155079629|NCT02533674|559722932|FG006|Dose Level VIII|Withdrawal by Subject|0|||
155079630|NCT02533674|559722933|FG007|Dose Level VIII|Withdrawal by Subject|1|||
155079631|NCT02533674|559722926|FG000|Dose Level VIII|Treatment-related AE|0|||
155079632|NCT02533674|559722927|FG001|Dose Level VIII|Treatment-related AE|0|||
155079633|NCT02533674|559722928|FG002|Dose Level VIII|Treatment-related AE|0|||
155079634|NCT02533674|559722929|FG003|Dose Level VIII|Treatment-related AE|0|||
155079635|NCT02533674|559722930|FG004|Dose Level VIII|Treatment-related AE|0|||
155079636|NCT02533674|559722931|FG005|Dose Level VIII|Treatment-related AE|0|||
155079637|NCT02533674|559722932|FG006|Dose Level VIII|Treatment-related AE|0|||
155079638|NCT02533674|559722933|FG007|Dose Level VIII|Treatment-related AE|1|||
155079639|NCT02533674|559722926|FG000|Dose Level VIII|Never treated|0|||
155079640|NCT02533674|559722927|FG001|Dose Level VIII|Never treated|0|||
155079641|NCT02533674|559722928|FG002|Dose Level VIII|Never treated|0|||
155079642|NCT02533674|559722929|FG003|Dose Level VIII|Never treated|0|||
155079643|NCT02533674|559722930|FG004|Dose Level VIII|Never treated|0|||
155079644|NCT02533674|559722931|FG005|Dose Level VIII|Never treated|0|||
155079645|NCT02533674|559722932|FG006|Dose Level VIII|Never treated|0|||
155079646|NCT02533674|559722933|FG007|Dose Level VIII|Never treated|1|||
155079647|NCT03021005|559722934|FG000|Overall Study|Lost to Follow-up|39|||
155079648|NCT03021005|559722935|FG001|Overall Study|Lost to Follow-up|26|||
155079649|NCT03188705|559722936|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
155079650|NCT03188705|559722936|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
155079651|NCT01174459|559722937|FG000|Overall Study|case report form (CRF) not collected|5|||
155079652|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
155079653|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
155079654|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
155079655|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
155079656|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
155079657|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
155079658|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
155079659|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
155079660|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
155079661|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
155079662|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
155079663|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
155165228|NCT00330967|560041907|FG001|Overall Study|Withdrawal by Subject|5|||
155165229|NCT00330967|560041906|FG000|Overall Study|Physician Decision|0|||
155165230|NCT00330967|560041907|FG001|Overall Study|Physician Decision|9|||
155079664|NCT00290758|559722938|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
155079665|NCT00290758|559722939|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
155079666|NCT00290758|559722938|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
155079667|NCT00290758|559722939|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
155079668|NCT01111292|559722941|FG000|Treatment|Physician Decision|1|||
155079669|NCT01111292|559722942|FG001|Treatment|Physician Decision|1|||
155079670|NCT01096186|559722943|FG000|Overall Study|Adverse Event|16|||
155079671|NCT01096186|559722943|FG000|Overall Study|Death|4|||
155079672|NCT01096186|559722943|FG000|Overall Study|Lack of Efficacy|4|||
155079673|NCT01096186|559722943|FG000|Overall Study|Lost to Follow-up|2|||
155079674|NCT01096186|559722943|FG000|Overall Study|Withdrawal by Subject|22|||
155079675|NCT01096186|559722943|FG000|Overall Study|Physician Decision|1|||
155079676|NCT01096186|559722943|FG000|Overall Study|Noncompliance with study drug|1|||
155079677|NCT03156621|559722948|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
155079678|NCT03156621|559722949|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
155079679|NCT03156621|559722948|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
155079680|NCT03156621|559722949|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
155079681|NCT00799864|559722950|FG000|Overall Study|Participant reached a virologic endpoint|9|||
155165231|NCT00337675|560041908|FG000|Overall Study|Adverse Event|10|||
155165232|NCT00337675|560041909|FG001|Overall Study|Adverse Event|9|||
155079682|NCT00799864|559722951|FG001|Overall Study|Participant reached a virologic endpoint|2|||
155079683|NCT00799864|559722952|FG002|Overall Study|Participant reached a virologic endpoint|2|||
155079684|NCT00799864|559722953|FG003|Overall Study|Participant reached a virologic endpoint|0|||
155079685|NCT00799864|559722954|FG004|Overall Study|Participant reached a virologic endpoint|0|||
155079686|NCT00799864|559722950|FG000|Overall Study|Other|2|||
155079687|NCT00799864|559722951|FG001|Overall Study|Other|1|||
155079688|NCT00799864|559722952|FG002|Overall Study|Other|0|||
155165233|NCT00337675|560041910|FG002|Overall Study|Adverse Event|19|||
155079689|NCT00799864|559722953|FG003|Overall Study|Other|0|||
155079690|NCT00799864|559722954|FG004|Overall Study|Other|0|||
155079691|NCT00225758|559722955|FG000|Overall Study|Adverse Event|4|||
155165234|NCT00337675|560041908|FG000|Overall Study|Lack of Efficacy|10|||
155079692|NCT04641975|559722956|FG000|Overall Study|Protocol Violation|1|||
155079693|NCT04641975|559722957|FG001|Overall Study|Protocol Violation|2|||
155079694|NCT04641975|559722958|FG002|Overall Study|Protocol Violation|0|||
155079695|NCT04641975|559722959|FG003|Overall Study|Protocol Violation|0|||
155079696|NCT04641975|559722956|FG000|Overall Study|Adverse Event|0|||
155165235|NCT00337675|560041909|FG001|Overall Study|Lack of Efficacy|7|||
155165236|NCT00337675|560041910|FG002|Overall Study|Lack of Efficacy|9|||
155079697|NCT04641975|559722957|FG001|Overall Study|Adverse Event|0|||
155079698|NCT04641975|559722958|FG002|Overall Study|Adverse Event|1|||
155079699|NCT04641975|559722959|FG003|Overall Study|Adverse Event|1|||
155079700|NCT04641975|559722956|FG000|Overall Study|Withdrawal by Subject|1|||
155079701|NCT04641975|559722957|FG001|Overall Study|Withdrawal by Subject|0|||
155079702|NCT04641975|559722958|FG002|Overall Study|Withdrawal by Subject|0|||
155079703|NCT04641975|559722959|FG003|Overall Study|Withdrawal by Subject|0|||
155079704|NCT01259024|559722963|FG000|Overall Study|Physician Decision|1|||
155079705|NCT01657500|559722964|FG000|Overall Study|set impropperly matched|3|||
155079706|NCT01657500|559722965|FG001|Overall Study|set impropperly matched|3|||
155079707|NCT01657500|559722964|FG000|Overall Study|Lost to Follow-up|2|||
155079708|NCT01657500|559722965|FG001|Overall Study|Lost to Follow-up|2|||
155079709|NCT00552279|559722967|FG000|Overall Study|Adverse Event|0|||
155079710|NCT00552279|559722968|FG001|Overall Study|Adverse Event|1|||
155079711|NCT00552279|559722967|FG000|Overall Study|Withdrawal by Subject|12|||
155079712|NCT00552279|559722968|FG001|Overall Study|Withdrawal by Subject|1|||
155079713|NCT00552279|559722967|FG000|Overall Study|Lost to Follow-up|1|||
155079714|NCT00552279|559722968|FG001|Overall Study|Lost to Follow-up|0|||
155079715|NCT00552279|559722967|FG000|Overall Study|Other|1|||
155079716|NCT00552279|559722968|FG001|Overall Study|Other|1|||
155079717|NCT02453191|559722969|FG000|Overall Study|Withdrawal by Subject|1|||
155079718|NCT01520714|559722970|FG000|Overall Study|Protocol Violation|0|||
155079719|NCT01520714|559722971|FG001|Overall Study|Protocol Violation|3|||
155079720|NCT01520714|559722970|FG000|Overall Study|Adverse Event|0|||
155079721|NCT01520714|559722971|FG001|Overall Study|Adverse Event|2|||
155079722|NCT01520714|559722970|FG000|Overall Study|Lack of Efficacy|0|||
155079723|NCT01520714|559722971|FG001|Overall Study|Lack of Efficacy|1|||
155079724|NCT01210443|559722974|FG000|Overall Study|Study terminated by sponsor|2|||
155079725|NCT02807181|559722977|FG000|Overall Study|Death|28|||
155079726|NCT02807181|559722978|FG001|Overall Study|Death|24|||
155079727|NCT02807181|559722977|FG000|Overall Study|Withdrawal by Subject|1|||
155079728|NCT02807181|559722978|FG001|Overall Study|Withdrawal by Subject|1|||
155079729|NCT02807181|559722977|FG000|Overall Study|Lost to Follow-up|0|||
155079730|NCT02807181|559722978|FG001|Overall Study|Lost to Follow-up|2|||
155079731|NCT02807181|559722977|FG000|Overall Study|Subject decision|1|||
155079732|NCT02807181|559722978|FG001|Overall Study|Subject decision|0|||
155079733|NCT02807181|559722977|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
155079734|NCT02807181|559722978|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
155079735|NCT02807181|559722977|FG000|Overall Study|In Study|3|||
155079736|NCT02807181|559722978|FG001|Overall Study|In Study|3|||
155079737|NCT02807181|559722977|FG000|Overall Study|Post Progression|3|||
155079738|NCT02807181|559722978|FG001|Overall Study|Post Progression|2|||
155079739|NCT01489358|559722979|FG000|Overall Study|Lost to Follow-up|0|||
155079740|NCT01489358|559722980|FG001|Overall Study|Lost to Follow-up|0|||
155079741|NCT01489358|559722981|FG002|Overall Study|Lost to Follow-up|2|||
155079742|NCT03518203|559722982|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
155079743|NCT03518203|559722982|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
155079744|NCT02675452|559722984|FG000|Overall Study|Sponsor decision|0|||
155079745|NCT02675452|559722985|FG001|Overall Study|Sponsor decision|0|||
155079746|NCT02675452|559722986|FG002|Overall Study|Sponsor decision|0|||
155079747|NCT02675452|559722987|FG003|Overall Study|Sponsor decision|0|||
155079748|NCT02675452|559722988|FG004|Overall Study|Sponsor decision|0|||
155079749|NCT02675452|559722989|FG005|Overall Study|Sponsor decision|0|||
155079750|NCT02675452|559722990|FG006|Overall Study|Sponsor decision|0|||
155079751|NCT02675452|559722991|FG007|Overall Study|Sponsor decision|0|||
155079752|NCT02675452|559722992|FG008|Overall Study|Sponsor decision|0|||
155079753|NCT02675452|559722993|FG009|Overall Study|Sponsor decision|1|||
155079754|NCT02675452|559722994|FG010|Overall Study|Sponsor decision|0|||
155079755|NCT02675452|559722995|FG011|Overall Study|Sponsor decision|0|||
155079756|NCT02675452|559722996|FG012|Overall Study|Sponsor decision|0|||
155079757|NCT02675452|559722997|FG013|Overall Study|Sponsor decision|2|||
155165237|NCT00337675|560041908|FG000|Overall Study|Lost to Follow-up|22|||
155165238|NCT00337675|560041909|FG001|Overall Study|Lost to Follow-up|19|||
155079758|NCT02675452|559722998|FG014|Overall Study|Sponsor decision|1|||
155079759|NCT02675452|559722999|FG015|Overall Study|Sponsor decision|0|||
155079760|NCT02675452|559723000|FG016|Overall Study|Sponsor decision|1|||
155079761|NCT02675452|559723001|FG017|Overall Study|Sponsor decision|0|||
155079762|NCT02675452|559723002|FG018|Overall Study|Sponsor decision|0|||
155079763|NCT02675452|559723003|FG019|Overall Study|Sponsor decision|0|||
155079764|NCT02675452|559723004|FG020|Overall Study|Sponsor decision|0|||
155079765|NCT02675452|559723005|FG021|Overall Study|Sponsor decision|0|||
155079766|NCT02675452|559723006|FG022|Overall Study|Sponsor decision|0|||
155079767|NCT02675452|559723007|FG023|Overall Study|Sponsor decision|0|||
155079768|NCT02675452|559723008|FG024|Overall Study|Sponsor decision|0|||
155079769|NCT02675452|559723009|FG025|Overall Study|Sponsor decision|0|||
155079770|NCT02675452|559723010|FG026|Overall Study|Sponsor decision|2|||
155079771|NCT02675452|559723011|FG027|Overall Study|Sponsor decision|0|||
155079772|NCT02675452|559723012|FG028|Overall Study|Sponsor decision|0|||
155079773|NCT02675452|559722984|FG000|Overall Study|Withdrawal by Subject|0|||
155079774|NCT02675452|559722985|FG001|Overall Study|Withdrawal by Subject|0|||
155079775|NCT02675452|559722986|FG002|Overall Study|Withdrawal by Subject|0|||
155079776|NCT02675452|559722987|FG003|Overall Study|Withdrawal by Subject|0|||
155079777|NCT02675452|559722988|FG004|Overall Study|Withdrawal by Subject|0|||
155079778|NCT02675452|559722989|FG005|Overall Study|Withdrawal by Subject|0|||
155079779|NCT02675452|559722990|FG006|Overall Study|Withdrawal by Subject|0|||
155079780|NCT02675452|559722991|FG007|Overall Study|Withdrawal by Subject|0|||
155079781|NCT02675452|559722992|FG008|Overall Study|Withdrawal by Subject|0|||
155079782|NCT02675452|559722993|FG009|Overall Study|Withdrawal by Subject|1|||
155079783|NCT02675452|559722994|FG010|Overall Study|Withdrawal by Subject|0|||
155079784|NCT02675452|559722995|FG011|Overall Study|Withdrawal by Subject|1|||
155079785|NCT02675452|559722996|FG012|Overall Study|Withdrawal by Subject|0|||
155079786|NCT02675452|559722997|FG013|Overall Study|Withdrawal by Subject|1|||
155079787|NCT02675452|559722998|FG014|Overall Study|Withdrawal by Subject|1|||
155079788|NCT02675452|559722999|FG015|Overall Study|Withdrawal by Subject|0|||
155079789|NCT02675452|559723000|FG016|Overall Study|Withdrawal by Subject|2|||
155079790|NCT02675452|559723001|FG017|Overall Study|Withdrawal by Subject|0|||
155079791|NCT02675452|559723002|FG018|Overall Study|Withdrawal by Subject|0|||
155079792|NCT02675452|559723003|FG019|Overall Study|Withdrawal by Subject|0|||
155079793|NCT02675452|559723004|FG020|Overall Study|Withdrawal by Subject|0|||
155079794|NCT02675452|559723005|FG021|Overall Study|Withdrawal by Subject|0|||
155079795|NCT02675452|559723006|FG022|Overall Study|Withdrawal by Subject|3|||
155079796|NCT02675452|559723007|FG023|Overall Study|Withdrawal by Subject|0|||
155079797|NCT02675452|559723008|FG024|Overall Study|Withdrawal by Subject|1|||
155079798|NCT02675452|559723009|FG025|Overall Study|Withdrawal by Subject|0|||
155079799|NCT02675452|559723010|FG026|Overall Study|Withdrawal by Subject|1|||
155079800|NCT02675452|559723011|FG027|Overall Study|Withdrawal by Subject|3|||
155079801|NCT02675452|559723012|FG028|Overall Study|Withdrawal by Subject|4|||
155079802|NCT02675452|559722984|FG000|Overall Study|Death|0|||
155079803|NCT02675452|559722985|FG001|Overall Study|Death|0|||
155079804|NCT02675452|559722986|FG002|Overall Study|Death|1|||
155079805|NCT02675452|559722987|FG003|Overall Study|Death|0|||
155079806|NCT02675452|559722988|FG004|Overall Study|Death|0|||
155079807|NCT02675452|559722989|FG005|Overall Study|Death|1|||
155079808|NCT02675452|559722990|FG006|Overall Study|Death|0|||
155079809|NCT02675452|559722991|FG007|Overall Study|Death|0|||
155079810|NCT02675452|559722992|FG008|Overall Study|Death|1|||
155079811|NCT02675452|559722993|FG009|Overall Study|Death|0|||
155079812|NCT02675452|559722994|FG010|Overall Study|Death|0|||
155079813|NCT02675452|559722995|FG011|Overall Study|Death|0|||
155079814|NCT02675452|559722996|FG012|Overall Study|Death|1|||
155079815|NCT02675452|559722997|FG013|Overall Study|Death|0|||
155079816|NCT02675452|559722998|FG014|Overall Study|Death|0|||
155079817|NCT02675452|559722999|FG015|Overall Study|Death|2|||
155079818|NCT02675452|559723000|FG016|Overall Study|Death|0|||
155079819|NCT02675452|559723001|FG017|Overall Study|Death|0|||
155079820|NCT02675452|559723002|FG018|Overall Study|Death|4|||
155079821|NCT02675452|559723003|FG019|Overall Study|Death|3|||
155079822|NCT02675452|559723004|FG020|Overall Study|Death|3|||
155079823|NCT02675452|559723005|FG021|Overall Study|Death|3|||
155079824|NCT02675452|559723006|FG022|Overall Study|Death|7|||
155079825|NCT02675452|559723007|FG023|Overall Study|Death|5|||
155079826|NCT02675452|559723008|FG024|Overall Study|Death|3|||
155079827|NCT02675452|559723009|FG025|Overall Study|Death|4|||
155079828|NCT02675452|559723010|FG026|Overall Study|Death|7|||
155079829|NCT02675452|559723011|FG027|Overall Study|Death|6|||
155079830|NCT02675452|559723012|FG028|Overall Study|Death|9|||
155079831|NCT02675452|559722984|FG000|Overall Study|Lost to Follow-up|0|||
155079832|NCT02675452|559722985|FG001|Overall Study|Lost to Follow-up|1|||
155079833|NCT02675452|559722986|FG002|Overall Study|Lost to Follow-up|0|||
155079834|NCT02675452|559722987|FG003|Overall Study|Lost to Follow-up|0|||
155079835|NCT02675452|559722988|FG004|Overall Study|Lost to Follow-up|0|||
155079836|NCT02675452|559722989|FG005|Overall Study|Lost to Follow-up|0|||
155079837|NCT02675452|559722990|FG006|Overall Study|Lost to Follow-up|0|||
155079838|NCT02675452|559722991|FG007|Overall Study|Lost to Follow-up|0|||
155079839|NCT02675452|559722992|FG008|Overall Study|Lost to Follow-up|0|||
155079840|NCT02675452|559722993|FG009|Overall Study|Lost to Follow-up|0|||
155079841|NCT02675452|559722994|FG010|Overall Study|Lost to Follow-up|0|||
155079842|NCT02675452|559722995|FG011|Overall Study|Lost to Follow-up|0|||
155079843|NCT02675452|559722996|FG012|Overall Study|Lost to Follow-up|1|||
155079844|NCT02675452|559722997|FG013|Overall Study|Lost to Follow-up|0|||
155079845|NCT02675452|559722998|FG014|Overall Study|Lost to Follow-up|0|||
155079846|NCT02675452|559722999|FG015|Overall Study|Lost to Follow-up|0|||
155079847|NCT02675452|559723000|FG016|Overall Study|Lost to Follow-up|0|||
155079848|NCT02675452|559723001|FG017|Overall Study|Lost to Follow-up|0|||
155079849|NCT02675452|559723002|FG018|Overall Study|Lost to Follow-up|0|||
155079850|NCT02675452|559723003|FG019|Overall Study|Lost to Follow-up|0|||
155079851|NCT02675452|559723004|FG020|Overall Study|Lost to Follow-up|0|||
155079852|NCT02675452|559723005|FG021|Overall Study|Lost to Follow-up|0|||
155079853|NCT02675452|559723006|FG022|Overall Study|Lost to Follow-up|0|||
155079854|NCT02675452|559723007|FG023|Overall Study|Lost to Follow-up|0|||
155079855|NCT02675452|559723008|FG024|Overall Study|Lost to Follow-up|0|||
155079856|NCT02675452|559723009|FG025|Overall Study|Lost to Follow-up|0|||
155079857|NCT02675452|559723010|FG026|Overall Study|Lost to Follow-up|1|||
155079858|NCT02675452|559723011|FG027|Overall Study|Lost to Follow-up|0|||
155079859|NCT02675452|559723012|FG028|Overall Study|Lost to Follow-up|0|||
155079860|NCT02675452|559722984|FG000|Overall Study|Other|0|||
155079861|NCT02675452|559722985|FG001|Overall Study|Other|0|||
155079862|NCT02675452|559722986|FG002|Overall Study|Other|0|||
155079863|NCT02675452|559722987|FG003|Overall Study|Other|0|||
155079864|NCT02675452|559722988|FG004|Overall Study|Other|0|||
155079865|NCT02675452|559722989|FG005|Overall Study|Other|0|||
155079866|NCT02675452|559722990|FG006|Overall Study|Other|0|||
155079867|NCT02675452|559722991|FG007|Overall Study|Other|0|||
155079868|NCT02675452|559722992|FG008|Overall Study|Other|0|||
155079869|NCT02675452|559722993|FG009|Overall Study|Other|0|||
155079870|NCT02675452|559722994|FG010|Overall Study|Other|0|||
155079871|NCT02675452|559722995|FG011|Overall Study|Other|0|||
155079872|NCT02675452|559722996|FG012|Overall Study|Other|0|||
155079873|NCT02675452|559722997|FG013|Overall Study|Other|0|||
155079874|NCT02675452|559722998|FG014|Overall Study|Other|0|||
155079875|NCT02675452|559722999|FG015|Overall Study|Other|0|||
155079876|NCT02675452|559723000|FG016|Overall Study|Other|0|||
155079877|NCT02675452|559723001|FG017|Overall Study|Other|0|||
155079878|NCT02675452|559723002|FG018|Overall Study|Other|0|||
155079879|NCT02675452|559723003|FG019|Overall Study|Other|0|||
155079880|NCT02675452|559723004|FG020|Overall Study|Other|0|||
155165239|NCT00337675|560041910|FG002|Overall Study|Lost to Follow-up|17|||
155079881|NCT02675452|559723005|FG021|Overall Study|Other|0|||
155079882|NCT02675452|559723006|FG022|Overall Study|Other|0|||
155079883|NCT02675452|559723007|FG023|Overall Study|Other|0|||
155079884|NCT02675452|559723008|FG024|Overall Study|Other|0|||
155079885|NCT02675452|559723009|FG025|Overall Study|Other|0|||
155079886|NCT02675452|559723010|FG026|Overall Study|Other|1|||
155079887|NCT02675452|559723011|FG027|Overall Study|Other|0|||
155079888|NCT02675452|559723012|FG028|Overall Study|Other|0|||
155079889|NCT03467945|559723013|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155079890|NCT03467945|559723014|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155079891|NCT03467945|559723015|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155079892|NCT03467945|559723016|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155079893|NCT03467945|559723013|FG000|Treatment Period 3|Withdrawal by Subject|1|||
155079894|NCT03467945|559723014|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155079895|NCT03467945|559723015|FG002|Treatment Period 3|Withdrawal by Subject|2|||
155079896|NCT03467945|559723016|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155079897|NCT04595370|559723019|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
155079898|NCT04595370|559723020|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155079899|NCT04595370|559723021|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155079900|NCT04595370|559723022|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155079901|NCT04595370|559723023|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155079902|NCT04595370|559723024|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
155079903|NCT04595370|559723019|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155079904|NCT04595370|559723020|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155079905|NCT04595370|559723021|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
155079906|NCT04595370|559723022|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155079907|NCT04595370|559723023|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155079908|NCT04595370|559723024|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
155079909|NCT04595370|559723019|FG000|Overall Study|Adverse Event|0|||
155079910|NCT04595370|559723020|FG001|Overall Study|Adverse Event|4|||
155079911|NCT04595370|559723021|FG002|Overall Study|Adverse Event|3|||
155079912|NCT04595370|559723022|FG003|Overall Study|Adverse Event|1|||
155079913|NCT04595370|559723023|FG004|Overall Study|Adverse Event|1|||
155079914|NCT04595370|559723024|FG005|Overall Study|Adverse Event|1|||
155079915|NCT04595370|559723019|FG000|Overall Study|Withdrawal of Consent|1|||
155079916|NCT04595370|559723020|FG001|Overall Study|Withdrawal of Consent|1|||
155079917|NCT04595370|559723021|FG002|Overall Study|Withdrawal of Consent|1|||
155079918|NCT04595370|559723022|FG003|Overall Study|Withdrawal of Consent|0|||
155079919|NCT04595370|559723023|FG004|Overall Study|Withdrawal of Consent|0|||
155079920|NCT04595370|559723024|FG005|Overall Study|Withdrawal of Consent|0|||
155079921|NCT04595370|559723019|FG000|Overall Study|Death|0|||
155079922|NCT04595370|559723020|FG001|Overall Study|Death|1|||
155079923|NCT04595370|559723021|FG002|Overall Study|Death|0|||
155079924|NCT04595370|559723022|FG003|Overall Study|Death|0|||
155079925|NCT04595370|559723023|FG004|Overall Study|Death|1|||
155079926|NCT04595370|559723024|FG005|Overall Study|Death|0|||
155079927|NCT04595370|559723019|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155079928|NCT04595370|559723020|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155079929|NCT04595370|559723021|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155079930|NCT04595370|559723022|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155079931|NCT04595370|559723023|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155079932|NCT04595370|559723024|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155079933|NCT04595370|559723019|FG000|Overall Study|Withdrawal by Subject|0|||
155079934|NCT04595370|559723020|FG001|Overall Study|Withdrawal by Subject|0|||
155079935|NCT04595370|559723021|FG002|Overall Study|Withdrawal by Subject|1|||
155079936|NCT04595370|559723022|FG003|Overall Study|Withdrawal by Subject|0|||
155079937|NCT04595370|559723023|FG004|Overall Study|Withdrawal by Subject|2|||
155079938|NCT04595370|559723024|FG005|Overall Study|Withdrawal by Subject|0|||
155079939|NCT04595370|559723019|FG000|Overall Study|Lost to Follow-up|0|||
155079940|NCT04595370|559723020|FG001|Overall Study|Lost to Follow-up|0|||
155079941|NCT04595370|559723021|FG002|Overall Study|Lost to Follow-up|0|||
155079942|NCT04595370|559723022|FG003|Overall Study|Lost to Follow-up|0|||
155079943|NCT04595370|559723023|FG004|Overall Study|Lost to Follow-up|1|||
155079944|NCT04595370|559723024|FG005|Overall Study|Lost to Follow-up|0|||
155079945|NCT04595370|559723019|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
155079946|NCT04595370|559723020|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
155079947|NCT04595370|559723021|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
155079948|NCT04595370|559723022|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
155079949|NCT04595370|559723023|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
155079950|NCT04595370|559723024|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
155079951|NCT03520387|559723025|FG000|Pre-Randomization|Withdrawal by Subject|1|||
155079952|NCT03520387|559723026|FG001|Pre-Randomization|Withdrawal by Subject|0|||
155079953|NCT03520387|559723027|FG002|Pre-Randomization|Withdrawal by Subject|0|||
155079954|NCT03520387|559723028|FG003|Pre-Randomization|Withdrawal by Subject|0|||
155079955|NCT03520387|559723029|FG004|Pre-Randomization|Withdrawal by Subject|0|||
155079956|NCT03520387|559723025|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
155079957|NCT03520387|559723026|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155079958|NCT03520387|559723027|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155079959|NCT03520387|559723028|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155079960|NCT03520387|559723029|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
155079961|NCT00541775|559723030|FG000|Overall Study|Adverse Event|3|||
155079962|NCT00541775|559723031|FG001|Overall Study|Adverse Event|2|||
155079963|NCT00541775|559723032|FG002|Overall Study|Adverse Event|1|||
155079964|NCT00541775|559723030|FG000|Overall Study|Lack of Efficacy|0|||
155165240|NCT00337675|560041908|FG000|Overall Study|Physician Decision|9|||
155165241|NCT00337675|560041909|FG001|Overall Study|Physician Decision|17|||
155079965|NCT00541775|559723031|FG001|Overall Study|Lack of Efficacy|0|||
155079966|NCT00541775|559723032|FG002|Overall Study|Lack of Efficacy|3|||
155165242|NCT00337675|560041910|FG002|Overall Study|Physician Decision|14|||
155079967|NCT00541775|559723030|FG000|Overall Study|Lost to Follow-up|0|||
155079968|NCT00541775|559723031|FG001|Overall Study|Lost to Follow-up|0|||
155342767|NCT03246724|560687128|FG000|Overall Study|Unable to obtain medication timely|0|||
155342768|NCT03246724|560687129|FG001|Overall Study|Unable to obtain medication timely|2|||
155342769|NCT03246724|560687130|FG002|Overall Study|Unable to obtain medication timely|2|||
155342770|NCT03246724|560687131|FG003|Overall Study|Unable to obtain medication timely|1|||
155342771|NCT03246724|560687128|FG000|Overall Study|Re-consented to participate|0|||
155342772|NCT03246724|560687129|FG001|Overall Study|Re-consented to participate|0|||
155342773|NCT03246724|560687130|FG002|Overall Study|Re-consented to participate|0|||
155342774|NCT03246724|560687131|FG003|Overall Study|Re-consented to participate|1|||
155342775|NCT00655824|560687132|FG000|Overall Study|Adverse Event|3|||
155342776|NCT00655824|560687132|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
155342777|NCT00655824|560687132|FG000|Overall Study|Protocol Violation|1|||
155342778|NCT00655824|560687132|FG000|Overall Study|Withdrawal by Subject|4|||
155342779|NCT00655824|560687132|FG000|Overall Study|Deterioration of Trial Disease|2|||
155342780|NCT00589628|560687133|FG000|Overall Study|Lost to Follow-up|0|||
155342781|NCT00589628|560687134|FG001|Overall Study|Lost to Follow-up|1|||
155342782|NCT02189759|560687142|FG000|Overall Study|Lost to Follow-up|0|||
155342783|NCT02189759|560687143|FG001|Overall Study|Lost to Follow-up|0|||
155342784|NCT02189759|560687144|FG002|Overall Study|Lost to Follow-up|2|||
155342785|NCT02189759|560687145|FG003|Overall Study|Lost to Follow-up|5|||
155342786|NCT02470806|560687146|FG000|Overall Study|Lost to Follow-up|1|||
155342787|NCT02470806|560687147|FG001|Overall Study|Lost to Follow-up|1|||
155342788|NCT02470806|560687146|FG000|Overall Study|Adverse Event|5|||
155342789|NCT02470806|560687147|FG001|Overall Study|Adverse Event|2|||
155342790|NCT02470806|560687146|FG000|Overall Study|Protocol Violation|4|||
155342791|NCT02470806|560687147|FG001|Overall Study|Protocol Violation|11|||
155342792|NCT02470806|560687146|FG000|Overall Study|Physician Decision|0|||
155342793|NCT02470806|560687147|FG001|Overall Study|Physician Decision|3|||
155342794|NCT02470806|560687146|FG000|Overall Study|Withdrawal by Subject|3|||
155342795|NCT02470806|560687147|FG001|Overall Study|Withdrawal by Subject|10|||
155342796|NCT02470806|560687146|FG000|Overall Study|Lack of Efficacy|5|||
155342797|NCT02470806|560687147|FG001|Overall Study|Lack of Efficacy|15|||
155342798|NCT03032198|560687148|FG000|Overall Study|Screen Fail|1|||
155342799|NCT00866619|560687149|FG000|Overall Study|Adverse Event|112|||
155342800|NCT00866619|560687150|FG001|Overall Study|Adverse Event|106|||
155342801|NCT00866619|560687151|FG002|Overall Study|Adverse Event|47|||
155342802|NCT00866619|560687152|FG003|Overall Study|Adverse Event|44|||
155342803|NCT00866619|560687149|FG000|Overall Study|Protocol Violation|2|||
154963930|NCT01010503|559293493|FG000|Overall Study|Adverse Event|1|||
154963931|NCT01010503|559293493|FG000|Overall Study|Death|1|||
155342804|NCT00866619|560687150|FG001|Overall Study|Protocol Violation|39|||
155342805|NCT00866619|560687151|FG002|Overall Study|Protocol Violation|2|||
155342806|NCT00866619|560687152|FG003|Overall Study|Protocol Violation|17|||
154963932|NCT06336356|559293494|FG000|Overall Study|Withdrawal by Subject|1|||
155342807|NCT00866619|560687149|FG000|Overall Study|Withdrawal by Subject|587|||
155342808|NCT00866619|560687150|FG001|Overall Study|Withdrawal by Subject|295|||
155342809|NCT00866619|560687151|FG002|Overall Study|Withdrawal by Subject|272|||
155342810|NCT00866619|560687152|FG003|Overall Study|Withdrawal by Subject|144|||
155342811|NCT00866619|560687149|FG000|Overall Study|Lost to Follow-up|1145|||
155342812|NCT00866619|560687150|FG001|Overall Study|Lost to Follow-up|830|||
155342813|NCT00866619|560687151|FG002|Overall Study|Lost to Follow-up|568|||
155342814|NCT00866619|560687152|FG003|Overall Study|Lost to Follow-up|425|||
155342815|NCT01147471|560687153|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
155342816|NCT01147471|560687154|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
155342817|NCT01147471|560687153|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
155342818|NCT01147471|560687154|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
155342819|NCT01147471|560687153|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
155342820|NCT01147471|560687154|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
155342821|NCT01147471|560687153|FG000|3 Month Follow Up|Lost to Follow-up|1|||
155342822|NCT01147471|560687154|FG001|3 Month Follow Up|Lost to Follow-up|1|||
155342823|NCT01147471|560687153|FG000|3 Month Follow Up|Physician Decision|0|||
155342824|NCT01147471|560687154|FG001|3 Month Follow Up|Physician Decision|1|||
155342825|NCT01147471|560687153|FG000|6 Month Follow Up|Lost to Follow-up|4|||
155342826|NCT01147471|560687154|FG001|6 Month Follow Up|Lost to Follow-up|2|||
155342827|NCT00946998|560688485|FG000|Overall Study|Exited prior to first outcome assessment|5|||
155342828|NCT00946998|560688486|FG001|Overall Study|Exited prior to first outcome assessment|3|||
155342829|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
155342830|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
155342831|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
155342832|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
155342833|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
155342834|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
155342835|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
155342836|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
155342837|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
155342838|NCT01020487|560688491|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
155342839|NCT01020487|560688492|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
155342840|NCT01020487|560688493|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
155342841|NCT01020487|560688491|FG000|Part 2 Open-label Period|Adverse Event|0|||
155342842|NCT01020487|560688492|FG001|Part 2 Open-label Period|Adverse Event|4|||
155342843|NCT01020487|560688493|FG002|Part 2 Open-label Period|Adverse Event|1|||
155342844|NCT01922102|560688496|FG000|Overall Study|Withdrawal by Subject|7|||
155342845|NCT01922102|560688497|FG001|Overall Study|Withdrawal by Subject|3|||
155342846|NCT01922102|560688498|FG002|Overall Study|Withdrawal by Subject|7|||
155342847|NCT01922102|560688496|FG000|Overall Study|Physician Decision|0|||
155342848|NCT01922102|560688497|FG001|Overall Study|Physician Decision|2|||
155342849|NCT01922102|560688498|FG002|Overall Study|Physician Decision|1|||
155342850|NCT01922102|560688496|FG000|Overall Study|Adverse Event|1|||
155342851|NCT01922102|560688497|FG001|Overall Study|Adverse Event|2|||
155342852|NCT01922102|560688498|FG002|Overall Study|Adverse Event|0|||
155342853|NCT01922102|560688496|FG000|Overall Study|Lost to Follow-up|1|||
155342854|NCT01922102|560688497|FG001|Overall Study|Lost to Follow-up|0|||
155342855|NCT01922102|560688498|FG002|Overall Study|Lost to Follow-up|0|||
155342856|NCT01922102|560688496|FG000|Overall Study|Administrative problems|0|||
155342857|NCT01922102|560688497|FG001|Overall Study|Administrative problems|2|||
155342858|NCT01922102|560688498|FG002|Overall Study|Administrative problems|0|||
155342859|NCT00447499|560688501|FG000|Overall Study|Adverse Event|1|||
155342860|NCT00447499|560688501|FG000|Overall Study|Patient Decision|4|||
155342861|NCT00447499|560688501|FG000|Overall Study|Sponsor Decision|1|||
155342862|NCT00447499|560688501|FG000|Overall Study|Physician Decision|1|||
155342863|NCT01322347|560688503|FG000|Overall Study|Adverse Event|7|||
155079969|NCT00541775|559723032|FG002|Overall Study|Lost to Follow-up|2|||
155079970|NCT00541775|559723030|FG000|Overall Study|Protocol Violation|1|||
155079971|NCT00541775|559723031|FG001|Overall Study|Protocol Violation|0|||
155079972|NCT00541775|559723032|FG002|Overall Study|Protocol Violation|0|||
155079973|NCT00541775|559723030|FG000|Overall Study|Withdrawal by Subject and Other|5|||
155079974|NCT00541775|559723031|FG001|Overall Study|Withdrawal by Subject and Other|0|||
155079975|NCT00541775|559723032|FG002|Overall Study|Withdrawal by Subject and Other|2|||
155342864|NCT01322347|560688504|FG001|Overall Study|Adverse Event|2|||
155342865|NCT01322347|560688503|FG000|Overall Study|Death|5|||
155342866|NCT01322347|560688504|FG001|Overall Study|Death|3|||
155342867|NCT01322347|560688503|FG000|Overall Study|Physician Decision|2|||
155342868|NCT01322347|560688504|FG001|Overall Study|Physician Decision|1|||
155342869|NCT01322347|560688503|FG000|Overall Study|Protocol Violation|5|||
155342870|NCT01322347|560688504|FG001|Overall Study|Protocol Violation|2|||
155342871|NCT01322347|560688503|FG000|Overall Study|Withdrawal by Subject|1|||
155342872|NCT01322347|560688504|FG001|Overall Study|Withdrawal by Subject|4|||
155342873|NCT01322347|560688503|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
155342874|NCT01322347|560688504|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
155342875|NCT01322347|560688503|FG000|Overall Study|blood transfusion|5|||
155342876|NCT01322347|560688504|FG001|Overall Study|blood transfusion|5|||
155342877|NCT01322347|560688503|FG000|Overall Study|sponsor decision|1|||
155342878|NCT01322347|560688504|FG001|Overall Study|sponsor decision|3|||
155342879|NCT01322347|560688503|FG000|Overall Study|ineligible|6|||
155342880|NCT01322347|560688504|FG001|Overall Study|ineligible|3|||
155342881|NCT01322347|560688503|FG000|Overall Study|kidney transplant|3|||
155342882|NCT01322347|560688504|FG001|Overall Study|kidney transplant|1|||
155342883|NCT01322347|560688503|FG000|Overall Study|study drug withheld > 12 wks|0|||
155342884|NCT01322347|560688504|FG001|Overall Study|study drug withheld > 12 wks|1|||
155342885|NCT01322347|560688503|FG000|Overall Study|moved/changed dialysis|2|||
155342886|NCT01322347|560688504|FG001|Overall Study|moved/changed dialysis|4|||
155342887|NCT01193283|560688505|FG000|Overall Study|Death|1|||
155342888|NCT04883541|560688506|FG000|Overall Study|Not attending regular yoga class|16|||
155342889|NCT04883541|560688507|FG001|Overall Study|Not attending regular yoga class|0|||
155342890|NCT04883541|560688506|FG000|Overall Study|Not attending the pregnancy school|0|||
155342891|NCT04883541|560688507|FG001|Overall Study|Not attending the pregnancy school|9|||
155342892|NCT02823574|560688513|FG000|Randomization|Disease Progression|0|||
155342893|NCT02823574|560688514|FG001|Randomization|Disease Progression|0|||
155342894|NCT02823574|560688515|FG002|Randomization|Disease Progression|1|||
155342895|NCT02823574|560688516|FG003|Randomization|Disease Progression|0|||
155342896|NCT02823574|560688513|FG000|Randomization|AE unrelated to Study Drug|1|||
155342897|NCT02823574|560688514|FG001|Randomization|AE unrelated to Study Drug|0|||
155342898|NCT02823574|560688515|FG002|Randomization|AE unrelated to Study Drug|0|||
155342899|NCT02823574|560688516|FG003|Randomization|AE unrelated to Study Drug|0|||
155342900|NCT02823574|560688513|FG000|Treatment Period|Poor/Non Compliance|1|||
155342901|NCT02823574|560688514|FG001|Treatment Period|Poor/Non Compliance|0|||
155342902|NCT02823574|560688515|FG002|Treatment Period|Poor/Non Compliance|0|||
155342903|NCT02823574|560688516|FG003|Treatment Period|Poor/Non Compliance|1|||
155342904|NCT02823574|560688513|FG000|Treatment Period|Maximum Clinical Benefit|8|||
155342905|NCT02823574|560688514|FG001|Treatment Period|Maximum Clinical Benefit|4|||
155342906|NCT02823574|560688515|FG002|Treatment Period|Maximum Clinical Benefit|7|||
155342907|NCT02823574|560688516|FG003|Treatment Period|Maximum Clinical Benefit|1|||
155342908|NCT02823574|560688513|FG000|Treatment Period|Lost to Follow-up|1|||
155342909|NCT02823574|560688514|FG001|Treatment Period|Lost to Follow-up|1|||
155342910|NCT02823574|560688515|FG002|Treatment Period|Lost to Follow-up|0|||
155342911|NCT02823574|560688516|FG003|Treatment Period|Lost to Follow-up|0|||
155342912|NCT02823574|560688513|FG000|Treatment Period|Participant withdrew consent|4|||
155342913|NCT02823574|560688514|FG001|Treatment Period|Participant withdrew consent|0|||
155342914|NCT02823574|560688515|FG002|Treatment Period|Participant withdrew consent|0|||
155342915|NCT02823574|560688516|FG003|Treatment Period|Participant withdrew consent|1|||
155342916|NCT02823574|560688513|FG000|Treatment Period|Participant request to discontinue|5|||
155342917|NCT02823574|560688514|FG001|Treatment Period|Participant request to discontinue|0|||
155342918|NCT02823574|560688515|FG002|Treatment Period|Participant request to discontinue|3|||
155342919|NCT02823574|560688516|FG003|Treatment Period|Participant request to discontinue|2|||
155342920|NCT02823574|560688513|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
155342921|NCT02823574|560688514|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
155342922|NCT02823574|560688515|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
155342923|NCT02823574|560688516|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
155342924|NCT02823574|560688513|FG000|Treatment Period|Study Drug Toxicity|11|||
155342925|NCT02823574|560688514|FG001|Treatment Period|Study Drug Toxicity|2|||
155342926|NCT02823574|560688515|FG002|Treatment Period|Study Drug Toxicity|14|||
155342927|NCT02823574|560688516|FG003|Treatment Period|Study Drug Toxicity|4|||
155342928|NCT02823574|560688513|FG000|Treatment Period|Disease Progression|113|||
155342929|NCT02823574|560688514|FG001|Treatment Period|Disease Progression|64|||
155342930|NCT02823574|560688515|FG002|Treatment Period|Disease Progression|82|||
155342931|NCT02823574|560688516|FG003|Treatment Period|Disease Progression|43|||
155342932|NCT02823574|560688513|FG000|Treatment Period|Other reasons|5|||
155342933|NCT02823574|560688514|FG001|Treatment Period|Other reasons|9|||
155342934|NCT02823574|560688515|FG002|Treatment Period|Other reasons|3|||
155342935|NCT02823574|560688516|FG003|Treatment Period|Other reasons|6|||
155342936|NCT02823574|560688513|FG000|Treatment Period|Participant no longer meets study criteria|0|||
155342937|NCT02823574|560688514|FG001|Treatment Period|Participant no longer meets study criteria|0|||
155342938|NCT02823574|560688515|FG002|Treatment Period|Participant no longer meets study criteria|1|||
155342939|NCT02823574|560688516|FG003|Treatment Period|Participant no longer meets study criteria|0|||
155342940|NCT02823574|560688513|FG000|Treatment Period|Death|0|||
155342941|NCT02823574|560688514|FG001|Treatment Period|Death|0|||
155342942|NCT02823574|560688515|FG002|Treatment Period|Death|3|||
155342943|NCT02823574|560688516|FG003|Treatment Period|Death|1|||
155342944|NCT00590759|560688517|FG000|Overall Study|Death|52|||
155342945|NCT00590759|560688517|FG000|Overall Study|Lost to Follow-up|28|||
155342946|NCT02542696|560688523|FG000|Overall Study|Adverse Event|167|||
155342947|NCT02542696|560688523|FG000|Overall Study|Lack of Efficacy|26|||
155342948|NCT02542696|560688523|FG000|Overall Study|Lost to Follow-up|6|||
155342949|NCT02542696|560688523|FG000|Overall Study|Withdrawal by Subject|104|||
155342950|NCT02542696|560688523|FG000|Overall Study|Protocol Violation|5|||
155342951|NCT02542696|560688523|FG000|Overall Study|Death|8|||
155342952|NCT02542696|560688523|FG000|Overall Study|DECREASED OFF TIME|1|||
155342953|NCT02542696|560688523|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
155342954|NCT02542696|560688523|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
155342955|NCT02542696|560688523|FG000|Overall Study|MEDICAL HISTORY|1|||
155342956|NCT02542696|560688523|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
155342957|NCT02542696|560688523|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
155342958|NCT02542696|560688523|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
155342959|NCT02542696|560688523|FG000|Overall Study|SPONSOR DECISION|3|||
155342960|NCT02542696|560688523|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
155342961|NCT02542696|560688523|FG000|Overall Study|SUBJECT DECISION|2|||
155342962|NCT03345407|560688524|FG000|Overall Study|Withdrawal by Subject|11|||
155342963|NCT03345407|560688525|FG001|Overall Study|Withdrawal by Subject|1|||
155342964|NCT03345407|560688526|FG002|Overall Study|Withdrawal by Subject|5|||
155342965|NCT03345407|560688527|FG003|Overall Study|Withdrawal by Subject|6|||
155342966|NCT03345407|560688528|FG004|Overall Study|Withdrawal by Subject|3|||
155342967|NCT03345407|560688529|FG005|Overall Study|Withdrawal by Subject|6|||
155342968|NCT03345407|560688530|FG006|Overall Study|Withdrawal by Subject|16|||
155342969|NCT03345407|560688524|FG000|Overall Study|Physician Decision|3|||
155342970|NCT03345407|560688525|FG001|Overall Study|Physician Decision|1|||
155342971|NCT03345407|560688526|FG002|Overall Study|Physician Decision|0|||
155342972|NCT03345407|560688527|FG003|Overall Study|Physician Decision|0|||
155342973|NCT03345407|560688528|FG004|Overall Study|Physician Decision|1|||
155079976|NCT01945242|559723033|FG000|Overall Study|Physician Decision|3|||
155079977|NCT01945242|559723034|FG001|Overall Study|Physician Decision|3|||
155079978|NCT04913675|559723035|FG000|Main Study (Up to Week 36)|Death|0|||
155079979|NCT04913675|559723036|FG001|Main Study (Up to Week 36)|Death|2|||
155079980|NCT04913675|559723037|FG002|Main Study (Up to Week 36)|Death|2|||
155079981|NCT04913675|559723038|FG003|Main Study (Up to Week 36)|Death|0|||
155079982|NCT04913675|559723035|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
155079983|NCT04913675|559723036|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
155079984|NCT04913675|559723037|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
155079985|NCT04913675|559723038|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
155079986|NCT04913675|559723035|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
155079987|NCT04913675|559723036|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
155079988|NCT04913675|559723037|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
155079989|NCT04913675|559723038|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
155079990|NCT04913675|559723035|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
155079991|NCT04913675|559723036|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
155079992|NCT04913675|559723037|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
155079993|NCT04913675|559723038|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
155079994|NCT04913675|559723035|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
155079995|NCT04913675|559723036|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
155079996|NCT04913675|559723037|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
155079997|NCT04913675|559723038|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
155079998|NCT01541254|559723041|FG000|Overall Study|Withdrawal by Subject|1|||
155079999|NCT01541254|559723041|FG000|Overall Study|excluded - metal allergy|1|||
155342974|NCT03345407|560688529|FG005|Overall Study|Physician Decision|2|||
155342975|NCT03345407|560688530|FG006|Overall Study|Physician Decision|3|||
155342976|NCT03345407|560688524|FG000|Overall Study|Lost to Follow-up|2|||
155342977|NCT03345407|560688525|FG001|Overall Study|Lost to Follow-up|0|||
155342978|NCT03345407|560688526|FG002|Overall Study|Lost to Follow-up|1|||
155342979|NCT03345407|560688527|FG003|Overall Study|Lost to Follow-up|0|||
155342980|NCT03345407|560688528|FG004|Overall Study|Lost to Follow-up|1|||
155342981|NCT03345407|560688529|FG005|Overall Study|Lost to Follow-up|2|||
155342982|NCT03345407|560688530|FG006|Overall Study|Lost to Follow-up|3|||
155342983|NCT03345407|560688524|FG000|Overall Study|Protocol-defined stopping criteria|9|||
155342984|NCT03345407|560688525|FG001|Overall Study|Protocol-defined stopping criteria|0|||
155342985|NCT03345407|560688526|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155342986|NCT03345407|560688527|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155342987|NCT03345407|560688528|FG004|Overall Study|Protocol-defined stopping criteria|2|||
155342988|NCT03345407|560688529|FG005|Overall Study|Protocol-defined stopping criteria|1|||
155342989|NCT03345407|560688530|FG006|Overall Study|Protocol-defined stopping criteria|1|||
155342990|NCT03345407|560688524|FG000|Overall Study|Protocol Violation|2|||
155342991|NCT03345407|560688525|FG001|Overall Study|Protocol Violation|0|||
155342992|NCT03345407|560688526|FG002|Overall Study|Protocol Violation|0|||
155342993|NCT03345407|560688527|FG003|Overall Study|Protocol Violation|0|||
155342994|NCT03345407|560688528|FG004|Overall Study|Protocol Violation|1|||
155342995|NCT03345407|560688529|FG005|Overall Study|Protocol Violation|0|||
155342996|NCT03345407|560688530|FG006|Overall Study|Protocol Violation|3|||
155342997|NCT03345407|560688524|FG000|Overall Study|Lack of Efficacy|1|||
155342998|NCT03345407|560688525|FG001|Overall Study|Lack of Efficacy|1|||
155342999|NCT03345407|560688526|FG002|Overall Study|Lack of Efficacy|1|||
155343000|NCT03345407|560688527|FG003|Overall Study|Lack of Efficacy|1|||
155343001|NCT03345407|560688528|FG004|Overall Study|Lack of Efficacy|1|||
155343002|NCT03345407|560688529|FG005|Overall Study|Lack of Efficacy|0|||
155343003|NCT03345407|560688530|FG006|Overall Study|Lack of Efficacy|3|||
155343004|NCT03345407|560688524|FG000|Overall Study|Adverse Event|4|||
155343005|NCT03345407|560688525|FG001|Overall Study|Adverse Event|0|||
155343006|NCT03345407|560688526|FG002|Overall Study|Adverse Event|5|||
155343007|NCT03345407|560688527|FG003|Overall Study|Adverse Event|4|||
155343008|NCT03345407|560688528|FG004|Overall Study|Adverse Event|6|||
155343009|NCT03345407|560688529|FG005|Overall Study|Adverse Event|5|||
155343010|NCT03345407|560688530|FG006|Overall Study|Adverse Event|16|||
155343011|NCT03262389|560688533|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
155343012|NCT03262389|560688533|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
155343013|NCT03262389|560688533|FG000|Overall Study|opted out of PET/MR|1|||
155343014|NCT02256553|560688535|FG000|Period I|Adverse Event|5|||
155343015|NCT02256553|560688535|FG000|Period I|Protocol Violation|1|||
155343016|NCT02256553|560688535|FG000|Period II|Adverse Event|1|||
155343017|NCT02256553|560688535|FG000|Period II|Subject Moved|1|||
155343018|NCT02256553|560688535|FG000|Period III|Adverse Event|3|||
155343019|NCT02865083|560688536|FG000|Overall Study|Early Termination|3|||
155343020|NCT02865083|560688537|FG001|Overall Study|Early Termination|1|||
155343021|NCT03651271|560688538|FG000|Overall Study|Death|4|||
155343022|NCT03651271|560688539|FG001|Overall Study|Death|37|||
155343023|NCT03651271|560688540|FG002|Overall Study|Death|0|||
155343024|NCT03651271|560688541|FG003|Overall Study|Death|2|||
155343025|NCT03651271|560688542|FG004|Overall Study|Death|6|||
155343026|NCT03651271|560688538|FG000|Overall Study|Lost to Follow-up|1|||
155343027|NCT03651271|560688539|FG001|Overall Study|Lost to Follow-up|5|||
155343028|NCT03651271|560688540|FG002|Overall Study|Lost to Follow-up|0|||
155343029|NCT03651271|560688541|FG003|Overall Study|Lost to Follow-up|1|||
155343030|NCT03651271|560688542|FG004|Overall Study|Lost to Follow-up|0|||
155343031|NCT03651271|560688538|FG000|Overall Study|Physician Decision|0|||
155343032|NCT03651271|560688539|FG001|Overall Study|Physician Decision|2|||
155343033|NCT03651271|560688540|FG002|Overall Study|Physician Decision|0|||
155343034|NCT03651271|560688541|FG003|Overall Study|Physician Decision|0|||
155343035|NCT03651271|560688542|FG004|Overall Study|Physician Decision|0|||
155343036|NCT03651271|560688538|FG000|Overall Study|Withdrawal by Subject|1|||
155343037|NCT03651271|560688539|FG001|Overall Study|Withdrawal by Subject|15|||
155343038|NCT03651271|560688540|FG002|Overall Study|Withdrawal by Subject|0|||
155343039|NCT03651271|560688541|FG003|Overall Study|Withdrawal by Subject|0|||
155343040|NCT03651271|560688542|FG004|Overall Study|Withdrawal by Subject|1|||
155343041|NCT03651271|560688538|FG000|Overall Study|Patient medically unable to continue|0|||
155080000|NCT01541254|559723041|FG000|Overall Study|enrolled after study closed|1|||
155343042|NCT03651271|560688539|FG001|Overall Study|Patient medically unable to continue|0|||
155343043|NCT03651271|560688540|FG002|Overall Study|Patient medically unable to continue|0|||
155343044|NCT03651271|560688541|FG003|Overall Study|Patient medically unable to continue|1|||
155343045|NCT03651271|560688542|FG004|Overall Study|Patient medically unable to continue|0|||
155343046|NCT00821093|560688544|FG000|Overall Study|Adverse Event|20|||
155343047|NCT00821093|560688545|FG001|Overall Study|Adverse Event|12|||
155343048|NCT00821093|560688544|FG000|Overall Study|Withdrawal by Subject|9|||
155343049|NCT00821093|560688545|FG001|Overall Study|Withdrawal by Subject|13|||
155343050|NCT00821093|560688544|FG000|Overall Study|Lost to Follow-up|9|||
155343051|NCT00821093|560688545|FG001|Overall Study|Lost to Follow-up|3|||
155343052|NCT00821093|560688544|FG000|Overall Study|Protocol deviation|3|||
155343053|NCT00821093|560688545|FG001|Overall Study|Protocol deviation|6|||
155343054|NCT00821093|560688544|FG000|Overall Study|Abnormal laboratory value(s)|2|||
155343055|NCT00821093|560688545|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155343056|NCT00821093|560688544|FG000|Overall Study|Lack of Efficacy|2|||
155343057|NCT00821093|560688545|FG001|Overall Study|Lack of Efficacy|2|||
155343058|NCT00821093|560688544|FG000|Overall Study|Death|2|||
155343059|NCT00821093|560688545|FG001|Overall Study|Death|1|||
155343060|NCT00821093|560688544|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155343061|NCT00821093|560688545|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155343062|NCT00821093|560688544|FG000|Overall Study|Administrative problems|1|||
155343063|NCT00821093|560688545|FG001|Overall Study|Administrative problems|2|||
155343064|NCT02469155|560688548|FG000|Overall Study|Adverse Event|6|||
155343065|NCT02469155|560688549|FG001|Overall Study|Adverse Event|0|||
155343066|NCT02469155|560688550|FG002|Overall Study|Adverse Event|1|||
155343067|NCT02469155|560688551|FG003|Overall Study|Adverse Event|10|||
155343068|NCT02469155|560688548|FG000|Overall Study|Lack of Efficacy|13|||
155080001|NCT01541254|559723041|FG000|Overall Study|GI bleed prior to procedure|1|||
155080002|NCT01541254|559723041|FG000|Overall Study|stent not required|1|||
155080003|NCT01541254|559723041|FG000|Overall Study|alternate stent used|1|||
155343069|NCT02469155|560688549|FG001|Overall Study|Lack of Efficacy|10|||
155343070|NCT02469155|560688550|FG002|Overall Study|Lack of Efficacy|10|||
155343071|NCT02469155|560688551|FG003|Overall Study|Lack of Efficacy|8|||
155343072|NCT02469155|560688548|FG000|Overall Study|Death|0|||
155343073|NCT02469155|560688549|FG001|Overall Study|Death|0|||
155343074|NCT02469155|560688550|FG002|Overall Study|Death|0|||
155343075|NCT02469155|560688551|FG003|Overall Study|Death|1|||
155343076|NCT02469155|560688548|FG000|Overall Study|Lost to Follow-up|5|||
155343077|NCT02469155|560688549|FG001|Overall Study|Lost to Follow-up|2|||
155343078|NCT02469155|560688550|FG002|Overall Study|Lost to Follow-up|7|||
155343079|NCT02469155|560688551|FG003|Overall Study|Lost to Follow-up|2|||
155343080|NCT02469155|560688548|FG000|Overall Study|Physician Decision|0|||
155343081|NCT02469155|560688549|FG001|Overall Study|Physician Decision|0|||
155343082|NCT02469155|560688550|FG002|Overall Study|Physician Decision|1|||
155343083|NCT02469155|560688551|FG003|Overall Study|Physician Decision|0|||
155343084|NCT02469155|560688548|FG000|Overall Study|Withdrawal by Subject|34|||
155343085|NCT02469155|560688549|FG001|Overall Study|Withdrawal by Subject|30|||
155343086|NCT02469155|560688550|FG002|Overall Study|Withdrawal by Subject|20|||
155343087|NCT02469155|560688551|FG003|Overall Study|Withdrawal by Subject|37|||
155343088|NCT02469155|560688548|FG000|Overall Study|Other|3|||
155343089|NCT02469155|560688549|FG001|Overall Study|Other|3|||
155343090|NCT02469155|560688550|FG002|Overall Study|Other|2|||
155343091|NCT02469155|560688551|FG003|Overall Study|Other|10|||
155343092|NCT02469155|560688548|FG000|Overall Study|Protocol Violation|0|||
155343093|NCT02469155|560688549|FG001|Overall Study|Protocol Violation|1|||
155343094|NCT02469155|560688550|FG002|Overall Study|Protocol Violation|0|||
155343095|NCT02469155|560688551|FG003|Overall Study|Protocol Violation|1|||
155343096|NCT03150589|560688553|FG000|Overall Study|Withdrawal by Subject|16|||
155343097|NCT03150589|560688554|FG001|Overall Study|Withdrawal by Subject|9|||
155343098|NCT03150589|560688553|FG000|Overall Study|Adverse Event|7|||
155343099|NCT03150589|560688554|FG001|Overall Study|Adverse Event|6|||
155343100|NCT03150589|560688553|FG000|Overall Study|Protocol Violation|4|||
155343101|NCT03150589|560688554|FG001|Overall Study|Protocol Violation|3|||
155343102|NCT03150589|560688553|FG000|Overall Study|Lost to Follow-up|3|||
155343103|NCT03150589|560688554|FG001|Overall Study|Lost to Follow-up|3|||
155343104|NCT03150589|560688553|FG000|Overall Study|Death|2|||
155343105|NCT03150589|560688554|FG001|Overall Study|Death|3|||
155343106|NCT03150589|560688553|FG000|Overall Study|IP non-compliance and other reasons|12|||
155343107|NCT03150589|560688554|FG001|Overall Study|IP non-compliance and other reasons|3|||
155343108|NCT01405508|560688555|FG000|Overall Study|AE, non-serious non-fatal|1|||
155343109|NCT01405508|560688556|FG001|Overall Study|AE, non-serious non-fatal|1|||
155343110|NCT01405508|560688557|FG002|Overall Study|AE, non-serious non-fatal|0|||
155343111|NCT01405508|560688558|FG003|Overall Study|AE, non-serious non-fatal|0|||
155343112|NCT01989156|560688561|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
155343113|NCT01989156|560688562|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
155343114|NCT01989156|560688563|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
155343115|NCT01989156|560688561|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
155343116|NCT01989156|560688562|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
155343117|NCT01989156|560688563|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
155343118|NCT01989156|560688561|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
155343119|NCT01989156|560688562|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
155080004|NCT05660538|559723042|FG000|Overall Study|Adverse Event|0|||
155080005|NCT05660538|559723043|FG001|Overall Study|Adverse Event|0|||
155080006|NCT05660538|559723044|FG002|Overall Study|Adverse Event|1|||
155080007|NCT05660538|559723045|FG003|Overall Study|Adverse Event|0|||
155343120|NCT01989156|560688563|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
155343121|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
155343122|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
155343123|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
155343124|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
155343125|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
155343126|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
155343127|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
155343128|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
155343129|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
155343130|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
155343131|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
155343132|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
155343133|NCT01989156|560688561|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
155343134|NCT01989156|560688562|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
155343135|NCT01989156|560688563|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
155343136|NCT03839355|560688564|FG000|Overall Study|Withdrawal by Subject|1|||
155343137|NCT03839355|560688565|FG001|Overall Study|Withdrawal by Subject|0|||
155343138|NCT02892019|560688567|FG000|Overall Study|randomized but not treated|0|||
155343139|NCT02892019|560688568|FG001|Overall Study|randomized but not treated|1|||
155343140|NCT02892019|560688567|FG000|Overall Study|Withdrawal by Subject|0|||
155343141|NCT02892019|560688568|FG001|Overall Study|Withdrawal by Subject|1|||
155343142|NCT02892019|560688567|FG000|Overall Study|Adverse Event|1|||
155343143|NCT02892019|560688568|FG001|Overall Study|Adverse Event|1|||
155343144|NCT00689351|560688569|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
155343145|NCT00689351|560688570|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
155343146|NCT00689351|560688569|FG000|Infant Series of Dosing|Adverse Event|1|||
155343147|NCT00689351|560688570|FG001|Infant Series of Dosing|Adverse Event|0|||
155343148|NCT00689351|560688569|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
155343149|NCT00689351|560688570|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
155343150|NCT00689351|560688569|FG000|After Infant Series|Parent/legal guardian request|1|||
155343151|NCT00689351|560688570|FG001|After Infant Series|Parent/legal guardian request|0|||
155343152|NCT01766206|560688571|FG000|Overall Study|Withdrawal by Subject|22|||
155343153|NCT01766206|560688571|FG000|Overall Study|Lost to Follow-up|10|||
155343154|NCT01766206|560688571|FG000|Overall Study|Inappropriate enrollment|18|||
155343155|NCT01766206|560688571|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
155343156|NCT01662505|560688572|FG000|Overall Study|Progressive disease|6|||
155343157|NCT01662505|560688573|FG001|Overall Study|Progressive disease|1|||
155343158|NCT01662505|560688574|FG002|Overall Study|Progressive disease|5|||
155343159|NCT01662505|560688572|FG000|Overall Study|Refused cont. medication|0|||
155343160|NCT01662505|560688573|FG001|Overall Study|Refused cont. medication|0|||
155343161|NCT01662505|560688574|FG002|Overall Study|Refused cont. medication|1|||
155343162|NCT01662505|560688572|FG000|Overall Study|Not specified above|1|||
155343163|NCT01662505|560688573|FG001|Overall Study|Not specified above|3|||
155343164|NCT01662505|560688574|FG002|Overall Study|Not specified above|2|||
155343165|NCT01313663|560688575|FG000|Overall Study|Study Closed/Terminated|2|||
155343166|NCT01313663|560688576|FG001|Overall Study|Study Closed/Terminated|4|||
155343167|NCT01313663|560688575|FG000|Overall Study|Lost to Follow-up|0|||
155343168|NCT01313663|560688576|FG001|Overall Study|Lost to Follow-up|1|||
155343169|NCT01313663|560688575|FG000|Overall Study|Physician Decision|0|||
155343170|NCT01313663|560688576|FG001|Overall Study|Physician Decision|2|||
155343171|NCT01313663|560688575|FG000|Overall Study|Withdrawal by Subject|2|||
155343172|NCT01313663|560688576|FG001|Overall Study|Withdrawal by Subject|1|||
155343173|NCT01661972|560688579|FG000|Overall Study|Adverse Event|1|||
155343174|NCT01661972|560688580|FG001|Overall Study|Adverse Event|2|||
155343175|NCT01661972|560688579|FG000|Overall Study|Death during Treatment period|1|||
155343176|NCT01661972|560688580|FG001|Overall Study|Death during Treatment period|1|||
155343177|NCT01661972|560688579|FG000|Overall Study|Withdrawal by Subject|0|||
155343178|NCT01661972|560688580|FG001|Overall Study|Withdrawal by Subject|1|||
155080008|NCT05660538|559723042|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155343179|NCT02138838|560688584|FG000|Overall Study|Study Closure|7|||
155343180|NCT02138838|560688585|FG001|Overall Study|Study Closure|6|||
155343181|NCT02138838|560688584|FG000|Overall Study|Withdrawal by Subject|1|||
155343182|NCT02138838|560688585|FG001|Overall Study|Withdrawal by Subject|5|||
155343183|NCT01294644|560688587|FG000|Overall Study|Adverse Event|2|||
155343184|NCT01294644|560688588|FG001|Overall Study|Adverse Event|0|||
155343185|NCT01294644|560688589|FG002|Overall Study|Adverse Event|1|||
155343186|NCT01294644|560688587|FG000|Overall Study|Withdrawal by Subject|3|||
155343187|NCT01294644|560688588|FG001|Overall Study|Withdrawal by Subject|7|||
155343188|NCT01294644|560688589|FG002|Overall Study|Withdrawal by Subject|4|||
155343189|NCT01294644|560688587|FG000|Overall Study|Lost to Follow-up|3|||
155343190|NCT01294644|560688588|FG001|Overall Study|Lost to Follow-up|2|||
155343191|NCT01294644|560688589|FG002|Overall Study|Lost to Follow-up|5|||
155343192|NCT01294644|560688587|FG000|Overall Study|Miscellaneous Reason|2|||
155343193|NCT01294644|560688588|FG001|Overall Study|Miscellaneous Reason|1|||
155343194|NCT01294644|560688589|FG002|Overall Study|Miscellaneous Reason|4|||
155343195|NCT02367794|560688590|FG000|Overall Study|Death|252|||
155343196|NCT02367794|560688591|FG001|Overall Study|Death|245|||
155343197|NCT02367794|560688592|FG002|Overall Study|Death|243|||
155343198|NCT02367794|560688590|FG000|Overall Study|Lost to Follow-up|1|||
155343199|NCT02367794|560688591|FG001|Overall Study|Lost to Follow-up|2|||
155343200|NCT02367794|560688592|FG002|Overall Study|Lost to Follow-up|2|||
155343201|NCT02367794|560688590|FG000|Overall Study|Physician Decision|0|||
155343202|NCT02367794|560688591|FG001|Overall Study|Physician Decision|5|||
155343203|NCT02367794|560688592|FG002|Overall Study|Physician Decision|3|||
155343204|NCT02367794|560688590|FG000|Overall Study|Protocol Violation|1|||
155343205|NCT02367794|560688591|FG001|Overall Study|Protocol Violation|0|||
155343206|NCT02367794|560688592|FG002|Overall Study|Protocol Violation|1|||
155343207|NCT02367794|560688590|FG000|Overall Study|Withdrawal by Subject|25|||
155080009|NCT05660538|559723043|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155080010|NCT05660538|559723044|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
155343208|NCT02367794|560688591|FG001|Overall Study|Withdrawal by Subject|12|||
155343209|NCT02367794|560688592|FG002|Overall Study|Withdrawal by Subject|20|||
155343210|NCT02367794|560688590|FG000|Overall Study|Brain metastasis|1|||
155343211|NCT02367794|560688591|FG001|Overall Study|Brain metastasis|0|||
155343212|NCT02367794|560688592|FG002|Overall Study|Brain metastasis|0|||
155343213|NCT02367794|560688590|FG000|Overall Study|Randomized in error|0|||
155343214|NCT02367794|560688591|FG001|Overall Study|Randomized in error|0|||
155343215|NCT02367794|560688592|FG002|Overall Study|Randomized in error|1|||
155343216|NCT02367794|560688590|FG000|Overall Study|Patient unable to receive carboplatin|0|||
155343217|NCT02367794|560688591|FG001|Overall Study|Patient unable to receive carboplatin|0|||
155343218|NCT02367794|560688592|FG002|Overall Study|Patient unable to receive carboplatin|1|||
155343219|NCT02367794|560688590|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
155343220|NCT02367794|560688591|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
155343221|NCT02367794|560688592|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
155343222|NCT02367794|560688590|FG000|Overall Study|Adverse Event|0|||
155343223|NCT02367794|560688591|FG001|Overall Study|Adverse Event|0|||
155343224|NCT02367794|560688592|FG002|Overall Study|Adverse Event|2|||
155343225|NCT02367794|560688590|FG000|Overall Study|Study Terminated By Sponsor|0|||
155343226|NCT02367794|560688591|FG001|Overall Study|Study Terminated By Sponsor|1|||
155343227|NCT02367794|560688592|FG002|Overall Study|Study Terminated By Sponsor|1|||
155343228|NCT02367794|560688590|FG000|Overall Study|Moved to Roll-Over Study|0|||
155343229|NCT02367794|560688591|FG001|Overall Study|Moved to Roll-Over Study|15|||
155343230|NCT02367794|560688592|FG002|Overall Study|Moved to Roll-Over Study|13|||
155343231|NCT02367794|560688590|FG000|Overall Study|Sponsor Request|60|||
155343232|NCT02367794|560688591|FG001|Overall Study|Sponsor Request|57|||
155343233|NCT02367794|560688592|FG002|Overall Study|Sponsor Request|45|||
155343234|NCT02367794|560688590|FG000|Overall Study|Moved into PTAP Study|0|||
155343235|NCT02367794|560688591|FG001|Overall Study|Moved into PTAP Study|2|||
155343236|NCT02367794|560688592|FG002|Overall Study|Moved into PTAP Study|3|||
155343237|NCT02367794|560688590|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
155343238|NCT02367794|560688591|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
155080011|NCT05660538|559723045|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
155080012|NCT05660538|559723042|FG000|Overall Study|Lost to Follow-up|0|||
155080013|NCT05660538|559723043|FG001|Overall Study|Lost to Follow-up|0|||
155080014|NCT05660538|559723044|FG002|Overall Study|Lost to Follow-up|1|||
155080015|NCT05660538|559723045|FG003|Overall Study|Lost to Follow-up|1|||
155080016|NCT05660538|559723042|FG000|Overall Study|Death|0|||
155080017|NCT05660538|559723043|FG001|Overall Study|Death|0|||
155080018|NCT05660538|559723044|FG002|Overall Study|Death|1|||
155080019|NCT05660538|559723045|FG003|Overall Study|Death|0|||
155080020|NCT05660538|559723042|FG000|Overall Study|Physician Decision|0|||
155080021|NCT05660538|559723043|FG001|Overall Study|Physician Decision|0|||
155080022|NCT05660538|559723044|FG002|Overall Study|Physician Decision|0|||
155080023|NCT05660538|559723045|FG003|Overall Study|Physician Decision|1|||
155165243|NCT00337675|560041908|FG000|Overall Study|Protocol Violation|21|||
155343239|NCT02367794|560688592|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
155343240|NCT02367794|560688590|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
155343241|NCT02367794|560688591|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
155343242|NCT02367794|560688592|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
155343243|NCT02367794|560688590|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
155343244|NCT02367794|560688591|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
155343245|NCT02367794|560688592|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
155343246|NCT02367794|560688590|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
155343247|NCT02367794|560688591|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
155165244|NCT00337675|560041909|FG001|Overall Study|Protocol Violation|24|||
155080024|NCT05660538|559723042|FG000|Overall Study|Sponsor Decision|1|||
155343248|NCT02367794|560688592|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
155343249|NCT01986348|560688593|FG000|Overall Study|Death|8|||
155343250|NCT01986348|560688594|FG001|Overall Study|Death|22|||
155343251|NCT01986348|560688595|FG002|Overall Study|Death|10|||
155343252|NCT01986348|560688596|FG003|Overall Study|Death|21|||
155343253|NCT01986348|560688593|FG000|Overall Study|Lost to Follow-up|0|||
155343254|NCT01986348|560688594|FG001|Overall Study|Lost to Follow-up|0|||
155343255|NCT01986348|560688595|FG002|Overall Study|Lost to Follow-up|0|||
155343256|NCT01986348|560688596|FG003|Overall Study|Lost to Follow-up|2|||
155343257|NCT01986348|560688593|FG000|Overall Study|Physician Decision|0|||
155343258|NCT01986348|560688594|FG001|Overall Study|Physician Decision|0|||
155343259|NCT01986348|560688595|FG002|Overall Study|Physician Decision|0|||
155343260|NCT01986348|560688596|FG003|Overall Study|Physician Decision|1|||
155343261|NCT01986348|560688593|FG000|Overall Study|Progressive Disease|0|||
155343262|NCT01986348|560688594|FG001|Overall Study|Progressive Disease|0|||
155343263|NCT01986348|560688595|FG002|Overall Study|Progressive Disease|2|||
155343264|NCT01986348|560688596|FG003|Overall Study|Progressive Disease|0|||
155343265|NCT01986348|560688593|FG000|Overall Study|Withdrawal by Participant|0|||
155343266|NCT01986348|560688594|FG001|Overall Study|Withdrawal by Participant|1|||
155343267|NCT01986348|560688595|FG002|Overall Study|Withdrawal by Participant|2|||
155343268|NCT01986348|560688596|FG003|Overall Study|Withdrawal by Participant|1|||
155343269|NCT01986348|560688593|FG000|Overall Study|Study Terminated by Sponsor|0|||
155080025|NCT05660538|559723043|FG001|Overall Study|Sponsor Decision|0|||
155080026|NCT05660538|559723044|FG002|Overall Study|Sponsor Decision|0|||
155080027|NCT05660538|559723045|FG003|Overall Study|Sponsor Decision|0|||
155080028|NCT05660538|559723042|FG000|Overall Study|Other|1|||
155080029|NCT05660538|559723043|FG001|Overall Study|Other|0|||
155343270|NCT01986348|560688594|FG001|Overall Study|Study Terminated by Sponsor|0|||
155343271|NCT01986348|560688595|FG002|Overall Study|Study Terminated by Sponsor|0|||
155080030|NCT05660538|559723044|FG002|Overall Study|Other|0|||
155343272|NCT01986348|560688596|FG003|Overall Study|Study Terminated by Sponsor|3|||
155343273|NCT01986348|560688593|FG000|Overall Study|Other-unspecified|0|||
155343274|NCT01986348|560688594|FG001|Overall Study|Other-unspecified|1|||
155343275|NCT01986348|560688595|FG002|Overall Study|Other-unspecified|0|||
155080031|NCT05660538|559723045|FG003|Overall Study|Other|1|||
155343276|NCT01986348|560688596|FG003|Overall Study|Other-unspecified|2|||
155343277|NCT02010684|560688597|FG000|Overall Study|Lost to Follow-up|8|||
155343278|NCT02010684|560688598|FG001|Overall Study|Lost to Follow-up|18|||
155080032|NCT05660538|559723042|FG000|Overall Study|Randomized but did not receive study drug|1|||
155165245|NCT00337675|560041910|FG002|Overall Study|Protocol Violation|19|||
155343279|NCT02010684|560688597|FG000|Overall Study|Withdrawal by Subject|4|||
155343280|NCT02010684|560688598|FG001|Overall Study|Withdrawal by Subject|5|||
155343281|NCT01884571|560688603|FG000|Overall Study|Adverse Event|1|||
155343282|NCT01884571|560688603|FG000|Overall Study|Death|2|||
155343283|NCT01884571|560688603|FG000|Overall Study|Withdrawal by Subject|2|||
155343284|NCT01884571|560688603|FG000|Overall Study|Disease progression|3|||
155343285|NCT02158806|560688608|FG000|Overall Study|Death|2|||
155343286|NCT02158806|560688609|FG001|Overall Study|Death|0|||
155343287|NCT02158806|560688608|FG000|Overall Study|Withdrawal by Subject|2|||
155343288|NCT02158806|560688609|FG001|Overall Study|Withdrawal by Subject|0|||
155343289|NCT02158806|560688608|FG000|Overall Study|Lost to Follow-up|0|||
155343290|NCT02158806|560688609|FG001|Overall Study|Lost to Follow-up|3|||
155343291|NCT02158806|560688608|FG000|Overall Study|Moved out of area|0|||
155343292|NCT02158806|560688609|FG001|Overall Study|Moved out of area|1|||
155343293|NCT02158806|560688608|FG000|Overall Study|Transferred to palliative care|0|||
155343294|NCT02158806|560688609|FG001|Overall Study|Transferred to palliative care|1|||
155343295|NCT01898299|560688613|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
155343296|NCT01898299|560688614|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
155343297|NCT02340806|560688615|FG000|Overall Study|Protocol Violation|2|||
155343298|NCT02340806|560688616|FG001|Overall Study|Protocol Violation|0|||
155343299|NCT02340806|560688615|FG000|Overall Study|epidural catheter replaced|2|||
155343300|NCT02340806|560688616|FG001|Overall Study|epidural catheter replaced|1|||
155343301|NCT02340806|560688615|FG000|Overall Study|history of chronic pain medication|1|||
155343302|NCT02340806|560688616|FG001|Overall Study|history of chronic pain medication|0|||
155343303|NCT02340806|560688615|FG000|Overall Study|re-dose < 90 min of CSE|1|||
155343304|NCT02340806|560688616|FG001|Overall Study|re-dose < 90 min of CSE|3|||
155343305|NCT01159600|560688618|FG000|Overall Study|Not treated|0|||
155343306|NCT01159600|560688619|FG001|Overall Study|Not treated|0|||
155343307|NCT01159600|560688620|FG002|Overall Study|Not treated|1|||
155343308|NCT01159600|560688621|FG003|Overall Study|Not treated|0|||
155343309|NCT01159600|560688622|FG004|Overall Study|Not treated|0|||
155343310|NCT01159600|560688623|FG005|Overall Study|Not treated|1|||
155343311|NCT01159600|560688624|FG006|Overall Study|Not treated|2|||
155343312|NCT01159600|560688625|FG007|Overall Study|Not treated|2|||
155343313|NCT01159600|560688618|FG000|Overall Study|Adverse Event|7|||
155343314|NCT01159600|560688619|FG001|Overall Study|Adverse Event|2|||
155343315|NCT01159600|560688620|FG002|Overall Study|Adverse Event|5|||
155343316|NCT01159600|560688621|FG003|Overall Study|Adverse Event|1|||
155343317|NCT01159600|560688622|FG004|Overall Study|Adverse Event|8|||
155343318|NCT01159600|560688623|FG005|Overall Study|Adverse Event|6|||
155343319|NCT01159600|560688624|FG006|Overall Study|Adverse Event|7|||
155343320|NCT01159600|560688625|FG007|Overall Study|Adverse Event|5|||
155343321|NCT01159600|560688618|FG000|Overall Study|Lack of Efficacy|0|||
155343322|NCT01159600|560688619|FG001|Overall Study|Lack of Efficacy|0|||
155343323|NCT01159600|560688620|FG002|Overall Study|Lack of Efficacy|0|||
155343324|NCT01159600|560688621|FG003|Overall Study|Lack of Efficacy|0|||
155343325|NCT01159600|560688622|FG004|Overall Study|Lack of Efficacy|2|||
155343326|NCT01159600|560688623|FG005|Overall Study|Lack of Efficacy|0|||
155343327|NCT01159600|560688624|FG006|Overall Study|Lack of Efficacy|0|||
155343328|NCT01159600|560688625|FG007|Overall Study|Lack of Efficacy|1|||
155343329|NCT01159600|560688618|FG000|Overall Study|Non compliant with protocol|2|||
155343330|NCT01159600|560688619|FG001|Overall Study|Non compliant with protocol|1|||
155343331|NCT01159600|560688620|FG002|Overall Study|Non compliant with protocol|0|||
155343332|NCT01159600|560688621|FG003|Overall Study|Non compliant with protocol|0|||
155343333|NCT01159600|560688622|FG004|Overall Study|Non compliant with protocol|2|||
155343334|NCT01159600|560688623|FG005|Overall Study|Non compliant with protocol|0|||
154963933|NCT06336356|559293495|FG001|Overall Study|Withdrawal by Subject|0|||
154963934|NCT06336356|559293494|FG000|Overall Study|Lost to Follow Up|1|||
154963935|NCT06336356|559293495|FG001|Overall Study|Lost to Follow Up|0|||
155343335|NCT01159600|560688624|FG006|Overall Study|Non compliant with protocol|2|||
155343336|NCT01159600|560688625|FG007|Overall Study|Non compliant with protocol|0|||
155343337|NCT01159600|560688618|FG000|Overall Study|Lost to Follow-up|2|||
155343338|NCT01159600|560688619|FG001|Overall Study|Lost to Follow-up|3|||
155343339|NCT01159600|560688620|FG002|Overall Study|Lost to Follow-up|4|||
155343340|NCT01159600|560688621|FG003|Overall Study|Lost to Follow-up|3|||
155343341|NCT01159600|560688622|FG004|Overall Study|Lost to Follow-up|3|||
155343342|NCT01159600|560688623|FG005|Overall Study|Lost to Follow-up|0|||
155343343|NCT01159600|560688624|FG006|Overall Study|Lost to Follow-up|3|||
155343344|NCT01159600|560688625|FG007|Overall Study|Lost to Follow-up|2|||
155343345|NCT01159600|560688618|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
155080033|NCT05660538|559723043|FG001|Overall Study|Randomized but did not receive study drug|0|||
155080034|NCT05660538|559723044|FG002|Overall Study|Randomized but did not receive study drug|0|||
155080035|NCT05660538|559723045|FG003|Overall Study|Randomized but did not receive study drug|1|||
155080036|NCT05660538|559723042|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
155343346|NCT01159600|560688619|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
155343347|NCT01159600|560688620|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
155343348|NCT01159600|560688621|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
155343349|NCT01159600|560688622|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
155343350|NCT01159600|560688623|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
155343351|NCT01159600|560688624|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
155343352|NCT01159600|560688625|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
155343353|NCT01159600|560688618|FG000|Overall Study|Other reason not defined above|3|||
155343354|NCT01159600|560688619|FG001|Overall Study|Other reason not defined above|0|||
155343355|NCT01159600|560688620|FG002|Overall Study|Other reason not defined above|4|||
155343356|NCT01159600|560688621|FG003|Overall Study|Other reason not defined above|2|||
155343357|NCT01159600|560688622|FG004|Overall Study|Other reason not defined above|5|||
155343358|NCT01159600|560688623|FG005|Overall Study|Other reason not defined above|7|||
155343359|NCT01159600|560688624|FG006|Overall Study|Other reason not defined above|3|||
155343360|NCT01159600|560688625|FG007|Overall Study|Other reason not defined above|3|||
155343361|NCT00760877|560689783|FG000|Overall Study|Protocol Violation|1|||
155343362|NCT00760877|560689784|FG001|Overall Study|Protocol Violation|0|||
155343363|NCT00760877|560689783|FG000|Overall Study|Non-compliance with protocol treatment|2|||
155343364|NCT00760877|560689784|FG001|Overall Study|Non-compliance with protocol treatment|1|||
155343365|NCT00760877|560689783|FG000|Overall Study|Pregnancy|1|||
155343366|NCT00760877|560689784|FG001|Overall Study|Pregnancy|4|||
155343367|NCT00760877|560689783|FG000|Overall Study|Death|2|||
155343368|NCT00760877|560689784|FG001|Overall Study|Death|1|||
155343369|NCT00760877|560689783|FG000|Overall Study|Withdrawal by Subject|7|||
155343370|NCT00760877|560689784|FG001|Overall Study|Withdrawal by Subject|3|||
155343371|NCT00760877|560689783|FG000|Overall Study|Adverse Event|19|||
155343372|NCT00760877|560689784|FG001|Overall Study|Adverse Event|12|||
155343373|NCT00760877|560689783|FG000|Overall Study|Participant diagnosed with AML|0|||
155343374|NCT00760877|560689784|FG001|Overall Study|Participant diagnosed with AML|1|||
155343375|NCT00760877|560689783|FG000|Overall Study|Participant not eligible to cross-over|0|||
155343376|NCT00760877|560689784|FG001|Overall Study|Participant not eligible to cross-over|1|||
155343377|NCT00760877|560689783|FG000|Overall Study|Physician Decision|1|||
155343378|NCT00760877|560689784|FG001|Overall Study|Physician Decision|2|||
155343379|NCT00760877|560689783|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
155343380|NCT00760877|560689784|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
155343381|NCT00760877|560689783|FG000|Overall Study|Treatment failure|1|||
155343382|NCT00760877|560689784|FG001|Overall Study|Treatment failure|0|||
155343383|NCT02101554|560689790|FG000|Overall Study|Protocol Violation|0|||
155343384|NCT02101554|560689791|FG001|Overall Study|Protocol Violation|1|||
155343385|NCT02101554|560689792|FG002|Overall Study|Protocol Violation|0|||
155343386|NCT02101554|560689790|FG000|Overall Study|Insufficient Clinical Response|0|||
155343387|NCT02101554|560689791|FG001|Overall Study|Insufficient Clinical Response|2|||
155343388|NCT02101554|560689792|FG002|Overall Study|Insufficient Clinical Response|0|||
155343389|NCT02101554|560689790|FG000|Overall Study|Adverse Event|2|||
155343390|NCT02101554|560689791|FG001|Overall Study|Adverse Event|1|||
155343391|NCT02101554|560689792|FG002|Overall Study|Adverse Event|1|||
155343392|NCT02101554|560689790|FG000|Overall Study|Lost to Follow-up|0|||
155343393|NCT02101554|560689791|FG001|Overall Study|Lost to Follow-up|1|||
155343394|NCT02101554|560689792|FG002|Overall Study|Lost to Follow-up|0|||
155343395|NCT02101554|560689790|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
155343396|NCT02101554|560689791|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
155343397|NCT02101554|560689792|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
155343398|NCT04820023|560689793|FG000|Overall Study|Death|0|||
155343399|NCT04820023|560689794|FG001|Overall Study|Death|0|||
155343400|NCT04820023|560689795|FG002|Overall Study|Death|0|||
155343401|NCT04820023|560689796|FG003|Overall Study|Death|0|||
155343402|NCT04820023|560689797|FG004|Overall Study|Death|0|||
154963936|NCT05871151|559293496|FG000|Overall Study|Lost to Follow-up|1|||
154963937|NCT05871151|559293497|FG001|Overall Study|Lost to Follow-up|0|||
154963938|NCT05871151|559293496|FG000|Overall Study|Unrelated illness|0|||
154963939|NCT05871151|559293497|FG001|Overall Study|Unrelated illness|1|||
154963940|NCT06041256|559293498|FG000|Overall Study|Withdrawal by Subject|1|||
155343403|NCT04820023|560689798|FG005|Overall Study|Death|0|||
155343404|NCT04820023|560689799|FG006|Overall Study|Death|1|||
155343405|NCT04820023|560689800|FG007|Overall Study|Death|0|||
155343406|NCT04820023|560689801|FG008|Overall Study|Death|1|||
155343407|NCT04820023|560689793|FG000|Overall Study|Withdrawal by Subject|1|||
155343408|NCT04820023|560689794|FG001|Overall Study|Withdrawal by Subject|2|||
155343409|NCT04820023|560689795|FG002|Overall Study|Withdrawal by Subject|2|||
154963941|NCT06041256|559293499|FG001|Overall Study|Withdrawal by Subject|0|||
155080037|NCT05660538|559723043|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
155080038|NCT05660538|559723044|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
155343410|NCT04820023|560689796|FG003|Overall Study|Withdrawal by Subject|1|||
155343411|NCT04820023|560689797|FG004|Overall Study|Withdrawal by Subject|4|||
155343412|NCT04820023|560689798|FG005|Overall Study|Withdrawal by Subject|3|||
155343413|NCT04820023|560689799|FG006|Overall Study|Withdrawal by Subject|3|||
155343414|NCT04820023|560689800|FG007|Overall Study|Withdrawal by Subject|6|||
155343415|NCT04820023|560689801|FG008|Overall Study|Withdrawal by Subject|5|||
155343416|NCT04820023|560689793|FG000|Overall Study|Progressive Disease|3|||
155343417|NCT04820023|560689794|FG001|Overall Study|Progressive Disease|0|||
155343418|NCT04820023|560689795|FG002|Overall Study|Progressive Disease|2|||
155343419|NCT04820023|560689796|FG003|Overall Study|Progressive Disease|2|||
155343420|NCT04820023|560689797|FG004|Overall Study|Progressive Disease|2|||
155343421|NCT04820023|560689798|FG005|Overall Study|Progressive Disease|0|||
155343422|NCT04820023|560689799|FG006|Overall Study|Progressive Disease|1|||
155343423|NCT04820023|560689800|FG007|Overall Study|Progressive Disease|1|||
155343424|NCT04820023|560689801|FG008|Overall Study|Progressive Disease|0|||
155343425|NCT04820023|560689793|FG000|Overall Study|New anti-cancer therapy|0|||
155343426|NCT04820023|560689794|FG001|Overall Study|New anti-cancer therapy|0|||
155343427|NCT04820023|560689795|FG002|Overall Study|New anti-cancer therapy|0|||
155343428|NCT04820023|560689796|FG003|Overall Study|New anti-cancer therapy|0|||
155343429|NCT04820023|560689797|FG004|Overall Study|New anti-cancer therapy|2|||
155343430|NCT04820023|560689798|FG005|Overall Study|New anti-cancer therapy|0|||
155343431|NCT04820023|560689799|FG006|Overall Study|New anti-cancer therapy|0|||
155343432|NCT04820023|560689800|FG007|Overall Study|New anti-cancer therapy|0|||
155343433|NCT04820023|560689801|FG008|Overall Study|New anti-cancer therapy|0|||
155343434|NCT04820023|560689793|FG000|Overall Study|Other|0|||
155343435|NCT04820023|560689794|FG001|Overall Study|Other|1|||
155343436|NCT04820023|560689795|FG002|Overall Study|Other|0|||
155343437|NCT04820023|560689796|FG003|Overall Study|Other|0|||
155080039|NCT05660538|559723045|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
155080040|NCT04518410|559723046|FG000|Overall Study|Lost to Follow-up|1|||
155343438|NCT04820023|560689797|FG004|Overall Study|Other|0|||
155343439|NCT04820023|560689798|FG005|Overall Study|Other|0|||
155343440|NCT04820023|560689799|FG006|Overall Study|Other|0|||
155343441|NCT04820023|560689800|FG007|Overall Study|Other|2|||
155343442|NCT04820023|560689801|FG008|Overall Study|Other|0|||
155343443|NCT04049578|560689803|FG000|Overall Study|Physician Decision|1|||
155343444|NCT01945593|560689808|FG000|Overall Study|Adverse Event|0|||
155343445|NCT01945593|560689809|FG001|Overall Study|Adverse Event|0|||
155343446|NCT01945593|560689810|FG002|Overall Study|Adverse Event|0|||
155343447|NCT01945593|560689811|FG003|Overall Study|Adverse Event|5|||
155343448|NCT01945593|560689808|FG000|Overall Study|Physician Decision|0|||
155343449|NCT01945593|560689809|FG001|Overall Study|Physician Decision|0|||
155343450|NCT01945593|560689810|FG002|Overall Study|Physician Decision|1|||
155343451|NCT01945593|560689811|FG003|Overall Study|Physician Decision|1|||
155343452|NCT01945593|560689808|FG000|Overall Study|Withdrawal by Subject|0|||
155343453|NCT01945593|560689809|FG001|Overall Study|Withdrawal by Subject|2|||
155343454|NCT01945593|560689810|FG002|Overall Study|Withdrawal by Subject|0|||
155343455|NCT01945593|560689811|FG003|Overall Study|Withdrawal by Subject|4|||
155080041|NCT04518410|559723047|FG001|Overall Study|Lost to Follow-up|1|||
155343456|NCT01945593|560689808|FG000|Overall Study|Protocol Violation|0|||
155343457|NCT01945593|560689809|FG001|Overall Study|Protocol Violation|2|||
155343458|NCT01945593|560689810|FG002|Overall Study|Protocol Violation|1|||
155343459|NCT01945593|560689811|FG003|Overall Study|Protocol Violation|3|||
155343460|NCT01945593|560689808|FG000|Overall Study|Death|0|||
155343461|NCT01945593|560689809|FG001|Overall Study|Death|0|||
155343462|NCT01945593|560689810|FG002|Overall Study|Death|1|||
155343463|NCT01945593|560689811|FG003|Overall Study|Death|0|||
155343464|NCT01945593|560689808|FG000|Overall Study|Other: Terminated|0|||
155080042|NCT04518410|559723048|FG002|Overall Study|Lost to Follow-up|8|||
155343465|NCT01945593|560689809|FG001|Overall Study|Other: Terminated|0|||
155343466|NCT01945593|560689810|FG002|Overall Study|Other: Terminated|0|||
155343467|NCT01945593|560689811|FG003|Overall Study|Other: Terminated|1|||
155080043|NCT04518410|559723049|FG003|Overall Study|Lost to Follow-up|5|||
155343468|NCT01945593|560689808|FG000|Overall Study|Other: Surgical Procedure|0|||
155343469|NCT01945593|560689809|FG001|Overall Study|Other: Surgical Procedure|2|||
155343470|NCT01945593|560689810|FG002|Overall Study|Other: Surgical Procedure|0|||
155343471|NCT01945593|560689811|FG003|Overall Study|Other: Surgical Procedure|6|||
155343472|NCT01945593|560689808|FG000|Overall Study|Other: Screen Failure|0|||
155343473|NCT01945593|560689809|FG001|Overall Study|Other: Screen Failure|2|||
155343474|NCT01945593|560689810|FG002|Overall Study|Other: Screen Failure|0|||
155343475|NCT01945593|560689811|FG003|Overall Study|Other: Screen Failure|0|||
155343476|NCT00228813|560689812|FG000|Overall Study|Death|4|||
155343477|NCT02109172|560689819|FG000|Overall Study|Withdrawal by Subject|1|||
155343478|NCT02109172|560689820|FG001|Overall Study|Withdrawal by Subject|0|||
155343479|NCT02109172|560689821|FG002|Overall Study|Withdrawal by Subject|0|||
155343480|NCT02109172|560689822|FG003|Overall Study|Withdrawal by Subject|1|||
155343481|NCT02109172|560689823|FG004|Overall Study|Withdrawal by Subject|0|||
155343482|NCT02109172|560689824|FG005|Overall Study|Withdrawal by Subject|0|||
155343483|NCT02109172|560689819|FG000|Overall Study|Adverse Event|0|||
155343484|NCT02109172|560689820|FG001|Overall Study|Adverse Event|0|||
155343485|NCT02109172|560689821|FG002|Overall Study|Adverse Event|1|||
155343486|NCT02109172|560689822|FG003|Overall Study|Adverse Event|0|||
155343487|NCT02109172|560689823|FG004|Overall Study|Adverse Event|0|||
155343488|NCT02109172|560689824|FG005|Overall Study|Adverse Event|1|||
155343489|NCT02109172|560689819|FG000|Overall Study|Death|0|||
155343490|NCT02109172|560689820|FG001|Overall Study|Death|0|||
155343491|NCT02109172|560689821|FG002|Overall Study|Death|0|||
155343492|NCT02109172|560689822|FG003|Overall Study|Death|0|||
155343493|NCT02109172|560689823|FG004|Overall Study|Death|1|||
155343494|NCT02109172|560689824|FG005|Overall Study|Death|0|||
155343495|NCT03605745|560689825|FG000|Overall Study|Study was terminated for business reasons|47|||
155343496|NCT01279447|560689826|FG000|Overall Study|Lost to Follow-up|3|||
155343497|NCT01279447|560689827|FG001|Overall Study|Lost to Follow-up|1|||
155343498|NCT02213094|560689831|FG000|Overall Study|Adverse Event|1|||
155343499|NCT02213094|560689832|FG001|Overall Study|Adverse Event|0|||
155343500|NCT01074229|560689833|FG000|Overall Study|Lost to Follow-up|1|||
155343501|NCT01074229|560689834|FG001|Overall Study|Lost to Follow-up|0|||
155343502|NCT01074229|560689835|FG002|Overall Study|Lost to Follow-up|0|||
155343503|NCT01074229|560689833|FG000|Overall Study|Change to open surgical procedure|1|||
155343504|NCT01074229|560689834|FG001|Overall Study|Change to open surgical procedure|3|||
155343505|NCT01074229|560689835|FG002|Overall Study|Change to open surgical procedure|4|||
155343506|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
155343507|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
155343508|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
155343509|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
155343510|NCT02163499|560689836|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
155343511|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
155343512|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
155343513|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
155343514|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
155343515|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
155343516|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
155343517|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
155343518|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
155343519|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
155343520|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Death|8|||
155343521|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
155343522|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
155343523|NCT02163499|560689836|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
155343524|NCT00555620|560689838|FG000|Overall Study|Death|0|||
155343525|NCT00555620|560689839|FG001|Overall Study|Death|1|||
155343526|NCT00555620|560689840|FG002|Overall Study|Death|0|||
155343527|NCT00555620|560689841|FG003|Overall Study|Death|0|||
155343528|NCT00555620|560689842|FG004|Overall Study|Death|0|||
155343529|NCT00555620|560689843|FG005|Overall Study|Death|1|||
155343530|NCT00555620|560689838|FG000|Overall Study|Study terminated by sponsor|0|||
155343531|NCT00555620|560689839|FG001|Overall Study|Study terminated by sponsor|0|||
155343532|NCT00555620|560689840|FG002|Overall Study|Study terminated by sponsor|1|||
155343533|NCT00555620|560689841|FG003|Overall Study|Study terminated by sponsor|0|||
155343534|NCT00555620|560689842|FG004|Overall Study|Study terminated by sponsor|0|||
155343535|NCT00555620|560689843|FG005|Overall Study|Study terminated by sponsor|0|||
155343536|NCT00555620|560689838|FG000|Overall Study|Adverse Event|0|||
155343537|NCT00555620|560689839|FG001|Overall Study|Adverse Event|0|||
155343538|NCT00555620|560689840|FG002|Overall Study|Adverse Event|1|||
155080044|NCT04518410|559723050|FG004|Overall Study|Lost to Follow-up|92|||
155080045|NCT04518410|559723051|FG005|Overall Study|Lost to Follow-up|25|||
155080046|NCT04518410|559723052|FG006|Overall Study|Lost to Follow-up|25|||
155080047|NCT04518410|559723053|FG007|Overall Study|Lost to Follow-up|3|||
155343539|NCT00555620|560689841|FG003|Overall Study|Adverse Event|5|||
155080048|NCT04518410|559723054|FG008|Overall Study|Lost to Follow-up|2|||
155080049|NCT04518410|559723055|FG009|Overall Study|Lost to Follow-up|13|||
155343540|NCT00555620|560689842|FG004|Overall Study|Adverse Event|0|||
155343541|NCT00555620|560689843|FG005|Overall Study|Adverse Event|1|||
155343542|NCT00555620|560689838|FG000|Overall Study|Objective progression or relapse|6|||
155343543|NCT00555620|560689839|FG001|Overall Study|Objective progression or relapse|5|||
155343544|NCT00555620|560689840|FG002|Overall Study|Objective progression or relapse|12|||
155343545|NCT00555620|560689841|FG003|Overall Study|Objective progression or relapse|17|||
155343546|NCT00555620|560689842|FG004|Overall Study|Objective progression or relapse|3|||
155343547|NCT00555620|560689843|FG005|Overall Study|Objective progression or relapse|16|||
155343548|NCT00555620|560689838|FG000|Overall Study|Participant refused treatment|0|||
155343549|NCT00555620|560689839|FG001|Overall Study|Participant refused treatment|1|||
155343550|NCT00555620|560689840|FG002|Overall Study|Participant refused treatment|1|||
155343551|NCT00555620|560689841|FG003|Overall Study|Participant refused treatment|0|||
155343552|NCT00555620|560689842|FG004|Overall Study|Participant refused treatment|0|||
155343553|NCT00555620|560689843|FG005|Overall Study|Participant refused treatment|1|||
155343554|NCT00555620|560689838|FG000|Overall Study|Other|0|||
155343555|NCT00555620|560689839|FG001|Overall Study|Other|0|||
155343556|NCT00555620|560689840|FG002|Overall Study|Other|0|||
155343557|NCT00555620|560689841|FG003|Overall Study|Other|1|||
155343558|NCT00555620|560689842|FG004|Overall Study|Other|0|||
155343559|NCT00555620|560689843|FG005|Overall Study|Other|3|||
155343560|NCT05203822|560689844|FG000|Overall Study|Adverse Event|1|||
155343561|NCT05203822|560689844|FG000|Overall Study|Withdrawal by Subject|1|||
155343562|NCT05361304|560689849|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
155343563|NCT05361304|560689850|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
155343564|NCT05361304|560689849|FG000|Overall Study|COVID-19 Related|1|||
155343565|NCT05361304|560689850|FG001|Overall Study|COVID-19 Related|2|||
155343566|NCT05361304|560689849|FG000|Overall Study|Withdrawal by Subject|1|||
155343567|NCT05361304|560689850|FG001|Overall Study|Withdrawal by Subject|0|||
155343568|NCT03320941|560689851|FG000|Overall Study|subject/guardian decision|0|||
155343569|NCT03320941|560689852|FG001|Overall Study|subject/guardian decision|0|||
155343570|NCT03320941|560689853|FG002|Overall Study|subject/guardian decision|0|||
155343571|NCT03320941|560689854|FG003|Overall Study|subject/guardian decision|1|||
155343572|NCT03320941|560689855|FG004|Overall Study|subject/guardian decision|0|||
155343573|NCT03360071|560689857|FG000|Overall Study|Lost to Follow-up|1|||
155343574|NCT03360071|560689858|FG001|Overall Study|Lost to Follow-up|0|||
155343575|NCT03184519|560689863|FG000|Overall Study|Lost to Follow-up|6|||
155343576|NCT03184519|560689863|FG000|Overall Study|Physician Decision|21|||
155343577|NCT05104242|560689868|FG000|Overall Study|Withdrawal by Subject|1|||
155343578|NCT05104242|560689869|FG001|Overall Study|Withdrawal by Subject|5|||
155343579|NCT05104242|560689868|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
155343580|NCT05104242|560689869|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
155343581|NCT00901459|560689875|FG000|Overall Study|Withdrawal by Subject|6|||
155343582|NCT04765046|560689876|FG000|Overall Study|Screen Failure|2|||
155343583|NCT04765046|560689876|FG000|Overall Study|Withdrawal by Subject|4|||
155343584|NCT04765046|560689876|FG000|Overall Study|Physician Decision|4|||
155343585|NCT04765046|560689876|FG000|Overall Study|Surgery Cancelled|8|||
155343586|NCT02959866|560689880|FG000|Overall Study|Withdrawal by Subject|1|||
155343587|NCT05740371|560689884|FG000|Overall Study|Death|1|||
155343588|NCT04529941|560689885|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
155343589|NCT04529941|560689886|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
155343590|NCT01005914|560689887|FG000|Overall Study|Adverse Event|4|||
155343591|NCT01005914|560689887|FG000|Overall Study|Death|4|||
155343592|NCT01005914|560689887|FG000|Overall Study|Lack of Efficacy|1|||
155343593|NCT01005914|560689887|FG000|Overall Study|Withdrawal by Subject|1|||
155343594|NCT01240785|560689888|FG000|Overall Study|Lost to Follow-up|1|||
155343595|NCT01240785|560689889|FG001|Overall Study|Lost to Follow-up|0|||
155343596|NCT01240785|560689888|FG000|Overall Study|Protocol Violation|0|||
155343597|NCT01240785|560689889|FG001|Overall Study|Protocol Violation|3|||
155343598|NCT00321555|560689894|FG000|Overall Study|Developed antibodies|1|||
155343599|NCT00321555|560689894|FG000|Overall Study|Switched to alternative treatment|3|||
155343600|NCT00321555|560689894|FG000|Overall Study|Physician Decision|1|||
155343601|NCT00321555|560689894|FG000|Overall Study|Disease progression on study|1|||
155343602|NCT04520256|560689897|FG000|Overall Study|Lost to Follow-up|6|||
155343603|NCT04520256|560689898|FG001|Overall Study|Lost to Follow-up|4|||
155343604|NCT04520256|560689899|FG002|Overall Study|Lost to Follow-up|2|||
155343605|NCT04520256|560689900|FG003|Overall Study|Lost to Follow-up|3|||
155343606|NCT04520256|560689901|FG004|Overall Study|Lost to Follow-up|6|||
155343607|NCT04520256|560689902|FG005|Overall Study|Lost to Follow-up|6|||
155343608|NCT04520256|560689903|FG006|Overall Study|Lost to Follow-up|4|||
155343609|NCT04520256|560689904|FG007|Overall Study|Lost to Follow-up|6|||
155343610|NCT04520256|560689905|FG008|Overall Study|Lost to Follow-up|1|||
155343611|NCT04520256|560689906|FG009|Overall Study|Lost to Follow-up|3|||
155343612|NCT04520256|560689907|FG010|Overall Study|Lost to Follow-up|3|||
155343613|NCT04520256|560689908|FG011|Overall Study|Lost to Follow-up|2|||
155343614|NCT04520256|560689909|FG012|Overall Study|Lost to Follow-up|5|||
155343615|NCT04520256|560689910|FG013|Overall Study|Lost to Follow-up|3|||
155343616|NCT04520256|560689911|FG014|Overall Study|Lost to Follow-up|3|||
155343617|NCT04520256|560689912|FG015|Overall Study|Lost to Follow-up|6|||
155343618|NCT04520256|560689913|FG016|Overall Study|Lost to Follow-up|6|||
155343619|NCT04520256|560689914|FG017|Overall Study|Lost to Follow-up|4|||
155343620|NCT04520256|560689915|FG018|Overall Study|Lost to Follow-up|3|||
155343621|NCT04520256|560689916|FG019|Overall Study|Lost to Follow-up|3|||
155343622|NCT04520256|560689917|FG020|Overall Study|Lost to Follow-up|7|||
155343623|NCT04520256|560689918|FG021|Overall Study|Lost to Follow-up|3|||
155343624|NCT04520256|560689919|FG022|Overall Study|Lost to Follow-up|3|||
155343625|NCT04520256|560689920|FG023|Overall Study|Lost to Follow-up|8|||
155343626|NCT04520256|560689921|FG024|Overall Study|Lost to Follow-up|5|||
155343627|NCT04520256|560689922|FG025|Overall Study|Lost to Follow-up|4|||
155343628|NCT04520256|560689923|FG026|Overall Study|Lost to Follow-up|3|||
155343629|NCT04520256|560689924|FG027|Overall Study|Lost to Follow-up|4|||
155343630|NCT04520256|560689925|FG028|Overall Study|Lost to Follow-up|3|||
155343631|NCT04520256|560689926|FG029|Overall Study|Lost to Follow-up|4|||
155343632|NCT04520256|560689927|FG030|Overall Study|Lost to Follow-up|4|||
155343633|NCT04520256|560689928|FG031|Overall Study|Lost to Follow-up|4|||
155343634|NCT01730118|560691323|FG000|Dose Escalation|Death on study|5|||
155343635|NCT01730118|560691324|FG001|Dose Escalation|Death on study|7|||
155343636|NCT01730118|560691325|FG002|Dose Escalation|Death on study|2|||
155343637|NCT01730118|560691326|FG003|Dose Escalation|Death on study|6|||
155343638|NCT01730118|560691327|FG004|Dose Escalation|Death on study|0|||
155343639|NCT01730118|560691328|FG005|Dose Escalation|Death on study|0|||
155343640|NCT01730118|560691329|FG006|Dose Escalation|Death on study|0|||
155343641|NCT01730118|560691323|FG000|Dose Escalation|Died before treatment|0|||
155343642|NCT01730118|560691324|FG001|Dose Escalation|Died before treatment|0|||
155343643|NCT01730118|560691325|FG002|Dose Escalation|Died before treatment|0|||
155343644|NCT01730118|560691326|FG003|Dose Escalation|Died before treatment|0|||
155343645|NCT01730118|560691327|FG004|Dose Escalation|Died before treatment|0|||
155343646|NCT01730118|560691328|FG005|Dose Escalation|Died before treatment|0|||
155343647|NCT01730118|560691329|FG006|Dose Escalation|Died before treatment|1|||
155343648|NCT01730118|560691323|FG000|Dose Escalation|Chose to start a different treatment|1|||
155343649|NCT01730118|560691324|FG001|Dose Escalation|Chose to start a different treatment|0|||
155343650|NCT01730118|560691325|FG002|Dose Escalation|Chose to start a different treatment|0|||
155343651|NCT01730118|560691326|FG003|Dose Escalation|Chose to start a different treatment|0|||
155343652|NCT01730118|560691327|FG004|Dose Escalation|Chose to start a different treatment|0|||
155343653|NCT01730118|560691328|FG005|Dose Escalation|Chose to start a different treatment|0|||
155343654|NCT01730118|560691329|FG006|Dose Escalation|Chose to start a different treatment|0|||
155343655|NCT01730118|560691323|FG000|Dose Escalation|Withdrawal by Subject|0|||
155343656|NCT01730118|560691324|FG001|Dose Escalation|Withdrawal by Subject|0|||
155343657|NCT01730118|560691325|FG002|Dose Escalation|Withdrawal by Subject|1|||
155343658|NCT01730118|560691326|FG003|Dose Escalation|Withdrawal by Subject|0|||
155343659|NCT01730118|560691327|FG004|Dose Escalation|Withdrawal by Subject|0|||
155343660|NCT01730118|560691328|FG005|Dose Escalation|Withdrawal by Subject|0|||
155343661|NCT01730118|560691329|FG006|Dose Escalation|Withdrawal by Subject|0|||
155343662|NCT01730118|560691323|FG000|Dose Escalation|Disease progression prior to treatment|0|||
155343663|NCT01730118|560691324|FG001|Dose Escalation|Disease progression prior to treatment|0|||
155343664|NCT01730118|560691325|FG002|Dose Escalation|Disease progression prior to treatment|0|||
155343665|NCT01730118|560691326|FG003|Dose Escalation|Disease progression prior to treatment|0|||
155343666|NCT01730118|560691327|FG004|Dose Escalation|Disease progression prior to treatment|0|||
155343667|NCT01730118|560691328|FG005|Dose Escalation|Disease progression prior to treatment|0|||
155343668|NCT01730118|560691329|FG006|Dose Escalation|Disease progression prior to treatment|1|||
155343669|NCT01730118|560691323|FG000|Dose Expansion|Death|0|||
155343670|NCT01730118|560691324|FG001|Dose Expansion|Death|0|||
155343671|NCT01730118|560691325|FG002|Dose Expansion|Death|0|||
155343672|NCT01730118|560691326|FG003|Dose Expansion|Death|0|||
155343673|NCT01730118|560691327|FG004|Dose Expansion|Death|1|||
155343674|NCT01730118|560691328|FG005|Dose Expansion|Death|0|||
155343675|NCT01730118|560691329|FG006|Dose Expansion|Death|0|||
155343676|NCT01730118|560691323|FG000|Dose Expansion|Other medical condition|0|||
155343677|NCT01730118|560691324|FG001|Dose Expansion|Other medical condition|0|||
155343678|NCT01730118|560691325|FG002|Dose Expansion|Other medical condition|0|||
155080050|NCT04518410|559723056|FG010|Overall Study|Lost to Follow-up|9|||
155343679|NCT01730118|560691326|FG003|Dose Expansion|Other medical condition|0|||
155343680|NCT01730118|560691327|FG004|Dose Expansion|Other medical condition|1|||
155343681|NCT01730118|560691328|FG005|Dose Expansion|Other medical condition|0|||
155343682|NCT01730118|560691329|FG006|Dose Expansion|Other medical condition|0|||
155343683|NCT01730118|560691323|FG000|Dose Expansion|Withdrawal by Subject|0|||
155080051|NCT04518410|559723057|FG011|Overall Study|Lost to Follow-up|13|||
155343684|NCT01730118|560691324|FG001|Dose Expansion|Withdrawal by Subject|0|||
155343685|NCT01730118|560691325|FG002|Dose Expansion|Withdrawal by Subject|0|||
155343686|NCT01730118|560691326|FG003|Dose Expansion|Withdrawal by Subject|0|||
155343687|NCT01730118|560691327|FG004|Dose Expansion|Withdrawal by Subject|1|||
155343688|NCT01730118|560691328|FG005|Dose Expansion|Withdrawal by Subject|0|||
155343689|NCT01730118|560691329|FG006|Dose Expansion|Withdrawal by Subject|0|||
155165246|NCT00337675|560041908|FG000|Overall Study|Withdrawal by Subject|25|||
155165247|NCT00337675|560041909|FG001|Overall Study|Withdrawal by Subject|25|||
155165248|NCT00337675|560041910|FG002|Overall Study|Withdrawal by Subject|19|||
155165249|NCT00337675|560041908|FG000|Overall Study|Progressive Disease|0|||
155165250|NCT00337675|560041909|FG001|Overall Study|Progressive Disease|2|||
155165251|NCT00337675|560041910|FG002|Overall Study|Progressive Disease|0|||
155165252|NCT00337675|560041908|FG000|Overall Study|Trial Terminated|0|||
155165253|NCT00337675|560041909|FG001|Overall Study|Trial Terminated|0|||
155165254|NCT00337675|560041910|FG002|Overall Study|Trial Terminated|2|||
155165255|NCT04693234|560041911|FG000|Overall Study|Death|79|||
155165256|NCT04693234|560041912|FG001|Overall Study|Death|19|||
155165257|NCT04693234|560041911|FG000|Overall Study|Sponsor Ended Study|47|||
155165258|NCT04693234|560041912|FG001|Overall Study|Sponsor Ended Study|18|||
155165259|NCT04693234|560041911|FG000|Overall Study|Withdrawal by Subject|10|||
155165260|NCT04693234|560041912|FG001|Overall Study|Withdrawal by Subject|2|||
155165261|NCT04693234|560041911|FG000|Overall Study|Lost to Follow-up|2|||
155165262|NCT04693234|560041912|FG001|Overall Study|Lost to Follow-up|1|||
155165263|NCT02578706|560041915|FG000|Overall Study|Withdrawal by Subject|1|||
155165264|NCT02578706|560041916|FG001|Overall Study|Withdrawal by Subject|0|||
155165265|NCT02578706|560041917|FG002|Overall Study|Withdrawal by Subject|0|||
155165266|NCT02578706|560041915|FG000|Overall Study|Lost to Follow-up|0|||
155165267|NCT02578706|560041916|FG001|Overall Study|Lost to Follow-up|4|||
155343690|NCT01730118|560691323|FG000|Dose Expansion|Disease progression|0|||
155343691|NCT01730118|560691324|FG001|Dose Expansion|Disease progression|0|||
155343692|NCT01730118|560691325|FG002|Dose Expansion|Disease progression|0|||
155343693|NCT01730118|560691326|FG003|Dose Expansion|Disease progression|0|||
155343694|NCT01730118|560691327|FG004|Dose Expansion|Disease progression|0|||
155343695|NCT01730118|560691328|FG005|Dose Expansion|Disease progression|1|||
155343696|NCT01730118|560691329|FG006|Dose Expansion|Disease progression|0|||
155343697|NCT01730118|560691323|FG000|Dose Expansion|Inability to return|0|||
155343698|NCT01730118|560691324|FG001|Dose Expansion|Inability to return|0|||
155343699|NCT01730118|560691325|FG002|Dose Expansion|Inability to return|0|||
155343700|NCT01730118|560691326|FG003|Dose Expansion|Inability to return|0|||
155343701|NCT01730118|560691327|FG004|Dose Expansion|Inability to return|0|||
155343702|NCT01730118|560691328|FG005|Dose Expansion|Inability to return|1|||
155343703|NCT01730118|560691329|FG006|Dose Expansion|Inability to return|0|||
155343704|NCT01730118|560691323|FG000|Dose Expansion|Physician Decision|0|||
155343705|NCT01730118|560691324|FG001|Dose Expansion|Physician Decision|0|||
155343706|NCT01730118|560691325|FG002|Dose Expansion|Physician Decision|0|||
155343707|NCT01730118|560691326|FG003|Dose Expansion|Physician Decision|0|||
155343708|NCT01730118|560691327|FG004|Dose Expansion|Physician Decision|0|||
155343709|NCT01730118|560691328|FG005|Dose Expansion|Physician Decision|1|||
155343710|NCT01730118|560691329|FG006|Dose Expansion|Physician Decision|0|||
155343711|NCT05356130|560691331|FG000|Overall Study|Withdrawal by Subject|0|||
155343712|NCT05356130|560691332|FG001|Overall Study|Withdrawal by Subject|0|||
155343713|NCT05356130|560691333|FG002|Overall Study|Withdrawal by Subject|3|||
155343714|NCT04851587|560691334|FG000|Overall Study|Lost to Follow-up|18|||
155165268|NCT02578706|560041917|FG002|Overall Study|Lost to Follow-up|0|||
155165269|NCT02578706|560041915|FG000|Overall Study|Physician Decision|0|||
155165270|NCT02578706|560041916|FG001|Overall Study|Physician Decision|1|||
155165271|NCT02578706|560041917|FG002|Overall Study|Physician Decision|0|||
155165272|NCT01662102|560041920|FG000|Overall Study|Sponsor's decision|1|||
155080052|NCT04518410|559723058|FG012|Overall Study|Lost to Follow-up|9|||
155080053|NCT04518410|559723059|FG013|Overall Study|Lost to Follow-up|13|||
155080054|NCT04518410|559723060|FG014|Overall Study|Lost to Follow-up|8|||
155080055|NCT04518410|559723061|FG015|Overall Study|Lost to Follow-up|10|||
155080056|NCT04518410|559723062|FG016|Overall Study|Lost to Follow-up|6|||
155080057|NCT04518410|559723063|FG017|Overall Study|Lost to Follow-up|13|||
155080058|NCT04518410|559723064|FG018|Overall Study|Lost to Follow-up|21|||
155080059|NCT04518410|559723065|FG019|Overall Study|Lost to Follow-up|6|||
155080060|NCT04518410|559723066|FG020|Overall Study|Lost to Follow-up|7|||
155343715|NCT00538629|560691336|FG000|Overall Study|At subject's request|1|||
155343716|NCT00538629|560691336|FG000|Overall Study|Adverse Event|2|||
155343717|NCT00538629|560691336|FG000|Overall Study|Lack of Efficacy|12|||
155343718|NCT00538629|560691336|FG000|Overall Study|Lost to Follow-up|6|||
155343719|NCT00538629|560691336|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
155343720|NCT04454125|560691341|FG000|Overall Study|Lost to Follow-up|0|||
155080061|NCT04518410|559723067|FG021|Overall Study|Lost to Follow-up|21|||
155343721|NCT04454125|560691342|FG001|Overall Study|Lost to Follow-up|1|||
155343722|NCT01183013|560691345|FG000|Overall Study|Adverse Event|6|||
155343723|NCT01183013|560691346|FG001|Overall Study|Adverse Event|8|||
155343724|NCT01183013|560691347|FG002|Overall Study|Adverse Event|5|||
155343725|NCT01183013|560691348|FG003|Overall Study|Adverse Event|5|||
155343726|NCT01183013|560691349|FG004|Overall Study|Adverse Event|10|||
155343727|NCT01183013|560691350|FG005|Overall Study|Adverse Event|10|||
155343728|NCT01183013|560691351|FG006|Overall Study|Adverse Event|6|||
155343729|NCT01183013|560691345|FG000|Overall Study|Lack of Efficacy|3|||
155343730|NCT01183013|560691346|FG001|Overall Study|Lack of Efficacy|2|||
155343731|NCT01183013|560691347|FG002|Overall Study|Lack of Efficacy|1|||
155343732|NCT01183013|560691348|FG003|Overall Study|Lack of Efficacy|2|||
155343733|NCT01183013|560691349|FG004|Overall Study|Lack of Efficacy|1|||
155343734|NCT01183013|560691350|FG005|Overall Study|Lack of Efficacy|2|||
155080062|NCT04518410|559723068|FG022|Overall Study|Lost to Follow-up|1|||
155080063|NCT04518410|559723069|FG023|Overall Study|Lost to Follow-up|7|||
155080064|NCT04518410|559723070|FG024|Overall Study|Lost to Follow-up|6|||
155080065|NCT04518410|559723046|FG000|Overall Study|Withdrawal by Subject|1|||
155080066|NCT04518410|559723047|FG001|Overall Study|Withdrawal by Subject|2|||
155080067|NCT04518410|559723048|FG002|Overall Study|Withdrawal by Subject|2|||
155080068|NCT04518410|559723049|FG003|Overall Study|Withdrawal by Subject|3|||
155080069|NCT04518410|559723050|FG004|Overall Study|Withdrawal by Subject|20|||
155080070|NCT04518410|559723051|FG005|Overall Study|Withdrawal by Subject|20|||
155080071|NCT04518410|559723052|FG006|Overall Study|Withdrawal by Subject|25|||
155080072|NCT04518410|559723053|FG007|Overall Study|Withdrawal by Subject|6|||
155080073|NCT04518410|559723054|FG008|Overall Study|Withdrawal by Subject|1|||
155080074|NCT04518410|559723055|FG009|Overall Study|Withdrawal by Subject|12|||
155080075|NCT04518410|559723056|FG010|Overall Study|Withdrawal by Subject|5|||
155080076|NCT04518410|559723057|FG011|Overall Study|Withdrawal by Subject|7|||
155080077|NCT04518410|559723058|FG012|Overall Study|Withdrawal by Subject|2|||
155080078|NCT04518410|559723059|FG013|Overall Study|Withdrawal by Subject|13|||
155080079|NCT04518410|559723060|FG014|Overall Study|Withdrawal by Subject|4|||
155080080|NCT04518410|559723061|FG015|Overall Study|Withdrawal by Subject|9|||
155080081|NCT04518410|559723062|FG016|Overall Study|Withdrawal by Subject|0|||
155080082|NCT04518410|559723063|FG017|Overall Study|Withdrawal by Subject|15|||
155080083|NCT04518410|559723064|FG018|Overall Study|Withdrawal by Subject|12|||
155080084|NCT04518410|559723065|FG019|Overall Study|Withdrawal by Subject|9|||
155080085|NCT04518410|559723066|FG020|Overall Study|Withdrawal by Subject|14|||
155080086|NCT04518410|559723067|FG021|Overall Study|Withdrawal by Subject|3|||
155080087|NCT04518410|559723068|FG022|Overall Study|Withdrawal by Subject|2|||
155080088|NCT04518410|559723069|FG023|Overall Study|Withdrawal by Subject|9|||
155080089|NCT04518410|559723070|FG024|Overall Study|Withdrawal by Subject|8|||
155080090|NCT04518410|559723046|FG000|Overall Study|Other|1|||
155080091|NCT04518410|559723047|FG001|Overall Study|Other|0|||
155080092|NCT04518410|559723048|FG002|Overall Study|Other|0|||
155080093|NCT04518410|559723049|FG003|Overall Study|Other|1|||
155080094|NCT04518410|559723050|FG004|Overall Study|Other|6|||
155343735|NCT01183013|560691351|FG006|Overall Study|Lack of Efficacy|0|||
155343736|NCT01183013|560691345|FG000|Overall Study|Protocol Violation|5|||
155343737|NCT01183013|560691346|FG001|Overall Study|Protocol Violation|2|||
155080095|NCT04518410|559723051|FG005|Overall Study|Other|6|||
155165273|NCT01662102|560041921|FG001|Overall Study|Sponsor's decision|0|||
155080096|NCT04518410|559723052|FG006|Overall Study|Other|5|||
155080097|NCT04518410|559723053|FG007|Overall Study|Other|2|||
155080098|NCT04518410|559723054|FG008|Overall Study|Other|0|||
155080099|NCT04518410|559723055|FG009|Overall Study|Other|1|||
155080100|NCT04518410|559723056|FG010|Overall Study|Other|0|||
155343738|NCT01183013|560691347|FG002|Overall Study|Protocol Violation|4|||
155343739|NCT01183013|560691348|FG003|Overall Study|Protocol Violation|0|||
155343740|NCT01183013|560691349|FG004|Overall Study|Protocol Violation|4|||
155343741|NCT01183013|560691350|FG005|Overall Study|Protocol Violation|3|||
155343742|NCT01183013|560691351|FG006|Overall Study|Protocol Violation|3|||
155343743|NCT01183013|560691345|FG000|Overall Study|Lost to Follow-up|7|||
155343744|NCT01183013|560691346|FG001|Overall Study|Lost to Follow-up|3|||
155343745|NCT01183013|560691347|FG002|Overall Study|Lost to Follow-up|4|||
155343746|NCT01183013|560691348|FG003|Overall Study|Lost to Follow-up|3|||
155343747|NCT01183013|560691349|FG004|Overall Study|Lost to Follow-up|2|||
155343748|NCT01183013|560691350|FG005|Overall Study|Lost to Follow-up|6|||
155343749|NCT01183013|560691351|FG006|Overall Study|Lost to Follow-up|5|||
155343750|NCT01183013|560691345|FG000|Overall Study|Withdrawal by Subject|9|||
155343751|NCT01183013|560691346|FG001|Overall Study|Withdrawal by Subject|13|||
155343752|NCT01183013|560691347|FG002|Overall Study|Withdrawal by Subject|10|||
155343753|NCT01183013|560691348|FG003|Overall Study|Withdrawal by Subject|8|||
155343754|NCT01183013|560691349|FG004|Overall Study|Withdrawal by Subject|7|||
155343755|NCT01183013|560691350|FG005|Overall Study|Withdrawal by Subject|9|||
155343756|NCT01183013|560691351|FG006|Overall Study|Withdrawal by Subject|10|||
155343757|NCT01183013|560691345|FG000|Overall Study|Reasons other than stated above|15|||
155343758|NCT01183013|560691346|FG001|Overall Study|Reasons other than stated above|11|||
155343759|NCT01183013|560691347|FG002|Overall Study|Reasons other than stated above|17|||
155343760|NCT01183013|560691348|FG003|Overall Study|Reasons other than stated above|12|||
155343761|NCT01183013|560691349|FG004|Overall Study|Reasons other than stated above|12|||
155343762|NCT01183013|560691350|FG005|Overall Study|Reasons other than stated above|15|||
155343763|NCT01183013|560691351|FG006|Overall Study|Reasons other than stated above|13|||
155080101|NCT04518410|559723057|FG011|Overall Study|Other|2|||
155080102|NCT04518410|559723058|FG012|Overall Study|Other|0|||
155080103|NCT04518410|559723059|FG013|Overall Study|Other|0|||
155080104|NCT04518410|559723060|FG014|Overall Study|Other|0|||
155080105|NCT04518410|559723061|FG015|Overall Study|Other|3|||
155080106|NCT04518410|559723062|FG016|Overall Study|Other|1|||
155080107|NCT04518410|559723063|FG017|Overall Study|Other|1|||
155080108|NCT04518410|559723064|FG018|Overall Study|Other|1|||
155080109|NCT04518410|559723065|FG019|Overall Study|Other|0|||
155080110|NCT04518410|559723066|FG020|Overall Study|Other|1|||
155080111|NCT04518410|559723067|FG021|Overall Study|Other|0|||
155080112|NCT04518410|559723068|FG022|Overall Study|Other|1|||
155080113|NCT04518410|559723069|FG023|Overall Study|Other|2|||
155080114|NCT04518410|559723070|FG024|Overall Study|Other|2|||
155080115|NCT04518410|559723046|FG000|Overall Study|Protocol Violation|0|||
155080116|NCT04518410|559723047|FG001|Overall Study|Protocol Violation|0|||
155080117|NCT04518410|559723048|FG002|Overall Study|Protocol Violation|0|||
155080118|NCT04518410|559723049|FG003|Overall Study|Protocol Violation|2|||
155080119|NCT04518410|559723050|FG004|Overall Study|Protocol Violation|17|||
155080120|NCT04518410|559723051|FG005|Overall Study|Protocol Violation|1|||
155080121|NCT04518410|559723052|FG006|Overall Study|Protocol Violation|2|||
155080122|NCT04518410|559723053|FG007|Overall Study|Protocol Violation|1|||
155080123|NCT04518410|559723054|FG008|Overall Study|Protocol Violation|0|||
155080124|NCT04518410|559723055|FG009|Overall Study|Protocol Violation|0|||
155080125|NCT04518410|559723056|FG010|Overall Study|Protocol Violation|0|||
155080126|NCT04518410|559723057|FG011|Overall Study|Protocol Violation|0|||
155080127|NCT04518410|559723058|FG012|Overall Study|Protocol Violation|0|||
155080128|NCT04518410|559723059|FG013|Overall Study|Protocol Violation|0|||
155080129|NCT04518410|559723060|FG014|Overall Study|Protocol Violation|0|||
155080130|NCT04518410|559723061|FG015|Overall Study|Protocol Violation|0|||
155080131|NCT04518410|559723062|FG016|Overall Study|Protocol Violation|1|||
155080132|NCT04518410|559723063|FG017|Overall Study|Protocol Violation|1|||
155080133|NCT04518410|559723064|FG018|Overall Study|Protocol Violation|0|||
155080134|NCT04518410|559723065|FG019|Overall Study|Protocol Violation|0|||
155165274|NCT00392769|560041922|FG000|Overall Study|Clinical Deterioration|9|||
155343764|NCT00584909|560691352|FG000|Overall Study|Adverse Event|4|||
155343765|NCT02092909|560691353|FG000|Overall Study|Adverse Event|0|||
155343766|NCT02092909|560691354|FG001|Overall Study|Adverse Event|0|||
155343767|NCT02092909|560691355|FG002|Overall Study|Adverse Event|4|||
155343768|NCT02092909|560691356|FG003|Overall Study|Adverse Event|2|||
155343769|NCT02092909|560691353|FG000|Overall Study|Lack of Efficacy|0|||
155343770|NCT02092909|560691354|FG001|Overall Study|Lack of Efficacy|2|||
155165275|NCT00392769|560041922|FG000|Overall Study|Adverse Event|1|||
155343771|NCT02092909|560691355|FG002|Overall Study|Lack of Efficacy|1|||
155343772|NCT02092909|560691356|FG003|Overall Study|Lack of Efficacy|0|||
155080135|NCT04518410|559723066|FG020|Overall Study|Protocol Violation|1|||
155080136|NCT04518410|559723067|FG021|Overall Study|Protocol Violation|2|||
155080137|NCT04518410|559723068|FG022|Overall Study|Protocol Violation|0|||
155080138|NCT04518410|559723069|FG023|Overall Study|Protocol Violation|3|||
155080139|NCT04518410|559723070|FG024|Overall Study|Protocol Violation|0|||
155080140|NCT04518410|559723046|FG000|Overall Study|Death|0|||
155080141|NCT04518410|559723047|FG001|Overall Study|Death|0|||
155080142|NCT04518410|559723048|FG002|Overall Study|Death|0|||
155080143|NCT04518410|559723049|FG003|Overall Study|Death|0|||
155080144|NCT04518410|559723050|FG004|Overall Study|Death|12|||
155080145|NCT04518410|559723051|FG005|Overall Study|Death|2|||
155343773|NCT02092909|560691353|FG000|Overall Study|Withdrawal by Subject|0|||
155343774|NCT02092909|560691354|FG001|Overall Study|Withdrawal by Subject|0|||
155343775|NCT02092909|560691355|FG002|Overall Study|Withdrawal by Subject|2|||
155343776|NCT02092909|560691356|FG003|Overall Study|Withdrawal by Subject|1|||
155343777|NCT02092909|560691353|FG000|Overall Study|Study terminated by Sponsor|0|||
155080146|NCT04518410|559723052|FG006|Overall Study|Death|11|||
155080147|NCT04518410|559723053|FG007|Overall Study|Death|0|||
155080148|NCT04518410|559723054|FG008|Overall Study|Death|1|||
155080149|NCT04518410|559723055|FG009|Overall Study|Death|0|||
155080150|NCT04518410|559723056|FG010|Overall Study|Death|0|||
155080151|NCT04518410|559723057|FG011|Overall Study|Death|0|||
155080152|NCT04518410|559723058|FG012|Overall Study|Death|0|||
155080153|NCT04518410|559723059|FG013|Overall Study|Death|1|||
155080154|NCT04518410|559723060|FG014|Overall Study|Death|1|||
155080155|NCT04518410|559723061|FG015|Overall Study|Death|0|||
155080156|NCT04518410|559723062|FG016|Overall Study|Death|0|||
155080157|NCT04518410|559723063|FG017|Overall Study|Death|1|||
155080158|NCT04518410|559723064|FG018|Overall Study|Death|4|||
155080159|NCT04518410|559723065|FG019|Overall Study|Death|4|||
155080160|NCT04518410|559723066|FG020|Overall Study|Death|1|||
155080161|NCT04518410|559723067|FG021|Overall Study|Death|0|||
155080162|NCT04518410|559723068|FG022|Overall Study|Death|0|||
155080163|NCT04518410|559723069|FG023|Overall Study|Death|0|||
155080164|NCT04518410|559723070|FG024|Overall Study|Death|0|||
155080165|NCT04518410|559723046|FG000|Overall Study|Requirement to start alternative therapy|0|||
155080166|NCT04518410|559723047|FG001|Overall Study|Requirement to start alternative therapy|0|||
155080167|NCT04518410|559723048|FG002|Overall Study|Requirement to start alternative therapy|1|||
155080168|NCT04518410|559723049|FG003|Overall Study|Requirement to start alternative therapy|0|||
155080169|NCT04518410|559723050|FG004|Overall Study|Requirement to start alternative therapy|0|||
155080170|NCT04518410|559723051|FG005|Overall Study|Requirement to start alternative therapy|0|||
155080171|NCT04518410|559723052|FG006|Overall Study|Requirement to start alternative therapy|0|||
155080172|NCT04518410|559723053|FG007|Overall Study|Requirement to start alternative therapy|0|||
155080173|NCT04518410|559723054|FG008|Overall Study|Requirement to start alternative therapy|0|||
155080174|NCT04518410|559723055|FG009|Overall Study|Requirement to start alternative therapy|0|||
155080175|NCT04518410|559723056|FG010|Overall Study|Requirement to start alternative therapy|0|||
155080176|NCT04518410|559723057|FG011|Overall Study|Requirement to start alternative therapy|0|||
155080177|NCT04518410|559723058|FG012|Overall Study|Requirement to start alternative therapy|0|||
155080178|NCT04518410|559723059|FG013|Overall Study|Requirement to start alternative therapy|0|||
155080179|NCT04518410|559723060|FG014|Overall Study|Requirement to start alternative therapy|0|||
155080180|NCT04518410|559723061|FG015|Overall Study|Requirement to start alternative therapy|0|||
155080181|NCT04518410|559723062|FG016|Overall Study|Requirement to start alternative therapy|0|||
155080182|NCT04518410|559723063|FG017|Overall Study|Requirement to start alternative therapy|0|||
155080183|NCT04518410|559723064|FG018|Overall Study|Requirement to start alternative therapy|0|||
155080184|NCT04518410|559723065|FG019|Overall Study|Requirement to start alternative therapy|0|||
155080185|NCT04518410|559723066|FG020|Overall Study|Requirement to start alternative therapy|0|||
155080186|NCT04518410|559723067|FG021|Overall Study|Requirement to start alternative therapy|0|||
155080187|NCT04518410|559723068|FG022|Overall Study|Requirement to start alternative therapy|0|||
155080188|NCT04518410|559723069|FG023|Overall Study|Requirement to start alternative therapy|0|||
155080189|NCT04518410|559723070|FG024|Overall Study|Requirement to start alternative therapy|0|||
155080190|NCT04518410|559723046|FG000|Overall Study|Randomized but not treated|0|||
155080191|NCT04518410|559723047|FG001|Overall Study|Randomized but not treated|0|||
155080192|NCT04518410|559723048|FG002|Overall Study|Randomized but not treated|0|||
155080193|NCT04518410|559723049|FG003|Overall Study|Randomized but not treated|2|||
155080194|NCT04518410|559723050|FG004|Overall Study|Randomized but not treated|6|||
155080195|NCT04518410|559723051|FG005|Overall Study|Randomized but not treated|4|||
155080196|NCT04518410|559723052|FG006|Overall Study|Randomized but not treated|3|||
155080197|NCT04518410|559723053|FG007|Overall Study|Randomized but not treated|3|||
155080198|NCT04518410|559723054|FG008|Overall Study|Randomized but not treated|0|||
155080199|NCT04518410|559723055|FG009|Overall Study|Randomized but not treated|4|||
155080200|NCT04518410|559723056|FG010|Overall Study|Randomized but not treated|0|||
155080201|NCT04518410|559723057|FG011|Overall Study|Randomized but not treated|0|||
155080202|NCT04518410|559723058|FG012|Overall Study|Randomized but not treated|1|||
155080203|NCT04518410|559723059|FG013|Overall Study|Randomized but not treated|3|||
155080204|NCT04518410|559723060|FG014|Overall Study|Randomized but not treated|3|||
155343778|NCT02092909|560691354|FG001|Overall Study|Study terminated by Sponsor|0|||
155343779|NCT02092909|560691355|FG002|Overall Study|Study terminated by Sponsor|0|||
155343780|NCT02092909|560691356|FG003|Overall Study|Study terminated by Sponsor|2|||
155080205|NCT04518410|559723061|FG015|Overall Study|Randomized but not treated|3|||
155080206|NCT04518410|559723062|FG016|Overall Study|Randomized but not treated|4|||
155080207|NCT04518410|559723063|FG017|Overall Study|Randomized but not treated|5|||
155080208|NCT04518410|559723064|FG018|Overall Study|Randomized but not treated|4|||
155080209|NCT04518410|559723065|FG019|Overall Study|Randomized but not treated|0|||
155080210|NCT04518410|559723066|FG020|Overall Study|Randomized but not treated|0|||
155343781|NCT02092909|560691353|FG000|Overall Study|Miscellaneous|1|||
155343782|NCT02092909|560691354|FG001|Overall Study|Miscellaneous|1|||
155343783|NCT02092909|560691355|FG002|Overall Study|Miscellaneous|2|||
155343784|NCT02092909|560691356|FG003|Overall Study|Miscellaneous|1|||
155343785|NCT00910871|560691365|FG000|Overall Study|Adverse Event|5|||
155343786|NCT00910871|560691365|FG000|Overall Study|Death|12|||
155343787|NCT00910871|560691365|FG000|Overall Study|Lost to Follow-up|8|||
155343788|NCT00910871|560691365|FG000|Overall Study|Protocol Violation|11|||
155343789|NCT00910871|560691365|FG000|Overall Study|Withdrawal by Subject|12|||
155343790|NCT00910871|560691365|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
155343791|NCT00910871|560691365|FG000|Overall Study|Undefined|1|||
155343792|NCT00850993|560691366|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
155343793|NCT00850993|560691367|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
155343794|NCT00850993|560691368|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
155343795|NCT00850993|560691369|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
155343796|NCT04501614|560691374|FG000|Overall Study|Study Terminated by Sponsor|6|||
155343797|NCT04501614|560691375|FG001|Overall Study|Study Terminated by Sponsor|3|||
155343798|NCT04501614|560691374|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
155343799|NCT04501614|560691375|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
155343800|NCT02555397|560691379|FG000|Overall Study|Withdrawal by Subject|1|||
155343801|NCT02555397|560691380|FG001|Overall Study|Withdrawal by Subject|0|||
155343802|NCT02555397|560691381|FG002|Overall Study|Withdrawal by Subject|0|||
155343803|NCT02555397|560691382|FG003|Overall Study|Withdrawal by Subject|0|||
155343804|NCT02555397|560691383|FG004|Overall Study|Withdrawal by Subject|0|||
155343805|NCT00237809|560691389|FG000|Overall Study|Lost to Follow-up|11|||
155343806|NCT00237809|560691390|FG001|Overall Study|Lost to Follow-up|10|||
155343807|NCT00237809|560691391|FG002|Overall Study|Lost to Follow-up|9|||
155343808|NCT00237809|560691392|FG003|Overall Study|Lost to Follow-up|9|||
155343809|NCT02006641|560691393|FG000|Overall Study|Withdrawal before treatment|2|||
155343810|NCT02006641|560691394|FG001|Overall Study|Withdrawal before treatment|5|||
155343811|NCT02006641|560691395|FG002|Overall Study|Withdrawal before treatment|3|||
155343812|NCT02006641|560691393|FG000|Overall Study|Adverse Event|15|||
155343813|NCT02006641|560691394|FG001|Overall Study|Adverse Event|11|||
155080211|NCT04518410|559723067|FG021|Overall Study|Randomized but not treated|5|||
155080212|NCT04518410|559723068|FG022|Overall Study|Randomized but not treated|0|||
155080213|NCT04518410|559723069|FG023|Overall Study|Randomized but not treated|3|||
155080214|NCT04518410|559723070|FG024|Overall Study|Randomized but not treated|1|||
155080215|NCT04518410|559723046|FG000|Overall Study|Screen Fail but Randomized|0|||
155080216|NCT04518410|559723047|FG001|Overall Study|Screen Fail but Randomized|0|||
155080217|NCT04518410|559723048|FG002|Overall Study|Screen Fail but Randomized|0|||
155080218|NCT04518410|559723049|FG003|Overall Study|Screen Fail but Randomized|0|||
155080219|NCT04518410|559723050|FG004|Overall Study|Screen Fail but Randomized|2|||
155080220|NCT04518410|559723051|FG005|Overall Study|Screen Fail but Randomized|0|||
155080221|NCT04518410|559723052|FG006|Overall Study|Screen Fail but Randomized|0|||
155080222|NCT04518410|559723053|FG007|Overall Study|Screen Fail but Randomized|0|||
155080223|NCT04518410|559723054|FG008|Overall Study|Screen Fail but Randomized|0|||
155080224|NCT04518410|559723055|FG009|Overall Study|Screen Fail but Randomized|0|||
155080225|NCT04518410|559723056|FG010|Overall Study|Screen Fail but Randomized|0|||
155080226|NCT04518410|559723057|FG011|Overall Study|Screen Fail but Randomized|0|||
155080227|NCT04518410|559723058|FG012|Overall Study|Screen Fail but Randomized|0|||
155080228|NCT04518410|559723059|FG013|Overall Study|Screen Fail but Randomized|0|||
155080229|NCT04518410|559723060|FG014|Overall Study|Screen Fail but Randomized|0|||
155080230|NCT04518410|559723061|FG015|Overall Study|Screen Fail but Randomized|0|||
155080231|NCT04518410|559723062|FG016|Overall Study|Screen Fail but Randomized|0|||
155080232|NCT04518410|559723063|FG017|Overall Study|Screen Fail but Randomized|0|||
155080233|NCT04518410|559723064|FG018|Overall Study|Screen Fail but Randomized|0|||
155080234|NCT04518410|559723065|FG019|Overall Study|Screen Fail but Randomized|0|||
155165276|NCT00439517|560041924|FG000|Overall Study|Subject on treatment|1|||
155343814|NCT02006641|560691395|FG002|Overall Study|Adverse Event|15|||
155343815|NCT02006641|560691393|FG000|Overall Study|Protocol Violation|0|||
155343816|NCT02006641|560691394|FG001|Overall Study|Protocol Violation|2|||
155080235|NCT04518410|559723066|FG020|Overall Study|Screen Fail but Randomized|0|||
155080236|NCT04518410|559723067|FG021|Overall Study|Screen Fail but Randomized|0|||
155080237|NCT04518410|559723068|FG022|Overall Study|Screen Fail but Randomized|0|||
155080238|NCT04518410|559723069|FG023|Overall Study|Screen Fail but Randomized|0|||
155080239|NCT04518410|559723070|FG024|Overall Study|Screen Fail but Randomized|0|||
155165277|NCT00439517|560041925|FG001|Overall Study|Subject on treatment|0|||
155343817|NCT02006641|560691395|FG002|Overall Study|Protocol Violation|2|||
155343818|NCT02006641|560691393|FG000|Overall Study|Lost to Follow-up|0|||
155343819|NCT02006641|560691394|FG001|Overall Study|Lost to Follow-up|1|||
155165278|NCT00439517|560041924|FG000|Overall Study|Subject in survival follow-up|1|||
155165279|NCT00439517|560041925|FG001|Overall Study|Subject in survival follow-up|0|||
155165280|NCT01262989|560041928|FG000|Period 1|Lost to Follow-up|1|||
155165281|NCT01262989|560041929|FG001|Period 1|Lost to Follow-up|1|||
155165282|NCT01262989|560041928|FG000|Period 1|Intercurrent disease|0|||
155165283|NCT01262989|560041929|FG001|Period 1|Intercurrent disease|1|||
155165284|NCT01262989|560041928|FG000|Period 1|Positive answer for exclusion criteria|0|||
155165285|NCT01262989|560041929|FG001|Period 1|Positive answer for exclusion criteria|1|||
155165286|NCT01262989|560041928|FG000|Period 2|Intercurrent disease|0|||
155165287|NCT01262989|560041929|FG001|Period 2|Intercurrent disease|1|||
155165288|NCT00470275|560041930|FG000|Overall Study|Death|1|||
155165289|NCT00470275|560041930|FG000|Overall Study|Lack of Efficacy|7|||
155165290|NCT00470275|560041930|FG000|Overall Study|Withdrawal by Subject|2|||
155165291|NCT00526071|560041931|FG000|Overall Study|Adverse Event|1|||
155165292|NCT00526071|560041931|FG000|Overall Study|Withdrawal by Subject|1|||
155343820|NCT02006641|560691395|FG002|Overall Study|Lost to Follow-up|0|||
155343821|NCT02006641|560691393|FG000|Overall Study|Withdrawal by Subject|7|||
155343822|NCT02006641|560691394|FG001|Overall Study|Withdrawal by Subject|12|||
155343823|NCT02006641|560691395|FG002|Overall Study|Withdrawal by Subject|11|||
155343824|NCT02006641|560691393|FG000|Overall Study|Other reason: patient didn't show up|1|||
155343825|NCT02006641|560691394|FG001|Overall Study|Other reason: patient didn't show up|0|||
155343826|NCT02006641|560691395|FG002|Overall Study|Other reason: patient didn't show up|0|||
155343827|NCT02006641|560691393|FG000|Overall Study|Other reason:patient didn't want to come|0|||
155343828|NCT02006641|560691394|FG001|Overall Study|Other reason:patient didn't want to come|0|||
155343829|NCT02006641|560691395|FG002|Overall Study|Other reason:patient didn't want to come|1|||
155343830|NCT02006641|560691393|FG000|Overall Study|Other reason: patient has moved|1|||
155343831|NCT02006641|560691394|FG001|Overall Study|Other reason: patient has moved|0|||
155343832|NCT02006641|560691395|FG002|Overall Study|Other reason: patient has moved|1|||
155343833|NCT02006641|560691393|FG000|Overall Study|Other reason: caregiver in hospital|0|||
155343834|NCT02006641|560691394|FG001|Overall Study|Other reason: caregiver in hospital|1|||
155343835|NCT02006641|560691395|FG002|Overall Study|Other reason: caregiver in hospital|0|||
155343836|NCT02006641|560691393|FG000|Overall Study|Other reason: patient's wife has died|0|||
155343837|NCT02006641|560691394|FG001|Overall Study|Other reason: patient's wife has died|0|||
155343838|NCT02006641|560691395|FG002|Overall Study|Other reason: patient's wife has died|1|||
155343839|NCT02006641|560691393|FG000|Overall Study|Other reason: hospitalisation|0|||
155343840|NCT02006641|560691394|FG001|Overall Study|Other reason: hospitalisation|1|||
155343841|NCT02006641|560691395|FG002|Overall Study|Other reason: hospitalisation|0|||
155343842|NCT02006641|560691393|FG000|Overall Study|Other reason: caregiver impossibility|0|||
155343843|NCT02006641|560691394|FG001|Overall Study|Other reason: caregiver impossibility|0|||
155343844|NCT02006641|560691395|FG002|Overall Study|Other reason: caregiver impossibility|1|||
155343845|NCT02006641|560691393|FG000|Overall Study|Other reason: protocol non-compliance|0|||
155343846|NCT02006641|560691394|FG001|Overall Study|Other reason: protocol non-compliance|0|||
155343847|NCT02006641|560691395|FG002|Overall Study|Other reason: protocol non-compliance|1|||
155343848|NCT01613599|560691396|FG000|Overall Study|Death|9|||
155343849|NCT01613599|560691396|FG000|Overall Study|Lost to Follow-up|5|||
155343850|NCT01613599|560691396|FG000|Overall Study|Withdrawal by Subject|8|||
155343851|NCT01613599|560691396|FG000|Overall Study|Reason not specified|3|||
155343852|NCT02132195|560691399|FG000|Initial Assignment|Relapsed|14|||
155343853|NCT02132195|560691400|FG001|Initial Assignment|Relapsed|0|||
155343854|NCT02132195|560691401|FG002|Initial Assignment|Relapsed|0|||
155343855|NCT02132195|560691399|FG000|Rescue Therapy|Relapsed|0|||
155343856|NCT02132195|560691400|FG001|Rescue Therapy|Relapsed|0|||
155343857|NCT02132195|560691401|FG002|Rescue Therapy|Relapsed|7|||
155165293|NCT00526071|560041931|FG000|Overall Study|Lack of Response to Study Drug|4|||
155080240|NCT04518410|559723046|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155080241|NCT04518410|559723047|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155080242|NCT04518410|559723048|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155080243|NCT04518410|559723049|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155343858|NCT02132195|560691399|FG000|Rescue Therapy|Physician Decision|0|||
155343859|NCT02132195|560691400|FG001|Rescue Therapy|Physician Decision|0|||
155343860|NCT02132195|560691401|FG002|Rescue Therapy|Physician Decision|1|||
155343861|NCT02132195|560691399|FG000|Rescue Therapy|Withdrawal by Subject|0|||
155343862|NCT02132195|560691400|FG001|Rescue Therapy|Withdrawal by Subject|0|||
155343863|NCT02132195|560691401|FG002|Rescue Therapy|Withdrawal by Subject|1|||
155343864|NCT02132195|560691399|FG000|Rescue Therapy|Adverse Event|0|||
155343865|NCT02132195|560691400|FG001|Rescue Therapy|Adverse Event|0|||
155343866|NCT02132195|560691401|FG002|Rescue Therapy|Adverse Event|2|||
155343867|NCT02066389|560691403|FG000|Overall Study|Adverse Event|1|||
155343868|NCT02066389|560691404|FG001|Overall Study|Adverse Event|1|||
155343869|NCT02066389|560691405|FG002|Overall Study|Adverse Event|1|||
155343870|NCT02066389|560691406|FG003|Overall Study|Adverse Event|1|||
155343871|NCT02066389|560691407|FG004|Overall Study|Adverse Event|5|||
155343872|NCT02066389|560691408|FG005|Overall Study|Adverse Event|1|||
155343873|NCT02066389|560691403|FG000|Overall Study|Withdrawal by Subject|4|||
155343874|NCT02066389|560691404|FG001|Overall Study|Withdrawal by Subject|0|||
155343875|NCT02066389|560691405|FG002|Overall Study|Withdrawal by Subject|5|||
155343876|NCT02066389|560691406|FG003|Overall Study|Withdrawal by Subject|1|||
155343877|NCT02066389|560691407|FG004|Overall Study|Withdrawal by Subject|1|||
155343878|NCT02066389|560691408|FG005|Overall Study|Withdrawal by Subject|2|||
155343879|NCT02066389|560691403|FG000|Overall Study|Lost to Follow-up|0|||
155343880|NCT02066389|560691404|FG001|Overall Study|Lost to Follow-up|0|||
155343881|NCT02066389|560691405|FG002|Overall Study|Lost to Follow-up|0|||
155343882|NCT02066389|560691406|FG003|Overall Study|Lost to Follow-up|1|||
155080244|NCT04518410|559723050|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
155080245|NCT04518410|559723051|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
155080246|NCT04518410|559723052|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
155080247|NCT04518410|559723053|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155343883|NCT02066389|560691407|FG004|Overall Study|Lost to Follow-up|1|||
155343884|NCT02066389|560691408|FG005|Overall Study|Lost to Follow-up|1|||
155343885|NCT02066389|560691403|FG000|Overall Study|Randomized in Error|0|||
155343886|NCT02066389|560691404|FG001|Overall Study|Randomized in Error|0|||
155343887|NCT02066389|560691405|FG002|Overall Study|Randomized in Error|0|||
155343888|NCT02066389|560691406|FG003|Overall Study|Randomized in Error|0|||
155343889|NCT02066389|560691407|FG004|Overall Study|Randomized in Error|0|||
155343890|NCT02066389|560691408|FG005|Overall Study|Randomized in Error|1|||
155343891|NCT01468597|560691417|FG000|Overall Study|Found ineligible|17|||
155343892|NCT01468597|560691417|FG000|Overall Study|concomitant valves|12|||
155343893|NCT01468597|560691417|FG000|Overall Study|off-pump CABG|1|||
155343894|NCT01468597|560691417|FG000|Overall Study|no platelet function data|5|||
155343895|NCT02561195|560691419|FG000|Vaccination 1 to 3|Adverse Event|4|||
155343896|NCT02561195|560691420|FG001|Vaccination 1 to 3|Adverse Event|5|||
155343897|NCT02561195|560691421|FG002|Vaccination 1 to 3|Adverse Event|0|||
155343898|NCT02561195|560691422|FG003|Vaccination 1 to 3|Adverse Event|3|||
155343899|NCT02561195|560691423|FG004|Vaccination 1 to 3|Adverse Event|4|||
155343900|NCT02561195|560691424|FG005|Vaccination 1 to 3|Adverse Event|0|||
155343901|NCT02561195|560691425|FG006|Vaccination 1 to 3|Adverse Event|0|||
155343902|NCT02561195|560691426|FG007|Vaccination 1 to 3|Adverse Event|0|||
155343903|NCT02561195|560691427|FG008|Vaccination 1 to 3|Adverse Event|0|||
155343904|NCT02561195|560691428|FG009|Vaccination 1 to 3|Adverse Event|0|||
155343905|NCT02561195|560691429|FG010|Vaccination 1 to 3|Adverse Event|0|||
155343906|NCT02561195|560691430|FG011|Vaccination 1 to 3|Adverse Event|0|||
155343907|NCT02561195|560691431|FG012|Vaccination 1 to 3|Adverse Event|0|||
155343908|NCT02561195|560691432|FG013|Vaccination 1 to 3|Adverse Event|0|||
155343909|NCT02561195|560691419|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
155343910|NCT02561195|560691420|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
155343911|NCT02561195|560691421|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
155343912|NCT02561195|560691422|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
155343913|NCT02561195|560691423|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
155343914|NCT02561195|560691424|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
155343915|NCT02561195|560691425|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
155343916|NCT02561195|560691426|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
155343917|NCT02561195|560691427|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
155343918|NCT02561195|560691428|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
155343919|NCT02561195|560691429|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
155343920|NCT02561195|560691430|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
155343921|NCT02561195|560691431|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
155343922|NCT02561195|560691432|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
155343923|NCT02561195|560691419|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343924|NCT02561195|560691420|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
155343925|NCT02561195|560691421|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343926|NCT02561195|560691422|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
155343927|NCT02561195|560691423|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
155343928|NCT02561195|560691424|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
155343929|NCT02561195|560691425|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343930|NCT02561195|560691426|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343931|NCT02561195|560691427|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343932|NCT02561195|560691428|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343933|NCT02561195|560691429|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343934|NCT02561195|560691430|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343935|NCT02561195|560691431|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343936|NCT02561195|560691432|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
155343937|NCT02561195|560691419|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
155343938|NCT02561195|560691420|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
155343939|NCT02561195|560691421|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
155343940|NCT02561195|560691422|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
155343941|NCT02561195|560691423|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
155343942|NCT02561195|560691424|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
155343943|NCT02561195|560691425|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
155343944|NCT02561195|560691426|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
155343945|NCT02561195|560691427|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
155343946|NCT02561195|560691428|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
155343947|NCT02561195|560691429|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
155343948|NCT02561195|560691430|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
155343949|NCT02561195|560691431|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
155343950|NCT02561195|560691432|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
155343951|NCT02561195|560691419|FG000|Vaccination 1 to 3|Other|7|||
155343952|NCT02561195|560691420|FG001|Vaccination 1 to 3|Other|3|||
155343953|NCT02561195|560691421|FG002|Vaccination 1 to 3|Other|1|||
155343954|NCT02561195|560691422|FG003|Vaccination 1 to 3|Other|7|||
155343955|NCT02561195|560691423|FG004|Vaccination 1 to 3|Other|5|||
155343956|NCT02561195|560691424|FG005|Vaccination 1 to 3|Other|1|||
155343957|NCT02561195|560691425|FG006|Vaccination 1 to 3|Other|0|||
155343958|NCT02561195|560691426|FG007|Vaccination 1 to 3|Other|0|||
155343959|NCT02561195|560691427|FG008|Vaccination 1 to 3|Other|0|||
155343960|NCT02561195|560691428|FG009|Vaccination 1 to 3|Other|0|||
155343961|NCT02561195|560691429|FG010|Vaccination 1 to 3|Other|0|||
155343962|NCT02561195|560691430|FG011|Vaccination 1 to 3|Other|0|||
155343963|NCT02561195|560691431|FG012|Vaccination 1 to 3|Other|0|||
155343964|NCT02561195|560691432|FG013|Vaccination 1 to 3|Other|0|||
155343965|NCT02561195|560691419|FG000|Vaccination 1 to 3|Protocol Violation|1|||
155343966|NCT02561195|560691420|FG001|Vaccination 1 to 3|Protocol Violation|0|||
155343967|NCT02561195|560691421|FG002|Vaccination 1 to 3|Protocol Violation|1|||
155343968|NCT02561195|560691422|FG003|Vaccination 1 to 3|Protocol Violation|2|||
155343969|NCT02561195|560691423|FG004|Vaccination 1 to 3|Protocol Violation|5|||
155343970|NCT02561195|560691424|FG005|Vaccination 1 to 3|Protocol Violation|2|||
155343971|NCT02561195|560691425|FG006|Vaccination 1 to 3|Protocol Violation|0|||
155343972|NCT02561195|560691426|FG007|Vaccination 1 to 3|Protocol Violation|0|||
155343973|NCT02561195|560691427|FG008|Vaccination 1 to 3|Protocol Violation|0|||
155343974|NCT02561195|560691428|FG009|Vaccination 1 to 3|Protocol Violation|0|||
155343975|NCT02561195|560691429|FG010|Vaccination 1 to 3|Protocol Violation|0|||
155165294|NCT00459186|560041932|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
155165295|NCT00459186|560041932|FG000|PET Imaging and Assessment|Adverse Event|3|||
155165296|NCT02920242|560041933|FG000|Overall Study|Withdrawal by Subject|1|||
155165297|NCT02920242|560041934|FG001|Overall Study|Withdrawal by Subject|0|||
155165298|NCT02920242|560041935|FG002|Overall Study|Withdrawal by Subject|1|||
155165299|NCT02920242|560041933|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
155165300|NCT02920242|560041934|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
155165301|NCT02920242|560041935|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
155165302|NCT00634101|560041936|FG000|Overall Study|Study Terminated|3|||
155165303|NCT00634101|560041937|FG001|Overall Study|Study Terminated|3|||
155165304|NCT00634101|560041936|FG000|Overall Study|Lost to Follow-up|2|||
155165305|NCT00634101|560041937|FG001|Overall Study|Lost to Follow-up|0|||
155165306|NCT03306173|560041939|FG000|Overall Study|Lost to Follow-up|16|||
155343976|NCT02561195|560691430|FG011|Vaccination 1 to 3|Protocol Violation|0|||
155343977|NCT02561195|560691431|FG012|Vaccination 1 to 3|Protocol Violation|0|||
155343978|NCT02561195|560691432|FG013|Vaccination 1 to 3|Protocol Violation|0|||
155343979|NCT02561195|560691419|FG000|Vaccination 1 to 3|Death|2|||
155343980|NCT02561195|560691420|FG001|Vaccination 1 to 3|Death|1|||
155343981|NCT02561195|560691421|FG002|Vaccination 1 to 3|Death|0|||
155343982|NCT02561195|560691422|FG003|Vaccination 1 to 3|Death|2|||
155343983|NCT02561195|560691423|FG004|Vaccination 1 to 3|Death|0|||
155343984|NCT02561195|560691424|FG005|Vaccination 1 to 3|Death|0|||
155343985|NCT02561195|560691425|FG006|Vaccination 1 to 3|Death|0|||
155343986|NCT02561195|560691426|FG007|Vaccination 1 to 3|Death|0|||
155343987|NCT02561195|560691427|FG008|Vaccination 1 to 3|Death|0|||
155343988|NCT02561195|560691428|FG009|Vaccination 1 to 3|Death|0|||
155343989|NCT02561195|560691429|FG010|Vaccination 1 to 3|Death|0|||
155343990|NCT02561195|560691430|FG011|Vaccination 1 to 3|Death|0|||
155343991|NCT02561195|560691431|FG012|Vaccination 1 to 3|Death|0|||
155165307|NCT03306173|560041940|FG001|Overall Study|Lost to Follow-up|23|||
155343992|NCT02561195|560691432|FG013|Vaccination 1 to 3|Death|0|||
155343993|NCT02561195|560691419|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
155343994|NCT02561195|560691420|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
155343995|NCT02561195|560691421|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
155343996|NCT02561195|560691422|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
155343997|NCT02561195|560691423|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
155343998|NCT02561195|560691424|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
155343999|NCT02561195|560691425|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
155165308|NCT03306173|560041939|FG000|Overall Study|Withdrawal by Subject|4|||
155344000|NCT02561195|560691426|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344001|NCT02561195|560691427|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344002|NCT02561195|560691428|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344003|NCT02561195|560691429|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344004|NCT02561195|560691430|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344005|NCT02561195|560691431|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344006|NCT02561195|560691432|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
155344007|NCT02561195|560691419|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
155344008|NCT02561195|560691420|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
155344009|NCT02561195|560691421|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
155344010|NCT02561195|560691422|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
155344011|NCT02561195|560691423|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
155344012|NCT02561195|560691424|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
155344013|NCT02561195|560691425|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
155344014|NCT02561195|560691426|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
155344015|NCT02561195|560691427|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
155344016|NCT02561195|560691428|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
155344017|NCT02561195|560691429|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
155344018|NCT02561195|560691430|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
155344019|NCT02561195|560691431|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
155344020|NCT02561195|560691432|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
155344021|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344022|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344023|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344024|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344025|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344026|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155080248|NCT04518410|559723054|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
155080249|NCT04518410|559723055|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
155080250|NCT04518410|559723056|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155080251|NCT04518410|559723057|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155080252|NCT04518410|559723058|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155080253|NCT04518410|559723059|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155080254|NCT04518410|559723060|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
155080255|NCT04518410|559723061|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
155344027|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344028|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344029|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
155344030|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
155344031|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
155344032|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
155344033|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
155344034|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
155344035|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344036|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344037|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344038|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344039|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344040|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344041|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344042|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344043|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344044|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344045|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344046|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344047|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
155344048|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
155344049|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Death|0|||
155344050|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Death|0|||
155344051|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Death|0|||
155344052|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Death|0|||
155344053|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Death|0|||
155344054|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Death|0|||
155344055|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Death|0|||
155344056|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Death|0|||
155344057|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Death|0|||
155344058|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Death|1|||
155344059|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Death|0|||
155344060|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Death|0|||
155344061|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Death|0|||
155344062|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Death|0|||
155344063|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344064|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344065|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344066|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344067|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344068|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344069|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344070|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344071|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344072|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
155344073|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
155344074|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344075|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
155344076|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
155344077|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344078|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344079|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344080|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344081|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344082|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344083|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344084|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344085|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344086|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344087|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
155344088|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
155344089|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
155344090|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
155344091|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Other|0|||
155344092|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Other|0|||
155344093|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Other|0|||
155344094|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Other|0|||
155344095|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Other|0|||
155344096|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Other|0|||
155344097|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Other|0|||
155344098|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Other|0|||
155344099|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Other|0|||
155344100|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Other|0|||
155344101|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Other|2|||
155344102|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Other|2|||
155344103|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Other|1|||
155344104|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Other|0|||
155344105|NCT02561195|560691419|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344106|NCT02561195|560691420|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344107|NCT02561195|560691421|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344108|NCT02561195|560691422|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344109|NCT02561195|560691423|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344110|NCT02561195|560691424|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344111|NCT02561195|560691425|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
155344112|NCT02561195|560691426|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344113|NCT02561195|560691427|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344114|NCT02561195|560691428|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344115|NCT02561195|560691429|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
155344116|NCT02561195|560691430|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
155344117|NCT02561195|560691431|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
155344118|NCT02561195|560691432|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
155344119|NCT03905512|560691433|FG000|Overall Study|Withdrawal by Subject|9|||
155344120|NCT03905512|560691434|FG001|Overall Study|Withdrawal by Subject|8|||
155344121|NCT03905512|560691433|FG000|Overall Study|Adverse Event|1|||
155344122|NCT03905512|560691434|FG001|Overall Study|Adverse Event|2|||
155344123|NCT03905512|560691433|FG000|Overall Study|Lost to Follow-up|4|||
155344124|NCT03905512|560691434|FG001|Overall Study|Lost to Follow-up|3|||
155344125|NCT03905512|560691433|FG000|Overall Study|Other than Specified|7|||
155344126|NCT03905512|560691434|FG001|Overall Study|Other than Specified|4|||
155344127|NCT00736502|560691439|FG000|Overall Study|Adverse Event|22|||
155344128|NCT00736502|560691439|FG000|Overall Study|Lack of Efficacy|16|||
155344129|NCT00736502|560691439|FG000|Overall Study|Lost to Follow-up|27|||
155344130|NCT03987074|560691441|FG000|Overall Study|Withdrew Consent|1|||
155344131|NCT03987074|560691442|FG001|Overall Study|Withdrew Consent|1|||
155344132|NCT03987074|560691443|FG002|Overall Study|Withdrew Consent|0|||
155344133|NCT03987074|560691444|FG003|Overall Study|Withdrew Consent|2|||
155344134|NCT03987074|560691445|FG004|Overall Study|Withdrew Consent|1|||
155344135|NCT03987074|560691441|FG000|Overall Study|Adverse Event|2|||
155344136|NCT03987074|560691442|FG001|Overall Study|Adverse Event|1|||
155344137|NCT03987074|560691443|FG002|Overall Study|Adverse Event|0|||
155344138|NCT03987074|560691444|FG003|Overall Study|Adverse Event|0|||
155344139|NCT03987074|560691445|FG004|Overall Study|Adverse Event|1|||
155344140|NCT03987074|560691441|FG000|Overall Study|Lost to Follow-up|0|||
155344141|NCT03987074|560691442|FG001|Overall Study|Lost to Follow-up|0|||
155344142|NCT03987074|560691443|FG002|Overall Study|Lost to Follow-up|1|||
155344143|NCT03987074|560691444|FG003|Overall Study|Lost to Follow-up|1|||
155344144|NCT03987074|560691445|FG004|Overall Study|Lost to Follow-up|0|||
155344145|NCT03987074|560691441|FG000|Overall Study|Investigator's Discretion|0|||
155344146|NCT03987074|560691442|FG001|Overall Study|Investigator's Discretion|0|||
155344147|NCT03987074|560691443|FG002|Overall Study|Investigator's Discretion|0|||
155344148|NCT03987074|560691444|FG003|Overall Study|Investigator's Discretion|1|||
155344149|NCT03987074|560691445|FG004|Overall Study|Investigator's Discretion|0|||
155344150|NCT01307800|560691446|FG000|Overall Study|Adverse Event|9|||
155344151|NCT01307800|560691447|FG001|Overall Study|Adverse Event|8|||
155344152|NCT01307800|560691448|FG002|Overall Study|Adverse Event|10|||
155344153|NCT01307800|560691449|FG003|Overall Study|Adverse Event|14|||
155344154|NCT01307800|560691446|FG000|Overall Study|Entry Criteria Not Met|0|||
155344155|NCT01307800|560691447|FG001|Overall Study|Entry Criteria Not Met|0|||
155344156|NCT01307800|560691448|FG002|Overall Study|Entry Criteria Not Met|0|||
155344157|NCT01307800|560691449|FG003|Overall Study|Entry Criteria Not Met|2|||
155344158|NCT01307800|560691446|FG000|Overall Study|Lost to Follow-up|5|||
155344159|NCT01307800|560691447|FG001|Overall Study|Lost to Follow-up|6|||
155344160|NCT01307800|560691448|FG002|Overall Study|Lost to Follow-up|2|||
155080256|NCT04518410|559723062|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
155080257|NCT04518410|559723063|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
155080258|NCT04518410|559723064|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
155080259|NCT04518410|559723065|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
155080260|NCT04518410|559723066|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
155080261|NCT04518410|559723067|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
155080262|NCT04518410|559723068|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
155080263|NCT04518410|559723069|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
155080264|NCT04518410|559723070|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
155080265|NCT04518410|559723046|FG000|Overall Study|Dual Enrolled Subject|0|||
155080266|NCT04518410|559723047|FG001|Overall Study|Dual Enrolled Subject|0|||
155080267|NCT04518410|559723048|FG002|Overall Study|Dual Enrolled Subject|0|||
155080268|NCT04518410|559723049|FG003|Overall Study|Dual Enrolled Subject|0|||
155080269|NCT04518410|559723050|FG004|Overall Study|Dual Enrolled Subject|0|||
155080270|NCT04518410|559723051|FG005|Overall Study|Dual Enrolled Subject|0|||
155080271|NCT04518410|559723052|FG006|Overall Study|Dual Enrolled Subject|0|||
155080272|NCT04518410|559723053|FG007|Overall Study|Dual Enrolled Subject|0|||
155080273|NCT04518410|559723054|FG008|Overall Study|Dual Enrolled Subject|0|||
155080274|NCT04518410|559723055|FG009|Overall Study|Dual Enrolled Subject|0|||
155080275|NCT04518410|559723056|FG010|Overall Study|Dual Enrolled Subject|0|||
155080276|NCT04518410|559723057|FG011|Overall Study|Dual Enrolled Subject|0|||
155080277|NCT04518410|559723058|FG012|Overall Study|Dual Enrolled Subject|0|||
155080278|NCT04518410|559723059|FG013|Overall Study|Dual Enrolled Subject|0|||
155080279|NCT04518410|559723060|FG014|Overall Study|Dual Enrolled Subject|0|||
155080280|NCT04518410|559723061|FG015|Overall Study|Dual Enrolled Subject|0|||
155080281|NCT04518410|559723062|FG016|Overall Study|Dual Enrolled Subject|0|||
155080282|NCT04518410|559723063|FG017|Overall Study|Dual Enrolled Subject|1|||
155080283|NCT04518410|559723064|FG018|Overall Study|Dual Enrolled Subject|0|||
155080284|NCT04518410|559723065|FG019|Overall Study|Dual Enrolled Subject|0|||
155080285|NCT04518410|559723066|FG020|Overall Study|Dual Enrolled Subject|0|||
155080286|NCT04518410|559723067|FG021|Overall Study|Dual Enrolled Subject|0|||
155080287|NCT04518410|559723068|FG022|Overall Study|Dual Enrolled Subject|0|||
155080288|NCT04518410|559723069|FG023|Overall Study|Dual Enrolled Subject|0|||
155080289|NCT04518410|559723070|FG024|Overall Study|Dual Enrolled Subject|0|||
155080290|NCT02218268|559723071|FG000|24 Hour Washout|Physician Decision|11|||
155344161|NCT01307800|560691449|FG003|Overall Study|Lost to Follow-up|8|||
155344162|NCT01307800|560691446|FG000|Overall Study|Perceived Lack of Efficacy|24|||
155344163|NCT01307800|560691447|FG001|Overall Study|Perceived Lack of Efficacy|23|||
155344164|NCT01307800|560691448|FG002|Overall Study|Perceived Lack of Efficacy|20|||
155344165|NCT01307800|560691449|FG003|Overall Study|Perceived Lack of Efficacy|33|||
155344166|NCT01307800|560691446|FG000|Overall Study|Protocol Violation|0|||
155344167|NCT01307800|560691447|FG001|Overall Study|Protocol Violation|3|||
155080291|NCT02218268|559723072|FG001|24 Hour Washout|Physician Decision|9|||
155080292|NCT03651336|559723073|FG000|Overall Study|Withdrawal by Subject|4|||
155080293|NCT01341990|559723074|FG000|Overall Study|Adverse Event|0|||
155080294|NCT01341990|559723075|FG001|Overall Study|Adverse Event|1|||
155080295|NCT01341990|559723074|FG000|Overall Study|Torn Study Lens|1|||
155080296|NCT01341990|559723075|FG001|Overall Study|Torn Study Lens|0|||
155080297|NCT01341990|559723074|FG000|Overall Study|Withdrawal by Subject|2|||
155080298|NCT01341990|559723075|FG001|Overall Study|Withdrawal by Subject|0|||
155080299|NCT03259308|559723080|FG000|Overall Study|Adverse Event|5|||
155080300|NCT03259308|559723081|FG001|Overall Study|Adverse Event|4|||
155080301|NCT03259308|559723082|FG002|Overall Study|Adverse Event|1|||
155080302|NCT03259308|559723080|FG000|Overall Study|Withdrawal by Subject|2|||
155080303|NCT03259308|559723081|FG001|Overall Study|Withdrawal by Subject|1|||
155080304|NCT03259308|559723082|FG002|Overall Study|Withdrawal by Subject|3|||
155344168|NCT01307800|560691448|FG002|Overall Study|Protocol Violation|4|||
155344169|NCT01307800|560691449|FG003|Overall Study|Protocol Violation|5|||
155344170|NCT01307800|560691446|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
155344171|NCT01307800|560691447|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
155344172|NCT01307800|560691448|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
155344173|NCT01307800|560691449|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
155344174|NCT01307800|560691446|FG000|Overall Study|Sponsor Decision|6|||
155344175|NCT01307800|560691447|FG001|Overall Study|Sponsor Decision|9|||
155344176|NCT01307800|560691448|FG002|Overall Study|Sponsor Decision|12|||
155344177|NCT01307800|560691449|FG003|Overall Study|Sponsor Decision|28|||
155344178|NCT01307800|560691446|FG000|Overall Study|Withdrawal by Subject|10|||
155344179|NCT01307800|560691447|FG001|Overall Study|Withdrawal by Subject|11|||
155344180|NCT01307800|560691448|FG002|Overall Study|Withdrawal by Subject|8|||
155344181|NCT01307800|560691449|FG003|Overall Study|Withdrawal by Subject|15|||
155344182|NCT01307800|560691446|FG000|Overall Study|Participant Moved|0|||
155344183|NCT01307800|560691447|FG001|Overall Study|Participant Moved|2|||
155344184|NCT01307800|560691448|FG002|Overall Study|Participant Moved|1|||
155344185|NCT01307800|560691449|FG003|Overall Study|Participant Moved|3|||
155344186|NCT01517282|560691452|FG000|Overall Study|Consent withdrawn|0|||
155344187|NCT01517282|560691453|FG001|Overall Study|Consent withdrawn|1|||
155344188|NCT01517282|560691454|FG002|Overall Study|Consent withdrawn|1|||
155344189|NCT01517282|560691455|FG003|Overall Study|Consent withdrawn|1|||
155344190|NCT01517282|560691452|FG000|Overall Study|Physician Decision|1|||
155344191|NCT01517282|560691453|FG001|Overall Study|Physician Decision|0|||
155344192|NCT01517282|560691454|FG002|Overall Study|Physician Decision|0|||
155344193|NCT01517282|560691455|FG003|Overall Study|Physician Decision|0|||
155344194|NCT01199302|560691462|FG000|Overall Study|Adverse Event|1|||
155344195|NCT01199302|560691463|FG001|Overall Study|Adverse Event|1|||
155344196|NCT01199302|560691464|FG002|Overall Study|Adverse Event|2|||
155344197|NCT01199302|560691465|FG003|Overall Study|Adverse Event|0|||
155344198|NCT01199302|560691462|FG000|Overall Study|Withdrawal by Subject|2|||
155344199|NCT01199302|560691463|FG001|Overall Study|Withdrawal by Subject|2|||
155344200|NCT01199302|560691464|FG002|Overall Study|Withdrawal by Subject|3|||
155344201|NCT01199302|560691465|FG003|Overall Study|Withdrawal by Subject|0|||
155344202|NCT01199302|560691462|FG000|Overall Study|Disease Progression|3|||
155344203|NCT01199302|560691463|FG001|Overall Study|Disease Progression|4|||
155344204|NCT01199302|560691464|FG002|Overall Study|Disease Progression|4|||
155344205|NCT01199302|560691465|FG003|Overall Study|Disease Progression|2|||
155344206|NCT01199302|560691462|FG000|Overall Study|Study Termination|13|||
155344207|NCT01199302|560691463|FG001|Overall Study|Study Termination|8|||
155344208|NCT01199302|560691464|FG002|Overall Study|Study Termination|11|||
155344209|NCT01199302|560691465|FG003|Overall Study|Study Termination|9|||
155344210|NCT01199302|560691462|FG000|Overall Study|Lost to Follow-up|0|||
155344211|NCT01199302|560691463|FG001|Overall Study|Lost to Follow-up|1|||
155344212|NCT01199302|560691464|FG002|Overall Study|Lost to Follow-up|0|||
155344213|NCT01199302|560691465|FG003|Overall Study|Lost to Follow-up|0|||
155344214|NCT01199302|560691462|FG000|Overall Study|Other|1|||
155344215|NCT01199302|560691463|FG001|Overall Study|Other|0|||
155344216|NCT01199302|560691464|FG002|Overall Study|Other|0|||
155344217|NCT01199302|560691465|FG003|Overall Study|Other|0|||
155344218|NCT04433091|560691466|FG000|Overall Study|Lost to Follow-up|1|||
155344219|NCT04433091|560691467|FG001|Overall Study|Lost to Follow-up|0|||
155344220|NCT04433091|560691466|FG000|Overall Study|Withdrawn .|2|||
155344221|NCT04433091|560691467|FG001|Overall Study|Withdrawn .|4|||
155080305|NCT03259308|559723080|FG000|Overall Study|Lost to Follow-up|0|||
155080306|NCT03259308|559723081|FG001|Overall Study|Lost to Follow-up|0|||
155344222|NCT03820024|560691468|FG000|Overall Study|Physician Decision|1|||
155344223|NCT03820024|560691469|FG001|Overall Study|Physician Decision|2|||
155344224|NCT05379400|560692866|FG000|Overall Study|Lost to Follow-up|1|||
155344225|NCT05379400|560692867|FG001|Overall Study|Lost to Follow-up|1|||
155344226|NCT03409276|560692870|FG000|Overall Study|Withdrawal by Subject|0|||
155344227|NCT03409276|560692871|FG001|Overall Study|Withdrawal by Subject|0|||
155344228|NCT03409276|560692872|FG002|Overall Study|Withdrawal by Subject|0|||
155344229|NCT03409276|560692873|FG003|Overall Study|Withdrawal by Subject|0|||
155080307|NCT03259308|559723082|FG002|Overall Study|Lost to Follow-up|1|||
155080308|NCT03259308|559723080|FG000|Overall Study|Pregnancy|0|||
155080309|NCT03259308|559723081|FG001|Overall Study|Pregnancy|0|||
155080310|NCT03259308|559723082|FG002|Overall Study|Pregnancy|1|||
155080311|NCT03259308|559723080|FG000|Overall Study|Protocol Deviation|0|||
155080312|NCT03259308|559723081|FG001|Overall Study|Protocol Deviation|3|||
155080313|NCT03259308|559723082|FG002|Overall Study|Protocol Deviation|0|||
155165309|NCT03306173|560041940|FG001|Overall Study|Withdrawal by Subject|3|||
155165310|NCT03306173|560041939|FG000|Overall Study|Discontinued|4|||
155165311|NCT03306173|560041940|FG001|Overall Study|Discontinued|4|||
155165312|NCT00573144|560041941|FG000|Overall Study|Withdrawal by Subject|2|||
155165313|NCT00573144|560041942|FG001|Overall Study|Withdrawal by Subject|3|||
155165314|NCT03051178|560041943|FG000|Overall Study|Withdrawal by Subject|5|||
155165315|NCT02813577|560041944|FG000|Overall Study|Study terminated|4|||
155165316|NCT00060840|560041945|FG000|Overall Study|Change in surgical plan|2|||
155165317|NCT00060840|560041946|FG001|Overall Study|Change in surgical plan|6|||
155165318|NCT00060840|560041945|FG000|Overall Study|Death|0|||
155165319|NCT00060840|560041946|FG001|Overall Study|Death|1|||
155165320|NCT00060840|560041945|FG000|Overall Study|Withdrawal by Subject|0|||
155165321|NCT00060840|560041946|FG001|Overall Study|Withdrawal by Subject|1|||
155165322|NCT00060840|560041945|FG000|Overall Study|Subinvestigator unavailable|0|||
155165323|NCT00060840|560041946|FG001|Overall Study|Subinvestigator unavailable|1|||
155165324|NCT00060840|560041945|FG000|Overall Study|Physician Decision|1|||
155165325|NCT00060840|560041946|FG001|Overall Study|Physician Decision|0|||
155165326|NCT00060840|560041945|FG000|Overall Study|Other|1|||
155165327|NCT00060840|560041946|FG001|Overall Study|Other|0|||
155165328|NCT01415882|560041947|FG000|Overall Study|Ineligible|1|||
155165329|NCT01415882|560041948|FG001|Overall Study|Ineligible|0|||
155165330|NCT01415882|560041949|FG002|Overall Study|Ineligible|0|||
155165331|NCT01415882|560041950|FG003|Overall Study|Ineligible|3|||
155165332|NCT01415882|560041951|FG004|Overall Study|Ineligible|0|||
155165333|NCT01415882|560041947|FG000|Overall Study|Withdrawal by Subject|0|||
155165334|NCT01415882|560041948|FG001|Overall Study|Withdrawal by Subject|1|||
155165335|NCT01415882|560041949|FG002|Overall Study|Withdrawal by Subject|0|||
155165336|NCT01415882|560041950|FG003|Overall Study|Withdrawal by Subject|1|||
155165337|NCT01415882|560041951|FG004|Overall Study|Withdrawal by Subject|0|||
155165338|NCT00976560|560041952|FG000|Overall Study|Adverse Event|5|||
155165339|NCT00976560|560041953|FG001|Overall Study|Adverse Event|5|||
155165340|NCT00976560|560041952|FG000|Overall Study|Lack of Efficacy|3|||
155165341|NCT00976560|560041953|FG001|Overall Study|Lack of Efficacy|5|||
155165342|NCT00976560|560041952|FG000|Overall Study|Protocol Violation|1|||
155165343|NCT00976560|560041953|FG001|Overall Study|Protocol Violation|0|||
155165344|NCT00976560|560041952|FG000|Overall Study|Lost to Follow-up|1|||
155165345|NCT00976560|560041953|FG001|Overall Study|Lost to Follow-up|0|||
155165346|NCT00976560|560041952|FG000|Overall Study|Physician Decision|2|||
155165347|NCT00976560|560041953|FG001|Overall Study|Physician Decision|0|||
155165348|NCT00976560|560041952|FG000|Overall Study|Withdrawal by Subject|2|||
155165349|NCT00976560|560041953|FG001|Overall Study|Withdrawal by Subject|3|||
155165350|NCT00125164|560041954|FG000|Overall Study|Adverse Event|0|||
155165351|NCT00125164|560041955|FG001|Overall Study|Adverse Event|0|||
155165352|NCT00125164|560041956|FG002|Overall Study|Adverse Event|2|||
155165353|NCT00125164|560041957|FG003|Overall Study|Adverse Event|4|||
155165354|NCT00125164|560041954|FG000|Overall Study|Lost to Follow-up|0|||
155165355|NCT00125164|560041955|FG001|Overall Study|Lost to Follow-up|0|||
155165356|NCT00125164|560041956|FG002|Overall Study|Lost to Follow-up|1|||
155165357|NCT00125164|560041957|FG003|Overall Study|Lost to Follow-up|1|||
155165358|NCT00125164|560041954|FG000|Overall Study|Withdrawal by Subject|2|||
155165359|NCT00125164|560041955|FG001|Overall Study|Withdrawal by Subject|0|||
155165360|NCT00125164|560041956|FG002|Overall Study|Withdrawal by Subject|1|||
155165361|NCT00125164|560041957|FG003|Overall Study|Withdrawal by Subject|1|||
155080314|NCT03259308|559723080|FG000|Overall Study|Lack of Efficacy|0|||
155165362|NCT01339052|560041958|FG000|Overall Study|Disease progression|13|||
155165363|NCT01339052|560041959|FG001|Overall Study|Disease progression|46|||
155165364|NCT01339052|560041958|FG000|Overall Study|Adverse Event|1|||
155165365|NCT01339052|560041959|FG001|Overall Study|Adverse Event|1|||
155165366|NCT01339052|560041958|FG000|Overall Study|Withdrawal by Subject|0|||
155165367|NCT01339052|560041959|FG001|Overall Study|Withdrawal by Subject|3|||
155344230|NCT03409276|560692874|FG004|Overall Study|Withdrawal by Subject|1|||
154963942|NCT06041256|559293500|FG002|Overall Study|Withdrawal by Subject|3|||
155080315|NCT03259308|559723081|FG001|Overall Study|Lack of Efficacy|0|||
155080316|NCT03259308|559723082|FG002|Overall Study|Lack of Efficacy|1|||
155165368|NCT01339052|560041958|FG000|Overall Study|Physician Decision|1|||
155165369|NCT01339052|560041959|FG001|Overall Study|Physician Decision|0|||
155165370|NCT02722499|560041963|FG000|Overall Study|Lost to Follow-up|2|||
155165371|NCT02722499|560041964|FG001|Overall Study|Lost to Follow-up|0|||
155165372|NCT02722499|560041965|FG002|Overall Study|Lost to Follow-up|1|||
155165373|NCT01599637|560041968|FG000|Overall Study|administrative problems|0|||
155165374|NCT01599637|560041969|FG001|Overall Study|administrative problems|2|||
155165375|NCT01599637|560041970|FG002|Overall Study|administrative problems|0|||
155165376|NCT01599637|560041968|FG000|Overall Study|Adverse Event|1|||
155165377|NCT01599637|560041969|FG001|Overall Study|Adverse Event|0|||
155165378|NCT01599637|560041970|FG002|Overall Study|Adverse Event|0|||
155165379|NCT04476797|560041973|FG000|Overall Study|Withdrawal by Subject|1|||
155165380|NCT04476797|560041974|FG001|Overall Study|Withdrawal by Subject|0|||
155165381|NCT04476797|560041975|FG002|Overall Study|Withdrawal by Subject|0|||
155165382|NCT04476797|560041973|FG000|Overall Study|Death|0|||
155344231|NCT03409276|560692870|FG000|Overall Study|Lost to Follow-up|0|||
155344232|NCT03409276|560692871|FG001|Overall Study|Lost to Follow-up|0|||
155344233|NCT03409276|560692872|FG002|Overall Study|Lost to Follow-up|0|||
155344234|NCT03409276|560692873|FG003|Overall Study|Lost to Follow-up|2|||
155344235|NCT03409276|560692874|FG004|Overall Study|Lost to Follow-up|2|||
155344236|NCT01816165|560692877|FG000|Overall Study|Adverse Event|1|||
155344237|NCT01816165|560692878|FG001|Overall Study|Adverse Event|0|||
155344238|NCT01816165|560692879|FG002|Overall Study|Adverse Event|0|||
155344239|NCT01816165|560692880|FG003|Overall Study|Adverse Event|0|||
155344240|NCT03960437|560692881|FG000|Overall Study|Removed by PI|4|||
155344241|NCT03960437|560692881|FG000|Overall Study|Lost to Follow-up|2|||
155344242|NCT03960437|560692881|FG000|Overall Study|Withdrawal by Subject|1|||
155344243|NCT03960437|560692881|FG000|Overall Study|Death|2|||
155344244|NCT02368691|560692882|FG000|Overall Study|Death|13|||
155344245|NCT02368691|560692882|FG000|Overall Study|Lack of Efficacy|15|||
155344246|NCT02368691|560692882|FG000|Overall Study|Physician Decision|4|||
155344247|NCT01838447|560692883|FG000|Overall Study|Change in surgical plan|1|||
155344248|NCT01838447|560692884|FG001|Overall Study|Change in surgical plan|2|||
155344249|NCT01838447|560692883|FG000|Overall Study|Withdrawal by Subject|1|||
155344250|NCT01838447|560692884|FG001|Overall Study|Withdrawal by Subject|1|||
155344251|NCT01114217|560692885|FG000|Overall Study|Adverse Event|5|||
155165383|NCT04476797|560041974|FG001|Overall Study|Death|1|||
155165384|NCT04476797|560041975|FG002|Overall Study|Death|2|||
155165385|NCT04476797|560041973|FG000|Overall Study|Sponsor Terminated Study|0|||
155165386|NCT04476797|560041974|FG001|Overall Study|Sponsor Terminated Study|18|||
155165387|NCT04476797|560041975|FG002|Overall Study|Sponsor Terminated Study|17|||
155165388|NCT00396253|560041977|FG000|Overall Study|Protocol Violation|1|||
155165389|NCT00396253|560041977|FG000|Overall Study|Withdrawal by Subject|7|||
155165390|NCT00396253|560041977|FG000|Overall Study|Death|3|||
155165391|NCT00396253|560041977|FG000|Overall Study|Physician Decision|1|||
155165392|NCT00396253|560041977|FG000|Overall Study|Change in eligibility status|1|||
155165393|NCT05340478|560041980|FG000|Overall Study|Scheduling Issues|10|||
155165394|NCT05340478|560041981|FG001|Overall Study|Scheduling Issues|4|||
155165395|NCT05340478|560041980|FG000|Overall Study|Neither member of dyad started treatment|2|||
155165396|NCT05340478|560041981|FG001|Overall Study|Neither member of dyad started treatment|2|||
155165397|NCT05340478|560041980|FG000|Overall Study|Withdrawn from study|2|||
155165398|NCT05340478|560041981|FG001|Overall Study|Withdrawn from study|2|||
155165399|NCT05340478|560041980|FG000|Overall Study|Lost to Follow-up|1|||
155165400|NCT05340478|560041981|FG001|Overall Study|Lost to Follow-up|4|||
155165401|NCT00092443|560041982|FG000|Overall Study|Adverse Event|9|||
155165402|NCT00092443|560041983|FG001|Overall Study|Adverse Event|13|||
155165403|NCT00092443|560041982|FG000|Overall Study|Lost to Follow-up|7|||
155165404|NCT00092443|560041983|FG001|Overall Study|Lost to Follow-up|3|||
155165405|NCT00092443|560041982|FG000|Overall Study|Protocol Violation|11|||
155165406|NCT00092443|560041983|FG001|Overall Study|Protocol Violation|9|||
155165407|NCT00092443|560041982|FG000|Overall Study|Withdrawal by Subject|9|||
155165408|NCT00092443|560041983|FG001|Overall Study|Withdrawal by Subject|11|||
155165409|NCT00092443|560041982|FG000|Overall Study|Moved|5|||
155344252|NCT01114217|560692886|FG001|Overall Study|Adverse Event|3|||
155344253|NCT01114217|560692885|FG000|Overall Study|Lost to Follow-up|17|||
155344254|NCT01114217|560692886|FG001|Overall Study|Lost to Follow-up|33|||
155344255|NCT01114217|560692885|FG000|Overall Study|Withdrawal by Subject|21|||
155344256|NCT01114217|560692886|FG001|Overall Study|Withdrawal by Subject|28|||
155344257|NCT01114217|560692885|FG000|Overall Study|Other-Clerical Error|3|||
155344258|NCT01114217|560692886|FG001|Overall Study|Other-Clerical Error|0|||
155344259|NCT01114217|560692885|FG000|Overall Study|Other-Early termination|6|||
155344260|NCT01114217|560692886|FG001|Overall Study|Other-Early termination|10|||
155165410|NCT00092443|560041983|FG001|Overall Study|Moved|5|||
155165411|NCT00092443|560041982|FG000|Overall Study|Other|17|||
155165412|NCT00092443|560041983|FG001|Overall Study|Other|13|||
155165413|NCT04717336|560041984|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
155165414|NCT04717336|560041985|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
155165415|NCT04717336|560041984|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
155165416|NCT04717336|560041985|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
155165417|NCT02039843|560041986|FG000|Randomization and Observation Period|Adverse Event|2|||
155344261|NCT01114217|560692885|FG000|Overall Study|Other-Procedure|1|||
155165418|NCT02039843|560041987|FG001|Randomization and Observation Period|Adverse Event|0|||
155344262|NCT01114217|560692886|FG001|Overall Study|Other-Procedure|1|||
155344263|NCT01114217|560692885|FG000|Overall Study|Other-Pregnancy|2|||
155344264|NCT01114217|560692886|FG001|Overall Study|Other-Pregnancy|4|||
155165419|NCT02039843|560041986|FG000|Randomization and Observation Period|Death|1|||
155165420|NCT02039843|560041987|FG001|Randomization and Observation Period|Death|0|||
155344265|NCT01114217|560692885|FG000|Overall Study|Other-Protocol Violation|1|||
155344266|NCT01114217|560692886|FG001|Overall Study|Other-Protocol Violation|3|||
155344267|NCT01114217|560692885|FG000|Overall Study|Other-Lack of Efficacy|1|||
155344268|NCT01114217|560692886|FG001|Overall Study|Other-Lack of Efficacy|0|||
155344269|NCT01114217|560692885|FG000|Overall Study|Other-Non Compliance|2|||
155344270|NCT01114217|560692886|FG001|Overall Study|Other-Non Compliance|0|||
155344271|NCT01114217|560692885|FG000|Overall Study|Other-Physician Decision|1|||
155344272|NCT01114217|560692886|FG001|Overall Study|Other-Physician Decision|1|||
155344273|NCT01114217|560692885|FG000|Overall Study|Other-Sponsor Decision|10|||
155344274|NCT01114217|560692886|FG001|Overall Study|Other-Sponsor Decision|12|||
155344275|NCT01114217|560692885|FG000|Overall Study|Other-Study Termination|0|||
155344276|NCT01114217|560692886|FG001|Overall Study|Other-Study Termination|1|||
155344277|NCT01114217|560692885|FG000|Overall Study|Other-Study Withdrawn|1|||
155344278|NCT01114217|560692886|FG001|Overall Study|Other-Study Withdrawn|1|||
155344279|NCT01114217|560692885|FG000|Overall Study|Other-Site Stopped Communicating|2|||
155344280|NCT01114217|560692886|FG001|Overall Study|Other-Site Stopped Communicating|0|||
155344281|NCT01114217|560692885|FG000|Overall Study|Other-Lost to Follow-up|1|||
155344282|NCT01114217|560692886|FG001|Overall Study|Other-Lost to Follow-up|0|||
155344283|NCT01114217|560692885|FG000|Overall Study|Other-Withdrawal by Subject|1|||
155344284|NCT01114217|560692886|FG001|Overall Study|Other-Withdrawal by Subject|1|||
155344285|NCT06247488|560692887|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
155344286|NCT06247488|560692888|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344287|NCT06247488|560692889|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344288|NCT06247488|560692890|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344289|NCT06247488|560692891|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344290|NCT06247488|560692892|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
155344291|NCT06247488|560692887|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155344292|NCT06247488|560692888|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155080317|NCT01049828|559723083|FG000|Overall Study|Claustrophibia and Frustration|2|||
155344293|NCT06247488|560692889|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155344294|NCT06247488|560692890|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
155344295|NCT06247488|560692891|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155344296|NCT06247488|560692892|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
155080318|NCT00290238|559723084|FG000|Overall Study|Study terminated|27|||
155080319|NCT00290238|559723085|FG001|Overall Study|Study terminated|27|||
155080320|NCT00290238|559723084|FG000|Overall Study|Lost to Follow-up|0|||
155080321|NCT00290238|559723085|FG001|Overall Study|Lost to Follow-up|1|||
155080322|NCT00290238|559723084|FG000|Overall Study|Withdrawal by Subject|15|||
155080323|NCT00290238|559723085|FG001|Overall Study|Withdrawal by Subject|13|||
155080324|NCT03834883|559723086|FG000|Second Treatment|Withdrawal by Subject|1|||
155080325|NCT03834883|559723087|FG001|Second Treatment|Withdrawal by Subject|0|||
155080326|NCT03834883|559723088|FG002|Second Treatment|Withdrawal by Subject|0|||
155080327|NCT03834883|559723089|FG003|Second Treatment|Withdrawal by Subject|0|||
155080328|NCT03834883|559723086|FG000|Second Treatment|COVID-19 pandemic|1|||
155080329|NCT03834883|559723087|FG001|Second Treatment|COVID-19 pandemic|0|||
155080330|NCT03834883|559723088|FG002|Second Treatment|COVID-19 pandemic|1|||
155080331|NCT03834883|559723089|FG003|Second Treatment|COVID-19 pandemic|1|||
155080332|NCT01569763|559725283|FG000|Overall Study|Lack of Efficacy|2|||
155080333|NCT01569763|559725284|FG001|Overall Study|Lack of Efficacy|7|||
155080334|NCT01569763|559725283|FG000|Overall Study|Adverse Event|1|||
155080335|NCT01569763|559725284|FG001|Overall Study|Adverse Event|0|||
155080336|NCT01926509|559725285|FG000|Overall Study|vital sign met discontinuation criteria|1|||
155080337|NCT01926509|559725286|FG001|Overall Study|vital sign met discontinuation criteria|0|||
155080338|NCT01926509|559725287|FG002|Overall Study|vital sign met discontinuation criteria|0|||
155080339|NCT01926509|559725288|FG003|Overall Study|vital sign met discontinuation criteria|0|||
155344297|NCT06247488|560692887|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
155344298|NCT06247488|560692888|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155080340|NCT02730169|559725289|FG000|Overall Study|Protocol Violation|1|||
155080341|NCT02730169|559725290|FG001|Overall Study|Protocol Violation|0|||
155080342|NCT02730169|559725291|FG002|Overall Study|Protocol Violation|0|||
155080343|NCT02730169|559725292|FG003|Overall Study|Protocol Violation|1|||
155080344|NCT02730169|559725289|FG000|Overall Study|Adverse Event|2|||
155080345|NCT02730169|559725290|FG001|Overall Study|Adverse Event|3|||
155080346|NCT02730169|559725291|FG002|Overall Study|Adverse Event|3|||
155080347|NCT02730169|559725292|FG003|Overall Study|Adverse Event|0|||
155080348|NCT02730169|559725289|FG000|Overall Study|Adverse Event of Special Interest|0|||
155080349|NCT02730169|559725290|FG001|Overall Study|Adverse Event of Special Interest|1|||
155080350|NCT02730169|559725291|FG002|Overall Study|Adverse Event of Special Interest|2|||
155080351|NCT02730169|559725292|FG003|Overall Study|Adverse Event of Special Interest|0|||
155080352|NCT02730169|559725289|FG000|Overall Study|Withdrawal by Subject|6|||
155080353|NCT02730169|559725290|FG001|Overall Study|Withdrawal by Subject|11|||
155080354|NCT02730169|559725291|FG002|Overall Study|Withdrawal by Subject|6|||
155080355|NCT02730169|559725292|FG003|Overall Study|Withdrawal by Subject|8|||
155080356|NCT02730169|559725289|FG000|Overall Study|Lost to Follow-up|5|||
155080357|NCT02730169|559725290|FG001|Overall Study|Lost to Follow-up|6|||
155080358|NCT02730169|559725291|FG002|Overall Study|Lost to Follow-up|5|||
155080359|NCT02730169|559725292|FG003|Overall Study|Lost to Follow-up|6|||
155080360|NCT02730169|559725289|FG000|Overall Study|Other|0|||
155080361|NCT02730169|559725290|FG001|Overall Study|Other|0|||
155080362|NCT02730169|559725291|FG002|Overall Study|Other|1|||
155080363|NCT02730169|559725292|FG003|Overall Study|Other|1|||
155080364|NCT03681093|559725293|FG000|Overall Study|Subject decision|0|||
155080365|NCT03681093|559725294|FG001|Overall Study|Subject decision|2|||
155080366|NCT03681093|559725295|FG002|Overall Study|Subject decision|1|||
155080367|NCT01213251|559725297|FG000|Overall Study|Death|2|||
155080368|NCT01213251|559725298|FG001|Overall Study|Death|1|||
155080369|NCT01213251|559725299|FG002|Overall Study|Death|2|||
155080370|NCT01213251|559725297|FG000|Overall Study|Exit|3|||
155080371|NCT01213251|559725298|FG001|Overall Study|Exit|2|||
155080372|NCT01213251|559725299|FG002|Overall Study|Exit|8|||
155080373|NCT01213251|559725297|FG000|Overall Study|Protocol Violation|1|||
155080374|NCT01213251|559725298|FG001|Overall Study|Protocol Violation|1|||
155080375|NCT01213251|559725299|FG002|Overall Study|Protocol Violation|0|||
155080376|NCT01213251|559725297|FG000|Overall Study|Missed 18-Month Follow-up|0|||
155080377|NCT01213251|559725298|FG001|Overall Study|Missed 18-Month Follow-up|0|||
155080378|NCT01213251|559725299|FG002|Overall Study|Missed 18-Month Follow-up|1|||
155080379|NCT02698787|559725300|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
155080380|NCT02698787|559725301|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
155080381|NCT01882829|559725304|FG000|Overall Study|Adverse Event|4|||
155080382|NCT01882829|559725304|FG000|Overall Study|Protocol Violation|1|||
155080383|NCT01882829|559725304|FG000|Overall Study|Withdrawal by Subject|1|||
155080384|NCT00326495|559725311|FG000|Overall Study|Switched to alternative treatment|1|||
155080385|NCT00326495|559725311|FG000|Overall Study|Disease progression before treatment|1|||
155080386|NCT00326495|559725311|FG000|Overall Study|Refused further treatment|2|||
155080387|NCT00326495|559725311|FG000|Overall Study|Subject off study before assessment|1|||
155080388|NCT02802865|559725312|FG000|Overall Study|Pregnancy|1|||
155080389|NCT02802865|559725313|FG001|Overall Study|Pregnancy|1|||
155080390|NCT02802865|559725312|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
155080391|NCT02802865|559725313|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
155080392|NCT01862029|559725314|FG000|Overall Study|Physician Decision|1|||
155080393|NCT03931785|559725316|FG000|Overall Study|Lost to Follow-up|4|||
155080394|NCT03931785|559725317|FG001|Overall Study|Lost to Follow-up|1|||
155080395|NCT03931785|559725318|FG002|Overall Study|Lost to Follow-up|4|||
155080396|NCT03931785|559725319|FG003|Overall Study|Lost to Follow-up|3|||
155165421|NCT02039843|560041986|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
155165422|NCT02039843|560041987|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
155165423|NCT02039843|560041986|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
155165424|NCT02039843|560041987|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
155165425|NCT02039843|560041986|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
155165426|NCT02039843|560041987|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
155165427|NCT02039843|560041986|FG000|Pairing With a Study Dog|Death|1|||
155165428|NCT02039843|560041987|FG001|Pairing With a Study Dog|Death|0|||
155165429|NCT02039843|560041986|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
155165430|NCT02039843|560041987|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
155165431|NCT02039843|560041986|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
155165432|NCT02039843|560041987|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
155165433|NCT02039843|560041986|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
155165434|NCT02039843|560041987|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
155165435|NCT01500720|560041991|FG000|Overall Study|Randomized But Not Treated|1|||
155165436|NCT01500720|560041992|FG001|Overall Study|Randomized But Not Treated|1|||
155165437|NCT01500720|560041991|FG000|Overall Study|Other|4|||
155165438|NCT01500720|560041992|FG001|Overall Study|Other|8|||
155165439|NCT00630838|560041995|FG000|Overall Study|Death|0|||
155165440|NCT00630838|560041996|FG001|Overall Study|Death|1|||
155165441|NCT00630838|560041995|FG000|Overall Study|Lost to Follow-up|0|||
155165442|NCT00630838|560041996|FG001|Overall Study|Lost to Follow-up|1|||
155165443|NCT00928408|560041997|FG000|Overall Study|Other|2|||
155165444|NCT00928408|560041997|FG000|Overall Study|Withdrawal by Subject|4|||
155165445|NCT00928408|560041997|FG000|Overall Study|Death|5|||
155165446|NCT00928408|560041997|FG000|Overall Study|Lost to Follow-up|12|||
155165447|NCT01104311|560042008|FG000|Overall Study|Withdrawal by Subject|6|||
155165448|NCT01104311|560042009|FG001|Overall Study|Withdrawal by Subject|6|||
155165449|NCT01104311|560042008|FG000|Overall Study|Protocol Violation|0|||
155165450|NCT01104311|560042009|FG001|Overall Study|Protocol Violation|1|||
155165451|NCT01104311|560042008|FG000|Overall Study|Physician Decision|2|||
155165452|NCT01104311|560042009|FG001|Overall Study|Physician Decision|2|||
155165453|NCT01104311|560042008|FG000|Overall Study|low compliance|1|||
155165454|NCT01104311|560042009|FG001|Overall Study|low compliance|1|||
155165455|NCT01104311|560042008|FG000|Overall Study|Adverse Event|1|||
155165456|NCT01104311|560042009|FG001|Overall Study|Adverse Event|2|||
155165457|NCT01077050|560043423|FG000|Overall Study|Subjects signed ICF could not be located|1|||
155165458|NCT01077050|560043423|FG000|Overall Study|Screen failure|8|||
155165459|NCT02565784|560043427|FG000|First Treatment|Adverse Event|1|||
155165460|NCT02565784|560043427|FG000|First Treatment|Withdrawal by Subject|1|||
155165461|NCT02565784|560043427|FG000|Second Treatment|Withdrawal by Subject|2|||
155165462|NCT01193257|560043434|FG000|Overall Study|Death|202|||
155165463|NCT01193257|560043435|FG001|Overall Study|Death|391|||
155165464|NCT01193257|560043434|FG000|Overall Study|Study termination by sponsor|0|||
155165465|NCT01193257|560043435|FG001|Overall Study|Study termination by sponsor|3|||
155165466|NCT01193257|560043434|FG000|Overall Study|Withdrawal by Subject|26|||
155165467|NCT01193257|560043435|FG001|Overall Study|Withdrawal by Subject|86|||
155165468|NCT01193257|560043434|FG000|Overall Study|Lost to Follow-up|2|||
155165469|NCT01193257|560043435|FG001|Overall Study|Lost to Follow-up|3|||
155165470|NCT01193257|560043434|FG000|Overall Study|Unblinded due to futility|135|||
155165471|NCT01193257|560043435|FG001|Overall Study|Unblinded due to futility|251|||
155165472|NCT03126344|560043446|FG000|Overall Study|Lost to Follow-up|0|||
155344299|NCT06247488|560692889|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344300|NCT06247488|560692890|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344301|NCT06247488|560692891|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344302|NCT06247488|560692892|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
155344303|NCT06247488|560692887|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344304|NCT06247488|560692888|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344305|NCT06247488|560692889|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344306|NCT06247488|560692890|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
155165473|NCT03126344|560043447|FG001|Overall Study|Lost to Follow-up|0|||
155165474|NCT03126344|560043448|FG002|Overall Study|Lost to Follow-up|5|||
155165475|NCT01715857|560043449|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
155165476|NCT02563067|560043451|FG000|Overall Study|Subject/guardian decision|14|||
155165477|NCT02563067|560043452|FG001|Overall Study|Subject/guardian decision|20|||
155165478|NCT02563067|560043453|FG002|Overall Study|Subject/guardian decision|16|||
155165479|NCT02563067|560043451|FG000|Overall Study|Physician Decision|0|||
155165480|NCT02563067|560043452|FG001|Overall Study|Physician Decision|1|||
155165481|NCT02563067|560043453|FG002|Overall Study|Physician Decision|3|||
155165482|NCT02563067|560043451|FG000|Overall Study|Lost to Follow-up|1|||
155165483|NCT02563067|560043452|FG001|Overall Study|Lost to Follow-up|2|||
155165484|NCT02563067|560043453|FG002|Overall Study|Lost to Follow-up|0|||
155165485|NCT02563067|560043451|FG000|Overall Study|Technical problems|0|||
155165486|NCT02563067|560043452|FG001|Overall Study|Technical problems|1|||
155080397|NCT03931785|559725316|FG000|Overall Study|Adverse Event|1|||
155080398|NCT03931785|559725317|FG001|Overall Study|Adverse Event|0|||
155344307|NCT06247488|560692891|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344308|NCT06247488|560692892|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
155344309|NCT06247488|560692887|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344310|NCT06247488|560692888|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344311|NCT06247488|560692889|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344312|NCT06247488|560692890|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344313|NCT06247488|560692891|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
155344314|NCT06247488|560692892|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
155344315|NCT06247488|560692887|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
155344316|NCT06247488|560692888|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
155344317|NCT06247488|560692889|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
155344318|NCT06247488|560692890|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
155344319|NCT06247488|560692891|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
155344320|NCT06247488|560692892|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
155344321|NCT06247488|560692887|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344322|NCT06247488|560692888|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344323|NCT06247488|560692889|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
154963943|NCT06041256|559293501|FG003|Overall Study|Withdrawal by Subject|1|||
154963944|NCT06041256|559293502|FG004|Overall Study|Withdrawal by Subject|1|||
154963945|NCT06041256|559293498|FG000|Overall Study|Rescue|17|||
155080399|NCT03931785|559725318|FG002|Overall Study|Adverse Event|3|||
155080400|NCT03931785|559725319|FG003|Overall Study|Adverse Event|4|||
155080401|NCT03931785|559725316|FG000|Overall Study|Protocol Violation|0|||
155080402|NCT03931785|559725317|FG001|Overall Study|Protocol Violation|1|||
155080403|NCT03931785|559725318|FG002|Overall Study|Protocol Violation|0|||
155080404|NCT03931785|559725319|FG003|Overall Study|Protocol Violation|0|||
155080405|NCT03931785|559725316|FG000|Overall Study|Noncompliance With Study drug|0|||
155080406|NCT03931785|559725317|FG001|Overall Study|Noncompliance With Study drug|1|||
155080407|NCT03931785|559725318|FG002|Overall Study|Noncompliance With Study drug|0|||
155080408|NCT03931785|559725319|FG003|Overall Study|Noncompliance With Study drug|0|||
155080409|NCT03931785|559725316|FG000|Overall Study|Other Not specified|0|||
155080410|NCT03931785|559725317|FG001|Overall Study|Other Not specified|2|||
155080411|NCT03931785|559725318|FG002|Overall Study|Other Not specified|2|||
155080412|NCT03931785|559725319|FG003|Overall Study|Other Not specified|2|||
155080413|NCT03931785|559725316|FG000|Overall Study|Withdrawal by Subject|0|||
155080414|NCT03931785|559725317|FG001|Overall Study|Withdrawal by Subject|2|||
155080415|NCT03931785|559725318|FG002|Overall Study|Withdrawal by Subject|4|||
155080416|NCT03931785|559725319|FG003|Overall Study|Withdrawal by Subject|1|||
155080417|NCT03931785|559725316|FG000|Overall Study|Pregnancy|0|||
155080418|NCT03931785|559725317|FG001|Overall Study|Pregnancy|0|||
155080419|NCT03931785|559725318|FG002|Overall Study|Pregnancy|0|||
155080420|NCT03931785|559725319|FG003|Overall Study|Pregnancy|1|||
155080421|NCT03211858|559725320|FG000|Overall Study|Adverse Event|8|||
155080422|NCT03211858|559725321|FG001|Overall Study|Adverse Event|6|||
155080423|NCT03211858|559725320|FG000|Overall Study|Lack of Efficacy|0|||
155080424|NCT03211858|559725321|FG001|Overall Study|Lack of Efficacy|4|||
155080425|NCT03211858|559725320|FG000|Overall Study|Poor compliance to protocol|6|||
155080426|NCT03211858|559725321|FG001|Overall Study|Poor compliance to protocol|2|||
155080427|NCT03211858|559725320|FG000|Overall Study|Non-serious Hypoglycemia|1|||
155080428|NCT03211858|559725321|FG001|Overall Study|Non-serious Hypoglycemia|0|||
155080429|NCT03211858|559725320|FG000|Overall Study|Other than specified above|22|||
155080430|NCT03211858|559725321|FG001|Overall Study|Other than specified above|21|||
155080431|NCT01529112|559725324|FG000|Overall Study|Adverse Event|2|||
155080432|NCT01529112|559725325|FG001|Overall Study|Adverse Event|0|||
155080433|NCT01529112|559725324|FG000|Overall Study|Death|59|||
155080434|NCT01529112|559725325|FG001|Overall Study|Death|38|||
154963946|NCT06041256|559293499|FG001|Overall Study|Rescue|6|||
155080435|NCT01529112|559725324|FG000|Overall Study|Protocol Violation|1|||
155080436|NCT01529112|559725325|FG001|Overall Study|Protocol Violation|0|||
155080437|NCT01529112|559725324|FG000|Overall Study|Withdrawal by Subject|7|||
155080438|NCT01529112|559725325|FG001|Overall Study|Withdrawal by Subject|3|||
155344324|NCT06247488|560692890|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155344325|NCT06247488|560692891|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
155080439|NCT02123511|559725330|FG000|Overall Study|Cancelled treatment|1|||
155080440|NCT02123511|559725331|FG001|Overall Study|Cancelled treatment|0|||
155080441|NCT02123511|559725330|FG000|Overall Study|Incomplete data|1|||
155080442|NCT02123511|559725331|FG001|Overall Study|Incomplete data|3|||
155080443|NCT02123511|559725330|FG000|Overall Study|Ineligible|0|||
155080444|NCT02123511|559725331|FG001|Overall Study|Ineligible|1|||
155080445|NCT01423084|559725332|FG000|Overall Study|Adverse Event|0|||
155080446|NCT01423084|559725333|FG001|Overall Study|Adverse Event|1|||
155080447|NCT01423084|559725332|FG000|Overall Study|Withdrawal by Subject|2|||
155344326|NCT06247488|560692892|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
155344327|NCT03436797|560692896|FG000|Main Study|Withdrawal by Subject|2|||
155344328|NCT03436797|560692896|FG000|Main Study|Adverse Event|4|||
155344329|NCT03436797|560692896|FG000|Main Study|Lost to Follow-up|1|||
155344330|NCT03436797|560692896|FG000|Main Study|Death|1|||
155344331|NCT03436797|560692896|FG000|Main Study|Non-Specific|2|||
155344332|NCT03436797|560692896|FG000|Extended Dosing|Patient decision|1|||
155344333|NCT04739306|560692897|FG000|Main Study Period|Adverse Event|6|||
155344334|NCT04739306|560692898|FG001|Main Study Period|Adverse Event|7|||
155344335|NCT04739306|560692897|FG000|Main Study Period|Lost to Follow-up|4|||
155344336|NCT04739306|560692898|FG001|Main Study Period|Lost to Follow-up|6|||
155344337|NCT04739306|560692897|FG000|Main Study Period|Physician Decision|1|||
155344338|NCT04739306|560692898|FG001|Main Study Period|Physician Decision|1|||
155344339|NCT04739306|560692897|FG000|Main Study Period|Withdrawal by Subject|8|||
155344340|NCT04739306|560692898|FG001|Main Study Period|Withdrawal by Subject|6|||
155080448|NCT01423084|559725333|FG001|Overall Study|Withdrawal by Subject|3|||
155080449|NCT01908699|559725342|FG000|Overall Study|Adverse Event|8|||
155080450|NCT01908699|559725343|FG001|Overall Study|Adverse Event|12|||
155080451|NCT01908699|559725342|FG000|Overall Study|Lack of Efficacy|2|||
155080452|NCT01908699|559725343|FG001|Overall Study|Lack of Efficacy|2|||
155080453|NCT01908699|559725342|FG000|Overall Study|Lost to Follow-up|2|||
155080454|NCT01908699|559725343|FG001|Overall Study|Lost to Follow-up|4|||
155080455|NCT01908699|559725342|FG000|Overall Study|Physician Decision|8|||
155080456|NCT01908699|559725343|FG001|Overall Study|Physician Decision|8|||
155080457|NCT01908699|559725342|FG000|Overall Study|Withdrawal by Subject|15|||
155080458|NCT01908699|559725343|FG001|Overall Study|Withdrawal by Subject|10|||
155080459|NCT01908699|559725342|FG000|Overall Study|Pregnancy|0|||
155080460|NCT01908699|559725343|FG001|Overall Study|Pregnancy|1|||
155080461|NCT01908699|559725342|FG000|Overall Study|Randomized in Error|1|||
155080462|NCT01908699|559725343|FG001|Overall Study|Randomized in Error|0|||
155080463|NCT01908699|559725342|FG000|Overall Study|Death|9|||
155080464|NCT01908699|559725343|FG001|Overall Study|Death|12|||
155080465|NCT01908699|559725342|FG000|Overall Study|Progressive Disease|30|||
155080466|NCT01908699|559725343|FG001|Overall Study|Progressive Disease|29|||
155080467|NCT02105012|559725344|FG000|Overall Study|Withdrawal by Subject|11|||
155080468|NCT02105012|559725344|FG000|Overall Study|Protocol Specified Criteria|9|||
155080469|NCT02105012|559725344|FG000|Overall Study|Lost to Follow-up|4|||
155080470|NCT02105012|559725344|FG000|Overall Study|Protocol Violation|4|||
155080471|NCT02105012|559725344|FG000|Overall Study|Physician Decision|3|||
155080472|NCT02105012|559725344|FG000|Overall Study|Adverse Event|1|||
155080473|NCT02105012|559725344|FG000|Overall Study|Lack of Efficacy|1|||
155080474|NCT00493285|559725345|FG000|Overall Study|Lost to Follow-up|0|||
155080475|NCT00493285|559725346|FG001|Overall Study|Lost to Follow-up|0|||
155080476|NCT00493285|559725347|FG002|Overall Study|Lost to Follow-up|0|||
155080477|NCT00493285|559725348|FG003|Overall Study|Lost to Follow-up|0|||
155080478|NCT00493285|559725349|FG004|Overall Study|Lost to Follow-up|1|||
155080479|NCT00493285|559725350|FG005|Overall Study|Lost to Follow-up|0|||
155080480|NCT00474968|559725354|FG000|Overall Study|Withdrawal by Subject|8|||
155080481|NCT00474968|559725355|FG001|Overall Study|Withdrawal by Subject|7|||
155080482|NCT00474968|559725354|FG000|Overall Study|Protocol Violation|9|||
155080483|NCT00474968|559725355|FG001|Overall Study|Protocol Violation|8|||
155080484|NCT00474968|559725354|FG000|Overall Study|Sample not collected|1|||
155080485|NCT00474968|559725355|FG001|Overall Study|Sample not collected|1|||
155080486|NCT00215553|559725356|FG000|Overall Study|Adverse Event|0|||
155080487|NCT00215553|559725357|FG001|Overall Study|Adverse Event|1|||
155080488|NCT00215553|559725358|FG002|Overall Study|Adverse Event|2|||
155080489|NCT00215553|559725359|FG003|Overall Study|Adverse Event|1|||
155080490|NCT00215553|559725360|FG004|Overall Study|Adverse Event|2|||
155080491|NCT00215553|559725361|FG005|Overall Study|Adverse Event|6|||
155080492|NCT00215553|559725362|FG006|Overall Study|Adverse Event|0|||
155080493|NCT01429623|559725363|FG000|Overall Study|Death|1|||
155080494|NCT01429623|559725364|FG001|Overall Study|Death|0|||
155080495|NCT01429623|559725363|FG000|Overall Study|Adverse Event|7|||
155080496|NCT01429623|559725364|FG001|Overall Study|Adverse Event|14|||
155080497|NCT01429623|559725363|FG000|Overall Study|Withdrawal by Subject|19|||
155080498|NCT01429623|559725364|FG001|Overall Study|Withdrawal by Subject|13|||
155080499|NCT01429623|559725363|FG000|Overall Study|Physician Decision|2|||
155080500|NCT01429623|559725364|FG001|Overall Study|Physician Decision|3|||
155080501|NCT01429623|559725363|FG000|Overall Study|Protocol Violation|3|||
155080502|NCT01429623|559725364|FG001|Overall Study|Protocol Violation|2|||
155080503|NCT01429623|559725363|FG000|Overall Study|Assorted|1|||
155080504|NCT01429623|559725364|FG001|Overall Study|Assorted|2|||
155080505|NCT01429623|559725363|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
155344341|NCT04739306|560692897|FG000|Main Study Period|Protocol Violation|0|||
155080506|NCT01429623|559725364|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
155080507|NCT01429623|559725363|FG000|Overall Study|No post baseline data|4|||
155080508|NCT01429623|559725364|FG001|Overall Study|No post baseline data|4|||
155080509|NCT00981175|559725365|FG000|Primary Dose Vaccination|Adverse Event|1|||
155080510|NCT00981175|559725366|FG001|Primary Dose Vaccination|Adverse Event|0|||
155080511|NCT00981175|559725365|FG000|Primary Dose Vaccination|Protocol Violation|0|||
155080512|NCT00981175|559725366|FG001|Primary Dose Vaccination|Protocol Violation|1|||
155344342|NCT04739306|560692898|FG001|Main Study Period|Protocol Violation|1|||
155344343|NCT04739306|560692897|FG000|Main Study Period|War in Ukraine|1|||
155344344|NCT04739306|560692898|FG001|Main Study Period|War in Ukraine|1|||
155080513|NCT00981175|559725365|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
155080514|NCT00981175|559725366|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
155344345|NCT01951105|560692903|FG000|Overall Study|Adverse Event|0|||
155344346|NCT01951105|560692904|FG001|Overall Study|Adverse Event|5|||
155344347|NCT01951105|560692905|FG002|Overall Study|Adverse Event|0|||
155344348|NCT01951105|560692903|FG000|Overall Study|Lost to Follow-up|0|||
155344349|NCT01951105|560692904|FG001|Overall Study|Lost to Follow-up|1|||
155344350|NCT01951105|560692905|FG002|Overall Study|Lost to Follow-up|0|||
155344351|NCT01951105|560692903|FG000|Overall Study|Protocol Violation|1|||
155344352|NCT01951105|560692904|FG001|Overall Study|Protocol Violation|1|||
155344353|NCT01951105|560692905|FG002|Overall Study|Protocol Violation|1|||
155344354|NCT01951105|560692903|FG000|Overall Study|Withdrawal by Subject|0|||
155344355|NCT01951105|560692904|FG001|Overall Study|Withdrawal by Subject|3|||
155344356|NCT01951105|560692905|FG002|Overall Study|Withdrawal by Subject|1|||
155080515|NCT00981175|559725365|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
155080516|NCT00981175|559725366|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
155080517|NCT05345405|559725367|FG000|Overall Study|Withdrawal by Subject|2|||
155080518|NCT05345405|559725368|FG001|Overall Study|Withdrawal by Subject|0|||
155344357|NCT04175392|560692906|FG000|Overall Study|Withdrawal by Subject|3|||
155344358|NCT04175392|560692907|FG001|Overall Study|Withdrawal by Subject|2|||
155344359|NCT02727998|560692908|FG000|Overall Study|Lost to Follow-up|3|||
155344360|NCT02727998|560692909|FG001|Overall Study|Lost to Follow-up|3|||
155344361|NCT02727998|560692908|FG000|Overall Study|Withdrawal by Subject|0|||
155344362|NCT02727998|560692909|FG001|Overall Study|Withdrawal by Subject|1|||
155344363|NCT02105688|560692910|FG000|Part A: Double-Blind|Adverse Event|1|||
155344364|NCT02105688|560692911|FG001|Part A: Double-Blind|Adverse Event|0|||
155344365|NCT02105688|560692910|FG000|Part A: Double-Blind|Death|0|||
155344366|NCT02105688|560692911|FG001|Part A: Double-Blind|Death|1|||
155344367|NCT02105688|560692910|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
155344368|NCT02105688|560692911|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
155344369|NCT02105688|560692910|FG000|Part A: Double-Blind|Physician Decision|0|||
155344370|NCT02105688|560692911|FG001|Part A: Double-Blind|Physician Decision|1|||
155344371|NCT02105688|560692910|FG000|Part A: Double-Blind|Status Unknown|0|||
155344372|NCT02105688|560692911|FG001|Part A: Double-Blind|Status Unknown|2|||
155344373|NCT02105688|560692910|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
155344374|NCT02105688|560692911|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
155344375|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Death|2|||
155344376|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Death|1|||
155344377|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
155344378|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
155344379|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
155344380|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
155344381|NCT02105688|560692910|FG000|Part B: Observational Follow-up|Physician Decision|3|||
155344382|NCT02105688|560692911|FG001|Part B: Observational Follow-up|Physician Decision|1|||
155344383|NCT00561678|560692912|FG000|Overall Study|Withdrawal by Subject|4|||
155344384|NCT00561678|560692913|FG001|Overall Study|Withdrawal by Subject|3|||
155344385|NCT00561678|560692912|FG000|Overall Study|surgery cancelled|1|||
155344386|NCT00561678|560692913|FG001|Overall Study|surgery cancelled|1|||
155344387|NCT00561678|560692912|FG000|Overall Study|surgery rescheduled to different site|2|||
155344388|NCT00561678|560692913|FG001|Overall Study|surgery rescheduled to different site|2|||
155344389|NCT00561678|560692912|FG000|Overall Study|anesthesia provider refusal|1|||
155344390|NCT00561678|560692913|FG001|Overall Study|anesthesia provider refusal|0|||
155344391|NCT01103141|560692914|FG000|Overall Study|Death|0|||
155344392|NCT01103141|560692915|FG001|Overall Study|Death|1|||
155344393|NCT01103141|560692914|FG000|Overall Study|Lost to Follow-up|2|||
155344394|NCT01103141|560692915|FG001|Overall Study|Lost to Follow-up|1|||
155344395|NCT05072795|560692916|FG000|Overall Study|Lost to Follow-up|5|||
155344396|NCT00422162|560692924|FG000|Overall Study|Adverse Event|11|||
155344397|NCT00422162|560692925|FG001|Overall Study|Adverse Event|9|||
155344398|NCT00422162|560692924|FG000|Overall Study|Lack of Efficacy|4|||
155344399|NCT00422162|560692925|FG001|Overall Study|Lack of Efficacy|10|||
155344400|NCT00422162|560692924|FG000|Overall Study|Withdrawal by Subject|7|||
155344401|NCT00422162|560692925|FG001|Overall Study|Withdrawal by Subject|6|||
155344402|NCT00422162|560692924|FG000|Overall Study|Lost to Follow-up|1|||
155344403|NCT00422162|560692925|FG001|Overall Study|Lost to Follow-up|2|||
155344404|NCT00422162|560692924|FG000|Overall Study|Non-Compliant with Protocol|1|||
155344405|NCT00422162|560692925|FG001|Overall Study|Non-Compliant with Protocol|1|||
155344406|NCT00422162|560692924|FG000|Overall Study|Other|0|||
155344407|NCT00422162|560692925|FG001|Overall Study|Other|1|||
154963947|NCT06041256|559293500|FG002|Overall Study|Rescue|9|||
155344408|NCT00422162|560692924|FG000|Overall Study|Didn't Receive Treatment|0|||
155344409|NCT00422162|560692925|FG001|Overall Study|Didn't Receive Treatment|1|||
155344410|NCT05274906|560692926|FG000|Overall Study|Withdrawal by Subject|2|||
155344411|NCT05274906|560692927|FG001|Overall Study|Withdrawal by Subject|1|||
155344412|NCT00848198|560692928|FG000|Overall Study|Incomplete Case Report Forms|15|||
155344413|NCT02062827|560692929|FG000|Overall Study|Death|1|||
155344414|NCT02062827|560692930|FG001|Overall Study|Death|0|||
154963948|NCT06041256|559293501|FG003|Overall Study|Rescue|6|||
155165487|NCT02563067|560043453|FG002|Overall Study|Technical problems|0|||
155344415|NCT02062827|560692931|FG002|Overall Study|Death|0|||
155344416|NCT02062827|560692932|FG003|Overall Study|Death|0|||
155344417|NCT02062827|560692933|FG004|Overall Study|Death|0|||
155344418|NCT02062827|560692934|FG005|Overall Study|Death|0|||
155344419|NCT02062827|560692935|FG006|Overall Study|Death|0|||
155344420|NCT02062827|560692936|FG007|Overall Study|Death|0|||
155344421|NCT02062827|560692929|FG000|Overall Study|Withdrawal by Subject|3|||
155344422|NCT02062827|560692930|FG001|Overall Study|Withdrawal by Subject|1|||
155344423|NCT02062827|560692931|FG002|Overall Study|Withdrawal by Subject|1|||
155344424|NCT02062827|560692932|FG003|Overall Study|Withdrawal by Subject|2|||
155344425|NCT02062827|560692933|FG004|Overall Study|Withdrawal by Subject|6|||
155344426|NCT02062827|560692934|FG005|Overall Study|Withdrawal by Subject|0|||
155344427|NCT02062827|560692935|FG006|Overall Study|Withdrawal by Subject|5|||
155344428|NCT02062827|560692936|FG007|Overall Study|Withdrawal by Subject|0|||
155344429|NCT02062827|560692929|FG000|Overall Study|Screen Fail|0|||
155344430|NCT02062827|560692930|FG001|Overall Study|Screen Fail|0|||
155344431|NCT02062827|560692931|FG002|Overall Study|Screen Fail|0|||
155344432|NCT02062827|560692932|FG003|Overall Study|Screen Fail|0|||
155344433|NCT02062827|560692933|FG004|Overall Study|Screen Fail|0|||
155344434|NCT02062827|560692934|FG005|Overall Study|Screen Fail|0|||
155344435|NCT02062827|560692935|FG006|Overall Study|Screen Fail|0|||
155344436|NCT02062827|560692936|FG007|Overall Study|Screen Fail|8|||
155344437|NCT04930263|560692937|FG000|Overall Study|Withdrawal by Subject|3|||
155344438|NCT04930263|560692938|FG001|Overall Study|Withdrawal by Subject|5|||
155344439|NCT02812706|560692939|FG000|Phase 1|Adverse Event|0|||
155344440|NCT02812706|560692940|FG001|Phase 1|Adverse Event|2|||
155344441|NCT02812706|560692941|FG002|Phase 1|Adverse Event|0|||
155165488|NCT02563067|560043451|FG000|Overall Study|Lack of Efficacy|1|||
155165489|NCT02563067|560043452|FG001|Overall Study|Lack of Efficacy|0|||
155165490|NCT02563067|560043453|FG002|Overall Study|Lack of Efficacy|0|||
155165491|NCT02563067|560043451|FG000|Overall Study|Death|0|||
155165492|NCT02563067|560043452|FG001|Overall Study|Death|1|||
155165493|NCT02563067|560043453|FG002|Overall Study|Death|1|||
155165494|NCT02563067|560043451|FG000|Overall Study|Adverse Event|2|||
155344442|NCT02812706|560692939|FG000|Phase 1|Progressive disease|3|||
155344443|NCT02812706|560692940|FG001|Phase 1|Progressive disease|3|||
155344444|NCT02812706|560692941|FG002|Phase 1|Progressive disease|0|||
155344445|NCT02812706|560692939|FG000|Phase 2|Adverse Event|0|||
155344446|NCT02812706|560692940|FG001|Phase 2|Adverse Event|0|||
155344447|NCT02812706|560692941|FG002|Phase 2|Adverse Event|2|||
155344448|NCT02812706|560692939|FG000|Phase 2|Progressive disease|0|||
155344449|NCT02812706|560692940|FG001|Phase 2|Progressive disease|0|||
155344450|NCT02812706|560692941|FG002|Phase 2|Progressive disease|22|||
155344451|NCT02812706|560692939|FG000|Phase 2|Other-Unspecified|0|||
155344452|NCT02812706|560692940|FG001|Phase 2|Other-Unspecified|0|||
155344453|NCT02812706|560692941|FG002|Phase 2|Other-Unspecified|4|||
155344454|NCT04362176|560692942|FG000|Overall Study|Lost to Follow-up|5|||
155344455|NCT04362176|560692943|FG001|Overall Study|Lost to Follow-up|8|||
155344456|NCT04362176|560692942|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
155344457|NCT04362176|560692943|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
155344458|NCT06312566|560692944|FG000|Overall Study|Protocol Violation|0|||
155344459|NCT06312566|560692945|FG001|Overall Study|Protocol Violation|1|||
155344460|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
155344461|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
155344462|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
155344463|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
155344464|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
155344465|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
155165495|NCT02563067|560043452|FG001|Overall Study|Adverse Event|1|||
155344466|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
155344467|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
155165496|NCT02563067|560043453|FG002|Overall Study|Adverse Event|0|||
155344468|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
155344469|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
155344470|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
155165497|NCT02563067|560043451|FG000|Overall Study|Death post Treatment/safety period|1|||
155344471|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
155344472|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
155344473|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
155165498|NCT02563067|560043452|FG001|Overall Study|Death post Treatment/safety period|0|||
155344474|NCT02971683|560692946|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
155080519|NCT05345405|559725369|FG002|Overall Study|Withdrawal by Subject|0|||
155344475|NCT02971683|560692947|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
155344476|NCT02971683|560692946|FG000|Open-Label|Lost to Follow-up|1|||
155344477|NCT02971683|560692947|FG001|Open-Label|Lost to Follow-up|0|||
155344478|NCT02971683|560692946|FG000|Open-Label|Participants withdrew consent|0|||
155344479|NCT02971683|560692947|FG001|Open-Label|Participants withdrew consent|2|||
155344480|NCT02971683|560692946|FG000|Open-Label|Participant request to discontinue study treatment|1|||
155344481|NCT02971683|560692947|FG001|Open-Label|Participant request to discontinue study treatment|0|||
155344482|NCT02971683|560692946|FG000|Open-Label|Lack of Efficacy|2|||
155344483|NCT02971683|560692947|FG001|Open-Label|Lack of Efficacy|0|||
155344484|NCT02971683|560692946|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
155344485|NCT02971683|560692947|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
155344486|NCT02971683|560692946|FG000|Long-Term Open Label|Participant withdrew consent|1|||
155344487|NCT02971683|560692947|FG001|Long-Term Open Label|Participant withdrew consent|0|||
155344488|NCT02971683|560692946|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
155344489|NCT02971683|560692947|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
155344490|NCT02971683|560692946|FG000|Long-Term Open Label|Adverse Event|1|||
155344491|NCT02971683|560692947|FG001|Long-Term Open Label|Adverse Event|2|||
155344492|NCT02971683|560692946|FG000|Long-Term Open Label|Lack of Efficacy|1|||
155344493|NCT02971683|560692947|FG001|Long-Term Open Label|Lack of Efficacy|1|||
155344494|NCT01699178|560692948|FG000|Overall Study|Adverse Event|1|||
155344495|NCT01699178|560692949|FG001|Overall Study|Adverse Event|5|||
155344496|NCT01699178|560692948|FG000|Overall Study|Lost to Follow-up|1|||
155344497|NCT01699178|560692949|FG001|Overall Study|Lost to Follow-up|6|||
155344498|NCT01699178|560692948|FG000|Overall Study|Non-compliance with Study Drug|3|||
155344499|NCT01699178|560692949|FG001|Overall Study|Non-compliance with Study Drug|1|||
155344500|NCT01699178|560692948|FG000|Overall Study|Physician Decision|1|||
155344501|NCT01699178|560692949|FG001|Overall Study|Physician Decision|0|||
155344502|NCT01699178|560692948|FG000|Overall Study|Withdrawal by Subject|4|||
155344503|NCT01699178|560692949|FG001|Overall Study|Withdrawal by Subject|12|||
155344504|NCT01699178|560692948|FG000|Overall Study|Hematocrit >54%|1|||
155344505|NCT01699178|560692949|FG001|Overall Study|Hematocrit >54%|1|||
155344506|NCT01699178|560692948|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
155344507|NCT01699178|560692949|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
155344508|NCT01699178|560692948|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
155344509|NCT01699178|560692949|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
155344510|NCT04016415|560692952|FG000|Overall Study|Adverse Event|2|||
155344511|NCT04016415|560692953|FG001|Overall Study|Adverse Event|1|||
155344512|NCT04016415|560692952|FG000|Overall Study|Lost to Follow-up|6|||
155344513|NCT04016415|560692953|FG001|Overall Study|Lost to Follow-up|2|||
155344514|NCT04016415|560692952|FG000|Overall Study|Physician Decision|5|||
155344515|NCT04016415|560692953|FG001|Overall Study|Physician Decision|1|||
155344516|NCT04016415|560692952|FG000|Overall Study|Pregnancy|0|||
155344517|NCT04016415|560692953|FG001|Overall Study|Pregnancy|1|||
155344518|NCT04016415|560692952|FG000|Overall Study|Withdrawal by Subject|24|||
155344519|NCT04016415|560692953|FG001|Overall Study|Withdrawal by Subject|27|||
155344520|NCT04016415|560692952|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
155344521|NCT04016415|560692953|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
155344522|NCT00912964|560692956|FG000|Overall Study|Eligibility criterion not met|1|||
155344523|NCT00912964|560692957|FG001|Overall Study|Eligibility criterion not met|1|||
155344524|NCT00912964|560692958|FG002|Overall Study|Eligibility criterion not met|0|||
155344525|NCT00912964|560692956|FG000|Overall Study|Adverse Event|15|||
155344526|NCT00912964|560692957|FG001|Overall Study|Adverse Event|18|||
155344527|NCT00912964|560692958|FG002|Overall Study|Adverse Event|12|||
155344528|NCT00912964|560692956|FG000|Overall Study|Lack of Efficacy|11|||
155344529|NCT00912964|560692957|FG001|Overall Study|Lack of Efficacy|4|||
155344530|NCT00912964|560692958|FG002|Overall Study|Lack of Efficacy|3|||
155344531|NCT00912964|560692956|FG000|Overall Study|Withdrawal by Subject|20|||
155344532|NCT00912964|560692957|FG001|Overall Study|Withdrawal by Subject|12|||
155344533|NCT00912964|560692958|FG002|Overall Study|Withdrawal by Subject|18|||
155344534|NCT00912964|560692956|FG000|Overall Study|Lost to Follow-up|4|||
155344535|NCT00912964|560692957|FG001|Overall Study|Lost to Follow-up|3|||
155344536|NCT00912964|560692958|FG002|Overall Study|Lost to Follow-up|3|||
155344537|NCT00912964|560692956|FG000|Overall Study|Protocol Violation|5|||
155344538|NCT00912964|560692957|FG001|Overall Study|Protocol Violation|3|||
155344539|NCT00912964|560692958|FG002|Overall Study|Protocol Violation|8|||
155344540|NCT00912964|560692956|FG000|Overall Study|Taking exclusionary medications|7|||
155080520|NCT05345405|559725367|FG000|Overall Study|Did not meet eligibility criteria|0|||
155080521|NCT05345405|559725368|FG001|Overall Study|Did not meet eligibility criteria|2|||
155080522|NCT05345405|559725369|FG002|Overall Study|Did not meet eligibility criteria|0|||
155080523|NCT05345405|559725367|FG000|Overall Study|Lost to Follow-up|0|||
155344541|NCT00912964|560692957|FG001|Overall Study|Taking exclusionary medications|4|||
155344542|NCT00912964|560692958|FG002|Overall Study|Taking exclusionary medications|8|||
155344543|NCT00912964|560692956|FG000|Overall Study|Medical History|1|||
155344544|NCT00912964|560692957|FG001|Overall Study|Medical History|0|||
155344545|NCT00912964|560692958|FG002|Overall Study|Medical History|0|||
155344546|NCT00912964|560692956|FG000|Overall Study|Non-compliance with study procedures|2|||
155344547|NCT00912964|560692957|FG001|Overall Study|Non-compliance with study procedures|0|||
155344548|NCT00912964|560692958|FG002|Overall Study|Non-compliance with study procedures|0|||
155344549|NCT00912964|560692956|FG000|Overall Study|Violation of exclusion criterion|0|||
155344550|NCT00912964|560692957|FG001|Overall Study|Violation of exclusion criterion|0|||
155344551|NCT00912964|560692958|FG002|Overall Study|Violation of exclusion criterion|2|||
155344552|NCT00912964|560692956|FG000|Overall Study|Randomized but never received study drug|0|||
155344553|NCT00912964|560692957|FG001|Overall Study|Randomized but never received study drug|1|||
155344554|NCT00912964|560692958|FG002|Overall Study|Randomized but never received study drug|0|||
155344555|NCT02260154|560692959|FG000|Overall Study|Screening failure|2|||
155344556|NCT03547167|560692964|FG000|Overall Study|Withdrawal by Subject|34|||
155344557|NCT03547167|560692965|FG001|Overall Study|Withdrawal by Subject|12|||
155344558|NCT03547167|560692964|FG000|Overall Study|Screen Failure|0|||
155344559|NCT03547167|560692965|FG001|Overall Study|Screen Failure|1|||
155344560|NCT03547167|560692964|FG000|Overall Study|Lost to Follow-up|59|||
155344561|NCT03547167|560692965|FG001|Overall Study|Lost to Follow-up|15|||
155344562|NCT03547167|560692964|FG000|Overall Study|Death|4|||
155344563|NCT03547167|560692965|FG001|Overall Study|Death|2|||
155344564|NCT00070317|560692966|FG000|Overall Study|Inevaluable (Never Treated)|1|||
155344565|NCT00070317|560692966|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
155344566|NCT00070317|560692966|FG000|Overall Study|Ineligible required test not done|1|||
155344567|NCT00070317|560692966|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
155344568|NCT00070317|560692966|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
155344569|NCT01885559|560692967|FG000|Overall Study|Lost to Follow-up|15|||
155344570|NCT01885559|560692968|FG001|Overall Study|Lost to Follow-up|16|||
155344571|NCT01885559|560692967|FG000|Overall Study|Less than full participation|9|||
155344572|NCT01885559|560692968|FG001|Overall Study|Less than full participation|19|||
155344573|NCT01885559|560692967|FG000|Overall Study|Protocol Violation|0|||
155344574|NCT01885559|560692968|FG001|Overall Study|Protocol Violation|1|||
155344575|NCT00645411|560692969|FG000|Overall Study|Adverse Event|0|||
155344576|NCT00645411|560692970|FG001|Overall Study|Adverse Event|0|||
155344577|NCT00645411|560692971|FG002|Overall Study|Adverse Event|0|||
155344578|NCT00645411|560692972|FG003|Overall Study|Adverse Event|2|||
155344579|NCT00645411|560692969|FG000|Overall Study|Withdrawal by Subject|2|||
155344580|NCT00645411|560692970|FG001|Overall Study|Withdrawal by Subject|1|||
155344581|NCT00645411|560692971|FG002|Overall Study|Withdrawal by Subject|19|||
155344582|NCT00645411|560692972|FG003|Overall Study|Withdrawal by Subject|21|||
155344583|NCT00645411|560692969|FG000|Overall Study|Lost to Follow-up|10|||
155344584|NCT00645411|560692970|FG001|Overall Study|Lost to Follow-up|5|||
155344585|NCT00645411|560692971|FG002|Overall Study|Lost to Follow-up|124|||
155344586|NCT00645411|560692972|FG003|Overall Study|Lost to Follow-up|75|||
155344587|NCT00645411|560692969|FG000|Overall Study|Protocol Violation|1|||
155344588|NCT00645411|560692970|FG001|Overall Study|Protocol Violation|0|||
155344589|NCT00645411|560692971|FG002|Overall Study|Protocol Violation|1|||
155344590|NCT00645411|560692972|FG003|Overall Study|Protocol Violation|0|||
155344591|NCT00645411|560692969|FG000|Overall Study|Inappropriate enrollment|0|||
155344592|NCT00645411|560692970|FG001|Overall Study|Inappropriate enrollment|0|||
155344593|NCT00645411|560692971|FG002|Overall Study|Inappropriate enrollment|4|||
155344594|NCT00645411|560692972|FG003|Overall Study|Inappropriate enrollment|1|||
155344595|NCT00645411|560692969|FG000|Overall Study|Unable to classify|0|||
155344596|NCT00645411|560692970|FG001|Overall Study|Unable to classify|0|||
155344597|NCT00645411|560692971|FG002|Overall Study|Unable to classify|3|||
155344598|NCT00645411|560692972|FG003|Overall Study|Unable to classify|4|||
155344599|NCT03560206|560692973|FG000|Overall Study|Lost to Follow-up|19|||
155344600|NCT03560206|560692974|FG001|Overall Study|Lost to Follow-up|11|||
154963949|NCT06041256|559293502|FG004|Overall Study|Rescue|2|||
155344601|NCT03560206|560692973|FG000|Overall Study|Withdrawal by Subject|2|||
155344602|NCT03560206|560692974|FG001|Overall Study|Withdrawal by Subject|4|||
155344603|NCT03560206|560692973|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
155344604|NCT03560206|560692974|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
155344605|NCT03560206|560692973|FG000|Overall Study|Busy schedule|14|||
155344606|NCT03560206|560692974|FG001|Overall Study|Busy schedule|2|||
155344607|NCT03560206|560692973|FG000|Overall Study|patients' new health condition such as cancer|10|||
155344608|NCT03560206|560692974|FG001|Overall Study|patients' new health condition such as cancer|1|||
155344609|NCT03100370|560692975|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344610|NCT03100370|560692976|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344611|NCT03100370|560692977|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155080524|NCT05345405|559725368|FG001|Overall Study|Lost to Follow-up|0|||
155080525|NCT05345405|559725369|FG002|Overall Study|Lost to Follow-up|1|||
155080526|NCT01750281|559725371|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
155080527|NCT01750281|559725372|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
155080528|NCT01750281|559725373|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
155080529|NCT01750281|559725371|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
155344612|NCT03100370|560692978|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155344613|NCT03100370|560692979|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344614|NCT03100370|560692980|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155344615|NCT00738400|560692981|FG000|Overall Study|Adverse Event|3|||
155344616|NCT00738400|560692982|FG001|Overall Study|Adverse Event|1|||
155344617|NCT00738400|560692981|FG000|Overall Study|Withdrawal by Subject|0|||
155344618|NCT00738400|560692982|FG001|Overall Study|Withdrawal by Subject|1|||
155344619|NCT00738400|560692981|FG000|Overall Study|Lack of Efficacy|0|||
155344620|NCT00738400|560692982|FG001|Overall Study|Lack of Efficacy|1|||
155344621|NCT00738400|560692981|FG000|Overall Study|Lost to Follow-up|0|||
155344622|NCT00738400|560692982|FG001|Overall Study|Lost to Follow-up|3|||
155344623|NCT00738400|560692981|FG000|Overall Study|Protocol Violation|1|||
155344624|NCT00738400|560692982|FG001|Overall Study|Protocol Violation|0|||
155344625|NCT00738400|560692981|FG000|Overall Study|Non-compliant with study medication|0|||
155344626|NCT00738400|560692982|FG001|Overall Study|Non-compliant with study medication|1|||
155344627|NCT02674399|560692983|FG000|Overall Study|Lost to Follow-up|2|||
155344628|NCT02674399|560692984|FG001|Overall Study|Lost to Follow-up|0|||
155344629|NCT00508144|560692985|FG000|Overall Study|Not eligible|6|||
155344630|NCT00508144|560692985|FG000|Overall Study|Death|5|||
155344631|NCT01084772|560692989|FG000|Baseline|Withdrawal by Subject|7|||
155344632|NCT01084772|560692990|FG001|Baseline|Withdrawal by Subject|6|||
155344633|NCT01084772|560692989|FG000|3 Months|Death|1|||
155344634|NCT01084772|560692990|FG001|3 Months|Death|0|||
155344635|NCT01084772|560692989|FG000|3 Months|Study Termination|2|||
155344636|NCT01084772|560692990|FG001|3 Months|Study Termination|2|||
155344637|NCT01084772|560692989|FG000|1 Year|Withdrawal by Subject|0|||
155344638|NCT01084772|560692990|FG001|1 Year|Withdrawal by Subject|1|||
155344639|NCT01084772|560692989|FG000|1 Year|Lost to Follow-up|3|||
155344640|NCT01084772|560692990|FG001|1 Year|Lost to Follow-up|0|||
155344641|NCT01084772|560692989|FG000|1 Year|Study Termination|0|||
155344642|NCT01084772|560692990|FG001|1 Year|Study Termination|7|||
155344643|NCT01084772|560692989|FG000|2 Years|Withdrawal by Subject|1|||
155344644|NCT01084772|560692990|FG001|2 Years|Withdrawal by Subject|0|||
155344645|NCT01084772|560692989|FG000|2 Years|Lost to Follow-up|5|||
155344646|NCT01084772|560692990|FG001|2 Years|Lost to Follow-up|2|||
155344647|NCT01084772|560692989|FG000|2 Years|Study Termination|3|||
155344648|NCT01084772|560692990|FG001|2 Years|Study Termination|2|||
155344649|NCT00091572|560693004|FG000|Overall Study|Lost to Follow-up|1|||
155344650|NCT00091572|560693005|FG001|Overall Study|Lost to Follow-up|1|||
155344651|NCT00091572|560693004|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
155344652|NCT00091572|560693005|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
155344653|NCT00091572|560693004|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
155344654|NCT00091572|560693005|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
155344655|NCT00091572|560693004|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
155344656|NCT00091572|560693005|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
155344657|NCT00091572|560693004|FG000|Overall Study|Other Reason|6|||
155344658|NCT00091572|560693005|FG001|Overall Study|Other Reason|13|||
155344659|NCT00091572|560693004|FG000|Overall Study|Ongoing (still on treatment)|8|||
155344660|NCT00091572|560693005|FG001|Overall Study|Ongoing (still on treatment)|12|||
155344661|NCT00091572|560693004|FG000|Overall Study|Major Protocol Violation|2|||
155344662|NCT00091572|560693005|FG001|Overall Study|Major Protocol Violation|0|||
155344663|NCT00091572|560693004|FG000|Overall Study|Toxicity (Related AE)|53|||
155344664|NCT00091572|560693005|FG001|Overall Study|Toxicity (Related AE)|9|||
155344665|NCT04097535|560693006|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
155344666|NCT03070301|560693007|FG000|Overall Study|Progression of disease|16|||
155344667|NCT03070301|560693007|FG000|Overall Study|Physician Decision|3|||
155344668|NCT03070301|560693007|FG000|Overall Study|Withdrawal by Subject|1|||
155344669|NCT04413149|560694052|FG000|Overall Study|Death|10|||
155344670|NCT04413149|560694053|FG001|Overall Study|Death|5|||
155344671|NCT04413149|560694052|FG000|Overall Study|Lung transplantation|1|||
155344672|NCT04413149|560694053|FG001|Overall Study|Lung transplantation|0|||
155344673|NCT02878590|560694054|FG000|Overall Study|Withdrawal by Subject|2|||
155344674|NCT00814632|560694055|FG000|Overall Study|Lack of Efficacy|2|||
155344675|NCT02514577|560694061|FG000|Overall Study|Lost to Follow-up|6|||
155344676|NCT02514577|560694062|FG001|Overall Study|Lost to Follow-up|6|||
155344677|NCT02514577|560694061|FG000|Overall Study|Protocol Violation|1|||
155344678|NCT02514577|560694062|FG001|Overall Study|Protocol Violation|0|||
155344679|NCT02514577|560694061|FG000|Overall Study|Withdrawal by Subject|6|||
155344680|NCT02514577|560694062|FG001|Overall Study|Withdrawal by Subject|6|||
155344681|NCT02514577|560694061|FG000|Overall Study|Adverse Event|1|||
155344682|NCT02514577|560694062|FG001|Overall Study|Adverse Event|1|||
155344683|NCT00489489|560694063|FG000|Overall Study|Not treated due to protocol violation|0|||
155344684|NCT00489489|560694064|FG001|Overall Study|Not treated due to protocol violation|1|||
155344685|NCT00489489|560694065|FG002|Overall Study|Not treated due to protocol violation|1|||
155344686|NCT00489489|560694063|FG000|Overall Study|Adverse Event|1|||
155344687|NCT00489489|560694064|FG001|Overall Study|Adverse Event|1|||
155344688|NCT00489489|560694065|FG002|Overall Study|Adverse Event|1|||
155344689|NCT00489489|560694063|FG000|Overall Study|Protocol Violation|1|||
155344690|NCT00489489|560694064|FG001|Overall Study|Protocol Violation|0|||
155344691|NCT00489489|560694065|FG002|Overall Study|Protocol Violation|1|||
155344692|NCT00489489|560694063|FG000|Overall Study|Progressive disease|0|||
155344693|NCT00489489|560694064|FG001|Overall Study|Progressive disease|1|||
155344694|NCT00489489|560694065|FG002|Overall Study|Progressive disease|0|||
155344695|NCT00489489|560694063|FG000|Overall Study|Participant did not wish to continue|1|||
155344696|NCT00489489|560694064|FG001|Overall Study|Participant did not wish to continue|1|||
155344697|NCT00489489|560694065|FG002|Overall Study|Participant did not wish to continue|0|||
155344698|NCT00489489|560694063|FG000|Overall Study|Other than above|0|||
155344699|NCT00489489|560694064|FG001|Overall Study|Other than above|1|||
155344700|NCT00489489|560694065|FG002|Overall Study|Other than above|0|||
155344701|NCT03978130|560694070|FG000|Overall Study|Lost to Follow-up|13|||
155344702|NCT03978130|560694071|FG001|Overall Study|Lost to Follow-up|14|||
155344703|NCT03978130|560694070|FG000|Overall Study|Withdrawal by Subject|12|||
155344704|NCT03978130|560694071|FG001|Overall Study|Withdrawal by Subject|2|||
155344705|NCT03978130|560694070|FG000|Overall Study|Adverse Event|2|||
155344706|NCT03978130|560694071|FG001|Overall Study|Adverse Event|1|||
155344707|NCT02880293|560694072|FG000|Overall Study|Inevaluable|5|||
155344708|NCT04198428|560694075|FG000|Overall Study|Withdrawal by Subject|150|||
155344709|NCT04198428|560694076|FG001|Overall Study|Withdrawal by Subject|156|||
155344710|NCT05878990|560694078|FG000|Overall Study|Lost to Follow-up|7|||
155344711|NCT05878990|560694078|FG000|Overall Study|Withdrawal by Subject|1|||
155344712|NCT00668746|560694079|FG000|Overall Study|Lost to Follow-up|2|||
155344713|NCT00668746|560694080|FG001|Overall Study|Lost to Follow-up|1|||
155344714|NCT01038128|560694082|FG000|Overall Study|Lack of Efficacy|1|||
155344715|NCT01038128|560694082|FG000|Overall Study|Lost to Follow-up|1|||
155344716|NCT01038128|560694082|FG000|Overall Study|Withdrawal by Subject|2|||
155344717|NCT04203199|560694091|FG000|First Intervention Period|Lost to Follow-up|0|||
155344718|NCT04203199|560694092|FG001|First Intervention Period|Lost to Follow-up|1|||
155344719|NCT04203199|560694091|FG000|Second Intervention Period|Medication change|1|||
155344720|NCT04203199|560694092|FG001|Second Intervention Period|Medication change|0|||
155344721|NCT01838499|560694093|FG000|Overall Study|Protocol Violation|0|||
155344722|NCT01838499|560694094|FG001|Overall Study|Protocol Violation|1|||
155344723|NCT01838499|560694093|FG000|Overall Study|Lost to Follow-up|2|||
155344724|NCT01838499|560694094|FG001|Overall Study|Lost to Follow-up|4|||
155165499|NCT02563067|560043453|FG002|Overall Study|Death post Treatment/safety period|0|||
155165500|NCT01039519|560043463|FG000|Treatment|Progressive disease|20|||
155344725|NCT01838499|560694093|FG000|Overall Study|Lack of Efficacy|1|||
155344726|NCT01838499|560694094|FG001|Overall Study|Lack of Efficacy|2|||
155344727|NCT01838499|560694093|FG000|Overall Study|Adverse Event|2|||
155344728|NCT01838499|560694094|FG001|Overall Study|Adverse Event|1|||
155344729|NCT01838499|560694093|FG000|Overall Study|Withdrawal by Subject|19|||
155344730|NCT01838499|560694094|FG001|Overall Study|Withdrawal by Subject|9|||
155344731|NCT03614923|560694095|FG000|Overall Study|Withdrawal by Subject|2|||
155344732|NCT03614923|560694096|FG001|Overall Study|Withdrawal by Subject|1|||
155344733|NCT03614923|560694097|FG002|Overall Study|Withdrawal by Subject|1|||
155344734|NCT03614923|560694095|FG000|Overall Study|Adverse Event|0|||
155344735|NCT03614923|560694096|FG001|Overall Study|Adverse Event|2|||
155344736|NCT03614923|560694097|FG002|Overall Study|Adverse Event|1|||
155344737|NCT03614923|560694095|FG000|Overall Study|Lost to Follow-up|1|||
155344738|NCT03614923|560694096|FG001|Overall Study|Lost to Follow-up|0|||
155344739|NCT03614923|560694097|FG002|Overall Study|Lost to Follow-up|1|||
155344740|NCT03614923|560694095|FG000|Overall Study|Lack of Efficacy|2|||
155344741|NCT03614923|560694096|FG001|Overall Study|Lack of Efficacy|0|||
155344742|NCT03614923|560694097|FG002|Overall Study|Lack of Efficacy|1|||
155344743|NCT03614923|560694095|FG000|Overall Study|Non-compliance|0|||
155344744|NCT03614923|560694096|FG001|Overall Study|Non-compliance|1|||
155344745|NCT03614923|560694097|FG002|Overall Study|Non-compliance|0|||
155344746|NCT03614923|560694095|FG000|Overall Study|Other|0|||
155344747|NCT03614923|560694096|FG001|Overall Study|Other|1|||
155344748|NCT03614923|560694097|FG002|Overall Study|Other|1|||
155344749|NCT01136733|560694098|FG000|Phase 1b|Adverse Event|0|||
155344750|NCT01136733|560694099|FG001|Phase 1b|Adverse Event|3|||
155344751|NCT01136733|560694100|FG002|Phase 1b|Adverse Event|1|||
155344752|NCT01136733|560694101|FG003|Phase 1b|Adverse Event|0|||
155344753|NCT01136733|560694102|FG004|Phase 1b|Adverse Event|0|||
155344754|NCT01136733|560694103|FG005|Phase 1b|Adverse Event|0|||
155344755|NCT01136733|560694104|FG006|Phase 1b|Adverse Event|0|||
155344756|NCT01136733|560694098|FG000|Phase 1b|Participant Choice|0|||
155344757|NCT01136733|560694099|FG001|Phase 1b|Participant Choice|0|||
155344758|NCT01136733|560694100|FG002|Phase 1b|Participant Choice|1|||
155344759|NCT01136733|560694101|FG003|Phase 1b|Participant Choice|0|||
155344760|NCT01136733|560694102|FG004|Phase 1b|Participant Choice|0|||
155344761|NCT01136733|560694103|FG005|Phase 1b|Participant Choice|0|||
155344762|NCT01136733|560694104|FG006|Phase 1b|Participant Choice|0|||
155344763|NCT01136733|560694098|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
155344764|NCT01136733|560694099|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
155344765|NCT01136733|560694100|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
155344766|NCT01136733|560694101|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
155344767|NCT01136733|560694102|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
155344768|NCT01136733|560694103|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
155344769|NCT01136733|560694104|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
155344770|NCT01136733|560694098|FG000|Phase 1b|Clinical Progression|1|||
155344771|NCT01136733|560694099|FG001|Phase 1b|Clinical Progression|1|||
155344772|NCT01136733|560694100|FG002|Phase 1b|Clinical Progression|0|||
155344773|NCT01136733|560694101|FG003|Phase 1b|Clinical Progression|0|||
155344774|NCT01136733|560694102|FG004|Phase 1b|Clinical Progression|0|||
155344775|NCT01136733|560694103|FG005|Phase 1b|Clinical Progression|0|||
155344776|NCT01136733|560694104|FG006|Phase 1b|Clinical Progression|0|||
155344777|NCT01136733|560694098|FG000|Phase 2|Disease Progression|0|||
155344778|NCT01136733|560694099|FG001|Phase 2|Disease Progression|0|||
155344779|NCT01136733|560694100|FG002|Phase 2|Disease Progression|0|||
155344780|NCT01136733|560694101|FG003|Phase 2|Disease Progression|0|||
155344781|NCT01136733|560694102|FG004|Phase 2|Disease Progression|30|||
155344782|NCT01136733|560694103|FG005|Phase 2|Disease Progression|32|||
155344783|NCT01136733|560694104|FG006|Phase 2|Disease Progression|38|||
155344784|NCT01136733|560694098|FG000|Phase 2|Adverse Event|0|||
155344785|NCT01136733|560694099|FG001|Phase 2|Adverse Event|0|||
155344786|NCT01136733|560694100|FG002|Phase 2|Adverse Event|0|||
155344787|NCT01136733|560694101|FG003|Phase 2|Adverse Event|0|||
155344788|NCT01136733|560694102|FG004|Phase 2|Adverse Event|11|||
155344789|NCT01136733|560694103|FG005|Phase 2|Adverse Event|13|||
155344790|NCT01136733|560694104|FG006|Phase 2|Adverse Event|5|||
155344791|NCT01136733|560694098|FG000|Phase 2|Participant Choice|0|||
155344792|NCT01136733|560694099|FG001|Phase 2|Participant Choice|0|||
155344793|NCT01136733|560694100|FG002|Phase 2|Participant Choice|0|||
155344794|NCT01136733|560694101|FG003|Phase 2|Participant Choice|0|||
155344795|NCT01136733|560694102|FG004|Phase 2|Participant Choice|3|||
155344796|NCT01136733|560694103|FG005|Phase 2|Participant Choice|0|||
155344797|NCT01136733|560694104|FG006|Phase 2|Participant Choice|1|||
155344798|NCT01136733|560694098|FG000|Phase 2|Administrative-Withdrew Consent|0|||
155344799|NCT01136733|560694099|FG001|Phase 2|Administrative-Withdrew Consent|0|||
155344800|NCT01136733|560694100|FG002|Phase 2|Administrative-Withdrew Consent|0|||
155344801|NCT01136733|560694101|FG003|Phase 2|Administrative-Withdrew Consent|0|||
155344802|NCT01136733|560694102|FG004|Phase 2|Administrative-Withdrew Consent|1|||
155344803|NCT01136733|560694103|FG005|Phase 2|Administrative-Withdrew Consent|0|||
155344804|NCT01136733|560694104|FG006|Phase 2|Administrative-Withdrew Consent|0|||
155344805|NCT01136733|560694098|FG000|Phase 2|Other|0|||
155344806|NCT01136733|560694099|FG001|Phase 2|Other|0|||
155344807|NCT01136733|560694100|FG002|Phase 2|Other|0|||
155344808|NCT01136733|560694101|FG003|Phase 2|Other|0|||
155344809|NCT01136733|560694102|FG004|Phase 2|Other|6|||
155344810|NCT01136733|560694103|FG005|Phase 2|Other|7|||
155344811|NCT01136733|560694104|FG006|Phase 2|Other|6|||
155344812|NCT01882088|560694106|FG000|Overall Study|Intolerance of esophageal manometry|1|||
155344813|NCT01882088|560694106|FG000|Overall Study|no possibility to place the catheter|1|||
155344814|NCT01882088|560694106|FG000|Overall Study|Protocol Violation|1|||
155344815|NCT01882088|560694106|FG000|Overall Study|inadequate pH-impedance tracings|2|||
155344816|NCT02186015|560694107|FG000|Overall Study|Physician Decision|1|||
155344817|NCT02186015|560694108|FG001|Overall Study|Physician Decision|0|||
155344818|NCT02069366|560694111|FG000|Overall Study|Lost to Follow-up|0|||
155344819|NCT02069366|560694112|FG001|Overall Study|Lost to Follow-up|0|||
155344820|NCT02069366|560694113|FG002|Overall Study|Lost to Follow-up|1|||
155344821|NCT02069366|560694114|FG003|Overall Study|Lost to Follow-up|0|||
155344822|NCT02069366|560694115|FG004|Overall Study|Lost to Follow-up|0|||
155344823|NCT02069366|560694116|FG005|Overall Study|Lost to Follow-up|2|||
155344824|NCT02069366|560694111|FG000|Overall Study|Protocol Violation|0|||
155344825|NCT02069366|560694112|FG001|Overall Study|Protocol Violation|0|||
155344826|NCT02069366|560694113|FG002|Overall Study|Protocol Violation|1|||
155344827|NCT02069366|560694114|FG003|Overall Study|Protocol Violation|0|||
155344828|NCT02069366|560694115|FG004|Overall Study|Protocol Violation|0|||
155344829|NCT02069366|560694116|FG005|Overall Study|Protocol Violation|0|||
155344830|NCT02069366|560694111|FG000|Overall Study|Withdrawal by Subject|1|||
155344831|NCT02069366|560694112|FG001|Overall Study|Withdrawal by Subject|0|||
155344832|NCT02069366|560694113|FG002|Overall Study|Withdrawal by Subject|1|||
155344833|NCT02069366|560694114|FG003|Overall Study|Withdrawal by Subject|2|||
155344834|NCT02069366|560694115|FG004|Overall Study|Withdrawal by Subject|0|||
155344835|NCT02069366|560694116|FG005|Overall Study|Withdrawal by Subject|0|||
155344836|NCT00168805|560694119|FG000|Overall Study|Adverse Event|7|||
155344837|NCT00168805|560694120|FG001|Overall Study|Adverse Event|11|||
155344838|NCT00168805|560694121|FG002|Overall Study|Adverse Event|16|||
155344839|NCT00168805|560694119|FG000|Overall Study|Protocol Violation|12|||
155344840|NCT00168805|560694120|FG001|Overall Study|Protocol Violation|11|||
155344841|NCT00168805|560694121|FG002|Overall Study|Protocol Violation|8|||
155344842|NCT00168805|560694119|FG000|Overall Study|Lost to Follow-up|12|||
155344843|NCT00168805|560694120|FG001|Overall Study|Lost to Follow-up|17|||
155344844|NCT00168805|560694121|FG002|Overall Study|Lost to Follow-up|11|||
155344845|NCT00168805|560694119|FG000|Overall Study|Withdrawal by Subject|16|||
155344846|NCT00168805|560694120|FG001|Overall Study|Withdrawal by Subject|18|||
155344847|NCT00168805|560694121|FG002|Overall Study|Withdrawal by Subject|21|||
155344848|NCT00168805|560694119|FG000|Overall Study|Other|24|||
155344849|NCT00168805|560694120|FG001|Overall Study|Other|21|||
155344850|NCT00168805|560694121|FG002|Overall Study|Other|22|||
155344851|NCT00168805|560694119|FG000|Treatment|Adverse Event|25|||
155344852|NCT00168805|560694120|FG001|Treatment|Adverse Event|26|||
155344853|NCT00168805|560694121|FG002|Treatment|Adverse Event|32|||
155344854|NCT00168805|560694119|FG000|Treatment|Protocol Violation|3|||
155344855|NCT00168805|560694120|FG001|Treatment|Protocol Violation|5|||
155344856|NCT00168805|560694121|FG002|Treatment|Protocol Violation|5|||
155344857|NCT00168805|560694119|FG000|Treatment|Withdrawal by Subject|3|||
155344858|NCT00168805|560694120|FG001|Treatment|Withdrawal by Subject|7|||
155344859|NCT00168805|560694121|FG002|Treatment|Withdrawal by Subject|8|||
155344860|NCT00168805|560694119|FG000|Treatment|Other|18|||
155344861|NCT00168805|560694120|FG001|Treatment|Other|18|||
155344862|NCT00168805|560694121|FG002|Treatment|Other|17|||
155344863|NCT01837719|560694122|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
155344864|NCT01837719|560694122|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
155344865|NCT02604199|560694124|FG000|Overall Study|Pregnancy|0|||
155344866|NCT02604199|560694125|FG001|Overall Study|Pregnancy|0|||
155344867|NCT02604199|560694126|FG002|Overall Study|Pregnancy|0|||
155344868|NCT02604199|560694127|FG003|Overall Study|Pregnancy|1|||
155344869|NCT02604199|560694124|FG000|Overall Study|Study terminated by sponsor|0|||
155344870|NCT02604199|560694125|FG001|Overall Study|Study terminated by sponsor|2|||
155344871|NCT02604199|560694126|FG002|Overall Study|Study terminated by sponsor|0|||
155344872|NCT02604199|560694127|FG003|Overall Study|Study terminated by sponsor|2|||
155344873|NCT02604199|560694124|FG000|Overall Study|Withdrawal by Subject|0|||
155344874|NCT02604199|560694125|FG001|Overall Study|Withdrawal by Subject|1|||
155344875|NCT02604199|560694126|FG002|Overall Study|Withdrawal by Subject|0|||
155344876|NCT02604199|560694127|FG003|Overall Study|Withdrawal by Subject|0|||
155344877|NCT02255474|560694129|FG000|Overall Study|Lost to Follow-up|1|||
155344878|NCT02255474|560694130|FG001|Overall Study|Lost to Follow-up|1|||
155344879|NCT02255474|560694131|FG002|Overall Study|Lost to Follow-up|3|||
155344880|NCT02255474|560694129|FG000|Overall Study|Withdrawal by Subject|1|||
155344881|NCT02255474|560694130|FG001|Overall Study|Withdrawal by Subject|1|||
155344882|NCT02255474|560694131|FG002|Overall Study|Withdrawal by Subject|0|||
155344883|NCT02993926|560694132|FG000|Enantone Treatment Phase|Adverse Event|1|||
155344884|NCT02993926|560694133|FG001|Enantone Treatment Phase|Adverse Event|0|||
155344885|NCT02993926|560694134|FG002|Enantone Treatment Phase|Adverse Event|0|||
155344886|NCT02993926|560694132|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
155344887|NCT02993926|560694133|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
155344888|NCT02993926|560694134|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
155344889|NCT02993926|560694132|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
155344890|NCT02993926|560694133|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
155344891|NCT02993926|560694134|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
155344892|NCT02993926|560694132|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
155344893|NCT02993926|560694133|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
155344894|NCT02993926|560694134|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
155344895|NCT01867307|560694135|FG000|Overall Study|Protocol Violation|2|||
155344896|NCT01867307|560694136|FG001|Overall Study|Protocol Violation|0|||
155344897|NCT01867307|560694135|FG000|Overall Study|Other Adverse Event|1|||
155344898|NCT01867307|560694136|FG001|Overall Study|Other Adverse Event|3|||
155344899|NCT02009865|560694140|FG000|Overall Study|Adverse Event|0|||
155344900|NCT02009865|560694141|FG001|Overall Study|Adverse Event|2|||
155344901|NCT02009865|560694140|FG000|Overall Study|Protocol Violation|0|||
155344902|NCT02009865|560694141|FG001|Overall Study|Protocol Violation|2|||
155344903|NCT02009865|560694140|FG000|Overall Study|Withdrawal by Subject|1|||
155344904|NCT02009865|560694141|FG001|Overall Study|Withdrawal by Subject|1|||
155344905|NCT01760876|560694142|FG000|Overall Study|Non-cardiac death (head injury)|1|||
155344906|NCT01760876|560694142|FG000|Overall Study|Carcinoma of prostate|1|||
155344907|NCT01760876|560694142|FG000|Overall Study|Impaired renal function|1|||
155344908|NCT01760876|560694142|FG000|Overall Study|Major depression|1|||
155344909|NCT01760876|560694142|FG000|Overall Study|Very poor baseline OCT quality|2|||
155344910|NCT00525915|560694146|FG000|Overall Study|Non-Compliance|0|||
155344911|NCT00525915|560694147|FG001|Overall Study|Non-Compliance|1|||
155344912|NCT00525915|560694146|FG000|Overall Study|Disease Progression|5|||
155344913|NCT00525915|560694147|FG001|Overall Study|Disease Progression|6|||
155344914|NCT00525915|560694146|FG000|Overall Study|Withdrawal by Subject|1|||
155344915|NCT00525915|560694147|FG001|Overall Study|Withdrawal by Subject|0|||
155344916|NCT00525915|560694146|FG000|Overall Study|Refused Surgery|1|||
155344917|NCT00525915|560694147|FG001|Overall Study|Refused Surgery|2|||
155344918|NCT00525915|560694146|FG000|Overall Study|Unrelated illness|1|||
155344919|NCT00525915|560694147|FG001|Overall Study|Unrelated illness|0|||
155344920|NCT00732498|560694148|FG000|Overall Study|Ineligible|1|||
155344921|NCT00732498|560694148|FG000|Overall Study|Adverse Event|2|||
155344922|NCT00732498|560694148|FG000|Overall Study|Physician Decision|3|||
155344923|NCT03394508|560694149|FG000|Overall Study|Protocol Violation|0|||
155344924|NCT03394508|560694150|FG001|Overall Study|Protocol Violation|3|||
155344925|NCT03394508|560694149|FG000|Overall Study|Lost to Follow-up|1|||
155344926|NCT03394508|560694150|FG001|Overall Study|Lost to Follow-up|0|||
155344927|NCT00267865|560694151|FG000|Induction Treatment|Died before completing.|2|||
155344928|NCT00267865|560694151|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
155344929|NCT04295499|560694155|FG000|Overall Study|moving out of state|1|||
155344930|NCT04295499|560694156|FG001|Overall Study|moving out of state|0|||
155344931|NCT04295499|560694155|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
155344932|NCT04295499|560694156|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
155344933|NCT01755598|560694157|FG000|Overall Study|Other|109|||
155344934|NCT01755598|560694158|FG001|Overall Study|Other|109|||
155344935|NCT01755598|560694157|FG000|Overall Study|Lost to Follow-up|32|||
155344936|NCT01755598|560694158|FG001|Overall Study|Lost to Follow-up|43|||
155344937|NCT01755598|560694157|FG000|Overall Study|Migrated/moved from study area|76|||
155344938|NCT01755598|560694158|FG001|Overall Study|Migrated/moved from study area|65|||
155344939|NCT01755598|560694157|FG000|Overall Study|Withdrawal by Subject|22|||
155344940|NCT01755598|560694158|FG001|Overall Study|Withdrawal by Subject|31|||
155344941|NCT01755598|560694157|FG000|Overall Study|Protocol Violation|7|||
155344942|NCT01755598|560694158|FG001|Overall Study|Protocol Violation|7|||
155344943|NCT01755598|560694157|FG000|Overall Study|Adverse Event|19|||
155344944|NCT01755598|560694158|FG001|Overall Study|Adverse Event|28|||
155344945|NCT03122548|560694159|FG000|Overall Study|Death|2|||
155344946|NCT03122548|560694159|FG000|Overall Study|Progression - subject went into hospice|1|||
155344947|NCT03122548|560694159|FG000|Overall Study|Study Terminated by Sponsor|2|||
155344948|NCT02332889|560694162|FG000|Overall Study|Physician Decision|1|||
155344949|NCT00308113|560694163|FG000|Overall Study|Protocol closure|0|||
155344950|NCT00308113|560694164|FG001|Overall Study|Protocol closure|0|||
155344951|NCT00308113|560694165|FG002|Overall Study|Protocol closure|0|||
155344952|NCT00308113|560694166|FG003|Overall Study|Protocol closure|1|||
155344953|NCT01634165|560694167|FG000|Period 2|Adverse Event|0|||
155344954|NCT01634165|560694168|FG001|Period 2|Adverse Event|1|||
155344955|NCT01634165|560694169|FG002|Period 2|Adverse Event|0|||
155344956|NCT01634165|560694170|FG003|Period 2|Adverse Event|0|||
155344957|NCT02135445|560694171|FG000|Overall Study|Lost to Follow-up|1|||
155344958|NCT02135445|560694172|FG001|Overall Study|Lost to Follow-up|0|||
155344959|NCT02135445|560694171|FG000|Overall Study|Withdrawal by Subject|1|||
155344960|NCT02135445|560694172|FG001|Overall Study|Withdrawal by Subject|0|||
155344961|NCT00676195|560695372|FG000|Overall Study|Lost to Follow-up|1|||
155344962|NCT00676195|560695372|FG000|Overall Study|Adverse Event|1|||
155344963|NCT00676195|560695372|FG000|Overall Study|Physician Decision|1|||
155344964|NCT03322514|560695373|FG000|Overall Study|Withdrawal by Subject|1|||
155344965|NCT03322514|560695374|FG001|Overall Study|Withdrawal by Subject|1|||
155344966|NCT04523571|560695375|FG000|Received 2 Doses|Withdrawal by Subject|0|||
155344967|NCT04523571|560695376|FG001|Received 2 Doses|Withdrawal by Subject|0|||
155344968|NCT04523571|560695377|FG002|Received 2 Doses|Withdrawal by Subject|0|||
155344969|NCT04523571|560695378|FG003|Received 2 Doses|Withdrawal by Subject|1|||
155344970|NCT04523571|560695379|FG004|Received 2 Doses|Withdrawal by Subject|1|||
155344971|NCT04523571|560695380|FG005|Received 2 Doses|Withdrawal by Subject|0|||
155344972|NCT04523571|560695375|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
155344973|NCT04523571|560695376|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344974|NCT04523571|560695377|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
155344975|NCT04523571|560695378|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344976|NCT04523571|560695379|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344977|NCT04523571|560695380|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
155344978|NCT04523571|560695375|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344979|NCT04523571|560695376|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344980|NCT04523571|560695377|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344981|NCT04523571|560695378|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344982|NCT04523571|560695379|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
155344983|NCT04523571|560695380|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
155344984|NCT04523571|560695375|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344985|NCT04523571|560695376|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344986|NCT04523571|560695377|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344987|NCT04523571|560695378|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
155344988|NCT04523571|560695379|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
155344989|NCT04523571|560695380|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
155344990|NCT00627523|560695381|FG000|Overall Study|Lack of Efficacy|1|||
155344991|NCT00627523|560695382|FG001|Overall Study|Lack of Efficacy|0|||
155344992|NCT00627523|560695381|FG000|Overall Study|Withdrawal by Subject|0|||
155344993|NCT00627523|560695382|FG001|Overall Study|Withdrawal by Subject|2|||
155344994|NCT00627523|560695381|FG000|Overall Study|Other|1|||
155344995|NCT00627523|560695382|FG001|Overall Study|Other|0|||
155344996|NCT02011568|560695387|FG000|Overall Study|Withdrawal by Subject|8|||
155344997|NCT02011568|560695388|FG001|Overall Study|Withdrawal by Subject|10|||
155344998|NCT02011568|560695387|FG000|Overall Study|Physician Decision|1|||
155344999|NCT02011568|560695388|FG001|Overall Study|Physician Decision|3|||
155345000|NCT03344458|560695389|FG000|Overall Study|Physician Decision|1|||
155345001|NCT03344458|560695389|FG000|Overall Study|Withdrawal by Subject|16|||
155345002|NCT03344458|560695389|FG000|Overall Study|Other reasons|10|||
155345003|NCT03344458|560695389|FG000|Overall Study|Lost to Follow-up|9|||
155345004|NCT03344458|560695389|FG000|Overall Study|Protocol Violation|3|||
155345005|NCT00396409|560695395|FG000|Period 1 - 2007|Adverse Event|0|||
155345006|NCT00396409|560695396|FG001|Period 1 - 2007|Adverse Event|1|||
155345007|NCT00396409|560695395|FG000|Period 1 - 2007|Lack of Efficacy|0|||
155345008|NCT00396409|560695396|FG001|Period 1 - 2007|Lack of Efficacy|1|||
155345009|NCT00396409|560695395|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
155345010|NCT00396409|560695396|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
155345011|NCT00396409|560695395|FG000|Period 1 - 2007|Lost to Follow-up|2|||
155345012|NCT00396409|560695396|FG001|Period 1 - 2007|Lost to Follow-up|3|||
155345013|NCT00396409|560695395|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
155345014|NCT00396409|560695396|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
155345015|NCT00396409|560695395|FG000|Period 2 - 2008|Protocol Violation|1|||
155345016|NCT00396409|560695396|FG001|Period 2 - 2008|Protocol Violation|0|||
155345017|NCT00396409|560695395|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
155345018|NCT00396409|560695396|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
155345019|NCT00396409|560695395|FG000|Period 2 - 2008|Lost to Follow-up|3|||
155345020|NCT00396409|560695396|FG001|Period 2 - 2008|Lost to Follow-up|1|||
155345021|NCT00331799|560695397|FG000|Overall Study|Withdrawal by Subject|2|||
155345022|NCT00331799|560695397|FG000|Overall Study|Sedation|1|||
155345023|NCT02889809|560695398|FG000|Overall Study|Withdrawal by Subject|30|||
155345024|NCT02889809|560695399|FG001|Overall Study|Withdrawal by Subject|21|||
155345025|NCT02889809|560695398|FG000|Overall Study|Lost to Follow-up|1|||
155345026|NCT02889809|560695399|FG001|Overall Study|Lost to Follow-up|1|||
155345027|NCT02889809|560695398|FG000|Overall Study|Site Closed|12|||
155345028|NCT02889809|560695399|FG001|Overall Study|Site Closed|11|||
155345029|NCT03696342|560695400|FG000|Overall Study|Lost to Follow-up|1|||
155345030|NCT03696342|560695401|FG001|Overall Study|Lost to Follow-up|0|||
155345031|NCT02409732|560695402|FG000|Overall Study|Withdrawal by Subject|4|||
155345032|NCT02409732|560695402|FG000|Overall Study|Lost to Follow-up|2|||
155345033|NCT03314233|560695412|FG000|Overall Study|No longer eligible at time of delivery|1|||
155345034|NCT01797705|560695413|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
155345035|NCT01797705|560695413|FG000|Overall Study|Withdrawal by Subject|1|||
155345036|NCT03785210|560695414|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
155345037|NCT03785210|560695415|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
155345038|NCT04468633|560695416|FG000|Overall Study|Withdrawal by Subject|4|||
155345039|NCT04468633|560695417|FG001|Overall Study|Withdrawal by Subject|0|||
155345040|NCT00460434|560695418|FG000|Overall Study|Lost to Follow-up|3|||
155345041|NCT00460434|560695419|FG001|Overall Study|Lost to Follow-up|7|||
155345042|NCT01498445|560695420|FG000|Overall Study|Lack of Efficacy|0|||
155345043|NCT01498445|560695421|FG001|Overall Study|Lack of Efficacy|0|||
155345044|NCT01498445|560695422|FG002|Overall Study|Lack of Efficacy|1|||
155345045|NCT01498445|560695423|FG003|Overall Study|Lack of Efficacy|2|||
155345046|NCT01498445|560695424|FG004|Overall Study|Lack of Efficacy|0|||
155345047|NCT01498445|560695425|FG005|Overall Study|Lack of Efficacy|0|||
155345048|NCT01498445|560695420|FG000|Overall Study|Screen Failure|0|||
155345049|NCT01498445|560695421|FG001|Overall Study|Screen Failure|0|||
155345050|NCT01498445|560695422|FG002|Overall Study|Screen Failure|0|||
155345051|NCT01498445|560695423|FG003|Overall Study|Screen Failure|0|||
155345052|NCT01498445|560695424|FG004|Overall Study|Screen Failure|1|||
155345053|NCT01498445|560695425|FG005|Overall Study|Screen Failure|1|||
155345054|NCT02722278|560695426|FG000|Overall Study|Withdrawal by Subject|5|||
155345055|NCT02722278|560695427|FG001|Overall Study|Withdrawal by Subject|3|||
155345056|NCT02722278|560695426|FG000|Overall Study|Adverse Event|4|||
155345057|NCT02722278|560695427|FG001|Overall Study|Adverse Event|1|||
155345058|NCT02722278|560695426|FG000|Overall Study|Lost to Follow-up|2|||
155345059|NCT02722278|560695427|FG001|Overall Study|Lost to Follow-up|0|||
155345060|NCT02722278|560695426|FG000|Overall Study|Protocol Violation|1|||
155345061|NCT02722278|560695427|FG001|Overall Study|Protocol Violation|0|||
155345062|NCT02722278|560695426|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
155345063|NCT02722278|560695427|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
155345064|NCT02722278|560695426|FG000|Overall Study|Subject declined after tx assignment|0|||
154963950|NCT03215706|559293503|FG000|Randomization|Adverse Event unrelated to study drug|1|||
155345065|NCT02722278|560695427|FG001|Overall Study|Subject declined after tx assignment|1|||
155345066|NCT02722278|560695426|FG000|Overall Study|Site closure not study related|0|||
155345067|NCT02722278|560695427|FG001|Overall Study|Site closure not study related|1|||
155345068|NCT02465866|560695428|FG000|Period 3|Withdrawal by Subject|0|||
155345069|NCT02465866|560695429|FG001|Period 3|Withdrawal by Subject|1|||
155345070|NCT02465866|560695430|FG002|Period 3|Withdrawal by Subject|0|||
155345071|NCT02465866|560695431|FG003|Period 3|Withdrawal by Subject|0|||
155345072|NCT02023099|560695432|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
155345073|NCT02023099|560695433|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
155345074|NCT02023099|560695434|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
155345075|NCT02023099|560695432|FG000|Overall Study|Withdrawn Consent|3|||
155345076|NCT02023099|560695433|FG001|Overall Study|Withdrawn Consent|0|||
155345077|NCT02023099|560695434|FG002|Overall Study|Withdrawn Consent|1|||
155345078|NCT02023099|560695432|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
155345079|NCT02023099|560695433|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
155080530|NCT01750281|559725372|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
155080531|NCT01750281|559725373|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
155080532|NCT01750281|559725371|FG000|Overall Study|Did not receive treatment|0|||
155080533|NCT01750281|559725372|FG001|Overall Study|Did not receive treatment|1|||
155080534|NCT01750281|559725373|FG002|Overall Study|Did not receive treatment|0|||
155080535|NCT04189588|559725374|FG000|Overall Study|Death|0|||
155345080|NCT02023099|560695434|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
155345081|NCT00203502|560695435|FG000|Overall Study|Death|1|||
155345082|NCT01469819|560695436|FG000|Overall Study|Withdrawal by Subject|1|||
155345083|NCT01469819|560695436|FG000|Overall Study|Did not meet inclusionary criteria|2|||
155345084|NCT01469819|560695436|FG000|Overall Study|Could not swallow SmartPill|2|||
155345085|NCT01469819|560695436|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
155345086|NCT01403805|560695439|FG000|Overall Study|Withdrawal by Subject|0|||
155345087|NCT01403805|560695440|FG001|Overall Study|Withdrawal by Subject|4|||
155345088|NCT01403805|560695439|FG000|Overall Study|Lost to Follow-up|0|||
155345089|NCT01403805|560695440|FG001|Overall Study|Lost to Follow-up|2|||
155345090|NCT01403805|560695439|FG000|Overall Study|Death|0|||
155345091|NCT01403805|560695440|FG001|Overall Study|Death|1|||
155345092|NCT01695993|560695441|FG000|Overall Study|Lost to Follow-up|2|||
155345093|NCT01695993|560695442|FG001|Overall Study|Lost to Follow-up|1|||
155345094|NCT01695993|560695443|FG002|Overall Study|Lost to Follow-up|3|||
155345095|NCT01695993|560695441|FG000|Overall Study|Withdrawal by Subject|2|||
155345096|NCT01695993|560695442|FG001|Overall Study|Withdrawal by Subject|2|||
155345097|NCT01695993|560695443|FG002|Overall Study|Withdrawal by Subject|2|||
155345098|NCT01695993|560695441|FG000|Overall Study|To ill to continue|1|||
155345099|NCT01695993|560695442|FG001|Overall Study|To ill to continue|2|||
155345100|NCT01695993|560695443|FG002|Overall Study|To ill to continue|0|||
155345101|NCT01695993|560695441|FG000|Overall Study|Changed Medical Facility|0|||
155345102|NCT01695993|560695442|FG001|Overall Study|Changed Medical Facility|0|||
155345103|NCT01695993|560695443|FG002|Overall Study|Changed Medical Facility|1|||
155345104|NCT01601821|560695444|FG000|Overall Study|Death|2|||
155345105|NCT01601821|560695445|FG001|Overall Study|Death|5|||
155345106|NCT01601821|560695444|FG000|Overall Study|Protocol Violation|2|||
155345107|NCT01601821|560695445|FG001|Overall Study|Protocol Violation|2|||
155345108|NCT01601821|560695444|FG000|Overall Study|Lost to Follow-up|6|||
155345109|NCT01601821|560695445|FG001|Overall Study|Lost to Follow-up|14|||
155345110|NCT01601821|560695444|FG000|Overall Study|Withdrawal by Subject|1|||
155345111|NCT01601821|560695445|FG001|Overall Study|Withdrawal by Subject|0|||
155345112|NCT01601821|560695444|FG000|Overall Study|Graft Loss|6|||
155345113|NCT01601821|560695445|FG001|Overall Study|Graft Loss|6|||
155345114|NCT01601821|560695444|FG000|Overall Study|Study Events|7|||
155345115|NCT01601821|560695445|FG001|Overall Study|Study Events|1|||
155345116|NCT01601821|560695444|FG000|Overall Study|Other|5|||
155345117|NCT01601821|560695445|FG001|Overall Study|Other|1|||
155345118|NCT00147745|560695446|FG000|Overall Study|Withdrawal by Subject|1|||
155345119|NCT00147745|560695447|FG001|Overall Study|Withdrawal by Subject|0|||
155345120|NCT00147745|560695448|FG002|Overall Study|Withdrawal by Subject|0|||
155345121|NCT01901302|560695449|FG000|Overall Study|Adverse Event|2|||
155345122|NCT01901302|560695450|FG001|Overall Study|Adverse Event|1|||
155345123|NCT01901302|560695449|FG000|Overall Study|Lack of Efficacy|0|||
155345124|NCT01901302|560695450|FG001|Overall Study|Lack of Efficacy|2|||
155345125|NCT01901302|560695449|FG000|Overall Study|Study Terminated by Sponsor|23|||
155345126|NCT01901302|560695450|FG001|Overall Study|Study Terminated by Sponsor|20|||
155345127|NCT01901302|560695449|FG000|Overall Study|Withdrawal by Subject|2|||
155345128|NCT01901302|560695450|FG001|Overall Study|Withdrawal by Subject|0|||
155345129|NCT00510783|560695452|FG000|Overall Study|Lost to Follow-up|29|||
155345130|NCT00510783|560695453|FG001|Overall Study|Lost to Follow-up|25|||
155345131|NCT00510783|560695452|FG000|Overall Study|Withdrawal by Subject|2|||
155345132|NCT00510783|560695453|FG001|Overall Study|Withdrawal by Subject|3|||
155345133|NCT00510783|560695452|FG000|Overall Study|Protocol Violation|0|||
155345134|NCT00510783|560695453|FG001|Overall Study|Protocol Violation|1|||
155345135|NCT00316121|560695454|FG000|Overall Study|Death|1|||
155345136|NCT00316121|560695455|FG001|Overall Study|Death|0|||
155345137|NCT00316121|560695454|FG000|Overall Study|Lost to Follow-up|14|||
155345138|NCT00316121|560695455|FG001|Overall Study|Lost to Follow-up|8|||
155345139|NCT00316121|560695454|FG000|Overall Study|Withdrawal by Subject|2|||
155345140|NCT00316121|560695455|FG001|Overall Study|Withdrawal by Subject|0|||
155345141|NCT00316121|560695454|FG000|Overall Study|Reason is missing|1|||
155345142|NCT00316121|560695455|FG001|Overall Study|Reason is missing|0|||
155345143|NCT00316121|560695454|FG000|Overall Study|Subject relocated|1|||
155345144|NCT00316121|560695455|FG001|Overall Study|Subject relocated|1|||
155345145|NCT00316121|560695454|FG000|Overall Study|Subject refused to return|1|||
155345146|NCT00316121|560695455|FG001|Overall Study|Subject refused to return|0|||
155080536|NCT04189588|559725375|FG001|Overall Study|Death|1|||
155345147|NCT00316121|560695454|FG000|Overall Study|Subject no show for visit x 3|1|||
155345148|NCT00316121|560695455|FG001|Overall Study|Subject no show for visit x 3|0|||
155345149|NCT00316121|560695454|FG000|Overall Study|Subject did not have 24 month visit|1|||
155345150|NCT00316121|560695455|FG001|Overall Study|Subject did not have 24 month visit|0|||
155165501|NCT01039519|560043463|FG000|Treatment|Treatment failure|2|||
155165502|NCT01039519|560043463|FG000|Treatment|Adverse Event|3|||
155345151|NCT03708744|560695461|FG000|Overall Study|Withdrawal by Subject|0|||
155345152|NCT03708744|560695462|FG001|Overall Study|Withdrawal by Subject|0|||
155345153|NCT03708744|560695463|FG002|Overall Study|Withdrawal by Subject|1|||
155345154|NCT03708744|560695464|FG003|Overall Study|Withdrawal by Subject|0|||
155345155|NCT00460577|560695472|FG000|Overall Study|Protocol Violation|2|||
155345156|NCT00460577|560695473|FG001|Overall Study|Protocol Violation|6|||
155345157|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
155345158|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
155345159|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
155345160|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
155345161|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
155345162|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
155345163|NCT02213458|560695474|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
155345164|NCT02213458|560695475|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
155345165|NCT02213458|560695474|FG000|Overall Study|Refused re-consent|6|||
155345166|NCT02213458|560695475|FG001|Overall Study|Refused re-consent|0|||
155345167|NCT02213458|560695474|FG000|Overall Study|Lost to Follow-up|2|||
155345168|NCT02213458|560695475|FG001|Overall Study|Lost to Follow-up|2|||
155345169|NCT02213458|560695474|FG000|Overall Study|Withdrawal by Subject|26|||
155345170|NCT02213458|560695475|FG001|Overall Study|Withdrawal by Subject|8|||
155345171|NCT04043806|560695476|FG000|Overall Study|Commercial drug is available for participants|13|||
155345172|NCT04043806|560695476|FG000|Overall Study|Physician Decision|2|||
155345173|NCT04043806|560695476|FG000|Overall Study|Other|12|||
155345174|NCT04043806|560695476|FG000|Overall Study|Adverse Event|2|||
155345175|NCT04043806|560695476|FG000|Overall Study|Lost to Follow-up|6|||
155345176|NCT04043806|560695476|FG000|Overall Study|Other non-compliance|2|||
155345177|NCT04043806|560695476|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
155345178|NCT04043806|560695476|FG000|Overall Study|Never Dosed|1|||
155345179|NCT03166215|560695477|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
155345180|NCT03166215|560695478|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
155345181|NCT03166215|560695479|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
155345182|NCT03166215|560695477|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
155345183|NCT03166215|560695478|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
155345184|NCT03166215|560695479|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
155345185|NCT04985604|560695483|FG000|Overall Study|Death|4|||
155345186|NCT04985604|560695484|FG001|Overall Study|Death|6|||
155345187|NCT04985604|560695483|FG000|Overall Study|Withdrawal by Subject|0|||
155345188|NCT04985604|560695484|FG001|Overall Study|Withdrawal by Subject|1|||
155345189|NCT00658632|560695485|FG000|Overall Study|Adverse Event|13|||
155345190|NCT00658632|560695486|FG001|Overall Study|Adverse Event|11|||
155345191|NCT00658632|560695485|FG000|Overall Study|Lost to Follow-up|25|||
155345192|NCT00658632|560695486|FG001|Overall Study|Lost to Follow-up|23|||
155345193|NCT00658632|560695485|FG000|Overall Study|Withdrawal by Subject|10|||
155345194|NCT00658632|560695486|FG001|Overall Study|Withdrawal by Subject|7|||
155345195|NCT00658632|560695485|FG000|Overall Study|Lack of Efficacy|0|||
155345196|NCT00658632|560695486|FG001|Overall Study|Lack of Efficacy|1|||
155345197|NCT00658632|560695485|FG000|Overall Study|Withdrawal of consent|8|||
155345198|NCT00658632|560695486|FG001|Overall Study|Withdrawal of consent|14|||
155345199|NCT00658632|560695485|FG000|Overall Study|Pregnancy|1|||
155345200|NCT00658632|560695486|FG001|Overall Study|Pregnancy|1|||
155345201|NCT00658632|560695485|FG000|Overall Study|Other|7|||
155345202|NCT00658632|560695486|FG001|Overall Study|Other|8|||
155345203|NCT05263492|560695488|FG000|Overall Study|Adverse Event|1|||
155345204|NCT05263492|560695488|FG000|Overall Study|Disease progression during active treatment|3|||
155345205|NCT03345420|560695491|FG000|Overall Study|Withdrawal by Subject|1|||
155345206|NCT04551053|560695492|FG000|Overall Study|Death|10|||
155345207|NCT04551053|560695493|FG001|Overall Study|Death|9|||
155165503|NCT01039519|560043463|FG000|Treatment|Physician Decision|2|||
155165504|NCT01039519|560043463|FG000|Survival Follow-up|Death|23|||
155345208|NCT04551053|560695492|FG000|Overall Study|Lost to Follow-up|0|||
155345209|NCT04551053|560695493|FG001|Overall Study|Lost to Follow-up|2|||
155345210|NCT04551053|560695492|FG000|Overall Study|Study Terminated by Sponsor|57|||
155165505|NCT01039519|560043463|FG000|Survival Follow-up|Sponsor decision|4|||
155345211|NCT04551053|560695493|FG001|Overall Study|Study Terminated by Sponsor|65|||
155345212|NCT04551053|560695492|FG000|Overall Study|Withdrawal by Subject|12|||
155345213|NCT04551053|560695493|FG001|Overall Study|Withdrawal by Subject|5|||
155165506|NCT01330108|560043467|FG000|Overall Study|Withdrawal by Subject|4|||
155165507|NCT01864603|560043470|FG000|Stage 2|DSMB design modification|86056|||
155345214|NCT04551053|560695492|FG000|Overall Study|Adverse Event|2|||
155345215|NCT04551053|560695493|FG001|Overall Study|Adverse Event|0|||
155165508|NCT01864603|560043471|FG001|Stage 2|DSMB design modification|92558|||
155165509|NCT02881567|560043475|FG000|Overall Study|Adverse Event|1|||
155165510|NCT02881567|560043475|FG000|Overall Study|Lost to Follow-up|3|||
155345216|NCT04551053|560695492|FG000|Overall Study|Lack of Efficacy|2|||
155345217|NCT04551053|560695493|FG001|Overall Study|Lack of Efficacy|1|||
155345218|NCT04551053|560695492|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
155345219|NCT04551053|560695493|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
155345220|NCT04551053|560695492|FG000|Overall Study|Splenapendectomi|1|||
155345221|NCT04551053|560695493|FG001|Overall Study|Splenapendectomi|0|||
155345222|NCT04551053|560695492|FG000|Overall Study|Medical Decision|1|||
155345223|NCT04551053|560695493|FG001|Overall Study|Medical Decision|1|||
155345224|NCT00596960|560695495|FG000|Overall Study|Death|1|||
155345225|NCT00596960|560695496|FG001|Overall Study|Death|2|||
155345226|NCT00596960|560695495|FG000|Overall Study|Lost to Follow-up|6|||
155345227|NCT00596960|560695496|FG001|Overall Study|Lost to Follow-up|5|||
155345228|NCT00596960|560695495|FG000|Overall Study|Withdrawal by Subject|1|||
155345229|NCT00596960|560695496|FG001|Overall Study|Withdrawal by Subject|0|||
155345230|NCT00596960|560695495|FG000|Overall Study|Incarcerated|2|||
155345231|NCT00596960|560695496|FG001|Overall Study|Incarcerated|0|||
155345232|NCT00596960|560695495|FG000|Overall Study|Physician Decision|1|||
155345233|NCT00596960|560695496|FG001|Overall Study|Physician Decision|0|||
155345234|NCT00596960|560695495|FG000|Overall Study|Protocol Violation|0|||
155345235|NCT00596960|560695496|FG001|Overall Study|Protocol Violation|1|||
155345236|NCT00596960|560695495|FG000|Overall Study|No alcohol use data|0|||
155345237|NCT00596960|560695496|FG001|Overall Study|No alcohol use data|1|||
155345238|NCT03503188|560695497|FG000|Overall Study|Non eligible in the sub study|0|||
155345239|NCT03503188|560695498|FG001|Overall Study|Non eligible in the sub study|1|||
155345240|NCT03556891|560695508|FG000|Initial Pivotal Study|Adverse Event|4|||
155345241|NCT03556891|560695508|FG000|Initial Pivotal Study|MRI Need|3|||
155345242|NCT03556891|560695508|FG000|Initial Pivotal Study|Device Failure|1|||
155345243|NCT03556891|560695508|FG000|Initial Pivotal Study|Death|1|||
155345244|NCT03556891|560695508|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
155345245|NCT03556891|560695508|FG000|Initial Pivotal Study|Missing at random|1|||
155345246|NCT03556891|560695508|FG000|Initial Pivotal Study|Missing due to COVID|1|||
155345247|NCT03556891|560695508|FG000|Initial Pivotal Study|Protocol Violation|1|||
155345248|NCT02661490|560698086|FG000|Overall Study|Lost to Follow-up|0|||
155345249|NCT02661490|560698087|FG001|Overall Study|Lost to Follow-up|1|||
155345250|NCT02661490|560698088|FG002|Overall Study|Lost to Follow-up|0|||
155345251|NCT02661490|560698089|FG003|Overall Study|Lost to Follow-up|0|||
155345252|NCT02661490|560698090|FG004|Overall Study|Lost to Follow-up|2|||
155345253|NCT02661490|560698086|FG000|Overall Study|Withdrawal by Subject|2|||
155345254|NCT02661490|560698087|FG001|Overall Study|Withdrawal by Subject|0|||
155345255|NCT02661490|560698088|FG002|Overall Study|Withdrawal by Subject|2|||
155345256|NCT02661490|560698089|FG003|Overall Study|Withdrawal by Subject|0|||
155345257|NCT02661490|560698090|FG004|Overall Study|Withdrawal by Subject|0|||
155345258|NCT02661490|560698086|FG000|Overall Study|Death|1|||
155345259|NCT02661490|560698087|FG001|Overall Study|Death|1|||
155345260|NCT02661490|560698088|FG002|Overall Study|Death|0|||
155345261|NCT02661490|560698089|FG003|Overall Study|Death|1|||
155345262|NCT02661490|560698090|FG004|Overall Study|Death|0|||
155345263|NCT02661490|560698086|FG000|Overall Study|Reason not Specified|0|||
155345264|NCT02661490|560698087|FG001|Overall Study|Reason not Specified|0|||
155345265|NCT02661490|560698088|FG002|Overall Study|Reason not Specified|0|||
155345266|NCT02661490|560698089|FG003|Overall Study|Reason not Specified|0|||
155345267|NCT02661490|560698090|FG004|Overall Study|Reason not Specified|1|||
155345268|NCT00961298|560698091|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
155345269|NCT00961298|560698091|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
155345270|NCT00961298|560698091|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
155345271|NCT02388932|560698096|FG000|Overall Study|Death|1|||
155345272|NCT05927753|560698099|FG000|Overall Study|Withdrawal by Subject|0|||
155345273|NCT05927753|560698100|FG001|Overall Study|Withdrawal by Subject|2|||
155345274|NCT05927753|560698099|FG000|Overall Study|Physician Decision|0|||
155345275|NCT05927753|560698100|FG001|Overall Study|Physician Decision|1|||
155345276|NCT02136797|560698102|FG000|Overall Study|Not Treated|8|||
155345277|NCT00409006|560698104|FG000|Overall Study|Death|15|||
155345278|NCT00409006|560698105|FG001|Overall Study|Death|6|||
155345279|NCT00409006|560698104|FG000|Overall Study|Lost to Follow-up|1|||
155345280|NCT00409006|560698105|FG001|Overall Study|Lost to Follow-up|2|||
155345281|NCT00409006|560698104|FG000|Overall Study|Withdrawal by Subject|3|||
155345282|NCT00409006|560698105|FG001|Overall Study|Withdrawal by Subject|2|||
155345283|NCT00409006|560698104|FG000|Overall Study|Physician Decision|1|||
155345284|NCT00409006|560698105|FG001|Overall Study|Physician Decision|2|||
155345285|NCT02123797|560698106|FG000|Baseline Intervention|Death|9|||
155345286|NCT02123797|560698107|FG001|Baseline Intervention|Death|16|||
155345287|NCT02123797|560698108|FG002|Baseline Intervention|Death|0|||
155345288|NCT02123797|560698109|FG003|Baseline Intervention|Death|0|||
155345289|NCT02123797|560698110|FG004|Baseline Intervention|Death|0|||
155345290|NCT02123797|560698106|FG000|Baseline Intervention|Withdrawal by Subject|2|||
155345291|NCT02123797|560698107|FG001|Baseline Intervention|Withdrawal by Subject|8|||
155345292|NCT02123797|560698108|FG002|Baseline Intervention|Withdrawal by Subject|0|||
155345293|NCT02123797|560698109|FG003|Baseline Intervention|Withdrawal by Subject|0|||
155345294|NCT02123797|560698110|FG004|Baseline Intervention|Withdrawal by Subject|0|||
155345295|NCT02123797|560698106|FG000|Baseline Intervention|Relocation|2|||
155345296|NCT02123797|560698107|FG001|Baseline Intervention|Relocation|0|||
155345297|NCT02123797|560698108|FG002|Baseline Intervention|Relocation|0|||
155345298|NCT02123797|560698109|FG003|Baseline Intervention|Relocation|0|||
155345299|NCT02123797|560698110|FG004|Baseline Intervention|Relocation|0|||
155345300|NCT02123797|560698106|FG000|Baseline Intervention|Out of window for initial survey|6|||
155345301|NCT02123797|560698107|FG001|Baseline Intervention|Out of window for initial survey|13|||
155345302|NCT02123797|560698108|FG002|Baseline Intervention|Out of window for initial survey|0|||
155345303|NCT02123797|560698109|FG003|Baseline Intervention|Out of window for initial survey|0|||
155345304|NCT02123797|560698110|FG004|Baseline Intervention|Out of window for initial survey|0|||
155345305|NCT02123797|560698106|FG000|Baseline Intervention|Lost to Follow-up|0|||
155345306|NCT02123797|560698107|FG001|Baseline Intervention|Lost to Follow-up|5|||
155345307|NCT02123797|560698108|FG002|Baseline Intervention|Lost to Follow-up|0|||
155345308|NCT02123797|560698109|FG003|Baseline Intervention|Lost to Follow-up|0|||
155345309|NCT02123797|560698110|FG004|Baseline Intervention|Lost to Follow-up|0|||
155345310|NCT02123797|560698106|FG000|Baseline Intervention|Other Disease|3|||
155345311|NCT02123797|560698107|FG001|Baseline Intervention|Other Disease|0|||
155345312|NCT02123797|560698108|FG002|Baseline Intervention|Other Disease|0|||
155345313|NCT02123797|560698109|FG003|Baseline Intervention|Other Disease|0|||
155345314|NCT02123797|560698110|FG004|Baseline Intervention|Other Disease|0|||
155345315|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
155345316|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
155345317|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
155345318|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
155345319|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
155345320|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
155345321|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
155345322|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
155345323|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
155345324|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
155345325|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
155345326|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
155345327|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345328|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345329|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345330|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345331|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
155345332|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345333|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345334|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
155345335|NCT02123797|560698106|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
155345336|NCT02123797|560698107|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
155345337|NCT02123797|560698108|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
155345338|NCT02123797|560698109|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
155345339|NCT02123797|560698110|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
155345340|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
155345341|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
155345342|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
155345343|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
155345344|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
155345345|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
155345346|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
155345347|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
155345348|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
155345349|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
155345350|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
155345351|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
155345352|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345353|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345354|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
155345355|NCT02123797|560698106|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345356|NCT02123797|560698107|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
155345357|NCT02123797|560698108|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345358|NCT02123797|560698109|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
155165511|NCT02881567|560043475|FG000|Overall Study|Consent withdrawn|1|||
155345359|NCT02123797|560698110|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
155345360|NCT03602053|560698120|FG000|Overall Study|Withdrawal by Subject|7|||
155345361|NCT03602053|560698121|FG001|Overall Study|Withdrawal by Subject|9|||
155345362|NCT03602053|560698122|FG002|Overall Study|Withdrawal by Subject|7|||
155345363|NCT03602053|560698120|FG000|Overall Study|Lost to Follow-up|5|||
155345364|NCT03602053|560698121|FG001|Overall Study|Lost to Follow-up|6|||
155345365|NCT03602053|560698122|FG002|Overall Study|Lost to Follow-up|0|||
155345366|NCT03602053|560698120|FG000|Overall Study|Protocol Violation|3|||
155345367|NCT03602053|560698121|FG001|Overall Study|Protocol Violation|0|||
155345368|NCT03602053|560698122|FG002|Overall Study|Protocol Violation|4|||
155345369|NCT03602053|560698120|FG000|Overall Study|Physician Decision|1|||
155345370|NCT03602053|560698121|FG001|Overall Study|Physician Decision|0|||
155345371|NCT03602053|560698122|FG002|Overall Study|Physician Decision|0|||
155345372|NCT03602053|560698120|FG000|Overall Study|migration|2|||
155345373|NCT03602053|560698121|FG001|Overall Study|migration|3|||
155345374|NCT03602053|560698122|FG002|Overall Study|migration|0|||
155345375|NCT03602053|560698120|FG000|Overall Study|Other|1|||
155345376|NCT03602053|560698121|FG001|Overall Study|Other|0|||
155345377|NCT03602053|560698122|FG002|Overall Study|Other|0|||
155345378|NCT03672188|560698133|FG000|Overall Study|Withdrawal by Subject|0|||
155345379|NCT03672188|560698134|FG001|Overall Study|Withdrawal by Subject|0|||
155345380|NCT03672188|560698135|FG002|Overall Study|Withdrawal by Subject|0|||
155345381|NCT03672188|560698136|FG003|Overall Study|Withdrawal by Subject|3|||
155345382|NCT03672188|560698137|FG004|Overall Study|Withdrawal by Subject|0|||
155345383|NCT03672188|560698138|FG005|Overall Study|Withdrawal by Subject|0|||
155345384|NCT03672188|560698139|FG006|Overall Study|Withdrawal by Subject|0|||
155345385|NCT03672188|560698140|FG007|Overall Study|Withdrawal by Subject|0|||
155345386|NCT03672188|560698141|FG008|Overall Study|Withdrawal by Subject|0|||
155345387|NCT03672188|560698142|FG009|Overall Study|Withdrawal by Subject|0|||
155345388|NCT03672188|560698143|FG010|Overall Study|Withdrawal by Subject|0|||
155345389|NCT03672188|560698144|FG011|Overall Study|Withdrawal by Subject|0|||
155345390|NCT03672188|560698145|FG012|Overall Study|Withdrawal by Subject|0|||
155345391|NCT03672188|560698146|FG013|Overall Study|Withdrawal by Subject|0|||
155345392|NCT03672188|560698147|FG014|Overall Study|Withdrawal by Subject|0|||
155345393|NCT03672188|560698133|FG000|Overall Study|Death|0|||
155345394|NCT03672188|560698134|FG001|Overall Study|Death|0|||
155345395|NCT03672188|560698135|FG002|Overall Study|Death|0|||
155345396|NCT03672188|560698136|FG003|Overall Study|Death|0|||
155345397|NCT03672188|560698137|FG004|Overall Study|Death|0|||
155345398|NCT03672188|560698138|FG005|Overall Study|Death|0|||
155345399|NCT03672188|560698139|FG006|Overall Study|Death|0|||
155345400|NCT03672188|560698140|FG007|Overall Study|Death|0|||
155345401|NCT03672188|560698141|FG008|Overall Study|Death|0|||
155345402|NCT03672188|560698142|FG009|Overall Study|Death|0|||
155345403|NCT03672188|560698143|FG010|Overall Study|Death|0|||
155345404|NCT03672188|560698144|FG011|Overall Study|Death|0|||
155345405|NCT03672188|560698145|FG012|Overall Study|Death|1|||
155345406|NCT03672188|560698146|FG013|Overall Study|Death|0|||
155345407|NCT03672188|560698147|FG014|Overall Study|Death|0|||
155345408|NCT03672188|560698133|FG000|Overall Study|Lost to Follow-up|0|||
155345409|NCT03672188|560698134|FG001|Overall Study|Lost to Follow-up|0|||
155345410|NCT03672188|560698135|FG002|Overall Study|Lost to Follow-up|1|||
155345411|NCT03672188|560698136|FG003|Overall Study|Lost to Follow-up|0|||
155345412|NCT03672188|560698137|FG004|Overall Study|Lost to Follow-up|0|||
155345413|NCT03672188|560698138|FG005|Overall Study|Lost to Follow-up|0|||
155345414|NCT03672188|560698139|FG006|Overall Study|Lost to Follow-up|0|||
155345415|NCT03672188|560698140|FG007|Overall Study|Lost to Follow-up|0|||
155345416|NCT03672188|560698141|FG008|Overall Study|Lost to Follow-up|0|||
155345417|NCT03672188|560698142|FG009|Overall Study|Lost to Follow-up|0|||
155345418|NCT03672188|560698143|FG010|Overall Study|Lost to Follow-up|0|||
155345419|NCT03672188|560698144|FG011|Overall Study|Lost to Follow-up|0|||
155345420|NCT03672188|560698145|FG012|Overall Study|Lost to Follow-up|0|||
155345421|NCT03672188|560698146|FG013|Overall Study|Lost to Follow-up|0|||
155345422|NCT03672188|560698147|FG014|Overall Study|Lost to Follow-up|0|||
155345423|NCT01234675|560698148|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
155345424|NCT01234675|560698149|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155345425|NCT01234675|560698148|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155345426|NCT01234675|560698149|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
155345427|NCT03997409|560698150|FG000|Overall Study|Protocol Violation|1|||
155345428|NCT03997409|560698151|FG001|Overall Study|Protocol Violation|1|||
155345429|NCT03997409|560698152|FG002|Overall Study|Protocol Violation|0|||
155345430|NCT03997409|560698150|FG000|Overall Study|Withdrawal by Subject|3|||
155345431|NCT03997409|560698151|FG001|Overall Study|Withdrawal by Subject|0|||
155345432|NCT03997409|560698152|FG002|Overall Study|Withdrawal by Subject|0|||
155345433|NCT03997409|560698150|FG000|Overall Study|Lost to Follow-up|0|||
155345434|NCT03997409|560698151|FG001|Overall Study|Lost to Follow-up|0|||
155345435|NCT03997409|560698152|FG002|Overall Study|Lost to Follow-up|1|||
155345436|NCT01753323|560698153|FG000|Overall Study|Lack of Efficacy|0|||
155345437|NCT01753323|560698154|FG001|Overall Study|Lack of Efficacy|0|||
155345438|NCT01753323|560698155|FG002|Overall Study|Lack of Efficacy|8|||
155345439|NCT01753323|560698153|FG000|Overall Study|Protocol deviation|1|||
155345440|NCT01753323|560698154|FG001|Overall Study|Protocol deviation|0|||
155345441|NCT01753323|560698155|FG002|Overall Study|Protocol deviation|0|||
155345442|NCT01753323|560698153|FG000|Overall Study|Adverse Event|0|||
155345443|NCT01753323|560698154|FG001|Overall Study|Adverse Event|0|||
155345444|NCT01753323|560698155|FG002|Overall Study|Adverse Event|1|||
155345445|NCT01870999|560698156|FG000|Overall Study|Adverse Event|0|||
155345446|NCT01870999|560698157|FG001|Overall Study|Adverse Event|4|||
155345447|NCT01870999|560698158|FG002|Overall Study|Adverse Event|1|||
155345448|NCT01870999|560698156|FG000|Overall Study|Subject met withdrawal criteria|3|||
155345449|NCT01870999|560698157|FG001|Overall Study|Subject met withdrawal criteria|2|||
155345450|NCT01870999|560698158|FG002|Overall Study|Subject met withdrawal criteria|0|||
155345451|NCT01870999|560698156|FG000|Overall Study|Subject withdrawn by Investigator|1|||
155345452|NCT01870999|560698157|FG001|Overall Study|Subject withdrawn by Investigator|0|||
155345453|NCT01870999|560698158|FG002|Overall Study|Subject withdrawn by Investigator|0|||
155345454|NCT01870999|560698156|FG000|Overall Study|Withdrawal by Subject|0|||
155345455|NCT01870999|560698157|FG001|Overall Study|Withdrawal by Subject|2|||
155345456|NCT01870999|560698158|FG002|Overall Study|Withdrawal by Subject|5|||
155345457|NCT01870999|560698156|FG000|Overall Study|Protocol Violation|0|||
155345458|NCT01870999|560698157|FG001|Overall Study|Protocol Violation|0|||
155345459|NCT01870999|560698158|FG002|Overall Study|Protocol Violation|1|||
155345460|NCT00116584|560698169|FG000|Overall Study|Withdrawal by Subject|1|||
155345461|NCT00116584|560698170|FG001|Overall Study|Withdrawal by Subject|0|||
155345462|NCT00116584|560698169|FG000|Overall Study|Protocol Violation|1|||
155345463|NCT00116584|560698170|FG001|Overall Study|Protocol Violation|1|||
155345464|NCT01745380|560698171|FG000|Overall Study|Lost to Follow-up|1|||
155345465|NCT01745380|560698172|FG001|Overall Study|Lost to Follow-up|0|||
155345466|NCT01745380|560698171|FG000|Overall Study|Lack of Efficacy|0|||
155345467|NCT01745380|560698172|FG001|Overall Study|Lack of Efficacy|1|||
155345468|NCT02660034|560698173|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
155345469|NCT02660034|560698174|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
155345470|NCT02660034|560698175|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
155345471|NCT02660034|560698176|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
155345472|NCT02660034|560698177|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
155345473|NCT02660034|560698178|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
155345474|NCT02660034|560698179|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
155345475|NCT02660034|560698180|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
155345476|NCT02660034|560698181|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
155345477|NCT02660034|560698182|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
155345478|NCT02660034|560698183|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
155345479|NCT02660034|560698184|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
155345480|NCT02660034|560698185|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
155345481|NCT02660034|560698186|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
155345482|NCT02660034|560698173|FG000|Overall Study|Progressive Disease (Clinical)|7|||
155345483|NCT02660034|560698174|FG001|Overall Study|Progressive Disease (Clinical)|8|||
155345484|NCT02660034|560698175|FG002|Overall Study|Progressive Disease (Clinical)|3|||
155345485|NCT02660034|560698176|FG003|Overall Study|Progressive Disease (Clinical)|9|||
155345486|NCT02660034|560698177|FG004|Overall Study|Progressive Disease (Clinical)|3|||
155345487|NCT02660034|560698178|FG005|Overall Study|Progressive Disease (Clinical)|0|||
155345488|NCT02660034|560698179|FG006|Overall Study|Progressive Disease (Clinical)|0|||
155345489|NCT02660034|560698180|FG007|Overall Study|Progressive Disease (Clinical)|0|||
155345490|NCT02660034|560698181|FG008|Overall Study|Progressive Disease (Clinical)|0|||
155345491|NCT02660034|560698182|FG009|Overall Study|Progressive Disease (Clinical)|0|||
155345492|NCT02660034|560698183|FG010|Overall Study|Progressive Disease (Clinical)|0|||
155345493|NCT02660034|560698184|FG011|Overall Study|Progressive Disease (Clinical)|0|||
155345494|NCT02660034|560698185|FG012|Overall Study|Progressive Disease (Clinical)|0|||
155345495|NCT02660034|560698186|FG013|Overall Study|Progressive Disease (Clinical)|0|||
155345496|NCT02660034|560698173|FG000|Overall Study|Lost to Follow-up|0|||
155345497|NCT02660034|560698174|FG001|Overall Study|Lost to Follow-up|0|||
155345498|NCT02660034|560698175|FG002|Overall Study|Lost to Follow-up|1|||
155080537|NCT04189588|559725374|FG000|Overall Study|Lost to Follow-up|0|||
155080538|NCT04189588|559725375|FG001|Overall Study|Lost to Follow-up|1|||
155345499|NCT02660034|560698176|FG003|Overall Study|Lost to Follow-up|1|||
155345500|NCT02660034|560698177|FG004|Overall Study|Lost to Follow-up|0|||
155345501|NCT02660034|560698178|FG005|Overall Study|Lost to Follow-up|0|||
155345502|NCT02660034|560698179|FG006|Overall Study|Lost to Follow-up|0|||
155345503|NCT02660034|560698180|FG007|Overall Study|Lost to Follow-up|0|||
155080539|NCT01658735|559725380|FG000|Overall Study|Lack of Efficacy|1|||
155080540|NCT01658735|559725381|FG001|Overall Study|Lack of Efficacy|0|||
155080541|NCT01658735|559725382|FG002|Overall Study|Lack of Efficacy|1|||
155080542|NCT01658735|559725380|FG000|Overall Study|Lost to Follow-up|1|||
155080543|NCT01658735|559725381|FG001|Overall Study|Lost to Follow-up|1|||
155080544|NCT01658735|559725382|FG002|Overall Study|Lost to Follow-up|0|||
155080545|NCT01658735|559725380|FG000|Overall Study|Protocol Violation|0|||
155345504|NCT02660034|560698181|FG008|Overall Study|Lost to Follow-up|0|||
155345505|NCT02660034|560698182|FG009|Overall Study|Lost to Follow-up|1|||
155345506|NCT02660034|560698183|FG010|Overall Study|Lost to Follow-up|1|||
155345507|NCT02660034|560698184|FG011|Overall Study|Lost to Follow-up|1|||
155345508|NCT02660034|560698185|FG012|Overall Study|Lost to Follow-up|0|||
155345509|NCT02660034|560698186|FG013|Overall Study|Lost to Follow-up|0|||
155345510|NCT02660034|560698173|FG000|Overall Study|Participant moved into special access scheme|1|||
155345511|NCT02660034|560698174|FG001|Overall Study|Participant moved into special access scheme|2|||
155345512|NCT02660034|560698175|FG002|Overall Study|Participant moved into special access scheme|0|||
155345513|NCT02660034|560698176|FG003|Overall Study|Participant moved into special access scheme|0|||
155345514|NCT02660034|560698177|FG004|Overall Study|Participant moved into special access scheme|0|||
155345515|NCT02660034|560698178|FG005|Overall Study|Participant moved into special access scheme|0|||
155345516|NCT02660034|560698179|FG006|Overall Study|Participant moved into special access scheme|0|||
155345517|NCT02660034|560698180|FG007|Overall Study|Participant moved into special access scheme|0|||
155345518|NCT02660034|560698181|FG008|Overall Study|Participant moved into special access scheme|0|||
155345519|NCT02660034|560698182|FG009|Overall Study|Participant moved into special access scheme|0|||
155345520|NCT02660034|560698183|FG010|Overall Study|Participant moved into special access scheme|0|||
155345521|NCT02660034|560698184|FG011|Overall Study|Participant moved into special access scheme|0|||
155345522|NCT02660034|560698185|FG012|Overall Study|Participant moved into special access scheme|0|||
155345523|NCT02660034|560698186|FG013|Overall Study|Participant moved into special access scheme|0|||
155345524|NCT02660034|560698173|FG000|Overall Study|Adverse Event|1|||
155345525|NCT02660034|560698174|FG001|Overall Study|Adverse Event|0|||
155345526|NCT02660034|560698175|FG002|Overall Study|Adverse Event|0|||
155345527|NCT02660034|560698176|FG003|Overall Study|Adverse Event|0|||
155345528|NCT02660034|560698177|FG004|Overall Study|Adverse Event|0|||
155345529|NCT02660034|560698178|FG005|Overall Study|Adverse Event|0|||
155345530|NCT02660034|560698179|FG006|Overall Study|Adverse Event|0|||
155345531|NCT02660034|560698180|FG007|Overall Study|Adverse Event|0|||
155345532|NCT02660034|560698181|FG008|Overall Study|Adverse Event|0|||
155345533|NCT02660034|560698182|FG009|Overall Study|Adverse Event|0|||
155345534|NCT02660034|560698183|FG010|Overall Study|Adverse Event|0|||
155345535|NCT02660034|560698184|FG011|Overall Study|Adverse Event|0|||
155345536|NCT02660034|560698185|FG012|Overall Study|Adverse Event|0|||
155345537|NCT02660034|560698186|FG013|Overall Study|Adverse Event|0|||
155345538|NCT02660034|560698173|FG000|Overall Study|Sponsor Decision|0|||
155345539|NCT02660034|560698174|FG001|Overall Study|Sponsor Decision|1|||
155345540|NCT02660034|560698175|FG002|Overall Study|Sponsor Decision|2|||
155345541|NCT02660034|560698176|FG003|Overall Study|Sponsor Decision|2|||
155345542|NCT02660034|560698177|FG004|Overall Study|Sponsor Decision|3|||
155345543|NCT02660034|560698178|FG005|Overall Study|Sponsor Decision|0|||
155345544|NCT02660034|560698179|FG006|Overall Study|Sponsor Decision|0|||
155345545|NCT02660034|560698180|FG007|Overall Study|Sponsor Decision|0|||
155345546|NCT02660034|560698181|FG008|Overall Study|Sponsor Decision|0|||
155345547|NCT02660034|560698182|FG009|Overall Study|Sponsor Decision|0|||
155345548|NCT02660034|560698183|FG010|Overall Study|Sponsor Decision|0|||
155345549|NCT02660034|560698184|FG011|Overall Study|Sponsor Decision|0|||
155345550|NCT02660034|560698185|FG012|Overall Study|Sponsor Decision|0|||
155345551|NCT02660034|560698186|FG013|Overall Study|Sponsor Decision|1|||
155345552|NCT02660034|560698173|FG000|Overall Study|Withdrawal by Subject|0|||
155345553|NCT02660034|560698174|FG001|Overall Study|Withdrawal by Subject|0|||
155345554|NCT02660034|560698175|FG002|Overall Study|Withdrawal by Subject|0|||
155345555|NCT02660034|560698176|FG003|Overall Study|Withdrawal by Subject|0|||
155345556|NCT02660034|560698177|FG004|Overall Study|Withdrawal by Subject|0|||
155345557|NCT02660034|560698178|FG005|Overall Study|Withdrawal by Subject|0|||
155345558|NCT02660034|560698179|FG006|Overall Study|Withdrawal by Subject|1|||
155345559|NCT02660034|560698180|FG007|Overall Study|Withdrawal by Subject|1|||
155345560|NCT02660034|560698181|FG008|Overall Study|Withdrawal by Subject|1|||
155345561|NCT02660034|560698182|FG009|Overall Study|Withdrawal by Subject|0|||
155345562|NCT02660034|560698183|FG010|Overall Study|Withdrawal by Subject|0|||
155345563|NCT02660034|560698184|FG011|Overall Study|Withdrawal by Subject|1|||
155345564|NCT02660034|560698185|FG012|Overall Study|Withdrawal by Subject|2|||
155345565|NCT02660034|560698186|FG013|Overall Study|Withdrawal by Subject|0|||
155345566|NCT02660034|560698173|FG000|Overall Study|Death|0|||
155345567|NCT02660034|560698174|FG001|Overall Study|Death|0|||
155345568|NCT02660034|560698175|FG002|Overall Study|Death|0|||
155345569|NCT02660034|560698176|FG003|Overall Study|Death|0|||
155345570|NCT02660034|560698177|FG004|Overall Study|Death|0|||
155345571|NCT02660034|560698178|FG005|Overall Study|Death|13|||
155345572|NCT02660034|560698179|FG006|Overall Study|Death|14|||
155345573|NCT02660034|560698180|FG007|Overall Study|Death|10|||
155345574|NCT02660034|560698181|FG008|Overall Study|Death|9|||
155345575|NCT02660034|560698182|FG009|Overall Study|Death|21|||
155345576|NCT02660034|560698183|FG010|Overall Study|Death|17|||
155345577|NCT02660034|560698184|FG011|Overall Study|Death|15|||
155345578|NCT02660034|560698185|FG012|Overall Study|Death|18|||
155345579|NCT02660034|560698186|FG013|Overall Study|Death|7|||
155345580|NCT02660034|560698173|FG000|Overall Study|Physician Decision|0|||
155080546|NCT01658735|559725381|FG001|Overall Study|Protocol Violation|1|||
155080547|NCT01658735|559725382|FG002|Overall Study|Protocol Violation|0|||
155080548|NCT01658735|559725380|FG000|Overall Study|Withdrawal by Subject|3|||
155080549|NCT01658735|559725381|FG001|Overall Study|Withdrawal by Subject|5|||
155080550|NCT01658735|559725382|FG002|Overall Study|Withdrawal by Subject|3|||
155080551|NCT03302936|559725385|FG000|Overall Study|Protocol Violation|3|||
155345581|NCT02660034|560698174|FG001|Overall Study|Physician Decision|0|||
155345582|NCT02660034|560698175|FG002|Overall Study|Physician Decision|0|||
155345583|NCT02660034|560698176|FG003|Overall Study|Physician Decision|0|||
155345584|NCT02660034|560698177|FG004|Overall Study|Physician Decision|0|||
155345585|NCT02660034|560698178|FG005|Overall Study|Physician Decision|0|||
155345586|NCT02660034|560698179|FG006|Overall Study|Physician Decision|0|||
155345587|NCT02660034|560698180|FG007|Overall Study|Physician Decision|0|||
155345588|NCT02660034|560698181|FG008|Overall Study|Physician Decision|0|||
155345589|NCT02660034|560698182|FG009|Overall Study|Physician Decision|0|||
155345590|NCT02660034|560698183|FG010|Overall Study|Physician Decision|0|||
155345591|NCT02660034|560698184|FG011|Overall Study|Physician Decision|0|||
155345592|NCT02660034|560698185|FG012|Overall Study|Physician Decision|0|||
155345593|NCT02660034|560698186|FG013|Overall Study|Physician Decision|1|||
155345594|NCT02660034|560698173|FG000|Overall Study|Participants transferred to LTE|0|||
155345595|NCT02660034|560698174|FG001|Overall Study|Participants transferred to LTE|0|||
155345596|NCT02660034|560698175|FG002|Overall Study|Participants transferred to LTE|0|||
155345597|NCT02660034|560698176|FG003|Overall Study|Participants transferred to LTE|0|||
155345598|NCT02660034|560698177|FG004|Overall Study|Participants transferred to LTE|0|||
155345599|NCT02660034|560698178|FG005|Overall Study|Participants transferred to LTE|10|||
155345600|NCT02660034|560698179|FG006|Overall Study|Participants transferred to LTE|8|||
155345601|NCT02660034|560698180|FG007|Overall Study|Participants transferred to LTE|8|||
155345602|NCT02660034|560698181|FG008|Overall Study|Participants transferred to LTE|10|||
155345603|NCT02660034|560698182|FG009|Overall Study|Participants transferred to LTE|1|||
155345604|NCT02660034|560698183|FG010|Overall Study|Participants transferred to LTE|2|||
155345605|NCT02660034|560698184|FG011|Overall Study|Participants transferred to LTE|4|||
155345606|NCT02660034|560698185|FG012|Overall Study|Participants transferred to LTE|1|||
155345607|NCT02660034|560698186|FG013|Overall Study|Participants transferred to LTE|1|||
155345608|NCT01533181|560698189|FG000|Overall Study|Disease progression pre-active treatment|0|||
155345609|NCT01533181|560698190|FG001|Overall Study|Disease progression pre-active treatment|1|||
155345610|NCT01533181|560698189|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
155345611|NCT01533181|560698190|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
155345612|NCT02030847|560698191|FG000|Overall Study|Death|10|||
155345613|NCT02030847|560698191|FG000|Overall Study|Disease Progression|15|||
155345614|NCT02030847|560698191|FG000|Overall Study|New Cancer Therapy|8|||
155345615|NCT02030847|560698191|FG000|Overall Study|Physician Decision|3|||
155345616|NCT02030847|560698191|FG000|Overall Study|Withdrawal by Subject|1|||
155345617|NCT01703988|560698192|FG000|Overall Study|Investigator Judgment|0|||
155345618|NCT01703988|560698193|FG001|Overall Study|Investigator Judgment|0|||
155345619|NCT01703988|560698194|FG002|Overall Study|Investigator Judgment|0|||
155345620|NCT01703988|560698195|FG003|Overall Study|Investigator Judgment|1|||
155345621|NCT02995733|560698196|FG000|Overall Study|Study site closed|9|||
155345622|NCT02995733|560698197|FG001|Overall Study|Study site closed|10|||
155345623|NCT02995733|560698196|FG000|Overall Study|Death|3|||
155345624|NCT02995733|560698197|FG001|Overall Study|Death|4|||
155345625|NCT02995733|560698196|FG000|Overall Study|Withdrawal by Subject|6|||
155345626|NCT02995733|560698197|FG001|Overall Study|Withdrawal by Subject|2|||
155345627|NCT02995733|560698196|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
155345628|NCT02995733|560698197|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
155345629|NCT02995733|560698196|FG000|Overall Study|Lost to Follow-up|48|||
155345630|NCT02995733|560698197|FG001|Overall Study|Lost to Follow-up|37|||
155345631|NCT02995733|560698196|FG000|Overall Study|Other|0|||
155345632|NCT02995733|560698197|FG001|Overall Study|Other|1|||
155345633|NCT02720198|560698200|FG000|Overall Study|Withdrawal by Subject|0|||
155345634|NCT02720198|560698201|FG001|Overall Study|Withdrawal by Subject|1|||
155345635|NCT04879823|560698202|FG000|Overall Study|Physician Decision|3|||
155345636|NCT04879823|560698203|FG001|Overall Study|Physician Decision|1|||
155345637|NCT04879823|560698202|FG000|Overall Study|Protocol Violation|2|||
155345638|NCT04879823|560698203|FG001|Overall Study|Protocol Violation|3|||
155345639|NCT04879823|560698202|FG000|Overall Study|Lost to Follow-up|43|||
155345640|NCT04879823|560698203|FG001|Overall Study|Lost to Follow-up|35|||
155345641|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
155345642|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
155345643|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
155345644|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
155345645|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
155345646|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
155345647|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Other|3|||
155345648|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Other|0|||
155345649|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Other|0|||
155345650|NCT02592434|560698206|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
155345651|NCT02592434|560698207|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
155345652|NCT02592434|560698208|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
155345653|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
155345654|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
155345655|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
155345656|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
155345657|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
155345658|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
155345659|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Other|0|||
155345660|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Other|1|||
155345661|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Other|0|||
155345662|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
155345663|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
155345664|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
155345665|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
155345666|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
155345667|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
155345668|NCT02592434|560698206|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
155345669|NCT02592434|560698207|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
155345670|NCT02592434|560698208|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
155345671|NCT00472199|560698209|FG000|Overall Study|Adverse Event|19|||
155345672|NCT00472199|560698210|FG001|Overall Study|Adverse Event|23|||
155345673|NCT00472199|560698209|FG000|Overall Study|Lack of Efficacy|4|||
155345674|NCT00472199|560698210|FG001|Overall Study|Lack of Efficacy|25|||
155345675|NCT00472199|560698209|FG000|Overall Study|Lost to Follow-up|2|||
155345676|NCT00472199|560698210|FG001|Overall Study|Lost to Follow-up|4|||
155345677|NCT00472199|560698209|FG000|Overall Study|Protocol Violation|3|||
155345678|NCT00472199|560698210|FG001|Overall Study|Protocol Violation|2|||
155345679|NCT00472199|560698209|FG000|Overall Study|Withdrawal by Subject|6|||
155345680|NCT00472199|560698210|FG001|Overall Study|Withdrawal by Subject|5|||
155345681|NCT00472199|560698209|FG000|Overall Study|personal reason|0|||
155345682|NCT00472199|560698210|FG001|Overall Study|personal reason|1|||
155345683|NCT00472199|560698209|FG000|Overall Study|patient was asymptomatic|1|||
155345684|NCT00472199|560698210|FG001|Overall Study|patient was asymptomatic|0|||
155345685|NCT01106586|560698212|FG000|Overall Study|Adverse Event|9|||
155345686|NCT01106586|560698213|FG001|Overall Study|Adverse Event|15|||
155345687|NCT01106586|560698212|FG000|Overall Study|Death|1|||
155345688|NCT01106586|560698213|FG001|Overall Study|Death|3|||
155345689|NCT01106586|560698212|FG000|Overall Study|Pregnancy|2|||
155345690|NCT01106586|560698213|FG001|Overall Study|Pregnancy|2|||
155345691|NCT01106586|560698212|FG000|Overall Study|Lack of Efficacy|1|||
155345692|NCT01106586|560698213|FG001|Overall Study|Lack of Efficacy|0|||
155345693|NCT01106586|560698212|FG000|Overall Study|Investigator's Discretion|5|||
155345694|NCT01106586|560698213|FG001|Overall Study|Investigator's Discretion|8|||
155345695|NCT01106586|560698212|FG000|Overall Study|Withdrew Consent|18|||
155345696|NCT01106586|560698213|FG001|Overall Study|Withdrew Consent|30|||
155345697|NCT01106586|560698212|FG000|Overall Study|Lost to Follow-up|24|||
155345698|NCT01106586|560698213|FG001|Overall Study|Lost to Follow-up|20|||
155345699|NCT01106586|560698212|FG000|Overall Study|Participant Noncompliance|12|||
155345700|NCT01106586|560698213|FG001|Overall Study|Participant Noncompliance|10|||
155345701|NCT01106586|560698212|FG000|Overall Study|Protocol Violation|1|||
155345702|NCT01106586|560698213|FG001|Overall Study|Protocol Violation|0|||
155345703|NCT01106586|560698212|FG000|Overall Study|Participant Transferred to Another Study|212|||
155345704|NCT01106586|560698213|FG001|Overall Study|Participant Transferred to Another Study|197|||
155345705|NCT00105521|560698214|FG000|Overall Study|Other|1|||
155345706|NCT00105521|560698215|FG001|Overall Study|Other|1|||
155345707|NCT00105521|560698216|FG002|Overall Study|Other|2|||
155345708|NCT00105521|560698217|FG003|Overall Study|Other|0|||
155345709|NCT00105521|560698214|FG000|Overall Study|Adverse Event|10|||
155345710|NCT00105521|560698215|FG001|Overall Study|Adverse Event|4|||
155345711|NCT00105521|560698216|FG002|Overall Study|Adverse Event|10|||
155345712|NCT00105521|560698217|FG003|Overall Study|Adverse Event|8|||
155345713|NCT00105521|560698214|FG000|Overall Study|Withdrawal by Subject|1|||
155345714|NCT00105521|560698215|FG001|Overall Study|Withdrawal by Subject|0|||
155345715|NCT00105521|560698216|FG002|Overall Study|Withdrawal by Subject|1|||
155345716|NCT00105521|560698217|FG003|Overall Study|Withdrawal by Subject|4|||
155345717|NCT00105521|560698214|FG000|Overall Study|Lack of Efficacy|0|||
155345718|NCT00105521|560698215|FG001|Overall Study|Lack of Efficacy|0|||
155345719|NCT00105521|560698216|FG002|Overall Study|Lack of Efficacy|0|||
155345720|NCT00105521|560698217|FG003|Overall Study|Lack of Efficacy|1|||
155345721|NCT00105521|560698214|FG000|Overall Study|Protocol Violation|3|||
155345722|NCT00105521|560698215|FG001|Overall Study|Protocol Violation|5|||
155345723|NCT00105521|560698216|FG002|Overall Study|Protocol Violation|4|||
155345724|NCT00105521|560698217|FG003|Overall Study|Protocol Violation|4|||
155345725|NCT00105521|560698214|FG000|Overall Study|Lost to Follow-up|0|||
155345726|NCT00105521|560698215|FG001|Overall Study|Lost to Follow-up|1|||
155345727|NCT00105521|560698216|FG002|Overall Study|Lost to Follow-up|0|||
155345728|NCT00105521|560698217|FG003|Overall Study|Lost to Follow-up|0|||
155345729|NCT01622088|560698222|FG000|Overall Study|Adverse Event|20|||
155345730|NCT01622088|560698222|FG000|Overall Study|Lost to Follow-up|1|||
155345731|NCT01622088|560698222|FG000|Overall Study|Withdrawal by Subject|20|||
155345732|NCT01622088|560698222|FG000|Overall Study|Investigator Decision|1|||
155345733|NCT01622088|560698222|FG000|Overall Study|Death|53|||
155345734|NCT01622088|560698222|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
155345735|NCT01721109|560698228|FG000|Overall Study|Lack of Efficacy|1|||
155345736|NCT01721109|560698228|FG000|Overall Study|Non- Compliance with Study Drug|3|||
155345737|NCT01721109|560698228|FG000|Overall Study|Withdrew Consent|1|||
155345738|NCT01721109|560698228|FG000|Overall Study|Lost to Follow-up|2|||
155345739|NCT03045302|560698229|FG000|Overall Study|Pre-treatment adverse event|1|||
155345740|NCT00134056|560698230|FG000|Randomization|Not eligible for assigned treatment|22|||
155345741|NCT00134056|560698231|FG001|Randomization|Not eligible for assigned treatment|20|||
155345742|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
155345743|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
155345744|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
155345745|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
155345746|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
155345747|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
155345748|NCT00134056|560698230|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
155345749|NCT00134056|560698231|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
155345750|NCT00742560|560698233|FG000|Overall Study|Adverse Event|0|||
155345751|NCT00742560|560698234|FG001|Overall Study|Adverse Event|0|||
155345752|NCT00742560|560698235|FG002|Overall Study|Adverse Event|1|||
155345753|NCT00742560|560698236|FG003|Overall Study|Adverse Event|1|||
155345754|NCT00742560|560698237|FG004|Overall Study|Adverse Event|1|||
155345755|NCT00742560|560698233|FG000|Overall Study|Death|0|||
155345756|NCT00742560|560698234|FG001|Overall Study|Death|2|||
155345757|NCT00742560|560698235|FG002|Overall Study|Death|0|||
155345758|NCT00742560|560698236|FG003|Overall Study|Death|2|||
155345759|NCT00742560|560698237|FG004|Overall Study|Death|3|||
155345760|NCT00742560|560698233|FG000|Overall Study|Subject's Decision|1|||
155345761|NCT00742560|560698234|FG001|Overall Study|Subject's Decision|0|||
155345762|NCT00742560|560698235|FG002|Overall Study|Subject's Decision|2|||
155345763|NCT00742560|560698236|FG003|Overall Study|Subject's Decision|3|||
155345764|NCT00742560|560698237|FG004|Overall Study|Subject's Decision|3|||
155345765|NCT00742560|560698233|FG000|Overall Study|Investigator's Decision|0|||
155345766|NCT00742560|560698234|FG001|Overall Study|Investigator's Decision|0|||
155345767|NCT00742560|560698235|FG002|Overall Study|Investigator's Decision|4|||
155345768|NCT00742560|560698236|FG003|Overall Study|Investigator's Decision|1|||
155345769|NCT00742560|560698237|FG004|Overall Study|Investigator's Decision|0|||
155345770|NCT00742560|560698233|FG000|Overall Study|Disease Progression|1|||
155345771|NCT00742560|560698234|FG001|Overall Study|Disease Progression|0|||
155345772|NCT00742560|560698235|FG002|Overall Study|Disease Progression|5|||
155345773|NCT00742560|560698236|FG003|Overall Study|Disease Progression|17|||
155345774|NCT00742560|560698237|FG004|Overall Study|Disease Progression|16|||
155345775|NCT00742560|560698233|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
155345776|NCT00742560|560698234|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
155345777|NCT00742560|560698235|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
155345778|NCT00742560|560698236|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
155345779|NCT00742560|560698237|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
155345780|NCT00742560|560698233|FG000|Overall Study|Other|0|||
155345781|NCT00742560|560698234|FG001|Overall Study|Other|1|||
155345782|NCT00742560|560698235|FG002|Overall Study|Other|8|||
155345783|NCT00742560|560698236|FG003|Overall Study|Other|9|||
155345784|NCT00742560|560698237|FG004|Overall Study|Other|9|||
155345785|NCT00742560|560698233|FG000|Overall Study|MIssing|0|||
155345786|NCT00742560|560698234|FG001|Overall Study|MIssing|0|||
155345787|NCT00742560|560698235|FG002|Overall Study|MIssing|0|||
155345788|NCT00742560|560698236|FG003|Overall Study|MIssing|0|||
155345789|NCT00742560|560698237|FG004|Overall Study|MIssing|1|||
155345790|NCT01536795|560698238|FG000|Overall Study|Lost to Follow-up|0|||
155345791|NCT01536795|560698239|FG001|Overall Study|Lost to Follow-up|2|||
155345792|NCT01536795|560698238|FG000|Overall Study|Lack of Efficacy|1|||
155345793|NCT01536795|560698239|FG001|Overall Study|Lack of Efficacy|0|||
155345794|NCT01812837|560698240|FG000|Overall Study|Lost to Follow-up|1|||
155345795|NCT01812837|560698241|FG001|Overall Study|Lost to Follow-up|1|||
155345796|NCT01812837|560698242|FG002|Overall Study|Lost to Follow-up|0|||
155345797|NCT01812837|560698240|FG000|Overall Study|Protocol Violation|1|||
155345798|NCT01812837|560698241|FG001|Overall Study|Protocol Violation|0|||
155345799|NCT01812837|560698242|FG002|Overall Study|Protocol Violation|0|||
155345800|NCT05008224|560698243|FG000|Overall Study|Death|3|||
155345801|NCT05008224|560698243|FG000|Overall Study|Lost to Follow-up|2|||
155345802|NCT05008224|560698243|FG000|Overall Study|Did Not Continue on Extension Study|39|||
155345803|NCT05008224|560698243|FG000|Overall Study|Transferred to Extension Study|100|||
155345804|NCT05008224|560698243|FG000|Overall Study|Withdrawal by Subject|2|||
155345805|NCT04598776|560698244|FG000|Overall Study|Protocol Violation|5|||
155345806|NCT04598776|560698244|FG000|Overall Study|Physician Decision|4|||
155345807|NCT00348283|560698245|FG000|Induction|Adverse Event|0|||
155345808|NCT00348283|560698246|FG001|Induction|Adverse Event|2|||
155345809|NCT00348283|560698245|FG000|Induction|Protocol Violation|0|||
155345810|NCT00348283|560698246|FG001|Induction|Protocol Violation|4|||
155345811|NCT00348283|560698245|FG000|Double Blind|Adverse Event|2|||
155345812|NCT00348283|560698246|FG001|Double Blind|Adverse Event|5|||
155345813|NCT00348283|560698245|FG000|Double Blind|Withdrawal by Subject|1|||
155345814|NCT00348283|560698246|FG001|Double Blind|Withdrawal by Subject|1|||
155345815|NCT00348283|560698245|FG000|Double Blind|Protocol Violation|0|||
155345816|NCT00348283|560698246|FG001|Double Blind|Protocol Violation|1|||
155345817|NCT00348283|560698245|FG000|Double Blind|Lack of Efficacy|2|||
155345818|NCT00348283|560698246|FG001|Double Blind|Lack of Efficacy|2|||
155345819|NCT00348283|560698245|FG000|Double Blind|Pregnancy|0|||
155345820|NCT00348283|560698246|FG001|Double Blind|Pregnancy|1|||
155345821|NCT00348283|560698245|FG000|Open Label|Adverse Event|0|||
155345822|NCT00348283|560698246|FG001|Open Label|Adverse Event|8|||
155345823|NCT00348283|560698245|FG000|Open Label|Withdrawal by Subject|0|||
155345824|NCT00348283|560698246|FG001|Open Label|Withdrawal by Subject|4|||
155345825|NCT00348283|560698245|FG000|Open Label|Lost to Follow-up|0|||
155345826|NCT00348283|560698246|FG001|Open Label|Lost to Follow-up|1|||
155345827|NCT00348283|560698245|FG000|Open Label|Lack of Efficacy|0|||
155345828|NCT00348283|560698246|FG001|Open Label|Lack of Efficacy|13|||
155345829|NCT00348283|560698245|FG000|Open Label|Administrative reasons|0|||
155345830|NCT00348283|560698246|FG001|Open Label|Administrative reasons|5|||
155345831|NCT00348283|560698245|FG000|Open Label|Subject moved to the United States|0|||
155345832|NCT00348283|560698246|FG001|Open Label|Subject moved to the United States|1|||
155345833|NCT00348283|560698245|FG000|Open Label|Pregnancy|0|||
155345834|NCT00348283|560698246|FG001|Open Label|Pregnancy|1|||
155345835|NCT00348283|560698245|FG000|Open Label|Sponsor decision|0|||
155345836|NCT00348283|560698246|FG001|Open Label|Sponsor decision|1|||
155345837|NCT02282761|560698249|FG000|Overall Study|Death|0|||
155345838|NCT02282761|560698250|FG001|Overall Study|Death|0|||
155345839|NCT02282761|560698251|FG002|Overall Study|Death|1|||
155345840|NCT02282761|560698249|FG000|Overall Study|Adverse Event|6|||
155345841|NCT02282761|560698250|FG001|Overall Study|Adverse Event|2|||
155345842|NCT02282761|560698251|FG002|Overall Study|Adverse Event|0|||
155345843|NCT02282761|560698249|FG000|Overall Study|Lack of Efficacy|11|||
155345844|NCT02282761|560698250|FG001|Overall Study|Lack of Efficacy|6|||
155345845|NCT02282761|560698251|FG002|Overall Study|Lack of Efficacy|17|||
155345846|NCT02282761|560698249|FG000|Overall Study|Lost to Follow-up|2|||
155345847|NCT02282761|560698250|FG001|Overall Study|Lost to Follow-up|2|||
155345848|NCT02282761|560698251|FG002|Overall Study|Lost to Follow-up|1|||
155345849|NCT02282761|560698249|FG000|Overall Study|Physician Decision|0|||
155345850|NCT02282761|560698250|FG001|Overall Study|Physician Decision|0|||
155345851|NCT02282761|560698251|FG002|Overall Study|Physician Decision|2|||
155345852|NCT02282761|560698249|FG000|Overall Study|Withdrawal by Subject|8|||
155345853|NCT02282761|560698250|FG001|Overall Study|Withdrawal by Subject|10|||
155345854|NCT02282761|560698251|FG002|Overall Study|Withdrawal by Subject|16|||
155345855|NCT02282761|560698249|FG000|Overall Study|Other|3|||
155345856|NCT02282761|560698250|FG001|Overall Study|Other|2|||
155080552|NCT03302936|559725386|FG001|Overall Study|Protocol Violation|4|||
155080553|NCT01379937|559725387|FG000|Overall Study|Protocol Violation|0|||
155345857|NCT02282761|560698251|FG002|Overall Study|Other|1|||
155080554|NCT01379937|559725388|FG001|Overall Study|Protocol Violation|0|||
154963951|NCT03215706|559293504|FG001|Randomization|Adverse Event unrelated to study drug|0|||
155080555|NCT01379937|559725389|FG002|Overall Study|Protocol Violation|0|||
155345858|NCT02632045|560698254|FG000|Overall Study|Withdrawal by Subject|1|||
155345859|NCT02632045|560698255|FG001|Overall Study|Withdrawal by Subject|2|||
155345860|NCT05878522|560698256|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345861|NCT05878522|560698257|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155080556|NCT01379937|559725390|FG003|Overall Study|Protocol Violation|1|||
155345862|NCT05878522|560698258|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345863|NCT05878522|560698259|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345864|NCT05878522|560698260|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345865|NCT05878522|560698261|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345866|NCT05878522|560698262|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345867|NCT05878522|560698263|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345868|NCT05878522|560698264|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
155345869|NCT05878522|560698265|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345870|NCT05878522|560698266|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345871|NCT05878522|560698267|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
155345872|NCT05878522|560698256|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
155345873|NCT05878522|560698257|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345874|NCT05878522|560698258|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345875|NCT05878522|560698259|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345876|NCT05878522|560698260|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345877|NCT05878522|560698261|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345878|NCT05878522|560698262|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345879|NCT05878522|560698263|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345880|NCT05878522|560698264|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345881|NCT05878522|560698265|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
155345882|NCT05878522|560698266|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345883|NCT05878522|560698267|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
155345884|NCT05878522|560698256|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345885|NCT05878522|560698257|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
155345886|NCT05878522|560698258|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345887|NCT05878522|560698259|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
155345888|NCT05878522|560698260|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345889|NCT05878522|560698261|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345890|NCT05878522|560698262|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345891|NCT05878522|560698263|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345892|NCT05878522|560698264|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345893|NCT05878522|560698265|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345894|NCT05878522|560698266|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345895|NCT05878522|560698267|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
155345896|NCT05878522|560698256|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345897|NCT05878522|560698257|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345898|NCT05878522|560698258|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345899|NCT05878522|560698259|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345900|NCT05878522|560698260|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
155345901|NCT05878522|560698261|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345902|NCT05878522|560698262|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345903|NCT05878522|560698263|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345904|NCT05878522|560698264|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345905|NCT05878522|560698265|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345906|NCT05878522|560698266|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345907|NCT05878522|560698267|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
155345908|NCT05216835|560698268|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345909|NCT05216835|560698269|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345910|NCT05216835|560698270|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345911|NCT05216835|560698271|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
155345912|NCT05216835|560698272|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
155345913|NCT05216835|560698273|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
155345914|NCT05216835|560698274|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
155345915|NCT05216835|560698275|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
155345916|NCT05216835|560698268|FG000|Overall Study|Death|0|||
155345917|NCT05216835|560698269|FG001|Overall Study|Death|0|||
155345918|NCT05216835|560698270|FG002|Overall Study|Death|0|||
155345919|NCT05216835|560698271|FG003|Overall Study|Death|1|||
155345920|NCT05216835|560698272|FG004|Overall Study|Death|1|||
155345921|NCT05216835|560698273|FG005|Overall Study|Death|1|||
155345922|NCT05216835|560698274|FG006|Overall Study|Death|1|||
155345923|NCT05216835|560698275|FG007|Overall Study|Death|1|||
155345924|NCT05216835|560698268|FG000|Overall Study|Physician Decision|0|||
155345925|NCT05216835|560698269|FG001|Overall Study|Physician Decision|0|||
155345926|NCT05216835|560698270|FG002|Overall Study|Physician Decision|0|||
155345927|NCT05216835|560698271|FG003|Overall Study|Physician Decision|0|||
155345928|NCT05216835|560698272|FG004|Overall Study|Physician Decision|0|||
155345929|NCT05216835|560698273|FG005|Overall Study|Physician Decision|1|||
155345930|NCT05216835|560698274|FG006|Overall Study|Physician Decision|1|||
155345931|NCT05216835|560698275|FG007|Overall Study|Physician Decision|0|||
155345932|NCT05216835|560698268|FG000|Overall Study|Study terminated by Sponsor|0|||
155345933|NCT05216835|560698269|FG001|Overall Study|Study terminated by Sponsor|0|||
155345934|NCT05216835|560698270|FG002|Overall Study|Study terminated by Sponsor|0|||
155345935|NCT05216835|560698271|FG003|Overall Study|Study terminated by Sponsor|0|||
155345936|NCT05216835|560698272|FG004|Overall Study|Study terminated by Sponsor|0|||
155345937|NCT05216835|560698273|FG005|Overall Study|Study terminated by Sponsor|0|||
155345938|NCT05216835|560698274|FG006|Overall Study|Study terminated by Sponsor|0|||
155345939|NCT05216835|560698275|FG007|Overall Study|Study terminated by Sponsor|1|||
155345940|NCT05216835|560698268|FG000|Overall Study|Withdrawal by Subject|1|||
155345941|NCT05216835|560698269|FG001|Overall Study|Withdrawal by Subject|0|||
155345942|NCT05216835|560698270|FG002|Overall Study|Withdrawal by Subject|1|||
155345943|NCT05216835|560698271|FG003|Overall Study|Withdrawal by Subject|0|||
155345944|NCT05216835|560698272|FG004|Overall Study|Withdrawal by Subject|1|||
155345945|NCT05216835|560698273|FG005|Overall Study|Withdrawal by Subject|0|||
155345946|NCT05216835|560698274|FG006|Overall Study|Withdrawal by Subject|0|||
155345947|NCT05216835|560698275|FG007|Overall Study|Withdrawal by Subject|1|||
155345948|NCT05216835|560698268|FG000|Overall Study|Other|0|||
155345949|NCT05216835|560698269|FG001|Overall Study|Other|1|||
155345950|NCT05216835|560698270|FG002|Overall Study|Other|0|||
155345951|NCT05216835|560698271|FG003|Overall Study|Other|0|||
155345952|NCT05216835|560698272|FG004|Overall Study|Other|0|||
155345953|NCT05216835|560698273|FG005|Overall Study|Other|0|||
155345954|NCT05216835|560698274|FG006|Overall Study|Other|0|||
155345955|NCT05216835|560698275|FG007|Overall Study|Other|0|||
155345956|NCT03861078|560698276|FG000|Overall Study|COVID-19 shut down|4|||
155345957|NCT03861078|560698276|FG000|Overall Study|Lost to Follow-up|1|||
155345958|NCT03861078|560698276|FG000|Overall Study|Protocol Violation|2|||
155345959|NCT03861078|560698276|FG000|Overall Study|lack of venous access|1|||
155345960|NCT01075815|560698277|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
155345961|NCT01075815|560698278|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
155345962|NCT01075815|560698277|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
155345963|NCT01075815|560698278|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
155345964|NCT01075815|560698277|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
155345965|NCT01075815|560698278|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
155345966|NCT00617708|560698279|FG000|Overall Study|Adverse Event|0|||
155345967|NCT00617708|560698280|FG001|Overall Study|Adverse Event|6|||
155345968|NCT00617708|560698281|FG002|Overall Study|Adverse Event|9|||
155345969|NCT00617708|560698279|FG000|Overall Study|Withdrawal by Subject|1|||
155345970|NCT00617708|560698280|FG001|Overall Study|Withdrawal by Subject|1|||
155345971|NCT00617708|560698281|FG002|Overall Study|Withdrawal by Subject|7|||
155345972|NCT00617708|560698279|FG000|Overall Study|Death|0|||
155345973|NCT00617708|560698280|FG001|Overall Study|Death|6|||
155345974|NCT00617708|560698281|FG002|Overall Study|Death|5|||
155345975|NCT00617708|560698279|FG000|Overall Study|Progression/Relapse|7|||
155345976|NCT00617708|560698280|FG001|Overall Study|Progression/Relapse|40|||
155345977|NCT00617708|560698281|FG002|Overall Study|Progression/Relapse|36|||
155345978|NCT00617708|560698279|FG000|Overall Study|Not protocol specified|1|||
155345979|NCT00617708|560698280|FG001|Overall Study|Not protocol specified|4|||
155345980|NCT00617708|560698281|FG002|Overall Study|Not protocol specified|2|||
155345981|NCT00617708|560698279|FG000|Overall Study|Not eligible|1|||
155345982|NCT00617708|560698280|FG001|Overall Study|Not eligible|3|||
155345983|NCT00617708|560698281|FG002|Overall Study|Not eligible|5|||
155345984|NCT02058992|560698282|FG000|Overall Study|Lost to Follow-up|4|||
155345985|NCT02058992|560698282|FG000|Overall Study|Protocol Violation|92|||
155345986|NCT02058992|560698282|FG000|Overall Study|CRF Uncollected|20|||
155345987|NCT02991456|560698283|FG000|Overall Study|Adverse Event|2|||
155345988|NCT02991456|560698284|FG001|Overall Study|Adverse Event|0|||
155345989|NCT02991456|560698283|FG000|Overall Study|Lost to Follow-up|0|||
155345990|NCT02991456|560698284|FG001|Overall Study|Lost to Follow-up|2|||
155345991|NCT02991456|560698283|FG000|Overall Study|Withdrawal by Subject|1|||
155345992|NCT02991456|560698284|FG001|Overall Study|Withdrawal by Subject|0|||
155345993|NCT03747575|560698285|FG000|Overall Study|Withdrawal by Subject|6|||
155345994|NCT03747575|560698286|FG001|Overall Study|Withdrawal by Subject|3|||
155345995|NCT03747575|560698285|FG000|Overall Study|Lost to Follow-up|3|||
155345996|NCT03747575|560698286|FG001|Overall Study|Lost to Follow-up|3|||
155345997|NCT03747575|560698285|FG000|Overall Study|Adverse Event|0|||
155345998|NCT03747575|560698286|FG001|Overall Study|Adverse Event|1|||
155345999|NCT00936065|560698291|FG000|Overall Study|Adverse Event|1|||
155346000|NCT00936065|560698292|FG001|Overall Study|Adverse Event|0|||
155346001|NCT00936065|560698293|FG002|Overall Study|Adverse Event|1|||
155346002|NCT00936065|560698291|FG000|Overall Study|Lack of Efficacy|1|||
155346003|NCT00936065|560698292|FG001|Overall Study|Lack of Efficacy|0|||
155346004|NCT00936065|560698293|FG002|Overall Study|Lack of Efficacy|1|||
155346005|NCT00936065|560698291|FG000|Overall Study|Lost to Follow-up|1|||
155346006|NCT00936065|560698292|FG001|Overall Study|Lost to Follow-up|0|||
155346007|NCT00936065|560698293|FG002|Overall Study|Lost to Follow-up|0|||
155346008|NCT00936065|560698291|FG000|Overall Study|Protocol Violation|1|||
155346009|NCT00936065|560698292|FG001|Overall Study|Protocol Violation|2|||
155346010|NCT00936065|560698293|FG002|Overall Study|Protocol Violation|1|||
155346011|NCT00936065|560698291|FG000|Overall Study|Withdrawal by Subject|0|||
155346012|NCT00936065|560698292|FG001|Overall Study|Withdrawal by Subject|2|||
155346013|NCT00936065|560698293|FG002|Overall Study|Withdrawal by Subject|4|||
155346014|NCT01549951|560698296|FG000|Overall Study|Adverse Event|15|||
155346015|NCT01549951|560698296|FG000|Overall Study|Withdrawal by Subject|2|||
155346016|NCT01549951|560698296|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
155346017|NCT01549951|560698296|FG000|Overall Study|Progressive disease|29|||
155346018|NCT01549951|560698296|FG000|Overall Study|Symptomatic deterioration|1|||
155346019|NCT01549951|560698296|FG000|Overall Study|Other|2|||
155346020|NCT00990314|560698297|FG000|Overall Study|Death|2|||
155346021|NCT00990314|560698297|FG000|Overall Study|Adverse Event|2|||
155346022|NCT00990314|560698297|FG000|Overall Study|Withdrawal by Subject|3|||
155346023|NCT00990314|560698297|FG000|Overall Study|Non-Compliance|1|||
155346024|NCT00990314|560698297|FG000|Overall Study|Physician Decision|3|||
155346025|NCT00990314|560698297|FG000|Overall Study|Lack of Efficacy|1|||
155346026|NCT02819141|560698300|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
155346027|NCT02819141|560698301|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
155346028|NCT00705614|560699579|FG000|Initial Intervention|Adverse Event|40|||
155346029|NCT00705614|560699580|FG001|Initial Intervention|Adverse Event|21|||
155346030|NCT00705614|560699579|FG000|Initial Intervention|Lost to Follow-up|310|||
155346031|NCT00705614|560699580|FG001|Initial Intervention|Lost to Follow-up|191|||
155346032|NCT00705614|560699579|FG000|Initial Intervention|Withdrawal by Subject|114|||
155346033|NCT00705614|560699580|FG001|Initial Intervention|Withdrawal by Subject|71|||
155346034|NCT00705614|560699579|FG000|Initial Intervention|Administrative Reason|51|||
155346035|NCT00705614|560699580|FG001|Initial Intervention|Administrative Reason|38|||
155346036|NCT00705614|560699579|FG000|Initial Intervention|Status completion unknown|3|||
155346037|NCT00705614|560699580|FG001|Initial Intervention|Status completion unknown|0|||
155346038|NCT00705614|560699579|FG000|Switch to Remicade|Adverse Event|0|||
155346039|NCT00705614|560699580|FG001|Switch to Remicade|Adverse Event|5|||
155346040|NCT00705614|560699579|FG000|Switch to Remicade|Lost to Follow-up|0|||
155346041|NCT00705614|560699580|FG001|Switch to Remicade|Lost to Follow-up|23|||
155346042|NCT00705614|560699579|FG000|Switch to Remicade|Withdrawal by Subject|0|||
155346043|NCT00705614|560699580|FG001|Switch to Remicade|Withdrawal by Subject|12|||
155346044|NCT00705614|560699579|FG000|Switch to Remicade|Administrative Reason|0|||
155346045|NCT00705614|560699580|FG001|Switch to Remicade|Administrative Reason|9|||
155346046|NCT00088452|560699584|FG000|Overall Study|Did not receive intervention|1|||
155346047|NCT00088452|560699585|FG001|Overall Study|Did not receive intervention|0|||
155346048|NCT00088452|560699586|FG002|Overall Study|Did not receive intervention|1|||
155346049|NCT01184859|560699587|FG000|Period 1: Single Dose|Insufficient urine production|0|||
155346050|NCT01184859|560699588|FG001|Period 1: Single Dose|Insufficient urine production|1|||
155346051|NCT01184859|560699589|FG002|Period 1: Single Dose|Insufficient urine production|0|||
155346052|NCT01184859|560699590|FG003|Period 1: Single Dose|Insufficient urine production|0|||
155346053|NCT01184859|560699591|FG004|Period 1: Single Dose|Insufficient urine production|0|||
155346054|NCT01184859|560699587|FG000|Period 1: Single Dose|Protocol Violation|0|||
155346055|NCT01184859|560699588|FG001|Period 1: Single Dose|Protocol Violation|1|||
155346056|NCT01184859|560699589|FG002|Period 1: Single Dose|Protocol Violation|0|||
155346057|NCT01184859|560699590|FG003|Period 1: Single Dose|Protocol Violation|0|||
155346058|NCT01184859|560699591|FG004|Period 1: Single Dose|Protocol Violation|0|||
155346059|NCT01184859|560699587|FG000|Period 1: Single Dose|Adverse Event|0|||
155346060|NCT01184859|560699588|FG001|Period 1: Single Dose|Adverse Event|0|||
155346061|NCT01184859|560699589|FG002|Period 1: Single Dose|Adverse Event|0|||
155346062|NCT01184859|560699590|FG003|Period 1: Single Dose|Adverse Event|0|||
155346063|NCT01184859|560699591|FG004|Period 1: Single Dose|Adverse Event|1|||
155346064|NCT01184859|560699587|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346065|NCT01184859|560699588|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346066|NCT01184859|560699589|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346067|NCT01184859|560699590|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
155346068|NCT01184859|560699591|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
155346069|NCT01184859|560699587|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
155346070|NCT01184859|560699588|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155346071|NCT01184859|560699589|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155346072|NCT01184859|560699590|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155346073|NCT01184859|560699591|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
155346074|NCT02081196|560699593|FG000|Overall Study|Lost to Follow-up|1|||
155346075|NCT05335005|560699601|FG000|Overall Study|Lost to Follow-up|1|||
155346076|NCT04385849|560699604|FG000|Overall Study|Lost to Follow-up|1|||
155346077|NCT04385849|560699605|FG001|Overall Study|Lost to Follow-up|0|||
155346078|NCT01375777|560699606|FG000|Overall Study|Withdrawal by Subject|0|||
155346079|NCT01375777|560699607|FG001|Overall Study|Withdrawal by Subject|2|||
155346080|NCT01375777|560699608|FG002|Overall Study|Withdrawal by Subject|1|||
155346081|NCT01375777|560699609|FG003|Overall Study|Withdrawal by Subject|0|||
155346082|NCT01375777|560699610|FG004|Overall Study|Withdrawal by Subject|1|||
155346083|NCT01375777|560699611|FG005|Overall Study|Withdrawal by Subject|1|||
155346084|NCT01375777|560699612|FG006|Overall Study|Withdrawal by Subject|1|||
155346085|NCT01375777|560699613|FG007|Overall Study|Withdrawal by Subject|2|||
155346086|NCT01375777|560699614|FG008|Overall Study|Withdrawal by Subject|1|||
155346087|NCT01375777|560699606|FG000|Overall Study|Lost to Follow-up|1|||
155346088|NCT01375777|560699607|FG001|Overall Study|Lost to Follow-up|0|||
155346089|NCT01375777|560699608|FG002|Overall Study|Lost to Follow-up|0|||
155346090|NCT01375777|560699609|FG003|Overall Study|Lost to Follow-up|0|||
155346091|NCT01375777|560699610|FG004|Overall Study|Lost to Follow-up|0|||
155346092|NCT01375777|560699611|FG005|Overall Study|Lost to Follow-up|0|||
155346093|NCT01375777|560699612|FG006|Overall Study|Lost to Follow-up|1|||
155346094|NCT01375777|560699613|FG007|Overall Study|Lost to Follow-up|0|||
155346095|NCT01375777|560699614|FG008|Overall Study|Lost to Follow-up|0|||
155346096|NCT01375777|560699606|FG000|Overall Study|Other|1|||
155346097|NCT01375777|560699607|FG001|Overall Study|Other|1|||
155346098|NCT01375777|560699608|FG002|Overall Study|Other|0|||
155346099|NCT01375777|560699609|FG003|Overall Study|Other|0|||
155346100|NCT01375777|560699610|FG004|Overall Study|Other|0|||
155346101|NCT01375777|560699611|FG005|Overall Study|Other|0|||
155346102|NCT01375777|560699612|FG006|Overall Study|Other|0|||
155346103|NCT01375777|560699613|FG007|Overall Study|Other|0|||
155346104|NCT01375777|560699614|FG008|Overall Study|Other|1|||
155346105|NCT00355784|560699615|FG000|Overall Study|Withdrawal by Subject|0|||
155346106|NCT00355784|560699616|FG001|Overall Study|Withdrawal by Subject|0|||
155346107|NCT00355784|560699617|FG002|Overall Study|Withdrawal by Subject|2|||
155346108|NCT03034772|560699618|FG000|Overall Study|Adverse Event|0|||
155346109|NCT03034772|560699619|FG001|Overall Study|Adverse Event|1|||
155346110|NCT03034772|560699618|FG000|Overall Study|Withdrawal by Subject|0|||
155346111|NCT03034772|560699619|FG001|Overall Study|Withdrawal by Subject|1|||
155346112|NCT00730925|560699629|FG000|Overall Study|Progressive Disease|21|||
155346113|NCT00730925|560699629|FG000|Overall Study|Dose reducing Event|2|||
155346114|NCT00730925|560699629|FG000|Overall Study|Other Averse Event|7|||
155346115|NCT00730925|560699629|FG000|Overall Study|Protocol Violation|1|||
155346116|NCT00730925|560699629|FG000|Overall Study|Withdrawal by Subject|1|||
155346117|NCT00730925|560699629|FG000|Overall Study|Switch to combination therapy|8|||
155346118|NCT00730925|560699629|FG000|Overall Study|Other|1|||
155346119|NCT02137239|560699630|FG000|Overall Study|Discontinued Study Treatment|0|||
155346120|NCT02137239|560699631|FG001|Overall Study|Discontinued Study Treatment|3|||
155346121|NCT02137239|560699630|FG000|Overall Study|Withdrew Consent|1|||
155346122|NCT02137239|560699631|FG001|Overall Study|Withdrew Consent|1|||
155346123|NCT02137239|560699630|FG000|Overall Study|Adverse Event|2|||
155346124|NCT02137239|560699631|FG001|Overall Study|Adverse Event|2|||
155346125|NCT02446912|560699632|FG000|Overall Study|Adverse Event|3|||
155346126|NCT02446912|560699633|FG001|Overall Study|Adverse Event|13|||
155346127|NCT02446912|560699634|FG002|Overall Study|Adverse Event|5|||
155346128|NCT02446912|560699632|FG000|Overall Study|Condition under investigation worsened|0|||
155346129|NCT02446912|560699633|FG001|Overall Study|Condition under investigation worsened|1|||
155346130|NCT02446912|560699634|FG002|Overall Study|Condition under investigation worsened|1|||
155346131|NCT02446912|560699632|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155346132|NCT02446912|560699633|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155346133|NCT02446912|560699634|FG002|Overall Study|Study-specific withdrawal criteria|0|||
155346134|NCT02446912|560699632|FG000|Overall Study|Lack of Efficacy|1|||
155346135|NCT02446912|560699633|FG001|Overall Study|Lack of Efficacy|4|||
155346136|NCT02446912|560699634|FG002|Overall Study|Lack of Efficacy|7|||
155346137|NCT02446912|560699632|FG000|Overall Study|Lost to Follow-up|0|||
155346138|NCT02446912|560699633|FG001|Overall Study|Lost to Follow-up|0|||
155346139|NCT02446912|560699634|FG002|Overall Study|Lost to Follow-up|2|||
155346140|NCT02446912|560699632|FG000|Overall Study|Severe non-compliance to protocol|1|||
155346141|NCT02446912|560699633|FG001|Overall Study|Severe non-compliance to protocol|0|||
155346142|NCT02446912|560699634|FG002|Overall Study|Severe non-compliance to protocol|1|||
155346143|NCT02446912|560699632|FG000|Overall Study|Withdrawal by Subject|10|||
155346144|NCT02446912|560699633|FG001|Overall Study|Withdrawal by Subject|15|||
155346145|NCT02446912|560699634|FG002|Overall Study|Withdrawal by Subject|15|||
155346146|NCT02446912|560699632|FG000|Overall Study|Miscellaneous|2|||
155346147|NCT02446912|560699633|FG001|Overall Study|Miscellaneous|2|||
155346148|NCT02446912|560699634|FG002|Overall Study|Miscellaneous|4|||
155346149|NCT01757171|560699637|FG000|Overall Study|Adverse Event|5|||
155346150|NCT01757171|560699638|FG001|Overall Study|Adverse Event|1|||
155346151|NCT01757171|560699637|FG000|Overall Study|Disease Progression|1|||
155346152|NCT01757171|560699638|FG001|Overall Study|Disease Progression|0|||
155346153|NCT01757171|560699637|FG000|Overall Study|Hospitalization|1|||
155346154|NCT01757171|560699638|FG001|Overall Study|Hospitalization|0|||
155346155|NCT01757171|560699637|FG000|Overall Study|ECOG decline|1|||
155346156|NCT01757171|560699638|FG001|Overall Study|ECOG decline|0|||
155346157|NCT00385697|560699643|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
155346158|NCT00385697|560699644|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
155346159|NCT00385697|560699645|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
155346160|NCT00385697|560699646|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
155346161|NCT00385697|560699647|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
155346162|NCT00385697|560699643|FG000|Open-label Segment 1|Lost to Follow-up|1|||
155346163|NCT00385697|560699644|FG001|Open-label Segment 1|Lost to Follow-up|0|||
155346164|NCT00385697|560699645|FG002|Open-label Segment 1|Lost to Follow-up|0|||
155346165|NCT00385697|560699646|FG003|Open-label Segment 1|Lost to Follow-up|0|||
155346166|NCT00385697|560699647|FG004|Open-label Segment 1|Lost to Follow-up|0|||
155346167|NCT00385697|560699643|FG000|Double-blind Segment 2|Adverse Event|0|||
155346168|NCT00385697|560699644|FG001|Double-blind Segment 2|Adverse Event|3|||
155346169|NCT00385697|560699645|FG002|Double-blind Segment 2|Adverse Event|1|||
155346170|NCT00385697|560699646|FG003|Double-blind Segment 2|Adverse Event|0|||
155346171|NCT00385697|560699647|FG004|Double-blind Segment 2|Adverse Event|0|||
155346172|NCT00385697|560699643|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
155346173|NCT00385697|560699644|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
155346174|NCT00385697|560699645|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
155346175|NCT00385697|560699646|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
155346176|NCT00385697|560699647|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
155346177|NCT00385697|560699643|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
155346178|NCT00385697|560699644|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
155346179|NCT00385697|560699645|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
155346180|NCT00385697|560699646|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
155346181|NCT00385697|560699647|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
155346182|NCT00385697|560699643|FG000|Double-blind Segment 2|Other|0|||
155346183|NCT00385697|560699644|FG001|Double-blind Segment 2|Other|2|||
155346184|NCT00385697|560699645|FG002|Double-blind Segment 2|Other|0|||
155346185|NCT00385697|560699646|FG003|Double-blind Segment 2|Other|0|||
155346186|NCT00385697|560699647|FG004|Double-blind Segment 2|Other|0|||
155346187|NCT00442559|560699650|FG000|Overall Study|Lost to Follow-up|32|||
155346188|NCT00442559|560699651|FG001|Overall Study|Lost to Follow-up|34|||
155346189|NCT00442559|560699650|FG000|Overall Study|Protocol Violation|1|||
155346190|NCT00442559|560699651|FG001|Overall Study|Protocol Violation|1|||
155346191|NCT00442559|560699650|FG000|Overall Study|Withdrawal by Subject|1|||
155346192|NCT00442559|560699651|FG001|Overall Study|Withdrawal by Subject|0|||
155346193|NCT02305797|560699652|FG000|Overall Study|Adverse Event|11|||
155346194|NCT02305797|560699653|FG001|Overall Study|Adverse Event|2|||
155346195|NCT02305797|560699652|FG000|Overall Study|Withdrawal by Subject|9|||
155346196|NCT02305797|560699653|FG001|Overall Study|Withdrawal by Subject|10|||
155346197|NCT02305797|560699652|FG000|Overall Study|Lack of Efficacy|6|||
155346198|NCT02305797|560699653|FG001|Overall Study|Lack of Efficacy|0|||
155346199|NCT02305797|560699652|FG000|Overall Study|Lost to Follow-up|5|||
155346200|NCT02305797|560699653|FG001|Overall Study|Lost to Follow-up|11|||
155346201|NCT02305797|560699652|FG000|Overall Study|Pregnancy|0|||
155346202|NCT02305797|560699653|FG001|Overall Study|Pregnancy|2|||
155346203|NCT02305797|560699652|FG000|Overall Study|Noncompliance|14|||
155346204|NCT02305797|560699653|FG001|Overall Study|Noncompliance|12|||
155346205|NCT02305797|560699652|FG000|Overall Study|Reason not collected|0|||
155346206|NCT02305797|560699653|FG001|Overall Study|Reason not collected|1|||
155346207|NCT03906240|560699654|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
155346208|NCT03906240|560699655|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
155346209|NCT03906240|560699654|FG000|Overall Study|Lost to Follow-up|1|||
155346210|NCT03906240|560699655|FG001|Overall Study|Lost to Follow-up|0|||
155346211|NCT03906240|560699654|FG000|Overall Study|Withdrawal by Subject|0|||
155346212|NCT03906240|560699655|FG001|Overall Study|Withdrawal by Subject|1|||
155346213|NCT02267746|560699656|FG000|Overall Study|Adverse Event|0|||
155346214|NCT02267746|560699657|FG001|Overall Study|Adverse Event|2|||
155346215|NCT02267746|560699658|FG002|Overall Study|Adverse Event|1|||
155346216|NCT02267746|560699656|FG000|Overall Study|Protocol Violation|8|||
155346217|NCT02267746|560699657|FG001|Overall Study|Protocol Violation|7|||
155346218|NCT02267746|560699658|FG002|Overall Study|Protocol Violation|3|||
155346219|NCT02267746|560699656|FG000|Overall Study|Lack of Efficacy|11|||
155346220|NCT02267746|560699657|FG001|Overall Study|Lack of Efficacy|11|||
155346221|NCT02267746|560699658|FG002|Overall Study|Lack of Efficacy|15|||
155346222|NCT02267746|560699656|FG000|Overall Study|Protocol Violation|1|||
155346223|NCT02267746|560699657|FG001|Overall Study|Protocol Violation|2|||
155346224|NCT02267746|560699658|FG002|Overall Study|Protocol Violation|1|||
155346225|NCT02267746|560699656|FG000|Overall Study|Miscellaneous|1|||
155346226|NCT02267746|560699657|FG001|Overall Study|Miscellaneous|0|||
155346227|NCT02267746|560699658|FG002|Overall Study|Miscellaneous|1|||
155346228|NCT05234632|560699663|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
155346229|NCT05234632|560699664|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
155346230|NCT05234632|560699663|FG000|Overall Study|Withdrawal by Subject|2|||
155346231|NCT05234632|560699664|FG001|Overall Study|Withdrawal by Subject|0|||
155346232|NCT05234632|560699663|FG000|Overall Study|Adverse Event|0|||
155346233|NCT05234632|560699664|FG001|Overall Study|Adverse Event|4|||
155346234|NCT05234632|560699663|FG000|Overall Study|Physician Decision|1|||
155346235|NCT05234632|560699664|FG001|Overall Study|Physician Decision|1|||
155346236|NCT05234632|560699663|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
155346237|NCT05234632|560699664|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
155346238|NCT05234632|560699663|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
155346239|NCT05234632|560699664|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
155346240|NCT02849509|560699666|FG000|Overall Study|Worsening of disease under study|1|||
155346241|NCT02849509|560699667|FG001|Overall Study|Worsening of disease under study|1|||
155346242|NCT02849509|560699668|FG002|Overall Study|Worsening of disease under study|1|||
155346243|NCT02849509|560699666|FG000|Overall Study|Worsening of other pre-existing disease|0|||
155346244|NCT02849509|560699667|FG001|Overall Study|Worsening of other pre-existing disease|1|||
155346245|NCT02849509|560699668|FG002|Overall Study|Worsening of other pre-existing disease|2|||
155346246|NCT02849509|560699666|FG000|Overall Study|Other adverse event|36|||
155346247|NCT02849509|560699667|FG001|Overall Study|Other adverse event|41|||
155346248|NCT02849509|560699668|FG002|Overall Study|Other adverse event|8|||
155346249|NCT02849509|560699666|FG000|Overall Study|Withdrawal by Subject|6|||
155346250|NCT02849509|560699667|FG001|Overall Study|Withdrawal by Subject|17|||
155346251|NCT02849509|560699668|FG002|Overall Study|Withdrawal by Subject|12|||
155346252|NCT02849509|560699666|FG000|Overall Study|Lost to Follow-up|27|||
155346253|NCT02849509|560699667|FG001|Overall Study|Lost to Follow-up|67|||
155346254|NCT02849509|560699668|FG002|Overall Study|Lost to Follow-up|36|||
155346255|NCT02849509|560699666|FG000|Overall Study|Other, reason not specified|14|||
155346256|NCT02849509|560699667|FG001|Overall Study|Other, reason not specified|29|||
155346257|NCT02849509|560699668|FG002|Overall Study|Other, reason not specified|25|||
155346258|NCT02849509|560699666|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
155346259|NCT02849509|560699667|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
155346260|NCT02849509|560699668|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
155346261|NCT02924051|560699675|FG000|Overall Study|Withdrawal by Subject|1|||
155346262|NCT02924051|560699676|FG001|Overall Study|Withdrawal by Subject|9|||
155346263|NCT05615870|560699677|FG000|Overall Study|Lost to Follow-up|10|||
155346264|NCT05615870|560699678|FG001|Overall Study|Lost to Follow-up|13|||
155346265|NCT05615870|560699677|FG000|Overall Study|Physician Decision|2|||
155346266|NCT05615870|560699678|FG001|Overall Study|Physician Decision|0|||
155346267|NCT05615870|560699677|FG000|Overall Study|Withdrawal by Subject|0|||
155346268|NCT05615870|560699678|FG001|Overall Study|Withdrawal by Subject|2|||
155346269|NCT05615870|560699677|FG000|Overall Study|Protocol Violation|0|||
155346270|NCT05615870|560699678|FG001|Overall Study|Protocol Violation|3|||
155346271|NCT05615870|560699677|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
155346272|NCT05615870|560699678|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
155346273|NCT05615870|560699677|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
155346274|NCT05615870|560699678|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
155346275|NCT05615870|560699677|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
155346276|NCT05615870|560699678|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
155346277|NCT02130401|560699679|FG000|Overall Study|Poor enrollment|6|||
155346278|NCT03019289|560699680|FG000|Overall Study|Adverse Event|1|||
155346279|NCT03019289|560699681|FG001|Overall Study|Adverse Event|0|||
155346280|NCT03019289|560699682|FG002|Overall Study|Adverse Event|0|||
155346281|NCT03019289|560699683|FG003|Overall Study|Adverse Event|0|||
155346282|NCT03019289|560699684|FG004|Overall Study|Adverse Event|0|||
155346283|NCT03019289|560699685|FG005|Overall Study|Adverse Event|0|||
155346284|NCT03019289|560699686|FG006|Overall Study|Adverse Event|0|||
155346285|NCT03019289|560699687|FG007|Overall Study|Adverse Event|0|||
155346286|NCT03019289|560699688|FG008|Overall Study|Adverse Event|1|||
155346287|NCT03019289|560699680|FG000|Overall Study|Other|1|||
155346288|NCT03019289|560699681|FG001|Overall Study|Other|0|||
154963952|NCT03215706|559293503|FG000|Randomization|participant withdrew consent|1|||
155165512|NCT02881567|560043475|FG000|Overall Study|Investigator decision|1|||
155165513|NCT02881567|560043475|FG000|Overall Study|Study terminated by sponsor|9|||
155165514|NCT02881567|560043475|FG000|Overall Study|Reason not Specified|3|||
155165515|NCT04661579|560043476|FG000|Overall Study|Lost to Follow-up|19|||
155165516|NCT04661579|560043477|FG001|Overall Study|Lost to Follow-up|10|||
155165517|NCT04661579|560043478|FG002|Overall Study|Lost to Follow-up|2|||
155165518|NCT04661579|560043479|FG003|Overall Study|Lost to Follow-up|7|||
155165519|NCT04661579|560043480|FG004|Overall Study|Lost to Follow-up|11|||
155165520|NCT04661579|560043476|FG000|Overall Study|Physician Decision|2|||
155165521|NCT04661579|560043477|FG001|Overall Study|Physician Decision|0|||
155165522|NCT04661579|560043478|FG002|Overall Study|Physician Decision|0|||
155165523|NCT04661579|560043479|FG003|Overall Study|Physician Decision|1|||
155346289|NCT03019289|560699682|FG002|Overall Study|Other|0|||
155346290|NCT03019289|560699683|FG003|Overall Study|Other|0|||
155346291|NCT03019289|560699684|FG004|Overall Study|Other|0|||
155346292|NCT03019289|560699685|FG005|Overall Study|Other|0|||
155346293|NCT03019289|560699686|FG006|Overall Study|Other|0|||
155346294|NCT03019289|560699687|FG007|Overall Study|Other|0|||
155346295|NCT03019289|560699688|FG008|Overall Study|Other|0|||
155346296|NCT01334606|560699691|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
155346297|NCT02312245|560699692|FG000|Overall Study|Death|0|||
155346298|NCT02312245|560699693|FG001|Overall Study|Death|0|||
155346299|NCT02312245|560699694|FG002|Overall Study|Death|0|||
155346300|NCT02312245|560699695|FG003|Overall Study|Death|1|||
155346301|NCT02312245|560699692|FG000|Overall Study|Withdrawal by Subject|1|||
155346302|NCT02312245|560699693|FG001|Overall Study|Withdrawal by Subject|1|||
155346303|NCT02312245|560699694|FG002|Overall Study|Withdrawal by Subject|0|||
155346304|NCT02312245|560699695|FG003|Overall Study|Withdrawal by Subject|2|||
155346305|NCT02312245|560699692|FG000|Overall Study|Alternative Therapy|1|||
155346306|NCT02312245|560699693|FG001|Overall Study|Alternative Therapy|0|||
155346307|NCT02312245|560699694|FG002|Overall Study|Alternative Therapy|0|||
155346308|NCT02312245|560699695|FG003|Overall Study|Alternative Therapy|0|||
155346309|NCT02312245|560699692|FG000|Overall Study|Progression|0|||
155346310|NCT02312245|560699693|FG001|Overall Study|Progression|0|||
155346311|NCT02312245|560699694|FG002|Overall Study|Progression|0|||
155346312|NCT02312245|560699695|FG003|Overall Study|Progression|5|||
155346313|NCT02312245|560699692|FG000|Overall Study|Patient went to hospice|0|||
155346314|NCT02312245|560699693|FG001|Overall Study|Patient went to hospice|0|||
155346315|NCT02312245|560699694|FG002|Overall Study|Patient went to hospice|0|||
155346316|NCT02312245|560699695|FG003|Overall Study|Patient went to hospice|1|||
155346317|NCT02312245|560699692|FG000|Overall Study|Ineligible|1|||
155346318|NCT02312245|560699693|FG001|Overall Study|Ineligible|0|||
155346319|NCT02312245|560699694|FG002|Overall Study|Ineligible|0|||
155346320|NCT02312245|560699695|FG003|Overall Study|Ineligible|0|||
155346321|NCT03689452|560699699|FG000|Overall Study|Lost to Follow-up|1|||
155346322|NCT03689452|560699700|FG001|Overall Study|Lost to Follow-up|1|||
155165524|NCT04661579|560043480|FG004|Overall Study|Physician Decision|0|||
155165525|NCT04661579|560043476|FG000|Overall Study|Withdrawal by Subject|1|||
155165526|NCT04661579|560043477|FG001|Overall Study|Withdrawal by Subject|4|||
155346323|NCT02676778|560699701|FG000|Overall Study|Disease Progression|7|||
155346324|NCT02676778|560699702|FG001|Overall Study|Disease Progression|3|||
155346325|NCT02676778|560699703|FG002|Overall Study|Disease Progression|1|||
155346326|NCT02676778|560699701|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
155346327|NCT02676778|560699702|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
155346328|NCT02676778|560699703|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
155346329|NCT02676778|560699701|FG000|Overall Study|Withdrawal by Subject|3|||
155346330|NCT02676778|560699702|FG001|Overall Study|Withdrawal by Subject|2|||
155346331|NCT02676778|560699703|FG002|Overall Study|Withdrawal by Subject|0|||
155346332|NCT02676778|560699701|FG000|Overall Study|Other|4|||
155346333|NCT02676778|560699702|FG001|Overall Study|Other|3|||
155346334|NCT02676778|560699703|FG002|Overall Study|Other|0|||
155346335|NCT02676778|560699701|FG000|Overall Study|Adverse Event|2|||
155346336|NCT02676778|560699702|FG001|Overall Study|Adverse Event|3|||
155346337|NCT02676778|560699703|FG002|Overall Study|Adverse Event|0|||
155346338|NCT03686176|560699708|FG000|Overall Study|Procedure cancelled|1|||
155346339|NCT03686176|560699709|FG001|Overall Study|Procedure cancelled|0|||
155346340|NCT03686176|560699710|FG002|Overall Study|Procedure cancelled|0|||
155346341|NCT03686176|560699708|FG000|Overall Study|VR Malfunction|1|||
155346342|NCT03686176|560699709|FG001|Overall Study|VR Malfunction|0|||
155346343|NCT03686176|560699710|FG002|Overall Study|VR Malfunction|0|||
155346344|NCT01232569|560701261|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
155346345|NCT01232569|560701262|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155346346|NCT01232569|560701263|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155346347|NCT01232569|560701264|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
155346348|NCT01232569|560701261|FG000|Double-blind Treatment Period|Escape|2|||
155346349|NCT01232569|560701262|FG001|Double-blind Treatment Period|Escape|2|||
155346350|NCT01232569|560701263|FG002|Double-blind Treatment Period|Escape|0|||
155346351|NCT01232569|560701264|FG003|Double-blind Treatment Period|Escape|0|||
155346352|NCT01232569|560701261|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
155346353|NCT01232569|560701262|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155346354|NCT01232569|560701263|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155346355|NCT01232569|560701264|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155346356|NCT01232569|560701261|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
155346357|NCT01232569|560701262|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
155346358|NCT01232569|560701263|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
155346359|NCT01232569|560701264|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
155346360|NCT01232569|560701261|FG000|Double-blind Treatment Period|Physician Decision|1|||
155346361|NCT01232569|560701262|FG001|Double-blind Treatment Period|Physician Decision|0|||
155346362|NCT01232569|560701263|FG002|Double-blind Treatment Period|Physician Decision|0|||
155346363|NCT01232569|560701264|FG003|Double-blind Treatment Period|Physician Decision|0|||
155346364|NCT01232569|560701261|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
155346365|NCT01232569|560701262|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
155346366|NCT01232569|560701263|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
155346367|NCT01232569|560701264|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
155346368|NCT01232569|560701261|FG000|Double-blind Treatment Period|Death|2|||
155346369|NCT01232569|560701262|FG001|Double-blind Treatment Period|Death|0|||
155346370|NCT01232569|560701263|FG002|Double-blind Treatment Period|Death|0|||
155346371|NCT01232569|560701264|FG003|Double-blind Treatment Period|Death|0|||
155346372|NCT04044352|560701265|FG000|Overall Study|Lost to Follow-up|9|||
155346373|NCT04044352|560701265|FG000|Overall Study|Withdrawal by Subject|2|||
155346374|NCT02176356|560701271|FG000|Overall Study|Screen Failure|14|||
155346375|NCT02176356|560701271|FG000|Overall Study|Lost to Follow-up|4|||
155346376|NCT02176356|560701271|FG000|Overall Study|Personal Reasons|3|||
155346377|NCT02176356|560701271|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155080557|NCT01379937|559725387|FG000|Overall Study|Consent withdrawal|0|||
155080558|NCT01379937|559725388|FG001|Overall Study|Consent withdrawal|1|||
155080559|NCT01379937|559725389|FG002|Overall Study|Consent withdrawal|0|||
155080560|NCT01379937|559725390|FG003|Overall Study|Consent withdrawal|0|||
155080561|NCT01379937|559725387|FG000|Overall Study|Lost to Follow-up|1|||
155080562|NCT01379937|559725388|FG001|Overall Study|Lost to Follow-up|2|||
155080563|NCT01379937|559725389|FG002|Overall Study|Lost to Follow-up|2|||
155080564|NCT01379937|559725390|FG003|Overall Study|Lost to Follow-up|0|||
155080565|NCT01122680|559725391|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
155080566|NCT01122680|559725392|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
155080567|NCT01122680|559725393|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
155080568|NCT01122680|559725394|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
155080569|NCT01122680|559725391|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
155080570|NCT01122680|559725392|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
155080571|NCT01122680|559725393|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
155080572|NCT01122680|559725394|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
155080573|NCT01122680|559725391|FG000|Period 1 (4 Weeks)|Other|1|||
155080574|NCT01122680|559725392|FG001|Period 1 (4 Weeks)|Other|1|||
155080575|NCT01122680|559725393|FG002|Period 1 (4 Weeks)|Other|0|||
155346378|NCT00958711|560701273|FG000|Overall Study|Withdrawal by Subject|0|||
155346379|NCT00958711|560701274|FG001|Overall Study|Withdrawal by Subject|4|||
155346380|NCT00958711|560701273|FG000|Overall Study|Physician Decision|5|||
155346381|NCT00958711|560701274|FG001|Overall Study|Physician Decision|7|||
155346382|NCT00958711|560701273|FG000|Overall Study|Lost to Follow-up|4|||
155346383|NCT00958711|560701274|FG001|Overall Study|Lost to Follow-up|1|||
155346384|NCT00958711|560701273|FG000|Overall Study|Other|2|||
155346385|NCT00958711|560701274|FG001|Overall Study|Other|5|||
155346386|NCT00958711|560701273|FG000|Overall Study|Death|1|||
155346387|NCT00958711|560701274|FG001|Overall Study|Death|2|||
155080576|NCT01122680|559725394|FG003|Period 1 (4 Weeks)|Other|0|||
155080577|NCT01122680|559725391|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
155080578|NCT01122680|559725392|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
155346388|NCT00958711|560701273|FG000|Overall Study|Adverse Event|1|||
155346389|NCT00958711|560701274|FG001|Overall Study|Adverse Event|2|||
155346390|NCT03722485|560701275|FG000|Overall Study|Withdrawal by Subject|1|||
155346391|NCT03722485|560701276|FG001|Overall Study|Withdrawal by Subject|0|||
155346392|NCT03722485|560701275|FG000|Overall Study|Adverse Event|0|||
155346393|NCT03722485|560701276|FG001|Overall Study|Adverse Event|2|||
155346394|NCT03722485|560701275|FG000|Overall Study|subject discharged prior to study completion|1|||
155346395|NCT03722485|560701276|FG001|Overall Study|subject discharged prior to study completion|5|||
155346396|NCT03722485|560701275|FG000|Overall Study|eligibility criteria not met|2|||
155346397|NCT03722485|560701276|FG001|Overall Study|eligibility criteria not met|0|||
155346398|NCT02151643|560701279|FG000|Overall Study|Adverse Event|2|||
155346399|NCT02151643|560701280|FG001|Overall Study|Adverse Event|0|||
155346400|NCT02151643|560701281|FG002|Overall Study|Adverse Event|1|||
155346401|NCT02151643|560701282|FG003|Overall Study|Adverse Event|4|||
155346402|NCT02151643|560701283|FG004|Overall Study|Adverse Event|0|||
155346403|NCT02151643|560701279|FG000|Overall Study|Withdrawal by Subject|0|||
155346404|NCT02151643|560701280|FG001|Overall Study|Withdrawal by Subject|1|||
155346405|NCT02151643|560701281|FG002|Overall Study|Withdrawal by Subject|1|||
155346406|NCT02151643|560701282|FG003|Overall Study|Withdrawal by Subject|1|||
155346407|NCT02151643|560701283|FG004|Overall Study|Withdrawal by Subject|1|||
155346408|NCT02151643|560701279|FG000|Overall Study|Hyperphosphataemia|1|||
155346409|NCT02151643|560701280|FG001|Overall Study|Hyperphosphataemia|0|||
155346410|NCT02151643|560701281|FG002|Overall Study|Hyperphosphataemia|0|||
155346411|NCT02151643|560701282|FG003|Overall Study|Hyperphosphataemia|0|||
155346412|NCT02151643|560701283|FG004|Overall Study|Hyperphosphataemia|1|||
155346413|NCT02151643|560701279|FG000|Overall Study|High Ferritin levels|3|||
155346414|NCT02151643|560701280|FG001|Overall Study|High Ferritin levels|3|||
155346415|NCT02151643|560701281|FG002|Overall Study|High Ferritin levels|2|||
155346416|NCT02151643|560701282|FG003|Overall Study|High Ferritin levels|2|||
155346417|NCT02151643|560701283|FG004|Overall Study|High Ferritin levels|1|||
155346418|NCT03087851|560701285|FG000|Overall Study|Withdraw on medical grounds|0|||
155346419|NCT03087851|560701286|FG001|Overall Study|Withdraw on medical grounds|1|||
155346420|NCT03087851|560701287|FG002|Overall Study|Withdraw on medical grounds|2|||
155346421|NCT00644332|560701288|FG000|Overall Study|Adverse Event|11|||
155346422|NCT00644332|560701288|FG000|Overall Study|Withdrawal by Subject|6|||
155346423|NCT00644332|560701288|FG000|Overall Study|Completion Status Unknown|2|||
155346424|NCT00644332|560701288|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
155346425|NCT00644332|560701288|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
155346426|NCT03694210|560701289|FG000|Overall Study|Death|1|||
155346427|NCT03694210|560701289|FG000|Overall Study|Screen Failure|7|||
155346428|NCT03050372|560701290|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
155346429|NCT03050372|560701291|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
155346430|NCT03050372|560701290|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
155346431|NCT03050372|560701291|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
155346432|NCT00443755|560701296|FG000|Overall Study|Withdrawal by Subject|2|||
155346433|NCT00443755|560701297|FG001|Overall Study|Withdrawal by Subject|1|||
155346434|NCT02775214|560701298|FG000|Overall Study|Withdrawal by Subject|2|||
155346435|NCT02775214|560701299|FG001|Overall Study|Withdrawal by Subject|0|||
155346436|NCT02706834|560701301|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155346437|NCT02706834|560701302|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155346438|NCT02706834|560701303|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155080579|NCT01122680|559725393|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
155080580|NCT01122680|559725394|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
155080581|NCT01122680|559725391|FG000|Period 2 (4 Weeks)|Other|1|||
155080582|NCT01122680|559725392|FG001|Period 2 (4 Weeks)|Other|0|||
155346439|NCT02706834|560701304|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
155346440|NCT02706834|560701305|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
155346441|NCT02706834|560701306|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
155346442|NCT02706834|560701307|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
155346443|NCT02706834|560701308|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
155346444|NCT02706834|560701309|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
155346445|NCT02706834|560701310|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
155346446|NCT02706834|560701311|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
155346447|NCT02706834|560701301|FG000|Overall Study|Lost to Follow-up|0|||
155346448|NCT02706834|560701302|FG001|Overall Study|Lost to Follow-up|0|||
155346449|NCT02706834|560701303|FG002|Overall Study|Lost to Follow-up|1|||
155346450|NCT02706834|560701304|FG003|Overall Study|Lost to Follow-up|0|||
155346451|NCT02706834|560701305|FG004|Overall Study|Lost to Follow-up|0|||
155346452|NCT02706834|560701306|FG005|Overall Study|Lost to Follow-up|0|||
155346453|NCT02706834|560701307|FG006|Overall Study|Lost to Follow-up|0|||
155346454|NCT02706834|560701308|FG007|Overall Study|Lost to Follow-up|0|||
155346455|NCT02706834|560701309|FG008|Overall Study|Lost to Follow-up|0|||
155346456|NCT02706834|560701310|FG009|Overall Study|Lost to Follow-up|0|||
155346457|NCT02706834|560701311|FG010|Overall Study|Lost to Follow-up|0|||
155346458|NCT02706834|560701301|FG000|Overall Study|Voluntary Withdrawal|1|||
155346459|NCT02706834|560701302|FG001|Overall Study|Voluntary Withdrawal|0|||
155346460|NCT02706834|560701303|FG002|Overall Study|Voluntary Withdrawal|0|||
155346461|NCT02706834|560701304|FG003|Overall Study|Voluntary Withdrawal|0|||
155346462|NCT02706834|560701305|FG004|Overall Study|Voluntary Withdrawal|0|||
155346463|NCT02706834|560701306|FG005|Overall Study|Voluntary Withdrawal|0|||
155346464|NCT02706834|560701307|FG006|Overall Study|Voluntary Withdrawal|0|||
155346465|NCT02706834|560701308|FG007|Overall Study|Voluntary Withdrawal|0|||
155346466|NCT02706834|560701309|FG008|Overall Study|Voluntary Withdrawal|0|||
155346467|NCT02706834|560701310|FG009|Overall Study|Voluntary Withdrawal|1|||
155346468|NCT02706834|560701311|FG010|Overall Study|Voluntary Withdrawal|0|||
155346469|NCT02706834|560701301|FG000|Overall Study|Other Reason Not Specified|1|||
155346470|NCT02706834|560701302|FG001|Overall Study|Other Reason Not Specified|0|||
155346471|NCT02706834|560701303|FG002|Overall Study|Other Reason Not Specified|0|||
155346472|NCT02706834|560701304|FG003|Overall Study|Other Reason Not Specified|0|||
155346473|NCT02706834|560701305|FG004|Overall Study|Other Reason Not Specified|1|||
155346474|NCT02706834|560701306|FG005|Overall Study|Other Reason Not Specified|0|||
155346475|NCT02706834|560701307|FG006|Overall Study|Other Reason Not Specified|0|||
155346476|NCT02706834|560701308|FG007|Overall Study|Other Reason Not Specified|0|||
155346477|NCT02706834|560701309|FG008|Overall Study|Other Reason Not Specified|0|||
155346478|NCT02706834|560701310|FG009|Overall Study|Other Reason Not Specified|0|||
155346479|NCT02706834|560701311|FG010|Overall Study|Other Reason Not Specified|0|||
155346480|NCT00678899|560701312|FG000|Overall Study|Adverse Event|1|||
155346481|NCT02543294|560701313|FG000|Overall Study|Lost to Follow-up|3|||
155346482|NCT02543294|560701313|FG000|Overall Study|Physician Decision|2|||
155346483|NCT02543294|560701313|FG000|Overall Study|Withdrawal by Subject|7|||
155346484|NCT01636258|560701319|FG000|Overall Study|Lost to Follow-up|1|||
155346485|NCT01636258|560701320|FG001|Overall Study|Lost to Follow-up|0|||
155346486|NCT01107353|560701321|FG000|Overall Study|Positive Drug Screen|1|||
155346487|NCT01107353|560701322|FG001|Overall Study|Positive Drug Screen|0|||
155346488|NCT02798861|560701325|FG000|Overall Study|Lost to Follow-up|22|||
155346489|NCT02798861|560701325|FG000|Overall Study|Withdrawal by Subject|1|||
155346490|NCT00907517|560701326|FG000|Overall Study|Progressive Disease|3|||
155346491|NCT00907517|560701327|FG001|Overall Study|Progressive Disease|3|||
155346492|NCT00907517|560701328|FG002|Overall Study|Progressive Disease|4|||
155346493|NCT00907517|560701329|FG003|Overall Study|Progressive Disease|4|||
155346494|NCT00907517|560701330|FG004|Overall Study|Progressive Disease|4|||
155346495|NCT00907517|560701326|FG000|Overall Study|Symptomatic Deterioration|0|||
155346496|NCT00907517|560701327|FG001|Overall Study|Symptomatic Deterioration|0|||
155346497|NCT00907517|560701328|FG002|Overall Study|Symptomatic Deterioration|0|||
155346498|NCT00907517|560701329|FG003|Overall Study|Symptomatic Deterioration|0|||
155346499|NCT00907517|560701330|FG004|Overall Study|Symptomatic Deterioration|1|||
155346500|NCT04057937|560701353|FG000|Placebo-controlled Phase|Adverse Event|3|||
155346501|NCT04057937|560701354|FG001|Placebo-controlled Phase|Adverse Event|0|||
155346502|NCT04057937|560701353|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
155346503|NCT04057937|560701354|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
155346504|NCT04057937|560701353|FG000|Active-treatment Phase|Pregnancy|0|||
155346505|NCT04057937|560701354|FG001|Active-treatment Phase|Pregnancy|1|||
155346506|NCT04057937|560701353|FG000|Active-treatment Phase|Physician Decision|0|||
155346507|NCT04057937|560701354|FG001|Active-treatment Phase|Physician Decision|1|||
155346508|NCT02029521|560701355|FG000|Overall Study|Protocol Violation|1|||
155346509|NCT02029521|560701356|FG001|Overall Study|Protocol Violation|0|||
155346510|NCT02029521|560701355|FG000|Overall Study|Withdrawal by Subject|1|||
155346511|NCT02029521|560701356|FG001|Overall Study|Withdrawal by Subject|1|||
155346512|NCT01072396|560701357|FG000|Period One|Adverse Event|1|||
155346513|NCT01072396|560701358|FG001|Period One|Adverse Event|1|||
155346514|NCT01072396|560701357|FG000|Period One|Protocol Violation|2|||
155346515|NCT01072396|560701358|FG001|Period One|Protocol Violation|1|||
155346516|NCT01072396|560701357|FG000|Period One|Withdrawal by Subject|2|||
155346517|NCT01072396|560701358|FG001|Period One|Withdrawal by Subject|0|||
155346518|NCT01072396|560701357|FG000|Washout Period|Missing termination information|0|||
155346519|NCT01072396|560701358|FG001|Washout Period|Missing termination information|1|||
155346520|NCT01072396|560701357|FG000|Period Two|Adverse Event|0|||
155346521|NCT01072396|560701358|FG001|Period Two|Adverse Event|3|||
155346522|NCT01072396|560701357|FG000|Period Two|Lost to Follow-up|1|||
155346523|NCT01072396|560701358|FG001|Period Two|Lost to Follow-up|0|||
155346524|NCT01268488|560701359|FG000|Overall Study|Adverse Event|3|||
155346525|NCT01268488|560701359|FG000|Overall Study|Physician Decision|2|||
155346526|NCT05287178|560701361|FG000|Overall Study|Lost to Follow-up|2|||
155346527|NCT01426217|560701362|FG000|Overall Study|lost sample|8|||
155346528|NCT01426217|560701363|FG001|Overall Study|lost sample|14|||
155346529|NCT01648699|560701364|FG000|Overall Study|Death|1|||
155346530|NCT01648699|560701364|FG000|Overall Study|Lost to Follow-up|2|||
155346531|NCT01648699|560701364|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
155346532|NCT01920178|560701365|FG000|Overall Study|Lost to Follow-up|2|||
155346533|NCT01920178|560701366|FG001|Overall Study|Lost to Follow-up|1|||
155346534|NCT03023878|560701367|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
155346535|NCT03023878|560701367|FG000|Pre-Study Run-In Period|Death|1|||
155346536|NCT03023878|560701367|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
155346537|NCT03023878|560701367|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
155346538|NCT03023878|560701367|FG000|Treatment Period|Disease Progression|1|||
155346539|NCT03023878|560701367|FG000|Treatment Period|Withdrawal by Subject|1|||
155346540|NCT03023878|560701367|FG000|Treatment Period|Adverse Event|1|||
155346541|NCT03023878|560701367|FG000|Long Term Follow-Up Period|Death|2|||
155346542|NCT00288353|560701368|FG000|Overall Study|Lack of Efficacy|2|||
155346543|NCT00288353|560701369|FG001|Overall Study|Lack of Efficacy|2|||
155346544|NCT00288353|560701368|FG000|Overall Study|Withdrawal by Subject|5|||
155346545|NCT00288353|560701369|FG001|Overall Study|Withdrawal by Subject|5|||
155346546|NCT04799587|560701370|FG000|Overall Study|Withdrawal by Subject|0|||
155346547|NCT04799587|560701371|FG001|Overall Study|Withdrawal by Subject|1|||
155346548|NCT00728884|560701372|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
155346549|NCT00728884|560701372|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
155346550|NCT02374476|560701380|FG000|VT Induced Ablation|Screening Failures|36|||
155346551|NCT02374476|560701381|FG001|VT Induced Ablation|Screening Failures|0|||
155346552|NCT02374476|560701382|FG002|VT Induced Ablation|Screening Failures|0|||
155346553|NCT02374476|560701380|FG000|Arm Assignment|Withdrawal by Subject|0|||
155346554|NCT02374476|560701381|FG001|Arm Assignment|Withdrawal by Subject|0|||
155346555|NCT02374476|560701382|FG002|Arm Assignment|Withdrawal by Subject|1|||
155346556|NCT05431543|560701383|FG000|Overall Study|Medical History|1|||
155346557|NCT05431543|560701384|FG001|Overall Study|Medical History|0|||
155346558|NCT05431543|560701385|FG002|Overall Study|Medical History|0|||
155346559|NCT02784535|560701386|FG000|Overall Study|Adverse Event|1|||
155346560|NCT02784535|560701387|FG001|Overall Study|Adverse Event|0|||
155346561|NCT02784535|560701386|FG000|Overall Study|Withdrawal by Subject|0|||
155346562|NCT02784535|560701387|FG001|Overall Study|Withdrawal by Subject|1|||
155346563|NCT02784535|560701386|FG000|Overall Study|Physician Decision|0|||
155346564|NCT02784535|560701387|FG001|Overall Study|Physician Decision|1|||
155346565|NCT00914732|560701388|FG000|Overall Study|Lost to Follow-up|6|||
155346566|NCT00914732|560701389|FG001|Overall Study|Lost to Follow-up|7|||
155346567|NCT00914732|560701390|FG002|Overall Study|Lost to Follow-up|9|||
155346568|NCT00914732|560701388|FG000|Overall Study|Withdrawal by Subject|3|||
155346569|NCT00914732|560701389|FG001|Overall Study|Withdrawal by Subject|0|||
155346570|NCT00914732|560701390|FG002|Overall Study|Withdrawal by Subject|2|||
155346571|NCT00914732|560701388|FG000|Overall Study|Adverse Event|1|||
155346572|NCT00914732|560701389|FG001|Overall Study|Adverse Event|0|||
155346573|NCT00914732|560701390|FG002|Overall Study|Adverse Event|0|||
155346574|NCT03005106|560701393|FG000|Overall Study|Lost to Follow-up|16|||
155346575|NCT03005106|560701393|FG000|Overall Study|Adverse Event|1|||
155346576|NCT03005106|560701393|FG000|Overall Study|Physician Decision|1|||
155346577|NCT03005106|560701393|FG000|Overall Study|Death|2|||
155346578|NCT00321672|560701396|FG000|Overall Study|Withdrawal by Subject|5|||
155346579|NCT00321672|560701397|FG001|Overall Study|Withdrawal by Subject|1|||
155346580|NCT00321672|560701398|FG002|Overall Study|Withdrawal by Subject|2|||
155346581|NCT00321672|560701399|FG003|Overall Study|Withdrawal by Subject|0|||
155346582|NCT00321672|560701396|FG000|Overall Study|Noncompliance|1|||
155346583|NCT00321672|560701397|FG001|Overall Study|Noncompliance|2|||
155346584|NCT00321672|560701398|FG002|Overall Study|Noncompliance|1|||
155346585|NCT00321672|560701399|FG003|Overall Study|Noncompliance|0|||
155346586|NCT00321672|560701396|FG000|Overall Study|Adverse Event|1|||
154963953|NCT03215706|559293504|FG001|Randomization|participant withdrew consent|3|||
155346587|NCT00321672|560701397|FG001|Overall Study|Adverse Event|1|||
155346588|NCT00321672|560701398|FG002|Overall Study|Adverse Event|0|||
155346589|NCT00321672|560701399|FG003|Overall Study|Adverse Event|0|||
155346590|NCT00321672|560701396|FG000|Overall Study|Lack of Efficacy|1|||
155346591|NCT00321672|560701397|FG001|Overall Study|Lack of Efficacy|1|||
155346592|NCT00321672|560701398|FG002|Overall Study|Lack of Efficacy|0|||
155346593|NCT00321672|560701399|FG003|Overall Study|Lack of Efficacy|0|||
155346594|NCT00321672|560701396|FG000|Overall Study|Lost to Follow-up|2|||
155346595|NCT00321672|560701397|FG001|Overall Study|Lost to Follow-up|0|||
155346596|NCT00321672|560701398|FG002|Overall Study|Lost to Follow-up|4|||
155346597|NCT00321672|560701399|FG003|Overall Study|Lost to Follow-up|2|||
155346598|NCT00321672|560701396|FG000|Overall Study|Death|1|||
155346599|NCT00321672|560701397|FG001|Overall Study|Death|0|||
155346600|NCT00321672|560701398|FG002|Overall Study|Death|0|||
155346601|NCT00321672|560701399|FG003|Overall Study|Death|0|||
155346602|NCT00321672|560701396|FG000|Overall Study|Too far to travel for visits|1|||
155346603|NCT00321672|560701397|FG001|Overall Study|Too far to travel for visits|0|||
155346604|NCT00321672|560701398|FG002|Overall Study|Too far to travel for visits|0|||
155346605|NCT00321672|560701399|FG003|Overall Study|Too far to travel for visits|0|||
155346606|NCT00321672|560701396|FG000|Overall Study|Incarcerated|0|||
155346607|NCT00321672|560701397|FG001|Overall Study|Incarcerated|0|||
155346608|NCT00321672|560701398|FG002|Overall Study|Incarcerated|2|||
155346609|NCT00321672|560701399|FG003|Overall Study|Incarcerated|0|||
155346610|NCT00321672|560701396|FG000|Overall Study|Moved out of state|0|||
155346611|NCT00321672|560701397|FG001|Overall Study|Moved out of state|1|||
155346612|NCT00321672|560701398|FG002|Overall Study|Moved out of state|1|||
155346613|NCT00321672|560701399|FG003|Overall Study|Moved out of state|0|||
155346614|NCT00321672|560701396|FG000|Overall Study|Protocol Violation|0|||
155346615|NCT00321672|560701397|FG001|Overall Study|Protocol Violation|0|||
155346616|NCT00321672|560701398|FG002|Overall Study|Protocol Violation|1|||
155346617|NCT00321672|560701399|FG003|Overall Study|Protocol Violation|0|||
155346618|NCT00321672|560701396|FG000|Overall Study|Diagnosis of testicular cancer|0|||
155346619|NCT00321672|560701397|FG001|Overall Study|Diagnosis of testicular cancer|1|||
155346620|NCT00321672|560701398|FG002|Overall Study|Diagnosis of testicular cancer|0|||
155346621|NCT00321672|560701399|FG003|Overall Study|Diagnosis of testicular cancer|0|||
155346622|NCT00321672|560701396|FG000|Overall Study|Extensive travel required for new job|0|||
155346623|NCT00321672|560701397|FG001|Overall Study|Extensive travel required for new job|1|||
155346624|NCT00321672|560701398|FG002|Overall Study|Extensive travel required for new job|0|||
155346625|NCT00321672|560701399|FG003|Overall Study|Extensive travel required for new job|0|||
155346626|NCT03953079|560701400|FG000|Core Study|Withdrawal by Subject|1|||
155346627|NCT03953079|560701401|FG001|Core Study|Withdrawal by Subject|2|||
155346628|NCT03953079|560701402|FG002|Core Study|Withdrawal by Subject|1|||
155346629|NCT03953079|560701400|FG000|Core Study|COVID-19|0|||
155346630|NCT03953079|560701401|FG001|Core Study|COVID-19|1|||
155346631|NCT03953079|560701402|FG002|Core Study|COVID-19|0|||
155346632|NCT03953079|560701400|FG000|Core Study|Difficulties leaving the house|0|||
155346633|NCT03953079|560701401|FG001|Core Study|Difficulties leaving the house|1|||
155346634|NCT03953079|560701402|FG002|Core Study|Difficulties leaving the house|0|||
155346635|NCT03953079|560701400|FG000|Extension Study|Withdrawal by Subject|1|||
155346636|NCT03953079|560701401|FG001|Extension Study|Withdrawal by Subject|0|||
155346637|NCT03953079|560701402|FG002|Extension Study|Withdrawal by Subject|0|||
155346638|NCT03953079|560701400|FG000|Extension Study|Received Rescue Treatment|5|||
155346639|NCT03953079|560701401|FG001|Extension Study|Received Rescue Treatment|6|||
155346640|NCT03953079|560701402|FG002|Extension Study|Received Rescue Treatment|5|||
155346641|NCT02389894|560701404|FG000|Overall Study|Death|4|||
155346642|NCT02389894|560701405|FG001|Overall Study|Death|5|||
155346643|NCT02389894|560701406|FG002|Overall Study|Death|3|||
155346644|NCT02389894|560701404|FG000|Overall Study|Withdrawal by Subject|2|||
155346645|NCT02389894|560701405|FG001|Overall Study|Withdrawal by Subject|4|||
155346646|NCT02389894|560701406|FG002|Overall Study|Withdrawal by Subject|5|||
155346647|NCT02389894|560701404|FG000|Overall Study|Lost to Follow-up|2|||
155346648|NCT02389894|560701405|FG001|Overall Study|Lost to Follow-up|1|||
155346649|NCT02389894|560701406|FG002|Overall Study|Lost to Follow-up|1|||
155346650|NCT00145496|560701407|FG000|Overall Study|Adverse Event|42|||
155346651|NCT00145496|560701408|FG001|Overall Study|Adverse Event|30|||
155346652|NCT00145496|560701407|FG000|Overall Study|Lack of Efficacy|12|||
155346653|NCT00145496|560701408|FG001|Overall Study|Lack of Efficacy|7|||
155346654|NCT00145496|560701407|FG000|Overall Study|Withdrawal by Subject|32|||
155346655|NCT00145496|560701408|FG001|Overall Study|Withdrawal by Subject|26|||
155346656|NCT00145496|560701407|FG000|Overall Study|Lost to Follow-up|12|||
155346657|NCT00145496|560701408|FG001|Overall Study|Lost to Follow-up|5|||
155346658|NCT00145496|560701407|FG000|Overall Study|Other|25|||
155346659|NCT00145496|560701408|FG001|Overall Study|Other|13|||
155346660|NCT01429285|560701412|FG000|Overall Study|Protocol Violation|9|||
155346661|NCT01429285|560701413|FG001|Overall Study|Protocol Violation|4|||
155346662|NCT01429285|560701412|FG000|Overall Study|Missing Data|5|||
155346663|NCT01429285|560701413|FG001|Overall Study|Missing Data|3|||
155080583|NCT01122680|559725393|FG002|Period 2 (4 Weeks)|Other|0|||
155080584|NCT01122680|559725394|FG003|Period 2 (4 Weeks)|Other|0|||
155080585|NCT01122680|559725391|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
155346664|NCT01429285|560701412|FG000|Overall Study|Erroneously Enrolled Twice|8|||
155346665|NCT01429285|560701413|FG001|Overall Study|Erroneously Enrolled Twice|2|||
155346666|NCT01288729|560701414|FG000|Overall Study|Withdrawal by Subject|1|||
155346667|NCT01288729|560701415|FG001|Overall Study|Withdrawal by Subject|0|||
155346668|NCT01002547|560703343|FG000|Overall Study|Withdrawal by Subject|4|||
155346669|NCT01002547|560703344|FG001|Overall Study|Withdrawal by Subject|0|||
155346670|NCT01002547|560703345|FG002|Overall Study|Withdrawal by Subject|5|||
155346671|NCT01002547|560703343|FG000|Overall Study|Lost to Follow-up|2|||
155346672|NCT01002547|560703344|FG001|Overall Study|Lost to Follow-up|1|||
155346673|NCT01002547|560703345|FG002|Overall Study|Lost to Follow-up|1|||
155346674|NCT01002547|560703343|FG000|Overall Study|Physician Decision|1|||
155346675|NCT01002547|560703344|FG001|Overall Study|Physician Decision|0|||
155346676|NCT01002547|560703345|FG002|Overall Study|Physician Decision|0|||
155346677|NCT01002547|560703343|FG000|Overall Study|Death|0|||
155346678|NCT01002547|560703344|FG001|Overall Study|Death|2|||
155346679|NCT01002547|560703345|FG002|Overall Study|Death|2|||
155346680|NCT01002547|560703343|FG000|Overall Study|Adverse Event|1|||
155346681|NCT01002547|560703344|FG001|Overall Study|Adverse Event|0|||
155346682|NCT01002547|560703345|FG002|Overall Study|Adverse Event|0|||
155346683|NCT00925288|560703348|FG000|Overall Study|Lost to Follow-up|9|||
155346684|NCT00925288|560703349|FG001|Overall Study|Lost to Follow-up|7|||
155346685|NCT00434577|560703350|FG000|Months 0-3|Serious Adverse Event|0|||
155346686|NCT00434577|560703351|FG001|Months 0-3|Serious Adverse Event|0|||
155346687|NCT00434577|560703352|FG002|Months 0-3|Serious Adverse Event|1|||
155346688|NCT00434577|560703353|FG003|Months 0-3|Serious Adverse Event|0|||
155346689|NCT00434577|560703354|FG004|Months 0-3|Serious Adverse Event|0|||
155346690|NCT00434577|560703350|FG000|Months 0-3|Adverse Event|0|||
155346691|NCT00434577|560703351|FG001|Months 0-3|Adverse Event|1|||
155346692|NCT00434577|560703352|FG002|Months 0-3|Adverse Event|1|||
155346693|NCT00434577|560703353|FG003|Months 0-3|Adverse Event|0|||
155346694|NCT00434577|560703354|FG004|Months 0-3|Adverse Event|0|||
155346695|NCT00434577|560703350|FG000|Months 0-3|Lost to Follow-up|0|||
155346696|NCT00434577|560703351|FG001|Months 0-3|Lost to Follow-up|0|||
155346697|NCT00434577|560703352|FG002|Months 0-3|Lost to Follow-up|0|||
155346698|NCT00434577|560703353|FG003|Months 0-3|Lost to Follow-up|0|||
155346699|NCT00434577|560703354|FG004|Months 0-3|Lost to Follow-up|2|||
155346700|NCT00434577|560703350|FG000|Months 0-3|Protocol Violation|1|||
155346701|NCT00434577|560703351|FG001|Months 0-3|Protocol Violation|0|||
155346702|NCT00434577|560703352|FG002|Months 0-3|Protocol Violation|1|||
155346703|NCT00434577|560703353|FG003|Months 0-3|Protocol Violation|0|||
155346704|NCT00434577|560703354|FG004|Months 0-3|Protocol Violation|0|||
155346705|NCT00434577|560703350|FG000|Months 0-3|Withdrawal by Subject|2|||
155346706|NCT00434577|560703351|FG001|Months 0-3|Withdrawal by Subject|1|||
155346707|NCT00434577|560703352|FG002|Months 0-3|Withdrawal by Subject|1|||
155346708|NCT00434577|560703353|FG003|Months 0-3|Withdrawal by Subject|1|||
155346709|NCT00434577|560703354|FG004|Months 0-3|Withdrawal by Subject|1|||
155346710|NCT00651937|560703355|FG000|Overall Study|Withdrawal by Subject|4|||
155346711|NCT00651937|560703356|FG001|Overall Study|Withdrawal by Subject|1|||
155346712|NCT01904019|560703359|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
155346713|NCT01904019|560703359|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
155346714|NCT01904019|560703359|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
155346715|NCT01904019|560703359|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
155346716|NCT01904019|560703359|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
155346717|NCT01904019|560703359|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
155346718|NCT01537120|560703363|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
155346719|NCT01537120|560703363|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
155346720|NCT04816708|560703366|FG000|Overall Study|Lost to Follow-up|10|||
155346721|NCT04816708|560703367|FG001|Overall Study|Lost to Follow-up|4|||
155346722|NCT01732627|560703368|FG000|Overall Study|Withdrawal by Subject|1|||
155346723|NCT01732627|560703369|FG001|Overall Study|Withdrawal by Subject|0|||
155346724|NCT02475733|560703372|FG000|Overall Study|Withdrawal by Subject|1|||
155346725|NCT02475733|560703373|FG001|Overall Study|Withdrawal by Subject|0|||
155346726|NCT02475733|560703372|FG000|Overall Study|Physician Decision|1|||
155346727|NCT02475733|560703373|FG001|Overall Study|Physician Decision|0|||
155346728|NCT02131155|560703375|FG000|Overall Study|Adverse Event|1|||
155346729|NCT02131155|560703376|FG001|Overall Study|Adverse Event|0|||
155346730|NCT02131155|560703375|FG000|Overall Study|Treatment completed|1|||
155346731|NCT02131155|560703376|FG001|Overall Study|Treatment completed|0|||
155346732|NCT02131155|560703375|FG000|Overall Study|Primary tumour recurrence|2|||
154963954|NCT03215706|559293503|FG000|Randomization|no longer meets study criteria|1|||
154963955|NCT03215706|559293504|FG001|Randomization|no longer meets study criteria|4|||
155346733|NCT02131155|560703376|FG001|Overall Study|Primary tumour recurrence|1|||
155346734|NCT02131155|560703375|FG000|Overall Study|Refused to continue study medication|1|||
155346735|NCT02131155|560703376|FG001|Overall Study|Refused to continue study medication|0|||
155346736|NCT02131155|560703375|FG000|Overall Study|Study early termination|20|||
155346737|NCT02131155|560703376|FG001|Overall Study|Study early termination|10|||
155346738|NCT01887418|560703379|FG000|Overall Study|Travelling difficulties|0|||
155346739|NCT01887418|560703380|FG001|Overall Study|Travelling difficulties|0|||
155346740|NCT01887418|560703381|FG002|Overall Study|Travelling difficulties|1|||
155346741|NCT02744898|560703382|FG000|Overall Study|Progressive Disease|2|||
155346742|NCT02744898|560703382|FG000|Overall Study|Physician Decision|1|||
155346743|NCT02744898|560703382|FG000|Overall Study|Toxicity|1|||
155346744|NCT01014013|560703383|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
155346745|NCT01014013|560703384|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
155346746|NCT01014013|560703383|FG000|Overall Study|Clinical adverse experience|4|||
155346747|NCT01014013|560703384|FG001|Overall Study|Clinical adverse experience|2|||
155346748|NCT01014013|560703383|FG000|Overall Study|Laboratory adverse experience|1|||
155346749|NCT01014013|560703384|FG001|Overall Study|Laboratory adverse experience|1|||
155346750|NCT01014013|560703383|FG000|Overall Study|Protocol Violation|1|||
155346751|NCT01014013|560703384|FG001|Overall Study|Protocol Violation|3|||
155346752|NCT01014013|560703383|FG000|Overall Study|Withdrawal by Subject|7|||
155346753|NCT01014013|560703384|FG001|Overall Study|Withdrawal by Subject|4|||
155346754|NCT01014013|560703383|FG000|Overall Study|Clinical/microbiologic failure|1|||
155080586|NCT01122680|559725392|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
155080587|NCT01122680|559725393|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
155080588|NCT01122680|559725394|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
155080589|NCT01122680|559725391|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155080590|NCT01122680|559725392|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
155080591|NCT01122680|559725393|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155080592|NCT01122680|559725394|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
155080593|NCT04985682|559725395|FG000|Overall Study|Withdrawal by Subject|1|||
155080594|NCT03016403|559725400|FG000|Baseline|Death|5|||
155080595|NCT03016403|559725401|FG001|Baseline|Death|8|||
155080596|NCT03016403|559725402|FG002|Baseline|Death|1|||
155080597|NCT03016403|559725403|FG003|Baseline|Death|0|||
155080598|NCT03016403|559725400|FG000|Baseline|Withdrawal by Subject|2|||
155080599|NCT03016403|559725401|FG001|Baseline|Withdrawal by Subject|8|||
155080600|NCT03016403|559725402|FG002|Baseline|Withdrawal by Subject|4|||
155080601|NCT03016403|559725403|FG003|Baseline|Withdrawal by Subject|10|||
155080602|NCT03016403|559725400|FG000|Baseline|Lost to Follow-up|9|||
155080603|NCT03016403|559725401|FG001|Baseline|Lost to Follow-up|11|||
155080604|NCT03016403|559725402|FG002|Baseline|Lost to Follow-up|6|||
155080605|NCT03016403|559725403|FG003|Baseline|Lost to Follow-up|24|||
155080606|NCT03016403|559725400|FG000|6-week Follow-up|Death|1|||
155080607|NCT03016403|559725401|FG001|6-week Follow-up|Death|4|||
155080608|NCT03016403|559725402|FG002|6-week Follow-up|Death|0|||
155080609|NCT03016403|559725403|FG003|6-week Follow-up|Death|0|||
155346755|NCT01014013|560703384|FG001|Overall Study|Clinical/microbiologic failure|2|||
155346756|NCT01014013|560703383|FG000|Overall Study|Pathogen culture = no growth|26|||
155346757|NCT01014013|560703384|FG001|Overall Study|Pathogen culture = no growth|34|||
155346758|NCT01014013|560703383|FG000|Overall Study|Negative urine culture|2|||
155346759|NCT01014013|560703384|FG001|Overall Study|Negative urine culture|0|||
155346760|NCT01014013|560703383|FG000|Overall Study|Pathogen resistant|7|||
155346761|NCT01014013|560703384|FG001|Overall Study|Pathogen resistant|4|||
155346762|NCT01014013|560703383|FG000|Overall Study|Physician Decision|0|||
155346763|NCT01014013|560703384|FG001|Overall Study|Physician Decision|1|||
155346764|NCT01014013|560703383|FG000|Overall Study|Another antibiotic therapy required|0|||
155346765|NCT01014013|560703384|FG001|Overall Study|Another antibiotic therapy required|1|||
155346766|NCT01014013|560703383|FG000|Overall Study|Appendectomy|1|||
155346767|NCT01014013|560703384|FG001|Overall Study|Appendectomy|0|||
155346768|NCT01014013|560703383|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
155346769|NCT01014013|560703384|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
155346770|NCT03508830|560703391|FG000|Overall Study|Withdrawal by Subject|3|||
155346771|NCT03508830|560703392|FG001|Overall Study|Withdrawal by Subject|4|||
155346772|NCT03508830|560703391|FG000|Overall Study|Physician Decision|2|||
155346773|NCT03508830|560703392|FG001|Overall Study|Physician Decision|2|||
155346774|NCT02522299|560703393|FG000|Overall Study|Adverse Event|2|||
155346775|NCT02522299|560703394|FG001|Overall Study|Adverse Event|0|||
155346776|NCT02522299|560703393|FG000|Overall Study|Physician Decision|0|||
155346777|NCT02522299|560703394|FG001|Overall Study|Physician Decision|1|||
155346778|NCT02522299|560703393|FG000|Overall Study|Withdrawal by Subject|2|||
155346779|NCT02522299|560703394|FG001|Overall Study|Withdrawal by Subject|0|||
155346780|NCT02097056|560703397|FG000|Overall Study|Protocol Violation|2|||
155346781|NCT02097056|560703397|FG000|Overall Study|Withdrawal by Subject|15|||
155346782|NCT02097056|560703397|FG000|Overall Study|Lost to Follow-up|2|||
155346783|NCT02097056|560703397|FG000|Overall Study|Adverse Event|37|||
155346784|NCT02097056|560703397|FG000|Overall Study|Other|2|||
155080610|NCT03016403|559725400|FG000|6-week Follow-up|Lost to Follow-up|2|||
155080611|NCT03016403|559725401|FG001|6-week Follow-up|Lost to Follow-up|7|||
155080612|NCT03016403|559725402|FG002|6-week Follow-up|Lost to Follow-up|4|||
155080613|NCT03016403|559725403|FG003|6-week Follow-up|Lost to Follow-up|8|||
155080614|NCT03016403|559725400|FG000|6-week Follow-up|Withdrawal by Subject|0|||
155080615|NCT03016403|559725401|FG001|6-week Follow-up|Withdrawal by Subject|2|||
155080616|NCT03016403|559725402|FG002|6-week Follow-up|Withdrawal by Subject|0|||
155346785|NCT01446042|560703398|FG000|Overall Study|Withdrawal by Subject|12|||
155346786|NCT01446042|560703399|FG001|Overall Study|Withdrawal by Subject|2|||
155346787|NCT01446042|560703400|FG002|Overall Study|Withdrawal by Subject|4|||
155080617|NCT03016403|559725403|FG003|6-week Follow-up|Withdrawal by Subject|1|||
155080618|NCT03016403|559725400|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
155080619|NCT03016403|559725401|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
155080620|NCT03016403|559725402|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
155080621|NCT03016403|559725403|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
155080622|NCT03016403|559725400|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
155346788|NCT01446042|560703398|FG000|Overall Study|Adverse Event|1|||
155346789|NCT01446042|560703399|FG001|Overall Study|Adverse Event|0|||
155346790|NCT01446042|560703400|FG002|Overall Study|Adverse Event|4|||
155346791|NCT01446042|560703398|FG000|Overall Study|Lost to Follow-up|5|||
155346792|NCT01446042|560703399|FG001|Overall Study|Lost to Follow-up|0|||
155346793|NCT01446042|560703400|FG002|Overall Study|Lost to Follow-up|0|||
155346794|NCT01446042|560703398|FG000|Overall Study|Other reasons|2|||
155346795|NCT01446042|560703399|FG001|Overall Study|Other reasons|1|||
155080623|NCT03016403|559725401|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
155080624|NCT03016403|559725402|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
155080625|NCT03016403|559725403|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
155080626|NCT03016403|559725400|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
155080627|NCT03016403|559725401|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
155080628|NCT03016403|559725402|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
155080629|NCT03016403|559725403|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
155346796|NCT01446042|560703400|FG002|Overall Study|Other reasons|1|||
155346797|NCT03575572|560703407|FG000|Overall Study|Withdrawal by Subject|2|||
155346798|NCT03575572|560703407|FG000|Overall Study|Physician Decision|2|||
155346799|NCT04908800|560703408|FG000|Overall Study|Adverse Event|0|||
155346800|NCT04908800|560703409|FG001|Overall Study|Adverse Event|0|||
155346801|NCT04908800|560703410|FG002|Overall Study|Adverse Event|0|||
155346802|NCT04908800|560703411|FG003|Overall Study|Adverse Event|0|||
155346803|NCT04908800|560703412|FG004|Overall Study|Adverse Event|0|||
155346804|NCT04908800|560703413|FG005|Overall Study|Adverse Event|0|||
155346805|NCT04908800|560703414|FG006|Overall Study|Adverse Event|0|||
155346806|NCT04908800|560703415|FG007|Overall Study|Adverse Event|0|||
155346807|NCT04908800|560703416|FG008|Overall Study|Adverse Event|0|||
155346808|NCT04908800|560703417|FG009|Overall Study|Adverse Event|0|||
155346809|NCT04908800|560703418|FG010|Overall Study|Adverse Event|1|||
155346810|NCT04908800|560703419|FG011|Overall Study|Adverse Event|0|||
155346811|NCT04908800|560703420|FG012|Overall Study|Adverse Event|0|||
155080630|NCT05463705|559725404|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
155080631|NCT05463705|559725405|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
155346812|NCT03751280|560703421|FG000|Overall Study|Adverse Event|0|||
155346813|NCT03751280|560703422|FG001|Overall Study|Adverse Event|1|||
155346814|NCT03751280|560703421|FG000|Overall Study|Lost to Follow-up|3|||
155346815|NCT03751280|560703422|FG001|Overall Study|Lost to Follow-up|5|||
155346816|NCT03751280|560703421|FG000|Overall Study|Physician Decision|0|||
155346817|NCT03751280|560703422|FG001|Overall Study|Physician Decision|2|||
155346818|NCT03751280|560703421|FG000|Overall Study|Protocol Violation|0|||
155346819|NCT03751280|560703422|FG001|Overall Study|Protocol Violation|2|||
155346820|NCT03751280|560703421|FG000|Overall Study|Withdrawal by Subject|5|||
155346821|NCT03751280|560703422|FG001|Overall Study|Withdrawal by Subject|2|||
155346822|NCT00296504|560703424|FG000|Interim Analysis|Withdrawal by Subject|8|||
155346823|NCT00296504|560703425|FG001|Interim Analysis|Withdrawal by Subject|0|||
155346824|NCT00296504|560703426|FG002|Interim Analysis|Withdrawal by Subject|12|||
155346825|NCT00296504|560703427|FG003|Interim Analysis|Withdrawal by Subject|0|||
155346826|NCT00296504|560703428|FG004|Interim Analysis|Withdrawal by Subject|5|||
155346827|NCT00296504|560703429|FG005|Interim Analysis|Withdrawal by Subject|5|||
155346828|NCT00296504|560703430|FG006|Interim Analysis|Withdrawal by Subject|9|||
155346829|NCT00296504|560703431|FG007|Interim Analysis|Withdrawal by Subject|3|||
154963956|NCT03215706|559293503|FG000|Randomization|other reasons|0|||
155080632|NCT05463705|559725406|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
155080633|NCT05463705|559725407|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
155080634|NCT05463705|559725408|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
155080635|NCT05463705|559725409|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
155080636|NCT00079781|559725410|FG000|Pre-implant Period|Withdrawal by Subject|2|||
155080637|NCT00079781|559725411|FG001|Pre-implant Period|Withdrawal by Subject|0|||
155080638|NCT00079781|559725412|FG002|Pre-implant Period|Withdrawal by Subject|0|||
155080639|NCT00079781|559725410|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
155080640|NCT00079781|559725411|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
155080641|NCT00079781|559725412|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
155080642|NCT00079781|559725410|FG000|Follow-up Period|Withdrawal by Subject|3|||
155080643|NCT00079781|559725411|FG001|Follow-up Period|Withdrawal by Subject|0|||
155080644|NCT00079781|559725412|FG002|Follow-up Period|Withdrawal by Subject|1|||
155080645|NCT00079781|559725410|FG000|Follow-up Period|Lost to Follow-up|1|||
155080646|NCT00079781|559725411|FG001|Follow-up Period|Lost to Follow-up|0|||
155346830|NCT00296504|560703432|FG008|Interim Analysis|Withdrawal by Subject|0|||
155346831|NCT00296504|560703424|FG000|Interim Analysis|Lost to Follow-up|13|||
155346832|NCT00296504|560703425|FG001|Interim Analysis|Lost to Follow-up|3|||
155346833|NCT00296504|560703426|FG002|Interim Analysis|Lost to Follow-up|26|||
155346834|NCT00296504|560703427|FG003|Interim Analysis|Lost to Follow-up|8|||
155346835|NCT00296504|560703428|FG004|Interim Analysis|Lost to Follow-up|14|||
155346836|NCT00296504|560703429|FG005|Interim Analysis|Lost to Follow-up|4|||
155346837|NCT00296504|560703430|FG006|Interim Analysis|Lost to Follow-up|11|||
155346838|NCT00296504|560703431|FG007|Interim Analysis|Lost to Follow-up|4|||
155346839|NCT00296504|560703432|FG008|Interim Analysis|Lost to Follow-up|0|||
155346840|NCT00296504|560703424|FG000|Interim Analysis|Clinical Progression|1|||
155080647|NCT00079781|559725412|FG002|Follow-up Period|Lost to Follow-up|0|||
155080648|NCT00079781|559725410|FG000|Follow-up Period|Death|0|||
155080649|NCT00079781|559725411|FG001|Follow-up Period|Death|0|||
155080650|NCT00079781|559725412|FG002|Follow-up Period|Death|1|||
155080651|NCT00621322|559725413|FG000|Overall Study|Lost to Follow-up|0|||
155080652|NCT00621322|559725414|FG001|Overall Study|Lost to Follow-up|0|||
155080653|NCT00621322|559725415|FG002|Overall Study|Lost to Follow-up|0|||
155080654|NCT00621322|559725416|FG003|Overall Study|Lost to Follow-up|0|||
155080655|NCT00621322|559725417|FG004|Overall Study|Lost to Follow-up|1|||
155080656|NCT00621322|559725418|FG005|Overall Study|Lost to Follow-up|0|||
155080657|NCT00621322|559725413|FG000|Overall Study|Physician Decision|0|||
155080658|NCT00621322|559725414|FG001|Overall Study|Physician Decision|0|||
155080659|NCT00621322|559725415|FG002|Overall Study|Physician Decision|1|||
155080660|NCT00621322|559725416|FG003|Overall Study|Physician Decision|1|||
155080661|NCT00621322|559725417|FG004|Overall Study|Physician Decision|0|||
155080662|NCT00621322|559725418|FG005|Overall Study|Physician Decision|0|||
155080663|NCT00621322|559725413|FG000|Overall Study|Withdrawal by Subject|0|||
155346841|NCT00296504|560703425|FG001|Interim Analysis|Clinical Progression|0|||
155346842|NCT00296504|560703426|FG002|Interim Analysis|Clinical Progression|1|||
155346843|NCT00296504|560703427|FG003|Interim Analysis|Clinical Progression|1|||
155346844|NCT00296504|560703428|FG004|Interim Analysis|Clinical Progression|0|||
155346845|NCT00296504|560703429|FG005|Interim Analysis|Clinical Progression|2|||
155346846|NCT00296504|560703430|FG006|Interim Analysis|Clinical Progression|1|||
155346847|NCT00296504|560703431|FG007|Interim Analysis|Clinical Progression|2|||
155346848|NCT00296504|560703432|FG008|Interim Analysis|Clinical Progression|0|||
155346849|NCT00296504|560703424|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
155346850|NCT00296504|560703425|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
155346851|NCT00296504|560703426|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
155346852|NCT00296504|560703427|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
155346853|NCT00296504|560703428|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
155346854|NCT00296504|560703429|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
155346855|NCT00296504|560703430|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
155346856|NCT00296504|560703431|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
155346857|NCT00296504|560703432|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
155346858|NCT00296504|560703424|FG000|Interim Analysis|Adverse Event|0|||
155346859|NCT00296504|560703425|FG001|Interim Analysis|Adverse Event|0|||
155346860|NCT00296504|560703426|FG002|Interim Analysis|Adverse Event|13|||
155346861|NCT00296504|560703427|FG003|Interim Analysis|Adverse Event|4|||
155346862|NCT00296504|560703428|FG004|Interim Analysis|Adverse Event|6|||
155346863|NCT00296504|560703429|FG005|Interim Analysis|Adverse Event|3|||
155346864|NCT00296504|560703430|FG006|Interim Analysis|Adverse Event|4|||
155346865|NCT00296504|560703431|FG007|Interim Analysis|Adverse Event|5|||
155346866|NCT00296504|560703432|FG008|Interim Analysis|Adverse Event|0|||
155346867|NCT00296504|560703424|FG000|Interim Analysis|Protocol Violation|0|||
155346868|NCT00296504|560703425|FG001|Interim Analysis|Protocol Violation|0|||
155346869|NCT00296504|560703426|FG002|Interim Analysis|Protocol Violation|2|||
155346870|NCT00296504|560703427|FG003|Interim Analysis|Protocol Violation|0|||
155346871|NCT00296504|560703428|FG004|Interim Analysis|Protocol Violation|1|||
155346872|NCT00296504|560703429|FG005|Interim Analysis|Protocol Violation|0|||
155346873|NCT00296504|560703430|FG006|Interim Analysis|Protocol Violation|0|||
155346874|NCT00296504|560703431|FG007|Interim Analysis|Protocol Violation|1|||
155346875|NCT00296504|560703432|FG008|Interim Analysis|Protocol Violation|0|||
155346876|NCT00296504|560703424|FG000|Interim Analysis|Insufficient CD4 Response|0|||
155346877|NCT00296504|560703425|FG001|Interim Analysis|Insufficient CD4 Response|0|||
155346878|NCT00296504|560703426|FG002|Interim Analysis|Insufficient CD4 Response|0|||
155346879|NCT00296504|560703427|FG003|Interim Analysis|Insufficient CD4 Response|0|||
155346880|NCT00296504|560703428|FG004|Interim Analysis|Insufficient CD4 Response|1|||
155080664|NCT00621322|559725414|FG001|Overall Study|Withdrawal by Subject|0|||
155080665|NCT00621322|559725415|FG002|Overall Study|Withdrawal by Subject|0|||
155080666|NCT00621322|559725416|FG003|Overall Study|Withdrawal by Subject|1|||
155165527|NCT04661579|560043478|FG002|Overall Study|Withdrawal by Subject|0|||
155165528|NCT04661579|560043479|FG003|Overall Study|Withdrawal by Subject|2|||
155165529|NCT04661579|560043480|FG004|Overall Study|Withdrawal by Subject|0|||
155346881|NCT00296504|560703429|FG005|Interim Analysis|Insufficient CD4 Response|1|||
155346882|NCT00296504|560703430|FG006|Interim Analysis|Insufficient CD4 Response|0|||
155346883|NCT00296504|560703431|FG007|Interim Analysis|Insufficient CD4 Response|0|||
155080667|NCT00621322|559725417|FG004|Overall Study|Withdrawal by Subject|0|||
155080668|NCT00621322|559725418|FG005|Overall Study|Withdrawal by Subject|2|||
155346884|NCT00296504|560703432|FG008|Interim Analysis|Insufficient CD4 Response|0|||
155346885|NCT00296504|560703424|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
155346886|NCT00296504|560703425|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
155346887|NCT00296504|560703426|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
155346888|NCT00296504|560703427|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
155346889|NCT00296504|560703428|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
155346890|NCT00296504|560703429|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
155080669|NCT00621322|559725413|FG000|Overall Study|Migrated/moved from study area|1|||
155080670|NCT00621322|559725414|FG001|Overall Study|Migrated/moved from study area|0|||
155080671|NCT00621322|559725415|FG002|Overall Study|Migrated/moved from study area|1|||
155080672|NCT00621322|559725416|FG003|Overall Study|Migrated/moved from study area|1|||
155080673|NCT00621322|559725417|FG004|Overall Study|Migrated/moved from study area|0|||
155080674|NCT00621322|559725418|FG005|Overall Study|Migrated/moved from study area|2|||
155080675|NCT00576407|559725419|FG000|Overall Study|Death|7|||
155080676|NCT00576407|559725419|FG000|Overall Study|Physician Decision|1|||
155080677|NCT01530997|559725423|FG000|Overall Study|Physician Decision|1|||
155080678|NCT01530997|559725423|FG000|Overall Study|Withdrawal by Subject|1|||
155080679|NCT01309100|559725426|FG000|Overall Study|Protocol Violation|1|||
155080680|NCT01309100|559725426|FG000|Overall Study|Positive Slit lamp finding|1|||
155080681|NCT00407030|559725427|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
155080682|NCT00407030|559725428|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
155080683|NCT00407030|559725429|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
155080684|NCT00407030|559725427|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
155080685|NCT00407030|559725428|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
155080686|NCT00407030|559725429|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
155080687|NCT00407030|559725427|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
155080688|NCT00407030|559725428|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
155080689|NCT00407030|559725429|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
155080690|NCT00407030|559725427|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
155080691|NCT00407030|559725428|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
155080692|NCT00407030|559725429|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
155080693|NCT00407030|559725427|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
155080694|NCT00407030|559725428|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
155080695|NCT00407030|559725429|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
155080696|NCT00407030|559725427|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
155080697|NCT00407030|559725428|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
155080698|NCT00407030|559725429|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
155080699|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
155080700|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
155080701|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
155080702|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
155080703|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
155080704|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
155080705|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
155080706|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
155080707|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
155080708|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
155080709|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
155080710|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
155080711|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
155080712|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
155080713|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
155080714|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
155080715|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
155346891|NCT00296504|560703430|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
155346892|NCT00296504|560703431|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
155346893|NCT00296504|560703432|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
155346894|NCT00296504|560703424|FG000|Interim Analysis|Pregnancy|4|||
155346895|NCT00296504|560703425|FG001|Interim Analysis|Pregnancy|1|||
155346896|NCT00296504|560703426|FG002|Interim Analysis|Pregnancy|4|||
155346897|NCT00296504|560703427|FG003|Interim Analysis|Pregnancy|2|||
155346898|NCT00296504|560703428|FG004|Interim Analysis|Pregnancy|0|||
155346899|NCT00296504|560703429|FG005|Interim Analysis|Pregnancy|1|||
155346900|NCT00296504|560703430|FG006|Interim Analysis|Pregnancy|1|||
155346901|NCT00296504|560703431|FG007|Interim Analysis|Pregnancy|1|||
155346902|NCT00296504|560703432|FG008|Interim Analysis|Pregnancy|0|||
155346903|NCT00296504|560703424|FG000|Interim Analysis|Death|1|||
154963957|NCT03215706|559293504|FG001|Randomization|other reasons|2|||
154963958|NCT03215706|559293503|FG000|Treatment Period|Disease Progression|184|||
154963959|NCT03215706|559293504|FG001|Treatment Period|Disease Progression|174|||
154963960|NCT03215706|559293503|FG000|Treatment Period|Study Drug Toxicity|70|||
155080716|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
155080717|NCT00407030|559725427|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
155080718|NCT00407030|559725428|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
155346904|NCT00296504|560703425|FG001|Interim Analysis|Death|0|||
155346905|NCT00296504|560703426|FG002|Interim Analysis|Death|3|||
155346906|NCT00296504|560703427|FG003|Interim Analysis|Death|0|||
155346907|NCT00296504|560703428|FG004|Interim Analysis|Death|0|||
155346908|NCT00296504|560703429|FG005|Interim Analysis|Death|0|||
155080719|NCT00407030|559725429|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
155080720|NCT03722030|559725430|FG000|Overall Study|Withdrawal by Subject|1|||
155080721|NCT03722030|559725431|FG001|Overall Study|Withdrawal by Subject|0|||
155080722|NCT00754559|559725435|FG000|Overall Study|Adverse Event|15|||
155080723|NCT00754559|559725435|FG000|Overall Study|Protocol Violation|11|||
155080724|NCT00754559|559725435|FG000|Overall Study|Lack of Efficacy|10|||
155080725|NCT00754559|559725435|FG000|Overall Study|Lost to Follow-up|2|||
155080726|NCT00754559|559725435|FG000|Overall Study|Administrative reason|1|||
155080727|NCT00754559|559725435|FG000|Overall Study|Other|5|||
155080728|NCT00754559|559725435|FG000|Overall Study|Withdrawal by Subject|3|||
155080729|NCT00345592|559725437|FG000|Overall Study|Death|14|||
155080730|NCT00345592|559725438|FG001|Overall Study|Death|16|||
155080731|NCT00345592|559725437|FG000|Overall Study|Withdrawal by Subject|11|||
155080732|NCT00345592|559725438|FG001|Overall Study|Withdrawal by Subject|8|||
155080733|NCT01663987|559725439|FG000|Overall Study|Adverse Event|7|||
155080734|NCT01663987|559725440|FG001|Overall Study|Adverse Event|2|||
155080735|NCT01663987|559725439|FG000|Overall Study|Lost to Follow-up|1|||
155080736|NCT01663987|559725440|FG001|Overall Study|Lost to Follow-up|1|||
155080737|NCT01663987|559725439|FG000|Overall Study|Withdrawal by Subject|2|||
155080738|NCT01663987|559725440|FG001|Overall Study|Withdrawal by Subject|3|||
155080739|NCT01663987|559725439|FG000|Overall Study|Other reason not defined above|3|||
155080740|NCT01663987|559725440|FG001|Overall Study|Other reason not defined above|0|||
155080741|NCT04000724|559725444|FG000|Overall Study|Withdrawal by Subject|5|||
155080742|NCT04000724|559725445|FG001|Overall Study|Withdrawal by Subject|3|||
155080743|NCT04000724|559725446|FG002|Overall Study|Withdrawal by Subject|4|||
155080744|NCT04000724|559725444|FG000|Overall Study|Lost to Follow-up|11|||
155080745|NCT04000724|559725445|FG001|Overall Study|Lost to Follow-up|7|||
155080746|NCT04000724|559725446|FG002|Overall Study|Lost to Follow-up|13|||
155080747|NCT00455455|559725447|FG000|Washout|Withdrawal by Subject|0|||
155080748|NCT00455455|559725448|FG001|Washout|Withdrawal by Subject|1|||
155080749|NCT00455455|559725447|FG000|Washout|Withdrawal by Subject|1|||
155080750|NCT00455455|559725448|FG001|Washout|Withdrawal by Subject|0|||
155080751|NCT01370538|559725449|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
155080752|NCT01370538|559725450|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
155080753|NCT01370538|559725449|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155080754|NCT01370538|559725450|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155080755|NCT01370538|559725449|FG000|Overall Study|Adverse Event|1|||
155080756|NCT01370538|559725450|FG001|Overall Study|Adverse Event|0|||
155080757|NCT01370538|559725449|FG000|Overall Study|Protocol Violation|8|||
155080758|NCT01370538|559725450|FG001|Overall Study|Protocol Violation|5|||
155080759|NCT01370538|559725449|FG000|Overall Study|Development of study specific withdrawal|1|||
155080760|NCT01370538|559725450|FG001|Overall Study|Development of study specific withdrawal|1|||
155080761|NCT01370538|559725449|FG000|Overall Study|Lost to follow up|6|||
155080762|NCT01370538|559725450|FG001|Overall Study|Lost to follow up|10|||
155080763|NCT01084135|559725451|FG000|20 Week|Physician Decision|0|||
155080764|NCT01084135|559725452|FG001|20 Week|Physician Decision|1|||
155346909|NCT00296504|560703430|FG006|Interim Analysis|Death|0|||
155346910|NCT00296504|560703431|FG007|Interim Analysis|Death|0|||
155346911|NCT00296504|560703432|FG008|Interim Analysis|Death|0|||
155346912|NCT00296504|560703424|FG000|Interim Analysis|Participant Non-compliant|0|||
155346913|NCT00296504|560703425|FG001|Interim Analysis|Participant Non-compliant|1|||
155346914|NCT00296504|560703426|FG002|Interim Analysis|Participant Non-compliant|2|||
155346915|NCT00296504|560703427|FG003|Interim Analysis|Participant Non-compliant|1|||
155346916|NCT00296504|560703428|FG004|Interim Analysis|Participant Non-compliant|1|||
155346917|NCT00296504|560703429|FG005|Interim Analysis|Participant Non-compliant|3|||
155346918|NCT00296504|560703430|FG006|Interim Analysis|Participant Non-compliant|6|||
155346919|NCT00296504|560703431|FG007|Interim Analysis|Participant Non-compliant|2|||
155346920|NCT00296504|560703432|FG008|Interim Analysis|Participant Non-compliant|0|||
155346921|NCT00296504|560703424|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346922|NCT00296504|560703425|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346923|NCT00296504|560703426|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
155080765|NCT02366130|559725453|FG000|Overall Study|Withdrawal by Subject|3|||
155080766|NCT02366130|559725453|FG000|Overall Study|Ineligible|6|||
155346924|NCT00296504|560703427|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155080767|NCT01065766|559725454|FG000|Overall Study|Assessed before the contracted date|1|||
155080768|NCT01065766|559725454|FG000|Overall Study|Contraindication to administration|6|||
155080769|NCT01065766|559725454|FG000|Overall Study|Violated dosage/administration|25|||
155080770|NCT02945046|559725459|FG000|Overall Study|Adverse Event|1|||
155080771|NCT02945046|559725460|FG001|Overall Study|Adverse Event|0|||
155080772|NCT02945046|559725461|FG002|Overall Study|Adverse Event|2|||
155080773|NCT02945046|559725459|FG000|Overall Study|Withdrawal by Subject|3|||
155080774|NCT02945046|559725460|FG001|Overall Study|Withdrawal by Subject|3|||
155080775|NCT02945046|559725461|FG002|Overall Study|Withdrawal by Subject|3|||
155080776|NCT02945046|559725459|FG000|Overall Study|Protocol Violation|2|||
155346925|NCT00296504|560703428|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155080777|NCT02945046|559725460|FG001|Overall Study|Protocol Violation|3|||
155080778|NCT02945046|559725461|FG002|Overall Study|Protocol Violation|2|||
155080779|NCT02945046|559725459|FG000|Overall Study|Lost to Follow-up|1|||
155080780|NCT02945046|559725460|FG001|Overall Study|Lost to Follow-up|1|||
155080781|NCT02945046|559725461|FG002|Overall Study|Lost to Follow-up|0|||
155080782|NCT02945046|559725459|FG000|Overall Study|Lack of Efficacy|1|||
155080783|NCT02945046|559725460|FG001|Overall Study|Lack of Efficacy|2|||
155346926|NCT00296504|560703429|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
155346927|NCT00296504|560703430|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346928|NCT00296504|560703431|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346929|NCT00296504|560703432|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
155346930|NCT00296504|560703424|FG000|Interim Analysis|To Simplify Treatment|0|||
155346931|NCT00296504|560703425|FG001|Interim Analysis|To Simplify Treatment|0|||
155346932|NCT00296504|560703426|FG002|Interim Analysis|To Simplify Treatment|1|||
155346933|NCT00296504|560703427|FG003|Interim Analysis|To Simplify Treatment|0|||
155346934|NCT00296504|560703428|FG004|Interim Analysis|To Simplify Treatment|0|||
155346935|NCT00296504|560703429|FG005|Interim Analysis|To Simplify Treatment|0|||
155346936|NCT00296504|560703430|FG006|Interim Analysis|To Simplify Treatment|2|||
155346937|NCT00296504|560703431|FG007|Interim Analysis|To Simplify Treatment|0|||
155346938|NCT00296504|560703432|FG008|Interim Analysis|To Simplify Treatment|0|||
155346939|NCT00296504|560703424|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346940|NCT00296504|560703425|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346941|NCT00296504|560703426|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
155346942|NCT00296504|560703427|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346943|NCT00296504|560703428|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346944|NCT00296504|560703429|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346945|NCT00296504|560703430|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346946|NCT00296504|560703431|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346947|NCT00296504|560703432|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
155346948|NCT00296504|560703424|FG000|Interim Analysis|Participant Moved|1|||
155346949|NCT00296504|560703425|FG001|Interim Analysis|Participant Moved|0|||
155346950|NCT00296504|560703426|FG002|Interim Analysis|Participant Moved|1|||
155346951|NCT00296504|560703427|FG003|Interim Analysis|Participant Moved|0|||
155346952|NCT00296504|560703428|FG004|Interim Analysis|Participant Moved|0|||
155346953|NCT00296504|560703429|FG005|Interim Analysis|Participant Moved|1|||
155346954|NCT00296504|560703430|FG006|Interim Analysis|Participant Moved|1|||
155346955|NCT00296504|560703431|FG007|Interim Analysis|Participant Moved|0|||
155346956|NCT00296504|560703432|FG008|Interim Analysis|Participant Moved|0|||
155346957|NCT00296504|560703424|FG000|Interim Analysis|Participant Was Incarcerated|2|||
155346958|NCT00296504|560703425|FG001|Interim Analysis|Participant Was Incarcerated|0|||
155346959|NCT00296504|560703426|FG002|Interim Analysis|Participant Was Incarcerated|1|||
155346960|NCT00296504|560703427|FG003|Interim Analysis|Participant Was Incarcerated|0|||
155346961|NCT00296504|560703428|FG004|Interim Analysis|Participant Was Incarcerated|0|||
155346962|NCT00296504|560703429|FG005|Interim Analysis|Participant Was Incarcerated|0|||
155346963|NCT00296504|560703430|FG006|Interim Analysis|Participant Was Incarcerated|0|||
155346964|NCT00296504|560703431|FG007|Interim Analysis|Participant Was Incarcerated|0|||
155346965|NCT00296504|560703432|FG008|Interim Analysis|Participant Was Incarcerated|0|||
155080784|NCT02945046|559725461|FG002|Overall Study|Lack of Efficacy|1|||
155080785|NCT02945046|559725459|FG000|Overall Study|Other than specified|5|||
155346966|NCT00296504|560703424|FG000|Interim Analysis|Resistance to FPV|0|||
155346967|NCT00296504|560703425|FG001|Interim Analysis|Resistance to FPV|0|||
155346968|NCT00296504|560703426|FG002|Interim Analysis|Resistance to FPV|1|||
155346969|NCT00296504|560703427|FG003|Interim Analysis|Resistance to FPV|0|||
155346970|NCT00296504|560703428|FG004|Interim Analysis|Resistance to FPV|0|||
155346971|NCT00296504|560703429|FG005|Interim Analysis|Resistance to FPV|0|||
155346972|NCT00296504|560703430|FG006|Interim Analysis|Resistance to FPV|0|||
155080786|NCT02945046|559725460|FG001|Overall Study|Other than specified|4|||
155080787|NCT02945046|559725461|FG002|Overall Study|Other than specified|7|||
155080788|NCT01608308|559725463|FG000|Overall Study|pretreatment medical and billing reasons|0|||
155080789|NCT01608308|559725464|FG001|Overall Study|pretreatment medical and billing reasons|2|||
155080790|NCT00032487|559725476|FG000|Overall Study|Withdrawal by Subject|67|||
155080791|NCT00032487|559725477|FG001|Overall Study|Withdrawal by Subject|43|||
155080792|NCT00032487|559725476|FG000|Overall Study|Adverse Event|3|||
155346973|NCT00296504|560703431|FG007|Interim Analysis|Resistance to FPV|0|||
155346974|NCT00296504|560703432|FG008|Interim Analysis|Resistance to FPV|0|||
155346975|NCT00296504|560703424|FG000|Interim Analysis|Physician Decision|0|||
155346976|NCT00296504|560703425|FG001|Interim Analysis|Physician Decision|0|||
155080793|NCT00032487|559725477|FG001|Overall Study|Adverse Event|7|||
155080794|NCT00032487|559725476|FG000|Overall Study|Lost to Follow-up|57|||
155080795|NCT00032487|559725477|FG001|Overall Study|Lost to Follow-up|58|||
155080796|NCT00032487|559725476|FG000|Overall Study|Had other reason|12|||
155080797|NCT00032487|559725477|FG001|Overall Study|Had other reason|12|||
155080798|NCT01117350|559725487|FG000|Comparative Period|Not Treated|5|||
155080799|NCT01117350|559725488|FG001|Comparative Period|Not Treated|8|||
155080800|NCT01117350|559725487|FG000|Comparative Period|Adverse Event|6|||
155080801|NCT01117350|559725488|FG001|Comparative Period|Adverse Event|33|||
155080802|NCT01117350|559725487|FG000|Comparative Period|Lost to Follow-up|11|||
155080803|NCT01117350|559725488|FG001|Comparative Period|Lost to Follow-up|7|||
155080804|NCT01117350|559725487|FG000|Comparative Period|Withdrawal by Subject|9|||
155080805|NCT01117350|559725488|FG001|Comparative Period|Withdrawal by Subject|13|||
155080806|NCT01117350|559725487|FG000|Comparative Period|Protocol Violation|8|||
155080807|NCT01117350|559725488|FG001|Comparative Period|Protocol Violation|12|||
155080808|NCT01117350|559725487|FG000|Comparative Period|Lack of Efficacy|1|||
155080809|NCT01117350|559725488|FG001|Comparative Period|Lack of Efficacy|0|||
155080810|NCT01117350|559725487|FG000|Comparative Period|Physician Decision|0|||
155080811|NCT01117350|559725488|FG001|Comparative Period|Physician Decision|1|||
155080812|NCT01117350|559725487|FG000|Comparative Period|Move to another city/country|2|||
155080813|NCT01117350|559725488|FG001|Comparative Period|Move to another city/country|1|||
155080814|NCT01117350|559725487|FG000|Extension Period|Not included in extension, not treated|0|||
155080815|NCT01117350|559725488|FG001|Extension Period|Not included in extension, not treated|50|||
155080816|NCT01117350|559725487|FG000|Extension Period|Adverse Event|0|||
155080817|NCT01117350|559725488|FG001|Extension Period|Adverse Event|2|||
155080818|NCT01117350|559725487|FG000|Extension Period|Protocol Violation|0|||
155080819|NCT01117350|559725488|FG001|Extension Period|Protocol Violation|2|||
155080820|NCT01117350|559725487|FG000|Extension Period|Lost to Follow-up|0|||
155080821|NCT01117350|559725488|FG001|Extension Period|Lost to Follow-up|2|||
155080822|NCT01117350|559725487|FG000|Extension Period|Withdrawal by Subject|0|||
155080823|NCT01117350|559725488|FG001|Extension Period|Withdrawal by Subject|3|||
155080824|NCT01117350|559725487|FG000|Extension Period|Lack of Efficacy|0|||
155080825|NCT01117350|559725488|FG001|Extension Period|Lack of Efficacy|2|||
155080826|NCT01117350|559725487|FG000|Extension Period|Inclusion criteria not respected|0|||
155080827|NCT01117350|559725488|FG001|Extension Period|Inclusion criteria not respected|1|||
155080828|NCT01117350|559725487|FG000|Extension Period|Prohibited medication|0|||
155080829|NCT01117350|559725488|FG001|Extension Period|Prohibited medication|1|||
155080830|NCT02487199|559725495|FG000|Overall Study|Withdrew Consent|0|||
155080831|NCT02487199|559725496|FG001|Overall Study|Withdrew Consent|1|||
155080832|NCT02004275|559726958|FG000|Phase 1|Ineligible|0|||
155080833|NCT02004275|559726959|FG001|Phase 1|Ineligible|0|||
155080834|NCT02004275|559726960|FG002|Phase 1|Ineligible|0|||
155080835|NCT02004275|559726961|FG003|Phase 1|Ineligible|1|||
155080836|NCT02004275|559726962|FG004|Phase 1|Ineligible|1|||
155080837|NCT02004275|559726963|FG005|Phase 1|Ineligible|0|||
155080838|NCT02004275|559726958|FG000|Phase 1|Protocol Violation|0|||
155080839|NCT02004275|559726959|FG001|Phase 1|Protocol Violation|0|||
155080840|NCT02004275|559726960|FG002|Phase 1|Protocol Violation|0|||
155080841|NCT02004275|559726961|FG003|Phase 1|Protocol Violation|1|||
155346977|NCT00296504|560703426|FG002|Interim Analysis|Physician Decision|1|||
155346978|NCT00296504|560703427|FG003|Interim Analysis|Physician Decision|0|||
155346979|NCT00296504|560703428|FG004|Interim Analysis|Physician Decision|0|||
155346980|NCT00296504|560703429|FG005|Interim Analysis|Physician Decision|0|||
155346981|NCT00296504|560703430|FG006|Interim Analysis|Physician Decision|0|||
155080842|NCT02004275|559726962|FG004|Phase 1|Protocol Violation|0|||
155080843|NCT02004275|559726963|FG005|Phase 1|Protocol Violation|5|||
155080844|NCT02004275|559726958|FG000|Phase 2 Part 1|Ineligible|6|||
155080845|NCT02004275|559726959|FG001|Phase 2 Part 1|Ineligible|9|||
155080846|NCT02004275|559726960|FG002|Phase 2 Part 1|Ineligible|0|||
155080847|NCT02004275|559726961|FG003|Phase 2 Part 1|Ineligible|0|||
155080848|NCT02004275|559726962|FG004|Phase 2 Part 1|Ineligible|0|||
155080849|NCT02004275|559726963|FG005|Phase 2 Part 1|Ineligible|0|||
155080850|NCT02004275|559726958|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
155080851|NCT02004275|559726959|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
155080852|NCT02004275|559726960|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
155346982|NCT00296504|560703431|FG007|Interim Analysis|Physician Decision|0|||
155346983|NCT00296504|560703432|FG008|Interim Analysis|Physician Decision|0|||
155080853|NCT02004275|559726961|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
155346984|NCT00296504|560703424|FG000|Interim Analysis|Principle Investigator Discretion|2|||
155346985|NCT00296504|560703425|FG001|Interim Analysis|Principle Investigator Discretion|0|||
155346986|NCT00296504|560703426|FG002|Interim Analysis|Principle Investigator Discretion|1|||
155346987|NCT00296504|560703427|FG003|Interim Analysis|Principle Investigator Discretion|1|||
155346988|NCT00296504|560703428|FG004|Interim Analysis|Principle Investigator Discretion|0|||
155080854|NCT02004275|559726962|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
155080855|NCT02004275|559726963|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
155080856|NCT00458705|559726964|FG000|Overall Study|Adverse Event|4|||
155080857|NCT00458705|559726964|FG000|Overall Study|Not Treated|1|||
155080858|NCT01133977|559726975|FG000|Overall Study|Adverse Event|0|||
155080859|NCT01133977|559726976|FG001|Overall Study|Adverse Event|0|||
155080860|NCT01133977|559726977|FG002|Overall Study|Adverse Event|1|||
155080861|NCT01133977|559726978|FG003|Overall Study|Adverse Event|0|||
155080862|NCT01133977|559726979|FG004|Overall Study|Adverse Event|0|||
155080863|NCT01133977|559726975|FG000|Overall Study|Death|1|||
155080864|NCT01133977|559726976|FG001|Overall Study|Death|1|||
155080865|NCT01133977|559726977|FG002|Overall Study|Death|1|||
155080866|NCT01133977|559726978|FG003|Overall Study|Death|7|||
155080867|NCT01133977|559726979|FG004|Overall Study|Death|3|||
155080868|NCT01133977|559726975|FG000|Overall Study|Started a New Line of Therapy|2|||
155080869|NCT01133977|559726976|FG001|Overall Study|Started a New Line of Therapy|6|||
155080870|NCT01133977|559726977|FG002|Overall Study|Started a New Line of Therapy|4|||
155080871|NCT01133977|559726978|FG003|Overall Study|Started a New Line of Therapy|25|||
155080872|NCT01133977|559726979|FG004|Overall Study|Started a New Line of Therapy|33|||
155080873|NCT01133977|559726975|FG000|Overall Study|Lost to Follow-up|0|||
155080874|NCT01133977|559726976|FG001|Overall Study|Lost to Follow-up|0|||
155080875|NCT01133977|559726977|FG002|Overall Study|Lost to Follow-up|0|||
155080876|NCT01133977|559726978|FG003|Overall Study|Lost to Follow-up|2|||
155080877|NCT01133977|559726979|FG004|Overall Study|Lost to Follow-up|1|||
155080878|NCT01133977|559726975|FG000|Overall Study|Withdrawal by Subject|0|||
155080879|NCT01133977|559726976|FG001|Overall Study|Withdrawal by Subject|0|||
155080880|NCT01133977|559726977|FG002|Overall Study|Withdrawal by Subject|0|||
155080881|NCT01133977|559726978|FG003|Overall Study|Withdrawal by Subject|5|||
155080882|NCT01133977|559726979|FG004|Overall Study|Withdrawal by Subject|1|||
155080883|NCT02462057|559726980|FG000|Overall Study|Left Vitality|32|||
155080884|NCT02462057|559726981|FG001|Overall Study|Left Vitality|27|||
155080885|NCT02462057|559726982|FG002|Overall Study|Left Vitality|23|||
155080886|NCT02462057|559726983|FG003|Overall Study|Left Vitality|35|||
155080887|NCT02462057|559726984|FG004|Overall Study|Left Vitality|33|||
155080888|NCT02462057|559726980|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
155080889|NCT02462057|559726981|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
155080890|NCT02462057|559726982|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
155080891|NCT02462057|559726983|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
155080892|NCT02462057|559726984|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
155080893|NCT03071965|559727001|FG000|Overall Study|Adverse Event|0|||
155080894|NCT03071965|559727002|FG001|Overall Study|Adverse Event|0|||
155080895|NCT03071965|559727003|FG002|Overall Study|Adverse Event|1|||
155080896|NCT03071965|559727004|FG003|Overall Study|Adverse Event|0|||
155080897|NCT03071965|559727001|FG000|Overall Study|Death|0|||
155080898|NCT03071965|559727002|FG001|Overall Study|Death|0|||
155080899|NCT03071965|559727003|FG002|Overall Study|Death|1|||
155080900|NCT03071965|559727004|FG003|Overall Study|Death|1|||
155080901|NCT03071965|559727001|FG000|Overall Study|COVID-19|0|||
155080902|NCT03071965|559727002|FG001|Overall Study|COVID-19|1|||
155080903|NCT03071965|559727003|FG002|Overall Study|COVID-19|0|||
155080904|NCT03071965|559727004|FG003|Overall Study|COVID-19|1|||
155080905|NCT03071965|559727001|FG000|Overall Study|Other Health Reason|0|||
155080906|NCT03071965|559727002|FG001|Overall Study|Other Health Reason|0|||
155080907|NCT03071965|559727003|FG002|Overall Study|Other Health Reason|0|||
155080908|NCT03071965|559727004|FG003|Overall Study|Other Health Reason|1|||
155080909|NCT01655069|559727005|FG000|Overall Study|Physician Decision|0|||
155080910|NCT01655069|559727006|FG001|Overall Study|Physician Decision|0|||
155080911|NCT01655069|559727007|FG002|Overall Study|Physician Decision|0|||
155080912|NCT01655069|559727008|FG003|Overall Study|Physician Decision|1|||
155080913|NCT01655069|559727005|FG000|Overall Study|Adverse Event|6|||
155080914|NCT01655069|559727006|FG001|Overall Study|Adverse Event|7|||
155080915|NCT01655069|559727007|FG002|Overall Study|Adverse Event|2|||
155080916|NCT01655069|559727008|FG003|Overall Study|Adverse Event|3|||
155080917|NCT01655069|559727005|FG000|Overall Study|Lack of Efficacy|0|||
155080918|NCT01655069|559727006|FG001|Overall Study|Lack of Efficacy|1|||
155080919|NCT01655069|559727007|FG002|Overall Study|Lack of Efficacy|0|||
155080920|NCT01655069|559727008|FG003|Overall Study|Lack of Efficacy|0|||
155080921|NCT01655069|559727005|FG000|Overall Study|No Treatment Needed|0|||
155080922|NCT01655069|559727006|FG001|Overall Study|No Treatment Needed|1|||
155080923|NCT01655069|559727007|FG002|Overall Study|No Treatment Needed|0|||
155346989|NCT00296504|560703429|FG005|Interim Analysis|Principle Investigator Discretion|0|||
155346990|NCT00296504|560703430|FG006|Interim Analysis|Principle Investigator Discretion|0|||
155080924|NCT01655069|559727008|FG003|Overall Study|No Treatment Needed|0|||
155080925|NCT01655069|559727005|FG000|Overall Study|Withdrawal by Subject|2|||
155080926|NCT01655069|559727006|FG001|Overall Study|Withdrawal by Subject|3|||
155080927|NCT01655069|559727007|FG002|Overall Study|Withdrawal by Subject|0|||
155080928|NCT01655069|559727008|FG003|Overall Study|Withdrawal by Subject|0|||
155080929|NCT04034056|559727009|FG000|Overall Study|Withdrawal by Subject|2|||
155080930|NCT04034056|559727009|FG000|Overall Study|Reason Not Specified|13|||
155080931|NCT04034056|559727009|FG000|Overall Study|Adverse Event|56|||
155080932|NCT00609973|559727010|FG000|Overall Study|Adverse Event|2|||
155080933|NCT00609973|559727011|FG001|Overall Study|Adverse Event|1|||
155080934|NCT00609973|559727010|FG000|Overall Study|Protocol Violation|4|||
155080935|NCT00609973|559727011|FG001|Overall Study|Protocol Violation|3|||
155080936|NCT00609973|559727010|FG000|Overall Study|Lost to Follow-up|2|||
155080937|NCT00609973|559727011|FG001|Overall Study|Lost to Follow-up|1|||
155080938|NCT00609973|559727010|FG000|Overall Study|Withdrawal by Subject|0|||
155080939|NCT00609973|559727011|FG001|Overall Study|Withdrawal by Subject|1|||
155080940|NCT01362270|559727012|FG000|Overall Study|Withdrawal by Subject|1|||
155080941|NCT01362270|559727013|FG001|Overall Study|Withdrawal by Subject|0|||
155080942|NCT01362270|559727012|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
155080943|NCT01362270|559727013|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
155080944|NCT01362270|559727012|FG000|Overall Study|Met excl. criteria before 1st session|1|||
155080945|NCT01362270|559727013|FG001|Overall Study|Met excl. criteria before 1st session|1|||
155080946|NCT01691482|559727014|FG000|Treatment Period 2|Adverse Event|0|||
155080947|NCT01691482|559727015|FG001|Treatment Period 2|Adverse Event|1|||
155080948|NCT01691482|559727014|FG000|Treatment Period 2|Protocol Violation|1|||
155080949|NCT01691482|559727015|FG001|Treatment Period 2|Protocol Violation|1|||
155080950|NCT02571244|559727016|FG000|Overall Study|Lost to Follow-up|0|||
155080951|NCT02571244|559727017|FG001|Overall Study|Lost to Follow-up|1|||
155080952|NCT02571244|559727016|FG000|Overall Study|Unable to reach out post discharge|3|||
155080953|NCT02571244|559727017|FG001|Overall Study|Unable to reach out post discharge|0|||
155080954|NCT01696214|559727018|FG000|Overall Study|Lost to Follow-up|1|||
155080955|NCT01696214|559727019|FG001|Overall Study|Lost to Follow-up|0|||
155080956|NCT01696214|559727020|FG002|Overall Study|Lost to Follow-up|0|||
155080957|NCT01696214|559727021|FG003|Overall Study|Lost to Follow-up|0|||
155080958|NCT02134028|559727022|FG000|Overall Study|Lack of Efficacy|1|||
155080959|NCT02134028|559727023|FG001|Overall Study|Lack of Efficacy|0|||
155080960|NCT02134028|559727024|FG002|Overall Study|Lack of Efficacy|3|||
155080961|NCT02134028|559727025|FG003|Overall Study|Lack of Efficacy|2|||
155080962|NCT02134028|559727026|FG004|Overall Study|Lack of Efficacy|1|||
155080963|NCT02134028|559727027|FG005|Overall Study|Lack of Efficacy|2|||
155080964|NCT02134028|559727028|FG006|Overall Study|Lack of Efficacy|1|||
155080965|NCT02134028|559727029|FG007|Overall Study|Lack of Efficacy|0|||
155080966|NCT02134028|559727022|FG000|Overall Study|Poor compliance to protocol|1|||
155080967|NCT02134028|559727023|FG001|Overall Study|Poor compliance to protocol|1|||
155080968|NCT02134028|559727024|FG002|Overall Study|Poor compliance to protocol|3|||
155080969|NCT02134028|559727025|FG003|Overall Study|Poor compliance to protocol|7|||
155080970|NCT02134028|559727026|FG004|Overall Study|Poor compliance to protocol|1|||
155080971|NCT02134028|559727027|FG005|Overall Study|Poor compliance to protocol|1|||
155080972|NCT02134028|559727028|FG006|Overall Study|Poor compliance to protocol|0|||
155080973|NCT02134028|559727029|FG007|Overall Study|Poor compliance to protocol|0|||
155080974|NCT02134028|559727022|FG000|Overall Study|Other unspecified|4|||
155080975|NCT02134028|559727023|FG001|Overall Study|Other unspecified|22|||
155080976|NCT02134028|559727024|FG002|Overall Study|Other unspecified|33|||
155080977|NCT02134028|559727025|FG003|Overall Study|Other unspecified|64|||
155080978|NCT02134028|559727026|FG004|Overall Study|Other unspecified|8|||
155080979|NCT02134028|559727027|FG005|Overall Study|Other unspecified|6|||
155080980|NCT02134028|559727028|FG006|Overall Study|Other unspecified|2|||
155080981|NCT02134028|559727029|FG007|Overall Study|Other unspecified|1|||
155080982|NCT02134028|559727022|FG000|Overall Study|Adverse Event|3|||
155080983|NCT02134028|559727023|FG001|Overall Study|Adverse Event|19|||
155080984|NCT02134028|559727024|FG002|Overall Study|Adverse Event|13|||
155080985|NCT02134028|559727025|FG003|Overall Study|Adverse Event|32|||
155080986|NCT02134028|559727026|FG004|Overall Study|Adverse Event|4|||
155080987|NCT02134028|559727027|FG005|Overall Study|Adverse Event|5|||
155080988|NCT02134028|559727028|FG006|Overall Study|Adverse Event|1|||
155080989|NCT02134028|559727029|FG007|Overall Study|Adverse Event|2|||
155080990|NCT01452789|559727034|FG000|Overall Study|Withdrawal by Subject|3|||
155080991|NCT01452789|559727035|FG001|Overall Study|Withdrawal by Subject|2|||
155080992|NCT00066170|559727036|FG000|Overall Study|Adverse Event|2|||
155080993|NCT00066170|559727037|FG001|Overall Study|Adverse Event|4|||
155080994|NCT00066170|559727038|FG002|Overall Study|Adverse Event|1|||
155080995|NCT00066170|559727039|FG003|Overall Study|Adverse Event|7|||
155080996|NCT00066170|559727036|FG000|Overall Study|Serious Adverse Event|0|||
155080997|NCT00066170|559727037|FG001|Overall Study|Serious Adverse Event|0|||
155080998|NCT00066170|559727038|FG002|Overall Study|Serious Adverse Event|1|||
155080999|NCT00066170|559727039|FG003|Overall Study|Serious Adverse Event|1|||
155081000|NCT00066170|559727036|FG000|Overall Study|Lost to Follow-up|0|||
155081001|NCT00066170|559727037|FG001|Overall Study|Lost to Follow-up|1|||
155081002|NCT00066170|559727038|FG002|Overall Study|Lost to Follow-up|0|||
155081003|NCT00066170|559727039|FG003|Overall Study|Lost to Follow-up|0|||
155081004|NCT00066170|559727036|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
155081005|NCT00066170|559727037|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
155081006|NCT00066170|559727038|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
155081007|NCT00066170|559727039|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
155081008|NCT00066170|559727036|FG000|Overall Study|Protocol Violation|3|||
155081009|NCT00066170|559727037|FG001|Overall Study|Protocol Violation|0|||
155081010|NCT00066170|559727038|FG002|Overall Study|Protocol Violation|0|||
155081011|NCT00066170|559727039|FG003|Overall Study|Protocol Violation|0|||
155081012|NCT00066170|559727036|FG000|Overall Study|Other|1|||
155081013|NCT00066170|559727037|FG001|Overall Study|Other|5|||
155081014|NCT00066170|559727038|FG002|Overall Study|Other|2|||
155081015|NCT00066170|559727039|FG003|Overall Study|Other|0|||
155081016|NCT01370642|559727042|FG000|Overall Study|Adverse Event|2|||
155081017|NCT01370642|559727043|FG001|Overall Study|Adverse Event|1|||
155081018|NCT01370642|559727044|FG002|Overall Study|Adverse Event|1|||
155081019|NCT01370642|559727042|FG000|Overall Study|Detectable HCV RNA|0|||
155081020|NCT01370642|559727043|FG001|Overall Study|Detectable HCV RNA|0|||
155081021|NCT01370642|559727044|FG002|Overall Study|Detectable HCV RNA|22|||
155081022|NCT01370642|559727042|FG000|Overall Study|Lost to Follow-up|0|||
155081023|NCT01370642|559727043|FG001|Overall Study|Lost to Follow-up|0|||
155081024|NCT01370642|559727044|FG002|Overall Study|Lost to Follow-up|1|||
155081025|NCT01370642|559727042|FG000|Overall Study|Physician Decision|4|||
155081026|NCT01370642|559727043|FG001|Overall Study|Physician Decision|1|||
155081027|NCT01370642|559727044|FG002|Overall Study|Physician Decision|2|||
155081028|NCT01370642|559727042|FG000|Overall Study|Withdrawal by Subject|2|||
155081029|NCT01370642|559727043|FG001|Overall Study|Withdrawal by Subject|4|||
155081030|NCT01370642|559727044|FG002|Overall Study|Withdrawal by Subject|3|||
155081031|NCT00987935|559727051|FG000|Overall Study|Progressive disease|3|||
155081032|NCT00987935|559727052|FG001|Overall Study|Progressive disease|2|||
155081033|NCT00987935|559727053|FG002|Overall Study|Progressive disease|3|||
155081034|NCT00987935|559727054|FG003|Overall Study|Progressive disease|2|||
155081035|NCT00987935|559727055|FG004|Overall Study|Progressive disease|5|||
155081036|NCT00987935|559727056|FG005|Overall Study|Progressive disease|3|||
155081037|NCT00987935|559727057|FG006|Overall Study|Progressive disease|9|||
155081038|NCT00987935|559727058|FG007|Overall Study|Progressive disease|48|||
155081039|NCT00987935|559727059|FG008|Overall Study|Progressive disease|23|||
155081040|NCT00987935|559727051|FG000|Overall Study|Adverse Event|0|||
155081041|NCT00987935|559727052|FG001|Overall Study|Adverse Event|1|||
155081042|NCT00987935|559727053|FG002|Overall Study|Adverse Event|0|||
155081043|NCT00987935|559727054|FG003|Overall Study|Adverse Event|1|||
155081044|NCT00987935|559727055|FG004|Overall Study|Adverse Event|1|||
155081045|NCT00987935|559727056|FG005|Overall Study|Adverse Event|0|||
155081046|NCT00987935|559727057|FG006|Overall Study|Adverse Event|2|||
155081047|NCT00987935|559727058|FG007|Overall Study|Adverse Event|10|||
155081048|NCT00987935|559727059|FG008|Overall Study|Adverse Event|6|||
155081049|NCT00987935|559727051|FG000|Overall Study|Refused to continue taking trial med.|1|||
155081050|NCT00987935|559727052|FG001|Overall Study|Refused to continue taking trial med.|0|||
155081051|NCT00987935|559727053|FG002|Overall Study|Refused to continue taking trial med.|0|||
155081052|NCT00987935|559727054|FG003|Overall Study|Refused to continue taking trial med.|0|||
155081053|NCT00987935|559727055|FG004|Overall Study|Refused to continue taking trial med.|1|||
155081054|NCT00987935|559727056|FG005|Overall Study|Refused to continue taking trial med.|0|||
155081055|NCT00987935|559727057|FG006|Overall Study|Refused to continue taking trial med.|4|||
155081056|NCT00987935|559727058|FG007|Overall Study|Refused to continue taking trial med.|4|||
155081057|NCT00987935|559727059|FG008|Overall Study|Refused to continue taking trial med.|2|||
155081058|NCT00987935|559727051|FG000|Overall Study|Reason other than those specified above|0|||
155081059|NCT00987935|559727052|FG001|Overall Study|Reason other than those specified above|0|||
155081060|NCT00987935|559727053|FG002|Overall Study|Reason other than those specified above|0|||
155081061|NCT00987935|559727054|FG003|Overall Study|Reason other than those specified above|0|||
155081062|NCT00987935|559727055|FG004|Overall Study|Reason other than those specified above|0|||
155081063|NCT00987935|559727056|FG005|Overall Study|Reason other than those specified above|0|||
155081064|NCT00987935|559727057|FG006|Overall Study|Reason other than those specified above|0|||
155081065|NCT00987935|559727058|FG007|Overall Study|Reason other than those specified above|0|||
155081066|NCT00987935|559727059|FG008|Overall Study|Reason other than those specified above|1|||
155081067|NCT01089543|559727060|FG000|Overall Study|Withdrawal by Subject|2|||
155081068|NCT01089543|559727061|FG001|Overall Study|Withdrawal by Subject|3|||
155081069|NCT01089543|559727062|FG002|Overall Study|Withdrawal by Subject|3|||
155081070|NCT01089543|559727063|FG003|Overall Study|Withdrawal by Subject|1|||
155081071|NCT01089543|559727060|FG000|Overall Study|Physician Decision|1|||
155081072|NCT01089543|559727061|FG001|Overall Study|Physician Decision|0|||
155081073|NCT01089543|559727062|FG002|Overall Study|Physician Decision|0|||
155081074|NCT01089543|559727063|FG003|Overall Study|Physician Decision|1|||
155081075|NCT01089543|559727060|FG000|Overall Study|Adverse Event|0|||
155081076|NCT01089543|559727061|FG001|Overall Study|Adverse Event|1|||
155081077|NCT01089543|559727062|FG002|Overall Study|Adverse Event|0|||
155081078|NCT01089543|559727063|FG003|Overall Study|Adverse Event|0|||
155081079|NCT00309244|559727064|FG000|Overall Study|Adverse Event|29|||
155081080|NCT00309244|559727065|FG001|Overall Study|Adverse Event|12|||
155081081|NCT00309244|559727064|FG000|Overall Study|Lost to Follow-up|6|||
155081082|NCT00309244|559727065|FG001|Overall Study|Lost to Follow-up|22|||
155081083|NCT00309244|559727064|FG000|Overall Study|Physician Decision|5|||
155081084|NCT00309244|559727065|FG001|Overall Study|Physician Decision|8|||
155081085|NCT00309244|559727064|FG000|Overall Study|Protocol Violation|6|||
155081086|NCT00309244|559727065|FG001|Overall Study|Protocol Violation|3|||
155081087|NCT00309244|559727064|FG000|Overall Study|Withdrawal by Subject|50|||
155081088|NCT00309244|559727065|FG001|Overall Study|Withdrawal by Subject|32|||
155081089|NCT00309244|559727064|FG000|Overall Study|Various|7|||
155081090|NCT00309244|559727065|FG001|Overall Study|Various|7|||
155081091|NCT00309244|559727064|FG000|Overall Study|Randomized but not dosed|11|||
155081092|NCT00309244|559727065|FG001|Overall Study|Randomized but not dosed|12|||
155081093|NCT00309244|559727064|FG000|Overall Study|Death|4|||
155081094|NCT00309244|559727065|FG001|Overall Study|Death|1|||
155081095|NCT03438656|559727066|FG000|Overall Study|Lost to Follow-up|2|||
155081096|NCT03335566|559727067|FG000|Overall Study|Adverse Event|0|||
155081097|NCT03335566|559727068|FG001|Overall Study|Adverse Event|1|||
155081098|NCT03335566|559727067|FG000|Overall Study|Lost to Follow-up|1|||
155081099|NCT03335566|559727068|FG001|Overall Study|Lost to Follow-up|0|||
155081100|NCT03335566|559727067|FG000|Overall Study|Technical Problems|1|||
155081101|NCT03335566|559727068|FG001|Overall Study|Technical Problems|0|||
155081102|NCT03335566|559727067|FG000|Overall Study|Protocol Violation|1|||
155081103|NCT03335566|559727068|FG001|Overall Study|Protocol Violation|0|||
155081104|NCT03335566|559727067|FG000|Overall Study|Other than specified above|1|||
155081105|NCT03335566|559727068|FG001|Overall Study|Other than specified above|2|||
155081106|NCT04223687|559727069|FG000|Overall Study|Missing primary outcome|1|||
155081107|NCT04223687|559727070|FG001|Overall Study|Missing primary outcome|0|||
155081108|NCT04128228|559727074|FG000|Overall Study|Withdrawal by Subject|3|||
155081109|NCT04128228|559727075|FG001|Overall Study|Withdrawal by Subject|3|||
155081110|NCT04128228|559727076|FG002|Overall Study|Withdrawal by Subject|0|||
155081111|NCT04128228|559727077|FG003|Overall Study|Withdrawal by Subject|0|||
155081112|NCT04128228|559727074|FG000|Overall Study|noncompliance|2|||
155081113|NCT04128228|559727075|FG001|Overall Study|noncompliance|2|||
155081114|NCT04128228|559727076|FG002|Overall Study|noncompliance|0|||
155081115|NCT04128228|559727077|FG003|Overall Study|noncompliance|0|||
155081116|NCT03163264|559727078|FG000|Overall Study|Withdrawal by Subject|13|||
155081117|NCT03163264|559727079|FG001|Overall Study|Withdrawal by Subject|3|||
155081118|NCT03163264|559727080|FG002|Overall Study|Withdrawal by Subject|4|||
155081119|NCT03163264|559727081|FG003|Overall Study|Withdrawal by Subject|2|||
155081120|NCT03163264|559727078|FG000|Overall Study|Lost to Follow-up|17|||
155081121|NCT03163264|559727079|FG001|Overall Study|Lost to Follow-up|20|||
155081122|NCT03163264|559727080|FG002|Overall Study|Lost to Follow-up|0|||
155081123|NCT03163264|559727081|FG003|Overall Study|Lost to Follow-up|0|||
155081124|NCT03163264|559727078|FG000|Overall Study|Death|0|||
155081125|NCT03163264|559727079|FG001|Overall Study|Death|2|||
155081126|NCT03163264|559727080|FG002|Overall Study|Death|0|||
155081127|NCT03163264|559727081|FG003|Overall Study|Death|0|||
155081128|NCT04648241|559727082|FG000|Overall Study|Lost to Follow-up|1|||
155081129|NCT04648241|559727083|FG001|Overall Study|Lost to Follow-up|0|||
155081130|NCT02057666|559727084|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
155081131|NCT02057666|559727085|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
155081132|NCT02057666|559727084|FG000|Double Blind Treatment Period|Poor tolerability|7|||
155081133|NCT02057666|559727085|FG001|Double Blind Treatment Period|Poor tolerability|2|||
155081134|NCT02057666|559727084|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
155081135|NCT02057666|559727085|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
155081136|NCT02057666|559727084|FG000|Double Blind Treatment Period|Physician Decision|1|||
155081137|NCT02057666|559727085|FG001|Double Blind Treatment Period|Physician Decision|0|||
155081138|NCT02057666|559727084|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
155081139|NCT02057666|559727085|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
155081140|NCT02057666|559727084|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
155081141|NCT02057666|559727085|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
155081142|NCT02057666|559727084|FG000|Double Blind Treatment Period|Sponsor's request|70|||
155081143|NCT02057666|559727085|FG001|Double Blind Treatment Period|Sponsor's request|34|||
155081144|NCT02057666|559727084|FG000|Open-Label Treatment Period|Poor tolerability|0|||
155081145|NCT02057666|559727085|FG001|Open-Label Treatment Period|Poor tolerability|1|||
155081146|NCT02057666|559727084|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
155081147|NCT02057666|559727085|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
155081148|NCT02057666|559727084|FG000|Open-Label Treatment Period|Sponsor's request|0|||
155081149|NCT02057666|559727085|FG001|Open-Label Treatment Period|Sponsor's request|4|||
155081150|NCT05661734|559727086|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
155081151|NCT05661734|559727086|FG000|Overall Study|Lost to Follow-up|13|||
155081152|NCT05661734|559727086|FG000|Overall Study|Enrolled but not dosed|2|||
155081153|NCT02489045|559727087|FG000|Overall Study|unable to collect usable data|53|||
155081154|NCT02489045|559727087|FG000|Follow-up|Lost to Follow-up|10|||
155081155|NCT01108055|559727096|FG000|Overall Study|Ineligible|11|||
155081156|NCT01108055|559727096|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
155081157|NCT03339453|559727097|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
155081158|NCT03339453|559727098|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
155081159|NCT00236197|559727103|FG000|Overall Study|Withdrawal by Subject|3|||
155081160|NCT00236197|559727104|FG001|Overall Study|Withdrawal by Subject|2|||
155081161|NCT00236197|559727103|FG000|Overall Study|Lost to Follow-up|1|||
155081162|NCT00236197|559727104|FG001|Overall Study|Lost to Follow-up|5|||
155081163|NCT00236197|559727103|FG000|Overall Study|Protocol Violation|0|||
155081164|NCT00236197|559727104|FG001|Overall Study|Protocol Violation|3|||
155081165|NCT00236197|559727103|FG000|Overall Study|Medication non-compliance|1|||
155081166|NCT00236197|559727104|FG001|Overall Study|Medication non-compliance|2|||
155081167|NCT00236197|559727103|FG000|Overall Study|Other|0|||
155081168|NCT00236197|559727104|FG001|Overall Study|Other|2|||
155081169|NCT03760666|559727107|FG000|Overall Study|Adverse Event|2|||
155081170|NCT03760666|559727108|FG001|Overall Study|Adverse Event|4|||
155081171|NCT03760666|559727109|FG002|Overall Study|Adverse Event|1|||
155081172|NCT03760666|559727107|FG000|Overall Study|AML Disease Progression|3|||
155081173|NCT03760666|559727108|FG001|Overall Study|AML Disease Progression|3|||
155081174|NCT03760666|559727109|FG002|Overall Study|AML Disease Progression|0|||
155081175|NCT03760666|559727107|FG000|Overall Study|Physician Decision|0|||
155081176|NCT03760666|559727108|FG001|Overall Study|Physician Decision|3|||
155081177|NCT03760666|559727109|FG002|Overall Study|Physician Decision|0|||
155081178|NCT03760666|559727107|FG000|Overall Study|Withdrawal by Subject|0|||
155081179|NCT03760666|559727108|FG001|Overall Study|Withdrawal by Subject|1|||
155081180|NCT03760666|559727109|FG002|Overall Study|Withdrawal by Subject|0|||
155081181|NCT01800058|559727114|FG000|Overall Study|Lost to Follow-up|1|||
155081182|NCT06868667|559727115|FG000|Overall Study|Death|0|||
155081183|NCT06868667|559727116|FG001|Overall Study|Death|4|||
155081184|NCT06868667|559727115|FG000|Overall Study|Lost to Follow-up|0|||
155081185|NCT06868667|559727116|FG001|Overall Study|Lost to Follow-up|1|||
155081186|NCT06868667|559727115|FG000|Overall Study|Withdrawal by Subject|1|||
155081187|NCT06868667|559727116|FG001|Overall Study|Withdrawal by Subject|0|||
155081188|NCT06868667|559727115|FG000|Overall Study|Ongoing|9|||
155081189|NCT06868667|559727116|FG001|Overall Study|Ongoing|9|||
155081190|NCT00286455|559727120|FG000|Overall Study|Hyperglycemia rescue|19|||
155081191|NCT00286455|559727121|FG001|Overall Study|Hyperglycemia rescue|13|||
155081192|NCT00286455|559727122|FG002|Overall Study|Hyperglycemia rescue|10|||
155081193|NCT00286455|559727120|FG000|Overall Study|Adverse Event|1|||
155081194|NCT00286455|559727121|FG001|Overall Study|Adverse Event|3|||
155081195|NCT00286455|559727122|FG002|Overall Study|Adverse Event|2|||
155081196|NCT00286455|559727120|FG000|Overall Study|Lost to Follow-up|0|||
155081197|NCT00286455|559727121|FG001|Overall Study|Lost to Follow-up|3|||
155165530|NCT04661579|560043476|FG000|Overall Study|Death|1|||
155081198|NCT00286455|559727122|FG002|Overall Study|Lost to Follow-up|3|||
155165531|NCT04661579|560043477|FG001|Overall Study|Death|0|||
155081199|NCT00286455|559727120|FG000|Overall Study|Physician Decision|3|||
155081200|NCT00286455|559727121|FG001|Overall Study|Physician Decision|0|||
155081201|NCT00286455|559727122|FG002|Overall Study|Physician Decision|2|||
155081202|NCT00286455|559727120|FG000|Overall Study|Protocol Violation|1|||
155081203|NCT00286455|559727121|FG001|Overall Study|Protocol Violation|1|||
155081204|NCT00286455|559727122|FG002|Overall Study|Protocol Violation|0|||
155081205|NCT00286455|559727120|FG000|Overall Study|Participant Non-compliance|1|||
155081206|NCT00286455|559727121|FG001|Overall Study|Participant Non-compliance|0|||
155165532|NCT04661579|560043478|FG002|Overall Study|Death|0|||
155081207|NCT00286455|559727122|FG002|Overall Study|Participant Non-compliance|0|||
155081208|NCT00286455|559727120|FG000|Overall Study|Withdrawal by Subject|0|||
155081209|NCT00286455|559727121|FG001|Overall Study|Withdrawal by Subject|8|||
155081210|NCT00286455|559727122|FG002|Overall Study|Withdrawal by Subject|7|||
155081211|NCT00394472|559729366|FG000|Overall Study|Protocol Violation|1|||
155081212|NCT00394472|559729367|FG001|Overall Study|Protocol Violation|3|||
155081213|NCT00394472|559729366|FG000|Overall Study|incorrect enrolment|4|||
155081214|NCT00394472|559729367|FG001|Overall Study|incorrect enrolment|2|||
155081215|NCT00394472|559729366|FG000|Overall Study|Adverse Event|4|||
155081216|NCT00394472|559729367|FG001|Overall Study|Adverse Event|2|||
155081217|NCT00394472|559729366|FG000|Overall Study|Withdrawal by Subject|0|||
155081218|NCT00394472|559729367|FG001|Overall Study|Withdrawal by Subject|2|||
155081219|NCT00394472|559729366|FG000|Overall Study|Physician Decision|0|||
155081220|NCT00394472|559729367|FG001|Overall Study|Physician Decision|1|||
155081221|NCT00394472|559729366|FG000|Overall Study|Lost to Follow-up|0|||
155081222|NCT00394472|559729367|FG001|Overall Study|Lost to Follow-up|1|||
155081223|NCT01654250|559729368|FG000|Overall Study|Lost to Follow-up|1|||
155081224|NCT01654250|559729369|FG001|Overall Study|Lost to Follow-up|0|||
155081225|NCT01013870|559729371|FG000|Overall Study|Lost to Follow-up|1|||
155081226|NCT01013870|559729372|FG001|Overall Study|Lost to Follow-up|3|||
155081227|NCT00090402|559729373|FG000|Overall Study|Death|1|||
155081228|NCT00090402|559729374|FG001|Overall Study|Death|1|||
155081229|NCT00090402|559729375|FG002|Overall Study|Death|0|||
155081230|NCT00090402|559729373|FG000|Overall Study|subject moved|0|||
155081231|NCT00090402|559729374|FG001|Overall Study|subject moved|1|||
155081232|NCT00090402|559729375|FG002|Overall Study|subject moved|0|||
155081233|NCT00090402|559729373|FG000|Overall Study|stopped taking study medication|1|||
155081234|NCT00090402|559729374|FG001|Overall Study|stopped taking study medication|0|||
155081235|NCT00090402|559729375|FG002|Overall Study|stopped taking study medication|1|||
155081236|NCT00862277|559729380|FG000|Overall Study|Protocol Violation|1|||
155081237|NCT00862277|559729381|FG001|Overall Study|Protocol Violation|2|||
155081238|NCT00862277|559729382|FG002|Overall Study|Protocol Violation|5|||
155081239|NCT02168439|559729383|FG000|Overall Study|Protocol Violation|0|||
155081240|NCT02168439|559729384|FG001|Overall Study|Protocol Violation|2|||
155081241|NCT01292473|559729385|FG000|Overall Study|Adverse Event|1|||
155081242|NCT01292473|559729386|FG001|Overall Study|Adverse Event|0|||
155081243|NCT01292473|559729387|FG002|Overall Study|Adverse Event|1|||
155081244|NCT01292473|559729388|FG003|Overall Study|Adverse Event|1|||
155081245|NCT01292473|559729385|FG000|Overall Study|Lost to Follow-up|1|||
155081246|NCT01292473|559729386|FG001|Overall Study|Lost to Follow-up|1|||
155081247|NCT01292473|559729387|FG002|Overall Study|Lost to Follow-up|2|||
155081248|NCT01292473|559729388|FG003|Overall Study|Lost to Follow-up|2|||
155081249|NCT01292473|559729385|FG000|Overall Study|Withdrawal by Subject|3|||
155081250|NCT01292473|559729386|FG001|Overall Study|Withdrawal by Subject|4|||
155081251|NCT01292473|559729387|FG002|Overall Study|Withdrawal by Subject|3|||
155081252|NCT01292473|559729388|FG003|Overall Study|Withdrawal by Subject|3|||
155081253|NCT01292473|559729385|FG000|Overall Study|Physician Decision|0|||
155081254|NCT01292473|559729386|FG001|Overall Study|Physician Decision|1|||
155081255|NCT01292473|559729387|FG002|Overall Study|Physician Decision|0|||
155081256|NCT01292473|559729388|FG003|Overall Study|Physician Decision|0|||
155081257|NCT01292473|559729385|FG000|Overall Study|Disease Progression|0|||
155081258|NCT01292473|559729386|FG001|Overall Study|Disease Progression|1|||
155081259|NCT01292473|559729387|FG002|Overall Study|Disease Progression|3|||
155081260|NCT01292473|559729388|FG003|Overall Study|Disease Progression|6|||
155081261|NCT04432298|559729389|FG000|Overall Study|Other than specified|1|||
155081262|NCT04432298|559729390|FG001|Overall Study|Other than specified|0|||
155081263|NCT04432298|559729389|FG000|Overall Study|Lost to Follow-up|0|||
155081264|NCT04432298|559729390|FG001|Overall Study|Lost to Follow-up|1|||
154963961|NCT03215706|559293504|FG001|Treatment Period|Study Drug Toxicity|24|||
155081265|NCT04432298|559729389|FG000|Overall Study|Death|3|||
155081266|NCT04432298|559729390|FG001|Overall Study|Death|2|||
155081267|NCT04432298|559729389|FG000|Overall Study|Withdrawal by Subject|2|||
155081268|NCT04432298|559729390|FG001|Overall Study|Withdrawal by Subject|0|||
155081269|NCT02451007|559729391|FG000|Overall Study|Withdrawal by Subject|4|||
154963962|NCT03215706|559293503|FG000|Treatment Period|Death|7|||
155081270|NCT02451007|559729391|FG000|Overall Study|Adverse Event|1|||
155081271|NCT02451007|559729391|FG000|Overall Study|Disease Progression|2|||
155081272|NCT01716559|559729392|FG000|Overall Study|Adverse Event|11|||
155081273|NCT01716559|559729392|FG000|Overall Study|Death|21|||
155081274|NCT01716559|559729392|FG000|Overall Study|Withdrawal by Subject|4|||
154963963|NCT03215706|559293504|FG001|Treatment Period|Death|1|||
155081275|NCT01716559|559729392|FG000|Overall Study|Other withdrawal reason|75|||
155081276|NCT00348374|559729393|FG000|Overall Study|Adverse Event|1|||
155081277|NCT00348374|559729394|FG001|Overall Study|Adverse Event|4|||
155081278|NCT00348374|559729393|FG000|Overall Study|Lost to Follow-up|1|||
155081279|NCT00348374|559729394|FG001|Overall Study|Lost to Follow-up|3|||
155081280|NCT00348374|559729393|FG000|Overall Study|Withdrawal by Subject|5|||
155081281|NCT00348374|559729394|FG001|Overall Study|Withdrawal by Subject|5|||
155081282|NCT00348374|559729393|FG000|Overall Study|Other|11|||
155081283|NCT00348374|559729394|FG001|Overall Study|Other|12|||
155081284|NCT00348374|559729393|FG000|Overall Study|ongoing at date of cutoff|1|||
155081285|NCT00348374|559729394|FG001|Overall Study|ongoing at date of cutoff|1|||
155081286|NCT00348374|559729393|FG000|Overall Study|randomized but did not receive treatment|0|||
155081287|NCT00348374|559729394|FG001|Overall Study|randomized but did not receive treatment|7|||
155081288|NCT00378560|559729406|FG000|Overall Study|Adverse Event|1|||
155081289|NCT00378560|559729407|FG001|Overall Study|Adverse Event|0|||
155081290|NCT00378560|559729406|FG000|Overall Study|Lost to Follow-up|24|||
155081291|NCT00378560|559729407|FG001|Overall Study|Lost to Follow-up|29|||
155081292|NCT00378560|559729406|FG000|Overall Study|Protocol Violation|2|||
155081293|NCT00378560|559729407|FG001|Overall Study|Protocol Violation|0|||
155081294|NCT00378560|559729406|FG000|Overall Study|Withdrawal by Subject|17|||
155081295|NCT00378560|559729407|FG001|Overall Study|Withdrawal by Subject|21|||
155081296|NCT00378560|559729406|FG000|Overall Study|Moved|4|||
155081297|NCT00378560|559729407|FG001|Overall Study|Moved|3|||
155081298|NCT00378560|559729406|FG000|Overall Study|Pregnancy|7|||
155081299|NCT00378560|559729407|FG001|Overall Study|Pregnancy|5|||
155081300|NCT00378560|559729406|FG000|Overall Study|Laboratory test values abnormal|1|||
155081301|NCT00378560|559729407|FG001|Overall Study|Laboratory test values abnormal|0|||
155081302|NCT02070380|559729408|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
155081303|NCT02070380|559729409|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
155081304|NCT02070380|559729410|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
155081305|NCT02070380|559729411|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
155081306|NCT02070380|559729408|FG000|Second Injection|Image sets missing or technically inadeq|0|||
155081307|NCT02070380|559729409|FG001|Second Injection|Image sets missing or technically inadeq|1|||
155081308|NCT02070380|559729410|FG002|Second Injection|Image sets missing or technically inadeq|0|||
155081309|NCT02070380|559729411|FG003|Second Injection|Image sets missing or technically inadeq|0|||
155081310|NCT02070380|559729408|FG000|Second Injection|Protocol Violation|0|||
155081311|NCT02070380|559729409|FG001|Second Injection|Protocol Violation|1|||
155081312|NCT02070380|559729410|FG002|Second Injection|Protocol Violation|1|||
155081313|NCT02070380|559729411|FG003|Second Injection|Protocol Violation|5|||
155081314|NCT01682603|559729412|FG000|Overall Study|Lost to Follow-up|3|||
155081315|NCT01791205|559729413|FG000|Phase II|Lack of Efficacy|6|||
155081316|NCT01791205|559729414|FG001|Phase II|Lack of Efficacy|0|||
155081317|NCT01791205|559729413|FG000|Phase II|Adverse Event|2|||
155081318|NCT01791205|559729414|FG001|Phase II|Adverse Event|0|||
155081319|NCT01791205|559729413|FG000|Phase II|Safety|1|||
155081320|NCT01791205|559729414|FG001|Phase II|Safety|0|||
155081321|NCT01791205|559729413|FG000|Phase II|Lost to Follow-up|1|||
155081322|NCT01791205|559729414|FG001|Phase II|Lost to Follow-up|0|||
155081323|NCT01791205|559729413|FG000|Phase II|Remission of disease|1|||
155081324|NCT01791205|559729414|FG001|Phase II|Remission of disease|0|||
155081325|NCT01791205|559729413|FG000|Phase II|Physician's decision|1|||
155081326|NCT01791205|559729414|FG001|Phase II|Physician's decision|0|||
155081327|NCT01697501|559729416|FG000|Overall Study|Protocol Violation|2|||
155081328|NCT02242903|559729417|FG000|Overall Study|Withdrawal by Subject|1|||
155081329|NCT02242903|559729418|FG001|Overall Study|Withdrawal by Subject|0|||
155081330|NCT02242903|559729419|FG002|Overall Study|Withdrawal by Subject|0|||
155081331|NCT02242903|559729420|FG003|Overall Study|Withdrawal by Subject|0|||
155081332|NCT02242903|559729421|FG004|Overall Study|Withdrawal by Subject|0|||
155081333|NCT02242903|559729422|FG005|Overall Study|Withdrawal by Subject|0|||
155081334|NCT02242903|559729423|FG006|Overall Study|Withdrawal by Subject|0|||
155081335|NCT00779909|559729430|FG000|Overall Study|Lost to Follow-up|1|||
155346991|NCT00296504|560703431|FG007|Interim Analysis|Principle Investigator Discretion|0|||
155346992|NCT00296504|560703432|FG008|Interim Analysis|Principle Investigator Discretion|0|||
155346993|NCT00296504|560703424|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
155346994|NCT00296504|560703425|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
155346995|NCT00296504|560703426|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
155346996|NCT00296504|560703427|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
155346997|NCT00296504|560703428|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
155346998|NCT00296504|560703429|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
155346999|NCT00296504|560703430|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
155347000|NCT00296504|560703431|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
155347001|NCT00296504|560703432|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
155347002|NCT00296504|560703424|FG000|Interim Analysis|Non-adherence|2|||
155347003|NCT00296504|560703425|FG001|Interim Analysis|Non-adherence|0|||
155081336|NCT00779909|559729431|FG001|Overall Study|Lost to Follow-up|0|||
155081337|NCT00779909|559729432|FG002|Overall Study|Lost to Follow-up|0|||
155081338|NCT00779909|559729433|FG003|Overall Study|Lost to Follow-up|1|||
155081339|NCT00779909|559729430|FG000|Overall Study|Withdrawal by Subject|0|||
155081340|NCT00779909|559729431|FG001|Overall Study|Withdrawal by Subject|1|||
155081341|NCT00779909|559729432|FG002|Overall Study|Withdrawal by Subject|0|||
155081342|NCT00779909|559729433|FG003|Overall Study|Withdrawal by Subject|0|||
155081343|NCT00337194|559729434|FG000|Overall Study|Adverse Event|5|||
155081344|NCT00337194|559729435|FG001|Overall Study|Adverse Event|1|||
155081345|NCT00337194|559729434|FG000|Overall Study|Death|2|||
155347004|NCT00296504|560703426|FG002|Interim Analysis|Non-adherence|0|||
155081346|NCT00337194|559729435|FG001|Overall Study|Death|0|||
155081347|NCT00337194|559729434|FG000|Overall Study|Withdrawal by Subject|1|||
155081348|NCT00337194|559729435|FG001|Overall Study|Withdrawal by Subject|0|||
155081349|NCT00337194|559729434|FG000|Overall Study|Disease progression|1|||
155081350|NCT00337194|559729435|FG001|Overall Study|Disease progression|2|||
155081351|NCT00337194|559729434|FG000|Overall Study|Subsequent non-protocol therapy|3|||
155081352|NCT00337194|559729435|FG001|Overall Study|Subsequent non-protocol therapy|1|||
155081353|NCT01896986|559729436|FG000|Overall Study|samples lost|14|||
155081354|NCT01896986|559729437|FG001|Overall Study|samples lost|23|||
155081355|NCT03757715|559729440|FG000|Overall Study|Lost to Follow-up|4|||
155081356|NCT03757715|559729441|FG001|Overall Study|Lost to Follow-up|9|||
155081357|NCT03757715|559729440|FG000|Overall Study|Withdrawal by Subject|1|||
155081358|NCT03757715|559729441|FG001|Overall Study|Withdrawal by Subject|1|||
155081359|NCT00281580|559729442|FG000|Overall Study|Adverse Event|2|||
155081360|NCT00281580|559729443|FG001|Overall Study|Adverse Event|0|||
155347005|NCT00296504|560703427|FG003|Interim Analysis|Non-adherence|0|||
155347006|NCT00296504|560703428|FG004|Interim Analysis|Non-adherence|1|||
155347007|NCT00296504|560703429|FG005|Interim Analysis|Non-adherence|0|||
155347008|NCT00296504|560703430|FG006|Interim Analysis|Non-adherence|0|||
155347009|NCT00296504|560703431|FG007|Interim Analysis|Non-adherence|1|||
155347010|NCT00296504|560703432|FG008|Interim Analysis|Non-adherence|0|||
155347011|NCT00296504|560703424|FG000|Interim Analysis|Site Closing|1|||
155347012|NCT00296504|560703425|FG001|Interim Analysis|Site Closing|0|||
155347013|NCT00296504|560703426|FG002|Interim Analysis|Site Closing|0|||
155347014|NCT00296504|560703427|FG003|Interim Analysis|Site Closing|0|||
155347015|NCT00296504|560703428|FG004|Interim Analysis|Site Closing|0|||
155347016|NCT00296504|560703429|FG005|Interim Analysis|Site Closing|1|||
155347017|NCT00296504|560703430|FG006|Interim Analysis|Site Closing|2|||
155347018|NCT00296504|560703431|FG007|Interim Analysis|Site Closing|0|||
155347019|NCT00296504|560703432|FG008|Interim Analysis|Site Closing|0|||
155347020|NCT00296504|560703424|FG000|Interim Analysis|Lack of Personnel at Site|1|||
155347021|NCT00296504|560703425|FG001|Interim Analysis|Lack of Personnel at Site|0|||
155347022|NCT00296504|560703426|FG002|Interim Analysis|Lack of Personnel at Site|0|||
155347023|NCT00296504|560703427|FG003|Interim Analysis|Lack of Personnel at Site|0|||
155347024|NCT00296504|560703428|FG004|Interim Analysis|Lack of Personnel at Site|0|||
155347025|NCT00296504|560703429|FG005|Interim Analysis|Lack of Personnel at Site|0|||
155081361|NCT00281580|559729444|FG002|Overall Study|Adverse Event|2|||
155081362|NCT00281580|559729445|FG003|Overall Study|Adverse Event|4|||
155081363|NCT00281580|559729446|FG004|Overall Study|Adverse Event|1|||
155081364|NCT00281580|559729447|FG005|Overall Study|Adverse Event|0|||
155081365|NCT00281580|559729448|FG006|Overall Study|Adverse Event|1|||
155081366|NCT00281580|559729449|FG007|Overall Study|Adverse Event|0|||
155081367|NCT00281580|559729450|FG008|Overall Study|Adverse Event|1|||
155081368|NCT00281580|559729451|FG009|Overall Study|Adverse Event|6|||
155081369|NCT00281580|559729452|FG010|Overall Study|Adverse Event|0|||
155081370|NCT00281580|559729453|FG011|Overall Study|Adverse Event|5|||
155081371|NCT00281580|559729454|FG012|Overall Study|Adverse Event|8|||
155081372|NCT00281580|559729455|FG013|Overall Study|Adverse Event|2|||
155081373|NCT00281580|559729456|FG014|Overall Study|Adverse Event|3|||
155081374|NCT00281580|559729457|FG015|Overall Study|Adverse Event|3|||
155081375|NCT00281580|559729442|FG000|Overall Study|Protocol Violation|0|||
155081376|NCT00281580|559729443|FG001|Overall Study|Protocol Violation|0|||
155081377|NCT00281580|559729444|FG002|Overall Study|Protocol Violation|1|||
155081378|NCT00281580|559729445|FG003|Overall Study|Protocol Violation|1|||
155081379|NCT00281580|559729446|FG004|Overall Study|Protocol Violation|0|||
155081380|NCT00281580|559729447|FG005|Overall Study|Protocol Violation|0|||
155081381|NCT00281580|559729448|FG006|Overall Study|Protocol Violation|1|||
155165533|NCT04661579|560043479|FG003|Overall Study|Death|0|||
155165534|NCT04661579|560043480|FG004|Overall Study|Death|0|||
155347026|NCT00296504|560703430|FG006|Interim Analysis|Lack of Personnel at Site|0|||
155347027|NCT00296504|560703431|FG007|Interim Analysis|Lack of Personnel at Site|0|||
155081382|NCT00281580|559729449|FG007|Overall Study|Protocol Violation|0|||
155081383|NCT00281580|559729450|FG008|Overall Study|Protocol Violation|2|||
155081384|NCT00281580|559729451|FG009|Overall Study|Protocol Violation|0|||
155081385|NCT00281580|559729452|FG010|Overall Study|Protocol Violation|1|||
155081386|NCT00281580|559729453|FG011|Overall Study|Protocol Violation|2|||
155165535|NCT04661579|560043476|FG000|Overall Study|Other|1|||
155081387|NCT00281580|559729454|FG012|Overall Study|Protocol Violation|0|||
155081388|NCT00281580|559729455|FG013|Overall Study|Protocol Violation|1|||
155081389|NCT00281580|559729456|FG014|Overall Study|Protocol Violation|1|||
155081390|NCT00281580|559729457|FG015|Overall Study|Protocol Violation|3|||
155081391|NCT00281580|559729442|FG000|Overall Study|Withdrawal by Subject|3|||
155081392|NCT00281580|559729443|FG001|Overall Study|Withdrawal by Subject|0|||
155165536|NCT04661579|560043477|FG001|Overall Study|Other|2|||
155347028|NCT00296504|560703432|FG008|Interim Analysis|Lack of Personnel at Site|0|||
155347029|NCT00296504|560703424|FG000|Interim Analysis|Missed Schedule Date|1|||
155347030|NCT00296504|560703425|FG001|Interim Analysis|Missed Schedule Date|0|||
155347031|NCT00296504|560703426|FG002|Interim Analysis|Missed Schedule Date|0|||
155347032|NCT00296504|560703427|FG003|Interim Analysis|Missed Schedule Date|0|||
155081393|NCT00281580|559729444|FG002|Overall Study|Withdrawal by Subject|1|||
155081394|NCT00281580|559729445|FG003|Overall Study|Withdrawal by Subject|1|||
155081395|NCT00281580|559729446|FG004|Overall Study|Withdrawal by Subject|1|||
155081396|NCT00281580|559729447|FG005|Overall Study|Withdrawal by Subject|2|||
155081397|NCT00281580|559729448|FG006|Overall Study|Withdrawal by Subject|2|||
155081398|NCT00281580|559729449|FG007|Overall Study|Withdrawal by Subject|0|||
155081399|NCT00281580|559729450|FG008|Overall Study|Withdrawal by Subject|1|||
155081400|NCT00281580|559729451|FG009|Overall Study|Withdrawal by Subject|4|||
155081401|NCT00281580|559729452|FG010|Overall Study|Withdrawal by Subject|1|||
155081402|NCT00281580|559729453|FG011|Overall Study|Withdrawal by Subject|1|||
155081403|NCT00281580|559729454|FG012|Overall Study|Withdrawal by Subject|2|||
155081404|NCT00281580|559729455|FG013|Overall Study|Withdrawal by Subject|2|||
155081405|NCT00281580|559729456|FG014|Overall Study|Withdrawal by Subject|1|||
155081406|NCT00281580|559729457|FG015|Overall Study|Withdrawal by Subject|5|||
155081407|NCT00281580|559729442|FG000|Overall Study|Lack of Efficacy|2|||
155081408|NCT00281580|559729443|FG001|Overall Study|Lack of Efficacy|1|||
155081409|NCT00281580|559729444|FG002|Overall Study|Lack of Efficacy|1|||
155081410|NCT00281580|559729445|FG003|Overall Study|Lack of Efficacy|6|||
155081411|NCT00281580|559729446|FG004|Overall Study|Lack of Efficacy|2|||
155081412|NCT00281580|559729447|FG005|Overall Study|Lack of Efficacy|0|||
155081413|NCT00281580|559729448|FG006|Overall Study|Lack of Efficacy|0|||
155081414|NCT00281580|559729449|FG007|Overall Study|Lack of Efficacy|0|||
155081415|NCT00281580|559729450|FG008|Overall Study|Lack of Efficacy|0|||
155081416|NCT00281580|559729451|FG009|Overall Study|Lack of Efficacy|0|||
155081417|NCT00281580|559729452|FG010|Overall Study|Lack of Efficacy|0|||
155081418|NCT00281580|559729453|FG011|Overall Study|Lack of Efficacy|1|||
155081419|NCT00281580|559729454|FG012|Overall Study|Lack of Efficacy|0|||
155081420|NCT00281580|559729455|FG013|Overall Study|Lack of Efficacy|2|||
155081421|NCT00281580|559729456|FG014|Overall Study|Lack of Efficacy|1|||
155081422|NCT00281580|559729457|FG015|Overall Study|Lack of Efficacy|0|||
155081423|NCT00281580|559729442|FG000|Overall Study|Lost to Follow-up|0|||
155081424|NCT00281580|559729443|FG001|Overall Study|Lost to Follow-up|0|||
155081425|NCT00281580|559729444|FG002|Overall Study|Lost to Follow-up|0|||
155081426|NCT00281580|559729445|FG003|Overall Study|Lost to Follow-up|3|||
155081427|NCT00281580|559729446|FG004|Overall Study|Lost to Follow-up|0|||
155347033|NCT00296504|560703428|FG004|Interim Analysis|Missed Schedule Date|0|||
155347034|NCT00296504|560703429|FG005|Interim Analysis|Missed Schedule Date|0|||
155347035|NCT00296504|560703430|FG006|Interim Analysis|Missed Schedule Date|0|||
155347036|NCT00296504|560703431|FG007|Interim Analysis|Missed Schedule Date|0|||
155347037|NCT00296504|560703432|FG008|Interim Analysis|Missed Schedule Date|0|||
155347038|NCT00296504|560703424|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
155347039|NCT00296504|560703425|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
155081428|NCT00281580|559729447|FG005|Overall Study|Lost to Follow-up|1|||
155081429|NCT00281580|559729448|FG006|Overall Study|Lost to Follow-up|0|||
155081430|NCT00281580|559729449|FG007|Overall Study|Lost to Follow-up|1|||
155081431|NCT00281580|559729450|FG008|Overall Study|Lost to Follow-up|2|||
155081432|NCT00281580|559729451|FG009|Overall Study|Lost to Follow-up|1|||
155081433|NCT00281580|559729452|FG010|Overall Study|Lost to Follow-up|1|||
155081434|NCT00281580|559729453|FG011|Overall Study|Lost to Follow-up|0|||
155081435|NCT00281580|559729454|FG012|Overall Study|Lost to Follow-up|1|||
155081436|NCT00281580|559729455|FG013|Overall Study|Lost to Follow-up|0|||
155081437|NCT00281580|559729456|FG014|Overall Study|Lost to Follow-up|0|||
155347040|NCT00296504|560703426|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
155081438|NCT00281580|559729457|FG015|Overall Study|Lost to Follow-up|0|||
155081439|NCT00281580|559729442|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
155081440|NCT00281580|559729443|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
155081441|NCT00281580|559729444|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
155081442|NCT00281580|559729445|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
155081443|NCT00281580|559729446|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
155081444|NCT00281580|559729447|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
155081445|NCT00281580|559729448|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
155081446|NCT00281580|559729449|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
155347041|NCT00296504|560703427|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
155081447|NCT00281580|559729450|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
155081448|NCT00281580|559729451|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
155081449|NCT00281580|559729452|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
155081450|NCT00281580|559729453|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
155081451|NCT00281580|559729454|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
155081452|NCT00281580|559729455|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
155081453|NCT00281580|559729456|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
155081454|NCT00281580|559729457|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
155347042|NCT00296504|560703428|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
155347043|NCT00296504|560703429|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
155347044|NCT00296504|560703430|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
155081455|NCT00276380|559729459|FG000|Overall Study|Adverse Event|5|||
155081456|NCT00276380|559729460|FG001|Overall Study|Adverse Event|3|||
155081457|NCT00276380|559729459|FG000|Overall Study|Lost to Follow-up|1|||
155081458|NCT00276380|559729460|FG001|Overall Study|Lost to Follow-up|1|||
155081459|NCT00276380|559729459|FG000|Overall Study|Withdrawal by Subject|3|||
155081460|NCT00276380|559729460|FG001|Overall Study|Withdrawal by Subject|6|||
155081461|NCT00276380|559729459|FG000|Overall Study|Death|5|||
155081462|NCT00276380|559729460|FG001|Overall Study|Death|3|||
155081463|NCT00276380|559729459|FG000|Overall Study|Abnormal aPPT Levels|0|||
155081464|NCT00276380|559729460|FG001|Overall Study|Abnormal aPPT Levels|1|||
155081465|NCT01651208|559729465|FG000|Overall Study|Lost to Follow-up|14|||
155081466|NCT01651208|559729466|FG001|Overall Study|Lost to Follow-up|16|||
155081467|NCT02067156|559729467|FG000|Overall Study|Lost to Follow-up|4|||
155081468|NCT03596983|559729468|FG000|Overall Study|Withdrawal by Subject|3|||
155347045|NCT00296504|560703431|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
155347046|NCT00296504|560703432|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
155347047|NCT00296504|560703424|FG000|Interim Analysis|Participant Stopped|0|||
155347048|NCT00296504|560703425|FG001|Interim Analysis|Participant Stopped|0|||
155347049|NCT00296504|560703426|FG002|Interim Analysis|Participant Stopped|0|||
155347050|NCT00296504|560703427|FG003|Interim Analysis|Participant Stopped|0|||
155347051|NCT00296504|560703428|FG004|Interim Analysis|Participant Stopped|1|||
155347052|NCT00296504|560703429|FG005|Interim Analysis|Participant Stopped|0|||
155347053|NCT00296504|560703430|FG006|Interim Analysis|Participant Stopped|0|||
155347054|NCT00296504|560703431|FG007|Interim Analysis|Participant Stopped|0|||
155347055|NCT00296504|560703432|FG008|Interim Analysis|Participant Stopped|0|||
155347056|NCT00296504|560703424|FG000|Interim Analysis|Physician and Participant Decision|0|||
155347057|NCT00296504|560703425|FG001|Interim Analysis|Physician and Participant Decision|0|||
155347058|NCT00296504|560703426|FG002|Interim Analysis|Physician and Participant Decision|0|||
155347059|NCT00296504|560703427|FG003|Interim Analysis|Physician and Participant Decision|0|||
155347060|NCT00296504|560703428|FG004|Interim Analysis|Physician and Participant Decision|0|||
155347061|NCT00296504|560703429|FG005|Interim Analysis|Physician and Participant Decision|1|||
155347062|NCT00296504|560703430|FG006|Interim Analysis|Physician and Participant Decision|0|||
155347063|NCT00296504|560703431|FG007|Interim Analysis|Physician and Participant Decision|0|||
155347064|NCT00296504|560703432|FG008|Interim Analysis|Physician and Participant Decision|0|||
155347065|NCT00296504|560703424|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
155347066|NCT00296504|560703425|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
155347067|NCT00296504|560703426|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
155347068|NCT00296504|560703427|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
155347069|NCT00296504|560703428|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
155347070|NCT00296504|560703429|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
155347071|NCT00296504|560703430|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
154963964|NCT03215706|559293503|FG000|Treatment Period|Adverse event unrelated to study drug|31|||
154963965|NCT03215706|559293504|FG001|Treatment Period|Adverse event unrelated to study drug|27|||
155081469|NCT04829214|559729469|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
155081470|NCT04829214|559729470|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
155081471|NCT04829214|559729469|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
155081472|NCT04829214|559729470|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
155081473|NCT06399471|559729471|FG000|Overall Study|Withdrawal by Subject|1|||
155081474|NCT04135352|559729473|FG000|Overall Study|Not treated-randomization error|0|||
155081475|NCT04135352|559729474|FG001|Overall Study|Not treated-randomization error|0|||
155347072|NCT00296504|560703431|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
155347073|NCT00296504|560703432|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
155081476|NCT04135352|559729475|FG002|Overall Study|Not treated-randomization error|1|||
155081477|NCT04135352|559729476|FG003|Overall Study|Not treated-randomization error|0|||
155347074|NCT00296504|560703424|FG000|Interim Analysis|Study Ended|0|||
155347075|NCT00296504|560703425|FG001|Interim Analysis|Study Ended|0|||
155347076|NCT00296504|560703426|FG002|Interim Analysis|Study Ended|0|||
155347077|NCT00296504|560703427|FG003|Interim Analysis|Study Ended|0|||
155347078|NCT00296504|560703428|FG004|Interim Analysis|Study Ended|0|||
155347079|NCT00296504|560703429|FG005|Interim Analysis|Study Ended|0|||
155347080|NCT00296504|560703430|FG006|Interim Analysis|Study Ended|1|||
155347081|NCT00296504|560703431|FG007|Interim Analysis|Study Ended|0|||
155347082|NCT00296504|560703432|FG008|Interim Analysis|Study Ended|0|||
155347083|NCT00296504|560703424|FG000|Interim Analysis|Participant Needed Interferon|0|||
155347084|NCT00296504|560703425|FG001|Interim Analysis|Participant Needed Interferon|0|||
155347085|NCT00296504|560703426|FG002|Interim Analysis|Participant Needed Interferon|0|||
155347086|NCT00296504|560703427|FG003|Interim Analysis|Participant Needed Interferon|0|||
155347087|NCT00296504|560703428|FG004|Interim Analysis|Participant Needed Interferon|0|||
155347088|NCT00296504|560703429|FG005|Interim Analysis|Participant Needed Interferon|0|||
155347089|NCT00296504|560703430|FG006|Interim Analysis|Participant Needed Interferon|0|||
155347090|NCT00296504|560703431|FG007|Interim Analysis|Participant Needed Interferon|1|||
155347091|NCT00296504|560703432|FG008|Interim Analysis|Participant Needed Interferon|0|||
155347092|NCT00296504|560703424|FG000|Interim Analysis|Ongoing|32|||
155347093|NCT00296504|560703425|FG001|Interim Analysis|Ongoing|12|||
155347094|NCT00296504|560703426|FG002|Interim Analysis|Ongoing|16|||
155347095|NCT00296504|560703427|FG003|Interim Analysis|Ongoing|22|||
155347096|NCT00296504|560703428|FG004|Interim Analysis|Ongoing|0|||
155347097|NCT00296504|560703429|FG005|Interim Analysis|Ongoing|0|||
155347098|NCT00296504|560703430|FG006|Interim Analysis|Ongoing|30|||
155347099|NCT00296504|560703431|FG007|Interim Analysis|Ongoing|1|||
155347100|NCT00296504|560703432|FG008|Interim Analysis|Ongoing|0|||
155347101|NCT00296504|560703424|FG000|Final Analysis|Withdrawal by Subject|0|||
155347102|NCT00296504|560703425|FG001|Final Analysis|Withdrawal by Subject|0|||
155347103|NCT00296504|560703426|FG002|Final Analysis|Withdrawal by Subject|0|||
155347104|NCT00296504|560703427|FG003|Final Analysis|Withdrawal by Subject|0|||
155347105|NCT00296504|560703428|FG004|Final Analysis|Withdrawal by Subject|0|||
155347106|NCT00296504|560703429|FG005|Final Analysis|Withdrawal by Subject|0|||
155347107|NCT00296504|560703430|FG006|Final Analysis|Withdrawal by Subject|0|||
155347108|NCT00296504|560703431|FG007|Final Analysis|Withdrawal by Subject|0|||
155347109|NCT00296504|560703432|FG008|Final Analysis|Withdrawal by Subject|1|||
155347110|NCT00296504|560703424|FG000|Final Analysis|Lost to Follow-up|0|||
155347111|NCT00296504|560703425|FG001|Final Analysis|Lost to Follow-up|0|||
155347112|NCT00296504|560703426|FG002|Final Analysis|Lost to Follow-up|0|||
155347113|NCT00296504|560703427|FG003|Final Analysis|Lost to Follow-up|0|||
155347114|NCT00296504|560703428|FG004|Final Analysis|Lost to Follow-up|0|||
155347115|NCT00296504|560703429|FG005|Final Analysis|Lost to Follow-up|0|||
155347116|NCT00296504|560703430|FG006|Final Analysis|Lost to Follow-up|0|||
155347117|NCT00296504|560703431|FG007|Final Analysis|Lost to Follow-up|0|||
155347118|NCT00296504|560703432|FG008|Final Analysis|Lost to Follow-up|5|||
155347119|NCT00296504|560703424|FG000|Final Analysis|Insufficient Viral Load Response|0|||
155347120|NCT00296504|560703425|FG001|Final Analysis|Insufficient Viral Load Response|0|||
155081478|NCT04135352|559729477|FG004|Overall Study|Not treated-randomization error|0|||
155081479|NCT04135352|559729478|FG005|Overall Study|Not treated-randomization error|0|||
155081480|NCT04135352|559729479|FG006|Overall Study|Not treated-randomization error|0|||
155081481|NCT04135352|559729480|FG007|Overall Study|Not treated-randomization error|0|||
155081482|NCT04135352|559729473|FG000|Overall Study|Withdrawal by Subject|0|||
155081483|NCT04135352|559729474|FG001|Overall Study|Withdrawal by Subject|0|||
155081484|NCT04135352|559729475|FG002|Overall Study|Withdrawal by Subject|2|||
155081485|NCT04135352|559729476|FG003|Overall Study|Withdrawal by Subject|0|||
155081486|NCT04135352|559729477|FG004|Overall Study|Withdrawal by Subject|0|||
155081487|NCT04135352|559729478|FG005|Overall Study|Withdrawal by Subject|0|||
155081488|NCT04135352|559729479|FG006|Overall Study|Withdrawal by Subject|0|||
155081489|NCT04135352|559729480|FG007|Overall Study|Withdrawal by Subject|0|||
155081490|NCT04135352|559729473|FG000|Overall Study|Sponsor Decision|0|||
155081491|NCT04135352|559729474|FG001|Overall Study|Sponsor Decision|0|||
155347121|NCT00296504|560703426|FG002|Final Analysis|Insufficient Viral Load Response|0|||
155347122|NCT00296504|560703427|FG003|Final Analysis|Insufficient Viral Load Response|0|||
155347123|NCT00296504|560703428|FG004|Final Analysis|Insufficient Viral Load Response|0|||
155347124|NCT00296504|560703429|FG005|Final Analysis|Insufficient Viral Load Response|0|||
155347125|NCT00296504|560703430|FG006|Final Analysis|Insufficient Viral Load Response|0|||
155347126|NCT00296504|560703431|FG007|Final Analysis|Insufficient Viral Load Response|0|||
155347127|NCT00296504|560703432|FG008|Final Analysis|Insufficient Viral Load Response|6|||
155347128|NCT00296504|560703424|FG000|Final Analysis|Adverse Event|0|||
155347129|NCT00296504|560703425|FG001|Final Analysis|Adverse Event|0|||
155081492|NCT04135352|559729475|FG002|Overall Study|Sponsor Decision|2|||
155081493|NCT04135352|559729476|FG003|Overall Study|Sponsor Decision|5|||
155165537|NCT04661579|560043478|FG002|Overall Study|Other|1|||
155347130|NCT00296504|560703426|FG002|Final Analysis|Adverse Event|0|||
155347131|NCT00296504|560703427|FG003|Final Analysis|Adverse Event|0|||
154963966|NCT03215706|559293503|FG000|Treatment Period|Request to D/C treatment|2|||
154963967|NCT03215706|559293504|FG001|Treatment Period|Request to D/C treatment|10|||
154963968|NCT03215706|559293503|FG000|Treatment Period|Participant withdrew consent|4|||
154963969|NCT03215706|559293504|FG001|Treatment Period|Participant withdrew consent|5|||
154963970|NCT03215706|559293503|FG000|Treatment Period|Lost to Follow-up|0|||
154963971|NCT03215706|559293504|FG001|Treatment Period|Lost to Follow-up|1|||
155081494|NCT04135352|559729477|FG004|Overall Study|Sponsor Decision|1|||
155081495|NCT04135352|559729478|FG005|Overall Study|Sponsor Decision|4|||
155081496|NCT04135352|559729479|FG006|Overall Study|Sponsor Decision|0|||
155081497|NCT04135352|559729480|FG007|Overall Study|Sponsor Decision|0|||
155081498|NCT04135352|559729473|FG000|Overall Study|Physician Decision|0|||
155081499|NCT04135352|559729474|FG001|Overall Study|Physician Decision|0|||
155081500|NCT04135352|559729475|FG002|Overall Study|Physician Decision|1|||
155081501|NCT04135352|559729476|FG003|Overall Study|Physician Decision|0|||
155081502|NCT04135352|559729477|FG004|Overall Study|Physician Decision|1|||
155081503|NCT04135352|559729478|FG005|Overall Study|Physician Decision|0|||
155081504|NCT04135352|559729479|FG006|Overall Study|Physician Decision|0|||
155081505|NCT04135352|559729480|FG007|Overall Study|Physician Decision|0|||
155081506|NCT04135352|559729473|FG000|Overall Study|Death|3|||
155081507|NCT04135352|559729474|FG001|Overall Study|Death|4|||
155081508|NCT04135352|559729475|FG002|Overall Study|Death|7|||
155081509|NCT04135352|559729476|FG003|Overall Study|Death|0|||
155081510|NCT04135352|559729477|FG004|Overall Study|Death|3|||
155081511|NCT04135352|559729478|FG005|Overall Study|Death|1|||
155081512|NCT04135352|559729479|FG006|Overall Study|Death|0|||
155081513|NCT04135352|559729480|FG007|Overall Study|Death|0|||
155081514|NCT01392495|559729483|FG000|Overall Study|Death|3|||
155081515|NCT01392495|559729483|FG000|Overall Study|Administrative problems|8|||
155081516|NCT01392495|559729483|FG000|Overall Study|Withdrawal by Subject|2|||
155081517|NCT01392495|559729483|FG000|Overall Study|Adverse Event|3|||
155081518|NCT00736476|559729486|FG000|Overall Study|Adverse Event|1|||
155081519|NCT00736476|559729487|FG001|Overall Study|Adverse Event|0|||
155081520|NCT01796470|559729488|FG000|Overall Study|Adverse Event|4|||
155081521|NCT01796470|559729489|FG001|Overall Study|Adverse Event|2|||
155081522|NCT01796470|559729490|FG002|Overall Study|Adverse Event|2|||
155081523|NCT01796470|559729491|FG003|Overall Study|Adverse Event|1|||
155081524|NCT01796470|559729492|FG004|Overall Study|Adverse Event|3|||
155081525|NCT01796470|559729488|FG000|Overall Study|Death|2|||
155081526|NCT01796470|559729489|FG001|Overall Study|Death|0|||
155081527|NCT01796470|559729490|FG002|Overall Study|Death|0|||
155081528|NCT01796470|559729491|FG003|Overall Study|Death|0|||
155081529|NCT01796470|559729492|FG004|Overall Study|Death|1|||
155081530|NCT01796470|559729488|FG000|Overall Study|Initiated New Therapy|9|||
155347132|NCT00296504|560703428|FG004|Final Analysis|Adverse Event|0|||
155347133|NCT00296504|560703429|FG005|Final Analysis|Adverse Event|0|||
155347134|NCT00296504|560703430|FG006|Final Analysis|Adverse Event|0|||
155347135|NCT00296504|560703431|FG007|Final Analysis|Adverse Event|0|||
155347136|NCT00296504|560703432|FG008|Final Analysis|Adverse Event|2|||
155347137|NCT00296504|560703424|FG000|Final Analysis|Pregnancy|0|||
155347138|NCT00296504|560703425|FG001|Final Analysis|Pregnancy|0|||
155347139|NCT00296504|560703426|FG002|Final Analysis|Pregnancy|0|||
155347140|NCT00296504|560703427|FG003|Final Analysis|Pregnancy|0|||
155347141|NCT00296504|560703428|FG004|Final Analysis|Pregnancy|0|||
155347142|NCT00296504|560703429|FG005|Final Analysis|Pregnancy|0|||
155347143|NCT00296504|560703430|FG006|Final Analysis|Pregnancy|0|||
155347144|NCT00296504|560703431|FG007|Final Analysis|Pregnancy|0|||
155347145|NCT00296504|560703432|FG008|Final Analysis|Pregnancy|4|||
155347146|NCT00296504|560703424|FG000|Final Analysis|Tuberculosis|0|||
155347147|NCT00296504|560703425|FG001|Final Analysis|Tuberculosis|0|||
155347148|NCT00296504|560703426|FG002|Final Analysis|Tuberculosis|0|||
155347149|NCT00296504|560703427|FG003|Final Analysis|Tuberculosis|0|||
155347150|NCT00296504|560703428|FG004|Final Analysis|Tuberculosis|0|||
155347151|NCT00296504|560703429|FG005|Final Analysis|Tuberculosis|0|||
155347152|NCT00296504|560703430|FG006|Final Analysis|Tuberculosis|0|||
155347153|NCT00296504|560703431|FG007|Final Analysis|Tuberculosis|0|||
155347154|NCT00296504|560703432|FG008|Final Analysis|Tuberculosis|1|||
155081531|NCT01796470|559729489|FG001|Overall Study|Initiated New Therapy|0|||
155081532|NCT01796470|559729490|FG002|Overall Study|Initiated New Therapy|0|||
155347155|NCT00296504|560703424|FG000|Final Analysis|Participant Moved to Another Country|0|||
155347156|NCT00296504|560703425|FG001|Final Analysis|Participant Moved to Another Country|0|||
155081533|NCT01796470|559729491|FG003|Overall Study|Initiated New Therapy|0|||
155347157|NCT00296504|560703426|FG002|Final Analysis|Participant Moved to Another Country|0|||
155081534|NCT01796470|559729492|FG004|Overall Study|Initiated New Therapy|2|||
155081535|NCT01796470|559729488|FG000|Overall Study|Lost to Follow-up|0|||
155081536|NCT01796470|559729489|FG001|Overall Study|Lost to Follow-up|1|||
155081537|NCT01796470|559729490|FG002|Overall Study|Lost to Follow-up|0|||
155081538|NCT01796470|559729491|FG003|Overall Study|Lost to Follow-up|0|||
155081539|NCT01796470|559729492|FG004|Overall Study|Lost to Follow-up|0|||
155347158|NCT00296504|560703427|FG003|Final Analysis|Participant Moved to Another Country|0|||
155347159|NCT00296504|560703428|FG004|Final Analysis|Participant Moved to Another Country|0|||
155347160|NCT00296504|560703429|FG005|Final Analysis|Participant Moved to Another Country|0|||
155347161|NCT00296504|560703430|FG006|Final Analysis|Participant Moved to Another Country|0|||
155081540|NCT01796470|559729488|FG000|Overall Study|Physician Decision|5|||
155081541|NCT01796470|559729489|FG001|Overall Study|Physician Decision|4|||
155081542|NCT01796470|559729490|FG002|Overall Study|Physician Decision|1|||
155081543|NCT01796470|559729491|FG003|Overall Study|Physician Decision|0|||
155347162|NCT00296504|560703431|FG007|Final Analysis|Participant Moved to Another Country|0|||
155347163|NCT00296504|560703432|FG008|Final Analysis|Participant Moved to Another Country|1|||
155347164|NCT00296504|560703424|FG000|Final Analysis|Poor Adherence|0|||
155347165|NCT00296504|560703425|FG001|Final Analysis|Poor Adherence|0|||
155347166|NCT00296504|560703426|FG002|Final Analysis|Poor Adherence|0|||
155347167|NCT00296504|560703427|FG003|Final Analysis|Poor Adherence|0|||
155347168|NCT00296504|560703428|FG004|Final Analysis|Poor Adherence|0|||
155347169|NCT00296504|560703429|FG005|Final Analysis|Poor Adherence|0|||
155081544|NCT01796470|559729492|FG004|Overall Study|Physician Decision|1|||
155081545|NCT01796470|559729488|FG000|Overall Study|Progressive Disease|7|||
155081546|NCT01796470|559729489|FG001|Overall Study|Progressive Disease|7|||
155081547|NCT01796470|559729490|FG002|Overall Study|Progressive Disease|3|||
155347170|NCT00296504|560703430|FG006|Final Analysis|Poor Adherence|0|||
155347171|NCT00296504|560703431|FG007|Final Analysis|Poor Adherence|0|||
155347172|NCT00296504|560703432|FG008|Final Analysis|Poor Adherence|1|||
155347173|NCT01323309|560703438|FG000|Overall Study|Death|9|||
155347174|NCT01323309|560703439|FG001|Overall Study|Death|15|||
155347175|NCT01323309|560703440|FG002|Overall Study|Death|5|||
155347176|NCT01323309|560703438|FG000|Overall Study|Lost to Follow-up|11|||
155347177|NCT01323309|560703439|FG001|Overall Study|Lost to Follow-up|14|||
155347178|NCT01323309|560703440|FG002|Overall Study|Lost to Follow-up|24|||
155347179|NCT01323309|560703438|FG000|Overall Study|Withdrawal by Subject|14|||
155347180|NCT01323309|560703439|FG001|Overall Study|Withdrawal by Subject|14|||
155347181|NCT01323309|560703440|FG002|Overall Study|Withdrawal by Subject|18|||
155347182|NCT01323309|560703438|FG000|Overall Study|Disease progression|5|||
155347183|NCT01323309|560703439|FG001|Overall Study|Disease progression|11|||
155347184|NCT01323309|560703440|FG002|Overall Study|Disease progression|4|||
155081548|NCT01796470|559729491|FG003|Overall Study|Progressive Disease|2|||
155081549|NCT01796470|559729492|FG004|Overall Study|Progressive Disease|0|||
155081550|NCT01796470|559729488|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
155081551|NCT01796470|559729489|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
155081552|NCT01796470|559729490|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
155081553|NCT01796470|559729491|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
155081554|NCT01796470|559729492|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
155081555|NCT01796470|559729488|FG000|Overall Study|Withdrawal by Subject|7|||
155081556|NCT01796470|559729489|FG001|Overall Study|Withdrawal by Subject|0|||
155081557|NCT01796470|559729490|FG002|Overall Study|Withdrawal by Subject|0|||
155081558|NCT01796470|559729491|FG003|Overall Study|Withdrawal by Subject|0|||
155081559|NCT01796470|559729492|FG004|Overall Study|Withdrawal by Subject|1|||
155081560|NCT00147537|559729493|FG000|Phase 1b|Death|0|||
155081561|NCT00147537|559729494|FG001|Phase 1b|Death|1|||
155081562|NCT00147537|559729495|FG002|Phase 1b|Death|2|||
155081563|NCT00147537|559729496|FG003|Phase 1b|Death|1|||
155081564|NCT00147537|559729497|FG004|Phase 1b|Death|2|||
155081565|NCT00147537|559729498|FG005|Phase 1b|Death|2|||
155081566|NCT00147537|559729499|FG006|Phase 1b|Death|1|||
155081567|NCT00147537|559729500|FG007|Phase 1b|Death|3|||
155081568|NCT00147537|559729501|FG008|Phase 1b|Death|9|||
155081569|NCT00147537|559729502|FG009|Phase 1b|Death|0|||
155081570|NCT00147537|559729503|FG010|Phase 1b|Death|0|||
155081571|NCT00147537|559729493|FG000|Phase 1b|Lost to Follow-up|2|||
155081572|NCT00147537|559729494|FG001|Phase 1b|Lost to Follow-up|1|||
155081573|NCT00147537|559729495|FG002|Phase 1b|Lost to Follow-up|0|||
155081574|NCT00147537|559729496|FG003|Phase 1b|Lost to Follow-up|0|||
155081575|NCT00147537|559729497|FG004|Phase 1b|Lost to Follow-up|0|||
155081576|NCT00147537|559729498|FG005|Phase 1b|Lost to Follow-up|0|||
155081577|NCT00147537|559729499|FG006|Phase 1b|Lost to Follow-up|2|||
155347185|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
155347186|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
155347187|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Adverse Event|4|||
155347188|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Adverse Event|1|||
155347189|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
155081578|NCT00147537|559729500|FG007|Phase 1b|Lost to Follow-up|0|||
155081579|NCT00147537|559729501|FG008|Phase 1b|Lost to Follow-up|1|||
155081580|NCT00147537|559729502|FG009|Phase 1b|Lost to Follow-up|0|||
155081581|NCT00147537|559729503|FG010|Phase 1b|Lost to Follow-up|0|||
155347190|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
155347191|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Physician Decision|0|||
155347192|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Physician Decision|2|||
155347193|NCT02162771|560703441|FG000|Core Study Period (Part 2)|Death|1|||
155081582|NCT00147537|559729493|FG000|Phase 1b|Other|0|||
155081583|NCT00147537|559729494|FG001|Phase 1b|Other|0|||
155347194|NCT02162771|560703442|FG001|Core Study Period (Part 2)|Death|0|||
155081584|NCT00147537|559729495|FG002|Phase 1b|Other|2|||
155081585|NCT00147537|559729496|FG003|Phase 1b|Other|1|||
155081586|NCT00147537|559729497|FG004|Phase 1b|Other|1|||
155081587|NCT00147537|559729498|FG005|Phase 1b|Other|1|||
155081588|NCT00147537|559729499|FG006|Phase 1b|Other|14|||
155347195|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
155347196|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
155347197|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
155347198|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
155347199|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Death|2|||
155347200|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Death|1|||
155347201|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
155347202|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
155347203|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
155347204|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
155347205|NCT02162771|560703441|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
155347206|NCT02162771|560703442|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
155347207|NCT01348763|560703443|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
155347208|NCT01348763|560703443|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
155347209|NCT01078571|560703447|FG000|Overall Study|Adverse Event|36|||
155347210|NCT01078571|560703447|FG000|Overall Study|Lack of effectiveness|36|||
155347211|NCT01078571|560703447|FG000|Overall Study|Reason not reported|21|||
155347212|NCT01078571|560703447|FG000|Overall Study|Withdrawal by Subject|12|||
155347213|NCT01078571|560703447|FG000|Overall Study|Lost to Follow-up|8|||
155347214|NCT01078571|560703447|FG000|Overall Study|Protocol Violation|2|||
155347215|NCT01047306|560703460|FG000|Overall Study|Withdrawal by Subject|2|||
155347216|NCT01047306|560703461|FG001|Overall Study|Withdrawal by Subject|0|||
155347217|NCT01047306|560703460|FG000|Overall Study|Lost to Follow-up|1|||
155347218|NCT01047306|560703461|FG001|Overall Study|Lost to Follow-up|0|||
155347219|NCT01878253|560703463|FG000|Overall Study|Death|1|||
155347220|NCT01878253|560703463|FG000|Overall Study|SIdus System Removal|3|||
155347221|NCT01878253|560703463|FG000|Overall Study|Withdrawal by Subject|1|||
155347222|NCT01878253|560703463|FG000|Overall Study|Lost to Follow-up|2|||
155347223|NCT01878253|560703463|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
155347224|NCT03647709|560703468|FG000|Overall Study|Lost to Follow-up|5|||
155347225|NCT03647709|560703468|FG000|Overall Study|Physician Decision|6|||
155347226|NCT03647709|560703468|FG000|Overall Study|Withdrawal by Subject|3|||
155347227|NCT00449033|560703471|FG000|Treatment Period|Adverse Event|117|||
155347228|NCT00449033|560703472|FG001|Treatment Period|Adverse Event|83|||
155347229|NCT00449033|560703471|FG000|Treatment Period|Death|21|||
155347230|NCT00449033|560703472|FG001|Treatment Period|Death|12|||
155347231|NCT00449033|560703471|FG000|Treatment Period|Lost to Follow-up|0|||
155347232|NCT00449033|560703472|FG001|Treatment Period|Lost to Follow-up|2|||
155347233|NCT00449033|560703471|FG000|Treatment Period|Physician Decision|4|||
155347234|NCT00449033|560703472|FG001|Treatment Period|Physician Decision|5|||
155347235|NCT00449033|560703471|FG000|Treatment Period|Protocol Violation|8|||
155347236|NCT00449033|560703472|FG001|Treatment Period|Protocol Violation|7|||
155347237|NCT00449033|560703471|FG000|Treatment Period|Disease Progression|231|||
155347238|NCT00449033|560703472|FG001|Treatment Period|Disease Progression|288|||
155347239|NCT00449033|560703471|FG000|Treatment Period|Consent Withdrawn|36|||
155347240|NCT00449033|560703472|FG001|Treatment Period|Consent Withdrawn|20|||
155347241|NCT00449033|560703471|FG000|Treatment Period|Amended Protocol Criteria|22|||
155347242|NCT00449033|560703472|FG001|Treatment Period|Amended Protocol Criteria|18|||
155347243|NCT00449033|560703471|FG000|Treatment Period|Non-compliance|7|||
155347244|NCT00449033|560703472|FG001|Treatment Period|Non-compliance|8|||
155347245|NCT00449033|560703471|FG000|Treatment Period|Second Malignancy|0|||
155347246|NCT00449033|560703472|FG001|Treatment Period|Second Malignancy|1|||
155347247|NCT00449033|560703471|FG000|Treatment Period|Reason Missing|0|||
155347248|NCT00449033|560703472|FG001|Treatment Period|Reason Missing|4|||
155347249|NCT00449033|560703471|FG000|Treatment Period|Treatment Ongoing|6|||
155081589|NCT00147537|559729500|FG007|Phase 1b|Other|4|||
155347250|NCT00449033|560703472|FG001|Treatment Period|Treatment Ongoing|4|||
155347251|NCT00449033|560703471|FG000|Follow-up Period|Death|299|||
155347252|NCT00449033|560703472|FG001|Follow-up Period|Death|311|||
155347253|NCT00449033|560703471|FG000|Follow-up Period|Lost to Follow-up|6|||
155347254|NCT00449033|560703472|FG001|Follow-up Period|Lost to Follow-up|10|||
155347255|NCT00449033|560703471|FG000|Follow-up Period|Reason Missing|120|||
155347256|NCT00449033|560703472|FG001|Follow-up Period|Reason Missing|113|||
155347257|NCT04393779|560703473|FG000|Overall Study|Death|1|||
155347258|NCT04393779|560703473|FG000|Overall Study|Device reintervention or explant|4|||
155347259|NCT03802513|560703475|FG000|Overall Study|Lost to Follow-up|1|||
155347260|NCT01190228|560703478|FG000|Overall Study|Protocol Violation|4|||
155347261|NCT01190228|560703479|FG001|Overall Study|Protocol Violation|0|||
155347262|NCT01190228|560703480|FG002|Overall Study|Protocol Violation|0|||
155347263|NCT01190228|560703478|FG000|Overall Study|Withdrawal by Subject|1|||
155347264|NCT01190228|560703479|FG001|Overall Study|Withdrawal by Subject|0|||
155347265|NCT01190228|560703480|FG002|Overall Study|Withdrawal by Subject|0|||
155081590|NCT00147537|559729501|FG008|Phase 1b|Other|4|||
155347266|NCT01855399|560703482|FG000|6 Month|Lost to Follow-up|12|||
155347267|NCT01855399|560703483|FG001|6 Month|Lost to Follow-up|9|||
155347268|NCT01855399|560703482|FG000|6 Month|Withdrawal by Subject|8|||
155347269|NCT01855399|560703483|FG001|6 Month|Withdrawal by Subject|6|||
155347270|NCT01855399|560703482|FG000|12 Month|Lost to Follow-up|7|||
155347271|NCT01855399|560703483|FG001|12 Month|Lost to Follow-up|11|||
155347272|NCT00512902|560703484|FG000|Overall Study|Adverse Event|7|||
155347273|NCT00512902|560703484|FG000|Overall Study|Lost to Follow-up|1|||
155347274|NCT03214198|560703485|FG000|Overall Study|Case Report Forms Uncollected|18|||
155347275|NCT03214198|560703485|FG000|Overall Study|Protocol Deviation|18|||
155347276|NCT02577315|560703488|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
155347277|NCT02577315|560703489|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
155347278|NCT03530345|560703495|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
155081591|NCT00147537|559729502|FG009|Phase 1b|Other|0|||
155081592|NCT00147537|559729503|FG010|Phase 1b|Other|0|||
155081593|NCT00147537|559729493|FG000|Phase 1b|Withdrawal by Subject|0|||
155081594|NCT00147537|559729494|FG001|Phase 1b|Withdrawal by Subject|0|||
155081595|NCT00147537|559729495|FG002|Phase 1b|Withdrawal by Subject|0|||
155081596|NCT00147537|559729496|FG003|Phase 1b|Withdrawal by Subject|0|||
155081597|NCT00147537|559729497|FG004|Phase 1b|Withdrawal by Subject|0|||
155081598|NCT00147537|559729498|FG005|Phase 1b|Withdrawal by Subject|0|||
155081599|NCT00147537|559729499|FG006|Phase 1b|Withdrawal by Subject|0|||
155081600|NCT00147537|559729500|FG007|Phase 1b|Withdrawal by Subject|0|||
155081601|NCT00147537|559729501|FG008|Phase 1b|Withdrawal by Subject|2|||
155081602|NCT00147537|559729502|FG009|Phase 1b|Withdrawal by Subject|0|||
155081603|NCT00147537|559729503|FG010|Phase 1b|Withdrawal by Subject|0|||
155081604|NCT00147537|559729493|FG000|Phase 1b|Randomized but not treated|0|||
155081605|NCT00147537|559729494|FG001|Phase 1b|Randomized but not treated|0|||
155081606|NCT00147537|559729495|FG002|Phase 1b|Randomized but not treated|0|||
155081607|NCT00147537|559729496|FG003|Phase 1b|Randomized but not treated|0|||
155081608|NCT00147537|559729497|FG004|Phase 1b|Randomized but not treated|0|||
155081609|NCT00147537|559729498|FG005|Phase 1b|Randomized but not treated|0|||
155081610|NCT00147537|559729499|FG006|Phase 1b|Randomized but not treated|1|||
155081611|NCT00147537|559729500|FG007|Phase 1b|Randomized but not treated|0|||
155081612|NCT00147537|559729501|FG008|Phase 1b|Randomized but not treated|1|||
155081613|NCT00147537|559729502|FG009|Phase 1b|Randomized but not treated|0|||
155081614|NCT00147537|559729503|FG010|Phase 1b|Randomized but not treated|0|||
155081615|NCT00147537|559729493|FG000|Phase 2|Death|0|||
155081616|NCT00147537|559729494|FG001|Phase 2|Death|0|||
155081617|NCT00147537|559729495|FG002|Phase 2|Death|0|||
155081618|NCT00147537|559729496|FG003|Phase 2|Death|0|||
155081619|NCT00147537|559729497|FG004|Phase 2|Death|0|||
155081620|NCT00147537|559729498|FG005|Phase 2|Death|0|||
155081621|NCT00147537|559729499|FG006|Phase 2|Death|0|||
155081622|NCT00147537|559729500|FG007|Phase 2|Death|0|||
155081623|NCT00147537|559729501|FG008|Phase 2|Death|0|||
155081624|NCT00147537|559729502|FG009|Phase 2|Death|85|||
155081625|NCT00147537|559729503|FG010|Phase 2|Death|31|||
155081626|NCT00147537|559729493|FG000|Phase 2|Lost to Follow-up|0|||
155081627|NCT00147537|559729494|FG001|Phase 2|Lost to Follow-up|0|||
155081628|NCT00147537|559729495|FG002|Phase 2|Lost to Follow-up|0|||
155081629|NCT00147537|559729496|FG003|Phase 2|Lost to Follow-up|0|||
155081630|NCT00147537|559729497|FG004|Phase 2|Lost to Follow-up|0|||
155081631|NCT00147537|559729498|FG005|Phase 2|Lost to Follow-up|0|||
155081632|NCT00147537|559729499|FG006|Phase 2|Lost to Follow-up|0|||
155081633|NCT00147537|559729500|FG007|Phase 2|Lost to Follow-up|0|||
155081634|NCT00147537|559729501|FG008|Phase 2|Lost to Follow-up|0|||
155081635|NCT00147537|559729502|FG009|Phase 2|Lost to Follow-up|12|||
155081636|NCT00147537|559729503|FG010|Phase 2|Lost to Follow-up|4|||
155081637|NCT00147537|559729493|FG000|Phase 2|Other|0|||
155081638|NCT00147537|559729494|FG001|Phase 2|Other|0|||
155081639|NCT00147537|559729495|FG002|Phase 2|Other|0|||
155081640|NCT00147537|559729496|FG003|Phase 2|Other|0|||
155081641|NCT00147537|559729497|FG004|Phase 2|Other|0|||
155081642|NCT00147537|559729498|FG005|Phase 2|Other|0|||
155081643|NCT00147537|559729499|FG006|Phase 2|Other|0|||
155081644|NCT00147537|559729500|FG007|Phase 2|Other|0|||
155081645|NCT00147537|559729501|FG008|Phase 2|Other|0|||
155081646|NCT00147537|559729502|FG009|Phase 2|Other|47|||
155347279|NCT03530345|560703496|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
155347280|NCT03530345|560703495|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
155347281|NCT03530345|560703496|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
155081647|NCT00147537|559729503|FG010|Phase 2|Other|12|||
155081648|NCT00147537|559729493|FG000|Phase 2|Withdrawal by Subject|0|||
155081649|NCT00147537|559729494|FG001|Phase 2|Withdrawal by Subject|0|||
155081650|NCT00147537|559729495|FG002|Phase 2|Withdrawal by Subject|0|||
155081651|NCT00147537|559729496|FG003|Phase 2|Withdrawal by Subject|0|||
155081652|NCT00147537|559729497|FG004|Phase 2|Withdrawal by Subject|0|||
155081653|NCT00147537|559729498|FG005|Phase 2|Withdrawal by Subject|0|||
155081654|NCT00147537|559729499|FG006|Phase 2|Withdrawal by Subject|0|||
155081655|NCT00147537|559729500|FG007|Phase 2|Withdrawal by Subject|0|||
155081656|NCT00147537|559729501|FG008|Phase 2|Withdrawal by Subject|0|||
155081657|NCT00147537|559729502|FG009|Phase 2|Withdrawal by Subject|16|||
155081658|NCT00147537|559729503|FG010|Phase 2|Withdrawal by Subject|4|||
155081659|NCT00147537|559729493|FG000|Phase 2|Randomized but not treated|0|||
155081660|NCT00147537|559729494|FG001|Phase 2|Randomized but not treated|0|||
155081661|NCT00147537|559729495|FG002|Phase 2|Randomized but not treated|0|||
155081662|NCT00147537|559729496|FG003|Phase 2|Randomized but not treated|0|||
155081663|NCT00147537|559729497|FG004|Phase 2|Randomized but not treated|0|||
155081664|NCT00147537|559729498|FG005|Phase 2|Randomized but not treated|0|||
155081665|NCT00147537|559729499|FG006|Phase 2|Randomized but not treated|0|||
155081666|NCT00147537|559729500|FG007|Phase 2|Randomized but not treated|0|||
155081667|NCT00147537|559729501|FG008|Phase 2|Randomized but not treated|0|||
155081668|NCT00147537|559729502|FG009|Phase 2|Randomized but not treated|1|||
155081669|NCT00147537|559729503|FG010|Phase 2|Randomized but not treated|1|||
155347282|NCT03530345|560703495|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
155347283|NCT03530345|560703496|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
155081670|NCT01927861|559729504|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
155081671|NCT01927861|559729505|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
155081672|NCT01927861|559729504|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
155081673|NCT01927861|559729505|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
155081674|NCT00452530|559729506|FG000|Overall Study|Death|1|||
155081675|NCT00452530|559729507|FG001|Overall Study|Death|0|||
155081676|NCT00452530|559729506|FG000|Overall Study|Adverse Event|40|||
155081677|NCT00452530|559729507|FG001|Overall Study|Adverse Event|44|||
155081678|NCT00452530|559729506|FG000|Overall Study|Withdrawal by Subject|68|||
155081679|NCT00452530|559729507|FG001|Overall Study|Withdrawal by Subject|57|||
155081680|NCT00452530|559729506|FG000|Overall Study|Lost to Follow-up|1|||
155081681|NCT00452530|559729507|FG001|Overall Study|Lost to Follow-up|0|||
155081682|NCT00452530|559729506|FG000|Overall Study|Poor compliance/noncompliance|1|||
155081683|NCT00452530|559729507|FG001|Overall Study|Poor compliance/noncompliance|2|||
155081684|NCT00452530|559729506|FG000|Overall Study|No longer met study criteria|18|||
155081685|NCT00452530|559729507|FG001|Overall Study|No longer met study criteria|22|||
155347284|NCT03530345|560703495|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
155347285|NCT03530345|560703496|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
155347286|NCT02442622|560703501|FG000|Overall Study|Withdrawal by Subject|3|||
155347287|NCT02442622|560703502|FG001|Overall Study|Withdrawal by Subject|1|||
155347288|NCT04448561|560703503|FG000|Overall Study|Noncompliance|1|||
155347289|NCT04448561|560703504|FG001|Overall Study|Noncompliance|0|||
155347290|NCT00635570|560704869|FG000|Overall Study|Lost to Follow-up|8|||
155347291|NCT00635570|560704870|FG001|Overall Study|Lost to Follow-up|8|||
155347292|NCT00635570|560704869|FG000|Overall Study|Withdrawal by Subject|1|||
155347293|NCT00635570|560704870|FG001|Overall Study|Withdrawal by Subject|1|||
155347294|NCT00635570|560704869|FG000|Overall Study|Adverse Event|2|||
155347295|NCT00635570|560704870|FG001|Overall Study|Adverse Event|0|||
155347296|NCT00635570|560704869|FG000|Overall Study|Physician Decision|1|||
155347297|NCT00635570|560704870|FG001|Overall Study|Physician Decision|0|||
155347298|NCT00635570|560704869|FG000|Overall Study|Did not complete survey|2|||
155347299|NCT00635570|560704870|FG001|Overall Study|Did not complete survey|1|||
155347300|NCT00635570|560704869|FG000|Overall Study|Early termination(No sexual activity)|1|||
155347301|NCT00635570|560704870|FG001|Overall Study|Early termination(No sexual activity)|1|||
155081686|NCT00452530|559729506|FG000|Overall Study|Other|7|||
155081687|NCT00452530|559729507|FG001|Overall Study|Other|11|||
155347302|NCT01816685|560704873|FG000|Overall Study|Lost to Follow-up|7|||
155347303|NCT01816685|560704874|FG001|Overall Study|Lost to Follow-up|9|||
155347304|NCT01816685|560704873|FG000|Overall Study|Surgery Cancelled|3|||
155347305|NCT01816685|560704874|FG001|Overall Study|Surgery Cancelled|2|||
155347306|NCT00381888|560704875|FG000|Overall Study|Death|1|||
155347307|NCT00381888|560704875|FG000|Overall Study|Withdrawal by Subject|1|||
155347308|NCT00381888|560704875|FG000|Overall Study|Physician Decision|1|||
155081688|NCT02006654|559729509|FG000|Overall Study|Withdrawal before treatment|4|||
155081689|NCT02006654|559729510|FG001|Overall Study|Withdrawal before treatment|2|||
155347309|NCT00381888|560704875|FG000|Overall Study|Protocol Violation|9|||
155347310|NCT00381888|560704875|FG000|Overall Study|Had laparoscopic surgery|2|||
155347311|NCT00381888|560704875|FG000|Overall Study|Surgery was cancelled|2|||
155347312|NCT00381888|560704875|FG000|Overall Study|Adverse Event|1|||
155347313|NCT00197106|560704879|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
155081690|NCT02006654|559729509|FG000|Overall Study|Adverse Event|16|||
155081691|NCT02006654|559729510|FG001|Overall Study|Adverse Event|17|||
155081692|NCT02006654|559729509|FG000|Overall Study|Death|1|||
155081693|NCT02006654|559729510|FG001|Overall Study|Death|0|||
155347314|NCT00197106|560704880|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
155081694|NCT02006654|559729509|FG000|Overall Study|Withdrawal by Subject|14|||
155081695|NCT02006654|559729510|FG001|Overall Study|Withdrawal by Subject|12|||
155347315|NCT00197106|560704881|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
155347316|NCT00197106|560704879|FG000|Overall Treatment Period|Lack of Efficacy|0|||
155347317|NCT00197106|560704880|FG001|Overall Treatment Period|Lack of Efficacy|1|||
155347318|NCT00197106|560704881|FG002|Overall Treatment Period|Lack of Efficacy|0|||
155347319|NCT00197106|560704879|FG000|Overall Treatment Period|Lost to Follow-up|0|||
155347320|NCT00197106|560704880|FG001|Overall Treatment Period|Lost to Follow-up|0|||
155347321|NCT00197106|560704881|FG002|Overall Treatment Period|Lost to Follow-up|2|||
155347322|NCT00197106|560704879|FG000|Overall Treatment Period|Protocol Violation|0|||
155347323|NCT00197106|560704880|FG001|Overall Treatment Period|Protocol Violation|0|||
155347324|NCT00197106|560704881|FG002|Overall Treatment Period|Protocol Violation|2|||
155347325|NCT00197106|560704879|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
155347326|NCT00197106|560704880|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
155347327|NCT00197106|560704881|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
155347328|NCT00762723|560704882|FG000|Overall Study|Study Terminated slow enrollement|5|||
155347329|NCT00762723|560704883|FG001|Overall Study|Study Terminated slow enrollement|5|||
155347330|NCT00762723|560704884|FG002|Overall Study|Study Terminated slow enrollement|3|||
155347331|NCT00382408|560704885|FG000|Overall Study|Did not meet protocol requirement|3|||
155347332|NCT00382408|560704886|FG001|Overall Study|Did not meet protocol requirement|3|||
155347333|NCT00382408|560704885|FG000|Overall Study|Protocol Violation|2|||
155347334|NCT00382408|560704886|FG001|Overall Study|Protocol Violation|2|||
155347335|NCT00382408|560704885|FG000|Overall Study|Physician Decision|1|||
155347336|NCT00382408|560704886|FG001|Overall Study|Physician Decision|0|||
155347337|NCT00382408|560704885|FG000|Overall Study|Withdrawal by Subject|17|||
155347338|NCT00382408|560704886|FG001|Overall Study|Withdrawal by Subject|6|||
155347339|NCT00382408|560704885|FG000|Overall Study|Pregnancy|2|||
155347340|NCT00382408|560704886|FG001|Overall Study|Pregnancy|0|||
155347341|NCT00382408|560704885|FG000|Overall Study|Lost to Follow-up|19|||
155347342|NCT00382408|560704886|FG001|Overall Study|Lost to Follow-up|8|||
155347343|NCT00382408|560704885|FG000|Overall Study|Other|100|||
155347344|NCT00382408|560704886|FG001|Overall Study|Other|35|||
154963972|NCT03215706|559293503|FG000|Treatment Period|Administrative reason by sponsor|0|||
154963973|NCT03215706|559293504|FG001|Treatment Period|Administrative reason by sponsor|2|||
154963974|NCT03215706|559293503|FG000|Treatment Period|other reasons|10|||
154963975|NCT03215706|559293504|FG001|Treatment Period|other reasons|5|||
154963976|NCT03215706|559293503|FG000|Treatment Period|Not reported|1|||
154963977|NCT03215706|559293504|FG001|Treatment Period|Not reported|0|||
154963978|NCT00640341|559295147|FG000|Overall Study|Adverse Event|0|||
154963979|NCT00640341|559295148|FG001|Overall Study|Adverse Event|0|||
154963980|NCT00640341|559295149|FG002|Overall Study|Adverse Event|1|||
154963981|NCT00640341|559295147|FG000|Overall Study|Positive Slit Lamp Findings|0|||
154963982|NCT00640341|559295148|FG001|Overall Study|Positive Slit Lamp Findings|0|||
154963983|NCT00640341|559295149|FG002|Overall Study|Positive Slit Lamp Findings|1|||
154963984|NCT00640341|559295147|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
154963985|NCT00640341|559295148|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
154963986|NCT00640341|559295149|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
154963987|NCT00640341|559295147|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
154963988|NCT00640341|559295148|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
154963989|NCT00640341|559295149|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
154963990|NCT00640341|559295147|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
154963991|NCT00640341|559295148|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
154963992|NCT00640341|559295149|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
154963993|NCT00640341|559295147|FG000|Overall Study|Lost to Follow-up|2|||
154963994|NCT00640341|559295148|FG001|Overall Study|Lost to Follow-up|0|||
154963995|NCT00640341|559295149|FG002|Overall Study|Lost to Follow-up|0|||
155347345|NCT02402465|560704889|FG000|Overall Study|Withdrawal by Subject|0|||
155347346|NCT02402465|560704890|FG001|Overall Study|Withdrawal by Subject|0|||
155347347|NCT02402465|560704891|FG002|Overall Study|Withdrawal by Subject|0|||
155347348|NCT02402465|560704892|FG003|Overall Study|Withdrawal by Subject|0|||
155347349|NCT02402465|560704893|FG004|Overall Study|Withdrawal by Subject|0|||
155347350|NCT02402465|560704894|FG005|Overall Study|Withdrawal by Subject|1|||
155347351|NCT02402465|560704889|FG000|Overall Study|Lost to Follow-up|0|||
155347352|NCT02402465|560704890|FG001|Overall Study|Lost to Follow-up|1|||
155347353|NCT02402465|560704891|FG002|Overall Study|Lost to Follow-up|0|||
154963996|NCT00640341|559295147|FG000|Overall Study|Withdrawal by Subject|4|||
154963997|NCT00640341|559295148|FG001|Overall Study|Withdrawal by Subject|0|||
154963998|NCT00640341|559295149|FG002|Overall Study|Withdrawal by Subject|1|||
155347354|NCT02402465|560704892|FG003|Overall Study|Lost to Follow-up|0|||
155347355|NCT02402465|560704893|FG004|Overall Study|Lost to Follow-up|1|||
154963999|NCT00640341|559295147|FG000|Overall Study|Unacceptable Lens Movement|1|||
154964000|NCT00640341|559295148|FG001|Overall Study|Unacceptable Lens Movement|0|||
154964001|NCT00640341|559295149|FG002|Overall Study|Unacceptable Lens Movement|0|||
154964002|NCT00640341|559295147|FG000|Overall Study|Poor fit/Uncomfortable|4|||
154964003|NCT00640341|559295148|FG001|Overall Study|Poor fit/Uncomfortable|0|||
154964004|NCT00640341|559295149|FG002|Overall Study|Poor fit/Uncomfortable|0|||
154964005|NCT00640341|559295147|FG000|Overall Study|Ineligable at Baseline|5|||
154964006|NCT00640341|559295148|FG001|Overall Study|Ineligable at Baseline|3|||
154964007|NCT00640341|559295149|FG002|Overall Study|Ineligable at Baseline|2|||
154964008|NCT00640341|559295147|FG000|Overall Study|Adverse event and positive slit lamp|1|||
154964009|NCT00640341|559295148|FG001|Overall Study|Adverse event and positive slit lamp|0|||
154964010|NCT00640341|559295149|FG002|Overall Study|Adverse event and positive slit lamp|0|||
154964011|NCT03578809|559295150|FG000|Overall Study|Death|0|||
154964012|NCT03578809|559295151|FG001|Overall Study|Death|2|||
154964013|NCT03578809|559295152|FG002|Overall Study|Death|0|||
154964014|NCT03578809|559295153|FG003|Overall Study|Death|1|||
154964015|NCT03578809|559295150|FG000|Overall Study|Lost to Follow-up|0|||
154964016|NCT03578809|559295151|FG001|Overall Study|Lost to Follow-up|1|||
154964017|NCT03578809|559295152|FG002|Overall Study|Lost to Follow-up|0|||
154964018|NCT03578809|559295153|FG003|Overall Study|Lost to Follow-up|0|||
154964019|NCT03578809|559295150|FG000|Overall Study|Withdrawal by Subject|3|||
154964020|NCT03578809|559295151|FG001|Overall Study|Withdrawal by Subject|5|||
154964021|NCT03578809|559295152|FG002|Overall Study|Withdrawal by Subject|2|||
154964022|NCT03578809|559295153|FG003|Overall Study|Withdrawal by Subject|0|||
154964023|NCT03578809|559295150|FG000|Overall Study|Other|3|||
154964024|NCT03578809|559295151|FG001|Overall Study|Other|6|||
154964025|NCT03578809|559295152|FG002|Overall Study|Other|2|||
154964026|NCT03578809|559295153|FG003|Overall Study|Other|8|||
154964027|NCT00830258|559295154|FG000|First Intervention|Adverse Event|1|||
154964028|NCT00830258|559295155|FG001|First Intervention|Adverse Event|0|||
154964029|NCT00830258|559295154|FG000|Washout: 7 Days|Protocol Violation|1|||
154964030|NCT00830258|559295155|FG001|Washout: 7 Days|Protocol Violation|0|||
154964031|NCT00798603|559295156|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
154964032|NCT00798603|559295156|FG000|Overall Study|Withdrawal by Subject|10|||
154964033|NCT00798603|559295156|FG000|Overall Study|Adverse Event|22|||
154964034|NCT00798603|559295156|FG000|Overall Study|Physician Decision|1|||
154964035|NCT00798603|559295156|FG000|Overall Study|Lack of insurance coverage|1|||
154964036|NCT00835705|559295157|FG000|First Intervention|Difficulty with vein|1|||
154964037|NCT00835705|559295158|FG001|First Intervention|Difficulty with vein|0|||
154964038|NCT00835705|559295157|FG000|Second Intervention|Difficulty with vein|1|||
154964039|NCT00835705|559295158|FG001|Second Intervention|Difficulty with vein|0|||
154964040|NCT01750294|559295159|FG000|Overall Study|Withdrawal by Subject|1|||
154964041|NCT01750294|559295159|FG000|Overall Study|Safety Endpoint|1|||
154964042|NCT01116739|559295162|FG000|Overall Study|Child had 2 years of HS|110|||
154964043|NCT01116739|559295163|FG001|Overall Study|Child had 2 years of HS|128|||
154964044|NCT01116739|559295162|FG000|Overall Study|Withdrawal by Subject|6|||
154964045|NCT01116739|559295163|FG001|Overall Study|Withdrawal by Subject|0|||
154964046|NCT01116739|559295162|FG000|Overall Study|child too young|2|||
154964047|NCT01116739|559295163|FG001|Overall Study|child too young|6|||
154964048|NCT01116739|559295162|FG000|Overall Study|child not enrolled in head start|10|||
154964049|NCT01116739|559295163|FG001|Overall Study|child not enrolled in head start|2|||
154964050|NCT01116739|559295162|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
154964051|NCT01116739|559295163|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
154964052|NCT01624233|559295164|FG000|Period 2 - Induction|Adverse Event|1|||
154964053|NCT01624233|559295164|FG000|Period 3 - Maintenance|Adverse Event|2|||
154964054|NCT01624233|559295164|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
154964055|NCT01624233|559295164|FG000|Period 3 - Maintenance|Physician Decision|2|||
154964056|NCT01624233|559295164|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
154964057|NCT01624233|559295164|FG000|Period 4 - Drug Free Period|Relapsed|61|||
154964058|NCT01624233|559295164|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
154964059|NCT01624233|559295164|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
154964060|NCT01624233|559295164|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
154964061|NCT01624233|559295164|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
154964062|NCT01624233|559295164|FG000|Period 6: Follow-up|Adverse Event|3|||
154964063|NCT01624233|559295164|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
154964064|NCT01624233|559295164|FG000|Period 6: Follow-up|Physician Decision|1|||
154964065|NCT01624233|559295164|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
154964066|NCT05090839|559295165|FG000|Overall Study|Lost to Follow-up|2|||
154964067|NCT05090839|559295166|FG001|Overall Study|Lost to Follow-up|3|||
154964068|NCT05090839|559295167|FG002|Overall Study|Lost to Follow-up|1|||
154964069|NCT05090839|559295168|FG003|Overall Study|Lost to Follow-up|1|||
154964070|NCT03121586|559295171|FG000|Overall Study|Study terminated by sponsor|0|||
154964071|NCT03121586|559295172|FG001|Overall Study|Study terminated by sponsor|0|||
154964072|NCT03121586|559295173|FG002|Overall Study|Study terminated by sponsor|99|||
154964073|NCT03121586|559295171|FG000|Overall Study|Withdrawal by Subject|37|||
154964074|NCT03121586|559295172|FG001|Overall Study|Withdrawal by Subject|14|||
154964075|NCT03121586|559295173|FG002|Overall Study|Withdrawal by Subject|9|||
154964076|NCT03121586|559295171|FG000|Overall Study|Not further specified|6|||
154964077|NCT03121586|559295172|FG001|Overall Study|Not further specified|11|||
154964078|NCT03121586|559295173|FG002|Overall Study|Not further specified|10|||
154964079|NCT03121586|559295171|FG000|Overall Study|Adverse Event|16|||
154964080|NCT03121586|559295172|FG001|Overall Study|Adverse Event|5|||
154964081|NCT03121586|559295173|FG002|Overall Study|Adverse Event|6|||
154964082|NCT03121586|559295171|FG000|Overall Study|Protocol Violation|0|||
154964083|NCT03121586|559295172|FG001|Overall Study|Protocol Violation|5|||
154964084|NCT03121586|559295173|FG002|Overall Study|Protocol Violation|0|||
154964085|NCT03121586|559295171|FG000|Overall Study|Lack of Efficacy|3|||
154964086|NCT03121586|559295172|FG001|Overall Study|Lack of Efficacy|3|||
154964087|NCT03121586|559295173|FG002|Overall Study|Lack of Efficacy|1|||
154964088|NCT03121586|559295171|FG000|Overall Study|Physician Decision|2|||
154964089|NCT03121586|559295172|FG001|Overall Study|Physician Decision|2|||
154964090|NCT03121586|559295173|FG002|Overall Study|Physician Decision|0|||
154964091|NCT03121586|559295171|FG000|Overall Study|Noncompliance with study drug|5|||
154964092|NCT03121586|559295172|FG001|Overall Study|Noncompliance with study drug|3|||
154964093|NCT03121586|559295173|FG002|Overall Study|Noncompliance with study drug|5|||
154964094|NCT03121586|559295171|FG000|Overall Study|Lost to Follow-up|4|||
154964095|NCT03121586|559295172|FG001|Overall Study|Lost to Follow-up|2|||
154964096|NCT03121586|559295173|FG002|Overall Study|Lost to Follow-up|0|||
154964097|NCT03121586|559295171|FG000|Overall Study|Death|2|||
154964098|NCT03121586|559295172|FG001|Overall Study|Death|0|||
154964099|NCT03121586|559295173|FG002|Overall Study|Death|0|||
154964100|NCT06381102|559295174|FG000|Washout 5 Days|Withdrawal by Subject|0|||
154964101|NCT06381102|559295175|FG001|Washout 5 Days|Withdrawal by Subject|2|||
154964102|NCT02832063|559295177|FG000|Overall Study|Adverse Event|2|||
154964103|NCT02832063|559295178|FG001|Overall Study|Adverse Event|1|||
154964104|NCT02832063|559295177|FG000|Overall Study|Physician Decision|5|||
154964105|NCT02832063|559295178|FG001|Overall Study|Physician Decision|7|||
154964106|NCT02832063|559295177|FG000|Overall Study|Lost to Follow-up|15|||
154964107|NCT02832063|559295178|FG001|Overall Study|Lost to Follow-up|8|||
154964108|NCT02832063|559295177|FG000|Overall Study|Withdrawal by Subject|10|||
154964109|NCT02832063|559295178|FG001|Overall Study|Withdrawal by Subject|21|||
154964110|NCT02832063|559295177|FG000|Overall Study|Other|2|||
154964111|NCT02832063|559295178|FG001|Overall Study|Other|1|||
154964112|NCT03733730|559295179|FG000|Overall Study|Lost to Follow-up|1|||
154964113|NCT03733730|559295180|FG001|Overall Study|Lost to Follow-up|32|||
154964114|NCT03733730|559295179|FG000|Overall Study|Other|1|||
154964115|NCT03733730|559295180|FG001|Overall Study|Other|0|||
154964116|NCT03733730|559295179|FG000|Overall Study|Adverse Event|0|||
154964117|NCT03733730|559295180|FG001|Overall Study|Adverse Event|4|||
154964118|NCT03733730|559295179|FG000|Overall Study|Death|0|||
154964119|NCT03733730|559295180|FG001|Overall Study|Death|5|||
154964120|NCT03733730|559295179|FG000|Overall Study|Withdrawal by Subject|0|||
154964121|NCT03733730|559295180|FG001|Overall Study|Withdrawal by Subject|8|||
154964122|NCT01987765|559295181|FG000|Overall Study|Protocol Violation|65|||
155165538|NCT04661579|560043479|FG003|Overall Study|Other|1|||
154964123|NCT01987765|559295181|FG000|Overall Study|Lost to Follow-up|37|||
154964124|NCT00772603|559295182|FG000|Overall Study|Withdrawal by Subject|11|||
154964125|NCT00772603|559295183|FG001|Overall Study|Withdrawal by Subject|10|||
154964126|NCT00772603|559295184|FG002|Overall Study|Withdrawal by Subject|6|||
154964127|NCT00772603|559295182|FG000|Overall Study|Adverse Event|37|||
154964128|NCT00772603|559295183|FG001|Overall Study|Adverse Event|18|||
155165539|NCT04661579|560043480|FG004|Overall Study|Other|1|||
155165540|NCT04661579|560043476|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
154964129|NCT00772603|559295184|FG002|Overall Study|Adverse Event|10|||
154964130|NCT00772603|559295182|FG000|Overall Study|Subject Non-compliance|1|||
154964131|NCT00772603|559295183|FG001|Overall Study|Subject Non-compliance|6|||
155347356|NCT02402465|560704894|FG005|Overall Study|Lost to Follow-up|0|||
155347357|NCT01284634|560704895|FG000|Overall Study|Adverse Event|1|||
155347358|NCT01284634|560704896|FG001|Overall Study|Adverse Event|0|||
155347359|NCT01284634|560704897|FG002|Overall Study|Adverse Event|2|||
155347360|NCT01284634|560704898|FG003|Overall Study|Adverse Event|1|||
155347361|NCT02236598|560704899|FG000|Overall Study|Adverse Event|0|||
155347362|NCT02236598|560704900|FG001|Overall Study|Adverse Event|1|||
155347363|NCT02236598|560704899|FG000|Overall Study|Withdrawal by Subject|0|||
155347364|NCT02236598|560704900|FG001|Overall Study|Withdrawal by Subject|1|||
155347365|NCT00428441|560704906|FG000|Overall Study|Lost to Follow-up|1|||
155347366|NCT00125853|560704907|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
155347367|NCT00125853|560704908|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
155347368|NCT03048058|560704913|FG000|Overall Study|Lost to Follow-up|4|||
155347369|NCT03048058|560704914|FG001|Overall Study|Lost to Follow-up|0|||
155347370|NCT03048058|560704913|FG000|Overall Study|Withdrawal by Subject|0|||
155347371|NCT03048058|560704914|FG001|Overall Study|Withdrawal by Subject|4|||
155347372|NCT01257698|560704915|FG000|Overall Study|Protocol Violation|4|||
155347373|NCT01257698|560704916|FG001|Overall Study|Protocol Violation|0|||
155347374|NCT01395914|560704917|FG000|Overall Study|Unrelated to study drug AE|6|||
155347375|NCT01395914|560704918|FG001|Overall Study|Unrelated to study drug AE|1|||
155347376|NCT01395914|560704917|FG000|Overall Study|Death|23|||
155347377|NCT01395914|560704918|FG001|Overall Study|Death|17|||
155347378|NCT01395914|560704917|FG000|Overall Study|Other|9|||
155347379|NCT01395914|560704918|FG001|Overall Study|Other|3|||
155347380|NCT01395914|560704917|FG000|Overall Study|Withdrawal by patient|27|||
155347381|NCT01395914|560704918|FG001|Overall Study|Withdrawal by patient|14|||
155347382|NCT01395914|560704917|FG000|Overall Study|Study drug-related AE|1|||
155347383|NCT01395914|560704918|FG001|Overall Study|Study drug-related AE|0|||
155347384|NCT01395914|560704917|FG000|Overall Study|Lost to Follow-up|6|||
155347385|NCT01395914|560704918|FG001|Overall Study|Lost to Follow-up|2|||
155347386|NCT02256488|560704921|FG000|Overall Study|Lost to Follow-up|6|||
155347387|NCT02256488|560704922|FG001|Overall Study|Lost to Follow-up|6|||
155347388|NCT02256488|560704923|FG002|Overall Study|Lost to Follow-up|9|||
155347389|NCT02256488|560704924|FG003|Overall Study|Lost to Follow-up|3|||
155347390|NCT02256488|560704921|FG000|Overall Study|OTHER|1|||
155347391|NCT02256488|560704922|FG001|Overall Study|OTHER|0|||
155347392|NCT02256488|560704923|FG002|Overall Study|OTHER|1|||
155347393|NCT02256488|560704924|FG003|Overall Study|OTHER|1|||
155347394|NCT02256488|560704921|FG000|Overall Study|Withdrawal by Subject|1|||
155347395|NCT02256488|560704922|FG001|Overall Study|Withdrawal by Subject|0|||
155347396|NCT02256488|560704923|FG002|Overall Study|Withdrawal by Subject|0|||
155347397|NCT02256488|560704924|FG003|Overall Study|Withdrawal by Subject|2|||
155347398|NCT02268526|560704925|FG000|Overall Study|Adverse Event|0|||
155347399|NCT02268526|560704926|FG001|Overall Study|Adverse Event|2|||
155347400|NCT02268526|560704927|FG002|Overall Study|Adverse Event|1|||
155347401|NCT02268526|560704925|FG000|Overall Study|Death|1|||
155347402|NCT02268526|560704926|FG001|Overall Study|Death|11|||
155347403|NCT02268526|560704927|FG002|Overall Study|Death|0|||
155347404|NCT02268526|560704925|FG000|Overall Study|protocol deviation|0|||
155347405|NCT02268526|560704926|FG001|Overall Study|protocol deviation|1|||
155347406|NCT02268526|560704927|FG002|Overall Study|protocol deviation|0|||
155347407|NCT02268526|560704925|FG000|Overall Study|Physician Decision|0|||
155347408|NCT02268526|560704926|FG001|Overall Study|Physician Decision|0|||
155347409|NCT02268526|560704927|FG002|Overall Study|Physician Decision|1|||
155347410|NCT02268526|560704925|FG000|Overall Study|Subject/guardian decision|0|||
155347411|NCT02268526|560704926|FG001|Overall Study|Subject/guardian decision|7|||
155081696|NCT02006654|559729509|FG000|Overall Study|Protocol Violation|5|||
155081697|NCT02006654|559729510|FG001|Overall Study|Protocol Violation|8|||
155081698|NCT02006654|559729509|FG000|Overall Study|Lost to Follow-up|1|||
155081699|NCT02006654|559729510|FG001|Overall Study|Lost to Follow-up|0|||
155081700|NCT02006654|559729509|FG000|Overall Study|patient's will|2|||
155347412|NCT02268526|560704927|FG002|Overall Study|Subject/guardian decision|3|||
155347413|NCT00975130|560704928|FG000|Study Part 1|Adverse Event|150|||
155347414|NCT00975130|560704929|FG001|Study Part 1|Adverse Event|0|||
155347415|NCT00975130|560704930|FG002|Study Part 1|Adverse Event|0|||
155347416|NCT00975130|560704928|FG000|Study Part 1|Lost to Follow-up|19|||
155347417|NCT00975130|560704929|FG001|Study Part 1|Lost to Follow-up|0|||
155347418|NCT00975130|560704930|FG002|Study Part 1|Lost to Follow-up|0|||
155347419|NCT00975130|560704928|FG000|Study Part 1|Withdrawal by Subject|61|||
155347420|NCT00975130|560704929|FG001|Study Part 1|Withdrawal by Subject|0|||
155347421|NCT00975130|560704930|FG002|Study Part 1|Withdrawal by Subject|0|||
155347422|NCT00975130|560704928|FG000|Study Part 1|Protocol Violation|13|||
155347423|NCT00975130|560704929|FG001|Study Part 1|Protocol Violation|0|||
155347424|NCT00975130|560704930|FG002|Study Part 1|Protocol Violation|0|||
155347425|NCT00975130|560704928|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
155347426|NCT00975130|560704929|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
155347427|NCT00975130|560704930|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
155347428|NCT00975130|560704928|FG000|Study Part 1|Administrative|4|||
155347429|NCT00975130|560704929|FG001|Study Part 1|Administrative|0|||
155347430|NCT00975130|560704930|FG002|Study Part 1|Administrative|0|||
155347431|NCT00975130|560704928|FG000|Study Part 1|Withdrew Consent|24|||
155347432|NCT00975130|560704929|FG001|Study Part 1|Withdrew Consent|0|||
155347433|NCT00975130|560704930|FG002|Study Part 1|Withdrew Consent|0|||
155347434|NCT00975130|560704928|FG000|Study Part 2|Adverse Event|0|||
155347435|NCT00975130|560704929|FG001|Study Part 2|Adverse Event|14|||
155347436|NCT00975130|560704930|FG002|Study Part 2|Adverse Event|7|||
155347437|NCT00975130|560704928|FG000|Study Part 2|Lost to Follow-up|0|||
155347438|NCT00975130|560704929|FG001|Study Part 2|Lost to Follow-up|0|||
155347439|NCT00975130|560704930|FG002|Study Part 2|Lost to Follow-up|1|||
155347440|NCT00975130|560704928|FG000|Study Part 2|Withdrawal by Subject|0|||
155347441|NCT00975130|560704929|FG001|Study Part 2|Withdrawal by Subject|13|||
155347442|NCT00975130|560704930|FG002|Study Part 2|Withdrawal by Subject|5|||
155347443|NCT00975130|560704928|FG000|Study Part 2|Withdrew Consent|0|||
155347444|NCT00975130|560704929|FG001|Study Part 2|Withdrew Consent|6|||
155081701|NCT02006654|559729510|FG001|Overall Study|patient's will|1|||
154964132|NCT00772603|559295184|FG002|Overall Study|Subject Non-compliance|4|||
155081702|NCT02006654|559729509|FG000|Overall Study|insufficient compliance|1|||
155081703|NCT02006654|559729510|FG001|Overall Study|insufficient compliance|0|||
155081704|NCT02006654|559729509|FG000|Overall Study|worsening cognitive condition|0|||
155081705|NCT02006654|559729510|FG001|Overall Study|worsening cognitive condition|1|||
155081706|NCT02006654|559729509|FG000|Overall Study|faecal incontinence|0|||
155081707|NCT02006654|559729510|FG001|Overall Study|faecal incontinence|1|||
155081708|NCT02006654|559729509|FG000|Overall Study|mood disorder|0|||
155081709|NCT02006654|559729510|FG001|Overall Study|mood disorder|1|||
155081710|NCT02006654|559729509|FG000|Overall Study|disallowed medication|1|||
155081711|NCT02006654|559729510|FG001|Overall Study|disallowed medication|0|||
155081712|NCT02006654|559729509|FG000|Overall Study|moving out of state|0|||
155081713|NCT02006654|559729510|FG001|Overall Study|moving out of state|1|||
155081714|NCT01905267|559729513|FG000|Overall Study|Physician Decision|2|||
155081715|NCT01905267|559729514|FG001|Overall Study|Physician Decision|2|||
155081716|NCT02294019|559729515|FG000|Overall Study|Adverse Event|2|||
155081717|NCT02294019|559729515|FG000|Overall Study|Protocol Violation|68|||
155081718|NCT02294019|559729515|FG000|Overall Study|Lost to Follow-up|31|||
155081719|NCT02294019|559729515|FG000|Overall Study|Other|1|||
155081720|NCT02294019|559729515|FG000|Overall Study|Withdrawal by Subject|1|||
155081721|NCT01189227|559729517|FG000|Overall Study|Study terminated due to low accrual|6|||
155081722|NCT01189227|559729518|FG001|Overall Study|Study terminated due to low accrual|3|||
155081723|NCT02991859|559729521|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155347445|NCT00975130|560704930|FG002|Study Part 2|Withdrew Consent|2|||
155347446|NCT00975130|560704928|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
155347447|NCT00975130|560704929|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
155347448|NCT00975130|560704930|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
155347449|NCT00975130|560704928|FG000|Study Part 2|Administrative|0|||
155081724|NCT02991859|559729522|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
155081725|NCT02991859|559729523|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081726|NCT02991859|559729524|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081727|NCT02991859|559729525|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
155347450|NCT00975130|560704929|FG001|Study Part 2|Administrative|1|||
155081728|NCT02991859|559729526|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081729|NCT02991859|559729527|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081730|NCT02991859|559729528|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081731|NCT02991859|559729529|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081732|NCT02991859|559729530|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081733|NCT02991859|559729531|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081734|NCT02991859|559729532|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081735|NCT02991859|559729533|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081736|NCT02991859|559729534|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081737|NCT02991859|559729535|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081738|NCT02991859|559729536|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081739|NCT02991859|559729537|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
155081740|NCT02991859|559729521|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081741|NCT02991859|559729522|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081742|NCT02991859|559729523|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081743|NCT02991859|559729524|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081744|NCT02991859|559729525|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081745|NCT02991859|559729526|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081746|NCT02991859|559729527|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081747|NCT02991859|559729528|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081748|NCT02991859|559729529|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081749|NCT02991859|559729530|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081750|NCT02991859|559729531|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081751|NCT02991859|559729532|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081752|NCT02991859|559729533|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
155081753|NCT02991859|559729534|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
155165541|NCT04661579|560043477|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
155347451|NCT00975130|560704930|FG002|Study Part 2|Administrative|0|||
155347452|NCT00975130|560704928|FG000|Study Part 2|Protocol Violation|0|||
155347453|NCT00975130|560704929|FG001|Study Part 2|Protocol Violation|0|||
155347454|NCT00975130|560704930|FG002|Study Part 2|Protocol Violation|1|||
155347455|NCT01261793|560704931|FG000|Overall Study|Lack of Efficacy|44|||
155347456|NCT01261793|560704932|FG001|Overall Study|Lack of Efficacy|37|||
155347457|NCT01261793|560704933|FG002|Overall Study|Lack of Efficacy|32|||
155347458|NCT01261793|560704931|FG000|Overall Study|Protocol Violation|3|||
155347459|NCT01261793|560704932|FG001|Overall Study|Protocol Violation|5|||
155347460|NCT01261793|560704933|FG002|Overall Study|Protocol Violation|6|||
155347461|NCT01261793|560704931|FG000|Overall Study|Lost to Follow-up|10|||
155347462|NCT01261793|560704932|FG001|Overall Study|Lost to Follow-up|3|||
155347463|NCT01261793|560704933|FG002|Overall Study|Lost to Follow-up|7|||
155347464|NCT01261793|560704931|FG000|Overall Study|Withdrawal by Subject|12|||
155347465|NCT01261793|560704932|FG001|Overall Study|Withdrawal by Subject|14|||
155347466|NCT01261793|560704933|FG002|Overall Study|Withdrawal by Subject|14|||
155347467|NCT01261793|560704931|FG000|Overall Study|Death|3|||
155347468|NCT01261793|560704932|FG001|Overall Study|Death|1|||
155347469|NCT01261793|560704933|FG002|Overall Study|Death|0|||
155347470|NCT01261793|560704931|FG000|Overall Study|Adverse Event|9|||
155347471|NCT01261793|560704932|FG001|Overall Study|Adverse Event|24|||
155347472|NCT01261793|560704933|FG002|Overall Study|Adverse Event|19|||
155347473|NCT01261793|560704931|FG000|Overall Study|Patient non-availability|1|||
155347474|NCT01261793|560704932|FG001|Overall Study|Patient non-availability|1|||
155347475|NCT01261793|560704933|FG002|Overall Study|Patient non-availability|1|||
155347476|NCT01261793|560704931|FG000|Overall Study|Suspected pregnancy|1|||
155347477|NCT01261793|560704932|FG001|Overall Study|Suspected pregnancy|1|||
155347478|NCT01261793|560704933|FG002|Overall Study|Suspected pregnancy|0|||
155347479|NCT01261793|560704931|FG000|Overall Study|Patient non-compliance|1|||
155347480|NCT01261793|560704932|FG001|Overall Study|Patient non-compliance|0|||
155347481|NCT01261793|560704933|FG002|Overall Study|Patient non-compliance|1|||
155347482|NCT01261793|560704931|FG000|Overall Study|Patient pregnant|1|||
155347483|NCT01261793|560704932|FG001|Overall Study|Patient pregnant|0|||
155081754|NCT02991859|559729535|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081755|NCT02991859|559729536|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081756|NCT02991859|559729537|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
155081757|NCT02991859|559729521|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081758|NCT02991859|559729522|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081759|NCT02991859|559729523|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081760|NCT02991859|559729524|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081761|NCT02991859|559729525|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081762|NCT02991859|559729526|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
155081763|NCT02991859|559729527|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081764|NCT02991859|559729528|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081765|NCT02991859|559729529|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081766|NCT02991859|559729530|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081767|NCT02991859|559729531|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081768|NCT02991859|559729532|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081769|NCT02991859|559729533|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081770|NCT02991859|559729534|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081771|NCT02991859|559729535|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081772|NCT02991859|559729536|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081773|NCT02991859|559729537|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
155081774|NCT02991859|559729521|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081775|NCT02991859|559729522|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081776|NCT02991859|559729523|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081777|NCT02991859|559729524|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081778|NCT02991859|559729525|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081779|NCT02991859|559729526|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081780|NCT02991859|559729527|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081781|NCT02991859|559729528|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081782|NCT02991859|559729529|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081783|NCT02991859|559729530|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
155081784|NCT02991859|559729531|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081785|NCT02991859|559729532|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081786|NCT02991859|559729533|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081787|NCT02991859|559729534|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081788|NCT02991859|559729535|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081789|NCT02991859|559729536|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081790|NCT02991859|559729537|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
155081791|NCT02991859|559729521|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081792|NCT02991859|559729522|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081793|NCT02991859|559729523|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081794|NCT02991859|559729524|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081795|NCT02991859|559729525|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081796|NCT02991859|559729526|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081797|NCT02991859|559729527|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081798|NCT02991859|559729528|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081799|NCT02991859|559729529|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
155081800|NCT02991859|559729530|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081801|NCT02991859|559729531|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081802|NCT02991859|559729532|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081803|NCT02991859|559729533|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081804|NCT02991859|559729534|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081805|NCT02991859|559729535|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081806|NCT02991859|559729536|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081807|NCT02991859|559729537|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
155081808|NCT01016015|559729538|FG000|Overall Study|Not Treated|3|||
155081809|NCT01016015|559729538|FG000|Overall Study|Withdrawal by Subject|1|||
155081810|NCT01016015|559729538|FG000|Overall Study|Adverse Event|15|||
155081811|NCT02774278|559729539|FG000|Overall Study|Lack of Efficacy|199|||
155081812|NCT02774278|559729539|FG000|Overall Study|Death|29|||
155081813|NCT02774278|559729539|FG000|Overall Study|Adverse event/intercurrent illness|16|||
155081814|NCT02774278|559729539|FG000|Overall Study|Refused treatment/did not cooperate|9|||
155081815|NCT02774278|559729539|FG000|Overall Study|Administrative reasons|6|||
155081816|NCT02774278|559729539|FG000|Overall Study|Withdrawal by Subject|3|||
155081817|NCT02774278|559729539|FG000|Overall Study|Protocol Violation|2|||
155081818|NCT00930176|559729543|FG000|Overall Study|Death|1|||
155081819|NCT00362609|559729544|FG000|Overall Study|Withdrawal by Subject|0|||
154964133|NCT00772603|559295182|FG000|Overall Study|Protocol Violation|0|||
154964134|NCT00772603|559295183|FG001|Overall Study|Protocol Violation|1|||
155081820|NCT00362609|559729545|FG001|Overall Study|Withdrawal by Subject|1|||
155081821|NCT00362609|559729544|FG000|Overall Study|Protocol Violation|0|||
155081822|NCT00362609|559729545|FG001|Overall Study|Protocol Violation|1|||
155081823|NCT06097273|559729546|FG000|Overall Study|Death|2|||
155081824|NCT06097273|559729547|FG001|Overall Study|Death|1|||
155081825|NCT06097273|559729548|FG002|Overall Study|Death|2|||
155081826|NCT06097273|559729549|FG003|Overall Study|Death|2|||
155081827|NCT06097273|559729546|FG000|Overall Study|Lost to Follow-up|27|||
155081828|NCT06097273|559729547|FG001|Overall Study|Lost to Follow-up|18|||
155081829|NCT06097273|559729548|FG002|Overall Study|Lost to Follow-up|36|||
155081830|NCT06097273|559729549|FG003|Overall Study|Lost to Follow-up|31|||
155081831|NCT06097273|559729546|FG000|Overall Study|Physician Decision|0|||
155081832|NCT06097273|559729547|FG001|Overall Study|Physician Decision|1|||
155081833|NCT06097273|559729548|FG002|Overall Study|Physician Decision|0|||
155081834|NCT06097273|559729549|FG003|Overall Study|Physician Decision|3|||
155081835|NCT06097273|559729546|FG000|Overall Study|Protocol Violation|1|||
155081836|NCT06097273|559729547|FG001|Overall Study|Protocol Violation|1|||
155081837|NCT06097273|559729548|FG002|Overall Study|Protocol Violation|2|||
155081838|NCT06097273|559729549|FG003|Overall Study|Protocol Violation|1|||
155081839|NCT06097273|559729546|FG000|Overall Study|Withdrawal by Subject|14|||
155081840|NCT06097273|559729547|FG001|Overall Study|Withdrawal by Subject|11|||
155081841|NCT06097273|559729548|FG002|Overall Study|Withdrawal by Subject|14|||
155081842|NCT06097273|559729549|FG003|Overall Study|Withdrawal by Subject|15|||
155081843|NCT06097273|559729546|FG000|Overall Study|Other Than Specified|7|||
155081844|NCT06097273|559729547|FG001|Overall Study|Other Than Specified|3|||
155081845|NCT06097273|559729548|FG002|Overall Study|Other Than Specified|11|||
155081846|NCT06097273|559729549|FG003|Overall Study|Other Than Specified|6|||
155081847|NCT01251965|559731107|FG000|Overall Study|Participant/physician decision|1|||
155081848|NCT01251965|559731108|FG001|Overall Study|Participant/physician decision|2|||
155081849|NCT01251965|559731109|FG002|Overall Study|Participant/physician decision|0|||
155081850|NCT01251965|559731107|FG000|Overall Study|Death|0|||
155081851|NCT01251965|559731108|FG001|Overall Study|Death|0|||
155081852|NCT01251965|559731109|FG002|Overall Study|Death|11|||
155081853|NCT01027754|559731110|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
155081854|NCT01027754|559731111|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
155081855|NCT01027754|559731110|FG000|Overall Study|Withdrawal by Subject|0|||
155081856|NCT01027754|559731111|FG001|Overall Study|Withdrawal by Subject|5|||
155081857|NCT02529488|559731112|FG000|Overall Study|Adverse Event|1|||
155081858|NCT02529488|559731112|FG000|Overall Study|Death|3|||
155081859|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
155081860|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155081861|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155081862|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155081863|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155081864|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
155081865|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
155081866|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
155081867|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155081868|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
155081869|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155081870|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155081871|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155081872|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
155081873|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
155081874|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155081875|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155081876|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155081877|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155081878|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155081879|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
155081880|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
155081881|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155081882|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155081883|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155081884|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155081885|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
155081886|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
155081887|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155165542|NCT04661579|560043478|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
155081888|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
155081889|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155081890|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155081891|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155081892|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155081893|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
155081894|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155081895|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155081896|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155081897|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155081898|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
155081899|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
155081900|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
155081901|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155081902|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
155081903|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
155081904|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155081905|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155081906|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
155081907|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
155081908|NCT01557244|559731113|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
155081909|NCT01557244|559731114|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155081910|NCT01557244|559731115|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
155081911|NCT01557244|559731116|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155081912|NCT01557244|559731117|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155081913|NCT01557244|559731118|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155081914|NCT01557244|559731119|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
155081915|NCT01557244|559731113|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
155081916|NCT01557244|559731114|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
155081917|NCT01557244|559731115|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155081918|NCT01557244|559731116|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155081919|NCT01557244|559731117|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155081920|NCT01557244|559731118|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
155081921|NCT01557244|559731119|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
155081922|NCT01557244|559731113|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
155081923|NCT01557244|559731114|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
155081924|NCT01557244|559731115|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155081925|NCT01557244|559731116|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155081926|NCT01557244|559731117|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155081927|NCT01557244|559731118|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155081928|NCT01557244|559731119|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
155081929|NCT01557244|559731113|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155081930|NCT01557244|559731114|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155081931|NCT01557244|559731115|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155081932|NCT01557244|559731116|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
155081933|NCT01557244|559731117|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155081934|NCT01557244|559731118|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155081935|NCT01557244|559731119|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
155081936|NCT01557244|559731113|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
155081937|NCT01557244|559731114|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
155081938|NCT01557244|559731115|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155347484|NCT01261793|560704933|FG002|Overall Study|Patient pregnant|0|||
155347485|NCT01261793|560704931|FG000|Overall Study|Outside the study area|0|||
155347486|NCT01261793|560704932|FG001|Overall Study|Outside the study area|2|||
155347487|NCT01261793|560704933|FG002|Overall Study|Outside the study area|1|||
155347488|NCT01261793|560704931|FG000|Overall Study|Lack of efficacy & patient not available|0|||
155347489|NCT01261793|560704932|FG001|Overall Study|Lack of efficacy & patient not available|1|||
155347490|NCT01261793|560704933|FG002|Overall Study|Lack of efficacy & patient not available|0|||
155347491|NCT01261793|560704931|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
155347492|NCT01261793|560704932|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
155347493|NCT01261793|560704933|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
155347494|NCT01261793|560704931|FG000|Overall Study|Randomization error|0|||
155347495|NCT01261793|560704932|FG001|Overall Study|Randomization error|1|||
155081939|NCT01557244|559731116|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155081940|NCT01557244|559731117|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155081941|NCT01557244|559731118|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155081942|NCT01557244|559731119|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
155081943|NCT01313676|559731120|FG000|Overall Study|Adverse Event|395|||
155081944|NCT01313676|559731121|FG001|Overall Study|Adverse Event|365|||
155081945|NCT01313676|559731122|FG002|Overall Study|Adverse Event|372|||
155081946|NCT01313676|559731123|FG003|Overall Study|Adverse Event|333|||
155081947|NCT01313676|559731120|FG000|Overall Study|Lack of Efficacy|98|||
155081948|NCT01313676|559731121|FG001|Overall Study|Lack of Efficacy|90|||
155081949|NCT01313676|559731122|FG002|Overall Study|Lack of Efficacy|65|||
155081950|NCT01313676|559731123|FG003|Overall Study|Lack of Efficacy|46|||
155081951|NCT01313676|559731120|FG000|Overall Study|Protocol Violation|37|||
155081952|NCT01313676|559731121|FG001|Overall Study|Protocol Violation|44|||
155081953|NCT01313676|559731122|FG002|Overall Study|Protocol Violation|46|||
155081954|NCT01313676|559731123|FG003|Overall Study|Protocol Violation|44|||
155081955|NCT01313676|559731120|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
155081956|NCT01313676|559731121|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
155081957|NCT01313676|559731122|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
155081958|NCT01313676|559731123|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
155081959|NCT01313676|559731120|FG000|Overall Study|Study Closed/terminated|7|||
155081960|NCT01313676|559731121|FG001|Overall Study|Study Closed/terminated|6|||
155081961|NCT01313676|559731122|FG002|Overall Study|Study Closed/terminated|9|||
155081962|NCT01313676|559731123|FG003|Overall Study|Study Closed/terminated|9|||
155081963|NCT01313676|559731120|FG000|Overall Study|Lost to Follow-up|0|||
155081964|NCT01313676|559731121|FG001|Overall Study|Lost to Follow-up|0|||
155081965|NCT01313676|559731122|FG002|Overall Study|Lost to Follow-up|1|||
155081966|NCT01313676|559731123|FG003|Overall Study|Lost to Follow-up|0|||
155081967|NCT01313676|559731120|FG000|Overall Study|Physician Decision|53|||
155081968|NCT01313676|559731121|FG001|Overall Study|Physician Decision|64|||
155081969|NCT01313676|559731122|FG002|Overall Study|Physician Decision|62|||
155081970|NCT01313676|559731123|FG003|Overall Study|Physician Decision|48|||
155081971|NCT01313676|559731120|FG000|Overall Study|Decision by Participant or Proxy|643|||
155081972|NCT01313676|559731121|FG001|Overall Study|Decision by Participant or Proxy|527|||
155081973|NCT01313676|559731122|FG002|Overall Study|Decision by Participant or Proxy|515|||
155081974|NCT01313676|559731123|FG003|Overall Study|Decision by Participant or Proxy|492|||
155081975|NCT01313676|559731120|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
155081976|NCT01313676|559731121|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
155081977|NCT01313676|559731122|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
155081978|NCT01313676|559731123|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
155081979|NCT01313676|559731120|FG000|Overall Study|Investigator Site Closed|12|||
155081980|NCT01313676|559731121|FG001|Overall Study|Investigator Site Closed|11|||
155081981|NCT01313676|559731122|FG002|Overall Study|Investigator Site Closed|15|||
155081982|NCT01313676|559731123|FG003|Overall Study|Investigator Site Closed|10|||
155081983|NCT01313676|559731120|FG000|Overall Study|Missing|1|||
155081984|NCT01313676|559731121|FG001|Overall Study|Missing|1|||
155081985|NCT01313676|559731122|FG002|Overall Study|Missing|1|||
155081986|NCT01313676|559731123|FG003|Overall Study|Missing|0|||
155081987|NCT02562040|559731124|FG000|Overall Study|Lost to Follow-up|20|||
155081988|NCT02562040|559731125|FG001|Overall Study|Lost to Follow-up|28|||
155081989|NCT02562040|559731124|FG000|Overall Study|Withdrawal by Subject|8|||
155081990|NCT02562040|559731125|FG001|Overall Study|Withdrawal by Subject|7|||
155081991|NCT02562040|559731124|FG000|Overall Study|Adverse Event|1|||
155081992|NCT02562040|559731125|FG001|Overall Study|Adverse Event|0|||
155081993|NCT00368849|559731129|FG000|Overall Study|Withdrawal by Subject|0|||
155081994|NCT00368849|559731130|FG001|Overall Study|Withdrawal by Subject|1|||
155081995|NCT00368849|559731129|FG000|Overall Study|Physician Decision|0|||
155081996|NCT00368849|559731130|FG001|Overall Study|Physician Decision|1|||
155081997|NCT01902303|559731132|FG000|Overall Study|Adverse Event|0|||
155081998|NCT01902303|559731133|FG001|Overall Study|Adverse Event|1|||
155081999|NCT01902303|559731132|FG000|Overall Study|Lost to Follow-up|0|||
155082000|NCT01902303|559731133|FG001|Overall Study|Lost to Follow-up|1|||
155082001|NCT01902303|559731132|FG000|Overall Study|Protocol Violation|2|||
155082002|NCT01902303|559731133|FG001|Overall Study|Protocol Violation|2|||
155082003|NCT01902303|559731132|FG000|Overall Study|subject lost investigational product|0|||
155082004|NCT01902303|559731133|FG001|Overall Study|subject lost investigational product|1|||
155082005|NCT01902303|559731132|FG000|Overall Study|Did not develop a cold sore|21|||
155082006|NCT01902303|559731133|FG001|Overall Study|Did not develop a cold sore|19|||
155082007|NCT01699685|559731134|FG000|Period 1|Adverse Event|1|||
154964135|NCT00772603|559295184|FG002|Overall Study|Protocol Violation|1|||
154964136|NCT00772603|559295182|FG000|Overall Study|Lost to Follow-up|1|||
155082008|NCT01699685|559731135|FG001|Period 1|Adverse Event|1|||
155082009|NCT01699685|559731134|FG000|Period 1|Medical or ethical, noncompliance|2|||
155082010|NCT01699685|559731135|FG001|Period 1|Medical or ethical, noncompliance|0|||
155082011|NCT01699685|559731134|FG000|Period 1|Other|0|||
155082012|NCT01699685|559731135|FG001|Period 1|Other|1|||
155082013|NCT01699685|559731134|FG000|Period 1|Patient request|0|||
155082014|NCT01699685|559731135|FG001|Period 1|Patient request|1|||
155082015|NCT01699685|559731134|FG000|Period 2|Lost to Follow-up|1|||
155082016|NCT01699685|559731135|FG001|Period 2|Lost to Follow-up|0|||
155082017|NCT03635996|559731136|FG000|Overall Study|Study terminated by Sponsor|94|||
155082018|NCT03635996|559731136|FG000|Overall Study|Withdrawal by Subject|20|||
155082019|NCT03635996|559731136|FG000|Overall Study|Ablation|26|||
155082020|NCT03635996|559731136|FG000|Overall Study|Adverse Event|7|||
155082021|NCT03635996|559731136|FG000|Overall Study|Physician Decision|3|||
155082022|NCT03635996|559731136|FG000|Overall Study|Prohibited medication|5|||
155082023|NCT03635996|559731136|FG000|Overall Study|Did not meet eligibility criteria|5|||
155082024|NCT03635996|559731136|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
155082025|NCT03635996|559731136|FG000|Overall Study|Protocol Violation|1|||
155082026|NCT03635996|559731136|FG000|Overall Study|Lost to Follow-up|1|||
155082027|NCT02821000|559731137|FG000|Overall Study|Death|89|||
155082028|NCT02821000|559731137|FG000|Overall Study|Sponsor Decision|12|||
155082029|NCT02821000|559731137|FG000|Overall Study|Withdrawal by Subject|2|||
155082030|NCT05058456|559731138|FG000|Overall Study|Death|1|||
155082031|NCT05058456|559731138|FG000|Overall Study|End of Study data not yet due for release|34|||
155082032|NCT02933151|559731139|FG000|Overall Study|Lost to Follow-up|19|||
155082033|NCT02933151|559731140|FG001|Overall Study|Lost to Follow-up|18|||
155082034|NCT02933151|559731139|FG000|Overall Study|Death|1732|||
155347496|NCT01261793|560704933|FG002|Overall Study|Randomization error|0|||
155347497|NCT01261793|560704931|FG000|Overall Study|Patient unable to start IV line|0|||
155347498|NCT01261793|560704932|FG001|Overall Study|Patient unable to start IV line|0|||
155347499|NCT01261793|560704933|FG002|Overall Study|Patient unable to start IV line|1|||
155347500|NCT03219216|560704934|FG000|Overall Study|Lost to Follow-up|0|||
155347501|NCT03219216|560704935|FG001|Overall Study|Lost to Follow-up|1|||
155347502|NCT03305458|560704936|FG000|Overall Study|Withdrawal by Subject|50|||
155347503|NCT03305458|560704937|FG001|Overall Study|Withdrawal by Subject|46|||
155347504|NCT03305458|560704938|FG002|Overall Study|Withdrawal by Subject|93|||
155347505|NCT03305458|560704936|FG000|Overall Study|Lost to Follow-up|85|||
155347506|NCT03305458|560704937|FG001|Overall Study|Lost to Follow-up|85|||
155347507|NCT03305458|560704938|FG002|Overall Study|Lost to Follow-up|35|||
155347508|NCT02332824|560704939|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
155347509|NCT02332824|560704940|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155347510|NCT02332824|560704941|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155347511|NCT02332824|560704942|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155347512|NCT02332824|560704943|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
155347513|NCT02332824|560704944|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
155347514|NCT02332824|560704939|FG000|Overall Study|Voluntary Withdrawal|1|||
155347515|NCT02332824|560704940|FG001|Overall Study|Voluntary Withdrawal|0|||
155347516|NCT02332824|560704941|FG002|Overall Study|Voluntary Withdrawal|0|||
155347517|NCT02332824|560704942|FG003|Overall Study|Voluntary Withdrawal|0|||
155347518|NCT02332824|560704943|FG004|Overall Study|Voluntary Withdrawal|0|||
155347519|NCT02332824|560704944|FG005|Overall Study|Voluntary Withdrawal|0|||
155347520|NCT02332824|560704939|FG000|Overall Study|Inconvenient schedule|1|||
155347521|NCT02332824|560704940|FG001|Overall Study|Inconvenient schedule|1|||
155347522|NCT02332824|560704941|FG002|Overall Study|Inconvenient schedule|0|||
155347523|NCT02332824|560704942|FG003|Overall Study|Inconvenient schedule|0|||
155347524|NCT02332824|560704943|FG004|Overall Study|Inconvenient schedule|0|||
155347525|NCT02332824|560704944|FG005|Overall Study|Inconvenient schedule|0|||
155082035|NCT02933151|559731140|FG001|Overall Study|Death|1827|||
155082036|NCT02933151|559731139|FG000|Overall Study|Transplant|210|||
155347526|NCT02332824|560704939|FG000|Overall Study|Transfer|0|||
154964137|NCT00772603|559295183|FG001|Overall Study|Lost to Follow-up|5|||
154964138|NCT00772603|559295184|FG002|Overall Study|Lost to Follow-up|2|||
155082037|NCT02933151|559731140|FG001|Overall Study|Transplant|278|||
155082038|NCT02933151|559731139|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
155082039|NCT02933151|559731140|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
155082040|NCT02933151|559731139|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
155082041|NCT02933151|559731140|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
155082042|NCT02933151|559731139|FG000|Overall Study|Recovered Kidney Function|47|||
155347527|NCT02332824|560704940|FG001|Overall Study|Transfer|0|||
155347528|NCT02332824|560704941|FG002|Overall Study|Transfer|1|||
155347529|NCT02332824|560704942|FG003|Overall Study|Transfer|1|||
155347530|NCT02332824|560704943|FG004|Overall Study|Transfer|0|||
155347531|NCT02332824|560704944|FG005|Overall Study|Transfer|0|||
155082043|NCT02933151|559731140|FG001|Overall Study|Recovered Kidney Function|29|||
155082044|NCT01832038|559731141|FG000|Overall Study|Death|5|||
155082045|NCT01832038|559731141|FG000|Overall Study|Adverse Event|50|||
155082046|NCT01832038|559731141|FG000|Overall Study|Lack of Efficacy|81|||
155082047|NCT01832038|559731141|FG000|Overall Study|Protocol Violation|7|||
155082048|NCT01832038|559731141|FG000|Overall Study|Lost to Follow-up|10|||
155082049|NCT01832038|559731141|FG000|Overall Study|Withdrawal by Subject|49|||
155082050|NCT01832038|559731141|FG000|Overall Study|Visit non-compliance|2|||
155082051|NCT01832038|559731141|FG000|Overall Study|Subject refused to return visit|2|||
155082052|NCT01832038|559731141|FG000|Overall Study|Not convenient to come back to site|2|||
155082053|NCT01832038|559731141|FG000|Overall Study|Participant was asked to quit|5|||
155082054|NCT01832038|559731141|FG000|Overall Study|Back home|1|||
155082055|NCT01832038|559731141|FG000|Overall Study|Pregnancy|1|||
155082056|NCT01832038|559731141|FG000|Overall Study|Low compliance|3|||
155082057|NCT01832038|559731141|FG000|Overall Study|Prohibit procedure|2|||
155082058|NCT01832038|559731141|FG000|Overall Study|Not possible to visit the hospital|1|||
155082059|NCT01832038|559731141|FG000|Overall Study|Changes of implementation system|3|||
155082060|NCT01832038|559731141|FG000|Overall Study|Plan to pregnancy|7|||
155082061|NCT01832038|559731141|FG000|Overall Study|Bad mood and has suicidal thought|1|||
155082062|NCT01832038|559731141|FG000|Overall Study|Prohibited concomitant medication|1|||
155082063|NCT01832038|559731141|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
155082064|NCT01832038|559731141|FG000|Overall Study|Subject considered the efficacy was poor|1|||
155082065|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
155082066|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
155165543|NCT04661579|560043479|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
155165544|NCT04661579|560043480|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
155165545|NCT01396447|560043481|FG000|Overall Study|Did Not Receive Treatment|3|||
155165546|NCT01396447|560043482|FG001|Overall Study|Did Not Receive Treatment|2|||
155347532|NCT00498797|560704945|FG000|Overall Study|Withdrawal by Subject|4|||
155082067|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
155082068|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
155082069|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
155165547|NCT01396447|560043483|FG002|Overall Study|Did Not Receive Treatment|1|||
155165548|NCT01396447|560043484|FG003|Overall Study|Did Not Receive Treatment|0|||
155165549|NCT01396447|560043481|FG000|Overall Study|Adverse Event|15|||
155165550|NCT01396447|560043482|FG001|Overall Study|Adverse Event|12|||
155347533|NCT00498797|560704946|FG001|Overall Study|Withdrawal by Subject|2|||
155347534|NCT00498797|560704945|FG000|Overall Study|Adverse Event|12|||
155082070|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
155082071|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
155082072|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
155082073|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
155082074|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
155082075|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
155082076|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
155082077|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
155082078|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
155082079|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
155082080|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
155082081|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
155082082|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
155082083|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
155082084|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
155082085|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
155082086|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
155347535|NCT00498797|560704946|FG001|Overall Study|Adverse Event|5|||
155347536|NCT00498797|560704945|FG000|Overall Study|Condition under investigation worsened|19|||
155347537|NCT00498797|560704946|FG001|Overall Study|Condition under investigation worsened|21|||
155347538|NCT00498797|560704945|FG000|Overall Study|Other|3|||
155347539|NCT00498797|560704946|FG001|Overall Study|Other|1|||
155347540|NCT03562117|560704947|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
155082087|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
155082088|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
155082089|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
155082090|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
155082091|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
155082092|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
155082093|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
155165551|NCT01396447|560043483|FG002|Overall Study|Adverse Event|12|||
155347541|NCT03562117|560704948|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
155082094|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
155082095|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
155082096|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
155082097|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
155082098|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
155082099|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
155082100|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
155347542|NCT03562117|560704949|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
155347543|NCT03928821|560704950|FG000|Overall Study|Death|0|||
155347544|NCT03928821|560704951|FG001|Overall Study|Death|1|||
155347545|NCT03928821|560704952|FG002|Overall Study|Death|0|||
155347546|NCT03928821|560704953|FG003|Overall Study|Death|0|||
155347547|NCT03928821|560704950|FG000|Overall Study|Lost to Follow-up|0|||
155347548|NCT03928821|560704951|FG001|Overall Study|Lost to Follow-up|2|||
155347549|NCT03928821|560704952|FG002|Overall Study|Lost to Follow-up|3|||
155347550|NCT03928821|560704953|FG003|Overall Study|Lost to Follow-up|0|||
155347551|NCT03928821|560704950|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155347552|NCT03928821|560704951|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155347553|NCT03928821|560704952|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
155347554|NCT03928821|560704953|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
155347555|NCT04743999|560704960|FG000|3-month Questionnaire|Death|1|||
155347556|NCT04743999|560704960|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
155347557|NCT04743999|560704960|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
155347558|NCT04743999|560704960|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
155347559|NCT01721759|560704961|FG000|Treatment Period|Disease Progression|85|||
155347560|NCT01721759|560704961|FG000|Treatment Period|Study drug toxicity|14|||
155347561|NCT01721759|560704961|FG000|Treatment Period|Death|1|||
155347562|NCT01721759|560704961|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
155347563|NCT01721759|560704961|FG000|Treatment Period|Participant request to withdraw|3|||
155347564|NCT01721759|560704961|FG000|Treatment Period|Other Reasons|3|||
155347565|NCT01721759|560704961|FG000|End of Study Period|Participant Withdrew Consent|5|||
155347566|NCT01721759|560704961|FG000|End of Study Period|Death|101|||
155347567|NCT01721759|560704961|FG000|End of Study Period|Lost to Follow-up|1|||
155347568|NCT01721759|560704961|FG000|End of Study Period|Other Reasons|10|||
155347569|NCT03138499|560704967|FG000|Overall Study|Lost to Follow-up|1|||
155347570|NCT03138499|560704968|FG001|Overall Study|Lost to Follow-up|0|||
155347571|NCT03138499|560704967|FG000|Overall Study|Participants withdrew consent|1|||
155347572|NCT03138499|560704968|FG001|Overall Study|Participants withdrew consent|0|||
155347573|NCT03138499|560704967|FG000|Overall Study|Participant discontinued study before treatment|0|||
155347574|NCT03138499|560704968|FG001|Overall Study|Participant discontinued study before treatment|1|||
155347575|NCT03138499|560704967|FG000|Overall Study|Disease Progression|2|||
155347576|NCT03138499|560704968|FG001|Overall Study|Disease Progression|6|||
155347577|NCT03138499|560704967|FG000|Overall Study|Study drug toxicity|2|||
155347578|NCT03138499|560704968|FG001|Overall Study|Study drug toxicity|2|||
155347579|NCT03138499|560704967|FG000|Overall Study|Participant request to discontinue study treatment|1|||
155347580|NCT03138499|560704968|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155347581|NCT03138499|560704967|FG000|Overall Study|Other reasons|2|||
155347582|NCT03138499|560704968|FG001|Overall Study|Other reasons|0|||
155347583|NCT01123200|560704972|FG000|Overall Study|Withdrawal by Subject|1|||
155347584|NCT01052714|560704975|FG000|Overall Study|Adverse Event|6|||
155347585|NCT01052714|560704976|FG001|Overall Study|Adverse Event|3|||
155347586|NCT01052714|560704977|FG002|Overall Study|Adverse Event|0|||
155347587|NCT01052714|560704975|FG000|Overall Study|Death|1|||
155347588|NCT01052714|560704976|FG001|Overall Study|Death|2|||
155347589|NCT01052714|560704977|FG002|Overall Study|Death|0|||
155347590|NCT01052714|560704975|FG000|Overall Study|Lost to Follow-up|2|||
155347591|NCT01052714|560704976|FG001|Overall Study|Lost to Follow-up|3|||
155347592|NCT01052714|560704977|FG002|Overall Study|Lost to Follow-up|0|||
155347593|NCT01052714|560704975|FG000|Overall Study|Physician Decision|9|||
155347594|NCT01052714|560704976|FG001|Overall Study|Physician Decision|9|||
155347595|NCT01052714|560704977|FG002|Overall Study|Physician Decision|1|||
155347596|NCT01052714|560704975|FG000|Overall Study|Withdrawal by Subject|7|||
155347597|NCT01052714|560704976|FG001|Overall Study|Withdrawal by Subject|12|||
155347598|NCT01052714|560704977|FG002|Overall Study|Withdrawal by Subject|1|||
155347599|NCT01636778|560704990|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
155347600|NCT01636778|560704991|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
155347601|NCT01636778|560704992|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
155347602|NCT01636778|560704990|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
155347603|NCT01636778|560704991|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
155347604|NCT01636778|560704992|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
155347605|NCT01636778|560704990|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
155165552|NCT01396447|560043484|FG003|Overall Study|Adverse Event|17|||
155082101|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
155082102|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
155082103|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
155082104|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
155082105|NCT02596893|559731142|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
155082106|NCT02596893|559731143|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
155082107|NCT02596893|559731144|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
155082108|NCT02596893|559731145|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
155082109|NCT03280615|559731146|FG000|Overall Study|Lost to Follow-up|1|||
155082110|NCT03280615|559731147|FG001|Overall Study|Lost to Follow-up|2|||
155082111|NCT03280615|559731146|FG000|Overall Study|Adverse Event|1|||
155082112|NCT03280615|559731147|FG001|Overall Study|Adverse Event|1|||
155082113|NCT03280615|559731146|FG000|Overall Study|Withdrawal by Subject|2|||
155082114|NCT03280615|559731147|FG001|Overall Study|Withdrawal by Subject|2|||
155082115|NCT00004228|559731152|FG000|Overall Study|Adverse Event|0|||
155347606|NCT01636778|560704991|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
155347607|NCT01636778|560704992|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
155347608|NCT01636778|560704990|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
155347609|NCT01636778|560704991|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
155347610|NCT01636778|560704992|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
155347611|NCT01636778|560704990|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
155347612|NCT01636778|560704991|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
155347613|NCT01636778|560704992|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
155347614|NCT01636778|560704990|FG000|Follow-up Period After Part 2|Other|0|||
155347615|NCT01636778|560704991|FG001|Follow-up Period After Part 2|Other|0|||
155347616|NCT01636778|560704992|FG002|Follow-up Period After Part 2|Other|1|||
155347617|NCT01636778|560704990|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
155347618|NCT01636778|560704991|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
155347619|NCT01636778|560704992|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
155347620|NCT01636778|560704990|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
155347621|NCT01636778|560704991|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
155347622|NCT01636778|560704992|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
155347623|NCT00170950|560704993|FG000|Overall Study|Death|236|||
155347624|NCT00170950|560704994|FG001|Overall Study|Death|274|||
155347625|NCT00170950|560704993|FG000|Overall Study|Withdrawal by Subject|496|||
155347626|NCT00170950|560704994|FG001|Overall Study|Withdrawal by Subject|498|||
155347627|NCT00170950|560704993|FG000|Overall Study|Lost to Follow-up|134|||
155347628|NCT00170950|560704994|FG001|Overall Study|Lost to Follow-up|115|||
155347629|NCT00170950|560704993|FG000|Overall Study|Missing|2|||
155347630|NCT00170950|560704994|FG001|Overall Study|Missing|1|||
155347631|NCT00170950|560704993|FG000|Overall Study|Termination Data Not Recorded|17|||
155347632|NCT00170950|560704994|FG001|Overall Study|Termination Data Not Recorded|22|||
155347633|NCT00748098|560704995|FG000|First Treatment Intervention Period|Adverse Event|1|||
155347634|NCT00748098|560704996|FG001|First Treatment Intervention Period|Adverse Event|1|||
155347635|NCT00748098|560704995|FG000|First Treatment Intervention Period|Protocol Violation|1|||
155347636|NCT00748098|560704996|FG001|First Treatment Intervention Period|Protocol Violation|0|||
155347637|NCT00748098|560704995|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
155347638|NCT00748098|560704996|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
155347639|NCT00748098|560704995|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
155347640|NCT00748098|560704996|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
155347641|NCT00748098|560704995|FG000|First Taper Period|Protocol Violation|1|||
155347642|NCT00748098|560704996|FG001|First Taper Period|Protocol Violation|0|||
155347643|NCT00748098|560704995|FG000|First Taper Period|Withdrawal by Subject|2|||
155347644|NCT00748098|560704996|FG001|First Taper Period|Withdrawal by Subject|0|||
155347645|NCT00748098|560704995|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
155347646|NCT00748098|560704996|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
155347647|NCT00748098|560704995|FG000|1-Week Washout Period|Adverse Event|0|||
155347648|NCT00748098|560704996|FG001|1-Week Washout Period|Adverse Event|1|||
155347649|NCT00748098|560704995|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
155347650|NCT00748098|560704996|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
155347651|NCT00748098|560704995|FG000|Second Treatment Intervention Period|Adverse Event|4|||
155347652|NCT00748098|560704996|FG001|Second Treatment Intervention Period|Adverse Event|1|||
155347653|NCT00748098|560704995|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
155347654|NCT00748098|560704996|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
155347655|NCT00748098|560704995|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
155082116|NCT00004228|559731153|FG001|Overall Study|Adverse Event|1|||
155082117|NCT00004228|559731154|FG002|Overall Study|Adverse Event|0|||
155082118|NCT00004228|559731155|FG003|Overall Study|Adverse Event|0|||
155082119|NCT00004228|559731156|FG004|Overall Study|Adverse Event|1|||
155082120|NCT00004228|559731157|FG005|Overall Study|Adverse Event|0|||
155082121|NCT00004228|559731158|FG006|Overall Study|Adverse Event|0|||
155082122|NCT00004228|559731152|FG000|Overall Study|Death|0|||
155082123|NCT00004228|559731153|FG001|Overall Study|Death|1|||
155082124|NCT00004228|559731154|FG002|Overall Study|Death|2|||
155082125|NCT00004228|559731155|FG003|Overall Study|Death|0|||
155082126|NCT00004228|559731156|FG004|Overall Study|Death|1|||
155082127|NCT00004228|559731157|FG005|Overall Study|Death|0|||
155082128|NCT00004228|559731158|FG006|Overall Study|Death|0|||
155082129|NCT00004228|559731152|FG000|Overall Study|Lack of Efficacy|1|||
155082130|NCT00004228|559731153|FG001|Overall Study|Lack of Efficacy|6|||
155082131|NCT00004228|559731154|FG002|Overall Study|Lack of Efficacy|5|||
155082132|NCT00004228|559731155|FG003|Overall Study|Lack of Efficacy|3|||
155082133|NCT00004228|559731156|FG004|Overall Study|Lack of Efficacy|9|||
155082134|NCT00004228|559731157|FG005|Overall Study|Lack of Efficacy|8|||
155082135|NCT00004228|559731158|FG006|Overall Study|Lack of Efficacy|4|||
155082136|NCT00004228|559731152|FG000|Overall Study|Lost to Follow-up|0|||
155082137|NCT00004228|559731153|FG001|Overall Study|Lost to Follow-up|0|||
155082138|NCT00004228|559731154|FG002|Overall Study|Lost to Follow-up|1|||
155082139|NCT00004228|559731155|FG003|Overall Study|Lost to Follow-up|0|||
155082140|NCT00004228|559731156|FG004|Overall Study|Lost to Follow-up|0|||
155082141|NCT00004228|559731157|FG005|Overall Study|Lost to Follow-up|0|||
155082142|NCT00004228|559731158|FG006|Overall Study|Lost to Follow-up|0|||
155082143|NCT00004228|559731152|FG000|Overall Study|Physician Decision|1|||
155082144|NCT00004228|559731153|FG001|Overall Study|Physician Decision|0|||
155082145|NCT00004228|559731154|FG002|Overall Study|Physician Decision|3|||
155082146|NCT00004228|559731155|FG003|Overall Study|Physician Decision|2|||
155082147|NCT00004228|559731156|FG004|Overall Study|Physician Decision|1|||
155082148|NCT00004228|559731157|FG005|Overall Study|Physician Decision|1|||
155082149|NCT00004228|559731158|FG006|Overall Study|Physician Decision|1|||
155082150|NCT00004228|559731152|FG000|Overall Study|Protocol Violation|0|||
155082151|NCT00004228|559731153|FG001|Overall Study|Protocol Violation|5|||
155082152|NCT00004228|559731154|FG002|Overall Study|Protocol Violation|2|||
155082153|NCT00004228|559731155|FG003|Overall Study|Protocol Violation|1|||
155082154|NCT00004228|559731156|FG004|Overall Study|Protocol Violation|1|||
155082155|NCT00004228|559731157|FG005|Overall Study|Protocol Violation|2|||
155082156|NCT00004228|559731158|FG006|Overall Study|Protocol Violation|0|||
155082157|NCT00004228|559731152|FG000|Overall Study|Withdrawal by Subject|3|||
155082158|NCT00004228|559731153|FG001|Overall Study|Withdrawal by Subject|0|||
155082159|NCT00004228|559731154|FG002|Overall Study|Withdrawal by Subject|1|||
155082160|NCT00004228|559731155|FG003|Overall Study|Withdrawal by Subject|0|||
155082161|NCT00004228|559731156|FG004|Overall Study|Withdrawal by Subject|2|||
155082162|NCT00004228|559731157|FG005|Overall Study|Withdrawal by Subject|1|||
155082163|NCT00004228|559731158|FG006|Overall Study|Withdrawal by Subject|2|||
155082164|NCT00004228|559731152|FG000|Overall Study|Other|0|||
155082165|NCT00004228|559731153|FG001|Overall Study|Other|0|||
155082166|NCT00004228|559731154|FG002|Overall Study|Other|1|||
155082167|NCT00004228|559731155|FG003|Overall Study|Other|0|||
155082168|NCT00004228|559731156|FG004|Overall Study|Other|0|||
155082169|NCT00004228|559731157|FG005|Overall Study|Other|0|||
155082170|NCT00004228|559731158|FG006|Overall Study|Other|0|||
155082171|NCT00004228|559731152|FG000|Overall Study|ineligible|4|||
155082172|NCT00004228|559731153|FG001|Overall Study|ineligible|2|||
155082173|NCT00004228|559731154|FG002|Overall Study|ineligible|4|||
155082174|NCT00004228|559731155|FG003|Overall Study|ineligible|1|||
155082175|NCT00004228|559731156|FG004|Overall Study|ineligible|1|||
155082176|NCT00004228|559731157|FG005|Overall Study|ineligible|2|||
155082177|NCT00004228|559731158|FG006|Overall Study|ineligible|5|||
155082178|NCT02457546|559731162|FG000|Overall Study|Other reasons|4|||
155082179|NCT02457546|559731163|FG001|Overall Study|Other reasons|1|||
155082180|NCT02457546|559731162|FG000|Overall Study|Refused to complete study/procedures|1|||
155082181|NCT02457546|559731163|FG001|Overall Study|Refused to complete study/procedures|1|||
155082182|NCT02457546|559731162|FG000|Overall Study|Lost to Follow-up|4|||
155082183|NCT02457546|559731163|FG001|Overall Study|Lost to Follow-up|1|||
155082184|NCT02457546|559731162|FG000|Overall Study|Adverse Event|0|||
155082185|NCT02457546|559731163|FG001|Overall Study|Adverse Event|1|||
155082186|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
155082187|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
155082188|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
155082189|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
155082190|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
155082191|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
155082192|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
155082193|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
155082194|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
155082195|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
155082196|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
155082197|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
155082198|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
155082199|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
155082200|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
155082201|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
155082202|NCT01755156|559731173|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
155082203|NCT01755156|559731174|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
155082204|NCT01755156|559731173|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
155082205|NCT01755156|559731174|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
155082206|NCT01755156|559731173|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
155082207|NCT01755156|559731174|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
155082208|NCT00871000|559731175|FG000|Overall Study|Withdrawal by Subject|1|||
155082209|NCT00871000|559731176|FG001|Overall Study|Withdrawal by Subject|0|||
155082210|NCT01052428|559731177|FG000|Overall Study|Death|1|||
155082211|NCT01052428|559731178|FG001|Overall Study|Death|0|||
155082212|NCT01052428|559731177|FG000|Overall Study|Withdrawal by Subject|0|||
155082213|NCT01052428|559731178|FG001|Overall Study|Withdrawal by Subject|1|||
155082214|NCT02180672|559731182|FG000|Overall Study|Lost to Follow-up|5|||
155082215|NCT02180672|559731183|FG001|Overall Study|Lost to Follow-up|7|||
155082216|NCT01061710|559731186|FG000|Overall Study|Protocol Violation|14|||
155082217|NCT02771145|559731192|FG000|Overall Study|Adverse Event|3|||
155082218|NCT02771145|559731192|FG000|Overall Study|Lost to Follow-up|1|||
155082219|NCT03473301|559731196|FG000|Overall Study|Protocol Violation|4|||
155082220|NCT03473301|559731197|FG001|Overall Study|Protocol Violation|0|||
155082221|NCT03473301|559731198|FG002|Overall Study|Protocol Violation|0|||
155347656|NCT00748098|560704996|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
155347657|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
155347658|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
155347659|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
155347660|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
155347661|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
155347662|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
155347663|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
155082222|NCT03473301|559731196|FG000|Overall Study|Withdrawal by Subject|0|||
155082223|NCT03473301|559731197|FG001|Overall Study|Withdrawal by Subject|1|||
155082224|NCT03473301|559731198|FG002|Overall Study|Withdrawal by Subject|0|||
155082225|NCT03473301|559731196|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
155082226|NCT03473301|559731197|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
155082227|NCT03473301|559731198|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
155082228|NCT05287685|559731199|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
155082229|NCT05287685|559731200|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
155082230|NCT05287685|559731199|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
155082231|NCT05287685|559731200|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
155082232|NCT05529173|559731201|FG000|Overall Study|Physician Decision|3|||
155082233|NCT05529173|559731202|FG001|Overall Study|Physician Decision|6|||
155082234|NCT05529173|559731201|FG000|Overall Study|Sample shipment delay more than one day|4|||
155082235|NCT05529173|559731202|FG001|Overall Study|Sample shipment delay more than one day|0|||
155082236|NCT01570192|559731203|FG000|Overall Study|no qualifying organism|6|||
155082237|NCT01570192|559731204|FG001|Overall Study|no qualifying organism|12|||
155082238|NCT01570192|559731203|FG000|Overall Study|changed to palliative care|1|||
155082239|NCT01570192|559731204|FG001|Overall Study|changed to palliative care|0|||
155082240|NCT01570192|559731203|FG000|Overall Study|Physician Decision|0|||
155082241|NCT01570192|559731204|FG001|Overall Study|Physician Decision|1|||
155082242|NCT02965976|559731205|FG000|Overall Study|Withdrawal by Subject|2|||
155165553|NCT01396447|560043481|FG000|Overall Study|Insufficient Therapeutic Response|5|||
155165554|NCT01396447|560043482|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155082243|NCT02965976|559731206|FG001|Overall Study|Withdrawal by Subject|0|||
155082244|NCT00806026|559731207|FG000|Overall Study|Death|0|||
155082245|NCT00806026|559731208|FG001|Overall Study|Death|0|||
155082246|NCT00806026|559731209|FG002|Overall Study|Death|0|||
155082247|NCT00806026|559731210|FG003|Overall Study|Death|1|||
155082248|NCT00806026|559731211|FG004|Overall Study|Death|0|||
155082249|NCT00806026|559731212|FG005|Overall Study|Death|0|||
155082250|NCT00806026|559731207|FG000|Overall Study|Did not meet entrance criteria|4|||
155082251|NCT00806026|559731208|FG001|Overall Study|Did not meet entrance criteria|1|||
155082252|NCT00806026|559731209|FG002|Overall Study|Did not meet entrance criteria|2|||
155165555|NCT01396447|560043483|FG002|Overall Study|Insufficient Therapeutic Response|2|||
155347664|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
155347665|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
155347666|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
155347667|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
155347668|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
155347669|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
155347670|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
155347671|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
155347672|NCT00332488|560706461|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
155347673|NCT00332488|560706462|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
155347674|NCT00332488|560706463|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
155347675|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
155347676|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
155347677|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
155347678|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
155347679|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
155347680|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
155347681|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
155347682|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
155347683|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
155347684|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
155347685|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
155347686|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
155347687|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
155347688|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
155347689|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
155347690|NCT00332488|560706461|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
155347691|NCT00332488|560706462|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
155347692|NCT00332488|560706463|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
155347693|NCT00792259|560706464|FG000|Overall Study|Poor Quality Scans|1|||
155347694|NCT00792259|560706465|FG001|Overall Study|Poor Quality Scans|0|||
155347695|NCT00792259|560706466|FG002|Overall Study|Poor Quality Scans|0|||
155347696|NCT03721978|560706467|FG000|Overall Study|Withdrawal by Subject|6|||
155347697|NCT03721978|560706468|FG001|Overall Study|Withdrawal by Subject|1|||
155347698|NCT03721978|560706467|FG000|Overall Study|Adverse Event|1|||
155347699|NCT03721978|560706468|FG001|Overall Study|Adverse Event|1|||
155347700|NCT03721978|560706467|FG000|Overall Study|Progressive Disease|1|||
155347701|NCT03721978|560706468|FG001|Overall Study|Progressive Disease|0|||
155347702|NCT03721978|560706467|FG000|Overall Study|Lost to Follow-up|5|||
155347703|NCT03721978|560706468|FG001|Overall Study|Lost to Follow-up|1|||
155347704|NCT03721978|560706467|FG000|Overall Study|Reason not Specified|0|||
155347705|NCT03721978|560706468|FG001|Overall Study|Reason not Specified|2|||
155347706|NCT05244226|560706469|FG000|Overall Study|Adverse Event|1|||
155082253|NCT00806026|559731210|FG003|Overall Study|Did not meet entrance criteria|1|||
155082254|NCT00806026|559731211|FG004|Overall Study|Did not meet entrance criteria|0|||
155082255|NCT00806026|559731212|FG005|Overall Study|Did not meet entrance criteria|0|||
155082256|NCT00806026|559731207|FG000|Overall Study|Lack of Efficacy|5|||
155082257|NCT00806026|559731208|FG001|Overall Study|Lack of Efficacy|18|||
155347707|NCT05244226|560706470|FG001|Overall Study|Adverse Event|0|||
155347708|NCT05244226|560706471|FG002|Overall Study|Adverse Event|0|||
155347709|NCT05244226|560706469|FG000|Overall Study|Lost to Follow-up|0|||
155347710|NCT05244226|560706470|FG001|Overall Study|Lost to Follow-up|0|||
155347711|NCT05244226|560706471|FG002|Overall Study|Lost to Follow-up|1|||
155347712|NCT05244226|560706469|FG000|Overall Study|Protocol Violation|0|||
155347713|NCT05244226|560706470|FG001|Overall Study|Protocol Violation|2|||
155347714|NCT05244226|560706471|FG002|Overall Study|Protocol Violation|2|||
155347715|NCT04050722|560706480|FG000|Overall Study|Withdrawal by Subject|1|||
155347716|NCT04050722|560706481|FG001|Overall Study|Withdrawal by Subject|0|||
155347717|NCT00377312|560706482|FG000|Overall Study|Adverse Event|1|||
155347718|NCT00377312|560706483|FG001|Overall Study|Adverse Event|1|||
155082258|NCT00806026|559731209|FG002|Overall Study|Lack of Efficacy|13|||
155082259|NCT00806026|559731210|FG003|Overall Study|Lack of Efficacy|4|||
155082260|NCT00806026|559731211|FG004|Overall Study|Lack of Efficacy|8|||
155347719|NCT03451292|560706486|FG000|Overall Study|Death|44|||
155347720|NCT03451292|560706487|FG001|Overall Study|Death|59|||
155347721|NCT03451292|560706486|FG000|Overall Study|Withdrawal by Subject|18|||
155347722|NCT03451292|560706487|FG001|Overall Study|Withdrawal by Subject|13|||
155347723|NCT03451292|560706486|FG000|Overall Study|Transplantation|18|||
155347724|NCT03451292|560706487|FG001|Overall Study|Transplantation|12|||
155347725|NCT03451292|560706486|FG000|Overall Study|Lost to Follow-up|4|||
155347726|NCT03451292|560706487|FG001|Overall Study|Lost to Follow-up|12|||
155347727|NCT03451292|560706486|FG000|Overall Study|Physician Decision|4|||
155347728|NCT03451292|560706487|FG001|Overall Study|Physician Decision|3|||
155347729|NCT03451292|560706486|FG000|Overall Study|Adverse Event|3|||
155347730|NCT03451292|560706487|FG001|Overall Study|Adverse Event|3|||
155347731|NCT03451292|560706486|FG000|Overall Study|Non-compliance with Study Drug|2|||
155347732|NCT03451292|560706487|FG001|Overall Study|Non-compliance with Study Drug|0|||
155347733|NCT01572493|560706490|FG000|Overall Study|Physician Decision|1|||
155347734|NCT01572493|560706491|FG001|Overall Study|Physician Decision|0|||
155347735|NCT01572493|560706492|FG002|Overall Study|Physician Decision|0|||
155347736|NCT01572493|560706493|FG003|Overall Study|Physician Decision|0|||
155347737|NCT01572493|560706494|FG004|Overall Study|Physician Decision|0|||
155347738|NCT01572493|560706495|FG005|Overall Study|Physician Decision|0|||
155347739|NCT01572493|560706496|FG006|Overall Study|Physician Decision|0|||
155347740|NCT01572493|560706497|FG007|Overall Study|Physician Decision|0|||
155347741|NCT01572493|560706498|FG008|Overall Study|Physician Decision|0|||
155347742|NCT01572493|560706490|FG000|Overall Study|Switched to alternative treatment|0|||
155347743|NCT01572493|560706491|FG001|Overall Study|Switched to alternative treatment|1|||
155347744|NCT01572493|560706492|FG002|Overall Study|Switched to alternative treatment|2|||
155347745|NCT01572493|560706493|FG003|Overall Study|Switched to alternative treatment|1|||
155347746|NCT01572493|560706494|FG004|Overall Study|Switched to alternative treatment|2|||
155347747|NCT01572493|560706495|FG005|Overall Study|Switched to alternative treatment|0|||
155347748|NCT01572493|560706496|FG006|Overall Study|Switched to alternative treatment|2|||
155347749|NCT01572493|560706497|FG007|Overall Study|Switched to alternative treatment|0|||
155347750|NCT01572493|560706498|FG008|Overall Study|Switched to alternative treatment|2|||
155347751|NCT01572493|560706490|FG000|Overall Study|Death|0|||
155347752|NCT01572493|560706491|FG001|Overall Study|Death|0|||
155347753|NCT01572493|560706492|FG002|Overall Study|Death|0|||
155347754|NCT01572493|560706493|FG003|Overall Study|Death|1|||
155347755|NCT01572493|560706494|FG004|Overall Study|Death|0|||
155347756|NCT01572493|560706495|FG005|Overall Study|Death|1|||
155347757|NCT01572493|560706496|FG006|Overall Study|Death|0|||
155347758|NCT01572493|560706497|FG007|Overall Study|Death|0|||
155347759|NCT01572493|560706498|FG008|Overall Study|Death|0|||
155347760|NCT01572493|560706490|FG000|Overall Study|Adverse Event|0|||
155347761|NCT01572493|560706491|FG001|Overall Study|Adverse Event|0|||
155347762|NCT01572493|560706492|FG002|Overall Study|Adverse Event|0|||
155347763|NCT01572493|560706493|FG003|Overall Study|Adverse Event|0|||
155347764|NCT01572493|560706494|FG004|Overall Study|Adverse Event|0|||
155347765|NCT01572493|560706495|FG005|Overall Study|Adverse Event|0|||
155347766|NCT01572493|560706496|FG006|Overall Study|Adverse Event|1|||
155347767|NCT01572493|560706497|FG007|Overall Study|Adverse Event|0|||
155347768|NCT01572493|560706498|FG008|Overall Study|Adverse Event|0|||
155347769|NCT01090076|560706499|FG000|Overall Study|Death|1|||
155082261|NCT00806026|559731212|FG005|Overall Study|Lack of Efficacy|7|||
155082262|NCT00806026|559731207|FG000|Overall Study|Lost to Follow-up|8|||
155082263|NCT00806026|559731208|FG001|Overall Study|Lost to Follow-up|15|||
155082264|NCT00806026|559731209|FG002|Overall Study|Lost to Follow-up|8|||
155082265|NCT00806026|559731210|FG003|Overall Study|Lost to Follow-up|2|||
155347770|NCT01090076|560706500|FG001|Overall Study|Death|1|||
155347771|NCT01090076|560706499|FG000|Overall Study|Withdrawal by Subject|0|||
155347772|NCT01090076|560706500|FG001|Overall Study|Withdrawal by Subject|1|||
155347773|NCT00191984|560706510|FG000|Overall Study|Disease Progression|21|||
155347774|NCT00191984|560706510|FG000|Overall Study|Adverse Event|4|||
155347775|NCT00191984|560706510|FG000|Overall Study|Death|2|||
155347776|NCT00191984|560706510|FG000|Overall Study|Entry Criteria Exclusion|1|||
155347777|NCT00191984|560706510|FG000|Overall Study|Withdrawal by Subject|7|||
155347778|NCT00191984|560706510|FG000|Overall Study|Physician Decision|4|||
155347779|NCT01654289|560706511|FG000|Overall Study|Withdrawal by Subject|10|||
155347780|NCT01654289|560706512|FG001|Overall Study|Withdrawal by Subject|8|||
155347781|NCT01654289|560706513|FG002|Overall Study|Withdrawal by Subject|5|||
155347782|NCT01654289|560706511|FG000|Overall Study|Withdrew from intervention only|17|||
155347783|NCT01654289|560706512|FG001|Overall Study|Withdrew from intervention only|20|||
155347784|NCT01654289|560706513|FG002|Overall Study|Withdrew from intervention only|0|||
155347785|NCT04748445|560706517|FG000|Overall Study|No longer met eligibility criteria|12|||
155347786|NCT04748445|560706517|FG000|Overall Study|Other|36|||
155082266|NCT00806026|559731211|FG004|Overall Study|Lost to Follow-up|6|||
155082267|NCT00806026|559731212|FG005|Overall Study|Lost to Follow-up|6|||
155347787|NCT04748445|560706517|FG000|Overall Study|Withdrawal by Subject|553|||
155347788|NCT04748445|560706517|FG000|Overall Study|Lost to Follow-up|30|||
155347789|NCT04736602|560706518|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
155347790|NCT04736602|560706518|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
155347791|NCT00938041|560706525|FG000|Overall Study|Lost to Follow-up|6|||
155347792|NCT00938041|560706525|FG000|Overall Study|Received Alternative Therapy|1|||
155347793|NCT00938041|560706525|FG000|Overall Study|Progressive Disease|5|||
155347794|NCT00938041|560706525|FG000|Overall Study|Death|12|||
155082268|NCT00806026|559731207|FG000|Overall Study|Withdrawal by Subject|14|||
155082269|NCT00806026|559731208|FG001|Overall Study|Withdrawal by Subject|17|||
155082270|NCT00806026|559731209|FG002|Overall Study|Withdrawal by Subject|9|||
155082271|NCT00806026|559731210|FG003|Overall Study|Withdrawal by Subject|2|||
155082272|NCT00806026|559731211|FG004|Overall Study|Withdrawal by Subject|5|||
155082273|NCT00806026|559731212|FG005|Overall Study|Withdrawal by Subject|3|||
155082274|NCT00806026|559731207|FG000|Overall Study|Other|3|||
155082275|NCT00806026|559731208|FG001|Overall Study|Other|6|||
155082276|NCT00806026|559731209|FG002|Overall Study|Other|8|||
155082277|NCT00806026|559731210|FG003|Overall Study|Other|2|||
155082278|NCT00806026|559731211|FG004|Overall Study|Other|0|||
155082279|NCT00806026|559731212|FG005|Overall Study|Other|4|||
155082280|NCT00806026|559731207|FG000|Overall Study|Protocol Violation|6|||
155082281|NCT00806026|559731208|FG001|Overall Study|Protocol Violation|9|||
155082282|NCT00806026|559731209|FG002|Overall Study|Protocol Violation|9|||
155082283|NCT00806026|559731210|FG003|Overall Study|Protocol Violation|0|||
155082284|NCT00806026|559731211|FG004|Overall Study|Protocol Violation|2|||
155347795|NCT00938041|560706525|FG000|Overall Study|Adrenal Insufficiency|3|||
155347796|NCT03042559|560706526|FG000|Overall Study|drop out|1|||
155347797|NCT03042559|560706527|FG001|Overall Study|drop out|1|||
155347798|NCT01536535|560706531|FG000|Overall Study|Withdrawal by Subject|10|||
155347799|NCT01536535|560706532|FG001|Overall Study|Withdrawal by Subject|5|||
155347800|NCT01536535|560706531|FG000|Overall Study|Lost to Follow-up|4|||
155347801|NCT01536535|560706532|FG001|Overall Study|Lost to Follow-up|6|||
155347802|NCT01536535|560706531|FG000|Overall Study|Physician Decision|1|||
155347803|NCT01536535|560706532|FG001|Overall Study|Physician Decision|1|||
155347804|NCT01536535|560706531|FG000|Overall Study|Participant moved|0|||
155347805|NCT01536535|560706532|FG001|Overall Study|Participant moved|1|||
155082285|NCT00806026|559731212|FG005|Overall Study|Protocol Violation|3|||
155082286|NCT00806026|559731207|FG000|Overall Study|Adverse Event|52|||
155082287|NCT00806026|559731208|FG001|Overall Study|Adverse Event|35|||
155082288|NCT00806026|559731209|FG002|Overall Study|Adverse Event|44|||
155082289|NCT00806026|559731210|FG003|Overall Study|Adverse Event|17|||
155082290|NCT00806026|559731211|FG004|Overall Study|Adverse Event|9|||
155082291|NCT00806026|559731212|FG005|Overall Study|Adverse Event|9|||
155082292|NCT00819832|559731213|FG000|Overall Study|Sponsor Termination of Study|3|||
155082293|NCT00819832|559731214|FG001|Overall Study|Sponsor Termination of Study|0|||
155082294|NCT00819832|559731215|FG002|Overall Study|Sponsor Termination of Study|0|||
155082295|NCT00819832|559731216|FG003|Overall Study|Sponsor Termination of Study|0|||
155082296|NCT00819832|559731217|FG004|Overall Study|Sponsor Termination of Study|0|||
155082297|NCT00819832|559731218|FG005|Overall Study|Sponsor Termination of Study|0|||
155082298|NCT01063881|559731220|FG000|Overall Study|Adverse Event|12|||
155082299|NCT01063881|559731221|FG001|Overall Study|Adverse Event|2|||
155082300|NCT01063881|559731222|FG002|Overall Study|Adverse Event|0|||
155082301|NCT01063881|559731220|FG000|Overall Study|Lost to Follow-up|13|||
155082302|NCT01063881|559731221|FG001|Overall Study|Lost to Follow-up|7|||
155082303|NCT01063881|559731222|FG002|Overall Study|Lost to Follow-up|1|||
155082304|NCT01063881|559731220|FG000|Overall Study|Withdrawal by Subject|25|||
155082305|NCT01063881|559731221|FG001|Overall Study|Withdrawal by Subject|1|||
155082306|NCT01063881|559731222|FG002|Overall Study|Withdrawal by Subject|0|||
155082307|NCT01063881|559731220|FG000|Overall Study|Reason for not completed not specified|5|||
155082308|NCT01063881|559731221|FG001|Overall Study|Reason for not completed not specified|1|||
155082309|NCT01063881|559731222|FG002|Overall Study|Reason for not completed not specified|0|||
155082310|NCT01340170|559731223|FG000|Overall Study|Lost to Follow-up|2|||
155082311|NCT01340170|559731224|FG001|Overall Study|Lost to Follow-up|4|||
155082312|NCT01340170|559731225|FG002|Overall Study|Lost to Follow-up|0|||
155082313|NCT01340170|559731223|FG000|Overall Study|Implant failure|1|||
155082314|NCT01340170|559731224|FG001|Overall Study|Implant failure|3|||
155082315|NCT01340170|559731225|FG002|Overall Study|Implant failure|0|||
155082316|NCT00468546|559731228|FG000|Week 24 Analysis|Lack of Efficacy|83|||
155082317|NCT00468546|559731229|FG001|Week 24 Analysis|Lack of Efficacy|37|||
155082318|NCT00468546|559731228|FG000|Week 24 Analysis|Refused treatment|5|||
155082319|NCT00468546|559731229|FG001|Week 24 Analysis|Refused treatment|5|||
155347806|NCT00404547|560706533|FG000|Overall Study|Adverse Event|39|||
155347807|NCT00404547|560706534|FG001|Overall Study|Adverse Event|6|||
155347808|NCT00404547|560706533|FG000|Overall Study|Withdrawal by Subject|19|||
155082320|NCT00468546|559731228|FG000|Week 24 Analysis|Adverse Event|1|||
155082321|NCT00468546|559731229|FG001|Week 24 Analysis|Adverse Event|8|||
155082322|NCT00468546|559731228|FG000|Week 24 Analysis|Failure to return|3|||
155082323|NCT00468546|559731229|FG001|Week 24 Analysis|Failure to return|4|||
155082324|NCT00468546|559731228|FG000|Week 24 Analysis|Rescue therapy|2|||
155082325|NCT00468546|559731229|FG001|Week 24 Analysis|Rescue therapy|0|||
155347809|NCT00404547|560706534|FG001|Overall Study|Withdrawal by Subject|2|||
155347810|NCT00404547|560706533|FG000|Overall Study|Protocol Violation|0|||
155347811|NCT00404547|560706534|FG001|Overall Study|Protocol Violation|1|||
155347812|NCT00404547|560706533|FG000|Overall Study|Lost to Follow-up|20|||
155082326|NCT00468546|559731228|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
155082327|NCT00468546|559731229|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
155082328|NCT00468546|559731228|FG000|Week 24 Analysis|Due to clinical hold|1|||
155082329|NCT00468546|559731229|FG001|Week 24 Analysis|Due to clinical hold|0|||
155082330|NCT00468546|559731228|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
155082331|NCT00468546|559731229|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
155082332|NCT00468546|559731228|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
155082333|NCT00468546|559731229|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
155082334|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
155082335|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
155082336|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Death|1|||
155082337|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Death|0|||
155082338|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
155082339|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
155082340|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
155082341|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
155082342|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
155082343|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
155082344|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
155082345|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
155082346|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
155082347|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
155082348|NCT00468546|559731228|FG000|Week 24 to Week 104 Analysis|Other|17|||
155082349|NCT00468546|559731229|FG001|Week 24 to Week 104 Analysis|Other|14|||
155082350|NCT00472641|559731231|FG000|Overall Study|Lack of Efficacy|3|||
155082351|NCT00472641|559731231|FG000|Overall Study|Adverse Event|3|||
155082352|NCT00472641|559731231|FG000|Overall Study|Lost to Follow-up|1|||
155082353|NCT03888482|559731232|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
155082354|NCT03888482|559731233|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
155082355|NCT03888482|559731232|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
155082356|NCT03888482|559731233|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
155082357|NCT05652140|559731236|FG000|Overall Study|Lost to Follow-up|7|||
155082358|NCT05652140|559731237|FG001|Overall Study|Lost to Follow-up|16|||
155082359|NCT05652140|559731238|FG002|Overall Study|Lost to Follow-up|22|||
155082360|NCT05652140|559731239|FG003|Overall Study|Lost to Follow-up|31|||
155082361|NCT00968968|559731242|FG000|Overall Study|Study closed/terminated|10|||
155082362|NCT00968968|559731243|FG001|Overall Study|Study closed/terminated|10|||
155082363|NCT00968968|559731242|FG000|Overall Study|Protocol defined stopping criteria|3|||
155082364|NCT00968968|559731243|FG001|Overall Study|Protocol defined stopping criteria|1|||
155082365|NCT00968968|559731242|FG000|Overall Study|Withdrawal by Subject|2|||
155082366|NCT00968968|559731243|FG001|Overall Study|Withdrawal by Subject|0|||
155082367|NCT00968968|559731242|FG000|Overall Study|Physician Decision|1|||
155082368|NCT00968968|559731243|FG001|Overall Study|Physician Decision|2|||
155082369|NCT00968968|559731242|FG000|Overall Study|Lost to Follow-up|0|||
155082370|NCT00968968|559731243|FG001|Overall Study|Lost to Follow-up|1|||
155082371|NCT04401293|559731244|FG000|Overall Study|Withdrawal by Subject|1|||
155082372|NCT04401293|559731245|FG001|Overall Study|Withdrawal by Subject|3|||
155082373|NCT01026038|559731246|FG000|Overall Study|Lost to Follow-up|1|||
155082374|NCT01026038|559731247|FG001|Overall Study|Lost to Follow-up|1|||
155082375|NCT01026038|559731248|FG002|Overall Study|Lost to Follow-up|0|||
155082376|NCT03679884|559731249|FG000|Overall Study|Other|12|||
155082377|NCT03679884|559731250|FG001|Overall Study|Other|12|||
155082378|NCT03679884|559731251|FG002|Overall Study|Other|12|||
155082379|NCT03679884|559731252|FG003|Overall Study|Other|7|||
155082380|NCT03679884|559731253|FG004|Overall Study|Other|8|||
155082381|NCT03679884|559731249|FG000|Overall Study|Lack of Efficacy|15|||
155082382|NCT03679884|559731250|FG001|Overall Study|Lack of Efficacy|29|||
155082383|NCT03679884|559731251|FG002|Overall Study|Lack of Efficacy|13|||
155082384|NCT03679884|559731252|FG003|Overall Study|Lack of Efficacy|29|||
155082385|NCT03679884|559731253|FG004|Overall Study|Lack of Efficacy|10|||
155082386|NCT03679884|559731249|FG000|Overall Study|Death|1|||
155082387|NCT03679884|559731250|FG001|Overall Study|Death|0|||
155082388|NCT03679884|559731251|FG002|Overall Study|Death|0|||
155082389|NCT03679884|559731252|FG003|Overall Study|Death|0|||
155082390|NCT03679884|559731253|FG004|Overall Study|Death|0|||
155082391|NCT03679884|559731249|FG000|Overall Study|Adverse Event|2|||
155082392|NCT03679884|559731250|FG001|Overall Study|Adverse Event|10|||
155082393|NCT03679884|559731251|FG002|Overall Study|Adverse Event|9|||
155082394|NCT03679884|559731252|FG003|Overall Study|Adverse Event|6|||
155082395|NCT03679884|559731253|FG004|Overall Study|Adverse Event|6|||
155082396|NCT03679884|559731249|FG000|Overall Study|Withdrawal by Subject|12|||
155082397|NCT03679884|559731250|FG001|Overall Study|Withdrawal by Subject|23|||
155165556|NCT01396447|560043484|FG003|Overall Study|Insufficient Therapeutic Response|4|||
155082398|NCT03679884|559731251|FG002|Overall Study|Withdrawal by Subject|8|||
155082399|NCT03679884|559731252|FG003|Overall Study|Withdrawal by Subject|8|||
155082400|NCT03679884|559731253|FG004|Overall Study|Withdrawal by Subject|9|||
155082401|NCT03679884|559731249|FG000|Overall Study|Lost to Follow-up|1|||
155082402|NCT03679884|559731250|FG001|Overall Study|Lost to Follow-up|4|||
155082403|NCT03679884|559731251|FG002|Overall Study|Lost to Follow-up|2|||
155082404|NCT03679884|559731252|FG003|Overall Study|Lost to Follow-up|0|||
155082405|NCT03679884|559731253|FG004|Overall Study|Lost to Follow-up|3|||
155082406|NCT00682435|559731257|FG000|Overall Study|Insufficient data|5|||
155082407|NCT00682435|559731257|FG000|Overall Study|Erroneously enrolled twice|2|||
155082408|NCT05330429|559731260|FG000|Overall Study|Study Terminated by Sponsor|4|||
155082409|NCT05330429|559731261|FG001|Overall Study|Study Terminated by Sponsor|33|||
155082410|NCT05330429|559731262|FG002|Overall Study|Study Terminated by Sponsor|12|||
155082411|NCT05330429|559731260|FG000|Overall Study|Death|5|||
155082412|NCT05330429|559731261|FG001|Overall Study|Death|2|||
155082413|NCT05330429|559731262|FG002|Overall Study|Death|4|||
155082414|NCT05330429|559731260|FG000|Overall Study|Withdrew Consent|0|||
155082415|NCT05330429|559731261|FG001|Overall Study|Withdrew Consent|5|||
155082416|NCT05330429|559731262|FG002|Overall Study|Withdrew Consent|4|||
155347813|NCT00404547|560706534|FG001|Overall Study|Lost to Follow-up|9|||
155347814|NCT00404547|560706533|FG000|Overall Study|Lack of compliance|5|||
155347815|NCT00404547|560706534|FG001|Overall Study|Lack of compliance|1|||
155347816|NCT00404547|560706533|FG000|Overall Study|Other|4|||
155347817|NCT00404547|560706534|FG001|Overall Study|Other|0|||
155347818|NCT00404547|560706533|FG000|Overall Study|Reason not stated|3|||
155347819|NCT00404547|560706534|FG001|Overall Study|Reason not stated|6|||
155347820|NCT01485991|560706535|FG000|Overall Study|Adverse Event|0|||
155082417|NCT05330429|559731260|FG000|Overall Study|Investigator's Discretion|0|||
155082418|NCT05330429|559731261|FG001|Overall Study|Investigator's Discretion|1|||
155082419|NCT05330429|559731262|FG002|Overall Study|Investigator's Discretion|3|||
155082420|NCT05330429|559731260|FG000|Overall Study|Subject Decision|1|||
155082421|NCT05330429|559731261|FG001|Overall Study|Subject Decision|2|||
155082422|NCT05330429|559731262|FG002|Overall Study|Subject Decision|0|||
155082423|NCT05330429|559731260|FG000|Overall Study|Lost to Follow-up|0|||
155082424|NCT05330429|559731261|FG001|Overall Study|Lost to Follow-up|1|||
155082425|NCT05330429|559731262|FG002|Overall Study|Lost to Follow-up|0|||
155082426|NCT04359680|559733189|FG000|Overall Study|Withdrawal by Subject|29|||
155082427|NCT04359680|559733190|FG001|Overall Study|Withdrawal by Subject|24|||
155082428|NCT04359680|559733189|FG000|Overall Study|Adverse Event|6|||
155082429|NCT04359680|559733190|FG001|Overall Study|Adverse Event|2|||
155082430|NCT04359680|559733189|FG000|Overall Study|Lost to Follow-up|56|||
155082431|NCT04359680|559733190|FG001|Overall Study|Lost to Follow-up|59|||
155347821|NCT01485991|560706536|FG001|Overall Study|Adverse Event|4|||
155347822|NCT01485991|560706535|FG000|Overall Study|Lost to Follow-up|13|||
155082432|NCT04359680|559733189|FG000|Overall Study|Protocol Violation|3|||
155082433|NCT04359680|559733190|FG001|Overall Study|Protocol Violation|5|||
155082434|NCT04359680|559733189|FG000|Overall Study|Physician Decision|1|||
155082435|NCT04359680|559733190|FG001|Overall Study|Physician Decision|1|||
155082436|NCT04359680|559733189|FG000|Overall Study|Sponsor Decision|0|||
155082437|NCT04359680|559733190|FG001|Overall Study|Sponsor Decision|1|||
155082438|NCT02255279|559733191|FG000|Overall Study|Lost to Follow-up|2|||
155082439|NCT02255279|559733192|FG001|Overall Study|Lost to Follow-up|2|||
155082440|NCT02255279|559733191|FG000|Overall Study|Protocol Violation|0|||
155082441|NCT02255279|559733192|FG001|Overall Study|Protocol Violation|1|||
155082442|NCT02255279|559733191|FG000|Overall Study|Withdrawal by Subject|3|||
155082443|NCT02255279|559733192|FG001|Overall Study|Withdrawal by Subject|6|||
155082444|NCT00107614|559733193|FG000|Overall Study|Physician Decision|10|||
155082445|NCT00107614|559733193|FG000|Overall Study|Death|2|||
155347823|NCT01485991|560706536|FG001|Overall Study|Lost to Follow-up|10|||
155347824|NCT01485991|560706535|FG000|Overall Study|Withdrawal by Subject|13|||
155347825|NCT01485991|560706536|FG001|Overall Study|Withdrawal by Subject|20|||
155082446|NCT01897896|559733197|FG000|Overall Study|Death|1|||
155082447|NCT01897896|559733198|FG001|Overall Study|Death|0|||
155082448|NCT01897896|559733197|FG000|Overall Study|Adverse Event|11|||
155082449|NCT01897896|559733198|FG001|Overall Study|Adverse Event|1|||
155165557|NCT01396447|560043481|FG000|Overall Study|Protocol Violation|5|||
155165558|NCT01396447|560043482|FG001|Overall Study|Protocol Violation|2|||
155165559|NCT01396447|560043483|FG002|Overall Study|Protocol Violation|3|||
155347826|NCT01485991|560706535|FG000|Overall Study|randomized but not treated|6|||
155347827|NCT01485991|560706536|FG001|Overall Study|randomized but not treated|2|||
155082450|NCT01897896|559733197|FG000|Overall Study|Lost to Follow-up|1|||
155082451|NCT01897896|559733198|FG001|Overall Study|Lost to Follow-up|0|||
155347828|NCT01475370|560706537|FG000|Overall Study|Exacerbation of primary disease|2|||
155347829|NCT01475370|560706538|FG001|Overall Study|Exacerbation of primary disease|2|||
155347830|NCT01475370|560706539|FG002|Overall Study|Exacerbation of primary disease|2|||
155347831|NCT01475370|560706537|FG000|Overall Study|Study drug administration difficult|0|||
155347832|NCT01475370|560706538|FG001|Overall Study|Study drug administration difficult|1|||
155082452|NCT01897896|559733197|FG000|Overall Study|Non-compliance with study drug dosing|1|||
155082453|NCT01897896|559733198|FG001|Overall Study|Non-compliance with study drug dosing|1|||
155082454|NCT01897896|559733197|FG000|Overall Study|Withdrawal by Subject|7|||
155082455|NCT01897896|559733198|FG001|Overall Study|Withdrawal by Subject|1|||
155082456|NCT01897896|559733197|FG000|Overall Study|Require drug that interfere with study|1|||
155082457|NCT01897896|559733198|FG001|Overall Study|Require drug that interfere with study|4|||
155082458|NCT01897896|559733197|FG000|Overall Study|Protocol Violation|1|||
155082459|NCT01897896|559733198|FG001|Overall Study|Protocol Violation|1|||
155082460|NCT01897896|559733197|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
155082461|NCT01897896|559733198|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
155082462|NCT01897896|559733197|FG000|Overall Study|Caregiver can no longer participate|0|||
155082463|NCT01897896|559733198|FG001|Overall Study|Caregiver can no longer participate|2|||
155082464|NCT01897896|559733197|FG000|Overall Study|Other than specified|2|||
155082465|NCT01897896|559733198|FG001|Overall Study|Other than specified|1|||
155082466|NCT00432991|559733199|FG000|Overall Study|Protocol Violation|7|||
155082467|NCT00432991|559733200|FG001|Overall Study|Protocol Violation|12|||
155082468|NCT00363467|559733201|FG000|Overall Study|Physician Decision|1|||
155082469|NCT05069415|559733204|FG000|Overall Study|Withdrawal by Subject|2|||
155082470|NCT05069415|559733205|FG001|Overall Study|Withdrawal by Subject|0|||
155082471|NCT05069415|559733204|FG000|Overall Study|Adverse Event|2|||
155082472|NCT05069415|559733205|FG001|Overall Study|Adverse Event|0|||
155082473|NCT03160573|559733206|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
155082474|NCT03160573|559733207|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
155082475|NCT03160573|559733208|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
155082476|NCT03160573|559733209|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
155082477|NCT00101400|559733210|FG000|Survival Follow-Up|Alive|7|||
155082478|NCT00382863|559733215|FG000|Overall Study|Death|9|||
155082479|NCT00382863|559733216|FG001|Overall Study|Death|9|||
155082480|NCT00382863|559733215|FG000|Overall Study|Lost to Follow-up|1|||
155082481|NCT00382863|559733216|FG001|Overall Study|Lost to Follow-up|2|||
155082482|NCT00382863|559733215|FG000|Overall Study|Withdrawal by Subject|5|||
155082483|NCT00382863|559733216|FG001|Overall Study|Withdrawal by Subject|25|||
155082484|NCT03400787|559733217|FG000|Overall Study|Lost to Follow-up|1|||
155082485|NCT03400787|559733218|FG001|Overall Study|Lost to Follow-up|0|||
155082486|NCT03400787|559733217|FG000|Overall Study|Death|1|||
155082487|NCT03400787|559733218|FG001|Overall Study|Death|0|||
155082488|NCT03400787|559733217|FG000|Overall Study|Protocol Violation|0|||
155082489|NCT03400787|559733218|FG001|Overall Study|Protocol Violation|2|||
155082490|NCT03400787|559733217|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
155082491|NCT03400787|559733218|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
155082492|NCT00449787|559733221|FG000|Overall Study|Lost to Follow-up|10|||
155082493|NCT00449787|559733222|FG001|Overall Study|Lost to Follow-up|8|||
155082494|NCT00449787|559733221|FG000|Overall Study|Did not require medication|95|||
155082495|NCT00449787|559733222|FG001|Overall Study|Did not require medication|92|||
155082496|NCT02595437|559733224|FG000|Triferic Via IV|Withdrawal by Subject|1|||
155082497|NCT03574389|559733226|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
155082498|NCT03574389|559733227|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
155082499|NCT03574389|559733228|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
155082500|NCT03574389|559733229|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
155082501|NCT03574389|559733230|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
155082502|NCT03574389|559733231|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
155082503|NCT03574389|559733232|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
155082504|NCT03574389|559733226|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
155082505|NCT03574389|559733227|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
155082506|NCT03574389|559733228|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
155082507|NCT03574389|559733229|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
155082508|NCT03574389|559733230|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
155082509|NCT03574389|559733231|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
155082510|NCT03574389|559733232|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
155082511|NCT03574389|559733226|FG000|Vaccination Period|Other|6|||
155082512|NCT03574389|559733227|FG001|Vaccination Period|Other|0|||
155347833|NCT01475370|560706539|FG002|Overall Study|Study drug administration difficult|1|||
155347834|NCT01475370|560706537|FG000|Overall Study|Other than specified|1|||
155347835|NCT01475370|560706538|FG001|Overall Study|Other than specified|0|||
155347836|NCT01475370|560706539|FG002|Overall Study|Other than specified|0|||
155347837|NCT02538471|560706540|FG000|Overall Study|Progression of disease|2|||
155347838|NCT00475735|560706541|FG000|Treatment Period 1|Adverse Event|2|||
155347839|NCT00475735|560706542|FG001|Treatment Period 1|Adverse Event|0|||
155347840|NCT00475735|560706543|FG002|Treatment Period 1|Adverse Event|0|||
155347841|NCT00475735|560706544|FG003|Treatment Period 1|Adverse Event|0|||
155082513|NCT03574389|559733228|FG002|Vaccination Period|Other|0|||
155082514|NCT03574389|559733229|FG003|Vaccination Period|Other|0|||
155082515|NCT03574389|559733230|FG004|Vaccination Period|Other|0|||
155082516|NCT03574389|559733231|FG005|Vaccination Period|Other|0|||
155082517|NCT03574389|559733232|FG006|Vaccination Period|Other|0|||
155082518|NCT03574389|559733226|FG000|Vaccination Period|Adverse Event|0|||
155082519|NCT03574389|559733227|FG001|Vaccination Period|Adverse Event|1|||
155082520|NCT03574389|559733228|FG002|Vaccination Period|Adverse Event|0|||
155082521|NCT03574389|559733229|FG003|Vaccination Period|Adverse Event|0|||
155082522|NCT03574389|559733230|FG004|Vaccination Period|Adverse Event|0|||
155082523|NCT03574389|559733231|FG005|Vaccination Period|Adverse Event|0|||
155082524|NCT03574389|559733232|FG006|Vaccination Period|Adverse Event|0|||
155082525|NCT03574389|559733226|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
155347842|NCT00475735|560706545|FG004|Treatment Period 1|Adverse Event|0|||
155082526|NCT03574389|559733227|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
155082527|NCT03574389|559733228|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
155082528|NCT03574389|559733229|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
155082529|NCT03574389|559733230|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
155082530|NCT03574389|559733231|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
155347843|NCT00475735|560706546|FG005|Treatment Period 1|Adverse Event|0|||
155082531|NCT03574389|559733232|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
155082532|NCT05166902|559733233|FG000|First Intervention|Lost to Follow-up|0|||
155082533|NCT05166902|559733234|FG001|First Intervention|Lost to Follow-up|1|||
155082534|NCT03436420|559733235|FG000|Overall Study|Lack of Efficacy|3|||
155082535|NCT00159874|559733236|FG000|Overall Study|Adverse Event|2|||
155082536|NCT00159874|559733237|FG001|Overall Study|Adverse Event|2|||
155082537|NCT00159874|559733238|FG002|Overall Study|Adverse Event|5|||
155082538|NCT00159874|559733239|FG003|Overall Study|Adverse Event|1|||
155082539|NCT00159874|559733240|FG004|Overall Study|Adverse Event|1|||
155082540|NCT00159874|559733241|FG005|Overall Study|Adverse Event|2|||
155082541|NCT00159874|559733242|FG006|Overall Study|Adverse Event|0|||
155082542|NCT00159874|559733236|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
155082543|NCT00159874|559733237|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
155082544|NCT00159874|559733238|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
155082545|NCT00159874|559733239|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
155082546|NCT00159874|559733240|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
155082547|NCT00159874|559733241|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
155082548|NCT00159874|559733242|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
155347844|NCT00475735|560706541|FG000|Treatment Period 1|Lack of Efficacy|1|||
155347845|NCT00475735|560706542|FG001|Treatment Period 1|Lack of Efficacy|0|||
155347846|NCT00475735|560706543|FG002|Treatment Period 1|Lack of Efficacy|0|||
155347847|NCT00475735|560706544|FG003|Treatment Period 1|Lack of Efficacy|0|||
155347848|NCT00475735|560706545|FG004|Treatment Period 1|Lack of Efficacy|0|||
155347849|NCT00475735|560706546|FG005|Treatment Period 1|Lack of Efficacy|0|||
155347850|NCT00475735|560706541|FG000|Treatment Period 1|Lost to Follow-up|0|||
155347851|NCT00475735|560706542|FG001|Treatment Period 1|Lost to Follow-up|0|||
155347852|NCT00475735|560706543|FG002|Treatment Period 1|Lost to Follow-up|0|||
155347853|NCT00475735|560706544|FG003|Treatment Period 1|Lost to Follow-up|0|||
155347854|NCT00475735|560706545|FG004|Treatment Period 1|Lost to Follow-up|0|||
155347855|NCT00475735|560706546|FG005|Treatment Period 1|Lost to Follow-up|1|||
155347856|NCT00475735|560706541|FG000|Treatment Period 1|Protocol Violation|0|||
155347857|NCT00475735|560706542|FG001|Treatment Period 1|Protocol Violation|0|||
155347858|NCT00475735|560706543|FG002|Treatment Period 1|Protocol Violation|0|||
155347859|NCT00475735|560706544|FG003|Treatment Period 1|Protocol Violation|1|||
155347860|NCT00475735|560706545|FG004|Treatment Period 1|Protocol Violation|0|||
155347861|NCT00475735|560706546|FG005|Treatment Period 1|Protocol Violation|0|||
155082549|NCT00159874|559733236|FG000|Overall Study|Lack of Efficacy|2|||
155347862|NCT00475735|560706541|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155082550|NCT00159874|559733237|FG001|Overall Study|Lack of Efficacy|0|||
155082551|NCT00159874|559733238|FG002|Overall Study|Lack of Efficacy|1|||
155082552|NCT00159874|559733239|FG003|Overall Study|Lack of Efficacy|1|||
155082553|NCT00159874|559733240|FG004|Overall Study|Lack of Efficacy|0|||
155165560|NCT01396447|560043484|FG003|Overall Study|Protocol Violation|7|||
155347863|NCT00475735|560706542|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155347864|NCT00475735|560706543|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155347865|NCT00475735|560706544|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155347866|NCT00475735|560706545|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155082554|NCT00159874|559733241|FG005|Overall Study|Lack of Efficacy|3|||
155082555|NCT00159874|559733242|FG006|Overall Study|Lack of Efficacy|0|||
155082556|NCT00159874|559733236|FG000|Overall Study|Lost to Follow-up|1|||
155082557|NCT00159874|559733237|FG001|Overall Study|Lost to Follow-up|0|||
155082558|NCT00159874|559733238|FG002|Overall Study|Lost to Follow-up|3|||
155082559|NCT00159874|559733239|FG003|Overall Study|Lost to Follow-up|0|||
155082560|NCT00159874|559733240|FG004|Overall Study|Lost to Follow-up|1|||
155082561|NCT00159874|559733241|FG005|Overall Study|Lost to Follow-up|2|||
155082562|NCT00159874|559733242|FG006|Overall Study|Lost to Follow-up|1|||
155082563|NCT00159874|559733236|FG000|Overall Study|Other|8|||
155082564|NCT00159874|559733237|FG001|Overall Study|Other|8|||
155082565|NCT00159874|559733238|FG002|Overall Study|Other|8|||
155082566|NCT00159874|559733239|FG003|Overall Study|Other|0|||
155082567|NCT00159874|559733240|FG004|Overall Study|Other|2|||
155082568|NCT00159874|559733241|FG005|Overall Study|Other|1|||
155082569|NCT00159874|559733242|FG006|Overall Study|Other|3|||
155082570|NCT00159874|559733236|FG000|Overall Study|Protocol Violation|0|||
155082571|NCT00159874|559733237|FG001|Overall Study|Protocol Violation|5|||
155082572|NCT00159874|559733238|FG002|Overall Study|Protocol Violation|2|||
155082573|NCT00159874|559733239|FG003|Overall Study|Protocol Violation|0|||
155347867|NCT00475735|560706546|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155347868|NCT00475735|560706541|FG000|Treatment Period 1|DC due to AE but continuing|0|||
155347869|NCT00475735|560706542|FG001|Treatment Period 1|DC due to AE but continuing|0|||
155347870|NCT00475735|560706543|FG002|Treatment Period 1|DC due to AE but continuing|0|||
155347871|NCT00475735|560706544|FG003|Treatment Period 1|DC due to AE but continuing|1|||
155347872|NCT00475735|560706545|FG004|Treatment Period 1|DC due to AE but continuing|2|||
155347873|NCT00475735|560706546|FG005|Treatment Period 1|DC due to AE but continuing|2|||
155347874|NCT00475735|560706541|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347875|NCT00475735|560706542|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
155347876|NCT00475735|560706543|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347877|NCT00475735|560706544|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347878|NCT00475735|560706545|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347879|NCT00475735|560706546|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
155347880|NCT00475735|560706541|FG000|Treatment Washout|Lost to Follow-up|0|||
155347881|NCT00475735|560706542|FG001|Treatment Washout|Lost to Follow-up|1|||
155347882|NCT00475735|560706543|FG002|Treatment Washout|Lost to Follow-up|0|||
155347883|NCT00475735|560706544|FG003|Treatment Washout|Lost to Follow-up|0|||
155347884|NCT00475735|560706545|FG004|Treatment Washout|Lost to Follow-up|0|||
155347885|NCT00475735|560706546|FG005|Treatment Washout|Lost to Follow-up|0|||
155347886|NCT00475735|560706541|FG000|Treatment Washout|Protocol Violation|0|||
155347887|NCT00475735|560706542|FG001|Treatment Washout|Protocol Violation|1|||
155347888|NCT00475735|560706543|FG002|Treatment Washout|Protocol Violation|0|||
155347889|NCT00475735|560706544|FG003|Treatment Washout|Protocol Violation|0|||
155347890|NCT00475735|560706545|FG004|Treatment Washout|Protocol Violation|0|||
155347891|NCT00475735|560706546|FG005|Treatment Washout|Protocol Violation|0|||
155347892|NCT00475735|560706541|FG000|Treatment Period 2|Adverse Event|0|||
155347893|NCT00475735|560706542|FG001|Treatment Period 2|Adverse Event|1|||
155347894|NCT00475735|560706543|FG002|Treatment Period 2|Adverse Event|0|||
155347895|NCT00475735|560706544|FG003|Treatment Period 2|Adverse Event|2|||
155347896|NCT00475735|560706545|FG004|Treatment Period 2|Adverse Event|0|||
155347897|NCT00475735|560706546|FG005|Treatment Period 2|Adverse Event|0|||
155347898|NCT00475735|560706541|FG000|Treatment Period 2|Lack of Efficacy|0|||
155347899|NCT00475735|560706542|FG001|Treatment Period 2|Lack of Efficacy|0|||
155347900|NCT00475735|560706543|FG002|Treatment Period 2|Lack of Efficacy|0|||
155347901|NCT00475735|560706544|FG003|Treatment Period 2|Lack of Efficacy|0|||
155347902|NCT00475735|560706545|FG004|Treatment Period 2|Lack of Efficacy|0|||
155347903|NCT00475735|560706546|FG005|Treatment Period 2|Lack of Efficacy|1|||
155347904|NCT00475735|560706541|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155347905|NCT00475735|560706542|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155347906|NCT00475735|560706543|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155347907|NCT00475735|560706544|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155347908|NCT00475735|560706545|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155347909|NCT00475735|560706546|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155347910|NCT03132753|560706547|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
155347911|NCT03132753|560706548|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
155347912|NCT03132753|560706547|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
155347913|NCT03132753|560706548|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
155347914|NCT00084747|560706549|FG000|Overall Study|Relapsed|8|||
155347915|NCT00084747|560706549|FG000|Overall Study|Death|3|||
155347916|NCT00084747|560706549|FG000|Overall Study|Withdrawal by Subject|2|||
155347917|NCT00679549|560706551|FG000|Overall Study|dropout|2|||
155347918|NCT00679549|560706552|FG001|Overall Study|dropout|4|||
155347919|NCT00679549|560706551|FG000|Overall Study|missing outcome echocardiograms|4|||
155347920|NCT00679549|560706552|FG001|Overall Study|missing outcome echocardiograms|5|||
155347921|NCT02350127|560706556|FG000|4-Month Assessment|Withdrawal by Subject|10|||
155347922|NCT02350127|560706557|FG001|4-Month Assessment|Withdrawal by Subject|9|||
155347923|NCT02350127|560706556|FG000|4-Month Assessment|Death|1|||
155347924|NCT02350127|560706557|FG001|4-Month Assessment|Death|0|||
155347925|NCT02350127|560706556|FG000|8-Month Assessment|Death|1|||
155347926|NCT02350127|560706557|FG001|8-Month Assessment|Death|1|||
155165561|NCT01396447|560043481|FG000|Overall Study|Withdrawal of Consent|11|||
155165562|NCT01396447|560043482|FG001|Overall Study|Withdrawal of Consent|9|||
155347927|NCT02350127|560706556|FG000|8-Month Assessment|Withdrawal by Subject|5|||
155347928|NCT02350127|560706557|FG001|8-Month Assessment|Withdrawal by Subject|8|||
155347929|NCT00157209|560706558|FG000|Overall Study|Ongoing at data cut-off|10|||
155082574|NCT00159874|559733240|FG004|Overall Study|Protocol Violation|0|||
155082575|NCT00159874|559733241|FG005|Overall Study|Protocol Violation|0|||
155082576|NCT00159874|559733242|FG006|Overall Study|Protocol Violation|0|||
155082577|NCT00159874|559733236|FG000|Overall Study|Death|3|||
155082578|NCT00159874|559733237|FG001|Overall Study|Death|8|||
155082579|NCT00159874|559733238|FG002|Overall Study|Death|15|||
155082580|NCT00159874|559733239|FG003|Overall Study|Death|0|||
155082581|NCT00159874|559733240|FG004|Overall Study|Death|1|||
155082582|NCT00159874|559733241|FG005|Overall Study|Death|2|||
155082583|NCT00159874|559733242|FG006|Overall Study|Death|0|||
155082584|NCT00159874|559733236|FG000|Overall Study|Withdrawal by Subject|2|||
155082585|NCT00159874|559733237|FG001|Overall Study|Withdrawal by Subject|6|||
155082586|NCT00159874|559733238|FG002|Overall Study|Withdrawal by Subject|8|||
155082587|NCT00159874|559733239|FG003|Overall Study|Withdrawal by Subject|4|||
155082588|NCT00159874|559733240|FG004|Overall Study|Withdrawal by Subject|3|||
155082589|NCT00159874|559733241|FG005|Overall Study|Withdrawal by Subject|2|||
155082590|NCT00159874|559733242|FG006|Overall Study|Withdrawal by Subject|1|||
155082591|NCT00159874|559733236|FG000|Overall Study|Pregnancy|1|||
155082592|NCT00159874|559733237|FG001|Overall Study|Pregnancy|1|||
155082593|NCT00159874|559733238|FG002|Overall Study|Pregnancy|0|||
155082594|NCT00159874|559733239|FG003|Overall Study|Pregnancy|0|||
155082595|NCT00159874|559733240|FG004|Overall Study|Pregnancy|0|||
155082596|NCT00159874|559733241|FG005|Overall Study|Pregnancy|0|||
155082597|NCT00159874|559733242|FG006|Overall Study|Pregnancy|0|||
155082598|NCT01104870|559733243|FG000|Overall Study|Adverse Event|1|||
155082599|NCT01104870|559733244|FG001|Overall Study|Adverse Event|1|||
155347930|NCT00157209|560706559|FG001|Overall Study|Ongoing at data cut-off|0|||
155347931|NCT04474691|560706560|FG000|Overall Study|Withdrawal by Subject|9|||
155347932|NCT00274846|560706566|FG000|Overall Study|Did not receive adequate NK cells|1|||
155347933|NCT00050167|560706573|FG000|Overall Study|not eligible not invasive|1|||
155347934|NCT00050167|560706574|FG001|Overall Study|not eligible not invasive|1|||
155347935|NCT02038803|560706578|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
155347936|NCT02038803|560706578|FG000|Overall Study|Lost to Follow-up|1|||
155347937|NCT04754594|560706579|FG000|Blinded Period|Withdrawal by Subject|4|||
155347938|NCT04754594|560706580|FG001|Blinded Period|Withdrawal by Subject|9|||
155347939|NCT04754594|560706581|FG002|Blinded Period|Withdrawal by Subject|0|||
155347940|NCT04754594|560706582|FG003|Blinded Period|Withdrawal by Subject|0|||
155347941|NCT04754594|560706579|FG000|Blinded Period|Protocol Violation|2|||
155347942|NCT04754594|560706580|FG001|Blinded Period|Protocol Violation|2|||
155347943|NCT04754594|560706581|FG002|Blinded Period|Protocol Violation|0|||
155347944|NCT04754594|560706582|FG003|Blinded Period|Protocol Violation|0|||
155347945|NCT04754594|560706579|FG000|Blinded Period|Lost to Follow-up|1|||
155347946|NCT04754594|560706580|FG001|Blinded Period|Lost to Follow-up|1|||
155347947|NCT04754594|560706581|FG002|Blinded Period|Lost to Follow-up|0|||
155347948|NCT04754594|560706582|FG003|Blinded Period|Lost to Follow-up|0|||
155347949|NCT04754594|560706579|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
155347950|NCT04754594|560706580|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
155347951|NCT04754594|560706581|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
155347952|NCT04754594|560706582|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
155347953|NCT04754594|560706579|FG000|Unblinded Period|Withdrawal by Subject|6|||
155347954|NCT04754594|560706580|FG001|Unblinded Period|Withdrawal by Subject|8|||
155347955|NCT04754594|560706581|FG002|Unblinded Period|Withdrawal by Subject|0|||
155347956|NCT04754594|560706582|FG003|Unblinded Period|Withdrawal by Subject|0|||
154964139|NCT00772603|559295182|FG000|Overall Study|Physician Decision|0|||
155082600|NCT01104870|559733245|FG002|Overall Study|Adverse Event|0|||
155082601|NCT01104870|559733243|FG000|Overall Study|Death|0|||
155082602|NCT01104870|559733244|FG001|Overall Study|Death|0|||
155082603|NCT01104870|559733245|FG002|Overall Study|Death|1|||
155082604|NCT01104870|559733243|FG000|Overall Study|Withdrawal by Subject|0|||
155082605|NCT01104870|559733244|FG001|Overall Study|Withdrawal by Subject|0|||
155082606|NCT01104870|559733245|FG002|Overall Study|Withdrawal by Subject|1|||
155082607|NCT02150863|559733246|FG000|Overall Study|Lost to Follow-up|0|||
155082608|NCT02150863|559733247|FG001|Overall Study|Lost to Follow-up|1|||
155082609|NCT02150863|559733248|FG002|Overall Study|Lost to Follow-up|0|||
155082610|NCT01853280|559733249|FG000|Overall Study|Lack of Efficacy|2|||
155082611|NCT01853280|559733250|FG001|Overall Study|Lack of Efficacy|2|||
155082612|NCT01853280|559733249|FG000|Overall Study|Lost to Follow-up|0|||
154964140|NCT00772603|559295183|FG001|Overall Study|Physician Decision|0|||
155082613|NCT01853280|559733250|FG001|Overall Study|Lost to Follow-up|1|||
155082614|NCT01853280|559733249|FG000|Overall Study|Physician Decision|0|||
155082615|NCT01853280|559733250|FG001|Overall Study|Physician Decision|1|||
155082616|NCT01853280|559733249|FG000|Overall Study|Withdrawal by Subject|0|||
155082617|NCT01853280|559733250|FG001|Overall Study|Withdrawal by Subject|1|||
155082618|NCT01853280|559733249|FG000|Overall Study|Ineligible|0|||
154964141|NCT00772603|559295184|FG002|Overall Study|Physician Decision|1|||
155082619|NCT01853280|559733250|FG001|Overall Study|Ineligible|1|||
155082620|NCT00835549|559733253|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
155082621|NCT00835549|559733254|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155082622|NCT00835042|559733255|FG000|First Intervention|Withdrawal by Subject|3|||
155165563|NCT01396447|560043483|FG002|Overall Study|Withdrawal of Consent|4|||
155165564|NCT01396447|560043484|FG003|Overall Study|Withdrawal of Consent|15|||
155165565|NCT01396447|560043481|FG000|Overall Study|Lost to Follow-up|4|||
155165566|NCT01396447|560043482|FG001|Overall Study|Lost to Follow-up|8|||
155165567|NCT01396447|560043483|FG002|Overall Study|Lost to Follow-up|7|||
155165568|NCT01396447|560043484|FG003|Overall Study|Lost to Follow-up|9|||
155165569|NCT01396447|560043481|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155082623|NCT00835042|559733256|FG001|First Intervention|Withdrawal by Subject|0|||
155082624|NCT00835042|559733255|FG000|First Intervention|Adverse Event|1|||
155165570|NCT01396447|560043482|FG001|Overall Study|Other Miscellaneous Reasons|2|||
155165571|NCT01396447|560043483|FG002|Overall Study|Other Miscellaneous Reasons|1|||
155165572|NCT01396447|560043484|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155347957|NCT04754594|560706579|FG000|Unblinded Period|Lost to Follow-up|5|||
155347958|NCT04754594|560706580|FG001|Unblinded Period|Lost to Follow-up|3|||
155347959|NCT04754594|560706581|FG002|Unblinded Period|Lost to Follow-up|0|||
155347960|NCT04754594|560706582|FG003|Unblinded Period|Lost to Follow-up|0|||
155347961|NCT04754594|560706579|FG000|Unblinded Period|Protocol Violation|2|||
155347962|NCT04754594|560706580|FG001|Unblinded Period|Protocol Violation|4|||
155347963|NCT04754594|560706581|FG002|Unblinded Period|Protocol Violation|0|||
155347964|NCT04754594|560706582|FG003|Unblinded Period|Protocol Violation|0|||
155347965|NCT04754594|560706579|FG000|Unblinded Period|Other|3|||
155347966|NCT04754594|560706580|FG001|Unblinded Period|Other|0|||
155347967|NCT04754594|560706581|FG002|Unblinded Period|Other|0|||
155347968|NCT04754594|560706582|FG003|Unblinded Period|Other|0|||
155082625|NCT00835042|559733256|FG001|First Intervention|Adverse Event|2|||
155165573|NCT01402102|560043486|FG000|Overall Study|Protocol Violation|1|||
155165574|NCT01402102|560043487|FG001|Overall Study|Protocol Violation|0|||
155165575|NCT01402102|560043486|FG000|Overall Study|Insufficiency of compliance|1|||
155347969|NCT04754594|560706579|FG000|Infant Participants|Withdrawal by Subject|0|||
155347970|NCT04754594|560706580|FG001|Infant Participants|Withdrawal by Subject|0|||
155347971|NCT04754594|560706581|FG002|Infant Participants|Withdrawal by Subject|9|||
155347972|NCT04754594|560706582|FG003|Infant Participants|Withdrawal by Subject|17|||
155347973|NCT04754594|560706579|FG000|Infant Participants|Lost to Follow-up|0|||
155347974|NCT04754594|560706580|FG001|Infant Participants|Lost to Follow-up|0|||
155347975|NCT04754594|560706581|FG002|Infant Participants|Lost to Follow-up|4|||
155347976|NCT04754594|560706582|FG003|Infant Participants|Lost to Follow-up|10|||
155347977|NCT04754594|560706579|FG000|Infant Participants|Death|0|||
154964142|NCT00772603|559295182|FG000|Overall Study|Other|2|||
155082626|NCT00835042|559733255|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
155347978|NCT04754594|560706580|FG001|Infant Participants|Death|0|||
155347979|NCT04754594|560706581|FG002|Infant Participants|Death|1|||
155347980|NCT04754594|560706582|FG003|Infant Participants|Death|1|||
155347981|NCT04754594|560706579|FG000|Infant Participants|Other|0|||
155347982|NCT04754594|560706580|FG001|Infant Participants|Other|0|||
155347983|NCT04754594|560706581|FG002|Infant Participants|Other|1|||
155347984|NCT04754594|560706582|FG003|Infant Participants|Other|1|||
155347985|NCT01247922|560706583|FG000|Overall Study|Disease progression|4|||
155347986|NCT04372186|560706584|FG000|Overall Study|Death|24|||
155347987|NCT04372186|560706585|FG001|Overall Study|Death|11|||
155347988|NCT04372186|560706584|FG000|Overall Study|Transferred to a different facility for care|0|||
155347989|NCT04372186|560706585|FG001|Overall Study|Transferred to a different facility for care|2|||
155347990|NCT04736472|560706586|FG000|Overall Study|Lost to Follow-up|1|||
155347991|NCT04736472|560706587|FG001|Overall Study|Lost to Follow-up|0|||
155347992|NCT04736472|560706588|FG002|Overall Study|Lost to Follow-up|0|||
155347993|NCT04736472|560706586|FG000|Overall Study|Withdrawal by Subject|2|||
155347994|NCT04736472|560706587|FG001|Overall Study|Withdrawal by Subject|0|||
155347995|NCT04736472|560706588|FG002|Overall Study|Withdrawal by Subject|0|||
155347996|NCT04736472|560706586|FG000|Overall Study|Protocol Violation|48|||
155347997|NCT04736472|560706587|FG001|Overall Study|Protocol Violation|0|||
155347998|NCT04736472|560706588|FG002|Overall Study|Protocol Violation|6|||
155347999|NCT01911819|560706591|FG000|Overall Study|Adverse Event|0|||
155348000|NCT01911819|560706592|FG001|Overall Study|Adverse Event|1|||
155348001|NCT01911819|560706593|FG002|Overall Study|Adverse Event|0|||
155348002|NCT01911819|560706591|FG000|Overall Study|Withdrawal by Subject|1|||
155348003|NCT01911819|560706592|FG001|Overall Study|Withdrawal by Subject|1|||
155348004|NCT01911819|560706593|FG002|Overall Study|Withdrawal by Subject|0|||
155348005|NCT04374253|560706594|FG000|Overall Study|Adverse Event|0|||
155348006|NCT04374253|560706595|FG001|Overall Study|Adverse Event|26|||
155348007|NCT04374253|560706596|FG002|Overall Study|Adverse Event|2|||
155348008|NCT04374253|560706597|FG003|Overall Study|Adverse Event|12|||
155348009|NCT04374253|560706594|FG000|Overall Study|Study terminated by sponsor|13|||
155348010|NCT04374253|560706595|FG001|Overall Study|Study terminated by sponsor|593|||
155348011|NCT04374253|560706596|FG002|Overall Study|Study terminated by sponsor|21|||
155348012|NCT04374253|560706597|FG003|Overall Study|Study terminated by sponsor|567|||
155348013|NCT04374253|560706594|FG000|Overall Study|Withdrawal by Subject|0|||
155348014|NCT04374253|560706595|FG001|Overall Study|Withdrawal by Subject|55|||
155348015|NCT04374253|560706596|FG002|Overall Study|Withdrawal by Subject|3|||
155348016|NCT04374253|560706597|FG003|Overall Study|Withdrawal by Subject|40|||
155348017|NCT04374253|560706594|FG000|Overall Study|Physician Decision|1|||
155348018|NCT04374253|560706595|FG001|Overall Study|Physician Decision|10|||
155348019|NCT04374253|560706596|FG002|Overall Study|Physician Decision|1|||
155348020|NCT04374253|560706597|FG003|Overall Study|Physician Decision|10|||
155082627|NCT00835042|559733256|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
155082628|NCT03760081|559733270|FG000|Overall Study|Miscellaneous|0|||
155082629|NCT03760081|559733271|FG001|Overall Study|Miscellaneous|1|||
155082630|NCT03760081|559733270|FG000|Overall Study|Progressive Disease|5|||
155082631|NCT03760081|559733271|FG001|Overall Study|Progressive Disease|10|||
155082632|NCT03760081|559733270|FG000|Overall Study|Death|1|||
155082633|NCT03760081|559733271|FG001|Overall Study|Death|1|||
155082634|NCT00986102|559733272|FG000|Overall Study|Lost to Follow-up|0|||
155082635|NCT00986102|559733273|FG001|Overall Study|Lost to Follow-up|1|||
155082636|NCT00986102|559733274|FG002|Overall Study|Lost to Follow-up|0|||
155082637|NCT00986102|559733275|FG003|Overall Study|Lost to Follow-up|1|||
155082638|NCT00986102|559733272|FG000|Overall Study|Withdrawal by Subject|1|||
155082639|NCT00986102|559733273|FG001|Overall Study|Withdrawal by Subject|1|||
155082640|NCT00986102|559733274|FG002|Overall Study|Withdrawal by Subject|0|||
155082641|NCT00986102|559733275|FG003|Overall Study|Withdrawal by Subject|0|||
155082642|NCT04008069|559733276|FG000|Open-Label Period|Adverse Event|1|||
155082643|NCT04008069|559733277|FG001|Open-Label Period|Adverse Event|0|||
155082644|NCT04008069|559733278|FG002|Open-Label Period|Adverse Event|0|||
155082645|NCT04008069|559733276|FG000|Open-Label Period|Lack of Efficacy|4|||
155082646|NCT04008069|559733277|FG001|Open-Label Period|Lack of Efficacy|0|||
155348021|NCT04374253|560706594|FG000|Overall Study|Protocol Violation|0|||
155348022|NCT04374253|560706595|FG001|Overall Study|Protocol Violation|0|||
155348023|NCT04374253|560706596|FG002|Overall Study|Protocol Violation|0|||
155348024|NCT04374253|560706597|FG003|Overall Study|Protocol Violation|2|||
155348025|NCT04374253|560706594|FG000|Overall Study|Death|0|||
155348026|NCT04374253|560706595|FG001|Overall Study|Death|3|||
155348027|NCT04374253|560706596|FG002|Overall Study|Death|1|||
155348028|NCT04374253|560706597|FG003|Overall Study|Death|1|||
155348029|NCT04374253|560706594|FG000|Overall Study|Lack of Efficacy|0|||
155348030|NCT04374253|560706595|FG001|Overall Study|Lack of Efficacy|0|||
155082647|NCT04008069|559733278|FG002|Open-Label Period|Lack of Efficacy|0|||
155082648|NCT04008069|559733276|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
155348031|NCT04374253|560706596|FG002|Overall Study|Lack of Efficacy|0|||
155348032|NCT04374253|560706597|FG003|Overall Study|Lack of Efficacy|1|||
155348033|NCT04374253|560706594|FG000|Overall Study|Lost to Follow-up|1|||
155348034|NCT04374253|560706595|FG001|Overall Study|Lost to Follow-up|1|||
155348035|NCT04374253|560706596|FG002|Overall Study|Lost to Follow-up|0|||
155348036|NCT04374253|560706597|FG003|Overall Study|Lost to Follow-up|2|||
155082649|NCT04008069|559733277|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
155082650|NCT04008069|559733278|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
155082651|NCT04008069|559733276|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
155082652|NCT04008069|559733277|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
155082653|NCT04008069|559733278|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
155082654|NCT00511199|559733279|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
155082655|NCT00511199|559733280|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
155082656|NCT00511199|559733279|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
155082657|NCT00511199|559733280|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
155082658|NCT00511199|559733279|FG000|Overall Study|Withdrawal of Informed Consent|19|||
155082659|NCT00511199|559733280|FG001|Overall Study|Withdrawal of Informed Consent|4|||
155082660|NCT00511199|559733279|FG000|Overall Study|Pregnancy|6|||
155082661|NCT00511199|559733280|FG001|Overall Study|Pregnancy|3|||
155082662|NCT00511199|559733279|FG000|Overall Study|Pregnancy Wish|16|||
155082663|NCT00511199|559733280|FG001|Overall Study|Pregnancy Wish|8|||
155082664|NCT00511199|559733279|FG000|Overall Study|Lost to Follow-up|40|||
155082665|NCT00511199|559733280|FG001|Overall Study|Lost to Follow-up|17|||
155082666|NCT00511199|559733279|FG000|Overall Study|Other Reason|78|||
155082667|NCT00511199|559733280|FG001|Overall Study|Other Reason|37|||
155082668|NCT02314247|559733288|FG000|Overall Study|Adverse Event|2|||
155082669|NCT02314247|559733289|FG001|Overall Study|Adverse Event|1|||
155082670|NCT02314247|559733290|FG002|Overall Study|Adverse Event|0|||
155082671|NCT02314247|559733288|FG000|Overall Study|Withdrawal by Subject|1|||
155082672|NCT02314247|559733289|FG001|Overall Study|Withdrawal by Subject|3|||
155082673|NCT02314247|559733290|FG002|Overall Study|Withdrawal by Subject|1|||
155082674|NCT02314247|559733288|FG000|Overall Study|Progression of Disease|6|||
155082675|NCT02314247|559733289|FG001|Overall Study|Progression of Disease|2|||
155082676|NCT02314247|559733290|FG002|Overall Study|Progression of Disease|0|||
155082677|NCT01953354|559733291|FG000|Overall Study|Withdrawal by Subject|0|||
155082678|NCT01953354|559733292|FG001|Overall Study|Withdrawal by Subject|1|||
155082679|NCT01953354|559733291|FG000|Overall Study|Decision of Sponsor|0|||
155082680|NCT01953354|559733292|FG001|Overall Study|Decision of Sponsor|1|||
155082681|NCT01953354|559733291|FG000|Overall Study|Disease Exacerbation|1|||
155082682|NCT01953354|559733292|FG001|Overall Study|Disease Exacerbation|0|||
155082683|NCT00489359|559733295|FG000|Overall Study|Death|0|||
155082684|NCT00489359|559733296|FG001|Overall Study|Death|2|||
155082685|NCT00489359|559733295|FG000|Overall Study|Progressive Disease|5|||
155082686|NCT00489359|559733296|FG001|Overall Study|Progressive Disease|6|||
155082687|NCT00489359|559733295|FG000|Overall Study|Lost to Follow-up|1|||
155082688|NCT00489359|559733296|FG001|Overall Study|Lost to Follow-up|0|||
155082689|NCT00489359|559733295|FG000|Overall Study|Withdrawal by Subject|1|||
155082690|NCT00489359|559733296|FG001|Overall Study|Withdrawal by Subject|5|||
155082691|NCT00489359|559733295|FG000|Overall Study|Adverse Event|0|||
155082692|NCT00489359|559733296|FG001|Overall Study|Adverse Event|16|||
155082693|NCT03180138|559733297|FG000|Overall Study|Mobile-phone could not be verified|2|||
155082694|NCT03180138|559733298|FG001|Overall Study|Mobile-phone could not be verified|13|||
155082695|NCT03180138|559733299|FG002|Overall Study|Mobile-phone could not be verified|15|||
155082696|NCT03180138|559733297|FG000|Overall Study|No prior immunization records|17|||
155082697|NCT03180138|559733298|FG001|Overall Study|No prior immunization records|0|||
155082698|NCT03180138|559733299|FG002|Overall Study|No prior immunization records|6|||
155082699|NCT03180138|559733297|FG000|Overall Study|Found to be >24 mon after randomization|3|||
155082700|NCT03180138|559733298|FG001|Overall Study|Found to be >24 mon after randomization|0|||
155082701|NCT03180138|559733299|FG002|Overall Study|Found to be >24 mon after randomization|3|||
155082702|NCT01260311|559733300|FG000|Overall Study|Adverse Event|11|||
155082703|NCT01260311|559733300|FG000|Overall Study|Lack of Efficacy|4|||
155082704|NCT01260311|559733300|FG000|Overall Study|Lost to Follow-up|25|||
155082705|NCT01260311|559733300|FG000|Overall Study|Withdrawal by Subject|6|||
155082706|NCT01260311|559733300|FG000|Overall Study|Financial Constraints|77|||
155082707|NCT01260311|559733300|FG000|Overall Study|Gone to Province|2|||
155082708|NCT01260311|559733300|FG000|Overall Study|Medication Stopped|1|||
155082709|NCT01260311|559733300|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
155082710|NCT01903733|559733301|FG000|Overall Study|Death|23|||
155082711|NCT01903733|559733302|FG001|Overall Study|Death|54|||
155082712|NCT01903733|559733303|FG002|Overall Study|Death|30|||
155082713|NCT01903733|559733304|FG003|Overall Study|Death|98|||
155082714|NCT01903733|559733301|FG000|Overall Study|Participant refused further follow-up|35|||
155082715|NCT01903733|559733302|FG001|Overall Study|Participant refused further follow-up|38|||
155082716|NCT01903733|559733303|FG002|Overall Study|Participant refused further follow-up|13|||
155082717|NCT01903733|559733304|FG003|Overall Study|Participant refused further follow-up|9|||
155082718|NCT01903733|559733301|FG000|Overall Study|Lost to Follow-up|18|||
155082719|NCT01903733|559733302|FG001|Overall Study|Lost to Follow-up|19|||
155082720|NCT01903733|559733303|FG002|Overall Study|Lost to Follow-up|6|||
155082721|NCT01903733|559733304|FG003|Overall Study|Lost to Follow-up|9|||
155082722|NCT01903733|559733301|FG000|Overall Study|Other|10|||
155082723|NCT01903733|559733302|FG001|Overall Study|Other|15|||
155082724|NCT01903733|559733303|FG002|Overall Study|Other|12|||
155082725|NCT01903733|559733304|FG003|Overall Study|Other|3|||
155082726|NCT01903733|559733301|FG000|Overall Study|Missing|2|||
155082727|NCT01903733|559733302|FG001|Overall Study|Missing|0|||
155082728|NCT01903733|559733303|FG002|Overall Study|Missing|0|||
155082729|NCT01903733|559733304|FG003|Overall Study|Missing|0|||
155082730|NCT01903733|559733301|FG000|Overall Study|Investigator request|18|||
155082731|NCT01903733|559733302|FG001|Overall Study|Investigator request|0|||
155082732|NCT01903733|559733303|FG002|Overall Study|Investigator request|0|||
155082733|NCT01903733|559733304|FG003|Overall Study|Investigator request|0|||
155082734|NCT01714063|559733305|FG000|Overall Study|Equipment malfunction|2|||
155082735|NCT02633527|559733306|FG000|Overall Study|Failed to meet eligibility|0|||
155082736|NCT02633527|559733307|FG001|Overall Study|Failed to meet eligibility|1|||
155082737|NCT02633527|559733308|FG002|Overall Study|Failed to meet eligibility|1|||
155082738|NCT02633527|559733309|FG003|Overall Study|Failed to meet eligibility|0|||
155082739|NCT02633527|559733310|FG004|Overall Study|Failed to meet eligibility|1|||
155082740|NCT02633527|559733306|FG000|Overall Study|Adverse Event|0|||
155082741|NCT02633527|559733307|FG001|Overall Study|Adverse Event|4|||
155082742|NCT02633527|559733308|FG002|Overall Study|Adverse Event|3|||
155082743|NCT02633527|559733309|FG003|Overall Study|Adverse Event|1|||
155082744|NCT02633527|559733310|FG004|Overall Study|Adverse Event|5|||
155082745|NCT02633527|559733306|FG000|Overall Study|Lost to Follow-up|1|||
155082746|NCT02633527|559733307|FG001|Overall Study|Lost to Follow-up|2|||
155082747|NCT02633527|559733308|FG002|Overall Study|Lost to Follow-up|5|||
155082748|NCT02633527|559733309|FG003|Overall Study|Lost to Follow-up|5|||
155082749|NCT02633527|559733310|FG004|Overall Study|Lost to Follow-up|4|||
155082750|NCT02633527|559733306|FG000|Overall Study|Withdrawal by Subject|0|||
155082751|NCT02633527|559733307|FG001|Overall Study|Withdrawal by Subject|3|||
155082752|NCT02633527|559733308|FG002|Overall Study|Withdrawal by Subject|5|||
155082753|NCT02633527|559733309|FG003|Overall Study|Withdrawal by Subject|4|||
155082754|NCT02633527|559733310|FG004|Overall Study|Withdrawal by Subject|4|||
155082755|NCT02633527|559733306|FG000|Overall Study|Protocol Violation|0|||
155082756|NCT02633527|559733307|FG001|Overall Study|Protocol Violation|1|||
155082757|NCT02633527|559733308|FG002|Overall Study|Protocol Violation|1|||
155082758|NCT02633527|559733309|FG003|Overall Study|Protocol Violation|1|||
155082759|NCT02633527|559733310|FG004|Overall Study|Protocol Violation|1|||
155082760|NCT02633527|559733306|FG000|Overall Study|Physician Decision|0|||
155082761|NCT02633527|559733307|FG001|Overall Study|Physician Decision|0|||
155082762|NCT02633527|559733308|FG002|Overall Study|Physician Decision|0|||
155082763|NCT02633527|559733309|FG003|Overall Study|Physician Decision|0|||
155082764|NCT02633527|559733310|FG004|Overall Study|Physician Decision|1|||
155082765|NCT02633527|559733306|FG000|Overall Study|Administrative reason|1|||
155348037|NCT04374253|560706594|FG000|Overall Study|Reason Not Specified|0|||
155348038|NCT04374253|560706595|FG001|Overall Study|Reason Not Specified|8|||
155348039|NCT04374253|560706596|FG002|Overall Study|Reason Not Specified|0|||
155348040|NCT04374253|560706597|FG003|Overall Study|Reason Not Specified|8|||
155348041|NCT00448344|560706598|FG000|Overall Study|Lost to Follow-up|20|||
155348042|NCT00448344|560706599|FG001|Overall Study|Lost to Follow-up|22|||
155348043|NCT00448344|560706598|FG000|Overall Study|Withdrawal by Subject|6|||
155348044|NCT00448344|560706599|FG001|Overall Study|Withdrawal by Subject|8|||
155348045|NCT00448344|560706598|FG000|Overall Study|Death|3|||
155348046|NCT00448344|560706599|FG001|Overall Study|Death|4|||
155348047|NCT00448344|560706598|FG000|Overall Study|Physician Decision|1|||
155348048|NCT00448344|560706599|FG001|Overall Study|Physician Decision|2|||
155348049|NCT00417989|560706600|FG000|Overall Study|Withdrawal by Subject|13|||
155348050|NCT00417989|560706601|FG001|Overall Study|Withdrawal by Subject|13|||
155348051|NCT00417989|560706600|FG000|Overall Study|Lost to Follow-up|1|||
155348052|NCT00417989|560706601|FG001|Overall Study|Lost to Follow-up|6|||
155348053|NCT00417989|560706600|FG000|Overall Study|Protocol Violation|1|||
155348054|NCT00417989|560706601|FG001|Overall Study|Protocol Violation|0|||
155348055|NCT00417989|560706600|FG000|Overall Study|Death|0|||
155348056|NCT00417989|560706601|FG001|Overall Study|Death|1|||
155348057|NCT00417989|560706600|FG000|Overall Study|Physician Decision|5|||
155348058|NCT00417989|560706601|FG001|Overall Study|Physician Decision|2|||
155348059|NCT00990821|560706602|FG000|Overall Study|Withdrawal by Subject|0|||
155348060|NCT00990821|560706603|FG001|Overall Study|Withdrawal by Subject|2|||
155348061|NCT00990821|560706604|FG002|Overall Study|Withdrawal by Subject|0|||
155348062|NCT00990821|560706605|FG003|Overall Study|Withdrawal by Subject|0|||
155348063|NCT00990821|560706606|FG004|Overall Study|Withdrawal by Subject|3|||
155082766|NCT02633527|559733307|FG001|Overall Study|Administrative reason|0|||
155082767|NCT02633527|559733308|FG002|Overall Study|Administrative reason|0|||
155348064|NCT00990821|560706607|FG005|Overall Study|Withdrawal by Subject|3|||
155348065|NCT00990821|560706608|FG006|Overall Study|Withdrawal by Subject|1|||
155082768|NCT02633527|559733309|FG003|Overall Study|Administrative reason|1|||
155082769|NCT02633527|559733310|FG004|Overall Study|Administrative reason|0|||
155082770|NCT02633527|559733306|FG000|Overall Study|Multiple reasons|1|||
155082771|NCT02633527|559733307|FG001|Overall Study|Multiple reasons|0|||
155082772|NCT02633527|559733308|FG002|Overall Study|Multiple reasons|2|||
155348066|NCT00990821|560706609|FG007|Overall Study|Withdrawal by Subject|0|||
155348067|NCT00990821|560706610|FG008|Overall Study|Withdrawal by Subject|0|||
155082773|NCT02633527|559733309|FG003|Overall Study|Multiple reasons|2|||
155082774|NCT02633527|559733310|FG004|Overall Study|Multiple reasons|1|||
155082775|NCT01248468|559733311|FG000|Overall Study|Administrative problem|1|||
155082776|NCT01248468|559733312|FG001|Overall Study|Administrative problem|0|||
155082777|NCT01248468|559733313|FG002|Overall Study|Administrative problem|0|||
155082778|NCT01248468|559733311|FG000|Overall Study|Lost to Follow-up|9|||
155082779|NCT01248468|559733312|FG001|Overall Study|Lost to Follow-up|12|||
155082780|NCT01248468|559733313|FG002|Overall Study|Lost to Follow-up|4|||
155082781|NCT01248468|559733311|FG000|Overall Study|Pregnancy|1|||
155082782|NCT01248468|559733312|FG001|Overall Study|Pregnancy|0|||
155082783|NCT01248468|559733313|FG002|Overall Study|Pregnancy|0|||
155082784|NCT01248468|559733311|FG000|Overall Study|Withdrawal by Subject|4|||
155082785|NCT01248468|559733312|FG001|Overall Study|Withdrawal by Subject|2|||
155082786|NCT01248468|559733313|FG002|Overall Study|Withdrawal by Subject|0|||
155082787|NCT02191397|559733314|FG000|Overall Study|Adverse Event|28|||
155082788|NCT02191397|559733315|FG001|Overall Study|Adverse Event|17|||
155082789|NCT02191397|559733314|FG000|Overall Study|Lack of Efficacy|10|||
155082790|NCT02191397|559733315|FG001|Overall Study|Lack of Efficacy|5|||
155082791|NCT02191397|559733314|FG000|Overall Study|Protocol Violation|0|||
155082792|NCT02191397|559733315|FG001|Overall Study|Protocol Violation|3|||
155082793|NCT02191397|559733314|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
155082794|NCT02191397|559733315|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
155082795|NCT02191397|559733314|FG000|Overall Study|Lost to Follow-up|10|||
155082796|NCT02191397|559733315|FG001|Overall Study|Lost to Follow-up|11|||
155082797|NCT02191397|559733314|FG000|Overall Study|Physician Decision|8|||
155082798|NCT02191397|559733315|FG001|Overall Study|Physician Decision|3|||
155082799|NCT02191397|559733314|FG000|Overall Study|Withdrawal by Subject|22|||
155082800|NCT02191397|559733315|FG001|Overall Study|Withdrawal by Subject|27|||
155082801|NCT03721107|559733319|FG000|Overall Study|Adverse Event|1|||
155082802|NCT03721107|559733320|FG001|Overall Study|Adverse Event|1|||
155082803|NCT03721107|559733321|FG002|Overall Study|Adverse Event|6|||
155082804|NCT03721107|559733322|FG003|Overall Study|Adverse Event|5|||
155082805|NCT03721107|559733319|FG000|Overall Study|Lost to Follow-up|2|||
155082806|NCT03721107|559733320|FG001|Overall Study|Lost to Follow-up|0|||
155082807|NCT03721107|559733321|FG002|Overall Study|Lost to Follow-up|3|||
155082808|NCT03721107|559733322|FG003|Overall Study|Lost to Follow-up|0|||
155082809|NCT03721107|559733319|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
155082810|NCT03721107|559733320|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
155082811|NCT03721107|559733321|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
155082812|NCT03721107|559733322|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
155082813|NCT03721107|559733319|FG000|Overall Study|Physician Decision|0|||
155082814|NCT03721107|559733320|FG001|Overall Study|Physician Decision|1|||
155348068|NCT00990821|560706611|FG009|Overall Study|Withdrawal by Subject|1|||
155348069|NCT00990821|560706612|FG010|Overall Study|Withdrawal by Subject|3|||
155348070|NCT00990821|560706613|FG011|Overall Study|Withdrawal by Subject|5|||
155348071|NCT00990821|560706614|FG012|Overall Study|Withdrawal by Subject|2|||
155348072|NCT00990821|560706615|FG013|Overall Study|Withdrawal by Subject|1|||
155348073|NCT04150250|560706616|FG000|Overall Study|Lost to Follow-up|0|||
155348074|NCT04150250|560706617|FG001|Overall Study|Lost to Follow-up|2|||
155348075|NCT01945086|560706620|FG000|Overall Study|Withdrawal by Subject|1|||
155348076|NCT01945086|560706621|FG001|Overall Study|Withdrawal by Subject|0|||
155348077|NCT01945086|560706622|FG002|Overall Study|Withdrawal by Subject|1|||
155348078|NCT01945086|560706620|FG000|Overall Study|Adverse Event|0|||
155348079|NCT01945086|560706621|FG001|Overall Study|Adverse Event|0|||
155348080|NCT01945086|560706622|FG002|Overall Study|Adverse Event|1|||
155348081|NCT04212299|560706627|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
155082815|NCT03721107|559733321|FG002|Overall Study|Physician Decision|0|||
155082816|NCT03721107|559733322|FG003|Overall Study|Physician Decision|0|||
155348082|NCT00509821|560708305|FG000|Study Period 1 (Induction)|Death|0|||
155082817|NCT03721107|559733319|FG000|Overall Study|Pregnancy|0|||
155082818|NCT03721107|559733320|FG001|Overall Study|Pregnancy|0|||
155082819|NCT03721107|559733321|FG002|Overall Study|Pregnancy|1|||
155082820|NCT03721107|559733322|FG003|Overall Study|Pregnancy|0|||
155082821|NCT03721107|559733319|FG000|Overall Study|Withdrawal by Subject|1|||
155082822|NCT03721107|559733320|FG001|Overall Study|Withdrawal by Subject|1|||
155082823|NCT03721107|559733321|FG002|Overall Study|Withdrawal by Subject|5|||
155082824|NCT03721107|559733322|FG003|Overall Study|Withdrawal by Subject|5|||
155082825|NCT03721107|559733319|FG000|Overall Study|Other|1|||
155082826|NCT03721107|559733320|FG001|Overall Study|Other|0|||
155082827|NCT03721107|559733321|FG002|Overall Study|Other|0|||
155082828|NCT03721107|559733322|FG003|Overall Study|Other|1|||
155082829|NCT04818086|559733325|FG000|Overall Study|Physician Decision|1|||
155082830|NCT04818086|559733326|FG001|Overall Study|Physician Decision|0|||
155348083|NCT00509821|560708306|FG001|Study Period 1 (Induction)|Death|1|||
155348084|NCT00509821|560708305|FG000|Study Period 1 (Induction)|Adverse Event|0|||
155082831|NCT04818086|559733325|FG000|Overall Study|Withdrawal by Subject|0|||
155082832|NCT04818086|559733326|FG001|Overall Study|Withdrawal by Subject|1|||
155082833|NCT01835431|559733329|FG000|Overall Study|Adverse Event|1|||
155082834|NCT01835431|559733330|FG001|Overall Study|Adverse Event|0|||
155082835|NCT01835431|559733329|FG000|Overall Study|other|0|||
155082836|NCT01835431|559733330|FG001|Overall Study|other|2|||
155082837|NCT01835431|559733329|FG000|Overall Study|Withdrawal by Subject|6|||
155082838|NCT01835431|559733330|FG001|Overall Study|Withdrawal by Subject|10|||
155082839|NCT01835431|559733329|FG000|Overall Study|Protocol Violation|1|||
155082840|NCT01835431|559733330|FG001|Overall Study|Protocol Violation|0|||
155082841|NCT00480025|559733337|FG000|Overall Study|Protocol Violation|12|||
155082842|NCT00480025|559733338|FG001|Overall Study|Protocol Violation|7|||
155082843|NCT00480025|559733337|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
155082844|NCT00480025|559733338|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
155082845|NCT00480025|559733337|FG000|Overall Study|Disease Progression / Recurrence|449|||
155082846|NCT00480025|559733338|FG001|Overall Study|Disease Progression / Recurrence|224|||
155082847|NCT00480025|559733337|FG000|Overall Study|Adverse Event|44|||
155082848|NCT00480025|559733338|FG001|Overall Study|Adverse Event|12|||
155082849|NCT00480025|559733337|FG000|Overall Study|Other|70|||
155082850|NCT00480025|559733338|FG001|Overall Study|Other|29|||
155082851|NCT00480025|559733337|FG000|Overall Study|SAE including intercurrent illness|76|||
155082852|NCT00480025|559733338|FG001|Overall Study|SAE including intercurrent illness|42|||
155082853|NCT02792257|559733339|FG000|Overall Study|Lost to Follow-up|3|||
155082854|NCT02792257|559733340|FG001|Overall Study|Lost to Follow-up|4|||
155082855|NCT02792257|559733339|FG000|Overall Study|Allergy|0|||
155082856|NCT02792257|559733340|FG001|Overall Study|Allergy|1|||
155082857|NCT02792257|559733339|FG000|Overall Study|Protocol Violation|2|||
155082858|NCT02792257|559733340|FG001|Overall Study|Protocol Violation|0|||
155082859|NCT02792257|559733339|FG000|Overall Study|Excessive Agitation|0|||
155082860|NCT02792257|559733340|FG001|Overall Study|Excessive Agitation|1|||
155082861|NCT02792257|559733339|FG000|Overall Study|Not Feeling Well|0|||
155082862|NCT02792257|559733340|FG001|Overall Study|Not Feeling Well|1|||
155082863|NCT01064622|559733342|FG000|Randomized Phase II|Withdrawal by Subject|2|||
155082864|NCT01064622|559733343|FG001|Randomized Phase II|Withdrawal by Subject|2|||
155082865|NCT01064622|559733342|FG000|Randomized Phase II|Protocol Violation|0|||
155082866|NCT01064622|559733343|FG001|Randomized Phase II|Protocol Violation|1|||
155082867|NCT02946996|559733344|FG000|Overall Study|non-evaluable|3|||
155082868|NCT02946996|559733345|FG001|Overall Study|non-evaluable|6|||
155082869|NCT02946996|559733346|FG002|Overall Study|non-evaluable|5|||
155082870|NCT02151604|559733349|FG000|Overall Study|Lost to Follow-up|3|||
155082871|NCT02151604|559733349|FG000|Overall Study|Withdrawal by Subject|2|||
155082872|NCT02151604|559733349|FG000|Overall Study|Physician Decision|3|||
155082873|NCT02151604|559733349|FG000|Overall Study|Death|1|||
155082874|NCT02568254|559733350|FG000|Period 2|Adverse Event|0|||
155082875|NCT02568254|559733351|FG001|Period 2|Adverse Event|0|||
155082876|NCT02568254|559733352|FG002|Period 2|Adverse Event|1|||
155082877|NCT02568254|559733353|FG003|Period 2|Adverse Event|0|||
155082878|NCT02568254|559733354|FG004|Period 2|Adverse Event|0|||
155082879|NCT02568254|559733355|FG005|Period 2|Adverse Event|0|||
155082880|NCT02568254|559733350|FG000|Period 3|Unstatisfactory Lens fitting|0|||
155082881|NCT02568254|559733351|FG001|Period 3|Unstatisfactory Lens fitting|0|||
155082882|NCT02568254|559733352|FG002|Period 3|Unstatisfactory Lens fitting|0|||
155082883|NCT02568254|559733353|FG003|Period 3|Unstatisfactory Lens fitting|0|||
155082884|NCT02568254|559733354|FG004|Period 3|Unstatisfactory Lens fitting|1|||
155082885|NCT02568254|559733355|FG005|Period 3|Unstatisfactory Lens fitting|0|||
155082886|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
155082887|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
155082888|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
155082889|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Adverse Event|5|||
155082890|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Adverse Event|1|||
155082891|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Adverse Event|0|||
155082892|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
155082893|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
155082894|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
155082895|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Death|8|||
155082896|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Death|24|||
155082897|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Death|0|||
155165576|NCT01402102|560043487|FG001|Overall Study|Insufficiency of compliance|1|||
155082898|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
155082899|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
155082900|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
155082901|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
155082902|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
155082903|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
155082904|NCT02931539|559733356|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
155082905|NCT02931539|559733357|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
155082906|NCT02931539|559733358|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
155082907|NCT02931539|559733356|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
155082908|NCT02931539|559733357|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
155082909|NCT02931539|559733358|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
155082910|NCT00655746|559733359|FG000|Overall Study|Withdrawal by Subject|1|||
155082911|NCT03178942|559733362|FG000|Overall Study|Withdrawal by Subject|2|||
155082912|NCT03178942|559733363|FG001|Overall Study|Withdrawal by Subject|0|||
155082913|NCT03178942|559733362|FG000|Overall Study|Lost to Follow-up|1|||
155082914|NCT03178942|559733363|FG001|Overall Study|Lost to Follow-up|2|||
155082915|NCT01197300|559735104|FG000|Overall Study|Lost to Follow-up|0|||
155082916|NCT01197300|559735105|FG001|Overall Study|Lost to Follow-up|1|||
155082917|NCT01197300|559735104|FG000|Overall Study|Protocol Violation|0|||
155082918|NCT01197300|559735105|FG001|Overall Study|Protocol Violation|1|||
155082919|NCT02113878|559735106|FG000|Overall Study|Adverse Event|1|||
155082920|NCT02113878|559735107|FG001|Overall Study|Adverse Event|0|||
155082921|NCT02113878|559735106|FG000|Overall Study|Withdrawal by Subject|1|||
155082922|NCT02113878|559735107|FG001|Overall Study|Withdrawal by Subject|0|||
155082923|NCT02113878|559735106|FG000|Overall Study|patient non-compliance|1|||
155082924|NCT02113878|559735107|FG001|Overall Study|patient non-compliance|0|||
155082925|NCT00530257|559735110|FG000|Overall Study|Lost to Follow-up|1|||
155348085|NCT00509821|560708306|FG001|Study Period 1 (Induction)|Adverse Event|2|||
155348086|NCT00509821|560708305|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
155082926|NCT05130281|559735113|FG000|Overall Study|Withdrawal by Subject|0|||
155082927|NCT05130281|559735114|FG001|Overall Study|Withdrawal by Subject|0|||
155082928|NCT05130281|559735115|FG002|Overall Study|Withdrawal by Subject|1|||
155082929|NCT03810365|559735120|FG000|Overall Study|Lost to Follow-up|2|||
155082930|NCT03810365|559735121|FG001|Overall Study|Lost to Follow-up|2|||
155082931|NCT03810365|559735120|FG000|Overall Study|Withdrawal by Subject|4|||
155082932|NCT03810365|559735121|FG001|Overall Study|Withdrawal by Subject|5|||
155082933|NCT03142451|559735124|FG000|Overall Study|Adverse Event|5|||
155082934|NCT03142451|559735125|FG001|Overall Study|Adverse Event|2|||
155082935|NCT03142451|559735124|FG000|Overall Study|Lost to Follow-up|25|||
155348087|NCT00509821|560708306|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
155348088|NCT02720185|560708307|FG000|Overall Study|Lost to Follow-up|1|||
155348089|NCT01157351|560708308|FG000|Overall Study|Adverse Event|5|||
155082936|NCT03142451|559735125|FG001|Overall Study|Lost to Follow-up|8|||
155082937|NCT03142451|559735124|FG000|Overall Study|Participant request|24|||
155082938|NCT03142451|559735125|FG001|Overall Study|Participant request|12|||
155082939|NCT03142451|559735124|FG000|Overall Study|Protocol Violation|3|||
155082940|NCT03142451|559735125|FG001|Overall Study|Protocol Violation|1|||
155082941|NCT03142451|559735124|FG000|Overall Study|Other|1|||
155082942|NCT03142451|559735125|FG001|Overall Study|Other|1|||
155082943|NCT05333965|559735126|FG000|First Intervention|Adverse Event|0|||
155082944|NCT05333965|559735127|FG001|First Intervention|Adverse Event|1|||
155082945|NCT05333965|559735126|FG000|First Intervention|Withdrawal by Subject|0|||
155082946|NCT05333965|559735127|FG001|First Intervention|Withdrawal by Subject|1|||
155082947|NCT03048019|559735128|FG000|Overall Study|Adverse Event|1|||
155082948|NCT03048019|559735129|FG001|Overall Study|Adverse Event|0|||
155082949|NCT01730729|559735130|FG000|Overall Study|Adverse Event|1|||
155082950|NCT01730729|559735130|FG000|Overall Study|Death|1|||
155082951|NCT01730729|559735130|FG000|Overall Study|Progressive Disease|12|||
155082952|NCT01959919|559735135|FG000|Overall Study|Did not meet the eligibility criteria|2|||
155082953|NCT03439072|559735136|FG000|Overall Study|Withdrawal by Subject|2|||
155082954|NCT03439072|559735137|FG001|Overall Study|Withdrawal by Subject|3|||
155082955|NCT03439072|559735136|FG000|Overall Study|Physician Decision|0|||
155082956|NCT03439072|559735137|FG001|Overall Study|Physician Decision|1|||
155082957|NCT02094885|559735141|FG000|Overall Study|Death|1|||
155082958|NCT02094885|559735142|FG001|Overall Study|Death|5|||
155082959|NCT02094885|559735141|FG000|Overall Study|Withdrawn due to age|1|||
155082960|NCT02094885|559735142|FG001|Overall Study|Withdrawn due to age|0|||
155348090|NCT01157351|560708309|FG001|Overall Study|Adverse Event|4|||
155348091|NCT01157351|560708308|FG000|Overall Study|Death|1|||
155082961|NCT02003898|559735143|FG000|Overall Study|Death|3|||
155082962|NCT02003898|559735143|FG000|Overall Study|Lost to Follow-up|12|||
155082963|NCT02003898|559735143|FG000|Overall Study|Withdrawal by Subject|52|||
155082964|NCT01903720|559735144|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
155082965|NCT01903720|559735144|FG000|Overall Study|Adverse Event|1|||
155082966|NCT01903720|559735144|FG000|Overall Study|Rescinding of informed consent|2|||
155082967|NCT01903720|559735144|FG000|Overall Study|Lost to Follow-up|2|||
155082968|NCT01903720|559735144|FG000|Overall Study|Treatment with alternative drug|1|||
155348092|NCT01157351|560708309|FG001|Overall Study|Death|0|||
155348093|NCT01157351|560708308|FG000|Overall Study|Lost to Follow-up|53|||
155348094|NCT01157351|560708309|FG001|Overall Study|Lost to Follow-up|55|||
155165577|NCT01402102|560043486|FG000|Overall Study|Withdrawal by Subject|0|||
155165578|NCT01402102|560043487|FG001|Overall Study|Withdrawal by Subject|2|||
155165579|NCT02586207|560043490|FG000|Overall Study|Physician Decision|1|||
155082969|NCT03627468|559735145|FG000|Overall Study|Adverse Event|5|||
155082970|NCT03627468|559735146|FG001|Overall Study|Adverse Event|33|||
155082971|NCT03627468|559735145|FG000|Overall Study|Withdrawal by Subject|13|||
155082972|NCT03627468|559735146|FG001|Overall Study|Withdrawal by Subject|23|||
155082973|NCT03627468|559735145|FG000|Overall Study|Physician Decision|1|||
155082974|NCT03627468|559735146|FG001|Overall Study|Physician Decision|0|||
155082975|NCT03627468|559735145|FG000|Overall Study|Protocol Violation|0|||
155082976|NCT03627468|559735146|FG001|Overall Study|Protocol Violation|2|||
155082977|NCT03627468|559735145|FG000|Overall Study|Lost to Follow-up|10|||
155082978|NCT03627468|559735146|FG001|Overall Study|Lost to Follow-up|16|||
155082979|NCT03627468|559735145|FG000|Overall Study|Death|1|||
155082980|NCT03627468|559735146|FG001|Overall Study|Death|0|||
155082981|NCT03627468|559735145|FG000|Overall Study|Pregnancy|1|||
155082982|NCT03627468|559735146|FG001|Overall Study|Pregnancy|1|||
155082983|NCT03627468|559735145|FG000|Overall Study|Lack of Efficacy|0|||
155082984|NCT03627468|559735146|FG001|Overall Study|Lack of Efficacy|2|||
155082985|NCT03627468|559735145|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
155082986|NCT03627468|559735146|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
155082987|NCT01550965|559735150|FG000|Overall Study|Adverse Event|26|||
155082988|NCT01550965|559735150|FG000|Overall Study|Withdrawal by Subject|10|||
155082989|NCT01550965|559735150|FG000|Overall Study|Lost to Follow-up|2|||
155082990|NCT01550965|559735150|FG000|Overall Study|Lack of Efficacy|59|||
155082991|NCT01550965|559735150|FG000|Overall Study|Other|13|||
155082992|NCT01347086|559735157|FG000|Overall Study|failed screening visit|0|||
155082993|NCT01347086|559735158|FG001|Overall Study|failed screening visit|0|||
155082994|NCT01347086|559735159|FG002|Overall Study|failed screening visit|1|||
155082995|NCT01347086|559735160|FG003|Overall Study|failed screening visit|0|||
155082996|NCT01347086|559735161|FG004|Overall Study|failed screening visit|0|||
155082997|NCT01347086|559735162|FG005|Overall Study|failed screening visit|0|||
155082998|NCT01347086|559735163|FG006|Overall Study|failed screening visit|1|||
155082999|NCT01347086|559735164|FG007|Overall Study|failed screening visit|1|||
155083000|NCT01347086|559735165|FG008|Overall Study|failed screening visit|0|||
155083001|NCT01347086|559735166|FG009|Overall Study|failed screening visit|1|||
155083002|NCT02624687|559735167|FG000|Overall Study|Withdrawal by Subject|1|||
155083003|NCT02624687|559735168|FG001|Overall Study|Withdrawal by Subject|1|||
155083004|NCT02624687|559735167|FG000|Overall Study|medical leave from work|0|||
155083005|NCT02624687|559735168|FG001|Overall Study|medical leave from work|1|||
155083006|NCT03111108|559735169|FG000|Overall Study|Death|0|||
155083007|NCT03111108|559735170|FG001|Overall Study|Death|1|||
155083008|NCT03111108|559735169|FG000|Overall Study|Withdrawal by Subject|1|||
155083009|NCT03111108|559735170|FG001|Overall Study|Withdrawal by Subject|0|||
155083010|NCT01514357|559735171|FG000|Overall Study|Screen failure|2|||
155083011|NCT01514357|559735172|FG001|Overall Study|Screen failure|0|||
155083012|NCT01514357|559735171|FG000|Overall Study|Withdrawal by Subject|2|||
155083013|NCT01514357|559735172|FG001|Overall Study|Withdrawal by Subject|0|||
155083014|NCT00104884|559735173|FG000|Overall Study|Disease progression|4|||
155083015|NCT03654326|559735174|FG000|Overall Study|Withdrawal by Subject|5|||
155165580|NCT02586207|560043490|FG000|Overall Study|Withdrawal by Subject|1|||
155165581|NCT03048578|560043491|FG000|Overall Study|Withdrawal by Subject|5|||
155165582|NCT03048578|560043492|FG001|Overall Study|Withdrawal by Subject|6|||
155165583|NCT03048578|560043491|FG000|Overall Study|Lost to Follow-up|22|||
155165584|NCT03048578|560043492|FG001|Overall Study|Lost to Follow-up|10|||
155165585|NCT03048578|560043491|FG000|Overall Study|Adverse Event|1|||
155165586|NCT03048578|560043492|FG001|Overall Study|Adverse Event|2|||
155165587|NCT03048578|560043491|FG000|Overall Study|Terminated|3|||
155165588|NCT03048578|560043492|FG001|Overall Study|Terminated|2|||
155165589|NCT01409811|560043493|FG000|Overall Study|Insurance denial|1|||
155165590|NCT00441064|560043496|FG000|Overall Study|Adverse Event|1|||
154964143|NCT00772603|559295183|FG001|Overall Study|Other|0|||
155083016|NCT03654326|559735175|FG001|Overall Study|Withdrawal by Subject|3|||
155083017|NCT03654326|559735174|FG000|Overall Study|Physician Decision|0|||
155083018|NCT03654326|559735175|FG001|Overall Study|Physician Decision|1|||
155083019|NCT03654326|559735174|FG000|Overall Study|Unable to adhere to study schedule|0|||
155083020|NCT03654326|559735175|FG001|Overall Study|Unable to adhere to study schedule|1|||
155083021|NCT03654326|559735174|FG000|Overall Study|Lost to Follow-up|1|||
155083022|NCT03654326|559735175|FG001|Overall Study|Lost to Follow-up|1|||
155083023|NCT02662582|559735176|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
155083024|NCT02662582|559735177|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
155165591|NCT00441064|560043497|FG001|Overall Study|Adverse Event|0|||
155083025|NCT02662582|559735176|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
155083026|NCT02662582|559735177|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
155083027|NCT02662582|559735176|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
155083028|NCT02662582|559735177|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
155165592|NCT00441064|560043496|FG000|Overall Study|Abnormal laboratory values|0|||
155165593|NCT00441064|560043497|FG001|Overall Study|Abnormal laboratory values|2|||
155083029|NCT02662582|559735176|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155083030|NCT02662582|559735177|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155083031|NCT04191733|559735178|FG000|Overall Study|Withdrawn due to study closure|13|||
155083032|NCT04191733|559735179|FG001|Overall Study|Withdrawn due to study closure|14|||
155083033|NCT04191733|559735178|FG000|Overall Study|Withdrawal by Subject|2|||
155083034|NCT04191733|559735179|FG001|Overall Study|Withdrawal by Subject|4|||
155083035|NCT04191733|559735178|FG000|Overall Study|Physician Decision|1|||
155083036|NCT04191733|559735179|FG001|Overall Study|Physician Decision|1|||
155083037|NCT04191733|559735178|FG000|Overall Study|Lost to Follow-up|5|||
155083038|NCT04191733|559735179|FG001|Overall Study|Lost to Follow-up|6|||
155083039|NCT04191733|559735178|FG000|Overall Study|Death|0|||
155083040|NCT04191733|559735179|FG001|Overall Study|Death|1|||
155083041|NCT03878602|559735181|FG000|Overall Study|cord blood donation|7|||
155348095|NCT01157351|560708308|FG000|Overall Study|Withdrawal by Subject|37|||
155348096|NCT01157351|560708309|FG001|Overall Study|Withdrawal by Subject|27|||
155348097|NCT01157351|560708308|FG000|Overall Study|Physician Decision|5|||
155348098|NCT01157351|560708309|FG001|Overall Study|Physician Decision|4|||
155348099|NCT01157351|560708308|FG000|Overall Study|Protocol Violation|0|||
155348100|NCT01157351|560708309|FG001|Overall Study|Protocol Violation|1|||
155348101|NCT01157351|560708308|FG000|Overall Study|Other|32|||
155348102|NCT01157351|560708309|FG001|Overall Study|Other|36|||
155083042|NCT03878602|559735182|FG001|Overall Study|cord blood donation|1|||
155083043|NCT03878602|559735181|FG000|Overall Study|incomplete data collection|2|||
155083044|NCT03878602|559735182|FG001|Overall Study|incomplete data collection|0|||
155083045|NCT00478140|559735183|FG000|Overall Study|Clinical Disease Progression|1|||
155083046|NCT01898091|559735186|FG000|Overall Study|Lost to Follow-up|1|||
155083047|NCT01898091|559735187|FG001|Overall Study|Lost to Follow-up|1|||
155083048|NCT01898091|559735186|FG000|Overall Study|Withdrawal by Subject|1|||
155083049|NCT01898091|559735187|FG001|Overall Study|Withdrawal by Subject|5|||
155083050|NCT00563316|559735188|FG000|Overall Study|Adverse Event|2|||
155083051|NCT00563316|559735188|FG000|Overall Study|Physician Decision|1|||
155083052|NCT00563316|559735188|FG000|Overall Study|Lost to Follow-up|2|||
155083053|NCT00563316|559735188|FG000|Overall Study|Death|1|||
155083054|NCT00563316|559735188|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
155083055|NCT00563316|559735188|FG000|Overall Study|Other|1|||
155083056|NCT06048705|559735198|FG000|Overall Study|Physician Decision|1|||
155083057|NCT06048705|559735199|FG001|Overall Study|Physician Decision|0|||
155083058|NCT06048705|559735200|FG002|Overall Study|Physician Decision|0|||
155083059|NCT06048705|559735198|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
155083060|NCT06048705|559735199|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
155083061|NCT06048705|559735200|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
155083062|NCT06048705|559735198|FG000|Overall Study|Death prior to lymphodepletion|0|||
155083063|NCT06048705|559735199|FG001|Overall Study|Death prior to lymphodepletion|0|||
155083064|NCT06048705|559735200|FG002|Overall Study|Death prior to lymphodepletion|1|||
155083065|NCT02614066|559735201|FG000|Overall Study|Death|6|||
155083066|NCT02614066|559735202|FG001|Overall Study|Death|14|||
155083067|NCT02614066|559735203|FG002|Overall Study|Death|11|||
155083068|NCT02614066|559735204|FG003|Overall Study|Death|29|||
155083069|NCT02614066|559735201|FG000|Overall Study|Full consent withdrawn|0|||
155083070|NCT02614066|559735202|FG001|Overall Study|Full consent withdrawn|1|||
155083071|NCT02614066|559735203|FG002|Overall Study|Full consent withdrawn|0|||
155083072|NCT02614066|559735204|FG003|Overall Study|Full consent withdrawn|8|||
155083073|NCT02614066|559735201|FG000|Overall Study|Lost to Follow-up|0|||
155083074|NCT02614066|559735202|FG001|Overall Study|Lost to Follow-up|2|||
155083075|NCT02614066|559735203|FG002|Overall Study|Lost to Follow-up|2|||
155083076|NCT02614066|559735204|FG003|Overall Study|Lost to Follow-up|2|||
155083077|NCT02614066|559735201|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
155083078|NCT02614066|559735202|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
155083079|NCT02614066|559735203|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
155083080|NCT02614066|559735204|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
155083081|NCT02614066|559735201|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
155083082|NCT02614066|559735202|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
155083083|NCT02614066|559735203|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
155083084|NCT02614066|559735204|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
155083085|NCT02614066|559735201|FG000|Overall Study|Reason not specified|0|||
155348103|NCT01157351|560708308|FG000|Overall Study|Noncompliance with Study Drug|0|||
155083086|NCT02614066|559735202|FG001|Overall Study|Reason not specified|2|||
155083087|NCT02614066|559735203|FG002|Overall Study|Reason not specified|1|||
155083088|NCT02614066|559735204|FG003|Overall Study|Reason not specified|1|||
155083089|NCT04565756|559735205|FG000|Overall Study|Withdrawal by Subject|0|||
155083090|NCT04565756|559735206|FG001|Overall Study|Withdrawal by Subject|0|||
155083091|NCT04565756|559735207|FG002|Overall Study|Withdrawal by Subject|0|||
155083092|NCT04565756|559735208|FG003|Overall Study|Withdrawal by Subject|0|||
155348104|NCT01157351|560708309|FG001|Overall Study|Noncompliance with Study Drug|3|||
155348105|NCT01157351|560708308|FG000|Overall Study|Randomized but not Treated|4|||
155083093|NCT04565756|559735209|FG004|Overall Study|Withdrawal by Subject|1|||
155083094|NCT04565756|559735210|FG005|Overall Study|Withdrawal by Subject|0|||
155083095|NCT04565756|559735205|FG000|Overall Study|Protocol Violation|0|||
155083096|NCT04565756|559735206|FG001|Overall Study|Protocol Violation|0|||
155083097|NCT04565756|559735207|FG002|Overall Study|Protocol Violation|0|||
155083098|NCT04565756|559735208|FG003|Overall Study|Protocol Violation|0|||
155083099|NCT04565756|559735209|FG004|Overall Study|Protocol Violation|0|||
155083100|NCT04565756|559735210|FG005|Overall Study|Protocol Violation|1|||
155083101|NCT03378635|559735218|FG000|Overall Study|Adverse Event|1|||
155083102|NCT03378635|559735219|FG001|Overall Study|Adverse Event|0|||
155083103|NCT03378635|559735220|FG002|Overall Study|Adverse Event|0|||
155083104|NCT03378635|559735218|FG000|Overall Study|Withdrawal by Subject|1|||
155083105|NCT03378635|559735219|FG001|Overall Study|Withdrawal by Subject|0|||
155083106|NCT03378635|559735220|FG002|Overall Study|Withdrawal by Subject|0|||
155083107|NCT02413346|559735221|FG000|Overall Study|Adverse Event|6|||
155083108|NCT02413346|559735222|FG001|Overall Study|Adverse Event|6|||
155083109|NCT02413346|559735221|FG000|Overall Study|Withdrawal by Subject|30|||
155083110|NCT02413346|559735222|FG001|Overall Study|Withdrawal by Subject|40|||
155083111|NCT02413346|559735221|FG000|Overall Study|Lost to Follow-up|17|||
155083112|NCT02413346|559735222|FG001|Overall Study|Lost to Follow-up|21|||
155083113|NCT02413346|559735221|FG000|Overall Study|Protocol Violation|2|||
155083114|NCT02413346|559735222|FG001|Overall Study|Protocol Violation|0|||
155083115|NCT02413346|559735221|FG000|Overall Study|Other Miscellaneous Reasons|4|||
155083116|NCT02413346|559735222|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155083117|NCT02205359|559735223|FG000|Overall Study|Death|293|||
155083118|NCT02205359|559735224|FG001|Overall Study|Death|327|||
155083119|NCT02205359|559735223|FG000|Overall Study|Lost to Follow-up|182|||
155083120|NCT02205359|559735224|FG001|Overall Study|Lost to Follow-up|162|||
155083121|NCT02205359|559735223|FG000|Overall Study|Physician Decision|51|||
155083122|NCT02205359|559735224|FG001|Overall Study|Physician Decision|53|||
155083123|NCT02205359|559735223|FG000|Overall Study|Withdrawal by Subject|167|||
155083124|NCT02205359|559735224|FG001|Overall Study|Withdrawal by Subject|169|||
155083125|NCT02766478|559735226|FG000|Overall Study|Withdrawal by Subject|1|||
155083126|NCT02766478|559735227|FG001|Overall Study|Withdrawal by Subject|1|||
155083127|NCT00089583|559735228|FG000|Overall Study|Adverse Event|0|||
155083128|NCT00089583|559735229|FG001|Overall Study|Adverse Event|3|||
155083129|NCT00089583|559735228|FG000|Overall Study|Insufficient Viral Load Response|5|||
155083130|NCT00089583|559735229|FG001|Overall Study|Insufficient Viral Load Response|5|||
155083131|NCT00089583|559735228|FG000|Overall Study|Withdrawal by Subject|0|||
155083132|NCT00089583|559735229|FG001|Overall Study|Withdrawal by Subject|4|||
155083133|NCT00089583|559735228|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
155083134|NCT00089583|559735229|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
155083135|NCT00089583|559735228|FG000|Overall Study|Participant Refused Study Medication|0|||
155083136|NCT00089583|559735229|FG001|Overall Study|Participant Refused Study Medication|2|||
155083137|NCT00089583|559735228|FG000|Overall Study|Non-Compliance|0|||
155083138|NCT00089583|559735229|FG001|Overall Study|Non-Compliance|4|||
155083139|NCT00089583|559735228|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
155083140|NCT00089583|559735229|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
155083141|NCT00089583|559735228|FG000|Overall Study|Participant Management Criteria Met|0|||
155083142|NCT00089583|559735229|FG001|Overall Study|Participant Management Criteria Met|1|||
155083143|NCT00089583|559735228|FG000|Overall Study|Reason Not Provided|0|||
155083144|NCT00089583|559735229|FG001|Overall Study|Reason Not Provided|1|||
155083145|NCT00089583|559735228|FG000|Overall Study|Protocol Violation|0|||
155083146|NCT00089583|559735229|FG001|Overall Study|Protocol Violation|3|||
155083147|NCT00089583|559735228|FG000|Overall Study|Principal Investigator Decision|0|||
155083148|NCT00089583|559735229|FG001|Overall Study|Principal Investigator Decision|10|||
155083149|NCT00089583|559735228|FG000|Overall Study|Start of Disallowed Medication|0|||
155083150|NCT00089583|559735229|FG001|Overall Study|Start of Disallowed Medication|1|||
155083151|NCT00089583|559735228|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
155083152|NCT00089583|559735229|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
155083153|NCT00089583|559735228|FG000|Overall Study|Participant Incarcerated|0|||
155083154|NCT00089583|559735229|FG001|Overall Study|Participant Incarcerated|1|||
155083155|NCT01412983|559735230|FG000|1st Period|Ineligible|0|||
155083156|NCT01412983|559735231|FG001|1st Period|Ineligible|1|||
155083157|NCT01412983|559735230|FG000|1st Period|Positive slit lamp finding|0|||
155083158|NCT01412983|559735231|FG001|1st Period|Positive slit lamp finding|1|||
155083159|NCT01412983|559735230|FG000|1st Period|Unacceptable lens movement|0|||
155083160|NCT01412983|559735231|FG001|1st Period|Unacceptable lens movement|1|||
155083161|NCT01412983|559735230|FG000|1st Period|Inability to maintain wear|0|||
155083162|NCT01412983|559735231|FG001|1st Period|Inability to maintain wear|1|||
155083163|NCT01623154|559735232|FG000|Overall Study|Did not drink Pranactin Citric|4|||
155083164|NCT04349098|559735233|FG000|Overall Study|Death|16|||
155083165|NCT04349098|559735234|FG001|Overall Study|Death|8|||
155083166|NCT04349098|559735233|FG000|Overall Study|Lost to Follow-up|11|||
155083167|NCT04349098|559735234|FG001|Overall Study|Lost to Follow-up|8|||
155083168|NCT04349098|559735233|FG000|Overall Study|Withdrawal by Subject|8|||
155083169|NCT04349098|559735234|FG001|Overall Study|Withdrawal by Subject|5|||
155083170|NCT04349098|559735233|FG000|Overall Study|Other|3|||
155083171|NCT04349098|559735234|FG001|Overall Study|Other|5|||
155083172|NCT00800384|559735235|FG000|Overall Study|Withdrawal by Subject|24|||
155083173|NCT00800384|559735236|FG001|Overall Study|Withdrawal by Subject|17|||
155083174|NCT00800384|559735235|FG000|Overall Study|Lost to Follow-up|17|||
155083175|NCT00800384|559735236|FG001|Overall Study|Lost to Follow-up|26|||
155083176|NCT01245049|559735238|FG000|Overall Study|Migrated/moved from study area|0|||
155083177|NCT01245049|559735239|FG001|Overall Study|Migrated/moved from study area|1|||
155083178|NCT01245049|559735238|FG000|Overall Study|Withdrawal by Subject|0|||
155083179|NCT01245049|559735239|FG001|Overall Study|Withdrawal by Subject|1|||
155083180|NCT01245049|559735238|FG000|Overall Study|Lost to Follow-up|1|||
155083181|NCT01245049|559735239|FG001|Overall Study|Lost to Follow-up|2|||
155083182|NCT00450749|559735240|FG000|Overall Study|Withdrawal by Subject|0|||
155083183|NCT00450749|559735241|FG001|Overall Study|Withdrawal by Subject|0|||
155083184|NCT00450749|559735242|FG002|Overall Study|Withdrawal by Subject|2|||
155083185|NCT00450749|559735240|FG000|Overall Study|Noncompliant|0|||
155083186|NCT00450749|559735241|FG001|Overall Study|Noncompliant|1|||
155083187|NCT00450749|559735242|FG002|Overall Study|Noncompliant|0|||
155083188|NCT00537082|559735243|FG000|Overall Study|Adverse Event|6|||
155083189|NCT00537082|559735244|FG001|Overall Study|Adverse Event|6|||
155083190|NCT00537082|559735245|FG002|Overall Study|Adverse Event|3|||
155083191|NCT00537082|559735243|FG000|Overall Study|Protocol Violation|0|||
155083192|NCT00537082|559735244|FG001|Overall Study|Protocol Violation|2|||
155083193|NCT00537082|559735245|FG002|Overall Study|Protocol Violation|1|||
155083194|NCT00537082|559735243|FG000|Overall Study|Lack of Efficacy|0|||
155083195|NCT00537082|559735244|FG001|Overall Study|Lack of Efficacy|0|||
155083196|NCT00537082|559735245|FG002|Overall Study|Lack of Efficacy|2|||
155083197|NCT00537082|559735243|FG000|Overall Study|Withdrawal by Subject|0|||
155083198|NCT00537082|559735244|FG001|Overall Study|Withdrawal by Subject|1|||
155083199|NCT00537082|559735245|FG002|Overall Study|Withdrawal by Subject|0|||
155083200|NCT00537082|559735243|FG000|Overall Study|Discontinued before initiating treatment|3|||
155083201|NCT00537082|559735244|FG001|Overall Study|Discontinued before initiating treatment|0|||
155083202|NCT00537082|559735245|FG002|Overall Study|Discontinued before initiating treatment|0|||
155083203|NCT04495478|559735246|FG000|Overall Study|Withdrawal by Subject|0|||
155083204|NCT04495478|559735247|FG001|Overall Study|Withdrawal by Subject|0|||
155083205|NCT04495478|559735248|FG002|Overall Study|Withdrawal by Subject|0|||
155083206|NCT04495478|559735249|FG003|Overall Study|Withdrawal by Subject|1|||
155083207|NCT04495478|559735250|FG004|Overall Study|Withdrawal by Subject|0|||
155083208|NCT04495478|559735251|FG005|Overall Study|Withdrawal by Subject|0|||
155083209|NCT04495478|559735252|FG006|Overall Study|Withdrawal by Subject|0|||
155083210|NCT04495478|559735246|FG000|Overall Study|Physician Decision|0|||
155083211|NCT04495478|559735247|FG001|Overall Study|Physician Decision|1|||
155083212|NCT04495478|559735248|FG002|Overall Study|Physician Decision|0|||
155083213|NCT04495478|559735249|FG003|Overall Study|Physician Decision|0|||
155083214|NCT04495478|559735250|FG004|Overall Study|Physician Decision|1|||
155083215|NCT04495478|559735251|FG005|Overall Study|Physician Decision|0|||
155083216|NCT04495478|559735252|FG006|Overall Study|Physician Decision|0|||
155083217|NCT03061214|559735254|FG000|Overall Study|Withdrawal by Subject|21|||
155083218|NCT03061214|559735255|FG001|Overall Study|Withdrawal by Subject|26|||
155083219|NCT03061214|559735256|FG002|Overall Study|Withdrawal by Subject|9|||
155083220|NCT03061214|559735254|FG000|Overall Study|Lost to Follow-up|3|||
155083221|NCT03061214|559735255|FG001|Overall Study|Lost to Follow-up|1|||
155083222|NCT03061214|559735256|FG002|Overall Study|Lost to Follow-up|1|||
155083223|NCT03061214|559735254|FG000|Overall Study|Death|1|||
155083224|NCT03061214|559735255|FG001|Overall Study|Death|1|||
155083225|NCT03061214|559735256|FG002|Overall Study|Death|0|||
155083226|NCT06844812|559737122|FG000|Overall Study|Lost to Follow-up|5|||
155083227|NCT06844812|559737122|FG000|Overall Study|stigmatization concerns|2|||
155083228|NCT06844812|559737122|FG000|Overall Study|medication refusal|2|||
155083229|NCT06844812|559737122|FG000|Overall Study|concerns about possible side effects|2|||
155083230|NCT06844812|559737122|FG000|Overall Study|wanting to seek another specialist opinion|2|||
155083231|NCT06844812|559737122|FG000|Overall Study|side effects (dizziness)|1|||
155083232|NCT00203242|559737145|FG000|Overall Study|Lost to Follow-up|1|||
155083233|NCT02837952|559737147|FG000|Overall Study|Adverse Event|0|||
155083234|NCT02837952|559737148|FG001|Overall Study|Adverse Event|1|||
155083235|NCT02837952|559737147|FG000|Overall Study|Withdrawal by Subject|4|||
155083236|NCT02837952|559737148|FG001|Overall Study|Withdrawal by Subject|5|||
155083237|NCT02837952|559737147|FG000|Overall Study|Medication Error|1|||
155083238|NCT02837952|559737148|FG001|Overall Study|Medication Error|0|||
155083239|NCT01517178|559737149|FG000|Period 1|Adverse Event|1|||
155083240|NCT01517178|559737150|FG001|Period 1|Adverse Event|2|||
155083241|NCT01517178|559737149|FG000|Period 1|Lack of Efficacy|0|||
155083242|NCT01517178|559737150|FG001|Period 1|Lack of Efficacy|1|||
155083243|NCT01517178|559737149|FG000|Period 1|E.g. study termination|3|||
155083244|NCT01517178|559737150|FG001|Period 1|E.g. study termination|1|||
155083245|NCT01517178|559737149|FG000|Period 1|Withdrawal by Subject|0|||
155083246|NCT01517178|559737150|FG001|Period 1|Withdrawal by Subject|1|||
155083247|NCT01517178|559737149|FG000|Period 2|Adverse Event|1|||
155083248|NCT01517178|559737150|FG001|Period 2|Adverse Event|0|||
155083249|NCT01517178|559737149|FG000|Period 2|Withdrawal by Subject|3|||
155083250|NCT01517178|559737150|FG001|Period 2|Withdrawal by Subject|0|||
155083251|NCT01517178|559737149|FG000|Period 2|E.g. study termination|2|||
155083252|NCT01517178|559737150|FG001|Period 2|E.g. study termination|2|||
155083253|NCT01537432|559737155|FG000|Overall Study|Lost to Follow-up|3|||
155083254|NCT01537432|559737156|FG001|Overall Study|Lost to Follow-up|1|||
155083255|NCT01537432|559737155|FG000|Overall Study|Withdrawal by Subject|0|||
155083256|NCT01537432|559737156|FG001|Overall Study|Withdrawal by Subject|1|||
155083257|NCT01537432|559737155|FG000|Overall Study|Administrative problems|1|||
155083258|NCT01537432|559737156|FG001|Overall Study|Administrative problems|0|||
155083259|NCT01537432|559737155|FG000|Overall Study|Adverse Event|1|||
155083260|NCT01537432|559737156|FG001|Overall Study|Adverse Event|0|||
155083261|NCT01537432|559737155|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155083262|NCT01537432|559737156|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155083263|NCT00889005|559737159|FG000|Overall Study|Lost to Follow-up|4|||
155083264|NCT00889005|559737160|FG001|Overall Study|Lost to Follow-up|2|||
155083265|NCT00889005|559737159|FG000|Overall Study|Withdrawal by Subject|4|||
155083266|NCT00889005|559737160|FG001|Overall Study|Withdrawal by Subject|0|||
155083267|NCT01998477|559737161|FG000|Overall Study|Lost to Follow-up|4|||
155083268|NCT01998477|559737162|FG001|Overall Study|Lost to Follow-up|5|||
155083269|NCT01998477|559737161|FG000|Overall Study|Withdrawal by Subject|6|||
155083270|NCT01998477|559737162|FG001|Overall Study|Withdrawal by Subject|0|||
155083271|NCT00129974|559737163|FG000|Overall Study|Other|1|||
155083272|NCT04893811|559737165|FG000|Vaccination Phase|Death|1|||
155083273|NCT04893811|559737166|FG001|Vaccination Phase|Death|0|||
155083274|NCT04893811|559737165|FG000|Vaccination Phase|Lost to Follow-up|1|||
155083275|NCT04893811|559737166|FG001|Vaccination Phase|Lost to Follow-up|1|||
155083276|NCT04893811|559737165|FG000|Vaccination Phase|Protocol Violation|2|||
155083277|NCT04893811|559737166|FG001|Vaccination Phase|Protocol Violation|0|||
155083278|NCT04893811|559737165|FG000|Vaccination Phase|Withdrawal by Subject|2|||
155083279|NCT04893811|559737166|FG001|Vaccination Phase|Withdrawal by Subject|1|||
155083280|NCT04893811|559737165|FG000|Vaccination Phase|Other|0|||
155083281|NCT04893811|559737166|FG001|Vaccination Phase|Other|1|||
155083282|NCT04893811|559737165|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
155083283|NCT04893811|559737166|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
155083284|NCT04893811|559737165|FG000|Follow-up Phase|Lost to Follow-up|0|||
155083285|NCT04893811|559737166|FG001|Follow-up Phase|Lost to Follow-up|1|||
155083286|NCT02739828|559737167|FG000|Overall Study|Adverse Event|1|||
155083287|NCT02739828|559737167|FG000|Overall Study|Lost to Follow-up|4|||
155083288|NCT02202577|559737175|FG000|Overall Study|Lost to Follow-up|6|||
155083289|NCT02202577|559737176|FG001|Overall Study|Lost to Follow-up|16|||
155083290|NCT02202577|559737175|FG000|Overall Study|Protocol Violation|7|||
155083291|NCT02202577|559737176|FG001|Overall Study|Protocol Violation|3|||
155083292|NCT02176525|559737177|FG000|Overall Study|Adverse Event|0|||
155083293|NCT02176525|559737178|FG001|Overall Study|Adverse Event|0|||
155083294|NCT02176525|559737179|FG002|Overall Study|Adverse Event|0|||
155083295|NCT02176525|559737180|FG003|Overall Study|Adverse Event|1|||
155083296|NCT02176525|559737181|FG004|Overall Study|Adverse Event|1|||
155083297|NCT02176525|559737182|FG005|Overall Study|Adverse Event|0|||
155083298|NCT02176525|559737183|FG006|Overall Study|Adverse Event|1|||
155083299|NCT02176525|559737184|FG007|Overall Study|Adverse Event|0|||
155083300|NCT02176525|559737177|FG000|Overall Study|not treated|1|||
155083301|NCT02176525|559737178|FG001|Overall Study|not treated|0|||
155083302|NCT02176525|559737179|FG002|Overall Study|not treated|0|||
155083303|NCT02176525|559737180|FG003|Overall Study|not treated|0|||
154964144|NCT00772603|559295184|FG002|Overall Study|Other|2|||
155083304|NCT02176525|559737181|FG004|Overall Study|not treated|0|||
155083305|NCT02176525|559737182|FG005|Overall Study|not treated|1|||
155083306|NCT02176525|559737183|FG006|Overall Study|not treated|0|||
155083307|NCT02176525|559737184|FG007|Overall Study|not treated|0|||
155083308|NCT02100644|559737185|FG000|LTG Escalation Phase|Adverse Event|9|||
155083309|NCT02100644|559737186|FG001|LTG Escalation Phase|Adverse Event|0|||
155083310|NCT02100644|559737187|FG002|LTG Escalation Phase|Adverse Event|0|||
155083311|NCT02100644|559737185|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
155083312|NCT02100644|559737186|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
155083313|NCT02100644|559737187|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
155083314|NCT02100644|559737185|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
155083315|NCT02100644|559737186|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
155083316|NCT02100644|559737187|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
155083317|NCT00728182|559737188|FG000|Overall Study|Adverse Event|1|||
155083318|NCT00728182|559737189|FG001|Overall Study|Adverse Event|0|||
155083319|NCT00728182|559737188|FG000|Overall Study|Lost to Follow-up|2|||
155083320|NCT00728182|559737189|FG001|Overall Study|Lost to Follow-up|0|||
155083321|NCT00728182|559737188|FG000|Overall Study|Death|0|||
155083322|NCT00728182|559737189|FG001|Overall Study|Death|2|||
155083323|NCT00728182|559737188|FG000|Overall Study|Protocol Noncompliance|0|||
155083324|NCT00728182|559737189|FG001|Overall Study|Protocol Noncompliance|1|||
155083325|NCT00425854|559737200|FG000|Overall Study|Progressive Disease|19|||
155083326|NCT00425854|559737201|FG001|Overall Study|Progressive Disease|12|||
155083327|NCT00425854|559737200|FG000|Overall Study|Dose reduction toxicity AE|8|||
155083328|NCT00425854|559737201|FG001|Overall Study|Dose reduction toxicity AE|7|||
155083329|NCT00425854|559737200|FG000|Overall Study|Other Adverse Event|2|||
155083330|NCT00425854|559737201|FG001|Overall Study|Other Adverse Event|2|||
155083331|NCT01514422|559737202|FG000|Overall Study|Lost to Follow-up|1|||
155083332|NCT01630811|559737203|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
155083333|NCT01630811|559737204|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155083334|NCT01725308|559737207|FG000|Treatment Period I|Did Not Receive Drug|1|||
155083335|NCT01725308|559737208|FG001|Treatment Period I|Did Not Receive Drug|0|||
155083336|NCT01725308|559737209|FG002|Treatment Period I|Did Not Receive Drug|0|||
155083337|NCT01725308|559737207|FG000|Treatment Period I|Adverse Event|5|||
155083338|NCT01725308|559737208|FG001|Treatment Period I|Adverse Event|4|||
155083339|NCT01725308|559737209|FG002|Treatment Period I|Adverse Event|21|||
155083340|NCT01725308|559737207|FG000|Treatment Period I|Insufficient Response|7|||
155083341|NCT01725308|559737208|FG001|Treatment Period I|Insufficient Response|0|||
155083342|NCT01725308|559737209|FG002|Treatment Period I|Insufficient Response|5|||
155083343|NCT01725308|559737207|FG000|Treatment Period I|Worsening of the Target Disease|8|||
155348106|NCT01157351|560708309|FG001|Overall Study|Randomized but not Treated|2|||
155348107|NCT01589523|560708310|FG000|Overall Study|Withdrawal by Subject|1|||
155348108|NCT00506922|560708311|FG000|Overall Study|Physician Decision|0|||
155348109|NCT00506922|560708312|FG001|Overall Study|Physician Decision|0|||
155348110|NCT00506922|560708313|FG002|Overall Study|Physician Decision|0|||
155348111|NCT00506922|560708314|FG003|Overall Study|Physician Decision|2|||
155348112|NCT00506922|560708315|FG004|Overall Study|Physician Decision|0|||
155348113|NCT00506922|560708311|FG000|Overall Study|Withdrawal by Subject|0|||
155348114|NCT00506922|560708312|FG001|Overall Study|Withdrawal by Subject|0|||
155348115|NCT00506922|560708313|FG002|Overall Study|Withdrawal by Subject|0|||
155348116|NCT00506922|560708314|FG003|Overall Study|Withdrawal by Subject|0|||
155348117|NCT00506922|560708315|FG004|Overall Study|Withdrawal by Subject|1|||
155348118|NCT02507687|560708318|FG000|Overall Study|Adverse Event|3|||
155348119|NCT02507687|560708319|FG001|Overall Study|Adverse Event|2|||
155348120|NCT02507687|560708320|FG002|Overall Study|Adverse Event|2|||
155348121|NCT02507687|560708321|FG003|Overall Study|Adverse Event|2|||
155348122|NCT02507687|560708318|FG000|Overall Study|Withdrawal by Subject|1|||
155348123|NCT02507687|560708319|FG001|Overall Study|Withdrawal by Subject|4|||
155348124|NCT02507687|560708320|FG002|Overall Study|Withdrawal by Subject|6|||
155348125|NCT02507687|560708321|FG003|Overall Study|Withdrawal by Subject|6|||
155348126|NCT02507687|560708318|FG000|Overall Study|Protocol Violation|1|||
155348127|NCT02507687|560708319|FG001|Overall Study|Protocol Violation|0|||
155348128|NCT02507687|560708320|FG002|Overall Study|Protocol Violation|2|||
155348129|NCT02507687|560708321|FG003|Overall Study|Protocol Violation|0|||
155348130|NCT02507687|560708318|FG000|Overall Study|Lost to Follow-up|0|||
155348131|NCT02507687|560708319|FG001|Overall Study|Lost to Follow-up|0|||
155083344|NCT01725308|559737208|FG001|Treatment Period I|Worsening of the Target Disease|0|||
155083345|NCT01725308|559737209|FG002|Treatment Period I|Worsening of the Target Disease|2|||
155083346|NCT01725308|559737207|FG000|Treatment Period I|Changes in the Episodes|3|||
155083347|NCT01725308|559737208|FG001|Treatment Period I|Changes in the Episodes|0|||
155348132|NCT02507687|560708320|FG002|Overall Study|Lost to Follow-up|2|||
155348133|NCT02507687|560708321|FG003|Overall Study|Lost to Follow-up|1|||
154964145|NCT00443651|559295189|FG000|Overall Study|Death|1|||
155083348|NCT01725308|559737209|FG002|Treatment Period I|Changes in the Episodes|2|||
155083349|NCT01725308|559737207|FG000|Treatment Period I|Withdrawal of Consent|12|||
155083350|NCT01725308|559737208|FG001|Treatment Period I|Withdrawal of Consent|7|||
155083351|NCT01725308|559737209|FG002|Treatment Period I|Withdrawal of Consent|5|||
155083352|NCT01725308|559737207|FG000|Treatment Period I|Lost to Follow-up|3|||
155083353|NCT01725308|559737208|FG001|Treatment Period I|Lost to Follow-up|2|||
155083354|NCT01725308|559737209|FG002|Treatment Period I|Lost to Follow-up|2|||
155083355|NCT01725308|559737207|FG000|Treatment Period I|Protocol Deviations|3|||
155348134|NCT02507687|560708318|FG000|Overall Study|Screen Failure|0|||
155348135|NCT02507687|560708319|FG001|Overall Study|Screen Failure|0|||
155348136|NCT02507687|560708320|FG002|Overall Study|Screen Failure|1|||
155348137|NCT02507687|560708321|FG003|Overall Study|Screen Failure|0|||
155348138|NCT02507687|560708318|FG000|Overall Study|Other, Not Specified|0|||
155083356|NCT01725308|559737208|FG001|Treatment Period I|Protocol Deviations|1|||
155348139|NCT02507687|560708319|FG001|Overall Study|Other, Not Specified|0|||
155348140|NCT02507687|560708320|FG002|Overall Study|Other, Not Specified|2|||
155348141|NCT02507687|560708321|FG003|Overall Study|Other, Not Specified|4|||
154964146|NCT00443651|559295190|FG001|Overall Study|Death|5|||
155165594|NCT00441064|560043496|FG000|Overall Study|Abnormal test procedure results|0|||
155348142|NCT02675998|560708322|FG000|8-Week Treatment Period|Adverse Event|6|||
155348143|NCT02675998|560708323|FG001|8-Week Treatment Period|Adverse Event|5|||
155348144|NCT02675998|560708324|FG002|8-Week Treatment Period|Adverse Event|6|||
155348145|NCT02675998|560708325|FG003|8-Week Treatment Period|Adverse Event|0|||
155348146|NCT02675998|560708322|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
155348147|NCT02675998|560708323|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
155348148|NCT02675998|560708324|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
155348149|NCT02675998|560708325|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
155348150|NCT02675998|560708322|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
155348151|NCT02675998|560708323|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
155348152|NCT02675998|560708324|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
155348153|NCT02675998|560708325|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
155348154|NCT02675998|560708322|FG000|8-Week Treatment Period|Physician Decision|1|||
155348155|NCT02675998|560708323|FG001|8-Week Treatment Period|Physician Decision|0|||
155348156|NCT02675998|560708324|FG002|8-Week Treatment Period|Physician Decision|2|||
155348157|NCT02675998|560708325|FG003|8-Week Treatment Period|Physician Decision|0|||
155348158|NCT02675998|560708322|FG000|8-Week Treatment Period|GI side Effects|1|||
155348159|NCT02675998|560708323|FG001|8-Week Treatment Period|GI side Effects|4|||
155348160|NCT02675998|560708324|FG002|8-Week Treatment Period|GI side Effects|2|||
155348161|NCT02675998|560708325|FG003|8-Week Treatment Period|GI side Effects|0|||
155348162|NCT02675998|560708322|FG000|8-Week Treatment Period|Protocol Violation|1|||
155348163|NCT02675998|560708323|FG001|8-Week Treatment Period|Protocol Violation|1|||
155083357|NCT01725308|559737209|FG002|Treatment Period I|Protocol Deviations|1|||
155083358|NCT01725308|559737207|FG000|Treatment Period I|Miscellaneous|2|||
155083359|NCT01725308|559737208|FG001|Treatment Period I|Miscellaneous|0|||
155083360|NCT01725308|559737209|FG002|Treatment Period I|Miscellaneous|3|||
155348164|NCT02675998|560708324|FG002|8-Week Treatment Period|Protocol Violation|1|||
155348165|NCT02675998|560708325|FG003|8-Week Treatment Period|Protocol Violation|0|||
155348166|NCT02675998|560708322|FG000|8-Week Treatment Period|Other|3|||
155348167|NCT02675998|560708323|FG001|8-Week Treatment Period|Other|1|||
155348168|NCT02675998|560708324|FG002|8-Week Treatment Period|Other|2|||
155348169|NCT02675998|560708325|FG003|8-Week Treatment Period|Other|0|||
155348170|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
155348171|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
155348172|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
155348173|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
155348174|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
155348175|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
155348176|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
155348177|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
155348178|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
155348179|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
155348180|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
155348181|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
155348182|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
155348183|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
155348184|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
155348185|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
155083361|NCT01725308|559737207|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
155348186|NCT02675998|560708322|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
155348187|NCT02675998|560708323|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
155083362|NCT01725308|559737208|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
155083363|NCT01725308|559737209|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
155083364|NCT01725308|559737207|FG000|Treatment Period II|Did Not Receive Drug|4|||
155083365|NCT01725308|559737208|FG001|Treatment Period II|Did Not Receive Drug|0|||
155083366|NCT01725308|559737209|FG002|Treatment Period II|Did Not Receive Drug|0|||
155083367|NCT01725308|559737207|FG000|Treatment Period II|Adverse Event|13|||
155083368|NCT01725308|559737208|FG001|Treatment Period II|Adverse Event|8|||
155083369|NCT01725308|559737209|FG002|Treatment Period II|Adverse Event|20|||
155083370|NCT01725308|559737207|FG000|Treatment Period II|Insufficient Response|2|||
155083371|NCT01725308|559737208|FG001|Treatment Period II|Insufficient Response|4|||
155083372|NCT01725308|559737209|FG002|Treatment Period II|Insufficient Response|6|||
155083373|NCT01725308|559737207|FG000|Treatment Period II|Worsening of the Target Disease|1|||
155348188|NCT02675998|560708324|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
155348189|NCT02675998|560708325|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
155348190|NCT00275301|560708326|FG000|Overall Study|Adverse Event|5|||
155348191|NCT02561078|560708331|FG000|Overall Study|Adverse Event|5|||
155348192|NCT02561078|560708332|FG001|Overall Study|Adverse Event|2|||
155348193|NCT02561078|560708331|FG000|Overall Study|Death|2|||
155348194|NCT02561078|560708332|FG001|Overall Study|Death|1|||
155348195|NCT02561078|560708331|FG000|Overall Study|Lost to Follow-up|2|||
155348196|NCT02561078|560708332|FG001|Overall Study|Lost to Follow-up|6|||
155348197|NCT02561078|560708331|FG000|Overall Study|Non-Compliance with Study Drug|6|||
155348198|NCT02561078|560708332|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155348199|NCT02561078|560708331|FG000|Overall Study|Physician Decision|2|||
155348200|NCT02561078|560708332|FG001|Overall Study|Physician Decision|3|||
155348201|NCT02561078|560708331|FG000|Overall Study|Withdrawal by Subject|13|||
154964147|NCT00443651|559295189|FG000|Overall Study|Adverse Event|5|||
154964148|NCT00443651|559295190|FG001|Overall Study|Adverse Event|6|||
154964149|NCT00443651|559295189|FG000|Overall Study|Lost to Follow-up|18|||
155083374|NCT01725308|559737208|FG001|Treatment Period II|Worsening of the Target Disease|4|||
155083375|NCT01725308|559737209|FG002|Treatment Period II|Worsening of the Target Disease|2|||
155083376|NCT01725308|559737207|FG000|Treatment Period II|Changes in the Episodes|1|||
155083377|NCT01725308|559737208|FG001|Treatment Period II|Changes in the Episodes|0|||
155083378|NCT01725308|559737209|FG002|Treatment Period II|Changes in the Episodes|5|||
155083379|NCT01725308|559737207|FG000|Treatment Period II|Withdrawal of Consent|28|||
155083380|NCT01725308|559737208|FG001|Treatment Period II|Withdrawal of Consent|2|||
155083381|NCT01725308|559737209|FG002|Treatment Period II|Withdrawal of Consent|16|||
155083382|NCT01725308|559737207|FG000|Treatment Period II|Lost to Follow-up|1|||
155083383|NCT01725308|559737208|FG001|Treatment Period II|Lost to Follow-up|5|||
155083384|NCT01725308|559737209|FG002|Treatment Period II|Lost to Follow-up|3|||
155083385|NCT01725308|559737207|FG000|Treatment Period II|Protocol Deviations|0|||
155083386|NCT01725308|559737208|FG001|Treatment Period II|Protocol Deviations|0|||
155083387|NCT01725308|559737209|FG002|Treatment Period II|Protocol Deviations|1|||
155083388|NCT01725308|559737207|FG000|Treatment Period II|Miscellaneous|5|||
155083389|NCT01725308|559737208|FG001|Treatment Period II|Miscellaneous|3|||
155083390|NCT01725308|559737209|FG002|Treatment Period II|Miscellaneous|7|||
155083391|NCT00215657|559737211|FG000|Overall Study|Adverse Event|5|||
155083392|NCT00215657|559737212|FG001|Overall Study|Adverse Event|1|||
155083393|NCT00215657|559737213|FG002|Overall Study|Adverse Event|3|||
155083394|NCT00215657|559737214|FG003|Overall Study|Adverse Event|0|||
155083395|NCT00215657|559737215|FG004|Overall Study|Adverse Event|3|||
155083396|NCT00215657|559737216|FG005|Overall Study|Adverse Event|1|||
155083397|NCT00215657|559737217|FG006|Overall Study|Adverse Event|0|||
155083398|NCT00215657|559737218|FG007|Overall Study|Adverse Event|3|||
155083399|NCT00215657|559737211|FG000|Overall Study|Withdrawal by Subject|6|||
155083400|NCT00215657|559737212|FG001|Overall Study|Withdrawal by Subject|3|||
155083401|NCT00215657|559737213|FG002|Overall Study|Withdrawal by Subject|3|||
155083402|NCT00215657|559737214|FG003|Overall Study|Withdrawal by Subject|1|||
155083403|NCT00215657|559737215|FG004|Overall Study|Withdrawal by Subject|6|||
155083404|NCT00215657|559737216|FG005|Overall Study|Withdrawal by Subject|1|||
155083405|NCT00215657|559737217|FG006|Overall Study|Withdrawal by Subject|10|||
155083406|NCT00215657|559737218|FG007|Overall Study|Withdrawal by Subject|3|||
155083407|NCT00215657|559737211|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
155083408|NCT00215657|559737212|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
155083409|NCT00215657|559737213|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
155083410|NCT00215657|559737214|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
155083411|NCT00215657|559737215|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
155083412|NCT00215657|559737216|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
155083413|NCT00215657|559737217|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
155348202|NCT02561078|560708332|FG001|Overall Study|Withdrawal by Subject|10|||
155348203|NCT00598871|560708335|FG000|Overall Study|Adverse Event|0|||
154964150|NCT00443651|559295190|FG001|Overall Study|Lost to Follow-up|12|||
154964151|NCT00443651|559295189|FG000|Overall Study|Patient's/Guardian's Decision|58|||
155083414|NCT00215657|559737218|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
155348204|NCT00598871|560708336|FG001|Overall Study|Adverse Event|1|||
155348205|NCT01194271|560708337|FG000|Overall Study|Withdrawal by Subject|1|||
155348206|NCT01194271|560708337|FG000|Overall Study|Ineligible, Screen Failure|1|||
154964152|NCT00443651|559295190|FG001|Overall Study|Patient's/Guardian's Decision|30|||
154964153|NCT00443651|559295189|FG000|Overall Study|Physician Decision|13|||
155348207|NCT01194271|560708337|FG000|Overall Study|Death|1|||
155348208|NCT00349622|560708338|FG000|Overall Study|Death|168|||
155348209|NCT00349622|560708339|FG001|Overall Study|Death|86|||
155348210|NCT00349622|560708338|FG000|Overall Study|Lost to Follow-up|5|||
155348211|NCT00349622|560708339|FG001|Overall Study|Lost to Follow-up|1|||
155348212|NCT00349622|560708338|FG000|Overall Study|Withdrawal by Subject|5|||
155348213|NCT00349622|560708339|FG001|Overall Study|Withdrawal by Subject|9|||
155348214|NCT03296566|560708342|FG000|Overall Study|Lost to Follow-up|19|||
155348215|NCT03296566|560708343|FG001|Overall Study|Lost to Follow-up|46|||
155348216|NCT03296566|560708342|FG000|Overall Study|Withdrawal by Subject|0|||
155348217|NCT03296566|560708343|FG001|Overall Study|Withdrawal by Subject|3|||
155348218|NCT01503515|560708349|FG000|Overall Study|Adverse Event|4|||
155348219|NCT01503515|560708350|FG001|Overall Study|Adverse Event|5|||
155348220|NCT01503515|560708349|FG000|Overall Study|Death|0|||
155348221|NCT01503515|560708350|FG001|Overall Study|Death|1|||
155083415|NCT00215657|559737211|FG000|Overall Study|Insufficient testosterone response|5|||
155083416|NCT00215657|559737212|FG001|Overall Study|Insufficient testosterone response|4|||
155083417|NCT00215657|559737213|FG002|Overall Study|Insufficient testosterone response|1|||
155083418|NCT00215657|559737214|FG003|Overall Study|Insufficient testosterone response|12|||
155083419|NCT00215657|559737215|FG004|Overall Study|Insufficient testosterone response|8|||
155083420|NCT00215657|559737216|FG005|Overall Study|Insufficient testosterone response|12|||
155083421|NCT00215657|559737217|FG006|Overall Study|Insufficient testosterone response|4|||
155083422|NCT00215657|559737218|FG007|Overall Study|Insufficient testosterone response|7|||
155083423|NCT00215657|559737211|FG000|Overall Study|Other|3|||
155348222|NCT01503515|560708349|FG000|Overall Study|Physician Decision|14|||
155348223|NCT01503515|560708350|FG001|Overall Study|Physician Decision|23|||
155348224|NCT01503515|560708349|FG000|Overall Study|Withdrawal by Subject|0|||
155348225|NCT01503515|560708350|FG001|Overall Study|Withdrawal by Subject|1|||
155348226|NCT01503515|560708349|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
155348227|NCT01503515|560708350|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
155348228|NCT01503515|560708349|FG000|Overall Study|Ineligible|1|||
155348229|NCT01503515|560708350|FG001|Overall Study|Ineligible|1|||
155348230|NCT01350102|560708351|FG000|Overall Study|Adverse Event|0|||
155348231|NCT01350102|560708352|FG001|Overall Study|Adverse Event|0|||
155348232|NCT01350102|560708353|FG002|Overall Study|Adverse Event|1|||
155348233|NCT01350102|560708354|FG003|Overall Study|Adverse Event|0|||
155348234|NCT00726388|560708361|FG000|Overall Study|Withdrawal by Subject|5|||
155348235|NCT00726388|560708361|FG000|Overall Study|Adverse Event|3|||
155348236|NCT00726388|560708361|FG000|Overall Study|Lost to Follow-up|10|||
155348237|NCT00726388|560708361|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
155348238|NCT00726388|560708361|FG000|Overall Study|Other|5|||
155348239|NCT00726388|560708361|FG000|Overall Study|Enrolled, Not Treated|79|||
155348240|NCT00609245|560708364|FG000|Overall Study|Adverse Event|1|||
155348241|NCT01631825|560708365|FG000|Overall Study|Adverse Event|42|||
155348242|NCT01631825|560708365|FG000|Overall Study|Lack of Efficacy|7|||
155083424|NCT00215657|559737212|FG001|Overall Study|Other|1|||
155083425|NCT00215657|559737213|FG002|Overall Study|Other|2|||
155083426|NCT00215657|559737214|FG003|Overall Study|Other|3|||
155083427|NCT00215657|559737215|FG004|Overall Study|Other|5|||
155083428|NCT00215657|559737216|FG005|Overall Study|Other|4|||
155083429|NCT00215657|559737217|FG006|Overall Study|Other|6|||
155083430|NCT00215657|559737218|FG007|Overall Study|Other|1|||
155083431|NCT01887600|559737221|FG000|Overall Study|Death|39|||
155083432|NCT01887600|559737222|FG001|Overall Study|Death|16|||
155083433|NCT01887600|559737221|FG000|Overall Study|Lack of Efficacy|3|||
155083434|NCT01887600|559737222|FG001|Overall Study|Lack of Efficacy|26|||
155083435|NCT01887600|559737221|FG000|Overall Study|Lost to Follow-up|5|||
155083436|NCT01887600|559737222|FG001|Overall Study|Lost to Follow-up|1|||
155083437|NCT01887600|559737221|FG000|Overall Study|Physician Decision|7|||
155083438|NCT01887600|559737222|FG001|Overall Study|Physician Decision|8|||
155083439|NCT01887600|559737221|FG000|Overall Study|Protocol Deviation|3|||
155083440|NCT01887600|559737222|FG001|Overall Study|Protocol Deviation|0|||
155083441|NCT01887600|559737221|FG000|Overall Study|Withdrawal by Subject|58|||
155083442|NCT01887600|559737222|FG001|Overall Study|Withdrawal by Subject|52|||
155083443|NCT01887600|559737221|FG000|Overall Study|Adverse Event|21|||
155348243|NCT01631825|560708365|FG000|Overall Study|Withdrawal by Subject|9|||
155348244|NCT01631825|560708365|FG000|Overall Study|Protocol Violation|4|||
155348245|NCT01631825|560708365|FG000|Overall Study|Discontinuation criteria|1|||
155348246|NCT01631825|560708365|FG000|Overall Study|Physician Decision|2|||
155348247|NCT03022045|560708368|FG000|Overall Study|Adverse Event|0|||
155348248|NCT03022045|560708369|FG001|Overall Study|Adverse Event|1|||
155348249|NCT03022045|560708368|FG000|Overall Study|Withdrawal by Subject|1|||
155348250|NCT03022045|560708369|FG001|Overall Study|Withdrawal by Subject|1|||
155083444|NCT01887600|559737222|FG001|Overall Study|Adverse Event|9|||
155083445|NCT01887600|559737221|FG000|Overall Study|Non-compliance with study drug|3|||
155083446|NCT01887600|559737222|FG001|Overall Study|Non-compliance with study drug|0|||
155083447|NCT01887600|559737221|FG000|Overall Study|Miscellaneous|6|||
155348251|NCT05372913|560708370|FG000|Overall Study|Withdrawal by Subject|0|||
155348252|NCT05372913|560708371|FG001|Overall Study|Withdrawal by Subject|2|||
155348253|NCT05372913|560708370|FG000|Overall Study|Protocol Violation|2|||
155348254|NCT05372913|560708371|FG001|Overall Study|Protocol Violation|2|||
155348255|NCT05372913|560708370|FG000|Overall Study|Adverse Event|0|||
155348256|NCT05372913|560708371|FG001|Overall Study|Adverse Event|1|||
155348257|NCT05012397|560708375|FG000|Overall Study|Death|10|||
155348258|NCT05012397|560708375|FG000|Overall Study|Physician Decision|9|||
155348259|NCT05012397|560708375|FG000|Overall Study|Withdrawal by Subject|5|||
155348260|NCT05012397|560708375|FG000|Overall Study|Lost to Follow-up|2|||
155348261|NCT03334747|560708376|FG000|Treatment Phase|Technical problems|0|||
155348262|NCT03334747|560708377|FG001|Treatment Phase|Technical problems|0|||
155348263|NCT03334747|560708378|FG002|Treatment Phase|Technical problems|0|||
155348264|NCT03334747|560708379|FG003|Treatment Phase|Technical problems|0|||
155348265|NCT03334747|560708380|FG004|Treatment Phase|Technical problems|1|||
155348266|NCT03334747|560708381|FG005|Treatment Phase|Technical problems|0|||
155083448|NCT01887600|559737222|FG001|Overall Study|Miscellaneous|2|||
155083449|NCT01887600|559737221|FG000|Overall Study|Progressive Disease|1|||
155083450|NCT01887600|559737222|FG001|Overall Study|Progressive Disease|0|||
155083451|NCT03688139|559737223|FG000|Overall Study|Lost to Follow-up|2|||
155083452|NCT03688139|559737224|FG001|Overall Study|Lost to Follow-up|0|||
155083453|NCT03688139|559737223|FG000|Overall Study|Physician Decision|0|||
155348267|NCT03334747|560708382|FG006|Treatment Phase|Technical problems|0|||
155348268|NCT03334747|560708383|FG007|Treatment Phase|Technical problems|0|||
155348269|NCT03334747|560708384|FG008|Treatment Phase|Technical problems|0|||
155348270|NCT03334747|560708376|FG000|Treatment Phase|Subject/guardian decision|1|||
155348271|NCT03334747|560708377|FG001|Treatment Phase|Subject/guardian decision|0|||
155083454|NCT03688139|559737224|FG001|Overall Study|Physician Decision|1|||
155083455|NCT03688139|559737223|FG000|Overall Study|Withdrawal by Subject|2|||
155083456|NCT03688139|559737224|FG001|Overall Study|Withdrawal by Subject|3|||
155083457|NCT01185366|559737225|FG000|First Line Therapy|Insurance Coverage Denied|1|||
155083458|NCT01185366|559737226|FG001|First Line Therapy|Insurance Coverage Denied|1|||
155083459|NCT01185366|559737225|FG000|First Line Therapy|Withdrawal by Subject|1|||
155083460|NCT01185366|559737226|FG001|First Line Therapy|Withdrawal by Subject|0|||
155083461|NCT01185366|559737225|FG000|First Line Therapy|Lack of Metastatic Site|1|||
155083462|NCT01185366|559737226|FG001|First Line Therapy|Lack of Metastatic Site|0|||
155083463|NCT01185366|559737225|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
155083464|NCT01185366|559737226|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
155083465|NCT01185366|559737225|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
155083466|NCT01185366|559737226|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
155083467|NCT01185366|559737225|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
155083468|NCT01185366|559737226|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
155083469|NCT01185366|559737225|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
155083470|NCT01185366|559737226|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
155083471|NCT01783938|559737232|FG000|Overall Study|Disease Progression|18|||
155083472|NCT01783938|559737233|FG001|Overall Study|Disease Progression|41|||
155083473|NCT01783938|559737232|FG000|Overall Study|Study Drug Toxicity|27|||
155083474|NCT01783938|559737233|FG001|Overall Study|Study Drug Toxicity|14|||
155083475|NCT01783938|559737232|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
155083476|NCT01783938|559737233|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
155083477|NCT01783938|559737232|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
155083478|NCT01783938|559737233|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
155083479|NCT01783938|559737232|FG000|Overall Study|Participant Withdrew Consent|2|||
155083480|NCT01783938|559737233|FG001|Overall Study|Participant Withdrew Consent|0|||
155083481|NCT01783938|559737232|FG000|Overall Study|Maximum Clinical Benefit|1|||
155083482|NCT01783938|559737233|FG001|Overall Study|Maximum Clinical Benefit|0|||
155083483|NCT01783938|559737232|FG000|Overall Study|Other Reasons|3|||
155083484|NCT01783938|559737233|FG001|Overall Study|Other Reasons|1|||
155083485|NCT00498485|559737234|FG000|Overall Study|Adverse Event|1|||
155083486|NCT00498485|559737235|FG001|Overall Study|Adverse Event|5|||
155083487|NCT00452400|559737238|FG000|Overall Study|Adverse Event|1|||
155083488|NCT00452400|559737239|FG001|Overall Study|Adverse Event|1|||
155083489|NCT00452400|559737240|FG002|Overall Study|Adverse Event|5|||
155083490|NCT00452400|559737241|FG003|Overall Study|Adverse Event|0|||
155083491|NCT00452400|559737242|FG004|Overall Study|Adverse Event|2|||
155083492|NCT00452400|559737238|FG000|Overall Study|Protocol Violation|0|||
155083493|NCT00452400|559737239|FG001|Overall Study|Protocol Violation|0|||
155083494|NCT00452400|559737240|FG002|Overall Study|Protocol Violation|1|||
155083495|NCT00452400|559737241|FG003|Overall Study|Protocol Violation|0|||
155348272|NCT03334747|560708378|FG002|Treatment Phase|Subject/guardian decision|0|||
155348273|NCT03334747|560708379|FG003|Treatment Phase|Subject/guardian decision|0|||
155348274|NCT03334747|560708380|FG004|Treatment Phase|Subject/guardian decision|0|||
155348275|NCT03334747|560708381|FG005|Treatment Phase|Subject/guardian decision|1|||
155348276|NCT03334747|560708382|FG006|Treatment Phase|Subject/guardian decision|0|||
155083496|NCT00452400|559737242|FG004|Overall Study|Protocol Violation|0|||
155083497|NCT00452400|559737238|FG000|Overall Study|Lost to Follow-up|1|||
155083498|NCT00452400|559737239|FG001|Overall Study|Lost to Follow-up|0|||
155083499|NCT00452400|559737240|FG002|Overall Study|Lost to Follow-up|0|||
155348277|NCT03334747|560708383|FG007|Treatment Phase|Subject/guardian decision|0|||
155348278|NCT03334747|560708384|FG008|Treatment Phase|Subject/guardian decision|0|||
155348279|NCT03334747|560708376|FG000|Follow-Up Phase|Subject/guardian decision|0|||
155348280|NCT03334747|560708377|FG001|Follow-Up Phase|Subject/guardian decision|0|||
155348281|NCT03334747|560708378|FG002|Follow-Up Phase|Subject/guardian decision|0|||
155348282|NCT03334747|560708379|FG003|Follow-Up Phase|Subject/guardian decision|0|||
155348283|NCT03334747|560708380|FG004|Follow-Up Phase|Subject/guardian decision|0|||
155348284|NCT03334747|560708381|FG005|Follow-Up Phase|Subject/guardian decision|0|||
155348285|NCT03334747|560708382|FG006|Follow-Up Phase|Subject/guardian decision|1|||
155348286|NCT03334747|560708383|FG007|Follow-Up Phase|Subject/guardian decision|0|||
155348287|NCT03334747|560708384|FG008|Follow-Up Phase|Subject/guardian decision|1|||
155348288|NCT03303521|560708385|FG000|Overall Study|Withdrawal by Subject|2|||
155348289|NCT03303521|560708386|FG001|Overall Study|Withdrawal by Subject|0|||
155348290|NCT03303521|560708385|FG000|Overall Study|Death|1|||
155348291|NCT03303521|560708386|FG001|Overall Study|Death|0|||
155348292|NCT03303521|560708385|FG000|Overall Study|Kidney transplantation|0|||
155348293|NCT03303521|560708386|FG001|Overall Study|Kidney transplantation|1|||
155348294|NCT03303521|560708385|FG000|Overall Study|Investigational product discontinuation|0|||
155348295|NCT03303521|560708386|FG001|Overall Study|Investigational product discontinuation|1|||
155348296|NCT03303521|560708385|FG000|Overall Study|Transferred to non-study dialysis center|1|||
155348297|NCT03303521|560708386|FG001|Overall Study|Transferred to non-study dialysis center|0|||
155348298|NCT03303521|560708385|FG000|Overall Study|Non-comliance to study protocol|0|||
155348299|NCT03303521|560708386|FG001|Overall Study|Non-comliance to study protocol|1|||
155348300|NCT03303521|560708385|FG000|Overall Study|Adverse Event|1|||
155348301|NCT03303521|560708386|FG001|Overall Study|Adverse Event|0|||
155348302|NCT00005908|560708387|FG000|Overall Study|Withdrawal by Subject|1|||
155348303|NCT00005908|560708388|FG001|Overall Study|Withdrawal by Subject|0|||
155348304|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Adverse Event|3|||
155348305|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Adverse Event|0|||
155348306|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
155348307|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
155348308|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Disease Progression|23|||
155348309|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Disease Progression|22|||
155348310|NCT01379521|560708389|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
155348311|NCT01379521|560708390|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
155348312|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
155348313|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
155348314|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
155348315|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
155348316|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
155348317|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
155348318|NCT01379521|560708389|FG000|Overall Study -Treatment Period|Death|2|||
155348319|NCT01379521|560708390|FG001|Overall Study -Treatment Period|Death|1|||
155348320|NCT01379521|560708389|FG000|Post-Treatment Evaluations|Disease Progression|22|||
155348321|NCT01379521|560708390|FG001|Post-Treatment Evaluations|Disease Progression|20|||
155348322|NCT01379521|560708389|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
155348323|NCT01379521|560708390|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
155348324|NCT01379521|560708389|FG000|Post-Treatment Evaluations|Death|1|||
155348325|NCT01379521|560708390|FG001|Post-Treatment Evaluations|Death|0|||
155348326|NCT02504502|560708391|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
155348327|NCT02504502|560708392|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
155348328|NCT02504502|560708391|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
155348329|NCT02504502|560708392|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
155348330|NCT00577096|560708399|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
155083500|NCT00452400|559737241|FG003|Overall Study|Lost to Follow-up|0|||
155083501|NCT00452400|559737242|FG004|Overall Study|Lost to Follow-up|0|||
155083502|NCT00452400|559737238|FG000|Overall Study|Withdrawal by Subject|1|||
155083503|NCT00452400|559737239|FG001|Overall Study|Withdrawal by Subject|0|||
155083504|NCT00452400|559737240|FG002|Overall Study|Withdrawal by Subject|1|||
155083505|NCT00452400|559737241|FG003|Overall Study|Withdrawal by Subject|0|||
155083506|NCT00452400|559737242|FG004|Overall Study|Withdrawal by Subject|0|||
155348331|NCT00577096|560708400|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
155083507|NCT00452400|559737238|FG000|Overall Study|Lack of Efficacy|2|||
155083508|NCT00452400|559737239|FG001|Overall Study|Lack of Efficacy|0|||
155348332|NCT00577096|560708399|FG000|Short Term Participation|Withdrawal by Subject|3|||
155083509|NCT00452400|559737240|FG002|Overall Study|Lack of Efficacy|0|||
155083510|NCT00452400|559737241|FG003|Overall Study|Lack of Efficacy|0|||
155083511|NCT00452400|559737242|FG004|Overall Study|Lack of Efficacy|0|||
155348333|NCT00577096|560708400|FG001|Short Term Participation|Withdrawal by Subject|5|||
155165595|NCT00441064|560043497|FG001|Overall Study|Abnormal test procedure results|1|||
155348334|NCT00577096|560708399|FG000|Short Term Participation|Death|1|||
155348335|NCT00577096|560708400|FG001|Short Term Participation|Death|1|||
155348336|NCT00832650|560708401|FG000|Overall Study|Randomized but not treated|0|||
155348337|NCT00832650|560708402|FG001|Overall Study|Randomized but not treated|0|||
155348338|NCT00832650|560708403|FG002|Overall Study|Randomized but not treated|1|||
155348339|NCT00440037|560708405|FG000|Overall Study|Withdrawal by Subject|6|||
155348340|NCT00440037|560708405|FG000|Overall Study|Administrative decision|3|||
155348341|NCT03356145|560708406|FG000|Overall Study|Withdrawal by Subject|2|||
155348342|NCT03356145|560708407|FG001|Overall Study|Withdrawal by Subject|1|||
155348343|NCT03356145|560708406|FG000|Overall Study|Did not meet inclusion criteria|1|||
155348344|NCT03356145|560708407|FG001|Overall Study|Did not meet inclusion criteria|0|||
155348345|NCT03740919|560708410|FG000|Lead-in Period|Lost to Follow-up|1|||
155348346|NCT03740919|560708411|FG001|Lead-in Period|Lost to Follow-up|0|||
155348347|NCT03740919|560708412|FG002|Lead-in Period|Lost to Follow-up|0|||
155348348|NCT03740919|560708413|FG003|Lead-in Period|Lost to Follow-up|0|||
155348349|NCT03740919|560708410|FG000|Lead-in Period|Physician Decision|2|||
155348350|NCT03740919|560708411|FG001|Lead-in Period|Physician Decision|0|||
155348351|NCT03740919|560708412|FG002|Lead-in Period|Physician Decision|0|||
155348352|NCT03740919|560708413|FG003|Lead-in Period|Physician Decision|0|||
155348353|NCT03740919|560708410|FG000|Lead-in Period|Protocol Violation|1|||
155348354|NCT03740919|560708411|FG001|Lead-in Period|Protocol Violation|0|||
155348355|NCT03740919|560708412|FG002|Lead-in Period|Protocol Violation|0|||
155348356|NCT03740919|560708413|FG003|Lead-in Period|Protocol Violation|0|||
155348357|NCT03740919|560708410|FG000|Lead-in Period|Withdrawal by Subject|10|||
155348358|NCT03740919|560708411|FG001|Lead-in Period|Withdrawal by Subject|0|||
155348359|NCT03740919|560708412|FG002|Lead-in Period|Withdrawal by Subject|0|||
155348360|NCT03740919|560708413|FG003|Lead-in Period|Withdrawal by Subject|0|||
155348361|NCT03740919|560708410|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
155348362|NCT03740919|560708411|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
155348363|NCT03740919|560708412|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
155348364|NCT03740919|560708413|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
155348365|NCT03740919|560708410|FG000|Lead-in Period|Study Task Too Burdensome|1|||
155348366|NCT03740919|560708411|FG001|Lead-in Period|Study Task Too Burdensome|0|||
155348367|NCT03740919|560708412|FG002|Lead-in Period|Study Task Too Burdensome|0|||
155348368|NCT03740919|560708413|FG003|Lead-in Period|Study Task Too Burdensome|0|||
155348369|NCT03740919|560708410|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
155348370|NCT03740919|560708411|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
155348371|NCT03740919|560708412|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
155348372|NCT03740919|560708413|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
155348373|NCT03740919|560708410|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
155348374|NCT03740919|560708411|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
155348375|NCT03740919|560708412|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
155348376|NCT03740919|560708413|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
155348377|NCT03740919|560708410|FG000|Treatment Period|Adverse Event|0|||
155348378|NCT03740919|560708411|FG001|Treatment Period|Adverse Event|0|||
155348379|NCT03740919|560708412|FG002|Treatment Period|Adverse Event|2|||
155348380|NCT03740919|560708413|FG003|Treatment Period|Adverse Event|0|||
155348381|NCT03740919|560708410|FG000|Treatment Period|Protocol Violation|0|||
155348382|NCT03740919|560708411|FG001|Treatment Period|Protocol Violation|1|||
155348383|NCT03740919|560708412|FG002|Treatment Period|Protocol Violation|0|||
155348384|NCT03740919|560708413|FG003|Treatment Period|Protocol Violation|0|||
155348385|NCT03740919|560708410|FG000|Treatment Period|Withdrawal by Subject|0|||
155348386|NCT03740919|560708411|FG001|Treatment Period|Withdrawal by Subject|7|||
155348387|NCT03740919|560708412|FG002|Treatment Period|Withdrawal by Subject|6|||
155348388|NCT03740919|560708413|FG003|Treatment Period|Withdrawal by Subject|2|||
155348389|NCT03740919|560708410|FG000|Treatment Period|Terminated by Sponsor|0|||
155348390|NCT03740919|560708411|FG001|Treatment Period|Terminated by Sponsor|1|||
155348391|NCT03740919|560708412|FG002|Treatment Period|Terminated by Sponsor|0|||
155348392|NCT03740919|560708413|FG003|Treatment Period|Terminated by Sponsor|0|||
155348393|NCT03740919|560708410|FG000|Treatment Period|Issue with Insulin Pump|0|||
155348394|NCT03740919|560708411|FG001|Treatment Period|Issue with Insulin Pump|1|||
155348395|NCT03740919|560708412|FG002|Treatment Period|Issue with Insulin Pump|0|||
155348396|NCT03740919|560708413|FG003|Treatment Period|Issue with Insulin Pump|0|||
155348397|NCT03740919|560708410|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
155348398|NCT03740919|560708411|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
155348399|NCT03740919|560708412|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
155348400|NCT03740919|560708413|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
155348401|NCT03740919|560708410|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
155348402|NCT03740919|560708411|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
155348403|NCT03740919|560708412|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
155348404|NCT03740919|560708413|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
155348405|NCT03740919|560708410|FG000|Treatment Period|Not Completing Diary|0|||
155348406|NCT03740919|560708411|FG001|Treatment Period|Not Completing Diary|0|||
155083512|NCT00452400|559737238|FG000|Overall Study|Other reasons not listed above|0|||
155083513|NCT00452400|559737239|FG001|Overall Study|Other reasons not listed above|0|||
155348407|NCT03740919|560708412|FG002|Treatment Period|Not Completing Diary|1|||
155348408|NCT03740919|560708413|FG003|Treatment Period|Not Completing Diary|0|||
155348409|NCT03740919|560708410|FG000|Treatment Period|Insulin Painful to Participant|0|||
155348410|NCT03740919|560708411|FG001|Treatment Period|Insulin Painful to Participant|0|||
155348411|NCT03740919|560708412|FG002|Treatment Period|Insulin Painful to Participant|1|||
155348412|NCT03740919|560708413|FG003|Treatment Period|Insulin Painful to Participant|0|||
155348413|NCT00985621|560708416|FG000|Overall Study|Adverse Event|2|||
155348414|NCT00985621|560708417|FG001|Overall Study|Adverse Event|3|||
155348415|NCT00985621|560708418|FG002|Overall Study|Adverse Event|4|||
155348416|NCT00985621|560708419|FG003|Overall Study|Adverse Event|16|||
155348417|NCT00985621|560708416|FG000|Overall Study|Lack of Efficacy|10|||
155348418|NCT00985621|560708417|FG001|Overall Study|Lack of Efficacy|6|||
155348419|NCT00985621|560708418|FG002|Overall Study|Lack of Efficacy|5|||
155348420|NCT00985621|560708419|FG003|Overall Study|Lack of Efficacy|12|||
155348421|NCT00985621|560708416|FG000|Overall Study|Lost to Follow-up|2|||
155348422|NCT00985621|560708417|FG001|Overall Study|Lost to Follow-up|3|||
155348423|NCT00985621|560708418|FG002|Overall Study|Lost to Follow-up|4|||
155083514|NCT00452400|559737240|FG002|Overall Study|Other reasons not listed above|0|||
155348424|NCT00985621|560708419|FG003|Overall Study|Lost to Follow-up|4|||
155083515|NCT00452400|559737241|FG003|Overall Study|Other reasons not listed above|1|||
155083516|NCT00452400|559737242|FG004|Overall Study|Other reasons not listed above|1|||
155083517|NCT01712074|559737245|FG000|Placebo Run-in Period|Adverse Event|2|||
155083518|NCT01712074|559737246|FG001|Placebo Run-in Period|Adverse Event|0|||
155083519|NCT01712074|559737247|FG002|Placebo Run-in Period|Adverse Event|0|||
155083520|NCT01712074|559737245|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
155083521|NCT01712074|559737246|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
155083522|NCT01712074|559737247|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
155083523|NCT01712074|559737245|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
155083524|NCT01712074|559737246|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
154964154|NCT00443651|559295190|FG001|Overall Study|Physician Decision|4|||
155083525|NCT01712074|559737247|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
155083526|NCT01712074|559737245|FG000|Placebo Run-in Period|Other|1|||
155083527|NCT01712074|559737246|FG001|Placebo Run-in Period|Other|0|||
155348425|NCT00985621|560708416|FG000|Overall Study|Study Terminated by Sponsor|89|||
155348426|NCT00985621|560708417|FG001|Overall Study|Study Terminated by Sponsor|108|||
155348427|NCT00985621|560708418|FG002|Overall Study|Study Terminated by Sponsor|99|||
155348428|NCT00985621|560708419|FG003|Overall Study|Study Terminated by Sponsor|92|||
155348429|NCT00985621|560708416|FG000|Overall Study|Protocol Violation|1|||
155348430|NCT00985621|560708417|FG001|Overall Study|Protocol Violation|1|||
155083528|NCT01712074|559737247|FG002|Placebo Run-in Period|Other|0|||
155348431|NCT00985621|560708418|FG002|Overall Study|Protocol Violation|1|||
155348432|NCT00985621|560708419|FG003|Overall Study|Protocol Violation|0|||
154964155|NCT00443651|559295189|FG000|Overall Study|Pregnancy|0|||
155348433|NCT00985621|560708416|FG000|Overall Study|Withdrawal by Subject|8|||
155348434|NCT00985621|560708417|FG001|Overall Study|Withdrawal by Subject|10|||
155348435|NCT00985621|560708418|FG002|Overall Study|Withdrawal by Subject|8|||
155348436|NCT00985621|560708419|FG003|Overall Study|Withdrawal by Subject|12|||
155348437|NCT00985621|560708416|FG000|Overall Study|Other|1|||
155083529|NCT01712074|559737245|FG000|Placebo Run-in Period|No longer willing to participate|1|||
155083530|NCT01712074|559737246|FG001|Placebo Run-in Period|No longer willing to participate|0|||
155083531|NCT01712074|559737247|FG002|Placebo Run-in Period|No longer willing to participate|0|||
155083532|NCT01712074|559737245|FG000|Double Blind Period|Adverse Event|0|||
155348438|NCT00985621|560708417|FG001|Overall Study|Other|0|||
155348439|NCT00985621|560708418|FG002|Overall Study|Other|0|||
155348440|NCT00985621|560708419|FG003|Overall Study|Other|0|||
155348441|NCT00985621|560708416|FG000|Overall Study|Randomized but not Treated|1|||
155348442|NCT00985621|560708417|FG001|Overall Study|Randomized but not Treated|0|||
155348443|NCT00985621|560708418|FG002|Overall Study|Randomized but not Treated|2|||
155348444|NCT00985621|560708419|FG003|Overall Study|Randomized but not Treated|1|||
155348445|NCT04394624|560708423|FG000|Overall Study|Adverse Event|6|||
155348446|NCT04394624|560708424|FG001|Overall Study|Adverse Event|0|||
155348447|NCT04394624|560708423|FG000|Overall Study|Progressive disease|24|||
155348448|NCT04394624|560708424|FG001|Overall Study|Progressive disease|0|||
155348449|NCT04394624|560708423|FG000|Overall Study|Not related to COVID-19|1|||
155348450|NCT04394624|560708424|FG001|Overall Study|Not related to COVID-19|0|||
155348451|NCT00905255|560708425|FG000|Overall Study|Adverse Event|7|||
155348452|NCT00905255|560708426|FG001|Overall Study|Adverse Event|5|||
155348453|NCT00905255|560708425|FG000|Overall Study|Withdrawal by Subject|5|||
155348454|NCT00905255|560708426|FG001|Overall Study|Withdrawal by Subject|4|||
155348455|NCT00905255|560708425|FG000|Overall Study|Familial and Personal Reasons|1|||
155348456|NCT00905255|560708426|FG001|Overall Study|Familial and Personal Reasons|0|||
155348457|NCT00603278|560708429|FG000|Overall Study|Lack of Efficacy|35|||
155348458|NCT00603278|560708430|FG001|Overall Study|Lack of Efficacy|10|||
155348459|NCT00603278|560708431|FG002|Overall Study|Lack of Efficacy|11|||
155348460|NCT00603278|560708432|FG003|Overall Study|Lack of Efficacy|8|||
155348461|NCT00603278|560708433|FG004|Overall Study|Lack of Efficacy|7|||
155348462|NCT00603278|560708434|FG005|Overall Study|Lack of Efficacy|14|||
155348463|NCT00603278|560708429|FG000|Overall Study|Adverse Event|0|||
155348464|NCT00603278|560708430|FG001|Overall Study|Adverse Event|3|||
155348465|NCT00603278|560708431|FG002|Overall Study|Adverse Event|1|||
155348466|NCT00603278|560708432|FG003|Overall Study|Adverse Event|0|||
155348467|NCT00603278|560708433|FG004|Overall Study|Adverse Event|2|||
155348468|NCT00603278|560708434|FG005|Overall Study|Adverse Event|1|||
155348469|NCT00603278|560708429|FG000|Overall Study|Withdrawal by Subject|2|||
155348470|NCT00603278|560708430|FG001|Overall Study|Withdrawal by Subject|3|||
155348471|NCT00603278|560708431|FG002|Overall Study|Withdrawal by Subject|1|||
155348472|NCT00603278|560708432|FG003|Overall Study|Withdrawal by Subject|2|||
155348473|NCT00603278|560708433|FG004|Overall Study|Withdrawal by Subject|1|||
155348474|NCT00603278|560708434|FG005|Overall Study|Withdrawal by Subject|2|||
155348475|NCT00603278|560708429|FG000|Overall Study|Protocol Violation|3|||
155348476|NCT00603278|560708430|FG001|Overall Study|Protocol Violation|0|||
155348477|NCT00603278|560708431|FG002|Overall Study|Protocol Violation|1|||
155348478|NCT00603278|560708432|FG003|Overall Study|Protocol Violation|1|||
155348479|NCT00603278|560708433|FG004|Overall Study|Protocol Violation|0|||
155348480|NCT00603278|560708434|FG005|Overall Study|Protocol Violation|1|||
155348481|NCT00603278|560708429|FG000|Overall Study|Physician Decision|0|||
155348482|NCT00603278|560708430|FG001|Overall Study|Physician Decision|1|||
155348483|NCT00603278|560708431|FG002|Overall Study|Physician Decision|0|||
155348484|NCT00603278|560708432|FG003|Overall Study|Physician Decision|0|||
155348485|NCT00603278|560708433|FG004|Overall Study|Physician Decision|2|||
155348486|NCT00603278|560708434|FG005|Overall Study|Physician Decision|1|||
155348487|NCT00603278|560708429|FG000|Overall Study|Lost to Follow-up|1|||
155348488|NCT00603278|560708430|FG001|Overall Study|Lost to Follow-up|0|||
155348489|NCT00603278|560708431|FG002|Overall Study|Lost to Follow-up|0|||
155083533|NCT01712074|559737246|FG001|Double Blind Period|Adverse Event|2|||
155083534|NCT01712074|559737247|FG002|Double Blind Period|Adverse Event|1|||
155083535|NCT01712074|559737245|FG000|Double Blind Period|No longer willing to participate|0|||
155083536|NCT01712074|559737246|FG001|Double Blind Period|No longer willing to participate|2|||
155083537|NCT01712074|559737247|FG002|Double Blind Period|No longer willing to participate|4|||
155083538|NCT01712074|559737245|FG000|Double Blind Period|Death|0|||
155083539|NCT01712074|559737246|FG001|Double Blind Period|Death|1|||
155083540|NCT01712074|559737247|FG002|Double Blind Period|Death|0|||
155083541|NCT01712074|559737245|FG000|Double Blind Period|Lost to Follow-up|0|||
155165596|NCT00441064|560043496|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155348490|NCT00603278|560708432|FG003|Overall Study|Lost to Follow-up|0|||
155348491|NCT00603278|560708433|FG004|Overall Study|Lost to Follow-up|1|||
155348492|NCT00603278|560708434|FG005|Overall Study|Lost to Follow-up|0|||
155348493|NCT02418819|560708436|FG000|Overall Study|Adverse Event|0|||
155348494|NCT02418819|560708437|FG001|Overall Study|Adverse Event|0|||
155348495|NCT02418819|560708438|FG002|Overall Study|Adverse Event|1|||
155348496|NCT02418819|560708439|FG003|Overall Study|Adverse Event|0|||
155348497|NCT02418819|560708436|FG000|Overall Study|Lost to Follow-up|1|||
155348498|NCT02418819|560708437|FG001|Overall Study|Lost to Follow-up|0|||
155348499|NCT02418819|560708438|FG002|Overall Study|Lost to Follow-up|0|||
155348500|NCT02418819|560708439|FG003|Overall Study|Lost to Follow-up|0|||
155348501|NCT02418819|560708436|FG000|Overall Study|No longer meets eligibility criteria|0|||
155348502|NCT02418819|560708437|FG001|Overall Study|No longer meets eligibility criteria|0|||
155348503|NCT02418819|560708438|FG002|Overall Study|No longer meets eligibility criteria|1|||
155348504|NCT02418819|560708439|FG003|Overall Study|No longer meets eligibility criteria|0|||
155348505|NCT02418819|560708436|FG000|Overall Study|No longer willing to participate|0|||
155348506|NCT02418819|560708437|FG001|Overall Study|No longer willing to participate|0|||
155348507|NCT02418819|560708438|FG002|Overall Study|No longer willing to participate|2|||
155348508|NCT02418819|560708439|FG003|Overall Study|No longer willing to participate|1|||
155348509|NCT01332318|560708443|FG000|Overall Study|Adverse Event|0|||
155348510|NCT01332318|560708444|FG001|Overall Study|Adverse Event|3|||
155348511|NCT01332318|560708445|FG002|Overall Study|Adverse Event|0|||
155348512|NCT01332318|560708446|FG003|Overall Study|Adverse Event|0|||
155348513|NCT01332318|560708443|FG000|Overall Study|Withdrawal by Subject|1|||
155348514|NCT01332318|560708444|FG001|Overall Study|Withdrawal by Subject|1|||
155348515|NCT01332318|560708445|FG002|Overall Study|Withdrawal by Subject|0|||
155348516|NCT01332318|560708446|FG003|Overall Study|Withdrawal by Subject|1|||
155348517|NCT01332318|560708443|FG000|Overall Study|Protocol Violation|1|||
155348518|NCT01332318|560708444|FG001|Overall Study|Protocol Violation|0|||
155348519|NCT01332318|560708445|FG002|Overall Study|Protocol Violation|1|||
155348520|NCT01332318|560708446|FG003|Overall Study|Protocol Violation|1|||
155348521|NCT02040532|560708447|FG000|Overall Study|Lost to Follow-up|1|||
155348522|NCT02040532|560708447|FG000|Overall Study|Physician Decision|4|||
155348523|NCT02040532|560708447|FG000|Overall Study|Adverse Event|4|||
155348524|NCT02040532|560708447|FG000|Overall Study|Withdrawal by Subject|3|||
155348525|NCT01207453|560708448|FG000|First Intervention|Adverse Event|2|||
155348526|NCT01207453|560708449|FG001|First Intervention|Adverse Event|1|||
155348527|NCT01207453|560708448|FG000|Washout|Adverse Event|1|||
155348528|NCT01207453|560708449|FG001|Washout|Adverse Event|0|||
155348529|NCT01207453|560708448|FG000|Washout|Lost to Follow-up|1|||
155348530|NCT01207453|560708449|FG001|Washout|Lost to Follow-up|0|||
155348531|NCT01207453|560708448|FG000|2nd Intervention|Adverse Event|1|||
155348532|NCT01207453|560708449|FG001|2nd Intervention|Adverse Event|2|||
155348533|NCT01207453|560708448|FG000|2nd Intervention|Lost to Follow-up|1|||
155348534|NCT01207453|560708449|FG001|2nd Intervention|Lost to Follow-up|0|||
155348535|NCT00676663|560708452|FG000|Overall Study|Death|43|||
155348536|NCT00676663|560708453|FG001|Overall Study|Death|27|||
155348537|NCT00676663|560708452|FG000|Overall Study|Withdrew Consent|1|||
155348538|NCT00676663|560708453|FG001|Overall Study|Withdrew Consent|8|||
155348539|NCT00676663|560708452|FG000|Overall Study|Lost to Follow-up|1|||
155348540|NCT00676663|560708453|FG001|Overall Study|Lost to Follow-up|3|||
155348541|NCT04382053|560708454|FG000|Overall Study|Death|6|||
155348542|NCT04382053|560708455|FG001|Overall Study|Death|8|||
155348543|NCT04382053|560708454|FG000|Overall Study|Lost to Follow-up|0|||
155348544|NCT04382053|560708455|FG001|Overall Study|Lost to Follow-up|2|||
155348545|NCT04382053|560708454|FG000|Overall Study|Protocol Deviation|1|||
155348546|NCT04382053|560708455|FG001|Overall Study|Protocol Deviation|2|||
155348547|NCT04382053|560708454|FG000|Overall Study|Withdrawal by Subject|2|||
155348548|NCT04382053|560708455|FG001|Overall Study|Withdrawal by Subject|1|||
155348549|NCT01399905|560708456|FG000|Overall Study|Withdrawal by Subject|1|||
155348550|NCT01399905|560708457|FG001|Overall Study|Withdrawal by Subject|1|||
155348551|NCT00714688|560708465|FG000|Overall Study|Lack of Efficacy|14|||
155348552|NCT00714688|560708466|FG001|Overall Study|Lack of Efficacy|1|||
155348553|NCT00714688|560708467|FG002|Overall Study|Lack of Efficacy|4|||
155348554|NCT00714688|560708465|FG000|Overall Study|Withdrawal by Subject|4|||
155348555|NCT00714688|560708466|FG001|Overall Study|Withdrawal by Subject|3|||
155348556|NCT00714688|560708467|FG002|Overall Study|Withdrawal by Subject|3|||
155083542|NCT01712074|559737246|FG001|Double Blind Period|Lost to Follow-up|2|||
155083543|NCT01712074|559737247|FG002|Double Blind Period|Lost to Follow-up|1|||
155348557|NCT00714688|560708465|FG000|Overall Study|Lost to Follow-up|5|||
155083544|NCT01712074|559737245|FG000|Double Blind Period|Other|0|||
155083545|NCT01712074|559737246|FG001|Double Blind Period|Other|4|||
155083546|NCT01712074|559737247|FG002|Double Blind Period|Other|1|||
155348558|NCT00714688|560708466|FG001|Overall Study|Lost to Follow-up|2|||
155348559|NCT00714688|560708467|FG002|Overall Study|Lost to Follow-up|0|||
155348560|NCT00714688|560708465|FG000|Overall Study|Adverse Event|2|||
155348561|NCT00714688|560708466|FG001|Overall Study|Adverse Event|15|||
155348562|NCT00714688|560708467|FG002|Overall Study|Adverse Event|19|||
155348563|NCT00714688|560708465|FG000|Overall Study|Subject Non-compliant|3|||
155348564|NCT00714688|560708466|FG001|Overall Study|Subject Non-compliant|5|||
155083547|NCT01712074|559737245|FG000|Double Blind Period|Protocol Violation|0|||
155083548|NCT01712074|559737246|FG001|Double Blind Period|Protocol Violation|0|||
155348565|NCT00714688|560708467|FG002|Overall Study|Subject Non-compliant|5|||
155348566|NCT00714688|560708465|FG000|Overall Study|Ineligible to Continue the Study|0|||
155348567|NCT00714688|560708466|FG001|Overall Study|Ineligible to Continue the Study|1|||
154964156|NCT00443651|559295190|FG001|Overall Study|Pregnancy|1|||
154964157|NCT01564394|559295191|FG000|Overall Study|Withdrawal by Subject|6|||
155083549|NCT01712074|559737247|FG002|Double Blind Period|Protocol Violation|1|||
155083550|NCT01712074|559737245|FG000|Double Blind Period|No longer met eligibility criteria|0|||
155083551|NCT01712074|559737246|FG001|Double Blind Period|No longer met eligibility criteria|3|||
155083552|NCT01712074|559737247|FG002|Double Blind Period|No longer met eligibility criteria|0|||
155083553|NCT03478787|559737248|FG000|Overall Study|Adverse Event|5|||
155083554|NCT03478787|559737249|FG001|Overall Study|Adverse Event|1|||
155348568|NCT00714688|560708467|FG002|Overall Study|Ineligible to Continue the Study|1|||
155348569|NCT00714688|560708465|FG000|Overall Study|Sponsor's Decision|0|||
155348570|NCT00714688|560708466|FG001|Overall Study|Sponsor's Decision|2|||
155348571|NCT00714688|560708467|FG002|Overall Study|Sponsor's Decision|0|||
155348572|NCT00714688|560708465|FG000|Overall Study|Other|1|||
155348573|NCT00714688|560708466|FG001|Overall Study|Other|6|||
155348574|NCT00714688|560708467|FG002|Overall Study|Other|5|||
155348575|NCT01786551|560708468|FG000|Overall Study|Participant withdrew consent|2|||
155348576|NCT04853394|560708471|FG000|Follow-up Interviews|Lost to Follow-up|22|||
155348577|NCT04853394|560708472|FG001|Follow-up Interviews|Lost to Follow-up|15|||
155348578|NCT01524887|560708473|FG000|Overall Study|Withdrawal by Subject|6|||
155348579|NCT01524887|560708474|FG001|Overall Study|Withdrawal by Subject|2|||
155348580|NCT01524887|560708475|FG002|Overall Study|Withdrawal by Subject|3|||
155348581|NCT01524887|560708473|FG000|Overall Study|Adverse Event|5|||
155348582|NCT01524887|560708474|FG001|Overall Study|Adverse Event|1|||
155348583|NCT01524887|560708475|FG002|Overall Study|Adverse Event|1|||
155348584|NCT01524887|560708473|FG000|Overall Study|Protocol Violation|0|||
155348585|NCT01524887|560708474|FG001|Overall Study|Protocol Violation|0|||
155348586|NCT01524887|560708475|FG002|Overall Study|Protocol Violation|1|||
155348587|NCT01524887|560708473|FG000|Overall Study|Study termination|73|||
155348588|NCT01524887|560708474|FG001|Overall Study|Study termination|87|||
155348589|NCT01524887|560708475|FG002|Overall Study|Study termination|79|||
155348590|NCT01524887|560708473|FG000|Overall Study|Withdrawal by Caregiver|0|||
155348591|NCT01524887|560708474|FG001|Overall Study|Withdrawal by Caregiver|0|||
155348592|NCT01524887|560708475|FG002|Overall Study|Withdrawal by Caregiver|2|||
155348593|NCT01524887|560708473|FG000|Overall Study|Use of prohibited medication|1|||
155348594|NCT01524887|560708474|FG001|Overall Study|Use of prohibited medication|0|||
155348595|NCT01524887|560708475|FG002|Overall Study|Use of prohibited medication|0|||
155348596|NCT01808144|560708476|FG000|Overall Study|Death|1|||
155348597|NCT01808144|560708477|FG001|Overall Study|Death|0|||
155348598|NCT01808144|560708476|FG000|Overall Study|Withdrawal by Subject|16|||
155348599|NCT01808144|560708477|FG001|Overall Study|Withdrawal by Subject|23|||
155348600|NCT01808144|560708476|FG000|Overall Study|Lost to Follow-up|6|||
155348601|NCT01808144|560708477|FG001|Overall Study|Lost to Follow-up|3|||
155348602|NCT01808144|560708476|FG000|Overall Study|Protocol Violation|6|||
155348603|NCT01808144|560708477|FG001|Overall Study|Protocol Violation|6|||
155348604|NCT01808144|560708476|FG000|Overall Study|Gout flare|0|||
155348605|NCT01808144|560708477|FG001|Overall Study|Gout flare|1|||
155348606|NCT01808144|560708476|FG000|Overall Study|Adverse Event|11|||
155348607|NCT01808144|560708477|FG001|Overall Study|Adverse Event|15|||
155348608|NCT03098797|560710574|FG000|Part 2 Open Label Extension|Adverse Event|2|||
155348609|NCT03098797|560710575|FG001|Part 2 Open Label Extension|Adverse Event|0|||
155348610|NCT02956278|560710576|FG000|Overall Study|Withdrawal by Subject|6|||
155348611|NCT02956278|560710577|FG001|Overall Study|Withdrawal by Subject|2|||
155348612|NCT02956278|560710578|FG002|Overall Study|Withdrawal by Subject|0|||
155348613|NCT02329223|560710579|FG000|Overall Study|Withdrawal by Subject|1|||
155348614|NCT02329223|560710580|FG001|Overall Study|Withdrawal by Subject|2|||
155348615|NCT02329223|560710581|FG002|Overall Study|Withdrawal by Subject|5|||
155348616|NCT02329223|560710579|FG000|Overall Study|Physician Decision|0|||
155348617|NCT02329223|560710580|FG001|Overall Study|Physician Decision|0|||
155348618|NCT02329223|560710581|FG002|Overall Study|Physician Decision|1|||
155348619|NCT02329223|560710579|FG000|Overall Study|Adverse Event|0|||
155348620|NCT02329223|560710580|FG001|Overall Study|Adverse Event|1|||
155348621|NCT02329223|560710581|FG002|Overall Study|Adverse Event|0|||
155348622|NCT00552513|560710586|FG000|Overall Study|Lost to Follow-up|5|||
155348623|NCT00552513|560710587|FG001|Overall Study|Lost to Follow-up|1|||
155348624|NCT04357964|560710588|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
155348625|NCT04357964|560710589|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
155348626|NCT04357964|560710588|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
155348627|NCT04357964|560710589|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
155348628|NCT04357964|560710588|FG000|Overall Study|Adipose sample was insufficient quality|0|||
154964158|NCT01564394|559295192|FG001|Overall Study|Withdrawal by Subject|10|||
155083555|NCT03478787|559737248|FG000|Overall Study|Protocol Violation|3|||
155083556|NCT03478787|559737249|FG001|Overall Study|Protocol Violation|0|||
155083557|NCT03478787|559737248|FG000|Overall Study|Lack of Efficacy|7|||
155083558|NCT03478787|559737249|FG001|Overall Study|Lack of Efficacy|1|||
155348629|NCT04357964|560710589|FG001|Overall Study|Adipose sample was insufficient quality|1|||
155348630|NCT00733226|560710590|FG000|Overall Study|Withdrawal by Subject|1|||
155348631|NCT00733226|560710591|FG001|Overall Study|Withdrawal by Subject|0|||
155348632|NCT00733226|560710590|FG000|Overall Study|Lost to Follow-up|2|||
155348633|NCT00733226|560710591|FG001|Overall Study|Lost to Follow-up|0|||
155348634|NCT00733226|560710590|FG000|Overall Study|moved to another place|2|||
155348635|NCT00733226|560710591|FG001|Overall Study|moved to another place|0|||
155348636|NCT00848393|560710592|FG000|Overall Study|Protocol Violation|0|||
155348637|NCT00848393|560710593|FG001|Overall Study|Protocol Violation|0|||
155348638|NCT00848393|560710594|FG002|Overall Study|Protocol Violation|1|||
155083559|NCT03478787|559737248|FG000|Overall Study|Lost to Follow-up|9|||
155348639|NCT00848393|560710592|FG000|Overall Study|surgical complications unrelated to stud|0|||
155348640|NCT00848393|560710593|FG001|Overall Study|surgical complications unrelated to stud|0|||
155348641|NCT00848393|560710594|FG002|Overall Study|surgical complications unrelated to stud|2|||
155348642|NCT00443898|560710599|FG000|Overall Study|Adverse Event|0|||
155348643|NCT00443898|560710600|FG001|Overall Study|Adverse Event|0|||
155348644|NCT00443898|560710601|FG002|Overall Study|Adverse Event|1|||
155348645|NCT00443898|560710602|FG003|Overall Study|Adverse Event|1|||
155348646|NCT00443898|560710599|FG000|Overall Study|Lack of Efficacy|2|||
155348647|NCT00443898|560710600|FG001|Overall Study|Lack of Efficacy|3|||
155348648|NCT00443898|560710601|FG002|Overall Study|Lack of Efficacy|3|||
155348649|NCT00443898|560710602|FG003|Overall Study|Lack of Efficacy|1|||
155348650|NCT00443898|560710599|FG000|Overall Study|Protocol Violation|1|||
155348651|NCT00443898|560710600|FG001|Overall Study|Protocol Violation|1|||
155348652|NCT00443898|560710601|FG002|Overall Study|Protocol Violation|1|||
155348653|NCT00443898|560710602|FG003|Overall Study|Protocol Violation|0|||
155348654|NCT00443898|560710599|FG000|Overall Study|Withdrawal by Subject|11|||
155348655|NCT00443898|560710600|FG001|Overall Study|Withdrawal by Subject|10|||
155348656|NCT00443898|560710601|FG002|Overall Study|Withdrawal by Subject|10|||
155348657|NCT00443898|560710602|FG003|Overall Study|Withdrawal by Subject|6|||
155348658|NCT00443898|560710599|FG000|Overall Study|Lost to Follow-up|10|||
155348659|NCT00443898|560710600|FG001|Overall Study|Lost to Follow-up|10|||
155348660|NCT00443898|560710601|FG002|Overall Study|Lost to Follow-up|14|||
155348661|NCT00443898|560710602|FG003|Overall Study|Lost to Follow-up|10|||
155348662|NCT00443898|560710599|FG000|Overall Study|Death|0|||
155348663|NCT00443898|560710600|FG001|Overall Study|Death|1|||
155348664|NCT00443898|560710601|FG002|Overall Study|Death|0|||
155348665|NCT00443898|560710602|FG003|Overall Study|Death|0|||
155348666|NCT00043186|560710603|FG000|Overall Study|Physician Decision|0|||
155348667|NCT00043186|560710604|FG001|Overall Study|Physician Decision|0|||
155348668|NCT00043186|560710605|FG002|Overall Study|Physician Decision|3|||
155348669|NCT00043186|560710606|FG003|Overall Study|Physician Decision|0|||
155348670|NCT00043186|560710607|FG004|Overall Study|Physician Decision|1|||
154964159|NCT03606174|559295193|FG000|Overall Study|Death|37|||
154964160|NCT03606174|559295194|FG001|Overall Study|Death|15|||
155083560|NCT03478787|559737249|FG001|Overall Study|Lost to Follow-up|5|||
155348671|NCT00043186|560710608|FG005|Overall Study|Physician Decision|0|||
155348672|NCT00043186|560710609|FG006|Overall Study|Physician Decision|0|||
155348673|NCT00043186|560710610|FG007|Overall Study|Physician Decision|1|||
155348674|NCT00043186|560710611|FG008|Overall Study|Physician Decision|1|||
155348675|NCT00043186|560710603|FG000|Overall Study|Adverse Event|2|||
155348676|NCT00043186|560710604|FG001|Overall Study|Adverse Event|2|||
155348677|NCT00043186|560710605|FG002|Overall Study|Adverse Event|2|||
155348678|NCT00043186|560710606|FG003|Overall Study|Adverse Event|3|||
155348679|NCT00043186|560710607|FG004|Overall Study|Adverse Event|2|||
155348680|NCT00043186|560710608|FG005|Overall Study|Adverse Event|1|||
155348681|NCT00043186|560710609|FG006|Overall Study|Adverse Event|2|||
154964161|NCT03606174|559295195|FG002|Overall Study|Death|15|||
154964162|NCT03606174|559295196|FG003|Overall Study|Death|7|||
154964163|NCT03606174|559295197|FG004|Overall Study|Death|35|||
155348682|NCT00043186|560710610|FG007|Overall Study|Adverse Event|1|||
155348683|NCT00043186|560710611|FG008|Overall Study|Adverse Event|3|||
155348684|NCT00043186|560710603|FG000|Overall Study|Withdrawal by Subject|11|||
155348685|NCT00043186|560710604|FG001|Overall Study|Withdrawal by Subject|8|||
155348686|NCT00043186|560710605|FG002|Overall Study|Withdrawal by Subject|11|||
155348687|NCT00043186|560710606|FG003|Overall Study|Withdrawal by Subject|13|||
155348688|NCT00043186|560710607|FG004|Overall Study|Withdrawal by Subject|14|||
155348689|NCT00043186|560710608|FG005|Overall Study|Withdrawal by Subject|6|||
155348690|NCT00043186|560710609|FG006|Overall Study|Withdrawal by Subject|12|||
155348691|NCT00043186|560710610|FG007|Overall Study|Withdrawal by Subject|9|||
155348692|NCT00043186|560710611|FG008|Overall Study|Withdrawal by Subject|10|||
155348693|NCT00043186|560710603|FG000|Overall Study|Death|0|||
155348694|NCT00043186|560710604|FG001|Overall Study|Death|0|||
155348695|NCT00043186|560710605|FG002|Overall Study|Death|1|||
155348696|NCT00043186|560710606|FG003|Overall Study|Death|0|||
155348697|NCT00043186|560710607|FG004|Overall Study|Death|0|||
155348698|NCT00043186|560710608|FG005|Overall Study|Death|0|||
155348699|NCT00043186|560710609|FG006|Overall Study|Death|2|||
155348700|NCT00043186|560710610|FG007|Overall Study|Death|0|||
155348701|NCT00043186|560710611|FG008|Overall Study|Death|0|||
155348702|NCT00043186|560710603|FG000|Overall Study|Disease progression|1|||
155348703|NCT00043186|560710604|FG001|Overall Study|Disease progression|0|||
155348704|NCT00043186|560710605|FG002|Overall Study|Disease progression|0|||
155348705|NCT00043186|560710606|FG003|Overall Study|Disease progression|3|||
155348706|NCT00043186|560710607|FG004|Overall Study|Disease progression|0|||
155348707|NCT00043186|560710608|FG005|Overall Study|Disease progression|0|||
155348708|NCT00043186|560710609|FG006|Overall Study|Disease progression|0|||
155348709|NCT00043186|560710610|FG007|Overall Study|Disease progression|4|||
155348710|NCT00043186|560710611|FG008|Overall Study|Disease progression|0|||
155348711|NCT00043186|560710603|FG000|Overall Study|Ineligibility determined|0|||
155348712|NCT00043186|560710604|FG001|Overall Study|Ineligibility determined|0|||
155348713|NCT00043186|560710605|FG002|Overall Study|Ineligibility determined|0|||
155348714|NCT00043186|560710606|FG003|Overall Study|Ineligibility determined|0|||
155348715|NCT00043186|560710607|FG004|Overall Study|Ineligibility determined|0|||
155348716|NCT00043186|560710608|FG005|Overall Study|Ineligibility determined|0|||
155348717|NCT00043186|560710609|FG006|Overall Study|Ineligibility determined|0|||
155348718|NCT00043186|560710610|FG007|Overall Study|Ineligibility determined|0|||
155348719|NCT00043186|560710611|FG008|Overall Study|Ineligibility determined|1|||
155348720|NCT00043186|560710603|FG000|Overall Study|Lost to Follow-up|3|||
155348721|NCT00043186|560710604|FG001|Overall Study|Lost to Follow-up|5|||
155348722|NCT00043186|560710605|FG002|Overall Study|Lost to Follow-up|1|||
155348723|NCT00043186|560710606|FG003|Overall Study|Lost to Follow-up|1|||
155348724|NCT00043186|560710607|FG004|Overall Study|Lost to Follow-up|1|||
155348725|NCT00043186|560710608|FG005|Overall Study|Lost to Follow-up|1|||
155348726|NCT00043186|560710609|FG006|Overall Study|Lost to Follow-up|1|||
155348727|NCT00043186|560710610|FG007|Overall Study|Lost to Follow-up|1|||
155348728|NCT00043186|560710611|FG008|Overall Study|Lost to Follow-up|2|||
155348729|NCT00043186|560710603|FG000|Overall Study|Noncompliance|0|||
155348730|NCT00043186|560710604|FG001|Overall Study|Noncompliance|0|||
155348731|NCT00043186|560710605|FG002|Overall Study|Noncompliance|1|||
155348732|NCT00043186|560710606|FG003|Overall Study|Noncompliance|1|||
155348733|NCT00043186|560710607|FG004|Overall Study|Noncompliance|0|||
155348734|NCT00043186|560710608|FG005|Overall Study|Noncompliance|0|||
155348735|NCT00043186|560710609|FG006|Overall Study|Noncompliance|0|||
155348736|NCT00043186|560710610|FG007|Overall Study|Noncompliance|0|||
155348737|NCT00043186|560710611|FG008|Overall Study|Noncompliance|0|||
155348738|NCT00043186|560710603|FG000|Overall Study|Other|0|||
155348739|NCT00043186|560710604|FG001|Overall Study|Other|0|||
155348740|NCT00043186|560710605|FG002|Overall Study|Other|1|||
155348741|NCT00043186|560710606|FG003|Overall Study|Other|1|||
155348742|NCT00043186|560710607|FG004|Overall Study|Other|0|||
155348743|NCT00043186|560710608|FG005|Overall Study|Other|0|||
155348744|NCT00043186|560710609|FG006|Overall Study|Other|0|||
155348745|NCT00043186|560710610|FG007|Overall Study|Other|0|||
155348746|NCT00043186|560710611|FG008|Overall Study|Other|0|||
155348747|NCT00508274|560710612|FG000|Overall Study|Adverse Event|5|||
155348748|NCT00508274|560710612|FG000|Overall Study|Death|7|||
155348749|NCT00508274|560710612|FG000|Overall Study|Disease progression|32|||
155348750|NCT00508274|560710612|FG000|Overall Study|Withdrawal by Subject|1|||
155348751|NCT00508274|560710612|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
155348752|NCT00508274|560710612|FG000|Overall Study|Missing|3|||
155348753|NCT00550771|560710615|FG000|Overall Study|Adverse Event|11|||
155348754|NCT00550771|560710616|FG001|Overall Study|Adverse Event|3|||
155348755|NCT00550771|560710615|FG000|Overall Study|Discontinued for study-related reasons|0|||
155348756|NCT00550771|560710616|FG001|Overall Study|Discontinued for study-related reasons|1|||
155348757|NCT00550771|560710615|FG000|Overall Study|Physician Decision|2|||
155348758|NCT00550771|560710616|FG001|Overall Study|Physician Decision|0|||
155348759|NCT00550771|560710615|FG000|Overall Study|Withdrawal by Subject|0|||
155348760|NCT00550771|560710616|FG001|Overall Study|Withdrawal by Subject|1|||
155348761|NCT00550771|560710615|FG000|Overall Study|Protocol Violation|4|||
155348762|NCT00550771|560710616|FG001|Overall Study|Protocol Violation|5|||
154964164|NCT03606174|559295198|FG005|Overall Study|Death|12|||
154964165|NCT03606174|559295199|FG006|Overall Study|Death|35|||
155348763|NCT03681353|560710617|FG000|Overall Study|Lost to Follow-up|2|||
155348764|NCT03681353|560710617|FG000|Overall Study|Withdrawal by Subject|3|||
155348765|NCT03681353|560710617|FG000|Overall Study|withdrawn by PI|2|||
155348766|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
155348767|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
154964166|NCT03606174|559295200|FG007|Overall Study|Death|8|||
155348768|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
155348769|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
155348770|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
155348771|NCT00520403|560710623|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
155348772|NCT00520403|560710623|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
155348773|NCT00520403|560710623|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
155348774|NCT03924947|560710624|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348775|NCT03924947|560710625|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348776|NCT03924947|560710626|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
155348777|NCT03924947|560710627|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348778|NCT03924947|560710628|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348779|NCT03924947|560710629|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
155348780|NCT01145417|560710630|FG000|Overall Study|Death|1|||
155348781|NCT01145417|560710631|FG001|Overall Study|Death|0|||
155348782|NCT01145417|560710630|FG000|Overall Study|Lost to Follow-up|2|||
155348783|NCT01145417|560710631|FG001|Overall Study|Lost to Follow-up|1|||
155348784|NCT01145417|560710630|FG000|Overall Study|Withdrawal by Subject|1|||
155348785|NCT01145417|560710631|FG001|Overall Study|Withdrawal by Subject|2|||
155348786|NCT01145417|560710630|FG000|Overall Study|Pregnancy|1|||
155348787|NCT01145417|560710631|FG001|Overall Study|Pregnancy|0|||
155348788|NCT01145417|560710630|FG000|Overall Study|Adverse Event|0|||
155348789|NCT01145417|560710631|FG001|Overall Study|Adverse Event|1|||
155348790|NCT01145417|560710630|FG000|Overall Study|Study terminated by sponsor|35|||
155348791|NCT01145417|560710631|FG001|Overall Study|Study terminated by sponsor|43|||
155348792|NCT01145417|560710630|FG000|Overall Study|Other|1|||
155348793|NCT01145417|560710631|FG001|Overall Study|Other|0|||
155348794|NCT01797562|560710632|FG000|Overall Study|Protocol Violation|5|||
155348795|NCT00917462|560710635|FG000|Overall Study|Clinical Deterioration|1|||
155348796|NCT03341312|560710642|FG000|Period 1|Withdrawal by Subject|0|||
155348797|NCT03341312|560710643|FG001|Period 1|Withdrawal by Subject|1|||
155083561|NCT03478787|559737248|FG000|Overall Study|Withdrawal by Subject|2|||
155083562|NCT03478787|559737249|FG001|Overall Study|Withdrawal by Subject|6|||
155083563|NCT03478787|559737248|FG000|Overall Study|Other, Not Specified|3|||
155348798|NCT03341312|560710644|FG002|Period 1|Withdrawal by Subject|0|||
155083564|NCT03478787|559737249|FG001|Overall Study|Other, Not Specified|0|||
155348799|NCT03341312|560710645|FG003|Period 1|Withdrawal by Subject|0|||
155348800|NCT00839306|560710646|FG000|Overall Study|Adverse Event|3|||
155348801|NCT00839306|560710647|FG001|Overall Study|Adverse Event|5|||
155348802|NCT00839306|560710646|FG000|Overall Study|Lost to Follow-up|6|||
155348803|NCT00839306|560710647|FG001|Overall Study|Lost to Follow-up|9|||
155348804|NCT00839306|560710646|FG000|Overall Study|Withdrawal by Subject|5|||
155348805|NCT00839306|560710647|FG001|Overall Study|Withdrawal by Subject|7|||
155348806|NCT00839306|560710646|FG000|Overall Study|Lack of Efficacy|5|||
155348807|NCT00839306|560710647|FG001|Overall Study|Lack of Efficacy|4|||
155348808|NCT00839306|560710646|FG000|Overall Study|Other|6|||
155348809|NCT00839306|560710647|FG001|Overall Study|Other|18|||
155348810|NCT01812707|560710648|FG000|Overall Study|Adverse Event|0|||
155348811|NCT01812707|560710649|FG001|Overall Study|Adverse Event|0|||
155348812|NCT01812707|560710650|FG002|Overall Study|Adverse Event|0|||
155083565|NCT02539394|559737250|FG000|Overall Study|Protocol Violation|1|||
155083566|NCT02539394|559737251|FG001|Overall Study|Protocol Violation|3|||
155083567|NCT02539394|559737250|FG000|Overall Study|Lost to Follow-up|1|||
155083568|NCT02539394|559737251|FG001|Overall Study|Lost to Follow-up|2|||
155083569|NCT02539394|559737250|FG000|Overall Study|Incomplete dataset|6|||
155083570|NCT02539394|559737251|FG001|Overall Study|Incomplete dataset|6|||
155083571|NCT01316900|559737272|FG000|Overall Study|Adverse Event|10|||
155083572|NCT01316900|559737273|FG001|Overall Study|Adverse Event|10|||
155083573|NCT01316900|559737274|FG002|Overall Study|Adverse Event|15|||
155083574|NCT01316900|559737275|FG003|Overall Study|Adverse Event|9|||
155083575|NCT01316900|559737272|FG000|Overall Study|Lack of Efficacy|17|||
155083576|NCT01316900|559737273|FG001|Overall Study|Lack of Efficacy|9|||
155083577|NCT01316900|559737274|FG002|Overall Study|Lack of Efficacy|5|||
155083578|NCT01316900|559737275|FG003|Overall Study|Lack of Efficacy|7|||
155083579|NCT01316900|559737272|FG000|Overall Study|Protocol Violation|7|||
155165597|NCT00441064|560043497|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155348813|NCT01812707|560710651|FG003|Overall Study|Adverse Event|2|||
155348814|NCT01812707|560710648|FG000|Overall Study|Poor compliance to protocol|1|||
155348815|NCT01812707|560710649|FG001|Overall Study|Poor compliance to protocol|0|||
155348816|NCT01812707|560710650|FG002|Overall Study|Poor compliance to protocol|0|||
155348817|NCT01812707|560710651|FG003|Overall Study|Poor compliance to protocol|0|||
155348818|NCT01812707|560710648|FG000|Overall Study|Consent withdrawn by participant|1|||
155348819|NCT01812707|560710649|FG001|Overall Study|Consent withdrawn by participant|0|||
155348820|NCT01812707|560710650|FG002|Overall Study|Consent withdrawn by participant|0|||
155083580|NCT01316900|559737273|FG001|Overall Study|Protocol Violation|1|||
155083581|NCT01316900|559737274|FG002|Overall Study|Protocol Violation|4|||
155348821|NCT01812707|560710651|FG003|Overall Study|Consent withdrawn by participant|0|||
155083582|NCT01316900|559737275|FG003|Overall Study|Protocol Violation|0|||
155083583|NCT01316900|559737272|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
155083584|NCT01316900|559737273|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
155348822|NCT05060237|560710653|FG000|Overall Study|Withdrawal by Subject|4|||
155348823|NCT05060237|560710653|FG000|Overall Study|Screening failure|8|||
155348824|NCT02396758|560710654|FG000|Overall Study|Withdrawal by Subject|2|||
155348825|NCT02396758|560710655|FG001|Overall Study|Withdrawal by Subject|0|||
155348826|NCT02396758|560710656|FG002|Overall Study|Withdrawal by Subject|0|||
155348827|NCT02396758|560710657|FG003|Overall Study|Withdrawal by Subject|1|||
155348828|NCT02396758|560710654|FG000|Overall Study|Lost to Follow-up|8|||
155348829|NCT02396758|560710655|FG001|Overall Study|Lost to Follow-up|5|||
155348830|NCT02396758|560710656|FG002|Overall Study|Lost to Follow-up|3|||
155348831|NCT02396758|560710657|FG003|Overall Study|Lost to Follow-up|3|||
155348832|NCT02396758|560710654|FG000|Overall Study|Death|1|||
155348833|NCT02396758|560710655|FG001|Overall Study|Death|1|||
155348834|NCT02396758|560710656|FG002|Overall Study|Death|0|||
155348835|NCT02396758|560710657|FG003|Overall Study|Death|1|||
155348836|NCT02396758|560710654|FG000|Overall Study|Randomized but not treated|1|||
155348837|NCT02396758|560710655|FG001|Overall Study|Randomized but not treated|0|||
155348838|NCT02396758|560710656|FG002|Overall Study|Randomized but not treated|1|||
155348839|NCT02396758|560710657|FG003|Overall Study|Randomized but not treated|0|||
155348840|NCT02176018|560710658|FG000|Overall Study|Adverse Event|0|||
155348841|NCT02176018|560710659|FG001|Overall Study|Adverse Event|2|||
155348842|NCT02176018|560710658|FG000|Overall Study|Lost to Follow-up|3|||
155348843|NCT02176018|560710659|FG001|Overall Study|Lost to Follow-up|1|||
155348844|NCT02176018|560710658|FG000|Overall Study|Protocol Violation|1|||
155348845|NCT02176018|560710659|FG001|Overall Study|Protocol Violation|1|||
155348846|NCT02176018|560710658|FG000|Overall Study|Withdrawal by Subject|1|||
155348847|NCT02176018|560710659|FG001|Overall Study|Withdrawal by Subject|2|||
155348848|NCT00265096|560710661|FG000|Overall Study|Adverse Event|14|||
155348849|NCT00265096|560710662|FG001|Overall Study|Adverse Event|18|||
155348850|NCT00265096|560710663|FG002|Overall Study|Adverse Event|18|||
155348851|NCT00265096|560710661|FG000|Overall Study|Lost to Follow-up|2|||
155348852|NCT00265096|560710662|FG001|Overall Study|Lost to Follow-up|5|||
155348853|NCT00265096|560710663|FG002|Overall Study|Lost to Follow-up|3|||
155348854|NCT00265096|560710661|FG000|Overall Study|Death|0|||
155348855|NCT00265096|560710662|FG001|Overall Study|Death|1|||
155348856|NCT00265096|560710663|FG002|Overall Study|Death|2|||
155348857|NCT00265096|560710661|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
155348858|NCT00265096|560710662|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155348859|NCT00265096|560710663|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
155348860|NCT00265096|560710661|FG000|Overall Study|Other|11|||
155348861|NCT00265096|560710662|FG001|Overall Study|Other|19|||
155348862|NCT00265096|560710663|FG002|Overall Study|Other|10|||
155348863|NCT01116440|560710664|FG000|Treatment|Withdrawal by Subject|2|||
155348864|NCT01116440|560710665|FG001|Treatment|Withdrawal by Subject|2|||
155348865|NCT01116440|560710664|FG000|Treatment|Lost to Follow-up|1|||
155348866|NCT01116440|560710665|FG001|Treatment|Lost to Follow-up|1|||
155348867|NCT01116440|560710664|FG000|Treatment|Protocol Violation|0|||
155348868|NCT01116440|560710665|FG001|Treatment|Protocol Violation|2|||
155348869|NCT01116440|560710664|FG000|Treatment|Lack of Efficacy|0|||
155348870|NCT01116440|560710665|FG001|Treatment|Lack of Efficacy|1|||
155348871|NCT01116440|560710664|FG000|Treatment|Adverse Event|0|||
155348872|NCT01116440|560710665|FG001|Treatment|Adverse Event|1|||
155348873|NCT01116440|560710664|FG000|Withdrawal|Withdrawal by Subject|0|||
155348874|NCT01116440|560710665|FG001|Withdrawal|Withdrawal by Subject|1|||
155083585|NCT01316900|559737274|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
155083586|NCT01316900|559737275|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
155083587|NCT01316900|559737272|FG000|Overall Study|Lost to Follow-up|1|||
155083588|NCT01316900|559737273|FG001|Overall Study|Lost to Follow-up|0|||
155083589|NCT01316900|559737274|FG002|Overall Study|Lost to Follow-up|1|||
155083590|NCT01316900|559737275|FG003|Overall Study|Lost to Follow-up|1|||
155083591|NCT01316900|559737272|FG000|Overall Study|Withdrawal by Subject|7|||
155083592|NCT01316900|559737273|FG001|Overall Study|Withdrawal by Subject|8|||
155083593|NCT01316900|559737274|FG002|Overall Study|Withdrawal by Subject|6|||
155083594|NCT01316900|559737275|FG003|Overall Study|Withdrawal by Subject|9|||
155083595|NCT00562861|559737276|FG000|Overall Study|Adverse Event|1|||
155083596|NCT00562861|559737277|FG001|Overall Study|Adverse Event|1|||
155083597|NCT00562861|559737276|FG000|Overall Study|Lack of Efficacy|5|||
155083598|NCT00562861|559737277|FG001|Overall Study|Lack of Efficacy|5|||
155083599|NCT00562861|559737276|FG000|Overall Study|noncompliance, moved|7|||
155083600|NCT00562861|559737277|FG001|Overall Study|noncompliance, moved|2|||
155083601|NCT00562861|559737276|FG000|Overall Study|Lost to Follow-up|7|||
155083602|NCT00562861|559737277|FG001|Overall Study|Lost to Follow-up|3|||
155083603|NCT00655356|559737278|FG000|Overall Study|Withdrawal by Subject|3|||
155083604|NCT00655356|559737279|FG001|Overall Study|Withdrawal by Subject|4|||
155083605|NCT00655356|559737278|FG000|Overall Study|Sponsor Request|10|||
155083606|NCT00655356|559737279|FG001|Overall Study|Sponsor Request|4|||
155083607|NCT00655356|559737278|FG000|Overall Study|Adverse Event|1|||
155083608|NCT00655356|559737279|FG001|Overall Study|Adverse Event|1|||
155083609|NCT00655356|559737278|FG000|Overall Study|Protocol Violation|2|||
155083610|NCT00655356|559737279|FG001|Overall Study|Protocol Violation|1|||
155083611|NCT00655356|559737278|FG000|Overall Study|Other Reason|1|||
155083612|NCT00655356|559737279|FG001|Overall Study|Other Reason|0|||
155083613|NCT01684033|559737280|FG000|Period 1, First 30 Days|Adverse Event|1|||
155083614|NCT01684033|559737281|FG001|Period 1, First 30 Days|Adverse Event|1|||
155083615|NCT01684033|559737280|FG000|Period 1, First 30 Days|Noncompliance|1|||
155083616|NCT01684033|559737281|FG001|Period 1, First 30 Days|Noncompliance|0|||
155083617|NCT01684033|559737280|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
155083618|NCT01684033|559737281|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
155348875|NCT01116440|560710664|FG000|Withdrawal|Lost to Follow-up|0|||
155348876|NCT01116440|560710665|FG001|Withdrawal|Lost to Follow-up|1|||
155348877|NCT01116440|560710664|FG000|Follow-up|Lost to Follow-up|0|||
155348878|NCT01116440|560710665|FG001|Follow-up|Lost to Follow-up|1|||
155348879|NCT01116440|560710664|FG000|Follow-up|Withdrawal by Subject|0|||
154964167|NCT03606174|559295201|FG008|Overall Study|Death|5|||
154964168|NCT03606174|559295202|FG009|Overall Study|Death|3|||
154964169|NCT03606174|559295203|FG010|Overall Study|Death|0|||
154964170|NCT03606174|559295193|FG000|Overall Study|Lost to Follow-up|0|||
155083619|NCT01684033|559737280|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
155083620|NCT01684033|559737281|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
155083621|NCT01684033|559737280|FG000|Period 2, Second 30 Days|Adverse Event|1|||
155083622|NCT01684033|559737281|FG001|Period 2, Second 30 Days|Adverse Event|0|||
155083623|NCT01093573|559737286|FG000|Overall Study|Physician Decision|0|||
155083624|NCT01093573|559737287|FG001|Overall Study|Physician Decision|0|||
155083625|NCT01093573|559737288|FG002|Overall Study|Physician Decision|1|||
155083626|NCT01093573|559737286|FG000|Overall Study|Insurance Denied|0|||
155083627|NCT01093573|559737287|FG001|Overall Study|Insurance Denied|0|||
155083628|NCT01093573|559737288|FG002|Overall Study|Insurance Denied|1|||
155348880|NCT01116440|560710665|FG001|Follow-up|Withdrawal by Subject|1|||
155348881|NCT00774306|560710666|FG000|Overall Study|Adverse Event|3|||
155348882|NCT00774306|560710667|FG001|Overall Study|Adverse Event|0|||
155348883|NCT00774306|560710668|FG002|Overall Study|Adverse Event|0|||
155348884|NCT00774306|560710669|FG003|Overall Study|Adverse Event|0|||
155348885|NCT00774306|560710666|FG000|Overall Study|Protocol Violation|2|||
155348886|NCT00774306|560710667|FG001|Overall Study|Protocol Violation|0|||
155348887|NCT00774306|560710668|FG002|Overall Study|Protocol Violation|3|||
155348888|NCT00774306|560710669|FG003|Overall Study|Protocol Violation|0|||
155348889|NCT00774306|560710666|FG000|Overall Study|Withdrawal by Subject|6|||
155348890|NCT00774306|560710667|FG001|Overall Study|Withdrawal by Subject|1|||
155348891|NCT00774306|560710668|FG002|Overall Study|Withdrawal by Subject|1|||
155348892|NCT00774306|560710669|FG003|Overall Study|Withdrawal by Subject|0|||
155348893|NCT00774306|560710666|FG000|Overall Study|Lost to Follow-up|6|||
155348894|NCT00774306|560710667|FG001|Overall Study|Lost to Follow-up|0|||
155348895|NCT00774306|560710668|FG002|Overall Study|Lost to Follow-up|4|||
155348896|NCT00774306|560710669|FG003|Overall Study|Lost to Follow-up|5|||
155348897|NCT00774306|560710666|FG000|Overall Study|Death|1|||
155348898|NCT00774306|560710667|FG001|Overall Study|Death|1|||
155348899|NCT00774306|560710668|FG002|Overall Study|Death|0|||
155348900|NCT00774306|560710669|FG003|Overall Study|Death|0|||
155348901|NCT03568708|560710673|FG000|Overall Study|Withdrawal by Subject|1|||
155348902|NCT03568708|560710674|FG001|Overall Study|Withdrawal by Subject|1|||
155348903|NCT03568708|560710673|FG000|Overall Study|Lost to Follow-up|0|||
155348904|NCT03568708|560710674|FG001|Overall Study|Lost to Follow-up|1|||
155348905|NCT01126879|560710675|FG000|Overall Study|Progressive Disease|3|||
155348906|NCT01126879|560710676|FG001|Overall Study|Progressive Disease|1|||
155348907|NCT01126879|560710675|FG000|Overall Study|Withdrawal by Subject|1|||
155348908|NCT01126879|560710676|FG001|Overall Study|Withdrawal by Subject|0|||
155348909|NCT01126879|560710675|FG000|Overall Study|Adverse Event|0|||
155348910|NCT01126879|560710676|FG001|Overall Study|Adverse Event|1|||
155348911|NCT01126879|560710675|FG000|Overall Study|Physician Decision|1|||
155348912|NCT01126879|560710676|FG001|Overall Study|Physician Decision|0|||
155348913|NCT00666835|560710677|FG000|Overall Study|Withdrawal by Subject|5|||
155348914|NCT00666835|560710678|FG001|Overall Study|Withdrawal by Subject|2|||
155348915|NCT00666835|560710677|FG000|Overall Study|Lack of Efficacy|0|||
155348916|NCT00666835|560710678|FG001|Overall Study|Lack of Efficacy|1|||
155348917|NCT00666835|560710677|FG000|Overall Study|Incl./excl. not fulfilled|7|||
155348918|NCT00666835|560710678|FG001|Overall Study|Incl./excl. not fulfilled|2|||
155348919|NCT00666835|560710677|FG000|Overall Study|Adverse Event|7|||
155348920|NCT00666835|560710678|FG001|Overall Study|Adverse Event|6|||
155348921|NCT00666835|560710677|FG000|Overall Study|Protocol Violation|2|||
155348922|NCT00666835|560710678|FG001|Overall Study|Protocol Violation|0|||
155348923|NCT00666835|560710677|FG000|Overall Study|Death|15|||
155348924|NCT00666835|560710678|FG001|Overall Study|Death|4|||
155348925|NCT00666835|560710677|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
155348926|NCT00666835|560710678|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
155348927|NCT00666835|560710677|FG000|Overall Study|Hemoglobulin concentration|4|||
155348928|NCT00666835|560710678|FG001|Overall Study|Hemoglobulin concentration|3|||
155348929|NCT00666835|560710677|FG000|Overall Study|Planned operation|2|||
155348930|NCT00666835|560710678|FG001|Overall Study|Planned operation|0|||
155348931|NCT00666835|560710677|FG000|Overall Study|Physician Decision|1|||
155348932|NCT00666835|560710678|FG001|Overall Study|Physician Decision|2|||
155348933|NCT00511147|560710681|FG000|Overall Study|Withdrawal by Subject|1|||
155348934|NCT00511147|560710681|FG000|Overall Study|Disease progression|5|||
155348935|NCT00511147|560710681|FG000|Overall Study|Required platelet transfusion|1|||
155348936|NCT00899379|560710682|FG000|Overall Study|Adverse Event|2|||
155348937|NCT00899379|560710683|FG001|Overall Study|Adverse Event|2|||
155348938|NCT00899379|560710684|FG002|Overall Study|Adverse Event|1|||
155348939|NCT00899379|560710685|FG003|Overall Study|Adverse Event|1|||
155348940|NCT00899379|560710686|FG004|Overall Study|Adverse Event|2|||
155348941|NCT00899379|560710682|FG000|Overall Study|Lack of Efficacy|0|||
155348942|NCT00899379|560710683|FG001|Overall Study|Lack of Efficacy|4|||
155348943|NCT00899379|560710684|FG002|Overall Study|Lack of Efficacy|3|||
155348944|NCT00899379|560710685|FG003|Overall Study|Lack of Efficacy|0|||
155348945|NCT00899379|560710686|FG004|Overall Study|Lack of Efficacy|1|||
155348946|NCT00899379|560710682|FG000|Overall Study|Lost to Follow-up|9|||
155348947|NCT00899379|560710683|FG001|Overall Study|Lost to Follow-up|3|||
155348948|NCT00899379|560710684|FG002|Overall Study|Lost to Follow-up|0|||
155348949|NCT00899379|560710685|FG003|Overall Study|Lost to Follow-up|6|||
155348950|NCT00899379|560710686|FG004|Overall Study|Lost to Follow-up|2|||
155348951|NCT00899379|560710682|FG000|Overall Study|Protocol Violation|0|||
155348952|NCT00899379|560710683|FG001|Overall Study|Protocol Violation|0|||
155348953|NCT00899379|560710684|FG002|Overall Study|Protocol Violation|1|||
155348954|NCT00899379|560710685|FG003|Overall Study|Protocol Violation|1|||
155348955|NCT00899379|560710686|FG004|Overall Study|Protocol Violation|0|||
155348956|NCT00899379|560710682|FG000|Overall Study|Withdrawal by Subject|2|||
155348957|NCT00899379|560710683|FG001|Overall Study|Withdrawal by Subject|4|||
155348958|NCT00899379|560710684|FG002|Overall Study|Withdrawal by Subject|2|||
155348959|NCT00899379|560710685|FG003|Overall Study|Withdrawal by Subject|3|||
155348960|NCT00899379|560710686|FG004|Overall Study|Withdrawal by Subject|6|||
155083629|NCT05626686|559737289|FG000|Overall Study|Protocol Violation|3|||
155083630|NCT05626686|559737289|FG000|Overall Study|Withdrawal by Subject|3|||
155083631|NCT02496156|559737290|FG000|Overall Study|Lost to Follow-up|5|||
155083632|NCT02496156|559737291|FG001|Overall Study|Lost to Follow-up|0|||
155083633|NCT02496156|559737290|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
155083634|NCT02496156|559737291|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
155083635|NCT00289900|559737292|FG000|Overall Study|Adverse Event|28|||
155083636|NCT00289900|559737293|FG001|Overall Study|Adverse Event|40|||
155083637|NCT00289900|559737294|FG002|Overall Study|Adverse Event|13|||
155083638|NCT00289900|559737295|FG003|Overall Study|Adverse Event|19|||
155083639|NCT00289900|559737296|FG004|Overall Study|Adverse Event|20|||
155083640|NCT00289900|559737297|FG005|Overall Study|Adverse Event|33|||
155083641|NCT00289900|559737292|FG000|Overall Study|Lost to Follow-up|7|||
155083642|NCT00289900|559737293|FG001|Overall Study|Lost to Follow-up|7|||
155083643|NCT00289900|559737294|FG002|Overall Study|Lost to Follow-up|8|||
155083644|NCT00289900|559737295|FG003|Overall Study|Lost to Follow-up|8|||
155083645|NCT00289900|559737296|FG004|Overall Study|Lost to Follow-up|4|||
155083646|NCT00289900|559737297|FG005|Overall Study|Lost to Follow-up|8|||
155083647|NCT00289900|559737292|FG000|Overall Study|Participant had flushing|18|||
155083648|NCT00289900|559737293|FG001|Overall Study|Participant had flushing|42|||
155083649|NCT00289900|559737294|FG002|Overall Study|Participant had flushing|1|||
155083650|NCT00289900|559737295|FG003|Overall Study|Participant had flushing|2|||
155083651|NCT00289900|559737296|FG004|Overall Study|Participant had flushing|0|||
155083652|NCT00289900|559737297|FG005|Overall Study|Participant had flushing|4|||
155083653|NCT00289900|559737292|FG000|Overall Study|Other|0|||
155083654|NCT00289900|559737293|FG001|Overall Study|Other|0|||
154964171|NCT03606174|559295194|FG001|Overall Study|Lost to Follow-up|0|||
154964172|NCT03606174|559295195|FG002|Overall Study|Lost to Follow-up|0|||
154964173|NCT03606174|559295196|FG003|Overall Study|Lost to Follow-up|0|||
154964174|NCT03606174|559295197|FG004|Overall Study|Lost to Follow-up|1|||
155348961|NCT00899379|560710682|FG000|Overall Study|Pregnancy|0|||
155348962|NCT00899379|560710683|FG001|Overall Study|Pregnancy|0|||
155348963|NCT00899379|560710684|FG002|Overall Study|Pregnancy|1|||
155348964|NCT00899379|560710685|FG003|Overall Study|Pregnancy|0|||
155348965|NCT00899379|560710686|FG004|Overall Study|Pregnancy|1|||
154964175|NCT03606174|559295198|FG005|Overall Study|Lost to Follow-up|1|||
154964176|NCT03606174|559295199|FG006|Overall Study|Lost to Follow-up|0|||
155083655|NCT00289900|559737294|FG002|Overall Study|Other|0|||
155083656|NCT00289900|559737295|FG003|Overall Study|Other|5|||
155083657|NCT00289900|559737296|FG004|Overall Study|Other|1|||
155083658|NCT00289900|559737297|FG005|Overall Study|Other|0|||
155083659|NCT00289900|559737292|FG000|Overall Study|Participant moved|1|||
155083660|NCT00289900|559737293|FG001|Overall Study|Participant moved|0|||
155083661|NCT00289900|559737294|FG002|Overall Study|Participant moved|0|||
155083662|NCT00289900|559737295|FG003|Overall Study|Participant moved|1|||
155083663|NCT00289900|559737296|FG004|Overall Study|Participant moved|1|||
155083664|NCT00289900|559737297|FG005|Overall Study|Participant moved|1|||
155083665|NCT00289900|559737292|FG000|Overall Study|Withdrawal by Subject|10|||
155083666|NCT00289900|559737293|FG001|Overall Study|Withdrawal by Subject|21|||
155348966|NCT00899379|560710682|FG000|Overall Study|Patient Uncooperative|0|||
155348967|NCT00899379|560710683|FG001|Overall Study|Patient Uncooperative|1|||
155348968|NCT00899379|560710684|FG002|Overall Study|Patient Uncooperative|0|||
155348969|NCT00899379|560710685|FG003|Overall Study|Patient Uncooperative|1|||
155348970|NCT00899379|560710686|FG004|Overall Study|Patient Uncooperative|2|||
155348971|NCT00899379|560710682|FG000|Overall Study|Abnormal Baseline ECG|0|||
155348972|NCT00899379|560710683|FG001|Overall Study|Abnormal Baseline ECG|0|||
155348973|NCT00899379|560710684|FG002|Overall Study|Abnormal Baseline ECG|0|||
155348974|NCT00899379|560710685|FG003|Overall Study|Abnormal Baseline ECG|1|||
155348975|NCT00899379|560710686|FG004|Overall Study|Abnormal Baseline ECG|0|||
155083667|NCT00289900|559737294|FG002|Overall Study|Withdrawal by Subject|8|||
155083668|NCT00289900|559737295|FG003|Overall Study|Withdrawal by Subject|18|||
155083669|NCT00289900|559737296|FG004|Overall Study|Withdrawal by Subject|12|||
155083670|NCT00289900|559737297|FG005|Overall Study|Withdrawal by Subject|11|||
155083671|NCT00289900|559737292|FG000|Overall Study|Protocol Violation|3|||
155083672|NCT00289900|559737293|FG001|Overall Study|Protocol Violation|9|||
155083673|NCT00289900|559737294|FG002|Overall Study|Protocol Violation|2|||
155083674|NCT00289900|559737295|FG003|Overall Study|Protocol Violation|6|||
155083675|NCT00289900|559737296|FG004|Overall Study|Protocol Violation|7|||
155348976|NCT00899379|560710682|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155083676|NCT00289900|559737297|FG005|Overall Study|Protocol Violation|4|||
155083677|NCT00289900|559737292|FG000|Overall Study|site terminated|1|||
155083678|NCT00289900|559737293|FG001|Overall Study|site terminated|0|||
155083679|NCT00289900|559737294|FG002|Overall Study|site terminated|1|||
155348977|NCT00899379|560710683|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155348978|NCT00899379|560710684|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
154964177|NCT03606174|559295200|FG007|Overall Study|Lost to Follow-up|0|||
154964178|NCT03606174|559295201|FG008|Overall Study|Lost to Follow-up|0|||
154964179|NCT03606174|559295202|FG009|Overall Study|Lost to Follow-up|0|||
154964180|NCT03606174|559295203|FG010|Overall Study|Lost to Follow-up|0|||
154964181|NCT03606174|559295193|FG000|Overall Study|Withdrawal by Subject|6|||
155083680|NCT00289900|559737295|FG003|Overall Study|site terminated|0|||
155083681|NCT00289900|559737296|FG004|Overall Study|site terminated|0|||
155083682|NCT00289900|559737297|FG005|Overall Study|site terminated|0|||
155083683|NCT00289900|559737292|FG000|Overall Study|Not treated|0|||
155348979|NCT00899379|560710685|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155348980|NCT00899379|560710686|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155348981|NCT00899379|560710682|FG000|Overall Study|Not Completed/Entered Extn|5|||
155348982|NCT00899379|560710683|FG001|Overall Study|Not Completed/Entered Extn|1|||
155348983|NCT00899379|560710684|FG002|Overall Study|Not Completed/Entered Extn|6|||
155348984|NCT00899379|560710685|FG003|Overall Study|Not Completed/Entered Extn|4|||
155348985|NCT00899379|560710686|FG004|Overall Study|Not Completed/Entered Extn|3|||
155348986|NCT00899379|560710682|FG000|Overall Study|Study Terminated|3|||
155348987|NCT00899379|560710683|FG001|Overall Study|Study Terminated|0|||
155348988|NCT00899379|560710684|FG002|Overall Study|Study Terminated|3|||
155348989|NCT00899379|560710685|FG003|Overall Study|Study Terminated|3|||
155348990|NCT00899379|560710686|FG004|Overall Study|Study Terminated|1|||
155348991|NCT00899379|560710682|FG000|Overall Study|Lost to Follow-up|3|||
155348992|NCT00899379|560710683|FG001|Overall Study|Lost to Follow-up|1|||
155348993|NCT00899379|560710684|FG002|Overall Study|Lost to Follow-up|0|||
155348994|NCT00899379|560710685|FG003|Overall Study|Lost to Follow-up|2|||
155348995|NCT00899379|560710686|FG004|Overall Study|Lost to Follow-up|5|||
155348996|NCT00899379|560710682|FG000|Overall Study|Withdrawal by Subject|4|||
155348997|NCT00899379|560710683|FG001|Overall Study|Withdrawal by Subject|7|||
155348998|NCT00899379|560710684|FG002|Overall Study|Withdrawal by Subject|4|||
155348999|NCT00899379|560710685|FG003|Overall Study|Withdrawal by Subject|7|||
155349000|NCT00899379|560710686|FG004|Overall Study|Withdrawal by Subject|2|||
155349001|NCT00899379|560710682|FG000|Overall Study|Pregnancy|1|||
155349002|NCT00899379|560710683|FG001|Overall Study|Pregnancy|0|||
155349003|NCT00899379|560710684|FG002|Overall Study|Pregnancy|0|||
155349004|NCT00899379|560710685|FG003|Overall Study|Pregnancy|0|||
155349005|NCT00899379|560710686|FG004|Overall Study|Pregnancy|0|||
155349006|NCT00899379|560710682|FG000|Overall Study|Patient Uncooperative|0|||
155349007|NCT00899379|560710683|FG001|Overall Study|Patient Uncooperative|0|||
155349008|NCT00899379|560710684|FG002|Overall Study|Patient Uncooperative|0|||
155349009|NCT00899379|560710685|FG003|Overall Study|Patient Uncooperative|1|||
155349010|NCT00899379|560710686|FG004|Overall Study|Patient Uncooperative|0|||
155349011|NCT00899379|560710682|FG000|Overall Study|Abnormal Prestudy Labs|0|||
155349012|NCT00899379|560710683|FG001|Overall Study|Abnormal Prestudy Labs|0|||
155349013|NCT00899379|560710684|FG002|Overall Study|Abnormal Prestudy Labs|0|||
155349014|NCT00899379|560710685|FG003|Overall Study|Abnormal Prestudy Labs|0|||
155349015|NCT00899379|560710686|FG004|Overall Study|Abnormal Prestudy Labs|2|||
155349016|NCT00899379|560710682|FG000|Overall Study|Abnormal Baseline ECG|0|||
155349017|NCT00899379|560710683|FG001|Overall Study|Abnormal Baseline ECG|0|||
155349018|NCT00899379|560710684|FG002|Overall Study|Abnormal Baseline ECG|1|||
155349019|NCT00899379|560710685|FG003|Overall Study|Abnormal Baseline ECG|1|||
155349020|NCT00899379|560710686|FG004|Overall Study|Abnormal Baseline ECG|0|||
155349021|NCT00899379|560710682|FG000|Overall Study|No Attack Pretreatment|3|||
155349022|NCT00899379|560710683|FG001|Overall Study|No Attack Pretreatment|5|||
155349023|NCT00899379|560710684|FG002|Overall Study|No Attack Pretreatment|5|||
155349024|NCT00899379|560710685|FG003|Overall Study|No Attack Pretreatment|6|||
155349025|NCT00899379|560710686|FG004|Overall Study|No Attack Pretreatment|4|||
155349026|NCT00899379|560710682|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155349027|NCT00899379|560710683|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349028|NCT00899379|560710684|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349029|NCT00899379|560710685|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349030|NCT00899379|560710686|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155349031|NCT00899379|560710682|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
155349032|NCT00899379|560710683|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
155349033|NCT00899379|560710684|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
155349034|NCT00899379|560710685|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
155349035|NCT00899379|560710686|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
155349036|NCT00744796|560710690|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
155349037|NCT05135156|560710691|FG000|Overall Study|Lost to Follow-up|0|||
155349038|NCT05135156|560710692|FG001|Overall Study|Lost to Follow-up|0|||
155349039|NCT05135156|560710693|FG002|Overall Study|Lost to Follow-up|2|||
155349040|NCT02986659|560710695|FG000|First Intervention Period|Adverse Event|3|||
155349041|NCT02986659|560710696|FG001|First Intervention Period|Adverse Event|1|||
155349042|NCT02986659|560710695|FG000|First Intervention Period|Lost to Follow-up|1|||
155349043|NCT02986659|560710696|FG001|First Intervention Period|Lost to Follow-up|0|||
155349044|NCT02986659|560710695|FG000|First Intervention Period|Withdrawal by Subject|0|||
155349045|NCT02986659|560710696|FG001|First Intervention Period|Withdrawal by Subject|1|||
154964182|NCT03606174|559295194|FG001|Overall Study|Withdrawal by Subject|0|||
155083684|NCT00289900|559737293|FG001|Overall Study|Not treated|1|||
154964183|NCT03606174|559295195|FG002|Overall Study|Withdrawal by Subject|0|||
154964184|NCT03606174|559295196|FG003|Overall Study|Withdrawal by Subject|1|||
154964185|NCT03606174|559295197|FG004|Overall Study|Withdrawal by Subject|2|||
154964186|NCT03606174|559295198|FG005|Overall Study|Withdrawal by Subject|1|||
154964187|NCT03606174|559295199|FG006|Overall Study|Withdrawal by Subject|4|||
154964188|NCT03606174|559295200|FG007|Overall Study|Withdrawal by Subject|0|||
154964189|NCT03606174|559295201|FG008|Overall Study|Withdrawal by Subject|0|||
154964190|NCT03606174|559295202|FG009|Overall Study|Withdrawal by Subject|0|||
154964191|NCT03606174|559295203|FG010|Overall Study|Withdrawal by Subject|1|||
154964192|NCT03606174|559295193|FG000|Overall Study|Study Terminated by Sponsor|5|||
154964193|NCT03606174|559295194|FG001|Overall Study|Study Terminated by Sponsor|7|||
154964194|NCT03606174|559295195|FG002|Overall Study|Study Terminated by Sponsor|3|||
154964195|NCT03606174|559295196|FG003|Overall Study|Study Terminated by Sponsor|0|||
154964196|NCT03606174|559295197|FG004|Overall Study|Study Terminated by Sponsor|11|||
154964197|NCT03606174|559295198|FG005|Overall Study|Study Terminated by Sponsor|6|||
154964198|NCT03606174|559295199|FG006|Overall Study|Study Terminated by Sponsor|12|||
154964199|NCT03606174|559295200|FG007|Overall Study|Study Terminated by Sponsor|1|||
154964200|NCT03606174|559295201|FG008|Overall Study|Study Terminated by Sponsor|3|||
154964201|NCT03606174|559295202|FG009|Overall Study|Study Terminated by Sponsor|1|||
154964202|NCT03606174|559295203|FG010|Overall Study|Study Terminated by Sponsor|2|||
154964203|NCT03606174|559295193|FG000|Overall Study|Miscellaneous|1|||
154964204|NCT03606174|559295194|FG001|Overall Study|Miscellaneous|1|||
154964205|NCT03606174|559295195|FG002|Overall Study|Miscellaneous|0|||
154964206|NCT03606174|559295196|FG003|Overall Study|Miscellaneous|1|||
154964207|NCT03606174|559295197|FG004|Overall Study|Miscellaneous|4|||
155083685|NCT00289900|559737294|FG002|Overall Study|Not treated|0|||
155349046|NCT02986659|560710695|FG000|Second Intervention Period|Adverse Event|0|||
155349047|NCT02986659|560710696|FG001|Second Intervention Period|Adverse Event|6|||
155349048|NCT02253147|560710697|FG000|Overall Study|Protocol Violation|30|||
155349049|NCT02253147|560710697|FG000|Overall Study|Did not consent to study extension|9|||
155349050|NCT02253147|560710697|FG000|Overall Study|Conditional re-treatment at W52|5|||
155349051|NCT02253147|560710697|FG000|Overall Study|Lost to Follow-up|2|||
155349052|NCT02253147|560710697|FG000|Overall Study|Withdrawal by Subject|1|||
155349053|NCT02254681|560710705|FG000|Overall Study|Lack of Efficacy|6|||
155349054|NCT02469077|560710706|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
155349055|NCT02469077|560710707|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
155349056|NCT02469077|560710706|FG000|Post Randomization/Intervention Period|Relocated|1|||
155349057|NCT02469077|560710707|FG001|Post Randomization/Intervention Period|Relocated|1|||
155349058|NCT02469077|560710706|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
155349059|NCT02469077|560710707|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
155349060|NCT02469077|560710706|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
155349061|NCT02469077|560710707|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
155349062|NCT00396097|560710708|FG000|Overall Study|Withdrawal by Subject|17|||
155349063|NCT00396097|560710709|FG001|Overall Study|Withdrawal by Subject|17|||
155349064|NCT00396097|560710708|FG000|Overall Study|Lost to Follow-up|4|||
155349065|NCT00396097|560710709|FG001|Overall Study|Lost to Follow-up|9|||
155349066|NCT00396097|560710708|FG000|Overall Study|Other|3|||
155349067|NCT00396097|560710709|FG001|Overall Study|Other|5|||
155349068|NCT00396097|560710708|FG000|Overall Study|Protocol Violation|0|||
155349069|NCT00396097|560710709|FG001|Overall Study|Protocol Violation|6|||
155349070|NCT00396097|560710708|FG000|Overall Study|Adverse Event|1|||
155349071|NCT00396097|560710709|FG001|Overall Study|Adverse Event|5|||
155349072|NCT00396097|560710708|FG000|Overall Study|Insufficient Clinical Response|1|||
155349073|NCT00396097|560710709|FG001|Overall Study|Insufficient Clinical Response|4|||
155349074|NCT02973477|560710710|FG000|First Intervention|Lost to Follow-up|0|||
155349075|NCT02973477|560710711|FG001|First Intervention|Lost to Follow-up|2|||
155349076|NCT02973477|560710710|FG000|Washout|Withdrawal by Subject|1|||
155349077|NCT02973477|560710711|FG001|Washout|Withdrawal by Subject|0|||
155349078|NCT02973477|560710710|FG000|Second Intervention|Lost to Follow-up|1|||
155349079|NCT02973477|560710711|FG001|Second Intervention|Lost to Follow-up|0|||
155349080|NCT03461211|560710712|FG000|Overall Study|Adverse Event|1|||
155349081|NCT03461211|560710713|FG001|Overall Study|Adverse Event|1|||
155349082|NCT03461211|560710712|FG000|Overall Study|Lack of Efficacy|0|||
155349083|NCT03461211|560710713|FG001|Overall Study|Lack of Efficacy|1|||
155349084|NCT03807700|560710714|FG000|Overall Study|Withdrawal by Subject|2|||
155349085|NCT03807700|560710715|FG001|Overall Study|Withdrawal by Subject|1|||
155349086|NCT01059526|560710716|FG000|Overall Study|Patient enrolled but not treated|20|||
154964208|NCT03606174|559295198|FG005|Overall Study|Miscellaneous|7|||
154964209|NCT03606174|559295199|FG006|Overall Study|Miscellaneous|5|||
154964210|NCT03606174|559295200|FG007|Overall Study|Miscellaneous|0|||
154964211|NCT03606174|559295201|FG008|Overall Study|Miscellaneous|0|||
154964212|NCT03606174|559295202|FG009|Overall Study|Miscellaneous|0|||
154964213|NCT03606174|559295203|FG010|Overall Study|Miscellaneous|1|||
155083686|NCT00289900|559737295|FG003|Overall Study|Not treated|0|||
155083687|NCT00289900|559737296|FG004|Overall Study|Not treated|0|||
155083688|NCT00289900|559737297|FG005|Overall Study|Not treated|0|||
155165598|NCT00441064|560043496|FG000|Overall Study|Protocol Deviation|3|||
155083689|NCT01703221|559737298|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
155083690|NCT01703221|559737299|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
155083691|NCT01703221|559737300|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155083692|NCT01703221|559737298|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
155083693|NCT01703221|559737299|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
155083694|NCT01703221|559737300|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
155349087|NCT01059526|560710717|FG001|Overall Study|Patient enrolled but not treated|17|||
155349088|NCT01059526|560710716|FG000|Overall Study|Adverse Event|2|||
155349089|NCT01059526|560710717|FG001|Overall Study|Adverse Event|2|||
155349090|NCT01059526|560710716|FG000|Overall Study|Protocol Violation|0|||
155349091|NCT01059526|560710717|FG001|Overall Study|Protocol Violation|1|||
155349092|NCT01059526|560710716|FG000|Overall Study|Withdrawal by Subject|3|||
155349093|NCT01059526|560710717|FG001|Overall Study|Withdrawal by Subject|1|||
155349094|NCT01059526|560710716|FG000|Overall Study|Lost to Follow-up|4|||
155349095|NCT01059526|560710717|FG001|Overall Study|Lost to Follow-up|1|||
155349096|NCT01059526|560710716|FG000|Overall Study|Patient found to be dermatographic|1|||
155349097|NCT01059526|560710717|FG001|Overall Study|Patient found to be dermatographic|0|||
155349098|NCT01732588|560710718|FG000|First Intervention (7 Days)|Adverse Event|0|||
155349099|NCT01732588|560710719|FG001|First Intervention (7 Days)|Adverse Event|1|||
155349100|NCT01732588|560710720|FG002|First Intervention (7 Days)|Adverse Event|0|||
155349101|NCT02720081|560710721|FG000|Overall Study|Adverse Event|0|||
155349102|NCT02720081|560710722|FG001|Overall Study|Adverse Event|3|||
155349103|NCT02720081|560710721|FG000|Overall Study|Protocol Violation|4|||
155349104|NCT02720081|560710722|FG001|Overall Study|Protocol Violation|1|||
155349105|NCT02005029|560710724|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
155349106|NCT02005029|560710725|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
155349107|NCT02316847|560710726|FG000|Overall Study|Adverse Event|0|||
155349108|NCT02316847|560710727|FG001|Overall Study|Adverse Event|3|||
155349109|NCT02316847|560710726|FG000|Overall Study|Lost to Follow-up|0|||
155349110|NCT02316847|560710727|FG001|Overall Study|Lost to Follow-up|2|||
155349111|NCT02316847|560710726|FG000|Overall Study|Physician Decision|0|||
155349112|NCT02316847|560710727|FG001|Overall Study|Physician Decision|1|||
155349113|NCT02316847|560710726|FG000|Overall Study|Pregnancy|0|||
155349114|NCT02316847|560710727|FG001|Overall Study|Pregnancy|1|||
155349115|NCT02316847|560710726|FG000|Overall Study|Withdrawal by Subject|2|||
155083695|NCT01703221|559737298|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
155165599|NCT00441064|560043497|FG001|Overall Study|Protocol Deviation|2|||
155349116|NCT02316847|560710727|FG001|Overall Study|Withdrawal by Subject|9|||
155349117|NCT02316847|560710726|FG000|Overall Study|Noncompliance with study drug|0|||
155349118|NCT02316847|560710727|FG001|Overall Study|Noncompliance with study drug|3|||
155349119|NCT02316847|560710726|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
155349120|NCT02316847|560710727|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
155349121|NCT02621047|560710728|FG000|Overall Study|Adverse Event|0|||
155349122|NCT02621047|560710729|FG001|Overall Study|Adverse Event|0|||
155349123|NCT02621047|560710730|FG002|Overall Study|Adverse Event|1|||
155349124|NCT01370018|560710731|FG000|Overall Study|Did not meet criteria for analysis|1|||
155349125|NCT01525641|560710734|FG000|Overall Study|Case report form not collected|25|||
155349126|NCT01525641|560710734|FG000|Overall Study|No visit since the first visit|16|||
155083696|NCT01703221|559737299|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155083697|NCT01703221|559737300|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155083698|NCT01703221|559737298|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
155083699|NCT01703221|559737299|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155083700|NCT01703221|559737300|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155083701|NCT01703221|559737298|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155083702|NCT01703221|559737299|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155083703|NCT01703221|559737300|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
155083704|NCT01703221|559737298|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
155083705|NCT01703221|559737299|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
155083706|NCT01703221|559737300|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
155083707|NCT01703221|559737298|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
155083708|NCT01703221|559737299|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
155083709|NCT01703221|559737300|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
155083710|NCT01703221|559737298|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
155083711|NCT01703221|559737299|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
155083712|NCT01703221|559737300|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
155083713|NCT03927846|559737302|FG000|Overall Study|Lost to Follow-up|10|||
155083714|NCT03927846|559737303|FG001|Overall Study|Lost to Follow-up|11|||
155083715|NCT00176254|559737304|FG000|Overall Study|Lost to Follow-up|1|||
155083716|NCT00992394|559737307|FG000|Overall Study|Lack of Efficacy|6|||
155083717|NCT00992394|559737308|FG001|Overall Study|Lack of Efficacy|3|||
155349127|NCT01525641|560710734|FG000|Overall Study|Adverse Event|73|||
155349128|NCT01525641|560710734|FG000|Overall Study|Lack of Efficacy|24|||
155349129|NCT01525641|560710734|FG000|Overall Study|Improvement|5|||
155349130|NCT01525641|560710734|FG000|Overall Study|Lost to follow-up (relocation)|1|||
155349131|NCT01525641|560710734|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
155349132|NCT01525641|560710734|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
155349133|NCT01525641|560710734|FG000|Overall Study|Other than stated above|7|||
155349134|NCT03772041|560710735|FG000|Overall Study|Adverse Event|8|||
155349135|NCT03772041|560710736|FG001|Overall Study|Adverse Event|3|||
155349136|NCT03772041|560710735|FG000|Overall Study|Withdrawal by Subject|0|||
155349137|NCT03772041|560710736|FG001|Overall Study|Withdrawal by Subject|2|||
155349138|NCT03772041|560710735|FG000|Overall Study|Protocol Violation|4|||
155349139|NCT03772041|560710736|FG001|Overall Study|Protocol Violation|2|||
155349140|NCT03772041|560710735|FG000|Overall Study|Physician Decision|2|||
155349141|NCT03772041|560710736|FG001|Overall Study|Physician Decision|3|||
155349142|NCT02204319|560710737|FG000|Overall Study|Pregnancy|1|||
155349143|NCT02204319|560710737|FG000|Overall Study|Withdrawal by Subject|2|||
155349144|NCT03544229|560710744|FG000|Overall Study|Adverse Event|1|||
155349145|NCT03544229|560710745|FG001|Overall Study|Adverse Event|0|||
155349146|NCT03544229|560710746|FG002|Overall Study|Adverse Event|1|||
155349147|NCT03544229|560710747|FG003|Overall Study|Adverse Event|0|||
155349148|NCT03544229|560710744|FG000|Overall Study|Protocol Deviation|0|||
155349149|NCT03544229|560710745|FG001|Overall Study|Protocol Deviation|0|||
155349150|NCT03544229|560710746|FG002|Overall Study|Protocol Deviation|1|||
155349151|NCT03544229|560710747|FG003|Overall Study|Protocol Deviation|0|||
155349152|NCT03544229|560710744|FG000|Overall Study|Lost to Follow-up|3|||
155349153|NCT03544229|560710745|FG001|Overall Study|Lost to Follow-up|0|||
155349154|NCT03544229|560710746|FG002|Overall Study|Lost to Follow-up|0|||
155349155|NCT03544229|560710747|FG003|Overall Study|Lost to Follow-up|2|||
155349156|NCT03544229|560710744|FG000|Overall Study|Voluntary Withdrawal|2|||
155349157|NCT03544229|560710745|FG001|Overall Study|Voluntary Withdrawal|1|||
155349158|NCT03544229|560710746|FG002|Overall Study|Voluntary Withdrawal|3|||
155349159|NCT03544229|560710747|FG003|Overall Study|Voluntary Withdrawal|0|||
155349160|NCT03544229|560710744|FG000|Overall Study|Lack of Efficacy|0|||
155349161|NCT03544229|560710745|FG001|Overall Study|Lack of Efficacy|1|||
155349162|NCT03544229|560710746|FG002|Overall Study|Lack of Efficacy|0|||
155349163|NCT03544229|560710747|FG003|Overall Study|Lack of Efficacy|0|||
155083718|NCT00992394|559737307|FG000|Overall Study|Adverse Event|4|||
155083719|NCT00992394|559737308|FG001|Overall Study|Adverse Event|5|||
155083720|NCT00992394|559737307|FG000|Overall Study|Withdrawal by Subject|8|||
155083721|NCT00992394|559737308|FG001|Overall Study|Withdrawal by Subject|2|||
155165600|NCT00441064|560043496|FG000|Overall Study|Patient withdrew consent|5|||
155349164|NCT01954771|560710748|FG000|Overall Study|Missing HbA1c of end-point|1|||
155349165|NCT01954771|560710749|FG001|Overall Study|Missing HbA1c of end-point|1|||
155083722|NCT00992394|559737307|FG000|Overall Study|Physician Decision|1|||
155165601|NCT00441064|560043497|FG001|Overall Study|Patient withdrew consent|2|||
155349166|NCT01954771|560710750|FG002|Overall Study|Missing HbA1c of end-point|0|||
155349167|NCT01954771|560710748|FG000|Overall Study|Missing CGMS of end-point|1|||
154964214|NCT00859521|559295204|FG000|Washout|Withdrawal by Subject|0|||
154964215|NCT00859521|559295205|FG001|Washout|Withdrawal by Subject|1|||
154964216|NCT02125461|559295206|FG000|Overall Study|Withdrawal by Subject|30|||
154964217|NCT02125461|559295207|FG001|Overall Study|Withdrawal by Subject|16|||
154964218|NCT02125461|559295206|FG000|Overall Study|Lost to Follow-up|8|||
154964219|NCT02125461|559295207|FG001|Overall Study|Lost to Follow-up|3|||
154964220|NCT02125461|559295206|FG000|Overall Study|Death|260|||
154964221|NCT02125461|559295207|FG001|Overall Study|Death|149|||
154964222|NCT02125461|559295206|FG000|Overall Study|Missing Termination Reason|0|||
154964223|NCT02125461|559295207|FG001|Overall Study|Missing Termination Reason|1|||
154964224|NCT03552484|559295212|FG000|Overall Study|Death|6|||
154964225|NCT03552484|559295213|FG001|Overall Study|Death|4|||
154964226|NCT03552484|559295212|FG000|Overall Study|Lost to Follow-up|0|||
154964227|NCT03552484|559295213|FG001|Overall Study|Lost to Follow-up|16|||
154964228|NCT03499353|559295214|FG000|Treatment|Adverse Event|3|||
154964229|NCT03499353|559295214|FG000|Treatment|Progressive Disease|10|||
154964230|NCT03499353|559295214|FG000|Treatment|Other|1|||
154964231|NCT03499353|559295214|FG000|Treatment|Withdrawal by Subject|2|||
154964232|NCT03499353|559295214|FG000|Long-Term Follow-up|Death|2|||
154964233|NCT03499353|559295214|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
154964234|NCT03499353|559295214|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
154964235|NCT01592240|559295215|FG000|Overall Study|Adverse Event|1|||
154964236|NCT01592240|559295216|FG001|Overall Study|Adverse Event|0|||
154964237|NCT01592240|559295217|FG002|Overall Study|Adverse Event|0|||
154964238|NCT01592240|559295218|FG003|Overall Study|Adverse Event|1|||
154964239|NCT01592240|559295219|FG004|Overall Study|Adverse Event|1|||
154964240|NCT01592240|559295220|FG005|Overall Study|Adverse Event|0|||
155349168|NCT01954771|560710749|FG001|Overall Study|Missing CGMS of end-point|1|||
155349169|NCT01954771|560710750|FG002|Overall Study|Missing CGMS of end-point|0|||
155349170|NCT01954771|560710748|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
155349171|NCT01954771|560710749|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
155349172|NCT01954771|560710750|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
155349173|NCT03635775|560710751|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
155349174|NCT03635775|560710752|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
155349175|NCT03635775|560710753|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
155349176|NCT03635775|560710754|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
155349177|NCT02588027|560710769|FG000|Overall Study|Withdrawal by Subject|1|||
155349178|NCT02588027|560710770|FG001|Overall Study|Withdrawal by Subject|3|||
155349179|NCT02588027|560710769|FG000|Overall Study|Protocol Violation|4|||
155349180|NCT02588027|560710770|FG001|Overall Study|Protocol Violation|1|||
155349181|NCT02116582|560710771|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
155349182|NCT02116582|560710771|FG000|Overall Study|Adverse Event|22|||
155349183|NCT02116582|560710771|FG000|Overall Study|Death|9|||
155349184|NCT02116582|560710771|FG000|Overall Study|Progressive Disease|148|||
155349185|NCT02116582|560710771|FG000|Overall Study|Protocol Violation|3|||
155349186|NCT02116582|560710771|FG000|Overall Study|Withdrawal by Subject|8|||
155349187|NCT02116582|560710771|FG000|Overall Study|Other: Miscellaneous|11|||
155349188|NCT02116582|560710771|FG000|Overall Study|Lost to Follow-up|1|||
155349189|NCT02116582|560710771|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
155349190|NCT01876823|560710772|FG000|Overall Study|Withdrawal by Subject|5|||
155349191|NCT01876823|560710772|FG000|Overall Study|Physician Decision|2|||
155349192|NCT01876823|560710772|FG000|Overall Study|Patients moved|2|||
155349193|NCT00961896|560712097|FG000|Overall Study|Abnormal laboratory value|0|||
155349194|NCT00961896|560712098|FG001|Overall Study|Abnormal laboratory value|0|||
155349195|NCT00961896|560712099|FG002|Overall Study|Abnormal laboratory value|1|||
155349196|NCT00755716|560712102|FG000|Overall Study|Adverse Event|1|||
154964241|NCT01592240|559295221|FG006|Overall Study|Adverse Event|0|||
154964242|NCT01592240|559295215|FG000|Overall Study|Death|0|||
154964243|NCT01592240|559295216|FG001|Overall Study|Death|1|||
154964244|NCT01592240|559295217|FG002|Overall Study|Death|0|||
154964245|NCT01592240|559295218|FG003|Overall Study|Death|0|||
154964246|NCT01592240|559295219|FG004|Overall Study|Death|0|||
154964247|NCT01592240|559295220|FG005|Overall Study|Death|0|||
155083723|NCT00992394|559737308|FG001|Overall Study|Physician Decision|0|||
154964248|NCT01592240|559295221|FG006|Overall Study|Death|0|||
154964249|NCT01592240|559295215|FG000|Overall Study|Lost to Follow-up|1|||
155349197|NCT00755716|560712103|FG001|Overall Study|Adverse Event|4|||
155349198|NCT00755716|560712104|FG002|Overall Study|Adverse Event|1|||
155349199|NCT00755716|560712102|FG000|Overall Study|Lack of Efficacy|2|||
154964250|NCT01592240|559295216|FG001|Overall Study|Lost to Follow-up|3|||
154964251|NCT01592240|559295217|FG002|Overall Study|Lost to Follow-up|1|||
154964252|NCT01592240|559295218|FG003|Overall Study|Lost to Follow-up|0|||
154964253|NCT01592240|559295219|FG004|Overall Study|Lost to Follow-up|3|||
154964254|NCT01592240|559295220|FG005|Overall Study|Lost to Follow-up|2|||
154964255|NCT01592240|559295221|FG006|Overall Study|Lost to Follow-up|0|||
154964256|NCT01592240|559295215|FG000|Overall Study|Protocol Violation|0|||
154964257|NCT01592240|559295216|FG001|Overall Study|Protocol Violation|0|||
154964258|NCT01592240|559295217|FG002|Overall Study|Protocol Violation|0|||
155083724|NCT00992394|559737307|FG000|Overall Study|Protocol Violation|2|||
155083725|NCT00992394|559737308|FG001|Overall Study|Protocol Violation|4|||
155083726|NCT00992394|559737307|FG000|Overall Study|Lost to Follow-up|2|||
155083727|NCT00992394|559737308|FG001|Overall Study|Lost to Follow-up|0|||
155083728|NCT00992394|559737307|FG000|Overall Study|Other event|1|||
155083729|NCT00992394|559737308|FG001|Overall Study|Other event|0|||
155083730|NCT00561821|559737309|FG000|Overall Study|Not treated|0|||
155083731|NCT00561821|559737310|FG001|Overall Study|Not treated|0|||
155349200|NCT00755716|560712103|FG001|Overall Study|Lack of Efficacy|0|||
155349201|NCT00755716|560712104|FG002|Overall Study|Lack of Efficacy|0|||
155349202|NCT00755716|560712102|FG000|Overall Study|Lost to Follow-up|5|||
155349203|NCT00755716|560712103|FG001|Overall Study|Lost to Follow-up|3|||
155349204|NCT00755716|560712104|FG002|Overall Study|Lost to Follow-up|1|||
155349205|NCT00755716|560712102|FG000|Overall Study|work schedule issues|0|||
155349206|NCT00755716|560712103|FG001|Overall Study|work schedule issues|1|||
155349207|NCT00755716|560712104|FG002|Overall Study|work schedule issues|1|||
155349208|NCT03022578|560712105|FG000|Overall Study|Adverse Event|1|||
155349209|NCT03022578|560712105|FG000|Overall Study|Lack of Efficacy|2|||
155083732|NCT00561821|559737311|FG002|Overall Study|Not treated|1|||
155083733|NCT00561821|559737312|FG003|Overall Study|Not treated|0|||
155349210|NCT03022578|560712105|FG000|Overall Study|Withdrawal by Subject|1|||
155349211|NCT00111839|560712106|FG000|Overall Study|Disease Progression|30|||
155349212|NCT00111839|560712107|FG001|Overall Study|Disease Progression|33|||
155349213|NCT00111839|560712108|FG002|Overall Study|Disease Progression|33|||
155349214|NCT00111839|560712106|FG000|Overall Study|Adverse Event|5|||
155349215|NCT00111839|560712107|FG001|Overall Study|Adverse Event|3|||
155349216|NCT00111839|560712108|FG002|Overall Study|Adverse Event|1|||
155349217|NCT00111839|560712106|FG000|Overall Study|Protocol Violation|2|||
155349218|NCT00111839|560712107|FG001|Overall Study|Protocol Violation|4|||
155349219|NCT00111839|560712108|FG002|Overall Study|Protocol Violation|2|||
155349220|NCT00111839|560712106|FG000|Overall Study|Death|1|||
155349221|NCT00111839|560712107|FG001|Overall Study|Death|1|||
155349222|NCT00111839|560712108|FG002|Overall Study|Death|6|||
155349223|NCT00111839|560712106|FG000|Overall Study|Withdrawal by Subject|2|||
155349224|NCT00111839|560712107|FG001|Overall Study|Withdrawal by Subject|2|||
155349225|NCT00111839|560712108|FG002|Overall Study|Withdrawal by Subject|2|||
155349226|NCT00111839|560712106|FG000|Overall Study|Lost to Follow-up|1|||
155349227|NCT00111839|560712107|FG001|Overall Study|Lost to Follow-up|0|||
155349228|NCT00111839|560712108|FG002|Overall Study|Lost to Follow-up|0|||
155349229|NCT00111839|560712106|FG000|Overall Study|Logistical Constraint|1|||
155349230|NCT00111839|560712107|FG001|Overall Study|Logistical Constraint|0|||
155349231|NCT00111839|560712108|FG002|Overall Study|Logistical Constraint|0|||
155349232|NCT00111839|560712106|FG000|Overall Study|Other|6|||
155349233|NCT00111839|560712107|FG001|Overall Study|Other|3|||
155349234|NCT00111839|560712108|FG002|Overall Study|Other|3|||
155349235|NCT00111839|560712106|FG000|Overall Study|Randomized but Not Treated|0|||
155083734|NCT00561821|559737309|FG000|Overall Study|Withdrawal by Subject|0|||
155083735|NCT00561821|559737310|FG001|Overall Study|Withdrawal by Subject|1|||
155083736|NCT00561821|559737311|FG002|Overall Study|Withdrawal by Subject|0|||
155083737|NCT00561821|559737312|FG003|Overall Study|Withdrawal by Subject|2|||
155349236|NCT00111839|560712107|FG001|Overall Study|Randomized but Not Treated|0|||
155349237|NCT00111839|560712108|FG002|Overall Study|Randomized but Not Treated|2|||
155349238|NCT00805285|560712113|FG000|Overall Study|Lack of Efficacy|1|||
155349239|NCT01441583|560712114|FG000|Overall Study|Withdrawal by Subject|1|||
155349240|NCT01441583|560712115|FG001|Overall Study|Withdrawal by Subject|1|||
155349241|NCT01441583|560712116|FG002|Overall Study|Withdrawal by Subject|1|||
155349242|NCT01441583|560712114|FG000|Overall Study|Death|1|||
155349243|NCT01441583|560712115|FG001|Overall Study|Death|0|||
155349244|NCT01441583|560712116|FG002|Overall Study|Death|4|||
155349245|NCT01441583|560712114|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
155349246|NCT01441583|560712115|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
155349247|NCT01441583|560712116|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
155083738|NCT00561821|559737309|FG000|Overall Study|Reasons not related to trial|2|||
155349248|NCT01066897|560712117|FG000|Overall Study|Withdrawal by Subject|1|||
155349249|NCT01066897|560712118|FG001|Overall Study|Withdrawal by Subject|0|||
155349250|NCT01066897|560712117|FG000|Overall Study|stopped study after developing the flu.|1|||
155349251|NCT01066897|560712118|FG001|Overall Study|stopped study after developing the flu.|0|||
155349252|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
155349253|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349254|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155083739|NCT00561821|559737310|FG001|Overall Study|Reasons not related to trial|1|||
155083740|NCT00561821|559737311|FG002|Overall Study|Reasons not related to trial|0|||
155349255|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349256|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349257|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349258|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349259|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349260|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349261|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
155349262|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349263|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349264|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349265|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349266|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349267|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
155349268|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349269|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349270|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349271|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
155349272|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
155349273|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349274|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349275|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349276|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349277|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349278|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349279|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349280|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349281|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
155349282|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349283|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349284|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349285|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349286|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349287|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349288|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349289|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155349290|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
155165602|NCT00953056|560043498|FG000|Overall Study|Withdrew Consent|0|||
155349291|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
155349292|NCT01697592|560712121|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349293|NCT01697592|560712122|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
155349294|NCT01697592|560712123|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
155349295|NCT01697592|560712124|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
155349296|NCT01697592|560712125|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349297|NCT01697592|560712126|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349298|NCT01697592|560712127|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
155349299|NCT01697592|560712128|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349300|NCT01697592|560712129|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
155349301|NCT01697592|560712130|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
155349302|NCT01697592|560712121|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
155349303|NCT01697592|560712122|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349304|NCT01697592|560712123|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349305|NCT01697592|560712124|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
155349306|NCT01697592|560712125|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349307|NCT01697592|560712126|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349308|NCT01697592|560712127|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349309|NCT01697592|560712128|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349310|NCT01697592|560712129|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349311|NCT01697592|560712130|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
155349312|NCT01697592|560712121|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
155349313|NCT01697592|560712122|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349314|NCT01697592|560712123|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349315|NCT01697592|560712124|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349316|NCT01697592|560712125|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349317|NCT01697592|560712126|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
155349318|NCT01697592|560712127|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349319|NCT01697592|560712128|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
155349320|NCT01697592|560712129|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349321|NCT01697592|560712130|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
155349322|NCT01697592|560712121|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
155349323|NCT01697592|560712122|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349324|NCT01697592|560712123|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349325|NCT01697592|560712124|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
155349326|NCT01697592|560712125|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
155349327|NCT01697592|560712126|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349328|NCT01697592|560712127|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
155349329|NCT01697592|560712128|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
155349330|NCT01697592|560712129|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
155349331|NCT01697592|560712130|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
155349332|NCT02110225|560712131|FG000|Overall Study|Lost to Follow-up|0|||
155349333|NCT02110225|560712132|FG001|Overall Study|Lost to Follow-up|1|||
155349334|NCT02110225|560712133|FG002|Overall Study|Lost to Follow-up|0|||
155349335|NCT00809783|560712136|FG000|Overall Study|Death|1|||
155349336|NCT00809783|560712137|FG001|Overall Study|Death|0|||
155349337|NCT00809783|560712138|FG002|Overall Study|Death|0|||
155349338|NCT00809783|560712136|FG000|Overall Study|Adverse Event|34|||
155349339|NCT00809783|560712137|FG001|Overall Study|Adverse Event|52|||
155349340|NCT00809783|560712138|FG002|Overall Study|Adverse Event|71|||
155349341|NCT00809783|560712136|FG000|Overall Study|Lack of Efficacy|39|||
155349342|NCT00809783|560712137|FG001|Overall Study|Lack of Efficacy|52|||
155349343|NCT00809783|560712138|FG002|Overall Study|Lack of Efficacy|63|||
155349344|NCT00809783|560712136|FG000|Overall Study|Lost to Follow-up|0|||
155349345|NCT00809783|560712137|FG001|Overall Study|Lost to Follow-up|3|||
155349346|NCT00809783|560712138|FG002|Overall Study|Lost to Follow-up|4|||
155349347|NCT00809783|560712136|FG000|Overall Study|Withdrawal by Subject|47|||
155349348|NCT00809783|560712137|FG001|Overall Study|Withdrawal by Subject|72|||
155349349|NCT00809783|560712138|FG002|Overall Study|Withdrawal by Subject|64|||
155349350|NCT00809783|560712136|FG000|Overall Study|Protocol Violation|2|||
155349351|NCT00809783|560712137|FG001|Overall Study|Protocol Violation|6|||
155349352|NCT00809783|560712138|FG002|Overall Study|Protocol Violation|5|||
155349353|NCT00809783|560712136|FG000|Overall Study|Randomized, but not treated|3|||
155349354|NCT00809783|560712137|FG001|Overall Study|Randomized, but not treated|0|||
155349355|NCT00809783|560712138|FG002|Overall Study|Randomized, but not treated|2|||
155349356|NCT00809783|560712136|FG000|Overall Study|Study Terminated by Sponsor|378|||
155349357|NCT00809783|560712137|FG001|Overall Study|Study Terminated by Sponsor|626|||
155349358|NCT00809783|560712138|FG002|Overall Study|Study Terminated by Sponsor|565|||
155349359|NCT00809783|560712136|FG000|Overall Study|Other|21|||
155349360|NCT00809783|560712137|FG001|Overall Study|Other|21|||
155349361|NCT00809783|560712138|FG002|Overall Study|Other|16|||
155349362|NCT00126555|560712139|FG000|Overall Study|Withdrawal by Subject|1|||
155349363|NCT00126555|560712139|FG000|Overall Study|Adverse Event|2|||
155349364|NCT00126555|560712139|FG000|Overall Study|Progressive Disease|3|||
155349365|NCT03441789|560712146|FG000|Overall Study|Withdrawal by Subject|1|||
154964259|NCT01592240|559295218|FG003|Overall Study|Protocol Violation|0|||
154964260|NCT01592240|559295219|FG004|Overall Study|Protocol Violation|0|||
154964261|NCT01592240|559295220|FG005|Overall Study|Protocol Violation|1|||
154964262|NCT01592240|559295221|FG006|Overall Study|Protocol Violation|0|||
154964263|NCT01592240|559295215|FG000|Overall Study|Withdrawal by Subject|0|||
155083741|NCT00561821|559737312|FG003|Overall Study|Reasons not related to trial|0|||
155083742|NCT00561821|559737309|FG000|Overall Study|Other (reason not specified)|1|||
155083743|NCT00561821|559737310|FG001|Overall Study|Other (reason not specified)|1|||
155083744|NCT00561821|559737311|FG002|Overall Study|Other (reason not specified)|0|||
155083745|NCT00561821|559737312|FG003|Overall Study|Other (reason not specified)|0|||
155083746|NCT00561821|559737309|FG000|Overall Study|Adverse Event|2|||
155083747|NCT00561821|559737310|FG001|Overall Study|Adverse Event|3|||
155349366|NCT03441789|560712147|FG001|Overall Study|Withdrawal by Subject|1|||
155349367|NCT03441789|560712146|FG000|Overall Study|Adverse Event|0|||
155349368|NCT03441789|560712147|FG001|Overall Study|Adverse Event|1|||
155349369|NCT03441789|560712146|FG000|Overall Study|Protocol Violation|0|||
155349370|NCT03441789|560712147|FG001|Overall Study|Protocol Violation|1|||
155349371|NCT03441789|560712146|FG000|Overall Study|Lost to Follow-up|0|||
155349372|NCT03441789|560712147|FG001|Overall Study|Lost to Follow-up|1|||
155349373|NCT01780545|560712148|FG000|Overall Study|Withdrawal by Subject|3|||
155349374|NCT01780545|560712149|FG001|Overall Study|Withdrawal by Subject|1|||
155349375|NCT01780545|560712148|FG000|Overall Study|Lost to Follow-up|1|||
155349376|NCT01780545|560712149|FG001|Overall Study|Lost to Follow-up|1|||
155349377|NCT02581189|560712154|FG000|Overall Study|Failure to return|36|||
155349378|NCT02581189|560712154|FG000|Overall Study|Withdrew consent|5|||
155349379|NCT02581189|560712154|FG000|Overall Study|Death|3|||
155349380|NCT02581189|560712154|FG000|Overall Study|Insufficient virological response|2|||
155349381|NCT02581189|560712154|FG000|Overall Study|Other, not specified|7|||
155349382|NCT03275402|560712159|FG000|Overall Study|Death|17|||
155349383|NCT03275402|560712159|FG000|Overall Study|Study terminated by sponsor|21|||
155349384|NCT03275402|560712159|FG000|Overall Study|Withdrawal by Subject|1|||
155349385|NCT01514864|560712160|FG000|Overall Study|Disease progression|7|||
155349386|NCT01514864|560712161|FG001|Overall Study|Disease progression|5|||
155349387|NCT01514864|560712160|FG000|Overall Study|Study drug toxicity|2|||
155349388|NCT01514864|560712161|FG001|Overall Study|Study drug toxicity|0|||
155349389|NCT03371485|560712162|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
155349390|NCT03371485|560712162|FG000|2-year Follow-up|Death|5|||
155349391|NCT03187353|560712163|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
155349392|NCT03187353|560712164|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
155349393|NCT03187353|560712163|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
155349394|NCT03187353|560712164|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155349395|NCT03187353|560712163|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
155349396|NCT03187353|560712164|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
155349397|NCT03187353|560712163|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155349398|NCT03187353|560712164|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
155349399|NCT03187353|560712163|FG000|Washout (2 Weeks)|Adverse Event|2|||
155349400|NCT03187353|560712164|FG001|Washout (2 Weeks)|Adverse Event|0|||
155349401|NCT03187353|560712163|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
155349402|NCT03187353|560712164|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
155349403|NCT02567227|560712165|FG000|9 Weeks|Adverse Event|5|||
155349404|NCT02567227|560712166|FG001|9 Weeks|Adverse Event|5|||
155349405|NCT02567227|560712165|FG000|9 Weeks|Withdrawal by Subject|18|||
155349406|NCT02567227|560712166|FG001|9 Weeks|Withdrawal by Subject|8|||
155349407|NCT02567227|560712165|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
155349408|NCT02567227|560712166|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
155349409|NCT02567227|560712165|FG000|6 Month|Death|2|||
155349410|NCT02567227|560712166|FG001|6 Month|Death|0|||
155349411|NCT02567227|560712165|FG000|6 Month|Lost to Follow-up|43|||
155349412|NCT02567227|560712166|FG001|6 Month|Lost to Follow-up|40|||
155349413|NCT02567227|560712165|FG000|12 Months|Lost to Follow-up|31|||
155349414|NCT02567227|560712166|FG001|12 Months|Lost to Follow-up|32|||
155349415|NCT02567227|560712165|FG000|12 Months|Death|0|||
155349416|NCT02567227|560712166|FG001|12 Months|Death|2|||
155349417|NCT01026103|560712169|FG000|Overall Study|Physician Decision|1|||
155349418|NCT01026103|560712169|FG000|Overall Study|did not receive study device bc of error|1|||
155349419|NCT02498418|560712170|FG000|Overall Study|Lack of Efficacy|0|||
154964264|NCT01592240|559295216|FG001|Overall Study|Withdrawal by Subject|4|||
155349420|NCT02498418|560712171|FG001|Overall Study|Lack of Efficacy|0|||
154964265|NCT01592240|559295217|FG002|Overall Study|Withdrawal by Subject|4|||
155349421|NCT02498418|560712172|FG002|Overall Study|Lack of Efficacy|1|||
155349422|NCT02498418|560712170|FG000|Overall Study|Withdrawal by Subject|2|||
155349423|NCT02498418|560712171|FG001|Overall Study|Withdrawal by Subject|0|||
155349424|NCT02498418|560712172|FG002|Overall Study|Withdrawal by Subject|3|||
155349425|NCT02498418|560712170|FG000|Overall Study|Lost to Follow-up|0|||
155165603|NCT00953056|560043499|FG001|Overall Study|Withdrew Consent|0|||
155083748|NCT00561821|559737311|FG002|Overall Study|Adverse Event|1|||
155083749|NCT00561821|559737312|FG003|Overall Study|Adverse Event|1|||
155083750|NCT04744831|559739084|FG000|Overall Study|Progressive Disease|31|||
155083751|NCT04744831|559739085|FG001|Overall Study|Progressive Disease|27|||
155083752|NCT04744831|559739086|FG002|Overall Study|Progressive Disease|25|||
155083753|NCT04744831|559739084|FG000|Overall Study|Adverse Event|3|||
155083754|NCT04744831|559739085|FG001|Overall Study|Adverse Event|3|||
155083755|NCT04744831|559739086|FG002|Overall Study|Adverse Event|3|||
155083756|NCT04744831|559739084|FG000|Overall Study|Clinical Progression|3|||
155083757|NCT04744831|559739085|FG001|Overall Study|Clinical Progression|2|||
155349426|NCT02498418|560712171|FG001|Overall Study|Lost to Follow-up|1|||
155349427|NCT02498418|560712172|FG002|Overall Study|Lost to Follow-up|1|||
155349428|NCT02498418|560712170|FG000|Overall Study|Participant taken prohibited medication|0|||
155349429|NCT02498418|560712171|FG001|Overall Study|Participant taken prohibited medication|1|||
155349430|NCT02498418|560712172|FG002|Overall Study|Participant taken prohibited medication|1|||
155349431|NCT01363297|560712181|FG000|Overall Study|Other|0|||
155349432|NCT01363297|560712182|FG001|Overall Study|Other|0|||
155349433|NCT01363297|560712183|FG002|Overall Study|Other|0|||
155349434|NCT01363297|560712184|FG003|Overall Study|Other|0|||
155349435|NCT01363297|560712185|FG004|Overall Study|Other|1|||
155349436|NCT01363297|560712181|FG000|Overall Study|Death|3|||
155349437|NCT01363297|560712182|FG001|Overall Study|Death|6|||
155349438|NCT01363297|560712183|FG002|Overall Study|Death|6|||
155349439|NCT01363297|560712184|FG003|Overall Study|Death|10|||
155349440|NCT01363297|560712185|FG004|Overall Study|Death|30|||
155349441|NCT00794573|560712190|FG000|Overall Study|Death|3|||
155349442|NCT00794573|560712191|FG001|Overall Study|Death|0|||
155349443|NCT00794573|560712190|FG000|Overall Study|Withdrawal by Subject|9|||
155349444|NCT00794573|560712191|FG001|Overall Study|Withdrawal by Subject|12|||
155349445|NCT00794573|560712190|FG000|Overall Study|Lost to Follow-up|26|||
155349446|NCT00794573|560712191|FG001|Overall Study|Lost to Follow-up|33|||
155165604|NCT00953056|560043500|FG002|Overall Study|Withdrew Consent|0|||
155349447|NCT01774929|560712194|FG000|Overall Study|Adverse Event|3|||
155349448|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
155349449|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
155349450|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
155349451|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
155349452|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
155349453|NCT00500539|560712195|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
155349454|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
155349455|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
155349456|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
155349457|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
155349458|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Death|1|||
155349459|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
155349460|NCT00500539|560712195|FG000|Follow-up Period (16 Weeks)|Missing|3|||
155349461|NCT03993054|560712198|FG000|Overall Study|PI Decision|1|||
155349462|NCT00383500|560712199|FG000|Overall Study|Withdrawal by Subject|8|||
155349463|NCT00383500|560712200|FG001|Overall Study|Withdrawal by Subject|3|||
155349464|NCT00383500|560712201|FG002|Overall Study|Withdrawal by Subject|0|||
155349465|NCT00383500|560712199|FG000|Overall Study|Lost to Follow-up|0|||
155349466|NCT00383500|560712200|FG001|Overall Study|Lost to Follow-up|0|||
155349467|NCT00383500|560712201|FG002|Overall Study|Lost to Follow-up|2|||
155349468|NCT01123642|560712205|FG000|Overall Study|Lost to Follow-up|23|||
155349469|NCT01123642|560712205|FG000|Overall Study|Withdrawal by Subject|9|||
155349470|NCT01123642|560712205|FG000|Overall Study|ineligible at baseline assessment|36|||
155349471|NCT04853238|560712206|FG000|Overall Study|Death|4|||
155349472|NCT04853238|560712207|FG001|Overall Study|Death|0|||
155349473|NCT04853238|560712208|FG002|Overall Study|Death|2|||
155349474|NCT04853238|560712206|FG000|Overall Study|Lost to Follow-up|16|||
155349475|NCT04853238|560712207|FG001|Overall Study|Lost to Follow-up|2|||
155349476|NCT04853238|560712208|FG002|Overall Study|Lost to Follow-up|37|||
155349477|NCT04853238|560712206|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
155349478|NCT04853238|560712207|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
155349479|NCT04853238|560712208|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
155349480|NCT04853238|560712206|FG000|Overall Study|Withdrawal by Subject|6|||
155349481|NCT04853238|560712207|FG001|Overall Study|Withdrawal by Subject|0|||
155349482|NCT04853238|560712208|FG002|Overall Study|Withdrawal by Subject|21|||
155349483|NCT04853238|560712206|FG000|Overall Study|Physician Decision|0|||
155349484|NCT04853238|560712207|FG001|Overall Study|Physician Decision|0|||
155349485|NCT04853238|560712208|FG002|Overall Study|Physician Decision|2|||
155349486|NCT04853238|560712206|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
155349487|NCT04853238|560712207|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
155349488|NCT04853238|560712208|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
155349489|NCT02093897|560713685|FG000|Overall Study|Physician Decision|1|||
155349490|NCT02093897|560713685|FG000|Overall Study|Planned age group closure - no's reached|17|||
155349491|NCT02093897|560713685|FG000|Overall Study|Adverse event, non-fatal|1|||
155349492|NCT02972242|560713686|FG000|Overall Study|Withdrawal by Subject|1|||
154964266|NCT01592240|559295218|FG003|Overall Study|Withdrawal by Subject|1|||
155083758|NCT04744831|559739086|FG002|Overall Study|Clinical Progression|5|||
155083759|NCT04744831|559739084|FG000|Overall Study|Other|0|||
155083760|NCT04744831|559739085|FG001|Overall Study|Other|2|||
155349493|NCT02972242|560713687|FG001|Overall Study|Withdrawal by Subject|0|||
155349494|NCT04572997|560713691|FG000|Overall Study|Adverse Event|1|||
155349495|NCT01967719|560713692|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349496|NCT01967719|560713693|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
155349497|NCT01967719|560713694|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349498|NCT01967719|560713695|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
155349499|NCT01967719|560713692|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
155349500|NCT01967719|560713693|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
155349501|NCT01967719|560713694|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
155349502|NCT01967719|560713695|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
155349503|NCT00371462|560713697|FG000|Overall Study|Withdrawal by Subject|1|||
155349504|NCT00371462|560713698|FG001|Overall Study|Withdrawal by Subject|0|||
155349505|NCT00371462|560713697|FG000|Overall Study|Other|7|||
155083761|NCT04744831|559739086|FG002|Overall Study|Other|1|||
155083762|NCT04744831|559739084|FG000|Overall Study|Death|0|||
155349506|NCT00371462|560713698|FG001|Overall Study|Other|8|||
155349507|NCT01983462|560713699|FG000|Overall Study|Adverse Event|1|||
155349508|NCT01983462|560713700|FG001|Overall Study|Adverse Event|0|||
155349509|NCT01983462|560713701|FG002|Overall Study|Adverse Event|0|||
155349510|NCT03511378|560713702|FG000|Overall Study|Withdrawal by Subject|2|||
155349511|NCT03511378|560713703|FG001|Overall Study|Withdrawal by Subject|2|||
155349512|NCT03511378|560713702|FG000|Overall Study|Patient not coming or schedule visit|1|||
155349513|NCT03511378|560713703|FG001|Overall Study|Patient not coming or schedule visit|0|||
155349514|NCT02229396|560713705|FG000|Overall Study|Adverse Event|6|||
155349515|NCT02229396|560713706|FG001|Overall Study|Adverse Event|12|||
154964267|NCT01592240|559295219|FG004|Overall Study|Withdrawal by Subject|3|||
155083763|NCT04744831|559739085|FG001|Overall Study|Death|2|||
155083764|NCT04744831|559739086|FG002|Overall Study|Death|1|||
155083765|NCT05401409|559739089|FG000|Overall Study|Lost to Follow-up|1|||
155083766|NCT05401409|559739090|FG001|Overall Study|Lost to Follow-up|0|||
155083767|NCT02144337|559739092|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
155083768|NCT02144337|559739093|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
155083769|NCT02144337|559739092|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
155083770|NCT02144337|559739093|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
155083771|NCT02144337|559739092|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
155083772|NCT02144337|559739093|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
155083773|NCT02144337|559739092|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
155083774|NCT02144337|559739093|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
155083775|NCT02144337|559739092|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
155083776|NCT02144337|559739093|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
155349516|NCT02229396|560713707|FG002|Overall Study|Adverse Event|12|||
155083777|NCT02402907|559739094|FG000|Overall Study|Delivered vaginally|9|||
155083778|NCT02402907|559739095|FG001|Overall Study|Delivered vaginally|3|||
155083779|NCT02402907|559739094|FG000|Overall Study|Delivered outside of Sinai|1|||
155083780|NCT02402907|559739095|FG001|Overall Study|Delivered outside of Sinai|1|||
155083781|NCT02402907|559739094|FG000|Overall Study|Lost to follow up after C-Section|10|||
155349517|NCT02229396|560713705|FG000|Overall Study|Death|2|||
155083782|NCT02402907|559739095|FG001|Overall Study|Lost to follow up after C-Section|23|||
155349518|NCT02229396|560713706|FG001|Overall Study|Death|3|||
155349519|NCT02229396|560713707|FG002|Overall Study|Death|1|||
155349520|NCT02229396|560713705|FG000|Overall Study|Lost to Follow-up|14|||
155349521|NCT02229396|560713706|FG001|Overall Study|Lost to Follow-up|14|||
155349522|NCT02229396|560713707|FG002|Overall Study|Lost to Follow-up|21|||
155349523|NCT02229396|560713705|FG000|Overall Study|Protocol Violation|2|||
155349524|NCT02229396|560713706|FG001|Overall Study|Protocol Violation|1|||
155349525|NCT02229396|560713707|FG002|Overall Study|Protocol Violation|0|||
155083783|NCT03701074|559739096|FG000|Overall Study|Physician Decision|1|||
155349526|NCT02229396|560713705|FG000|Overall Study|Patient Incorrectly Randomized|0|||
155349527|NCT02229396|560713706|FG001|Overall Study|Patient Incorrectly Randomized|0|||
155349528|NCT02229396|560713707|FG002|Overall Study|Patient Incorrectly Randomized|1|||
155083784|NCT03701074|559739097|FG001|Overall Study|Physician Decision|0|||
155083785|NCT01500135|559739100|FG000|Overall Study|Withdrawal of Consent|4|||
155083786|NCT01500135|559739101|FG001|Overall Study|Withdrawal of Consent|0|||
155083787|NCT01500135|559739100|FG000|Overall Study|Lost to Follow-up|6|||
155083788|NCT01500135|559739101|FG001|Overall Study|Lost to Follow-up|4|||
155083789|NCT01500135|559739100|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
155083790|NCT01500135|559739101|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
155083791|NCT01500135|559739100|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
155083792|NCT01500135|559739101|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
155083793|NCT01500135|559739100|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
155083794|NCT01500135|559739101|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
155083795|NCT01500135|559739100|FG000|Overall Study|Participant was a Safety Concern|1|||
155083796|NCT01500135|559739101|FG001|Overall Study|Participant was a Safety Concern|0|||
155083797|NCT01500135|559739100|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
155083798|NCT01500135|559739101|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
155083799|NCT00661687|559739102|FG000|Overall Study|Study related symptoms and complaints|5|||
155083800|NCT00661687|559739102|FG000|Overall Study|Positive slit lamp findings|4|||
155083801|NCT00661687|559739102|FG000|Overall Study|Inability to maintain wearing schedule|3|||
155083802|NCT00661687|559739102|FG000|Overall Study|Physician Decision|1|||
155083803|NCT00661687|559739102|FG000|Overall Study|Adverse Event|2|||
155083804|NCT00912509|559739103|FG000|Overall Study|Lost to Follow-up|1|||
155083805|NCT00912509|559739104|FG001|Overall Study|Lost to Follow-up|0|||
155083806|NCT00912509|559739103|FG000|Overall Study|Lack of Efficacy|4|||
155083807|NCT00912509|559739104|FG001|Overall Study|Lack of Efficacy|3|||
155083808|NCT01362530|559739106|FG000|Base Study (Cycle 1)|Adverse Event|2|||
155083809|NCT01362530|559739107|FG001|Base Study (Cycle 1)|Adverse Event|0|||
155083810|NCT01362530|559739106|FG000|Base Study (Cycle 1)|Physician Decision|0|||
155083811|NCT01362530|559739107|FG001|Base Study (Cycle 1)|Physician Decision|1|||
155083812|NCT01362530|559739106|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
155083813|NCT01362530|559739107|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
155083814|NCT01362530|559739106|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
155083815|NCT01362530|559739107|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
155083816|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
155083817|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
155083818|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
155083819|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
155083820|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
155083821|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
155083822|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
155083823|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
155083824|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
155083825|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
155083826|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
155083827|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
155083828|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
155083829|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
155083830|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
155083831|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
155083832|NCT01362530|559739106|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
155083833|NCT01362530|559739107|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
155083834|NCT01034657|559739108|FG000|Core Phase|Withdrawal by Subject|1|||
155083835|NCT01034657|559739109|FG001|Core Phase|Withdrawal by Subject|0|||
155083836|NCT01034657|559739110|FG002|Core Phase|Withdrawal by Subject|0|||
155083837|NCT01034657|559739108|FG000|Core Phase|Lack of Efficacy|2|||
155083838|NCT01034657|559739109|FG001|Core Phase|Lack of Efficacy|0|||
155083839|NCT01034657|559739110|FG002|Core Phase|Lack of Efficacy|0|||
155083840|NCT01034657|559739108|FG000|Core Phase|Abnormal laboratory value|1|||
155083841|NCT01034657|559739109|FG001|Core Phase|Abnormal laboratory value|0|||
155083842|NCT01034657|559739110|FG002|Core Phase|Abnormal laboratory value|0|||
155083843|NCT01034657|559739108|FG000|Core Phase|Adverse Event|8|||
155165605|NCT00953056|560043501|FG003|Overall Study|Withdrew Consent|0|||
155083844|NCT01034657|559739109|FG001|Core Phase|Adverse Event|0|||
155083845|NCT01034657|559739110|FG002|Core Phase|Adverse Event|0|||
155083846|NCT01034657|559739108|FG000|Core Phase|Protocol Violation|2|||
155083847|NCT01034657|559739109|FG001|Core Phase|Protocol Violation|0|||
155083848|NCT01034657|559739110|FG002|Core Phase|Protocol Violation|0|||
155083849|NCT01034657|559739108|FG000|Randomized Phase|Withdrawal by Subject|0|||
155083850|NCT01034657|559739109|FG001|Randomized Phase|Withdrawal by Subject|2|||
155083851|NCT01034657|559739110|FG002|Randomized Phase|Withdrawal by Subject|0|||
155083852|NCT01034657|559739108|FG000|Randomized Phase|Lack of Efficacy|5|||
155083853|NCT01034657|559739109|FG001|Randomized Phase|Lack of Efficacy|1|||
155083854|NCT01034657|559739110|FG002|Randomized Phase|Lack of Efficacy|0|||
155083855|NCT01034657|559739108|FG000|Randomized Phase|Abnormal laboratory value|0|||
155083856|NCT01034657|559739109|FG001|Randomized Phase|Abnormal laboratory value|1|||
155083857|NCT01034657|559739110|FG002|Randomized Phase|Abnormal laboratory value|0|||
155083858|NCT01034657|559739108|FG000|Randomized Phase|Adverse Event|0|||
155083859|NCT01034657|559739109|FG001|Randomized Phase|Adverse Event|2|||
155083860|NCT01034657|559739110|FG002|Randomized Phase|Adverse Event|1|||
155083861|NCT02715856|559739111|FG000|Overall Study|Software Issues|12|||
155083862|NCT02715856|559739112|FG001|Overall Study|Software Issues|7|||
155083863|NCT02715856|559739111|FG000|Overall Study|Death|6|||
155083864|NCT02715856|559739112|FG001|Overall Study|Death|5|||
155083865|NCT02715856|559739111|FG000|Overall Study|Non- Compliant|0|||
155083866|NCT02715856|559739112|FG001|Overall Study|Non- Compliant|40|||
155083867|NCT01557569|559739113|FG000|Overall Study|Adverse Event|2|||
155083868|NCT01557569|559739114|FG001|Overall Study|Adverse Event|0|||
155083869|NCT01557569|559739113|FG000|Overall Study|high blood pressure|0|||
155083870|NCT01557569|559739114|FG001|Overall Study|high blood pressure|1|||
155083871|NCT01557569|559739113|FG000|Overall Study|Withdrawal by Subject|3|||
155083872|NCT01557569|559739114|FG001|Overall Study|Withdrawal by Subject|5|||
155083873|NCT01557569|559739113|FG000|Overall Study|noncompliance with rules of residential|0|||
155083874|NCT01557569|559739114|FG001|Overall Study|noncompliance with rules of residential|1|||
155083875|NCT01050218|559739115|FG000|Overall Study|Adverse Event|37|||
155083876|NCT01050218|559739115|FG000|Overall Study|Lack of Efficacy|8|||
155083877|NCT01050218|559739115|FG000|Overall Study|Protocol Violation|3|||
155083878|NCT01050218|559739115|FG000|Overall Study|Withdrawal by Subject|18|||
155083879|NCT01050218|559739115|FG000|Overall Study|Discontinued by sponsor|18|||
155083880|NCT01050218|559739115|FG000|Overall Study|Compliance|2|||
155083881|NCT01050218|559739115|FG000|Overall Study|Failed to return|7|||
155083882|NCT01050218|559739115|FG000|Overall Study|Serious Adverse Event|1|||
155083883|NCT01050218|559739115|FG000|Overall Study|Family emergency|1|||
155083884|NCT03682367|559739118|FG000|Overall Study|Protocol Violation|2|||
155083885|NCT03682367|559739119|FG001|Overall Study|Protocol Violation|1|||
155083886|NCT03682367|559739118|FG000|Overall Study|Closed Study Early|0|||
155083887|NCT03682367|559739119|FG001|Overall Study|Closed Study Early|3|||
155083888|NCT00128492|559739120|FG000|Overall Study|AE unrelated to study|2|||
155083889|NCT00128492|559739121|FG001|Overall Study|AE unrelated to study|9|||
155165606|NCT00953056|560043502|FG004|Overall Study|Withdrew Consent|2|||
155349529|NCT02229396|560713705|FG000|Overall Study|Other|10|||
155349530|NCT02229396|560713706|FG001|Overall Study|Other|18|||
155349531|NCT02229396|560713707|FG002|Overall Study|Other|15|||
155349532|NCT02229396|560713705|FG000|Overall Study|Withdrawal by Subject|42|||
155349533|NCT02229396|560713706|FG001|Overall Study|Withdrawal by Subject|28|||
155349534|NCT02229396|560713707|FG002|Overall Study|Withdrawal by Subject|41|||
155349535|NCT02229396|560713705|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
155349536|NCT02229396|560713706|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155349537|NCT02229396|560713707|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
155349538|NCT02229396|560713705|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
155349539|NCT02229396|560713706|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
155349540|NCT02229396|560713707|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
155349541|NCT02679079|560713711|FG000|Overall Study|Adverse Event|2|||
155349542|NCT02679079|560713712|FG001|Overall Study|Adverse Event|0|||
155349543|NCT02679079|560713713|FG002|Overall Study|Adverse Event|2|||
155349544|NCT02679079|560713711|FG000|Overall Study|Protocol Violation|0|||
155349545|NCT02679079|560713712|FG001|Overall Study|Protocol Violation|1|||
155349546|NCT02679079|560713713|FG002|Overall Study|Protocol Violation|0|||
155349547|NCT02679079|560713711|FG000|Overall Study|Withdrawal by Subject|2|||
155349548|NCT02679079|560713712|FG001|Overall Study|Withdrawal by Subject|1|||
155349549|NCT02679079|560713713|FG002|Overall Study|Withdrawal by Subject|0|||
155349550|NCT03193216|560713717|FG000|Overall Study|Lost to Follow-up|1|||
155349551|NCT03193216|560713718|FG001|Overall Study|Lost to Follow-up|0|||
155349552|NCT03193216|560713717|FG000|Overall Study|Withdrawal by Subject|5|||
155349553|NCT03193216|560713718|FG001|Overall Study|Withdrawal by Subject|0|||
155349554|NCT03193216|560713717|FG000|Overall Study|Physician Decision|4|||
155349555|NCT03193216|560713718|FG001|Overall Study|Physician Decision|0|||
155349556|NCT02490878|560713719|FG000|Overall Study|deemed ineligible|0|||
155349557|NCT02490878|560713720|FG001|Overall Study|deemed ineligible|1|||
155349558|NCT02490878|560713719|FG000|Overall Study|progression prior to treatment|0|||
155349559|NCT02490878|560713720|FG001|Overall Study|progression prior to treatment|1|||
155349560|NCT02490878|560713719|FG000|Overall Study|only submitted baseline QOL|0|||
155349561|NCT02490878|560713720|FG001|Overall Study|only submitted baseline QOL|1|||
155083890|NCT00128492|559739120|FG000|Overall Study|Study drug intolerance (AE)|2|||
155083891|NCT00128492|559739121|FG001|Overall Study|Study drug intolerance (AE)|8|||
155083892|NCT00128492|559739120|FG000|Overall Study|AE related to study|1|||
155083893|NCT00128492|559739121|FG001|Overall Study|AE related to study|4|||
155083894|NCT00128492|559739120|FG000|Overall Study|Death|1|||
155083895|NCT00128492|559739121|FG001|Overall Study|Death|0|||
155083896|NCT00128492|559739120|FG000|Overall Study|Lost to Follow-up|1|||
155083897|NCT00128492|559739121|FG001|Overall Study|Lost to Follow-up|5|||
155083898|NCT00128492|559739120|FG000|Overall Study|Noncompliance|0|||
155083899|NCT00128492|559739121|FG001|Overall Study|Noncompliance|5|||
155083900|NCT00128492|559739120|FG000|Overall Study|Personal or administrative|10|||
155083901|NCT00128492|559739121|FG001|Overall Study|Personal or administrative|22|||
155083902|NCT00128492|559739120|FG000|Overall Study|Withdrawal by Subject|3|||
155083903|NCT00128492|559739121|FG001|Overall Study|Withdrawal by Subject|5|||
155083904|NCT00128492|559739120|FG000|Overall Study|Pregnancy|0|||
155083905|NCT00128492|559739121|FG001|Overall Study|Pregnancy|1|||
155083906|NCT00756314|559739125|FG000|Overall Study|Lost to Follow-up|2|||
155083907|NCT00756314|559739126|FG001|Overall Study|Lost to Follow-up|59|||
155083908|NCT02872142|559739127|FG000|Overall Study|Adverse Event|2|||
155083909|NCT02872142|559739127|FG000|Overall Study|Death|1|||
155083910|NCT02872142|559739127|FG000|Overall Study|Participant Decision|3|||
155083911|NCT04691115|559739130|FG000|Overall Study|Withdrawal by Subject|0|||
155083912|NCT04691115|559739131|FG001|Overall Study|Withdrawal by Subject|0|||
155083913|NCT04691115|559739132|FG002|Overall Study|Withdrawal by Subject|0|||
155083914|NCT04691115|559739133|FG003|Overall Study|Withdrawal by Subject|0|||
155083915|NCT04691115|559739134|FG004|Overall Study|Withdrawal by Subject|0|||
155083916|NCT04691115|559739135|FG005|Overall Study|Withdrawal by Subject|1|||
155083917|NCT04691115|559739136|FG006|Overall Study|Withdrawal by Subject|0|||
155083918|NCT04691115|559739137|FG007|Overall Study|Withdrawal by Subject|0|||
155083919|NCT04691115|559739138|FG008|Overall Study|Withdrawal by Subject|0|||
155349562|NCT01264887|560713721|FG000|Overall Study|Adverse Event|5|||
155349563|NCT01264887|560713721|FG000|Overall Study|Death|7|||
155349564|NCT01264887|560713721|FG000|Overall Study|Lack of Efficacy|5|||
155349565|NCT01264887|560713721|FG000|Overall Study|Physician Decision|4|||
155349566|NCT01264887|560713721|FG000|Overall Study|Withdrawal by Subject|6|||
155349567|NCT01264887|560713721|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
155349568|NCT01264887|560713721|FG000|Overall Study|Other|2|||
155349569|NCT02171130|560713722|FG000|Overall Study|Death|1|||
155349570|NCT02171130|560713722|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
155349571|NCT02171130|560713722|FG000|Overall Study|Discontinued; Site Termination|5|||
155349572|NCT02171130|560713722|FG000|Overall Study|Withdrawal by Subject|3|||
155349573|NCT02171130|560713722|FG000|Overall Study|Physician Decision|1|||
155349574|NCT02171130|560713722|FG000|Overall Study|Lost to Follow-up|1|||
155165607|NCT00953056|560043503|FG005|Overall Study|Withdrew Consent|3|||
155349575|NCT02171130|560713722|FG000|Overall Study|Met Exclusion Criteria|1|||
155349576|NCT04531813|560713723|FG000|Overall Study|Protocol Violation|1|||
154964268|NCT01592240|559295220|FG005|Overall Study|Withdrawal by Subject|0|||
155083920|NCT04691115|559739139|FG009|Overall Study|Withdrawal by Subject|0|||
155083921|NCT04691115|559739140|FG010|Overall Study|Withdrawal by Subject|0|||
155083922|NCT04691115|559739141|FG011|Overall Study|Withdrawal by Subject|0|||
155349577|NCT04531813|560713723|FG000|Overall Study|Withdrawal by Subject|1|||
155349578|NCT01340300|560713726|FG000|Overall Study|Lost to Follow-up|3|||
155349579|NCT01340300|560713727|FG001|Overall Study|Lost to Follow-up|0|||
155083923|NCT04691115|559739142|FG012|Overall Study|Withdrawal by Subject|0|||
155083924|NCT04691115|559739143|FG013|Overall Study|Withdrawal by Subject|0|||
155083925|NCT00830336|559739147|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
155083926|NCT00830336|559739148|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
155083927|NCT00867334|559739149|FG000|Overall Study|Withdrawal by Subject|0|||
155083928|NCT00867334|559739150|FG001|Overall Study|Withdrawal by Subject|1|||
155083929|NCT00867334|559739149|FG000|Overall Study|Withdrawal by Subject|1|||
155083930|NCT00867334|559739150|FG001|Overall Study|Withdrawal by Subject|0|||
155083931|NCT00867334|559739149|FG000|Overall Study|Withdrawal by Subject|1|||
155083932|NCT00867334|559739150|FG001|Overall Study|Withdrawal by Subject|0|||
155083933|NCT00347269|559739155|FG000|Overall Study|Lost to Follow-up|74|||
155083934|NCT00347269|559739156|FG001|Overall Study|Lost to Follow-up|65|||
155083935|NCT00347269|559739155|FG000|Overall Study|Withdrawal by Subject|18|||
155083936|NCT00347269|559739156|FG001|Overall Study|Withdrawal by Subject|38|||
155083937|NCT00347269|559739155|FG000|Overall Study|Death|2|||
155083938|NCT00347269|559739156|FG001|Overall Study|Death|3|||
155083939|NCT03032484|559739157|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
155083940|NCT03032484|559739158|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
155083941|NCT03032484|559739157|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
155083942|NCT03032484|559739158|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
155083943|NCT01725282|559739161|FG000|Overall Study|Adverse Event|1|||
155083944|NCT01725282|559739162|FG001|Overall Study|Adverse Event|3|||
155083945|NCT01725282|559739163|FG002|Overall Study|Adverse Event|6|||
155083946|NCT01725282|559739164|FG003|Overall Study|Adverse Event|4|||
155083947|NCT01725282|559739161|FG000|Overall Study|Exacerbation of Target Disease|1|||
155083948|NCT01725282|559739162|FG001|Overall Study|Exacerbation of Target Disease|0|||
155083949|NCT01725282|559739163|FG002|Overall Study|Exacerbation of Target Disease|0|||
155083950|NCT01725282|559739164|FG003|Overall Study|Exacerbation of Target Disease|1|||
155083951|NCT01725282|559739161|FG000|Overall Study|Met Exclusion Criteria|0|||
155083952|NCT01725282|559739162|FG001|Overall Study|Met Exclusion Criteria|0|||
155083953|NCT01725282|559739163|FG002|Overall Study|Met Exclusion Criteria|1|||
155083954|NCT01725282|559739164|FG003|Overall Study|Met Exclusion Criteria|0|||
155349580|NCT01340300|560713728|FG002|Overall Study|Lost to Follow-up|5|||
155349581|NCT01340300|560713729|FG003|Overall Study|Lost to Follow-up|10|||
155349582|NCT01340300|560713726|FG000|Overall Study|Withdrawal by Subject|5|||
155349583|NCT01340300|560713727|FG001|Overall Study|Withdrawal by Subject|6|||
155349584|NCT01340300|560713728|FG002|Overall Study|Withdrawal by Subject|6|||
155349585|NCT01340300|560713729|FG003|Overall Study|Withdrawal by Subject|3|||
155349586|NCT01340300|560713726|FG000|Overall Study|Adverse Event|1|||
155349587|NCT01340300|560713727|FG001|Overall Study|Adverse Event|0|||
155349588|NCT01340300|560713728|FG002|Overall Study|Adverse Event|4|||
155349589|NCT01340300|560713729|FG003|Overall Study|Adverse Event|0|||
155349590|NCT01340300|560713726|FG000|Overall Study|Physician Decision|0|||
155349591|NCT01340300|560713727|FG001|Overall Study|Physician Decision|1|||
155349592|NCT01340300|560713728|FG002|Overall Study|Physician Decision|0|||
155349593|NCT01340300|560713729|FG003|Overall Study|Physician Decision|0|||
155349594|NCT01340300|560713726|FG000|Overall Study|Unrelated sickness|0|||
155349595|NCT01340300|560713727|FG001|Overall Study|Unrelated sickness|2|||
155349596|NCT01340300|560713728|FG002|Overall Study|Unrelated sickness|0|||
155349597|NCT01340300|560713729|FG003|Overall Study|Unrelated sickness|1|||
155349598|NCT01061775|560713732|FG000|Overall Study|Physician Decision|2|||
155349599|NCT01061775|560713732|FG000|Overall Study|Lost to Follow-up|1|||
155349600|NCT00784277|560713733|FG000|IR Treatment|Adverse Event|4|||
155349601|NCT00784277|560713734|FG001|IR Treatment|Adverse Event|8|||
155349602|NCT00784277|560713735|FG002|IR Treatment|Adverse Event|19|||
155349603|NCT00784277|560713736|FG003|IR Treatment|Adverse Event|35|||
155349604|NCT00784277|560713737|FG004|IR Treatment|Adverse Event|0|||
155349605|NCT00784277|560713738|FG005|IR Treatment|Adverse Event|0|||
155083955|NCT01725282|559739161|FG000|Overall Study|Study Site Withdrawal|0|||
155083956|NCT01725282|559739162|FG001|Overall Study|Study Site Withdrawal|1|||
155083957|NCT01725282|559739163|FG002|Overall Study|Study Site Withdrawal|0|||
155083958|NCT01725282|559739164|FG003|Overall Study|Study Site Withdrawal|0|||
155083959|NCT01725282|559739161|FG000|Overall Study|Withdrawal by Subject|0|||
155083960|NCT01725282|559739162|FG001|Overall Study|Withdrawal by Subject|0|||
155083961|NCT01725282|559739163|FG002|Overall Study|Withdrawal by Subject|1|||
155083962|NCT01725282|559739164|FG003|Overall Study|Withdrawal by Subject|1|||
155083963|NCT01725282|559739161|FG000|Overall Study|Lack of Efficacy|0|||
155349606|NCT00784277|560713739|FG006|IR Treatment|Adverse Event|0|||
155349607|NCT00784277|560713733|FG000|IR Treatment|Lack of Efficacy|4|||
155349608|NCT00784277|560713734|FG001|IR Treatment|Lack of Efficacy|4|||
155083964|NCT01725282|559739162|FG001|Overall Study|Lack of Efficacy|1|||
155083965|NCT01725282|559739163|FG002|Overall Study|Lack of Efficacy|0|||
155083966|NCT01725282|559739164|FG003|Overall Study|Lack of Efficacy|1|||
155083967|NCT01646216|559739172|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
155083968|NCT01646216|559739173|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
155083969|NCT01646216|559739172|FG000|Overall Study|Did not complete training|0|||
155083970|NCT01646216|559739173|FG001|Overall Study|Did not complete training|2|||
155349609|NCT00784277|560713735|FG002|IR Treatment|Lack of Efficacy|1|||
155349610|NCT00784277|560713736|FG003|IR Treatment|Lack of Efficacy|0|||
155349611|NCT00784277|560713737|FG004|IR Treatment|Lack of Efficacy|0|||
155349612|NCT00784277|560713738|FG005|IR Treatment|Lack of Efficacy|0|||
155349613|NCT00784277|560713739|FG006|IR Treatment|Lack of Efficacy|0|||
155349614|NCT00784277|560713733|FG000|IR Treatment|Lost to Follow-up|1|||
155349615|NCT00784277|560713734|FG001|IR Treatment|Lost to Follow-up|0|||
155349616|NCT00784277|560713735|FG002|IR Treatment|Lost to Follow-up|1|||
155349617|NCT00784277|560713736|FG003|IR Treatment|Lost to Follow-up|0|||
155349618|NCT00784277|560713737|FG004|IR Treatment|Lost to Follow-up|0|||
155349619|NCT00784277|560713738|FG005|IR Treatment|Lost to Follow-up|0|||
155349620|NCT00784277|560713739|FG006|IR Treatment|Lost to Follow-up|0|||
155349621|NCT00784277|560713733|FG000|IR Treatment|Withdrawal by Subject|5|||
155349622|NCT00784277|560713734|FG001|IR Treatment|Withdrawal by Subject|1|||
155349623|NCT00784277|560713735|FG002|IR Treatment|Withdrawal by Subject|4|||
155349624|NCT00784277|560713736|FG003|IR Treatment|Withdrawal by Subject|6|||
155349625|NCT00784277|560713737|FG004|IR Treatment|Withdrawal by Subject|0|||
155349626|NCT00784277|560713738|FG005|IR Treatment|Withdrawal by Subject|0|||
155349627|NCT00784277|560713739|FG006|IR Treatment|Withdrawal by Subject|0|||
155349628|NCT00784277|560713733|FG000|IR Treatment|Resolution Of Pain|0|||
155349629|NCT00784277|560713734|FG001|IR Treatment|Resolution Of Pain|1|||
155349630|NCT00784277|560713735|FG002|IR Treatment|Resolution Of Pain|0|||
155349631|NCT00784277|560713736|FG003|IR Treatment|Resolution Of Pain|0|||
155349632|NCT00784277|560713737|FG004|IR Treatment|Resolution Of Pain|0|||
155349633|NCT00784277|560713738|FG005|IR Treatment|Resolution Of Pain|0|||
155349634|NCT00784277|560713739|FG006|IR Treatment|Resolution Of Pain|0|||
155349635|NCT00784277|560713733|FG000|IR Treatment|Other|2|||
155349636|NCT00784277|560713734|FG001|IR Treatment|Other|3|||
155349637|NCT00784277|560713735|FG002|IR Treatment|Other|3|||
155349638|NCT00784277|560713736|FG003|IR Treatment|Other|2|||
155349639|NCT00784277|560713737|FG004|IR Treatment|Other|0|||
155349640|NCT00784277|560713738|FG005|IR Treatment|Other|0|||
155349641|NCT00784277|560713739|FG006|IR Treatment|Other|0|||
155349642|NCT00784277|560713733|FG000|ER Treatment|Adverse Event|0|||
155349643|NCT00784277|560713734|FG001|ER Treatment|Adverse Event|0|||
155349644|NCT00784277|560713735|FG002|ER Treatment|Adverse Event|0|||
155349645|NCT00784277|560713736|FG003|ER Treatment|Adverse Event|0|||
155349646|NCT00784277|560713737|FG004|ER Treatment|Adverse Event|1|||
155349647|NCT00784277|560713738|FG005|ER Treatment|Adverse Event|7|||
155349648|NCT00784277|560713739|FG006|ER Treatment|Adverse Event|7|||
155349649|NCT00784277|560713733|FG000|ER Treatment|Lack of Efficacy|0|||
155349650|NCT00784277|560713734|FG001|ER Treatment|Lack of Efficacy|0|||
155349651|NCT00784277|560713735|FG002|ER Treatment|Lack of Efficacy|0|||
155349652|NCT00784277|560713736|FG003|ER Treatment|Lack of Efficacy|0|||
155349653|NCT00784277|560713737|FG004|ER Treatment|Lack of Efficacy|3|||
155349654|NCT00784277|560713738|FG005|ER Treatment|Lack of Efficacy|4|||
155349655|NCT00784277|560713739|FG006|ER Treatment|Lack of Efficacy|0|||
155349656|NCT00784277|560713733|FG000|ER Treatment|Lost to Follow-up|0|||
155349657|NCT00784277|560713734|FG001|ER Treatment|Lost to Follow-up|0|||
155349658|NCT00784277|560713735|FG002|ER Treatment|Lost to Follow-up|0|||
155349659|NCT00784277|560713736|FG003|ER Treatment|Lost to Follow-up|0|||
155349660|NCT00784277|560713737|FG004|ER Treatment|Lost to Follow-up|0|||
155349661|NCT00784277|560713738|FG005|ER Treatment|Lost to Follow-up|2|||
155349662|NCT00784277|560713739|FG006|ER Treatment|Lost to Follow-up|0|||
155349663|NCT00784277|560713733|FG000|ER Treatment|Withdrawal by Subject|0|||
155349664|NCT00784277|560713734|FG001|ER Treatment|Withdrawal by Subject|0|||
155349665|NCT00784277|560713735|FG002|ER Treatment|Withdrawal by Subject|0|||
155349666|NCT00784277|560713736|FG003|ER Treatment|Withdrawal by Subject|0|||
155349667|NCT00784277|560713737|FG004|ER Treatment|Withdrawal by Subject|2|||
155349668|NCT00784277|560713738|FG005|ER Treatment|Withdrawal by Subject|5|||
155349669|NCT00784277|560713739|FG006|ER Treatment|Withdrawal by Subject|3|||
155349670|NCT00784277|560713733|FG000|ER Treatment|Study Medication Non-Compliant|0|||
155349671|NCT00784277|560713734|FG001|ER Treatment|Study Medication Non-Compliant|0|||
155349672|NCT00784277|560713735|FG002|ER Treatment|Study Medication Non-Compliant|0|||
155349673|NCT00784277|560713736|FG003|ER Treatment|Study Medication Non-Compliant|0|||
155349674|NCT00784277|560713737|FG004|ER Treatment|Study Medication Non-Compliant|2|||
155349675|NCT00784277|560713738|FG005|ER Treatment|Study Medication Non-Compliant|3|||
155349676|NCT00784277|560713739|FG006|ER Treatment|Study Medication Non-Compliant|3|||
155349677|NCT00784277|560713733|FG000|ER Treatment|Other|0|||
155349678|NCT00784277|560713734|FG001|ER Treatment|Other|0|||
155349679|NCT00784277|560713735|FG002|ER Treatment|Other|0|||
155349680|NCT00784277|560713736|FG003|ER Treatment|Other|0|||
155349681|NCT00784277|560713737|FG004|ER Treatment|Other|1|||
155349682|NCT00784277|560713738|FG005|ER Treatment|Other|3|||
155349683|NCT00784277|560713739|FG006|ER Treatment|Other|2|||
155349684|NCT01093222|560713740|FG000|Overall Study|Ineligible|6|||
155349685|NCT01093222|560713740|FG000|Overall Study|Adverse Event|7|||
155349686|NCT01093222|560713740|FG000|Overall Study|Progression/relapse|24|||
155349687|NCT01093222|560713740|FG000|Overall Study|Death|2|||
155349688|NCT01093222|560713740|FG000|Overall Study|Not protocol specified|1|||
155349689|NCT00588341|560713741|FG000|Overall Study|Withdrawal by Subject|3|||
155349690|NCT00588341|560713741|FG000|Overall Study|Not treated due to metastatic disease|1|||
155349691|NCT00588341|560713741|FG000|Overall Study|Patient ineligible|1|||
155349692|NCT03746483|560713742|FG000|Overall Study|Adverse Event|0|||
155349693|NCT03746483|560713743|FG001|Overall Study|Adverse Event|1|||
155349694|NCT03746483|560713742|FG000|Overall Study|Lack of Efficacy|3|||
155349695|NCT03746483|560713743|FG001|Overall Study|Lack of Efficacy|2|||
155349696|NCT03746483|560713742|FG000|Overall Study|Lost to Follow-up|1|||
155349697|NCT03746483|560713743|FG001|Overall Study|Lost to Follow-up|0|||
155349698|NCT03746483|560713742|FG000|Overall Study|Protocol Violation|2|||
155349699|NCT03746483|560713743|FG001|Overall Study|Protocol Violation|0|||
155349700|NCT01924806|560713746|FG000|Overall Study|Physician Decision|2|||
155349701|NCT01924806|560713747|FG001|Overall Study|Physician Decision|1|||
155349702|NCT00762502|560713752|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
155349703|NCT00762502|560713753|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
155349704|NCT00762502|560713754|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
155349705|NCT00762502|560713752|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
155349706|NCT00762502|560713753|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
155349707|NCT00762502|560713754|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
155349708|NCT00762502|560713752|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
155349709|NCT00762502|560713753|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
155349710|NCT00762502|560713754|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
155349711|NCT01675050|560713755|FG000|Period One Treatment|Withdrawal by Subject|1|||
155349712|NCT01675050|560713756|FG001|Period One Treatment|Withdrawal by Subject|0|||
155349713|NCT00264498|560713760|FG000|Randomized Treatment|Death|0|||
155349714|NCT00264498|560713761|FG001|Randomized Treatment|Death|3|||
155349715|NCT00264498|560713760|FG000|Randomized Treatment|Withdrawal by Subject|0|||
155349716|NCT00264498|560713761|FG001|Randomized Treatment|Withdrawal by Subject|1|||
155349717|NCT00264498|560713760|FG000|Randomized Treatment|Objective disease Progression|13|||
155349718|NCT00264498|560713761|FG001|Randomized Treatment|Objective disease Progression|14|||
155349719|NCT00264498|560713760|FG000|Randomized Treatment|Physician Decision|1|||
155349720|NCT00264498|560713761|FG001|Randomized Treatment|Physician Decision|0|||
155349721|NCT00264498|560713760|FG000|Randomized Treatment|Incorrectly randomized|1|||
155349722|NCT00264498|560713761|FG001|Randomized Treatment|Incorrectly randomized|0|||
155349723|NCT00264498|560713760|FG000|Randomized Treatment|Study Closure|1|||
155349724|NCT00264498|560713761|FG001|Randomized Treatment|Study Closure|0|||
155349725|NCT00264498|560713760|FG000|Randomized Treatment|Protocol Violation|1|||
155349726|NCT00264498|560713761|FG001|Randomized Treatment|Protocol Violation|0|||
155349727|NCT00264498|560713760|FG000|Crossover Treatment|Death|1|||
155349728|NCT00264498|560713761|FG001|Crossover Treatment|Death|3|||
155349729|NCT00264498|560713760|FG000|Crossover Treatment|Objective disease progression|4|||
155349730|NCT00264498|560713761|FG001|Crossover Treatment|Objective disease progression|5|||
155349731|NCT00264498|560713760|FG000|Crossover Treatment|Study closure|0|||
155349732|NCT00264498|560713761|FG001|Crossover Treatment|Study closure|1|||
155349733|NCT00264498|560713760|FG000|Crossover Treatment|Withdrawal by Subject|1|||
155349734|NCT00264498|560713761|FG001|Crossover Treatment|Withdrawal by Subject|0|||
155349735|NCT03794609|560713762|FG000|Overall Study|Other|10|||
155349736|NCT03794609|560713762|FG000|Overall Study|Withdrawal by Subject|66|||
155349737|NCT03794609|560713762|FG000|Overall Study|The child is enrolled in an interventional study|70|||
155349738|NCT03794609|560713762|FG000|Overall Study|Inclusion/exclusion criteria|8|||
155349739|NCT03794609|560713762|FG000|Overall Study|At sponsor's request|151|||
155349740|NCT03794609|560713762|FG000|Overall Study|Physician Decision|1|||
155349741|NCT03794609|560713762|FG000|Overall Study|Lost to Follow-up|5|||
155349742|NCT03638258|560713763|FG000|Overall Study|Adverse Event|1|||
155349743|NCT03638258|560713764|FG001|Overall Study|Adverse Event|0|||
155349744|NCT03638258|560713765|FG002|Overall Study|Adverse Event|2|||
155349745|NCT03638258|560713763|FG000|Overall Study|Lost to Follow-up|2|||
155083971|NCT01646216|559739172|FG000|Overall Study|Investigator decision|1|||
155083972|NCT01646216|559739173|FG001|Overall Study|Investigator decision|1|||
155349746|NCT03638258|560713764|FG001|Overall Study|Lost to Follow-up|4|||
155349747|NCT03638258|560713765|FG002|Overall Study|Lost to Follow-up|5|||
155349748|NCT03638258|560713763|FG000|Overall Study|Pregnancy|0|||
155349749|NCT03638258|560713764|FG001|Overall Study|Pregnancy|0|||
155349750|NCT03638258|560713765|FG002|Overall Study|Pregnancy|1|||
155349751|NCT03638258|560713763|FG000|Overall Study|Protocol Violation|0|||
155349752|NCT03638258|560713764|FG001|Overall Study|Protocol Violation|0|||
155349753|NCT03638258|560713765|FG002|Overall Study|Protocol Violation|1|||
155349754|NCT03638258|560713763|FG000|Overall Study|Withdrawal by Subject|4|||
155349755|NCT03638258|560713764|FG001|Overall Study|Withdrawal by Subject|5|||
155349756|NCT03638258|560713765|FG002|Overall Study|Withdrawal by Subject|12|||
155349757|NCT03638258|560713763|FG000|Overall Study|Lack of Efficacy|0|||
155349758|NCT03638258|560713764|FG001|Overall Study|Lack of Efficacy|0|||
155349759|NCT03638258|560713765|FG002|Overall Study|Lack of Efficacy|2|||
155349760|NCT04543942|560713766|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
155349761|NCT04543942|560713767|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
155349762|NCT04543942|560713766|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
155349763|NCT04543942|560713767|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
155083973|NCT00113373|559739174|FG000|Overall Study|Ineligible: wrong primary|1|||
155083974|NCT00113373|559739174|FG000|Overall Study|Ineligible: second primary|1|||
155083975|NCT00113373|559739174|FG000|Overall Study|Never Treated|1|||
155083976|NCT02395627|559739175|FG000|Overall Study|Withdrawal by Subject|0|||
155083977|NCT02395627|559739176|FG001|Overall Study|Withdrawal by Subject|2|||
155083978|NCT02395627|559739177|FG002|Overall Study|Withdrawal by Subject|0|||
155349764|NCT02205476|560713768|FG000|Overall Study|Study termination by Sponsor|7|||
155349765|NCT02205476|560713769|FG001|Overall Study|Study termination by Sponsor|3|||
155349766|NCT00139659|560713774|FG000|Overall Study|Adverse Event|12|||
155349767|NCT00139659|560713775|FG001|Overall Study|Adverse Event|1|||
155349768|NCT00139659|560713774|FG000|Overall Study|Lack of Efficacy|1|||
155165608|NCT00953056|560043498|FG000|Overall Study|Serious Adverse Event|0|||
155083979|NCT02395627|559739175|FG000|Overall Study|Did not receive pembrolizumab|3|||
155349769|NCT00139659|560713775|FG001|Overall Study|Lack of Efficacy|1|||
155349770|NCT00139659|560713774|FG000|Overall Study|Lost to Follow-up|7|||
155349771|NCT00139659|560713775|FG001|Overall Study|Lost to Follow-up|3|||
155349772|NCT00139659|560713774|FG000|Overall Study|Reason not Specified|6|||
155349773|NCT00139659|560713775|FG001|Overall Study|Reason not Specified|3|||
155349774|NCT00139659|560713774|FG000|Overall Study|Withdrawal by Subject|14|||
155349775|NCT00139659|560713775|FG001|Overall Study|Withdrawal by Subject|10|||
155349776|NCT02625922|560713781|FG000|Overall Study|Non-availability of IMP|1|||
155349777|NCT02625922|560713782|FG001|Overall Study|Non-availability of IMP|1|||
155349778|NCT02625922|560713781|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
155349779|NCT02625922|560713782|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
155349780|NCT02359552|560713783|FG000|Overall Study|Lost to Follow-up|3|||
155349781|NCT02359552|560713784|FG001|Overall Study|Lost to Follow-up|4|||
155349782|NCT01747629|560713796|FG000|Overall Study|Adverse Event|1|||
155349783|NCT01747629|560713797|FG001|Overall Study|Adverse Event|2|||
155349784|NCT01747629|560713796|FG000|Overall Study|Withdrawal by Subject|2|||
155349785|NCT01747629|560713797|FG001|Overall Study|Withdrawal by Subject|2|||
155349786|NCT01747629|560713796|FG000|Overall Study|Noncompliance|1|||
155349787|NCT01747629|560713797|FG001|Overall Study|Noncompliance|1|||
155349788|NCT01747629|560713796|FG000|Overall Study|Inclusion criteria not met|1|||
155349789|NCT01747629|560713797|FG001|Overall Study|Inclusion criteria not met|0|||
155349790|NCT01747629|560713796|FG000|Overall Study|Not treated|1|||
155349791|NCT01747629|560713797|FG001|Overall Study|Not treated|0|||
155349792|NCT01747629|560713796|FG000|Overall Study|Other|2|||
155349793|NCT01747629|560713797|FG001|Overall Study|Other|1|||
155349794|NCT01313299|560713798|FG000|Overall Study|Adverse Event|3|||
155349795|NCT01313299|560713799|FG001|Overall Study|Adverse Event|1|||
155349796|NCT01313299|560713800|FG002|Overall Study|Adverse Event|1|||
155349797|NCT01313299|560713798|FG000|Overall Study|Lost to Follow-up|1|||
155349798|NCT01313299|560713799|FG001|Overall Study|Lost to Follow-up|0|||
155349799|NCT01313299|560713800|FG002|Overall Study|Lost to Follow-up|0|||
155349800|NCT01313299|560713798|FG000|Overall Study|Protocol Violation|2|||
155349801|NCT01313299|560713799|FG001|Overall Study|Protocol Violation|0|||
155349802|NCT01313299|560713800|FG002|Overall Study|Protocol Violation|0|||
155349803|NCT01313299|560713798|FG000|Overall Study|Withdrawal by Subject|1|||
155349804|NCT01313299|560713799|FG001|Overall Study|Withdrawal by Subject|0|||
155349805|NCT01313299|560713800|FG002|Overall Study|Withdrawal by Subject|2|||
155349806|NCT01313299|560713798|FG000|Overall Study|Family reason and moved out of state|0|||
155349807|NCT01313299|560713799|FG001|Overall Study|Family reason and moved out of state|2|||
155349808|NCT01313299|560713800|FG002|Overall Study|Family reason and moved out of state|0|||
155349809|NCT01313299|560713798|FG000|Overall Study|Lack of subject compliance|0|||
155349810|NCT01313299|560713799|FG001|Overall Study|Lack of subject compliance|0|||
155349811|NCT01313299|560713800|FG002|Overall Study|Lack of subject compliance|1|||
155349812|NCT02506881|560713801|FG000|First Intervention (Day 1)|Protocol Violation|0|||
155349813|NCT02506881|560713802|FG001|First Intervention (Day 1)|Protocol Violation|0|||
155349814|NCT02506881|560713803|FG002|First Intervention (Day 1)|Protocol Violation|1|||
155349815|NCT02506881|560713804|FG003|First Intervention (Day 1)|Protocol Violation|0|||
155349816|NCT02506881|560713801|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
155349817|NCT02506881|560713802|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349818|NCT02506881|560713803|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349819|NCT02506881|560713804|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
155349820|NCT02506881|560713801|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
155349821|NCT02506881|560713802|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
155349822|NCT02506881|560713803|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
155349823|NCT02506881|560713804|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
155349824|NCT01919398|560713805|FG000|Overall Study|Progressive Disease|0|||
155349825|NCT01919398|560713806|FG001|Overall Study|Progressive Disease|0|||
155349826|NCT01919398|560713807|FG002|Overall Study|Progressive Disease|4|||
155349827|NCT02391545|560713809|FG000|Overall Study|Death|0|||
155083980|NCT02395627|559739176|FG001|Overall Study|Did not receive pembrolizumab|1|||
155083981|NCT02395627|559739177|FG002|Overall Study|Did not receive pembrolizumab|0|||
155083982|NCT06091956|559739178|FG000|Overall Study|Withdrawal by Subject|1|||
155083983|NCT06091956|559739178|FG000|Overall Study|Complicating Disease|1|||
155083984|NCT02369159|559739184|FG000|Overall Study|Adverse Event|0|||
155083985|NCT02369159|559739185|FG001|Overall Study|Adverse Event|1|||
155083986|NCT02369159|559739184|FG000|Overall Study|Lost to Follow-up|1|||
155083987|NCT02369159|559739185|FG001|Overall Study|Lost to Follow-up|1|||
155083988|NCT02369159|559739184|FG000|Overall Study|Withdrawal by Subject|7|||
155083989|NCT02369159|559739185|FG001|Overall Study|Withdrawal by Subject|0|||
155349828|NCT02391545|560713810|FG001|Overall Study|Death|2|||
155349829|NCT02391545|560713809|FG000|Overall Study|Lost to Follow-up|0|||
155349830|NCT02391545|560713810|FG001|Overall Study|Lost to Follow-up|1|||
155349831|NCT02391545|560713809|FG000|Overall Study|Termination of study by sponsor|20|||
155349832|NCT02391545|560713810|FG001|Overall Study|Termination of study by sponsor|20|||
155349833|NCT02391545|560713809|FG000|Overall Study|Withdrawal by Subject|0|||
155349834|NCT02391545|560713810|FG001|Overall Study|Withdrawal by Subject|1|||
154964269|NCT01592240|559295221|FG006|Overall Study|Withdrawal by Subject|2|||
155083990|NCT03511209|559739186|FG000|Overall Study|Withdrawal by Subject|2|||
155083991|NCT03511209|559739187|FG001|Overall Study|Withdrawal by Subject|4|||
154964270|NCT01592240|559295215|FG000|Overall Study|Other|0|||
155083992|NCT03511209|559739186|FG000|Overall Study|Death|1|||
155349835|NCT02391545|560713809|FG000|Overall Study|Other Reasons|6|||
155349836|NCT02391545|560713810|FG001|Overall Study|Other Reasons|4|||
155349837|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
155349838|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Duplication|2|||
155349839|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
155349840|NCT02016690|560713811|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
155349841|NCT02016690|560713811|FG000|Overall Study|Did not meet inclusion criteria|13|||
155349842|NCT02016690|560713811|FG000|Overall Study|Hospitalized for RSV at study start|3|||
155349843|NCT01222078|560713812|FG000|Overall Study|Early termination of the study|1|||
155083993|NCT03511209|559739187|FG001|Overall Study|Death|0|||
155349844|NCT04089332|560713813|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
155349845|NCT04089332|560713813|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
155349846|NCT04089332|560713813|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
155349847|NCT00495612|560713817|FG000|Overall Study|Lost to Follow-up|1|||
155349848|NCT00495612|560713818|FG001|Overall Study|Lost to Follow-up|0|||
155349849|NCT00495612|560713817|FG000|Overall Study|Subject's Decision to Withdraw|3|||
155349850|NCT00495612|560713818|FG001|Overall Study|Subject's Decision to Withdraw|0|||
155349851|NCT01770509|560713827|FG000|Overall Study|Injury|0|||
155349852|NCT01770509|560713828|FG001|Overall Study|Injury|1|||
155349853|NCT01770509|560713827|FG000|Overall Study|Lost to Follow-up|1|||
155349854|NCT01770509|560713828|FG001|Overall Study|Lost to Follow-up|2|||
155349855|NCT02865135|560713832|FG000|Overall Study|Death|0|||
155349856|NCT02865135|560713833|FG001|Overall Study|Death|1|||
155083994|NCT03511209|559739186|FG000|Overall Study|Lost to Follow-up|0|||
155083995|NCT03511209|559739187|FG001|Overall Study|Lost to Follow-up|2|||
155083996|NCT02971137|559739192|FG000|Overall Study|Lost to Follow-up|44|||
155083997|NCT02971137|559739193|FG001|Overall Study|Lost to Follow-up|56|||
155083998|NCT02757963|559739194|FG000|Overall Study|Adverse Event|3|||
155349857|NCT02865135|560713834|FG002|Overall Study|Death|0|||
155349858|NCT02865135|560713832|FG000|Overall Study|Progression|6|||
155349859|NCT02865135|560713833|FG001|Overall Study|Progression|2|||
155083999|NCT02757963|559739194|FG000|Overall Study|Reached Stopping Criteria|1054|||
155084000|NCT02757963|559739194|FG000|Overall Study|Lost to Follow-up|5|||
155084001|NCT02757963|559739194|FG000|Overall Study|Physician Decision|1|||
155084002|NCT02757963|559739194|FG000|Overall Study|Withdrawal by Subject|34|||
155349860|NCT02865135|560713834|FG002|Overall Study|Progression|2|||
155349861|NCT02762500|560716095|FG000|Overall Study|Lack of Efficacy|1|||
155349862|NCT02762500|560716096|FG001|Overall Study|Lack of Efficacy|0|||
155349863|NCT02762500|560716095|FG000|Overall Study|Withdrawal by Subject|1|||
155349864|NCT02762500|560716096|FG001|Overall Study|Withdrawal by Subject|1|||
155349865|NCT02762500|560716095|FG000|Overall Study|Adverse Event|0|||
155349866|NCT02762500|560716096|FG001|Overall Study|Adverse Event|2|||
155349867|NCT00730847|560716097|FG000|Overall Study|Adverse Event|1|||
155349868|NCT00730847|560716097|FG000|Overall Study|Protocol Violation|2|||
155349869|NCT00730847|560716097|FG000|Overall Study|Withdrawal by Subject|16|||
155349870|NCT00730847|560716097|FG000|Overall Study|Lost to Follow-up|67|||
155349871|NCT00730847|560716097|FG000|Overall Study|Unknown completion status|21|||
155349872|NCT00730847|560716097|FG000|Overall Study|Other|24|||
155349873|NCT00280683|560716098|FG000|Overall Study|Withdrawal by Subject|1|||
155349874|NCT00280683|560716099|FG001|Overall Study|Withdrawal by Subject|2|||
155349875|NCT00280683|560716098|FG000|Overall Study|Adverse Event|1|||
155349876|NCT00280683|560716099|FG001|Overall Study|Adverse Event|1|||
155349877|NCT01243411|560716100|FG000|Overall Study|Withdrawal by Subject|18|||
155349878|NCT01243411|560716100|FG000|Overall Study|Lost to Follow-up|10|||
155349879|NCT01243411|560716100|FG000|Overall Study|Adverse Event|5|||
155349880|NCT01243411|560716100|FG000|Overall Study|Other|8|||
155349881|NCT00488319|560716109|FG000|Overall Study|Adverse Event|1|||
155349882|NCT00488319|560716110|FG001|Overall Study|Adverse Event|2|||
155349883|NCT00488319|560716111|FG002|Overall Study|Adverse Event|23|||
155349884|NCT00488319|560716109|FG000|Overall Study|Lack of Efficacy|6|||
155349885|NCT00488319|560716110|FG001|Overall Study|Lack of Efficacy|12|||
155349886|NCT00488319|560716111|FG002|Overall Study|Lack of Efficacy|27|||
155349887|NCT00488319|560716109|FG000|Overall Study|Lost to Follow-up|3|||
155349888|NCT00488319|560716110|FG001|Overall Study|Lost to Follow-up|5|||
155349889|NCT00488319|560716111|FG002|Overall Study|Lost to Follow-up|16|||
155349890|NCT00488319|560716109|FG000|Overall Study|Withdrawal by Subject|5|||
155349891|NCT00488319|560716110|FG001|Overall Study|Withdrawal by Subject|20|||
155349892|NCT00488319|560716111|FG002|Overall Study|Withdrawal by Subject|44|||
155349893|NCT00488319|560716109|FG000|Overall Study|Other reasons for withdrawal|0|||
155349894|NCT00488319|560716110|FG001|Overall Study|Other reasons for withdrawal|4|||
155349895|NCT00488319|560716111|FG002|Overall Study|Other reasons for withdrawal|12|||
155349896|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
155349897|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
155084003|NCT00911157|559739195|FG000|Overall Study|Adverse Event|4|||
155084004|NCT00911157|559739196|FG001|Overall Study|Adverse Event|1|||
155084005|NCT00911157|559739195|FG000|Overall Study|Withdrawal by Subject|1|||
155349898|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
155349899|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
155349900|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
155349901|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
155349902|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
155349903|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
155349904|NCT00352053|560716114|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
155349905|NCT00352053|560716115|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
155349906|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
155349907|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
155349908|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
155349909|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
155349910|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
155349911|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
155349912|NCT00352053|560716114|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
155349913|NCT00352053|560716115|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
155349914|NCT00352053|560716114|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
155084006|NCT00911157|559739196|FG001|Overall Study|Withdrawal by Subject|1|||
155349915|NCT00352053|560716115|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
155349916|NCT00352053|560716114|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
155084007|NCT00911157|559739195|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
155084008|NCT00911157|559739196|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
155084009|NCT00911157|559739195|FG000|Overall Study|Need to treat for lung cancer|1|||
155349917|NCT00352053|560716115|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
155349918|NCT00352053|560716114|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
155349919|NCT00352053|560716115|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
155349920|NCT00352053|560716114|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
155349921|NCT00352053|560716115|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
155349922|NCT02499835|560716121|FG000|Overall Study|Withdrawal by Subject|1|||
155349923|NCT02499835|560716122|FG001|Overall Study|Withdrawal by Subject|0|||
155349924|NCT02499835|560716123|FG002|Overall Study|Withdrawal by Subject|0|||
155349925|NCT02499835|560716124|FG003|Overall Study|Withdrawal by Subject|1|||
155349926|NCT02499835|560716121|FG000|Overall Study|Physician Decision|0|||
155349927|NCT02499835|560716122|FG001|Overall Study|Physician Decision|3|||
155349928|NCT02499835|560716123|FG002|Overall Study|Physician Decision|18|||
155349929|NCT02499835|560716124|FG003|Overall Study|Physician Decision|7|||
155349930|NCT02499835|560716121|FG000|Overall Study|Adverse Event|0|||
155349931|NCT02499835|560716122|FG001|Overall Study|Adverse Event|0|||
155084010|NCT00911157|559739196|FG001|Overall Study|Need to treat for lung cancer|0|||
155349932|NCT02499835|560716123|FG002|Overall Study|Adverse Event|0|||
155349933|NCT02499835|560716124|FG003|Overall Study|Adverse Event|1|||
155349934|NCT02499835|560716121|FG000|Overall Study|Disease progression|2|||
155084011|NCT03769467|559739200|FG000|Overall Study|Adverse Event|1|||
155084012|NCT03769467|559739201|FG001|Overall Study|Adverse Event|1|||
155084013|NCT03769467|559739202|FG002|Overall Study|Adverse Event|0|||
155084014|NCT03769467|559739200|FG000|Overall Study|Death|3|||
155084015|NCT03769467|559739201|FG001|Overall Study|Death|3|||
155084016|NCT03769467|559739202|FG002|Overall Study|Death|0|||
155084017|NCT03769467|559739200|FG000|Overall Study|Study Terminated By Sponsor|2|||
155084018|NCT03769467|559739201|FG001|Overall Study|Study Terminated By Sponsor|1|||
155084019|NCT03769467|559739202|FG002|Overall Study|Study Terminated By Sponsor|0|||
155084020|NCT03769467|559739200|FG000|Overall Study|Withdrawal by Subject|0|||
155084021|NCT03769467|559739201|FG001|Overall Study|Withdrawal by Subject|1|||
155084022|NCT03769467|559739202|FG002|Overall Study|Withdrawal by Subject|0|||
155084023|NCT05259722|559739205|FG000|Overall Study|Adverse Event|2|||
155084024|NCT05259722|559739206|FG001|Overall Study|Adverse Event|24|||
155084025|NCT05259722|559739205|FG000|Overall Study|Lost to Follow-up|5|||
155084026|NCT05259722|559739206|FG001|Overall Study|Lost to Follow-up|1|||
155084027|NCT05259722|559739205|FG000|Overall Study|Lack of Efficacy|8|||
155084028|NCT05259722|559739206|FG001|Overall Study|Lack of Efficacy|26|||
155084029|NCT05259722|559739205|FG000|Overall Study|Withdrawal by Subject|15|||
155084030|NCT05259722|559739206|FG001|Overall Study|Withdrawal by Subject|33|||
155084031|NCT05259722|559739205|FG000|Overall Study|Various reasons|3|||
155084032|NCT05259722|559739206|FG001|Overall Study|Various reasons|9|||
155084033|NCT05259722|559739205|FG000|Overall Study|Not exposed to IMP|1|||
155349935|NCT02499835|560716122|FG001|Overall Study|Disease progression|1|||
155349936|NCT02499835|560716123|FG002|Overall Study|Disease progression|0|||
155349937|NCT02499835|560716124|FG003|Overall Study|Disease progression|7|||
155349938|NCT03226353|560716133|FG000|Overall Study|Withdrawal by Subject|1|||
155349939|NCT03226353|560716133|FG000|Overall Study|Screen Failure|5|||
155349940|NCT03319719|560716134|FG000|Overall Study|Lost to Follow-up|1|||
155349941|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
155349942|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
155349943|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155349944|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
155349945|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
155349946|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
155349947|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
155349948|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
155084034|NCT05259722|559739206|FG001|Overall Study|Not exposed to IMP|12|||
155084035|NCT05259722|559739205|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
155084036|NCT05259722|559739206|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
155084037|NCT00962650|559739207|FG000|Overall Study|Transgastric DP was not completed|2|||
155084038|NCT00420056|559739208|FG000|Overall Study|Objective progression or relapse|17|||
155084039|NCT03111732|559739210|FG000|Overall Study|Enrolled in different study|1|||
155349949|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
155084040|NCT03111732|559739210|FG000|Overall Study|Progressive disease|3|||
155084041|NCT03111732|559739210|FG000|Overall Study|Withdrawal by Subject|1|||
155084042|NCT03072875|559739214|FG000|Overall Study|Lost to Follow-up|1|||
155084043|NCT00401830|559739215|FG000|Overall Study|Adverse Event|10|||
155084044|NCT00401830|559739216|FG001|Overall Study|Adverse Event|18|||
154964271|NCT01592240|559295216|FG001|Overall Study|Other|3|||
154964272|NCT01592240|559295217|FG002|Overall Study|Other|1|||
154964273|NCT01592240|559295218|FG003|Overall Study|Other|1|||
154964274|NCT01592240|559295219|FG004|Overall Study|Other|0|||
154964275|NCT01592240|559295220|FG005|Overall Study|Other|0|||
154964276|NCT01592240|559295221|FG006|Overall Study|Other|1|||
154964277|NCT01592240|559295215|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
154964278|NCT01592240|559295216|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
154964279|NCT01592240|559295217|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
154964280|NCT01592240|559295218|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
154964281|NCT01592240|559295219|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
154964282|NCT01592240|559295220|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
154964283|NCT01592240|559295221|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
154964284|NCT00469898|559295226|FG000|Overall Study|Adverse Event|7|||
154964285|NCT00469898|559295226|FG000|Overall Study|Withdrawal by Subject|4|||
154964286|NCT00469898|559295226|FG000|Overall Study|Death|4|||
154964287|NCT00469898|559295226|FG000|Overall Study|Disease progression|9|||
154964288|NCT00469898|559295226|FG000|Overall Study|Decreased performance status|1|||
154964289|NCT01205035|559295229|FG000|Overall Study|Withdrawal by Subject|1|||
154964290|NCT01205035|559295230|FG001|Overall Study|Withdrawal by Subject|0|||
154964291|NCT01205035|559295229|FG000|Overall Study|Physician Decision|1|||
154964292|NCT01205035|559295230|FG001|Overall Study|Physician Decision|0|||
154964293|NCT02663349|559295231|FG000|Overall Study|Withdrawal by Subject|6|||
154964294|NCT01896934|559295232|FG000|Overall Study|Adverse Event|1|||
154964295|NCT01896934|559295232|FG000|Overall Study|Withdrawal by Subject|1|||
154964296|NCT01557751|559295233|FG000|Overall Study|Physician Decision|3|||
154964297|NCT04590027|559295235|FG000|Overall Study|Lost to Follow-up|17|||
154964298|NCT04590027|559295236|FG001|Overall Study|Lost to Follow-up|14|||
154964299|NCT04590027|559295235|FG000|Overall Study|Protocol Violation|0|||
154964300|NCT04590027|559295236|FG001|Overall Study|Protocol Violation|3|||
154964301|NCT03276754|559295237|FG000|Overall Study|Withdrawal of informed consent|4|||
154964302|NCT03276754|559295237|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
154964303|NCT03276754|559295237|FG000|Overall Study|Lost to Follow-up|27|||
154964304|NCT03276754|559295237|FG000|Overall Study|No data reported at Month 24|31|||
154964305|NCT03276754|559295237|FG000|Overall Study|Death|39|||
154964306|NCT00316277|559295238|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
154964307|NCT00316277|559295239|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
154964308|NCT00316277|559295238|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
154964309|NCT00316277|559295239|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
154964310|NCT00316277|559295238|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
154964311|NCT00316277|559295239|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
154964312|NCT00316277|559295238|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
154964313|NCT00316277|559295239|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
154964314|NCT00316277|559295238|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
154964315|NCT00316277|559295239|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
154964316|NCT00848536|559295240|FG000|Overall Study|Adverse Event|2|||
154964317|NCT00848536|559295241|FG001|Overall Study|Adverse Event|2|||
154964318|NCT00848536|559295240|FG000|Overall Study|Withdrawal by Subject|0|||
154964319|NCT00848536|559295241|FG001|Overall Study|Withdrawal by Subject|1|||
154964320|NCT00848536|559295240|FG000|Overall Study|Protocol Violation|0|||
154964321|NCT00848536|559295241|FG001|Overall Study|Protocol Violation|1|||
154964322|NCT00848536|559295240|FG000|Overall Study|Noncompliance|1|||
154964323|NCT00848536|559295241|FG001|Overall Study|Noncompliance|0|||
154964324|NCT00848536|559295240|FG000|Overall Study|Inadequate Control of IOP|1|||
155084045|NCT00401830|559739215|FG000|Overall Study|Lack of Efficacy|11|||
155084046|NCT00401830|559739216|FG001|Overall Study|Lack of Efficacy|5|||
154964325|NCT00848536|559295241|FG001|Overall Study|Inadequate Control of IOP|1|||
154964326|NCT00848536|559295240|FG000|Overall Study|Patient Moved|0|||
154964327|NCT00848536|559295241|FG001|Overall Study|Patient Moved|2|||
154964328|NCT01572662|559295242|FG000|Overall Study|Withdrawal by Subject|1|||
154964329|NCT01572662|559295243|FG001|Overall Study|Withdrawal by Subject|0|||
154964330|NCT01572662|559295242|FG000|Overall Study|Physician Decision|0|||
154964331|NCT01572662|559295243|FG001|Overall Study|Physician Decision|1|||
154964332|NCT04692155|559295244|FG000|Overall Study|Death|1|||
155349950|NCT02959177|560716139|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155349951|NCT02959177|560716140|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155349952|NCT02959177|560716141|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155349953|NCT02959177|560716139|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
155349954|NCT02959177|560716140|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
155349955|NCT02959177|560716141|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
155349956|NCT02959177|560716139|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
155349957|NCT02959177|560716140|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
155349958|NCT02959177|560716141|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
155349959|NCT02959177|560716139|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
155349960|NCT02959177|560716140|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
155349961|NCT02959177|560716141|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
155349962|NCT00591409|560716145|FG000|Overall Study|Not Treated|0|||
155349963|NCT00591409|560716146|FG001|Overall Study|Not Treated|0|||
155349964|NCT00591409|560716147|FG002|Overall Study|Not Treated|0|||
155349965|NCT00591409|560716148|FG003|Overall Study|Not Treated|0|||
155349966|NCT00591409|560716149|FG004|Overall Study|Not Treated|1|||
155349967|NCT00591409|560716150|FG005|Overall Study|Not Treated|0|||
155349968|NCT00591409|560716151|FG006|Overall Study|Not Treated|0|||
155349969|NCT00591409|560716152|FG007|Overall Study|Not Treated|0|||
155349970|NCT00591409|560716153|FG008|Overall Study|Not Treated|0|||
155349971|NCT00591409|560716154|FG009|Overall Study|Not Treated|1|||
155349972|NCT02853305|560716155|FG000|Overall Study|Death|287|||
155349973|NCT02853305|560716156|FG001|Overall Study|Death|249|||
155349974|NCT02853305|560716157|FG002|Overall Study|Death|300|||
155349975|NCT02853305|560716155|FG000|Overall Study|Withdrawal by Subject|2|||
155349976|NCT02853305|560716156|FG001|Overall Study|Withdrawal by Subject|8|||
155349977|NCT02853305|560716157|FG002|Overall Study|Withdrawal by Subject|3|||
155349978|NCT02853305|560716155|FG000|Overall Study|Transferred to Extension Study|46|||
155349979|NCT02853305|560716156|FG001|Overall Study|Transferred to Extension Study|30|||
155084047|NCT00401830|559739215|FG000|Overall Study|Withdrawal by Subject|4|||
155084048|NCT00401830|559739216|FG001|Overall Study|Withdrawal by Subject|3|||
155084049|NCT00401830|559739215|FG000|Overall Study|Protocol Violation|3|||
155084050|NCT00401830|559739216|FG001|Overall Study|Protocol Violation|3|||
155349980|NCT02853305|560716157|FG002|Overall Study|Transferred to Extension Study|25|||
155349981|NCT02853305|560716155|FG000|Overall Study|Did Not Continue on Extension Study|16|||
155349982|NCT02853305|560716156|FG001|Overall Study|Did Not Continue on Extension Study|20|||
155349983|NCT02853305|560716157|FG002|Overall Study|Did Not Continue on Extension Study|24|||
155349984|NCT02381652|560716160|FG000|Overall Study|Withdrawal by Subject|0|||
155084051|NCT00401830|559739215|FG000|Overall Study|Non-compliance with drug study|1|||
155084052|NCT00401830|559739216|FG001|Overall Study|Non-compliance with drug study|0|||
155084053|NCT00401830|559739215|FG000|Overall Study|Lost to Follow-up|1|||
155084054|NCT00401830|559739216|FG001|Overall Study|Lost to Follow-up|3|||
155084055|NCT00401830|559739215|FG000|Overall Study|Other: Personal / Family problems|1|||
155084056|NCT00401830|559739216|FG001|Overall Study|Other: Personal / Family problems|0|||
155084057|NCT01943825|559739217|FG000|Overall Study|Lost to Follow-up|9|||
155084058|NCT01943825|559739218|FG001|Overall Study|Lost to Follow-up|3|||
155084059|NCT01943825|559739219|FG002|Overall Study|Lost to Follow-up|12|||
155084060|NCT01943825|559739220|FG003|Overall Study|Lost to Follow-up|8|||
155084061|NCT01943825|559739217|FG000|Overall Study|Withdrawal by Subject|1|||
155084062|NCT01943825|559739218|FG001|Overall Study|Withdrawal by Subject|0|||
155084063|NCT01943825|559739219|FG002|Overall Study|Withdrawal by Subject|3|||
155084064|NCT01943825|559739220|FG003|Overall Study|Withdrawal by Subject|2|||
155349985|NCT02381652|560716161|FG001|Overall Study|Withdrawal by Subject|0|||
155349986|NCT02381652|560716162|FG002|Overall Study|Withdrawal by Subject|1|||
155349987|NCT04772313|560716163|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
155349988|NCT04772313|560716163|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
155349989|NCT01836198|560716164|FG000|Part A, Period 2|Protocol Violation|0|||
155349990|NCT01836198|560716165|FG001|Part A, Period 2|Protocol Violation|1|||
155349991|NCT01836198|560716166|FG002|Part A, Period 2|Protocol Violation|0|||
155349992|NCT02215954|560716167|FG000|Overall Study|Adverse Event|0|||
155349993|NCT02215954|560716168|FG001|Overall Study|Adverse Event|0|||
155349994|NCT02215954|560716169|FG002|Overall Study|Adverse Event|1|||
155349995|NCT02215954|560716167|FG000|Overall Study|Withdrawal by Subject|0|||
155349996|NCT02215954|560716168|FG001|Overall Study|Withdrawal by Subject|0|||
155349997|NCT02215954|560716169|FG002|Overall Study|Withdrawal by Subject|2|||
155349998|NCT02215954|560716167|FG000|Overall Study|Not exposed|1|||
155349999|NCT02215954|560716168|FG001|Overall Study|Not exposed|1|||
155350000|NCT02215954|560716169|FG002|Overall Study|Not exposed|3|||
155350001|NCT00187135|560716174|FG000|Visit One|Withdrawal by Subject|1|||
155350002|NCT00187135|560716175|FG001|Visit One|Withdrawal by Subject|0|||
155350003|NCT00187135|560716176|FG002|Visit One|Withdrawal by Subject|0|||
155350004|NCT00187135|560716177|FG003|Visit One|Withdrawal by Subject|0|||
155350005|NCT00187135|560716178|FG004|Visit One|Withdrawal by Subject|0|||
155350006|NCT00187135|560716179|FG005|Visit One|Withdrawal by Subject|1|||
155350007|NCT00187135|560716174|FG000|Visit One|Physician Decision|3|||
155350008|NCT00187135|560716175|FG001|Visit One|Physician Decision|1|||
155350009|NCT00187135|560716176|FG002|Visit One|Physician Decision|0|||
155350010|NCT00187135|560716177|FG003|Visit One|Physician Decision|0|||
155350011|NCT00187135|560716178|FG004|Visit One|Physician Decision|0|||
155350012|NCT00187135|560716179|FG005|Visit One|Physician Decision|1|||
155350013|NCT00187135|560716174|FG000|Visit Two|Death|0|||
155350014|NCT00187135|560716175|FG001|Visit Two|Death|0|||
155350015|NCT00187135|560716176|FG002|Visit Two|Death|0|||
155350016|NCT00187135|560716177|FG003|Visit Two|Death|1|||
155350017|NCT00187135|560716178|FG004|Visit Two|Death|0|||
155350018|NCT00187135|560716179|FG005|Visit Two|Death|1|||
155350019|NCT00187135|560716174|FG000|Visit Two|Physician Decision|1|||
155165609|NCT00953056|560043499|FG001|Overall Study|Serious Adverse Event|0|||
155165610|NCT00953056|560043500|FG002|Overall Study|Serious Adverse Event|0|||
155350020|NCT00187135|560716175|FG001|Visit Two|Physician Decision|0|||
155350021|NCT00187135|560716176|FG002|Visit Two|Physician Decision|0|||
155350022|NCT00187135|560716177|FG003|Visit Two|Physician Decision|0|||
155350023|NCT00187135|560716178|FG004|Visit Two|Physician Decision|0|||
155084065|NCT01943825|559739217|FG000|Overall Study|Other than specified above|0|||
155165611|NCT00953056|560043501|FG003|Overall Study|Serious Adverse Event|0|||
155350024|NCT00187135|560716179|FG005|Visit Two|Physician Decision|0|||
155350025|NCT00187135|560716174|FG000|Visit Two|Withdrawal by Subject|1|||
155350026|NCT00187135|560716175|FG001|Visit Two|Withdrawal by Subject|1|||
155350027|NCT00187135|560716176|FG002|Visit Two|Withdrawal by Subject|1|||
155084066|NCT01943825|559739218|FG001|Overall Study|Other than specified above|1|||
155084067|NCT01943825|559739219|FG002|Overall Study|Other than specified above|0|||
155350028|NCT00187135|560716177|FG003|Visit Two|Withdrawal by Subject|0|||
155350029|NCT00187135|560716178|FG004|Visit Two|Withdrawal by Subject|1|||
155350030|NCT00187135|560716179|FG005|Visit Two|Withdrawal by Subject|1|||
155350031|NCT00187135|560716174|FG000|Visit Two|Study Discontinued|3|||
155084068|NCT01943825|559739220|FG003|Overall Study|Other than specified above|1|||
155084069|NCT01044459|559739221|FG000|Overall Study|Withdrawal by Subject|21|||
155084070|NCT01044459|559739222|FG001|Overall Study|Withdrawal by Subject|28|||
155084071|NCT01044459|559739221|FG000|Overall Study|Terminated by Sponsor|22|||
155084072|NCT01044459|559739222|FG001|Overall Study|Terminated by Sponsor|21|||
155084073|NCT01044459|559739221|FG000|Overall Study|Adverse Event|22|||
155084074|NCT01044459|559739222|FG001|Overall Study|Adverse Event|20|||
155084075|NCT01044459|559739221|FG000|Overall Study|Lack of Efficacy|23|||
155084076|NCT01044459|559739222|FG001|Overall Study|Lack of Efficacy|12|||
155084077|NCT01044459|559739221|FG000|Overall Study|Protocol Violation|11|||
155084078|NCT01044459|559739222|FG001|Overall Study|Protocol Violation|16|||
155084079|NCT01044459|559739221|FG000|Overall Study|Other Reason|7|||
155084080|NCT01044459|559739222|FG001|Overall Study|Other Reason|14|||
155084081|NCT01044459|559739221|FG000|Overall Study|COPD exacerbation|9|||
155084082|NCT01044459|559739222|FG001|Overall Study|COPD exacerbation|8|||
155084083|NCT01044459|559739221|FG000|Overall Study|Lost to Follow-up|18|||
155084084|NCT01044459|559739222|FG001|Overall Study|Lost to Follow-up|12|||
155084085|NCT05346640|559739223|FG000|Overall Study|Lack of Efficacy|2|||
155084086|NCT05346640|559739223|FG000|Overall Study|Lost to Follow-up|14|||
155084087|NCT05346640|559739223|FG000|Overall Study|Protocol Violation|4|||
155084088|NCT05346640|559739223|FG000|Overall Study|Withdrawal by Subject|2|||
155084089|NCT05346640|559739223|FG000|Overall Study|Physiological Complications|3|||
155084090|NCT05346640|559739223|FG000|Overall Study|Other Reason|3|||
155084091|NCT04634331|559739224|FG000|Overall Study|Withdrawal by Subject|2|||
155350032|NCT00187135|560716175|FG001|Visit Two|Study Discontinued|2|||
155350033|NCT00187135|560716176|FG002|Visit Two|Study Discontinued|1|||
155350034|NCT00187135|560716177|FG003|Visit Two|Study Discontinued|7|||
155084092|NCT04634331|559739225|FG001|Overall Study|Withdrawal by Subject|2|||
155084093|NCT03726879|559739226|FG000|Overall Study|Death|11|||
155084094|NCT03726879|559739227|FG001|Overall Study|Death|13|||
155084095|NCT03726879|559739226|FG000|Overall Study|Physician Decision|0|||
155084096|NCT03726879|559739227|FG001|Overall Study|Physician Decision|2|||
155084097|NCT03726879|559739226|FG000|Overall Study|Protocol Violation|0|||
155084098|NCT03726879|559739227|FG001|Overall Study|Protocol Violation|1|||
155084099|NCT03726879|559739226|FG000|Overall Study|Withdrawal by Subject|5|||
155084100|NCT03726879|559739227|FG001|Overall Study|Withdrawal by Subject|6|||
155084101|NCT03726879|559739226|FG000|Overall Study|TSH result is unstable|0|||
155084102|NCT03726879|559739227|FG001|Overall Study|TSH result is unstable|1|||
155084103|NCT03726879|559739226|FG000|Overall Study|Disease relapse|1|||
155084104|NCT03726879|559739227|FG001|Overall Study|Disease relapse|0|||
155084105|NCT03726879|559739226|FG000|Overall Study|Lost to Follow-up|3|||
155084106|NCT03726879|559739227|FG001|Overall Study|Lost to Follow-up|0|||
155350035|NCT00187135|560716178|FG004|Visit Two|Study Discontinued|5|||
155350036|NCT00187135|560716179|FG005|Visit Two|Study Discontinued|6|||
155350037|NCT00187135|560716174|FG000|Visit Three|Death|0|||
155350038|NCT00187135|560716175|FG001|Visit Three|Death|0|||
155350039|NCT00187135|560716176|FG002|Visit Three|Death|1|||
155350040|NCT00187135|560716177|FG003|Visit Three|Death|0|||
155350041|NCT00187135|560716178|FG004|Visit Three|Death|1|||
155350042|NCT00187135|560716179|FG005|Visit Three|Death|0|||
155350043|NCT00187135|560716174|FG000|Visit Three|Withdrawal by Subject|0|||
155350044|NCT00187135|560716175|FG001|Visit Three|Withdrawal by Subject|1|||
155350045|NCT00187135|560716176|FG002|Visit Three|Withdrawal by Subject|1|||
155084107|NCT00553475|559739229|FG000|Overall Study|Adverse Event|7|||
155084108|NCT00553475|559739230|FG001|Overall Study|Adverse Event|17|||
155084109|NCT00553475|559739231|FG002|Overall Study|Adverse Event|13|||
155084110|NCT00553475|559739229|FG000|Overall Study|Lack of Efficacy|7|||
155084111|NCT00553475|559739230|FG001|Overall Study|Lack of Efficacy|1|||
155084112|NCT00553475|559739231|FG002|Overall Study|Lack of Efficacy|0|||
155084113|NCT00553475|559739229|FG000|Overall Study|Withdrawal by Subject|1|||
155084114|NCT00553475|559739230|FG001|Overall Study|Withdrawal by Subject|1|||
155084115|NCT00553475|559739231|FG002|Overall Study|Withdrawal by Subject|0|||
155084116|NCT00553475|559739229|FG000|Overall Study|Physician Decision|1|||
155084117|NCT00553475|559739230|FG001|Overall Study|Physician Decision|0|||
155084118|NCT00553475|559739231|FG002|Overall Study|Physician Decision|0|||
155350046|NCT00187135|560716177|FG003|Visit Three|Withdrawal by Subject|2|||
155350047|NCT00187135|560716178|FG004|Visit Three|Withdrawal by Subject|0|||
155350048|NCT00187135|560716179|FG005|Visit Three|Withdrawal by Subject|0|||
155350049|NCT00187135|560716174|FG000|Visit Three|Study Discontinued|7|||
155350050|NCT00187135|560716175|FG001|Visit Three|Study Discontinued|6|||
155350051|NCT00187135|560716176|FG002|Visit Three|Study Discontinued|7|||
155350052|NCT00187135|560716177|FG003|Visit Three|Study Discontinued|7|||
155350053|NCT00187135|560716178|FG004|Visit Three|Study Discontinued|7|||
155084119|NCT00553475|559739229|FG000|Overall Study|Due to moving|0|||
155084120|NCT00553475|559739230|FG001|Overall Study|Due to moving|1|||
155350054|NCT00187135|560716179|FG005|Visit Three|Study Discontinued|6|||
155350055|NCT00745121|560716183|FG000|Overall Study|Death|3|||
155350056|NCT00745121|560716184|FG001|Overall Study|Death|0|||
155350057|NCT00745121|560716183|FG000|Overall Study|Adverse Event|1|||
155084121|NCT00553475|559739231|FG002|Overall Study|Due to moving|0|||
155084122|NCT00890097|559739232|FG000|Overall Study|Adverse Event|21|||
155350058|NCT00745121|560716184|FG001|Overall Study|Adverse Event|0|||
155084123|NCT00890097|559739233|FG001|Overall Study|Adverse Event|32|||
155084124|NCT00890097|559739234|FG002|Overall Study|Adverse Event|28|||
155084125|NCT00890097|559739232|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
155084126|NCT00890097|559739233|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
155084127|NCT00890097|559739234|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
155084128|NCT00890097|559739232|FG000|Overall Study|Withdrew Consent|9|||
155084129|NCT00890097|559739233|FG001|Overall Study|Withdrew Consent|6|||
155084130|NCT00890097|559739234|FG002|Overall Study|Withdrew Consent|9|||
155084131|NCT00890097|559739232|FG000|Overall Study|Lost to Follow-up|5|||
155084132|NCT00890097|559739233|FG001|Overall Study|Lost to Follow-up|5|||
155084133|NCT00890097|559739234|FG002|Overall Study|Lost to Follow-up|5|||
155350059|NCT00745121|560716183|FG000|Overall Study|Lost to Follow-up|1|||
155350060|NCT00745121|560716184|FG001|Overall Study|Lost to Follow-up|0|||
155350061|NCT00745121|560716183|FG000|Overall Study|Withdrawal by Subject|4|||
155350062|NCT00745121|560716184|FG001|Overall Study|Withdrawal by Subject|2|||
155350063|NCT03280108|560716185|FG000|Overall Study|Lost to Follow-up|2|||
155350064|NCT03280108|560716186|FG001|Overall Study|Lost to Follow-up|0|||
155350065|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
155350066|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350067|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350068|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350069|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155350070|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
155350071|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350072|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350073|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350074|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155350075|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
155350076|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350077|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350078|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350079|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155350080|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
155350081|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155350082|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155350083|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155084134|NCT00890097|559739232|FG000|Overall Study|Noncompliance|0|||
155084135|NCT00890097|559739233|FG001|Overall Study|Noncompliance|4|||
155084136|NCT00890097|559739234|FG002|Overall Study|Noncompliance|4|||
155084137|NCT00890097|559739232|FG000|Overall Study|Sponsor Decision|7|||
155084138|NCT00890097|559739233|FG001|Overall Study|Sponsor Decision|11|||
155350084|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155350085|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
155350086|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350087|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350088|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350089|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155350090|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
155350091|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350092|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350093|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350094|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155350095|NCT01187407|560716187|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
155350096|NCT01187407|560716188|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350097|NCT01187407|560716189|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350098|NCT01187407|560716190|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350099|NCT01187407|560716191|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155350100|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
155350101|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
155350102|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
155350103|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
155350104|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
155350105|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
155350106|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
155350107|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
155350108|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
155350109|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
155350110|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155350111|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
155350112|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
155350113|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
155350114|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
155350115|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155350116|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155350117|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155350118|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155350119|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
155350120|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
155350121|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
154964333|NCT04547192|559295245|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
154964334|NCT04547192|559295246|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
155084139|NCT00890097|559739234|FG002|Overall Study|Sponsor Decision|7|||
155084140|NCT00890097|559739232|FG000|Overall Study|Did not attend final visit|2|||
155350122|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155350123|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
155350124|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
155350125|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
155350126|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
155350127|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
155350128|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
155350129|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
155350130|NCT01187407|560716187|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155084141|NCT00890097|559739233|FG001|Overall Study|Did not attend final visit|3|||
155084142|NCT00890097|559739234|FG002|Overall Study|Did not attend final visit|0|||
155350131|NCT01187407|560716188|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155350132|NCT01187407|560716189|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155350133|NCT01187407|560716190|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155350134|NCT01187407|560716191|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
155350135|NCT02996097|560716192|FG000|Overall Study|Lost to Follow-up|11|||
155350136|NCT02996097|560716193|FG001|Overall Study|Lost to Follow-up|11|||
155350137|NCT01820637|560716194|FG000|Overall Study|Death|2|||
155350138|NCT01820637|560716194|FG000|Overall Study|Withdrawal by Subject|1|||
155350139|NCT02382406|560716195|FG000|Study Treatment|Disease Progression|8|||
155350140|NCT02382406|560716196|FG001|Study Treatment|Disease Progression|0|||
155350141|NCT02382406|560716197|FG002|Study Treatment|Disease Progression|20|||
155350142|NCT02382406|560716195|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
155350143|NCT02382406|560716196|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
155084143|NCT00890097|559739232|FG000|Overall Study|Subject Decision|3|||
155084144|NCT00890097|559739233|FG001|Overall Study|Subject Decision|2|||
155350144|NCT02382406|560716197|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
155350145|NCT02382406|560716195|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
155350146|NCT02382406|560716196|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
155350147|NCT02382406|560716197|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
155350148|NCT02382406|560716195|FG000|Study Treatment|symptomatic deterioration|1|||
155350149|NCT02382406|560716196|FG001|Study Treatment|symptomatic deterioration|0|||
155350150|NCT02382406|560716197|FG002|Study Treatment|symptomatic deterioration|1|||
154964335|NCT04547192|559295247|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
155084145|NCT00890097|559739234|FG002|Overall Study|Subject Decision|6|||
155084146|NCT00890097|559739232|FG000|Overall Study|Randomization Error|2|||
155084147|NCT00890097|559739233|FG001|Overall Study|Randomization Error|0|||
155084148|NCT00890097|559739234|FG002|Overall Study|Randomization Error|0|||
155084149|NCT00890097|559739232|FG000|Overall Study|Failed inclusion criteria|3|||
155084150|NCT00890097|559739233|FG001|Overall Study|Failed inclusion criteria|4|||
155084151|NCT00890097|559739234|FG002|Overall Study|Failed inclusion criteria|0|||
155084152|NCT00890097|559739232|FG000|Overall Study|Transportation|0|||
155084153|NCT00890097|559739233|FG001|Overall Study|Transportation|2|||
155084154|NCT00890097|559739234|FG002|Overall Study|Transportation|0|||
155084155|NCT00890097|559739232|FG000|Overall Study|Subject Moved|0|||
155084156|NCT00890097|559739233|FG001|Overall Study|Subject Moved|4|||
155084157|NCT00890097|559739234|FG002|Overall Study|Subject Moved|0|||
155084158|NCT00890097|559739232|FG000|Overall Study|Protocol Deviation|1|||
155084159|NCT00890097|559739233|FG001|Overall Study|Protocol Deviation|1|||
155084160|NCT00890097|559739234|FG002|Overall Study|Protocol Deviation|1|||
155084161|NCT01152385|559739235|FG000|Overall Study|Withdrawal by Subject|3|||
155084162|NCT01152385|559739236|FG001|Overall Study|Withdrawal by Subject|1|||
155084163|NCT01152385|559739237|FG002|Overall Study|Withdrawal by Subject|1|||
155084164|NCT01152385|559739238|FG003|Overall Study|Withdrawal by Subject|1|||
155084165|NCT01152385|559739235|FG000|Overall Study|Protocol Violation|0|||
155084166|NCT01152385|559739236|FG001|Overall Study|Protocol Violation|0|||
155350151|NCT02382406|560716195|FG000|Study Treatment|Death|0|||
155084167|NCT01152385|559739237|FG002|Overall Study|Protocol Violation|0|||
155084168|NCT01152385|559739238|FG003|Overall Study|Protocol Violation|1|||
155084169|NCT01152385|559739235|FG000|Overall Study|Adverse Event|1|||
155350152|NCT02382406|560716196|FG001|Study Treatment|Death|0|||
155084170|NCT01152385|559739236|FG001|Overall Study|Adverse Event|1|||
155084171|NCT01152385|559739237|FG002|Overall Study|Adverse Event|0|||
155084172|NCT01152385|559739238|FG003|Overall Study|Adverse Event|0|||
154964336|NCT04547192|559295248|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
154964337|NCT04547192|559295245|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
154964338|NCT04547192|559295246|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
155084173|NCT01152385|559739235|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155084174|NCT01152385|559739236|FG001|Overall Study|Study-specific withdrawal criteria|1|||
155084175|NCT01152385|559739237|FG002|Overall Study|Study-specific withdrawal criteria|2|||
155084176|NCT01152385|559739238|FG003|Overall Study|Study-specific withdrawal criteria|0|||
155084177|NCT01152385|559739235|FG000|Overall Study|Other|4|||
155084178|NCT01152385|559739236|FG001|Overall Study|Other|3|||
155084179|NCT01152385|559739237|FG002|Overall Study|Other|2|||
155084180|NCT01152385|559739238|FG003|Overall Study|Other|3|||
155084181|NCT02656173|559739239|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
155084182|NCT02656173|559739240|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
155084183|NCT02656173|559739239|FG000|Overall Study|Adverse Event|7|||
155084184|NCT02656173|559739240|FG001|Overall Study|Adverse Event|5|||
155084185|NCT02656173|559739239|FG000|Overall Study|Withdrawal by Subject|1|||
155084186|NCT02656173|559739240|FG001|Overall Study|Withdrawal by Subject|3|||
155084187|NCT02656173|559739239|FG000|Overall Study|Protocol Violation|0|||
155084188|NCT02656173|559739240|FG001|Overall Study|Protocol Violation|1|||
155084189|NCT02656173|559739239|FG000|Overall Study|Miscellaneous|2|||
155084190|NCT02656173|559739240|FG001|Overall Study|Miscellaneous|0|||
155084191|NCT00834587|559739243|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155084192|NCT00834587|559739244|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155084193|NCT03810495|559739245|FG000|Overall Study|Lost to Follow-up|2|||
155084194|NCT03810495|559739245|FG000|Overall Study|Withdrawal by Subject|1|||
155084195|NCT03289741|559739246|FG000|Overall Study|Adverse Event|1|||
155084196|NCT03289741|559739247|FG001|Overall Study|Adverse Event|1|||
155084197|NCT03289741|559739246|FG000|Overall Study|Physician Decision|2|||
155084198|NCT03289741|559739247|FG001|Overall Study|Physician Decision|2|||
155350153|NCT02382406|560716197|FG002|Study Treatment|Death|2|||
154964339|NCT04547192|559295247|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
154964340|NCT04547192|559295248|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
155084199|NCT03289741|559739246|FG000|Overall Study|Withdrawal by Subject|1|||
155084200|NCT03289741|559739247|FG001|Overall Study|Withdrawal by Subject|0|||
155084201|NCT03449147|559739250|FG000|52-week Treatment Period|Death|0|||
155084202|NCT03449147|559739251|FG001|52-week Treatment Period|Death|1|||
155350154|NCT02382406|560716195|FG000|Follow up|Death|11|||
155084203|NCT03449147|559739252|FG002|52-week Treatment Period|Death|0|||
155084204|NCT03449147|559739250|FG000|52-week Treatment Period|Lost to Follow-up|6|||
155350155|NCT02382406|560716196|FG001|Follow up|Death|0|||
155084205|NCT03449147|559739251|FG001|52-week Treatment Period|Lost to Follow-up|2|||
155084206|NCT03449147|559739252|FG002|52-week Treatment Period|Lost to Follow-up|5|||
155350156|NCT02382406|560716197|FG002|Follow up|Death|19|||
155350157|NCT02382406|560716195|FG000|Follow up|Symptomatic deterioration|1|||
155350158|NCT02382406|560716196|FG001|Follow up|Symptomatic deterioration|0|||
155350159|NCT02382406|560716197|FG002|Follow up|Symptomatic deterioration|1|||
155350160|NCT02382406|560716195|FG000|Follow up|Patient Refused Follow-up|1|||
155350161|NCT02382406|560716196|FG001|Follow up|Patient Refused Follow-up|0|||
155350162|NCT02382406|560716197|FG002|Follow up|Patient Refused Follow-up|0|||
155350163|NCT02382406|560716195|FG000|Follow up|Study Terminated|1|||
155350164|NCT02382406|560716196|FG001|Follow up|Study Terminated|0|||
155350165|NCT02382406|560716197|FG002|Follow up|Study Terminated|8|||
155350166|NCT02382406|560716195|FG000|Follow up|Withdrawal by Subject|0|||
155350167|NCT02382406|560716196|FG001|Follow up|Withdrawal by Subject|0|||
155350168|NCT02382406|560716197|FG002|Follow up|Withdrawal by Subject|2|||
155350169|NCT01713998|560716198|FG000|Overall Study|Lost to Follow-up|2|||
155350170|NCT01713998|560716199|FG001|Overall Study|Lost to Follow-up|0|||
155350171|NCT01713998|560716200|FG002|Overall Study|Lost to Follow-up|2|||
155350172|NCT01713998|560716198|FG000|Overall Study|Withdrawal by Subject|1|||
155350173|NCT01713998|560716199|FG001|Overall Study|Withdrawal by Subject|0|||
155350174|NCT01713998|560716200|FG002|Overall Study|Withdrawal by Subject|0|||
155350175|NCT00640042|560716201|FG000|Enrollment|Did not receive study drug|83|||
155350176|NCT02391116|560716202|FG000|Treatment|Withdrawal by Subject|1|||
155350177|NCT02391116|560716202|FG000|Treatment|Protocol Violation|1|||
155350178|NCT02391116|560716202|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
155350179|NCT02391116|560716202|FG000|Treatment|AE with Clinical PD|3|||
155350180|NCT02391116|560716202|FG000|Safety Follow-up|Adverse Event|1|||
155350181|NCT02391116|560716202|FG000|Safety Follow-up|Withdrawal by Subject|4|||
155350182|NCT02391116|560716202|FG000|Safety Follow-up|Switching to Other Therapy|4|||
155350183|NCT02391116|560716202|FG000|Safety Follow-up|No Follow Up|1|||
155350184|NCT02391116|560716202|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
155350185|NCT02391116|560716202|FG000|Active Follow-up|Withdrawal by Subject|1|||
155350186|NCT02391116|560716202|FG000|Active Follow-up|Switching to Other Therapy|2|||
155350187|NCT02391116|560716202|FG000|Survival Follow-up|Withdrawal by Subject|3|||
155350188|NCT02391116|560716202|FG000|Survival Follow-up|Switching to Other Therapy|1|||
155350189|NCT00607789|560716204|FG000|Overall Study|Adverse Event|3|||
155350190|NCT00607789|560716205|FG001|Overall Study|Adverse Event|0|||
155350191|NCT00607789|560716204|FG000|Overall Study|Lack of Efficacy|0|||
155350192|NCT00607789|560716205|FG001|Overall Study|Lack of Efficacy|1|||
155350193|NCT00607789|560716204|FG000|Overall Study|Inadequate adherence|3|||
155350194|NCT00607789|560716205|FG001|Overall Study|Inadequate adherence|0|||
155084207|NCT03449147|559739250|FG000|52-week Treatment Period|Other|0|||
155084208|NCT03449147|559739251|FG001|52-week Treatment Period|Other|1|||
155084209|NCT03449147|559739252|FG002|52-week Treatment Period|Other|2|||
155084210|NCT03449147|559739250|FG000|52-week Treatment Period|Physician Decision|1|||
155084211|NCT03449147|559739251|FG001|52-week Treatment Period|Physician Decision|0|||
155350195|NCT00607789|560716204|FG000|Overall Study|Lost to Follow-up|0|||
155350196|NCT00607789|560716205|FG001|Overall Study|Lost to Follow-up|5|||
155350197|NCT00607789|560716204|FG000|Overall Study|Withdrawal by Subject|1|||
155350198|NCT00607789|560716205|FG001|Overall Study|Withdrawal by Subject|0|||
155350199|NCT06016127|560716208|FG000|Overall Study|Withdrawal by Subject|4|||
155350200|NCT06016127|560716209|FG001|Overall Study|Withdrawal by Subject|3|||
155350201|NCT03340766|560716214|FG000|Overall Study|Withdrawal by Subject|2|||
155350202|NCT03340766|560716215|FG001|Overall Study|Withdrawal by Subject|1|||
155350203|NCT03340766|560716216|FG002|Overall Study|Withdrawal by Subject|3|||
155350204|NCT03340766|560716214|FG000|Overall Study|Lost to Follow-up|0|||
155350205|NCT03340766|560716215|FG001|Overall Study|Lost to Follow-up|0|||
155350206|NCT03340766|560716216|FG002|Overall Study|Lost to Follow-up|1|||
155350207|NCT03340766|560716214|FG000|Overall Study|Death|6|||
155350208|NCT03340766|560716215|FG001|Overall Study|Death|7|||
155350209|NCT03340766|560716216|FG002|Overall Study|Death|4|||
155350210|NCT00853021|560716217|FG000|Overall Study|Adverse Event|2|||
155350211|NCT00853021|560716217|FG000|Overall Study|Withdrawal by Subject|2|||
155350212|NCT00853021|560716217|FG000|Overall Study|Death|1|||
155350213|NCT02864147|560716218|FG000|Overall Study|Withdrawal by Subject|3|||
155350214|NCT02864147|560716219|FG001|Overall Study|Withdrawal by Subject|2|||
155350215|NCT02864147|560716220|FG002|Overall Study|Withdrawal by Subject|1|||
155084212|NCT03449147|559739252|FG002|52-week Treatment Period|Physician Decision|3|||
155084213|NCT03449147|559739250|FG000|52-week Treatment Period|Screen Failure|1|||
155084214|NCT03449147|559739251|FG001|52-week Treatment Period|Screen Failure|2|||
155084215|NCT03449147|559739252|FG002|52-week Treatment Period|Screen Failure|0|||
155084216|NCT03449147|559739250|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
155350216|NCT02864147|560716218|FG000|Overall Study|Lost to Follow-up|0|||
155350217|NCT02864147|560716219|FG001|Overall Study|Lost to Follow-up|4|||
155350218|NCT02864147|560716220|FG002|Overall Study|Lost to Follow-up|0|||
155350219|NCT02864147|560716218|FG000|Overall Study|Adverse Event|0|||
155350220|NCT02864147|560716219|FG001|Overall Study|Adverse Event|1|||
155350221|NCT02864147|560716220|FG002|Overall Study|Adverse Event|0|||
155350222|NCT02864147|560716218|FG000|Overall Study|Pregnancy|4|||
155350223|NCT02864147|560716219|FG001|Overall Study|Pregnancy|0|||
155350224|NCT02864147|560716220|FG002|Overall Study|Pregnancy|0|||
155350225|NCT02864147|560716218|FG000|Overall Study|Physician Decision|0|||
155350226|NCT02864147|560716219|FG001|Overall Study|Physician Decision|0|||
155350227|NCT02864147|560716220|FG002|Overall Study|Physician Decision|1|||
155350228|NCT02864147|560716218|FG000|Overall Study|Opted for excisional procedures|0|||
155350229|NCT02864147|560716219|FG001|Overall Study|Opted for excisional procedures|0|||
155350230|NCT02864147|560716220|FG002|Overall Study|Opted for excisional procedures|3|||
155350231|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
155350232|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
155350233|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
155350234|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
155350235|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
155350236|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
155350237|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
155350238|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
155350239|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
155350240|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
155350241|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
154964341|NCT04547192|559295245|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
154964342|NCT04547192|559295246|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
155084217|NCT03449147|559739251|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
155350242|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
155350243|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
155350244|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
155350245|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
154964343|NCT04547192|559295247|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
154964344|NCT04547192|559295248|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
155350246|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
155350247|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
155350248|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
155350249|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
155350250|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
155350251|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
155350252|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
155350253|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
155350254|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
155350255|NCT02269917|560716221|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
155350256|NCT02269917|560716222|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
155350257|NCT02269917|560716223|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
155350258|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155350259|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155350260|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
155350261|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155350262|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155350263|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
155350264|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155350265|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155350266|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
155350267|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155350268|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155350269|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
155350270|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
155350271|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
155350272|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
155350273|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155350274|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155350275|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
155350276|NCT02269917|560716221|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155350277|NCT02269917|560716222|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155350278|NCT02269917|560716223|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
155350279|NCT00240097|560716224|FG000|Part I|Adverse Event|1|||
155350280|NCT00240097|560716224|FG000|Part I|Death|1|||
155350281|NCT00240097|560716224|FG000|Part I|histology|1|||
155350282|NCT00240097|560716224|FG000|Part I|unevaluable|1|||
155350283|NCT00240097|560716224|FG000|Part II|did not continue from Part I|23|||
155350284|NCT00981578|560716228|FG000|Overall Study|Death|1|||
155350285|NCT00981578|560716228|FG000|Overall Study|Withdrawal by Subject|2|||
155350286|NCT01294358|560716231|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350287|NCT01294358|560716232|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
155350288|NCT01294358|560716233|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155084218|NCT03449147|559739252|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
155084219|NCT03449147|559739250|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
155084220|NCT03449147|559739251|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
155084221|NCT03449147|559739252|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
155084222|NCT03449147|559739250|FG000|12-Week Off-Treatment Durability Period|Other|0|||
155084223|NCT03449147|559739251|FG001|12-Week Off-Treatment Durability Period|Other|1|||
155084224|NCT03449147|559739252|FG002|12-Week Off-Treatment Durability Period|Other|0|||
155084225|NCT00954538|559739254|FG000|Part III|Withdrawal by Subject|0|||
155350289|NCT01294358|560716234|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350290|NCT01294358|560716235|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
155350291|NCT01294358|560716231|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350292|NCT01294358|560716232|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350293|NCT01294358|560716233|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
155350294|NCT01294358|560716234|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350295|NCT01294358|560716235|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
155350296|NCT01294358|560716231|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350297|NCT01294358|560716232|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350298|NCT01294358|560716233|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350299|NCT01294358|560716234|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
155350300|NCT01294358|560716235|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
155350301|NCT01294358|560716231|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350302|NCT01294358|560716232|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350303|NCT01294358|560716233|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350304|NCT01294358|560716234|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
155350305|NCT01294358|560716235|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
155350306|NCT02963922|560716236|FG000|Overall Study|Adverse Event|15|||
155350307|NCT02963922|560716237|FG001|Overall Study|Adverse Event|6|||
155350308|NCT02963922|560716236|FG000|Overall Study|Protocol deviation|6|||
155350309|NCT02963922|560716237|FG001|Overall Study|Protocol deviation|6|||
155350310|NCT02963922|560716236|FG000|Overall Study|Lack of Efficacy|1|||
155350311|NCT02963922|560716237|FG001|Overall Study|Lack of Efficacy|1|||
155350312|NCT02963922|560716236|FG000|Overall Study|Lost to Follow-up|2|||
155350313|NCT02963922|560716237|FG001|Overall Study|Lost to Follow-up|3|||
155350314|NCT02963922|560716236|FG000|Overall Study|Other|8|||
155350315|NCT02963922|560716237|FG001|Overall Study|Other|14|||
155084226|NCT00954538|559739255|FG001|Part III|Withdrawal by Subject|0|||
155084227|NCT00954538|559739256|FG002|Part III|Withdrawal by Subject|0|||
155350316|NCT01180790|560716247|FG000|Overall Study|Adverse Event|1|||
155350317|NCT01180790|560716248|FG001|Overall Study|Adverse Event|1|||
155350318|NCT01180790|560716249|FG002|Overall Study|Adverse Event|2|||
155350319|NCT01180790|560716250|FG003|Overall Study|Adverse Event|0|||
155350320|NCT01180790|560716251|FG004|Overall Study|Adverse Event|1|||
155350321|NCT01180790|560716252|FG005|Overall Study|Adverse Event|3|||
155350322|NCT01180790|560716253|FG006|Overall Study|Adverse Event|0|||
155350323|NCT01180790|560716247|FG000|Overall Study|Withdrawal by Subject|3|||
155350324|NCT01180790|560716248|FG001|Overall Study|Withdrawal by Subject|0|||
155350325|NCT01180790|560716249|FG002|Overall Study|Withdrawal by Subject|5|||
155350326|NCT01180790|560716250|FG003|Overall Study|Withdrawal by Subject|0|||
155350327|NCT01180790|560716251|FG004|Overall Study|Withdrawal by Subject|2|||
155350328|NCT01180790|560716252|FG005|Overall Study|Withdrawal by Subject|1|||
155350329|NCT01180790|560716253|FG006|Overall Study|Withdrawal by Subject|0|||
155350330|NCT01180790|560716247|FG000|Overall Study|Lost to Follow-up|3|||
155350331|NCT01180790|560716248|FG001|Overall Study|Lost to Follow-up|1|||
155350332|NCT01180790|560716249|FG002|Overall Study|Lost to Follow-up|0|||
155084228|NCT00954538|559739257|FG003|Part III|Withdrawal by Subject|0|||
155350333|NCT01180790|560716250|FG003|Overall Study|Lost to Follow-up|2|||
155350334|NCT01180790|560716251|FG004|Overall Study|Lost to Follow-up|1|||
155350335|NCT01180790|560716252|FG005|Overall Study|Lost to Follow-up|0|||
155350336|NCT01180790|560716253|FG006|Overall Study|Lost to Follow-up|1|||
155350337|NCT01180790|560716247|FG000|Overall Study|Physician Decision|1|||
155350338|NCT01180790|560716248|FG001|Overall Study|Physician Decision|0|||
155350339|NCT01180790|560716249|FG002|Overall Study|Physician Decision|0|||
155350340|NCT01180790|560716250|FG003|Overall Study|Physician Decision|1|||
155350341|NCT01180790|560716251|FG004|Overall Study|Physician Decision|0|||
155350342|NCT01180790|560716252|FG005|Overall Study|Physician Decision|0|||
155350343|NCT01180790|560716253|FG006|Overall Study|Physician Decision|0|||
155350344|NCT01180790|560716247|FG000|Overall Study|Lack of Efficacy|1|||
155350345|NCT01180790|560716248|FG001|Overall Study|Lack of Efficacy|2|||
155350346|NCT01180790|560716249|FG002|Overall Study|Lack of Efficacy|5|||
155084229|NCT00954538|559739258|FG004|Part III|Withdrawal by Subject|1|||
155350347|NCT01180790|560716250|FG003|Overall Study|Lack of Efficacy|6|||
155350348|NCT01180790|560716251|FG004|Overall Study|Lack of Efficacy|1|||
155350349|NCT01180790|560716252|FG005|Overall Study|Lack of Efficacy|3|||
155084230|NCT00954538|559739259|FG005|Part III|Withdrawal by Subject|0|||
155084231|NCT01657942|559739260|FG000|Overall Study|Alternative Treatment|7|||
155084232|NCT01657942|559739260|FG000|Overall Study|Lost to Follow-up|1|||
155084233|NCT03443401|559740622|FG000|Overall Study|Lost to Follow-up|13|||
155084234|NCT03443401|559740622|FG000|Overall Study|Influential outlier|1|||
155350350|NCT01180790|560716253|FG006|Overall Study|Lack of Efficacy|0|||
155350351|NCT01180790|560716247|FG000|Overall Study|compliance|0|||
155350352|NCT01180790|560716248|FG001|Overall Study|compliance|1|||
155350353|NCT01180790|560716249|FG002|Overall Study|compliance|0|||
155350354|NCT01180790|560716250|FG003|Overall Study|compliance|0|||
155350355|NCT01180790|560716251|FG004|Overall Study|compliance|0|||
155350356|NCT01180790|560716252|FG005|Overall Study|compliance|0|||
155350357|NCT01180790|560716253|FG006|Overall Study|compliance|0|||
155350358|NCT01180790|560716247|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350359|NCT01180790|560716248|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350360|NCT01180790|560716249|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
155350361|NCT01180790|560716250|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350362|NCT01180790|560716251|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350363|NCT01180790|560716252|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350364|NCT01180790|560716253|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
155350365|NCT00655668|560716254|FG000|Overall Study|Adverse Event|6|||
155350366|NCT00655668|560716254|FG000|Overall Study|Death|5|||
155350367|NCT00655668|560716254|FG000|Overall Study|Disease Progression|27|||
155350368|NCT00655668|560716254|FG000|Overall Study|Study Terminated|9|||
155350369|NCT00655668|560716254|FG000|Overall Study|Other|1|||
155350370|NCT00655668|560716254|FG000|Overall Study|New Lymphoma Treatment Started|4|||
155350371|NCT00655668|560716254|FG000|Overall Study|Withdrawal by Subject|2|||
155350372|NCT02335242|560716255|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
155350373|NCT02335242|560716256|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
155350374|NCT02335242|560716255|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
155350375|NCT02335242|560716256|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
155350376|NCT02335242|560716255|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
155350377|NCT02335242|560716256|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
155350378|NCT03840148|560716257|FG000|Study Drug Disposition|Adverse Event|13|||
155350379|NCT03840148|560716258|FG001|Study Drug Disposition|Adverse Event|2|||
155350380|NCT03840148|560716257|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
155350381|NCT03840148|560716258|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
155350382|NCT03840148|560716257|FG000|Study Drug Disposition|Lack of Efficacy|3|||
154964345|NCT04547192|559295245|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
154964346|NCT04547192|559295246|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
154964347|NCT04547192|559295247|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
154964348|NCT04547192|559295248|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
154964349|NCT04547192|559295245|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
155084235|NCT02363283|559740623|FG000|Overall Study|Withdrawal by Subject|1|||
155084236|NCT02363283|559740623|FG000|Overall Study|Not eligible due to transaminitis|1|||
155084237|NCT02371889|559740624|FG000|Overall Study|Adverse medication effect|11|||
155350383|NCT03840148|560716258|FG001|Study Drug Disposition|Lack of Efficacy|0|||
155350384|NCT03840148|560716257|FG000|Study Drug Disposition|Physician Decision|2|||
155350385|NCT03840148|560716258|FG001|Study Drug Disposition|Physician Decision|0|||
155350386|NCT03840148|560716257|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
155350387|NCT03840148|560716258|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
155350388|NCT03840148|560716257|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
155350389|NCT03840148|560716258|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
155350390|NCT03840148|560716257|FG000|Study Completion Disposition|Physician Decision|2|||
155350391|NCT03840148|560716258|FG001|Study Completion Disposition|Physician Decision|0|||
155350392|NCT03840148|560716257|FG000|Study Completion Disposition|Covid-19 related|2|||
155350393|NCT03840148|560716258|FG001|Study Completion Disposition|Covid-19 related|0|||
155350394|NCT03840148|560716257|FG000|Study Completion Disposition|Lost to Follow-up|1|||
155350395|NCT03840148|560716258|FG001|Study Completion Disposition|Lost to Follow-up|1|||
155350396|NCT03840148|560716257|FG000|Study Completion Disposition|Death|1|||
155350397|NCT03840148|560716258|FG001|Study Completion Disposition|Death|0|||
155350398|NCT03840148|560716257|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
155350399|NCT03840148|560716258|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
155350400|NCT03615404|560716259|FG000|Overall Study|Death|1|||
155350401|NCT03615404|560716259|FG000|Overall Study|vaccine did not pass quality assurance|1|||
155350402|NCT00257556|560716260|FG000|Overall Study|Adverse Event|1|||
155350403|NCT00257556|560716261|FG001|Overall Study|Adverse Event|4|||
155350404|NCT00257556|560716260|FG000|Overall Study|Physician Decision|6|||
155350405|NCT00257556|560716261|FG001|Overall Study|Physician Decision|0|||
155350406|NCT00257556|560716260|FG000|Overall Study|Did not meet hCG criterion|3|||
155084238|NCT02371889|559740625|FG001|Overall Study|Adverse medication effect|2|||
155084239|NCT02371889|559740624|FG000|Overall Study|Lost to Follow-up|6|||
155350407|NCT00257556|560716261|FG001|Overall Study|Did not meet hCG criterion|0|||
155350408|NCT00257556|560716260|FG000|Overall Study|other reason|4|||
155350409|NCT00257556|560716261|FG001|Overall Study|other reason|6|||
155350410|NCT03873038|560716262|FG000|Part 2|Withdrawal by Subject|0|||
155350411|NCT03873038|560716263|FG001|Part 2|Withdrawal by Subject|0|||
155350412|NCT03873038|560716264|FG002|Part 2|Withdrawal by Subject|0|||
155350413|NCT03873038|560716265|FG003|Part 2|Withdrawal by Subject|0|||
155350414|NCT03873038|560716266|FG004|Part 2|Withdrawal by Subject|0|||
155350415|NCT03873038|560716267|FG005|Part 2|Withdrawal by Subject|1|||
155350416|NCT03873038|560716262|FG000|Part 2|Unknon|0|||
155350417|NCT03873038|560716263|FG001|Part 2|Unknon|0|||
155350418|NCT03873038|560716264|FG002|Part 2|Unknon|0|||
155350419|NCT03873038|560716265|FG003|Part 2|Unknon|0|||
155350420|NCT03873038|560716266|FG004|Part 2|Unknon|1|||
155350421|NCT03873038|560716267|FG005|Part 2|Unknon|0|||
155350422|NCT04222088|560716269|FG000|Overall Study|Lost to Follow-up|5|||
155350423|NCT04222088|560716270|FG001|Overall Study|Lost to Follow-up|1|||
155350424|NCT04222088|560716269|FG000|Overall Study|Withdrawal by Subject|4|||
155350425|NCT04222088|560716270|FG001|Overall Study|Withdrawal by Subject|0|||
155350426|NCT00595764|560716271|FG000|Overall Study|Protocol Violation|24|||
155350427|NCT00595764|560716272|FG001|Overall Study|Protocol Violation|19|||
155350428|NCT00595764|560716271|FG000|Overall Study|Missed Medication >1 week|10|||
155350429|NCT00595764|560716272|FG001|Overall Study|Missed Medication >1 week|17|||
155350430|NCT00595764|560716271|FG000|Overall Study|Missed 3 PM visits|1|||
155350431|NCT00595764|560716272|FG001|Overall Study|Missed 3 PM visits|7|||
155165612|NCT00953056|560043502|FG004|Overall Study|Serious Adverse Event|0|||
155350432|NCT00595764|560716271|FG000|Overall Study|Withdrawal by Subject|4|||
155350433|NCT00595764|560716272|FG001|Overall Study|Withdrawal by Subject|0|||
155350434|NCT03849300|560716273|FG000|Overall Study|move out to different area|1|||
155350435|NCT03849300|560716274|FG001|Overall Study|move out to different area|3|||
155350436|NCT03849300|560716275|FG002|Overall Study|move out to different area|1|||
155350437|NCT03849300|560716276|FG003|Overall Study|move out to different area|4|||
155350438|NCT03849300|560716273|FG000|Overall Study|scheduling/transportation conflict|4|||
155350439|NCT03849300|560716274|FG001|Overall Study|scheduling/transportation conflict|4|||
155350440|NCT03849300|560716275|FG002|Overall Study|scheduling/transportation conflict|3|||
155350441|NCT03849300|560716276|FG003|Overall Study|scheduling/transportation conflict|2|||
155350442|NCT04839289|560716277|FG000|Overall Study|Withdrawal by Subject|1|||
155084240|NCT02371889|559740625|FG001|Overall Study|Lost to Follow-up|5|||
155084241|NCT02371889|559740624|FG000|Overall Study|Personal time constraints|2|||
155084242|NCT02371889|559740625|FG001|Overall Study|Personal time constraints|4|||
155084243|NCT02371889|559740624|FG000|Overall Study|Lack of Efficacy|0|||
155084244|NCT02371889|559740625|FG001|Overall Study|Lack of Efficacy|2|||
155084245|NCT02371889|559740624|FG000|Overall Study|Relapse|0|||
155084246|NCT02371889|559740625|FG001|Overall Study|Relapse|1|||
155084247|NCT05520333|559740626|FG000|Overall Study|Lost to Follow-up|3|||
155084248|NCT05520333|559740627|FG001|Overall Study|Lost to Follow-up|6|||
155084249|NCT02410200|559740628|FG000|Overall Study|Adverse Event|2|||
155350443|NCT04839289|560716278|FG001|Overall Study|Withdrawal by Subject|0|||
155350444|NCT00663923|560716281|FG000|Overall Study|Lost to Follow-up|2|||
155350445|NCT02785900|560716282|FG000|Overall Study|Study Termination by Sponsor|64|||
155350446|NCT02785900|560716283|FG001|Overall Study|Study Termination by Sponsor|81|||
155350447|NCT02785900|560716282|FG000|Overall Study|Death|46|||
155350448|NCT02785900|560716283|FG001|Overall Study|Death|32|||
155350449|NCT02785900|560716282|FG000|Overall Study|Withdrawal by Subject|4|||
155350450|NCT02785900|560716283|FG001|Overall Study|Withdrawal by Subject|8|||
155350451|NCT02785900|560716282|FG000|Overall Study|Physician Decision|3|||
155350452|NCT02785900|560716283|FG001|Overall Study|Physician Decision|2|||
155350453|NCT04341584|560716284|FG000|Overall Study|Withdrew consent|0|||
155350454|NCT04341584|560716285|FG001|Overall Study|Withdrew consent|2|||
155350455|NCT04341584|560716286|FG002|Overall Study|Withdrew consent|2|||
155350456|NCT04341584|560716287|FG003|Overall Study|Withdrew consent|1|||
155350457|NCT00497198|560716288|FG000|Overall Study|Adverse Event|4|||
155350458|NCT00497198|560716289|FG001|Overall Study|Adverse Event|2|||
155350459|NCT00497198|560716288|FG000|Overall Study|Physician Decision|1|||
155350460|NCT00497198|560716289|FG001|Overall Study|Physician Decision|2|||
155350461|NCT00497198|560716288|FG000|Overall Study|Withdrawal by Subject|0|||
155350462|NCT00497198|560716289|FG001|Overall Study|Withdrawal by Subject|1|||
155350463|NCT01772147|560717976|FG000|Overall Study|Adverse Event|13|||
155350464|NCT01772147|560717977|FG001|Overall Study|Adverse Event|10|||
155350465|NCT01772147|560717978|FG002|Overall Study|Adverse Event|6|||
155350466|NCT01772147|560717976|FG000|Overall Study|Withdrew Consent|7|||
155350467|NCT01772147|560717977|FG001|Overall Study|Withdrew Consent|8|||
155350468|NCT01772147|560717978|FG002|Overall Study|Withdrew Consent|4|||
155350469|NCT01772147|560717976|FG000|Overall Study|Lost to Follow-up|1|||
155084250|NCT01661595|559740631|FG000|Phase 1: Week 0-4|Adverse Event|1|||
155084251|NCT01661595|559740632|FG001|Phase 1: Week 0-4|Adverse Event|0|||
155084252|NCT01661595|559740633|FG002|Phase 1: Week 0-4|Adverse Event|0|||
155084253|NCT01661595|559740634|FG003|Phase 1: Week 0-4|Adverse Event|0|||
155084254|NCT01661595|559740631|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
155084255|NCT01661595|559740632|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
155084256|NCT01661595|559740633|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
155084257|NCT01661595|559740634|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
155084258|NCT05538728|559740635|FG000|Overall Study|Withdrawal by Subject|1|||
155084259|NCT05538728|559740636|FG001|Overall Study|Withdrawal by Subject|1|||
155084260|NCT02336555|559740637|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
155084261|NCT02336555|559740638|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
155084262|NCT02336555|559740637|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
155084263|NCT02336555|559740638|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
155350470|NCT01772147|560717977|FG001|Overall Study|Lost to Follow-up|0|||
155350471|NCT01772147|560717978|FG002|Overall Study|Lost to Follow-up|1|||
155350472|NCT01772147|560717976|FG000|Overall Study|Protocol Deviation|2|||
155350473|NCT01772147|560717977|FG001|Overall Study|Protocol Deviation|1|||
155350474|NCT01772147|560717978|FG002|Overall Study|Protocol Deviation|1|||
155350475|NCT01772147|560717976|FG000|Overall Study|Lack of Efficacy|8|||
155084264|NCT02336555|559740637|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
155084265|NCT02336555|559740638|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
155350476|NCT01772147|560717977|FG001|Overall Study|Lack of Efficacy|6|||
155350477|NCT01772147|560717978|FG002|Overall Study|Lack of Efficacy|6|||
155350478|NCT00796614|560717986|FG000|Overall Study|Adverse Event|1|||
155350479|NCT00796614|560717987|FG001|Overall Study|Adverse Event|2|||
155350480|NCT00796614|560717988|FG002|Overall Study|Adverse Event|0|||
155350481|NCT00796614|560717989|FG003|Overall Study|Adverse Event|0|||
155350482|NCT00796614|560717986|FG000|Overall Study|Protocol Violation|0|||
155350483|NCT00796614|560717987|FG001|Overall Study|Protocol Violation|0|||
155350484|NCT00796614|560717988|FG002|Overall Study|Protocol Violation|2|||
155350485|NCT00796614|560717989|FG003|Overall Study|Protocol Violation|0|||
155084266|NCT01772693|559740639|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
155084267|NCT01772693|559740640|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
155084268|NCT01772693|559740639|FG000|Overall Study|Withdrawal by Subject|2|||
155084269|NCT01772693|559740640|FG001|Overall Study|Withdrawal by Subject|0|||
155350486|NCT00796614|560717986|FG000|Overall Study|Lost to Follow-up|2|||
155350487|NCT00796614|560717987|FG001|Overall Study|Lost to Follow-up|2|||
155350488|NCT00796614|560717988|FG002|Overall Study|Lost to Follow-up|1|||
155350489|NCT00796614|560717989|FG003|Overall Study|Lost to Follow-up|0|||
155350490|NCT00796614|560717986|FG000|Overall Study|Withdrawal by Subject|1|||
155350491|NCT00796614|560717987|FG001|Overall Study|Withdrawal by Subject|0|||
155350492|NCT00796614|560717988|FG002|Overall Study|Withdrawal by Subject|0|||
155350493|NCT00796614|560717989|FG003|Overall Study|Withdrawal by Subject|1|||
155350494|NCT00796614|560717986|FG000|Overall Study|Other than stated|1|||
155350495|NCT00796614|560717987|FG001|Overall Study|Other than stated|0|||
155350496|NCT00796614|560717988|FG002|Overall Study|Other than stated|0|||
155350497|NCT00796614|560717989|FG003|Overall Study|Other than stated|0|||
155350498|NCT00740597|560717990|FG000|Overall Study|insurance would not cover treatment|1|||
155350499|NCT00746785|560717992|FG000|Overall Study|Lost to Follow-up|29|||
155350500|NCT00746785|560717993|FG001|Overall Study|Lost to Follow-up|25|||
155350501|NCT00746785|560717994|FG002|Overall Study|Lost to Follow-up|27|||
155350502|NCT01231464|560717995|FG000|Overall Study|Adverse Event|0|||
155350503|NCT01231464|560717996|FG001|Overall Study|Adverse Event|1|||
155350504|NCT01231464|560717995|FG000|Overall Study|Protocol Violation|1|||
155350505|NCT01231464|560717996|FG001|Overall Study|Protocol Violation|2|||
155350506|NCT01231464|560717995|FG000|Overall Study|Lost to Follow-up|1|||
155350507|NCT01231464|560717996|FG001|Overall Study|Lost to Follow-up|2|||
155350508|NCT01231464|560717995|FG000|Overall Study|Withdrawal by Subject|3|||
155350509|NCT01231464|560717996|FG001|Overall Study|Withdrawal by Subject|2|||
155350510|NCT00957996|560718002|FG000|Overall Study|Death|4|||
155350511|NCT00957996|560718003|FG001|Overall Study|Death|10|||
155350512|NCT00957996|560718002|FG000|Overall Study|Lost to Follow-up|4|||
155350513|NCT00957996|560718003|FG001|Overall Study|Lost to Follow-up|7|||
155350514|NCT00957996|560718002|FG000|Overall Study|Withdrawal by Subject|9|||
155350515|NCT00957996|560718003|FG001|Overall Study|Withdrawal by Subject|2|||
155350516|NCT00957996|560718002|FG000|Overall Study|Adverse Event|2|||
155350517|NCT00957996|560718003|FG001|Overall Study|Adverse Event|1|||
155350518|NCT00957996|560718002|FG000|Overall Study|Physician Decision|1|||
155350519|NCT00957996|560718003|FG001|Overall Study|Physician Decision|1|||
155350520|NCT00957996|560718002|FG000|Overall Study|Influenza-related complication|0|||
155350521|NCT00957996|560718003|FG001|Overall Study|Influenza-related complication|1|||
155350522|NCT00957996|560718002|FG000|Overall Study|Missing|1|||
155350523|NCT00957996|560718003|FG001|Overall Study|Missing|0|||
155350524|NCT00957996|560718002|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
155350525|NCT00957996|560718003|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
155350526|NCT00381797|560718011|FG000|Overall Study|Withdrawal by Subject|1|||
155350527|NCT00381797|560718012|FG001|Overall Study|Withdrawal by Subject|1|||
155350528|NCT00381797|560718013|FG002|Overall Study|Withdrawal by Subject|0|||
155350529|NCT00381797|560718014|FG003|Overall Study|Withdrawal by Subject|0|||
155350530|NCT00381797|560718015|FG004|Overall Study|Withdrawal by Subject|2|||
155350531|NCT00381797|560718011|FG000|Overall Study|Ineligible|0|||
155350532|NCT00381797|560718012|FG001|Overall Study|Ineligible|0|||
155350533|NCT00381797|560718013|FG002|Overall Study|Ineligible|0|||
155350534|NCT00381797|560718014|FG003|Overall Study|Ineligible|1|||
155350535|NCT00381797|560718015|FG004|Overall Study|Ineligible|0|||
155350536|NCT00684203|560718016|FG000|Overall Study|Adverse Event|6|||
155350537|NCT00684203|560718017|FG001|Overall Study|Adverse Event|4|||
155350538|NCT00684203|560718018|FG002|Overall Study|Adverse Event|8|||
155350539|NCT00684203|560718019|FG003|Overall Study|Adverse Event|0|||
155350540|NCT00684203|560718020|FG004|Overall Study|Adverse Event|0|||
155350541|NCT00684203|560718021|FG005|Overall Study|Adverse Event|0|||
155350542|NCT00684203|560718016|FG000|Overall Study|Protocol-defined clinical event|3|||
155350543|NCT00684203|560718017|FG001|Overall Study|Protocol-defined clinical event|1|||
155350544|NCT00684203|560718018|FG002|Overall Study|Protocol-defined clinical event|0|||
155350545|NCT00684203|560718019|FG003|Overall Study|Protocol-defined clinical event|0|||
155350546|NCT00684203|560718020|FG004|Overall Study|Protocol-defined clinical event|0|||
155350547|NCT00684203|560718021|FG005|Overall Study|Protocol-defined clinical event|0|||
155350548|NCT00684203|560718016|FG000|Overall Study|Withdrawal by Subject|0|||
155350549|NCT00684203|560718017|FG001|Overall Study|Withdrawal by Subject|2|||
155350550|NCT00684203|560718018|FG002|Overall Study|Withdrawal by Subject|1|||
155350551|NCT00684203|560718019|FG003|Overall Study|Withdrawal by Subject|0|||
155350552|NCT00684203|560718020|FG004|Overall Study|Withdrawal by Subject|0|||
155350553|NCT00684203|560718021|FG005|Overall Study|Withdrawal by Subject|0|||
155350554|NCT00684203|560718016|FG000|Overall Study|Did not meet protocol eligibility|0|||
155350555|NCT00684203|560718017|FG001|Overall Study|Did not meet protocol eligibility|1|||
155350556|NCT00684203|560718018|FG002|Overall Study|Did not meet protocol eligibility|0|||
155350557|NCT00684203|560718019|FG003|Overall Study|Did not meet protocol eligibility|0|||
155350558|NCT00684203|560718020|FG004|Overall Study|Did not meet protocol eligibility|0|||
155350559|NCT00684203|560718021|FG005|Overall Study|Did not meet protocol eligibility|0|||
155350560|NCT01902381|560718024|FG000|Overall Study|Withdrawal by Subject|1|||
155350561|NCT03972137|560718030|FG000|Overall Study|Lost to Follow-up|2|||
155350562|NCT03972137|560718030|FG000|Overall Study|Withdrawal by Subject|4|||
155350563|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
155350564|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
155350565|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
155350566|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
155084270|NCT01772693|559740639|FG000|Overall Study|Alternative Treatment|2|||
155350567|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
155350568|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
155350569|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
155350570|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
155350571|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
155350572|NCT00498433|560718031|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
155350573|NCT00498433|560718032|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
155350574|NCT00498433|560718033|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
155350575|NCT00922441|560718034|FG000|Overall Study|Protocol Violation|0|||
155350576|NCT00922441|560718035|FG001|Overall Study|Protocol Violation|0|||
155350577|NCT00922441|560718036|FG002|Overall Study|Protocol Violation|2|||
155350578|NCT00922441|560718034|FG000|Overall Study|Withdrawal by Subject|0|||
155350579|NCT00922441|560718035|FG001|Overall Study|Withdrawal by Subject|0|||
155350580|NCT00922441|560718036|FG002|Overall Study|Withdrawal by Subject|1|||
155350581|NCT01885936|560718037|FG000|Overall Study|Withdrawal by Subject|1|||
155350582|NCT01885936|560718038|FG001|Overall Study|Withdrawal by Subject|0|||
155350583|NCT00317603|560718039|FG000|Overall Study|Progressive Disease|3|||
155350584|NCT00523549|560718040|FG000|Overall Study|Adverse Event|6|||
155350585|NCT00523549|560718041|FG001|Overall Study|Adverse Event|3|||
155350586|NCT00523549|560718040|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155350587|NCT00523549|560718041|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155350588|NCT00523549|560718040|FG000|Overall Study|Protocol Deviation|3|||
155350589|NCT00523549|560718041|FG001|Overall Study|Protocol Deviation|1|||
155350590|NCT00523549|560718040|FG000|Overall Study|Patient withdrew consent|7|||
155350591|NCT00523549|560718041|FG001|Overall Study|Patient withdrew consent|6|||
155350592|NCT00523549|560718040|FG000|Overall Study|Lost to Follow-up|3|||
155350593|NCT00523549|560718041|FG001|Overall Study|Lost to Follow-up|5|||
155350594|NCT00439647|560718047|FG000|Overall Study|Withdrawal by Subject|25|||
155350595|NCT00439647|560718048|FG001|Overall Study|Withdrawal by Subject|22|||
155350596|NCT00439647|560718047|FG000|Overall Study|Death|15|||
155350597|NCT00439647|560718048|FG001|Overall Study|Death|18|||
155350598|NCT00439647|560718047|FG000|Overall Study|Adverse Event|11|||
155350599|NCT00439647|560718048|FG001|Overall Study|Adverse Event|11|||
155350600|NCT00439647|560718047|FG000|Overall Study|Lost to Follow-up|4|||
155350601|NCT00439647|560718048|FG001|Overall Study|Lost to Follow-up|12|||
155350602|NCT00439647|560718047|FG000|Overall Study|Protocol Violation|3|||
155350603|NCT00439647|560718048|FG001|Overall Study|Protocol Violation|4|||
155350604|NCT00439647|560718047|FG000|Overall Study|Lack of Efficacy|0|||
155350605|NCT00439647|560718048|FG001|Overall Study|Lack of Efficacy|4|||
154964350|NCT04547192|559295246|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
155084271|NCT01772693|559740640|FG001|Overall Study|Alternative Treatment|0|||
155084272|NCT01633112|559740643|FG000|Overall Study|Lack of Efficacy|1|||
155084273|NCT01633112|559740644|FG001|Overall Study|Lack of Efficacy|6|||
155084274|NCT01633112|559740645|FG002|Overall Study|Lack of Efficacy|13|||
155084275|NCT01633112|559740643|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155084276|NCT01633112|559740644|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155350606|NCT00843115|560718049|FG000|Overall Study|Death|4|||
155350607|NCT00843115|560718049|FG000|Overall Study|Adverse Event|30|||
155350608|NCT00843115|560718049|FG000|Overall Study|Lost to Follow-up|4|||
155350609|NCT00843115|560718049|FG000|Overall Study|Withdrawal by Subject|17|||
155350610|NCT00843115|560718049|FG000|Overall Study|Family wanted meds stopped|1|||
155350611|NCT00843115|560718049|FG000|Overall Study|Family does not want continuation|1|||
155350612|NCT00843115|560718049|FG000|Overall Study|Patient forgot to take meds|1|||
155350613|NCT00843115|560718049|FG000|Overall Study|Does not meet entrance criteria|1|||
155084277|NCT01633112|559740645|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155084278|NCT01633112|559740643|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155350614|NCT00843115|560718049|FG000|Overall Study|Physician Decision|1|||
155350615|NCT00843115|560718049|FG000|Overall Study|Family discontinued meds|1|||
155350616|NCT00843115|560718049|FG000|Overall Study|patient took for 2 days then stopped|1|||
155350617|NCT00843115|560718049|FG000|Overall Study|patient never took the medication|1|||
155350618|NCT00843115|560718049|FG000|Overall Study|hospitalized due to deterioration|1|||
155350619|NCT00843115|560718049|FG000|Overall Study|week 12 not done|1|||
155350620|NCT00843115|560718049|FG000|Overall Study|Syndrome De Glissement|1|||
155350621|NCT02845375|560718050|FG000|Overall Study|upper airway obstruction|1|||
155350622|NCT02845375|560718051|FG001|Overall Study|upper airway obstruction|2|||
155350623|NCT02845375|560718052|FG002|Overall Study|upper airway obstruction|1|||
155350624|NCT00677092|560718059|FG000|Overall Study|Adverse Event|1|||
154964351|NCT04547192|559295247|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
155084279|NCT01633112|559740644|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155084280|NCT01633112|559740645|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155084281|NCT01633112|559740643|FG000|Overall Study|Administrative problems|1|||
155084282|NCT01633112|559740644|FG001|Overall Study|Administrative problems|2|||
155084283|NCT01633112|559740645|FG002|Overall Study|Administrative problems|5|||
155084284|NCT01633112|559740643|FG000|Overall Study|Adverse Event|16|||
155084285|NCT01633112|559740644|FG001|Overall Study|Adverse Event|18|||
155084286|NCT01633112|559740645|FG002|Overall Study|Adverse Event|20|||
155350625|NCT00677092|560718059|FG000|Overall Study|Lost to Follow-up|1|||
155350626|NCT00677092|560718059|FG000|Overall Study|Withdrawal by Subject|3|||
155350627|NCT00677092|560718059|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
155350628|NCT02460562|560718061|FG000|Overall Study|Lost to Follow-up|15|||
155350629|NCT02460562|560718062|FG001|Overall Study|Lost to Follow-up|16|||
155350630|NCT04194541|560718063|FG000|Day 1 Through 13|Lost to Follow-up|3|||
155350631|NCT04194541|560718063|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
155350632|NCT04194541|560718063|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
155350633|NCT02642159|560718064|FG000|Overall Study|Randomized but not treated|1|||
155350634|NCT02642159|560718065|FG001|Overall Study|Randomized but not treated|0|||
155350635|NCT02642159|560718064|FG000|Overall Study|Adverse Event|10|||
155350636|NCT02642159|560718065|FG001|Overall Study|Adverse Event|4|||
155350637|NCT02642159|560718064|FG000|Overall Study|Withdrawal by Subject|9|||
155350638|NCT02642159|560718065|FG001|Overall Study|Withdrawal by Subject|1|||
155350639|NCT02642159|560718064|FG000|Overall Study|Poor compliance to study protocol|1|||
155350640|NCT02642159|560718065|FG001|Overall Study|Poor compliance to study protocol|0|||
155350641|NCT02642159|560718064|FG000|Overall Study|Other than specified above|10|||
155350642|NCT02642159|560718065|FG001|Overall Study|Other than specified above|3|||
155350643|NCT01951261|560718066|FG000|Overall Study|Death|1|||
155350644|NCT01951261|560718067|FG001|Overall Study|Death|0|||
155350645|NCT01951261|560718066|FG000|Overall Study|Lost to Follow-up|4|||
155350646|NCT01951261|560718067|FG001|Overall Study|Lost to Follow-up|3|||
155350647|NCT01951261|560718066|FG000|Overall Study|Protocol Violation|4|||
155350648|NCT01951261|560718067|FG001|Overall Study|Protocol Violation|3|||
155350649|NCT03927222|560718071|FG000|Overall Study|Progression|3|||
155350650|NCT03927222|560718071|FG000|Overall Study|CMV testing results inconclusive|1|||
155350651|NCT03927222|560718071|FG000|Overall Study|Unable to generate enough vaccines|1|||
155350652|NCT03927222|560718071|FG000|Overall Study|Early study termination|1|||
155350653|NCT03723915|560718075|FG000|Screening|Failed to meet screening requirements.|2|||
155350654|NCT03723915|560718075|FG000|On Treatment|Failed to meet treatment requirements|2|||
155084287|NCT01633112|559740643|FG000|Overall Study|Lost to Follow-up|7|||
155084288|NCT01633112|559740644|FG001|Overall Study|Lost to Follow-up|19|||
155350655|NCT00297778|560718076|FG000|Overall Study|Adverse Event|16|||
155350656|NCT00297778|560718077|FG001|Overall Study|Adverse Event|10|||
155350657|NCT00297778|560718076|FG000|Overall Study|Withdrawal by Subject|1|||
155350658|NCT00297778|560718077|FG001|Overall Study|Withdrawal by Subject|5|||
155084289|NCT01633112|559740645|FG002|Overall Study|Lost to Follow-up|6|||
155084290|NCT01633112|559740643|FG000|Overall Study|Protocol Violation|4|||
155084291|NCT01633112|559740644|FG001|Overall Study|Protocol Violation|0|||
155084292|NCT01633112|559740645|FG002|Overall Study|Protocol Violation|2|||
155084293|NCT01633112|559740643|FG000|Overall Study|Subject no longer requires study drug|0|||
155350659|NCT00297778|560718076|FG000|Overall Study|Lack of Efficacy|2|||
155350660|NCT00297778|560718077|FG001|Overall Study|Lack of Efficacy|1|||
155350661|NCT00297778|560718076|FG000|Overall Study|Non-compliant with trial protocol|0|||
155350662|NCT00297778|560718077|FG001|Overall Study|Non-compliant with trial protocol|3|||
155350663|NCT00297778|560718076|FG000|Overall Study|Other|0|||
155084294|NCT01633112|559740644|FG001|Overall Study|Subject no longer requires study drug|0|||
155084295|NCT01633112|559740645|FG002|Overall Study|Subject no longer requires study drug|1|||
155084296|NCT01633112|559740643|FG000|Overall Study|Withdrawal by Subject|20|||
155084297|NCT01633112|559740644|FG001|Overall Study|Withdrawal by Subject|12|||
155084298|NCT01633112|559740645|FG002|Overall Study|Withdrawal by Subject|41|||
155084299|NCT01633112|559740643|FG000|Overall Study|missing Study Completion CRF|1|||
155084300|NCT01633112|559740644|FG001|Overall Study|missing Study Completion CRF|1|||
155084301|NCT01633112|559740645|FG002|Overall Study|missing Study Completion CRF|4|||
155084302|NCT02605967|559740654|FG000|Overall Study|subject / guardian decision|1|||
155084303|NCT02605967|559740655|FG001|Overall Study|subject / guardian decision|2|||
155084304|NCT02605967|559740654|FG000|Overall Study|Physician Decision|10|||
155084305|NCT02605967|559740655|FG001|Overall Study|Physician Decision|1|||
155084306|NCT02605967|559740654|FG000|Overall Study|Death|4|||
155084307|NCT02605967|559740655|FG001|Overall Study|Death|2|||
155084308|NCT02605967|559740654|FG000|Overall Study|Adverse Event|1|||
155084309|NCT02605967|559740655|FG001|Overall Study|Adverse Event|0|||
155084310|NCT02605967|559740654|FG000|Overall Study|progressive disease|66|||
155084311|NCT02605967|559740655|FG001|Overall Study|progressive disease|35|||
155084312|NCT05122143|559740661|FG000|Overall Study|Adverse Event|1|||
155084313|NCT05122143|559740662|FG001|Overall Study|Adverse Event|0|||
155084314|NCT05122143|559740663|FG002|Overall Study|Adverse Event|0|||
155084315|NCT05122143|559740664|FG003|Overall Study|Adverse Event|0|||
155084316|NCT05122143|559740665|FG004|Overall Study|Adverse Event|1|||
155084317|NCT05122143|559740666|FG005|Overall Study|Adverse Event|0|||
155084318|NCT05122143|559740661|FG000|Overall Study|Protocol non-compliance|0|||
155084319|NCT05122143|559740662|FG001|Overall Study|Protocol non-compliance|0|||
155084320|NCT05122143|559740663|FG002|Overall Study|Protocol non-compliance|1|||
155084321|NCT05122143|559740664|FG003|Overall Study|Protocol non-compliance|0|||
155084322|NCT05122143|559740665|FG004|Overall Study|Protocol non-compliance|0|||
155084323|NCT05122143|559740666|FG005|Overall Study|Protocol non-compliance|0|||
155084324|NCT05122143|559740661|FG000|Overall Study|Covid contact|0|||
155084325|NCT05122143|559740662|FG001|Overall Study|Covid contact|0|||
155084326|NCT05122143|559740663|FG002|Overall Study|Covid contact|0|||
155084327|NCT05122143|559740664|FG003|Overall Study|Covid contact|0|||
155084328|NCT05122143|559740665|FG004|Overall Study|Covid contact|1|||
155084329|NCT05122143|559740666|FG005|Overall Study|Covid contact|0|||
155084330|NCT01475825|559740667|FG000|Overall Study|Adverse Event|41|||
155084331|NCT01475825|559740668|FG001|Overall Study|Adverse Event|15|||
155084332|NCT01475825|559740669|FG002|Overall Study|Adverse Event|27|||
155084333|NCT01475825|559740670|FG003|Overall Study|Adverse Event|11|||
155084334|NCT01475825|559740667|FG000|Overall Study|Death|1|||
155084335|NCT01475825|559740668|FG001|Overall Study|Death|0|||
155084336|NCT01475825|559740669|FG002|Overall Study|Death|1|||
155084337|NCT01475825|559740670|FG003|Overall Study|Death|0|||
155084338|NCT01475825|559740667|FG000|Overall Study|Lack of Efficacy|0|||
155084339|NCT01475825|559740668|FG001|Overall Study|Lack of Efficacy|0|||
155084340|NCT01475825|559740669|FG002|Overall Study|Lack of Efficacy|1|||
155084341|NCT01475825|559740670|FG003|Overall Study|Lack of Efficacy|0|||
155084342|NCT01475825|559740667|FG000|Overall Study|Lost to Follow-up|0|||
155350664|NCT00297778|560718077|FG001|Overall Study|Other|1|||
155350665|NCT02201771|560718078|FG000|Overall Study|Death|3|||
155350666|NCT02201771|560718079|FG001|Overall Study|Death|2|||
155350667|NCT02201771|560718080|FG002|Overall Study|Death|0|||
155350668|NCT02201771|560718078|FG000|Overall Study|Protocol Violation|10|||
155350669|NCT02201771|560718079|FG001|Overall Study|Protocol Violation|8|||
155350670|NCT02201771|560718080|FG002|Overall Study|Protocol Violation|10|||
155350671|NCT00583115|560718081|FG000|Overall Study|Death|1|||
155350672|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
155084343|NCT01475825|559740668|FG001|Overall Study|Lost to Follow-up|0|||
155084344|NCT01475825|559740669|FG002|Overall Study|Lost to Follow-up|3|||
155350673|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
155084345|NCT01475825|559740670|FG003|Overall Study|Lost to Follow-up|1|||
155084346|NCT01475825|559740667|FG000|Overall Study|Non-compliance with Study Drug|1|||
155084347|NCT01475825|559740668|FG001|Overall Study|Non-compliance with Study Drug|2|||
155084348|NCT01475825|559740669|FG002|Overall Study|Non-compliance with Study Drug|4|||
155084349|NCT01475825|559740670|FG003|Overall Study|Non-compliance with Study Drug|0|||
155084350|NCT01475825|559740667|FG000|Overall Study|Other: Not available|0|||
155084351|NCT01475825|559740668|FG001|Overall Study|Other: Not available|0|||
155084352|NCT01475825|559740669|FG002|Overall Study|Other: Not available|2|||
155084353|NCT01475825|559740670|FG003|Overall Study|Other: Not available|0|||
155084354|NCT01475825|559740667|FG000|Overall Study|Protocol Violation|1|||
155084355|NCT01475825|559740668|FG001|Overall Study|Protocol Violation|0|||
155350674|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
155350675|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
155350676|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
155084356|NCT01475825|559740669|FG002|Overall Study|Protocol Violation|0|||
155084357|NCT01475825|559740670|FG003|Overall Study|Protocol Violation|0|||
155084358|NCT01475825|559740667|FG000|Overall Study|Physician Decision|0|||
155084359|NCT01475825|559740668|FG001|Overall Study|Physician Decision|1|||
155350677|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
155084360|NCT01475825|559740669|FG002|Overall Study|Physician Decision|0|||
155084361|NCT01475825|559740670|FG003|Overall Study|Physician Decision|0|||
155084362|NCT01475825|559740667|FG000|Overall Study|Withdrawal by Subject|8|||
155084363|NCT01475825|559740668|FG001|Overall Study|Withdrawal by Subject|3|||
155084364|NCT01475825|559740669|FG002|Overall Study|Withdrawal by Subject|11|||
155084365|NCT01475825|559740670|FG003|Overall Study|Withdrawal by Subject|7|||
155084366|NCT01475825|559740667|FG000|Overall Study|Did not enter OLC|15|||
155084367|NCT01475825|559740668|FG001|Overall Study|Did not enter OLC|11|||
155084368|NCT01475825|559740669|FG002|Overall Study|Did not enter OLC|15|||
155084369|NCT01475825|559740670|FG003|Overall Study|Did not enter OLC|11|||
155084370|NCT04157738|559740671|FG000|Overall Study|Moved out of state|0|||
155084371|NCT04157738|559740672|FG001|Overall Study|Moved out of state|2|||
155084372|NCT04157738|559740671|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
155084373|NCT04157738|559740672|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
155084374|NCT00160563|559740673|FG000|Overall Study|Adverse Event|1|||
155084375|NCT00160563|559740674|FG001|Overall Study|Adverse Event|1|||
155084376|NCT00160563|559740675|FG002|Overall Study|Adverse Event|1|||
155084377|NCT00160563|559740673|FG000|Overall Study|Lost to Follow-up|1|||
155084378|NCT00160563|559740674|FG001|Overall Study|Lost to Follow-up|1|||
155084379|NCT00160563|559740675|FG002|Overall Study|Lost to Follow-up|2|||
155350678|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
155350679|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
155350680|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
155350681|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
155350682|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
155350683|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
155350684|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
155350685|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
155350686|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
155350687|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
155350688|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
155350689|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
155350690|NCT03569475|560718082|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
155350691|NCT03569475|560718083|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
155350692|NCT03569475|560718084|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
155350693|NCT03569475|560718082|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
155350694|NCT03569475|560718083|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
155350695|NCT03569475|560718084|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
155350696|NCT03569475|560718082|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
155350697|NCT03569475|560718083|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
155350698|NCT03569475|560718084|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
155350699|NCT02383927|560718091|FG000|Overall Study|Disease Progression|8|||
155350700|NCT02383927|560718092|FG001|Overall Study|Disease Progression|8|||
155350701|NCT02383927|560718093|FG002|Overall Study|Disease Progression|15|||
155350702|NCT02383927|560718094|FG003|Overall Study|Disease Progression|4|||
155350703|NCT02383927|560718091|FG000|Overall Study|Physician Decision|0|||
155350704|NCT02383927|560718092|FG001|Overall Study|Physician Decision|0|||
155350705|NCT02383927|560718093|FG002|Overall Study|Physician Decision|2|||
155350706|NCT02383927|560718094|FG003|Overall Study|Physician Decision|0|||
155350707|NCT02383927|560718091|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
155350708|NCT02383927|560718092|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
155084380|NCT00160563|559740673|FG000|Overall Study|Protocol Violation|0|||
155084381|NCT00160563|559740674|FG001|Overall Study|Protocol Violation|0|||
155350709|NCT02383927|560718093|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
155350710|NCT02383927|560718094|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
155084382|NCT00160563|559740675|FG002|Overall Study|Protocol Violation|3|||
155084383|NCT00160563|559740673|FG000|Overall Study|Withdrawal by Subject|1|||
155084384|NCT00160563|559740674|FG001|Overall Study|Withdrawal by Subject|2|||
155084385|NCT00160563|559740675|FG002|Overall Study|Withdrawal by Subject|3|||
155084386|NCT00160563|559740673|FG000|Overall Study|Other (listed in the study report)|48|||
155084387|NCT00160563|559740674|FG001|Overall Study|Other (listed in the study report)|40|||
155084388|NCT00160563|559740675|FG002|Overall Study|Other (listed in the study report)|81|||
155350711|NCT02383927|560718091|FG000|Overall Study|Adverse Event|4|||
155350712|NCT02383927|560718092|FG001|Overall Study|Adverse Event|1|||
155350713|NCT02383927|560718093|FG002|Overall Study|Adverse Event|3|||
155350714|NCT02383927|560718094|FG003|Overall Study|Adverse Event|5|||
155350715|NCT02383927|560718091|FG000|Overall Study|Miscellaneous|1|||
155350716|NCT02383927|560718092|FG001|Overall Study|Miscellaneous|0|||
155350717|NCT02383927|560718093|FG002|Overall Study|Miscellaneous|0|||
155350718|NCT02383927|560718094|FG003|Overall Study|Miscellaneous|1|||
155350719|NCT02383927|560718091|FG000|Overall Study|Withdrawal by Subject|0|||
155350720|NCT02383927|560718092|FG001|Overall Study|Withdrawal by Subject|1|||
155350721|NCT02383927|560718093|FG002|Overall Study|Withdrawal by Subject|4|||
155350722|NCT02383927|560718094|FG003|Overall Study|Withdrawal by Subject|0|||
155350723|NCT00734851|560718095|FG000|Overall Study|Withdrawal by Subject|2|||
155350724|NCT00734851|560718095|FG000|Overall Study|Lost to Follow-up|1|||
155350725|NCT00734851|560718095|FG000|Overall Study|Physician Decision|18|||
155350726|NCT03613454|560718098|FG000|Overall Study|Protocol Violation|1|||
155350727|NCT03613454|560718099|FG001|Overall Study|Protocol Violation|0|||
155350728|NCT03613454|560718098|FG000|Overall Study|Protocol Violation|0|||
155350729|NCT03613454|560718099|FG001|Overall Study|Protocol Violation|1|||
155350730|NCT00464737|560718101|FG000|Overall Study|Adverse Event|12|||
155350731|NCT00464737|560718102|FG001|Overall Study|Adverse Event|17|||
155350732|NCT00464737|560718103|FG002|Overall Study|Adverse Event|33|||
155350733|NCT00464737|560718101|FG000|Overall Study|Lack of Efficacy|7|||
155350734|NCT00464737|560718102|FG001|Overall Study|Lack of Efficacy|7|||
155350735|NCT00464737|560718103|FG002|Overall Study|Lack of Efficacy|4|||
155350736|NCT00464737|560718101|FG000|Overall Study|Withdrawal by Subject|5|||
155350737|NCT00464737|560718102|FG001|Overall Study|Withdrawal by Subject|3|||
155350738|NCT00464737|560718103|FG002|Overall Study|Withdrawal by Subject|5|||
155350739|NCT00464737|560718101|FG000|Overall Study|Protocol Violation|1|||
155350740|NCT00464737|560718102|FG001|Overall Study|Protocol Violation|1|||
155350741|NCT00464737|560718103|FG002|Overall Study|Protocol Violation|5|||
155350742|NCT00464737|560718101|FG000|Overall Study|Non-compliance|0|||
155350743|NCT00464737|560718102|FG001|Overall Study|Non-compliance|1|||
155350744|NCT00464737|560718103|FG002|Overall Study|Non-compliance|1|||
155350745|NCT00464737|560718101|FG000|Overall Study|Lost to Follow-up|5|||
155350746|NCT00464737|560718102|FG001|Overall Study|Lost to Follow-up|2|||
155084389|NCT00160563|559740673|FG000|Overall Study|Missing reason|0|||
155084390|NCT00160563|559740674|FG001|Overall Study|Missing reason|1|||
155084391|NCT00160563|559740675|FG002|Overall Study|Missing reason|0|||
155084392|NCT00309946|559740676|FG000|Overall Study|Withdrawal by Subject|1|||
155084393|NCT02244957|559740680|FG000|Overall Study|Lack of Efficacy|1|||
155084394|NCT02244957|559740681|FG001|Overall Study|Lack of Efficacy|0|||
155084395|NCT00395447|559740685|FG000|Overall Study|Death|37|||
155084396|NCT00395447|559740686|FG001|Overall Study|Death|32|||
155084397|NCT00395447|559740685|FG000|Overall Study|Lost to Follow-up|52|||
155084398|NCT00395447|559740686|FG001|Overall Study|Lost to Follow-up|43|||
155084399|NCT00395447|559740685|FG000|Overall Study|Withdrawal by Subject|24|||
155084400|NCT00395447|559740686|FG001|Overall Study|Withdrawal by Subject|19|||
155084401|NCT00395447|559740685|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
155084402|NCT00395447|559740686|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
155350747|NCT00464737|560718103|FG002|Overall Study|Lost to Follow-up|5|||
155350748|NCT00464737|560718101|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
155350749|NCT00464737|560718102|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
155350750|NCT00464737|560718103|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
155350751|NCT00464737|560718101|FG000|Overall Study|Other: Subject left town; family illness|1|||
155350752|NCT00464737|560718102|FG001|Overall Study|Other: Subject left town; family illness|0|||
155350753|NCT00464737|560718103|FG002|Overall Study|Other: Subject left town; family illness|0|||
155350754|NCT00464737|560718101|FG000|Overall Study|Other: Study demands too great|0|||
155350755|NCT00464737|560718102|FG001|Overall Study|Other: Study demands too great|1|||
155350756|NCT00464737|560718103|FG002|Overall Study|Other: Study demands too great|0|||
155350757|NCT00464737|560718101|FG000|Overall Study|Other: Personal family reasons|0|||
155350758|NCT00464737|560718102|FG001|Overall Study|Other: Personal family reasons|0|||
155350759|NCT00464737|560718103|FG002|Overall Study|Other: Personal family reasons|1|||
155350760|NCT00464737|560718101|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
155350761|NCT00464737|560718102|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
155350762|NCT00464737|560718103|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
155350763|NCT01894256|560718106|FG000|Part A|Adverse Event|0|||
155350764|NCT01894256|560718107|FG001|Part A|Adverse Event|1|||
155350765|NCT01894256|560718108|FG002|Part A|Adverse Event|0|||
155350766|NCT01894256|560718106|FG000|Part B|Death|0|||
155084403|NCT03766906|559740687|FG000|Overall Study|Withdrawal by Subject|6|||
155084404|NCT01437189|559740694|FG000|Overall Study|Adverse Event|3|||
155084405|NCT01437189|559740694|FG000|Overall Study|Lack of Efficacy|4|||
155084406|NCT01437189|559740694|FG000|Overall Study|Withdrawal by Subject|8|||
155084407|NCT01689649|559740695|FG000|Overall Study|Lack of Efficacy|3|||
155084408|NCT01689649|559740695|FG000|Overall Study|Non-compliance|11|||
155084409|NCT01689649|559740695|FG000|Overall Study|Protocol Violation|3|||
155350767|NCT01894256|560718107|FG001|Part B|Death|1|||
155350768|NCT01894256|560718108|FG002|Part B|Death|1|||
155350769|NCT01894256|560718106|FG000|Part B|Withdrawal by Subject|0|||
155350770|NCT01894256|560718107|FG001|Part B|Withdrawal by Subject|1|||
155350771|NCT01894256|560718108|FG002|Part B|Withdrawal by Subject|0|||
155350772|NCT01894256|560718106|FG000|Part B|Lack of Efficacy|15|||
155350773|NCT01894256|560718107|FG001|Part B|Lack of Efficacy|12|||
155350774|NCT01894256|560718108|FG002|Part B|Lack of Efficacy|13|||
155350775|NCT01780584|560718109|FG000|Overall Study|Death|1|||
155350776|NCT01780584|560718110|FG001|Overall Study|Death|0|||
155350777|NCT01780584|560718111|FG002|Overall Study|Death|1|||
155350778|NCT01780584|560718109|FG000|Overall Study|Adverse Event|0|||
155350779|NCT01780584|560718110|FG001|Overall Study|Adverse Event|1|||
155350780|NCT01780584|560718111|FG002|Overall Study|Adverse Event|0|||
155350781|NCT01780584|560718109|FG000|Overall Study|Protocol Violation|0|||
155350782|NCT01780584|560718110|FG001|Overall Study|Protocol Violation|0|||
155350783|NCT01780584|560718111|FG002|Overall Study|Protocol Violation|1|||
155350784|NCT01544153|560718119|FG000|Overall Study|Under 18|0|||
155350785|NCT01544153|560718120|FG001|Overall Study|Under 18|1|||
155350786|NCT01544153|560718121|FG002|Overall Study|Under 18|0|||
155350787|NCT01544153|560718122|FG003|Overall Study|Under 18|0|||
155350788|NCT01544153|560718119|FG000|Overall Study|Non-smoker|0|||
155350789|NCT01544153|560718120|FG001|Overall Study|Non-smoker|0|||
155350790|NCT01544153|560718121|FG002|Overall Study|Non-smoker|1|||
155350791|NCT01544153|560718122|FG003|Overall Study|Non-smoker|0|||
155350792|NCT00390806|560718127|FG000|Overall Study|Lost to Follow-up|7|||
155350793|NCT00390806|560718128|FG001|Overall Study|Lost to Follow-up|6|||
155350794|NCT00390806|560718127|FG000|Overall Study|Protocol Violation|2|||
155350795|NCT00390806|560718128|FG001|Overall Study|Protocol Violation|2|||
155350796|NCT00390806|560718127|FG000|Overall Study|Withdrawal by Subject|12|||
155350797|NCT00390806|560718128|FG001|Overall Study|Withdrawal by Subject|15|||
155350798|NCT00390806|560718127|FG000|Overall Study|Investigator Decision|4|||
155084410|NCT01689649|559740695|FG000|Overall Study|Lost to Follow-up|5|||
155084411|NCT04064567|559740699|FG000|Overall Study|Lost to Follow-up|23|||
155084412|NCT04064567|559740700|FG001|Overall Study|Lost to Follow-up|22|||
155084413|NCT04064567|559740699|FG000|Overall Study|Withdrawal by Subject|0|||
155350799|NCT00390806|560718128|FG001|Overall Study|Investigator Decision|6|||
155350800|NCT00390806|560718127|FG000|Overall Study|Death|1|||
155084414|NCT04064567|559740700|FG001|Overall Study|Withdrawal by Subject|1|||
155084415|NCT04064567|559740699|FG000|Overall Study|Reincarcerated|7|||
155350801|NCT00390806|560718128|FG001|Overall Study|Death|0|||
155350802|NCT00390806|560718127|FG000|Overall Study|Physician Decision|0|||
155350803|NCT00390806|560718128|FG001|Overall Study|Physician Decision|1|||
155350804|NCT00390806|560718127|FG000|Overall Study|Ongoing|4|||
155350805|NCT00390806|560718128|FG001|Overall Study|Ongoing|2|||
155350806|NCT00884793|560718131|FG000|Overall Study|Withdrawal by Subject|1|||
155350807|NCT03169530|560718132|FG000|Overall Study|Study ended by NIH|15|||
155350808|NCT03169530|560718133|FG001|Overall Study|Study ended by NIH|17|||
155350809|NCT04783519|560718134|FG000|Overall Study|Withdrawal by Subject|2|||
155350810|NCT04783519|560718135|FG001|Overall Study|Withdrawal by Subject|7|||
155350811|NCT04783519|560718136|FG002|Overall Study|Withdrawal by Subject|3|||
155350812|NCT04783519|560718134|FG000|Overall Study|Lost to Follow-up|9|||
155350813|NCT04783519|560718135|FG001|Overall Study|Lost to Follow-up|7|||
155350814|NCT04783519|560718136|FG002|Overall Study|Lost to Follow-up|6|||
155350815|NCT01032200|560718137|FG000|Overall Study|Death|1|||
155350816|NCT01032200|560718138|FG001|Overall Study|Death|1|||
155350817|NCT01032200|560718137|FG000|Overall Study|Withdrawal by Subject|1|||
155084416|NCT04064567|559740700|FG001|Overall Study|Reincarcerated|10|||
155350818|NCT01032200|560718138|FG001|Overall Study|Withdrawal by Subject|3|||
155350819|NCT01032200|560718137|FG000|Overall Study|Toxicity|0|||
155350820|NCT01032200|560718138|FG001|Overall Study|Toxicity|2|||
155350821|NCT01032200|560718137|FG000|Overall Study|Progression|1|||
155350822|NCT01032200|560718138|FG001|Overall Study|Progression|0|||
155350823|NCT01032200|560718137|FG000|Overall Study|Multiple|1|||
155350824|NCT01032200|560718138|FG001|Overall Study|Multiple|1|||
155350825|NCT00727259|560718142|FG000|Overall Study|Not all questionnaires completed|1055|||
155350826|NCT01021683|560718143|FG000|Overall Study|Lack of Efficacy|12|||
155084417|NCT04064567|559740699|FG000|Overall Study|Moved out of U.S.|0|||
155084418|NCT04064567|559740700|FG001|Overall Study|Moved out of U.S.|1|||
155084419|NCT03464461|559740701|FG000|Overall Study|exclusionary medication given ,|1|||
155350827|NCT01021683|560718143|FG000|Overall Study|Recovery of neutrophil count|51|||
155350828|NCT01021683|560718143|FG000|Overall Study|Other|8|||
155350829|NCT02273180|560718144|FG000|Overall Study|Adverse Event|2|||
155350830|NCT02273180|560718145|FG001|Overall Study|Adverse Event|2|||
155350831|NCT02273180|560718144|FG000|Overall Study|Lack of Efficacy|1|||
155350832|NCT02273180|560718145|FG001|Overall Study|Lack of Efficacy|0|||
155350833|NCT02273180|560718144|FG000|Overall Study|Protocol Violation|1|||
155350834|NCT02273180|560718145|FG001|Overall Study|Protocol Violation|7|||
155350835|NCT02273180|560718144|FG000|Overall Study|Randomized but not treated|1|||
155350836|NCT02273180|560718145|FG001|Overall Study|Randomized but not treated|0|||
155350837|NCT02273180|560718144|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
155084420|NCT03464461|559740702|FG001|Overall Study|exclusionary medication given ,|2|||
155084421|NCT03464461|559740703|FG002|Overall Study|exclusionary medication given ,|0|||
155084422|NCT03464461|559740701|FG000|Overall Study|Physician Decision|0|||
155084423|NCT03464461|559740702|FG001|Overall Study|Physician Decision|1|||
155084424|NCT03464461|559740703|FG002|Overall Study|Physician Decision|0|||
155084425|NCT05524948|559740704|FG000|Overall Study|Withdrawal by Subject|1|||
155084426|NCT05524948|559740705|FG001|Overall Study|Withdrawal by Subject|0|||
155084427|NCT05524948|559740704|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
155084428|NCT05524948|559740705|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
155084429|NCT05463952|559740706|FG000|Treatment|Progressive disease|4|||
155084430|NCT05463952|559740706|FG000|Treatment|Ongoing|2|||
155084431|NCT03211832|559740710|FG000|Overall Study|No longer with agency|32|||
155084432|NCT03211832|559740711|FG001|Overall Study|No longer with agency|49|||
155084433|NCT03211832|559740712|FG002|Overall Study|No longer with agency|30|||
155350838|NCT02273180|560718145|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
155350839|NCT02273180|560718144|FG000|Overall Study|Other than specified above|21|||
155350840|NCT02273180|560718145|FG001|Overall Study|Other than specified above|10|||
155350841|NCT00645099|560718146|FG000|Overall Study|Lack of Efficacy|15|||
155350842|NCT00645099|560718147|FG001|Overall Study|Lack of Efficacy|6|||
155350843|NCT00645099|560718146|FG000|Overall Study|Withdrawal by Subject|30|||
155350844|NCT00645099|560718147|FG001|Overall Study|Withdrawal by Subject|22|||
155350845|NCT00645099|560718146|FG000|Overall Study|Lost to Follow-up|6|||
155350846|NCT00645099|560718147|FG001|Overall Study|Lost to Follow-up|4|||
155350847|NCT00645099|560718146|FG000|Overall Study|Adverse Event|11|||
155350848|NCT00645099|560718147|FG001|Overall Study|Adverse Event|5|||
155084434|NCT03211832|559740710|FG000|Overall Study|Declined survey|3|||
155084435|NCT03211832|559740711|FG001|Overall Study|Declined survey|3|||
155084436|NCT03211832|559740712|FG002|Overall Study|Declined survey|2|||
155084437|NCT03211832|559740710|FG000|Overall Study|Not available during data collection|1|||
155084438|NCT03211832|559740711|FG001|Overall Study|Not available during data collection|0|||
155084439|NCT03211832|559740712|FG002|Overall Study|Not available during data collection|2|||
155084440|NCT02913326|559740713|FG000|Overall Study|Reason not listed|0|||
155084441|NCT02913326|559740714|FG001|Overall Study|Reason not listed|1|||
155084442|NCT02913326|559740713|FG000|Overall Study|Lost to Follow-up|0|||
155084443|NCT02913326|559740714|FG001|Overall Study|Lost to Follow-up|1|||
155084444|NCT02913326|559740713|FG000|Overall Study|Adverse Event|1|||
155084445|NCT02913326|559740714|FG001|Overall Study|Adverse Event|0|||
155084446|NCT01421459|559740715|FG000|Overall Study|Adverse Event|6|||
155084447|NCT01421459|559740716|FG001|Overall Study|Adverse Event|10|||
155084448|NCT01421459|559740715|FG000|Overall Study|Death|1|||
155084449|NCT01421459|559740716|FG001|Overall Study|Death|1|||
155084450|NCT01421459|559740715|FG000|Overall Study|Lack of Efficacy|1|||
155084451|NCT01421459|559740716|FG001|Overall Study|Lack of Efficacy|2|||
155350849|NCT00645099|560718146|FG000|Overall Study|Other|9|||
155350850|NCT00645099|560718147|FG001|Overall Study|Other|5|||
155350851|NCT01201915|560718148|FG000|Overall Study|Adverse Event|2|||
155350852|NCT01201915|560718149|FG001|Overall Study|Adverse Event|1|||
155084452|NCT01421459|559740715|FG000|Overall Study|Lost to Follow-up|8|||
155084453|NCT01421459|559740716|FG001|Overall Study|Lost to Follow-up|9|||
155084454|NCT01421459|559740715|FG000|Overall Study|Physician Decision|9|||
155084455|NCT01421459|559740716|FG001|Overall Study|Physician Decision|9|||
155084456|NCT01421459|559740715|FG000|Overall Study|Protocol Violation|8|||
155084457|NCT01421459|559740716|FG001|Overall Study|Protocol Violation|5|||
155084458|NCT01421459|559740715|FG000|Overall Study|Withdrawal by Subject|12|||
155084459|NCT01421459|559740716|FG001|Overall Study|Withdrawal by Subject|16|||
155350853|NCT01201915|560718150|FG002|Overall Study|Adverse Event|1|||
155350854|NCT01201915|560718148|FG000|Overall Study|Lost to Follow-up|0|||
155084460|NCT01422382|559740717|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
155084461|NCT00231465|559740725|FG000|Overall Study|Completed only one cycle|1|||
155350855|NCT01201915|560718149|FG001|Overall Study|Lost to Follow-up|4|||
155350856|NCT01201915|560718150|FG002|Overall Study|Lost to Follow-up|0|||
155350857|NCT01201915|560718148|FG000|Overall Study|Physician Decision|3|||
155350858|NCT01201915|560718149|FG001|Overall Study|Physician Decision|0|||
155350859|NCT01201915|560718150|FG002|Overall Study|Physician Decision|0|||
155350860|NCT01201915|560718148|FG000|Overall Study|Subject Decision|3|||
155350861|NCT01201915|560718149|FG001|Overall Study|Subject Decision|3|||
155350862|NCT01201915|560718150|FG002|Overall Study|Subject Decision|5|||
155350863|NCT01201915|560718148|FG000|Overall Study|Target Lesion Progression|0|||
155350864|NCT01201915|560718149|FG001|Overall Study|Target Lesion Progression|3|||
155350865|NCT01201915|560718150|FG002|Overall Study|Target Lesion Progression|0|||
155350866|NCT02316171|560718153|FG000|Overall Study|difficulties with urinary catheter|1|||
155350867|NCT02316171|560718154|FG001|Overall Study|difficulties with urinary catheter|0|||
155350868|NCT02316171|560718155|FG002|Overall Study|difficulties with urinary catheter|0|||
155350869|NCT02316171|560718156|FG003|Overall Study|difficulties with urinary catheter|0|||
155350870|NCT04130061|560718157|FG000|Overall Study|OR team forgot to request membrane|1|||
155350871|NCT04130061|560718158|FG001|Overall Study|OR team forgot to request membrane|0|||
155350872|NCT03449134|560719785|FG000|52-Week Treatment Period|Death|2|||
155350873|NCT03449134|560719786|FG001|52-Week Treatment Period|Death|1|||
155350874|NCT03449134|560719787|FG002|52-Week Treatment Period|Death|0|||
155350875|NCT03449134|560719785|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
155350876|NCT03449134|560719786|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
155350877|NCT03449134|560719787|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
155350878|NCT03449134|560719785|FG000|52-Week Treatment Period|Physician Decision|2|||
155350879|NCT03449134|560719786|FG001|52-Week Treatment Period|Physician Decision|3|||
155350880|NCT03449134|560719787|FG002|52-Week Treatment Period|Physician Decision|3|||
155350881|NCT03449134|560719785|FG000|52-Week Treatment Period|Screen Failure|1|||
155350882|NCT03449134|560719786|FG001|52-Week Treatment Period|Screen Failure|0|||
155350883|NCT03449134|560719787|FG002|52-Week Treatment Period|Screen Failure|1|||
155350884|NCT03449134|560719785|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
155350885|NCT03449134|560719786|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
155350886|NCT03449134|560719787|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
155350887|NCT03449134|560719785|FG000|52-Week Treatment Period|Site Closure|1|||
155350888|NCT03449134|560719786|FG001|52-Week Treatment Period|Site Closure|0|||
155350889|NCT03449134|560719787|FG002|52-Week Treatment Period|Site Closure|0|||
155350890|NCT02916706|560719788|FG000|Overall Study|Adverse Event|0|||
155350891|NCT02916706|560719789|FG001|Overall Study|Adverse Event|1|||
155350892|NCT02916706|560719788|FG000|Overall Study|Lost to Follow-up|0|||
155350893|NCT02916706|560719789|FG001|Overall Study|Lost to Follow-up|1|||
155350894|NCT02916706|560719788|FG000|Overall Study|Physician Decision|1|||
154964352|NCT04547192|559295248|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
155084462|NCT00231465|559740725|FG000|Overall Study|Did not have follow up CT scans|1|||
155350895|NCT02916706|560719789|FG001|Overall Study|Physician Decision|0|||
155350896|NCT02916706|560719788|FG000|Overall Study|Protocol Violation|3|||
155350897|NCT02916706|560719789|FG001|Overall Study|Protocol Violation|1|||
155350898|NCT02916706|560719788|FG000|Overall Study|Withdrawal by Subject|6|||
155350899|NCT02916706|560719789|FG001|Overall Study|Withdrawal by Subject|9|||
155350900|NCT02916706|560719788|FG000|Overall Study|Other|5|||
155350901|NCT02916706|560719789|FG001|Overall Study|Other|19|||
155350902|NCT01093599|560719790|FG000|Overall Study|Lost to Follow-up|32|||
155350903|NCT01093599|560719791|FG001|Overall Study|Lost to Follow-up|46|||
155350904|NCT01703845|560719792|FG000|Overall Study|Adverse Event|1|||
155350905|NCT01703845|560719793|FG001|Overall Study|Adverse Event|0|||
155350906|NCT01703845|560719792|FG000|Overall Study|Protocol Violation|1|||
155350907|NCT01703845|560719793|FG001|Overall Study|Protocol Violation|0|||
155350908|NCT01703845|560719792|FG000|Overall Study|other than stated above|1|||
155350909|NCT01703845|560719793|FG001|Overall Study|other than stated above|0|||
155350910|NCT00719212|560719794|FG000|Overall Study|Death|41|||
155350911|NCT00719212|560719794|FG000|Overall Study|Lost to Follow-up|2|||
155350912|NCT00719212|560719794|FG000|Overall Study|Withdrawal by Subject|1|||
155350913|NCT00526097|560719795|FG000|Overall Study|Adverse Event|6|||
155350914|NCT00526097|560719796|FG001|Overall Study|Adverse Event|44|||
155350915|NCT00526097|560719795|FG000|Overall Study|Protocol Violation|4|||
155350916|NCT00526097|560719796|FG001|Overall Study|Protocol Violation|10|||
155350917|NCT00526097|560719795|FG000|Overall Study|Withdrawal by Subject|3|||
155350918|NCT00526097|560719796|FG001|Overall Study|Withdrawal by Subject|1|||
155350919|NCT00526097|560719795|FG000|Overall Study|Other|2|||
155350920|NCT00526097|560719796|FG001|Overall Study|Other|1|||
155084463|NCT03624036|559740726|FG000|Overall Study|Death|2|||
155084464|NCT03624036|559740727|FG001|Overall Study|Death|3|||
155350921|NCT00966979|560719797|FG000|Overall Study|Death|1|||
155350922|NCT00966979|560719797|FG000|Overall Study|Lost to Follow-up|6|||
155350923|NCT00966979|560719797|FG000|Overall Study|Withdrawal by Subject|14|||
155350924|NCT00966979|560719797|FG000|Overall Study|Adverse Event|5|||
155350925|NCT00966979|560719797|FG000|Overall Study|Sponsor terminated early|49|||
155084465|NCT03624036|559740728|FG002|Overall Study|Death|0|||
155084466|NCT03624036|559740729|FG003|Overall Study|Death|1|||
155084467|NCT03624036|559740726|FG000|Overall Study|Withdrawal by Subject|1|||
155084468|NCT03624036|559740727|FG001|Overall Study|Withdrawal by Subject|0|||
155084469|NCT03624036|559740728|FG002|Overall Study|Withdrawal by Subject|1|||
155350926|NCT00966979|560719797|FG000|Overall Study|Censored because surgery not done|2|||
155350927|NCT00966979|560719797|FG000|Overall Study|Censored because study device was not implanted|14|||
155350928|NCT00966979|560719797|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
155350929|NCT00943618|560719801|FG000|Overall Study|Lost to Follow-up|38|||
155350930|NCT00943618|560719802|FG001|Overall Study|Lost to Follow-up|48|||
155350931|NCT00943618|560719803|FG002|Overall Study|Lost to Follow-up|20|||
155350932|NCT00943618|560719801|FG000|Overall Study|Discontinued Medication|17|||
155350933|NCT00943618|560719802|FG001|Overall Study|Discontinued Medication|29|||
155350934|NCT00943618|560719803|FG002|Overall Study|Discontinued Medication|11|||
155350935|NCT03713281|560719808|FG000|Overall Study|Lens handling difficuluties|2|||
155350936|NCT03713281|560719808|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
155350937|NCT01990313|560719810|FG000|Overall Study|Lost to Follow-up|1|||
155350938|NCT02412111|560719811|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
155350939|NCT02412111|560719812|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
155350940|NCT02412111|560719813|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
155350941|NCT02412111|560719811|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
155350942|NCT02412111|560719812|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
155350943|NCT02412111|560719813|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
155350944|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
155350945|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
155350946|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
155350947|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
155350948|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
155350949|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
155350950|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
155350951|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
155350952|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
155350953|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
155350954|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
155350955|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
155350956|NCT02412111|560719811|FG000|Active Comparator Period (8 Weeks)|Other|0|||
155350957|NCT02412111|560719812|FG001|Active Comparator Period (8 Weeks)|Other|0|||
155350958|NCT02412111|560719813|FG002|Active Comparator Period (8 Weeks)|Other|2|||
155350959|NCT00837096|560719814|FG000|Overall Study|Physician Decision|1|||
155350960|NCT00837096|560719815|FG001|Overall Study|Physician Decision|1|||
155350961|NCT00837096|560719814|FG000|Overall Study|Not reported|9|||
155350962|NCT00837096|560719815|FG001|Overall Study|Not reported|8|||
155350963|NCT00329550|560719816|FG000|Overall Study|Adverse Event|3|||
155350964|NCT00329550|560719817|FG001|Overall Study|Adverse Event|4|||
155350965|NCT00329550|560719818|FG002|Overall Study|Adverse Event|2|||
155350966|NCT00329550|560719816|FG000|Overall Study|Withdrawal of Consent|1|||
155350967|NCT00329550|560719817|FG001|Overall Study|Withdrawal of Consent|0|||
155350968|NCT00329550|560719818|FG002|Overall Study|Withdrawal of Consent|1|||
155350969|NCT00329550|560719816|FG000|Overall Study|Due to Relocation|0|||
155350970|NCT00329550|560719817|FG001|Overall Study|Due to Relocation|0|||
155350971|NCT00329550|560719818|FG002|Overall Study|Due to Relocation|1|||
155084470|NCT03624036|559740729|FG003|Overall Study|Withdrawal by Subject|0|||
155084471|NCT03624036|559740726|FG000|Overall Study|Enrolled but Never Treated|1|||
154964353|NCT01535222|559295249|FG000|Overall Study|Inclusion/exclusion|0|||
155084472|NCT03624036|559740727|FG001|Overall Study|Enrolled but Never Treated|0|||
155084473|NCT03624036|559740728|FG002|Overall Study|Enrolled but Never Treated|0|||
155084474|NCT03624036|559740729|FG003|Overall Study|Enrolled but Never Treated|0|||
155350972|NCT00494026|560719819|FG000|Overall Study|Sponsor Decision|4|||
155350973|NCT05153499|560719820|FG000|Overall Study|Withdrawal by Subject|1|||
155350974|NCT05153499|560719821|FG001|Overall Study|Withdrawal by Subject|0|||
155350975|NCT05153499|560719820|FG000|Overall Study|Clinical Hold|1|||
155350976|NCT05153499|560719821|FG001|Overall Study|Clinical Hold|0|||
155350977|NCT05153499|560719820|FG000|Overall Study|Study Termination|6|||
155350978|NCT05153499|560719821|FG001|Overall Study|Study Termination|5|||
155350979|NCT05109117|560719824|FG000|Overall Study|Lost to Follow-up|1|||
154964354|NCT01535222|559295250|FG001|Overall Study|Inclusion/exclusion|0|||
155084475|NCT03624036|559740726|FG000|Overall Study|Reason not Specified|3|||
155084476|NCT03624036|559740727|FG001|Overall Study|Reason not Specified|0|||
155350980|NCT05109117|560719824|FG000|Overall Study|Discontinued for non-compliance|1|||
155350981|NCT03168425|560719827|FG000|Overall Study|Lost to Follow-up|5|||
155084477|NCT03624036|559740728|FG002|Overall Study|Reason not Specified|2|||
155350982|NCT03168425|560719828|FG001|Overall Study|Lost to Follow-up|8|||
155350983|NCT03168425|560719827|FG000|Overall Study|unable to confirm post op opioids|2|||
155350984|NCT03168425|560719828|FG001|Overall Study|unable to confirm post op opioids|3|||
155350985|NCT01960114|560719829|FG000|Overall Study|Adverse Event|1|||
155350986|NCT01960114|560719830|FG001|Overall Study|Adverse Event|0|||
155350987|NCT01960114|560719829|FG000|Overall Study|Could not swallow study medication|0|||
155350988|NCT01960114|560719830|FG001|Overall Study|Could not swallow study medication|1|||
155350989|NCT00468858|560719833|FG000|Overall Study|Adverse Event|0|||
155350990|NCT00468858|560719834|FG001|Overall Study|Adverse Event|1|||
155350991|NCT00468858|560719835|FG002|Overall Study|Adverse Event|0|||
155350992|NCT00468858|560719833|FG000|Overall Study|Withdrawal by Subject|7|||
155350993|NCT00468858|560719834|FG001|Overall Study|Withdrawal by Subject|4|||
155350994|NCT00468858|560719835|FG002|Overall Study|Withdrawal by Subject|5|||
155350995|NCT00468858|560719833|FG000|Overall Study|Relocation|1|||
155350996|NCT00468858|560719834|FG001|Overall Study|Relocation|3|||
155350997|NCT00468858|560719835|FG002|Overall Study|Relocation|3|||
155350998|NCT00468858|560719833|FG000|Overall Study|Lost to Follow-up|1|||
155350999|NCT00468858|560719834|FG001|Overall Study|Lost to Follow-up|2|||
155351000|NCT00468858|560719835|FG002|Overall Study|Lost to Follow-up|5|||
155351001|NCT00468858|560719833|FG000|Overall Study|Other|0|||
155351002|NCT00468858|560719834|FG001|Overall Study|Other|0|||
155351003|NCT00468858|560719835|FG002|Overall Study|Other|1|||
155351004|NCT03214250|560719838|FG000|Overall Study|Death|5|||
155351005|NCT03214250|560719839|FG001|Overall Study|Death|5|||
155351006|NCT03214250|560719840|FG002|Overall Study|Death|7|||
155351007|NCT03214250|560719841|FG003|Overall Study|Death|4|||
155351008|NCT03214250|560719842|FG004|Overall Study|Death|23|||
155351009|NCT03214250|560719843|FG005|Overall Study|Death|23|||
155351010|NCT03214250|560719844|FG006|Overall Study|Death|24|||
155351011|NCT03214250|560719838|FG000|Overall Study|Lost to Follow-up|0|||
155351012|NCT03214250|560719839|FG001|Overall Study|Lost to Follow-up|0|||
155351013|NCT03214250|560719840|FG002|Overall Study|Lost to Follow-up|0|||
155351014|NCT03214250|560719841|FG003|Overall Study|Lost to Follow-up|1|||
155351015|NCT03214250|560719842|FG004|Overall Study|Lost to Follow-up|1|||
155351016|NCT03214250|560719843|FG005|Overall Study|Lost to Follow-up|2|||
155351017|NCT03214250|560719844|FG006|Overall Study|Lost to Follow-up|0|||
155351018|NCT03214250|560719838|FG000|Overall Study|Other|0|||
155351019|NCT03214250|560719839|FG001|Overall Study|Other|0|||
155351020|NCT03214250|560719840|FG002|Overall Study|Other|0|||
155351021|NCT03214250|560719841|FG003|Overall Study|Other|0|||
155351022|NCT03214250|560719842|FG004|Overall Study|Other|1|||
155351023|NCT03214250|560719843|FG005|Overall Study|Other|1|||
155351024|NCT03214250|560719844|FG006|Overall Study|Other|2|||
155351025|NCT03214250|560719838|FG000|Overall Study|Remains on Study|2|||
155351026|NCT03214250|560719839|FG001|Overall Study|Remains on Study|2|||
155351027|NCT03214250|560719840|FG002|Overall Study|Remains on Study|0|||
155084478|NCT03624036|559740729|FG003|Overall Study|Reason not Specified|2|||
155351028|NCT03214250|560719841|FG003|Overall Study|Remains on Study|1|||
155351029|NCT03214250|560719842|FG004|Overall Study|Remains on Study|7|||
155351030|NCT03214250|560719843|FG005|Overall Study|Remains on Study|5|||
155351031|NCT03214250|560719844|FG006|Overall Study|Remains on Study|3|||
155351032|NCT03214250|560719838|FG000|Overall Study|Withdrawal by Subject|0|||
155351033|NCT03214250|560719839|FG001|Overall Study|Withdrawal by Subject|0|||
154964355|NCT01535222|559295251|FG002|Overall Study|Inclusion/exclusion|1|||
155351034|NCT03214250|560719840|FG002|Overall Study|Withdrawal by Subject|1|||
155351035|NCT03214250|560719841|FG003|Overall Study|Withdrawal by Subject|2|||
155351036|NCT03214250|560719842|FG004|Overall Study|Withdrawal by Subject|5|||
155351037|NCT03214250|560719843|FG005|Overall Study|Withdrawal by Subject|0|||
155351038|NCT03214250|560719844|FG006|Overall Study|Withdrawal by Subject|2|||
155351039|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|no longer interested|1|||
155351040|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|no longer interested|0|||
155351041|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
155351042|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
155351043|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
155351044|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
155351045|NCT00427778|560719845|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
155351046|NCT00427778|560719846|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
155351047|NCT00225277|560719847|FG000|Overall Study|Adverse Event|30|||
155351048|NCT00225277|560719848|FG001|Overall Study|Adverse Event|34|||
155351049|NCT00225277|560719847|FG000|Overall Study|Lack of Efficacy|4|||
155351050|NCT00225277|560719848|FG001|Overall Study|Lack of Efficacy|1|||
155351051|NCT00225277|560719847|FG000|Overall Study|Lost to Follow-up|4|||
155351052|NCT00225277|560719848|FG001|Overall Study|Lost to Follow-up|6|||
155351053|NCT00225277|560719847|FG000|Overall Study|Physician Decision|6|||
155351054|NCT00225277|560719848|FG001|Overall Study|Physician Decision|8|||
155351055|NCT00225277|560719847|FG000|Overall Study|Protocol Violation|6|||
155351056|NCT00225277|560719848|FG001|Overall Study|Protocol Violation|3|||
155351057|NCT00225277|560719847|FG000|Overall Study|Withdrawal by Subject|40|||
155351058|NCT00225277|560719848|FG001|Overall Study|Withdrawal by Subject|34|||
155351059|NCT00225277|560719847|FG000|Overall Study|Other|7|||
155351060|NCT00225277|560719848|FG001|Overall Study|Other|9|||
155351061|NCT01177137|560719851|FG000|Overall Study|Withdrawal by Subject|10|||
155351062|NCT01177137|560719852|FG001|Overall Study|Withdrawal by Subject|10|||
155351063|NCT01177137|560719853|FG002|Overall Study|Withdrawal by Subject|2|||
155351064|NCT01287416|560719856|FG000|Pre-post Training|Withdrawal by Subject|17|||
155351065|NCT01287416|560719857|FG001|Pre-post Training|Withdrawal by Subject|24|||
155351066|NCT01287416|560719856|FG000|Pre-post Training|Lost to Follow-up|5|||
155351067|NCT01287416|560719857|FG001|Pre-post Training|Lost to Follow-up|1|||
155084479|NCT00127933|559740738|FG000|Overall Study|Randomized but not dosed|1|||
155351068|NCT01287416|560719856|FG000|6 Month Follow-up|Lost to Follow-up|3|||
155351069|NCT01287416|560719857|FG001|6 Month Follow-up|Lost to Follow-up|2|||
155351070|NCT02109107|560719858|FG000|Overall Study|Lost to Follow-up|2|||
155351071|NCT00818519|560719863|FG000|Overall Study|Adverse Event|2|||
155351072|NCT00818519|560719864|FG001|Overall Study|Adverse Event|2|||
155351073|NCT00818519|560719863|FG000|Overall Study|Lost to Follow-up|4|||
155351074|NCT00818519|560719864|FG001|Overall Study|Lost to Follow-up|6|||
155351075|NCT00818519|560719863|FG000|Overall Study|Protocol Violation|2|||
155351076|NCT00818519|560719864|FG001|Overall Study|Protocol Violation|1|||
155351077|NCT00818519|560719863|FG000|Overall Study|Pregnancy|0|||
155351078|NCT00818519|560719864|FG001|Overall Study|Pregnancy|1|||
155351079|NCT00818519|560719863|FG000|Overall Study|Withdrawal by Subject|4|||
155351080|NCT00818519|560719864|FG001|Overall Study|Withdrawal by Subject|9|||
155351081|NCT00818519|560719863|FG000|Overall Study|participant recovered completely|1|||
155351082|NCT00818519|560719864|FG001|Overall Study|participant recovered completely|0|||
155084480|NCT00127933|559740739|FG001|Overall Study|Randomized but not dosed|0|||
155084481|NCT01390584|559740740|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
155351083|NCT00818519|560719863|FG000|Overall Study|participant will leave for long tme|1|||
155351084|NCT00818519|560719864|FG001|Overall Study|participant will leave for long tme|0|||
155351085|NCT04167085|560719865|FG000|Baseline|Withdrawal by Subject|2|||
155351086|NCT04167085|560719866|FG001|Baseline|Withdrawal by Subject|1|||
155351087|NCT04167085|560719865|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
155351088|NCT04167085|560719866|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
155351089|NCT00580047|560719869|FG000|Overall Study|Lost to Follow-up|1|||
155351090|NCT00580047|560719870|FG001|Overall Study|Lost to Follow-up|1|||
155351091|NCT00580047|560719871|FG002|Overall Study|Lost to Follow-up|0|||
155351092|NCT00580047|560719869|FG000|Overall Study|Withdrawal by Subject|1|||
155351093|NCT00580047|560719870|FG001|Overall Study|Withdrawal by Subject|1|||
155351094|NCT00580047|560719871|FG002|Overall Study|Withdrawal by Subject|2|||
155351095|NCT00580047|560719869|FG000|Overall Study|Withdrawal by Subject|1|||
155351096|NCT00580047|560719870|FG001|Overall Study|Withdrawal by Subject|0|||
155351097|NCT00580047|560719871|FG002|Overall Study|Withdrawal by Subject|0|||
155351098|NCT02820298|560719872|FG000|Overall Study|Withdrawal by Subject|0|||
155351099|NCT02820298|560719873|FG001|Overall Study|Withdrawal by Subject|1|||
155351100|NCT02820298|560719872|FG000|Overall Study|Physician Decision|1|||
155351101|NCT02820298|560719873|FG001|Overall Study|Physician Decision|0|||
155351102|NCT02820298|560719872|FG000|Overall Study|Protocol Violation|0|||
155351103|NCT02820298|560719873|FG001|Overall Study|Protocol Violation|1|||
155351104|NCT00141271|560719874|FG000|Overall Study|Adverse Event|31|||
155351105|NCT00141271|560719875|FG001|Overall Study|Adverse Event|19|||
155351106|NCT00141271|560719876|FG002|Overall Study|Adverse Event|17|||
155351107|NCT00141271|560719874|FG000|Overall Study|Laboratory Abnormality|2|||
155351108|NCT00141271|560719875|FG001|Overall Study|Laboratory Abnormality|1|||
155351109|NCT00141271|560719876|FG002|Overall Study|Laboratory Abnormality|1|||
155351110|NCT00141271|560719874|FG000|Overall Study|Lack of Efficacy|7|||
155351111|NCT00141271|560719875|FG001|Overall Study|Lack of Efficacy|7|||
155351112|NCT00141271|560719876|FG002|Overall Study|Lack of Efficacy|3|||
155351113|NCT00141271|560719874|FG000|Overall Study|Lost to Follow-up|15|||
155351114|NCT00141271|560719875|FG001|Overall Study|Lost to Follow-up|15|||
155351115|NCT00141271|560719876|FG002|Overall Study|Lost to Follow-up|21|||
155351116|NCT00141271|560719874|FG000|Overall Study|Withdrawal by Subject|14|||
155351117|NCT00141271|560719875|FG001|Overall Study|Withdrawal by Subject|9|||
155351118|NCT00141271|560719876|FG002|Overall Study|Withdrawal by Subject|10|||
155351119|NCT00141271|560719874|FG000|Overall Study|Other|11|||
155351120|NCT00141271|560719875|FG001|Overall Study|Other|12|||
155351121|NCT00141271|560719876|FG002|Overall Study|Other|5|||
155351122|NCT01374971|560719879|FG000|Overall Study|Withdrawal by Subject|1|||
155351123|NCT02154516|560719880|FG000|Overall Study|Withdrawal by Subject|0|||
155351124|NCT02154516|560719881|FG001|Overall Study|Withdrawal by Subject|1|||
155351125|NCT02154516|560719880|FG000|Overall Study|Lost to Follow-up|1|||
155351126|NCT02154516|560719881|FG001|Overall Study|Lost to Follow-up|0|||
155351127|NCT02154516|560719880|FG000|Overall Study|Removal/revision of device|1|||
155351128|NCT02154516|560719881|FG001|Overall Study|Removal/revision of device|0|||
155351129|NCT02154516|560719880|FG000|Overall Study|Death|2|||
155351130|NCT02154516|560719881|FG001|Overall Study|Death|1|||
155351131|NCT03406507|560719882|FG000|Extension Period|Lack of Efficacy|0|||
155351132|NCT03406507|560719883|FG001|Extension Period|Lack of Efficacy|1|||
155351133|NCT01804140|560719886|FG000|Overall Study|No sampling or biopsy procedures done|114|||
155351134|NCT00547300|560719887|FG000|Overall Study|Study was Administratively Terminated|25|||
155351135|NCT00547300|560719888|FG001|Overall Study|Study was Administratively Terminated|24|||
155351136|NCT00547300|560719887|FG000|Overall Study|Did not Meet Entry Criteria|0|||
155351137|NCT00547300|560719888|FG001|Overall Study|Did not Meet Entry Criteria|2|||
155351138|NCT02965599|560719891|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
155351139|NCT02965599|560719892|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
155351140|NCT04435522|560719896|FG000|Overall Study|Withdrawal by Subject|2|||
155351141|NCT02799745|560719897|FG000|Overall Study|Participant moved out of state|1|||
155351142|NCT02799745|560719898|FG001|Overall Study|Participant moved out of state|0|||
155351143|NCT02799745|560719897|FG000|Overall Study|Discontinued due to planned surgery|1|||
155351144|NCT02799745|560719898|FG001|Overall Study|Discontinued due to planned surgery|0|||
155351145|NCT02799745|560719897|FG000|Overall Study|Withdrawal by Subject|16|||
155351146|NCT02799745|560719898|FG001|Overall Study|Withdrawal by Subject|25|||
155351147|NCT02799745|560719897|FG000|Overall Study|Protocol Deviation|4|||
155351148|NCT02799745|560719898|FG001|Overall Study|Protocol Deviation|5|||
155351149|NCT02799745|560719897|FG000|Overall Study|Progressive Disease|28|||
155351150|NCT02799745|560719898|FG001|Overall Study|Progressive Disease|38|||
155351151|NCT02799745|560719897|FG000|Overall Study|Lost to Follow-up|3|||
155351152|NCT02799745|560719898|FG001|Overall Study|Lost to Follow-up|2|||
155351153|NCT02799745|560719897|FG000|Overall Study|Death|3|||
154964356|NCT01535222|559295252|FG003|Overall Study|Inclusion/exclusion|0|||
155351154|NCT02799745|560719898|FG001|Overall Study|Death|0|||
155351155|NCT02799745|560719897|FG000|Overall Study|Adverse Event|0|||
155351156|NCT02799745|560719898|FG001|Overall Study|Adverse Event|1|||
155351157|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
155351158|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
155351159|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
155351160|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
155351161|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
155351162|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
155351163|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
155351164|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
155351165|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
155351166|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
155351167|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
155351168|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
155351169|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
155351170|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
155351171|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
155351172|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
155351173|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
155351174|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
155351175|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
155351176|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
155351177|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
155351178|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
155351179|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
155351180|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
155351181|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
155351182|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
155351183|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
155351184|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
154964357|NCT01535222|559295253|FG004|Overall Study|Inclusion/exclusion|0|||
154964358|NCT01535222|559295254|FG005|Overall Study|Inclusion/exclusion|0|||
154964359|NCT00935012|559295257|FG000|Overall Study|Death|19|||
155084482|NCT01390584|559740741|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
155351185|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
155351186|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
155351187|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
155351188|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
155351189|NCT00092521|560721574|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
155351190|NCT00092521|560721575|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
155351191|NCT00092521|560721576|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
155351192|NCT00092521|560721577|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
155351193|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
155351194|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
155351195|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
155351196|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
155351197|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
155351198|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
155351199|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
155351200|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
155351201|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
155351202|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
155351203|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
155351204|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
155351205|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Death|2|||
155351206|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Death|0|||
155351207|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Death|1|||
155351208|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Death|0|||
155351209|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
155351210|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
155351211|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
155351212|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
155351213|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
155351214|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
155351215|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
155351216|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
155351217|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
155351218|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
155351219|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
155351220|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
155351221|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Moved|32|||
155351222|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Moved|2|||
155351223|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Moved|28|||
155351224|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Moved|0|||
155351225|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
155351226|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
155351227|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
155351228|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
155351229|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Travel|2|||
155351230|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Travel|0|||
155351231|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Travel|0|||
155351232|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Travel|0|||
155351233|NCT00092521|560721574|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
155351234|NCT00092521|560721575|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
155351235|NCT00092521|560721576|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
155351236|NCT00092521|560721577|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
155351237|NCT00092521|560721574|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
155351238|NCT00092521|560721575|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
155351239|NCT00092521|560721576|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
155351240|NCT00092521|560721577|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
155351241|NCT00092521|560721574|FG000|Extension Study (Group 4)|Adverse Event|0|||
155351242|NCT00092521|560721575|FG001|Extension Study (Group 4)|Adverse Event|0|||
155351243|NCT00092521|560721576|FG002|Extension Study (Group 4)|Adverse Event|0|||
155351244|NCT00092521|560721577|FG003|Extension Study (Group 4)|Adverse Event|2|||
155351245|NCT00092521|560721574|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
155084483|NCT01390584|559740742|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
155084484|NCT01539525|559740743|FG000|Overall Study|Lost to Follow-up|19|||
155084485|NCT01539525|559740744|FG001|Overall Study|Lost to Follow-up|12|||
155084486|NCT01539525|559740745|FG002|Overall Study|Lost to Follow-up|11|||
155084487|NCT01539525|559740743|FG000|Overall Study|Withdrawal by Subject|0|||
155084488|NCT01539525|559740744|FG001|Overall Study|Withdrawal by Subject|3|||
155084489|NCT01539525|559740745|FG002|Overall Study|Withdrawal by Subject|2|||
155084490|NCT01539525|559740743|FG000|Overall Study|Protocol Violation|1|||
155084491|NCT01539525|559740744|FG001|Overall Study|Protocol Violation|1|||
155084492|NCT01539525|559740745|FG002|Overall Study|Protocol Violation|4|||
155084493|NCT02268851|559740746|FG000|Overall Study|Death|0|||
155084494|NCT02268851|559740747|FG001|Overall Study|Death|0|||
155084495|NCT02268851|559740748|FG002|Overall Study|Death|0|||
155084496|NCT02268851|559740749|FG003|Overall Study|Death|1|||
155084497|NCT02268851|559740750|FG004|Overall Study|Death|2|||
155084498|NCT02268851|559740751|FG005|Overall Study|Death|1|||
155084499|NCT02268851|559740746|FG000|Overall Study|Adverse Event|0|||
155084500|NCT02268851|559740747|FG001|Overall Study|Adverse Event|0|||
155084501|NCT02268851|559740748|FG002|Overall Study|Adverse Event|0|||
155084502|NCT02268851|559740749|FG003|Overall Study|Adverse Event|0|||
155084503|NCT02268851|559740750|FG004|Overall Study|Adverse Event|2|||
155084504|NCT02268851|559740751|FG005|Overall Study|Adverse Event|2|||
155084505|NCT02268851|559740746|FG000|Overall Study|Withdrawal by Subject|0|||
155084506|NCT02268851|559740747|FG001|Overall Study|Withdrawal by Subject|0|||
155084507|NCT02268851|559740748|FG002|Overall Study|Withdrawal by Subject|0|||
155084508|NCT02268851|559740749|FG003|Overall Study|Withdrawal by Subject|2|||
155084509|NCT02268851|559740750|FG004|Overall Study|Withdrawal by Subject|0|||
155084510|NCT02268851|559740751|FG005|Overall Study|Withdrawal by Subject|1|||
155084511|NCT02268851|559740746|FG000|Overall Study|Progressive Disease|1|||
155084512|NCT02268851|559740747|FG001|Overall Study|Progressive Disease|3|||
155084513|NCT02268851|559740748|FG002|Overall Study|Progressive Disease|0|||
155084514|NCT02268851|559740749|FG003|Overall Study|Progressive Disease|0|||
155084515|NCT02268851|559740750|FG004|Overall Study|Progressive Disease|1|||
155351246|NCT00092521|560721575|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
155351247|NCT00092521|560721576|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
155351248|NCT00092521|560721577|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
155351249|NCT00092521|560721574|FG000|Extension Study (Group 4)|Pregnancy|0|||
155351250|NCT00092521|560721575|FG001|Extension Study (Group 4)|Pregnancy|0|||
155351251|NCT00092521|560721576|FG002|Extension Study (Group 4)|Pregnancy|0|||
155351252|NCT00092521|560721577|FG003|Extension Study (Group 4)|Pregnancy|4|||
155351253|NCT00092521|560721574|FG000|Extension Study (Group 4)|Protocol Violation|0|||
155351254|NCT00092521|560721575|FG001|Extension Study (Group 4)|Protocol Violation|0|||
155351255|NCT00092521|560721576|FG002|Extension Study (Group 4)|Protocol Violation|0|||
155351256|NCT00092521|560721577|FG003|Extension Study (Group 4)|Protocol Violation|2|||
155351257|NCT00092521|560721574|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
155351258|NCT00092521|560721575|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
155351259|NCT00092521|560721576|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
155351260|NCT00092521|560721577|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
155351261|NCT00092521|560721574|FG000|Extension Study (Group 4)|Moved|0|||
155351262|NCT00092521|560721575|FG001|Extension Study (Group 4)|Moved|0|||
155351263|NCT00092521|560721576|FG002|Extension Study (Group 4)|Moved|0|||
155351264|NCT00092521|560721577|FG003|Extension Study (Group 4)|Moved|16|||
155351265|NCT00092521|560721574|FG000|Extension Study (Group 4)|Site Terminated|0|||
155351266|NCT00092521|560721575|FG001|Extension Study (Group 4)|Site Terminated|0|||
155351267|NCT00092521|560721576|FG002|Extension Study (Group 4)|Site Terminated|0|||
155351268|NCT00092521|560721577|FG003|Extension Study (Group 4)|Site Terminated|4|||
155351269|NCT00092521|560721574|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
155351270|NCT00092521|560721575|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
155351271|NCT00092521|560721576|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
155351272|NCT00092521|560721577|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
155351273|NCT01878383|560721578|FG000|Overall Study|Lost to Follow-up|0|||
155351274|NCT01878383|560721579|FG001|Overall Study|Lost to Follow-up|1499|||
155351275|NCT03464383|560721580|FG000|Overall Study|Lost to Follow-up|1|||
155351276|NCT03464383|560721581|FG001|Overall Study|Lost to Follow-up|0|||
155351277|NCT03464383|560721582|FG002|Overall Study|Lost to Follow-up|0|||
155351278|NCT03464383|560721580|FG000|Overall Study|Withdrawal by Subject|0|||
155351279|NCT03464383|560721581|FG001|Overall Study|Withdrawal by Subject|1|||
155351280|NCT03464383|560721582|FG002|Overall Study|Withdrawal by Subject|0|||
155351281|NCT00560313|560721583|FG000|Overall Study|Adverse Events or Death|2|||
155351282|NCT00560313|560721583|FG000|Overall Study|Withdrawal by Subject|2|||
155351283|NCT00560313|560721583|FG000|Overall Study|Lost to Follow-up|1|||
155084516|NCT02268851|559740751|FG005|Overall Study|Progressive Disease|4|||
155084517|NCT02268851|559740746|FG000|Overall Study|Physician Decision|0|||
155084518|NCT02268851|559740747|FG001|Overall Study|Physician Decision|0|||
155084519|NCT02268851|559740748|FG002|Overall Study|Physician Decision|1|||
155084520|NCT02268851|559740749|FG003|Overall Study|Physician Decision|0|||
155084521|NCT02268851|559740750|FG004|Overall Study|Physician Decision|0|||
155351284|NCT00560313|560721583|FG000|Overall Study|Protocol Violation|1|||
155351285|NCT03475056|560721584|FG000|Overall Study|Lost to Follow-up|0|||
155351286|NCT03475056|560721585|FG001|Overall Study|Lost to Follow-up|1|||
155351287|NCT03475056|560721584|FG000|Overall Study|Moved from Area|0|||
155351288|NCT03475056|560721585|FG001|Overall Study|Moved from Area|2|||
155351289|NCT00113269|560721588|FG000|Overall Study|Not transplanted, donor issues|4|||
155351290|NCT00113269|560721589|FG001|Overall Study|Not transplanted, donor issues|0|||
155351291|NCT00113269|560721590|FG002|Overall Study|Not transplanted, donor issues|2|||
155351292|NCT00113269|560721591|FG003|Overall Study|Not transplanted, donor issues|2|||
155351293|NCT00113269|560721588|FG000|Overall Study|Not transplanted, recipient issues|2|||
155351294|NCT00113269|560721589|FG001|Overall Study|Not transplanted, recipient issues|1|||
155351295|NCT00113269|560721590|FG002|Overall Study|Not transplanted, recipient issues|7|||
155351296|NCT00113269|560721591|FG003|Overall Study|Not transplanted, recipient issues|4|||
155351297|NCT00113269|560721588|FG000|Overall Study|Early graft loss, technical|0|||
155351298|NCT00113269|560721589|FG001|Overall Study|Early graft loss, technical|0|||
155351299|NCT00113269|560721590|FG002|Overall Study|Early graft loss, technical|2|||
155351300|NCT00113269|560721591|FG003|Overall Study|Early graft loss, technical|0|||
155351301|NCT00113269|560721588|FG000|Overall Study|Death in operating room|0|||
155351302|NCT00113269|560721589|FG001|Overall Study|Death in operating room|0|||
155351303|NCT00113269|560721590|FG002|Overall Study|Death in operating room|0|||
155351304|NCT00113269|560721591|FG003|Overall Study|Death in operating room|1|||
155351305|NCT00113269|560721588|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
155351306|NCT00113269|560721589|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
155351307|NCT00113269|560721590|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
155351308|NCT00113269|560721591|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
155351309|NCT00113269|560721588|FG000|Overall Study|Adverse Event|2|||
155351310|NCT00113269|560721589|FG001|Overall Study|Adverse Event|7|||
155351311|NCT00113269|560721590|FG002|Overall Study|Adverse Event|11|||
155351312|NCT00113269|560721591|FG003|Overall Study|Adverse Event|7|||
155351313|NCT00113269|560721588|FG000|Overall Study|Withdrawal by Subject|4|||
155351314|NCT00113269|560721589|FG001|Overall Study|Withdrawal by Subject|3|||
155351315|NCT00113269|560721590|FG002|Overall Study|Withdrawal by Subject|4|||
155351316|NCT00113269|560721591|FG003|Overall Study|Withdrawal by Subject|2|||
155351317|NCT00113269|560721588|FG000|Overall Study|Graft loss|6|||
155351318|NCT00113269|560721589|FG001|Overall Study|Graft loss|6|||
155351319|NCT00113269|560721590|FG002|Overall Study|Graft loss|4|||
155351320|NCT00113269|560721591|FG003|Overall Study|Graft loss|9|||
155351321|NCT00113269|560721588|FG000|Overall Study|Protocol Violation|1|||
155351322|NCT00113269|560721589|FG001|Overall Study|Protocol Violation|0|||
155351323|NCT00113269|560721590|FG002|Overall Study|Protocol Violation|4|||
155351324|NCT00113269|560721591|FG003|Overall Study|Protocol Violation|2|||
155351325|NCT00113269|560721588|FG000|Overall Study|Lost to Follow-up|2|||
155351326|NCT00113269|560721589|FG001|Overall Study|Lost to Follow-up|3|||
155351327|NCT00113269|560721590|FG002|Overall Study|Lost to Follow-up|6|||
155351328|NCT00113269|560721591|FG003|Overall Study|Lost to Follow-up|3|||
155351329|NCT00113269|560721588|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
155351330|NCT00113269|560721589|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
155351331|NCT00113269|560721590|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
155351332|NCT00113269|560721591|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
155351333|NCT00113269|560721588|FG000|Overall Study|Discontinued due to rejection|0|||
155351334|NCT00113269|560721589|FG001|Overall Study|Discontinued due to rejection|0|||
155351335|NCT00113269|560721590|FG002|Overall Study|Discontinued due to rejection|1|||
155351336|NCT00113269|560721591|FG003|Overall Study|Discontinued due to rejection|0|||
155351337|NCT00113269|560721588|FG000|Overall Study|Moved|0|||
155351338|NCT00113269|560721589|FG001|Overall Study|Moved|1|||
155351339|NCT00113269|560721590|FG002|Overall Study|Moved|0|||
155351340|NCT00113269|560721591|FG003|Overall Study|Moved|3|||
155351341|NCT00113269|560721588|FG000|Overall Study|Received pancreas transplant|0|||
155351342|NCT00113269|560721589|FG001|Overall Study|Received pancreas transplant|0|||
155351343|NCT00113269|560721590|FG002|Overall Study|Received pancreas transplant|0|||
155351344|NCT00113269|560721591|FG003|Overall Study|Received pancreas transplant|2|||
155351345|NCT00113269|560721588|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
155351346|NCT00113269|560721589|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
155351347|NCT00113269|560721590|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
155351348|NCT00113269|560721591|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
155084522|NCT02268851|559740751|FG005|Overall Study|Physician Decision|1|||
155351349|NCT00113269|560721588|FG000|Overall Study|Did not meet eligibility criteria|1|||
155351350|NCT00113269|560721589|FG001|Overall Study|Did not meet eligibility criteria|0|||
155351351|NCT00113269|560721590|FG002|Overall Study|Did not meet eligibility criteria|0|||
155351352|NCT00113269|560721591|FG003|Overall Study|Did not meet eligibility criteria|1|||
155351353|NCT00113269|560721588|FG000|Overall Study|Unable to return for follow up|2|||
155351354|NCT00113269|560721589|FG001|Overall Study|Unable to return for follow up|1|||
155351355|NCT00113269|560721590|FG002|Overall Study|Unable to return for follow up|0|||
155351356|NCT00113269|560721591|FG003|Overall Study|Unable to return for follow up|0|||
155351357|NCT01960348|560721598|FG000|Overall Study|Adverse event, not serious|2|||
155351358|NCT01960348|560721599|FG001|Overall Study|Adverse event, not serious|2|||
155351359|NCT01960348|560721598|FG000|Overall Study|Adverse event, serious fatal|6|||
155351360|NCT01960348|560721599|FG001|Overall Study|Adverse event, serious fatal|5|||
155351361|NCT01960348|560721598|FG000|Overall Study|Adverse event, serious non-fatal|0|||
155351362|NCT01960348|560721599|FG001|Overall Study|Adverse event, serious non-fatal|3|||
155351363|NCT01960348|560721598|FG000|Overall Study|Withdrawal by Subject|1|||
155351364|NCT01960348|560721599|FG001|Overall Study|Withdrawal by Subject|11|||
155351365|NCT01960348|560721598|FG000|Overall Study|Physician Decision|0|||
155351366|NCT01960348|560721599|FG001|Overall Study|Physician Decision|1|||
155351367|NCT01960348|560721598|FG000|Overall Study|Protocol Violation|1|||
155351368|NCT01960348|560721599|FG001|Overall Study|Protocol Violation|0|||
155351369|NCT01580995|560721600|FG000|Overall Study|Lost to Follow-up|2|||
155351370|NCT01580995|560721601|FG001|Overall Study|Lost to Follow-up|2|||
155351371|NCT01821729|560721602|FG000|Overall Study|Withdrawal by Subject|1|||
155351372|NCT02517528|560721603|FG000|Overall Study|Withdrawal by Subject|1|||
155351373|NCT01644188|560721607|FG000|Overall Study|Adverse Event|44|||
155351374|NCT01644188|560721608|FG001|Overall Study|Adverse Event|20|||
155351375|NCT01644188|560721607|FG000|Overall Study|Poor compliance to protocol|26|||
155351376|NCT01644188|560721608|FG001|Overall Study|Poor compliance to protocol|14|||
155351377|NCT01644188|560721607|FG000|Overall Study|Physician Decision|1|||
155351378|NCT01644188|560721608|FG001|Overall Study|Physician Decision|3|||
155351379|NCT01644188|560721607|FG000|Overall Study|Participant moved|7|||
155351380|NCT01644188|560721608|FG001|Overall Study|Participant moved|2|||
155351381|NCT01644188|560721607|FG000|Overall Study|Related to auto-injector administration|2|||
155351382|NCT01644188|560721608|FG001|Overall Study|Related to auto-injector administration|2|||
155351383|NCT01644188|560721607|FG000|Overall Study|Consent withdrawn by participant|14|||
155351384|NCT01644188|560721608|FG001|Overall Study|Consent withdrawn by participant|7|||
155351385|NCT01644188|560721607|FG000|Overall Study|Selection criteria finally not met|2|||
155351386|NCT01644188|560721608|FG001|Overall Study|Selection criteria finally not met|0|||
155351387|NCT01644188|560721607|FG000|Overall Study|Lost to Follow-up|1|||
155351388|NCT01644188|560721608|FG001|Overall Study|Lost to Follow-up|0|||
155351389|NCT01644188|560721607|FG000|Overall Study|Death|4|||
154964360|NCT00935012|559295257|FG000|Overall Study|Withdrawal by Subject|3|||
154964361|NCT00935012|559295257|FG000|Overall Study|Other|5|||
154964362|NCT00935012|559295257|FG000|Overall Study|Adverse Event|2|||
154964363|NCT01442155|559295258|FG000|Overall Study|Complete remission|35|||
154964364|NCT01442155|559295258|FG000|Overall Study|Recurrence|26|||
154964365|NCT01442155|559295258|FG000|Overall Study|Adverse Event|2|||
154964366|NCT01442155|559295258|FG000|Overall Study|Lost to Follow-up|2|||
155084523|NCT02268851|559740746|FG000|Overall Study|Patient Compliance|0|||
155084524|NCT02268851|559740747|FG001|Overall Study|Patient Compliance|0|||
155084525|NCT02268851|559740748|FG002|Overall Study|Patient Compliance|0|||
155084526|NCT02268851|559740749|FG003|Overall Study|Patient Compliance|0|||
155351390|NCT01644188|560721608|FG001|Overall Study|Death|3|||
155351391|NCT01644188|560721607|FG000|Overall Study|Last visit outside protocol visit window|14|||
155351392|NCT01644188|560721608|FG001|Overall Study|Last visit outside protocol visit window|16|||
155351393|NCT01644188|560721607|FG000|Overall Study|Site closure|1|||
155351394|NCT01644188|560721608|FG001|Overall Study|Site closure|1|||
155351395|NCT01644188|560721607|FG000|Overall Study|Other than specified above|6|||
155351396|NCT01644188|560721608|FG001|Overall Study|Other than specified above|7|||
155351397|NCT01845649|560721614|FG000|Overall Study|Adverse Event|7|||
155351398|NCT01845649|560721615|FG001|Overall Study|Adverse Event|10|||
155351399|NCT01845649|560721614|FG000|Overall Study|Lack of Efficacy|1|||
155351400|NCT01845649|560721615|FG001|Overall Study|Lack of Efficacy|1|||
154964367|NCT01590563|559295265|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
154964368|NCT02699463|559295266|FG000|Overall Study|Lost to Follow-up|11|||
155084527|NCT02268851|559740750|FG004|Overall Study|Patient Compliance|1|||
154964369|NCT02699463|559295267|FG001|Overall Study|Lost to Follow-up|8|||
155351401|NCT01845649|560721614|FG000|Overall Study|Lost to Follow-up|2|||
155351402|NCT01845649|560721615|FG001|Overall Study|Lost to Follow-up|2|||
155351403|NCT01845649|560721614|FG000|Overall Study|Withdrew Consent|12|||
155351404|NCT01845649|560721615|FG001|Overall Study|Withdrew Consent|4|||
155351405|NCT01845649|560721614|FG000|Overall Study|Protocol Deviation|7|||
155351406|NCT01845649|560721615|FG001|Overall Study|Protocol Deviation|4|||
155351407|NCT01845649|560721614|FG000|Overall Study|Reason not Specified|2|||
155351408|NCT01845649|560721615|FG001|Overall Study|Reason not Specified|1|||
155351409|NCT04140266|560721621|FG000|Overall Study|Physician Decision|2|||
155351410|NCT04140266|560721622|FG001|Overall Study|Physician Decision|0|||
155351411|NCT04140266|560721621|FG000|Overall Study|Withdrawal by Subject|4|||
155351412|NCT04140266|560721622|FG001|Overall Study|Withdrawal by Subject|2|||
155351413|NCT00721214|560721623|FG000|Overall Study|Chose another center for transplant|1|||
155351414|NCT00721214|560721623|FG000|Overall Study|Death|3|||
155351415|NCT00983905|560721624|FG000|Theophylline Alone|Adverse Event|1|||
155351416|NCT00983905|560721624|FG000|Colchicine Alone|Adverse Event|2|||
155351417|NCT01169636|560721625|FG000|Overall Study|Adverse Event|0|||
155351418|NCT01169636|560721626|FG001|Overall Study|Adverse Event|0|||
155351419|NCT01169636|560721627|FG002|Overall Study|Adverse Event|1|||
155351420|NCT01169636|560721628|FG003|Overall Study|Adverse Event|1|||
155351421|NCT01169636|560721629|FG004|Overall Study|Adverse Event|0|||
155351422|NCT01169636|560721625|FG000|Overall Study|Screen failure|0|||
155351423|NCT01169636|560721626|FG001|Overall Study|Screen failure|0|||
155351424|NCT01169636|560721627|FG002|Overall Study|Screen failure|2|||
155351425|NCT01169636|560721628|FG003|Overall Study|Screen failure|0|||
155351426|NCT01169636|560721629|FG004|Overall Study|Screen failure|0|||
155351427|NCT01169636|560721625|FG000|Overall Study|Withdrawal by Subject|0|||
155351428|NCT01169636|560721626|FG001|Overall Study|Withdrawal by Subject|0|||
155351429|NCT01169636|560721627|FG002|Overall Study|Withdrawal by Subject|0|||
155351430|NCT01169636|560721628|FG003|Overall Study|Withdrawal by Subject|0|||
155351431|NCT01169636|560721629|FG004|Overall Study|Withdrawal by Subject|3|||
155351432|NCT02396953|560721630|FG000|Overall Study|Withdrawal by Subject|0|||
155351433|NCT02396953|560721631|FG001|Overall Study|Withdrawal by Subject|0|||
155351434|NCT02396953|560721632|FG002|Overall Study|Withdrawal by Subject|1|||
155351435|NCT02396953|560721630|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
155351436|NCT02396953|560721631|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
155351437|NCT02396953|560721632|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
155351438|NCT02396953|560721630|FG000|Overall Study|Personal Reasons|1|||
155351439|NCT02396953|560721631|FG001|Overall Study|Personal Reasons|1|||
155351440|NCT02396953|560721632|FG002|Overall Study|Personal Reasons|0|||
155351441|NCT02994784|560721634|FG000|6 Months Follow-up|Lost to Follow-up|3|||
155351442|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
155351443|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
155084528|NCT02268851|559740751|FG005|Overall Study|Patient Compliance|1|||
155084529|NCT02268851|559740746|FG000|Overall Study|Co-Morbid Condition|0|||
155084530|NCT02268851|559740747|FG001|Overall Study|Co-Morbid Condition|0|||
155084531|NCT02268851|559740748|FG002|Overall Study|Co-Morbid Condition|0|||
155084532|NCT02268851|559740749|FG003|Overall Study|Co-Morbid Condition|0|||
155084533|NCT02268851|559740750|FG004|Overall Study|Co-Morbid Condition|1|||
155084534|NCT02268851|559740751|FG005|Overall Study|Co-Morbid Condition|1|||
155084535|NCT01472835|559740754|FG000|Overall Study|Lost to Follow-up|2|||
155084536|NCT01472835|559740755|FG001|Overall Study|Lost to Follow-up|0|||
155084537|NCT03425188|559740757|FG000|Overall Study|Withdrawal by Subject|1|||
155084538|NCT01694771|559740758|FG000|Overall Study|Adverse Event|18|||
155084539|NCT01694771|559740759|FG001|Overall Study|Adverse Event|16|||
155084540|NCT01694771|559740758|FG000|Overall Study|Lack of Efficacy|1|||
155084541|NCT01694771|559740759|FG001|Overall Study|Lack of Efficacy|0|||
155084542|NCT01694771|559740758|FG000|Overall Study|Non compliance protocol|7|||
155084543|NCT01694771|559740759|FG001|Overall Study|Non compliance protocol|6|||
155084544|NCT01694771|559740758|FG000|Overall Study|Lost to Follow-up|2|||
155084545|NCT01694771|559740759|FG001|Overall Study|Lost to Follow-up|3|||
155084546|NCT01694771|559740758|FG000|Overall Study|Consent withdrawn|7|||
155084547|NCT01694771|559740759|FG001|Overall Study|Consent withdrawn|9|||
155084548|NCT01694771|559740758|FG000|Overall Study|Other reasons|5|||
155084549|NCT01694771|559740759|FG001|Overall Study|Other reasons|6|||
155084550|NCT02536339|559740761|FG000|Overall Study|Death|20|||
155084551|NCT02536339|559740761|FG000|Overall Study|Withdrawal by Subject|3|||
155084552|NCT02536339|559740761|FG000|Overall Study|Lost to Follow-up|2|||
155084553|NCT02536339|559740761|FG000|Overall Study|Treatment discontinued|2|||
155084554|NCT02536339|559740761|FG000|Overall Study|Physician Decision|1|||
155084555|NCT01905683|559740762|FG000|Overall Study|Protocol Violation|1|||
155084556|NCT01905683|559740762|FG000|Overall Study|Re-injection criteria not met; others|13|||
155084557|NCT01905683|559740762|FG000|Overall Study|Physician Decision|1|||
155084558|NCT01905683|559740762|FG000|Overall Study|Lack of Efficacy|8|||
155084559|NCT01905683|559740762|FG000|Overall Study|Withdrawal by Subject|20|||
155084560|NCT01905683|559740762|FG000|Overall Study|Adverse Event|4|||
155084561|NCT01905683|559740762|FG000|Overall Study|Lost to Follow-up|4|||
155084562|NCT02037984|559740765|FG000|Overall Study|Lack of Efficacy|0|||
155084563|NCT02037984|559740766|FG001|Overall Study|Lack of Efficacy|0|||
155084564|NCT02037984|559740767|FG002|Overall Study|Lack of Efficacy|3|||
155084565|NCT02037984|559740768|FG003|Overall Study|Lack of Efficacy|10|||
155084566|NCT02037984|559740769|FG004|Overall Study|Lack of Efficacy|2|||
155084567|NCT02037984|559740770|FG005|Overall Study|Lack of Efficacy|2|||
155084568|NCT02037984|559740771|FG006|Overall Study|Lack of Efficacy|4|||
155084569|NCT02037984|559740772|FG007|Overall Study|Lack of Efficacy|3|||
155084570|NCT02037984|559740765|FG000|Overall Study|Lost to Follow-up|1|||
155084571|NCT02037984|559740766|FG001|Overall Study|Lost to Follow-up|0|||
155084572|NCT02037984|559740767|FG002|Overall Study|Lost to Follow-up|3|||
155084573|NCT02037984|559740768|FG003|Overall Study|Lost to Follow-up|5|||
155084574|NCT02037984|559740769|FG004|Overall Study|Lost to Follow-up|2|||
155084575|NCT02037984|559740770|FG005|Overall Study|Lost to Follow-up|2|||
155084576|NCT02037984|559740771|FG006|Overall Study|Lost to Follow-up|2|||
155351444|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
155351445|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
155351446|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
155351447|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
155351448|NCT02466243|560721635|FG000|Part B Open-label Treatment Period|Missing|2|||
155351449|NCT02466243|560721636|FG001|Part B Open-label Treatment Period|Missing|2|||
155351450|NCT01649557|560721638|FG000|Overall Study|Lost to Follow-up|5|||
155351451|NCT01649557|560721639|FG001|Overall Study|Lost to Follow-up|0|||
155084577|NCT02037984|559740772|FG007|Overall Study|Lost to Follow-up|4|||
155351452|NCT01649557|560721640|FG002|Overall Study|Lost to Follow-up|3|||
155351453|NCT01649557|560721638|FG000|Overall Study|Adverse Event|7|||
155351454|NCT01649557|560721639|FG001|Overall Study|Adverse Event|5|||
155084578|NCT02037984|559740765|FG000|Overall Study|Physician Decision|0|||
155351455|NCT01649557|560721640|FG002|Overall Study|Adverse Event|1|||
155351456|NCT01649557|560721638|FG000|Overall Study|Met withdrawal criteria|4|||
155351457|NCT01649557|560721639|FG001|Overall Study|Met withdrawal criteria|0|||
155084579|NCT02037984|559740766|FG001|Overall Study|Physician Decision|0|||
155084580|NCT02037984|559740767|FG002|Overall Study|Physician Decision|0|||
155084581|NCT02037984|559740768|FG003|Overall Study|Physician Decision|0|||
155084582|NCT02037984|559740769|FG004|Overall Study|Physician Decision|0|||
155084583|NCT02037984|559740770|FG005|Overall Study|Physician Decision|0|||
155084584|NCT02037984|559740771|FG006|Overall Study|Physician Decision|1|||
155084585|NCT02037984|559740772|FG007|Overall Study|Physician Decision|0|||
155084586|NCT02037984|559740765|FG000|Overall Study|Protocol Violation|0|||
155084587|NCT02037984|559740766|FG001|Overall Study|Protocol Violation|0|||
155084588|NCT02037984|559740767|FG002|Overall Study|Protocol Violation|0|||
155084589|NCT02037984|559740768|FG003|Overall Study|Protocol Violation|0|||
155084590|NCT02037984|559740769|FG004|Overall Study|Protocol Violation|0|||
155084591|NCT02037984|559740770|FG005|Overall Study|Protocol Violation|1|||
155084592|NCT02037984|559740771|FG006|Overall Study|Protocol Violation|2|||
155084593|NCT02037984|559740772|FG007|Overall Study|Protocol Violation|0|||
155084594|NCT02037984|559740765|FG000|Overall Study|Technical Problems|0|||
155084595|NCT02037984|559740766|FG001|Overall Study|Technical Problems|0|||
155084596|NCT02037984|559740767|FG002|Overall Study|Technical Problems|3|||
155351458|NCT01649557|560721640|FG002|Overall Study|Met withdrawal criteria|0|||
155351459|NCT01649557|560721638|FG000|Overall Study|Physician Decision|8|||
155351460|NCT01649557|560721639|FG001|Overall Study|Physician Decision|2|||
155351461|NCT01649557|560721640|FG002|Overall Study|Physician Decision|1|||
155351462|NCT01649557|560721638|FG000|Overall Study|Withdrawal by Subject|15|||
155351463|NCT01649557|560721639|FG001|Overall Study|Withdrawal by Subject|5|||
155351464|NCT01649557|560721640|FG002|Overall Study|Withdrawal by Subject|4|||
155351465|NCT01649557|560721638|FG000|Overall Study|Protocol deviation|0|||
155351466|NCT01649557|560721639|FG001|Overall Study|Protocol deviation|2|||
155351467|NCT01649557|560721640|FG002|Overall Study|Protocol deviation|0|||
155351468|NCT01649557|560721638|FG000|Overall Study|Lack of Efficacy|5|||
155351469|NCT01649557|560721639|FG001|Overall Study|Lack of Efficacy|0|||
155351470|NCT01649557|560721640|FG002|Overall Study|Lack of Efficacy|0|||
155351471|NCT01011049|560721641|FG000|Overall Study|Protocol Violation|0|||
155084597|NCT02037984|559740768|FG003|Overall Study|Technical Problems|3|||
155084598|NCT02037984|559740769|FG004|Overall Study|Technical Problems|2|||
155351472|NCT01011049|560721642|FG001|Overall Study|Protocol Violation|0|||
155351473|NCT01011049|560721643|FG002|Overall Study|Protocol Violation|2|||
155351474|NCT01011049|560721644|FG003|Overall Study|Protocol Violation|0|||
155084599|NCT02037984|559740770|FG005|Overall Study|Technical Problems|3|||
155084600|NCT02037984|559740771|FG006|Overall Study|Technical Problems|4|||
155084601|NCT02037984|559740772|FG007|Overall Study|Technical Problems|2|||
155351475|NCT01011049|560721641|FG000|Overall Study|Lost to Follow-up|1|||
155351476|NCT01011049|560721642|FG001|Overall Study|Lost to Follow-up|2|||
155351477|NCT01011049|560721643|FG002|Overall Study|Lost to Follow-up|1|||
155351478|NCT01011049|560721644|FG003|Overall Study|Lost to Follow-up|0|||
155351479|NCT01011049|560721641|FG000|Overall Study|Withdrawal by Subject|0|||
155351480|NCT01011049|560721642|FG001|Overall Study|Withdrawal by Subject|0|||
155351481|NCT01011049|560721643|FG002|Overall Study|Withdrawal by Subject|1|||
155351482|NCT01011049|560721644|FG003|Overall Study|Withdrawal by Subject|0|||
155351483|NCT02435381|560721645|FG000|Overall Study|Lost to Follow-up|2|||
155351484|NCT02435381|560721646|FG001|Overall Study|Lost to Follow-up|1|||
155351485|NCT04150341|560721649|FG000|Overall Study|Physician Decision|0|||
154964370|NCT02699463|559295266|FG000|Overall Study|Withdrawal by Subject|4|||
155084602|NCT02037984|559740765|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155084603|NCT02037984|559740766|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155084604|NCT02037984|559740767|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
155084605|NCT02037984|559740768|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
155084606|NCT02037984|559740769|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
155351486|NCT04150341|560721650|FG001|Overall Study|Physician Decision|0|||
155351487|NCT04150341|560721651|FG002|Overall Study|Physician Decision|1|||
155351488|NCT04150341|560721652|FG003|Overall Study|Physician Decision|0|||
154964371|NCT02699463|559295267|FG001|Overall Study|Withdrawal by Subject|1|||
154964372|NCT01370733|559295268|FG000|Overall Study|Withdrawal by Subject|8|||
154964373|NCT01370733|559295269|FG001|Overall Study|Withdrawal by Subject|8|||
154964374|NCT01370733|559295268|FG000|Overall Study|Lost to Follow-up|3|||
154964375|NCT01370733|559295269|FG001|Overall Study|Lost to Follow-up|0|||
154964376|NCT01370733|559295268|FG000|Overall Study|Adverse Event|2|||
154964377|NCT01370733|559295269|FG001|Overall Study|Adverse Event|4|||
154964378|NCT01370733|559295268|FG000|Overall Study|Lack of Efficacy|3|||
154964379|NCT01370733|559295269|FG001|Overall Study|Lack of Efficacy|5|||
154964380|NCT01370733|559295268|FG000|Overall Study|Physician Decision|0|||
154964381|NCT01370733|559295269|FG001|Overall Study|Physician Decision|2|||
154964382|NCT01370733|559295268|FG000|Overall Study|Protocol Violation|1|||
154964383|NCT01370733|559295269|FG001|Overall Study|Protocol Violation|3|||
154964384|NCT00909038|559295272|FG000|Overall Study|Protocol Violation|187|||
154964385|NCT00909038|559295272|FG000|Overall Study|Non-evaluable Subjects|230|||
154964386|NCT01895335|559295279|FG000|Overall Study|Adverse Event|106|||
154964387|NCT01895335|559295279|FG000|Overall Study|Lack of Efficacy|53|||
154964388|NCT01895335|559295279|FG000|Overall Study|Poor Compliance to Protocol|11|||
154964389|NCT01895335|559295279|FG000|Overall Study|Included But Not treated|1|||
154964390|NCT01895335|559295279|FG000|Overall Study|Other than Specified Above|44|||
154964391|NCT03480763|559295280|FG000|Overall Study|Withdrawal by Subject|18|||
154964392|NCT03480763|559295281|FG001|Overall Study|Withdrawal by Subject|10|||
154964393|NCT03480763|559295280|FG000|Overall Study|Lost to Follow-up|4|||
154964394|NCT03480763|559295281|FG001|Overall Study|Lost to Follow-up|7|||
154964395|NCT03480763|559295280|FG000|Overall Study|non-study pneumococcal vaccine|1|||
154964396|NCT03480763|559295281|FG001|Overall Study|non-study pneumococcal vaccine|0|||
154964397|NCT03480763|559295280|FG000|Overall Study|oncological treatment|0|||
154964398|NCT03480763|559295281|FG001|Overall Study|oncological treatment|2|||
154964399|NCT03480763|559295280|FG000|Overall Study|pain with vaccination|1|||
154964400|NCT03480763|559295281|FG001|Overall Study|pain with vaccination|0|||
154964401|NCT01647828|559295282|FG000|Overall Study|Death|3|||
154964402|NCT01647828|559295283|FG001|Overall Study|Death|4|||
154964403|NCT01647828|559295284|FG002|Overall Study|Death|4|||
154964404|NCT01647828|559295285|FG003|Overall Study|Death|5|||
154964405|NCT01647828|559295286|FG004|Overall Study|Death|6|||
154964406|NCT01647828|559295287|FG005|Overall Study|Death|3|||
154964407|NCT01647828|559295288|FG006|Overall Study|Death|10|||
154964408|NCT01647828|559295289|FG007|Overall Study|Death|60|||
154964409|NCT01647828|559295290|FG008|Overall Study|Death|71|||
154964410|NCT01647828|559295282|FG000|Overall Study|Withdrawal by Subject|2|||
154964411|NCT01647828|559295283|FG001|Overall Study|Withdrawal by Subject|0|||
154964412|NCT01647828|559295284|FG002|Overall Study|Withdrawal by Subject|0|||
154964413|NCT01647828|559295285|FG003|Overall Study|Withdrawal by Subject|1|||
154964414|NCT01647828|559295286|FG004|Overall Study|Withdrawal by Subject|0|||
154964415|NCT01647828|559295287|FG005|Overall Study|Withdrawal by Subject|0|||
154964416|NCT01647828|559295288|FG006|Overall Study|Withdrawal by Subject|1|||
154964417|NCT01647828|559295289|FG007|Overall Study|Withdrawal by Subject|0|||
154964418|NCT01647828|559295290|FG008|Overall Study|Withdrawal by Subject|2|||
154964419|NCT01647828|559295282|FG000|Overall Study|Study terminated by Sponsor|0|||
154964420|NCT01647828|559295283|FG001|Overall Study|Study terminated by Sponsor|0|||
154964421|NCT01647828|559295284|FG002|Overall Study|Study terminated by Sponsor|0|||
154964422|NCT01647828|559295285|FG003|Overall Study|Study terminated by Sponsor|0|||
154964423|NCT01647828|559295286|FG004|Overall Study|Study terminated by Sponsor|0|||
154964424|NCT01647828|559295287|FG005|Overall Study|Study terminated by Sponsor|0|||
154964425|NCT01647828|559295288|FG006|Overall Study|Study terminated by Sponsor|1|||
154964426|NCT01647828|559295289|FG007|Overall Study|Study terminated by Sponsor|26|||
154964427|NCT01647828|559295290|FG008|Overall Study|Study terminated by Sponsor|16|||
155351489|NCT04150341|560721653|FG004|Overall Study|Physician Decision|0|||
155351490|NCT04150341|560721654|FG005|Overall Study|Physician Decision|0|||
155351491|NCT04150341|560721649|FG000|Overall Study|Adverse Event|0|||
155351492|NCT04150341|560721650|FG001|Overall Study|Adverse Event|0|||
154964428|NCT01647828|559295282|FG000|Overall Study|Lost to Follow-up|0|||
154964429|NCT01647828|559295283|FG001|Overall Study|Lost to Follow-up|0|||
154964430|NCT01647828|559295284|FG002|Overall Study|Lost to Follow-up|0|||
154964431|NCT01647828|559295285|FG003|Overall Study|Lost to Follow-up|0|||
154964432|NCT01647828|559295286|FG004|Overall Study|Lost to Follow-up|0|||
154964433|NCT01647828|559295287|FG005|Overall Study|Lost to Follow-up|0|||
155351493|NCT04150341|560721651|FG002|Overall Study|Adverse Event|0|||
154964434|NCT01647828|559295288|FG006|Overall Study|Lost to Follow-up|0|||
154964435|NCT01647828|559295289|FG007|Overall Study|Lost to Follow-up|2|||
154964436|NCT01647828|559295290|FG008|Overall Study|Lost to Follow-up|0|||
154964437|NCT00115063|559295293|FG000|Overall Study|Lost to Follow-up|98|||
154964438|NCT00115063|559295294|FG001|Overall Study|Lost to Follow-up|104|||
154964439|NCT00115063|559295293|FG000|Overall Study|Death|1|||
154964440|NCT00115063|559295294|FG001|Overall Study|Death|0|||
154964441|NCT03808376|559295295|FG000|Overall Study|Withdrawal by Subject|10|||
154964442|NCT00185458|559295298|FG000|Contraception Phase|Adverse Event|37|||
154964443|NCT00185458|559295298|FG000|Contraception Phase|Lost to Follow-up|10|||
154964444|NCT00185458|559295298|FG000|Contraception Phase|Protocol Violation|2|||
155084607|NCT02037984|559740770|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
155084608|NCT02037984|559740771|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
155084609|NCT02037984|559740772|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
155084610|NCT02037984|559740765|FG000|Overall Study|Withdrawal by Subject|0|||
155084611|NCT02037984|559740766|FG001|Overall Study|Withdrawal by Subject|0|||
155084612|NCT02037984|559740767|FG002|Overall Study|Withdrawal by Subject|0|||
155084613|NCT02037984|559740768|FG003|Overall Study|Withdrawal by Subject|1|||
155084614|NCT02037984|559740769|FG004|Overall Study|Withdrawal by Subject|1|||
155084615|NCT02037984|559740770|FG005|Overall Study|Withdrawal by Subject|3|||
155084616|NCT02037984|559740771|FG006|Overall Study|Withdrawal by Subject|0|||
155084617|NCT02037984|559740772|FG007|Overall Study|Withdrawal by Subject|1|||
155084618|NCT00974233|559740778|FG000|Induction Chemoimmunotherapy|Death|2|||
155084619|NCT00974233|559740778|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
155084620|NCT00974233|559740778|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
155084621|NCT00974233|559740778|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
155084622|NCT00974233|559740778|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
155084623|NCT00974233|559740778|FG000|Maintenance Lenalidomide|Adverse Event|8|||
155084624|NCT01691092|559740779|FG000|Overall Study|Lost to Follow-up|10|||
155084625|NCT01691092|559740779|FG000|Overall Study|Physician Decision|4|||
155084626|NCT01691092|559740779|FG000|Overall Study|Withdrawal by Subject|3|||
155084627|NCT01691092|559740779|FG000|Overall Study|non-compliance|3|||
155084628|NCT01691092|559740779|FG000|Overall Study|used for different study|2|||
155084629|NCT01691092|559740779|FG000|Overall Study|screen fail|19|||
155084630|NCT00581100|559742332|FG000|Overall Study|Death|1|||
155084631|NCT00581100|559742333|FG001|Overall Study|Death|0|||
155084632|NCT00581100|559742332|FG000|Overall Study|Adverse Event|2|||
155084633|NCT00581100|559742333|FG001|Overall Study|Adverse Event|1|||
155084634|NCT00581100|559742332|FG000|Overall Study|Withdrawal by Subject|1|||
155084635|NCT00581100|559742333|FG001|Overall Study|Withdrawal by Subject|4|||
155084636|NCT00581100|559742332|FG000|Overall Study|Other|3|||
155084637|NCT00581100|559742333|FG001|Overall Study|Other|0|||
155084638|NCT04129398|559742334|FG000|Overall Study|Physician Decision|2|||
155084639|NCT00590317|559742335|FG000|Overall Study|Lack of Efficacy|1|||
155084640|NCT00590317|559742336|FG001|Overall Study|Lack of Efficacy|5|||
155084641|NCT04280783|559742337|FG000|Overall Study|Family issues unrelated to the study.|1|||
155084642|NCT04280783|559742338|FG001|Overall Study|Family issues unrelated to the study.|0|||
155084643|NCT04280783|559742337|FG000|Overall Study|Withdrawal by Subject|0|||
155084644|NCT04280783|559742338|FG001|Overall Study|Withdrawal by Subject|1|||
155084645|NCT01394185|559742339|FG000|Overall Study|Withdrawal by Subject|2|||
155084646|NCT01394185|559742340|FG001|Overall Study|Withdrawal by Subject|0|||
155084647|NCT01394185|559742341|FG002|Overall Study|Withdrawal by Subject|0|||
155084648|NCT01394185|559742342|FG003|Overall Study|Withdrawal by Subject|0|||
155084649|NCT01394185|559742343|FG004|Overall Study|Withdrawal by Subject|1|||
155084650|NCT01394185|559742344|FG005|Overall Study|Withdrawal by Subject|0|||
155351494|NCT04150341|560721652|FG003|Overall Study|Adverse Event|0|||
155351495|NCT04150341|560721653|FG004|Overall Study|Adverse Event|1|||
155351496|NCT04150341|560721654|FG005|Overall Study|Adverse Event|0|||
155351497|NCT00875615|560721655|FG000|Overall Study|Withdrawal by Subject|1|||
155351498|NCT00405912|560721657|FG000|Overall Study|Withdrawal by Subject|12|||
155351499|NCT00405912|560721658|FG001|Overall Study|Withdrawal by Subject|11|||
155351500|NCT00405912|560721659|FG002|Overall Study|Withdrawal by Subject|12|||
155351501|NCT00405912|560721657|FG000|Overall Study|Lost to Follow-up|4|||
155351502|NCT00405912|560721658|FG001|Overall Study|Lost to Follow-up|8|||
155351503|NCT00405912|560721659|FG002|Overall Study|Lost to Follow-up|4|||
155351504|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
155351505|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
155351506|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
155351507|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
155351508|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
155351509|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
155351510|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
155351511|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
155351512|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Death|6|||
155351513|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Death|2|||
155351514|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Death|2|||
155351515|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Death|9|||
155084651|NCT01394185|559742339|FG000|Overall Study|Change in protocol|3|||
155084652|NCT01394185|559742340|FG001|Overall Study|Change in protocol|0|||
155084653|NCT01394185|559742341|FG002|Overall Study|Change in protocol|0|||
155084654|NCT01394185|559742342|FG003|Overall Study|Change in protocol|0|||
155084655|NCT01394185|559742343|FG004|Overall Study|Change in protocol|3|||
155084656|NCT01394185|559742344|FG005|Overall Study|Change in protocol|0|||
155084657|NCT01394185|559742339|FG000|Overall Study|Protocol Violation|1|||
155084658|NCT01394185|559742340|FG001|Overall Study|Protocol Violation|0|||
155084659|NCT01394185|559742341|FG002|Overall Study|Protocol Violation|0|||
155084660|NCT01394185|559742342|FG003|Overall Study|Protocol Violation|1|||
155351516|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
155351517|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155351518|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155351519|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
155351520|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
155351521|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
155351522|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
155351523|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
155351524|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
155351525|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
155351526|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
155351527|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
155351528|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
155351529|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
155351530|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
155351531|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
155351532|NCT03730662|560721660|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
155351533|NCT03730662|560721661|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
155351534|NCT03730662|560721662|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
155165613|NCT00953056|560043503|FG005|Overall Study|Serious Adverse Event|1|||
155351535|NCT03730662|560721663|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
155351536|NCT03730662|560721660|FG000|Variable Treatment Period|Adverse Event|1|||
155351537|NCT03730662|560721661|FG001|Variable Treatment Period|Adverse Event|2|||
155351538|NCT03730662|560721662|FG002|Variable Treatment Period|Adverse Event|0|||
155351539|NCT03730662|560721663|FG003|Variable Treatment Period|Adverse Event|7|||
155351540|NCT03730662|560721660|FG000|Variable Treatment Period|Death|9|||
155351541|NCT03730662|560721661|FG001|Variable Treatment Period|Death|0|||
155351542|NCT03730662|560721662|FG002|Variable Treatment Period|Death|6|||
155351543|NCT03730662|560721663|FG003|Variable Treatment Period|Death|26|||
155351544|NCT03730662|560721660|FG000|Variable Treatment Period|Lost to Follow-up|2|||
155351545|NCT03730662|560721661|FG001|Variable Treatment Period|Lost to Follow-up|1|||
155351546|NCT03730662|560721662|FG002|Variable Treatment Period|Lost to Follow-up|4|||
155351547|NCT03730662|560721663|FG003|Variable Treatment Period|Lost to Follow-up|11|||
155351548|NCT03730662|560721660|FG000|Variable Treatment Period|Personal Reason|0|||
155351549|NCT03730662|560721661|FG001|Variable Treatment Period|Personal Reason|2|||
155351550|NCT03730662|560721662|FG002|Variable Treatment Period|Personal Reason|1|||
155351551|NCT03730662|560721663|FG003|Variable Treatment Period|Personal Reason|6|||
155351552|NCT03730662|560721660|FG000|Variable Treatment Period|Physician Decision|0|||
155351553|NCT03730662|560721661|FG001|Variable Treatment Period|Physician Decision|0|||
155351554|NCT03730662|560721662|FG002|Variable Treatment Period|Physician Decision|0|||
155351555|NCT03730662|560721663|FG003|Variable Treatment Period|Physician Decision|3|||
155351556|NCT03730662|560721660|FG000|Variable Treatment Period|Protocol Violation|0|||
155351557|NCT03730662|560721661|FG001|Variable Treatment Period|Protocol Violation|1|||
155351558|NCT03730662|560721662|FG002|Variable Treatment Period|Protocol Violation|1|||
155351559|NCT03730662|560721663|FG003|Variable Treatment Period|Protocol Violation|1|||
155351560|NCT03730662|560721660|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
155351561|NCT03730662|560721661|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
155351562|NCT03730662|560721662|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
155351563|NCT03730662|560721663|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
155351564|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
155351565|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
155351566|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
155351567|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
155351568|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Death|0|||
155351569|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Death|1|||
155351570|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
155351571|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
155351572|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
155351573|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
155351574|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
155351575|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
155351576|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
155351577|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
155351578|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
155351579|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
155351580|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
155351581|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
155351582|NCT01309243|560721669|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
155351583|NCT01309243|560721670|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
155351584|NCT01309243|560721669|FG000|Extension Phase|Lost to Follow-up|6|||
155351585|NCT01309243|560721670|FG001|Extension Phase|Lost to Follow-up|0|||
155351586|NCT00632931|560721671|FG000|Part 1, Period 1|Protocol Violation|1|||
155351587|NCT00632931|560721672|FG001|Part 1, Period 1|Protocol Violation|0|||
155351588|NCT00632931|560721673|FG002|Part 1, Period 1|Protocol Violation|0|||
155351589|NCT00632931|560721671|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
155351590|NCT00632931|560721672|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
155351591|NCT00632931|560721673|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
155351592|NCT00632931|560721671|FG000|Part 2|Adverse Event|0|||
155351593|NCT00632931|560721672|FG001|Part 2|Adverse Event|0|||
155351594|NCT00632931|560721673|FG002|Part 2|Adverse Event|3|||
155351595|NCT00632931|560721671|FG000|Part 2|Death|0|||
155351596|NCT00632931|560721672|FG001|Part 2|Death|0|||
155351597|NCT00632931|560721673|FG002|Part 2|Death|1|||
155351598|NCT00632931|560721671|FG000|Part 2|Lack of Efficacy|0|||
155351599|NCT00632931|560721672|FG001|Part 2|Lack of Efficacy|0|||
155351600|NCT00632931|560721673|FG002|Part 2|Lack of Efficacy|17|||
155351601|NCT00632931|560721671|FG000|Part 2|Withdrawal by Subject|0|||
155351602|NCT00632931|560721672|FG001|Part 2|Withdrawal by Subject|0|||
155351603|NCT00632931|560721673|FG002|Part 2|Withdrawal by Subject|3|||
155351604|NCT00833898|560721674|FG000|Overall Study|Withdrawal by Subject|33|||
155351605|NCT00833898|560721675|FG001|Overall Study|Withdrawal by Subject|27|||
155351606|NCT00833898|560721674|FG000|Overall Study|Lost to Follow-up|7|||
155351607|NCT00833898|560721675|FG001|Overall Study|Lost to Follow-up|7|||
155351608|NCT00833898|560721674|FG000|Overall Study|Patient did not receive transplant|0|||
155351609|NCT00833898|560721675|FG001|Overall Study|Patient did not receive transplant|2|||
155351610|NCT01402063|560721678|FG000|Overall Study|Withdrawal by Subject|3|||
155351611|NCT01402063|560721679|FG001|Overall Study|Withdrawal by Subject|3|||
155351612|NCT03712449|560721684|FG000|Overall Study|Withdraw Consent|0|||
155351613|NCT03712449|560721685|FG001|Overall Study|Withdraw Consent|1|||
155351614|NCT00666198|560721686|FG000|Overall Study|Protocol Violation|10|||
155351615|NCT00666198|560721686|FG000|Overall Study|No Visit After First Day of Treatment|13|||
155351616|NCT00666198|560721686|FG000|Overall Study|Safety Not Assessable|6|||
155351617|NCT00666198|560721686|FG000|Overall Study|No Drug Administration|4|||
154964445|NCT00185458|559295298|FG000|Contraception Phase|Physician Decision|2|||
154964446|NCT00185458|559295298|FG000|Contraception Phase|Withdrawal by Subject|7|||
154964447|NCT00185458|559295298|FG000|HRT Phase|Adverse Event|18|||
154964448|NCT00185458|559295298|FG000|HRT Phase|Lost to Follow-up|4|||
154964449|NCT00185458|559295298|FG000|HRT Phase|Protocol Violation|2|||
154964450|NCT00185458|559295298|FG000|HRT Phase|Withdrawal by Subject|3|||
154964451|NCT03503318|559295299|FG000|Overall Study|Death|1|||
154964452|NCT03503318|559295300|FG001|Overall Study|Death|0|||
154964453|NCT03503318|559295301|FG002|Overall Study|Death|4|||
154964454|NCT03503318|559295299|FG000|Overall Study|Adverse Event|3|||
154964455|NCT03503318|559295300|FG001|Overall Study|Adverse Event|4|||
154964456|NCT03503318|559295301|FG002|Overall Study|Adverse Event|2|||
154964457|NCT03503318|559295299|FG000|Overall Study|Withdrawal by Subject|12|||
154964458|NCT03503318|559295300|FG001|Overall Study|Withdrawal by Subject|17|||
154964459|NCT03503318|559295301|FG002|Overall Study|Withdrawal by Subject|16|||
154964460|NCT03503318|559295299|FG000|Overall Study|Protocol Violation|5|||
154964461|NCT03503318|559295300|FG001|Overall Study|Protocol Violation|0|||
154964462|NCT03503318|559295301|FG002|Overall Study|Protocol Violation|3|||
154964463|NCT03503318|559295299|FG000|Overall Study|Lost to Follow-up|17|||
154964464|NCT03503318|559295300|FG001|Overall Study|Lost to Follow-up|15|||
154964465|NCT03503318|559295301|FG002|Overall Study|Lost to Follow-up|12|||
154964466|NCT03503318|559295299|FG000|Overall Study|Other than specified|1|||
154964467|NCT03503318|559295300|FG001|Overall Study|Other than specified|3|||
154964468|NCT03503318|559295301|FG002|Overall Study|Other than specified|3|||
154964469|NCT01838681|559295305|FG000|Period A|Adverse Event|39|||
154964470|NCT01838681|559295306|FG001|Period A|Adverse Event|0|||
154964471|NCT01838681|559295307|FG002|Period A|Adverse Event|0|||
154964472|NCT01838681|559295308|FG003|Period A|Adverse Event|0|||
154964473|NCT01838681|559295305|FG000|Period A|Lack of Efficacy|21|||
154964474|NCT01838681|559295306|FG001|Period A|Lack of Efficacy|0|||
154964475|NCT01838681|559295307|FG002|Period A|Lack of Efficacy|0|||
154964476|NCT01838681|559295308|FG003|Period A|Lack of Efficacy|0|||
154964477|NCT01838681|559295305|FG000|Period A|Early response|148|||
154964478|NCT01838681|559295306|FG001|Period A|Early response|0|||
154964479|NCT01838681|559295307|FG002|Period A|Early response|0|||
154964480|NCT01838681|559295308|FG003|Period A|Early response|0|||
154964481|NCT01838681|559295305|FG000|Period A|Withdrawal by Subject|70|||
154964482|NCT01838681|559295306|FG001|Period A|Withdrawal by Subject|0|||
154964483|NCT01838681|559295307|FG002|Period A|Withdrawal by Subject|0|||
154964484|NCT01838681|559295308|FG003|Period A|Withdrawal by Subject|0|||
155084661|NCT01394185|559742343|FG004|Overall Study|Protocol Violation|0|||
155084662|NCT01394185|559742344|FG005|Overall Study|Protocol Violation|1|||
155084663|NCT04110145|559742345|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155084664|NCT04110145|559742346|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155084665|NCT04110145|559742347|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155084666|NCT04110145|559742348|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
155084667|NCT04110145|559742349|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
155084668|NCT02904265|559742350|FG000|Overall Study|Physician Decision|1|||
155084669|NCT02904265|559742351|FG001|Overall Study|Physician Decision|2|||
155084670|NCT00185614|559742354|FG000|Inter-treatment Period|Physician Decision|1|||
154964485|NCT01838681|559295305|FG000|Period A|Protocol Violation|16|||
154964486|NCT01838681|559295306|FG001|Period A|Protocol Violation|0|||
155084671|NCT00185614|559742354|FG000|Inter-treatment Period|Relapse|2|||
155351618|NCT03220776|560721687|FG000|Overall Study|Claustrophobia|0|||
155351619|NCT03220776|560721688|FG001|Overall Study|Claustrophobia|1|||
155351620|NCT03220776|560721689|FG002|Overall Study|Claustrophobia|1|||
155351621|NCT03220776|560721690|FG003|Overall Study|Claustrophobia|0|||
155351622|NCT03220776|560721691|FG004|Overall Study|Claustrophobia|1|||
155351623|NCT03220776|560721692|FG005|Overall Study|Claustrophobia|0|||
155351624|NCT03220776|560721687|FG000|Overall Study|MRI Equipment Failure|1|||
155351625|NCT03220776|560721688|FG001|Overall Study|MRI Equipment Failure|0|||
155351626|NCT03220776|560721689|FG002|Overall Study|MRI Equipment Failure|0|||
155351627|NCT03220776|560721690|FG003|Overall Study|MRI Equipment Failure|0|||
155351628|NCT03220776|560721691|FG004|Overall Study|MRI Equipment Failure|0|||
155351629|NCT03220776|560721692|FG005|Overall Study|MRI Equipment Failure|0|||
155351630|NCT03220776|560721687|FG000|Overall Study|Inclimate Weather|0|||
155351631|NCT03220776|560721688|FG001|Overall Study|Inclimate Weather|0|||
155351632|NCT03220776|560721689|FG002|Overall Study|Inclimate Weather|0|||
155351633|NCT03220776|560721690|FG003|Overall Study|Inclimate Weather|0|||
155351634|NCT03220776|560721691|FG004|Overall Study|Inclimate Weather|0|||
154964487|NCT01838681|559295307|FG002|Period A|Protocol Violation|0|||
154964488|NCT01838681|559295308|FG003|Period A|Protocol Violation|0|||
154964489|NCT01838681|559295305|FG000|Period A|Non-compliance with IMP|6|||
154964490|NCT01838681|559295306|FG001|Period A|Non-compliance with IMP|0|||
154964491|NCT01838681|559295307|FG002|Period A|Non-compliance with IMP|0|||
154964492|NCT01838681|559295308|FG003|Period A|Non-compliance with IMP|0|||
155351635|NCT03220776|560721692|FG005|Overall Study|Inclimate Weather|1|||
155351636|NCT03220776|560721687|FG000|Overall Study|Physician Decision|0|||
155351637|NCT03220776|560721688|FG001|Overall Study|Physician Decision|0|||
155084672|NCT00185614|559742354|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
155084673|NCT00866775|559742364|FG000|Overall Study|Adverse Event|5|||
155084674|NCT00866775|559742365|FG001|Overall Study|Adverse Event|19|||
155084675|NCT00866775|559742364|FG000|Overall Study|Death|1|||
155084676|NCT00866775|559742365|FG001|Overall Study|Death|0|||
155084677|NCT00866775|559742364|FG000|Overall Study|Lost to Follow-up|0|||
155084678|NCT00866775|559742365|FG001|Overall Study|Lost to Follow-up|4|||
155084679|NCT00866775|559742364|FG000|Overall Study|Physician Decision|0|||
155084680|NCT00866775|559742365|FG001|Overall Study|Physician Decision|3|||
155084681|NCT00866775|559742364|FG000|Overall Study|Protocol Violation|3|||
155084682|NCT00866775|559742365|FG001|Overall Study|Protocol Violation|4|||
155084683|NCT00866775|559742364|FG000|Overall Study|Withdrawal by Subject|4|||
155084684|NCT00866775|559742365|FG001|Overall Study|Withdrawal by Subject|4|||
155084685|NCT00866775|559742364|FG000|Overall Study|met exit criteria|23|||
155084686|NCT00866775|559742365|FG001|Overall Study|met exit criteria|17|||
155084687|NCT00866775|559742364|FG000|Overall Study|discontinued due to communication error|0|||
155084688|NCT00866775|559742365|FG001|Overall Study|discontinued due to communication error|1|||
155084689|NCT00003907|559742366|FG000|Overall Study|Adverse Event|2|||
155084690|NCT00003907|559742367|FG001|Overall Study|Adverse Event|11|||
155084691|NCT00003907|559742366|FG000|Overall Study|Death|2|||
155084692|NCT00003907|559742367|FG001|Overall Study|Death|0|||
155084693|NCT00003907|559742366|FG000|Overall Study|Withdrawal by Subject|1|||
155084694|NCT00003907|559742367|FG001|Overall Study|Withdrawal by Subject|3|||
155084695|NCT00003907|559742366|FG000|Overall Study|Progressive disease|4|||
155084696|NCT00003907|559742367|FG001|Overall Study|Progressive disease|4|||
155084697|NCT00003907|559742366|FG000|Overall Study|Complicating disease|1|||
155084698|NCT00003907|559742367|FG001|Overall Study|Complicating disease|0|||
155084699|NCT00003907|559742366|FG000|Overall Study|Other|1|||
155084700|NCT00003907|559742367|FG001|Overall Study|Other|3|||
155084701|NCT00003907|559742366|FG000|Overall Study|ineligible or not treated|2|||
155084702|NCT00003907|559742367|FG001|Overall Study|ineligible or not treated|2|||
155084703|NCT02254460|559742370|FG000|Overall Study|Adverse Event|1|||
155084704|NCT02254460|559742371|FG001|Overall Study|Adverse Event|0|||
155084705|NCT00993473|559742372|FG000|Overall Study|Adverse Event|0|||
155084706|NCT00993473|559742373|FG001|Overall Study|Adverse Event|2|||
155084707|NCT00993473|559742372|FG000|Overall Study|Protocol Violation|1|||
155084708|NCT00993473|559742373|FG001|Overall Study|Protocol Violation|2|||
155084709|NCT00993473|559742372|FG000|Overall Study|Lost to Follow-up|1|||
155084710|NCT00993473|559742373|FG001|Overall Study|Lost to Follow-up|0|||
155084711|NCT00993473|559742372|FG000|Overall Study|Withdrawal by Subject|1|||
155084712|NCT00993473|559742373|FG001|Overall Study|Withdrawal by Subject|5|||
155084713|NCT00993473|559742372|FG000|Overall Study|Technical problem with CGM device|0|||
155084714|NCT00993473|559742373|FG001|Overall Study|Technical problem with CGM device|1|||
155084715|NCT00993473|559742372|FG000|Overall Study|Family event|1|||
155084716|NCT00993473|559742373|FG001|Overall Study|Family event|0|||
155084717|NCT00770679|559742376|FG000|Overall Study|Lost to Follow-up|3|||
155084718|NCT00770679|559742376|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
155084719|NCT01148771|559742378|FG000|Washout Period|Withdrawal by Subject|0|||
155084720|NCT01148771|559742379|FG001|Washout Period|Withdrawal by Subject|1|||
155084721|NCT01047540|559742380|FG000|Overall Study|Protocol Violation|1|||
155084722|NCT01047540|559742381|FG001|Overall Study|Protocol Violation|0|||
155084723|NCT01047540|559742382|FG002|Overall Study|Protocol Violation|0|||
155084724|NCT01047540|559742383|FG003|Overall Study|Protocol Violation|0|||
155084725|NCT01047540|559742384|FG004|Overall Study|Protocol Violation|0|||
155084726|NCT01047540|559742380|FG000|Overall Study|Lost to Follow-up|1|||
155084727|NCT01047540|559742381|FG001|Overall Study|Lost to Follow-up|0|||
155351638|NCT03220776|560721689|FG002|Overall Study|Physician Decision|0|||
155351639|NCT03220776|560721690|FG003|Overall Study|Physician Decision|1|||
155351640|NCT03220776|560721691|FG004|Overall Study|Physician Decision|0|||
155351641|NCT03220776|560721692|FG005|Overall Study|Physician Decision|0|||
155351642|NCT03220776|560721687|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351643|NCT03220776|560721688|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155084728|NCT01047540|559742382|FG002|Overall Study|Lost to Follow-up|0|||
155351644|NCT03220776|560721689|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351645|NCT03220776|560721690|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
155084729|NCT01047540|559742383|FG003|Overall Study|Lost to Follow-up|0|||
155084730|NCT01047540|559742384|FG004|Overall Study|Lost to Follow-up|0|||
155084731|NCT01047540|559742380|FG000|Overall Study|Withdrawal by Subject|1|||
155084732|NCT01047540|559742381|FG001|Overall Study|Withdrawal by Subject|0|||
155084733|NCT01047540|559742382|FG002|Overall Study|Withdrawal by Subject|3|||
155084734|NCT01047540|559742383|FG003|Overall Study|Withdrawal by Subject|0|||
155084735|NCT01047540|559742384|FG004|Overall Study|Withdrawal by Subject|1|||
155084736|NCT01047540|559742380|FG000|Overall Study|Pregnancy|1|||
155084737|NCT01047540|559742381|FG001|Overall Study|Pregnancy|0|||
155084738|NCT01047540|559742382|FG002|Overall Study|Pregnancy|0|||
155351646|NCT03220776|560721691|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351647|NCT03220776|560721692|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
155351648|NCT03220776|560721687|FG000|Overall Study|Protocol Violation|0|||
155351649|NCT03220776|560721688|FG001|Overall Study|Protocol Violation|0|||
155351650|NCT03220776|560721689|FG002|Overall Study|Protocol Violation|0|||
155351651|NCT03220776|560721690|FG003|Overall Study|Protocol Violation|2|||
155351652|NCT03220776|560721691|FG004|Overall Study|Protocol Violation|0|||
155351653|NCT03220776|560721692|FG005|Overall Study|Protocol Violation|1|||
155351654|NCT03220776|560721687|FG000|Overall Study|Withdrawal by Subject|1|||
155351655|NCT03220776|560721688|FG001|Overall Study|Withdrawal by Subject|0|||
155351656|NCT03220776|560721689|FG002|Overall Study|Withdrawal by Subject|0|||
155351657|NCT03220776|560721690|FG003|Overall Study|Withdrawal by Subject|0|||
155351658|NCT03220776|560721691|FG004|Overall Study|Withdrawal by Subject|0|||
155351659|NCT03220776|560721692|FG005|Overall Study|Withdrawal by Subject|0|||
154964493|NCT01838681|559295305|FG000|Period A|Lost to Follow-up|4|||
155351660|NCT03029234|560721694|FG000|Overall Study|Sponsor Decision|1|||
154964494|NCT01838681|559295306|FG001|Period A|Lost to Follow-up|0|||
155351661|NCT03029234|560721694|FG000|Overall Study|Withdrawal by Subject|5|||
155351662|NCT03029234|560721694|FG000|Overall Study|Death|91|||
155351663|NCT03029234|560721694|FG000|Overall Study|Lost to Follow-up|2|||
155351664|NCT04491006|560721695|FG000|Overall Study|Adverse Event|0|||
155351665|NCT04491006|560721696|FG001|Overall Study|Adverse Event|3|||
155351666|NCT04491006|560721697|FG002|Overall Study|Adverse Event|5|||
155351667|NCT04491006|560721695|FG000|Overall Study|Withdrawal by Subject|1|||
155351668|NCT04491006|560721696|FG001|Overall Study|Withdrawal by Subject|0|||
155351669|NCT04491006|560721697|FG002|Overall Study|Withdrawal by Subject|2|||
155351670|NCT02166047|560721698|FG000|Overall Study|Withdrawal by Participant|0|||
155351671|NCT02166047|560721699|FG001|Overall Study|Withdrawal by Participant|1|||
155351672|NCT02166047|560721700|FG002|Overall Study|Withdrawal by Participant|2|||
155351673|NCT02166047|560721701|FG003|Overall Study|Withdrawal by Participant|0|||
155351674|NCT02166047|560721702|FG004|Overall Study|Withdrawal by Participant|0|||
155351675|NCT02166047|560721703|FG005|Overall Study|Withdrawal by Participant|0|||
155351676|NCT02166047|560721704|FG006|Overall Study|Withdrawal by Participant|1|||
155351677|NCT02166047|560721705|FG007|Overall Study|Withdrawal by Participant|0|||
155351678|NCT02166047|560721706|FG008|Overall Study|Withdrawal by Participant|0|||
155351679|NCT02166047|560721707|FG009|Overall Study|Withdrawal by Participant|0|||
155351680|NCT02166047|560721708|FG010|Overall Study|Withdrawal by Participant|0|||
155351681|NCT02166047|560721709|FG011|Overall Study|Withdrawal by Participant|0|||
155351682|NCT02166047|560721698|FG000|Overall Study|Adverse Event|0|||
155351683|NCT02166047|560721699|FG001|Overall Study|Adverse Event|0|||
155351684|NCT02166047|560721700|FG002|Overall Study|Adverse Event|0|||
155351685|NCT02166047|560721701|FG003|Overall Study|Adverse Event|0|||
155351686|NCT02166047|560721702|FG004|Overall Study|Adverse Event|1|||
155351687|NCT02166047|560721703|FG005|Overall Study|Adverse Event|0|||
155351688|NCT02166047|560721704|FG006|Overall Study|Adverse Event|1|||
155351689|NCT02166047|560721705|FG007|Overall Study|Adverse Event|0|||
155351690|NCT02166047|560721706|FG008|Overall Study|Adverse Event|0|||
155351691|NCT02166047|560721707|FG009|Overall Study|Adverse Event|0|||
155351692|NCT02166047|560721708|FG010|Overall Study|Adverse Event|2|||
155351693|NCT02166047|560721709|FG011|Overall Study|Adverse Event|0|||
155351694|NCT00451555|560721718|FG000|Overall Study|Protocol Violation|2|||
155351695|NCT00451555|560721719|FG001|Overall Study|Protocol Violation|2|||
155351696|NCT00451555|560721718|FG000|Overall Study|Adverse Event|3|||
155351697|NCT00451555|560721719|FG001|Overall Study|Adverse Event|1|||
155351698|NCT00451555|560721718|FG000|Overall Study|Withdrawal by Subject|6|||
155351699|NCT00451555|560721719|FG001|Overall Study|Withdrawal by Subject|0|||
155351700|NCT00451555|560721718|FG000|Overall Study|Physician Decision|2|||
155351701|NCT00451555|560721719|FG001|Overall Study|Physician Decision|1|||
155351702|NCT01004185|560721728|FG000|Overall Study|Adverse Event|1|||
155351703|NCT01004185|560721729|FG001|Overall Study|Adverse Event|1|||
155351704|NCT01004185|560721728|FG000|Overall Study|Lost to Follow-up|0|||
155351705|NCT01004185|560721729|FG001|Overall Study|Lost to Follow-up|1|||
155351706|NCT01004185|560721728|FG000|Overall Study|Lack of Efficacy|2|||
155351707|NCT01004185|560721729|FG001|Overall Study|Lack of Efficacy|1|||
155351708|NCT01004185|560721728|FG000|Overall Study|Sponsor Terminated Study|4|||
155351709|NCT01004185|560721729|FG001|Overall Study|Sponsor Terminated Study|5|||
155351710|NCT01004185|560721728|FG000|Overall Study|Withdrawal by Subject|2|||
155351711|NCT01004185|560721729|FG001|Overall Study|Withdrawal by Subject|1|||
155351712|NCT00797511|560721730|FG000|Overall Study|Withdrawal by Subject|1|||
155351713|NCT01990664|560721731|FG000|Overall Study|Lost to Follow-up|2|||
155351714|NCT01990664|560721732|FG001|Overall Study|Lost to Follow-up|6|||
155351715|NCT01990664|560721731|FG000|Overall Study|Withdrawal by Subject|2|||
155351716|NCT01990664|560721732|FG001|Overall Study|Withdrawal by Subject|3|||
155351717|NCT01990664|560721731|FG000|Overall Study|Protocol Violation|1|||
155351718|NCT01990664|560721732|FG001|Overall Study|Protocol Violation|0|||
155351719|NCT01990664|560721731|FG000|Overall Study|Lens Discomfort|1|||
155351720|NCT01990664|560721732|FG001|Overall Study|Lens Discomfort|1|||
155351721|NCT01990664|560721731|FG000|Overall Study|Lens Handling Difficulties|1|||
155351722|NCT01990664|560721732|FG001|Overall Study|Lens Handling Difficulties|0|||
155351723|NCT01990664|560721731|FG000|Overall Study|Unsatisfactory Visual Response|0|||
155351724|NCT01990664|560721732|FG001|Overall Study|Unsatisfactory Visual Response|1|||
155351725|NCT02630706|560721737|FG000|Overall Study|Adverse Event|2|||
155351726|NCT02630706|560721738|FG001|Overall Study|Adverse Event|1|||
155351727|NCT02630706|560721739|FG002|Overall Study|Adverse Event|1|||
155351728|NCT02630706|560721737|FG000|Overall Study|Lost to Follow-up|0|||
155351729|NCT02630706|560721738|FG001|Overall Study|Lost to Follow-up|1|||
155351730|NCT02630706|560721739|FG002|Overall Study|Lost to Follow-up|2|||
155351731|NCT02630706|560721737|FG000|Overall Study|Physician Decision|1|||
155351732|NCT02630706|560721738|FG001|Overall Study|Physician Decision|1|||
155351733|NCT02630706|560721739|FG002|Overall Study|Physician Decision|0|||
155351734|NCT02630706|560721737|FG000|Overall Study|Pregnancy|0|||
155351735|NCT02630706|560721738|FG001|Overall Study|Pregnancy|1|||
155351736|NCT02630706|560721739|FG002|Overall Study|Pregnancy|0|||
155351737|NCT02630706|560721737|FG000|Overall Study|Withdrawal by Subject|4|||
155351738|NCT02630706|560721738|FG001|Overall Study|Withdrawal by Subject|5|||
155351739|NCT02630706|560721739|FG002|Overall Study|Withdrawal by Subject|7|||
155351740|NCT01678898|560721741|FG000|PB-102-F01|Adverse Event|0|||
155351741|NCT01678898|560721742|FG001|PB-102-F01|Adverse Event|1|||
155351742|NCT01678898|560721743|FG002|PB-102-F01|Adverse Event|0|||
155351743|NCT01678898|560721741|FG000|PB-102-F01|Physician Decision|0|||
155351744|NCT01678898|560721742|FG001|PB-102-F01|Physician Decision|1|||
155351745|NCT01678898|560721743|FG002|PB-102-F01|Physician Decision|0|||
155351746|NCT00853372|560722970|FG000|Overall Study|Death|30|||
155351747|NCT00853372|560722971|FG001|Overall Study|Death|26|||
155351748|NCT00853372|560722970|FG000|Overall Study|Lost to Follow-up|1|||
155351749|NCT00853372|560722971|FG001|Overall Study|Lost to Follow-up|2|||
155351750|NCT00853372|560722970|FG000|Overall Study|Full Consent Withdrawn|1|||
155351751|NCT00853372|560722971|FG001|Overall Study|Full Consent Withdrawn|1|||
155351752|NCT01268098|560722974|FG000|Overall Study|Adverse Event|1|||
155351753|NCT01268098|560722975|FG001|Overall Study|Adverse Event|0|||
155351754|NCT02624869|560722979|FG000|Overall Study|Lost to Follow-up|0|||
155351755|NCT02624869|560722980|FG001|Overall Study|Lost to Follow-up|0|||
155351756|NCT02624869|560722981|FG002|Overall Study|Lost to Follow-up|1|||
155351757|NCT02624869|560722979|FG000|Overall Study|Withdrawal by Subject|1|||
155351758|NCT02624869|560722980|FG001|Overall Study|Withdrawal by Subject|3|||
155351759|NCT02624869|560722981|FG002|Overall Study|Withdrawal by Subject|1|||
155351760|NCT00510198|560722982|FG000|Overall Study|Withdrawal by Subject|5|||
155351761|NCT00510198|560722983|FG001|Overall Study|Withdrawal by Subject|4|||
155351762|NCT01037413|560722984|FG000|Part A: Skin Testing|Adverse Event|1|||
155351763|NCT01037413|560722985|FG001|Part A: Skin Testing|Adverse Event|0|||
155351764|NCT01037413|560722984|FG000|Part A: Skin Testing|Protocol Violation|1|||
155351765|NCT01037413|560722985|FG001|Part A: Skin Testing|Protocol Violation|0|||
155351766|NCT01037413|560722984|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
155351767|NCT01037413|560722985|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
155351768|NCT01037413|560722984|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
155351769|NCT01037413|560722985|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
155351770|NCT00619983|560722986|FG000|Test Drug Alone|Withdrawal by Subject|1|||
155351771|NCT00619983|560722987|FG001|Test Drug Alone|Withdrawal by Subject|0|||
155351772|NCT00619983|560722988|FG002|Test Drug Alone|Withdrawal by Subject|0|||
155351773|NCT00619983|560722989|FG003|Test Drug Alone|Withdrawal by Subject|1|||
155351774|NCT00619983|560722986|FG000|Test Drug Alone|Failure of daily diary device|1|||
155351775|NCT00619983|560722987|FG001|Test Drug Alone|Failure of daily diary device|1|||
155351776|NCT00619983|560722988|FG002|Test Drug Alone|Failure of daily diary device|2|||
155351777|NCT00619983|560722989|FG003|Test Drug Alone|Failure of daily diary device|2|||
155351778|NCT00809341|560722990|FG000|Overall Study|Physician Decision|0|||
155351779|NCT00809341|560722991|FG001|Overall Study|Physician Decision|1|||
155351780|NCT00496626|560722992|FG000|Overall Study|Lost to Follow-up|0|||
155351781|NCT00496626|560722993|FG001|Overall Study|Lost to Follow-up|1|||
155351782|NCT00496626|560722992|FG000|Overall Study|Protocol Violation|1|||
155351783|NCT00496626|560722993|FG001|Overall Study|Protocol Violation|0|||
155351784|NCT00496626|560722992|FG000|Overall Study|Withdrawal by Subject|5|||
155351785|NCT00496626|560722993|FG001|Overall Study|Withdrawal by Subject|4|||
155351786|NCT00496626|560722992|FG000|Overall Study|Relocated|0|||
155351787|NCT00496626|560722993|FG001|Overall Study|Relocated|1|||
155351788|NCT00570921|560722997|FG000|Overall Study|Protocol Violation|1|||
155351789|NCT00570921|560722997|FG000|Overall Study|Physician Decision|1|||
155351790|NCT02560389|560723004|FG000|Overall Study|Lost to Follow-up|1|||
155351791|NCT02560389|560723005|FG001|Overall Study|Lost to Follow-up|2|||
155351792|NCT02560389|560723006|FG002|Overall Study|Lost to Follow-up|2|||
155351793|NCT02560389|560723004|FG000|Overall Study|Tested positive for illicit substance|0|||
155351794|NCT02560389|560723005|FG001|Overall Study|Tested positive for illicit substance|1|||
155351795|NCT02560389|560723006|FG002|Overall Study|Tested positive for illicit substance|0|||
155351796|NCT02716298|560723007|FG000|First Intervention (1 Month)|Lens discomfort|1|||
155351797|NCT02716298|560723008|FG001|First Intervention (1 Month)|Lens discomfort|1|||
154964495|NCT01838681|559295307|FG002|Period A|Lost to Follow-up|0|||
155351798|NCT01281917|560723022|FG000|Overall Study|Withdrawal by Subject|1|||
155351799|NCT00802438|560723023|FG000|Overall Study|Screen Failure|20|||
155351800|NCT00802438|560723023|FG000|Overall Study|Withdrawal by Subject|7|||
155351801|NCT00802438|560723023|FG000|Overall Study|Physician Decision|1|||
155351802|NCT04016805|560723025|FG000|Overall Study|Sponsor's Discretion|30|||
155351803|NCT04016805|560723026|FG001|Overall Study|Sponsor's Discretion|6|||
155351804|NCT04016805|560723027|FG002|Overall Study|Sponsor's Discretion|5|||
155351805|NCT00740870|560723028|FG000|Overall Study|Not Catheterized|4|||
155351806|NCT00740870|560723028|FG000|Overall Study|Further testing contraindicated implant|17|||
155351807|NCT00819013|560723029|FG000|Overall Study|Not meeting continuing study eligibility|2|||
155351808|NCT00819013|560723030|FG001|Overall Study|Not meeting continuing study eligibility|1|||
155351809|NCT00819013|560723031|FG002|Overall Study|Not meeting continuing study eligibility|2|||
155351810|NCT00819013|560723032|FG003|Overall Study|Not meeting continuing study eligibility|1|||
155351811|NCT00819013|560723029|FG000|Overall Study|Adverse Event|0|||
155351812|NCT00819013|560723030|FG001|Overall Study|Adverse Event|0|||
155351813|NCT00819013|560723031|FG002|Overall Study|Adverse Event|1|||
155351814|NCT00819013|560723032|FG003|Overall Study|Adverse Event|0|||
155351815|NCT00819013|560723029|FG000|Overall Study|Withdrawal by Subject|1|||
155351816|NCT00819013|560723030|FG001|Overall Study|Withdrawal by Subject|0|||
155351817|NCT00819013|560723031|FG002|Overall Study|Withdrawal by Subject|1|||
155351818|NCT00819013|560723032|FG003|Overall Study|Withdrawal by Subject|0|||
155351819|NCT00819013|560723029|FG000|Overall Study|Lost to Follow-up|0|||
155351820|NCT00819013|560723030|FG001|Overall Study|Lost to Follow-up|0|||
155351821|NCT00819013|560723031|FG002|Overall Study|Lost to Follow-up|1|||
155351822|NCT00819013|560723032|FG003|Overall Study|Lost to Follow-up|2|||
155351823|NCT00819013|560723029|FG000|Overall Study|Death|0|||
155351824|NCT00819013|560723030|FG001|Overall Study|Death|0|||
155351825|NCT00819013|560723031|FG002|Overall Study|Death|0|||
155351826|NCT00819013|560723032|FG003|Overall Study|Death|1|||
155351827|NCT00607997|560723034|FG000|Overall Study|Lack of Efficacy|6|||
155351828|NCT00607997|560723035|FG001|Overall Study|Lack of Efficacy|20|||
154964496|NCT01838681|559295308|FG003|Period A|Lost to Follow-up|0|||
154964497|NCT01838681|559295305|FG000|Period A|Withdrawal before treatment|4|||
154964498|NCT01838681|559295306|FG001|Period A|Withdrawal before treatment|0|||
154964499|NCT01838681|559295307|FG002|Period A|Withdrawal before treatment|0|||
154964500|NCT01838681|559295308|FG003|Period A|Withdrawal before treatment|0|||
154964501|NCT01838681|559295305|FG000|Period A|Administrative or other reasons|17|||
155351829|NCT00607997|560723036|FG002|Overall Study|Lack of Efficacy|14|||
155351830|NCT00607997|560723037|FG003|Overall Study|Lack of Efficacy|10|||
155351831|NCT00607997|560723034|FG000|Overall Study|Death|8|||
155351832|NCT00607997|560723035|FG001|Overall Study|Death|5|||
155351833|NCT00607997|560723036|FG002|Overall Study|Death|2|||
154964502|NCT01838681|559295306|FG001|Period A|Administrative or other reasons|0|||
154964503|NCT01838681|559295307|FG002|Period A|Administrative or other reasons|0|||
154964504|NCT01838681|559295308|FG003|Period A|Administrative or other reasons|0|||
154964505|NCT01838681|559295305|FG000|Period B/A+|Adverse Event|0|||
154964506|NCT01838681|559295306|FG001|Period B/A+|Adverse Event|13|||
154964507|NCT01838681|559295307|FG002|Period B/A+|Adverse Event|27|||
154964508|NCT01838681|559295308|FG003|Period B/A+|Adverse Event|16|||
155084739|NCT01047540|559742383|FG003|Overall Study|Pregnancy|0|||
155351834|NCT00607997|560723037|FG003|Overall Study|Death|5|||
155351835|NCT00607997|560723034|FG000|Overall Study|Adverse Event|3|||
155351836|NCT00607997|560723035|FG001|Overall Study|Adverse Event|1|||
155351837|NCT00607997|560723036|FG002|Overall Study|Adverse Event|2|||
155351838|NCT00607997|560723037|FG003|Overall Study|Adverse Event|0|||
154964509|NCT01838681|559295305|FG000|Period B/A+|Lack of Efficacy|0|||
154964510|NCT01838681|559295306|FG001|Period B/A+|Lack of Efficacy|9|||
155084740|NCT01047540|559742384|FG004|Overall Study|Pregnancy|0|||
155084741|NCT01047540|559742380|FG000|Overall Study|Adverse Event|1|||
155084742|NCT01047540|559742381|FG001|Overall Study|Adverse Event|0|||
155084743|NCT01047540|559742382|FG002|Overall Study|Adverse Event|0|||
155351839|NCT00607997|560723034|FG000|Overall Study|Physician Decision|4|||
155084744|NCT01047540|559742383|FG003|Overall Study|Adverse Event|0|||
155351840|NCT00607997|560723035|FG001|Overall Study|Physician Decision|1|||
155351841|NCT00607997|560723036|FG002|Overall Study|Physician Decision|0|||
154964511|NCT01838681|559295307|FG002|Period B/A+|Lack of Efficacy|11|||
154964512|NCT01838681|559295308|FG003|Period B/A+|Lack of Efficacy|6|||
155084745|NCT01047540|559742384|FG004|Overall Study|Adverse Event|0|||
155351842|NCT00607997|560723037|FG003|Overall Study|Physician Decision|0|||
155351843|NCT00607997|560723034|FG000|Overall Study|Relapse, recurrent illness|4|||
155351844|NCT00607997|560723035|FG001|Overall Study|Relapse, recurrent illness|0|||
155351845|NCT00607997|560723036|FG002|Overall Study|Relapse, recurrent illness|2|||
155351846|NCT00607997|560723037|FG003|Overall Study|Relapse, recurrent illness|0|||
155351847|NCT00607997|560723034|FG000|Overall Study|Other without explanation|2|||
155351848|NCT00607997|560723035|FG001|Overall Study|Other without explanation|0|||
154964513|NCT01838681|559295305|FG000|Period B/A+|Withdrawal by Subject|0|||
155351849|NCT00607997|560723036|FG002|Overall Study|Other without explanation|4|||
155351850|NCT00607997|560723037|FG003|Overall Study|Other without explanation|1|||
154964514|NCT01838681|559295306|FG001|Period B/A+|Withdrawal by Subject|28|||
154964515|NCT01838681|559295307|FG002|Period B/A+|Withdrawal by Subject|35|||
154964516|NCT01838681|559295308|FG003|Period B/A+|Withdrawal by Subject|47|||
154964517|NCT01838681|559295305|FG000|Period B/A+|Protocol Violation|0|||
154964518|NCT01838681|559295306|FG001|Period B/A+|Protocol Violation|1|||
154964519|NCT01838681|559295307|FG002|Period B/A+|Protocol Violation|4|||
154964520|NCT01838681|559295308|FG003|Period B/A+|Protocol Violation|6|||
154964521|NCT01838681|559295305|FG000|Period B/A+|Non-compliance with IMP|0|||
154964522|NCT01838681|559295306|FG001|Period B/A+|Non-compliance with IMP|2|||
154964523|NCT01838681|559295307|FG002|Period B/A+|Non-compliance with IMP|3|||
154964524|NCT01838681|559295308|FG003|Period B/A+|Non-compliance with IMP|3|||
154964525|NCT01838681|559295305|FG000|Period B/A+|Lost to Follow-up|0|||
154964526|NCT01838681|559295306|FG001|Period B/A+|Lost to Follow-up|2|||
154964527|NCT01838681|559295307|FG002|Period B/A+|Lost to Follow-up|5|||
154964528|NCT01838681|559295308|FG003|Period B/A+|Lost to Follow-up|11|||
154964529|NCT01838681|559295305|FG000|Period B/A+|Withdrawal before treatment|0|||
154964530|NCT01838681|559295306|FG001|Period B/A+|Withdrawal before treatment|1|||
154964531|NCT01838681|559295307|FG002|Period B/A+|Withdrawal before treatment|0|||
154964532|NCT01838681|559295308|FG003|Period B/A+|Withdrawal before treatment|0|||
154964533|NCT01838681|559295305|FG000|Period B/A+|Administrative or other reasons|0|||
154964534|NCT01838681|559295306|FG001|Period B/A+|Administrative or other reasons|6|||
154964535|NCT01838681|559295307|FG002|Period B/A+|Administrative or other reasons|10|||
154964536|NCT01838681|559295308|FG003|Period B/A+|Administrative or other reasons|28|||
154964537|NCT00796562|559295309|FG000|Overall Study|Death|49|||
154964538|NCT03100344|559295310|FG000|Overall Study|Adverse Event|0|||
154964539|NCT03100344|559295311|FG001|Overall Study|Adverse Event|3|||
154964540|NCT03100344|559295312|FG002|Overall Study|Adverse Event|2|||
154964541|NCT03100344|559295313|FG003|Overall Study|Adverse Event|3|||
154964542|NCT03100344|559295310|FG000|Overall Study|Lack of Efficacy|2|||
154964543|NCT03100344|559295311|FG001|Overall Study|Lack of Efficacy|0|||
154964544|NCT03100344|559295312|FG002|Overall Study|Lack of Efficacy|0|||
154964545|NCT03100344|559295313|FG003|Overall Study|Lack of Efficacy|0|||
154964546|NCT03100344|559295310|FG000|Overall Study|Protocol Violation|1|||
154964547|NCT03100344|559295311|FG001|Overall Study|Protocol Violation|0|||
154964548|NCT03100344|559295312|FG002|Overall Study|Protocol Violation|0|||
154964549|NCT03100344|559295313|FG003|Overall Study|Protocol Violation|0|||
154964550|NCT03100344|559295310|FG000|Overall Study|Withdrawal by Subject|10|||
154964551|NCT03100344|559295311|FG001|Overall Study|Withdrawal by Subject|7|||
154964552|NCT03100344|559295312|FG002|Overall Study|Withdrawal by Subject|4|||
154964553|NCT03100344|559295313|FG003|Overall Study|Withdrawal by Subject|8|||
154964554|NCT03100344|559295310|FG000|Overall Study|Lost to Follow-up|1|||
154964555|NCT03100344|559295311|FG001|Overall Study|Lost to Follow-up|1|||
154964556|NCT03100344|559295312|FG002|Overall Study|Lost to Follow-up|1|||
154964557|NCT03100344|559295313|FG003|Overall Study|Lost to Follow-up|1|||
154964558|NCT04827394|559295314|FG000|Overall Study|Physician Decision|0|||
154964559|NCT04827394|559295315|FG001|Overall Study|Physician Decision|2|||
154964560|NCT01541215|559297430|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
154964561|NCT01541215|559297431|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
154964562|NCT01541215|559297430|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
154964563|NCT01541215|559297431|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
154964564|NCT01541215|559297430|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
154964565|NCT01541215|559297431|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
154964566|NCT01541215|559297430|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
154964567|NCT01541215|559297431|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
154964568|NCT01541215|559297430|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
154964569|NCT01541215|559297431|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
154964570|NCT01541215|559297430|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
154964571|NCT01541215|559297431|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
154964572|NCT03599193|559297432|FG000|Overall Study|Adverse Event|0|||
154964573|NCT03599193|559297433|FG001|Overall Study|Adverse Event|2|||
154964574|NCT03599193|559297432|FG000|Overall Study|Withdrawal by Subject|1|||
154964575|NCT03599193|559297433|FG001|Overall Study|Withdrawal by Subject|0|||
154964576|NCT03599193|559297432|FG000|Overall Study|Protocol Violation|1|||
154964577|NCT03599193|559297433|FG001|Overall Study|Protocol Violation|0|||
154964578|NCT03599193|559297432|FG000|Overall Study|Lost to Follow-up|0|||
154964579|NCT03599193|559297433|FG001|Overall Study|Lost to Follow-up|1|||
154964580|NCT05511935|559297434|FG000|Overall Study|Lost to Follow-up|9|||
154964581|NCT05511935|559297435|FG001|Overall Study|Lost to Follow-up|27|||
154964582|NCT04102345|559297436|FG000|Overall Study|Withdrawal by Subject|1|||
154964583|NCT04102345|559297437|FG001|Overall Study|Withdrawal by Subject|0|||
154964584|NCT01609257|559297440|FG000|Overall Study|Lost to Follow-up|2|||
154964585|NCT01609257|559297441|FG001|Overall Study|Lost to Follow-up|1|||
154964586|NCT01609257|559297440|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
154964587|NCT01609257|559297441|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
154964588|NCT01609257|559297440|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
154964589|NCT01609257|559297441|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
154964590|NCT01015287|559297448|FG000|Overall Study|Death|21|||
155351851|NCT00839332|560723038|FG000|Phase 1|Disease Progression|38|||
155351852|NCT00839332|560723039|FG001|Phase 1|Disease Progression|0|||
155351853|NCT00839332|560723040|FG002|Phase 1|Disease Progression|0|||
155351854|NCT00839332|560723038|FG000|Phase 1|Adverse Event|6|||
155351855|NCT00839332|560723039|FG001|Phase 1|Adverse Event|0|||
155351856|NCT00839332|560723040|FG002|Phase 1|Adverse Event|0|||
155351857|NCT00839332|560723038|FG000|Phase 1|Withdrawal by Subject|4|||
155351858|NCT00839332|560723039|FG001|Phase 1|Withdrawal by Subject|0|||
155351859|NCT00839332|560723040|FG002|Phase 1|Withdrawal by Subject|0|||
155351860|NCT00839332|560723038|FG000|Phase 1|Physician Decision|2|||
154964591|NCT01015287|559297449|FG001|Overall Study|Death|16|||
154964592|NCT01015287|559297448|FG000|Overall Study|Adverse Event|1|||
155084746|NCT05071027|559742387|FG000|Overall Study|Lost to Follow-up|1|||
155351861|NCT00839332|560723039|FG001|Phase 1|Physician Decision|0|||
155351862|NCT00839332|560723040|FG002|Phase 1|Physician Decision|0|||
155351863|NCT00839332|560723038|FG000|Phase 2|Protocol Violation|0|||
155351864|NCT00839332|560723039|FG001|Phase 2|Protocol Violation|1|||
154964593|NCT01015287|559297449|FG001|Overall Study|Adverse Event|0|||
155351865|NCT00839332|560723040|FG002|Phase 2|Protocol Violation|0|||
155351866|NCT00839332|560723038|FG000|Phase 2|Disease Progression|0|||
155351867|NCT00839332|560723039|FG001|Phase 2|Disease Progression|46|||
155351868|NCT00839332|560723040|FG002|Phase 2|Disease Progression|21|||
155351869|NCT00839332|560723038|FG000|Phase 2|Adverse Event|0|||
155351870|NCT00839332|560723039|FG001|Phase 2|Adverse Event|8|||
155351871|NCT00839332|560723040|FG002|Phase 2|Adverse Event|6|||
155351872|NCT00839332|560723038|FG000|Phase 2|Death|0|||
155351873|NCT00839332|560723039|FG001|Phase 2|Death|4|||
155351874|NCT00839332|560723040|FG002|Phase 2|Death|2|||
155351875|NCT00839332|560723038|FG000|Phase 2|Withdrawal by Subject|0|||
155351876|NCT00839332|560723039|FG001|Phase 2|Withdrawal by Subject|5|||
155351877|NCT00839332|560723040|FG002|Phase 2|Withdrawal by Subject|8|||
155351878|NCT00839332|560723038|FG000|Phase 2|Physician Decision|0|||
155351879|NCT00839332|560723039|FG001|Phase 2|Physician Decision|4|||
155351880|NCT00839332|560723040|FG002|Phase 2|Physician Decision|1|||
155351881|NCT00839332|560723038|FG000|Phase 2|Lost to Follow-up|0|||
155084747|NCT05071027|559742388|FG001|Overall Study|Lost to Follow-up|4|||
155084748|NCT04576481|559742389|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
155084749|NCT04576481|559742390|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
155084750|NCT04576481|559742391|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
155084751|NCT04576481|559742392|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
155084752|NCT00595075|559742403|FG000|Overall Study|Withdrawal by Subject|1|||
155084753|NCT00595075|559742404|FG001|Overall Study|Withdrawal by Subject|0|||
155084754|NCT05261490|559742407|FG000|Overall Study|Other|1|||
155351882|NCT00839332|560723039|FG001|Phase 2|Lost to Follow-up|0|||
155351883|NCT00839332|560723040|FG002|Phase 2|Lost to Follow-up|1|||
155351884|NCT01200485|560723041|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
155351885|NCT01200485|560723042|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
155351886|NCT01200485|560723043|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
155351887|NCT01200485|560723041|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
155351888|NCT01200485|560723042|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
155351889|NCT01200485|560723043|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
154964594|NCT01015287|559297448|FG000|Overall Study|Sponsor Decision|3|||
155351890|NCT06080438|560723044|FG000|Overall Study|Lost to Follow-up|2|||
155351891|NCT03078751|560723049|FG000|Overall Study|Adverse Event|4|||
155351892|NCT03078751|560723050|FG001|Overall Study|Adverse Event|0|||
155351893|NCT03078751|560723049|FG000|Overall Study|Physician Decision|1|||
155351894|NCT03078751|560723050|FG001|Overall Study|Physician Decision|0|||
155351895|NCT03078751|560723049|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
155351896|NCT03078751|560723050|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
155351897|NCT03078751|560723049|FG000|Overall Study|Subject/guardian decision|8|||
155351898|NCT03078751|560723050|FG001|Overall Study|Subject/guardian decision|1|||
155351899|NCT03078751|560723049|FG000|Overall Study|Untreated|0|||
155351900|NCT03078751|560723050|FG001|Overall Study|Untreated|4|||
155351901|NCT04414397|560723051|FG000|Control Period|Withdrawal by Subject|2|||
155351902|NCT04414397|560723052|FG001|Control Period|Withdrawal by Subject|2|||
155351903|NCT04414397|560723051|FG000|Control Period|Lost to Follow-up|0|||
155351904|NCT04414397|560723052|FG001|Control Period|Lost to Follow-up|4|||
155351905|NCT04414397|560723051|FG000|Control Period|Protocol deviation|0|||
155351906|NCT04414397|560723052|FG001|Control Period|Protocol deviation|1|||
155351907|NCT04414397|560723051|FG000|Post-Control Period|Withdrawal by Subject|3|||
155351908|NCT04414397|560723052|FG001|Post-Control Period|Withdrawal by Subject|6|||
155351909|NCT04414397|560723051|FG000|Post-Control Period|Lost to Follow-up|4|||
155351910|NCT04414397|560723052|FG001|Post-Control Period|Lost to Follow-up|9|||
155351911|NCT04414397|560723051|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
155351912|NCT04414397|560723052|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
155351913|NCT04414397|560723051|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
155351914|NCT04414397|560723052|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
155351915|NCT02515097|560723058|FG000|Overall Study|Lost to Follow-up|4|||
155351916|NCT02515097|560723059|FG001|Overall Study|Lost to Follow-up|2|||
155351917|NCT02515097|560723058|FG000|Overall Study|Withdrawal by Subject|1|||
155351918|NCT02515097|560723059|FG001|Overall Study|Withdrawal by Subject|3|||
155351919|NCT02515097|560723058|FG000|Overall Study|Adverse Event|2|||
155351920|NCT02515097|560723059|FG001|Overall Study|Adverse Event|1|||
155351921|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
155351922|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
155351923|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
155351924|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Other|1|||
155351925|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Other|0|||
155351926|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Other|0|||
155351927|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Physician Decision|3|||
155351928|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Physician Decision|0|||
155351929|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Physician Decision|0|||
155351930|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
155351931|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
155351932|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
155351933|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
155351934|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
155351935|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
155351936|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Adverse Event|18|||
155351937|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Adverse Event|0|||
155351938|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Adverse Event|0|||
155351939|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
155351940|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
155351941|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
155351942|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
155351943|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
155351944|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
155351945|NCT03030599|560723062|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
155351946|NCT03030599|560723063|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
155351947|NCT03030599|560723064|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
155351948|NCT03030599|560723062|FG000|Stable Dose|Protocol deviation|3|||
155351949|NCT03030599|560723063|FG001|Stable Dose|Protocol deviation|0|||
155351950|NCT03030599|560723064|FG002|Stable Dose|Protocol deviation|0|||
155351951|NCT03030599|560723062|FG000|Stable Dose|Adverse Event|1|||
155351952|NCT03030599|560723063|FG001|Stable Dose|Adverse Event|0|||
155351953|NCT03030599|560723064|FG002|Stable Dose|Adverse Event|0|||
155351954|NCT03030599|560723062|FG000|Stable Dose|Lost to Follow-up|1|||
155351955|NCT03030599|560723063|FG001|Stable Dose|Lost to Follow-up|0|||
155351956|NCT03030599|560723064|FG002|Stable Dose|Lost to Follow-up|0|||
155351957|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
155351958|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
155351959|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
155351960|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
155351961|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
155351962|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
155084755|NCT05261490|559742408|FG001|Overall Study|Other|0|||
155084756|NCT05261490|559742409|FG002|Overall Study|Other|0|||
155084757|NCT05261490|559742407|FG000|Overall Study|Study Terminated by Sponsor|1|||
155351963|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
155351964|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
155351965|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
155351966|NCT03030599|560723062|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
155351967|NCT03030599|560723063|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
155351968|NCT03030599|560723064|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
155351969|NCT03030599|560723062|FG000|Open-label Extension|Adverse Event|3|||
155351970|NCT03030599|560723063|FG001|Open-label Extension|Adverse Event|0|||
155351971|NCT03030599|560723064|FG002|Open-label Extension|Adverse Event|0|||
155351972|NCT03030599|560723062|FG000|Open-label Extension|Lost to Follow-up|2|||
155351973|NCT03030599|560723063|FG001|Open-label Extension|Lost to Follow-up|0|||
155084758|NCT05261490|559742408|FG001|Overall Study|Study Terminated by Sponsor|1|||
155084759|NCT05261490|559742409|FG002|Overall Study|Study Terminated by Sponsor|4|||
155351974|NCT03030599|560723064|FG002|Open-label Extension|Lost to Follow-up|0|||
155351975|NCT03030599|560723062|FG000|Open-label Extension|Lack of Efficacy|1|||
155351976|NCT03030599|560723063|FG001|Open-label Extension|Lack of Efficacy|0|||
155351977|NCT03030599|560723064|FG002|Open-label Extension|Lack of Efficacy|0|||
155084760|NCT05261490|559742407|FG000|Overall Study|Death|1|||
155084761|NCT05261490|559742408|FG001|Overall Study|Death|2|||
155084762|NCT05261490|559742409|FG002|Overall Study|Death|0|||
155084763|NCT01682720|559742413|FG000|Overall Study|Randomized but Not Treated|0|||
155084764|NCT01682720|559742414|FG001|Overall Study|Randomized but Not Treated|1|||
155084765|NCT01682720|559742415|FG002|Overall Study|Randomized but Not Treated|1|||
155084766|NCT01682720|559742416|FG003|Overall Study|Randomized but Not Treated|0|||
155084767|NCT01682720|559742413|FG000|Overall Study|Terminated by Sponsor|83|||
155084768|NCT01682720|559742414|FG001|Overall Study|Terminated by Sponsor|0|||
155084769|NCT01682720|559742415|FG002|Overall Study|Terminated by Sponsor|0|||
155084770|NCT01682720|559742416|FG003|Overall Study|Terminated by Sponsor|0|||
155084771|NCT01682720|559742413|FG000|Overall Study|Efficacy Failure|0|||
155084772|NCT01682720|559742414|FG001|Overall Study|Efficacy Failure|3|||
155084773|NCT01682720|559742415|FG002|Overall Study|Efficacy Failure|3|||
155084774|NCT01682720|559742416|FG003|Overall Study|Efficacy Failure|30|||
155084775|NCT01682720|559742413|FG000|Overall Study|Lost to Follow-up|1|||
155084776|NCT01682720|559742414|FG001|Overall Study|Lost to Follow-up|1|||
155084777|NCT01682720|559742415|FG002|Overall Study|Lost to Follow-up|0|||
155084778|NCT01682720|559742416|FG003|Overall Study|Lost to Follow-up|6|||
155351978|NCT03030599|560723062|FG000|Open-label Extension|Other Reason|1|||
155351979|NCT03030599|560723063|FG001|Open-label Extension|Other Reason|0|||
155351980|NCT03030599|560723064|FG002|Open-label Extension|Other Reason|0|||
155351981|NCT01592383|560723065|FG000|Overall Study|Adverse Event|1|||
155351982|NCT01064856|560723066|FG000|Double-blind (DB) Period|Adverse Event|1|||
155351983|NCT01064856|560723067|FG001|Double-blind (DB) Period|Adverse Event|0|||
155351984|NCT01064856|560723068|FG002|Double-blind (DB) Period|Adverse Event|0|||
155351985|NCT01064856|560723069|FG003|Double-blind (DB) Period|Adverse Event|0|||
155351986|NCT01064856|560723066|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
155351987|NCT01064856|560723067|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
155351988|NCT01064856|560723068|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
155351989|NCT01064856|560723069|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
155351990|NCT01064856|560723066|FG000|Open-label (OL) Period|Adverse Event|0|||
155351991|NCT01064856|560723067|FG001|Open-label (OL) Period|Adverse Event|0|||
155351992|NCT01064856|560723068|FG002|Open-label (OL) Period|Adverse Event|12|||
155351993|NCT01064856|560723069|FG003|Open-label (OL) Period|Adverse Event|6|||
155351994|NCT01064856|560723066|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
155351995|NCT01064856|560723067|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
155351996|NCT01064856|560723068|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
155351997|NCT01064856|560723069|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
155351998|NCT01064856|560723066|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
155351999|NCT01064856|560723067|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
155352000|NCT01064856|560723068|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
155352001|NCT01064856|560723069|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
155352002|NCT01064856|560723066|FG000|Open-label (OL) Period|Other|0|||
155352003|NCT01064856|560723067|FG001|Open-label (OL) Period|Other|0|||
155352004|NCT01064856|560723068|FG002|Open-label (OL) Period|Other|7|||
155352005|NCT01064856|560723069|FG003|Open-label (OL) Period|Other|7|||
155352006|NCT02133131|560723070|FG000|Overall Study|Adverse Event|0|||
155352007|NCT02133131|560723071|FG001|Overall Study|Adverse Event|0|||
155352008|NCT02133131|560723072|FG002|Overall Study|Adverse Event|0|||
155352009|NCT02133131|560723073|FG003|Overall Study|Adverse Event|1|||
155084779|NCT01682720|559742413|FG000|Overall Study|Subject Withdrew Consent|0|||
155084780|NCT01682720|559742414|FG001|Overall Study|Subject Withdrew Consent|0|||
155084781|NCT01682720|559742415|FG002|Overall Study|Subject Withdrew Consent|2|||
155084782|NCT01682720|559742416|FG003|Overall Study|Subject Withdrew Consent|2|||
155084783|NCT01682720|559742413|FG000|Overall Study|Adverse Event|1|||
155084784|NCT01682720|559742414|FG001|Overall Study|Adverse Event|0|||
155084785|NCT01682720|559742415|FG002|Overall Study|Adverse Event|1|||
155084786|NCT01682720|559742416|FG003|Overall Study|Adverse Event|1|||
155084787|NCT01687595|559742417|FG000|Overall Study|Withdrawal by Subject|8|||
155084788|NCT01687595|559742418|FG001|Overall Study|Withdrawal by Subject|0|||
155084789|NCT01687595|559742417|FG000|Overall Study|Lost to Follow-up|3|||
155084790|NCT01687595|559742418|FG001|Overall Study|Lost to Follow-up|1|||
154964595|NCT01015287|559297449|FG001|Overall Study|Sponsor Decision|7|||
154964596|NCT01015287|559297448|FG000|Overall Study|Physician Decision|19|||
154964597|NCT01015287|559297449|FG001|Overall Study|Physician Decision|21|||
155084791|NCT01687595|559742417|FG000|Overall Study|Investigator's decision|1|||
155084792|NCT01687595|559742418|FG001|Overall Study|Investigator's decision|0|||
155084793|NCT01687595|559742417|FG000|Overall Study|Sponsor's decision|1|||
155084794|NCT01687595|559742418|FG001|Overall Study|Sponsor's decision|0|||
155084795|NCT01687595|559742417|FG000|Overall Study|Noncompliance|1|||
155084796|NCT01687595|559742418|FG001|Overall Study|Noncompliance|2|||
155084797|NCT01687595|559742417|FG000|Overall Study|Other than specified|56|||
155084798|NCT01687595|559742418|FG001|Overall Study|Other than specified|7|||
155352010|NCT02133131|560723074|FG004|Overall Study|Adverse Event|0|||
155352011|NCT02133131|560723075|FG005|Overall Study|Adverse Event|0|||
154964598|NCT01015287|559297448|FG000|Overall Study|Withdrawal by Subject|14|||
154964599|NCT01015287|559297449|FG001|Overall Study|Withdrawal by Subject|19|||
155084799|NCT04204902|559742419|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
155084800|NCT04204902|559742420|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
155084801|NCT05451329|559742421|FG000|Overall Study|Adverse Event|1|||
155352012|NCT02133131|560723076|FG006|Overall Study|Adverse Event|0|||
155352013|NCT02133131|560723070|FG000|Overall Study|Lost to Follow-up|1|||
155352014|NCT02133131|560723071|FG001|Overall Study|Lost to Follow-up|0|||
155352015|NCT02133131|560723072|FG002|Overall Study|Lost to Follow-up|0|||
155352016|NCT02133131|560723073|FG003|Overall Study|Lost to Follow-up|1|||
155352017|NCT02133131|560723074|FG004|Overall Study|Lost to Follow-up|0|||
155352018|NCT02133131|560723075|FG005|Overall Study|Lost to Follow-up|0|||
155352019|NCT02133131|560723076|FG006|Overall Study|Lost to Follow-up|0|||
155352020|NCT02133131|560723070|FG000|Overall Study|Status not recorded|4|||
155352021|NCT02133131|560723071|FG001|Overall Study|Status not recorded|5|||
155352022|NCT02133131|560723072|FG002|Overall Study|Status not recorded|1|||
155352023|NCT02133131|560723073|FG003|Overall Study|Status not recorded|4|||
155352024|NCT02133131|560723074|FG004|Overall Study|Status not recorded|0|||
155352025|NCT02133131|560723075|FG005|Overall Study|Status not recorded|0|||
155352026|NCT02133131|560723076|FG006|Overall Study|Status not recorded|0|||
155352027|NCT02133131|560723070|FG000|Overall Study|Ongoing in study|0|||
155352028|NCT02133131|560723071|FG001|Overall Study|Ongoing in study|0|||
155352029|NCT02133131|560723072|FG002|Overall Study|Ongoing in study|0|||
155352030|NCT02133131|560723073|FG003|Overall Study|Ongoing in study|0|||
155352031|NCT02133131|560723074|FG004|Overall Study|Ongoing in study|15|||
155352032|NCT02133131|560723075|FG005|Overall Study|Ongoing in study|14|||
155352033|NCT02133131|560723076|FG006|Overall Study|Ongoing in study|11|||
155352034|NCT02133131|560723070|FG000|Overall Study|Protocol Violation|0|||
155352035|NCT02133131|560723071|FG001|Overall Study|Protocol Violation|0|||
155352036|NCT02133131|560723072|FG002|Overall Study|Protocol Violation|0|||
155352037|NCT02133131|560723073|FG003|Overall Study|Protocol Violation|0|||
155352038|NCT02133131|560723074|FG004|Overall Study|Protocol Violation|0|||
155352039|NCT02133131|560723075|FG005|Overall Study|Protocol Violation|0|||
155352040|NCT02133131|560723076|FG006|Overall Study|Protocol Violation|1|||
155352041|NCT00509925|560723077|FG000|Overall Study|Personal reasons|0|||
155352042|NCT00509925|560723078|FG001|Overall Study|Personal reasons|1|||
155352043|NCT00230971|560723079|FG000|Randomization|No study drug administered|3|||
155352044|NCT00230971|560723080|FG001|Randomization|No study drug administered|3|||
155352045|NCT00230971|560723079|FG000|Baseline Participants|Lost to Follow-up|5|||
155352046|NCT00230971|560723080|FG001|Baseline Participants|Lost to Follow-up|12|||
155352047|NCT00230971|560723079|FG000|Baseline Participants|Death|6|||
155352048|NCT00230971|560723080|FG001|Baseline Participants|Death|5|||
155352049|NCT00230971|560723079|FG000|Baseline Participants|Withdrawal by Subject|7|||
155352050|NCT00230971|560723080|FG001|Baseline Participants|Withdrawal by Subject|1|||
155352051|NCT00230971|560723079|FG000|Baseline Participants|Adverse Event|1|||
155352052|NCT00230971|560723080|FG001|Baseline Participants|Adverse Event|0|||
155352053|NCT00230971|560723079|FG000|Baseline Participants|No bacteria observed|1|||
155352054|NCT00230971|560723080|FG001|Baseline Participants|No bacteria observed|0|||
155352055|NCT00230971|560723079|FG000|Baseline Participants|Failure to return|1|||
155352056|NCT00230971|560723080|FG001|Baseline Participants|Failure to return|1|||
155352057|NCT00230971|560723079|FG000|Baseline Participants|Reintervention|1|||
155084802|NCT05451329|559742422|FG001|Overall Study|Adverse Event|1|||
155084803|NCT05451329|559742423|FG002|Overall Study|Adverse Event|0|||
155084804|NCT05451329|559742421|FG000|Overall Study|Withdrawal by Subject|1|||
155084805|NCT05451329|559742422|FG001|Overall Study|Withdrawal by Subject|0|||
155084806|NCT05451329|559742423|FG002|Overall Study|Withdrawal by Subject|0|||
155084807|NCT05451329|559742421|FG000|Overall Study|Investigational Product Lot exchange|1|||
155084808|NCT05451329|559742422|FG001|Overall Study|Investigational Product Lot exchange|1|||
155084809|NCT05451329|559742423|FG002|Overall Study|Investigational Product Lot exchange|0|||
155084810|NCT00069953|559742424|FG000|Overall Study|Protocol Violation|2|||
155084811|NCT03253627|559742427|FG000|Overall Study|Lost to Follow-up|1|||
155084812|NCT03253627|559742428|FG001|Overall Study|Lost to Follow-up|2|||
155084813|NCT03253627|559742427|FG000|Overall Study|Withdrawal by Subject|0|||
155084814|NCT03253627|559742428|FG001|Overall Study|Withdrawal by Subject|2|||
155084815|NCT03253627|559742427|FG000|Overall Study|Inability to complete MRI|1|||
155084816|NCT03253627|559742428|FG001|Overall Study|Inability to complete MRI|0|||
155084817|NCT03829683|559742429|FG000|Overall Study|Lost to Follow-up|1|||
155084818|NCT03829683|559742430|FG001|Overall Study|Lost to Follow-up|0|||
155084819|NCT03829683|559742429|FG000|Overall Study|Physician Decision|3|||
155084820|NCT03829683|559742430|FG001|Overall Study|Physician Decision|1|||
155084821|NCT03829683|559742429|FG000|Overall Study|Withdrawal by Subject|0|||
155084822|NCT03829683|559742430|FG001|Overall Study|Withdrawal by Subject|1|||
155084823|NCT03829683|559742429|FG000|Overall Study|Discharge from hospital|1|||
155084824|NCT03829683|559742430|FG001|Overall Study|Discharge from hospital|0|||
155084825|NCT04629521|559742437|FG000|Overall Study|Death|1|||
155084826|NCT04629521|559742437|FG000|Overall Study|Lost to Follow-up|3|||
155084827|NCT04629521|559742437|FG000|Overall Study|Subject withdrew consent|3|||
155084828|NCT04629521|559742437|FG000|Overall Study|Enrolled in error|1|||
155084829|NCT03163667|559742438|FG000|Overall Study|Death|15|||
154964600|NCT01015287|559297448|FG000|Overall Study|Entry Criteria not Met|11|||
154964601|NCT01015287|559297449|FG001|Overall Study|Entry Criteria not Met|14|||
154964602|NCT01015287|559297448|FG000|Overall Study|Lost to Follow-up|2|||
154964603|NCT01015287|559297449|FG001|Overall Study|Lost to Follow-up|1|||
155084830|NCT03163667|559742439|FG001|Overall Study|Death|27|||
155084831|NCT03163667|559742438|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
154964604|NCT01015287|559297448|FG000|Overall Study|Protocol Violation|1|||
154964605|NCT01015287|559297449|FG001|Overall Study|Protocol Violation|1|||
154964606|NCT01117623|559297450|FG000|Overall Study|Adverse Event|0|||
154964607|NCT01117623|559297451|FG001|Overall Study|Adverse Event|2|||
154964608|NCT01117623|559297452|FG002|Overall Study|Adverse Event|4|||
154964609|NCT01117623|559297453|FG003|Overall Study|Adverse Event|0|||
154964610|NCT01117623|559297454|FG004|Overall Study|Adverse Event|2|||
154964611|NCT01117623|559297455|FG005|Overall Study|Adverse Event|0|||
154964612|NCT01117623|559297456|FG006|Overall Study|Adverse Event|0|||
154964613|NCT01117623|559297457|FG007|Overall Study|Adverse Event|2|||
154964614|NCT01117623|559297450|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
154964615|NCT01117623|559297451|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
154964616|NCT01117623|559297452|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
154964617|NCT01117623|559297453|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
154964618|NCT01117623|559297454|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
154964619|NCT01117623|559297455|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
154964620|NCT01117623|559297456|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
154964621|NCT01117623|559297457|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
154964622|NCT01117623|559297450|FG000|Overall Study|Withdrawal by Subject|0|||
154964623|NCT01117623|559297451|FG001|Overall Study|Withdrawal by Subject|0|||
154964624|NCT01117623|559297452|FG002|Overall Study|Withdrawal by Subject|2|||
154964625|NCT01117623|559297453|FG003|Overall Study|Withdrawal by Subject|0|||
154964626|NCT01117623|559297454|FG004|Overall Study|Withdrawal by Subject|0|||
154964627|NCT01117623|559297455|FG005|Overall Study|Withdrawal by Subject|1|||
154964628|NCT01117623|559297456|FG006|Overall Study|Withdrawal by Subject|1|||
154964629|NCT01117623|559297457|FG007|Overall Study|Withdrawal by Subject|1|||
154964630|NCT01117623|559297450|FG000|Overall Study|Non-compliance with study medication|0|||
155084832|NCT03163667|559742439|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
155084833|NCT01335685|559742440|FG000|Overall Study|Study Terminated by Sponsor|2|||
155084834|NCT01335685|559742441|FG001|Overall Study|Study Terminated by Sponsor|1|||
155084835|NCT01335685|559742442|FG002|Overall Study|Study Terminated by Sponsor|1|||
155084836|NCT01335685|559742443|FG003|Overall Study|Study Terminated by Sponsor|10|||
155084837|NCT01335685|559742444|FG004|Overall Study|Study Terminated by Sponsor|0|||
154964631|NCT01117623|559297451|FG001|Overall Study|Non-compliance with study medication|0|||
154964632|NCT01117623|559297452|FG002|Overall Study|Non-compliance with study medication|0|||
154964633|NCT01117623|559297453|FG003|Overall Study|Non-compliance with study medication|0|||
155084838|NCT01335685|559742445|FG005|Overall Study|Study Terminated by Sponsor|4|||
155084839|NCT01335685|559742446|FG006|Overall Study|Study Terminated by Sponsor|2|||
155084840|NCT01335685|559742447|FG007|Overall Study|Study Terminated by Sponsor|3|||
155084841|NCT01335685|559742440|FG000|Overall Study|Withdrawal by Subject|1|||
155084842|NCT01335685|559742441|FG001|Overall Study|Withdrawal by Subject|0|||
155084843|NCT01335685|559742442|FG002|Overall Study|Withdrawal by Subject|0|||
155084844|NCT01335685|559742443|FG003|Overall Study|Withdrawal by Subject|1|||
155084845|NCT01335685|559742444|FG004|Overall Study|Withdrawal by Subject|0|||
155084846|NCT01335685|559742445|FG005|Overall Study|Withdrawal by Subject|0|||
155084847|NCT01335685|559742446|FG006|Overall Study|Withdrawal by Subject|0|||
155084848|NCT01335685|559742447|FG007|Overall Study|Withdrawal by Subject|0|||
155084849|NCT01335685|559742440|FG000|Overall Study|Reason not Specified|0|||
155084850|NCT01335685|559742441|FG001|Overall Study|Reason not Specified|0|||
155084851|NCT01335685|559742442|FG002|Overall Study|Reason not Specified|1|||
155084852|NCT01335685|559742443|FG003|Overall Study|Reason not Specified|0|||
155084853|NCT01335685|559742444|FG004|Overall Study|Reason not Specified|0|||
155084854|NCT01335685|559742445|FG005|Overall Study|Reason not Specified|1|||
155084855|NCT01335685|559742446|FG006|Overall Study|Reason not Specified|0|||
155084856|NCT01335685|559742447|FG007|Overall Study|Reason not Specified|0|||
155084857|NCT02554474|559742448|FG000|Overall Study|Protocol Violation|1|||
155084858|NCT02554474|559742449|FG001|Overall Study|Protocol Violation|1|||
155084859|NCT02554474|559742448|FG000|Overall Study|Health issue not related to the study|1|||
155084860|NCT02554474|559742449|FG001|Overall Study|Health issue not related to the study|0|||
155084861|NCT02554474|559742448|FG000|Overall Study|Withdrawal by Subject|1|||
155084862|NCT02554474|559742449|FG001|Overall Study|Withdrawal by Subject|1|||
155084863|NCT00855166|559742452|FG000|Overall Study|Adverse Event|0|||
154964634|NCT01117623|559297454|FG004|Overall Study|Non-compliance with study medication|0|||
155084864|NCT00855166|559742453|FG001|Overall Study|Adverse Event|2|||
155084865|NCT00855166|559742452|FG000|Overall Study|Death|0|||
155084866|NCT00855166|559742453|FG001|Overall Study|Death|1|||
155084867|NCT00855166|559742452|FG000|Overall Study|Withdrawal by Subject|1|||
155084868|NCT00855166|559742453|FG001|Overall Study|Withdrawal by Subject|4|||
155084869|NCT00855166|559742452|FG000|Overall Study|Poor/non-compliance|2|||
155084870|NCT00855166|559742453|FG001|Overall Study|Poor/non-compliance|0|||
155084871|NCT00855166|559742452|FG000|Overall Study|Administrative reasons by sponsor|1|||
155084872|NCT00855166|559742453|FG001|Overall Study|Administrative reasons by sponsor|0|||
155084873|NCT00855166|559742452|FG000|Overall Study|Subject no longer meets study criteria|1|||
155084874|NCT00855166|559742453|FG001|Overall Study|Subject no longer meets study criteria|1|||
155084875|NCT03777020|559742457|FG000|Overall Study|Withdrawal by Subject|4|||
155084876|NCT03777020|559742458|FG001|Overall Study|Withdrawal by Subject|4|||
155084877|NCT03777020|559742457|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
155352058|NCT00230971|560723080|FG001|Baseline Participants|Reintervention|0|||
155352059|NCT00951171|560723082|FG000|Overall Study|Adverse Event|2|||
155352060|NCT00951171|560723083|FG001|Overall Study|Adverse Event|0|||
155352061|NCT05294328|560723088|FG000|Overall Study|Adverse Event|1|||
155352062|NCT05294328|560723089|FG001|Overall Study|Adverse Event|0|||
155352063|NCT05294328|560723090|FG002|Overall Study|Adverse Event|0|||
155352064|NCT05294328|560723088|FG000|Overall Study|Physician Decision|1|||
155352065|NCT05294328|560723089|FG001|Overall Study|Physician Decision|1|||
155352066|NCT05294328|560723090|FG002|Overall Study|Physician Decision|0|||
155352067|NCT05294328|560723088|FG000|Overall Study|Withdrawal by Subject|0|||
155352068|NCT05294328|560723089|FG001|Overall Study|Withdrawal by Subject|2|||
154964635|NCT01117623|559297455|FG005|Overall Study|Non-compliance with study medication|0|||
154964636|NCT01117623|559297456|FG006|Overall Study|Non-compliance with study medication|0|||
154964637|NCT01117623|559297457|FG007|Overall Study|Non-compliance with study medication|1|||
154964638|NCT01117623|559297450|FG000|Overall Study|Invest. text: completed all planned txs|0|||
155084878|NCT03777020|559742458|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
155084879|NCT00489476|559742459|FG000|Overall Study|Lost to Follow-up|0|||
155084880|NCT00489476|559742460|FG001|Overall Study|Lost to Follow-up|1|||
155084881|NCT00489476|559742461|FG002|Overall Study|Lost to Follow-up|0|||
155084882|NCT00489476|559742462|FG003|Overall Study|Lost to Follow-up|0|||
155084883|NCT03460704|559742463|FG000|Overall Study|Withdrawal by Subject|11|||
155084884|NCT03460704|559742464|FG001|Overall Study|Withdrawal by Subject|14|||
155084885|NCT03460704|559742463|FG000|Overall Study|Study terminated by the Sponsor|29|||
155084886|NCT03460704|559742464|FG001|Overall Study|Study terminated by the Sponsor|19|||
155084887|NCT03460704|559742463|FG000|Overall Study|Adverse Event|10|||
155084888|NCT03460704|559742464|FG001|Overall Study|Adverse Event|5|||
155084889|NCT03460704|559742463|FG000|Overall Study|Death|3|||
155084890|NCT03460704|559742464|FG001|Overall Study|Death|2|||
155084891|NCT03460704|559742463|FG000|Overall Study|Non-Compliance with Study Drug|3|||
155084892|NCT03460704|559742464|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155084893|NCT03460704|559742463|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155084894|NCT03460704|559742464|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
155084895|NCT03460704|559742463|FG000|Overall Study|Other|2|||
155352069|NCT05294328|560723090|FG002|Overall Study|Withdrawal by Subject|1|||
155352070|NCT05294328|560723088|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
155352071|NCT05294328|560723089|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
155352072|NCT05294328|560723090|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
155084896|NCT03460704|559742464|FG001|Overall Study|Other|1|||
155084897|NCT01767857|559742465|FG000|Overall Study|Adverse Event|27|||
155084898|NCT01767857|559742466|FG001|Overall Study|Adverse Event|7|||
155084899|NCT01767857|559742465|FG000|Overall Study|Death|28|||
155352073|NCT04267393|560723091|FG000|Randomization|Adverse Event|1|||
155352074|NCT04267393|560723092|FG001|Randomization|Adverse Event|0|||
155352075|NCT04267393|560723093|FG002|Randomization|Adverse Event|0|||
155352076|NCT04267393|560723091|FG000|Randomization|Administrative Reasons by Sponsor|0|||
155352077|NCT04267393|560723092|FG001|Randomization|Administrative Reasons by Sponsor|1|||
155352078|NCT04267393|560723093|FG002|Randomization|Administrative Reasons by Sponsor|0|||
155352079|NCT04267393|560723091|FG000|Treatment Period|Adverse Event|0|||
155352080|NCT04267393|560723092|FG001|Treatment Period|Adverse Event|2|||
155352081|NCT04267393|560723093|FG002|Treatment Period|Adverse Event|3|||
155352082|NCT04267393|560723091|FG000|Treatment Period|Participant Withdrew Consent|0|||
155352083|NCT04267393|560723092|FG001|Treatment Period|Participant Withdrew Consent|0|||
155352084|NCT04267393|560723093|FG002|Treatment Period|Participant Withdrew Consent|1|||
155352085|NCT04267393|560723091|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
155352086|NCT04267393|560723092|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
155352087|NCT04267393|560723093|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
155352088|NCT03864341|560725578|FG000|Overall Study|Withdrawal by Subject|1|||
155352089|NCT01066936|560725579|FG000|Overall Study|Death|2|||
155352090|NCT01066936|560725579|FG000|Overall Study|Device revised/removed|1|||
155352091|NCT01066936|560725579|FG000|Overall Study|Lost to Follow-up|3|||
155352092|NCT01066936|560725579|FG000|Overall Study|Withdrawal by Subject|4|||
155352093|NCT04156399|560725585|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
155352094|NCT04156399|560725585|FG000|Overall Study|study suspension due to COVID pandemic|3|||
155352095|NCT01929876|560725588|FG000|Period 2|Non-Compliance|1|||
155352096|NCT03991988|560725589|FG000|Overall Study|Withdrawal by Subject|2|||
155352097|NCT03991988|560725590|FG001|Overall Study|Withdrawal by Subject|2|||
155084900|NCT01767857|559742466|FG001|Overall Study|Death|13|||
155084901|NCT01767857|559742465|FG000|Overall Study|Lack of Efficacy|299|||
155084902|NCT01767857|559742466|FG001|Overall Study|Lack of Efficacy|151|||
155084903|NCT01767857|559742465|FG000|Overall Study|Lost to Follow-up|1|||
155084904|NCT01767857|559742466|FG001|Overall Study|Lost to Follow-up|1|||
155352098|NCT01222533|560725592|FG000|Overall Study|Adverse Event|5|||
155084905|NCT01767857|559742465|FG000|Overall Study|Withdrawal by Subject|38|||
155084906|NCT01767857|559742466|FG001|Overall Study|Withdrawal by Subject|18|||
155084907|NCT01767857|559742465|FG000|Overall Study|Physician Decision|17|||
155084908|NCT01767857|559742466|FG001|Overall Study|Physician Decision|10|||
155084909|NCT01767857|559742465|FG000|Overall Study|Protocol Terminated|1|||
155084910|NCT01767857|559742466|FG001|Overall Study|Protocol Terminated|0|||
155084911|NCT01767857|559742465|FG000|Overall Study|Randomized But Never Treated|19|||
155084912|NCT01767857|559742466|FG001|Overall Study|Randomized But Never Treated|13|||
155084913|NCT02899754|559742467|FG000|Overall Study|Lost to Follow-up|7|||
155084914|NCT02899754|559742468|FG001|Overall Study|Lost to Follow-up|9|||
155084915|NCT04082364|559742469|FG000|Overall Study|Death|23|||
155084916|NCT04082364|559742470|FG001|Overall Study|Death|1|||
155084917|NCT04082364|559742471|FG002|Overall Study|Death|1|||
155084918|NCT04082364|559742472|FG003|Overall Study|Death|2|||
155084919|NCT04082364|559742473|FG004|Overall Study|Death|1|||
155084920|NCT04082364|559742469|FG000|Overall Study|Lost to Follow-up|1|||
155084921|NCT04082364|559742470|FG001|Overall Study|Lost to Follow-up|0|||
155084922|NCT04082364|559742471|FG002|Overall Study|Lost to Follow-up|0|||
155084923|NCT04082364|559742472|FG003|Overall Study|Lost to Follow-up|0|||
155084924|NCT04082364|559742473|FG004|Overall Study|Lost to Follow-up|1|||
155084925|NCT04082364|559742469|FG000|Overall Study|Physician Decision|1|||
155084926|NCT04082364|559742470|FG001|Overall Study|Physician Decision|1|||
155084927|NCT04082364|559742471|FG002|Overall Study|Physician Decision|0|||
155084928|NCT04082364|559742472|FG003|Overall Study|Physician Decision|2|||
155084929|NCT04082364|559742473|FG004|Overall Study|Physician Decision|1|||
155084930|NCT04082364|559742469|FG000|Overall Study|Withdrawal by Subject|1|||
155084931|NCT04082364|559742470|FG001|Overall Study|Withdrawal by Subject|1|||
155084932|NCT04082364|559742471|FG002|Overall Study|Withdrawal by Subject|0|||
155084933|NCT04082364|559742472|FG003|Overall Study|Withdrawal by Subject|0|||
155352099|NCT01222533|560725592|FG000|Overall Study|Withdrawal by Subject|5|||
155352100|NCT01222533|560725592|FG000|Overall Study|Other|4|||
155352101|NCT03418493|560725593|FG000|Overall Study|Adverse Event|1|||
155352102|NCT03418493|560725594|FG001|Overall Study|Adverse Event|0|||
155352103|NCT03418493|560725595|FG002|Overall Study|Adverse Event|0|||
155352104|NCT03418493|560725596|FG003|Overall Study|Adverse Event|0|||
155352105|NCT03418493|560725597|FG004|Overall Study|Adverse Event|0|||
155352106|NCT03418493|560725598|FG005|Overall Study|Adverse Event|0|||
155352107|NCT03418493|560725599|FG006|Overall Study|Adverse Event|0|||
155352108|NCT03418493|560725600|FG007|Overall Study|Adverse Event|0|||
155352109|NCT03418493|560725601|FG008|Overall Study|Adverse Event|0|||
155352110|NCT03418493|560725602|FG009|Overall Study|Adverse Event|0|||
155352111|NCT03418493|560725603|FG010|Overall Study|Adverse Event|0|||
155352112|NCT03418493|560725593|FG000|Overall Study|Protocol Violation|0|||
155352113|NCT03418493|560725594|FG001|Overall Study|Protocol Violation|0|||
155352114|NCT03418493|560725595|FG002|Overall Study|Protocol Violation|0|||
155352115|NCT03418493|560725596|FG003|Overall Study|Protocol Violation|0|||
155352116|NCT03418493|560725597|FG004|Overall Study|Protocol Violation|0|||
155352117|NCT03418493|560725598|FG005|Overall Study|Protocol Violation|0|||
155352118|NCT03418493|560725599|FG006|Overall Study|Protocol Violation|0|||
155352119|NCT03418493|560725600|FG007|Overall Study|Protocol Violation|0|||
155352120|NCT03418493|560725601|FG008|Overall Study|Protocol Violation|0|||
155352121|NCT03418493|560725602|FG009|Overall Study|Protocol Violation|1|||
155352122|NCT03418493|560725603|FG010|Overall Study|Protocol Violation|0|||
155352123|NCT01947517|560725604|FG000|Overall Study|Withdrawal by Subject|1|||
155084934|NCT04082364|559742473|FG004|Overall Study|Withdrawal by Subject|1|||
155084935|NCT04082364|559742469|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
155084936|NCT04082364|559742470|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
155352124|NCT01947517|560725605|FG001|Overall Study|Withdrawal by Subject|1|||
155352125|NCT05446714|560725606|FG000|Overall Study|Lost to Follow-up|1|||
155352126|NCT05446714|560725607|FG001|Overall Study|Lost to Follow-up|3|||
155352127|NCT05446714|560725608|FG002|Overall Study|Lost to Follow-up|2|||
155352128|NCT05446714|560725606|FG000|Overall Study|Protocol Violation|2|||
155352129|NCT05446714|560725607|FG001|Overall Study|Protocol Violation|0|||
155352130|NCT05446714|560725608|FG002|Overall Study|Protocol Violation|0|||
155352131|NCT02418845|560725614|FG000|Overall Study|Lost to Follow-up|7|||
155352132|NCT02418845|560725615|FG001|Overall Study|Lost to Follow-up|2|||
155084937|NCT04082364|559742471|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
155084938|NCT04082364|559742472|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
155084939|NCT04082364|559742473|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
155084940|NCT04082364|559742469|FG000|Overall Study|Disease progression|0|||
155084941|NCT04082364|559742470|FG001|Overall Study|Disease progression|0|||
155084942|NCT04082364|559742471|FG002|Overall Study|Disease progression|0|||
155084943|NCT04082364|559742472|FG003|Overall Study|Disease progression|1|||
155084944|NCT04082364|559742473|FG004|Overall Study|Disease progression|0|||
155352133|NCT02418845|560725614|FG000|Overall Study|Lack of Efficacy|0|||
155352134|NCT02418845|560725615|FG001|Overall Study|Lack of Efficacy|3|||
155352135|NCT02418845|560725614|FG000|Overall Study|Physician Decision|5|||
155084945|NCT02514746|559742476|FG000|Overall Study|Chronically Ill|1|||
155352136|NCT02418845|560725615|FG001|Overall Study|Physician Decision|5|||
155352137|NCT02418845|560725614|FG000|Overall Study|Protocol Violation|1|||
155352138|NCT02418845|560725615|FG001|Overall Study|Protocol Violation|0|||
155352139|NCT02418845|560725614|FG000|Overall Study|Withdrawal by Subject|3|||
155352140|NCT02418845|560725615|FG001|Overall Study|Withdrawal by Subject|2|||
155352141|NCT00460564|560725616|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
155352142|NCT00460564|560725617|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
155352143|NCT00460564|560725618|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352144|NCT00460564|560725619|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352145|NCT00460564|560725620|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352146|NCT00460564|560725621|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352147|NCT00460564|560725622|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352148|NCT00460564|560725623|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155352149|NCT00460564|560725616|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
155352150|NCT00460564|560725617|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352151|NCT00460564|560725618|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352152|NCT00460564|560725619|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352153|NCT00460564|560725620|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352154|NCT00460564|560725621|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352155|NCT00460564|560725622|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352156|NCT00460564|560725623|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155352157|NCT00460564|560725616|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352158|NCT00460564|560725617|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352159|NCT00460564|560725618|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352160|NCT00460564|560725619|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352161|NCT00460564|560725620|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
155352162|NCT00460564|560725621|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
155352163|NCT00460564|560725622|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
155352164|NCT00460564|560725623|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155352165|NCT00460564|560725616|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352166|NCT00460564|560725617|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352167|NCT00460564|560725618|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352168|NCT00460564|560725619|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352169|NCT00460564|560725620|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
155352170|NCT00460564|560725621|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
155352171|NCT00460564|560725622|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352172|NCT00460564|560725623|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155352173|NCT00460564|560725616|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352174|NCT00460564|560725617|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352175|NCT00460564|560725618|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352176|NCT00460564|560725619|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352177|NCT00460564|560725620|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
155352178|NCT00460564|560725621|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352179|NCT00460564|560725622|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352180|NCT00460564|560725623|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
155352181|NCT00630552|560725624|FG000|Overall Study|Adverse Event|0|||
155352182|NCT00630552|560725625|FG001|Overall Study|Adverse Event|1|||
155352183|NCT00630552|560725626|FG002|Overall Study|Adverse Event|5|||
155352184|NCT00630552|560725627|FG003|Overall Study|Adverse Event|4|||
155352185|NCT00630552|560725628|FG004|Overall Study|Adverse Event|2|||
155352186|NCT00630552|560725624|FG000|Overall Study|Disease progression|5|||
155352187|NCT00630552|560725625|FG001|Overall Study|Disease progression|6|||
155352188|NCT00630552|560725626|FG002|Overall Study|Disease progression|27|||
155352189|NCT00630552|560725627|FG003|Overall Study|Disease progression|22|||
155352190|NCT00630552|560725628|FG004|Overall Study|Disease progression|31|||
155352191|NCT00630552|560725624|FG000|Overall Study|Never received IP|0|||
155352192|NCT00630552|560725625|FG001|Overall Study|Never received IP|0|||
155352193|NCT00630552|560725626|FG002|Overall Study|Never received IP|0|||
155352194|NCT00630552|560725627|FG003|Overall Study|Never received IP|2|||
155352195|NCT00630552|560725628|FG004|Overall Study|Never received IP|2|||
155352196|NCT00630552|560725624|FG000|Overall Study|Ineligibility determined|0|||
155352197|NCT00630552|560725625|FG001|Overall Study|Ineligibility determined|0|||
155352198|NCT00630552|560725626|FG002|Overall Study|Ineligibility determined|0|||
155352199|NCT00630552|560725627|FG003|Overall Study|Ineligibility determined|0|||
155352200|NCT00630552|560725628|FG004|Overall Study|Ineligibility determined|1|||
155352201|NCT00630552|560725624|FG000|Overall Study|Protocol Violation|0|||
155352202|NCT00630552|560725625|FG001|Overall Study|Protocol Violation|0|||
155352203|NCT00630552|560725626|FG002|Overall Study|Protocol Violation|0|||
155352204|NCT00630552|560725627|FG003|Overall Study|Protocol Violation|1|||
155352205|NCT00630552|560725628|FG004|Overall Study|Protocol Violation|0|||
155352206|NCT00630552|560725624|FG000|Overall Study|Physician Decision|0|||
155352207|NCT00630552|560725625|FG001|Overall Study|Physician Decision|0|||
155084946|NCT02514746|559742477|FG001|Overall Study|Chronically Ill|2|||
155084947|NCT02514746|559742476|FG000|Overall Study|Physician Decision|4|||
155084948|NCT02514746|559742477|FG001|Overall Study|Physician Decision|2|||
155084949|NCT02514746|559742476|FG000|Overall Study|Withdrawal by Subject|12|||
155084950|NCT02514746|559742477|FG001|Overall Study|Withdrawal by Subject|10|||
155084951|NCT02514746|559742476|FG000|Overall Study|Other|5|||
155084952|NCT02514746|559742477|FG001|Overall Study|Other|1|||
155084953|NCT04003142|559742480|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
155084954|NCT04003142|559742481|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
155084955|NCT04003142|559742482|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
155084956|NCT04003142|559742483|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
155084957|NCT04003142|559742484|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
155084958|NCT04003142|559742480|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
155084959|NCT04003142|559742481|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
155084960|NCT04003142|559742482|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
155084961|NCT04003142|559742483|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
155084962|NCT04003142|559742484|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
155084963|NCT04003142|559742480|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
155084964|NCT04003142|559742481|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
155084965|NCT04003142|559742482|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
155084966|NCT04003142|559742483|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
155084967|NCT04003142|559742484|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
155084968|NCT04003142|559742480|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
155084969|NCT04003142|559742481|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
155084970|NCT04003142|559742482|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
155084971|NCT04003142|559742483|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
155084972|NCT04003142|559742484|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
155084973|NCT04003142|559742480|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
155084974|NCT04003142|559742481|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
155084975|NCT04003142|559742482|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
155084976|NCT04003142|559742483|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
155084977|NCT04003142|559742484|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
155084978|NCT04003142|559742480|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
155084979|NCT04003142|559742481|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
155084980|NCT04003142|559742482|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
155084981|NCT04003142|559742483|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
155084982|NCT04003142|559742484|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
155084983|NCT04003142|559742480|FG000|Extension Period (40 Weeks)|Death|0|||
155084984|NCT04003142|559742481|FG001|Extension Period (40 Weeks)|Death|0|||
155084985|NCT04003142|559742482|FG002|Extension Period (40 Weeks)|Death|0|||
155084986|NCT04003142|559742483|FG003|Extension Period (40 Weeks)|Death|0|||
155352208|NCT00630552|560725626|FG002|Overall Study|Physician Decision|0|||
155352209|NCT00630552|560725627|FG003|Overall Study|Physician Decision|0|||
155352210|NCT00630552|560725628|FG004|Overall Study|Physician Decision|1|||
155352211|NCT00630552|560725624|FG000|Overall Study|Death|0|||
155352212|NCT00630552|560725625|FG001|Overall Study|Death|0|||
155352213|NCT00630552|560725626|FG002|Overall Study|Death|1|||
155352214|NCT00630552|560725627|FG003|Overall Study|Death|2|||
155352215|NCT00630552|560725628|FG004|Overall Study|Death|2|||
155084987|NCT04003142|559742484|FG004|Extension Period (40 Weeks)|Death|1|||
155084988|NCT04003142|559742480|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
155352216|NCT00630552|560725624|FG000|Overall Study|Withdrawal by Subject|0|||
155352217|NCT00630552|560725625|FG001|Overall Study|Withdrawal by Subject|0|||
155352218|NCT00630552|560725626|FG002|Overall Study|Withdrawal by Subject|0|||
155352219|NCT00630552|560725627|FG003|Overall Study|Withdrawal by Subject|1|||
155352220|NCT00630552|560725628|FG004|Overall Study|Withdrawal by Subject|0|||
155352221|NCT00630552|560725624|FG000|Overall Study|Other|0|||
155352222|NCT00630552|560725625|FG001|Overall Study|Other|0|||
155352223|NCT00630552|560725626|FG002|Overall Study|Other|4|||
155352224|NCT00630552|560725627|FG003|Overall Study|Other|2|||
155352225|NCT00630552|560725628|FG004|Overall Study|Other|0|||
155084989|NCT04003142|559742481|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
155084990|NCT04003142|559742482|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
155352226|NCT03226106|560725629|FG000|Overall Study|Withdrawal by Subject|2|||
155352227|NCT03226106|560725630|FG001|Overall Study|Withdrawal by Subject|0|||
155352228|NCT03226106|560725629|FG000|Overall Study|Adverse Event|1|||
155352229|NCT03226106|560725630|FG001|Overall Study|Adverse Event|0|||
155352230|NCT03226106|560725629|FG000|Overall Study|Lost to Follow-up|2|||
155084991|NCT04003142|559742483|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
155084992|NCT04003142|559742484|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
155084993|NCT04003142|559742480|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
155352231|NCT03226106|560725630|FG001|Overall Study|Lost to Follow-up|0|||
155352232|NCT04349644|560725631|FG000|Allocation/Pretest|Lost to pretest|0|||
155352233|NCT04349644|560725632|FG001|Allocation/Pretest|Lost to pretest|3|||
155352234|NCT04349644|560725631|FG000|Posttest|Lost to posttest|0|||
155084994|NCT04003142|559742481|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
155084995|NCT04003142|559742482|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
155084996|NCT04003142|559742483|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
155084997|NCT04003142|559742484|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
155084998|NCT04003142|559742480|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
155084999|NCT04003142|559742481|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
155085000|NCT04003142|559742482|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
155085001|NCT04003142|559742483|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
155085002|NCT04003142|559742484|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
155085003|NCT04003142|559742480|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
155085004|NCT04003142|559742481|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
155085005|NCT04003142|559742482|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
155085006|NCT04003142|559742483|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
155085007|NCT04003142|559742484|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
155085008|NCT03973489|559742487|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
155085009|NCT03973489|559742488|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155085010|NCT03973489|559742489|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155085011|NCT03973489|559742490|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155085012|NCT03973489|559742491|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
155085013|NCT03973489|559742492|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155085014|NCT03973489|559742493|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155085015|NCT03973489|559742494|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
155085016|NCT03973489|559742487|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155085017|NCT03973489|559742488|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155085018|NCT03973489|559742489|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155085019|NCT03973489|559742490|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
155085020|NCT03973489|559742491|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
155085021|NCT03973489|559742492|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155085022|NCT03973489|559742493|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155085023|NCT03973489|559742494|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
155085024|NCT03973489|559742487|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
155085025|NCT03973489|559742488|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
155085026|NCT03973489|559742489|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
155085027|NCT03973489|559742490|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
155085028|NCT03973489|559742491|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
155085029|NCT03973489|559742492|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
155085030|NCT03973489|559742493|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
155085031|NCT03973489|559742494|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
155085032|NCT03973489|559742487|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
155085033|NCT03973489|559742488|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155085034|NCT03973489|559742489|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155085035|NCT03973489|559742490|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
155085036|NCT03973489|559742491|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155085037|NCT03973489|559742492|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155085038|NCT03973489|559742493|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155085039|NCT03973489|559742494|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
155085040|NCT03973489|559742487|FG000|Second Intervention (1 Day)|Adverse Event|0|||
155085041|NCT03973489|559742488|FG001|Second Intervention (1 Day)|Adverse Event|0|||
155085042|NCT03973489|559742489|FG002|Second Intervention (1 Day)|Adverse Event|0|||
155085043|NCT03973489|559742490|FG003|Second Intervention (1 Day)|Adverse Event|1|||
155085044|NCT03973489|559742491|FG004|Second Intervention (1 Day)|Adverse Event|0|||
155085045|NCT03973489|559742492|FG005|Second Intervention (1 Day)|Adverse Event|0|||
155085046|NCT03973489|559742493|FG006|Second Intervention (1 Day)|Adverse Event|0|||
155085047|NCT03973489|559742494|FG007|Second Intervention (1 Day)|Adverse Event|0|||
155085048|NCT03247673|559742495|FG000|Overall Study|Withdrawal by Subject|1|||
155085049|NCT03247673|559742496|FG001|Overall Study|Withdrawal by Subject|0|||
155085050|NCT03247673|559742497|FG002|Overall Study|Withdrawal by Subject|3|||
155085051|NCT03247673|559742495|FG000|Overall Study|Lost to Follow-up|0|||
155085052|NCT03247673|559742496|FG001|Overall Study|Lost to Follow-up|0|||
155085053|NCT03247673|559742497|FG002|Overall Study|Lost to Follow-up|1|||
155085054|NCT04754399|559742501|FG000|Overall Study|Adverse Event|5|||
155085055|NCT04754399|559742501|FG000|Overall Study|Withdrawal by Subject|6|||
155352235|NCT04349644|560725632|FG001|Posttest|Lost to posttest|8|||
155352236|NCT04349644|560725631|FG000|Posttest|Discontinued intervention|6|||
155352237|NCT04349644|560725632|FG001|Posttest|Discontinued intervention|0|||
155352238|NCT04349644|560725631|FG000|Follow-up|Lost to Follow-up|0|||
155352239|NCT04349644|560725632|FG001|Follow-up|Lost to Follow-up|2|||
155352240|NCT01084239|560725633|FG000|28-Day Follow-up|Lost to Follow-up|4|||
155352241|NCT01084239|560725634|FG001|28-Day Follow-up|Lost to Follow-up|9|||
155085056|NCT04616196|559743812|FG000|Overall Study|Progressive Disease|3|||
155085057|NCT04616196|559743813|FG001|Overall Study|Progressive Disease|0|||
155085058|NCT04616196|559743814|FG002|Overall Study|Progressive Disease|4|||
155085059|NCT04616196|559743815|FG003|Overall Study|Progressive Disease|1|||
155085060|NCT04616196|559743812|FG000|Overall Study|Death|2|||
155085061|NCT04616196|559743813|FG001|Overall Study|Death|4|||
155085062|NCT04616196|559743814|FG002|Overall Study|Death|1|||
155085063|NCT04616196|559743815|FG003|Overall Study|Death|0|||
155085064|NCT04616196|559743812|FG000|Overall Study|Withdrawal by Subject|0|||
155085065|NCT04616196|559743813|FG001|Overall Study|Withdrawal by Subject|2|||
155085066|NCT04616196|559743814|FG002|Overall Study|Withdrawal by Subject|0|||
155085067|NCT04616196|559743815|FG003|Overall Study|Withdrawal by Subject|0|||
155085068|NCT04616196|559743812|FG000|Overall Study|Lost to Follow-up|1|||
155085069|NCT04616196|559743813|FG001|Overall Study|Lost to Follow-up|0|||
155085070|NCT04616196|559743814|FG002|Overall Study|Lost to Follow-up|0|||
155085071|NCT04616196|559743815|FG003|Overall Study|Lost to Follow-up|0|||
155085072|NCT04616196|559743812|FG000|Overall Study|Sponsor request|2|||
155085073|NCT04616196|559743813|FG001|Overall Study|Sponsor request|1|||
155085074|NCT04616196|559743814|FG002|Overall Study|Sponsor request|1|||
155085075|NCT04616196|559743815|FG003|Overall Study|Sponsor request|2|||
155085076|NCT03283241|559743816|FG000|Overall Study|Adverse Event|4|||
155085077|NCT03283241|559743817|FG001|Overall Study|Adverse Event|1|||
155085078|NCT03283241|559743816|FG000|Overall Study|Withdrawal by Subject|0|||
155085079|NCT03283241|559743817|FG001|Overall Study|Withdrawal by Subject|1|||
155085080|NCT03283241|559743816|FG000|Overall Study|Subject relocated to Finland|0|||
155085081|NCT03283241|559743817|FG001|Overall Study|Subject relocated to Finland|1|||
155085082|NCT02439957|559743818|FG000|Overall Study|Study Terminated|3|||
155085083|NCT02439957|559743819|FG001|Overall Study|Study Terminated|3|||
155085084|NCT00586157|559743820|FG000|First Intervention|Worsening behavior|1|||
155085085|NCT00586157|559743821|FG001|First Intervention|Worsening behavior|0|||
155085086|NCT00586157|559743820|FG000|Second Intervention|Withdrawal by Subject|1|||
155085087|NCT00586157|559743821|FG001|Second Intervention|Withdrawal by Subject|0|||
155085088|NCT00586157|559743820|FG000|Second Intervention|Worsening behavior|1|||
155085089|NCT00586157|559743821|FG001|Second Intervention|Worsening behavior|0|||
155085090|NCT00586157|559743820|FG000|Second Intervention|Adverse Event|0|||
155085091|NCT00586157|559743821|FG001|Second Intervention|Adverse Event|1|||
155085092|NCT01225952|559743823|FG000|Overall Study|Lost to Follow-up|1|||
155085093|NCT01225952|559743824|FG001|Overall Study|Lost to Follow-up|0|||
155085094|NCT01225952|559743825|FG002|Overall Study|Lost to Follow-up|0|||
155085095|NCT01225952|559743823|FG000|Overall Study|Study Eye Explanted|0|||
155085096|NCT01225952|559743824|FG001|Overall Study|Study Eye Explanted|0|||
155085097|NCT01225952|559743825|FG002|Overall Study|Study Eye Explanted|1|||
155085098|NCT01225952|559743823|FG000|Overall Study|Withdrawal by Subject|4|||
155085099|NCT01225952|559743824|FG001|Overall Study|Withdrawal by Subject|4|||
155085100|NCT01225952|559743825|FG002|Overall Study|Withdrawal by Subject|5|||
155085101|NCT01225952|559743823|FG000|Overall Study|Surgical complications|1|||
155085102|NCT01225952|559743824|FG001|Overall Study|Surgical complications|0|||
155352242|NCT05006417|560725635|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
155352243|NCT00863798|560725636|FG000|Overall Study|Adverse Event|5|||
155352244|NCT00863798|560725637|FG001|Overall Study|Adverse Event|2|||
155352245|NCT00863798|560725638|FG002|Overall Study|Adverse Event|4|||
155352246|NCT00863798|560725636|FG000|Overall Study|Participant failed to return|2|||
155085103|NCT01225952|559743825|FG002|Overall Study|Surgical complications|0|||
155085104|NCT00831389|559743826|FG000|Overall Study|Withdrawal by Subject|0|||
155085105|NCT00831389|559743827|FG001|Overall Study|Withdrawal by Subject|1|||
155085106|NCT00278161|559743829|FG000|Overall Study|Death|11|||
155085107|NCT01817777|559743830|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
155085108|NCT01817777|559743831|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
155085109|NCT01817777|559743832|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
155085110|NCT01817777|559743830|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
155085111|NCT01817777|559743831|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
155085112|NCT01817777|559743832|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
155085113|NCT01817777|559743830|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
155352247|NCT00863798|560725637|FG001|Overall Study|Participant failed to return|1|||
155352248|NCT00863798|560725638|FG002|Overall Study|Participant failed to return|0|||
155352249|NCT00863798|560725636|FG000|Overall Study|Investigator request|1|||
155352250|NCT00863798|560725637|FG001|Overall Study|Investigator request|2|||
155352251|NCT00863798|560725638|FG002|Overall Study|Investigator request|1|||
155352252|NCT00863798|560725636|FG000|Overall Study|Lack of Efficacy|4|||
155085114|NCT01817777|559743831|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
155085115|NCT01817777|559743832|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
155085116|NCT01817777|559743830|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
155085117|NCT01817777|559743831|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
155352253|NCT00863798|560725637|FG001|Overall Study|Lack of Efficacy|3|||
155352254|NCT00863798|560725638|FG002|Overall Study|Lack of Efficacy|6|||
155085118|NCT01817777|559743832|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
155085119|NCT01817777|559743830|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
155085120|NCT01817777|559743831|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
155085121|NCT01817777|559743832|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
155085122|NCT01935947|559743833|FG000|Overall Study|Adverse Event|0|||
155085123|NCT01935947|559743834|FG001|Overall Study|Adverse Event|2|||
155085124|NCT01935947|559743835|FG002|Overall Study|Adverse Event|0|||
155085125|NCT01935947|559743833|FG000|Overall Study|Diease Progression|2|||
155085126|NCT01935947|559743834|FG001|Overall Study|Diease Progression|2|||
155085127|NCT01935947|559743835|FG002|Overall Study|Diease Progression|2|||
155352255|NCT00863798|560725636|FG000|Overall Study|Lost to Follow-up|6|||
155352256|NCT00863798|560725637|FG001|Overall Study|Lost to Follow-up|9|||
155352257|NCT00863798|560725638|FG002|Overall Study|Lost to Follow-up|5|||
155352258|NCT00863798|560725636|FG000|Overall Study|Other|2|||
155352259|NCT00863798|560725637|FG001|Overall Study|Other|3|||
155352260|NCT00863798|560725638|FG002|Overall Study|Other|1|||
155352261|NCT00863798|560725636|FG000|Overall Study|Protocol Violation|0|||
155352262|NCT00863798|560725637|FG001|Overall Study|Protocol Violation|1|||
155352263|NCT00863798|560725638|FG002|Overall Study|Protocol Violation|1|||
155352264|NCT00863798|560725636|FG000|Overall Study|Withdrawal by Subject|8|||
155352265|NCT00863798|560725637|FG001|Overall Study|Withdrawal by Subject|7|||
155352266|NCT00863798|560725638|FG002|Overall Study|Withdrawal by Subject|4|||
155352267|NCT00863798|560725636|FG000|Overall Study|Randomized not treated|4|||
155352268|NCT00863798|560725637|FG001|Overall Study|Randomized not treated|2|||
155085128|NCT01935947|559743833|FG000|Overall Study|Death|1|||
155085129|NCT01935947|559743834|FG001|Overall Study|Death|0|||
155352269|NCT00863798|560725638|FG002|Overall Study|Randomized not treated|3|||
155352270|NCT04238520|560725639|FG000|Overall Study|Withdrawal by Subject|1|||
155352271|NCT04238520|560725640|FG001|Overall Study|Withdrawal by Subject|1|||
155352272|NCT04238520|560725639|FG000|Overall Study|Lost to Follow-up|1|||
155352273|NCT04238520|560725640|FG001|Overall Study|Lost to Follow-up|2|||
155352274|NCT04238520|560725639|FG000|Overall Study|Death|0|||
155085130|NCT01935947|559743835|FG002|Overall Study|Death|0|||
155085131|NCT00692237|559743836|FG000|Overall Study|Withdrawal by Subject|1|||
155352275|NCT04238520|560725640|FG001|Overall Study|Death|2|||
155085132|NCT00692237|559743837|FG001|Overall Study|Withdrawal by Subject|3|||
155085133|NCT00692237|559743836|FG000|Overall Study|Adverse Event|0|||
155085134|NCT00692237|559743837|FG001|Overall Study|Adverse Event|1|||
155085135|NCT00752219|559743838|FG000|Overall Study|Clinical failure|0|||
155085136|NCT00752219|559743839|FG001|Overall Study|Clinical failure|1|||
155085137|NCT00752219|559743838|FG000|Overall Study|Adverse Event|5|||
155352276|NCT04238520|560725639|FG000|Overall Study|Unsafe home environment for research staff|0|||
155352277|NCT04238520|560725640|FG001|Overall Study|Unsafe home environment for research staff|1|||
155352278|NCT01470599|560725641|FG000|Overall Study|Did not meet entrance criteria|1|||
155352279|NCT01470599|560725642|FG001|Overall Study|Did not meet entrance criteria|0|||
155352280|NCT01470599|560725641|FG000|Overall Study|Lost to Follow-up|2|||
155352281|NCT01470599|560725642|FG001|Overall Study|Lost to Follow-up|1|||
155352282|NCT01470599|560725641|FG000|Overall Study|Withdrawal by Subject|3|||
155352283|NCT01470599|560725642|FG001|Overall Study|Withdrawal by Subject|4|||
155352284|NCT01470599|560725641|FG000|Overall Study|Other|1|||
155352285|NCT01470599|560725642|FG001|Overall Study|Other|0|||
155352286|NCT01470599|560725641|FG000|Overall Study|Protocol Violation|3|||
155352287|NCT01470599|560725642|FG001|Overall Study|Protocol Violation|1|||
155085138|NCT00752219|559743839|FG001|Overall Study|Adverse Event|3|||
155085139|NCT00752219|559743838|FG000|Overall Study|Protocol deviation|1|||
155085140|NCT00752219|559743839|FG001|Overall Study|Protocol deviation|0|||
155085141|NCT00752219|559743838|FG000|Overall Study|Lost to Follow-up|1|||
155352288|NCT01470599|560725641|FG000|Overall Study|Adverse event related to study drug|2|||
155085142|NCT00752219|559743839|FG001|Overall Study|Lost to Follow-up|2|||
155085143|NCT00752219|559743838|FG000|Overall Study|Randomized but not treated|1|||
155352289|NCT01470599|560725642|FG001|Overall Study|Adverse event related to study drug|5|||
155352290|NCT01470599|560725641|FG000|Overall Study|Insufficient clinical response|6|||
154964639|NCT01117623|559297451|FG001|Overall Study|Invest. text: completed all planned txs|0|||
154964640|NCT01117623|559297452|FG002|Overall Study|Invest. text: completed all planned txs|0|||
155085144|NCT00752219|559743839|FG001|Overall Study|Randomized but not treated|0|||
155165614|NCT01077076|560043504|FG000|First Intervention|Withdrawal by Subject|1|||
155165615|NCT01077076|560043505|FG001|First Intervention|Withdrawal by Subject|0|||
155352291|NCT01470599|560725642|FG001|Overall Study|Insufficient clinical response|27|||
155352292|NCT01470599|560725641|FG000|Overall Study|Adverse event not related to study drug|1|||
155352293|NCT01470599|560725642|FG001|Overall Study|Adverse event not related to study drug|5|||
155352294|NCT00195442|560725643|FG000|Overall Study|Less than expected therapeutic effect|38|||
155352295|NCT00195442|560725643|FG000|Overall Study|Lost to Follow-up|27|||
155352296|NCT00195442|560725643|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
155085145|NCT00752219|559743838|FG000|Overall Study|Other|3|||
155085146|NCT00752219|559743839|FG001|Overall Study|Other|0|||
155085147|NCT00836901|559743842|FG000|First Intervention|Withdrawal by Subject|1|||
155085148|NCT00836901|559743843|FG001|First Intervention|Withdrawal by Subject|0|||
155085149|NCT03268499|559743845|FG000|Overall Study|Withdrawal by Subject|2|||
155085150|NCT03268499|559743846|FG001|Overall Study|Withdrawal by Subject|1|||
155085151|NCT02758626|559743851|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
155085152|NCT02758626|559743852|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
155085153|NCT02758626|559743851|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
155352297|NCT00195442|560725643|FG000|Overall Study|Intermittent product shortage|21|||
155352298|NCT00195442|560725643|FG000|Overall Study|Death|7|||
155352299|NCT00195442|560725643|FG000|Overall Study|No reason specified|4|||
155352300|NCT00195442|560725643|FG000|Overall Study|Poor cooperation|2|||
155352301|NCT00195442|560725643|FG000|Overall Study|Other|14|||
155352302|NCT01917006|560725644|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
155352303|NCT01917006|560725645|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
155352304|NCT01917006|560725646|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
155352305|NCT01917006|560725647|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
155352306|NCT01917006|560725648|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
155352307|NCT01917006|560725649|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
155352308|NCT01917006|560725650|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
155352309|NCT01917006|560725651|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
155352310|NCT01917006|560725644|FG000|Randomized-treatment Period|Personal Reasons|0|||
155352311|NCT01917006|560725645|FG001|Randomized-treatment Period|Personal Reasons|0|||
155352312|NCT01917006|560725646|FG002|Randomized-treatment Period|Personal Reasons|0|||
155352313|NCT01917006|560725647|FG003|Randomized-treatment Period|Personal Reasons|0|||
155352314|NCT01917006|560725648|FG004|Randomized-treatment Period|Personal Reasons|0|||
155352315|NCT01917006|560725649|FG005|Randomized-treatment Period|Personal Reasons|1|||
155352316|NCT01917006|560725650|FG006|Randomized-treatment Period|Personal Reasons|0|||
155352317|NCT01917006|560725651|FG007|Randomized-treatment Period|Personal Reasons|0|||
155352318|NCT01917006|560725644|FG000|Randomized-treatment Period|Protocol Violation|1|||
155352319|NCT01917006|560725645|FG001|Randomized-treatment Period|Protocol Violation|0|||
155352320|NCT01917006|560725646|FG002|Randomized-treatment Period|Protocol Violation|0|||
155352321|NCT01917006|560725647|FG003|Randomized-treatment Period|Protocol Violation|0|||
155352322|NCT01917006|560725648|FG004|Randomized-treatment Period|Protocol Violation|0|||
155352323|NCT01917006|560725649|FG005|Randomized-treatment Period|Protocol Violation|0|||
155352324|NCT01917006|560725650|FG006|Randomized-treatment Period|Protocol Violation|0|||
155352325|NCT01917006|560725651|FG007|Randomized-treatment Period|Protocol Violation|0|||
155352326|NCT01917006|560725644|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352327|NCT01917006|560725645|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352328|NCT01917006|560725646|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352329|NCT01917006|560725647|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352330|NCT01917006|560725648|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352331|NCT01917006|560725649|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352332|NCT01917006|560725650|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
155352333|NCT01917006|560725651|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
155352334|NCT01917006|560725644|FG000|Open-label Period|Adverse Event|0|||
155352335|NCT01917006|560725645|FG001|Open-label Period|Adverse Event|0|||
155352336|NCT01917006|560725646|FG002|Open-label Period|Adverse Event|0|||
155352337|NCT01917006|560725647|FG003|Open-label Period|Adverse Event|0|||
155352338|NCT01917006|560725648|FG004|Open-label Period|Adverse Event|0|||
155085154|NCT02758626|559743852|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
155085155|NCT02758626|559743851|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
155085156|NCT02758626|559743852|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
155352339|NCT01917006|560725649|FG005|Open-label Period|Adverse Event|0|||
155352340|NCT01917006|560725650|FG006|Open-label Period|Adverse Event|0|||
155085157|NCT02758626|559743851|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
155085158|NCT02758626|559743852|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
155085159|NCT00456365|559743862|FG000|Overall Study|Lost to Follow-up|1|||
155085160|NCT00456365|559743863|FG001|Overall Study|Lost to Follow-up|3|||
155085161|NCT00456365|559743862|FG000|Overall Study|Withdrawal by Subject|4|||
155085162|NCT00456365|559743863|FG001|Overall Study|Withdrawal by Subject|7|||
155085163|NCT00456365|559743862|FG000|Overall Study|Pregnancy|1|||
155085164|NCT00456365|559743863|FG001|Overall Study|Pregnancy|1|||
155085165|NCT00456365|559743862|FG000|Overall Study|oncologic diagnosis|1|||
155085166|NCT00456365|559743863|FG001|Overall Study|oncologic diagnosis|1|||
155085167|NCT01491919|559743878|FG000|Overall Study|Insufficient PK sampling|1|||
155085168|NCT01491919|559743879|FG001|Overall Study|Insufficient PK sampling|2|||
155085169|NCT01491919|559743880|FG002|Overall Study|Insufficient PK sampling|1|||
155085170|NCT04003389|559743881|FG000|Overall Study|Adverse Event|27|||
155085171|NCT04003389|559743882|FG001|Overall Study|Adverse Event|34|||
155085172|NCT04003389|559743883|FG002|Overall Study|Adverse Event|28|||
155085173|NCT04003389|559743881|FG000|Overall Study|Lost to Follow-up|39|||
155085174|NCT04003389|559743882|FG001|Overall Study|Lost to Follow-up|30|||
155085175|NCT04003389|559743883|FG002|Overall Study|Lost to Follow-up|33|||
155085176|NCT04003389|559743881|FG000|Overall Study|Protocol Violation|1|||
155085177|NCT04003389|559743882|FG001|Overall Study|Protocol Violation|6|||
155085178|NCT04003389|559743883|FG002|Overall Study|Protocol Violation|5|||
155085179|NCT04003389|559743881|FG000|Overall Study|Withdrawal by Subject|119|||
155085180|NCT04003389|559743882|FG001|Overall Study|Withdrawal by Subject|79|||
155085181|NCT04003389|559743883|FG002|Overall Study|Withdrawal by Subject|85|||
155085182|NCT04003389|559743881|FG000|Overall Study|Miscellaneous|14|||
155085183|NCT04003389|559743882|FG001|Overall Study|Miscellaneous|11|||
155085184|NCT04003389|559743883|FG002|Overall Study|Miscellaneous|14|||
155085185|NCT04003389|559743881|FG000|Overall Study|Participant did not receive study drug|1|||
155085186|NCT04003389|559743882|FG001|Overall Study|Participant did not receive study drug|0|||
155085187|NCT04003389|559743883|FG002|Overall Study|Participant did not receive study drug|0|||
155085188|NCT04818229|559743884|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
155085189|NCT04818229|559743885|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
155085190|NCT04818229|559743886|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
155085191|NCT04818229|559743884|FG000|Overall Study|Adverse Event|3|||
155085192|NCT04818229|559743885|FG001|Overall Study|Adverse Event|1|||
154964641|NCT01117623|559297453|FG003|Overall Study|Invest. text: completed all planned txs|0|||
155085193|NCT04818229|559743886|FG002|Overall Study|Adverse Event|1|||
155085194|NCT04818229|559743884|FG000|Overall Study|Withdrawal by Subject|0|||
155085195|NCT04818229|559743885|FG001|Overall Study|Withdrawal by Subject|0|||
155085196|NCT04818229|559743886|FG002|Overall Study|Withdrawal by Subject|2|||
155085197|NCT04818229|559743884|FG000|Overall Study|Lost to Follow-up|0|||
155085198|NCT04818229|559743885|FG001|Overall Study|Lost to Follow-up|0|||
155085199|NCT04818229|559743886|FG002|Overall Study|Lost to Follow-up|1|||
155085200|NCT03186378|559743887|FG000|Overall Study|Lost to Follow-up|1|||
155085201|NCT03186378|559743888|FG001|Overall Study|Lost to Follow-up|0|||
155085202|NCT03769116|559743889|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
155085203|NCT03769116|559743890|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
155085204|NCT03769116|559743889|FG000|Part 3 - Open Label|Physician Decision|1|||
155085205|NCT03769116|559743890|FG001|Part 3 - Open Label|Physician Decision|0|||
155085206|NCT03769116|559743889|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
155085207|NCT03769116|559743890|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
155085208|NCT03382873|559743891|FG000|Overall Study|Lost to Follow-up|9|||
155085209|NCT03382873|559743892|FG001|Overall Study|Lost to Follow-up|10|||
155085210|NCT03382873|559743891|FG000|Overall Study|Withdrawal by Subject|6|||
155085211|NCT03382873|559743892|FG001|Overall Study|Withdrawal by Subject|11|||
155085212|NCT03382873|559743891|FG000|Overall Study|Visit not completed due to pandemic|16|||
154964642|NCT01117623|559297454|FG004|Overall Study|Invest. text: completed all planned txs|0|||
155085213|NCT03382873|559743892|FG001|Overall Study|Visit not completed due to pandemic|41|||
155085214|NCT05021224|559743894|FG000|Overall Study|Did not complete all survey items|4|||
155165616|NCT01077076|560043506|FG002|First Intervention|Withdrawal by Subject|0|||
155085215|NCT05021224|559743895|FG001|Overall Study|Did not complete all survey items|1|||
154964643|NCT01117623|559297455|FG005|Overall Study|Invest. text: completed all planned txs|1|||
155085216|NCT05021224|559743896|FG002|Overall Study|Did not complete all survey items|0|||
155085217|NCT05021224|559743897|FG003|Overall Study|Did not complete all survey items|2|||
154964644|NCT01117623|559297456|FG006|Overall Study|Invest. text: completed all planned txs|0|||
154964645|NCT01117623|559297457|FG007|Overall Study|Invest. text: completed all planned txs|0|||
154964646|NCT02727192|559297462|FG000|Overall Study|Lost to Follow-up|1|||
154964647|NCT02727192|559297463|FG001|Overall Study|Lost to Follow-up|0|||
154964648|NCT02727192|559297464|FG002|Overall Study|Lost to Follow-up|0|||
154964649|NCT00928057|559297465|FG000|Overall Study|Adverse Event|1|||
154964650|NCT00928057|559297466|FG001|Overall Study|Adverse Event|2|||
154964651|NCT00928057|559297465|FG000|Overall Study|Withdrawal by Subject|1|||
154964652|NCT00928057|559297466|FG001|Overall Study|Withdrawal by Subject|0|||
154964653|NCT00928057|559297465|FG000|Overall Study|Lost to Follow-up|0|||
154964654|NCT00928057|559297466|FG001|Overall Study|Lost to Follow-up|1|||
154964655|NCT00928057|559297465|FG000|Overall Study|Protocol Violation|0|||
154964656|NCT00928057|559297466|FG001|Overall Study|Protocol Violation|1|||
154964657|NCT03206749|559297467|FG000|Overall Study|Withdrawal of consent|5|||
154964658|NCT03206749|559297468|FG001|Overall Study|Withdrawal of consent|3|||
154964659|NCT03206749|559297469|FG002|Overall Study|Withdrawal of consent|6|||
154964660|NCT03206749|559297467|FG000|Overall Study|Lost to Follow-up|0|||
154964661|NCT03206749|559297468|FG001|Overall Study|Lost to Follow-up|0|||
154964662|NCT03206749|559297469|FG002|Overall Study|Lost to Follow-up|1|||
154964663|NCT02451696|559297470|FG000|Overall Study|Surgery postponed|1|||
154964664|NCT02451696|559297471|FG001|Overall Study|Surgery postponed|0|||
154964665|NCT03674892|559297472|FG000|Overall Study|Lack of Efficacy|5|||
154964666|NCT03674892|559297472|FG000|Overall Study|Lost to Follow-up|3|||
154964667|NCT03674892|559297472|FG000|Overall Study|Migraine|2|||
154964668|NCT03674892|559297472|FG000|Overall Study|Excessive Tearing|1|||
154964669|NCT03674892|559297472|FG000|Overall Study|Increased Eye Pain|1|||
154964670|NCT03674892|559297472|FG000|Overall Study|Increased Facial Pain|1|||
154964671|NCT03674892|559297472|FG000|Overall Study|Sinus Irritation|1|||
154964672|NCT03674892|559297472|FG000|Overall Study|Sinus Infection|1|||
154964673|NCT05099380|559297473|FG000|Overall Study|Subject enrolled in error|1|||
154964674|NCT05099380|559297474|FG001|Overall Study|Subject enrolled in error|0|||
154964675|NCT05099380|559297473|FG000|Overall Study|Study Procedure|1|||
154964676|NCT05099380|559297474|FG001|Overall Study|Study Procedure|0|||
154964677|NCT05099380|559297473|FG000|Overall Study|Protocol Violation|1|||
154964678|NCT05099380|559297474|FG001|Overall Study|Protocol Violation|0|||
154964679|NCT05099380|559297473|FG000|Overall Study|Adverse Event|1|||
154964680|NCT05099380|559297474|FG001|Overall Study|Adverse Event|1|||
154964681|NCT05099380|559297473|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
154964682|NCT05099380|559297474|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
154964683|NCT01959672|559297480|FG000|Overall Study|Death|1|||
154964684|NCT02392195|559297481|FG000|Overall Study|Lost to Follow-up|4|||
154964685|NCT02392195|559297481|FG000|Overall Study|Withdrawal by Subject|4|||
154964686|NCT00840216|559297482|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
154964687|NCT00840216|559297483|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
154964688|NCT00545792|559297486|FG000|Overall Study|Withdrawal by Subject|1|||
154964689|NCT05041361|559297488|FG000|Overall Study|Lost to Follow-up|1|||
154964690|NCT05041361|559297489|FG001|Overall Study|Lost to Follow-up|3|||
154964691|NCT01642277|559297490|FG000|Overall Study|Adverse Event|10|||
154964692|NCT01642277|559297491|FG001|Overall Study|Adverse Event|0|||
154964693|NCT01642277|559297490|FG000|Overall Study|Physician Decision|2|||
154964694|NCT01642277|559297491|FG001|Overall Study|Physician Decision|0|||
154964695|NCT01642277|559297490|FG000|Overall Study|Protocol Violation|1|||
154964696|NCT01642277|559297491|FG001|Overall Study|Protocol Violation|0|||
154964697|NCT01642277|559297490|FG000|Overall Study|Withdrawal by Subject|11|||
154964698|NCT01642277|559297491|FG001|Overall Study|Withdrawal by Subject|0|||
154964699|NCT03679598|559297492|FG000|Overall Study|Adverse Event|2|||
154964700|NCT03679598|559297493|FG001|Overall Study|Adverse Event|0|||
154964701|NCT00927069|559297494|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
154964702|NCT00927069|559297495|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
155085218|NCT03996395|559743898|FG000|Overall Study|Lost to Follow-up|4|||
155085219|NCT03996395|559743898|FG000|Overall Study|Withdrawal by Subject|1|||
155085220|NCT03996395|559743898|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
155085221|NCT05375929|559743905|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
155085222|NCT05375929|559743906|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
155085223|NCT05375929|559743907|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
155085224|NCT05375929|559743908|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
155085225|NCT05375929|559743905|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155085226|NCT05375929|559743906|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155085227|NCT05375929|559743907|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155352341|NCT01917006|560725651|FG007|Open-label Period|Adverse Event|1|||
155352342|NCT01917006|560725644|FG000|Open-label Period|Lost to Follow-up|0|||
155352343|NCT01917006|560725645|FG001|Open-label Period|Lost to Follow-up|0|||
155352344|NCT01917006|560725646|FG002|Open-label Period|Lost to Follow-up|0|||
155352345|NCT01917006|560725647|FG003|Open-label Period|Lost to Follow-up|0|||
155352346|NCT01917006|560725648|FG004|Open-label Period|Lost to Follow-up|0|||
155352347|NCT01917006|560725649|FG005|Open-label Period|Lost to Follow-up|0|||
155085228|NCT05375929|559743908|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155085229|NCT05375929|559743905|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
155085230|NCT05375929|559743906|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
155085231|NCT05375929|559743907|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
155085232|NCT05375929|559743908|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
155085233|NCT05375929|559743905|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
155085234|NCT05375929|559743906|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
155085235|NCT05375929|559743907|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
155085236|NCT05375929|559743908|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
155085237|NCT05375929|559743905|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
155352348|NCT01917006|560725650|FG006|Open-label Period|Lost to Follow-up|0|||
155352349|NCT01917006|560725651|FG007|Open-label Period|Lost to Follow-up|1|||
155085238|NCT05375929|559743906|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
155085239|NCT05375929|559743907|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
155085240|NCT05375929|559743908|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
155085241|NCT05375929|559743905|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
155085242|NCT05375929|559743906|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
155085243|NCT05375929|559743907|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
155085244|NCT05375929|559743908|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
155085245|NCT05375929|559743905|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
155085246|NCT05375929|559743906|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
155085247|NCT05375929|559743907|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
155085248|NCT05375929|559743908|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
155085249|NCT05375929|559743905|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
155085250|NCT05375929|559743906|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
155085251|NCT05375929|559743907|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
155085252|NCT05375929|559743908|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
155085253|NCT05375929|559743905|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
155352350|NCT02158247|560725657|FG000|Overall Study|Invisible vocal cords|5|||
155352351|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
155352352|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
155352353|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
155352354|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
155352355|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
155352356|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
155352357|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
155352358|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
155352359|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
155352360|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
155352361|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
154964703|NCT00927069|559297496|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
154964704|NCT00927069|559297497|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
155085254|NCT05375929|559743906|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
155352362|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
155352363|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
154964705|NCT00927069|559297494|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
154964706|NCT00927069|559297495|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
154964707|NCT00927069|559297496|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
154964708|NCT00927069|559297497|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
155085255|NCT05375929|559743907|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
155085256|NCT05375929|559743908|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
155085257|NCT05375929|559743905|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
155085258|NCT05375929|559743906|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
155085259|NCT05375929|559743907|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
155085260|NCT05375929|559743908|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
155085261|NCT03301415|559743909|FG000|Overall Study|Lost to Follow-up|2|||
155085262|NCT03301415|559743909|FG000|Overall Study|Unable to comply with visit schedule|2|||
155085263|NCT00392288|559743910|FG000|Overall Study|Adverse Event|17|||
155085264|NCT00392288|559743911|FG001|Overall Study|Adverse Event|7|||
155085265|NCT00392288|559743912|FG002|Overall Study|Adverse Event|8|||
155085266|NCT00392288|559743910|FG000|Overall Study|Lack of Efficacy|8|||
155085267|NCT00392288|559743911|FG001|Overall Study|Lack of Efficacy|5|||
155085268|NCT00392288|559743912|FG002|Overall Study|Lack of Efficacy|3|||
155085269|NCT00392288|559743910|FG000|Overall Study|Protocol Violation|1|||
155085270|NCT00392288|559743911|FG001|Overall Study|Protocol Violation|3|||
155085271|NCT00392288|559743912|FG002|Overall Study|Protocol Violation|1|||
155085272|NCT00392288|559743910|FG000|Overall Study|Lost to Follow-up|1|||
155085273|NCT00392288|559743911|FG001|Overall Study|Lost to Follow-up|1|||
155085274|NCT00392288|559743912|FG002|Overall Study|Lost to Follow-up|1|||
155085275|NCT00392288|559743910|FG000|Overall Study|Withdrawal by Subject|1|||
155085276|NCT00392288|559743911|FG001|Overall Study|Withdrawal by Subject|0|||
155352364|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
155352365|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
155352366|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
155085277|NCT00392288|559743912|FG002|Overall Study|Withdrawal by Subject|2|||
155085278|NCT00392288|559743910|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
155085279|NCT00392288|559743911|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
155085280|NCT00392288|559743912|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
155085281|NCT00392288|559743910|FG000|Overall Study|Other|3|||
155085282|NCT00392288|559743911|FG001|Overall Study|Other|4|||
155085283|NCT00392288|559743912|FG002|Overall Study|Other|1|||
155085284|NCT04755231|559743915|FG000|Overall Study|Lost to Follow-up|5|||
155085285|NCT04755231|559743915|FG000|Overall Study|Withdrawal by Subject|5|||
155085286|NCT00025233|559743918|FG000|Overall Study|Ineligible: wrong cell type|1|||
155085287|NCT00025233|559743918|FG000|Overall Study|Ineligible: wrong primary|1|||
155085288|NCT00025233|559743918|FG000|Overall Study|Ineligible: improper prior treatment|1|||
155352367|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
155352368|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
155352369|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
155352370|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
155352371|NCT02637856|560725664|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
155352372|NCT02637856|560725665|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
155352373|NCT02637856|560725664|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
155352374|NCT02637856|560725665|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
155352375|NCT02637856|560725664|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
155352376|NCT02637856|560725665|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
155352377|NCT02509312|560725666|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
155352378|NCT02509312|560725667|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
155352379|NCT02509312|560725666|FG000|Overall Study|Obstetrician refusal|0|||
155352380|NCT02509312|560725667|FG001|Overall Study|Obstetrician refusal|1|||
155352381|NCT02509312|560725666|FG000|Overall Study|Patient elected for TOLAC|1|||
155352382|NCT02509312|560725667|FG001|Overall Study|Patient elected for TOLAC|0|||
155352383|NCT02509312|560725666|FG000|Overall Study|Cesarean deemed stat|1|||
155352384|NCT02509312|560725667|FG001|Overall Study|Cesarean deemed stat|0|||
155352385|NCT02509312|560725666|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
155352386|NCT02509312|560725667|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
155352387|NCT02815735|560725668|FG000|First Intervention (4 Weeks)|Discomfort|1|||
155352388|NCT02815735|560725669|FG001|First Intervention (4 Weeks)|Discomfort|0|||
155352389|NCT02815735|560725668|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
155352390|NCT02815735|560725669|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155352391|NCT02815735|560725668|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
155352392|NCT02815735|560725669|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
155352393|NCT02815735|560725668|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
155352394|NCT02815735|560725669|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
155352395|NCT00702650|560725670|FG000|Overall Study|Withdrawal by Subject|9|||
155352396|NCT00702650|560725670|FG000|Overall Study|Non-Compliance of Study Drug|3|||
155352397|NCT00702650|560725670|FG000|Overall Study|Lost to Follow-up|2|||
155352398|NCT00702650|560725670|FG000|Overall Study|Non-Compliance with Site Directives|1|||
155085289|NCT00025233|559743918|FG000|Overall Study|Never treated|1|||
155085290|NCT01720602|559743919|FG000|Overall Study|Adverse Event|3|||
155085291|NCT01720602|559743919|FG000|Overall Study|Progressive disease on therapy|2|||
155085292|NCT02184442|559743920|FG000|Overall Study|Death|61|||
155085293|NCT02184442|559743921|FG001|Overall Study|Death|65|||
155085294|NCT02184442|559743920|FG000|Overall Study|Withdrawal by Subject|3|||
155085295|NCT02184442|559743921|FG001|Overall Study|Withdrawal by Subject|11|||
155085296|NCT04105725|559743922|FG000|Primary Intervention|Lost to Follow-up|0|||
155085297|NCT04105725|559743923|FG001|Primary Intervention|Lost to Follow-up|2|||
155085298|NCT04105725|559743922|FG000|Primary Intervention|Withdrawal by Subject|0|||
155085299|NCT04105725|559743923|FG001|Primary Intervention|Withdrawal by Subject|1|||
155085300|NCT02691494|559743928|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
155085301|NCT02691494|559743929|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
155085302|NCT02691494|559743930|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
155085303|NCT02691494|559743928|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155085304|NCT02691494|559743929|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155085305|NCT02691494|559743930|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
155085306|NCT02691494|559743928|FG000|Post-Treatment Follow-Up Period|Other|2|||
155085307|NCT02691494|559743929|FG001|Post-Treatment Follow-Up Period|Other|1|||
155085308|NCT02691494|559743930|FG002|Post-Treatment Follow-Up Period|Other|1|||
155085309|NCT02691494|559743928|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
155085310|NCT02691494|559743929|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
155085311|NCT02691494|559743930|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
155085312|NCT02691494|559743928|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155085313|NCT02691494|559743929|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
155085314|NCT02691494|559743930|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
155085315|NCT00787800|559743931|FG000|Overall Study|Withdrawal by Subject|3|||
155085316|NCT00787800|559743932|FG001|Overall Study|Withdrawal by Subject|5|||
155085317|NCT00787800|559743931|FG000|Overall Study|Death|0|||
155085318|NCT00787800|559743932|FG001|Overall Study|Death|2|||
155085319|NCT00507507|559743936|FG000|Treatment Period|Lost to Follow-up|0|||
155085320|NCT00507507|559743937|FG001|Treatment Period|Lost to Follow-up|2|||
155085321|NCT00507507|559743936|FG000|Treatment Period|Physician Decision|4|||
155085322|NCT00507507|559743937|FG001|Treatment Period|Physician Decision|1|||
155085323|NCT00507507|559743936|FG000|Treatment Period|Protocol Violation|1|||
155085324|NCT00507507|559743937|FG001|Treatment Period|Protocol Violation|2|||
155085325|NCT00507507|559743936|FG000|Treatment Period|Adverse Event|1|||
155085326|NCT00507507|559743937|FG001|Treatment Period|Adverse Event|1|||
155085327|NCT00507507|559743936|FG000|Treatment Period|Withdrawal by Subject|46|||
155085328|NCT00507507|559743937|FG001|Treatment Period|Withdrawal by Subject|47|||
155352399|NCT00702650|560725670|FG000|Overall Study|Sponsor Request|1|||
155352400|NCT00702650|560725670|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
155352401|NCT00702650|560725670|FG000|Overall Study|Adverse Event|3|||
155352402|NCT00943722|560725672|FG000|Base Study|Adverse Event|0|||
155352403|NCT00943722|560725673|FG001|Base Study|Adverse Event|0|||
155352404|NCT00943722|560725674|FG002|Base Study|Adverse Event|0|||
155352405|NCT00943722|560725675|FG003|Base Study|Adverse Event|1|||
155352406|NCT00943722|560725676|FG004|Base Study|Adverse Event|0|||
155352407|NCT00943722|560725677|FG005|Base Study|Adverse Event|0|||
155352408|NCT00943722|560725678|FG006|Base Study|Adverse Event|0|||
155352409|NCT00943722|560725672|FG000|Base Study|Lost to Follow-up|12|||
155352410|NCT00943722|560725673|FG001|Base Study|Lost to Follow-up|8|||
155352411|NCT00943722|560725674|FG002|Base Study|Lost to Follow-up|10|||
155352412|NCT00943722|560725675|FG003|Base Study|Lost to Follow-up|8|||
155352413|NCT00943722|560725676|FG004|Base Study|Lost to Follow-up|11|||
155352414|NCT00943722|560725677|FG005|Base Study|Lost to Follow-up|0|||
155352415|NCT00943722|560725678|FG006|Base Study|Lost to Follow-up|0|||
155352416|NCT00943722|560725672|FG000|Base Study|Physician Decision|1|||
155352417|NCT00943722|560725673|FG001|Base Study|Physician Decision|0|||
155352418|NCT00943722|560725674|FG002|Base Study|Physician Decision|0|||
155352419|NCT00943722|560725675|FG003|Base Study|Physician Decision|0|||
155352420|NCT00943722|560725676|FG004|Base Study|Physician Decision|1|||
155352421|NCT00943722|560725677|FG005|Base Study|Physician Decision|0|||
155352422|NCT00943722|560725678|FG006|Base Study|Physician Decision|0|||
155352423|NCT00943722|560725672|FG000|Base Study|Pregnancy|0|||
155352424|NCT00943722|560725673|FG001|Base Study|Pregnancy|0|||
155352425|NCT00943722|560725674|FG002|Base Study|Pregnancy|1|||
155352426|NCT00943722|560725675|FG003|Base Study|Pregnancy|0|||
155352427|NCT00943722|560725676|FG004|Base Study|Pregnancy|2|||
155352428|NCT00943722|560725677|FG005|Base Study|Pregnancy|0|||
155352429|NCT00943722|560725678|FG006|Base Study|Pregnancy|0|||
155352430|NCT00943722|560725672|FG000|Base Study|Protocol Violation|0|||
155352431|NCT00943722|560725673|FG001|Base Study|Protocol Violation|1|||
155352432|NCT00943722|560725674|FG002|Base Study|Protocol Violation|0|||
155352433|NCT00943722|560725675|FG003|Base Study|Protocol Violation|0|||
155352434|NCT00943722|560725676|FG004|Base Study|Protocol Violation|2|||
155352435|NCT00943722|560725677|FG005|Base Study|Protocol Violation|0|||
155352436|NCT00943722|560725678|FG006|Base Study|Protocol Violation|0|||
155352437|NCT00943722|560725672|FG000|Base Study|Withdrawal by Subject|12|||
155352438|NCT00943722|560725673|FG001|Base Study|Withdrawal by Subject|13|||
155352439|NCT00943722|560725674|FG002|Base Study|Withdrawal by Subject|2|||
155352440|NCT00943722|560725675|FG003|Base Study|Withdrawal by Subject|13|||
155352441|NCT00943722|560725676|FG004|Base Study|Withdrawal by Subject|8|||
155352442|NCT00943722|560725677|FG005|Base Study|Withdrawal by Subject|0|||
155352443|NCT00943722|560725678|FG006|Base Study|Withdrawal by Subject|0|||
155352444|NCT00943722|560725672|FG000|Base Study|Month 12 visit not completed|0|||
155352445|NCT00943722|560725673|FG001|Base Study|Month 12 visit not completed|0|||
155352446|NCT00943722|560725674|FG002|Base Study|Month 12 visit not completed|0|||
155352447|NCT00943722|560725675|FG003|Base Study|Month 12 visit not completed|0|||
155352448|NCT00943722|560725676|FG004|Base Study|Month 12 visit not completed|2|||
155085329|NCT00507507|559743936|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
155085330|NCT00507507|559743937|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
155085331|NCT00507507|559743936|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
155352449|NCT00943722|560725677|FG005|Base Study|Month 12 visit not completed|0|||
155352450|NCT00943722|560725678|FG006|Base Study|Month 12 visit not completed|0|||
155352451|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Adverse Event|0|||
155352452|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Adverse Event|0|||
155352453|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Adverse Event|0|||
155352454|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Adverse Event|0|||
155352455|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Adverse Event|0|||
155085332|NCT00507507|559743937|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
155085333|NCT00507507|559743936|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
155085334|NCT00507507|559743937|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
155085335|NCT02916433|559743938|FG000|Overall Study|Withdrawal by Subject|1|||
155085336|NCT02916433|559743939|FG001|Overall Study|Withdrawal by Subject|0|||
155085337|NCT02916433|559743938|FG000|Overall Study|Physician Decision|1|||
155085338|NCT02916433|559743939|FG001|Overall Study|Physician Decision|0|||
155085339|NCT03878069|559743942|FG000|Overall Study|Death|0|||
155085340|NCT03878069|559743943|FG001|Overall Study|Death|1|||
155085341|NCT03878069|559743944|FG002|Overall Study|Death|0|||
155085342|NCT06790303|559745801|FG000|Overall Study|Study Terminated by sponsor|4|||
155085343|NCT06790303|559745801|FG000|Overall Study|Death|4|||
155085344|NCT02579759|559745807|FG000|Overall Study|Protocol Violation|2|||
155085345|NCT02579759|559745808|FG001|Overall Study|Protocol Violation|0|||
155085346|NCT02579759|559745809|FG002|Overall Study|Protocol Violation|0|||
155085347|NCT02579759|559745807|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
155085348|NCT02579759|559745808|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
155085349|NCT02579759|559745809|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
155085350|NCT02579759|559745807|FG000|Overall Study|BfArM hold|13|||
155085351|NCT02579759|559745808|FG001|Overall Study|BfArM hold|12|||
155085352|NCT02579759|559745809|FG002|Overall Study|BfArM hold|12|||
155085353|NCT02579759|559745807|FG000|Overall Study|Sponsor stopped Dose 2|0|||
155085354|NCT02579759|559745808|FG001|Overall Study|Sponsor stopped Dose 2|41|||
155085355|NCT02579759|559745809|FG002|Overall Study|Sponsor stopped Dose 2|0|||
155085356|NCT02579759|559745807|FG000|Overall Study|Non compliance|0|||
155085357|NCT02579759|559745808|FG001|Overall Study|Non compliance|1|||
155085358|NCT02579759|559745809|FG002|Overall Study|Non compliance|0|||
155085359|NCT02579759|559745807|FG000|Overall Study|Pregnancy|0|||
155085360|NCT02579759|559745808|FG001|Overall Study|Pregnancy|1|||
155085361|NCT02579759|559745809|FG002|Overall Study|Pregnancy|0|||
155085362|NCT02579759|559745807|FG000|Overall Study|Inclusion/exclusion criteria|0|||
155085363|NCT02579759|559745808|FG001|Overall Study|Inclusion/exclusion criteria|0|||
155085364|NCT02579759|559745809|FG002|Overall Study|Inclusion/exclusion criteria|1|||
155085365|NCT02579759|559745807|FG000|Overall Study|Adverse Event|4|||
155085366|NCT02579759|559745808|FG001|Overall Study|Adverse Event|3|||
155085367|NCT02579759|559745809|FG002|Overall Study|Adverse Event|1|||
155085368|NCT02579759|559745807|FG000|Overall Study|Withdrawal by Subject|3|||
155085369|NCT02579759|559745808|FG001|Overall Study|Withdrawal by Subject|3|||
155085370|NCT02579759|559745809|FG002|Overall Study|Withdrawal by Subject|5|||
155085371|NCT02579759|559745807|FG000|Overall Study|Lost to Follow-up|2|||
155085372|NCT02579759|559745808|FG001|Overall Study|Lost to Follow-up|2|||
155085373|NCT02579759|559745809|FG002|Overall Study|Lost to Follow-up|2|||
155085374|NCT01904279|559745819|FG000|Overall Study|Lack of Efficacy|2|||
155085375|NCT01904279|559745820|FG001|Overall Study|Lack of Efficacy|3|||
155085376|NCT01904279|559745819|FG000|Overall Study|Withdrawal by Subject|1|||
155085377|NCT01904279|559745820|FG001|Overall Study|Withdrawal by Subject|0|||
155085378|NCT01356940|559745828|FG000|First Intervention (28 Days)|Adverse Event|1|||
155085379|NCT01356940|559745829|FG001|First Intervention (28 Days)|Adverse Event|0|||
155085380|NCT01356940|559745828|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
155085381|NCT01356940|559745829|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
155085382|NCT03412591|559745835|FG000|Overall Study|Withdrawal by Subject|1|||
155085383|NCT03412591|559745836|FG001|Overall Study|Withdrawal by Subject|8|||
155085384|NCT03412591|559745835|FG000|Overall Study|Adverse Event|0|||
155085385|NCT03412591|559745836|FG001|Overall Study|Adverse Event|1|||
155085386|NCT00505687|559745839|FG000|Overall Study|Important protocol violation|2|||
155085387|NCT00505687|559745839|FG000|Overall Study|Lack of Efficacy|15|||
155352456|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Adverse Event|1|||
155352457|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Adverse Event|0|||
155352458|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352459|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352460|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
155352461|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
154964709|NCT00927069|559297494|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
154964710|NCT00927069|559297495|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
155085388|NCT00505687|559745839|FG000|Overall Study|Adverse Event|48|||
155085389|NCT00505687|559745839|FG000|Overall Study|Subject withdrew consent|15|||
155085390|NCT00505687|559745839|FG000|Overall Study|Lost to Follow-up|1|||
155085391|NCT00505687|559745839|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
155085392|NCT00505687|559745839|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
155085393|NCT00505687|559745839|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
155085394|NCT00505687|559745839|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
155165617|NCT01077076|560043507|FG003|First Intervention|Withdrawal by Subject|0|||
155165618|NCT01077076|560043508|FG004|First Intervention|Withdrawal by Subject|0|||
155352462|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
155085395|NCT00505687|559745839|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
155352463|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
154964711|NCT00927069|559297496|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
154964712|NCT00927069|559297497|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
154964713|NCT00927069|559297494|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
154964714|NCT00927069|559297495|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
154964715|NCT00927069|559297496|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
154964716|NCT00927069|559297497|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
155085396|NCT00505687|559745839|FG000|Overall Study|Other: Disease Progression|1|||
155085397|NCT00505687|559745839|FG000|Overall Study|Other: As Per Sponsor|8|||
155085398|NCT00666263|559745842|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
155085399|NCT00666263|559745843|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
155085400|NCT00666263|559745842|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
155085401|NCT00666263|559745843|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
155085402|NCT00666263|559745842|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
155085403|NCT00666263|559745843|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
155085404|NCT03242434|559745844|FG000|Overall Study|Death|0|||
155085405|NCT03242434|559745845|FG001|Overall Study|Death|2|||
155085406|NCT00414609|559745846|FG000|Core Study|Adverse Event|9|||
155085407|NCT00414609|559745847|FG001|Core Study|Adverse Event|11|||
155085408|NCT00414609|559745848|FG002|Core Study|Adverse Event|0|||
155085409|NCT00414609|559745846|FG000|Core Study|Abnormal laboratory values|0|||
155085410|NCT00414609|559745847|FG001|Core Study|Abnormal laboratory values|1|||
155085411|NCT00414609|559745848|FG002|Core Study|Abnormal laboratory values|0|||
155085412|NCT00414609|559745846|FG000|Core Study|Abnormal test procedure results|1|||
155085413|NCT00414609|559745847|FG001|Core Study|Abnormal test procedure results|1|||
155085414|NCT00414609|559745848|FG002|Core Study|Abnormal test procedure results|0|||
155085415|NCT00414609|559745846|FG000|Core Study|Protocol deviation|0|||
155085416|NCT00414609|559745847|FG001|Core Study|Protocol deviation|1|||
155085417|NCT00414609|559745848|FG002|Core Study|Protocol deviation|0|||
155085418|NCT00414609|559745846|FG000|Core Study|Patient withdrew consent|10|||
155085419|NCT00414609|559745847|FG001|Core Study|Patient withdrew consent|11|||
155085420|NCT00414609|559745848|FG002|Core Study|Patient withdrew consent|0|||
155085421|NCT00414609|559745846|FG000|Core Study|Lost to Follow-up|7|||
155085422|NCT00414609|559745847|FG001|Core Study|Lost to Follow-up|4|||
155085423|NCT00414609|559745848|FG002|Core Study|Lost to Follow-up|0|||
155085424|NCT00414609|559745846|FG000|Core Study|Administrative problems|0|||
155085425|NCT00414609|559745847|FG001|Core Study|Administrative problems|2|||
155085426|NCT00414609|559745848|FG002|Core Study|Administrative problems|0|||
155085427|NCT00414609|559745846|FG000|Core Study|Death|7|||
155085428|NCT00414609|559745847|FG001|Core Study|Death|14|||
155085429|NCT00414609|559745848|FG002|Core Study|Death|0|||
155085430|NCT00414609|559745846|FG000|Extension Study|Adverse Event|0|||
155085431|NCT00414609|559745847|FG001|Extension Study|Adverse Event|0|||
155085432|NCT00414609|559745848|FG002|Extension Study|Adverse Event|14|||
155085433|NCT00414609|559745846|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
155085434|NCT00414609|559745847|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
155085435|NCT00414609|559745848|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
155085436|NCT00414609|559745846|FG000|Extension Study|Withdrawal by Subject|0|||
155085437|NCT00414609|559745847|FG001|Extension Study|Withdrawal by Subject|0|||
155085438|NCT00414609|559745848|FG002|Extension Study|Withdrawal by Subject|13|||
155085439|NCT00414609|559745846|FG000|Extension Study|Lost to Follow-up|0|||
155085440|NCT00414609|559745847|FG001|Extension Study|Lost to Follow-up|0|||
155085441|NCT00414609|559745848|FG002|Extension Study|Lost to Follow-up|10|||
155085442|NCT00414609|559745846|FG000|Extension Study|Administrative problems|0|||
155085443|NCT00414609|559745847|FG001|Extension Study|Administrative problems|0|||
155085444|NCT00414609|559745848|FG002|Extension Study|Administrative problems|1|||
155085445|NCT00414609|559745846|FG000|Extension Study|Death|0|||
155085446|NCT00414609|559745847|FG001|Extension Study|Death|0|||
155085447|NCT00414609|559745848|FG002|Extension Study|Death|17|||
155085448|NCT00266032|559745849|FG000|Treatment|Adverse Event|42|||
155085449|NCT00266032|559745850|FG001|Treatment|Adverse Event|26|||
155085450|NCT00266032|559745851|FG002|Treatment|Adverse Event|10|||
155085451|NCT00266032|559745849|FG000|Treatment|Lost to Follow-up|19|||
155085452|NCT00266032|559745850|FG001|Treatment|Lost to Follow-up|4|||
155085453|NCT00266032|559745851|FG002|Treatment|Lost to Follow-up|2|||
155085454|NCT00266032|559745849|FG000|Treatment|Pregnancy|3|||
155085455|NCT00266032|559745850|FG001|Treatment|Pregnancy|2|||
155085456|NCT00266032|559745851|FG002|Treatment|Pregnancy|2|||
155085457|NCT00266032|559745849|FG000|Treatment|Protocol Violation|6|||
155165619|NCT01077076|560043509|FG005|First Intervention|Withdrawal by Subject|0|||
155085458|NCT00266032|559745850|FG001|Treatment|Protocol Violation|14|||
155085459|NCT00266032|559745851|FG002|Treatment|Protocol Violation|13|||
155085460|NCT00266032|559745849|FG000|Treatment|Withdrawal by Subject|28|||
154964717|NCT00927069|559297494|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
155085461|NCT00266032|559745850|FG001|Treatment|Withdrawal by Subject|13|||
155085462|NCT00266032|559745851|FG002|Treatment|Withdrawal by Subject|12|||
155085463|NCT00266032|559745849|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
155085464|NCT00266032|559745850|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
155352464|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
155352465|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352466|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352467|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352468|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352469|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
155352470|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
155352471|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
155352472|NCT00943722|560725672|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
155352473|NCT00943722|560725673|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
155352474|NCT00943722|560725674|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
155352475|NCT00943722|560725675|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
155352476|NCT00943722|560725676|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
155085465|NCT00266032|559745851|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
155352477|NCT00943722|560725677|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
155352478|NCT00943722|560725678|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
155352479|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
155085466|NCT00266032|559745849|FG000|Open-label Safety Extension|Adverse Event|5|||
155085467|NCT00266032|559745850|FG001|Open-label Safety Extension|Adverse Event|0|||
155085468|NCT00266032|559745851|FG002|Open-label Safety Extension|Adverse Event|4|||
155352480|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
155352481|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
155352482|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
155352483|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
155352484|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
155352485|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
155352486|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
154964718|NCT00927069|559297495|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
154964719|NCT00927069|559297496|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
155085469|NCT00266032|559745849|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
155352487|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155085470|NCT00266032|559745850|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
155085471|NCT00266032|559745851|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
155085472|NCT00266032|559745849|FG000|Open-label Safety Extension|Pregnancy|4|||
155085473|NCT00266032|559745850|FG001|Open-label Safety Extension|Pregnancy|1|||
155085474|NCT00266032|559745851|FG002|Open-label Safety Extension|Pregnancy|2|||
155085475|NCT00266032|559745849|FG000|Open-label Safety Extension|Protocol Violation|1|||
155085476|NCT00266032|559745850|FG001|Open-label Safety Extension|Protocol Violation|3|||
155085477|NCT00266032|559745851|FG002|Open-label Safety Extension|Protocol Violation|2|||
155085478|NCT00266032|559745849|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
155085479|NCT00266032|559745850|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
155085480|NCT00266032|559745851|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
155085481|NCT00266032|559745849|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
155085482|NCT00266032|559745850|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
155085483|NCT00266032|559745851|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
155085484|NCT00814983|559745854|FG000|Overall Study|Screen failure|1|||
155085485|NCT00814983|559745855|FG001|Overall Study|Screen failure|0|||
155085486|NCT00814983|559745854|FG000|Overall Study|Withdrawal by Subject|1|||
155085487|NCT00814983|559745855|FG001|Overall Study|Withdrawal by Subject|0|||
155085488|NCT00814983|559745854|FG000|Overall Study|Graft failure|1|||
155085489|NCT00814983|559745855|FG001|Overall Study|Graft failure|0|||
155085490|NCT01229111|559745856|FG000|Overall Study|Death|1|||
155085491|NCT04102514|559745857|FG000|Overall Study|Death|3|||
155085492|NCT04102514|559745858|FG001|Overall Study|Death|0|||
155085493|NCT04102514|559745859|FG002|Overall Study|Death|0|||
155085494|NCT04102514|559745860|FG003|Overall Study|Death|0|||
155085495|NCT04102514|559745857|FG000|Overall Study|Lost to Follow-up|0|||
155085496|NCT04102514|559745858|FG001|Overall Study|Lost to Follow-up|0|||
155085497|NCT04102514|559745859|FG002|Overall Study|Lost to Follow-up|3|||
155085498|NCT04102514|559745860|FG003|Overall Study|Lost to Follow-up|0|||
155085499|NCT04102514|559745857|FG000|Overall Study|Physician Decision|0|||
155085500|NCT04102514|559745858|FG001|Overall Study|Physician Decision|0|||
155085501|NCT04102514|559745859|FG002|Overall Study|Physician Decision|1|||
155085502|NCT04102514|559745860|FG003|Overall Study|Physician Decision|0|||
155085503|NCT04102514|559745857|FG000|Overall Study|Withdrawal by Subject|7|||
155085504|NCT04102514|559745858|FG001|Overall Study|Withdrawal by Subject|13|||
155085505|NCT04102514|559745859|FG002|Overall Study|Withdrawal by Subject|7|||
155085506|NCT04102514|559745860|FG003|Overall Study|Withdrawal by Subject|14|||
155085507|NCT04102514|559745857|FG000|Overall Study|Moved to longterm care facility|6|||
155085508|NCT04102514|559745858|FG001|Overall Study|Moved to longterm care facility|0|||
155085509|NCT04102514|559745859|FG002|Overall Study|Moved to longterm care facility|4|||
155085510|NCT04102514|559745860|FG003|Overall Study|Moved to longterm care facility|0|||
155085511|NCT05418426|559745865|FG000|Overall Study|Adverse Event|0|||
155352488|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155352489|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155352490|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
155352491|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
155352492|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
155352493|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
155352494|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
155085512|NCT05418426|559745866|FG001|Overall Study|Adverse Event|1|||
155085513|NCT05418426|559745867|FG002|Overall Study|Adverse Event|0|||
155085514|NCT05418426|559745865|FG000|Overall Study|Withdrawal by Subject|0|||
155352495|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
155352496|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
155352497|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
155352498|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
155352499|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
155352500|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
155352501|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
155352502|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
155352503|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
155352504|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
155352505|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
155352506|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
155085515|NCT05418426|559745866|FG001|Overall Study|Withdrawal by Subject|1|||
155085516|NCT05418426|559745867|FG002|Overall Study|Withdrawal by Subject|0|||
155085517|NCT05418426|559745865|FG000|Overall Study|Protocol Violation|0|||
155085518|NCT05418426|559745866|FG001|Overall Study|Protocol Violation|0|||
155165620|NCT01077076|560043504|FG000|Third Intervention|Death in the participant's family|0|||
155165621|NCT01077076|560043505|FG001|Third Intervention|Death in the participant's family|0|||
155352507|NCT00943722|560725672|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352508|NCT00943722|560725673|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352509|NCT00943722|560725674|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352510|NCT00943722|560725675|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155085519|NCT05418426|559745867|FG002|Overall Study|Protocol Violation|1|||
155085520|NCT02096354|559745873|FG000|Overall Study|Physician Decision|4|||
155085521|NCT02096354|559745874|FG001|Overall Study|Physician Decision|5|||
155085522|NCT02096354|559745875|FG002|Overall Study|Physician Decision|0|||
155352511|NCT00943722|560725676|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
155352512|NCT00943722|560725677|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
155352513|NCT00943722|560725678|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
155352514|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
155352515|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
155352516|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
155352517|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
155352518|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
155352519|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
155352520|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
155352521|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
155352522|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
155352523|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
155085523|NCT02096354|559745873|FG000|Overall Study|Withdrawal by Subject|3|||
155085524|NCT02096354|559745874|FG001|Overall Study|Withdrawal by Subject|1|||
155085525|NCT02096354|559745875|FG002|Overall Study|Withdrawal by Subject|0|||
155085526|NCT02096354|559745873|FG000|Overall Study|Adverse Event|7|||
155085527|NCT02096354|559745874|FG001|Overall Study|Adverse Event|4|||
155085528|NCT02096354|559745875|FG002|Overall Study|Adverse Event|0|||
155085529|NCT02096354|559745873|FG000|Overall Study|Ineligible|0|||
155085530|NCT02096354|559745874|FG001|Overall Study|Ineligible|0|||
155085531|NCT02096354|559745875|FG002|Overall Study|Ineligible|11|||
155085532|NCT02951819|559745876|FG000|Overall Study|Death|9|||
155352524|NCT01772823|560725679|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
155352525|NCT01772823|560725680|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
155352526|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
155352527|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
155352528|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
155352529|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
155352530|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
155352531|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
155352532|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
155352533|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
155352534|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
155352535|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
155352536|NCT01772823|560725679|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
155352537|NCT01772823|560725680|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
155352538|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
155352539|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
155352540|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
155352541|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
155352542|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
155352543|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
155352544|NCT01772823|560725679|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
155352545|NCT01772823|560725680|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
155352546|NCT01036165|560725685|FG000|Overall Study|Adverse Event|6|||
155352547|NCT01036165|560725685|FG000|Overall Study|Lost to Follow-up|2|||
155352548|NCT01036165|560725685|FG000|Overall Study|Withdrawal by Subject|3|||
155352549|NCT01036165|560725685|FG000|Overall Study|Device Related Issues|3|||
155352550|NCT01036165|560725685|FG000|Overall Study|Problems finding proper area to inject|1|||
155352551|NCT02895360|560725690|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
155352552|NCT02895360|560725691|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352553|NCT02895360|560725692|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352554|NCT02895360|560725693|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352555|NCT02895360|560725694|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352556|NCT02895360|560725695|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
155352557|NCT02895360|560725690|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352558|NCT02895360|560725691|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
155352559|NCT02895360|560725692|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155085533|NCT02951819|559745877|FG001|Overall Study|Death|7|||
155085534|NCT02951819|559745876|FG000|Overall Study|Withdrawal by Subject|3|||
155085535|NCT02951819|559745877|FG001|Overall Study|Withdrawal by Subject|0|||
155085536|NCT02951819|559745876|FG000|Overall Study|Adverse Event|1|||
155085537|NCT02951819|559745877|FG001|Overall Study|Adverse Event|0|||
155085538|NCT02951819|559745876|FG000|Overall Study|Lack of Efficacy|4|||
155085539|NCT02951819|559745877|FG001|Overall Study|Lack of Efficacy|0|||
155352560|NCT02895360|560725693|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352561|NCT02895360|560725694|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352562|NCT02895360|560725695|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
155352563|NCT02895360|560725690|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352564|NCT02895360|560725691|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352565|NCT02895360|560725692|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
155352566|NCT02895360|560725693|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352567|NCT02895360|560725694|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352568|NCT02895360|560725695|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
155352569|NCT02895360|560725690|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352570|NCT02895360|560725691|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352571|NCT02895360|560725692|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
155352572|NCT02895360|560725693|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352573|NCT02895360|560725694|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352574|NCT02895360|560725695|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
155352575|NCT02895360|560725690|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352576|NCT02895360|560725691|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352577|NCT02895360|560725692|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352578|NCT02895360|560725693|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
155352579|NCT02895360|560725694|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352580|NCT02895360|560725695|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
155352581|NCT02895360|560725690|FG000|Phase 2a|Adverse Event|0|||
155352582|NCT02895360|560725691|FG001|Phase 2a|Adverse Event|0|||
155352583|NCT02895360|560725692|FG002|Phase 2a|Adverse Event|0|||
155085540|NCT02951819|559745876|FG000|Overall Study|Lost to Follow-up|1|||
155085541|NCT02951819|559745877|FG001|Overall Study|Lost to Follow-up|0|||
155085542|NCT02951819|559745876|FG000|Overall Study|Progressive Disease|1|||
155085543|NCT02951819|559745877|FG001|Overall Study|Progressive Disease|0|||
155352584|NCT02895360|560725693|FG003|Phase 2a|Adverse Event|0|||
155352585|NCT02895360|560725694|FG004|Phase 2a|Adverse Event|0|||
155352586|NCT02895360|560725695|FG005|Phase 2a|Adverse Event|1|||
155352587|NCT02895360|560725690|FG000|Phase 2a|Progressive disease|0|||
155352588|NCT02895360|560725691|FG001|Phase 2a|Progressive disease|0|||
155352589|NCT02895360|560725692|FG002|Phase 2a|Progressive disease|0|||
155352590|NCT02895360|560725693|FG003|Phase 2a|Progressive disease|0|||
155352591|NCT02895360|560725694|FG004|Phase 2a|Progressive disease|11|||
155085544|NCT02951819|559745876|FG000|Overall Study|Other|9|||
155085545|NCT02951819|559745877|FG001|Overall Study|Other|0|||
155085546|NCT03715829|559745878|FG000|Dose Ranging Period|Adverse Event|2|||
155085547|NCT03715829|559745879|FG001|Dose Ranging Period|Adverse Event|4|||
155085548|NCT03715829|559745880|FG002|Dose Ranging Period|Adverse Event|5|||
155085549|NCT03715829|559745881|FG003|Dose Ranging Period|Adverse Event|2|||
155352592|NCT02895360|560725695|FG005|Phase 2a|Progressive disease|11|||
155352593|NCT00307164|560725696|FG000|Overall Study|Death|1|||
155352594|NCT00307164|560725697|FG001|Overall Study|Death|0|||
155352595|NCT00307164|560725696|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155352596|NCT00307164|560725697|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155352597|NCT00307164|560725696|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
155352598|NCT00307164|560725697|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
155352599|NCT00307164|560725696|FG000|Overall Study|Withdrawal by Subject|1|||
155352600|NCT00307164|560725697|FG001|Overall Study|Withdrawal by Subject|8|||
155352601|NCT00307164|560725696|FG000|Overall Study|Not compliant with requirements|4|||
155352602|NCT00307164|560725697|FG001|Overall Study|Not compliant with requirements|4|||
155352603|NCT00307164|560725696|FG000|Overall Study|Lost to Follow-up|6|||
155352604|NCT00307164|560725697|FG001|Overall Study|Lost to Follow-up|1|||
155085550|NCT03715829|559745882|FG004|Dose Ranging Period|Adverse Event|3|||
155085551|NCT03715829|559745883|FG005|Dose Ranging Period|Adverse Event|3|||
155085552|NCT03715829|559745884|FG006|Dose Ranging Period|Adverse Event|0|||
155085553|NCT03715829|559745885|FG007|Dose Ranging Period|Adverse Event|0|||
155085554|NCT03715829|559745886|FG008|Dose Ranging Period|Adverse Event|0|||
155352605|NCT02544113|560725700|FG000|Overall Study|Death|3|||
155352606|NCT02544113|560725701|FG001|Overall Study|Death|4|||
155352607|NCT02847637|560725703|FG000|Overall Study|Withdrawal by Subject|0|||
155352608|NCT02847637|560725704|FG001|Overall Study|Withdrawal by Subject|1|||
155352609|NCT02847637|560725705|FG002|Overall Study|Withdrawal by Subject|1|||
155352610|NCT02847637|560725706|FG003|Overall Study|Withdrawal by Subject|0|||
155352611|NCT02847637|560725703|FG000|Overall Study|Lost to Follow-up|1|||
155352612|NCT02847637|560725704|FG001|Overall Study|Lost to Follow-up|1|||
155352613|NCT02847637|560725705|FG002|Overall Study|Lost to Follow-up|0|||
155352614|NCT02847637|560725706|FG003|Overall Study|Lost to Follow-up|0|||
155352615|NCT01746108|560725709|FG000|Overall Study|Migrated /moved from study area|0|||
155352616|NCT01746108|560725710|FG001|Overall Study|Migrated /moved from study area|1|||
155352617|NCT01746108|560725711|FG002|Overall Study|Migrated /moved from study area|0|||
155352618|NCT01746108|560725709|FG000|Overall Study|Adverse event, non-fatal|0|||
155352619|NCT01746108|560725710|FG001|Overall Study|Adverse event, non-fatal|1|||
155352620|NCT01746108|560725711|FG002|Overall Study|Adverse event, non-fatal|0|||
155352621|NCT01746108|560725709|FG000|Overall Study|Withdrawal by Subject|0|||
155352622|NCT01746108|560725710|FG001|Overall Study|Withdrawal by Subject|1|||
155352623|NCT01746108|560725711|FG002|Overall Study|Withdrawal by Subject|0|||
155352624|NCT01746108|560725709|FG000|Overall Study|Lost to Follow-up|0|||
155352625|NCT01746108|560725710|FG001|Overall Study|Lost to Follow-up|1|||
155352626|NCT01746108|560725711|FG002|Overall Study|Lost to Follow-up|0|||
155352627|NCT03036150|560725712|FG000|Overall Study|Withdrawal by Subject|8|||
155352628|NCT03036150|560725713|FG001|Overall Study|Withdrawal by Subject|3|||
155352629|NCT03036150|560725712|FG000|Overall Study|Lost to Follow-up|2|||
155352630|NCT03036150|560725713|FG001|Overall Study|Lost to Follow-up|2|||
155352631|NCT00053352|560725724|FG000|Overall Study|Lost to Follow-up|0|||
155352632|NCT00053352|560725725|FG001|Overall Study|Lost to Follow-up|1|||
155352633|NCT00053352|560725724|FG000|Overall Study|Physician Decision|11|||
155352634|NCT00053352|560725725|FG001|Overall Study|Physician Decision|1|||
155352635|NCT00053352|560725724|FG000|Overall Study|Withdrawal by Subject|1|||
155352636|NCT00053352|560725725|FG001|Overall Study|Withdrawal by Subject|0|||
155352637|NCT00053352|560725724|FG000|Overall Study|Ineligible|8|||
155352638|NCT00053352|560725725|FG001|Overall Study|Ineligible|8|||
155352639|NCT00053352|560725724|FG000|Overall Study|Disease at new site|1|||
155352640|NCT00053352|560725725|FG001|Overall Study|Disease at new site|0|||
155352641|NCT02741713|560725728|FG000|Overall Study|Surgery type changed intra-operatively|2|||
155352642|NCT02741713|560725729|FG001|Overall Study|Surgery type changed intra-operatively|1|||
155352643|NCT01388478|560725730|FG000|Overall Study|Adverse Event|4|||
155352644|NCT01388478|560725730|FG000|Overall Study|Withdrawal by Subject|1|||
155352645|NCT00550446|560725733|FG000|Up To Week 12|Adverse Event|2|||
155352646|NCT00550446|560725734|FG001|Up To Week 12|Adverse Event|2|||
155085555|NCT03715829|559745887|FG009|Dose Ranging Period|Adverse Event|0|||
155085556|NCT03715829|559745888|FG010|Dose Ranging Period|Adverse Event|0|||
155085557|NCT03715829|559745878|FG000|Dose Ranging Period|Lack of Efficacy|0|||
155085558|NCT03715829|559745879|FG001|Dose Ranging Period|Lack of Efficacy|1|||
155085559|NCT03715829|559745880|FG002|Dose Ranging Period|Lack of Efficacy|0|||
155085560|NCT03715829|559745881|FG003|Dose Ranging Period|Lack of Efficacy|1|||
155085561|NCT03715829|559745882|FG004|Dose Ranging Period|Lack of Efficacy|0|||
155085562|NCT03715829|559745883|FG005|Dose Ranging Period|Lack of Efficacy|0|||
155085563|NCT03715829|559745884|FG006|Dose Ranging Period|Lack of Efficacy|0|||
155085564|NCT03715829|559745885|FG007|Dose Ranging Period|Lack of Efficacy|0|||
155085565|NCT03715829|559745886|FG008|Dose Ranging Period|Lack of Efficacy|0|||
155085566|NCT03715829|559745887|FG009|Dose Ranging Period|Lack of Efficacy|0|||
155085567|NCT03715829|559745888|FG010|Dose Ranging Period|Lack of Efficacy|0|||
155085568|NCT03715829|559745878|FG000|Dose Ranging Period|Lost to Follow-up|2|||
155085569|NCT03715829|559745879|FG001|Dose Ranging Period|Lost to Follow-up|0|||
155085570|NCT03715829|559745880|FG002|Dose Ranging Period|Lost to Follow-up|1|||
155085571|NCT03715829|559745881|FG003|Dose Ranging Period|Lost to Follow-up|1|||
155085572|NCT03715829|559745882|FG004|Dose Ranging Period|Lost to Follow-up|1|||
155085573|NCT03715829|559745883|FG005|Dose Ranging Period|Lost to Follow-up|2|||
155085574|NCT03715829|559745884|FG006|Dose Ranging Period|Lost to Follow-up|0|||
155085575|NCT03715829|559745885|FG007|Dose Ranging Period|Lost to Follow-up|0|||
155085576|NCT03715829|559745886|FG008|Dose Ranging Period|Lost to Follow-up|0|||
155085577|NCT03715829|559745887|FG009|Dose Ranging Period|Lost to Follow-up|0|||
155352647|NCT00550446|560725735|FG002|Up To Week 12|Adverse Event|0|||
155352648|NCT00550446|560725736|FG003|Up To Week 12|Adverse Event|0|||
155352649|NCT00550446|560725737|FG004|Up To Week 12|Adverse Event|2|||
155085578|NCT03715829|559745888|FG010|Dose Ranging Period|Lost to Follow-up|0|||
155085579|NCT03715829|559745878|FG000|Dose Ranging Period|Protocol Violation|0|||
155085580|NCT03715829|559745879|FG001|Dose Ranging Period|Protocol Violation|0|||
155352650|NCT00550446|560725738|FG005|Up To Week 12|Adverse Event|2|||
155085581|NCT03715829|559745880|FG002|Dose Ranging Period|Protocol Violation|0|||
155085582|NCT03715829|559745881|FG003|Dose Ranging Period|Protocol Violation|1|||
155085583|NCT03715829|559745882|FG004|Dose Ranging Period|Protocol Violation|0|||
155085584|NCT03715829|559745883|FG005|Dose Ranging Period|Protocol Violation|0|||
155085585|NCT03715829|559745884|FG006|Dose Ranging Period|Protocol Violation|0|||
155085586|NCT03715829|559745885|FG007|Dose Ranging Period|Protocol Violation|0|||
155085587|NCT03715829|559745886|FG008|Dose Ranging Period|Protocol Violation|0|||
155352651|NCT00550446|560725739|FG006|Up To Week 12|Adverse Event|1|||
155352652|NCT00550446|560725740|FG007|Up To Week 12|Adverse Event|0|||
155352653|NCT00550446|560725741|FG008|Up To Week 12|Adverse Event|0|||
155352654|NCT00550446|560725742|FG009|Up To Week 12|Adverse Event|0|||
155352655|NCT00550446|560725743|FG010|Up To Week 12|Adverse Event|0|||
155352656|NCT00550446|560725733|FG000|Up To Week 12|Lack of Efficacy|3|||
155352657|NCT00550446|560725734|FG001|Up To Week 12|Lack of Efficacy|1|||
155085588|NCT03715829|559745887|FG009|Dose Ranging Period|Protocol Violation|0|||
155085589|NCT03715829|559745888|FG010|Dose Ranging Period|Protocol Violation|0|||
155085590|NCT03715829|559745878|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
155085591|NCT03715829|559745879|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
155085592|NCT03715829|559745880|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
155085593|NCT03715829|559745881|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
155085594|NCT03715829|559745882|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
155085595|NCT03715829|559745883|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
155085596|NCT03715829|559745884|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
155085597|NCT03715829|559745885|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
155085598|NCT03715829|559745886|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
155085599|NCT03715829|559745887|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
155085600|NCT03715829|559745888|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
155085601|NCT03715829|559745878|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085602|NCT03715829|559745879|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085603|NCT03715829|559745880|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
155085604|NCT03715829|559745881|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085605|NCT03715829|559745882|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085606|NCT03715829|559745883|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085607|NCT03715829|559745884|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085608|NCT03715829|559745885|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085609|NCT03715829|559745886|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085610|NCT03715829|559745887|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085611|NCT03715829|559745888|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
155085612|NCT03715829|559745878|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155085613|NCT03715829|559745879|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155352658|NCT00550446|560725735|FG002|Up To Week 12|Lack of Efficacy|0|||
155085614|NCT03715829|559745880|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
155085615|NCT03715829|559745881|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155085616|NCT03715829|559745882|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
155085617|NCT03715829|559745883|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155085618|NCT03715829|559745884|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155085619|NCT03715829|559745885|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155085620|NCT03715829|559745886|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155352659|NCT00550446|560725736|FG003|Up To Week 12|Lack of Efficacy|1|||
155085621|NCT03715829|559745887|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155085622|NCT03715829|559745888|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
155352660|NCT00550446|560725737|FG004|Up To Week 12|Lack of Efficacy|0|||
155352661|NCT00550446|560725738|FG005|Up To Week 12|Lack of Efficacy|3|||
155085623|NCT03715829|559745878|FG000|Dose Ranging Period|Other|0|||
155085624|NCT03715829|559745879|FG001|Dose Ranging Period|Other|0|||
155085625|NCT03715829|559745880|FG002|Dose Ranging Period|Other|2|||
155085626|NCT03715829|559745881|FG003|Dose Ranging Period|Other|0|||
155085627|NCT03715829|559745882|FG004|Dose Ranging Period|Other|0|||
155085628|NCT03715829|559745883|FG005|Dose Ranging Period|Other|3|||
155352662|NCT00550446|560725739|FG006|Up To Week 12|Lack of Efficacy|3|||
155352663|NCT00550446|560725740|FG007|Up To Week 12|Lack of Efficacy|0|||
155352664|NCT00550446|560725741|FG008|Up To Week 12|Lack of Efficacy|0|||
155352665|NCT00550446|560725742|FG009|Up To Week 12|Lack of Efficacy|0|||
155352666|NCT00550446|560725743|FG010|Up To Week 12|Lack of Efficacy|0|||
155352667|NCT00550446|560725733|FG000|Up To Week 12|Lost to Follow-up|0|||
155352668|NCT00550446|560725734|FG001|Up To Week 12|Lost to Follow-up|1|||
155352669|NCT00550446|560725735|FG002|Up To Week 12|Lost to Follow-up|0|||
155352670|NCT00550446|560725736|FG003|Up To Week 12|Lost to Follow-up|0|||
155352671|NCT00550446|560725737|FG004|Up To Week 12|Lost to Follow-up|1|||
155352672|NCT00550446|560725738|FG005|Up To Week 12|Lost to Follow-up|1|||
155352673|NCT00550446|560725739|FG006|Up To Week 12|Lost to Follow-up|2|||
155352674|NCT00550446|560725740|FG007|Up To Week 12|Lost to Follow-up|0|||
155352675|NCT00550446|560725741|FG008|Up To Week 12|Lost to Follow-up|0|||
155352676|NCT00550446|560725742|FG009|Up To Week 12|Lost to Follow-up|0|||
155352677|NCT00550446|560725743|FG010|Up To Week 12|Lost to Follow-up|0|||
155352678|NCT00550446|560725733|FG000|Up To Week 12|Withdrawal by Subject|2|||
155352679|NCT00550446|560725734|FG001|Up To Week 12|Withdrawal by Subject|0|||
155352680|NCT00550446|560725735|FG002|Up To Week 12|Withdrawal by Subject|3|||
155352681|NCT00550446|560725736|FG003|Up To Week 12|Withdrawal by Subject|2|||
155352682|NCT00550446|560725737|FG004|Up To Week 12|Withdrawal by Subject|0|||
155352683|NCT00550446|560725738|FG005|Up To Week 12|Withdrawal by Subject|1|||
155352684|NCT00550446|560725739|FG006|Up To Week 12|Withdrawal by Subject|3|||
155352685|NCT00550446|560725740|FG007|Up To Week 12|Withdrawal by Subject|0|||
155352686|NCT00550446|560725741|FG008|Up To Week 12|Withdrawal by Subject|0|||
155352687|NCT00550446|560725742|FG009|Up To Week 12|Withdrawal by Subject|0|||
155352688|NCT00550446|560725743|FG010|Up To Week 12|Withdrawal by Subject|0|||
155352689|NCT00550446|560725733|FG000|Up To Week 12|Other|3|||
155352690|NCT00550446|560725734|FG001|Up To Week 12|Other|0|||
155352691|NCT00550446|560725735|FG002|Up To Week 12|Other|0|||
155352692|NCT00550446|560725736|FG003|Up To Week 12|Other|0|||
155352693|NCT00550446|560725737|FG004|Up To Week 12|Other|0|||
155352694|NCT00550446|560725738|FG005|Up To Week 12|Other|1|||
155352695|NCT00550446|560725739|FG006|Up To Week 12|Other|4|||
155352696|NCT00550446|560725740|FG007|Up To Week 12|Other|0|||
155352697|NCT00550446|560725741|FG008|Up To Week 12|Other|0|||
155352698|NCT00550446|560725742|FG009|Up To Week 12|Other|0|||
155352699|NCT00550446|560725743|FG010|Up To Week 12|Other|0|||
155352700|NCT00550446|560725733|FG000|Up To Week 12|Randomized not treated|0|||
155352701|NCT00550446|560725734|FG001|Up To Week 12|Randomized not treated|1|||
155352702|NCT00550446|560725735|FG002|Up To Week 12|Randomized not treated|1|||
155352703|NCT00550446|560725736|FG003|Up To Week 12|Randomized not treated|0|||
155352704|NCT00550446|560725737|FG004|Up To Week 12|Randomized not treated|0|||
155085629|NCT03715829|559745884|FG006|Dose Ranging Period|Other|0|||
155085630|NCT03715829|559745885|FG007|Dose Ranging Period|Other|0|||
155085631|NCT03715829|559745886|FG008|Dose Ranging Period|Other|0|||
155085632|NCT03715829|559745887|FG009|Dose Ranging Period|Other|0|||
155352705|NCT00550446|560725738|FG005|Up To Week 12|Randomized not treated|0|||
155352706|NCT00550446|560725739|FG006|Up To Week 12|Randomized not treated|0|||
155352707|NCT00550446|560725740|FG007|Up To Week 12|Randomized not treated|0|||
155352708|NCT00550446|560725741|FG008|Up To Week 12|Randomized not treated|0|||
155352709|NCT00550446|560725742|FG009|Up To Week 12|Randomized not treated|0|||
155352710|NCT00550446|560725743|FG010|Up To Week 12|Randomized not treated|0|||
155352711|NCT00550446|560725733|FG000|Post Week 12|Adverse Event|2|||
155085633|NCT03715829|559745888|FG010|Dose Ranging Period|Other|0|||
155085634|NCT03715829|559745878|FG000|Extension Period|Adverse Event|0|||
155085635|NCT03715829|559745879|FG001|Extension Period|Adverse Event|0|||
155165622|NCT01077076|560043506|FG002|Third Intervention|Death in the participant's family|0|||
155352712|NCT00550446|560725734|FG001|Post Week 12|Adverse Event|1|||
155352713|NCT00550446|560725735|FG002|Post Week 12|Adverse Event|1|||
155352714|NCT00550446|560725736|FG003|Post Week 12|Adverse Event|1|||
155352715|NCT00550446|560725737|FG004|Post Week 12|Adverse Event|1|||
155352716|NCT00550446|560725738|FG005|Post Week 12|Adverse Event|1|||
155352717|NCT00550446|560725739|FG006|Post Week 12|Adverse Event|0|||
155352718|NCT00550446|560725740|FG007|Post Week 12|Adverse Event|0|||
155352719|NCT00550446|560725741|FG008|Post Week 12|Adverse Event|0|||
155352720|NCT00550446|560725742|FG009|Post Week 12|Adverse Event|4|||
155085636|NCT03715829|559745880|FG002|Extension Period|Adverse Event|0|||
155085637|NCT03715829|559745881|FG003|Extension Period|Adverse Event|0|||
155085638|NCT03715829|559745882|FG004|Extension Period|Adverse Event|0|||
155085639|NCT03715829|559745883|FG005|Extension Period|Adverse Event|0|||
155085640|NCT03715829|559745884|FG006|Extension Period|Adverse Event|3|||
155085641|NCT03715829|559745885|FG007|Extension Period|Adverse Event|1|||
155085642|NCT03715829|559745886|FG008|Extension Period|Adverse Event|6|||
155085643|NCT03715829|559745887|FG009|Extension Period|Adverse Event|0|||
155085644|NCT03715829|559745888|FG010|Extension Period|Adverse Event|0|||
155085645|NCT03715829|559745878|FG000|Extension Period|Lack of Efficacy|0|||
155085646|NCT03715829|559745879|FG001|Extension Period|Lack of Efficacy|0|||
155085647|NCT03715829|559745880|FG002|Extension Period|Lack of Efficacy|0|||
155085648|NCT03715829|559745881|FG003|Extension Period|Lack of Efficacy|0|||
155085649|NCT03715829|559745882|FG004|Extension Period|Lack of Efficacy|0|||
155085650|NCT03715829|559745883|FG005|Extension Period|Lack of Efficacy|0|||
155085651|NCT03715829|559745884|FG006|Extension Period|Lack of Efficacy|1|||
155085652|NCT03715829|559745885|FG007|Extension Period|Lack of Efficacy|9|||
155085653|NCT03715829|559745886|FG008|Extension Period|Lack of Efficacy|2|||
155085654|NCT03715829|559745887|FG009|Extension Period|Lack of Efficacy|0|||
155085655|NCT03715829|559745888|FG010|Extension Period|Lack of Efficacy|0|||
155085656|NCT03715829|559745878|FG000|Extension Period|Lost to Follow-up|0|||
155085657|NCT03715829|559745879|FG001|Extension Period|Lost to Follow-up|0|||
155085658|NCT03715829|559745880|FG002|Extension Period|Lost to Follow-up|0|||
155085659|NCT03715829|559745881|FG003|Extension Period|Lost to Follow-up|0|||
155085660|NCT03715829|559745882|FG004|Extension Period|Lost to Follow-up|0|||
155085661|NCT03715829|559745883|FG005|Extension Period|Lost to Follow-up|0|||
155085662|NCT03715829|559745884|FG006|Extension Period|Lost to Follow-up|0|||
155085663|NCT03715829|559745885|FG007|Extension Period|Lost to Follow-up|0|||
155085664|NCT03715829|559745886|FG008|Extension Period|Lost to Follow-up|2|||
155085665|NCT03715829|559745887|FG009|Extension Period|Lost to Follow-up|0|||
155085666|NCT03715829|559745888|FG010|Extension Period|Lost to Follow-up|0|||
155085667|NCT03715829|559745878|FG000|Extension Period|Protocol Violation|0|||
155085668|NCT03715829|559745879|FG001|Extension Period|Protocol Violation|0|||
155085669|NCT03715829|559745880|FG002|Extension Period|Protocol Violation|0|||
155085670|NCT03715829|559745881|FG003|Extension Period|Protocol Violation|0|||
155085671|NCT03715829|559745882|FG004|Extension Period|Protocol Violation|0|||
155085672|NCT03715829|559745883|FG005|Extension Period|Protocol Violation|0|||
155085673|NCT03715829|559745884|FG006|Extension Period|Protocol Violation|0|||
155085674|NCT03715829|559745885|FG007|Extension Period|Protocol Violation|0|||
155085675|NCT03715829|559745886|FG008|Extension Period|Protocol Violation|1|||
155085676|NCT03715829|559745887|FG009|Extension Period|Protocol Violation|0|||
155085677|NCT03715829|559745888|FG010|Extension Period|Protocol Violation|0|||
155085678|NCT03715829|559745878|FG000|Extension Period|Withdrawal by Subject|0|||
155085679|NCT03715829|559745879|FG001|Extension Period|Withdrawal by Subject|0|||
155085680|NCT03715829|559745880|FG002|Extension Period|Withdrawal by Subject|0|||
155085681|NCT03715829|559745881|FG003|Extension Period|Withdrawal by Subject|0|||
155085682|NCT03715829|559745882|FG004|Extension Period|Withdrawal by Subject|0|||
155085683|NCT03715829|559745883|FG005|Extension Period|Withdrawal by Subject|0|||
155085684|NCT03715829|559745884|FG006|Extension Period|Withdrawal by Subject|3|||
155085685|NCT03715829|559745885|FG007|Extension Period|Withdrawal by Subject|3|||
155085686|NCT03715829|559745886|FG008|Extension Period|Withdrawal by Subject|12|||
155085687|NCT03715829|559745887|FG009|Extension Period|Withdrawal by Subject|3|||
155085688|NCT03715829|559745888|FG010|Extension Period|Withdrawal by Subject|0|||
155085689|NCT03715829|559745878|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085690|NCT03715829|559745879|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085691|NCT03715829|559745880|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085692|NCT03715829|559745881|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085693|NCT03715829|559745882|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085694|NCT03715829|559745883|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085695|NCT03715829|559745884|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085696|NCT03715829|559745885|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
155085697|NCT03715829|559745886|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
155085698|NCT03715829|559745887|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
155352721|NCT00550446|560725743|FG010|Post Week 12|Adverse Event|0|||
155085699|NCT03715829|559745888|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
155085700|NCT03715829|559745878|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
155352722|NCT00550446|560725733|FG000|Post Week 12|Lack of Efficacy|0|||
155352723|NCT00550446|560725734|FG001|Post Week 12|Lack of Efficacy|0|||
155085701|NCT03715829|559745879|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085702|NCT03715829|559745880|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085703|NCT03715829|559745881|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085704|NCT03715829|559745882|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085705|NCT03715829|559745883|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085706|NCT03715829|559745884|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085707|NCT03715829|559745885|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085708|NCT03715829|559745886|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
155085709|NCT03715829|559745887|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085710|NCT03715829|559745888|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
155085711|NCT03715829|559745878|FG000|Extension Period|Other|0|||
155085712|NCT03715829|559745879|FG001|Extension Period|Other|0|||
155085713|NCT03715829|559745880|FG002|Extension Period|Other|0|||
155085714|NCT03715829|559745881|FG003|Extension Period|Other|0|||
155085715|NCT03715829|559745882|FG004|Extension Period|Other|0|||
155085716|NCT03715829|559745883|FG005|Extension Period|Other|0|||
155085717|NCT03715829|559745884|FG006|Extension Period|Other|1|||
155165623|NCT01077076|560043507|FG003|Third Intervention|Death in the participant's family|0|||
155165624|NCT01077076|560043508|FG004|Third Intervention|Death in the participant's family|0|||
155165625|NCT01077076|560043509|FG005|Third Intervention|Death in the participant's family|1|||
155165626|NCT01388335|560043512|FG000|Period 1|Progressive Disease|1|||
155165627|NCT01388335|560043512|FG000|Period 2|Progressive Disease|2|||
155165628|NCT01388335|560043512|FG000|Period 2|Sponsor Decision|1|||
155165629|NCT01388335|560043512|FG000|Safety Extension|Progressive Disease|7|||
155085718|NCT03715829|559745885|FG007|Extension Period|Other|2|||
155085719|NCT03715829|559745886|FG008|Extension Period|Other|4|||
155352724|NCT00550446|560725735|FG002|Post Week 12|Lack of Efficacy|1|||
155352725|NCT00550446|560725736|FG003|Post Week 12|Lack of Efficacy|0|||
155085720|NCT03715829|559745887|FG009|Extension Period|Other|0|||
155165630|NCT01301027|560043517|FG000|Overall Study|Physician Decision|2|||
155165631|NCT01301027|560043518|FG001|Overall Study|Physician Decision|0|||
155165632|NCT01301027|560043517|FG000|Overall Study|Withdrawal by Subject|2|||
155165633|NCT01301027|560043518|FG001|Overall Study|Withdrawal by Subject|3|||
155165634|NCT01301027|560043517|FG000|Overall Study|Adverse Event|0|||
155165635|NCT01301027|560043518|FG001|Overall Study|Adverse Event|2|||
155165636|NCT01301027|560043517|FG000|Overall Study|Fracture|1|||
155165637|NCT01301027|560043518|FG001|Overall Study|Fracture|3|||
155165638|NCT01301027|560043517|FG000|Overall Study|Transplant|0|||
155165639|NCT01301027|560043518|FG001|Overall Study|Transplant|2|||
155165640|NCT01301027|560043517|FG000|Overall Study|Volume Overload|3|||
155165641|NCT01301027|560043518|FG001|Overall Study|Volume Overload|0|||
155165642|NCT00845897|560043519|FG000|Overall Study|Lost to Follow-up|1|||
155165643|NCT00845897|560043520|FG001|Overall Study|Lost to Follow-up|1|||
155165644|NCT00845897|560043521|FG002|Overall Study|Lost to Follow-up|0|||
155165645|NCT00845897|560043519|FG000|Overall Study|Withdrawal by Subject|0|||
155165646|NCT00845897|560043520|FG001|Overall Study|Withdrawal by Subject|3|||
155165647|NCT00845897|560043521|FG002|Overall Study|Withdrawal by Subject|2|||
155165648|NCT00845897|560043519|FG000|Overall Study|Ulcer did not heal|1|||
155352726|NCT00550446|560725737|FG004|Post Week 12|Lack of Efficacy|0|||
155352727|NCT00550446|560725738|FG005|Post Week 12|Lack of Efficacy|0|||
155352728|NCT00550446|560725739|FG006|Post Week 12|Lack of Efficacy|0|||
155352729|NCT00550446|560725740|FG007|Post Week 12|Lack of Efficacy|1|||
155085721|NCT03715829|559745888|FG010|Extension Period|Other|0|||
155085722|NCT03579719|559745891|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
155085723|NCT01443026|559745892|FG000|Overall Study|Physician Decision|1|||
155165649|NCT00845897|560043520|FG001|Overall Study|Ulcer did not heal|0|||
155165650|NCT00845897|560043521|FG002|Overall Study|Ulcer did not heal|1|||
155165651|NCT00845897|560043519|FG000|Overall Study|Too ill to participate|0|||
155165652|NCT00845897|560043520|FG001|Overall Study|Too ill to participate|1|||
155165653|NCT00845897|560043521|FG002|Overall Study|Too ill to participate|0|||
155165654|NCT03566485|560043530|FG000|Overall Study|Disease progression|5|||
155165655|NCT03566485|560043531|FG001|Overall Study|Disease progression|4|||
155352730|NCT00550446|560725741|FG008|Post Week 12|Lack of Efficacy|1|||
155352731|NCT00550446|560725742|FG009|Post Week 12|Lack of Efficacy|2|||
155352732|NCT00550446|560725743|FG010|Post Week 12|Lack of Efficacy|1|||
155085724|NCT01443026|559745893|FG001|Overall Study|Physician Decision|0|||
155085725|NCT01443026|559745892|FG000|Overall Study|Death|0|||
155085726|NCT01443026|559745893|FG001|Overall Study|Death|1|||
155165656|NCT03566485|560043530|FG000|Overall Study|Clinical progression|0|||
155165657|NCT03566485|560043531|FG001|Overall Study|Clinical progression|1|||
155165658|NCT03566485|560043530|FG000|Overall Study|Toxicity|0|||
155165659|NCT03566485|560043531|FG001|Overall Study|Toxicity|2|||
155352733|NCT00550446|560725733|FG000|Post Week 12|Lost to Follow-up|0|||
155352734|NCT00550446|560725734|FG001|Post Week 12|Lost to Follow-up|0|||
155352735|NCT00550446|560725735|FG002|Post Week 12|Lost to Follow-up|1|||
155352736|NCT00550446|560725736|FG003|Post Week 12|Lost to Follow-up|1|||
155352737|NCT00550446|560725737|FG004|Post Week 12|Lost to Follow-up|0|||
155352738|NCT00550446|560725738|FG005|Post Week 12|Lost to Follow-up|0|||
155352739|NCT00550446|560725739|FG006|Post Week 12|Lost to Follow-up|1|||
155352740|NCT00550446|560725740|FG007|Post Week 12|Lost to Follow-up|0|||
155352741|NCT00550446|560725741|FG008|Post Week 12|Lost to Follow-up|0|||
155352742|NCT00550446|560725742|FG009|Post Week 12|Lost to Follow-up|0|||
155352743|NCT00550446|560725743|FG010|Post Week 12|Lost to Follow-up|0|||
155352744|NCT00550446|560725733|FG000|Post Week 12|Withdrawal by Subject|0|||
155352745|NCT00550446|560725734|FG001|Post Week 12|Withdrawal by Subject|0|||
155352746|NCT00550446|560725735|FG002|Post Week 12|Withdrawal by Subject|0|||
155352747|NCT00550446|560725736|FG003|Post Week 12|Withdrawal by Subject|0|||
155352748|NCT00550446|560725737|FG004|Post Week 12|Withdrawal by Subject|1|||
155352749|NCT00550446|560725738|FG005|Post Week 12|Withdrawal by Subject|0|||
155352750|NCT00550446|560725739|FG006|Post Week 12|Withdrawal by Subject|0|||
155352751|NCT00550446|560725740|FG007|Post Week 12|Withdrawal by Subject|0|||
155352752|NCT00550446|560725741|FG008|Post Week 12|Withdrawal by Subject|0|||
155352753|NCT00550446|560725742|FG009|Post Week 12|Withdrawal by Subject|0|||
155352754|NCT00550446|560725743|FG010|Post Week 12|Withdrawal by Subject|0|||
155352755|NCT00550446|560725733|FG000|Post Week 12|Other|1|||
155352756|NCT00550446|560725734|FG001|Post Week 12|Other|1|||
155352757|NCT00550446|560725735|FG002|Post Week 12|Other|0|||
155352758|NCT00550446|560725736|FG003|Post Week 12|Other|1|||
155352759|NCT00550446|560725737|FG004|Post Week 12|Other|0|||
155352760|NCT00550446|560725738|FG005|Post Week 12|Other|0|||
155352761|NCT00550446|560725739|FG006|Post Week 12|Other|1|||
155352762|NCT00550446|560725740|FG007|Post Week 12|Other|0|||
155352763|NCT00550446|560725741|FG008|Post Week 12|Other|1|||
155352764|NCT00550446|560725742|FG009|Post Week 12|Other|1|||
155352765|NCT00550446|560725743|FG010|Post Week 12|Other|0|||
155352766|NCT04081389|560725750|FG000|Overall Study|Withdrawal by Subject|0|||
155352767|NCT04081389|560725751|FG001|Overall Study|Withdrawal by Subject|0|||
155352768|NCT04081389|560725752|FG002|Overall Study|Withdrawal by Subject|1|||
155352769|NCT04081389|560725753|FG003|Overall Study|Withdrawal by Subject|0|||
155352770|NCT01114672|560725759|FG000|Overall Study|Death|0|||
155352771|NCT01114672|560725760|FG001|Overall Study|Death|1|||
155352772|NCT01114672|560725759|FG000|Overall Study|Withdrawal by Subject|2|||
155352773|NCT01114672|560725760|FG001|Overall Study|Withdrawal by Subject|1|||
155352774|NCT01114672|560725759|FG000|Overall Study|Lost to Follow-up|1|||
155352775|NCT01114672|560725760|FG001|Overall Study|Lost to Follow-up|0|||
155352776|NCT01114672|560725759|FG000|Overall Study|transplanted|1|||
155352777|NCT01114672|560725760|FG001|Overall Study|transplanted|0|||
155165660|NCT03610269|560043532|FG000|Overall Study|Physician Decision|10|||
155165661|NCT03610269|560043532|FG000|Overall Study|Protocol Violation|1|||
155165662|NCT03610269|560043532|FG000|Overall Study|Unable to draw blood|1|||
155165663|NCT03610269|560043532|FG000|Overall Study|Screen fail|4|||
155165664|NCT01354314|560043533|FG000|Overall Study|Lost to Follow-up|1|||
155165665|NCT01354314|560043534|FG001|Overall Study|Lost to Follow-up|0|||
155165666|NCT01354314|560043535|FG002|Overall Study|Lost to Follow-up|1|||
155165667|NCT01354314|560043536|FG003|Overall Study|Lost to Follow-up|1|||
155165668|NCT01354314|560043533|FG000|Overall Study|Withdrawal by Subject|0|||
155165669|NCT01354314|560043534|FG001|Overall Study|Withdrawal by Subject|0|||
155165670|NCT01354314|560043535|FG002|Overall Study|Withdrawal by Subject|1|||
155165671|NCT01354314|560043536|FG003|Overall Study|Withdrawal by Subject|0|||
155165672|NCT01354314|560043533|FG000|Overall Study|Adverse Event|0|||
155165673|NCT01354314|560043534|FG001|Overall Study|Adverse Event|0|||
155165674|NCT01354314|560043535|FG002|Overall Study|Adverse Event|0|||
155165675|NCT01354314|560043536|FG003|Overall Study|Adverse Event|1|||
155165676|NCT01354314|560043533|FG000|Overall Study|Protocol Violation|1|||
155165677|NCT01354314|560043534|FG001|Overall Study|Protocol Violation|1|||
155165678|NCT01354314|560043535|FG002|Overall Study|Protocol Violation|0|||
155165679|NCT01354314|560043536|FG003|Overall Study|Protocol Violation|0|||
155165680|NCT01354314|560043533|FG000|Overall Study|Less than 90% Adherence|4|||
155165681|NCT01354314|560043534|FG001|Overall Study|Less than 90% Adherence|2|||
155352778|NCT01710800|560725761|FG000|Overall Study|Withdrawal by Subject|21|||
155085727|NCT01443026|559745892|FG000|Overall Study|Withdrawal by Subject|0|||
155352779|NCT01710800|560725761|FG000|Overall Study|Protocol Violation|1|||
155352780|NCT00827775|560725762|FG000|Overall Study|Withdrawal by Subject|0|||
155352781|NCT00827775|560725763|FG001|Overall Study|Withdrawal by Subject|5|||
155352782|NCT03891641|560725764|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
155352783|NCT03891641|560725765|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
155352784|NCT02212301|560725766|FG000|Period 1|Lost to Follow-up|0|||
155352785|NCT02212301|560725767|FG001|Period 1|Lost to Follow-up|1|||
155352786|NCT00866918|560725770|FG000|Overall Study|Death|1|||
155352787|NCT00866918|560725771|FG001|Overall Study|Death|5|||
155352788|NCT00866918|560725770|FG000|Overall Study|Lack of Efficacy|1|||
155352789|NCT00866918|560725771|FG001|Overall Study|Lack of Efficacy|1|||
155352790|NCT00866918|560725770|FG000|Overall Study|Physician Decision|10|||
155352791|NCT00866918|560725771|FG001|Overall Study|Physician Decision|2|||
155352792|NCT00866918|560725770|FG000|Overall Study|Ineligible|2|||
155352793|NCT00866918|560725771|FG001|Overall Study|Ineligible|4|||
155352794|NCT00866918|560725770|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
155352795|NCT00866918|560725771|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
155085728|NCT01443026|559745893|FG001|Overall Study|Withdrawal by Subject|3|||
155085729|NCT01443026|559745892|FG000|Overall Study|Lost to Follow-up|2|||
155085730|NCT01443026|559745893|FG001|Overall Study|Lost to Follow-up|1|||
155085731|NCT00829868|559745894|FG000|Washout|Physician Decision|1|||
155085732|NCT00829868|559745895|FG001|Washout|Physician Decision|0|||
155085733|NCT01922895|559745899|FG000|Overall Study|Death|0|||
155085734|NCT01922895|559745900|FG001|Overall Study|Death|1|||
155085735|NCT01922895|559745899|FG000|Overall Study|Withdrawal by Subject|1|||
155165682|NCT01354314|560043535|FG002|Overall Study|Less than 90% Adherence|6|||
155352796|NCT00866918|560725770|FG000|Overall Study|Secondary malignancy|1|||
155352797|NCT00866918|560725771|FG001|Overall Study|Secondary malignancy|0|||
155165683|NCT01354314|560043536|FG003|Overall Study|Less than 90% Adherence|4|||
155165684|NCT00714870|560043537|FG000|Overall Study|Lost to Follow-up|22|||
155165685|NCT00714870|560043538|FG001|Overall Study|Lost to Follow-up|5|||
155352798|NCT03041701|560725772|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
155352799|NCT03041701|560725773|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
155352800|NCT03041701|560725774|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
155352801|NCT03041701|560725772|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
155352802|NCT03041701|560725773|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
155085736|NCT01922895|559745900|FG001|Overall Study|Withdrawal by Subject|2|||
155085737|NCT01922895|559745899|FG000|Overall Study|Lost to Follow-up|5|||
155165686|NCT00714870|560043537|FG000|Overall Study|patient unable to come b/c back pain|1|||
155352803|NCT03041701|560725774|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
155352804|NCT00527514|560725775|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
155352805|NCT00527514|560725775|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
155352806|NCT00527514|560725775|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
155352807|NCT00527514|560725775|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
155352808|NCT00527514|560725775|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
155352809|NCT00527514|560725775|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
155352810|NCT00527514|560725775|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
155352811|NCT00001941|560725776|FG000|Overall Study|not treated- rapidly progressing disease|0|||
155352812|NCT00001941|560725777|FG001|Overall Study|not treated- rapidly progressing disease|0|||
155352813|NCT00001941|560725778|FG002|Overall Study|not treated- rapidly progressing disease|0|||
155352814|NCT00001941|560725779|FG003|Overall Study|not treated- rapidly progressing disease|0|||
155352815|NCT00001941|560725780|FG004|Overall Study|not treated- rapidly progressing disease|1|||
155352816|NCT04380688|560725784|FG000|Overall Study|Death|2|||
155352817|NCT04380688|560725785|FG001|Overall Study|Death|2|||
155352818|NCT04380688|560725784|FG000|Overall Study|Lost to Follow-up|2|||
155352819|NCT04380688|560725785|FG001|Overall Study|Lost to Follow-up|4|||
155352820|NCT04380688|560725784|FG000|Overall Study|Withdrawal by Subject|3|||
155352821|NCT04380688|560725785|FG001|Overall Study|Withdrawal by Subject|3|||
155352822|NCT00919061|560725786|FG000|Overall Study|Adverse Event|1|||
155352823|NCT00919061|560725786|FG000|Overall Study|Withdrawal by Subject|1|||
155352824|NCT02056873|560725787|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
155352825|NCT00605566|560727700|FG000|Overall Study|Adverse Event|1|||
155352826|NCT00605566|560727700|FG000|Overall Study|Clinical deterioration|1|||
155352827|NCT00605566|560727700|FG000|Overall Study|Poor compliance in run-in period|1|||
155352828|NCT01904136|560727701|FG000|Overall Study|Physician Decision|0|||
155352829|NCT01904136|560727702|FG001|Overall Study|Physician Decision|0|||
155352830|NCT01904136|560727703|FG002|Overall Study|Physician Decision|0|||
155352831|NCT01904136|560727704|FG003|Overall Study|Physician Decision|0|||
155352832|NCT01904136|560727705|FG004|Overall Study|Physician Decision|0|||
155352833|NCT01904136|560727706|FG005|Overall Study|Physician Decision|1|||
155352834|NCT01904136|560727707|FG006|Overall Study|Physician Decision|0|||
155352835|NCT01904136|560727708|FG007|Overall Study|Physician Decision|0|||
155352836|NCT01904136|560727709|FG008|Overall Study|Physician Decision|0|||
155352837|NCT02202109|560727711|FG000|Overall Study|Lost to Follow-up|88|||
155352838|NCT02202109|560727712|FG001|Overall Study|Lost to Follow-up|87|||
155085738|NCT01922895|559745900|FG001|Overall Study|Lost to Follow-up|11|||
155085739|NCT00979407|559745901|FG000|Overall Study|Withdrawal by Subject|3|||
155085740|NCT00979407|559745902|FG001|Overall Study|Withdrawal by Subject|4|||
155085741|NCT00979407|559745901|FG000|Overall Study|Lost to Follow-up|3|||
155085742|NCT00979407|559745902|FG001|Overall Study|Lost to Follow-up|3|||
155085743|NCT01166646|559745903|FG000|Overall Study|Protocol Violation|0|||
155085744|NCT01166646|559745904|FG001|Overall Study|Protocol Violation|1|||
155085745|NCT01166646|559745903|FG000|Overall Study|Adverse Event|1|||
155085746|NCT01166646|559745904|FG001|Overall Study|Adverse Event|0|||
155085747|NCT02420314|559745905|FG000|Overall Study|Withdrawal by Subject|1|||
155085748|NCT02420314|559745905|FG000|Overall Study|Protocol Violation|1|||
155085749|NCT05430919|559745906|FG000|Overall Study|Protocol Violation|0|||
155085750|NCT05430919|559745907|FG001|Overall Study|Protocol Violation|0|||
155085751|NCT05430919|559745908|FG002|Overall Study|Protocol Violation|1|||
155085752|NCT05430919|559745909|FG003|Overall Study|Protocol Violation|0|||
155085753|NCT05430919|559745906|FG000|Overall Study|Lost to Follow-up|0|||
155085754|NCT05430919|559745907|FG001|Overall Study|Lost to Follow-up|1|||
155085755|NCT05430919|559745908|FG002|Overall Study|Lost to Follow-up|0|||
155085756|NCT05430919|559745909|FG003|Overall Study|Lost to Follow-up|0|||
155085757|NCT05430919|559745906|FG000|Overall Study|Withdrawal by Subject|3|||
155085758|NCT05430919|559745907|FG001|Overall Study|Withdrawal by Subject|0|||
155085759|NCT05430919|559745908|FG002|Overall Study|Withdrawal by Subject|0|||
155085760|NCT05430919|559745909|FG003|Overall Study|Withdrawal by Subject|1|||
155085761|NCT00803049|559745913|FG000|Overall Study|Adverse Event|21|||
155085762|NCT00803049|559745914|FG001|Overall Study|Adverse Event|33|||
155085763|NCT00803049|559745915|FG002|Overall Study|Adverse Event|13|||
155352839|NCT02202109|560727711|FG000|Overall Study|Withdrawal by Subject|2|||
155352840|NCT02202109|560727712|FG001|Overall Study|Withdrawal by Subject|0|||
155352841|NCT03834623|560727715|FG000|Overall Study|Progression|0|||
155352842|NCT03834623|560727716|FG001|Overall Study|Progression|1|||
155352843|NCT03024996|560727717|FG000|Overall Study|Death|57|||
155352844|NCT03024996|560727718|FG001|Overall Study|Death|55|||
155352845|NCT03024996|560727717|FG000|Overall Study|Disease relapse|1|||
155352846|NCT03024996|560727718|FG001|Overall Study|Disease relapse|0|||
155352847|NCT03024996|560727717|FG000|Overall Study|Lost to Follow-up|5|||
155352848|NCT03024996|560727718|FG001|Overall Study|Lost to Follow-up|10|||
155352849|NCT03024996|560727717|FG000|Overall Study|Other|3|||
155352850|NCT03024996|560727718|FG001|Overall Study|Other|3|||
155352851|NCT03024996|560727717|FG000|Overall Study|Physician Decision|0|||
155352852|NCT03024996|560727718|FG001|Overall Study|Physician Decision|1|||
155352853|NCT03024996|560727717|FG000|Overall Study|Study terminated by sponsor|303|||
155352854|NCT03024996|560727718|FG001|Overall Study|Study terminated by sponsor|283|||
155352855|NCT03024996|560727717|FG000|Overall Study|Withdrawal by Subject|21|||
155352856|NCT03024996|560727718|FG001|Overall Study|Withdrawal by Subject|36|||
155352857|NCT00478647|560727719|FG000|Overall Study|Adverse Event|1|||
155352858|NCT00478647|560727719|FG000|Overall Study|Withdrawal by Subject|1|||
155352859|NCT00487552|560727732|FG000|Overall Study|Unsuccessful magnet placements|3|||
155352860|NCT00487552|560727732|FG000|Overall Study|Death due to progressive malignancy|2|||
155352861|NCT00487552|560727732|FG000|Overall Study|Stent not placed|1|||
155352862|NCT03119688|560727733|FG000|Overall Study|Adverse Event|4|||
155352863|NCT00320398|560727734|FG000|Overall Study|Adverse Event|1|||
155352864|NCT00320398|560727735|FG001|Overall Study|Adverse Event|4|||
155085764|NCT00803049|559745916|FG003|Overall Study|Adverse Event|27|||
155085765|NCT00803049|559745913|FG000|Overall Study|Lack of Efficacy|10|||
155085766|NCT00803049|559745914|FG001|Overall Study|Lack of Efficacy|19|||
155085767|NCT00803049|559745915|FG002|Overall Study|Lack of Efficacy|6|||
155085768|NCT00803049|559745916|FG003|Overall Study|Lack of Efficacy|13|||
155085769|NCT00803049|559745913|FG000|Overall Study|Lost to Follow-up|0|||
155352865|NCT00320398|560727734|FG000|Overall Study|Other|1|||
154964720|NCT00927069|559297497|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
154964721|NCT02842853|559297500|FG000|Overall Study|Non-compliance with the protocol|3|||
155085770|NCT00803049|559745914|FG001|Overall Study|Lost to Follow-up|2|||
155352866|NCT00320398|560727735|FG001|Overall Study|Other|0|||
155352867|NCT02705625|560727736|FG000|Overall Study|Protocol Violation|1|||
155352868|NCT02705625|560727737|FG001|Overall Study|Protocol Violation|0|||
155352869|NCT02705625|560727738|FG002|Overall Study|Protocol Violation|0|||
155352870|NCT02705625|560727736|FG000|Overall Study|Adverse Event|6|||
155085771|NCT00803049|559745915|FG002|Overall Study|Lost to Follow-up|0|||
155085772|NCT00803049|559745916|FG003|Overall Study|Lost to Follow-up|3|||
155085773|NCT00803049|559745913|FG000|Overall Study|Death|2|||
155085774|NCT00803049|559745914|FG001|Overall Study|Death|1|||
155352871|NCT02705625|560727737|FG001|Overall Study|Adverse Event|5|||
155085775|NCT00803049|559745915|FG002|Overall Study|Death|0|||
155085776|NCT00803049|559745916|FG003|Overall Study|Death|2|||
155085777|NCT00803049|559745913|FG000|Overall Study|Progressive Disease|6|||
155085778|NCT00803049|559745914|FG001|Overall Study|Progressive Disease|10|||
155085779|NCT00803049|559745915|FG002|Overall Study|Progressive Disease|6|||
155352872|NCT02705625|560727738|FG002|Overall Study|Adverse Event|2|||
155352873|NCT02705625|560727736|FG000|Overall Study|Death|0|||
155352874|NCT02705625|560727737|FG001|Overall Study|Death|0|||
155352875|NCT02705625|560727738|FG002|Overall Study|Death|1|||
155352876|NCT02705625|560727736|FG000|Overall Study|Withdrawal by Subject|1|||
155352877|NCT02705625|560727737|FG001|Overall Study|Withdrawal by Subject|4|||
155352878|NCT02705625|560727738|FG002|Overall Study|Withdrawal by Subject|5|||
155352879|NCT02705625|560727736|FG000|Overall Study|Lost to Follow-up|0|||
155352880|NCT02705625|560727737|FG001|Overall Study|Lost to Follow-up|0|||
155352881|NCT02705625|560727738|FG002|Overall Study|Lost to Follow-up|1|||
155352882|NCT02705625|560727736|FG000|Overall Study|Non-compliance|0|||
155352883|NCT02705625|560727737|FG001|Overall Study|Non-compliance|1|||
155352884|NCT02705625|560727738|FG002|Overall Study|Non-compliance|1|||
155352885|NCT02705625|560727736|FG000|Overall Study|Overdosing|0|||
155352886|NCT02705625|560727737|FG001|Overall Study|Overdosing|0|||
155352887|NCT02705625|560727738|FG002|Overall Study|Overdosing|1|||
155352888|NCT04544865|560727740|FG000|Overall Study|Death|0|||
155352889|NCT04544865|560727741|FG001|Overall Study|Death|2|||
155352890|NCT04544865|560727740|FG000|Overall Study|Lost to Follow-up|11|||
155352891|NCT04544865|560727741|FG001|Overall Study|Lost to Follow-up|7|||
155352892|NCT04544865|560727740|FG000|Overall Study|Withdrawal by Subject|0|||
155352893|NCT04544865|560727741|FG001|Overall Study|Withdrawal by Subject|1|||
155352894|NCT04544865|560727740|FG000|Overall Study|Other|0|||
155352895|NCT04544865|560727741|FG001|Overall Study|Other|1|||
155352896|NCT01649297|560727743|FG000|Overall Study|Adverse Event|5|||
155352897|NCT01649297|560727744|FG001|Overall Study|Adverse Event|5|||
155352898|NCT01649297|560727745|FG002|Overall Study|Adverse Event|4|||
155352899|NCT01649297|560727746|FG003|Overall Study|Adverse Event|13|||
155352900|NCT01649297|560727747|FG004|Overall Study|Adverse Event|1|||
155352901|NCT01649297|560727743|FG000|Overall Study|Lack of Efficacy|0|||
155352902|NCT01649297|560727744|FG001|Overall Study|Lack of Efficacy|0|||
155352903|NCT01649297|560727745|FG002|Overall Study|Lack of Efficacy|0|||
155352904|NCT01649297|560727746|FG003|Overall Study|Lack of Efficacy|0|||
155352905|NCT01649297|560727747|FG004|Overall Study|Lack of Efficacy|1|||
155352906|NCT01649297|560727743|FG000|Overall Study|Non compliant with Protocol|1|||
155352907|NCT01649297|560727744|FG001|Overall Study|Non compliant with Protocol|0|||
155352908|NCT01649297|560727745|FG002|Overall Study|Non compliant with Protocol|3|||
155352909|NCT01649297|560727746|FG003|Overall Study|Non compliant with Protocol|2|||
155352910|NCT01649297|560727747|FG004|Overall Study|Non compliant with Protocol|1|||
155352911|NCT01649297|560727743|FG000|Overall Study|Lost to Follow-up|1|||
155352912|NCT01649297|560727744|FG001|Overall Study|Lost to Follow-up|1|||
155352913|NCT01649297|560727745|FG002|Overall Study|Lost to Follow-up|4|||
155352914|NCT01649297|560727746|FG003|Overall Study|Lost to Follow-up|3|||
155352915|NCT01649297|560727747|FG004|Overall Study|Lost to Follow-up|0|||
155352916|NCT01649297|560727743|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
155352917|NCT01649297|560727744|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
155352918|NCT01649297|560727745|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
155352919|NCT01649297|560727746|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
155352920|NCT01649297|560727747|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
155352921|NCT01649297|560727743|FG000|Overall Study|For other reason|4|||
155352922|NCT01649297|560727744|FG001|Overall Study|For other reason|1|||
155352923|NCT01649297|560727745|FG002|Overall Study|For other reason|2|||
155352924|NCT01649297|560727746|FG003|Overall Study|For other reason|0|||
155352925|NCT01649297|560727747|FG004|Overall Study|For other reason|0|||
155352926|NCT01685047|560727748|FG000|Overall Study|Withdrawal by Subject|20|||
155352927|NCT01685047|560727748|FG000|Overall Study|Death|26|||
155352928|NCT01685047|560727748|FG000|Overall Study|Lost to Follow-up|8|||
155352929|NCT01685047|560727748|FG000|Overall Study|Physician Decision|25|||
155352930|NCT01685047|560727748|FG000|Overall Study|Adverse Event|5|||
155352931|NCT01685047|560727748|FG000|Overall Study|patient withdrawn by sponsor|1|||
155352932|NCT01732926|560727750|FG000|Overall Study|Study Terminated by Sponsor|168|||
154964722|NCT02842853|559297501|FG001|Overall Study|Non-compliance with the protocol|7|||
155085780|NCT00803049|559745916|FG003|Overall Study|Progressive Disease|6|||
155085781|NCT00803049|559745913|FG000|Overall Study|Withdrawal by Subject|19|||
155085782|NCT00803049|559745914|FG001|Overall Study|Withdrawal by Subject|43|||
155085783|NCT00803049|559745915|FG002|Overall Study|Withdrawal by Subject|16|||
155085784|NCT00803049|559745916|FG003|Overall Study|Withdrawal by Subject|44|||
155085785|NCT00803049|559745913|FG000|Overall Study|Protocol Violation|0|||
155085786|NCT00803049|559745914|FG001|Overall Study|Protocol Violation|1|||
155085787|NCT00803049|559745915|FG002|Overall Study|Protocol Violation|1|||
155085788|NCT00803049|559745916|FG003|Overall Study|Protocol Violation|0|||
155085789|NCT00803049|559745913|FG000|Overall Study|Randomized and Not Treated|0|||
155085790|NCT00803049|559745914|FG001|Overall Study|Randomized and Not Treated|0|||
155085791|NCT00803049|559745915|FG002|Overall Study|Randomized and Not Treated|0|||
155085792|NCT00803049|559745916|FG003|Overall Study|Randomized and Not Treated|2|||
155085793|NCT00803049|559745913|FG000|Overall Study|Other than Specified Above|3|||
155085794|NCT00803049|559745914|FG001|Overall Study|Other than Specified Above|9|||
155085795|NCT00803049|559745915|FG002|Overall Study|Other than Specified Above|2|||
155352933|NCT01732926|560727751|FG001|Overall Study|Study Terminated by Sponsor|80|||
155352934|NCT01732926|560727750|FG000|Overall Study|Withdrawal by Subject|46|||
155352935|NCT01732926|560727751|FG001|Overall Study|Withdrawal by Subject|8|||
155352936|NCT01732926|560727750|FG000|Overall Study|Physician Decision|24|||
155352937|NCT01732926|560727751|FG001|Overall Study|Physician Decision|11|||
155352938|NCT01732926|560727750|FG000|Overall Study|Other Reason|21|||
155352939|NCT01732926|560727751|FG001|Overall Study|Other Reason|4|||
155352940|NCT01732926|560727750|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
155352941|NCT01732926|560727751|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
155352942|NCT01732926|560727750|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
155352943|NCT01732926|560727751|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
155352944|NCT02262364|560727754|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
155352945|NCT01049984|560727755|FG000|Overall Study|Withdrawal by Subject|1|||
155352946|NCT01049984|560727756|FG001|Overall Study|Withdrawal by Subject|5|||
155352947|NCT01049984|560727755|FG000|Overall Study|Protocol Violation|3|||
155352948|NCT01049984|560727756|FG001|Overall Study|Protocol Violation|4|||
155352949|NCT01049984|560727755|FG000|Overall Study|Lost to Follow-up|2|||
155352950|NCT01049984|560727756|FG001|Overall Study|Lost to Follow-up|1|||
155352951|NCT01049984|560727755|FG000|Overall Study|Adverse Event|13|||
155352952|NCT01049984|560727756|FG001|Overall Study|Adverse Event|7|||
155352953|NCT01049984|560727755|FG000|Overall Study|Treatment failure|0|||
155352954|NCT01049984|560727756|FG001|Overall Study|Treatment failure|2|||
155352955|NCT00337285|560727757|FG000|Overall Study|Withdrawal by Subject|42|||
155352956|NCT00337285|560727757|FG000|Overall Study|Lost to Follow-up|41|||
155352957|NCT00337285|560727757|FG000|Overall Study|Adverse Event|28|||
155352958|NCT00337285|560727757|FG000|Overall Study|Protocol Violation|27|||
155352959|NCT00337285|560727757|FG000|Overall Study|Lack of Efficacy|11|||
155352960|NCT00337285|560727757|FG000|Overall Study|Death|1|||
155352961|NCT00337285|560727757|FG000|Overall Study|Physician Decision|1|||
155352962|NCT00337285|560727757|FG000|Overall Study|Lack of protocol compliance|7|||
155352963|NCT01040403|560727758|FG000|Overall Study|Adverse Event|10|||
155352964|NCT01040403|560727758|FG000|Overall Study|Protocol Violation|2|||
155352965|NCT01040403|560727758|FG000|Overall Study|Lost to Follow-up|1|||
155352966|NCT01040403|560727758|FG000|Overall Study|Not treated|1|||
155352967|NCT01040403|560727758|FG000|Overall Study|Other reason not defined above|6|||
155352968|NCT00931918|560727762|FG000|Overall Study|Adverse Event|4|||
155352969|NCT00931918|560727763|FG001|Overall Study|Adverse Event|6|||
155352970|NCT00931918|560727762|FG000|Overall Study|Progressive Disease|2|||
155352971|NCT00931918|560727763|FG001|Overall Study|Progressive Disease|1|||
155352972|NCT00931918|560727762|FG000|Overall Study|Symptomatic Deterioration|1|||
155352973|NCT00931918|560727763|FG001|Overall Study|Symptomatic Deterioration|0|||
155352974|NCT00931918|560727762|FG000|Overall Study|Withdrawal by Patient|3|||
155352975|NCT00931918|560727763|FG001|Overall Study|Withdrawal by Patient|4|||
155352976|NCT00931918|560727762|FG000|Overall Study|Other Reason not Specified|4|||
155352977|NCT00931918|560727763|FG001|Overall Study|Other Reason not Specified|4|||
155352978|NCT00931918|560727762|FG000|Overall Study|Did not receive study drug|3|||
155352979|NCT00931918|560727763|FG001|Overall Study|Did not receive study drug|2|||
155352980|NCT04191148|560727766|FG000|Overall Study|Withdrawal by Subject|1|||
155352981|NCT04191148|560727767|FG001|Overall Study|Withdrawal by Subject|0|||
155352982|NCT04191148|560727766|FG000|Overall Study|Adverse Event|1|||
155352983|NCT04191148|560727767|FG001|Overall Study|Adverse Event|0|||
155352984|NCT02647788|560727768|FG000|Overall Study|Lost to Follow-up|13|||
155352985|NCT02647788|560727769|FG001|Overall Study|Lost to Follow-up|11|||
155352986|NCT02647788|560727768|FG000|Overall Study|Did not want opiate|0|||
155352987|NCT02647788|560727769|FG001|Overall Study|Did not want opiate|1|||
155352988|NCT02647788|560727768|FG000|Overall Study|Withdrawal by Subject|1|||
155352989|NCT02647788|560727769|FG001|Overall Study|Withdrawal by Subject|0|||
155352990|NCT02647788|560727768|FG000|Overall Study|Felt itchy with assigned medication|1|||
155352991|NCT02647788|560727769|FG001|Overall Study|Felt itchy with assigned medication|0|||
155352992|NCT02647788|560727768|FG000|Overall Study|Felt nauseous with assigned medication|1|||
155352993|NCT02647788|560727769|FG001|Overall Study|Felt nauseous with assigned medication|1|||
155352994|NCT03245619|560727770|FG000|Part A (Up to Day 22)|Physician Decision|4|||
154964723|NCT02842853|559297502|FG002|Overall Study|Non-compliance with the protocol|2|||
155085796|NCT00803049|559745916|FG003|Overall Study|Other than Specified Above|5|||
155085797|NCT04126174|559745917|FG000|Overall Study|Lost to Follow-up|3|||
155085798|NCT04126174|559745918|FG001|Overall Study|Lost to Follow-up|3|||
155352995|NCT03245619|560727771|FG001|Part A (Up to Day 22)|Physician Decision|6|||
155352996|NCT03245619|560727772|FG002|Part A (Up to Day 22)|Physician Decision|6|||
155352997|NCT03245619|560727773|FG003|Part A (Up to Day 22)|Physician Decision|0|||
155352998|NCT03245619|560727774|FG004|Part A (Up to Day 22)|Physician Decision|0|||
155085799|NCT03131479|559745919|FG000|Overall Study|Adverse Event|0|||
155352999|NCT03245619|560727775|FG005|Part A (Up to Day 22)|Physician Decision|0|||
155353000|NCT03245619|560727776|FG006|Part A (Up to Day 22)|Physician Decision|0|||
155353001|NCT03245619|560727777|FG007|Part A (Up to Day 22)|Physician Decision|0|||
155353002|NCT03245619|560727778|FG008|Part A (Up to Day 22)|Physician Decision|0|||
155085800|NCT03131479|559745920|FG001|Overall Study|Adverse Event|0|||
155085801|NCT03131479|559745921|FG002|Overall Study|Adverse Event|1|||
155085802|NCT03131479|559745922|FG003|Overall Study|Adverse Event|1|||
155085803|NCT03131479|559745923|FG004|Overall Study|Adverse Event|0|||
155085804|NCT03131479|559745919|FG000|Overall Study|Subject/Guardian Decision|0|||
155085805|NCT03131479|559745920|FG001|Overall Study|Subject/Guardian Decision|0|||
155085806|NCT03131479|559745921|FG002|Overall Study|Subject/Guardian Decision|0|||
155085807|NCT03131479|559745922|FG003|Overall Study|Subject/Guardian Decision|1|||
155085808|NCT03131479|559745923|FG004|Overall Study|Subject/Guardian Decision|0|||
155085809|NCT05305651|559745924|FG000|Overall Study|Death|1|||
155085810|NCT05305651|559745924|FG000|Overall Study|Withdrawal by Subject|4|||
155085811|NCT05305651|559745924|FG000|Overall Study|Lost to Follow-up|4|||
155085812|NCT01272219|559745925|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
155085813|NCT01272219|559745926|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
155085814|NCT01272219|559745927|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
155353003|NCT03245619|560727779|FG009|Part A (Up to Day 22)|Physician Decision|0|||
155353004|NCT03245619|560727780|FG010|Part A (Up to Day 22)|Physician Decision|0|||
155353005|NCT03245619|560727781|FG011|Part A (Up to Day 22)|Physician Decision|0|||
155353006|NCT03245619|560727782|FG012|Part A (Up to Day 22)|Physician Decision|0|||
155353007|NCT03245619|560727783|FG013|Part A (Up to Day 22)|Physician Decision|0|||
155353008|NCT03245619|560727784|FG014|Part A (Up to Day 22)|Physician Decision|0|||
154964724|NCT02842853|559297503|FG003|Overall Study|Non-compliance with the protocol|5|||
154964725|NCT02842853|559297500|FG000|Overall Study|Subject met exclusion criteria|0|||
154964726|NCT02842853|559297501|FG001|Overall Study|Subject met exclusion criteria|1|||
154964727|NCT02842853|559297502|FG002|Overall Study|Subject met exclusion criteria|0|||
155085815|NCT01272219|559745928|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
155353009|NCT03245619|560727785|FG015|Part A (Up to Day 22)|Physician Decision|0|||
155353010|NCT03245619|560727786|FG016|Part A (Up to Day 22)|Physician Decision|0|||
155353011|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
155353012|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
155353013|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
155353014|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
155353015|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
155353016|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
155353017|NCT03201900|560727788|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
155353018|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
155353019|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
155353020|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
155353021|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
155353022|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
155353023|NCT03201900|560727788|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
155353024|NCT02971228|560727804|FG000|Overall Study|Withdrawal by Subject|1|||
155353025|NCT02971228|560727805|FG001|Overall Study|Withdrawal by Subject|1|||
155353026|NCT02971228|560727806|FG002|Overall Study|Withdrawal by Subject|0|||
155353027|NCT02971228|560727807|FG003|Overall Study|Withdrawal by Subject|0|||
155353028|NCT02971228|560727808|FG004|Overall Study|Withdrawal by Subject|0|||
155353029|NCT02971228|560727804|FG000|Overall Study|Logistical challenges|0|||
155353030|NCT02971228|560727805|FG001|Overall Study|Logistical challenges|1|||
155353031|NCT02971228|560727806|FG002|Overall Study|Logistical challenges|0|||
155353032|NCT02971228|560727807|FG003|Overall Study|Logistical challenges|0|||
155353033|NCT02971228|560727808|FG004|Overall Study|Logistical challenges|0|||
155353034|NCT01233999|560727809|FG000|Overall Study|Withdrawal by Subject|1|||
155353035|NCT01233999|560727809|FG000|Overall Study|Lost to Follow-up|1|||
155353036|NCT00129649|560727810|FG000|Overall Study|Withdrawal by Subject|76|||
155353037|NCT00129649|560727811|FG001|Overall Study|Withdrawal by Subject|65|||
155353038|NCT00025506|560727812|FG000|Overall Study|Ineligible: clerical error|1|||
155353039|NCT00025506|560727812|FG000|Overall Study|Ineligible: wrong cell type|5|||
155353040|NCT00025506|560727812|FG000|Overall Study|Ineligible: inadequate pathology|2|||
155353041|NCT00025506|560727812|FG000|Overall Study|Never Treated|2|||
155353042|NCT00713206|560727813|FG000|Overall Study|Lost to Follow-up|4|||
155353043|NCT00713206|560727814|FG001|Overall Study|Lost to Follow-up|4|||
155353044|NCT00713206|560727813|FG000|Overall Study|Death|1|||
155353045|NCT00713206|560727814|FG001|Overall Study|Death|0|||
155353046|NCT04952701|560727815|FG000|Control Lens|Physician Decision|4|||
155353047|NCT04952701|560727815|FG000|Test Lens|Physician Decision|1|||
155353048|NCT01657877|560727816|FG000|Overall Study|Withdrawal by Subject|4|||
155353049|NCT01657877|560727816|FG000|Overall Study|Protocol Violation|6|||
155353050|NCT01657877|560727816|FG000|Overall Study|Adverse Event|2|||
155085816|NCT01272219|559745929|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
155085817|NCT01272219|559745930|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
155085818|NCT01272219|559745925|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
155085819|NCT01272219|559745926|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
155085820|NCT01272219|559745927|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
155085821|NCT01272219|559745928|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
155085822|NCT01272219|559745929|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
155085823|NCT01272219|559745930|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
155085824|NCT01272219|559745925|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
155085825|NCT01272219|559745926|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
155085826|NCT01272219|559745927|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
155085827|NCT01272219|559745928|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
155085828|NCT01272219|559745929|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
155085829|NCT01272219|559745930|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
155085830|NCT01272219|559745925|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
155085831|NCT01272219|559745926|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
155085832|NCT01272219|559745927|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
155085833|NCT01272219|559745928|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
155085834|NCT01272219|559745929|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
155353051|NCT01657877|560727816|FG000|Overall Study|Other Reason|2|||
155353052|NCT01670188|560727824|FG000|Overall Study|Death|0|||
155353053|NCT01670188|560727825|FG001|Overall Study|Death|1|||
155353054|NCT02427958|560727828|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
155353055|NCT02427958|560727828|FG000|Overall Study|Lost to Follow-up|6|||
155353056|NCT02427958|560727828|FG000|Overall Study|Withdrawal by Subject|14|||
155353057|NCT02427958|560727828|FG000|Overall Study|Lack of Efficacy|1|||
155353058|NCT00578318|560727829|FG000|Overall Study|Lost to Follow-up|2|||
155353059|NCT00578318|560727830|FG001|Overall Study|Lost to Follow-up|0|||
155353060|NCT00578318|560727829|FG000|Overall Study|Physician Decision|1|||
155353061|NCT00578318|560727830|FG001|Overall Study|Physician Decision|0|||
155353062|NCT02025985|560727831|FG000|Overall Study|Consent withdrawn|0|||
155353063|NCT02025985|560727832|FG001|Overall Study|Consent withdrawn|0|||
155353064|NCT02025985|560727833|FG002|Overall Study|Consent withdrawn|1|||
155353065|NCT02025985|560727834|FG003|Overall Study|Consent withdrawn|0|||
155353066|NCT02025985|560727835|FG004|Overall Study|Consent withdrawn|0|||
155353067|NCT02025985|560727831|FG000|Overall Study|Termination of study by Sponsor|4|||
155353068|NCT02025985|560727832|FG001|Overall Study|Termination of study by Sponsor|3|||
155353069|NCT02025985|560727833|FG002|Overall Study|Termination of study by Sponsor|1|||
155353070|NCT02025985|560727834|FG003|Overall Study|Termination of study by Sponsor|1|||
155353071|NCT02025985|560727835|FG004|Overall Study|Termination of study by Sponsor|3|||
155353072|NCT02025985|560727831|FG000|Overall Study|Death|21|||
155353073|NCT02025985|560727832|FG001|Overall Study|Death|20|||
155353074|NCT02025985|560727833|FG002|Overall Study|Death|23|||
154964728|NCT02842853|559297503|FG003|Overall Study|Subject met exclusion criteria|0|||
154964729|NCT02842853|559297500|FG000|Overall Study|Withdrawal by Subject|11|||
154964730|NCT02842853|559297501|FG001|Overall Study|Withdrawal by Subject|13|||
155085835|NCT01272219|559745930|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
155085836|NCT01272219|559745925|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
155085837|NCT01272219|559745926|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
155085838|NCT01272219|559745927|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
155085839|NCT01272219|559745928|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
155085840|NCT01272219|559745929|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
155085841|NCT01272219|559745930|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
155085842|NCT01272219|559745925|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
155085843|NCT01272219|559745926|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
155085844|NCT01272219|559745927|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
155085845|NCT01272219|559745928|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
155085846|NCT01272219|559745929|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
155085847|NCT01272219|559745930|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
155085848|NCT01272219|559745925|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155085849|NCT01272219|559745926|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155085850|NCT01272219|559745927|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155085851|NCT01272219|559745928|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
155085852|NCT01272219|559745929|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155085853|NCT01272219|559745930|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
155085854|NCT01272219|559745925|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155085855|NCT01272219|559745926|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
155085856|NCT01272219|559745927|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155085857|NCT01272219|559745928|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
155085858|NCT01272219|559745929|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155085859|NCT01272219|559745930|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
155165687|NCT00714870|560043538|FG001|Overall Study|patient unable to come b/c back pain|0|||
155353075|NCT02025985|560727834|FG003|Overall Study|Death|20|||
155353076|NCT02025985|560727835|FG004|Overall Study|Death|17|||
155353077|NCT00920699|560727843|FG000|Overall Study|Withdrawal by Subject|2|||
154964731|NCT02842853|559297502|FG002|Overall Study|Withdrawal by Subject|9|||
155353078|NCT00920699|560727844|FG001|Overall Study|Withdrawal by Subject|0|||
155353079|NCT00920699|560727845|FG002|Overall Study|Withdrawal by Subject|2|||
155353080|NCT00920699|560727843|FG000|Overall Study|no longer met eligibility|0|||
155353081|NCT00920699|560727844|FG001|Overall Study|no longer met eligibility|1|||
155353082|NCT00920699|560727845|FG002|Overall Study|no longer met eligibility|0|||
155353083|NCT00920699|560727843|FG000|Overall Study|Lost to Follow-up|0|||
155353084|NCT00920699|560727844|FG001|Overall Study|Lost to Follow-up|0|||
155353085|NCT00920699|560727845|FG002|Overall Study|Lost to Follow-up|2|||
155353086|NCT02287883|560727847|FG000|Overall Study|Death|8|||
155353087|NCT02287883|560727848|FG001|Overall Study|Death|7|||
155353088|NCT02287883|560727847|FG000|Overall Study|No longer eligible|222|||
155353089|NCT02287883|560727848|FG001|Overall Study|No longer eligible|182|||
155353090|NCT02287883|560727847|FG000|Overall Study|Non-response to survey|229|||
155353091|NCT02287883|560727848|FG001|Overall Study|Non-response to survey|237|||
155353092|NCT02101268|560727854|FG000|Randomized Treatment Phase|Subject Decision|8|||
155353093|NCT02101268|560727855|FG001|Randomized Treatment Phase|Subject Decision|4|||
155353094|NCT02101268|560727856|FG002|Randomized Treatment Phase|Subject Decision|0|||
155353095|NCT02101268|560727857|FG003|Randomized Treatment Phase|Subject Decision|0|||
155353096|NCT02101268|560727854|FG000|Randomized Treatment Phase|Physician Decision|4|||
155353097|NCT02101268|560727855|FG001|Randomized Treatment Phase|Physician Decision|1|||
155353098|NCT02101268|560727856|FG002|Randomized Treatment Phase|Physician Decision|0|||
155353099|NCT02101268|560727857|FG003|Randomized Treatment Phase|Physician Decision|0|||
155353100|NCT02101268|560727854|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
155353101|NCT02101268|560727855|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
155353102|NCT02101268|560727856|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
155353103|NCT02101268|560727857|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
155353104|NCT02101268|560727854|FG000|Randomized Treatment Phase|Adverse Event|6|||
155353105|NCT02101268|560727855|FG001|Randomized Treatment Phase|Adverse Event|0|||
155353106|NCT02101268|560727856|FG002|Randomized Treatment Phase|Adverse Event|0|||
155353107|NCT02101268|560727857|FG003|Randomized Treatment Phase|Adverse Event|0|||
155353108|NCT02101268|560727854|FG000|Randomized Treatment Phase|Death|5|||
155353109|NCT02101268|560727855|FG001|Randomized Treatment Phase|Death|4|||
155353110|NCT02101268|560727856|FG002|Randomized Treatment Phase|Death|0|||
155353111|NCT02101268|560727857|FG003|Randomized Treatment Phase|Death|0|||
155353112|NCT02101268|560727854|FG000|Randomized Treatment Phase|Disease Progression|4|||
155353113|NCT02101268|560727855|FG001|Randomized Treatment Phase|Disease Progression|1|||
155353114|NCT02101268|560727856|FG002|Randomized Treatment Phase|Disease Progression|0|||
155353115|NCT02101268|560727857|FG003|Randomized Treatment Phase|Disease Progression|0|||
155353116|NCT02101268|560727854|FG000|Extended Treatment Phase|Subject Decision|0|||
155353117|NCT02101268|560727855|FG001|Extended Treatment Phase|Subject Decision|0|||
155353118|NCT02101268|560727856|FG002|Extended Treatment Phase|Subject Decision|3|||
155353119|NCT02101268|560727857|FG003|Extended Treatment Phase|Subject Decision|2|||
155353120|NCT02101268|560727854|FG000|Extended Treatment Phase|Physician Decision|0|||
155353121|NCT02101268|560727855|FG001|Extended Treatment Phase|Physician Decision|0|||
155353122|NCT02101268|560727856|FG002|Extended Treatment Phase|Physician Decision|5|||
155353123|NCT02101268|560727857|FG003|Extended Treatment Phase|Physician Decision|2|||
155353124|NCT02101268|560727854|FG000|Extended Treatment Phase|Adverse Event|0|||
155353125|NCT02101268|560727855|FG001|Extended Treatment Phase|Adverse Event|0|||
155353126|NCT02101268|560727856|FG002|Extended Treatment Phase|Adverse Event|14|||
155353127|NCT02101268|560727857|FG003|Extended Treatment Phase|Adverse Event|18|||
155353128|NCT02101268|560727854|FG000|Extended Treatment Phase|Death|0|||
155353129|NCT02101268|560727855|FG001|Extended Treatment Phase|Death|0|||
155353130|NCT02101268|560727856|FG002|Extended Treatment Phase|Death|5|||
155353131|NCT02101268|560727857|FG003|Extended Treatment Phase|Death|1|||
155353132|NCT02101268|560727854|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
155353133|NCT02101268|560727855|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
155353134|NCT02101268|560727856|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
155353135|NCT02101268|560727857|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
155353136|NCT02101268|560727854|FG000|Extended Treatment Phase|Disease Progression|0|||
155353137|NCT02101268|560727855|FG001|Extended Treatment Phase|Disease Progression|0|||
155353138|NCT02101268|560727856|FG002|Extended Treatment Phase|Disease Progression|13|||
155353139|NCT02101268|560727857|FG003|Extended Treatment Phase|Disease Progression|6|||
155353140|NCT02101268|560727854|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
155353141|NCT02101268|560727855|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
155353142|NCT02101268|560727856|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
155353143|NCT02101268|560727857|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
154964732|NCT02842853|559297503|FG003|Overall Study|Withdrawal by Subject|8|||
154964733|NCT02842853|559297500|FG000|Overall Study|Lost to Follow-up|9|||
154964734|NCT02842853|559297501|FG001|Overall Study|Lost to Follow-up|13|||
154964735|NCT02842853|559297502|FG002|Overall Study|Lost to Follow-up|10|||
154964736|NCT02842853|559297503|FG003|Overall Study|Lost to Follow-up|11|||
154964737|NCT04089553|559297504|FG000|Overall Study|Death|1|||
154964738|NCT04089553|559297505|FG001|Overall Study|Death|1|||
154964739|NCT04089553|559297504|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
154964740|NCT04089553|559297505|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
154964741|NCT04089553|559297504|FG000|Overall Study|Withdrawal by Subject|3|||
154964742|NCT04089553|559297505|FG001|Overall Study|Withdrawal by Subject|3|||
154964743|NCT04089553|559297504|FG000|Overall Study|Physician Decision|1|||
154964744|NCT04089553|559297505|FG001|Overall Study|Physician Decision|0|||
154964745|NCT04089553|559297504|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
154964746|NCT04089553|559297505|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
155085860|NCT01272219|559745925|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
155353144|NCT00576823|560727861|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
155353145|NCT00576823|560727862|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
155353146|NCT00576823|560727863|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
155353147|NCT00576823|560727861|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
155353148|NCT00576823|560727862|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
155353149|NCT00576823|560727863|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
155353150|NCT01242371|560727864|FG000|Overall Study|Withdrawal by Subject|2|||
155353151|NCT01242371|560727865|FG001|Overall Study|Withdrawal by Subject|2|||
155353152|NCT01242371|560727864|FG000|Overall Study|Protocol Violation|0|||
155353153|NCT01242371|560727865|FG001|Overall Study|Protocol Violation|3|||
155353154|NCT00510146|560727868|FG000|Double-Blind Treatment|Adverse Event|30|||
155353155|NCT00510146|560727869|FG001|Double-Blind Treatment|Adverse Event|13|||
155353156|NCT00510146|560727868|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
155085861|NCT01272219|559745926|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
155085862|NCT01272219|559745927|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
155085863|NCT01272219|559745928|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
155085864|NCT01272219|559745929|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
155085865|NCT01272219|559745930|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
155085866|NCT01272219|559745925|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
155085867|NCT01272219|559745926|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
155085868|NCT01272219|559745927|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
155085869|NCT01272219|559745928|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
155085870|NCT01272219|559745929|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
155085871|NCT01272219|559745930|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
155085872|NCT01272219|559745925|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
155085873|NCT01272219|559745926|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
155085874|NCT01272219|559745927|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
155085875|NCT01272219|559745928|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
155085876|NCT01272219|559745929|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
155085877|NCT01272219|559745930|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
155085878|NCT01272219|559745925|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155085879|NCT01272219|559745926|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155085880|NCT01272219|559745927|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155085881|NCT01272219|559745928|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
155085882|NCT01272219|559745929|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
155085883|NCT01272219|559745930|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
155085884|NCT01272219|559745925|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155085885|NCT01272219|559745926|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155085886|NCT01272219|559745927|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155085887|NCT01272219|559745928|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
155085888|NCT01272219|559745929|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
155085889|NCT01272219|559745930|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
155085890|NCT01272219|559745925|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155085891|NCT01272219|559745926|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155085892|NCT01272219|559745927|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155353157|NCT00510146|560727869|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
155353158|NCT00510146|560727868|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
155085893|NCT01272219|559745928|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
155353159|NCT00510146|560727869|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
155353160|NCT00510146|560727868|FG000|Double-Blind Treatment|Physician Decision|6|||
155353161|NCT00510146|560727869|FG001|Double-Blind Treatment|Physician Decision|0|||
155353162|NCT00510146|560727868|FG000|Double-Blind Treatment|Protocol Violation|1|||
154964747|NCT04089553|559297504|FG000|Overall Study|Other|1|||
155085894|NCT01272219|559745929|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
155085895|NCT01272219|559745930|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
155085896|NCT01272219|559745925|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
155085897|NCT01272219|559745926|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
155085898|NCT01272219|559745927|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
155085899|NCT01272219|559745928|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
155085900|NCT01272219|559745929|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
155085901|NCT01272219|559745930|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
155085902|NCT01272219|559745925|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
155085903|NCT01272219|559745926|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
155085904|NCT01272219|559745927|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
155085905|NCT01272219|559745928|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
155085906|NCT01272219|559745929|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
155085907|NCT01272219|559745930|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
155085908|NCT00967499|559745933|FG000|Overall Study|Adverse Event|0|||
155085909|NCT00967499|559745934|FG001|Overall Study|Adverse Event|1|||
155085910|NCT00967499|559745933|FG000|Overall Study|Protocol Violation|1|||
155085911|NCT00967499|559745934|FG001|Overall Study|Protocol Violation|0|||
155085912|NCT00967499|559745933|FG000|Overall Study|Sponsor Decision|1|||
155085913|NCT00967499|559745934|FG001|Overall Study|Sponsor Decision|0|||
155085914|NCT00967499|559745933|FG000|Overall Study|Randomized but not treated|63|||
155085915|NCT00967499|559745934|FG001|Overall Study|Randomized but not treated|59|||
155085916|NCT04439903|559745937|FG000|Overall Study|Withdrawal by Subject|2|||
155085917|NCT04439903|559745937|FG000|Overall Study|Screen Failure|1|||
155085918|NCT02181413|559745946|FG000|Overall Study|Withdrawal by Subject|45|||
155085919|NCT02181413|559745947|FG001|Overall Study|Withdrawal by Subject|61|||
155085920|NCT02181413|559745946|FG000|Overall Study|Reason Not Specified|2|||
155085921|NCT02181413|559745947|FG001|Overall Study|Reason Not Specified|5|||
155085922|NCT02181413|559745946|FG000|Overall Study|Lost to Follow-up|8|||
155085923|NCT02181413|559745947|FG001|Overall Study|Lost to Follow-up|7|||
155085924|NCT04806373|559745950|FG000|Overall Study|Withdrawal by Subject|1|||
155085925|NCT04806373|559745951|FG001|Overall Study|Withdrawal by Subject|1|||
155085926|NCT05810597|559745952|FG000|Period 1|Adverse Event|2|||
155085927|NCT05810597|559745953|FG001|Period 1|Adverse Event|0|||
155085928|NCT05810597|559745952|FG000|Period 1|Physician Decision|1|||
155085929|NCT05810597|559745953|FG001|Period 1|Physician Decision|0|||
155085930|NCT01450631|559745954|FG000|Overall Study|Lost to Follow-up|2|||
155085931|NCT01450631|559745955|FG001|Overall Study|Lost to Follow-up|4|||
155085932|NCT01450631|559745954|FG000|Overall Study|Withdrawal by Subject|1|||
155085933|NCT01450631|559745955|FG001|Overall Study|Withdrawal by Subject|0|||
155085934|NCT03249558|559745964|FG000|Overall Study|Lost to Follow-up|2|||
155085935|NCT03249558|559745965|FG001|Overall Study|Lost to Follow-up|1|||
155085936|NCT03249558|559745966|FG002|Overall Study|Lost to Follow-up|4|||
155085937|NCT03249558|559745964|FG000|Overall Study|Physician Decision|1|||
155085938|NCT03249558|559745965|FG001|Overall Study|Physician Decision|0|||
155085939|NCT03249558|559745966|FG002|Overall Study|Physician Decision|0|||
155085940|NCT03249558|559745964|FG000|Overall Study|Withdrawal by Subject|6|||
155085941|NCT03249558|559745965|FG001|Overall Study|Withdrawal by Subject|5|||
155085942|NCT03249558|559745966|FG002|Overall Study|Withdrawal by Subject|7|||
155085943|NCT03249558|559745964|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
155085944|NCT03249558|559745965|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
155085945|NCT03249558|559745966|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
155165688|NCT00714870|560043537|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
155165689|NCT00714870|560043538|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
155165690|NCT02721966|560043539|FG000|Overall Study|Protocol Violation|1|||
155165691|NCT02721966|560043540|FG001|Overall Study|Protocol Violation|0|||
155165692|NCT02721966|560043541|FG002|Overall Study|Protocol Violation|0|||
155165693|NCT02721966|560043542|FG003|Overall Study|Protocol Violation|0|||
155165694|NCT02721966|560043543|FG004|Overall Study|Protocol Violation|0|||
155085946|NCT03249558|559745964|FG000|Overall Study|Protocol Violation|1|||
155085947|NCT03249558|559745965|FG001|Overall Study|Protocol Violation|1|||
155085948|NCT03249558|559745966|FG002|Overall Study|Protocol Violation|2|||
155085949|NCT02657356|559747558|FG000|Overall Study|Death|1|||
155085950|NCT02657356|559747559|FG001|Overall Study|Death|0|||
155085951|NCT02657356|559747558|FG000|Overall Study|Withdrawal by Subject|5|||
155085952|NCT02657356|559747559|FG001|Overall Study|Withdrawal by Subject|6|||
155085953|NCT02657356|559747558|FG000|Overall Study|Terminated by Sponsor|8|||
155085954|NCT02657356|559747559|FG001|Overall Study|Terminated by Sponsor|5|||
155085955|NCT02657356|559747558|FG000|Overall Study|Rolled over to EAP study|6|||
155085956|NCT02657356|559747559|FG001|Overall Study|Rolled over to EAP study|4|||
155165695|NCT02721966|560043539|FG000|Overall Study|Withdrawal by Subject|9|||
155085957|NCT03379870|559747560|FG000|Overall Study|Lost to Follow-up|1|||
155085958|NCT03379870|559747561|FG001|Overall Study|Lost to Follow-up|0|||
155353163|NCT00510146|560727869|FG001|Double-Blind Treatment|Protocol Violation|2|||
155085959|NCT03379870|559747560|FG000|Overall Study|Protocol Violation|1|||
155165696|NCT02721966|560043540|FG001|Overall Study|Withdrawal by Subject|2|||
155353164|NCT00510146|560727868|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
155353165|NCT00510146|560727869|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
155353166|NCT00510146|560727868|FG000|Double-Blind Treatment|Clinical Relapse|0|||
155353167|NCT00510146|560727869|FG001|Double-Blind Treatment|Clinical Relapse|1|||
155353168|NCT00510146|560727868|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
155353169|NCT00510146|560727869|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
155353170|NCT00510146|560727868|FG000|Open-Label Treatment|Adverse Event|22|||
155353171|NCT00510146|560727869|FG001|Open-Label Treatment|Adverse Event|8|||
155353172|NCT00510146|560727868|FG000|Open-Label Treatment|Death|1|||
155353173|NCT00510146|560727869|FG001|Open-Label Treatment|Death|1|||
155353174|NCT00510146|560727868|FG000|Open-Label Treatment|Lack of Efficacy|4|||
155353175|NCT00510146|560727869|FG001|Open-Label Treatment|Lack of Efficacy|0|||
155353176|NCT00510146|560727868|FG000|Open-Label Treatment|Lost to Follow-up|10|||
155353177|NCT00510146|560727869|FG001|Open-Label Treatment|Lost to Follow-up|1|||
155353178|NCT00510146|560727868|FG000|Open-Label Treatment|Physician Decision|3|||
155353179|NCT00510146|560727869|FG001|Open-Label Treatment|Physician Decision|1|||
155353180|NCT00510146|560727868|FG000|Open-Label Treatment|Protocol Violation|4|||
155353181|NCT00510146|560727869|FG001|Open-Label Treatment|Protocol Violation|2|||
155353182|NCT00510146|560727868|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
155353183|NCT00510146|560727869|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
155353184|NCT00510146|560727868|FG000|Open-Label Treatment|Clinical Relapse|1|||
155353185|NCT00510146|560727869|FG001|Open-Label Treatment|Clinical Relapse|1|||
155353186|NCT00510146|560727868|FG000|Open-Label Treatment|Sponsor Decision|2|||
155353187|NCT00510146|560727869|FG001|Open-Label Treatment|Sponsor Decision|0|||
155353188|NCT02132117|560727870|FG000|Overall Study|Adverse Event|6|||
155353189|NCT02132117|560727871|FG001|Overall Study|Adverse Event|1|||
155353190|NCT02132117|560727870|FG000|Overall Study|Lost to Follow-up|2|||
154964748|NCT04089553|559297505|FG001|Overall Study|Other|0|||
155353191|NCT02132117|560727871|FG001|Overall Study|Lost to Follow-up|2|||
155353192|NCT02132117|560727870|FG000|Overall Study|Personal Reasons|1|||
155353193|NCT02132117|560727871|FG001|Overall Study|Personal Reasons|2|||
155353194|NCT02132117|560727870|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155353195|NCT02132117|560727871|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155353196|NCT03589300|560727873|FG000|Overall Study|Adverse Event|2|||
155085960|NCT03379870|559747561|FG001|Overall Study|Protocol Violation|1|||
155085961|NCT03058952|559747562|FG000|Overall Study|Adverse Event|1|||
155085962|NCT03058952|559747563|FG001|Overall Study|Adverse Event|0|||
155353197|NCT03589300|560727873|FG000|Overall Study|Death|4|||
155353198|NCT03589300|560727873|FG000|Overall Study|Lost to Follow-up|12|||
155353199|NCT03589300|560727873|FG000|Overall Study|Withdrawal by Subject|5|||
155353200|NCT04947436|560727874|FG000|Overall Study|Lost to Follow-up|3|||
155353201|NCT04947436|560727875|FG001|Overall Study|Lost to Follow-up|7|||
155353202|NCT04947436|560727876|FG002|Overall Study|Lost to Follow-up|5|||
155353203|NCT04947436|560727874|FG000|Overall Study|Death|1|||
155353204|NCT04947436|560727875|FG001|Overall Study|Death|1|||
155353205|NCT04947436|560727876|FG002|Overall Study|Death|1|||
155353206|NCT02551692|560727879|FG000|Overall Study|Lost to Follow-up|0|||
155353207|NCT02551692|560727880|FG001|Overall Study|Lost to Follow-up|1|||
155353208|NCT02551692|560727881|FG002|Overall Study|Lost to Follow-up|4|||
155353209|NCT02551692|560727879|FG000|Overall Study|Withdrawal by Subject|1|||
155353210|NCT02551692|560727880|FG001|Overall Study|Withdrawal by Subject|0|||
155353211|NCT02551692|560727881|FG002|Overall Study|Withdrawal by Subject|1|||
155353212|NCT01196741|560727882|FG000|Overall Study|Disease progression|34|||
155353213|NCT01196741|560727883|FG001|Overall Study|Disease progression|14|||
155353214|NCT01196741|560727882|FG000|Overall Study|Adverse Event|10|||
155353215|NCT01196741|560727883|FG001|Overall Study|Adverse Event|6|||
155353216|NCT01196741|560727882|FG000|Overall Study|Serious Adverse Event|3|||
155353217|NCT01196741|560727883|FG001|Overall Study|Serious Adverse Event|1|||
155353218|NCT01196741|560727882|FG000|Overall Study|Dose limiting Adverse Event|2|||
155353219|NCT01196741|560727883|FG001|Overall Study|Dose limiting Adverse Event|1|||
155353220|NCT01196741|560727882|FG000|Overall Study|Withdrawal by Subject|3|||
155353221|NCT01196741|560727883|FG001|Overall Study|Withdrawal by Subject|0|||
155353222|NCT01196741|560727882|FG000|Overall Study|Other reason|3|||
155353223|NCT01196741|560727883|FG001|Overall Study|Other reason|3|||
155353224|NCT01196741|560727882|FG000|Overall Study|Other|3|||
155353225|NCT01196741|560727883|FG001|Overall Study|Other|2|||
155353226|NCT01196741|560727882|FG000|Overall Study|Protocol Violation|2|||
155353227|NCT01196741|560727883|FG001|Overall Study|Protocol Violation|1|||
155353228|NCT04582864|560727884|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
155353229|NCT04582864|560727884|FG000|Overall Study|Death|1|||
155353230|NCT03640754|560727885|FG000|Overall Study|Withdrawal by Subject|1|||
155353231|NCT03640754|560727886|FG001|Overall Study|Withdrawal by Subject|0|||
155353232|NCT03640754|560727885|FG000|Overall Study|Lost to Follow-up|0|||
155353233|NCT03640754|560727886|FG001|Overall Study|Lost to Follow-up|1|||
155353234|NCT01679613|560727889|FG000|Overall Study|other than stated above|0|||
155353235|NCT01679613|560727890|FG001|Overall Study|other than stated above|1|||
155353236|NCT01679613|560727891|FG002|Overall Study|other than stated above|2|||
155353237|NCT01679613|560727892|FG003|Overall Study|other than stated above|2|||
155085963|NCT03058952|559747562|FG000|Overall Study|Lost to Follow-up|15|||
155353238|NCT01932762|560729558|FG000|Overall Study|Withdrawal by Subject|1|||
155353239|NCT01932762|560729559|FG001|Overall Study|Withdrawal by Subject|2|||
155353240|NCT01932762|560729560|FG002|Overall Study|Withdrawal by Subject|0|||
155353241|NCT01932762|560729561|FG003|Overall Study|Withdrawal by Subject|0|||
155353242|NCT01932762|560729558|FG000|Overall Study|Lost to Follow-up|4|||
155353243|NCT01932762|560729559|FG001|Overall Study|Lost to Follow-up|0|||
155353244|NCT01932762|560729560|FG002|Overall Study|Lost to Follow-up|0|||
155353245|NCT01932762|560729561|FG003|Overall Study|Lost to Follow-up|1|||
155353246|NCT01932762|560729558|FG000|Overall Study|Physician Decision|1|||
155353247|NCT01932762|560729559|FG001|Overall Study|Physician Decision|0|||
155353248|NCT01932762|560729560|FG002|Overall Study|Physician Decision|0|||
155353249|NCT01932762|560729561|FG003|Overall Study|Physician Decision|0|||
155353250|NCT02210208|560729562|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
155353251|NCT02210208|560729562|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
154964749|NCT04089553|559297504|FG000|Overall Study|Adverse Event|1|||
154964750|NCT04089553|559297505|FG001|Overall Study|Adverse Event|1|||
154964751|NCT01403194|559297513|FG000|Overall Study|Screen Failure|2|||
154964752|NCT01403194|559297513|FG000|Overall Study|Lost to Follow-up|8|||
154964753|NCT01175135|559297516|FG000|Overall Study|Adverse Event|2|||
154964754|NCT01175135|559297517|FG001|Overall Study|Adverse Event|5|||
154964755|NCT01175135|559297518|FG002|Overall Study|Adverse Event|3|||
154964756|NCT01175135|559297519|FG003|Overall Study|Adverse Event|4|||
154964757|NCT01175135|559297516|FG000|Overall Study|Death|1|||
154964758|NCT01175135|559297517|FG001|Overall Study|Death|0|||
154964759|NCT01175135|559297518|FG002|Overall Study|Death|0|||
154964760|NCT01175135|559297519|FG003|Overall Study|Death|0|||
154964761|NCT01175135|559297516|FG000|Overall Study|Lack of Efficacy|4|||
154964762|NCT01175135|559297517|FG001|Overall Study|Lack of Efficacy|5|||
154964763|NCT01175135|559297518|FG002|Overall Study|Lack of Efficacy|0|||
154964764|NCT01175135|559297519|FG003|Overall Study|Lack of Efficacy|5|||
154964765|NCT01175135|559297516|FG000|Overall Study|Lost to Follow-up|1|||
154964766|NCT01175135|559297517|FG001|Overall Study|Lost to Follow-up|2|||
154964767|NCT01175135|559297518|FG002|Overall Study|Lost to Follow-up|0|||
154964768|NCT01175135|559297519|FG003|Overall Study|Lost to Follow-up|0|||
154964769|NCT01175135|559297516|FG000|Overall Study|Protocol Violation|1|||
154964770|NCT01175135|559297517|FG001|Overall Study|Protocol Violation|1|||
154964771|NCT01175135|559297518|FG002|Overall Study|Protocol Violation|0|||
154964772|NCT01175135|559297519|FG003|Overall Study|Protocol Violation|0|||
154964773|NCT01175135|559297516|FG000|Overall Study|Withdrawal by Subject|4|||
154964774|NCT01175135|559297517|FG001|Overall Study|Withdrawal by Subject|8|||
154964775|NCT01175135|559297518|FG002|Overall Study|Withdrawal by Subject|5|||
154964776|NCT01175135|559297519|FG003|Overall Study|Withdrawal by Subject|5|||
154964777|NCT01175135|559297516|FG000|Overall Study|Other|3|||
154964778|NCT01175135|559297517|FG001|Overall Study|Other|1|||
154964779|NCT01175135|559297518|FG002|Overall Study|Other|3|||
154964780|NCT01175135|559297519|FG003|Overall Study|Other|0|||
154964781|NCT01175135|559297516|FG000|Overall Study|Randomized But Not Treated|0|||
154964782|NCT01175135|559297517|FG001|Overall Study|Randomized But Not Treated|0|||
154964783|NCT01175135|559297518|FG002|Overall Study|Randomized But Not Treated|1|||
154964784|NCT01175135|559297519|FG003|Overall Study|Randomized But Not Treated|0|||
154964785|NCT03428750|559297520|FG000|Overall Study|Withdrawal by Subject|11|||
154964786|NCT03428750|559297521|FG001|Overall Study|Withdrawal by Subject|10|||
154964787|NCT03428750|559297520|FG000|Overall Study|Lost to Follow-up|3|||
154964788|NCT03428750|559297521|FG001|Overall Study|Lost to Follow-up|9|||
154964789|NCT03428750|559297520|FG000|Overall Study|Adverse Event|9|||
154964790|NCT03428750|559297521|FG001|Overall Study|Adverse Event|1|||
154964791|NCT03428750|559297520|FG000|Overall Study|Protocol Violation|1|||
154964792|NCT03428750|559297521|FG001|Overall Study|Protocol Violation|0|||
154964793|NCT03428750|559297520|FG000|Overall Study|Administrative|0|||
154964794|NCT03428750|559297521|FG001|Overall Study|Administrative|1|||
155353252|NCT02210208|560729562|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
155353253|NCT00695136|560729563|FG000|Overall Study|Withdrawal by Subject|1|||
155353254|NCT00695136|560729563|FG000|Overall Study|unrelated adverse event|1|||
154964795|NCT03364192|559297522|FG000|Overall Study|Ineligible|10|||
154964796|NCT03364192|559297522|FG000|Overall Study|Withdrawal by Subject|5|||
155353255|NCT01726049|560729565|FG000|Overall Study|Death|1|||
154964797|NCT03364192|559297522|FG000|Overall Study|Lost to Follow-up|1|||
154964798|NCT00274651|559297527|FG000|Overall Study|Adverse Event|6|||
154964799|NCT00274651|559297528|FG001|Overall Study|Adverse Event|3|||
154964800|NCT00274651|559297527|FG000|Overall Study|Lack of Efficacy|13|||
155353256|NCT01726049|560729566|FG001|Overall Study|Death|1|||
155353257|NCT01726049|560729565|FG000|Overall Study|Adverse Event|4|||
155353258|NCT01726049|560729566|FG001|Overall Study|Adverse Event|1|||
154964801|NCT00274651|559297528|FG001|Overall Study|Lack of Efficacy|6|||
154964802|NCT00274651|559297527|FG000|Overall Study|Death|1|||
154964803|NCT00274651|559297528|FG001|Overall Study|Death|3|||
154964804|NCT00274651|559297527|FG000|Overall Study|Withdrawal by Subject|0|||
154964805|NCT00274651|559297528|FG001|Overall Study|Withdrawal by Subject|1|||
154964806|NCT00274651|559297527|FG000|Overall Study|Physician Decision|8|||
154964807|NCT00274651|559297528|FG001|Overall Study|Physician Decision|7|||
155085964|NCT03058952|559747563|FG001|Overall Study|Lost to Follow-up|15|||
155085965|NCT03058952|559747562|FG000|Overall Study|Withdrawal by Subject|7|||
155353259|NCT01726049|560729565|FG000|Overall Study|refused second HC|0|||
155353260|NCT01726049|560729566|FG001|Overall Study|refused second HC|2|||
155353261|NCT01333111|560729569|FG000|Overall Study|patient undergoing major surgery|0|||
155353262|NCT01333111|560729570|FG001|Overall Study|patient undergoing major surgery|2|||
155353263|NCT01333111|560729571|FG002|Overall Study|patient undergoing major surgery|0|||
155353264|NCT01333111|560729569|FG000|Overall Study|personal reasons|0|||
155353265|NCT01333111|560729570|FG001|Overall Study|personal reasons|0|||
155353266|NCT01333111|560729571|FG002|Overall Study|personal reasons|1|||
155353267|NCT01333111|560729569|FG000|Overall Study|unclassified|1|||
155353268|NCT01333111|560729570|FG001|Overall Study|unclassified|0|||
155353269|NCT01333111|560729571|FG002|Overall Study|unclassified|0|||
155353270|NCT01333111|560729569|FG000|Overall Study|withdrawal criteria|0|||
155353271|NCT01333111|560729570|FG001|Overall Study|withdrawal criteria|1|||
155353272|NCT01333111|560729571|FG002|Overall Study|withdrawal criteria|0|||
155353273|NCT01333111|560729569|FG000|Overall Study|Non-compliance|1|||
155353274|NCT01333111|560729570|FG001|Overall Study|Non-compliance|0|||
155353275|NCT01333111|560729571|FG002|Overall Study|Non-compliance|0|||
155353276|NCT01333111|560729569|FG000|Overall Study|Ineffective therapy|0|||
155353277|NCT01333111|560729570|FG001|Overall Study|Ineffective therapy|0|||
155353278|NCT01333111|560729571|FG002|Overall Study|Ineffective therapy|1|||
155353279|NCT02161406|560729572|FG000|Overall Study|Death|2|||
155353280|NCT02161406|560729573|FG001|Overall Study|Death|1|||
155353281|NCT02161406|560729572|FG000|Overall Study|Lost to Follow-up|2|||
155353282|NCT02161406|560729573|FG001|Overall Study|Lost to Follow-up|1|||
155353283|NCT02161406|560729572|FG000|Overall Study|Withdrawal by Subject|2|||
155353284|NCT02161406|560729573|FG001|Overall Study|Withdrawal by Subject|4|||
155353285|NCT02161406|560729572|FG000|Overall Study|investigator withdrew subject|3|||
155353286|NCT02161406|560729573|FG001|Overall Study|investigator withdrew subject|1|||
155353287|NCT02161406|560729572|FG000|Overall Study|Lack of Efficacy|1|||
155353288|NCT02161406|560729573|FG001|Overall Study|Lack of Efficacy|1|||
155353289|NCT02161406|560729572|FG000|Overall Study|relocation|0|||
155353290|NCT02161406|560729573|FG001|Overall Study|relocation|1|||
155353291|NCT00664105|560729574|FG000|Overall Study|Death|3|||
155353292|NCT00664105|560729574|FG000|Overall Study|Withdrawal by Subject|5|||
155353293|NCT00664105|560729574|FG000|Overall Study|Adverse Event|9|||
155353294|NCT00664105|560729574|FG000|Overall Study|Disease progression|7|||
155353295|NCT00847132|560729578|FG000|Overall Study|Death|1|||
155353296|NCT00847132|560729579|FG001|Overall Study|Death|1|||
155353297|NCT01057251|560729580|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
155353298|NCT01057251|560729581|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
155353299|NCT01057251|560729580|FG000|Overall Study|Adverse Event|4|||
155353300|NCT01057251|560729581|FG001|Overall Study|Adverse Event|2|||
155353301|NCT01057251|560729580|FG000|Overall Study|Lack of Efficacy|2|||
155353302|NCT01057251|560729581|FG001|Overall Study|Lack of Efficacy|11|||
155353303|NCT01057251|560729580|FG000|Overall Study|Protocol Violation|6|||
155085966|NCT03058952|559747563|FG001|Overall Study|Withdrawal by Subject|11|||
155085967|NCT03768336|559747566|FG000|Overall Study|Lost to Follow-up|3|||
155085968|NCT03768336|559747567|FG001|Overall Study|Lost to Follow-up|2|||
155085969|NCT03768336|559747566|FG000|Overall Study|Became Ineligible|2|||
155085970|NCT03768336|559747567|FG001|Overall Study|Became Ineligible|0|||
155085971|NCT03768336|559747566|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
155085972|NCT03768336|559747567|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
155085973|NCT03768336|559747566|FG000|Overall Study|Missed final survey (post-treatment|0|||
155085974|NCT03768336|559747567|FG001|Overall Study|Missed final survey (post-treatment|1|||
155085975|NCT05654181|559747568|FG000|Overall Study|Adverse Event|1|||
155085976|NCT05654181|559747569|FG001|Overall Study|Adverse Event|0|||
155085977|NCT05654181|559747570|FG002|Overall Study|Adverse Event|0|||
155085978|NCT05654181|559747571|FG003|Overall Study|Adverse Event|0|||
155085979|NCT05654181|559747572|FG004|Overall Study|Adverse Event|0|||
155085980|NCT05654181|559747573|FG005|Overall Study|Adverse Event|0|||
155085981|NCT05654181|559747574|FG006|Overall Study|Adverse Event|0|||
155085982|NCT05654181|559747575|FG007|Overall Study|Adverse Event|1|||
155165697|NCT02721966|560043541|FG002|Overall Study|Withdrawal by Subject|3|||
155353304|NCT01057251|560729581|FG001|Overall Study|Protocol Violation|2|||
155353305|NCT01057251|560729580|FG000|Overall Study|Withdrawal by Subject|4|||
155353306|NCT01057251|560729581|FG001|Overall Study|Withdrawal by Subject|5|||
155353307|NCT01057251|560729580|FG000|Overall Study|Lost to Follow-up|7|||
155353308|NCT01057251|560729581|FG001|Overall Study|Lost to Follow-up|6|||
155353309|NCT01057251|560729580|FG000|Overall Study|Other Reason|1|||
155353310|NCT01057251|560729581|FG001|Overall Study|Other Reason|1|||
155085983|NCT05654181|559747576|FG008|Overall Study|Adverse Event|0|||
155353311|NCT00784147|560729582|FG000|Overall Study|Lost to Follow-up|2|||
155353312|NCT00784147|560729583|FG001|Overall Study|Lost to Follow-up|4|||
155353313|NCT00784147|560729582|FG000|Overall Study|Withdrawal by Subject|1|||
155353314|NCT00784147|560729583|FG001|Overall Study|Withdrawal by Subject|3|||
155353315|NCT00784147|560729582|FG000|Overall Study|Physician Decision|2|||
155353316|NCT00784147|560729583|FG001|Overall Study|Physician Decision|1|||
155353317|NCT00784147|560729582|FG000|Overall Study|Protocol Violation|1|||
155353318|NCT00784147|560729583|FG001|Overall Study|Protocol Violation|1|||
155353319|NCT00784147|560729582|FG000|Overall Study|Death|2|||
155353320|NCT00784147|560729583|FG001|Overall Study|Death|0|||
155353321|NCT03596242|560729584|FG000|Overall Study|Lost to Follow-up|2|||
155353322|NCT03596242|560729585|FG001|Overall Study|Lost to Follow-up|2|||
155353323|NCT02973802|560729591|FG000|Overall Study|Lost to Follow-up|1|||
155353324|NCT02973802|560729591|FG000|Overall Study|Withdrawal by Subject|1|||
155353325|NCT03357471|560729592|FG000|Overall Study|Adverse Event|1|||
155353326|NCT03357471|560729593|FG001|Overall Study|Adverse Event|0|||
155353327|NCT03357471|560729592|FG000|Overall Study|Lost to Follow-up|1|||
155353328|NCT03357471|560729593|FG001|Overall Study|Lost to Follow-up|0|||
155353329|NCT01202409|560729594|FG000|Overall Study|Adverse Event|1|||
155353330|NCT01202409|560729594|FG000|Overall Study|Ineligible - KRAS mutants|7|||
155353331|NCT00292981|560729599|FG000|Overall Study|Adverse Event|1|||
155353332|NCT00292981|560729599|FG000|Overall Study|Lost to Follow-up|13|||
155353333|NCT00292981|560729599|FG000|Overall Study|Withdrawal by Subject|22|||
155353334|NCT00292981|560729599|FG000|Overall Study|Other|3|||
155353335|NCT01085812|560729600|FG000|Open-Label Period|Adverse Event|0|||
155353336|NCT01085812|560729601|FG001|Open-Label Period|Adverse Event|80|||
155353337|NCT01085812|560729600|FG000|Open-Label Period|Lack of Efficacy|0|||
155353338|NCT01085812|560729601|FG001|Open-Label Period|Lack of Efficacy|26|||
155353339|NCT01085812|560729600|FG000|Open-Label Period|Protocol Violation|0|||
155353340|NCT01085812|560729601|FG001|Open-Label Period|Protocol Violation|39|||
155353341|NCT01085812|560729600|FG000|Open-Label Period|Withdrawal by Subject|0|||
155353342|NCT01085812|560729601|FG001|Open-Label Period|Withdrawal by Subject|53|||
155353343|NCT01085812|560729600|FG000|Open-Label Period|Lost to Follow-up|0|||
155353344|NCT01085812|560729601|FG001|Open-Label Period|Lost to Follow-up|42|||
155353345|NCT01085812|560729600|FG000|Double-Blind Period|Adverse Event|3|||
155353346|NCT01085812|560729601|FG001|Double-Blind Period|Adverse Event|8|||
155353347|NCT01085812|560729600|FG000|Double-Blind Period|Protocol Violation|2|||
155353348|NCT01085812|560729601|FG001|Double-Blind Period|Protocol Violation|7|||
155353349|NCT01085812|560729600|FG000|Double-Blind Period|Withdrawal by Subject|11|||
155353350|NCT01085812|560729601|FG001|Double-Blind Period|Withdrawal by Subject|24|||
155353351|NCT01085812|560729600|FG000|Double-Blind Period|Lost to Follow-up|5|||
155353352|NCT01085812|560729601|FG001|Double-Blind Period|Lost to Follow-up|17|||
155353353|NCT01085812|560729600|FG000|Double-Blind Period|Other Reasons|0|||
155353354|NCT01085812|560729601|FG001|Double-Blind Period|Other Reasons|2|||
155353355|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
155353356|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
155353357|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
155353358|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
155353359|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
155353360|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
155353361|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
155353362|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
155353363|NCT01085812|560729600|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
155353364|NCT01085812|560729601|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
155353365|NCT00594178|560729604|FG000|Overall Study|Physician Decision|5|||
155353366|NCT04582669|560729607|FG000|Overall Study|Subject missed appointment(s).|1|||
155353367|NCT04582669|560729608|FG001|Overall Study|Subject missed appointment(s).|0|||
155353368|NCT04582669|560729609|FG002|Overall Study|Subject missed appointment(s).|1|||
155353369|NCT04582669|560729610|FG003|Overall Study|Subject missed appointment(s).|2|||
155353370|NCT04582669|560729607|FG000|Overall Study|Protocol Violation|0|||
155353371|NCT04582669|560729608|FG001|Overall Study|Protocol Violation|1|||
155353372|NCT04582669|560729609|FG002|Overall Study|Protocol Violation|1|||
155085984|NCT05654181|559747577|FG009|Overall Study|Adverse Event|0|||
155085985|NCT05654181|559747568|FG000|Overall Study|Withdrawal by Subject|0|||
155085986|NCT05654181|559747569|FG001|Overall Study|Withdrawal by Subject|0|||
155085987|NCT05654181|559747570|FG002|Overall Study|Withdrawal by Subject|0|||
155353373|NCT04582669|560729610|FG003|Overall Study|Protocol Violation|0|||
155353374|NCT01274559|560729611|FG000|Overall Study|Adverse Event|57|||
155353375|NCT01274559|560729612|FG001|Overall Study|Adverse Event|13|||
155353376|NCT01274559|560729611|FG000|Overall Study|Death|1|||
155353377|NCT01274559|560729612|FG001|Overall Study|Death|1|||
155353378|NCT01274559|560729611|FG000|Overall Study|Lost to Follow-up|3|||
155353379|NCT01274559|560729612|FG001|Overall Study|Lost to Follow-up|3|||
154964808|NCT05133180|559297529|FG000|Overall Study|Withdrawal of consent|1|||
154964809|NCT05133180|559297530|FG001|Overall Study|Withdrawal of consent|1|||
154964810|NCT05133180|559297529|FG000|Overall Study|Lost to Follow-up|1|||
154964811|NCT05133180|559297530|FG001|Overall Study|Lost to Follow-up|1|||
154964812|NCT05133180|559297529|FG000|Overall Study|Documented disease progression|0|||
154964813|NCT05133180|559297530|FG001|Overall Study|Documented disease progression|1|||
154964814|NCT02488239|559297535|FG000|Overall Study|Death|3|||
154964815|NCT02488239|559297535|FG000|Overall Study|Withdrawal by Subject|3|||
154964816|NCT02488239|559297535|FG000|Overall Study|Physician Decision|2|||
154964817|NCT02488239|559297535|FG000|Overall Study|Consent ineligible|1|||
154964818|NCT02488239|559297535|FG000|Overall Study|Did not undergo implant procedure|1|||
154964819|NCT03325881|559297539|FG000|Overall Study|Protocol Violation|0|||
154964820|NCT03325881|559297540|FG001|Overall Study|Protocol Violation|1|||
154964821|NCT03325881|559297539|FG000|Overall Study|Withdrawal by Subject|0|||
154964822|NCT03325881|559297540|FG001|Overall Study|Withdrawal by Subject|2|||
154964823|NCT03325881|559297539|FG000|Overall Study|Lack of Efficacy|2|||
154964824|NCT03325881|559297540|FG001|Overall Study|Lack of Efficacy|0|||
155165698|NCT02721966|560043542|FG003|Overall Study|Withdrawal by Subject|7|||
155165699|NCT02721966|560043543|FG004|Overall Study|Withdrawal by Subject|0|||
155353380|NCT01274559|560729611|FG000|Overall Study|Non-compliance with Study Drug|2|||
155353381|NCT01274559|560729612|FG001|Overall Study|Non-compliance with Study Drug|4|||
155353382|NCT01274559|560729611|FG000|Overall Study|Physician Decision|2|||
155353383|NCT01274559|560729612|FG001|Overall Study|Physician Decision|1|||
155353384|NCT01274559|560729611|FG000|Overall Study|Protocol Violation|28|||
155353385|NCT01274559|560729612|FG001|Overall Study|Protocol Violation|23|||
155353386|NCT01274559|560729611|FG000|Overall Study|Study Terminated by Sponsor|79|||
155353387|NCT01274559|560729612|FG001|Overall Study|Study Terminated by Sponsor|87|||
155353388|NCT01274559|560729611|FG000|Overall Study|Withdrawal by Subject|25|||
155353389|NCT01274559|560729612|FG001|Overall Study|Withdrawal by Subject|13|||
155353390|NCT01167192|560729615|FG000|Overall Study|Adverse Event|1|||
155353391|NCT01167192|560729615|FG000|Overall Study|Death|1|||
155353392|NCT01167192|560729615|FG000|Overall Study|Withdrawal by Subject|1|||
155353393|NCT01167192|560729615|FG000|Overall Study|Insurance denial|1|||
155353394|NCT02482935|560729629|FG000|Period 1|Withdrawal by Subject|1|||
155353395|NCT02482935|560729630|FG001|Period 1|Withdrawal by Subject|0|||
155353396|NCT03503162|560729631|FG000|Overall Study|did not meet eligibility|1|||
155353397|NCT02835092|560729632|FG000|Overall Study|Withdrawal by Subject|3|||
155353398|NCT02835092|560729633|FG001|Overall Study|Withdrawal by Subject|6|||
155353399|NCT02835092|560729634|FG002|Overall Study|Withdrawal by Subject|3|||
155353400|NCT02835092|560729632|FG000|Overall Study|Lost to Follow-up|0|||
155353401|NCT02835092|560729633|FG001|Overall Study|Lost to Follow-up|2|||
155353402|NCT02835092|560729634|FG002|Overall Study|Lost to Follow-up|0|||
155353403|NCT02246218|560729635|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155353404|NCT02246218|560729636|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155353405|NCT02246218|560729635|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
155353406|NCT02246218|560729636|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
155353407|NCT02246218|560729635|FG000|Overall Study|Adverse Event|1|||
155353408|NCT02246218|560729636|FG001|Overall Study|Adverse Event|1|||
155353409|NCT02246218|560729635|FG000|Overall Study|Lost to Follow-up|1|||
155353410|NCT02246218|560729636|FG001|Overall Study|Lost to Follow-up|0|||
155353411|NCT01321723|560729637|FG000|Overall Study|Adverse Event|3|||
155353412|NCT01321723|560729638|FG001|Overall Study|Adverse Event|5|||
155165700|NCT02721966|560043539|FG000|Overall Study|Adverse Event|4|||
155353413|NCT01321723|560729639|FG002|Overall Study|Adverse Event|2|||
155353414|NCT01321723|560729637|FG000|Overall Study|Withdrawal by Subject|2|||
155353415|NCT01321723|560729638|FG001|Overall Study|Withdrawal by Subject|0|||
155353416|NCT01321723|560729639|FG002|Overall Study|Withdrawal by Subject|2|||
155353417|NCT02561806|560729640|FG000|Induction Period|Adverse Event|0|||
155353418|NCT02561806|560729641|FG001|Induction Period|Adverse Event|2|||
155353419|NCT02561806|560729640|FG000|Induction Period|Lack of Efficacy|1|||
155353420|NCT02561806|560729641|FG001|Induction Period|Lack of Efficacy|0|||
155353421|NCT02561806|560729640|FG000|Induction Period|Withdrawal by Subject|0|||
154964825|NCT03325881|559297539|FG000|Overall Study|Not treated|1|||
154964826|NCT03325881|559297540|FG001|Overall Study|Not treated|0|||
154964827|NCT03676634|559297541|FG000|Overall Study|Red blood cell loss|1|||
155353422|NCT02561806|560729641|FG001|Induction Period|Withdrawal by Subject|2|||
155353423|NCT02561806|560729640|FG000|Induction Period|Site staff became unblinded|1|||
154964828|NCT03676634|559297541|FG000|Overall Study|Out-of-limit pulse|2|||
154964829|NCT01188681|559297542|FG000|Overall Study|bladder cancer|0|||
154964830|NCT01188681|559297543|FG001|Overall Study|bladder cancer|0|||
155085988|NCT05654181|559747571|FG003|Overall Study|Withdrawal by Subject|0|||
155085989|NCT05654181|559747572|FG004|Overall Study|Withdrawal by Subject|0|||
155085990|NCT05654181|559747573|FG005|Overall Study|Withdrawal by Subject|0|||
155085991|NCT05654181|559747574|FG006|Overall Study|Withdrawal by Subject|0|||
155085992|NCT05654181|559747575|FG007|Overall Study|Withdrawal by Subject|1|||
155085993|NCT05654181|559747576|FG008|Overall Study|Withdrawal by Subject|0|||
155085994|NCT05654181|559747577|FG009|Overall Study|Withdrawal by Subject|0|||
155085995|NCT05654181|559747568|FG000|Overall Study|Other|0|||
155085996|NCT05654181|559747569|FG001|Overall Study|Other|0|||
155085997|NCT05654181|559747570|FG002|Overall Study|Other|0|||
155085998|NCT05654181|559747571|FG003|Overall Study|Other|0|||
155085999|NCT05654181|559747572|FG004|Overall Study|Other|1|||
155086000|NCT05654181|559747573|FG005|Overall Study|Other|1|||
155086001|NCT05654181|559747574|FG006|Overall Study|Other|0|||
155086002|NCT05654181|559747575|FG007|Overall Study|Other|0|||
155086003|NCT05654181|559747576|FG008|Overall Study|Other|0|||
155086004|NCT05654181|559747577|FG009|Overall Study|Other|0|||
155086005|NCT04101331|559747578|FG000|Overall Study|Adverse Event|9|||
155086006|NCT04101331|559747578|FG000|Overall Study|Disease progression|82|||
155086007|NCT04101331|559747578|FG000|Overall Study|Withdrawal by Subject|1|||
155086008|NCT04101331|559747578|FG000|Overall Study|Investigator decision|6|||
155086009|NCT04101331|559747578|FG000|Overall Study|Death|6|||
155086010|NCT04101331|559747578|FG000|Overall Study|Allogenic transplant|1|||
155086011|NCT01444781|559747579|FG000|Overall Study|Lost to Follow-up|0|||
155086012|NCT01444781|559747580|FG001|Overall Study|Lost to Follow-up|3|||
155086013|NCT01444781|559747581|FG002|Overall Study|Lost to Follow-up|1|||
155086014|NCT01444781|559747579|FG000|Overall Study|Withdrawal by Subject|3|||
155086015|NCT01444781|559747580|FG001|Overall Study|Withdrawal by Subject|1|||
155086016|NCT01444781|559747581|FG002|Overall Study|Withdrawal by Subject|2|||
155086017|NCT02254291|559747582|FG000|Overall Study|Withdrawal by Subject|0|||
155086018|NCT02254291|559747583|FG001|Overall Study|Withdrawal by Subject|3|||
155086019|NCT02254291|559747584|FG002|Overall Study|Withdrawal by Subject|1|||
155086020|NCT02254291|559747582|FG000|Overall Study|Missing follow-up information|0|||
155086021|NCT02254291|559747583|FG001|Overall Study|Missing follow-up information|0|||
155086022|NCT02254291|559747584|FG002|Overall Study|Missing follow-up information|1|||
155086023|NCT00833703|559747589|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
155086024|NCT00833703|559747590|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
155086025|NCT03033784|559747591|FG000|Overall Study|Anxiety related to MRI scanner|0|||
155086026|NCT03033784|559747592|FG001|Overall Study|Anxiety related to MRI scanner|1|||
155086027|NCT03033784|559747593|FG002|Overall Study|Anxiety related to MRI scanner|0|||
155086028|NCT03033784|559747594|FG003|Overall Study|Anxiety related to MRI scanner|0|||
155086029|NCT03033784|559747595|FG004|Overall Study|Anxiety related to MRI scanner|0|||
155086030|NCT03033784|559747596|FG005|Overall Study|Anxiety related to MRI scanner|0|||
155086031|NCT03033784|559747597|FG006|Overall Study|Anxiety related to MRI scanner|0|||
155086032|NCT03033784|559747598|FG007|Overall Study|Anxiety related to MRI scanner|0|||
155086033|NCT03033784|559747599|FG008|Overall Study|Anxiety related to MRI scanner|0|||
155086034|NCT03033784|559747600|FG009|Overall Study|Anxiety related to MRI scanner|0|||
155086035|NCT03033784|559747601|FG010|Overall Study|Anxiety related to MRI scanner|0|||
155086036|NCT03033784|559747602|FG011|Overall Study|Anxiety related to MRI scanner|0|||
155086037|NCT03033784|559747603|FG012|Overall Study|Anxiety related to MRI scanner|0|||
155086038|NCT03033784|559747591|FG000|Overall Study|Withdrawal by Subject|0|||
155086039|NCT03033784|559747592|FG001|Overall Study|Withdrawal by Subject|0|||
155086040|NCT03033784|559747593|FG002|Overall Study|Withdrawal by Subject|0|||
155086041|NCT03033784|559747594|FG003|Overall Study|Withdrawal by Subject|0|||
155086042|NCT03033784|559747595|FG004|Overall Study|Withdrawal by Subject|0|||
155165701|NCT02721966|560043540|FG001|Overall Study|Adverse Event|4|||
155086043|NCT03033784|559747596|FG005|Overall Study|Withdrawal by Subject|0|||
155086044|NCT03033784|559747597|FG006|Overall Study|Withdrawal by Subject|0|||
155086045|NCT03033784|559747598|FG007|Overall Study|Withdrawal by Subject|0|||
155086046|NCT03033784|559747599|FG008|Overall Study|Withdrawal by Subject|0|||
155086047|NCT03033784|559747600|FG009|Overall Study|Withdrawal by Subject|0|||
155086048|NCT03033784|559747601|FG010|Overall Study|Withdrawal by Subject|0|||
155086049|NCT03033784|559747602|FG011|Overall Study|Withdrawal by Subject|0|||
155086050|NCT03033784|559747603|FG012|Overall Study|Withdrawal by Subject|2|||
155086051|NCT03257657|559747606|FG000|Overall Study|Lost to Follow-up|0|||
155086052|NCT03257657|559747607|FG001|Overall Study|Lost to Follow-up|3|||
155086053|NCT03257657|559747606|FG000|Overall Study|Withdrawn|0|||
155086054|NCT03257657|559747607|FG001|Overall Study|Withdrawn|1|||
155086055|NCT03257657|559747606|FG000|Overall Study|Noted not eligible right after enrolled|0|||
155086056|NCT03257657|559747607|FG001|Overall Study|Noted not eligible right after enrolled|1|||
155086057|NCT02801578|559747608|FG000|Overall Study|Adverse Event|2|||
155086058|NCT00137449|559747609|FG000|Overall Study|Disease Progression|8|||
155086059|NCT00137449|559747610|FG001|Overall Study|Disease Progression|13|||
155086060|NCT00137449|559747609|FG000|Overall Study|Death|4|||
155086061|NCT00137449|559747610|FG001|Overall Study|Death|3|||
155086062|NCT00137449|559747609|FG000|Overall Study|Adverse Event|3|||
155086063|NCT00137449|559747610|FG001|Overall Study|Adverse Event|1|||
155353424|NCT02561806|560729641|FG001|Induction Period|Site staff became unblinded|0|||
155353425|NCT02561806|560729640|FG000|Induction Period|Randomized but not treated|0|||
155353426|NCT02561806|560729641|FG001|Induction Period|Randomized but not treated|1|||
155086064|NCT00137449|559747609|FG000|Overall Study|Withdrawal by Subject|1|||
155086065|NCT00137449|559747610|FG001|Overall Study|Withdrawal by Subject|1|||
155086066|NCT00668642|559747613|FG000|First Off-cycle|Cancer progression|1|||
155086067|NCT00668642|559747614|FG001|First Off-cycle|Cancer progression|0|||
155353427|NCT02561806|560729640|FG000|Maintenance Period|Adverse Event|2|||
155353428|NCT02561806|560729641|FG001|Maintenance Period|Adverse Event|1|||
155353429|NCT02561806|560729640|FG000|Maintenance Period|Lack of Efficacy|3|||
155086068|NCT00668642|559747613|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
155086069|NCT00668642|559747614|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
155086070|NCT02272985|559747615|FG000|Overall Study|Withdrawal by Subject|1|||
155086071|NCT02272985|559747615|FG000|Overall Study|hip fracture|1|||
155086072|NCT02272985|559747615|FG000|Overall Study|kidney transplantation|1|||
155086073|NCT03707821|559747620|FG000|Overall Study|Protocol Violation|0|||
155086074|NCT03707821|559747621|FG001|Overall Study|Protocol Violation|1|||
155086075|NCT03707821|559747620|FG000|Overall Study|Unsatisfactory Visual Response|1|||
155086076|NCT03707821|559747621|FG001|Overall Study|Unsatisfactory Visual Response|0|||
155086077|NCT03707821|559747620|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
155086078|NCT03707821|559747621|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
155086079|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
155086080|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
155086081|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
155086082|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
155086083|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
155086084|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
155086085|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
155086086|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
155353430|NCT02561806|560729641|FG001|Maintenance Period|Lack of Efficacy|1|||
155353431|NCT02561806|560729640|FG000|Maintenance Period|Lost to Follow-up|2|||
155353432|NCT02561806|560729641|FG001|Maintenance Period|Lost to Follow-up|2|||
155353433|NCT02561806|560729640|FG000|Maintenance Period|Protocol Violation|1|||
155353434|NCT02561806|560729641|FG001|Maintenance Period|Protocol Violation|0|||
155353435|NCT02561806|560729640|FG000|Maintenance Period|Withdrawal by Subject|5|||
155353436|NCT02561806|560729641|FG001|Maintenance Period|Withdrawal by Subject|3|||
155353437|NCT02561806|560729640|FG000|Maintenance Period|Site staff became unblinded|0|||
155353438|NCT02561806|560729641|FG001|Maintenance Period|Site staff became unblinded|1|||
155353439|NCT02561806|560729640|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
155353440|NCT02561806|560729641|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
155353441|NCT02561806|560729640|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
155353442|NCT02561806|560729641|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
155353443|NCT02547441|560729642|FG000|Double-Blind Study Period|Adverse Event|4|||
155353444|NCT02547441|560729643|FG001|Double-Blind Study Period|Adverse Event|9|||
155353445|NCT02547441|560729642|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
155353446|NCT02547441|560729643|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
155353447|NCT02547441|560729642|FG000|Double-Blind Study Period|Physician Decision|1|||
155353448|NCT02547441|560729643|FG001|Double-Blind Study Period|Physician Decision|0|||
155353449|NCT02547441|560729642|FG000|Double-Blind Study Period|Protocol Violation|1|||
155353450|NCT02547441|560729643|FG001|Double-Blind Study Period|Protocol Violation|2|||
155353451|NCT02547441|560729642|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
155353452|NCT02547441|560729643|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
155353453|NCT02547441|560729642|FG000|Double-Blind Study Period|Sponsor Decision|1|||
155353454|NCT02547441|560729643|FG001|Double-Blind Study Period|Sponsor Decision|0|||
155086087|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
155086088|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
155086089|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
155086090|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
155086091|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
155353455|NCT02547441|560729642|FG000|Open-Label Study Period|Adverse Event|10|||
155353456|NCT02547441|560729643|FG001|Open-Label Study Period|Adverse Event|11|||
155353457|NCT02547441|560729642|FG000|Open-Label Study Period|Lack of Efficacy|3|||
155086092|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
155086093|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
155086094|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
155353458|NCT02547441|560729643|FG001|Open-Label Study Period|Lack of Efficacy|2|||
155353459|NCT02547441|560729642|FG000|Open-Label Study Period|Lost to Follow-up|7|||
155353460|NCT02547441|560729643|FG001|Open-Label Study Period|Lost to Follow-up|8|||
155353461|NCT02547441|560729642|FG000|Open-Label Study Period|Physician Decision|1|||
155353462|NCT02547441|560729643|FG001|Open-Label Study Period|Physician Decision|0|||
155353463|NCT02547441|560729642|FG000|Open-Label Study Period|Protocol Violation|2|||
155353464|NCT02547441|560729643|FG001|Open-Label Study Period|Protocol Violation|0|||
155353465|NCT02547441|560729642|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
155353466|NCT02547441|560729643|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
155353467|NCT02547441|560729642|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
154964831|NCT01188681|559297544|FG002|Overall Study|bladder cancer|1|||
155086095|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
155086096|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
155353468|NCT02547441|560729643|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
155353469|NCT01322009|560729644|FG000|Overall Study|Death|0|||
155353470|NCT01322009|560729645|FG001|Overall Study|Death|1|||
155086097|NCT01432444|559747622|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
155353471|NCT01322009|560729644|FG000|Overall Study|Adverse Event|0|||
155353472|NCT01322009|560729645|FG001|Overall Study|Adverse Event|1|||
155353473|NCT01322009|560729644|FG000|Overall Study|ng tube discontinued|0|||
155353474|NCT01322009|560729645|FG001|Overall Study|ng tube discontinued|1|||
155353475|NCT00905034|560729646|FG000|Overall Study|Withdrawal by Subject|1|||
155353476|NCT00394589|560729647|FG000|Overall Study|Adverse Event|2|||
155353477|NCT00394589|560729648|FG001|Overall Study|Adverse Event|1|||
155353478|NCT00394589|560729649|FG002|Overall Study|Adverse Event|2|||
155353479|NCT00394589|560729647|FG000|Overall Study|Lack of Efficacy|2|||
155353480|NCT00394589|560729648|FG001|Overall Study|Lack of Efficacy|2|||
155086098|NCT01432444|559747623|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
155086099|NCT01432444|559747624|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
155086100|NCT01432444|559747622|FG000|Treatment Phase|Lost to Follow-up|0|||
155086101|NCT01432444|559747623|FG001|Treatment Phase|Lost to Follow-up|33|||
155086102|NCT01432444|559747624|FG002|Treatment Phase|Lost to Follow-up|0|||
155353481|NCT00394589|560729649|FG002|Overall Study|Lack of Efficacy|3|||
155353482|NCT00394589|560729647|FG000|Overall Study|Protocol Violation|4|||
155353483|NCT00394589|560729648|FG001|Overall Study|Protocol Violation|0|||
155353484|NCT00394589|560729649|FG002|Overall Study|Protocol Violation|2|||
155353485|NCT03409731|560729650|FG000|Overall Study|Withdrawal by Subject|17|||
155353486|NCT03409731|560729650|FG000|Overall Study|Death|4|||
155353487|NCT04545476|560729651|FG000|Overall Study|Lost to Follow-up|1|||
155353488|NCT04545476|560729652|FG001|Overall Study|Lost to Follow-up|1|||
155353489|NCT04545476|560729653|FG002|Overall Study|Lost to Follow-up|0|||
155353490|NCT04545476|560729654|FG003|Overall Study|Lost to Follow-up|0|||
155353491|NCT03175198|560729657|FG000|Overall Study|Adverse Event|480|||
155353492|NCT03175198|560729657|FG000|Overall Study|No actual visit|120|||
155353493|NCT03175198|560729657|FG000|Overall Study|Registration rule not followed|4|||
155353494|NCT03175198|560729657|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
155353495|NCT03175198|560729657|FG000|Overall Study|Other personal reason|509|||
155353496|NCT03175198|560729657|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
155353497|NCT03175198|560729657|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
155353498|NCT03175198|560729657|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
155353499|NCT03175198|560729657|FG000|Overall Study|To conduct invasive treatment of operation|53|||
155353500|NCT03175198|560729657|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
155353501|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
155353502|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
155353503|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
155353504|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
155353505|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
155353506|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
155353507|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Rejections|0|||
155353508|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Rejections|0|||
155353509|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Rejections|55|||
155353510|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
155353511|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
155353512|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
155353513|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
155353514|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
155353515|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
155353516|NCT00634920|560729659|FG000|Period 1 - Pre-Randomization|Other issues|0|||
155353517|NCT00634920|560729660|FG001|Period 1 - Pre-Randomization|Other issues|0|||
155353518|NCT00634920|560729661|FG002|Period 1 - Pre-Randomization|Other issues|6|||
155353519|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
155353520|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
155353521|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
155353522|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Rejection|11|||
155353523|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Rejection|5|||
155353524|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Rejection|0|||
155353525|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Death|2|||
155353526|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Death|5|||
155353527|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Death|0|||
155353528|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
155353529|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
154964832|NCT01188681|559297545|FG003|Overall Study|bladder cancer|0|||
155086103|NCT01432444|559747622|FG000|Treatment Phase|Adverse Event|0|||
155086104|NCT01432444|559747623|FG001|Treatment Phase|Adverse Event|37|||
155353530|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
155353531|NCT00634920|560729659|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
155353532|NCT00634920|560729660|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
155086105|NCT01432444|559747624|FG002|Treatment Phase|Adverse Event|0|||
155086106|NCT01432444|559747622|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
155086107|NCT01432444|559747623|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
155086108|NCT01432444|559747624|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
155086109|NCT01432444|559747622|FG000|Treatment Phase|Physician Decision|0|||
155086110|NCT01432444|559747623|FG001|Treatment Phase|Physician Decision|5|||
155086111|NCT01432444|559747624|FG002|Treatment Phase|Physician Decision|0|||
155086112|NCT01432444|559747622|FG000|Treatment Phase|Withdrawal by Subject|0|||
155086113|NCT01432444|559747623|FG001|Treatment Phase|Withdrawal by Subject|41|||
155086114|NCT01432444|559747624|FG002|Treatment Phase|Withdrawal by Subject|0|||
155086115|NCT01432444|559747622|FG000|Treatment Phase|Protocol Deviation|0|||
155086116|NCT01432444|559747623|FG001|Treatment Phase|Protocol Deviation|3|||
155086117|NCT01432444|559747624|FG002|Treatment Phase|Protocol Deviation|0|||
155086118|NCT01432444|559747622|FG000|Treatment Phase|Lack of Efficacy|0|||
155086119|NCT01432444|559747623|FG001|Treatment Phase|Lack of Efficacy|10|||
155086120|NCT01432444|559747624|FG002|Treatment Phase|Lack of Efficacy|0|||
155086121|NCT01432444|559747622|FG000|Extension Phase|Lost to Follow-up|0|||
155086122|NCT01432444|559747623|FG001|Extension Phase|Lost to Follow-up|0|||
155086123|NCT01432444|559747624|FG002|Extension Phase|Lost to Follow-up|17|||
155086124|NCT01432444|559747622|FG000|Extension Phase|Adverse Event|0|||
155086125|NCT01432444|559747623|FG001|Extension Phase|Adverse Event|0|||
155086126|NCT01432444|559747624|FG002|Extension Phase|Adverse Event|10|||
155086127|NCT01432444|559747622|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
155086128|NCT01432444|559747623|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
155086129|NCT01432444|559747624|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
155086130|NCT01432444|559747622|FG000|Extension Phase|Met Withdrawal Criteria|0|||
155086131|NCT01432444|559747623|FG001|Extension Phase|Met Withdrawal Criteria|0|||
155086132|NCT01432444|559747624|FG002|Extension Phase|Met Withdrawal Criteria|144|||
155086133|NCT01432444|559747622|FG000|Extension Phase|Physician Decision|0|||
155086134|NCT01432444|559747623|FG001|Extension Phase|Physician Decision|0|||
155086135|NCT01432444|559747624|FG002|Extension Phase|Physician Decision|1|||
155086136|NCT01432444|559747622|FG000|Extension Phase|Withdrawal by Subject|0|||
155086137|NCT01432444|559747623|FG001|Extension Phase|Withdrawal by Subject|0|||
155086138|NCT01432444|559747624|FG002|Extension Phase|Withdrawal by Subject|13|||
155086139|NCT02014467|559747625|FG000|Overall Study|Adverse Event|4|||
155086140|NCT02014467|559747626|FG001|Overall Study|Adverse Event|0|||
155086141|NCT02014467|559747625|FG000|Overall Study|Protocol Violation|3|||
155086142|NCT02014467|559747626|FG001|Overall Study|Protocol Violation|0|||
155086143|NCT02014467|559747625|FG000|Overall Study|Physician Decision|2|||
155086144|NCT02014467|559747626|FG001|Overall Study|Physician Decision|3|||
155086145|NCT02014467|559747625|FG000|Overall Study|Withdrawal by Subject|16|||
155086146|NCT02014467|559747626|FG001|Overall Study|Withdrawal by Subject|4|||
155086147|NCT00124657|559747633|FG000|Overall Study|Toxicity|0|||
155086148|NCT00124657|559747634|FG001|Overall Study|Toxicity|0|||
155086149|NCT00124657|559747635|FG002|Overall Study|Toxicity|1|||
155086150|NCT00124657|559747633|FG000|Overall Study|Non-compliance|1|||
155086151|NCT00124657|559747634|FG001|Overall Study|Non-compliance|0|||
155086152|NCT00124657|559747635|FG002|Overall Study|Non-compliance|4|||
155086153|NCT00124657|559747633|FG000|Overall Study|Progressive disease|14|||
155086154|NCT00124657|559747634|FG001|Overall Study|Progressive disease|5|||
155086155|NCT00124657|559747635|FG002|Overall Study|Progressive disease|27|||
155086156|NCT00124657|559747633|FG000|Overall Study|Intercurrent illness|1|||
155086157|NCT00124657|559747634|FG001|Overall Study|Intercurrent illness|0|||
155086158|NCT00124657|559747635|FG002|Overall Study|Intercurrent illness|0|||
155086159|NCT00619918|559747640|FG000|Overall Study|Withdrawal by Subject|4|||
155086160|NCT00619918|559747641|FG001|Overall Study|Withdrawal by Subject|3|||
155086161|NCT00619918|559747640|FG000|Overall Study|Physician Decision|2|||
155086162|NCT00619918|559747641|FG001|Overall Study|Physician Decision|4|||
155086163|NCT00619918|559747640|FG000|Overall Study|Transfer to outside facility|3|||
155086164|NCT00619918|559747641|FG001|Overall Study|Transfer to outside facility|3|||
155086165|NCT00619918|559747640|FG000|Overall Study|Left before receiving first dose|7|||
155086166|NCT00619918|559747641|FG001|Overall Study|Left before receiving first dose|6|||
155165702|NCT02721966|560043541|FG002|Overall Study|Adverse Event|3|||
155165703|NCT02721966|560043542|FG003|Overall Study|Adverse Event|0|||
155086167|NCT00619918|559747640|FG000|Overall Study|ICU admission|4|||
155086168|NCT00619918|559747641|FG001|Overall Study|ICU admission|6|||
155086169|NCT03647137|559747645|FG000|Overall Study|Scan Limitation|2|||
155086170|NCT03647137|559747646|FG001|Overall Study|Scan Limitation|1|||
155086171|NCT03647137|559747647|FG002|Overall Study|Scan Limitation|1|||
155086172|NCT03647137|559747648|FG003|Overall Study|Scan Limitation|2|||
155086173|NCT01969409|559747649|FG000|Overall Study|Death|2|||
155086174|NCT01969409|559747650|FG001|Overall Study|Death|2|||
155086175|NCT01969409|559747649|FG000|Overall Study|Transplant|1|||
155086176|NCT01969409|559747650|FG001|Overall Study|Transplant|1|||
155086177|NCT01969409|559747649|FG000|Overall Study|Withdrawal by Subject|0|||
155086178|NCT01969409|559747650|FG001|Overall Study|Withdrawal by Subject|1|||
155086179|NCT02799043|559747651|FG000|Overall Study|Adverse Event|0|||
155086180|NCT02799043|559747652|FG001|Overall Study|Adverse Event|1|||
155165704|NCT02721966|560043543|FG004|Overall Study|Adverse Event|0|||
155353533|NCT00634920|560729661|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
155353534|NCT01193218|560729662|FG000|0-12 Weeks|Adverse Event|6|||
155353535|NCT01193218|560729663|FG001|0-12 Weeks|Adverse Event|0|||
155353536|NCT01193218|560729664|FG002|0-12 Weeks|Adverse Event|1|||
155353537|NCT01193218|560729665|FG003|0-12 Weeks|Adverse Event|0|||
155353538|NCT01193218|560729666|FG004|0-12 Weeks|Adverse Event|0|||
155353539|NCT01193218|560729667|FG005|0-12 Weeks|Adverse Event|2|||
155353540|NCT01193218|560729668|FG006|0-12 Weeks|Adverse Event|2|||
155353541|NCT01193218|560729669|FG007|0-12 Weeks|Adverse Event|0|||
155353542|NCT01193218|560729662|FG000|0-12 Weeks|Protocol Violation|0|||
155353543|NCT01193218|560729663|FG001|0-12 Weeks|Protocol Violation|0|||
155353544|NCT01193218|560729664|FG002|0-12 Weeks|Protocol Violation|0|||
155353545|NCT01193218|560729665|FG003|0-12 Weeks|Protocol Violation|0|||
155353546|NCT01193218|560729666|FG004|0-12 Weeks|Protocol Violation|1|||
155353547|NCT01193218|560729667|FG005|0-12 Weeks|Protocol Violation|1|||
155353548|NCT01193218|560729668|FG006|0-12 Weeks|Protocol Violation|0|||
155353549|NCT01193218|560729669|FG007|0-12 Weeks|Protocol Violation|0|||
155353550|NCT01193218|560729662|FG000|0-12 Weeks|Withdrawal by Subject|3|||
155353551|NCT01193218|560729663|FG001|0-12 Weeks|Withdrawal by Subject|0|||
155353552|NCT01193218|560729664|FG002|0-12 Weeks|Withdrawal by Subject|2|||
155353553|NCT01193218|560729665|FG003|0-12 Weeks|Withdrawal by Subject|0|||
155353554|NCT01193218|560729666|FG004|0-12 Weeks|Withdrawal by Subject|0|||
155353555|NCT01193218|560729667|FG005|0-12 Weeks|Withdrawal by Subject|0|||
155353556|NCT01193218|560729668|FG006|0-12 Weeks|Withdrawal by Subject|1|||
155353557|NCT01193218|560729669|FG007|0-12 Weeks|Withdrawal by Subject|0|||
155353558|NCT01193218|560729662|FG000|12-52 Weeks|Adverse Event|1|||
155353559|NCT01193218|560729663|FG001|12-52 Weeks|Adverse Event|0|||
155353560|NCT01193218|560729664|FG002|12-52 Weeks|Adverse Event|1|||
155353561|NCT01193218|560729665|FG003|12-52 Weeks|Adverse Event|2|||
155353562|NCT01193218|560729666|FG004|12-52 Weeks|Adverse Event|3|||
155353563|NCT01193218|560729667|FG005|12-52 Weeks|Adverse Event|3|||
155353564|NCT01193218|560729668|FG006|12-52 Weeks|Adverse Event|1|||
155353565|NCT01193218|560729669|FG007|12-52 Weeks|Adverse Event|2|||
155086181|NCT02799043|559747651|FG000|Overall Study|Death|1|||
155353566|NCT01193218|560729662|FG000|12-52 Weeks|Lack of Efficacy|0|||
155086182|NCT02799043|559747652|FG001|Overall Study|Death|1|||
155353567|NCT01193218|560729663|FG001|12-52 Weeks|Lack of Efficacy|0|||
155353568|NCT01193218|560729664|FG002|12-52 Weeks|Lack of Efficacy|0|||
155353569|NCT01193218|560729665|FG003|12-52 Weeks|Lack of Efficacy|0|||
155353570|NCT01193218|560729666|FG004|12-52 Weeks|Lack of Efficacy|0|||
155353571|NCT01193218|560729667|FG005|12-52 Weeks|Lack of Efficacy|0|||
155353572|NCT01193218|560729668|FG006|12-52 Weeks|Lack of Efficacy|1|||
155086183|NCT02799043|559747651|FG000|Overall Study|Lost to Follow-up|3|||
155353573|NCT01193218|560729669|FG007|12-52 Weeks|Lack of Efficacy|0|||
155086184|NCT02799043|559747652|FG001|Overall Study|Lost to Follow-up|6|||
155353574|NCT01193218|560729662|FG000|12-52 Weeks|Withdrawal by Subject|3|||
155353575|NCT01193218|560729663|FG001|12-52 Weeks|Withdrawal by Subject|0|||
155353576|NCT01193218|560729664|FG002|12-52 Weeks|Withdrawal by Subject|3|||
155353577|NCT01193218|560729665|FG003|12-52 Weeks|Withdrawal by Subject|0|||
155353578|NCT01193218|560729666|FG004|12-52 Weeks|Withdrawal by Subject|0|||
155353579|NCT01193218|560729667|FG005|12-52 Weeks|Withdrawal by Subject|2|||
155353580|NCT01193218|560729668|FG006|12-52 Weeks|Withdrawal by Subject|1|||
155353581|NCT01193218|560729669|FG007|12-52 Weeks|Withdrawal by Subject|2|||
155353582|NCT01193218|560729662|FG000|12-52 Weeks|Other reason than above|1|||
155353583|NCT01193218|560729663|FG001|12-52 Weeks|Other reason than above|0|||
155353584|NCT01193218|560729664|FG002|12-52 Weeks|Other reason than above|0|||
155353585|NCT01193218|560729665|FG003|12-52 Weeks|Other reason than above|1|||
155353586|NCT01193218|560729666|FG004|12-52 Weeks|Other reason than above|1|||
155353587|NCT01193218|560729667|FG005|12-52 Weeks|Other reason than above|0|||
155353588|NCT01193218|560729668|FG006|12-52 Weeks|Other reason than above|0|||
155353589|NCT01193218|560729669|FG007|12-52 Weeks|Other reason than above|0|||
155353590|NCT00363649|560729670|FG000|Overall Study|Withdrawal by Subject|1|||
155353591|NCT00363649|560729671|FG001|Overall Study|Withdrawal by Subject|1|||
155353592|NCT00363649|560729670|FG000|Overall Study|Adverse Event|6|||
155353593|NCT00363649|560729671|FG001|Overall Study|Adverse Event|0|||
155353594|NCT01013740|560729672|FG000|Overall Study|Lost to Follow-up|3|||
155353595|NCT01013740|560729673|FG001|Overall Study|Lost to Follow-up|5|||
155353596|NCT01013740|560729672|FG000|Overall Study|Physician Decision|2|||
155353597|NCT01013740|560729673|FG001|Overall Study|Physician Decision|0|||
155353598|NCT01013740|560729672|FG000|Overall Study|Withdrawal by Subject|2|||
155353599|NCT01013740|560729673|FG001|Overall Study|Withdrawal by Subject|10|||
155353600|NCT01013740|560729672|FG000|Overall Study|study close / terminated : done in error|2|||
155353601|NCT01013740|560729673|FG001|Overall Study|study close / terminated : done in error|1|||
155353602|NCT01013740|560729672|FG000|Overall Study|Missing|2|||
155353603|NCT01013740|560729673|FG001|Overall Study|Missing|1|||
155353604|NCT01013740|560729672|FG000|Overall Study|Ongoing: Study records not completed|0|||
155353605|NCT01013740|560729673|FG001|Overall Study|Ongoing: Study records not completed|2|||
155353606|NCT02161185|560729674|FG000|Treatment Phase|Administrative/Other|7|||
155353607|NCT00776984|560729676|FG000|Overall Study|Adverse Event|8|||
155353608|NCT00776984|560729677|FG001|Overall Study|Adverse Event|2|||
155353609|NCT00776984|560729676|FG000|Overall Study|Protocol Violation|4|||
155353610|NCT00776984|560729677|FG001|Overall Study|Protocol Violation|2|||
155353611|NCT00776984|560729676|FG000|Overall Study|Lost to Follow-up|2|||
155353612|NCT00776984|560729677|FG001|Overall Study|Lost to Follow-up|0|||
155353613|NCT00776984|560729676|FG000|Overall Study|Withdrawal by Subject|12|||
155353614|NCT00776984|560729677|FG001|Overall Study|Withdrawal by Subject|7|||
155353615|NCT00776984|560729676|FG000|Overall Study|Lack of Efficacy|0|||
155353616|NCT00776984|560729677|FG001|Overall Study|Lack of Efficacy|1|||
155353617|NCT00776984|560729676|FG000|Overall Study|Other|5|||
155353618|NCT00776984|560729677|FG001|Overall Study|Other|9|||
155353619|NCT01544309|560729680|FG000|Overall Study|Withdrawal by Subject|12|||
155353620|NCT01544309|560729681|FG001|Overall Study|Withdrawal by Subject|7|||
155353621|NCT01544309|560729680|FG000|Overall Study|Protocol Violation|2|||
155353622|NCT01544309|560729681|FG001|Overall Study|Protocol Violation|1|||
155353623|NCT01544309|560729680|FG000|Overall Study|Physician Decision|4|||
155353624|NCT01544309|560729681|FG001|Overall Study|Physician Decision|1|||
155353625|NCT01544309|560729680|FG000|Overall Study|Not performed pre-dose examination|1|||
155353626|NCT01544309|560729681|FG001|Overall Study|Not performed pre-dose examination|2|||
155353627|NCT01544309|560729680|FG000|Overall Study|Administered prohibit prior medication|1|||
155353628|NCT01544309|560729681|FG001|Overall Study|Administered prohibit prior medication|0|||
155353629|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
155353630|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
155353631|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
155353632|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
155353633|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
155353634|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
155353635|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
155353636|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
155086185|NCT02799043|559747651|FG000|Overall Study|Withdrawal by Subject|4|||
155353637|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
155353638|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
155353639|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
155086186|NCT02799043|559747652|FG001|Overall Study|Withdrawal by Subject|4|||
155086187|NCT02799043|559747651|FG000|Overall Study|Moved to different country|0|||
155086188|NCT02799043|559747652|FG001|Overall Study|Moved to different country|1|||
155086189|NCT02799043|559747651|FG000|Overall Study|Trial Screen Failure|1|||
155086190|NCT02799043|559747652|FG001|Overall Study|Trial Screen Failure|0|||
155086191|NCT02799043|559747651|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
155086192|NCT02799043|559747652|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
155086193|NCT01554904|559747655|FG000|Overall Study|Withdrawal by Subject|3|||
155086194|NCT01554904|559747655|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
155086195|NCT01051661|559747658|FG000|Overall Study|Adverse Event|1|||
155086196|NCT01051661|559747659|FG001|Overall Study|Adverse Event|1|||
155086197|NCT01051661|559747660|FG002|Overall Study|Adverse Event|1|||
155086198|NCT01051661|559747661|FG003|Overall Study|Adverse Event|1|||
155086199|NCT01051661|559747662|FG004|Overall Study|Adverse Event|0|||
155086200|NCT01051661|559747663|FG005|Overall Study|Adverse Event|0|||
155086201|NCT01051661|559747658|FG000|Overall Study|Lost to Follow-up|13|||
155086202|NCT01051661|559747659|FG001|Overall Study|Lost to Follow-up|22|||
155086203|NCT01051661|559747660|FG002|Overall Study|Lost to Follow-up|15|||
155086204|NCT01051661|559747661|FG003|Overall Study|Lost to Follow-up|17|||
155086205|NCT01051661|559747662|FG004|Overall Study|Lost to Follow-up|10|||
155086206|NCT01051661|559747663|FG005|Overall Study|Lost to Follow-up|24|||
155086207|NCT01051661|559747658|FG000|Overall Study|Migrated/moved from study area|1|||
155086208|NCT01051661|559747659|FG001|Overall Study|Migrated/moved from study area|6|||
155086209|NCT01051661|559747660|FG002|Overall Study|Migrated/moved from study area|6|||
155086210|NCT01051661|559747661|FG003|Overall Study|Migrated/moved from study area|8|||
155086211|NCT01051661|559747662|FG004|Overall Study|Migrated/moved from study area|7|||
155086212|NCT01051661|559747663|FG005|Overall Study|Migrated/moved from study area|3|||
155086213|NCT01051661|559747658|FG000|Overall Study|Refused blood sampling|0|||
155086214|NCT01051661|559747659|FG001|Overall Study|Refused blood sampling|0|||
155086215|NCT01051661|559747660|FG002|Overall Study|Refused blood sampling|0|||
155086216|NCT01051661|559747661|FG003|Overall Study|Refused blood sampling|0|||
155086217|NCT01051661|559747662|FG004|Overall Study|Refused blood sampling|0|||
155086218|NCT01051661|559747663|FG005|Overall Study|Refused blood sampling|1|||
155086219|NCT01051661|559747658|FG000|Overall Study|Data not reliable|1|||
155086220|NCT01051661|559747659|FG001|Overall Study|Data not reliable|0|||
155086221|NCT01051661|559747660|FG002|Overall Study|Data not reliable|0|||
155353640|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
155353641|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
155353642|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
155353643|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
155353644|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
155353645|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
155353646|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
155353647|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
155353648|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
155353649|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
155353650|NCT01125566|560729691|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
155353651|NCT01125566|560729692|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
155353652|NCT01125566|560729693|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
155353653|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
155353654|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
155353655|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
155353656|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
155353657|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
155353658|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
155353659|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
155353660|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
155086222|NCT01051661|559747661|FG003|Overall Study|Data not reliable|0|||
155086223|NCT01051661|559747662|FG004|Overall Study|Data not reliable|0|||
155086224|NCT01051661|559747663|FG005|Overall Study|Data not reliable|1|||
155086225|NCT01051661|559747658|FG000|Overall Study|Unable to attend visit(s)|2|||
155086226|NCT01051661|559747659|FG001|Overall Study|Unable to attend visit(s)|4|||
155086227|NCT01051661|559747660|FG002|Overall Study|Unable to attend visit(s)|2|||
155353661|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
155353662|NCT01125566|560729691|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
155353663|NCT01125566|560729692|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
155353664|NCT01125566|560729693|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
155353665|NCT00988117|560729694|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
155353666|NCT00988117|560729694|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
155353667|NCT04088500|560729695|FG000|Overall Study|Reason unknown|1|||
155353668|NCT04088500|560729695|FG000|Overall Study|Participant withdrew consent|1|||
155353669|NCT04088500|560729695|FG000|Overall Study|Disease progression|3|||
155353670|NCT01091519|560729698|FG000|Overall Study|Adverse Event|12|||
155353671|NCT01091519|560729699|FG001|Overall Study|Adverse Event|16|||
155353672|NCT01091519|560729698|FG000|Overall Study|Death|1|||
155353673|NCT01091519|560729699|FG001|Overall Study|Death|0|||
155353674|NCT01091519|560729698|FG000|Overall Study|Lack of Efficacy|16|||
155353675|NCT01091519|560729699|FG001|Overall Study|Lack of Efficacy|19|||
155353676|NCT01091519|560729698|FG000|Overall Study|Lost to Follow-up|14|||
155353677|NCT01091519|560729699|FG001|Overall Study|Lost to Follow-up|24|||
155353678|NCT01091519|560729698|FG000|Overall Study|Withdrawal by Subject|2|||
155353679|NCT01091519|560729699|FG001|Overall Study|Withdrawal by Subject|2|||
155353680|NCT01091519|560729698|FG000|Overall Study|Other|6|||
155353681|NCT01091519|560729699|FG001|Overall Study|Other|8|||
155353682|NCT01091519|560729698|FG000|Overall Study|Randomized not treated|4|||
155353683|NCT01091519|560729699|FG001|Overall Study|Randomized not treated|4|||
155353684|NCT01227928|560729702|FG000|Overall Study|Lost to Follow-up|4|||
155353685|NCT01227928|560729703|FG001|Overall Study|Lost to Follow-up|2|||
155353686|NCT01227928|560729702|FG000|Overall Study|Withdrawal by Subject|4|||
155353687|NCT01227928|560729703|FG001|Overall Study|Withdrawal by Subject|3|||
155353688|NCT01227928|560729702|FG000|Overall Study|Death|14|||
155353689|NCT01227928|560729703|FG001|Overall Study|Death|12|||
155353690|NCT01204775|560729704|FG000|Overall Study|Poor/non-compliance|0|||
155353691|NCT01204775|560729705|FG001|Overall Study|Poor/non-compliance|1|||
155353692|NCT01204775|560729704|FG000|Overall Study|Withdrawal by Subject|1|||
155353693|NCT01204775|560729705|FG001|Overall Study|Withdrawal by Subject|0|||
155353694|NCT00276016|560729706|FG000|Intervention 1|Withdrawal by Subject|0|||
155353695|NCT00276016|560729707|FG001|Intervention 1|Withdrawal by Subject|1|||
155353696|NCT00276016|560729708|FG002|Intervention 1|Withdrawal by Subject|0|||
155353697|NCT00276016|560729709|FG003|Intervention 1|Withdrawal by Subject|0|||
155353698|NCT00276016|560729710|FG004|Intervention 1|Withdrawal by Subject|0|||
155353699|NCT00276016|560729711|FG005|Intervention 1|Withdrawal by Subject|0|||
155353700|NCT01468077|560731369|FG000|Overall Study|Adverse Event|2|||
155353701|NCT01468077|560731370|FG001|Overall Study|Adverse Event|2|||
155353702|NCT01468077|560731369|FG000|Overall Study|Lack of Efficacy|1|||
155353703|NCT01468077|560731370|FG001|Overall Study|Lack of Efficacy|1|||
155353704|NCT01468077|560731369|FG000|Overall Study|Physician Decision|1|||
155353705|NCT01468077|560731370|FG001|Overall Study|Physician Decision|0|||
155353706|NCT04333147|560731371|FG000|Overall Study|Adverse Event|43|||
155353707|NCT04333147|560731372|FG001|Overall Study|Adverse Event|40|||
155353708|NCT04333147|560731371|FG000|Overall Study|Lack of Efficacy|49|||
155353709|NCT04333147|560731372|FG001|Overall Study|Lack of Efficacy|48|||
155353710|NCT04333147|560731371|FG000|Overall Study|Lost to Follow-up|19|||
155353711|NCT04333147|560731372|FG001|Overall Study|Lost to Follow-up|16|||
155353712|NCT04333147|560731371|FG000|Overall Study|Physician Decision|17|||
155353713|NCT04333147|560731372|FG001|Overall Study|Physician Decision|20|||
155353714|NCT04333147|560731371|FG000|Overall Study|Withdrawal by Subject|65|||
155353715|NCT04333147|560731372|FG001|Overall Study|Withdrawal by Subject|68|||
155353716|NCT04333147|560731371|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
155353717|NCT04333147|560731372|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
155353718|NCT04333147|560731371|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
155353719|NCT04333147|560731372|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
155353720|NCT04333147|560731371|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
155353721|NCT04333147|560731372|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
155353722|NCT00706914|560731377|FG000|Overall Study|Lack of Efficacy|0|||
155353723|NCT00706914|560731378|FG001|Overall Study|Lack of Efficacy|1|||
155353724|NCT00706914|560731379|FG002|Overall Study|Lack of Efficacy|0|||
155353725|NCT00706914|560731377|FG000|Overall Study|Lost to Follow-up|1|||
155353726|NCT00706914|560731378|FG001|Overall Study|Lost to Follow-up|0|||
155353727|NCT00706914|560731379|FG002|Overall Study|Lost to Follow-up|0|||
155353728|NCT00706914|560731377|FG000|Overall Study|Adverse Event|2|||
155353729|NCT00706914|560731378|FG001|Overall Study|Adverse Event|2|||
155353730|NCT00706914|560731379|FG002|Overall Study|Adverse Event|0|||
155353731|NCT00706914|560731377|FG000|Overall Study|Protocol Violation|3|||
155353732|NCT00706914|560731378|FG001|Overall Study|Protocol Violation|1|||
155353733|NCT00706914|560731379|FG002|Overall Study|Protocol Violation|1|||
155353734|NCT01850823|560731381|FG000|Overall Study|Early Visit Window|0|||
155353735|NCT01850823|560731382|FG001|Overall Study|Early Visit Window|1|||
155353736|NCT01850823|560731383|FG002|Overall Study|Early Visit Window|4|||
155353737|NCT01850823|560731381|FG000|Overall Study|Enrolled in Error|0|||
155353738|NCT01850823|560731382|FG001|Overall Study|Enrolled in Error|1|||
155353739|NCT01850823|560731383|FG002|Overall Study|Enrolled in Error|2|||
155353740|NCT01850823|560731381|FG000|Overall Study|Lack of Efficacy|1|||
155353741|NCT01850823|560731382|FG001|Overall Study|Lack of Efficacy|0|||
155353742|NCT01850823|560731383|FG002|Overall Study|Lack of Efficacy|0|||
155353743|NCT01850823|560731381|FG000|Overall Study|Lost to Follow-up|0|||
155353744|NCT01850823|560731382|FG001|Overall Study|Lost to Follow-up|0|||
155353745|NCT01850823|560731383|FG002|Overall Study|Lost to Follow-up|1|||
155353746|NCT01850823|560731381|FG000|Overall Study|Restricted Medication|0|||
155353747|NCT01850823|560731382|FG001|Overall Study|Restricted Medication|0|||
155353748|NCT01850823|560731383|FG002|Overall Study|Restricted Medication|2|||
155353749|NCT01850823|560731381|FG000|Overall Study|Significant worstening of SAR|0|||
155353750|NCT01850823|560731382|FG001|Overall Study|Significant worstening of SAR|1|||
155353751|NCT01850823|560731383|FG002|Overall Study|Significant worstening of SAR|0|||
155353752|NCT01850823|560731381|FG000|Overall Study|Withdrawal by Subject|2|||
155353753|NCT01850823|560731382|FG001|Overall Study|Withdrawal by Subject|0|||
155353754|NCT01850823|560731383|FG002|Overall Study|Withdrawal by Subject|1|||
155353755|NCT01751165|560731384|FG000|Overall Study|Adverse event, serious fatal|1|||
155353756|NCT01751165|560731385|FG001|Overall Study|Adverse event, serious fatal|0|||
155353757|NCT01751165|560731386|FG002|Overall Study|Adverse event, serious fatal|1|||
155353758|NCT01751165|560731384|FG000|Overall Study|Withdrawal by Subject|0|||
155353759|NCT01751165|560731385|FG001|Overall Study|Withdrawal by Subject|0|||
155353760|NCT01751165|560731386|FG002|Overall Study|Withdrawal by Subject|1|||
155353761|NCT01751165|560731384|FG000|Overall Study|Serious adverse event|0|||
155353762|NCT01751165|560731385|FG001|Overall Study|Serious adverse event|2|||
155353763|NCT01751165|560731386|FG002|Overall Study|Serious adverse event|0|||
155353764|NCT01751165|560731384|FG000|Overall Study|Lost to Follow-up|1|||
155353765|NCT01751165|560731385|FG001|Overall Study|Lost to Follow-up|1|||
155353766|NCT01751165|560731386|FG002|Overall Study|Lost to Follow-up|1|||
155353767|NCT00988533|560731387|FG000|Overall Study|Lost to Follow-up|3|||
155353768|NCT00913523|560731389|FG000|Overall Study|Withdrawal by Subject|3|||
155353769|NCT00913523|560731390|FG001|Overall Study|Withdrawal by Subject|2|||
155353770|NCT00913523|560731391|FG002|Overall Study|Withdrawal by Subject|2|||
155353771|NCT00913523|560731389|FG000|Overall Study|Lost to Follow-up|1|||
155353772|NCT00913523|560731390|FG001|Overall Study|Lost to Follow-up|1|||
155353773|NCT00913523|560731391|FG002|Overall Study|Lost to Follow-up|1|||
155353774|NCT00913523|560731389|FG000|Overall Study|Adverse Event|1|||
155353775|NCT00913523|560731390|FG001|Overall Study|Adverse Event|0|||
155353776|NCT00913523|560731391|FG002|Overall Study|Adverse Event|0|||
155353777|NCT00913523|560731389|FG000|Overall Study|Protocol Violation|5|||
155353778|NCT00913523|560731390|FG001|Overall Study|Protocol Violation|8|||
155353779|NCT00913523|560731391|FG002|Overall Study|Protocol Violation|8|||
155353780|NCT00913523|560731389|FG000|Overall Study|Pregnancy|1|||
155353781|NCT00913523|560731390|FG001|Overall Study|Pregnancy|3|||
155353782|NCT00913523|560731391|FG002|Overall Study|Pregnancy|0|||
155353783|NCT00913523|560731389|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
155353784|NCT00913523|560731390|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
155353785|NCT00913523|560731391|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
155353786|NCT01475461|560731392|FG000|Run-in Period|Not meet eligibility criteria|16|||
155353787|NCT01475461|560731393|FG001|Run-in Period|Not meet eligibility criteria|0|||
155353788|NCT01475461|560731394|FG002|Run-in Period|Not meet eligibility criteria|0|||
155353789|NCT01475461|560731395|FG003|Run-in Period|Not meet eligibility criteria|0|||
155353790|NCT01475461|560731396|FG004|Run-in Period|Not meet eligibility criteria|0|||
155353791|NCT01475461|560731397|FG005|Run-in Period|Not meet eligibility criteria|0|||
155353792|NCT01475461|560731398|FG006|Run-in Period|Not meet eligibility criteria|0|||
155353793|NCT01475461|560731392|FG000|Run-in Period|Lost to Follow-up|7|||
155353794|NCT01475461|560731393|FG001|Run-in Period|Lost to Follow-up|0|||
155353795|NCT01475461|560731394|FG002|Run-in Period|Lost to Follow-up|0|||
155353796|NCT01475461|560731395|FG003|Run-in Period|Lost to Follow-up|0|||
155353797|NCT01475461|560731396|FG004|Run-in Period|Lost to Follow-up|0|||
155353798|NCT01475461|560731397|FG005|Run-in Period|Lost to Follow-up|0|||
155353799|NCT01475461|560731398|FG006|Run-in Period|Lost to Follow-up|0|||
155086228|NCT01051661|559747661|FG003|Overall Study|Unable to attend visit(s)|1|||
155086229|NCT01051661|559747662|FG004|Overall Study|Unable to attend visit(s)|3|||
155353800|NCT01475461|560731392|FG000|Run-in Period|Withdrawal by Subject|11|||
155353801|NCT01475461|560731393|FG001|Run-in Period|Withdrawal by Subject|0|||
155353802|NCT01475461|560731394|FG002|Run-in Period|Withdrawal by Subject|0|||
155353803|NCT01475461|560731395|FG003|Run-in Period|Withdrawal by Subject|0|||
155353804|NCT01475461|560731396|FG004|Run-in Period|Withdrawal by Subject|0|||
155353805|NCT01475461|560731397|FG005|Run-in Period|Withdrawal by Subject|0|||
155353806|NCT01475461|560731398|FG006|Run-in Period|Withdrawal by Subject|0|||
155353807|NCT01475461|560731392|FG000|Run-in Period|Other|3|||
155353808|NCT01475461|560731393|FG001|Run-in Period|Other|0|||
155353809|NCT01475461|560731394|FG002|Run-in Period|Other|0|||
155353810|NCT01475461|560731395|FG003|Run-in Period|Other|0|||
155353811|NCT01475461|560731396|FG004|Run-in Period|Other|0|||
155086230|NCT01051661|559747663|FG005|Overall Study|Unable to attend visit(s)|2|||
155086231|NCT01051661|559747658|FG000|Overall Study|Consent not received from both parents|0|||
155086232|NCT01051661|559747659|FG001|Overall Study|Consent not received from both parents|0|||
155086233|NCT01051661|559747660|FG002|Overall Study|Consent not received from both parents|0|||
155353812|NCT01475461|560731397|FG005|Run-in Period|Other|0|||
155353813|NCT01475461|560731398|FG006|Run-in Period|Other|0|||
155353814|NCT01475461|560731392|FG000|Run-in Period|Protocol Violation|4|||
155353815|NCT01475461|560731393|FG001|Run-in Period|Protocol Violation|0|||
155353816|NCT01475461|560731394|FG002|Run-in Period|Protocol Violation|0|||
155353817|NCT01475461|560731395|FG003|Run-in Period|Protocol Violation|0|||
155353818|NCT01475461|560731396|FG004|Run-in Period|Protocol Violation|0|||
155353819|NCT01475461|560731397|FG005|Run-in Period|Protocol Violation|0|||
155353820|NCT01475461|560731398|FG006|Run-in Period|Protocol Violation|0|||
155353821|NCT01475461|560731392|FG000|Treatment Period|Death|0|||
155353822|NCT01475461|560731393|FG001|Treatment Period|Death|0|||
155353823|NCT01475461|560731394|FG002|Treatment Period|Death|0|||
155353824|NCT01475461|560731395|FG003|Treatment Period|Death|1|||
155353825|NCT01475461|560731396|FG004|Treatment Period|Death|0|||
155353826|NCT01475461|560731397|FG005|Treatment Period|Death|0|||
155353827|NCT01475461|560731398|FG006|Treatment Period|Death|0|||
155353828|NCT01475461|560731392|FG000|Treatment Period|Lost to Follow-up|0|||
155353829|NCT01475461|560731393|FG001|Treatment Period|Lost to Follow-up|3|||
155353830|NCT01475461|560731394|FG002|Treatment Period|Lost to Follow-up|2|||
155353831|NCT01475461|560731395|FG003|Treatment Period|Lost to Follow-up|3|||
155353832|NCT01475461|560731396|FG004|Treatment Period|Lost to Follow-up|1|||
155353833|NCT01475461|560731397|FG005|Treatment Period|Lost to Follow-up|2|||
155353834|NCT01475461|560731398|FG006|Treatment Period|Lost to Follow-up|1|||
155353835|NCT01475461|560731392|FG000|Treatment Period|Withdrawal by Subject|0|||
155353836|NCT01475461|560731393|FG001|Treatment Period|Withdrawal by Subject|2|||
155353837|NCT01475461|560731394|FG002|Treatment Period|Withdrawal by Subject|2|||
155353838|NCT01475461|560731395|FG003|Treatment Period|Withdrawal by Subject|0|||
155353839|NCT01475461|560731396|FG004|Treatment Period|Withdrawal by Subject|2|||
155353840|NCT01475461|560731397|FG005|Treatment Period|Withdrawal by Subject|2|||
155353841|NCT01475461|560731398|FG006|Treatment Period|Withdrawal by Subject|0|||
155353842|NCT01475461|560731392|FG000|Treatment Period|Other|0|||
155353843|NCT01475461|560731393|FG001|Treatment Period|Other|1|||
155353844|NCT01475461|560731394|FG002|Treatment Period|Other|0|||
155353845|NCT01475461|560731395|FG003|Treatment Period|Other|0|||
155353846|NCT01475461|560731396|FG004|Treatment Period|Other|0|||
155353847|NCT01475461|560731397|FG005|Treatment Period|Other|0|||
155353848|NCT01475461|560731398|FG006|Treatment Period|Other|0|||
155353849|NCT01475461|560731392|FG000|Treatment Period|Protocol Violation|0|||
155353850|NCT01475461|560731393|FG001|Treatment Period|Protocol Violation|1|||
155353851|NCT01475461|560731394|FG002|Treatment Period|Protocol Violation|0|||
155353852|NCT01475461|560731395|FG003|Treatment Period|Protocol Violation|0|||
155353853|NCT01475461|560731396|FG004|Treatment Period|Protocol Violation|0|||
155353854|NCT01475461|560731397|FG005|Treatment Period|Protocol Violation|0|||
155353855|NCT01475461|560731398|FG006|Treatment Period|Protocol Violation|1|||
155353856|NCT01475461|560731392|FG000|Treatment Period|Lack of Efficacy|0|||
155353857|NCT01475461|560731393|FG001|Treatment Period|Lack of Efficacy|2|||
155353858|NCT01475461|560731394|FG002|Treatment Period|Lack of Efficacy|0|||
155353859|NCT01475461|560731395|FG003|Treatment Period|Lack of Efficacy|2|||
155353860|NCT01475461|560731396|FG004|Treatment Period|Lack of Efficacy|1|||
155353861|NCT01475461|560731397|FG005|Treatment Period|Lack of Efficacy|1|||
155353862|NCT01475461|560731398|FG006|Treatment Period|Lack of Efficacy|0|||
155353863|NCT01475461|560731392|FG000|Treatment Period|Medication Error|0|||
155353864|NCT01475461|560731393|FG001|Treatment Period|Medication Error|0|||
155353865|NCT01475461|560731394|FG002|Treatment Period|Medication Error|0|||
155353866|NCT01475461|560731395|FG003|Treatment Period|Medication Error|1|||
155353867|NCT01475461|560731396|FG004|Treatment Period|Medication Error|0|||
155353868|NCT01475461|560731397|FG005|Treatment Period|Medication Error|0|||
155353869|NCT01475461|560731398|FG006|Treatment Period|Medication Error|0|||
155353870|NCT01475461|560731392|FG000|Treatment Period|Adverse Event|0|||
155086234|NCT01051661|559747661|FG003|Overall Study|Consent not received from both parents|0|||
155353871|NCT01475461|560731393|FG001|Treatment Period|Adverse Event|0|||
155353872|NCT01475461|560731394|FG002|Treatment Period|Adverse Event|0|||
155353873|NCT01475461|560731395|FG003|Treatment Period|Adverse Event|1|||
155353874|NCT01475461|560731396|FG004|Treatment Period|Adverse Event|0|||
155353875|NCT01475461|560731397|FG005|Treatment Period|Adverse Event|0|||
155353876|NCT01475461|560731398|FG006|Treatment Period|Adverse Event|0|||
155353877|NCT04051242|560731399|FG000|Overall Study|Withdrawal by Subject|1|||
155353878|NCT04051242|560731399|FG000|Overall Study|Physician Decision|1|||
155353879|NCT02512861|560731402|FG000|Overall Study|Protocol Violation|3|||
155353880|NCT02512861|560731403|FG001|Overall Study|Protocol Violation|7|||
155353881|NCT02512861|560731402|FG000|Overall Study|Physician Decision|3|||
155353882|NCT02512861|560731403|FG001|Overall Study|Physician Decision|1|||
155086235|NCT01051661|559747662|FG004|Overall Study|Consent not received from both parents|0|||
155086236|NCT01051661|559747663|FG005|Overall Study|Consent not received from both parents|1|||
155086237|NCT01051661|559747658|FG000|Overall Study|Failure to comply with protocol|0|||
155353883|NCT02512861|560731402|FG000|Overall Study|Withdrawal by Subject|0|||
155353884|NCT02512861|560731403|FG001|Overall Study|Withdrawal by Subject|1|||
155353885|NCT00553605|560731404|FG000|Overall Study|Did not meet entrance criteria|1|||
155353886|NCT00553605|560731405|FG001|Overall Study|Did not meet entrance criteria|3|||
155353887|NCT00553605|560731404|FG000|Overall Study|Did not receive full dose|1|||
155353888|NCT00553605|560731405|FG001|Overall Study|Did not receive full dose|0|||
155086238|NCT01051661|559747659|FG001|Overall Study|Failure to comply with protocol|0|||
155086239|NCT01051661|559747660|FG002|Overall Study|Failure to comply with protocol|2|||
155086240|NCT01051661|559747661|FG003|Overall Study|Failure to comply with protocol|0|||
155086241|NCT01051661|559747662|FG004|Overall Study|Failure to comply with protocol|0|||
155086242|NCT01051661|559747663|FG005|Overall Study|Failure to comply with protocol|0|||
155086243|NCT01051661|559747658|FG000|Overall Study|Subject lost legal representation|0|||
155086244|NCT01051661|559747659|FG001|Overall Study|Subject lost legal representation|0|||
155086245|NCT01051661|559747660|FG002|Overall Study|Subject lost legal representation|0|||
155086246|NCT01051661|559747661|FG003|Overall Study|Subject lost legal representation|0|||
155086247|NCT01051661|559747662|FG004|Overall Study|Subject lost legal representation|1|||
155086248|NCT01051661|559747663|FG005|Overall Study|Subject lost legal representation|0|||
155086249|NCT01051661|559747658|FG000|Overall Study|Protocol Violation|0|||
155086250|NCT01051661|559747659|FG001|Overall Study|Protocol Violation|0|||
155086251|NCT01051661|559747660|FG002|Overall Study|Protocol Violation|0|||
155086252|NCT01051661|559747661|FG003|Overall Study|Protocol Violation|1|||
155086253|NCT01051661|559747662|FG004|Overall Study|Protocol Violation|2|||
155086254|NCT01051661|559747663|FG005|Overall Study|Protocol Violation|1|||
155086255|NCT01051661|559747658|FG000|Overall Study|Withdrawal by Subject|16|||
155086256|NCT01051661|559747659|FG001|Overall Study|Withdrawal by Subject|30|||
155086257|NCT01051661|559747660|FG002|Overall Study|Withdrawal by Subject|13|||
155086258|NCT01051661|559747661|FG003|Overall Study|Withdrawal by Subject|28|||
155086259|NCT01051661|559747662|FG004|Overall Study|Withdrawal by Subject|12|||
155086260|NCT01051661|559747663|FG005|Overall Study|Withdrawal by Subject|34|||
155086261|NCT01681849|559747664|FG000|Overall Study|Protocol Violation|2|||
155086262|NCT01681849|559747665|FG001|Overall Study|Protocol Violation|0|||
155086263|NCT01681849|559747666|FG002|Overall Study|Protocol Violation|0|||
155086264|NCT01681849|559747664|FG000|Overall Study|Withdrawal by Subject|3|||
155086265|NCT01681849|559747665|FG001|Overall Study|Withdrawal by Subject|5|||
155086266|NCT01681849|559747666|FG002|Overall Study|Withdrawal by Subject|33|||
155086267|NCT01681849|559747664|FG000|Overall Study|Lost to Follow-up|3|||
155086268|NCT01681849|559747665|FG001|Overall Study|Lost to Follow-up|2|||
155086269|NCT01681849|559747666|FG002|Overall Study|Lost to Follow-up|6|||
155086270|NCT02852005|559747670|FG000|Overall Study|Lost to Follow-up|0|||
155086271|NCT02852005|559747671|FG001|Overall Study|Lost to Follow-up|0|||
155086272|NCT02852005|559747672|FG002|Overall Study|Lost to Follow-up|0|||
155086273|NCT02852005|559747673|FG003|Overall Study|Lost to Follow-up|0|||
155086274|NCT02852005|559747674|FG004|Overall Study|Lost to Follow-up|1|||
155086275|NCT02852005|559747670|FG000|Overall Study|Withdrawal by Subject|1|||
155086276|NCT02852005|559747671|FG001|Overall Study|Withdrawal by Subject|0|||
155086277|NCT02852005|559747672|FG002|Overall Study|Withdrawal by Subject|0|||
155086278|NCT02852005|559747673|FG003|Overall Study|Withdrawal by Subject|0|||
155086279|NCT02852005|559747674|FG004|Overall Study|Withdrawal by Subject|0|||
155086280|NCT04525183|559747675|FG000|Overall Study|Withdrawal by Subject|0|||
155086281|NCT04525183|559747676|FG001|Overall Study|Withdrawal by Subject|0|||
155086282|NCT04525183|559747677|FG002|Overall Study|Withdrawal by Subject|3|||
155086283|NCT04525183|559747675|FG000|Overall Study|Study non-compliance|0|||
155086284|NCT04525183|559747676|FG001|Overall Study|Study non-compliance|0|||
155086285|NCT04525183|559747677|FG002|Overall Study|Study non-compliance|1|||
155086286|NCT04525183|559747675|FG000|Overall Study|Recurrent disease before starting on study|0|||
155353889|NCT00553605|560731404|FG000|Overall Study|Randomized but not treated|2|||
155353890|NCT00553605|560731405|FG001|Overall Study|Randomized but not treated|0|||
155353891|NCT01874665|560731407|FG000|Overall Study|Adverse Event|6|||
155086287|NCT04525183|559747676|FG001|Overall Study|Recurrent disease before starting on study|0|||
155086288|NCT04525183|559747677|FG002|Overall Study|Recurrent disease before starting on study|1|||
155086289|NCT01916226|559747678|FG000|Overall Study|Adverse Event|1|||
155086290|NCT01916226|559747679|FG001|Overall Study|Adverse Event|0|||
155086291|NCT01916226|559747680|FG002|Overall Study|Adverse Event|1|||
155086292|NCT01916226|559747681|FG003|Overall Study|Adverse Event|1|||
155086293|NCT01916226|559747678|FG000|Overall Study|Lack of Efficacy|0|||
155086294|NCT01916226|559747679|FG001|Overall Study|Lack of Efficacy|0|||
155086295|NCT01916226|559747680|FG002|Overall Study|Lack of Efficacy|2|||
155086296|NCT01916226|559747681|FG003|Overall Study|Lack of Efficacy|1|||
155086297|NCT01916226|559747678|FG000|Overall Study|Protocol Violation|0|||
155086298|NCT01916226|559747679|FG001|Overall Study|Protocol Violation|1|||
155086299|NCT01916226|559747680|FG002|Overall Study|Protocol Violation|0|||
155086300|NCT01916226|559747681|FG003|Overall Study|Protocol Violation|1|||
155353892|NCT01874665|560731408|FG001|Overall Study|Adverse Event|2|||
155353893|NCT01874665|560731407|FG000|Overall Study|Withdrawal by Subject|4|||
155353894|NCT01874665|560731408|FG001|Overall Study|Withdrawal by Subject|1|||
155353895|NCT01874665|560731407|FG000|Overall Study|Physician Decision|3|||
155353896|NCT01874665|560731408|FG001|Overall Study|Physician Decision|0|||
155086301|NCT01916226|559747678|FG000|Overall Study|Physician Decision|0|||
155086302|NCT01916226|559747679|FG001|Overall Study|Physician Decision|0|||
155086303|NCT01916226|559747680|FG002|Overall Study|Physician Decision|0|||
155086304|NCT01916226|559747681|FG003|Overall Study|Physician Decision|1|||
155086305|NCT05142306|559747683|FG000|Overall Study|Withdrawal by Subject|0|||
155086306|NCT05142306|559747684|FG001|Overall Study|Withdrawal by Subject|0|||
155086307|NCT05142306|559747685|FG002|Overall Study|Withdrawal by Subject|1|||
155086308|NCT04042311|559747687|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
155086309|NCT04042311|559747687|FG000|Overall Study|Unable to tolerate|4|||
155086310|NCT04042311|559747687|FG000|Overall Study|Concurrent illness|2|||
155086311|NCT04042311|559747687|FG000|Overall Study|Adverse Event|2|||
155086312|NCT04042311|559747687|FG000|Overall Study|No longer meeting inclusion criteria|2|||
155086313|NCT04042311|559747687|FG000|Overall Study|No reason given|1|||
155086314|NCT04042311|559747687|FG000|Overall Study|Withdrawal by Subject|4|||
155086315|NCT04903093|559747688|FG000|Overall Study|Withdrawal by Subject|0|||
155086316|NCT04903093|559747689|FG001|Overall Study|Withdrawal by Subject|0|||
155086317|NCT04903093|559747690|FG002|Overall Study|Withdrawal by Subject|0|||
155086318|NCT04903093|559747691|FG003|Overall Study|Withdrawal by Subject|1|||
155086319|NCT04903093|559747692|FG004|Overall Study|Withdrawal by Subject|0|||
155086320|NCT04903093|559747693|FG005|Overall Study|Withdrawal by Subject|0|||
155086321|NCT02528305|559747694|FG000|Overall Study|Withdrawal by Subject|1|||
155086322|NCT02528305|559747694|FG000|Overall Study|Adverse Event|1|||
155086323|NCT02528305|559747694|FG000|Overall Study|Physician Decision|1|||
155086324|NCT01852214|559747695|FG000|Period 1|Adverse Event|1|||
155086325|NCT01852214|559747696|FG001|Period 1|Adverse Event|2|||
155086326|NCT01852214|559747695|FG000|Period 1|Withdrawal by Subject|0|||
155086327|NCT01852214|559747696|FG001|Period 1|Withdrawal by Subject|1|||
155086328|NCT01852214|559747695|FG000|Washout Period|Withdrawal by Subject|0|||
155086329|NCT01852214|559747696|FG001|Washout Period|Withdrawal by Subject|1|||
155086330|NCT00421408|559747697|FG000|Overall Study|Lost to Follow-up|30|||
155086331|NCT00421408|559747698|FG001|Overall Study|Lost to Follow-up|20|||
155086332|NCT00421408|559747697|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
155086333|NCT00421408|559747698|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
155086334|NCT00480532|559749062|FG000|Overall Study|Withdrawal by Subject|2|||
155086335|NCT00480532|559749063|FG001|Overall Study|Withdrawal by Subject|4|||
155086336|NCT00480532|559749064|FG002|Overall Study|Withdrawal by Subject|3|||
155086337|NCT00480532|559749065|FG003|Overall Study|Withdrawal by Subject|1|||
155086338|NCT00480532|559749062|FG000|Overall Study|Protocol Violation|0|||
155086339|NCT00480532|559749063|FG001|Overall Study|Protocol Violation|0|||
155086340|NCT00480532|559749064|FG002|Overall Study|Protocol Violation|1|||
155086341|NCT00480532|559749065|FG003|Overall Study|Protocol Violation|0|||
155086342|NCT00443456|559749066|FG000|Overall Study|Adverse Event|16|||
155086343|NCT00443456|559749066|FG000|Overall Study|Move|1|||
155086344|NCT00443456|559749066|FG000|Overall Study|Withdrawal by Subject|1|||
155086345|NCT00557440|559749067|FG000|Treatment Period 1|Adverse Event|0|||
155086346|NCT00557440|559749068|FG001|Treatment Period 1|Adverse Event|0|||
155086347|NCT00557440|559749069|FG002|Treatment Period 1|Adverse Event|1|||
155086348|NCT02157610|559749070|FG000|Overall Study|Death|4|||
155086349|NCT02157610|559749071|FG001|Overall Study|Death|4|||
155086350|NCT01592747|559749072|FG000|Overall Study|Loss of Therapeutic Response|107|||
155086351|NCT01592747|559749073|FG001|Overall Study|Loss of Therapeutic Response|108|||
155353897|NCT01874665|560731407|FG000|Overall Study|Clinical Progressive Disease|4|||
155353898|NCT01874665|560731408|FG001|Overall Study|Clinical Progressive Disease|3|||
155353899|NCT01874665|560731407|FG000|Overall Study|Study Terminated by Sponsor|0|||
155353900|NCT01874665|560731408|FG001|Overall Study|Study Terminated by Sponsor|2|||
155353901|NCT01874665|560731407|FG000|Overall Study|Documented Progressive Disease|11|||
155353902|NCT01874665|560731408|FG001|Overall Study|Documented Progressive Disease|7|||
155086352|NCT01592747|559749074|FG002|Overall Study|Loss of Therapeutic Response|100|||
155086353|NCT01592747|559749072|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155086354|NCT01592747|559749073|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
155086355|NCT01592747|559749074|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
155086356|NCT01592747|559749072|FG000|Overall Study|Adverse Event|1|||
155086357|NCT01592747|559749073|FG001|Overall Study|Adverse Event|0|||
155086358|NCT01592747|559749074|FG002|Overall Study|Adverse Event|0|||
155086359|NCT01592747|559749072|FG000|Overall Study|Protocol Violation|4|||
155086360|NCT01592747|559749073|FG001|Overall Study|Protocol Violation|0|||
155086361|NCT01592747|559749074|FG002|Overall Study|Protocol Violation|4|||
155165705|NCT02721966|560043539|FG000|Overall Study|Death|1|||
155353903|NCT01874665|560731407|FG000|Overall Study|Other|2|||
155086362|NCT01592747|559749072|FG000|Overall Study|Lack of Efficacy|0|||
155086363|NCT01592747|559749073|FG001|Overall Study|Lack of Efficacy|1|||
155165706|NCT02721966|560043540|FG001|Overall Study|Death|0|||
155353904|NCT01874665|560731408|FG001|Overall Study|Other|0|||
155353905|NCT00776659|560731413|FG000|Overall Study|Lost to Follow-up|15|||
155353906|NCT00776659|560731413|FG000|Overall Study|Withdrawal by Subject|10|||
155353907|NCT00776659|560731413|FG000|Overall Study|Study Terminated by Sponsor|1|||
155353908|NCT01585298|560731414|FG000|Overall Study|Study completion was not documented.|1|||
155353909|NCT01585298|560731414|FG000|Overall Study|Protocol deviation|1|||
155353910|NCT01585298|560731414|FG000|Overall Study|Administrative problems|4|||
155353911|NCT01585298|560731414|FG000|Overall Study|Lost to Follow-up|2|||
155353912|NCT01585298|560731414|FG000|Overall Study|Withdrawal by Subject|4|||
155353913|NCT01585298|560731414|FG000|Overall Study|Abnormal test procedure results|1|||
155353914|NCT01585298|560731414|FG000|Overall Study|Adverse Event|24|||
155353915|NCT01978236|560731417|FG000|Overall Study|Discontinued due to study close|2|||
155353916|NCT03811834|560731418|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
155353917|NCT01527500|560731419|FG000|Part A|Administrative|11|||
155353918|NCT01527500|560731420|FG001|Part A|Administrative|7|||
155353919|NCT01527500|560731419|FG000|Part A|Adverse Event|4|||
155353920|NCT01527500|560731420|FG001|Part A|Adverse Event|2|||
155353921|NCT01527500|560731419|FG000|Part A|Death|4|||
155353922|NCT01527500|560731420|FG001|Part A|Death|1|||
155353923|NCT01527500|560731419|FG000|Part A|Lost to Follow-up|0|||
155353924|NCT01527500|560731420|FG001|Part A|Lost to Follow-up|1|||
155353925|NCT01527500|560731419|FG000|Part A|Protocol Deviation|9|||
155086364|NCT01592747|559749074|FG002|Overall Study|Lack of Efficacy|0|||
155086365|NCT01592747|559749072|FG000|Overall Study|Withdrawal by Subject|2|||
155086366|NCT01592747|559749073|FG001|Overall Study|Withdrawal by Subject|0|||
155086367|NCT01592747|559749074|FG002|Overall Study|Withdrawal by Subject|2|||
155086368|NCT01592747|559749072|FG000|Overall Study|Lost to Follow-up|1|||
155086369|NCT01592747|559749073|FG001|Overall Study|Lost to Follow-up|0|||
155086370|NCT01592747|559749074|FG002|Overall Study|Lost to Follow-up|1|||
155086371|NCT01592747|559749072|FG000|Overall Study|Other Reasons|1|||
155086372|NCT01592747|559749073|FG001|Overall Study|Other Reasons|1|||
155086373|NCT01592747|559749074|FG002|Overall Study|Other Reasons|0|||
155086374|NCT02367885|559749075|FG000|Overall Study|Lost to Follow-up|1|||
155086375|NCT02367885|559749076|FG001|Overall Study|Lost to Follow-up|0|||
155086376|NCT02367885|559749077|FG002|Overall Study|Lost to Follow-up|0|||
155086377|NCT02367885|559749075|FG000|Overall Study|Withdrawal by Subject|1|||
155086378|NCT02367885|559749076|FG001|Overall Study|Withdrawal by Subject|0|||
155086379|NCT02367885|559749077|FG002|Overall Study|Withdrawal by Subject|0|||
155086380|NCT01602484|559749078|FG000|Overall Study|Airway issues unrelated to study|0|||
155086381|NCT01602484|559749079|FG001|Overall Study|Airway issues unrelated to study|1|||
155086382|NCT01378195|559749080|FG000|Overall Study|Lost to Follow-up|29|||
155086383|NCT01378195|559749081|FG001|Overall Study|Lost to Follow-up|18|||
155086384|NCT00425555|559749082|FG000|Overall Study|Withdrawal by Subject|11|||
155086385|NCT00425555|559749083|FG001|Overall Study|Withdrawal by Subject|8|||
155086386|NCT00425555|559749082|FG000|Overall Study|Lost to Follow-up|0|||
155086387|NCT00425555|559749083|FG001|Overall Study|Lost to Follow-up|1|||
155086388|NCT00425555|559749082|FG000|Overall Study|Administrative problems|3|||
155086389|NCT00425555|559749083|FG001|Overall Study|Administrative problems|0|||
155086390|NCT00425555|559749082|FG000|Overall Study|Death|1|||
155086391|NCT00425555|559749083|FG001|Overall Study|Death|2|||
155086392|NCT00425555|559749082|FG000|Overall Study|New cancer therapy|2|||
155086393|NCT00425555|559749083|FG001|Overall Study|New cancer therapy|1|||
155353926|NCT01527500|560731420|FG001|Part A|Protocol Deviation|2|||
155353927|NCT01527500|560731419|FG000|Part A|Withdrawal by Subject|2|||
155353928|NCT01527500|560731420|FG001|Part A|Withdrawal by Subject|0|||
155353929|NCT01527500|560731419|FG000|Part B|Adverse Event|1|||
155353930|NCT01527500|560731420|FG001|Part B|Adverse Event|0|||
155353931|NCT00372255|560731421|FG000|Overall Study|Withdrawn for other reasons|2|||
155353932|NCT00372255|560731422|FG001|Overall Study|Withdrawn for other reasons|1|||
155086394|NCT00425555|559749082|FG000|Overall Study|Disease progression|36|||
155353933|NCT02573883|560731426|FG000|Six Month Follow Up|Lost to Follow-up|1|||
155086395|NCT00425555|559749083|FG001|Overall Study|Disease progression|33|||
155086396|NCT00425555|559749082|FG000|Overall Study|Adverse Event|25|||
155086397|NCT00425555|559749083|FG001|Overall Study|Adverse Event|15|||
155086398|NCT00425555|559749082|FG000|Overall Study|Protocol Violation|1|||
155086399|NCT00425555|559749083|FG001|Overall Study|Protocol Violation|0|||
155086400|NCT03787615|559749084|FG000|Overall Study|Withdrawal by Subject|2|||
155086401|NCT03787615|559749084|FG000|Overall Study|Lost to Follow-up|2|||
155086402|NCT03533491|559749086|FG000|Overall Study|Lost to Follow-up|2|||
155353934|NCT02573883|560731427|FG001|Six Month Follow Up|Lost to Follow-up|0|||
155353935|NCT02573883|560731428|FG002|Six Month Follow Up|Lost to Follow-up|0|||
155353936|NCT02573883|560731429|FG003|Six Month Follow Up|Lost to Follow-up|0|||
155353937|NCT02573883|560731426|FG000|One Year Follow Up|Lost to Follow-up|2|||
155353938|NCT02573883|560731427|FG001|One Year Follow Up|Lost to Follow-up|1|||
155353939|NCT02573883|560731428|FG002|One Year Follow Up|Lost to Follow-up|0|||
155353940|NCT02573883|560731429|FG003|One Year Follow Up|Lost to Follow-up|0|||
155353941|NCT00582114|560731430|FG000|Overall Study|Death|4|||
155353942|NCT00582114|560731431|FG001|Overall Study|Death|4|||
155086403|NCT02034565|559749087|FG000|Overall Study|Adverse Event|1|||
155086404|NCT02034565|559749088|FG001|Overall Study|Adverse Event|0|||
155086405|NCT00721110|559749093|FG000|Overall Study|Ultram use|1|||
155086406|NCT00721110|559749094|FG001|Overall Study|Ultram use|0|||
155086407|NCT00721110|559749095|FG002|Overall Study|Ultram use|0|||
155086408|NCT00721110|559749096|FG003|Overall Study|Ultram use|0|||
155086409|NCT00721110|559749093|FG000|Overall Study|vertical incision|0|||
155086410|NCT00721110|559749094|FG001|Overall Study|vertical incision|0|||
155086411|NCT00721110|559749095|FG002|Overall Study|vertical incision|1|||
155086412|NCT00721110|559749096|FG003|Overall Study|vertical incision|0|||
155086413|NCT04079920|559749103|FG000|Overall Study|Adverse event, not related to study drug|2|||
155086414|NCT04079920|559749103|FG000|Overall Study|Adverse event related to study drug|10|||
155086415|NCT04079920|559749103|FG000|Overall Study|Death|2|||
155086416|NCT04079920|559749103|FG000|Overall Study|Lost to Follow-up|22|||
155086417|NCT04079920|559749103|FG000|Overall Study|Physician Decision|1|||
155086418|NCT04079920|559749103|FG000|Overall Study|Withdrawal by Subject|11|||
155086419|NCT03760068|559749104|FG000|Overall Study|Withdrawal by Subject|7|||
155086420|NCT03760068|559749105|FG001|Overall Study|Withdrawal by Subject|8|||
155086421|NCT03760068|559749104|FG000|Overall Study|Adverse Event|1|||
155086422|NCT03760068|559749105|FG001|Overall Study|Adverse Event|2|||
155086423|NCT03760068|559749104|FG000|Overall Study|Administrative Decision by Sponsor|0|||
155086424|NCT03760068|559749105|FG001|Overall Study|Administrative Decision by Sponsor|2|||
155086425|NCT03760068|559749104|FG000|Overall Study|Physician Decision|1|||
155086426|NCT03760068|559749105|FG001|Overall Study|Physician Decision|2|||
155086427|NCT03760068|559749104|FG000|Overall Study|Lost to Follow-up|4|||
155086428|NCT03760068|559749105|FG001|Overall Study|Lost to Follow-up|9|||
155086429|NCT03760068|559749104|FG000|Overall Study|Subject Moved Out of State|1|||
155086430|NCT03760068|559749105|FG001|Overall Study|Subject Moved Out of State|0|||
155086431|NCT01618708|559749106|FG000|Overall Study|Adverse Event|10|||
155086432|NCT01618708|559749107|FG001|Overall Study|Adverse Event|10|||
155086433|NCT01618708|559749106|FG000|Overall Study|Lost to Follow-up|3|||
155086434|NCT01618708|559749107|FG001|Overall Study|Lost to Follow-up|3|||
155086435|NCT01618708|559749106|FG000|Overall Study|Withdrawal by Subject|17|||
155086436|NCT01618708|559749107|FG001|Overall Study|Withdrawal by Subject|22|||
155086437|NCT01618708|559749106|FG000|Overall Study|Lack of Efficacy|8|||
155086438|NCT01618708|559749107|FG001|Overall Study|Lack of Efficacy|8|||
155086439|NCT01618708|559749106|FG000|Overall Study|Technical problems|2|||
155086440|NCT01618708|559749107|FG001|Overall Study|Technical problems|0|||
155086441|NCT01618708|559749106|FG000|Overall Study|Other than specified above|1|||
155086442|NCT01618708|559749107|FG001|Overall Study|Other than specified above|1|||
155086443|NCT01618708|559749106|FG000|Overall Study|Randomized but not treated|3|||
155086444|NCT01618708|559749107|FG001|Overall Study|Randomized but not treated|2|||
155086445|NCT05014919|559749110|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
155086446|NCT05014919|559749111|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
155086447|NCT05014919|559749112|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
155086448|NCT05014919|559749110|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
155086449|NCT05014919|559749111|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
155086450|NCT05014919|559749112|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
155086451|NCT05014919|559749110|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
155086452|NCT05014919|559749111|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
155086453|NCT05014919|559749112|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
155086454|NCT05014919|559749110|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
155086455|NCT05014919|559749111|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
155086456|NCT05014919|559749112|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
155086457|NCT05014919|559749110|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
155086458|NCT05014919|559749111|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
155086459|NCT05014919|559749112|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
155086460|NCT05014919|559749110|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
155086461|NCT05014919|559749111|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
155086462|NCT05014919|559749112|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
155086463|NCT05014919|559749110|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
155086464|NCT05014919|559749111|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
155086465|NCT05014919|559749112|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
155086466|NCT05014919|559749110|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
155086467|NCT05014919|559749111|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
155086468|NCT05014919|559749112|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
155086469|NCT00680914|559749113|FG000|Overall Study|Consent withdrawal|6|||
155086470|NCT00680914|559749114|FG001|Overall Study|Consent withdrawal|3|||
155353943|NCT00582114|560731430|FG000|Overall Study|Kidney Transplant|3|||
155353944|NCT00582114|560731431|FG001|Overall Study|Kidney Transplant|1|||
155086471|NCT00680914|559749113|FG000|Overall Study|Lost to Follow-up|4|||
155086472|NCT00680914|559749114|FG001|Overall Study|Lost to Follow-up|0|||
155086473|NCT00680914|559749113|FG000|Overall Study|serious adverse event (SAE)|0|||
155086474|NCT00680914|559749114|FG001|Overall Study|serious adverse event (SAE)|1|||
155086475|NCT01848457|559749115|FG000|Overall Study|Death|1|||
155086476|NCT01848457|559749116|FG001|Overall Study|Death|0|||
155086477|NCT01848457|559749117|FG002|Overall Study|Death|0|||
155086478|NCT01848457|559749118|FG003|Overall Study|Death|0|||
155086479|NCT02940223|559749119|FG000|Overall Study|Failed Requirement|2|||
155086480|NCT02940223|559749120|FG001|Overall Study|Failed Requirement|0|||
155086481|NCT03773562|559749124|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
155086482|NCT03773562|559749124|FG000|Overall Study|Lost to Follow-up|10|||
155086483|NCT03773562|559749124|FG000|Overall Study|Withdrawal by Subject|1|||
155086484|NCT03518060|559749130|FG000|Overall Study|Death|1|||
155086485|NCT03518060|559749130|FG000|Overall Study|Poor adherence|1|||
155086486|NCT03518060|559749130|FG000|Overall Study|Withdrawal of informed consent|2|||
155086487|NCT03518060|559749130|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
155086488|NCT03518060|559749130|FG000|Overall Study|Physician Decision|7|||
155086489|NCT03518060|559749130|FG000|Overall Study|Adverse drug reactions|23|||
155086490|NCT03518060|559749130|FG000|Overall Study|Withdrawal by Subject|25|||
155086491|NCT03518060|559749130|FG000|Overall Study|Lost to Follow-up|13|||
155086492|NCT03204812|559749137|FG000|Overall Study|Adverse Event|3|||
155086493|NCT02412436|559749138|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
155086494|NCT02412436|559749138|FG000|Overall Study|Lost to Follow-up|6|||
155086495|NCT02412436|559749138|FG000|Overall Study|Unable to get to clinic|3|||
155086496|NCT02412436|559749138|FG000|Overall Study|Death|1|||
155086497|NCT02412436|559749138|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
155086498|NCT02544763|559749139|FG000|Overall Study|Adverse Event|8|||
155086499|NCT02544763|559749140|FG001|Overall Study|Adverse Event|8|||
155086500|NCT02544763|559749141|FG002|Overall Study|Adverse Event|0|||
155086501|NCT02544763|559749139|FG000|Overall Study|Withdrawn by parent/guardian|1|||
155353945|NCT00582114|560731430|FG000|Overall Study|Lost to Follow-up|7|||
155353946|NCT00582114|560731431|FG001|Overall Study|Lost to Follow-up|6|||
155353947|NCT00582114|560731430|FG000|Overall Study|Withdrawal by Subject|8|||
155353948|NCT00582114|560731431|FG001|Overall Study|Withdrawal by Subject|16|||
155353949|NCT00582114|560731430|FG000|Overall Study|Adverse Event|1|||
155353950|NCT00582114|560731431|FG001|Overall Study|Adverse Event|1|||
155353951|NCT00582114|560731430|FG000|Overall Study|Physician Decision|0|||
155353952|NCT00582114|560731431|FG001|Overall Study|Physician Decision|6|||
155353953|NCT00582114|560731430|FG000|Overall Study|Stopped by data safety monitoring board|19|||
155353954|NCT00582114|560731431|FG001|Overall Study|Stopped by data safety monitoring board|20|||
155353955|NCT00130728|560731432|FG000|Overall Study|Death|258|||
155353956|NCT00130728|560731433|FG001|Overall Study|Death|258|||
155353957|NCT00130728|560731432|FG000|Overall Study|Lost to Follow-up|4|||
155353958|NCT00130728|560731433|FG001|Overall Study|Lost to Follow-up|0|||
155353959|NCT00130728|560731432|FG000|Overall Study|Withdrawal by Subject|0|||
155353960|NCT00130728|560731433|FG001|Overall Study|Withdrawal by Subject|2|||
155353961|NCT03796208|560731435|FG000|Overall Study|Withdrawal by Subject|3|||
155353962|NCT03796208|560731436|FG001|Overall Study|Withdrawal by Subject|0|||
155353963|NCT03796208|560731435|FG000|Overall Study|Loss of pregnancy|1|||
155353964|NCT03796208|560731436|FG001|Overall Study|Loss of pregnancy|1|||
155353965|NCT03796208|560731435|FG000|Overall Study|Changed prenatal clinics|0|||
155353966|NCT03796208|560731436|FG001|Overall Study|Changed prenatal clinics|5|||
155353967|NCT03796208|560731435|FG000|Overall Study|Lost to Follow-up|20|||
155353968|NCT03796208|560731436|FG001|Overall Study|Lost to Follow-up|16|||
155086502|NCT02544763|559749140|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155086503|NCT02544763|559749141|FG002|Overall Study|Withdrawn by parent/guardian|1|||
155086504|NCT02544763|559749139|FG000|Overall Study|Met withdrawal criteria|0|||
155086505|NCT02544763|559749140|FG001|Overall Study|Met withdrawal criteria|2|||
155086506|NCT02544763|559749141|FG002|Overall Study|Met withdrawal criteria|0|||
155086507|NCT02544763|559749139|FG000|Overall Study|Physician Decision|0|||
155353969|NCT01560585|560731438|FG000|Overall Study|Physician Decision|3|||
155353970|NCT00519285|560731439|FG000|Overall Study|Adverse Event|127|||
155353971|NCT00519285|560731440|FG001|Overall Study|Adverse Event|266|||
155086508|NCT02544763|559749140|FG001|Overall Study|Physician Decision|1|||
155086509|NCT02544763|559749141|FG002|Overall Study|Physician Decision|0|||
155086510|NCT02544763|559749139|FG000|Overall Study|Difficulties taking IMP|1|||
155086511|NCT02544763|559749140|FG001|Overall Study|Difficulties taking IMP|0|||
155353972|NCT00519285|560731439|FG000|Overall Study|Disease progression|334|||
155353973|NCT00519285|560731440|FG001|Overall Study|Disease progression|186|||
155086512|NCT02544763|559749141|FG002|Overall Study|Difficulties taking IMP|0|||
155086513|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
155086514|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155086515|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155353974|NCT00519285|560731439|FG000|Overall Study|Physician Decision|75|||
155353975|NCT00519285|560731440|FG001|Overall Study|Physician Decision|47|||
155353976|NCT00519285|560731439|FG000|Overall Study|Participant's request|53|||
155353977|NCT00519285|560731440|FG001|Overall Study|Participant's request|84|||
155353978|NCT00519285|560731439|FG000|Overall Study|Consent withdrawn|4|||
155353979|NCT00519285|560731440|FG001|Overall Study|Consent withdrawn|5|||
155353980|NCT00519285|560731439|FG000|Overall Study|Poor compliance to protocol|5|||
155353981|NCT00519285|560731440|FG001|Overall Study|Poor compliance to protocol|7|||
155353982|NCT00519285|560731439|FG000|Overall Study|Reason unspecified|5|||
155353983|NCT00519285|560731440|FG001|Overall Study|Reason unspecified|8|||
155353984|NCT00519285|560731439|FG000|Overall Study|Not treated|8|||
155353985|NCT00519285|560731440|FG001|Overall Study|Not treated|7|||
155353986|NCT00519285|560731439|FG000|Overall Study|Treatment ongoing|1|||
155353987|NCT00519285|560731440|FG001|Overall Study|Treatment ongoing|2|||
155353988|NCT04206384|560731443|FG000|Overall Study|Withdrawal by Subject|8|||
155353989|NCT04206384|560731443|FG000|Overall Study|Adverse Event|2|||
155353990|NCT01078584|560731446|FG000|Overall Study|Final Status Unknown|1073|||
155353991|NCT01078584|560731446|FG000|Overall Study|Lost to Follow-up|670|||
155353992|NCT01078584|560731446|FG000|Overall Study|Non-serious Adverse Event|577|||
155353993|NCT01078584|560731446|FG000|Overall Study|Withdrawal of Consent|244|||
155353994|NCT01078584|560731446|FG000|Overall Study|Physician Withdrew from Study|90|||
155353995|NCT01078584|560731446|FG000|Overall Study|Non-compliance|67|||
155353996|NCT01078584|560731446|FG000|Overall Study|Blood Pressure Controlled|49|||
155353997|NCT01078584|560731446|FG000|Overall Study|Physician Switched Medication|26|||
155353998|NCT01078584|560731446|FG000|Overall Study|Physician Discontinued Patient|12|||
155353999|NCT01078584|560731446|FG000|Overall Study|Lack of Efficacy|98|||
155354000|NCT01078584|560731446|FG000|Overall Study|Protocol Violation|75|||
155354001|NCT01078584|560731446|FG000|Overall Study|Serious Adverse Event|27|||
155354002|NCT01078584|560731446|FG000|Overall Study|Multiple Reasons|2|||
155354003|NCT01208870|560731447|FG000|Overall Study|Lost to Follow-up|2|||
155354004|NCT01208870|560731448|FG001|Overall Study|Lost to Follow-up|8|||
155354005|NCT01121185|560731449|FG000|Overall Study|Not infused|0|||
155354006|NCT01121185|560731450|FG001|Overall Study|Not infused|1|||
155354007|NCT01121185|560731449|FG000|Overall Study|Not transplanted|1|||
155354008|NCT01121185|560731450|FG001|Overall Study|Not transplanted|0|||
155354009|NCT01260142|560731451|FG000|Treatment Period 1|Study on hold|1|||
155354010|NCT01260142|560731452|FG001|Treatment Period 1|Study on hold|1|||
155354011|NCT01260142|560731453|FG002|Treatment Period 1|Study on hold|0|||
155354012|NCT01260142|560731454|FG003|Treatment Period 1|Study on hold|0|||
155354013|NCT01260142|560731455|FG004|Treatment Period 1|Study on hold|1|||
155354014|NCT01260142|560731456|FG005|Treatment Period 1|Study on hold|2|||
155354015|NCT01260142|560731451|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354016|NCT01260142|560731452|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354017|NCT01260142|560731453|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354018|NCT01260142|560731454|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354019|NCT01260142|560731455|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
155354020|NCT01260142|560731456|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
155354021|NCT01260142|560731451|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155354022|NCT01260142|560731452|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155354023|NCT01260142|560731453|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155354024|NCT01260142|560731454|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155354025|NCT01260142|560731455|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155354026|NCT01260142|560731456|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155354027|NCT00496834|560731462|FG000|Overall Study|Withdrawal by Subject|4|||
155354028|NCT00496834|560731463|FG001|Overall Study|Withdrawal by Subject|6|||
155354029|NCT00496834|560731462|FG000|Overall Study|Contraindicated medication administered|0|||
155354030|NCT00496834|560731463|FG001|Overall Study|Contraindicated medication administered|1|||
155354031|NCT00496834|560731462|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
155354032|NCT00496834|560731463|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
155354033|NCT00496834|560731462|FG000|Overall Study|Adverse Event|5|||
155354034|NCT00496834|560731463|FG001|Overall Study|Adverse Event|3|||
155354035|NCT00496834|560731462|FG000|Overall Study|IP administration violation|2|||
155354036|NCT00496834|560731463|FG001|Overall Study|IP administration violation|0|||
155354037|NCT00496834|560731462|FG000|Overall Study|Lost to Follow-up|2|||
155354038|NCT00496834|560731463|FG001|Overall Study|Lost to Follow-up|0|||
155354039|NCT00496834|560731462|FG000|Overall Study|Blood Pressure control failure|2|||
155354040|NCT00496834|560731463|FG001|Overall Study|Blood Pressure control failure|1|||
155354041|NCT00356759|560731466|FG000|Overall Study|Death|5|||
155354042|NCT00356759|560731467|FG001|Overall Study|Death|2|||
155354043|NCT00356759|560731466|FG000|Overall Study|Withdrawal by Subject|2|||
155354044|NCT00356759|560731467|FG001|Overall Study|Withdrawal by Subject|2|||
155354045|NCT00356759|560731466|FG000|Overall Study|Adverse Event|1|||
155354046|NCT00356759|560731467|FG001|Overall Study|Adverse Event|3|||
155354047|NCT00356759|560731466|FG000|Overall Study|Lost to Follow-up|1|||
155354048|NCT00356759|560731467|FG001|Overall Study|Lost to Follow-up|1|||
155354049|NCT00356759|560731466|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
155086516|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155086517|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
155354050|NCT00356759|560731467|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
155354051|NCT01494298|560731468|FG000|Overall Study|Protocol Violation|2|||
155354052|NCT01494298|560731469|FG001|Overall Study|Protocol Violation|8|||
155354053|NCT04159805|560731470|FG000|Overall Study|Withdrawal by Subject|0|||
155354054|NCT04159805|560731471|FG001|Overall Study|Withdrawal by Subject|2|||
155354055|NCT04159805|560731472|FG002|Overall Study|Withdrawal by Subject|2|||
155354056|NCT02930837|560731473|FG000|Overall Study|Adverse Event|6|||
155354057|NCT02930837|560731473|FG000|Overall Study|Lost to Follow-up|5|||
155354058|NCT02930837|560731473|FG000|Overall Study|Withdrawal by Subject|1|||
155354059|NCT01393613|560731474|FG000|Overall Study|Adverse Event|11|||
155354060|NCT01393613|560731475|FG001|Overall Study|Adverse Event|11|||
155354061|NCT01393613|560731476|FG002|Overall Study|Adverse Event|13|||
155354062|NCT01393613|560731477|FG003|Overall Study|Adverse Event|22|||
155354063|NCT01393613|560731474|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
155354064|NCT01393613|560731475|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
155354065|NCT01393613|560731476|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
155354066|NCT01393613|560731477|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
155354067|NCT01393613|560731474|FG000|Overall Study|Physician Decision|2|||
155354068|NCT01393613|560731475|FG001|Overall Study|Physician Decision|0|||
155354069|NCT01393613|560731476|FG002|Overall Study|Physician Decision|0|||
155354070|NCT01393613|560731477|FG003|Overall Study|Physician Decision|1|||
155354071|NCT01393613|560731474|FG000|Overall Study|Withdrawal by Subject|15|||
155086518|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
155086519|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155354072|NCT01393613|560731475|FG001|Overall Study|Withdrawal by Subject|25|||
155354073|NCT01393613|560731476|FG002|Overall Study|Withdrawal by Subject|23|||
155354074|NCT01393613|560731477|FG003|Overall Study|Withdrawal by Subject|21|||
155354075|NCT01393613|560731474|FG000|Overall Study|Protocol Deviation|2|||
155354076|NCT01393613|560731475|FG001|Overall Study|Protocol Deviation|1|||
155354077|NCT01393613|560731476|FG002|Overall Study|Protocol Deviation|0|||
155354078|NCT01393613|560731477|FG003|Overall Study|Protocol Deviation|0|||
155354079|NCT01393613|560731474|FG000|Overall Study|Lack of Efficacy|9|||
155354080|NCT01393613|560731475|FG001|Overall Study|Lack of Efficacy|20|||
155354081|NCT01393613|560731476|FG002|Overall Study|Lack of Efficacy|16|||
155354082|NCT01393613|560731477|FG003|Overall Study|Lack of Efficacy|21|||
155354083|NCT02998918|560731483|FG000|Overall Study|Withdrawal by Subject|1|||
155354084|NCT02998918|560731484|FG001|Overall Study|Withdrawal by Subject|0|||
155354085|NCT00006436|560731485|FG000|Overall Study|Refused further treatment|2|||
155354086|NCT00006436|560731485|FG000|Overall Study|Declined to participate (before treatment started)|1|||
155354087|NCT01071317|560731486|FG000|Overall Study|Lost to Follow-up|2|||
155354088|NCT01071317|560731487|FG001|Overall Study|Lost to Follow-up|2|||
155354089|NCT00316589|560731488|FG000|Overall Study|Withdrawal by Subject|0|||
155354090|NCT00316589|560731489|FG001|Overall Study|Withdrawal by Subject|5|||
155354091|NCT00316589|560731490|FG002|Overall Study|Withdrawal by Subject|0|||
155354092|NCT00316589|560731491|FG003|Overall Study|Withdrawal by Subject|1|||
155354093|NCT00316589|560731488|FG000|Overall Study|Subject unwilling/unable to comply|0|||
155354094|NCT00316589|560731489|FG001|Overall Study|Subject unwilling/unable to comply|6|||
155354095|NCT00316589|560731490|FG002|Overall Study|Subject unwilling/unable to comply|0|||
155354096|NCT00316589|560731491|FG003|Overall Study|Subject unwilling/unable to comply|2|||
155354097|NCT00316589|560731488|FG000|Overall Study|Adverse Event|1|||
155354098|NCT00316589|560731489|FG001|Overall Study|Adverse Event|0|||
155354099|NCT00316589|560731490|FG002|Overall Study|Adverse Event|0|||
155354100|NCT00316589|560731491|FG003|Overall Study|Adverse Event|1|||
155354101|NCT00316589|560731488|FG000|Overall Study|Physician Decision|0|||
155354102|NCT00316589|560731489|FG001|Overall Study|Physician Decision|1|||
155354103|NCT00316589|560731490|FG002|Overall Study|Physician Decision|0|||
155354104|NCT00316589|560731491|FG003|Overall Study|Physician Decision|0|||
155354105|NCT00316589|560731488|FG000|Overall Study|Other reason|0|||
155354106|NCT00316589|560731489|FG001|Overall Study|Other reason|12|||
155354107|NCT00316589|560731490|FG002|Overall Study|Other reason|1|||
155354108|NCT00316589|560731491|FG003|Overall Study|Other reason|1|||
155354109|NCT01283971|560731496|FG000|Overall Study|Adverse Event|3|||
155354110|NCT01283971|560731497|FG001|Overall Study|Adverse Event|5|||
155354111|NCT01283971|560731496|FG000|Overall Study|Insufficient therapeutic responses|3|||
154964833|NCT01188681|559297542|FG000|Overall Study|Withdrawal by Subject|0|||
154964834|NCT01188681|559297543|FG001|Overall Study|Withdrawal by Subject|0|||
155086520|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155086521|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155354112|NCT01283971|560731497|FG001|Overall Study|Insufficient therapeutic responses|3|||
155354113|NCT01283971|560731496|FG000|Overall Study|Protocol Violation|5|||
155354114|NCT01283971|560731497|FG001|Overall Study|Protocol Violation|1|||
155354115|NCT01283971|560731496|FG000|Overall Study|Refused treatment|3|||
155354116|NCT01283971|560731497|FG001|Overall Study|Refused treatment|1|||
155354117|NCT01283971|560731496|FG000|Overall Study|Failure to return|0|||
155354118|NCT01283971|560731497|FG001|Overall Study|Failure to return|1|||
155354119|NCT01283971|560731496|FG000|Overall Study|Administrative reasons|1|||
155086522|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
155086523|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
155086524|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155086525|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155354120|NCT01283971|560731497|FG001|Overall Study|Administrative reasons|1|||
155354121|NCT00562484|560731506|FG000|Overall Study|Adverse Event|6|||
155354122|NCT00562484|560731507|FG001|Overall Study|Adverse Event|1|||
155354123|NCT00562484|560731506|FG000|Overall Study|Protocol Violation|11|||
155086526|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155086527|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
155086528|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
155086529|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155086530|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155086531|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155086532|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
155086533|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
155086534|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155086535|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155086536|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155086537|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
155086538|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
155086539|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155086540|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155086541|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155086542|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
155086543|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
155086544|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155086545|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155086546|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155086547|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
155086548|NCT01111552|559749142|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
155086549|NCT01111552|559749143|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155086550|NCT01111552|559749144|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155086551|NCT01111552|559749145|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155086552|NCT01111552|559749146|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
155086553|NCT01111552|559749142|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155086554|NCT01111552|559749143|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155086555|NCT01111552|559749144|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155086556|NCT01111552|559749145|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
155086557|NCT01111552|559749146|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
155086558|NCT01111552|559749142|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
155354124|NCT00562484|560731507|FG001|Overall Study|Protocol Violation|2|||
155354125|NCT00562484|560731506|FG000|Overall Study|Withdrawal by Subject|12|||
155354126|NCT00562484|560731507|FG001|Overall Study|Withdrawal by Subject|9|||
155354127|NCT00562484|560731506|FG000|Overall Study|Moved away from the study area|20|||
155354128|NCT00562484|560731507|FG001|Overall Study|Moved away from the study area|9|||
155354129|NCT00562484|560731506|FG000|Overall Study|Lost to Follow-up|132|||
155354130|NCT00562484|560731507|FG001|Overall Study|Lost to Follow-up|71|||
155354131|NCT00562484|560731506|FG000|Overall Study|Reason not provided or not specified|25|||
155354132|NCT00562484|560731507|FG001|Overall Study|Reason not provided or not specified|12|||
155354133|NCT02598934|560731508|FG000|Overall Study|Adverse Event|11|||
155354134|NCT02598934|560731509|FG001|Overall Study|Adverse Event|13|||
155354135|NCT02598934|560731508|FG000|Overall Study|Failure to Return|3|||
155354136|NCT02598934|560731509|FG001|Overall Study|Failure to Return|3|||
155354137|NCT02598934|560731508|FG000|Overall Study|Withdrawal by Subject|2|||
155354138|NCT02598934|560731509|FG001|Overall Study|Withdrawal by Subject|3|||
155354139|NCT02598934|560731508|FG000|Overall Study|Administrative|2|||
155354140|NCT02598934|560731509|FG001|Overall Study|Administrative|1|||
155354141|NCT02598934|560731508|FG000|Overall Study|Protocol Violation|1|||
155354142|NCT02598934|560731509|FG001|Overall Study|Protocol Violation|2|||
155086559|NCT01111552|559749143|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
155086560|NCT01111552|559749144|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
155086561|NCT01111552|559749145|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
155086562|NCT01111552|559749146|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
155086563|NCT01111552|559749142|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155086564|NCT01111552|559749143|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
155086565|NCT01111552|559749144|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155086566|NCT01111552|559749145|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155086567|NCT01111552|559749146|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
155086568|NCT01111552|559749142|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155086569|NCT01111552|559749143|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
155086570|NCT01111552|559749144|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155086571|NCT01111552|559749145|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155086572|NCT01111552|559749146|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
155086573|NCT01111552|559749142|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155086574|NCT01111552|559749143|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
155086575|NCT01111552|559749144|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155086576|NCT01111552|559749145|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155086577|NCT01111552|559749146|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
155086578|NCT01111552|559749142|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155086579|NCT01111552|559749143|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155086580|NCT01111552|559749144|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
155086581|NCT01111552|559749145|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155086582|NCT01111552|559749146|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
155086583|NCT02097225|559749147|FG000|Dose Level 4|Adverse Event|0|||
155086584|NCT02097225|559749148|FG001|Dose Level 4|Adverse Event|0|||
155086585|NCT02097225|559749149|FG002|Dose Level 4|Adverse Event|0|||
155086586|NCT02097225|559749150|FG003|Dose Level 4|Adverse Event|0|||
155086587|NCT02097225|559749151|FG004|Dose Level 4|Adverse Event|1|||
155086588|NCT01027351|559749153|FG000|Overall Study|Withdrawal by Subject|1|||
155086589|NCT01027351|559749154|FG001|Overall Study|Withdrawal by Subject|0|||
155086590|NCT01027351|559749155|FG002|Overall Study|Withdrawal by Subject|1|||
155086591|NCT01027351|559749156|FG003|Overall Study|Withdrawal by Subject|0|||
155086592|NCT01027351|559749157|FG004|Overall Study|Withdrawal by Subject|3|||
155086593|NCT01027351|559749158|FG005|Overall Study|Withdrawal by Subject|5|||
155086594|NCT01027351|559749153|FG000|Overall Study|Lost to Follow-up|1|||
155086595|NCT01027351|559749154|FG001|Overall Study|Lost to Follow-up|1|||
155086596|NCT01027351|559749155|FG002|Overall Study|Lost to Follow-up|0|||
155086597|NCT01027351|559749156|FG003|Overall Study|Lost to Follow-up|1|||
155086598|NCT01027351|559749157|FG004|Overall Study|Lost to Follow-up|6|||
155086599|NCT01027351|559749158|FG005|Overall Study|Lost to Follow-up|0|||
155086600|NCT01027351|559749153|FG000|Overall Study|Inappropriate enrollment|0|||
155086601|NCT01027351|559749154|FG001|Overall Study|Inappropriate enrollment|0|||
155354143|NCT00702520|560731511|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
155354144|NCT00702520|560731512|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
155354145|NCT00702520|560731513|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
155354146|NCT00702520|560731514|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
155354147|NCT00702520|560731511|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
155354148|NCT00702520|560731512|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
155354149|NCT00702520|560731513|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
155354150|NCT00702520|560731514|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
155354151|NCT00702520|560731511|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
155354152|NCT00702520|560731512|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
155354153|NCT00702520|560731513|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
155354154|NCT00702520|560731514|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
155354155|NCT02154347|560731515|FG000|Double-blind Period|Adverse Event|1|||
155354156|NCT02154347|560731516|FG001|Double-blind Period|Adverse Event|2|||
155354157|NCT02154347|560731515|FG000|Double-blind Period|Lack of Efficacy|1|||
155354158|NCT02154347|560731516|FG001|Double-blind Period|Lack of Efficacy|0|||
155354159|NCT02154347|560731515|FG000|Double-blind Period|Physician Decision|0|||
155086602|NCT01027351|559749155|FG002|Overall Study|Inappropriate enrollment|0|||
155086603|NCT01027351|559749156|FG003|Overall Study|Inappropriate enrollment|0|||
155086604|NCT01027351|559749157|FG004|Overall Study|Inappropriate enrollment|1|||
155086605|NCT01027351|559749158|FG005|Overall Study|Inappropriate enrollment|0|||
155086606|NCT01027351|559749153|FG000|Overall Study|Protocol Violation|1|||
155086607|NCT01027351|559749154|FG001|Overall Study|Protocol Violation|0|||
155354160|NCT02154347|560731516|FG001|Double-blind Period|Physician Decision|1|||
155354161|NCT02154347|560731515|FG000|Double-blind Period|Withdrawal by Subject|1|||
155354162|NCT02154347|560731516|FG001|Double-blind Period|Withdrawal by Subject|1|||
155354163|NCT02154347|560731515|FG000|Open-label Period|Adverse Event|3|||
155354164|NCT02154347|560731516|FG001|Open-label Period|Adverse Event|4|||
155354165|NCT02154347|560731515|FG000|Open-label Period|Lack of Efficacy|4|||
155354166|NCT02154347|560731516|FG001|Open-label Period|Lack of Efficacy|19|||
155354167|NCT02154347|560731515|FG000|Open-label Period|Protocol Violation|0|||
155354168|NCT02154347|560731516|FG001|Open-label Period|Protocol Violation|1|||
155354169|NCT02154347|560731515|FG000|Open-label Period|Withdrawal by Subject|0|||
155354170|NCT02154347|560731516|FG001|Open-label Period|Withdrawal by Subject|1|||
155354171|NCT02481934|560731517|FG000|Overall Study|Death|2|||
155354172|NCT03302559|560731521|FG000|Overall Study|Adverse Event|2|||
155354173|NCT03302559|560731521|FG000|Overall Study|Lost to Follow-up|1|||
155354174|NCT03302559|560731521|FG000|Overall Study|Withdrew Consent|3|||
155354175|NCT01181609|560733201|FG000|Overall Study|Adverse Event|1|||
155354176|NCT01181609|560733201|FG000|Overall Study|Withdrawal by Subject|1|||
155354177|NCT01181609|560733201|FG000|Overall Study|Lost to Follow-up|1|||
155354178|NCT01181609|560733201|FG000|Overall Study|Death|50|||
155354179|NCT00612352|560733202|FG000|Overall Study|Adverse Event|1|||
155354180|NCT00612352|560733203|FG001|Overall Study|Adverse Event|0|||
155354181|NCT00612352|560733202|FG000|Overall Study|Withdrawal by Subject|3|||
155354182|NCT00612352|560733203|FG001|Overall Study|Withdrawal by Subject|5|||
155354183|NCT00612352|560733202|FG000|Overall Study|moved out of state|1|||
155354184|NCT00612352|560733203|FG001|Overall Study|moved out of state|0|||
155354185|NCT00612352|560733202|FG000|Overall Study|didn't return calls/show up on test date|4|||
155354186|NCT00612352|560733203|FG001|Overall Study|didn't return calls/show up on test date|1|||
155354187|NCT00263211|560733206|FG000|Overall Study|Death|1|||
155354188|NCT00263211|560733207|FG001|Overall Study|Death|0|||
155354189|NCT00263211|560733206|FG000|Overall Study|Withdrawal by Subject|3|||
155354190|NCT00263211|560733207|FG001|Overall Study|Withdrawal by Subject|0|||
155354191|NCT00263211|560733206|FG000|Overall Study|Protocol Violation|1|||
155354192|NCT00263211|560733207|FG001|Overall Study|Protocol Violation|0|||
155354193|NCT00263211|560733206|FG000|Overall Study|Disease Progression|0|||
155354194|NCT00263211|560733207|FG001|Overall Study|Disease Progression|1|||
155354195|NCT02820597|560733208|FG000|Overall Study|Lost to Follow-up|12|||
155354196|NCT00545571|560733211|FG000|Overall Study|Administrative Reasons|1|||
155354197|NCT00545571|560733211|FG000|Overall Study|Adverse Event|2|||
155354198|NCT00545571|560733211|FG000|Overall Study|Death|5|||
155354199|NCT00545571|560733211|FG000|Overall Study|Lack of Efficacy|1|||
155354200|NCT00545571|560733211|FG000|Overall Study|Protocol Violation|2|||
155354201|NCT00545571|560733211|FG000|Overall Study|Refused Treatment|1|||
155354202|NCT00545571|560733211|FG000|Overall Study|Screen Failure|16|||
155354203|NCT00545571|560733211|FG000|Overall Study|Transfusion|12|||
155354204|NCT00545571|560733211|FG000|Overall Study|Early Termination of Study|24|||
155354205|NCT00545571|560733211|FG000|Overall Study|Kidney Transplantation|3|||
155354206|NCT00874497|560733212|FG000|Overall Study|Lost to Follow-up|2|||
155354207|NCT00874497|560733213|FG001|Overall Study|Lost to Follow-up|4|||
155354208|NCT00874497|560733212|FG000|Overall Study|Adverse Event|9|||
155354209|NCT00874497|560733213|FG001|Overall Study|Adverse Event|4|||
155354210|NCT00874497|560733212|FG000|Overall Study|Sponsor Discontinued Trial|7|||
155354211|NCT00874497|560733213|FG001|Overall Study|Sponsor Discontinued Trial|3|||
155354212|NCT00874497|560733212|FG000|Overall Study|Met Withdrawal Criteria|4|||
155354213|NCT00874497|560733213|FG001|Overall Study|Met Withdrawal Criteria|2|||
155354214|NCT00874497|560733212|FG000|Overall Study|Physician Decision|1|||
155354215|NCT00874497|560733213|FG001|Overall Study|Physician Decision|1|||
155354216|NCT00874497|560733212|FG000|Overall Study|Withdrawal by Subject|5|||
155354217|NCT00874497|560733213|FG001|Overall Study|Withdrawal by Subject|4|||
155354218|NCT00644878|560733215|FG000|Overall Study|Adverse Event|2|||
155086608|NCT01027351|559749155|FG002|Overall Study|Protocol Violation|0|||
155354219|NCT00644878|560733215|FG000|Overall Study|Abnormal laboratory value|3|||
155354220|NCT00644878|560733215|FG000|Overall Study|Protocol deviation|2|||
155354221|NCT00644878|560733215|FG000|Overall Study|Treatment duration completed as per protocol|11|||
155354222|NCT04353817|560733216|FG000|Overall Study|Adverse Event|0|||
155354223|NCT04353817|560733217|FG001|Overall Study|Adverse Event|1|||
155354224|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
155354225|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
155354226|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
155354227|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Death|0|||
155354228|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Death|0|||
155086609|NCT01027351|559749156|FG003|Overall Study|Protocol Violation|1|||
155354229|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Death|1|||
155354230|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
155354231|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
155354232|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
155354233|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
155354234|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
155354235|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
155354236|NCT00665223|560733220|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
155354237|NCT00665223|560733221|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
155354238|NCT00665223|560733222|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
155354239|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
155354240|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
155354241|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
155354242|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Death|0|||
155354243|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Death|1|||
155354244|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Death|0|||
155354245|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
155354246|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
155354247|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
155354248|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
155354249|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
155354250|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
155354251|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
155354252|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
155354253|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
155354254|NCT00665223|560733220|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
155354255|NCT00665223|560733221|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
155354256|NCT00665223|560733222|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
155354257|NCT00591591|560733223|FG000|Overall Study|Withdrawal by Subject|1|||
155354258|NCT00591591|560733224|FG001|Overall Study|Withdrawal by Subject|37|||
155354259|NCT00591591|560733223|FG000|Overall Study|Lack of Efficacy|10|||
155354260|NCT00591591|560733224|FG001|Overall Study|Lack of Efficacy|2|||
155354261|NCT00338949|560733229|FG000|Subject Screening|Screen failures|11|||
155354262|NCT00338949|560733230|FG001|Subject Screening|Screen failures|11|||
155354263|NCT00338949|560733229|FG000|Randomization|Withdrawal by Subject|1|||
155354264|NCT00338949|560733230|FG001|Randomization|Withdrawal by Subject|0|||
155354265|NCT00338949|560733229|FG000|Randomization|Adverse Event|0|||
155354266|NCT00338949|560733230|FG001|Randomization|Adverse Event|5|||
155354267|NCT00878553|560733231|FG000|Sleep Study|Withdrawal by Subject|2|||
155354268|NCT00878553|560733232|FG001|Sleep Study|Withdrawal by Subject|0|||
155354269|NCT00878553|560733233|FG002|Sleep Study|Withdrawal by Subject|0|||
155354270|NCT00878553|560733234|FG003|Sleep Study|Withdrawal by Subject|0|||
155354271|NCT00878553|560733235|FG004|Sleep Study|Withdrawal by Subject|0|||
155354272|NCT00878553|560733231|FG000|Sleep Study|Lost to Follow-up|1|||
155354273|NCT00878553|560733232|FG001|Sleep Study|Lost to Follow-up|0|||
155086610|NCT01027351|559749157|FG004|Overall Study|Protocol Violation|1|||
155086611|NCT01027351|559749158|FG005|Overall Study|Protocol Violation|0|||
155086612|NCT04650893|559749159|FG000|Overall Study|Lost to Follow-up|11|||
155086613|NCT04650893|559749160|FG001|Overall Study|Lost to Follow-up|10|||
155086614|NCT04650893|559749161|FG002|Overall Study|Lost to Follow-up|11|||
155086615|NCT04091438|559749162|FG000|Treatment Period 1 (1 Day)|Other|1|||
155086616|NCT04091438|559749163|FG001|Treatment Period 1 (1 Day)|Other|0|||
155086617|NCT04091438|559749162|FG000|Washout Period (1 Day)|Protocol deviation|0|||
155086618|NCT04091438|559749163|FG001|Washout Period (1 Day)|Protocol deviation|1|||
155086619|NCT04091438|559749162|FG000|Washout Period (1 Day)|Other|0|||
155086620|NCT04091438|559749163|FG001|Washout Period (1 Day)|Other|1|||
155086621|NCT04309500|559749164|FG000|Overall Study|Lost to Follow-up|1|||
155086622|NCT04309500|559749165|FG001|Overall Study|Lost to Follow-up|0|||
155086623|NCT04309500|559749166|FG002|Overall Study|Lost to Follow-up|0|||
155086624|NCT04309500|559749167|FG003|Overall Study|Lost to Follow-up|0|||
155086625|NCT00773461|559749168|FG000|Overall Study|Adverse Event|1|||
155354274|NCT00878553|560733233|FG002|Sleep Study|Lost to Follow-up|0|||
155354275|NCT00878553|560733234|FG003|Sleep Study|Lost to Follow-up|0|||
155354276|NCT00878553|560733235|FG004|Sleep Study|Lost to Follow-up|0|||
155354277|NCT00878553|560733231|FG000|Sleep Study|car accident|1|||
155354278|NCT00878553|560733232|FG001|Sleep Study|car accident|0|||
155354279|NCT00878553|560733233|FG002|Sleep Study|car accident|0|||
155354280|NCT00878553|560733234|FG003|Sleep Study|car accident|0|||
155354281|NCT00878553|560733235|FG004|Sleep Study|car accident|0|||
155086626|NCT00773461|559749169|FG001|Overall Study|Adverse Event|3|||
155086627|NCT00773461|559749168|FG000|Overall Study|Withdrawal by Subject|4|||
155086628|NCT00773461|559749169|FG001|Overall Study|Withdrawal by Subject|1|||
155086629|NCT00913835|559749170|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
155086630|NCT00913835|559749171|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
155086631|NCT00913835|559749170|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
155086632|NCT00913835|559749171|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
155086633|NCT00913835|559749170|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
155086634|NCT00913835|559749171|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
155086635|NCT00913835|559749170|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
155086636|NCT00913835|559749171|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
155086637|NCT00913835|559749170|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
155086638|NCT00913835|559749171|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
155354282|NCT00878553|560733231|FG000|Sleep Study|family emergency|1|||
155354283|NCT00878553|560733232|FG001|Sleep Study|family emergency|0|||
155086639|NCT00637156|559749174|FG000|Overall Study|Withdrawal by Subject|0|||
155086640|NCT00637156|559749175|FG001|Overall Study|Withdrawal by Subject|7|||
155086641|NCT00637156|559749174|FG000|Overall Study|Death|0|||
155086642|NCT00637156|559749175|FG001|Overall Study|Death|1|||
155086643|NCT00637156|559749174|FG000|Overall Study|Lost to Follow-up|10|||
155086644|NCT00637156|559749175|FG001|Overall Study|Lost to Follow-up|16|||
155086645|NCT00461812|559749176|FG000|Overall Study|study terminated|10|||
155086646|NCT02679274|559749177|FG000|Overall Study|Withdrawal by Subject|1|||
155086647|NCT02679274|559749178|FG001|Overall Study|Withdrawal by Subject|0|||
155086648|NCT01308788|559749179|FG000|2-year Treatment|medication change by treating physician|4|||
155086649|NCT01308788|559749180|FG001|2-year Treatment|medication change by treating physician|11|||
155086650|NCT00322218|559749181|FG000|Overall Study|Death|3|||
155086651|NCT00322218|559749182|FG001|Overall Study|Death|6|||
155086652|NCT04976855|559749189|FG000|Part I|Withdrawal by Subject|0|||
155086653|NCT04976855|559749190|FG001|Part I|Withdrawal by Subject|1|||
155086654|NCT04976855|559749191|FG002|Part I|Withdrawal by Subject|0|||
155086655|NCT04976855|559749192|FG003|Part I|Withdrawal by Subject|0|||
155086656|NCT04976855|559749193|FG004|Part I|Withdrawal by Subject|0|||
155165707|NCT02721966|560043541|FG002|Overall Study|Death|0|||
155354284|NCT00878553|560733233|FG002|Sleep Study|family emergency|0|||
155354285|NCT00878553|560733234|FG003|Sleep Study|family emergency|0|||
155354286|NCT00878553|560733235|FG004|Sleep Study|family emergency|0|||
155354287|NCT00878553|560733231|FG000|PK Study|Withdrawal by Subject|0|||
155354288|NCT00878553|560733232|FG001|PK Study|Withdrawal by Subject|0|||
155354289|NCT00878553|560733233|FG002|PK Study|Withdrawal by Subject|0|||
155354290|NCT00878553|560733234|FG003|PK Study|Withdrawal by Subject|1|||
155354291|NCT00878553|560733235|FG004|PK Study|Withdrawal by Subject|0|||
155354292|NCT03517111|560733236|FG000|Enrolled|Withdrawal by Subject|0|||
155354293|NCT03517111|560733237|FG001|Enrolled|Withdrawal by Subject|1|||
155354294|NCT03517111|560733238|FG002|Enrolled|Withdrawal by Subject|0|||
155354295|NCT03517111|560733236|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
155354296|NCT03517111|560733237|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
155354297|NCT03517111|560733238|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
155354298|NCT03517111|560733236|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
155354299|NCT03517111|560733237|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
155354300|NCT03517111|560733238|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
155354301|NCT03517111|560733236|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
155165708|NCT02721966|560043542|FG003|Overall Study|Death|0|||
155086657|NCT04976855|559749194|FG005|Part I|Withdrawal by Subject|0|||
155354302|NCT03517111|560733237|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
155354303|NCT03517111|560733238|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
155354304|NCT03517111|560733236|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
155354305|NCT03517111|560733237|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
155086658|NCT04976855|559749195|FG006|Part I|Withdrawal by Subject|0|||
155086659|NCT04976855|559749189|FG000|Part II|Adverse Event|0|||
155165709|NCT02721966|560043543|FG004|Overall Study|Death|0|||
155354306|NCT03517111|560733238|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
155354307|NCT03188536|560733239|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
155354308|NCT03188536|560733239|FG000|Overall Study|Not participated/met inclusion criteria|1|||
155354309|NCT01930214|560733240|FG000|Overall Study|Death|4|||
155354310|NCT01930214|560733241|FG001|Overall Study|Death|4|||
155354311|NCT01930214|560733242|FG002|Overall Study|Death|11|||
155354312|NCT01930214|560733240|FG000|Overall Study|Lost to Follow-up|12|||
155354313|NCT01930214|560733241|FG001|Overall Study|Lost to Follow-up|13|||
155086660|NCT04976855|559749190|FG001|Part II|Adverse Event|0|||
155354314|NCT01930214|560733242|FG002|Overall Study|Lost to Follow-up|12|||
155354315|NCT01930214|560733240|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
155354316|NCT01930214|560733241|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
155354317|NCT01930214|560733242|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
155354318|NCT01930214|560733240|FG000|Overall Study|Physician Decision|2|||
155354319|NCT01930214|560733241|FG001|Overall Study|Physician Decision|0|||
155354320|NCT01930214|560733242|FG002|Overall Study|Physician Decision|0|||
155354321|NCT00025662|560733245|FG000|Overall Study|Withdrawal by Subject|2|||
155354322|NCT00025662|560733245|FG000|Overall Study|Technical failure of manipulation|1|||
155354323|NCT02062645|560733248|FG000|Overall Study|Adverse Event|2|||
155354324|NCT02062645|560733248|FG000|Overall Study|Protocol Violation|8|||
155354325|NCT02062645|560733248|FG000|Overall Study|Lost to Follow-up|5|||
155354326|NCT02864342|560733250|FG000|Overall Study|Eligibility Criteria Deviation|2|||
155354327|NCT02864342|560733251|FG001|Overall Study|Eligibility Criteria Deviation|3|||
155354328|NCT02864342|560733250|FG000|Overall Study|Withdrawal by Subject|4|||
155354329|NCT02864342|560733251|FG001|Overall Study|Withdrawal by Subject|2|||
155354330|NCT02864342|560733250|FG000|Overall Study|Device Technology Issue|6|||
155354331|NCT02864342|560733251|FG001|Overall Study|Device Technology Issue|7|||
155354332|NCT02864342|560733250|FG000|Overall Study|Death|0|||
155354333|NCT02864342|560733251|FG001|Overall Study|Death|1|||
155354334|NCT02864342|560733250|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
155354335|NCT02864342|560733251|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
155354336|NCT02864342|560733250|FG000|Overall Study|Lost to Follow-up|1|||
155354337|NCT02864342|560733251|FG001|Overall Study|Lost to Follow-up|5|||
155354338|NCT02864342|560733250|FG000|Overall Study|Lost Device|1|||
155354339|NCT02864342|560733251|FG001|Overall Study|Lost Device|0|||
155354340|NCT02864342|560733250|FG000|Overall Study|Adverse Event|1|||
155354341|NCT02864342|560733251|FG001|Overall Study|Adverse Event|0|||
155354342|NCT00118703|560733252|FG000|Overall Study|Protocol Violation|1|||
155354343|NCT00118703|560733253|FG001|Overall Study|Protocol Violation|0|||
155354344|NCT00118703|560733252|FG000|Overall Study|Adverse Event|1|||
155354345|NCT00118703|560733253|FG001|Overall Study|Adverse Event|1|||
155354346|NCT00118703|560733252|FG000|Overall Study|Participant took two different treatment|0|||
155354347|NCT00118703|560733253|FG001|Overall Study|Participant took two different treatment|1|||
155354348|NCT00118703|560733252|FG000|Overall Study|Withdrawal by Subject|2|||
155354349|NCT00118703|560733253|FG001|Overall Study|Withdrawal by Subject|5|||
155354350|NCT00118703|560733252|FG000|Overall Study|Lost to Follow-up|1|||
155354351|NCT00118703|560733253|FG001|Overall Study|Lost to Follow-up|2|||
155354352|NCT02261285|560733254|FG000|Overall Study|Disease progression|0|||
155354353|NCT02261285|560733255|FG001|Overall Study|Disease progression|0|||
155354354|NCT02261285|560733256|FG002|Overall Study|Disease progression|1|||
155354355|NCT02344173|560733257|FG000|Procedure|Ablation Procedure Not Performed|7|||
155354356|NCT02344173|560733257|FG000|12-month Visit|Death|8|||
155354357|NCT02344173|560733257|FG000|12-month Visit|Withdrawal by Subject|30|||
155354358|NCT02344173|560733257|FG000|12-month Visit|Lost to Follow-up|58|||
155354359|NCT01209286|560733258|FG000|Overall Study|Adverse Event|4|||
155354360|NCT01209286|560733259|FG001|Overall Study|Adverse Event|3|||
155354361|NCT01209286|560733260|FG002|Overall Study|Adverse Event|1|||
155354362|NCT01209286|560733258|FG000|Overall Study|Hematological Relapse After Remission|0|||
155354363|NCT01209286|560733259|FG001|Overall Study|Hematological Relapse After Remission|1|||
155354364|NCT01209286|560733260|FG002|Overall Study|Hematological Relapse After Remission|1|||
155354365|NCT01209286|560733258|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
155354366|NCT01209286|560733259|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
155354367|NCT01209286|560733260|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
155354368|NCT01209286|560733258|FG000|Overall Study|Physician Decision|0|||
155354369|NCT01209286|560733259|FG001|Overall Study|Physician Decision|2|||
155354370|NCT01209286|560733260|FG002|Overall Study|Physician Decision|0|||
155354371|NCT01209286|560733258|FG000|Overall Study|Other|0|||
155354372|NCT01209286|560733259|FG001|Overall Study|Other|1|||
155354373|NCT01209286|560733260|FG002|Overall Study|Other|0|||
155354374|NCT01349036|560733261|FG000|Overall Study|Disease progression|13|||
155354375|NCT01349036|560733262|FG001|Overall Study|Disease progression|22|||
155354376|NCT01349036|560733261|FG000|Overall Study|Other|1|||
155354377|NCT01349036|560733262|FG001|Overall Study|Other|0|||
155354378|NCT01349036|560733261|FG000|Overall Study|Withdrawal by Subject|0|||
155354379|NCT01349036|560733262|FG001|Overall Study|Withdrawal by Subject|2|||
155354380|NCT01161628|560733263|FG000|Overall Study|Death|6|||
155354381|NCT01161628|560733263|FG000|Overall Study|Lack of Efficacy|2|||
155354382|NCT01263925|560733266|FG000|Overall Study|Protocol Violation|1|||
155354383|NCT01263925|560733267|FG001|Overall Study|Protocol Violation|0|||
155354384|NCT01263925|560733266|FG000|Overall Study|Lack of Efficacy|0|||
155354385|NCT01263925|560733267|FG001|Overall Study|Lack of Efficacy|1|||
155354386|NCT01263925|560733266|FG000|Overall Study|Adverse Event|23|||
155354387|NCT01263925|560733267|FG001|Overall Study|Adverse Event|22|||
155354388|NCT01263925|560733266|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
155354389|NCT01263925|560733267|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
155354390|NCT01263925|560733266|FG000|Overall Study|Withdrawal by Subject|6|||
155354391|NCT01263925|560733267|FG001|Overall Study|Withdrawal by Subject|8|||
155354392|NCT01263925|560733266|FG000|Overall Study|Other|4|||
155354393|NCT01263925|560733267|FG001|Overall Study|Other|4|||
155354394|NCT01263925|560733266|FG000|Overall Study|Lost to Follow-up|3|||
155354395|NCT01263925|560733267|FG001|Overall Study|Lost to Follow-up|1|||
155354396|NCT01263925|560733266|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
155354397|NCT01263925|560733267|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
155354398|NCT01263925|560733266|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
155354399|NCT01263925|560733267|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
155354400|NCT01263925|560733266|FG000|Overall Study|AE/ Withdrawal|1|||
155354401|NCT01263925|560733267|FG001|Overall Study|AE/ Withdrawal|4|||
155354402|NCT01263925|560733266|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
155354403|NCT01263925|560733267|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
155354404|NCT01263925|560733266|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
155354405|NCT01263925|560733267|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
155354406|NCT01263925|560733266|FG000|Overall Study|Withdrawal/ Not specified|0|||
155354407|NCT01263925|560733267|FG001|Overall Study|Withdrawal/ Not specified|1|||
155354408|NCT03029819|560733268|FG000|Overall Study|Lost to Follow-up|3|||
155354409|NCT03029819|560733269|FG001|Overall Study|Lost to Follow-up|5|||
155354410|NCT03029819|560733268|FG000|Overall Study|Removed due to disruptive behavior|0|||
155354411|NCT03029819|560733269|FG001|Overall Study|Removed due to disruptive behavior|1|||
155354412|NCT01215032|560733273|FG000|Overall Study|Adverse Event|3|||
155354413|NCT01215032|560733273|FG000|Overall Study|Lack of Efficacy|17|||
155354414|NCT01020747|560733278|FG000|Overall Study|Withdrawal by Subject|1|||
155354415|NCT02970305|560733279|FG000|Overall Study|Adverse Event|10|||
155354416|NCT02970305|560733280|FG001|Overall Study|Adverse Event|6|||
155354417|NCT02970305|560733279|FG000|Overall Study|Lack of Efficacy|1|||
155354418|NCT02970305|560733280|FG001|Overall Study|Lack of Efficacy|1|||
155354419|NCT02970305|560733279|FG000|Overall Study|Noncompliance with study drug|2|||
155086661|NCT04976855|559749191|FG002|Part II|Adverse Event|0|||
155086662|NCT04976855|559749192|FG003|Part II|Adverse Event|1|||
155354420|NCT02970305|560733280|FG001|Overall Study|Noncompliance with study drug|4|||
155086663|NCT04976855|559749193|FG004|Part II|Adverse Event|0|||
155086664|NCT04976855|559749194|FG005|Part II|Adverse Event|0|||
155354421|NCT02970305|560733279|FG000|Overall Study|Protocol Violation|2|||
155354422|NCT02970305|560733280|FG001|Overall Study|Protocol Violation|2|||
155086665|NCT04976855|559749195|FG006|Part II|Adverse Event|0|||
155354423|NCT02970305|560733279|FG000|Overall Study|Withdrawal by Subject|12|||
155354424|NCT02970305|560733280|FG001|Overall Study|Withdrawal by Subject|11|||
155354425|NCT02970305|560733279|FG000|Overall Study|Not further specified|1|||
155354426|NCT02970305|560733280|FG001|Overall Study|Not further specified|2|||
155354427|NCT02970305|560733279|FG000|Overall Study|Lost to Follow-up|1|||
155354428|NCT02970305|560733280|FG001|Overall Study|Lost to Follow-up|2|||
155354429|NCT02175745|560733281|FG000|Overall Study|Not Eligible|1|||
155354430|NCT00983892|560733282|FG000|Overall Study|Withdrawal by Subject|10|||
155354431|NCT00983892|560733283|FG001|Overall Study|Withdrawal by Subject|12|||
155354432|NCT00808899|560733284|FG000|Overall Study|Death|1|||
155354433|NCT00808899|560733284|FG000|Overall Study|Physician Decision|3|||
155354434|NCT02881047|560733285|FG000|Overall Study|Adverse Event|1|||
155354435|NCT02881047|560733285|FG000|Overall Study|Withdrawal by Subject|1|||
155354436|NCT01726517|560733286|FG000|Overall Study|Withdrawal by Subject|0|||
155354437|NCT01726517|560733287|FG001|Overall Study|Withdrawal by Subject|0|||
155354438|NCT01726517|560733288|FG002|Overall Study|Withdrawal by Subject|1|||
155354439|NCT01726517|560733289|FG003|Overall Study|Withdrawal by Subject|0|||
155354440|NCT01726517|560733290|FG004|Overall Study|Withdrawal by Subject|0|||
155354441|NCT03765164|560733295|FG000|Pre-intervention|Withdrawal by Subject|5|||
155354442|NCT03765164|560733296|FG001|Pre-intervention|Withdrawal by Subject|6|||
155354443|NCT01813305|560733297|FG000|Overall Study|Withdrawal by Subject|12|||
155354444|NCT01813305|560733298|FG001|Overall Study|Withdrawal by Subject|5|||
155354445|NCT01813305|560733297|FG000|Overall Study|Safety Concern|4|||
155354446|NCT01813305|560733298|FG001|Overall Study|Safety Concern|0|||
155354447|NCT01813305|560733297|FG000|Overall Study|Ulcer became worse|4|||
155354448|NCT01813305|560733298|FG001|Overall Study|Ulcer became worse|0|||
155354449|NCT01813305|560733297|FG000|Overall Study|Physician Decision|4|||
155354450|NCT01813305|560733298|FG001|Overall Study|Physician Decision|0|||
155354451|NCT01813305|560733297|FG000|Overall Study|Lost to Follow-up|3|||
155354452|NCT01813305|560733298|FG001|Overall Study|Lost to Follow-up|1|||
155354453|NCT01813305|560733297|FG000|Overall Study|Protocol Violation|1|||
155354454|NCT01813305|560733298|FG001|Overall Study|Protocol Violation|0|||
155354455|NCT01813305|560733297|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
155354456|NCT01813305|560733298|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
155354457|NCT00770588|560733302|FG000|Overall Study|Adverse Event|9|||
155354458|NCT00770588|560733303|FG001|Overall Study|Adverse Event|2|||
155086666|NCT04976855|559749189|FG000|Part II|Withdrawal by Subject|0|||
155354459|NCT00770588|560733302|FG000|Overall Study|Death caused by progression of disease|70|||
155354460|NCT00770588|560733303|FG001|Overall Study|Death caused by progression of disease|91|||
155354461|NCT00770588|560733302|FG000|Overall Study|Lost to Follow-up|1|||
155354462|NCT00770588|560733303|FG001|Overall Study|Lost to Follow-up|1|||
155354463|NCT00770588|560733302|FG000|Overall Study|Withdrawal by Subject|1|||
155086667|NCT04976855|559749190|FG001|Part II|Withdrawal by Subject|0|||
155086668|NCT04976855|559749191|FG002|Part II|Withdrawal by Subject|0|||
155354464|NCT00770588|560733303|FG001|Overall Study|Withdrawal by Subject|1|||
155354465|NCT01424189|560733304|FG000|Overall Study|Adverse Event|1|||
155354466|NCT01424189|560733305|FG001|Overall Study|Adverse Event|0|||
155354467|NCT01424189|560733304|FG000|Overall Study|Lost to Follow-up|4|||
155354468|NCT01424189|560733305|FG001|Overall Study|Lost to Follow-up|1|||
155354469|NCT01424189|560733304|FG000|Overall Study|Withdrawal by Subject|4|||
155086669|NCT04976855|559749192|FG003|Part II|Withdrawal by Subject|0|||
155086670|NCT04976855|559749193|FG004|Part II|Withdrawal by Subject|1|||
155086671|NCT04976855|559749194|FG005|Part II|Withdrawal by Subject|0|||
155086672|NCT04976855|559749195|FG006|Part II|Withdrawal by Subject|0|||
155354470|NCT01424189|560733305|FG001|Overall Study|Withdrawal by Subject|4|||
155354471|NCT01424189|560733304|FG000|Overall Study|Subject moved|1|||
155354472|NCT01424189|560733305|FG001|Overall Study|Subject moved|0|||
155354473|NCT01424189|560733304|FG000|Overall Study|Death|3|||
155354474|NCT01424189|560733305|FG001|Overall Study|Death|1|||
155354475|NCT03120949|560733306|FG000|Overall Study|randomized in error|1|||
155354476|NCT03120949|560733307|FG001|Overall Study|randomized in error|0|||
155354477|NCT03120949|560733306|FG000|Overall Study|Death|13|||
155086673|NCT04976855|559749189|FG000|Part II|Lost to Follow-up|0|||
155354478|NCT03120949|560733307|FG001|Overall Study|Death|13|||
155354479|NCT03120949|560733306|FG000|Overall Study|Lost to Follow-up|23|||
155354480|NCT03120949|560733307|FG001|Overall Study|Lost to Follow-up|13|||
155354481|NCT03120949|560733306|FG000|Overall Study|Withdrawal by Subject|139|||
155354482|NCT03120949|560733307|FG001|Overall Study|Withdrawal by Subject|124|||
155354483|NCT03120949|560733306|FG000|Overall Study|Covid-19|43|||
155354484|NCT03120949|560733307|FG001|Overall Study|Covid-19|34|||
155354485|NCT03120949|560733306|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
155354486|NCT03120949|560733307|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
155354487|NCT03120949|560733306|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
155354488|NCT03120949|560733307|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
155354489|NCT03120949|560733306|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
155354490|NCT03120949|560733307|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
155354491|NCT03120949|560733306|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
155354492|NCT03120949|560733307|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
155354493|NCT03120949|560733306|FG000|Overall Study|Site was closed|2|||
155354494|NCT03120949|560733307|FG001|Overall Study|Site was closed|3|||
155354495|NCT03120949|560733306|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
155354496|NCT03120949|560733307|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
155354497|NCT03120949|560733306|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
155354498|NCT03120949|560733307|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
155354499|NCT03120949|560733306|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
155354500|NCT03120949|560733307|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
155354501|NCT03120949|560733306|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
155354502|NCT03120949|560733307|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
155354503|NCT03120949|560733306|FG000|Overall Study|Other: Adverse Event|0|||
155354504|NCT03120949|560733307|FG001|Overall Study|Other: Adverse Event|1|||
155354505|NCT03120949|560733306|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
155354506|NCT03120949|560733307|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
155354507|NCT03120949|560733306|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
155354508|NCT03120949|560733307|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
155354509|NCT03120949|560733306|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
155354510|NCT03120949|560733307|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
155354511|NCT03120949|560733306|FG000|Overall Study|Personal Reasons|0|||
155354512|NCT03120949|560733307|FG001|Overall Study|Personal Reasons|1|||
155354513|NCT03120949|560733306|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
155354514|NCT03120949|560733307|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
155354515|NCT03120949|560733306|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
155354516|NCT03120949|560733307|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
155354517|NCT03120949|560733306|FG000|Overall Study|Compliance With Medication|0|||
155354518|NCT03120949|560733307|FG001|Overall Study|Compliance With Medication|1|||
155354519|NCT03120949|560733306|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
155354520|NCT03120949|560733307|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
155354521|NCT03120949|560733306|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
155354522|NCT03120949|560733307|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
155354523|NCT03120949|560733306|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
155354524|NCT03120949|560733307|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
155354525|NCT01705145|560733308|FG000|Part B|Adverse Event|1|||
155354526|NCT01203956|560733309|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
155354527|NCT01203956|560733310|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
155354528|NCT02230306|560733313|FG000|Overall Study|Did not receive study treatment|1|||
155086674|NCT04976855|559749190|FG001|Part II|Lost to Follow-up|0|||
155086675|NCT04976855|559749191|FG002|Part II|Lost to Follow-up|0|||
155086676|NCT04976855|559749192|FG003|Part II|Lost to Follow-up|0|||
155086677|NCT04976855|559749193|FG004|Part II|Lost to Follow-up|0|||
155086678|NCT04976855|559749194|FG005|Part II|Lost to Follow-up|1|||
155086679|NCT04976855|559749195|FG006|Part II|Lost to Follow-up|0|||
155086680|NCT05487378|559749196|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
155086681|NCT05487378|559749197|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
155086682|NCT05487378|559749196|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
155086683|NCT05487378|559749197|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
155086684|NCT00003645|559750677|FG000|Overall Study|Death|4|||
155354529|NCT00312845|560733314|FG000|Overall Study|Adverse Event|19|||
155354530|NCT00312845|560733315|FG001|Overall Study|Adverse Event|5|||
155354531|NCT00312845|560733314|FG000|Overall Study|Death|2|||
155354532|NCT00312845|560733315|FG001|Overall Study|Death|2|||
155086685|NCT00003645|559750678|FG001|Overall Study|Death|1|||
155086686|NCT00003645|559750677|FG000|Overall Study|Lost to Follow-up|7|||
155086687|NCT00003645|559750678|FG001|Overall Study|Lost to Follow-up|8|||
155086688|NCT00003645|559750677|FG000|Overall Study|Withdrawal by Subject|1|||
155086689|NCT00003645|559750678|FG001|Overall Study|Withdrawal by Subject|3|||
155086690|NCT00980044|559750683|FG000|Overall Study|Withdrawal by Subject|5|||
155086691|NCT00980044|559750684|FG001|Overall Study|Withdrawal by Subject|7|||
155086692|NCT00980044|559750685|FG002|Overall Study|Withdrawal by Subject|3|||
155086693|NCT00980044|559750683|FG000|Overall Study|Protocol Violation|0|||
155086694|NCT00980044|559750684|FG001|Overall Study|Protocol Violation|0|||
155086695|NCT00980044|559750685|FG002|Overall Study|Protocol Violation|2|||
155086696|NCT00500331|559750687|FG000|Overall Study|Adverse Event|0|||
155086697|NCT00500331|559750688|FG001|Overall Study|Adverse Event|2|||
155086698|NCT00500331|559750689|FG002|Overall Study|Adverse Event|0|||
155086699|NCT00500331|559750690|FG003|Overall Study|Adverse Event|1|||
155086700|NCT00500331|559750691|FG004|Overall Study|Adverse Event|2|||
155086701|NCT00500331|559750692|FG005|Overall Study|Adverse Event|2|||
155086702|NCT00500331|559750693|FG006|Overall Study|Adverse Event|0|||
155086703|NCT00500331|559750687|FG000|Overall Study|Lost to Follow-up|1|||
155354533|NCT00312845|560733314|FG000|Overall Study|Withdrawal by Subject|14|||
155354534|NCT00312845|560733315|FG001|Overall Study|Withdrawal by Subject|6|||
155354535|NCT00312845|560733314|FG000|Overall Study|Disease Progression|56|||
155354536|NCT00312845|560733315|FG001|Overall Study|Disease Progression|77|||
155354537|NCT00312845|560733314|FG000|Overall Study|Lost to Follow-up|2|||
155354538|NCT00312845|560733315|FG001|Overall Study|Lost to Follow-up|0|||
155354539|NCT00312845|560733314|FG000|Overall Study|Other|6|||
155354540|NCT00312845|560733315|FG001|Overall Study|Other|5|||
155354541|NCT02212197|560733316|FG000|Overall Study|Need for radiotherapy|1|||
155354542|NCT02212197|560733317|FG001|Overall Study|Need for radiotherapy|0|||
155354543|NCT02212197|560733318|FG002|Overall Study|Need for radiotherapy|0|||
155354544|NCT01077622|560733320|FG000|Overall Study|Physician Decision|2|||
155354545|NCT01077622|560733320|FG000|Overall Study|Withdrawal by Subject|1|||
155354546|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
155354547|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
155354548|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
155354549|NCT00424177|560733321|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
155354550|NCT00424177|560733321|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
155354551|NCT00424177|560733321|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
155354552|NCT00424177|560733321|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
155354553|NCT00424177|560733321|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
155354554|NCT00424177|560733321|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
155354555|NCT00424177|560733321|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
155354556|NCT01503164|560733322|FG000|Overall Study|Withdrawal by Subject|2|||
155354557|NCT01503164|560733323|FG001|Overall Study|Withdrawal by Subject|1|||
155354558|NCT04088136|560733324|FG000|Overall Study|Withdrawal by Subject|5|||
155354559|NCT04088136|560733325|FG001|Overall Study|Withdrawal by Subject|0|||
155354560|NCT04088136|560733324|FG000|Overall Study|Lack of Efficacy|0|||
155354561|NCT04088136|560733325|FG001|Overall Study|Lack of Efficacy|1|||
155354562|NCT02473913|560733326|FG000|Overall Study|Lost to Follow-up|3|||
155354563|NCT02473913|560733327|FG001|Overall Study|Lost to Follow-up|3|||
155354564|NCT05041439|560733328|FG000|Overall Study|Withdrawal by Subject|1|||
155354565|NCT05041439|560733329|FG001|Overall Study|Withdrawal by Subject|1|||
155086704|NCT00500331|559750688|FG001|Overall Study|Lost to Follow-up|1|||
155086705|NCT00500331|559750689|FG002|Overall Study|Lost to Follow-up|1|||
155086706|NCT00500331|559750690|FG003|Overall Study|Lost to Follow-up|2|||
155086707|NCT00500331|559750691|FG004|Overall Study|Lost to Follow-up|1|||
155086708|NCT00500331|559750692|FG005|Overall Study|Lost to Follow-up|0|||
155354566|NCT05041439|560733328|FG000|Overall Study|Death|1|||
155354567|NCT05041439|560733329|FG001|Overall Study|Death|0|||
155086709|NCT00500331|559750693|FG006|Overall Study|Lost to Follow-up|0|||
155086710|NCT00500331|559750687|FG000|Overall Study|Protocol Violation|3|||
155354568|NCT02979613|560733332|FG000|Double-Blind Phase|Withdrew Consent|2|||
155354569|NCT02979613|560733333|FG001|Double-Blind Phase|Withdrew Consent|4|||
155354570|NCT02979613|560733332|FG000|Double-Blind Phase|Pregnancy|2|||
155354571|NCT02979613|560733333|FG001|Double-Blind Phase|Pregnancy|2|||
155354572|NCT02979613|560733332|FG000|Double-Blind Phase|Adverse Event|2|||
155354573|NCT02979613|560733333|FG001|Double-Blind Phase|Adverse Event|0|||
155354574|NCT02979613|560733332|FG000|Double-Blind Phase|Lost to Follow-up|1|||
155354575|NCT02979613|560733333|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155354576|NCT02979613|560733332|FG000|Double-Blind Phase|Protocol Violation|1|||
155354577|NCT02979613|560733333|FG001|Double-Blind Phase|Protocol Violation|1|||
155354578|NCT02979613|560733332|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
155354579|NCT02979613|560733333|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
155354580|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
155354581|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
155354582|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
155354583|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
155354584|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Death|0|||
155354585|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Death|1|||
155354586|NCT02979613|560733332|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
155354587|NCT02979613|560733333|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
155354588|NCT02250183|560733339|FG000|Overall Study|Withdrawal by Subject|2|||
155165710|NCT02721966|560043539|FG000|Overall Study|Lack of Efficacy|7|||
155354589|NCT02250183|560733339|FG000|Overall Study|Adverse Event|5|||
155354590|NCT02250183|560733339|FG000|Overall Study|Lost to Follow-up|1|||
155354591|NCT03282799|560733340|FG000|Overall Study|Pregnancy|1|||
155354592|NCT03282799|560733341|FG001|Overall Study|Pregnancy|0|||
155354593|NCT03282799|560733340|FG000|Overall Study|Physician Decision|1|||
155354594|NCT03282799|560733341|FG001|Overall Study|Physician Decision|0|||
155354595|NCT03749616|560733342|FG000|Overall Study|Lost to Follow-up|4|||
155354596|NCT03749616|560733343|FG001|Overall Study|Lost to Follow-up|7|||
155354597|NCT03749616|560733342|FG000|Overall Study|Screen Failure|1|||
155354598|NCT03749616|560733343|FG001|Overall Study|Screen Failure|1|||
155354599|NCT03749616|560733342|FG000|Overall Study|Withdrawal by Subject|2|||
155354600|NCT03749616|560733343|FG001|Overall Study|Withdrawal by Subject|0|||
155354601|NCT03614676|560734891|FG000|Overall Study|Delivery before planned visit|2|||
155354602|NCT03614676|560734892|FG001|Overall Study|Delivery before planned visit|0|||
155354603|NCT03614676|560734891|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
155354604|NCT03614676|560734892|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
155354605|NCT03614676|560734891|FG000|Overall Study|Migrated / moved from the study area|30|||
155354606|NCT03614676|560734892|FG001|Overall Study|Migrated / moved from the study area|22|||
155354607|NCT03614676|560734891|FG000|Overall Study|Lost to Follow-up|17|||
155354608|NCT03614676|560734892|FG001|Overall Study|Lost to Follow-up|42|||
155354609|NCT03614676|560734891|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
155354610|NCT03614676|560734892|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
155354611|NCT03614676|560734891|FG000|Overall Study|Other|16|||
155354612|NCT03614676|560734892|FG001|Overall Study|Other|47|||
155354613|NCT03614676|560734891|FG000|Overall Study|Protocol Violation|0|||
155354614|NCT03614676|560734892|FG001|Overall Study|Protocol Violation|2|||
155354615|NCT03614676|560734891|FG000|Overall Study|Neonatal event of interest|0|||
155354616|NCT03614676|560734892|FG001|Overall Study|Neonatal event of interest|6|||
155354617|NCT03614676|560734891|FG000|Overall Study|Death in infant greater than 28 days old|0|||
155354618|NCT03614676|560734892|FG001|Overall Study|Death in infant greater than 28 days old|12|||
155354619|NCT03614676|560734891|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
155354620|NCT03614676|560734892|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
155354621|NCT02388347|560734893|FG000|Overall Study|Withdrawal by Subject|0|||
155354622|NCT02388347|560734894|FG001|Overall Study|Withdrawal by Subject|0|||
155354623|NCT02388347|560734895|FG002|Overall Study|Withdrawal by Subject|1|||
155354624|NCT02388347|560734896|FG003|Overall Study|Withdrawal by Subject|0|||
155354625|NCT02388347|560734897|FG004|Overall Study|Withdrawal by Subject|0|||
155354626|NCT00497874|560734898|FG000|Overall Study|Withdrawal by Subject|48|||
155354627|NCT00497874|560734899|FG001|Overall Study|Withdrawal by Subject|17|||
155354628|NCT00497874|560734898|FG000|Overall Study|Illness|8|||
155354629|NCT00497874|560734899|FG001|Overall Study|Illness|4|||
155354630|NCT00497874|560734898|FG000|Overall Study|Death|2|||
155354631|NCT00497874|560734899|FG001|Overall Study|Death|4|||
155354632|NCT00497874|560734898|FG000|Overall Study|Unable to contact|52|||
155354633|NCT00497874|560734899|FG001|Overall Study|Unable to contact|67|||
155354634|NCT00497874|560734898|FG000|Overall Study|Unable to schedule|37|||
155354635|NCT00497874|560734899|FG001|Overall Study|Unable to schedule|24|||
155354636|NCT02080403|560734900|FG000|Overall Study|Adverse Event|5|||
155354637|NCT02080403|560734901|FG001|Overall Study|Adverse Event|1|||
155354638|NCT02080403|560734900|FG000|Overall Study|Death|0|||
155354639|NCT02080403|560734901|FG001|Overall Study|Death|2|||
155086711|NCT00500331|559750688|FG001|Overall Study|Protocol Violation|1|||
155086712|NCT00500331|559750689|FG002|Overall Study|Protocol Violation|1|||
155086713|NCT00500331|559750690|FG003|Overall Study|Protocol Violation|0|||
155086714|NCT00500331|559750691|FG004|Overall Study|Protocol Violation|1|||
155086715|NCT00500331|559750692|FG005|Overall Study|Protocol Violation|1|||
155086716|NCT00500331|559750693|FG006|Overall Study|Protocol Violation|1|||
155086717|NCT00500331|559750687|FG000|Overall Study|Withdrawal by Subject|4|||
155086718|NCT00500331|559750688|FG001|Overall Study|Withdrawal by Subject|0|||
155086719|NCT00500331|559750689|FG002|Overall Study|Withdrawal by Subject|1|||
155086720|NCT00500331|559750690|FG003|Overall Study|Withdrawal by Subject|5|||
155086721|NCT00500331|559750691|FG004|Overall Study|Withdrawal by Subject|0|||
155086722|NCT00500331|559750692|FG005|Overall Study|Withdrawal by Subject|1|||
155086723|NCT00500331|559750693|FG006|Overall Study|Withdrawal by Subject|1|||
155086724|NCT00500331|559750687|FG000|Overall Study|Lack of Efficacy|3|||
155086725|NCT00500331|559750688|FG001|Overall Study|Lack of Efficacy|1|||
155086726|NCT00500331|559750689|FG002|Overall Study|Lack of Efficacy|0|||
155086727|NCT00500331|559750690|FG003|Overall Study|Lack of Efficacy|0|||
155086728|NCT00500331|559750691|FG004|Overall Study|Lack of Efficacy|0|||
155086729|NCT00500331|559750692|FG005|Overall Study|Lack of Efficacy|0|||
155086730|NCT00500331|559750693|FG006|Overall Study|Lack of Efficacy|0|||
155086731|NCT00500331|559750687|FG000|Overall Study|Liver function test abnormality|0|||
155086732|NCT00500331|559750688|FG001|Overall Study|Liver function test abnormality|0|||
155086733|NCT00500331|559750689|FG002|Overall Study|Liver function test abnormality|1|||
155086734|NCT00500331|559750690|FG003|Overall Study|Liver function test abnormality|0|||
155086735|NCT00500331|559750691|FG004|Overall Study|Liver function test abnormality|0|||
155086736|NCT00500331|559750692|FG005|Overall Study|Liver function test abnormality|0|||
155086737|NCT00500331|559750693|FG006|Overall Study|Liver function test abnormality|0|||
155086738|NCT00500331|559750687|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
155086739|NCT00500331|559750688|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
155086740|NCT00500331|559750689|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
155086741|NCT00500331|559750690|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
155086742|NCT00500331|559750691|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
155086743|NCT00500331|559750692|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
155086744|NCT00500331|559750693|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
155086745|NCT00500331|559750687|FG000|Overall Study|Didn't return for continuation of study|1|||
155086746|NCT00500331|559750688|FG001|Overall Study|Didn't return for continuation of study|0|||
155086747|NCT00500331|559750689|FG002|Overall Study|Didn't return for continuation of study|0|||
155086748|NCT00500331|559750690|FG003|Overall Study|Didn't return for continuation of study|0|||
155086749|NCT00500331|559750691|FG004|Overall Study|Didn't return for continuation of study|0|||
155086750|NCT00500331|559750692|FG005|Overall Study|Didn't return for continuation of study|0|||
155086751|NCT00500331|559750693|FG006|Overall Study|Didn't return for continuation of study|0|||
155086752|NCT00500331|559750687|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
155086753|NCT00500331|559750688|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
155086754|NCT00500331|559750689|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
155086755|NCT00500331|559750690|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
155086756|NCT00500331|559750691|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
155086757|NCT00500331|559750692|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
155354640|NCT02080403|560734900|FG000|Overall Study|Lost to Follow-up|2|||
155354641|NCT02080403|560734901|FG001|Overall Study|Lost to Follow-up|0|||
155354642|NCT02080403|560734900|FG000|Overall Study|Pregnancy|0|||
155354643|NCT02080403|560734901|FG001|Overall Study|Pregnancy|1|||
155354644|NCT02080403|560734900|FG000|Overall Study|Protocol Violation|3|||
155354645|NCT02080403|560734901|FG001|Overall Study|Protocol Violation|7|||
155354646|NCT02080403|560734900|FG000|Overall Study|Withdrawal by Subject|5|||
155086758|NCT00500331|559750693|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
155086759|NCT00500331|559750687|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
155165711|NCT02721966|560043540|FG001|Overall Study|Lack of Efficacy|4|||
155354647|NCT02080403|560734901|FG001|Overall Study|Withdrawal by Subject|1|||
155354648|NCT01999972|560734902|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
155354649|NCT01999972|560734903|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
155354650|NCT01999972|560734904|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
155354651|NCT01999972|560734905|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
155354652|NCT01999972|560734906|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
155354653|NCT01999972|560734907|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
155354654|NCT01999972|560734902|FG000|Dose Escalation Part|Death|0|||
155354655|NCT01999972|560734903|FG001|Dose Escalation Part|Death|1|||
155354656|NCT01999972|560734904|FG002|Dose Escalation Part|Death|0|||
155354657|NCT01999972|560734905|FG003|Dose Escalation Part|Death|0|||
155354658|NCT01999972|560734906|FG004|Dose Escalation Part|Death|0|||
155354659|NCT01999972|560734907|FG005|Dose Escalation Part|Death|0|||
155354660|NCT01999972|560734902|FG000|Dose Escalation Part|Enrolled but not treated|0|||
155354661|NCT01999972|560734903|FG001|Dose Escalation Part|Enrolled but not treated|0|||
155086760|NCT00500331|559750688|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
155086761|NCT00500331|559750689|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
155086762|NCT00500331|559750690|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
155086763|NCT00500331|559750691|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
155086764|NCT00500331|559750692|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
155086765|NCT00500331|559750693|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
155086766|NCT00500331|559750687|FG000|Overall Study|Participant was randomized by mistake|1|||
155165712|NCT02721966|560043541|FG002|Overall Study|Lack of Efficacy|0|||
155354662|NCT01999972|560734904|FG002|Dose Escalation Part|Enrolled but not treated|1|||
155354663|NCT01999972|560734905|FG003|Dose Escalation Part|Enrolled but not treated|1|||
155354664|NCT01999972|560734906|FG004|Dose Escalation Part|Enrolled but not treated|0|||
155354665|NCT01999972|560734907|FG005|Dose Escalation Part|Enrolled but not treated|0|||
155354666|NCT01999972|560734902|FG000|Dose Escalation Part|Disease progression|3|||
155354667|NCT01999972|560734903|FG001|Dose Escalation Part|Disease progression|2|||
155354668|NCT01999972|560734904|FG002|Dose Escalation Part|Disease progression|3|||
155354669|NCT01999972|560734905|FG003|Dose Escalation Part|Disease progression|6|||
155354670|NCT01999972|560734906|FG004|Dose Escalation Part|Disease progression|0|||
155354671|NCT01999972|560734907|FG005|Dose Escalation Part|Disease progression|0|||
155354672|NCT01999972|560734902|FG000|Dose Escalation Part|Adverse Event|0|||
155354673|NCT01999972|560734903|FG001|Dose Escalation Part|Adverse Event|0|||
155354674|NCT01999972|560734904|FG002|Dose Escalation Part|Adverse Event|0|||
155354675|NCT01999972|560734905|FG003|Dose Escalation Part|Adverse Event|2|||
155354676|NCT01999972|560734906|FG004|Dose Escalation Part|Adverse Event|0|||
155354677|NCT01999972|560734907|FG005|Dose Escalation Part|Adverse Event|0|||
155354678|NCT01999972|560734902|FG000|Dose Escalation Part|Global deterioration of health status|1|||
155354679|NCT01999972|560734903|FG001|Dose Escalation Part|Global deterioration of health status|0|||
155354680|NCT01999972|560734904|FG002|Dose Escalation Part|Global deterioration of health status|0|||
155354681|NCT01999972|560734905|FG003|Dose Escalation Part|Global deterioration of health status|1|||
155086767|NCT00500331|559750688|FG001|Overall Study|Participant was randomized by mistake|0|||
155165713|NCT02721966|560043542|FG003|Overall Study|Lack of Efficacy|0|||
155354682|NCT01999972|560734906|FG004|Dose Escalation Part|Global deterioration of health status|0|||
155354683|NCT01999972|560734907|FG005|Dose Escalation Part|Global deterioration of health status|0|||
155354684|NCT01999972|560734902|FG000|Dose Expansion Part|Death|0|||
155354685|NCT01999972|560734903|FG001|Dose Expansion Part|Death|0|||
155354686|NCT01999972|560734904|FG002|Dose Expansion Part|Death|0|||
155354687|NCT01999972|560734905|FG003|Dose Expansion Part|Death|0|||
155354688|NCT01999972|560734906|FG004|Dose Expansion Part|Death|2|||
155354689|NCT01999972|560734907|FG005|Dose Expansion Part|Death|1|||
155354690|NCT01999972|560734902|FG000|Dose Expansion Part|Disease progression|0|||
155354691|NCT01999972|560734903|FG001|Dose Expansion Part|Disease progression|0|||
155086768|NCT00500331|559750689|FG002|Overall Study|Participant was randomized by mistake|0|||
155086769|NCT00500331|559750690|FG003|Overall Study|Participant was randomized by mistake|0|||
155086770|NCT00500331|559750691|FG004|Overall Study|Participant was randomized by mistake|0|||
155086771|NCT00500331|559750692|FG005|Overall Study|Participant was randomized by mistake|0|||
155354692|NCT01999972|560734904|FG002|Dose Expansion Part|Disease progression|0|||
155354693|NCT01999972|560734905|FG003|Dose Expansion Part|Disease progression|0|||
155354694|NCT01999972|560734906|FG004|Dose Expansion Part|Disease progression|9|||
155354695|NCT01999972|560734907|FG005|Dose Expansion Part|Disease progression|3|||
155086772|NCT00500331|559750693|FG006|Overall Study|Participant was randomized by mistake|0|||
155086773|NCT00500331|559750687|FG000|Overall Study|Diabetologist nurse in the study|0|||
155086774|NCT00500331|559750688|FG001|Overall Study|Diabetologist nurse in the study|0|||
155086775|NCT00500331|559750689|FG002|Overall Study|Diabetologist nurse in the study|1|||
155086776|NCT00500331|559750690|FG003|Overall Study|Diabetologist nurse in the study|0|||
155086777|NCT00500331|559750691|FG004|Overall Study|Diabetologist nurse in the study|0|||
155086778|NCT00500331|559750692|FG005|Overall Study|Diabetologist nurse in the study|0|||
155086779|NCT00500331|559750693|FG006|Overall Study|Diabetologist nurse in the study|0|||
155086780|NCT00500331|559750687|FG000|Overall Study|State ban of biological samples export|0|||
155086781|NCT00500331|559750688|FG001|Overall Study|State ban of biological samples export|0|||
155086782|NCT00500331|559750689|FG002|Overall Study|State ban of biological samples export|0|||
155086783|NCT00500331|559750690|FG003|Overall Study|State ban of biological samples export|1|||
155086784|NCT00500331|559750691|FG004|Overall Study|State ban of biological samples export|0|||
155086785|NCT00500331|559750692|FG005|Overall Study|State ban of biological samples export|0|||
155086786|NCT00500331|559750693|FG006|Overall Study|State ban of biological samples export|0|||
155086787|NCT00500331|559750687|FG000|Overall Study|Protocol violated|0|||
155086788|NCT00500331|559750688|FG001|Overall Study|Protocol violated|0|||
155086789|NCT00500331|559750689|FG002|Overall Study|Protocol violated|0|||
155086790|NCT00500331|559750690|FG003|Overall Study|Protocol violated|1|||
155086791|NCT00500331|559750691|FG004|Overall Study|Protocol violated|0|||
155086792|NCT00500331|559750692|FG005|Overall Study|Protocol violated|0|||
155086793|NCT00500331|559750693|FG006|Overall Study|Protocol violated|0|||
155086794|NCT03345550|559750694|FG000|Overall Study|Withdrawal by Subject|1|||
155086795|NCT03345550|559750695|FG001|Overall Study|Withdrawal by Subject|0|||
155086796|NCT03345550|559750694|FG000|Overall Study|Lost to Follow-up|4|||
155086797|NCT03345550|559750695|FG001|Overall Study|Lost to Follow-up|5|||
155086798|NCT03014089|559750699|FG000|Overall Study|Withdrawal by Subject|0|||
155086799|NCT03014089|559750700|FG001|Overall Study|Withdrawal by Subject|1|||
155086800|NCT03014089|559750701|FG002|Overall Study|Withdrawal by Subject|1|||
155086801|NCT03014089|559750702|FG003|Overall Study|Withdrawal by Subject|1|||
155086802|NCT03014089|559750699|FG000|Overall Study|Lost to Follow-up|1|||
155086803|NCT03014089|559750700|FG001|Overall Study|Lost to Follow-up|0|||
155086804|NCT03014089|559750701|FG002|Overall Study|Lost to Follow-up|0|||
155086805|NCT03014089|559750702|FG003|Overall Study|Lost to Follow-up|0|||
155086806|NCT03014089|559750699|FG000|Overall Study|Adverse Event|1|||
155086807|NCT03014089|559750700|FG001|Overall Study|Adverse Event|0|||
155086808|NCT03014089|559750701|FG002|Overall Study|Adverse Event|1|||
155086809|NCT03014089|559750702|FG003|Overall Study|Adverse Event|0|||
155086810|NCT01149460|559750703|FG000|Overall Study|Withdrawal by Subject|0|||
155086811|NCT01149460|559750704|FG001|Overall Study|Withdrawal by Subject|2|||
155086812|NCT00321932|559750705|FG000|Overall Study|Death|3|||
155086813|NCT00321932|559750706|FG001|Overall Study|Death|6|||
155086814|NCT00321932|559750705|FG000|Overall Study|Withdrawal by Subject|3|||
155086815|NCT00321932|559750706|FG001|Overall Study|Withdrawal by Subject|6|||
155086816|NCT00321932|559750705|FG000|Overall Study|Early relapse|2|||
155086817|NCT00321932|559750706|FG001|Overall Study|Early relapse|8|||
155086818|NCT00321932|559750705|FG000|Overall Study|Missing data|2|||
155086819|NCT00321932|559750706|FG001|Overall Study|Missing data|1|||
155354696|NCT01999972|560734902|FG000|Dose Expansion Part|Sponsor decision|0|||
155354697|NCT01999972|560734903|FG001|Dose Expansion Part|Sponsor decision|0|||
155086820|NCT00734032|559750707|FG000|Overall Study|Adverse Event|0|||
155086821|NCT00734032|559750708|FG001|Overall Study|Adverse Event|1|||
155086822|NCT00734032|559750709|FG002|Overall Study|Adverse Event|0|||
155086823|NCT00734032|559750710|FG003|Overall Study|Adverse Event|0|||
155086824|NCT02489279|559750711|FG000|Overall Study|Lost to Follow-up|12|||
155086825|NCT02489279|559750712|FG001|Overall Study|Lost to Follow-up|10|||
155086826|NCT02263547|559750713|FG000|Overall Study|Adverse Event|1|||
155086827|NCT02263547|559750713|FG000|Overall Study|Lost to Follow-up|2|||
155086828|NCT00856557|559750714|FG000|Overall Study|No patients with contextual flags|12|||
155354698|NCT01999972|560734904|FG002|Dose Expansion Part|Sponsor decision|0|||
155354699|NCT01999972|560734905|FG003|Dose Expansion Part|Sponsor decision|0|||
155086829|NCT00856557|559750715|FG001|Overall Study|No patients with contextual flags|16|||
155086830|NCT02301897|559750716|FG000|Treatment Course 1|Non-Compliance|0|||
155086831|NCT02301897|559750717|FG001|Treatment Course 1|Non-Compliance|0|||
155086832|NCT02301897|559750718|FG002|Treatment Course 1|Non-Compliance|1|||
155086833|NCT02301897|559750716|FG000|Treatment Course 1|Adverse Event|1|||
155086834|NCT02301897|559750717|FG001|Treatment Course 1|Adverse Event|1|||
155086835|NCT02301897|559750718|FG002|Treatment Course 1|Adverse Event|0|||
155086836|NCT02301897|559750716|FG000|Treatment Course 1|Lost to Follow-up|1|||
155086837|NCT02301897|559750717|FG001|Treatment Course 1|Lost to Follow-up|2|||
155086838|NCT02301897|559750718|FG002|Treatment Course 1|Lost to Follow-up|1|||
155086839|NCT02301897|559750716|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
155086840|NCT02301897|559750717|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
155086841|NCT02301897|559750718|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
155086842|NCT02301897|559750716|FG000|Treatment Course 1|Withdrawal by Subject|0|||
155086843|NCT02301897|559750717|FG001|Treatment Course 1|Withdrawal by Subject|0|||
155086844|NCT02301897|559750718|FG002|Treatment Course 1|Withdrawal by Subject|2|||
155086845|NCT02301897|559750716|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
155086846|NCT02301897|559750717|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
155086847|NCT02301897|559750718|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
155086848|NCT02301897|559750716|FG000|Treatment Course 2|Lost to Follow-up|0|||
155086849|NCT02301897|559750717|FG001|Treatment Course 2|Lost to Follow-up|2|||
155086850|NCT02301897|559750718|FG002|Treatment Course 2|Lost to Follow-up|0|||
155086851|NCT02301897|559750716|FG000|Treatment Course 2|Pregnancy|0|||
155086852|NCT02301897|559750717|FG001|Treatment Course 2|Pregnancy|1|||
155086853|NCT02301897|559750718|FG002|Treatment Course 2|Pregnancy|1|||
155086854|NCT02301897|559750716|FG000|Treatment Course 2|Withdrawal by Subject|0|||
155086855|NCT02301897|559750717|FG001|Treatment Course 2|Withdrawal by Subject|2|||
155086856|NCT02301897|559750718|FG002|Treatment Course 2|Withdrawal by Subject|0|||
155086857|NCT02301897|559750716|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
155354700|NCT01999972|560734906|FG004|Dose Expansion Part|Sponsor decision|1|||
155354701|NCT01999972|560734907|FG005|Dose Expansion Part|Sponsor decision|0|||
155354702|NCT01999972|560734902|FG000|Dose Expansion Part|Adverse Event|0|||
155354703|NCT01999972|560734903|FG001|Dose Expansion Part|Adverse Event|0|||
155354704|NCT01999972|560734904|FG002|Dose Expansion Part|Adverse Event|0|||
155354705|NCT01999972|560734905|FG003|Dose Expansion Part|Adverse Event|0|||
155354706|NCT01999972|560734906|FG004|Dose Expansion Part|Adverse Event|4|||
155354707|NCT01999972|560734907|FG005|Dose Expansion Part|Adverse Event|2|||
155354708|NCT01999972|560734902|FG000|Dose Expansion Part|Participant's non-compliance|0|||
155354709|NCT01999972|560734903|FG001|Dose Expansion Part|Participant's non-compliance|0|||
155354710|NCT01999972|560734904|FG002|Dose Expansion Part|Participant's non-compliance|0|||
155354711|NCT01999972|560734905|FG003|Dose Expansion Part|Participant's non-compliance|0|||
155354712|NCT01999972|560734906|FG004|Dose Expansion Part|Participant's non-compliance|0|||
155354713|NCT01999972|560734907|FG005|Dose Expansion Part|Participant's non-compliance|1|||
155354714|NCT01999972|560734902|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
155354715|NCT01999972|560734903|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
155354716|NCT01999972|560734904|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
155354717|NCT01999972|560734905|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
155354718|NCT01999972|560734906|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
155354719|NCT01999972|560734907|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
155354720|NCT01999972|560734902|FG000|Dose Expansion Part|Changed to standard of care|0|||
155354721|NCT01999972|560734903|FG001|Dose Expansion Part|Changed to standard of care|0|||
155354722|NCT01999972|560734904|FG002|Dose Expansion Part|Changed to standard of care|0|||
155354723|NCT01999972|560734905|FG003|Dose Expansion Part|Changed to standard of care|0|||
155354724|NCT01999972|560734906|FG004|Dose Expansion Part|Changed to standard of care|1|||
155354725|NCT01999972|560734907|FG005|Dose Expansion Part|Changed to standard of care|0|||
155354726|NCT01171183|560734908|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
155354727|NCT01171183|560734909|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
155354728|NCT01171183|560734908|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
155354729|NCT01171183|560734909|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
155354730|NCT01171183|560734908|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
155354731|NCT01171183|560734909|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
155354732|NCT01171183|560734908|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
155354733|NCT01171183|560734909|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
155354734|NCT01171183|560734908|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
155354735|NCT01171183|560734909|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
155086858|NCT02301897|559750717|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
155086859|NCT02301897|559750718|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
155086860|NCT03673176|559750719|FG000|Overall Study|Death prior to intervention|1|||
155354736|NCT01171183|560734908|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
155354737|NCT01171183|560734909|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
155354738|NCT01101334|560734910|FG000|Overall Study|Adverse Event|9|||
155354739|NCT01101334|560734911|FG001|Overall Study|Adverse Event|4|||
155354740|NCT01101334|560734910|FG000|Overall Study|Death|7|||
155354741|NCT01101334|560734911|FG001|Overall Study|Death|1|||
155354742|NCT01101334|560734910|FG000|Overall Study|Withdrawal by Subject|4|||
155354743|NCT01101334|560734911|FG001|Overall Study|Withdrawal by Subject|3|||
155354744|NCT01101334|560734910|FG000|Overall Study|Withdrawal by Sponsor|1|||
155354745|NCT01101334|560734911|FG001|Overall Study|Withdrawal by Sponsor|1|||
155354746|NCT01101334|560734910|FG000|Overall Study|Progressive Disease|22|||
155354747|NCT01101334|560734911|FG001|Overall Study|Progressive Disease|35|||
155354748|NCT01101334|560734910|FG000|Overall Study|Other|2|||
155354749|NCT01101334|560734911|FG001|Overall Study|Other|1|||
155354750|NCT02826798|560734914|FG000|Overall Study|Withdrawal by Subject|0|||
155354751|NCT02826798|560734915|FG001|Overall Study|Withdrawal by Subject|1|||
155354752|NCT02826798|560734916|FG002|Overall Study|Withdrawal by Subject|0|||
155354753|NCT02826798|560734917|FG003|Overall Study|Withdrawal by Subject|1|||
155354754|NCT02826798|560734918|FG004|Overall Study|Withdrawal by Subject|0|||
155354755|NCT02806505|560734919|FG000|Overall Study|Adverse event/intercurrent illness|1|||
155354756|NCT02806505|560734920|FG001|Overall Study|Adverse event/intercurrent illness|3|||
155354757|NCT02806505|560734919|FG000|Overall Study|Death|4|||
155354758|NCT02806505|560734920|FG001|Overall Study|Death|0|||
155354759|NCT02806505|560734919|FG000|Overall Study|Did not cooperate/refused treatment|3|||
155354760|NCT02806505|560734920|FG001|Overall Study|Did not cooperate/refused treatment|3|||
155354761|NCT02806505|560734919|FG000|Overall Study|Failure to return|0|||
155354762|NCT02806505|560734920|FG001|Overall Study|Failure to return|1|||
155354763|NCT02806505|560734919|FG000|Overall Study|Insufficient therapeutic response|2|||
155354764|NCT02806505|560734920|FG001|Overall Study|Insufficient therapeutic response|4|||
155354765|NCT03440047|560734922|FG000|Overall Study|Withdrawal by Subject|2|||
155354766|NCT04843579|560734931|FG000|Overall Study|Adverse Event|1|||
155354767|NCT04843579|560734931|FG000|Overall Study|Disease Progression|1|||
155354768|NCT04009629|560734932|FG000|Overall Study|Withdrawal by Subject|2|||
155354769|NCT04009629|560734933|FG001|Overall Study|Withdrawal by Subject|0|||
155354770|NCT04702893|560734939|FG000|Overall Study|Other reasons than listed|11|||
155354771|NCT04702893|560734939|FG000|Overall Study|Withdrawal by Subject|3|||
155354772|NCT04702893|560734939|FG000|Overall Study|Lost to Follow-up|7|||
155354773|NCT04702893|560734939|FG000|Overall Study|Death|10|||
155354774|NCT04702893|560734939|FG000|Overall Study|Not treated|6|||
155354775|NCT04606199|560734940|FG000|Overall Study|Withdrawal by Subject|2|||
155354776|NCT00408928|560734941|FG000|Overall Study|Withdrawal by Subject|1|||
155354777|NCT00408928|560734941|FG000|Overall Study|Death|1|||
155354778|NCT00408928|560734941|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
155354779|NCT01114139|560734944|FG000|Overall Study|Adverse Event|3|||
155354780|NCT01114139|560734945|FG001|Overall Study|Adverse Event|2|||
155354781|NCT01114139|560734944|FG000|Overall Study|Lost to Follow-up|15|||
155354782|NCT01114139|560734945|FG001|Overall Study|Lost to Follow-up|3|||
155354783|NCT01114139|560734944|FG000|Overall Study|Withdrawal by Subject|17|||
155354784|NCT01114139|560734945|FG001|Overall Study|Withdrawal by Subject|6|||
155354785|NCT01114139|560734944|FG000|Overall Study|Other-Missed 1 visit|1|||
155354786|NCT01114139|560734945|FG001|Overall Study|Other-Missed 1 visit|0|||
155354787|NCT01114139|560734944|FG000|Overall Study|Other-Protocol Violation|1|||
155354788|NCT01114139|560734945|FG001|Overall Study|Other-Protocol Violation|0|||
155354789|NCT01114139|560734944|FG000|Overall Study|Other-Out of window for study drug dose|1|||
155354790|NCT01114139|560734945|FG001|Overall Study|Other-Out of window for study drug dose|0|||
155354791|NCT01114139|560734944|FG000|Overall Study|Other-Participant falsified records|0|||
155354792|NCT01114139|560734945|FG001|Overall Study|Other-Participant falsified records|1|||
155354793|NCT01114139|560734944|FG000|Overall Study|Other-Participant went on hospice|0|||
155354794|NCT01114139|560734945|FG001|Overall Study|Other-Participant went on hospice|1|||
155354795|NCT01114139|560734944|FG000|Overall Study|Other-Physician changed treatment|1|||
155354796|NCT01114139|560734945|FG001|Overall Study|Other-Physician changed treatment|0|||
155354797|NCT01114139|560734944|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
155354798|NCT01114139|560734945|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
155354799|NCT01951378|560734946|FG000|Overall Study|Study Terminated-Not completed|23|||
155354800|NCT01951378|560734947|FG001|Overall Study|Study Terminated-Not completed|17|||
155354801|NCT00477464|560734949|FG000|Overall Study|Lost to Follow-up|1|||
155354802|NCT00477464|560734949|FG000|Overall Study|Death|36|||
155354803|NCT00477464|560734949|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
155354804|NCT03568812|560734950|FG000|Overall Study|Physician Decision|0|||
155354805|NCT03568812|560734951|FG001|Overall Study|Physician Decision|1|||
155354806|NCT00639769|560734956|FG000|Overall Study|Death|2|||
155354807|NCT00639769|560734956|FG000|Overall Study|Adverse Event|7|||
155354808|NCT00639769|560734956|FG000|Overall Study|Lack of Efficacy|1|||
155354809|NCT00639769|560734956|FG000|Overall Study|Disease progression|26|||
155354810|NCT00639769|560734956|FG000|Overall Study|Withdrawal by Subject|4|||
155354811|NCT00634842|560734957|FG000|Overall Study|Adverse Event|2|||
155354812|NCT00634842|560734958|FG001|Overall Study|Adverse Event|3|||
155086861|NCT03673176|559750719|FG000|Overall Study|Death following intervention|3|||
155086862|NCT03673176|559750719|FG000|Overall Study|Withdrawal by Subject|1|||
155086863|NCT00337168|559750720|FG000|Overall Study|Death|5|||
155086864|NCT00337168|559750720|FG000|Overall Study|Not protocol specified|2|||
155086865|NCT00337168|559750720|FG000|Overall Study|Did not start therapy|1|||
155086866|NCT02378480|559750721|FG000|Overall Study|Physician Decision|1|||
155086867|NCT02378480|559750722|FG001|Overall Study|Physician Decision|1|||
155086868|NCT02378480|559750721|FG000|Overall Study|Death|1|||
155086869|NCT02378480|559750722|FG001|Overall Study|Death|2|||
155354813|NCT00634842|560734957|FG000|Overall Study|Protocol Violation|8|||
155354814|NCT00634842|560734958|FG001|Overall Study|Protocol Violation|4|||
155354815|NCT00634842|560734957|FG000|Overall Study|Move to another state|1|||
155354816|NCT00634842|560734958|FG001|Overall Study|Move to another state|0|||
155354817|NCT00634842|560734957|FG000|Overall Study|Inclusion criteria were not met|1|||
155354818|NCT00634842|560734958|FG001|Overall Study|Inclusion criteria were not met|0|||
155354819|NCT00634842|560734957|FG000|Overall Study|Lost to Follow-up|1|||
155354820|NCT00634842|560734958|FG001|Overall Study|Lost to Follow-up|2|||
155354821|NCT00634842|560734957|FG000|Overall Study|Physician Decision|1|||
155354822|NCT00634842|560734958|FG001|Overall Study|Physician Decision|0|||
155354823|NCT00634842|560734957|FG000|Overall Study|Withdrawal by Subject|1|||
155354824|NCT00634842|560734958|FG001|Overall Study|Withdrawal by Subject|3|||
155354825|NCT00634842|560734957|FG000|Overall Study|Lack of time and intolerance to drug|0|||
155354826|NCT00634842|560734958|FG001|Overall Study|Lack of time and intolerance to drug|1|||
155354827|NCT00634842|560734957|FG000|Overall Study|Discontinued due to injection|0|||
155354828|NCT00634842|560734958|FG001|Overall Study|Discontinued due to injection|2|||
155354829|NCT00634842|560734957|FG000|Overall Study|No need of study drug to treat diabetes|0|||
155354830|NCT00634842|560734958|FG001|Overall Study|No need of study drug to treat diabetes|1|||
155354831|NCT00634842|560734957|FG000|Overall Study|No wish to keep taking Avandia|0|||
155354832|NCT00634842|560734958|FG001|Overall Study|No wish to keep taking Avandia|1|||
155354833|NCT00634842|560734957|FG000|Overall Study|Subject off study drug for too long|0|||
155354834|NCT00634842|560734958|FG001|Overall Study|Subject off study drug for too long|1|||
155354835|NCT01774019|560734960|FG000|Overall Study|No longer meets protocol criteria|2|||
155354836|NCT01774019|560734961|FG001|Overall Study|No longer meets protocol criteria|0|||
155086870|NCT02378480|559750721|FG000|Overall Study|Randomized, but Not Treated|6|||
155086871|NCT02378480|559750722|FG001|Overall Study|Randomized, but Not Treated|4|||
155354837|NCT01774019|560734960|FG000|Overall Study|Withdrawal by Subject|1|||
155086872|NCT02378480|559750721|FG000|Overall Study|Adverse Event|0|||
155086873|NCT02378480|559750722|FG001|Overall Study|Adverse Event|1|||
155086874|NCT02378480|559750721|FG000|Overall Study|Missed EOT/PTE Visit|1|||
155354838|NCT01774019|560734961|FG001|Overall Study|Withdrawal by Subject|0|||
155354839|NCT01774019|560734960|FG000|Overall Study|Surgery delayed > 120 days|1|||
155354840|NCT01774019|560734961|FG001|Overall Study|Surgery delayed > 120 days|0|||
155354841|NCT01774019|560734960|FG000|Overall Study|Patient refused surgery|1|||
155354842|NCT01774019|560734961|FG001|Overall Study|Patient refused surgery|1|||
155354843|NCT01774019|560734960|FG000|Overall Study|Unable to implant study device|1|||
155354844|NCT01774019|560734961|FG001|Overall Study|Unable to implant study device|0|||
155354845|NCT01774019|560734960|FG000|Overall Study|Lost to Follow-up|0|||
155354846|NCT01774019|560734961|FG001|Overall Study|Lost to Follow-up|3|||
155354847|NCT02447432|560734962|FG000|Epoch 001|Adverse Event|1|||
155354848|NCT02447432|560734963|FG001|Epoch 001|Adverse Event|1|||
155354849|NCT02447432|560734962|FG000|Epoch 001|Withdrawal by Subject|0|||
155354850|NCT02447432|560734963|FG001|Epoch 001|Withdrawal by Subject|4|||
155354851|NCT02447432|560734962|FG000|Epoch 001|Migrated/moved from study area|3|||
155354852|NCT02447432|560734963|FG001|Epoch 001|Migrated/moved from study area|5|||
155354853|NCT02447432|560734962|FG000|Epoch 001|Lost to Follow-up|1|||
155354854|NCT02447432|560734963|FG001|Epoch 001|Lost to Follow-up|3|||
155354855|NCT03470545|560734964|FG000|Overall Study|Death|0|||
155354856|NCT03470545|560734965|FG001|Overall Study|Death|1|||
155354857|NCT03470545|560734964|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
155354858|NCT03470545|560734965|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
155354859|NCT03470545|560734964|FG000|Overall Study|Adverse Event|2|||
155354860|NCT03470545|560734965|FG001|Overall Study|Adverse Event|0|||
155354861|NCT03470545|560734964|FG000|Overall Study|Withdrawal by Subject|1|||
155354862|NCT03470545|560734965|FG001|Overall Study|Withdrawal by Subject|1|||
155354863|NCT03470545|560734964|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
155354864|NCT03470545|560734965|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
155354865|NCT04035577|560734968|FG000|Overall Study|Lost to Follow-up|1|||
155354866|NCT04035577|560734968|FG000|Overall Study|Withdrawal by Subject|1|||
155354867|NCT00505414|560734970|FG000|Titration Phase|Adverse Event|0|||
155354868|NCT00505414|560734971|FG001|Titration Phase|Adverse Event|0|||
155354869|NCT00505414|560734972|FG002|Titration Phase|Adverse Event|0|||
155354870|NCT00505414|560734973|FG003|Titration Phase|Adverse Event|8|||
155354871|NCT00505414|560734974|FG004|Titration Phase|Adverse Event|3|||
155354872|NCT00505414|560734970|FG000|Titration Phase|Death|0|||
155354873|NCT00505414|560734971|FG001|Titration Phase|Death|0|||
155354874|NCT00505414|560734972|FG002|Titration Phase|Death|0|||
155354875|NCT00505414|560734973|FG003|Titration Phase|Death|2|||
155354876|NCT00505414|560734974|FG004|Titration Phase|Death|0|||
155354877|NCT00505414|560734970|FG000|Titration Phase|Lack of Efficacy|0|||
155354878|NCT00505414|560734971|FG001|Titration Phase|Lack of Efficacy|0|||
155354879|NCT00505414|560734972|FG002|Titration Phase|Lack of Efficacy|0|||
155354880|NCT00505414|560734973|FG003|Titration Phase|Lack of Efficacy|10|||
155354881|NCT00505414|560734974|FG004|Titration Phase|Lack of Efficacy|1|||
155354882|NCT00505414|560734970|FG000|Titration Phase|Protocol Violation|0|||
155354883|NCT00505414|560734971|FG001|Titration Phase|Protocol Violation|0|||
155354884|NCT00505414|560734972|FG002|Titration Phase|Protocol Violation|0|||
155354885|NCT00505414|560734973|FG003|Titration Phase|Protocol Violation|0|||
155354886|NCT00505414|560734974|FG004|Titration Phase|Protocol Violation|1|||
155354887|NCT00505414|560734970|FG000|Titration Phase|Withdrawal by Subject|0|||
155354888|NCT00505414|560734971|FG001|Titration Phase|Withdrawal by Subject|0|||
155354889|NCT00505414|560734972|FG002|Titration Phase|Withdrawal by Subject|0|||
155354890|NCT00505414|560734973|FG003|Titration Phase|Withdrawal by Subject|3|||
155354891|NCT00505414|560734974|FG004|Titration Phase|Withdrawal by Subject|4|||
155354892|NCT00505414|560734970|FG000|Titration Phase|Underlying disease and therapy required|0|||
155354893|NCT00505414|560734971|FG001|Titration Phase|Underlying disease and therapy required|0|||
155354894|NCT00505414|560734972|FG002|Titration Phase|Underlying disease and therapy required|0|||
155354895|NCT00505414|560734973|FG003|Titration Phase|Underlying disease and therapy required|7|||
155354896|NCT00505414|560734974|FG004|Titration Phase|Underlying disease and therapy required|3|||
155354897|NCT00505414|560734970|FG000|Maintenance Phase|Adverse Event|2|||
155354898|NCT00505414|560734971|FG001|Maintenance Phase|Adverse Event|2|||
155354899|NCT00505414|560734972|FG002|Maintenance Phase|Adverse Event|3|||
155354900|NCT00505414|560734973|FG003|Maintenance Phase|Adverse Event|0|||
155354901|NCT00505414|560734974|FG004|Maintenance Phase|Adverse Event|0|||
155354902|NCT00505414|560734970|FG000|Maintenance Phase|Death|2|||
155354903|NCT00505414|560734971|FG001|Maintenance Phase|Death|0|||
155354904|NCT00505414|560734972|FG002|Maintenance Phase|Death|1|||
155354905|NCT00505414|560734973|FG003|Maintenance Phase|Death|0|||
155354906|NCT00505414|560734974|FG004|Maintenance Phase|Death|0|||
155354907|NCT00505414|560734970|FG000|Maintenance Phase|Lack of Efficacy|2|||
155354908|NCT00505414|560734971|FG001|Maintenance Phase|Lack of Efficacy|1|||
155354909|NCT00505414|560734972|FG002|Maintenance Phase|Lack of Efficacy|1|||
155354910|NCT00505414|560734973|FG003|Maintenance Phase|Lack of Efficacy|0|||
155354911|NCT00505414|560734974|FG004|Maintenance Phase|Lack of Efficacy|0|||
155354912|NCT00505414|560734970|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155354913|NCT00505414|560734971|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155354914|NCT00505414|560734972|FG002|Maintenance Phase|Withdrawal by Subject|1|||
155354915|NCT00505414|560734973|FG003|Maintenance Phase|Withdrawal by Subject|0|||
155354916|NCT00505414|560734974|FG004|Maintenance Phase|Withdrawal by Subject|0|||
155354917|NCT00505414|560734970|FG000|Maintenance Phase|underlying disease and therapy required|0|||
155354918|NCT00505414|560734971|FG001|Maintenance Phase|underlying disease and therapy required|2|||
155354919|NCT00505414|560734972|FG002|Maintenance Phase|underlying disease and therapy required|2|||
155354920|NCT00505414|560734973|FG003|Maintenance Phase|underlying disease and therapy required|0|||
155354921|NCT00505414|560734974|FG004|Maintenance Phase|underlying disease and therapy required|0|||
155354922|NCT00846768|560734975|FG000|Overall Study|Adverse Event|0|||
155354923|NCT00846768|560734976|FG001|Overall Study|Adverse Event|1|||
155354924|NCT00846768|560734977|FG002|Overall Study|Adverse Event|0|||
155354925|NCT00846768|560734978|FG003|Overall Study|Adverse Event|0|||
155354926|NCT00002597|560734979|FG000|Overall Study|Protocol Violation|19|||
155354927|NCT00002597|560734980|FG001|Overall Study|Protocol Violation|17|||
155354928|NCT00002597|560734979|FG000|Overall Study|Withdrawal by Subject|7|||
155354929|NCT00002597|560734980|FG001|Overall Study|Withdrawal by Subject|6|||
155354930|NCT02143063|560734981|FG000|Overall Study|Lost to Follow-up|16|||
155354931|NCT02143063|560734982|FG001|Overall Study|Lost to Follow-up|28|||
155354932|NCT02143063|560734983|FG002|Overall Study|Lost to Follow-up|29|||
155354933|NCT02143063|560734981|FG000|Overall Study|Withdrawal by Subject|0|||
155354934|NCT02143063|560734982|FG001|Overall Study|Withdrawal by Subject|1|||
155354935|NCT02143063|560734983|FG002|Overall Study|Withdrawal by Subject|0|||
155354936|NCT02143063|560734981|FG000|Overall Study|Death|0|||
155354937|NCT02143063|560734982|FG001|Overall Study|Death|1|||
155354938|NCT02143063|560734983|FG002|Overall Study|Death|1|||
155354939|NCT00912223|560734986|FG000|Overall Study|Withdrawal by Subject|1|||
155354940|NCT00912223|560734986|FG000|Overall Study|Not transplanted|1|||
155354941|NCT00912223|560734986|FG000|Overall Study|Transformed disease|1|||
155354942|NCT02601209|560734987|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
155354943|NCT02601209|560734988|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
155354944|NCT02601209|560734989|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
155354945|NCT02601209|560734990|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354946|NCT02601209|560734991|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354947|NCT02601209|560734992|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354948|NCT02601209|560734993|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354949|NCT02601209|560734994|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354950|NCT02601209|560734995|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
155354951|NCT02601209|560734987|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354952|NCT02601209|560734988|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354953|NCT02601209|560734989|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354954|NCT02601209|560734990|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354955|NCT02601209|560734991|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
155354956|NCT02601209|560734992|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
155354957|NCT02601209|560734993|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
155354958|NCT02601209|560734994|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354959|NCT02601209|560734995|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
155354960|NCT00927901|560734996|FG000|Treatment Period 1|Subject withdrew consent|0|||
155354961|NCT00927901|560734997|FG001|Treatment Period 1|Subject withdrew consent|0|||
155354962|NCT00927901|560734998|FG002|Treatment Period 1|Subject withdrew consent|1|||
155354963|NCT00927901|560734999|FG003|Treatment Period 1|Subject withdrew consent|0|||
155354964|NCT00927901|560734996|FG000|Treatment Period 4|Adverse Event|0|||
155354965|NCT00927901|560734997|FG001|Treatment Period 4|Adverse Event|0|||
155354966|NCT00927901|560734998|FG002|Treatment Period 4|Adverse Event|0|||
155354967|NCT00927901|560734999|FG003|Treatment Period 4|Adverse Event|1|||
155354968|NCT00927901|560734996|FG000|Treatment Period 4|Subject withdrew consent|0|||
155354969|NCT00927901|560734997|FG001|Treatment Period 4|Subject withdrew consent|0|||
155354970|NCT00927901|560734998|FG002|Treatment Period 4|Subject withdrew consent|1|||
155354971|NCT00927901|560734999|FG003|Treatment Period 4|Subject withdrew consent|0|||
155354972|NCT00746356|560735002|FG000|Overall Study|Withdrawal by Subject|2|||
155354973|NCT00746356|560735003|FG001|Overall Study|Withdrawal by Subject|3|||
155354974|NCT00746356|560735002|FG000|Overall Study|Death|7|||
155354975|NCT00746356|560735003|FG001|Overall Study|Death|3|||
155354976|NCT00746356|560735002|FG000|Overall Study|Lost to Follow-up|1|||
155354977|NCT00746356|560735003|FG001|Overall Study|Lost to Follow-up|0|||
155354978|NCT00746356|560735002|FG000|Overall Study|Removal of Device|0|||
155354979|NCT00746356|560735003|FG001|Overall Study|Removal of Device|1|||
155354980|NCT00746356|560735002|FG000|Overall Study|Patient relocated|1|||
155354981|NCT00746356|560735003|FG001|Overall Study|Patient relocated|0|||
155354982|NCT03605368|560735006|FG000|Overall Study|Lost to Follow-up|2|||
155354983|NCT03605368|560735007|FG001|Overall Study|Lost to Follow-up|1|||
155354984|NCT03605368|560735008|FG002|Overall Study|Lost to Follow-up|3|||
155354985|NCT03605368|560735009|FG003|Overall Study|Lost to Follow-up|2|||
155354986|NCT03605368|560735006|FG000|Overall Study|Withdrawal by Subject|0|||
155354987|NCT03605368|560735007|FG001|Overall Study|Withdrawal by Subject|0|||
155354988|NCT03605368|560735008|FG002|Overall Study|Withdrawal by Subject|4|||
155354989|NCT03605368|560735009|FG003|Overall Study|Withdrawal by Subject|3|||
155354990|NCT03028012|560735012|FG000|Overall Study|Lost to Follow-up|2|||
155354991|NCT03028012|560735013|FG001|Overall Study|Lost to Follow-up|3|||
155354992|NCT03028012|560735014|FG002|Overall Study|Lost to Follow-up|3|||
155354993|NCT02484547|560735019|FG000|Placebo-Controlled Period|Adverse Event|10|||
155354994|NCT02484547|560735020|FG001|Placebo-Controlled Period|Adverse Event|13|||
155354995|NCT02484547|560735021|FG002|Placebo-Controlled Period|Adverse Event|20|||
155354996|NCT02484547|560735022|FG003|Placebo-Controlled Period|Adverse Event|0|||
155354997|NCT02484547|560735023|FG004|Placebo-Controlled Period|Adverse Event|0|||
155354998|NCT02484547|560735024|FG005|Placebo-Controlled Period|Adverse Event|0|||
155354999|NCT02484547|560735025|FG006|Placebo-Controlled Period|Adverse Event|0|||
155355000|NCT02484547|560735019|FG000|Placebo-Controlled Period|Change of Treatment|0|||
155355001|NCT02484547|560735020|FG001|Placebo-Controlled Period|Change of Treatment|0|||
155355002|NCT02484547|560735021|FG002|Placebo-Controlled Period|Change of Treatment|1|||
155355003|NCT02484547|560735022|FG003|Placebo-Controlled Period|Change of Treatment|0|||
155355004|NCT02484547|560735023|FG004|Placebo-Controlled Period|Change of Treatment|0|||
155355005|NCT02484547|560735024|FG005|Placebo-Controlled Period|Change of Treatment|0|||
155355006|NCT02484547|560735025|FG006|Placebo-Controlled Period|Change of Treatment|0|||
155355007|NCT02484547|560735019|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
155355008|NCT02484547|560735020|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
155355009|NCT02484547|560735021|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
155355010|NCT02484547|560735022|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
155355011|NCT02484547|560735023|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
155355012|NCT02484547|560735024|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
155355013|NCT02484547|560735025|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
155355014|NCT02484547|560735019|FG000|Placebo-Controlled Period|Death|5|||
155355015|NCT02484547|560735020|FG001|Placebo-Controlled Period|Death|0|||
155355016|NCT02484547|560735021|FG002|Placebo-Controlled Period|Death|6|||
155355017|NCT02484547|560735022|FG003|Placebo-Controlled Period|Death|0|||
155355018|NCT02484547|560735023|FG004|Placebo-Controlled Period|Death|0|||
155355019|NCT02484547|560735024|FG005|Placebo-Controlled Period|Death|0|||
155355020|NCT02484547|560735025|FG006|Placebo-Controlled Period|Death|0|||
155355021|NCT02484547|560735019|FG000|Placebo-Controlled Period|Disease Progression|2|||
155355022|NCT02484547|560735020|FG001|Placebo-Controlled Period|Disease Progression|0|||
155355023|NCT02484547|560735021|FG002|Placebo-Controlled Period|Disease Progression|1|||
155355024|NCT02484547|560735022|FG003|Placebo-Controlled Period|Disease Progression|0|||
155355025|NCT02484547|560735023|FG004|Placebo-Controlled Period|Disease Progression|0|||
155355026|NCT02484547|560735024|FG005|Placebo-Controlled Period|Disease Progression|0|||
155355027|NCT02484547|560735025|FG006|Placebo-Controlled Period|Disease Progression|0|||
155355028|NCT02484547|560735019|FG000|Placebo-Controlled Period|Investigator Decision|2|||
155355029|NCT02484547|560735020|FG001|Placebo-Controlled Period|Investigator Decision|2|||
155355030|NCT02484547|560735021|FG002|Placebo-Controlled Period|Investigator Decision|5|||
155355031|NCT02484547|560735022|FG003|Placebo-Controlled Period|Investigator Decision|0|||
155355032|NCT02484547|560735023|FG004|Placebo-Controlled Period|Investigator Decision|0|||
155355033|NCT02484547|560735024|FG005|Placebo-Controlled Period|Investigator Decision|0|||
155355034|NCT02484547|560735025|FG006|Placebo-Controlled Period|Investigator Decision|0|||
155355035|NCT02484547|560735019|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
155355036|NCT02484547|560735020|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
155355037|NCT02484547|560735021|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
155355038|NCT02484547|560735022|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
155355039|NCT02484547|560735023|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
155355040|NCT02484547|560735024|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
155086875|NCT02378480|559750722|FG001|Overall Study|Missed EOT/PTE Visit|2|||
155086876|NCT02378480|559750721|FG000|Overall Study|Withdrawal by Subject|9|||
155086877|NCT02378480|559750722|FG001|Overall Study|Withdrawal by Subject|4|||
155086878|NCT02378480|559750721|FG000|Overall Study|Lost to Follow-up|10|||
155355041|NCT02484547|560735025|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
155355042|NCT02484547|560735019|FG000|Placebo-Controlled Period|Relocation|1|||
155355043|NCT02484547|560735020|FG001|Placebo-Controlled Period|Relocation|1|||
155355044|NCT02484547|560735021|FG002|Placebo-Controlled Period|Relocation|1|||
155355045|NCT02484547|560735022|FG003|Placebo-Controlled Period|Relocation|0|||
155355046|NCT02484547|560735023|FG004|Placebo-Controlled Period|Relocation|0|||
155355047|NCT02484547|560735024|FG005|Placebo-Controlled Period|Relocation|0|||
155355048|NCT02484547|560735025|FG006|Placebo-Controlled Period|Relocation|0|||
155355049|NCT02484547|560735019|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
155355050|NCT02484547|560735020|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
155086879|NCT02378480|559750722|FG001|Overall Study|Lost to Follow-up|18|||
155086880|NCT01230060|559750726|FG000|Overall Study|Withdrawal by Subject|1|||
155086881|NCT01217892|559750727|FG000|Overall Study|Adverse Event|1|||
155086882|NCT01217892|559750728|FG001|Overall Study|Adverse Event|1|||
155086883|NCT01217892|559750729|FG002|Overall Study|Adverse Event|1|||
155086884|NCT01217892|559750730|FG003|Overall Study|Adverse Event|0|||
155086885|NCT01217892|559750727|FG000|Overall Study|Withdrawal by Subject|0|||
155086886|NCT01217892|559750728|FG001|Overall Study|Withdrawal by Subject|2|||
155086887|NCT01217892|559750729|FG002|Overall Study|Withdrawal by Subject|1|||
155086888|NCT01217892|559750730|FG003|Overall Study|Withdrawal by Subject|0|||
155086889|NCT01217892|559750727|FG000|Overall Study|Lab value|1|||
155086890|NCT01217892|559750728|FG001|Overall Study|Lab value|0|||
155086891|NCT01217892|559750729|FG002|Overall Study|Lab value|1|||
155086892|NCT01217892|559750730|FG003|Overall Study|Lab value|0|||
155086893|NCT01217892|559750727|FG000|Overall Study|Subject no longer meets study criteria|5|||
155086894|NCT01217892|559750728|FG001|Overall Study|Subject no longer meets study criteria|2|||
155086895|NCT01217892|559750729|FG002|Overall Study|Subject no longer meets study criteria|4|||
155086896|NCT01217892|559750730|FG003|Overall Study|Subject no longer meets study criteria|8|||
155086897|NCT01217892|559750727|FG000|Overall Study|Incorrect enrollment|0|||
155086898|NCT01217892|559750728|FG001|Overall Study|Incorrect enrollment|1|||
155086899|NCT01217892|559750729|FG002|Overall Study|Incorrect enrollment|1|||
155086900|NCT01217892|559750730|FG003|Overall Study|Incorrect enrollment|0|||
155086901|NCT01217892|559750727|FG000|Overall Study|Poor/Non-Compliance|0|||
155086902|NCT01217892|559750728|FG001|Overall Study|Poor/Non-Compliance|0|||
155086903|NCT01217892|559750729|FG002|Overall Study|Poor/Non-Compliance|1|||
155086904|NCT01217892|559750730|FG003|Overall Study|Poor/Non-Compliance|0|||
155086905|NCT03802916|559750731|FG000|Overall Study|Adverse Event|0|||
155086906|NCT03802916|559750732|FG001|Overall Study|Adverse Event|1|||
155086907|NCT03802916|559750731|FG000|Overall Study|Withdrawal by Subject|0|||
155086908|NCT03802916|559750732|FG001|Overall Study|Withdrawal by Subject|1|||
155086909|NCT03524157|559750742|FG000|Overall Study|cytology not readable|0|||
155086910|NCT03524157|559750743|FG001|Overall Study|cytology not readable|0|||
155086911|NCT03524157|559750744|FG002|Overall Study|cytology not readable|1|||
155086912|NCT04507763|559750745|FG000|Overall Study|Participants did not meet entrance criteria|201|||
155086913|NCT03322566|559750746|FG000|Overall Study|Death|34|||
155086914|NCT03322566|559750747|FG001|Overall Study|Death|35|||
155086915|NCT03322566|559750748|FG002|Overall Study|Death|23|||
155086916|NCT03322566|559750746|FG000|Overall Study|Physician Decision|6|||
155086917|NCT03322566|559750747|FG001|Overall Study|Physician Decision|7|||
155086918|NCT03322566|559750748|FG002|Overall Study|Physician Decision|2|||
155086919|NCT03322566|559750746|FG000|Overall Study|Withdrawal by Subject|4|||
155086920|NCT03322566|559750747|FG001|Overall Study|Withdrawal by Subject|3|||
155086921|NCT03322566|559750748|FG002|Overall Study|Withdrawal by Subject|6|||
155086922|NCT03322566|559750746|FG000|Overall Study|Lost to Follow-up|0|||
155086923|NCT03322566|559750747|FG001|Overall Study|Lost to Follow-up|0|||
155086924|NCT03322566|559750748|FG002|Overall Study|Lost to Follow-up|1|||
155086925|NCT03322566|559750746|FG000|Overall Study|Study terminated by sponsor|1|||
155086926|NCT03322566|559750747|FG001|Overall Study|Study terminated by sponsor|0|||
155086927|NCT03322566|559750748|FG002|Overall Study|Study terminated by sponsor|1|||
155086928|NCT05763381|559750752|FG000|Overall Study|Lost to Follow-up|2|||
155086929|NCT05763381|559750753|FG001|Overall Study|Lost to Follow-up|3|||
155086930|NCT05763381|559750752|FG000|Overall Study|Withdrawal by Subject|1|||
155086931|NCT05763381|559750753|FG001|Overall Study|Withdrawal by Subject|2|||
155086932|NCT00841815|559750754|FG000|Washout|Withdrawal by Subject|0|||
155086933|NCT00841815|559750755|FG001|Washout|Withdrawal by Subject|1|||
155355051|NCT02484547|560735021|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
155086934|NCT03729609|559750756|FG000|Overall Study|Protocol Violation|1|||
155086935|NCT02327169|559750762|FG000|Overall Study|Progressive Disease|1|||
155086936|NCT02327169|559750763|FG001|Overall Study|Progressive Disease|3|||
155086937|NCT02327169|559750764|FG002|Overall Study|Progressive Disease|4|||
155086938|NCT02327169|559750765|FG003|Overall Study|Progressive Disease|3|||
155086939|NCT02327169|559750766|FG004|Overall Study|Progressive Disease|4|||
155086940|NCT02327169|559750767|FG005|Overall Study|Progressive Disease|3|||
155086941|NCT02327169|559750768|FG006|Overall Study|Progressive Disease|3|||
155086942|NCT02327169|559750769|FG007|Overall Study|Progressive Disease|3|||
155355052|NCT02484547|560735022|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
155355053|NCT02484547|560735023|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
155355054|NCT02484547|560735024|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
155355055|NCT02484547|560735025|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
155355056|NCT02484547|560735019|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
155355057|NCT02484547|560735020|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155355058|NCT02484547|560735021|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
155355059|NCT02484547|560735022|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355060|NCT02484547|560735023|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355061|NCT02484547|560735024|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355062|NCT02484547|560735025|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
155355063|NCT02484547|560735019|FG000|Placebo-Controlled Period|Reason not Specified|216|||
155355064|NCT02484547|560735020|FG001|Placebo-Controlled Period|Reason not Specified|194|||
155355065|NCT02484547|560735021|FG002|Placebo-Controlled Period|Reason not Specified|183|||
155355066|NCT02484547|560735022|FG003|Placebo-Controlled Period|Reason not Specified|0|||
155355067|NCT02484547|560735023|FG004|Placebo-Controlled Period|Reason not Specified|0|||
155355068|NCT02484547|560735024|FG005|Placebo-Controlled Period|Reason not Specified|0|||
155355069|NCT02484547|560735025|FG006|Placebo-Controlled Period|Reason not Specified|0|||
155355070|NCT02484547|560735019|FG000|Long-Term Extension Period|Adverse Event|0|||
155355071|NCT02484547|560735020|FG001|Long-Term Extension Period|Adverse Event|0|||
155355072|NCT02484547|560735021|FG002|Long-Term Extension Period|Adverse Event|0|||
155355073|NCT02484547|560735022|FG003|Long-Term Extension Period|Adverse Event|0|||
155355074|NCT02484547|560735023|FG004|Long-Term Extension Period|Adverse Event|1|||
155355075|NCT02484547|560735024|FG005|Long-Term Extension Period|Adverse Event|3|||
155355076|NCT02484547|560735025|FG006|Long-Term Extension Period|Adverse Event|2|||
155355077|NCT02484547|560735019|FG000|Long-Term Extension Period|Death|0|||
155355078|NCT02484547|560735020|FG001|Long-Term Extension Period|Death|0|||
155355079|NCT02484547|560735021|FG002|Long-Term Extension Period|Death|0|||
155355080|NCT02484547|560735022|FG003|Long-Term Extension Period|Death|0|||
155355081|NCT02484547|560735023|FG004|Long-Term Extension Period|Death|0|||
155355082|NCT02484547|560735024|FG005|Long-Term Extension Period|Death|3|||
155355083|NCT02484547|560735025|FG006|Long-Term Extension Period|Death|0|||
155355084|NCT02484547|560735019|FG000|Long-Term Extension Period|Disease Progression|0|||
155086943|NCT02327169|559750770|FG008|Overall Study|Progressive Disease|4|||
155086944|NCT02327169|559750771|FG009|Overall Study|Progressive Disease|4|||
155355085|NCT02484547|560735020|FG001|Long-Term Extension Period|Disease Progression|0|||
155355086|NCT02484547|560735021|FG002|Long-Term Extension Period|Disease Progression|0|||
155355087|NCT02484547|560735022|FG003|Long-Term Extension Period|Disease Progression|0|||
155355088|NCT02484547|560735023|FG004|Long-Term Extension Period|Disease Progression|2|||
155086945|NCT02327169|559750772|FG010|Overall Study|Progressive Disease|4|||
155086946|NCT02327169|559750773|FG011|Overall Study|Progressive Disease|3|||
155086947|NCT02327169|559750774|FG012|Overall Study|Progressive Disease|1|||
155086948|NCT02327169|559750775|FG013|Overall Study|Progressive Disease|3|||
155086949|NCT02327169|559750776|FG014|Overall Study|Progressive Disease|3|||
155086950|NCT02327169|559750762|FG000|Overall Study|Adverse Event|2|||
155086951|NCT02327169|559750763|FG001|Overall Study|Adverse Event|0|||
155086952|NCT02327169|559750764|FG002|Overall Study|Adverse Event|1|||
155086953|NCT02327169|559750765|FG003|Overall Study|Adverse Event|0|||
155086954|NCT02327169|559750766|FG004|Overall Study|Adverse Event|1|||
155086955|NCT02327169|559750767|FG005|Overall Study|Adverse Event|0|||
155086956|NCT02327169|559750768|FG006|Overall Study|Adverse Event|0|||
155086957|NCT02327169|559750769|FG007|Overall Study|Adverse Event|0|||
155086958|NCT02327169|559750770|FG008|Overall Study|Adverse Event|0|||
155086959|NCT02327169|559750771|FG009|Overall Study|Adverse Event|2|||
155355089|NCT02484547|560735024|FG005|Long-Term Extension Period|Disease Progression|4|||
155355090|NCT02484547|560735025|FG006|Long-Term Extension Period|Disease Progression|0|||
155355091|NCT02484547|560735019|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
155355092|NCT02484547|560735020|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
155355093|NCT02484547|560735021|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
155355094|NCT02484547|560735022|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
155355095|NCT02484547|560735023|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
155355096|NCT02484547|560735024|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
155355097|NCT02484547|560735025|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
155355098|NCT02484547|560735019|FG000|Long-Term Extension Period|Loss of Capacity|0|||
155355099|NCT02484547|560735020|FG001|Long-Term Extension Period|Loss of Capacity|0|||
155355100|NCT02484547|560735021|FG002|Long-Term Extension Period|Loss of Capacity|0|||
155355101|NCT02484547|560735022|FG003|Long-Term Extension Period|Loss of Capacity|0|||
155355102|NCT02484547|560735023|FG004|Long-Term Extension Period|Loss of Capacity|1|||
155355103|NCT02484547|560735024|FG005|Long-Term Extension Period|Loss of Capacity|0|||
155355104|NCT02484547|560735025|FG006|Long-Term Extension Period|Loss of Capacity|0|||
155355105|NCT02484547|560735019|FG000|Long-Term Extension Period|Change of Treatment|0|||
155355106|NCT02484547|560735020|FG001|Long-Term Extension Period|Change of Treatment|0|||
155355107|NCT02484547|560735021|FG002|Long-Term Extension Period|Change of Treatment|0|||
155355108|NCT02484547|560735022|FG003|Long-Term Extension Period|Change of Treatment|0|||
155355109|NCT02484547|560735023|FG004|Long-Term Extension Period|Change of Treatment|0|||
155355110|NCT02484547|560735024|FG005|Long-Term Extension Period|Change of Treatment|0|||
155355111|NCT02484547|560735025|FG006|Long-Term Extension Period|Change of Treatment|1|||
155355112|NCT02484547|560735019|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
155355113|NCT02484547|560735020|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
155355114|NCT02484547|560735021|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
155355115|NCT02484547|560735022|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
155355116|NCT02484547|560735023|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
155355117|NCT02484547|560735024|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
155355118|NCT02484547|560735025|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
155355119|NCT02484547|560735019|FG000|Long-Term Extension Period|Investigator Decision|0|||
155355120|NCT02484547|560735020|FG001|Long-Term Extension Period|Investigator Decision|0|||
155355121|NCT02484547|560735021|FG002|Long-Term Extension Period|Investigator Decision|0|||
155355122|NCT02484547|560735022|FG003|Long-Term Extension Period|Investigator Decision|2|||
155355123|NCT02484547|560735023|FG004|Long-Term Extension Period|Investigator Decision|1|||
154964835|NCT01188681|559297544|FG002|Overall Study|Withdrawal by Subject|0|||
154964836|NCT01188681|559297545|FG003|Overall Study|Withdrawal by Subject|1|||
154964837|NCT04345653|559297546|FG000|Overall Study|Withdrawal by Subject|2|||
154964838|NCT03214588|559297547|FG000|Overall Study|Adverse Event|1|||
154964839|NCT03214588|559297548|FG001|Overall Study|Adverse Event|0|||
155086960|NCT02327169|559750772|FG010|Overall Study|Adverse Event|0|||
155086961|NCT02327169|559750773|FG011|Overall Study|Adverse Event|3|||
155086962|NCT02327169|559750774|FG012|Overall Study|Adverse Event|0|||
155086963|NCT02327169|559750775|FG013|Overall Study|Adverse Event|2|||
155355124|NCT02484547|560735024|FG005|Long-Term Extension Period|Investigator Decision|0|||
155355125|NCT02484547|560735025|FG006|Long-Term Extension Period|Investigator Decision|1|||
155355126|NCT02484547|560735019|FG000|Long-Term Extension Period|Relocation|0|||
155355127|NCT02484547|560735020|FG001|Long-Term Extension Period|Relocation|0|||
155355128|NCT02484547|560735021|FG002|Long-Term Extension Period|Relocation|0|||
155355129|NCT02484547|560735022|FG003|Long-Term Extension Period|Relocation|1|||
155086964|NCT02327169|559750776|FG014|Overall Study|Adverse Event|1|||
155086965|NCT02327169|559750762|FG000|Overall Study|Symptomatic Deterioration|0|||
155355130|NCT02484547|560735023|FG004|Long-Term Extension Period|Relocation|1|||
155355131|NCT02484547|560735024|FG005|Long-Term Extension Period|Relocation|0|||
155355132|NCT02484547|560735025|FG006|Long-Term Extension Period|Relocation|0|||
155355133|NCT02484547|560735019|FG000|Long-Term Extension Period|Study Visit Burden|0|||
155355134|NCT02484547|560735020|FG001|Long-Term Extension Period|Study Visit Burden|0|||
155355135|NCT02484547|560735021|FG002|Long-Term Extension Period|Study Visit Burden|0|||
155355136|NCT02484547|560735022|FG003|Long-Term Extension Period|Study Visit Burden|2|||
155355137|NCT02484547|560735023|FG004|Long-Term Extension Period|Study Visit Burden|0|||
155355138|NCT02484547|560735024|FG005|Long-Term Extension Period|Study Visit Burden|0|||
155355139|NCT02484547|560735025|FG006|Long-Term Extension Period|Study Visit Burden|3|||
155355140|NCT02484547|560735019|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155355141|NCT02484547|560735020|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155355142|NCT02484547|560735021|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
155355143|NCT02484547|560735022|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
154964840|NCT03214588|559297549|FG002|Overall Study|Adverse Event|2|||
154964841|NCT03214588|559297547|FG000|Overall Study|Reason Not Specified|0|||
154964842|NCT03214588|559297548|FG001|Overall Study|Reason Not Specified|1|||
154964843|NCT03214588|559297549|FG002|Overall Study|Reason Not Specified|0|||
154964844|NCT00418938|559297550|FG000|Overall Study|Reimbursement|1|||
154964845|NCT00418938|559297551|FG001|Overall Study|Reimbursement|0|||
154964846|NCT00418938|559297550|FG000|Overall Study|Administrative decision|3|||
154964847|NCT00418938|559297551|FG001|Overall Study|Administrative decision|3|||
154964848|NCT00418938|559297550|FG000|Overall Study|Withdrawal by Subject|16|||
154964849|NCT00418938|559297551|FG001|Overall Study|Withdrawal by Subject|15|||
154964850|NCT00418938|559297550|FG000|Overall Study|Lost to Follow-up|1|||
154964851|NCT00418938|559297551|FG001|Overall Study|Lost to Follow-up|3|||
155355144|NCT02484547|560735023|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
155355145|NCT02484547|560735024|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
155355146|NCT02484547|560735025|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
155355147|NCT02484547|560735019|FG000|Long-Term Extension Period|Reason not Specified|0|||
155355148|NCT02484547|560735020|FG001|Long-Term Extension Period|Reason not Specified|0|||
155355149|NCT02484547|560735021|FG002|Long-Term Extension Period|Reason not Specified|0|||
155355150|NCT02484547|560735022|FG003|Long-Term Extension Period|Reason not Specified|119|||
155355151|NCT02484547|560735023|FG004|Long-Term Extension Period|Reason not Specified|117|||
155355152|NCT02484547|560735024|FG005|Long-Term Extension Period|Reason not Specified|223|||
155355153|NCT02484547|560735025|FG006|Long-Term Extension Period|Reason not Specified|231|||
155355154|NCT03448536|560735026|FG000|Overall Study|Protocol Violation|2|||
155355155|NCT03448536|560735027|FG001|Overall Study|Protocol Violation|0|||
155355156|NCT03448536|560735026|FG000|Overall Study|Pregnancy|1|||
155355157|NCT03448536|560735027|FG001|Overall Study|Pregnancy|0|||
155355158|NCT03448536|560735026|FG000|Overall Study|Withdrawal by Subject|1|||
155355159|NCT03448536|560735027|FG001|Overall Study|Withdrawal by Subject|2|||
155355160|NCT03448536|560735026|FG000|Overall Study|Lost to Follow-up|3|||
155355161|NCT03448536|560735027|FG001|Overall Study|Lost to Follow-up|2|||
155355162|NCT03448536|560735026|FG000|Overall Study|Inadequate pain reporter|1|||
155355163|NCT03448536|560735027|FG001|Overall Study|Inadequate pain reporter|0|||
155355164|NCT03448536|560735026|FG000|Overall Study|Other|3|||
155355165|NCT03448536|560735027|FG001|Overall Study|Other|0|||
155355166|NCT03448536|560735026|FG000|Overall Study|Physician Decision|1|||
155355167|NCT03448536|560735027|FG001|Overall Study|Physician Decision|0|||
155355168|NCT01665599|560735028|FG000|Overall Study|Adverse Event|1|||
155355169|NCT01665599|560735028|FG000|Overall Study|Consent Withdrawn|1|||
155355170|NCT01665599|560735028|FG000|Overall Study|Investigator/Sponsor decision|1|||
155355171|NCT01665599|560735028|FG000|Overall Study|Death|1|||
155355172|NCT01665599|560735028|FG000|Overall Study|Lost to Follow-up|2|||
155355173|NCT01665599|560735028|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
154964852|NCT00418938|559297550|FG000|Overall Study|Adverse Event|1|||
155355174|NCT01665599|560735028|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
155355175|NCT04688086|560735029|FG000|Overall Study|Lost to Follow-up|164|||
155355176|NCT04688086|560735029|FG000|Overall Study|Imaging error;|64|||
155355177|NCT03015181|560735033|FG000|Overall Study|Enrolled, but product never administered|1|||
155355178|NCT03015181|560735034|FG001|Overall Study|Enrolled, but product never administered|0|||
155355179|NCT03015181|560735035|FG002|Overall Study|Enrolled, but product never administered|0|||
155355180|NCT03015181|560735036|FG003|Overall Study|Enrolled, but product never administered|0|||
155355181|NCT03015181|560735037|FG004|Overall Study|Enrolled, but product never administered|0|||
154964853|NCT00418938|559297551|FG001|Overall Study|Adverse Event|1|||
155355182|NCT03015181|560735038|FG005|Overall Study|Enrolled, but product never administered|0|||
155355183|NCT03015181|560735039|FG006|Overall Study|Enrolled, but product never administered|0|||
155355184|NCT03015181|560735033|FG000|Overall Study|Withdrawal by Subject|0|||
155355185|NCT03015181|560735034|FG001|Overall Study|Withdrawal by Subject|0|||
155355186|NCT03015181|560735035|FG002|Overall Study|Withdrawal by Subject|0|||
155355187|NCT03015181|560735036|FG003|Overall Study|Withdrawal by Subject|0|||
154964854|NCT00418938|559297550|FG000|Overall Study|On-going|1|||
154964855|NCT00418938|559297551|FG001|Overall Study|On-going|1|||
154964856|NCT00418938|559297550|FG000|Overall Study|Ineligibility Determined|1|||
155355188|NCT03015181|560735037|FG004|Overall Study|Withdrawal by Subject|0|||
155355189|NCT03015181|560735038|FG005|Overall Study|Withdrawal by Subject|1|||
155355190|NCT03015181|560735039|FG006|Overall Study|Withdrawal by Subject|0|||
155355191|NCT03015181|560735033|FG000|Overall Study|Physician Decision|0|||
155355192|NCT03015181|560735034|FG001|Overall Study|Physician Decision|0|||
155355193|NCT03015181|560735035|FG002|Overall Study|Physician Decision|0|||
155355194|NCT03015181|560735036|FG003|Overall Study|Physician Decision|0|||
155355195|NCT03015181|560735037|FG004|Overall Study|Physician Decision|0|||
155355196|NCT03015181|560735038|FG005|Overall Study|Physician Decision|0|||
155355197|NCT03015181|560735039|FG006|Overall Study|Physician Decision|1|||
155355198|NCT01831726|560735042|FG000|Overall Study|Adverse Event|16|||
155355199|NCT01831726|560735042|FG000|Overall Study|Death|7|||
155355200|NCT01831726|560735042|FG000|Overall Study|Disease Progression|49|||
155355201|NCT01831726|560735042|FG000|Overall Study|Physician Decision|1|||
155355202|NCT01831726|560735042|FG000|Overall Study|Subject/guardian decision|7|||
155355203|NCT03821064|560735043|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
155355204|NCT00474383|560735044|FG000|Main Study|Adverse Event|11|||
155355205|NCT00474383|560735045|FG001|Main Study|Adverse Event|0|||
155355206|NCT00474383|560735044|FG000|Main Study|Symptomatic Deterioration|1|||
155355207|NCT00474383|560735045|FG001|Main Study|Symptomatic Deterioration|0|||
155355208|NCT00474383|560735044|FG000|Main Study|Progressive Disease|23|||
155355209|NCT00474383|560735045|FG001|Main Study|Progressive Disease|0|||
155355210|NCT00474383|560735044|FG000|Main Study|Other|1|||
155355211|NCT00474383|560735045|FG001|Main Study|Other|0|||
155355212|NCT00474383|560735044|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
155355213|NCT00474383|560735045|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
155355214|NCT00474383|560735044|FG000|Extension|Progressive Disease|0|||
155355215|NCT00474383|560735045|FG001|Extension|Progressive Disease|5|||
155355216|NCT01482819|560735047|FG000|Overall Study|Lost to Follow-up|2|||
155355217|NCT01502371|560735052|FG000|Overall Study|Withdrawal by Subject|1|||
155355218|NCT01502371|560735053|FG001|Overall Study|Withdrawal by Subject|2|||
155355219|NCT01502371|560735054|FG002|Overall Study|Withdrawal by Subject|1|||
154964857|NCT00418938|559297551|FG001|Overall Study|Ineligibility Determined|0|||
154964858|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
155086966|NCT02327169|559750763|FG001|Overall Study|Symptomatic Deterioration|0|||
155355220|NCT01502371|560735055|FG003|Overall Study|Withdrawal by Subject|1|||
155355221|NCT01502371|560735056|FG004|Overall Study|Withdrawal by Subject|1|||
155355222|NCT01502371|560735052|FG000|Overall Study|Adverse Event|2|||
154964859|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
155355223|NCT01502371|560735053|FG001|Overall Study|Adverse Event|1|||
155355224|NCT01502371|560735054|FG002|Overall Study|Adverse Event|0|||
155355225|NCT01502371|560735055|FG003|Overall Study|Adverse Event|4|||
155355226|NCT01502371|560735056|FG004|Overall Study|Adverse Event|3|||
155355227|NCT01502371|560735052|FG000|Overall Study|Treatment Failure|22|||
155355228|NCT01502371|560735053|FG001|Overall Study|Treatment Failure|20|||
155355229|NCT01502371|560735054|FG002|Overall Study|Treatment Failure|12|||
155355230|NCT01502371|560735055|FG003|Overall Study|Treatment Failure|19|||
155086967|NCT02327169|559750764|FG002|Overall Study|Symptomatic Deterioration|1|||
155086968|NCT02327169|559750765|FG003|Overall Study|Symptomatic Deterioration|0|||
155086969|NCT02327169|559750766|FG004|Overall Study|Symptomatic Deterioration|1|||
155086970|NCT02327169|559750767|FG005|Overall Study|Symptomatic Deterioration|1|||
155086971|NCT02327169|559750768|FG006|Overall Study|Symptomatic Deterioration|0|||
155086972|NCT02327169|559750769|FG007|Overall Study|Symptomatic Deterioration|0|||
155355231|NCT01502371|560735056|FG004|Overall Study|Treatment Failure|30|||
155355232|NCT01502371|560735052|FG000|Overall Study|Lack of Efficacy|3|||
155355233|NCT01502371|560735053|FG001|Overall Study|Lack of Efficacy|3|||
155355234|NCT01502371|560735054|FG002|Overall Study|Lack of Efficacy|2|||
155355235|NCT01502371|560735055|FG003|Overall Study|Lack of Efficacy|2|||
155355236|NCT01502371|560735056|FG004|Overall Study|Lack of Efficacy|4|||
155355237|NCT01502371|560735052|FG000|Overall Study|Physician Decision|3|||
155355238|NCT01502371|560735053|FG001|Overall Study|Physician Decision|0|||
155355239|NCT01502371|560735054|FG002|Overall Study|Physician Decision|0|||
155355240|NCT01502371|560735055|FG003|Overall Study|Physician Decision|0|||
155355241|NCT01502371|560735056|FG004|Overall Study|Physician Decision|1|||
155355242|NCT01502371|560735052|FG000|Overall Study|Noncompliance with Study Drug|0|||
155355243|NCT01502371|560735053|FG001|Overall Study|Noncompliance with Study Drug|0|||
155355244|NCT01502371|560735054|FG002|Overall Study|Noncompliance with Study Drug|1|||
155355245|NCT01502371|560735055|FG003|Overall Study|Noncompliance with Study Drug|2|||
155355246|NCT01502371|560735056|FG004|Overall Study|Noncompliance with Study Drug|1|||
155355247|NCT01502371|560735052|FG000|Overall Study|Technical Problems|1|||
155355248|NCT01502371|560735053|FG001|Overall Study|Technical Problems|0|||
155355249|NCT01502371|560735054|FG002|Overall Study|Technical Problems|2|||
155355250|NCT01502371|560735055|FG003|Overall Study|Technical Problems|4|||
155355251|NCT01502371|560735056|FG004|Overall Study|Technical Problems|1|||
155355252|NCT01502371|560735052|FG000|Overall Study|Protocol Violation|9|||
155355253|NCT01502371|560735053|FG001|Overall Study|Protocol Violation|5|||
155355254|NCT01502371|560735054|FG002|Overall Study|Protocol Violation|6|||
155355255|NCT01502371|560735055|FG003|Overall Study|Protocol Violation|5|||
155355256|NCT01502371|560735056|FG004|Overall Study|Protocol Violation|10|||
155355257|NCT01502371|560735052|FG000|Overall Study|Excluded Medication|0|||
155355258|NCT01502371|560735053|FG001|Overall Study|Excluded Medication|1|||
155355259|NCT01502371|560735054|FG002|Overall Study|Excluded Medication|1|||
155355260|NCT01502371|560735055|FG003|Overall Study|Excluded Medication|0|||
155355261|NCT01502371|560735056|FG004|Overall Study|Excluded Medication|1|||
155355262|NCT00514813|560735061|FG000|Overall Study|Study terminated|14|||
155355263|NCT00514813|560735062|FG001|Overall Study|Study terminated|74|||
155355264|NCT00514813|560735063|FG002|Overall Study|Study terminated|40|||
155355265|NCT00514813|560735064|FG003|Overall Study|Study terminated|2|||
155355266|NCT00514813|560735061|FG000|Overall Study|Adverse Event|0|||
155355267|NCT00514813|560735062|FG001|Overall Study|Adverse Event|2|||
155355268|NCT00514813|560735063|FG002|Overall Study|Adverse Event|2|||
155355269|NCT00514813|560735064|FG003|Overall Study|Adverse Event|0|||
155355270|NCT00514813|560735061|FG000|Overall Study|Protocol Violation|1|||
155355271|NCT00514813|560735062|FG001|Overall Study|Protocol Violation|0|||
155355272|NCT00514813|560735063|FG002|Overall Study|Protocol Violation|0|||
155355273|NCT00514813|560735064|FG003|Overall Study|Protocol Violation|0|||
155355274|NCT00514813|560735061|FG000|Overall Study|Withdrawal by Subject|0|||
155355275|NCT00514813|560735062|FG001|Overall Study|Withdrawal by Subject|1|||
155086973|NCT02327169|559750770|FG008|Overall Study|Symptomatic Deterioration|2|||
155086974|NCT02327169|559750771|FG009|Overall Study|Symptomatic Deterioration|1|||
155355276|NCT00514813|560735063|FG002|Overall Study|Withdrawal by Subject|0|||
155355277|NCT00514813|560735064|FG003|Overall Study|Withdrawal by Subject|0|||
155355278|NCT00514813|560735061|FG000|Overall Study|Lack of Efficacy|0|||
155355279|NCT00514813|560735062|FG001|Overall Study|Lack of Efficacy|1|||
155355280|NCT00514813|560735063|FG002|Overall Study|Lack of Efficacy|0|||
155355281|NCT00514813|560735064|FG003|Overall Study|Lack of Efficacy|0|||
155355282|NCT00514813|560735061|FG000|Overall Study|Kidney transplant|0|||
155355283|NCT00514813|560735062|FG001|Overall Study|Kidney transplant|6|||
155355284|NCT00514813|560735063|FG002|Overall Study|Kidney transplant|2|||
155355285|NCT00514813|560735064|FG003|Overall Study|Kidney transplant|0|||
155355286|NCT00514813|560735061|FG000|Overall Study|Death|0|||
155355287|NCT00514813|560735062|FG001|Overall Study|Death|2|||
155355288|NCT00514813|560735063|FG002|Overall Study|Death|3|||
155355289|NCT00514813|560735064|FG003|Overall Study|Death|2|||
155355290|NCT01075100|560735069|FG000|Overall Study|Adverse Event|15|||
155355291|NCT01075100|560735070|FG001|Overall Study|Adverse Event|18|||
155086975|NCT02327169|559750772|FG010|Overall Study|Symptomatic Deterioration|0|||
155086976|NCT02327169|559750773|FG011|Overall Study|Symptomatic Deterioration|0|||
155165714|NCT02721966|560043543|FG004|Overall Study|Lack of Efficacy|0|||
155355292|NCT01075100|560735069|FG000|Overall Study|Patient Request|4|||
155355293|NCT01075100|560735070|FG001|Overall Study|Patient Request|4|||
155355294|NCT01075100|560735069|FG000|Overall Study|Investigator Request|2|||
155355295|NCT01075100|560735070|FG001|Overall Study|Investigator Request|1|||
155355296|NCT01075100|560735069|FG000|Overall Study|Disease Progression|25|||
155355297|NCT01075100|560735070|FG001|Overall Study|Disease Progression|29|||
155355298|NCT01075100|560735069|FG000|Overall Study|Other|3|||
155355299|NCT01075100|560735070|FG001|Overall Study|Other|1|||
155355300|NCT04944784|560735071|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
155355301|NCT04944784|560735072|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
155355302|NCT04944784|560735073|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
155355303|NCT04944784|560735074|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
155355304|NCT04944784|560735071|FG000|Double-blind Period|Adverse Event|20|||
155355305|NCT04944784|560735072|FG001|Double-blind Period|Adverse Event|4|||
155355306|NCT04944784|560735073|FG002|Double-blind Period|Adverse Event|0|||
155355307|NCT04944784|560735074|FG003|Double-blind Period|Adverse Event|0|||
155355308|NCT04944784|560735071|FG000|Double-blind Period|Withdrawal by Subject|15|||
155355309|NCT04944784|560735072|FG001|Double-blind Period|Withdrawal by Subject|4|||
155355310|NCT04944784|560735073|FG002|Double-blind Period|Withdrawal by Subject|0|||
155355311|NCT04944784|560735074|FG003|Double-blind Period|Withdrawal by Subject|0|||
155355312|NCT04944784|560735071|FG000|Double-blind Period|Death|7|||
155355313|NCT04944784|560735072|FG001|Double-blind Period|Death|2|||
155355314|NCT04944784|560735073|FG002|Double-blind Period|Death|0|||
155355315|NCT04944784|560735074|FG003|Double-blind Period|Death|0|||
155355316|NCT04944784|560735071|FG000|Double-blind Period|Physician Decision|2|||
155355317|NCT04944784|560735072|FG001|Double-blind Period|Physician Decision|1|||
155355318|NCT04944784|560735073|FG002|Double-blind Period|Physician Decision|0|||
155355319|NCT04944784|560735074|FG003|Double-blind Period|Physician Decision|0|||
155355320|NCT04944784|560735071|FG000|Double-blind Period|Lack of Efficacy|0|||
155355321|NCT04944784|560735072|FG001|Double-blind Period|Lack of Efficacy|1|||
155355322|NCT04944784|560735073|FG002|Double-blind Period|Lack of Efficacy|0|||
155355323|NCT04944784|560735074|FG003|Double-blind Period|Lack of Efficacy|0|||
155355324|NCT04944784|560735071|FG000|Double-blind Period|Sponsor Request|2|||
155355325|NCT04944784|560735072|FG001|Double-blind Period|Sponsor Request|1|||
155355326|NCT04944784|560735073|FG002|Double-blind Period|Sponsor Request|0|||
155355327|NCT04944784|560735074|FG003|Double-blind Period|Sponsor Request|0|||
155355328|NCT04944784|560735071|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
155355329|NCT04944784|560735072|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
155355330|NCT04944784|560735073|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
155355331|NCT04944784|560735074|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
155355332|NCT04944784|560735071|FG000|Double-blind Period|Participant Choice|1|||
155355333|NCT04944784|560735072|FG001|Double-blind Period|Participant Choice|1|||
155355334|NCT04944784|560735073|FG002|Double-blind Period|Participant Choice|0|||
155355335|NCT04944784|560735074|FG003|Double-blind Period|Participant Choice|0|||
155355336|NCT04944784|560735071|FG000|Double-blind Period|Progressive Disease|2|||
155355337|NCT04944784|560735072|FG001|Double-blind Period|Progressive Disease|2|||
155355338|NCT04944784|560735073|FG002|Double-blind Period|Progressive Disease|0|||
155355339|NCT04944784|560735074|FG003|Double-blind Period|Progressive Disease|0|||
155355340|NCT04944784|560735071|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
155355341|NCT04944784|560735072|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
155355342|NCT04944784|560735073|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
155355343|NCT04944784|560735074|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
155355344|NCT04944784|560735071|FG000|Active Drug Period|Adverse Event|0|||
155355345|NCT04944784|560735072|FG001|Active Drug Period|Adverse Event|0|||
155355346|NCT04944784|560735073|FG002|Active Drug Period|Adverse Event|3|||
155355347|NCT04944784|560735074|FG003|Active Drug Period|Adverse Event|6|||
155355348|NCT04944784|560735071|FG000|Active Drug Period|Withdrawal by Subject|0|||
155355349|NCT04944784|560735072|FG001|Active Drug Period|Withdrawal by Subject|0|||
155355350|NCT04944784|560735073|FG002|Active Drug Period|Withdrawal by Subject|4|||
155355351|NCT04944784|560735074|FG003|Active Drug Period|Withdrawal by Subject|7|||
155355352|NCT04944784|560735071|FG000|Active Drug Period|Death|0|||
155355353|NCT04944784|560735072|FG001|Active Drug Period|Death|0|||
155355354|NCT04944784|560735073|FG002|Active Drug Period|Death|3|||
155355355|NCT04944784|560735074|FG003|Active Drug Period|Death|4|||
155355356|NCT04944784|560735071|FG000|Active Drug Period|Lack of Efficacy|0|||
155355357|NCT04944784|560735072|FG001|Active Drug Period|Lack of Efficacy|0|||
155355358|NCT04944784|560735073|FG002|Active Drug Period|Lack of Efficacy|2|||
155355359|NCT04944784|560735074|FG003|Active Drug Period|Lack of Efficacy|2|||
155355360|NCT04944784|560735071|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
155355361|NCT04944784|560735072|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
155355362|NCT04944784|560735073|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
155355363|NCT04944784|560735074|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
155355364|NCT04944784|560735071|FG000|Active Drug Period|Participant Choice|0|||
155355365|NCT04944784|560735072|FG001|Active Drug Period|Participant Choice|0|||
155355366|NCT04944784|560735073|FG002|Active Drug Period|Participant Choice|0|||
155355367|NCT04944784|560735074|FG003|Active Drug Period|Participant Choice|1|||
155355368|NCT04944784|560735071|FG000|Active Drug Period|Progressive Disease|0|||
155355369|NCT04944784|560735072|FG001|Active Drug Period|Progressive Disease|0|||
155355370|NCT04944784|560735073|FG002|Active Drug Period|Progressive Disease|4|||
155355371|NCT04944784|560735074|FG003|Active Drug Period|Progressive Disease|4|||
155355372|NCT04944784|560735071|FG000|Active Drug Period|Lost to Follow-up|0|||
155355373|NCT04944784|560735072|FG001|Active Drug Period|Lost to Follow-up|0|||
155355374|NCT04944784|560735073|FG002|Active Drug Period|Lost to Follow-up|0|||
155355375|NCT04944784|560735074|FG003|Active Drug Period|Lost to Follow-up|1|||
155355376|NCT04398368|560736547|FG000|Overall Study|Withdrawal by Subject|2|||
155355377|NCT03602586|560736548|FG000|Overall Study|Withdrawal by Subject|3|||
155355378|NCT00511836|560736553|FG000|Double-blind Period|Lost to Follow-up|1|||
155355379|NCT00511836|560736554|FG001|Double-blind Period|Lost to Follow-up|0|||
155355380|NCT00030823|560736555|FG000|Overall Study|Withdrawal by Subject|1|||
155355381|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
155355382|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
155355383|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
155355384|NCT01755546|560736556|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
155355385|NCT01755546|560736556|FG000|Titration Phase|Adverse Event|11|||
155355386|NCT01755546|560736556|FG000|Titration Phase|Lack of Efficacy|18|||
155355387|NCT01755546|560736556|FG000|Titration Phase|Protocol Violation|9|||
155355388|NCT01755546|560736556|FG000|Titration Phase|Lost to Follow-up|2|||
155355389|NCT01755546|560736556|FG000|Titration Phase|Other and Continuing|22|||
155355390|NCT01755546|560736556|FG000|Titration Phase|Withdrawal by Subject|8|||
155355391|NCT01755546|560736556|FG000|Long Term Treatment|Adverse Event|12|||
155355392|NCT01755546|560736556|FG000|Long Term Treatment|Lack of Efficacy|6|||
155355393|NCT01755546|560736556|FG000|Long Term Treatment|Protocol Violation|10|||
155355394|NCT01755546|560736556|FG000|Long Term Treatment|Withdrawal by Subject|35|||
155355395|NCT01755546|560736556|FG000|Long Term Treatment|Lost to Follow-up|17|||
155355396|NCT01755546|560736556|FG000|Long Term Treatment|other and ongoing|41|||
155355397|NCT00891046|560736557|FG000|Overall Study|Protocol Violation|1|||
155355398|NCT00891046|560736558|FG001|Overall Study|Protocol Violation|1|||
155355399|NCT00891046|560736559|FG002|Overall Study|Protocol Violation|0|||
155355400|NCT00891046|560736560|FG003|Overall Study|Protocol Violation|0|||
155355401|NCT00891046|560736561|FG004|Overall Study|Protocol Violation|1|||
155355402|NCT00891046|560736557|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155355403|NCT00891046|560736558|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155355404|NCT00891046|560736559|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
155355405|NCT00891046|560736560|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
155355406|NCT00891046|560736561|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
155355407|NCT00891046|560736557|FG000|Overall Study|Administrative problems|0|||
155355408|NCT00891046|560736558|FG001|Overall Study|Administrative problems|0|||
155355409|NCT00891046|560736559|FG002|Overall Study|Administrative problems|0|||
155355410|NCT00891046|560736560|FG003|Overall Study|Administrative problems|0|||
155355411|NCT00891046|560736561|FG004|Overall Study|Administrative problems|1|||
155355412|NCT00891046|560736557|FG000|Overall Study|Participant no longer required drug|0|||
155355413|NCT00891046|560736558|FG001|Overall Study|Participant no longer required drug|2|||
155355414|NCT00891046|560736559|FG002|Overall Study|Participant no longer required drug|0|||
155355415|NCT00891046|560736560|FG003|Overall Study|Participant no longer required drug|0|||
155355416|NCT00891046|560736561|FG004|Overall Study|Participant no longer required drug|1|||
155355417|NCT00891046|560736557|FG000|Overall Study|Adverse Event|4|||
155355418|NCT00891046|560736558|FG001|Overall Study|Adverse Event|3|||
155355419|NCT00891046|560736559|FG002|Overall Study|Adverse Event|2|||
155355420|NCT00891046|560736560|FG003|Overall Study|Adverse Event|0|||
155355421|NCT00891046|560736561|FG004|Overall Study|Adverse Event|14|||
155355422|NCT00891046|560736557|FG000|Overall Study|Withdrawal by Subject|2|||
155355423|NCT00891046|560736558|FG001|Overall Study|Withdrawal by Subject|1|||
155355424|NCT00891046|560736559|FG002|Overall Study|Withdrawal by Subject|2|||
155355425|NCT00891046|560736560|FG003|Overall Study|Withdrawal by Subject|1|||
155355426|NCT00891046|560736561|FG004|Overall Study|Withdrawal by Subject|1|||
155355427|NCT00891046|560736557|FG000|Overall Study|Lost to Follow-up|0|||
155355428|NCT00891046|560736558|FG001|Overall Study|Lost to Follow-up|0|||
155355429|NCT00891046|560736559|FG002|Overall Study|Lost to Follow-up|0|||
155355430|NCT00891046|560736560|FG003|Overall Study|Lost to Follow-up|0|||
155355431|NCT00891046|560736561|FG004|Overall Study|Lost to Follow-up|1|||
155355432|NCT00362375|560736562|FG000|Overall Study|Lost to Follow-up|40|||
155355433|NCT00362375|560736563|FG001|Overall Study|Lost to Follow-up|35|||
155355434|NCT02106195|560736564|FG000|Overall Study|Adverse Event|2|||
155355435|NCT02106195|560736564|FG000|Overall Study|Protocol Violation|1|||
155355436|NCT04984239|560736565|FG000|Overall Study|Lost to Follow-up|1|||
155355437|NCT03294941|560736566|FG000|Overall Study|Withdrawal by Subject|0|||
155355438|NCT03294941|560736567|FG001|Overall Study|Withdrawal by Subject|2|||
155355439|NCT04629443|560736568|FG000|Overall Study|Adverse Event|2|||
155355440|NCT04629443|560736569|FG001|Overall Study|Adverse Event|1|||
155355441|NCT04629443|560736570|FG002|Overall Study|Adverse Event|2|||
155355442|NCT04629443|560736568|FG000|Overall Study|Progressive Disease|2|||
155355443|NCT04629443|560736569|FG001|Overall Study|Progressive Disease|3|||
155355444|NCT04629443|560736570|FG002|Overall Study|Progressive Disease|3|||
155355445|NCT04629443|560736568|FG000|Overall Study|Physician Decision|1|||
155086977|NCT02327169|559750774|FG012|Overall Study|Symptomatic Deterioration|0|||
155086978|NCT02327169|559750775|FG013|Overall Study|Symptomatic Deterioration|2|||
155086979|NCT02327169|559750776|FG014|Overall Study|Symptomatic Deterioration|1|||
155086980|NCT02327169|559750762|FG000|Overall Study|Reason Not Specified|0|||
155355446|NCT04629443|560736569|FG001|Overall Study|Physician Decision|3|||
155355447|NCT04629443|560736570|FG002|Overall Study|Physician Decision|0|||
155355448|NCT00916305|560736576|FG000|Overall Study|Lost to Follow-up|21|||
155355449|NCT00916305|560736577|FG001|Overall Study|Lost to Follow-up|27|||
155355450|NCT00916305|560736576|FG000|Overall Study|Withdrawal by Subject|0|||
155355451|NCT00916305|560736577|FG001|Overall Study|Withdrawal by Subject|1|||
155355452|NCT00858247|560736582|FG000|Baseline Assessment|Withdrawal by Subject|1|||
155355453|NCT00858247|560736583|FG001|Baseline Assessment|Withdrawal by Subject|1|||
155355454|NCT00858247|560736582|FG000|Baseline Assessment|Poor IV access|1|||
155355455|NCT00858247|560736583|FG001|Baseline Assessment|Poor IV access|0|||
155355456|NCT00858247|560736582|FG000|Baseline Assessment|Protocol Violation|0|||
155355457|NCT00858247|560736583|FG001|Baseline Assessment|Protocol Violation|1|||
155355458|NCT00858247|560736582|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
155355459|NCT00858247|560736583|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
155355460|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
155355461|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
155355462|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
155355463|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
155355464|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
155355465|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
155355466|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
155355467|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
155355468|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
155355469|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
155355470|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
155355471|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
155355472|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
155355473|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
155355474|NCT01664923|560736586|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
155355475|NCT01664923|560736587|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
155355476|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
155355477|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
155355478|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
155355479|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
155355480|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
155355481|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
155355482|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
155355483|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
155355484|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
155355485|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
155355486|NCT01664923|560736586|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
155355487|NCT01664923|560736587|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
155355488|NCT01336205|560736588|FG000|Overall Study|Other|22|||
155355489|NCT01336205|560736589|FG001|Overall Study|Other|9|||
155355490|NCT01336205|560736588|FG000|Overall Study|Lost to Follow-up|40|||
155355491|NCT01336205|560736589|FG001|Overall Study|Lost to Follow-up|20|||
155355492|NCT01336205|560736588|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
155355493|NCT01336205|560736589|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
155355494|NCT01336205|560736588|FG000|Overall Study|Lack of Efficacy|4|||
155355495|NCT01336205|560736589|FG001|Overall Study|Lack of Efficacy|0|||
155355496|NCT01336205|560736588|FG000|Overall Study|Severe noncompliance with protocol|9|||
155355497|NCT01336205|560736589|FG001|Overall Study|Severe noncompliance with protocol|2|||
155355498|NCT01336205|560736588|FG000|Overall Study|Adverse Event|56|||
155355499|NCT01336205|560736589|FG001|Overall Study|Adverse Event|6|||
155355500|NCT01336205|560736588|FG000|Overall Study|Death|1|||
155355501|NCT01336205|560736589|FG001|Overall Study|Death|1|||
155355502|NCT01336205|560736588|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
155355503|NCT01336205|560736589|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
155355504|NCT01336205|560736588|FG000|Overall Study|Withdrawal by Subject|72|||
155355505|NCT01336205|560736589|FG001|Overall Study|Withdrawal by Subject|38|||
155086981|NCT02327169|559750763|FG001|Overall Study|Reason Not Specified|0|||
155086982|NCT02327169|559750764|FG002|Overall Study|Reason Not Specified|1|||
155355506|NCT01336205|560736588|FG000|Overall Study|Did not receive treatment|4|||
155355507|NCT01336205|560736589|FG001|Overall Study|Did not receive treatment|0|||
155355508|NCT01086384|560736591|FG000|2-week Run-in Period|Adverse Event|1|||
155355509|NCT01086384|560736592|FG001|2-week Run-in Period|Adverse Event|0|||
155355510|NCT01086384|560736593|FG002|2-week Run-in Period|Adverse Event|0|||
155355511|NCT01086384|560736591|FG000|2-week Run-in Period|Protocol Violation|1|||
155355512|NCT01086384|560736592|FG001|2-week Run-in Period|Protocol Violation|0|||
155355513|NCT01086384|560736593|FG002|2-week Run-in Period|Protocol Violation|0|||
155355514|NCT01086384|560736591|FG000|2-week Run-in Period|Lost to Follow-up|1|||
155355515|NCT01086384|560736592|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155355516|NCT01086384|560736593|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155355517|NCT01086384|560736591|FG000|2-week Run-in Period|Physician Decision|6|||
155355518|NCT01086384|560736592|FG001|2-week Run-in Period|Physician Decision|0|||
155355519|NCT01086384|560736593|FG002|2-week Run-in Period|Physician Decision|0|||
155355520|NCT01086384|560736591|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
155355521|NCT01086384|560736592|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155355522|NCT01086384|560736593|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155355523|NCT01086384|560736591|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
155355524|NCT01086384|560736592|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
155355525|NCT01086384|560736593|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
155355526|NCT01086384|560736591|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
155355527|NCT01086384|560736592|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
155355528|NCT01086384|560736593|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
155355529|NCT01086384|560736591|FG000|2-week Run-in Period|Randomized in Error|1|||
155355530|NCT01086384|560736592|FG001|2-week Run-in Period|Randomized in Error|0|||
155355531|NCT01086384|560736593|FG002|2-week Run-in Period|Randomized in Error|0|||
155355532|NCT01086384|560736591|FG000|Treatment Period|Withdrawal by Subject|0|||
155355533|NCT01086384|560736592|FG001|Treatment Period|Withdrawal by Subject|53|||
155355534|NCT01086384|560736593|FG002|Treatment Period|Withdrawal by Subject|55|||
155355535|NCT01086384|560736591|FG000|Treatment Period|Protocol Violation|0|||
155355536|NCT01086384|560736592|FG001|Treatment Period|Protocol Violation|26|||
155355537|NCT01086384|560736593|FG002|Treatment Period|Protocol Violation|17|||
155355538|NCT01086384|560736591|FG000|Treatment Period|Lack of Efficacy|0|||
155355539|NCT01086384|560736592|FG001|Treatment Period|Lack of Efficacy|22|||
155355540|NCT01086384|560736593|FG002|Treatment Period|Lack of Efficacy|13|||
155355541|NCT01086384|560736591|FG000|Treatment Period|Adverse Event|0|||
155355542|NCT01086384|560736592|FG001|Treatment Period|Adverse Event|19|||
155355543|NCT01086384|560736593|FG002|Treatment Period|Adverse Event|15|||
155355544|NCT01086384|560736591|FG000|Treatment Period|Lost to Follow-up|0|||
155355545|NCT01086384|560736592|FG001|Treatment Period|Lost to Follow-up|11|||
155355546|NCT01086384|560736593|FG002|Treatment Period|Lost to Follow-up|9|||
155355547|NCT01086384|560736591|FG000|Treatment Period|Physician Decision|0|||
155355548|NCT01086384|560736592|FG001|Treatment Period|Physician Decision|9|||
155355549|NCT01086384|560736593|FG002|Treatment Period|Physician Decision|6|||
155355550|NCT01086384|560736591|FG000|Treatment Period|Study Closed/Terminated|0|||
155355551|NCT01086384|560736592|FG001|Treatment Period|Study Closed/Terminated|7|||
155355552|NCT01086384|560736593|FG002|Treatment Period|Study Closed/Terminated|8|||
155355553|NCT01086384|560736591|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
155355554|NCT01086384|560736592|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
155355555|NCT01086384|560736593|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
155355556|NCT01086384|560736591|FG000|Treatment Period|Received Treatment in Error|0|||
155355557|NCT01086384|560736592|FG001|Treatment Period|Received Treatment in Error|1|||
155355558|NCT01086384|560736593|FG002|Treatment Period|Received Treatment in Error|0|||
155355559|NCT02586415|560736596|FG000|Overall Study|Death|13|||
155355560|NCT02586415|560736597|FG001|Overall Study|Death|23|||
155355561|NCT02586415|560736596|FG000|Overall Study|Lost to Follow-up|1|||
155355562|NCT02586415|560736597|FG001|Overall Study|Lost to Follow-up|2|||
155355563|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
155355564|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
155355565|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
155355566|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
155355567|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
155355568|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Death|1|||
155355569|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Death|0|||
155355570|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Death|0|||
155165715|NCT02721966|560043539|FG000|Overall Study|Lost to Follow-up|0|||
155165716|NCT02721966|560043540|FG001|Overall Study|Lost to Follow-up|0|||
155165717|NCT02721966|560043541|FG002|Overall Study|Lost to Follow-up|3|||
155165718|NCT02721966|560043542|FG003|Overall Study|Lost to Follow-up|0|||
155165719|NCT02721966|560043543|FG004|Overall Study|Lost to Follow-up|0|||
155165720|NCT02721966|560043539|FG000|Overall Study|Physician Decision|1|||
155355571|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Death|0|||
155355572|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Death|0|||
155355573|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355574|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
155355575|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355576|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355577|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
155355578|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355579|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
155355580|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355581|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355582|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
155355583|NCT03974100|560736598|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
155355584|NCT03974100|560736599|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
155355585|NCT03974100|560736600|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
155355586|NCT03974100|560736601|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
155355587|NCT03974100|560736602|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
155355588|NCT03974100|560736598|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355589|NCT03974100|560736599|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355590|NCT03974100|560736600|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355591|NCT03974100|560736601|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
155355592|NCT03974100|560736602|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
155355593|NCT03974100|560736598|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
155355594|NCT03974100|560736599|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
155355595|NCT03974100|560736600|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
155355596|NCT03974100|560736601|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
155355597|NCT03974100|560736602|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
155355598|NCT03318783|560736603|FG000|Overall Study|Withdrawal by Subject|0|||
155355599|NCT03318783|560736604|FG001|Overall Study|Withdrawal by Subject|1|||
155355600|NCT03318783|560736603|FG000|Overall Study|Death|0|||
155355601|NCT03318783|560736604|FG001|Overall Study|Death|1|||
155355602|NCT04358068|560736611|FG000|Overall Study|Did not initiate study treatment|2|||
155355603|NCT04358068|560736612|FG001|Overall Study|Did not initiate study treatment|2|||
155355604|NCT01426113|560736613|FG000|Overall Study|Study Discontinued|1|||
155355605|NCT01426113|560736614|FG001|Overall Study|Study Discontinued|1|||
155355606|NCT01426113|560736613|FG000|Overall Study|Adverse Event|0|||
155355607|NCT01426113|560736614|FG001|Overall Study|Adverse Event|1|||
155355608|NCT02719743|560736617|FG000|Overall Study|Consent withdrawal|0|||
155355609|NCT02719743|560736618|FG001|Overall Study|Consent withdrawal|2|||
155355610|NCT02719743|560736619|FG002|Overall Study|Consent withdrawal|0|||
155355611|NCT02719743|560736620|FG003|Overall Study|Consent withdrawal|1|||
155355612|NCT02719743|560736621|FG004|Overall Study|Consent withdrawal|0|||
155355613|NCT02719743|560736617|FG000|Overall Study|Migrated/moved from study area|0|||
155355614|NCT02719743|560736618|FG001|Overall Study|Migrated/moved from study area|0|||
155355615|NCT02719743|560736619|FG002|Overall Study|Migrated/moved from study area|0|||
155355616|NCT02719743|560736620|FG003|Overall Study|Migrated/moved from study area|0|||
155355617|NCT02719743|560736621|FG004|Overall Study|Migrated/moved from study area|2|||
155355618|NCT02719743|560736617|FG000|Overall Study|Lost to Follow-up|1|||
155355619|NCT02719743|560736618|FG001|Overall Study|Lost to Follow-up|1|||
155355620|NCT02719743|560736619|FG002|Overall Study|Lost to Follow-up|0|||
155355621|NCT02719743|560736620|FG003|Overall Study|Lost to Follow-up|0|||
155355622|NCT02719743|560736621|FG004|Overall Study|Lost to Follow-up|0|||
155355623|NCT01438840|560736622|FG000|Core Study|Adverse Event|0|||
155355624|NCT01438840|560736623|FG001|Core Study|Adverse Event|3|||
155355625|NCT01438840|560736624|FG002|Core Study|Adverse Event|0|||
155355626|NCT01438840|560736622|FG000|Core Study|Lack of Efficacy|15|||
155355627|NCT01438840|560736623|FG001|Core Study|Lack of Efficacy|7|||
155355628|NCT01438840|560736624|FG002|Core Study|Lack of Efficacy|0|||
155355629|NCT01438840|560736622|FG000|Core Study|Withdrawal of consent|1|||
155355630|NCT01438840|560736623|FG001|Core Study|Withdrawal of consent|0|||
155355631|NCT01438840|560736624|FG002|Core Study|Withdrawal of consent|0|||
155355632|NCT01438840|560736622|FG000|Extension Phase|Adverse Event|0|||
155355633|NCT01438840|560736623|FG001|Extension Phase|Adverse Event|0|||
155355634|NCT01438840|560736624|FG002|Extension Phase|Adverse Event|3|||
155355635|NCT01438840|560736622|FG000|Extension Phase|Lost to Follow-up|0|||
155355636|NCT01438840|560736623|FG001|Extension Phase|Lost to Follow-up|0|||
155355637|NCT01438840|560736624|FG002|Extension Phase|Lost to Follow-up|1|||
155355638|NCT01438840|560736622|FG000|Extension Phase|Withdrawal by Subject|0|||
155355639|NCT01438840|560736623|FG001|Extension Phase|Withdrawal by Subject|0|||
155355640|NCT01438840|560736624|FG002|Extension Phase|Withdrawal by Subject|3|||
155355641|NCT01438840|560736622|FG000|Extension Phase|Lack of Efficacy|0|||
155355642|NCT01438840|560736623|FG001|Extension Phase|Lack of Efficacy|0|||
155355643|NCT01438840|560736624|FG002|Extension Phase|Lack of Efficacy|2|||
155355644|NCT01438840|560736622|FG000|Extension Phase|Other|0|||
155355645|NCT01438840|560736623|FG001|Extension Phase|Other|0|||
155355646|NCT01438840|560736624|FG002|Extension Phase|Other|1|||
155355647|NCT00461123|560736627|FG000|Overall Study|Adverse Event|1|||
154964860|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
154964861|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
154964862|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
154964863|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
155086983|NCT02327169|559750765|FG003|Overall Study|Reason Not Specified|0|||
155086984|NCT02327169|559750766|FG004|Overall Study|Reason Not Specified|0|||
155086985|NCT02327169|559750767|FG005|Overall Study|Reason Not Specified|0|||
155086986|NCT02327169|559750768|FG006|Overall Study|Reason Not Specified|0|||
155086987|NCT02327169|559750769|FG007|Overall Study|Reason Not Specified|0|||
155086988|NCT02327169|559750770|FG008|Overall Study|Reason Not Specified|0|||
155086989|NCT02327169|559750771|FG009|Overall Study|Reason Not Specified|1|||
155086990|NCT02327169|559750772|FG010|Overall Study|Reason Not Specified|2|||
155086991|NCT02327169|559750773|FG011|Overall Study|Reason Not Specified|1|||
155086992|NCT02327169|559750774|FG012|Overall Study|Reason Not Specified|0|||
155086993|NCT02327169|559750775|FG013|Overall Study|Reason Not Specified|0|||
155086994|NCT02327169|559750776|FG014|Overall Study|Reason Not Specified|2|||
155086995|NCT02327169|559750762|FG000|Overall Study|Withdrawal by Subject|1|||
155086996|NCT02327169|559750763|FG001|Overall Study|Withdrawal by Subject|0|||
155086997|NCT02327169|559750764|FG002|Overall Study|Withdrawal by Subject|0|||
155086998|NCT02327169|559750765|FG003|Overall Study|Withdrawal by Subject|0|||
155355648|NCT00461123|560736628|FG001|Overall Study|Adverse Event|0|||
155355649|NCT00461123|560736627|FG000|Overall Study|Lost to Follow-up|1|||
155355650|NCT00461123|560736628|FG001|Overall Study|Lost to Follow-up|1|||
155355651|NCT00461123|560736627|FG000|Overall Study|Protocol Violation|3|||
155355652|NCT00461123|560736628|FG001|Overall Study|Protocol Violation|2|||
155355653|NCT00461123|560736627|FG000|Overall Study|Withdrawal by Subject|1|||
155355654|NCT00461123|560736628|FG001|Overall Study|Withdrawal by Subject|3|||
155355655|NCT02024750|560736629|FG000|Overall Study|Withdrawal by Subject|2|||
155355656|NCT02024750|560736630|FG001|Overall Study|Withdrawal by Subject|1|||
155355657|NCT01891890|560736632|FG000|Overall Study|Lost to Follow-up|0|||
155355658|NCT01891890|560736633|FG001|Overall Study|Lost to Follow-up|0|||
155355659|NCT01891890|560736634|FG002|Overall Study|Lost to Follow-up|1|||
155355660|NCT01891890|560736632|FG000|Overall Study|Study ended before endpoint reached|7|||
155355661|NCT01891890|560736633|FG001|Overall Study|Study ended before endpoint reached|3|||
155355662|NCT01891890|560736634|FG002|Overall Study|Study ended before endpoint reached|6|||
155355663|NCT02725008|560736637|FG000|Overall Study|Lost to Follow-up|7|||
155355664|NCT02725008|560736638|FG001|Overall Study|Lost to Follow-up|9|||
155355665|NCT02725008|560736637|FG000|Overall Study|Withdrawal by Subject|2|||
155355666|NCT02725008|560736638|FG001|Overall Study|Withdrawal by Subject|2|||
155355667|NCT02725008|560736637|FG000|Overall Study|Admitted to hospital|0|||
155355668|NCT02725008|560736638|FG001|Overall Study|Admitted to hospital|1|||
155355669|NCT01329419|560736641|FG000|Overall Study|Protocol Violation|235|||
155355670|NCT00361842|560736642|FG000|Overall Study|Withdrawal by Subject|2|||
155355671|NCT00361842|560736643|FG001|Overall Study|Withdrawal by Subject|3|||
155355672|NCT00361842|560736642|FG000|Overall Study|Death|2|||
155355673|NCT00361842|560736643|FG001|Overall Study|Death|1|||
155355674|NCT00361842|560736642|FG000|Overall Study|Disease progression|19|||
154964864|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Death|9|||
155086999|NCT02327169|559750766|FG004|Overall Study|Withdrawal by Subject|1|||
155087000|NCT02327169|559750767|FG005|Overall Study|Withdrawal by Subject|0|||
155087001|NCT02327169|559750768|FG006|Overall Study|Withdrawal by Subject|0|||
155355675|NCT00361842|560736643|FG001|Overall Study|Disease progression|20|||
155355676|NCT00361842|560736642|FG000|Overall Study|Adverse Event|2|||
155355677|NCT00361842|560736643|FG001|Overall Study|Adverse Event|3|||
155355678|NCT00361842|560736642|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
155355679|NCT00361842|560736643|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
155355680|NCT00361842|560736642|FG000|Overall Study|Other|1|||
155087002|NCT02327169|559750769|FG007|Overall Study|Withdrawal by Subject|1|||
155355681|NCT00361842|560736643|FG001|Overall Study|Other|0|||
155087003|NCT02327169|559750770|FG008|Overall Study|Withdrawal by Subject|0|||
155165721|NCT02721966|560043540|FG001|Overall Study|Physician Decision|1|||
155355682|NCT00361842|560736642|FG000|Overall Study|Other|0|||
155355683|NCT00361842|560736643|FG001|Overall Study|Other|2|||
155355684|NCT03512288|560736644|FG000|Overall Study|Adverse Event|1|||
155355685|NCT03512288|560736645|FG001|Overall Study|Adverse Event|0|||
155355686|NCT03512288|560736644|FG000|Overall Study|Lost to Follow-up|12|||
155355687|NCT03512288|560736645|FG001|Overall Study|Lost to Follow-up|15|||
155355688|NCT03512288|560736644|FG000|Overall Study|Physician Decision|0|||
155355689|NCT03512288|560736645|FG001|Overall Study|Physician Decision|2|||
155355690|NCT03512288|560736644|FG000|Overall Study|Protocol Violation|6|||
155355691|NCT03512288|560736645|FG001|Overall Study|Protocol Violation|4|||
155355692|NCT03512288|560736644|FG000|Overall Study|Medication error without associated adverse event|1|||
155355693|NCT03512288|560736645|FG001|Overall Study|Medication error without associated adverse event|0|||
155355694|NCT03512288|560736644|FG000|Overall Study|No longer met eligibility criteria|5|||
155355695|NCT03512288|560736645|FG001|Overall Study|No longer met eligibility criteria|2|||
155355696|NCT03512288|560736644|FG000|Overall Study|Withdrawal by parent/guardian|14|||
155165722|NCT02721966|560043541|FG002|Overall Study|Physician Decision|0|||
155165723|NCT02721966|560043542|FG003|Overall Study|Physician Decision|0|||
155355697|NCT03512288|560736645|FG001|Overall Study|Withdrawal by parent/guardian|18|||
155355698|NCT03512288|560736644|FG000|Overall Study|Other|1|||
155355699|NCT03512288|560736645|FG001|Overall Study|Other|1|||
155355700|NCT03512288|560736644|FG000|Overall Study|Randomized but not treated|1|||
155355701|NCT03512288|560736645|FG001|Overall Study|Randomized but not treated|1|||
155087004|NCT02327169|559750771|FG009|Overall Study|Withdrawal by Subject|0|||
155087005|NCT02327169|559750772|FG010|Overall Study|Withdrawal by Subject|0|||
155087006|NCT02327169|559750773|FG011|Overall Study|Withdrawal by Subject|0|||
155087007|NCT02327169|559750774|FG012|Overall Study|Withdrawal by Subject|0|||
155355702|NCT01177228|560736653|FG000|Overall Study|Positive tuberculosis test|0|||
155355703|NCT01177228|560736654|FG001|Overall Study|Positive tuberculosis test|1|||
155355704|NCT01177228|560736655|FG002|Overall Study|Positive tuberculosis test|0|||
155355705|NCT01177228|560736656|FG003|Overall Study|Positive tuberculosis test|0|||
155355706|NCT01177228|560736653|FG000|Overall Study|Worsening disease activity|1|||
155355707|NCT01177228|560736654|FG001|Overall Study|Worsening disease activity|0|||
155355708|NCT01177228|560736655|FG002|Overall Study|Worsening disease activity|0|||
155355709|NCT01177228|560736656|FG003|Overall Study|Worsening disease activity|0|||
155355710|NCT01177228|560736653|FG000|Overall Study|Withdrawal by Subject|0|||
155355711|NCT01177228|560736654|FG001|Overall Study|Withdrawal by Subject|1|||
155355712|NCT01177228|560736655|FG002|Overall Study|Withdrawal by Subject|0|||
155355713|NCT01177228|560736656|FG003|Overall Study|Withdrawal by Subject|0|||
155355714|NCT03325608|560736657|FG000|Overall Study|Lost to Follow-up|23|||
155355715|NCT03325608|560736658|FG001|Overall Study|Lost to Follow-up|23|||
155355716|NCT03325608|560736659|FG002|Overall Study|Lost to Follow-up|30|||
155355717|NCT03325608|560736660|FG003|Overall Study|Lost to Follow-up|30|||
155355718|NCT03325608|560736657|FG000|Overall Study|Death of Caregiver|0|||
155355719|NCT03325608|560736658|FG001|Overall Study|Death of Caregiver|0|||
155355720|NCT03325608|560736659|FG002|Overall Study|Death of Caregiver|2|||
155355721|NCT03325608|560736660|FG003|Overall Study|Death of Caregiver|2|||
155355722|NCT03325608|560736657|FG000|Overall Study|Death of Care Recipient|34|||
155355723|NCT03325608|560736658|FG001|Overall Study|Death of Care Recipient|34|||
155355724|NCT03325608|560736659|FG002|Overall Study|Death of Care Recipient|28|||
155355725|NCT03325608|560736660|FG003|Overall Study|Death of Care Recipient|28|||
155355726|NCT03325608|560736657|FG000|Overall Study|Withdrawal by Subject|49|||
155355727|NCT03325608|560736658|FG001|Overall Study|Withdrawal by Subject|49|||
155355728|NCT03325608|560736659|FG002|Overall Study|Withdrawal by Subject|35|||
155355729|NCT03325608|560736660|FG003|Overall Study|Withdrawal by Subject|35|||
155355730|NCT03325608|560736657|FG000|Overall Study|Ineligible|7|||
155355731|NCT03325608|560736658|FG001|Overall Study|Ineligible|7|||
155355732|NCT03325608|560736659|FG002|Overall Study|Ineligible|5|||
155355733|NCT03325608|560736660|FG003|Overall Study|Ineligible|5|||
155355734|NCT00942188|560736661|FG000|Overall Study|Adverse Event|0|||
155355735|NCT00942188|560736662|FG001|Overall Study|Adverse Event|3|||
155355736|NCT00942188|560736663|FG002|Overall Study|Adverse Event|2|||
155355737|NCT00942188|560736664|FG003|Overall Study|Adverse Event|0|||
155355738|NCT00942188|560736661|FG000|Overall Study|Lack of Efficacy|0|||
155355739|NCT00942188|560736662|FG001|Overall Study|Lack of Efficacy|0|||
155355740|NCT00942188|560736663|FG002|Overall Study|Lack of Efficacy|0|||
155355741|NCT00942188|560736664|FG003|Overall Study|Lack of Efficacy|1|||
155355742|NCT00942188|560736661|FG000|Overall Study|Protocol Violation|1|||
155355743|NCT00942188|560736662|FG001|Overall Study|Protocol Violation|1|||
155355744|NCT00942188|560736663|FG002|Overall Study|Protocol Violation|0|||
155355745|NCT00942188|560736664|FG003|Overall Study|Protocol Violation|0|||
155355746|NCT00942188|560736661|FG000|Overall Study|Lost to Follow-up|2|||
155355747|NCT00942188|560736662|FG001|Overall Study|Lost to Follow-up|1|||
155355748|NCT00942188|560736663|FG002|Overall Study|Lost to Follow-up|2|||
155355749|NCT00942188|560736664|FG003|Overall Study|Lost to Follow-up|0|||
155355750|NCT00942188|560736661|FG000|Overall Study|Withdrawal by Subject|1|||
155355751|NCT00942188|560736662|FG001|Overall Study|Withdrawal by Subject|3|||
155355752|NCT00942188|560736663|FG002|Overall Study|Withdrawal by Subject|4|||
155355753|NCT00942188|560736664|FG003|Overall Study|Withdrawal by Subject|2|||
155355754|NCT00942188|560736661|FG000|Overall Study|Physician Decision|0|||
155355755|NCT00942188|560736662|FG001|Overall Study|Physician Decision|0|||
154964865|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Death|7|||
155087008|NCT02327169|559750775|FG013|Overall Study|Withdrawal by Subject|0|||
155087009|NCT02327169|559750776|FG014|Overall Study|Withdrawal by Subject|3|||
155087010|NCT02327169|559750762|FG000|Overall Study|Lost to Follow-up|0|||
155087011|NCT02327169|559750763|FG001|Overall Study|Lost to Follow-up|0|||
155087012|NCT02327169|559750764|FG002|Overall Study|Lost to Follow-up|0|||
155355756|NCT00942188|560736663|FG002|Overall Study|Physician Decision|1|||
155355757|NCT00942188|560736664|FG003|Overall Study|Physician Decision|0|||
155355758|NCT00942188|560736661|FG000|Overall Study|Sponsor Decision|0|||
155355759|NCT00942188|560736662|FG001|Overall Study|Sponsor Decision|2|||
155355760|NCT00942188|560736663|FG002|Overall Study|Sponsor Decision|0|||
155355761|NCT00942188|560736664|FG003|Overall Study|Sponsor Decision|1|||
155355762|NCT02188784|560736665|FG000|Overall Study|Death|3|||
155355763|NCT02188784|560736666|FG001|Overall Study|Death|1|||
155087013|NCT02327169|559750765|FG003|Overall Study|Lost to Follow-up|0|||
155355764|NCT02188784|560736665|FG000|Overall Study|Lost to Follow-up|1|||
155087014|NCT02327169|559750766|FG004|Overall Study|Lost to Follow-up|1|||
155355765|NCT02188784|560736666|FG001|Overall Study|Lost to Follow-up|0|||
155355766|NCT02188784|560736665|FG000|Overall Study|Withdrawal by Subject|3|||
155355767|NCT02188784|560736666|FG001|Overall Study|Withdrawal by Subject|9|||
155355768|NCT02188784|560736665|FG000|Overall Study|Physician Decision|2|||
155165724|NCT02721966|560043543|FG004|Overall Study|Physician Decision|0|||
155165725|NCT02721966|560043539|FG000|Overall Study|Pregnancy|1|||
155355769|NCT02188784|560736666|FG001|Overall Study|Physician Decision|3|||
155355770|NCT01568112|560736672|FG000|Overall Study|Randomized But Not Treated|0|||
155355771|NCT01568112|560736673|FG001|Overall Study|Randomized But Not Treated|1|||
155355772|NCT01568112|560736674|FG002|Overall Study|Randomized But Not Treated|0|||
155355773|NCT01568112|560736675|FG003|Overall Study|Randomized But Not Treated|0|||
155355774|NCT01568112|560736672|FG000|Overall Study|Withdrew due to Adverse Event|2|||
155355775|NCT01568112|560736673|FG001|Overall Study|Withdrew due to Adverse Event|4|||
155355776|NCT01568112|560736674|FG002|Overall Study|Withdrew due to Adverse Event|6|||
155355777|NCT01568112|560736675|FG003|Overall Study|Withdrew due to Adverse Event|3|||
155355778|NCT01568112|560736672|FG000|Overall Study|Lost to Follow-up|0|||
155355779|NCT01568112|560736673|FG001|Overall Study|Lost to Follow-up|0|||
155355780|NCT01568112|560736674|FG002|Overall Study|Lost to Follow-up|0|||
155355781|NCT01568112|560736675|FG003|Overall Study|Lost to Follow-up|1|||
155355782|NCT01568112|560736672|FG000|Overall Study|Withdrawal by Subject|2|||
155355783|NCT01568112|560736673|FG001|Overall Study|Withdrawal by Subject|3|||
155355784|NCT01568112|560736674|FG002|Overall Study|Withdrawal by Subject|0|||
155355785|NCT01568112|560736675|FG003|Overall Study|Withdrawal by Subject|7|||
155355786|NCT01568112|560736672|FG000|Overall Study|Withdrawal by Physician|1|||
155355787|NCT01568112|560736673|FG001|Overall Study|Withdrawal by Physician|0|||
155355788|NCT01568112|560736674|FG002|Overall Study|Withdrawal by Physician|1|||
155355789|NCT01568112|560736675|FG003|Overall Study|Withdrawal by Physician|1|||
155355790|NCT01722045|560738160|FG000|Overall Study|Adverse Event|8|||
155355791|NCT01722045|560738160|FG000|Overall Study|Death|3|||
155355792|NCT01722045|560738160|FG000|Overall Study|Withdrawal by Subject|8|||
155355793|NCT01722045|560738160|FG000|Overall Study|Lost to Follow-up|4|||
155355794|NCT01722045|560738160|FG000|Overall Study|Protocol Deviation|1|||
155355795|NCT01722045|560738160|FG000|Overall Study|Physician Decision|3|||
155355796|NCT01722045|560738160|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
155355797|NCT02034162|560738161|FG000|Double-blind|Lost to Follow-up|3|||
155355798|NCT02034162|560738162|FG001|Double-blind|Lost to Follow-up|0|||
155355799|NCT02034162|560738163|FG002|Double-blind|Lost to Follow-up|0|||
155355800|NCT02034162|560738161|FG000|Double-blind|Physician Decision|1|||
155355801|NCT02034162|560738162|FG001|Double-blind|Physician Decision|0|||
155355802|NCT02034162|560738163|FG002|Double-blind|Physician Decision|0|||
155355803|NCT02034162|560738161|FG000|Double-blind|Protocol Violation|0|||
155355804|NCT02034162|560738162|FG001|Double-blind|Protocol Violation|1|||
155355805|NCT02034162|560738163|FG002|Double-blind|Protocol Violation|0|||
155355806|NCT02034162|560738161|FG000|Double-blind|Withdrawal by Subject|5|||
155355807|NCT02034162|560738162|FG001|Double-blind|Withdrawal by Subject|7|||
155355808|NCT02034162|560738163|FG002|Double-blind|Withdrawal by Subject|0|||
155355809|NCT00760513|560738164|FG000|Overall Study|Withdrawal by Subject|5|||
155355810|NCT00760513|560738165|FG001|Overall Study|Withdrawal by Subject|7|||
155355811|NCT01053247|560738166|FG000|Overall Study|Withdrawal by Subject|9|||
155355812|NCT01053247|560738167|FG001|Overall Study|Withdrawal by Subject|4|||
155355813|NCT01053247|560738168|FG002|Overall Study|Withdrawal by Subject|15|||
155355814|NCT01053247|560738166|FG000|Overall Study|Lack of Efficacy|1|||
155355815|NCT01053247|560738167|FG001|Overall Study|Lack of Efficacy|0|||
155355816|NCT01053247|560738168|FG002|Overall Study|Lack of Efficacy|1|||
155355817|NCT01053247|560738166|FG000|Overall Study|Protocol Violation|2|||
155355818|NCT01053247|560738167|FG001|Overall Study|Protocol Violation|1|||
155355819|NCT01053247|560738168|FG002|Overall Study|Protocol Violation|2|||
155355820|NCT01053247|560738166|FG000|Overall Study|Lost to Follow-up|8|||
155355821|NCT01053247|560738167|FG001|Overall Study|Lost to Follow-up|5|||
155355822|NCT01053247|560738168|FG002|Overall Study|Lost to Follow-up|7|||
155355823|NCT01053247|560738166|FG000|Overall Study|Adverse Event|0|||
155355824|NCT01053247|560738167|FG001|Overall Study|Adverse Event|9|||
155355825|NCT01053247|560738168|FG002|Overall Study|Adverse Event|3|||
155355826|NCT03458728|560738169|FG000|Overall Study|Adverse Event|1|||
155355827|NCT03458728|560738170|FG001|Overall Study|Adverse Event|0|||
155355828|NCT03458728|560738169|FG000|Overall Study|Physician Decision|1|||
155355829|NCT03458728|560738170|FG001|Overall Study|Physician Decision|0|||
155355830|NCT03458728|560738169|FG000|Overall Study|Progressive disease - clinical assessment|1|||
155355831|NCT03458728|560738170|FG001|Overall Study|Progressive disease - clinical assessment|0|||
155355832|NCT03458728|560738169|FG000|Overall Study|Progressive disease - radiological progression|21|||
155355833|NCT03458728|560738170|FG001|Overall Study|Progressive disease - radiological progression|6|||
155355834|NCT03458728|560738169|FG000|Overall Study|Withdrawal by Subject|0|||
155355835|NCT03458728|560738170|FG001|Overall Study|Withdrawal by Subject|1|||
155355836|NCT03898700|560738173|FG000|Overall Study|Withdrawal by Subject|2|||
155355837|NCT00701909|560738177|FG000|Overall Study|Withdrawal by Subject|0|||
155355838|NCT00701909|560738178|FG001|Overall Study|Withdrawal by Subject|1|||
155355839|NCT00908349|560738179|FG000|Overall Study|Adverse Event|10|||
155355840|NCT00908349|560738179|FG000|Overall Study|Withdrawal by Subject|9|||
155355841|NCT00908349|560738179|FG000|Overall Study|Physician Decision|5|||
155165726|NCT02721966|560043540|FG001|Overall Study|Pregnancy|0|||
155355842|NCT00908349|560738179|FG000|Overall Study|Lost to Follow-up|5|||
155087015|NCT02327169|559750767|FG005|Overall Study|Lost to Follow-up|0|||
155087016|NCT02327169|559750768|FG006|Overall Study|Lost to Follow-up|0|||
155087017|NCT02327169|559750769|FG007|Overall Study|Lost to Follow-up|0|||
155087018|NCT02327169|559750770|FG008|Overall Study|Lost to Follow-up|0|||
155087019|NCT02327169|559750771|FG009|Overall Study|Lost to Follow-up|0|||
155087020|NCT02327169|559750772|FG010|Overall Study|Lost to Follow-up|0|||
155087021|NCT02327169|559750773|FG011|Overall Study|Lost to Follow-up|0|||
155087022|NCT02327169|559750774|FG012|Overall Study|Lost to Follow-up|0|||
155087023|NCT02327169|559750775|FG013|Overall Study|Lost to Follow-up|0|||
155087024|NCT02327169|559750776|FG014|Overall Study|Lost to Follow-up|0|||
155087025|NCT06582732|559750779|FG000|Initial Study Period|Adverse Event|0|||
155087026|NCT06582732|559750780|FG001|Initial Study Period|Adverse Event|0|||
155087027|NCT06582732|559750781|FG002|Initial Study Period|Adverse Event|0|||
155087028|NCT06582732|559750782|FG003|Initial Study Period|Adverse Event|2|||
155087029|NCT06582732|559750783|FG004|Initial Study Period|Adverse Event|0|||
155087030|NCT06582732|559750784|FG005|Initial Study Period|Adverse Event|0|||
155087031|NCT06582732|559750785|FG006|Initial Study Period|Adverse Event|0|||
155087032|NCT06582732|559750779|FG000|Initial Study Period|Death|1|||
155087033|NCT06582732|559750780|FG001|Initial Study Period|Death|0|||
155087034|NCT06582732|559750781|FG002|Initial Study Period|Death|0|||
155087035|NCT06582732|559750782|FG003|Initial Study Period|Death|0|||
155087036|NCT06582732|559750783|FG004|Initial Study Period|Death|1|||
155087037|NCT06582732|559750784|FG005|Initial Study Period|Death|0|||
155087038|NCT06582732|559750785|FG006|Initial Study Period|Death|0|||
155087039|NCT06582732|559750779|FG000|Initial Study Period|Lost to Follow-up|0|||
155087040|NCT06582732|559750780|FG001|Initial Study Period|Lost to Follow-up|0|||
155087041|NCT06582732|559750781|FG002|Initial Study Period|Lost to Follow-up|2|||
155087042|NCT06582732|559750782|FG003|Initial Study Period|Lost to Follow-up|0|||
155087043|NCT06582732|559750783|FG004|Initial Study Period|Lost to Follow-up|0|||
155087044|NCT06582732|559750784|FG005|Initial Study Period|Lost to Follow-up|0|||
155087045|NCT06582732|559750785|FG006|Initial Study Period|Lost to Follow-up|0|||
155165727|NCT02721966|560043541|FG002|Overall Study|Pregnancy|0|||
155355843|NCT00908349|560738179|FG000|Overall Study|Various|6|||
155355844|NCT00971997|560738182|FG000|Overall Study|Adverse Event|2|||
155355845|NCT00971997|560738182|FG000|Overall Study|Death|1|||
155355846|NCT00971997|560738182|FG000|Overall Study|Protocol Violation|4|||
155355847|NCT00971997|560738182|FG000|Overall Study|Withdrawal by Subject|5|||
155355848|NCT00971997|560738182|FG000|Overall Study|Physician Decision|7|||
155355849|NCT00761956|560738184|FG000|Overall Study|Lost to Follow-up|6|||
155355850|NCT00761956|560738185|FG001|Overall Study|Lost to Follow-up|11|||
155355851|NCT00761956|560738184|FG000|Overall Study|Withdrawal by Subject|3|||
155355852|NCT00761956|560738185|FG001|Overall Study|Withdrawal by Subject|8|||
155355853|NCT00761956|560738184|FG000|Overall Study|Death|0|||
155355854|NCT00761956|560738185|FG001|Overall Study|Death|1|||
155355855|NCT00761956|560738184|FG000|Overall Study|Adverse Event|26|||
155355856|NCT00761956|560738185|FG001|Overall Study|Adverse Event|34|||
155355857|NCT02808975|560738191|FG000|Overall Study|Adverse Event|3|||
155355858|NCT02808975|560738192|FG001|Overall Study|Adverse Event|4|||
155355859|NCT02808975|560738191|FG000|Overall Study|Withdrew consent|9|||
155355860|NCT02808975|560738192|FG001|Overall Study|Withdrew consent|8|||
155355861|NCT02808975|560738191|FG000|Overall Study|Lost to Follow-up|4|||
155355862|NCT02808975|560738192|FG001|Overall Study|Lost to Follow-up|6|||
155355863|NCT02808975|560738191|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
155355864|NCT02808975|560738192|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
155355865|NCT02808975|560738191|FG000|Overall Study|Other, not specified|5|||
155355866|NCT02808975|560738192|FG001|Overall Study|Other, not specified|1|||
155355867|NCT01288209|560738193|FG000|Overall Study|Withdrawal by Subject|1|||
155355868|NCT01288209|560738194|FG001|Overall Study|Withdrawal by Subject|3|||
155355869|NCT01288209|560738193|FG000|Overall Study|Other|1|||
155355870|NCT01288209|560738194|FG001|Overall Study|Other|0|||
155355871|NCT01379703|560738195|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
155355872|NCT01379703|560738196|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
155087046|NCT06582732|559750779|FG000|Initial Study Period|Withdrawal by Subject|0|||
155355873|NCT01379703|560738197|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
155355874|NCT01379703|560738195|FG000|Study Start Through 9 Months|Adverse Event|0|||
155355875|NCT01379703|560738196|FG001|Study Start Through 9 Months|Adverse Event|14|||
155355876|NCT01379703|560738197|FG002|Study Start Through 9 Months|Adverse Event|10|||
155355877|NCT01379703|560738195|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
155087047|NCT06582732|559750780|FG001|Initial Study Period|Withdrawal by Subject|1|||
155087048|NCT06582732|559750781|FG002|Initial Study Period|Withdrawal by Subject|0|||
155087049|NCT06582732|559750782|FG003|Initial Study Period|Withdrawal by Subject|1|||
155087050|NCT06582732|559750783|FG004|Initial Study Period|Withdrawal by Subject|3|||
155087051|NCT06582732|559750784|FG005|Initial Study Period|Withdrawal by Subject|1|||
155355878|NCT01379703|560738196|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
155355879|NCT01379703|560738197|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
155355880|NCT01379703|560738195|FG000|Study Start Through 9 Months|Treatment Failure|0|||
155355881|NCT01379703|560738196|FG001|Study Start Through 9 Months|Treatment Failure|2|||
155355882|NCT01379703|560738197|FG002|Study Start Through 9 Months|Treatment Failure|2|||
155355883|NCT01379703|560738195|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
155355884|NCT01379703|560738196|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
155355885|NCT01379703|560738197|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
155355886|NCT01379703|560738195|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
155355887|NCT01379703|560738196|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
155355888|NCT01379703|560738197|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
155355889|NCT01379703|560738195|FG000|Study Start Through 9 Months|Medication not available|0|||
155355890|NCT01379703|560738196|FG001|Study Start Through 9 Months|Medication not available|2|||
155355891|NCT01379703|560738197|FG002|Study Start Through 9 Months|Medication not available|1|||
155355892|NCT01379703|560738195|FG000|Study Start Through 9 Months|Poor general condition|0|||
155355893|NCT01379703|560738196|FG001|Study Start Through 9 Months|Poor general condition|1|||
155355894|NCT01379703|560738197|FG002|Study Start Through 9 Months|Poor general condition|0|||
155355895|NCT01379703|560738195|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
155355896|NCT01379703|560738196|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
155355897|NCT01379703|560738197|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
155355898|NCT01379703|560738195|FG000|Study Start Through 9 Months|Reason unknown|2|||
155355899|NCT01379703|560738196|FG001|Study Start Through 9 Months|Reason unknown|31|||
155355900|NCT01379703|560738197|FG002|Study Start Through 9 Months|Reason unknown|24|||
155355901|NCT01379703|560738195|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
155355902|NCT01379703|560738196|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
155355903|NCT01379703|560738197|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
155355904|NCT01379703|560738195|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
155355905|NCT01379703|560738196|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
155355906|NCT01379703|560738197|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
155355907|NCT01379703|560738195|FG000|9 Months Through 18 Months|Adverse Event|0|||
155355908|NCT01379703|560738196|FG001|9 Months Through 18 Months|Adverse Event|6|||
155355909|NCT01379703|560738197|FG002|9 Months Through 18 Months|Adverse Event|0|||
155355910|NCT01379703|560738195|FG000|9 Months Through 18 Months|Treatment failure|0|||
155355911|NCT01379703|560738196|FG001|9 Months Through 18 Months|Treatment failure|5|||
155355912|NCT01379703|560738197|FG002|9 Months Through 18 Months|Treatment failure|0|||
155355913|NCT01379703|560738195|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
155355914|NCT01379703|560738196|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
155355915|NCT01379703|560738197|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
155355916|NCT01379703|560738195|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
155355917|NCT01379703|560738196|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
155355918|NCT01379703|560738197|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
155355919|NCT01379703|560738195|FG000|9 Months Through 18 Months|Fatigue|0|||
155355920|NCT01379703|560738196|FG001|9 Months Through 18 Months|Fatigue|1|||
155355921|NCT01379703|560738197|FG002|9 Months Through 18 Months|Fatigue|0|||
155355922|NCT01379703|560738195|FG000|9 Months Through 18 Months|Reason Unknown|0|||
155355923|NCT01379703|560738196|FG001|9 Months Through 18 Months|Reason Unknown|23|||
155355924|NCT01379703|560738197|FG002|9 Months Through 18 Months|Reason Unknown|0|||
155355925|NCT03463577|560738198|FG000|Overall Study|Lost to Follow-up|238|||
155355926|NCT03463577|560738199|FG001|Overall Study|Lost to Follow-up|435|||
155355927|NCT03463577|560738200|FG002|Overall Study|Lost to Follow-up|0|||
155355928|NCT03463577|560738201|FG003|Overall Study|Lost to Follow-up|0|||
155355929|NCT03463577|560738202|FG004|Overall Study|Lost to Follow-up|0|||
155355930|NCT03463577|560738203|FG005|Overall Study|Lost to Follow-up|0|||
155355931|NCT03463577|560738198|FG000|Overall Study|With unknown pregnancy outcome|0|||
155355932|NCT03463577|560738199|FG001|Overall Study|With unknown pregnancy outcome|5|||
155355933|NCT03463577|560738200|FG002|Overall Study|With unknown pregnancy outcome|0|||
155355934|NCT03463577|560738201|FG003|Overall Study|With unknown pregnancy outcome|0|||
155355935|NCT03463577|560738202|FG004|Overall Study|With unknown pregnancy outcome|0|||
155355936|NCT03463577|560738203|FG005|Overall Study|With unknown pregnancy outcome|0|||
155355937|NCT03463577|560738198|FG000|Overall Study|Maternal death|2|||
155355938|NCT03463577|560738199|FG001|Overall Study|Maternal death|0|||
155355939|NCT03463577|560738200|FG002|Overall Study|Maternal death|0|||
155355940|NCT03463577|560738201|FG003|Overall Study|Maternal death|0|||
155355941|NCT03463577|560738202|FG004|Overall Study|Maternal death|0|||
155355942|NCT03463577|560738203|FG005|Overall Study|Maternal death|0|||
155355943|NCT03463577|560738198|FG000|Overall Study|Neonatal death|0|||
155087052|NCT06582732|559750785|FG006|Initial Study Period|Withdrawal by Subject|2|||
155355944|NCT03463577|560738199|FG001|Overall Study|Neonatal death|0|||
155355945|NCT03463577|560738200|FG002|Overall Study|Neonatal death|0|||
155355946|NCT03463577|560738201|FG003|Overall Study|Neonatal death|15|||
155355947|NCT03463577|560738202|FG004|Overall Study|Neonatal death|17|||
155355948|NCT03463577|560738203|FG005|Overall Study|Neonatal death|0|||
155355949|NCT00236184|560738204|FG000|Overall Study|Adverse Event|5|||
155355950|NCT00236184|560738205|FG001|Overall Study|Adverse Event|2|||
155355951|NCT00236184|560738204|FG000|Overall Study|Lack of Efficacy|0|||
155355952|NCT00236184|560738205|FG001|Overall Study|Lack of Efficacy|1|||
155355953|NCT00236184|560738204|FG000|Overall Study|Lost to Follow-up|3|||
155355954|NCT00236184|560738205|FG001|Overall Study|Lost to Follow-up|4|||
155355955|NCT00236184|560738204|FG000|Overall Study|Physician Decision|1|||
155355956|NCT00236184|560738205|FG001|Overall Study|Physician Decision|1|||
155355957|NCT00236184|560738204|FG000|Overall Study|Withdrawal by Subject|3|||
155355958|NCT00236184|560738205|FG001|Overall Study|Withdrawal by Subject|0|||
155355959|NCT00236184|560738204|FG000|Overall Study|Protocol Violation|3|||
155355960|NCT00236184|560738205|FG001|Overall Study|Protocol Violation|0|||
155355961|NCT00236184|560738204|FG000|Overall Study|non-compliance with study drug|2|||
155355962|NCT00236184|560738205|FG001|Overall Study|non-compliance with study drug|1|||
155355963|NCT00236184|560738204|FG000|Overall Study|other|1|||
155355964|NCT00236184|560738205|FG001|Overall Study|other|2|||
155355965|NCT01172639|560738206|FG000|Overall Study|Death|1|||
155355966|NCT01172639|560738207|FG001|Overall Study|Death|1|||
155355967|NCT01172639|560738208|FG002|Overall Study|Death|0|||
155355968|NCT01172639|560738209|FG003|Overall Study|Death|0|||
155355969|NCT01172639|560738210|FG004|Overall Study|Death|0|||
155355970|NCT01172639|560738206|FG000|Overall Study|Lost to Follow-up|9|||
155355971|NCT01172639|560738207|FG001|Overall Study|Lost to Follow-up|7|||
155355972|NCT01172639|560738208|FG002|Overall Study|Lost to Follow-up|11|||
155355973|NCT01172639|560738209|FG003|Overall Study|Lost to Follow-up|6|||
155355974|NCT01172639|560738210|FG004|Overall Study|Lost to Follow-up|6|||
155355975|NCT01172639|560738206|FG000|Overall Study|Withdrawal by Subject|3|||
155355976|NCT01172639|560738207|FG001|Overall Study|Withdrawal by Subject|3|||
155355977|NCT01172639|560738208|FG002|Overall Study|Withdrawal by Subject|5|||
155355978|NCT01172639|560738209|FG003|Overall Study|Withdrawal by Subject|5|||
155355979|NCT01172639|560738210|FG004|Overall Study|Withdrawal by Subject|0|||
155355980|NCT02172950|560738211|FG000|Overall Study|Physician Decision|3|||
155355981|NCT02172950|560738212|FG001|Overall Study|Physician Decision|3|||
155355982|NCT02172950|560738211|FG000|Overall Study|Lack of Efficacy|1|||
155355983|NCT02172950|560738212|FG001|Overall Study|Lack of Efficacy|0|||
155355984|NCT02172950|560738211|FG000|Overall Study|Adverse Event|4|||
155355985|NCT02172950|560738212|FG001|Overall Study|Adverse Event|1|||
155355986|NCT02172950|560738211|FG000|Overall Study|Withdrawal by Subject|10|||
155355987|NCT02172950|560738212|FG001|Overall Study|Withdrawal by Subject|0|||
155355988|NCT02172950|560738211|FG000|Overall Study|Protocol Violation|1|||
155355989|NCT02172950|560738212|FG001|Overall Study|Protocol Violation|0|||
155355990|NCT02172950|560738211|FG000|Overall Study|Lost to Follow-up|1|||
155355991|NCT02172950|560738212|FG001|Overall Study|Lost to Follow-up|0|||
155355992|NCT02172950|560738211|FG000|Overall Study|Death|1|||
155355993|NCT02172950|560738212|FG001|Overall Study|Death|0|||
155355994|NCT02172950|560738211|FG000|Overall Study|Patient traveling|1|||
155355995|NCT02172950|560738212|FG001|Overall Study|Patient traveling|0|||
155355996|NCT02172950|560738211|FG000|Overall Study|Patient went to other country|1|||
155355997|NCT02172950|560738212|FG001|Overall Study|Patient went to other country|0|||
155355998|NCT02172950|560738211|FG000|Overall Study|Patient relocated overseas|1|||
155355999|NCT02172950|560738212|FG001|Overall Study|Patient relocated overseas|1|||
155356000|NCT02172950|560738211|FG000|Overall Study|Patient moving|1|||
155356001|NCT02172950|560738212|FG001|Overall Study|Patient moving|0|||
155356002|NCT00704171|560738217|FG000|Overall Study|Withdrawal by Subject|1|||
155356003|NCT00704171|560738218|FG001|Overall Study|Withdrawal by Subject|0|||
155087053|NCT06582732|559750779|FG000|Initial Study Period|Moved Away|0|||
155087054|NCT06582732|559750780|FG001|Initial Study Period|Moved Away|0|||
155356004|NCT00813098|560738223|FG000|Overall Study|Adverse Event|2|||
155356005|NCT00813098|560738224|FG001|Overall Study|Adverse Event|4|||
155356006|NCT00813098|560738225|FG002|Overall Study|Adverse Event|1|||
155356007|NCT00813098|560738223|FG000|Overall Study|Withdrawal by Subject|0|||
155356008|NCT00813098|560738224|FG001|Overall Study|Withdrawal by Subject|1|||
155356009|NCT00813098|560738225|FG002|Overall Study|Withdrawal by Subject|0|||
155356010|NCT00813098|560738223|FG000|Overall Study|Inability to complete study procedures|1|||
155356011|NCT00813098|560738224|FG001|Overall Study|Inability to complete study procedures|0|||
155356012|NCT00813098|560738225|FG002|Overall Study|Inability to complete study procedures|0|||
155356013|NCT00813098|560738223|FG000|Overall Study|Lost to Follow-up|0|||
155087055|NCT06582732|559750781|FG002|Initial Study Period|Moved Away|0|||
155356014|NCT00813098|560738224|FG001|Overall Study|Lost to Follow-up|1|||
155356015|NCT00813098|560738225|FG002|Overall Study|Lost to Follow-up|0|||
155356016|NCT00813098|560738223|FG000|Overall Study|Protocol Violation|0|||
155087056|NCT06582732|559750782|FG003|Initial Study Period|Moved Away|0|||
155356017|NCT00813098|560738224|FG001|Overall Study|Protocol Violation|0|||
155356018|NCT00813098|560738225|FG002|Overall Study|Protocol Violation|1|||
155356019|NCT00813098|560738223|FG000|Overall Study|Principal Investigator decision|0|||
155356020|NCT00813098|560738224|FG001|Overall Study|Principal Investigator decision|1|||
155356021|NCT00813098|560738225|FG002|Overall Study|Principal Investigator decision|0|||
155356022|NCT00813098|560738223|FG000|Overall Study|Withdrew Consent|0|||
155356023|NCT00813098|560738224|FG001|Overall Study|Withdrew Consent|1|||
155356024|NCT00813098|560738225|FG002|Overall Study|Withdrew Consent|0|||
155356025|NCT01777490|560738228|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
155356026|NCT01777490|560738229|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
155356027|NCT01777490|560738230|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
155356028|NCT01777490|560738231|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
155356029|NCT01772563|560738232|FG000|Cycle 1|Dose limiting toxicity|2|||
155356030|NCT01772563|560738232|FG000|Cycle 1|Progressive disease|2|||
155356031|NCT01772563|560738232|FG000|Cycle 2 and Beyond|Progressive disease|17|||
155356032|NCT01772563|560738232|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
155356033|NCT01772563|560738232|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
155356034|NCT00832000|560738233|FG000|Overall Study|Adverse Event|2|||
155356035|NCT00832000|560738234|FG001|Overall Study|Adverse Event|0|||
155356036|NCT00832000|560738233|FG000|Overall Study|Withdrawal by Subject|1|||
155356037|NCT00832000|560738234|FG001|Overall Study|Withdrawal by Subject|0|||
155356038|NCT00832000|560738233|FG000|Overall Study|No calls to IVR in either period|1|||
155356039|NCT00832000|560738234|FG001|Overall Study|No calls to IVR in either period|1|||
155356040|NCT00832000|560738233|FG000|Overall Study|No calls to IVR in period 2|2|||
155356041|NCT00832000|560738234|FG001|Overall Study|No calls to IVR in period 2|0|||
155356042|NCT01898442|560738236|FG000|Overall Study|Hemolysis/technical problems|1|||
155356043|NCT01898442|560738237|FG001|Overall Study|Hemolysis/technical problems|2|||
155356044|NCT01898442|560738238|FG002|Overall Study|Hemolysis/technical problems|2|||
155356045|NCT01898442|560738236|FG000|Overall Study|Patient vomited pills|0|||
155356046|NCT01898442|560738237|FG001|Overall Study|Patient vomited pills|0|||
155356047|NCT01898442|560738238|FG002|Overall Study|Patient vomited pills|1|||
155356048|NCT00255944|560738239|FG000|Overall Study|Lost to Follow-up|797|||
155356049|NCT00255944|560738240|FG001|Overall Study|Lost to Follow-up|834|||
155356050|NCT01121913|560738242|FG000|First Intervention Period|Adverse Event|0|||
155087057|NCT06582732|559750783|FG004|Initial Study Period|Moved Away|1|||
155087058|NCT06582732|559750784|FG005|Initial Study Period|Moved Away|0|||
155087059|NCT06582732|559750785|FG006|Initial Study Period|Moved Away|0|||
155087060|NCT03931330|559750786|FG000|Overall Study|Physician Decision|1|||
155087061|NCT03412929|559750787|FG000|Overall Study|Protocol Violation|3|||
155087062|NCT04661839|559750790|FG000|Overall Study|Not Treated|0|||
155087063|NCT04661839|559750791|FG001|Overall Study|Not Treated|0|||
155087064|NCT04661839|559750792|FG002|Overall Study|Not Treated|1|||
155356051|NCT01121913|560738243|FG001|First Intervention Period|Adverse Event|0|||
155356052|NCT01121913|560738244|FG002|First Intervention Period|Adverse Event|1|||
155356053|NCT01121913|560738245|FG003|First Intervention Period|Adverse Event|0|||
155356054|NCT01121913|560738242|FG000|First Washout Period|Withdrawal by Subject|1|||
155356055|NCT01121913|560738243|FG001|First Washout Period|Withdrawal by Subject|0|||
155356056|NCT01121913|560738244|FG002|First Washout Period|Withdrawal by Subject|0|||
155356057|NCT01121913|560738245|FG003|First Washout Period|Withdrawal by Subject|0|||
155356058|NCT01121913|560738242|FG000|Second Intervention Period|Adverse Event|0|||
155356059|NCT01121913|560738243|FG001|Second Intervention Period|Adverse Event|0|||
155356060|NCT01121913|560738244|FG002|Second Intervention Period|Adverse Event|1|||
155356061|NCT01121913|560738245|FG003|Second Intervention Period|Adverse Event|0|||
155356062|NCT01121913|560738242|FG000|Second Washout Period|Withdrawal by Subject|0|||
155356063|NCT01121913|560738243|FG001|Second Washout Period|Withdrawal by Subject|0|||
155356064|NCT01121913|560738244|FG002|Second Washout Period|Withdrawal by Subject|1|||
155356065|NCT01121913|560738245|FG003|Second Washout Period|Withdrawal by Subject|0|||
155356066|NCT01121913|560738242|FG000|Third Washout Period|Adverse Event|1|||
155356067|NCT01121913|560738243|FG001|Third Washout Period|Adverse Event|0|||
155356068|NCT01121913|560738244|FG002|Third Washout Period|Adverse Event|0|||
155356069|NCT01121913|560738245|FG003|Third Washout Period|Adverse Event|0|||
155356070|NCT00690378|560738246|FG000|Overall Study|Adverse Event|1|||
155356071|NCT00690378|560738247|FG001|Overall Study|Adverse Event|0|||
155356072|NCT00690378|560738246|FG000|Overall Study|Withdrawal by Subject|2|||
155356073|NCT00690378|560738247|FG001|Overall Study|Withdrawal by Subject|0|||
155356074|NCT00690378|560738246|FG000|Overall Study|Protocol Violation|1|||
155356075|NCT00690378|560738247|FG001|Overall Study|Protocol Violation|0|||
155356076|NCT00690378|560738246|FG000|Overall Study|Lost to Follow-up|2|||
155356077|NCT00690378|560738247|FG001|Overall Study|Lost to Follow-up|3|||
155356078|NCT00690378|560738246|FG000|Overall Study|Did not meet inc/exc criteria|13|||
155356079|NCT00690378|560738247|FG001|Overall Study|Did not meet inc/exc criteria|11|||
155356080|NCT00690378|560738246|FG000|Overall Study|Social problem|1|||
155356081|NCT00690378|560738247|FG001|Overall Study|Social problem|0|||
155356082|NCT02019641|560738257|FG000|10-Week Follow up|Withdrawal by investigator|2|||
155356083|NCT02019641|560738258|FG001|10-Week Follow up|Withdrawal by investigator|0|||
155356084|NCT02019641|560738259|FG002|10-Week Follow up|Withdrawal by investigator|0|||
155356085|NCT02019641|560738257|FG000|10-Week Follow up|Withdrawal by Subject|1|||
155356086|NCT02019641|560738258|FG001|10-Week Follow up|Withdrawal by Subject|1|||
155356087|NCT02019641|560738259|FG002|10-Week Follow up|Withdrawal by Subject|0|||
155356088|NCT02019641|560738257|FG000|20-Week Follow up|Withdrawal by investigator|0|||
155356089|NCT02019641|560738258|FG001|20-Week Follow up|Withdrawal by investigator|0|||
155356090|NCT02019641|560738259|FG002|20-Week Follow up|Withdrawal by investigator|1|||
155356091|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356092|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356093|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
155356094|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356095|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356096|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356097|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
155356098|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
155356099|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
155356100|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
155356101|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
155356102|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
155356103|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
155356104|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
155356105|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
155356106|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
155356107|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356108|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356109|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
155356110|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
155356111|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356112|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356113|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356114|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
155356115|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155087065|NCT04661839|559750793|FG003|Overall Study|Not Treated|0|||
155356116|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
155087066|NCT04661839|559750790|FG000|Overall Study|Lost to Follow-up|1|||
155087067|NCT04661839|559750791|FG001|Overall Study|Lost to Follow-up|0|||
155087068|NCT04661839|559750792|FG002|Overall Study|Lost to Follow-up|0|||
155356117|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356118|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356119|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
155356120|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
155356121|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
155356122|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
155356123|NCT00937521|560738260|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
155356124|NCT00937521|560738261|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356125|NCT00937521|560738262|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356126|NCT00937521|560738263|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356127|NCT00937521|560738264|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356128|NCT00937521|560738265|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356129|NCT00937521|560738266|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
155356130|NCT00937521|560738267|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
155356131|NCT00937521|560738260|FG000|Booster Phase|Adverse Event|0|||
155356132|NCT00937521|560738261|FG001|Booster Phase|Adverse Event|0|||
155356133|NCT00937521|560738262|FG002|Booster Phase|Adverse Event|0|||
155356134|NCT00937521|560738263|FG003|Booster Phase|Adverse Event|0|||
155356135|NCT00937521|560738264|FG004|Booster Phase|Adverse Event|0|||
155356136|NCT00937521|560738265|FG005|Booster Phase|Adverse Event|0|||
155356137|NCT00937521|560738266|FG006|Booster Phase|Adverse Event|1|||
155356138|NCT00937521|560738267|FG007|Booster Phase|Adverse Event|0|||
155356139|NCT00937521|560738260|FG000|Booster Phase|Withdrawal by Subject|1|||
155356140|NCT00937521|560738261|FG001|Booster Phase|Withdrawal by Subject|0|||
155356141|NCT00937521|560738262|FG002|Booster Phase|Withdrawal by Subject|0|||
155356142|NCT00937521|560738263|FG003|Booster Phase|Withdrawal by Subject|1|||
155356143|NCT00937521|560738264|FG004|Booster Phase|Withdrawal by Subject|0|||
155356144|NCT00937521|560738265|FG005|Booster Phase|Withdrawal by Subject|0|||
155356145|NCT00937521|560738266|FG006|Booster Phase|Withdrawal by Subject|0|||
155356146|NCT00937521|560738267|FG007|Booster Phase|Withdrawal by Subject|2|||
155356147|NCT00937521|560738260|FG000|Booster Phase|Lost to Follow-up|2|||
155356148|NCT00937521|560738261|FG001|Booster Phase|Lost to Follow-up|2|||
155356149|NCT00937521|560738262|FG002|Booster Phase|Lost to Follow-up|4|||
155356150|NCT00937521|560738263|FG003|Booster Phase|Lost to Follow-up|2|||
155356151|NCT00937521|560738264|FG004|Booster Phase|Lost to Follow-up|4|||
155356152|NCT00937521|560738265|FG005|Booster Phase|Lost to Follow-up|4|||
155356153|NCT00937521|560738266|FG006|Booster Phase|Lost to Follow-up|3|||
155356154|NCT00937521|560738267|FG007|Booster Phase|Lost to Follow-up|0|||
155356155|NCT00937521|560738260|FG000|Booster Phase|Administrative Reason|0|||
155356156|NCT00937521|560738261|FG001|Booster Phase|Administrative Reason|0|||
155356157|NCT00937521|560738262|FG002|Booster Phase|Administrative Reason|1|||
155356158|NCT00937521|560738263|FG003|Booster Phase|Administrative Reason|0|||
155356159|NCT00937521|560738264|FG004|Booster Phase|Administrative Reason|1|||
155356160|NCT00937521|560738265|FG005|Booster Phase|Administrative Reason|1|||
155356161|NCT00937521|560738266|FG006|Booster Phase|Administrative Reason|0|||
155356162|NCT00937521|560738267|FG007|Booster Phase|Administrative Reason|0|||
155356163|NCT00937521|560738260|FG000|Booster Phase|Protocol Deviation|0|||
155356164|NCT00937521|560738261|FG001|Booster Phase|Protocol Deviation|0|||
155356165|NCT00937521|560738262|FG002|Booster Phase|Protocol Deviation|0|||
155356166|NCT00937521|560738263|FG003|Booster Phase|Protocol Deviation|0|||
155356167|NCT00937521|560738264|FG004|Booster Phase|Protocol Deviation|0|||
155356168|NCT00937521|560738265|FG005|Booster Phase|Protocol Deviation|0|||
155356169|NCT00937521|560738266|FG006|Booster Phase|Protocol Deviation|1|||
155356170|NCT00937521|560738267|FG007|Booster Phase|Protocol Deviation|0|||
155356171|NCT00468130|560738268|FG000|Overall Study|Adverse Event|2|||
155356172|NCT00468130|560738269|FG001|Overall Study|Adverse Event|1|||
155356173|NCT00468130|560738268|FG000|Overall Study|Withdrawal by Subject|0|||
155356174|NCT00468130|560738269|FG001|Overall Study|Withdrawal by Subject|1|||
155356175|NCT02485899|560738270|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
155356176|NCT02485899|560738271|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155087069|NCT04661839|559750793|FG003|Overall Study|Lost to Follow-up|1|||
155356177|NCT02485899|560738270|FG000|Overall Study|Withdrawal by Subject|1|||
155356178|NCT02485899|560738271|FG001|Overall Study|Withdrawal by Subject|0|||
155356179|NCT02485899|560738270|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
155087070|NCT01946880|559750794|FG000|Overall Study|Lost to Follow-up|1|||
155356180|NCT02485899|560738271|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
155356181|NCT00436956|560738272|FG000|Overall Study|Not evaluable|1|||
155356182|NCT00436956|560738273|FG001|Overall Study|Not evaluable|0|||
155356183|NCT01841112|560738275|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
155356184|NCT01841112|560738276|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
155356185|NCT01841112|560738277|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
155087071|NCT01946880|559750795|FG001|Overall Study|Lost to Follow-up|0|||
155087072|NCT01946880|559750794|FG000|Overall Study|Physician Decision|1|||
155356186|NCT01841112|560738278|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
155356187|NCT01841112|560738279|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
155087073|NCT01946880|559750795|FG001|Overall Study|Physician Decision|1|||
155087074|NCT01946880|559750794|FG000|Overall Study|Withdrawal by Subject|3|||
155087075|NCT01946880|559750795|FG001|Overall Study|Withdrawal by Subject|2|||
155087076|NCT01946880|559750794|FG000|Overall Study|Met Primary Endpoint|1|||
155087077|NCT01946880|559750795|FG001|Overall Study|Met Primary Endpoint|0|||
155087078|NCT01946880|559750794|FG000|Overall Study|Personal and Family Issues|1|||
155356188|NCT00623363|560738280|FG000|Overall Study|Adverse Event|2|||
155356189|NCT00623363|560738281|FG001|Overall Study|Adverse Event|2|||
155356190|NCT03713320|560738282|FG000|Randomized Period|Adverse Event|1|||
155356191|NCT03713320|560738283|FG001|Randomized Period|Adverse Event|5|||
155356192|NCT03713320|560738284|FG002|Randomized Period|Adverse Event|0|||
155356193|NCT03713320|560738282|FG000|Randomized Period|Physician Decision|1|||
155356194|NCT03713320|560738283|FG001|Randomized Period|Physician Decision|1|||
155356195|NCT03713320|560738284|FG002|Randomized Period|Physician Decision|0|||
155356196|NCT03713320|560738282|FG000|Randomized Period|Withdrawal by Subject|4|||
155356197|NCT03713320|560738283|FG001|Randomized Period|Withdrawal by Subject|0|||
155356198|NCT03713320|560738284|FG002|Randomized Period|Withdrawal by Subject|0|||
155356199|NCT03713320|560738282|FG000|Randomized Period|Participant decision|3|||
155356200|NCT03713320|560738283|FG001|Randomized Period|Participant decision|1|||
155356201|NCT03713320|560738284|FG002|Randomized Period|Participant decision|0|||
155356202|NCT03713320|560738282|FG000|Randomized Period|Study terminated by sponsor|6|||
155356203|NCT03713320|560738283|FG001|Randomized Period|Study terminated by sponsor|3|||
155356204|NCT03713320|560738284|FG002|Randomized Period|Study terminated by sponsor|0|||
155356205|NCT03713320|560738282|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
155356206|NCT03713320|560738283|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
155356207|NCT03713320|560738284|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
155356208|NCT03713320|560738282|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
155356209|NCT03713320|560738283|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
155356210|NCT03713320|560738284|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
155356211|NCT01880437|560738285|FG000|Overall Study|Death|12|||
155356212|NCT01880437|560738286|FG001|Overall Study|Death|4|||
155356213|NCT01880437|560738287|FG002|Overall Study|Death|17|||
155356214|NCT01880437|560738285|FG000|Overall Study|Study terminated by Sponsor|3|||
155356215|NCT01880437|560738286|FG001|Overall Study|Study terminated by Sponsor|0|||
155356216|NCT01880437|560738287|FG002|Overall Study|Study terminated by Sponsor|2|||
155356217|NCT00909532|560738288|FG000|Overall Study|Adverse Event|4|||
155356218|NCT00909532|560738289|FG001|Overall Study|Adverse Event|1|||
155356219|NCT00909532|560738288|FG000|Overall Study|Pregnancy|0|||
155356220|NCT00909532|560738289|FG001|Overall Study|Pregnancy|1|||
155356221|NCT00909532|560738288|FG000|Overall Study|Prohibited Medication|2|||
155356222|NCT00909532|560738289|FG001|Overall Study|Prohibited Medication|1|||
155356223|NCT00909532|560738288|FG000|Overall Study|Withdrawal of Consent|1|||
155356224|NCT00909532|560738289|FG001|Overall Study|Withdrawal of Consent|1|||
155356225|NCT00909532|560738288|FG000|Overall Study|Noncompliance with Study Requirements|0|||
155356226|NCT00909532|560738289|FG001|Overall Study|Noncompliance with Study Requirements|2|||
155356227|NCT00909532|560738288|FG000|Overall Study|Physician Decision|1|||
155356228|NCT00909532|560738289|FG001|Overall Study|Physician Decision|0|||
155356229|NCT00909532|560738288|FG000|Overall Study|Wrong Genotype|1|||
155356230|NCT00909532|560738289|FG001|Overall Study|Wrong Genotype|0|||
155356231|NCT00909532|560738288|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
155356232|NCT00909532|560738289|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
155356233|NCT01209598|560738290|FG000|Overall Study|Withdrawal by Subject|1|||
155356234|NCT01209598|560738291|FG001|Overall Study|Withdrawal by Subject|0|||
154964866|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Death|14|||
154964867|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Death|7|||
155356235|NCT00085566|560738293|FG000|Overall Study|Adverse Event|0|||
155087079|NCT01946880|559750795|FG001|Overall Study|Personal and Family Issues|0|||
155087080|NCT02609503|559750796|FG000|Overall Study|Adverse Event|1|||
155087081|NCT02609503|559750796|FG000|Overall Study|Death|1|||
155356236|NCT00085566|560738294|FG001|Overall Study|Adverse Event|0|||
155356237|NCT00085566|560738295|FG002|Overall Study|Adverse Event|10|||
155356238|NCT00085566|560738293|FG000|Overall Study|Patient Not treated|0|||
155356239|NCT00085566|560738294|FG001|Overall Study|Patient Not treated|0|||
155356240|NCT00085566|560738295|FG002|Overall Study|Patient Not treated|3|||
155356241|NCT00085566|560738293|FG000|Overall Study|Clinical progression|0|||
155356242|NCT00085566|560738294|FG001|Overall Study|Clinical progression|0|||
155356243|NCT00085566|560738295|FG002|Overall Study|Clinical progression|1|||
155356244|NCT02604342|560738297|FG000|Overall Study|Death|32|||
155356245|NCT02604342|560738298|FG001|Overall Study|Death|16|||
155356246|NCT02604342|560738297|FG000|Overall Study|Progression of disease|1|||
155356247|NCT02604342|560738298|FG001|Overall Study|Progression of disease|0|||
155356248|NCT02604342|560738297|FG000|Overall Study|Withdrawal by Subject|5|||
155356249|NCT02604342|560738298|FG001|Overall Study|Withdrawal by Subject|6|||
155356250|NCT02604342|560738297|FG000|Overall Study|Other|1|||
155356251|NCT02604342|560738298|FG001|Overall Study|Other|0|||
155356252|NCT02604342|560738297|FG000|Overall Study|Study Termination by Sponsor|1|||
155356253|NCT02604342|560738298|FG001|Overall Study|Study Termination by Sponsor|0|||
155356254|NCT02604342|560738297|FG000|Overall Study|Lost to Follow-up|1|||
155356255|NCT02604342|560738298|FG001|Overall Study|Lost to Follow-up|1|||
155356256|NCT02604342|560738297|FG000|Overall Study|Physician Decision|2|||
155356257|NCT02604342|560738298|FG001|Overall Study|Physician Decision|0|||
155356258|NCT01702519|560738299|FG000|Washout Period|Lost to Follow-up|1|||
155356259|NCT01702519|560738300|FG001|Washout Period|Lost to Follow-up|0|||
155356260|NCT01702519|560738299|FG000|Washout Period|Withdrawal by Subject|0|||
155356261|NCT01702519|560738300|FG001|Washout Period|Withdrawal by Subject|2|||
155356262|NCT01837797|560738302|FG000|Period 1|Adverse Event|9|||
155356263|NCT01837797|560738303|FG001|Period 1|Adverse Event|0|||
155356264|NCT01837797|560738304|FG002|Period 1|Adverse Event|0|||
155356265|NCT01837797|560738305|FG003|Period 1|Adverse Event|0|||
155356266|NCT01837797|560738306|FG004|Period 1|Adverse Event|0|||
155356267|NCT01837797|560738302|FG000|Period 1|Withdrawal by Subject|6|||
155356268|NCT01837797|560738303|FG001|Period 1|Withdrawal by Subject|0|||
155356269|NCT01837797|560738304|FG002|Period 1|Withdrawal by Subject|0|||
155356270|NCT01837797|560738305|FG003|Period 1|Withdrawal by Subject|0|||
155356271|NCT01837797|560738306|FG004|Period 1|Withdrawal by Subject|0|||
155356272|NCT01837797|560738302|FG000|Period 1|Administrative reasons|76|||
155356273|NCT01837797|560738303|FG001|Period 1|Administrative reasons|0|||
155356274|NCT01837797|560738304|FG002|Period 1|Administrative reasons|0|||
155356275|NCT01837797|560738305|FG003|Period 1|Administrative reasons|0|||
155356276|NCT01837797|560738306|FG004|Period 1|Administrative reasons|0|||
155356277|NCT01837797|560738302|FG000|Period 1|Withdrawal of consent before treatment|1|||
155356278|NCT01837797|560738303|FG001|Period 1|Withdrawal of consent before treatment|0|||
155356279|NCT01837797|560738304|FG002|Period 1|Withdrawal of consent before treatment|0|||
155356280|NCT01837797|560738305|FG003|Period 1|Withdrawal of consent before treatment|0|||
155356281|NCT01837797|560738306|FG004|Period 1|Withdrawal of consent before treatment|0|||
155356282|NCT01837797|560738302|FG000|Period 1|Other|10|||
155356283|NCT01837797|560738303|FG001|Period 1|Other|0|||
155356284|NCT01837797|560738304|FG002|Period 1|Other|0|||
155356285|NCT01837797|560738305|FG003|Period 1|Other|0|||
155356286|NCT01837797|560738306|FG004|Period 1|Other|0|||
155356287|NCT01837797|560738302|FG000|Period 2|Administrative or other reasons|0|||
155356288|NCT01837797|560738303|FG001|Period 2|Administrative or other reasons|5|||
155356289|NCT01837797|560738304|FG002|Period 2|Administrative or other reasons|2|||
155356290|NCT01837797|560738305|FG003|Period 2|Administrative or other reasons|4|||
155087082|NCT02609503|559750796|FG000|Overall Study|Withdrawal by Subject|1|||
155087083|NCT02609503|559750796|FG000|Overall Study|Disease progression|1|||
155087084|NCT00581919|559750800|FG000|Overall Study|Adverse Event|8|||
155087085|NCT00581919|559750800|FG000|Overall Study|Death|1|||
155087086|NCT00581919|559750800|FG000|Overall Study|Disease Progression|10|||
155087087|NCT00581919|559750800|FG000|Overall Study|Physician Decision|1|||
155087088|NCT00581919|559750800|FG000|Overall Study|Other Complicating Disease|1|||
155356291|NCT01837797|560738306|FG004|Period 2|Administrative or other reasons|0|||
155087089|NCT00581919|559750800|FG000|Overall Study|Started Non-Protocol Therapy|2|||
155087090|NCT00581919|559750800|FG000|Overall Study|Withdrawal by Subject|1|||
155356292|NCT01837797|560738302|FG000|Period 2|Adverse Event|0|||
155356293|NCT01837797|560738303|FG001|Period 2|Adverse Event|0|||
155356294|NCT01837797|560738304|FG002|Period 2|Adverse Event|0|||
155356295|NCT01837797|560738305|FG003|Period 2|Adverse Event|1|||
155356296|NCT01837797|560738306|FG004|Period 2|Adverse Event|0|||
155356297|NCT01837797|560738302|FG000|Period 3|Adverse Event|0|||
155356298|NCT01837797|560738303|FG001|Period 3|Adverse Event|0|||
155356299|NCT01837797|560738304|FG002|Period 3|Adverse Event|0|||
155356300|NCT01837797|560738305|FG003|Period 3|Adverse Event|0|||
155356301|NCT01837797|560738306|FG004|Period 3|Adverse Event|1|||
155356302|NCT01837797|560738302|FG000|Period 3|Administrative reasons|0|||
155356303|NCT01837797|560738303|FG001|Period 3|Administrative reasons|0|||
155356304|NCT01837797|560738304|FG002|Period 3|Administrative reasons|0|||
155356305|NCT01837797|560738305|FG003|Period 3|Administrative reasons|0|||
155356306|NCT01837797|560738306|FG004|Period 3|Administrative reasons|20|||
155356307|NCT01837797|560738302|FG000|Period 3|Other|0|||
155356308|NCT01837797|560738303|FG001|Period 3|Other|0|||
155356309|NCT01837797|560738304|FG002|Period 3|Other|0|||
155356310|NCT01837797|560738305|FG003|Period 3|Other|0|||
155356311|NCT01837797|560738306|FG004|Period 3|Other|2|||
155356312|NCT04522778|560738308|FG000|Overall Study|Patient did not want to wear the device|1|||
155356313|NCT04522778|560738309|FG001|Overall Study|Patient did not want to wear the device|0|||
155356314|NCT04522778|560738308|FG000|Overall Study|Lost to Follow-up|0|||
155356315|NCT04522778|560738309|FG001|Overall Study|Lost to Follow-up|1|||
155356316|NCT00069277|560738310|FG000|Overall Study|Adverse Event|3|||
155356317|NCT00069277|560738310|FG000|Overall Study|Withdrawal by Subject|1|||
155356318|NCT00069277|560738310|FG000|Overall Study|Progressive Disease|15|||
155356319|NCT00069277|560738310|FG000|Overall Study|Physician Decision|2|||
155356320|NCT01225159|560738313|FG000|Overall Study|Change operation|1|||
155356321|NCT01225159|560738314|FG001|Overall Study|Change operation|0|||
155356322|NCT01220856|560738321|FG000|Overall Study|graft loss|3|||
155356323|NCT01220856|560738322|FG001|Overall Study|graft loss|3|||
155356324|NCT01220856|560738321|FG000|Overall Study|Lost to Follow-up|1|||
155356325|NCT01220856|560738322|FG001|Overall Study|Lost to Follow-up|0|||
155356326|NCT04814992|560738323|FG000|Overall Study|Withdrawal by Subject|6|||
155356327|NCT04814992|560738324|FG001|Overall Study|Withdrawal by Subject|3|||
155356328|NCT04814992|560738323|FG000|Overall Study|Lost to Follow-up|1|||
155356329|NCT04814992|560738324|FG001|Overall Study|Lost to Follow-up|4|||
155356330|NCT00934700|560738327|FG000|Overall Study|missing scan|5|||
155356331|NCT00934700|560738328|FG001|Overall Study|missing scan|9|||
155356332|NCT00934700|560738327|FG000|Overall Study|Death|8|||
155356333|NCT00934700|560738328|FG001|Overall Study|Death|3|||
155356334|NCT00143598|560738329|FG000|Overall Study|Lost to Follow-up|23|||
155356335|NCT00143598|560738330|FG001|Overall Study|Lost to Follow-up|21|||
155356336|NCT00143598|560738329|FG000|Overall Study|Withdrawal by Subject|33|||
155356337|NCT00143598|560738330|FG001|Overall Study|Withdrawal by Subject|37|||
155087091|NCT03193437|559750803|FG000|Overall Study|Adverse Event|4|||
155087092|NCT03193437|559750803|FG000|Overall Study|Withdrawal by Subject|2|||
155087093|NCT03193437|559750803|FG000|Overall Study|Disease Progression|2|||
155165728|NCT02721966|560043542|FG003|Overall Study|Pregnancy|0|||
155165729|NCT02721966|560043543|FG004|Overall Study|Pregnancy|0|||
155165730|NCT02721966|560043539|FG000|Overall Study|Did not continue to period 2|5|||
155356338|NCT00143598|560738329|FG000|Overall Study|Death|36|||
155356339|NCT00143598|560738330|FG001|Overall Study|Death|36|||
155356340|NCT03900715|560738331|FG000|Overall Study|Protocol Deviation|1|||
155356341|NCT03900715|560738331|FG000|Overall Study|Lack of Efficacy|1|||
155356342|NCT03900715|560738331|FG000|Overall Study|Progressive Disease|6|||
155356343|NCT03900715|560738331|FG000|Overall Study|Adverse Event|2|||
155356344|NCT03900715|560738331|FG000|Overall Study|Other reasons|11|||
155356345|NCT03113383|560740347|FG000|Overall Study|Death|4|||
155356346|NCT03113383|560740348|FG001|Overall Study|Death|0|||
155356347|NCT03062449|560740350|FG000|Overall Study|Withdrawal by Subject|7|||
155356348|NCT03062449|560740351|FG001|Overall Study|Withdrawal by Subject|1|||
155356349|NCT03194867|560740356|FG000|Overall Study|Incorrect completion of end of study form|0|||
155356350|NCT03194867|560740357|FG001|Overall Study|Incorrect completion of end of study form|0|||
155356351|NCT03194867|560740358|FG002|Overall Study|Incorrect completion of end of study form|1|||
155356352|NCT03194867|560740359|FG003|Overall Study|Incorrect completion of end of study form|0|||
155356353|NCT00543062|560740360|FG000|Overall Study|Withdrawal by Subject|1|||
155356354|NCT00543062|560740361|FG001|Overall Study|Withdrawal by Subject|0|||
155356355|NCT00543062|560740362|FG002|Overall Study|Withdrawal by Subject|2|||
155356356|NCT00543062|560740363|FG003|Overall Study|Withdrawal by Subject|0|||
155356357|NCT00543062|560740360|FG000|Overall Study|Adverse Event|0|||
155356358|NCT00543062|560740361|FG001|Overall Study|Adverse Event|1|||
155356359|NCT00543062|560740362|FG002|Overall Study|Adverse Event|1|||
155356360|NCT00543062|560740363|FG003|Overall Study|Adverse Event|1|||
155356361|NCT00543062|560740360|FG000|Overall Study|Protocol Violation|1|||
155356362|NCT00543062|560740361|FG001|Overall Study|Protocol Violation|0|||
155087094|NCT01385995|559750804|FG000|Period 1, 2 Months|Physician Decision|1|||
155087095|NCT01385995|559750805|FG001|Period 1, 2 Months|Physician Decision|0|||
155087096|NCT02414841|559750806|FG000|Overall Study|Withdrawal by Subject|7|||
155087097|NCT02414841|559750807|FG001|Overall Study|Withdrawal by Subject|5|||
155087098|NCT02414841|559750806|FG000|Overall Study|Lost to Follow-up|13|||
155087099|NCT02414841|559750807|FG001|Overall Study|Lost to Follow-up|6|||
155087100|NCT02414841|559750806|FG000|Overall Study|Death|17|||
155087101|NCT02414841|559750807|FG001|Overall Study|Death|14|||
155087102|NCT02414841|559750806|FG000|Overall Study|Received a Kidney Transplant|13|||
155087103|NCT02414841|559750807|FG001|Overall Study|Received a Kidney Transplant|4|||
155087104|NCT02414841|559750806|FG000|Overall Study|Randomized But Not Treated|6|||
155087105|NCT02414841|559750807|FG001|Overall Study|Randomized But Not Treated|4|||
155087106|NCT00112385|559750808|FG000|Overall Study|Lost to Follow-up|1|||
155165731|NCT02721966|560043540|FG001|Overall Study|Did not continue to period 2|12|||
155356363|NCT00543062|560740362|FG002|Overall Study|Protocol Violation|0|||
155356364|NCT00543062|560740363|FG003|Overall Study|Protocol Violation|0|||
155356365|NCT00464945|560740364|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
155356366|NCT00464945|560740365|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
155356367|NCT00464945|560740364|FG000|Infant Series|Protocol Violation|1|||
155356368|NCT00464945|560740365|FG001|Infant Series|Protocol Violation|0|||
155356369|NCT00464945|560740364|FG000|Infant Series|Lost to Follow-up|1|||
155356370|NCT00464945|560740365|FG001|Infant Series|Lost to Follow-up|0|||
155356371|NCT00464945|560740364|FG000|After Infant Series|Withdrawal by Subject|0|||
155356372|NCT00464945|560740365|FG001|After Infant Series|Withdrawal by Subject|2|||
155356373|NCT00464945|560740364|FG000|Toddler Dose|Lost to Follow-up|0|||
155356374|NCT00464945|560740365|FG001|Toddler Dose|Lost to Follow-up|1|||
155087107|NCT00112385|559750809|FG001|Overall Study|Lost to Follow-up|0|||
155087108|NCT00112385|559750808|FG000|Overall Study|Withdrawal by Subject|0|||
155087109|NCT00112385|559750809|FG001|Overall Study|Withdrawal by Subject|1|||
155165732|NCT02721966|560043541|FG002|Overall Study|Did not continue to period 2|0|||
155087110|NCT00908141|559750815|FG000|Overall Study|Withdrawal by Subject|0|||
155356375|NCT02438371|560740368|FG000|Overall Study|Lost to Follow-up|3|||
155356376|NCT02438371|560740369|FG001|Overall Study|Lost to Follow-up|2|||
155356377|NCT02438371|560740368|FG000|Overall Study|Withdrawal by Subject|1|||
155356378|NCT02438371|560740369|FG001|Overall Study|Withdrawal by Subject|1|||
155356379|NCT01161446|560740370|FG000|Overall Study|Lost to Follow-up|18|||
155356380|NCT01161446|560740371|FG001|Overall Study|Lost to Follow-up|14|||
155356381|NCT01161446|560740370|FG000|Overall Study|Withdrawal by Subject|0|||
155356382|NCT01161446|560740371|FG001|Overall Study|Withdrawal by Subject|1|||
155356383|NCT02536742|560740372|FG000|Overall Study|Did not start protocol therapy|1|||
155356384|NCT02536742|560740372|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
155356385|NCT01844726|560740373|FG000|Overall Study|Withdrawal by Subject|0|||
155356386|NCT01844726|560740374|FG001|Overall Study|Withdrawal by Subject|1|||
155356387|NCT01844726|560740373|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
155356388|NCT01844726|560740374|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
155356389|NCT03898960|560740375|FG000|Overall Study|Death|10|||
155356390|NCT03481556|560740376|FG000|Overall Study|Adverse Event|1|||
155356391|NCT03481556|560740377|FG001|Overall Study|Adverse Event|0|||
155356392|NCT03481556|560740378|FG002|Overall Study|Adverse Event|0|||
155356393|NCT03481556|560740379|FG003|Overall Study|Adverse Event|0|||
155356394|NCT03481556|560740376|FG000|Overall Study|Death|4|||
155356395|NCT03481556|560740377|FG001|Overall Study|Death|2|||
155356396|NCT03481556|560740378|FG002|Overall Study|Death|3|||
155356397|NCT03481556|560740379|FG003|Overall Study|Death|16|||
155356398|NCT03481556|560740376|FG000|Overall Study|Study Terminated by Sponsor|10|||
155356399|NCT03481556|560740377|FG001|Overall Study|Study Terminated by Sponsor|5|||
155356400|NCT03481556|560740378|FG002|Overall Study|Study Terminated by Sponsor|2|||
155356401|NCT03481556|560740379|FG003|Overall Study|Study Terminated by Sponsor|9|||
155356402|NCT01101997|560740380|FG000|Overall Study|Withdrawal by Subject|2|||
155356403|NCT01316887|560740381|FG000|Overall Study|Adverse Event|13|||
155356404|NCT01316887|560740382|FG001|Overall Study|Adverse Event|21|||
155356405|NCT01316887|560740383|FG002|Overall Study|Adverse Event|17|||
155356406|NCT01316887|560740381|FG000|Overall Study|Lack of Efficacy|9|||
155356407|NCT01316887|560740382|FG001|Overall Study|Lack of Efficacy|3|||
155356408|NCT01316887|560740383|FG002|Overall Study|Lack of Efficacy|1|||
155087111|NCT00908141|559750816|FG001|Overall Study|Withdrawal by Subject|1|||
155087112|NCT01373281|559752120|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
155087113|NCT01373281|559752121|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
155356409|NCT01316887|560740381|FG000|Overall Study|Protocol Violation|2|||
155356410|NCT01316887|560740382|FG001|Overall Study|Protocol Violation|6|||
155356411|NCT01316887|560740383|FG002|Overall Study|Protocol Violation|6|||
155356412|NCT01316887|560740381|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
155356413|NCT01316887|560740382|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
155356414|NCT01316887|560740383|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
155356415|NCT01316887|560740381|FG000|Overall Study|Study Closed/Terminated|2|||
155356416|NCT01316887|560740382|FG001|Overall Study|Study Closed/Terminated|4|||
155356417|NCT01316887|560740383|FG002|Overall Study|Study Closed/Terminated|3|||
155356418|NCT01316887|560740381|FG000|Overall Study|Lost to Follow-up|1|||
155356419|NCT01316887|560740382|FG001|Overall Study|Lost to Follow-up|7|||
155356420|NCT01316887|560740383|FG002|Overall Study|Lost to Follow-up|5|||
155356421|NCT01316887|560740381|FG000|Overall Study|Withdrawal by Subject|8|||
155356422|NCT01316887|560740382|FG001|Overall Study|Withdrawal by Subject|16|||
155356423|NCT01316887|560740383|FG002|Overall Study|Withdrawal by Subject|15|||
155356424|NCT00469456|560740384|FG000|Overall Study|Adverse Event|4|||
155356425|NCT00469456|560740385|FG001|Overall Study|Adverse Event|3|||
155356426|NCT00469456|560740384|FG000|Overall Study|Protocol Violation|1|||
155356427|NCT00469456|560740385|FG001|Overall Study|Protocol Violation|0|||
155356428|NCT00469456|560740384|FG000|Overall Study|Withdrawal by Subject|4|||
155356429|NCT00469456|560740385|FG001|Overall Study|Withdrawal by Subject|1|||
155356430|NCT03672175|560740390|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
155356431|NCT03672175|560740391|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
155356432|NCT03672175|560740392|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
155356433|NCT03672175|560740390|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
155356434|NCT03672175|560740391|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
155356435|NCT03672175|560740392|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
155356436|NCT03672175|560740390|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
155356437|NCT03672175|560740391|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
155356438|NCT03672175|560740392|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
155356439|NCT03672175|560740390|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
155356440|NCT03672175|560740391|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
155356441|NCT03672175|560740392|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
155356442|NCT03672175|560740390|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
155356443|NCT03672175|560740391|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
155356444|NCT03672175|560740392|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
155356445|NCT03672175|560740390|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
155356446|NCT03672175|560740391|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
155356447|NCT03672175|560740392|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
155356448|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
155356449|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
155356450|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
155356451|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
155356452|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
155356453|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
155356454|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
155356455|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
155356456|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
155356457|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
155356458|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
155356459|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
155356460|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
155356461|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
155356462|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
155356463|NCT03672175|560740390|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
155356464|NCT03672175|560740391|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
155356465|NCT03672175|560740392|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
155356466|NCT01129115|560740395|FG000|Overall Study|Adverse Event|1|||
155356467|NCT01129115|560740396|FG001|Overall Study|Adverse Event|2|||
155356468|NCT01129115|560740397|FG002|Overall Study|Adverse Event|3|||
155356469|NCT01129115|560740398|FG003|Overall Study|Adverse Event|3|||
155356470|NCT01129115|560740395|FG000|Overall Study|Withdrawal by Subject|1|||
155356471|NCT01129115|560740396|FG001|Overall Study|Withdrawal by Subject|3|||
155356472|NCT01129115|560740397|FG002|Overall Study|Withdrawal by Subject|1|||
155356473|NCT01129115|560740398|FG003|Overall Study|Withdrawal by Subject|4|||
155356474|NCT01129115|560740395|FG000|Overall Study|Protocol Violation|0|||
155356475|NCT01129115|560740396|FG001|Overall Study|Protocol Violation|2|||
155356476|NCT01129115|560740397|FG002|Overall Study|Protocol Violation|2|||
155356477|NCT01129115|560740398|FG003|Overall Study|Protocol Violation|2|||
155087114|NCT01373281|559752120|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
155087115|NCT01373281|559752121|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
155087116|NCT01373281|559752120|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
155087117|NCT01373281|559752121|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
155087118|NCT01373281|559752120|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
155087119|NCT01373281|559752121|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
155087120|NCT01373281|559752120|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
155356478|NCT01747837|560740399|FG000|Overall Study|Lost to Follow-up|5|||
155356479|NCT01747837|560740400|FG001|Overall Study|Lost to Follow-up|2|||
155356480|NCT01747837|560740399|FG000|Overall Study|Death|4|||
155356481|NCT01747837|560740400|FG001|Overall Study|Death|4|||
155356482|NCT00935259|560740401|FG000|Period 1|Administrative (scheduling conflict)|1|||
155356483|NCT00935259|560740402|FG001|Period 1|Administrative (scheduling conflict)|1|||
155356484|NCT03856047|560740405|FG000|Overall Study|Withdrawal by Subject|0|||
155356485|NCT03856047|560740406|FG001|Overall Study|Withdrawal by Subject|1|||
155356486|NCT03856047|560740407|FG002|Overall Study|Withdrawal by Subject|1|||
155356487|NCT03856047|560740408|FG003|Overall Study|Withdrawal by Subject|0|||
155356488|NCT03856047|560740409|FG004|Overall Study|Withdrawal by Subject|3|||
155356489|NCT03856047|560740410|FG005|Overall Study|Withdrawal by Subject|0|||
155356490|NCT03856047|560740411|FG006|Overall Study|Withdrawal by Subject|2|||
155356491|NCT03856047|560740405|FG000|Overall Study|Lost to Follow-up|4|||
155356492|NCT03856047|560740406|FG001|Overall Study|Lost to Follow-up|2|||
155356493|NCT03856047|560740407|FG002|Overall Study|Lost to Follow-up|3|||
155356494|NCT03856047|560740408|FG003|Overall Study|Lost to Follow-up|1|||
155356495|NCT03856047|560740409|FG004|Overall Study|Lost to Follow-up|4|||
155356496|NCT03856047|560740410|FG005|Overall Study|Lost to Follow-up|4|||
155356497|NCT03856047|560740411|FG006|Overall Study|Lost to Follow-up|4|||
155356498|NCT03410108|560740412|FG000|Overall Study|Ongoing|41|||
155356499|NCT03410108|560740412|FG000|Overall Study|Adverse Event|4|||
155356500|NCT03410108|560740412|FG000|Overall Study|Progressive Disease|58|||
155356501|NCT03410108|560740412|FG000|Overall Study|Withdrawal by Subject|1|||
155356502|NCT01313624|560740417|FG000|Double-Blind Phase|Adverse Event|27|||
155356503|NCT01313624|560740418|FG001|Double-Blind Phase|Adverse Event|4|||
155356504|NCT01313624|560740417|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
155356505|NCT01313624|560740418|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
155356506|NCT01313624|560740417|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155356507|NCT01313624|560740418|FG001|Double-Blind Phase|Lost to Follow-up|2|||
155356508|NCT01313624|560740417|FG000|Double-Blind Phase|Physician Decision|1|||
155356509|NCT01313624|560740418|FG001|Double-Blind Phase|Physician Decision|0|||
155356510|NCT01313624|560740417|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155356511|NCT01313624|560740418|FG001|Double-Blind Phase|Lack of Efficacy|0|||
155356512|NCT01313624|560740417|FG000|Open-Label Phase|Adverse Event|1|||
155356513|NCT01313624|560740418|FG001|Open-Label Phase|Adverse Event|10|||
155356514|NCT01313624|560740417|FG000|Open-Label Phase|Withdrawal by Subject|2|||
155356515|NCT01313624|560740418|FG001|Open-Label Phase|Withdrawal by Subject|2|||
155356516|NCT01313624|560740417|FG000|Open-Label Phase|Lost to Follow-up|1|||
155356517|NCT01313624|560740418|FG001|Open-Label Phase|Lost to Follow-up|1|||
155356518|NCT01017263|560740419|FG000|Overall Study|not eligible|12|||
155356519|NCT02980705|560740420|FG000|Overall Study|Adverse Event|0|||
155356520|NCT02980705|560740421|FG001|Overall Study|Adverse Event|1|||
155356521|NCT02980705|560740420|FG000|Overall Study|Withdrawal by Subject|6|||
155356522|NCT02980705|560740421|FG001|Overall Study|Withdrawal by Subject|9|||
155356523|NCT02980705|560740420|FG000|Overall Study|withdrew participation|0|||
155356524|NCT02980705|560740421|FG001|Overall Study|withdrew participation|1|||
155356525|NCT02980705|560740420|FG000|Overall Study|Lost to Follow-up|2|||
155356526|NCT02980705|560740421|FG001|Overall Study|Lost to Follow-up|0|||
155356527|NCT01721746|560740422|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
155356528|NCT01721746|560740423|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
155356529|NCT01721746|560740422|FG000|Pre-Treatment|Withdrawal by Subject|1|||
155356530|NCT01721746|560740423|FG001|Pre-Treatment|Withdrawal by Subject|16|||
155356531|NCT01721746|560740422|FG000|Pre-Treatment|Poor/Non-compliance|1|||
155356532|NCT01721746|560740423|FG001|Pre-Treatment|Poor/Non-compliance|0|||
155356533|NCT01721746|560740422|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
155356534|NCT01721746|560740423|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
155356535|NCT01721746|560740422|FG000|Treatment|Disease Progression|192|||
155356536|NCT01721746|560740423|FG001|Treatment|Disease Progression|74|||
155356537|NCT01721746|560740422|FG000|Treatment|Study Drug Toxicity|19|||
155356538|NCT01721746|560740423|FG001|Treatment|Study Drug Toxicity|11|||
155356539|NCT01721746|560740422|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
155356540|NCT01721746|560740423|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
155356541|NCT01721746|560740422|FG000|Treatment|Participant request to discontinue Study treatment|26|||
155356542|NCT01721746|560740423|FG001|Treatment|Participant request to discontinue Study treatment|7|||
155356543|NCT01721746|560740422|FG000|Treatment|Participant withdrew consent|4|||
155356544|NCT01721746|560740423|FG001|Treatment|Participant withdrew consent|2|||
155356545|NCT01721746|560740422|FG000|Treatment|Maximum Clinical Benefit|9|||
155356546|NCT01721746|560740423|FG001|Treatment|Maximum Clinical Benefit|3|||
155356547|NCT01721746|560740422|FG000|Treatment|Poor/Non-compliance|2|||
155356548|NCT01721746|560740423|FG001|Treatment|Poor/Non-compliance|0|||
155356549|NCT01721746|560740422|FG000|Treatment|Participant no longer met Study criteria|4|||
155356550|NCT01721746|560740423|FG001|Treatment|Participant no longer met Study criteria|0|||
155356551|NCT01721746|560740422|FG000|Treatment|Other reasons|6|||
155356552|NCT01721746|560740423|FG001|Treatment|Other reasons|2|||
155356553|NCT00263575|560740424|FG000|Titration Period|Adverse Event|14|||
155356554|NCT00263575|560740424|FG000|Titration Period|Withdrawal by Subject|10|||
155356555|NCT00263575|560740424|FG000|Titration Period|Protocol Violation|9|||
155356556|NCT00263575|560740424|FG000|Titration Period|Sponsor Decision|2|||
155356557|NCT00263575|560740424|FG000|Titration Period|Other|2|||
155356558|NCT00263575|560740424|FG000|Titration Period|Lack of Efficacy|6|||
155356559|NCT00263575|560740424|FG000|Maintence Period|Adverse Event|23|||
155356560|NCT00263575|560740424|FG000|Maintence Period|Withdrawal by Subject|8|||
155356561|NCT00263575|560740424|FG000|Maintence Period|Protocol Violation|4|||
155356562|NCT00263575|560740424|FG000|Maintence Period|Lack of Efficacy|4|||
155356563|NCT00263575|560740424|FG000|Maintence Period|Physician Decision|6|||
155356564|NCT00263575|560740424|FG000|Maintence Period|Lost to Follow-up|1|||
155356565|NCT00263575|560740424|FG000|Maintence Period|Sponsor Decision|24|||
155356566|NCT00263575|560740424|FG000|Maintence Period|Other|7|||
155356567|NCT02447718|560740427|FG000|Overall Study|Lost to Follow-up|8|||
155356568|NCT02447718|560740428|FG001|Overall Study|Lost to Follow-up|0|||
155356569|NCT02447718|560740427|FG000|Overall Study|Withdrawal by Subject|3|||
155356570|NCT02447718|560740428|FG001|Overall Study|Withdrawal by Subject|0|||
155356571|NCT02447718|560740427|FG000|Overall Study|Screen Failure|1|||
155356572|NCT02447718|560740428|FG001|Overall Study|Screen Failure|0|||
155356573|NCT00239681|560740429|FG000|Overall Study|Adverse Event|100|||
155356574|NCT00239681|560740430|FG001|Overall Study|Adverse Event|99|||
155356575|NCT00239681|560740429|FG000|Overall Study|Withdrawal by Subject|458|||
155356576|NCT00239681|560740430|FG001|Overall Study|Withdrawal by Subject|489|||
155356577|NCT00239681|560740429|FG000|Overall Study|Lost to Follow-up|28|||
155356578|NCT00239681|560740430|FG001|Overall Study|Lost to Follow-up|22|||
155356579|NCT00239681|560740429|FG000|Overall Study|Protocol Violation|4|||
155356580|NCT00239681|560740430|FG001|Overall Study|Protocol Violation|4|||
155356581|NCT00239681|560740429|FG000|Overall Study|Physician Decision|13|||
155356582|NCT00239681|560740430|FG001|Overall Study|Physician Decision|17|||
155356583|NCT00239681|560740429|FG000|Overall Study|No information chacked on CaseReportForm|90|||
155356584|NCT00239681|560740430|FG001|Overall Study|No information chacked on CaseReportForm|84|||
155356585|NCT02654132|560740433|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
155356586|NCT02654132|560740434|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
155356587|NCT02654132|560740433|FG000|Treatment Period|Disease progression|43|||
155356588|NCT02654132|560740434|FG001|Treatment Period|Disease progression|38|||
155356589|NCT02654132|560740433|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
155356590|NCT02654132|560740434|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
155356591|NCT02654132|560740433|FG000|Treatment Period|Other reasons|4|||
155356592|NCT02654132|560740434|FG001|Treatment Period|Other reasons|2|||
155356593|NCT02654132|560740433|FG000|Treatment Period|Study drug toxicity|2|||
155356594|NCT02654132|560740434|FG001|Treatment Period|Study drug toxicity|2|||
155356595|NCT02654132|560740433|FG000|Treatment Period|Withdrawal by Subject|2|||
155356596|NCT02654132|560740434|FG001|Treatment Period|Withdrawal by Subject|1|||
155356597|NCT02654132|560740433|FG000|Treatment Period|Maximum Clinical Benefit|0|||
155356598|NCT02654132|560740434|FG001|Treatment Period|Maximum Clinical Benefit|2|||
155356599|NCT02654132|560740433|FG000|Treatment Period|Participant request to discontinue|2|||
155356600|NCT02654132|560740434|FG001|Treatment Period|Participant request to discontinue|0|||
155356601|NCT02654132|560740433|FG000|Treatment Period|Administrative reasons by sponsor|0|||
155356602|NCT02654132|560740434|FG001|Treatment Period|Administrative reasons by sponsor|1|||
155356603|NCT02654132|560740433|FG000|Treatment Period|Death|1|||
155356604|NCT02654132|560740434|FG001|Treatment Period|Death|0|||
155356605|NCT01781832|560740438|FG000|Overall Study|Withdrawal by Subject|1|||
155356606|NCT03772613|560740440|FG000|Overall Study|Lost to Follow-up|0|||
155356607|NCT03772613|560740441|FG001|Overall Study|Lost to Follow-up|1|||
155356608|NCT03772613|560740442|FG002|Overall Study|Lost to Follow-up|1|||
155356609|NCT01185171|560740445|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
155356610|NCT01185171|560740445|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
155356611|NCT01185171|560740445|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
155356612|NCT01185171|560740445|FG000|Maintenance|Elevated liver transaminases|3|||
155356613|NCT01185171|560740445|FG000|Maintenance|Rush|2|||
155356614|NCT01185171|560740445|FG000|Maintenance|Diarrhea|1|||
155356615|NCT01185171|560740445|FG000|Maintenance|Xerostomia|1|||
155356616|NCT01185171|560740445|FG000|Maintenance|Nausea|1|||
155356617|NCT01185171|560740445|FG000|Maintenance|Comorbid Illness|2|||
155356618|NCT01185171|560740445|FG000|Maintenance|Withdrawal by Subject|1|||
155356619|NCT01185171|560740445|FG000|Maintenance|Disease Recurrence|1|||
155356620|NCT01482429|560740446|FG000|Care Usual|Protocol Violation|0|||
155356621|NCT01482429|560740447|FG001|Care Usual|Protocol Violation|172|||
155356622|NCT01482429|560740446|FG000|Care Usual|Lost to Follow-up|0|||
155356623|NCT01482429|560740447|FG001|Care Usual|Lost to Follow-up|1|||
155356624|NCT01482429|560740446|FG000|Protocol|Protocol Violation|275|||
155356625|NCT01482429|560740447|FG001|Protocol|Protocol Violation|0|||
155356626|NCT03561597|560740451|FG000|Overall Study|Lost to Follow-up|20|||
155356627|NCT00573651|560740452|FG000|Overall Study|Lost to Follow-up|3|||
155356628|NCT00573651|560740452|FG000|Overall Study|Withdrawal by Subject|1|||
155356629|NCT03797989|560740480|FG000|VAC069A|Withdrawal by Subject|0|||
155356630|NCT03797989|560740481|FG001|VAC069A|Withdrawal by Subject|0|||
155356631|NCT03797989|560740482|FG002|VAC069A|Withdrawal by Subject|1|||
155356632|NCT03797989|560740483|FG003|VAC069A|Withdrawal by Subject|0|||
155356633|NCT03797989|560740484|FG004|VAC069A|Withdrawal by Subject|0|||
155356634|NCT03797989|560740485|FG005|VAC069A|Withdrawal by Subject|0|||
155356635|NCT03797989|560740486|FG006|VAC069A|Withdrawal by Subject|0|||
155087121|NCT01373281|559752121|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
155356636|NCT03797989|560740487|FG007|VAC069A|Withdrawal by Subject|0|||
155356637|NCT03797989|560740488|FG008|VAC069A|Withdrawal by Subject|0|||
155356638|NCT03797989|560740489|FG009|VAC069A|Withdrawal by Subject|0|||
155356639|NCT03797989|560740490|FG010|VAC069A|Withdrawal by Subject|0|||
155356640|NCT03797989|560740491|FG011|VAC069A|Withdrawal by Subject|0|||
155356641|NCT04052997|560740492|FG000|Overall Study|Withdrawal by Subject|17|||
155356642|NCT04052997|560740492|FG000|Overall Study|Physician Decision|50|||
155356643|NCT04052997|560740492|FG000|Overall Study|Death|43|||
155356644|NCT04052997|560740492|FG000|Overall Study|Lost to Follow-up|5|||
155356645|NCT04052997|560740492|FG000|Overall Study|Progression of Disease|1|||
155356646|NCT04594733|560740493|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155356647|NCT04594733|560740494|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155356648|NCT04594733|560740493|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
155356649|NCT04594733|560740494|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
155356650|NCT04594733|560740493|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
155356651|NCT04594733|560740494|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
155356652|NCT01024036|560740499|FG000|Blinded Treatment|Adverse Event|1|||
155356653|NCT01024036|560740500|FG001|Blinded Treatment|Adverse Event|1|||
155356654|NCT01024036|560740499|FG000|Blinded Treatment|Lack of Efficacy|16|||
155356655|NCT01024036|560740500|FG001|Blinded Treatment|Lack of Efficacy|14|||
155356656|NCT01024036|560740499|FG000|Blinded Treatment|Physician Decision|1|||
155356657|NCT01024036|560740500|FG001|Blinded Treatment|Physician Decision|0|||
155356658|NCT01024036|560740499|FG000|Blinded Treatment|Death|0|||
155356659|NCT01024036|560740500|FG001|Blinded Treatment|Death|2|||
155356660|NCT01024036|560740499|FG000|Blinded Treatment|Withdrawal by Subject|4|||
155356661|NCT01024036|560740500|FG001|Blinded Treatment|Withdrawal by Subject|3|||
155356662|NCT01024036|560740499|FG000|Unblinded Treatment|Adverse Event|0|||
155356663|NCT01024036|560740500|FG001|Unblinded Treatment|Adverse Event|1|||
155356664|NCT01024036|560740499|FG000|Unblinded Treatment|Lack of Efficacy|0|||
155356665|NCT01024036|560740500|FG001|Unblinded Treatment|Lack of Efficacy|2|||
155356666|NCT01024036|560740499|FG000|Follow-Up Period|Lost to Follow-up|1|||
155356667|NCT01024036|560740500|FG001|Follow-Up Period|Lost to Follow-up|1|||
155356668|NCT01024036|560740499|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155356669|NCT01024036|560740500|FG001|Follow-Up Period|Withdrawal by Subject|1|||
155356670|NCT01024036|560740499|FG000|Follow-Up Period|Adverse Event|4|||
155356671|NCT01024036|560740500|FG001|Follow-Up Period|Adverse Event|1|||
155356672|NCT01251887|560740505|FG000|Overall Study|Scheduling conflict|1|||
155356673|NCT01251887|560740506|FG001|Overall Study|Scheduling conflict|2|||
155356674|NCT01251887|560740507|FG002|Overall Study|Scheduling conflict|2|||
155356675|NCT01251887|560740505|FG000|Overall Study|Physician Decision|0|||
155356676|NCT01251887|560740506|FG001|Overall Study|Physician Decision|1|||
155356677|NCT01251887|560740507|FG002|Overall Study|Physician Decision|0|||
155356678|NCT04811339|560740508|FG000|Overall Study|lack of transportation not wanting to return|4|||
155356679|NCT04811339|560740509|FG001|Overall Study|lack of transportation not wanting to return|8|||
155356680|NCT04811339|560740510|FG002|Overall Study|lack of transportation not wanting to return|0|||
155356681|NCT04811339|560740508|FG000|Overall Study|Adverse Event|3|||
155356682|NCT04811339|560740509|FG001|Overall Study|Adverse Event|0|||
155356683|NCT04811339|560740510|FG002|Overall Study|Adverse Event|0|||
155356684|NCT04811339|560740508|FG000|Overall Study|Lost to Follow-up|1|||
155356685|NCT04811339|560740509|FG001|Overall Study|Lost to Follow-up|0|||
155356686|NCT04811339|560740510|FG002|Overall Study|Lost to Follow-up|0|||
155356687|NCT04811339|560740508|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
155356688|NCT04811339|560740509|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
155356689|NCT04811339|560740510|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
155356690|NCT04811339|560740508|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
155356691|NCT04811339|560740509|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
155356692|NCT04811339|560740510|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
155356693|NCT04811339|560740508|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
155356694|NCT04811339|560740509|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
155356695|NCT04811339|560740510|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
155356696|NCT04811339|560740508|FG000|Overall Study|Withdrawal by Subject|0|||
155356697|NCT04811339|560740509|FG001|Overall Study|Withdrawal by Subject|3|||
155356698|NCT04811339|560740510|FG002|Overall Study|Withdrawal by Subject|0|||
155356699|NCT04811339|560740508|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
155356700|NCT04811339|560740509|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
155356701|NCT04811339|560740510|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
155356702|NCT04811339|560740508|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
155356703|NCT04811339|560740509|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
155356704|NCT04811339|560740510|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
155356705|NCT05896696|560740511|FG000|Overall Study|Screening Failure|7|||
155356706|NCT05896696|560740511|FG000|Overall Study|Withdrawal by Subject|2|||
155356707|NCT01131104|560742353|FG000|Overall Study|Withdrawal by Subject|3|||
155356708|NCT01131104|560742353|FG000|Overall Study|Physician Decision|4|||
155356709|NCT01131104|560742353|FG000|Overall Study|Information Not Available|5|||
155356710|NCT01131104|560742353|FG000|Overall Study|No Information on Index Date of Onset|1|||
155356711|NCT04523207|560742354|FG000|Overall Study|Adverse Event|5|||
155356712|NCT04523207|560742355|FG001|Overall Study|Adverse Event|1|||
155087122|NCT01373281|559752120|FG000|Surveillance Expansion Period|Protocol Violation|9|||
155356713|NCT04523207|560742354|FG000|Overall Study|Lost to Follow-up|2|||
155356714|NCT04523207|560742355|FG001|Overall Study|Lost to Follow-up|0|||
155356715|NCT04523207|560742354|FG000|Overall Study|Withdrawal by Subject|2|||
155356716|NCT04523207|560742355|FG001|Overall Study|Withdrawal by Subject|0|||
155356717|NCT04523207|560742354|FG000|Overall Study|Progressive Disease|2|||
155356718|NCT04523207|560742355|FG001|Overall Study|Progressive Disease|1|||
155087123|NCT01373281|559752121|FG001|Surveillance Expansion Period|Protocol Violation|1|||
155356719|NCT04523207|560742354|FG000|Overall Study|Other|7|||
155356720|NCT04523207|560742355|FG001|Overall Study|Other|1|||
155356721|NCT02641587|560742356|FG000|Confinement Period|Adverse Event|1|||
155356722|NCT02641587|560742357|FG001|Confinement Period|Adverse Event|0|||
155356723|NCT02641587|560742356|FG000|Confinement Period|Withdrawal by Subject|2|||
155356724|NCT02641587|560742357|FG001|Confinement Period|Withdrawal by Subject|1|||
155356725|NCT02641587|560742356|FG000|Ambulatory Period|Withdrawal by Subject|1|||
155356726|NCT02641587|560742357|FG001|Ambulatory Period|Withdrawal by Subject|0|||
155356727|NCT01663506|560742359|FG000|Overall Study|Lack of Efficacy|3|||
155356728|NCT01663506|560742359|FG000|Overall Study|Consent Withdrawal by Subject|1|||
155356729|NCT01663506|560742359|FG000|Overall Study|Lost to Follow-up|1|||
155356730|NCT01663506|560742359|FG000|Overall Study|Adverse Event|1|||
155356731|NCT01663506|560742359|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
155356732|NCT02094898|560742365|FG000|Overall Study|Clinical Worsening|2|||
155356733|NCT02094898|560742365|FG000|Overall Study|Adverse Event|2|||
155356734|NCT02094898|560742365|FG000|Overall Study|Lack of Efficacy|1|||
155356735|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Death|2|||
155356736|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Death|2|||
155356737|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Death|3|||
155356738|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Death|2|||
155356739|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Death|6|||
155356740|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Death|5|||
155356741|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Death|3|||
155356742|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Death|2|||
155356743|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Death|3|||
155356744|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Death|1|||
155356745|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Death|5|||
155356746|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Death|7|||
155356747|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Death|11|||
155356748|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Death|0|||
155356749|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Death|0|||
155356750|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Death|0|||
155356751|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Death|0|||
155356752|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Death|0|||
155356753|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Death|0|||
155356754|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
155356755|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356756|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356757|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
155356758|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
155356759|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
155356760|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356761|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
155356762|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356763|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
155356764|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356765|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356766|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
155356767|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356768|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356769|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356770|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356771|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356772|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
155356773|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356774|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356775|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155087124|NCT01373281|559752120|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
155356776|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356777|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356778|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356779|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155087125|NCT01373281|559752121|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
155087126|NCT01373281|559752120|FG000|Surveillance Expansion Period|Serious adverse event|3|||
155356780|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356781|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356782|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356783|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356784|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356785|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
155356786|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356787|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356788|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356789|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356790|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
155356791|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
154964868|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Death|0|||
155087127|NCT01373281|559752121|FG001|Surveillance Expansion Period|Serious adverse event|4|||
155087128|NCT01397253|559752122|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
155356792|NCT03520075|560742366|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356793|NCT03520075|560742367|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356794|NCT03520075|560742368|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356795|NCT03520075|560742369|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356796|NCT03520075|560742370|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356797|NCT03520075|560742371|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356798|NCT03520075|560742372|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356799|NCT03520075|560742373|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356800|NCT03520075|560742374|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356801|NCT03520075|560742375|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
155356802|NCT03520075|560742376|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356803|NCT03520075|560742377|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356804|NCT03520075|560742378|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
155356805|NCT03520075|560742379|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356806|NCT03520075|560742380|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356807|NCT03520075|560742381|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356808|NCT03520075|560742382|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356809|NCT03520075|560742383|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356810|NCT03520075|560742384|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
155356811|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Death|0|||
155356812|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Death|0|||
155356813|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Death|0|||
155356814|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Death|0|||
155356815|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Death|0|||
155356816|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Death|0|||
155356817|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Death|0|||
155356818|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Death|0|||
155356819|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Death|0|||
155356820|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Death|0|||
155356821|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Death|0|||
155356822|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Death|0|||
155356823|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Death|0|||
155356824|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Death|20|||
155356825|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Death|13|||
155356826|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Death|9|||
155356827|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Death|5|||
155356828|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Death|14|||
155356829|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Death|12|||
155356830|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356831|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356832|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356833|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356834|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356835|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356836|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356837|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356838|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356839|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356840|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356841|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356842|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356843|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
155356844|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
155356845|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
155356846|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
155356847|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
155356848|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
155356849|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356850|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356851|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356852|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356853|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356854|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356855|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356856|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356857|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356858|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356859|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356860|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356861|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356862|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356863|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155356864|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155356865|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356866|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
155356867|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
155356868|NCT03520075|560742366|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356869|NCT03520075|560742367|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356870|NCT03520075|560742368|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356871|NCT03520075|560742369|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356872|NCT03520075|560742370|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356873|NCT03520075|560742371|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356874|NCT03520075|560742372|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356875|NCT03520075|560742373|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356876|NCT03520075|560742374|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356877|NCT03520075|560742375|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356878|NCT03520075|560742376|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356879|NCT03520075|560742377|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356880|NCT03520075|560742378|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356881|NCT03520075|560742379|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
155356882|NCT03520075|560742380|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356883|NCT03520075|560742381|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356884|NCT03520075|560742382|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
155356885|NCT03520075|560742383|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
155356886|NCT03520075|560742384|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
155356887|NCT00328562|560742387|FG000|Overall Study|Disease progression|1|||
155356888|NCT03305809|560742388|FG000|Overall Study|Adverse Event|2|||
155356889|NCT03305809|560742389|FG001|Overall Study|Adverse Event|2|||
155356890|NCT03305809|560742390|FG002|Overall Study|Adverse Event|6|||
155356891|NCT03305809|560742391|FG003|Overall Study|Adverse Event|6|||
155356892|NCT03305809|560742388|FG000|Overall Study|Death|0|||
155356893|NCT03305809|560742389|FG001|Overall Study|Death|0|||
155356894|NCT03305809|560742390|FG002|Overall Study|Death|1|||
155356895|NCT03305809|560742391|FG003|Overall Study|Death|1|||
155356896|NCT03305809|560742388|FG000|Overall Study|Lost to Follow-up|1|||
155356897|NCT03305809|560742389|FG001|Overall Study|Lost to Follow-up|2|||
155356898|NCT03305809|560742390|FG002|Overall Study|Lost to Follow-up|0|||
155356899|NCT03305809|560742391|FG003|Overall Study|Lost to Follow-up|0|||
155356900|NCT03305809|560742388|FG000|Overall Study|Sponsor Decision|1|||
155356901|NCT03305809|560742389|FG001|Overall Study|Sponsor Decision|0|||
155356902|NCT03305809|560742390|FG002|Overall Study|Sponsor Decision|1|||
155356903|NCT03305809|560742391|FG003|Overall Study|Sponsor Decision|8|||
155356904|NCT03305809|560742388|FG000|Overall Study|Physician Decision|0|||
155356905|NCT03305809|560742389|FG001|Overall Study|Physician Decision|0|||
155356906|NCT03305809|560742390|FG002|Overall Study|Physician Decision|2|||
155356907|NCT03305809|560742391|FG003|Overall Study|Physician Decision|4|||
155356908|NCT03305809|560742388|FG000|Overall Study|Progressive Disease|0|||
155356909|NCT03305809|560742389|FG001|Overall Study|Progressive Disease|0|||
155356910|NCT03305809|560742390|FG002|Overall Study|Progressive Disease|1|||
155356911|NCT03305809|560742391|FG003|Overall Study|Progressive Disease|0|||
155356912|NCT03305809|560742388|FG000|Overall Study|Protocol Violation|1|||
155356913|NCT03305809|560742389|FG001|Overall Study|Protocol Violation|0|||
155356914|NCT03305809|560742390|FG002|Overall Study|Protocol Violation|2|||
155356915|NCT03305809|560742391|FG003|Overall Study|Protocol Violation|3|||
155356916|NCT03305809|560742388|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
155356917|NCT03305809|560742389|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
155356918|NCT03305809|560742390|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
155356919|NCT03305809|560742391|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
155356920|NCT03305809|560742388|FG000|Overall Study|Withdrawal by Subject|2|||
155356921|NCT03305809|560742389|FG001|Overall Study|Withdrawal by Subject|4|||
155356922|NCT03305809|560742390|FG002|Overall Study|Withdrawal by Subject|5|||
155356923|NCT03305809|560742391|FG003|Overall Study|Withdrawal by Subject|2|||
155356924|NCT03305809|560742388|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
155356925|NCT03305809|560742389|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
155356926|NCT03305809|560742390|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
155356927|NCT03305809|560742391|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
155356928|NCT00816556|560742392|FG000|Overall Study|Adverse Event|1|||
155356929|NCT00816556|560742393|FG001|Overall Study|Adverse Event|1|||
155356930|NCT00816556|560742394|FG002|Overall Study|Adverse Event|1|||
155356931|NCT00816556|560742392|FG000|Overall Study|Withdrawal by Subject|1|||
155356932|NCT00816556|560742393|FG001|Overall Study|Withdrawal by Subject|1|||
155356933|NCT00816556|560742394|FG002|Overall Study|Withdrawal by Subject|1|||
155356934|NCT00816556|560742392|FG000|Overall Study|Lost to Follow-up|0|||
155356935|NCT00816556|560742393|FG001|Overall Study|Lost to Follow-up|0|||
155356936|NCT00816556|560742394|FG002|Overall Study|Lost to Follow-up|1|||
155356937|NCT04014790|560742397|FG000|Overall Study|Death|4|||
155356938|NCT04014790|560742397|FG000|Overall Study|Adverse Event|1|||
155356939|NCT04014790|560742397|FG000|Overall Study|Withdrawal by Subject|1|||
155356940|NCT03546816|560742398|FG000|Overall Study|Adverse Event|5|||
155356941|NCT03546816|560742399|FG001|Overall Study|Adverse Event|3|||
155356942|NCT03546816|560742398|FG000|Overall Study|Lack of Efficacy|2|||
155356943|NCT03546816|560742399|FG001|Overall Study|Lack of Efficacy|4|||
155356944|NCT03546816|560742398|FG000|Overall Study|Pregnancy|1|||
155356945|NCT03546816|560742399|FG001|Overall Study|Pregnancy|0|||
155356946|NCT03546816|560742398|FG000|Overall Study|Physician Decision|2|||
155356947|NCT03546816|560742399|FG001|Overall Study|Physician Decision|0|||
155356948|NCT03546816|560742398|FG000|Overall Study|Withdrawal by Subject|8|||
155356949|NCT03546816|560742399|FG001|Overall Study|Withdrawal by Subject|10|||
154964869|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Death|0|||
154964870|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
155356950|NCT03546816|560742398|FG000|Overall Study|Lost to Follow-up|3|||
155356951|NCT03546816|560742399|FG001|Overall Study|Lost to Follow-up|2|||
155356952|NCT00810342|560742400|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
155356953|NCT00810342|560742401|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
155356954|NCT00810342|560742400|FG000|Month 1 Follow-up|Pregnancy|1|||
155356955|NCT00810342|560742401|FG001|Month 1 Follow-up|Pregnancy|0|||
155356956|NCT00810342|560742400|FG000|6-month Follow-up|Lost to Follow-up|18|||
155356957|NCT00810342|560742401|FG001|6-month Follow-up|Lost to Follow-up|6|||
155356958|NCT00810342|560742400|FG000|6-month Follow-up|Pregnancy|6|||
155087129|NCT01397253|559752123|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
155087130|NCT02296476|559752124|FG000|Overall Study|Disease Progression|6|||
155087131|NCT02296476|559752125|FG001|Overall Study|Disease Progression|4|||
155087132|NCT02296476|559752126|FG002|Overall Study|Disease Progression|2|||
155356959|NCT00810342|560742401|FG001|6-month Follow-up|Pregnancy|2|||
155356960|NCT00810342|560742400|FG000|12-month Followup|Pregnancy|9|||
155356961|NCT00810342|560742401|FG001|12-month Followup|Pregnancy|10|||
155356962|NCT00810342|560742400|FG000|12-month Followup|Lost to Follow-up|3|||
155356963|NCT00810342|560742401|FG001|12-month Followup|Lost to Follow-up|1|||
155356964|NCT03065933|560742403|FG000|Overall Study|study terminated|5|||
155356965|NCT04504630|560742404|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
155356966|NCT04504630|560742405|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
155356967|NCT04504630|560742404|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
155356968|NCT04504630|560742405|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
155356969|NCT01010204|560742406|FG000|Overall Study|Lost to Follow-up|2|||
155356970|NCT01010204|560742407|FG001|Overall Study|Lost to Follow-up|2|||
155356971|NCT01010204|560742406|FG000|Overall Study|Adverse Event|1|||
155356972|NCT01010204|560742407|FG001|Overall Study|Adverse Event|3|||
155356973|NCT01010204|560742406|FG000|Overall Study|Withdrawal by Subject|2|||
155356974|NCT01010204|560742407|FG001|Overall Study|Withdrawal by Subject|3|||
155356975|NCT01010204|560742406|FG000|Overall Study|psychiatric hospitalization|2|||
155356976|NCT01010204|560742407|FG001|Overall Study|psychiatric hospitalization|1|||
155356977|NCT01513330|560742408|FG000|SenSura Mio First,|Adverse Event|2|||
155356978|NCT01513330|560742409|FG001|SenSura Mio First,|Adverse Event|0|||
155356979|NCT01513330|560742408|FG000|SenSura Mio First,|Lack of Efficacy|0|||
155356980|NCT01513330|560742409|FG001|SenSura Mio First,|Lack of Efficacy|1|||
155356981|NCT01513330|560742408|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
155356982|NCT01513330|560742409|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
155356983|NCT01513330|560742408|FG000|SenSura Mio First,|Other|1|||
155356984|NCT01513330|560742409|FG001|SenSura Mio First,|Other|0|||
155356985|NCT01513330|560742408|FG000|Standard Care First,|Lack of Efficacy|2|||
155356986|NCT01513330|560742409|FG001|Standard Care First,|Lack of Efficacy|2|||
155356987|NCT01513330|560742408|FG000|Standard Care First,|Withdrawal by Subject|1|||
155356988|NCT01513330|560742409|FG001|Standard Care First,|Withdrawal by Subject|2|||
155356989|NCT01513330|560742408|FG000|Standard Care First,|Other|1|||
155356990|NCT01513330|560742409|FG001|Standard Care First,|Other|0|||
155356991|NCT01519778|560742410|FG000|Overall Study|Withdrawal by Subject|3|||
155356992|NCT01519778|560742410|FG000|Overall Study|Lost to Follow-up|10|||
155356993|NCT01519778|560742410|FG000|Overall Study|Physician Decision|1|||
155356994|NCT02270671|560742411|FG000|Overall Study|Withdrawal by Subject|1|||
155356995|NCT02270671|560742412|FG001|Overall Study|Withdrawal by Subject|1|||
155356996|NCT02270671|560742411|FG000|Overall Study|Protocol Violation|0|||
155356997|NCT02270671|560742412|FG001|Overall Study|Protocol Violation|1|||
155356998|NCT02270671|560742411|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
155356999|NCT02270671|560742412|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
155357000|NCT02270671|560742411|FG000|Overall Study|Lost to Follow-up|2|||
155357001|NCT02270671|560742412|FG001|Overall Study|Lost to Follow-up|1|||
155357002|NCT02330562|560742420|FG000|Overall Study|Adverse Event|0|||
155357003|NCT02330562|560742421|FG001|Overall Study|Adverse Event|0|||
155357004|NCT02330562|560742422|FG002|Overall Study|Adverse Event|3|||
155357005|NCT02330562|560742423|FG003|Overall Study|Adverse Event|0|||
155357006|NCT02330562|560742424|FG004|Overall Study|Adverse Event|3|||
155357007|NCT02330562|560742425|FG005|Overall Study|Adverse Event|1|||
155357008|NCT02330562|560742426|FG006|Overall Study|Adverse Event|0|||
155357009|NCT02330562|560742427|FG007|Overall Study|Adverse Event|0|||
155357010|NCT02330562|560742428|FG008|Overall Study|Adverse Event|0|||
155357011|NCT02330562|560742429|FG009|Overall Study|Adverse Event|1|||
155357012|NCT02330562|560742430|FG010|Overall Study|Adverse Event|1|||
155357013|NCT02330562|560742420|FG000|Overall Study|Participant decision|1|||
155087133|NCT03502681|559752131|FG000|Overall Study|Adverse Event|1|||
155087134|NCT03502681|559752132|FG001|Overall Study|Adverse Event|1|||
155087135|NCT03502681|559752131|FG000|Overall Study|Disease Progression|2|||
155357014|NCT02330562|560742421|FG001|Overall Study|Participant decision|0|||
155357015|NCT02330562|560742422|FG002|Overall Study|Participant decision|4|||
155357016|NCT02330562|560742423|FG003|Overall Study|Participant decision|1|||
155357017|NCT02330562|560742424|FG004|Overall Study|Participant decision|5|||
155357018|NCT02330562|560742425|FG005|Overall Study|Participant decision|2|||
155357019|NCT02330562|560742426|FG006|Overall Study|Participant decision|0|||
155357020|NCT02330562|560742427|FG007|Overall Study|Participant decision|0|||
155357021|NCT02330562|560742428|FG008|Overall Study|Participant decision|0|||
155357022|NCT02330562|560742429|FG009|Overall Study|Participant decision|3|||
155357023|NCT02330562|560742430|FG010|Overall Study|Participant decision|0|||
155357024|NCT02330562|560742420|FG000|Overall Study|Disease progression|5|||
155357025|NCT02330562|560742421|FG001|Overall Study|Disease progression|3|||
155357026|NCT02330562|560742422|FG002|Overall Study|Disease progression|20|||
155357027|NCT02330562|560742423|FG003|Overall Study|Disease progression|28|||
155357028|NCT02330562|560742424|FG004|Overall Study|Disease progression|23|||
155087136|NCT03502681|559752132|FG001|Overall Study|Disease Progression|1|||
155087137|NCT00442702|559752133|FG000|Titration Period|Adverse Event|2|||
155087138|NCT00442702|559752134|FG001|Titration Period|Adverse Event|0|||
155087139|NCT00442702|559752133|FG000|Titration Period|Death|3|||
155087140|NCT00442702|559752134|FG001|Titration Period|Death|2|||
155087141|NCT00442702|559752133|FG000|Titration Period|Insufficient Therapeutic Response|1|||
155087142|NCT00442702|559752134|FG001|Titration Period|Insufficient Therapeutic Response|0|||
155087143|NCT00442702|559752133|FG000|Titration Period|Refused Treatment|4|||
155087144|NCT00442702|559752134|FG001|Titration Period|Refused Treatment|1|||
155087145|NCT00442702|559752133|FG000|Titration Period|Failure to return|1|||
155087146|NCT00442702|559752134|FG001|Titration Period|Failure to return|0|||
155087147|NCT00442702|559752133|FG000|Titration Period|Hospitalized in another hospital|1|||
155087148|NCT00442702|559752134|FG001|Titration Period|Hospitalized in another hospital|0|||
155087149|NCT00442702|559752133|FG000|Evaluation Period|Adverse Event|1|||
155087150|NCT00442702|559752134|FG001|Evaluation Period|Adverse Event|0|||
155087151|NCT00442702|559752133|FG000|Evaluation Period|Death|1|||
155087152|NCT00442702|559752134|FG001|Evaluation Period|Death|1|||
155087153|NCT00442702|559752133|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
155087154|NCT00442702|559752134|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
155087155|NCT00442702|559752133|FG000|Evaluation Period|Refused treatment|1|||
155087156|NCT00442702|559752134|FG001|Evaluation Period|Refused treatment|1|||
155087157|NCT00442702|559752133|FG000|Evaluation Period|Renal transplant|0|||
155087158|NCT00442702|559752134|FG001|Evaluation Period|Renal transplant|1|||
155087159|NCT00442702|559752133|FG000|Evaluation Period|Failure to return|1|||
155087160|NCT00442702|559752134|FG001|Evaluation Period|Failure to return|0|||
155087161|NCT00442702|559752133|FG000|Evaluation Period|Site closure|0|||
155087162|NCT00442702|559752134|FG001|Evaluation Period|Site closure|1|||
155087163|NCT03436732|559752142|FG000|Overall Study|Not treated-enrolled in different study|1|||
155087164|NCT03436732|559752143|FG001|Overall Study|Not treated-enrolled in different study|0|||
155087165|NCT03436732|559752142|FG000|Overall Study|Off study after cycle 1|1|||
155087166|NCT03436732|559752143|FG001|Overall Study|Off study after cycle 1|0|||
155087167|NCT03436732|559752142|FG000|Overall Study|Adverse Event|2|||
155087168|NCT03436732|559752143|FG001|Overall Study|Adverse Event|0|||
155087169|NCT03436732|559752142|FG000|Overall Study|Death|0|||
155087170|NCT03436732|559752143|FG001|Overall Study|Death|1|||
155087171|NCT00267488|559752144|FG000|Overall Study|Sponsor Terminated Study|9|||
155087172|NCT00267488|559752144|FG000|Overall Study|Protocol Violation|1|||
155087173|NCT00267488|559752144|FG000|Overall Study|Other (Disease Progression)|1|||
155087174|NCT02093520|559752145|FG000|Overall Study|Not treated|6|||
155087175|NCT02093520|559752146|FG001|Overall Study|Not treated|22|||
155087176|NCT00851084|559752147|FG000|Overall Study|Randomized but not treated|1|||
155087177|NCT00851084|559752148|FG001|Overall Study|Randomized but not treated|0|||
155087178|NCT00851084|559752147|FG000|Overall Study|Adverse Event|26|||
155087179|NCT00851084|559752148|FG001|Overall Study|Adverse Event|36|||
155087180|NCT00851084|559752147|FG000|Overall Study|Disease progression|52|||
155087181|NCT00851084|559752148|FG001|Overall Study|Disease progression|47|||
155087182|NCT00851084|559752147|FG000|Overall Study|Poor compliance to protocol|1|||
155087183|NCT00851084|559752148|FG001|Overall Study|Poor compliance to protocol|1|||
155087184|NCT00851084|559752147|FG000|Overall Study|Physician Decision|13|||
155087185|NCT00851084|559752148|FG001|Overall Study|Physician Decision|14|||
155087186|NCT00851084|559752147|FG000|Overall Study|Consent withdrawn|0|||
155357029|NCT02330562|560742425|FG005|Overall Study|Disease progression|7|||
155357030|NCT02330562|560742426|FG006|Overall Study|Disease progression|1|||
155357031|NCT02330562|560742427|FG007|Overall Study|Disease progression|1|||
155357032|NCT02330562|560742428|FG008|Overall Study|Disease progression|1|||
155357033|NCT02330562|560742429|FG009|Overall Study|Disease progression|0|||
155357034|NCT02330562|560742430|FG010|Overall Study|Disease progression|5|||
155357035|NCT02330562|560742420|FG000|Overall Study|Other reasons|0|||
155357036|NCT02330562|560742421|FG001|Overall Study|Other reasons|0|||
155357037|NCT02330562|560742422|FG002|Overall Study|Other reasons|0|||
155357038|NCT02330562|560742423|FG003|Overall Study|Other reasons|1|||
154964871|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
155087187|NCT00851084|559752148|FG001|Overall Study|Consent withdrawn|2|||
155087188|NCT00851084|559752147|FG000|Overall Study|Withdrawal by Subject|11|||
155087189|NCT00851084|559752148|FG001|Overall Study|Withdrawal by Subject|12|||
155165733|NCT02721966|560043542|FG003|Overall Study|Did not continue to period 2|0|||
155087190|NCT00851084|559752147|FG000|Overall Study|Metastatic surgery|6|||
155087191|NCT00851084|559752148|FG001|Overall Study|Metastatic surgery|6|||
155087192|NCT00851084|559752147|FG000|Overall Study|Other|7|||
155087193|NCT00851084|559752148|FG001|Overall Study|Other|1|||
155087194|NCT03468998|559752149|FG000|Overall Study|Withdrawal by Subject|1|||
155357039|NCT02330562|560742424|FG004|Overall Study|Other reasons|0|||
155357040|NCT02330562|560742425|FG005|Overall Study|Other reasons|0|||
155087195|NCT03468998|559752150|FG001|Overall Study|Withdrawal by Subject|1|||
155087196|NCT03468998|559752151|FG002|Overall Study|Withdrawal by Subject|0|||
155087197|NCT03468998|559752152|FG003|Overall Study|Withdrawal by Subject|4|||
155087198|NCT03468998|559752153|FG004|Overall Study|Withdrawal by Subject|1|||
155357041|NCT02330562|560742426|FG006|Overall Study|Other reasons|0|||
155087199|NCT03468998|559752154|FG005|Overall Study|Withdrawal by Subject|0|||
155087200|NCT01892189|559752155|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
155087201|NCT01892189|559752156|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
155087202|NCT01892189|559752157|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
155087203|NCT01892189|559752158|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
155087204|NCT01892189|559752159|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
155087205|NCT01892189|559752160|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
155087206|NCT01892189|559752161|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
155087207|NCT01892189|559752162|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
155087208|NCT01892189|559752163|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
155087209|NCT01892189|559752155|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155087210|NCT01892189|559752156|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155087211|NCT01892189|559752157|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
155087212|NCT01892189|559752158|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155087213|NCT01892189|559752159|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155087214|NCT01892189|559752160|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155087215|NCT01892189|559752161|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155087216|NCT01892189|559752162|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155087217|NCT01892189|559752163|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155357042|NCT02330562|560742427|FG007|Overall Study|Other reasons|0|||
155357043|NCT02330562|560742428|FG008|Overall Study|Other reasons|0|||
155357044|NCT02330562|560742429|FG009|Overall Study|Other reasons|0|||
155357045|NCT02330562|560742430|FG010|Overall Study|Other reasons|0|||
155357046|NCT02330562|560742420|FG000|Overall Study|Withdrawal by Subject|0|||
155357047|NCT02330562|560742421|FG001|Overall Study|Withdrawal by Subject|0|||
155357048|NCT02330562|560742422|FG002|Overall Study|Withdrawal by Subject|0|||
155357049|NCT02330562|560742423|FG003|Overall Study|Withdrawal by Subject|0|||
155357050|NCT02330562|560742424|FG004|Overall Study|Withdrawal by Subject|0|||
155357051|NCT02330562|560742425|FG005|Overall Study|Withdrawal by Subject|0|||
155357052|NCT02330562|560742426|FG006|Overall Study|Withdrawal by Subject|0|||
155357053|NCT02330562|560742427|FG007|Overall Study|Withdrawal by Subject|0|||
155357054|NCT02330562|560742428|FG008|Overall Study|Withdrawal by Subject|0|||
155357055|NCT02330562|560742429|FG009|Overall Study|Withdrawal by Subject|1|||
155357056|NCT02330562|560742430|FG010|Overall Study|Withdrawal by Subject|0|||
155357057|NCT01547117|560742431|FG000|Overall Study|Physician Decision|0|||
155357058|NCT01547117|560742432|FG001|Overall Study|Physician Decision|1|||
155357059|NCT01547117|560742433|FG002|Overall Study|Physician Decision|1|||
155357060|NCT01547117|560742434|FG003|Overall Study|Physician Decision|3|||
155357061|NCT01547117|560742431|FG000|Overall Study|Withdrawal by Subject|1|||
155357062|NCT01547117|560742432|FG001|Overall Study|Withdrawal by Subject|2|||
155357063|NCT01547117|560742433|FG002|Overall Study|Withdrawal by Subject|1|||
155357064|NCT01547117|560742434|FG003|Overall Study|Withdrawal by Subject|2|||
155357065|NCT03927690|560742436|FG000|Overall Study|Withdrawal by Subject|3|||
155357066|NCT03927690|560742437|FG001|Overall Study|Withdrawal by Subject|1|||
155357067|NCT03927690|560742438|FG002|Overall Study|Withdrawal by Subject|1|||
155357068|NCT03927690|560742436|FG000|Overall Study|Adverse Event|1|||
155357069|NCT03927690|560742437|FG001|Overall Study|Adverse Event|0|||
155357070|NCT03927690|560742438|FG002|Overall Study|Adverse Event|0|||
155357071|NCT03927690|560742436|FG000|Overall Study|Death|1|||
155357072|NCT03927690|560742437|FG001|Overall Study|Death|0|||
155357073|NCT03927690|560742438|FG002|Overall Study|Death|0|||
155357074|NCT03927690|560742436|FG000|Overall Study|Lost to Follow-up|2|||
155357075|NCT03927690|560742437|FG001|Overall Study|Lost to Follow-up|2|||
155357076|NCT03927690|560742438|FG002|Overall Study|Lost to Follow-up|1|||
155357077|NCT01496365|560742451|FG000|Overall Study|Adverse Event|2|||
155357078|NCT01496365|560742452|FG001|Overall Study|Adverse Event|3|||
155357079|NCT01496365|560742453|FG002|Overall Study|Adverse Event|3|||
155087218|NCT01892189|559752155|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155087219|NCT01892189|559752156|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155087220|NCT01892189|559752157|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155357080|NCT01496365|560742454|FG003|Overall Study|Adverse Event|2|||
155357081|NCT01496365|560742455|FG004|Overall Study|Adverse Event|5|||
155087221|NCT01892189|559752158|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155087222|NCT01892189|559752159|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155087223|NCT01892189|559752160|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
155087224|NCT01892189|559752161|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155357082|NCT01496365|560742456|FG005|Overall Study|Adverse Event|6|||
155357083|NCT01496365|560742457|FG006|Overall Study|Adverse Event|4|||
155357084|NCT01496365|560742451|FG000|Overall Study|Withdrawal by Subject|6|||
155357085|NCT01496365|560742452|FG001|Overall Study|Withdrawal by Subject|6|||
155357086|NCT01496365|560742453|FG002|Overall Study|Withdrawal by Subject|0|||
155357087|NCT01496365|560742454|FG003|Overall Study|Withdrawal by Subject|1|||
155357088|NCT01496365|560742455|FG004|Overall Study|Withdrawal by Subject|3|||
155357089|NCT01496365|560742456|FG005|Overall Study|Withdrawal by Subject|2|||
155357090|NCT01496365|560742457|FG006|Overall Study|Withdrawal by Subject|1|||
155357091|NCT01496365|560742451|FG000|Overall Study|Protocol Violation|2|||
155357092|NCT01496365|560742452|FG001|Overall Study|Protocol Violation|1|||
155357093|NCT01496365|560742453|FG002|Overall Study|Protocol Violation|1|||
155357094|NCT01496365|560742454|FG003|Overall Study|Protocol Violation|0|||
155357095|NCT01496365|560742455|FG004|Overall Study|Protocol Violation|0|||
155357096|NCT01496365|560742456|FG005|Overall Study|Protocol Violation|1|||
155357097|NCT01496365|560742457|FG006|Overall Study|Protocol Violation|0|||
155357098|NCT01496365|560742451|FG000|Overall Study|Lack of Efficacy|1|||
155357099|NCT01496365|560742452|FG001|Overall Study|Lack of Efficacy|0|||
155357100|NCT01496365|560742453|FG002|Overall Study|Lack of Efficacy|0|||
155357101|NCT01496365|560742454|FG003|Overall Study|Lack of Efficacy|0|||
155357102|NCT01496365|560742455|FG004|Overall Study|Lack of Efficacy|0|||
155357103|NCT01496365|560742456|FG005|Overall Study|Lack of Efficacy|1|||
155357104|NCT01496365|560742457|FG006|Overall Study|Lack of Efficacy|0|||
155357105|NCT01496365|560742451|FG000|Overall Study|Lost to Follow-up|0|||
155357106|NCT01496365|560742452|FG001|Overall Study|Lost to Follow-up|1|||
155357107|NCT01496365|560742453|FG002|Overall Study|Lost to Follow-up|0|||
155357108|NCT01496365|560742454|FG003|Overall Study|Lost to Follow-up|0|||
155357109|NCT01496365|560742455|FG004|Overall Study|Lost to Follow-up|2|||
155357110|NCT01496365|560742456|FG005|Overall Study|Lost to Follow-up|0|||
155357111|NCT01496365|560742457|FG006|Overall Study|Lost to Follow-up|0|||
155357112|NCT01496365|560742451|FG000|Overall Study|Other|4|||
155357113|NCT01496365|560742452|FG001|Overall Study|Other|4|||
155357114|NCT01496365|560742453|FG002|Overall Study|Other|2|||
155357115|NCT01496365|560742454|FG003|Overall Study|Other|1|||
155357116|NCT01496365|560742455|FG004|Overall Study|Other|3|||
155357117|NCT01496365|560742456|FG005|Overall Study|Other|0|||
155357118|NCT01496365|560742457|FG006|Overall Study|Other|1|||
155357119|NCT01015677|560742458|FG000|Overall Study|Adverse Event|0|||
155357120|NCT01015677|560742459|FG001|Overall Study|Adverse Event|1|||
155357121|NCT01015677|560742460|FG002|Overall Study|Adverse Event|0|||
155357122|NCT01015677|560742458|FG000|Overall Study|Lack of Efficacy|0|||
155357123|NCT01015677|560742459|FG001|Overall Study|Lack of Efficacy|1|||
155357124|NCT01015677|560742460|FG002|Overall Study|Lack of Efficacy|0|||
155357125|NCT01015677|560742458|FG000|Overall Study|Protocol Violation|0|||
155357126|NCT01015677|560742459|FG001|Overall Study|Protocol Violation|1|||
155357127|NCT01015677|560742460|FG002|Overall Study|Protocol Violation|0|||
155357128|NCT01015677|560742458|FG000|Overall Study|Withdrawal by Subject|1|||
155357129|NCT01015677|560742459|FG001|Overall Study|Withdrawal by Subject|1|||
155357130|NCT01015677|560742460|FG002|Overall Study|Withdrawal by Subject|0|||
155357131|NCT01660256|560742461|FG000|Overall Study|Adverse Event|4|||
155357132|NCT01660256|560742462|FG001|Overall Study|Adverse Event|0|||
154964872|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
155357133|NCT01660256|560742463|FG002|Overall Study|Adverse Event|2|||
155357134|NCT01660256|560742461|FG000|Overall Study|Withdrawal by Subject|1|||
155357135|NCT01660256|560742462|FG001|Overall Study|Withdrawal by Subject|0|||
155357136|NCT01660256|560742463|FG002|Overall Study|Withdrawal by Subject|2|||
155357137|NCT01646385|560742465|FG000|Overall Study|Death|202|||
155357138|NCT01646385|560742466|FG001|Overall Study|Death|222|||
155357139|NCT01646385|560742465|FG000|Overall Study|Switched to alternate biologic|636|||
155357140|NCT01646385|560742466|FG001|Overall Study|Switched to alternate biologic|649|||
155357141|NCT03491215|560742467|FG000|Overall Study|Death|6|||
155357142|NCT03491215|560742468|FG001|Overall Study|Death|2|||
155357143|NCT03491215|560742469|FG002|Overall Study|Death|1|||
154964873|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
155357144|NCT03491215|560742470|FG003|Overall Study|Death|0|||
155357145|NCT03491215|560742467|FG000|Overall Study|Physician Decision|1|||
155357146|NCT03491215|560742468|FG001|Overall Study|Physician Decision|0|||
155357147|NCT03491215|560742469|FG002|Overall Study|Physician Decision|0|||
155357148|NCT03491215|560742470|FG003|Overall Study|Physician Decision|0|||
155357149|NCT00548847|560742477|FG000|Overall Study|Disease progression|7|||
155357150|NCT00511797|560742481|FG000|Overall Study|Adverse Event|1|||
155357151|NCT00511797|560742482|FG001|Overall Study|Adverse Event|2|||
155357152|NCT00511797|560742483|FG002|Overall Study|Adverse Event|2|||
155357153|NCT00511797|560742484|FG003|Overall Study|Adverse Event|2|||
155087225|NCT01892189|559752162|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155087226|NCT01892189|559752163|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
155357154|NCT00511797|560742481|FG000|Overall Study|Lost to Follow-up|1|||
155357155|NCT00511797|560742482|FG001|Overall Study|Lost to Follow-up|0|||
155357156|NCT00511797|560742483|FG002|Overall Study|Lost to Follow-up|0|||
155357157|NCT00511797|560742484|FG003|Overall Study|Lost to Follow-up|1|||
155087227|NCT01052779|559752169|FG000|Overall Study|Adverse Event|1|||
155087228|NCT01052779|559752170|FG001|Overall Study|Adverse Event|4|||
155357158|NCT00511797|560742481|FG000|Overall Study|Pregnancy|0|||
155357159|NCT00511797|560742482|FG001|Overall Study|Pregnancy|0|||
155357160|NCT00511797|560742483|FG002|Overall Study|Pregnancy|0|||
155357161|NCT00511797|560742484|FG003|Overall Study|Pregnancy|1|||
155357162|NCT00511797|560742481|FG000|Overall Study|Protocol Violation|0|||
155357163|NCT00511797|560742482|FG001|Overall Study|Protocol Violation|2|||
155357164|NCT00511797|560742483|FG002|Overall Study|Protocol Violation|2|||
155357165|NCT00511797|560742484|FG003|Overall Study|Protocol Violation|3|||
155357166|NCT00511797|560742481|FG000|Overall Study|Withdrawal by Subject|3|||
155087229|NCT01052779|559752169|FG000|Overall Study|Withdrawal by Subject|1|||
155087230|NCT01052779|559752170|FG001|Overall Study|Withdrawal by Subject|2|||
155087231|NCT01052779|559752169|FG000|Overall Study|Other-Protocol Violation|1|||
155087232|NCT01052779|559752170|FG001|Overall Study|Other-Protocol Violation|1|||
155087233|NCT01052779|559752169|FG000|Overall Study|Other-Surgery|0|||
155087234|NCT01052779|559752170|FG001|Overall Study|Other-Surgery|2|||
155087235|NCT01052779|559752169|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
155087236|NCT01052779|559752170|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
155087237|NCT01285102|559752171|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
155357167|NCT00511797|560742482|FG001|Overall Study|Withdrawal by Subject|3|||
155357168|NCT00511797|560742483|FG002|Overall Study|Withdrawal by Subject|4|||
155357169|NCT00511797|560742484|FG003|Overall Study|Withdrawal by Subject|2|||
155357170|NCT00511797|560742481|FG000|Overall Study|Never dispensed|1|||
155357171|NCT00511797|560742482|FG001|Overall Study|Never dispensed|0|||
155357172|NCT00511797|560742483|FG002|Overall Study|Never dispensed|1|||
155357173|NCT00511797|560742484|FG003|Overall Study|Never dispensed|3|||
155357174|NCT00511797|560742481|FG000|Overall Study|Study drug not taken|0|||
155357175|NCT00511797|560742482|FG001|Overall Study|Study drug not taken|1|||
155357176|NCT00511797|560742483|FG002|Overall Study|Study drug not taken|0|||
155357177|NCT00511797|560742484|FG003|Overall Study|Study drug not taken|1|||
155357178|NCT00511797|560742481|FG000|Overall Study|Partially missing diary|0|||
155357179|NCT00511797|560742482|FG001|Overall Study|Partially missing diary|0|||
155357180|NCT00511797|560742483|FG002|Overall Study|Partially missing diary|1|||
155357181|NCT00511797|560742484|FG003|Overall Study|Partially missing diary|0|||
155357182|NCT00511797|560742481|FG000|Overall Study|Other (moving etc)|1|||
155357183|NCT00511797|560742482|FG001|Overall Study|Other (moving etc)|0|||
155357184|NCT00511797|560742483|FG002|Overall Study|Other (moving etc)|1|||
155357185|NCT00511797|560742484|FG003|Overall Study|Other (moving etc)|2|||
155357186|NCT03269695|560742485|FG000|Overall Study|Adverse Event|2|||
155357187|NCT03269695|560742486|FG001|Overall Study|Adverse Event|1|||
155357188|NCT03269695|560742485|FG000|Overall Study|Lack of Efficacy|0|||
155357189|NCT03269695|560742486|FG001|Overall Study|Lack of Efficacy|1|||
155357190|NCT03269695|560742485|FG000|Overall Study|Withdrawal by Subject|0|||
155357191|NCT03269695|560742486|FG001|Overall Study|Withdrawal by Subject|1|||
155357192|NCT05043883|560742487|FG000|Overall Study|Minimum required measurements could not be taken|4|||
155357193|NCT00905359|560742492|FG000|Overall Study|Lost to Follow-up|17|||
155357194|NCT00905359|560742493|FG001|Overall Study|Lost to Follow-up|10|||
155357195|NCT00905359|560742492|FG000|Overall Study|Death|2|||
155357196|NCT00905359|560742493|FG001|Overall Study|Death|0|||
155357197|NCT00905359|560742492|FG000|Overall Study|Withdrawal consent|5|||
155357198|NCT00905359|560742493|FG001|Overall Study|Withdrawal consent|6|||
155357199|NCT04354168|560742500|FG000|Overall Study|Lost to Follow-up|22|||
155357200|NCT02287233|560742501|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
155357201|NCT02287233|560742502|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
155357202|NCT02287233|560742503|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
155357203|NCT02287233|560742501|FG000|Overall Study|Adverse Event Related to Progression|0|||
155357204|NCT02287233|560742502|FG001|Overall Study|Adverse Event Related to Progression|2|||
155357205|NCT02287233|560742503|FG002|Overall Study|Adverse Event Related to Progression|8|||
155357206|NCT02287233|560742501|FG000|Overall Study|Physician Decision|1|||
155357207|NCT02287233|560742502|FG001|Overall Study|Physician Decision|2|||
155357208|NCT02287233|560742503|FG002|Overall Study|Physician Decision|4|||
155357209|NCT02287233|560742501|FG000|Overall Study|Progressive Disease with Death|0|||
155357210|NCT02287233|560742502|FG001|Overall Study|Progressive Disease with Death|0|||
155087238|NCT03427619|559752172|FG000|Overall Study|Physician Decision|3|||
155087239|NCT03427619|559752172|FG000|Overall Study|Withdrawal by Subject|4|||
155357211|NCT02287233|560742503|FG002|Overall Study|Progressive Disease with Death|10|||
155357212|NCT02287233|560742501|FG000|Overall Study|Progressive Disease Without Death|2|||
155357213|NCT02287233|560742502|FG001|Overall Study|Progressive Disease Without Death|3|||
155357214|NCT02287233|560742503|FG002|Overall Study|Progressive Disease Without Death|20|||
155357215|NCT02287233|560742501|FG000|Overall Study|Withdrawal by Subject|1|||
155357216|NCT02287233|560742502|FG001|Overall Study|Withdrawal by Subject|1|||
155357217|NCT02287233|560742503|FG002|Overall Study|Withdrawal by Subject|7|||
155357218|NCT02287233|560742501|FG000|Overall Study|Other|3|||
155357219|NCT02287233|560742502|FG001|Overall Study|Other|0|||
155357220|NCT02287233|560742503|FG002|Overall Study|Other|15|||
155357221|NCT02287233|560742501|FG000|Overall Study|Did Not Receive Treatment|0|||
155357222|NCT02287233|560742502|FG001|Overall Study|Did Not Receive Treatment|0|||
155357223|NCT02287233|560742503|FG002|Overall Study|Did Not Receive Treatment|2|||
155357224|NCT02804399|560742506|FG000|Period 2|Adverse Event|0|||
155357225|NCT02804399|560742507|FG001|Period 2|Adverse Event|1|||
155357226|NCT01174264|560742508|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
155357227|NCT01174264|560742509|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
155357228|NCT01174264|560742510|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
155357229|NCT01174264|560742508|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
155357230|NCT01174264|560742509|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
155357231|NCT01174264|560742510|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
155357232|NCT01174264|560742508|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
155357233|NCT01174264|560742509|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
155357234|NCT01174264|560742510|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
155357235|NCT03432390|560742511|FG000|Apnea Period|Protocol Violation|2|||
155357236|NCT03432390|560742512|FG001|Apnea Period|Protocol Violation|2|||
155357237|NCT01774305|560742515|FG000|Overall Study|Physician Decision|1|||
155357238|NCT01774305|560742516|FG001|Overall Study|Physician Decision|0|||
155357239|NCT03738397|560742517|FG000|Overall Study|Adverse Event|3|||
155357240|NCT03738397|560742518|FG001|Overall Study|Adverse Event|7|||
155357241|NCT03738397|560742517|FG000|Overall Study|Withdrawal by Subject|8|||
155357242|NCT03738397|560742518|FG001|Overall Study|Withdrawal by Subject|11|||
155357243|NCT03738397|560742517|FG000|Overall Study|Lost to Follow-up|7|||
155357244|NCT03738397|560742518|FG001|Overall Study|Lost to Follow-up|5|||
155357245|NCT03738397|560742517|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155357246|NCT03738397|560742518|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
155357247|NCT03738397|560742517|FG000|Overall Study|Other|4|||
155357248|NCT03738397|560742518|FG001|Overall Study|Other|6|||
155357249|NCT00691678|560742519|FG000|Overall Study|Adverse Event|5|||
155357250|NCT00691678|560742519|FG000|Overall Study|life events, pain|11|||
155357251|NCT03049306|560742520|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
155357252|NCT03049306|560742521|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
155357253|NCT00903760|560744326|FG000|Overall Study|Disease Progression/Death|8|||
155357254|NCT00903760|560744327|FG001|Overall Study|Disease Progression/Death|6|||
155357255|NCT00903760|560744326|FG000|Overall Study|Stem Cell Transplant|8|||
155357256|NCT00903760|560744327|FG001|Overall Study|Stem Cell Transplant|4|||
155357257|NCT00903760|560744326|FG000|Overall Study|Physician Decision|1|||
155357258|NCT00903760|560744327|FG001|Overall Study|Physician Decision|2|||
155357259|NCT00903760|560744326|FG000|Overall Study|Death|0|||
155357260|NCT00903760|560744327|FG001|Overall Study|Death|1|||
155357261|NCT00903760|560744326|FG000|Overall Study|Lost to Follow-up|1|||
155357262|NCT00903760|560744327|FG001|Overall Study|Lost to Follow-up|0|||
155357263|NCT00903760|560744326|FG000|Overall Study|Withdrawal by Subject|1|||
155357264|NCT00903760|560744327|FG001|Overall Study|Withdrawal by Subject|2|||
155357265|NCT00903760|560744326|FG000|Overall Study|Off treatment for long period|0|||
155357266|NCT00903760|560744327|FG001|Overall Study|Off treatment for long period|1|||
155357267|NCT01639742|560744329|FG000|Overall Study|Study Ongoing|17|||
155357268|NCT01639742|560744329|FG000|Overall Study|Lost to Follow-up|1|||
155357269|NCT01256671|560744333|FG000|Overall Study|Adverse Event|29|||
155357270|NCT01256671|560744333|FG000|Overall Study|Lost to Follow-up|16|||
155357271|NCT01256671|560744333|FG000|Overall Study|Withdrawal by Subject|31|||
155357272|NCT01256671|560744333|FG000|Overall Study|Physician Decision|3|||
155357273|NCT01256671|560744333|FG000|Overall Study|Lack of Efficacy|4|||
155357274|NCT01256671|560744333|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
155357275|NCT01266018|560744334|FG000|Overall Study|Physician Decision|1|||
155357276|NCT01266018|560744335|FG001|Overall Study|Physician Decision|0|||
155357277|NCT01266018|560744334|FG000|Overall Study|Progressive disease|0|||
154964874|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
155357278|NCT01266018|560744335|FG001|Overall Study|Progressive disease|1|||
155357279|NCT03167151|560744336|FG000|Overall Study|Withdrawal by Subject|1|||
155357280|NCT03167151|560744337|FG001|Overall Study|Withdrawal by Subject|0|||
155357281|NCT03167151|560744338|FG002|Overall Study|Withdrawal by Subject|0|||
155357282|NCT03167151|560744336|FG000|Overall Study|No evidence of tumour at surgery|0|||
154964875|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
154964876|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Other Event|49|||
154964877|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Other Event|52|||
155357283|NCT03167151|560744337|FG001|Overall Study|No evidence of tumour at surgery|1|||
155357284|NCT03167151|560744338|FG002|Overall Study|No evidence of tumour at surgery|1|||
155357285|NCT01458522|560744339|FG000|Overall Study|Withdrawal by Subject|2|||
155357286|NCT01458522|560744340|FG001|Overall Study|Withdrawal by Subject|2|||
155357287|NCT01458522|560744339|FG000|Overall Study|Physician Decision|1|||
155357288|NCT01458522|560744340|FG001|Overall Study|Physician Decision|9|||
155357289|NCT00516139|560744341|FG000|Overall Study|Adverse Event|27|||
155357290|NCT00516139|560744341|FG000|Overall Study|Lost to Follow-up|1|||
155357291|NCT00516139|560744341|FG000|Overall Study|Protocol Violation|1|||
155357292|NCT00516139|560744341|FG000|Overall Study|Withdrawal by Subject|8|||
155357293|NCT00516139|560744341|FG000|Overall Study|Lack of Efficacy|1|||
155357294|NCT00416598|560744342|FG000|Induction & Intensification|Adverse Event|38|||
155357295|NCT00416598|560744342|FG000|Induction & Intensification|Death|32|||
155357296|NCT00416598|560744342|FG000|Induction & Intensification|Withdrawal by Subject|46|||
155357297|NCT00416598|560744342|FG000|Induction & Intensification|Alternative Treatment|135|||
155357298|NCT00416598|560744342|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
155357299|NCT00416598|560744342|FG000|Induction & Intensification|Relapse/progression|29|||
155357300|NCT00416598|560744342|FG000|Induction & Intensification|Failed induction|87|||
155357301|NCT00416598|560744342|FG000|Decitabine Maintenance|Adverse Event|5|||
155357302|NCT00416598|560744342|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
155357303|NCT00416598|560744342|FG000|Decitabine Maintenance|Progression/relapse|38|||
155357304|NCT00416598|560744342|FG000|Decitabine Maintenance|Alternative treatment|2|||
155357305|NCT00416598|560744342|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
155357306|NCT02166476|560744349|FG000|Overall Study|Withdrawal by Subject|5|||
155357307|NCT02166476|560744350|FG001|Overall Study|Withdrawal by Subject|7|||
155357308|NCT02166476|560744349|FG000|Overall Study|Adverse Event|3|||
155357309|NCT02166476|560744350|FG001|Overall Study|Adverse Event|3|||
155357310|NCT02166476|560744349|FG000|Overall Study|Lost to Follow-up|5|||
155357311|NCT02166476|560744350|FG001|Overall Study|Lost to Follow-up|10|||
155357312|NCT02166476|560744349|FG000|Overall Study|Physician Decision|1|||
155357313|NCT02166476|560744350|FG001|Overall Study|Physician Decision|0|||
155357314|NCT02166476|560744349|FG000|Overall Study|Unable to Come for Visit|0|||
155357315|NCT02166476|560744350|FG001|Overall Study|Unable to Come for Visit|3|||
155357316|NCT04367480|560744357|FG000|Overall Study|Adverse Event|1|||
155357317|NCT04367480|560744358|FG001|Overall Study|Adverse Event|1|||
155357318|NCT04367480|560744357|FG000|Overall Study|Death|1|||
155357319|NCT04367480|560744358|FG001|Overall Study|Death|0|||
155357320|NCT04367480|560744357|FG000|Overall Study|Lost to Follow-up|1|||
155357321|NCT04367480|560744358|FG001|Overall Study|Lost to Follow-up|1|||
155357322|NCT04367480|560744357|FG000|Overall Study|Withdrawal by Subject|0|||
155357323|NCT04367480|560744358|FG001|Overall Study|Withdrawal by Subject|3|||
155357324|NCT04367480|560744357|FG000|Overall Study|App glitch during the study|1|||
155357325|NCT04367480|560744358|FG001|Overall Study|App glitch during the study|0|||
155357326|NCT04367480|560744357|FG000|Overall Study|Device Distribution Error|0|||
155357327|NCT04367480|560744358|FG001|Overall Study|Device Distribution Error|2|||
155357328|NCT04367480|560744357|FG000|Overall Study|Ineligible after Randomization|0|||
155357329|NCT04367480|560744358|FG001|Overall Study|Ineligible after Randomization|1|||
155357330|NCT04367480|560744357|FG000|Overall Study|Other Medical Reasons|0|||
155357331|NCT04367480|560744358|FG001|Overall Study|Other Medical Reasons|2|||
155357332|NCT03382561|560744359|FG000|Overall Study|Disease progression|47|||
155357333|NCT03382561|560744360|FG001|Overall Study|Disease progression|6|||
155357334|NCT03382561|560744359|FG000|Overall Study|Adverse Event|10|||
155357335|NCT03382561|560744360|FG001|Overall Study|Adverse Event|2|||
155357336|NCT03382561|560744359|FG000|Overall Study|Death|8|||
155357337|NCT03382561|560744360|FG001|Overall Study|Death|3|||
155357338|NCT03382561|560744359|FG000|Overall Study|Withdrawal by Subject|6|||
155165734|NCT02721966|560043543|FG004|Overall Study|Did not continue to period 2|5|||
155165735|NCT01047553|560043544|FG000|Overall Study|Adverse Event|10|||
155165736|NCT01047553|560043545|FG001|Overall Study|Adverse Event|5|||
155165737|NCT01047553|560043544|FG000|Overall Study|Withdrawal by Subject|4|||
155357339|NCT03382561|560744360|FG001|Overall Study|Withdrawal by Subject|5|||
155357340|NCT03382561|560744359|FG000|Overall Study|Alternative therapy|2|||
155357341|NCT03382561|560744360|FG001|Overall Study|Alternative therapy|8|||
155357342|NCT03382561|560744359|FG000|Overall Study|Never started treatment|3|||
155357343|NCT03382561|560744360|FG001|Overall Study|Never started treatment|6|||
155357344|NCT03382561|560744359|FG000|Overall Study|Lack of Efficacy|0|||
155357345|NCT03382561|560744360|FG001|Overall Study|Lack of Efficacy|1|||
155357346|NCT03382561|560744359|FG000|Overall Study|Physician Decision|0|||
155357347|NCT03382561|560744360|FG001|Overall Study|Physician Decision|1|||
155357348|NCT03382561|560744359|FG000|Overall Study|Other complicating disease|0|||
155357349|NCT03382561|560744360|FG001|Overall Study|Other complicating disease|1|||
155357350|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
155357351|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
155357352|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
155357353|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
155357354|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
155357355|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
155357356|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
155357357|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
155357358|NCT00781937|560744363|FG000|Main Trial Period Through Week 56|Unclassified|10|||
155357359|NCT00781937|560744364|FG001|Main Trial Period Through Week 56|Unclassified|15|||
155357360|NCT00781937|560744363|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
155357361|NCT00781937|560744364|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
155357362|NCT00781937|560744363|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
155357363|NCT00781937|560744364|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
155357364|NCT00013611|560744365|FG000|Overall Study|Lost to Follow-up|91|||
155357365|NCT00013611|560744366|FG001|Overall Study|Lost to Follow-up|100|||
155357366|NCT01150045|560744367|FG000|Overall Study|Protocol Violation|0|||
155357367|NCT01150045|560744368|FG001|Overall Study|Protocol Violation|1|||
155357368|NCT01150045|560744369|FG002|Overall Study|Protocol Violation|0|||
155357369|NCT01150045|560744370|FG003|Overall Study|Protocol Violation|1|||
155357370|NCT01432626|560744371|FG000|Overall Study|LV function recovered|2|||
155357371|NCT01432626|560744371|FG000|Overall Study|Withdrawal by Subject|2|||
155357372|NCT01432626|560744371|FG000|Overall Study|Only 1 image competed|2|||
155357373|NCT01432626|560744371|FG000|Overall Study|Imaging agent not available|1|||
155357374|NCT01657799|560744374|FG000|Overall Study|Adverse Event Related to progression|6|||
155357375|NCT01657799|560744375|FG001|Overall Study|Adverse Event Related to progression|8|||
155357376|NCT01657799|560744376|FG002|Overall Study|Adverse Event Related to progression|12|||
155357377|NCT01657799|560744374|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
155357378|NCT01657799|560744375|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
155357379|NCT01657799|560744376|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
155357380|NCT01657799|560744374|FG000|Overall Study|Withdrawal by Subject|13|||
155357381|NCT01657799|560744375|FG001|Overall Study|Withdrawal by Subject|10|||
155357382|NCT01657799|560744376|FG002|Overall Study|Withdrawal by Subject|10|||
155357383|NCT01657799|560744374|FG000|Overall Study|Lost to Follow-up|1|||
155357384|NCT01657799|560744375|FG001|Overall Study|Lost to Follow-up|0|||
155357385|NCT01657799|560744376|FG002|Overall Study|Lost to Follow-up|1|||
155357386|NCT01657799|560744374|FG000|Overall Study|Disease Progression|2|||
155357387|NCT01657799|560744375|FG001|Overall Study|Disease Progression|4|||
155357388|NCT01657799|560744376|FG002|Overall Study|Disease Progression|4|||
155357389|NCT01657799|560744374|FG000|Overall Study|Progressive Disease Clinical|7|||
155357390|NCT01657799|560744375|FG001|Overall Study|Progressive Disease Clinical|4|||
155357391|NCT01657799|560744376|FG002|Overall Study|Progressive Disease Clinical|7|||
155357392|NCT01657799|560744374|FG000|Overall Study|Radiographic & Clinical Progression|16|||
155357393|NCT01657799|560744375|FG001|Overall Study|Radiographic & Clinical Progression|11|||
155357394|NCT01657799|560744376|FG002|Overall Study|Radiographic & Clinical Progression|15|||
155357395|NCT01657799|560744374|FG000|Overall Study|Other|52|||
155357396|NCT01657799|560744375|FG001|Overall Study|Other|62|||
155357397|NCT01657799|560744376|FG002|Overall Study|Other|49|||
155357398|NCT00174447|560744377|FG000|Overall Study|Adverse Event|19|||
155357399|NCT00174447|560744377|FG000|Overall Study|Withdrawal by Subject|15|||
155357400|NCT00174447|560744377|FG000|Overall Study|Protocol Violation|1|||
155357401|NCT00174447|560744377|FG000|Overall Study|Lack of Efficacy|1|||
155357402|NCT00174447|560744377|FG000|Overall Study|Administrative reason/Other|2|||
155357403|NCT03021551|560744380|FG000|Overall Study|Equipment Issues|2|||
155357404|NCT03021551|560744380|FG000|Overall Study|Protocol Violation|1|||
155357405|NCT02229578|560744381|FG000|Overall Study|Withdrawal by Subject|1|||
155357406|NCT02229578|560744382|FG001|Overall Study|Withdrawal by Subject|3|||
155357407|NCT02229578|560744381|FG000|Overall Study|Protocol Violation|2|||
155357408|NCT02229578|560744382|FG001|Overall Study|Protocol Violation|0|||
155357409|NCT00412880|560744385|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
155357410|NCT00412880|560744385|FG000|Overall Study|Consent withdrawn|1|||
155357411|NCT00412880|560744385|FG000|Overall Study|Adverse Event|1|||
155357412|NCT00412880|560744385|FG000|Overall Study|Progressive disease|20|||
155357413|NCT02232399|560744387|FG000|Overall Study|Adverse Event|1|||
155357414|NCT02232399|560744388|FG001|Overall Study|Adverse Event|0|||
155357415|NCT02232399|560744387|FG000|Overall Study|Withdrawal by Subject|0|||
155357416|NCT02232399|560744388|FG001|Overall Study|Withdrawal by Subject|1|||
155357417|NCT02706951|560744390|FG000|Period 1|Adverse Event|1|||
155357418|NCT02706951|560744391|FG001|Period 1|Adverse Event|5|||
155357419|NCT02706951|560744392|FG002|Period 1|Adverse Event|3|||
155357420|NCT02706951|560744393|FG003|Period 1|Adverse Event|0|||
155357421|NCT02706951|560744394|FG004|Period 1|Adverse Event|0|||
155357422|NCT02706951|560744390|FG000|Period 1|Withdrawal by Subject|10|||
155357423|NCT02706951|560744391|FG001|Period 1|Withdrawal by Subject|6|||
155357424|NCT02706951|560744392|FG002|Period 1|Withdrawal by Subject|6|||
155357425|NCT02706951|560744393|FG003|Period 1|Withdrawal by Subject|0|||
155357426|NCT02706951|560744394|FG004|Period 1|Withdrawal by Subject|0|||
155357427|NCT02706951|560744390|FG000|Period 1|Lost to Follow-up|0|||
155357428|NCT02706951|560744391|FG001|Period 1|Lost to Follow-up|4|||
155357429|NCT02706951|560744392|FG002|Period 1|Lost to Follow-up|1|||
155357430|NCT02706951|560744393|FG003|Period 1|Lost to Follow-up|0|||
155357431|NCT02706951|560744394|FG004|Period 1|Lost to Follow-up|0|||
155357432|NCT02706951|560744390|FG000|Period 1|Other|2|||
155357433|NCT02706951|560744391|FG001|Period 1|Other|1|||
155357434|NCT02706951|560744392|FG002|Period 1|Other|0|||
155357435|NCT02706951|560744393|FG003|Period 1|Other|0|||
155357436|NCT02706951|560744394|FG004|Period 1|Other|0|||
155357437|NCT02706951|560744390|FG000|Period 2|Adverse Event|0|||
155357438|NCT02706951|560744391|FG001|Period 2|Adverse Event|0|||
155357439|NCT02706951|560744392|FG002|Period 2|Adverse Event|0|||
155357440|NCT02706951|560744393|FG003|Period 2|Adverse Event|25|||
155357441|NCT02706951|560744394|FG004|Period 2|Adverse Event|34|||
155357442|NCT02706951|560744390|FG000|Period 2|Withdrawal by Subject|0|||
155357443|NCT02706951|560744391|FG001|Period 2|Withdrawal by Subject|0|||
155357444|NCT02706951|560744392|FG002|Period 2|Withdrawal by Subject|0|||
155357445|NCT02706951|560744393|FG003|Period 2|Withdrawal by Subject|38|||
155357446|NCT02706951|560744394|FG004|Period 2|Withdrawal by Subject|44|||
155357447|NCT02706951|560744390|FG000|Period 2|Lost to Follow-up|0|||
155357448|NCT02706951|560744391|FG001|Period 2|Lost to Follow-up|0|||
155357449|NCT02706951|560744392|FG002|Period 2|Lost to Follow-up|0|||
155357450|NCT02706951|560744393|FG003|Period 2|Lost to Follow-up|17|||
155357451|NCT02706951|560744394|FG004|Period 2|Lost to Follow-up|9|||
155357452|NCT02706951|560744390|FG000|Period 2|COVID-19 Related|0|||
155357453|NCT02706951|560744391|FG001|Period 2|COVID-19 Related|0|||
155357454|NCT02706951|560744392|FG002|Period 2|COVID-19 Related|0|||
155357455|NCT02706951|560744393|FG003|Period 2|COVID-19 Related|1|||
155357456|NCT02706951|560744394|FG004|Period 2|COVID-19 Related|2|||
155357457|NCT02706951|560744390|FG000|Period 2|Other|0|||
155357458|NCT02706951|560744391|FG001|Period 2|Other|0|||
155357459|NCT02706951|560744392|FG002|Period 2|Other|0|||
155357460|NCT02706951|560744393|FG003|Period 2|Other|37|||
155357461|NCT02706951|560744394|FG004|Period 2|Other|31|||
155357462|NCT03603639|560744398|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357463|NCT03603639|560744399|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357464|NCT03603639|560744400|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357465|NCT03603639|560744401|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
155357466|NCT03603639|560744402|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357467|NCT03603639|560744403|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
155357468|NCT03603639|560744398|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
155357469|NCT03603639|560744399|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
155357470|NCT03603639|560744400|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
155357471|NCT03603639|560744401|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
155357472|NCT03603639|560744402|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
155357473|NCT03603639|560744403|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
155357474|NCT00551135|560744409|FG000|Overall Study|Adverse Event|1|||
155357475|NCT00551135|560744410|FG001|Overall Study|Adverse Event|0|||
155357476|NCT00551135|560744411|FG002|Overall Study|Adverse Event|1|||
155357477|NCT00551135|560744412|FG003|Overall Study|Adverse Event|1|||
155357478|NCT00551135|560744409|FG000|Overall Study|Lost to Follow-up|0|||
155357479|NCT00551135|560744410|FG001|Overall Study|Lost to Follow-up|0|||
155357480|NCT00551135|560744411|FG002|Overall Study|Lost to Follow-up|0|||
155357481|NCT00551135|560744412|FG003|Overall Study|Lost to Follow-up|1|||
155357482|NCT00551135|560744409|FG000|Overall Study|Other|3|||
155357483|NCT00551135|560744410|FG001|Overall Study|Other|2|||
155357484|NCT00551135|560744411|FG002|Overall Study|Other|1|||
155357485|NCT00551135|560744412|FG003|Overall Study|Other|2|||
155357486|NCT00551135|560744409|FG000|Overall Study|Withdrawal by Subject|1|||
155357487|NCT00551135|560744410|FG001|Overall Study|Withdrawal by Subject|0|||
155357488|NCT00551135|560744411|FG002|Overall Study|Withdrawal by Subject|3|||
155357489|NCT00551135|560744412|FG003|Overall Study|Withdrawal by Subject|1|||
155357490|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
155357491|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
155357492|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
155357493|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
155357494|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
155357495|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
155357496|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
155357497|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
155357498|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
155357499|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
155357500|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
155165738|NCT01047553|560043545|FG001|Overall Study|Withdrawal by Subject|2|||
155165739|NCT01047553|560043544|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
155357501|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
155357502|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
155357503|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
155357504|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
155357505|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
155357506|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
155357507|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
155357508|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
155357509|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
155357510|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
155357511|NCT04599855|560744413|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
155357512|NCT04599855|560744414|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
155357513|NCT04599855|560744415|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
155357514|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
155357515|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
155357516|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
155357517|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
155357518|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
155357519|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
155357520|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
155357521|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
155357522|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
155357523|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
155357524|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
155357525|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
155357526|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
155357527|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
155357528|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
155357529|NCT04599855|560744413|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
155357530|NCT04599855|560744414|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
155357531|NCT04599855|560744415|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
155357532|NCT04294667|560744416|FG000|Overall Study|Lack of Efficacy|4|||
155357533|NCT04294667|560744417|FG001|Overall Study|Lack of Efficacy|4|||
155357534|NCT04294667|560744416|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
155357535|NCT04294667|560744417|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
155357536|NCT04294667|560744416|FG000|Overall Study|Patient has a Renal Flare|1|||
155357537|NCT04294667|560744417|FG001|Overall Study|Patient has a Renal Flare|0|||
155357538|NCT04294667|560744416|FG000|Overall Study|SLE Worsening|0|||
155357539|NCT04294667|560744417|FG001|Overall Study|SLE Worsening|1|||
155357540|NCT04294667|560744416|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
155357541|NCT04294667|560744417|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
155357542|NCT04294667|560744416|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
155357543|NCT04294667|560744417|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
155357544|NCT04294667|560744416|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
155357545|NCT04294667|560744417|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
155357546|NCT04294667|560744416|FG000|Overall Study|Subject Moved to Another State|0|||
155357547|NCT04294667|560744417|FG001|Overall Study|Subject Moved to Another State|1|||
155357548|NCT04294667|560744416|FG000|Overall Study|Adverse event, serious fatal|0|||
155357549|NCT04294667|560744417|FG001|Overall Study|Adverse event, serious fatal|1|||
155357550|NCT04294667|560744416|FG000|Overall Study|Adverse event, non-fatal|3|||
155357551|NCT04294667|560744417|FG001|Overall Study|Adverse event, non-fatal|4|||
155357552|NCT02165397|560744418|FG000|Overall Study|Death|7|||
155357553|NCT02165397|560744419|FG001|Overall Study|Death|10|||
155357554|NCT02165397|560744420|FG002|Overall Study|Death|8|||
155357555|NCT02165397|560744418|FG000|Overall Study|Lost to Follow-up|1|||
155357556|NCT02165397|560744419|FG001|Overall Study|Lost to Follow-up|3|||
155357557|NCT02165397|560744420|FG002|Overall Study|Lost to Follow-up|0|||
155357558|NCT02165397|560744418|FG000|Overall Study|Withdrawal by Subject|6|||
155357559|NCT02165397|560744419|FG001|Overall Study|Withdrawal by Subject|6|||
155357560|NCT02165397|560744420|FG002|Overall Study|Withdrawal by Subject|1|||
155357561|NCT02165397|560744418|FG000|Overall Study|Other, Not Specified|0|||
155357562|NCT02165397|560744419|FG001|Overall Study|Other, Not Specified|0|||
155357563|NCT02165397|560744420|FG002|Overall Study|Other, Not Specified|1|||
155357564|NCT04799418|560744421|FG000|Overall Study|Death|1|||
155357565|NCT04799418|560744422|FG001|Overall Study|Death|1|||
155357566|NCT04799418|560744421|FG000|Overall Study|Lack of Efficacy|14|||
155357567|NCT04799418|560744422|FG001|Overall Study|Lack of Efficacy|14|||
155357568|NCT04799418|560744421|FG000|Overall Study|Withdrawal by Subject|10|||
155357569|NCT04799418|560744422|FG001|Overall Study|Withdrawal by Subject|7|||
155357570|NCT04799418|560744421|FG000|Overall Study|Adverse Event|3|||
155357571|NCT04799418|560744422|FG001|Overall Study|Adverse Event|2|||
155357572|NCT03297398|560744423|FG000|Overall Study|Sponsor's decision|6|||
155357573|NCT03297398|560744424|FG001|Overall Study|Sponsor's decision|9|||
154964878|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Other Event|41|||
155357574|NCT03297398|560744425|FG002|Overall Study|Sponsor's decision|7|||
155357575|NCT03297398|560744423|FG000|Overall Study|Adverse Event|1|||
155357576|NCT03297398|560744424|FG001|Overall Study|Adverse Event|4|||
155357577|NCT03297398|560744425|FG002|Overall Study|Adverse Event|4|||
155357578|NCT03297398|560744423|FG000|Overall Study|Withdrawal by Subject|1|||
155087240|NCT03427619|559752172|FG000|Overall Study|Lost to Follow-up|5|||
155087241|NCT03427619|559752172|FG000|Overall Study|Administrative|4|||
155087242|NCT03427619|559752172|FG000|Overall Study|Other|2|||
155087243|NCT03427619|559752172|FG000|Overall Study|Unknown or Missing Completion Status|48|||
155087244|NCT00605189|559752173|FG000|Overall Study|Adverse Event|1|||
155087245|NCT00605189|559752174|FG001|Overall Study|Adverse Event|0|||
155087246|NCT00605189|559752175|FG002|Overall Study|Adverse Event|0|||
155087247|NCT00605189|559752173|FG000|Overall Study|Other|2|||
155087248|NCT00605189|559752174|FG001|Overall Study|Other|2|||
155087249|NCT00605189|559752175|FG002|Overall Study|Other|0|||
155087250|NCT02697448|559752176|FG000|Overall Study|Protocol Violation|2|||
155087251|NCT02697448|559752177|FG001|Overall Study|Protocol Violation|4|||
155087252|NCT02697448|559752176|FG000|Overall Study|Clinical concerns during ablation|1|||
155087253|NCT02697448|559752177|FG001|Overall Study|Clinical concerns during ablation|1|||
155087254|NCT02697448|559752176|FG000|Overall Study|No data collected|2|||
155087255|NCT02697448|559752177|FG001|Overall Study|No data collected|0|||
155087256|NCT02919618|559752182|FG000|Overall Study|Death|1|||
155087257|NCT01674062|559752190|FG000|Overall Study|Insufficient Therapeutic Response|56|||
155087258|NCT01674062|559752191|FG001|Overall Study|Insufficient Therapeutic Response|26|||
155087259|NCT01674062|559752190|FG000|Overall Study|Other|8|||
155087260|NCT01674062|559752191|FG001|Overall Study|Other|1|||
155087261|NCT01674062|559752190|FG000|Overall Study|Adverse Event|1|||
155087262|NCT01674062|559752191|FG001|Overall Study|Adverse Event|1|||
155087263|NCT01674062|559752190|FG000|Overall Study|Death|0|||
155087264|NCT01674062|559752191|FG001|Overall Study|Death|1|||
155087265|NCT01674062|559752190|FG000|Overall Study|Programming Error|1|||
155087266|NCT01674062|559752191|FG001|Overall Study|Programming Error|0|||
155087267|NCT03895372|559752192|FG000|Investigational Treatment Period|Adverse Event|1|||
155087268|NCT03895372|559752193|FG001|Investigational Treatment Period|Adverse Event|0|||
155087269|NCT03895372|559752194|FG002|Investigational Treatment Period|Adverse Event|0|||
155087270|NCT03895372|559752195|FG003|Investigational Treatment Period|Adverse Event|0|||
155087271|NCT03895372|559752196|FG004|Investigational Treatment Period|Adverse Event|0|||
155087272|NCT03895372|559752197|FG005|Investigational Treatment Period|Adverse Event|0|||
155087273|NCT03895372|559752198|FG006|Investigational Treatment Period|Adverse Event|4|||
155087274|NCT03895372|559752199|FG007|Investigational Treatment Period|Adverse Event|3|||
155087275|NCT03895372|559752192|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
154964879|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Other Event|58|||
154964880|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Other Event|0|||
154964881|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Other Event|0|||
154964882|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
154964883|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
154964884|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
154964885|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
154964886|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
154964887|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
154964888|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
154964889|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
154964890|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
154964891|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
154964892|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
154964893|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
154964894|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
154964895|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
154964896|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
154964897|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
154964898|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
154964899|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
155087276|NCT03895372|559752193|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
155087277|NCT03895372|559752194|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
155087278|NCT03895372|559752195|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
155087279|NCT03895372|559752196|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
155357579|NCT03297398|560744424|FG001|Overall Study|Withdrawal by Subject|2|||
155357580|NCT03297398|560744425|FG002|Overall Study|Withdrawal by Subject|2|||
155357581|NCT03297398|560744423|FG000|Overall Study|Protocol Violation|0|||
155357582|NCT03297398|560744424|FG001|Overall Study|Protocol Violation|2|||
155357583|NCT03297398|560744425|FG002|Overall Study|Protocol Violation|0|||
155357584|NCT03297398|560744423|FG000|Overall Study|Physician Decision|0|||
155357585|NCT03297398|560744424|FG001|Overall Study|Physician Decision|0|||
155357586|NCT03297398|560744425|FG002|Overall Study|Physician Decision|1|||
155357587|NCT03297398|560744423|FG000|Overall Study|Lost to Follow-up|0|||
155357588|NCT03297398|560744424|FG001|Overall Study|Lost to Follow-up|0|||
155357589|NCT03297398|560744425|FG002|Overall Study|Lost to Follow-up|1|||
155357590|NCT00611715|560744430|FG000|Overall Study|Disease Progression|24|||
155357591|NCT00611715|560744431|FG001|Overall Study|Disease Progression|4|||
155357592|NCT00611715|560744430|FG000|Overall Study|Withdrawal by Subject|5|||
155357593|NCT00611715|560744431|FG001|Overall Study|Withdrawal by Subject|1|||
155357594|NCT00611715|560744430|FG000|Overall Study|Adverse Event|9|||
155357595|NCT00611715|560744431|FG001|Overall Study|Adverse Event|1|||
155357596|NCT00611715|560744430|FG000|Overall Study|Death|1|||
155357597|NCT00611715|560744431|FG001|Overall Study|Death|0|||
155357598|NCT00611715|560744430|FG000|Overall Study|two patients are still on treatment|2|||
155357599|NCT00611715|560744431|FG001|Overall Study|two patients are still on treatment|0|||
155357600|NCT00107978|560744432|FG000|Overall Study|Adverse Event|1|||
155357601|NCT00107978|560744433|FG001|Overall Study|Adverse Event|5|||
155357602|NCT00107978|560744432|FG000|Overall Study|Death|3|||
155357603|NCT00107978|560744433|FG001|Overall Study|Death|3|||
155357604|NCT00107978|560744432|FG000|Overall Study|Lost to Follow-up|20|||
155357605|NCT00107978|560744433|FG001|Overall Study|Lost to Follow-up|28|||
155357606|NCT00107978|560744432|FG000|Overall Study|Withdrawal by Subject|4|||
155357607|NCT00107978|560744433|FG001|Overall Study|Withdrawal by Subject|9|||
155357608|NCT00107978|560744432|FG000|Overall Study|Protocol Violation|0|||
155357609|NCT00107978|560744433|FG001|Overall Study|Protocol Violation|1|||
155357610|NCT00107978|560744432|FG000|Overall Study|Other|5|||
155357611|NCT00107978|560744433|FG001|Overall Study|Other|4|||
155357612|NCT02669407|560744434|FG000|Overall Study|Physician Decision|3|||
155357613|NCT01841697|560744435|FG000|Overall Study|Death|0|||
155357614|NCT01841697|560744436|FG001|Overall Study|Death|1|||
154964900|NCT00205777|559297552|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
154964901|NCT00205777|559297553|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
154964902|NCT00205777|559297554|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
155357615|NCT01841697|560744435|FG000|Overall Study|Lost to Follow-up|4|||
155357616|NCT01841697|560744436|FG001|Overall Study|Lost to Follow-up|1|||
155357617|NCT01841697|560744435|FG000|Overall Study|Withdrawal by Subject|16|||
155357618|NCT01841697|560744436|FG001|Overall Study|Withdrawal by Subject|16|||
154964903|NCT00205777|559297555|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
154964904|NCT00205777|559297556|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
155087280|NCT03895372|559752197|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
155087281|NCT03895372|559752198|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
155357619|NCT00727415|560744437|FG000|Phase I|Dose Limiting Toxicity|2|||
155357620|NCT03634839|560744442|FG000|First Intervention (2 Hours)|Adverse Event|0|||
155357621|NCT03634839|560744443|FG001|First Intervention (2 Hours)|Adverse Event|2|||
155087282|NCT03895372|559752199|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
155087283|NCT03895372|559752192|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
155087284|NCT03895372|559752193|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
155087285|NCT03895372|559752194|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
155087286|NCT03895372|559752195|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
155087287|NCT03895372|559752196|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
155087288|NCT03895372|559752197|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
155087289|NCT03895372|559752198|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
155087290|NCT03895372|559752199|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
155087291|NCT03895372|559752192|FG000|Investigational Treatment Period|Other|0|||
155087292|NCT03895372|559752193|FG001|Investigational Treatment Period|Other|0|||
155087293|NCT03895372|559752194|FG002|Investigational Treatment Period|Other|0|||
155087294|NCT03895372|559752195|FG003|Investigational Treatment Period|Other|0|||
155087295|NCT03895372|559752196|FG004|Investigational Treatment Period|Other|0|||
155087296|NCT03895372|559752197|FG005|Investigational Treatment Period|Other|1|||
155087297|NCT03895372|559752198|FG006|Investigational Treatment Period|Other|0|||
155087298|NCT03895372|559752199|FG007|Investigational Treatment Period|Other|2|||
155087299|NCT03895372|559752192|FG000|Investigational Treatment Period|Protocol Violation|0|||
155087300|NCT03895372|559752193|FG001|Investigational Treatment Period|Protocol Violation|0|||
155087301|NCT03895372|559752194|FG002|Investigational Treatment Period|Protocol Violation|0|||
155087302|NCT03895372|559752195|FG003|Investigational Treatment Period|Protocol Violation|1|||
155087303|NCT03895372|559752196|FG004|Investigational Treatment Period|Protocol Violation|0|||
155087304|NCT03895372|559752197|FG005|Investigational Treatment Period|Protocol Violation|0|||
155087305|NCT03895372|559752198|FG006|Investigational Treatment Period|Protocol Violation|0|||
155087306|NCT03895372|559752199|FG007|Investigational Treatment Period|Protocol Violation|0|||
155087307|NCT03895372|559752192|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
155087308|NCT03895372|559752193|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
155087309|NCT03895372|559752194|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
155087310|NCT03895372|559752195|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
155087311|NCT03895372|559752196|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
155087312|NCT03895372|559752197|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
155087313|NCT03895372|559752198|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
155087314|NCT03895372|559752199|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
155087315|NCT03895372|559752192|FG000|Extension Treatment Period|Adverse Event|0|||
155087316|NCT03895372|559752193|FG001|Extension Treatment Period|Adverse Event|1|||
155087317|NCT03895372|559752194|FG002|Extension Treatment Period|Adverse Event|0|||
155087318|NCT03895372|559752195|FG003|Extension Treatment Period|Adverse Event|1|||
155087319|NCT03895372|559752196|FG004|Extension Treatment Period|Adverse Event|0|||
155087320|NCT03895372|559752197|FG005|Extension Treatment Period|Adverse Event|0|||
155087321|NCT03895372|559752198|FG006|Extension Treatment Period|Adverse Event|3|||
155087322|NCT03895372|559752199|FG007|Extension Treatment Period|Adverse Event|3|||
155087323|NCT03895372|559752192|FG000|Extension Treatment Period|Other|1|||
155087324|NCT03895372|559752193|FG001|Extension Treatment Period|Other|3|||
155165740|NCT01047553|560043545|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
155165741|NCT01047553|560043544|FG000|Overall Study|Lost to Follow-up|1|||
155165742|NCT01047553|560043545|FG001|Overall Study|Lost to Follow-up|0|||
155357622|NCT00350298|560744444|FG000|Overall Study|Death|7|||
155357623|NCT00350298|560744445|FG001|Overall Study|Death|8|||
155357624|NCT00350298|560744444|FG000|Overall Study|Lost to Follow-up|1|||
155357625|NCT00350298|560744445|FG001|Overall Study|Lost to Follow-up|2|||
155357626|NCT00350298|560744444|FG000|Overall Study|Withdrawal by Subject|1|||
155357627|NCT00350298|560744445|FG001|Overall Study|Withdrawal by Subject|3|||
155357628|NCT00233389|560744448|FG000|Overall Study|Adverse Event|5|||
155357629|NCT00233389|560744449|FG001|Overall Study|Adverse Event|5|||
155357630|NCT00233389|560744448|FG000|Overall Study|Lack of Efficacy|11|||
155357631|NCT00233389|560744449|FG001|Overall Study|Lack of Efficacy|8|||
155357632|NCT00233389|560744448|FG000|Overall Study|Lost to Follow-up|1|||
155357633|NCT00233389|560744449|FG001|Overall Study|Lost to Follow-up|1|||
155357634|NCT00233389|560744448|FG000|Overall Study|Physician Decision|1|||
155357635|NCT00233389|560744449|FG001|Overall Study|Physician Decision|0|||
155357636|NCT00233389|560744448|FG000|Overall Study|Protocol Violation|0|||
155357637|NCT00233389|560744449|FG001|Overall Study|Protocol Violation|1|||
155087325|NCT03895372|559752194|FG002|Extension Treatment Period|Other|0|||
155357638|NCT00233389|560744448|FG000|Overall Study|Withdrawal by Subject|0|||
155357639|NCT00233389|560744449|FG001|Overall Study|Withdrawal by Subject|1|||
155087326|NCT03895372|559752195|FG003|Extension Treatment Period|Other|0|||
155087327|NCT03895372|559752196|FG004|Extension Treatment Period|Other|1|||
155165743|NCT01047553|560043544|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
155357640|NCT00719043|560744455|FG000|Overall Study|Adverse Event|5|||
155357641|NCT00719043|560744456|FG001|Overall Study|Adverse Event|1|||
155357642|NCT00719043|560744457|FG002|Overall Study|Adverse Event|2|||
155357643|NCT00719043|560744458|FG003|Overall Study|Adverse Event|2|||
155357644|NCT00719043|560744459|FG004|Overall Study|Adverse Event|1|||
155357645|NCT00719043|560744460|FG005|Overall Study|Adverse Event|4|||
155357646|NCT00719043|560744461|FG006|Overall Study|Adverse Event|4|||
155357647|NCT00719043|560744455|FG000|Overall Study|Lost to Follow-up|14|||
155357648|NCT00719043|560744456|FG001|Overall Study|Lost to Follow-up|10|||
155357649|NCT00719043|560744457|FG002|Overall Study|Lost to Follow-up|8|||
155357650|NCT00719043|560744458|FG003|Overall Study|Lost to Follow-up|9|||
155357651|NCT00719043|560744459|FG004|Overall Study|Lost to Follow-up|10|||
155357652|NCT00719043|560744460|FG005|Overall Study|Lost to Follow-up|9|||
155357653|NCT00719043|560744461|FG006|Overall Study|Lost to Follow-up|9|||
155357654|NCT00719043|560744455|FG000|Overall Study|Protocol Violation|0|||
155357655|NCT00719043|560744456|FG001|Overall Study|Protocol Violation|0|||
155357656|NCT00719043|560744457|FG002|Overall Study|Protocol Violation|0|||
155357657|NCT00719043|560744458|FG003|Overall Study|Protocol Violation|0|||
155357658|NCT00719043|560744459|FG004|Overall Study|Protocol Violation|0|||
155357659|NCT00719043|560744460|FG005|Overall Study|Protocol Violation|1|||
155357660|NCT00719043|560744461|FG006|Overall Study|Protocol Violation|0|||
155357661|NCT00719043|560744455|FG000|Overall Study|Other|1|||
155357662|NCT00719043|560744456|FG001|Overall Study|Other|0|||
155357663|NCT00719043|560744457|FG002|Overall Study|Other|1|||
155357664|NCT00719043|560744458|FG003|Overall Study|Other|2|||
155357665|NCT00719043|560744459|FG004|Overall Study|Other|0|||
155357666|NCT00719043|560744460|FG005|Overall Study|Other|2|||
155357667|NCT00719043|560744461|FG006|Overall Study|Other|1|||
155357668|NCT00719043|560744455|FG000|Overall Study|Withdrawal by Subject|12|||
155357669|NCT00719043|560744456|FG001|Overall Study|Withdrawal by Subject|14|||
155357670|NCT00719043|560744457|FG002|Overall Study|Withdrawal by Subject|9|||
155357671|NCT00719043|560744458|FG003|Overall Study|Withdrawal by Subject|10|||
155357672|NCT00719043|560744459|FG004|Overall Study|Withdrawal by Subject|16|||
155357673|NCT00719043|560744460|FG005|Overall Study|Withdrawal by Subject|18|||
155357674|NCT00719043|560744461|FG006|Overall Study|Withdrawal by Subject|14|||
155357675|NCT01588366|560744464|FG000|Overall Study|Adverse Event|0|||
155357676|NCT01588366|560744465|FG001|Overall Study|Adverse Event|1|||
155357677|NCT01588366|560744466|FG002|Overall Study|Adverse Event|0|||
155357678|NCT01588366|560744467|FG003|Overall Study|Adverse Event|1|||
155357679|NCT01588366|560744468|FG004|Overall Study|Adverse Event|0|||
155357680|NCT01588366|560744469|FG005|Overall Study|Adverse Event|2|||
155357681|NCT00302159|560744470|FG000|Overall Study|pt declined before treatment started|1|||
155357682|NCT00302159|560744470|FG000|Overall Study|pt started Avastin|1|||
155357683|NCT04962698|560744473|FG000|Motor Imagery|Technical difficulty|1|||
154964905|NCT00205777|559297557|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
155357684|NCT04962698|560744474|FG001|Motor Imagery|Technical difficulty|0|||
155357685|NCT04962698|560744473|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
155357686|NCT04962698|560744474|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
154964906|NCT00205777|559297552|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
154964907|NCT00205777|559297553|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
155087328|NCT03895372|559752197|FG005|Extension Treatment Period|Other|0|||
155357687|NCT04962698|560744473|FG000|Kinesthetic MI|Technical difficulty|1|||
155357688|NCT04962698|560744474|FG001|Kinesthetic MI|Technical difficulty|0|||
155357689|NCT04962698|560744473|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
155357690|NCT04962698|560744474|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
155357691|NCT04962698|560744473|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
155357692|NCT04962698|560744474|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
155357693|NCT04962698|560744473|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
155357694|NCT04962698|560744474|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
155357695|NCT04962698|560744473|FG000|Virtual-hand Interaction|Technical difficulty|1|||
155357696|NCT04962698|560744474|FG001|Virtual-hand Interaction|Technical difficulty|0|||
155357697|NCT04962698|560744473|FG000|Robotic Action Observation|Technical difficulty|1|||
155357698|NCT04962698|560744474|FG001|Robotic Action Observation|Technical difficulty|0|||
155357699|NCT04962698|560744473|FG000|Rest|Technical difficulty|1|||
155357700|NCT04962698|560744474|FG001|Rest|Technical difficulty|0|||
155357701|NCT04962698|560744473|FG000|Rest|Exclusion criteria met after enrollment|0|||
155357702|NCT04962698|560744474|FG001|Rest|Exclusion criteria met after enrollment|2|||
155357703|NCT00853229|560744475|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
155357704|NCT00853229|560744476|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
155357705|NCT00585975|560744480|FG000|Overall Study|Withdrawal by Subject|3|||
155357706|NCT00585975|560744481|FG001|Overall Study|Withdrawal by Subject|3|||
155357707|NCT00585975|560744480|FG000|Overall Study|Lost to Follow-up|2|||
155357708|NCT00585975|560744481|FG001|Overall Study|Lost to Follow-up|1|||
155357709|NCT00585975|560744480|FG000|Overall Study|Enrollment met/over-enrolled|10|||
155357710|NCT00585975|560744481|FG001|Overall Study|Enrollment met/over-enrolled|9|||
155357711|NCT03082612|560744482|FG000|Overall Study|Lost to Follow-up|2|||
155357712|NCT03082612|560744483|FG001|Overall Study|Lost to Follow-up|0|||
155357713|NCT00952848|560744488|FG000|Overall Study|Withdrawal by Subject|4|||
155357714|NCT02413593|560744489|FG000|Overall Study|Lost to Follow-up|3|||
155357715|NCT02413593|560744489|FG000|Overall Study|Adverse Event|1|||
155357716|NCT03845075|560744490|FG000|Part 1 - DB|Withdrawal by Subject|1|||
155357717|NCT03845075|560744491|FG001|Part 1 - DB|Withdrawal by Subject|1|||
155357718|NCT03845075|560744492|FG002|Part 1 - DB|Withdrawal by Subject|0|||
155357719|NCT03845075|560744493|FG003|Part 1 - DB|Withdrawal by Subject|0|||
155357720|NCT03845075|560744490|FG000|Part 1 - DB|Adverse Event|0|||
155357721|NCT03845075|560744491|FG001|Part 1 - DB|Adverse Event|1|||
155357722|NCT03845075|560744492|FG002|Part 1 - DB|Adverse Event|0|||
155357723|NCT03845075|560744493|FG003|Part 1 - DB|Adverse Event|0|||
155087329|NCT03895372|559752198|FG006|Extension Treatment Period|Other|0|||
155087330|NCT03895372|559752199|FG007|Extension Treatment Period|Other|2|||
155087331|NCT03895372|559752192|FG000|Extension Treatment Period|Pregnancy|0|||
155087332|NCT03895372|559752193|FG001|Extension Treatment Period|Pregnancy|0|||
155087333|NCT03895372|559752194|FG002|Extension Treatment Period|Pregnancy|0|||
155087334|NCT03895372|559752195|FG003|Extension Treatment Period|Pregnancy|0|||
155087335|NCT03895372|559752196|FG004|Extension Treatment Period|Pregnancy|1|||
155087336|NCT03895372|559752197|FG005|Extension Treatment Period|Pregnancy|0|||
155087337|NCT03895372|559752198|FG006|Extension Treatment Period|Pregnancy|0|||
155087338|NCT03895372|559752199|FG007|Extension Treatment Period|Pregnancy|0|||
155087339|NCT03895372|559752192|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
155087340|NCT03895372|559752193|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
155087341|NCT03895372|559752194|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155357724|NCT03845075|560744490|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
155357725|NCT03845075|560744491|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
155357726|NCT03845075|560744492|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
155357727|NCT03845075|560744493|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
155357728|NCT02564718|560744494|FG000|Overall Study|Withdrew from treatment|0|||
155357729|NCT02564718|560744495|FG001|Overall Study|Withdrew from treatment|1|||
155357730|NCT00104637|560744496|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
155357731|NCT00104637|560744497|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
155357732|NCT00857233|560744498|FG000|Overall Study|Adverse Event|24|||
155357733|NCT00857233|560744498|FG000|Overall Study|Lack of Efficacy|1|||
155357734|NCT00857233|560744498|FG000|Overall Study|Non-compliance|1|||
155357735|NCT00857233|560744498|FG000|Overall Study|Withdrawal of Consent|9|||
155357736|NCT00857233|560744498|FG000|Overall Study|Lost to Follow-up|4|||
155357737|NCT00857233|560744498|FG000|Overall Study|Nursing Home Placement|14|||
155357738|NCT00857233|560744498|FG000|Overall Study|Other Reasons|2|||
155357739|NCT01130168|560744499|FG000|Period 1|Withdrawal by Subject|0|||
155357740|NCT01130168|560744500|FG001|Period 1|Withdrawal by Subject|1|||
155357741|NCT01130168|560744501|FG002|Period 1|Withdrawal by Subject|0|||
155357742|NCT01130168|560744502|FG003|Period 1|Withdrawal by Subject|1|||
155357743|NCT01130168|560744503|FG004|Period 1|Withdrawal by Subject|0|||
155357744|NCT01130168|560744504|FG005|Period 1|Withdrawal by Subject|0|||
155357745|NCT01130168|560744499|FG000|Period 1|Discontinued For Other Reason|0|||
155357746|NCT01130168|560744500|FG001|Period 1|Discontinued For Other Reason|0|||
155357747|NCT01130168|560744501|FG002|Period 1|Discontinued For Other Reason|1|||
155357748|NCT01130168|560744502|FG003|Period 1|Discontinued For Other Reason|1|||
155357749|NCT01130168|560744503|FG004|Period 1|Discontinued For Other Reason|0|||
155357750|NCT01130168|560744504|FG005|Period 1|Discontinued For Other Reason|0|||
155357751|NCT01130168|560744499|FG000|Period 1|Adverse Event|0|||
155357752|NCT01130168|560744500|FG001|Period 1|Adverse Event|0|||
155357753|NCT01130168|560744501|FG002|Period 1|Adverse Event|0|||
155357754|NCT01130168|560744502|FG003|Period 1|Adverse Event|1|||
155357755|NCT01130168|560744503|FG004|Period 1|Adverse Event|0|||
155357756|NCT01130168|560744504|FG005|Period 1|Adverse Event|0|||
155357757|NCT02725528|560744505|FG000|Overall Study|Lost to Follow-up|1|||
155357758|NCT02725528|560744506|FG001|Overall Study|Lost to Follow-up|4|||
155357759|NCT02725528|560744505|FG000|Overall Study|Withdrawal by Subject|0|||
155357760|NCT02725528|560744506|FG001|Overall Study|Withdrawal by Subject|1|||
155357761|NCT02058836|560744507|FG000|Overall Study|Withdrawal by Subject|1|||
155357762|NCT02058836|560744508|FG001|Overall Study|Withdrawal by Subject|1|||
155357763|NCT03151551|560744514|FG000|Open-Label Treatment Period|Adverse Event|0|||
155357764|NCT03151551|560744515|FG001|Open-Label Treatment Period|Adverse Event|2|||
155357765|NCT03151551|560744514|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
155357766|NCT03151551|560744515|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
155357767|NCT03151551|560744514|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
155357768|NCT03151551|560744515|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
155357769|NCT03151551|560744514|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
155357770|NCT03151551|560744515|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
155357771|NCT03151551|560744514|FG000|Open-Label Treatment Period|Physician Decision|3|||
155357772|NCT03151551|560744515|FG001|Open-Label Treatment Period|Physician Decision|0|||
155357773|NCT03151551|560744514|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
155357774|NCT03151551|560744515|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
155357775|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
155357776|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
155357777|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
155357778|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155357779|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
155357780|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
155357781|NCT03151551|560744514|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
155357782|NCT03151551|560744515|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
155357783|NCT03526679|560746393|FG000|Overall Study|still under treatment|2|||
155357784|NCT00966264|560746394|FG000|Overall Study|Lost to Follow-up|4|||
155357785|NCT00966264|560746395|FG001|Overall Study|Lost to Follow-up|3|||
155357786|NCT02366143|560746398|FG000|Overall Study|Death|307|||
155357787|NCT02366143|560746399|FG001|Overall Study|Death|278|||
155357788|NCT02366143|560746400|FG002|Overall Study|Death|280|||
155357789|NCT02366143|560746398|FG000|Overall Study|Lost to Follow-up|2|||
155357790|NCT02366143|560746399|FG001|Overall Study|Lost to Follow-up|4|||
155357791|NCT02366143|560746400|FG002|Overall Study|Lost to Follow-up|2|||
155357792|NCT02366143|560746398|FG000|Overall Study|Physician Decision|1|||
155357793|NCT02366143|560746399|FG001|Overall Study|Physician Decision|2|||
155357794|NCT02366143|560746400|FG002|Overall Study|Physician Decision|1|||
155357795|NCT02366143|560746398|FG000|Overall Study|Protocol Violation|0|||
155357796|NCT02366143|560746399|FG001|Overall Study|Protocol Violation|0|||
155357797|NCT02366143|560746400|FG002|Overall Study|Protocol Violation|2|||
155357798|NCT02366143|560746398|FG000|Overall Study|Withdrawal by Subject|16|||
155357799|NCT02366143|560746399|FG001|Overall Study|Withdrawal by Subject|17|||
155357800|NCT02366143|560746400|FG002|Overall Study|Withdrawal by Subject|22|||
155357801|NCT02366143|560746398|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
155357802|NCT02366143|560746399|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
155165744|NCT01047553|560043545|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
154964908|NCT00205777|559297554|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
154964909|NCT00205777|559297555|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
154964910|NCT00205777|559297556|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
154964911|NCT00205777|559297557|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
154964912|NCT00205777|559297552|FG000|Completed Core Study, Entered SE I|Other Event|52|||
154964913|NCT00205777|559297553|FG001|Completed Core Study, Entered SE I|Other Event|46|||
154964914|NCT00205777|559297554|FG002|Completed Core Study, Entered SE I|Other Event|47|||
154964915|NCT00205777|559297555|FG003|Completed Core Study, Entered SE I|Other Event|50|||
154964916|NCT00205777|559297556|FG004|Completed Core Study, Entered SE I|Other Event|0|||
154964917|NCT00205777|559297557|FG005|Completed Core Study, Entered SE I|Other Event|0|||
154964918|NCT00205777|559297552|FG000|Study Extension I|Adverse Event|57|||
154964919|NCT00205777|559297553|FG001|Study Extension I|Adverse Event|0|||
154964920|NCT00205777|559297554|FG002|Study Extension I|Adverse Event|0|||
154964921|NCT00205777|559297555|FG003|Study Extension I|Adverse Event|61|||
154964922|NCT00205777|559297556|FG004|Study Extension I|Adverse Event|58|||
154964923|NCT00205777|559297557|FG005|Study Extension I|Adverse Event|0|||
154964924|NCT00205777|559297552|FG000|Study Extension I|Death|5|||
154964925|NCT00205777|559297553|FG001|Study Extension I|Death|0|||
154964926|NCT00205777|559297554|FG002|Study Extension I|Death|0|||
154964927|NCT00205777|559297555|FG003|Study Extension I|Death|1|||
154964928|NCT00205777|559297556|FG004|Study Extension I|Death|2|||
154964929|NCT00205777|559297557|FG005|Study Extension I|Death|0|||
154964930|NCT00205777|559297552|FG000|Study Extension I|Withdrawal by Subject|99|||
155165745|NCT01047553|560043544|FG000|Overall Study|PI's decision|0|||
155165746|NCT01047553|560043545|FG001|Overall Study|PI's decision|1|||
155165747|NCT02817464|560043547|FG000|Overall Study|Lost to Follow-up|1|||
155165748|NCT02817464|560043548|FG001|Overall Study|Lost to Follow-up|0|||
155165749|NCT02817464|560043547|FG000|Overall Study|Discontinued early due to personal decision|1|||
155165750|NCT02817464|560043548|FG001|Overall Study|Discontinued early due to personal decision|1|||
155165751|NCT03532451|560043553|FG000|Overall Study|Withdrawal by Subject|0|||
155165752|NCT03532451|560043554|FG001|Overall Study|Withdrawal by Subject|1|||
155165753|NCT03532451|560043553|FG000|Overall Study|Did not undergo surgery|1|||
155165754|NCT03532451|560043554|FG001|Overall Study|Did not undergo surgery|1|||
155165755|NCT02527421|560043555|FG000|Overall Study|Withdrawal by Subject|1|||
155165756|NCT02527421|560043556|FG001|Overall Study|Withdrawal by Subject|0|||
155165757|NCT02541604|560043557|FG000|Overall Study|Death|6|||
155357803|NCT02366143|560746400|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
155357804|NCT02366143|560746398|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
155357805|NCT02366143|560746399|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
155357806|NCT02366143|560746400|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
155357807|NCT02366143|560746398|FG000|Overall Study|Randomization Error|1|||
155357808|NCT02366143|560746399|FG001|Overall Study|Randomization Error|0|||
155357809|NCT02366143|560746400|FG002|Overall Study|Randomization Error|0|||
155357810|NCT02366143|560746398|FG000|Overall Study|PI Move and Site Closure|1|||
155357811|NCT02366143|560746399|FG001|Overall Study|PI Move and Site Closure|0|||
155357812|NCT02366143|560746400|FG002|Overall Study|PI Move and Site Closure|1|||
155357813|NCT02366143|560746398|FG000|Overall Study|Study Terminated By Sponsor|0|||
155357814|NCT02366143|560746399|FG001|Overall Study|Study Terminated By Sponsor|0|||
155357815|NCT02366143|560746400|FG002|Overall Study|Study Terminated By Sponsor|2|||
155357816|NCT02366143|560746398|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
155357817|NCT02366143|560746399|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
155357818|NCT02366143|560746400|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
155357819|NCT02366143|560746398|FG000|Overall Study|Patient moved to roll-over study|1|||
155357820|NCT02366143|560746399|FG001|Overall Study|Patient moved to roll-over study|19|||
155357821|NCT02366143|560746400|FG002|Overall Study|Patient moved to roll-over study|28|||
155357822|NCT02366143|560746398|FG000|Overall Study|Patient moved to commercial stock|0|||
155357823|NCT02366143|560746399|FG001|Overall Study|Patient moved to commercial stock|0|||
154964931|NCT00205777|559297553|FG001|Study Extension I|Withdrawal by Subject|0|||
154964932|NCT00205777|559297554|FG002|Study Extension I|Withdrawal by Subject|0|||
154964933|NCT00205777|559297555|FG003|Study Extension I|Withdrawal by Subject|106|||
155165758|NCT02541604|560043558|FG001|Overall Study|Death|5|||
155165759|NCT02541604|560043559|FG002|Overall Study|Death|7|||
155357824|NCT02366143|560746400|FG002|Overall Study|Patient moved to commercial stock|1|||
155357825|NCT02366143|560746398|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
155357826|NCT02366143|560746399|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
155357827|NCT02366143|560746400|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
155357828|NCT02366143|560746398|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
155357829|NCT02366143|560746399|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
155357830|NCT02366143|560746400|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
155357831|NCT02366143|560746398|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
155357832|NCT02366143|560746399|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
155357833|NCT02366143|560746400|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
155357834|NCT02366143|560746398|FG000|Overall Study|Requester's instructions|1|||
155357835|NCT02366143|560746399|FG001|Overall Study|Requester's instructions|1|||
155357836|NCT02366143|560746400|FG002|Overall Study|Requester's instructions|1|||
155357837|NCT02366143|560746398|FG000|Overall Study|Uneligible|0|||
155357838|NCT02366143|560746399|FG001|Overall Study|Uneligible|1|||
155357839|NCT02366143|560746400|FG002|Overall Study|Uneligible|0|||
155357840|NCT02366143|560746398|FG000|Overall Study|Post Trial Migration|0|||
155357841|NCT02366143|560746399|FG001|Overall Study|Post Trial Migration|1|||
155357842|NCT02366143|560746400|FG002|Overall Study|Post Trial Migration|0|||
155357843|NCT02366143|560746398|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
155357844|NCT02366143|560746399|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
155357845|NCT02366143|560746400|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
155357846|NCT02366143|560746398|FG000|Overall Study|Patient switched to PTAP|0|||
155357847|NCT02366143|560746399|FG001|Overall Study|Patient switched to PTAP|1|||
155357848|NCT02366143|560746400|FG002|Overall Study|Patient switched to PTAP|0|||
155357849|NCT02366143|560746398|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
155357850|NCT02366143|560746399|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
155357851|NCT02366143|560746400|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
155357852|NCT00575042|560746401|FG000|Overall Study|Adverse Event|2|||
155357853|NCT00575042|560746401|FG000|Overall Study|Lost to Follow-up|1|||
155357854|NCT00589303|560746406|FG000|Overall Study|Withdrawal by Subject|2|||
155357855|NCT00589303|560746407|FG001|Overall Study|Withdrawal by Subject|1|||
155357856|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357857|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
155357858|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
155357859|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
155357860|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357861|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357862|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357863|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
155357864|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357865|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
155357866|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
155357867|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
155357868|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357869|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357870|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357871|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155357872|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
155357873|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357874|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357875|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357876|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357877|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357878|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357879|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
155357880|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
155357881|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357882|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357883|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357884|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357885|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357886|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
155357887|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
155087342|NCT03895372|559752195|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
155087343|NCT03895372|559752196|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
155087344|NCT03895372|559752197|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
155087345|NCT03895372|559752198|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
155087346|NCT03895372|559752199|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
155087347|NCT03685149|559752200|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
155087348|NCT03685149|559752201|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
155087349|NCT03685149|559752200|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155087350|NCT03685149|559752201|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155087351|NCT03685149|559752200|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
155087352|NCT03685149|559752201|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
155087353|NCT03900650|559752205|FG000|Overall Study|Withdrawal by Subject|1|||
155087354|NCT03900650|559752206|FG001|Overall Study|Withdrawal by Subject|1|||
155087355|NCT03900650|559752207|FG002|Overall Study|Withdrawal by Subject|0|||
155087356|NCT03900650|559752208|FG003|Overall Study|Withdrawal by Subject|0|||
155087357|NCT03900650|559752205|FG000|Overall Study|Withdrawn by staff|1|||
155087358|NCT03900650|559752206|FG001|Overall Study|Withdrawn by staff|0|||
155087359|NCT03900650|559752207|FG002|Overall Study|Withdrawn by staff|0|||
155087360|NCT03900650|559752208|FG003|Overall Study|Withdrawn by staff|0|||
155087361|NCT02655601|559752209|FG000|Overall Study|Adverse Event|0|||
155087362|NCT02655601|559752210|FG001|Overall Study|Adverse Event|0|||
155087363|NCT02655601|559752211|FG002|Overall Study|Adverse Event|0|||
155087364|NCT02655601|559752212|FG003|Overall Study|Adverse Event|1|||
155087365|NCT02655601|559752213|FG004|Overall Study|Adverse Event|1|||
155087366|NCT02655601|559752214|FG005|Overall Study|Adverse Event|0|||
155087367|NCT02655601|559752209|FG000|Overall Study|Physician Decision|0|||
155087368|NCT02655601|559752210|FG001|Overall Study|Physician Decision|0|||
155087369|NCT02655601|559752211|FG002|Overall Study|Physician Decision|0|||
155087370|NCT02655601|559752212|FG003|Overall Study|Physician Decision|0|||
155087371|NCT02655601|559752213|FG004|Overall Study|Physician Decision|1|||
155087372|NCT02655601|559752214|FG005|Overall Study|Physician Decision|1|||
155087373|NCT02655601|559752209|FG000|Overall Study|Withdrawal by Subject|0|||
155087374|NCT02655601|559752210|FG001|Overall Study|Withdrawal by Subject|0|||
155087375|NCT02655601|559752211|FG002|Overall Study|Withdrawal by Subject|0|||
155087376|NCT02655601|559752212|FG003|Overall Study|Withdrawal by Subject|0|||
155087377|NCT02655601|559752213|FG004|Overall Study|Withdrawal by Subject|4|||
155087378|NCT02655601|559752214|FG005|Overall Study|Withdrawal by Subject|8|||
155087379|NCT02655601|559752209|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
155357888|NCT04836559|560746408|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357889|NCT04836559|560746409|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357890|NCT04836559|560746410|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357891|NCT04836559|560746411|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
155357892|NCT04836559|560746412|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357893|NCT04836559|560746413|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357894|NCT04836559|560746414|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357895|NCT04836559|560746415|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
155357896|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357897|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357898|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357899|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
155357900|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
155357901|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
155087380|NCT02655601|559752210|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155087381|NCT02655601|559752211|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155087382|NCT02655601|559752212|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155087383|NCT02655601|559752213|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155165760|NCT02541604|560043560|FG003|Overall Study|Death|2|||
155165761|NCT02541604|560043561|FG004|Overall Study|Death|9|||
155165762|NCT02541604|560043562|FG005|Overall Study|Death|8|||
155165763|NCT02541604|560043563|FG006|Overall Study|Death|9|||
155165764|NCT02541604|560043564|FG007|Overall Study|Death|9|||
155165765|NCT02541604|560043565|FG008|Overall Study|Death|3|||
155165766|NCT02541604|560043566|FG009|Overall Study|Death|4|||
155165767|NCT02541604|560043567|FG010|Overall Study|Death|2|||
155165768|NCT02541604|560043568|FG011|Overall Study|Death|3|||
155165769|NCT02541604|560043557|FG000|Overall Study|Lost to Follow-up|2|||
155165770|NCT02541604|560043558|FG001|Overall Study|Lost to Follow-up|0|||
154964934|NCT00205777|559297556|FG004|Study Extension I|Withdrawal by Subject|89|||
154964935|NCT00205777|559297557|FG005|Study Extension I|Withdrawal by Subject|0|||
154964936|NCT00205777|559297552|FG000|Study Extension I|Protocol Violation|4|||
155165771|NCT02541604|560043559|FG002|Overall Study|Lost to Follow-up|1|||
155165772|NCT02541604|560043560|FG003|Overall Study|Lost to Follow-up|0|||
155165773|NCT02541604|560043561|FG004|Overall Study|Lost to Follow-up|0|||
155165774|NCT02541604|560043562|FG005|Overall Study|Lost to Follow-up|1|||
155165775|NCT02541604|560043563|FG006|Overall Study|Lost to Follow-up|1|||
155165776|NCT02541604|560043564|FG007|Overall Study|Lost to Follow-up|0|||
155165777|NCT02541604|560043565|FG008|Overall Study|Lost to Follow-up|0|||
155165778|NCT02541604|560043566|FG009|Overall Study|Lost to Follow-up|0|||
155165779|NCT02541604|560043567|FG010|Overall Study|Lost to Follow-up|0|||
155165780|NCT02541604|560043568|FG011|Overall Study|Lost to Follow-up|0|||
155165781|NCT02541604|560043557|FG000|Overall Study|Withdrawal by Subject|2|||
155165782|NCT02541604|560043558|FG001|Overall Study|Withdrawal by Subject|0|||
155165783|NCT02541604|560043559|FG002|Overall Study|Withdrawal by Subject|1|||
155165784|NCT02541604|560043560|FG003|Overall Study|Withdrawal by Subject|0|||
155165785|NCT02541604|560043561|FG004|Overall Study|Withdrawal by Subject|1|||
155165786|NCT02541604|560043562|FG005|Overall Study|Withdrawal by Subject|1|||
155165787|NCT02541604|560043563|FG006|Overall Study|Withdrawal by Subject|0|||
155165788|NCT02541604|560043564|FG007|Overall Study|Withdrawal by Subject|0|||
155165789|NCT02541604|560043565|FG008|Overall Study|Withdrawal by Subject|1|||
155165790|NCT02541604|560043566|FG009|Overall Study|Withdrawal by Subject|0|||
155165791|NCT02541604|560043567|FG010|Overall Study|Withdrawal by Subject|0|||
154964937|NCT00205777|559297553|FG001|Study Extension I|Protocol Violation|0|||
155165792|NCT02541604|560043568|FG011|Overall Study|Withdrawal by Subject|0|||
155165793|NCT02541604|560043557|FG000|Overall Study|Study Terminated by Sponsor|1|||
155165794|NCT02541604|560043558|FG001|Overall Study|Study Terminated by Sponsor|4|||
155165795|NCT02541604|560043559|FG002|Overall Study|Study Terminated by Sponsor|2|||
155165796|NCT02541604|560043560|FG003|Overall Study|Study Terminated by Sponsor|1|||
155165797|NCT02541604|560043561|FG004|Overall Study|Study Terminated by Sponsor|0|||
155165798|NCT02541604|560043562|FG005|Overall Study|Study Terminated by Sponsor|0|||
155165799|NCT02541604|560043563|FG006|Overall Study|Study Terminated by Sponsor|0|||
155165800|NCT02541604|560043564|FG007|Overall Study|Study Terminated by Sponsor|0|||
155165801|NCT02541604|560043565|FG008|Overall Study|Study Terminated by Sponsor|0|||
155165802|NCT02541604|560043566|FG009|Overall Study|Study Terminated by Sponsor|0|||
155357902|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
155357903|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
155357904|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357905|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155087384|NCT02655601|559752214|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
155357906|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357907|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
155357908|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
155087385|NCT02014376|559752215|FG000|Overall Study|Adverse Event|1|||
155357909|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
155357910|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
155357911|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
155357912|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357913|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357914|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357915|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357916|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
155357917|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
155357918|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
155357919|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
155357920|NCT04836559|560746408|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357921|NCT04836559|560746409|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357922|NCT04836559|560746410|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357923|NCT04836559|560746411|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357924|NCT04836559|560746412|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357925|NCT04836559|560746413|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357926|NCT04836559|560746414|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
155357927|NCT04836559|560746415|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
155357928|NCT00730015|560746416|FG000|Overall Study|Adverse Event|11|||
155357929|NCT00730015|560746417|FG001|Overall Study|Adverse Event|10|||
155357930|NCT00730015|560746418|FG002|Overall Study|Adverse Event|8|||
155357931|NCT00730015|560746416|FG000|Overall Study|Protocol Violation|2|||
155357932|NCT00730015|560746417|FG001|Overall Study|Protocol Violation|6|||
155357933|NCT00730015|560746418|FG002|Overall Study|Protocol Violation|4|||
155357934|NCT00730015|560746416|FG000|Overall Study|Withdrawal by Subject|12|||
155357935|NCT00730015|560746417|FG001|Overall Study|Withdrawal by Subject|12|||
155357936|NCT00730015|560746418|FG002|Overall Study|Withdrawal by Subject|8|||
155357937|NCT00730015|560746416|FG000|Overall Study|Lost to Follow-up|4|||
155357938|NCT00730015|560746417|FG001|Overall Study|Lost to Follow-up|10|||
155357939|NCT00730015|560746418|FG002|Overall Study|Lost to Follow-up|3|||
155357940|NCT00730015|560746416|FG000|Overall Study|Lack of Efficacy|1|||
155357941|NCT00730015|560746417|FG001|Overall Study|Lack of Efficacy|2|||
155357942|NCT00730015|560746418|FG002|Overall Study|Lack of Efficacy|8|||
155357943|NCT00730015|560746416|FG000|Overall Study|Other Reason|1|||
155357944|NCT00730015|560746417|FG001|Overall Study|Other Reason|0|||
155357945|NCT00730015|560746418|FG002|Overall Study|Other Reason|1|||
155357946|NCT04978350|560746419|FG000|Overall Study|Lost to Follow-up|6|||
155357947|NCT02370251|560746420|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
155357948|NCT02370251|560746420|FG000|Overall Study|Death|4|||
155357949|NCT04469465|560746421|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
155357950|NCT04469465|560746422|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
155357951|NCT04469465|560746421|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
155357952|NCT04469465|560746422|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
155357953|NCT04469465|560746421|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
155357954|NCT04469465|560746422|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
155357955|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
155357956|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
155357957|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
155357958|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
155357959|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
155357960|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
155357961|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Death|0|||
155357962|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Death|1|||
155357963|NCT04469465|560746421|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
155087386|NCT02014376|559752216|FG001|Overall Study|Adverse Event|1|||
155087387|NCT02014376|559752217|FG002|Overall Study|Adverse Event|0|||
155357964|NCT04469465|560746422|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
155357965|NCT04120376|560746423|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
155357966|NCT04120376|560746424|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
155357967|NCT02053610|560746425|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
155357968|NCT02053610|560746426|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
155357969|NCT02053610|560746425|FG000|Overall Study|Withdrew Consent|2|||
155357970|NCT02053610|560746426|FG001|Overall Study|Withdrew Consent|9|||
155357971|NCT02053610|560746425|FG000|Overall Study|Death|5|||
155357972|NCT02053610|560746426|FG001|Overall Study|Death|5|||
155357973|NCT02053610|560746425|FG000|Overall Study|Administrative/Other|1|||
155357974|NCT02053610|560746426|FG001|Overall Study|Administrative/Other|1|||
155357975|NCT02053610|560746425|FG000|Overall Study|Disease Progression|2|||
155357976|NCT02053610|560746426|FG001|Overall Study|Disease Progression|3|||
155357977|NCT02053610|560746425|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
155357978|NCT02053610|560746426|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
155357979|NCT02053610|560746425|FG000|Overall Study|Did not Receive Treatment|4|||
155357980|NCT02053610|560746426|FG001|Overall Study|Did not Receive Treatment|2|||
155357981|NCT02053610|560746425|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155357982|NCT02053610|560746426|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155357983|NCT02053610|560746425|FG000|Overall Study|Violation of Selection Criteria|1|||
155357984|NCT02053610|560746426|FG001|Overall Study|Violation of Selection Criteria|0|||
155357985|NCT01165177|560746427|FG000|Overall Study|Serious Adverse Event|227|||
155357986|NCT01165177|560746428|FG001|Overall Study|Serious Adverse Event|235|||
155357987|NCT01165177|560746427|FG000|Overall Study|Withdrawal by Subject|368|||
155357988|NCT01165177|560746428|FG001|Overall Study|Withdrawal by Subject|354|||
155357989|NCT01165177|560746427|FG000|Overall Study|Protocol Violation|19|||
155357990|NCT01165177|560746428|FG001|Overall Study|Protocol Violation|21|||
155357991|NCT01165177|560746427|FG000|Overall Study|Non-serious adverse event|30|||
155357992|NCT01165177|560746428|FG001|Overall Study|Non-serious adverse event|18|||
155357993|NCT01165177|560746427|FG000|Overall Study|Other unspecified reasons|47|||
155357994|NCT01165177|560746428|FG001|Overall Study|Other unspecified reasons|35|||
155357995|NCT01165177|560746427|FG000|Overall Study|Suspected HZ episode|0|||
155357996|NCT01165177|560746428|FG001|Overall Study|Suspected HZ episode|2|||
155357997|NCT01165177|560746427|FG000|Overall Study|Lost to Follow-up|183|||
155357998|NCT01165177|560746428|FG001|Overall Study|Lost to Follow-up|194|||
155357999|NCT01165177|560746427|FG000|Overall Study|Migrated/ moved from study area|48|||
155358000|NCT01165177|560746428|FG001|Overall Study|Migrated/ moved from study area|43|||
155358001|NCT00126659|560746429|FG000|Overall Study|Adverse Event|0|||
155358002|NCT00126659|560746430|FG001|Overall Study|Adverse Event|0|||
155358003|NCT00126659|560746431|FG002|Overall Study|Adverse Event|2|||
155358004|NCT00490945|560746442|FG000|Overall Study|Adverse Event|0|||
155358005|NCT00490945|560746443|FG001|Overall Study|Adverse Event|1|||
155358006|NCT00490945|560746444|FG002|Overall Study|Adverse Event|0|||
155358007|NCT00490945|560746445|FG003|Overall Study|Adverse Event|0|||
155358008|NCT00490945|560746446|FG004|Overall Study|Adverse Event|0|||
155358009|NCT02312206|560746457|FG000|Overall Study|Adverse Event|3|||
155358010|NCT02312206|560746458|FG001|Overall Study|Adverse Event|6|||
155358011|NCT02312206|560746457|FG000|Overall Study|Withdrawal by Subject|6|||
155358012|NCT02312206|560746458|FG001|Overall Study|Withdrawal by Subject|6|||
155358013|NCT02312206|560746457|FG000|Overall Study|Physician Decision|7|||
155358014|NCT02312206|560746458|FG001|Overall Study|Physician Decision|6|||
155358015|NCT02312206|560746457|FG000|Overall Study|Death|31|||
155358016|NCT02312206|560746458|FG001|Overall Study|Death|36|||
155358017|NCT02312206|560746457|FG000|Overall Study|Study Terminated by Sponsor|81|||
155358018|NCT02312206|560746458|FG001|Overall Study|Study Terminated by Sponsor|74|||
155358019|NCT02312206|560746457|FG000|Overall Study|Patient transferred to hospice|0|||
155358020|NCT02312206|560746458|FG001|Overall Study|Patient transferred to hospice|1|||
155358021|NCT02312206|560746457|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
155358022|NCT02312206|560746458|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
155358023|NCT02312206|560746457|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
155358024|NCT02312206|560746458|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
155358025|NCT02312206|560746457|FG000|Overall Study|Disease Progression|1|||
155358026|NCT02312206|560746458|FG001|Overall Study|Disease Progression|0|||
155358027|NCT01006616|560746461|FG000|Period 1 (6 Months)|Adverse Event|10|||
155358028|NCT01006616|560746462|FG001|Period 1 (6 Months)|Adverse Event|31|||
155087388|NCT02014376|559752215|FG000|Overall Study|Lost to Follow-up|2|||
155358029|NCT01006616|560746463|FG002|Period 1 (6 Months)|Adverse Event|37|||
155358030|NCT01006616|560746464|FG003|Period 1 (6 Months)|Adverse Event|9|||
155358031|NCT01006616|560746461|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
155358032|NCT01006616|560746462|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
155358033|NCT01006616|560746463|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
155358034|NCT01006616|560746464|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
155358035|NCT01006616|560746461|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
155358036|NCT01006616|560746462|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
155358037|NCT01006616|560746463|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
155358038|NCT01006616|560746464|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
155087389|NCT02014376|559752216|FG001|Overall Study|Lost to Follow-up|0|||
155087390|NCT02014376|559752217|FG002|Overall Study|Lost to Follow-up|0|||
155087391|NCT04642079|559752222|FG000|Overall Study|Lost to Follow-up|2|||
155087392|NCT04642079|559752223|FG001|Overall Study|Lost to Follow-up|5|||
155087393|NCT04642079|559752224|FG002|Overall Study|Lost to Follow-up|2|||
155087394|NCT04642079|559752225|FG003|Overall Study|Lost to Follow-up|0|||
155087395|NCT04642079|559752222|FG000|Overall Study|Withdrawal by Subject|0|||
155087396|NCT04642079|559752223|FG001|Overall Study|Withdrawal by Subject|4|||
155087397|NCT04642079|559752224|FG002|Overall Study|Withdrawal by Subject|1|||
155087398|NCT04642079|559752225|FG003|Overall Study|Withdrawal by Subject|2|||
155087399|NCT04642079|559752222|FG000|Overall Study|Other|0|||
155087400|NCT04642079|559752223|FG001|Overall Study|Other|0|||
155087401|NCT04642079|559752224|FG002|Overall Study|Other|0|||
155087402|NCT04642079|559752225|FG003|Overall Study|Other|1|||
155358039|NCT01006616|560746461|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
155087403|NCT04642079|559752222|FG000|Overall Study|No longer met eligibility criteria|1|||
155087404|NCT04642079|559752223|FG001|Overall Study|No longer met eligibility criteria|0|||
155087405|NCT04642079|559752224|FG002|Overall Study|No longer met eligibility criteria|1|||
155087406|NCT04642079|559752225|FG003|Overall Study|No longer met eligibility criteria|1|||
155087407|NCT02226653|559752226|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
155087408|NCT02226653|559752227|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
155087409|NCT02226653|559752226|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
155087410|NCT02226653|559752227|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
155087411|NCT00759395|559752228|FG000|Overall Study|Adverse Event|1|||
155087412|NCT00759395|559752229|FG001|Overall Study|Adverse Event|0|||
155087413|NCT00759395|559752228|FG000|Overall Study|Withdrawal by Subject|1|||
155087414|NCT00759395|559752229|FG001|Overall Study|Withdrawal by Subject|0|||
155087415|NCT00759395|559752228|FG000|Overall Study|Lack of Efficacy|0|||
155087416|NCT00759395|559752229|FG001|Overall Study|Lack of Efficacy|2|||
155087417|NCT01435356|559752230|FG000|Overall Study|Adverse Event|2|||
155358040|NCT01006616|560746462|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
155358041|NCT01006616|560746463|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
155358042|NCT01006616|560746464|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
155358043|NCT01006616|560746461|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
154964938|NCT00205777|559297554|FG002|Study Extension I|Protocol Violation|0|||
154964939|NCT00205777|559297555|FG003|Study Extension I|Protocol Violation|8|||
154964940|NCT00205777|559297556|FG004|Study Extension I|Protocol Violation|8|||
154964941|NCT00205777|559297557|FG005|Study Extension I|Protocol Violation|0|||
154964942|NCT00205777|559297552|FG000|Study Extension I|Lack of Efficacy|0|||
154964943|NCT00205777|559297553|FG001|Study Extension I|Lack of Efficacy|0|||
154964944|NCT00205777|559297554|FG002|Study Extension I|Lack of Efficacy|0|||
154964945|NCT00205777|559297555|FG003|Study Extension I|Lack of Efficacy|1|||
154964946|NCT00205777|559297556|FG004|Study Extension I|Lack of Efficacy|2|||
154964947|NCT00205777|559297557|FG005|Study Extension I|Lack of Efficacy|0|||
154964948|NCT00205777|559297552|FG000|Study Extension I|Failed to return|15|||
154964949|NCT00205777|559297553|FG001|Study Extension I|Failed to return|0|||
154964950|NCT00205777|559297554|FG002|Study Extension I|Failed to return|0|||
154964951|NCT00205777|559297555|FG003|Study Extension I|Failed to return|17|||
155087418|NCT01435356|559752231|FG001|Overall Study|Adverse Event|0|||
155087419|NCT01435356|559752230|FG000|Overall Study|Disease progression/recurrence|17|||
155087420|NCT01435356|559752231|FG001|Overall Study|Disease progression/recurrence|10|||
155087421|NCT01435356|559752230|FG000|Overall Study|Protocol Violation|0|||
155087422|NCT01435356|559752231|FG001|Overall Study|Protocol Violation|1|||
155087423|NCT01435356|559752230|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
155087424|NCT01435356|559752231|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
155087425|NCT01435356|559752230|FG000|Overall Study|Withdrawal by Subject|1|||
155165803|NCT02541604|560043567|FG010|Overall Study|Study Terminated by Sponsor|0|||
155358044|NCT01006616|560746462|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
155358045|NCT01006616|560746463|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
154964952|NCT00205777|559297556|FG004|Study Extension I|Failed to return|13|||
154964953|NCT00205777|559297557|FG005|Study Extension I|Failed to return|0|||
154964954|NCT00205777|559297552|FG000|Study Extension I|Other Event|34|||
154964955|NCT00205777|559297553|FG001|Study Extension I|Other Event|0|||
154964956|NCT00205777|559297554|FG002|Study Extension I|Other Event|0|||
154964957|NCT00205777|559297555|FG003|Study Extension I|Other Event|34|||
154964958|NCT00205777|559297556|FG004|Study Extension I|Other Event|29|||
154964959|NCT00205777|559297557|FG005|Study Extension I|Other Event|0|||
154964960|NCT00205777|559297552|FG000|Study Extension I|Withdrawn as per protocol|0|||
155087426|NCT01435356|559752231|FG001|Overall Study|Withdrawal by Subject|1|||
155087427|NCT01435356|559752230|FG000|Overall Study|Facial palsy|1|||
155087428|NCT01435356|559752231|FG001|Overall Study|Facial palsy|0|||
155087429|NCT01435356|559752230|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
155087430|NCT01435356|559752231|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
155087431|NCT01435356|559752230|FG000|Overall Study|Physician Decision|1|||
155087432|NCT01435356|559752231|FG001|Overall Study|Physician Decision|0|||
155358046|NCT01006616|560746464|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
155358047|NCT01006616|560746461|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
155358048|NCT01006616|560746462|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
155358049|NCT01006616|560746463|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
155358050|NCT01006616|560746464|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
155358051|NCT01006616|560746461|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
155358052|NCT01006616|560746462|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
155358053|NCT01006616|560746463|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
155358054|NCT01006616|560746464|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
155358055|NCT01006616|560746461|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
155358056|NCT01006616|560746462|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
155358057|NCT01006616|560746463|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
155358058|NCT01006616|560746464|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
155358059|NCT01006616|560746461|FG000|Period 1 (6 Months)|Not Treated|0|||
155358060|NCT01006616|560746462|FG001|Period 1 (6 Months)|Not Treated|0|||
155358061|NCT01006616|560746463|FG002|Period 1 (6 Months)|Not Treated|1|||
155358062|NCT01006616|560746464|FG003|Period 1 (6 Months)|Not Treated|1|||
155358063|NCT01006616|560746461|FG000|Period 2 (18 Months)|Adverse Event|6|||
155358064|NCT01006616|560746462|FG001|Period 2 (18 Months)|Adverse Event|6|||
155358065|NCT01006616|560746463|FG002|Period 2 (18 Months)|Adverse Event|6|||
155358066|NCT01006616|560746464|FG003|Period 2 (18 Months)|Adverse Event|4|||
155358067|NCT01006616|560746461|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
155358068|NCT01006616|560746462|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
155358069|NCT01006616|560746463|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
155358070|NCT01006616|560746464|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
155358071|NCT01006616|560746461|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
155358072|NCT01006616|560746462|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
155358073|NCT01006616|560746463|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
155358074|NCT01006616|560746464|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
155358075|NCT01006616|560746461|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
155358076|NCT01006616|560746462|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
155358077|NCT01006616|560746463|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
155358078|NCT01006616|560746464|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
155358079|NCT01006616|560746461|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
155358080|NCT01006616|560746462|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
155358081|NCT01006616|560746463|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
155358082|NCT01006616|560746464|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
155358083|NCT01006616|560746461|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
155358084|NCT01006616|560746462|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
155358085|NCT01006616|560746463|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
155358086|NCT01006616|560746464|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
155358087|NCT01006616|560746461|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
155358088|NCT01006616|560746462|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
155358089|NCT01006616|560746463|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
155358090|NCT01006616|560746464|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
155358091|NCT01006616|560746461|FG000|Period 2 (18 Months)|Study Terminated|63|||
155358092|NCT01006616|560746462|FG001|Period 2 (18 Months)|Study Terminated|46|||
155358093|NCT01006616|560746463|FG002|Period 2 (18 Months)|Study Terminated|44|||
155358094|NCT01006616|560746464|FG003|Period 2 (18 Months)|Study Terminated|70|||
155358095|NCT03414047|560746465|FG000|Overall Study|Adverse Event|0|||
155358096|NCT03414047|560746466|FG001|Overall Study|Adverse Event|0|||
155358097|NCT03414047|560746467|FG002|Overall Study|Adverse Event|1|||
155358098|NCT03414047|560746468|FG003|Overall Study|Adverse Event|1|||
155358099|NCT03414047|560746465|FG000|Overall Study|Physician Decision|1|||
155358100|NCT03414047|560746466|FG001|Overall Study|Physician Decision|0|||
155358101|NCT03414047|560746467|FG002|Overall Study|Physician Decision|0|||
155358102|NCT03414047|560746468|FG003|Overall Study|Physician Decision|1|||
155358103|NCT03414047|560746465|FG000|Overall Study|Withdrawal by Subject|1|||
155358104|NCT03414047|560746466|FG001|Overall Study|Withdrawal by Subject|0|||
155165804|NCT02541604|560043568|FG011|Overall Study|Study Terminated by Sponsor|0|||
155165805|NCT02541604|560043557|FG000|Overall Study|Medical condition may jeopardize safety|0|||
155165806|NCT02541604|560043558|FG001|Overall Study|Medical condition may jeopardize safety|0|||
155165807|NCT02541604|560043559|FG002|Overall Study|Medical condition may jeopardize safety|0|||
155165808|NCT02541604|560043560|FG003|Overall Study|Medical condition may jeopardize safety|0|||
155165809|NCT02541604|560043561|FG004|Overall Study|Medical condition may jeopardize safety|0|||
155165810|NCT02541604|560043562|FG005|Overall Study|Medical condition may jeopardize safety|0|||
155358105|NCT03414047|560746467|FG002|Overall Study|Withdrawal by Subject|2|||
155358106|NCT03414047|560746468|FG003|Overall Study|Withdrawal by Subject|0|||
155358107|NCT04593823|560746469|FG000|Overall Study|Withdrawal by Subject|1|||
155358108|NCT04593823|560746470|FG001|Overall Study|Withdrawal by Subject|1|||
155358109|NCT04593823|560746469|FG000|Overall Study|Lost to Follow-up|0|||
155358110|NCT04593823|560746470|FG001|Overall Study|Lost to Follow-up|1|||
155087433|NCT01435356|559752230|FG000|Overall Study|Patient decision|3|||
155087434|NCT01435356|559752231|FG001|Overall Study|Patient decision|0|||
155087435|NCT01435356|559752230|FG000|Overall Study|Patient moved to another city|1|||
155358111|NCT00992992|560746476|FG000|Overall Study|Lost to Follow-up|3|||
155358112|NCT00992992|560746476|FG000|Overall Study|Death|16|||
155358113|NCT00992992|560746476|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
155358114|NCT00992992|560746476|FG000|Overall Study|Sponsor Closed the Study|4|||
155358115|NCT00217022|560746478|FG000|Overall Study|Withdrawal by Subject|1|||
155358116|NCT00217022|560746479|FG001|Overall Study|Withdrawal by Subject|1|||
155358117|NCT00458393|560746480|FG000|Overall Study|Withdrawal by Subject|67|||
155358118|NCT00458393|560746481|FG001|Overall Study|Withdrawal by Subject|80|||
155358119|NCT00458393|560746480|FG000|Overall Study|Physician Decision|31|||
155358120|NCT00458393|560746481|FG001|Overall Study|Physician Decision|22|||
155358121|NCT00458393|560746480|FG000|Overall Study|Relocated|77|||
155358122|NCT00458393|560746481|FG001|Overall Study|Relocated|81|||
155358123|NCT00458393|560746480|FG000|Overall Study|Lost to Follow-up|115|||
155358124|NCT00458393|560746481|FG001|Overall Study|Lost to Follow-up|92|||
155358125|NCT00458393|560746480|FG000|Overall Study|Sites marked other on the form.|19|||
155358126|NCT00458393|560746481|FG001|Overall Study|Sites marked other on the form.|20|||
155358127|NCT02725567|560746482|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
155358128|NCT02725567|560746483|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
155358129|NCT02725567|560746482|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
155358130|NCT02725567|560746483|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
155358131|NCT02725567|560746482|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
155358132|NCT02725567|560746483|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
155358133|NCT02777242|560746485|FG000|Overall Study|Other|2|||
155358134|NCT02777242|560746485|FG000|Overall Study|Lost to Follow-up|1|||
155358135|NCT02777242|560746485|FG000|Overall Study|Multiple|1|||
155358136|NCT02777242|560746485|FG000|Overall Study|Sponsor's request|1|||
155358137|NCT02777242|560746485|FG000|Overall Study|Withdrawal by Subject|1|||
155358138|NCT05178979|560746486|FG000|Overall Study|Death|0|||
155358139|NCT05178979|560746487|FG001|Overall Study|Death|5|||
155358140|NCT05178979|560746488|FG002|Overall Study|Death|0|||
155358141|NCT05178979|560746489|FG003|Overall Study|Death|3|||
155358142|NCT05178979|560746486|FG000|Overall Study|Adverse Event|0|||
155358143|NCT05178979|560746487|FG001|Overall Study|Adverse Event|1|||
155358144|NCT05178979|560746488|FG002|Overall Study|Adverse Event|0|||
155358145|NCT05178979|560746489|FG003|Overall Study|Adverse Event|0|||
155358146|NCT05178979|560746486|FG000|Overall Study|Lost to Follow-up|1|||
155358147|NCT05178979|560746487|FG001|Overall Study|Lost to Follow-up|8|||
155358148|NCT05178979|560746488|FG002|Overall Study|Lost to Follow-up|3|||
155358149|NCT05178979|560746489|FG003|Overall Study|Lost to Follow-up|8|||
155358150|NCT00817336|560746491|FG000|Overall Study|Withdrawal by Subject|1|||
155358151|NCT00817336|560746492|FG001|Overall Study|Withdrawal by Subject|1|||
155358152|NCT01253447|560746493|FG000|Overall Study|Adverse Event|2|||
155358153|NCT02299427|560746494|FG000|Overall Study|Withdrawal by Subject|1|||
155358154|NCT02299427|560746495|FG001|Overall Study|Withdrawal by Subject|0|||
155358155|NCT02299427|560746494|FG000|Overall Study|Lost to Follow-up|1|||
155358156|NCT02299427|560746495|FG001|Overall Study|Lost to Follow-up|3|||
155358157|NCT02299427|560746494|FG000|Overall Study|not adherent to dog website use|21|||
155358158|NCT02299427|560746495|FG001|Overall Study|not adherent to dog website use|0|||
155358159|NCT02108652|560746496|FG000|Overall Study|Death|253|||
155358160|NCT02108652|560746496|FG000|Overall Study|Lost to Follow-up|2|||
155358161|NCT02108652|560746496|FG000|Overall Study|Withdrawal by Subject|16|||
155087436|NCT01435356|559752231|FG001|Overall Study|Patient moved to another city|1|||
155087437|NCT02796651|559752232|FG000|Overall Study|Adverse Event|6|||
155087438|NCT02796651|559752232|FG000|Overall Study|Lost to Follow-up|1|||
155087439|NCT02796651|559752232|FG000|Overall Study|Withdrawal by Subject|4|||
155087440|NCT02796651|559752232|FG000|Overall Study|Protocol Violation|4|||
155087441|NCT02796651|559752232|FG000|Overall Study|Lack of Efficacy|1|||
155087442|NCT02796651|559752232|FG000|Overall Study|Other|10|||
155087443|NCT02251041|559752236|FG000|Overall Study|Did not receive intervention|15|||
155087444|NCT02251041|559752237|FG001|Overall Study|Did not receive intervention|4|||
155358162|NCT02108652|560746496|FG000|Overall Study|Study Terminated By Sponsor|31|||
155358163|NCT02108652|560746496|FG000|Overall Study|Non-Compliance|1|||
155358164|NCT02108652|560746496|FG000|Overall Study|Physician Decision|6|||
155358165|NCT02108652|560746496|FG000|Overall Study|Progression Of Disease|1|||
155358166|NCT01182181|560746504|FG000|First Intervention|Adverse Event|1|||
155358167|NCT01182181|560746505|FG001|First Intervention|Adverse Event|0|||
155358168|NCT01182181|560746504|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
155358169|NCT01182181|560746505|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
155358170|NCT04706793|560746509|FG000|Treatment|Disease worsening|10|||
155358171|NCT04706793|560746510|FG001|Treatment|Disease worsening|10|||
155087445|NCT00526799|559752240|FG000|Overall Study|Withdrawal by Subject|1|||
155087446|NCT00526799|559752241|FG001|Overall Study|Withdrawal by Subject|0|||
155087447|NCT00526799|559752240|FG000|Overall Study|Intercurrent Complicating Disease|0|||
155087448|NCT00526799|559752241|FG001|Overall Study|Intercurrent Complicating Disease|1|||
155358172|NCT04706793|560746509|FG000|Follow-up|Lack of Efficacy|1|||
155358173|NCT04706793|560746510|FG001|Follow-up|Lack of Efficacy|0|||
155358174|NCT04706793|560746509|FG000|Follow-up|Disease worsening|8|||
155358175|NCT04706793|560746510|FG001|Follow-up|Disease worsening|10|||
155358176|NCT04706793|560746509|FG000|Follow-up|Adverse Event|1|||
155358177|NCT04706793|560746510|FG001|Follow-up|Adverse Event|0|||
155358178|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
155358179|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
155358180|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
155358181|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
155358182|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
155358183|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
155358184|NCT00823836|560746513|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
155358185|NCT00823836|560746514|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
155358186|NCT00823836|560746513|FG000|Long-term Phase|Adverse Event|3|||
155358187|NCT00823836|560746514|FG001|Long-term Phase|Adverse Event|2|||
155358188|NCT00823836|560746513|FG000|Long-term Phase|Physician Decision|1|||
155358189|NCT00823836|560746514|FG001|Long-term Phase|Physician Decision|2|||
155358190|NCT00823836|560746513|FG000|Long-term Phase|Withdrawal by Subject|1|||
155358191|NCT00823836|560746514|FG001|Long-term Phase|Withdrawal by Subject|1|||
155358192|NCT00745498|560746517|FG000|Overall Study|Lost to Follow-up|1|||
155358193|NCT00745498|560746518|FG001|Overall Study|Lost to Follow-up|1|||
155358194|NCT00745498|560746519|FG002|Overall Study|Lost to Follow-up|3|||
155358195|NCT00745498|560746517|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
155358196|NCT00745498|560746518|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
155358197|NCT00745498|560746519|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
155358198|NCT00745498|560746517|FG000|Overall Study|Non-PDR related VH|0|||
155358199|NCT00745498|560746518|FG001|Overall Study|Non-PDR related VH|1|||
155358200|NCT00745498|560746519|FG002|Overall Study|Non-PDR related VH|1|||
155358201|NCT00745498|560746517|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
155358202|NCT00745498|560746518|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
155358203|NCT00745498|560746519|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
155358204|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
155358205|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
155087449|NCT02298946|559752243|FG000|Overall Study|Did not receive treatment|2|||
155358206|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
155358207|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
155358208|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
155358209|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
155358210|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
155358211|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
155358212|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
155358213|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
155358214|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
155358215|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
155358216|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Other|4|||
155358217|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Other|4|||
155087450|NCT02298946|559752244|FG001|Overall Study|Did not receive treatment|0|||
155087451|NCT02298946|559752243|FG000|Overall Study|Unevaluable|2|||
155087452|NCT02298946|559752244|FG001|Overall Study|Unevaluable|1|||
155087453|NCT03034044|559752245|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
155087454|NCT04197583|559752246|FG000|Overall Study|Study Stent Replacement|34|||
155087455|NCT04197583|559752247|FG001|Overall Study|Study Stent Replacement|8|||
155087456|NCT04197583|559752246|FG000|Overall Study|Lost to Follow-up|14|||
155087457|NCT04197583|559752247|FG001|Overall Study|Lost to Follow-up|3|||
155087458|NCT04197583|559752246|FG000|Overall Study|Death|3|||
155087459|NCT04197583|559752247|FG001|Overall Study|Death|0|||
155165811|NCT02541604|560043563|FG006|Overall Study|Medical condition may jeopardize safety|0|||
155358218|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Other|2|||
155358219|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Other|2|||
155358220|NCT02706847|560746520|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
155358221|NCT02706847|560746521|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
155358222|NCT02706847|560746522|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
155358223|NCT02706847|560746523|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
155358224|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
155358225|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
155358226|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
155358227|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
155358228|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
155358229|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
155358230|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
155087460|NCT04197583|559752246|FG000|Overall Study|Physician Decision|1|||
155087461|NCT04197583|559752247|FG001|Overall Study|Physician Decision|0|||
155087462|NCT04197583|559752246|FG000|Overall Study|Withdrawal by Subject|1|||
155165812|NCT02541604|560043564|FG007|Overall Study|Medical condition may jeopardize safety|1|||
155165813|NCT02541604|560043565|FG008|Overall Study|Medical condition may jeopardize safety|0|||
155165814|NCT02541604|560043566|FG009|Overall Study|Medical condition may jeopardize safety|0|||
155165815|NCT02541604|560043567|FG010|Overall Study|Medical condition may jeopardize safety|0|||
155165816|NCT02541604|560043568|FG011|Overall Study|Medical condition may jeopardize safety|0|||
155165817|NCT02840461|560043570|FG000|Overall Study|Adverse Event|1|||
155165818|NCT02840461|560043571|FG001|Overall Study|Adverse Event|5|||
155165819|NCT02840461|560043572|FG002|Overall Study|Adverse Event|3|||
155165820|NCT02840461|560043570|FG000|Overall Study|Lost to Follow-up|10|||
155165821|NCT02840461|560043571|FG001|Overall Study|Lost to Follow-up|7|||
155165822|NCT02840461|560043572|FG002|Overall Study|Lost to Follow-up|6|||
155165823|NCT02840461|560043570|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
155165824|NCT02840461|560043571|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
155165825|NCT02840461|560043572|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
155165826|NCT02840461|560043570|FG000|Overall Study|Protocol Violation|2|||
155165827|NCT02840461|560043571|FG001|Overall Study|Protocol Violation|3|||
155165828|NCT02840461|560043572|FG002|Overall Study|Protocol Violation|1|||
155165829|NCT02840461|560043570|FG000|Overall Study|Withdrawal by Subject|10|||
155165830|NCT02840461|560043571|FG001|Overall Study|Withdrawal by Subject|6|||
155165831|NCT02840461|560043572|FG002|Overall Study|Withdrawal by Subject|2|||
155165832|NCT02840461|560043570|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
155165833|NCT02840461|560043571|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
155165834|NCT02840461|560043572|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
155165835|NCT04672655|560043576|FG000|Overall Study|Lost to Follow-up|12|||
155165836|NCT04672655|560043577|FG001|Overall Study|Lost to Follow-up|17|||
155087463|NCT04197583|559752247|FG001|Overall Study|Withdrawal by Subject|1|||
155087464|NCT04197583|559752246|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
155087465|NCT04197583|559752247|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
155087466|NCT04197583|559752246|FG000|Overall Study|Screen Failure|0|||
155087467|NCT04197583|559752247|FG001|Overall Study|Screen Failure|20|||
155087468|NCT04134936|559752248|FG000|Overall Study|Adverse Event|3|||
154964961|NCT00205777|559297553|FG001|Study Extension I|Withdrawn as per protocol|0|||
155087469|NCT04134936|559752249|FG001|Overall Study|Adverse Event|2|||
155087470|NCT04134936|559752248|FG000|Overall Study|Withdrawal by Subject|2|||
155087471|NCT04134936|559752249|FG001|Overall Study|Withdrawal by Subject|3|||
155087472|NCT04134936|559752248|FG000|Overall Study|Physician Decision|0|||
155165837|NCT04672655|560043576|FG000|Overall Study|Withdrawal by Subject|1|||
155165838|NCT04672655|560043577|FG001|Overall Study|Withdrawal by Subject|0|||
155087473|NCT04134936|559752249|FG001|Overall Study|Physician Decision|1|||
155087474|NCT04134936|559752248|FG000|Overall Study|Progressive disease, joined another trial|1|||
155165839|NCT04672655|560043576|FG000|Overall Study|Withdrawal by Study|1|||
155165840|NCT04672655|560043577|FG001|Overall Study|Withdrawal by Study|0|||
155165841|NCT00560352|560043581|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155358231|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
155358232|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
155358233|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
155358234|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
155358235|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
155358236|NCT02706847|560746520|FG000|Period 1: Week 12 to Week 24|Other|1|||
155358237|NCT02706847|560746521|FG001|Period 1: Week 12 to Week 24|Other|0|||
155358238|NCT02706847|560746522|FG002|Period 1: Week 12 to Week 24|Other|1|||
155358239|NCT02706847|560746523|FG003|Period 1: Week 12 to Week 24|Other|4|||
155358240|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
155358241|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
155358242|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
155358243|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
155358244|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
155358245|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
155358246|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
155358247|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
155358248|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
155358249|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
155358250|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
155358251|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
155358252|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
155358253|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
155358254|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
155358255|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
155358256|NCT02706847|560746520|FG000|Period 2: Week 24 to Week 260|Other|8|||
155358257|NCT02706847|560746521|FG001|Period 2: Week 24 to Week 260|Other|5|||
155358258|NCT02706847|560746522|FG002|Period 2: Week 24 to Week 260|Other|15|||
155358259|NCT02706847|560746523|FG003|Period 2: Week 24 to Week 260|Other|15|||
155358260|NCT01062971|560746524|FG000|Overall Study|Protocol Violation|1|||
155358261|NCT01062971|560746525|FG001|Overall Study|Protocol Violation|3|||
155358262|NCT01062971|560746524|FG000|Overall Study|Lost to Follow-up|3|||
155358263|NCT01062971|560746525|FG001|Overall Study|Lost to Follow-up|4|||
155358264|NCT00904722|560746536|FG000|Overall Study|Physician Decision|1|||
155358265|NCT00661713|560746537|FG000|Overall Study|Death|1|||
155358266|NCT00661713|560746538|FG001|Overall Study|Death|0|||
155358267|NCT00661713|560746539|FG002|Overall Study|Death|0|||
155358268|NCT00661713|560746540|FG003|Overall Study|Death|0|||
155358269|NCT00661713|560746541|FG004|Overall Study|Death|1|||
155358270|NCT00661713|560746542|FG005|Overall Study|Death|0|||
155358271|NCT00661713|560746543|FG006|Overall Study|Death|0|||
155358272|NCT00661713|560746544|FG007|Overall Study|Death|0|||
155358273|NCT00661713|560746537|FG000|Overall Study|Unable to Classify|1|||
155358274|NCT00661713|560746538|FG001|Overall Study|Unable to Classify|0|||
155358275|NCT00661713|560746539|FG002|Overall Study|Unable to Classify|0|||
155358276|NCT00661713|560746540|FG003|Overall Study|Unable to Classify|0|||
155358277|NCT00661713|560746541|FG004|Overall Study|Unable to Classify|0|||
155358278|NCT00661713|560746542|FG005|Overall Study|Unable to Classify|0|||
155358279|NCT00661713|560746543|FG006|Overall Study|Unable to Classify|0|||
155358280|NCT00661713|560746544|FG007|Overall Study|Unable to Classify|0|||
155358281|NCT00661713|560746537|FG000|Overall Study|Protocol Violation|1|||
155358282|NCT00661713|560746538|FG001|Overall Study|Protocol Violation|6|||
155358283|NCT00661713|560746539|FG002|Overall Study|Protocol Violation|3|||
155358284|NCT00661713|560746540|FG003|Overall Study|Protocol Violation|3|||
155358285|NCT00661713|560746541|FG004|Overall Study|Protocol Violation|0|||
155358286|NCT00661713|560746542|FG005|Overall Study|Protocol Violation|2|||
155165842|NCT00560352|560043582|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155358287|NCT00661713|560746543|FG006|Overall Study|Protocol Violation|2|||
155358288|NCT00661713|560746544|FG007|Overall Study|Protocol Violation|1|||
155358289|NCT00661713|560746537|FG000|Overall Study|Withdrawal by Subject|11|||
155358290|NCT00661713|560746538|FG001|Overall Study|Withdrawal by Subject|25|||
155358291|NCT00661713|560746539|FG002|Overall Study|Withdrawal by Subject|12|||
155358292|NCT00661713|560746540|FG003|Overall Study|Withdrawal by Subject|21|||
155358293|NCT00661713|560746541|FG004|Overall Study|Withdrawal by Subject|12|||
155358294|NCT00661713|560746542|FG005|Overall Study|Withdrawal by Subject|26|||
155165843|NCT00560352|560043583|FG002|Overall Study|Adverse event unrelated to study drug|1|||
155358295|NCT00661713|560746543|FG006|Overall Study|Withdrawal by Subject|45|||
155358296|NCT00661713|560746544|FG007|Overall Study|Withdrawal by Subject|9|||
155358297|NCT00661713|560746537|FG000|Overall Study|Lost to Follow-up|2|||
155358298|NCT00661713|560746538|FG001|Overall Study|Lost to Follow-up|7|||
155358299|NCT00661713|560746539|FG002|Overall Study|Lost to Follow-up|2|||
155358300|NCT00661713|560746540|FG003|Overall Study|Lost to Follow-up|2|||
155358301|NCT00661713|560746541|FG004|Overall Study|Lost to Follow-up|5|||
155358302|NCT00661713|560746542|FG005|Overall Study|Lost to Follow-up|7|||
155358303|NCT00661713|560746543|FG006|Overall Study|Lost to Follow-up|14|||
155358304|NCT00661713|560746544|FG007|Overall Study|Lost to Follow-up|1|||
155358305|NCT00661713|560746537|FG000|Overall Study|Administrative Reason|0|||
155358306|NCT00661713|560746538|FG001|Overall Study|Administrative Reason|1|||
155358307|NCT00661713|560746539|FG002|Overall Study|Administrative Reason|0|||
155358308|NCT00661713|560746540|FG003|Overall Study|Administrative Reason|2|||
155358309|NCT00661713|560746541|FG004|Overall Study|Administrative Reason|2|||
155358310|NCT00661713|560746542|FG005|Overall Study|Administrative Reason|2|||
155358311|NCT00661713|560746543|FG006|Overall Study|Administrative Reason|1|||
155358312|NCT00661713|560746544|FG007|Overall Study|Administrative Reason|0|||
155358313|NCT00661713|560746537|FG000|Overall Study|Adverse Event|0|||
155358314|NCT00661713|560746538|FG001|Overall Study|Adverse Event|0|||
155358315|NCT00661713|560746539|FG002|Overall Study|Adverse Event|0|||
155358316|NCT00661713|560746540|FG003|Overall Study|Adverse Event|0|||
154964962|NCT00205777|559297554|FG002|Study Extension I|Withdrawn as per protocol|1070|||
154964963|NCT00205777|559297555|FG003|Study Extension I|Withdrawn as per protocol|0|||
154964964|NCT00205777|559297556|FG004|Study Extension I|Withdrawn as per protocol|0|||
154964965|NCT00205777|559297557|FG005|Study Extension I|Withdrawn as per protocol|0|||
154964966|NCT00205777|559297552|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
154964967|NCT00205777|559297553|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
154964968|NCT00205777|559297554|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
154964969|NCT00205777|559297555|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
154964970|NCT00205777|559297556|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
154964971|NCT00205777|559297557|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
154964972|NCT00205777|559297552|FG000|Study Extension II|Adverse Event|0|||
154964973|NCT00205777|559297553|FG001|Study Extension II|Adverse Event|0|||
154964974|NCT00205777|559297554|FG002|Study Extension II|Adverse Event|0|||
154964975|NCT00205777|559297555|FG003|Study Extension II|Adverse Event|14|||
154964976|NCT00205777|559297556|FG004|Study Extension II|Adverse Event|0|||
154964977|NCT00205777|559297557|FG005|Study Extension II|Adverse Event|30|||
154964978|NCT00205777|559297552|FG000|Study Extension II|Death|0|||
154964979|NCT00205777|559297553|FG001|Study Extension II|Death|0|||
154964980|NCT00205777|559297554|FG002|Study Extension II|Death|0|||
154964981|NCT00205777|559297555|FG003|Study Extension II|Death|2|||
154964982|NCT00205777|559297556|FG004|Study Extension II|Death|0|||
154964983|NCT00205777|559297557|FG005|Study Extension II|Death|5|||
154964984|NCT00205777|559297552|FG000|Study Extension II|Withdrawal by Subject|0|||
154964985|NCT00205777|559297553|FG001|Study Extension II|Withdrawal by Subject|0|||
154964986|NCT00205777|559297554|FG002|Study Extension II|Withdrawal by Subject|0|||
154964987|NCT00205777|559297555|FG003|Study Extension II|Withdrawal by Subject|35|||
155087475|NCT04134936|559752249|FG001|Overall Study|Progressive disease, joined another trial|0|||
155087476|NCT04134936|559752248|FG000|Overall Study|Progressive disease|1|||
155087477|NCT04134936|559752249|FG001|Overall Study|Progressive disease|0|||
155087478|NCT04629196|559752250|FG000|Overall Study|Subject discontinued study drug|1|||
155358317|NCT00661713|560746541|FG004|Overall Study|Adverse Event|0|||
155358318|NCT00661713|560746542|FG005|Overall Study|Adverse Event|0|||
155358319|NCT00661713|560746543|FG006|Overall Study|Adverse Event|1|||
155358320|NCT00661713|560746544|FG007|Overall Study|Adverse Event|0|||
155358321|NCT00661713|560746537|FG000|Overall Study|Inappropriate Enrollment|0|||
155358322|NCT00661713|560746538|FG001|Overall Study|Inappropriate Enrollment|0|||
155358323|NCT00661713|560746539|FG002|Overall Study|Inappropriate Enrollment|0|||
155358324|NCT00661713|560746540|FG003|Overall Study|Inappropriate Enrollment|0|||
155358325|NCT00661713|560746541|FG004|Overall Study|Inappropriate Enrollment|0|||
155358326|NCT00661713|560746542|FG005|Overall Study|Inappropriate Enrollment|0|||
155358327|NCT00661713|560746543|FG006|Overall Study|Inappropriate Enrollment|1|||
155358328|NCT00661713|560746544|FG007|Overall Study|Inappropriate Enrollment|0|||
155358329|NCT01801982|560746545|FG000|Overall Study|Lost to Follow-up|1|||
155358330|NCT00727506|560746548|FG000|Overall Study|Adverse Event|0|||
155358331|NCT00727506|560746549|FG001|Overall Study|Adverse Event|0|||
154964988|NCT00205777|559297556|FG004|Study Extension II|Withdrawal by Subject|0|||
154964989|NCT00205777|559297557|FG005|Study Extension II|Withdrawal by Subject|59|||
154964990|NCT00205777|559297552|FG000|Study Extension II|Protocol Violation|0|||
154964991|NCT00205777|559297553|FG001|Study Extension II|Protocol Violation|0|||
154964992|NCT00205777|559297554|FG002|Study Extension II|Protocol Violation|0|||
154964993|NCT00205777|559297555|FG003|Study Extension II|Protocol Violation|1|||
154964994|NCT00205777|559297556|FG004|Study Extension II|Protocol Violation|0|||
154964995|NCT00205777|559297557|FG005|Study Extension II|Protocol Violation|10|||
154964996|NCT00205777|559297552|FG000|Study Extension II|Lack of Efficacy|0|||
154964997|NCT00205777|559297553|FG001|Study Extension II|Lack of Efficacy|0|||
154964998|NCT00205777|559297554|FG002|Study Extension II|Lack of Efficacy|0|||
155087479|NCT04629196|559752251|FG001|Overall Study|Subject discontinued study drug|0|||
155165844|NCT00560352|560043581|FG000|Overall Study|Study drug toxicity|3|||
155358332|NCT00727506|560746550|FG002|Overall Study|Adverse Event|4|||
154964999|NCT00205777|559297555|FG003|Study Extension II|Lack of Efficacy|0|||
154965000|NCT00205777|559297556|FG004|Study Extension II|Lack of Efficacy|0|||
154965001|NCT00205777|559297557|FG005|Study Extension II|Lack of Efficacy|1|||
154965002|NCT00205777|559297552|FG000|Study Extension II|Failed to return|0|||
155358333|NCT00727506|560746551|FG003|Overall Study|Adverse Event|4|||
155358334|NCT00727506|560746552|FG004|Overall Study|Adverse Event|1|||
155358335|NCT00727506|560746553|FG005|Overall Study|Adverse Event|8|||
155358336|NCT00727506|560746548|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155358337|NCT00727506|560746549|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358338|NCT00727506|560746550|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155358339|NCT00727506|560746551|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358340|NCT00727506|560746552|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358341|NCT00727506|560746553|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155358342|NCT00727506|560746548|FG000|Overall Study|Progressive disease|4|||
155358343|NCT00727506|560746549|FG001|Overall Study|Progressive disease|7|||
155358344|NCT00727506|560746550|FG002|Overall Study|Progressive disease|9|||
155358345|NCT00727506|560746551|FG003|Overall Study|Progressive disease|28|||
155358346|NCT00727506|560746552|FG004|Overall Study|Progressive disease|38|||
155358347|NCT00727506|560746553|FG005|Overall Study|Progressive disease|28|||
155358348|NCT00727506|560746548|FG000|Overall Study|Refused to continue medication|0|||
155358349|NCT00727506|560746549|FG001|Overall Study|Refused to continue medication|1|||
155358350|NCT00727506|560746550|FG002|Overall Study|Refused to continue medication|2|||
155358351|NCT00727506|560746551|FG003|Overall Study|Refused to continue medication|3|||
155358352|NCT00727506|560746552|FG004|Overall Study|Refused to continue medication|1|||
155358353|NCT00727506|560746553|FG005|Overall Study|Refused to continue medication|2|||
155358354|NCT00727506|560746548|FG000|Overall Study|Other reason not described above|0|||
155358355|NCT00727506|560746549|FG001|Overall Study|Other reason not described above|0|||
155358356|NCT00727506|560746550|FG002|Overall Study|Other reason not described above|1|||
155358357|NCT00727506|560746551|FG003|Overall Study|Other reason not described above|4|||
155358358|NCT00727506|560746552|FG004|Overall Study|Other reason not described above|1|||
155358359|NCT00727506|560746553|FG005|Overall Study|Other reason not described above|1|||
155358360|NCT01214421|560746554|FG000|Overall Study|Lost to Follow-up|7|||
155358361|NCT01214421|560746555|FG001|Overall Study|Lost to Follow-up|3|||
155358362|NCT01214421|560746556|FG002|Overall Study|Lost to Follow-up|7|||
155358363|NCT01214421|560746557|FG003|Overall Study|Lost to Follow-up|3|||
155358364|NCT01214421|560746554|FG000|Overall Study|Adverse Event|16|||
155358365|NCT01214421|560746555|FG001|Overall Study|Adverse Event|35|||
155358366|NCT01214421|560746556|FG002|Overall Study|Adverse Event|14|||
155358367|NCT01214421|560746557|FG003|Overall Study|Adverse Event|3|||
155358368|NCT01214421|560746554|FG000|Overall Study|Sponsor Discontinued Site|1|||
155358369|NCT01214421|560746555|FG001|Overall Study|Sponsor Discontinued Site|2|||
155358370|NCT01214421|560746556|FG002|Overall Study|Sponsor Discontinued Site|0|||
155358371|NCT01214421|560746557|FG003|Overall Study|Sponsor Discontinued Site|0|||
155358372|NCT01214421|560746554|FG000|Overall Study|Withdrawal Criteria Met|3|||
155358373|NCT01214421|560746555|FG001|Overall Study|Withdrawal Criteria Met|0|||
155358374|NCT01214421|560746556|FG002|Overall Study|Withdrawal Criteria Met|2|||
155358375|NCT01214421|560746557|FG003|Overall Study|Withdrawal Criteria Met|1|||
155358376|NCT01214421|560746554|FG000|Overall Study|Physician Decision|2|||
155358377|NCT01214421|560746555|FG001|Overall Study|Physician Decision|0|||
155358378|NCT01214421|560746556|FG002|Overall Study|Physician Decision|4|||
155358379|NCT01214421|560746557|FG003|Overall Study|Physician Decision|0|||
155358380|NCT01214421|560746554|FG000|Overall Study|Withdrawal by Subject|21|||
155358381|NCT01214421|560746555|FG001|Overall Study|Withdrawal by Subject|18|||
155358382|NCT01214421|560746556|FG002|Overall Study|Withdrawal by Subject|11|||
155358383|NCT01214421|560746557|FG003|Overall Study|Withdrawal by Subject|2|||
155358384|NCT03783689|560746558|FG000|Overall Study|Adverse Event|2|||
155358385|NCT03783689|560746559|FG001|Overall Study|Adverse Event|0|||
155358386|NCT03783689|560746558|FG000|Overall Study|Lost to Follow-up|2|||
155358387|NCT03783689|560746559|FG001|Overall Study|Lost to Follow-up|1|||
155165845|NCT00560352|560043582|FG001|Overall Study|Study drug toxicity|0|||
155358388|NCT03783689|560746558|FG000|Overall Study|Physician Decision|2|||
155358389|NCT03783689|560746559|FG001|Overall Study|Physician Decision|1|||
155358390|NCT03783689|560746558|FG000|Overall Study|Withdrawal by Subject|3|||
155358391|NCT03783689|560746559|FG001|Overall Study|Withdrawal by Subject|3|||
155358392|NCT04887506|560746561|FG000|Overall Study|Death|1|||
155358393|NCT04887506|560746562|FG001|Overall Study|Death|1|||
155358394|NCT04887506|560746561|FG000|Overall Study|Withdrawal by Subject|0|||
155358395|NCT04887506|560746562|FG001|Overall Study|Withdrawal by Subject|3|||
155358396|NCT04887506|560746561|FG000|Overall Study|Adverse Event|4|||
155358397|NCT04887506|560746562|FG001|Overall Study|Adverse Event|3|||
155358398|NCT04887506|560746561|FG000|Overall Study|Other - Not Reported|1|||
155358399|NCT04887506|560746562|FG001|Overall Study|Other - Not Reported|1|||
155358400|NCT01190449|560746566|FG000|Overall Study|Ineligible|0|||
155358401|NCT01190449|560746567|FG001|Overall Study|Ineligible|4|||
155358402|NCT00487825|560748302|FG000|Overall Study|Adverse Event|2|||
155358403|NCT00487825|560748303|FG001|Overall Study|Adverse Event|2|||
155358404|NCT00487825|560748302|FG000|Overall Study|Lack of Efficacy|1|||
155358405|NCT00487825|560748303|FG001|Overall Study|Lack of Efficacy|1|||
155358406|NCT00487825|560748302|FG000|Overall Study|Other|3|||
155358407|NCT00487825|560748303|FG001|Overall Study|Other|2|||
155358408|NCT01986114|560748304|FG000|Overall Study|Adverse Event|59|||
155358409|NCT01986114|560748304|FG000|Overall Study|Lack of Efficacy|23|||
155358410|NCT01986114|560748304|FG000|Overall Study|Withdrawal by Subject|58|||
155358411|NCT01986114|560748304|FG000|Overall Study|Noncompliance|3|||
155358412|NCT01986114|560748304|FG000|Overall Study|Protocol Violation|1|||
155358413|NCT01986114|560748304|FG000|Overall Study|Lost to Follow-up|5|||
155358414|NCT01986114|560748304|FG000|Overall Study|Other reason|7|||
155358415|NCT01190644|560748305|FG000|Overall Study|Death|2|||
155358416|NCT01190644|560748305|FG000|Overall Study|Disease progression|1|||
155358417|NCT04411186|560748306|FG000|Overall Study|Withdrawn due to protocol violation|0|||
155087480|NCT04629196|559752250|FG000|Overall Study|Subject study drug dosing increased|1|||
155358418|NCT04411186|560748307|FG001|Overall Study|Withdrawn due to protocol violation|1|||
155358419|NCT02172911|560748308|FG000|Overall Study|Serious Adverse Event|0|||
155358420|NCT02172911|560748309|FG001|Overall Study|Serious Adverse Event|1|||
155358421|NCT02172911|560748308|FG000|Overall Study|Progression of Disease|0|||
155358422|NCT02172911|560748309|FG001|Overall Study|Progression of Disease|1|||
155358423|NCT02172911|560748308|FG000|Overall Study|Loss of insurance coverage|1|||
155358424|NCT02172911|560748309|FG001|Overall Study|Loss of insurance coverage|0|||
155358425|NCT04795336|560748314|FG000|Overall Study|Withdrawal by Subject|3|||
155358426|NCT04795336|560748315|FG001|Overall Study|Withdrawal by Subject|4|||
155358427|NCT04795336|560748316|FG002|Overall Study|Withdrawal by Subject|3|||
155358428|NCT04795336|560748317|FG003|Overall Study|Withdrawal by Subject|12|||
155358429|NCT04795336|560748314|FG000|Overall Study|Lost study logs|0|||
155358430|NCT04795336|560748315|FG001|Overall Study|Lost study logs|1|||
155358431|NCT04795336|560748316|FG002|Overall Study|Lost study logs|0|||
155358432|NCT04795336|560748317|FG003|Overall Study|Lost study logs|2|||
155358433|NCT04795336|560748314|FG000|Overall Study|Did not take study medication|2|||
155358434|NCT04795336|560748315|FG001|Overall Study|Did not take study medication|0|||
155358435|NCT04795336|560748316|FG002|Overall Study|Did not take study medication|0|||
155358436|NCT04795336|560748317|FG003|Overall Study|Did not take study medication|0|||
155358437|NCT01638390|560748318|FG000|Overall Study|screening failures|21|||
155358438|NCT04596995|560748321|FG000|Overall Study|Lack of Efficacy|8|||
155358439|NCT04596995|560748321|FG000|Overall Study|Lost to Follow-up|3|||
155358440|NCT04596995|560748321|FG000|Overall Study|Withdrawal by Subject|12|||
155358441|NCT04596995|560748321|FG000|Overall Study|Sponsor decision|3|||
155358442|NCT04596995|560748321|FG000|Overall Study|Enrolled in managed access program|3|||
155358443|NCT05499130|560748322|FG000|Overall Study|Adverse Event|2|||
155358444|NCT05499130|560748323|FG001|Overall Study|Adverse Event|0|||
155358445|NCT05499130|560748324|FG002|Overall Study|Adverse Event|1|||
155358446|NCT05499130|560748325|FG003|Overall Study|Adverse Event|0|||
155358447|NCT05499130|560748326|FG004|Overall Study|Adverse Event|1|||
155358448|NCT05499130|560748327|FG005|Overall Study|Adverse Event|4|||
155358449|NCT05499130|560748328|FG006|Overall Study|Adverse Event|1|||
155358450|NCT05499130|560748329|FG007|Overall Study|Adverse Event|0|||
155358451|NCT05499130|560748322|FG000|Overall Study|Lack of Efficacy|1|||
155358452|NCT05499130|560748323|FG001|Overall Study|Lack of Efficacy|0|||
155358453|NCT05499130|560748324|FG002|Overall Study|Lack of Efficacy|0|||
155358454|NCT05499130|560748325|FG003|Overall Study|Lack of Efficacy|0|||
155358455|NCT05499130|560748326|FG004|Overall Study|Lack of Efficacy|5|||
155358456|NCT05499130|560748327|FG005|Overall Study|Lack of Efficacy|0|||
155358457|NCT05499130|560748328|FG006|Overall Study|Lack of Efficacy|1|||
155358458|NCT05499130|560748329|FG007|Overall Study|Lack of Efficacy|0|||
155358459|NCT05499130|560748322|FG000|Overall Study|Withdrawal by Subject|2|||
155358460|NCT05499130|560748323|FG001|Overall Study|Withdrawal by Subject|0|||
155358461|NCT05499130|560748324|FG002|Overall Study|Withdrawal by Subject|0|||
155358462|NCT05499130|560748325|FG003|Overall Study|Withdrawal by Subject|0|||
155358463|NCT05499130|560748326|FG004|Overall Study|Withdrawal by Subject|1|||
155358464|NCT05499130|560748327|FG005|Overall Study|Withdrawal by Subject|2|||
155358465|NCT05499130|560748328|FG006|Overall Study|Withdrawal by Subject|0|||
155358466|NCT05499130|560748329|FG007|Overall Study|Withdrawal by Subject|0|||
155358467|NCT05499130|560748322|FG000|Overall Study|Lost to Follow-up|0|||
155358468|NCT05499130|560748323|FG001|Overall Study|Lost to Follow-up|0|||
155358469|NCT05499130|560748324|FG002|Overall Study|Lost to Follow-up|0|||
155358470|NCT05499130|560748325|FG003|Overall Study|Lost to Follow-up|0|||
155358471|NCT05499130|560748326|FG004|Overall Study|Lost to Follow-up|0|||
155087481|NCT04629196|559752251|FG001|Overall Study|Subject study drug dosing increased|1|||
155358472|NCT05499130|560748327|FG005|Overall Study|Lost to Follow-up|2|||
155358473|NCT05499130|560748328|FG006|Overall Study|Lost to Follow-up|0|||
155358474|NCT05499130|560748329|FG007|Overall Study|Lost to Follow-up|0|||
155358475|NCT05499130|560748322|FG000|Overall Study|Other Than Specified|0|||
155358476|NCT05499130|560748323|FG001|Overall Study|Other Than Specified|0|||
155358477|NCT05499130|560748324|FG002|Overall Study|Other Than Specified|0|||
155358478|NCT05499130|560748325|FG003|Overall Study|Other Than Specified|0|||
155358479|NCT05499130|560748326|FG004|Overall Study|Other Than Specified|1|||
155358480|NCT05499130|560748327|FG005|Overall Study|Other Than Specified|1|||
155358481|NCT05499130|560748328|FG006|Overall Study|Other Than Specified|2|||
155358482|NCT05499130|560748329|FG007|Overall Study|Other Than Specified|0|||
155358483|NCT05499130|560748322|FG000|Overall Study|Protocol Violation|0|||
155358484|NCT05499130|560748323|FG001|Overall Study|Protocol Violation|0|||
155358485|NCT05499130|560748324|FG002|Overall Study|Protocol Violation|0|||
155358486|NCT05499130|560748325|FG003|Overall Study|Protocol Violation|0|||
155358487|NCT05499130|560748326|FG004|Overall Study|Protocol Violation|1|||
155358488|NCT05499130|560748327|FG005|Overall Study|Protocol Violation|0|||
154965003|NCT00205777|559297553|FG001|Study Extension II|Failed to return|0|||
154965004|NCT00205777|559297554|FG002|Study Extension II|Failed to return|0|||
154965005|NCT00205777|559297555|FG003|Study Extension II|Failed to return|14|||
154965006|NCT00205777|559297556|FG004|Study Extension II|Failed to return|0|||
154965007|NCT00205777|559297557|FG005|Study Extension II|Failed to return|26|||
154965008|NCT00205777|559297552|FG000|Study Extension II|Other Event|0|||
154965009|NCT00205777|559297553|FG001|Study Extension II|Other Event|0|||
154965010|NCT00205777|559297554|FG002|Study Extension II|Other Event|0|||
154965011|NCT00205777|559297555|FG003|Study Extension II|Other Event|12|||
154965012|NCT00205777|559297556|FG004|Study Extension II|Other Event|0|||
154965013|NCT00205777|559297557|FG005|Study Extension II|Other Event|20|||
154965014|NCT00205777|559297552|FG000|Study Extension II|Enrolled but not treated|0|||
154965015|NCT00205777|559297553|FG001|Study Extension II|Enrolled but not treated|0|||
154965016|NCT00205777|559297554|FG002|Study Extension II|Enrolled but not treated|0|||
154965017|NCT00205777|559297555|FG003|Study Extension II|Enrolled but not treated|71|||
154965018|NCT00205777|559297556|FG004|Study Extension II|Enrolled but not treated|0|||
154965019|NCT00205777|559297557|FG005|Study Extension II|Enrolled but not treated|131|||
154965020|NCT00700739|559297561|FG000|Overall Study|Lost to Follow-up|4|||
154965021|NCT00700739|559297562|FG001|Overall Study|Lost to Follow-up|4|||
155358489|NCT05499130|560748328|FG006|Overall Study|Protocol Violation|0|||
155358490|NCT05499130|560748329|FG007|Overall Study|Protocol Violation|0|||
154965022|NCT01794845|559297564|FG000|Overall Study|Withdrawal by Subject|1|||
154965023|NCT02139826|559297565|FG000|Overall Study|Adverse Event|1|||
154965024|NCT01004510|559297569|FG000|Overall Study|Adverse Event|1|||
154965025|NCT01824576|559297571|FG000|Overall Study|Device deficiency|2|||
154965026|NCT02911025|559297573|FG000|Overall Study|Lost to Follow-up|3|||
154965027|NCT03719040|559297574|FG000|Overall Study|Withdrawal by Subject|177|||
154965028|NCT03719040|559297574|FG000|Overall Study|Lost to Follow-up|26|||
154965029|NCT06647173|559297575|FG000|Overall Study|Lost to Follow-up|24|||
154965030|NCT02923349|559297576|FG000|Overall Study|Other|1|||
154965031|NCT02923349|559297577|FG001|Overall Study|Other|2|||
154965032|NCT02923349|559297578|FG002|Overall Study|Other|4|||
154965033|NCT02923349|559297579|FG003|Overall Study|Other|1|||
154965034|NCT02923349|559297580|FG004|Overall Study|Other|3|||
154965035|NCT02923349|559297581|FG005|Overall Study|Other|0|||
154965036|NCT02923349|559297582|FG006|Overall Study|Other|1|||
154965037|NCT02923349|559297576|FG000|Overall Study|Withdrawal by Subject|2|||
154965038|NCT02923349|559297577|FG001|Overall Study|Withdrawal by Subject|2|||
154965039|NCT02923349|559297578|FG002|Overall Study|Withdrawal by Subject|8|||
154965040|NCT02923349|559297579|FG003|Overall Study|Withdrawal by Subject|10|||
155165846|NCT00560352|560043583|FG002|Overall Study|Study drug toxicity|1|||
155165847|NCT00560352|560043581|FG000|Overall Study|Disease progression|0|||
155358491|NCT05382039|560748330|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
155358492|NCT05382039|560748331|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
155358493|NCT05382039|560748332|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
155358494|NCT05382039|560748330|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
155358495|NCT05382039|560748331|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
154965041|NCT02923349|559297580|FG004|Overall Study|Withdrawal by Subject|12|||
154965042|NCT02923349|559297581|FG005|Overall Study|Withdrawal by Subject|3|||
154965043|NCT02923349|559297582|FG006|Overall Study|Withdrawal by Subject|0|||
154965044|NCT02923349|559297576|FG000|Overall Study|Physician Decision|0|||
154965045|NCT02923349|559297577|FG001|Overall Study|Physician Decision|0|||
154965046|NCT02923349|559297578|FG002|Overall Study|Physician Decision|0|||
154965047|NCT02923349|559297579|FG003|Overall Study|Physician Decision|1|||
154965048|NCT02923349|559297580|FG004|Overall Study|Physician Decision|1|||
154965049|NCT02923349|559297581|FG005|Overall Study|Physician Decision|0|||
154965050|NCT02923349|559297582|FG006|Overall Study|Physician Decision|2|||
154965051|NCT02923349|559297576|FG000|Overall Study|Lost to Follow-up|0|||
154965052|NCT02923349|559297577|FG001|Overall Study|Lost to Follow-up|0|||
154965053|NCT02923349|559297578|FG002|Overall Study|Lost to Follow-up|3|||
154965054|NCT02923349|559297579|FG003|Overall Study|Lost to Follow-up|0|||
154965055|NCT02923349|559297580|FG004|Overall Study|Lost to Follow-up|1|||
154965056|NCT02923349|559297581|FG005|Overall Study|Lost to Follow-up|1|||
154965057|NCT02923349|559297582|FG006|Overall Study|Lost to Follow-up|0|||
154965058|NCT02923349|559297576|FG000|Overall Study|Death|1|||
154965059|NCT02923349|559297577|FG001|Overall Study|Death|0|||
154965060|NCT02923349|559297578|FG002|Overall Study|Death|2|||
154965061|NCT02923349|559297579|FG003|Overall Study|Death|4|||
154965062|NCT02923349|559297580|FG004|Overall Study|Death|2|||
154965063|NCT02923349|559297581|FG005|Overall Study|Death|3|||
154965064|NCT02923349|559297582|FG006|Overall Study|Death|0|||
155358496|NCT05382039|560748332|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
155358497|NCT05382039|560748330|FG000|Overall Study|waiting for confirmation|0|||
155358498|NCT05382039|560748331|FG001|Overall Study|waiting for confirmation|0|||
155358499|NCT05382039|560748332|FG002|Overall Study|waiting for confirmation|1|||
155358500|NCT04464421|560748333|FG000|Overall Study|Lost to Follow-up|2|||
155358501|NCT04464421|560748334|FG001|Overall Study|Lost to Follow-up|2|||
155358502|NCT02577003|560748335|FG000|Overall Study|Adverse Event|2|||
155358503|NCT02577003|560748336|FG001|Overall Study|Adverse Event|4|||
155358504|NCT02577003|560748335|FG000|Overall Study|Withdrawal by Subject|0|||
155358505|NCT02577003|560748336|FG001|Overall Study|Withdrawal by Subject|1|||
155358506|NCT02786004|560748337|FG000|Overall Study|Withdrawal by Subject|0|||
155358507|NCT02786004|560748338|FG001|Overall Study|Withdrawal by Subject|1|||
155358508|NCT01234883|560748339|FG000|Overall Study|Early treatment release|8|||
155358509|NCT01234883|560748340|FG001|Overall Study|Early treatment release|10|||
155358510|NCT01234883|560748339|FG000|Overall Study|Parent/guardian withdrew consent|1|||
155358511|NCT01234883|560748340|FG001|Overall Study|Parent/guardian withdrew consent|2|||
155358512|NCT01234883|560748339|FG000|Overall Study|Technical difficulties with IV infusion|0|||
155358513|NCT01234883|560748340|FG001|Overall Study|Technical difficulties with IV infusion|1|||
155358514|NCT01234883|560748339|FG000|Overall Study|Inclusion/exclusion failure|1|||
155358515|NCT01234883|560748340|FG001|Overall Study|Inclusion/exclusion failure|0|||
155358516|NCT03210519|560748341|FG000|Overall Study|Adverse Event|2|||
155358517|NCT03210519|560748342|FG001|Overall Study|Adverse Event|0|||
155358518|NCT03865953|560748345|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
155358519|NCT03865953|560748346|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155358520|NCT03865953|560748345|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
155358521|NCT03865953|560748346|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
155358522|NCT03865953|560748345|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
155358523|NCT03865953|560748346|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
155358524|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
155358525|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
155358526|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
155358527|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
155358528|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
155358529|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
155358530|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
155358531|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
155358532|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
155358533|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
155358534|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
155358535|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
155358536|NCT01216072|560748352|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
155358537|NCT01216072|560748353|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
155358538|NCT01216072|560748352|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
154965065|NCT01120028|559297585|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
155087482|NCT04629196|559752250|FG000|Overall Study|Withdrawal by Subject|1|||
155087483|NCT04629196|559752251|FG001|Overall Study|Withdrawal by Subject|2|||
155087484|NCT00323622|559752255|FG000|Overall Study|Other|30|||
155087485|NCT00323622|559752256|FG001|Overall Study|Other|91|||
155087486|NCT00323622|559752257|FG002|Overall Study|Other|4|||
155087487|NCT00323622|559752258|FG003|Overall Study|Other|12|||
155087488|NCT00323622|559752259|FG004|Overall Study|Other|32|||
155087489|NCT00323622|559752260|FG005|Overall Study|Other|74|||
155087490|NCT00323622|559752261|FG006|Overall Study|Other|5|||
155087491|NCT00323622|559752262|FG007|Overall Study|Other|13|||
155087492|NCT00323622|559752255|FG000|Overall Study|Death|1|||
155087493|NCT00323622|559752256|FG001|Overall Study|Death|1|||
155087494|NCT00323622|559752257|FG002|Overall Study|Death|0|||
155087495|NCT00323622|559752258|FG003|Overall Study|Death|0|||
155087496|NCT00323622|559752259|FG004|Overall Study|Death|7|||
155087497|NCT00323622|559752260|FG005|Overall Study|Death|0|||
155087498|NCT00323622|559752261|FG006|Overall Study|Death|0|||
155087499|NCT00323622|559752262|FG007|Overall Study|Death|2|||
155087500|NCT02061085|559752265|FG000|Overall Study|Adverse Event|8|||
155087501|NCT03709472|559752270|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
155087502|NCT03709472|559752271|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
155087503|NCT03709472|559752270|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
155087504|NCT03709472|559752271|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
155087505|NCT02038036|559752275|FG000|Core Study|Adverse Event|7|||
155358539|NCT01216072|560748353|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
155358540|NCT01216072|560748352|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
155358541|NCT01216072|560748353|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
155087506|NCT02038036|559752276|FG001|Core Study|Adverse Event|7|||
155087507|NCT02038036|559752275|FG000|Core Study|Death|1|||
155087508|NCT02038036|559752276|FG001|Core Study|Death|1|||
155087509|NCT02038036|559752275|FG000|Core Study|Disease progression|2|||
155087510|NCT02038036|559752276|FG001|Core Study|Disease progression|2|||
155087511|NCT02038036|559752275|FG000|Core Study|Lost to Follow-up|0|||
155087512|NCT02038036|559752276|FG001|Core Study|Lost to Follow-up|1|||
155087513|NCT02038036|559752275|FG000|Core Study|Physician Decision|2|||
155087514|NCT02038036|559752276|FG001|Core Study|Physician Decision|1|||
155087515|NCT02038036|559752275|FG000|Core Study|Subject/guardian decision|0|||
155087516|NCT02038036|559752276|FG001|Core Study|Subject/guardian decision|1|||
155087517|NCT02038036|559752275|FG000|Core Study|Withdrawal by Subject|3|||
155087518|NCT02038036|559752276|FG001|Core Study|Withdrawal by Subject|1|||
155087519|NCT02038036|559752275|FG000|Crossover Period|Withdrawal by Subject|0|||
155087520|NCT02038036|559752276|FG001|Crossover Period|Withdrawal by Subject|3|||
155087521|NCT02038036|559752275|FG000|Crossover Period|Adverse Event|0|||
155087522|NCT02038036|559752276|FG001|Crossover Period|Adverse Event|9|||
155087523|NCT02038036|559752275|FG000|Crossover Period|Death|0|||
155087524|NCT02038036|559752276|FG001|Crossover Period|Death|2|||
155087525|NCT02038036|559752275|FG000|Crossover Period|Disease progression|0|||
155087526|NCT02038036|559752276|FG001|Crossover Period|Disease progression|3|||
155087527|NCT02038036|559752275|FG000|Crossover Period|Lost to Follow-up|0|||
155087528|NCT02038036|559752276|FG001|Crossover Period|Lost to Follow-up|1|||
155087529|NCT02038036|559752275|FG000|Crossover Period|Physician Decision|0|||
155087530|NCT02038036|559752276|FG001|Crossover Period|Physician Decision|2|||
155087531|NCT02613507|559752281|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
155087532|NCT02613507|559752282|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
155087533|NCT02613507|559752281|FG000|Pre-Treamtent|Participant withdrew consent|0|||
155087534|NCT02613507|559752282|FG001|Pre-Treamtent|Participant withdrew consent|4|||
155087535|NCT02613507|559752281|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
155087536|NCT02613507|559752282|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
155087537|NCT02613507|559752281|FG000|Treatment|Not reported|3|||
155087538|NCT02613507|559752282|FG001|Treatment|Not reported|0|||
155087539|NCT02613507|559752281|FG000|Treatment|Other reasons|8|||
155087540|NCT02613507|559752282|FG001|Treatment|Other reasons|0|||
155087541|NCT02613507|559752281|FG000|Treatment|Participant no longer meets criteria|3|||
155087542|NCT02613507|559752282|FG001|Treatment|Participant no longer meets criteria|0|||
155087543|NCT02613507|559752281|FG000|Treatment|Maximum clinical benefit|5|||
155087544|NCT02613507|559752282|FG001|Treatment|Maximum clinical benefit|10|||
155087545|NCT02613507|559752281|FG000|Treatment|Lost to Follow-up|1|||
155087546|NCT02613507|559752282|FG001|Treatment|Lost to Follow-up|0|||
155087547|NCT02613507|559752281|FG000|Treatment|Participant withdrew consent|0|||
155087548|NCT02613507|559752282|FG001|Treatment|Participant withdrew consent|2|||
155358542|NCT01216072|560748352|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
155358543|NCT01216072|560748353|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
155358544|NCT01704547|560748357|FG000|Overall Study|Physician Decision|4|||
155358545|NCT01704547|560748357|FG000|Overall Study|Withdrawal by Subject|1|||
155358546|NCT01560871|560748358|FG000|Overall Study|transportation issues|2|||
155358547|NCT01560871|560748359|FG001|Overall Study|transportation issues|1|||
155358548|NCT01560871|560748358|FG000|Overall Study|relocation|1|||
155358549|NCT01560871|560748359|FG001|Overall Study|relocation|0|||
155358550|NCT01560871|560748358|FG000|Overall Study|readmission to a hospital|2|||
155087549|NCT02613507|559752281|FG000|Treatment|Participant request to discontinue study treatment|13|||
155087550|NCT02613507|559752282|FG001|Treatment|Participant request to discontinue study treatment|17|||
155087551|NCT02613507|559752281|FG000|Treatment|Adverse event unrelated to study drug|20|||
155087552|NCT02613507|559752282|FG001|Treatment|Adverse event unrelated to study drug|3|||
155087553|NCT02613507|559752281|FG000|Treatment|Death|2|||
155358551|NCT01560871|560748359|FG001|Overall Study|readmission to a hospital|1|||
155358552|NCT01560871|560748358|FG000|Overall Study|Lost to Follow-up|1|||
155358553|NCT01560871|560748359|FG001|Overall Study|Lost to Follow-up|0|||
155358554|NCT00409409|560748360|FG000|Overall Study|Adverse Event|7|||
155358555|NCT00409409|560748361|FG001|Overall Study|Adverse Event|2|||
155358556|NCT00409409|560748360|FG000|Overall Study|Withdrawal by Subject|1|||
155358557|NCT00409409|560748361|FG001|Overall Study|Withdrawal by Subject|1|||
155358558|NCT00409409|560748360|FG000|Overall Study|Any other reason not above-mentioned|0|||
155358559|NCT00409409|560748361|FG001|Overall Study|Any other reason not above-mentioned|1|||
155358560|NCT01278615|560748362|FG000|Overall Study|Withdrawal by Subject|2|||
155358561|NCT02138253|560748363|FG000|Overall Study|Adverse Event|3|||
155358562|NCT02138253|560748364|FG001|Overall Study|Adverse Event|3|||
155358563|NCT02138253|560748363|FG000|Overall Study|Lost to Follow-up|2|||
155358564|NCT02138253|560748364|FG001|Overall Study|Lost to Follow-up|1|||
155358565|NCT02138253|560748363|FG000|Overall Study|Physician Decision|2|||
155358566|NCT02138253|560748364|FG001|Overall Study|Physician Decision|0|||
155358567|NCT02138253|560748363|FG000|Overall Study|Non compliance|1|||
155087554|NCT02613507|559752282|FG001|Treatment|Death|0|||
155087555|NCT02613507|559752281|FG000|Treatment|Study drug toxicity|19|||
155087556|NCT02613507|559752282|FG001|Treatment|Study drug toxicity|14|||
155087557|NCT02613507|559752281|FG000|Treatment|Disease progression|263|||
155087558|NCT02613507|559752282|FG001|Treatment|Disease progression|110|||
155087559|NCT03514134|559754315|FG000|Overall Study|Lost to Follow-up|0|||
155087560|NCT03514134|559754316|FG001|Overall Study|Lost to Follow-up|1|||
155087561|NCT02471144|559754317|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
155087562|NCT02471144|559754318|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
155087563|NCT02471144|559754319|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
155087564|NCT02471144|559754320|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
155087565|NCT02471144|559754321|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
155087566|NCT02471144|559754322|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
155087567|NCT02471144|559754323|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
155087568|NCT02471144|559754324|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
155087569|NCT02471144|559754325|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
155087570|NCT02471144|559754326|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
155087571|NCT02471144|559754327|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
155087572|NCT02471144|559754317|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087573|NCT02471144|559754318|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087574|NCT02471144|559754319|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087575|NCT02471144|559754320|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
155087576|NCT02471144|559754321|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087577|NCT02471144|559754322|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087578|NCT02471144|559754323|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087579|NCT02471144|559754324|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155358568|NCT02138253|560748364|FG001|Overall Study|Non compliance|0|||
155358569|NCT02138253|560748363|FG000|Overall Study|Withdrawal by Subject|1|||
155358570|NCT02138253|560748364|FG001|Overall Study|Withdrawal by Subject|0|||
155358571|NCT01918371|560748365|FG000|Overall Study|Missing Data|1|||
155358572|NCT01918371|560748366|FG001|Overall Study|Missing Data|1|||
155358573|NCT01006889|560748367|FG000|Overall Study|Withdrawal by Subject|3|||
155358574|NCT00243022|560748368|FG000|Overall Study|Withdrawal by Subject|1|||
155087580|NCT02471144|559754325|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087581|NCT02471144|559754326|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087582|NCT02471144|559754327|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
155087583|NCT02471144|559754317|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087584|NCT02471144|559754318|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087585|NCT02471144|559754319|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
155087586|NCT02471144|559754320|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155358575|NCT00243022|560748369|FG001|Overall Study|Withdrawal by Subject|0|||
155358576|NCT00243022|560748368|FG000|Overall Study|Death|1|||
155358577|NCT00243022|560748369|FG001|Overall Study|Death|0|||
155358578|NCT00243022|560748368|FG000|Overall Study|Difficult Travel Distance|0|||
155358579|NCT00243022|560748369|FG001|Overall Study|Difficult Travel Distance|1|||
155358580|NCT01390441|560748374|FG000|Treatment Period|Protocol Violation|0|||
155087587|NCT02471144|559754321|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087588|NCT02471144|559754322|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087589|NCT02471144|559754323|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087590|NCT02471144|559754324|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087591|NCT02471144|559754325|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087592|NCT02471144|559754326|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087593|NCT02471144|559754327|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
155087594|NCT02471144|559754317|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
155087595|NCT02471144|559754318|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
155087596|NCT02471144|559754319|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087597|NCT02471144|559754320|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087598|NCT02471144|559754321|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155358581|NCT01390441|560748375|FG001|Treatment Period|Protocol Violation|1|||
155358582|NCT01390441|560748376|FG002|Treatment Period|Protocol Violation|0|||
155358583|NCT01390441|560748377|FG003|Treatment Period|Protocol Violation|0|||
155358584|NCT01390441|560748378|FG004|Treatment Period|Protocol Violation|0|||
155358585|NCT01390441|560748374|FG000|Treatment Period|Physician Decision|0|||
155358586|NCT01390441|560748375|FG001|Treatment Period|Physician Decision|0|||
155358587|NCT01390441|560748376|FG002|Treatment Period|Physician Decision|0|||
155358588|NCT01390441|560748377|FG003|Treatment Period|Physician Decision|1|||
155358589|NCT01390441|560748378|FG004|Treatment Period|Physician Decision|0|||
155087599|NCT02471144|559754322|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087600|NCT02471144|559754323|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087601|NCT02471144|559754324|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087602|NCT02471144|559754325|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155358590|NCT01390441|560748374|FG000|Treatment Period|Lack of Efficacy|0|||
155358591|NCT01390441|560748375|FG001|Treatment Period|Lack of Efficacy|0|||
155358592|NCT01390441|560748376|FG002|Treatment Period|Lack of Efficacy|0|||
155358593|NCT01390441|560748377|FG003|Treatment Period|Lack of Efficacy|0|||
155358594|NCT01390441|560748378|FG004|Treatment Period|Lack of Efficacy|1|||
155358595|NCT01390441|560748374|FG000|Treatment Period|Unknown due to early stopping of study|0|||
155358596|NCT01390441|560748375|FG001|Treatment Period|Unknown due to early stopping of study|0|||
155358597|NCT01390441|560748376|FG002|Treatment Period|Unknown due to early stopping of study|8|||
155358598|NCT01390441|560748377|FG003|Treatment Period|Unknown due to early stopping of study|11|||
155358599|NCT01390441|560748378|FG004|Treatment Period|Unknown due to early stopping of study|7|||
155358600|NCT01390441|560748374|FG000|Treatment Period|Adverse Event|0|||
155358601|NCT01390441|560748375|FG001|Treatment Period|Adverse Event|0|||
155358602|NCT01390441|560748376|FG002|Treatment Period|Adverse Event|1|||
155358603|NCT01390441|560748377|FG003|Treatment Period|Adverse Event|1|||
155358604|NCT01390441|560748378|FG004|Treatment Period|Adverse Event|2|||
154965066|NCT01120028|559297586|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
155358605|NCT01390441|560748374|FG000|Treatment Period|Withdrawal by Subject|0|||
155358606|NCT01390441|560748375|FG001|Treatment Period|Withdrawal by Subject|0|||
155358607|NCT01390441|560748376|FG002|Treatment Period|Withdrawal by Subject|1|||
155358608|NCT01390441|560748377|FG003|Treatment Period|Withdrawal by Subject|0|||
155358609|NCT01390441|560748378|FG004|Treatment Period|Withdrawal by Subject|1|||
155358610|NCT01390441|560748374|FG000|Treatment Period|Lost to Follow-up|1|||
155358611|NCT01390441|560748375|FG001|Treatment Period|Lost to Follow-up|0|||
155358612|NCT01390441|560748376|FG002|Treatment Period|Lost to Follow-up|0|||
155358613|NCT01390441|560748377|FG003|Treatment Period|Lost to Follow-up|0|||
155358614|NCT01390441|560748378|FG004|Treatment Period|Lost to Follow-up|0|||
155358615|NCT01390441|560748374|FG000|Extension Period|Protocol Violation|3|||
155358616|NCT01390441|560748375|FG001|Extension Period|Protocol Violation|1|||
155358617|NCT01390441|560748376|FG002|Extension Period|Protocol Violation|0|||
155358618|NCT01390441|560748377|FG003|Extension Period|Protocol Violation|1|||
155358619|NCT01390441|560748378|FG004|Extension Period|Protocol Violation|0|||
155358620|NCT03802617|560748379|FG000|Overall Study|Adverse Event|0|||
155358621|NCT03802617|560748380|FG001|Overall Study|Adverse Event|4|||
155358622|NCT03802617|560748381|FG002|Overall Study|Adverse Event|5|||
155358623|NCT03802617|560748382|FG003|Overall Study|Adverse Event|1|||
155358624|NCT03802617|560748379|FG000|Overall Study|Lack of Efficacy|0|||
155358625|NCT03802617|560748380|FG001|Overall Study|Lack of Efficacy|1|||
155358626|NCT03802617|560748381|FG002|Overall Study|Lack of Efficacy|0|||
155358627|NCT03802617|560748382|FG003|Overall Study|Lack of Efficacy|2|||
155358628|NCT03802617|560748379|FG000|Overall Study|Protocol Violation|1|||
155358629|NCT03802617|560748380|FG001|Overall Study|Protocol Violation|1|||
155358630|NCT03802617|560748381|FG002|Overall Study|Protocol Violation|1|||
155358631|NCT03802617|560748382|FG003|Overall Study|Protocol Violation|0|||
155358632|NCT03802617|560748379|FG000|Overall Study|Withdrawal by Subject|1|||
155358633|NCT03802617|560748380|FG001|Overall Study|Withdrawal by Subject|1|||
155358634|NCT03802617|560748381|FG002|Overall Study|Withdrawal by Subject|1|||
155358635|NCT03802617|560748382|FG003|Overall Study|Withdrawal by Subject|0|||
155358636|NCT03802617|560748379|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
155358637|NCT03802617|560748380|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
155358638|NCT03802617|560748381|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
155358639|NCT03802617|560748382|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
155358640|NCT00621192|560748383|FG000|Overall Study|Withdrawal by Subject|0|||
155358641|NCT00621192|560748384|FG001|Overall Study|Withdrawal by Subject|0|||
155358642|NCT00621192|560748385|FG002|Overall Study|Withdrawal by Subject|2|||
155358643|NCT00621192|560748386|FG003|Overall Study|Withdrawal by Subject|0|||
155358644|NCT00621192|560748383|FG000|Overall Study|Physician Decision|1|||
155358645|NCT00621192|560748384|FG001|Overall Study|Physician Decision|3|||
155358646|NCT00621192|560748385|FG002|Overall Study|Physician Decision|0|||
155358647|NCT00621192|560748386|FG003|Overall Study|Physician Decision|0|||
155358648|NCT00621192|560748383|FG000|Overall Study|Protocol Violation|1|||
155358649|NCT00621192|560748384|FG001|Overall Study|Protocol Violation|0|||
155358650|NCT00621192|560748385|FG002|Overall Study|Protocol Violation|0|||
155358651|NCT00621192|560748386|FG003|Overall Study|Protocol Violation|1|||
155358652|NCT00621192|560748383|FG000|Overall Study|Adverse Event|0|||
155358653|NCT00621192|560748384|FG001|Overall Study|Adverse Event|1|||
155358654|NCT00621192|560748385|FG002|Overall Study|Adverse Event|0|||
155358655|NCT00621192|560748386|FG003|Overall Study|Adverse Event|1|||
155358656|NCT00621192|560748383|FG000|Overall Study|Death|2|||
155358657|NCT00621192|560748384|FG001|Overall Study|Death|5|||
155358658|NCT00621192|560748385|FG002|Overall Study|Death|0|||
155358659|NCT00621192|560748386|FG003|Overall Study|Death|0|||
155358660|NCT00621192|560748383|FG000|Overall Study|Final Assessments not Completed|0|||
155358661|NCT00621192|560748384|FG001|Overall Study|Final Assessments not Completed|0|||
155358662|NCT00621192|560748385|FG002|Overall Study|Final Assessments not Completed|3|||
155358663|NCT00621192|560748386|FG003|Overall Study|Final Assessments not Completed|1|||
155358664|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
155358665|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
155358666|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
155358667|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
155358668|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
155358669|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
155358670|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
155358671|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
155358672|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
155358673|NCT01099579|560748387|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
155358674|NCT01099579|560748388|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
155358675|NCT01099579|560748389|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
155358676|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
155358677|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
155358678|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
155358679|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
155358680|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
155358681|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
155358682|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
155358683|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
155358684|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
155358685|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
155358686|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
155358687|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
155358688|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
155358689|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
155358690|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
155358691|NCT01099579|560748387|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
155358692|NCT01099579|560748388|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
155358693|NCT01099579|560748389|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
155358694|NCT02569957|560748390|FG000|Overall Study|Withdrawal by Subject|0|||
155358695|NCT02569957|560748391|FG001|Overall Study|Withdrawal by Subject|1|||
155358696|NCT02635386|560748392|FG000|Overall Study|Pregnancy|2|||
155358697|NCT02635386|560748393|FG001|Overall Study|Pregnancy|0|||
155358698|NCT02635386|560748394|FG002|Overall Study|Pregnancy|0|||
155358699|NCT02635386|560748395|FG003|Overall Study|Pregnancy|0|||
155358700|NCT02635386|560748396|FG004|Overall Study|Pregnancy|2|||
155358701|NCT02635386|560748392|FG000|Overall Study|Withdrawal by Subject|1|||
155358702|NCT02635386|560748393|FG001|Overall Study|Withdrawal by Subject|1|||
155358703|NCT02635386|560748394|FG002|Overall Study|Withdrawal by Subject|0|||
155358704|NCT02635386|560748395|FG003|Overall Study|Withdrawal by Subject|1|||
155358705|NCT02635386|560748396|FG004|Overall Study|Withdrawal by Subject|0|||
155358706|NCT02635386|560748392|FG000|Overall Study|Physician Decision|0|||
155358707|NCT02635386|560748393|FG001|Overall Study|Physician Decision|1|||
155358708|NCT02635386|560748394|FG002|Overall Study|Physician Decision|0|||
155358709|NCT02635386|560748395|FG003|Overall Study|Physician Decision|0|||
155358710|NCT02635386|560748396|FG004|Overall Study|Physician Decision|0|||
155358711|NCT02635386|560748392|FG000|Overall Study|Moved Out of State|0|||
155358712|NCT02635386|560748393|FG001|Overall Study|Moved Out of State|1|||
155358713|NCT02635386|560748394|FG002|Overall Study|Moved Out of State|0|||
155358714|NCT02635386|560748395|FG003|Overall Study|Moved Out of State|0|||
155358715|NCT02635386|560748396|FG004|Overall Study|Moved Out of State|0|||
155358716|NCT02635386|560748392|FG000|Overall Study|Noncompliant|0|||
155358717|NCT02635386|560748393|FG001|Overall Study|Noncompliant|2|||
155358718|NCT02635386|560748394|FG002|Overall Study|Noncompliant|1|||
155358719|NCT02635386|560748395|FG003|Overall Study|Noncompliant|1|||
155358720|NCT02635386|560748396|FG004|Overall Study|Noncompliant|1|||
155358721|NCT02635386|560748392|FG000|Overall Study|side effects|0|||
155358722|NCT02635386|560748393|FG001|Overall Study|side effects|0|||
155358723|NCT02635386|560748394|FG002|Overall Study|side effects|1|||
155358724|NCT02635386|560748395|FG003|Overall Study|side effects|4|||
155087603|NCT02471144|559754326|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087604|NCT02471144|559754327|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
155087605|NCT02471144|559754317|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087606|NCT02471144|559754318|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087607|NCT02471144|559754319|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087608|NCT02471144|559754320|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087609|NCT02471144|559754321|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
155087610|NCT02471144|559754322|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087611|NCT02471144|559754323|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
155087612|NCT02471144|559754324|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087613|NCT02471144|559754325|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
155087614|NCT02471144|559754326|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087615|NCT02471144|559754327|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
155087616|NCT02471144|559754317|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087617|NCT02471144|559754318|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087618|NCT02471144|559754319|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087619|NCT02471144|559754320|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087620|NCT02471144|559754321|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087621|NCT02471144|559754322|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
155165848|NCT00560352|560043582|FG001|Overall Study|Disease progression|1|||
155358725|NCT02635386|560748396|FG004|Overall Study|side effects|6|||
155358726|NCT02635386|560748392|FG000|Overall Study|needed other major surgery|0|||
155358727|NCT02635386|560748393|FG001|Overall Study|needed other major surgery|1|||
155358728|NCT02635386|560748394|FG002|Overall Study|needed other major surgery|0|||
155358729|NCT02635386|560748395|FG003|Overall Study|needed other major surgery|0|||
155358730|NCT02635386|560748396|FG004|Overall Study|needed other major surgery|0|||
155358731|NCT02635386|560748392|FG000|Overall Study|Other medical problems not drug related|0|||
155358732|NCT02635386|560748393|FG001|Overall Study|Other medical problems not drug related|0|||
155358733|NCT02635386|560748394|FG002|Overall Study|Other medical problems not drug related|0|||
155087622|NCT02471144|559754323|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155358734|NCT02635386|560748395|FG003|Overall Study|Other medical problems not drug related|1|||
155358735|NCT02635386|560748396|FG004|Overall Study|Other medical problems not drug related|0|||
155358736|NCT03174782|560748397|FG000|Overall Study|Protocol Violation|1|||
155358737|NCT03174782|560748398|FG001|Overall Study|Protocol Violation|0|||
155358738|NCT03174782|560748397|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
155358739|NCT03174782|560748398|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
155358740|NCT03178045|560748399|FG000|Overall Study|Withdrawal by Subject|5|||
155358741|NCT03178045|560748400|FG001|Overall Study|Withdrawal by Subject|7|||
155358742|NCT03178045|560748399|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
155358743|NCT03178045|560748400|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
155358744|NCT03178045|560748399|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
155358745|NCT03178045|560748400|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
155358746|NCT01078922|560748401|FG000|Overall Study|Adverse Event|1|||
155358747|NCT00725543|560748410|FG000|Overall Study|Adverse Event|10|||
155358748|NCT00725543|560748410|FG000|Overall Study|Lack of Efficacy|3|||
155358749|NCT00725543|560748410|FG000|Overall Study|Withdrawal by Subject|10|||
155358750|NCT00725543|560748410|FG000|Overall Study|Physician Decision|5|||
155358751|NCT00725543|560748410|FG000|Overall Study|Lost to Follow-up|4|||
155358752|NCT00725543|560748410|FG000|Overall Study|Non-compliance|2|||
155358753|NCT00725543|560748410|FG000|Overall Study|Other|119|||
155358754|NCT02168478|560748411|FG000|Overall Study|Withdrawal by Subject|1|||
155358755|NCT02168478|560748411|FG000|Overall Study|Did Not Consent to Participation|2|||
155358756|NCT02168478|560748411|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
155358757|NCT01157377|560748412|FG000|Overall Study|Lost to Follow-up|0|||
155358758|NCT01157377|560748413|FG001|Overall Study|Lost to Follow-up|0|||
155358759|NCT01157377|560748414|FG002|Overall Study|Lost to Follow-up|1|||
155358760|NCT01157377|560748415|FG003|Overall Study|Lost to Follow-up|0|||
155358761|NCT01157377|560748416|FG004|Overall Study|Lost to Follow-up|1|||
155358762|NCT01157377|560748417|FG005|Overall Study|Lost to Follow-up|1|||
155358763|NCT01157377|560748418|FG006|Overall Study|Lost to Follow-up|0|||
155358764|NCT01157377|560748412|FG000|Overall Study|Personal Reasons|2|||
155358765|NCT01157377|560748413|FG001|Overall Study|Personal Reasons|1|||
155358766|NCT01157377|560748414|FG002|Overall Study|Personal Reasons|0|||
155358767|NCT01157377|560748415|FG003|Overall Study|Personal Reasons|1|||
155358768|NCT01157377|560748416|FG004|Overall Study|Personal Reasons|0|||
155358769|NCT01157377|560748417|FG005|Overall Study|Personal Reasons|0|||
155358770|NCT01157377|560748418|FG006|Overall Study|Personal Reasons|0|||
155358771|NCT01157377|560748412|FG000|Overall Study|Protocol Violation|0|||
155358772|NCT01157377|560748413|FG001|Overall Study|Protocol Violation|0|||
155358773|NCT01157377|560748414|FG002|Overall Study|Protocol Violation|0|||
155358774|NCT01157377|560748415|FG003|Overall Study|Protocol Violation|0|||
155358775|NCT01157377|560748416|FG004|Overall Study|Protocol Violation|0|||
155358776|NCT01157377|560748417|FG005|Overall Study|Protocol Violation|1|||
155358777|NCT01157377|560748418|FG006|Overall Study|Protocol Violation|0|||
155358778|NCT01157377|560748412|FG000|Overall Study|Lack of Efficacy|0|||
155358779|NCT01157377|560748413|FG001|Overall Study|Lack of Efficacy|0|||
155358780|NCT01157377|560748414|FG002|Overall Study|Lack of Efficacy|0|||
155358781|NCT01157377|560748415|FG003|Overall Study|Lack of Efficacy|0|||
155358782|NCT01157377|560748416|FG004|Overall Study|Lack of Efficacy|0|||
155358783|NCT01157377|560748417|FG005|Overall Study|Lack of Efficacy|0|||
155358784|NCT01157377|560748418|FG006|Overall Study|Lack of Efficacy|1|||
155358785|NCT01157377|560748412|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155358786|NCT01157377|560748413|FG001|Overall Study|Other Miscellaneous Reasons|2|||
155358787|NCT01157377|560748414|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155358788|NCT01157377|560748415|FG003|Overall Study|Other Miscellaneous Reasons|0|||
155358789|NCT01157377|560748416|FG004|Overall Study|Other Miscellaneous Reasons|1|||
155358790|NCT01157377|560748417|FG005|Overall Study|Other Miscellaneous Reasons|1|||
155358791|NCT01157377|560748418|FG006|Overall Study|Other Miscellaneous Reasons|1|||
155358792|NCT05523219|560748419|FG000|Overall Study|Wrong inclusion|1|||
155358793|NCT05523219|560748419|FG000|Overall Study|Lost to Follow-up|7|||
155087623|NCT02471144|559754324|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087624|NCT02471144|559754325|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
155358794|NCT01087814|560748420|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
155358795|NCT01087814|560748421|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
155358796|NCT01087814|560748420|FG000|Second Intervention (5 Days)|Physician Decision|1|||
155358797|NCT01087814|560748421|FG001|Second Intervention (5 Days)|Physician Decision|0|||
155358798|NCT02918292|560748422|FG000|Study Enrollment Prior to Transplant|Death|1|||
155358799|NCT02918292|560748422|FG000|Study Follow up After Transplant|Death|6|||
155358800|NCT02650466|560748423|FG000|Overall Study|Physician Decision|1|||
155358801|NCT02650466|560748423|FG000|Overall Study|Withdrawal by Subject|5|||
155358802|NCT02650466|560748423|FG000|Overall Study|Lost to Follow-up|1|||
155358803|NCT02392104|560748425|FG000|Overall Study|discontinuation of warfarin|3|||
155358804|NCT02392104|560748425|FG000|Overall Study|bleeding event|1|||
155358805|NCT02392104|560748425|FG000|Overall Study|transferred care to another doctor|2|||
155358806|NCT02392104|560748425|FG000|Overall Study|INR goal range changed|1|||
154965067|NCT01120028|559297587|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
154965068|NCT01120028|559297588|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
154965069|NCT01120028|559297585|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
154965070|NCT01120028|559297586|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
154965071|NCT01120028|559297587|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
154965072|NCT01120028|559297588|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
154965073|NCT00725322|559297589|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
154965074|NCT00725322|559297590|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
155087625|NCT02471144|559754326|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
155087626|NCT02471144|559754327|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
154965075|NCT00725322|559297589|FG000|Washout (28 Days)|Protocol Violation|0|||
154965076|NCT00725322|559297590|FG001|Washout (28 Days)|Protocol Violation|1|||
155087627|NCT02471144|559754317|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087628|NCT02471144|559754318|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087629|NCT02471144|559754319|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087630|NCT02471144|559754320|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087631|NCT02471144|559754321|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087632|NCT02471144|559754322|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087633|NCT02471144|559754323|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087634|NCT02471144|559754324|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087635|NCT02471144|559754325|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
155087636|NCT02471144|559754326|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087637|NCT02471144|559754327|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
155087638|NCT02471144|559754317|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087639|NCT02471144|559754318|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087640|NCT02471144|559754319|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087641|NCT02471144|559754320|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155358807|NCT02392104|560748425|FG000|Overall Study|admitted to skilled nursing facility|3|||
155358808|NCT02392104|560748425|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
155358809|NCT02636608|560748429|FG000|Overall Study|Failure to Return|4|||
155358810|NCT02636608|560748429|FG000|Overall Study|Insufficient Virological Response|1|||
155358811|NCT02636608|560748429|FG000|Overall Study|Death|3|||
155358812|NCT02636608|560748429|FG000|Overall Study|Other|2|||
155358813|NCT02636608|560748429|FG000|Overall Study|Did Not Receive Treatment|1|||
155358814|NCT03912532|560748430|FG000|Overall Study|Adverse Event|3|||
155358815|NCT03912532|560748431|FG001|Overall Study|Adverse Event|3|||
155358816|NCT03912532|560748432|FG002|Overall Study|Adverse Event|2|||
155358817|NCT03912532|560748433|FG003|Overall Study|Adverse Event|2|||
155358818|NCT03912532|560748430|FG000|Overall Study|Lost to Follow-up|3|||
155358819|NCT03912532|560748431|FG001|Overall Study|Lost to Follow-up|2|||
155358820|NCT03912532|560748432|FG002|Overall Study|Lost to Follow-up|1|||
155358821|NCT03912532|560748433|FG003|Overall Study|Lost to Follow-up|2|||
155358822|NCT03912532|560748430|FG000|Overall Study|Withdrawal by Subject|1|||
155358823|NCT03912532|560748431|FG001|Overall Study|Withdrawal by Subject|1|||
155358824|NCT03912532|560748432|FG002|Overall Study|Withdrawal by Subject|2|||
155358825|NCT03912532|560748433|FG003|Overall Study|Withdrawal by Subject|0|||
155358826|NCT03912532|560748430|FG000|Overall Study|Physician Decision|1|||
155358827|NCT03912532|560748431|FG001|Overall Study|Physician Decision|0|||
155358828|NCT03912532|560748432|FG002|Overall Study|Physician Decision|0|||
155358829|NCT03912532|560748433|FG003|Overall Study|Physician Decision|3|||
155358830|NCT03912532|560748430|FG000|Overall Study|Other|0|||
155358831|NCT03912532|560748431|FG001|Overall Study|Other|1|||
155358832|NCT03912532|560748432|FG002|Overall Study|Other|1|||
155358833|NCT03912532|560748433|FG003|Overall Study|Other|0|||
155358834|NCT04913948|560748434|FG000|Overall Study|Withdrawal by Subject|2|||
155358835|NCT04913948|560748434|FG000|Overall Study|Sample processing issues|1|||
155358836|NCT04913948|560748434|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
155358837|NCT03783871|560748437|FG000|Overall Study|Withdrawal by Subject|15|||
155087642|NCT02471144|559754321|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087643|NCT02471144|559754322|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087644|NCT02471144|559754323|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155358838|NCT03783871|560748437|FG000|Overall Study|Death|13|||
154965077|NCT00258856|559298801|FG000|Overall Study|Lost to Follow-up|1|||
155087645|NCT02471144|559754324|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
155087646|NCT02471144|559754325|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
155358839|NCT03783871|560748437|FG000|Overall Study|Lost to Follow-up|2|||
155358840|NCT05990387|560748439|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
155358841|NCT05990387|560748440|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
154965078|NCT00258856|559298802|FG001|Overall Study|Lost to Follow-up|0|||
155358842|NCT00815919|560748441|FG000|Overall Study|Unrelated Fungal Infection|1|||
155358843|NCT00815919|560748441|FG000|Overall Study|AML Relapse|1|||
154965079|NCT00258856|559298803|FG002|Overall Study|Lost to Follow-up|2|||
155087647|NCT02471144|559754326|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087648|NCT02471144|559754327|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
155087649|NCT02471144|559754317|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155087650|NCT02471144|559754318|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155087651|NCT02471144|559754319|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155358844|NCT00815919|560748441|FG000|Overall Study|Lack of Efficacy|2|||
155358845|NCT03522389|560748442|FG000|Overall Study|Lost to Follow-up|1|||
155358846|NCT03522389|560748443|FG001|Overall Study|Lost to Follow-up|1|||
155358847|NCT03522389|560748444|FG002|Overall Study|Lost to Follow-up|2|||
155358848|NCT03522389|560748442|FG000|Overall Study|had herniated nucleus pulposus|0|||
155358849|NCT03522389|560748443|FG001|Overall Study|had herniated nucleus pulposus|1|||
155358850|NCT03522389|560748444|FG002|Overall Study|had herniated nucleus pulposus|0|||
155358851|NCT03522389|560748442|FG000|Overall Study|go to work in other province|1|||
155358852|NCT03522389|560748443|FG001|Overall Study|go to work in other province|0|||
155358853|NCT03522389|560748444|FG002|Overall Study|go to work in other province|0|||
155358854|NCT04680637|560748445|FG000|Overall Study|Lost to Follow-up|0|||
155358855|NCT04680637|560748446|FG001|Overall Study|Lost to Follow-up|1|||
155358856|NCT04680637|560748447|FG002|Overall Study|Lost to Follow-up|0|||
155358857|NCT04680637|560748448|FG003|Overall Study|Lost to Follow-up|1|||
155358858|NCT04680637|560748445|FG000|Overall Study|Death|1|||
155358859|NCT04680637|560748446|FG001|Overall Study|Death|0|||
155358860|NCT04680637|560748447|FG002|Overall Study|Death|0|||
155358861|NCT04680637|560748448|FG003|Overall Study|Death|0|||
155358862|NCT04680637|560748445|FG000|Overall Study|Withdrawal by Subject|7|||
155358863|NCT04680637|560748446|FG001|Overall Study|Withdrawal by Subject|10|||
155358864|NCT04680637|560748447|FG002|Overall Study|Withdrawal by Subject|17|||
155358865|NCT04680637|560748448|FG003|Overall Study|Withdrawal by Subject|15|||
155358866|NCT04680637|560748445|FG000|Overall Study|Decision by Sponsor|21|||
155358867|NCT04680637|560748446|FG001|Overall Study|Decision by Sponsor|15|||
155358868|NCT04680637|560748447|FG002|Overall Study|Decision by Sponsor|7|||
155358869|NCT04680637|560748448|FG003|Overall Study|Decision by Sponsor|32|||
155358870|NCT00604188|560748449|FG000|Overall Study|Adverse Event|1|||
155358871|NCT00604188|560748450|FG001|Overall Study|Adverse Event|4|||
155358872|NCT00604188|560748449|FG000|Overall Study|Lost to Follow-up|17|||
155358873|NCT00604188|560748450|FG001|Overall Study|Lost to Follow-up|15|||
155358874|NCT00604188|560748449|FG000|Overall Study|Withdrawal by Subject|5|||
155358875|NCT00604188|560748450|FG001|Overall Study|Withdrawal by Subject|1|||
155358876|NCT00604188|560748449|FG000|Overall Study|Non-compliance with protocol|4|||
155358877|NCT00604188|560748450|FG001|Overall Study|Non-compliance with protocol|4|||
155358878|NCT00604188|560748449|FG000|Overall Study|Did not receive study drug|0|||
155358879|NCT00604188|560748450|FG001|Overall Study|Did not receive study drug|1|||
155358880|NCT02242643|560748453|FG000|Overall Study|Protocol Violation|1|||
155358881|NCT02242643|560748454|FG001|Overall Study|Protocol Violation|2|||
155358882|NCT02242643|560748453|FG000|Overall Study|Withdrawal by Subject|15|||
155358883|NCT02242643|560748454|FG001|Overall Study|Withdrawal by Subject|10|||
155358884|NCT02242643|560748453|FG000|Overall Study|Migrated/moved from study area|1|||
155358885|NCT02242643|560748454|FG001|Overall Study|Migrated/moved from study area|3|||
155358886|NCT02242643|560748453|FG000|Overall Study|Lost to Follow-up|54|||
155358887|NCT02242643|560748454|FG001|Overall Study|Lost to Follow-up|61|||
155358888|NCT02242643|560748453|FG000|Overall Study|Child placed in foster care by family|0|||
155358889|NCT02242643|560748454|FG001|Overall Study|Child placed in foster care by family|1|||
155358890|NCT02242643|560748453|FG000|Overall Study|Non-compliance|1|||
155358891|NCT02242643|560748454|FG001|Overall Study|Non-compliance|0|||
155358892|NCT02242643|560748453|FG000|Overall Study|Consent withdrawal by parent|1|||
155358893|NCT02242643|560748454|FG001|Overall Study|Consent withdrawal by parent|0|||
155358894|NCT02242643|560748453|FG000|Overall Study|Protocol requirements not followed|1|||
155358895|NCT02242643|560748454|FG001|Overall Study|Protocol requirements not followed|0|||
155358896|NCT02242643|560748453|FG000|Overall Study|Language barrier|1|||
155358897|NCT02242643|560748454|FG001|Overall Study|Language barrier|0|||
155358898|NCT02242643|560748453|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
155358899|NCT02242643|560748454|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
155358900|NCT01103232|560748456|FG000|Overall Study|Withdrawal by Subject|1|||
155358901|NCT01103232|560748457|FG001|Overall Study|Withdrawal by Subject|1|||
155087652|NCT02471144|559754320|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155087653|NCT02471144|559754321|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155087654|NCT02471144|559754322|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155165849|NCT00560352|560043583|FG002|Overall Study|Disease progression|1|||
155358902|NCT01103232|560748456|FG000|Overall Study|Protocol Violation|0|||
155358903|NCT01103232|560748457|FG001|Overall Study|Protocol Violation|1|||
155358904|NCT00443599|560748461|FG000|Overall Study|Physician Decision|2|||
155358905|NCT00443599|560748462|FG001|Overall Study|Physician Decision|1|||
155358906|NCT00443599|560748461|FG000|Overall Study|Death|1|||
155358907|NCT00443599|560748462|FG001|Overall Study|Death|1|||
155358908|NCT00443599|560748461|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
155358909|NCT00443599|560748462|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
155358910|NCT05093504|560748463|FG000|Overall Study|Death|0|||
155358911|NCT05093504|560748464|FG001|Overall Study|Death|1|||
155358912|NCT05347485|560748469|FG000|Overall Study|Death|14|||
155358913|NCT05347485|560748469|FG000|Overall Study|Lost to Follow-up|2|||
155358914|NCT05347485|560748469|FG000|Overall Study|Withdrawal by Subject|13|||
155087655|NCT02471144|559754323|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155087656|NCT02471144|559754324|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155358915|NCT05347485|560748469|FG000|Overall Study|Progressive Disease|1|||
155358916|NCT05347485|560748469|FG000|Overall Study|Study Terminated by Sponsor|49|||
155358917|NCT05347485|560748469|FG000|Overall Study|Other|1|||
155358918|NCT05347485|560748469|FG000|Overall Study|Enrolled (consented) but not treated|4|||
155358919|NCT05347485|560748469|FG000|Overall Study|Disease Relapse|2|||
155358920|NCT01536587|560750024|FG000|Overall Study|Adverse Event|2|||
155358921|NCT02666664|560750025|FG000|Overall Study|Physician Decision|0|||
155358922|NCT02666664|560750026|FG001|Overall Study|Physician Decision|1|||
155358923|NCT02666664|560750025|FG000|Overall Study|Protocol Violation|0|||
155358924|NCT02666664|560750026|FG001|Overall Study|Protocol Violation|2|||
155358925|NCT02666664|560750025|FG000|Overall Study|Other|0|||
155358926|NCT02666664|560750026|FG001|Overall Study|Other|1|||
155358927|NCT02666664|560750025|FG000|Overall Study|Adverse Event|12|||
155358928|NCT02666664|560750026|FG001|Overall Study|Adverse Event|37|||
155358929|NCT02666664|560750025|FG000|Overall Study|Withdrawal by participant|23|||
155358930|NCT02666664|560750026|FG001|Overall Study|Withdrawal by participant|40|||
155358931|NCT02666664|560750025|FG000|Overall Study|Sponsor decision|0|||
155358932|NCT02666664|560750026|FG001|Overall Study|Sponsor decision|1|||
155358933|NCT02666664|560750025|FG000|Overall Study|Lost to Follow-up|1|||
155358934|NCT02666664|560750026|FG001|Overall Study|Lost to Follow-up|2|||
155358935|NCT03616964|560750027|FG000|Overall Study|Adverse Event|15|||
155358936|NCT03616964|560750028|FG001|Overall Study|Adverse Event|10|||
155358937|NCT03616964|560750029|FG002|Overall Study|Adverse Event|16|||
155358938|NCT03616964|560750027|FG000|Overall Study|Death|3|||
155358939|NCT03616964|560750028|FG001|Overall Study|Death|0|||
155358940|NCT03616964|560750029|FG002|Overall Study|Death|4|||
155358941|NCT03616964|560750027|FG000|Overall Study|Lack of Efficacy|4|||
155358942|NCT03616964|560750028|FG001|Overall Study|Lack of Efficacy|8|||
155358943|NCT03616964|560750029|FG002|Overall Study|Lack of Efficacy|8|||
155358944|NCT03616964|560750027|FG000|Overall Study|Lost to Follow-up|2|||
155358945|NCT03616964|560750028|FG001|Overall Study|Lost to Follow-up|1|||
155358946|NCT03616964|560750029|FG002|Overall Study|Lost to Follow-up|3|||
155358947|NCT03616964|560750027|FG000|Overall Study|Withdrawal by Subject|18|||
155358948|NCT03616964|560750028|FG001|Overall Study|Withdrawal by Subject|14|||
155087657|NCT02471144|559754325|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
155087658|NCT02471144|559754326|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
155087659|NCT02471144|559754327|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
155087660|NCT02471144|559754317|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155358949|NCT03616964|560750029|FG002|Overall Study|Withdrawal by Subject|21|||
155358950|NCT03616964|560750027|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
155358951|NCT03616964|560750028|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
155358952|NCT03616964|560750029|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
155358953|NCT03616964|560750027|FG000|Overall Study|Sponsor's Decision|1|||
155358954|NCT03616964|560750028|FG001|Overall Study|Sponsor's Decision|0|||
155358955|NCT03616964|560750029|FG002|Overall Study|Sponsor's Decision|0|||
155087661|NCT02471144|559754318|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155358956|NCT03616964|560750027|FG000|Overall Study|Physician Decision|0|||
155358957|NCT03616964|560750028|FG001|Overall Study|Physician Decision|2|||
155358958|NCT03616964|560750029|FG002|Overall Study|Physician Decision|0|||
155358959|NCT03616964|560750027|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
155358960|NCT03616964|560750028|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
155358961|NCT03616964|560750029|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
155358962|NCT03616964|560750027|FG000|Overall Study|Protocol Violation|0|||
155358963|NCT03616964|560750028|FG001|Overall Study|Protocol Violation|1|||
155358964|NCT03616964|560750029|FG002|Overall Study|Protocol Violation|0|||
155358965|NCT03616964|560750027|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
155358966|NCT03616964|560750028|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
155358967|NCT03616964|560750029|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
155358968|NCT03616964|560750027|FG000|Overall Study|Randomized but Never Treated|1|||
155358969|NCT03616964|560750028|FG001|Overall Study|Randomized but Never Treated|1|||
155358970|NCT03616964|560750029|FG002|Overall Study|Randomized but Never Treated|1|||
155358971|NCT04090528|560750033|FG000|Overall Study|participants still on study|9|||
155358972|NCT04090528|560750034|FG001|Overall Study|participants still on study|13|||
155358973|NCT02056626|560750035|FG000|Overall Study|patient did not follow directions|3|||
155358974|NCT02056626|560750036|FG001|Overall Study|patient did not follow directions|1|||
155358975|NCT02056626|560750037|FG002|Overall Study|patient did not follow directions|0|||
155358976|NCT02056626|560750038|FG003|Overall Study|patient did not follow directions|0|||
155358977|NCT04916002|560750042|FG000|Overall Study|Adverse Event|0|||
155358978|NCT04916002|560750043|FG001|Overall Study|Adverse Event|1|||
155358979|NCT04916002|560750044|FG002|Overall Study|Adverse Event|0|||
155358980|NCT04916002|560750045|FG003|Overall Study|Adverse Event|1|||
155358981|NCT04916002|560750046|FG004|Overall Study|Adverse Event|0|||
155358982|NCT04916002|560750042|FG000|Overall Study|Withdrawal by Subject|3|||
155358983|NCT04916002|560750043|FG001|Overall Study|Withdrawal by Subject|1|||
155358984|NCT04916002|560750044|FG002|Overall Study|Withdrawal by Subject|0|||
155358985|NCT04916002|560750045|FG003|Overall Study|Withdrawal by Subject|1|||
155358986|NCT04916002|560750046|FG004|Overall Study|Withdrawal by Subject|0|||
155358987|NCT04916002|560750042|FG000|Overall Study|Death|8|||
155358988|NCT04916002|560750043|FG001|Overall Study|Death|7|||
155358989|NCT04916002|560750044|FG002|Overall Study|Death|4|||
155358990|NCT04916002|560750045|FG003|Overall Study|Death|9|||
155358991|NCT04916002|560750046|FG004|Overall Study|Death|0|||
155358992|NCT04916002|560750042|FG000|Overall Study|Study Terminated by Sponsor|11|||
155358993|NCT04916002|560750043|FG001|Overall Study|Study Terminated by Sponsor|10|||
155358994|NCT04916002|560750044|FG002|Overall Study|Study Terminated by Sponsor|8|||
155358995|NCT04916002|560750045|FG003|Overall Study|Study Terminated by Sponsor|5|||
155358996|NCT04916002|560750046|FG004|Overall Study|Study Terminated by Sponsor|4|||
155358997|NCT04916002|560750042|FG000|Overall Study|End of trial|1|||
155358998|NCT04916002|560750043|FG001|Overall Study|End of trial|0|||
155358999|NCT04916002|560750044|FG002|Overall Study|End of trial|0|||
155359000|NCT04916002|560750045|FG003|Overall Study|End of trial|0|||
155359001|NCT04916002|560750046|FG004|Overall Study|End of trial|0|||
155359002|NCT04916002|560750042|FG000|Overall Study|Progressive disease|0|||
155359003|NCT04916002|560750043|FG001|Overall Study|Progressive disease|0|||
155359004|NCT04916002|560750044|FG002|Overall Study|Progressive disease|1|||
155359005|NCT04916002|560750045|FG003|Overall Study|Progressive disease|0|||
155359006|NCT04916002|560750046|FG004|Overall Study|Progressive disease|0|||
155359007|NCT04916002|560750042|FG000|Overall Study|Participant non-compliance|2|||
155359008|NCT04916002|560750043|FG001|Overall Study|Participant non-compliance|0|||
155359009|NCT04916002|560750044|FG002|Overall Study|Participant non-compliance|0|||
155359010|NCT04916002|560750045|FG003|Overall Study|Participant non-compliance|0|||
155359011|NCT04916002|560750046|FG004|Overall Study|Participant non-compliance|0|||
155359012|NCT05923112|560750047|FG000|Overall Study|Protocol Violation|4|||
155359013|NCT05923112|560750047|FG000|Overall Study|No informed consent on publication of study results|243|||
155359014|NCT04351269|560750048|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
155359015|NCT04351269|560750049|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
155359016|NCT04351269|560750050|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
155359017|NCT04351269|560750048|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
155359018|NCT04351269|560750049|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
155359019|NCT04351269|560750050|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
155359020|NCT04351269|560750048|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
155359021|NCT04351269|560750049|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
155359022|NCT04351269|560750050|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
155359023|NCT04351269|560750048|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
155359024|NCT04351269|560750049|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
155359025|NCT04351269|560750050|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
155359026|NCT04351269|560750048|FG000|Overall Study|Lost to Follow-up|1|||
155359027|NCT04351269|560750049|FG001|Overall Study|Lost to Follow-up|3|||
155359028|NCT04351269|560750050|FG002|Overall Study|Lost to Follow-up|0|||
155359029|NCT04486313|560750051|FG000|Overall Study|Lost to Follow-up|7|||
155359030|NCT04486313|560750052|FG001|Overall Study|Lost to Follow-up|9|||
155359031|NCT04486313|560750051|FG000|Overall Study|Withdrawal by Subject|8|||
155359032|NCT04486313|560750052|FG001|Overall Study|Withdrawal by Subject|6|||
155359033|NCT04486313|560750051|FG000|Overall Study|Physician Decision|1|||
155359034|NCT04486313|560750052|FG001|Overall Study|Physician Decision|1|||
155359035|NCT04486313|560750051|FG000|Overall Study|Death|2|||
155359036|NCT04486313|560750052|FG001|Overall Study|Death|0|||
155359037|NCT04486313|560750051|FG000|Overall Study|Protocol Violation|1|||
155359038|NCT04486313|560750052|FG001|Overall Study|Protocol Violation|1|||
155359039|NCT01162135|560750061|FG000|Overall Study|Withdrawal by Subject|1|||
155359040|NCT01162135|560750061|FG000|Overall Study|Severe back pain|1|||
155359041|NCT01162135|560750061|FG000|Overall Study|Ineligible|1|||
155359042|NCT01777334|560750062|FG000|Overall Study|Adverse Event|18|||
155359043|NCT01777334|560750063|FG001|Overall Study|Adverse Event|14|||
155359044|NCT01777334|560750062|FG000|Overall Study|Lack of Efficacy|15|||
155359045|NCT01777334|560750063|FG001|Overall Study|Lack of Efficacy|29|||
155359046|NCT01777334|560750062|FG000|Overall Study|Protocol Violation|3|||
155359047|NCT01777334|560750063|FG001|Overall Study|Protocol Violation|7|||
155359048|NCT01777334|560750062|FG000|Overall Study|Lost to Follow-up|3|||
155359049|NCT01777334|560750063|FG001|Overall Study|Lost to Follow-up|2|||
155359050|NCT01777334|560750062|FG000|Overall Study|Withdrawal by Subject|14|||
155359051|NCT01777334|560750063|FG001|Overall Study|Withdrawal by Subject|11|||
155359052|NCT06136897|560750070|FG000|Overall Study|Ineligible|3|||
155359053|NCT06136897|560750070|FG000|Overall Study|Mutation status not confirmed|7|||
155359054|NCT06136897|560750070|FG000|Overall Study|Adverse Event|2|||
155359055|NCT06136897|560750070|FG000|Overall Study|Death|1|||
155359056|NCT06136897|560750070|FG000|Overall Study|Disease progression|18|||
155359057|NCT06136897|560750070|FG000|Overall Study|Other complicating disease|1|||
155359058|NCT06136897|560750070|FG000|Overall Study|Withdrawal by Subject|1|||
155359059|NCT06136897|560750070|FG000|Overall Study|Still on treatment|1|||
155359060|NCT06136897|560750070|FG000|Overall Study|Lost to Follow-up|1|||
155359061|NCT00756457|560750071|FG000|Overall Study|Lost to Follow-up|1|||
155359062|NCT00756457|560750072|FG001|Overall Study|Lost to Follow-up|2|||
155359063|NCT02947100|560750073|FG000|Overall Study|study terminated early|3|||
155359064|NCT02947100|560750073|FG000|Overall Study|did not meet inclusion criteria|1|||
155359065|NCT00822770|560750074|FG000|Overall Study|Not treated|1|||
155359066|NCT00822770|560750075|FG001|Overall Study|Not treated|0|||
155359067|NCT00822770|560750074|FG000|Overall Study|Complication/Incomplete treatment|1|||
155359068|NCT00822770|560750075|FG001|Overall Study|Complication/Incomplete treatment|0|||
155359069|NCT00822770|560750074|FG000|Overall Study|Death|1|||
155359070|NCT00822770|560750075|FG001|Overall Study|Death|1|||
155359071|NCT02402322|560750076|FG000|Pretreatment|Withdrawal by Subject|3|||
155359072|NCT02402322|560750077|FG001|Pretreatment|Withdrawal by Subject|1|||
155359073|NCT02402322|560750078|FG002|Pretreatment|Withdrawal by Subject|1|||
155359074|NCT02402322|560750076|FG000|Follow-up|Withdrawal by Subject|6|||
155359075|NCT02402322|560750077|FG001|Follow-up|Withdrawal by Subject|3|||
155359076|NCT02402322|560750078|FG002|Follow-up|Withdrawal by Subject|24|||
155359077|NCT02818998|560750079|FG000|Overall Study|Adverse Event|3|||
155359078|NCT02818998|560750080|FG001|Overall Study|Adverse Event|2|||
155359079|NCT02818998|560750081|FG002|Overall Study|Adverse Event|1|||
155359080|NCT02818998|560750079|FG000|Overall Study|Lost to Follow-up|4|||
155359081|NCT02818998|560750080|FG001|Overall Study|Lost to Follow-up|1|||
155359082|NCT02818998|560750081|FG002|Overall Study|Lost to Follow-up|2|||
155359083|NCT02818998|560750079|FG000|Overall Study|Withdrawal by sponsor|0|||
155359084|NCT02818998|560750080|FG001|Overall Study|Withdrawal by sponsor|1|||
155359085|NCT02818998|560750081|FG002|Overall Study|Withdrawal by sponsor|1|||
155359086|NCT02818998|560750079|FG000|Overall Study|Death|3|||
155359087|NCT02818998|560750080|FG001|Overall Study|Death|6|||
155359088|NCT02818998|560750081|FG002|Overall Study|Death|8|||
155359089|NCT02818998|560750079|FG000|Overall Study|Withdrawal by Subject|7|||
155359090|NCT02818998|560750080|FG001|Overall Study|Withdrawal by Subject|6|||
155359091|NCT02818998|560750081|FG002|Overall Study|Withdrawal by Subject|6|||
155359092|NCT02818998|560750079|FG000|Overall Study|Physician Decision|1|||
155359093|NCT02818998|560750080|FG001|Overall Study|Physician Decision|0|||
155359094|NCT02818998|560750081|FG002|Overall Study|Physician Decision|0|||
155359095|NCT00632021|560750086|FG000|Overall Study|Withdrawal/death|4|||
155359096|NCT00632021|560750087|FG001|Overall Study|Withdrawal/death|7|||
155359097|NCT01296555|560750088|FG000|Overall Study|Adverse Event|0|||
155359098|NCT01296555|560750089|FG001|Overall Study|Adverse Event|0|||
155359099|NCT01296555|560750090|FG002|Overall Study|Adverse Event|1|||
155359100|NCT01296555|560750091|FG003|Overall Study|Adverse Event|1|||
155359101|NCT01296555|560750092|FG004|Overall Study|Adverse Event|2|||
155359102|NCT01296555|560750093|FG005|Overall Study|Adverse Event|4|||
155359103|NCT01296555|560750094|FG006|Overall Study|Adverse Event|1|||
154965080|NCT00258856|559298804|FG003|Overall Study|Lost to Follow-up|0|||
155359104|NCT01296555|560750095|FG007|Overall Study|Adverse Event|4|||
155359105|NCT01296555|560750096|FG008|Overall Study|Adverse Event|3|||
155359106|NCT01296555|560750097|FG009|Overall Study|Adverse Event|1|||
155359107|NCT01296555|560750098|FG010|Overall Study|Adverse Event|0|||
155359108|NCT01296555|560750099|FG011|Overall Study|Adverse Event|4|||
155359109|NCT01296555|560750100|FG012|Overall Study|Adverse Event|1|||
155359110|NCT01296555|560750101|FG013|Overall Study|Adverse Event|4|||
155359111|NCT01296555|560750102|FG014|Overall Study|Adverse Event|0|||
155359112|NCT01296555|560750103|FG015|Overall Study|Adverse Event|0|||
155359113|NCT01296555|560750104|FG016|Overall Study|Adverse Event|0|||
155359114|NCT01296555|560750105|FG017|Overall Study|Adverse Event|0|||
155359115|NCT01296555|560750106|FG018|Overall Study|Adverse Event|0|||
155359116|NCT01296555|560750107|FG019|Overall Study|Adverse Event|1|||
155359117|NCT01296555|560750108|FG020|Overall Study|Adverse Event|0|||
155359118|NCT01296555|560750109|FG021|Overall Study|Adverse Event|0|||
155359119|NCT01296555|560750110|FG022|Overall Study|Adverse Event|0|||
155359120|NCT01296555|560750111|FG023|Overall Study|Adverse Event|0|||
155359121|NCT01296555|560750112|FG024|Overall Study|Adverse Event|0|||
155359122|NCT01296555|560750113|FG025|Overall Study|Adverse Event|0|||
155359123|NCT01296555|560750114|FG026|Overall Study|Adverse Event|0|||
155359124|NCT01296555|560750115|FG027|Overall Study|Adverse Event|0|||
155359125|NCT01296555|560750116|FG028|Overall Study|Adverse Event|0|||
155359126|NCT01296555|560750088|FG000|Overall Study|Reason Not Specified|0|||
155359127|NCT01296555|560750089|FG001|Overall Study|Reason Not Specified|0|||
155359128|NCT01296555|560750090|FG002|Overall Study|Reason Not Specified|0|||
155359129|NCT01296555|560750091|FG003|Overall Study|Reason Not Specified|0|||
155359130|NCT01296555|560750092|FG004|Overall Study|Reason Not Specified|0|||
155359131|NCT01296555|560750093|FG005|Overall Study|Reason Not Specified|0|||
155359132|NCT01296555|560750094|FG006|Overall Study|Reason Not Specified|0|||
155359133|NCT01296555|560750095|FG007|Overall Study|Reason Not Specified|0|||
155359134|NCT01296555|560750096|FG008|Overall Study|Reason Not Specified|0|||
155359135|NCT01296555|560750097|FG009|Overall Study|Reason Not Specified|0|||
155359136|NCT01296555|560750098|FG010|Overall Study|Reason Not Specified|0|||
155359137|NCT01296555|560750099|FG011|Overall Study|Reason Not Specified|0|||
155359138|NCT01296555|560750100|FG012|Overall Study|Reason Not Specified|0|||
155359139|NCT01296555|560750101|FG013|Overall Study|Reason Not Specified|1|||
155359140|NCT01296555|560750102|FG014|Overall Study|Reason Not Specified|2|||
155359141|NCT01296555|560750103|FG015|Overall Study|Reason Not Specified|3|||
155359142|NCT01296555|560750104|FG016|Overall Study|Reason Not Specified|7|||
155359143|NCT01296555|560750105|FG017|Overall Study|Reason Not Specified|4|||
155359144|NCT01296555|560750106|FG018|Overall Study|Reason Not Specified|3|||
155359145|NCT01296555|560750107|FG019|Overall Study|Reason Not Specified|7|||
155359146|NCT01296555|560750108|FG020|Overall Study|Reason Not Specified|11|||
155359147|NCT01296555|560750109|FG021|Overall Study|Reason Not Specified|5|||
155359148|NCT01296555|560750110|FG022|Overall Study|Reason Not Specified|5|||
155359149|NCT01296555|560750111|FG023|Overall Study|Reason Not Specified|7|||
155359150|NCT01296555|560750112|FG024|Overall Study|Reason Not Specified|2|||
155359151|NCT01296555|560750113|FG025|Overall Study|Reason Not Specified|2|||
155359152|NCT01296555|560750114|FG026|Overall Study|Reason Not Specified|19|||
155359153|NCT01296555|560750115|FG027|Overall Study|Reason Not Specified|11|||
155359154|NCT01296555|560750116|FG028|Overall Study|Reason Not Specified|9|||
155359155|NCT01296555|560750088|FG000|Overall Study|Physician Decision|0|||
155359156|NCT01296555|560750089|FG001|Overall Study|Physician Decision|0|||
155359157|NCT01296555|560750090|FG002|Overall Study|Physician Decision|0|||
155359158|NCT01296555|560750091|FG003|Overall Study|Physician Decision|0|||
155359159|NCT01296555|560750092|FG004|Overall Study|Physician Decision|1|||
155359160|NCT01296555|560750093|FG005|Overall Study|Physician Decision|0|||
155359161|NCT01296555|560750094|FG006|Overall Study|Physician Decision|0|||
155359162|NCT01296555|560750095|FG007|Overall Study|Physician Decision|0|||
155359163|NCT01296555|560750096|FG008|Overall Study|Physician Decision|0|||
155359164|NCT01296555|560750097|FG009|Overall Study|Physician Decision|0|||
155359165|NCT01296555|560750098|FG010|Overall Study|Physician Decision|0|||
155359166|NCT01296555|560750099|FG011|Overall Study|Physician Decision|0|||
155359167|NCT01296555|560750100|FG012|Overall Study|Physician Decision|0|||
155359168|NCT01296555|560750101|FG013|Overall Study|Physician Decision|1|||
155359169|NCT01296555|560750102|FG014|Overall Study|Physician Decision|0|||
155359170|NCT01296555|560750103|FG015|Overall Study|Physician Decision|0|||
155359171|NCT01296555|560750104|FG016|Overall Study|Physician Decision|0|||
155359172|NCT01296555|560750105|FG017|Overall Study|Physician Decision|0|||
155359173|NCT01296555|560750106|FG018|Overall Study|Physician Decision|0|||
155359174|NCT01296555|560750107|FG019|Overall Study|Physician Decision|1|||
155359175|NCT01296555|560750108|FG020|Overall Study|Physician Decision|0|||
155359176|NCT01296555|560750109|FG021|Overall Study|Physician Decision|0|||
155359177|NCT01296555|560750110|FG022|Overall Study|Physician Decision|0|||
155359178|NCT01296555|560750111|FG023|Overall Study|Physician Decision|0|||
155359179|NCT01296555|560750112|FG024|Overall Study|Physician Decision|0|||
155359180|NCT01296555|560750113|FG025|Overall Study|Physician Decision|0|||
155359181|NCT01296555|560750114|FG026|Overall Study|Physician Decision|0|||
155359182|NCT01296555|560750115|FG027|Overall Study|Physician Decision|0|||
155359183|NCT01296555|560750116|FG028|Overall Study|Physician Decision|0|||
155359184|NCT01296555|560750088|FG000|Overall Study|Progressive Disease|6|||
155359185|NCT01296555|560750089|FG001|Overall Study|Progressive Disease|3|||
155359186|NCT01296555|560750090|FG002|Overall Study|Progressive Disease|3|||
155359187|NCT01296555|560750091|FG003|Overall Study|Progressive Disease|7|||
155359188|NCT01296555|560750092|FG004|Overall Study|Progressive Disease|6|||
155359189|NCT01296555|560750093|FG005|Overall Study|Progressive Disease|16|||
155359190|NCT01296555|560750094|FG006|Overall Study|Progressive Disease|16|||
155359191|NCT01296555|560750095|FG007|Overall Study|Progressive Disease|8|||
155359192|NCT01296555|560750096|FG008|Overall Study|Progressive Disease|7|||
155359193|NCT01296555|560750097|FG009|Overall Study|Progressive Disease|18|||
155359194|NCT01296555|560750098|FG010|Overall Study|Progressive Disease|7|||
155359195|NCT01296555|560750099|FG011|Overall Study|Progressive Disease|14|||
155359196|NCT01296555|560750100|FG012|Overall Study|Progressive Disease|5|||
155359197|NCT01296555|560750101|FG013|Overall Study|Progressive Disease|12|||
155359198|NCT01296555|560750102|FG014|Overall Study|Progressive Disease|1|||
155359199|NCT01296555|560750103|FG015|Overall Study|Progressive Disease|1|||
155359200|NCT01296555|560750104|FG016|Overall Study|Progressive Disease|0|||
155359201|NCT01296555|560750105|FG017|Overall Study|Progressive Disease|0|||
155359202|NCT01296555|560750106|FG018|Overall Study|Progressive Disease|0|||
155359203|NCT01296555|560750107|FG019|Overall Study|Progressive Disease|1|||
155359204|NCT01296555|560750108|FG020|Overall Study|Progressive Disease|0|||
155359205|NCT01296555|560750109|FG021|Overall Study|Progressive Disease|0|||
155359206|NCT01296555|560750110|FG022|Overall Study|Progressive Disease|0|||
155359207|NCT01296555|560750111|FG023|Overall Study|Progressive Disease|0|||
155359208|NCT01296555|560750112|FG024|Overall Study|Progressive Disease|1|||
155359209|NCT01296555|560750113|FG025|Overall Study|Progressive Disease|0|||
155359210|NCT01296555|560750114|FG026|Overall Study|Progressive Disease|5|||
155359211|NCT01296555|560750115|FG027|Overall Study|Progressive Disease|1|||
155359212|NCT01296555|560750116|FG028|Overall Study|Progressive Disease|0|||
155359213|NCT01296555|560750088|FG000|Overall Study|Protocol Violation|0|||
155359214|NCT01296555|560750089|FG001|Overall Study|Protocol Violation|0|||
155359215|NCT01296555|560750090|FG002|Overall Study|Protocol Violation|0|||
155359216|NCT01296555|560750091|FG003|Overall Study|Protocol Violation|0|||
155359217|NCT01296555|560750092|FG004|Overall Study|Protocol Violation|0|||
155359218|NCT01296555|560750093|FG005|Overall Study|Protocol Violation|0|||
155359219|NCT01296555|560750094|FG006|Overall Study|Protocol Violation|0|||
155359220|NCT01296555|560750095|FG007|Overall Study|Protocol Violation|0|||
155359221|NCT01296555|560750096|FG008|Overall Study|Protocol Violation|0|||
155359222|NCT01296555|560750097|FG009|Overall Study|Protocol Violation|0|||
155359223|NCT01296555|560750098|FG010|Overall Study|Protocol Violation|0|||
155359224|NCT01296555|560750099|FG011|Overall Study|Protocol Violation|0|||
155359225|NCT01296555|560750100|FG012|Overall Study|Protocol Violation|0|||
155359226|NCT01296555|560750101|FG013|Overall Study|Protocol Violation|1|||
155359227|NCT01296555|560750102|FG014|Overall Study|Protocol Violation|0|||
155359228|NCT01296555|560750103|FG015|Overall Study|Protocol Violation|0|||
155359229|NCT01296555|560750104|FG016|Overall Study|Protocol Violation|0|||
155359230|NCT01296555|560750105|FG017|Overall Study|Protocol Violation|0|||
155359231|NCT01296555|560750106|FG018|Overall Study|Protocol Violation|0|||
155359232|NCT01296555|560750107|FG019|Overall Study|Protocol Violation|0|||
155359233|NCT01296555|560750108|FG020|Overall Study|Protocol Violation|0|||
155359234|NCT01296555|560750109|FG021|Overall Study|Protocol Violation|0|||
155359235|NCT01296555|560750110|FG022|Overall Study|Protocol Violation|0|||
155359236|NCT01296555|560750111|FG023|Overall Study|Protocol Violation|0|||
155359237|NCT01296555|560750112|FG024|Overall Study|Protocol Violation|0|||
155359238|NCT01296555|560750113|FG025|Overall Study|Protocol Violation|0|||
155359239|NCT01296555|560750114|FG026|Overall Study|Protocol Violation|0|||
155359240|NCT01296555|560750115|FG027|Overall Study|Protocol Violation|0|||
155359241|NCT01296555|560750116|FG028|Overall Study|Protocol Violation|0|||
155359242|NCT01296555|560750088|FG000|Overall Study|Study Terminated By Sponsor|0|||
155359243|NCT01296555|560750089|FG001|Overall Study|Study Terminated By Sponsor|0|||
155359244|NCT01296555|560750090|FG002|Overall Study|Study Terminated By Sponsor|0|||
155359245|NCT01296555|560750091|FG003|Overall Study|Study Terminated By Sponsor|0|||
155359246|NCT01296555|560750092|FG004|Overall Study|Study Terminated By Sponsor|0|||
155359247|NCT01296555|560750093|FG005|Overall Study|Study Terminated By Sponsor|0|||
155359248|NCT01296555|560750094|FG006|Overall Study|Study Terminated By Sponsor|0|||
155359249|NCT01296555|560750095|FG007|Overall Study|Study Terminated By Sponsor|0|||
155359250|NCT01296555|560750096|FG008|Overall Study|Study Terminated By Sponsor|0|||
155359251|NCT01296555|560750097|FG009|Overall Study|Study Terminated By Sponsor|0|||
155359252|NCT01296555|560750098|FG010|Overall Study|Study Terminated By Sponsor|0|||
155359253|NCT01296555|560750099|FG011|Overall Study|Study Terminated By Sponsor|0|||
155359254|NCT01296555|560750100|FG012|Overall Study|Study Terminated By Sponsor|0|||
155359255|NCT01296555|560750101|FG013|Overall Study|Study Terminated By Sponsor|0|||
155359256|NCT01296555|560750102|FG014|Overall Study|Study Terminated By Sponsor|0|||
155359257|NCT01296555|560750103|FG015|Overall Study|Study Terminated By Sponsor|0|||
155359258|NCT01296555|560750104|FG016|Overall Study|Study Terminated By Sponsor|0|||
155359259|NCT01296555|560750105|FG017|Overall Study|Study Terminated By Sponsor|0|||
155359260|NCT01296555|560750106|FG018|Overall Study|Study Terminated By Sponsor|0|||
155359261|NCT01296555|560750107|FG019|Overall Study|Study Terminated By Sponsor|0|||
155359262|NCT01296555|560750108|FG020|Overall Study|Study Terminated By Sponsor|0|||
154965081|NCT00258856|559298801|FG000|Overall Study|Non-compliance|2|||
155359263|NCT01296555|560750109|FG021|Overall Study|Study Terminated By Sponsor|0|||
155359264|NCT01296555|560750110|FG022|Overall Study|Study Terminated By Sponsor|0|||
155359265|NCT01296555|560750111|FG023|Overall Study|Study Terminated By Sponsor|0|||
155359266|NCT01296555|560750112|FG024|Overall Study|Study Terminated By Sponsor|0|||
155359267|NCT01296555|560750113|FG025|Overall Study|Study Terminated By Sponsor|1|||
155359268|NCT01296555|560750114|FG026|Overall Study|Study Terminated By Sponsor|0|||
155359269|NCT01296555|560750115|FG027|Overall Study|Study Terminated By Sponsor|0|||
155359270|NCT01296555|560750116|FG028|Overall Study|Study Terminated By Sponsor|0|||
155359271|NCT01296555|560750088|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359272|NCT01296555|560750089|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359273|NCT01296555|560750090|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359274|NCT01296555|560750091|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359275|NCT01296555|560750092|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359276|NCT01296555|560750093|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359277|NCT01296555|560750094|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359278|NCT01296555|560750095|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359279|NCT01296555|560750096|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359280|NCT01296555|560750097|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359281|NCT01296555|560750098|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359282|NCT01296555|560750099|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359283|NCT01296555|560750100|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359284|NCT01296555|560750101|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359285|NCT01296555|560750102|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359286|NCT01296555|560750103|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359287|NCT01296555|560750104|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359288|NCT01296555|560750105|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359289|NCT01296555|560750106|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359290|NCT01296555|560750107|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
155359291|NCT01296555|560750108|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359292|NCT01296555|560750109|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359293|NCT01296555|560750110|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359294|NCT01296555|560750111|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359295|NCT01296555|560750112|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359296|NCT01296555|560750113|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359297|NCT01296555|560750114|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359298|NCT01296555|560750115|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359299|NCT01296555|560750116|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
155359300|NCT01296555|560750088|FG000|Overall Study|Death|0|||
155359301|NCT01296555|560750089|FG001|Overall Study|Death|0|||
155359302|NCT01296555|560750090|FG002|Overall Study|Death|0|||
155359303|NCT01296555|560750091|FG003|Overall Study|Death|2|||
155359304|NCT01296555|560750092|FG004|Overall Study|Death|1|||
155359305|NCT01296555|560750093|FG005|Overall Study|Death|0|||
155359306|NCT01296555|560750094|FG006|Overall Study|Death|2|||
155359307|NCT01296555|560750095|FG007|Overall Study|Death|0|||
155359308|NCT01296555|560750096|FG008|Overall Study|Death|0|||
155359309|NCT01296555|560750097|FG009|Overall Study|Death|1|||
155359310|NCT01296555|560750098|FG010|Overall Study|Death|0|||
155359311|NCT01296555|560750099|FG011|Overall Study|Death|1|||
155359312|NCT01296555|560750100|FG012|Overall Study|Death|0|||
155359313|NCT01296555|560750101|FG013|Overall Study|Death|2|||
155359314|NCT01296555|560750102|FG014|Overall Study|Death|27|||
155359315|NCT01296555|560750103|FG015|Overall Study|Death|15|||
155359316|NCT01296555|560750104|FG016|Overall Study|Death|11|||
155359317|NCT01296555|560750105|FG017|Overall Study|Death|11|||
155359318|NCT01296555|560750106|FG018|Overall Study|Death|17|||
155359319|NCT01296555|560750107|FG019|Overall Study|Death|12|||
155359320|NCT01296555|560750108|FG020|Overall Study|Death|13|||
155359321|NCT01296555|560750109|FG021|Overall Study|Death|12|||
155359322|NCT01296555|560750110|FG022|Overall Study|Death|12|||
155359323|NCT01296555|560750111|FG023|Overall Study|Death|13|||
155359324|NCT01296555|560750112|FG024|Overall Study|Death|7|||
155359325|NCT01296555|560750113|FG025|Overall Study|Death|7|||
155359326|NCT01296555|560750114|FG026|Overall Study|Death|35|||
155359327|NCT01296555|560750115|FG027|Overall Study|Death|92|||
155359328|NCT01296555|560750116|FG028|Overall Study|Death|44|||
155359329|NCT01296555|560750088|FG000|Overall Study|Lost to Follow-up|0|||
155359330|NCT01296555|560750089|FG001|Overall Study|Lost to Follow-up|0|||
155359331|NCT01296555|560750090|FG002|Overall Study|Lost to Follow-up|0|||
155359332|NCT01296555|560750091|FG003|Overall Study|Lost to Follow-up|0|||
155359333|NCT01296555|560750092|FG004|Overall Study|Lost to Follow-up|0|||
155359334|NCT01296555|560750093|FG005|Overall Study|Lost to Follow-up|0|||
155359335|NCT01296555|560750094|FG006|Overall Study|Lost to Follow-up|0|||
155359336|NCT01296555|560750095|FG007|Overall Study|Lost to Follow-up|0|||
155359337|NCT01296555|560750096|FG008|Overall Study|Lost to Follow-up|0|||
155359338|NCT01296555|560750097|FG009|Overall Study|Lost to Follow-up|0|||
155359339|NCT01296555|560750098|FG010|Overall Study|Lost to Follow-up|0|||
155359340|NCT01296555|560750099|FG011|Overall Study|Lost to Follow-up|0|||
155359341|NCT01296555|560750100|FG012|Overall Study|Lost to Follow-up|0|||
155359342|NCT01296555|560750101|FG013|Overall Study|Lost to Follow-up|0|||
155359343|NCT01296555|560750102|FG014|Overall Study|Lost to Follow-up|2|||
155359344|NCT01296555|560750103|FG015|Overall Study|Lost to Follow-up|1|||
155359345|NCT01296555|560750104|FG016|Overall Study|Lost to Follow-up|0|||
155359346|NCT01296555|560750105|FG017|Overall Study|Lost to Follow-up|2|||
155359347|NCT01296555|560750106|FG018|Overall Study|Lost to Follow-up|0|||
155359348|NCT01296555|560750107|FG019|Overall Study|Lost to Follow-up|2|||
155359349|NCT01296555|560750108|FG020|Overall Study|Lost to Follow-up|3|||
155359350|NCT01296555|560750109|FG021|Overall Study|Lost to Follow-up|2|||
155359351|NCT01296555|560750110|FG022|Overall Study|Lost to Follow-up|0|||
155359352|NCT01296555|560750111|FG023|Overall Study|Lost to Follow-up|0|||
155359353|NCT01296555|560750112|FG024|Overall Study|Lost to Follow-up|0|||
155359354|NCT01296555|560750113|FG025|Overall Study|Lost to Follow-up|0|||
155359355|NCT01296555|560750114|FG026|Overall Study|Lost to Follow-up|3|||
155359356|NCT01296555|560750115|FG027|Overall Study|Lost to Follow-up|13|||
155359357|NCT01296555|560750116|FG028|Overall Study|Lost to Follow-up|5|||
155359358|NCT01296555|560750088|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155359359|NCT01296555|560750089|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155359360|NCT01296555|560750090|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155359361|NCT01296555|560750091|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155359362|NCT01296555|560750092|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155359363|NCT01296555|560750093|FG005|Overall Study|Non-Compliance With Study Drug|0|||
155359364|NCT01296555|560750094|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155359365|NCT01296555|560750095|FG007|Overall Study|Non-Compliance With Study Drug|1|||
155359366|NCT01296555|560750096|FG008|Overall Study|Non-Compliance With Study Drug|0|||
155359367|NCT01296555|560750097|FG009|Overall Study|Non-Compliance With Study Drug|0|||
155359368|NCT01296555|560750098|FG010|Overall Study|Non-Compliance With Study Drug|0|||
155359369|NCT01296555|560750099|FG011|Overall Study|Non-Compliance With Study Drug|0|||
155359370|NCT01296555|560750100|FG012|Overall Study|Non-Compliance With Study Drug|0|||
155359371|NCT01296555|560750101|FG013|Overall Study|Non-Compliance With Study Drug|0|||
155359372|NCT01296555|560750102|FG014|Overall Study|Non-Compliance With Study Drug|0|||
155359373|NCT01296555|560750103|FG015|Overall Study|Non-Compliance With Study Drug|0|||
155359374|NCT01296555|560750104|FG016|Overall Study|Non-Compliance With Study Drug|0|||
155359375|NCT01296555|560750105|FG017|Overall Study|Non-Compliance With Study Drug|0|||
155359376|NCT01296555|560750106|FG018|Overall Study|Non-Compliance With Study Drug|0|||
155359377|NCT01296555|560750107|FG019|Overall Study|Non-Compliance With Study Drug|0|||
155359378|NCT01296555|560750108|FG020|Overall Study|Non-Compliance With Study Drug|0|||
155359379|NCT01296555|560750109|FG021|Overall Study|Non-Compliance With Study Drug|0|||
155359380|NCT01296555|560750110|FG022|Overall Study|Non-Compliance With Study Drug|0|||
155359381|NCT01296555|560750111|FG023|Overall Study|Non-Compliance With Study Drug|0|||
155359382|NCT01296555|560750112|FG024|Overall Study|Non-Compliance With Study Drug|0|||
155359383|NCT01296555|560750113|FG025|Overall Study|Non-Compliance With Study Drug|0|||
155359384|NCT01296555|560750114|FG026|Overall Study|Non-Compliance With Study Drug|0|||
155359385|NCT01296555|560750115|FG027|Overall Study|Non-Compliance With Study Drug|0|||
155359386|NCT01296555|560750116|FG028|Overall Study|Non-Compliance With Study Drug|0|||
155359387|NCT01296555|560750088|FG000|Overall Study|Withdrawal by Subject|0|||
155359388|NCT01296555|560750089|FG001|Overall Study|Withdrawal by Subject|0|||
155359389|NCT01296555|560750090|FG002|Overall Study|Withdrawal by Subject|0|||
155359390|NCT01296555|560750091|FG003|Overall Study|Withdrawal by Subject|0|||
155359391|NCT01296555|560750092|FG004|Overall Study|Withdrawal by Subject|1|||
155359392|NCT01296555|560750093|FG005|Overall Study|Withdrawal by Subject|0|||
155359393|NCT01296555|560750094|FG006|Overall Study|Withdrawal by Subject|1|||
155359394|NCT01296555|560750095|FG007|Overall Study|Withdrawal by Subject|0|||
155359395|NCT01296555|560750096|FG008|Overall Study|Withdrawal by Subject|0|||
155359396|NCT01296555|560750097|FG009|Overall Study|Withdrawal by Subject|0|||
155165850|NCT00560352|560043581|FG000|Overall Study|Withdrawal by Subject|1|||
155165851|NCT00560352|560043582|FG001|Overall Study|Withdrawal by Subject|1|||
155165852|NCT00560352|560043583|FG002|Overall Study|Withdrawal by Subject|1|||
155359397|NCT01296555|560750098|FG010|Overall Study|Withdrawal by Subject|1|||
155359398|NCT01296555|560750099|FG011|Overall Study|Withdrawal by Subject|1|||
155359399|NCT01296555|560750100|FG012|Overall Study|Withdrawal by Subject|0|||
155359400|NCT01296555|560750101|FG013|Overall Study|Withdrawal by Subject|0|||
155359401|NCT01296555|560750102|FG014|Overall Study|Withdrawal by Subject|3|||
155359402|NCT01296555|560750103|FG015|Overall Study|Withdrawal by Subject|0|||
155359403|NCT01296555|560750104|FG016|Overall Study|Withdrawal by Subject|2|||
155359404|NCT01296555|560750105|FG017|Overall Study|Withdrawal by Subject|1|||
155359405|NCT01296555|560750106|FG018|Overall Study|Withdrawal by Subject|0|||
155359406|NCT01296555|560750107|FG019|Overall Study|Withdrawal by Subject|1|||
155359407|NCT01296555|560750108|FG020|Overall Study|Withdrawal by Subject|1|||
155359408|NCT01296555|560750109|FG021|Overall Study|Withdrawal by Subject|1|||
155359409|NCT01296555|560750110|FG022|Overall Study|Withdrawal by Subject|3|||
155359410|NCT01296555|560750111|FG023|Overall Study|Withdrawal by Subject|0|||
155087662|NCT02471144|559754319|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155087663|NCT02471144|559754320|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155359411|NCT01296555|560750112|FG024|Overall Study|Withdrawal by Subject|0|||
155359412|NCT01296555|560750113|FG025|Overall Study|Withdrawal by Subject|0|||
155359413|NCT01296555|560750114|FG026|Overall Study|Withdrawal by Subject|8|||
155359414|NCT01296555|560750115|FG027|Overall Study|Withdrawal by Subject|4|||
155359415|NCT01296555|560750116|FG028|Overall Study|Withdrawal by Subject|2|||
155359416|NCT02250534|560750117|FG000|Overall Study|Lost to Follow-up|18|||
155359417|NCT02250534|560750118|FG001|Overall Study|Lost to Follow-up|28|||
155359418|NCT02250534|560750119|FG002|Overall Study|Lost to Follow-up|33|||
155359419|NCT02250534|560750117|FG000|Overall Study|Personal reasons|7|||
155359420|NCT02250534|560750118|FG001|Overall Study|Personal reasons|8|||
155359421|NCT02250534|560750119|FG002|Overall Study|Personal reasons|14|||
155359422|NCT02250534|560750117|FG000|Overall Study|Adverse Event|6|||
155359423|NCT02250534|560750118|FG001|Overall Study|Adverse Event|3|||
155359424|NCT02250534|560750119|FG002|Overall Study|Adverse Event|8|||
155359425|NCT02250534|560750117|FG000|Overall Study|incarcerated|2|||
155359426|NCT02250534|560750118|FG001|Overall Study|incarcerated|1|||
155359427|NCT02250534|560750119|FG002|Overall Study|incarcerated|2|||
155359428|NCT02250534|560750117|FG000|Overall Study|Withdrawal by Subject|0|||
155359429|NCT02250534|560750118|FG001|Overall Study|Withdrawal by Subject|1|||
155359430|NCT02250534|560750119|FG002|Overall Study|Withdrawal by Subject|2|||
155359431|NCT02250534|560750117|FG000|Overall Study|Death|0|||
155359432|NCT02250534|560750118|FG001|Overall Study|Death|1|||
155359433|NCT02250534|560750119|FG002|Overall Study|Death|1|||
155359434|NCT02250534|560750117|FG000|Overall Study|Physician Decision|1|||
155359435|NCT02250534|560750118|FG001|Overall Study|Physician Decision|3|||
155359436|NCT02250534|560750119|FG002|Overall Study|Physician Decision|1|||
155359437|NCT02250534|560750117|FG000|Overall Study|Protocol Violation|1|||
155359438|NCT02250534|560750118|FG001|Overall Study|Protocol Violation|0|||
155359439|NCT02250534|560750119|FG002|Overall Study|Protocol Violation|1|||
155359440|NCT02250534|560750117|FG000|Overall Study|Reason unknown|1|||
155359441|NCT02250534|560750118|FG001|Overall Study|Reason unknown|0|||
155359442|NCT02250534|560750119|FG002|Overall Study|Reason unknown|0|||
155359443|NCT01101061|560750120|FG000|Overall Study|Adverse Event|0|||
155359444|NCT01101061|560750121|FG001|Overall Study|Adverse Event|0|||
155359445|NCT01101061|560750122|FG002|Overall Study|Adverse Event|1|||
155359446|NCT01101061|560750123|FG003|Overall Study|Adverse Event|0|||
155359447|NCT01101061|560750124|FG004|Overall Study|Adverse Event|0|||
155359448|NCT01101061|560750125|FG005|Overall Study|Adverse Event|0|||
155359449|NCT01587118|560750126|FG000|Overall Study|Adverse Event|3|||
155359450|NCT01587118|560750126|FG000|Overall Study|Lost to Follow-up|2|||
155359451|NCT01587118|560750126|FG000|Overall Study|Relocation|1|||
155359452|NCT01587118|560750126|FG000|Overall Study|nonresponse|1|||
155359453|NCT00537329|560750127|FG000|Overall Study|Death|10|||
155359454|NCT00537329|560750127|FG000|Overall Study|Adverse Event|3|||
155359455|NCT00537329|560750127|FG000|Overall Study|Lack of Efficacy|2|||
155359456|NCT00537329|560750127|FG000|Overall Study|Lost to Follow-up|6|||
155359457|NCT00537329|560750127|FG000|Overall Study|Withdrawal by Subject|4|||
155359458|NCT00537329|560750127|FG000|Overall Study|Other|1|||
155359459|NCT03599622|560750128|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
155359460|NCT03599622|560750129|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
155359461|NCT03599622|560750130|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
155359462|NCT03599622|560750131|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
155359463|NCT03599622|560750128|FG000|Pre-Treatment Period|Other reasons|1|||
155359464|NCT03599622|560750129|FG001|Pre-Treatment Period|Other reasons|1|||
155359465|NCT03599622|560750130|FG002|Pre-Treatment Period|Other reasons|1|||
155359466|NCT03599622|560750131|FG003|Pre-Treatment Period|Other reasons|0|||
155359467|NCT03599622|560750128|FG000|Treatment Period|Adverse Event|11|||
155359468|NCT03599622|560750129|FG001|Treatment Period|Adverse Event|20|||
155359469|NCT03599622|560750130|FG002|Treatment Period|Adverse Event|18|||
155359470|NCT03599622|560750131|FG003|Treatment Period|Adverse Event|2|||
155087664|NCT02471144|559754321|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155087665|NCT02471144|559754322|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155087666|NCT02471144|559754323|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155087667|NCT02471144|559754324|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155087668|NCT02471144|559754325|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155359471|NCT03599622|560750128|FG000|Treatment Period|Lack of Efficacy|18|||
155359472|NCT03599622|560750129|FG001|Treatment Period|Lack of Efficacy|12|||
155359473|NCT03599622|560750130|FG002|Treatment Period|Lack of Efficacy|13|||
155359474|NCT03599622|560750131|FG003|Treatment Period|Lack of Efficacy|2|||
155359475|NCT03599622|560750128|FG000|Treatment Period|Withdrawal by Subject|5|||
155359476|NCT03599622|560750129|FG001|Treatment Period|Withdrawal by Subject|11|||
155359477|NCT03599622|560750130|FG002|Treatment Period|Withdrawal by Subject|16|||
155359478|NCT03599622|560750131|FG003|Treatment Period|Withdrawal by Subject|1|||
155359479|NCT03599622|560750128|FG000|Treatment Period|Other reasons|4|||
155359480|NCT03599622|560750129|FG001|Treatment Period|Other reasons|6|||
155359481|NCT03599622|560750130|FG002|Treatment Period|Other reasons|7|||
155359482|NCT03599622|560750131|FG003|Treatment Period|Other reasons|0|||
155359483|NCT03599622|560750128|FG000|Treatment Period|Lost to Follow-up|1|||
155359484|NCT03599622|560750129|FG001|Treatment Period|Lost to Follow-up|0|||
155359485|NCT03599622|560750130|FG002|Treatment Period|Lost to Follow-up|0|||
155359486|NCT03599622|560750131|FG003|Treatment Period|Lost to Follow-up|0|||
155359487|NCT03599622|560750128|FG000|Treatment Period|Study terminated by sponsor|7|||
155359488|NCT03599622|560750129|FG001|Treatment Period|Study terminated by sponsor|20|||
155359489|NCT03599622|560750130|FG002|Treatment Period|Study terminated by sponsor|15|||
155359490|NCT03599622|560750131|FG003|Treatment Period|Study terminated by sponsor|0|||
155359491|NCT03599622|560750128|FG000|Treatment Period|Site terminated by sponsor|0|||
155359492|NCT03599622|560750129|FG001|Treatment Period|Site terminated by sponsor|1|||
155359493|NCT03599622|560750130|FG002|Treatment Period|Site terminated by sponsor|0|||
155359494|NCT03599622|560750131|FG003|Treatment Period|Site terminated by sponsor|0|||
155359495|NCT00778921|560750132|FG000|Overall Study|Adverse Event|9|||
155359496|NCT00778921|560750133|FG001|Overall Study|Adverse Event|10|||
155359497|NCT00778921|560750134|FG002|Overall Study|Adverse Event|14|||
155359498|NCT00778921|560750132|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155359499|NCT00778921|560750133|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
155359500|NCT00778921|560750134|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155359501|NCT00778921|560750132|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
155359502|NCT00778921|560750133|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155359503|NCT00778921|560750134|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
155359504|NCT00778921|560750132|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
155359505|NCT00778921|560750133|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
155359506|NCT00778921|560750134|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
155359507|NCT00778921|560750132|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
155359508|NCT00778921|560750133|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
155359509|NCT00778921|560750134|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
155359510|NCT00778921|560750132|FG000|Overall Study|Patient withdrew request|3|||
155359511|NCT00778921|560750133|FG001|Overall Study|Patient withdrew request|1|||
155359512|NCT00778921|560750134|FG002|Overall Study|Patient withdrew request|6|||
155359513|NCT00778921|560750132|FG000|Overall Study|Lost to Follow-up|0|||
155359514|NCT00778921|560750133|FG001|Overall Study|Lost to Follow-up|2|||
155359515|NCT00778921|560750134|FG002|Overall Study|Lost to Follow-up|1|||
155359516|NCT00778921|560750132|FG000|Overall Study|Administrative Problems|1|||
155359517|NCT00778921|560750133|FG001|Overall Study|Administrative Problems|2|||
155359518|NCT00778921|560750134|FG002|Overall Study|Administrative Problems|0|||
155359519|NCT00778921|560750132|FG000|Overall Study|Protocol Violation|3|||
155359520|NCT00778921|560750133|FG001|Overall Study|Protocol Violation|0|||
155359521|NCT00778921|560750134|FG002|Overall Study|Protocol Violation|2|||
155359522|NCT00778921|560750132|FG000|Overall Study|Not treated|0|||
155359523|NCT00778921|560750133|FG001|Overall Study|Not treated|2|||
155359524|NCT00778921|560750134|FG002|Overall Study|Not treated|2|||
155359525|NCT00572533|560750135|FG000|Overall Study|Death|4|||
155359526|NCT00572533|560750136|FG001|Overall Study|Death|1|||
155359527|NCT00572533|560750135|FG000|Overall Study|Received Kidney Transplant|2|||
155359528|NCT00572533|560750136|FG001|Overall Study|Received Kidney Transplant|1|||
155359529|NCT00572533|560750135|FG000|Overall Study|Social Issues|1|||
155359530|NCT00572533|560750136|FG001|Overall Study|Social Issues|0|||
155359531|NCT00572533|560750135|FG000|Overall Study|Transfer out of Facility|0|||
155359532|NCT00572533|560750136|FG001|Overall Study|Transfer out of Facility|1|||
155359533|NCT00267098|560750137|FG000|Overall Study|Death|0|||
155359534|NCT00267098|560750138|FG001|Overall Study|Death|0|||
155359535|NCT00267098|560750139|FG002|Overall Study|Death|57|||
155359536|NCT00267098|560750140|FG003|Overall Study|Death|66|||
155359537|NCT00267098|560750141|FG004|Overall Study|Death|14|||
154965082|NCT00258856|559298802|FG001|Overall Study|Non-compliance|0|||
155165853|NCT00560352|560043581|FG000|Overall Study|Maximum clinical benefit|1|||
155165854|NCT00560352|560043582|FG001|Overall Study|Maximum clinical benefit|0|||
155165855|NCT00560352|560043583|FG002|Overall Study|Maximum clinical benefit|0|||
155165856|NCT03892967|560043587|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
155359538|NCT00267098|560750142|FG005|Overall Study|Death|23|||
155359539|NCT00267098|560750143|FG006|Overall Study|Death|28|||
155359540|NCT00267098|560750144|FG007|Overall Study|Death|9|||
155359541|NCT00267098|560750137|FG000|Overall Study|Lost to Follow-up|0|||
155359542|NCT00267098|560750138|FG001|Overall Study|Lost to Follow-up|0|||
155359543|NCT00267098|560750139|FG002|Overall Study|Lost to Follow-up|6|||
155359544|NCT00267098|560750140|FG003|Overall Study|Lost to Follow-up|5|||
155359545|NCT00267098|560750141|FG004|Overall Study|Lost to Follow-up|2|||
155359546|NCT00267098|560750142|FG005|Overall Study|Lost to Follow-up|3|||
155359547|NCT00267098|560750143|FG006|Overall Study|Lost to Follow-up|1|||
155359548|NCT00267098|560750144|FG007|Overall Study|Lost to Follow-up|1|||
155359549|NCT00267098|560750137|FG000|Overall Study|Withdrawal by Subject|8|||
155359550|NCT00267098|560750138|FG001|Overall Study|Withdrawal by Subject|0|||
155359551|NCT00267098|560750139|FG002|Overall Study|Withdrawal by Subject|24|||
155359552|NCT00267098|560750140|FG003|Overall Study|Withdrawal by Subject|21|||
155359553|NCT00267098|560750141|FG004|Overall Study|Withdrawal by Subject|12|||
155359554|NCT00267098|560750142|FG005|Overall Study|Withdrawal by Subject|9|||
155359555|NCT00267098|560750143|FG006|Overall Study|Withdrawal by Subject|12|||
155359556|NCT00267098|560750144|FG007|Overall Study|Withdrawal by Subject|5|||
155359557|NCT00267098|560750137|FG000|Overall Study|Physician Decision|5|||
155359558|NCT00267098|560750138|FG001|Overall Study|Physician Decision|0|||
155359559|NCT00267098|560750139|FG002|Overall Study|Physician Decision|7|||
155359560|NCT00267098|560750140|FG003|Overall Study|Physician Decision|11|||
155359561|NCT00267098|560750141|FG004|Overall Study|Physician Decision|5|||
155359562|NCT00267098|560750142|FG005|Overall Study|Physician Decision|4|||
155359563|NCT00267098|560750143|FG006|Overall Study|Physician Decision|3|||
155359564|NCT00267098|560750144|FG007|Overall Study|Physician Decision|0|||
155359565|NCT00267098|560750137|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
155359566|NCT00267098|560750138|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359567|NCT00267098|560750139|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359568|NCT00267098|560750140|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359569|NCT00267098|560750141|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
155359570|NCT00267098|560750142|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359571|NCT00267098|560750143|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359572|NCT00267098|560750144|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155359573|NCT00267098|560750137|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359574|NCT00267098|560750138|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
155359575|NCT00267098|560750139|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359576|NCT00267098|560750140|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359577|NCT00267098|560750141|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359578|NCT00267098|560750142|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359579|NCT00267098|560750143|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359580|NCT00267098|560750144|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
155359581|NCT00267098|560750137|FG000|Overall Study|Site closure|0|||
155359582|NCT00267098|560750138|FG001|Overall Study|Site closure|0|||
155359583|NCT00267098|560750139|FG002|Overall Study|Site closure|0|||
155359584|NCT00267098|560750140|FG003|Overall Study|Site closure|1|||
155359585|NCT00267098|560750141|FG004|Overall Study|Site closure|0|||
155359586|NCT00267098|560750142|FG005|Overall Study|Site closure|1|||
155359587|NCT00267098|560750143|FG006|Overall Study|Site closure|1|||
155359588|NCT00267098|560750144|FG007|Overall Study|Site closure|0|||
155359589|NCT00267098|560750137|FG000|Overall Study|Explanted Medtronic device|0|||
155359590|NCT00267098|560750138|FG001|Overall Study|Explanted Medtronic device|0|||
155359591|NCT00267098|560750139|FG002|Overall Study|Explanted Medtronic device|0|||
155359592|NCT00267098|560750140|FG003|Overall Study|Explanted Medtronic device|1|||
155359593|NCT00267098|560750141|FG004|Overall Study|Explanted Medtronic device|0|||
155359594|NCT00267098|560750142|FG005|Overall Study|Explanted Medtronic device|0|||
155359595|NCT00267098|560750143|FG006|Overall Study|Explanted Medtronic device|0|||
155359596|NCT00267098|560750144|FG007|Overall Study|Explanted Medtronic device|0|||
155359597|NCT00267098|560750137|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359598|NCT00267098|560750138|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359599|NCT00267098|560750139|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359600|NCT00267098|560750140|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359601|NCT00267098|560750141|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
155359602|NCT00267098|560750142|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359603|NCT00267098|560750143|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359604|NCT00267098|560750144|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
155359605|NCT00267098|560750137|FG000|Overall Study|Subject listed for heart transplant|0|||
155359606|NCT00267098|560750138|FG001|Overall Study|Subject listed for heart transplant|0|||
155359607|NCT00267098|560750139|FG002|Overall Study|Subject listed for heart transplant|0|||
155359608|NCT00267098|560750140|FG003|Overall Study|Subject listed for heart transplant|0|||
155359609|NCT00267098|560750141|FG004|Overall Study|Subject listed for heart transplant|0|||
155359610|NCT00267098|560750142|FG005|Overall Study|Subject listed for heart transplant|0|||
155359611|NCT00267098|560750143|FG006|Overall Study|Subject listed for heart transplant|1|||
155359612|NCT00267098|560750144|FG007|Overall Study|Subject listed for heart transplant|0|||
155359613|NCT00267098|560750137|FG000|Overall Study|Sponsor withdrew subject|0|||
155359614|NCT00267098|560750138|FG001|Overall Study|Sponsor withdrew subject|0|||
155359615|NCT00267098|560750139|FG002|Overall Study|Sponsor withdrew subject|0|||
155359616|NCT00267098|560750140|FG003|Overall Study|Sponsor withdrew subject|1|||
155359617|NCT00267098|560750141|FG004|Overall Study|Sponsor withdrew subject|0|||
155359618|NCT00267098|560750142|FG005|Overall Study|Sponsor withdrew subject|0|||
155359619|NCT00267098|560750143|FG006|Overall Study|Sponsor withdrew subject|0|||
155359620|NCT00267098|560750144|FG007|Overall Study|Sponsor withdrew subject|0|||
155359621|NCT00798304|560750145|FG000|Overall Study|Adverse Event|0|||
155359622|NCT00798304|560750146|FG001|Overall Study|Adverse Event|1|||
155359623|NCT00798304|560750147|FG002|Overall Study|Adverse Event|1|||
155359624|NCT00798304|560750145|FG000|Overall Study|Discontinuation by Sponsor|14|||
155359625|NCT00798304|560750146|FG001|Overall Study|Discontinuation by Sponsor|21|||
155359626|NCT00798304|560750147|FG002|Overall Study|Discontinuation by Sponsor|9|||
155359627|NCT02031536|560750148|FG000|Overall Study|ineligible|1|||
155359628|NCT02031536|560750149|FG001|Overall Study|ineligible|0|||
155359629|NCT04211389|560750150|FG000|Overall Study|Adverse Event|1|||
155359630|NCT04211389|560750151|FG001|Overall Study|Adverse Event|2|||
155359631|NCT04211389|560750150|FG000|Overall Study|Lost to Follow-up|15|||
155359632|NCT04211389|560750151|FG001|Overall Study|Lost to Follow-up|7|||
155359633|NCT04211389|560750150|FG000|Overall Study|Protocol Violation|0|||
155359634|NCT04211389|560750151|FG001|Overall Study|Protocol Violation|1|||
155359635|NCT04211389|560750150|FG000|Overall Study|Withdrawal by Subject|10|||
155359636|NCT04211389|560750151|FG001|Overall Study|Withdrawal by Subject|11|||
155359637|NCT00547534|560750153|FG000|Overall Study|Adverse Event|7|||
155359638|NCT00547534|560750153|FG000|Overall Study|Disease Progression|4|||
155359639|NCT04206085|560750154|FG000|Overall Study|Lost to Follow-up|0|||
155359640|NCT04206085|560750155|FG001|Overall Study|Lost to Follow-up|1|||
155359641|NCT04206085|560750156|FG002|Overall Study|Lost to Follow-up|0|||
155359642|NCT04206085|560750154|FG000|Overall Study|Lost to Follow-up|0|||
155359643|NCT04206085|560750155|FG001|Overall Study|Lost to Follow-up|0|||
155359644|NCT04206085|560750156|FG002|Overall Study|Lost to Follow-up|1|||
155359645|NCT00087555|560750163|FG000|Overall Study|Adverse Event|3|||
155359646|NCT00087555|560750164|FG001|Overall Study|Adverse Event|6|||
155359647|NCT00087555|560750165|FG002|Overall Study|Adverse Event|14|||
155359648|NCT00087555|560750163|FG000|Overall Study|Lost to Follow-up|0|||
155359649|NCT00087555|560750164|FG001|Overall Study|Lost to Follow-up|1|||
155359650|NCT00087555|560750165|FG002|Overall Study|Lost to Follow-up|1|||
155359651|NCT00087555|560750163|FG000|Overall Study|Non - Compliance|1|||
155359652|NCT00087555|560750164|FG001|Overall Study|Non - Compliance|0|||
155359653|NCT00087555|560750165|FG002|Overall Study|Non - Compliance|0|||
155359654|NCT00087555|560750163|FG000|Overall Study|Protocol Violation|0|||
155359655|NCT00087555|560750164|FG001|Overall Study|Protocol Violation|0|||
155359656|NCT00087555|560750165|FG002|Overall Study|Protocol Violation|2|||
155359657|NCT00087555|560750163|FG000|Overall Study|Screen Failure|1|||
155359658|NCT00087555|560750164|FG001|Overall Study|Screen Failure|1|||
155359659|NCT00087555|560750165|FG002|Overall Study|Screen Failure|0|||
155359660|NCT00087555|560750163|FG000|Overall Study|Pregnancy|0|||
155359661|NCT00087555|560750164|FG001|Overall Study|Pregnancy|1|||
155359662|NCT00087555|560750165|FG002|Overall Study|Pregnancy|1|||
155359663|NCT00087555|560750163|FG000|Overall Study|Withdrawal by Subject|3|||
155359664|NCT00087555|560750164|FG001|Overall Study|Withdrawal by Subject|2|||
155359665|NCT00087555|560750165|FG002|Overall Study|Withdrawal by Subject|1|||
155359666|NCT00087555|560750163|FG000|Overall Study|Lack of Efficacy|2|||
155359667|NCT00087555|560750164|FG001|Overall Study|Lack of Efficacy|0|||
155359668|NCT00087555|560750165|FG002|Overall Study|Lack of Efficacy|1|||
155359669|NCT00087555|560750163|FG000|Overall Study|Non Compliance|0|||
155359670|NCT00087555|560750164|FG001|Overall Study|Non Compliance|0|||
155359671|NCT00087555|560750165|FG002|Overall Study|Non Compliance|1|||
155359672|NCT00087555|560750163|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
155359673|NCT00087555|560750164|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
155359674|NCT00087555|560750165|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
155359675|NCT00087555|560750163|FG000|Overall Study|Patient wanted to go back on Med|1|||
155359676|NCT00087555|560750164|FG001|Overall Study|Patient wanted to go back on Med|0|||
155359677|NCT00087555|560750165|FG002|Overall Study|Patient wanted to go back on Med|0|||
155359678|NCT01530087|560750166|FG000|Overall Study|Physician Decision|2|||
155359679|NCT02760485|560750167|FG000|Phase 1|Death|3|||
155359680|NCT02760485|560750168|FG001|Phase 1|Death|6|||
155359681|NCT02760485|560750169|FG002|Phase 1|Death|0|||
155359682|NCT02760485|560750167|FG000|Phase 1|Withdrawal by Subject|2|||
155359683|NCT02760485|560750168|FG001|Phase 1|Withdrawal by Subject|0|||
155359684|NCT02760485|560750169|FG002|Phase 1|Withdrawal by Subject|0|||
155359685|NCT02760485|560750167|FG000|Phase 1|Progressive Disease|1|||
155359686|NCT02760485|560750168|FG001|Phase 1|Progressive Disease|0|||
155359687|NCT02760485|560750169|FG002|Phase 1|Progressive Disease|0|||
155359688|NCT02760485|560750167|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
155359689|NCT02760485|560750168|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
154965083|NCT00258856|559298803|FG002|Overall Study|Non-compliance|0|||
154965084|NCT00258856|559298804|FG003|Overall Study|Non-compliance|1|||
154965085|NCT03247686|559298805|FG000|Overall Study|Withdrawal by Subject|1|||
154965086|NCT03247686|559298806|FG001|Overall Study|Withdrawal by Subject|2|||
155359690|NCT02760485|560750169|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
155359691|NCT02760485|560750167|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
155359692|NCT02760485|560750168|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
155359693|NCT02760485|560750169|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
155359694|NCT02760485|560750167|FG000|Phase 2|Death|0|||
155359695|NCT02760485|560750168|FG001|Phase 2|Death|0|||
155359696|NCT02760485|560750169|FG002|Phase 2|Death|12|||
155359697|NCT02760485|560750167|FG000|Phase 2|Withdrawal by Subject|0|||
155359698|NCT02760485|560750168|FG001|Phase 2|Withdrawal by Subject|0|||
155359699|NCT02760485|560750169|FG002|Phase 2|Withdrawal by Subject|3|||
155359700|NCT02760485|560750167|FG000|Phase 2|Progressive Disease|0|||
155359701|NCT02760485|560750168|FG001|Phase 2|Progressive Disease|0|||
155359702|NCT02760485|560750169|FG002|Phase 2|Progressive Disease|1|||
155359703|NCT02760485|560750167|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
155359704|NCT02760485|560750168|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
155359705|NCT02760485|560750169|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
155359706|NCT03845023|560750170|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
155359707|NCT03845023|560750171|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
155165857|NCT03892967|560043588|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
155165858|NCT03892967|560043589|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
155165859|NCT03892967|560043590|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
155165860|NCT03892967|560043591|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
155165861|NCT03892967|560043587|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
155165862|NCT03892967|560043588|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
155165863|NCT03892967|560043589|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
155165864|NCT03892967|560043590|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
155165865|NCT03892967|560043591|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
155165866|NCT03892967|560043587|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
155165867|NCT03892967|560043588|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
155165868|NCT03892967|560043589|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
155165869|NCT03892967|560043590|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
155165870|NCT03892967|560043591|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
155165871|NCT03892967|560043587|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
155165872|NCT03892967|560043588|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
155165873|NCT03892967|560043589|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
155165874|NCT03892967|560043590|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
155165875|NCT03892967|560043591|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
155165876|NCT03892967|560043587|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
155165877|NCT03892967|560043588|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
155165878|NCT03892967|560043589|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
155165879|NCT03892967|560043590|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
155359708|NCT03845023|560750172|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
155359709|NCT03845023|560750173|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
155359710|NCT03845023|560750170|FG000|Follow-Up (14 Days)|Adverse Event|0|||
155359711|NCT03845023|560750171|FG001|Follow-Up (14 Days)|Adverse Event|0|||
155359712|NCT03845023|560750172|FG002|Follow-Up (14 Days)|Adverse Event|1|||
155359713|NCT03845023|560750173|FG003|Follow-Up (14 Days)|Adverse Event|1|||
155359714|NCT01182207|560750174|FG000|First Intervention|Positive Hepatitis Results|0|||
155359715|NCT01182207|560750175|FG001|First Intervention|Positive Hepatitis Results|1|||
155359716|NCT01182207|560750174|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
154965087|NCT02488109|559298812|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
155087669|NCT02471144|559754326|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
155087670|NCT02471144|559754327|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
155087671|NCT02471144|559754317|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087672|NCT02471144|559754318|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087673|NCT02471144|559754319|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087674|NCT02471144|559754320|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087675|NCT02471144|559754321|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087676|NCT02471144|559754322|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087677|NCT02471144|559754323|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087678|NCT02471144|559754324|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087679|NCT02471144|559754325|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087680|NCT02471144|559754326|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
155087681|NCT02471144|559754327|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
155087682|NCT02471144|559754317|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155087683|NCT02471144|559754318|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155087684|NCT02471144|559754319|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155087685|NCT02471144|559754320|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155087686|NCT02471144|559754321|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155087687|NCT02471144|559754322|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155087688|NCT02471144|559754323|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155359717|NCT01182207|560750175|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
155359718|NCT01427738|560750176|FG000|Overall Study|Death|12|||
155087689|NCT02471144|559754324|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155359719|NCT01427738|560750177|FG001|Overall Study|Death|9|||
155359720|NCT01427738|560750176|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155359721|NCT01427738|560750177|FG001|Overall Study|Severe debilitation, unable to continue|1|||
155359722|NCT01427738|560750176|FG000|Overall Study|Subject unable to get to clinic|5|||
155359723|NCT01427738|560750177|FG001|Overall Study|Subject unable to get to clinic|2|||
155359724|NCT01427738|560750176|FG000|Overall Study|Withdrawal by Subject|0|||
155359725|NCT01427738|560750177|FG001|Overall Study|Withdrawal by Subject|2|||
155359726|NCT01427738|560750176|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
155359727|NCT01427738|560750177|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
155359728|NCT01427738|560750176|FG000|Overall Study|Lost to Follow-up|1|||
155359729|NCT01427738|560750177|FG001|Overall Study|Lost to Follow-up|5|||
155359730|NCT02353871|560750178|FG000|Overall Study|Protocol deviation|0|||
155087690|NCT02471144|559754325|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
155359731|NCT02353871|560750179|FG001|Overall Study|Protocol deviation|1|||
155359732|NCT02353871|560750178|FG000|Overall Study|Consent withdrawn|1|||
155359733|NCT02353871|560750179|FG001|Overall Study|Consent withdrawn|8|||
155359734|NCT02353871|560750178|FG000|Overall Study|Lost to Follow-up|2|||
155359735|NCT02353871|560750179|FG001|Overall Study|Lost to Follow-up|0|||
155359736|NCT05314374|560750180|FG000|Overall Study|Adverse Event|2|||
155359737|NCT05314374|560750181|FG001|Overall Study|Adverse Event|2|||
155359738|NCT02658175|560750184|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
155087691|NCT02471144|559754326|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
155087692|NCT02471144|559754327|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
155087693|NCT02471144|559754317|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087694|NCT02471144|559754318|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087695|NCT02471144|559754319|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087696|NCT02471144|559754320|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087697|NCT02471144|559754321|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087698|NCT02471144|559754322|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087699|NCT02471144|559754323|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087700|NCT02471144|559754324|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087701|NCT02471144|559754325|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155087702|NCT02471144|559754326|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
155087703|NCT02471144|559754327|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
155359739|NCT02658175|560750185|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
155359740|NCT02658175|560750186|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
155359741|NCT02658175|560750184|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
155359742|NCT02658175|560750185|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
155359743|NCT02658175|560750186|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
154965088|NCT02488109|559298813|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
155087704|NCT02471144|559754317|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087705|NCT02471144|559754318|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087706|NCT02471144|559754319|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155359744|NCT02658175|560750184|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
155359745|NCT02658175|560750185|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
155359746|NCT02658175|560750186|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
155359747|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
155359748|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
155359749|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
155359750|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
155359751|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
155359752|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
155359753|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
155359754|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
155359755|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
155359756|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
155359757|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
155359758|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
155359759|NCT02658175|560750184|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
155359760|NCT02658175|560750185|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
155359761|NCT02658175|560750186|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
155359762|NCT02658175|560750184|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
155359763|NCT02658175|560750185|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
155359764|NCT02658175|560750186|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
155359765|NCT02658175|560750184|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
155359766|NCT02658175|560750185|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
155359767|NCT02658175|560750186|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
155359768|NCT05739994|560750194|FG000|Overall Study|Withdrawal by Subject|2|||
155359769|NCT05739994|560750195|FG001|Overall Study|Withdrawal by Subject|2|||
155359770|NCT05739994|560750196|FG002|Overall Study|Withdrawal by Subject|4|||
155359771|NCT02647645|560750197|FG000|Overall Study|Lost to Follow-up|2|||
155359772|NCT02647645|560750198|FG001|Overall Study|Lost to Follow-up|1|||
155359773|NCT04599907|560750201|FG000|Overall Study|Withdrawal by Subject|1|||
155359774|NCT04599907|560750202|FG001|Overall Study|Withdrawal by Subject|7|||
155359775|NCT04599907|560750203|FG002|Overall Study|Withdrawal by Subject|6|||
155359776|NCT04599907|560750201|FG000|Overall Study|Lost to Follow-up|0|||
155359777|NCT04599907|560750202|FG001|Overall Study|Lost to Follow-up|1|||
155359778|NCT04599907|560750203|FG002|Overall Study|Lost to Follow-up|0|||
155359779|NCT01466790|560750204|FG000|Overall Study|Adverse Event|1|||
155359780|NCT01466790|560750205|FG001|Overall Study|Adverse Event|0|||
155359781|NCT01466790|560750206|FG002|Overall Study|Adverse Event|0|||
155359782|NCT01466790|560750207|FG003|Overall Study|Adverse Event|0|||
155359783|NCT01466790|560750208|FG004|Overall Study|Adverse Event|2|||
155359784|NCT01466790|560750209|FG005|Overall Study|Adverse Event|0|||
155359785|NCT01466790|560750210|FG006|Overall Study|Adverse Event|0|||
155359786|NCT01466790|560750211|FG007|Overall Study|Adverse Event|0|||
155359787|NCT01466790|560750204|FG000|Overall Study|Lost to Follow-up|2|||
155359788|NCT01466790|560750205|FG001|Overall Study|Lost to Follow-up|0|||
155359789|NCT01466790|560750206|FG002|Overall Study|Lost to Follow-up|0|||
155359790|NCT01466790|560750207|FG003|Overall Study|Lost to Follow-up|0|||
155359791|NCT01466790|560750208|FG004|Overall Study|Lost to Follow-up|0|||
155359792|NCT01466790|560750209|FG005|Overall Study|Lost to Follow-up|0|||
155359793|NCT01466790|560750210|FG006|Overall Study|Lost to Follow-up|0|||
155359794|NCT01466790|560750211|FG007|Overall Study|Lost to Follow-up|0|||
155359795|NCT01466790|560750204|FG000|Overall Study|Withdrawal by Subject|1|||
155165880|NCT03892967|560043591|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
155165881|NCT03892967|560043587|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
155165882|NCT03892967|560043588|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
155165883|NCT03892967|560043589|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
155165884|NCT03892967|560043590|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
155359796|NCT01466790|560750205|FG001|Overall Study|Withdrawal by Subject|1|||
155359797|NCT01466790|560750206|FG002|Overall Study|Withdrawal by Subject|0|||
154965089|NCT02488109|559298812|FG000|12-month Follow-Up|Lost to Follow-up|4|||
154965090|NCT02488109|559298813|FG001|12-month Follow-Up|Lost to Follow-up|7|||
155359798|NCT01466790|560750207|FG003|Overall Study|Withdrawal by Subject|0|||
155359799|NCT01466790|560750208|FG004|Overall Study|Withdrawal by Subject|1|||
155359800|NCT01466790|560750209|FG005|Overall Study|Withdrawal by Subject|0|||
155359801|NCT01466790|560750210|FG006|Overall Study|Withdrawal by Subject|1|||
154965091|NCT02302716|559298814|FG000|Overall Study|Adverse Event|1|||
154965092|NCT02302716|559298815|FG001|Overall Study|Adverse Event|1|||
154965093|NCT02302716|559298814|FG000|Overall Study|Death|0|||
154965094|NCT02302716|559298815|FG001|Overall Study|Death|1|||
154965095|NCT02302716|559298814|FG000|Overall Study|Lack of Efficacy|0|||
154965096|NCT02302716|559298815|FG001|Overall Study|Lack of Efficacy|1|||
154965097|NCT02302716|559298814|FG000|Overall Study|Lost to Follow-up|2|||
154965098|NCT02302716|559298815|FG001|Overall Study|Lost to Follow-up|4|||
154965099|NCT02302716|559298814|FG000|Overall Study|Physician Decision|3|||
154965100|NCT02302716|559298815|FG001|Overall Study|Physician Decision|4|||
154965101|NCT02302716|559298814|FG000|Overall Study|Withdrawal by Subject|13|||
154965102|NCT02302716|559298815|FG001|Overall Study|Withdrawal by Subject|7|||
154965103|NCT02302716|559298814|FG000|Overall Study|Protocol Violation|0|||
154965104|NCT02302716|559298815|FG001|Overall Study|Protocol Violation|1|||
154965105|NCT00557245|559298823|FG000|Overall Study|Lost to Follow-up|7|||
154965106|NCT00557245|559298824|FG001|Overall Study|Lost to Follow-up|8|||
154965107|NCT00557245|559298825|FG002|Overall Study|Lost to Follow-up|10|||
154965108|NCT00557245|559298823|FG000|Overall Study|Ineligible|5|||
154965109|NCT00557245|559298824|FG001|Overall Study|Ineligible|4|||
154965110|NCT00557245|559298825|FG002|Overall Study|Ineligible|2|||
154965111|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Subject request|8|||
154965112|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Subject request|11|||
154965113|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
154965114|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
155359802|NCT01466790|560750211|FG007|Overall Study|Withdrawal by Subject|1|||
155359803|NCT00356811|560750212|FG000|Overall Study|Death|35|||
155359804|NCT00356811|560750212|FG000|Overall Study|Lost to Follow-up|2|||
154965115|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
154965116|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
154965117|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
154965118|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
155359805|NCT00356811|560750212|FG000|Overall Study|Withdrawal by Subject|6|||
155359806|NCT00356811|560750212|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
155359807|NCT00356811|560750212|FG000|Overall Study|Study Is Terminating|3|||
155359808|NCT00356811|560750212|FG000|Overall Study|Site Closed during Follow-up|2|||
155359809|NCT03668223|560750213|FG000|Overall Study|Death|10|||
155359810|NCT03668223|560750214|FG001|Overall Study|Death|5|||
155359811|NCT03668223|560750213|FG000|Overall Study|Lost to Follow-up|12|||
155359812|NCT03668223|560750214|FG001|Overall Study|Lost to Follow-up|12|||
155359813|NCT03668223|560750213|FG000|Overall Study|Withdrawal by Subject|8|||
155359814|NCT03668223|560750214|FG001|Overall Study|Withdrawal by Subject|3|||
155359815|NCT05502783|560750215|FG000|Overall Study|Lack of Efficacy|1|||
155359816|NCT00129935|560751546|FG000|Overall Study|Adverse Event|18|||
155359817|NCT00129935|560751547|FG001|Overall Study|Adverse Event|56|||
155359818|NCT00129935|560751546|FG000|Overall Study|Death|1|||
155359819|NCT00129935|560751547|FG001|Overall Study|Death|1|||
155359820|NCT00129935|560751546|FG000|Overall Study|Withdrawal by Subject|7|||
155359821|NCT00129935|560751547|FG001|Overall Study|Withdrawal by Subject|20|||
155359822|NCT00129935|560751546|FG000|Overall Study|Protocol Violation|0|||
155359823|NCT00129935|560751547|FG001|Overall Study|Protocol Violation|4|||
155359824|NCT00129935|560751546|FG000|Overall Study|Physician Decision|3|||
155359825|NCT00129935|560751547|FG001|Overall Study|Physician Decision|4|||
155359826|NCT00129935|560751546|FG000|Overall Study|Recurrence|1|||
155359827|NCT00129935|560751547|FG001|Overall Study|Recurrence|3|||
155359828|NCT00129935|560751546|FG000|Overall Study|Second primary|0|||
155359829|NCT00129935|560751547|FG001|Overall Study|Second primary|1|||
154965119|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
154965120|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
154965121|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
154965122|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
155359830|NCT00129935|560751546|FG000|Overall Study|Other|3|||
155359831|NCT00129935|560751547|FG001|Overall Study|Other|2|||
154965123|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Death|1|||
154965124|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Death|0|||
154965125|NCT00521586|559298829|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
154965126|NCT00521586|559298830|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
154965127|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
154965128|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
155359832|NCT00129935|560751546|FG000|Overall Study|Crossed to the other arm|2|||
155359833|NCT00129935|560751547|FG001|Overall Study|Crossed to the other arm|1|||
155359834|NCT00129935|560751546|FG000|Overall Study|Incorrect study treatment|1|||
155359835|NCT00129935|560751547|FG001|Overall Study|Incorrect study treatment|0|||
155359836|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
155359837|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
155359838|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
155359839|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Death|4|||
154965129|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
154965130|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
155087707|NCT02471144|559754320|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087708|NCT02471144|559754321|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087709|NCT02471144|559754322|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087710|NCT02471144|559754323|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087711|NCT02471144|559754324|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087712|NCT02471144|559754325|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
155087713|NCT02471144|559754326|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
155087714|NCT02471144|559754327|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
155087715|NCT00791648|559754332|FG000|Overall Study|Physician Decision|0|||
155087716|NCT00791648|559754333|FG001|Overall Study|Physician Decision|1|||
155087717|NCT00791648|559754332|FG000|Overall Study|Withdrawal by Subject|0|||
155359840|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Death|2|||
155359841|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Death|3|||
155359842|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155359843|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155359844|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
155359845|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
155359846|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
155359847|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
155359848|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
155359849|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
155359850|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
155359851|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
155359852|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
155359853|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
155359854|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
155359855|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
155359856|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
155359857|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
155359858|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
155359859|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
155359860|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
155359861|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
155359862|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
155359863|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
155359864|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
155359865|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
155359866|NCT02783573|560751548|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
155359867|NCT02783573|560751549|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
155359868|NCT02783573|560751550|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
155359869|NCT02783573|560751548|FG000|Delayed-Start Period|Sponsor Decision|0|||
155359870|NCT02783573|560751549|FG001|Delayed-Start Period|Sponsor Decision|17|||
155359871|NCT02783573|560751550|FG002|Delayed-Start Period|Sponsor Decision|12|||
155359872|NCT01434680|560751553|FG000|Overall Study|Withdrawal by Subject|1|||
155359873|NCT01434680|560751554|FG001|Overall Study|Withdrawal by Subject|0|||
155359874|NCT01434680|560751555|FG002|Overall Study|Withdrawal by Subject|2|||
155359875|NCT01434680|560751556|FG003|Overall Study|Withdrawal by Subject|0|||
155359876|NCT01434680|560751553|FG000|Overall Study|Lost to Follow-up|1|||
155359877|NCT01434680|560751554|FG001|Overall Study|Lost to Follow-up|1|||
155359878|NCT01434680|560751555|FG002|Overall Study|Lost to Follow-up|0|||
155359879|NCT01434680|560751556|FG003|Overall Study|Lost to Follow-up|0|||
155359880|NCT01434680|560751553|FG000|Overall Study|Protocol Violation|1|||
155359881|NCT01434680|560751554|FG001|Overall Study|Protocol Violation|1|||
155359882|NCT01434680|560751555|FG002|Overall Study|Protocol Violation|0|||
155359883|NCT01434680|560751556|FG003|Overall Study|Protocol Violation|0|||
155359884|NCT04991766|560751557|FG000|Overall Study|Withdrawal by Subject|2|||
155359885|NCT04991766|560751558|FG001|Overall Study|Withdrawal by Subject|0|||
155359886|NCT05765435|560751568|FG000|Overall Study|Lost to Follow-up|0|||
155359887|NCT05765435|560751569|FG001|Overall Study|Lost to Follow-up|1|||
155359888|NCT05765435|560751570|FG002|Overall Study|Lost to Follow-up|0|||
155359889|NCT05765435|560751568|FG000|Overall Study|Withdrawal by Subject|0|||
155359890|NCT05765435|560751569|FG001|Overall Study|Withdrawal by Subject|0|||
155359891|NCT05765435|560751570|FG002|Overall Study|Withdrawal by Subject|1|||
155359892|NCT01952847|560751571|FG000|Overall Study|Ineligible|1|||
155359893|NCT01952847|560751572|FG001|Overall Study|Ineligible|0|||
155359894|NCT01952847|560751573|FG002|Overall Study|Ineligible|0|||
155359895|NCT01952847|560751574|FG003|Overall Study|Ineligible|0|||
155359896|NCT01952847|560751571|FG000|Overall Study|Lack of Insurance Coverage|0|||
155359897|NCT01952847|560751572|FG001|Overall Study|Lack of Insurance Coverage|1|||
155359898|NCT01952847|560751573|FG002|Overall Study|Lack of Insurance Coverage|0|||
155359899|NCT01952847|560751574|FG003|Overall Study|Lack of Insurance Coverage|0|||
155359900|NCT01952847|560751571|FG000|Overall Study|Withdrawal by Subject|1|||
155359901|NCT01952847|560751572|FG001|Overall Study|Withdrawal by Subject|1|||
155359902|NCT01952847|560751573|FG002|Overall Study|Withdrawal by Subject|0|||
155359903|NCT01952847|560751574|FG003|Overall Study|Withdrawal by Subject|1|||
155359904|NCT01013961|560751580|FG000|Overall Study|Adverse Event|2|||
155359905|NCT01013961|560751581|FG001|Overall Study|Adverse Event|2|||
155359906|NCT01013961|560751580|FG000|Overall Study|Withdrawal by Subject|1|||
155359907|NCT01013961|560751581|FG001|Overall Study|Withdrawal by Subject|0|||
155359908|NCT01013961|560751580|FG000|Overall Study|Physician Decision|0|||
155359909|NCT01013961|560751581|FG001|Overall Study|Physician Decision|1|||
155359910|NCT01271504|560751584|FG000|Overall Study|Death|7|||
155359911|NCT01271504|560751585|FG001|Overall Study|Death|6|||
155359912|NCT01271504|560751586|FG002|Overall Study|Death|32|||
155359913|NCT01271504|560751587|FG003|Overall Study|Death|32|||
155359914|NCT01271504|560751584|FG000|Overall Study|Lost to Follow-up|0|||
155359915|NCT01271504|560751585|FG001|Overall Study|Lost to Follow-up|1|||
155359916|NCT01271504|560751586|FG002|Overall Study|Lost to Follow-up|3|||
155359917|NCT01271504|560751587|FG003|Overall Study|Lost to Follow-up|1|||
155359918|NCT01271504|560751584|FG000|Overall Study|Protocol Violation|0|||
155359919|NCT01271504|560751585|FG001|Overall Study|Protocol Violation|0|||
155359920|NCT01271504|560751586|FG002|Overall Study|Protocol Violation|0|||
155359921|NCT01271504|560751587|FG003|Overall Study|Protocol Violation|2|||
155359922|NCT01271504|560751584|FG000|Overall Study|Administrative Reasons|0|||
155359923|NCT01271504|560751585|FG001|Overall Study|Administrative Reasons|0|||
155359924|NCT01271504|560751586|FG002|Overall Study|Administrative Reasons|6|||
155359925|NCT01271504|560751587|FG003|Overall Study|Administrative Reasons|5|||
155359926|NCT01271504|560751584|FG000|Overall Study|Withdrawal by Subject|0|||
155359927|NCT01271504|560751585|FG001|Overall Study|Withdrawal by Subject|0|||
155359928|NCT01271504|560751586|FG002|Overall Study|Withdrawal by Subject|1|||
155359929|NCT01271504|560751587|FG003|Overall Study|Withdrawal by Subject|3|||
155359930|NCT01271504|560751584|FG000|Overall Study|Other|0|||
155359931|NCT01271504|560751585|FG001|Overall Study|Other|1|||
155359932|NCT01271504|560751586|FG002|Overall Study|Other|2|||
155359933|NCT01271504|560751587|FG003|Overall Study|Other|0|||
155359934|NCT00940875|560751588|FG000|Treatment Phase|Adverse Event|9|||
155359935|NCT00940875|560751589|FG001|Treatment Phase|Adverse Event|3|||
155359936|NCT00940875|560751588|FG000|Treatment Phase|Death|3|||
155359937|NCT00940875|560751589|FG001|Treatment Phase|Death|5|||
155359938|NCT00940875|560751588|FG000|Treatment Phase|Lack of Efficacy|1|||
155359939|NCT00940875|560751589|FG001|Treatment Phase|Lack of Efficacy|0|||
155359940|NCT00940875|560751588|FG000|Treatment Phase|Withdrawal by Subject|3|||
155359941|NCT00940875|560751589|FG001|Treatment Phase|Withdrawal by Subject|0|||
155359942|NCT00940875|560751588|FG000|Treatment Phase|Disease progression|9|||
155359943|NCT00940875|560751589|FG001|Treatment Phase|Disease progression|11|||
155359944|NCT00940875|560751588|FG000|Treatment Phase|Physician Decision|1|||
155359945|NCT00940875|560751589|FG001|Treatment Phase|Physician Decision|0|||
155359946|NCT00940875|560751588|FG000|Post-Study Treatment|Death|0|||
155359947|NCT00940875|560751589|FG001|Post-Study Treatment|Death|1|||
155359948|NCT00940875|560751588|FG000|Post-Study Treatment|Disease Progression|0|||
155359949|NCT00940875|560751589|FG001|Post-Study Treatment|Disease Progression|2|||
155359950|NCT00943787|560751590|FG000|Overall Study|Physician Decision|4|||
155359951|NCT00943787|560751590|FG000|Overall Study|Withdrawal by Subject|3|||
155359952|NCT01850589|560751591|FG000|Overall Study|Withdrawal by Subject|8|||
155359953|NCT01850589|560751592|FG001|Overall Study|Withdrawal by Subject|0|||
155359954|NCT03721705|560751593|FG000|Overall Study|Adverse Event|2|||
155359955|NCT03721705|560751594|FG001|Overall Study|Adverse Event|0|||
155359956|NCT03721705|560751593|FG000|Overall Study|Withdrawal by Subject|4|||
155359957|NCT03721705|560751594|FG001|Overall Study|Withdrawal by Subject|10|||
155359958|NCT03721705|560751593|FG000|Overall Study|No Suitable Study Partner|1|||
155359959|NCT03721705|560751594|FG001|Overall Study|No Suitable Study Partner|0|||
155359960|NCT03721705|560751593|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
155359961|NCT03721705|560751594|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
155359962|NCT03721705|560751593|FG000|Overall Study|Death|0|||
155359963|NCT03721705|560751594|FG001|Overall Study|Death|1|||
155359964|NCT01843777|560751595|FG000|Overall Study|Withdrawal by Subject|1|||
155359965|NCT01843777|560751596|FG001|Overall Study|Withdrawal by Subject|0|||
155359966|NCT05147350|560751598|FG000|Overall Study|Death|2|||
155359967|NCT05147350|560751599|FG001|Overall Study|Death|3|||
155359968|NCT05147350|560751600|FG002|Overall Study|Death|3|||
155359969|NCT05147350|560751601|FG003|Overall Study|Death|2|||
155359970|NCT05147350|560751602|FG004|Overall Study|Death|2|||
155359971|NCT05147350|560751603|FG005|Overall Study|Death|1|||
155359972|NCT05147350|560751604|FG006|Overall Study|Death|1|||
155359973|NCT05147350|560751605|FG007|Overall Study|Death|3|||
155359974|NCT05147350|560751598|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
155359975|NCT05147350|560751599|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
155359976|NCT05147350|560751600|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
155359977|NCT05147350|560751601|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
155359978|NCT05147350|560751602|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
155359979|NCT05147350|560751603|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
155359980|NCT05147350|560751604|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
155359981|NCT05147350|560751605|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
155359982|NCT05147350|560751598|FG000|Overall Study|Withdrawal by Subject|0|||
155359983|NCT05147350|560751599|FG001|Overall Study|Withdrawal by Subject|0|||
155359984|NCT05147350|560751600|FG002|Overall Study|Withdrawal by Subject|3|||
155359985|NCT05147350|560751601|FG003|Overall Study|Withdrawal by Subject|1|||
155359986|NCT05147350|560751602|FG004|Overall Study|Withdrawal by Subject|1|||
155359987|NCT05147350|560751603|FG005|Overall Study|Withdrawal by Subject|0|||
155359988|NCT05147350|560751604|FG006|Overall Study|Withdrawal by Subject|1|||
155359989|NCT05147350|560751605|FG007|Overall Study|Withdrawal by Subject|0|||
155359990|NCT05147350|560751598|FG000|Overall Study|Other Reasons|0|||
155359991|NCT05147350|560751599|FG001|Overall Study|Other Reasons|0|||
155359992|NCT05147350|560751600|FG002|Overall Study|Other Reasons|2|||
155359993|NCT05147350|560751601|FG003|Overall Study|Other Reasons|0|||
155359994|NCT05147350|560751602|FG004|Overall Study|Other Reasons|0|||
155359995|NCT05147350|560751603|FG005|Overall Study|Other Reasons|2|||
155359996|NCT05147350|560751604|FG006|Overall Study|Other Reasons|1|||
155359997|NCT05147350|560751605|FG007|Overall Study|Other Reasons|1|||
155359998|NCT01080326|560751606|FG000|Overall Study|Patient deterioration prior to procedure|3|||
155359999|NCT01080326|560751606|FG000|Overall Study|Surgeon decision|1|||
155360000|NCT01628692|560751611|FG000|Overall Study|Lack of Efficacy|4|||
155360001|NCT01628692|560751612|FG001|Overall Study|Lack of Efficacy|4|||
155360002|NCT01628692|560751613|FG002|Overall Study|Lack of Efficacy|5|||
155360003|NCT01628692|560751614|FG003|Overall Study|Lack of Efficacy|1|||
155360004|NCT01628692|560751615|FG004|Overall Study|Lack of Efficacy|4|||
155360005|NCT01628692|560751616|FG005|Overall Study|Lack of Efficacy|7|||
155360006|NCT01628692|560751611|FG000|Overall Study|Adverse Event|2|||
155360007|NCT01628692|560751612|FG001|Overall Study|Adverse Event|0|||
155360008|NCT01628692|560751613|FG002|Overall Study|Adverse Event|2|||
155360009|NCT01628692|560751614|FG003|Overall Study|Adverse Event|0|||
155360010|NCT01628692|560751615|FG004|Overall Study|Adverse Event|0|||
155360011|NCT01628692|560751616|FG005|Overall Study|Adverse Event|0|||
155360012|NCT01628692|560751611|FG000|Overall Study|Withdrawal by Subject|0|||
155360013|NCT01628692|560751612|FG001|Overall Study|Withdrawal by Subject|1|||
155360014|NCT01628692|560751613|FG002|Overall Study|Withdrawal by Subject|1|||
155360015|NCT01628692|560751614|FG003|Overall Study|Withdrawal by Subject|0|||
155360016|NCT01628692|560751615|FG004|Overall Study|Withdrawal by Subject|0|||
155360017|NCT01628692|560751616|FG005|Overall Study|Withdrawal by Subject|0|||
155360018|NCT01628692|560751611|FG000|Overall Study|Death|0|||
155360019|NCT01628692|560751612|FG001|Overall Study|Death|1|||
155360020|NCT01628692|560751613|FG002|Overall Study|Death|0|||
155360021|NCT01628692|560751614|FG003|Overall Study|Death|0|||
155360022|NCT01628692|560751615|FG004|Overall Study|Death|0|||
155360023|NCT01628692|560751616|FG005|Overall Study|Death|0|||
155360024|NCT01628692|560751611|FG000|Overall Study|Poor compliance/noncompliance|1|||
155360025|NCT01628692|560751612|FG001|Overall Study|Poor compliance/noncompliance|0|||
155360026|NCT01628692|560751613|FG002|Overall Study|Poor compliance/noncompliance|0|||
155360027|NCT01628692|560751614|FG003|Overall Study|Poor compliance/noncompliance|0|||
155360028|NCT01628692|560751615|FG004|Overall Study|Poor compliance/noncompliance|0|||
155360029|NCT01628692|560751616|FG005|Overall Study|Poor compliance/noncompliance|0|||
155360030|NCT01628692|560751611|FG000|Overall Study|Administrative reason by sponsor|0|||
155360031|NCT01628692|560751612|FG001|Overall Study|Administrative reason by sponsor|0|||
155360032|NCT01628692|560751613|FG002|Overall Study|Administrative reason by sponsor|0|||
155360033|NCT01628692|560751614|FG003|Overall Study|Administrative reason by sponsor|0|||
155360034|NCT01628692|560751615|FG004|Overall Study|Administrative reason by sponsor|0|||
155360035|NCT01628692|560751616|FG005|Overall Study|Administrative reason by sponsor|1|||
155360036|NCT01628692|560751611|FG000|Overall Study|Completed 12 Week only|0|||
155360037|NCT01628692|560751612|FG001|Overall Study|Completed 12 Week only|0|||
155360038|NCT01628692|560751613|FG002|Overall Study|Completed 12 Week only|0|||
155360039|NCT01628692|560751614|FG003|Overall Study|Completed 12 Week only|0|||
155360040|NCT01628692|560751615|FG004|Overall Study|Completed 12 Week only|0|||
155360041|NCT01628692|560751616|FG005|Overall Study|Completed 12 Week only|1|||
155360042|NCT02437071|560751617|FG000|Overall Study|Withdrawal by Subject|1|||
155360043|NCT02437071|560751618|FG001|Overall Study|Withdrawal by Subject|0|||
155360044|NCT03513068|560751621|FG000|Overall Study|Death|1|||
155360045|NCT03513068|560751622|FG001|Overall Study|Death|0|||
155360046|NCT03513068|560751621|FG000|Overall Study|Withdrawal by Subject|4|||
155360047|NCT03513068|560751622|FG001|Overall Study|Withdrawal by Subject|6|||
155360048|NCT04788511|560751623|FG000|Overall Study|Withdrawal by Subject|2|||
155360049|NCT04788511|560751624|FG001|Overall Study|Withdrawal by Subject|1|||
155360050|NCT04788511|560751623|FG000|Overall Study|Lost to Follow-up|2|||
154965131|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
154965132|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
154965133|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
154965134|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
154965135|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
154965136|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
154965137|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
154965138|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
154965139|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
154965140|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
154965141|NCT00521586|559298829|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
154965142|NCT00521586|559298830|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
154965143|NCT00521586|559298829|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
154965144|NCT00521586|559298830|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
154965145|NCT00521586|559298829|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
155087718|NCT00791648|559754333|FG001|Overall Study|Withdrawal by Subject|1|||
155360051|NCT04788511|560751624|FG001|Overall Study|Lost to Follow-up|7|||
155360052|NCT04788511|560751623|FG000|Overall Study|Death|3|||
155360053|NCT04788511|560751624|FG001|Overall Study|Death|4|||
155360054|NCT03636373|560751625|FG000|Overall Study|Study closure due to Covid-19|1|||
155360055|NCT03636373|560751626|FG001|Overall Study|Study closure due to Covid-19|0|||
155360056|NCT02353468|560751627|FG000|Overall Study|Study terminated|3|||
155360057|NCT00003477|560751628|FG000|Overall Study|Not evalauable|4|||
155360058|NCT01236352|560751630|FG000|Overall Study|Death|0|||
155360059|NCT01236352|560751631|FG001|Overall Study|Death|0|||
155360060|NCT01236352|560751632|FG002|Overall Study|Death|0|||
155360061|NCT01236352|560751633|FG003|Overall Study|Death|0|||
155360062|NCT01236352|560751634|FG004|Overall Study|Death|0|||
155360063|NCT01236352|560751635|FG005|Overall Study|Death|0|||
155360064|NCT01236352|560751636|FG006|Overall Study|Death|0|||
155360065|NCT01236352|560751637|FG007|Overall Study|Death|1|||
155360066|NCT01236352|560751638|FG008|Overall Study|Death|0|||
155360067|NCT01236352|560751639|FG009|Overall Study|Death|0|||
155360068|NCT01236352|560751640|FG010|Overall Study|Death|0|||
155360069|NCT01236352|560751630|FG000|Overall Study|Withdrawal by Subject|0|||
155360070|NCT01236352|560751631|FG001|Overall Study|Withdrawal by Subject|0|||
155360071|NCT01236352|560751632|FG002|Overall Study|Withdrawal by Subject|0|||
155360072|NCT01236352|560751633|FG003|Overall Study|Withdrawal by Subject|0|||
155360073|NCT01236352|560751634|FG004|Overall Study|Withdrawal by Subject|0|||
155360074|NCT01236352|560751635|FG005|Overall Study|Withdrawal by Subject|0|||
155360075|NCT01236352|560751636|FG006|Overall Study|Withdrawal by Subject|0|||
155360076|NCT01236352|560751637|FG007|Overall Study|Withdrawal by Subject|0|||
155360077|NCT01236352|560751638|FG008|Overall Study|Withdrawal by Subject|0|||
155360078|NCT01236352|560751639|FG009|Overall Study|Withdrawal by Subject|2|||
155360079|NCT01236352|560751640|FG010|Overall Study|Withdrawal by Subject|1|||
155360080|NCT01236352|560751630|FG000|Overall Study|Adverse Event|0|||
155360081|NCT01236352|560751631|FG001|Overall Study|Adverse Event|0|||
155360082|NCT01236352|560751632|FG002|Overall Study|Adverse Event|0|||
155360083|NCT01236352|560751633|FG003|Overall Study|Adverse Event|0|||
155360084|NCT01236352|560751634|FG004|Overall Study|Adverse Event|0|||
155360085|NCT01236352|560751635|FG005|Overall Study|Adverse Event|0|||
155360086|NCT01236352|560751636|FG006|Overall Study|Adverse Event|2|||
155360087|NCT01236352|560751637|FG007|Overall Study|Adverse Event|0|||
155360088|NCT01236352|560751638|FG008|Overall Study|Adverse Event|0|||
155360089|NCT01236352|560751639|FG009|Overall Study|Adverse Event|4|||
155360090|NCT01236352|560751640|FG010|Overall Study|Adverse Event|1|||
155360091|NCT01236352|560751630|FG000|Overall Study|Study drug toxicity|0|||
155360092|NCT01236352|560751631|FG001|Overall Study|Study drug toxicity|0|||
155360093|NCT01236352|560751632|FG002|Overall Study|Study drug toxicity|0|||
155360094|NCT01236352|560751633|FG003|Overall Study|Study drug toxicity|0|||
155360095|NCT01236352|560751634|FG004|Overall Study|Study drug toxicity|0|||
155360096|NCT01236352|560751635|FG005|Overall Study|Study drug toxicity|1|||
155360097|NCT01236352|560751636|FG006|Overall Study|Study drug toxicity|1|||
155360098|NCT01236352|560751637|FG007|Overall Study|Study drug toxicity|0|||
155087719|NCT00462826|559754334|FG000|Overall Study|Ineligible - second primary|1|||
155087720|NCT00462826|559754334|FG000|Overall Study|Ineligible - wrong cell type|1|||
155087721|NCT00462826|559754334|FG000|Overall Study|Ineligible - wrong primary|2|||
155360099|NCT01236352|560751638|FG008|Overall Study|Study drug toxicity|0|||
155360100|NCT01236352|560751639|FG009|Overall Study|Study drug toxicity|2|||
155360101|NCT01236352|560751640|FG010|Overall Study|Study drug toxicity|2|||
155360102|NCT01236352|560751630|FG000|Overall Study|Disease progression|1|||
155360103|NCT01236352|560751631|FG001|Overall Study|Disease progression|2|||
155360104|NCT01236352|560751632|FG002|Overall Study|Disease progression|1|||
155360105|NCT01236352|560751633|FG003|Overall Study|Disease progression|2|||
155360106|NCT01236352|560751634|FG004|Overall Study|Disease progression|2|||
155360107|NCT01236352|560751635|FG005|Overall Study|Disease progression|2|||
155360108|NCT01236352|560751636|FG006|Overall Study|Disease progression|1|||
155360109|NCT01236352|560751637|FG007|Overall Study|Disease progression|3|||
155360110|NCT01236352|560751638|FG008|Overall Study|Disease progression|2|||
155360111|NCT01236352|560751639|FG009|Overall Study|Disease progression|2|||
155360112|NCT01236352|560751640|FG010|Overall Study|Disease progression|2|||
155360113|NCT01236352|560751630|FG000|Overall Study|Poor/Non-compliance|1|||
155360114|NCT01236352|560751631|FG001|Overall Study|Poor/Non-compliance|0|||
155360115|NCT01236352|560751632|FG002|Overall Study|Poor/Non-compliance|0|||
155360116|NCT01236352|560751633|FG003|Overall Study|Poor/Non-compliance|0|||
155360117|NCT01236352|560751634|FG004|Overall Study|Poor/Non-compliance|0|||
155360118|NCT01236352|560751635|FG005|Overall Study|Poor/Non-compliance|0|||
155360119|NCT01236352|560751636|FG006|Overall Study|Poor/Non-compliance|0|||
155360120|NCT01236352|560751637|FG007|Overall Study|Poor/Non-compliance|0|||
155360121|NCT01236352|560751638|FG008|Overall Study|Poor/Non-compliance|0|||
155360122|NCT01236352|560751639|FG009|Overall Study|Poor/Non-compliance|0|||
155360123|NCT01236352|560751640|FG010|Overall Study|Poor/Non-compliance|0|||
155360124|NCT01236352|560751630|FG000|Overall Study|Maximum clinical benefit|1|||
155360125|NCT01236352|560751631|FG001|Overall Study|Maximum clinical benefit|1|||
155360126|NCT01236352|560751632|FG002|Overall Study|Maximum clinical benefit|1|||
155360127|NCT01236352|560751633|FG003|Overall Study|Maximum clinical benefit|0|||
155360128|NCT01236352|560751634|FG004|Overall Study|Maximum clinical benefit|2|||
155360129|NCT01236352|560751635|FG005|Overall Study|Maximum clinical benefit|0|||
155360130|NCT01236352|560751636|FG006|Overall Study|Maximum clinical benefit|3|||
155087722|NCT00462826|559754334|FG000|Overall Study|Never treated|1|||
155087723|NCT03977155|559754335|FG000|Overall Study|Adverse Event|3|||
155087724|NCT03977155|559754336|FG001|Overall Study|Adverse Event|0|||
155087725|NCT03977155|559754337|FG002|Overall Study|Adverse Event|0|||
155087726|NCT03977155|559754335|FG000|Overall Study|Lost to Follow-up|0|||
155087727|NCT03977155|559754336|FG001|Overall Study|Lost to Follow-up|1|||
155087728|NCT03977155|559754337|FG002|Overall Study|Lost to Follow-up|0|||
155087729|NCT03977155|559754335|FG000|Overall Study|Withdrawal by Subject|1|||
155087730|NCT03977155|559754336|FG001|Overall Study|Withdrawal by Subject|1|||
155087731|NCT03977155|559754337|FG002|Overall Study|Withdrawal by Subject|2|||
155087732|NCT03977155|559754335|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
155087733|NCT03977155|559754336|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
155087734|NCT03977155|559754337|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
155087735|NCT00936936|559754338|FG000|Overall Study|Adverse Event|7|||
155087736|NCT00936936|559754339|FG001|Overall Study|Adverse Event|1|||
155087737|NCT00936936|559754338|FG000|Overall Study|Disease Progression|2|||
155360131|NCT01236352|560751637|FG007|Overall Study|Maximum clinical benefit|1|||
155360132|NCT01236352|560751638|FG008|Overall Study|Maximum clinical benefit|1|||
155087738|NCT00936936|559754339|FG001|Overall Study|Disease Progression|2|||
155087739|NCT00936936|559754338|FG000|Overall Study|Unrelated|3|||
155087740|NCT00936936|559754339|FG001|Overall Study|Unrelated|1|||
155170041|NCT00830869|560062408|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
155360133|NCT01236352|560751639|FG009|Overall Study|Maximum clinical benefit|4|||
155087741|NCT02278003|559754341|FG000|Overall Study|Withdrawal by Subject|11|||
155360134|NCT01236352|560751640|FG010|Overall Study|Maximum clinical benefit|2|||
155087742|NCT02278003|559754342|FG001|Overall Study|Withdrawal by Subject|0|||
155087743|NCT02278003|559754341|FG000|Overall Study|Not Treated|1|||
155087744|NCT02278003|559754342|FG001|Overall Study|Not Treated|0|||
155087745|NCT02278003|559754341|FG000|Overall Study|Recognition task improperly completed|7|||
155087746|NCT02278003|559754342|FG001|Overall Study|Recognition task improperly completed|0|||
155087747|NCT03440385|559754355|FG000|Overall Study|Other Reason|4|||
155087748|NCT03440385|559754356|FG001|Overall Study|Other Reason|1|||
155087749|NCT03440385|559754355|FG000|Overall Study|Site Closed|1|||
155087750|NCT03440385|559754356|FG001|Overall Study|Site Closed|0|||
155087751|NCT03440385|559754355|FG000|Overall Study|Lost to Follow-up|2|||
155087752|NCT03440385|559754356|FG001|Overall Study|Lost to Follow-up|0|||
155087753|NCT03440385|559754355|FG000|Overall Study|Withdrawal by Subject|12|||
155087754|NCT03440385|559754356|FG001|Overall Study|Withdrawal by Subject|6|||
155087755|NCT03440385|559754355|FG000|Overall Study|Lack of Efficacy|9|||
155087756|NCT03440385|559754356|FG001|Overall Study|Lack of Efficacy|2|||
155087757|NCT03440385|559754355|FG000|Overall Study|Adverse Event|15|||
155087758|NCT03440385|559754356|FG001|Overall Study|Adverse Event|11|||
155087759|NCT04123704|559754357|FG000|Overall Study|Disease progression|2|||
155087760|NCT00488293|559754358|FG000|Overall Study|Lost to Follow-up|28|||
155087761|NCT00488293|559754359|FG001|Overall Study|Lost to Follow-up|25|||
155087762|NCT00488293|559754358|FG000|Overall Study|Withdrawal by Subject|5|||
155087763|NCT00488293|559754359|FG001|Overall Study|Withdrawal by Subject|3|||
155087764|NCT00488293|559754358|FG000|Overall Study|Death|2|||
155087765|NCT00488293|559754359|FG001|Overall Study|Death|1|||
155087766|NCT00488293|559754358|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
155087767|NCT00488293|559754359|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
155087768|NCT00939185|559754360|FG000|Overall Study|Adverse Event|3|||
155087769|NCT00939185|559754360|FG000|Overall Study|Lack of Efficacy|1|||
155360135|NCT01236352|560751630|FG000|Overall Study|Subject request to discontinue treatment|0|||
155360136|NCT01236352|560751631|FG001|Overall Study|Subject request to discontinue treatment|0|||
155360137|NCT01236352|560751632|FG002|Overall Study|Subject request to discontinue treatment|1|||
155360138|NCT01236352|560751633|FG003|Overall Study|Subject request to discontinue treatment|1|||
155360139|NCT01236352|560751634|FG004|Overall Study|Subject request to discontinue treatment|0|||
155360140|NCT01236352|560751635|FG005|Overall Study|Subject request to discontinue treatment|1|||
155360141|NCT01236352|560751636|FG006|Overall Study|Subject request to discontinue treatment|0|||
155360142|NCT01236352|560751637|FG007|Overall Study|Subject request to discontinue treatment|0|||
155360143|NCT01236352|560751638|FG008|Overall Study|Subject request to discontinue treatment|0|||
155360144|NCT01236352|560751639|FG009|Overall Study|Subject request to discontinue treatment|1|||
155360145|NCT01236352|560751640|FG010|Overall Study|Subject request to discontinue treatment|4|||
155360146|NCT01236352|560751630|FG000|Overall Study|Subject to receive drug via EAP|1|||
155360147|NCT01236352|560751631|FG001|Overall Study|Subject to receive drug via EAP|1|||
155360148|NCT01236352|560751632|FG002|Overall Study|Subject to receive drug via EAP|1|||
155360149|NCT01236352|560751633|FG003|Overall Study|Subject to receive drug via EAP|0|||
155360150|NCT01236352|560751634|FG004|Overall Study|Subject to receive drug via EAP|0|||
155360151|NCT01236352|560751635|FG005|Overall Study|Subject to receive drug via EAP|0|||
155360152|NCT01236352|560751636|FG006|Overall Study|Subject to receive drug via EAP|0|||
155360153|NCT01236352|560751637|FG007|Overall Study|Subject to receive drug via EAP|2|||
155360154|NCT01236352|560751638|FG008|Overall Study|Subject to receive drug via EAP|0|||
155360155|NCT01236352|560751639|FG009|Overall Study|Subject to receive drug via EAP|4|||
155360156|NCT01236352|560751640|FG010|Overall Study|Subject to receive drug via EAP|0|||
155360157|NCT01236352|560751630|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
155360158|NCT01236352|560751631|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
155360159|NCT01236352|560751632|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
155360160|NCT01236352|560751633|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
155087770|NCT00939185|559754360|FG000|Overall Study|Lost to Follow-up|6|||
155087771|NCT00939185|559754360|FG000|Overall Study|Other|3|||
155360161|NCT01236352|560751634|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
155360162|NCT01236352|560751635|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
155087772|NCT00939185|559754360|FG000|Overall Study|Withdrawal by Subject|2|||
155087773|NCT00939185|559754360|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
155087774|NCT02374255|559754361|FG000|Overall Study|Withdrawal by Subject|2|||
155087775|NCT02374255|559754362|FG001|Overall Study|Withdrawal by Subject|0|||
155360163|NCT01236352|560751636|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
155360164|NCT01236352|560751637|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
155360165|NCT01236352|560751638|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
155360166|NCT01236352|560751639|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
155360167|NCT01236352|560751640|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
155360168|NCT01236352|560751630|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360169|NCT01236352|560751631|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360170|NCT01236352|560751632|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360171|NCT01236352|560751633|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360172|NCT01236352|560751634|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360173|NCT01236352|560751635|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360174|NCT01236352|560751636|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360175|NCT01236352|560751637|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360176|NCT01236352|560751638|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360177|NCT01236352|560751639|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
155360178|NCT01236352|560751640|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
155360179|NCT01236352|560751630|FG000|Overall Study|Lack of response to drug|0|||
155360180|NCT01236352|560751631|FG001|Overall Study|Lack of response to drug|0|||
155360181|NCT01236352|560751632|FG002|Overall Study|Lack of response to drug|0|||
155360182|NCT01236352|560751633|FG003|Overall Study|Lack of response to drug|0|||
155360183|NCT01236352|560751634|FG004|Overall Study|Lack of response to drug|0|||
155360184|NCT01236352|560751635|FG005|Overall Study|Lack of response to drug|0|||
155360185|NCT01236352|560751636|FG006|Overall Study|Lack of response to drug|0|||
155360186|NCT01236352|560751637|FG007|Overall Study|Lack of response to drug|0|||
155360187|NCT01236352|560751638|FG008|Overall Study|Lack of response to drug|0|||
155360188|NCT01236352|560751639|FG009|Overall Study|Lack of response to drug|1|||
155360189|NCT01236352|560751640|FG010|Overall Study|Lack of response to drug|1|||
155360190|NCT01236352|560751630|FG000|Overall Study|Patient transferred to IST|0|||
155360191|NCT01236352|560751631|FG001|Overall Study|Patient transferred to IST|0|||
155360192|NCT01236352|560751632|FG002|Overall Study|Patient transferred to IST|0|||
155360193|NCT01236352|560751633|FG003|Overall Study|Patient transferred to IST|0|||
155360194|NCT01236352|560751634|FG004|Overall Study|Patient transferred to IST|0|||
155360195|NCT01236352|560751635|FG005|Overall Study|Patient transferred to IST|0|||
155360196|NCT01236352|560751636|FG006|Overall Study|Patient transferred to IST|0|||
155360197|NCT01236352|560751637|FG007|Overall Study|Patient transferred to IST|0|||
155360198|NCT01236352|560751638|FG008|Overall Study|Patient transferred to IST|0|||
155360199|NCT01236352|560751639|FG009|Overall Study|Patient transferred to IST|2|||
155360200|NCT01236352|560751640|FG010|Overall Study|Patient transferred to IST|6|||
155360201|NCT01575873|560751641|FG000|Overall Study|Withdrawal by Subject|15|||
155360202|NCT01575873|560751642|FG001|Overall Study|Withdrawal by Subject|20|||
155360203|NCT01575873|560751643|FG002|Overall Study|Withdrawal by Subject|34|||
155360204|NCT01575873|560751644|FG003|Overall Study|Withdrawal by Subject|34|||
155360205|NCT01575873|560751641|FG000|Overall Study|Adverse Event|7|||
155360206|NCT01575873|560751642|FG001|Overall Study|Adverse Event|7|||
155360207|NCT01575873|560751643|FG002|Overall Study|Adverse Event|9|||
155360208|NCT01575873|560751644|FG003|Overall Study|Adverse Event|12|||
155360209|NCT01575873|560751641|FG000|Overall Study|Lost to Follow-up|1|||
155360210|NCT01575873|560751642|FG001|Overall Study|Lost to Follow-up|3|||
155360211|NCT01575873|560751643|FG002|Overall Study|Lost to Follow-up|13|||
155360212|NCT01575873|560751644|FG003|Overall Study|Lost to Follow-up|5|||
155360213|NCT01575873|560751641|FG000|Overall Study|Death|3|||
155360214|NCT01575873|560751642|FG001|Overall Study|Death|2|||
155360215|NCT01575873|560751643|FG002|Overall Study|Death|8|||
155360216|NCT01575873|560751644|FG003|Overall Study|Death|9|||
155360217|NCT01575873|560751641|FG000|Overall Study|Noncompliance|1|||
155360218|NCT01575873|560751642|FG001|Overall Study|Noncompliance|2|||
155360219|NCT01575873|560751643|FG002|Overall Study|Noncompliance|4|||
155360220|NCT01575873|560751644|FG003|Overall Study|Noncompliance|3|||
155360221|NCT01575873|560751641|FG000|Overall Study|Administrative decision|1|||
155360222|NCT01575873|560751642|FG001|Overall Study|Administrative decision|1|||
155360223|NCT01575873|560751643|FG002|Overall Study|Administrative decision|1|||
155360224|NCT01575873|560751644|FG003|Overall Study|Administrative decision|0|||
155360225|NCT01575873|560751641|FG000|Overall Study|Protocol deviation|0|||
155360226|NCT01575873|560751642|FG001|Overall Study|Protocol deviation|1|||
155360227|NCT01575873|560751643|FG002|Overall Study|Protocol deviation|0|||
155360228|NCT01575873|560751644|FG003|Overall Study|Protocol deviation|1|||
155360229|NCT01575873|560751641|FG000|Overall Study|Requirement for Alternative Therapy|0|||
155360230|NCT01575873|560751642|FG001|Overall Study|Requirement for Alternative Therapy|0|||
155360231|NCT01575873|560751643|FG002|Overall Study|Requirement for Alternative Therapy|1|||
155360232|NCT01575873|560751644|FG003|Overall Study|Requirement for Alternative Therapy|1|||
155360233|NCT01575873|560751641|FG000|Overall Study|Other|0|||
155360234|NCT01575873|560751642|FG001|Overall Study|Other|0|||
155360235|NCT01575873|560751643|FG002|Overall Study|Other|4|||
155360236|NCT01575873|560751644|FG003|Overall Study|Other|2|||
155360237|NCT02688530|560751650|FG000|Overall Study|Withdrawal by Subject|0|||
155360238|NCT02688530|560751651|FG001|Overall Study|Withdrawal by Subject|1|||
155360239|NCT02688530|560751652|FG002|Overall Study|Withdrawal by Subject|0|||
155360240|NCT02688530|560751653|FG003|Overall Study|Withdrawal by Subject|0|||
155360241|NCT02688530|560751650|FG000|Overall Study|Lost to Follow-up|0|||
155360242|NCT02688530|560751651|FG001|Overall Study|Lost to Follow-up|0|||
155360243|NCT02688530|560751652|FG002|Overall Study|Lost to Follow-up|2|||
155360244|NCT02688530|560751653|FG003|Overall Study|Lost to Follow-up|0|||
155360245|NCT01658020|560751654|FG000|Overall Study|Adverse Event|3|||
155360246|NCT01658020|560751655|FG001|Overall Study|Adverse Event|3|||
155360247|NCT01658020|560751654|FG000|Overall Study|Lost to Follow-up|1|||
155360248|NCT01658020|560751655|FG001|Overall Study|Lost to Follow-up|0|||
155360249|NCT01658020|560751654|FG000|Overall Study|Withdrawal by Subject|4|||
155360250|NCT01658020|560751655|FG001|Overall Study|Withdrawal by Subject|5|||
155360251|NCT01658020|560751654|FG000|Overall Study|Protocol Violation|0|||
155360252|NCT01658020|560751655|FG001|Overall Study|Protocol Violation|1|||
155360253|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Death|1|||
155360254|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Death|0|||
155360255|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Death|0|||
155360256|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Death|0|||
155360257|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Death|0|||
155360258|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Other|1|||
155360259|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Other|2|||
155360260|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Other|1|||
155360261|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Other|0|||
155360262|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Other|0|||
155360263|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360264|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360265|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
155360266|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360267|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
155360268|NCT05903183|560751658|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
155360269|NCT05903183|560751659|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360270|NCT05903183|560751660|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360271|NCT05903183|560751661|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360272|NCT05903183|560751662|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
155360273|NCT05903183|560751658|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
155360274|NCT05903183|560751659|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
155360275|NCT05903183|560751660|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
155360276|NCT05903183|560751661|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
155360277|NCT05903183|560751662|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
155360278|NCT03371823|560751663|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
155360279|NCT03371823|560751664|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
155360280|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360281|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360282|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360283|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360284|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
155360285|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
155360286|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360287|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360288|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360289|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360290|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
155360291|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
155360292|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360293|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360294|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360295|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360296|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
155360297|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
155360298|NCT04870957|560751665|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360299|NCT04870957|560751666|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360300|NCT04870957|560751667|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360301|NCT04870957|560751668|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360302|NCT04870957|560751669|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
155360303|NCT04870957|560751670|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
155360304|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Adverse Event|1|||
155360305|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Adverse Event|1|||
155360306|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Adverse Event|0|||
155360307|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Adverse Event|0|||
155360308|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Adverse Event|0|||
155360309|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Adverse Event|0|||
155360310|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
155360311|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
155360312|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
155360313|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
155360314|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
155360315|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
155360316|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
155360317|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
155360318|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
155360319|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
155360320|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
155360321|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
155360322|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Physician Decision|0|||
155360323|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Physician Decision|0|||
155360324|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Physician Decision|2|||
155360325|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Physician Decision|1|||
155360326|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Physician Decision|0|||
155360327|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Physician Decision|0|||
155360328|NCT04870957|560751665|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
155360329|NCT04870957|560751666|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
155360330|NCT04870957|560751667|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
155360331|NCT04870957|560751668|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
155360332|NCT04870957|560751669|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
155360333|NCT04870957|560751670|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
155360334|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
155360335|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
155360336|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
155360337|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
155360338|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
155360339|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
155360340|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
155360341|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
155360342|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
155360343|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
155360344|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
155360345|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
155360346|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
155360347|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
155360348|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
155360349|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
155360350|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
155360351|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
155360352|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
155360353|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
155360354|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
155360355|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
155360356|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
155360357|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
155360358|NCT04870957|560751665|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
155360359|NCT04870957|560751666|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
155360360|NCT04870957|560751667|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
155360361|NCT04870957|560751668|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
155360362|NCT04870957|560751669|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
155360363|NCT04870957|560751670|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
155360364|NCT04870957|560751665|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360365|NCT04870957|560751666|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360366|NCT04870957|560751667|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360367|NCT04870957|560751668|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360368|NCT04870957|560751669|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
155360369|NCT04870957|560751670|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
155360370|NCT04870957|560751665|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360371|NCT04870957|560751666|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360372|NCT04870957|560751667|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360373|NCT04870957|560751668|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360374|NCT04870957|560751669|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
155360375|NCT04870957|560751670|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
155360376|NCT04870957|560751665|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360377|NCT04870957|560751666|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360378|NCT04870957|560751667|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360379|NCT04870957|560751668|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360380|NCT04870957|560751669|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
155360381|NCT04870957|560751670|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
155360382|NCT05970640|560751671|FG000|Overall Study|Adverse Event|1|||
155360383|NCT05970640|560751672|FG001|Overall Study|Adverse Event|3|||
155360384|NCT05970640|560751673|FG002|Overall Study|Adverse Event|1|||
155360385|NCT05970640|560751674|FG003|Overall Study|Adverse Event|0|||
155360386|NCT05970640|560751671|FG000|Overall Study|Withdrawal by Subject|0|||
155360387|NCT05970640|560751672|FG001|Overall Study|Withdrawal by Subject|0|||
155360388|NCT05970640|560751673|FG002|Overall Study|Withdrawal by Subject|1|||
155360389|NCT05970640|560751674|FG003|Overall Study|Withdrawal by Subject|1|||
155360390|NCT05970640|560751671|FG000|Overall Study|Sponsor decision|0|||
155360391|NCT05970640|560751672|FG001|Overall Study|Sponsor decision|0|||
155360392|NCT05970640|560751673|FG002|Overall Study|Sponsor decision|1|||
155360393|NCT05970640|560751674|FG003|Overall Study|Sponsor decision|1|||
155360394|NCT04340843|560751675|FG000|Overall Study|Adverse Event|0|||
155360395|NCT04340843|560751676|FG001|Overall Study|Adverse Event|2|||
155360396|NCT04340843|560751675|FG000|Overall Study|Withdrawal by Subject|0|||
155360397|NCT04340843|560751676|FG001|Overall Study|Withdrawal by Subject|2|||
155360398|NCT03733899|560751681|FG000|Period 1|Protocol Violation|0|||
155360399|NCT03733899|560751682|FG001|Period 1|Protocol Violation|0|||
155360400|NCT03733899|560751683|FG002|Period 1|Protocol Violation|0|||
155360401|NCT03733899|560751684|FG003|Period 1|Protocol Violation|0|||
155360402|NCT03733899|560751685|FG004|Period 1|Protocol Violation|0|||
155360403|NCT03733899|560751686|FG005|Period 1|Protocol Violation|1|||
155360404|NCT03733899|560751681|FG000|Period 2|Unscuccessful Treatment|0|||
155360405|NCT03733899|560751682|FG001|Period 2|Unscuccessful Treatment|1|||
155360406|NCT03733899|560751683|FG002|Period 2|Unscuccessful Treatment|0|||
155360407|NCT03733899|560751684|FG003|Period 2|Unscuccessful Treatment|0|||
155360408|NCT03733899|560751685|FG004|Period 2|Unscuccessful Treatment|0|||
155360409|NCT03733899|560751686|FG005|Period 2|Unscuccessful Treatment|0|||
155360410|NCT03733899|560751681|FG000|Period 3|Withdrawal by Subject|1|||
155360411|NCT03733899|560751682|FG001|Period 3|Withdrawal by Subject|0|||
155360412|NCT03733899|560751683|FG002|Period 3|Withdrawal by Subject|0|||
155360413|NCT03733899|560751684|FG003|Period 3|Withdrawal by Subject|0|||
155360414|NCT03733899|560751685|FG004|Period 3|Withdrawal by Subject|0|||
155360415|NCT03733899|560751686|FG005|Period 3|Withdrawal by Subject|0|||
155360416|NCT00307047|560753824|FG000|Overall Study|Lost to Follow-up|35|||
155360417|NCT00307047|560753825|FG001|Overall Study|Lost to Follow-up|24|||
155360418|NCT00307047|560753824|FG000|Overall Study|Withdrawal by Subject|6|||
155360419|NCT00307047|560753825|FG001|Overall Study|Withdrawal by Subject|6|||
155360420|NCT00307047|560753824|FG000|Overall Study|Physician Decision|1|||
155360421|NCT00307047|560753825|FG001|Overall Study|Physician Decision|2|||
155360422|NCT00307047|560753824|FG000|Overall Study|Lost to follow-up for other reasons|0|||
155360423|NCT00307047|560753825|FG001|Overall Study|Lost to follow-up for other reasons|1|||
155360424|NCT00307047|560753824|FG000|Overall Study|All death, all MI, all Revascularization|27|||
155360425|NCT00307047|560753825|FG001|Overall Study|All death, all MI, all Revascularization|16|||
155165885|NCT03892967|560043591|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
155165886|NCT04434937|560043592|FG000|Overall Study|Death|4|||
155165887|NCT04434937|560043592|FG000|Overall Study|Withdrawal by Subject|1|||
155165888|NCT04434937|560043592|FG000|Overall Study|Transitioned to Rollover Study|19|||
155165889|NCT04434937|560043592|FG000|Overall Study|Progressive Disease|18|||
155165890|NCT03079102|560046126|FG000|Overall Study|Physician Decision|0|||
155165891|NCT03079102|560046127|FG001|Overall Study|Physician Decision|1|||
155165892|NCT02923921|560046128|FG000|Overall Study|Sponsor Decision|39|||
155165893|NCT02923921|560046129|FG001|Overall Study|Sponsor Decision|38|||
155360426|NCT00379769|560753826|FG000|Main Study|Death|57|||
155360427|NCT00379769|560753827|FG001|Main Study|Death|67|||
155360428|NCT00379769|560753828|FG002|Main Study|Death|54|||
155360429|NCT00379769|560753829|FG003|Main Study|Death|72|||
155360430|NCT00379769|560753830|FG004|Main Study|Death|0|||
155165894|NCT02923921|560046128|FG000|Overall Study|Lost to Follow-up|1|||
155360431|NCT00379769|560753831|FG005|Main Study|Death|0|||
155360432|NCT00379769|560753826|FG000|Main Study|Adverse Event|5|||
155360433|NCT00379769|560753827|FG001|Main Study|Adverse Event|8|||
155360434|NCT00379769|560753828|FG002|Main Study|Adverse Event|10|||
155360435|NCT00379769|560753829|FG003|Main Study|Adverse Event|11|||
155165895|NCT02923921|560046129|FG001|Overall Study|Lost to Follow-up|0|||
155360436|NCT00379769|560753830|FG004|Main Study|Adverse Event|0|||
155360437|NCT00379769|560753831|FG005|Main Study|Adverse Event|0|||
155360438|NCT00379769|560753826|FG000|Main Study|Lost to Follow-up|29|||
155360439|NCT00379769|560753827|FG001|Main Study|Lost to Follow-up|29|||
155360440|NCT00379769|560753828|FG002|Main Study|Lost to Follow-up|25|||
155360441|NCT00379769|560753829|FG003|Main Study|Lost to Follow-up|26|||
155360442|NCT00379769|560753830|FG004|Main Study|Lost to Follow-up|0|||
155360443|NCT00379769|560753831|FG005|Main Study|Lost to Follow-up|0|||
155360444|NCT00379769|560753826|FG000|Main Study|Withdrawal by Subject|46|||
155360445|NCT00379769|560753827|FG001|Main Study|Withdrawal by Subject|56|||
155360446|NCT00379769|560753828|FG002|Main Study|Withdrawal by Subject|72|||
155360447|NCT00379769|560753829|FG003|Main Study|Withdrawal by Subject|70|||
155360448|NCT00379769|560753830|FG004|Main Study|Withdrawal by Subject|0|||
155360449|NCT00379769|560753831|FG005|Main Study|Withdrawal by Subject|0|||
155360450|NCT00379769|560753826|FG000|Main Study|Moved to survival status follow-up only|27|||
155360451|NCT00379769|560753827|FG001|Main Study|Moved to survival status follow-up only|25|||
155360452|NCT00379769|560753828|FG002|Main Study|Moved to survival status follow-up only|32|||
155360453|NCT00379769|560753829|FG003|Main Study|Moved to survival status follow-up only|36|||
155360454|NCT00379769|560753830|FG004|Main Study|Moved to survival status follow-up only|0|||
155360455|NCT00379769|560753831|FG005|Main Study|Moved to survival status follow-up only|0|||
155360456|NCT00379769|560753826|FG000|Main Study|Participant moved|3|||
155165896|NCT02923921|560046128|FG000|Overall Study|Withdrawal by Subject|6|||
155165897|NCT02923921|560046129|FG001|Overall Study|Withdrawal by Subject|13|||
155165898|NCT02923921|560046128|FG000|Overall Study|Unknown, Not Collected|7|||
155165899|NCT02923921|560046129|FG001|Overall Study|Unknown, Not Collected|6|||
155165900|NCT00479687|560046130|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
155165901|NCT00479687|560046131|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
155165902|NCT00479687|560046132|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
155165903|NCT00479687|560046130|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
155165904|NCT00479687|560046131|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
155165905|NCT00479687|560046132|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
155165906|NCT00479687|560046130|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
155165907|NCT00479687|560046131|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
155165908|NCT00479687|560046132|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
155165909|NCT00479687|560046130|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
155165910|NCT00479687|560046131|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
155165911|NCT00479687|560046132|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
155165912|NCT00479687|560046130|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
155165913|NCT00479687|560046131|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
155165914|NCT00479687|560046132|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
155165915|NCT00479687|560046130|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
155165916|NCT00479687|560046131|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
155165917|NCT00479687|560046132|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
155165918|NCT00479687|560046130|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
155165919|NCT00479687|560046131|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
155165920|NCT00479687|560046132|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
155165921|NCT00479687|560046130|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
155165922|NCT00479687|560046131|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
155165923|NCT00479687|560046132|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
155165924|NCT00479687|560046130|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
155165925|NCT00479687|560046131|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
155165926|NCT00479687|560046132|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
155360457|NCT00379769|560753827|FG001|Main Study|Participant moved|2|||
155360458|NCT00379769|560753828|FG002|Main Study|Participant moved|3|||
155360459|NCT00379769|560753829|FG003|Main Study|Participant moved|3|||
155087776|NCT02374255|559754363|FG002|Overall Study|Withdrawal by Subject|0|||
155360460|NCT00379769|560753830|FG004|Main Study|Participant moved|0|||
155360461|NCT00379769|560753831|FG005|Main Study|Participant moved|0|||
155360462|NCT00379769|560753826|FG000|Main Study|Poor compliance|3|||
155360463|NCT00379769|560753827|FG001|Main Study|Poor compliance|2|||
155360464|NCT00379769|560753828|FG002|Main Study|Poor compliance|2|||
155360465|NCT00379769|560753829|FG003|Main Study|Poor compliance|1|||
155360466|NCT00379769|560753830|FG004|Main Study|Poor compliance|0|||
155360467|NCT00379769|560753831|FG005|Main Study|Poor compliance|0|||
155360468|NCT00379769|560753826|FG000|Main Study|Prohibited glucose lowering medication|0|||
155360469|NCT00379769|560753827|FG001|Main Study|Prohibited glucose lowering medication|3|||
155360470|NCT00379769|560753828|FG002|Main Study|Prohibited glucose lowering medication|0|||
155360471|NCT00379769|560753829|FG003|Main Study|Prohibited glucose lowering medication|1|||
155360472|NCT00379769|560753830|FG004|Main Study|Prohibited glucose lowering medication|0|||
155360473|NCT00379769|560753831|FG005|Main Study|Prohibited glucose lowering medication|0|||
155360474|NCT00379769|560753826|FG000|Main Study|Site closed|4|||
155360475|NCT00379769|560753827|FG001|Main Study|Site closed|4|||
155360476|NCT00379769|560753828|FG002|Main Study|Site closed|4|||
155360477|NCT00379769|560753829|FG003|Main Study|Site closed|8|||
155360478|NCT00379769|560753830|FG004|Main Study|Site closed|0|||
155360479|NCT00379769|560753831|FG005|Main Study|Site closed|0|||
155360480|NCT00379769|560753826|FG000|Main Study|Entry criteria violation|0|||
155360481|NCT00379769|560753827|FG001|Main Study|Entry criteria violation|0|||
155360482|NCT00379769|560753828|FG002|Main Study|Entry criteria violation|1|||
155360483|NCT00379769|560753829|FG003|Main Study|Entry criteria violation|1|||
155360484|NCT00379769|560753830|FG004|Main Study|Entry criteria violation|0|||
155360485|NCT00379769|560753831|FG005|Main Study|Entry criteria violation|0|||
155360486|NCT00379769|560753826|FG000|Main Study|Participant did not take study drug|0|||
155360487|NCT00379769|560753827|FG001|Main Study|Participant did not take study drug|0|||
155360488|NCT00379769|560753828|FG002|Main Study|Participant did not take study drug|1|||
155360489|NCT00379769|560753829|FG003|Main Study|Participant did not take study drug|0|||
155360490|NCT00379769|560753830|FG004|Main Study|Participant did not take study drug|0|||
155360491|NCT00379769|560753831|FG005|Main Study|Participant did not take study drug|0|||
155360492|NCT00379769|560753826|FG000|Main Study|Physician Decision|2|||
155360493|NCT00379769|560753827|FG001|Main Study|Physician Decision|2|||
155360494|NCT00379769|560753828|FG002|Main Study|Physician Decision|1|||
155360495|NCT00379769|560753829|FG003|Main Study|Physician Decision|1|||
155360496|NCT00379769|560753830|FG004|Main Study|Physician Decision|0|||
155360497|NCT00379769|560753831|FG005|Main Study|Physician Decision|0|||
155360498|NCT00379769|560753826|FG000|Main Study|Participant completed study at visit 27|1|||
155360499|NCT00379769|560753827|FG001|Main Study|Participant completed study at visit 27|0|||
155360500|NCT00379769|560753828|FG002|Main Study|Participant completed study at visit 27|0|||
155360501|NCT00379769|560753829|FG003|Main Study|Participant completed study at visit 27|0|||
155360502|NCT00379769|560753830|FG004|Main Study|Participant completed study at visit 27|0|||
155360503|NCT00379769|560753831|FG005|Main Study|Participant completed study at visit 27|0|||
155360504|NCT00379769|560753826|FG000|Main Study|Personal reasons|1|||
155360505|NCT00379769|560753827|FG001|Main Study|Personal reasons|0|||
155360506|NCT00379769|560753828|FG002|Main Study|Personal reasons|0|||
155360507|NCT00379769|560753829|FG003|Main Study|Personal reasons|0|||
155360508|NCT00379769|560753830|FG004|Main Study|Personal reasons|0|||
155360509|NCT00379769|560753831|FG005|Main Study|Personal reasons|0|||
155360510|NCT00379769|560753826|FG000|Main Study|Risk of heart failure|0|||
155360511|NCT00379769|560753827|FG001|Main Study|Risk of heart failure|1|||
155360512|NCT00379769|560753828|FG002|Main Study|Risk of heart failure|0|||
155360513|NCT00379769|560753829|FG003|Main Study|Risk of heart failure|0|||
155360514|NCT00379769|560753830|FG004|Main Study|Risk of heart failure|0|||
155360515|NCT00379769|560753831|FG005|Main Study|Risk of heart failure|0|||
155360516|NCT00379769|560753826|FG000|Main Study|Investigator refused to log temperature|0|||
155360517|NCT00379769|560753827|FG001|Main Study|Investigator refused to log temperature|0|||
155360518|NCT00379769|560753828|FG002|Main Study|Investigator refused to log temperature|1|||
155360519|NCT00379769|560753829|FG003|Main Study|Investigator refused to log temperature|0|||
155360520|NCT00379769|560753830|FG004|Main Study|Investigator refused to log temperature|0|||
155360521|NCT00379769|560753831|FG005|Main Study|Investigator refused to log temperature|0|||
155360522|NCT00379769|560753826|FG000|Main Study|Reason unspecified|0|||
155360523|NCT00379769|560753827|FG001|Main Study|Reason unspecified|0|||
155087777|NCT02374255|559754364|FG003|Overall Study|Withdrawal by Subject|0|||
155087778|NCT03360344|559754367|FG000|Overall Study|Withdrawal by Subject|0|||
155087779|NCT03360344|559754368|FG001|Overall Study|Withdrawal by Subject|1|||
155360524|NCT00379769|560753828|FG002|Main Study|Reason unspecified|1|||
155360525|NCT00379769|560753829|FG003|Main Study|Reason unspecified|0|||
155360526|NCT00379769|560753830|FG004|Main Study|Reason unspecified|0|||
155360527|NCT00379769|560753831|FG005|Main Study|Reason unspecified|0|||
155360528|NCT00379769|560753826|FG000|Observational Follow-up|Death|0|||
155087780|NCT03360344|559754369|FG002|Overall Study|Withdrawal by Subject|1|||
155087781|NCT00133705|559754370|FG000|Overall Study|Withdrawal by Subject|2|||
155360529|NCT00379769|560753827|FG001|Observational Follow-up|Death|0|||
155360530|NCT00379769|560753828|FG002|Observational Follow-up|Death|0|||
155087782|NCT00133705|559754371|FG001|Overall Study|Withdrawal by Subject|3|||
155087783|NCT00959049|559754372|FG000|Overall Study|Adverse Event|1|||
155087784|NCT00959049|559754373|FG001|Overall Study|Adverse Event|0|||
155087785|NCT00959049|559754374|FG002|Overall Study|Adverse Event|0|||
155087786|NCT00959049|559754375|FG003|Overall Study|Adverse Event|0|||
155087787|NCT00959049|559754376|FG004|Overall Study|Adverse Event|0|||
155087788|NCT00959049|559754377|FG005|Overall Study|Adverse Event|0|||
155087789|NCT00959049|559754372|FG000|Overall Study|Lost to Follow-up|17|||
155087790|NCT00959049|559754373|FG001|Overall Study|Lost to Follow-up|5|||
155087791|NCT00959049|559754374|FG002|Overall Study|Lost to Follow-up|1|||
155087792|NCT00959049|559754375|FG003|Overall Study|Lost to Follow-up|10|||
155087793|NCT00959049|559754376|FG004|Overall Study|Lost to Follow-up|9|||
155087794|NCT00959049|559754377|FG005|Overall Study|Lost to Follow-up|1|||
155087795|NCT00959049|559754372|FG000|Overall Study|Contraindicated medication|0|||
155360531|NCT00379769|560753829|FG003|Observational Follow-up|Death|0|||
155360532|NCT00379769|560753830|FG004|Observational Follow-up|Death|78|||
155360533|NCT00379769|560753831|FG005|Observational Follow-up|Death|70|||
155360534|NCT00379769|560753826|FG000|Observational Follow-up|Adverse Event|0|||
155360535|NCT00379769|560753827|FG001|Observational Follow-up|Adverse Event|0|||
155360536|NCT00379769|560753828|FG002|Observational Follow-up|Adverse Event|0|||
155360537|NCT00379769|560753829|FG003|Observational Follow-up|Adverse Event|0|||
155360538|NCT00379769|560753830|FG004|Observational Follow-up|Adverse Event|1|||
155360539|NCT00379769|560753831|FG005|Observational Follow-up|Adverse Event|0|||
155360540|NCT00379769|560753826|FG000|Observational Follow-up|Lost to Follow-up|0|||
155087796|NCT00959049|559754373|FG001|Overall Study|Contraindicated medication|0|||
155087797|NCT00959049|559754374|FG002|Overall Study|Contraindicated medication|0|||
155087798|NCT00959049|559754375|FG003|Overall Study|Contraindicated medication|1|||
155087799|NCT00959049|559754376|FG004|Overall Study|Contraindicated medication|0|||
155087800|NCT00959049|559754377|FG005|Overall Study|Contraindicated medication|0|||
155087801|NCT00959049|559754372|FG000|Overall Study|Withdrawal by Subject|0|||
155087802|NCT00959049|559754373|FG001|Overall Study|Withdrawal by Subject|2|||
155087803|NCT00959049|559754374|FG002|Overall Study|Withdrawal by Subject|0|||
155087804|NCT00959049|559754375|FG003|Overall Study|Withdrawal by Subject|0|||
155087805|NCT00959049|559754376|FG004|Overall Study|Withdrawal by Subject|0|||
155087806|NCT00959049|559754377|FG005|Overall Study|Withdrawal by Subject|0|||
155087807|NCT00836706|559754386|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
155087808|NCT00836706|559754387|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
155087809|NCT01992757|559754388|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
155087810|NCT03440411|559754390|FG000|Overall Study|Adverse Event|0|||
155087811|NCT03440411|559754391|FG001|Overall Study|Adverse Event|0|||
155087812|NCT03440411|559754392|FG002|Overall Study|Adverse Event|1|||
155087813|NCT03440411|559754393|FG003|Overall Study|Adverse Event|0|||
155087814|NCT03440411|559754390|FG000|Overall Study|PD|2|||
155087815|NCT03440411|559754391|FG001|Overall Study|PD|1|||
155087816|NCT03440411|559754392|FG002|Overall Study|PD|1|||
155087817|NCT03440411|559754393|FG003|Overall Study|PD|1|||
155360541|NCT00379769|560753827|FG001|Observational Follow-up|Lost to Follow-up|0|||
155360542|NCT00379769|560753828|FG002|Observational Follow-up|Lost to Follow-up|0|||
155360543|NCT00379769|560753829|FG003|Observational Follow-up|Lost to Follow-up|0|||
155360544|NCT00379769|560753830|FG004|Observational Follow-up|Lost to Follow-up|25|||
155360545|NCT00379769|560753831|FG005|Observational Follow-up|Lost to Follow-up|27|||
155360546|NCT00379769|560753826|FG000|Observational Follow-up|Withdrawal by Subject|0|||
154965146|NCT00521586|559298830|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
154965147|NCT00521586|559298829|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
154965148|NCT00521586|559298830|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
154965149|NCT00828321|559298831|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
154965150|NCT00828321|559298832|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
154965151|NCT00828321|559298831|FG000|Second Intervention|Protocol Violation|0|||
155087818|NCT03440411|559754390|FG000|Overall Study|Withdrawal by Subject|1|||
155087819|NCT03440411|559754391|FG001|Overall Study|Withdrawal by Subject|0|||
155360547|NCT00379769|560753827|FG001|Observational Follow-up|Withdrawal by Subject|0|||
155360548|NCT00379769|560753828|FG002|Observational Follow-up|Withdrawal by Subject|0|||
155360549|NCT00379769|560753829|FG003|Observational Follow-up|Withdrawal by Subject|0|||
155360550|NCT00379769|560753830|FG004|Observational Follow-up|Withdrawal by Subject|12|||
155360551|NCT00379769|560753831|FG005|Observational Follow-up|Withdrawal by Subject|12|||
155360552|NCT00379769|560753826|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360553|NCT00379769|560753827|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360554|NCT00379769|560753828|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360555|NCT00379769|560753829|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
155360556|NCT00379769|560753830|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
155360557|NCT00379769|560753831|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
155360558|NCT00379769|560753826|FG000|Observational Follow-up|Physician Decision|0|||
155360559|NCT00379769|560753827|FG001|Observational Follow-up|Physician Decision|0|||
155360560|NCT00379769|560753828|FG002|Observational Follow-up|Physician Decision|0|||
155360561|NCT00379769|560753829|FG003|Observational Follow-up|Physician Decision|0|||
155360562|NCT00379769|560753830|FG004|Observational Follow-up|Physician Decision|8|||
155360563|NCT00379769|560753831|FG005|Observational Follow-up|Physician Decision|8|||
155360564|NCT00379769|560753826|FG000|Observational Follow-up|Site Closed Early|0|||
155360565|NCT00379769|560753827|FG001|Observational Follow-up|Site Closed Early|0|||
155360566|NCT00379769|560753828|FG002|Observational Follow-up|Site Closed Early|0|||
155360567|NCT00379769|560753829|FG003|Observational Follow-up|Site Closed Early|0|||
155360568|NCT00379769|560753830|FG004|Observational Follow-up|Site Closed Early|6|||
155360569|NCT00379769|560753831|FG005|Observational Follow-up|Site Closed Early|7|||
155360570|NCT00379769|560753826|FG000|Observational Follow-up|Participant Moved|0|||
155360571|NCT00379769|560753827|FG001|Observational Follow-up|Participant Moved|0|||
155360572|NCT00379769|560753828|FG002|Observational Follow-up|Participant Moved|0|||
155360573|NCT00379769|560753829|FG003|Observational Follow-up|Participant Moved|0|||
155360574|NCT00379769|560753830|FG004|Observational Follow-up|Participant Moved|0|||
155360575|NCT00379769|560753831|FG005|Observational Follow-up|Participant Moved|1|||
155360576|NCT00379769|560753826|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
155360577|NCT00379769|560753827|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
154965152|NCT00828321|559298832|FG001|Second Intervention|Protocol Violation|1|||
155087820|NCT03440411|559754392|FG002|Overall Study|Withdrawal by Subject|0|||
155087821|NCT03440411|559754393|FG003|Overall Study|Withdrawal by Subject|0|||
155087822|NCT03440411|559754390|FG000|Overall Study|Closed study by sponsor|0|||
155087823|NCT03440411|559754391|FG001|Overall Study|Closed study by sponsor|0|||
155087824|NCT03440411|559754392|FG002|Overall Study|Closed study by sponsor|0|||
155087825|NCT03440411|559754393|FG003|Overall Study|Closed study by sponsor|1|||
155087826|NCT03663582|559754394|FG000|Overall Study|Physician Decision|1|||
155087827|NCT02853136|559754397|FG000|Wash-out|Adverse Event|0|||
155087828|NCT02853136|559754398|FG001|Wash-out|Adverse Event|0|||
155165927|NCT01474239|560046133|FG000|Overall Study|Disease Progression|37|||
155360578|NCT00379769|560753828|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
155360579|NCT00379769|560753829|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
155360580|NCT00379769|560753830|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
155360581|NCT00379769|560753831|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
155360582|NCT02825251|560753832|FG000|Overall Study|Adverse Event|0|||
155360583|NCT02825251|560753833|FG001|Overall Study|Adverse Event|1|||
155360584|NCT02825251|560753832|FG000|Overall Study|Lost to Follow-up|0|||
154965153|NCT04406194|559298835|FG000|Period 1|Withdrawal by Subject|0|||
155360585|NCT02825251|560753833|FG001|Overall Study|Lost to Follow-up|1|||
155360586|NCT02825251|560753832|FG000|Overall Study|Withdrawal by Subject|1|||
155360587|NCT02825251|560753833|FG001|Overall Study|Withdrawal by Subject|4|||
155360588|NCT02825251|560753832|FG000|Overall Study|Unclassified|2|||
154965154|NCT04406194|559298836|FG001|Period 1|Withdrawal by Subject|1|||
155087829|NCT02853136|559754399|FG002|Wash-out|Adverse Event|0|||
155087830|NCT02853136|559754400|FG003|Wash-out|Adverse Event|1|||
155087831|NCT00863304|559754401|FG000|Overall Study|Adverse Event|10|||
155087832|NCT00863304|559754402|FG001|Overall Study|Adverse Event|4|||
155165928|NCT01474239|560046134|FG001|Overall Study|Disease Progression|25|||
155360589|NCT02825251|560753833|FG001|Overall Study|Unclassified|0|||
155360590|NCT01689363|560753840|FG000|Overall Study|Protocol Violation|0|||
155360591|NCT01689363|560753841|FG001|Overall Study|Protocol Violation|1|||
155360592|NCT01689363|560753842|FG002|Overall Study|Protocol Violation|0|||
155360593|NCT01689363|560753843|FG003|Overall Study|Protocol Violation|0|||
155360594|NCT01689363|560753844|FG004|Overall Study|Protocol Violation|0|||
155087833|NCT00863304|559754403|FG002|Overall Study|Adverse Event|14|||
155360595|NCT01689363|560753845|FG005|Overall Study|Protocol Violation|0|||
155360596|NCT01689363|560753846|FG006|Overall Study|Protocol Violation|0|||
155360597|NCT01689363|560753847|FG007|Overall Study|Protocol Violation|0|||
155360598|NCT00321685|560753848|FG000|Overall Study|Adverse Event|18|||
155087834|NCT00863304|559754404|FG003|Overall Study|Adverse Event|16|||
155087835|NCT00863304|559754401|FG000|Overall Study|Lost to Follow-up|1|||
155087836|NCT00863304|559754402|FG001|Overall Study|Lost to Follow-up|5|||
155087837|NCT00863304|559754403|FG002|Overall Study|Lost to Follow-up|4|||
155087838|NCT00863304|559754404|FG003|Overall Study|Lost to Follow-up|2|||
155087839|NCT00863304|559754401|FG000|Overall Study|Lack of Efficacy|57|||
155087840|NCT00863304|559754402|FG001|Overall Study|Lack of Efficacy|26|||
155087841|NCT00863304|559754403|FG002|Overall Study|Lack of Efficacy|30|||
155087842|NCT00863304|559754404|FG003|Overall Study|Lack of Efficacy|28|||
155087843|NCT00863304|559754401|FG000|Overall Study|Withdrawal by Subject|19|||
155087844|NCT00863304|559754402|FG001|Overall Study|Withdrawal by Subject|14|||
155087845|NCT00863304|559754403|FG002|Overall Study|Withdrawal by Subject|20|||
155087846|NCT00863304|559754404|FG003|Overall Study|Withdrawal by Subject|18|||
155087847|NCT00863304|559754401|FG000|Overall Study|Other|1|||
155087848|NCT00863304|559754402|FG001|Overall Study|Other|0|||
155087849|NCT00863304|559754403|FG002|Overall Study|Other|0|||
155087850|NCT00863304|559754404|FG003|Overall Study|Other|1|||
155087851|NCT00863304|559754401|FG000|Overall Study|Protocol Violation|2|||
155087852|NCT00863304|559754402|FG001|Overall Study|Protocol Violation|6|||
155087853|NCT00863304|559754403|FG002|Overall Study|Protocol Violation|2|||
155087854|NCT00863304|559754404|FG003|Overall Study|Protocol Violation|0|||
155087855|NCT00863304|559754401|FG000|Overall Study|Randomized, but not Treated|3|||
155087856|NCT00863304|559754402|FG001|Overall Study|Randomized, but not Treated|1|||
155087857|NCT00863304|559754403|FG002|Overall Study|Randomized, but not Treated|4|||
155087858|NCT00863304|559754404|FG003|Overall Study|Randomized, but not Treated|1|||
155087859|NCT00863304|559754401|FG000|Overall Study|Entered extension study|101|||
155087860|NCT00863304|559754402|FG001|Overall Study|Entered extension study|129|||
155087861|NCT00863304|559754403|FG002|Overall Study|Entered extension study|113|||
155087862|NCT00863304|559754404|FG003|Overall Study|Entered extension study|125|||
155087863|NCT00478257|559754405|FG000|Overall Study|Withdrawal by Subject|8|||
155087864|NCT00478257|559754406|FG001|Overall Study|Withdrawal by Subject|3|||
155087865|NCT01182350|559754407|FG000|Overall Study|Adverse Event|5|||
155087866|NCT01182350|559754408|FG001|Overall Study|Adverse Event|0|||
155087867|NCT01182350|559754409|FG002|Overall Study|Adverse Event|0|||
155087868|NCT01182350|559754410|FG003|Overall Study|Adverse Event|0|||
155087869|NCT01182350|559754411|FG004|Overall Study|Adverse Event|0|||
155087870|NCT01182350|559754407|FG000|Overall Study|Disease Progression|15|||
155087871|NCT01182350|559754408|FG001|Overall Study|Disease Progression|12|||
155087872|NCT01182350|559754409|FG002|Overall Study|Disease Progression|0|||
155087873|NCT01182350|559754410|FG003|Overall Study|Disease Progression|1|||
155087874|NCT01182350|559754411|FG004|Overall Study|Disease Progression|0|||
155087875|NCT01182350|559754407|FG000|Overall Study|Death|0|||
155087876|NCT01182350|559754408|FG001|Overall Study|Death|1|||
155087877|NCT01182350|559754409|FG002|Overall Study|Death|1|||
155087878|NCT01182350|559754410|FG003|Overall Study|Death|0|||
155087879|NCT01182350|559754411|FG004|Overall Study|Death|0|||
155087880|NCT01182350|559754407|FG000|Overall Study|Withdrawal by Subject|3|||
155087881|NCT01182350|559754408|FG001|Overall Study|Withdrawal by Subject|1|||
155087882|NCT01182350|559754409|FG002|Overall Study|Withdrawal by Subject|0|||
155087883|NCT01182350|559754410|FG003|Overall Study|Withdrawal by Subject|1|||
155087884|NCT01182350|559754411|FG004|Overall Study|Withdrawal by Subject|0|||
155087885|NCT01182350|559754407|FG000|Overall Study|Alternative Therapy|2|||
155087886|NCT01182350|559754408|FG001|Overall Study|Alternative Therapy|0|||
155087887|NCT01182350|559754409|FG002|Overall Study|Alternative Therapy|1|||
155087888|NCT01182350|559754410|FG003|Overall Study|Alternative Therapy|0|||
155087889|NCT01182350|559754411|FG004|Overall Study|Alternative Therapy|0|||
155087890|NCT01182350|559754407|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
155087891|NCT01182350|559754408|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
155087892|NCT01182350|559754409|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
155087893|NCT01182350|559754410|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
155087894|NCT01182350|559754411|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
155087895|NCT01182350|559754407|FG000|Overall Study|Unevaluable for Biopsy|0|||
155087896|NCT01182350|559754408|FG001|Overall Study|Unevaluable for Biopsy|0|||
155087897|NCT01182350|559754409|FG002|Overall Study|Unevaluable for Biopsy|0|||
155360599|NCT00321685|560753848|FG000|Overall Study|Death|2|||
155087898|NCT01182350|559754410|FG003|Overall Study|Unevaluable for Biopsy|0|||
155087899|NCT01182350|559754411|FG004|Overall Study|Unevaluable for Biopsy|3|||
155087900|NCT02592863|559754416|FG000|Overall Study|Withdrawal by Subject|2|||
155087901|NCT02592863|559754417|FG001|Overall Study|Withdrawal by Subject|2|||
155360600|NCT00321685|560753848|FG000|Overall Study|Withdrawal by Subject|8|||
155360601|NCT00321685|560753848|FG000|Overall Study|Alternative therapy|1|||
155360602|NCT00321685|560753848|FG000|Overall Study|Complicating disese|1|||
155360603|NCT00321685|560753848|FG000|Overall Study|Other|5|||
155360604|NCT00321685|560753848|FG000|Overall Study|Not start protocol therapy|2|||
155360605|NCT00321685|560753848|FG000|Overall Study|Ineligible|2|||
155360606|NCT05064488|560753852|FG000|Overall Study|Withdrawal by Subject|2|||
155360607|NCT05064488|560753853|FG001|Overall Study|Withdrawal by Subject|0|||
155360608|NCT03023722|560753854|FG000|Overall Study|No follow-up assessment|4|||
154965155|NCT02888756|559298837|FG000|Analytical Treatment Interruption|Physician Decision|10|||
154965156|NCT02888756|559298838|FG001|Analytical Treatment Interruption|Physician Decision|6|||
154965157|NCT02888756|559298839|FG002|Analytical Treatment Interruption|Physician Decision|5|||
154965158|NCT03605342|559298845|FG000|Overall Study|Withdrawal by Subject|9|||
154965159|NCT03605342|559298846|FG001|Overall Study|Withdrawal by Subject|7|||
154965160|NCT03605342|559298845|FG000|Overall Study|Lost to Follow-up|1|||
154965161|NCT03605342|559298846|FG001|Overall Study|Lost to Follow-up|1|||
154965162|NCT01604941|559298847|FG000|Overall Study|Adverse Event|1|||
154965163|NCT01604941|559298848|FG001|Overall Study|Adverse Event|2|||
154965164|NCT01604941|559298849|FG002|Overall Study|Adverse Event|0|||
154965165|NCT01604941|559298850|FG003|Overall Study|Adverse Event|0|||
154965166|NCT01604941|559298851|FG004|Overall Study|Adverse Event|1|||
154965167|NCT01604941|559298852|FG005|Overall Study|Adverse Event|5|||
154965168|NCT01604941|559298847|FG000|Overall Study|Non-compliance|1|||
154965169|NCT01604941|559298848|FG001|Overall Study|Non-compliance|0|||
154965170|NCT01604941|559298849|FG002|Overall Study|Non-compliance|0|||
154965171|NCT01604941|559298850|FG003|Overall Study|Non-compliance|0|||
154965172|NCT01604941|559298851|FG004|Overall Study|Non-compliance|0|||
154965173|NCT01604941|559298852|FG005|Overall Study|Non-compliance|0|||
154965174|NCT01604941|559298847|FG000|Overall Study|Participant Decision|0|||
154965175|NCT01604941|559298848|FG001|Overall Study|Participant Decision|0|||
154965176|NCT01604941|559298849|FG002|Overall Study|Participant Decision|0|||
154965177|NCT01604941|559298850|FG003|Overall Study|Participant Decision|0|||
154965178|NCT01604941|559298851|FG004|Overall Study|Participant Decision|0|||
154965179|NCT01604941|559298852|FG005|Overall Study|Participant Decision|2|||
154965180|NCT01604941|559298847|FG000|Overall Study|Early Study Termination|9|||
154965181|NCT01604941|559298848|FG001|Overall Study|Early Study Termination|2|||
155087902|NCT02592863|559754416|FG000|Overall Study|Lost to Follow-up|1|||
155087903|NCT02592863|559754417|FG001|Overall Study|Lost to Follow-up|1|||
155087904|NCT02743221|559754418|FG000|Overall Study|Progressive disease|29|||
155087905|NCT02743221|559754419|FG001|Overall Study|Progressive disease|38|||
155087906|NCT02743221|559754418|FG000|Overall Study|Adverse Event|17|||
155087907|NCT02743221|559754419|FG001|Overall Study|Adverse Event|14|||
155087908|NCT02743221|559754418|FG000|Overall Study|non medical reason|8|||
155087909|NCT02743221|559754419|FG001|Overall Study|non medical reason|2|||
155087910|NCT02743221|559754418|FG000|Overall Study|Physician Decision|2|||
155087911|NCT02743221|559754419|FG001|Overall Study|Physician Decision|5|||
155087912|NCT02743221|559754418|FG000|Overall Study|Patient not eligible, not treated|0|||
155087913|NCT02743221|559754419|FG001|Overall Study|Patient not eligible, not treated|1|||
155087914|NCT03411044|559754422|FG000|Overall Study|Death|30|||
155087915|NCT03411044|559754422|FG000|Overall Study|Withdrawal by Subject|48|||
155087916|NCT03411044|559754422|FG000|Overall Study|Lost to Follow-up|78|||
155087917|NCT03411044|559754422|FG000|Overall Study|Adverse Event|30|||
155087918|NCT03411044|559754422|FG000|Overall Study|Missing status|4|||
155087919|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
155087920|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
155087921|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
155087922|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
155360609|NCT00590564|560753855|FG000|Overall Study|Withdrawal by Subject|4|||
155360610|NCT00590564|560753855|FG000|Overall Study|Lost to Follow-up|6|||
155360611|NCT00590564|560753855|FG000|Overall Study|Protocol Violation|1|||
155360612|NCT00590564|560753855|FG000|Overall Study|Patient Found to be Ineligible|1|||
155360613|NCT00590564|560753855|FG000|Overall Study|Patient Non-compliance|6|||
154965182|NCT01604941|559298849|FG002|Overall Study|Early Study Termination|3|||
155087923|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
155087924|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
155165929|NCT01474239|560046133|FG000|Overall Study|Adverse Event|12|||
154965183|NCT01604941|559298850|FG003|Overall Study|Early Study Termination|3|||
154965184|NCT01604941|559298851|FG004|Overall Study|Early Study Termination|0|||
154965185|NCT01604941|559298852|FG005|Overall Study|Early Study Termination|0|||
155087925|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
155087926|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
155360614|NCT02684123|560753857|FG000|Phase 1|Lack of Efficacy|5|||
155360615|NCT02684123|560753858|FG001|Phase 1|Lack of Efficacy|0|||
155360616|NCT02684123|560753857|FG000|Phase 1|Adverse Event|3|||
154965186|NCT03366792|559298853|FG000|Overall Study|Withdrawal by Subject|7|||
154965187|NCT03366792|559298853|FG000|Overall Study|Lost to Follow-up|2|||
155087927|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
155360617|NCT02684123|560753858|FG001|Phase 1|Adverse Event|0|||
155360618|NCT02684123|560753857|FG000|Phase 1|Lost to Follow-up|0|||
155360619|NCT02684123|560753858|FG001|Phase 1|Lost to Follow-up|1|||
155360620|NCT02684123|560753857|FG000|Phase 2|Lack of Efficacy|1|||
155360621|NCT02684123|560753858|FG001|Phase 2|Lack of Efficacy|8|||
155360622|NCT02037477|560753861|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
155360623|NCT02037477|560753862|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
155360624|NCT02037477|560753863|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
155360625|NCT02037477|560753864|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
155360626|NCT01245140|560753865|FG000|Overall Study|Adverse Event|1|||
155360627|NCT01245140|560753866|FG001|Overall Study|Adverse Event|3|||
155360628|NCT01245140|560753865|FG000|Overall Study|Lack of Efficacy|2|||
155360629|NCT01245140|560753866|FG001|Overall Study|Lack of Efficacy|4|||
155360630|NCT01245140|560753865|FG000|Overall Study|Protocol Violation|0|||
155360631|NCT01245140|560753866|FG001|Overall Study|Protocol Violation|1|||
155360632|NCT01245140|560753865|FG000|Overall Study|Withdrawal by Subject|0|||
155360633|NCT01245140|560753866|FG001|Overall Study|Withdrawal by Subject|1|||
155360634|NCT01245140|560753865|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
155360635|NCT01245140|560753866|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
155360636|NCT02635360|560753867|FG000|Overall Study|Adverse Event|0|||
155360637|NCT02635360|560753868|FG001|Overall Study|Adverse Event|3|||
155360638|NCT02635360|560753867|FG000|Overall Study|Withdrawal by Subject|2|||
155360639|NCT02635360|560753868|FG001|Overall Study|Withdrawal by Subject|0|||
155360640|NCT02635360|560753867|FG000|Overall Study|Non-Compliance|3|||
155360641|NCT02635360|560753868|FG001|Overall Study|Non-Compliance|1|||
155360642|NCT02635360|560753867|FG000|Overall Study|Disease Progression|0|||
155360643|NCT02635360|560753868|FG001|Overall Study|Disease Progression|2|||
155360644|NCT02635360|560753867|FG000|Overall Study|Lost to Follow-up|1|||
155360645|NCT02635360|560753868|FG001|Overall Study|Lost to Follow-up|1|||
155360646|NCT04082429|560753869|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
155360647|NCT04082429|560753870|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360648|NCT04082429|560753871|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
155360649|NCT04082429|560753872|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
155360650|NCT04082429|560753873|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
155360651|NCT04082429|560753874|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360652|NCT04082429|560753875|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360653|NCT04082429|560753876|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360654|NCT04082429|560753877|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
155360655|NCT04082429|560753869|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360656|NCT04082429|560753870|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360657|NCT04082429|560753871|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360658|NCT04082429|560753872|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360659|NCT04082429|560753873|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
155360660|NCT04082429|560753874|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360661|NCT04082429|560753875|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360662|NCT04082429|560753876|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360663|NCT04082429|560753877|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
155360664|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Death|0|||
155360665|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Death|0|||
155360666|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Death|0|||
155360667|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Death|0|||
155360668|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Death|1|||
155360669|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Death|0|||
155360670|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Death|0|||
155360671|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Death|0|||
154965188|NCT03366792|559298853|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
155360672|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Death|0|||
155360673|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360674|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360675|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360676|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
155087928|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
155087929|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
155360677|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360678|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
155360679|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360680|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360681|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
155360682|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360683|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360684|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
155360685|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
155360686|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360687|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360688|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
155360689|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
155360690|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
155360691|NCT04082429|560753869|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
155360692|NCT04082429|560753870|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360693|NCT04082429|560753871|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360694|NCT04082429|560753872|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360695|NCT04082429|560753873|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360696|NCT04082429|560753874|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
155360697|NCT04082429|560753875|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360698|NCT04082429|560753876|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360699|NCT04082429|560753877|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
155360700|NCT04082429|560753869|FG000|Extension Part|Ongoing|0|||
155360701|NCT04082429|560753870|FG001|Extension Part|Ongoing|7|||
155360702|NCT04082429|560753871|FG002|Extension Part|Ongoing|17|||
155360703|NCT04082429|560753872|FG003|Extension Part|Ongoing|6|||
155360704|NCT04082429|560753873|FG004|Extension Part|Ongoing|45|||
155360705|NCT04082429|560753874|FG005|Extension Part|Ongoing|0|||
155360706|NCT04082429|560753875|FG006|Extension Part|Ongoing|10|||
155360707|NCT04082429|560753876|FG007|Extension Part|Ongoing|23|||
155360708|NCT04082429|560753877|FG008|Extension Part|Ongoing|25|||
155360709|NCT00334542|560753878|FG000|Overall Study|Adverse Event|3|||
155360710|NCT00334542|560753878|FG000|Overall Study|Withdrawal by Subject|1|||
155360711|NCT00334542|560753878|FG000|Overall Study|New cancer diagnosis|1|||
155360712|NCT03118050|560753879|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
155360713|NCT03118050|560753880|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
155360714|NCT03118050|560753881|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
155360715|NCT03118050|560753882|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
155360716|NCT03118050|560753883|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
155360717|NCT03118050|560753884|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
155360718|NCT03118050|560753885|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
155360719|NCT02125279|560753889|FG000|Overall Study|Lack of Efficacy|2|||
155360720|NCT02125279|560753889|FG000|Overall Study|Withdrawal by Subject|6|||
155360721|NCT02125279|560753889|FG000|Overall Study|Protocol Violation|1|||
155360722|NCT02125279|560753889|FG000|Overall Study|Lost to Follow-up|4|||
155360723|NCT01607879|560753890|FG000|Overall Study|Death|1|||
155360724|NCT01607879|560753891|FG001|Overall Study|Death|0|||
155360725|NCT03845140|560753892|FG000|Overall Study|Participant travelled outside study area|0|||
155360726|NCT03845140|560753893|FG001|Overall Study|Participant travelled outside study area|1|||
155360727|NCT03845140|560753894|FG002|Overall Study|Participant travelled outside study area|0|||
155360728|NCT03845140|560753895|FG003|Overall Study|Participant travelled outside study area|0|||
155360729|NCT03845140|560753896|FG004|Overall Study|Participant travelled outside study area|0|||
155360730|NCT03845140|560753897|FG005|Overall Study|Participant travelled outside study area|0|||
155087930|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
155360731|NCT01592045|560753900|FG000|Overall Study|Disease Progression|1|||
155360732|NCT01592045|560753901|FG001|Overall Study|Disease Progression|1|||
155360733|NCT01592045|560753900|FG000|Overall Study|Adverse Event|1|||
155360734|NCT01592045|560753901|FG001|Overall Study|Adverse Event|1|||
155165930|NCT01474239|560046134|FG001|Overall Study|Adverse Event|3|||
155360735|NCT01592045|560753900|FG000|Overall Study|Withdrawal by Subject|1|||
155360736|NCT01592045|560753901|FG001|Overall Study|Withdrawal by Subject|0|||
155360737|NCT01592045|560753900|FG000|Overall Study|Moved out of country|2|||
155360738|NCT01592045|560753901|FG001|Overall Study|Moved out of country|0|||
155360739|NCT02472145|560753904|FG000|Overall Study|Death|10|||
155360740|NCT02472145|560753905|FG001|Overall Study|Death|101|||
155087931|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
155087932|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
155087933|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
155087934|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
155087935|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
155360741|NCT02472145|560753906|FG002|Overall Study|Death|99|||
155360742|NCT02472145|560753904|FG000|Overall Study|Lost to Follow-up|0|||
155360743|NCT02472145|560753905|FG001|Overall Study|Lost to Follow-up|1|||
155360744|NCT02472145|560753906|FG002|Overall Study|Lost to Follow-up|0|||
155360745|NCT02472145|560753904|FG000|Overall Study|Withdrawal by Subject|0|||
155360746|NCT02472145|560753905|FG001|Overall Study|Withdrawal by Subject|9|||
155360747|NCT02472145|560753906|FG002|Overall Study|Withdrawal by Subject|13|||
155360748|NCT02472145|560753904|FG000|Overall Study|Sponsor decision|0|||
155360749|NCT02472145|560753905|FG001|Overall Study|Sponsor decision|3|||
155360750|NCT02472145|560753906|FG002|Overall Study|Sponsor decision|2|||
155360751|NCT02472145|560753904|FG000|Overall Study|Other|0|||
155360752|NCT02472145|560753905|FG001|Overall Study|Other|45|||
155360753|NCT02472145|560753906|FG002|Overall Study|Other|43|||
155360754|NCT02049515|560753909|FG000|Overall Study|Adverse Event|46|||
155360755|NCT02049515|560753910|FG001|Overall Study|Adverse Event|2|||
155360756|NCT02049515|560753909|FG000|Overall Study|Protocol-specified Disease Progression|23|||
155360757|NCT02049515|560753910|FG001|Overall Study|Protocol-specified Disease Progression|2|||
155360758|NCT02049515|560753909|FG000|Overall Study|Death|6|||
155360759|NCT02049515|560753910|FG001|Overall Study|Death|0|||
155360760|NCT02049515|560753909|FG000|Overall Study|Physician Decision|5|||
155360761|NCT02049515|560753910|FG001|Overall Study|Physician Decision|1|||
155360762|NCT02049515|560753909|FG000|Overall Study|Withdrawal by Subject|3|||
155360763|NCT02049515|560753910|FG001|Overall Study|Withdrawal by Subject|0|||
155360764|NCT02049515|560753909|FG000|Overall Study|Termination of the Study by Sponsor|2|||
155360765|NCT02049515|560753910|FG001|Overall Study|Termination of the Study by Sponsor|0|||
155360766|NCT02049515|560753909|FG000|Overall Study|Protocol Violation|1|||
155360767|NCT02049515|560753910|FG001|Overall Study|Protocol Violation|1|||
155360768|NCT02049515|560753909|FG000|Overall Study|Clinical Deterioration|1|||
155360769|NCT02049515|560753910|FG001|Overall Study|Clinical Deterioration|0|||
155360770|NCT02049515|560753909|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
155360771|NCT02049515|560753910|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
155360772|NCT02049515|560753909|FG000|Overall Study|Treatment Interruption >42 Days|1|||
155360773|NCT02049515|560753910|FG001|Overall Study|Treatment Interruption >42 Days|0|||
155360774|NCT02049515|560753909|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
155360775|NCT02049515|560753910|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
155360776|NCT00825305|560753927|FG000|Overall Study|Adverse Event|1|||
155360777|NCT00825305|560753928|FG001|Overall Study|Adverse Event|1|||
155360778|NCT00825305|560753927|FG000|Overall Study|Withdrawal by Subject|6|||
155360779|NCT00825305|560753928|FG001|Overall Study|Withdrawal by Subject|12|||
155360780|NCT00825305|560753927|FG000|Overall Study|Inappropriate inclusion|1|||
155360781|NCT00825305|560753928|FG001|Overall Study|Inappropriate inclusion|0|||
155360782|NCT00825305|560753927|FG000|Overall Study|Protocol Violation|9|||
155360783|NCT00825305|560753928|FG001|Overall Study|Protocol Violation|9|||
155360784|NCT00825305|560753927|FG000|Overall Study|Can not be classified|0|||
155360785|NCT00825305|560753928|FG001|Overall Study|Can not be classified|1|||
155360786|NCT01850030|560753932|FG000|Overall Study|Adverse Event|64|||
155360787|NCT01850030|560753933|FG001|Overall Study|Adverse Event|82|||
155087936|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
155087937|NCT00086515|559754425|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
155087938|NCT00086515|559754426|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
155087939|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
155087940|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
155087941|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
155087942|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
155087943|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
155360788|NCT01850030|560753932|FG000|Overall Study|Lack of Efficacy|3|||
155360789|NCT01850030|560753933|FG001|Overall Study|Lack of Efficacy|1|||
155360790|NCT01850030|560753932|FG000|Overall Study|Lost to Follow-up|5|||
155360791|NCT01850030|560753933|FG001|Overall Study|Lost to Follow-up|5|||
155360792|NCT01850030|560753932|FG000|Overall Study|Withdrawal by Subject|3|||
155360793|NCT01850030|560753933|FG001|Overall Study|Withdrawal by Subject|4|||
155360794|NCT01850030|560753932|FG000|Overall Study|Protocol Violation|24|||
155360795|NCT01850030|560753933|FG001|Overall Study|Protocol Violation|28|||
155360796|NCT01850030|560753932|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
155087944|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
155087945|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
155087946|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
155087947|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
155087948|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
155165931|NCT01474239|560046133|FG000|Overall Study|Withdrawal by Subject|1|||
155165932|NCT01474239|560046134|FG001|Overall Study|Withdrawal by Subject|2|||
155360797|NCT01850030|560753933|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
155360798|NCT00246090|560753934|FG000|Overall Study|Adverse Event|25|||
155360799|NCT00246090|560753934|FG000|Overall Study|Withdrawal by Subject|7|||
155360800|NCT00246090|560753934|FG000|Overall Study|Progressive Disease|212|||
155360801|NCT00246090|560753934|FG000|Overall Study|Clinical Progression|30|||
155360802|NCT00246090|560753934|FG000|Overall Study|Physician Decision|11|||
155360803|NCT00246090|560753934|FG000|Overall Study|Not Otherwise Specified|10|||
155360804|NCT02554383|560753937|FG000|Overall Study|Ineligible|3|||
155360805|NCT02554383|560753938|FG001|Overall Study|Ineligible|2|||
155360806|NCT02554383|560753937|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
155360807|NCT02554383|560753938|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
155360808|NCT02554383|560753937|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
155360809|NCT02554383|560753938|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
155360810|NCT02554383|560753937|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
155360811|NCT02554383|560753938|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
155360812|NCT00715117|560753941|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
155087949|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
155087950|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
155165933|NCT01474239|560046133|FG000|Overall Study|Death|1|||
155087951|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
155087952|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
155087953|NCT00086515|559754425|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
155087954|NCT00086515|559754426|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
155087955|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
155087956|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
155087957|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
155360813|NCT00715117|560753942|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
155360814|NCT02581059|560753946|FG000|Study Treatment|Disease Progression|1|||
155360815|NCT02581059|560753947|FG001|Study Treatment|Disease Progression|1|||
155360816|NCT02581059|560753946|FG000|Study Treatment|Adverse Event|2|||
155360817|NCT02581059|560753947|FG001|Study Treatment|Adverse Event|1|||
155360818|NCT02581059|560753946|FG000|Study Treatment|Death|1|||
155360819|NCT02581059|560753947|FG001|Study Treatment|Death|1|||
155360820|NCT02581059|560753946|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
155360821|NCT02581059|560753947|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
155360822|NCT02581059|560753946|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
155360823|NCT02581059|560753947|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
155360824|NCT02581059|560753946|FG000|Follow up|Death|1|||
155360825|NCT02581059|560753947|FG001|Follow up|Death|3|||
155360826|NCT02581059|560753946|FG000|Follow up|study terminated|1|||
155360827|NCT02581059|560753947|FG001|Follow up|study terminated|1|||
155360828|NCT02581059|560753946|FG000|Follow up|screen failure|0|||
155360829|NCT02581059|560753947|FG001|Follow up|screen failure|1|||
155360830|NCT02581059|560753946|FG000|Follow up|Patient started new clinical trial|1|||
155360831|NCT02581059|560753947|FG001|Follow up|Patient started new clinical trial|0|||
155360832|NCT04590404|560753951|FG000|Overall Study|Death|16|||
155360833|NCT04590404|560753952|FG001|Overall Study|Death|17|||
155360834|NCT04590404|560753951|FG000|Overall Study|Withdrawal by Subject|7|||
155360835|NCT04590404|560753952|FG001|Overall Study|Withdrawal by Subject|2|||
155087958|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
155087959|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
155087960|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
155087961|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
155087962|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
155087963|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
155087964|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
155087965|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
155087966|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
155087967|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
155087968|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
155087969|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
155087970|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
155087971|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
155087972|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
155087973|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
155087974|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
155087975|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
155087976|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
155087977|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
155087978|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
155087979|NCT00086515|559754425|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
155360836|NCT02394665|560753953|FG000|Overall Study|Physician Decision|1|||
155360837|NCT02394665|560753954|FG001|Overall Study|Physician Decision|0|||
155360838|NCT02394665|560753955|FG002|Overall Study|Physician Decision|0|||
155360839|NCT00569127|560753956|FG000|Overall Study|Adverse Event|57|||
155360840|NCT00569127|560753957|FG001|Overall Study|Adverse Event|47|||
155360841|NCT00569127|560753956|FG000|Overall Study|Withdrawal by Subject|13|||
155360842|NCT00569127|560753957|FG001|Overall Study|Withdrawal by Subject|27|||
155360843|NCT00569127|560753956|FG000|Overall Study|Progression|99|||
155360844|NCT00569127|560753957|FG001|Overall Study|Progression|100|||
155360845|NCT00569127|560753956|FG000|Overall Study|Death|4|||
155087980|NCT00086515|559754426|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
155087981|NCT02971163|559754427|FG000|Overall Study|Lost to Follow-up|4|||
155087982|NCT02971163|559754428|FG001|Overall Study|Lost to Follow-up|2|||
155087983|NCT02871219|559754437|FG000|Overall Study|Adverse Event|15|||
155360846|NCT00569127|560753957|FG001|Overall Study|Death|3|||
155360847|NCT00569127|560753956|FG000|Overall Study|Other|20|||
155360848|NCT00569127|560753957|FG001|Overall Study|Other|19|||
155087984|NCT02871219|559754437|FG000|Overall Study|Death|3|||
155087985|NCT02871219|559754437|FG000|Overall Study|Progression|3|||
155360849|NCT00569127|560753956|FG000|Overall Study|Lost to Follow-up|0|||
155360850|NCT00569127|560753957|FG001|Overall Study|Lost to Follow-up|3|||
155360851|NCT00569127|560753956|FG000|Overall Study|Not Eligible|14|||
155360852|NCT00569127|560753957|FG001|Overall Study|Not Eligible|11|||
155360853|NCT00569127|560753956|FG000|Overall Study|Still on Treatment|7|||
155360854|NCT00569127|560753957|FG001|Overall Study|Still on Treatment|3|||
155360855|NCT03149029|560753972|FG000|Overall Study|Adverse Event|2|||
155087986|NCT02871219|559754437|FG000|Overall Study|Infections|7|||
155087987|NCT02871219|559754437|FG000|Overall Study|Infusion Related|4|||
155087988|NCT05081843|559754438|FG000|Overall Study|Lost to Follow-up|135|||
155087989|NCT05081843|559754439|FG001|Overall Study|Lost to Follow-up|145|||
155087990|NCT00050011|559754442|FG000|Overall Study|Adverse Event|41|||
155087991|NCT00050011|559754443|FG001|Overall Study|Adverse Event|46|||
155087992|NCT00050011|559754442|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155087993|NCT00050011|559754443|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155087994|NCT00050011|559754442|FG000|Overall Study|Abnormal test procedure results|0|||
155087995|NCT00050011|559754443|FG001|Overall Study|Abnormal test procedure results|1|||
155087996|NCT00050011|559754442|FG000|Overall Study|Lack of Efficacy|16|||
155087997|NCT00050011|559754443|FG001|Overall Study|Lack of Efficacy|21|||
155087998|NCT00050011|559754442|FG000|Overall Study|Participant condition no longer required|1|||
155087999|NCT00050011|559754443|FG001|Overall Study|Participant condition no longer required|0|||
155088000|NCT00050011|559754442|FG000|Overall Study|Protocol Violation|4|||
155088001|NCT00050011|559754443|FG001|Overall Study|Protocol Violation|10|||
155088002|NCT00050011|559754442|FG000|Overall Study|Withdrawal by Subject|34|||
155088003|NCT00050011|559754443|FG001|Overall Study|Withdrawal by Subject|26|||
155088004|NCT00050011|559754442|FG000|Overall Study|Lost to Follow-up|7|||
155088005|NCT00050011|559754443|FG001|Overall Study|Lost to Follow-up|9|||
155088006|NCT00050011|559754442|FG000|Overall Study|Administrative problems|10|||
155088007|NCT00050011|559754443|FG001|Overall Study|Administrative problems|6|||
155088008|NCT00050011|559754442|FG000|Overall Study|Death|7|||
155088009|NCT00050011|559754443|FG001|Overall Study|Death|4|||
155088010|NCT00050011|559754442|FG000|Overall Study|Unknown - Reason is missing|0|||
155088011|NCT00050011|559754443|FG001|Overall Study|Unknown - Reason is missing|2|||
155088012|NCT00835354|559754444|FG000|First Intervention|Adverse Event|0|||
155088013|NCT00835354|559754445|FG001|First Intervention|Adverse Event|1|||
155088014|NCT03648372|559754461|FG000|Overall Study|Withdrawal by Subject|2|||
155088015|NCT03648372|559754462|FG001|Overall Study|Withdrawal by Subject|0|||
155088016|NCT03648372|559754463|FG002|Overall Study|Withdrawal by Subject|0|||
155088017|NCT03648372|559754464|FG003|Overall Study|Withdrawal by Subject|0|||
155088018|NCT03648372|559754465|FG004|Overall Study|Withdrawal by Subject|0|||
155088019|NCT03648372|559754466|FG005|Overall Study|Withdrawal by Subject|1|||
155088020|NCT03648372|559754467|FG006|Overall Study|Withdrawal by Subject|2|||
155088021|NCT03648372|559754468|FG007|Overall Study|Withdrawal by Subject|0|||
155088022|NCT03648372|559754469|FG008|Overall Study|Withdrawal by Subject|0|||
155088023|NCT03648372|559754470|FG009|Overall Study|Withdrawal by Subject|0|||
155088024|NCT03648372|559754471|FG010|Overall Study|Withdrawal by Subject|2|||
155088025|NCT03648372|559754472|FG011|Overall Study|Withdrawal by Subject|0|||
155088026|NCT03648372|559754473|FG012|Overall Study|Withdrawal by Subject|2|||
155088027|NCT03648372|559754474|FG013|Overall Study|Withdrawal by Subject|0|||
155088028|NCT03648372|559754475|FG014|Overall Study|Withdrawal by Subject|0|||
155088029|NCT03648372|559754476|FG015|Overall Study|Withdrawal by Subject|0|||
155088030|NCT03648372|559754477|FG016|Overall Study|Withdrawal by Subject|1|||
155088031|NCT03648372|559754478|FG017|Overall Study|Withdrawal by Subject|0|||
155088032|NCT03648372|559754479|FG018|Overall Study|Withdrawal by Subject|0|||
155088033|NCT03648372|559754480|FG019|Overall Study|Withdrawal by Subject|0|||
155088034|NCT03648372|559754481|FG020|Overall Study|Withdrawal by Subject|0|||
155088035|NCT03648372|559754461|FG000|Overall Study|Progressive Disease|2|||
155088036|NCT03648372|559754462|FG001|Overall Study|Progressive Disease|3|||
155088037|NCT03648372|559754463|FG002|Overall Study|Progressive Disease|4|||
155088038|NCT03648372|559754464|FG003|Overall Study|Progressive Disease|3|||
155088039|NCT03648372|559754465|FG004|Overall Study|Progressive Disease|2|||
155088040|NCT03648372|559754466|FG005|Overall Study|Progressive Disease|2|||
155088041|NCT03648372|559754467|FG006|Overall Study|Progressive Disease|3|||
155088042|NCT03648372|559754468|FG007|Overall Study|Progressive Disease|3|||
155088043|NCT03648372|559754469|FG008|Overall Study|Progressive Disease|5|||
155360856|NCT03149029|560753973|FG001|Overall Study|Adverse Event|0|||
155360857|NCT03735121|560753978|FG000|Overall Study|Death|3|||
155360858|NCT03735121|560753979|FG001|Overall Study|Death|6|||
155360859|NCT03735121|560753980|FG002|Overall Study|Death|19|||
155360860|NCT03735121|560753981|FG003|Overall Study|Death|97|||
155088044|NCT03648372|559754470|FG009|Overall Study|Progressive Disease|5|||
155088045|NCT03648372|559754471|FG010|Overall Study|Progressive Disease|2|||
155088046|NCT03648372|559754472|FG011|Overall Study|Progressive Disease|3|||
155088047|NCT03648372|559754473|FG012|Overall Study|Progressive Disease|3|||
155088048|NCT03648372|559754474|FG013|Overall Study|Progressive Disease|3|||
155088049|NCT03648372|559754475|FG014|Overall Study|Progressive Disease|6|||
155088050|NCT03648372|559754476|FG015|Overall Study|Progressive Disease|0|||
155088051|NCT03648372|559754477|FG016|Overall Study|Progressive Disease|0|||
155088052|NCT03648372|559754478|FG017|Overall Study|Progressive Disease|0|||
155360861|NCT03735121|560753982|FG004|Overall Study|Death|205|||
155360862|NCT03735121|560753978|FG000|Overall Study|Lost to Follow-up|0|||
155088053|NCT03648372|559754479|FG018|Overall Study|Progressive Disease|0|||
155360863|NCT03735121|560753979|FG001|Overall Study|Lost to Follow-up|0|||
155360864|NCT03735121|560753980|FG002|Overall Study|Lost to Follow-up|0|||
155360865|NCT03735121|560753981|FG003|Overall Study|Lost to Follow-up|2|||
155360866|NCT03735121|560753982|FG004|Overall Study|Lost to Follow-up|3|||
155360867|NCT03735121|560753978|FG000|Overall Study|New Therapy|0|||
155360868|NCT03735121|560753979|FG001|Overall Study|New Therapy|1|||
155360869|NCT03735121|560753980|FG002|Overall Study|New Therapy|0|||
155088054|NCT03648372|559754480|FG019|Overall Study|Progressive Disease|0|||
155088055|NCT03648372|559754481|FG020|Overall Study|Progressive Disease|0|||
155088056|NCT03648372|559754461|FG000|Overall Study|Other|0|||
155088057|NCT03648372|559754462|FG001|Overall Study|Other|0|||
155088058|NCT03648372|559754463|FG002|Overall Study|Other|0|||
155088059|NCT03648372|559754464|FG003|Overall Study|Other|0|||
155088060|NCT03648372|559754465|FG004|Overall Study|Other|1|||
155088061|NCT03648372|559754466|FG005|Overall Study|Other|0|||
155088062|NCT03648372|559754467|FG006|Overall Study|Other|0|||
155088063|NCT03648372|559754468|FG007|Overall Study|Other|0|||
155088064|NCT03648372|559754469|FG008|Overall Study|Other|0|||
155088065|NCT03648372|559754470|FG009|Overall Study|Other|0|||
155088066|NCT03648372|559754471|FG010|Overall Study|Other|1|||
155088067|NCT03648372|559754472|FG011|Overall Study|Other|2|||
155088068|NCT03648372|559754473|FG012|Overall Study|Other|1|||
155088069|NCT03648372|559754474|FG013|Overall Study|Other|3|||
155088070|NCT03648372|559754475|FG014|Overall Study|Other|0|||
155088071|NCT03648372|559754476|FG015|Overall Study|Other|5|||
155088072|NCT03648372|559754477|FG016|Overall Study|Other|1|||
155088073|NCT03648372|559754478|FG017|Overall Study|Other|5|||
155088074|NCT03648372|559754479|FG018|Overall Study|Other|0|||
155088075|NCT03648372|559754480|FG019|Overall Study|Other|1|||
155088076|NCT03648372|559754481|FG020|Overall Study|Other|0|||
155088077|NCT03648372|559754461|FG000|Overall Study|Lost to Follow-up|0|||
155088078|NCT03648372|559754462|FG001|Overall Study|Lost to Follow-up|0|||
155088079|NCT03648372|559754463|FG002|Overall Study|Lost to Follow-up|0|||
155088080|NCT03648372|559754464|FG003|Overall Study|Lost to Follow-up|0|||
155088081|NCT03648372|559754465|FG004|Overall Study|Lost to Follow-up|0|||
155088082|NCT03648372|559754466|FG005|Overall Study|Lost to Follow-up|0|||
155088083|NCT03648372|559754467|FG006|Overall Study|Lost to Follow-up|0|||
155088084|NCT03648372|559754468|FG007|Overall Study|Lost to Follow-up|0|||
155088085|NCT03648372|559754469|FG008|Overall Study|Lost to Follow-up|0|||
155088086|NCT03648372|559754470|FG009|Overall Study|Lost to Follow-up|0|||
155088087|NCT03648372|559754471|FG010|Overall Study|Lost to Follow-up|0|||
155088088|NCT03648372|559754472|FG011|Overall Study|Lost to Follow-up|0|||
155088089|NCT03648372|559754473|FG012|Overall Study|Lost to Follow-up|0|||
155088090|NCT03648372|559754474|FG013|Overall Study|Lost to Follow-up|1|||
155088091|NCT03648372|559754475|FG014|Overall Study|Lost to Follow-up|0|||
155088092|NCT03648372|559754476|FG015|Overall Study|Lost to Follow-up|1|||
155088093|NCT03648372|559754477|FG016|Overall Study|Lost to Follow-up|0|||
155088094|NCT03648372|559754478|FG017|Overall Study|Lost to Follow-up|1|||
155088095|NCT03648372|559754479|FG018|Overall Study|Lost to Follow-up|0|||
155088096|NCT03648372|559754480|FG019|Overall Study|Lost to Follow-up|0|||
155088097|NCT03648372|559754481|FG020|Overall Study|Lost to Follow-up|0|||
155088098|NCT03648372|559754461|FG000|Overall Study|Start of a New Systemic Treatment|0|||
155088099|NCT03648372|559754462|FG001|Overall Study|Start of a New Systemic Treatment|0|||
155165934|NCT01474239|560046134|FG001|Overall Study|Death|1|||
155360870|NCT03735121|560753981|FG003|Overall Study|New Therapy|0|||
155360871|NCT03735121|560753982|FG004|Overall Study|New Therapy|0|||
155360872|NCT03735121|560753978|FG000|Overall Study|Study Ended by Sponsor|1|||
155360873|NCT03735121|560753979|FG001|Overall Study|Study Ended by Sponsor|0|||
155360874|NCT03735121|560753980|FG002|Overall Study|Study Ended by Sponsor|1|||
155360875|NCT03735121|560753981|FG003|Overall Study|Study Ended by Sponsor|17|||
155360876|NCT03735121|560753982|FG004|Overall Study|Study Ended by Sponsor|28|||
155360877|NCT03735121|560753978|FG000|Overall Study|Withdrawal by Subject|1|||
155360878|NCT03735121|560753979|FG001|Overall Study|Withdrawal by Subject|1|||
155088100|NCT03648372|559754463|FG002|Overall Study|Start of a New Systemic Treatment|0|||
155088101|NCT03648372|559754464|FG003|Overall Study|Start of a New Systemic Treatment|0|||
155088102|NCT03648372|559754465|FG004|Overall Study|Start of a New Systemic Treatment|0|||
155360879|NCT03735121|560753980|FG002|Overall Study|Withdrawal by Subject|6|||
155360880|NCT03735121|560753981|FG003|Overall Study|Withdrawal by Subject|8|||
155360881|NCT03735121|560753982|FG004|Overall Study|Withdrawal by Subject|11|||
155088103|NCT03648372|559754466|FG005|Overall Study|Start of a New Systemic Treatment|0|||
155088104|NCT03648372|559754467|FG006|Overall Study|Start of a New Systemic Treatment|0|||
155360882|NCT04750577|560753983|FG000|Overall Study|Adverse Event|2|||
155088105|NCT03648372|559754468|FG007|Overall Study|Start of a New Systemic Treatment|2|||
155088106|NCT03648372|559754469|FG008|Overall Study|Start of a New Systemic Treatment|0|||
155088107|NCT03648372|559754470|FG009|Overall Study|Start of a New Systemic Treatment|0|||
155088108|NCT03648372|559754471|FG010|Overall Study|Start of a New Systemic Treatment|1|||
155360883|NCT04750577|560753984|FG001|Overall Study|Adverse Event|10|||
155088109|NCT03648372|559754472|FG011|Overall Study|Start of a New Systemic Treatment|0|||
155088110|NCT03648372|559754473|FG012|Overall Study|Start of a New Systemic Treatment|0|||
155165935|NCT01474239|560046133|FG000|Overall Study|Clinical Disease Progression|7|||
155165936|NCT01474239|560046134|FG001|Overall Study|Clinical Disease Progression|1|||
155165937|NCT01474239|560046133|FG000|Overall Study|Withdrawal for Economic Reason|1|||
155165938|NCT01474239|560046134|FG001|Overall Study|Withdrawal for Economic Reason|0|||
155165939|NCT00854113|560046138|FG000|Overall Study|Adverse Event|0|||
155165940|NCT00854113|560046139|FG001|Overall Study|Adverse Event|0|||
155165941|NCT00854113|560046140|FG002|Overall Study|Adverse Event|0|||
155165942|NCT00854113|560046141|FG003|Overall Study|Adverse Event|0|||
155165943|NCT00854113|560046142|FG004|Overall Study|Adverse Event|0|||
155165944|NCT00854113|560046143|FG005|Overall Study|Adverse Event|0|||
155165945|NCT00854113|560046144|FG006|Overall Study|Adverse Event|0|||
155165946|NCT00854113|560046145|FG007|Overall Study|Adverse Event|2|||
155165947|NCT00854113|560046146|FG008|Overall Study|Adverse Event|0|||
155165948|NCT00854113|560046147|FG009|Overall Study|Adverse Event|0|||
155165949|NCT00854113|560046148|FG010|Overall Study|Adverse Event|0|||
155165950|NCT00854113|560046138|FG000|Overall Study|Withdrawal by Subject|0|||
155165951|NCT00854113|560046139|FG001|Overall Study|Withdrawal by Subject|0|||
154965189|NCT03366792|559298853|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
154965190|NCT00867360|559298858|FG000|Overall Study|Withdrawal by Subject|1|||
154965191|NCT00867360|559298859|FG001|Overall Study|Withdrawal by Subject|0|||
154965192|NCT00867360|559298858|FG000|Overall Study|Physician Decision|0|||
155088111|NCT03648372|559754474|FG013|Overall Study|Start of a New Systemic Treatment|0|||
155088112|NCT03648372|559754475|FG014|Overall Study|Start of a New Systemic Treatment|0|||
155088113|NCT03648372|559754476|FG015|Overall Study|Start of a New Systemic Treatment|0|||
155088114|NCT03648372|559754477|FG016|Overall Study|Start of a New Systemic Treatment|0|||
155088115|NCT03648372|559754478|FG017|Overall Study|Start of a New Systemic Treatment|0|||
155088116|NCT03648372|559754479|FG018|Overall Study|Start of a New Systemic Treatment|0|||
155088117|NCT03648372|559754480|FG019|Overall Study|Start of a New Systemic Treatment|0|||
155088118|NCT03648372|559754481|FG020|Overall Study|Start of a New Systemic Treatment|0|||
155088119|NCT04976777|559755963|FG000|Overall Study|COVID-19 Infection|1|||
155088120|NCT04976777|559755964|FG001|Overall Study|COVID-19 Infection|0|||
155088121|NCT00363298|559755965|FG000|First Study Week|Lack of Efficacy|6|||
155088122|NCT00363298|559755966|FG001|First Study Week|Lack of Efficacy|5|||
155088123|NCT00363298|559755965|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
155088124|NCT00363298|559755966|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
155088125|NCT03332056|559755973|FG000|Overall Study|Incomplete questionnaires|8|||
155088126|NCT03332056|559755974|FG001|Overall Study|Incomplete questionnaires|9|||
155088127|NCT03332056|559755973|FG000|Overall Study|Passed stone prior to surgery date|1|||
155088128|NCT03332056|559755974|FG001|Overall Study|Passed stone prior to surgery date|0|||
155088129|NCT03332056|559755973|FG000|Overall Study|Did not require a ureteral stent|0|||
155088130|NCT03332056|559755974|FG001|Overall Study|Did not require a ureteral stent|1|||
155088131|NCT00730327|559755975|FG000|Overall Study|Lost to Follow-up|14|||
155088132|NCT00730327|559755976|FG001|Overall Study|Lost to Follow-up|16|||
155088133|NCT00730327|559755975|FG000|Overall Study|Adverse Event|8|||
155088134|NCT00730327|559755976|FG001|Overall Study|Adverse Event|1|||
155088135|NCT00730327|559755975|FG000|Overall Study|Withdrawal by Subject|3|||
155088136|NCT00730327|559755976|FG001|Overall Study|Withdrawal by Subject|13|||
155088137|NCT00730327|559755975|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
155088138|NCT00730327|559755976|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
155088139|NCT02989857|559755982|FG000|Randomization Phase|Not Treated|3|||
155088140|NCT02989857|559755983|FG001|Randomization Phase|Not Treated|2|||
155088141|NCT02989857|559755984|FG002|Randomization Phase|Not Treated|0|||
155088142|NCT00688740|559755985|FG000|Overall Study|Adverse Event|45|||
155088143|NCT00688740|559755986|FG001|Overall Study|Adverse Event|8|||
155088144|NCT00688740|559755985|FG000|Overall Study|Death|2|||
155088145|NCT00688740|559755986|FG001|Overall Study|Death|2|||
155088146|NCT00688740|559755985|FG000|Overall Study|Lost to Follow-up|0|||
155088147|NCT00688740|559755986|FG001|Overall Study|Lost to Follow-up|1|||
155088148|NCT00688740|559755985|FG000|Overall Study|Consent Withdrawn|17|||
155088149|NCT00688740|559755986|FG001|Overall Study|Consent Withdrawn|17|||
155088150|NCT00688740|559755985|FG000|Overall Study|Breast Cancer Relapse|1|||
155088151|NCT00688740|559755986|FG001|Overall Study|Breast Cancer Relapse|4|||
155088152|NCT00688740|559755985|FG000|Overall Study|Violation of Inclusion Criteria|1|||
155088153|NCT00688740|559755986|FG001|Overall Study|Violation of Inclusion Criteria|3|||
155088154|NCT02332928|559755989|FG000|Overall Study|Withdrawal by Subject|0|||
155088155|NCT02332928|559755990|FG001|Overall Study|Withdrawal by Subject|2|||
155088156|NCT02332928|559755989|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
155088157|NCT02332928|559755990|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
155088158|NCT01497197|559755991|FG000|Overall Study|Lost to Follow-up|1|||
155088159|NCT01497197|559755992|FG001|Overall Study|Lost to Follow-up|0|||
154965193|NCT00867360|559298859|FG001|Overall Study|Physician Decision|1|||
155088160|NCT01497197|559755991|FG000|Overall Study|Protocol Violation|0|||
155165952|NCT00854113|560046140|FG002|Overall Study|Withdrawal by Subject|0|||
155165953|NCT00854113|560046141|FG003|Overall Study|Withdrawal by Subject|0|||
155165954|NCT00854113|560046142|FG004|Overall Study|Withdrawal by Subject|0|||
155360884|NCT04750577|560753985|FG002|Overall Study|Adverse Event|8|||
155165955|NCT00854113|560046143|FG005|Overall Study|Withdrawal by Subject|0|||
155165956|NCT00854113|560046144|FG006|Overall Study|Withdrawal by Subject|0|||
155165957|NCT00854113|560046145|FG007|Overall Study|Withdrawal by Subject|1|||
155165958|NCT00854113|560046146|FG008|Overall Study|Withdrawal by Subject|1|||
155165959|NCT00854113|560046147|FG009|Overall Study|Withdrawal by Subject|0|||
155165960|NCT00854113|560046148|FG010|Overall Study|Withdrawal by Subject|0|||
155165961|NCT00796419|560046150|FG000|Overall Study|Death|0|||
155165962|NCT00796419|560046151|FG001|Overall Study|Death|1|||
155165963|NCT00539864|560046152|FG000|Overall Study|Lost to Follow-up|0|||
155165964|NCT00539864|560046153|FG001|Overall Study|Lost to Follow-up|1|||
155165965|NCT00539864|560046152|FG000|Overall Study|Withdrawal by Subject|1|||
155165966|NCT00539864|560046153|FG001|Overall Study|Withdrawal by Subject|1|||
155165967|NCT01250145|560046154|FG000|Overall Study|Adverse Event|2|||
155165968|NCT01250145|560046155|FG001|Overall Study|Adverse Event|1|||
155088161|NCT01497197|559755992|FG001|Overall Study|Protocol Violation|2|||
155088162|NCT01497197|559755991|FG000|Overall Study|Withdrawal by Subject|2|||
155088163|NCT01497197|559755992|FG001|Overall Study|Withdrawal by Subject|1|||
155088164|NCT01497197|559755991|FG000|Overall Study|Excessive/lack of response to treatment|1|||
155088165|NCT01497197|559755992|FG001|Overall Study|Excessive/lack of response to treatment|0|||
155088166|NCT01497197|559755991|FG000|Overall Study|Risk of OHSS|1|||
155088167|NCT01497197|559755992|FG001|Overall Study|Risk of OHSS|0|||
155088168|NCT01497197|559755991|FG000|Overall Study|No oocytes retrieved|3|||
155088169|NCT01497197|559755992|FG001|Overall Study|No oocytes retrieved|2|||
155088170|NCT01497197|559755991|FG000|Overall Study|No fertilisation|6|||
155088171|NCT01497197|559755992|FG001|Overall Study|No fertilisation|5|||
155088172|NCT01497197|559755991|FG000|Overall Study|Intention to freeze all embryos|0|||
155088173|NCT01497197|559755992|FG001|Overall Study|Intention to freeze all embryos|1|||
155165969|NCT01250145|560046154|FG000|Overall Study|Withdrawal by Subject|0|||
155165970|NCT01250145|560046155|FG001|Overall Study|Withdrawal by Subject|4|||
155165971|NCT02840799|560046158|FG000|Phase 1|Physician Decision|1|||
155165972|NCT02840799|560046159|FG001|Phase 1|Physician Decision|3|||
155165973|NCT02840799|560046158|FG000|Phase 1|Withdrawal by Subject|4|||
155165974|NCT02840799|560046159|FG001|Phase 1|Withdrawal by Subject|0|||
155165975|NCT02840799|560046158|FG000|Phase 2 (Crossover)|Adverse Event|0|||
155165976|NCT02840799|560046159|FG001|Phase 2 (Crossover)|Adverse Event|1|||
155165977|NCT02840799|560046158|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
155165978|NCT02840799|560046159|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
155165979|NCT02687191|560046163|FG000|Overall Study|Death|0|||
155165980|NCT02687191|560046164|FG001|Overall Study|Death|1|||
155165981|NCT02687191|560046165|FG002|Overall Study|Death|1|||
155165982|NCT02687191|560046166|FG003|Overall Study|Death|0|||
155165983|NCT02687191|560046167|FG004|Overall Study|Death|1|||
155165984|NCT02687191|560046168|FG005|Overall Study|Death|1|||
155165985|NCT02687191|560046163|FG000|Overall Study|Withdrawal by Subject|0|||
155165986|NCT02687191|560046164|FG001|Overall Study|Withdrawal by Subject|0|||
155165987|NCT02687191|560046165|FG002|Overall Study|Withdrawal by Subject|0|||
155165988|NCT02687191|560046166|FG003|Overall Study|Withdrawal by Subject|1|||
155165989|NCT02687191|560046167|FG004|Overall Study|Withdrawal by Subject|0|||
155165990|NCT02687191|560046168|FG005|Overall Study|Withdrawal by Subject|0|||
155165991|NCT00943072|560046169|FG000|Overall Study|Adverse Event|0|||
155165992|NCT00943072|560046170|FG001|Overall Study|Adverse Event|3|||
155165993|NCT00943072|560046169|FG000|Overall Study|Death|0|||
155165994|NCT00943072|560046170|FG001|Overall Study|Death|2|||
155165995|NCT00943072|560046169|FG000|Overall Study|Withdrawal by Subject|3|||
155165996|NCT00943072|560046170|FG001|Overall Study|Withdrawal by Subject|1|||
155165997|NCT00943072|560046169|FG000|Overall Study|Protocol Violation|0|||
155165998|NCT00943072|560046170|FG001|Overall Study|Protocol Violation|1|||
155165999|NCT00943072|560046169|FG000|Overall Study|Lost to Follow-up|1|||
155166000|NCT00943072|560046170|FG001|Overall Study|Lost to Follow-up|2|||
155166001|NCT00943072|560046169|FG000|Overall Study|Lack of Efficacy|0|||
155166002|NCT00943072|560046170|FG001|Overall Study|Lack of Efficacy|4|||
155166003|NCT00943072|560046169|FG000|Overall Study|Other|1|||
155166004|NCT00943072|560046170|FG001|Overall Study|Other|1|||
155166005|NCT01349049|560046171|FG000|Overall Study|Disease progression|3|||
155166006|NCT01349049|560046172|FG001|Overall Study|Disease progression|5|||
155166007|NCT01349049|560046173|FG002|Overall Study|Disease progression|3|||
155166008|NCT01349049|560046174|FG003|Overall Study|Disease progression|2|||
155166009|NCT01349049|560046175|FG004|Overall Study|Disease progression|2|||
155166010|NCT01349049|560046176|FG005|Overall Study|Disease progression|2|||
155166011|NCT01349049|560046177|FG006|Overall Study|Disease progression|3|||
155088174|NCT01497197|559755991|FG000|Overall Study|All embryos discarded|0|||
155088175|NCT01497197|559755992|FG001|Overall Study|All embryos discarded|3|||
155166012|NCT01349049|560046178|FG007|Overall Study|Disease progression|2|||
155166013|NCT01349049|560046179|FG008|Overall Study|Disease progression|33|||
155166014|NCT01349049|560046171|FG000|Overall Study|Adverse Event|0|||
155166015|NCT01349049|560046172|FG001|Overall Study|Adverse Event|1|||
155166016|NCT01349049|560046173|FG002|Overall Study|Adverse Event|0|||
155166017|NCT01349049|560046174|FG003|Overall Study|Adverse Event|0|||
155166018|NCT01349049|560046175|FG004|Overall Study|Adverse Event|0|||
155360885|NCT04750577|560753986|FG003|Overall Study|Adverse Event|1|||
155360886|NCT04750577|560753983|FG000|Overall Study|Change of residence|0|||
155360887|NCT04750577|560753984|FG001|Overall Study|Change of residence|0|||
155360888|NCT04750577|560753985|FG002|Overall Study|Change of residence|1|||
155360889|NCT04750577|560753986|FG003|Overall Study|Change of residence|0|||
155360890|NCT04750577|560753983|FG000|Overall Study|Burden of study procedures|0|||
155360891|NCT04750577|560753984|FG001|Overall Study|Burden of study procedures|2|||
155360892|NCT04750577|560753985|FG002|Overall Study|Burden of study procedures|2|||
155360893|NCT04750577|560753986|FG003|Overall Study|Burden of study procedures|0|||
155360894|NCT04750577|560753983|FG000|Overall Study|Prematurely discontinued|0|||
154965194|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
154965195|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
155088176|NCT01497197|559755991|FG000|Overall Study|Other|3|||
155088177|NCT01497197|559755992|FG001|Overall Study|Other|1|||
155088178|NCT04484857|559755993|FG000|Overall Study|Adverse Event|2|||
155088179|NCT04484857|559755993|FG000|Overall Study|Death|10|||
155088180|NCT04484857|559755993|FG000|Overall Study|Withdrawal by Subject|3|||
155088181|NCT04484857|559755993|FG000|Overall Study|Transferred/Relocation|5|||
155088182|NCT04484857|559755993|FG000|Overall Study|Kidney Transplant|7|||
155088183|NCT04484857|559755993|FG000|Overall Study|Other than specified|4|||
155088184|NCT04484857|559755993|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
155088185|NCT01425814|559755994|FG000|Period 1|Stability criteria not fulfilled|0|||
155088186|NCT01425814|559755995|FG001|Period 1|Stability criteria not fulfilled|1|||
155088187|NCT01425814|559755996|FG002|Period 1|Stability criteria not fulfilled|0|||
155088188|NCT01425814|559755997|FG003|Period 1|Stability criteria not fulfilled|0|||
155088189|NCT01425814|559755998|FG004|Period 1|Stability criteria not fulfilled|0|||
155088190|NCT01425814|559755999|FG005|Period 1|Stability criteria not fulfilled|0|||
155088191|NCT01425814|559755994|FG000|Period 2|Stability criteria not fulfilled|0|||
155088192|NCT01425814|559755995|FG001|Period 2|Stability criteria not fulfilled|1|||
155088193|NCT01425814|559755996|FG002|Period 2|Stability criteria not fulfilled|0|||
155088194|NCT01425814|559755997|FG003|Period 2|Stability criteria not fulfilled|0|||
155088195|NCT01425814|559755998|FG004|Period 2|Stability criteria not fulfilled|0|||
155088196|NCT01425814|559755999|FG005|Period 2|Stability criteria not fulfilled|0|||
155088197|NCT01425814|559755994|FG000|Period 3|Adverse Event|0|||
155088198|NCT01425814|559755995|FG001|Period 3|Adverse Event|0|||
155088199|NCT01425814|559755996|FG002|Period 3|Adverse Event|0|||
155088200|NCT01425814|559755997|FG003|Period 3|Adverse Event|0|||
155088201|NCT01425814|559755998|FG004|Period 3|Adverse Event|0|||
155088202|NCT01425814|559755999|FG005|Period 3|Adverse Event|1|||
155088203|NCT01425814|559755994|FG000|Period 4|Adverse Event|1|||
155088204|NCT01425814|559755995|FG001|Period 4|Adverse Event|0|||
155088205|NCT01425814|559755996|FG002|Period 4|Adverse Event|1|||
155088206|NCT01425814|559755997|FG003|Period 4|Adverse Event|0|||
155088207|NCT01425814|559755998|FG004|Period 4|Adverse Event|0|||
155088208|NCT01425814|559755999|FG005|Period 4|Adverse Event|0|||
155088209|NCT01425814|559755994|FG000|Period 5|Stability criteria not fulfilled|0|||
155088210|NCT01425814|559755995|FG001|Period 5|Stability criteria not fulfilled|0|||
155088211|NCT01425814|559755996|FG002|Period 5|Stability criteria not fulfilled|1|||
155088212|NCT01425814|559755997|FG003|Period 5|Stability criteria not fulfilled|0|||
155088213|NCT01425814|559755998|FG004|Period 5|Stability criteria not fulfilled|0|||
155088214|NCT01425814|559755999|FG005|Period 5|Stability criteria not fulfilled|1|||
155088215|NCT00565747|559756000|FG000|Overall Study|No embryo transfer|67|||
155088216|NCT00565747|559756001|FG001|Overall Study|No embryo transfer|73|||
155088217|NCT02684461|559756002|FG000|Overall Study|Adverse Event|1|||
155088218|NCT02684461|559756003|FG001|Overall Study|Adverse Event|0|||
155088219|NCT02684461|559756004|FG002|Overall Study|Adverse Event|0|||
155088220|NCT02684461|559756002|FG000|Overall Study|Lack of Efficacy|1|||
155088221|NCT02684461|559756003|FG001|Overall Study|Lack of Efficacy|2|||
155088222|NCT02684461|559756004|FG002|Overall Study|Lack of Efficacy|0|||
155088223|NCT04507204|559756005|FG000|Overall Study|Adverse Event|8|||
155088224|NCT04507204|559756006|FG001|Overall Study|Adverse Event|13|||
155088225|NCT04507204|559756005|FG000|Overall Study|Death|0|||
155088226|NCT04507204|559756006|FG001|Overall Study|Death|1|||
155088227|NCT04507204|559756005|FG000|Overall Study|Lost to Follow-up|15|||
155088228|NCT04507204|559756006|FG001|Overall Study|Lost to Follow-up|14|||
155088229|NCT04507204|559756005|FG000|Overall Study|Poor Compliance with Protocol|2|||
155360895|NCT04750577|560753984|FG001|Overall Study|Prematurely discontinued|0|||
155088230|NCT04507204|559756006|FG001|Overall Study|Poor Compliance with Protocol|4|||
155088231|NCT04507204|559756005|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
155088232|NCT04507204|559756006|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
155088233|NCT04507204|559756005|FG000|Overall Study|Withdrawal of Patient Consent|21|||
155088234|NCT04507204|559756006|FG001|Overall Study|Withdrawal of Patient Consent|13|||
155088235|NCT03580044|559756007|FG000|Overall Study|Death|2|||
155088236|NCT03580044|559756008|FG001|Overall Study|Death|1|||
155088237|NCT03580044|559756007|FG000|Overall Study|Withdrawal by Subject|1|||
155088238|NCT03580044|559756008|FG001|Overall Study|Withdrawal by Subject|1|||
155088239|NCT01905540|559756009|FG000|Period 3|Other|1|||
155088240|NCT01905540|559756010|FG001|Period 3|Other|0|||
155088241|NCT01905540|559756011|FG002|Period 3|Other|1|||
155088242|NCT01905540|559756012|FG003|Period 3|Other|1|||
155088243|NCT02743962|559756013|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
155088244|NCT02743962|559756014|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
155088245|NCT00725985|559756015|FG000|ITP- Treatment Disposition|Adverse Event|20|||
155088246|NCT00725985|559756016|FG001|ITP- Treatment Disposition|Adverse Event|10|||
155088247|NCT00725985|559756017|FG002|ITP- Treatment Disposition|Adverse Event|5|||
155088248|NCT00725985|559756018|FG003|ITP- Treatment Disposition|Adverse Event|0|||
155088249|NCT00725985|559756019|FG004|ITP- Treatment Disposition|Adverse Event|0|||
155088250|NCT00725985|559756020|FG005|ITP- Treatment Disposition|Adverse Event|0|||
155088251|NCT00725985|559756021|FG006|ITP- Treatment Disposition|Adverse Event|0|||
155088252|NCT00725985|559756022|FG007|ITP- Treatment Disposition|Adverse Event|0|||
155088253|NCT00725985|559756023|FG008|ITP- Treatment Disposition|Adverse Event|0|||
155088254|NCT00725985|559756024|FG009|ITP- Treatment Disposition|Adverse Event|0|||
155166019|NCT01349049|560046176|FG005|Overall Study|Adverse Event|3|||
155360896|NCT04750577|560753985|FG002|Overall Study|Prematurely discontinued|0|||
155360897|NCT04750577|560753986|FG003|Overall Study|Prematurely discontinued|2|||
155360898|NCT04750577|560753983|FG000|Overall Study|Protocol deviation|1|||
155360899|NCT04750577|560753984|FG001|Overall Study|Protocol deviation|1|||
155360900|NCT04750577|560753985|FG002|Overall Study|Protocol deviation|1|||
155360901|NCT04750577|560753986|FG003|Overall Study|Protocol deviation|1|||
155360902|NCT04750577|560753983|FG000|Overall Study|Other than listed|3|||
155360903|NCT04750577|560753984|FG001|Overall Study|Other than listed|2|||
155360904|NCT04750577|560753985|FG002|Overall Study|Other than listed|2|||
155360905|NCT04750577|560753986|FG003|Overall Study|Other than listed|1|||
155360906|NCT04750577|560753983|FG000|Overall Study|Not treated|0|||
155360907|NCT04750577|560753984|FG001|Overall Study|Not treated|0|||
155360908|NCT04750577|560753985|FG002|Overall Study|Not treated|0|||
155360909|NCT04750577|560753986|FG003|Overall Study|Not treated|2|||
155360910|NCT02473042|560753989|FG000|Overall Study|Withdrawal by Subject|1|||
155360911|NCT02473042|560753990|FG001|Overall Study|Withdrawal by Subject|0|||
155360912|NCT02473042|560753989|FG000|Overall Study|Patient became ineligible after enrollment|2|||
155360913|NCT02473042|560753990|FG001|Overall Study|Patient became ineligible after enrollment|5|||
155360914|NCT02473042|560753989|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
155360915|NCT02473042|560753990|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
155360916|NCT02473042|560753989|FG000|Overall Study|PACU data unable to be collected|3|||
155360917|NCT02473042|560753990|FG001|Overall Study|PACU data unable to be collected|0|||
155360918|NCT02037256|560753993|FG000|Overall Study|Protocol Violation|0|||
155360919|NCT02037256|560753994|FG001|Overall Study|Protocol Violation|1|||
155360920|NCT02037256|560753993|FG000|Overall Study|Withdrawn prior to Velcade|0|||
155360921|NCT02037256|560753994|FG001|Overall Study|Withdrawn prior to Velcade|2|||
155360922|NCT03007732|560753995|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
155360923|NCT03007732|560753996|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
155360924|NCT03007732|560753997|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
155360925|NCT03007732|560753998|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
155360926|NCT02386839|560754000|FG000|Overall Study|Death|1|||
155360927|NCT02386839|560754001|FG001|Overall Study|Death|0|||
155360928|NCT02386839|560754000|FG000|Overall Study|Withdrawal by Subject|9|||
155360929|NCT02386839|560754001|FG001|Overall Study|Withdrawal by Subject|10|||
155360930|NCT02386839|560754000|FG000|Overall Study|Lost to Follow-up|4|||
155360931|NCT02386839|560754001|FG001|Overall Study|Lost to Follow-up|4|||
155360932|NCT02386839|560754000|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
155360933|NCT02386839|560754001|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
155360934|NCT02386839|560754000|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
155360935|NCT02386839|560754001|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
155360936|NCT02386839|560754000|FG000|Overall Study|Other (unspecified)|1|||
155360937|NCT02386839|560754001|FG001|Overall Study|Other (unspecified)|0|||
155360938|NCT02101983|560754002|FG000|Overall Study|Physician Decision|1|||
155360939|NCT02101983|560754003|FG001|Overall Study|Physician Decision|0|||
155360940|NCT03725605|560754007|FG000|Overall Study|Unsuccessful TIL expansion|2|||
155360941|NCT01503086|560754008|FG000|Overall Study|Lost to Follow-up|0|||
155360942|NCT01503086|560754009|FG001|Overall Study|Lost to Follow-up|1|||
155360943|NCT01503086|560754010|FG002|Overall Study|Lost to Follow-up|0|||
155360944|NCT01503086|560754008|FG000|Overall Study|Did Not Start Treatment|4|||
155360945|NCT01503086|560754009|FG001|Overall Study|Did Not Start Treatment|3|||
155360946|NCT01503086|560754010|FG002|Overall Study|Did Not Start Treatment|3|||
155360947|NCT01503086|560754008|FG000|Overall Study|Progressive disease|3|||
155360948|NCT01503086|560754009|FG001|Overall Study|Progressive disease|1|||
155360949|NCT01503086|560754010|FG002|Overall Study|Progressive disease|0|||
155088255|NCT00725985|559756025|FG010|ITP- Treatment Disposition|Adverse Event|0|||
155088256|NCT00725985|559756026|FG011|ITP- Treatment Disposition|Adverse Event|0|||
155088257|NCT00725985|559756015|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088258|NCT00725985|559756016|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088259|NCT00725985|559756017|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
155088260|NCT00725985|559756018|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088261|NCT00725985|559756019|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088262|NCT00725985|559756020|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088263|NCT00725985|559756021|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088264|NCT00725985|559756022|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088265|NCT00725985|559756023|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088266|NCT00725985|559756024|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088267|NCT00725985|559756025|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088268|NCT00725985|559756026|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
155088269|NCT00725985|559756015|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
155088270|NCT00725985|559756016|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
155088271|NCT00725985|559756017|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
155088272|NCT00725985|559756018|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
155088273|NCT00725985|559756019|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
155088274|NCT00725985|559756020|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
155088275|NCT00725985|559756021|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
155088276|NCT00725985|559756022|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
155088277|NCT00725985|559756023|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
155088278|NCT00725985|559756024|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
155088279|NCT00725985|559756025|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
155088280|NCT00725985|559756026|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
155088281|NCT00725985|559756015|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
155088282|NCT00725985|559756016|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
155088283|NCT00725985|559756017|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
155088284|NCT00725985|559756018|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
155088285|NCT00725985|559756019|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
155088286|NCT00725985|559756020|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
155088287|NCT00725985|559756021|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
155088288|NCT00725985|559756022|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
155088289|NCT00725985|559756023|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
155088290|NCT00725985|559756024|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
155088291|NCT00725985|559756025|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
155088292|NCT00725985|559756026|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
155088293|NCT00725985|559756015|FG000|ITP- Treatment Disposition|Other|50|||
155088294|NCT00725985|559756016|FG001|ITP- Treatment Disposition|Other|38|||
155088295|NCT00725985|559756017|FG002|ITP- Treatment Disposition|Other|24|||
155088296|NCT00725985|559756018|FG003|ITP- Treatment Disposition|Other|0|||
155088297|NCT00725985|559756019|FG004|ITP- Treatment Disposition|Other|0|||
155088298|NCT00725985|559756020|FG005|ITP- Treatment Disposition|Other|0|||
155088299|NCT00725985|559756021|FG006|ITP- Treatment Disposition|Other|0|||
155088300|NCT00725985|559756022|FG007|ITP- Treatment Disposition|Other|0|||
155088301|NCT00725985|559756023|FG008|ITP- Treatment Disposition|Other|0|||
155088302|NCT00725985|559756024|FG009|ITP- Treatment Disposition|Other|0|||
155088303|NCT00725985|559756025|FG010|ITP- Treatment Disposition|Other|0|||
155088304|NCT00725985|559756026|FG011|ITP- Treatment Disposition|Other|0|||
155088305|NCT00725985|559756015|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088306|NCT00725985|559756016|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088307|NCT00725985|559756017|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088308|NCT00725985|559756018|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
155088309|NCT00725985|559756019|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
155088310|NCT00725985|559756020|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
155088311|NCT00725985|559756021|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088312|NCT00725985|559756022|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088313|NCT00725985|559756023|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088314|NCT00725985|559756024|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088315|NCT00725985|559756025|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088316|NCT00725985|559756026|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
155088317|NCT00725985|559756015|FG000|OLMP (Up to 96 Weeks)|Death|0|||
155088318|NCT00725985|559756016|FG001|OLMP (Up to 96 Weeks)|Death|0|||
155088319|NCT00725985|559756017|FG002|OLMP (Up to 96 Weeks)|Death|0|||
155088320|NCT00725985|559756018|FG003|OLMP (Up to 96 Weeks)|Death|0|||
155088321|NCT00725985|559756019|FG004|OLMP (Up to 96 Weeks)|Death|1|||
155088322|NCT00725985|559756020|FG005|OLMP (Up to 96 Weeks)|Death|0|||
155088323|NCT00725985|559756021|FG006|OLMP (Up to 96 Weeks)|Death|0|||
155088324|NCT00725985|559756022|FG007|OLMP (Up to 96 Weeks)|Death|0|||
155088325|NCT00725985|559756023|FG008|OLMP (Up to 96 Weeks)|Death|0|||
155088326|NCT00725985|559756024|FG009|OLMP (Up to 96 Weeks)|Death|0|||
155088327|NCT00725985|559756025|FG010|OLMP (Up to 96 Weeks)|Death|0|||
155088328|NCT00725985|559756026|FG011|OLMP (Up to 96 Weeks)|Death|0|||
155088329|NCT00725985|559756015|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088330|NCT00725985|559756016|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088331|NCT00725985|559756017|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088332|NCT00725985|559756018|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
155088333|NCT00725985|559756019|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088334|NCT00725985|559756020|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088335|NCT00725985|559756021|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088336|NCT00725985|559756022|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088337|NCT00725985|559756023|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088338|NCT00725985|559756024|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088339|NCT00725985|559756025|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088340|NCT00725985|559756026|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
155088341|NCT00725985|559756015|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088342|NCT00725985|559756016|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088343|NCT00725985|559756017|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088344|NCT00725985|559756018|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088345|NCT00725985|559756019|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088346|NCT00725985|559756020|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
155088347|NCT00725985|559756021|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088348|NCT00725985|559756022|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088349|NCT00725985|559756023|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088350|NCT00725985|559756024|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088351|NCT00725985|559756025|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088352|NCT00725985|559756026|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
155088353|NCT00725985|559756015|FG000|OLMP (Up to 96 Weeks)|Other|0|||
155088354|NCT00725985|559756016|FG001|OLMP (Up to 96 Weeks)|Other|0|||
155088355|NCT00725985|559756017|FG002|OLMP (Up to 96 Weeks)|Other|0|||
155088356|NCT00725985|559756018|FG003|OLMP (Up to 96 Weeks)|Other|15|||
155088357|NCT00725985|559756019|FG004|OLMP (Up to 96 Weeks)|Other|20|||
155088358|NCT00725985|559756020|FG005|OLMP (Up to 96 Weeks)|Other|44|||
155088359|NCT00725985|559756021|FG006|OLMP (Up to 96 Weeks)|Other|0|||
155088360|NCT00725985|559756022|FG007|OLMP (Up to 96 Weeks)|Other|0|||
155088361|NCT00725985|559756023|FG008|OLMP (Up to 96 Weeks)|Other|0|||
155088362|NCT00725985|559756024|FG009|OLMP (Up to 96 Weeks)|Other|0|||
155088363|NCT00725985|559756025|FG010|OLMP (Up to 96 Weeks)|Other|0|||
155088364|NCT00725985|559756026|FG011|OLMP (Up to 96 Weeks)|Other|0|||
155360950|NCT01503086|560754008|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
155360951|NCT01503086|560754009|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
155360952|NCT01503086|560754010|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
155360953|NCT01503086|560754008|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
155360954|NCT01503086|560754009|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
155360955|NCT01503086|560754010|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
155360956|NCT04021043|560755497|FG000|Overall Study|Adverse Event|3|||
155360957|NCT04021043|560755498|FG001|Overall Study|Adverse Event|1|||
155360958|NCT04021043|560755499|FG002|Overall Study|Adverse Event|1|||
155360959|NCT04021043|560755500|FG003|Overall Study|Adverse Event|0|||
155360960|NCT04021043|560755497|FG000|Overall Study|Death|2|||
155360961|NCT04021043|560755498|FG001|Overall Study|Death|3|||
155360962|NCT04021043|560755499|FG002|Overall Study|Death|1|||
155360963|NCT04021043|560755500|FG003|Overall Study|Death|3|||
155360964|NCT04021043|560755497|FG000|Overall Study|Withdrawal by Subject|1|||
155360965|NCT04021043|560755498|FG001|Overall Study|Withdrawal by Subject|1|||
155360966|NCT04021043|560755499|FG002|Overall Study|Withdrawal by Subject|1|||
155360967|NCT04021043|560755500|FG003|Overall Study|Withdrawal by Subject|6|||
155360968|NCT04021043|560755497|FG000|Overall Study|Discontinued due to disease progression|4|||
155360969|NCT04021043|560755498|FG001|Overall Study|Discontinued due to disease progression|5|||
155360970|NCT04021043|560755499|FG002|Overall Study|Discontinued due to disease progression|7|||
155360971|NCT04021043|560755500|FG003|Overall Study|Discontinued due to disease progression|10|||
155360972|NCT00826228|560755501|FG000|Overall Study|Withdrawal by Subject|1|||
155360973|NCT01246999|560755502|FG000|Overall Study|Lost to Follow-up|0|||
155360974|NCT01246999|560755503|FG001|Overall Study|Lost to Follow-up|1|||
155360975|NCT01246999|560755504|FG002|Overall Study|Lost to Follow-up|0|||
155360976|NCT01246999|560755505|FG003|Overall Study|Lost to Follow-up|0|||
155360977|NCT01246999|560755502|FG000|Overall Study|Withdrawal by Subject|0|||
155088365|NCT00725985|559756015|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088366|NCT00725985|559756016|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088367|NCT00725985|559756017|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088368|NCT00725985|559756018|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088369|NCT00725985|559756019|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088370|NCT00725985|559756020|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088371|NCT00725985|559756021|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088372|NCT00725985|559756022|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
155360978|NCT01246999|560755503|FG001|Overall Study|Withdrawal by Subject|0|||
155166020|NCT01349049|560046177|FG006|Overall Study|Adverse Event|1|||
155166021|NCT01349049|560046178|FG007|Overall Study|Adverse Event|0|||
155166022|NCT01349049|560046179|FG008|Overall Study|Adverse Event|4|||
155166023|NCT01349049|560046171|FG000|Overall Study|Physician Decision|0|||
155166024|NCT01349049|560046172|FG001|Overall Study|Physician Decision|1|||
155166025|NCT01349049|560046173|FG002|Overall Study|Physician Decision|0|||
155166026|NCT01349049|560046174|FG003|Overall Study|Physician Decision|0|||
155166027|NCT01349049|560046175|FG004|Overall Study|Physician Decision|0|||
155166028|NCT01349049|560046176|FG005|Overall Study|Physician Decision|0|||
155166029|NCT01349049|560046177|FG006|Overall Study|Physician Decision|0|||
155166030|NCT01349049|560046178|FG007|Overall Study|Physician Decision|0|||
155166031|NCT01349049|560046179|FG008|Overall Study|Physician Decision|2|||
155360979|NCT01246999|560755504|FG002|Overall Study|Withdrawal by Subject|0|||
155360980|NCT01246999|560755505|FG003|Overall Study|Withdrawal by Subject|2|||
155360981|NCT01867047|560755506|FG000|Overall Study|Lost to Follow-up|3|||
155360982|NCT01867047|560755507|FG001|Overall Study|Lost to Follow-up|3|||
155360983|NCT01867047|560755506|FG000|Overall Study|Withdrawal by Subject|2|||
155360984|NCT01867047|560755507|FG001|Overall Study|Withdrawal by Subject|0|||
155360985|NCT01867047|560755506|FG000|Overall Study|Physician Decision|2|||
155360986|NCT01867047|560755507|FG001|Overall Study|Physician Decision|0|||
155360987|NCT01867047|560755506|FG000|Overall Study|surgery not indicated in protocol|1|||
155360988|NCT01867047|560755507|FG001|Overall Study|surgery not indicated in protocol|2|||
155360989|NCT04650698|560755508|FG000|Overall Study|Protocol Violation|2|||
155360990|NCT04650698|560755509|FG001|Overall Study|Protocol Violation|1|||
155360991|NCT04650698|560755508|FG000|Overall Study|Withdrawal by Subject|0|||
155360992|NCT04650698|560755509|FG001|Overall Study|Withdrawal by Subject|1|||
155360993|NCT01090011|560755510|FG000|Overall Study|Progressive disease|128|||
155360994|NCT01090011|560755510|FG000|Overall Study|Adverse Event|32|||
155360995|NCT01090011|560755510|FG000|Overall Study|Protocol Violation|1|||
155360996|NCT01090011|560755510|FG000|Overall Study|Refusal to start/continue medication|5|||
155360997|NCT01090011|560755510|FG000|Overall Study|Other reason not defined above|5|||
155360998|NCT03778294|560755511|FG000|Overall Study|Death|1|||
155360999|NCT03778294|560755511|FG000|Overall Study|Issues with insurance|1|||
155361000|NCT03778294|560755511|FG000|Overall Study|disease progression before treatment|2|||
155361001|NCT02859064|560755513|FG000|Overall Study|Progressive Disease|3|||
155361002|NCT02859064|560755513|FG000|Overall Study|Physician Decision|1|||
155361003|NCT02859064|560755513|FG000|Overall Study|Withdrawal by Subject|1|||
155361004|NCT02859064|560755513|FG000|Overall Study|Death|1|||
155361005|NCT01730950|560755519|FG000|Overall Study|Protocol Violation|6|||
155361006|NCT01730950|560755520|FG001|Overall Study|Protocol Violation|6|||
155361007|NCT02737826|560755521|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
155361008|NCT02737826|560755522|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
155361009|NCT02737826|560755523|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
155361010|NCT00667459|560755524|FG000|Overall Study|Death|0|||
155361011|NCT00667459|560755525|FG001|Overall Study|Death|2|||
155361012|NCT00667459|560755524|FG000|Overall Study|Lost to Follow-up|8|||
155361013|NCT00667459|560755525|FG001|Overall Study|Lost to Follow-up|43|||
155361014|NCT02568397|560755526|FG000|Period 2|Withdrawal by Subject|0|||
155361015|NCT02568397|560755527|FG001|Period 2|Withdrawal by Subject|1|||
155361016|NCT02568397|560755526|FG000|Period 2|Physician Decision|0|||
155361017|NCT02568397|560755527|FG001|Period 2|Physician Decision|1|||
155361018|NCT00078377|560755528|FG000|Overall Study|Adverse Event|2|||
155361019|NCT00078377|560755529|FG001|Overall Study|Adverse Event|5|||
155361020|NCT00078377|560755530|FG002|Overall Study|Adverse Event|1|||
155361021|NCT00078377|560755528|FG000|Overall Study|Lack of Efficacy|2|||
155361022|NCT00078377|560755529|FG001|Overall Study|Lack of Efficacy|0|||
155361023|NCT00078377|560755530|FG002|Overall Study|Lack of Efficacy|2|||
155361024|NCT00078377|560755528|FG000|Overall Study|Lost to Follow-up|0|||
155361025|NCT00078377|560755529|FG001|Overall Study|Lost to Follow-up|1|||
155361026|NCT00078377|560755530|FG002|Overall Study|Lost to Follow-up|1|||
155361027|NCT00078377|560755528|FG000|Overall Study|Physician Decision|2|||
155361028|NCT00078377|560755529|FG001|Overall Study|Physician Decision|0|||
155166032|NCT01349049|560046171|FG000|Overall Study|Protocol Violation|0|||
155166033|NCT01349049|560046172|FG001|Overall Study|Protocol Violation|0|||
155166034|NCT01349049|560046173|FG002|Overall Study|Protocol Violation|0|||
155166035|NCT01349049|560046174|FG003|Overall Study|Protocol Violation|0|||
155166036|NCT01349049|560046175|FG004|Overall Study|Protocol Violation|0|||
155166037|NCT01349049|560046176|FG005|Overall Study|Protocol Violation|0|||
155361029|NCT00078377|560755530|FG002|Overall Study|Physician Decision|0|||
155361030|NCT00078377|560755528|FG000|Overall Study|Withdrawal by Subject|3|||
155361031|NCT00078377|560755529|FG001|Overall Study|Withdrawal by Subject|4|||
155361032|NCT00078377|560755530|FG002|Overall Study|Withdrawal by Subject|4|||
155361033|NCT00078377|560755528|FG000|Overall Study|Miscellaneous|2|||
155361034|NCT00078377|560755529|FG001|Overall Study|Miscellaneous|6|||
155361035|NCT00078377|560755530|FG002|Overall Study|Miscellaneous|1|||
155361036|NCT02354651|560755531|FG000|Overall Study|Withdrawal by Subject|2|||
155088373|NCT00725985|559756023|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088374|NCT00725985|559756024|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088375|NCT00725985|559756025|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088376|NCT00725985|559756026|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
155088377|NCT00725985|559756015|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088378|NCT00725985|559756016|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088379|NCT00725985|559756017|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088380|NCT00725985|559756018|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088381|NCT00725985|559756019|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088382|NCT00725985|559756020|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088383|NCT00725985|559756021|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088384|NCT00725985|559756022|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088385|NCT00725985|559756023|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
155088386|NCT00725985|559756024|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088387|NCT00725985|559756025|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088388|NCT00725985|559756026|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
155088389|NCT00725985|559756015|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088390|NCT00725985|559756016|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088391|NCT00725985|559756017|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088392|NCT00725985|559756018|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088393|NCT00725985|559756019|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088394|NCT00725985|559756020|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088395|NCT00725985|559756021|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
155088396|NCT00725985|559756022|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
155088397|NCT00725985|559756023|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
155088398|NCT00725985|559756024|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088399|NCT00725985|559756025|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088400|NCT00725985|559756026|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
155088401|NCT00725985|559756015|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088402|NCT00725985|559756016|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088403|NCT00725985|559756017|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088404|NCT00725985|559756018|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088405|NCT00725985|559756019|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088406|NCT00725985|559756020|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088407|NCT00725985|559756021|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088408|NCT00725985|559756022|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088409|NCT00725985|559756023|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
155088410|NCT00725985|559756024|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
155088411|NCT00725985|559756025|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
155088412|NCT00725985|559756026|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
155088413|NCT01381679|559756027|FG000|Overall Study|Adverse Event|3|||
155088414|NCT01381679|559756027|FG000|Overall Study|Lost to Follow-up|885|||
155088415|NCT05473715|559756028|FG000|Overall Study|Trial terminate|2|||
155088416|NCT05473715|559756029|FG001|Overall Study|Trial terminate|1|||
155088417|NCT03528902|559756030|FG000|Overall Study|Adverse Event|1|||
155088418|NCT03528902|559756031|FG001|Overall Study|Adverse Event|0|||
155088419|NCT04770285|559756032|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
155088420|NCT04770285|559756033|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
155088421|NCT04770285|559756032|FG000|Overall Study|Lack of Efficacy|0|||
155088422|NCT04770285|559756033|FG001|Overall Study|Lack of Efficacy|1|||
155088423|NCT04770285|559756032|FG000|Overall Study|Lost to Follow-up|11|||
155088424|NCT04770285|559756033|FG001|Overall Study|Lost to Follow-up|8|||
155088425|NCT04770285|559756032|FG000|Overall Study|Protocol Deviation|6|||
155088426|NCT04770285|559756033|FG001|Overall Study|Protocol Deviation|6|||
155088427|NCT04770285|559756032|FG000|Overall Study|Technical Problem|0|||
155088428|NCT04770285|559756033|FG001|Overall Study|Technical Problem|1|||
155088429|NCT04770285|559756032|FG000|Overall Study|Withdrawal by Subject|9|||
155088430|NCT04770285|559756033|FG001|Overall Study|Withdrawal by Subject|8|||
155088431|NCT04770285|559756032|FG000|Overall Study|Reason Not Specified|0|||
155088432|NCT04770285|559756033|FG001|Overall Study|Reason Not Specified|1|||
155088433|NCT04620668|559756034|FG000|Overall Study|Withdrawal by Subject|2|||
155088434|NCT04620668|559756035|FG001|Overall Study|Withdrawal by Subject|0|||
155088435|NCT04620668|559756034|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
155088436|NCT04620668|559756035|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
155088437|NCT04620668|559756034|FG000|Overall Study|Removed before analysis: missing data|2|||
155088438|NCT04620668|559756035|FG001|Overall Study|Removed before analysis: missing data|0|||
155088439|NCT04620668|559756034|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
155088440|NCT04620668|559756035|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
155088441|NCT04620668|559756034|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
155361037|NCT02354651|560755531|FG000|Overall Study|Physician Decision|1|||
155361038|NCT00581893|560755532|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
155166038|NCT01349049|560046177|FG006|Overall Study|Protocol Violation|0|||
155166039|NCT01349049|560046178|FG007|Overall Study|Protocol Violation|0|||
155166040|NCT01349049|560046179|FG008|Overall Study|Protocol Violation|1|||
155166041|NCT01349049|560046171|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
155166042|NCT01349049|560046172|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
155166043|NCT01349049|560046173|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
155166044|NCT01349049|560046174|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
155166045|NCT01349049|560046175|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
155166046|NCT01349049|560046176|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
155166047|NCT01349049|560046177|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
155166048|NCT01349049|560046178|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
155166049|NCT01349049|560046179|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
155166050|NCT01349049|560046171|FG000|Overall Study|Other|0|||
155166051|NCT01349049|560046172|FG001|Overall Study|Other|0|||
155166052|NCT01349049|560046173|FG002|Overall Study|Other|0|||
155166053|NCT01349049|560046174|FG003|Overall Study|Other|0|||
155166054|NCT01349049|560046175|FG004|Overall Study|Other|0|||
155166055|NCT01349049|560046176|FG005|Overall Study|Other|1|||
155166056|NCT01349049|560046177|FG006|Overall Study|Other|0|||
155166057|NCT01349049|560046178|FG007|Overall Study|Other|0|||
155166058|NCT01349049|560046179|FG008|Overall Study|Other|4|||
155088442|NCT04620668|559756035|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
155088443|NCT03559530|559756036|FG000|Overall Study|non-location of medical records|44|||
155088444|NCT03559530|559756037|FG001|Overall Study|non-location of medical records|0|||
155088445|NCT03559530|559756036|FG000|Overall Study|culture results not considered for treat|29|||
155088446|NCT03559530|559756037|FG001|Overall Study|culture results not considered for treat|0|||
155088447|NCT03559530|559756036|FG000|Overall Study|duplicate cases|8|||
155088448|NCT03559530|559756037|FG001|Overall Study|duplicate cases|0|||
155088449|NCT03559530|559756036|FG000|Overall Study|other species of Acinetobacte|7|||
155088450|NCT03559530|559756037|FG001|Overall Study|other species of Acinetobacte|0|||
155088451|NCT03559530|559756036|FG000|Overall Study|contamination / colonization|3|||
155088452|NCT03559530|559756037|FG001|Overall Study|contamination / colonization|0|||
155088453|NCT01472185|559756040|FG000|Overall Study|Randomized but Not Treated|0|||
155088454|NCT01472185|559756041|FG001|Overall Study|Randomized but Not Treated|1|||
155088455|NCT01472185|559756040|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
155088456|NCT01472185|559756041|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
155088457|NCT01472185|559756040|FG000|Overall Study|Hyperglycemia|5|||
155088458|NCT01472185|559756041|FG001|Overall Study|Hyperglycemia|2|||
155088459|NCT01472185|559756040|FG000|Overall Study|Investigator's Discretion|3|||
155088460|NCT01472185|559756041|FG001|Overall Study|Investigator's Discretion|1|||
155088461|NCT01472185|559756040|FG000|Overall Study|Lost to Follow-up|4|||
155088462|NCT01472185|559756041|FG001|Overall Study|Lost to Follow-up|1|||
155088463|NCT01472185|559756040|FG000|Overall Study|Protocol Violation|5|||
155088464|NCT01472185|559756041|FG001|Overall Study|Protocol Violation|1|||
155088465|NCT01472185|559756040|FG000|Overall Study|Subject Noncompliance|8|||
155088466|NCT01472185|559756041|FG001|Overall Study|Subject Noncompliance|15|||
155088467|NCT01472185|559756040|FG000|Overall Study|Subject Withdrew Consent|6|||
155088468|NCT01472185|559756041|FG001|Overall Study|Subject Withdrew Consent|3|||
155088469|NCT03232567|559756044|FG000|Overall Study|Withdrawal by Subject|0|||
155088470|NCT03232567|559756045|FG001|Overall Study|Withdrawal by Subject|1|||
155088471|NCT03232567|559756046|FG002|Overall Study|Withdrawal by Subject|0|||
155088472|NCT03232567|559756047|FG003|Overall Study|Withdrawal by Subject|0|||
155088473|NCT05837481|559756048|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
155088474|NCT05837481|559756049|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
155088475|NCT00427700|559756050|FG000|Overall Study|Lost to Follow-up|2|||
155088476|NCT00427700|559756051|FG001|Overall Study|Lost to Follow-up|5|||
155088477|NCT00427700|559756050|FG000|Overall Study|no induction of menses|1|||
155088478|NCT00427700|559756051|FG001|Overall Study|no induction of menses|4|||
155088479|NCT00427700|559756050|FG000|Overall Study|Pregnancy|0|||
155088480|NCT00427700|559756051|FG001|Overall Study|Pregnancy|2|||
155088481|NCT04581395|559756052|FG000|Overall Study|Protocol Violation|4|||
155088482|NCT04581395|559756053|FG001|Overall Study|Protocol Violation|3|||
155088483|NCT04581395|559756054|FG002|Overall Study|Protocol Violation|2|||
155166059|NCT01349049|560046171|FG000|Overall Study|Death|0|||
155166060|NCT01349049|560046172|FG001|Overall Study|Death|0|||
155088484|NCT04581395|559756052|FG000|Overall Study|Physician Decision|0|||
155088485|NCT04581395|559756053|FG001|Overall Study|Physician Decision|1|||
155166061|NCT01349049|560046173|FG002|Overall Study|Death|0|||
155166062|NCT01349049|560046174|FG003|Overall Study|Death|0|||
155166063|NCT01349049|560046175|FG004|Overall Study|Death|0|||
155166064|NCT01349049|560046176|FG005|Overall Study|Death|0|||
155088486|NCT04581395|559756054|FG002|Overall Study|Physician Decision|0|||
155088487|NCT00815633|559756059|FG000|Overall Study|study terminated|1|||
155166065|NCT01349049|560046177|FG006|Overall Study|Death|0|||
155166066|NCT01349049|560046178|FG007|Overall Study|Death|1|||
155088488|NCT02457065|559756060|FG000|Overall Study|Lost to Follow-up|9|||
155166067|NCT01349049|560046179|FG008|Overall Study|Death|5|||
154965196|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
155088489|NCT02457065|559756061|FG001|Overall Study|Lost to Follow-up|11|||
155088490|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
155088491|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155088492|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155088493|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155088494|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155088495|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155088496|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
155088497|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
155088498|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
155088499|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
155088500|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
155088501|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
155088502|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
155088503|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
155088504|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
155088505|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
155088506|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
155088507|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
155088508|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
155088509|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
155088510|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
155088511|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
155088512|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
155088513|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
155088514|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
155088515|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
155088516|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
155088517|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
155088518|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
155088519|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
155088520|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
155088521|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
155088522|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
155088523|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
155088524|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
155088525|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
155088526|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
155088527|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
155088528|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
155088529|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
155088530|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
155088531|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
155088532|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
155088533|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155088534|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155088535|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155088536|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155361039|NCT00581893|560755533|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
155361040|NCT02550938|560755534|FG000|Overall Study|Lost to Follow-up|8|||
155361041|NCT02550938|560755535|FG001|Overall Study|Lost to Follow-up|7|||
155088537|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155088538|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
155088539|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155088540|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
155361042|NCT02550938|560755536|FG002|Overall Study|Lost to Follow-up|12|||
155361043|NCT02550938|560755537|FG003|Overall Study|Lost to Follow-up|11|||
155361044|NCT01367847|560755538|FG000|Overall Study|Withdrawal by Subject|2|||
155361045|NCT01367847|560755539|FG001|Overall Study|Withdrawal by Subject|2|||
155361046|NCT01454739|560755540|FG000|Overall Study|Protocol Violation|2|||
155361047|NCT01454739|560755541|FG001|Overall Study|Protocol Violation|3|||
155361048|NCT01454739|560755540|FG000|Overall Study|Withdrawal by Subject|2|||
155361049|NCT01454739|560755541|FG001|Overall Study|Withdrawal by Subject|6|||
155361050|NCT01454739|560755540|FG000|Overall Study|Other|3|||
155361051|NCT01454739|560755541|FG001|Overall Study|Other|5|||
155361052|NCT01454739|560755540|FG000|Overall Study|Physician Decision|0|||
155361053|NCT01454739|560755541|FG001|Overall Study|Physician Decision|5|||
155361054|NCT01454739|560755540|FG000|Overall Study|Lost to Follow-up|0|||
155166068|NCT01349049|560046171|FG000|Overall Study|Non-compliance|0|||
155361055|NCT01454739|560755541|FG001|Overall Study|Lost to Follow-up|1|||
155361056|NCT01454739|560755540|FG000|Overall Study|Adverse Event|0|||
155361057|NCT01454739|560755541|FG001|Overall Study|Adverse Event|1|||
155088541|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155088542|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155088543|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155088544|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155088545|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
155088546|NCT01362790|559756062|FG000|Pilot Phase & Phase 2|Death on study|0|||
155088547|NCT01362790|559756063|FG001|Pilot Phase & Phase 2|Death on study|0|||
155088548|NCT01362790|559756064|FG002|Pilot Phase & Phase 2|Death on study|0|||
155088549|NCT01362790|559756065|FG003|Pilot Phase & Phase 2|Death on study|1|||
155088550|NCT01362790|559756066|FG004|Pilot Phase & Phase 2|Death on study|0|||
155088551|NCT01362790|559756067|FG005|Pilot Phase & Phase 2|Death on study|0|||
155088552|NCT01362790|559756068|FG006|Pilot Phase & Phase 2|Death on study|0|||
155088553|NCT01362790|559756062|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
155088554|NCT01362790|559756063|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
155088555|NCT01362790|559756064|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
155088556|NCT01362790|559756065|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
155088557|NCT01362790|559756066|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
155088558|NCT01362790|559756067|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
155088559|NCT01362790|559756068|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
155088560|NCT01362790|559756062|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155088561|NCT01362790|559756063|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155088562|NCT01362790|559756064|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155088563|NCT01362790|559756065|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155088564|NCT01362790|559756066|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
155088565|NCT01362790|559756067|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155088566|NCT01362790|559756068|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
155088567|NCT01362790|559756062|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
155088568|NCT01362790|559756063|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
155088569|NCT01362790|559756064|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
155088570|NCT01362790|559756065|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
155088571|NCT01362790|559756066|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
155088572|NCT01362790|559756067|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
155088573|NCT01362790|559756068|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
155088574|NCT00635050|559756069|FG000|Overall Study|Withdrawal by Subject|1|||
155088575|NCT03485157|559756070|FG000|Double Blind Phase|Lost to Follow-up|4|||
155088576|NCT03485157|559756071|FG001|Double Blind Phase|Lost to Follow-up|4|||
155088577|NCT03485157|559756070|FG000|Double Blind Phase|Adverse Event|2|||
155088578|NCT03485157|559756071|FG001|Double Blind Phase|Adverse Event|1|||
155088579|NCT03485157|559756070|FG000|Double Blind Phase|Withdrawal by Subject|6|||
155088580|NCT03485157|559756071|FG001|Double Blind Phase|Withdrawal by Subject|9|||
155088581|NCT03485157|559756070|FG000|Double Blind Phase|Removal by PI|3|||
155088582|NCT03485157|559756071|FG001|Double Blind Phase|Removal by PI|7|||
155088583|NCT03485157|559756070|FG000|Open Label Phase|Lost to Follow-up|1|||
155088584|NCT03485157|559756071|FG001|Open Label Phase|Lost to Follow-up|2|||
155088585|NCT03485157|559756070|FG000|Open Label Phase|Adverse Event|0|||
155088586|NCT03485157|559756071|FG001|Open Label Phase|Adverse Event|1|||
155088587|NCT03485157|559756070|FG000|Open Label Phase|Withdrawal by Subject|1|||
155088588|NCT03485157|559756071|FG001|Open Label Phase|Withdrawal by Subject|2|||
155088589|NCT03485157|559756070|FG000|Open Label Phase|Removal by PI|2|||
155088590|NCT03485157|559756071|FG001|Open Label Phase|Removal by PI|0|||
155088591|NCT01849276|559756072|FG000|Followed for Survival for 5 Years|Death|1|||
155088592|NCT01849276|559756072|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
155088593|NCT02011542|559756074|FG000|Overall Study|Physician Decision|1|||
155088594|NCT01813357|559756075|FG000|Overall Study|Lost to Follow-up|5|||
155088595|NCT01813357|559756076|FG001|Overall Study|Lost to Follow-up|6|||
155088596|NCT00522379|559756077|FG000|Overall Study|Adverse Event|12|||
155088597|NCT00522379|559756078|FG001|Overall Study|Adverse Event|15|||
155088598|NCT00522379|559756079|FG002|Overall Study|Adverse Event|12|||
155088599|NCT00522379|559756080|FG003|Overall Study|Adverse Event|5|||
155088600|NCT00522379|559756081|FG004|Overall Study|Adverse Event|17|||
155088601|NCT00522379|559756077|FG000|Overall Study|Lack of Efficacy|3|||
155361058|NCT01375751|560755544|FG000|Overall Study|Other|0|||
155088602|NCT00522379|559756078|FG001|Overall Study|Lack of Efficacy|0|||
155088603|NCT00522379|559756079|FG002|Overall Study|Lack of Efficacy|2|||
155088604|NCT00522379|559756080|FG003|Overall Study|Lack of Efficacy|2|||
155088605|NCT00522379|559756081|FG004|Overall Study|Lack of Efficacy|7|||
155088606|NCT00522379|559756077|FG000|Overall Study|Withdrawal by Subject|2|||
155088607|NCT00522379|559756078|FG001|Overall Study|Withdrawal by Subject|3|||
155088608|NCT00522379|559756079|FG002|Overall Study|Withdrawal by Subject|1|||
155088609|NCT00522379|559756080|FG003|Overall Study|Withdrawal by Subject|2|||
155088610|NCT00522379|559756081|FG004|Overall Study|Withdrawal by Subject|0|||
155088611|NCT00522379|559756077|FG000|Overall Study|Protocol Violation|1|||
155361059|NCT01375751|560755545|FG001|Overall Study|Other|1|||
155088612|NCT00522379|559756078|FG001|Overall Study|Protocol Violation|1|||
155088613|NCT00522379|559756079|FG002|Overall Study|Protocol Violation|2|||
155088614|NCT00522379|559756080|FG003|Overall Study|Protocol Violation|0|||
155088615|NCT00522379|559756081|FG004|Overall Study|Protocol Violation|0|||
155088616|NCT00522379|559756077|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
155088617|NCT00522379|559756078|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
155088618|NCT00522379|559756079|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
155088619|NCT00522379|559756080|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
155088620|NCT00522379|559756081|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
155088621|NCT00522379|559756077|FG000|Overall Study|Lost to Follow-up|1|||
155088622|NCT00522379|559756078|FG001|Overall Study|Lost to Follow-up|0|||
155088623|NCT00522379|559756079|FG002|Overall Study|Lost to Follow-up|4|||
155088624|NCT00522379|559756080|FG003|Overall Study|Lost to Follow-up|2|||
155088625|NCT00522379|559756081|FG004|Overall Study|Lost to Follow-up|2|||
155088626|NCT00522379|559756077|FG000|Overall Study|Randomization error|0|||
155088627|NCT00522379|559756078|FG001|Overall Study|Randomization error|0|||
155088628|NCT00522379|559756079|FG002|Overall Study|Randomization error|0|||
155088629|NCT00522379|559756080|FG003|Overall Study|Randomization error|0|||
155088630|NCT00522379|559756081|FG004|Overall Study|Randomization error|1|||
155088631|NCT00522379|559756077|FG000|Overall Study|Dispensing error|1|||
155088632|NCT00522379|559756078|FG001|Overall Study|Dispensing error|0|||
155088633|NCT00522379|559756079|FG002|Overall Study|Dispensing error|0|||
155088634|NCT00522379|559756080|FG003|Overall Study|Dispensing error|1|||
155088635|NCT00522379|559756081|FG004|Overall Study|Dispensing error|0|||
155361060|NCT01375751|560755546|FG002|Overall Study|Other|0|||
155361061|NCT02980523|560755547|FG000|Overall Study|Lost to Follow-up|1|||
155361062|NCT02980523|560755548|FG001|Overall Study|Lost to Follow-up|4|||
155361063|NCT02980523|560755549|FG002|Overall Study|Lost to Follow-up|1|||
155088636|NCT00522379|559756077|FG000|Overall Study|Subject Moved|1|||
155088637|NCT00522379|559756078|FG001|Overall Study|Subject Moved|1|||
155088638|NCT00522379|559756079|FG002|Overall Study|Subject Moved|0|||
155088639|NCT00522379|559756080|FG003|Overall Study|Subject Moved|0|||
155088640|NCT00522379|559756081|FG004|Overall Study|Subject Moved|0|||
155088641|NCT00522379|559756077|FG000|Overall Study|Sponsor Request|0|||
155088642|NCT00522379|559756078|FG001|Overall Study|Sponsor Request|1|||
155088643|NCT00522379|559756079|FG002|Overall Study|Sponsor Request|0|||
155088644|NCT00522379|559756080|FG003|Overall Study|Sponsor Request|0|||
155361064|NCT02980523|560755550|FG003|Overall Study|Lost to Follow-up|2|||
155361065|NCT02980523|560755551|FG004|Overall Study|Lost to Follow-up|1|||
155361066|NCT02980523|560755547|FG000|Overall Study|Excluded from analysis|1|||
155361067|NCT02980523|560755548|FG001|Overall Study|Excluded from analysis|3|||
155361068|NCT02980523|560755549|FG002|Overall Study|Excluded from analysis|1|||
155361069|NCT02980523|560755550|FG003|Overall Study|Excluded from analysis|1|||
155361070|NCT02980523|560755551|FG004|Overall Study|Excluded from analysis|1|||
155361071|NCT02980523|560755547|FG000|Overall Study|Lack of Efficacy|1|||
155361072|NCT02980523|560755548|FG001|Overall Study|Lack of Efficacy|4|||
155361073|NCT02980523|560755549|FG002|Overall Study|Lack of Efficacy|4|||
155361074|NCT02980523|560755550|FG003|Overall Study|Lack of Efficacy|5|||
155361075|NCT02980523|560755551|FG004|Overall Study|Lack of Efficacy|8|||
155361076|NCT02980523|560755547|FG000|Overall Study|Did not receive intervention|0|||
155361077|NCT02980523|560755548|FG001|Overall Study|Did not receive intervention|0|||
155361078|NCT02980523|560755549|FG002|Overall Study|Did not receive intervention|0|||
155361079|NCT02980523|560755550|FG003|Overall Study|Did not receive intervention|1|||
155361080|NCT02980523|560755551|FG004|Overall Study|Did not receive intervention|0|||
155361081|NCT00633945|560755552|FG000|Overall Study|Physician Decision|2|||
155361082|NCT00882115|560755553|FG000|Overall Study|Withdrawal by Subject|3|||
155361083|NCT00882115|560755553|FG000|Overall Study|did not respond to DEP challe|6|||
155361084|NCT02552147|560755554|FG000|First Intervention (7 Days)|Protocol Violation|1|||
155361085|NCT02552147|560755555|FG001|First Intervention (7 Days)|Protocol Violation|0|||
155361086|NCT02552147|560755554|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
155361087|NCT02552147|560755555|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
155361088|NCT01547598|560755556|FG000|Overall Study|Withdrew consent|1|||
155361089|NCT01547598|560755557|FG001|Overall Study|Withdrew consent|1|||
155361090|NCT01547598|560755556|FG000|Overall Study|Lost to Follow-up|1|||
155361091|NCT01547598|560755557|FG001|Overall Study|Lost to Follow-up|1|||
155361092|NCT01547598|560755556|FG000|Overall Study|Adverse Event|1|||
155361093|NCT01547598|560755557|FG001|Overall Study|Adverse Event|1|||
155361094|NCT01547598|560755556|FG000|Overall Study|Protocol Violation|1|||
155361095|NCT01547598|560755557|FG001|Overall Study|Protocol Violation|1|||
155088645|NCT00522379|559756081|FG004|Overall Study|Sponsor Request|0|||
155088646|NCT00522379|559756077|FG000|Overall Study|Family Problem|0|||
155088647|NCT00522379|559756078|FG001|Overall Study|Family Problem|0|||
155088648|NCT00522379|559756079|FG002|Overall Study|Family Problem|1|||
155361096|NCT01547598|560755556|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155361097|NCT01547598|560755557|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155361098|NCT00872001|560755561|FG000|Overall Study|Adverse Event|34|||
155361099|NCT00872001|560755562|FG001|Overall Study|Adverse Event|23|||
155361100|NCT00872001|560755561|FG000|Overall Study|Protocol Defined Clinical Event|5|||
155166069|NCT01349049|560046172|FG001|Overall Study|Non-compliance|0|||
155166070|NCT01349049|560046173|FG002|Overall Study|Non-compliance|0|||
155166071|NCT01349049|560046174|FG003|Overall Study|Non-compliance|1|||
155166072|NCT01349049|560046175|FG004|Overall Study|Non-compliance|0|||
155166073|NCT01349049|560046176|FG005|Overall Study|Non-compliance|0|||
155166074|NCT01349049|560046177|FG006|Overall Study|Non-compliance|0|||
155166075|NCT01349049|560046178|FG007|Overall Study|Non-compliance|0|||
155166076|NCT01349049|560046179|FG008|Overall Study|Non-compliance|0|||
155361101|NCT00872001|560755562|FG001|Overall Study|Protocol Defined Clinical Event|7|||
155361102|NCT00872001|560755561|FG000|Overall Study|Lost to Follow-up|13|||
155361103|NCT00872001|560755562|FG001|Overall Study|Lost to Follow-up|12|||
155361104|NCT00872001|560755561|FG000|Overall Study|Withdrawal by Subject|18|||
155361105|NCT00872001|560755562|FG001|Overall Study|Withdrawal by Subject|30|||
155361106|NCT00872001|560755561|FG000|Overall Study|Protocol Violation|5|||
155361107|NCT00872001|560755562|FG001|Overall Study|Protocol Violation|8|||
155361108|NCT00872001|560755561|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
155361109|NCT00872001|560755562|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
155361110|NCT00872001|560755561|FG000|Overall Study|Administrative|23|||
155361111|NCT00872001|560755562|FG001|Overall Study|Administrative|15|||
155361112|NCT04071301|560755563|FG000|Overall Study|Withdrawal by Subject|6|||
155361113|NCT04071301|560755563|FG000|Overall Study|Death|1|||
155361114|NCT00121667|560755564|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
155361115|NCT00121667|560755565|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
155361116|NCT00121667|560755566|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
155361117|NCT00121667|560755567|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
155361118|NCT00121667|560755564|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
155361119|NCT00121667|560755565|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
155361120|NCT00121667|560755566|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
155361121|NCT00121667|560755567|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
155088649|NCT00522379|559756080|FG003|Overall Study|Family Problem|0|||
155088650|NCT00522379|559756081|FG004|Overall Study|Family Problem|0|||
155088651|NCT00522379|559756077|FG000|Overall Study|Site Closed|0|||
155088652|NCT00522379|559756078|FG001|Overall Study|Site Closed|0|||
155088653|NCT00522379|559756079|FG002|Overall Study|Site Closed|0|||
155088654|NCT00522379|559756080|FG003|Overall Study|Site Closed|1|||
155088655|NCT00522379|559756081|FG004|Overall Study|Site Closed|0|||
155088656|NCT00522379|559756077|FG000|Overall Study|Subject Withdrawal|0|||
155088657|NCT00522379|559756078|FG001|Overall Study|Subject Withdrawal|0|||
155088658|NCT00522379|559756079|FG002|Overall Study|Subject Withdrawal|0|||
155088659|NCT00522379|559756080|FG003|Overall Study|Subject Withdrawal|1|||
155088660|NCT00522379|559756081|FG004|Overall Study|Subject Withdrawal|0|||
155088661|NCT02607722|559756085|FG000|Overall Study|No data reliability|1|||
155088662|NCT02607722|559756085|FG000|Overall Study|no patient visit|18|||
155088663|NCT02607722|559756085|FG000|Overall Study|missing info in CRF|13|||
155088664|NCT02607722|559756085|FG000|Overall Study|Withdrawal by Subject|616|||
155088665|NCT02607722|559756085|FG000|Overall Study|Lost to Follow-up|312|||
155088666|NCT02607722|559756085|FG000|Overall Study|Improved|22|||
155088667|NCT02607722|559756085|FG000|Overall Study|Lack of Efficacy|316|||
155088668|NCT02607722|559756085|FG000|Overall Study|Adverse Event|2553|||
155088669|NCT02607722|559756085|FG000|Overall Study|Not treated|1|||
155088670|NCT02607722|559756085|FG000|Overall Study|No CRF collected|138|||
155088671|NCT02607722|559756085|FG000|Overall Study|without CRF|4225|||
155088672|NCT02607722|559756085|FG000|Overall Study|Physician Decision|367|||
155088673|NCT03312543|559756088|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
155088674|NCT03312543|559756089|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
155088675|NCT03312543|559756088|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
155088676|NCT03312543|559756089|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
155088677|NCT03312543|559756088|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
155088678|NCT03312543|559756089|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
155088679|NCT03312543|559756088|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
155088680|NCT03312543|559756089|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
155088681|NCT03312543|559756088|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
155088682|NCT03312543|559756089|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
155088683|NCT03312543|559756088|FG000|Regression (Week 12 to Week 24)|Death|0|||
155088684|NCT03312543|559756089|FG001|Regression (Week 12 to Week 24)|Death|1|||
155088685|NCT04507269|559756090|FG000|Overall Study|Withdrawal by Subject|1|||
155088686|NCT04507269|559756091|FG001|Overall Study|Withdrawal by Subject|1|||
155088687|NCT04507269|559756092|FG002|Overall Study|Withdrawal by Subject|0|||
155166077|NCT01349049|560046171|FG000|Overall Study|Withdrawal by Subject|0|||
155166078|NCT01349049|560046172|FG001|Overall Study|Withdrawal by Subject|0|||
155166079|NCT01349049|560046173|FG002|Overall Study|Withdrawal by Subject|0|||
155361122|NCT00121667|560755564|FG000|Short Term (ST) Period|Adverse Event|5|||
155361123|NCT00121667|560755565|FG001|Short Term (ST) Period|Adverse Event|6|||
155361124|NCT00121667|560755566|FG002|Short Term (ST) Period|Adverse Event|5|||
155361125|NCT00121667|560755567|FG003|Short Term (ST) Period|Adverse Event|3|||
155361126|NCT00121667|560755564|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
155166080|NCT01349049|560046174|FG003|Overall Study|Withdrawal by Subject|0|||
155166081|NCT01349049|560046175|FG004|Overall Study|Withdrawal by Subject|0|||
155166082|NCT01349049|560046176|FG005|Overall Study|Withdrawal by Subject|0|||
155166083|NCT01349049|560046177|FG006|Overall Study|Withdrawal by Subject|0|||
155166084|NCT01349049|560046178|FG007|Overall Study|Withdrawal by Subject|0|||
155166085|NCT01349049|560046179|FG008|Overall Study|Withdrawal by Subject|6|||
155166086|NCT01675544|560046182|FG000|Overall Study|Withdrawal by Subject|2|||
155166087|NCT00243269|560046183|FG000|Overall Study|Protocol Violation|2|||
155166088|NCT00243269|560046184|FG001|Overall Study|Protocol Violation|1|||
155166089|NCT00243269|560046185|FG002|Overall Study|Protocol Violation|0|||
155166090|NCT00243269|560046186|FG003|Overall Study|Protocol Violation|1|||
155361127|NCT00121667|560755565|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
155361128|NCT00121667|560755566|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
155361129|NCT00121667|560755567|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
155361130|NCT00121667|560755564|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
155361131|NCT00121667|560755565|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
155361132|NCT00121667|560755566|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
155361133|NCT00121667|560755567|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
155361134|NCT00121667|560755564|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
155361135|NCT00121667|560755565|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
155361136|NCT00121667|560755566|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
155361137|NCT00121667|560755567|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
155361138|NCT00121667|560755564|FG000|Short Term (ST) Period|Other Reason|3|||
155361139|NCT00121667|560755565|FG001|Short Term (ST) Period|Other Reason|0|||
155361140|NCT00121667|560755566|FG002|Short Term (ST) Period|Other Reason|0|||
155361141|NCT00121667|560755567|FG003|Short Term (ST) Period|Other Reason|0|||
155361142|NCT00121667|560755564|FG000|Short Term (ST) Period|Death|0|||
155361143|NCT00121667|560755565|FG001|Short Term (ST) Period|Death|0|||
155361144|NCT00121667|560755566|FG002|Short Term (ST) Period|Death|0|||
155361145|NCT00121667|560755567|FG003|Short Term (ST) Period|Death|1|||
155361146|NCT00121667|560755564|FG000|Short Term (ST) Period|Pregnancy|0|||
155361147|NCT00121667|560755565|FG001|Short Term (ST) Period|Pregnancy|0|||
155361148|NCT00121667|560755566|FG002|Short Term (ST) Period|Pregnancy|0|||
155361149|NCT00121667|560755567|FG003|Short Term (ST) Period|Pregnancy|1|||
155361150|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
155361151|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
155361152|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
155361153|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
155361154|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
155361155|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
155361156|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
155361157|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
155361158|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
155361159|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
155166091|NCT00243269|560046183|FG000|Overall Study|Lost to Follow-up|1|||
155166092|NCT00243269|560046184|FG001|Overall Study|Lost to Follow-up|0|||
155166093|NCT00243269|560046185|FG002|Overall Study|Lost to Follow-up|1|||
155166094|NCT00243269|560046186|FG003|Overall Study|Lost to Follow-up|3|||
155166095|NCT00485134|560046187|FG000|Overall Study|Lost to Follow-up|1|||
155166096|NCT00485134|560046188|FG001|Overall Study|Lost to Follow-up|0|||
155166097|NCT00485134|560046189|FG002|Overall Study|Lost to Follow-up|0|||
155166098|NCT00485134|560046190|FG003|Overall Study|Lost to Follow-up|0|||
155166099|NCT00485134|560046191|FG004|Overall Study|Lost to Follow-up|0|||
155166100|NCT00485134|560046192|FG005|Overall Study|Lost to Follow-up|0|||
155166101|NCT00485134|560046193|FG006|Overall Study|Lost to Follow-up|0|||
155166102|NCT00485134|560046194|FG007|Overall Study|Lost to Follow-up|0|||
155166103|NCT00485134|560046187|FG000|Overall Study|Withdrawal by Subject|0|||
155166104|NCT00485134|560046188|FG001|Overall Study|Withdrawal by Subject|1|||
155361160|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
155361161|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
155361162|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
154965197|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
155361163|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
155361164|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
155166105|NCT00485134|560046189|FG002|Overall Study|Withdrawal by Subject|0|||
154965198|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
155166106|NCT00485134|560046190|FG003|Overall Study|Withdrawal by Subject|0|||
155166107|NCT00485134|560046191|FG004|Overall Study|Withdrawal by Subject|0|||
155166108|NCT00485134|560046192|FG005|Overall Study|Withdrawal by Subject|0|||
155166109|NCT00485134|560046193|FG006|Overall Study|Withdrawal by Subject|0|||
155166110|NCT00485134|560046194|FG007|Overall Study|Withdrawal by Subject|0|||
155361165|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
155361166|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
155361167|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
155361168|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
155361169|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
155361170|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
155361171|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
155088688|NCT04507269|559756093|FG003|Overall Study|Withdrawal by Subject|0|||
155088689|NCT04507269|559756094|FG004|Overall Study|Withdrawal by Subject|0|||
155088690|NCT04507269|559756095|FG005|Overall Study|Withdrawal by Subject|0|||
155088691|NCT04507269|559756090|FG000|Overall Study|Lost to Follow-up|0|||
155088692|NCT04507269|559756091|FG001|Overall Study|Lost to Follow-up|0|||
155088693|NCT04507269|559756092|FG002|Overall Study|Lost to Follow-up|0|||
155088694|NCT04507269|559756093|FG003|Overall Study|Lost to Follow-up|0|||
155088695|NCT04507269|559756094|FG004|Overall Study|Lost to Follow-up|1|||
155088696|NCT04507269|559756095|FG005|Overall Study|Lost to Follow-up|0|||
155088697|NCT05852340|559756096|FG000|Period 5|Not completing the meal|0|||
155088698|NCT05852340|559756097|FG001|Period 5|Not completing the meal|1|||
155088699|NCT05852340|559756098|FG002|Period 5|Not completing the meal|0|||
155088700|NCT05852340|559756099|FG003|Period 5|Not completing the meal|0|||
155088701|NCT05852340|559756096|FG000|Period 5|Adverse Event|0|||
155088702|NCT05852340|559756097|FG001|Period 5|Adverse Event|0|||
155088703|NCT05852340|559756098|FG002|Period 5|Adverse Event|0|||
155088704|NCT05852340|559756099|FG003|Period 5|Adverse Event|1|||
155088705|NCT02402647|559756102|FG000|Overall Study|Lost to Follow-up|13|||
155088706|NCT02402647|559756103|FG001|Overall Study|Lost to Follow-up|7|||
155088707|NCT02402647|559756102|FG000|Overall Study|Protocol Violation|1|||
155088708|NCT02402647|559756103|FG001|Overall Study|Protocol Violation|1|||
155088709|NCT02402647|559756102|FG000|Overall Study|scheduled and timed out|2|||
155088710|NCT02402647|559756103|FG001|Overall Study|scheduled and timed out|1|||
155088711|NCT02402647|559756102|FG000|Overall Study|medical illness|2|||
155088712|NCT02402647|559756103|FG001|Overall Study|medical illness|4|||
155088713|NCT02402647|559756102|FG000|Overall Study|Moved|2|||
155088714|NCT02402647|559756103|FG001|Overall Study|Moved|0|||
155088715|NCT02402647|559756102|FG000|Overall Study|loved one illness|1|||
155088716|NCT02402647|559756103|FG001|Overall Study|loved one illness|0|||
155088717|NCT02402647|559756102|FG000|Overall Study|deceased preexisting condition|2|||
155088718|NCT02402647|559756103|FG001|Overall Study|deceased preexisting condition|0|||
155088719|NCT02402647|559756102|FG000|Overall Study|Other|2|||
155088720|NCT02402647|559756103|FG001|Overall Study|Other|1|||
155088721|NCT03211416|559756107|FG000|Overall Study|Adverse Event|7|||
155088722|NCT03211416|559756107|FG000|Overall Study|Lack of Efficacy|2|||
155088723|NCT03211416|559756107|FG000|Overall Study|Physician Decision|1|||
155088724|NCT03559556|559756111|FG000|Overall Study|Withdrawal by Subject|1|||
155088725|NCT01344356|559757383|FG000|Overall Study|Physician Decision|0|||
155088726|NCT01344356|559757384|FG001|Overall Study|Physician Decision|3|||
155088727|NCT01344356|559757383|FG000|Overall Study|Lost to Follow-up|0|||
155088728|NCT01344356|559757384|FG001|Overall Study|Lost to Follow-up|6|||
155088729|NCT00095576|559757385|FG000|Overall Study|Adverse Event|5|||
155088730|NCT00095576|559757386|FG001|Overall Study|Adverse Event|3|||
155088731|NCT00095576|559757385|FG000|Overall Study|Lost to Follow-up|233|||
154965199|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
155088732|NCT00095576|559757386|FG001|Overall Study|Lost to Follow-up|229|||
155088733|NCT00095576|559757385|FG000|Overall Study|Protocol Violation|1|||
155088734|NCT00095576|559757386|FG001|Overall Study|Protocol Violation|0|||
155088735|NCT00095576|559757385|FG000|Overall Study|Withdrawal by Subject|34|||
155088736|NCT00095576|559757386|FG001|Overall Study|Withdrawal by Subject|47|||
155088737|NCT00095576|559757385|FG000|Overall Study|Option to switch to a rollover study|1097|||
155088738|NCT00095576|559757386|FG001|Overall Study|Option to switch to a rollover study|1099|||
155088739|NCT00095576|559757385|FG000|Overall Study|Site terminated|75|||
155088740|NCT00095576|559757386|FG001|Overall Study|Site terminated|67|||
155088741|NCT00095576|559757385|FG000|Overall Study|Subject moved|30|||
155088742|NCT00095576|559757386|FG001|Overall Study|Subject moved|36|||
155088743|NCT02390076|559757390|FG000|Overall Study|Lost to Follow-up|2|||
155088744|NCT02390076|559757391|FG001|Overall Study|Lost to Follow-up|1|||
155361172|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
155361173|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
155361174|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
155361175|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
155361176|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
155361177|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
155361178|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
155361179|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
155361180|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
155361181|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
155361182|NCT00121667|560755564|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
155088745|NCT02390076|559757392|FG002|Overall Study|Lost to Follow-up|4|||
155088746|NCT01206517|559757393|FG000|Overall Study|Withdrawal by Subject|0|||
155088747|NCT01206517|559757394|FG001|Overall Study|Withdrawal by Subject|0|||
155088748|NCT01206517|559757395|FG002|Overall Study|Withdrawal by Subject|2|||
155088749|NCT01206517|559757396|FG003|Overall Study|Withdrawal by Subject|0|||
155088750|NCT01206517|559757397|FG004|Overall Study|Withdrawal by Subject|1|||
155088751|NCT01206517|559757398|FG005|Overall Study|Withdrawal by Subject|0|||
155088752|NCT01822925|559757401|FG000|Overall Study|Adverse Event|1|||
155088753|NCT01822925|559757402|FG001|Overall Study|Adverse Event|1|||
155088754|NCT01822925|559757403|FG002|Overall Study|Adverse Event|1|||
155088755|NCT01822925|559757404|FG003|Overall Study|Adverse Event|1|||
155088756|NCT01822925|559757401|FG000|Overall Study|Lost to Follow-up|0|||
155088757|NCT01822925|559757402|FG001|Overall Study|Lost to Follow-up|1|||
155088758|NCT01822925|559757403|FG002|Overall Study|Lost to Follow-up|0|||
155088759|NCT01822925|559757404|FG003|Overall Study|Lost to Follow-up|0|||
155088760|NCT01822925|559757401|FG000|Overall Study|Protocol Violation|1|||
155088761|NCT01822925|559757402|FG001|Overall Study|Protocol Violation|0|||
155088762|NCT01822925|559757403|FG002|Overall Study|Protocol Violation|0|||
155088763|NCT01822925|559757404|FG003|Overall Study|Protocol Violation|1|||
155088764|NCT01822925|559757401|FG000|Overall Study|Withdrawal by Subject|2|||
155088765|NCT01822925|559757402|FG001|Overall Study|Withdrawal by Subject|0|||
155088766|NCT01822925|559757403|FG002|Overall Study|Withdrawal by Subject|2|||
155088767|NCT01822925|559757404|FG003|Overall Study|Withdrawal by Subject|2|||
155361183|NCT00121667|560755565|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
155361184|NCT00121667|560755566|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
155361185|NCT00121667|560755567|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
155361186|NCT05186311|560755568|FG000|Part A: Serum|Withdrawal by Subject|1|||
155361187|NCT02879383|560755569|FG000|First 24 Weeks|Physician Decision|0|||
155361188|NCT02879383|560755570|FG001|First 24 Weeks|Physician Decision|1|||
155361189|NCT02879383|560755571|FG002|First 24 Weeks|Physician Decision|0|||
155361190|NCT02879383|560755572|FG003|First 24 Weeks|Physician Decision|0|||
155361191|NCT04468230|560755580|FG000|Overall Study|Adverse Event|2|||
155361192|NCT00983853|560755585|FG000|Overall Study|Lost to Follow-up|1|||
155361193|NCT00983853|560755586|FG001|Overall Study|Lost to Follow-up|1|||
155361194|NCT00983853|560755587|FG002|Overall Study|Lost to Follow-up|2|||
155361195|NCT00983853|560755588|FG003|Overall Study|Lost to Follow-up|2|||
155361196|NCT00983853|560755589|FG004|Overall Study|Lost to Follow-up|2|||
155361197|NCT00983853|560755590|FG005|Overall Study|Lost to Follow-up|1|||
155361198|NCT00983853|560755585|FG000|Overall Study|Withdrawal by Subject|0|||
155361199|NCT00983853|560755586|FG001|Overall Study|Withdrawal by Subject|0|||
155361200|NCT00983853|560755587|FG002|Overall Study|Withdrawal by Subject|1|||
155361201|NCT00983853|560755588|FG003|Overall Study|Withdrawal by Subject|0|||
155361202|NCT00983853|560755589|FG004|Overall Study|Withdrawal by Subject|1|||
155361203|NCT00983853|560755590|FG005|Overall Study|Withdrawal by Subject|0|||
155361204|NCT00983853|560755585|FG000|Overall Study|Unable to come to study follow-up visits|0|||
155361205|NCT00983853|560755586|FG001|Overall Study|Unable to come to study follow-up visits|1|||
155361206|NCT00983853|560755587|FG002|Overall Study|Unable to come to study follow-up visits|0|||
155361207|NCT00983853|560755588|FG003|Overall Study|Unable to come to study follow-up visits|0|||
155361208|NCT00983853|560755589|FG004|Overall Study|Unable to come to study follow-up visits|0|||
155088768|NCT01822925|559757401|FG000|Overall Study|Taking prohibited medication|2|||
155088769|NCT01822925|559757402|FG001|Overall Study|Taking prohibited medication|0|||
155088770|NCT01822925|559757403|FG002|Overall Study|Taking prohibited medication|0|||
155088771|NCT01822925|559757404|FG003|Overall Study|Taking prohibited medication|1|||
155088772|NCT01767987|559757407|FG000|Overall Study|Physician Decision|4|||
155088773|NCT01767987|559757408|FG001|Overall Study|Physician Decision|1|||
155088774|NCT01153516|559757409|FG000|Overall Study|Both subjects refused surgery|2|||
155361209|NCT00983853|560755590|FG005|Overall Study|Unable to come to study follow-up visits|0|||
155361210|NCT02599688|560755591|FG000|Overall Study|Lack of Efficacy|1|||
155361211|NCT02599688|560755591|FG000|Overall Study|Withdrawal by Subject|1|||
155361212|NCT02599688|560755591|FG000|Overall Study|Termination by Sponsor|2|||
155361213|NCT01318876|560755595|FG000|Day 8 Survey|email address invalid|96|||
155361214|NCT01318876|560755595|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
155361215|NCT01318876|560755595|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
155361216|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
155361217|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
155361218|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
155361219|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
155361220|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
155361221|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
155361222|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
155361223|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
155361224|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
155361225|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
155361226|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
155361227|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
155361228|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
155361229|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
155361230|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
155361231|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
155361232|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
155088775|NCT01153516|559757410|FG001|Overall Study|Both subjects refused surgery|0|||
155088776|NCT03038087|559757415|FG000|Overall Study|lost data|1|||
155088777|NCT00654355|559757416|FG000|Overall Study|Lost to Follow-up|2|||
155088778|NCT00654355|559757417|FG001|Overall Study|Lost to Follow-up|2|||
155088779|NCT00209131|559757432|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
155088780|NCT00209131|559757433|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
155088781|NCT05360784|559757434|FG000|Overall Study|Discontinued|25|||
155361233|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
155361234|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Missing|2|||
155361235|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Missing|1|||
155361236|NCT00443209|560755596|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
155361237|NCT00443209|560755597|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
155361238|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
155361239|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
155361240|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
155361241|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
155361242|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
155361243|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
155361244|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
155361245|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
155361246|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
155361247|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
155361248|NCT00443209|560755596|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
155361249|NCT00443209|560755597|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
155361250|NCT00224029|560755598|FG000|Overall Study|Lost to Follow-up|1|||
155361251|NCT00224029|560755598|FG000|Overall Study|Withdrawal by Subject|4|||
155361252|NCT00224029|560755598|FG000|Overall Study|Other|1|||
155361253|NCT04016272|560755600|FG000|Overall Study|Withdrawal by Subject|1|||
155361254|NCT04016272|560755601|FG001|Overall Study|Withdrawal by Subject|2|||
155361255|NCT00763451|560755609|FG000|Overall Study|Adverse Event|4|||
155361256|NCT00763451|560755610|FG001|Overall Study|Adverse Event|6|||
155361257|NCT00763451|560755611|FG002|Overall Study|Adverse Event|19|||
155361258|NCT00763451|560755612|FG003|Overall Study|Adverse Event|14|||
155361259|NCT00763451|560755609|FG000|Overall Study|Lack of Efficacy|1|||
155361260|NCT00763451|560755610|FG001|Overall Study|Lack of Efficacy|4|||
155361261|NCT00763451|560755611|FG002|Overall Study|Lack of Efficacy|3|||
155088782|NCT05360784|559757435|FG001|Overall Study|Discontinued|11|||
155088783|NCT00437073|559757436|FG000|Overall Study|Sponsor Terminated Study|1|||
155088784|NCT00437073|559757437|FG001|Overall Study|Sponsor Terminated Study|0|||
155088785|NCT00437073|559757436|FG000|Overall Study|Physician Decision|0|||
155088786|NCT00437073|559757437|FG001|Overall Study|Physician Decision|1|||
155088787|NCT04875533|559757438|FG000|Overall Study|Adverse Event|6|||
155088788|NCT04875533|559757439|FG001|Overall Study|Adverse Event|4|||
155088789|NCT04875533|559757438|FG000|Overall Study|Protocol Violation|4|||
155361262|NCT00763451|560755612|FG003|Overall Study|Lack of Efficacy|2|||
155361263|NCT00763451|560755609|FG000|Overall Study|Withdrawal by Subject|1|||
155361264|NCT00763451|560755610|FG001|Overall Study|Withdrawal by Subject|6|||
155361265|NCT00763451|560755611|FG002|Overall Study|Withdrawal by Subject|9|||
155361266|NCT00763451|560755612|FG003|Overall Study|Withdrawal by Subject|7|||
155361267|NCT00763451|560755609|FG000|Overall Study|Protocol Violation|0|||
155361268|NCT00763451|560755610|FG001|Overall Study|Protocol Violation|0|||
155361269|NCT00763451|560755611|FG002|Overall Study|Protocol Violation|1|||
155361270|NCT00763451|560755612|FG003|Overall Study|Protocol Violation|0|||
155166111|NCT00485134|560046187|FG000|Overall Study|Change in health status|0|||
155166112|NCT00485134|560046188|FG001|Overall Study|Change in health status|1|||
155166113|NCT00485134|560046189|FG002|Overall Study|Change in health status|2|||
155166114|NCT00485134|560046190|FG003|Overall Study|Change in health status|1|||
155166115|NCT00485134|560046191|FG004|Overall Study|Change in health status|0|||
155166116|NCT00485134|560046192|FG005|Overall Study|Change in health status|1|||
155166117|NCT00485134|560046193|FG006|Overall Study|Change in health status|0|||
155166118|NCT00485134|560046194|FG007|Overall Study|Change in health status|0|||
155166119|NCT00485134|560046187|FG000|Overall Study|Withdrew for adverse event|0|||
155166120|NCT00485134|560046188|FG001|Overall Study|Withdrew for adverse event|0|||
155166121|NCT00485134|560046189|FG002|Overall Study|Withdrew for adverse event|1|||
155166122|NCT00485134|560046190|FG003|Overall Study|Withdrew for adverse event|0|||
155166123|NCT00485134|560046191|FG004|Overall Study|Withdrew for adverse event|0|||
155166124|NCT00485134|560046192|FG005|Overall Study|Withdrew for adverse event|0|||
155361271|NCT00763451|560755609|FG000|Overall Study|Poor Compliance to Protocol|1|||
155361272|NCT00763451|560755610|FG001|Overall Study|Poor Compliance to Protocol|1|||
155361273|NCT00763451|560755611|FG002|Overall Study|Poor Compliance to Protocol|2|||
155361274|NCT00763451|560755612|FG003|Overall Study|Poor Compliance to Protocol|2|||
155361275|NCT00763451|560755609|FG000|Overall Study|Familial and Personal Reasons|5|||
155361276|NCT00763451|560755610|FG001|Overall Study|Familial and Personal Reasons|3|||
155361277|NCT00763451|560755611|FG002|Overall Study|Familial and Personal Reasons|5|||
155361278|NCT00763451|560755612|FG003|Overall Study|Familial and Personal Reasons|4|||
155361279|NCT00763451|560755609|FG000|Overall Study|Randomized but not Treated|1|||
155361280|NCT00763451|560755610|FG001|Overall Study|Randomized but not Treated|1|||
155361281|NCT00763451|560755611|FG002|Overall Study|Randomized but not Treated|0|||
155361282|NCT00763451|560755612|FG003|Overall Study|Randomized but not Treated|0|||
155361283|NCT00763451|560755609|FG000|Overall Study|Study Site Reason|0|||
155361284|NCT00763451|560755610|FG001|Overall Study|Study Site Reason|1|||
155361285|NCT00763451|560755611|FG002|Overall Study|Study Site Reason|1|||
155361286|NCT00763451|560755612|FG003|Overall Study|Study Site Reason|1|||
155361287|NCT01827046|560755613|FG000|Overall Study|Lost to Follow-up|1|||
155361288|NCT01827046|560755614|FG001|Overall Study|Lost to Follow-up|5|||
155361289|NCT01827046|560755613|FG000|Overall Study|Withdrawal by Subject|0|||
155361290|NCT01827046|560755614|FG001|Overall Study|Withdrawal by Subject|4|||
155361291|NCT02282917|560755622|FG000|Overall Study|Withdrawal by Subject|1|||
155361292|NCT02282917|560755622|FG000|Overall Study|Screen Failure/Not Eligible|1|||
154965200|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965201|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965202|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
155088790|NCT04875533|559757439|FG001|Overall Study|Protocol Violation|0|||
155088791|NCT04875533|559757438|FG000|Overall Study|Withdrawal by Subject|8|||
155088792|NCT04875533|559757439|FG001|Overall Study|Withdrawal by Subject|5|||
155088793|NCT04875533|559757438|FG000|Overall Study|No longer meets eligibility criteria|1|||
155088794|NCT04875533|559757439|FG001|Overall Study|No longer meets eligibility criteria|0|||
155088795|NCT04875533|559757438|FG000|Overall Study|Other|0|||
155088796|NCT04875533|559757439|FG001|Overall Study|Other|2|||
155088797|NCT04918771|559757440|FG000|Overall Study|Withdrawal by Subject|4|||
155088798|NCT04918771|559757441|FG001|Overall Study|Withdrawal by Subject|5|||
155088799|NCT04918771|559757440|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
155088800|NCT04918771|559757441|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
155088801|NCT00539500|559757444|FG000|Overall Study|Disease Progression|1|||
155088802|NCT00539500|559757444|FG000|Overall Study|Lost to Follow-up|2|||
155088803|NCT02657343|559757445|FG000|Overall Study|Death|0|||
155088804|NCT02657343|559757446|FG001|Overall Study|Death|2|||
155088805|NCT02657343|559757447|FG002|Overall Study|Death|0|||
155088806|NCT02657343|559757448|FG003|Overall Study|Death|0|||
155088807|NCT02657343|559757449|FG004|Overall Study|Death|0|||
155088808|NCT02657343|559757450|FG005|Overall Study|Death|0|||
155088809|NCT02657343|559757445|FG000|Overall Study|Patient went to hospice|1|||
155088810|NCT02657343|559757446|FG001|Overall Study|Patient went to hospice|0|||
155088811|NCT02657343|559757447|FG002|Overall Study|Patient went to hospice|0|||
155088812|NCT02657343|559757448|FG003|Overall Study|Patient went to hospice|0|||
155088813|NCT02657343|559757449|FG004|Overall Study|Patient went to hospice|0|||
155088814|NCT02657343|559757450|FG005|Overall Study|Patient went to hospice|0|||
155088815|NCT02657343|559757445|FG000|Overall Study|Withdrawal by Subject|0|||
155166125|NCT00485134|560046193|FG006|Overall Study|Withdrew for adverse event|0|||
155361293|NCT00115336|560755623|FG000|Overall Study|Hospital discharge before study drug|0|||
154965203|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
155088816|NCT02657343|559757446|FG001|Overall Study|Withdrawal by Subject|0|||
155088817|NCT02657343|559757447|FG002|Overall Study|Withdrawal by Subject|0|||
155088818|NCT02657343|559757448|FG003|Overall Study|Withdrawal by Subject|0|||
155166126|NCT00485134|560046194|FG007|Overall Study|Withdrew for adverse event|0|||
155166127|NCT00485134|560046187|FG000|Overall Study|Positive drug test|0|||
155361294|NCT00115336|560755624|FG001|Overall Study|Hospital discharge before study drug|1|||
155361295|NCT02165826|560755633|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
154965204|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965205|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965206|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965207|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965208|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965209|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965210|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965211|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965212|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965213|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965214|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965215|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965216|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965217|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965218|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965219|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
154965220|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965221|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
154965222|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965223|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965224|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965225|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965226|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965227|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965228|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965229|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965230|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965231|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965232|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965233|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965234|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965235|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965236|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965237|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965238|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965239|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965240|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155088819|NCT02657343|559757449|FG004|Overall Study|Withdrawal by Subject|1|||
155088820|NCT02657343|559757450|FG005|Overall Study|Withdrawal by Subject|0|||
155088821|NCT01299961|559757453|FG000|Overall Study|Adverse Event|3|||
155088822|NCT01299961|559757453|FG000|Overall Study|Lack of Efficacy|2|||
155088823|NCT01299961|559757453|FG000|Overall Study|Lost to Follow-up|1|||
155088824|NCT02904096|559757454|FG000|Overall Study|Adverse Event|1|||
155088825|NCT02904096|559757455|FG001|Overall Study|Adverse Event|0|||
155088826|NCT02904096|559757454|FG000|Overall Study|Withdrawal by Subject|4|||
155088827|NCT02904096|559757455|FG001|Overall Study|Withdrawal by Subject|3|||
155088828|NCT02904096|559757454|FG000|Overall Study|Lost to Follow-up|10|||
155088829|NCT02904096|559757455|FG001|Overall Study|Lost to Follow-up|17|||
155088830|NCT02904096|559757454|FG000|Overall Study|Non-compliant|3|||
155088831|NCT02904096|559757455|FG001|Overall Study|Non-compliant|1|||
155088832|NCT02904096|559757454|FG000|Overall Study|Sponsor instructed|1|||
155088833|NCT02904096|559757455|FG001|Overall Study|Sponsor instructed|0|||
155088834|NCT00663260|559757457|FG000|Overall Study|Lack of Efficacy|2|||
155088835|NCT00663260|559757458|FG001|Overall Study|Lack of Efficacy|0|||
155088836|NCT00663260|559757459|FG002|Overall Study|Lack of Efficacy|0|||
155088837|NCT00663260|559757457|FG000|Overall Study|Adverse Event|12|||
155088838|NCT00663260|559757458|FG001|Overall Study|Adverse Event|7|||
155088839|NCT00663260|559757459|FG002|Overall Study|Adverse Event|6|||
155088840|NCT00663260|559757457|FG000|Overall Study|Withdrawal by Subject|3|||
155088841|NCT00663260|559757458|FG001|Overall Study|Withdrawal by Subject|1|||
155088842|NCT00663260|559757459|FG002|Overall Study|Withdrawal by Subject|6|||
155088843|NCT00663260|559757457|FG000|Overall Study|Death|1|||
155088844|NCT00663260|559757458|FG001|Overall Study|Death|0|||
155166128|NCT00485134|560046188|FG001|Overall Study|Positive drug test|0|||
155361296|NCT02165826|560755634|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
154965241|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965242|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965243|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155088845|NCT00663260|559757459|FG002|Overall Study|Death|1|||
155088846|NCT00663260|559757457|FG000|Overall Study|Lost to Follow-up|0|||
154965244|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
154965245|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
155088847|NCT00663260|559757458|FG001|Overall Study|Lost to Follow-up|1|||
155088848|NCT00663260|559757459|FG002|Overall Study|Lost to Follow-up|0|||
155088849|NCT00663260|559757457|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
155166129|NCT00485134|560046189|FG002|Overall Study|Positive drug test|0|||
155166130|NCT00485134|560046190|FG003|Overall Study|Positive drug test|0|||
155166131|NCT00485134|560046191|FG004|Overall Study|Positive drug test|2|||
155166132|NCT00485134|560046192|FG005|Overall Study|Positive drug test|1|||
155166133|NCT00485134|560046193|FG006|Overall Study|Positive drug test|0|||
155166134|NCT00485134|560046194|FG007|Overall Study|Positive drug test|0|||
155166135|NCT00485134|560046187|FG000|Overall Study|Non-compliance|0|||
155166136|NCT00485134|560046188|FG001|Overall Study|Non-compliance|0|||
155166137|NCT00485134|560046189|FG002|Overall Study|Non-compliance|0|||
155166138|NCT00485134|560046190|FG003|Overall Study|Non-compliance|0|||
155166139|NCT00485134|560046191|FG004|Overall Study|Non-compliance|1|||
155166140|NCT00485134|560046192|FG005|Overall Study|Non-compliance|2|||
155361297|NCT02165826|560755635|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
155361298|NCT02165826|560755633|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
155361299|NCT02165826|560755634|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
155361300|NCT02165826|560755635|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
155361301|NCT02165826|560755633|FG000|Main Treatment Period|Lost to Follow-up|4|||
155361302|NCT02165826|560755634|FG001|Main Treatment Period|Lost to Follow-up|2|||
155088850|NCT00663260|559757458|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
155088851|NCT00663260|559757459|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
155088852|NCT01979185|559757463|FG000|Period 2|Other|0|||
155088853|NCT01979185|559757464|FG001|Period 2|Other|1|||
155088854|NCT00980798|559757465|FG000|Overall Study|Adverse Event|7|||
155088855|NCT00980798|559757466|FG001|Overall Study|Adverse Event|36|||
155088856|NCT00980798|559757465|FG000|Overall Study|Lack of Efficacy|16|||
155088857|NCT00980798|559757466|FG001|Overall Study|Lack of Efficacy|5|||
155088858|NCT00980798|559757465|FG000|Overall Study|Lost to Follow-up|0|||
155088859|NCT00980798|559757466|FG001|Overall Study|Lost to Follow-up|1|||
155088860|NCT00980798|559757465|FG000|Overall Study|Physician Decision|2|||
155088861|NCT00980798|559757466|FG001|Overall Study|Physician Decision|1|||
155088862|NCT00980798|559757465|FG000|Overall Study|Withdrawal by Subject|8|||
155088863|NCT00980798|559757466|FG001|Overall Study|Withdrawal by Subject|11|||
155088864|NCT00980798|559757465|FG000|Overall Study|Other|0|||
155088865|NCT00980798|559757466|FG001|Overall Study|Other|1|||
155088866|NCT04347538|559757469|FG000|Overall Study|Lost to Follow-up|4|||
155088867|NCT04347538|559757470|FG001|Overall Study|Lost to Follow-up|5|||
155088868|NCT04347538|559757471|FG002|Overall Study|Lost to Follow-up|7|||
155088869|NCT02135133|559757472|FG000|Overall Study|Adverse Event|10|||
155088870|NCT02135133|559757472|FG000|Overall Study|regulatory mandate|5|||
155088871|NCT02259231|559757473|FG000|Overall Study|Adverse Event|1|||
155088872|NCT02259231|559757474|FG001|Overall Study|Adverse Event|1|||
155088873|NCT02259231|559757475|FG002|Overall Study|Adverse Event|2|||
155088874|NCT02259231|559757476|FG003|Overall Study|Adverse Event|0|||
155088875|NCT02259231|559757477|FG004|Overall Study|Adverse Event|0|||
155088876|NCT02259231|559757478|FG005|Overall Study|Adverse Event|0|||
155088877|NCT02259231|559757479|FG006|Overall Study|Adverse Event|0|||
155088878|NCT02259231|559757473|FG000|Overall Study|Progressive Disease|4|||
155088879|NCT02259231|559757474|FG001|Overall Study|Progressive Disease|5|||
155088880|NCT02259231|559757475|FG002|Overall Study|Progressive Disease|4|||
155088881|NCT02259231|559757476|FG003|Overall Study|Progressive Disease|5|||
155088882|NCT02259231|559757477|FG004|Overall Study|Progressive Disease|4|||
155088883|NCT02259231|559757478|FG005|Overall Study|Progressive Disease|5|||
155088884|NCT02259231|559757479|FG006|Overall Study|Progressive Disease|4|||
155088885|NCT02259231|559757473|FG000|Overall Study|Sponsor termination of study|1|||
155088886|NCT02259231|559757474|FG001|Overall Study|Sponsor termination of study|0|||
155088887|NCT02259231|559757475|FG002|Overall Study|Sponsor termination of study|0|||
155088888|NCT02259231|559757476|FG003|Overall Study|Sponsor termination of study|1|||
155088889|NCT02259231|559757477|FG004|Overall Study|Sponsor termination of study|2|||
155088890|NCT02259231|559757478|FG005|Overall Study|Sponsor termination of study|1|||
155088891|NCT02259231|559757479|FG006|Overall Study|Sponsor termination of study|1|||
155088892|NCT03238196|559757480|FG000|Overall Study|Adverse Event|3|||
155166141|NCT00485134|560046193|FG006|Overall Study|Non-compliance|2|||
155361303|NCT02165826|560755635|FG002|Main Treatment Period|Lost to Follow-up|1|||
155088893|NCT03238196|559757481|FG001|Overall Study|Adverse Event|0|||
155088894|NCT03238196|559757482|FG002|Overall Study|Adverse Event|2|||
155166142|NCT00485134|560046194|FG007|Overall Study|Non-compliance|0|||
155166143|NCT00485134|560046187|FG000|Overall Study|Unable to comply with study schedule|0|||
155166144|NCT00485134|560046188|FG001|Overall Study|Unable to comply with study schedule|0|||
155088895|NCT03238196|559757483|FG003|Overall Study|Adverse Event|2|||
155088896|NCT03238196|559757480|FG000|Overall Study|Withdrawal by Subject|4|||
155088897|NCT03238196|559757481|FG001|Overall Study|Withdrawal by Subject|1|||
155088898|NCT03238196|559757482|FG002|Overall Study|Withdrawal by Subject|1|||
155088899|NCT03238196|559757483|FG003|Overall Study|Withdrawal by Subject|0|||
155166145|NCT00485134|560046189|FG002|Overall Study|Unable to comply with study schedule|0|||
155166146|NCT00485134|560046190|FG003|Overall Study|Unable to comply with study schedule|0|||
155166147|NCT00485134|560046191|FG004|Overall Study|Unable to comply with study schedule|0|||
155166148|NCT00485134|560046192|FG005|Overall Study|Unable to comply with study schedule|0|||
155361304|NCT02165826|560755633|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
155361305|NCT02165826|560755634|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
155166149|NCT00485134|560046193|FG006|Overall Study|Unable to comply with study schedule|0|||
155166150|NCT00485134|560046194|FG007|Overall Study|Unable to comply with study schedule|1|||
155361306|NCT02165826|560755635|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
155361307|NCT02165826|560755633|FG000|Main Treatment Period|Lack of Efficacy|2|||
155361308|NCT02165826|560755634|FG001|Main Treatment Period|Lack of Efficacy|0|||
155361309|NCT02165826|560755635|FG002|Main Treatment Period|Lack of Efficacy|0|||
155361310|NCT02165826|560755633|FG000|Main Treatment Period|Reason Not Specified|8|||
155361311|NCT02165826|560755634|FG001|Main Treatment Period|Reason Not Specified|5|||
155166151|NCT00485134|560046187|FG000|Overall Study|Pregnancy|0|||
155166152|NCT00485134|560046188|FG001|Overall Study|Pregnancy|0|||
155166153|NCT00485134|560046189|FG002|Overall Study|Pregnancy|0|||
155166154|NCT00485134|560046190|FG003|Overall Study|Pregnancy|0|||
155166155|NCT00485134|560046191|FG004|Overall Study|Pregnancy|0|||
155166156|NCT00485134|560046192|FG005|Overall Study|Pregnancy|0|||
155166157|NCT00485134|560046193|FG006|Overall Study|Pregnancy|1|||
155166158|NCT00485134|560046194|FG007|Overall Study|Pregnancy|0|||
155166159|NCT00481091|560046195|FG000|Overall Study|Withdrawal by Subject|0|||
155166160|NCT00481091|560046196|FG001|Overall Study|Withdrawal by Subject|1|||
155166161|NCT00481091|560046197|FG002|Overall Study|Withdrawal by Subject|1|||
155361312|NCT02165826|560755635|FG002|Main Treatment Period|Reason Not Specified|16|||
155361313|NCT02165826|560755633|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
155166162|NCT00481091|560046198|FG003|Overall Study|Withdrawal by Subject|0|||
155166163|NCT00481091|560046199|FG004|Overall Study|Withdrawal by Subject|0|||
155166164|NCT00481091|560046200|FG005|Overall Study|Withdrawal by Subject|0|||
155166165|NCT00481091|560046201|FG006|Overall Study|Withdrawal by Subject|0|||
155166166|NCT00481091|560046202|FG007|Overall Study|Withdrawal by Subject|0|||
155166167|NCT00481091|560046203|FG008|Overall Study|Withdrawal by Subject|1|||
155166168|NCT00481091|560046204|FG009|Overall Study|Withdrawal by Subject|6|||
155166169|NCT00481091|560046195|FG000|Overall Study|Other, Not Specified|0|||
155166170|NCT00481091|560046196|FG001|Overall Study|Other, Not Specified|1|||
155166171|NCT00481091|560046197|FG002|Overall Study|Other, Not Specified|1|||
155166172|NCT00481091|560046198|FG003|Overall Study|Other, Not Specified|0|||
155166173|NCT00481091|560046199|FG004|Overall Study|Other, Not Specified|0|||
155361314|NCT02165826|560755634|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
155361315|NCT02165826|560755635|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
155361316|NCT02165826|560755633|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
155361317|NCT02165826|560755634|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
155361318|NCT02165826|560755635|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
155361319|NCT02165826|560755633|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
155361320|NCT02165826|560755634|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
155361321|NCT02165826|560755635|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
155361322|NCT02165826|560755633|FG000|Down-Titration Period|Reason Not Specified|1|||
155361323|NCT02165826|560755634|FG001|Down-Titration Period|Reason Not Specified|0|||
155361324|NCT02165826|560755635|FG002|Down-Titration Period|Reason Not Specified|2|||
155361325|NCT03698019|560755636|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
155361326|NCT03698019|560755637|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
155361327|NCT03698019|560755636|FG000|Step 1: Registration|Withdrawal by Subject|7|||
155361328|NCT03698019|560755637|FG001|Step 1: Registration|Withdrawal by Subject|2|||
155361329|NCT03698019|560755636|FG000|Step 1: Registration|Toxicity|0|||
155361330|NCT03698019|560755637|FG001|Step 1: Registration|Toxicity|1|||
155361331|NCT03698019|560755636|FG000|Step 1: Registration|Disease Progression|0|||
155361332|NCT03698019|560755637|FG001|Step 1: Registration|Disease Progression|12|||
155361333|NCT03698019|560755636|FG000|Step 1: Registration|Co-morbidities|0|||
155361334|NCT03698019|560755637|FG001|Step 1: Registration|Co-morbidities|1|||
155361335|NCT03698019|560755636|FG000|Step 1: Registration|Scheduling Issues|1|||
155166174|NCT00481091|560046200|FG005|Overall Study|Other, Not Specified|1|||
155166175|NCT00481091|560046201|FG006|Overall Study|Other, Not Specified|0|||
155166176|NCT00481091|560046202|FG007|Overall Study|Other, Not Specified|0|||
155166177|NCT00481091|560046203|FG008|Overall Study|Other, Not Specified|0|||
155361336|NCT03698019|560755637|FG001|Step 1: Registration|Scheduling Issues|0|||
155166178|NCT00481091|560046204|FG009|Overall Study|Other, Not Specified|4|||
155166179|NCT00481091|560046195|FG000|Overall Study|Adverse Event|1|||
155166180|NCT00481091|560046196|FG001|Overall Study|Adverse Event|2|||
155166181|NCT00481091|560046197|FG002|Overall Study|Adverse Event|0|||
155361337|NCT03698019|560755636|FG000|Step 1: Registration|Participant Refusal|0|||
155361338|NCT03698019|560755637|FG001|Step 1: Registration|Participant Refusal|1|||
155361339|NCT03698019|560755636|FG000|Step 2: Surgery|Participant Refusal|2|||
155088900|NCT03238196|559757480|FG000|Overall Study|Disease progression|14|||
155088901|NCT03238196|559757481|FG001|Overall Study|Disease progression|2|||
155088902|NCT03238196|559757482|FG002|Overall Study|Disease progression|3|||
155361340|NCT03698019|560755637|FG001|Step 2: Surgery|Participant Refusal|1|||
155361341|NCT03698019|560755636|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
155361342|NCT03698019|560755637|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
155361343|NCT03698019|560755636|FG000|Step 2: Surgery|Metastatic Disease|16|||
155361344|NCT03698019|560755637|FG001|Step 2: Surgery|Metastatic Disease|9|||
155361345|NCT03698019|560755636|FG000|Step 2: Surgery|Residual Disease|2|||
155361346|NCT03698019|560755637|FG001|Step 2: Surgery|Residual Disease|1|||
155361347|NCT03698019|560755636|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
155361348|NCT03698019|560755637|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
155361349|NCT03698019|560755636|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
155361350|NCT03698019|560755637|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
155361351|NCT03698019|560755636|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
155361352|NCT03698019|560755637|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
155361353|NCT03698019|560755636|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
155361354|NCT03698019|560755637|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
155361355|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
155361356|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
155361357|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
155361358|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
155361359|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
155361360|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
155361361|NCT03698019|560755636|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
155361362|NCT03698019|560755637|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
155361363|NCT03569891|560755638|FG000|Lead-in|Ineligible during lead-in|8|||
155361364|NCT03569891|560755638|FG000|Lead-in|Withdrawal by Subject|3|||
155361365|NCT03569891|560755638|FG000|Lead-in|Risks related to COVID-19|2|||
155361366|NCT03569891|560755638|FG000|AMT-061|Adverse Event|1|||
155361367|NCT02176863|560755639|FG000|Overall Study|Physician Decision|1|||
155361368|NCT02176863|560755640|FG001|Overall Study|Physician Decision|0|||
155361369|NCT02176863|560755641|FG002|Overall Study|Physician Decision|0|||
155361370|NCT02176863|560755642|FG003|Overall Study|Physician Decision|0|||
155361371|NCT02176863|560755643|FG004|Overall Study|Physician Decision|0|||
155361372|NCT02176863|560755639|FG000|Overall Study|Adverse Event|10|||
155361373|NCT02176863|560755640|FG001|Overall Study|Adverse Event|4|||
155088903|NCT03238196|559757483|FG003|Overall Study|Disease progression|2|||
155088904|NCT03238196|559757480|FG000|Overall Study|Still on treatment|1|||
155361374|NCT02176863|560755641|FG002|Overall Study|Adverse Event|4|||
155088905|NCT03238196|559757481|FG001|Overall Study|Still on treatment|0|||
155361375|NCT02176863|560755642|FG003|Overall Study|Adverse Event|1|||
155361376|NCT02176863|560755643|FG004|Overall Study|Adverse Event|1|||
155361377|NCT02176863|560755639|FG000|Overall Study|Protocol Violation|2|||
155361378|NCT02176863|560755640|FG001|Overall Study|Protocol Violation|0|||
155361379|NCT02176863|560755641|FG002|Overall Study|Protocol Violation|1|||
155361380|NCT02176863|560755642|FG003|Overall Study|Protocol Violation|1|||
155361381|NCT02176863|560755643|FG004|Overall Study|Protocol Violation|0|||
155361382|NCT02176863|560755639|FG000|Overall Study|Withdrawal by Subject|4|||
155361383|NCT02176863|560755640|FG001|Overall Study|Withdrawal by Subject|2|||
155361384|NCT02176863|560755641|FG002|Overall Study|Withdrawal by Subject|2|||
155361385|NCT02176863|560755642|FG003|Overall Study|Withdrawal by Subject|3|||
155361386|NCT02176863|560755643|FG004|Overall Study|Withdrawal by Subject|4|||
155361387|NCT02176863|560755639|FG000|Overall Study|Reason not specified|0|||
155361388|NCT02176863|560755640|FG001|Overall Study|Reason not specified|1|||
155361389|NCT02176863|560755641|FG002|Overall Study|Reason not specified|1|||
155361390|NCT02176863|560755642|FG003|Overall Study|Reason not specified|2|||
155361391|NCT02176863|560755643|FG004|Overall Study|Reason not specified|1|||
155361392|NCT02176863|560755639|FG000|Overall Study|Lost to Follow-up|0|||
155361393|NCT02176863|560755640|FG001|Overall Study|Lost to Follow-up|1|||
155088906|NCT03238196|559757482|FG002|Overall Study|Still on treatment|0|||
155088907|NCT03238196|559757483|FG003|Overall Study|Still on treatment|0|||
155361394|NCT02176863|560755641|FG002|Overall Study|Lost to Follow-up|1|||
155361395|NCT02176863|560755642|FG003|Overall Study|Lost to Follow-up|0|||
155361396|NCT02176863|560755643|FG004|Overall Study|Lost to Follow-up|0|||
155361397|NCT02419417|560757307|FG000|Overall Study|Disease progression|5|||
155361398|NCT02419417|560757308|FG001|Overall Study|Disease progression|4|||
155361399|NCT02419417|560757309|FG002|Overall Study|Disease progression|13|||
155361400|NCT02419417|560757310|FG003|Overall Study|Disease progression|10|||
155361401|NCT02419417|560757311|FG004|Overall Study|Disease progression|10|||
155361402|NCT02419417|560757312|FG005|Overall Study|Disease progression|3|||
155361403|NCT02419417|560757313|FG006|Overall Study|Disease progression|4|||
155361404|NCT02419417|560757314|FG007|Overall Study|Disease progression|5|||
155361405|NCT02419417|560757315|FG008|Overall Study|Disease progression|13|||
155361406|NCT02419417|560757316|FG009|Overall Study|Disease progression|9|||
155361407|NCT02419417|560757317|FG010|Overall Study|Disease progression|0|||
155361408|NCT02419417|560757307|FG000|Overall Study|Study drug toxicity|0|||
155361409|NCT02419417|560757308|FG001|Overall Study|Study drug toxicity|0|||
155361410|NCT02419417|560757309|FG002|Overall Study|Study drug toxicity|0|||
155361411|NCT02419417|560757310|FG003|Overall Study|Study drug toxicity|0|||
155361412|NCT02419417|560757311|FG004|Overall Study|Study drug toxicity|1|||
155361413|NCT02419417|560757312|FG005|Overall Study|Study drug toxicity|0|||
155361414|NCT02419417|560757313|FG006|Overall Study|Study drug toxicity|0|||
155361415|NCT02419417|560757314|FG007|Overall Study|Study drug toxicity|0|||
155361416|NCT02419417|560757315|FG008|Overall Study|Study drug toxicity|0|||
155361417|NCT02419417|560757316|FG009|Overall Study|Study drug toxicity|0|||
155361418|NCT02419417|560757317|FG010|Overall Study|Study drug toxicity|0|||
155361419|NCT02419417|560757307|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155361420|NCT02419417|560757308|FG001|Overall Study|Adverse event unrelated to study drug|0|||
155361421|NCT02419417|560757309|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155361422|NCT02419417|560757310|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155361423|NCT02419417|560757311|FG004|Overall Study|Adverse event unrelated to study drug|2|||
155361424|NCT02419417|560757312|FG005|Overall Study|Adverse event unrelated to study drug|1|||
155361425|NCT02419417|560757313|FG006|Overall Study|Adverse event unrelated to study drug|0|||
155361426|NCT02419417|560757314|FG007|Overall Study|Adverse event unrelated to study drug|1|||
155361427|NCT02419417|560757315|FG008|Overall Study|Adverse event unrelated to study drug|0|||
155361428|NCT02419417|560757316|FG009|Overall Study|Adverse event unrelated to study drug|0|||
155361429|NCT02419417|560757317|FG010|Overall Study|Adverse event unrelated to study drug|0|||
155361430|NCT02419417|560757307|FG000|Overall Study|Participant request to discontinue|0|||
155361431|NCT02419417|560757308|FG001|Overall Study|Participant request to discontinue|0|||
155361432|NCT02419417|560757309|FG002|Overall Study|Participant request to discontinue|0|||
155361433|NCT02419417|560757310|FG003|Overall Study|Participant request to discontinue|0|||
155361434|NCT02419417|560757311|FG004|Overall Study|Participant request to discontinue|0|||
155361435|NCT02419417|560757312|FG005|Overall Study|Participant request to discontinue|0|||
155361436|NCT02419417|560757313|FG006|Overall Study|Participant request to discontinue|0|||
155361437|NCT02419417|560757314|FG007|Overall Study|Participant request to discontinue|0|||
155361438|NCT02419417|560757315|FG008|Overall Study|Participant request to discontinue|0|||
155361439|NCT02419417|560757316|FG009|Overall Study|Participant request to discontinue|1|||
155361440|NCT02419417|560757317|FG010|Overall Study|Participant request to discontinue|0|||
155361441|NCT02419417|560757307|FG000|Overall Study|Withdrawal by Subject|0|||
155361442|NCT02419417|560757308|FG001|Overall Study|Withdrawal by Subject|0|||
155361443|NCT02419417|560757309|FG002|Overall Study|Withdrawal by Subject|0|||
155361444|NCT02419417|560757310|FG003|Overall Study|Withdrawal by Subject|0|||
155361445|NCT02419417|560757311|FG004|Overall Study|Withdrawal by Subject|0|||
155361446|NCT02419417|560757312|FG005|Overall Study|Withdrawal by Subject|0|||
155361447|NCT02419417|560757313|FG006|Overall Study|Withdrawal by Subject|0|||
155361448|NCT02419417|560757314|FG007|Overall Study|Withdrawal by Subject|0|||
155361449|NCT02419417|560757315|FG008|Overall Study|Withdrawal by Subject|0|||
155361450|NCT02419417|560757316|FG009|Overall Study|Withdrawal by Subject|0|||
155361451|NCT02419417|560757317|FG010|Overall Study|Withdrawal by Subject|1|||
155361452|NCT01240551|560757318|FG000|Overall Study|Refused further treatment|3|||
155361453|NCT01240551|560757319|FG001|Overall Study|Refused further treatment|2|||
155361454|NCT01240551|560757318|FG000|Overall Study|Lost to Follow-up|1|||
155361455|NCT01240551|560757319|FG001|Overall Study|Lost to Follow-up|1|||
155361456|NCT03945773|560757326|FG000|Overall Study|Consent Withdrawn|1|||
155361457|NCT03945773|560757327|FG001|Overall Study|Consent Withdrawn|1|||
155361458|NCT03945773|560757326|FG000|Overall Study|Lost to Follow-up|1|||
155361459|NCT03945773|560757327|FG001|Overall Study|Lost to Follow-up|0|||
155361460|NCT03945773|560757326|FG000|Overall Study|Death|46|||
155361461|NCT03945773|560757327|FG001|Overall Study|Death|22|||
155361462|NCT03945773|560757326|FG000|Overall Study|Physician Decision|1|||
155361463|NCT03945773|560757327|FG001|Overall Study|Physician Decision|0|||
155361464|NCT03945773|560757326|FG000|Overall Study|Other|1|||
155361465|NCT03945773|560757327|FG001|Overall Study|Other|0|||
155361466|NCT03945773|560757326|FG000|Overall Study|Ongoing at the time of DCO|4|||
155361467|NCT03945773|560757327|FG001|Overall Study|Ongoing at the time of DCO|3|||
155361468|NCT00725712|560757328|FG000|Overall Study|Withdrawal by Subject|2|||
155361469|NCT00725712|560757329|FG001|Overall Study|Withdrawal by Subject|1|||
155361470|NCT00725712|560757328|FG000|Overall Study|Protocol Violation|1|||
155361471|NCT00725712|560757329|FG001|Overall Study|Protocol Violation|0|||
155361472|NCT00725712|560757328|FG000|Overall Study|Progressive disease|37|||
155361473|NCT00725712|560757329|FG001|Overall Study|Progressive disease|16|||
155361474|NCT00725712|560757328|FG000|Overall Study|Clinical progression not based on RECIST|0|||
155361475|NCT00725712|560757329|FG001|Overall Study|Clinical progression not based on RECIST|3|||
155361476|NCT00725712|560757328|FG000|Overall Study|Adverse Event|5|||
155361477|NCT00725712|560757329|FG001|Overall Study|Adverse Event|5|||
155361478|NCT00725712|560757328|FG000|Overall Study|Death|2|||
155361479|NCT00725712|560757329|FG001|Overall Study|Death|0|||
155361480|NCT00725712|560757328|FG000|Overall Study|Other: Death|1|||
155361481|NCT00725712|560757329|FG001|Overall Study|Other: Death|0|||
155361482|NCT00725712|560757328|FG000|Overall Study|Hospitalized, unable to continue|0|||
155166182|NCT00481091|560046198|FG003|Overall Study|Adverse Event|1|||
155166183|NCT00481091|560046199|FG004|Overall Study|Adverse Event|1|||
155166184|NCT00481091|560046200|FG005|Overall Study|Adverse Event|1|||
155166185|NCT00481091|560046201|FG006|Overall Study|Adverse Event|2|||
155166186|NCT00481091|560046202|FG007|Overall Study|Adverse Event|1|||
155166187|NCT00481091|560046203|FG008|Overall Study|Adverse Event|1|||
155166188|NCT00481091|560046204|FG009|Overall Study|Adverse Event|6|||
155166189|NCT00481091|560046195|FG000|Overall Study|Progressive disease clinical|0|||
155166190|NCT00481091|560046196|FG001|Overall Study|Progressive disease clinical|0|||
155166191|NCT00481091|560046197|FG002|Overall Study|Progressive disease clinical|0|||
155166192|NCT00481091|560046198|FG003|Overall Study|Progressive disease clinical|0|||
155166193|NCT00481091|560046199|FG004|Overall Study|Progressive disease clinical|0|||
155166194|NCT00481091|560046200|FG005|Overall Study|Progressive disease clinical|0|||
155166195|NCT00481091|560046201|FG006|Overall Study|Progressive disease clinical|0|||
155166196|NCT00481091|560046202|FG007|Overall Study|Progressive disease clinical|0|||
155166197|NCT00481091|560046203|FG008|Overall Study|Progressive disease clinical|1|||
155166198|NCT00481091|560046204|FG009|Overall Study|Progressive disease clinical|7|||
155166199|NCT00481091|560046195|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
155166200|NCT00481091|560046196|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
155166201|NCT00481091|560046197|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166202|NCT00481091|560046198|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166203|NCT00481091|560046199|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166204|NCT00481091|560046200|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
155166205|NCT00481091|560046201|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166206|NCT00481091|560046202|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166207|NCT00481091|560046203|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166208|NCT00481091|560046204|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
155166209|NCT00481091|560046195|FG000|Overall Study|Progressive disease other|1|||
155166210|NCT00481091|560046196|FG001|Overall Study|Progressive disease other|1|||
155166211|NCT00481091|560046197|FG002|Overall Study|Progressive disease other|0|||
155166212|NCT00481091|560046198|FG003|Overall Study|Progressive disease other|1|||
155166213|NCT00481091|560046199|FG004|Overall Study|Progressive disease other|1|||
155166214|NCT00481091|560046200|FG005|Overall Study|Progressive disease other|1|||
155166215|NCT00481091|560046201|FG006|Overall Study|Progressive disease other|0|||
155166216|NCT00481091|560046202|FG007|Overall Study|Progressive disease other|2|||
155166217|NCT00481091|560046203|FG008|Overall Study|Progressive disease other|0|||
155166218|NCT00481091|560046204|FG009|Overall Study|Progressive disease other|0|||
155166219|NCT00481091|560046195|FG000|Overall Study|No reason given|0|||
155166220|NCT00481091|560046196|FG001|Overall Study|No reason given|0|||
155166221|NCT00481091|560046197|FG002|Overall Study|No reason given|1|||
155166222|NCT00481091|560046198|FG003|Overall Study|No reason given|1|||
155166223|NCT00481091|560046199|FG004|Overall Study|No reason given|1|||
155166224|NCT00481091|560046200|FG005|Overall Study|No reason given|0|||
155166225|NCT00481091|560046201|FG006|Overall Study|No reason given|1|||
155166226|NCT00481091|560046202|FG007|Overall Study|No reason given|1|||
155166227|NCT00481091|560046203|FG008|Overall Study|No reason given|1|||
155166228|NCT00481091|560046204|FG009|Overall Study|No reason given|4|||
155361483|NCT00725712|560757329|FG001|Overall Study|Hospitalized, unable to continue|1|||
155361484|NCT04024462|560757335|FG000|Overall Study|Withdrawal by Subject|6|||
155361485|NCT04024462|560757336|FG001|Overall Study|Withdrawal by Subject|7|||
155361486|NCT04024462|560757335|FG000|Overall Study|Progressive Disease|0|||
155361487|NCT04024462|560757336|FG001|Overall Study|Progressive Disease|1|||
155361488|NCT04024462|560757335|FG000|Overall Study|Adverse Event|0|||
155361489|NCT04024462|560757336|FG001|Overall Study|Adverse Event|1|||
155361490|NCT04024462|560757335|FG000|Overall Study|Death|0|||
155361491|NCT04024462|560757336|FG001|Overall Study|Death|1|||
155361492|NCT04024462|560757335|FG000|Overall Study|Lost to Follow-up|1|||
155361493|NCT04024462|560757336|FG001|Overall Study|Lost to Follow-up|0|||
155361494|NCT04024462|560757335|FG000|Overall Study|Ongoing in the Study|94|||
155361495|NCT04024462|560757336|FG001|Overall Study|Ongoing in the Study|89|||
155166229|NCT04294680|560046205|FG000|Overall Study|Withdrawal by Subject|2|||
155166230|NCT04294680|560046206|FG001|Overall Study|Withdrawal by Subject|1|||
155361496|NCT05687032|560757340|FG000|Treatment Phase|Adverse Event|13|||
154965246|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155166231|NCT04294680|560046205|FG000|Overall Study|Follow-up visits completed outside of window|1|||
155166232|NCT04294680|560046206|FG001|Overall Study|Follow-up visits completed outside of window|0|||
155166233|NCT00373113|560046208|FG000|Overall Study|Death|1|||
155361497|NCT05687032|560757340|FG000|Treatment Phase|Death|1|||
155361498|NCT05687032|560757340|FG000|Treatment Phase|Physician Decision|3|||
155088908|NCT04562090|559757484|FG000|Overall Study|Withdrawal by Subject|3|||
155088909|NCT04562090|559757485|FG001|Overall Study|Withdrawal by Subject|4|||
155088910|NCT04562090|559757484|FG000|Overall Study|Protocol Violation|2|||
155088911|NCT04562090|559757485|FG001|Overall Study|Protocol Violation|0|||
155088912|NCT04562090|559757484|FG000|Overall Study|Lack of Efficacy|0|||
155088913|NCT04562090|559757485|FG001|Overall Study|Lack of Efficacy|1|||
155088914|NCT04562090|559757484|FG000|Overall Study|Adverse Event|1|||
155088915|NCT04562090|559757485|FG001|Overall Study|Adverse Event|4|||
155088916|NCT04562090|559757484|FG000|Overall Study|Miscellaneous|0|||
155088917|NCT04562090|559757485|FG001|Overall Study|Miscellaneous|3|||
155088918|NCT00847730|559757486|FG000|Overall Study|Multiple interruptions in therapy|8|||
155088919|NCT04938427|559757489|FG000|Overall Study|Adverse Event|5|||
155088920|NCT04938427|559757490|FG001|Overall Study|Adverse Event|19|||
155088921|NCT04938427|559757489|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155088922|NCT04938427|559757490|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155088923|NCT04938427|559757489|FG000|Overall Study|Withdrawal by Subject|1|||
155088924|NCT04938427|559757490|FG001|Overall Study|Withdrawal by Subject|0|||
155088925|NCT04938427|559757489|FG000|Overall Study|Reason Not Specified|2|||
155088926|NCT04938427|559757490|FG001|Overall Study|Reason Not Specified|1|||
155088927|NCT03633058|559757499|FG000|Overall Study|Adverse Event|0|||
155088928|NCT03633058|559757500|FG001|Overall Study|Adverse Event|0|||
155088929|NCT03633058|559757501|FG002|Overall Study|Adverse Event|1|||
155088930|NCT03633058|559757502|FG003|Overall Study|Adverse Event|0|||
155088931|NCT01969058|559757510|FG000|Overall Study|Withdrawal by Subject|2|||
155088932|NCT01969058|559757511|FG001|Overall Study|Withdrawal by Subject|0|||
155088933|NCT01969058|559757510|FG000|Overall Study|Adverse Event|1|||
155088934|NCT01969058|559757511|FG001|Overall Study|Adverse Event|0|||
155088935|NCT04090749|559757514|FG000|Open Label Pilot|Lost to Follow-up|1|||
155088936|NCT04090749|559757515|FG001|Open Label Pilot|Lost to Follow-up|0|||
155088937|NCT04090749|559757516|FG002|Open Label Pilot|Lost to Follow-up|0|||
155088938|NCT04090749|559757514|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
155088939|NCT04090749|559757515|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
155088940|NCT04090749|559757516|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
155088941|NCT04090749|559757514|FG000|Pilot Trial|Lost to Follow-up|0|||
155088942|NCT04090749|559757515|FG001|Pilot Trial|Lost to Follow-up|1|||
155088943|NCT04090749|559757516|FG002|Pilot Trial|Lost to Follow-up|1|||
155088944|NCT03510715|559757517|FG000|Overall Study|Adverse Event|1|||
155088945|NCT03510715|559757518|FG001|Overall Study|Adverse Event|0|||
155088946|NCT04144517|559757524|FG000|Overall Study|Physician Decision|0|||
155088947|NCT04144517|559757525|FG001|Overall Study|Physician Decision|1|||
155088948|NCT04144517|559757524|FG000|Overall Study|Other|2|||
155088949|NCT04144517|559757525|FG001|Overall Study|Other|2|||
155088950|NCT04144517|559757524|FG000|Overall Study|Death|6|||
155088951|NCT04144517|559757525|FG001|Overall Study|Death|3|||
155088952|NCT02457793|559757530|FG000|Overall Study|Reason not specified|0|||
155088953|NCT02457793|559757531|FG001|Overall Study|Reason not specified|0|||
155088954|NCT02457793|559757532|FG002|Overall Study|Reason not specified|0|||
155166234|NCT00373113|560046209|FG001|Overall Study|Death|7|||
155088955|NCT02457793|559757533|FG003|Overall Study|Reason not specified|1|||
155088956|NCT02457793|559757534|FG004|Overall Study|Reason not specified|1|||
155088957|NCT02457793|559757535|FG005|Overall Study|Reason not specified|1|||
155088958|NCT02457793|559757530|FG000|Overall Study|Withdrawal by Subject|0|||
155088959|NCT02457793|559757531|FG001|Overall Study|Withdrawal by Subject|4|||
155088960|NCT02457793|559757532|FG002|Overall Study|Withdrawal by Subject|2|||
155088961|NCT02457793|559757533|FG003|Overall Study|Withdrawal by Subject|2|||
155088962|NCT02457793|559757534|FG004|Overall Study|Withdrawal by Subject|2|||
155088963|NCT02457793|559757535|FG005|Overall Study|Withdrawal by Subject|2|||
155361499|NCT05687032|560757340|FG000|Treatment Phase|Progressive disease|9|||
155361500|NCT05687032|560757340|FG000|Treatment Phase|Withdrawal by Subject|5|||
155361501|NCT05687032|560757340|FG000|Follow-Up Phase|Death|16|||
155361502|NCT05687032|560757340|FG000|Follow-Up Phase|Ongoing|26|||
155361503|NCT01437423|560757349|FG000|Overall Study|Lost to Follow-up|12|||
155361504|NCT01437423|560757349|FG000|Overall Study|Off label usage|3|||
155088964|NCT02457793|559757530|FG000|Overall Study|Adverse Event|0|||
155088965|NCT02457793|559757531|FG001|Overall Study|Adverse Event|0|||
155088966|NCT02457793|559757532|FG002|Overall Study|Adverse Event|0|||
155088967|NCT02457793|559757533|FG003|Overall Study|Adverse Event|1|||
155088968|NCT02457793|559757534|FG004|Overall Study|Adverse Event|0|||
155088969|NCT02457793|559757535|FG005|Overall Study|Adverse Event|0|||
155088970|NCT02457793|559757530|FG000|Overall Study|Physician Decision|1|||
155088971|NCT02457793|559757531|FG001|Overall Study|Physician Decision|0|||
155088972|NCT02457793|559757532|FG002|Overall Study|Physician Decision|1|||
155088973|NCT02457793|559757533|FG003|Overall Study|Physician Decision|1|||
155088974|NCT02457793|559757534|FG004|Overall Study|Physician Decision|1|||
155088975|NCT02457793|559757535|FG005|Overall Study|Physician Decision|3|||
155088976|NCT00835172|559757540|FG000|Washout|Protocol Violation|0|||
155088977|NCT00835172|559757541|FG001|Washout|Protocol Violation|1|||
155088978|NCT03941093|559757542|FG000|Overall Study|Protocol Violation|0|||
155088979|NCT03941093|559757543|FG001|Overall Study|Protocol Violation|1|||
155088980|NCT03941093|559757542|FG000|Overall Study|Withdrawal by Subject|9|||
155088981|NCT03941093|559757543|FG001|Overall Study|Withdrawal by Subject|6|||
155088982|NCT03243084|559759665|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
155088983|NCT03243084|559759666|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
155088984|NCT00553254|559759670|FG000|Overall Study|Death|3|||
155088985|NCT00553254|559759671|FG001|Overall Study|Death|6|||
155088986|NCT00553254|559759672|FG002|Overall Study|Death|25|||
155088987|NCT00553254|559759670|FG000|Overall Study|Lost to Follow-up|0|||
155088988|NCT00553254|559759671|FG001|Overall Study|Lost to Follow-up|0|||
155088989|NCT00553254|559759672|FG002|Overall Study|Lost to Follow-up|2|||
155088990|NCT00553254|559759670|FG000|Overall Study|Withdrawal by Subject|2|||
155088991|NCT00553254|559759671|FG001|Overall Study|Withdrawal by Subject|0|||
155088992|NCT00553254|559759672|FG002|Overall Study|Withdrawal by Subject|2|||
155088993|NCT00553254|559759670|FG000|Overall Study|Study terminated by Sponsor|0|||
155088994|NCT00553254|559759671|FG001|Overall Study|Study terminated by Sponsor|0|||
155088995|NCT00553254|559759672|FG002|Overall Study|Study terminated by Sponsor|1|||
155088996|NCT00553254|559759670|FG000|Overall Study|Other|1|||
155088997|NCT00553254|559759671|FG001|Overall Study|Other|0|||
155088998|NCT00553254|559759672|FG002|Overall Study|Other|13|||
155088999|NCT02314923|559759673|FG000|Overall Study|Death|0|||
155089000|NCT02314923|559759674|FG001|Overall Study|Death|0|||
155089001|NCT02314923|559759675|FG002|Overall Study|Death|0|||
155089002|NCT02314923|559759676|FG003|Overall Study|Death|1|||
155089003|NCT02314923|559759677|FG004|Overall Study|Death|0|||
155089004|NCT02314923|559759678|FG005|Overall Study|Death|0|||
155089005|NCT02314923|559759679|FG006|Overall Study|Death|0|||
155089006|NCT02314923|559759680|FG007|Overall Study|Death|0|||
155089007|NCT02314923|559759681|FG008|Overall Study|Death|0|||
155089008|NCT02314923|559759682|FG009|Overall Study|Death|0|||
155089009|NCT02314923|559759673|FG000|Overall Study|Lost to Follow-up|2|||
155089010|NCT02314923|559759674|FG001|Overall Study|Lost to Follow-up|3|||
155089011|NCT02314923|559759675|FG002|Overall Study|Lost to Follow-up|1|||
155089012|NCT02314923|559759676|FG003|Overall Study|Lost to Follow-up|0|||
155089013|NCT02314923|559759677|FG004|Overall Study|Lost to Follow-up|0|||
155361505|NCT03912662|560757355|FG000|Overall Study|Adverse Event|3|||
155361506|NCT03912662|560757355|FG000|Overall Study|Adverse Event and Death|1|||
155361507|NCT03912662|560757355|FG000|Overall Study|Death|1|||
155361508|NCT03912662|560757355|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
155089014|NCT02314923|559759678|FG005|Overall Study|Lost to Follow-up|0|||
155089015|NCT02314923|559759679|FG006|Overall Study|Lost to Follow-up|3|||
155089016|NCT02314923|559759680|FG007|Overall Study|Lost to Follow-up|4|||
155089017|NCT02314923|559759681|FG008|Overall Study|Lost to Follow-up|2|||
155089018|NCT02314923|559759682|FG009|Overall Study|Lost to Follow-up|0|||
155089019|NCT02314923|559759673|FG000|Overall Study|Withdrawal by Subject|0|||
155089020|NCT02314923|559759674|FG001|Overall Study|Withdrawal by Subject|0|||
155361509|NCT03912662|560757355|FG000|Overall Study|Mesh Removal|1|||
155089021|NCT02314923|559759675|FG002|Overall Study|Withdrawal by Subject|1|||
155089022|NCT02314923|559759676|FG003|Overall Study|Withdrawal by Subject|0|||
155089023|NCT02314923|559759677|FG004|Overall Study|Withdrawal by Subject|1|||
155089024|NCT02314923|559759678|FG005|Overall Study|Withdrawal by Subject|0|||
155089025|NCT02314923|559759679|FG006|Overall Study|Withdrawal by Subject|1|||
155361510|NCT03912662|560757355|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
155361511|NCT03912662|560757355|FG000|Overall Study|Early study termination|20|||
155361512|NCT01790295|560757364|FG000|Overall Study|Adverse Event|1|||
155361513|NCT01790295|560757364|FG000|Overall Study|Death|4|||
155361514|NCT01790295|560757364|FG000|Overall Study|Lack of Efficacy|2|||
155361515|NCT01790295|560757364|FG000|Overall Study|Study closure|4|||
155361516|NCT02872012|560757382|FG000|Overall Study|Withdrawal by Subject|1|||
155361517|NCT02872012|560757383|FG001|Overall Study|Withdrawal by Subject|0|||
155361518|NCT02872012|560757384|FG002|Overall Study|Withdrawal by Subject|0|||
155361519|NCT02872012|560757385|FG003|Overall Study|Withdrawal by Subject|0|||
155361520|NCT02872012|560757386|FG004|Overall Study|Withdrawal by Subject|0|||
155361521|NCT03000348|560757387|FG000|Overall Study|Adverse Event|1|||
155361522|NCT03000348|560757388|FG001|Overall Study|Adverse Event|1|||
155361523|NCT03000348|560757389|FG002|Overall Study|Adverse Event|1|||
155361524|NCT03000348|560757390|FG003|Overall Study|Adverse Event|1|||
155361525|NCT03000348|560757391|FG004|Overall Study|Adverse Event|1|||
155361526|NCT03000348|560757392|FG005|Overall Study|Adverse Event|1|||
155361527|NCT03000348|560757387|FG000|Overall Study|Lost to Follow-up|0|||
155361528|NCT03000348|560757388|FG001|Overall Study|Lost to Follow-up|0|||
155361529|NCT03000348|560757389|FG002|Overall Study|Lost to Follow-up|1|||
155361530|NCT03000348|560757390|FG003|Overall Study|Lost to Follow-up|0|||
155361531|NCT03000348|560757391|FG004|Overall Study|Lost to Follow-up|0|||
155361532|NCT03000348|560757392|FG005|Overall Study|Lost to Follow-up|0|||
155361533|NCT03000348|560757387|FG000|Overall Study|Withdrawal by Subject|0|||
155361534|NCT03000348|560757388|FG001|Overall Study|Withdrawal by Subject|1|||
155361535|NCT03000348|560757389|FG002|Overall Study|Withdrawal by Subject|0|||
155361536|NCT03000348|560757390|FG003|Overall Study|Withdrawal by Subject|0|||
155361537|NCT03000348|560757391|FG004|Overall Study|Withdrawal by Subject|0|||
155089026|NCT02314923|559759680|FG007|Overall Study|Withdrawal by Subject|0|||
155089027|NCT02314923|559759681|FG008|Overall Study|Withdrawal by Subject|0|||
155089028|NCT02314923|559759682|FG009|Overall Study|Withdrawal by Subject|0|||
155089029|NCT02314923|559759673|FG000|Overall Study|Physician Decision|0|||
155089030|NCT02314923|559759674|FG001|Overall Study|Physician Decision|1|||
155089031|NCT02314923|559759675|FG002|Overall Study|Physician Decision|0|||
155089032|NCT02314923|559759676|FG003|Overall Study|Physician Decision|0|||
155089033|NCT02314923|559759677|FG004|Overall Study|Physician Decision|0|||
155089034|NCT02314923|559759678|FG005|Overall Study|Physician Decision|0|||
155089035|NCT02314923|559759679|FG006|Overall Study|Physician Decision|0|||
155089036|NCT02314923|559759680|FG007|Overall Study|Physician Decision|0|||
155089037|NCT02314923|559759681|FG008|Overall Study|Physician Decision|0|||
155089038|NCT02314923|559759682|FG009|Overall Study|Physician Decision|0|||
155089039|NCT02314923|559759673|FG000|Overall Study|Participant unavailable|0|||
155089040|NCT02314923|559759674|FG001|Overall Study|Participant unavailable|0|||
155089041|NCT02314923|559759675|FG002|Overall Study|Participant unavailable|0|||
155089042|NCT02314923|559759676|FG003|Overall Study|Participant unavailable|0|||
155089043|NCT02314923|559759677|FG004|Overall Study|Participant unavailable|0|||
155089044|NCT02314923|559759678|FG005|Overall Study|Participant unavailable|1|||
155089045|NCT02314923|559759679|FG006|Overall Study|Participant unavailable|0|||
155089046|NCT02314923|559759680|FG007|Overall Study|Participant unavailable|0|||
155089047|NCT02314923|559759681|FG008|Overall Study|Participant unavailable|0|||
155089048|NCT02314923|559759682|FG009|Overall Study|Participant unavailable|0|||
155089049|NCT02314923|559759673|FG000|Overall Study|Screen failure|0|||
155089050|NCT02314923|559759674|FG001|Overall Study|Screen failure|0|||
155361538|NCT03000348|560757392|FG005|Overall Study|Withdrawal by Subject|0|||
155361539|NCT03000348|560757387|FG000|Overall Study|Consent|0|||
155361540|NCT03000348|560757388|FG001|Overall Study|Consent|0|||
155361541|NCT03000348|560757389|FG002|Overall Study|Consent|0|||
155361542|NCT03000348|560757390|FG003|Overall Study|Consent|0|||
155361543|NCT03000348|560757391|FG004|Overall Study|Consent|1|||
155361544|NCT03000348|560757392|FG005|Overall Study|Consent|0|||
155361545|NCT03000348|560757387|FG000|Overall Study|Failure to expectorate sputum|1|||
155089051|NCT02314923|559759675|FG002|Overall Study|Screen failure|0|||
155089052|NCT02314923|559759676|FG003|Overall Study|Screen failure|0|||
155089053|NCT02314923|559759677|FG004|Overall Study|Screen failure|0|||
155089054|NCT02314923|559759678|FG005|Overall Study|Screen failure|0|||
155089055|NCT02314923|559759679|FG006|Overall Study|Screen failure|1|||
155089056|NCT02314923|559759680|FG007|Overall Study|Screen failure|0|||
155089057|NCT02314923|559759681|FG008|Overall Study|Screen failure|0|||
155361546|NCT03000348|560757388|FG001|Overall Study|Failure to expectorate sputum|0|||
155361547|NCT03000348|560757389|FG002|Overall Study|Failure to expectorate sputum|1|||
155361548|NCT03000348|560757390|FG003|Overall Study|Failure to expectorate sputum|0|||
155361549|NCT03000348|560757391|FG004|Overall Study|Failure to expectorate sputum|1|||
155361550|NCT03000348|560757392|FG005|Overall Study|Failure to expectorate sputum|0|||
155361551|NCT03000348|560757387|FG000|Overall Study|No gram negative|1|||
155361552|NCT03000348|560757388|FG001|Overall Study|No gram negative|2|||
155361553|NCT03000348|560757389|FG002|Overall Study|No gram negative|1|||
155361554|NCT03000348|560757390|FG003|Overall Study|No gram negative|1|||
155166235|NCT00373113|560046208|FG000|Overall Study|Adverse Event|38|||
155166236|NCT00373113|560046209|FG001|Overall Study|Adverse Event|24|||
155166237|NCT00373113|560046208|FG000|Overall Study|Study terminated by sponsor|9|||
155166238|NCT00373113|560046209|FG001|Overall Study|Study terminated by sponsor|1|||
155166239|NCT00373113|560046208|FG000|Overall Study|Global deterioration of health status|10|||
155166240|NCT00373113|560046209|FG001|Overall Study|Global deterioration of health status|7|||
155166241|NCT00373113|560046208|FG000|Overall Study|Lost to Follow-up|1|||
155166242|NCT00373113|560046209|FG001|Overall Study|Lost to Follow-up|3|||
155166243|NCT00373113|560046208|FG000|Overall Study|Objective progression or relapse|150|||
155166244|NCT00373113|560046209|FG001|Overall Study|Objective progression or relapse|169|||
155166245|NCT00373113|560046208|FG000|Overall Study|Other|14|||
155166246|NCT00373113|560046209|FG001|Overall Study|Other|17|||
155166247|NCT00373113|560046208|FG000|Overall Study|Protocol Violation|5|||
155166248|NCT00373113|560046209|FG001|Overall Study|Protocol Violation|1|||
155166249|NCT00373113|560046208|FG000|Overall Study|Withdrawal by Subject|10|||
155166250|NCT00373113|560046209|FG001|Overall Study|Withdrawal by Subject|15|||
155166251|NCT03275350|560046210|FG000|Overall Study|Lost to Follow-up|4|||
155166252|NCT03275350|560046211|FG001|Overall Study|Lost to Follow-up|6|||
155166253|NCT03275350|560046210|FG000|Overall Study|Death|2|||
155166254|NCT03275350|560046211|FG001|Overall Study|Death|1|||
155166255|NCT03275350|560046210|FG000|Overall Study|Physician Decision|1|||
155166256|NCT03275350|560046211|FG001|Overall Study|Physician Decision|0|||
155166257|NCT03275350|560046210|FG000|Overall Study|Incarcerated|1|||
155166258|NCT03275350|560046211|FG001|Overall Study|Incarcerated|1|||
155361555|NCT03000348|560757391|FG004|Overall Study|No gram negative|1|||
155361556|NCT03000348|560757392|FG005|Overall Study|No gram negative|1|||
155361557|NCT03000348|560757387|FG000|Overall Study|Patient had no transport|0|||
155361558|NCT03000348|560757388|FG001|Overall Study|Patient had no transport|0|||
155361559|NCT03000348|560757389|FG002|Overall Study|Patient had no transport|0|||
155361560|NCT03000348|560757390|FG003|Overall Study|Patient had no transport|1|||
155361561|NCT03000348|560757391|FG004|Overall Study|Patient had no transport|0|||
155361562|NCT03000348|560757392|FG005|Overall Study|Patient had no transport|0|||
155361563|NCT03000348|560757387|FG000|Overall Study|Dosing|0|||
155361564|NCT03000348|560757388|FG001|Overall Study|Dosing|0|||
155361565|NCT03000348|560757389|FG002|Overall Study|Dosing|0|||
155361566|NCT03000348|560757390|FG003|Overall Study|Dosing|0|||
155361567|NCT03000348|560757391|FG004|Overall Study|Dosing|1|||
155361568|NCT03000348|560757392|FG005|Overall Study|Dosing|0|||
155166259|NCT03656562|560046214|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
155166260|NCT03656562|560046215|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
155166261|NCT03656562|560046216|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
155166262|NCT03656562|560046217|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
155166263|NCT03656562|560046214|FG000|Overall Study|Physician Decision|1|||
155166264|NCT03656562|560046215|FG001|Overall Study|Physician Decision|2|||
155166265|NCT03656562|560046216|FG002|Overall Study|Physician Decision|0|||
155166266|NCT03656562|560046217|FG003|Overall Study|Physician Decision|0|||
155166267|NCT03656562|560046214|FG000|Overall Study|Subject Decision|3|||
155166268|NCT03656562|560046215|FG001|Overall Study|Subject Decision|5|||
155166269|NCT03656562|560046216|FG002|Overall Study|Subject Decision|0|||
155166270|NCT03656562|560046217|FG003|Overall Study|Subject Decision|2|||
155166271|NCT04335136|560046218|FG000|Overall Study|Death|8|||
155166272|NCT04335136|560046219|FG001|Overall Study|Death|4|||
155361569|NCT00723125|560757393|FG000|Overall Study|Met Dx|1|||
155361570|NCT00723125|560757394|FG001|Overall Study|Met Dx|0|||
155361571|NCT00723125|560757393|FG000|Overall Study|Withdrawal by Subject|15|||
155361572|NCT00723125|560757394|FG001|Overall Study|Withdrawal by Subject|6|||
155361573|NCT00723125|560757393|FG000|Overall Study|Adverse Event|2|||
155361574|NCT00723125|560757394|FG001|Overall Study|Adverse Event|0|||
155361575|NCT01807182|560757395|FG000|Overall Study|Death|1|||
155361576|NCT01807182|560757395|FG000|Overall Study|New therapy|1|||
155361577|NCT01807182|560757395|FG000|Overall Study|Moved to hospice care|1|||
155166273|NCT04335136|560046218|FG000|Overall Study|Lost to Follow-up|2|||
155166274|NCT04335136|560046219|FG001|Overall Study|Lost to Follow-up|0|||
155166275|NCT04335136|560046218|FG000|Overall Study|Protocol Violation|1|||
155166276|NCT04335136|560046219|FG001|Overall Study|Protocol Violation|0|||
155166277|NCT04335136|560046218|FG000|Overall Study|Withdrawal by Subject|1|||
155361578|NCT00478205|560757397|FG000|Overall Study|Adverse Event|182|||
155166278|NCT04335136|560046219|FG001|Overall Study|Withdrawal by Subject|1|||
155361579|NCT00478205|560757398|FG001|Overall Study|Adverse Event|39|||
155361580|NCT00478205|560757397|FG000|Overall Study|Medication Non-compliance|9|||
155361581|NCT00478205|560757398|FG001|Overall Study|Medication Non-compliance|4|||
155361582|NCT00478205|560757397|FG000|Overall Study|Protocol Violation|15|||
155089058|NCT02314923|559759682|FG009|Overall Study|Screen failure|0|||
155089059|NCT02314923|559759673|FG000|Overall Study|Participant relocation|1|||
155089060|NCT02314923|559759674|FG001|Overall Study|Participant relocation|0|||
155089061|NCT02314923|559759675|FG002|Overall Study|Participant relocation|0|||
155089062|NCT02314923|559759676|FG003|Overall Study|Participant relocation|0|||
155089063|NCT02314923|559759677|FG004|Overall Study|Participant relocation|0|||
155089064|NCT02314923|559759678|FG005|Overall Study|Participant relocation|0|||
155361583|NCT00478205|560757398|FG001|Overall Study|Protocol Violation|5|||
155361584|NCT00478205|560757397|FG000|Overall Study|Request of Investigator or Sponsor|4|||
155361585|NCT00478205|560757398|FG001|Overall Study|Request of Investigator or Sponsor|5|||
155361586|NCT00478205|560757397|FG000|Overall Study|Withdrawal by Subject|61|||
155361587|NCT00478205|560757398|FG001|Overall Study|Withdrawal by Subject|22|||
155361588|NCT00478205|560757397|FG000|Overall Study|Lack of Efficacy|1|||
155361589|NCT00478205|560757398|FG001|Overall Study|Lack of Efficacy|0|||
155361590|NCT00478205|560757397|FG000|Overall Study|Other|24|||
155361591|NCT00478205|560757398|FG001|Overall Study|Other|12|||
155361592|NCT01012947|560757399|FG000|Overall Study|Lost to Follow-up|131|||
155361593|NCT01012947|560757400|FG001|Overall Study|Lost to Follow-up|135|||
155361594|NCT01012947|560757401|FG002|Overall Study|Lost to Follow-up|130|||
155361595|NCT01012947|560757402|FG003|Overall Study|Lost to Follow-up|118|||
155361596|NCT01012947|560757403|FG004|Overall Study|Lost to Follow-up|142|||
155361597|NCT02127125|560757404|FG000|Overall Study|Lost to Follow-up|0|||
155361598|NCT02127125|560757405|FG001|Overall Study|Lost to Follow-up|0|||
155361599|NCT02127125|560757406|FG002|Overall Study|Lost to Follow-up|0|||
155361600|NCT02127125|560757407|FG003|Overall Study|Lost to Follow-up|0|||
155361601|NCT02127125|560757408|FG004|Overall Study|Lost to Follow-up|2|||
155361602|NCT02127125|560757409|FG005|Overall Study|Lost to Follow-up|1|||
155361603|NCT02127125|560757410|FG006|Overall Study|Lost to Follow-up|0|||
155361604|NCT02127125|560757411|FG007|Overall Study|Lost to Follow-up|0|||
155361605|NCT02127125|560757412|FG008|Overall Study|Lost to Follow-up|0|||
155361606|NCT02127125|560757404|FG000|Overall Study|Withdrawal by Subject|0|||
155361607|NCT02127125|560757405|FG001|Overall Study|Withdrawal by Subject|0|||
155361608|NCT02127125|560757406|FG002|Overall Study|Withdrawal by Subject|0|||
155361609|NCT02127125|560757407|FG003|Overall Study|Withdrawal by Subject|1|||
155089065|NCT02314923|559759679|FG006|Overall Study|Participant relocation|0|||
155089066|NCT02314923|559759680|FG007|Overall Study|Participant relocation|1|||
155089067|NCT02314923|559759681|FG008|Overall Study|Participant relocation|0|||
155089068|NCT02314923|559759682|FG009|Overall Study|Participant relocation|0|||
155089069|NCT02546323|559759683|FG000|Overall Study|Withdrawal by Subject|36|||
155089070|NCT02546323|559759684|FG001|Overall Study|Withdrawal by Subject|33|||
155089071|NCT02546323|559759683|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
155089072|NCT02546323|559759684|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
155089073|NCT02546323|559759683|FG000|Overall Study|Adverse Event|17|||
155089074|NCT02546323|559759684|FG001|Overall Study|Adverse Event|11|||
155089075|NCT02546323|559759683|FG000|Overall Study|Patient Specific Reasons|1|||
155089076|NCT02546323|559759684|FG001|Overall Study|Patient Specific Reasons|2|||
155089077|NCT02546323|559759683|FG000|Overall Study|Lost to Follow-up|2|||
155089078|NCT02546323|559759684|FG001|Overall Study|Lost to Follow-up|3|||
155089079|NCT02546323|559759683|FG000|Overall Study|Non-compliance with Study Drug|2|||
155089080|NCT02546323|559759684|FG001|Overall Study|Non-compliance with Study Drug|2|||
155089081|NCT02546323|559759683|FG000|Overall Study|Met Withdrawal Criteria|2|||
155089082|NCT02546323|559759684|FG001|Overall Study|Met Withdrawal Criteria|14|||
155089083|NCT04476784|559759685|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
155089084|NCT04476784|559759686|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
155089085|NCT01055028|559759692|FG000|Screening|Screen Failure|1|||
155089086|NCT01055028|559759693|FG001|Screening|Screen Failure|1|||
155089087|NCT01055028|559759692|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
155089088|NCT01055028|559759693|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
155361610|NCT02127125|560757408|FG004|Overall Study|Withdrawal by Subject|0|||
155361611|NCT02127125|560757409|FG005|Overall Study|Withdrawal by Subject|0|||
155361612|NCT02127125|560757410|FG006|Overall Study|Withdrawal by Subject|0|||
155361613|NCT02127125|560757411|FG007|Overall Study|Withdrawal by Subject|0|||
155361614|NCT02127125|560757412|FG008|Overall Study|Withdrawal by Subject|0|||
155361615|NCT02127125|560757404|FG000|Overall Study|Physician Decision|0|||
155361616|NCT02127125|560757405|FG001|Overall Study|Physician Decision|0|||
155361617|NCT02127125|560757406|FG002|Overall Study|Physician Decision|1|||
155361618|NCT02127125|560757407|FG003|Overall Study|Physician Decision|0|||
155361619|NCT02127125|560757408|FG004|Overall Study|Physician Decision|1|||
155361620|NCT02127125|560757409|FG005|Overall Study|Physician Decision|2|||
155361621|NCT02127125|560757410|FG006|Overall Study|Physician Decision|0|||
155361622|NCT02127125|560757411|FG007|Overall Study|Physician Decision|0|||
155361623|NCT02127125|560757412|FG008|Overall Study|Physician Decision|0|||
154965247|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
154965248|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965249|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155166279|NCT04335136|560046218|FG000|Overall Study|Health-threatening condition|0|||
155166280|NCT04335136|560046219|FG001|Overall Study|Health-threatening condition|1|||
154965250|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965251|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155089089|NCT01055028|559759692|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
155089090|NCT01055028|559759693|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
155089091|NCT01055028|559759692|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
155089092|NCT01055028|559759693|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
155166281|NCT04335136|560046218|FG000|Overall Study|Adverse Event|0|||
155166282|NCT04335136|560046219|FG001|Overall Study|Adverse Event|1|||
155361624|NCT03332784|560757416|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361625|NCT03332784|560757417|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
155361626|NCT03332784|560757418|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361627|NCT03332784|560757419|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361628|NCT03332784|560757420|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361629|NCT03332784|560757421|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361630|NCT03332784|560757422|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361631|NCT03332784|560757423|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155089093|NCT04023487|559759694|FG000|Overall Study|Lost to Follow-up|5|||
155089094|NCT04023487|559759695|FG001|Overall Study|Lost to Follow-up|4|||
155089095|NCT04023487|559759694|FG000|Overall Study|Pregnancy|1|||
155166283|NCT04335136|560046218|FG000|Overall Study|Erroneously randomized|2|||
155166284|NCT04335136|560046219|FG001|Overall Study|Erroneously randomized|0|||
155166285|NCT00905645|560046220|FG000|Overall Study|Death (not device related)|10|||
155361632|NCT03332784|560757424|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361633|NCT03332784|560757425|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361634|NCT03332784|560757426|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361635|NCT03332784|560757427|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361636|NCT03332784|560757428|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155166286|NCT00905645|560046221|FG001|Overall Study|Death (not device related)|4|||
155361637|NCT03332784|560757429|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361638|NCT03332784|560757430|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
155361639|NCT03332784|560757431|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361640|NCT03332784|560757432|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361641|NCT03332784|560757433|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361642|NCT03332784|560757434|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361643|NCT03332784|560757435|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
155361644|NCT01018732|560757436|FG000|Overall Study|Lost to Follow-up|0|||
155361645|NCT01018732|560757437|FG001|Overall Study|Lost to Follow-up|0|||
155361646|NCT01018732|560757438|FG002|Overall Study|Lost to Follow-up|3|||
155361647|NCT01018732|560757436|FG000|Overall Study|Protocol Violation|1|||
155361648|NCT01018732|560757437|FG001|Overall Study|Protocol Violation|1|||
155361649|NCT01018732|560757438|FG002|Overall Study|Protocol Violation|0|||
155361650|NCT01018732|560757436|FG000|Overall Study|Inappropriate Enrollment|0|||
155361651|NCT01018732|560757437|FG001|Overall Study|Inappropriate Enrollment|1|||
155361652|NCT01018732|560757438|FG002|Overall Study|Inappropriate Enrollment|0|||
154965252|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155361653|NCT01018732|560757436|FG000|Overall Study|Unable to Classify|0|||
155361654|NCT01018732|560757437|FG001|Overall Study|Unable to Classify|0|||
155361655|NCT01018732|560757438|FG002|Overall Study|Unable to Classify|1|||
155166287|NCT00905645|560046222|FG002|Overall Study|Death (not device related)|15|||
155089096|NCT04023487|559759695|FG001|Overall Study|Pregnancy|2|||
155089097|NCT04023487|559759694|FG000|Overall Study|Withdrawal by Subject|4|||
155089098|NCT04023487|559759695|FG001|Overall Study|Withdrawal by Subject|5|||
155089099|NCT04023487|559759694|FG000|Overall Study|Partially completed testing|8|||
155089100|NCT04023487|559759695|FG001|Overall Study|Partially completed testing|4|||
155089101|NCT03898180|559759696|FG000|Overall Study|Death|178|||
155089102|NCT03898180|559759697|FG001|Overall Study|Death|173|||
155166288|NCT00905645|560046223|FG003|Overall Study|Death (not device related)|8|||
155166289|NCT00905645|560046220|FG000|Overall Study|Explantation of study device(s)|78|||
155166290|NCT00905645|560046221|FG001|Overall Study|Explantation of study device(s)|47|||
155166291|NCT00905645|560046222|FG002|Overall Study|Explantation of study device(s)|28|||
155166292|NCT00905645|560046223|FG003|Overall Study|Explantation of study device(s)|21|||
155166293|NCT00905645|560046220|FG000|Overall Study|Subject Request|41|||
155166294|NCT00905645|560046221|FG001|Overall Study|Subject Request|17|||
155166295|NCT00905645|560046222|FG002|Overall Study|Subject Request|13|||
155166296|NCT00905645|560046223|FG003|Overall Study|Subject Request|11|||
155166297|NCT00905645|560046220|FG000|Overall Study|Lost to Follow-up|299|||
155361656|NCT00978562|560757439|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
155361657|NCT03299959|560757440|FG000|Overall Study|Lost to Follow-up|7|||
155361658|NCT03299959|560757441|FG001|Overall Study|Lost to Follow-up|9|||
155361659|NCT03299959|560757440|FG000|Overall Study|Death|1|||
155361660|NCT03299959|560757441|FG001|Overall Study|Death|0|||
155361661|NCT03299959|560757440|FG000|Overall Study|Withdrawal by Subject|13|||
155361662|NCT03299959|560757441|FG001|Overall Study|Withdrawal by Subject|9|||
155361663|NCT03299959|560757440|FG000|Overall Study|Changes in study team and government regulations|1|||
155361664|NCT03299959|560757441|FG001|Overall Study|Changes in study team and government regulations|1|||
155361665|NCT03299959|560757440|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
155361666|NCT03299959|560757441|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
155089103|NCT03898180|559759696|FG000|Overall Study|Physician Decision|1|||
155089104|NCT03898180|559759697|FG001|Overall Study|Physician Decision|0|||
155089105|NCT03898180|559759696|FG000|Overall Study|Sponsor Decision|3|||
155089106|NCT03898180|559759697|FG001|Overall Study|Sponsor Decision|0|||
155089107|NCT03898180|559759696|FG000|Overall Study|Lost to Follow-up|1|||
155089108|NCT03898180|559759697|FG001|Overall Study|Lost to Follow-up|0|||
155166298|NCT00905645|560046221|FG001|Overall Study|Lost to Follow-up|103|||
155166299|NCT00905645|560046222|FG002|Overall Study|Lost to Follow-up|51|||
155361667|NCT01310699|560757442|FG000|Overall Study|Patients did not complete tandem.|4|||
155361668|NCT01310699|560757443|FG001|Overall Study|Patients did not complete tandem.|6|||
155361669|NCT00926575|560757444|FG000|Overall Study|Adverse Event|1|||
155361670|NCT00926575|560757445|FG001|Overall Study|Adverse Event|1|||
155361671|NCT00926575|560757444|FG000|Overall Study|Death|4|||
155361672|NCT00926575|560757445|FG001|Overall Study|Death|4|||
155361673|NCT00926575|560757444|FG000|Overall Study|Lost to Follow-up|1|||
155361674|NCT00926575|560757445|FG001|Overall Study|Lost to Follow-up|1|||
155361675|NCT00926575|560757444|FG000|Overall Study|Physician Decision|1|||
155361676|NCT00926575|560757445|FG001|Overall Study|Physician Decision|2|||
155361677|NCT00926575|560757444|FG000|Overall Study|Protocol Violation|1|||
155361678|NCT00926575|560757445|FG001|Overall Study|Protocol Violation|0|||
155361679|NCT00926575|560757444|FG000|Overall Study|Withdrawal by Subject|8|||
155361680|NCT00926575|560757445|FG001|Overall Study|Withdrawal by Subject|9|||
155361681|NCT00490698|560757446|FG000|Overall Study|Withdrawal by Subject|1|||
155361682|NCT00490698|560757446|FG000|Overall Study|Disease Progression|7|||
155361683|NCT00490698|560757446|FG000|Overall Study|Physician Decision|2|||
155361684|NCT00469859|560757448|FG000|Overall Study|Inevaluable|0|||
155361685|NCT00469859|560757449|FG001|Overall Study|Inevaluable|2|||
155361686|NCT04124471|560757450|FG000|Overall Study|screen failure|1|||
155361687|NCT02394925|560757453|FG000|Overall Study|Adverse Event|1|||
155361688|NCT02394925|560757453|FG000|Overall Study|Lens Discomfort|3|||
155089109|NCT03898180|559759696|FG000|Overall Study|Withdrawal by Subject|5|||
155089110|NCT03898180|559759697|FG001|Overall Study|Withdrawal by Subject|4|||
155089111|NCT02507934|559759698|FG000|Overall Study|Lost to Follow-up|2|||
155089112|NCT02507934|559759699|FG001|Overall Study|Lost to Follow-up|0|||
155089113|NCT02507934|559759698|FG000|Overall Study|Withdrawal by Subject|2|||
155089114|NCT02507934|559759699|FG001|Overall Study|Withdrawal by Subject|0|||
155089115|NCT03766399|559759701|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089116|NCT03766399|559759702|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089117|NCT03766399|559759703|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089118|NCT03766399|559759704|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089119|NCT03766399|559759705|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089120|NCT03766399|559759706|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089121|NCT03766399|559759707|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089122|NCT03766399|559759708|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089123|NCT03766399|559759709|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089124|NCT03766399|559759710|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089125|NCT03766399|559759711|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089126|NCT03766399|559759712|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089127|NCT03766399|559759713|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089128|NCT03766399|559759714|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
155089129|NCT03766399|559759715|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089130|NCT03766399|559759716|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089131|NCT03766399|559759717|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089132|NCT03766399|559759718|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
155089133|NCT05030766|559759719|FG000|Phase 1 Participants|Lost to Follow-up|12|||
155089134|NCT05030766|559759720|FG001|Phase 1 Participants|Lost to Follow-up|22|||
155089135|NCT05030766|559759721|FG002|Phase 1 Participants|Lost to Follow-up|0|||
155089136|NCT05030766|559759722|FG003|Phase 1 Participants|Lost to Follow-up|0|||
155089137|NCT05030766|559759719|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
155089138|NCT05030766|559759720|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
155089139|NCT05030766|559759721|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
155089140|NCT05030766|559759722|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
155089141|NCT05030766|559759719|FG000|Phase 2 Participants|Lost to Follow-up|0|||
155089142|NCT05030766|559759720|FG001|Phase 2 Participants|Lost to Follow-up|0|||
155089143|NCT05030766|559759721|FG002|Phase 2 Participants|Lost to Follow-up|6|||
155089144|NCT05030766|559759722|FG003|Phase 2 Participants|Lost to Follow-up|2|||
155089145|NCT00645658|559759723|FG000|Overall Study|Withdrawal by Subject|1|||
155089146|NCT00645658|559759724|FG001|Overall Study|Withdrawal by Subject|0|||
155089147|NCT00645658|559759723|FG000|Overall Study|Did not complete all assesments|0|||
155089148|NCT00645658|559759724|FG001|Overall Study|Did not complete all assesments|2|||
155089149|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
155089150|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
155089151|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
155089152|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
155089153|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
155089154|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
155089155|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
155166300|NCT00905645|560046223|FG003|Overall Study|Lost to Follow-up|12|||
155089156|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
155089157|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
155089158|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
155089159|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
155089160|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
155089161|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
155089162|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
155089163|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
155089164|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
155089165|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
155089166|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
155089167|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
155089168|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
155089169|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
155089170|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
155089171|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
155089172|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
155089173|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
155089174|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
155089175|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
155089176|NCT03093415|559759727|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
155089177|NCT03093415|559759728|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
155089178|NCT03093415|559759729|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
155089179|NCT03093415|559759727|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
155089180|NCT03093415|559759728|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
155089181|NCT03093415|559759729|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
155089182|NCT01559935|559759734|FG000|Car Phase|Toxicity|4|||
155089183|NCT01559935|559759734|FG000|Car Phase|Death|1|||
155089184|NCT01559935|559759734|FG000|Car Phase|Lack of Efficacy|2|||
155089185|NCT01559935|559759734|FG000|Car Phase|Lost to Follow-up|1|||
155089186|NCT01559935|559759734|FG000|Car Phase|Physician Decision|1|||
155089187|NCT01559935|559759734|FG000|Car Phase|Withdrawal by Subject|2|||
155089188|NCT01559935|559759734|FG000|Car Phase|Per protocol|1|||
155089189|NCT01559935|559759734|FG000|Car Phase|Insurance|1|||
155089190|NCT01559935|559759734|FG000|Car Phase|non-compliance|1|||
155089191|NCT01559935|559759734|FG000|BiRD Phase|Toxicity|1|||
155089192|NCT01559935|559759734|FG000|BiRD Phase|Lack of Efficacy|1|||
155089193|NCT01559935|559759734|FG000|BiRD Phase|Withdrawal by Subject|2|||
155361689|NCT02394925|560757453|FG000|Overall Study|Lens handling difficulities|5|||
155361690|NCT02394925|560757453|FG000|Overall Study|Lost to Follow-up|9|||
155361691|NCT02394925|560757453|FG000|Overall Study|Protocol Violation|5|||
155361692|NCT02394925|560757453|FG000|Overall Study|No longer meet eligibility criteria|1|||
155361693|NCT02394925|560757453|FG000|Overall Study|Unsatisfactory Visual Response|5|||
155361694|NCT03459846|560757457|FG000|Overall Study|Death|52|||
155089194|NCT01559935|559759734|FG000|Maintenance Phase|Remains on study|28|||
155089195|NCT01559935|559759734|FG000|Maintenance Phase|Toxicity|1|||
155089196|NCT01559935|559759734|FG000|Maintenance Phase|Lack of Efficacy|18|||
155089197|NCT01559935|559759734|FG000|Maintenance Phase|Withdrawal by Subject|5|||
155089198|NCT01559935|559759734|FG000|Maintenance Phase|Non-compliance|2|||
155089199|NCT05889468|559759736|FG000|Overall Study|Lost to Follow-up|9|||
155089200|NCT05889468|559759737|FG001|Overall Study|Lost to Follow-up|2|||
155089201|NCT05889468|559759736|FG000|Overall Study|Withdrawal by Subject|2|||
155089202|NCT05889468|559759737|FG001|Overall Study|Withdrawal by Subject|2|||
155089203|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089204|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
155089205|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089206|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
155089207|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
155089208|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
155361695|NCT03459846|560757458|FG001|Overall Study|Death|46|||
155361696|NCT03459846|560757457|FG000|Overall Study|Study terminated by sponsor|24|||
155361697|NCT03459846|560757458|FG001|Overall Study|Study terminated by sponsor|28|||
155361698|NCT03459846|560757457|FG000|Overall Study|Withdrawal by Subject|2|||
155361699|NCT03459846|560757458|FG001|Overall Study|Withdrawal by Subject|2|||
155361700|NCT02035696|560759121|FG000|Overall Study|Lost to Follow-up|0|||
155361701|NCT02035696|560759122|FG001|Overall Study|Lost to Follow-up|3|||
155361702|NCT02035696|560759123|FG002|Overall Study|Lost to Follow-up|1|||
155361703|NCT02035696|560759124|FG003|Overall Study|Lost to Follow-up|2|||
155361704|NCT02035696|560759121|FG000|Overall Study|Withdrawal by Subject|3|||
155361705|NCT02035696|560759122|FG001|Overall Study|Withdrawal by Subject|0|||
155361706|NCT02035696|560759123|FG002|Overall Study|Withdrawal by Subject|2|||
155361707|NCT02035696|560759124|FG003|Overall Study|Withdrawal by Subject|1|||
155361708|NCT02358668|560759126|FG000|Overall Study|Adverse Event|2|||
154965253|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155089209|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
155089210|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089211|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089212|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089213|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089214|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089215|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089216|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089217|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089218|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
155089219|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
155089220|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
155089221|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
155089222|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
155089223|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
155089224|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
155089225|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
155089226|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
155089227|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
155089228|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
155089229|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
155089230|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
155089231|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
155089232|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
155089233|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
155089234|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
155089235|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
155089236|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
155089237|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089238|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089239|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089240|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089241|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089242|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089243|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089244|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155166301|NCT01386970|560046224|FG000|Overall Study|Withdrawal by Subject|0|||
155166302|NCT01386970|560046225|FG001|Overall Study|Withdrawal by Subject|1|||
155361709|NCT02358668|560759127|FG001|Overall Study|Adverse Event|0|||
155361710|NCT02358668|560759128|FG002|Overall Study|Adverse Event|0|||
155361711|NCT02358668|560759126|FG000|Overall Study|Withdrawal by Subject|0|||
155361712|NCT02358668|560759127|FG001|Overall Study|Withdrawal by Subject|1|||
154965254|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965255|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965256|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965257|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155089245|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089246|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089247|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089248|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089249|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089250|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
155089251|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
155089252|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089253|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
155361713|NCT02358668|560759128|FG002|Overall Study|Withdrawal by Subject|0|||
155361714|NCT02104505|560759129|FG000|First Intervention (14 Days)|Adverse Event|2|||
155361715|NCT02104505|560759130|FG001|First Intervention (14 Days)|Adverse Event|0|||
155361716|NCT02104505|560759129|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
155361717|NCT02104505|560759130|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
155089254|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155089255|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155089256|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155089257|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
155089258|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089259|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089260|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089261|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089262|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089263|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089264|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089265|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089266|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155089267|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089268|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089269|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089270|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
155089271|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089272|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089273|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
155089274|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089275|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155361718|NCT02104505|560759129|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
155361719|NCT02104505|560759130|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
155361720|NCT02104505|560759129|FG000|First Intervention (14 Days)|exclusionary condition|0|||
155361721|NCT02104505|560759130|FG001|First Intervention (14 Days)|exclusionary condition|1|||
155361722|NCT02104505|560759129|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155361723|NCT02104505|560759130|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155361724|NCT02104505|560759129|FG000|Second Intervention (14 Days)|Adverse Event|2|||
155361725|NCT02104505|560759130|FG001|Second Intervention (14 Days)|Adverse Event|0|||
155361726|NCT01845805|560759131|FG000|Overall Study|Withdrawal by Subject|1|||
155361727|NCT01845805|560759132|FG001|Overall Study|Withdrawal by Subject|2|||
155361728|NCT01845805|560759131|FG000|Overall Study|Disease Progression|13|||
155361729|NCT01845805|560759132|FG001|Overall Study|Disease Progression|14|||
155089276|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089277|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089278|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089279|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089280|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089281|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089282|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
155089283|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089284|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089285|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
155089286|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089287|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089288|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089289|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089290|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089291|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089292|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089293|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089294|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089295|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089296|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089297|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089298|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
155089299|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155089300|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155089301|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155089302|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089303|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089304|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089305|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089306|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089307|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089308|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089309|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089310|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089311|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089312|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089313|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089314|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155089315|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
155089316|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
155089317|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
155089318|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
155089319|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
155089320|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
155089321|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
155089322|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
155089323|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
155089324|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
155089325|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
155089326|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
155089327|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
155089328|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
155089329|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
155089330|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
155089331|NCT02958865|559759738|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089332|NCT02958865|559759739|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089333|NCT02958865|559759740|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089334|NCT02958865|559759741|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155361730|NCT01845805|560759131|FG000|Overall Study|Drug-related Toxicity|4|||
155361731|NCT01845805|560759132|FG001|Overall Study|Drug-related Toxicity|0|||
155361732|NCT01317875|560759133|FG000|Overall Study|Other|0|||
155361733|NCT01317875|560759134|FG001|Overall Study|Other|0|||
155361734|NCT01317875|560759135|FG002|Overall Study|Other|1|||
155361735|NCT01317875|560759136|FG003|Overall Study|Other|0|||
155361736|NCT01317875|560759137|FG004|Overall Study|Other|0|||
155361737|NCT01317875|560759138|FG005|Overall Study|Other|0|||
154965258|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155361738|NCT01317875|560759139|FG006|Overall Study|Other|0|||
155361739|NCT01317875|560759140|FG007|Overall Study|Other|0|||
155361740|NCT01317875|560759141|FG008|Overall Study|Other|0|||
155361741|NCT01317875|560759142|FG009|Overall Study|Other|0|||
155361742|NCT01317875|560759133|FG000|Overall Study|Noncompliance with study drug|0|||
155361743|NCT01317875|560759134|FG001|Overall Study|Noncompliance with study drug|0|||
155361744|NCT01317875|560759135|FG002|Overall Study|Noncompliance with study drug|1|||
155361745|NCT01317875|560759136|FG003|Overall Study|Noncompliance with study drug|0|||
155361746|NCT01317875|560759137|FG004|Overall Study|Noncompliance with study drug|0|||
155361747|NCT01317875|560759138|FG005|Overall Study|Noncompliance with study drug|0|||
155361748|NCT01317875|560759139|FG006|Overall Study|Noncompliance with study drug|0|||
155361749|NCT01317875|560759140|FG007|Overall Study|Noncompliance with study drug|0|||
155361750|NCT01317875|560759141|FG008|Overall Study|Noncompliance with study drug|0|||
155361751|NCT01317875|560759142|FG009|Overall Study|Noncompliance with study drug|0|||
155361752|NCT01317875|560759133|FG000|Overall Study|Progressive Disease|1|||
155361753|NCT01317875|560759134|FG001|Overall Study|Progressive Disease|0|||
155361754|NCT01317875|560759135|FG002|Overall Study|Progressive Disease|2|||
155361755|NCT01317875|560759136|FG003|Overall Study|Progressive Disease|0|||
155361756|NCT01317875|560759137|FG004|Overall Study|Progressive Disease|1|||
155361757|NCT01317875|560759138|FG005|Overall Study|Progressive Disease|0|||
155361758|NCT01317875|560759139|FG006|Overall Study|Progressive Disease|0|||
155166303|NCT01386970|560046224|FG000|Overall Study|Adverse Event|4|||
155166304|NCT01386970|560046225|FG001|Overall Study|Adverse Event|1|||
155166305|NCT04881942|560046227|FG000|Overall Study|Adverse Event|0|||
155166306|NCT04881942|560046228|FG001|Overall Study|Adverse Event|0|||
155166307|NCT04881942|560046229|FG002|Overall Study|Adverse Event|0|||
155166308|NCT04881942|560046230|FG003|Overall Study|Adverse Event|0|||
155166309|NCT04881942|560046231|FG004|Overall Study|Adverse Event|1|||
155166310|NCT04881942|560046227|FG000|Overall Study|Alternates|0|||
155166311|NCT04881942|560046228|FG001|Overall Study|Alternates|0|||
155166312|NCT04881942|560046229|FG002|Overall Study|Alternates|0|||
155166313|NCT04881942|560046230|FG003|Overall Study|Alternates|0|||
155166314|NCT04881942|560046231|FG004|Overall Study|Alternates|2|||
155166315|NCT02423902|560046232|FG000|Overall Study|Disease progression|1|||
155166316|NCT02423902|560046233|FG001|Overall Study|Disease progression|4|||
155166317|NCT02136069|560046234|FG000|Overall Study|UC flare-up|1|||
155089335|NCT02958865|559759742|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
155089336|NCT02958865|559759743|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089337|NCT02958865|559759744|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089338|NCT02958865|559759745|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089339|NCT02958865|559759746|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089340|NCT02958865|559759747|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089341|NCT02958865|559759748|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089342|NCT02958865|559759749|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089343|NCT02958865|559759750|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089344|NCT02958865|559759751|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089345|NCT02958865|559759752|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089346|NCT02958865|559759753|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155089347|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089348|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089349|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089350|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155166318|NCT02136069|560046235|FG001|Overall Study|UC flare-up|0|||
155166319|NCT02136069|560046234|FG000|Overall Study|Adverse Event|6|||
155166320|NCT02136069|560046235|FG001|Overall Study|Adverse Event|8|||
155166321|NCT02136069|560046234|FG000|Overall Study|Death|0|||
155166322|NCT02136069|560046235|FG001|Overall Study|Death|1|||
155166323|NCT02136069|560046234|FG000|Overall Study|Lack of Efficacy|10|||
155166324|NCT02136069|560046235|FG001|Overall Study|Lack of Efficacy|4|||
155166325|NCT02136069|560046234|FG000|Overall Study|Lost to Follow-up|1|||
155361759|NCT01317875|560759140|FG007|Overall Study|Progressive Disease|1|||
155361760|NCT01317875|560759141|FG008|Overall Study|Progressive Disease|0|||
155361761|NCT01317875|560759142|FG009|Overall Study|Progressive Disease|0|||
155361762|NCT01317875|560759133|FG000|Overall Study|Withdrawal by Subject|0|||
155361763|NCT01317875|560759134|FG001|Overall Study|Withdrawal by Subject|0|||
155361764|NCT01317875|560759135|FG002|Overall Study|Withdrawal by Subject|0|||
155361765|NCT01317875|560759136|FG003|Overall Study|Withdrawal by Subject|0|||
155361766|NCT01317875|560759137|FG004|Overall Study|Withdrawal by Subject|1|||
155361767|NCT01317875|560759138|FG005|Overall Study|Withdrawal by Subject|0|||
155361768|NCT01317875|560759139|FG006|Overall Study|Withdrawal by Subject|0|||
155361769|NCT01317875|560759140|FG007|Overall Study|Withdrawal by Subject|3|||
155166326|NCT02136069|560046235|FG001|Overall Study|Lost to Follow-up|0|||
155166327|NCT02136069|560046234|FG000|Overall Study|Non-Compliance|1|||
155361770|NCT01317875|560759141|FG008|Overall Study|Withdrawal by Subject|0|||
155361771|NCT01317875|560759142|FG009|Overall Study|Withdrawal by Subject|0|||
155361772|NCT01317875|560759133|FG000|Overall Study|Physician Decision|0|||
155361773|NCT01317875|560759134|FG001|Overall Study|Physician Decision|1|||
155361774|NCT01317875|560759135|FG002|Overall Study|Physician Decision|1|||
155361775|NCT01317875|560759136|FG003|Overall Study|Physician Decision|0|||
155361776|NCT01317875|560759137|FG004|Overall Study|Physician Decision|2|||
155361777|NCT01317875|560759138|FG005|Overall Study|Physician Decision|0|||
155361778|NCT01317875|560759139|FG006|Overall Study|Physician Decision|0|||
155361779|NCT01317875|560759140|FG007|Overall Study|Physician Decision|2|||
155361780|NCT01317875|560759141|FG008|Overall Study|Physician Decision|0|||
155361781|NCT01317875|560759142|FG009|Overall Study|Physician Decision|0|||
155361782|NCT01317875|560759133|FG000|Overall Study|Death|0|||
155361783|NCT01317875|560759134|FG001|Overall Study|Death|0|||
155361784|NCT01317875|560759135|FG002|Overall Study|Death|2|||
155361785|NCT01317875|560759136|FG003|Overall Study|Death|1|||
155361786|NCT01317875|560759137|FG004|Overall Study|Death|0|||
155361787|NCT01317875|560759138|FG005|Overall Study|Death|1|||
155361788|NCT01317875|560759139|FG006|Overall Study|Death|0|||
155361789|NCT01317875|560759140|FG007|Overall Study|Death|4|||
155361790|NCT01317875|560759141|FG008|Overall Study|Death|0|||
155361791|NCT01317875|560759142|FG009|Overall Study|Death|0|||
155361792|NCT01317875|560759133|FG000|Overall Study|Adverse Event|2|||
155361793|NCT01317875|560759134|FG001|Overall Study|Adverse Event|1|||
155361794|NCT01317875|560759135|FG002|Overall Study|Adverse Event|2|||
155361795|NCT01317875|560759136|FG003|Overall Study|Adverse Event|1|||
155361796|NCT01317875|560759137|FG004|Overall Study|Adverse Event|5|||
155361797|NCT01317875|560759138|FG005|Overall Study|Adverse Event|1|||
155361798|NCT01317875|560759139|FG006|Overall Study|Adverse Event|2|||
155361799|NCT01317875|560759140|FG007|Overall Study|Adverse Event|5|||
155361800|NCT01317875|560759141|FG008|Overall Study|Adverse Event|0|||
155089351|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089352|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089353|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089354|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155089355|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155089356|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
155089357|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
155089358|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155089359|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
155089360|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155089361|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
155089362|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
155089363|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089364|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089365|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089366|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089367|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089368|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089369|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089370|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089371|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
155166328|NCT02136069|560046235|FG001|Overall Study|Non-Compliance|0|||
155166329|NCT02136069|560046234|FG000|Overall Study|Physician Decision|5|||
155089372|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
155089373|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089374|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
155089375|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155089376|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
155361801|NCT01317875|560759142|FG009|Overall Study|Adverse Event|0|||
155361802|NCT01381575|560759143|FG000|Overall Study|Serious Adverse Event|1|||
155089377|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
155361803|NCT01381575|560759144|FG001|Overall Study|Serious Adverse Event|0|||
155361804|NCT01381575|560759145|FG002|Overall Study|Serious Adverse Event|0|||
155361805|NCT01381575|560759143|FG000|Overall Study|Non-Serious Adverse Event|0|||
155361806|NCT01381575|560759144|FG001|Overall Study|Non-Serious Adverse Event|0|||
155361807|NCT01381575|560759145|FG002|Overall Study|Non-Serious Adverse Event|1|||
155361808|NCT01381575|560759143|FG000|Overall Study|Protocol Violation|0|||
155089378|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
155361809|NCT01381575|560759144|FG001|Overall Study|Protocol Violation|1|||
155361810|NCT01381575|560759145|FG002|Overall Study|Protocol Violation|1|||
155361811|NCT01381575|560759143|FG000|Overall Study|Withdrawal by Subject|15|||
155361812|NCT01381575|560759144|FG001|Overall Study|Withdrawal by Subject|9|||
155361813|NCT01381575|560759145|FG002|Overall Study|Withdrawal by Subject|7|||
155361814|NCT01381575|560759143|FG000|Overall Study|Migrated/moved from study area|2|||
155361815|NCT01381575|560759144|FG001|Overall Study|Migrated/moved from study area|12|||
155361816|NCT01381575|560759145|FG002|Overall Study|Migrated/moved from study area|2|||
155361817|NCT01381575|560759143|FG000|Overall Study|Lost to Follow-up|8|||
155361818|NCT01381575|560759144|FG001|Overall Study|Lost to Follow-up|17|||
155361819|NCT01381575|560759145|FG002|Overall Study|Lost to Follow-up|9|||
155361820|NCT01377389|560759146|FG000|Overall Study|Withdrawal by Subject|1|||
155361821|NCT01377389|560759146|FG000|Overall Study|Screen failure|2|||
155361822|NCT04546217|560759147|FG000|Overall Study|Withdrawal by Subject|2|||
155361823|NCT04546217|560759148|FG001|Overall Study|Withdrawal by Subject|0|||
155361824|NCT04546217|560759147|FG000|Overall Study|Uncontrolled hypertension|1|||
155361825|NCT04546217|560759148|FG001|Overall Study|Uncontrolled hypertension|0|||
155361826|NCT03020069|560759149|FG000|Overall Study|Lost to Follow-up|0|||
155361827|NCT03020069|560759150|FG001|Overall Study|Lost to Follow-up|1|||
155361828|NCT01439867|560759154|FG000|Overall Study|Non-compliance|0|||
155361829|NCT01439867|560759155|FG001|Overall Study|Non-compliance|1|||
155361830|NCT01439867|560759154|FG000|Overall Study|Withdrawal by Subject|1|||
155361831|NCT01439867|560759155|FG001|Overall Study|Withdrawal by Subject|2|||
155361832|NCT01439867|560759154|FG000|Overall Study|Administrative Decision|4|||
155361833|NCT01439867|560759155|FG001|Overall Study|Administrative Decision|5|||
155361834|NCT01439867|560759154|FG000|Overall Study|Protocol-specified Criteria|1|||
155089379|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089380|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089381|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089382|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089383|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089384|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089385|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089386|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089387|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155361835|NCT01439867|560759155|FG001|Overall Study|Protocol-specified Criteria|0|||
155089388|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
155089389|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089390|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089391|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089392|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089393|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
155089394|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
155089395|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089396|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089397|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089398|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089399|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089400|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089401|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089402|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089403|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089404|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089405|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
155089406|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
155089407|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
155166330|NCT02136069|560046235|FG001|Overall Study|Physician Decision|4|||
155166331|NCT02136069|560046234|FG000|Overall Study|Withdrawal by Subject|10|||
155166332|NCT02136069|560046235|FG001|Overall Study|Withdrawal by Subject|11|||
155166333|NCT04838626|560046236|FG000|Overall Study|Adverse Event|2|||
155166334|NCT04838626|560046236|FG000|Overall Study|Physician Decision|6|||
155166335|NCT04838626|560046236|FG000|Overall Study|Protocol Violation|3|||
155166336|NCT04838626|560046236|FG000|Overall Study|Withdrawal by Subject|9|||
155361836|NCT00863512|560759156|FG000|Overall Study|Adverse Event|2|||
155361837|NCT00863512|560759157|FG001|Overall Study|Adverse Event|0|||
155089408|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
155166337|NCT04838626|560046236|FG000|Overall Study|Technical Problems|2|||
155361838|NCT00863512|560759156|FG000|Overall Study|Withdrawal by Subject|11|||
155361839|NCT00863512|560759157|FG001|Overall Study|Withdrawal by Subject|0|||
155361840|NCT00863512|560759156|FG000|Overall Study|Physician Decision|1|||
155089409|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
155089410|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
155089411|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
155361841|NCT00863512|560759157|FG001|Overall Study|Physician Decision|0|||
155361842|NCT01920932|560759160|FG000|Overall Study|Death|1|||
155361843|NCT01920932|560759160|FG000|Overall Study|Withdrawal of consent|1|||
155361844|NCT02906020|560759161|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
155361845|NCT02906020|560759162|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
155361846|NCT02906020|560759163|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
155361847|NCT02906020|560759164|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
155089412|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
155089413|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
155089414|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
155089415|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
155089416|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
155089417|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
155089418|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
155089419|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
155089420|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
155089421|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
155089422|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
155089423|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
155089424|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
155089425|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
155089426|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
155089427|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089428|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089429|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089430|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089431|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089432|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089433|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089434|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089435|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089436|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089437|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089438|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089439|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089440|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
155089441|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089442|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
155089443|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089444|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089445|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089446|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089447|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089448|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155361848|NCT02906020|560759165|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
155361849|NCT02906020|560759166|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
155361850|NCT02906020|560759167|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
155361851|NCT02906020|560759168|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
155361852|NCT02906020|560759169|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
155361853|NCT02906020|560759170|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
155361854|NCT02906020|560759171|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
155361855|NCT02906020|560759172|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
155361856|NCT02906020|560759173|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
155361857|NCT02906020|560759174|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
155361858|NCT02906020|560759175|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
155361859|NCT02906020|560759176|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
155361860|NCT02906020|560759161|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361861|NCT02906020|560759162|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361862|NCT02906020|560759163|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361863|NCT02906020|560759164|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361864|NCT02906020|560759165|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361865|NCT02906020|560759166|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155089449|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089450|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089451|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089452|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155361866|NCT02906020|560759167|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361867|NCT02906020|560759168|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361868|NCT02906020|560759169|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
155361869|NCT02906020|560759170|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
155361870|NCT02906020|560759171|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361871|NCT02906020|560759172|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361872|NCT02906020|560759173|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361873|NCT02906020|560759174|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155089453|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089454|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089455|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089456|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
155089457|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089458|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
155089459|NCT02958865|559759738|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089460|NCT02958865|559759739|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089461|NCT02958865|559759740|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089462|NCT02958865|559759741|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089463|NCT02958865|559759742|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089464|NCT02958865|559759743|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089465|NCT02958865|559759744|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089466|NCT02958865|559759745|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089467|NCT02958865|559759746|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089468|NCT02958865|559759747|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
155089469|NCT02958865|559759748|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089470|NCT02958865|559759749|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089471|NCT02958865|559759750|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089472|NCT02958865|559759751|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089473|NCT02958865|559759752|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089474|NCT02958865|559759753|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
155089475|NCT01309230|559759754|FG000|Overall Study|Withdrawal by Subject|0|||
155089476|NCT01309230|559759755|FG001|Overall Study|Withdrawal by Subject|2|||
155089477|NCT01309230|559759754|FG000|Overall Study|Observation arm closed|0|||
155089478|NCT01309230|559759755|FG001|Overall Study|Observation arm closed|2|||
155089479|NCT02661815|559759756|FG000|Overall Study|Withdrawal by Subject|1|||
155089480|NCT02661815|559759757|FG001|Overall Study|Withdrawal by Subject|0|||
155089481|NCT02661815|559759758|FG002|Overall Study|Withdrawal by Subject|0|||
155089482|NCT02661815|559759759|FG003|Overall Study|Withdrawal by Subject|0|||
155089483|NCT01605097|559759766|FG000|Overall Study|Protocol Violation|1|||
155089484|NCT04380142|559759769|FG000|LD/CD Stabilization Period|Adverse Event|3|||
155089485|NCT04380142|559759770|FG001|LD/CD Stabilization Period|Adverse Event|0|||
155089486|NCT04380142|559759771|FG002|LD/CD Stabilization Period|Adverse Event|0|||
155089487|NCT04380142|559759769|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
155166338|NCT00578292|560046237|FG000|Overall Study|Death|1|||
155166339|NCT00578292|560046237|FG000|Overall Study|Graft failure|2|||
155166340|NCT03901469|560046238|FG000|Overall Study|Radiographic Progression|4|||
155166341|NCT03901469|560046239|FG001|Overall Study|Radiographic Progression|6|||
155361874|NCT02906020|560759175|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361875|NCT02906020|560759176|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
155361876|NCT02906020|560759161|FG000|Part 2: Double-blind Treatment Period|Other|0|||
155361877|NCT02906020|560759162|FG001|Part 2: Double-blind Treatment Period|Other|0|||
155361878|NCT02906020|560759163|FG002|Part 2: Double-blind Treatment Period|Other|0|||
155361879|NCT02906020|560759164|FG003|Part 2: Double-blind Treatment Period|Other|0|||
155361880|NCT02906020|560759165|FG004|Part 2: Double-blind Treatment Period|Other|0|||
155361881|NCT02906020|560759166|FG005|Part 2: Double-blind Treatment Period|Other|0|||
155361882|NCT02906020|560759167|FG006|Part 2: Double-blind Treatment Period|Other|0|||
155361883|NCT02906020|560759168|FG007|Part 2: Double-blind Treatment Period|Other|0|||
155361884|NCT02906020|560759169|FG008|Part 2: Double-blind Treatment Period|Other|6|||
155361885|NCT02906020|560759170|FG009|Part 2: Double-blind Treatment Period|Other|10|||
155361886|NCT02906020|560759171|FG010|Part 2: Double-blind Treatment Period|Other|0|||
155361887|NCT02906020|560759172|FG011|Part 2: Double-blind Treatment Period|Other|0|||
155361888|NCT02906020|560759173|FG012|Part 2: Double-blind Treatment Period|Other|0|||
155361889|NCT02906020|560759174|FG013|Part 2: Double-blind Treatment Period|Other|0|||
155361890|NCT02906020|560759175|FG014|Part 2: Double-blind Treatment Period|Other|0|||
155361891|NCT02906020|560759176|FG015|Part 2: Double-blind Treatment Period|Other|0|||
155361892|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361893|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361894|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361895|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361896|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361897|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361898|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361899|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361900|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361901|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361902|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361903|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361904|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
155361905|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
155361906|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361907|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
155361908|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361909|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361910|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361911|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361912|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361913|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361914|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361915|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361916|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361917|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361918|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361919|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361920|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
155361921|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
155361922|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
155361923|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
155361924|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361925|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361926|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361927|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361928|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361929|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361930|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361931|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361932|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361933|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361934|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361935|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361936|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
155361937|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
155361938|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361939|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
155361940|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361941|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361942|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361943|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361944|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361945|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361946|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361947|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361948|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361949|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361950|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
154965259|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965260|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155361951|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361952|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
155361953|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
155361954|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361955|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
155361956|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361957|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361958|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361959|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361960|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361961|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361962|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361963|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361964|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361965|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361966|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361967|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
155361968|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
155361969|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
155361970|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
155361971|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
155361972|NCT02906020|560759161|FG000|Part 2: Long-term Follow-up Period|Other|0|||
155361973|NCT02906020|560759162|FG001|Part 2: Long-term Follow-up Period|Other|0|||
155361974|NCT02906020|560759163|FG002|Part 2: Long-term Follow-up Period|Other|0|||
155361975|NCT02906020|560759164|FG003|Part 2: Long-term Follow-up Period|Other|0|||
155361976|NCT02906020|560759165|FG004|Part 2: Long-term Follow-up Period|Other|0|||
155361977|NCT02906020|560759166|FG005|Part 2: Long-term Follow-up Period|Other|0|||
155361978|NCT02906020|560759167|FG006|Part 2: Long-term Follow-up Period|Other|0|||
155361979|NCT02906020|560759168|FG007|Part 2: Long-term Follow-up Period|Other|0|||
155361980|NCT02906020|560759169|FG008|Part 2: Long-term Follow-up Period|Other|0|||
155361981|NCT02906020|560759170|FG009|Part 2: Long-term Follow-up Period|Other|0|||
155361982|NCT02906020|560759171|FG010|Part 2: Long-term Follow-up Period|Other|0|||
155361983|NCT02906020|560759172|FG011|Part 2: Long-term Follow-up Period|Other|0|||
155361984|NCT02906020|560759173|FG012|Part 2: Long-term Follow-up Period|Other|13|||
155361985|NCT02906020|560759174|FG013|Part 2: Long-term Follow-up Period|Other|8|||
155361986|NCT02906020|560759175|FG014|Part 2: Long-term Follow-up Period|Other|3|||
155361987|NCT02906020|560759176|FG015|Part 2: Long-term Follow-up Period|Other|2|||
155361988|NCT01124097|560759177|FG000|Overall Study|Withdrawal by Subject|4|||
155361989|NCT01124097|560759178|FG001|Overall Study|Withdrawal by Subject|3|||
155361990|NCT01124097|560759179|FG002|Overall Study|Withdrawal by Subject|2|||
155361991|NCT01124097|560759180|FG003|Overall Study|Withdrawal by Subject|3|||
155361992|NCT01124097|560759177|FG000|Overall Study|Lack of Efficacy|2|||
155361993|NCT01124097|560759178|FG001|Overall Study|Lack of Efficacy|3|||
155361994|NCT01124097|560759179|FG002|Overall Study|Lack of Efficacy|1|||
155361995|NCT01124097|560759180|FG003|Overall Study|Lack of Efficacy|3|||
155361996|NCT01124097|560759177|FG000|Overall Study|Adverse Event|24|||
155361997|NCT01124097|560759178|FG001|Overall Study|Adverse Event|15|||
155361998|NCT01124097|560759179|FG002|Overall Study|Adverse Event|15|||
155361999|NCT01124097|560759180|FG003|Overall Study|Adverse Event|7|||
155362000|NCT01124097|560759177|FG000|Overall Study|Protocol Violation|2|||
155362001|NCT01124097|560759178|FG001|Overall Study|Protocol Violation|0|||
155362002|NCT01124097|560759179|FG002|Overall Study|Protocol Violation|2|||
155362003|NCT01124097|560759180|FG003|Overall Study|Protocol Violation|1|||
155362004|NCT01124097|560759177|FG000|Overall Study|Physician Decision|2|||
155362005|NCT01124097|560759178|FG001|Overall Study|Physician Decision|1|||
155362006|NCT01124097|560759179|FG002|Overall Study|Physician Decision|0|||
155362007|NCT01124097|560759180|FG003|Overall Study|Physician Decision|0|||
155362008|NCT00425607|560759181|FG000|Overall Study|Death|1|||
155362009|NCT00425607|560759181|FG000|Overall Study|Withdrawal by Subject|1|||
155362010|NCT00193479|560759182|FG000|Induction Chemotherapy|Adverse Event|2|||
155362011|NCT00193479|560759182|FG000|Induction Chemotherapy|Disease Progression|1|||
155362012|NCT00193479|560759182|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
155362013|NCT00193479|560759182|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
155362014|NCT00079339|560759183|FG000|Overall Study|Adverse Event|1|||
155362015|NCT00079339|560759184|FG001|Overall Study|Adverse Event|7|||
155362016|NCT00079339|560759185|FG002|Overall Study|Adverse Event|2|||
155362017|NCT00079339|560759183|FG000|Overall Study|Death|1|||
155362018|NCT00079339|560759184|FG001|Overall Study|Death|0|||
155362019|NCT00079339|560759185|FG002|Overall Study|Death|0|||
155362020|NCT00079339|560759183|FG000|Overall Study|Non-compliance|0|||
155362021|NCT00079339|560759184|FG001|Overall Study|Non-compliance|0|||
155362022|NCT00079339|560759185|FG002|Overall Study|Non-compliance|1|||
155362023|NCT00079339|560759183|FG000|Overall Study|Withdrawal by Subject|0|||
155362024|NCT00079339|560759184|FG001|Overall Study|Withdrawal by Subject|4|||
155362025|NCT00079339|560759185|FG002|Overall Study|Withdrawal by Subject|1|||
155362026|NCT00079339|560759183|FG000|Overall Study|Disease progression|3|||
155362027|NCT00079339|560759184|FG001|Overall Study|Disease progression|28|||
155362028|NCT00079339|560759185|FG002|Overall Study|Disease progression|2|||
155362029|NCT00559377|560759186|FG000|Overall Study|Withdrawal by Subject|9|||
155166342|NCT03901469|560046240|FG002|Overall Study|Radiographic Progression|3|||
155362030|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
155362031|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362032|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362033|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
155362034|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362035|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
155362036|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
155362037|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
155362038|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
155362039|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
155362040|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
155362041|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
155362042|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362043|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362044|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
155362045|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362046|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362047|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
155362048|NCT02563548|560759188|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362049|NCT02563548|560759189|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362050|NCT02563548|560759190|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
155362051|NCT02563548|560759191|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
155362052|NCT02563548|560759192|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362053|NCT02563548|560759193|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
155362054|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362055|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362056|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362057|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
155362058|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
155362059|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
155362060|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362061|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362062|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362063|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
155362064|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
155362065|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
155362066|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362067|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362068|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362069|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362070|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
155362071|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
155362072|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362073|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362074|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155166343|NCT03901469|560046241|FG003|Overall Study|Radiographic Progression|30|||
155166344|NCT03901469|560046242|FG004|Overall Study|Radiographic Progression|7|||
155166345|NCT03901469|560046243|FG005|Overall Study|Radiographic Progression|2|||
155362075|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
155362076|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
155362077|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
155362078|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362079|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362080|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362081|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362082|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
155362083|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
155362084|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362085|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362086|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362087|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362088|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
155362089|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
155362090|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155166346|NCT03901469|560046244|FG006|Overall Study|Radiographic Progression|11|||
155166347|NCT03901469|560046238|FG000|Overall Study|Clinical Progression|0|||
155362091|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362092|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362093|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
155362094|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
154965261|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965262|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965263|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
155362095|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
155362096|NCT02563548|560759188|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362097|NCT02563548|560759189|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362098|NCT02563548|560759190|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362099|NCT02563548|560759191|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362100|NCT02563548|560759192|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
155362101|NCT02563548|560759193|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
155362102|NCT00203047|560759198|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
155362103|NCT00203047|560759199|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
155362104|NCT00203047|560759198|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
155362105|NCT00203047|560759199|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
155362106|NCT00203047|560759198|FG000|Overall Study|Withdrawal by Subject|13|||
155362107|NCT00203047|560759199|FG001|Overall Study|Withdrawal by Subject|47|||
155362108|NCT00203047|560759198|FG000|Overall Study|Teva requested participant withdrawal|1|||
155362109|NCT00203047|560759199|FG001|Overall Study|Teva requested participant withdrawal|1|||
155362110|NCT00203047|560759198|FG000|Overall Study|Physician Decision|8|||
155362111|NCT00203047|560759199|FG001|Overall Study|Physician Decision|7|||
155362112|NCT00203047|560759198|FG000|Overall Study|Non-compliance|4|||
155362113|NCT00203047|560759199|FG001|Overall Study|Non-compliance|8|||
155362114|NCT00203047|560759198|FG000|Overall Study|Protocol Violation|1|||
155362115|NCT00203047|560759199|FG001|Overall Study|Protocol Violation|0|||
155362116|NCT00203047|560759198|FG000|Overall Study|Lost to Follow-up|11|||
155362117|NCT00203047|560759199|FG001|Overall Study|Lost to Follow-up|5|||
155362118|NCT00203047|560759198|FG000|Overall Study|Adverse Event|8|||
155362119|NCT00203047|560759199|FG001|Overall Study|Adverse Event|18|||
155362120|NCT00203047|560759198|FG000|Overall Study|Death|1|||
155362121|NCT00203047|560759199|FG001|Overall Study|Death|2|||
155362122|NCT00203047|560759198|FG000|Overall Study|Pregnancy|3|||
155362123|NCT00203047|560759199|FG001|Overall Study|Pregnancy|0|||
155362124|NCT00203047|560759198|FG000|Overall Study|Other|5|||
155362125|NCT00203047|560759199|FG001|Overall Study|Other|5|||
155362126|NCT01453023|560759202|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
155362127|NCT01453023|560759203|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
155362128|NCT01453023|560759202|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
155362129|NCT01453023|560759203|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
155362130|NCT01453023|560759202|FG000|Treatment Period 2|Protocol Violation|0|||
155362131|NCT01453023|560759203|FG001|Treatment Period 2|Protocol Violation|1|||
155362132|NCT03721172|560759204|FG000|Placebo-controlled Phase|Adverse Event|7|||
155362133|NCT03721172|560759205|FG001|Placebo-controlled Phase|Adverse Event|7|||
155362134|NCT03721172|560759206|FG002|Placebo-controlled Phase|Adverse Event|0|||
155362135|NCT03721172|560759204|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
155362136|NCT03721172|560759205|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
154965264|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965265|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965266|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965267|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965268|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965269|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965270|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965271|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
154965272|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
154965273|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155362137|NCT03721172|560759206|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
154965274|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
154965275|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
155362138|NCT03721172|560759204|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
155362139|NCT03721172|560759205|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
155362140|NCT03721172|560759206|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
155362141|NCT03721172|560759204|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
155362142|NCT03721172|560759205|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
155362143|NCT03721172|560759206|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
155362144|NCT03721172|560759204|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
155362145|NCT03721172|560759205|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
154965276|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
155362146|NCT03721172|560759206|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
155362147|NCT03721172|560759204|FG000|Placebo-controlled Phase|Other|3|||
155362148|NCT03721172|560759205|FG001|Placebo-controlled Phase|Other|0|||
155362149|NCT03721172|560759206|FG002|Placebo-controlled Phase|Other|0|||
155362150|NCT03721172|560759204|FG000|Apremilast Extension Phase|Adverse Event|0|||
155362151|NCT03721172|560759205|FG001|Apremilast Extension Phase|Adverse Event|0|||
155362152|NCT03721172|560759206|FG002|Apremilast Extension Phase|Adverse Event|10|||
155362153|NCT03721172|560759204|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
155362154|NCT03721172|560759205|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
155362155|NCT03721172|560759206|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
155362156|NCT03721172|560759204|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
155362157|NCT03721172|560759205|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
155362158|NCT03721172|560759206|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
155362159|NCT03721172|560759204|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
155362160|NCT03721172|560759205|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
155362161|NCT03721172|560759206|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
155362162|NCT03721172|560759204|FG000|Apremilast Extension Phase|Protocol Violation|0|||
155362163|NCT03721172|560759205|FG001|Apremilast Extension Phase|Protocol Violation|0|||
155362164|NCT03721172|560759206|FG002|Apremilast Extension Phase|Protocol Violation|1|||
155362165|NCT03721172|560759204|FG000|Apremilast Extension Phase|Physician Decision|0|||
155362166|NCT03721172|560759205|FG001|Apremilast Extension Phase|Physician Decision|0|||
155362167|NCT03721172|560759206|FG002|Apremilast Extension Phase|Physician Decision|1|||
155362168|NCT03721172|560759204|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
155362169|NCT03721172|560759205|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
155362170|NCT03721172|560759206|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
155362171|NCT03721172|560759204|FG000|Apremilast Extension Phase|Other|0|||
155362172|NCT03721172|560759205|FG001|Apremilast Extension Phase|Other|0|||
155362173|NCT03721172|560759206|FG002|Apremilast Extension Phase|Other|3|||
155362174|NCT03721172|560759204|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
155362175|NCT03721172|560759205|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
155362176|NCT03721172|560759206|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
155362177|NCT00420784|560759207|FG000|Overall Study|Adverse Event|11|||
155362178|NCT00420784|560759208|FG001|Overall Study|Adverse Event|29|||
155362179|NCT00420784|560759209|FG002|Overall Study|Adverse Event|10|||
155362180|NCT00420784|560759210|FG003|Overall Study|Adverse Event|5|||
155362181|NCT00420784|560759207|FG000|Overall Study|Withdrawal by Subject|0|||
155362182|NCT00420784|560759208|FG001|Overall Study|Withdrawal by Subject|1|||
155362183|NCT00420784|560759209|FG002|Overall Study|Withdrawal by Subject|0|||
155362184|NCT00420784|560759210|FG003|Overall Study|Withdrawal by Subject|0|||
155362185|NCT00420784|560759207|FG000|Overall Study|Lost to Follow-up|0|||
155362186|NCT00420784|560759208|FG001|Overall Study|Lost to Follow-up|0|||
155362187|NCT00420784|560759209|FG002|Overall Study|Lost to Follow-up|2|||
155362188|NCT00420784|560759210|FG003|Overall Study|Lost to Follow-up|1|||
155362189|NCT00420784|560759207|FG000|Overall Study|Virologic Stopping Rule|17|||
155362190|NCT00420784|560759208|FG001|Overall Study|Virologic Stopping Rule|26|||
155362191|NCT00420784|560759209|FG002|Overall Study|Virologic Stopping Rule|41|||
155362192|NCT00420784|560759210|FG003|Overall Study|Virologic Stopping Rule|67|||
155362193|NCT00420784|560759207|FG000|Overall Study|Other|1|||
155362194|NCT00420784|560759208|FG001|Overall Study|Other|2|||
155362195|NCT00420784|560759209|FG002|Overall Study|Other|0|||
155362196|NCT00420784|560759210|FG003|Overall Study|Other|5|||
155362197|NCT03934099|560759213|FG000|Overall Study|Adverse Event|0|||
155362198|NCT03934099|560759214|FG001|Overall Study|Adverse Event|3|||
155362199|NCT03934099|560759215|FG002|Overall Study|Adverse Event|1|||
155362200|NCT03934099|560759216|FG003|Overall Study|Adverse Event|0|||
155362201|NCT03934099|560759213|FG000|Overall Study|Lost to Follow-up|1|||
155362202|NCT03934099|560759214|FG001|Overall Study|Lost to Follow-up|2|||
155362203|NCT03934099|560759215|FG002|Overall Study|Lost to Follow-up|1|||
155362204|NCT03934099|560759216|FG003|Overall Study|Lost to Follow-up|1|||
155362205|NCT03934099|560759213|FG000|Overall Study|Protocol Violation|1|||
155362206|NCT03934099|560759214|FG001|Overall Study|Protocol Violation|0|||
155362207|NCT03934099|560759215|FG002|Overall Study|Protocol Violation|0|||
155362208|NCT03934099|560759216|FG003|Overall Study|Protocol Violation|0|||
155362209|NCT03934099|560759213|FG000|Overall Study|Withdrawal by Subject|2|||
155362210|NCT03934099|560759214|FG001|Overall Study|Withdrawal by Subject|0|||
155362211|NCT03934099|560759215|FG002|Overall Study|Withdrawal by Subject|1|||
155362212|NCT03934099|560759216|FG003|Overall Study|Withdrawal by Subject|1|||
155362213|NCT03934099|560759213|FG000|Overall Study|Other reasons|0|||
155362214|NCT03934099|560759214|FG001|Overall Study|Other reasons|1|||
155362215|NCT03934099|560759215|FG002|Overall Study|Other reasons|0|||
155362216|NCT03934099|560759216|FG003|Overall Study|Other reasons|0|||
155362217|NCT02417441|560759217|FG000|Overall Study|Inconclusive due to missing data|52|||
155362218|NCT02417441|560759218|FG001|Overall Study|Inconclusive due to missing data|19|||
155362219|NCT05628285|560759219|FG000|Overall Study|Lost to Follow-up|1|||
155362220|NCT02339506|560759220|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
155362221|NCT02339506|560759221|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
155362222|NCT02339506|560759220|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
155362223|NCT02339506|560759221|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
155362224|NCT02869867|560759222|FG000|Overall Study|Protocol Violation|1|||
155362225|NCT02869867|560759223|FG001|Overall Study|Protocol Violation|0|||
155362226|NCT02869867|560759222|FG000|Overall Study|Lost to Follow-up|5|||
155362227|NCT02869867|560759223|FG001|Overall Study|Lost to Follow-up|5|||
155362228|NCT05555615|560759228|FG000|Overall Study|Adverse Event|7|||
155362229|NCT05555615|560759228|FG000|Overall Study|Lack of Efficacy|12|||
155362230|NCT05555615|560759228|FG000|Overall Study|Lost to Follow-up|10|||
155362231|NCT05555615|560759228|FG000|Overall Study|Noncompliance with study drug|5|||
155362232|NCT05555615|560759228|FG000|Overall Study|Physician Decision|2|||
155362233|NCT05555615|560759228|FG000|Overall Study|Study terminated by sponsor|80|||
155362234|NCT05555615|560759228|FG000|Overall Study|Prohibited medication use|2|||
155362235|NCT05555615|560759228|FG000|Overall Study|Withdrawal by Subject|20|||
155362236|NCT05555615|560759228|FG000|Overall Study|Not further specified|4|||
155362237|NCT03016598|560759229|FG000|Overall Study|Lost to Follow-up|0|||
155362238|NCT03016598|560759230|FG001|Overall Study|Lost to Follow-up|2|||
155362239|NCT01728623|560759234|FG000|Overall Study|Disease progression|26|||
155362240|NCT01728623|560759234|FG000|Overall Study|Adverse Event|1|||
155362241|NCT01728623|560759234|FG000|Overall Study|Withdrawal by Subject|1|||
155166348|NCT03901469|560046239|FG001|Overall Study|Clinical Progression|2|||
155166349|NCT03901469|560046240|FG002|Overall Study|Clinical Progression|0|||
155166350|NCT03901469|560046241|FG003|Overall Study|Clinical Progression|7|||
155166351|NCT03901469|560046242|FG004|Overall Study|Clinical Progression|6|||
155166352|NCT03901469|560046243|FG005|Overall Study|Clinical Progression|0|||
155166353|NCT03901469|560046244|FG006|Overall Study|Clinical Progression|2|||
155362242|NCT01667549|560759235|FG000|Overall Study|Withdrawal by Subject|3|||
155362243|NCT01667549|560759236|FG001|Overall Study|Withdrawal by Subject|5|||
155362244|NCT01667549|560759237|FG002|Overall Study|Withdrawal by Subject|7|||
155362245|NCT01667549|560759238|FG003|Overall Study|Withdrawal by Subject|6|||
155362246|NCT01667549|560759239|FG004|Overall Study|Withdrawal by Subject|1|||
155362247|NCT01407276|560759240|FG000|Overall Study|Withdrawal by Subject|0|||
155362248|NCT01407276|560759241|FG001|Overall Study|Withdrawal by Subject|0|||
155362249|NCT01407276|560759242|FG002|Overall Study|Withdrawal by Subject|0|||
155362250|NCT01407276|560759243|FG003|Overall Study|Withdrawal by Subject|0|||
155362251|NCT01407276|560759244|FG004|Overall Study|Withdrawal by Subject|0|||
155362252|NCT01407276|560759245|FG005|Overall Study|Withdrawal by Subject|0|||
155362253|NCT01407276|560759246|FG006|Overall Study|Withdrawal by Subject|0|||
155362254|NCT01407276|560759247|FG007|Overall Study|Withdrawal by Subject|1|||
155362255|NCT04092452|560759249|FG000|Overall Study|Adverse Event|1|||
155362256|NCT04092452|560759250|FG001|Overall Study|Adverse Event|3|||
155362257|NCT04092452|560759251|FG002|Overall Study|Adverse Event|3|||
155362258|NCT04092452|560759252|FG003|Overall Study|Adverse Event|7|||
155362259|NCT04092452|560759249|FG000|Overall Study|Lack of Efficacy|1|||
155362260|NCT04092452|560759250|FG001|Overall Study|Lack of Efficacy|1|||
155362261|NCT04092452|560759251|FG002|Overall Study|Lack of Efficacy|1|||
155362262|NCT04092452|560759252|FG003|Overall Study|Lack of Efficacy|0|||
155362263|NCT04092452|560759249|FG000|Overall Study|Lost to Follow-up|4|||
155362264|NCT04092452|560759250|FG001|Overall Study|Lost to Follow-up|3|||
155362265|NCT04092452|560759251|FG002|Overall Study|Lost to Follow-up|5|||
155362266|NCT04092452|560759252|FG003|Overall Study|Lost to Follow-up|1|||
155362267|NCT04092452|560759249|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155362268|NCT04092452|560759250|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155362269|NCT04092452|560759251|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155362270|NCT04092452|560759252|FG003|Overall Study|Non-Compliance With Study Drug|1|||
155362271|NCT04092452|560759249|FG000|Overall Study|Physician Decision|1|||
155362272|NCT04092452|560759250|FG001|Overall Study|Physician Decision|0|||
155362273|NCT04092452|560759251|FG002|Overall Study|Physician Decision|1|||
155362274|NCT04092452|560759252|FG003|Overall Study|Physician Decision|0|||
155362275|NCT04092452|560759249|FG000|Overall Study|Pregnancy|2|||
154965277|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965278|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
155166354|NCT03901469|560046238|FG000|Overall Study|Adverse Event|1|||
155166355|NCT03901469|560046239|FG001|Overall Study|Adverse Event|0|||
155166356|NCT03901469|560046240|FG002|Overall Study|Adverse Event|0|||
155166357|NCT03901469|560046241|FG003|Overall Study|Adverse Event|0|||
155362276|NCT04092452|560759250|FG001|Overall Study|Pregnancy|0|||
155362277|NCT04092452|560759251|FG002|Overall Study|Pregnancy|0|||
155362278|NCT04092452|560759252|FG003|Overall Study|Pregnancy|0|||
155362279|NCT04092452|560759249|FG000|Overall Study|Protocol Deviation|1|||
155362280|NCT04092452|560759250|FG001|Overall Study|Protocol Deviation|0|||
155362281|NCT04092452|560759251|FG002|Overall Study|Protocol Deviation|0|||
155362282|NCT04092452|560759252|FG003|Overall Study|Protocol Deviation|0|||
155362283|NCT04092452|560759249|FG000|Overall Study|Withdrawal by Subject|3|||
155362284|NCT04092452|560759250|FG001|Overall Study|Withdrawal by Subject|10|||
155362285|NCT04092452|560759251|FG002|Overall Study|Withdrawal by Subject|3|||
155362286|NCT04092452|560759252|FG003|Overall Study|Withdrawal by Subject|5|||
155362287|NCT04092452|560759249|FG000|Overall Study|Other|0|||
155362288|NCT04092452|560759250|FG001|Overall Study|Other|0|||
155362289|NCT04092452|560759251|FG002|Overall Study|Other|1|||
155362290|NCT04092452|560759252|FG003|Overall Study|Other|2|||
155362291|NCT01791413|560759261|FG000|Overall Study|Lost to Follow-up|5|||
155362292|NCT01791413|560759262|FG001|Overall Study|Lost to Follow-up|1|||
155362293|NCT05594589|560759265|FG000|Overall Study|Other|0|||
155362294|NCT05594589|560759266|FG001|Overall Study|Other|1|||
155362295|NCT05594589|560759267|FG002|Overall Study|Other|0|||
155362296|NCT01536171|560759268|FG000|Overall Study|Withdrawal by Subject|1|||
155362297|NCT01262092|560759269|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
155362298|NCT01262092|560759270|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
155362299|NCT01262092|560759269|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
155362300|NCT01262092|560759270|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
155362301|NCT01262092|560759269|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
155362302|NCT01262092|560759270|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
155362303|NCT01262092|560759269|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
155362304|NCT01262092|560759270|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
155362305|NCT03784820|560759271|FG000|Overall Study|Lost to Follow-up|5|||
155362306|NCT03784820|560759272|FG001|Overall Study|Lost to Follow-up|5|||
155362307|NCT03784820|560759273|FG002|Overall Study|Lost to Follow-up|3|||
155362308|NCT03784820|560759274|FG003|Overall Study|Lost to Follow-up|3|||
155362309|NCT02336425|560759275|FG000|Overall Study|Study terminated.|2|||
155362310|NCT02336425|560759276|FG001|Overall Study|Study terminated.|2|||
155362311|NCT02336425|560759277|FG002|Overall Study|Study terminated.|3|||
155362312|NCT02336425|560759278|FG003|Overall Study|Study terminated.|3|||
155362313|NCT01191008|560759279|FG000|Overall Study|Protocol Violation|7|||
155362314|NCT01191008|560759279|FG000|Overall Study|Lost to Follow-up|8|||
155362315|NCT02201901|560759283|FG000|Overall Study|Randomized but never treated|0|||
155362316|NCT02201901|560759284|FG001|Overall Study|Randomized but never treated|1|||
155362317|NCT02201901|560759285|FG002|Overall Study|Randomized but never treated|0|||
155362318|NCT02201901|560759283|FG000|Overall Study|Lack of Efficacy|7|||
155362319|NCT02201901|560759284|FG001|Overall Study|Lack of Efficacy|1|||
155362320|NCT02201901|560759285|FG002|Overall Study|Lack of Efficacy|6|||
155362321|NCT02201901|560759283|FG000|Overall Study|Death|3|||
155362322|NCT02201901|560759284|FG001|Overall Study|Death|3|||
155362323|NCT02201901|560759285|FG002|Overall Study|Death|3|||
155362324|NCT02201901|560759283|FG000|Overall Study|Lost to Follow-up|2|||
155362325|NCT02201901|560759284|FG001|Overall Study|Lost to Follow-up|3|||
155362326|NCT02201901|560759285|FG002|Overall Study|Lost to Follow-up|2|||
155362327|NCT02201901|560759283|FG000|Overall Study|Withdrew Consent|2|||
155362328|NCT02201901|560759284|FG001|Overall Study|Withdrew Consent|0|||
155362329|NCT02201901|560759285|FG002|Overall Study|Withdrew Consent|2|||
155362330|NCT02201901|560759283|FG000|Overall Study|Adverse Event|1|||
155362331|NCT02201901|560759284|FG001|Overall Study|Adverse Event|1|||
155362332|NCT02201901|560759285|FG002|Overall Study|Adverse Event|0|||
155362333|NCT04441905|560761471|FG000|Overall Study|Lost to Follow-up|1|||
155362334|NCT04441905|560761472|FG001|Overall Study|Lost to Follow-up|0|||
155362335|NCT04441905|560761473|FG002|Overall Study|Lost to Follow-up|0|||
155362336|NCT04441905|560761474|FG003|Overall Study|Lost to Follow-up|0|||
155362337|NCT04441905|560761475|FG004|Overall Study|Lost to Follow-up|0|||
155362338|NCT04441905|560761476|FG005|Overall Study|Lost to Follow-up|0|||
155362339|NCT04441905|560761471|FG000|Overall Study|Enrolled but treatment not administered|0|||
155362340|NCT04441905|560761472|FG001|Overall Study|Enrolled but treatment not administered|1|||
155362341|NCT04441905|560761473|FG002|Overall Study|Enrolled but treatment not administered|0|||
155362342|NCT04441905|560761474|FG003|Overall Study|Enrolled but treatment not administered|0|||
155362343|NCT04441905|560761475|FG004|Overall Study|Enrolled but treatment not administered|0|||
155362344|NCT04441905|560761476|FG005|Overall Study|Enrolled but treatment not administered|0|||
155362345|NCT04441905|560761471|FG000|Overall Study|Became ineligible after enrollment|0|||
155362346|NCT04441905|560761472|FG001|Overall Study|Became ineligible after enrollment|0|||
155362347|NCT04441905|560761473|FG002|Overall Study|Became ineligible after enrollment|0|||
155362348|NCT04441905|560761474|FG003|Overall Study|Became ineligible after enrollment|0|||
155362349|NCT04441905|560761475|FG004|Overall Study|Became ineligible after enrollment|1|||
155362350|NCT04441905|560761476|FG005|Overall Study|Became ineligible after enrollment|0|||
155362351|NCT00127842|560761477|FG000|Overall Study|Adverse Event|15|||
155362352|NCT00127842|560761477|FG000|Overall Study|Withdrawal by Subject|3|||
155362353|NCT00127842|560761477|FG000|Overall Study|Lost to Follow-up|1|||
155362354|NCT00127842|560761477|FG000|Overall Study|Lack of Efficacy|12|||
155362355|NCT00127842|560761477|FG000|Overall Study|Noncompliance|2|||
155362356|NCT00127842|560761477|FG000|Overall Study|Protocol Violation|1|||
155362357|NCT00127842|560761477|FG000|Overall Study|Other|5|||
155362358|NCT01385748|560761478|FG000|Overall Study|Withdrawal by Subject|7|||
155362359|NCT01385748|560761479|FG001|Overall Study|Withdrawal by Subject|4|||
155362360|NCT01385748|560761480|FG002|Overall Study|Withdrawal by Subject|5|||
155362361|NCT01385748|560761478|FG000|Overall Study|Noncompliance|3|||
155362362|NCT01385748|560761479|FG001|Overall Study|Noncompliance|1|||
155362363|NCT01385748|560761480|FG002|Overall Study|Noncompliance|6|||
155362364|NCT01385748|560761478|FG000|Overall Study|Other|1|||
155362365|NCT01385748|560761479|FG001|Overall Study|Other|7|||
155362366|NCT01385748|560761480|FG002|Overall Study|Other|1|||
155362367|NCT01385748|560761478|FG000|Overall Study|Adverse Event|4|||
155362368|NCT01385748|560761479|FG001|Overall Study|Adverse Event|2|||
155362369|NCT01385748|560761480|FG002|Overall Study|Adverse Event|1|||
155362370|NCT01443403|560761481|FG000|Overall Study|Adverse Event|1|||
155362371|NCT01443403|560761482|FG001|Overall Study|Adverse Event|1|||
155362372|NCT01443403|560761483|FG002|Overall Study|Adverse Event|4|||
155362373|NCT01443403|560761484|FG003|Overall Study|Adverse Event|5|||
155362374|NCT01443403|560761481|FG000|Overall Study|Withdrawal by Subject|0|||
155362375|NCT01443403|560761482|FG001|Overall Study|Withdrawal by Subject|1|||
155362376|NCT01443403|560761483|FG002|Overall Study|Withdrawal by Subject|2|||
155362377|NCT01443403|560761484|FG003|Overall Study|Withdrawal by Subject|1|||
155362378|NCT01443403|560761481|FG000|Overall Study|Lost to Follow-up|0|||
155362379|NCT01443403|560761482|FG001|Overall Study|Lost to Follow-up|0|||
155362380|NCT01443403|560761483|FG002|Overall Study|Lost to Follow-up|0|||
155362381|NCT01443403|560761484|FG003|Overall Study|Lost to Follow-up|1|||
155362382|NCT01443403|560761481|FG000|Overall Study|Protocol Violation|2|||
155362383|NCT01443403|560761482|FG001|Overall Study|Protocol Violation|1|||
155362384|NCT01443403|560761483|FG002|Overall Study|Protocol Violation|1|||
155362385|NCT01443403|560761484|FG003|Overall Study|Protocol Violation|1|||
155362386|NCT01443403|560761481|FG000|Overall Study|Use of Prohibited Treatment|2|||
155362387|NCT01443403|560761482|FG001|Overall Study|Use of Prohibited Treatment|3|||
155362388|NCT01443403|560761483|FG002|Overall Study|Use of Prohibited Treatment|0|||
155362389|NCT01443403|560761484|FG003|Overall Study|Use of Prohibited Treatment|0|||
155362390|NCT01443403|560761481|FG000|Overall Study|Other - Miscellaneous|1|||
155362391|NCT01443403|560761482|FG001|Overall Study|Other - Miscellaneous|0|||
155362392|NCT01443403|560761483|FG002|Overall Study|Other - Miscellaneous|0|||
155362393|NCT01443403|560761484|FG003|Overall Study|Other - Miscellaneous|1|||
155362394|NCT02562235|560761485|FG000|Overall Study|Adverse Event|3|||
155362395|NCT01200342|560761486|FG000|Overall Study|Disease Progression|1|||
155362396|NCT03595124|560761489|FG000|Overall Study|Physician Decision|1|||
155362397|NCT03595124|560761490|FG001|Overall Study|Physician Decision|1|||
155362398|NCT03595124|560761491|FG002|Overall Study|Physician Decision|1|||
155362399|NCT03595124|560761489|FG000|Overall Study|Ineligible|1|||
155362400|NCT03595124|560761490|FG001|Overall Study|Ineligible|1|||
155362401|NCT03595124|560761491|FG002|Overall Study|Ineligible|0|||
155362402|NCT03595124|560761489|FG000|Overall Study|Disease Progression|4|||
155362403|NCT03595124|560761490|FG001|Overall Study|Disease Progression|1|||
155362404|NCT03595124|560761491|FG002|Overall Study|Disease Progression|4|||
155362405|NCT03607422|560761494|FG000|Overall Study|Adverse Event|7|||
155362406|NCT03607422|560761495|FG001|Overall Study|Adverse Event|3|||
155362407|NCT03607422|560761496|FG002|Overall Study|Adverse Event|2|||
155362408|NCT03607422|560761497|FG003|Overall Study|Adverse Event|0|||
155362409|NCT03607422|560761498|FG004|Overall Study|Adverse Event|2|||
155362410|NCT03607422|560761499|FG005|Overall Study|Adverse Event|0|||
155362411|NCT03607422|560761494|FG000|Overall Study|Withdrawal by Subject|11|||
155362412|NCT03607422|560761495|FG001|Overall Study|Withdrawal by Subject|3|||
155362413|NCT03607422|560761496|FG002|Overall Study|Withdrawal by Subject|6|||
155362414|NCT03607422|560761497|FG003|Overall Study|Withdrawal by Subject|2|||
155362415|NCT03607422|560761498|FG004|Overall Study|Withdrawal by Subject|0|||
155362416|NCT03607422|560761499|FG005|Overall Study|Withdrawal by Subject|0|||
155362417|NCT03607422|560761494|FG000|Overall Study|Lost to Follow-up|0|||
155362418|NCT03607422|560761495|FG001|Overall Study|Lost to Follow-up|0|||
155362419|NCT03607422|560761496|FG002|Overall Study|Lost to Follow-up|1|||
155362420|NCT03607422|560761497|FG003|Overall Study|Lost to Follow-up|0|||
155362421|NCT03607422|560761498|FG004|Overall Study|Lost to Follow-up|0|||
155362422|NCT03607422|560761499|FG005|Overall Study|Lost to Follow-up|0|||
155362423|NCT03607422|560761494|FG000|Overall Study|Other|12|||
155362424|NCT03607422|560761495|FG001|Overall Study|Other|4|||
155362425|NCT03607422|560761496|FG002|Overall Study|Other|1|||
155362426|NCT03607422|560761497|FG003|Overall Study|Other|2|||
155362427|NCT03607422|560761498|FG004|Overall Study|Other|0|||
155362428|NCT03607422|560761499|FG005|Overall Study|Other|2|||
155362429|NCT03607422|560761494|FG000|Overall Study|Ongoing at Time of Analysis|8|||
155362430|NCT03607422|560761495|FG001|Overall Study|Ongoing at Time of Analysis|0|||
155089488|NCT04380142|559759770|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
155362431|NCT03607422|560761496|FG002|Overall Study|Ongoing at Time of Analysis|2|||
155362432|NCT03607422|560761497|FG003|Overall Study|Ongoing at Time of Analysis|1|||
155362433|NCT03607422|560761498|FG004|Overall Study|Ongoing at Time of Analysis|1|||
155362434|NCT03607422|560761499|FG005|Overall Study|Ongoing at Time of Analysis|1|||
155362435|NCT03258723|560761500|FG000|Overall Study|COVID Interruption of study|54|||
155362436|NCT03258723|560761500|FG000|Overall Study|Lost to Follow-up|8|||
155362437|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Death|1|||
155362438|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Death|0|||
155362439|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Death|0|||
155362440|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Death|0|||
155362441|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Death|0|||
155362442|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Death|0|||
155362443|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Death|0|||
155362444|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Death|0|||
155362445|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Death|0|||
155362446|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Death|0|||
155362447|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155362448|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155362449|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
155362450|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362451|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362452|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362453|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362454|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362455|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362456|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
155362457|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155362458|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
155362459|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
155362460|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
155362461|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362462|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362463|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362464|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362465|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362466|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
155362467|NCT04832971|560761501|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362468|NCT04832971|560761502|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
155362469|NCT04832971|560761503|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362470|NCT04832971|560761504|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362471|NCT04832971|560761505|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362472|NCT04832971|560761506|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362473|NCT04832971|560761507|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362474|NCT04832971|560761508|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362475|NCT04832971|560761509|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362476|NCT04832971|560761510|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
155362477|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362478|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
155089489|NCT04380142|559759771|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
155089490|NCT04380142|559759769|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
155362479|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362480|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362481|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362482|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
155362483|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
155362484|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
155362485|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
155362486|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
155362487|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Death|0|||
155362488|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Death|0|||
155362489|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Death|0|||
155362490|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Death|0|||
155362491|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Death|0|||
155362492|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Death|0|||
155362493|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Death|0|||
155362494|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Death|1|||
155362495|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Death|0|||
155362496|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Death|0|||
155362497|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362498|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362499|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362500|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362501|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362502|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362503|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
155362504|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
155362505|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362506|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
155362507|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362508|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362509|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362510|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
155362511|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
155362512|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
155362513|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
155362514|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
155362515|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
155362516|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
155362517|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362518|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362519|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362520|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362521|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
155362522|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
155362523|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155362524|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155362525|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155362526|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
155362527|NCT04832971|560761501|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362528|NCT04832971|560761502|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362529|NCT04832971|560761503|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362530|NCT04832971|560761504|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362531|NCT04832971|560761505|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362532|NCT04832971|560761506|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362533|NCT04832971|560761507|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
155362534|NCT04832971|560761508|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
155362535|NCT04832971|560761509|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
155362536|NCT04832971|560761510|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
155362537|NCT01107899|560761511|FG000|Overall Study|Physician Decision|5|||
155362538|NCT01107899|560761512|FG001|Overall Study|Physician Decision|0|||
155362539|NCT01107899|560761513|FG002|Overall Study|Physician Decision|3|||
155362540|NCT01107899|560761511|FG000|Overall Study|Withdrawal by Subject|0|||
155362541|NCT01107899|560761512|FG001|Overall Study|Withdrawal by Subject|0|||
155362542|NCT01107899|560761513|FG002|Overall Study|Withdrawal by Subject|1|||
155362543|NCT03584152|560761514|FG000|Overall Study|Discontinued intervention|7|||
155362544|NCT03584152|560761515|FG001|Overall Study|Discontinued intervention|4|||
155362545|NCT05274750|560761520|FG000|Overall Study|Adverse Event|0|||
155362546|NCT05274750|560761521|FG001|Overall Study|Adverse Event|1|||
155089491|NCT04380142|559759770|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
155089492|NCT04380142|559759771|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
155089493|NCT04380142|559759769|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
155089494|NCT04380142|559759770|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
155089495|NCT04380142|559759771|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
155362547|NCT05274750|560761520|FG000|Overall Study|Lost to Follow-up|2|||
155362548|NCT05274750|560761521|FG001|Overall Study|Lost to Follow-up|3|||
155362549|NCT05274750|560761520|FG000|Overall Study|Physician Decision|3|||
155362550|NCT05274750|560761521|FG001|Overall Study|Physician Decision|0|||
155362551|NCT05274750|560761520|FG000|Overall Study|Withdrawal by Subject|10|||
155362552|NCT05274750|560761521|FG001|Overall Study|Withdrawal by Subject|9|||
155362553|NCT05274750|560761520|FG000|Overall Study|GCP Violation|0|||
155362554|NCT05274750|560761521|FG001|Overall Study|GCP Violation|4|||
155362555|NCT05274750|560761520|FG000|Overall Study|Randomized, not treated|0|||
155362556|NCT05274750|560761521|FG001|Overall Study|Randomized, not treated|1|||
155362557|NCT00983749|560761522|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
155362558|NCT00983749|560761523|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
155362559|NCT04292470|560761524|FG000|Overall Study|Withdrawal by Subject|0|||
155362560|NCT04292470|560761525|FG001|Overall Study|Withdrawal by Subject|1|||
155362561|NCT01375673|560761548|FG000|Overall Study|Withdrawal by Subject|0|||
155362562|NCT01375673|560761549|FG001|Overall Study|Withdrawal by Subject|1|||
155362563|NCT04340947|560761554|FG000|7-day Washout Period|Lost to Follow-up|5|||
155362564|NCT04340947|560761555|FG001|7-day Washout Period|Lost to Follow-up|4|||
155362565|NCT04698915|560761556|FG000|Overall Study|Adverse Event|2|||
155362566|NCT04698915|560761557|FG001|Overall Study|Adverse Event|0|||
155362567|NCT04698915|560761556|FG000|Overall Study|Death|23|||
155089496|NCT04380142|559759769|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
155089497|NCT04380142|559759770|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
155362568|NCT04698915|560761557|FG001|Overall Study|Death|20|||
155362569|NCT04698915|560761556|FG000|Overall Study|Physician Decision|1|||
155362570|NCT04698915|560761557|FG001|Overall Study|Physician Decision|1|||
155362571|NCT04698915|560761556|FG000|Overall Study|Lost to Follow-up|1|||
155362572|NCT04698915|560761557|FG001|Overall Study|Lost to Follow-up|0|||
155362573|NCT04698915|560761556|FG000|Overall Study|Study Terminated by Sponsor|55|||
155362574|NCT04698915|560761557|FG001|Overall Study|Study Terminated by Sponsor|60|||
155362575|NCT04698915|560761556|FG000|Overall Study|Withdrawal by Subject|2|||
155362576|NCT04698915|560761557|FG001|Overall Study|Withdrawal by Subject|3|||
155362577|NCT02312557|560761558|FG000|Overall Study|Survival follow-up|4|||
155362578|NCT00979953|560761559|FG000|Overall Study|Adverse Event|5|||
155362579|NCT00979953|560761560|FG001|Overall Study|Adverse Event|2|||
155362580|NCT00979953|560761561|FG002|Overall Study|Adverse Event|17|||
155362581|NCT00979953|560761562|FG003|Overall Study|Adverse Event|4|||
155362582|NCT00979953|560761559|FG000|Overall Study|Lack of Efficacy|1|||
155362583|NCT00979953|560761560|FG001|Overall Study|Lack of Efficacy|2|||
155362584|NCT00979953|560761561|FG002|Overall Study|Lack of Efficacy|0|||
155362585|NCT00979953|560761562|FG003|Overall Study|Lack of Efficacy|0|||
155362586|NCT00979953|560761559|FG000|Overall Study|Lost to Follow-up|1|||
155362587|NCT00979953|560761560|FG001|Overall Study|Lost to Follow-up|1|||
155362588|NCT00979953|560761561|FG002|Overall Study|Lost to Follow-up|1|||
155362589|NCT00979953|560761562|FG003|Overall Study|Lost to Follow-up|0|||
155362590|NCT00979953|560761559|FG000|Overall Study|Withdrawal by Subject|0|||
155362591|NCT00979953|560761560|FG001|Overall Study|Withdrawal by Subject|0|||
155362592|NCT00979953|560761561|FG002|Overall Study|Withdrawal by Subject|2|||
155362593|NCT00979953|560761562|FG003|Overall Study|Withdrawal by Subject|1|||
155362594|NCT00979953|560761559|FG000|Overall Study|Protocol Violation|1|||
155362595|NCT00979953|560761560|FG001|Overall Study|Protocol Violation|0|||
155362596|NCT00979953|560761561|FG002|Overall Study|Protocol Violation|2|||
155362597|NCT00979953|560761562|FG003|Overall Study|Protocol Violation|2|||
155362598|NCT04829747|560761566|FG000|Overall Study|Protocol Violation|1|||
155362599|NCT02367352|560761569|FG000|Overall Study|Progressive disease|7|||
155362600|NCT02367352|560761570|FG001|Overall Study|Progressive disease|0|||
155362601|NCT02367352|560761571|FG002|Overall Study|Progressive disease|0|||
155362602|NCT02367352|560761569|FG000|Overall Study|Participant Received Alternative Therapy|1|||
155362603|NCT02367352|560761570|FG001|Overall Study|Participant Received Alternative Therapy|0|||
155362604|NCT02367352|560761571|FG002|Overall Study|Participant Received Alternative Therapy|0|||
155362605|NCT02367352|560761569|FG000|Overall Study|Adverse Event|1|||
155362606|NCT02367352|560761570|FG001|Overall Study|Adverse Event|0|||
155362607|NCT02367352|560761571|FG002|Overall Study|Adverse Event|0|||
155362608|NCT05878873|560761572|FG000|Overall Study|Lost to Follow-up|2|||
155362609|NCT05878873|560761573|FG001|Overall Study|Lost to Follow-up|0|||
155362610|NCT02375347|560761580|FG000|Overall Study|Protocol Violation|1|||
155362611|NCT02229227|560761581|FG000|Overall Study|Adverse Event|14|||
155362612|NCT02229227|560761582|FG001|Overall Study|Adverse Event|9|||
155362613|NCT02229227|560761581|FG000|Overall Study|Lack of Efficacy|3|||
155362614|NCT02229227|560761582|FG001|Overall Study|Lack of Efficacy|3|||
155362615|NCT02229227|560761581|FG000|Overall Study|Protocol Violation|6|||
155362616|NCT02229227|560761582|FG001|Overall Study|Protocol Violation|8|||
155362617|NCT02229227|560761581|FG000|Overall Study|Protocol defined stopping criteria|1|||
155362618|NCT02229227|560761582|FG001|Overall Study|Protocol defined stopping criteria|3|||
155362619|NCT02229227|560761581|FG000|Overall Study|Lost to Follow-up|3|||
155362620|NCT02229227|560761582|FG001|Overall Study|Lost to Follow-up|3|||
155362621|NCT02229227|560761581|FG000|Overall Study|Study terminated by sponsor|11|||
155362622|NCT02229227|560761582|FG001|Overall Study|Study terminated by sponsor|11|||
155362623|NCT02229227|560761581|FG000|Overall Study|Withdrawal by Subject|8|||
155362624|NCT02229227|560761582|FG001|Overall Study|Withdrawal by Subject|12|||
155362625|NCT02229227|560761581|FG000|Overall Study|Other|0|||
155362626|NCT02229227|560761582|FG001|Overall Study|Other|1|||
155362627|NCT02229227|560761581|FG000|Overall Study|Physician Decision|5|||
155362628|NCT02229227|560761582|FG001|Overall Study|Physician Decision|12|||
155362629|NCT00340704|560761583|FG000|PK Study|Adverse Event|0|||
155362630|NCT00340704|560761584|FG001|PK Study|Adverse Event|1|||
155362631|NCT00340704|560761585|FG002|PK Study|Adverse Event|0|||
155362632|NCT00340704|560761586|FG003|PK Study|Adverse Event|0|||
155362633|NCT00340704|560761587|FG004|PK Study|Adverse Event|0|||
155362634|NCT00340704|560761588|FG005|PK Study|Adverse Event|0|||
155362635|NCT00340704|560761589|FG006|PK Study|Adverse Event|0|||
155362636|NCT00340704|560761590|FG007|PK Study|Adverse Event|0|||
155362637|NCT00340704|560761591|FG008|PK Study|Adverse Event|0|||
155089498|NCT04380142|559759771|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
155362638|NCT00340704|560761583|FG000|PK Study|Not treated|0|||
155362639|NCT00340704|560761584|FG001|PK Study|Not treated|0|||
155362640|NCT00340704|560761585|FG002|PK Study|Not treated|1|||
155362641|NCT00340704|560761586|FG003|PK Study|Not treated|0|||
155362642|NCT00340704|560761587|FG004|PK Study|Not treated|0|||
155362643|NCT00340704|560761588|FG005|PK Study|Not treated|0|||
155362644|NCT00340704|560761589|FG006|PK Study|Not treated|0|||
155362645|NCT00340704|560761590|FG007|PK Study|Not treated|0|||
155362646|NCT00340704|560761591|FG008|PK Study|Not treated|0|||
155362647|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362648|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362649|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362650|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
155362651|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
155362652|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155362653|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
155089499|NCT04380142|559759769|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
155362654|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
155089500|NCT04380142|559759770|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
155089501|NCT04380142|559759771|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
155089502|NCT04380142|559759769|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155089503|NCT04380142|559759770|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155089504|NCT04380142|559759771|FG002|Double-Blind Treatment Period|Adverse Event|14|||
155089505|NCT04380142|559759769|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
155089506|NCT04380142|559759770|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
155362655|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
155362656|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362657|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362658|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362659|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362660|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362661|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
155362662|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362663|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362664|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
155362665|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155089507|NCT04380142|559759771|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
155089508|NCT04380142|559759769|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155089509|NCT04380142|559759770|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
155089510|NCT04380142|559759771|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
155089511|NCT04380142|559759769|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
155089512|NCT04380142|559759770|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
155089513|NCT04380142|559759771|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
155089514|NCT04380142|559759769|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
155089515|NCT04380142|559759770|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
155089516|NCT04380142|559759771|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
155089517|NCT04380142|559759769|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
155089518|NCT04380142|559759770|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
155089519|NCT04380142|559759771|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
155089520|NCT01506726|559759776|FG000|Overall Study|Adverse Event|1|||
155089521|NCT01506726|559759777|FG001|Overall Study|Adverse Event|2|||
155089522|NCT05552859|559759778|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
155089523|NCT05552859|559759779|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
155089524|NCT01380080|559759780|FG000|Overall Study|Death|36|||
155089525|NCT01380080|559759781|FG001|Overall Study|Death|44|||
155089526|NCT01380080|559759780|FG000|Overall Study|Site is closing|28|||
155089527|NCT01380080|559759781|FG001|Overall Study|Site is closing|31|||
155089528|NCT01380080|559759780|FG000|Overall Study|Not able to get to clinic|7|||
155089529|NCT01380080|559759781|FG001|Overall Study|Not able to get to clinic|1|||
155089530|NCT01380080|559759780|FG000|Overall Study|Not willing to adhere to requirements|6|||
155089531|NCT01380080|559759781|FG001|Overall Study|Not willing to adhere to requirements|2|||
155089532|NCT01380080|559759780|FG000|Overall Study|Withdrawal by Subject|5|||
155089533|NCT01380080|559759781|FG001|Overall Study|Withdrawal by Subject|2|||
155089534|NCT01380080|559759780|FG000|Overall Study|Lost to Follow-up|3|||
155089535|NCT01380080|559759781|FG001|Overall Study|Lost to Follow-up|3|||
155089536|NCT00210132|559759782|FG000|Overall Study|Protocol Violation|1|||
155089537|NCT00210132|559759783|FG001|Overall Study|Protocol Violation|4|||
155089538|NCT00071032|559759784|FG000|Overall Study|Lost to Follow-up|1|||
155089539|NCT00071032|559759785|FG001|Overall Study|Lost to Follow-up|1|||
155089540|NCT00071032|559759784|FG000|Overall Study|Withdrawal by Subject|8|||
155362666|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362667|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362668|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362669|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
155362670|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
155362671|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362672|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
155362673|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
154965279|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965280|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965281|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965282|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965283|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965284|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965285|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965286|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965287|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965288|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965289|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965290|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965291|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965292|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965293|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965294|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965295|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965296|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965297|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
154965298|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
154965299|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
154965300|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
154965301|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
154965302|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
154965303|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965304|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155089541|NCT00071032|559759785|FG001|Overall Study|Withdrawal by Subject|6|||
155089542|NCT00071032|559759784|FG000|Overall Study|Missing Primary Outcome|0|||
155089543|NCT00071032|559759785|FG001|Overall Study|Missing Primary Outcome|1|||
155362674|NCT00340704|560761583|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362675|NCT00340704|560761584|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362676|NCT00340704|560761585|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362677|NCT00340704|560761586|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362678|NCT00340704|560761587|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
155362679|NCT00340704|560761588|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
155362680|NCT00340704|560761589|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
155362681|NCT00340704|560761590|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
155362682|NCT00340704|560761591|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
155362683|NCT03880019|560761596|FG000|Overall Study|Competing disease|1|||
155362684|NCT05218499|560761597|FG000|Overall Study|Not treated|1|||
155362685|NCT05218499|560761598|FG001|Overall Study|Not treated|1|||
155362686|NCT05218499|560761599|FG002|Overall Study|Not treated|8|||
155362687|NCT05218499|560761597|FG000|Overall Study|Death|2|||
155362688|NCT05218499|560761598|FG001|Overall Study|Death|0|||
155362689|NCT05218499|560761599|FG002|Overall Study|Death|0|||
155362690|NCT05218499|560761597|FG000|Overall Study|Other than listed|3|||
155362691|NCT05218499|560761598|FG001|Overall Study|Other than listed|7|||
155362692|NCT05218499|560761599|FG002|Overall Study|Other than listed|10|||
155362693|NCT05218499|560761597|FG000|Overall Study|Protocol deviation|5|||
155362694|NCT05218499|560761598|FG001|Overall Study|Protocol deviation|6|||
155362695|NCT05218499|560761599|FG002|Overall Study|Protocol deviation|4|||
155362696|NCT05218499|560761597|FG000|Overall Study|Technical problems|0|||
155362697|NCT05218499|560761598|FG001|Overall Study|Technical problems|1|||
155362698|NCT05218499|560761599|FG002|Overall Study|Technical problems|0|||
155362699|NCT05218499|560761597|FG000|Overall Study|Burden of trial procedures|0|||
155362700|NCT05218499|560761598|FG001|Overall Study|Burden of trial procedures|1|||
155089544|NCT01722669|559759787|FG000|Overall Study|Withdrawal by Subject|0|||
155362701|NCT05218499|560761599|FG002|Overall Study|Burden of trial procedures|2|||
155089545|NCT01722669|559759788|FG001|Overall Study|Withdrawal by Subject|0|||
155089546|NCT01722669|559759789|FG002|Overall Study|Withdrawal by Subject|0|||
155089547|NCT01722669|559759790|FG003|Overall Study|Withdrawal by Subject|0|||
155089548|NCT01722669|559759791|FG004|Overall Study|Withdrawal by Subject|0|||
155089549|NCT01722669|559759792|FG005|Overall Study|Withdrawal by Subject|2|||
155089550|NCT02496000|559759797|FG000|Overall Study|Withdrawal by Subject|1|||
154965305|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965306|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155089551|NCT02496000|559759798|FG001|Overall Study|Withdrawal by Subject|2|||
155362702|NCT05218499|560761597|FG000|Overall Study|Clinical disease progression|6|||
155362703|NCT05218499|560761598|FG001|Overall Study|Clinical disease progression|6|||
155362704|NCT05218499|560761599|FG002|Overall Study|Clinical disease progression|11|||
155362705|NCT05218499|560761597|FG000|Overall Study|Objective disease progression|44|||
155089552|NCT02496000|559759799|FG002|Overall Study|Withdrawal by Subject|0|||
155089553|NCT02496000|559759797|FG000|Overall Study|Lost to Follow-up|1|||
155089554|NCT02496000|559759798|FG001|Overall Study|Lost to Follow-up|0|||
155089555|NCT02496000|559759799|FG002|Overall Study|Lost to Follow-up|1|||
155089556|NCT02496000|559759797|FG000|Overall Study|Protocol Violation|0|||
155089557|NCT02496000|559759798|FG001|Overall Study|Protocol Violation|0|||
155089558|NCT02496000|559759799|FG002|Overall Study|Protocol Violation|1|||
155089559|NCT02496000|559759797|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
155362706|NCT05218499|560761598|FG001|Overall Study|Objective disease progression|61|||
155362707|NCT05218499|560761599|FG002|Overall Study|Objective disease progression|42|||
155362708|NCT05218499|560761597|FG000|Overall Study|Adverse Event|11|||
155362709|NCT05218499|560761598|FG001|Overall Study|Adverse Event|36|||
155362710|NCT05218499|560761599|FG002|Overall Study|Adverse Event|9|||
155362711|NCT05218499|560761597|FG000|Overall Study|On treatment at time of snapshot|18|||
155362712|NCT05218499|560761598|FG001|Overall Study|On treatment at time of snapshot|29|||
155362713|NCT05218499|560761599|FG002|Overall Study|On treatment at time of snapshot|0|||
155362714|NCT03635086|560761605|FG000|Overall Study|Withdrawal of consent|0|||
155362715|NCT03635086|560761606|FG001|Overall Study|Withdrawal of consent|0|||
155362716|NCT03635086|560761607|FG002|Overall Study|Withdrawal of consent|1|||
155362717|NCT03635086|560761608|FG003|Overall Study|Withdrawal of consent|0|||
155362718|NCT03635086|560761609|FG004|Overall Study|Withdrawal of consent|0|||
155362719|NCT03635086|560761605|FG000|Overall Study|Adverse Event|0|||
155362720|NCT03635086|560761606|FG001|Overall Study|Adverse Event|1|||
155362721|NCT03635086|560761607|FG002|Overall Study|Adverse Event|0|||
155362722|NCT03635086|560761608|FG003|Overall Study|Adverse Event|0|||
155362723|NCT03635086|560761609|FG004|Overall Study|Adverse Event|0|||
155362724|NCT03635086|560761605|FG000|Overall Study|Lost to Follow-up|1|||
155362725|NCT03635086|560761606|FG001|Overall Study|Lost to Follow-up|0|||
155362726|NCT03635086|560761607|FG002|Overall Study|Lost to Follow-up|0|||
155362727|NCT03635086|560761608|FG003|Overall Study|Lost to Follow-up|0|||
155362728|NCT03635086|560761609|FG004|Overall Study|Lost to Follow-up|0|||
155362729|NCT02196077|560761610|FG000|Overall Study|Adverse Event|4|||
155362730|NCT02196077|560761610|FG000|Overall Study|Lack of Efficacy|1|||
155362731|NCT02196077|560761610|FG000|Overall Study|Withdrawal by Subject|14|||
155362732|NCT02196077|560761610|FG000|Overall Study|Physician Decision|1|||
155362733|NCT02196077|560761610|FG000|Overall Study|Lost to Follow-up|3|||
155362734|NCT02196077|560761610|FG000|Overall Study|Protocol Violation|24|||
155362735|NCT03482752|560761615|FG000|Overall Study|Withdrawal by Subject|2|||
155362736|NCT03482752|560761615|FG000|Overall Study|Lost to Follow-up|1|||
155089560|NCT02496000|559759798|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
155089561|NCT02496000|559759799|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
155089562|NCT02496000|559759797|FG000|Overall Study|undetermined|0|||
155089563|NCT02496000|559759798|FG001|Overall Study|undetermined|1|||
155362737|NCT03482752|560761615|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
155362738|NCT03566979|560761616|FG000|Overall Study|Withdrawal by Subject|2|||
155362739|NCT03566979|560761617|FG001|Overall Study|Withdrawal by Subject|0|||
155362740|NCT03566979|560761618|FG002|Overall Study|Withdrawal by Subject|1|||
155362741|NCT03566979|560761619|FG003|Overall Study|Withdrawal by Subject|1|||
155362742|NCT03566979|560761616|FG000|Overall Study|Lost to Follow-up|2|||
155362743|NCT03566979|560761617|FG001|Overall Study|Lost to Follow-up|7|||
155362744|NCT03566979|560761618|FG002|Overall Study|Lost to Follow-up|9|||
155362745|NCT03566979|560761619|FG003|Overall Study|Lost to Follow-up|5|||
155362746|NCT03566979|560761616|FG000|Overall Study|Adverse Event|1|||
155089564|NCT02496000|559759799|FG002|Overall Study|undetermined|0|||
155089565|NCT02255656|559759800|FG000|Overall Study|Adverse Event|11|||
155089566|NCT02255656|559759800|FG000|Overall Study|Poor compliance to protocol|3|||
155089567|NCT02255656|559759800|FG000|Overall Study|Lost to Follow-up|30|||
155362747|NCT03566979|560761617|FG001|Overall Study|Adverse Event|0|||
155362748|NCT03566979|560761618|FG002|Overall Study|Adverse Event|0|||
155362749|NCT03566979|560761619|FG003|Overall Study|Adverse Event|0|||
155362750|NCT00658606|560761620|FG000|Overall Study|Adverse Event|2|||
155362751|NCT00658606|560761621|FG001|Overall Study|Adverse Event|1|||
154965307|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155089568|NCT02255656|559759800|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
155089569|NCT02255656|559759800|FG000|Overall Study|Other|126|||
155362752|NCT00658606|560761620|FG000|Overall Study|Lack of Efficacy|6|||
155362753|NCT00658606|560761621|FG001|Overall Study|Lack of Efficacy|3|||
155362754|NCT00658606|560761620|FG000|Overall Study|Lost to Follow-up|1|||
155362755|NCT00658606|560761621|FG001|Overall Study|Lost to Follow-up|0|||
155362756|NCT00658606|560761620|FG000|Overall Study|Withdrawal by Subject|7|||
155362757|NCT00658606|560761621|FG001|Overall Study|Withdrawal by Subject|16|||
155362758|NCT00658606|560761620|FG000|Overall Study|Lack of Compliance|0|||
155362759|NCT00658606|560761621|FG001|Overall Study|Lack of Compliance|3|||
155362760|NCT01056263|560761622|FG000|Overall Study|Adverse Event|12|||
155362761|NCT01056263|560761622|FG000|Overall Study|Death|1|||
155362762|NCT01056263|560761622|FG000|Overall Study|Withdrawal by Subject|1|||
155166358|NCT03901469|560046242|FG004|Overall Study|Adverse Event|0|||
155166359|NCT03901469|560046243|FG005|Overall Study|Adverse Event|0|||
155166360|NCT03901469|560046244|FG006|Overall Study|Adverse Event|9|||
155166361|NCT03901469|560046238|FG000|Overall Study|Physician Decision|0|||
155166362|NCT03901469|560046239|FG001|Overall Study|Physician Decision|0|||
155166363|NCT03901469|560046240|FG002|Overall Study|Physician Decision|0|||
155166364|NCT03901469|560046241|FG003|Overall Study|Physician Decision|1|||
155166365|NCT03901469|560046242|FG004|Overall Study|Physician Decision|0|||
155166366|NCT03901469|560046243|FG005|Overall Study|Physician Decision|0|||
155166367|NCT03901469|560046244|FG006|Overall Study|Physician Decision|0|||
155166368|NCT03901469|560046238|FG000|Overall Study|Withdrawal by Subject|0|||
155166369|NCT03901469|560046239|FG001|Overall Study|Withdrawal by Subject|0|||
155166370|NCT03901469|560046240|FG002|Overall Study|Withdrawal by Subject|0|||
155166371|NCT03901469|560046241|FG003|Overall Study|Withdrawal by Subject|0|||
155166372|NCT03901469|560046242|FG004|Overall Study|Withdrawal by Subject|2|||
155166373|NCT03901469|560046243|FG005|Overall Study|Withdrawal by Subject|0|||
155166374|NCT03901469|560046244|FG006|Overall Study|Withdrawal by Subject|8|||
155166375|NCT03901469|560046238|FG000|Overall Study|Death|0|||
155362763|NCT01056263|560761622|FG000|Overall Study|Lack of Efficacy|29|||
155362764|NCT01056263|560761622|FG000|Overall Study|Progressive disease|2|||
155362765|NCT01056263|560761622|FG000|Overall Study|Neoplasm progression|1|||
155362766|NCT01056263|560761622|FG000|Overall Study|Objective progression or relapse|1|||
155362767|NCT01056263|560761622|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
155362768|NCT01358331|560761627|FG000|Overall Study|Lost to Follow-up|0|||
155362769|NCT01358331|560761628|FG001|Overall Study|Lost to Follow-up|0|||
155362770|NCT01358331|560761629|FG002|Overall Study|Lost to Follow-up|0|||
155362771|NCT01358331|560761630|FG003|Overall Study|Lost to Follow-up|1|||
155362772|NCT01358331|560761631|FG004|Overall Study|Lost to Follow-up|0|||
155362773|NCT01358331|560761632|FG005|Overall Study|Lost to Follow-up|0|||
155362774|NCT01358331|560761627|FG000|Overall Study|Withdrawal by Subject|0|||
155362775|NCT01358331|560761628|FG001|Overall Study|Withdrawal by Subject|0|||
155362776|NCT01358331|560761629|FG002|Overall Study|Withdrawal by Subject|0|||
155362777|NCT01358331|560761630|FG003|Overall Study|Withdrawal by Subject|1|||
155362778|NCT01358331|560761631|FG004|Overall Study|Withdrawal by Subject|1|||
155362779|NCT01358331|560761632|FG005|Overall Study|Withdrawal by Subject|1|||
155362780|NCT01358331|560761627|FG000|Overall Study|Adverse Events|1|||
155362781|NCT01358331|560761628|FG001|Overall Study|Adverse Events|1|||
155362782|NCT01358331|560761629|FG002|Overall Study|Adverse Events|1|||
155362783|NCT01358331|560761630|FG003|Overall Study|Adverse Events|0|||
155362784|NCT01358331|560761631|FG004|Overall Study|Adverse Events|1|||
155362785|NCT01358331|560761632|FG005|Overall Study|Adverse Events|5|||
155362786|NCT01358331|560761627|FG000|Overall Study|Symptomatic Deterioration|0|||
155362787|NCT01358331|560761628|FG001|Overall Study|Symptomatic Deterioration|0|||
155362788|NCT01358331|560761629|FG002|Overall Study|Symptomatic Deterioration|0|||
155362789|NCT01358331|560761630|FG003|Overall Study|Symptomatic Deterioration|0|||
155362790|NCT01358331|560761631|FG004|Overall Study|Symptomatic Deterioration|1|||
155362791|NCT01358331|560761632|FG005|Overall Study|Symptomatic Deterioration|0|||
155362792|NCT01358331|560761627|FG000|Overall Study|Participants did not wish to continue|0|||
155362793|NCT01358331|560761628|FG001|Overall Study|Participants did not wish to continue|0|||
155362794|NCT01358331|560761629|FG002|Overall Study|Participants did not wish to continue|0|||
155362795|NCT01358331|560761630|FG003|Overall Study|Participants did not wish to continue|0|||
155362796|NCT01358331|560761631|FG004|Overall Study|Participants did not wish to continue|1|||
155362797|NCT01358331|560761632|FG005|Overall Study|Participants did not wish to continue|0|||
155362798|NCT01358331|560761627|FG000|Overall Study|Progress of disease under investigation|1|||
155362799|NCT01358331|560761628|FG001|Overall Study|Progress of disease under investigation|2|||
155362800|NCT01358331|560761629|FG002|Overall Study|Progress of disease under investigation|3|||
155362801|NCT01358331|560761630|FG003|Overall Study|Progress of disease under investigation|1|||
155362802|NCT01358331|560761631|FG004|Overall Study|Progress of disease under investigation|3|||
155362803|NCT01358331|560761632|FG005|Overall Study|Progress of disease under investigation|0|||
155362804|NCT01431950|560761641|FG000|Overall Study|Study Site Closed/Terminated|7|||
155362805|NCT01431950|560761642|FG001|Overall Study|Study Site Closed/Terminated|3|||
155166376|NCT03901469|560046239|FG001|Overall Study|Death|0|||
155166377|NCT03901469|560046240|FG002|Overall Study|Death|0|||
155166378|NCT03901469|560046241|FG003|Overall Study|Death|3|||
155166379|NCT03901469|560046242|FG004|Overall Study|Death|5|||
155166380|NCT03901469|560046243|FG005|Overall Study|Death|0|||
155166381|NCT03901469|560046244|FG006|Overall Study|Death|1|||
155362806|NCT01431950|560761641|FG000|Overall Study|Withdrawal by Subject|4|||
155362807|NCT01431950|560761642|FG001|Overall Study|Withdrawal by Subject|3|||
155362808|NCT01431950|560761641|FG000|Overall Study|Protocol Violation|2|||
155362809|NCT01431950|560761642|FG001|Overall Study|Protocol Violation|3|||
155362810|NCT01431950|560761641|FG000|Overall Study|Adverse Event|2|||
155362811|NCT01431950|560761642|FG001|Overall Study|Adverse Event|2|||
155362812|NCT01431950|560761641|FG000|Overall Study|Physician Decision|2|||
155362813|NCT01431950|560761642|FG001|Overall Study|Physician Decision|1|||
155362814|NCT01431950|560761641|FG000|Overall Study|Lack of Efficacy|2|||
155362815|NCT01431950|560761642|FG001|Overall Study|Lack of Efficacy|1|||
155362816|NCT01431950|560761641|FG000|Overall Study|Lost to Follow-up|0|||
155362817|NCT01431950|560761642|FG001|Overall Study|Lost to Follow-up|1|||
155362818|NCT01431950|560761641|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
155362819|NCT01431950|560761642|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155362820|NCT00738283|560761643|FG000|Overall Study|Death|1|||
155362821|NCT00738283|560761643|FG000|Overall Study|Transfer to another facility|2|||
155362822|NCT00738283|560761643|FG000|Overall Study|Discharge home prior to end of study|1|||
155362823|NCT01210651|560761644|FG000|Overall Study|Lost to Follow-up|1|||
155362824|NCT01210651|560761645|FG001|Overall Study|Lost to Follow-up|1|||
155362825|NCT01210651|560761644|FG000|Overall Study|schedule conflicts|1|||
155362826|NCT01210651|560761645|FG001|Overall Study|schedule conflicts|5|||
155362827|NCT01210651|560761644|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
155362828|NCT01210651|560761645|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
155362829|NCT01210651|560761644|FG000|Overall Study|Withdrawal by Subject|1|||
155362830|NCT01210651|560761645|FG001|Overall Study|Withdrawal by Subject|1|||
155362831|NCT01210651|560761644|FG000|Overall Study|Injury outside study|2|||
155362832|NCT01210651|560761645|FG001|Overall Study|Injury outside study|0|||
155362833|NCT02559310|560761646|FG000|Overall Study|Death|4|||
155362834|NCT02559310|560761647|FG001|Overall Study|Death|3|||
155362835|NCT02559310|560761646|FG000|Overall Study|Lost to Follow-up|5|||
155362836|NCT02559310|560761647|FG001|Overall Study|Lost to Follow-up|3|||
155362837|NCT02559310|560761646|FG000|Overall Study|Physician Decision|2|||
155362838|NCT02559310|560761647|FG001|Overall Study|Physician Decision|1|||
155362839|NCT02559310|560761646|FG000|Overall Study|Withdrawal by Subject|13|||
155362840|NCT02559310|560761647|FG001|Overall Study|Withdrawal by Subject|9|||
155362841|NCT02559310|560761646|FG000|Overall Study|Sponsor Decision|0|||
155362842|NCT02559310|560761647|FG001|Overall Study|Sponsor Decision|1|||
155362843|NCT02559310|560761646|FG000|Overall Study|Randomized but not treated|3|||
155362844|NCT02559310|560761647|FG001|Overall Study|Randomized but not treated|2|||
155362845|NCT03595878|560761648|FG000|Overall Study|Death|2|||
155362846|NCT03595878|560761649|FG001|Overall Study|Death|1|||
155362847|NCT03595878|560761650|FG002|Overall Study|Death|0|||
155362848|NCT03595878|560761648|FG000|Overall Study|Disease progression|2|||
155362849|NCT03595878|560761649|FG001|Overall Study|Disease progression|1|||
155362850|NCT03595878|560761650|FG002|Overall Study|Disease progression|2|||
155362851|NCT03494985|560761651|FG000|Overall Study|Adverse Event|3|||
155362852|NCT03494985|560761652|FG001|Overall Study|Adverse Event|2|||
155362853|NCT03494985|560761653|FG002|Overall Study|Adverse Event|3|||
155362854|NCT03494985|560761654|FG003|Overall Study|Adverse Event|0|||
155362855|NCT03494985|560761651|FG000|Overall Study|Other (Withdrawal of consent)|2|||
155089570|NCT03909971|559759801|FG000|Overall Study|Participant transition to rollover study|26|||
155089571|NCT03909971|559759802|FG001|Overall Study|Participant transition to rollover study|9|||
155089572|NCT03909971|559759801|FG000|Overall Study|Global Deterioration of Health Status|2|||
155089573|NCT03909971|559759802|FG001|Overall Study|Global Deterioration of Health Status|2|||
155362856|NCT03494985|560761652|FG001|Overall Study|Other (Withdrawal of consent)|3|||
155362857|NCT03494985|560761653|FG002|Overall Study|Other (Withdrawal of consent)|2|||
155362858|NCT03494985|560761654|FG003|Overall Study|Other (Withdrawal of consent)|5|||
155089574|NCT03909971|559759801|FG000|Overall Study|Progressive Disease|28|||
155089575|NCT03909971|559759802|FG001|Overall Study|Progressive Disease|21|||
155089576|NCT03909971|559759801|FG000|Overall Study|Death|6|||
155362859|NCT03494985|560761651|FG000|Overall Study|Other (Not specified)|0|||
155362860|NCT03494985|560761652|FG001|Overall Study|Other (Not specified)|1|||
155362861|NCT03494985|560761653|FG002|Overall Study|Other (Not specified)|1|||
155362862|NCT03494985|560761654|FG003|Overall Study|Other (Not specified)|0|||
155362863|NCT03036124|560761655|FG000|Overall Study|Lost to Follow-up|0|||
155362864|NCT03036124|560761656|FG001|Overall Study|Lost to Follow-up|2|||
155362865|NCT03036124|560761655|FG000|Overall Study|Withdrawal by Subject|5|||
155089577|NCT03909971|559759802|FG001|Overall Study|Death|6|||
155362866|NCT03036124|560761656|FG001|Overall Study|Withdrawal by Subject|4|||
155362867|NCT02282059|560761657|FG000|Overall Study|Other|15|||
155362868|NCT02282059|560761658|FG001|Overall Study|Other|3|||
155362869|NCT02282059|560761657|FG000|Overall Study|Participant refused further follow-up|8|||
155362870|NCT02282059|560761658|FG001|Overall Study|Participant refused further follow-up|4|||
155362871|NCT02282059|560761657|FG000|Overall Study|Lost to Follow-up|19|||
155362872|NCT02282059|560761658|FG001|Overall Study|Lost to Follow-up|3|||
155362873|NCT02282059|560761657|FG000|Overall Study|Death|40|||
155362874|NCT02282059|560761658|FG001|Overall Study|Death|8|||
155362875|NCT04886518|560761661|FG000|Overall Study|Noncompliance with study drug|1|||
155362876|NCT04886518|560761662|FG001|Overall Study|Noncompliance with study drug|0|||
155362877|NCT04886518|560761663|FG002|Overall Study|Noncompliance with study drug|0|||
155362878|NCT04886518|560761661|FG000|Overall Study|Adverse Event|0|||
155089578|NCT03909971|559759801|FG000|Overall Study|Adverse Event|1|||
155089579|NCT03909971|559759802|FG001|Overall Study|Adverse Event|2|||
155362879|NCT04886518|560761662|FG001|Overall Study|Adverse Event|1|||
155362880|NCT04886518|560761663|FG002|Overall Study|Adverse Event|0|||
155362881|NCT04886518|560761661|FG000|Overall Study|Withdrawal by Subject|1|||
155362882|NCT04886518|560761662|FG001|Overall Study|Withdrawal by Subject|0|||
155362883|NCT04886518|560761663|FG002|Overall Study|Withdrawal by Subject|0|||
155362884|NCT00433511|560763718|FG000|Step 1|Adverse Event|50|||
155362885|NCT00433511|560763719|FG001|Step 1|Adverse Event|157|||
155362886|NCT00433511|560763720|FG002|Step 1|Adverse Event|153|||
155362887|NCT00433511|560763718|FG000|Step 1|Withdrawal by Subject|45|||
155362888|NCT00433511|560763719|FG001|Step 1|Withdrawal by Subject|143|||
155362889|NCT00433511|560763720|FG002|Step 1|Withdrawal by Subject|154|||
155362890|NCT00433511|560763718|FG000|Step 1|Death|3|||
155362891|NCT00433511|560763719|FG001|Step 1|Death|1|||
155362892|NCT00433511|560763720|FG002|Step 1|Death|1|||
155362893|NCT00433511|560763718|FG000|Step 1|Physician Decision|1|||
155362894|NCT00433511|560763719|FG001|Step 1|Physician Decision|4|||
155362895|NCT00433511|560763720|FG002|Step 1|Physician Decision|3|||
155362896|NCT00433511|560763718|FG000|Step 1|Never started protocol therapy|28|||
155362897|NCT00433511|560763719|FG001|Step 1|Never started protocol therapy|64|||
155362898|NCT00433511|560763720|FG002|Step 1|Never started protocol therapy|66|||
155362899|NCT00433511|560763718|FG000|Step 1|Alternative therapy|2|||
155362900|NCT00433511|560763719|FG001|Step 1|Alternative therapy|1|||
155362901|NCT00433511|560763720|FG002|Step 1|Alternative therapy|3|||
155362902|NCT00433511|560763718|FG000|Step 1|Disease progression, relapse|5|||
155362903|NCT00433511|560763719|FG001|Step 1|Disease progression, relapse|3|||
155362904|NCT00433511|560763720|FG002|Step 1|Disease progression, relapse|3|||
155362905|NCT00433511|560763718|FG000|Step 1|Other complicating disease|2|||
155362906|NCT00433511|560763719|FG001|Step 1|Other complicating disease|6|||
155362907|NCT00433511|560763720|FG002|Step 1|Other complicating disease|3|||
155362908|NCT00433511|560763718|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
155362909|NCT00433511|560763719|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
155089580|NCT03909971|559759801|FG000|Overall Study|Withdrawal by Subject|2|||
155089581|NCT03909971|559759802|FG001|Overall Study|Withdrawal by Subject|1|||
155089582|NCT03909971|559759801|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
155089583|NCT03909971|559759802|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
155362910|NCT00433511|560763720|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
155362911|NCT00433511|560763718|FG000|Step 1|Suspected recurrence|0|||
155089584|NCT03909971|559759801|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
155089585|NCT03909971|559759802|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
155089586|NCT03734536|559759803|FG000|Overall Study|Withdrew Consent|1|||
155089587|NCT03734536|559759804|FG001|Overall Study|Withdrew Consent|5|||
155089588|NCT03734536|559759803|FG000|Overall Study|Lost to Follow-up|10|||
155362912|NCT00433511|560763719|FG001|Step 1|Suspected recurrence|1|||
155362913|NCT00433511|560763720|FG002|Step 1|Suspected recurrence|0|||
155362914|NCT00433511|560763718|FG000|Step 1|Insurance/drug distribution issues|0|||
155362915|NCT00433511|560763719|FG001|Step 1|Insurance/drug distribution issues|1|||
155362916|NCT00433511|560763720|FG002|Step 1|Insurance/drug distribution issues|2|||
155362917|NCT00433511|560763718|FG000|Step 1|Patient moved|0|||
155362918|NCT00433511|560763719|FG001|Step 1|Patient moved|0|||
155362919|NCT00433511|560763720|FG002|Step 1|Patient moved|1|||
155089589|NCT03734536|559759804|FG001|Overall Study|Lost to Follow-up|7|||
155362920|NCT00433511|560763718|FG000|Step 2 (Arm D)|Adverse Event|0|||
155362921|NCT00433511|560763719|FG001|Step 2 (Arm D)|Adverse Event|0|||
155362922|NCT00433511|560763720|FG002|Step 2 (Arm D)|Adverse Event|135|||
155089590|NCT01877278|559759805|FG000|Overall Study|Lost to Follow-up|3|||
155362923|NCT00433511|560763718|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
155362924|NCT00433511|560763719|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
155362925|NCT00433511|560763720|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
155362926|NCT00433511|560763718|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
155362927|NCT00433511|560763719|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
155362928|NCT00433511|560763720|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
155362929|NCT00433511|560763718|FG000|Step 2 (Arm D)|Physician Decision|0|||
155362930|NCT00433511|560763719|FG001|Step 2 (Arm D)|Physician Decision|0|||
155362931|NCT00433511|560763720|FG002|Step 2 (Arm D)|Physician Decision|9|||
155362932|NCT00433511|560763718|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
155362933|NCT00433511|560763719|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
155362934|NCT00433511|560763720|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
155362935|NCT00433511|560763718|FG000|Step 2 (Arm D)|Other complicating disease|0|||
155362936|NCT00433511|560763719|FG001|Step 2 (Arm D)|Other complicating disease|0|||
155362937|NCT00433511|560763720|FG002|Step 2 (Arm D)|Other complicating disease|3|||
155362938|NCT00433511|560763718|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
155362939|NCT00433511|560763719|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
155362940|NCT00433511|560763720|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
155362941|NCT00433511|560763718|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
155362942|NCT00433511|560763719|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
155362943|NCT00433511|560763720|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
155362944|NCT00433511|560763718|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
155362945|NCT00433511|560763719|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
155362946|NCT00433511|560763720|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
155362947|NCT00433511|560763718|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
155362948|NCT00433511|560763719|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
155362949|NCT00433511|560763720|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
155362950|NCT04328623|560763721|FG000|Overall Study|Protocol Violation|0|||
155362951|NCT04328623|560763722|FG001|Overall Study|Protocol Violation|1|||
155362952|NCT00742326|560763725|FG000|Overall Study|Physician Decision|0|||
155362953|NCT00742326|560763726|FG001|Overall Study|Physician Decision|1|||
155362954|NCT00150618|560763727|FG000|Overall Study|Adverse Event|2|||
155362955|NCT00150618|560763728|FG001|Overall Study|Adverse Event|2|||
155362956|NCT00150618|560763729|FG002|Overall Study|Adverse Event|6|||
155362957|NCT00150618|560763730|FG003|Overall Study|Adverse Event|9|||
155362958|NCT00150618|560763731|FG004|Overall Study|Adverse Event|5|||
155362959|NCT00150618|560763727|FG000|Overall Study|Withdrawal by Subject|6|||
155362960|NCT00150618|560763728|FG001|Overall Study|Withdrawal by Subject|8|||
155362961|NCT00150618|560763729|FG002|Overall Study|Withdrawal by Subject|8|||
155362962|NCT00150618|560763730|FG003|Overall Study|Withdrawal by Subject|4|||
155362963|NCT00150618|560763731|FG004|Overall Study|Withdrawal by Subject|5|||
155362964|NCT00150618|560763727|FG000|Overall Study|Lost to Follow-up|4|||
155362965|NCT00150618|560763728|FG001|Overall Study|Lost to Follow-up|1|||
155362966|NCT00150618|560763729|FG002|Overall Study|Lost to Follow-up|5|||
155362967|NCT00150618|560763730|FG003|Overall Study|Lost to Follow-up|8|||
155362968|NCT00150618|560763731|FG004|Overall Study|Lost to Follow-up|4|||
155362969|NCT00150618|560763727|FG000|Overall Study|Protocol Violation|1|||
155362970|NCT00150618|560763728|FG001|Overall Study|Protocol Violation|0|||
155362971|NCT00150618|560763729|FG002|Overall Study|Protocol Violation|0|||
155362972|NCT00150618|560763730|FG003|Overall Study|Protocol Violation|0|||
155089591|NCT01877278|559759806|FG001|Overall Study|Lost to Follow-up|3|||
155362973|NCT00150618|560763731|FG004|Overall Study|Protocol Violation|1|||
155362974|NCT00150618|560763727|FG000|Overall Study|Lack of Efficacy|1|||
155362975|NCT00150618|560763728|FG001|Overall Study|Lack of Efficacy|4|||
155362976|NCT00150618|560763729|FG002|Overall Study|Lack of Efficacy|7|||
155362977|NCT00150618|560763730|FG003|Overall Study|Lack of Efficacy|4|||
155362978|NCT00150618|560763731|FG004|Overall Study|Lack of Efficacy|6|||
155362979|NCT00150618|560763727|FG000|Overall Study|No study meds|0|||
155362980|NCT00150618|560763728|FG001|Overall Study|No study meds|0|||
155362981|NCT00150618|560763729|FG002|Overall Study|No study meds|0|||
155362982|NCT00150618|560763730|FG003|Overall Study|No study meds|0|||
155089592|NCT04727151|559759810|FG000|Overall Study|Death|0|||
155089593|NCT04727151|559759811|FG001|Overall Study|Death|0|||
155089594|NCT04727151|559759812|FG002|Overall Study|Death|0|||
155089595|NCT04727151|559759813|FG003|Overall Study|Death|0|||
155362983|NCT00150618|560763731|FG004|Overall Study|No study meds|2|||
155362984|NCT00150618|560763727|FG000|Overall Study|Physician Decision|0|||
155362985|NCT00150618|560763728|FG001|Overall Study|Physician Decision|2|||
155362986|NCT00150618|560763729|FG002|Overall Study|Physician Decision|0|||
155362987|NCT00150618|560763730|FG003|Overall Study|Physician Decision|0|||
155362988|NCT00150618|560763731|FG004|Overall Study|Physician Decision|1|||
155362989|NCT00150618|560763727|FG000|Overall Study|Lack of compliance|2|||
155362990|NCT00150618|560763728|FG001|Overall Study|Lack of compliance|1|||
155362991|NCT00150618|560763729|FG002|Overall Study|Lack of compliance|1|||
155362992|NCT00150618|560763730|FG003|Overall Study|Lack of compliance|0|||
155166382|NCT03901469|560046238|FG000|Overall Study|Termination of study by sponsor|0|||
155089596|NCT04727151|559759814|FG004|Overall Study|Death|3|||
155089597|NCT04727151|559759810|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155166383|NCT03901469|560046239|FG001|Overall Study|Termination of study by sponsor|0|||
155362993|NCT00150618|560763731|FG004|Overall Study|Lack of compliance|1|||
155089598|NCT04727151|559759811|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155166384|NCT03901469|560046240|FG002|Overall Study|Termination of study by sponsor|0|||
155166385|NCT03901469|560046241|FG003|Overall Study|Termination of study by sponsor|0|||
155166386|NCT03901469|560046242|FG004|Overall Study|Termination of study by sponsor|1|||
155166387|NCT03901469|560046243|FG005|Overall Study|Termination of study by sponsor|1|||
155166388|NCT03901469|560046244|FG006|Overall Study|Termination of study by sponsor|0|||
155166389|NCT03901469|560046238|FG000|Overall Study|Not Reported|1|||
155166390|NCT03901469|560046239|FG001|Overall Study|Not Reported|0|||
155166391|NCT03901469|560046240|FG002|Overall Study|Not Reported|0|||
155166392|NCT03901469|560046241|FG003|Overall Study|Not Reported|1|||
155166393|NCT03901469|560046242|FG004|Overall Study|Not Reported|0|||
155166394|NCT03901469|560046243|FG005|Overall Study|Not Reported|0|||
155166395|NCT03901469|560046244|FG006|Overall Study|Not Reported|1|||
155166396|NCT04380519|560046245|FG000|Overall Study|Withdrawal by Subject|4|||
155166397|NCT04380519|560046246|FG001|Overall Study|Withdrawal by Subject|0|||
155166398|NCT04380519|560046247|FG002|Overall Study|Withdrawal by Subject|1|||
155166399|NCT04380519|560046245|FG000|Overall Study|Death|14|||
155166400|NCT04380519|560046246|FG001|Overall Study|Death|9|||
155166401|NCT04380519|560046247|FG002|Overall Study|Death|6|||
155166402|NCT04380519|560046245|FG000|Overall Study|Adverse Event|0|||
155166403|NCT04380519|560046246|FG001|Overall Study|Adverse Event|1|||
155166404|NCT04380519|560046247|FG002|Overall Study|Adverse Event|0|||
155166405|NCT04380519|560046245|FG000|Overall Study|relatives' decision|0|||
155166406|NCT04380519|560046246|FG001|Overall Study|relatives' decision|1|||
155166407|NCT04380519|560046247|FG002|Overall Study|relatives' decision|0|||
155166408|NCT01485172|560046250|FG000|Overall Study|Adverse Event|2|||
155166409|NCT01485172|560046251|FG001|Overall Study|Adverse Event|1|||
155166410|NCT01485172|560046252|FG002|Overall Study|Adverse Event|2|||
155166411|NCT01485172|560046253|FG003|Overall Study|Adverse Event|2|||
155166412|NCT01485172|560046254|FG004|Overall Study|Adverse Event|1|||
155166413|NCT01485172|560046255|FG005|Overall Study|Adverse Event|2|||
155166414|NCT01485172|560046250|FG000|Overall Study|Lack of Efficacy|2|||
155166415|NCT01485172|560046251|FG001|Overall Study|Lack of Efficacy|0|||
155166416|NCT01485172|560046252|FG002|Overall Study|Lack of Efficacy|0|||
155166417|NCT01485172|560046253|FG003|Overall Study|Lack of Efficacy|0|||
155166418|NCT01485172|560046254|FG004|Overall Study|Lack of Efficacy|0|||
155166419|NCT01485172|560046255|FG005|Overall Study|Lack of Efficacy|0|||
155166420|NCT01485172|560046250|FG000|Overall Study|Protocol Violation|0|||
155166421|NCT01485172|560046251|FG001|Overall Study|Protocol Violation|0|||
155362994|NCT00150618|560763727|FG000|Overall Study|Abnormal ECG|1|||
155089599|NCT04727151|559759812|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155089600|NCT04727151|559759813|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
155089601|NCT04727151|559759814|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
155089602|NCT05185453|559759823|FG000|Overall Study|Lost to Follow-up|13|||
155089603|NCT05185453|559759824|FG001|Overall Study|Lost to Follow-up|3|||
155089604|NCT01972659|559759825|FG000|Overall Study|Protocol Violation|2|||
155089605|NCT01972659|559759826|FG001|Overall Study|Protocol Violation|2|||
155089606|NCT01972659|559759825|FG000|Overall Study|problems realted to acceleromyograph|2|||
155089607|NCT01972659|559759826|FG001|Overall Study|problems realted to acceleromyograph|1|||
155166422|NCT01485172|560046252|FG002|Overall Study|Protocol Violation|4|||
155166423|NCT01485172|560046253|FG003|Overall Study|Protocol Violation|5|||
155166424|NCT01485172|560046254|FG004|Overall Study|Protocol Violation|1|||
155166425|NCT01485172|560046255|FG005|Overall Study|Protocol Violation|0|||
155362995|NCT00150618|560763728|FG001|Overall Study|Abnormal ECG|0|||
155166426|NCT01485172|560046250|FG000|Overall Study|Protocol defined stopping criteria|1|||
155166427|NCT01485172|560046251|FG001|Overall Study|Protocol defined stopping criteria|0|||
155166428|NCT01485172|560046252|FG002|Overall Study|Protocol defined stopping criteria|0|||
155362996|NCT00150618|560763729|FG002|Overall Study|Abnormal ECG|0|||
155089608|NCT03814044|559759830|FG000|Overall Study|Protocol deviation|1|||
155362997|NCT00150618|560763730|FG003|Overall Study|Abnormal ECG|0|||
155362998|NCT00150618|560763731|FG004|Overall Study|Abnormal ECG|0|||
155362999|NCT00150618|560763727|FG000|Overall Study|Sponsor's decision|0|||
155363000|NCT00150618|560763728|FG001|Overall Study|Sponsor's decision|0|||
155363001|NCT00150618|560763729|FG002|Overall Study|Sponsor's decision|0|||
155363002|NCT00150618|560763730|FG003|Overall Study|Sponsor's decision|1|||
155363003|NCT00150618|560763731|FG004|Overall Study|Sponsor's decision|0|||
155363004|NCT02493946|560763733|FG000|DB Period|Withdrawal by Subject|8|||
155363005|NCT02493946|560763734|FG001|DB Period|Withdrawal by Subject|5|||
155363006|NCT02493946|560763735|FG002|DB Period|Withdrawal by Subject|0|||
155363007|NCT02493946|560763733|FG000|Open Label Period|Withdrawal by Subject|0|||
155363008|NCT02493946|560763734|FG001|Open Label Period|Withdrawal by Subject|0|||
155363009|NCT02493946|560763735|FG002|Open Label Period|Withdrawal by Subject|74|||
155363010|NCT02493946|560763733|FG000|Open Label Period|Adverse Event|0|||
155363011|NCT02493946|560763734|FG001|Open Label Period|Adverse Event|0|||
155363012|NCT02493946|560763735|FG002|Open Label Period|Adverse Event|4|||
155363013|NCT02493946|560763733|FG000|Open Label Period|Lost to Follow-up|0|||
155363014|NCT02493946|560763734|FG001|Open Label Period|Lost to Follow-up|0|||
155363015|NCT02493946|560763735|FG002|Open Label Period|Lost to Follow-up|1|||
155363016|NCT02493946|560763733|FG000|Open Label Period|Investigator decision, non-compliance|0|||
155363017|NCT02493946|560763734|FG001|Open Label Period|Investigator decision, non-compliance|0|||
155363018|NCT02493946|560763735|FG002|Open Label Period|Investigator decision, non-compliance|2|||
155363019|NCT02493946|560763733|FG000|Open Label Period|Investigator decision, non-availability|0|||
155363020|NCT02493946|560763734|FG001|Open Label Period|Investigator decision, non-availability|0|||
155363021|NCT02493946|560763735|FG002|Open Label Period|Investigator decision, non-availability|1|||
155363022|NCT02493946|560763733|FG000|Open Label Period|Pregnancy|0|||
155166429|NCT01485172|560046253|FG003|Overall Study|Protocol defined stopping criteria|0|||
155166430|NCT01485172|560046254|FG004|Overall Study|Protocol defined stopping criteria|1|||
155363023|NCT02493946|560763734|FG001|Open Label Period|Pregnancy|0|||
155363024|NCT02493946|560763735|FG002|Open Label Period|Pregnancy|3|||
155166431|NCT01485172|560046255|FG005|Overall Study|Protocol defined stopping criteria|0|||
155166432|NCT01485172|560046250|FG000|Overall Study|Lost to Follow-up|0|||
155166433|NCT01485172|560046251|FG001|Overall Study|Lost to Follow-up|0|||
155166434|NCT01485172|560046252|FG002|Overall Study|Lost to Follow-up|1|||
155166435|NCT01485172|560046253|FG003|Overall Study|Lost to Follow-up|0|||
155166436|NCT01485172|560046254|FG004|Overall Study|Lost to Follow-up|0|||
155166437|NCT01485172|560046255|FG005|Overall Study|Lost to Follow-up|1|||
155166438|NCT01485172|560046250|FG000|Overall Study|Physician Decision|0|||
155166439|NCT01485172|560046251|FG001|Overall Study|Physician Decision|0|||
155166440|NCT01485172|560046252|FG002|Overall Study|Physician Decision|0|||
155166441|NCT01485172|560046253|FG003|Overall Study|Physician Decision|0|||
155166442|NCT01485172|560046254|FG004|Overall Study|Physician Decision|1|||
155363025|NCT02493946|560763733|FG000|Open Label Period|Site error|0|||
155166443|NCT01485172|560046255|FG005|Overall Study|Physician Decision|0|||
155166444|NCT01485172|560046250|FG000|Overall Study|Withdrawal by Subject|2|||
155166445|NCT01485172|560046251|FG001|Overall Study|Withdrawal by Subject|0|||
155166446|NCT01485172|560046252|FG002|Overall Study|Withdrawal by Subject|0|||
155166447|NCT01485172|560046253|FG003|Overall Study|Withdrawal by Subject|1|||
155363026|NCT02493946|560763734|FG001|Open Label Period|Site error|0|||
155363027|NCT02493946|560763735|FG002|Open Label Period|Site error|1|||
155363028|NCT00965497|560763736|FG000|Overall Study|Physician Decision|1|||
155166448|NCT01485172|560046254|FG004|Overall Study|Withdrawal by Subject|1|||
155166449|NCT01485172|560046255|FG005|Overall Study|Withdrawal by Subject|1|||
155363029|NCT02878603|560763737|FG000|Overall Study|Lost to Follow-up|4|||
155363030|NCT02878603|560763738|FG001|Overall Study|Lost to Follow-up|1|||
155363031|NCT02878603|560763737|FG000|Overall Study|Withdrawal by Subject|1|||
155363032|NCT02878603|560763738|FG001|Overall Study|Withdrawal by Subject|1|||
155363033|NCT02878603|560763737|FG000|Overall Study|Death|1|||
155363034|NCT02878603|560763738|FG001|Overall Study|Death|0|||
155363035|NCT02878603|560763737|FG000|Overall Study|Physician Decision|0|||
155363036|NCT02878603|560763738|FG001|Overall Study|Physician Decision|3|||
155363037|NCT02689453|560763739|FG000|Overall Study|Progressive disease|0|||
155363038|NCT02689453|560763740|FG001|Overall Study|Progressive disease|1|||
155363039|NCT02689453|560763741|FG002|Overall Study|Progressive disease|1|||
155363040|NCT01162486|560763742|FG000|Overall Study|low ANC|1|||
155363041|NCT01162486|560763743|FG001|Overall Study|low ANC|0|||
155166450|NCT04995419|560046261|FG000|Overall Study|Withdrawal by Subject|3|||
155166451|NCT04995419|560046261|FG000|Overall Study|Progressive Disease|19|||
155166452|NCT04995419|560046261|FG000|Overall Study|Adverse Event|2|||
155166453|NCT04995419|560046261|FG000|Overall Study|Ongoing|16|||
155166454|NCT00838513|560046262|FG000|Screening Period|Screen Failure|3|||
155166455|NCT00838513|560046262|FG000|Extension Treatment Period|Death|1|||
155166456|NCT00838513|560046262|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
155166457|NCT00369265|560046267|FG000|Overall Study|Study terminated|4|||
155166458|NCT00369265|560046268|FG001|Overall Study|Study terminated|7|||
155166459|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
155166460|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
155166461|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
155166462|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
155166463|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
155166464|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
155166465|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
155166466|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155166467|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155166468|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166469|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
155166470|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166471|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166472|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166473|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
155166474|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
155166475|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
155166476|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
155166477|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155166478|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155166479|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155166480|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
155166481|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155166482|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
155166483|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155166484|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155166485|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155166486|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
155166487|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
155166488|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
155166489|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
155166490|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
155166491|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
155166492|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
155166493|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
155166494|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
155166495|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166496|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166497|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166498|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166499|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166500|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166501|NCT05019521|560046271|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155166502|NCT05019521|560046272|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155363042|NCT01162486|560763744|FG002|Overall Study|low ANC|0|||
155363043|NCT01162486|560763745|FG003|Overall Study|low ANC|0|||
155363044|NCT01162486|560763746|FG004|Overall Study|low ANC|0|||
155363045|NCT01162486|560763742|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
155363046|NCT01162486|560763743|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363047|NCT01162486|560763744|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363048|NCT01162486|560763745|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363049|NCT01162486|560763746|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
155363050|NCT01162486|560763742|FG000|Overall Study|elevated LFTs|0|||
155363051|NCT01162486|560763743|FG001|Overall Study|elevated LFTs|0|||
155363052|NCT01162486|560763744|FG002|Overall Study|elevated LFTs|1|||
155363053|NCT01162486|560763745|FG003|Overall Study|elevated LFTs|0|||
155363054|NCT01162486|560763746|FG004|Overall Study|elevated LFTs|0|||
155363055|NCT01162486|560763742|FG000|Overall Study|Pregnancy|0|||
155363056|NCT01162486|560763743|FG001|Overall Study|Pregnancy|0|||
155363057|NCT01162486|560763744|FG002|Overall Study|Pregnancy|0|||
155363058|NCT01162486|560763745|FG003|Overall Study|Pregnancy|1|||
155363059|NCT01162486|560763746|FG004|Overall Study|Pregnancy|0|||
155363060|NCT00794924|560763747|FG000|Overall Study|Lost to Follow-up|6|||
155363061|NCT00794924|560763748|FG001|Overall Study|Lost to Follow-up|8|||
155363062|NCT00794924|560763747|FG000|Overall Study|Withdrawal by Subject|48|||
155363063|NCT00794924|560763748|FG001|Overall Study|Withdrawal by Subject|60|||
155363064|NCT00794924|560763747|FG000|Overall Study|Adverse Event|6|||
155363065|NCT00794924|560763748|FG001|Overall Study|Adverse Event|2|||
155363066|NCT00953615|560763749|FG000|Overall Study|Adverse Event|1|||
155363067|NCT03274895|560763750|FG000|Overall Study|Lack of Efficacy|1|||
155363068|NCT03274895|560763751|FG001|Overall Study|Lack of Efficacy|0|||
155363069|NCT03274895|560763750|FG000|Overall Study|Adverse Event|8|||
155363070|NCT03274895|560763751|FG001|Overall Study|Adverse Event|7|||
155363071|NCT03274895|560763750|FG000|Overall Study|Lost to Follow-up|1|||
155363072|NCT03274895|560763751|FG001|Overall Study|Lost to Follow-up|0|||
155363073|NCT03274895|560763750|FG000|Overall Study|Diagnosis not confirmed|3|||
155363074|NCT03274895|560763751|FG001|Overall Study|Diagnosis not confirmed|4|||
155363075|NCT01969851|560763756|FG000|Overall Study|Adverse Event|0|||
155089609|NCT02757768|559759831|FG000|Overall Study|Randomized Never Received Study Drug|3|||
155089610|NCT02757768|559759832|FG001|Overall Study|Randomized Never Received Study Drug|4|||
155089611|NCT02757768|559759831|FG000|Overall Study|Adverse Event|5|||
155089612|NCT02757768|559759832|FG001|Overall Study|Adverse Event|3|||
155089613|NCT02757768|559759831|FG000|Overall Study|Lack of Efficacy|2|||
155089614|NCT02757768|559759832|FG001|Overall Study|Lack of Efficacy|1|||
155089615|NCT02757768|559759831|FG000|Overall Study|Lost to Follow-up|1|||
155089616|NCT02757768|559759832|FG001|Overall Study|Lost to Follow-up|0|||
155089617|NCT02757768|559759831|FG000|Overall Study|Protocol Deviation|2|||
155089618|NCT02757768|559759832|FG001|Overall Study|Protocol Deviation|9|||
155089619|NCT02757768|559759831|FG000|Overall Study|Withdrawal by Subject|16|||
155089620|NCT02757768|559759832|FG001|Overall Study|Withdrawal by Subject|9|||
155089621|NCT02757768|559759831|FG000|Overall Study|Miscellaneous|4|||
155089622|NCT02757768|559759832|FG001|Overall Study|Miscellaneous|2|||
155089623|NCT00835367|559759844|FG000|Washout|Adverse Event|2|||
155089624|NCT00835367|559759845|FG001|Washout|Adverse Event|0|||
155089625|NCT00835367|559759844|FG000|Washout|Withdrawal by Subject|1|||
155089626|NCT00835367|559759845|FG001|Washout|Withdrawal by Subject|0|||
155089627|NCT00835367|559759844|FG000|Second Intervention|Adverse Event|1|||
155089628|NCT00835367|559759845|FG001|Second Intervention|Adverse Event|1|||
155089629|NCT05929326|559759846|FG000|Overall Study|unqualified sample|2|||
155089630|NCT05929326|559759847|FG001|Overall Study|unqualified sample|3|||
155089631|NCT05929326|559759848|FG002|Overall Study|unqualified sample|7|||
155089632|NCT04569084|559759856|FG000|Overall Study|Adverse Event|10|||
155363076|NCT01969851|560763757|FG001|Overall Study|Adverse Event|0|||
155089633|NCT04569084|559759857|FG001|Overall Study|Adverse Event|14|||
155089634|NCT04569084|559759856|FG000|Overall Study|Death|2|||
155089635|NCT04569084|559759857|FG001|Overall Study|Death|3|||
155089636|NCT04569084|559759856|FG000|Overall Study|Lost to Follow-up|1|||
155363077|NCT01969851|560763758|FG002|Overall Study|Adverse Event|3|||
155363078|NCT01969851|560763756|FG000|Overall Study|Lack of Efficacy|0|||
155363079|NCT01969851|560763757|FG001|Overall Study|Lack of Efficacy|3|||
155363080|NCT01969851|560763758|FG002|Overall Study|Lack of Efficacy|1|||
155363081|NCT01969851|560763756|FG000|Overall Study|Withdrawal by Subject|1|||
155363082|NCT01969851|560763757|FG001|Overall Study|Withdrawal by Subject|0|||
155089637|NCT04569084|559759857|FG001|Overall Study|Lost to Follow-up|1|||
155089638|NCT04569084|559759856|FG000|Overall Study|Physician Decision|3|||
155363083|NCT01969851|560763758|FG002|Overall Study|Withdrawal by Subject|1|||
155363084|NCT01969851|560763756|FG000|Overall Study|No effective dose in Titration period|0|||
155363085|NCT01969851|560763757|FG001|Overall Study|No effective dose in Titration period|0|||
155363086|NCT01969851|560763758|FG002|Overall Study|No effective dose in Titration period|1|||
155363087|NCT01969851|560763756|FG000|Overall Study|Sponsor decision|0|||
155363088|NCT01969851|560763757|FG001|Overall Study|Sponsor decision|0|||
155363089|NCT01969851|560763758|FG002|Overall Study|Sponsor decision|1|||
155363090|NCT01294436|560763759|FG000|Overall Study|Adverse Event|10|||
155363091|NCT01294436|560763760|FG001|Overall Study|Adverse Event|17|||
155089639|NCT04569084|559759857|FG001|Overall Study|Physician Decision|3|||
155089640|NCT04569084|559759856|FG000|Overall Study|Protocol Violation|2|||
155363092|NCT01294436|560763759|FG000|Overall Study|Withdrawal by Subject|11|||
155363093|NCT01294436|560763760|FG001|Overall Study|Withdrawal by Subject|28|||
155089641|NCT04569084|559759857|FG001|Overall Study|Protocol Violation|1|||
155089642|NCT04569084|559759856|FG000|Overall Study|Withdrawal by Subject|20|||
155089643|NCT04569084|559759857|FG001|Overall Study|Withdrawal by Subject|21|||
155089644|NCT04569084|559759856|FG000|Overall Study|Study terminated by sponsor|26|||
155089645|NCT04569084|559759857|FG001|Overall Study|Study terminated by sponsor|23|||
155089646|NCT04569084|559759856|FG000|Overall Study|Other|3|||
155089647|NCT04569084|559759857|FG001|Overall Study|Other|5|||
155089648|NCT02495883|559759858|FG000|Overall Study|Excessive head motion|1|||
155089649|NCT02495883|559759859|FG001|Overall Study|Excessive head motion|0|||
155089650|NCT03557502|559759860|FG000|Protocol 2|Withdrawal by Subject|1|||
155089651|NCT03557502|559759861|FG001|Protocol 2|Withdrawal by Subject|1|||
155089652|NCT03557502|559759860|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
155089653|NCT03557502|559759861|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
155089654|NCT00964678|559759862|FG000|Overall Study|Physician Decision|4|||
155089655|NCT03359395|559759863|FG000|First Intervention A / B|Withdrawal by Subject|1|||
155089656|NCT03359395|559759864|FG001|First Intervention A / B|Withdrawal by Subject|0|||
155089657|NCT03359395|559759863|FG000|First Intervention A / B|Lost to Follow-up|2|||
155089658|NCT03359395|559759864|FG001|First Intervention A / B|Lost to Follow-up|3|||
155089659|NCT03359395|559759863|FG000|Second Intervention B/A|Exclusion criteria|0|||
155089660|NCT03359395|559759864|FG001|Second Intervention B/A|Exclusion criteria|1|||
155089661|NCT03359395|559759863|FG000|Second Intervention B/A|Lost to Follow-up|3|||
155089662|NCT03359395|559759864|FG001|Second Intervention B/A|Lost to Follow-up|2|||
155089663|NCT03164356|559759867|FG000|Overall Study|Lost to Follow-up|1|||
155089664|NCT03164356|559759868|FG001|Overall Study|Lost to Follow-up|1|||
155089665|NCT03164356|559759869|FG002|Overall Study|Lost to Follow-up|2|||
155089666|NCT03164356|559759870|FG003|Overall Study|Lost to Follow-up|1|||
155089667|NCT03164356|559759867|FG000|Overall Study|Physician Decision|0|||
155089668|NCT03164356|559759868|FG001|Overall Study|Physician Decision|0|||
155089669|NCT03164356|559759869|FG002|Overall Study|Physician Decision|3|||
155089670|NCT03164356|559759870|FG003|Overall Study|Physician Decision|0|||
155089671|NCT03164356|559759867|FG000|Overall Study|Protocol Violation|2|||
155089672|NCT03164356|559759868|FG001|Overall Study|Protocol Violation|1|||
155089673|NCT03164356|559759869|FG002|Overall Study|Protocol Violation|0|||
155089674|NCT03164356|559759870|FG003|Overall Study|Protocol Violation|0|||
155089675|NCT03164356|559759867|FG000|Overall Study|Withdrawal by Subject|1|||
155089676|NCT03164356|559759868|FG001|Overall Study|Withdrawal by Subject|0|||
155089677|NCT03164356|559759869|FG002|Overall Study|Withdrawal by Subject|0|||
155089678|NCT03164356|559759870|FG003|Overall Study|Withdrawal by Subject|0|||
155089679|NCT03164356|559759867|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
155089680|NCT03164356|559759868|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
155089681|NCT03164356|559759869|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
155089682|NCT03164356|559759870|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
155089683|NCT03164356|559759867|FG000|Overall Study|Subject Incarcerated|0|||
155089684|NCT03164356|559759868|FG001|Overall Study|Subject Incarcerated|1|||
155089685|NCT03164356|559759869|FG002|Overall Study|Subject Incarcerated|0|||
155089686|NCT03164356|559759870|FG003|Overall Study|Subject Incarcerated|0|||
155089687|NCT03164356|559759867|FG000|Overall Study|Prosthetist unable to participate|0|||
155089688|NCT03164356|559759868|FG001|Overall Study|Prosthetist unable to participate|2|||
155089689|NCT03164356|559759869|FG002|Overall Study|Prosthetist unable to participate|1|||
155089690|NCT03164356|559759870|FG003|Overall Study|Prosthetist unable to participate|0|||
155089691|NCT03396445|559761843|FG000|Treatment Period|Death|2|||
155089692|NCT03396445|559761844|FG001|Treatment Period|Death|2|||
155089693|NCT03396445|559761845|FG002|Treatment Period|Death|1|||
155089694|NCT03396445|559761846|FG003|Treatment Period|Death|1|||
155089695|NCT03396445|559761847|FG004|Treatment Period|Death|3|||
155089696|NCT03396445|559761848|FG005|Treatment Period|Death|2|||
155089697|NCT03396445|559761849|FG006|Treatment Period|Death|5|||
155089698|NCT03396445|559761850|FG007|Treatment Period|Death|3|||
155089699|NCT03396445|559761851|FG008|Treatment Period|Death|3|||
155089700|NCT03396445|559761852|FG009|Treatment Period|Death|3|||
155089701|NCT03396445|559761853|FG010|Treatment Period|Death|7|||
155089702|NCT03396445|559761854|FG011|Treatment Period|Death|12|||
155363094|NCT01294436|560763759|FG000|Overall Study|subject no longer meets study criteria|5|||
155363095|NCT01294436|560763760|FG001|Overall Study|subject no longer meets study criteria|20|||
155363096|NCT01294436|560763759|FG000|Overall Study|poor/non-compliance|2|||
155363097|NCT01294436|560763760|FG001|Overall Study|poor/non-compliance|5|||
155363098|NCT02389764|560763761|FG000|Overall Study|Lack of Efficacy|9|||
155363099|NCT02498236|560763769|FG000|Overall Study|Did not show for testing|1|||
155363100|NCT02498236|560763770|FG001|Overall Study|Did not show for testing|0|||
155363101|NCT02498236|560763771|FG002|Overall Study|Did not show for testing|0|||
155363102|NCT02498236|560763772|FG003|Overall Study|Did not show for testing|0|||
155363103|NCT02498236|560763773|FG004|Overall Study|Did not show for testing|0|||
155363104|NCT02498236|560763774|FG005|Overall Study|Did not show for testing|0|||
155363105|NCT02498236|560763775|FG006|Overall Study|Did not show for testing|0|||
155363106|NCT02498236|560763776|FG007|Overall Study|Did not show for testing|1|||
155363107|NCT02498236|560763769|FG000|Overall Study|Equipment failure|0|||
155363108|NCT02498236|560763770|FG001|Overall Study|Equipment failure|0|||
155363109|NCT02498236|560763771|FG002|Overall Study|Equipment failure|0|||
155363110|NCT02498236|560763772|FG003|Overall Study|Equipment failure|0|||
155363111|NCT02498236|560763773|FG004|Overall Study|Equipment failure|0|||
155363112|NCT02498236|560763774|FG005|Overall Study|Equipment failure|0|||
155363113|NCT02498236|560763775|FG006|Overall Study|Equipment failure|1|||
155363114|NCT02498236|560763776|FG007|Overall Study|Equipment failure|0|||
155363115|NCT02498236|560763769|FG000|Overall Study|Withdrawal by Subject|0|||
155363116|NCT02498236|560763770|FG001|Overall Study|Withdrawal by Subject|0|||
155363117|NCT02498236|560763771|FG002|Overall Study|Withdrawal by Subject|0|||
155363118|NCT02498236|560763772|FG003|Overall Study|Withdrawal by Subject|0|||
155363119|NCT02498236|560763773|FG004|Overall Study|Withdrawal by Subject|1|||
155363120|NCT02498236|560763774|FG005|Overall Study|Withdrawal by Subject|0|||
155363121|NCT02498236|560763775|FG006|Overall Study|Withdrawal by Subject|0|||
155363122|NCT02498236|560763776|FG007|Overall Study|Withdrawal by Subject|0|||
155363123|NCT02296892|560763777|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
155363124|NCT02296892|560763778|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
155363125|NCT02296892|560763779|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
155363126|NCT02296892|560763777|FG000|Overall Study|Lost to Follow-up|5|||
155363127|NCT02296892|560763778|FG001|Overall Study|Lost to Follow-up|0|||
155363128|NCT02296892|560763779|FG002|Overall Study|Lost to Follow-up|1|||
155363129|NCT00585078|560763780|FG000|Overall Study|Withdrawal by Subject|4|||
155363130|NCT00585078|560763780|FG000|Overall Study|Poor performance status|1|||
155363131|NCT00585078|560763780|FG000|Overall Study|Disease Progression|24|||
155363132|NCT00585078|560763780|FG000|Overall Study|Adverse Event|10|||
155363133|NCT00585078|560763780|FG000|Overall Study|Death|1|||
155363134|NCT01814072|560763785|FG000|Overall Study|Lost to Follow-up|2|||
155363135|NCT01814072|560763786|FG001|Overall Study|Lost to Follow-up|2|||
155363136|NCT01814072|560763787|FG002|Overall Study|Lost to Follow-up|2|||
155363137|NCT01814072|560763788|FG003|Overall Study|Lost to Follow-up|0|||
155363138|NCT01814072|560763789|FG004|Overall Study|Lost to Follow-up|2|||
155363139|NCT01814072|560763790|FG005|Overall Study|Lost to Follow-up|3|||
155363140|NCT01814072|560763791|FG006|Overall Study|Lost to Follow-up|3|||
155363141|NCT01814072|560763792|FG007|Overall Study|Lost to Follow-up|1|||
155363142|NCT01814072|560763793|FG008|Overall Study|Lost to Follow-up|2|||
155363143|NCT01814072|560763794|FG009|Overall Study|Lost to Follow-up|3|||
155363144|NCT01814072|560763795|FG010|Overall Study|Lost to Follow-up|1|||
155363145|NCT01814072|560763796|FG011|Overall Study|Lost to Follow-up|2|||
155363146|NCT01814072|560763797|FG012|Overall Study|Lost to Follow-up|2|||
155363147|NCT01814072|560763798|FG013|Overall Study|Lost to Follow-up|1|||
155089703|NCT03396445|559761855|FG012|Treatment Period|Death|28|||
155363148|NCT01814072|560763799|FG014|Overall Study|Lost to Follow-up|2|||
155363149|NCT01814072|560763800|FG015|Overall Study|Lost to Follow-up|1|||
155363150|NCT01814072|560763801|FG016|Overall Study|Lost to Follow-up|3|||
155363151|NCT01814072|560763802|FG017|Overall Study|Lost to Follow-up|1|||
155363152|NCT01814072|560763803|FG018|Overall Study|Lost to Follow-up|3|||
155363153|NCT01814072|560763804|FG019|Overall Study|Lost to Follow-up|3|||
155363154|NCT01814072|560763805|FG020|Overall Study|Lost to Follow-up|2|||
154965308|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155363155|NCT01814072|560763806|FG021|Overall Study|Lost to Follow-up|1|||
155363156|NCT01814072|560763807|FG022|Overall Study|Lost to Follow-up|3|||
155363157|NCT01814072|560763808|FG023|Overall Study|Lost to Follow-up|1|||
155363158|NCT01814072|560763809|FG024|Overall Study|Lost to Follow-up|4|||
155089704|NCT03396445|559761856|FG013|Treatment Period|Death|14|||
155089705|NCT03396445|559761857|FG014|Treatment Period|Death|10|||
155089706|NCT03396445|559761858|FG015|Treatment Period|Death|8|||
155089707|NCT03396445|559761859|FG016|Treatment Period|Death|18|||
155089708|NCT03396445|559761860|FG017|Treatment Period|Death|0|||
155089709|NCT03396445|559761861|FG018|Treatment Period|Death|0|||
155363159|NCT01814072|560763810|FG025|Overall Study|Lost to Follow-up|1|||
155363160|NCT01814072|560763811|FG026|Overall Study|Lost to Follow-up|1|||
155363161|NCT01814072|560763812|FG027|Overall Study|Lost to Follow-up|2|||
155363162|NCT01814072|560763813|FG028|Overall Study|Lost to Follow-up|3|||
155363163|NCT01814072|560763814|FG029|Overall Study|Lost to Follow-up|3|||
155363164|NCT01814072|560763815|FG030|Overall Study|Lost to Follow-up|2|||
155363165|NCT01814072|560763816|FG031|Overall Study|Lost to Follow-up|0|||
155363166|NCT01814072|560763785|FG000|Overall Study|Withdrawal by Subject|2|||
155363167|NCT01814072|560763786|FG001|Overall Study|Withdrawal by Subject|0|||
155363168|NCT01814072|560763787|FG002|Overall Study|Withdrawal by Subject|1|||
155363169|NCT01814072|560763788|FG003|Overall Study|Withdrawal by Subject|0|||
155363170|NCT01814072|560763789|FG004|Overall Study|Withdrawal by Subject|2|||
155363171|NCT01814072|560763790|FG005|Overall Study|Withdrawal by Subject|3|||
155363172|NCT01814072|560763791|FG006|Overall Study|Withdrawal by Subject|1|||
155363173|NCT01814072|560763792|FG007|Overall Study|Withdrawal by Subject|0|||
155089710|NCT03396445|559761862|FG019|Treatment Period|Death|0|||
155089711|NCT03396445|559761863|FG020|Treatment Period|Death|0|||
155089712|NCT03396445|559761864|FG021|Treatment Period|Death|0|||
155089713|NCT03396445|559761865|FG022|Treatment Period|Death|0|||
155089714|NCT03396445|559761866|FG023|Treatment Period|Death|0|||
155089715|NCT03396445|559761867|FG024|Treatment Period|Death|0|||
155089716|NCT03396445|559761868|FG025|Treatment Period|Death|0|||
155089717|NCT03396445|559761843|FG000|Treatment Period|Lost to Follow-up|0|||
155089718|NCT03396445|559761844|FG001|Treatment Period|Lost to Follow-up|0|||
155089719|NCT03396445|559761845|FG002|Treatment Period|Lost to Follow-up|0|||
155089720|NCT03396445|559761846|FG003|Treatment Period|Lost to Follow-up|0|||
155089721|NCT03396445|559761847|FG004|Treatment Period|Lost to Follow-up|0|||
155089722|NCT03396445|559761848|FG005|Treatment Period|Lost to Follow-up|0|||
155089723|NCT03396445|559761849|FG006|Treatment Period|Lost to Follow-up|0|||
155089724|NCT03396445|559761850|FG007|Treatment Period|Lost to Follow-up|0|||
155089725|NCT03396445|559761851|FG008|Treatment Period|Lost to Follow-up|0|||
155089726|NCT03396445|559761852|FG009|Treatment Period|Lost to Follow-up|0|||
155089727|NCT03396445|559761853|FG010|Treatment Period|Lost to Follow-up|0|||
155089728|NCT03396445|559761854|FG011|Treatment Period|Lost to Follow-up|0|||
155089729|NCT03396445|559761855|FG012|Treatment Period|Lost to Follow-up|1|||
155089730|NCT03396445|559761856|FG013|Treatment Period|Lost to Follow-up|0|||
155089731|NCT03396445|559761857|FG014|Treatment Period|Lost to Follow-up|1|||
155089732|NCT03396445|559761858|FG015|Treatment Period|Lost to Follow-up|0|||
155089733|NCT03396445|559761859|FG016|Treatment Period|Lost to Follow-up|0|||
155089734|NCT03396445|559761860|FG017|Treatment Period|Lost to Follow-up|0|||
155363174|NCT01814072|560763793|FG008|Overall Study|Withdrawal by Subject|1|||
155363175|NCT01814072|560763794|FG009|Overall Study|Withdrawal by Subject|2|||
155363176|NCT01814072|560763795|FG010|Overall Study|Withdrawal by Subject|0|||
155363177|NCT01814072|560763796|FG011|Overall Study|Withdrawal by Subject|0|||
155363178|NCT01814072|560763797|FG012|Overall Study|Withdrawal by Subject|1|||
155363179|NCT01814072|560763798|FG013|Overall Study|Withdrawal by Subject|1|||
155363180|NCT01814072|560763799|FG014|Overall Study|Withdrawal by Subject|1|||
155363181|NCT01814072|560763800|FG015|Overall Study|Withdrawal by Subject|1|||
155363182|NCT01814072|560763801|FG016|Overall Study|Withdrawal by Subject|0|||
155363183|NCT01814072|560763802|FG017|Overall Study|Withdrawal by Subject|0|||
155363184|NCT01814072|560763803|FG018|Overall Study|Withdrawal by Subject|0|||
155363185|NCT01814072|560763804|FG019|Overall Study|Withdrawal by Subject|2|||
155363186|NCT01814072|560763805|FG020|Overall Study|Withdrawal by Subject|0|||
155363187|NCT01814072|560763806|FG021|Overall Study|Withdrawal by Subject|0|||
155363188|NCT01814072|560763807|FG022|Overall Study|Withdrawal by Subject|1|||
155363189|NCT01814072|560763808|FG023|Overall Study|Withdrawal by Subject|0|||
155363190|NCT01814072|560763809|FG024|Overall Study|Withdrawal by Subject|2|||
155363191|NCT01814072|560763810|FG025|Overall Study|Withdrawal by Subject|1|||
155363192|NCT01814072|560763811|FG026|Overall Study|Withdrawal by Subject|1|||
155363193|NCT01814072|560763812|FG027|Overall Study|Withdrawal by Subject|2|||
155363194|NCT01814072|560763813|FG028|Overall Study|Withdrawal by Subject|1|||
155363195|NCT01814072|560763814|FG029|Overall Study|Withdrawal by Subject|0|||
155363196|NCT01814072|560763815|FG030|Overall Study|Withdrawal by Subject|0|||
155363197|NCT01814072|560763816|FG031|Overall Study|Withdrawal by Subject|0|||
155363198|NCT01011868|560763822|FG000|After Week 18 Follow-up|Adverse Event|8|||
155363199|NCT01011868|560763823|FG001|After Week 18 Follow-up|Adverse Event|6|||
155363200|NCT01011868|560763824|FG002|After Week 18 Follow-up|Adverse Event|13|||
155363201|NCT01011868|560763822|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
155363202|NCT01011868|560763823|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
155363203|NCT01011868|560763824|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
155363204|NCT01011868|560763822|FG000|After Week 18 Follow-up|Protocol Violation|1|||
155363205|NCT01011868|560763823|FG001|After Week 18 Follow-up|Protocol Violation|1|||
155363206|NCT01011868|560763824|FG002|After Week 18 Follow-up|Protocol Violation|1|||
155363207|NCT01011868|560763822|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
155363208|NCT01011868|560763823|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
155363209|NCT01011868|560763824|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
155089735|NCT03396445|559761861|FG018|Treatment Period|Lost to Follow-up|0|||
155089736|NCT03396445|559761862|FG019|Treatment Period|Lost to Follow-up|0|||
155089737|NCT03396445|559761863|FG020|Treatment Period|Lost to Follow-up|0|||
155089738|NCT03396445|559761864|FG021|Treatment Period|Lost to Follow-up|0|||
155089739|NCT03396445|559761865|FG022|Treatment Period|Lost to Follow-up|0|||
155089740|NCT03396445|559761866|FG023|Treatment Period|Lost to Follow-up|0|||
155089741|NCT03396445|559761867|FG024|Treatment Period|Lost to Follow-up|0|||
155363210|NCT01011868|560763822|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
155363211|NCT01011868|560763823|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
155363212|NCT01011868|560763824|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
155363213|NCT01011868|560763822|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
155363214|NCT01011868|560763823|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
155363215|NCT01011868|560763824|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
155363216|NCT01011868|560763822|FG000|After Week 78 Follow-up|Adverse Event|14|||
155363217|NCT01011868|560763823|FG001|After Week 78 Follow-up|Adverse Event|18|||
155363218|NCT01011868|560763824|FG002|After Week 78 Follow-up|Adverse Event|21|||
155363219|NCT01011868|560763822|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
155363220|NCT01011868|560763823|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
155363221|NCT01011868|560763824|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
155363222|NCT01011868|560763822|FG000|After Week 78 Follow-up|Protocol Violation|9|||
155363223|NCT01011868|560763823|FG001|After Week 78 Follow-up|Protocol Violation|1|||
155363224|NCT01011868|560763824|FG002|After Week 78 Follow-up|Protocol Violation|2|||
155363225|NCT01011868|560763822|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
155363226|NCT01011868|560763823|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
155363227|NCT01011868|560763824|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
155363228|NCT01011868|560763822|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
155363229|NCT01011868|560763823|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
155363230|NCT01011868|560763824|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
155363231|NCT01011868|560763822|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
155363232|NCT01011868|560763823|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
155363233|NCT01011868|560763824|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
155363234|NCT01255761|560763825|FG000|Overall Study|Adverse Event|29|||
155363235|NCT01255761|560763826|FG001|Overall Study|Adverse Event|43|||
155363236|NCT01255761|560763825|FG000|Overall Study|Lack of Efficacy|86|||
155363237|NCT01255761|560763826|FG001|Overall Study|Lack of Efficacy|74|||
155363238|NCT01255761|560763825|FG000|Overall Study|Protocol Violation|9|||
155363239|NCT01255761|560763826|FG001|Overall Study|Protocol Violation|5|||
155363240|NCT01255761|560763825|FG000|Overall Study|Lost to Follow-up|10|||
155363241|NCT01255761|560763826|FG001|Overall Study|Lost to Follow-up|8|||
155363242|NCT01255761|560763825|FG000|Overall Study|Withdrawal by Subject|11|||
155363243|NCT01255761|560763826|FG001|Overall Study|Withdrawal by Subject|27|||
155363244|NCT01255761|560763825|FG000|Overall Study|Other Reasons|37|||
155363245|NCT01255761|560763826|FG001|Overall Study|Other Reasons|18|||
155363246|NCT04147858|560763827|FG000|Overall Study|Adverse Event|6|||
155363247|NCT04147858|560763828|FG001|Overall Study|Adverse Event|6|||
155363248|NCT04147858|560763829|FG002|Overall Study|Adverse Event|6|||
155363249|NCT04147858|560763827|FG000|Overall Study|Lack of Efficacy|3|||
155363250|NCT04147858|560763828|FG001|Overall Study|Lack of Efficacy|3|||
155363251|NCT04147858|560763829|FG002|Overall Study|Lack of Efficacy|1|||
155363252|NCT04147858|560763827|FG000|Overall Study|Lost to Follow-up|1|||
155363253|NCT04147858|560763828|FG001|Overall Study|Lost to Follow-up|6|||
155363254|NCT04147858|560763829|FG002|Overall Study|Lost to Follow-up|2|||
155363255|NCT04147858|560763827|FG000|Overall Study|Withdrawal by Subject|3|||
155363256|NCT04147858|560763828|FG001|Overall Study|Withdrawal by Subject|4|||
155363257|NCT04147858|560763829|FG002|Overall Study|Withdrawal by Subject|10|||
155363258|NCT04147858|560763827|FG000|Overall Study|Subject Noncompliance, Other|4|||
155363259|NCT04147858|560763828|FG001|Overall Study|Subject Noncompliance, Other|3|||
155363260|NCT04147858|560763829|FG002|Overall Study|Subject Noncompliance, Other|1|||
155363261|NCT02615938|560763832|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
155363262|NCT02615938|560763833|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
155363263|NCT02615938|560763834|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363264|NCT02615938|560763835|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363265|NCT02615938|560763832|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
155363266|NCT02615938|560763833|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
155363267|NCT02615938|560763834|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
155089742|NCT03396445|559761868|FG025|Treatment Period|Lost to Follow-up|0|||
155089743|NCT03396445|559761843|FG000|Treatment Period|Physician Decision|0|||
155089744|NCT03396445|559761844|FG001|Treatment Period|Physician Decision|0|||
155089745|NCT03396445|559761845|FG002|Treatment Period|Physician Decision|0|||
155089746|NCT03396445|559761846|FG003|Treatment Period|Physician Decision|0|||
155363268|NCT02615938|560763835|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
155363269|NCT02615938|560763832|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363270|NCT02615938|560763833|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363271|NCT02615938|560763834|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
155363272|NCT02615938|560763835|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
155363273|NCT04905849|560763837|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
155363274|NCT04905849|560763838|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
155363275|NCT00838929|560763848|FG000|Overall Study|Protocol Violation|0|||
155363276|NCT00838929|560763849|FG001|Overall Study|Protocol Violation|1|||
155363277|NCT00838929|560763850|FG002|Overall Study|Protocol Violation|0|||
155363278|NCT00838929|560763848|FG000|Overall Study|Disease progression|0|||
155363279|NCT00838929|560763849|FG001|Overall Study|Disease progression|2|||
155363280|NCT00838929|560763850|FG002|Overall Study|Disease progression|1|||
155363281|NCT03375320|560763857|FG000|Overall Study|Adverse Event|34|||
155363282|NCT03375320|560763858|FG001|Overall Study|Adverse Event|9|||
155363283|NCT03375320|560763859|FG002|Overall Study|Adverse Event|10|||
155363284|NCT03375320|560763860|FG003|Overall Study|Adverse Event|0|||
155363285|NCT03375320|560763857|FG000|Overall Study|Death|6|||
155363286|NCT03375320|560763858|FG001|Overall Study|Death|3|||
155363287|NCT03375320|560763859|FG002|Overall Study|Death|0|||
155363288|NCT03375320|560763860|FG003|Overall Study|Death|0|||
155363289|NCT03375320|560763857|FG000|Overall Study|Withdrawal by Subject|7|||
155363290|NCT03375320|560763858|FG001|Overall Study|Withdrawal by Subject|4|||
155363291|NCT03375320|560763859|FG002|Overall Study|Withdrawal by Subject|5|||
155363292|NCT03375320|560763860|FG003|Overall Study|Withdrawal by Subject|4|||
155363293|NCT03375320|560763857|FG000|Overall Study|Progressive disease|55|||
155363294|NCT03375320|560763858|FG001|Overall Study|Progressive disease|41|||
155363295|NCT03375320|560763859|FG002|Overall Study|Progressive disease|29|||
155363296|NCT03375320|560763860|FG003|Overall Study|Progressive disease|24|||
155363297|NCT03375320|560763857|FG000|Overall Study|Alternative treatment|6|||
155363298|NCT03375320|560763858|FG001|Overall Study|Alternative treatment|1|||
155363299|NCT03375320|560763859|FG002|Overall Study|Alternative treatment|1|||
155363300|NCT03375320|560763860|FG003|Overall Study|Alternative treatment|0|||
155363301|NCT03375320|560763857|FG000|Overall Study|Other disease|1|||
155363302|NCT03375320|560763858|FG001|Overall Study|Other disease|1|||
155363303|NCT03375320|560763859|FG002|Overall Study|Other disease|3|||
155363304|NCT03375320|560763860|FG003|Overall Study|Other disease|0|||
155363305|NCT03375320|560763857|FG000|Overall Study|Withdrawal prior to initiation|2|||
155363306|NCT03375320|560763858|FG001|Overall Study|Withdrawal prior to initiation|2|||
155363307|NCT03375320|560763859|FG002|Overall Study|Withdrawal prior to initiation|1|||
155363308|NCT03375320|560763860|FG003|Overall Study|Withdrawal prior to initiation|0|||
155363309|NCT03375320|560763857|FG000|Overall Study|Physician Decision|1|||
155363310|NCT03375320|560763858|FG001|Overall Study|Physician Decision|1|||
155363311|NCT03375320|560763859|FG002|Overall Study|Physician Decision|1|||
155363312|NCT03375320|560763860|FG003|Overall Study|Physician Decision|1|||
155363313|NCT03375320|560763857|FG000|Overall Study|Non-compliance|1|||
155363314|NCT03375320|560763858|FG001|Overall Study|Non-compliance|0|||
155363315|NCT03375320|560763859|FG002|Overall Study|Non-compliance|0|||
155363316|NCT03375320|560763860|FG003|Overall Study|Non-compliance|0|||
155089747|NCT03396445|559761847|FG004|Treatment Period|Physician Decision|1|||
155363317|NCT03348631|560763861|FG000|Overall Study|Not Eligible, No treatment|0|||
155363318|NCT03348631|560763862|FG001|Overall Study|Not Eligible, No treatment|1|||
155363319|NCT03348631|560763861|FG000|Overall Study|Not Eligible, Treated|2|||
155363320|NCT03348631|560763862|FG001|Overall Study|Not Eligible, Treated|0|||
155363321|NCT03348631|560763861|FG000|Overall Study|Eligible, No Treatment|1|||
155363322|NCT03348631|560763862|FG001|Overall Study|Eligible, No Treatment|0|||
155363323|NCT01068210|560763863|FG000|Overall Study|Lost to Follow-up|1|||
155363324|NCT01068210|560763864|FG001|Overall Study|Lost to Follow-up|2|||
155363325|NCT01068210|560763865|FG002|Overall Study|Lost to Follow-up|2|||
155363326|NCT01068210|560763866|FG003|Overall Study|Lost to Follow-up|1|||
155363327|NCT01068210|560763863|FG000|Overall Study|Second cancer|0|||
155363328|NCT01068210|560763864|FG001|Overall Study|Second cancer|1|||
155363329|NCT01068210|560763865|FG002|Overall Study|Second cancer|0|||
155363330|NCT01068210|560763866|FG003|Overall Study|Second cancer|0|||
155363331|NCT01068210|560763863|FG000|Overall Study|Disease progression|0|||
155363332|NCT01068210|560763864|FG001|Overall Study|Disease progression|0|||
155363333|NCT01068210|560763865|FG002|Overall Study|Disease progression|0|||
155363334|NCT01068210|560763866|FG003|Overall Study|Disease progression|2|||
155363335|NCT00699842|560763867|FG000|Overall Study|Death|0|||
155363336|NCT00699842|560763868|FG001|Overall Study|Death|1|||
155363337|NCT00699842|560763869|FG002|Overall Study|Death|0|||
155363338|NCT03170518|560763870|FG000|Overall Study|Lost to Follow-up|4|||
155363339|NCT03170518|560763871|FG001|Overall Study|Lost to Follow-up|1|||
155363340|NCT03170518|560763872|FG002|Overall Study|Lost to Follow-up|0|||
155363341|NCT03170518|560763870|FG000|Overall Study|Physician Decision|1|||
155363342|NCT03170518|560763871|FG001|Overall Study|Physician Decision|0|||
155363343|NCT03170518|560763872|FG002|Overall Study|Physician Decision|0|||
155363344|NCT03170518|560763870|FG000|Overall Study|Withdrawal by Subject|4|||
155363345|NCT03170518|560763871|FG001|Overall Study|Withdrawal by Subject|5|||
155363346|NCT03170518|560763872|FG002|Overall Study|Withdrawal by Subject|2|||
155363347|NCT03170518|560763870|FG000|Overall Study|Site terminated by sponsor|0|||
155363348|NCT03170518|560763871|FG001|Overall Study|Site terminated by sponsor|1|||
155363349|NCT03170518|560763872|FG002|Overall Study|Site terminated by sponsor|0|||
155363350|NCT03170518|560763870|FG000|Overall Study|Non-compliance with study drug|1|||
155363351|NCT03170518|560763871|FG001|Overall Study|Non-compliance with study drug|0|||
155363352|NCT03170518|560763872|FG002|Overall Study|Non-compliance with study drug|1|||
155363353|NCT03170518|560763870|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155363354|NCT03170518|560763871|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155363355|NCT03170518|560763872|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155363356|NCT03342196|560763873|FG000|Overall Study|Physician Decision|1|||
155363357|NCT00546078|560763874|FG000|Overall Study|Lost to Follow-up|1|||
155363358|NCT00546078|560763875|FG001|Overall Study|Lost to Follow-up|3|||
155363359|NCT00546078|560763874|FG000|Overall Study|Withdrawal by Subject|2|||
155363360|NCT00546078|560763875|FG001|Overall Study|Withdrawal by Subject|3|||
155363361|NCT00546078|560763874|FG000|Overall Study|Other reason|1|||
155363362|NCT00546078|560763875|FG001|Overall Study|Other reason|1|||
155363363|NCT03512197|560763878|FG000|Overall Study|Guardian decision|1|||
155363364|NCT03512197|560763879|FG001|Overall Study|Guardian decision|1|||
155363365|NCT03512197|560763878|FG000|Overall Study|Lack of Efficacy|19|||
155363366|NCT03512197|560763879|FG001|Overall Study|Lack of Efficacy|11|||
155363367|NCT03512197|560763878|FG000|Overall Study|New Therapy for Study Indication|16|||
155363368|NCT03512197|560763879|FG001|Overall Study|New Therapy for Study Indication|16|||
155363369|NCT03512197|560763878|FG000|Overall Study|Physician Decision|60|||
155363370|NCT03512197|560763879|FG001|Overall Study|Physician Decision|60|||
155363371|NCT03512197|560763878|FG000|Overall Study|Protocol Violation|0|||
155363372|NCT03512197|560763879|FG001|Overall Study|Protocol Violation|2|||
155363373|NCT03512197|560763878|FG000|Overall Study|Terminated by Sponsored|46|||
155363374|NCT03512197|560763879|FG001|Overall Study|Terminated by Sponsored|50|||
155363375|NCT03512197|560763878|FG000|Overall Study|Subject Decision|15|||
155363376|NCT03512197|560763879|FG001|Overall Study|Subject Decision|12|||
155363377|NCT03512197|560763878|FG000|Overall Study|Withdrawal of informed consent|20|||
155363378|NCT03512197|560763879|FG001|Overall Study|Withdrawal of informed consent|14|||
155363379|NCT03512197|560763878|FG000|Overall Study|Adverse Event|30|||
155363380|NCT03512197|560763879|FG001|Overall Study|Adverse Event|34|||
155363381|NCT03512197|560763878|FG000|Overall Study|Death|14|||
155363382|NCT03512197|560763879|FG001|Overall Study|Death|9|||
155363383|NCT03512197|560763878|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
155363384|NCT03512197|560763879|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
155363385|NCT03512197|560763878|FG000|Overall Study|Missing|3|||
155363386|NCT03512197|560763879|FG001|Overall Study|Missing|13|||
155363387|NCT01806389|560763880|FG000|Overall Study|Withdrawal by Subject|4|||
155363388|NCT03842436|560763881|FG000|Overall Study|Lost to Follow-up|1|||
155363389|NCT01948076|560763882|FG000|Overall Study|Withdrawal by Subject|0|||
155363390|NCT01948076|560763883|FG001|Overall Study|Withdrawal by Subject|1|||
155363391|NCT01151423|560763886|FG000|Overall Study|Study terminated by Sponsor|9|||
155363392|NCT01151423|560763887|FG001|Overall Study|Study terminated by Sponsor|10|||
155363393|NCT01151423|560763886|FG000|Overall Study|Protocol Violation|0|||
155363394|NCT01151423|560763887|FG001|Overall Study|Protocol Violation|1|||
155363395|NCT01151423|560763886|FG000|Overall Study|Physician Decision|1|||
155363396|NCT01151423|560763887|FG001|Overall Study|Physician Decision|1|||
155363397|NCT01151423|560763886|FG000|Overall Study|Pregnancy|0|||
155363398|NCT01151423|560763887|FG001|Overall Study|Pregnancy|1|||
155363399|NCT01151423|560763886|FG000|Overall Study|Death|0|||
155363400|NCT01151423|560763887|FG001|Overall Study|Death|1|||
155363401|NCT01151423|560763886|FG000|Overall Study|Adverse Event|3|||
155166503|NCT05019521|560046273|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155166504|NCT05019521|560046274|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
155166505|NCT05019521|560046275|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155166506|NCT05019521|560046276|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
154965309|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155166507|NCT05019521|560046277|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155166508|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
155363402|NCT01151423|560763887|FG001|Overall Study|Adverse Event|0|||
155363403|NCT01151423|560763886|FG000|Overall Study|Withdrawal by Subject|1|||
155363404|NCT01151423|560763887|FG001|Overall Study|Withdrawal by Subject|3|||
155363405|NCT01151423|560763886|FG000|Overall Study|Lost to Follow-up|1|||
155363406|NCT01151423|560763887|FG001|Overall Study|Lost to Follow-up|0|||
155363407|NCT01151423|560763886|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
155363408|NCT01151423|560763887|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
155363409|NCT01151423|560763886|FG000|Overall Study|Participated in other clinical trial|1|||
155166509|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
155166510|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
155166511|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
155166512|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
155166513|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
155166514|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
155166515|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155166516|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
155166517|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155166518|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166519|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166520|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
155166521|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
155166522|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
155166523|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155166524|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155166525|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
155166526|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
155363410|NCT01151423|560763887|FG001|Overall Study|Participated in other clinical trial|0|||
155363411|NCT01263054|560763889|FG000|Overall Study|Death|1|||
155363412|NCT01263054|560763890|FG001|Overall Study|Death|0|||
155363413|NCT01263054|560763889|FG000|Overall Study|Lost to Follow-up|2|||
155363414|NCT01263054|560763890|FG001|Overall Study|Lost to Follow-up|2|||
155363415|NCT01263054|560763889|FG000|Overall Study|Withdrawal by Subject|1|||
155363416|NCT01263054|560763890|FG001|Overall Study|Withdrawal by Subject|3|||
155363417|NCT01263054|560763889|FG000|Overall Study|Qualification Violation|1|||
155363418|NCT01263054|560763890|FG001|Overall Study|Qualification Violation|0|||
155363419|NCT01263054|560763889|FG000|Overall Study|Other|0|||
155363420|NCT01263054|560763890|FG001|Overall Study|Other|1|||
155363421|NCT03358238|560763891|FG000|Overall Study|Withdrawal by Subject|0|||
155363422|NCT03358238|560763892|FG001|Overall Study|Withdrawal by Subject|1|||
155363423|NCT04596540|560763896|FG000|Overall Study|Withdrawal by Subject|9|||
155363424|NCT04596540|560763897|FG001|Overall Study|Withdrawal by Subject|8|||
155363425|NCT04596540|560763898|FG002|Overall Study|Withdrawal by Subject|5|||
155363426|NCT04596540|560763896|FG000|Overall Study|Lost to Follow-up|1|||
155363427|NCT04596540|560763897|FG001|Overall Study|Lost to Follow-up|2|||
155363428|NCT04596540|560763898|FG002|Overall Study|Lost to Follow-up|1|||
155363429|NCT04596540|560763896|FG000|Overall Study|Sponsor Decision|2|||
155363430|NCT04596540|560763897|FG001|Overall Study|Sponsor Decision|0|||
155363431|NCT04596540|560763898|FG002|Overall Study|Sponsor Decision|0|||
155363432|NCT04596540|560763896|FG000|Overall Study|Physician Decision|0|||
155363433|NCT04596540|560763897|FG001|Overall Study|Physician Decision|1|||
155363434|NCT04596540|560763898|FG002|Overall Study|Physician Decision|1|||
155363435|NCT04596540|560763896|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
155363436|NCT04596540|560763897|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155363437|NCT04596540|560763898|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
155363438|NCT04596540|560763896|FG000|Overall Study|Other Than Specified|5|||
155363439|NCT04596540|560763897|FG001|Overall Study|Other Than Specified|5|||
155363440|NCT04596540|560763898|FG002|Overall Study|Other Than Specified|2|||
155363441|NCT02633397|560763899|FG000|Overall Study|Adverse Event|8|||
155363442|NCT02633397|560763900|FG001|Overall Study|Adverse Event|8|||
155363443|NCT02633397|560763899|FG000|Overall Study|Study Burden|4|||
155363444|NCT02633397|560763900|FG001|Overall Study|Study Burden|1|||
155363445|NCT02633397|560763899|FG000|Overall Study|Treatment interruption|2|||
155363446|NCT02633397|560763900|FG001|Overall Study|Treatment interruption|5|||
155363447|NCT02633397|560763899|FG000|Overall Study|Death|2|||
155363448|NCT02633397|560763900|FG001|Overall Study|Death|2|||
155166527|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
155363449|NCT02633397|560763899|FG000|Overall Study|Physician Decision|0|||
155363450|NCT02633397|560763900|FG001|Overall Study|Physician Decision|1|||
155363451|NCT02520310|560763903|FG000|At 6 Months Clinical Follow-up|Death|1|||
155363452|NCT02520310|560763903|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
155363453|NCT02520310|560763903|FG000|AT 3 Year Clinical Follow-up|Death|2|||
155363454|NCT02520310|560763903|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
155363455|NCT02520310|560763903|FG000|AT 4 Year Clinical Follow-up|Death|1|||
155363456|NCT02520310|560763903|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
155363457|NCT01340014|560763904|FG000|Period 1, First 7 Days|Adverse Event|1|||
155363458|NCT01340014|560763905|FG001|Period 1, First 7 Days|Adverse Event|0|||
155363459|NCT01340014|560763904|FG000|Period 1, First 7 Days|Personal Reasons|1|||
155363460|NCT01340014|560763905|FG001|Period 1, First 7 Days|Personal Reasons|0|||
155363461|NCT01340014|560763904|FG000|Period 2, Second 7 Days|Adverse Event|0|||
155363462|NCT01340014|560763905|FG001|Period 2, Second 7 Days|Adverse Event|1|||
155363463|NCT05101993|560763906|FG000|Overall Study|Withdrawal by Subject|1|||
155363464|NCT04577573|560763907|FG000|Overall Study|Technical - invalid protocol|0|||
155363465|NCT04577573|560763908|FG001|Overall Study|Technical - invalid protocol|2|||
155363466|NCT04577573|560763909|FG002|Overall Study|Technical - invalid protocol|0|||
155363467|NCT01124838|560763910|FG000|Overall Study|Miscellaneous|4|||
155363468|NCT01124838|560763911|FG001|Overall Study|Miscellaneous|2|||
155363469|NCT01124838|560763910|FG000|Overall Study|Adverse Event|7|||
155363470|NCT01124838|560763911|FG001|Overall Study|Adverse Event|11|||
155363471|NCT01124838|560763910|FG000|Overall Study|Lack of Efficacy|2|||
155363472|NCT01124838|560763911|FG001|Overall Study|Lack of Efficacy|0|||
155363473|NCT01124838|560763910|FG000|Overall Study|Withdrawal by Subject|3|||
155363474|NCT01124838|560763911|FG001|Overall Study|Withdrawal by Subject|2|||
155363475|NCT01124838|560763910|FG000|Overall Study|Lost to Follow-up|2|||
155363476|NCT01124838|560763911|FG001|Overall Study|Lost to Follow-up|0|||
155363477|NCT04526665|560763912|FG000|Overall Study|Withdrawal by Subject|6|||
155363478|NCT04526665|560763913|FG001|Overall Study|Withdrawal by Subject|3|||
155363479|NCT04526665|560763912|FG000|Overall Study|Adverse Event|4|||
155363480|NCT04526665|560763913|FG001|Overall Study|Adverse Event|1|||
155363481|NCT04526665|560763912|FG000|Overall Study|Physician Decision|2|||
155363482|NCT04526665|560763913|FG001|Overall Study|Physician Decision|2|||
155363483|NCT04526665|560763912|FG000|Overall Study|Death|2|||
155363484|NCT04526665|560763913|FG001|Overall Study|Death|0|||
155363485|NCT04526665|560763912|FG000|Overall Study|Other|0|||
155363486|NCT04526665|560763913|FG001|Overall Study|Other|1|||
155363487|NCT02065882|560763915|FG000|Part I: PK/PD|Screening failure|5|||
155363488|NCT02065882|560763915|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
155363489|NCT02065882|560763915|FG000|Part I: PK/PD|Adverse Event|1|||
155363490|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Screening failure|7|||
155363491|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
155363492|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
155363493|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
155363494|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
155363495|NCT02065882|560763915|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
155363496|NCT01784523|560765199|FG000|Overall Study|Study closed early|7|||
155363497|NCT01784523|560765200|FG001|Overall Study|Study closed early|4|||
155363498|NCT01907906|560765201|FG000|Overall Study|Withdrawal by Subject|1|||
155363499|NCT01907906|560765202|FG001|Overall Study|Withdrawal by Subject|0|||
155363500|NCT01907906|560765201|FG000|Overall Study|Physician Decision|3|||
155363501|NCT01907906|560765202|FG001|Overall Study|Physician Decision|1|||
155363502|NCT04052425|560765203|FG000|24-Week Double-blind Period|Adverse Event|0|||
155363503|NCT04052425|560765204|FG001|24-Week Double-blind Period|Adverse Event|1|||
155363504|NCT04052425|560765205|FG002|24-Week Double-blind Period|Adverse Event|0|||
155363505|NCT04052425|560765206|FG003|24-Week Double-blind Period|Adverse Event|0|||
155363506|NCT04052425|560765203|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
155363507|NCT04052425|560765204|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
155363508|NCT04052425|560765205|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
155363509|NCT04052425|560765206|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
155363510|NCT04052425|560765203|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
155363511|NCT04052425|560765204|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
155363512|NCT04052425|560765205|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
155363513|NCT04052425|560765206|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
155363514|NCT04052425|560765203|FG000|24-Week Double-blind Period|Physician Decision|1|||
155363515|NCT04052425|560765204|FG001|24-Week Double-blind Period|Physician Decision|0|||
155363516|NCT04052425|560765205|FG002|24-Week Double-blind Period|Physician Decision|0|||
155363517|NCT04052425|560765206|FG003|24-Week Double-blind Period|Physician Decision|0|||
155363518|NCT04052425|560765203|FG000|24-Week Double-blind Period|Protocol Violation|1|||
155363519|NCT04052425|560765204|FG001|24-Week Double-blind Period|Protocol Violation|0|||
155363520|NCT04052425|560765205|FG002|24-Week Double-blind Period|Protocol Violation|0|||
155363521|NCT04052425|560765206|FG003|24-Week Double-blind Period|Protocol Violation|0|||
155089748|NCT03396445|559761848|FG005|Treatment Period|Physician Decision|0|||
155363522|NCT04052425|560765203|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
155363523|NCT04052425|560765204|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
154965310|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965311|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155363524|NCT04052425|560765205|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
155363525|NCT04052425|560765206|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
155363526|NCT04052425|560765203|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
155363527|NCT04052425|560765204|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
155363528|NCT04052425|560765205|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
155363529|NCT04052425|560765206|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
155363530|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
154965312|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965313|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965314|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965315|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965316|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965317|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965318|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155089749|NCT03396445|559761849|FG006|Treatment Period|Physician Decision|0|||
155089750|NCT03396445|559761850|FG007|Treatment Period|Physician Decision|0|||
155089751|NCT03396445|559761851|FG008|Treatment Period|Physician Decision|0|||
155089752|NCT03396445|559761852|FG009|Treatment Period|Physician Decision|1|||
155363531|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
155363532|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
155363533|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
155363534|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
155363535|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
155363536|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
155363537|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
155363538|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155363539|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
155363540|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
155363541|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
155363542|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
155363543|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
155363544|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
155363545|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
155363546|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155363547|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
155363548|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
155363549|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
155363550|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
155363551|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
155363552|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
155363553|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
155363554|NCT04052425|560765203|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
155363555|NCT04052425|560765204|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
155363556|NCT04052425|560765205|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
155089753|NCT03396445|559761853|FG010|Treatment Period|Physician Decision|0|||
155089754|NCT03396445|559761854|FG011|Treatment Period|Physician Decision|0|||
155089755|NCT03396445|559761855|FG012|Treatment Period|Physician Decision|0|||
155089756|NCT03396445|559761856|FG013|Treatment Period|Physician Decision|0|||
155363557|NCT04052425|560765206|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
155363558|NCT04334278|560765207|FG000|Overall Study|Lost to Follow-up|0|||
155363559|NCT04334278|560765208|FG001|Overall Study|Lost to Follow-up|3|||
155363560|NCT04334278|560765207|FG000|Overall Study|Withdrawal by Subject|4|||
155363561|NCT04334278|560765208|FG001|Overall Study|Withdrawal by Subject|2|||
154965319|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965320|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
155089757|NCT03396445|559761857|FG014|Treatment Period|Physician Decision|0|||
155089758|NCT03396445|559761858|FG015|Treatment Period|Physician Decision|0|||
155089759|NCT03396445|559761859|FG016|Treatment Period|Physician Decision|0|||
155089760|NCT03396445|559761860|FG017|Treatment Period|Physician Decision|0|||
155089761|NCT03396445|559761861|FG018|Treatment Period|Physician Decision|0|||
155363562|NCT01732549|560765211|FG000|Overall Study|Adverse Event|13|||
155363563|NCT01732549|560765212|FG001|Overall Study|Adverse Event|3|||
155363564|NCT01732549|560765211|FG000|Overall Study|Consent withdrawn|13|||
155363565|NCT01732549|560765212|FG001|Overall Study|Consent withdrawn|6|||
155363566|NCT01732549|560765211|FG000|Overall Study|Disease progression|37|||
155363567|NCT01732549|560765212|FG001|Overall Study|Disease progression|50|||
155363568|NCT01732549|560765211|FG000|Overall Study|Other|8|||
155363569|NCT01732549|560765212|FG001|Overall Study|Other|14|||
155363570|NCT01681992|560765215|FG000|Overall Study|Adverse Event|3|||
155363571|NCT01681992|560765216|FG001|Overall Study|Adverse Event|2|||
155363572|NCT01681992|560765217|FG002|Overall Study|Adverse Event|3|||
155363573|NCT01681992|560765215|FG000|Overall Study|Lost to Follow-up|36|||
155363574|NCT01681992|560765216|FG001|Overall Study|Lost to Follow-up|38|||
155363575|NCT01681992|560765217|FG002|Overall Study|Lost to Follow-up|53|||
155363576|NCT01681992|560765215|FG000|Overall Study|As Per Sponsor Decision|0|||
155363577|NCT01681992|560765216|FG001|Overall Study|As Per Sponsor Decision|0|||
155363578|NCT01681992|560765217|FG002|Overall Study|As Per Sponsor Decision|1|||
155363579|NCT01681992|560765215|FG000|Overall Study|Protocol Violation|0|||
155363580|NCT01681992|560765216|FG001|Overall Study|Protocol Violation|0|||
155363581|NCT01681992|560765217|FG002|Overall Study|Protocol Violation|1|||
155363582|NCT01681992|560765215|FG000|Overall Study|Withdrawal by Subject|27|||
155363583|NCT01681992|560765216|FG001|Overall Study|Withdrawal by Subject|30|||
155363584|NCT01681992|560765217|FG002|Overall Study|Withdrawal by Subject|25|||
155363585|NCT03377361|560765220|FG000|Pre-Treatment|Subject withdrew consent|0|||
155363586|NCT03377361|560765221|FG001|Pre-Treatment|Subject withdrew consent|0|||
155363587|NCT03377361|560765222|FG002|Pre-Treatment|Subject withdrew consent|0|||
155363588|NCT03377361|560765223|FG003|Pre-Treatment|Subject withdrew consent|0|||
155089762|NCT03396445|559761862|FG019|Treatment Period|Physician Decision|0|||
155363589|NCT03377361|560765224|FG004|Pre-Treatment|Subject withdrew consent|0|||
155363590|NCT03377361|560765225|FG005|Pre-Treatment|Subject withdrew consent|0|||
155363591|NCT03377361|560765226|FG006|Pre-Treatment|Subject withdrew consent|0|||
155363592|NCT03377361|560765227|FG007|Pre-Treatment|Subject withdrew consent|3|||
155363593|NCT03377361|560765228|FG008|Pre-Treatment|Subject withdrew consent|1|||
154965321|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965322|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965323|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
154965324|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|moved|0|||
154965325|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|moved|1|||
154965326|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|moved|1|||
154965327|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|moved|0|||
154965328|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|moved|0|||
154965329|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|moved|0|||
154965330|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|moved|0|||
155166528|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
155363594|NCT03377361|560765229|FG009|Pre-Treatment|Subject withdrew consent|0|||
154965331|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|moved|0|||
154965332|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|moved|0|||
154965333|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|moved|0|||
154965334|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|moved|0|||
154965335|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|moved|0|||
154965336|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|moved|0|||
155166529|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155166530|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
155166531|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
155363595|NCT03377361|560765220|FG000|Pre-Treatment|Not Reported|0|||
155363596|NCT03377361|560765221|FG001|Pre-Treatment|Not Reported|0|||
155363597|NCT03377361|560765222|FG002|Pre-Treatment|Not Reported|0|||
155363598|NCT03377361|560765223|FG003|Pre-Treatment|Not Reported|0|||
155363599|NCT03377361|560765224|FG004|Pre-Treatment|Not Reported|0|||
155363600|NCT03377361|560765225|FG005|Pre-Treatment|Not Reported|0|||
155363601|NCT03377361|560765226|FG006|Pre-Treatment|Not Reported|0|||
155363602|NCT03377361|560765227|FG007|Pre-Treatment|Not Reported|0|||
155363603|NCT03377361|560765228|FG008|Pre-Treatment|Not Reported|3|||
155363604|NCT03377361|560765229|FG009|Pre-Treatment|Not Reported|0|||
155363605|NCT03377361|560765220|FG000|Treatment Period|Disease Progression|3|||
155363606|NCT03377361|560765221|FG001|Treatment Period|Disease Progression|2|||
155363607|NCT03377361|560765222|FG002|Treatment Period|Disease Progression|5|||
155363608|NCT03377361|560765223|FG003|Treatment Period|Disease Progression|3|||
155363609|NCT03377361|560765224|FG004|Treatment Period|Disease Progression|3|||
155363610|NCT03377361|560765225|FG005|Treatment Period|Disease Progression|3|||
155363611|NCT03377361|560765226|FG006|Treatment Period|Disease Progression|6|||
155363612|NCT03377361|560765227|FG007|Treatment Period|Disease Progression|106|||
155363613|NCT03377361|560765228|FG008|Treatment Period|Disease Progression|48|||
155363614|NCT03377361|560765229|FG009|Treatment Period|Disease Progression|59|||
155363615|NCT03377361|560765220|FG000|Treatment Period|Study Drug Toxicity|0|||
155363616|NCT03377361|560765221|FG001|Treatment Period|Study Drug Toxicity|0|||
155363617|NCT03377361|560765222|FG002|Treatment Period|Study Drug Toxicity|0|||
155363618|NCT03377361|560765223|FG003|Treatment Period|Study Drug Toxicity|1|||
155363619|NCT03377361|560765224|FG004|Treatment Period|Study Drug Toxicity|0|||
155363620|NCT03377361|560765225|FG005|Treatment Period|Study Drug Toxicity|0|||
155363621|NCT03377361|560765226|FG006|Treatment Period|Study Drug Toxicity|0|||
155363622|NCT03377361|560765227|FG007|Treatment Period|Study Drug Toxicity|7|||
155363623|NCT03377361|560765228|FG008|Treatment Period|Study Drug Toxicity|2|||
155363624|NCT03377361|560765229|FG009|Treatment Period|Study Drug Toxicity|16|||
155363625|NCT03377361|560765220|FG000|Treatment Period|Death|0|||
155363626|NCT03377361|560765221|FG001|Treatment Period|Death|0|||
155363627|NCT03377361|560765222|FG002|Treatment Period|Death|1|||
155363628|NCT03377361|560765223|FG003|Treatment Period|Death|0|||
155363629|NCT03377361|560765224|FG004|Treatment Period|Death|0|||
155363630|NCT03377361|560765225|FG005|Treatment Period|Death|0|||
155363631|NCT03377361|560765226|FG006|Treatment Period|Death|0|||
155363632|NCT03377361|560765227|FG007|Treatment Period|Death|2|||
155363633|NCT03377361|560765228|FG008|Treatment Period|Death|1|||
155363634|NCT03377361|560765229|FG009|Treatment Period|Death|3|||
154965337|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|moved|0|||
155166532|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155166533|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155363635|NCT03377361|560765220|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363636|NCT03377361|560765221|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363637|NCT03377361|560765222|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363638|NCT03377361|560765223|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363639|NCT03377361|560765224|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363640|NCT03377361|560765225|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363641|NCT03377361|560765226|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
154965338|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|moved|0|||
154965339|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|moved|0|||
154965340|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|moved|0|||
155166534|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
154965341|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|moved|0|||
154965342|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|moved|0|||
154965343|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|moved|0|||
154965344|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|moved|0|||
154965345|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|moved|0|||
154965346|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|moved|0|||
154965347|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|moved|0|||
154965348|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|moved|0|||
154965349|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|moved|0|||
154965350|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965351|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965352|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965353|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
154965354|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965355|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965356|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965357|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965358|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965359|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965360|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965361|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965362|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965363|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965364|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965365|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965366|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965367|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155363642|NCT03377361|560765227|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
155363643|NCT03377361|560765228|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
155363644|NCT03377361|560765229|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
155363645|NCT03377361|560765220|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
155363646|NCT03377361|560765221|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
155363647|NCT03377361|560765222|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
155363648|NCT03377361|560765223|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
155363649|NCT03377361|560765224|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
155363650|NCT03377361|560765225|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
155363651|NCT03377361|560765226|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
155363652|NCT03377361|560765227|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
155363653|NCT03377361|560765228|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
155363654|NCT03377361|560765229|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
155363655|NCT03377361|560765220|FG000|Treatment Period|Subject Withdrew Consent|0|||
155363656|NCT03377361|560765221|FG001|Treatment Period|Subject Withdrew Consent|0|||
155363657|NCT03377361|560765222|FG002|Treatment Period|Subject Withdrew Consent|0|||
155363658|NCT03377361|560765223|FG003|Treatment Period|Subject Withdrew Consent|0|||
155363659|NCT03377361|560765224|FG004|Treatment Period|Subject Withdrew Consent|0|||
155363660|NCT03377361|560765225|FG005|Treatment Period|Subject Withdrew Consent|0|||
155363661|NCT03377361|560765226|FG006|Treatment Period|Subject Withdrew Consent|0|||
155363662|NCT03377361|560765227|FG007|Treatment Period|Subject Withdrew Consent|0|||
155363663|NCT03377361|560765228|FG008|Treatment Period|Subject Withdrew Consent|2|||
155363664|NCT03377361|560765229|FG009|Treatment Period|Subject Withdrew Consent|1|||
155363665|NCT03377361|560765220|FG000|Treatment Period|No longer meets study criteria|0|||
155363666|NCT03377361|560765221|FG001|Treatment Period|No longer meets study criteria|1|||
155363667|NCT03377361|560765222|FG002|Treatment Period|No longer meets study criteria|0|||
155363668|NCT03377361|560765223|FG003|Treatment Period|No longer meets study criteria|0|||
155363669|NCT03377361|560765224|FG004|Treatment Period|No longer meets study criteria|0|||
155363670|NCT03377361|560765225|FG005|Treatment Period|No longer meets study criteria|0|||
155363671|NCT03377361|560765226|FG006|Treatment Period|No longer meets study criteria|0|||
155363672|NCT03377361|560765227|FG007|Treatment Period|No longer meets study criteria|1|||
155363673|NCT03377361|560765228|FG008|Treatment Period|No longer meets study criteria|0|||
155363674|NCT03377361|560765229|FG009|Treatment Period|No longer meets study criteria|0|||
155363675|NCT03377361|560765220|FG000|Treatment Period|Other Reasons|0|||
155363676|NCT03377361|560765221|FG001|Treatment Period|Other Reasons|0|||
154965368|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155363677|NCT03377361|560765222|FG002|Treatment Period|Other Reasons|0|||
155363678|NCT03377361|560765223|FG003|Treatment Period|Other Reasons|3|||
155363679|NCT03377361|560765224|FG004|Treatment Period|Other Reasons|0|||
155363680|NCT03377361|560765225|FG005|Treatment Period|Other Reasons|0|||
155363681|NCT03377361|560765226|FG006|Treatment Period|Other Reasons|0|||
155363682|NCT03377361|560765227|FG007|Treatment Period|Other Reasons|2|||
155363683|NCT03377361|560765228|FG008|Treatment Period|Other Reasons|0|||
155363684|NCT03377361|560765229|FG009|Treatment Period|Other Reasons|1|||
155363685|NCT03698994|560765230|FG000|Overall Study|Adverse Event|2|||
155363686|NCT03698994|560765230|FG000|Overall Study|Death|1|||
155363687|NCT03698994|560765230|FG000|Overall Study|Physician Decision|1|||
155363688|NCT03698994|560765230|FG000|Overall Study|Withdrawal by Subject|3|||
155363689|NCT03698994|560765230|FG000|Overall Study|Progressive Disease|12|||
155363690|NCT04042077|560765231|FG000|Overall Study|Adverse Event|0|||
155363691|NCT04042077|560765232|FG001|Overall Study|Adverse Event|1|||
155363692|NCT04042077|560765231|FG000|Overall Study|Death|2|||
155363693|NCT04042077|560765232|FG001|Overall Study|Death|1|||
155363694|NCT04042077|560765231|FG000|Overall Study|Physician Decision|2|||
155363695|NCT04042077|560765232|FG001|Overall Study|Physician Decision|0|||
155363696|NCT04042077|560765231|FG000|Overall Study|Withdrawal by Subject|3|||
155363697|NCT04042077|560765232|FG001|Overall Study|Withdrawal by Subject|2|||
155166535|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
155166536|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
155166537|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
155166538|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
155166539|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
155166540|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
155166541|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
155166542|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
155166543|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166544|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166545|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166546|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166547|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155363698|NCT04042077|560765231|FG000|Overall Study|Lack of Efficacy|0|||
155363699|NCT04042077|560765232|FG001|Overall Study|Lack of Efficacy|1|||
155363700|NCT01080300|560765233|FG000|Overall Study|Adverse Event|49|||
155363701|NCT01080300|560765234|FG001|Overall Study|Adverse Event|35|||
155363702|NCT01080300|560765233|FG000|Overall Study|Lack of Efficacy|12|||
155363703|NCT01080300|560765234|FG001|Overall Study|Lack of Efficacy|15|||
155363704|NCT01080300|560765233|FG000|Overall Study|Protocol Violation|7|||
155363705|NCT01080300|560765234|FG001|Overall Study|Protocol Violation|13|||
155363706|NCT01080300|560765233|FG000|Overall Study|Lost to Follow-up|10|||
155363707|NCT01080300|560765234|FG001|Overall Study|Lost to Follow-up|6|||
155363708|NCT01080300|560765233|FG000|Overall Study|Death|0|||
155363709|NCT01080300|560765234|FG001|Overall Study|Death|1|||
155363710|NCT01080300|560765233|FG000|Overall Study|Withdrawal by Subject|12|||
155363711|NCT01080300|560765234|FG001|Overall Study|Withdrawal by Subject|28|||
155363712|NCT01080300|560765233|FG000|Overall Study|Reasons not specified|4|||
155363713|NCT01080300|560765234|FG001|Overall Study|Reasons not specified|6|||
155363714|NCT02844777|560765235|FG000|Overall Study|Withdrawal by Subject|2|||
155363715|NCT02844777|560765236|FG001|Overall Study|Withdrawal by Subject|0|||
155363716|NCT02844777|560765237|FG002|Overall Study|Withdrawal by Subject|0|||
155363717|NCT01776008|560765238|FG000|Overall Study|ineligible|2|||
155363718|NCT01163474|560765239|FG000|Overall Study|Withdrawal by Subject|1|||
155363719|NCT01163474|560765239|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
155363720|NCT01163474|560765239|FG000|Overall Study|Lost to Follow-up|3|||
155363721|NCT00383123|560765240|FG000|Overall Study|Adverse Event|1|||
155363722|NCT00383123|560765241|FG001|Overall Study|Adverse Event|0|||
155363723|NCT00383123|560765240|FG000|Overall Study|Lost to Follow-up|68|||
155363724|NCT00383123|560765241|FG001|Overall Study|Lost to Follow-up|61|||
155363725|NCT00383123|560765240|FG000|Overall Study|Protocol Violation|5|||
155363726|NCT00383123|560765241|FG001|Overall Study|Protocol Violation|1|||
155363727|NCT00383123|560765240|FG000|Overall Study|Withdrawal by Subject|27|||
155166548|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
155363728|NCT00383123|560765241|FG001|Overall Study|Withdrawal by Subject|18|||
155363729|NCT00383123|560765240|FG000|Overall Study|Other reason|10|||
155363730|NCT00383123|560765241|FG001|Overall Study|Other reason|6|||
155363731|NCT02781311|560765242|FG000|Overall Study|Adverse Event|2|||
155363732|NCT02781311|560765243|FG001|Overall Study|Adverse Event|6|||
155363733|NCT02781311|560765244|FG002|Overall Study|Adverse Event|1|||
155363734|NCT02781311|560765242|FG000|Overall Study|Withdrawal of Consent|11|||
155363735|NCT02781311|560765243|FG001|Overall Study|Withdrawal of Consent|12|||
155363736|NCT02781311|560765244|FG002|Overall Study|Withdrawal of Consent|2|||
155363737|NCT02781311|560765242|FG000|Overall Study|Lost to Follow-up|11|||
155363738|NCT02781311|560765243|FG001|Overall Study|Lost to Follow-up|8|||
155363739|NCT02781311|560765244|FG002|Overall Study|Lost to Follow-up|1|||
155363740|NCT02781311|560765242|FG000|Overall Study|Non-Compliance with Study Drug|2|||
155363741|NCT02781311|560765243|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155363742|NCT02781311|560765244|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155363743|NCT04547023|560765247|FG000|Overall Study|Did Not Receive Intervention|3|||
155363744|NCT04547023|560765248|FG001|Overall Study|Did Not Receive Intervention|2|||
155363745|NCT04547023|560765247|FG000|Overall Study|Lost to Follow-up|1|||
155363746|NCT04547023|560765248|FG001|Overall Study|Lost to Follow-up|1|||
155363747|NCT00250432|560765249|FG000|Overall Study|Adverse Event|25|||
155363748|NCT00250432|560765250|FG001|Overall Study|Adverse Event|29|||
155363749|NCT00250432|560765249|FG000|Overall Study|Lack of Efficacy|2|||
155363750|NCT00250432|560765250|FG001|Overall Study|Lack of Efficacy|1|||
155363751|NCT00250432|560765249|FG000|Overall Study|Lost to Follow-up|6|||
155363752|NCT00250432|560765250|FG001|Overall Study|Lost to Follow-up|5|||
155363753|NCT00250432|560765249|FG000|Overall Study|Patient Moved|0|||
155363754|NCT00250432|560765250|FG001|Overall Study|Patient Moved|1|||
155363755|NCT00250432|560765249|FG000|Overall Study|Protocol Violation|0|||
155363756|NCT00250432|560765250|FG001|Overall Study|Protocol Violation|3|||
155363757|NCT00250432|560765249|FG000|Overall Study|Withdrawal by Subject|6|||
155363758|NCT00250432|560765250|FG001|Overall Study|Withdrawal by Subject|2|||
155363759|NCT00250432|560765249|FG000|Overall Study|Pt died out of posttherapy report period|6|||
155363760|NCT00250432|560765250|FG001|Overall Study|Pt died out of posttherapy report period|5|||
155363761|NCT00250432|560765249|FG000|Overall Study|Pt was considered untreatable|0|||
155363762|NCT00250432|560765250|FG001|Overall Study|Pt was considered untreatable|1|||
155363763|NCT01637077|560765251|FG000|Overall Study|Cancel|1|||
155363764|NCT01637077|560765252|FG001|Overall Study|Cancel|1|||
155363765|NCT01637077|560765251|FG000|Overall Study|Withdrawal by Subject|1|||
155363766|NCT01637077|560765252|FG001|Overall Study|Withdrawal by Subject|0|||
155363767|NCT01637077|560765251|FG000|Overall Study|No cycle 1 questionnaire data|2|||
155363768|NCT01637077|560765252|FG001|Overall Study|No cycle 1 questionnaire data|0|||
155363769|NCT02638103|560765253|FG000|Overall Study|Adverse Event|13|||
155363770|NCT02638103|560765254|FG001|Overall Study|Adverse Event|12|||
155363771|NCT02638103|560765255|FG002|Overall Study|Adverse Event|19|||
155363772|NCT02638103|560765256|FG003|Overall Study|Adverse Event|12|||
155363773|NCT02638103|560765253|FG000|Overall Study|Withdrawal by Subject|43|||
155363774|NCT02638103|560765254|FG001|Overall Study|Withdrawal by Subject|53|||
155089763|NCT03396445|559761863|FG020|Treatment Period|Physician Decision|0|||
155089764|NCT03396445|559761864|FG021|Treatment Period|Physician Decision|0|||
155089765|NCT03396445|559761865|FG022|Treatment Period|Physician Decision|0|||
155089766|NCT03396445|559761866|FG023|Treatment Period|Physician Decision|0|||
155089767|NCT03396445|559761867|FG024|Treatment Period|Physician Decision|0|||
155089768|NCT03396445|559761868|FG025|Treatment Period|Physician Decision|0|||
155089769|NCT03396445|559761843|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155166549|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
155166550|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155166551|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
155166552|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
155166553|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155166554|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155166555|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
155166556|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
155166557|NCT05019521|560046271|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
155166558|NCT05019521|560046272|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
155166559|NCT05019521|560046273|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
155166560|NCT05019521|560046274|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
155166561|NCT05019521|560046275|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
155166562|NCT05019521|560046276|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
155166563|NCT05019521|560046277|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
155166564|NCT01192191|560046278|FG000|Overall Study|Adverse Event|7|||
155166565|NCT01192191|560046279|FG001|Overall Study|Adverse Event|12|||
155166566|NCT01192191|560046278|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
155166567|NCT01192191|560046279|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
155166568|NCT01192191|560046278|FG000|Overall Study|Lost to Follow-up|0|||
155166569|NCT01192191|560046279|FG001|Overall Study|Lost to Follow-up|1|||
155166570|NCT01192191|560046278|FG000|Overall Study|Withdrawal by Subject|1|||
155166571|NCT01192191|560046279|FG001|Overall Study|Withdrawal by Subject|6|||
155166572|NCT00467753|560046280|FG000|Overall Study|Lost to Follow-up|1|||
155166573|NCT00467753|560046281|FG001|Overall Study|Lost to Follow-up|2|||
155166574|NCT00467753|560046280|FG000|Overall Study|Adverse Event|2|||
155166575|NCT00467753|560046281|FG001|Overall Study|Adverse Event|0|||
155166576|NCT01273519|560046287|FG000|Overall Study|Adverse Event|3|||
155166577|NCT01273519|560046288|FG001|Overall Study|Adverse Event|0|||
155166578|NCT01273519|560046289|FG002|Overall Study|Adverse Event|0|||
155166579|NCT01273519|560046287|FG000|Overall Study|Lost to Follow-up|2|||
155166580|NCT01273519|560046288|FG001|Overall Study|Lost to Follow-up|1|||
155166581|NCT01273519|560046289|FG002|Overall Study|Lost to Follow-up|3|||
155166582|NCT01273519|560046287|FG000|Overall Study|Lack of Efficacy|8|||
155166583|NCT01273519|560046288|FG001|Overall Study|Lack of Efficacy|3|||
155166584|NCT01273519|560046289|FG002|Overall Study|Lack of Efficacy|4|||
155166585|NCT01273519|560046287|FG000|Overall Study|Other|6|||
155166586|NCT01273519|560046288|FG001|Overall Study|Other|1|||
155166587|NCT01273519|560046289|FG002|Overall Study|Other|1|||
155166588|NCT04292899|560046290|FG000|Overall Study|Death|21|||
155166589|NCT04292899|560046291|FG001|Overall Study|Death|28|||
155166590|NCT04292899|560046292|FG002|Overall Study|Death|188|||
155166591|NCT04292899|560046293|FG003|Overall Study|Death|371|||
155166592|NCT04292899|560046290|FG000|Overall Study|Lost to Follow-up|8|||
155166593|NCT04292899|560046291|FG001|Overall Study|Lost to Follow-up|4|||
155166594|NCT04292899|560046292|FG002|Overall Study|Lost to Follow-up|22|||
155166595|NCT04292899|560046293|FG003|Overall Study|Lost to Follow-up|235|||
155166596|NCT04292899|560046290|FG000|Overall Study|Withdrew consent|1|||
155166597|NCT04292899|560046291|FG001|Overall Study|Withdrew consent|0|||
155166598|NCT04292899|560046292|FG002|Overall Study|Withdrew consent|11|||
155166599|NCT04292899|560046293|FG003|Overall Study|Withdrew consent|32|||
155166600|NCT04292899|560046290|FG000|Overall Study|Adverse Event|2|||
155166601|NCT04292899|560046291|FG001|Overall Study|Adverse Event|1|||
155166602|NCT04292899|560046292|FG002|Overall Study|Adverse Event|2|||
155166603|NCT04292899|560046293|FG003|Overall Study|Adverse Event|2|||
155166604|NCT04292899|560046290|FG000|Overall Study|Investigator's Discretion|0|||
155166605|NCT04292899|560046291|FG001|Overall Study|Investigator's Discretion|0|||
155166606|NCT04292899|560046292|FG002|Overall Study|Investigator's Discretion|0|||
155166607|NCT04292899|560046293|FG003|Overall Study|Investigator's Discretion|3|||
155166608|NCT04292899|560046290|FG000|Overall Study|Non-compliance With Study Drug|0|||
155166609|NCT04292899|560046291|FG001|Overall Study|Non-compliance With Study Drug|0|||
155166610|NCT04292899|560046292|FG002|Overall Study|Non-compliance With Study Drug|0|||
155166611|NCT04292899|560046293|FG003|Overall Study|Non-compliance With Study Drug|1|||
155166612|NCT04292899|560046290|FG000|Overall Study|Protocol Violation|0|||
155089770|NCT03396445|559761844|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
154965369|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965370|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155363775|NCT02638103|560765255|FG002|Overall Study|Withdrawal by Subject|30|||
155363776|NCT02638103|560765256|FG003|Overall Study|Withdrawal by Subject|61|||
155363777|NCT02638103|560765253|FG000|Overall Study|Protocol Violation|1|||
155363778|NCT02638103|560765254|FG001|Overall Study|Protocol Violation|2|||
155363779|NCT02638103|560765255|FG002|Overall Study|Protocol Violation|1|||
155363780|NCT02638103|560765256|FG003|Overall Study|Protocol Violation|4|||
155363781|NCT02638103|560765253|FG000|Overall Study|Pregnancy|2|||
155363782|NCT02638103|560765254|FG001|Overall Study|Pregnancy|3|||
155363783|NCT02638103|560765255|FG002|Overall Study|Pregnancy|0|||
155363784|NCT02638103|560765256|FG003|Overall Study|Pregnancy|1|||
155363785|NCT02638103|560765253|FG000|Overall Study|Non-compliance to Study Procedures|2|||
155363786|NCT02638103|560765254|FG001|Overall Study|Non-compliance to Study Procedures|1|||
155363787|NCT02638103|560765255|FG002|Overall Study|Non-compliance to Study Procedures|1|||
155363788|NCT02638103|560765256|FG003|Overall Study|Non-compliance to Study Procedures|1|||
155363789|NCT02638103|560765253|FG000|Overall Study|Lost to Follow-up|26|||
155363790|NCT02638103|560765254|FG001|Overall Study|Lost to Follow-up|33|||
155363791|NCT02638103|560765255|FG002|Overall Study|Lost to Follow-up|20|||
155363792|NCT02638103|560765256|FG003|Overall Study|Lost to Follow-up|37|||
155363793|NCT02638103|560765253|FG000|Overall Study|Lack of Efficacy|14|||
155363794|NCT02638103|560765254|FG001|Overall Study|Lack of Efficacy|10|||
155363795|NCT02638103|560765255|FG002|Overall Study|Lack of Efficacy|12|||
154965371|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
155089771|NCT03396445|559761845|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089772|NCT03396445|559761846|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089773|NCT03396445|559761847|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089774|NCT03396445|559761848|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089775|NCT03396445|559761849|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089776|NCT03396445|559761850|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089777|NCT03396445|559761851|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089778|NCT03396445|559761852|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089779|NCT03396445|559761853|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089780|NCT03396445|559761854|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089781|NCT03396445|559761855|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
155089782|NCT03396445|559761856|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089783|NCT03396445|559761857|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
155089784|NCT03396445|559761858|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089785|NCT03396445|559761859|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089786|NCT03396445|559761860|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089787|NCT03396445|559761861|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089788|NCT03396445|559761862|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089789|NCT03396445|559761863|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089790|NCT03396445|559761864|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089791|NCT03396445|559761865|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089792|NCT03396445|559761866|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089793|NCT03396445|559761867|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089794|NCT03396445|559761868|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
155089795|NCT03396445|559761843|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
155089796|NCT03396445|559761844|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
155089797|NCT03396445|559761845|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
155089798|NCT03396445|559761846|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
155089799|NCT03396445|559761847|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
155363796|NCT02638103|560765256|FG003|Overall Study|Lack of Efficacy|22|||
155363797|NCT02638103|560765253|FG000|Overall Study|Other than specified|5|||
155363798|NCT02638103|560765254|FG001|Overall Study|Other than specified|4|||
155363799|NCT02638103|560765255|FG002|Overall Study|Other than specified|2|||
155363800|NCT02638103|560765256|FG003|Overall Study|Other than specified|4|||
155363801|NCT04199052|560765262|FG000|Overall Study|Lost to Follow-up|11|||
155363802|NCT04199052|560765263|FG001|Overall Study|Lost to Follow-up|18|||
155363803|NCT04907357|560765264|FG000|Overall Study|Death|0|||
155363804|NCT04907357|560765265|FG001|Overall Study|Death|1|||
155363805|NCT04907357|560765264|FG000|Overall Study|Lost to Follow-up|9|||
155363806|NCT04907357|560765265|FG001|Overall Study|Lost to Follow-up|18|||
155363807|NCT04907357|560765264|FG000|Overall Study|Physician Decision|1|||
155363808|NCT04907357|560765265|FG001|Overall Study|Physician Decision|0|||
155363809|NCT04907357|560765264|FG000|Overall Study|Withdrawal by Subject|0|||
155363810|NCT04907357|560765265|FG001|Overall Study|Withdrawal by Subject|1|||
155363811|NCT04907357|560765264|FG000|Overall Study|Unable to attend visits|1|||
155363812|NCT04907357|560765265|FG001|Overall Study|Unable to attend visits|0|||
155363813|NCT04907357|560765264|FG000|Overall Study|Incarcerated|1|||
155363814|NCT04907357|560765265|FG001|Overall Study|Incarcerated|1|||
155363815|NCT00365547|560765266|FG000|Overall Study|Insurance did not cover Avastin|1|||
155363816|NCT00365547|560765266|FG000|Overall Study|Screen failure|1|||
155363817|NCT00365547|560765266|FG000|Overall Study|Withdrawal by Subject|1|||
155363818|NCT03692052|560765267|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
155363819|NCT03692052|560765267|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
155363820|NCT03692052|560765267|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
155363821|NCT03692052|560765267|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
155363822|NCT02257918|560765268|FG000|Overall Study|Lost to Follow-up|4|||
155363823|NCT02257918|560765269|FG001|Overall Study|Lost to Follow-up|1|||
155363824|NCT02257918|560765270|FG002|Overall Study|Lost to Follow-up|0|||
155363825|NCT02257918|560765268|FG000|Overall Study|Withdrawal by Subject|0|||
155363826|NCT02257918|560765269|FG001|Overall Study|Withdrawal by Subject|0|||
155363827|NCT02257918|560765270|FG002|Overall Study|Withdrawal by Subject|1|||
155363828|NCT02257918|560765268|FG000|Overall Study|Pregnancy|0|||
155363829|NCT02257918|560765269|FG001|Overall Study|Pregnancy|0|||
155363830|NCT02257918|560765270|FG002|Overall Study|Pregnancy|1|||
155363831|NCT00936598|560765271|FG000|Overall Study|Withdrawal by Subject|1|||
155363832|NCT00936598|560765272|FG001|Overall Study|Withdrawal by Subject|0|||
155363833|NCT00936598|560765271|FG000|Overall Study|Ineligible after consent|1|||
155363834|NCT00936598|560765272|FG001|Overall Study|Ineligible after consent|0|||
155363835|NCT00486252|560765276|FG000|Overall Study|Adverse Event|7|||
155363836|NCT00486252|560765276|FG000|Overall Study|Lack of Efficacy|9|||
155363837|NCT00486252|560765276|FG000|Overall Study|Lost to Follow-up|24|||
155363838|NCT00486252|560765276|FG000|Overall Study|Other|18|||
155363839|NCT01261247|560765277|FG000|Overall Study|Ineligible|2|||
155363840|NCT01740154|560765278|FG000|Overall Study|Adverse Event|1|||
155363841|NCT03358472|560765282|FG000|Overall Study|Death|6|||
155363842|NCT03358472|560765283|FG001|Overall Study|Death|3|||
155363843|NCT03358472|560765284|FG002|Overall Study|Death|10|||
155363844|NCT03358472|560765282|FG000|Overall Study|Physician Decision|0|||
155363845|NCT03358472|560765283|FG001|Overall Study|Physician Decision|1|||
155363846|NCT03358472|560765284|FG002|Overall Study|Physician Decision|0|||
155363847|NCT03358472|560765282|FG000|Overall Study|Withdrawal by Subject|0|||
155363848|NCT03358472|560765283|FG001|Overall Study|Withdrawal by Subject|0|||
155363849|NCT03358472|560765284|FG002|Overall Study|Withdrawal by Subject|1|||
155363850|NCT03358472|560765282|FG000|Overall Study|On-going at clinical cut off date|9|||
155363851|NCT03358472|560765283|FG001|Overall Study|On-going at clinical cut off date|6|||
155363852|NCT03358472|560765284|FG002|Overall Study|On-going at clinical cut off date|5|||
155363853|NCT04013971|560765287|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
155363854|NCT04013971|560765288|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
155363855|NCT04013971|560765287|FG000|Overall Study|Missing biomechanical data|0|||
155363856|NCT04013971|560765288|FG001|Overall Study|Missing biomechanical data|1|||
155363857|NCT04704219|560765295|FG000|Overall Study|Screen Failure|1|||
154965372|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965373|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965374|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965375|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
154965376|NCT00112437|559298862|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965377|NCT00112437|559298863|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965378|NCT00112437|559298864|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965379|NCT00112437|559298865|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965380|NCT00112437|559298866|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
154965381|NCT00112437|559298867|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965382|NCT00112437|559298868|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155363858|NCT04704219|560765295|FG000|Overall Study|Withdrawal by Subject|1|||
155363859|NCT04704219|560765295|FG000|Overall Study|Death|78|||
155363860|NCT04704219|560765295|FG000|Overall Study|Participants Ongoing|80|||
155363861|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
155363862|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
155363863|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
155363864|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
155363865|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
155363866|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
155363867|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
155363868|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
155363869|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
155363870|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
154965383|NCT00112437|559298869|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965384|NCT00112437|559298870|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965385|NCT00112437|559298871|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965386|NCT00112437|559298872|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965387|NCT00112437|559298873|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965388|NCT00112437|559298874|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965389|NCT00112437|559298875|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965390|NCT00112437|559298876|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965391|NCT00112437|559298877|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965392|NCT00112437|559298878|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965393|NCT00112437|559298879|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965394|NCT00112437|559298880|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155089800|NCT03396445|559761848|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089801|NCT03396445|559761849|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
155089802|NCT03396445|559761850|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089803|NCT03396445|559761851|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089804|NCT03396445|559761852|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089805|NCT03396445|559761853|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089806|NCT03396445|559761854|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155363871|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
154965395|NCT00112437|559298881|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
155363872|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
155363873|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
155363874|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
155363875|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
155363876|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
155089807|NCT03396445|559761855|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089808|NCT03396445|559761856|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089809|NCT03396445|559761857|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155363877|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
155363878|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
155363879|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
155363880|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
155363881|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
155363882|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
155363883|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
155363884|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
155363885|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
155363886|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
155363887|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
155363888|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
155363889|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
155363890|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
155363891|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
155363892|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
155363893|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
155363894|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
155363895|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
155363896|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
155363897|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
155363898|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
155363899|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
155363900|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
155363901|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
155363902|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
155363903|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
155363904|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
155363905|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
155363906|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
155363907|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
155363908|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
155363909|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
155363910|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
155363911|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
155363912|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
155363913|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
155363914|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
155363915|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
155363916|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
155363917|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
155089810|NCT03396445|559761858|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
154965396|NCT00112437|559298882|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965397|NCT00112437|559298883|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965398|NCT00112437|559298884|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965399|NCT00112437|559298885|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965400|NCT00112437|559298886|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965401|NCT00112437|559298887|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
154965402|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
154965403|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
154965404|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
154965405|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
155089811|NCT03396445|559761859|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089812|NCT03396445|559761860|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089813|NCT03396445|559761861|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089814|NCT03396445|559761862|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089815|NCT03396445|559761863|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089816|NCT03396445|559761864|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155363918|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
155363919|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
155363920|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
155363921|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
155363922|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
155363923|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
155363924|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
155363925|NCT00217737|560765296|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
155363926|NCT00217737|560765297|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
155363927|NCT00217737|560765298|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
155363928|NCT00217737|560765299|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
155363929|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
155363930|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
155363931|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
155363932|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
155363933|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
155363934|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
155363935|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
155363936|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
155363937|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Study suspension|0|||
155363938|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Study suspension|45|||
155363939|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Study suspension|0|||
155363940|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Study suspension|0|||
155363941|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
155363942|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
155363943|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
155363944|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
155363945|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Death|2|||
155363946|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Death|3|||
155363947|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Death|0|||
155363948|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Death|0|||
155363949|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
155363950|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
155363951|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
155166613|NCT04292899|560046291|FG001|Overall Study|Protocol Violation|0|||
155363952|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
155363953|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
155363954|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
155363955|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
155363956|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
155363957|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
155363958|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
155363959|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
155363960|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
155363961|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
155363962|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
155363963|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
155363964|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
155363965|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
155363966|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
155363967|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
155363968|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
155363969|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
155363970|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
155363971|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
155363972|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
155363973|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
155363974|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
155363975|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
155363976|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
155363977|NCT00217737|560765296|FG000|Step 2 Randomization/Registration|Other|1|||
155363978|NCT00217737|560765297|FG001|Step 2 Randomization/Registration|Other|2|||
155363979|NCT00217737|560765298|FG002|Step 2 Randomization/Registration|Other|0|||
155363980|NCT00217737|560765299|FG003|Step 2 Randomization/Registration|Other|0|||
155363981|NCT04949802|560766441|FG000|Overall Study|Lost to Follow-up|3|||
155363982|NCT00233480|560766442|FG000|Overall Study|Underwent status II heart transplant|0|||
155363983|NCT00233480|560766443|FG001|Overall Study|Underwent status II heart transplant|1|||
155363984|NCT00474526|560766444|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
155363985|NCT00474526|560766445|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
155363986|NCT00474526|560766446|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
155363987|NCT00474526|560766447|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
155363988|NCT00474526|560766448|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
155363989|NCT00474526|560766449|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
155363990|NCT00474526|560766450|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
155363991|NCT00474526|560766451|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
155363992|NCT00474526|560766452|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
155363993|NCT00474526|560766453|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
155363994|NCT00474526|560766454|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
155363995|NCT00474526|560766455|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
155363996|NCT00474526|560766456|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
155363997|NCT00474526|560766457|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
155363998|NCT00474526|560766458|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
155363999|NCT00474526|560766459|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
155364000|NCT00474526|560766460|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
155364001|NCT00474526|560766444|FG000|Overall Study|Adverse Event|2|||
155364002|NCT00474526|560766445|FG001|Overall Study|Adverse Event|0|||
155364003|NCT00474526|560766446|FG002|Overall Study|Adverse Event|2|||
155364004|NCT00474526|560766447|FG003|Overall Study|Adverse Event|4|||
155364005|NCT00474526|560766448|FG004|Overall Study|Adverse Event|2|||
155364006|NCT00474526|560766449|FG005|Overall Study|Adverse Event|1|||
155364007|NCT00474526|560766450|FG006|Overall Study|Adverse Event|1|||
155364008|NCT00474526|560766451|FG007|Overall Study|Adverse Event|0|||
155364009|NCT00474526|560766452|FG008|Overall Study|Adverse Event|0|||
155364010|NCT00474526|560766453|FG009|Overall Study|Adverse Event|0|||
155364011|NCT00474526|560766454|FG010|Overall Study|Adverse Event|0|||
155364012|NCT00474526|560766455|FG011|Overall Study|Adverse Event|0|||
155364013|NCT00474526|560766456|FG012|Overall Study|Adverse Event|0|||
155364014|NCT00474526|560766457|FG013|Overall Study|Adverse Event|0|||
155364015|NCT00474526|560766458|FG014|Overall Study|Adverse Event|1|||
155364016|NCT00474526|560766459|FG015|Overall Study|Adverse Event|1|||
155364017|NCT00474526|560766460|FG016|Overall Study|Adverse Event|0|||
155364018|NCT00474526|560766444|FG000|Overall Study|Death|0|||
155364019|NCT00474526|560766445|FG001|Overall Study|Death|0|||
155364020|NCT00474526|560766446|FG002|Overall Study|Death|0|||
155364021|NCT00474526|560766447|FG003|Overall Study|Death|0|||
155364022|NCT00474526|560766448|FG004|Overall Study|Death|0|||
155364023|NCT00474526|560766449|FG005|Overall Study|Death|0|||
155364024|NCT00474526|560766450|FG006|Overall Study|Death|0|||
155364025|NCT00474526|560766451|FG007|Overall Study|Death|0|||
155364026|NCT00474526|560766452|FG008|Overall Study|Death|0|||
155364027|NCT00474526|560766453|FG009|Overall Study|Death|0|||
155364028|NCT00474526|560766454|FG010|Overall Study|Death|0|||
155364029|NCT00474526|560766455|FG011|Overall Study|Death|0|||
155364030|NCT00474526|560766456|FG012|Overall Study|Death|0|||
155364031|NCT00474526|560766457|FG013|Overall Study|Death|3|||
155364032|NCT00474526|560766458|FG014|Overall Study|Death|0|||
155364033|NCT00474526|560766459|FG015|Overall Study|Death|0|||
155364034|NCT00474526|560766460|FG016|Overall Study|Death|0|||
155364035|NCT00474526|560766444|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364036|NCT00474526|560766445|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
155364037|NCT00474526|560766446|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364038|NCT00474526|560766447|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
155364039|NCT00474526|560766448|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
155364040|NCT00474526|560766449|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364041|NCT00474526|560766450|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364042|NCT00474526|560766451|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364043|NCT00474526|560766452|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364044|NCT00474526|560766453|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364045|NCT00474526|560766454|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364046|NCT00474526|560766455|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364047|NCT00474526|560766456|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364048|NCT00474526|560766457|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
155364049|NCT00474526|560766458|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
155364050|NCT00474526|560766459|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364051|NCT00474526|560766460|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
155364052|NCT00474526|560766444|FG000|Overall Study|Lost to Follow-up|8|||
155364053|NCT00474526|560766445|FG001|Overall Study|Lost to Follow-up|6|||
155364054|NCT00474526|560766446|FG002|Overall Study|Lost to Follow-up|13|||
155364055|NCT00474526|560766447|FG003|Overall Study|Lost to Follow-up|29|||
155364056|NCT00474526|560766448|FG004|Overall Study|Lost to Follow-up|11|||
155364057|NCT00474526|560766449|FG005|Overall Study|Lost to Follow-up|5|||
155364058|NCT00474526|560766450|FG006|Overall Study|Lost to Follow-up|8|||
155364059|NCT00474526|560766451|FG007|Overall Study|Lost to Follow-up|1|||
155364060|NCT00474526|560766452|FG008|Overall Study|Lost to Follow-up|0|||
155364061|NCT00474526|560766453|FG009|Overall Study|Lost to Follow-up|6|||
155364062|NCT00474526|560766454|FG010|Overall Study|Lost to Follow-up|2|||
155364063|NCT00474526|560766455|FG011|Overall Study|Lost to Follow-up|4|||
155364064|NCT00474526|560766456|FG012|Overall Study|Lost to Follow-up|6|||
155364065|NCT00474526|560766457|FG013|Overall Study|Lost to Follow-up|74|||
155364066|NCT00474526|560766458|FG014|Overall Study|Lost to Follow-up|29|||
155364067|NCT00474526|560766459|FG015|Overall Study|Lost to Follow-up|4|||
155364068|NCT00474526|560766460|FG016|Overall Study|Lost to Follow-up|5|||
155364069|NCT00474526|560766444|FG000|Overall Study|Protocol Violation|2|||
155364070|NCT00474526|560766445|FG001|Overall Study|Protocol Violation|6|||
155364071|NCT00474526|560766446|FG002|Overall Study|Protocol Violation|4|||
155364072|NCT00474526|560766447|FG003|Overall Study|Protocol Violation|12|||
155364073|NCT00474526|560766448|FG004|Overall Study|Protocol Violation|3|||
155364074|NCT00474526|560766449|FG005|Overall Study|Protocol Violation|1|||
155364075|NCT00474526|560766450|FG006|Overall Study|Protocol Violation|3|||
155364076|NCT00474526|560766451|FG007|Overall Study|Protocol Violation|0|||
155364077|NCT00474526|560766452|FG008|Overall Study|Protocol Violation|0|||
155364078|NCT00474526|560766453|FG009|Overall Study|Protocol Violation|4|||
155364079|NCT00474526|560766454|FG010|Overall Study|Protocol Violation|2|||
155364080|NCT00474526|560766455|FG011|Overall Study|Protocol Violation|2|||
155364081|NCT00474526|560766456|FG012|Overall Study|Protocol Violation|4|||
155364082|NCT00474526|560766457|FG013|Overall Study|Protocol Violation|19|||
155364083|NCT00474526|560766458|FG014|Overall Study|Protocol Violation|9|||
155364084|NCT00474526|560766459|FG015|Overall Study|Protocol Violation|6|||
155364085|NCT00474526|560766460|FG016|Overall Study|Protocol Violation|2|||
155364086|NCT00474526|560766444|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
155364087|NCT00474526|560766445|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
155166614|NCT04292899|560046292|FG002|Overall Study|Protocol Violation|0|||
155166615|NCT04292899|560046293|FG003|Overall Study|Protocol Violation|1|||
155166616|NCT00948441|560046294|FG000|Overall Study|no longer meet inclusion criteria|1|||
155166617|NCT00948441|560046295|FG001|Overall Study|no longer meet inclusion criteria|4|||
155166618|NCT01026324|560046296|FG000|Follow up/Survival|Withdrawal by Subject|1|||
155166619|NCT01026324|560046297|FG001|Follow up/Survival|Withdrawal by Subject|0|||
155166620|NCT01026324|560046298|FG002|Follow up/Survival|Withdrawal by Subject|0|||
155166621|NCT01032889|560046299|FG000|Overall Study|Adverse Event|2|||
155166622|NCT01032889|560046300|FG001|Overall Study|Adverse Event|2|||
155166623|NCT01032889|560046301|FG002|Overall Study|Adverse Event|0|||
155166624|NCT01032889|560046299|FG000|Overall Study|Withdrawal of Consent|1|||
155166625|NCT01032889|560046300|FG001|Overall Study|Withdrawal of Consent|2|||
155166626|NCT01032889|560046301|FG002|Overall Study|Withdrawal of Consent|1|||
155166627|NCT01032889|560046299|FG000|Overall Study|Patient Request|0|||
155166628|NCT01032889|560046300|FG001|Overall Study|Patient Request|1|||
155166629|NCT01032889|560046301|FG002|Overall Study|Patient Request|0|||
155166630|NCT01032889|560046299|FG000|Overall Study|Lost to Follow-up|1|||
155166631|NCT01032889|560046300|FG001|Overall Study|Lost to Follow-up|1|||
155166632|NCT01032889|560046301|FG002|Overall Study|Lost to Follow-up|0|||
155166633|NCT01032889|560046299|FG000|Overall Study|Lack of Submental Fat|2|||
155166634|NCT01032889|560046300|FG001|Overall Study|Lack of Submental Fat|8|||
155166635|NCT01032889|560046301|FG002|Overall Study|Lack of Submental Fat|1|||
155166636|NCT01032889|560046299|FG000|Overall Study|Miscellaneous Reasons|2|||
155166637|NCT01032889|560046300|FG001|Overall Study|Miscellaneous Reasons|1|||
155166638|NCT01032889|560046301|FG002|Overall Study|Miscellaneous Reasons|1|||
155166639|NCT02442804|560046302|FG000|Overall Study|Withdrawal by Subject|0|||
155166640|NCT02442804|560046303|FG001|Overall Study|Withdrawal by Subject|1|||
155166641|NCT02442804|560046302|FG000|Overall Study|Adverse Event|1|||
155166642|NCT02442804|560046303|FG001|Overall Study|Adverse Event|0|||
155364088|NCT00474526|560766446|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
155364089|NCT00474526|560766447|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
155364090|NCT00474526|560766448|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
155364091|NCT00474526|560766449|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
155364092|NCT00474526|560766450|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
155364093|NCT00474526|560766451|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
155364094|NCT00474526|560766452|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
155364095|NCT00474526|560766453|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
155364096|NCT00474526|560766454|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
155364097|NCT00474526|560766455|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
155364098|NCT00474526|560766456|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
155364099|NCT00474526|560766457|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
155364100|NCT00474526|560766458|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
155364101|NCT00474526|560766459|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
155364102|NCT00474526|560766460|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
155364103|NCT00474526|560766444|FG000|Overall Study|Withdrawal by Subject|9|||
155364104|NCT00474526|560766445|FG001|Overall Study|Withdrawal by Subject|24|||
155364105|NCT00474526|560766446|FG002|Overall Study|Withdrawal by Subject|21|||
155364106|NCT00474526|560766447|FG003|Overall Study|Withdrawal by Subject|52|||
155364107|NCT00474526|560766448|FG004|Overall Study|Withdrawal by Subject|38|||
155364108|NCT00474526|560766449|FG005|Overall Study|Withdrawal by Subject|6|||
155364109|NCT00474526|560766450|FG006|Overall Study|Withdrawal by Subject|12|||
155364110|NCT00474526|560766451|FG007|Overall Study|Withdrawal by Subject|4|||
155364111|NCT00474526|560766452|FG008|Overall Study|Withdrawal by Subject|4|||
155364112|NCT00474526|560766453|FG009|Overall Study|Withdrawal by Subject|13|||
155364113|NCT00474526|560766454|FG010|Overall Study|Withdrawal by Subject|5|||
155364114|NCT00474526|560766455|FG011|Overall Study|Withdrawal by Subject|4|||
155364115|NCT00474526|560766456|FG012|Overall Study|Withdrawal by Subject|4|||
155364116|NCT00474526|560766457|FG013|Overall Study|Withdrawal by Subject|37|||
155364117|NCT00474526|560766458|FG014|Overall Study|Withdrawal by Subject|22|||
155364118|NCT00474526|560766459|FG015|Overall Study|Withdrawal by Subject|1|||
155364119|NCT00474526|560766460|FG016|Overall Study|Withdrawal by Subject|1|||
155364120|NCT00953147|560766461|FG000|Overall Study|Adverse Event|8|||
155364121|NCT00953147|560766462|FG001|Overall Study|Adverse Event|16|||
155364122|NCT00953147|560766463|FG002|Overall Study|Adverse Event|6|||
155364123|NCT00953147|560766461|FG000|Overall Study|Protocol Violation|2|||
155364124|NCT00953147|560766462|FG001|Overall Study|Protocol Violation|8|||
155166643|NCT02624986|560046310|FG000|Overall Study|Death|0|||
155166644|NCT02624986|560046311|FG001|Overall Study|Death|1|||
155166645|NCT02624986|560046312|FG002|Overall Study|Death|2|||
155166646|NCT02624986|560046313|FG003|Overall Study|Death|2|||
155364125|NCT00953147|560766463|FG002|Overall Study|Protocol Violation|4|||
155364126|NCT00953147|560766461|FG000|Overall Study|Withdrawal by Subject|13|||
155364127|NCT00953147|560766462|FG001|Overall Study|Withdrawal by Subject|15|||
155364128|NCT00953147|560766463|FG002|Overall Study|Withdrawal by Subject|12|||
155364129|NCT00953147|560766461|FG000|Overall Study|Lost to Follow-up|8|||
155364130|NCT00953147|560766462|FG001|Overall Study|Lost to Follow-up|9|||
155364131|NCT00953147|560766463|FG002|Overall Study|Lost to Follow-up|4|||
155364132|NCT00953147|560766461|FG000|Overall Study|Physician Decision|2|||
155364133|NCT00953147|560766462|FG001|Overall Study|Physician Decision|7|||
155364134|NCT00953147|560766463|FG002|Overall Study|Physician Decision|3|||
155166647|NCT02624986|560046314|FG004|Overall Study|Death|2|||
155364135|NCT00953147|560766461|FG000|Overall Study|Other|4|||
155364136|NCT00953147|560766462|FG001|Overall Study|Other|11|||
155364137|NCT00953147|560766463|FG002|Overall Study|Other|13|||
155364138|NCT01484431|560766464|FG000|Period 1: High Dose|Physician Decision|0|||
155364139|NCT01484431|560766465|FG001|Period 1: High Dose|Physician Decision|1|||
155364140|NCT01484431|560766466|FG002|Period 1: High Dose|Physician Decision|0|||
155364141|NCT01484431|560766464|FG000|Period 2|Death|0|||
155364142|NCT01484431|560766465|FG001|Period 2|Death|1|||
155364143|NCT01484431|560766466|FG002|Period 2|Death|1|||
155364144|NCT01484431|560766464|FG000|Period 2|Physician Decision|0|||
155364145|NCT01484431|560766465|FG001|Period 2|Physician Decision|0|||
155364146|NCT01484431|560766466|FG002|Period 2|Physician Decision|1|||
155364147|NCT01484431|560766464|FG000|Period 2|Non-Compliance with Study Drug|1|||
155364148|NCT01484431|560766465|FG001|Period 2|Non-Compliance with Study Drug|0|||
155364149|NCT01484431|560766466|FG002|Period 2|Non-Compliance with Study Drug|0|||
155364150|NCT01251770|560766468|FG000|Overall Study|Protocol Violation|13|||
155364151|NCT01251770|560766469|FG001|Overall Study|Protocol Violation|7|||
155364152|NCT02763215|560766470|FG000|Overall Study|Participants withdrew from study|3|||
155364153|NCT02763215|560766470|FG000|Overall Study|Missed visit|1|||
155364154|NCT02763215|560766470|FG000|Overall Study|Visit outside visit-window|1|||
155364155|NCT02763215|560766470|FG000|Overall Study|Death|1|||
155364156|NCT02763215|560766470|FG000|Overall Study|Lost to Follow-up|1|||
155364157|NCT01020877|560766475|FG000|Second Intervention|Withdrawal by Subject|1|||
155364158|NCT01020877|560766476|FG001|Second Intervention|Withdrawal by Subject|0|||
155364159|NCT00953771|560766477|FG000|Overall Study|Death|1|||
155364160|NCT00953771|560766478|FG001|Overall Study|Death|0|||
155364161|NCT00974259|560766479|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
155364162|NCT00974259|560766480|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
155364163|NCT00944229|560766481|FG000|Overall Study|Withdrawal by Subject|11|||
155364164|NCT00944229|560766481|FG000|Overall Study|Physician Decision|14|||
155364165|NCT02963090|560766482|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
155364166|NCT02963090|560766483|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
155364167|NCT00709228|560766487|FG000|Overall Study|Not treated|14|||
155364168|NCT00709228|560766487|FG000|Overall Study|Eligibility criteria not met|281|||
155364169|NCT00709228|560766487|FG000|Overall Study|Adverse events|2|||
155364170|NCT00709228|560766487|FG000|Overall Study|Discontinued treatment|14|||
155364171|NCT00709228|560766487|FG000|Overall Study|Did not enter follow-up|4|||
155364172|NCT00709228|560766487|FG000|Overall Study|Discontinued follow-up|5|||
155364173|NCT00709228|560766487|FG000|Overall Study|Disease progression|1|||
155364174|NCT00709228|560766487|FG000|Overall Study|Lost to Follow-up|6|||
155364175|NCT00709228|560766487|FG000|Overall Study|Non-compliance|5|||
155364176|NCT02179177|560766490|FG000|Overall Study|Lost to Follow-up|1|||
155364177|NCT02179177|560766491|FG001|Overall Study|Lost to Follow-up|1|||
155364178|NCT02179177|560766490|FG000|Overall Study|Withdrawal by Subject|1|||
155364179|NCT02179177|560766491|FG001|Overall Study|Withdrawal by Subject|1|||
155364180|NCT00022659|560766492|FG000|Overall Study|Ineligible: wrong primary|1|||
155364181|NCT00022659|560766492|FG000|Overall Study|Never treated|1|||
155364182|NCT00884650|560766495|FG000|Overall Study|Did not return complete pain diaries|7|||
155364183|NCT00884650|560766496|FG001|Overall Study|Did not return complete pain diaries|7|||
155364184|NCT00884650|560766495|FG000|Overall Study|Admitted Post-Op|1|||
155364185|NCT00884650|560766496|FG001|Overall Study|Admitted Post-Op|0|||
155364186|NCT00884650|560766495|FG000|Overall Study|Femoral Stress Fracture|1|||
155364187|NCT00884650|560766496|FG001|Overall Study|Femoral Stress Fracture|0|||
155364188|NCT00884650|560766495|FG000|Overall Study|Pain Pump Complication|0|||
155364189|NCT00884650|560766496|FG001|Overall Study|Pain Pump Complication|1|||
155364190|NCT01516749|560766505|FG000|Active Therapy|Lost to Follow-up|1|||
155364191|NCT01516749|560766505|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
155364192|NCT03994731|560766507|FG000|Pegloticase + IMM Period|Death|2|||
155364193|NCT03994731|560766508|FG001|Pegloticase + IMM Period|Death|0|||
155364194|NCT03994731|560766507|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
155364195|NCT03994731|560766508|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
155364196|NCT03994731|560766507|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
155364197|NCT03994731|560766508|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
155364198|NCT00732992|560766511|FG000|Overall Study|Adverse Event|1|||
155364199|NCT00732992|560766512|FG001|Overall Study|Adverse Event|1|||
155364200|NCT00732992|560766511|FG000|Overall Study|Objective Progression or Relapse|3|||
155166648|NCT02624986|560046315|FG005|Overall Study|Death|0|||
155364201|NCT00732992|560766512|FG001|Overall Study|Objective Progression or Relapse|5|||
155364202|NCT00732992|560766511|FG000|Overall Study|Global Deterioration of Health Status|1|||
155364203|NCT00732992|560766512|FG001|Overall Study|Global Deterioration of Health Status|0|||
155364204|NCT00732992|560766511|FG000|Overall Study|Withdrawal by Subject|1|||
155364205|NCT00732992|560766512|FG001|Overall Study|Withdrawal by Subject|0|||
155166649|NCT02624986|560046316|FG006|Overall Study|Death|0|||
155364206|NCT00762476|560766516|FG000|Overall Study|Adverse Event|7|||
155364207|NCT00762476|560766517|FG001|Overall Study|Adverse Event|1|||
155364208|NCT00762476|560766516|FG000|Overall Study|Lost to Follow-up|2|||
155166650|NCT02624986|560046317|FG007|Overall Study|Death|1|||
155364209|NCT00762476|560766517|FG001|Overall Study|Lost to Follow-up|0|||
155364210|NCT00762476|560766516|FG000|Overall Study|Protocol Violation|5|||
155364211|NCT00762476|560766517|FG001|Overall Study|Protocol Violation|6|||
155364212|NCT00762476|560766516|FG000|Overall Study|Physician Decision|2|||
155364213|NCT00762476|560766517|FG001|Overall Study|Physician Decision|14|||
155364214|NCT00762476|560766516|FG000|Overall Study|Withdrawal by Subject|6|||
155364215|NCT00762476|560766517|FG001|Overall Study|Withdrawal by Subject|12|||
155364216|NCT00762476|560766516|FG000|Overall Study|antibiotic use|0|||
155364217|NCT00762476|560766517|FG001|Overall Study|antibiotic use|1|||
155364218|NCT00762476|560766516|FG000|Overall Study|non-compliance with study visits|0|||
155364219|NCT00762476|560766517|FG001|Overall Study|non-compliance with study visits|2|||
155364220|NCT00762476|560766516|FG000|Overall Study|Seasonal allergies|1|||
155364221|NCT00762476|560766517|FG001|Overall Study|Seasonal allergies|0|||
155364222|NCT02838134|560766518|FG000|Overall Study|Lost to Follow-up|1|||
155364223|NCT02838134|560766519|FG001|Overall Study|Lost to Follow-up|2|||
155364224|NCT02838134|560766518|FG000|Overall Study|logistic problems|1|||
155364225|NCT02838134|560766519|FG001|Overall Study|logistic problems|1|||
155364226|NCT04674189|560766527|FG000|Overall Study|Adverse Event|0|||
155364227|NCT04674189|560766528|FG001|Overall Study|Adverse Event|0|||
155364228|NCT04674189|560766529|FG002|Overall Study|Adverse Event|1|||
155364229|NCT04674189|560766527|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
155364230|NCT04674189|560766528|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
155364231|NCT04674189|560766529|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
155364232|NCT04674189|560766527|FG000|Overall Study|Physician Decision|1|||
155364233|NCT04674189|560766528|FG001|Overall Study|Physician Decision|0|||
155364234|NCT04674189|560766529|FG002|Overall Study|Physician Decision|0|||
155364235|NCT04674189|560766527|FG000|Overall Study|Withdrawal by Participant|83|||
155364236|NCT04674189|560766528|FG001|Overall Study|Withdrawal by Participant|71|||
155364237|NCT04674189|560766529|FG002|Overall Study|Withdrawal by Participant|142|||
155364238|NCT04674189|560766527|FG000|Overall Study|Lost to Follow-up|55|||
155364239|NCT04674189|560766528|FG001|Overall Study|Lost to Follow-up|53|||
155364240|NCT04674189|560766529|FG002|Overall Study|Lost to Follow-up|44|||
155364241|NCT04674189|560766527|FG000|Overall Study|Miscellaneous|27|||
155364242|NCT04674189|560766528|FG001|Overall Study|Miscellaneous|23|||
155364243|NCT04674189|560766529|FG002|Overall Study|Miscellaneous|207|||
155364244|NCT04674189|560766527|FG000|Overall Study|Did Not Receive Treatment|3|||
155364245|NCT04674189|560766528|FG001|Overall Study|Did Not Receive Treatment|1|||
155364246|NCT04674189|560766529|FG002|Overall Study|Did Not Receive Treatment|2|||
155364247|NCT03023423|560766531|FG000|Overall Study|Death|5|||
155364248|NCT03023423|560766532|FG001|Overall Study|Death|12|||
155364249|NCT03023423|560766533|FG002|Overall Study|Death|20|||
155364250|NCT03023423|560766531|FG000|Overall Study|Other|0|||
155364251|NCT03023423|560766532|FG001|Overall Study|Other|2|||
155364252|NCT03023423|560766533|FG002|Overall Study|Other|2|||
155364253|NCT03023423|560766531|FG000|Overall Study|Ongoing|2|||
155364254|NCT03023423|560766532|FG001|Overall Study|Ongoing|32|||
155364255|NCT03023423|560766533|FG002|Overall Study|Ongoing|24|||
155364256|NCT00681668|560766534|FG000|Overall Study|Protocol Violation|1|||
155364257|NCT00681668|560766534|FG000|Overall Study|Withdrawal by Subject|1|||
155364258|NCT04277507|560766535|FG000|Overall Study|Lost to Follow-up|17|||
155364259|NCT04277507|560766535|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
155364260|NCT04277507|560766535|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
155364261|NCT04277507|560766535|FG000|Overall Study|Withdrawal by Subject|3|||
155364262|NCT04277507|560766535|FG000|Overall Study|Death due to COVID-19|1|||
155364263|NCT04277507|560766535|FG000|Overall Study|Data missing for full evaluation|5|||
155364264|NCT00583947|560766536|FG000|Cross-over Period|Adverse Event|2|||
155364265|NCT00583947|560766537|FG001|Cross-over Period|Adverse Event|0|||
155364266|NCT00583947|560766536|FG000|Cross-over Period|Withdrawal by Subject|2|||
155364267|NCT00583947|560766537|FG001|Cross-over Period|Withdrawal by Subject|0|||
155364268|NCT00583947|560766536|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
155364269|NCT00583947|560766537|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
155364270|NCT00583947|560766536|FG000|Cross-over Period|Other|1|||
155364271|NCT00583947|560766537|FG001|Cross-over Period|Other|1|||
155364272|NCT05226130|560766538|FG000|Overall Study|Lost to Follow-up|0|||
155364273|NCT05226130|560766539|FG001|Overall Study|Lost to Follow-up|1|||
155364274|NCT05226130|560766538|FG000|Overall Study|Not treatment adherent|0|||
155364275|NCT05226130|560766539|FG001|Overall Study|Not treatment adherent|2|||
155364276|NCT03974022|560766540|FG000|Overall Study|Death|0|||
154965406|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
154965407|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
155364277|NCT03974022|560766541|FG001|Overall Study|Death|1|||
155364278|NCT03974022|560766542|FG002|Overall Study|Death|0|||
155364279|NCT03974022|560766543|FG003|Overall Study|Death|2|||
155364280|NCT03974022|560766544|FG004|Overall Study|Death|0|||
155364281|NCT03974022|560766545|FG005|Overall Study|Death|1|||
155364282|NCT03974022|560766546|FG006|Overall Study|Death|0|||
155364283|NCT03974022|560766547|FG007|Overall Study|Death|2|||
155364284|NCT03974022|560766548|FG008|Overall Study|Death|1|||
155364285|NCT03974022|560766549|FG009|Overall Study|Death|4|||
155364286|NCT03974022|560766550|FG010|Overall Study|Death|0|||
155364287|NCT03974022|560766551|FG011|Overall Study|Death|0|||
155364288|NCT03974022|560766552|FG012|Overall Study|Death|0|||
155364289|NCT03974022|560766553|FG013|Overall Study|Death|33|||
155364290|NCT03974022|560766554|FG014|Overall Study|Death|40|||
155364291|NCT03974022|560766540|FG000|Overall Study|Withdrawal by Subject|0|||
155364292|NCT03974022|560766541|FG001|Overall Study|Withdrawal by Subject|0|||
155364293|NCT03974022|560766542|FG002|Overall Study|Withdrawal by Subject|0|||
155364294|NCT03974022|560766543|FG003|Overall Study|Withdrawal by Subject|0|||
155364295|NCT03974022|560766544|FG004|Overall Study|Withdrawal by Subject|0|||
155364296|NCT03974022|560766545|FG005|Overall Study|Withdrawal by Subject|4|||
155364297|NCT03974022|560766546|FG006|Overall Study|Withdrawal by Subject|4|||
155364298|NCT03974022|560766547|FG007|Overall Study|Withdrawal by Subject|2|||
155364299|NCT03974022|560766548|FG008|Overall Study|Withdrawal by Subject|2|||
155364300|NCT03974022|560766549|FG009|Overall Study|Withdrawal by Subject|3|||
155364301|NCT03974022|560766550|FG010|Overall Study|Withdrawal by Subject|0|||
155364302|NCT03974022|560766551|FG011|Overall Study|Withdrawal by Subject|1|||
155364303|NCT03974022|560766552|FG012|Overall Study|Withdrawal by Subject|0|||
155364304|NCT03974022|560766553|FG013|Overall Study|Withdrawal by Subject|3|||
155364305|NCT03974022|560766554|FG014|Overall Study|Withdrawal by Subject|9|||
155364306|NCT03974022|560766540|FG000|Overall Study|Lost to Follow-up|0|||
155364307|NCT03974022|560766541|FG001|Overall Study|Lost to Follow-up|0|||
155364308|NCT03974022|560766542|FG002|Overall Study|Lost to Follow-up|0|||
155364309|NCT03974022|560766543|FG003|Overall Study|Lost to Follow-up|0|||
155364310|NCT03974022|560766544|FG004|Overall Study|Lost to Follow-up|0|||
155364311|NCT03974022|560766545|FG005|Overall Study|Lost to Follow-up|0|||
155364312|NCT03974022|560766546|FG006|Overall Study|Lost to Follow-up|1|||
155364313|NCT03974022|560766547|FG007|Overall Study|Lost to Follow-up|0|||
155364314|NCT03974022|560766548|FG008|Overall Study|Lost to Follow-up|0|||
155364315|NCT03974022|560766549|FG009|Overall Study|Lost to Follow-up|0|||
155364316|NCT03974022|560766550|FG010|Overall Study|Lost to Follow-up|0|||
155364317|NCT03974022|560766551|FG011|Overall Study|Lost to Follow-up|0|||
155364318|NCT03974022|560766552|FG012|Overall Study|Lost to Follow-up|0|||
155364319|NCT03974022|560766553|FG013|Overall Study|Lost to Follow-up|1|||
155364320|NCT03974022|560766554|FG014|Overall Study|Lost to Follow-up|1|||
155364321|NCT03974022|560766540|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
155364322|NCT03974022|560766541|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
155364323|NCT03974022|560766542|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
155364324|NCT03974022|560766543|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
155364325|NCT03974022|560766544|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
155364326|NCT03974022|560766545|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
155364327|NCT03974022|560766546|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
155364328|NCT03974022|560766547|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
155166651|NCT02624986|560046310|FG000|Overall Study|Study Terminated by Sponsor|1|||
155166652|NCT02624986|560046311|FG001|Overall Study|Study Terminated by Sponsor|1|||
155166653|NCT02624986|560046312|FG002|Overall Study|Study Terminated by Sponsor|0|||
155166654|NCT02624986|560046313|FG003|Overall Study|Study Terminated by Sponsor|1|||
155166655|NCT02624986|560046314|FG004|Overall Study|Study Terminated by Sponsor|2|||
155166656|NCT02624986|560046315|FG005|Overall Study|Study Terminated by Sponsor|2|||
155166657|NCT02624986|560046316|FG006|Overall Study|Study Terminated by Sponsor|4|||
155166658|NCT02624986|560046317|FG007|Overall Study|Study Terminated by Sponsor|3|||
155166659|NCT02624986|560046310|FG000|Overall Study|Progressive Disease|0|||
155166660|NCT02624986|560046311|FG001|Overall Study|Progressive Disease|1|||
155166661|NCT02624986|560046312|FG002|Overall Study|Progressive Disease|0|||
155166662|NCT02624986|560046313|FG003|Overall Study|Progressive Disease|0|||
155166663|NCT02624986|560046314|FG004|Overall Study|Progressive Disease|0|||
155166664|NCT02624986|560046315|FG005|Overall Study|Progressive Disease|0|||
155166665|NCT02624986|560046316|FG006|Overall Study|Progressive Disease|0|||
155166666|NCT02624986|560046317|FG007|Overall Study|Progressive Disease|0|||
155166667|NCT02624986|560046310|FG000|Overall Study|Protocol Violation|1|||
155166668|NCT02624986|560046311|FG001|Overall Study|Protocol Violation|0|||
155166669|NCT02624986|560046312|FG002|Overall Study|Protocol Violation|0|||
155166670|NCT02624986|560046313|FG003|Overall Study|Protocol Violation|0|||
155166671|NCT02624986|560046314|FG004|Overall Study|Protocol Violation|0|||
155166672|NCT02624986|560046315|FG005|Overall Study|Protocol Violation|0|||
155166673|NCT02624986|560046316|FG006|Overall Study|Protocol Violation|0|||
155364329|NCT03974022|560766548|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
155166674|NCT02624986|560046317|FG007|Overall Study|Protocol Violation|0|||
155166675|NCT02624986|560046310|FG000|Overall Study|Withdrawal by Subject|0|||
155166676|NCT02624986|560046311|FG001|Overall Study|Withdrawal by Subject|0|||
155166677|NCT02624986|560046312|FG002|Overall Study|Withdrawal by Subject|0|||
155166678|NCT02624986|560046313|FG003|Overall Study|Withdrawal by Subject|0|||
155364330|NCT03974022|560766549|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
155364331|NCT03974022|560766550|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
155364332|NCT03974022|560766551|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
154965408|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
154965409|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
154965410|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
154965411|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
154965412|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
154965413|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
154965414|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
154965415|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
154965416|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
154965417|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
154965418|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
154965419|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
154965420|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
154965421|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
154965422|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
154965423|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
155364333|NCT03974022|560766552|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
155364334|NCT03974022|560766553|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
155364335|NCT03974022|560766554|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
155364336|NCT06719986|560766557|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
155364337|NCT06719986|560766558|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
155364338|NCT06719986|560766559|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
155364339|NCT06719986|560766557|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
155364340|NCT06719986|560766558|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
155364341|NCT06719986|560766559|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
155364342|NCT03213704|560766561|FG000|Overall Study|Physician Decision|3|||
155364343|NCT03213704|560766561|FG000|Overall Study|Protocol Violation|1|||
155364344|NCT03213704|560766561|FG000|Overall Study|Progressive disease|4|||
155364345|NCT01183390|560768161|FG000|First Intervention|Adverse Event|0|||
155364346|NCT01183390|560768162|FG001|First Intervention|Adverse Event|1|||
155364347|NCT02113124|560768169|FG000|Overall Study|Unable to retrieve blood sample|1|||
155364348|NCT02113124|560768170|FG001|Overall Study|Unable to retrieve blood sample|1|||
155364349|NCT02514239|560768171|FG000|Overall Study|Refused to continue trial medication|0|||
155364350|NCT02514239|560768172|FG001|Overall Study|Refused to continue trial medication|0|||
155364351|NCT02514239|560768173|FG002|Overall Study|Refused to continue trial medication|0|||
155364352|NCT02514239|560768174|FG003|Overall Study|Refused to continue trial medication|0|||
155364353|NCT02514239|560768175|FG004|Overall Study|Refused to continue trial medication|0|||
155364354|NCT02514239|560768176|FG005|Overall Study|Refused to continue trial medication|0|||
155364355|NCT02514239|560768177|FG006|Overall Study|Refused to continue trial medication|0|||
155364356|NCT02514239|560768178|FG007|Overall Study|Refused to continue trial medication|0|||
155364357|NCT02514239|560768179|FG008|Overall Study|Refused to continue trial medication|0|||
155364358|NCT02514239|560768180|FG009|Overall Study|Refused to continue trial medication|1|||
155166679|NCT02624986|560046314|FG004|Overall Study|Withdrawal by Subject|0|||
155364359|NCT02514239|560768171|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364360|NCT02514239|560768172|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364361|NCT02514239|560768173|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364362|NCT02514239|560768174|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364363|NCT02514239|560768175|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364364|NCT02514239|560768176|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364365|NCT02514239|560768177|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364366|NCT02514239|560768178|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
155364367|NCT02514239|560768179|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
155364368|NCT02514239|560768180|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
155364369|NCT02514239|560768171|FG000|Overall Study|Not treated|0|||
155364370|NCT02514239|560768172|FG001|Overall Study|Not treated|1|||
155364371|NCT02514239|560768173|FG002|Overall Study|Not treated|0|||
155364372|NCT02514239|560768174|FG003|Overall Study|Not treated|0|||
155364373|NCT02514239|560768175|FG004|Overall Study|Not treated|0|||
155364374|NCT02514239|560768176|FG005|Overall Study|Not treated|0|||
155364375|NCT02514239|560768177|FG006|Overall Study|Not treated|0|||
155364376|NCT02514239|560768178|FG007|Overall Study|Not treated|0|||
155364377|NCT02514239|560768179|FG008|Overall Study|Not treated|0|||
155364378|NCT02514239|560768180|FG009|Overall Study|Not treated|0|||
155364379|NCT02514239|560768171|FG000|Overall Study|Other Adverse Events|2|||
155364380|NCT02514239|560768172|FG001|Overall Study|Other Adverse Events|0|||
155364381|NCT02514239|560768173|FG002|Overall Study|Other Adverse Events|0|||
155364382|NCT02514239|560768174|FG003|Overall Study|Other Adverse Events|1|||
155364383|NCT02514239|560768175|FG004|Overall Study|Other Adverse Events|0|||
155364384|NCT02514239|560768176|FG005|Overall Study|Other Adverse Events|1|||
155364385|NCT02514239|560768177|FG006|Overall Study|Other Adverse Events|0|||
155364386|NCT02514239|560768178|FG007|Overall Study|Other Adverse Events|1|||
155364387|NCT02514239|560768179|FG008|Overall Study|Other Adverse Events|2|||
155364388|NCT02514239|560768180|FG009|Overall Study|Other Adverse Events|0|||
155364389|NCT02514239|560768171|FG000|Overall Study|Progressive disease|3|||
155364390|NCT02514239|560768172|FG001|Overall Study|Progressive disease|3|||
155364391|NCT02514239|560768173|FG002|Overall Study|Progressive disease|2|||
155364392|NCT02514239|560768174|FG003|Overall Study|Progressive disease|2|||
155364393|NCT02514239|560768175|FG004|Overall Study|Progressive disease|3|||
155364394|NCT02514239|560768176|FG005|Overall Study|Progressive disease|3|||
155364395|NCT02514239|560768177|FG006|Overall Study|Progressive disease|4|||
155364396|NCT02514239|560768178|FG007|Overall Study|Progressive disease|2|||
155364397|NCT02514239|560768179|FG008|Overall Study|Progressive disease|5|||
155364398|NCT02514239|560768180|FG009|Overall Study|Progressive disease|0|||
155364399|NCT03299049|560768181|FG000|Overall Study|On-going|486|||
155364400|NCT03299049|560768182|FG001|Overall Study|On-going|481|||
155364401|NCT03299049|560768181|FG000|Overall Study|Withdrawal by Subject|6|||
155364402|NCT03299049|560768182|FG001|Overall Study|Withdrawal by Subject|21|||
155364403|NCT03299049|560768181|FG000|Overall Study|Physician Decision|5|||
155364404|NCT03299049|560768182|FG001|Overall Study|Physician Decision|1|||
155364405|NCT03299049|560768181|FG000|Overall Study|Lost to Follow-up|2|||
155364406|NCT03299049|560768182|FG001|Overall Study|Lost to Follow-up|0|||
155364407|NCT03299049|560768181|FG000|Overall Study|Pregnancy|1|||
155364408|NCT03299049|560768182|FG001|Overall Study|Pregnancy|3|||
155364409|NCT03299049|560768181|FG000|Overall Study|Protocol Violation|1|||
155364410|NCT03299049|560768182|FG001|Overall Study|Protocol Violation|1|||
155364411|NCT03299049|560768181|FG000|Overall Study|Lack of Efficacy|9|||
155364412|NCT03299049|560768182|FG001|Overall Study|Lack of Efficacy|3|||
155364413|NCT03299049|560768181|FG000|Overall Study|Adverse Event|12|||
155364414|NCT03299049|560768182|FG001|Overall Study|Adverse Event|13|||
155364415|NCT02980042|560768183|FG000|Overall Study|Lost to Follow-up|5|||
155364416|NCT02980042|560768184|FG001|Overall Study|Lost to Follow-up|0|||
155364417|NCT02980042|560768183|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
155364418|NCT02980042|560768184|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
155364419|NCT02460575|560768187|FG000|Overall Study|Lost to Follow-up|1|||
155364420|NCT02460575|560768188|FG001|Overall Study|Lost to Follow-up|0|||
155364421|NCT02521363|560768189|FG000|Overall Study|Withdrawal by Subject|1|||
155364422|NCT02521363|560768190|FG001|Overall Study|Withdrawal by Subject|2|||
155364423|NCT00592293|560768194|FG000|Overall Study|Withdrawal by Subject|1|||
155364424|NCT01606319|560768197|FG000|Overall Study|Lost to Follow-up|17|||
155364425|NCT01606319|560768198|FG001|Overall Study|Lost to Follow-up|14|||
155364426|NCT01606319|560768197|FG000|Overall Study|Withdrawal by Subject|9|||
155364427|NCT01606319|560768198|FG001|Overall Study|Withdrawal by Subject|12|||
155364428|NCT01606319|560768197|FG000|Overall Study|Physician Decision|1|||
155364429|NCT01606319|560768198|FG001|Overall Study|Physician Decision|2|||
155364430|NCT01606319|560768197|FG000|Overall Study|Lack of Efficacy|6|||
155364431|NCT01606319|560768198|FG001|Overall Study|Lack of Efficacy|8|||
155364432|NCT01606319|560768197|FG000|Overall Study|Adverse Event|1|||
155364433|NCT01606319|560768198|FG001|Overall Study|Adverse Event|4|||
155166680|NCT02624986|560046315|FG005|Overall Study|Withdrawal by Subject|0|||
155166681|NCT02624986|560046316|FG006|Overall Study|Withdrawal by Subject|0|||
155166682|NCT02624986|560046317|FG007|Overall Study|Withdrawal by Subject|1|||
155166683|NCT02116205|560046321|FG000|Overall Study|Withdrawal by Subject|2|||
155166684|NCT02116205|560046322|FG001|Overall Study|Withdrawal by Subject|4|||
155166685|NCT02116205|560046323|FG002|Overall Study|Withdrawal by Subject|1|||
155166686|NCT02116205|560046324|FG003|Overall Study|Withdrawal by Subject|3|||
155166687|NCT02116205|560046321|FG000|Overall Study|Lost to Follow-up|0|||
155166688|NCT02116205|560046322|FG001|Overall Study|Lost to Follow-up|2|||
155166689|NCT02116205|560046323|FG002|Overall Study|Lost to Follow-up|1|||
155166690|NCT02116205|560046324|FG003|Overall Study|Lost to Follow-up|2|||
155166691|NCT02116205|560046321|FG000|Overall Study|Physician Decision|0|||
155166692|NCT02116205|560046322|FG001|Overall Study|Physician Decision|1|||
155166693|NCT02116205|560046323|FG002|Overall Study|Physician Decision|1|||
155166694|NCT02116205|560046324|FG003|Overall Study|Physician Decision|1|||
155166695|NCT02116205|560046321|FG000|Overall Study|Exclusion criteria|0|||
155166696|NCT02116205|560046322|FG001|Overall Study|Exclusion criteria|0|||
155166697|NCT02116205|560046323|FG002|Overall Study|Exclusion criteria|1|||
155166698|NCT02116205|560046324|FG003|Overall Study|Exclusion criteria|0|||
155166699|NCT04200352|560046330|FG000|Overall Study|Death|1|||
155166700|NCT04200352|560046330|FG000|Overall Study|Adverse Event|6|||
155166701|NCT04200352|560046330|FG000|Overall Study|Withdrawal by parent/guardian|6|||
155166702|NCT04200352|560046330|FG000|Overall Study|Lack of Efficacy|1|||
155166703|NCT04200352|560046330|FG000|Overall Study|Other than specified|6|||
155166704|NCT00828204|560046331|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
155166705|NCT00828204|560046332|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
155166706|NCT00828204|560046331|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
155166707|NCT00828204|560046332|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
155166708|NCT00828204|560046331|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
155166709|NCT00828204|560046332|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
155166710|NCT00828204|560046331|FG000|Main Study: After Study Restart|Adverse Event|0|||
155166711|NCT00828204|560046332|FG001|Main Study: After Study Restart|Adverse Event|2|||
155166712|NCT00828204|560046331|FG000|Main Study: After Study Restart|Noncompliance|0|||
155166713|NCT00828204|560046332|FG001|Main Study: After Study Restart|Noncompliance|1|||
155166714|NCT00828204|560046331|FG000|Extension Study|Lost to Follow-up|0|||
155166715|NCT00828204|560046332|FG001|Extension Study|Lost to Follow-up|1|||
155166716|NCT00828204|560046331|FG000|Extension Study|Physician Decision|0|||
155166717|NCT00828204|560046332|FG001|Extension Study|Physician Decision|2|||
155166718|NCT00993148|560046333|FG000|Overall Study|Lost to Follow-up|2|||
155166719|NCT00993148|560046333|FG000|Overall Study|never initiated treatment|1|||
155166720|NCT00806819|560046334|FG000|Overall Study|progressive disease (modified RECIST )|217|||
155166721|NCT00806819|560046335|FG001|Overall Study|progressive disease (modified RECIST )|216|||
155166722|NCT00806819|560046334|FG000|Overall Study|Worsening or AE of underlying disease|18|||
155166723|NCT00806819|560046335|FG001|Overall Study|Worsening or AE of underlying disease|25|||
155166724|NCT00806819|560046334|FG000|Overall Study|Other AE|38|||
155166725|NCT00806819|560046335|FG001|Overall Study|Other AE|40|||
155166726|NCT00806819|560046334|FG000|Overall Study|Protocol Violation|9|||
155364434|NCT01270828|560768199|FG000|Pregabalin CR SB|Reason Unspecified|0|||
155364435|NCT01270828|560768200|FG001|Pregabalin CR SB|Reason Unspecified|0|||
155364436|NCT01270828|560768201|FG002|Pregabalin CR SB|Reason Unspecified|8|||
155166727|NCT00806819|560046335|FG001|Overall Study|Protocol Violation|4|||
155166728|NCT00806819|560046334|FG000|Overall Study|Lost to Follow-up|1|||
155166729|NCT00806819|560046335|FG001|Overall Study|Lost to Follow-up|0|||
155166730|NCT00806819|560046334|FG000|Overall Study|Withdrawal by Subject|32|||
155166731|NCT00806819|560046335|FG001|Overall Study|Withdrawal by Subject|29|||
155166732|NCT00806819|560046334|FG000|Overall Study|Not treated|6|||
155166733|NCT00806819|560046335|FG001|Overall Study|Not treated|3|||
155166734|NCT00806819|560046334|FG000|Overall Study|Reasons other than stated above|25|||
155166735|NCT00806819|560046335|FG001|Overall Study|Reasons other than stated above|41|||
155166736|NCT01737502|560046340|FG000|Phase I|Disease progression|2|||
155364437|NCT01270828|560768199|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
155364438|NCT01270828|560768200|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
155364439|NCT01270828|560768201|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
155364440|NCT01270828|560768199|FG000|Pregabalin CR SB|Related adverse event|0|||
155364441|NCT01270828|560768200|FG001|Pregabalin CR SB|Related adverse event|0|||
155364442|NCT01270828|560768201|FG002|Pregabalin CR SB|Related adverse event|46|||
155364443|NCT01270828|560768199|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
155364444|NCT01270828|560768200|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
155364445|NCT01270828|560768201|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
155364446|NCT01270828|560768199|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
155364447|NCT01270828|560768200|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
155364448|NCT01270828|560768201|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
155364449|NCT01270828|560768199|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
155364450|NCT01270828|560768200|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
155364451|NCT01270828|560768201|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
155364452|NCT01270828|560768199|FG000|Pregabalin CR SB|Unrelated AE|0|||
155364453|NCT01270828|560768200|FG001|Pregabalin CR SB|Unrelated AE|0|||
155364454|NCT01270828|560768201|FG002|Pregabalin CR SB|Unrelated AE|8|||
155364455|NCT01270828|560768199|FG000|Pregabalin CR SB|Protocol Violation|0|||
155364456|NCT01270828|560768200|FG001|Pregabalin CR SB|Protocol Violation|0|||
155364457|NCT01270828|560768201|FG002|Pregabalin CR SB|Protocol Violation|8|||
155364458|NCT01270828|560768199|FG000|Double Blind Phase|Death|0|||
155364459|NCT01270828|560768200|FG001|Double Blind Phase|Death|1|||
155364460|NCT01270828|560768201|FG002|Double Blind Phase|Death|0|||
155364461|NCT01270828|560768199|FG000|Double Blind Phase|Protocol Violation|0|||
155364462|NCT01270828|560768200|FG001|Double Blind Phase|Protocol Violation|1|||
155166737|NCT01737502|560046341|FG001|Phase I|Disease progression|3|||
155166738|NCT01737502|560046340|FG000|Phase I|Complicating disease|1|||
155364463|NCT01270828|560768201|FG002|Double Blind Phase|Protocol Violation|0|||
155364464|NCT01270828|560768199|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
155364465|NCT01270828|560768200|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
155364466|NCT01270828|560768201|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
155364467|NCT01270828|560768199|FG000|Double Blind Phase|Reason Unspecified|7|||
155364468|NCT01270828|560768200|FG001|Double Blind Phase|Reason Unspecified|4|||
155364469|NCT01270828|560768201|FG002|Double Blind Phase|Reason Unspecified|0|||
155364470|NCT01270828|560768199|FG000|Double Blind Phase|Withdrawal by Subject|6|||
155364471|NCT01270828|560768200|FG001|Double Blind Phase|Withdrawal by Subject|15|||
155364472|NCT01270828|560768201|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155364473|NCT01270828|560768199|FG000|Double Blind Phase|Lost to Follow-up|1|||
155364474|NCT01270828|560768200|FG001|Double Blind Phase|Lost to Follow-up|2|||
155364475|NCT01270828|560768201|FG002|Double Blind Phase|Lost to Follow-up|0|||
155364476|NCT01270828|560768199|FG000|Double Blind Phase|Lack of Efficacy|2|||
155364477|NCT01270828|560768200|FG001|Double Blind Phase|Lack of Efficacy|11|||
155364478|NCT01270828|560768201|FG002|Double Blind Phase|Lack of Efficacy|0|||
155364479|NCT01270828|560768199|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
155364480|NCT01270828|560768200|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
155364481|NCT01270828|560768201|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
155364482|NCT01270828|560768199|FG000|Double Blind Phase|Adverse event related to study drug|5|||
155364483|NCT01270828|560768200|FG001|Double Blind Phase|Adverse event related to study drug|7|||
155364484|NCT01270828|560768201|FG002|Double Blind Phase|Adverse event related to study drug|0|||
155364485|NCT01810939|560768202|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
155364486|NCT01810939|560768203|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
155364487|NCT01810939|560768204|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
155364488|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol Violation|2|||
155364489|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol Violation|0|||
155364490|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol Violation|0|||
155364491|NCT01810939|560768202|FG000|Part A Treatment Period|Adverse Event|10|||
155364492|NCT01810939|560768203|FG001|Part A Treatment Period|Adverse Event|0|||
155364493|NCT01810939|560768204|FG002|Part A Treatment Period|Adverse Event|0|||
155364494|NCT01810939|560768202|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
155364495|NCT01810939|560768203|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
155364496|NCT01810939|560768204|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
155364497|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
155364498|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
155364499|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
155364500|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
155364501|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
155364502|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
155364503|NCT01810939|560768202|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
155364504|NCT01810939|560768203|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
155364505|NCT01810939|560768204|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
155364506|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
155364507|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
155364508|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
154965424|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
155364509|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
155364510|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
154965425|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
154965426|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
155364511|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
155364512|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
155364513|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
155364514|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
155364515|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
155364516|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
155364517|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
155364518|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
155364519|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
155364520|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
155364521|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
155364522|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
155364523|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
155364524|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
155364525|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
155364526|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
155364527|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
155364528|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
155364529|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
155364530|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
155364531|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
155364532|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
155364533|NCT01810939|560768202|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
155364534|NCT01810939|560768203|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
155364535|NCT01810939|560768204|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
155364536|NCT02870972|560768205|FG000|Overall Study|Adverse Event|1|||
155364537|NCT02870972|560768206|FG001|Overall Study|Adverse Event|0|||
155364538|NCT02870972|560768207|FG002|Overall Study|Adverse Event|0|||
155364539|NCT02870972|560768208|FG003|Overall Study|Adverse Event|0|||
155364540|NCT02870972|560768209|FG004|Overall Study|Adverse Event|0|||
155364541|NCT04497389|560768210|FG000|Overall Study|Withdrawal by Subject|1|||
155364542|NCT04497389|560768211|FG001|Overall Study|Withdrawal by Subject|0|||
155364543|NCT04400487|560768212|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155364544|NCT04400487|560768212|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
155364545|NCT04400487|560768212|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
155364546|NCT01821937|560768213|FG000|Overall Study|Adverse Event|0|||
155364547|NCT01821937|560768214|FG001|Overall Study|Adverse Event|3|||
155364548|NCT01677299|560768215|FG000|Overall Study|Adverse Event|0|||
154965427|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
154965428|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965429|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965430|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965431|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965432|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965433|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
154965434|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
154965435|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965436|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965437|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
154965438|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965439|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965440|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965441|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965442|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155089817|NCT03396445|559761865|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
154965443|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155364549|NCT01677299|560768216|FG001|Overall Study|Adverse Event|2|||
155364550|NCT01677299|560768217|FG002|Overall Study|Adverse Event|1|||
155364551|NCT01677299|560768218|FG003|Overall Study|Adverse Event|0|||
155364552|NCT01677299|560768215|FG000|Overall Study|Withdrawal by Subject|0|||
155364553|NCT01677299|560768216|FG001|Overall Study|Withdrawal by Subject|1|||
155364554|NCT01677299|560768217|FG002|Overall Study|Withdrawal by Subject|0|||
155364555|NCT01677299|560768218|FG003|Overall Study|Withdrawal by Subject|1|||
155364556|NCT03445533|560768219|FG000|Overall Study|Progressive Disease|48|||
155364557|NCT03445533|560768220|FG001|Overall Study|Progressive Disease|81|||
155364558|NCT03445533|560768219|FG000|Overall Study|Adverse Event|60|||
155364559|NCT03445533|560768220|FG001|Overall Study|Adverse Event|64|||
155364560|NCT03445533|560768219|FG000|Overall Study|Death|9|||
155364561|NCT03445533|560768220|FG001|Overall Study|Death|19|||
155364562|NCT03445533|560768219|FG000|Overall Study|Miscellaneous|0|||
155364563|NCT03445533|560768220|FG001|Overall Study|Miscellaneous|16|||
155364564|NCT03445533|560768219|FG000|Overall Study|Withdrawal by Subject|3|||
155364565|NCT03445533|560768220|FG001|Overall Study|Withdrawal by Subject|4|||
155364566|NCT03445533|560768219|FG000|Overall Study|Physician Decision|1|||
155364567|NCT03445533|560768220|FG001|Overall Study|Physician Decision|3|||
155364568|NCT03445533|560768219|FG000|Overall Study|Sponsor Decision|0|||
155364569|NCT03445533|560768220|FG001|Overall Study|Sponsor Decision|1|||
155364570|NCT03445533|560768219|FG000|Overall Study|Lost to Follow-up|0|||
155364571|NCT03445533|560768220|FG001|Overall Study|Lost to Follow-up|1|||
155364572|NCT03445533|560768219|FG000|Overall Study|Never Received any Study Treatment|7|||
155364573|NCT03445533|560768220|FG001|Overall Study|Never Received any Study Treatment|4|||
155166739|NCT01737502|560046341|FG001|Phase I|Complicating disease|0|||
155364574|NCT02615509|560768221|FG000|Overall Study|Lost to Follow-up|134|||
155364575|NCT02615509|560768221|FG000|Overall Study|Death|4|||
155364576|NCT02615509|560768221|FG000|Overall Study|Withdrawal by Subject|8|||
155364577|NCT03274453|560768222|FG000|Overall Study|Lost to Follow-up|2|||
155364578|NCT03274453|560768223|FG001|Overall Study|Lost to Follow-up|5|||
155364579|NCT03274453|560768224|FG002|Overall Study|Lost to Follow-up|4|||
155364580|NCT03274453|560768225|FG003|Overall Study|Lost to Follow-up|1|||
155364581|NCT03274453|560768222|FG000|Overall Study|Physician Decision|2|||
155364582|NCT03274453|560768223|FG001|Overall Study|Physician Decision|0|||
155364583|NCT03274453|560768224|FG002|Overall Study|Physician Decision|0|||
155364584|NCT03274453|560768225|FG003|Overall Study|Physician Decision|3|||
155364585|NCT03274453|560768222|FG000|Overall Study|Surgery Cancelled|0|||
155364586|NCT03274453|560768223|FG001|Overall Study|Surgery Cancelled|1|||
155364587|NCT03274453|560768224|FG002|Overall Study|Surgery Cancelled|0|||
155364588|NCT03274453|560768225|FG003|Overall Study|Surgery Cancelled|0|||
155364589|NCT00945672|560768226|FG000|Overall Study|Withdrawal by Subject|0|||
155364590|NCT00945672|560768227|FG001|Overall Study|Withdrawal by Subject|0|||
155364591|NCT00945672|560768228|FG002|Overall Study|Withdrawal by Subject|0|||
155364592|NCT00945672|560768229|FG003|Overall Study|Withdrawal by Subject|1|||
155364593|NCT00447590|560768230|FG000|Overall Study|Withdrawal by Subject|26|||
155364594|NCT00447590|560768230|FG000|Overall Study|Lost to Follow-up|24|||
155364595|NCT00447590|560768230|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
155364596|NCT00609947|560768231|FG000|Overall Study|Death|1|||
155364597|NCT00504075|560768232|FG000|Overall Study|Adverse Event|1|||
155364598|NCT00504075|560768232|FG000|Overall Study|Lost to Follow-up|5|||
155364599|NCT00504075|560768232|FG000|Overall Study|Withdrawal by Subject|1|||
155364600|NCT00504075|560768232|FG000|Overall Study|Required other therapeutic intervention|1|||
155364601|NCT01689857|560768234|FG000|Overall Study|Lost to Follow-up|5|||
155364602|NCT01689857|560768235|FG001|Overall Study|Lost to Follow-up|2|||
155364603|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
155364604|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
155364605|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
155364606|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|Death|1|||
155364607|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|Death|0|||
155364608|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|Death|0|||
155364609|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
155364610|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
155364611|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
155364612|NCT02362503|560768240|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
155364613|NCT02362503|560768241|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
155364614|NCT02362503|560768242|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
155364615|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
155364616|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
155364617|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
155364618|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
155364619|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
155364620|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
155364621|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
155364622|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
155364623|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
155364624|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
155364625|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
155364626|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
155364627|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
155364628|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
155364629|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
155364630|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
155364631|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
155364632|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
155364633|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
155364634|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
155364635|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
155364636|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
155364637|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
155364638|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
155364639|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
155364640|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
155364641|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
155364642|NCT02362503|560768240|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
155364643|NCT02362503|560768241|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
155364644|NCT02362503|560768242|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
155364645|NCT02643628|560768243|FG000|Overall Study|Lost to Follow-up|1|||
155364646|NCT02643628|560768244|FG001|Overall Study|Lost to Follow-up|4|||
155364647|NCT02643628|560768243|FG000|Overall Study|Withdrawal by Subject|0|||
155364648|NCT02643628|560768244|FG001|Overall Study|Withdrawal by Subject|1|||
155364649|NCT02643628|560768243|FG000|Overall Study|Relocated out of state|0|||
155364650|NCT02643628|560768244|FG001|Overall Study|Relocated out of state|1|||
155364651|NCT04148651|560768253|FG000|Overall Study|Lost to Follow-up|2|||
155364652|NCT03392168|560768257|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
155364653|NCT03392168|560768258|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
155364654|NCT03392168|560768259|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
155364655|NCT03392168|560768260|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
155364656|NCT03392168|560768257|FG000|Period 2: Cohort 2|Other|0|||
155364657|NCT03392168|560768258|FG001|Period 2: Cohort 2|Other|1|||
155364658|NCT03392168|560768259|FG002|Period 2: Cohort 2|Other|0|||
155364659|NCT03392168|560768260|FG003|Period 2: Cohort 2|Other|0|||
155364660|NCT01245374|560768264|FG000|Overall Study|Protocol Violation|1|||
155364661|NCT01245374|560768264|FG000|Overall Study|Withdrawal by Subject|3|||
155364662|NCT01782690|560768266|FG000|Overall Study|Not reported|7|||
155166740|NCT01737502|560046340|FG000|Phase II|Adverse Event|0|||
155364663|NCT01782690|560768266|FG000|Overall Study|Toxicity of gemcitabine|1|||
155364664|NCT01782690|560768266|FG000|Overall Study|Toxicity of erlotinib|1|||
155364665|NCT01782690|560768266|FG000|Overall Study|Lost to Follow-up|31|||
155364666|NCT01782690|560768266|FG000|Overall Study|Withdrawal of informed consent|2|||
155364667|NCT01782690|560768266|FG000|Overall Study|Absent rash|9|||
155364668|NCT01782690|560768266|FG000|Overall Study|Physician Decision|13|||
155364669|NCT01782690|560768266|FG000|Overall Study|Patient's wish|21|||
155364670|NCT01782690|560768266|FG000|Overall Study|Tumor progression|74|||
155364671|NCT01782690|560768266|FG000|Overall Study|Death|133|||
155364672|NCT01782690|560768266|FG000|Overall Study|Study completion unknown|7|||
155364673|NCT04946942|560768267|FG000|Overall Study|Lost to Follow-up|6|||
155364674|NCT04946942|560768268|FG001|Overall Study|Lost to Follow-up|2|||
155364675|NCT04946942|560768269|FG002|Overall Study|Lost to Follow-up|0|||
155364676|NCT05032066|560768279|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
155364677|NCT05032066|560768280|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
155364678|NCT05032066|560768281|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
155364679|NCT05032066|560768279|FG000|Part 1: Core Phase|Physician Decision|0|||
155364680|NCT05032066|560768280|FG001|Part 1: Core Phase|Physician Decision|1|||
155364681|NCT05032066|560768281|FG002|Part 1: Core Phase|Physician Decision|1|||
155364682|NCT05032066|560768279|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
155364683|NCT05032066|560768280|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
155364684|NCT05032066|560768281|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
155364685|NCT05032066|560768279|FG000|Part 1: Core Phase|Death|3|||
155364686|NCT05032066|560768280|FG001|Part 1: Core Phase|Death|4|||
155364687|NCT05032066|560768281|FG002|Part 1: Core Phase|Death|2|||
155364688|NCT05032066|560768279|FG000|Part 1: Core Phase|Adverse Event|2|||
155364689|NCT05032066|560768280|FG001|Part 1: Core Phase|Adverse Event|3|||
155364690|NCT05032066|560768281|FG002|Part 1: Core Phase|Adverse Event|0|||
155364691|NCT05032066|560768279|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
155364692|NCT05032066|560768280|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
155364693|NCT05032066|560768281|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
155364694|NCT05032066|560768279|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
155364695|NCT05032066|560768280|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
155089818|NCT03396445|559761866|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089819|NCT03396445|559761867|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155364696|NCT05032066|560768281|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
155364697|NCT05032066|560768279|FG000|Part 2: Extension Phase|Physician Decision|1|||
155364698|NCT05032066|560768280|FG001|Part 2: Extension Phase|Physician Decision|2|||
155364699|NCT05032066|560768281|FG002|Part 2: Extension Phase|Physician Decision|0|||
155364700|NCT05032066|560768279|FG000|Part 2: Extension Phase|Death|2|||
155364701|NCT05032066|560768280|FG001|Part 2: Extension Phase|Death|4|||
155364702|NCT05032066|560768281|FG002|Part 2: Extension Phase|Death|5|||
155364703|NCT04297618|560768282|FG000|Overall Study|Adverse Event|1|||
155364704|NCT04297618|560768282|FG000|Overall Study|Withdrawal by Subject|1|||
155089820|NCT03396445|559761868|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
155089821|NCT03396445|559761843|FG000|Treatment Period|Withdrawal by Subject|0|||
155089822|NCT03396445|559761844|FG001|Treatment Period|Withdrawal by Subject|0|||
155089823|NCT03396445|559761845|FG002|Treatment Period|Withdrawal by Subject|0|||
155364705|NCT02600897|560768283|FG000|Overall Study|Death|1|||
155364706|NCT02600897|560768284|FG001|Overall Study|Death|2|||
155364707|NCT02600897|560768285|FG002|Overall Study|Death|1|||
155364708|NCT02600897|560768286|FG003|Overall Study|Death|2|||
155364709|NCT02600897|560768287|FG004|Overall Study|Death|3|||
155364710|NCT02600897|560768288|FG005|Overall Study|Death|2|||
155364711|NCT02600897|560768289|FG006|Overall Study|Death|10|||
155364712|NCT02600897|560768290|FG007|Overall Study|Death|7|||
155364713|NCT02600897|560768291|FG008|Overall Study|Death|20|||
155364714|NCT02600897|560768283|FG000|Overall Study|Lost to Follow-up|1|||
155364715|NCT02600897|560768284|FG001|Overall Study|Lost to Follow-up|0|||
155364716|NCT02600897|560768285|FG002|Overall Study|Lost to Follow-up|0|||
155364717|NCT02600897|560768286|FG003|Overall Study|Lost to Follow-up|0|||
155364718|NCT02600897|560768287|FG004|Overall Study|Lost to Follow-up|0|||
155364719|NCT02600897|560768288|FG005|Overall Study|Lost to Follow-up|0|||
155364720|NCT02600897|560768289|FG006|Overall Study|Lost to Follow-up|0|||
155364721|NCT02600897|560768290|FG007|Overall Study|Lost to Follow-up|1|||
155364722|NCT02600897|560768291|FG008|Overall Study|Lost to Follow-up|0|||
155364723|NCT02600897|560768283|FG000|Overall Study|Withdrawal by Subject|0|||
155089824|NCT03396445|559761846|FG003|Treatment Period|Withdrawal by Subject|0|||
155089825|NCT03396445|559761847|FG004|Treatment Period|Withdrawal by Subject|0|||
155089826|NCT03396445|559761848|FG005|Treatment Period|Withdrawal by Subject|0|||
155089827|NCT03396445|559761849|FG006|Treatment Period|Withdrawal by Subject|0|||
155089828|NCT03396445|559761850|FG007|Treatment Period|Withdrawal by Subject|0|||
155089829|NCT03396445|559761851|FG008|Treatment Period|Withdrawal by Subject|0|||
155089830|NCT03396445|559761852|FG009|Treatment Period|Withdrawal by Subject|0|||
155089831|NCT03396445|559761853|FG010|Treatment Period|Withdrawal by Subject|0|||
155089832|NCT03396445|559761854|FG011|Treatment Period|Withdrawal by Subject|0|||
155089833|NCT03396445|559761855|FG012|Treatment Period|Withdrawal by Subject|0|||
155089834|NCT03396445|559761856|FG013|Treatment Period|Withdrawal by Subject|0|||
155089835|NCT03396445|559761857|FG014|Treatment Period|Withdrawal by Subject|1|||
155089836|NCT03396445|559761858|FG015|Treatment Period|Withdrawal by Subject|0|||
155089837|NCT03396445|559761859|FG016|Treatment Period|Withdrawal by Subject|1|||
155089838|NCT03396445|559761860|FG017|Treatment Period|Withdrawal by Subject|0|||
155089839|NCT03396445|559761861|FG018|Treatment Period|Withdrawal by Subject|0|||
155089840|NCT03396445|559761862|FG019|Treatment Period|Withdrawal by Subject|0|||
155089841|NCT03396445|559761863|FG020|Treatment Period|Withdrawal by Subject|0|||
155166741|NCT01737502|560046341|FG001|Phase II|Adverse Event|3|||
155364724|NCT02600897|560768284|FG001|Overall Study|Withdrawal by Subject|0|||
155364725|NCT02600897|560768285|FG002|Overall Study|Withdrawal by Subject|0|||
155364726|NCT02600897|560768286|FG003|Overall Study|Withdrawal by Subject|0|||
155364727|NCT02600897|560768287|FG004|Overall Study|Withdrawal by Subject|0|||
155364728|NCT02600897|560768288|FG005|Overall Study|Withdrawal by Subject|0|||
155364729|NCT02600897|560768289|FG006|Overall Study|Withdrawal by Subject|0|||
155364730|NCT02600897|560768290|FG007|Overall Study|Withdrawal by Subject|4|||
155364731|NCT02600897|560768291|FG008|Overall Study|Withdrawal by Subject|2|||
155364732|NCT02600897|560768283|FG000|Overall Study|Reason Not Specified|0|||
155089842|NCT03396445|559761864|FG021|Treatment Period|Withdrawal by Subject|0|||
155089843|NCT03396445|559761865|FG022|Treatment Period|Withdrawal by Subject|0|||
155089844|NCT03396445|559761866|FG023|Treatment Period|Withdrawal by Subject|0|||
155089845|NCT03396445|559761867|FG024|Treatment Period|Withdrawal by Subject|0|||
155089846|NCT03396445|559761868|FG025|Treatment Period|Withdrawal by Subject|0|||
155089847|NCT03396445|559761843|FG000|Switch-over Period|Death|0|||
155089848|NCT03396445|559761844|FG001|Switch-over Period|Death|0|||
155089849|NCT03396445|559761845|FG002|Switch-over Period|Death|0|||
155089850|NCT03396445|559761846|FG003|Switch-over Period|Death|0|||
155089851|NCT03396445|559761847|FG004|Switch-over Period|Death|0|||
155089852|NCT03396445|559761848|FG005|Switch-over Period|Death|0|||
155089853|NCT03396445|559761849|FG006|Switch-over Period|Death|0|||
155089854|NCT03396445|559761850|FG007|Switch-over Period|Death|0|||
155089855|NCT03396445|559761851|FG008|Switch-over Period|Death|0|||
155089856|NCT03396445|559761852|FG009|Switch-over Period|Death|0|||
155089857|NCT03396445|559761853|FG010|Switch-over Period|Death|0|||
155089858|NCT03396445|559761854|FG011|Switch-over Period|Death|0|||
155089859|NCT03396445|559761855|FG012|Switch-over Period|Death|0|||
155089860|NCT03396445|559761856|FG013|Switch-over Period|Death|0|||
155089861|NCT03396445|559761857|FG014|Switch-over Period|Death|0|||
155089862|NCT03396445|559761858|FG015|Switch-over Period|Death|0|||
155089863|NCT03396445|559761859|FG016|Switch-over Period|Death|0|||
155089864|NCT03396445|559761860|FG017|Switch-over Period|Death|0|||
155089865|NCT03396445|559761861|FG018|Switch-over Period|Death|1|||
155089866|NCT03396445|559761862|FG019|Switch-over Period|Death|2|||
155089867|NCT03396445|559761863|FG020|Switch-over Period|Death|2|||
155089868|NCT03396445|559761864|FG021|Switch-over Period|Death|1|||
155089869|NCT03396445|559761865|FG022|Switch-over Period|Death|2|||
155089870|NCT03396445|559761866|FG023|Switch-over Period|Death|0|||
155089871|NCT03396445|559761867|FG024|Switch-over Period|Death|1|||
155089872|NCT03396445|559761868|FG025|Switch-over Period|Death|6|||
155089873|NCT03396445|559761843|FG000|Switch-over Period|Lost to Follow-up|0|||
155089874|NCT03396445|559761844|FG001|Switch-over Period|Lost to Follow-up|0|||
155089875|NCT03396445|559761845|FG002|Switch-over Period|Lost to Follow-up|0|||
155089876|NCT03396445|559761846|FG003|Switch-over Period|Lost to Follow-up|0|||
155089877|NCT03396445|559761847|FG004|Switch-over Period|Lost to Follow-up|0|||
155089878|NCT03396445|559761848|FG005|Switch-over Period|Lost to Follow-up|0|||
155364733|NCT02600897|560768284|FG001|Overall Study|Reason Not Specified|0|||
155364734|NCT02600897|560768285|FG002|Overall Study|Reason Not Specified|0|||
155364735|NCT02600897|560768286|FG003|Overall Study|Reason Not Specified|0|||
155364736|NCT02600897|560768287|FG004|Overall Study|Reason Not Specified|0|||
155364737|NCT02600897|560768288|FG005|Overall Study|Reason Not Specified|0|||
155364738|NCT02600897|560768289|FG006|Overall Study|Reason Not Specified|0|||
155364739|NCT02600897|560768290|FG007|Overall Study|Reason Not Specified|0|||
155364740|NCT02600897|560768291|FG008|Overall Study|Reason Not Specified|1|||
155364741|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Adverse Event|10|||
155364742|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Adverse Event|9|||
155364743|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Adverse Event|7|||
155364744|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
155364745|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
155364746|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
155364747|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
155364748|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
155364749|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
155364750|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Physician Decision|7|||
155364751|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Physician Decision|3|||
155364752|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Physician Decision|2|||
155364753|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Pregnancy|2|||
155089879|NCT03396445|559761849|FG006|Switch-over Period|Lost to Follow-up|0|||
155089880|NCT03396445|559761850|FG007|Switch-over Period|Lost to Follow-up|0|||
155089881|NCT03396445|559761851|FG008|Switch-over Period|Lost to Follow-up|0|||
155089882|NCT03396445|559761852|FG009|Switch-over Period|Lost to Follow-up|0|||
155364754|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Pregnancy|1|||
155089883|NCT03396445|559761853|FG010|Switch-over Period|Lost to Follow-up|0|||
155089884|NCT03396445|559761854|FG011|Switch-over Period|Lost to Follow-up|0|||
155089885|NCT03396445|559761855|FG012|Switch-over Period|Lost to Follow-up|0|||
155089886|NCT03396445|559761856|FG013|Switch-over Period|Lost to Follow-up|0|||
155089887|NCT03396445|559761857|FG014|Switch-over Period|Lost to Follow-up|0|||
155166742|NCT01737502|560046340|FG000|Phase II|Disease progression|0|||
155364755|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Pregnancy|3|||
155364756|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
155364757|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
155364758|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
155364759|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
155364760|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
155364761|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
155364762|NCT02614183|560768294|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
155364763|NCT02614183|560768295|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
155364764|NCT02614183|560768296|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
155364765|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
155089888|NCT03396445|559761858|FG015|Switch-over Period|Lost to Follow-up|0|||
155089889|NCT03396445|559761859|FG016|Switch-over Period|Lost to Follow-up|0|||
155089890|NCT03396445|559761860|FG017|Switch-over Period|Lost to Follow-up|0|||
155089891|NCT03396445|559761861|FG018|Switch-over Period|Lost to Follow-up|0|||
155089892|NCT03396445|559761862|FG019|Switch-over Period|Lost to Follow-up|0|||
155089893|NCT03396445|559761863|FG020|Switch-over Period|Lost to Follow-up|0|||
155089894|NCT03396445|559761864|FG021|Switch-over Period|Lost to Follow-up|0|||
155089895|NCT03396445|559761865|FG022|Switch-over Period|Lost to Follow-up|0|||
155089896|NCT03396445|559761866|FG023|Switch-over Period|Lost to Follow-up|1|||
155089897|NCT03396445|559761867|FG024|Switch-over Period|Lost to Follow-up|0|||
155364766|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
155364767|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
155364768|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
155364769|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
155364770|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
155364771|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
155364772|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
155364773|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
155364774|NCT02614183|560768294|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
155089898|NCT03396445|559761868|FG025|Switch-over Period|Lost to Follow-up|0|||
155089899|NCT03552029|559761872|FG000|Overall Study|Death|3|||
155089900|NCT03552029|559761873|FG001|Overall Study|Death|0|||
155089901|NCT03552029|559761872|FG000|Overall Study|Adverse Event|1|||
155089902|NCT03552029|559761873|FG001|Overall Study|Adverse Event|0|||
155364775|NCT02614183|560768295|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
155364776|NCT02614183|560768296|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
155089903|NCT03552029|559761872|FG000|Overall Study|Lack of Efficacy|0|||
155089904|NCT03552029|559761873|FG001|Overall Study|Lack of Efficacy|2|||
155089905|NCT03552029|559761872|FG000|Overall Study|Physician Decision|0|||
155089906|NCT03552029|559761873|FG001|Overall Study|Physician Decision|1|||
155089907|NCT03552029|559761872|FG000|Overall Study|Study terminated by Sponsor|0|||
155089908|NCT03552029|559761873|FG001|Overall Study|Study terminated by Sponsor|1|||
155089909|NCT03552029|559761872|FG000|Overall Study|Other|0|||
155089910|NCT03552029|559761873|FG001|Overall Study|Other|2|||
155089911|NCT00876447|559761881|FG000|Overall Study|Other miscellaneous reasons|3|||
155089912|NCT00876447|559761882|FG001|Overall Study|Other miscellaneous reasons|8|||
155089913|NCT00876447|559761881|FG000|Overall Study|Site closure|19|||
155089914|NCT00876447|559761882|FG001|Overall Study|Site closure|14|||
155089915|NCT00876447|559761881|FG000|Overall Study|Protocol Violation|9|||
155089916|NCT00876447|559761882|FG001|Overall Study|Protocol Violation|3|||
155089917|NCT00876447|559761881|FG000|Overall Study|Personal reasons|30|||
155364777|NCT05992922|560768300|FG000|Overall Study|Adverse Event|6|||
155364778|NCT05992922|560768301|FG001|Overall Study|Adverse Event|0|||
155364779|NCT05992922|560768300|FG000|Overall Study|Sponsor Termination of Study|14|||
155364780|NCT05992922|560768301|FG001|Overall Study|Sponsor Termination of Study|20|||
155364781|NCT04680533|560768302|FG000|Overall Study|Screen failure|1|||
155364782|NCT04991753|560770835|FG000|Overall Study|Withdrawal by Subject|0|||
155364783|NCT04991753|560770836|FG001|Overall Study|Withdrawal by Subject|1|||
155364784|NCT02797522|560770837|FG000|Overall Study|Study Terminated by Sponsor|0|||
155364785|NCT02797522|560770838|FG001|Overall Study|Study Terminated by Sponsor|0|||
155089918|NCT00876447|559761882|FG001|Overall Study|Personal reasons|28|||
155089919|NCT00876447|559761881|FG000|Overall Study|Lost to Follow-up|6|||
155089920|NCT00876447|559761882|FG001|Overall Study|Lost to Follow-up|15|||
155089921|NCT00876447|559761881|FG000|Overall Study|Pregnancy|4|||
155089922|NCT00876447|559761882|FG001|Overall Study|Pregnancy|2|||
155089923|NCT00876447|559761881|FG000|Overall Study|Lack of Efficacy|5|||
155089924|NCT00876447|559761882|FG001|Overall Study|Lack of Efficacy|3|||
155089925|NCT00876447|559761881|FG000|Overall Study|Adverse Event|4|||
155089926|NCT00876447|559761882|FG001|Overall Study|Adverse Event|8|||
155089927|NCT00567502|559761883|FG000|Overall Study|Lost to Follow-up|91|||
155089928|NCT00567502|559761884|FG001|Overall Study|Lost to Follow-up|14|||
155364786|NCT02797522|560770839|FG002|Overall Study|Study Terminated by Sponsor|0|||
155364787|NCT02797522|560770840|FG003|Overall Study|Study Terminated by Sponsor|0|||
155364788|NCT02797522|560770841|FG004|Overall Study|Study Terminated by Sponsor|0|||
155364789|NCT02797522|560770842|FG005|Overall Study|Study Terminated by Sponsor|0|||
155364790|NCT02797522|560770843|FG006|Overall Study|Study Terminated by Sponsor|0|||
155364791|NCT02797522|560770844|FG007|Overall Study|Study Terminated by Sponsor|4|||
155364792|NCT02797522|560770845|FG008|Overall Study|Study Terminated by Sponsor|2|||
155364793|NCT02797522|560770846|FG009|Overall Study|Study Terminated by Sponsor|4|||
155364794|NCT02797522|560770847|FG010|Overall Study|Study Terminated by Sponsor|1|||
155364795|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
155364796|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
155364797|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
155364798|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
155364799|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
155089929|NCT00567502|559761885|FG002|Overall Study|Lost to Follow-up|351|||
155089930|NCT00567502|559761886|FG003|Overall Study|Lost to Follow-up|2|||
155089931|NCT00567502|559761883|FG000|Overall Study|Death|65|||
155089932|NCT00567502|559761884|FG001|Overall Study|Death|16|||
155364800|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
155364801|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
155089933|NCT00567502|559761885|FG002|Overall Study|Death|360|||
155089934|NCT00567502|559761886|FG003|Overall Study|Death|5|||
155089935|NCT00567502|559761883|FG000|Overall Study|Other|64|||
155089936|NCT00567502|559761884|FG001|Overall Study|Other|2|||
155089937|NCT00567502|559761885|FG002|Overall Study|Other|134|||
155089938|NCT00567502|559761886|FG003|Overall Study|Other|6|||
155089939|NCT00567502|559761883|FG000|Overall Study|Participant request|12|||
155089940|NCT00567502|559761884|FG001|Overall Study|Participant request|1|||
155089941|NCT00567502|559761885|FG002|Overall Study|Participant request|33|||
155089942|NCT00567502|559761886|FG003|Overall Study|Participant request|1|||
155089943|NCT00567502|559761883|FG000|Overall Study|Sponsor request|9|||
155089944|NCT00567502|559761884|FG001|Overall Study|Sponsor request|0|||
155089945|NCT00567502|559761885|FG002|Overall Study|Sponsor request|30|||
155089946|NCT00567502|559761886|FG003|Overall Study|Sponsor request|1|||
155089947|NCT00567502|559761883|FG000|Overall Study|Never Initiated Treatment|0|||
155089948|NCT00567502|559761884|FG001|Overall Study|Never Initiated Treatment|0|||
155089949|NCT00567502|559761885|FG002|Overall Study|Never Initiated Treatment|0|||
155089950|NCT00567502|559761886|FG003|Overall Study|Never Initiated Treatment|72|||
155089951|NCT02297516|559761887|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
155089952|NCT02297516|559761888|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
155089953|NCT02297516|559761887|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
155089954|NCT02297516|559761888|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
155089955|NCT02297516|559761887|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
155089956|NCT02297516|559761888|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
155089957|NCT00710593|559761889|FG000|Overall Study|Incarceration|1|||
155089958|NCT00710593|559761890|FG001|Overall Study|Incarceration|0|||
155089959|NCT00710593|559761889|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
155089960|NCT00710593|559761890|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
155089961|NCT00710593|559761889|FG000|Overall Study|Lost to Follow-up|3|||
155089962|NCT00710593|559761890|FG001|Overall Study|Lost to Follow-up|1|||
155089963|NCT00710593|559761889|FG000|Overall Study|Moved out of area|1|||
155089964|NCT00710593|559761890|FG001|Overall Study|Moved out of area|0|||
155089965|NCT00710593|559761889|FG000|Overall Study|Failure to adhere or complete study eval|1|||
155089966|NCT00710593|559761890|FG001|Overall Study|Failure to adhere or complete study eval|1|||
155089967|NCT00710593|559761889|FG000|Overall Study|Protocol Violation|1|||
155089968|NCT00710593|559761890|FG001|Overall Study|Protocol Violation|1|||
155089969|NCT00710593|559761889|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
155089970|NCT00710593|559761890|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
155089971|NCT04490278|559761891|FG000|Overall Study|Lost to Follow-up|6|||
155089972|NCT00366457|559761895|FG000|Overall Study|never began study therapy|2|||
155089973|NCT02538614|559761896|FG000|Overall Study|Progressive Disease|2|||
155089974|NCT00183248|559761905|FG000|Overall Study|Lost to Follow-up|0|||
155089975|NCT00183248|559761906|FG001|Overall Study|Lost to Follow-up|1|||
155089976|NCT00183248|559761905|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
155089977|NCT00183248|559761906|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
155089978|NCT04734210|559761907|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
155089979|NCT04734210|559761908|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
155089980|NCT04734210|559761909|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
155089981|NCT04734210|559761907|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
155089982|NCT04734210|559761908|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
155089983|NCT04734210|559761909|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
155089984|NCT04734210|559761907|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
155089985|NCT04734210|559761908|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
155089986|NCT04734210|559761909|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
155089987|NCT04734210|559761907|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
155089988|NCT04734210|559761908|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
155089989|NCT04734210|559761909|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
155089990|NCT01358734|559761910|FG000|Overall Study|Adverse Event|4|||
155089991|NCT01358734|559761911|FG001|Overall Study|Adverse Event|7|||
155089992|NCT01358734|559761912|FG002|Overall Study|Adverse Event|3|||
155089993|NCT01358734|559761910|FG000|Overall Study|Lack of Efficacy|0|||
155089994|NCT01358734|559761911|FG001|Overall Study|Lack of Efficacy|1|||
155089995|NCT01358734|559761912|FG002|Overall Study|Lack of Efficacy|3|||
155089996|NCT01358734|559761910|FG000|Overall Study|Withdrawal by Subject|1|||
155089997|NCT01358734|559761911|FG001|Overall Study|Withdrawal by Subject|6|||
155089998|NCT01358734|559761912|FG002|Overall Study|Withdrawal by Subject|3|||
155089999|NCT01358734|559761910|FG000|Overall Study|Death|3|||
155090000|NCT01358734|559761911|FG001|Overall Study|Death|7|||
155090001|NCT01358734|559761912|FG002|Overall Study|Death|2|||
155166743|NCT01737502|560046341|FG001|Phase II|Disease progression|18|||
155166744|NCT01737502|560046340|FG000|Phase II|Death|0|||
155090002|NCT01358734|559761910|FG000|Overall Study|Progressive Disease|5|||
155090003|NCT01358734|559761911|FG001|Overall Study|Progressive Disease|13|||
155090004|NCT01358734|559761912|FG002|Overall Study|Progressive Disease|16|||
155090005|NCT01358734|559761910|FG000|Overall Study|Non-compliance with study drug|0|||
155090006|NCT01358734|559761911|FG001|Overall Study|Non-compliance with study drug|0|||
155090007|NCT01358734|559761912|FG002|Overall Study|Non-compliance with study drug|1|||
155090008|NCT01358734|559761910|FG000|Overall Study|Other|2|||
155090009|NCT01358734|559761911|FG001|Overall Study|Other|5|||
155090010|NCT01358734|559761912|FG002|Overall Study|Other|4|||
155090011|NCT01358734|559761910|FG000|Overall Study|Protocol Violation|0|||
155090012|NCT01358734|559761911|FG001|Overall Study|Protocol Violation|0|||
155090013|NCT01358734|559761912|FG002|Overall Study|Protocol Violation|2|||
155090014|NCT03847519|559761917|FG000|Overall Study|Death|5|||
155090015|NCT03847519|559761918|FG001|Overall Study|Death|8|||
155364802|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
155364803|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
155364804|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
155364805|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
155364806|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
155364807|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
155364808|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
155364809|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
155364810|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
155364811|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
155364812|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
155364813|NCT00132678|560770848|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
155364814|NCT00132678|560770849|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
155364815|NCT00132678|560770850|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
155364816|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Death|2|||
155364817|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Death|0|||
155364818|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Death|0|||
155364819|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
155364820|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
155364821|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
155364822|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
155364823|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
155364824|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
155364825|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
155364826|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
155364827|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
155090016|NCT03847519|559761919|FG002|Overall Study|Death|1|||
155090017|NCT03847519|559761917|FG000|Overall Study|Lost to Follow-up|1|||
155090018|NCT03847519|559761918|FG001|Overall Study|Lost to Follow-up|2|||
155090019|NCT03847519|559761919|FG002|Overall Study|Lost to Follow-up|0|||
155090020|NCT03847519|559761917|FG000|Overall Study|Study Terminated by Sponsor|0|||
155090021|NCT03847519|559761918|FG001|Overall Study|Study Terminated by Sponsor|3|||
155090022|NCT03847519|559761919|FG002|Overall Study|Study Terminated by Sponsor|2|||
155090023|NCT02095106|559761922|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155090024|NCT02095106|559761923|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155090025|NCT00023595|559761931|FG000|5 Year Follow up|Lost to Follow-up|2|||
155090026|NCT00023595|559761932|FG001|5 Year Follow up|Lost to Follow-up|2|||
155090027|NCT00023595|559761933|FG002|5 Year Follow up|Lost to Follow-up|1|||
155090028|NCT00023595|559761934|FG003|5 Year Follow up|Lost to Follow-up|7|||
155090029|NCT00023595|559761935|FG004|5 Year Follow up|Lost to Follow-up|3|||
155090030|NCT00023595|559761931|FG000|10 Year Follow up|Lost to Follow-up|12|||
155090031|NCT00023595|559761932|FG001|10 Year Follow up|Lost to Follow-up|10|||
155090032|NCT00023595|559761933|FG002|10 Year Follow up|Lost to Follow-up|3|||
155090033|NCT00023595|559761934|FG003|10 Year Follow up|Lost to Follow-up|0|||
155090034|NCT00023595|559761935|FG004|10 Year Follow up|Lost to Follow-up|0|||
155090035|NCT02284893|559761936|FG000|26 Week (Short Term)|Adverse Event|1|||
155090036|NCT02284893|559761937|FG001|26 Week (Short Term)|Adverse Event|9|||
155090037|NCT02284893|559761936|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
155090038|NCT02284893|559761937|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
155090039|NCT02284893|559761936|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
155090040|NCT02284893|559761937|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
155090041|NCT02284893|559761936|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
155090042|NCT02284893|559761937|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
155090043|NCT02284893|559761936|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
155090044|NCT02284893|559761937|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
155090045|NCT02284893|559761936|FG000|26 Week (Short Term)|Other|1|||
155090046|NCT02284893|559761937|FG001|26 Week (Short Term)|Other|1|||
155090047|NCT02284893|559761936|FG000|52 Week (Long Term)|Adverse Event|3|||
155090048|NCT02284893|559761937|FG001|52 Week (Long Term)|Adverse Event|1|||
155090049|NCT02284893|559761936|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
155090050|NCT02284893|559761937|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
155090051|NCT02284893|559761936|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
155090052|NCT02284893|559761937|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
155090053|NCT02284893|559761936|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
155090054|NCT02284893|559761937|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
155090055|NCT02284893|559761936|FG000|52 Week (Long Term)|Non-Compliance|2|||
155090056|NCT02284893|559761937|FG001|52 Week (Long Term)|Non-Compliance|3|||
155090057|NCT03078868|559761940|FG000|Overall Study|Physician Decision|3|||
155364828|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
155364829|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
155364830|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
155364831|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
155364832|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
155364833|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
155364834|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
155364835|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
155364836|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
155364837|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
155364838|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
155364839|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
155364840|NCT00132678|560770848|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
155364841|NCT00132678|560770849|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
155364842|NCT00132678|560770850|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
155364843|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
155364844|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
155364845|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
155364846|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
155364847|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
155364848|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
155364849|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
155364850|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
155364851|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
155364852|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
155364853|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
155364854|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
155364855|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
155364856|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
155364857|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
155364858|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
155364859|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
155364860|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
155364861|NCT00132678|560770848|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
155364862|NCT00132678|560770849|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
155364863|NCT00132678|560770850|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
155364864|NCT01901419|560770851|FG000|Overall Study|Protocol Violation|2|||
155364865|NCT01901419|560770852|FG001|Overall Study|Protocol Violation|6|||
155364866|NCT01901419|560770851|FG000|Overall Study|unavailable researchers|6|||
155364867|NCT01901419|560770852|FG001|Overall Study|unavailable researchers|3|||
155364868|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
155364869|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
155364870|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
155364871|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
155364872|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
155364873|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
155364874|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
155364875|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
155090058|NCT01983111|559761941|FG000|Overall Study|Withdrawal by Subject|8|||
155090059|NCT01983111|559761942|FG001|Overall Study|Withdrawal by Subject|6|||
155090060|NCT01983111|559761941|FG000|Overall Study|Adverse Event|4|||
155090061|NCT01983111|559761942|FG001|Overall Study|Adverse Event|0|||
155090062|NCT01983111|559761941|FG000|Overall Study|Protocol Violation|0|||
155090063|NCT01983111|559761942|FG001|Overall Study|Protocol Violation|1|||
155090064|NCT03038620|559761943|FG000|Overall Study|Lost to Follow-up|18|||
155090065|NCT03038620|559761944|FG001|Overall Study|Lost to Follow-up|23|||
155090066|NCT03038620|559761943|FG000|Overall Study|Withdrawal by Subject|0|||
155090067|NCT03038620|559761944|FG001|Overall Study|Withdrawal by Subject|15|||
155364876|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
155364877|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
155090068|NCT03038620|559761943|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
155090069|NCT03038620|559761944|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
155090070|NCT00105066|559761945|FG000|Overall Study|Adverse Event|2|||
155090071|NCT00105066|559761946|FG001|Overall Study|Adverse Event|5|||
155090072|NCT03261505|559761953|FG000|Overall Study|Withdrawal by Subject|2|||
155090073|NCT03261505|559761954|FG001|Overall Study|Withdrawal by Subject|3|||
155090074|NCT03261505|559761955|FG002|Overall Study|Withdrawal by Subject|4|||
155090075|NCT03261505|559761956|FG003|Overall Study|Withdrawal by Subject|3|||
155090076|NCT03261505|559761953|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
155090077|NCT03261505|559761954|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
155090078|NCT03261505|559761955|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
155090079|NCT03261505|559761956|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
155090080|NCT03261505|559761953|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
155090081|NCT03261505|559761954|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
155090082|NCT03261505|559761955|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
155090083|NCT03261505|559761956|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
155090084|NCT03261505|559761953|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
155090085|NCT03261505|559761954|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
155090086|NCT03261505|559761955|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
155364878|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
155364879|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
155364880|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
155090087|NCT03261505|559761956|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
155090088|NCT02231580|559761962|FG000|Overall Study|Adverse Event|5|||
155090089|NCT02231580|559761963|FG001|Overall Study|Adverse Event|0|||
155364881|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
154965444|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155364882|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364883|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364884|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364885|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364886|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364887|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
155364888|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
155364889|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
155364890|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
155364891|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
155364892|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
155364893|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
155364894|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
155364895|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
155364896|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364897|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364898|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364899|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364900|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
155364901|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364902|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
155364903|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364904|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
155364905|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364906|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364907|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155090090|NCT04079738|559761964|FG000|Study Treatment|Death|1|||
155090091|NCT04079738|559761965|FG001|Study Treatment|Death|0|||
155090092|NCT04079738|559761966|FG002|Study Treatment|Death|0|||
154965445|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155090093|NCT04079738|559761967|FG003|Study Treatment|Death|0|||
155090094|NCT04079738|559761964|FG000|Study Treatment|Adverse Event|2|||
155090095|NCT04079738|559761965|FG001|Study Treatment|Adverse Event|0|||
154965446|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965447|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155090096|NCT04079738|559761966|FG002|Study Treatment|Adverse Event|0|||
155090097|NCT04079738|559761967|FG003|Study Treatment|Adverse Event|0|||
155090098|NCT04079738|559761964|FG000|Study Treatment|withdrawal before treatment|1|||
155090099|NCT04079738|559761965|FG001|Study Treatment|withdrawal before treatment|0|||
155090100|NCT04079738|559761966|FG002|Study Treatment|withdrawal before treatment|0|||
155090101|NCT04079738|559761967|FG003|Study Treatment|withdrawal before treatment|0|||
155090102|NCT04079738|559761964|FG000|Study Treatment|symptomatic deterioration|2|||
155090103|NCT04079738|559761965|FG001|Study Treatment|symptomatic deterioration|0|||
155090104|NCT04079738|559761966|FG002|Study Treatment|symptomatic deterioration|0|||
155090105|NCT04079738|559761967|FG003|Study Treatment|symptomatic deterioration|0|||
155090106|NCT04079738|559761964|FG000|Study Treatment|Disease Progression|1|||
155090107|NCT04079738|559761965|FG001|Study Treatment|Disease Progression|0|||
155090108|NCT04079738|559761966|FG002|Study Treatment|Disease Progression|0|||
155090109|NCT04079738|559761967|FG003|Study Treatment|Disease Progression|0|||
155090110|NCT04079738|559761964|FG000|Study Treatment|withdrawal after treatment|1|||
155090111|NCT04079738|559761965|FG001|Study Treatment|withdrawal after treatment|0|||
155090112|NCT04079738|559761966|FG002|Study Treatment|withdrawal after treatment|0|||
155090113|NCT04079738|559761967|FG003|Study Treatment|withdrawal after treatment|0|||
155090114|NCT04079738|559761964|FG000|Follow up|Withdrawal by Subject|3|||
155090115|NCT04079738|559761965|FG001|Follow up|Withdrawal by Subject|0|||
155090116|NCT04079738|559761966|FG002|Follow up|Withdrawal by Subject|0|||
155090117|NCT04079738|559761967|FG003|Follow up|Withdrawal by Subject|0|||
155090118|NCT04079738|559761964|FG000|Follow up|Death|5|||
155090119|NCT04079738|559761965|FG001|Follow up|Death|0|||
155090120|NCT04079738|559761966|FG002|Follow up|Death|0|||
155090121|NCT04079738|559761967|FG003|Follow up|Death|0|||
155090122|NCT02711202|559761968|FG000|Overall Study|Adverse Event|3|||
154965448|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155090123|NCT02711202|559761969|FG001|Overall Study|Adverse Event|0|||
155090124|NCT02711202|559761968|FG000|Overall Study|graft loss|1|||
155090125|NCT02711202|559761969|FG001|Overall Study|graft loss|0|||
155090126|NCT00432965|559761970|FG000|Overall Study|Lost to Follow-up|22|||
155090127|NCT00432965|559761971|FG001|Overall Study|Lost to Follow-up|19|||
155090128|NCT00432965|559761970|FG000|Overall Study|Withdrawal by Subject|13|||
155090129|NCT00432965|559761971|FG001|Overall Study|Withdrawal by Subject|13|||
155090130|NCT00432965|559761970|FG000|Overall Study|Physician Decision|14|||
155090131|NCT00432965|559761971|FG001|Overall Study|Physician Decision|13|||
155090132|NCT00432965|559761970|FG000|Overall Study|Lack of Efficacy|8|||
155090133|NCT00432965|559761971|FG001|Overall Study|Lack of Efficacy|13|||
155090134|NCT00432965|559761970|FG000|Overall Study|Non-compliance|7|||
155090135|NCT00432965|559761971|FG001|Overall Study|Non-compliance|0|||
155090136|NCT00432965|559761970|FG000|Overall Study|Adverse Event|22|||
155364908|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364909|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
155364910|NCT01888874|560770853|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155090137|NCT00432965|559761971|FG001|Overall Study|Adverse Event|19|||
155090138|NCT00432965|559761970|FG000|Overall Study|Death|3|||
155090139|NCT00432965|559761971|FG001|Overall Study|Death|4|||
155090140|NCT00432965|559761970|FG000|Overall Study|Exclusionary Methods|1|||
155090141|NCT00432965|559761971|FG001|Overall Study|Exclusionary Methods|2|||
155090142|NCT00432965|559761970|FG000|Overall Study|Incomplete Data|4|||
155364911|NCT01888874|560770854|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
155364912|NCT01888874|560770855|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364913|NCT01888874|560770856|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364914|NCT01888874|560770857|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364915|NCT01888874|560770858|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
155364916|NCT01888874|560770859|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
155364917|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
155364918|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
155364919|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
155364920|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155364921|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
155364922|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155364923|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
155364924|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364925|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364926|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364927|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364928|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
155364929|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364930|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
155364931|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364932|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364933|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
155364934|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364935|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364936|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
155364937|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
155364938|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364939|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364940|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
155364941|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364942|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364943|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155090143|NCT00432965|559761971|FG001|Overall Study|Incomplete Data|3|||
155090144|NCT01889251|559761972|FG000|Overall Study|Adverse Event|1|||
155090145|NCT01889251|559761973|FG001|Overall Study|Adverse Event|0|||
155090146|NCT01903863|559761974|FG000|Overall Study|Physician Decision|2|||
155090147|NCT01903863|559761975|FG001|Overall Study|Physician Decision|0|||
155090148|NCT03448393|559761978|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090149|NCT03448393|559761979|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090150|NCT03448393|559761980|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
155090151|NCT03448393|559761981|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090152|NCT03448393|559761982|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090153|NCT03448393|559761983|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090154|NCT03448393|559761984|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090155|NCT03448393|559761985|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
155090156|NCT03448393|559761986|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
155090157|NCT03448393|559761978|FG000|Dose Expansion|Not treated - screen failure|0|||
155090158|NCT03448393|559761979|FG001|Dose Expansion|Not treated - screen failure|0|||
155364944|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
155364945|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
155364946|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
155364947|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
155364948|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
155364949|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
155364950|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
155364951|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
155364952|NCT01888874|560770853|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364953|NCT01888874|560770854|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
155364954|NCT01888874|560770855|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364955|NCT01888874|560770856|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364956|NCT01888874|560770857|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155364957|NCT01888874|560770858|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
155364958|NCT01888874|560770859|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
155090159|NCT03448393|559761980|FG002|Dose Expansion|Not treated - screen failure|0|||
155166745|NCT01737502|560046341|FG001|Phase II|Death|1|||
155364959|NCT00475644|560770861|FG000|Overall Study|Protocol Violation|13|||
155364960|NCT01411241|560770864|FG000|Overall Study|Protocol Violation|0|||
155364961|NCT01411241|560770865|FG001|Overall Study|Protocol Violation|5|||
155364962|NCT01411241|560770864|FG000|Overall Study|Withdrawal by Subject|9|||
155364963|NCT01411241|560770865|FG001|Overall Study|Withdrawal by Subject|10|||
155364964|NCT01411241|560770864|FG000|Overall Study|Serious Adverse Event|0|||
155364965|NCT01411241|560770865|FG001|Overall Study|Serious Adverse Event|3|||
155364966|NCT01411241|560770864|FG000|Overall Study|Lost to Follow-up|2|||
155364967|NCT01411241|560770865|FG001|Overall Study|Lost to Follow-up|4|||
155364968|NCT02412735|560770871|FG000|Overall Study|Adverse Event|0|||
155364969|NCT02412735|560770872|FG001|Overall Study|Adverse Event|1|||
155090160|NCT03448393|559761981|FG003|Dose Expansion|Not treated - screen failure|0|||
155090161|NCT03448393|559761982|FG004|Dose Expansion|Not treated - screen failure|0|||
155090162|NCT03448393|559761983|FG005|Dose Expansion|Not treated - screen failure|0|||
155090163|NCT03448393|559761984|FG006|Dose Expansion|Not treated - screen failure|0|||
155090164|NCT03448393|559761985|FG007|Dose Expansion|Not treated - screen failure|0|||
155090165|NCT03448393|559761986|FG008|Dose Expansion|Not treated - screen failure|7|||
155090166|NCT00642759|559761987|FG000|Overall Study|Protocol Violation|1|||
155090167|NCT03612570|559761992|FG000|Overall Study|Lost to Follow-up|1|||
155090168|NCT05318287|559761993|FG000|Overall Study|Lost to Follow-up|8|||
155090169|NCT03537508|559761994|FG000|Overall Study|Adverse Event|2|||
155090170|NCT03537508|559761995|FG001|Overall Study|Adverse Event|1|||
155090171|NCT03537508|559761994|FG000|Overall Study|Protocol Violation|65|||
155090172|NCT03537508|559761995|FG001|Overall Study|Protocol Violation|48|||
155090173|NCT03537508|559761994|FG000|Overall Study|Lost to Follow-up|86|||
155090174|NCT03537508|559761995|FG001|Overall Study|Lost to Follow-up|60|||
155090175|NCT03537508|559761994|FG000|Overall Study|Withdrawal by parent/guardian|263|||
155090176|NCT03537508|559761995|FG001|Overall Study|Withdrawal by parent/guardian|149|||
155090177|NCT04887831|559763558|FG000|Overall Study|Death|26|||
155090178|NCT04887831|559763559|FG001|Overall Study|Death|26|||
155090179|NCT04887831|559763558|FG000|Overall Study|Lost to Follow-up|0|||
155090180|NCT04887831|559763559|FG001|Overall Study|Lost to Follow-up|1|||
155090181|NCT04887831|559763558|FG000|Overall Study|Withdrawal by Subject|2|||
155090182|NCT04887831|559763559|FG001|Overall Study|Withdrawal by Subject|1|||
155090183|NCT04887831|559763558|FG000|Overall Study|Study Terminated by Sponsor|18|||
155090184|NCT04887831|559763559|FG001|Overall Study|Study Terminated by Sponsor|17|||
155090185|NCT04887831|559763558|FG000|Overall Study|Other|1|||
155090186|NCT04887831|559763559|FG001|Overall Study|Other|0|||
155090187|NCT03122184|559763560|FG000|Overall Study|Lost to Follow-up|4|||
155090188|NCT03122184|559763561|FG001|Overall Study|Lost to Follow-up|6|||
155090189|NCT03122184|559763560|FG000|Overall Study|Withdrawal by Subject|3|||
155090190|NCT03122184|559763561|FG001|Overall Study|Withdrawal by Subject|0|||
155090191|NCT03122184|559763560|FG000|Overall Study|Terminated due to cognitive problem|1|||
155090192|NCT03122184|559763561|FG001|Overall Study|Terminated due to cognitive problem|0|||
155090193|NCT00633126|559763562|FG000|Overall Study|Did not receive full dose|1|||
155090194|NCT00806585|559763571|FG000|Overall Study|Study terminated by Sponsor|0|||
155090195|NCT00806585|559763572|FG001|Overall Study|Study terminated by Sponsor|0|||
155090196|NCT00806585|559763573|FG002|Overall Study|Study terminated by Sponsor|1|||
155090197|NCT00806585|559763574|FG003|Overall Study|Study terminated by Sponsor|2|||
155090198|NCT00806585|559763575|FG004|Overall Study|Study terminated by Sponsor|0|||
155090199|NCT00806585|559763571|FG000|Overall Study|Protocol Violation|3|||
155090200|NCT00806585|559763572|FG001|Overall Study|Protocol Violation|1|||
155090201|NCT00806585|559763573|FG002|Overall Study|Protocol Violation|2|||
155090202|NCT00806585|559763574|FG003|Overall Study|Protocol Violation|0|||
155090203|NCT00806585|559763575|FG004|Overall Study|Protocol Violation|0|||
155090204|NCT00806585|559763571|FG000|Overall Study|Physician Decision|0|||
155090205|NCT00806585|559763572|FG001|Overall Study|Physician Decision|2|||
155090206|NCT00806585|559763573|FG002|Overall Study|Physician Decision|3|||
155090207|NCT00806585|559763574|FG003|Overall Study|Physician Decision|0|||
155090208|NCT00806585|559763575|FG004|Overall Study|Physician Decision|1|||
155090209|NCT00806585|559763571|FG000|Overall Study|Lost to Follow-up|2|||
155090210|NCT00806585|559763572|FG001|Overall Study|Lost to Follow-up|1|||
155364970|NCT02412735|560770873|FG002|Overall Study|Adverse Event|2|||
155364971|NCT02412735|560770871|FG000|Overall Study|Withdrawal by Subject|23|||
155364972|NCT02412735|560770872|FG001|Overall Study|Withdrawal by Subject|27|||
155090211|NCT00806585|559763573|FG002|Overall Study|Lost to Follow-up|2|||
155090212|NCT00806585|559763574|FG003|Overall Study|Lost to Follow-up|2|||
155090213|NCT00806585|559763575|FG004|Overall Study|Lost to Follow-up|5|||
155090214|NCT00806585|559763571|FG000|Overall Study|Lack of Efficacy|1|||
155090215|NCT00806585|559763572|FG001|Overall Study|Lack of Efficacy|0|||
155090216|NCT00806585|559763573|FG002|Overall Study|Lack of Efficacy|0|||
155090217|NCT00806585|559763574|FG003|Overall Study|Lack of Efficacy|0|||
155090218|NCT00806585|559763575|FG004|Overall Study|Lack of Efficacy|0|||
155090219|NCT00806585|559763571|FG000|Overall Study|Adverse Event|1|||
155090220|NCT00806585|559763572|FG001|Overall Study|Adverse Event|5|||
155090221|NCT00806585|559763573|FG002|Overall Study|Adverse Event|3|||
155090222|NCT00806585|559763574|FG003|Overall Study|Adverse Event|4|||
155090223|NCT00806585|559763575|FG004|Overall Study|Adverse Event|2|||
155364973|NCT02412735|560770873|FG002|Overall Study|Withdrawal by Subject|22|||
155364974|NCT02412735|560770871|FG000|Overall Study|Investigator Decision|3|||
155364975|NCT02412735|560770872|FG001|Overall Study|Investigator Decision|3|||
155364976|NCT02412735|560770873|FG002|Overall Study|Investigator Decision|2|||
155364977|NCT02412735|560770871|FG000|Overall Study|Lost to Follow-up|17|||
155364978|NCT02412735|560770872|FG001|Overall Study|Lost to Follow-up|11|||
155364979|NCT02412735|560770873|FG002|Overall Study|Lost to Follow-up|18|||
155364980|NCT02412735|560770871|FG000|Overall Study|Reason not Specified|3|||
155364981|NCT02412735|560770872|FG001|Overall Study|Reason not Specified|2|||
155364982|NCT02412735|560770873|FG002|Overall Study|Reason not Specified|2|||
155364983|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
155364984|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
155364985|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
155364986|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
155364987|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Death|13|||
155364988|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Death|12|||
155364989|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Progression|257|||
155364990|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Progression|218|||
155364991|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
155364992|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
155364993|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
155364994|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
155364995|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
155364996|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
155364997|NCT01006980|560770874|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
155364998|NCT01006980|560770875|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
155364999|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
155365000|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
155365001|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
155365002|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
155365003|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
155090224|NCT00806585|559763571|FG000|Overall Study|Withdrawal by Subject|10|||
155365004|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
155365005|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
155365006|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
155365007|NCT01006980|560770874|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
155365008|NCT01006980|560770875|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
155365009|NCT01483144|560770876|FG000|Overall Study|Adverse Event|9|||
155365010|NCT01483144|560770877|FG001|Overall Study|Adverse Event|4|||
155365011|NCT01483144|560770878|FG002|Overall Study|Adverse Event|6|||
155365012|NCT01483144|560770876|FG000|Overall Study|Withdrawal by Subject|0|||
155365013|NCT01483144|560770877|FG001|Overall Study|Withdrawal by Subject|2|||
155365014|NCT01483144|560770878|FG002|Overall Study|Withdrawal by Subject|5|||
155365015|NCT01483144|560770876|FG000|Overall Study|Physician Decision|1|||
155365016|NCT01483144|560770877|FG001|Overall Study|Physician Decision|0|||
155365017|NCT01483144|560770878|FG002|Overall Study|Physician Decision|0|||
155365018|NCT01483144|560770876|FG000|Overall Study|Lost to Follow-up|2|||
155365019|NCT01483144|560770877|FG001|Overall Study|Lost to Follow-up|4|||
155365020|NCT01483144|560770878|FG002|Overall Study|Lost to Follow-up|1|||
155365021|NCT01483144|560770876|FG000|Overall Study|Protocol Violation|3|||
155365022|NCT01483144|560770877|FG001|Overall Study|Protocol Violation|3|||
155365023|NCT01483144|560770878|FG002|Overall Study|Protocol Violation|3|||
155365024|NCT02124811|560770879|FG000|Overall Study|Early termination|2|||
155365025|NCT02124811|560770880|FG001|Overall Study|Early termination|2|||
155365026|NCT02124811|560770879|FG000|Overall Study|Withdrawal by Subject|1|||
155365027|NCT02124811|560770880|FG001|Overall Study|Withdrawal by Subject|0|||
155365028|NCT04896008|560770886|FG000|Overall Study|Ongoing|70|||
155365029|NCT04896008|560770887|FG001|Overall Study|Ongoing|38|||
155365030|NCT04896008|560770886|FG000|Overall Study|Adverse Event|0|||
155365031|NCT04896008|560770887|FG001|Overall Study|Adverse Event|2|||
155365032|NCT04896008|560770886|FG000|Overall Study|Death|5|||
155365033|NCT04896008|560770887|FG001|Overall Study|Death|10|||
155365034|NCT04896008|560770886|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
155365035|NCT04896008|560770887|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
155365036|NCT04896008|560770886|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
155365037|NCT04896008|560770887|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
155365038|NCT04896008|560770886|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
155365039|NCT04896008|560770887|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
155365040|NCT04896008|560770886|FG000|Overall Study|Withdrawal by Subject|1|||
155365041|NCT04896008|560770887|FG001|Overall Study|Withdrawal by Subject|4|||
155090225|NCT00806585|559763572|FG001|Overall Study|Withdrawal by Subject|8|||
155090226|NCT00806585|559763573|FG002|Overall Study|Withdrawal by Subject|9|||
155090227|NCT00806585|559763574|FG003|Overall Study|Withdrawal by Subject|3|||
155365042|NCT04896008|560770886|FG000|Overall Study|Investigator Decision|2|||
155365043|NCT04896008|560770887|FG001|Overall Study|Investigator Decision|0|||
155365044|NCT04896008|560770886|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
155365045|NCT04896008|560770887|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
155365046|NCT04201288|560770890|FG000|Overall Study|Death|1|||
155365047|NCT04201288|560770891|FG001|Overall Study|Death|1|||
155365048|NCT04201288|560770890|FG000|Overall Study|Lost to Follow-up|5|||
155365049|NCT04201288|560770891|FG001|Overall Study|Lost to Follow-up|3|||
155365050|NCT04201288|560770890|FG000|Overall Study|Withdrawal by Subject|1|||
155365051|NCT04201288|560770891|FG001|Overall Study|Withdrawal by Subject|0|||
155090228|NCT00806585|559763575|FG004|Overall Study|Withdrawal by Subject|11|||
155365052|NCT01594827|560770901|FG000|Overall Study|Adverse Event|1|||
155365053|NCT01594827|560770902|FG001|Overall Study|Adverse Event|0|||
155090229|NCT00806585|559763571|FG000|Overall Study|Completion status unknown|15|||
155365054|NCT01594827|560770901|FG000|Overall Study|Physician Decision|3|||
155090230|NCT00806585|559763572|FG001|Overall Study|Completion status unknown|14|||
155090231|NCT00806585|559763573|FG002|Overall Study|Completion status unknown|12|||
155090232|NCT00806585|559763574|FG003|Overall Study|Completion status unknown|4|||
155090233|NCT00806585|559763575|FG004|Overall Study|Completion status unknown|12|||
155365055|NCT01594827|560770902|FG001|Overall Study|Physician Decision|0|||
155365056|NCT03334253|560770903|FG000|Overall Study|Withdrawal by Subject|1|||
155365057|NCT03334253|560770904|FG001|Overall Study|Withdrawal by Subject|0|||
155090234|NCT04462471|559763580|FG000|Overall Study|Adverse Event|0|||
155090235|NCT04462471|559763581|FG001|Overall Study|Adverse Event|1|||
155090236|NCT04462471|559763582|FG002|Overall Study|Adverse Event|0|||
155090237|NCT04462471|559763583|FG003|Overall Study|Adverse Event|0|||
155090238|NCT04462471|559763580|FG000|Overall Study|Disease progression|1|||
155090239|NCT04462471|559763581|FG001|Overall Study|Disease progression|0|||
155090240|NCT04462471|559763582|FG002|Overall Study|Disease progression|0|||
155090241|NCT04462471|559763583|FG003|Overall Study|Disease progression|0|||
155090242|NCT02038647|559763584|FG000|Overall Study|Progressive Disease|50|||
155090243|NCT02038647|559763585|FG001|Overall Study|Progressive Disease|59|||
155365058|NCT03334253|560770903|FG000|Overall Study|Lost to Follow-up|4|||
155365059|NCT03334253|560770904|FG001|Overall Study|Lost to Follow-up|3|||
155365060|NCT03334253|560770903|FG000|Overall Study|Moved residence|2|||
155365061|NCT03334253|560770904|FG001|Overall Study|Moved residence|2|||
155365062|NCT00968526|560770905|FG000|Overall Study|Adverse Event|2|||
155365063|NCT00968526|560770906|FG001|Overall Study|Adverse Event|0|||
155365064|NCT00968526|560770905|FG000|Overall Study|Migrated/moved from study area|1|||
155365065|NCT00968526|560770906|FG001|Overall Study|Migrated/moved from study area|0|||
155365066|NCT02030002|560770910|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
155365067|NCT02030002|560770910|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
155365068|NCT02030002|560770910|FG000|Follow-up|Lost to Follow-up|2|||
155365069|NCT01327612|560770911|FG000|Overall Study|Withdrawal by Subject|0|||
155365070|NCT01327612|560770912|FG001|Overall Study|Withdrawal by Subject|0|||
155365071|NCT01327612|560770913|FG002|Overall Study|Withdrawal by Subject|0|||
155365072|NCT01327612|560770914|FG003|Overall Study|Withdrawal by Subject|0|||
155365073|NCT01327612|560770915|FG004|Overall Study|Withdrawal by Subject|0|||
155365074|NCT01327612|560770916|FG005|Overall Study|Withdrawal by Subject|1|||
155365075|NCT01327612|560770917|FG006|Overall Study|Withdrawal by Subject|0|||
155365076|NCT01327612|560770911|FG000|Overall Study|Disease Progression|1|||
155365077|NCT01327612|560770912|FG001|Overall Study|Disease Progression|1|||
155365078|NCT01327612|560770913|FG002|Overall Study|Disease Progression|1|||
155365079|NCT01327612|560770914|FG003|Overall Study|Disease Progression|0|||
155365080|NCT01327612|560770915|FG004|Overall Study|Disease Progression|1|||
155365081|NCT01327612|560770916|FG005|Overall Study|Disease Progression|2|||
155365082|NCT01327612|560770917|FG006|Overall Study|Disease Progression|2|||
155365083|NCT01327612|560770911|FG000|Overall Study|Administrative Decision|0|||
155365084|NCT01327612|560770912|FG001|Overall Study|Administrative Decision|0|||
155365085|NCT01327612|560770913|FG002|Overall Study|Administrative Decision|0|||
155365086|NCT01327612|560770914|FG003|Overall Study|Administrative Decision|1|||
155365087|NCT01327612|560770915|FG004|Overall Study|Administrative Decision|0|||
155365088|NCT01327612|560770916|FG005|Overall Study|Administrative Decision|0|||
155365089|NCT01327612|560770917|FG006|Overall Study|Administrative Decision|0|||
155365090|NCT01327612|560770911|FG000|Overall Study|Death|0|||
155365091|NCT01327612|560770912|FG001|Overall Study|Death|0|||
155365092|NCT01327612|560770913|FG002|Overall Study|Death|0|||
155365093|NCT01327612|560770914|FG003|Overall Study|Death|0|||
155365094|NCT01327612|560770915|FG004|Overall Study|Death|1|||
155365095|NCT01327612|560770916|FG005|Overall Study|Death|0|||
155365096|NCT01327612|560770917|FG006|Overall Study|Death|0|||
155365097|NCT01294397|560770918|FG000|Overall Study|Withdrawal by Subject|1|||
155365098|NCT01294397|560770918|FG000|Overall Study|Administrative Decision|1|||
155090244|NCT02038647|559763584|FG000|Overall Study|Adverse Event|18|||
155090245|NCT02038647|559763585|FG001|Overall Study|Adverse Event|10|||
155090246|NCT02038647|559763584|FG000|Overall Study|Symptomatic Deterioration|7|||
155090247|NCT02038647|559763585|FG001|Overall Study|Symptomatic Deterioration|7|||
155365099|NCT05569421|560770919|FG000|Overall Study|Withdrawal by Subject|1|||
155365100|NCT05569421|560770920|FG001|Overall Study|Withdrawal by Subject|0|||
155365101|NCT05569421|560770921|FG002|Overall Study|Withdrawal by Subject|0|||
155090248|NCT02038647|559763584|FG000|Overall Study|Withdrawal by Subject|5|||
155365102|NCT02406248|560770922|FG000|Overall Study|Death|7|||
155365103|NCT02406248|560770922|FG000|Overall Study|Withdrawal by Subject|2|||
155365104|NCT03812029|560770925|FG000|Overall Study|Protocol Violation|1|||
155365105|NCT03812029|560770926|FG001|Overall Study|Protocol Violation|0|||
155365106|NCT03812029|560770927|FG002|Overall Study|Protocol Violation|0|||
155365107|NCT03812029|560770928|FG003|Overall Study|Protocol Violation|1|||
155365108|NCT03812029|560770929|FG004|Overall Study|Protocol Violation|0|||
155365109|NCT03812029|560770925|FG000|Overall Study|Withdrawal by Subject|1|||
155365110|NCT03812029|560770926|FG001|Overall Study|Withdrawal by Subject|0|||
155090249|NCT02038647|559763585|FG001|Overall Study|Withdrawal by Subject|2|||
155090250|NCT02038647|559763584|FG000|Overall Study|Not Reported|0|||
155090251|NCT02038647|559763585|FG001|Overall Study|Not Reported|1|||
155090252|NCT02038647|559763584|FG000|Overall Study|Ongoing at Datacut|9|||
155365111|NCT03812029|560770927|FG002|Overall Study|Withdrawal by Subject|0|||
155090253|NCT02038647|559763585|FG001|Overall Study|Ongoing at Datacut|10|||
155090254|NCT00855335|559763588|FG000|Overall Study|Lost to Follow-up|0|||
155365112|NCT03812029|560770928|FG003|Overall Study|Withdrawal by Subject|2|||
155365113|NCT03812029|560770929|FG004|Overall Study|Withdrawal by Subject|2|||
155365114|NCT03812029|560770925|FG000|Overall Study|Stopping rules|0|||
155365115|NCT03812029|560770926|FG001|Overall Study|Stopping rules|1|||
155365116|NCT03812029|560770927|FG002|Overall Study|Stopping rules|0|||
155365117|NCT03812029|560770928|FG003|Overall Study|Stopping rules|0|||
155365118|NCT03812029|560770929|FG004|Overall Study|Stopping rules|0|||
155365119|NCT03812029|560770925|FG000|Overall Study|Adverse Event|0|||
155365120|NCT03812029|560770926|FG001|Overall Study|Adverse Event|9|||
155365121|NCT03812029|560770927|FG002|Overall Study|Adverse Event|0|||
155365122|NCT03812029|560770928|FG003|Overall Study|Adverse Event|3|||
155365123|NCT03812029|560770929|FG004|Overall Study|Adverse Event|5|||
155365124|NCT03812029|560770925|FG000|Overall Study|Lost to Follow-up|0|||
155090255|NCT00855335|559763589|FG001|Overall Study|Lost to Follow-up|0|||
155090256|NCT00855335|559763590|FG002|Overall Study|Lost to Follow-up|3|||
155090257|NCT00855335|559763591|FG003|Overall Study|Lost to Follow-up|1|||
155090258|NCT00855335|559763592|FG004|Overall Study|Lost to Follow-up|0|||
155090259|NCT00855335|559763588|FG000|Overall Study|Withdrawal by Subject|0|||
155090260|NCT00855335|559763589|FG001|Overall Study|Withdrawal by Subject|0|||
155090261|NCT00855335|559763590|FG002|Overall Study|Withdrawal by Subject|0|||
155090262|NCT00855335|559763591|FG003|Overall Study|Withdrawal by Subject|1|||
155090263|NCT00855335|559763592|FG004|Overall Study|Withdrawal by Subject|0|||
155090264|NCT00855335|559763588|FG000|Overall Study|Adverse Event|2|||
155090265|NCT00855335|559763589|FG001|Overall Study|Adverse Event|0|||
155090266|NCT00855335|559763590|FG002|Overall Study|Adverse Event|0|||
155090267|NCT00855335|559763591|FG003|Overall Study|Adverse Event|0|||
155090268|NCT00855335|559763592|FG004|Overall Study|Adverse Event|0|||
155090269|NCT00855335|559763588|FG000|Overall Study|Physician Decision|1|||
155090270|NCT00855335|559763589|FG001|Overall Study|Physician Decision|1|||
155090271|NCT00855335|559763590|FG002|Overall Study|Physician Decision|0|||
155090272|NCT00855335|559763591|FG003|Overall Study|Physician Decision|0|||
155090273|NCT00855335|559763592|FG004|Overall Study|Physician Decision|0|||
155090274|NCT00855335|559763588|FG000|Overall Study|Other|2|||
155090275|NCT00855335|559763589|FG001|Overall Study|Other|1|||
155090276|NCT00855335|559763590|FG002|Overall Study|Other|2|||
155090277|NCT00855335|559763591|FG003|Overall Study|Other|5|||
155090278|NCT00855335|559763592|FG004|Overall Study|Other|1|||
155090279|NCT02526290|559763593|FG000|Overall Study|Adverse Event|3|||
155090280|NCT02526290|559763593|FG000|Overall Study|Withdrawal by Subject|4|||
155166746|NCT01737502|560046340|FG000|Phase II|Transition to hospice care|0|||
155090281|NCT02526290|559763593|FG000|Overall Study|Physician Decision|1|||
155090282|NCT02082977|559763594|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
155090283|NCT02082977|559763595|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
155090284|NCT02082977|559763596|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
155365125|NCT03812029|560770926|FG001|Overall Study|Lost to Follow-up|0|||
155090285|NCT02082977|559763597|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
155090286|NCT02082977|559763598|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
155090287|NCT02082977|559763599|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
155090288|NCT02082977|559763600|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
155090289|NCT02082977|559763601|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
155090290|NCT02082977|559763602|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
155090291|NCT02082977|559763603|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
155090292|NCT02082977|559763594|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090293|NCT02082977|559763595|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090294|NCT02082977|559763596|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090295|NCT02082977|559763597|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090296|NCT02082977|559763598|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090297|NCT02082977|559763599|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090298|NCT02082977|559763600|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090299|NCT02082977|559763601|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
155090300|NCT02082977|559763602|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090301|NCT02082977|559763603|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
155090302|NCT02082977|559763594|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090303|NCT02082977|559763595|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090304|NCT02082977|559763596|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090305|NCT02082977|559763597|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090306|NCT02082977|559763598|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090307|NCT02082977|559763599|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
155090308|NCT02082977|559763600|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090309|NCT02082977|559763601|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090310|NCT02082977|559763602|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090311|NCT02082977|559763603|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
155090312|NCT02082977|559763594|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155090313|NCT02082977|559763595|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155090314|NCT02082977|559763596|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155090315|NCT02082977|559763597|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155090316|NCT02082977|559763598|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
155090317|NCT02082977|559763599|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
155365126|NCT03812029|560770927|FG002|Overall Study|Lost to Follow-up|0|||
155365127|NCT03812029|560770928|FG003|Overall Study|Lost to Follow-up|0|||
155365128|NCT03812029|560770929|FG004|Overall Study|Lost to Follow-up|3|||
155365129|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
155365130|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
155090318|NCT02082977|559763600|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
155090319|NCT02082977|559763601|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
155090320|NCT02082977|559763602|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
155090321|NCT02082977|559763603|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
155090322|NCT02082977|559763594|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090323|NCT02082977|559763595|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090324|NCT02082977|559763596|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090325|NCT02082977|559763597|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090326|NCT02082977|559763598|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090327|NCT02082977|559763599|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090328|NCT02082977|559763600|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090329|NCT02082977|559763601|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
155090330|NCT02082977|559763602|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090331|NCT02082977|559763603|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
155090332|NCT02106832|559763606|FG000|Overall Study|Adverse Event|1|||
155090333|NCT02106832|559763607|FG001|Overall Study|Adverse Event|2|||
155090334|NCT02106832|559763608|FG002|Overall Study|Adverse Event|3|||
155090335|NCT02106832|559763609|FG003|Overall Study|Adverse Event|0|||
155090336|NCT02106832|559763606|FG000|Overall Study|Death|4|||
155090337|NCT02106832|559763607|FG001|Overall Study|Death|4|||
155090338|NCT02106832|559763608|FG002|Overall Study|Death|1|||
155090339|NCT02106832|559763609|FG003|Overall Study|Death|4|||
155090340|NCT02106832|559763606|FG000|Overall Study|Deterioration of general conditions|0|||
155090341|NCT02106832|559763607|FG001|Overall Study|Deterioration of general conditions|0|||
155090342|NCT02106832|559763608|FG002|Overall Study|Deterioration of general conditions|1|||
155090343|NCT02106832|559763609|FG003|Overall Study|Deterioration of general conditions|0|||
155090344|NCT02106832|559763606|FG000|Overall Study|Lost to Follow-up|0|||
155090345|NCT02106832|559763607|FG001|Overall Study|Lost to Follow-up|1|||
155090346|NCT02106832|559763608|FG002|Overall Study|Lost to Follow-up|1|||
155090347|NCT02106832|559763609|FG003|Overall Study|Lost to Follow-up|3|||
155365131|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
155090348|NCT02106832|559763606|FG000|Overall Study|Physician Decision|1|||
155090349|NCT02106832|559763607|FG001|Overall Study|Physician Decision|0|||
155090350|NCT02106832|559763608|FG002|Overall Study|Physician Decision|0|||
155090351|NCT02106832|559763609|FG003|Overall Study|Physician Decision|0|||
155090352|NCT02106832|559763606|FG000|Overall Study|Protocol Violation|0|||
155090353|NCT02106832|559763607|FG001|Overall Study|Protocol Violation|0|||
155090354|NCT02106832|559763608|FG002|Overall Study|Protocol Violation|0|||
155090355|NCT02106832|559763609|FG003|Overall Study|Protocol Violation|1|||
155090356|NCT02106832|559763606|FG000|Overall Study|Withdrawal by Subject|17|||
155090357|NCT02106832|559763607|FG001|Overall Study|Withdrawal by Subject|17|||
155090358|NCT02106832|559763608|FG002|Overall Study|Withdrawal by Subject|10|||
155090359|NCT02106832|559763609|FG003|Overall Study|Withdrawal by Subject|7|||
155090360|NCT02106832|559763606|FG000|Overall Study|Technical problems|0|||
155090361|NCT02106832|559763607|FG001|Overall Study|Technical problems|1|||
155365132|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
155365133|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
155365134|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
155365135|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
155365136|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
155365137|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
155365138|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
155365139|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
155365140|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
155365141|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
155365142|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
155090362|NCT02106832|559763608|FG002|Overall Study|Technical problems|0|||
155090363|NCT02106832|559763609|FG003|Overall Study|Technical problems|0|||
155090364|NCT02706392|559763624|FG000|Overall Study|Death|1|||
155090365|NCT02706392|559763625|FG001|Overall Study|Death|0|||
155365143|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
155365144|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
155365145|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
155365146|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
155365147|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
155365148|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
155365149|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
155365150|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
155365151|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
155365152|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
155365153|NCT00479882|560770930|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
155365154|NCT00479882|560770931|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
155365155|NCT00479882|560770932|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
155365156|NCT00479882|560770933|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
155365157|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
155365158|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
155365159|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
155365160|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
155365161|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
155365162|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
155365163|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
155365164|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
155365165|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
155365166|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
155365167|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
155365168|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
155365169|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
155365170|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
155365171|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
155365172|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
155365173|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
155365174|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
155365175|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
155365176|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
155365177|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
155365178|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
155365179|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
155365180|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
155365181|NCT00479882|560770930|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
155365182|NCT00479882|560770931|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
155365183|NCT00479882|560770932|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
155365184|NCT00479882|560770933|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
155365185|NCT03106753|560770934|FG000|Overall Study|Withdrawal by Subject|0|||
155365186|NCT03106753|560770935|FG001|Overall Study|Withdrawal by Subject|1|||
155365187|NCT03149042|560770937|FG000|Overall Study|Invasive FFR not performed|21|||
155365188|NCT03149042|560770937|FG000|Overall Study|Poor CT Image Quality|1|||
155365189|NCT03149042|560770937|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
155365190|NCT01643044|560770938|FG000|Overall Study|Lost to Follow-up|1|||
155365191|NCT01643044|560770939|FG001|Overall Study|Lost to Follow-up|1|||
155365192|NCT01643044|560770938|FG000|Overall Study|Miscarried baby|2|||
155365193|NCT01643044|560770939|FG001|Overall Study|Miscarried baby|2|||
155365194|NCT01643044|560770938|FG000|Overall Study|Delivered outside of hospital|1|||
155365195|NCT01643044|560770939|FG001|Overall Study|Delivered outside of hospital|2|||
155365196|NCT01023958|560770946|FG000|Overall Study|Progressive disease|48|||
155365197|NCT01023958|560770946|FG000|Overall Study|Other adverse event|1|||
155365198|NCT01023958|560770946|FG000|Overall Study|Refused to continue medication|1|||
155365199|NCT00790205|560770950|FG000|Overall Study|Lost to Follow-up|61|||
155365200|NCT00790205|560770951|FG001|Overall Study|Lost to Follow-up|71|||
155365201|NCT00790205|560770950|FG000|Overall Study|Withdrawal by Subject|299|||
155365202|NCT00790205|560770951|FG001|Overall Study|Withdrawal by Subject|363|||
155365203|NCT03933462|560770952|FG000|Overall Study|Adverse Event|2|||
155365204|NCT03933462|560770953|FG001|Overall Study|Adverse Event|0|||
155365205|NCT04805073|560770960|FG000|Overall Study|study personnel not available|2|||
155365206|NCT04805073|560770961|FG001|Overall Study|study personnel not available|0|||
155365207|NCT04805073|560770960|FG000|Overall Study|spinal anesthesia failure|0|||
155365208|NCT04805073|560770961|FG001|Overall Study|spinal anesthesia failure|1|||
155365209|NCT04805073|560770960|FG000|Overall Study|Lost to Follow-up|0|||
155365210|NCT04805073|560770961|FG001|Overall Study|Lost to Follow-up|2|||
155365211|NCT02975102|560770963|FG000|Overall Study|Adverse Event|2|||
155365212|NCT02975102|560770964|FG001|Overall Study|Adverse Event|1|||
155365213|NCT02609672|560770965|FG000|Overall Study|Lost to Follow-up|3|||
155365214|NCT02609672|560770966|FG001|Overall Study|Lost to Follow-up|1|||
155365215|NCT01441635|560770967|FG000|Overall Study|Adverse Event|4|||
155365216|NCT01441635|560770968|FG001|Overall Study|Adverse Event|3|||
155365217|NCT01441635|560770969|FG002|Overall Study|Adverse Event|1|||
155365218|NCT01441635|560770970|FG003|Overall Study|Adverse Event|5|||
155365219|NCT01441635|560770971|FG004|Overall Study|Adverse Event|1|||
155365220|NCT01441635|560770972|FG005|Overall Study|Adverse Event|2|||
155365221|NCT01441635|560770973|FG006|Overall Study|Adverse Event|2|||
155365222|NCT01441635|560770974|FG007|Overall Study|Adverse Event|2|||
155365223|NCT01441635|560770975|FG008|Overall Study|Adverse Event|1|||
155365224|NCT01441635|560770976|FG009|Overall Study|Adverse Event|0|||
155365225|NCT01441635|560770967|FG000|Overall Study|Withdrawal by Subject|1|||
155365226|NCT01441635|560770968|FG001|Overall Study|Withdrawal by Subject|1|||
155365227|NCT01441635|560770969|FG002|Overall Study|Withdrawal by Subject|0|||
155365228|NCT01441635|560770970|FG003|Overall Study|Withdrawal by Subject|1|||
155365229|NCT01441635|560770971|FG004|Overall Study|Withdrawal by Subject|0|||
155365230|NCT01441635|560770972|FG005|Overall Study|Withdrawal by Subject|0|||
155365231|NCT01441635|560770973|FG006|Overall Study|Withdrawal by Subject|2|||
155365232|NCT01441635|560770974|FG007|Overall Study|Withdrawal by Subject|0|||
155365233|NCT01441635|560770975|FG008|Overall Study|Withdrawal by Subject|1|||
155365234|NCT01441635|560770976|FG009|Overall Study|Withdrawal by Subject|1|||
155365235|NCT01441635|560770967|FG000|Overall Study|Lost to Follow-up|0|||
155365236|NCT01441635|560770968|FG001|Overall Study|Lost to Follow-up|1|||
155365237|NCT01441635|560770969|FG002|Overall Study|Lost to Follow-up|1|||
155365238|NCT01441635|560770970|FG003|Overall Study|Lost to Follow-up|1|||
155365239|NCT01441635|560770971|FG004|Overall Study|Lost to Follow-up|1|||
155365240|NCT01441635|560770972|FG005|Overall Study|Lost to Follow-up|3|||
155365241|NCT01441635|560770973|FG006|Overall Study|Lost to Follow-up|1|||
155365242|NCT01441635|560770974|FG007|Overall Study|Lost to Follow-up|1|||
155365243|NCT01441635|560770975|FG008|Overall Study|Lost to Follow-up|0|||
155365244|NCT01441635|560770976|FG009|Overall Study|Lost to Follow-up|1|||
155365245|NCT01441635|560770967|FG000|Overall Study|Noncompliance|0|||
155365246|NCT01441635|560770968|FG001|Overall Study|Noncompliance|1|||
155365247|NCT01441635|560770969|FG002|Overall Study|Noncompliance|0|||
155365248|NCT01441635|560770970|FG003|Overall Study|Noncompliance|0|||
155365249|NCT01441635|560770971|FG004|Overall Study|Noncompliance|0|||
155365250|NCT01441635|560770972|FG005|Overall Study|Noncompliance|0|||
155365251|NCT01441635|560770973|FG006|Overall Study|Noncompliance|1|||
155365252|NCT01441635|560770974|FG007|Overall Study|Noncompliance|0|||
155365253|NCT01441635|560770975|FG008|Overall Study|Noncompliance|0|||
155365254|NCT01441635|560770976|FG009|Overall Study|Noncompliance|0|||
155365255|NCT01441635|560770967|FG000|Overall Study|Surgery or Invasive Intervention|0|||
155365256|NCT01441635|560770968|FG001|Overall Study|Surgery or Invasive Intervention|0|||
155365257|NCT01441635|560770969|FG002|Overall Study|Surgery or Invasive Intervention|1|||
155365258|NCT01441635|560770970|FG003|Overall Study|Surgery or Invasive Intervention|0|||
155365259|NCT01441635|560770971|FG004|Overall Study|Surgery or Invasive Intervention|0|||
155365260|NCT01441635|560770972|FG005|Overall Study|Surgery or Invasive Intervention|0|||
155365261|NCT01441635|560770973|FG006|Overall Study|Surgery or Invasive Intervention|0|||
155365262|NCT01441635|560770974|FG007|Overall Study|Surgery or Invasive Intervention|0|||
155365263|NCT01441635|560770975|FG008|Overall Study|Surgery or Invasive Intervention|0|||
155365264|NCT01441635|560770976|FG009|Overall Study|Surgery or Invasive Intervention|0|||
155365265|NCT01441635|560770967|FG000|Overall Study|Received Exclusionary Medication|1|||
155365266|NCT01441635|560770968|FG001|Overall Study|Received Exclusionary Medication|0|||
155365267|NCT01441635|560770969|FG002|Overall Study|Received Exclusionary Medication|0|||
155365268|NCT01441635|560770970|FG003|Overall Study|Received Exclusionary Medication|0|||
155365269|NCT01441635|560770971|FG004|Overall Study|Received Exclusionary Medication|0|||
155365270|NCT01441635|560770972|FG005|Overall Study|Received Exclusionary Medication|0|||
155365271|NCT01441635|560770973|FG006|Overall Study|Received Exclusionary Medication|0|||
155365272|NCT01441635|560770974|FG007|Overall Study|Received Exclusionary Medication|0|||
155365273|NCT01441635|560770975|FG008|Overall Study|Received Exclusionary Medication|0|||
155365274|NCT01441635|560770976|FG009|Overall Study|Received Exclusionary Medication|0|||
155365275|NCT01441635|560770967|FG000|Overall Study|Other|0|||
155365276|NCT01441635|560770968|FG001|Overall Study|Other|0|||
155365277|NCT01441635|560770969|FG002|Overall Study|Other|0|||
155365278|NCT01441635|560770970|FG003|Overall Study|Other|0|||
155365279|NCT01441635|560770971|FG004|Overall Study|Other|0|||
155365280|NCT01441635|560770972|FG005|Overall Study|Other|0|||
155365281|NCT01441635|560770973|FG006|Overall Study|Other|0|||
155365282|NCT01441635|560770974|FG007|Overall Study|Other|1|||
155365283|NCT01441635|560770975|FG008|Overall Study|Other|0|||
155365284|NCT01441635|560770976|FG009|Overall Study|Other|0|||
155365285|NCT01912404|560770977|FG000|Overall Study|Due to personal reasons|1|||
155365286|NCT01912404|560770978|FG001|Overall Study|Due to personal reasons|0|||
155365287|NCT02269423|560770985|FG000|Overall Study|Discontinued due to change in residence|0|||
155365288|NCT02269423|560770986|FG001|Overall Study|Discontinued due to change in residence|1|||
155365289|NCT02269423|560770987|FG002|Overall Study|Discontinued due to change in residence|0|||
155365290|NCT02269423|560770988|FG003|Overall Study|Discontinued due to change in residence|1|||
155365291|NCT01430468|560770989|FG000|Overall Study|Physician Decision|2|||
155365292|NCT01430468|560770990|FG001|Overall Study|Physician Decision|1|||
155365293|NCT01430468|560770989|FG000|Overall Study|Withdrawal by Subject|5|||
155365294|NCT01430468|560770990|FG001|Overall Study|Withdrawal by Subject|5|||
155365295|NCT01281839|560770991|FG000|Overall Study|Lost to Follow-up|6|||
155365296|NCT01281839|560770992|FG001|Overall Study|Lost to Follow-up|3|||
155365297|NCT01281839|560770991|FG000|Overall Study|Withdrawal by Subject|4|||
155365298|NCT01281839|560770992|FG001|Overall Study|Withdrawal by Subject|10|||
155365299|NCT01281839|560770991|FG000|Overall Study|Reason not specified|0|||
155365300|NCT01281839|560770992|FG001|Overall Study|Reason not specified|1|||
155365301|NCT01305239|560770993|FG000|Overall Study|Adverse Event|22|||
155365302|NCT01305239|560770993|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
155365303|NCT01754753|560770996|FG000|Overall Study|Study close|43|||
155365304|NCT01754753|560770997|FG001|Overall Study|Study close|44|||
155365305|NCT01754753|560770996|FG000|Overall Study|Lost to Follow-up|9|||
155365306|NCT01754753|560770997|FG001|Overall Study|Lost to Follow-up|5|||
155365307|NCT03229486|560770998|FG000|Overall Study|Protocol Violation|0|||
155365308|NCT03229486|560770999|FG001|Overall Study|Protocol Violation|1|||
155365309|NCT00856245|560771000|FG000|Overall Study|Was not transplanted|5|||
155365310|NCT01443923|560771001|FG000|Overall Study|Adverse Event|1|||
155365311|NCT01443923|560771002|FG001|Overall Study|Adverse Event|0|||
155365312|NCT00243074|560771006|FG000|Overall Study|Ineligible|6|||
155365313|NCT00243074|560771006|FG000|Overall Study|Adverse Event|6|||
155365314|NCT00243074|560771006|FG000|Overall Study|Withdrawal by Subject|2|||
155365315|NCT00243074|560771006|FG000|Overall Study|Lack of Efficacy|36|||
155365316|NCT00243074|560771006|FG000|Overall Study|Death|2|||
155365317|NCT00243074|560771006|FG000|Overall Study|not protocol specified|1|||
155365318|NCT00243074|560771006|FG000|Overall Study|Did not receive any treatment|1|||
155365319|NCT00344032|560771007|FG000|Overall Study|Adverse Event|0|||
155365320|NCT00344032|560771008|FG001|Overall Study|Adverse Event|1|||
155365321|NCT00344032|560771007|FG000|Overall Study|Withdrawal by Subject|6|||
155365322|NCT00344032|560771008|FG001|Overall Study|Withdrawal by Subject|2|||
155365323|NCT00344032|560771007|FG000|Overall Study|Lost to Follow-up|4|||
155365324|NCT00344032|560771008|FG001|Overall Study|Lost to Follow-up|6|||
155365325|NCT00344032|560771007|FG000|Overall Study|Physician Decision|4|||
155365326|NCT00344032|560771008|FG001|Overall Study|Physician Decision|1|||
155365327|NCT05131477|560771011|FG000|PART 1|Withdrawal by Subject|2|||
155365328|NCT05131477|560771012|FG001|PART 1|Withdrawal by Subject|9|||
155365329|NCT05131477|560771013|FG002|PART 1|Withdrawal by Subject|6|||
155365330|NCT05131477|560771014|FG003|PART 1|Withdrawal by Subject|2|||
155365331|NCT05131477|560771015|FG004|PART 1|Withdrawal by Subject|8|||
155365332|NCT05131477|560771016|FG005|PART 1|Withdrawal by Subject|0|||
155365333|NCT05131477|560771017|FG006|PART 1|Withdrawal by Subject|0|||
155365334|NCT05131477|560771018|FG007|PART 1|Withdrawal by Subject|0|||
155365335|NCT05131477|560771019|FG008|PART 1|Withdrawal by Subject|0|||
155365336|NCT05131477|560771020|FG009|PART 1|Withdrawal by Subject|0|||
155365337|NCT05131477|560771021|FG010|PART 1|Withdrawal by Subject|0|||
155365338|NCT05131477|560771022|FG011|PART 1|Withdrawal by Subject|0|||
155365339|NCT05131477|560771023|FG012|PART 1|Withdrawal by Subject|0|||
155365340|NCT05131477|560771024|FG013|PART 1|Withdrawal by Subject|0|||
155365341|NCT05131477|560771011|FG000|PART 1|Physician Decision|1|||
155365342|NCT05131477|560771012|FG001|PART 1|Physician Decision|0|||
155365343|NCT05131477|560771013|FG002|PART 1|Physician Decision|0|||
155365344|NCT05131477|560771014|FG003|PART 1|Physician Decision|0|||
155365345|NCT05131477|560771015|FG004|PART 1|Physician Decision|0|||
155365346|NCT05131477|560771016|FG005|PART 1|Physician Decision|0|||
155365347|NCT05131477|560771017|FG006|PART 1|Physician Decision|0|||
155365348|NCT05131477|560771018|FG007|PART 1|Physician Decision|0|||
155365349|NCT05131477|560771019|FG008|PART 1|Physician Decision|0|||
155365350|NCT05131477|560771020|FG009|PART 1|Physician Decision|0|||
155365351|NCT05131477|560771021|FG010|PART 1|Physician Decision|0|||
155365352|NCT05131477|560771022|FG011|PART 1|Physician Decision|0|||
155365353|NCT05131477|560771023|FG012|PART 1|Physician Decision|0|||
155365354|NCT05131477|560771024|FG013|PART 1|Physician Decision|0|||
155365355|NCT05131477|560771011|FG000|PART 1|Adverse Event|3|||
155365356|NCT05131477|560771012|FG001|PART 1|Adverse Event|5|||
155365357|NCT05131477|560771013|FG002|PART 1|Adverse Event|1|||
155365358|NCT05131477|560771014|FG003|PART 1|Adverse Event|6|||
155365359|NCT05131477|560771015|FG004|PART 1|Adverse Event|4|||
155365360|NCT05131477|560771016|FG005|PART 1|Adverse Event|0|||
155365361|NCT05131477|560771017|FG006|PART 1|Adverse Event|0|||
155365362|NCT05131477|560771018|FG007|PART 1|Adverse Event|0|||
155365363|NCT05131477|560771019|FG008|PART 1|Adverse Event|0|||
155365364|NCT05131477|560771020|FG009|PART 1|Adverse Event|0|||
155365365|NCT05131477|560771021|FG010|PART 1|Adverse Event|0|||
155365366|NCT05131477|560771022|FG011|PART 1|Adverse Event|0|||
155365367|NCT05131477|560771023|FG012|PART 1|Adverse Event|0|||
155365368|NCT05131477|560771024|FG013|PART 1|Adverse Event|0|||
155365369|NCT05131477|560771011|FG000|PART 1|unclassified|1|||
155365370|NCT05131477|560771012|FG001|PART 1|unclassified|1|||
155365371|NCT05131477|560771013|FG002|PART 1|unclassified|0|||
155365372|NCT05131477|560771014|FG003|PART 1|unclassified|0|||
155365373|NCT05131477|560771015|FG004|PART 1|unclassified|4|||
155365374|NCT05131477|560771016|FG005|PART 1|unclassified|0|||
155365375|NCT05131477|560771017|FG006|PART 1|unclassified|0|||
155365376|NCT05131477|560771018|FG007|PART 1|unclassified|0|||
155365377|NCT05131477|560771019|FG008|PART 1|unclassified|0|||
155365378|NCT05131477|560771020|FG009|PART 1|unclassified|0|||
155365379|NCT05131477|560771021|FG010|PART 1|unclassified|0|||
155365380|NCT05131477|560771022|FG011|PART 1|unclassified|0|||
155365381|NCT05131477|560771023|FG012|PART 1|unclassified|0|||
155365382|NCT05131477|560771024|FG013|PART 1|unclassified|0|||
155365383|NCT05131477|560771011|FG000|PART 1|Randomized and not treated|0|||
155365384|NCT05131477|560771012|FG001|PART 1|Randomized and not treated|0|||
155365385|NCT05131477|560771013|FG002|PART 1|Randomized and not treated|0|||
155365386|NCT05131477|560771014|FG003|PART 1|Randomized and not treated|1|||
155365387|NCT05131477|560771015|FG004|PART 1|Randomized and not treated|1|||
155365388|NCT05131477|560771016|FG005|PART 1|Randomized and not treated|0|||
155365389|NCT05131477|560771017|FG006|PART 1|Randomized and not treated|0|||
155365390|NCT05131477|560771018|FG007|PART 1|Randomized and not treated|0|||
155365391|NCT05131477|560771019|FG008|PART 1|Randomized and not treated|0|||
155365392|NCT05131477|560771020|FG009|PART 1|Randomized and not treated|0|||
155365393|NCT05131477|560771021|FG010|PART 1|Randomized and not treated|0|||
155365394|NCT05131477|560771022|FG011|PART 1|Randomized and not treated|0|||
155365395|NCT05131477|560771023|FG012|PART 1|Randomized and not treated|0|||
155365396|NCT05131477|560771024|FG013|PART 1|Randomized and not treated|0|||
155365397|NCT05131477|560771011|FG000|PART 1|Protocol Violation|2|||
155365398|NCT05131477|560771012|FG001|PART 1|Protocol Violation|0|||
155365399|NCT05131477|560771013|FG002|PART 1|Protocol Violation|0|||
155365400|NCT05131477|560771014|FG003|PART 1|Protocol Violation|1|||
155365401|NCT05131477|560771015|FG004|PART 1|Protocol Violation|0|||
155365402|NCT05131477|560771016|FG005|PART 1|Protocol Violation|0|||
155365403|NCT05131477|560771017|FG006|PART 1|Protocol Violation|0|||
155365404|NCT05131477|560771018|FG007|PART 1|Protocol Violation|0|||
155365405|NCT05131477|560771019|FG008|PART 1|Protocol Violation|0|||
155365406|NCT05131477|560771020|FG009|PART 1|Protocol Violation|0|||
155365407|NCT05131477|560771021|FG010|PART 1|Protocol Violation|0|||
155365408|NCT05131477|560771022|FG011|PART 1|Protocol Violation|0|||
155365409|NCT05131477|560771023|FG012|PART 1|Protocol Violation|0|||
155365410|NCT05131477|560771024|FG013|PART 1|Protocol Violation|0|||
155365411|NCT05131477|560771011|FG000|PART 1|Lack of Efficacy|0|||
155365412|NCT05131477|560771012|FG001|PART 1|Lack of Efficacy|1|||
155365413|NCT05131477|560771013|FG002|PART 1|Lack of Efficacy|1|||
155365414|NCT05131477|560771014|FG003|PART 1|Lack of Efficacy|2|||
155365415|NCT05131477|560771015|FG004|PART 1|Lack of Efficacy|5|||
155365416|NCT05131477|560771016|FG005|PART 1|Lack of Efficacy|0|||
155365417|NCT05131477|560771017|FG006|PART 1|Lack of Efficacy|0|||
155365418|NCT05131477|560771018|FG007|PART 1|Lack of Efficacy|0|||
155365419|NCT05131477|560771019|FG008|PART 1|Lack of Efficacy|0|||
155365420|NCT05131477|560771020|FG009|PART 1|Lack of Efficacy|0|||
155365421|NCT05131477|560771021|FG010|PART 1|Lack of Efficacy|0|||
155365422|NCT05131477|560771022|FG011|PART 1|Lack of Efficacy|0|||
155365423|NCT05131477|560771023|FG012|PART 1|Lack of Efficacy|0|||
155365424|NCT05131477|560771024|FG013|PART 1|Lack of Efficacy|0|||
155365425|NCT05131477|560771011|FG000|PART 2|Withdrawal by Subject|0|||
155365426|NCT05131477|560771012|FG001|PART 2|Withdrawal by Subject|0|||
155365427|NCT05131477|560771013|FG002|PART 2|Withdrawal by Subject|0|||
155365428|NCT05131477|560771014|FG003|PART 2|Withdrawal by Subject|0|||
155365429|NCT05131477|560771015|FG004|PART 2|Withdrawal by Subject|0|||
155365430|NCT05131477|560771016|FG005|PART 2|Withdrawal by Subject|0|||
155365431|NCT05131477|560771017|FG006|PART 2|Withdrawal by Subject|2|||
155365432|NCT05131477|560771018|FG007|PART 2|Withdrawal by Subject|0|||
155365433|NCT05131477|560771019|FG008|PART 2|Withdrawal by Subject|0|||
155365434|NCT05131477|560771020|FG009|PART 2|Withdrawal by Subject|0|||
155365435|NCT05131477|560771021|FG010|PART 2|Withdrawal by Subject|2|||
155365436|NCT05131477|560771022|FG011|PART 2|Withdrawal by Subject|0|||
155365437|NCT05131477|560771023|FG012|PART 2|Withdrawal by Subject|2|||
155365438|NCT05131477|560771024|FG013|PART 2|Withdrawal by Subject|2|||
155365439|NCT05131477|560771011|FG000|PART 2|Other|0|||
155365440|NCT05131477|560771012|FG001|PART 2|Other|0|||
155365441|NCT05131477|560771013|FG002|PART 2|Other|0|||
155365442|NCT05131477|560771014|FG003|PART 2|Other|0|||
155365443|NCT05131477|560771015|FG004|PART 2|Other|0|||
155365444|NCT05131477|560771016|FG005|PART 2|Other|0|||
155365445|NCT05131477|560771017|FG006|PART 2|Other|0|||
155365446|NCT05131477|560771018|FG007|PART 2|Other|0|||
155365447|NCT05131477|560771019|FG008|PART 2|Other|1|||
155365448|NCT05131477|560771020|FG009|PART 2|Other|1|||
155365449|NCT05131477|560771021|FG010|PART 2|Other|0|||
155365450|NCT05131477|560771022|FG011|PART 2|Other|0|||
155365451|NCT05131477|560771023|FG012|PART 2|Other|1|||
155365452|NCT05131477|560771024|FG013|PART 2|Other|0|||
155365453|NCT05131477|560771011|FG000|PART 2|Lack of Efficacy|0|||
155365454|NCT05131477|560771012|FG001|PART 2|Lack of Efficacy|0|||
155365455|NCT05131477|560771013|FG002|PART 2|Lack of Efficacy|0|||
155365456|NCT05131477|560771014|FG003|PART 2|Lack of Efficacy|0|||
155365457|NCT05131477|560771015|FG004|PART 2|Lack of Efficacy|0|||
155365458|NCT05131477|560771016|FG005|PART 2|Lack of Efficacy|1|||
155365459|NCT05131477|560771017|FG006|PART 2|Lack of Efficacy|1|||
155365460|NCT05131477|560771018|FG007|PART 2|Lack of Efficacy|0|||
155365461|NCT05131477|560771019|FG008|PART 2|Lack of Efficacy|3|||
155365462|NCT05131477|560771020|FG009|PART 2|Lack of Efficacy|0|||
155365463|NCT05131477|560771021|FG010|PART 2|Lack of Efficacy|1|||
155365464|NCT05131477|560771022|FG011|PART 2|Lack of Efficacy|0|||
155365465|NCT05131477|560771023|FG012|PART 2|Lack of Efficacy|2|||
155365466|NCT05131477|560771024|FG013|PART 2|Lack of Efficacy|0|||
155365467|NCT05131477|560771011|FG000|PART 2|Unclassified|0|||
155365468|NCT05131477|560771012|FG001|PART 2|Unclassified|0|||
155365469|NCT05131477|560771013|FG002|PART 2|Unclassified|0|||
155365470|NCT05131477|560771014|FG003|PART 2|Unclassified|0|||
155365471|NCT05131477|560771015|FG004|PART 2|Unclassified|0|||
155365472|NCT05131477|560771016|FG005|PART 2|Unclassified|0|||
155365473|NCT05131477|560771017|FG006|PART 2|Unclassified|0|||
155365474|NCT05131477|560771018|FG007|PART 2|Unclassified|0|||
155365475|NCT05131477|560771019|FG008|PART 2|Unclassified|0|||
155365476|NCT05131477|560771020|FG009|PART 2|Unclassified|0|||
155365477|NCT05131477|560771021|FG010|PART 2|Unclassified|1|||
155365478|NCT05131477|560771022|FG011|PART 2|Unclassified|0|||
155365479|NCT05131477|560771023|FG012|PART 2|Unclassified|0|||
155365480|NCT05131477|560771024|FG013|PART 2|Unclassified|0|||
155365481|NCT05131477|560771011|FG000|PART 2|Re-randomized and not treated|0|||
155365482|NCT05131477|560771012|FG001|PART 2|Re-randomized and not treated|0|||
155365483|NCT05131477|560771013|FG002|PART 2|Re-randomized and not treated|0|||
155365484|NCT05131477|560771014|FG003|PART 2|Re-randomized and not treated|0|||
155365485|NCT05131477|560771015|FG004|PART 2|Re-randomized and not treated|0|||
155365486|NCT05131477|560771016|FG005|PART 2|Re-randomized and not treated|0|||
155365487|NCT05131477|560771017|FG006|PART 2|Re-randomized and not treated|0|||
155365488|NCT05131477|560771018|FG007|PART 2|Re-randomized and not treated|1|||
155365489|NCT05131477|560771019|FG008|PART 2|Re-randomized and not treated|0|||
155365490|NCT05131477|560771020|FG009|PART 2|Re-randomized and not treated|0|||
155365491|NCT05131477|560771021|FG010|PART 2|Re-randomized and not treated|1|||
155365492|NCT05131477|560771022|FG011|PART 2|Re-randomized and not treated|0|||
155365493|NCT05131477|560771023|FG012|PART 2|Re-randomized and not treated|1|||
155365494|NCT05131477|560771024|FG013|PART 2|Re-randomized and not treated|1|||
155365495|NCT02194829|560771025|FG000|Overall Study|Adverse Event|2|||
155365496|NCT02194829|560771026|FG001|Overall Study|Adverse Event|2|||
155365497|NCT02194829|560771025|FG000|Overall Study|Death|0|||
155365498|NCT02194829|560771026|FG001|Overall Study|Death|1|||
155365499|NCT02194829|560771025|FG000|Overall Study|Disease progression|0|||
155365500|NCT02194829|560771026|FG001|Overall Study|Disease progression|1|||
155365501|NCT02194829|560771025|FG000|Overall Study|Withdrawal by Subject|0|||
155365502|NCT02194829|560771026|FG001|Overall Study|Withdrawal by Subject|1|||
155365503|NCT02194829|560771025|FG000|Overall Study|Never started protocol therapy|0|||
155365504|NCT02194829|560771026|FG001|Overall Study|Never started protocol therapy|1|||
155365505|NCT03939689|560772678|FG000|Overall Study|Radiographic progression|14|||
155365506|NCT03939689|560772679|FG001|Overall Study|Radiographic progression|17|||
155365507|NCT03939689|560772678|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
155365508|NCT03939689|560772679|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
155365509|NCT03939689|560772678|FG000|Overall Study|Adverse Event|1|||
155365510|NCT03939689|560772679|FG001|Overall Study|Adverse Event|8|||
155365511|NCT03939689|560772678|FG000|Overall Study|Unequivocal clinical progression|2|||
155365512|NCT03939689|560772679|FG001|Overall Study|Unequivocal clinical progression|5|||
155365513|NCT03939689|560772678|FG000|Overall Study|Other|1|||
155365514|NCT03939689|560772679|FG001|Overall Study|Other|4|||
155365515|NCT03939689|560772678|FG000|Overall Study|Death|0|||
155365516|NCT03939689|560772679|FG001|Overall Study|Death|3|||
155365517|NCT03939689|560772678|FG000|Overall Study|Participant decision|0|||
155365518|NCT03939689|560772679|FG001|Overall Study|Participant decision|3|||
155365519|NCT03939689|560772678|FG000|Overall Study|Withdrawal of consent|2|||
154965449|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965450|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965451|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155365520|NCT03939689|560772679|FG001|Overall Study|Withdrawal of consent|1|||
155365521|NCT03939689|560772678|FG000|Overall Study|Investigator decision|1|||
155365522|NCT03939689|560772679|FG001|Overall Study|Investigator decision|0|||
155365523|NCT04427280|560772680|FG000|Overall Study|Withdrawal by Subject|0|||
155365524|NCT04427280|560772681|FG001|Overall Study|Withdrawal by Subject|2|||
155365525|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Adverse Event|2|||
155365526|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Adverse Event|0|||
155365527|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Adverse Event|0|||
155365528|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Adverse Event|0|||
155365529|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
155365530|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
155365531|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
155365532|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
155365533|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
155365534|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
155365535|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
155365536|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
155365537|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Physician Decision|1|||
155365538|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Physician Decision|0|||
155365539|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Physician Decision|0|||
155365540|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Physician Decision|0|||
155365541|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Pregnancy|1|||
155365542|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Pregnancy|0|||
155365543|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Pregnancy|0|||
155365544|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Pregnancy|0|||
155365545|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
155365546|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
155365547|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155365548|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
155365549|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
155365550|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
155365551|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
155365552|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
155365553|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
155365554|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
155365555|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
155365556|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
155365557|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
155365558|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
155365559|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
155365560|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
155365561|NCT04057573|560772682|FG000|24-Week Double-Blind Period|Not Treated|1|||
155365562|NCT04057573|560772683|FG001|24-Week Double-Blind Period|Not Treated|0|||
155365563|NCT04057573|560772684|FG002|24-Week Double-Blind Period|Not Treated|0|||
155365564|NCT04057573|560772685|FG003|24-Week Double-Blind Period|Not Treated|0|||
155365565|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
155365566|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
155365567|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
155365568|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
155365569|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
155365570|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
155365571|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
155365572|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
155365573|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
155365574|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
155365575|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
155365576|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
155365577|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
155365578|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
155365579|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
155365580|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
155365581|NCT04057573|560772682|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
155365582|NCT04057573|560772683|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
155365583|NCT04057573|560772684|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
155365584|NCT04057573|560772685|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
155365585|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
155365586|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
155365587|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
155365588|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
155365589|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
155365590|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
155365591|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
155365592|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
155365593|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
155365594|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
155365595|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
155365596|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
155365597|NCT00790400|560772692|FG000|Double-blind Period (Core Phase)|Death|1|||
155365598|NCT00790400|560772693|FG001|Double-blind Period (Core Phase)|Death|0|||
155365599|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
155365600|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
155365601|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
155365602|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
155365603|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
155365604|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
155365605|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
155365606|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
155365607|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
155365608|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
155365609|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Death|1|||
155365610|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Death|0|||
155365611|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
155365612|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
155365613|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
155365614|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
155365615|NCT00790400|560772692|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
155365616|NCT00790400|560772693|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
155365617|NCT00699153|560772694|FG000|Overall Study|Lost to Follow-up|1|||
155365618|NCT00699153|560772695|FG001|Overall Study|Lost to Follow-up|0|||
155365619|NCT00699153|560772694|FG000|Overall Study|Adverse Event|0|||
155365620|NCT00699153|560772695|FG001|Overall Study|Adverse Event|2|||
155365621|NCT00699153|560772694|FG000|Overall Study|Protocol Violation|1|||
155365622|NCT00699153|560772695|FG001|Overall Study|Protocol Violation|0|||
155365623|NCT00699153|560772694|FG000|Overall Study|Travel Problem|1|||
155365624|NCT00699153|560772695|FG001|Overall Study|Travel Problem|0|||
155365625|NCT00078338|560772699|FG000|Overall Study|Adverse Event|31|||
155365626|NCT00078338|560772700|FG001|Overall Study|Adverse Event|24|||
155365627|NCT00078338|560772699|FG000|Overall Study|Lost to Follow-up|17|||
155365628|NCT00078338|560772700|FG001|Overall Study|Lost to Follow-up|2|||
155365629|NCT00078338|560772699|FG000|Overall Study|Protocol Violation|2|||
155365630|NCT00078338|560772700|FG001|Overall Study|Protocol Violation|2|||
155365631|NCT00078338|560772699|FG000|Overall Study|Disease Progression|4|||
155365632|NCT00078338|560772700|FG001|Overall Study|Disease Progression|7|||
155365633|NCT00078338|560772699|FG000|Overall Study|Other|28|||
155365634|NCT00078338|560772700|FG001|Overall Study|Other|16|||
155365635|NCT00078338|560772699|FG000|Overall Study|Subjects randomized, but not treated|3|||
155365636|NCT00078338|560772700|FG001|Overall Study|Subjects randomized, but not treated|3|||
155365637|NCT04043143|560772701|FG000|Overall Study|Lost to Follow-up|5|||
155365638|NCT04043143|560772702|FG001|Overall Study|Lost to Follow-up|5|||
155365639|NCT04043143|560772701|FG000|Overall Study|screen failure|1|||
155365640|NCT04043143|560772702|FG001|Overall Study|screen failure|0|||
155365641|NCT04307940|560772703|FG000|Overall Study|Adverse Event|1|||
155365642|NCT04307940|560772704|FG001|Overall Study|Adverse Event|0|||
155365643|NCT04307940|560772705|FG002|Overall Study|Adverse Event|0|||
155365644|NCT04307940|560772703|FG000|Overall Study|Withdrawal by Subject|2|||
155365645|NCT04307940|560772704|FG001|Overall Study|Withdrawal by Subject|3|||
155365646|NCT04307940|560772705|FG002|Overall Study|Withdrawal by Subject|1|||
155365647|NCT04307940|560772703|FG000|Overall Study|Lost to Follow-up|2|||
155365648|NCT04307940|560772704|FG001|Overall Study|Lost to Follow-up|0|||
155365649|NCT04307940|560772705|FG002|Overall Study|Lost to Follow-up|1|||
154965452|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
155365650|NCT04624243|560772709|FG000|Overall Study|Death|0|||
155365651|NCT04624243|560772710|FG001|Overall Study|Death|1|||
155365652|NCT04624243|560772711|FG002|Overall Study|Death|0|||
155365653|NCT04624243|560772712|FG003|Overall Study|Death|0|||
155365654|NCT04624243|560772713|FG004|Overall Study|Death|0|||
155365655|NCT04624243|560772709|FG000|Overall Study|Lost to Follow-up|2|||
155365656|NCT04624243|560772710|FG001|Overall Study|Lost to Follow-up|3|||
155365657|NCT04624243|560772711|FG002|Overall Study|Lost to Follow-up|7|||
155365658|NCT04624243|560772712|FG003|Overall Study|Lost to Follow-up|1|||
155365659|NCT04624243|560772713|FG004|Overall Study|Lost to Follow-up|3|||
155365660|NCT04624243|560772709|FG000|Overall Study|Physician Decision|3|||
155365661|NCT04624243|560772710|FG001|Overall Study|Physician Decision|8|||
155365662|NCT04624243|560772711|FG002|Overall Study|Physician Decision|15|||
155365663|NCT04624243|560772712|FG003|Overall Study|Physician Decision|2|||
155365664|NCT04624243|560772713|FG004|Overall Study|Physician Decision|11|||
155365665|NCT04624243|560772709|FG000|Overall Study|Withdrawal by Subject|19|||
155365666|NCT04624243|560772710|FG001|Overall Study|Withdrawal by Subject|44|||
155365667|NCT04624243|560772711|FG002|Overall Study|Withdrawal by Subject|40|||
155365668|NCT04624243|560772712|FG003|Overall Study|Withdrawal by Subject|21|||
155365669|NCT04624243|560772713|FG004|Overall Study|Withdrawal by Subject|39|||
155365670|NCT04624243|560772709|FG000|Overall Study|Miscellaneous|3|||
155365671|NCT04624243|560772710|FG001|Overall Study|Miscellaneous|12|||
155365672|NCT04624243|560772711|FG002|Overall Study|Miscellaneous|9|||
155365673|NCT04624243|560772712|FG003|Overall Study|Miscellaneous|4|||
155365674|NCT04624243|560772713|FG004|Overall Study|Miscellaneous|6|||
155365675|NCT04996004|560772714|FG000|Phase I|Death|1|||
155365676|NCT04996004|560772715|FG001|Phase I|Death|2|||
155365677|NCT04996004|560772716|FG002|Phase I|Death|1|||
155365678|NCT04996004|560772717|FG003|Phase I|Death|0|||
155365679|NCT04996004|560772718|FG004|Phase I|Death|0|||
155365680|NCT04996004|560772719|FG005|Phase I|Death|0|||
155365681|NCT04996004|560772714|FG000|Phase I|Study terminated by sponsor|2|||
155365682|NCT04996004|560772715|FG001|Phase I|Study terminated by sponsor|1|||
155365683|NCT04996004|560772716|FG002|Phase I|Study terminated by sponsor|2|||
155365684|NCT04996004|560772717|FG003|Phase I|Study terminated by sponsor|0|||
155365685|NCT04996004|560772718|FG004|Phase I|Study terminated by sponsor|0|||
155365686|NCT04996004|560772719|FG005|Phase I|Study terminated by sponsor|0|||
155365687|NCT04996004|560772714|FG000|Phase II|Study terminated by sponsor|0|||
155365688|NCT04996004|560772715|FG001|Phase II|Study terminated by sponsor|0|||
155365689|NCT04996004|560772716|FG002|Phase II|Study terminated by sponsor|0|||
155365690|NCT04996004|560772717|FG003|Phase II|Study terminated by sponsor|20|||
155365691|NCT04996004|560772718|FG004|Phase II|Study terminated by sponsor|10|||
155365692|NCT04996004|560772719|FG005|Phase II|Study terminated by sponsor|10|||
155365693|NCT04996004|560772714|FG000|Phase II|Withdrawal by Subject|0|||
155365694|NCT04996004|560772715|FG001|Phase II|Withdrawal by Subject|0|||
155365695|NCT04996004|560772716|FG002|Phase II|Withdrawal by Subject|0|||
155365696|NCT04996004|560772717|FG003|Phase II|Withdrawal by Subject|0|||
155365697|NCT04996004|560772718|FG004|Phase II|Withdrawal by Subject|1|||
155365698|NCT04996004|560772719|FG005|Phase II|Withdrawal by Subject|2|||
155365699|NCT04996004|560772714|FG000|Phase II|Death|0|||
154965453|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
154965454|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155365700|NCT04996004|560772715|FG001|Phase II|Death|0|||
155365701|NCT04996004|560772716|FG002|Phase II|Death|0|||
155365702|NCT04996004|560772717|FG003|Phase II|Death|12|||
154965455|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155365703|NCT04996004|560772718|FG004|Phase II|Death|2|||
155365704|NCT04996004|560772719|FG005|Phase II|Death|9|||
155365705|NCT04996004|560772714|FG000|Phase II|Other|0|||
154965456|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155365706|NCT04996004|560772715|FG001|Phase II|Other|0|||
155365707|NCT04996004|560772716|FG002|Phase II|Other|0|||
155365708|NCT04996004|560772717|FG003|Phase II|Other|0|||
155365709|NCT04996004|560772718|FG004|Phase II|Other|0|||
155365710|NCT04996004|560772719|FG005|Phase II|Other|1|||
155365711|NCT05543174|560772720|FG000|Overall Study|Ongoing|7|||
155365712|NCT03104075|560772721|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
155365713|NCT03104075|560772722|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
155365714|NCT00789360|560772723|FG000|Overall Study|Protocol Violation|3|||
155365715|NCT00789360|560772724|FG001|Overall Study|Protocol Violation|1|||
155365716|NCT03559062|560772725|FG000|Overall Study|Other|0|||
155365717|NCT03559062|560772726|FG001|Overall Study|Other|1|||
155365718|NCT03559062|560772727|FG002|Overall Study|Other|0|||
155365719|NCT01757197|560772728|FG000|Overall Study|Death|2|||
155365720|NCT03322540|560772729|FG000|Overall Study|Death|21|||
155365721|NCT03322540|560772730|FG001|Overall Study|Death|28|||
155365722|NCT03322540|560772729|FG000|Overall Study|Lost to Follow-up|0|||
155365723|NCT03322540|560772730|FG001|Overall Study|Lost to Follow-up|1|||
155365724|NCT03322540|560772729|FG000|Overall Study|Physician Decision|7|||
155365725|NCT03322540|560772730|FG001|Overall Study|Physician Decision|6|||
155365726|NCT03322540|560772729|FG000|Overall Study|Withdrawal by Subject|3|||
155365727|NCT03322540|560772730|FG001|Overall Study|Withdrawal by Subject|1|||
155365728|NCT03322540|560772729|FG000|Overall Study|Study terminated by sponsor|0|||
155365729|NCT03322540|560772730|FG001|Overall Study|Study terminated by sponsor|1|||
155365730|NCT02153905|560772731|FG000|Overall Study|Death|1|||
155365731|NCT02153905|560772732|FG001|Overall Study|Death|0|||
155365732|NCT00520845|560772733|FG000|Overall Study|Death|3|||
155365733|NCT00520845|560772733|FG000|Overall Study|Adverse Event|4|||
155365734|NCT00520845|560772733|FG000|Overall Study|Disease Progression, relapse|13|||
155365735|NCT00520845|560772733|FG000|Overall Study|Withdrawal by Subject|1|||
155365736|NCT00520845|560772733|FG000|Overall Study|Alternative Therapy|1|||
155365737|NCT00351377|560772734|FG000|Overall Study|Adverse Event|5|||
155365738|NCT00351377|560772734|FG000|Overall Study|Death|1|||
155365739|NCT00351377|560772734|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155365740|NCT02493062|560772736|FG000|Overall Study|Physician Decision|12|||
155365741|NCT01967069|560772738|FG000|Overall Study|Adverse Event|2|||
155365742|NCT01967069|560772739|FG001|Overall Study|Adverse Event|2|||
155365743|NCT01967069|560772738|FG000|Overall Study|Lost to Follow-up|5|||
155365744|NCT01967069|560772739|FG001|Overall Study|Lost to Follow-up|2|||
155365745|NCT01967069|560772738|FG000|Overall Study|Withdrawal by Subject|1|||
155365746|NCT01967069|560772739|FG001|Overall Study|Withdrawal by Subject|3|||
155365747|NCT01967069|560772738|FG000|Overall Study|Lack of Efficacy|0|||
155365748|NCT01967069|560772739|FG001|Overall Study|Lack of Efficacy|1|||
155365749|NCT00581477|560772743|FG000|Overall Study|Physician Decision|2|||
155365750|NCT03443414|560772746|FG000|Overall Study|Adverse Event|6|||
155365751|NCT03443414|560772747|FG001|Overall Study|Adverse Event|0|||
155365752|NCT03443414|560772748|FG002|Overall Study|Adverse Event|4|||
155365753|NCT03443414|560772749|FG003|Overall Study|Adverse Event|2|||
155365754|NCT03443414|560772750|FG004|Overall Study|Adverse Event|3|||
155365755|NCT03443414|560772746|FG000|Overall Study|Withdrawal by Subject|3|||
155365756|NCT03443414|560772747|FG001|Overall Study|Withdrawal by Subject|2|||
155365757|NCT03443414|560772748|FG002|Overall Study|Withdrawal by Subject|2|||
155365758|NCT03443414|560772749|FG003|Overall Study|Withdrawal by Subject|2|||
155365759|NCT03443414|560772750|FG004|Overall Study|Withdrawal by Subject|1|||
155365760|NCT03443414|560772746|FG000|Overall Study|Death|0|||
155365761|NCT03443414|560772747|FG001|Overall Study|Death|1|||
155365762|NCT03443414|560772748|FG002|Overall Study|Death|0|||
155365763|NCT03443414|560772749|FG003|Overall Study|Death|1|||
155365764|NCT03443414|560772750|FG004|Overall Study|Death|0|||
155365765|NCT03443414|560772746|FG000|Overall Study|Reason not specified|2|||
155365766|NCT03443414|560772747|FG001|Overall Study|Reason not specified|0|||
155365767|NCT03443414|560772748|FG002|Overall Study|Reason not specified|0|||
155365768|NCT03443414|560772749|FG003|Overall Study|Reason not specified|0|||
155365769|NCT03443414|560772750|FG004|Overall Study|Reason not specified|1|||
155365770|NCT03017742|560772752|FG000|Overall Study|Protocol Violation|36|||
155365771|NCT03017742|560772752|FG000|Overall Study|Withdrawal by Subject|37|||
155365772|NCT05262751|560772755|FG000|Washout Period 2|Adverse Event|1|||
155365773|NCT05262751|560772756|FG001|Washout Period 2|Adverse Event|0|||
155365774|NCT05262751|560772757|FG002|Washout Period 2|Adverse Event|0|||
155365775|NCT05262751|560772758|FG003|Washout Period 2|Adverse Event|0|||
155365776|NCT05262751|560772759|FG004|Washout Period 2|Adverse Event|0|||
155365777|NCT05262751|560772760|FG005|Washout Period 2|Adverse Event|0|||
155365778|NCT05262751|560772755|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
155365779|NCT05262751|560772756|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
155365780|NCT05262751|560772757|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
155365781|NCT05262751|560772758|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
155365782|NCT05262751|560772759|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
155365783|NCT05262751|560772760|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
155365784|NCT03690427|560772761|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
155365785|NCT03690427|560772762|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
155365786|NCT03519204|560772765|FG000|Overall Study|Lost to Follow-up|3|||
155365787|NCT03519204|560772766|FG001|Overall Study|Lost to Follow-up|8|||
155365788|NCT03519204|560772765|FG000|Overall Study|Withdrawal by Subject|9|||
155365789|NCT03519204|560772766|FG001|Overall Study|Withdrawal by Subject|7|||
155365790|NCT03519204|560772765|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155365791|NCT03519204|560772766|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155365792|NCT02956837|560772767|FG000|Overall Study|Serious Adverse Events|0|||
155365793|NCT02956837|560772768|FG001|Overall Study|Serious Adverse Events|1|||
155365794|NCT02956837|560772769|FG002|Overall Study|Serious Adverse Events|0|||
155365795|NCT02956837|560772770|FG003|Overall Study|Serious Adverse Events|0|||
155365796|NCT02956837|560772767|FG000|Overall Study|Withdrawal by Subject|0|||
155365797|NCT02956837|560772768|FG001|Overall Study|Withdrawal by Subject|1|||
155365798|NCT02956837|560772769|FG002|Overall Study|Withdrawal by Subject|0|||
155365799|NCT02956837|560772770|FG003|Overall Study|Withdrawal by Subject|3|||
155365800|NCT02956837|560772767|FG000|Overall Study|Lost to Follow-up|0|||
155365801|NCT02956837|560772768|FG001|Overall Study|Lost to Follow-up|1|||
155365802|NCT02956837|560772769|FG002|Overall Study|Lost to Follow-up|2|||
155365803|NCT02956837|560772770|FG003|Overall Study|Lost to Follow-up|0|||
155365804|NCT02597712|560772775|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
155365805|NCT02597712|560772776|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
155365806|NCT02597712|560772775|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
155365807|NCT02597712|560772776|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
155365808|NCT02597712|560772775|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
155365809|NCT02597712|560772776|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
155365810|NCT01727505|560772780|FG000|First 24 Hours|Adverse Event|0|||
155365811|NCT01727505|560772781|FG001|First 24 Hours|Adverse Event|1|||
155365812|NCT01727505|560772780|FG000|Second 24 Hours|Missing data|0|||
155365813|NCT01727505|560772781|FG001|Second 24 Hours|Missing data|1|||
155365814|NCT02637323|560772783|FG000|Overall Study|Lost to Follow-up|2|||
155365815|NCT02637323|560772784|FG001|Overall Study|Lost to Follow-up|0|||
155365816|NCT02637323|560772783|FG000|Overall Study|Protocol Violation|0|||
155365817|NCT02637323|560772784|FG001|Overall Study|Protocol Violation|1|||
155365818|NCT01154140|560772785|FG000|Overall Study|Death|71|||
155365819|NCT01154140|560772786|FG001|Overall Study|Death|81|||
155365820|NCT01154140|560772785|FG000|Overall Study|Lost to Follow-up|4|||
155365821|NCT01154140|560772786|FG001|Overall Study|Lost to Follow-up|5|||
155365822|NCT01154140|560772785|FG000|Overall Study|Withdrawal by Subject|12|||
155365823|NCT01154140|560772786|FG001|Overall Study|Withdrawal by Subject|13|||
155365824|NCT01154140|560772785|FG000|Overall Study|Other|3|||
155365825|NCT01154140|560772786|FG001|Overall Study|Other|1|||
155365826|NCT01154140|560772785|FG000|Overall Study|Randomized but not treated|1|||
155365827|NCT01154140|560772786|FG001|Overall Study|Randomized but not treated|2|||
155365828|NCT00358644|560772787|FG000|Overall Study|Progressive Disease|21|||
155365829|NCT00358644|560772787|FG000|Overall Study|Adverse Event|7|||
155365830|NCT00358644|560772787|FG000|Overall Study|Death|11|||
155365831|NCT00358644|560772787|FG000|Overall Study|Withdrawal by Subject|4|||
155365832|NCT00358644|560772787|FG000|Overall Study|Physician Decision|6|||
155365833|NCT00358644|560772787|FG000|Overall Study|Patient not eligible for study|1|||
155365834|NCT00513708|560772788|FG000|Overall Study|Lost to Follow-up|4|||
155365835|NCT00513708|560772789|FG001|Overall Study|Lost to Follow-up|4|||
155365836|NCT00513708|560772790|FG002|Overall Study|Lost to Follow-up|4|||
155365837|NCT00368875|560772791|FG000|Overall Study|Adverse Event|0|||
155365838|NCT00368875|560772792|FG001|Overall Study|Adverse Event|12|||
155365839|NCT00368875|560772791|FG000|Overall Study|Progressive disease|3|||
155365840|NCT00368875|560772792|FG001|Overall Study|Progressive disease|27|||
155365841|NCT00368875|560772791|FG000|Overall Study|Withdrawal by Subject|2|||
155365842|NCT00368875|560772792|FG001|Overall Study|Withdrawal by Subject|6|||
155365843|NCT00368875|560772791|FG000|Overall Study|Other Reason|0|||
155365844|NCT00368875|560772792|FG001|Overall Study|Other Reason|2|||
155365845|NCT00368875|560772791|FG000|Overall Study|Alternative Therapy|1|||
155365846|NCT00368875|560772792|FG001|Overall Study|Alternative Therapy|1|||
155365847|NCT03327831|560772793|FG000|Overall Study|Lost to Follow-up|2|||
155365848|NCT01564277|560772794|FG000|Overall Study|Protocol Violation|0|||
155365849|NCT01564277|560772795|FG001|Overall Study|Protocol Violation|1|||
155365850|NCT01564277|560772794|FG000|Overall Study|Physician Decision|1|||
155365851|NCT01564277|560772795|FG001|Overall Study|Physician Decision|0|||
155365852|NCT02595372|560772796|FG000|Overall Study|Adverse Event|6|||
155365853|NCT02595372|560772796|FG000|Overall Study|Physician Decision|2|||
155365854|NCT02595372|560772796|FG000|Overall Study|Disease Progression|1|||
155365855|NCT01594970|560772799|FG000|Overall Study|Non-Adverse Event Related|4|||
155365856|NCT01594970|560772800|FG001|Overall Study|Non-Adverse Event Related|5|||
155365857|NCT01594970|560772801|FG002|Overall Study|Non-Adverse Event Related|6|||
155365858|NCT01594970|560772799|FG000|Overall Study|Adverse Event|17|||
155365859|NCT01594970|560772800|FG001|Overall Study|Adverse Event|23|||
155365860|NCT01594970|560772801|FG002|Overall Study|Adverse Event|23|||
155365861|NCT01594970|560772799|FG000|Overall Study|Lost to Follow-up|54|||
155365862|NCT01594970|560772800|FG001|Overall Study|Lost to Follow-up|54|||
155365863|NCT01594970|560772801|FG002|Overall Study|Lost to Follow-up|37|||
155365864|NCT00401258|560772802|FG000|Overall Study|Adverse Event|7|||
155365865|NCT04276051|560772807|FG000|Overall Study|Lost to Follow-up|0|||
155365866|NCT04276051|560772808|FG001|Overall Study|Lost to Follow-up|1|||
155365867|NCT04276051|560772807|FG000|Overall Study|Physician Decision|0|||
155365868|NCT04276051|560772808|FG001|Overall Study|Physician Decision|1|||
155365869|NCT04276051|560772807|FG000|Overall Study|Withdrawal by Subject|1|||
155365870|NCT04276051|560772808|FG001|Overall Study|Withdrawal by Subject|1|||
155365871|NCT01299480|560772809|FG000|Overall Study|No longer willing to participate|19|||
155365872|NCT01299480|560772810|FG001|Overall Study|No longer willing to participate|17|||
155365873|NCT01299480|560772811|FG002|Overall Study|No longer willing to participate|14|||
155365874|NCT01299480|560772812|FG003|Overall Study|No longer willing to participate|13|||
155365875|NCT01299480|560772813|FG004|Overall Study|No longer willing to participate|10|||
155365876|NCT01299480|560772809|FG000|Overall Study|Protocol Violation|7|||
155365877|NCT01299480|560772810|FG001|Overall Study|Protocol Violation|5|||
155365878|NCT01299480|560772811|FG002|Overall Study|Protocol Violation|8|||
155365879|NCT01299480|560772812|FG003|Overall Study|Protocol Violation|1|||
155365880|NCT01299480|560772813|FG004|Overall Study|Protocol Violation|1|||
155365881|NCT01299480|560772809|FG000|Overall Study|Withdrawal by Subject|3|||
155365882|NCT01299480|560772810|FG001|Overall Study|Withdrawal by Subject|4|||
155365883|NCT01299480|560772811|FG002|Overall Study|Withdrawal by Subject|7|||
155365884|NCT01299480|560772812|FG003|Overall Study|Withdrawal by Subject|3|||
155365885|NCT01299480|560772813|FG004|Overall Study|Withdrawal by Subject|4|||
155365886|NCT01299480|560772809|FG000|Overall Study|Adverse Event|6|||
155365887|NCT01299480|560772810|FG001|Overall Study|Adverse Event|4|||
155365888|NCT01299480|560772811|FG002|Overall Study|Adverse Event|5|||
155365889|NCT01299480|560772812|FG003|Overall Study|Adverse Event|4|||
155365890|NCT01299480|560772813|FG004|Overall Study|Adverse Event|0|||
155365891|NCT01299480|560772809|FG000|Overall Study|Withdrawal due to pregnancy|0|||
155365892|NCT01299480|560772810|FG001|Overall Study|Withdrawal due to pregnancy|1|||
155365893|NCT01299480|560772811|FG002|Overall Study|Withdrawal due to pregnancy|1|||
155365894|NCT01299480|560772812|FG003|Overall Study|Withdrawal due to pregnancy|0|||
155365895|NCT01299480|560772813|FG004|Overall Study|Withdrawal due to pregnancy|0|||
155365896|NCT01299480|560772809|FG000|Overall Study|Physician Decision|1|||
155365897|NCT01299480|560772810|FG001|Overall Study|Physician Decision|1|||
155365898|NCT01299480|560772811|FG002|Overall Study|Physician Decision|0|||
155365899|NCT01299480|560772812|FG003|Overall Study|Physician Decision|2|||
155365900|NCT01299480|560772813|FG004|Overall Study|Physician Decision|0|||
155365901|NCT01299480|560772809|FG000|Overall Study|Lost to Follow-up|3|||
155365902|NCT01299480|560772810|FG001|Overall Study|Lost to Follow-up|1|||
155365903|NCT01299480|560772811|FG002|Overall Study|Lost to Follow-up|2|||
155365904|NCT01299480|560772812|FG003|Overall Study|Lost to Follow-up|1|||
155365905|NCT01299480|560772813|FG004|Overall Study|Lost to Follow-up|2|||
155365906|NCT01299480|560772809|FG000|Overall Study|Other|3|||
155365907|NCT01299480|560772810|FG001|Overall Study|Other|2|||
155365908|NCT01299480|560772811|FG002|Overall Study|Other|3|||
155365909|NCT01299480|560772812|FG003|Overall Study|Other|0|||
155365910|NCT01299480|560772813|FG004|Overall Study|Other|3|||
155365911|NCT01299480|560772809|FG000|Overall Study|Started, but not vaccinated|0|||
155365912|NCT01299480|560772810|FG001|Overall Study|Started, but not vaccinated|0|||
155365913|NCT01299480|560772811|FG002|Overall Study|Started, but not vaccinated|1|||
155365914|NCT01299480|560772812|FG003|Overall Study|Started, but not vaccinated|1|||
155365915|NCT01299480|560772813|FG004|Overall Study|Started, but not vaccinated|0|||
155365916|NCT01374568|560772814|FG000|Overall Study|Lab unable to analyze BTM|0|||
155365917|NCT01374568|560772815|FG001|Overall Study|Lab unable to analyze BTM|2|||
155365918|NCT00617929|560772816|FG000|Overall Study|Physician Decision|1|||
155365919|NCT04160988|560772817|FG000|Overall Study|poor image quality|28|||
155365920|NCT00844597|560772818|FG000|Overall Study|Adverse Event|0|||
155365921|NCT00844597|560772819|FG001|Overall Study|Adverse Event|0|||
155365922|NCT00844597|560772820|FG002|Overall Study|Adverse Event|0|||
155365923|NCT00844597|560772821|FG003|Overall Study|Adverse Event|1|||
155365924|NCT00844597|560772822|FG004|Overall Study|Adverse Event|0|||
155365925|NCT00844597|560772823|FG005|Overall Study|Adverse Event|0|||
155365926|NCT01250509|560772824|FG000|Overall Study|Lost to Follow-up|5|||
155365927|NCT01250509|560772825|FG001|Overall Study|Lost to Follow-up|2|||
155365928|NCT06840769|560772828|FG000|Overall Study|Withdrawal by Subject|1|||
155365929|NCT06840769|560772829|FG001|Overall Study|Withdrawal by Subject|0|||
155365930|NCT06840769|560772830|FG002|Overall Study|Withdrawal by Subject|0|||
155365931|NCT06840769|560772831|FG003|Overall Study|Withdrawal by Subject|0|||
155365932|NCT06840769|560772832|FG004|Overall Study|Withdrawal by Subject|0|||
155365933|NCT02726945|560772833|FG000|Overall Study|Withdrawal by Subject|0|||
155365934|NCT02726945|560772834|FG001|Overall Study|Withdrawal by Subject|0|||
155365935|NCT02726945|560772835|FG002|Overall Study|Withdrawal by Subject|1|||
155365936|NCT02726945|560772833|FG000|Overall Study|Elected to have total knee replacement|0|||
155365937|NCT02726945|560772834|FG001|Overall Study|Elected to have total knee replacement|1|||
155365938|NCT02726945|560772835|FG002|Overall Study|Elected to have total knee replacement|0|||
155365939|NCT02473965|560774581|FG000|Overall Study|Adverse Event|6|||
155365940|NCT02473965|560774582|FG001|Overall Study|Adverse Event|4|||
155365941|NCT02473965|560774581|FG000|Overall Study|MG worsening|4|||
155365942|NCT02473965|560774582|FG001|Overall Study|MG worsening|1|||
155365943|NCT02473965|560774581|FG000|Overall Study|Withdrawal by Subject|2|||
155365944|NCT02473965|560774582|FG001|Overall Study|Withdrawal by Subject|3|||
155365945|NCT02473965|560774581|FG000|Overall Study|Physician Decision|0|||
155365946|NCT02473965|560774582|FG001|Overall Study|Physician Decision|2|||
155365947|NCT03816761|560774583|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365948|NCT03816761|560774584|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365949|NCT03816761|560774585|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365950|NCT03816761|560774586|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365951|NCT03816761|560774587|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
155365952|NCT03816761|560774588|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
155365953|NCT03816761|560774583|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
155365954|NCT03816761|560774584|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
155365955|NCT03816761|560774585|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
155365956|NCT03816761|560774586|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
155365957|NCT03816761|560774587|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
155365958|NCT03816761|560774588|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
155365959|NCT01667926|560774600|FG000|Overall Study|Withdrawal by Subject|1|||
155365960|NCT01667926|560774601|FG001|Overall Study|Withdrawal by Subject|2|||
155365961|NCT01667926|560774602|FG002|Overall Study|Withdrawal by Subject|2|||
155365962|NCT01667926|560774600|FG000|Overall Study|Physician Decision|0|||
155365963|NCT01667926|560774601|FG001|Overall Study|Physician Decision|0|||
155365964|NCT01667926|560774602|FG002|Overall Study|Physician Decision|1|||
155365965|NCT01667926|560774600|FG000|Overall Study|Time committment|0|||
155365966|NCT01667926|560774601|FG001|Overall Study|Time committment|0|||
155365967|NCT01667926|560774602|FG002|Overall Study|Time committment|2|||
155365968|NCT01667926|560774600|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
155365969|NCT01667926|560774601|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
155365970|NCT01667926|560774602|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
155365971|NCT01667926|560774600|FG000|Overall Study|Lost to Follow-up|1|||
155365972|NCT01667926|560774601|FG001|Overall Study|Lost to Follow-up|2|||
155365973|NCT01667926|560774602|FG002|Overall Study|Lost to Follow-up|1|||
155365974|NCT01667926|560774600|FG000|Overall Study|Side effects|3|||
155365975|NCT01667926|560774601|FG001|Overall Study|Side effects|0|||
155365976|NCT01667926|560774602|FG002|Overall Study|Side effects|0|||
155365977|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
155365978|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
155365979|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
155365980|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
155365981|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155365982|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
155090366|NCT02706392|559763626|FG002|Overall Study|Death|2|||
155090367|NCT02706392|559763627|FG003|Overall Study|Death|2|||
155090368|NCT02706392|559763628|FG004|Overall Study|Death|5|||
155365983|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
155090369|NCT02706392|559763629|FG005|Overall Study|Death|2|||
155365984|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
155365985|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155090370|NCT00619866|559763630|FG000|Weeks 1 - 12|Adverse Event|0|||
155090371|NCT00619866|559763631|FG001|Weeks 1 - 12|Adverse Event|1|||
155090372|NCT00619866|559763632|FG002|Weeks 1 - 12|Adverse Event|2|||
155090373|NCT00619866|559763633|FG003|Weeks 1 - 12|Adverse Event|0|||
155090374|NCT00619866|559763634|FG004|Weeks 1 - 12|Adverse Event|0|||
155090375|NCT00619866|559763630|FG000|Weeks 1 - 12|Non-compliance|0|||
155365986|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
155365987|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
155365988|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155365989|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
155365990|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
155365991|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155365992|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
155365993|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
155365994|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
155365995|NCT00603525|560774605|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
155365996|NCT00603525|560774606|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
155365997|NCT00603525|560774607|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
155365998|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
155365999|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
155366000|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
155366001|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
155366002|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
155366003|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
155366004|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
155366005|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
155366006|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
155366007|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
155366008|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
155366009|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
155366010|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
155366011|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
155366012|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
155366013|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
155366014|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
155366015|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
155090376|NCT00619866|559763631|FG001|Weeks 1 - 12|Non-compliance|0|||
155366016|NCT00603525|560774605|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
155366017|NCT00603525|560774606|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
155366018|NCT00603525|560774607|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
155366019|NCT00603525|560774605|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
155366020|NCT00603525|560774606|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
155366021|NCT00603525|560774607|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
155366022|NCT03374488|560774609|FG000|Overall Study|Death|13|||
155366023|NCT03374488|560774610|FG001|Overall Study|Death|13|||
155366024|NCT03374488|560774609|FG000|Overall Study|Withdrawal by Subject|3|||
155366025|NCT03374488|560774610|FG001|Overall Study|Withdrawal by Subject|1|||
155366026|NCT03374488|560774609|FG000|Overall Study|Physician Decision|3|||
155366027|NCT03374488|560774610|FG001|Overall Study|Physician Decision|0|||
155366028|NCT03926195|560774619|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
155366029|NCT03926195|560774620|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
155366030|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
155366031|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
155366032|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
155366033|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
155366034|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
155366035|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
155366036|NCT03926195|560774619|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
155366037|NCT03926195|560774620|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
155366038|NCT03926195|560774619|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
155366039|NCT03926195|560774620|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
155366040|NCT03054337|560774621|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
155366041|NCT03054337|560774622|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
155366042|NCT03054337|560774623|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
155366043|NCT03054337|560774624|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
155366044|NCT03054337|560774625|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
155366045|NCT03054337|560774626|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
155366046|NCT01661205|560774629|FG000|Overall Study|Physician Decision|2|||
155366047|NCT00874731|560774631|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
155366048|NCT00874731|560774632|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
155366049|NCT00874731|560774633|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
155366050|NCT00874731|560774631|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
155366051|NCT00874731|560774632|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
155366052|NCT00874731|560774633|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
155366053|NCT00874731|560774631|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
155366054|NCT00874731|560774632|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
155366055|NCT00874731|560774633|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
155366056|NCT05105087|560774634|FG000|Overall Study|Withdrawal by Subject|2|||
155366057|NCT05105087|560774634|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
155366058|NCT01736540|560774635|FG000|Overall Study|Did not complete scan within 45 days|2|||
155366059|NCT01736540|560774635|FG000|Overall Study|Death|1|||
155366060|NCT01736540|560774635|FG000|Overall Study|Abnormal test procedure|1|||
155366061|NCT01736540|560774635|FG000|Overall Study|Withdrawal by Subject|5|||
155366062|NCT01736540|560774635|FG000|Overall Study|Protocol Violation|1|||
155366063|NCT01736540|560774635|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
155366064|NCT01736540|560774635|FG000|Overall Study|No show for MRI appointment|1|||
155366065|NCT01736540|560774635|FG000|Overall Study|Unable to make MRI appointment|3|||
155366066|NCT01735175|560774638|FG000|Overall Study|Withdrawal by Subject|9|||
155366067|NCT01735175|560774639|FG001|Overall Study|Withdrawal by Subject|2|||
155366068|NCT01735175|560774638|FG000|Overall Study|Lost to Follow-up|4|||
155366069|NCT01735175|560774639|FG001|Overall Study|Lost to Follow-up|2|||
155366070|NCT01735175|560774638|FG000|Overall Study|Death|3|||
155366071|NCT01735175|560774639|FG001|Overall Study|Death|2|||
155366072|NCT01735175|560774638|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
155366073|NCT01735175|560774639|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
155366074|NCT00755417|560774642|FG000|Overall Study|Adverse Event|28|||
155366075|NCT00755417|560774643|FG001|Overall Study|Adverse Event|20|||
155366076|NCT00755417|560774644|FG002|Overall Study|Adverse Event|7|||
155366077|NCT00755417|560774642|FG000|Overall Study|Lack of Efficacy|8|||
155366078|NCT00755417|560774643|FG001|Overall Study|Lack of Efficacy|4|||
155366079|NCT00755417|560774644|FG002|Overall Study|Lack of Efficacy|9|||
155366080|NCT00755417|560774642|FG000|Overall Study|Protocol Violation|2|||
155366081|NCT00755417|560774643|FG001|Overall Study|Protocol Violation|1|||
155366082|NCT00755417|560774644|FG002|Overall Study|Protocol Violation|1|||
155366083|NCT00755417|560774642|FG000|Overall Study|Lost to Follow-up|3|||
155366084|NCT00755417|560774643|FG001|Overall Study|Lost to Follow-up|0|||
155366085|NCT00755417|560774644|FG002|Overall Study|Lost to Follow-up|1|||
155366086|NCT00755417|560774642|FG000|Overall Study|Withdrawal by Subject|12|||
155366087|NCT00755417|560774643|FG001|Overall Study|Withdrawal by Subject|12|||
155366088|NCT00755417|560774644|FG002|Overall Study|Withdrawal by Subject|12|||
155366089|NCT00755417|560774642|FG000|Overall Study|Not specified or missing data|9|||
155366090|NCT00755417|560774643|FG001|Overall Study|Not specified or missing data|18|||
155366091|NCT00755417|560774644|FG002|Overall Study|Not specified or missing data|12|||
155366092|NCT05143138|560774645|FG000|Overall Study|Death|5|||
155366093|NCT05143138|560774646|FG001|Overall Study|Death|35|||
155366094|NCT05143138|560774647|FG002|Overall Study|Death|1|||
155366095|NCT05143138|560774645|FG000|Overall Study|Lost to Follow-up|2|||
155366096|NCT05143138|560774646|FG001|Overall Study|Lost to Follow-up|4|||
155366097|NCT05143138|560774647|FG002|Overall Study|Lost to Follow-up|0|||
155366098|NCT05143138|560774645|FG000|Overall Study|withdrawal|1|||
155366099|NCT05143138|560774646|FG001|Overall Study|withdrawal|1|||
155366100|NCT05143138|560774647|FG002|Overall Study|withdrawal|0|||
155366101|NCT01266161|560774653|FG000|Overall Study|Ineligible|1|||
155366102|NCT01266161|560774654|FG001|Overall Study|Ineligible|0|||
155366103|NCT01266161|560774653|FG000|Overall Study|Lack of Efficacy|0|||
155366104|NCT01266161|560774654|FG001|Overall Study|Lack of Efficacy|1|||
155366105|NCT01266161|560774653|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
155366106|NCT01266161|560774654|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
155366107|NCT01436305|560774656|FG000|Overall Study|Death|1|||
155366108|NCT01436305|560774657|FG001|Overall Study|Death|0|||
155366109|NCT01436305|560774658|FG002|Overall Study|Death|0|||
155366110|NCT01436305|560774656|FG000|Overall Study|Lost to Follow-up|0|||
155366111|NCT01436305|560774657|FG001|Overall Study|Lost to Follow-up|1|||
155366112|NCT01436305|560774658|FG002|Overall Study|Lost to Follow-up|0|||
155366113|NCT01436305|560774656|FG000|Overall Study|Withdrawal by Subject|1|||
155366114|NCT01436305|560774657|FG001|Overall Study|Withdrawal by Subject|3|||
155366115|NCT01436305|560774658|FG002|Overall Study|Withdrawal by Subject|0|||
155366116|NCT01485120|560774666|FG000|Overall Study|Withdrawal by Subject|2|||
155366117|NCT00422734|560774667|FG000|Overall Study|Physician Decision|1|||
155366118|NCT00422734|560774668|FG001|Overall Study|Physician Decision|1|||
155366119|NCT00422734|560774667|FG000|Overall Study|Protocol Violation|1|||
155366120|NCT00422734|560774668|FG001|Overall Study|Protocol Violation|6|||
155366121|NCT00422734|560774667|FG000|Overall Study|Withdrawal by Subject|12|||
155366122|NCT00422734|560774668|FG001|Overall Study|Withdrawal by Subject|8|||
155366123|NCT00422734|560774667|FG000|Overall Study|Adverse Event|0|||
155366124|NCT00422734|560774668|FG001|Overall Study|Adverse Event|3|||
155366125|NCT00422734|560774667|FG000|Overall Study|Partner Decision|0|||
155366126|NCT00422734|560774668|FG001|Overall Study|Partner Decision|3|||
155366127|NCT02344342|560774669|FG000|Overall Study|Industry partner dropped out|11|||
155366128|NCT02344342|560774670|FG001|Overall Study|Industry partner dropped out|9|||
155366129|NCT02344342|560774671|FG002|Overall Study|Industry partner dropped out|14|||
155366130|NCT02344342|560774672|FG003|Overall Study|Industry partner dropped out|10|||
155366131|NCT00848484|560774673|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
155366132|NCT00848484|560774674|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
155366133|NCT00848484|560774673|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
154965457|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965458|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965459|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155366134|NCT00848484|560774674|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
155366135|NCT00848484|560774673|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
155366136|NCT00848484|560774674|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
155366137|NCT00848484|560774673|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
155366138|NCT00848484|560774674|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
155366139|NCT00848484|560774673|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
155366140|NCT00848484|560774674|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
154965460|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155366141|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
155366142|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
155366143|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
155366144|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
155366145|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
155366146|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
155366147|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Death|0|||
155366148|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Death|0|||
155090377|NCT00619866|559763632|FG002|Weeks 1 - 12|Non-compliance|1|||
155366149|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Death|1|||
155366150|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Death|0|||
155366151|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Death|0|||
155366152|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Death|0|||
155366153|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
155366154|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
155366155|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
155366156|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
155366157|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
155366158|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
155366159|NCT03355209|560774675|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
155366160|NCT03355209|560774676|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
155366161|NCT03355209|560774677|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
155366162|NCT03355209|560774678|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155366163|NCT03355209|560774679|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155366164|NCT03355209|560774680|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155366165|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
155366166|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
155366167|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
155366168|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
155366169|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
155366170|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
155366171|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366172|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
155366173|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366174|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366175|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366176|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
155366177|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
155366178|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
155366179|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
155366180|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
155366181|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
155366182|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
155366183|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
155366184|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
155366185|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
155366186|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
155366187|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
155366188|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
155366189|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
155366190|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
155366191|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
155366192|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155366193|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155366194|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155366195|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366196|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366197|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366198|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
155366199|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
155366200|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
155366201|NCT03355209|560774675|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
155366202|NCT03355209|560774676|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366203|NCT03355209|560774677|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
155366204|NCT03355209|560774678|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366205|NCT03355209|560774679|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366206|NCT03355209|560774680|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
155366207|NCT01081886|560774681|FG000|Overall Study|Study termination|11|||
155366208|NCT01081886|560774682|FG001|Overall Study|Study termination|13|||
155366209|NCT02567708|560774683|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
155366210|NCT02567708|560774684|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
155366211|NCT02567708|560774683|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
155366212|NCT02567708|560774684|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
155366213|NCT02567708|560774683|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
155366214|NCT02567708|560774684|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
155366215|NCT02567708|560774683|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
155366216|NCT02567708|560774684|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
155366217|NCT00706654|560774685|FG000|Conversion Phase|Lost to Follow-up|4|||
155366218|NCT00706654|560774686|FG001|Conversion Phase|Lost to Follow-up|0|||
155366219|NCT00706654|560774687|FG002|Conversion Phase|Lost to Follow-up|0|||
155366220|NCT00706654|560774688|FG003|Conversion Phase|Lost to Follow-up|0|||
155366221|NCT00706654|560774685|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
155366222|NCT00706654|560774686|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
155366223|NCT00706654|560774687|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
155366224|NCT00706654|560774688|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
155366225|NCT00706654|560774685|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
155366226|NCT00706654|560774686|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
155366227|NCT00706654|560774687|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
155366228|NCT00706654|560774688|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
155366229|NCT00706654|560774685|FG000|Conversion Phase|Withdrawn by Investigator|14|||
155366230|NCT00706654|560774686|FG001|Conversion Phase|Withdrawn by Investigator|0|||
155366231|NCT00706654|560774687|FG002|Conversion Phase|Withdrawn by Investigator|0|||
155366232|NCT00706654|560774688|FG003|Conversion Phase|Withdrawn by Investigator|0|||
155366233|NCT00706654|560774685|FG000|Conversion Phase|Withdrew Consent|38|||
155366234|NCT00706654|560774686|FG001|Conversion Phase|Withdrew Consent|0|||
155366235|NCT00706654|560774687|FG002|Conversion Phase|Withdrew Consent|0|||
155366236|NCT00706654|560774688|FG003|Conversion Phase|Withdrew Consent|0|||
155366237|NCT00706654|560774685|FG000|Conversion Phase|Adverse Event|18|||
155366238|NCT00706654|560774686|FG001|Conversion Phase|Adverse Event|0|||
155366239|NCT00706654|560774687|FG002|Conversion Phase|Adverse Event|0|||
155366240|NCT00706654|560774688|FG003|Conversion Phase|Adverse Event|0|||
155366241|NCT00706654|560774685|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
155366242|NCT00706654|560774686|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155366243|NCT00706654|560774687|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155366244|NCT00706654|560774688|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
155366245|NCT00706654|560774685|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
155366246|NCT00706654|560774686|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155366247|NCT00706654|560774687|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155366248|NCT00706654|560774688|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
155366249|NCT00706654|560774685|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
155366250|NCT00706654|560774686|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
155366251|NCT00706654|560774687|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
155366252|NCT00706654|560774688|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
155366253|NCT00706654|560774685|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
155366254|NCT00706654|560774686|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
155366255|NCT00706654|560774687|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
155366256|NCT00706654|560774688|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
155366257|NCT00706654|560774685|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
155366258|NCT00706654|560774686|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155366259|NCT00706654|560774687|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155366260|NCT00706654|560774688|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155366261|NCT00706654|560774685|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
155366262|NCT00706654|560774686|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155366263|NCT00706654|560774687|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155366264|NCT00706654|560774688|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
155366265|NCT00706654|560774685|FG000|Oral Stabilization Phase|Withdrew consent|55|||
155366266|NCT00706654|560774686|FG001|Oral Stabilization Phase|Withdrew consent|0|||
155366267|NCT00706654|560774687|FG002|Oral Stabilization Phase|Withdrew consent|0|||
155366268|NCT00706654|560774688|FG003|Oral Stabilization Phase|Withdrew consent|0|||
155366269|NCT00706654|560774685|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
155366270|NCT00706654|560774686|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
155366271|NCT00706654|560774687|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
155366272|NCT00706654|560774688|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
155366273|NCT00706654|560774685|FG000|Oral Stabilization Phase|Adverse Event|21|||
155366274|NCT00706654|560774686|FG001|Oral Stabilization Phase|Adverse Event|0|||
155366275|NCT00706654|560774687|FG002|Oral Stabilization Phase|Adverse Event|0|||
155366276|NCT00706654|560774688|FG003|Oral Stabilization Phase|Adverse Event|0|||
155366277|NCT00706654|560774685|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
155366278|NCT00706654|560774686|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155366279|NCT00706654|560774687|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155366280|NCT00706654|560774688|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
155366281|NCT00706654|560774685|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
155366282|NCT00706654|560774686|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155366283|NCT00706654|560774687|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155366284|NCT00706654|560774688|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
155366285|NCT00706654|560774685|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
155366286|NCT00706654|560774686|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
155366287|NCT00706654|560774687|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
155366288|NCT00706654|560774688|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
155366289|NCT00706654|560774685|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
155366290|NCT00706654|560774686|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
155366291|NCT00706654|560774687|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
155366292|NCT00706654|560774688|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
155366293|NCT00706654|560774685|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
155366294|NCT00706654|560774686|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
155366295|NCT00706654|560774687|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
155366296|NCT00706654|560774688|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
155366297|NCT00706654|560774685|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
155366298|NCT00706654|560774686|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
155366299|NCT00706654|560774687|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
155366300|NCT00706654|560774688|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
155366301|NCT00706654|560774685|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
155366302|NCT00706654|560774686|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
155366303|NCT00706654|560774687|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
155366304|NCT00706654|560774688|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
155366305|NCT00706654|560774685|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
155366306|NCT00706654|560774686|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
155366307|NCT00706654|560774687|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
155366308|NCT00706654|560774688|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
155366309|NCT00706654|560774685|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
155366310|NCT00706654|560774686|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
155366311|NCT00706654|560774687|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
155366312|NCT00706654|560774688|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
155366313|NCT00706654|560774685|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
155366314|NCT00706654|560774686|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
155366315|NCT00706654|560774687|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
155366316|NCT00706654|560774688|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
155366317|NCT01261000|560774689|FG000|Overall Study|Screen failure|1|||
155366318|NCT01151215|560774690|FG000|Overall Study|Worsening of condition under study|1|||
155366319|NCT01151215|560774691|FG001|Overall Study|Worsening of condition under study|1|||
155366320|NCT01151215|560774692|FG002|Overall Study|Worsening of condition under study|1|||
155366321|NCT01151215|560774690|FG000|Overall Study|Death|16|||
155366322|NCT01151215|560774691|FG001|Overall Study|Death|20|||
155366323|NCT01151215|560774692|FG002|Overall Study|Death|11|||
155366324|NCT01151215|560774690|FG000|Overall Study|Lost to Follow-up|0|||
155366325|NCT01151215|560774691|FG001|Overall Study|Lost to Follow-up|0|||
155366326|NCT01151215|560774692|FG002|Overall Study|Lost to Follow-up|3|||
155366327|NCT01151215|560774690|FG000|Overall Study|Withdrawal by Subject|3|||
155366328|NCT01151215|560774691|FG001|Overall Study|Withdrawal by Subject|1|||
155366329|NCT01151215|560774692|FG002|Overall Study|Withdrawal by Subject|2|||
155366330|NCT01151215|560774690|FG000|Overall Study|Disease progression|0|||
155366331|NCT01151215|560774691|FG001|Overall Study|Disease progression|1|||
155366332|NCT01151215|560774692|FG002|Overall Study|Disease progression|1|||
155366333|NCT01151215|560774690|FG000|Overall Study|Safety as judged by the investigator|0|||
155366334|NCT01151215|560774691|FG001|Overall Study|Safety as judged by the investigator|0|||
155366335|NCT01151215|560774692|FG002|Overall Study|Safety as judged by the investigator|1|||
155366336|NCT01427725|560774693|FG000|Overall Study|Lost to Follow-up|17|||
155366337|NCT01427725|560774693|FG000|Overall Study|Protocol Violation|1|||
155366338|NCT01427725|560774693|FG000|Overall Study|Drug not administered|1|||
155366339|NCT01427725|560774693|FG000|Overall Study|Failure to visit|7|||
155366340|NCT01427725|560774693|FG000|Overall Study|Adverse Event|46|||
155366341|NCT01427725|560774693|FG000|Overall Study|Failure to visit after administration|40|||
155366342|NCT01427725|560774693|FG000|Overall Study|Patient's rejection|27|||
155366343|NCT01427725|560774693|FG000|Overall Study|Transfer to a different hospital|17|||
155366344|NCT01427725|560774693|FG000|Overall Study|Lack of Efficacy|8|||
155366345|NCT01427725|560774693|FG000|Overall Study|Death|7|||
155366346|NCT01427725|560774693|FG000|Overall Study|Symptom improvement|6|||
155366347|NCT01427725|560774693|FG000|Overall Study|AE and Patient's rejection|5|||
155366348|NCT01427725|560774693|FG000|Overall Study|Physician Decision|5|||
155366349|NCT01427725|560774693|FG000|Overall Study|Exacerbation of underlying disease|5|||
155366350|NCT01427725|560774693|FG000|Overall Study|Oral feeding difficulty|5|||
155366351|NCT01427725|560774693|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
155366352|NCT01427725|560774693|FG000|Overall Study|Forgetting prescription|1|||
155366353|NCT01427725|560774693|FG000|Overall Study|Other|2|||
155366354|NCT00760747|560774694|FG000|Study Period II|Adverse Event|3|||
155366355|NCT00760747|560774695|FG001|Study Period II|Adverse Event|4|||
155366356|NCT00760747|560774694|FG000|Study Period II|Lack of Efficacy|0|||
155366357|NCT00760747|560774695|FG001|Study Period II|Lack of Efficacy|6|||
155366358|NCT00760747|560774694|FG000|Study Period II|Parent/Caregiver Decision|3|||
155366359|NCT00760747|560774695|FG001|Study Period II|Parent/Caregiver Decision|0|||
155366360|NCT00760747|560774694|FG000|Study Period II|Protocol Violation|6|||
155366361|NCT00760747|560774695|FG001|Study Period II|Protocol Violation|3|||
155366362|NCT00760747|560774694|FG000|Study Period II|Withdrawal by Subject|1|||
155366363|NCT00760747|560774695|FG001|Study Period II|Withdrawal by Subject|0|||
155366364|NCT00760747|560774694|FG000|Study Period II|No drug administered|0|||
155366365|NCT00760747|560774695|FG001|Study Period II|No drug administered|1|||
155366366|NCT00760747|560774694|FG000|Study Period III|Adverse Event|1|||
155366367|NCT00760747|560774695|FG001|Study Period III|Adverse Event|0|||
155366368|NCT00760747|560774694|FG000|Study Period III|Lack of Efficacy|1|||
155366369|NCT00760747|560774695|FG001|Study Period III|Lack of Efficacy|0|||
155366370|NCT00760747|560774694|FG000|Study Period III|Parent/Caregiver Decision|0|||
155366371|NCT00760747|560774695|FG001|Study Period III|Parent/Caregiver Decision|1|||
155366372|NCT00760747|560774694|FG000|Study Period III|Protocol Violation|1|||
155366373|NCT00760747|560774695|FG001|Study Period III|Protocol Violation|1|||
155366374|NCT00760747|560774694|FG000|Study Period III|Physician Decision|0|||
155366375|NCT00760747|560774695|FG001|Study Period III|Physician Decision|1|||
155366376|NCT01447576|560774696|FG000|Overall Study|Lost to Follow-up|52|||
155366377|NCT01447576|560774696|FG000|Overall Study|Adverse Event|127|||
155366378|NCT01447576|560774696|FG000|Overall Study|Participant met withdrawal criteria|40|||
155366379|NCT01447576|560774696|FG000|Overall Study|Withdrawal by Subject|100|||
155366380|NCT01447576|560774696|FG000|Overall Study|Protocol deviation|83|||
155366381|NCT01447576|560774696|FG000|Overall Study|Lack of Efficacy|68|||
155366382|NCT01447576|560774696|FG000|Overall Study|Physician Decision|6|||
155366383|NCT03128671|560774697|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
155366384|NCT03128671|560774698|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
155366385|NCT03128671|560774697|FG000|Allocation|Death|1|||
155366386|NCT03128671|560774698|FG001|Allocation|Death|0|||
155366387|NCT03128671|560774697|FG000|Allocation|Withdrawal by Subject|4|||
155366388|NCT03128671|560774698|FG001|Allocation|Withdrawal by Subject|0|||
155366389|NCT03128671|560774697|FG000|Intervention|Withdrawal by Subject|11|||
155366390|NCT03128671|560774698|FG001|Intervention|Withdrawal by Subject|10|||
155366391|NCT03128671|560774697|FG000|Intervention|Palliative/hospice care initiated|9|||
155366392|NCT03128671|560774698|FG001|Intervention|Palliative/hospice care initiated|10|||
155366393|NCT03128671|560774697|FG000|Intervention|Death|13|||
155366394|NCT03128671|560774698|FG001|Intervention|Death|11|||
155366395|NCT03128671|560774697|FG000|Intervention|Interrupted by hurricane|1|||
155366396|NCT03128671|560774698|FG001|Intervention|Interrupted by hurricane|0|||
155366397|NCT03128671|560774697|FG000|Intervention|Physician Decision|2|||
155366398|NCT03128671|560774698|FG001|Intervention|Physician Decision|3|||
155366399|NCT04463680|560774702|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
155366400|NCT04463680|560774702|FG000|Overall Study|Not eligible due to implant duration of use|1|||
155366401|NCT04463680|560774702|FG000|Overall Study|Withdrawal by Subject|3|||
155366402|NCT02592707|560774705|FG000|Overall Study|Consent Withdrawn|0|||
155366403|NCT02592707|560774706|FG001|Overall Study|Consent Withdrawn|1|||
155366404|NCT02592707|560774707|FG002|Overall Study|Consent Withdrawn|2|||
155366405|NCT02592707|560774708|FG003|Overall Study|Consent Withdrawn|0|||
155366406|NCT02592707|560774705|FG000|Overall Study|Death|1|||
155366407|NCT02592707|560774706|FG001|Overall Study|Death|0|||
155366408|NCT02592707|560774707|FG002|Overall Study|Death|0|||
155366409|NCT02592707|560774708|FG003|Overall Study|Death|0|||
155366410|NCT02592707|560774705|FG000|Overall Study|Progressive Disease|4|||
155366411|NCT02592707|560774706|FG001|Overall Study|Progressive Disease|4|||
155366412|NCT02592707|560774707|FG002|Overall Study|Progressive Disease|3|||
155366413|NCT02592707|560774708|FG003|Overall Study|Progressive Disease|3|||
155366414|NCT02592707|560774705|FG000|Overall Study|Other|0|||
155366415|NCT02592707|560774706|FG001|Overall Study|Other|0|||
155366416|NCT02592707|560774707|FG002|Overall Study|Other|1|||
155366417|NCT02592707|560774708|FG003|Overall Study|Other|2|||
155366418|NCT02592707|560774705|FG000|Overall Study|Never entered LTFU period|1|||
155366419|NCT02592707|560774706|FG001|Overall Study|Never entered LTFU period|0|||
155366420|NCT02592707|560774707|FG002|Overall Study|Never entered LTFU period|0|||
155366421|NCT02592707|560774708|FG003|Overall Study|Never entered LTFU period|2|||
155366422|NCT02998476|560774709|FG000|Overall Study|Lost to Follow-up|1|||
155366423|NCT02998476|560774710|FG001|Overall Study|Lost to Follow-up|0|||
155366424|NCT02998476|560774709|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
155366425|NCT02998476|560774710|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
155366426|NCT02998476|560774709|FG000|Overall Study|Withdrawal by Subject|1|||
155366427|NCT02998476|560774710|FG001|Overall Study|Withdrawal by Subject|2|||
155366428|NCT02998476|560774709|FG000|Overall Study|Death|45|||
155366429|NCT02998476|560774710|FG001|Overall Study|Death|2|||
155366430|NCT02998476|560774709|FG000|Overall Study|Other|6|||
155366431|NCT02998476|560774710|FG001|Overall Study|Other|1|||
155366432|NCT04855734|560774711|FG000|Overall Study|Lost to Follow-up|2|||
155366433|NCT04855734|560774712|FG001|Overall Study|Lost to Follow-up|2|||
155366434|NCT03277352|560774713|FG000|Overall Study|Study Terminated By Sponsor|2|||
155366435|NCT03277352|560774713|FG000|Overall Study|Withdrawal by Subject|4|||
155366436|NCT03277352|560774713|FG000|Overall Study|Death|4|||
155366437|NCT01920477|560776121|FG000|Overall Study|Adverse Event|0|||
155366438|NCT01920477|560776122|FG001|Overall Study|Adverse Event|1|||
155366439|NCT01920477|560776121|FG000|Overall Study|Lack of Efficacy|1|||
155366440|NCT01920477|560776122|FG001|Overall Study|Lack of Efficacy|0|||
155366441|NCT01920477|560776121|FG000|Overall Study|Study closed/terminated|14|||
155366442|NCT01920477|560776122|FG001|Overall Study|Study closed/terminated|15|||
155366443|NCT01920477|560776121|FG000|Overall Study|Withdrawal by Subject|0|||
155366444|NCT01920477|560776122|FG001|Overall Study|Withdrawal by Subject|1|||
155366445|NCT01681277|560776123|FG000|Overall Study|Adverse Event|1|||
155366446|NCT01681277|560776124|FG001|Overall Study|Adverse Event|0|||
155366447|NCT01681277|560776125|FG002|Overall Study|Adverse Event|0|||
155366448|NCT01681277|560776126|FG003|Overall Study|Adverse Event|0|||
155366449|NCT01681277|560776127|FG004|Overall Study|Adverse Event|0|||
155366450|NCT03838731|560776128|FG000|Overall Study|Pregnancy|0|||
155366451|NCT03838731|560776129|FG001|Overall Study|Pregnancy|1|||
155366452|NCT03838731|560776128|FG000|Overall Study|Withdrawal of consent|1|||
155366453|NCT03838731|560776129|FG001|Overall Study|Withdrawal of consent|0|||
155366454|NCT02271984|560776132|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366455|NCT02271984|560776133|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366456|NCT02271984|560776134|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366457|NCT02271984|560776135|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366458|NCT02271984|560776136|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366459|NCT02271984|560776137|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
155366460|NCT02271984|560776138|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366461|NCT02271984|560776139|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
155366462|NCT02271984|560776140|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366463|NCT02271984|560776141|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366464|NCT02271984|560776142|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366465|NCT02271984|560776143|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
155366466|NCT01088984|560776144|FG000|Phase 1|Death|2|||
155366467|NCT01088984|560776145|FG001|Phase 1|Death|1|||
155366468|NCT01088984|560776144|FG000|Phase 1|Disease Progression|2|||
155366469|NCT01088984|560776145|FG001|Phase 1|Disease Progression|4|||
155366470|NCT01088984|560776144|FG000|Phase 1|Other|1|||
155366471|NCT01088984|560776145|FG001|Phase 1|Other|1|||
155366472|NCT01088984|560776144|FG000|Phase 2|Death|0|||
155366473|NCT01088984|560776145|FG001|Phase 2|Death|5|||
155366474|NCT01088984|560776144|FG000|Phase 2|Withdrawal by Subject|0|||
155366475|NCT01088984|560776145|FG001|Phase 2|Withdrawal by Subject|1|||
155366476|NCT01088984|560776144|FG000|Phase 2|DIsease Progression|0|||
155366477|NCT01088984|560776145|FG001|Phase 2|DIsease Progression|25|||
155366478|NCT01088984|560776144|FG000|Phase 2|Other|0|||
155366479|NCT01088984|560776145|FG001|Phase 2|Other|1|||
155366480|NCT01228318|560776146|FG000|Overall Study|Clinic no show to receive intervention|1|||
155366481|NCT01228318|560776147|FG001|Overall Study|Clinic no show to receive intervention|0|||
155366482|NCT01228318|560776146|FG000|Overall Study|Unable to contact|2|||
155366483|NCT01228318|560776147|FG001|Overall Study|Unable to contact|5|||
155366484|NCT01228318|560776146|FG000|Overall Study|Moved|0|||
155366485|NCT01228318|560776147|FG001|Overall Study|Moved|2|||
155366486|NCT01228318|560776146|FG000|Overall Study|Incarcerated|1|||
155366487|NCT01228318|560776147|FG001|Overall Study|Incarcerated|0|||
155366488|NCT00770029|560776152|FG000|Overall Study|Lost to Follow-up|2|||
155366489|NCT00770029|560776153|FG001|Overall Study|Lost to Follow-up|0|||
155366490|NCT00770029|560776152|FG000|Overall Study|Withdrawal by Subject|3|||
155366491|NCT00770029|560776153|FG001|Overall Study|Withdrawal by Subject|3|||
155166747|NCT01737502|560046341|FG001|Phase II|Transition to hospice care|1|||
155166748|NCT01326104|560046343|FG000|Overall Study|progressed prior to vaccine|0|||
155166749|NCT01326104|560046344|FG001|Overall Study|progressed prior to vaccine|2|||
155166750|NCT01326104|560046343|FG000|Overall Study|unable to make vaccine|0|||
155166751|NCT01326104|560046344|FG001|Overall Study|unable to make vaccine|2|||
155166752|NCT05064358|560046345|FG000|Overall Study|Death|23|||
155166753|NCT05064358|560046346|FG001|Overall Study|Death|23|||
155166754|NCT05064358|560046347|FG002|Overall Study|Death|25|||
155166755|NCT05064358|560046348|FG003|Overall Study|Death|21|||
155166756|NCT05064358|560046349|FG004|Overall Study|Death|5|||
155166757|NCT05064358|560046345|FG000|Overall Study|Lost to Follow-up|1|||
155166758|NCT05064358|560046346|FG001|Overall Study|Lost to Follow-up|2|||
155166759|NCT05064358|560046347|FG002|Overall Study|Lost to Follow-up|0|||
155166760|NCT05064358|560046348|FG003|Overall Study|Lost to Follow-up|2|||
155166761|NCT05064358|560046349|FG004|Overall Study|Lost to Follow-up|0|||
155166762|NCT05064358|560046345|FG000|Overall Study|Physician Decision|1|||
155166763|NCT05064358|560046346|FG001|Overall Study|Physician Decision|1|||
155166764|NCT05064358|560046347|FG002|Overall Study|Physician Decision|2|||
155166765|NCT05064358|560046348|FG003|Overall Study|Physician Decision|0|||
155166766|NCT05064358|560046349|FG004|Overall Study|Physician Decision|0|||
155166767|NCT05064358|560046345|FG000|Overall Study|Withdrawal by Subject|4|||
155166768|NCT05064358|560046346|FG001|Overall Study|Withdrawal by Subject|5|||
155166769|NCT05064358|560046347|FG002|Overall Study|Withdrawal by Subject|3|||
155166770|NCT05064358|560046348|FG003|Overall Study|Withdrawal by Subject|6|||
155166771|NCT05064358|560046349|FG004|Overall Study|Withdrawal by Subject|3|||
155166772|NCT05064358|560046345|FG000|Overall Study|Ongoing at the time of analysis|1|||
155166773|NCT05064358|560046346|FG001|Overall Study|Ongoing at the time of analysis|2|||
155166774|NCT05064358|560046347|FG002|Overall Study|Ongoing at the time of analysis|2|||
155166775|NCT05064358|560046348|FG003|Overall Study|Ongoing at the time of analysis|2|||
155166776|NCT05064358|560046349|FG004|Overall Study|Ongoing at the time of analysis|2|||
155166777|NCT04421027|560046350|FG000|Treatment Period|Adverse Event|5|||
155166778|NCT04421027|560046351|FG001|Treatment Period|Adverse Event|3|||
155166779|NCT04421027|560046352|FG002|Treatment Period|Adverse Event|0|||
155166780|NCT04421027|560046353|FG003|Treatment Period|Adverse Event|0|||
155166781|NCT04421027|560046350|FG000|Treatment Period|Death|98|||
155166782|NCT04421027|560046351|FG001|Treatment Period|Death|61|||
155166783|NCT04421027|560046352|FG002|Treatment Period|Death|0|||
155166784|NCT04421027|560046353|FG003|Treatment Period|Death|0|||
155166785|NCT04421027|560046350|FG000|Treatment Period|Lost to Follow-up|22|||
155166786|NCT04421027|560046351|FG001|Treatment Period|Lost to Follow-up|20|||
155166787|NCT04421027|560046352|FG002|Treatment Period|Lost to Follow-up|0|||
155166788|NCT04421027|560046353|FG003|Treatment Period|Lost to Follow-up|0|||
155166789|NCT04421027|560046350|FG000|Treatment Period|Other-Unknown|15|||
155166790|NCT04421027|560046351|FG001|Treatment Period|Other-Unknown|9|||
155166791|NCT04421027|560046352|FG002|Treatment Period|Other-Unknown|0|||
155166792|NCT04421027|560046353|FG003|Treatment Period|Other-Unknown|0|||
155166793|NCT04421027|560046350|FG000|Treatment Period|Physician Decision|1|||
155166794|NCT04421027|560046351|FG001|Treatment Period|Physician Decision|1|||
155166795|NCT04421027|560046352|FG002|Treatment Period|Physician Decision|0|||
155166796|NCT04421027|560046353|FG003|Treatment Period|Physician Decision|0|||
155166797|NCT04421027|560046350|FG000|Treatment Period|Withdrawal by Subject|7|||
155166798|NCT04421027|560046351|FG001|Treatment Period|Withdrawal by Subject|12|||
155166799|NCT04421027|560046352|FG002|Treatment Period|Withdrawal by Subject|0|||
155166800|NCT04421027|560046353|FG003|Treatment Period|Withdrawal by Subject|0|||
155166801|NCT04421027|560046350|FG000|Treatment Period|Randomized Not Dosed|9|||
155366492|NCT00770029|560776152|FG000|Overall Study|Adverse Event|1|||
155166802|NCT04421027|560046351|FG001|Treatment Period|Randomized Not Dosed|14|||
155166803|NCT04421027|560046352|FG002|Treatment Period|Randomized Not Dosed|0|||
155166804|NCT04421027|560046353|FG003|Treatment Period|Randomized Not Dosed|0|||
155166805|NCT04421027|560046350|FG000|Follow-Up Period|Adverse Event|0|||
155166806|NCT04421027|560046351|FG001|Follow-Up Period|Adverse Event|0|||
155166807|NCT04421027|560046352|FG002|Follow-Up Period|Adverse Event|0|||
155166808|NCT04421027|560046353|FG003|Follow-Up Period|Adverse Event|3|||
155166809|NCT04421027|560046350|FG000|Follow-Up Period|Death|0|||
155166810|NCT04421027|560046351|FG001|Follow-Up Period|Death|0|||
155166811|NCT04421027|560046352|FG002|Follow-Up Period|Death|16|||
155166812|NCT04421027|560046353|FG003|Follow-Up Period|Death|17|||
155166813|NCT04421027|560046350|FG000|Follow-Up Period|Lost to Follow-up|0|||
155166814|NCT04421027|560046351|FG001|Follow-Up Period|Lost to Follow-up|0|||
155166815|NCT04421027|560046352|FG002|Follow-Up Period|Lost to Follow-up|7|||
155166816|NCT04421027|560046353|FG003|Follow-Up Period|Lost to Follow-up|7|||
155366493|NCT00770029|560776153|FG001|Overall Study|Adverse Event|0|||
155366494|NCT03480932|560776154|FG000|Overall Study|Death|1|||
155366495|NCT03480932|560776155|FG001|Overall Study|Death|1|||
155366496|NCT03480932|560776156|FG002|Overall Study|Death|0|||
155366497|NCT03480932|560776154|FG000|Overall Study|Lost to Follow-up|0|||
155366498|NCT03480932|560776155|FG001|Overall Study|Lost to Follow-up|2|||
155366499|NCT03480932|560776156|FG002|Overall Study|Lost to Follow-up|3|||
155366500|NCT03480932|560776154|FG000|Overall Study|Incarcerated|2|||
155366501|NCT03480932|560776155|FG001|Overall Study|Incarcerated|2|||
155366502|NCT03480932|560776156|FG002|Overall Study|Incarcerated|2|||
155366503|NCT03057847|560776157|FG000|Overall Study|Lost to Follow-up|16|||
155366504|NCT02138786|560776161|FG000|Overall Study|Adverse Event|0|||
155366505|NCT02138786|560776162|FG001|Overall Study|Adverse Event|2|||
155366506|NCT02138786|560776163|FG002|Overall Study|Adverse Event|1|||
155366507|NCT02138786|560776161|FG000|Overall Study|Death|1|||
155366508|NCT02138786|560776162|FG001|Overall Study|Death|7|||
155366509|NCT02138786|560776163|FG002|Overall Study|Death|2|||
155366510|NCT02138786|560776161|FG000|Overall Study|Disease Progression|1|||
155366511|NCT02138786|560776162|FG001|Overall Study|Disease Progression|1|||
155366512|NCT02138786|560776163|FG002|Overall Study|Disease Progression|3|||
155366513|NCT02138786|560776161|FG000|Overall Study|Withdrawal by Subject|1|||
155366514|NCT02138786|560776162|FG001|Overall Study|Withdrawal by Subject|2|||
155366515|NCT02138786|560776163|FG002|Overall Study|Withdrawal by Subject|0|||
155366516|NCT02138786|560776161|FG000|Overall Study|Patient's Wish|0|||
155366517|NCT02138786|560776162|FG001|Overall Study|Patient's Wish|2|||
155366518|NCT02138786|560776163|FG002|Overall Study|Patient's Wish|0|||
155366519|NCT02138786|560776161|FG000|Overall Study|Sponsor Terminated Study|0|||
155366520|NCT02138786|560776162|FG001|Overall Study|Sponsor Terminated Study|1|||
155366521|NCT02138786|560776163|FG002|Overall Study|Sponsor Terminated Study|1|||
155366522|NCT02138786|560776161|FG000|Overall Study|Non-Compliance|0|||
155366523|NCT02138786|560776162|FG001|Overall Study|Non-Compliance|0|||
155366524|NCT02138786|560776163|FG002|Overall Study|Non-Compliance|1|||
155366525|NCT02088957|560776164|FG000|Overall Study|Lack of Efficacy|1|||
155166817|NCT04421027|560046350|FG000|Follow-Up Period|Protocol Deviation|0|||
155166818|NCT04421027|560046351|FG001|Follow-Up Period|Protocol Deviation|0|||
155166819|NCT04421027|560046352|FG002|Follow-Up Period|Protocol Deviation|1|||
155166820|NCT04421027|560046353|FG003|Follow-Up Period|Protocol Deviation|0|||
155166821|NCT04421027|560046350|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
155166822|NCT04421027|560046351|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
155166823|NCT04421027|560046352|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
155166824|NCT04421027|560046353|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
155166825|NCT04421027|560046350|FG000|Follow-Up Period|Left message, participant did not call back|0|||
155166826|NCT04421027|560046351|FG001|Follow-Up Period|Left message, participant did not call back|0|||
155166827|NCT04421027|560046352|FG002|Follow-Up Period|Left message, participant did not call back|0|||
155166828|NCT04421027|560046353|FG003|Follow-Up Period|Left message, participant did not call back|1|||
155166829|NCT04421027|560046350|FG000|Follow-Up Period|Participant died|0|||
155166830|NCT04421027|560046351|FG001|Follow-Up Period|Participant died|0|||
155166831|NCT04421027|560046352|FG002|Follow-Up Period|Participant died|0|||
155366526|NCT02088957|560776165|FG001|Overall Study|Lack of Efficacy|0|||
155366527|NCT00426127|560776169|FG000|Overall Study|Adverse Event|1|||
155366528|NCT00426127|560776169|FG000|Overall Study|Removed due to disease progression|1|||
155366529|NCT03111095|560776172|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
155366530|NCT03111095|560776173|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
155366531|NCT03111095|560776172|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
155366532|NCT03111095|560776173|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
155166832|NCT04421027|560046353|FG003|Follow-Up Period|Participant died|1|||
155166833|NCT04421027|560046350|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
155366533|NCT00955708|560776180|FG000|Overall Study|Death|269|||
155366534|NCT00955708|560776180|FG000|Overall Study|Lost to Follow-up|72|||
155366535|NCT00955708|560776180|FG000|Overall Study|Physician Decision|36|||
155366536|NCT00955708|560776180|FG000|Overall Study|Protocol Violation|134|||
155366537|NCT00955708|560776180|FG000|Overall Study|Registry Conclusion|186|||
155166834|NCT04421027|560046351|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
155366538|NCT00955708|560776180|FG000|Overall Study|Product removed from service|94|||
155366539|NCT00955708|560776180|FG000|Overall Study|Patient Refused to participate further|116|||
155366540|NCT00955708|560776180|FG000|Overall Study|Closure of study location|60|||
155366541|NCT00955708|560776180|FG000|Overall Study|Patient changed care provider/moved|91|||
155366542|NCT01016262|560776181|FG000|Double-blind Phase|Adverse Event|0|||
155366543|NCT01016262|560776182|FG001|Double-blind Phase|Adverse Event|0|||
155366544|NCT01016262|560776183|FG002|Double-blind Phase|Adverse Event|1|||
155366545|NCT01016262|560776184|FG003|Double-blind Phase|Adverse Event|0|||
155366546|NCT01016262|560776185|FG004|Double-blind Phase|Adverse Event|0|||
155366547|NCT01016262|560776186|FG005|Double-blind Phase|Adverse Event|0|||
155366548|NCT01016262|560776181|FG000|Double-blind Phase|Lack of Efficacy|1|||
155366549|NCT01016262|560776182|FG001|Double-blind Phase|Lack of Efficacy|0|||
155366550|NCT01016262|560776183|FG002|Double-blind Phase|Lack of Efficacy|5|||
155366551|NCT01016262|560776184|FG003|Double-blind Phase|Lack of Efficacy|0|||
155366552|NCT01016262|560776185|FG004|Double-blind Phase|Lack of Efficacy|0|||
155366553|NCT01016262|560776186|FG005|Double-blind Phase|Lack of Efficacy|0|||
155366554|NCT01016262|560776181|FG000|Double-blind Phase|Disease Progression|0|||
155366555|NCT01016262|560776182|FG001|Double-blind Phase|Disease Progression|1|||
155366556|NCT01016262|560776183|FG002|Double-blind Phase|Disease Progression|2|||
155366557|NCT01016262|560776184|FG003|Double-blind Phase|Disease Progression|0|||
155366558|NCT01016262|560776185|FG004|Double-blind Phase|Disease Progression|0|||
155366559|NCT01016262|560776186|FG005|Double-blind Phase|Disease Progression|0|||
155366560|NCT01016262|560776181|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366561|NCT01016262|560776182|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366562|NCT01016262|560776183|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
155366563|NCT01016262|560776184|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366564|NCT01016262|560776185|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366565|NCT01016262|560776186|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
155366566|NCT01016262|560776181|FG000|Open-Label Phase|Adverse Event|0|||
155366567|NCT01016262|560776182|FG001|Open-Label Phase|Adverse Event|0|||
155366568|NCT01016262|560776183|FG002|Open-Label Phase|Adverse Event|0|||
155366569|NCT01016262|560776184|FG003|Open-Label Phase|Adverse Event|1|||
155366570|NCT01016262|560776185|FG004|Open-Label Phase|Adverse Event|0|||
155366571|NCT01016262|560776186|FG005|Open-Label Phase|Adverse Event|0|||
155366572|NCT01016262|560776181|FG000|Open-Label Phase|Lost to Follow-up|0|||
155366573|NCT01016262|560776182|FG001|Open-Label Phase|Lost to Follow-up|0|||
155366574|NCT01016262|560776183|FG002|Open-Label Phase|Lost to Follow-up|0|||
155366575|NCT01016262|560776184|FG003|Open-Label Phase|Lost to Follow-up|0|||
155366576|NCT01016262|560776185|FG004|Open-Label Phase|Lost to Follow-up|1|||
155366577|NCT01016262|560776186|FG005|Open-Label Phase|Lost to Follow-up|0|||
155366578|NCT01016262|560776181|FG000|Open-Label Phase|Lack of Efficacy|0|||
155366579|NCT01016262|560776182|FG001|Open-Label Phase|Lack of Efficacy|0|||
155366580|NCT01016262|560776183|FG002|Open-Label Phase|Lack of Efficacy|0|||
155366581|NCT01016262|560776184|FG003|Open-Label Phase|Lack of Efficacy|1|||
155366582|NCT01016262|560776185|FG004|Open-Label Phase|Lack of Efficacy|0|||
155366583|NCT01016262|560776186|FG005|Open-Label Phase|Lack of Efficacy|0|||
155366584|NCT01016262|560776181|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366585|NCT01016262|560776182|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366586|NCT01016262|560776183|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366587|NCT01016262|560776184|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366588|NCT01016262|560776185|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
155366589|NCT01016262|560776186|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
155366590|NCT03738475|560776188|FG000|Overall Study|Participant Non-Compliance|1|||
155366591|NCT03738475|560776189|FG001|Overall Study|Participant Non-Compliance|0|||
155366592|NCT00677534|560776190|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
155366593|NCT00677534|560776190|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
155366594|NCT00677534|560776190|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
155366595|NCT04638660|560776192|FG000|Overall Study|Withdrawal by Subject|2|||
155366596|NCT04638660|560776193|FG001|Overall Study|Withdrawal by Subject|0|||
155366597|NCT04638660|560776192|FG000|Overall Study|Lost to Follow-up|1|||
155366598|NCT04638660|560776193|FG001|Overall Study|Lost to Follow-up|0|||
155366599|NCT00863681|560776200|FG000|Overall Study|Other|2|||
155366600|NCT00863681|560776201|FG001|Overall Study|Other|0|||
155366601|NCT00863681|560776202|FG002|Overall Study|Other|0|||
155366602|NCT00863681|560776200|FG000|Overall Study|Missing|1|||
155366603|NCT00863681|560776201|FG001|Overall Study|Missing|0|||
155366604|NCT00863681|560776202|FG002|Overall Study|Missing|0|||
155366605|NCT00863681|560776200|FG000|Overall Study|Death|40|||
155366606|NCT00863681|560776201|FG001|Overall Study|Death|23|||
155366607|NCT00863681|560776202|FG002|Overall Study|Death|6|||
155366608|NCT00863681|560776200|FG000|Overall Study|Withdrawal by Subject|12|||
155366609|NCT00863681|560776201|FG001|Overall Study|Withdrawal by Subject|5|||
155366610|NCT00863681|560776202|FG002|Overall Study|Withdrawal by Subject|2|||
155366611|NCT00863681|560776200|FG000|Overall Study|Protocol Violation|2|||
155366612|NCT00863681|560776201|FG001|Overall Study|Protocol Violation|0|||
155366613|NCT00863681|560776202|FG002|Overall Study|Protocol Violation|0|||
155366614|NCT00863681|560776200|FG000|Overall Study|Lost to Follow-up|3|||
155366615|NCT00863681|560776201|FG001|Overall Study|Lost to Follow-up|0|||
155366616|NCT00863681|560776202|FG002|Overall Study|Lost to Follow-up|3|||
155366617|NCT00863681|560776200|FG000|Overall Study|Adverse Event|28|||
155366618|NCT00863681|560776201|FG001|Overall Study|Adverse Event|10|||
155366619|NCT00863681|560776202|FG002|Overall Study|Adverse Event|6|||
155166835|NCT04421027|560046352|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
155166836|NCT04421027|560046353|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
155166837|NCT00505778|560047692|FG000|Overall Study|Adverse Event|2|||
155166838|NCT00505778|560047693|FG001|Overall Study|Adverse Event|7|||
155166839|NCT00505778|560047692|FG000|Overall Study|Physician Decision|8|||
155166840|NCT00505778|560047693|FG001|Overall Study|Physician Decision|14|||
155166841|NCT00505778|560047692|FG000|Overall Study|Lost to Follow-up|17|||
155166842|NCT00505778|560047693|FG001|Overall Study|Lost to Follow-up|23|||
155166843|NCT00505778|560047692|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
155366620|NCT00863681|560776200|FG000|Overall Study|Lack of Efficacy|2|||
155366621|NCT00863681|560776201|FG001|Overall Study|Lack of Efficacy|2|||
155366622|NCT00863681|560776202|FG002|Overall Study|Lack of Efficacy|1|||
155366623|NCT00863681|560776200|FG000|Overall Study|Non-compliance with study drug|1|||
155366624|NCT00863681|560776201|FG001|Overall Study|Non-compliance with study drug|3|||
155366625|NCT00863681|560776202|FG002|Overall Study|Non-compliance with study drug|0|||
155366626|NCT00659880|560776204|FG000|Overall Study|Lost to Follow-up|5|||
155366627|NCT01853475|560776205|FG000|Overall Study|Withdrawal by Subject|0|||
155366628|NCT01853475|560776206|FG001|Overall Study|Withdrawal by Subject|1|||
155366629|NCT01853475|560776207|FG002|Overall Study|Withdrawal by Subject|0|||
155366630|NCT03199469|560776208|FG000|Overall Study|Randomized, not treated|0|||
155366631|NCT03199469|560776209|FG001|Overall Study|Randomized, not treated|3|||
155166844|NCT00505778|560047693|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
155166845|NCT00505778|560047692|FG000|Overall Study|Protocol Violation|7|||
155166846|NCT00505778|560047693|FG001|Overall Study|Protocol Violation|9|||
155166847|NCT00505778|560047692|FG000|Overall Study|Withdrawal by Subject|29|||
155166848|NCT00505778|560047693|FG001|Overall Study|Withdrawal by Subject|14|||
155166849|NCT00505778|560047692|FG000|Overall Study|Relapse|65|||
155166850|NCT00505778|560047693|FG001|Overall Study|Relapse|65|||
155166851|NCT00505778|560047692|FG000|Overall Study|Took No Study Drug|2|||
155166852|NCT00505778|560047693|FG001|Overall Study|Took No Study Drug|2|||
155166853|NCT03790696|560047695|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
155166854|NCT03790696|560047696|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
155166855|NCT00970684|560047703|FG000|Overall Study|Lack of Efficacy|5|||
155166856|NCT00970684|560047703|FG000|Overall Study|Adverse Event|4|||
155166857|NCT00970684|560047703|FG000|Overall Study|Withdrawal by Subject|1|||
155166858|NCT01175083|560047704|FG000|Primary Epoch|Withdrawal by Subject|0|||
155166859|NCT01175083|560047705|FG001|Primary Epoch|Withdrawal by Subject|0|||
155166860|NCT01175083|560047706|FG002|Primary Epoch|Withdrawal by Subject|0|||
155166861|NCT01175083|560047707|FG003|Primary Epoch|Withdrawal by Subject|0|||
155166862|NCT01175083|560047708|FG004|Primary Epoch|Withdrawal by Subject|0|||
155166863|NCT01175083|560047709|FG005|Primary Epoch|Withdrawal by Subject|2|||
155166864|NCT01175083|560047704|FG000|Primary Epoch|Lost to Follow-up|0|||
155366632|NCT03199469|560776208|FG000|Overall Study|Withdrawal by Subject|1|||
155366633|NCT03199469|560776209|FG001|Overall Study|Withdrawal by Subject|0|||
155366634|NCT03199469|560776208|FG000|Overall Study|Death|1|||
155166865|NCT01175083|560047705|FG001|Primary Epoch|Lost to Follow-up|0|||
155166866|NCT01175083|560047706|FG002|Primary Epoch|Lost to Follow-up|0|||
155366635|NCT03199469|560776209|FG001|Overall Study|Death|3|||
155366636|NCT03199469|560776208|FG000|Overall Study|Ongoing|5|||
155366637|NCT03199469|560776209|FG001|Overall Study|Ongoing|14|||
155366638|NCT01031628|560776210|FG000|Overall Study|Study terminated early|0|||
155366639|NCT01031628|560776211|FG001|Overall Study|Study terminated early|1|||
155366640|NCT01031628|560776212|FG002|Overall Study|Study terminated early|3|||
155366641|NCT01031628|560776213|FG003|Overall Study|Study terminated early|0|||
155366642|NCT01304498|560776214|FG000|Overall Study|Adverse Event|1|||
155366643|NCT01304498|560776215|FG001|Overall Study|Adverse Event|1|||
155366644|NCT01304498|560776214|FG000|Overall Study|Withdrawal by Subject|2|||
155366645|NCT01304498|560776215|FG001|Overall Study|Withdrawal by Subject|3|||
155166867|NCT01175083|560047707|FG003|Primary Epoch|Lost to Follow-up|0|||
155166868|NCT01175083|560047708|FG004|Primary Epoch|Lost to Follow-up|0|||
155366646|NCT01304498|560776214|FG000|Overall Study|Protocol Violation|1|||
155366647|NCT01304498|560776215|FG001|Overall Study|Protocol Violation|0|||
155366648|NCT01304498|560776214|FG000|Overall Study|Lost to Follow-up|2|||
155366649|NCT01304498|560776215|FG001|Overall Study|Lost to Follow-up|1|||
155166869|NCT01175083|560047709|FG005|Primary Epoch|Lost to Follow-up|1|||
155166870|NCT01175083|560047704|FG000|Booster Epoch|Death|0|||
155166871|NCT01175083|560047705|FG001|Booster Epoch|Death|0|||
155166872|NCT01175083|560047706|FG002|Booster Epoch|Death|1|||
155166873|NCT01175083|560047707|FG003|Booster Epoch|Death|0|||
155166874|NCT01175083|560047708|FG004|Booster Epoch|Death|0|||
155166875|NCT01175083|560047709|FG005|Booster Epoch|Death|0|||
155366650|NCT03080493|560776216|FG000|Overall Study|Did not provide NRS pain results|1|||
155366651|NCT03080493|560776217|FG001|Overall Study|Did not provide NRS pain results|0|||
155366652|NCT03080493|560776216|FG000|Overall Study|Adverse Event|0|||
155366653|NCT03080493|560776217|FG001|Overall Study|Adverse Event|1|||
155366654|NCT03080493|560776216|FG000|Overall Study|Randomization error (parity group)|0|||
155366655|NCT03080493|560776217|FG001|Overall Study|Randomization error (parity group)|1|||
155366656|NCT02803593|560776218|FG000|Overall Study|Lost to Follow-up|17|||
155366657|NCT02803593|560776219|FG001|Overall Study|Lost to Follow-up|35|||
155366658|NCT04245345|560776228|FG000|Overall Study|Death|1|||
155366659|NCT04245345|560776228|FG000|Overall Study|Exited prior to implant|5|||
155366660|NCT04245345|560776228|FG000|Overall Study|Exited prior to 1-month|9|||
155366661|NCT04245345|560776228|FG000|Overall Study|Missed 1-month visit|3|||
155366662|NCT04245345|560776228|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
155366663|NCT04245345|560776228|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
155366664|NCT01834586|560776229|FG000|Overall Study|Adverse Event|1|||
155366665|NCT03325777|560776232|FG000|Overall Study|Lost to Follow-up|9|||
155366666|NCT03325777|560776233|FG001|Overall Study|Lost to Follow-up|12|||
155366667|NCT03004404|560776234|FG000|Period 2|Adverse Event|0|||
155366668|NCT03004404|560776235|FG001|Period 2|Adverse Event|0|||
155366669|NCT03004404|560776236|FG002|Period 2|Adverse Event|0|||
155366670|NCT03004404|560776237|FG003|Period 2|Adverse Event|0|||
155366671|NCT03004404|560776238|FG004|Period 2|Adverse Event|0|||
155366672|NCT03004404|560776239|FG005|Period 2|Adverse Event|0|||
155366673|NCT03004404|560776240|FG006|Period 2|Adverse Event|0|||
155366674|NCT03004404|560776241|FG007|Period 2|Adverse Event|0|||
155366675|NCT03004404|560776242|FG008|Period 2|Adverse Event|1|||
155366676|NCT03004404|560776243|FG009|Period 2|Adverse Event|0|||
155366677|NCT03004404|560776244|FG010|Period 2|Adverse Event|0|||
155366678|NCT03004404|560776245|FG011|Period 2|Adverse Event|0|||
155366679|NCT03004404|560776246|FG012|Period 2|Adverse Event|0|||
155366680|NCT03004404|560776247|FG013|Period 2|Adverse Event|0|||
155366681|NCT03004404|560776248|FG014|Period 2|Adverse Event|0|||
155366682|NCT03004404|560776249|FG015|Period 2|Adverse Event|1|||
155366683|NCT02522728|560776253|FG000|Overall Study|Withdrawal by Subject|6|||
155366684|NCT02522728|560776254|FG001|Overall Study|Withdrawal by Subject|6|||
155366685|NCT02522728|560776253|FG000|Overall Study|Death|4|||
155366686|NCT02522728|560776254|FG001|Overall Study|Death|3|||
155366687|NCT02522728|560776253|FG000|Overall Study|Adverse Event|2|||
155366688|NCT02522728|560776254|FG001|Overall Study|Adverse Event|1|||
155366689|NCT02522728|560776253|FG000|Overall Study|Did not receive randomized study device|0|||
155366690|NCT02522728|560776254|FG001|Overall Study|Did not receive randomized study device|1|||
155366691|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
155366692|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
155366693|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
155366694|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
155366695|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
155366696|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
155366697|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
155366698|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
155366699|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
155366700|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
155366701|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
155366702|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
155366703|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
155366704|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
155366705|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
155366706|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
155366707|NCT04210843|560776256|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
155166876|NCT01175083|560047704|FG000|Booster Epoch|Withdrawal by Subject|0|||
155166877|NCT01175083|560047705|FG001|Booster Epoch|Withdrawal by Subject|0|||
155366708|NCT04210843|560776257|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
155366709|NCT04210843|560776256|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
155366710|NCT04210843|560776257|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
155366711|NCT04210843|560776256|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
155366712|NCT04210843|560776257|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
155366713|NCT04210843|560776256|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
155366714|NCT04210843|560776257|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
155366715|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
155366716|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
155366717|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
155166878|NCT01175083|560047706|FG002|Booster Epoch|Withdrawal by Subject|0|||
155366718|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
155366719|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
155366720|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
155366721|NCT04210843|560776256|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
155366722|NCT04210843|560776257|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
155366723|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
155366724|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
155366725|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
155366726|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
155366727|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
155366728|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
155366729|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
155366730|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
155366731|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
155366732|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
155366733|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
155366734|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
155366735|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
155366736|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
155366737|NCT04210843|560776256|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
155366738|NCT04210843|560776257|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
155366739|NCT01099917|560776258|FG000|Overall Study|Adverse Event|3|||
155366740|NCT01099917|560776258|FG000|Overall Study|Not Treated|24|||
155366741|NCT02990468|560776259|FG000|Phase 2: MTD|Change in treatment|0|||
155366742|NCT02990468|560776260|FG001|Phase 2: MTD|Change in treatment|0|||
155366743|NCT02990468|560776261|FG002|Phase 2: MTD|Change in treatment|1|||
155366744|NCT01001390|560776263|FG000|Overall Study|Failure to wear AFO device|2|||
155366745|NCT01001390|560776264|FG001|Overall Study|Failure to wear AFO device|0|||
155366746|NCT01721954|560776268|FG000|Overall Study|Death|58|||
155366747|NCT01721954|560776269|FG001|Overall Study|Death|64|||
155366748|NCT01721954|560776268|FG000|Overall Study|Withdrawal by Subject|8|||
155366749|NCT01721954|560776269|FG001|Overall Study|Withdrawal by Subject|4|||
155366750|NCT01721954|560776268|FG000|Overall Study|Adverse Event|2|||
155366751|NCT01721954|560776269|FG001|Overall Study|Adverse Event|0|||
155366752|NCT01721954|560776268|FG000|Overall Study|Lost to Follow-up|2|||
155366753|NCT01721954|560776269|FG001|Overall Study|Lost to Follow-up|1|||
155366754|NCT01825577|560776270|FG000|Overall Study|Physician Decision|2|||
155366755|NCT01825577|560776270|FG000|Overall Study|Withdrawal by Subject|1|||
155366756|NCT01825577|560776270|FG000|Overall Study|Withdrawn by family members|2|||
155366757|NCT01825577|560776270|FG000|Overall Study|Lack of Efficacy|3|||
155366758|NCT04230122|560776273|FG000|Overall Study|Lost to Follow-up|1|||
155366759|NCT04230122|560776274|FG001|Overall Study|Lost to Follow-up|0|||
155366760|NCT00108745|560776292|FG000|Overall Study|Withdrawal by Subject|19|||
155366761|NCT00108745|560776293|FG001|Overall Study|Withdrawal by Subject|12|||
155366762|NCT00108745|560776294|FG002|Overall Study|Withdrawal by Subject|12|||
155366763|NCT00108745|560776292|FG000|Overall Study|Never Treated|8|||
155366764|NCT00108745|560776293|FG001|Overall Study|Never Treated|10|||
155366765|NCT00108745|560776294|FG002|Overall Study|Never Treated|12|||
155366766|NCT00108745|560776292|FG000|Overall Study|Ineligible|7|||
155366767|NCT00108745|560776293|FG001|Overall Study|Ineligible|13|||
155366768|NCT00108745|560776294|FG002|Overall Study|Ineligible|13|||
155366769|NCT01228175|560776295|FG000|Overall Study|Lost to Follow-up|64|||
155366770|NCT01228175|560776296|FG001|Overall Study|Lost to Follow-up|50|||
155366771|NCT01228175|560776295|FG000|Overall Study|Withdrawal by Subject|1|||
155366772|NCT01228175|560776296|FG001|Overall Study|Withdrawal by Subject|2|||
155366773|NCT01228175|560776295|FG000|Overall Study|Physician Decision|1|||
155366774|NCT01228175|560776296|FG001|Overall Study|Physician Decision|1|||
155366775|NCT00402051|560776297|FG000|Overall Study|Progressive Disease|13|||
155366776|NCT00402051|560776298|FG001|Overall Study|Progressive Disease|20|||
155366777|NCT00402051|560776297|FG000|Overall Study|Adverse Event|11|||
155366778|NCT00402051|560776298|FG001|Overall Study|Adverse Event|4|||
155366779|NCT00402051|560776297|FG000|Overall Study|Physician Decision|7|||
155366780|NCT00402051|560776298|FG001|Overall Study|Physician Decision|3|||
155366781|NCT00402051|560776297|FG000|Overall Study|Withdrawal by Subject|3|||
155366782|NCT00402051|560776298|FG001|Overall Study|Withdrawal by Subject|3|||
155366783|NCT00402051|560776297|FG000|Overall Study|Death - Related to Study Drug|1|||
155366784|NCT00402051|560776298|FG001|Overall Study|Death - Related to Study Drug|2|||
155366785|NCT00402051|560776297|FG000|Overall Study|Death Due to Study Disease|2|||
155366786|NCT00402051|560776298|FG001|Overall Study|Death Due to Study Disease|1|||
155366787|NCT00402051|560776297|FG000|Overall Study|Death Due to Adverse Event|0|||
155366788|NCT00402051|560776298|FG001|Overall Study|Death Due to Adverse Event|2|||
155366789|NCT00402051|560776297|FG000|Overall Study|Lost to Follow-up|1|||
155366790|NCT00402051|560776298|FG001|Overall Study|Lost to Follow-up|0|||
155366791|NCT00277095|560776299|FG000|Overall Study|Death|2|||
155366792|NCT00277095|560776299|FG000|Overall Study|Explanted|7|||
155366793|NCT00277095|560776299|FG000|Overall Study|Lost to Follow-up|2|||
155366794|NCT00277095|560776299|FG000|Overall Study|Missed Follow-up|9|||
155366795|NCT00277095|560776299|FG000|Overall Study|Physician Decision|1|||
155366796|NCT05415748|560776303|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
155366797|NCT05415748|560776304|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
155366798|NCT05415748|560776305|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
155366799|NCT05415748|560776306|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
155366800|NCT05415748|560776303|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
155366801|NCT05415748|560776304|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
155366802|NCT05415748|560776305|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
155366803|NCT05415748|560776306|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
155366804|NCT03075527|560776307|FG000|Overall Study|Death|1|||
155366805|NCT03075527|560776307|FG000|Overall Study|Withdrawal by Subject|1|||
155366806|NCT03075527|560776307|FG000|Overall Study|Physician Decision|3|||
155366807|NCT03075527|560776307|FG000|Overall Study|Progression/Relapse|14|||
155366808|NCT03832595|560776310|FG000|Overall Study|Death|142|||
155366809|NCT03832595|560776311|FG001|Overall Study|Death|130|||
155366810|NCT03832595|560776310|FG000|Overall Study|Medical management without dialysis|37|||
155366811|NCT03832595|560776311|FG001|Overall Study|Medical management without dialysis|1|||
155366812|NCT03412773|560778402|FG000|Overall Study|Lost to Follow-up|0|||
155366813|NCT03412773|560778403|FG001|Overall Study|Lost to Follow-up|7|||
155366814|NCT03412773|560778404|FG002|Overall Study|Lost to Follow-up|6|||
155366815|NCT03412773|560778402|FG000|Overall Study|Withdrawal by Subject|0|||
155366816|NCT03412773|560778403|FG001|Overall Study|Withdrawal by Subject|15|||
155366817|NCT03412773|560778404|FG002|Overall Study|Withdrawal by Subject|19|||
155366818|NCT03412773|560778402|FG000|Overall Study|Study Closed By Sponsor|3|||
155366819|NCT03412773|560778403|FG001|Overall Study|Study Closed By Sponsor|46|||
155366820|NCT03412773|560778404|FG002|Overall Study|Study Closed By Sponsor|33|||
155366821|NCT03412773|560778402|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
155366822|NCT03412773|560778403|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
155366823|NCT03412773|560778404|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
155366824|NCT03412773|560778402|FG000|Overall Study|Death|7|||
155366825|NCT03412773|560778403|FG001|Overall Study|Death|259|||
155366826|NCT03412773|560778404|FG002|Overall Study|Death|273|||
155366827|NCT03412773|560778402|FG000|Overall Study|Physician Decision|0|||
155366828|NCT03412773|560778403|FG001|Overall Study|Physician Decision|0|||
155366829|NCT03412773|560778404|FG002|Overall Study|Physician Decision|1|||
155366830|NCT02643303|560778407|FG000|Overall Study|Progressive Disease|4|||
155366831|NCT02643303|560778408|FG001|Overall Study|Progressive Disease|4|||
155366832|NCT02643303|560778409|FG002|Overall Study|Progressive Disease|1|||
155366833|NCT02643303|560778410|FG003|Overall Study|Progressive Disease|12|||
155090378|NCT00619866|559763633|FG003|Weeks 1 - 12|Non-compliance|0|||
155090379|NCT00619866|559763634|FG004|Weeks 1 - 12|Non-compliance|0|||
155366834|NCT02643303|560778411|FG004|Overall Study|Progressive Disease|6|||
155366835|NCT02643303|560778412|FG005|Overall Study|Progressive Disease|4|||
155366836|NCT02643303|560778413|FG006|Overall Study|Progressive Disease|8|||
155366837|NCT02643303|560778414|FG007|Overall Study|Progressive Disease|2|||
155366838|NCT02643303|560778415|FG008|Overall Study|Progressive Disease|6|||
155366839|NCT02643303|560778407|FG000|Overall Study|Adverse Event|0|||
155366840|NCT02643303|560778408|FG001|Overall Study|Adverse Event|1|||
155366841|NCT02643303|560778409|FG002|Overall Study|Adverse Event|0|||
155366842|NCT02643303|560778410|FG003|Overall Study|Adverse Event|0|||
155366843|NCT02643303|560778411|FG004|Overall Study|Adverse Event|1|||
155366844|NCT02643303|560778412|FG005|Overall Study|Adverse Event|0|||
155366845|NCT02643303|560778413|FG006|Overall Study|Adverse Event|0|||
155366846|NCT02643303|560778414|FG007|Overall Study|Adverse Event|0|||
155366847|NCT02643303|560778415|FG008|Overall Study|Adverse Event|0|||
155366848|NCT02643303|560778407|FG000|Overall Study|Withdrawal by Subject|0|||
155366849|NCT02643303|560778408|FG001|Overall Study|Withdrawal by Subject|0|||
155366850|NCT02643303|560778409|FG002|Overall Study|Withdrawal by Subject|0|||
155366851|NCT02643303|560778410|FG003|Overall Study|Withdrawal by Subject|1|||
155366852|NCT02643303|560778411|FG004|Overall Study|Withdrawal by Subject|0|||
155366853|NCT02643303|560778412|FG005|Overall Study|Withdrawal by Subject|0|||
155366854|NCT02643303|560778413|FG006|Overall Study|Withdrawal by Subject|1|||
155366855|NCT02643303|560778414|FG007|Overall Study|Withdrawal by Subject|1|||
155366856|NCT02643303|560778415|FG008|Overall Study|Withdrawal by Subject|1|||
155366857|NCT01174446|560778418|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
155366858|NCT01174446|560778419|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
155366859|NCT01174446|560778420|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
155366860|NCT01174446|560778421|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
155366861|NCT01174446|560778418|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
155366862|NCT01174446|560778419|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
155366863|NCT01174446|560778420|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
155366864|NCT01174446|560778421|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
155366865|NCT01174446|560778418|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
155366866|NCT01174446|560778419|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
155366867|NCT01174446|560778420|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
155366868|NCT01174446|560778421|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
155366869|NCT01174446|560778418|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
155366870|NCT01174446|560778419|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
155366871|NCT01174446|560778420|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
155366872|NCT01174446|560778421|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
155366873|NCT00847626|560778422|FG000|Overall Study|Adverse Event|10|||
155366874|NCT00847626|560778423|FG001|Overall Study|Adverse Event|10|||
155366875|NCT00847626|560778424|FG002|Overall Study|Adverse Event|6|||
155366876|NCT00847626|560778425|FG003|Overall Study|Adverse Event|19|||
155366877|NCT00847626|560778426|FG004|Overall Study|Adverse Event|11|||
155366878|NCT00847626|560778427|FG005|Overall Study|Adverse Event|22|||
155366879|NCT00847626|560778428|FG006|Overall Study|Adverse Event|4|||
155366880|NCT00847626|560778429|FG007|Overall Study|Adverse Event|6|||
155366881|NCT00847626|560778430|FG008|Overall Study|Adverse Event|3|||
155366882|NCT00847626|560778431|FG009|Overall Study|Adverse Event|6|||
155366883|NCT00847626|560778432|FG010|Overall Study|Adverse Event|6|||
155366884|NCT00847626|560778422|FG000|Overall Study|Protocol Violation|2|||
155366885|NCT00847626|560778423|FG001|Overall Study|Protocol Violation|1|||
155366886|NCT00847626|560778424|FG002|Overall Study|Protocol Violation|2|||
155366887|NCT00847626|560778425|FG003|Overall Study|Protocol Violation|1|||
155366888|NCT00847626|560778426|FG004|Overall Study|Protocol Violation|1|||
155366889|NCT00847626|560778427|FG005|Overall Study|Protocol Violation|1|||
155366890|NCT00847626|560778428|FG006|Overall Study|Protocol Violation|1|||
155366891|NCT00847626|560778429|FG007|Overall Study|Protocol Violation|1|||
155366892|NCT00847626|560778430|FG008|Overall Study|Protocol Violation|0|||
155366893|NCT00847626|560778431|FG009|Overall Study|Protocol Violation|1|||
155366894|NCT00847626|560778432|FG010|Overall Study|Protocol Violation|1|||
155366895|NCT00847626|560778422|FG000|Overall Study|Lost to Follow-up|0|||
155366896|NCT00847626|560778423|FG001|Overall Study|Lost to Follow-up|1|||
155366897|NCT00847626|560778424|FG002|Overall Study|Lost to Follow-up|1|||
155366898|NCT00847626|560778425|FG003|Overall Study|Lost to Follow-up|1|||
155366899|NCT00847626|560778426|FG004|Overall Study|Lost to Follow-up|0|||
155366900|NCT00847626|560778427|FG005|Overall Study|Lost to Follow-up|3|||
155366901|NCT00847626|560778428|FG006|Overall Study|Lost to Follow-up|1|||
155366902|NCT00847626|560778429|FG007|Overall Study|Lost to Follow-up|3|||
155366903|NCT00847626|560778430|FG008|Overall Study|Lost to Follow-up|1|||
155366904|NCT00847626|560778431|FG009|Overall Study|Lost to Follow-up|0|||
155366905|NCT00847626|560778432|FG010|Overall Study|Lost to Follow-up|1|||
155366906|NCT00847626|560778422|FG000|Overall Study|Withdrawal by Subject|5|||
155366907|NCT00847626|560778423|FG001|Overall Study|Withdrawal by Subject|5|||
155366908|NCT00847626|560778424|FG002|Overall Study|Withdrawal by Subject|3|||
155366909|NCT00847626|560778425|FG003|Overall Study|Withdrawal by Subject|8|||
155366910|NCT00847626|560778426|FG004|Overall Study|Withdrawal by Subject|12|||
155366911|NCT00847626|560778427|FG005|Overall Study|Withdrawal by Subject|9|||
155366912|NCT00847626|560778428|FG006|Overall Study|Withdrawal by Subject|8|||
155366913|NCT00847626|560778429|FG007|Overall Study|Withdrawal by Subject|4|||
155366914|NCT00847626|560778430|FG008|Overall Study|Withdrawal by Subject|4|||
155366915|NCT00847626|560778431|FG009|Overall Study|Withdrawal by Subject|5|||
155366916|NCT00847626|560778432|FG010|Overall Study|Withdrawal by Subject|2|||
155366917|NCT00847626|560778422|FG000|Overall Study|Lack of Efficacy|3|||
155366918|NCT00847626|560778423|FG001|Overall Study|Lack of Efficacy|1|||
155366919|NCT00847626|560778424|FG002|Overall Study|Lack of Efficacy|0|||
155366920|NCT00847626|560778425|FG003|Overall Study|Lack of Efficacy|1|||
155366921|NCT00847626|560778426|FG004|Overall Study|Lack of Efficacy|2|||
155366922|NCT00847626|560778427|FG005|Overall Study|Lack of Efficacy|0|||
155366923|NCT00847626|560778428|FG006|Overall Study|Lack of Efficacy|6|||
155366924|NCT00847626|560778429|FG007|Overall Study|Lack of Efficacy|2|||
155366925|NCT00847626|560778430|FG008|Overall Study|Lack of Efficacy|5|||
155366926|NCT00847626|560778431|FG009|Overall Study|Lack of Efficacy|1|||
155366927|NCT00847626|560778432|FG010|Overall Study|Lack of Efficacy|7|||
155366928|NCT00847626|560778422|FG000|Overall Study|Other|1|||
155366929|NCT00847626|560778423|FG001|Overall Study|Other|5|||
155366930|NCT00847626|560778424|FG002|Overall Study|Other|4|||
155366931|NCT00847626|560778425|FG003|Overall Study|Other|1|||
155366932|NCT00847626|560778426|FG004|Overall Study|Other|2|||
155366933|NCT00847626|560778427|FG005|Overall Study|Other|2|||
155366934|NCT00847626|560778428|FG006|Overall Study|Other|2|||
155366935|NCT00847626|560778429|FG007|Overall Study|Other|3|||
155366936|NCT00847626|560778430|FG008|Overall Study|Other|1|||
155366937|NCT00847626|560778431|FG009|Overall Study|Other|1|||
155366938|NCT00847626|560778432|FG010|Overall Study|Other|3|||
155366939|NCT00737477|560778433|FG000|Overall Study|Adverse Event|9|||
155366940|NCT00737477|560778433|FG000|Overall Study|Death|9|||
155366941|NCT00737477|560778433|FG000|Overall Study|Treatment Refusal|1|||
155366942|NCT00737477|560778433|FG000|Overall Study|Withdrawal by Subject|1|||
155366943|NCT00737477|560778433|FG000|Overall Study|Renal Transplantation|10|||
155366944|NCT00737477|560778433|FG000|Overall Study|Other|4|||
155366945|NCT01132820|560778434|FG000|Overall Study|Ineligible: wrong cell type|1|||
154965461|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155166879|NCT01175083|560047707|FG003|Booster Epoch|Withdrawal by Subject|1|||
155166880|NCT01175083|560047708|FG004|Booster Epoch|Withdrawal by Subject|0|||
155166881|NCT01175083|560047709|FG005|Booster Epoch|Withdrawal by Subject|0|||
155166882|NCT04329806|560047711|FG000|Overall Study|Physician Decision|3|||
155166883|NCT04329806|560047712|FG001|Overall Study|Physician Decision|4|||
155166884|NCT01349959|560047713|FG000|Overall Study|Adverse Event|7|||
155166885|NCT02675634|560047714|FG000|Test Period 1|Adverse Event|0|||
155166886|NCT02675634|560047715|FG001|Test Period 1|Adverse Event|1|||
155166887|NCT02675634|560047716|FG002|Test Period 1|Adverse Event|0|||
155166888|NCT02675634|560047717|FG003|Test Period 1|Adverse Event|1|||
155166889|NCT02675634|560047718|FG004|Test Period 1|Adverse Event|0|||
155166890|NCT02675634|560047719|FG005|Test Period 1|Adverse Event|0|||
155166891|NCT02675634|560047714|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
155166892|NCT02675634|560047715|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
155166893|NCT02675634|560047716|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
155166894|NCT02675634|560047717|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
155166895|NCT02675634|560047718|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
155166896|NCT02675634|560047719|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
155366946|NCT01132820|560778434|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
155366947|NCT01132820|560778434|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
155366948|NCT01132820|560778434|FG000|Overall Study|Never treated|1|||
155366949|NCT01132820|560778434|FG000|Overall Study|Inadequate data|1|||
155366950|NCT01370655|560778435|FG000|Period 1|Adverse Event|2|||
155366951|NCT01370655|560778436|FG001|Period 1|Adverse Event|0|||
155366952|NCT01370655|560778437|FG002|Period 1|Adverse Event|0|||
155366953|NCT01370655|560778438|FG003|Period 1|Adverse Event|0|||
155366954|NCT01370655|560778439|FG004|Period 1|Adverse Event|0|||
155366955|NCT01370655|560778440|FG005|Period 1|Adverse Event|0|||
155366956|NCT01370655|560778441|FG006|Period 1|Adverse Event|1|||
155366957|NCT01370655|560778442|FG007|Period 1|Adverse Event|0|||
155366958|NCT01370655|560778443|FG008|Period 1|Adverse Event|0|||
155366959|NCT01370655|560778444|FG009|Period 1|Adverse Event|0|||
155166897|NCT02675634|560047714|FG000|Test Period 2|Lack of Efficacy|1|||
155166898|NCT02675634|560047715|FG001|Test Period 2|Lack of Efficacy|0|||
155166899|NCT02675634|560047716|FG002|Test Period 2|Lack of Efficacy|0|||
155366960|NCT01370655|560778445|FG010|Period 1|Adverse Event|0|||
155366961|NCT01370655|560778446|FG011|Period 1|Adverse Event|0|||
155366962|NCT01370655|560778435|FG000|Period 2|Adverse Event|0|||
155366963|NCT01370655|560778436|FG001|Period 2|Adverse Event|0|||
155366964|NCT01370655|560778437|FG002|Period 2|Adverse Event|1|||
155366965|NCT01370655|560778438|FG003|Period 2|Adverse Event|0|||
155366966|NCT01370655|560778439|FG004|Period 2|Adverse Event|1|||
155366967|NCT01370655|560778440|FG005|Period 2|Adverse Event|0|||
155366968|NCT01370655|560778441|FG006|Period 2|Adverse Event|0|||
155366969|NCT01370655|560778442|FG007|Period 2|Adverse Event|1|||
155366970|NCT01370655|560778443|FG008|Period 2|Adverse Event|0|||
155366971|NCT01370655|560778444|FG009|Period 2|Adverse Event|0|||
155366972|NCT01370655|560778445|FG010|Period 2|Adverse Event|0|||
155366973|NCT01370655|560778446|FG011|Period 2|Adverse Event|0|||
155366974|NCT01370655|560778435|FG000|Period 2|met protocol specified stopping criteria|0|||
155366975|NCT01370655|560778436|FG001|Period 2|met protocol specified stopping criteria|0|||
155366976|NCT01370655|560778437|FG002|Period 2|met protocol specified stopping criteria|1|||
155366977|NCT01370655|560778438|FG003|Period 2|met protocol specified stopping criteria|0|||
155366978|NCT01370655|560778439|FG004|Period 2|met protocol specified stopping criteria|0|||
155366979|NCT01370655|560778440|FG005|Period 2|met protocol specified stopping criteria|0|||
155366980|NCT01370655|560778441|FG006|Period 2|met protocol specified stopping criteria|1|||
155366981|NCT01370655|560778442|FG007|Period 2|met protocol specified stopping criteria|0|||
155366982|NCT01370655|560778443|FG008|Period 2|met protocol specified stopping criteria|1|||
155366983|NCT01370655|560778444|FG009|Period 2|met protocol specified stopping criteria|0|||
155366984|NCT01370655|560778445|FG010|Period 2|met protocol specified stopping criteria|1|||
155366985|NCT01370655|560778446|FG011|Period 2|met protocol specified stopping criteria|0|||
155366986|NCT01370655|560778435|FG000|Period 2|Withdrawal by Subject|0|||
155366987|NCT01370655|560778436|FG001|Period 2|Withdrawal by Subject|0|||
155366988|NCT01370655|560778437|FG002|Period 2|Withdrawal by Subject|0|||
155366989|NCT01370655|560778438|FG003|Period 2|Withdrawal by Subject|0|||
155366990|NCT01370655|560778439|FG004|Period 2|Withdrawal by Subject|0|||
155366991|NCT01370655|560778440|FG005|Period 2|Withdrawal by Subject|0|||
155366992|NCT01370655|560778441|FG006|Period 2|Withdrawal by Subject|0|||
155366993|NCT01370655|560778442|FG007|Period 2|Withdrawal by Subject|0|||
155366994|NCT01370655|560778443|FG008|Period 2|Withdrawal by Subject|1|||
155366995|NCT01370655|560778444|FG009|Period 2|Withdrawal by Subject|0|||
155366996|NCT01370655|560778445|FG010|Period 2|Withdrawal by Subject|0|||
155366997|NCT01370655|560778446|FG011|Period 2|Withdrawal by Subject|0|||
155366998|NCT01730378|560778447|FG000|Overall Study|Lost to Follow-up|1|||
155366999|NCT01730378|560778448|FG001|Overall Study|Lost to Follow-up|0|||
155367000|NCT02687035|560778449|FG000|Overall Study|Withdrawal by Subject|1|||
155367001|NCT02687035|560778449|FG000|Overall Study|Death|87|||
155367002|NCT02687035|560778449|FG000|Overall Study|Lost to Follow-up|1|||
155367003|NCT02687035|560778449|FG000|Overall Study|Missed Visit|87|||
155367004|NCT02687035|560778449|FG000|Overall Study|Did not receive Study Device|8|||
155367005|NCT00667394|560778453|FG000|Overall Study|Adverse Event|3|||
155367006|NCT00667394|560778454|FG001|Overall Study|Adverse Event|0|||
155367007|NCT00667394|560778453|FG000|Overall Study|Progressive disease|1|||
155367008|NCT00667394|560778454|FG001|Overall Study|Progressive disease|0|||
155367009|NCT05000216|560778458|FG000|Stage 1|Lost to Follow-up|0|||
155367010|NCT05000216|560778459|FG001|Stage 1|Lost to Follow-up|0|||
155367011|NCT05000216|560778460|FG002|Stage 1|Lost to Follow-up|0|||
155367012|NCT05000216|560778461|FG003|Stage 1|Lost to Follow-up|0|||
155367013|NCT05000216|560778462|FG004|Stage 1|Lost to Follow-up|0|||
155367014|NCT05000216|560778463|FG005|Stage 1|Lost to Follow-up|0|||
155367015|NCT05000216|560778464|FG006|Stage 1|Lost to Follow-up|1|||
155367016|NCT05000216|560778465|FG007|Stage 1|Lost to Follow-up|1|||
155367017|NCT05000216|560778466|FG008|Stage 1|Lost to Follow-up|0|||
155367018|NCT05000216|560778467|FG009|Stage 1|Lost to Follow-up|2|||
155367019|NCT05000216|560778468|FG010|Stage 1|Lost to Follow-up|3|||
155367020|NCT05000216|560778469|FG011|Stage 1|Lost to Follow-up|0|||
155367021|NCT05000216|560778470|FG012|Stage 1|Lost to Follow-up|0|||
155367022|NCT05000216|560778471|FG013|Stage 1|Lost to Follow-up|0|||
155367023|NCT05000216|560778472|FG014|Stage 1|Lost to Follow-up|0|||
155367024|NCT05000216|560778473|FG015|Stage 1|Lost to Follow-up|0|||
155367025|NCT05000216|560778474|FG016|Stage 1|Lost to Follow-up|0|||
155367026|NCT05000216|560778475|FG017|Stage 1|Lost to Follow-up|0|||
155367027|NCT05000216|560778476|FG018|Stage 1|Lost to Follow-up|0|||
155367028|NCT05000216|560778477|FG019|Stage 1|Lost to Follow-up|0|||
155367029|NCT05000216|560778478|FG020|Stage 1|Lost to Follow-up|0|||
155367030|NCT05000216|560778479|FG021|Stage 1|Lost to Follow-up|0|||
155367031|NCT05000216|560778458|FG000|Stage 1|Physician Decision|0|||
155367032|NCT05000216|560778459|FG001|Stage 1|Physician Decision|0|||
155367033|NCT05000216|560778460|FG002|Stage 1|Physician Decision|0|||
155367034|NCT05000216|560778461|FG003|Stage 1|Physician Decision|0|||
155367035|NCT05000216|560778462|FG004|Stage 1|Physician Decision|0|||
155367036|NCT05000216|560778463|FG005|Stage 1|Physician Decision|0|||
155367037|NCT05000216|560778464|FG006|Stage 1|Physician Decision|0|||
155367038|NCT05000216|560778465|FG007|Stage 1|Physician Decision|1|||
155367039|NCT05000216|560778466|FG008|Stage 1|Physician Decision|1|||
155367040|NCT05000216|560778467|FG009|Stage 1|Physician Decision|0|||
155367041|NCT05000216|560778468|FG010|Stage 1|Physician Decision|0|||
155367042|NCT05000216|560778469|FG011|Stage 1|Physician Decision|0|||
155367043|NCT05000216|560778470|FG012|Stage 1|Physician Decision|0|||
155367044|NCT05000216|560778471|FG013|Stage 1|Physician Decision|0|||
155367045|NCT05000216|560778472|FG014|Stage 1|Physician Decision|0|||
155367046|NCT05000216|560778473|FG015|Stage 1|Physician Decision|0|||
155367047|NCT05000216|560778474|FG016|Stage 1|Physician Decision|0|||
155367048|NCT05000216|560778475|FG017|Stage 1|Physician Decision|0|||
155367049|NCT05000216|560778476|FG018|Stage 1|Physician Decision|0|||
155367050|NCT05000216|560778477|FG019|Stage 1|Physician Decision|0|||
155367051|NCT05000216|560778478|FG020|Stage 1|Physician Decision|0|||
155367052|NCT05000216|560778479|FG021|Stage 1|Physician Decision|0|||
155367053|NCT05000216|560778458|FG000|Stage 1|Withdrawal by Subject|0|||
155367054|NCT05000216|560778459|FG001|Stage 1|Withdrawal by Subject|1|||
155367055|NCT05000216|560778460|FG002|Stage 1|Withdrawal by Subject|0|||
155367056|NCT05000216|560778461|FG003|Stage 1|Withdrawal by Subject|0|||
155367057|NCT05000216|560778462|FG004|Stage 1|Withdrawal by Subject|0|||
155367058|NCT05000216|560778463|FG005|Stage 1|Withdrawal by Subject|0|||
155367059|NCT05000216|560778464|FG006|Stage 1|Withdrawal by Subject|0|||
155367060|NCT05000216|560778465|FG007|Stage 1|Withdrawal by Subject|0|||
155367061|NCT05000216|560778466|FG008|Stage 1|Withdrawal by Subject|0|||
155367062|NCT05000216|560778467|FG009|Stage 1|Withdrawal by Subject|3|||
155367063|NCT05000216|560778468|FG010|Stage 1|Withdrawal by Subject|10|||
155367064|NCT05000216|560778469|FG011|Stage 1|Withdrawal by Subject|0|||
155367065|NCT05000216|560778470|FG012|Stage 1|Withdrawal by Subject|0|||
155367066|NCT05000216|560778471|FG013|Stage 1|Withdrawal by Subject|0|||
155367067|NCT05000216|560778472|FG014|Stage 1|Withdrawal by Subject|0|||
155367068|NCT05000216|560778473|FG015|Stage 1|Withdrawal by Subject|0|||
155367069|NCT05000216|560778474|FG016|Stage 1|Withdrawal by Subject|0|||
155367070|NCT05000216|560778475|FG017|Stage 1|Withdrawal by Subject|0|||
155367071|NCT05000216|560778476|FG018|Stage 1|Withdrawal by Subject|0|||
155367072|NCT05000216|560778477|FG019|Stage 1|Withdrawal by Subject|0|||
155367073|NCT05000216|560778478|FG020|Stage 1|Withdrawal by Subject|0|||
155367074|NCT05000216|560778479|FG021|Stage 1|Withdrawal by Subject|0|||
155367075|NCT05000216|560778458|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
155367076|NCT05000216|560778459|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
155367077|NCT05000216|560778460|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
155367078|NCT05000216|560778461|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
155367079|NCT05000216|560778462|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
155367080|NCT05000216|560778463|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
155367081|NCT05000216|560778464|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
155367082|NCT05000216|560778465|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
155367083|NCT05000216|560778466|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
155367084|NCT05000216|560778467|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
155367085|NCT05000216|560778468|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
155367086|NCT05000216|560778469|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
155367087|NCT05000216|560778470|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
155367088|NCT05000216|560778471|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
155367089|NCT05000216|560778472|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
155367090|NCT05000216|560778473|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
155367091|NCT05000216|560778474|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
155367092|NCT05000216|560778475|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
155367093|NCT05000216|560778476|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
155367094|NCT05000216|560778477|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
155367095|NCT05000216|560778478|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
155367096|NCT05000216|560778479|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
155367097|NCT05000216|560778458|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367098|NCT05000216|560778459|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367099|NCT05000216|560778460|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367100|NCT05000216|560778461|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367101|NCT05000216|560778462|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367102|NCT05000216|560778463|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367103|NCT05000216|560778464|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367104|NCT05000216|560778465|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367105|NCT05000216|560778466|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
155367106|NCT05000216|560778467|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
154965462|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
155367107|NCT05000216|560778468|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367108|NCT05000216|560778469|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367109|NCT05000216|560778470|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367110|NCT05000216|560778471|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367111|NCT05000216|560778472|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367112|NCT05000216|560778473|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367113|NCT05000216|560778474|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367114|NCT05000216|560778475|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367115|NCT05000216|560778476|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367116|NCT05000216|560778477|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367117|NCT05000216|560778478|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367118|NCT05000216|560778479|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
155367119|NCT05000216|560778458|FG000|Stage 1|Other|0|||
155367120|NCT05000216|560778459|FG001|Stage 1|Other|0|||
155367121|NCT05000216|560778460|FG002|Stage 1|Other|0|||
155367122|NCT05000216|560778461|FG003|Stage 1|Other|0|||
155367123|NCT05000216|560778462|FG004|Stage 1|Other|1|||
155367124|NCT05000216|560778463|FG005|Stage 1|Other|0|||
155367125|NCT05000216|560778464|FG006|Stage 1|Other|0|||
155367126|NCT05000216|560778465|FG007|Stage 1|Other|2|||
155367127|NCT05000216|560778466|FG008|Stage 1|Other|0|||
155367128|NCT05000216|560778467|FG009|Stage 1|Other|0|||
155367129|NCT05000216|560778468|FG010|Stage 1|Other|1|||
155367130|NCT05000216|560778469|FG011|Stage 1|Other|1|||
155367131|NCT05000216|560778470|FG012|Stage 1|Other|0|||
155367132|NCT05000216|560778471|FG013|Stage 1|Other|0|||
155367133|NCT05000216|560778472|FG014|Stage 1|Other|0|||
155367134|NCT05000216|560778473|FG015|Stage 1|Other|0|||
155367135|NCT05000216|560778474|FG016|Stage 1|Other|0|||
155367136|NCT05000216|560778475|FG017|Stage 1|Other|0|||
155367137|NCT05000216|560778476|FG018|Stage 1|Other|0|||
155367138|NCT05000216|560778477|FG019|Stage 1|Other|0|||
155367139|NCT05000216|560778478|FG020|Stage 1|Other|0|||
155367140|NCT05000216|560778479|FG021|Stage 1|Other|0|||
155367141|NCT05000216|560778458|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
155367142|NCT05000216|560778459|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
155367143|NCT05000216|560778460|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
155166900|NCT02675634|560047717|FG003|Test Period 2|Lack of Efficacy|0|||
155166901|NCT02675634|560047718|FG004|Test Period 2|Lack of Efficacy|0|||
155166902|NCT02675634|560047719|FG005|Test Period 2|Lack of Efficacy|0|||
155166903|NCT02675634|560047714|FG000|Test Period 2|Adverse Event|0|||
155166904|NCT02675634|560047715|FG001|Test Period 2|Adverse Event|0|||
155166905|NCT02675634|560047716|FG002|Test Period 2|Adverse Event|0|||
155166906|NCT02675634|560047717|FG003|Test Period 2|Adverse Event|0|||
155166907|NCT02675634|560047718|FG004|Test Period 2|Adverse Event|0|||
155166908|NCT02675634|560047719|FG005|Test Period 2|Adverse Event|1|||
155166909|NCT00811018|560047720|FG000|Overall Study|Additional Chronic Treatment|31|||
155166910|NCT00811018|560047720|FG000|Overall Study|Adverse Event|79|||
155367144|NCT05000216|560778461|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
155367145|NCT05000216|560778462|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
155367146|NCT05000216|560778463|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
155367147|NCT05000216|560778464|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
155367148|NCT05000216|560778465|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
155367149|NCT05000216|560778466|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
155367150|NCT05000216|560778467|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
155367151|NCT05000216|560778468|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
155367152|NCT05000216|560778469|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
155367153|NCT05000216|560778470|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
155367154|NCT05000216|560778471|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
155367155|NCT05000216|560778472|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
155166911|NCT00811018|560047720|FG000|Overall Study|Death|147|||
155166912|NCT00811018|560047720|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
155166913|NCT00811018|560047720|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
155367156|NCT05000216|560778473|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
155367157|NCT05000216|560778474|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
155367158|NCT05000216|560778475|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
155367159|NCT05000216|560778476|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
155367160|NCT05000216|560778477|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
155367161|NCT05000216|560778478|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
155367162|NCT05000216|560778479|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
155367163|NCT05000216|560778458|FG000|Stage 2|Lost to Follow-up|0|||
155367164|NCT05000216|560778459|FG001|Stage 2|Lost to Follow-up|0|||
155367165|NCT05000216|560778460|FG002|Stage 2|Lost to Follow-up|0|||
155367166|NCT05000216|560778461|FG003|Stage 2|Lost to Follow-up|0|||
155367167|NCT05000216|560778462|FG004|Stage 2|Lost to Follow-up|0|||
155367168|NCT05000216|560778463|FG005|Stage 2|Lost to Follow-up|0|||
155367169|NCT05000216|560778464|FG006|Stage 2|Lost to Follow-up|0|||
155367170|NCT05000216|560778465|FG007|Stage 2|Lost to Follow-up|0|||
155367171|NCT05000216|560778466|FG008|Stage 2|Lost to Follow-up|0|||
155367172|NCT05000216|560778467|FG009|Stage 2|Lost to Follow-up|0|||
155367173|NCT05000216|560778468|FG010|Stage 2|Lost to Follow-up|0|||
155367174|NCT05000216|560778469|FG011|Stage 2|Lost to Follow-up|0|||
155367175|NCT05000216|560778470|FG012|Stage 2|Lost to Follow-up|0|||
155367176|NCT05000216|560778471|FG013|Stage 2|Lost to Follow-up|0|||
155367177|NCT05000216|560778472|FG014|Stage 2|Lost to Follow-up|0|||
155367178|NCT05000216|560778473|FG015|Stage 2|Lost to Follow-up|0|||
155367179|NCT05000216|560778474|FG016|Stage 2|Lost to Follow-up|4|||
155367180|NCT05000216|560778475|FG017|Stage 2|Lost to Follow-up|0|||
155367181|NCT05000216|560778476|FG018|Stage 2|Lost to Follow-up|0|||
155367182|NCT05000216|560778477|FG019|Stage 2|Lost to Follow-up|0|||
155367183|NCT05000216|560778478|FG020|Stage 2|Lost to Follow-up|0|||
155367184|NCT05000216|560778479|FG021|Stage 2|Lost to Follow-up|0|||
155367185|NCT05000216|560778458|FG000|Stage 2|Physician Decision|0|||
155367186|NCT05000216|560778459|FG001|Stage 2|Physician Decision|0|||
155367187|NCT05000216|560778460|FG002|Stage 2|Physician Decision|0|||
155367188|NCT05000216|560778461|FG003|Stage 2|Physician Decision|0|||
155367189|NCT05000216|560778462|FG004|Stage 2|Physician Decision|0|||
155367190|NCT05000216|560778463|FG005|Stage 2|Physician Decision|0|||
155367191|NCT05000216|560778464|FG006|Stage 2|Physician Decision|0|||
155367192|NCT05000216|560778465|FG007|Stage 2|Physician Decision|0|||
155367193|NCT05000216|560778466|FG008|Stage 2|Physician Decision|0|||
155367194|NCT05000216|560778467|FG009|Stage 2|Physician Decision|0|||
155367195|NCT05000216|560778468|FG010|Stage 2|Physician Decision|0|||
155367196|NCT05000216|560778469|FG011|Stage 2|Physician Decision|0|||
155367197|NCT05000216|560778470|FG012|Stage 2|Physician Decision|1|||
155367198|NCT05000216|560778471|FG013|Stage 2|Physician Decision|0|||
155367199|NCT05000216|560778472|FG014|Stage 2|Physician Decision|0|||
155367200|NCT05000216|560778473|FG015|Stage 2|Physician Decision|0|||
155367201|NCT05000216|560778474|FG016|Stage 2|Physician Decision|0|||
155367202|NCT05000216|560778475|FG017|Stage 2|Physician Decision|0|||
155367203|NCT05000216|560778476|FG018|Stage 2|Physician Decision|0|||
155367204|NCT05000216|560778477|FG019|Stage 2|Physician Decision|0|||
155367205|NCT05000216|560778478|FG020|Stage 2|Physician Decision|0|||
155367206|NCT05000216|560778479|FG021|Stage 2|Physician Decision|0|||
155367207|NCT05000216|560778458|FG000|Stage 2|Withdrawal by Subject|0|||
155367208|NCT05000216|560778459|FG001|Stage 2|Withdrawal by Subject|0|||
155367209|NCT05000216|560778460|FG002|Stage 2|Withdrawal by Subject|0|||
155367210|NCT05000216|560778461|FG003|Stage 2|Withdrawal by Subject|0|||
155367211|NCT05000216|560778462|FG004|Stage 2|Withdrawal by Subject|0|||
155367212|NCT05000216|560778463|FG005|Stage 2|Withdrawal by Subject|0|||
155367213|NCT05000216|560778464|FG006|Stage 2|Withdrawal by Subject|0|||
155367214|NCT05000216|560778465|FG007|Stage 2|Withdrawal by Subject|0|||
155367215|NCT05000216|560778466|FG008|Stage 2|Withdrawal by Subject|0|||
155367216|NCT05000216|560778467|FG009|Stage 2|Withdrawal by Subject|0|||
155367217|NCT05000216|560778468|FG010|Stage 2|Withdrawal by Subject|0|||
155367218|NCT05000216|560778469|FG011|Stage 2|Withdrawal by Subject|0|||
155367219|NCT05000216|560778470|FG012|Stage 2|Withdrawal by Subject|0|||
155367220|NCT05000216|560778471|FG013|Stage 2|Withdrawal by Subject|0|||
155166914|NCT00811018|560047720|FG000|Overall Study|Investigator Decision|57|||
155166915|NCT00811018|560047720|FG000|Overall Study|Lost to Follow-up|19|||
155367221|NCT05000216|560778472|FG014|Stage 2|Withdrawal by Subject|2|||
155367222|NCT05000216|560778473|FG015|Stage 2|Withdrawal by Subject|0|||
155367223|NCT05000216|560778474|FG016|Stage 2|Withdrawal by Subject|9|||
155367224|NCT05000216|560778475|FG017|Stage 2|Withdrawal by Subject|0|||
155367225|NCT05000216|560778476|FG018|Stage 2|Withdrawal by Subject|0|||
155367226|NCT05000216|560778477|FG019|Stage 2|Withdrawal by Subject|0|||
155367227|NCT05000216|560778478|FG020|Stage 2|Withdrawal by Subject|0|||
155367228|NCT05000216|560778479|FG021|Stage 2|Withdrawal by Subject|0|||
155367229|NCT05000216|560778458|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
155367230|NCT05000216|560778459|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
155367231|NCT05000216|560778460|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
155367232|NCT05000216|560778461|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
155367233|NCT05000216|560778462|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
155367234|NCT05000216|560778463|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
155166916|NCT00811018|560047720|FG000|Overall Study|Pregnancy|6|||
155367235|NCT05000216|560778464|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
155367236|NCT05000216|560778465|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
155367237|NCT05000216|560778466|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
155367238|NCT05000216|560778467|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
155367239|NCT05000216|560778468|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
155367240|NCT05000216|560778469|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
155367241|NCT05000216|560778470|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
155367242|NCT05000216|560778471|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
155367243|NCT05000216|560778472|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
155367244|NCT05000216|560778473|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
155367245|NCT05000216|560778474|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
155367246|NCT05000216|560778475|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
155367247|NCT05000216|560778476|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
155367248|NCT05000216|560778477|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
155367249|NCT05000216|560778478|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
155367250|NCT05000216|560778479|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
155367251|NCT05000216|560778458|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367252|NCT05000216|560778459|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367253|NCT05000216|560778460|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367254|NCT05000216|560778461|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367255|NCT05000216|560778462|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367256|NCT05000216|560778463|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367257|NCT05000216|560778464|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367258|NCT05000216|560778465|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367259|NCT05000216|560778466|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367260|NCT05000216|560778467|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367261|NCT05000216|560778468|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367262|NCT05000216|560778469|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367263|NCT05000216|560778470|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367264|NCT05000216|560778471|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367265|NCT05000216|560778472|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
155367266|NCT05000216|560778473|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367267|NCT05000216|560778474|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
155367268|NCT05000216|560778475|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367269|NCT05000216|560778476|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367270|NCT05000216|560778477|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367271|NCT05000216|560778478|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367272|NCT05000216|560778479|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
155367273|NCT05000216|560778458|FG000|Stage 2|Other reason|0|||
155367274|NCT05000216|560778459|FG001|Stage 2|Other reason|0|||
155367275|NCT05000216|560778460|FG002|Stage 2|Other reason|0|||
155367276|NCT05000216|560778461|FG003|Stage 2|Other reason|0|||
155367277|NCT05000216|560778462|FG004|Stage 2|Other reason|0|||
155367278|NCT05000216|560778463|FG005|Stage 2|Other reason|0|||
155367279|NCT05000216|560778464|FG006|Stage 2|Other reason|0|||
155367280|NCT05000216|560778465|FG007|Stage 2|Other reason|0|||
155367281|NCT05000216|560778466|FG008|Stage 2|Other reason|0|||
155367282|NCT05000216|560778467|FG009|Stage 2|Other reason|0|||
155367283|NCT05000216|560778468|FG010|Stage 2|Other reason|0|||
155367284|NCT05000216|560778469|FG011|Stage 2|Other reason|0|||
155367285|NCT05000216|560778470|FG012|Stage 2|Other reason|0|||
155367286|NCT05000216|560778471|FG013|Stage 2|Other reason|0|||
155367287|NCT05000216|560778472|FG014|Stage 2|Other reason|0|||
155367288|NCT05000216|560778473|FG015|Stage 2|Other reason|0|||
155367289|NCT05000216|560778474|FG016|Stage 2|Other reason|1|||
155367290|NCT05000216|560778475|FG017|Stage 2|Other reason|0|||
155367291|NCT05000216|560778476|FG018|Stage 2|Other reason|0|||
155367292|NCT05000216|560778477|FG019|Stage 2|Other reason|0|||
155367293|NCT05000216|560778478|FG020|Stage 2|Other reason|0|||
155367294|NCT05000216|560778479|FG021|Stage 2|Other reason|0|||
155367295|NCT05000216|560778458|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
155367296|NCT05000216|560778459|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
155367297|NCT05000216|560778460|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
155367298|NCT05000216|560778461|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
155367299|NCT05000216|560778462|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
155367300|NCT05000216|560778463|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
155367301|NCT05000216|560778464|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
155367302|NCT05000216|560778465|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
155367303|NCT05000216|560778466|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
155367304|NCT05000216|560778467|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
155367305|NCT05000216|560778468|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
155367306|NCT05000216|560778469|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
155367307|NCT05000216|560778470|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
155367308|NCT05000216|560778471|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
155367309|NCT05000216|560778472|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
155367310|NCT05000216|560778473|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
155367311|NCT05000216|560778474|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
155367312|NCT05000216|560778475|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
155367313|NCT05000216|560778476|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
155367314|NCT05000216|560778477|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
155367315|NCT05000216|560778478|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
155367316|NCT05000216|560778479|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
155367317|NCT05000216|560778458|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367318|NCT05000216|560778459|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367319|NCT05000216|560778460|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367320|NCT05000216|560778461|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367321|NCT05000216|560778462|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367322|NCT05000216|560778463|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367323|NCT05000216|560778464|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367324|NCT05000216|560778465|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367325|NCT05000216|560778466|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367326|NCT05000216|560778467|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367327|NCT05000216|560778468|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367328|NCT05000216|560778469|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367329|NCT05000216|560778470|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367330|NCT05000216|560778471|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367331|NCT05000216|560778472|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367332|NCT05000216|560778473|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
155367333|NCT05000216|560778474|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367334|NCT05000216|560778475|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367335|NCT05000216|560778476|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367336|NCT05000216|560778477|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367337|NCT05000216|560778478|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367338|NCT05000216|560778479|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
155367339|NCT05000216|560778458|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367340|NCT05000216|560778459|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367341|NCT05000216|560778460|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367342|NCT05000216|560778461|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367343|NCT05000216|560778462|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367344|NCT05000216|560778463|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367345|NCT05000216|560778464|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367346|NCT05000216|560778465|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367347|NCT05000216|560778466|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367348|NCT05000216|560778467|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367349|NCT05000216|560778468|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367350|NCT05000216|560778469|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367351|NCT05000216|560778470|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367352|NCT05000216|560778471|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
155367353|NCT05000216|560778472|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367354|NCT05000216|560778473|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
155367355|NCT05000216|560778474|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367356|NCT05000216|560778475|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367357|NCT05000216|560778476|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
155367358|NCT05000216|560778477|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367359|NCT05000216|560778478|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367360|NCT05000216|560778479|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
155367361|NCT04076943|560778480|FG000|Overall Study|Withdrawal by Subject|12|||
155367362|NCT04076943|560778480|FG000|Overall Study|Adverse Event|1|||
155367363|NCT04076943|560778480|FG000|Overall Study|Progressive Disease|2|||
155367364|NCT04076943|560778480|FG000|Overall Study|Death|13|||
155367365|NCT04076943|560778480|FG000|Overall Study|Other than specified|6|||
155367366|NCT02224703|560778483|FG000|Overall Study|Adverse Event|0|||
155367367|NCT02224703|560778484|FG001|Overall Study|Adverse Event|5|||
155367368|NCT02224703|560778485|FG002|Overall Study|Adverse Event|0|||
155367369|NCT02224703|560778483|FG000|Overall Study|Withdrawn by investigator|1|||
155367370|NCT02224703|560778484|FG001|Overall Study|Withdrawn by investigator|0|||
155367371|NCT02224703|560778485|FG002|Overall Study|Withdrawn by investigator|0|||
155367372|NCT02224703|560778483|FG000|Overall Study|Advised by medical monitor|1|||
155367373|NCT02224703|560778484|FG001|Overall Study|Advised by medical monitor|0|||
155367374|NCT02224703|560778485|FG002|Overall Study|Advised by medical monitor|0|||
155367375|NCT02224703|560778483|FG000|Overall Study|Withdrawn by parent/guardian|0|||
155367376|NCT02224703|560778484|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155367377|NCT02224703|560778485|FG002|Overall Study|Withdrawn by parent/guardian|0|||
155367378|NCT02224703|560778483|FG000|Overall Study|Lack of Efficacy|1|||
155367379|NCT02224703|560778484|FG001|Overall Study|Lack of Efficacy|0|||
155367380|NCT02224703|560778485|FG002|Overall Study|Lack of Efficacy|0|||
155367381|NCT00332462|560778486|FG000|Overall Study|Adverse Event|5|||
155367382|NCT00332462|560778486|FG000|Overall Study|Abnormal Lab Value|1|||
155367383|NCT00332462|560778486|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155367384|NCT00332462|560778486|FG000|Overall Study|no longer requires study drug|1|||
154965463|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965464|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155367385|NCT00332462|560778486|FG000|Overall Study|Death|3|||
155367386|NCT00332462|560778486|FG000|Overall Study|Graft Loss|2|||
155367387|NCT02922023|560778489|FG000|Overall Study|Lost to Follow-up|2|||
155367388|NCT02922023|560778490|FG001|Overall Study|Lost to Follow-up|0|||
155367389|NCT02159040|560778491|FG000|Overall Study|Death|1|||
155367390|NCT01602510|560778494|FG000|Open Label Phase|Adverse Event|46|||
155367391|NCT01602510|560778495|FG001|Open Label Phase|Adverse Event|0|||
155367392|NCT01602510|560778496|FG002|Open Label Phase|Adverse Event|0|||
155367393|NCT01602510|560778494|FG000|Open Label Phase|Lack of Efficacy|22|||
155367394|NCT01602510|560778495|FG001|Open Label Phase|Lack of Efficacy|0|||
155367395|NCT01602510|560778496|FG002|Open Label Phase|Lack of Efficacy|0|||
155367396|NCT01602510|560778494|FG000|Open Label Phase|Protocol Violation|15|||
155367397|NCT01602510|560778495|FG001|Open Label Phase|Protocol Violation|0|||
155367398|NCT01602510|560778496|FG002|Open Label Phase|Protocol Violation|0|||
155367399|NCT01602510|560778494|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
155367400|NCT01602510|560778495|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
155367401|NCT01602510|560778496|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
155367402|NCT01602510|560778494|FG000|Open Label Phase|Lost to Follow-up|22|||
155367403|NCT01602510|560778495|FG001|Open Label Phase|Lost to Follow-up|0|||
155367404|NCT01602510|560778496|FG002|Open Label Phase|Lost to Follow-up|0|||
155367405|NCT01602510|560778494|FG000|Open Label Phase|Physician Decision|19|||
155367406|NCT01602510|560778495|FG001|Open Label Phase|Physician Decision|0|||
155367407|NCT01602510|560778496|FG002|Open Label Phase|Physician Decision|0|||
155367408|NCT01602510|560778494|FG000|Open Label Phase|Withdrawal by Subject|57|||
155367409|NCT01602510|560778495|FG001|Open Label Phase|Withdrawal by Subject|0|||
155367410|NCT01602510|560778496|FG002|Open Label Phase|Withdrawal by Subject|0|||
155367411|NCT01602510|560778494|FG000|Randomized Phase|Adverse Event|0|||
155367412|NCT01602510|560778495|FG001|Randomized Phase|Adverse Event|2|||
155367413|NCT01602510|560778496|FG002|Randomized Phase|Adverse Event|6|||
155367414|NCT01602510|560778494|FG000|Randomized Phase|Lack of Efficacy|0|||
155367415|NCT01602510|560778495|FG001|Randomized Phase|Lack of Efficacy|4|||
155367416|NCT01602510|560778496|FG002|Randomized Phase|Lack of Efficacy|4|||
155367417|NCT01602510|560778494|FG000|Randomized Phase|Protocol Violation|0|||
155367418|NCT01602510|560778495|FG001|Randomized Phase|Protocol Violation|3|||
155367419|NCT01602510|560778496|FG002|Randomized Phase|Protocol Violation|3|||
155367420|NCT01602510|560778494|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
155367421|NCT01602510|560778495|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
155367422|NCT01602510|560778496|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
155367423|NCT01602510|560778494|FG000|Randomized Phase|Lost to Follow-up|0|||
155367424|NCT01602510|560778495|FG001|Randomized Phase|Lost to Follow-up|1|||
155367425|NCT01602510|560778496|FG002|Randomized Phase|Lost to Follow-up|3|||
155367426|NCT01602510|560778494|FG000|Randomized Phase|Physician Decision|0|||
155367427|NCT01602510|560778495|FG001|Randomized Phase|Physician Decision|0|||
155367428|NCT01602510|560778496|FG002|Randomized Phase|Physician Decision|2|||
155367429|NCT01602510|560778494|FG000|Randomized Phase|Withdrawal by Subject|0|||
155367430|NCT01602510|560778495|FG001|Randomized Phase|Withdrawal by Subject|6|||
155367431|NCT01602510|560778496|FG002|Randomized Phase|Withdrawal by Subject|7|||
155367432|NCT01195623|560778497|FG000|Overall Study|Lost to Follow-up|35|||
155367433|NCT01195623|560778498|FG001|Overall Study|Lost to Follow-up|37|||
155367434|NCT00534495|560778500|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
155367435|NCT00534495|560778501|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
155367436|NCT00534495|560778502|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
155367437|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
155367438|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
155367439|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
155367440|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
155367441|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
155367442|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
155367443|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
155367444|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
155367445|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
155367446|NCT00534495|560778500|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
155367447|NCT00534495|560778501|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
155367448|NCT00534495|560778502|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
155367449|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
155367450|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
155367451|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
155367452|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
155367453|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
155367454|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
155367455|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
155367456|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
155367457|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
155367458|NCT00534495|560778500|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
155367459|NCT00534495|560778501|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
155367460|NCT00534495|560778502|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
155367461|NCT02920970|560778503|FG000|First Intervention|Protocol Violation|0|||
155367462|NCT02920970|560778504|FG001|First Intervention|Protocol Violation|1|||
155367463|NCT02920970|560778503|FG000|First Intervention|Adverse Event|0|||
155367464|NCT02920970|560778504|FG001|First Intervention|Adverse Event|1|||
155367465|NCT02920970|560778503|FG000|Second Intervention|Poor Lens Fit|1|||
155367466|NCT02920970|560778504|FG001|Second Intervention|Poor Lens Fit|0|||
155367467|NCT01711853|560778505|FG000|Overall Study|Not treated|3|||
155367468|NCT04191616|560778506|FG000|Pre-assignment Period|Did not receive study treatment|2|||
155367469|NCT04191616|560778506|FG000|Treatment Period|Death|37|||
155367470|NCT04191616|560778506|FG000|Treatment Period|Sponsor decision|11|||
155367471|NCT04191616|560778506|FG000|Treatment Period|Withdrawal by Subject|4|||
155367472|NCT00604708|560778510|FG000|Overall Study|Withdrawal by Subject|9|||
155367473|NCT00604708|560778511|FG001|Overall Study|Withdrawal by Subject|10|||
155367474|NCT00604708|560778510|FG000|Overall Study|Protocol Violation|2|||
155367475|NCT00604708|560778511|FG001|Overall Study|Protocol Violation|8|||
155367476|NCT00604708|560778510|FG000|Overall Study|Lost to Follow-up|5|||
155367477|NCT00604708|560778511|FG001|Overall Study|Lost to Follow-up|5|||
155367478|NCT00604708|560778510|FG000|Overall Study|administrative reasons|9|||
155367479|NCT00604708|560778511|FG001|Overall Study|administrative reasons|11|||
155367480|NCT00604708|560778510|FG000|Overall Study|Adverse Event|6|||
155367481|NCT00604708|560778511|FG001|Overall Study|Adverse Event|6|||
155367482|NCT01277887|560778513|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
155367483|NCT01277887|560778514|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
155367484|NCT01277887|560778513|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
155367485|NCT01277887|560778514|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
155367486|NCT01277887|560778513|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
155367487|NCT01277887|560778514|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
155367488|NCT00415051|560778515|FG000|Overall Study|Protocol Violation|1|||
155367489|NCT04916730|560778516|FG000|Overall Study|Withdrawal by Subject|4|||
155367490|NCT04916730|560778517|FG001|Overall Study|Withdrawal by Subject|2|||
155367491|NCT04916730|560778516|FG000|Overall Study|Lost to Follow-up|0|||
155367492|NCT04916730|560778517|FG001|Overall Study|Lost to Follow-up|2|||
155367493|NCT04916730|560778516|FG000|Overall Study|Physician Decision|1|||
155367494|NCT04916730|560778517|FG001|Overall Study|Physician Decision|0|||
155367495|NCT02670122|560778518|FG000|Overall Study|Lost to Follow-up|4|||
155367496|NCT02762903|560778522|FG000|Overall Study|Lost to Follow-up|0|||
155367497|NCT02762903|560778523|FG001|Overall Study|Lost to Follow-up|1|||
155367498|NCT00996606|560778525|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
155367499|NCT00996606|560778525|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155367500|NCT00996606|560778525|FG000|Overall Study|Protocol Violation|1|||
155367501|NCT00996606|560778525|FG000|Overall Study|Withdrawal by Subject|3|||
155367502|NCT00281320|560778532|FG000|Overall Study|Adverse Event|12|||
155367503|NCT00281320|560778533|FG001|Overall Study|Adverse Event|9|||
155367504|NCT00281320|560778532|FG000|Overall Study|Lack of Efficacy|4|||
155367505|NCT00281320|560778533|FG001|Overall Study|Lack of Efficacy|3|||
155367506|NCT00281320|560778532|FG000|Overall Study|Withdrawal by Subject|5|||
155367507|NCT00281320|560778533|FG001|Overall Study|Withdrawal by Subject|6|||
155367508|NCT00281320|560778532|FG000|Overall Study|Lost to Follow-up|1|||
155367509|NCT00281320|560778533|FG001|Overall Study|Lost to Follow-up|2|||
155367510|NCT00281320|560778532|FG000|Overall Study|Other|3|||
155367511|NCT00281320|560778533|FG001|Overall Study|Other|1|||
155367512|NCT00475228|560778536|FG000|Overall Study|Lost to Follow-up|17|||
155367513|NCT00475228|560778537|FG001|Overall Study|Lost to Follow-up|17|||
155367514|NCT02209181|560778539|FG000|Overall Study|Adverse Event|1|||
155367515|NCT02209181|560778540|FG001|Overall Study|Adverse Event|0|||
155367516|NCT02209181|560778541|FG002|Overall Study|Adverse Event|1|||
155367517|NCT02209181|560778542|FG003|Overall Study|Adverse Event|0|||
155367518|NCT02209181|560778539|FG000|Overall Study|Withdrawal by Subject|0|||
155367519|NCT02209181|560778540|FG001|Overall Study|Withdrawal by Subject|1|||
155367520|NCT02209181|560778541|FG002|Overall Study|Withdrawal by Subject|0|||
155367521|NCT02209181|560778542|FG003|Overall Study|Withdrawal by Subject|0|||
155367522|NCT02579772|560778543|FG000|Overall Study|Withdrawal by Subject|0|||
155367523|NCT02579772|560778544|FG001|Overall Study|Withdrawal by Subject|1|||
155367524|NCT02579772|560778543|FG000|Overall Study|Usage of additional antioxidants|1|||
155367525|NCT02579772|560778544|FG001|Overall Study|Usage of additional antioxidants|0|||
155367526|NCT02579772|560778543|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
155367527|NCT02579772|560778544|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
155367528|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
155367529|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
155367530|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
155367531|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
155367532|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
155367533|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367534|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367535|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367536|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
155367537|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
155367538|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
155367539|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
155367540|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
155367541|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
155367542|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
155367543|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Death|1|||
155367544|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Death|0|||
155367545|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Death|0|||
155367546|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Death|0|||
155367547|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Death|0|||
155367548|NCT04641962|560778546|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
155367549|NCT04641962|560778547|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
155367550|NCT04641962|560778548|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
155367551|NCT04641962|560778549|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
155367552|NCT04641962|560778550|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
155367553|NCT04641962|560778546|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
155367554|NCT04641962|560778547|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
155367555|NCT04641962|560778548|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
155367556|NCT04641962|560778549|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
155367557|NCT04641962|560778550|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
155367558|NCT04641962|560778546|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367559|NCT04641962|560778547|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367560|NCT04641962|560778548|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
155367561|NCT04641962|560778549|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367562|NCT04641962|560778550|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
155367563|NCT05239598|560778554|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
155367564|NCT05239598|560778555|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
155367565|NCT05239598|560778554|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
155367566|NCT05239598|560778555|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
155367567|NCT04535544|560778558|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
155367568|NCT04535544|560778559|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
155367569|NCT04535544|560778560|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
155367570|NCT04535544|560778561|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
155367571|NCT04535544|560778558|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
155367572|NCT04535544|560778559|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
155367573|NCT04535544|560778560|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
155367574|NCT04535544|560778561|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
155367575|NCT04535544|560778558|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
155367576|NCT04535544|560778559|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
155367577|NCT04535544|560778560|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
155367578|NCT04535544|560778561|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
155367579|NCT04535544|560778558|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
155367580|NCT04535544|560778559|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
155367581|NCT04535544|560778560|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
155367582|NCT04535544|560778561|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
155367583|NCT04535544|560778558|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
155367584|NCT04535544|560778559|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
155367585|NCT04535544|560778560|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
155367586|NCT04535544|560778561|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
155367587|NCT04535544|560778558|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
155367588|NCT04535544|560778559|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
155367589|NCT04535544|560778560|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
155367590|NCT04535544|560778561|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
155367591|NCT04535544|560778558|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
155367592|NCT04535544|560778559|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
155367593|NCT04535544|560778560|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
155367594|NCT04535544|560778561|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
155367595|NCT04535544|560778558|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
155367596|NCT04535544|560778559|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
155367597|NCT04535544|560778560|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
155367598|NCT04535544|560778561|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
155367599|NCT02706405|560780397|FG000|Overall Study|Death|3|||
155367600|NCT02706405|560780398|FG001|Overall Study|Death|2|||
155367601|NCT02706405|560780399|FG002|Overall Study|Death|0|||
155367602|NCT02706405|560780400|FG003|Overall Study|Death|1|||
155367603|NCT02706405|560780401|FG004|Overall Study|Death|0|||
155367604|NCT02706405|560780402|FG005|Overall Study|Death|0|||
155367605|NCT02706405|560780403|FG006|Overall Study|Death|3|||
155367606|NCT02706405|560780404|FG007|Overall Study|Death|4|||
155367607|NCT02706405|560780397|FG000|Overall Study|Disease progression|0|||
155367608|NCT02706405|560780398|FG001|Overall Study|Disease progression|0|||
155367609|NCT02706405|560780399|FG002|Overall Study|Disease progression|0|||
155367610|NCT02706405|560780400|FG003|Overall Study|Disease progression|0|||
155367611|NCT02706405|560780401|FG004|Overall Study|Disease progression|0|||
155367612|NCT02706405|560780402|FG005|Overall Study|Disease progression|0|||
155367613|NCT02706405|560780403|FG006|Overall Study|Disease progression|0|||
155367614|NCT02706405|560780404|FG007|Overall Study|Disease progression|1|||
155367615|NCT02706405|560780397|FG000|Overall Study|Pt moved to new therapy|0|||
155367616|NCT02706405|560780398|FG001|Overall Study|Pt moved to new therapy|0|||
155367617|NCT02706405|560780399|FG002|Overall Study|Pt moved to new therapy|0|||
155367618|NCT02706405|560780400|FG003|Overall Study|Pt moved to new therapy|0|||
155367619|NCT02706405|560780401|FG004|Overall Study|Pt moved to new therapy|0|||
155367620|NCT02706405|560780402|FG005|Overall Study|Pt moved to new therapy|1|||
155367621|NCT02706405|560780403|FG006|Overall Study|Pt moved to new therapy|0|||
155367622|NCT02706405|560780404|FG007|Overall Study|Pt moved to new therapy|1|||
155367623|NCT02706405|560780397|FG000|Overall Study|Physician Decision|1|||
155367624|NCT02706405|560780398|FG001|Overall Study|Physician Decision|0|||
155367625|NCT02706405|560780399|FG002|Overall Study|Physician Decision|0|||
155367626|NCT02706405|560780400|FG003|Overall Study|Physician Decision|0|||
155367627|NCT02706405|560780401|FG004|Overall Study|Physician Decision|0|||
155367628|NCT02706405|560780402|FG005|Overall Study|Physician Decision|0|||
155367629|NCT02706405|560780403|FG006|Overall Study|Physician Decision|0|||
155367630|NCT02706405|560780404|FG007|Overall Study|Physician Decision|0|||
155367631|NCT01182441|560780405|FG000|Overall Study|Patient Still in Follow-up|152|||
155367632|NCT01182441|560780406|FG001|Overall Study|Patient Still in Follow-up|72|||
155367633|NCT01182441|560780405|FG000|Overall Study|Death|37|||
155367634|NCT01182441|560780406|FG001|Overall Study|Death|25|||
155367635|NCT01182441|560780405|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
155367636|NCT01182441|560780406|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
155367637|NCT01182441|560780405|FG000|Overall Study|Lost to Follow-up|5|||
155367638|NCT01182441|560780406|FG001|Overall Study|Lost to Follow-up|8|||
155367639|NCT01182441|560780405|FG000|Overall Study|Withdrawal by Subject|6|||
155367640|NCT01182441|560780406|FG001|Overall Study|Withdrawal by Subject|13|||
155367641|NCT01182441|560780405|FG000|Overall Study|Implant Not Attempted|4|||
155367642|NCT01182441|560780406|FG001|Overall Study|Implant Not Attempted|0|||
155367643|NCT01182441|560780405|FG000|Overall Study|Adverse Event|2|||
155367644|NCT01182441|560780406|FG001|Overall Study|Adverse Event|0|||
155367645|NCT01182441|560780405|FG000|Overall Study|Physician Decision|1|||
155367646|NCT01182441|560780406|FG001|Overall Study|Physician Decision|1|||
155367647|NCT02304705|560780407|FG000|Overall Study|Withdrawal by Subject|2|||
155367648|NCT02304705|560780408|FG001|Overall Study|Withdrawal by Subject|0|||
155367649|NCT02304705|560780407|FG000|Overall Study|Physician Decision|2|||
155367650|NCT02304705|560780408|FG001|Overall Study|Physician Decision|4|||
155367651|NCT02304705|560780407|FG000|Overall Study|Death|0|||
155367652|NCT02304705|560780408|FG001|Overall Study|Death|1|||
155367653|NCT02304705|560780407|FG000|Overall Study|Lost to Follow-up|0|||
155367654|NCT02304705|560780408|FG001|Overall Study|Lost to Follow-up|2|||
155367655|NCT03140280|560780409|FG000|Overall Study|Physician Decision|5|||
155367656|NCT00663702|560780418|FG000|Overall Study|Adverse Event|8|||
155367657|NCT00663702|560780419|FG001|Overall Study|Adverse Event|4|||
155367658|NCT00663702|560780418|FG000|Overall Study|Withdrawal by Subject|3|||
155367659|NCT00663702|560780419|FG001|Overall Study|Withdrawal by Subject|1|||
155367660|NCT00663702|560780418|FG000|Overall Study|Pregnancy|0|||
155367661|NCT00663702|560780419|FG001|Overall Study|Pregnancy|1|||
155367662|NCT00663702|560780418|FG000|Overall Study|Lost to Follow-up|3|||
155367663|NCT00663702|560780419|FG001|Overall Study|Lost to Follow-up|0|||
155367664|NCT00663702|560780418|FG000|Overall Study|Death|1|||
155367665|NCT00663702|560780419|FG001|Overall Study|Death|1|||
155367666|NCT00663702|560780418|FG000|Overall Study|Lack of Efficacy|3|||
155367667|NCT00663702|560780419|FG001|Overall Study|Lack of Efficacy|3|||
155367668|NCT03056300|560780420|FG000|Overall Study|Surgical reason per study protocol|3|||
155367669|NCT04079868|560780427|FG000|Overall Study|Lost to Follow-up|100|||
155367670|NCT04079868|560780428|FG001|Overall Study|Lost to Follow-up|200|||
155367671|NCT04079868|560780427|FG000|Overall Study|Physician Decision|100|||
155367672|NCT04079868|560780428|FG001|Overall Study|Physician Decision|0|||
155367673|NCT05262517|560780429|FG000|Overall Study|Randomized but not treated|5|||
155367674|NCT05262517|560780430|FG001|Overall Study|Randomized but not treated|11|||
155367675|NCT05620108|560780431|FG000|Overall Study|Physician Decision|1|||
155367676|NCT05620108|560780432|FG001|Overall Study|Physician Decision|2|||
155367677|NCT05602727|560780433|FG000|Overall Study|Physician Decision|0|||
155367678|NCT05602727|560780434|FG001|Overall Study|Physician Decision|1|||
155367679|NCT05602727|560780435|FG002|Overall Study|Physician Decision|0|||
155367680|NCT05602727|560780433|FG000|Overall Study|Randomized by mistake without study medication|1|||
155367681|NCT05602727|560780434|FG001|Overall Study|Randomized by mistake without study medication|0|||
155367682|NCT05602727|560780435|FG002|Overall Study|Randomized by mistake without study medication|0|||
155367683|NCT05602727|560780433|FG000|Overall Study|Study termination by Sponsor|18|||
155367684|NCT05602727|560780434|FG001|Overall Study|Study termination by Sponsor|15|||
155166917|NCT00811018|560047720|FG000|Overall Study|Sponsor Decision|450|||
155166918|NCT00811018|560047720|FG000|Overall Study|Withdrawal by Subject|70|||
155166919|NCT00811018|560047720|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
155166920|NCT00811018|560047720|FG000|Overall Study|Other|26|||
155166921|NCT05300763|560047721|FG000|Overall Study|Adverse Event|0|||
155166922|NCT05300763|560047722|FG001|Overall Study|Adverse Event|1|||
155166923|NCT05300763|560047721|FG000|Overall Study|Major Protocol Deviation|1|||
155166924|NCT05300763|560047722|FG001|Overall Study|Major Protocol Deviation|0|||
155166925|NCT05300763|560047721|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
155166926|NCT05300763|560047722|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155166927|NCT01727024|560047723|FG000|Period 1|Lost to Follow-up|1|||
155166928|NCT01727024|560047724|FG001|Period 1|Lost to Follow-up|1|||
155166929|NCT01727024|560047723|FG000|Period 1|Withdrawal by Subject|2|||
155166930|NCT01727024|560047724|FG001|Period 1|Withdrawal by Subject|3|||
155166931|NCT01587014|560047725|FG000|Overall Study|Death|2|||
155166932|NCT02948088|560047726|FG000|Overall Study|Lost to Follow-up|8|||
155166933|NCT02948088|560047726|FG000|Overall Study|Death|1|||
155166934|NCT02948088|560047726|FG000|Overall Study|Withdrawal by Subject|4|||
155367685|NCT05602727|560780435|FG002|Overall Study|Study termination by Sponsor|19|||
155367686|NCT05602727|560780433|FG000|Overall Study|Withdrawal by Subject|2|||
155367687|NCT05602727|560780434|FG001|Overall Study|Withdrawal by Subject|1|||
155367688|NCT05602727|560780435|FG002|Overall Study|Withdrawal by Subject|1|||
155367689|NCT05602727|560780433|FG000|Overall Study|Various reasons|1|||
155367690|NCT05602727|560780434|FG001|Overall Study|Various reasons|6|||
155367691|NCT05602727|560780435|FG002|Overall Study|Various reasons|1|||
155367692|NCT02038842|560780437|FG000|Overall Study|Withdrawal by Subject|2|||
155166935|NCT02948088|560047726|FG000|Overall Study|Other|2|||
155166936|NCT00139477|560047727|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
155166937|NCT00139477|560047728|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
155166938|NCT00139477|560047727|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
155166939|NCT00139477|560047728|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
155166940|NCT00139477|560047727|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
155367693|NCT02038842|560780438|FG001|Overall Study|Withdrawal by Subject|2|||
155367694|NCT02038842|560780439|FG002|Overall Study|Withdrawal by Subject|0|||
155367695|NCT02038842|560780440|FG003|Overall Study|Withdrawal by Subject|0|||
155367696|NCT02038842|560780437|FG000|Overall Study|Participant decision|0|||
155367697|NCT02038842|560780438|FG001|Overall Study|Participant decision|0|||
155367698|NCT02038842|560780439|FG002|Overall Study|Participant decision|2|||
155367699|NCT02038842|560780440|FG003|Overall Study|Participant decision|1|||
155367700|NCT02038842|560780437|FG000|Overall Study|Adverse Event|0|||
155367701|NCT02038842|560780438|FG001|Overall Study|Adverse Event|0|||
155367702|NCT02038842|560780439|FG002|Overall Study|Adverse Event|3|||
155367703|NCT02038842|560780440|FG003|Overall Study|Adverse Event|1|||
155367704|NCT02038842|560780437|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
155367705|NCT02038842|560780438|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
155367706|NCT02038842|560780439|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
155367707|NCT02038842|560780440|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
155367708|NCT00626197|560780445|FG000|Overall Study|Did not cooperate|2|||
155367709|NCT00626197|560780446|FG001|Overall Study|Did not cooperate|6|||
155367710|NCT00626197|560780447|FG002|Overall Study|Did not cooperate|1|||
155367711|NCT00626197|560780445|FG000|Overall Study|Failure to return|6|||
155367712|NCT00626197|560780446|FG001|Overall Study|Failure to return|5|||
155367713|NCT00626197|560780447|FG002|Overall Study|Failure to return|6|||
155367714|NCT00626197|560780445|FG000|Overall Study|Adverse event, serious fatal|3|||
155367715|NCT00626197|560780446|FG001|Overall Study|Adverse event, serious fatal|6|||
155367716|NCT00626197|560780447|FG002|Overall Study|Adverse event, serious fatal|6|||
155367717|NCT00626197|560780445|FG000|Overall Study|Adverse Event|1|||
155367718|NCT00626197|560780446|FG001|Overall Study|Adverse Event|1|||
155367719|NCT00626197|560780447|FG002|Overall Study|Adverse Event|2|||
155367720|NCT00626197|560780445|FG000|Overall Study|Withdrawal by Subject|17|||
155367721|NCT00626197|560780446|FG001|Overall Study|Withdrawal by Subject|17|||
155367722|NCT00626197|560780447|FG002|Overall Study|Withdrawal by Subject|7|||
155367723|NCT00626197|560780445|FG000|Overall Study|Administrative reasons|15|||
155367724|NCT00626197|560780446|FG001|Overall Study|Administrative reasons|19|||
155367725|NCT00626197|560780447|FG002|Overall Study|Administrative reasons|55|||
155367726|NCT05332912|560780448|FG000|Overall Study|Withdrawal by Subject|0|||
155367727|NCT05332912|560780449|FG001|Overall Study|Withdrawal by Subject|1|||
155367728|NCT05332912|560780450|FG002|Overall Study|Withdrawal by Subject|2|||
155367729|NCT05332912|560780451|FG003|Overall Study|Withdrawal by Subject|0|||
155367730|NCT05332912|560780448|FG000|Overall Study|Lost to Follow-up|0|||
155367731|NCT05332912|560780449|FG001|Overall Study|Lost to Follow-up|0|||
155367732|NCT05332912|560780450|FG002|Overall Study|Lost to Follow-up|1|||
155367733|NCT05332912|560780451|FG003|Overall Study|Lost to Follow-up|0|||
155367734|NCT00384189|560780456|FG000|Overall Study|Reason Not Specified|50|||
155367735|NCT00384189|560780457|FG001|Overall Study|Reason Not Specified|57|||
155367736|NCT00384189|560780458|FG002|Overall Study|Reason Not Specified|58|||
155367737|NCT00384189|560780459|FG003|Overall Study|Reason Not Specified|40|||
155367738|NCT04517669|560780460|FG000|Overall Study|Lost to Follow-up|2|||
155367739|NCT04517669|560780460|FG000|Overall Study|Withdrawal by Subject|3|||
155367740|NCT04517669|560780460|FG000|Overall Study|Drug withdrawn|44|||
155367741|NCT04517669|560780460|FG000|Overall Study|Other|1|||
155367742|NCT04517669|560780460|FG000|Overall Study|Eligibility criteria not met|4|||
155367743|NCT04517669|560780460|FG000|Overall Study|Did not receive treatment|3|||
155367744|NCT03338296|560780461|FG000|Overall Study|Adverse Event|0|||
155367745|NCT03338296|560780462|FG001|Overall Study|Adverse Event|1|||
155367746|NCT03338296|560780461|FG000|Overall Study|Withdrawal by Subject|14|||
155367747|NCT03338296|560780462|FG001|Overall Study|Withdrawal by Subject|13|||
155367748|NCT03338296|560780461|FG000|Overall Study|Lost to Follow-up|10|||
155367749|NCT03338296|560780462|FG001|Overall Study|Lost to Follow-up|10|||
155367750|NCT03338296|560780461|FG000|Overall Study|Study Terminated by Sponsor|77|||
155367751|NCT03338296|560780462|FG001|Overall Study|Study Terminated by Sponsor|76|||
155367752|NCT03338296|560780461|FG000|Overall Study|Other|2|||
155367753|NCT03338296|560780462|FG001|Overall Study|Other|7|||
155367754|NCT03338296|560780461|FG000|Overall Study|Missing|0|||
155367755|NCT03338296|560780462|FG001|Overall Study|Missing|1|||
155367756|NCT05048238|560780463|FG000|Overall Study|Withdrawal by Subject|1|||
155367757|NCT04481373|560780466|FG000|Overall Study|Protocol Violation|1|||
155367758|NCT04481373|560780467|FG001|Overall Study|Protocol Violation|0|||
155367759|NCT04481373|560780466|FG000|Overall Study|Viral load in hospital not over 1000|2|||
155367760|NCT04481373|560780467|FG001|Overall Study|Viral load in hospital not over 1000|1|||
155367761|NCT04481373|560780466|FG000|Overall Study|Death before hospital discharge|1|||
155367762|NCT04481373|560780467|FG001|Overall Study|Death before hospital discharge|0|||
155367763|NCT02057575|560780468|FG000|Overall Study|Adverse Event|0|||
155367764|NCT02057575|560780469|FG001|Overall Study|Adverse Event|2|||
155367765|NCT02057575|560780470|FG002|Overall Study|Adverse Event|0|||
155367766|NCT02057575|560780471|FG003|Overall Study|Adverse Event|1|||
155367767|NCT02057575|560780468|FG000|Overall Study|Withdrawal by Subject|1|||
155367768|NCT02057575|560780469|FG001|Overall Study|Withdrawal by Subject|0|||
155367769|NCT02057575|560780470|FG002|Overall Study|Withdrawal by Subject|0|||
155367770|NCT02057575|560780471|FG003|Overall Study|Withdrawal by Subject|0|||
155367771|NCT02057575|560780468|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
155367772|NCT02057575|560780469|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
155367773|NCT02057575|560780470|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
155090380|NCT00619866|559763630|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
155090381|NCT00619866|559763631|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
155090382|NCT00619866|559763632|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
155367774|NCT02057575|560780471|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
155367775|NCT02057575|560780468|FG000|Overall Study|Protocol Violation|0|||
155090383|NCT00619866|559763633|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
155367776|NCT02057575|560780469|FG001|Overall Study|Protocol Violation|1|||
155367777|NCT02057575|560780470|FG002|Overall Study|Protocol Violation|0|||
155367778|NCT02057575|560780471|FG003|Overall Study|Protocol Violation|0|||
155367779|NCT02979249|560780473|FG000|Overall Study|Lost to Follow-up|2|||
155367780|NCT02979249|560780473|FG000|Overall Study|Withdrawal by Subject|4|||
155367781|NCT01125046|560780474|FG000|First 6 Months of Treatment|Death|1|||
155367782|NCT01125046|560780474|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
155367783|NCT01125046|560780474|FG000|First 6 Months of Treatment|Non-compliance|1|||
155367784|NCT01125046|560780474|FG000|First 6 Months of Treatment|Surgery|1|||
155367785|NCT01125046|560780474|FG000|First 6 Months of Treatment|Progressive Disease|7|||
155367786|NCT01125046|560780474|FG000|First 6 Months of Treatment|Adverse Event|2|||
155367787|NCT01125046|560780474|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
155367788|NCT01125046|560780474|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
155367789|NCT01125046|560780474|FG000|Follow-up/Data Cut Off Point|Death|29|||
155367790|NCT01125046|560780474|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
155367791|NCT02766777|560780485|FG000|Overall Study|Adverse Event|12|||
155367792|NCT02766777|560780485|FG000|Overall Study|Lost to Follow-up|16|||
155367793|NCT02766777|560780485|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155367794|NCT02766777|560780485|FG000|Overall Study|Protocol Violation|1|||
155367795|NCT02766777|560780485|FG000|Overall Study|Withdrawal by Subject|4|||
155367796|NCT01886287|560780486|FG000|Overall Study|Radiographic disease progression|1|||
154965465|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965466|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965467|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965468|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965469|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965470|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965471|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965472|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965473|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155367797|NCT01886287|560780486|FG000|Overall Study|Clinical progression due to disease|1|||
155367798|NCT03842228|560780487|FG000|Overall Study|Adverse Event|1|||
155367799|NCT03842228|560780488|FG001|Overall Study|Adverse Event|1|||
155367800|NCT03842228|560780489|FG002|Overall Study|Adverse Event|1|||
155367801|NCT03842228|560780490|FG003|Overall Study|Adverse Event|0|||
155367802|NCT03842228|560780491|FG004|Overall Study|Adverse Event|0|||
155367803|NCT03842228|560780492|FG005|Overall Study|Adverse Event|0|||
155367804|NCT03842228|560780493|FG006|Overall Study|Adverse Event|0|||
155367805|NCT03842228|560780487|FG000|Overall Study|Death|0|||
155367806|NCT03842228|560780488|FG001|Overall Study|Death|1|||
155367807|NCT03842228|560780489|FG002|Overall Study|Death|0|||
155367808|NCT03842228|560780490|FG003|Overall Study|Death|0|||
155367809|NCT03842228|560780491|FG004|Overall Study|Death|0|||
155367810|NCT03842228|560780492|FG005|Overall Study|Death|0|||
155367811|NCT03842228|560780493|FG006|Overall Study|Death|0|||
155367812|NCT03842228|560780487|FG000|Overall Study|Withdrawal by Subject|0|||
155367813|NCT03842228|560780488|FG001|Overall Study|Withdrawal by Subject|0|||
155367814|NCT03842228|560780489|FG002|Overall Study|Withdrawal by Subject|2|||
155367815|NCT03842228|560780490|FG003|Overall Study|Withdrawal by Subject|1|||
155367816|NCT03842228|560780491|FG004|Overall Study|Withdrawal by Subject|0|||
155367817|NCT03842228|560780492|FG005|Overall Study|Withdrawal by Subject|0|||
155367818|NCT03842228|560780493|FG006|Overall Study|Withdrawal by Subject|2|||
155367819|NCT03842228|560780487|FG000|Overall Study|Progression|8|||
155367820|NCT03842228|560780488|FG001|Overall Study|Progression|1|||
155166941|NCT00139477|560047728|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
155166942|NCT00139477|560047727|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
155367821|NCT03842228|560780489|FG002|Overall Study|Progression|7|||
155367822|NCT03842228|560780490|FG003|Overall Study|Progression|5|||
155367823|NCT03842228|560780491|FG004|Overall Study|Progression|4|||
154965474|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155367824|NCT03842228|560780492|FG005|Overall Study|Progression|2|||
155367825|NCT03842228|560780493|FG006|Overall Study|Progression|3|||
155367826|NCT01361594|560780496|FG000|Overall Study|Withdrawal by Subject|1|||
154965475|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155367827|NCT01361594|560780497|FG001|Overall Study|Withdrawal by Subject|2|||
155367828|NCT03651700|560780499|FG000|Overall Study|Withdrawal by Subject|1|||
155367829|NCT03651700|560780500|FG001|Overall Study|Withdrawal by Subject|0|||
155367830|NCT01889069|560780504|FG000|Overall Study|Death|18|||
154965476|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155367831|NCT01889069|560780504|FG000|Overall Study|Progression of Disease|14|||
155367832|NCT01889069|560780504|FG000|Overall Study|Lost to Follow-up|6|||
155367833|NCT01889069|560780504|FG000|Overall Study|Other|4|||
155367834|NCT01889069|560780504|FG000|Overall Study|Consent Withdrawal|3|||
155367835|NCT01426347|560780508|FG000|Overall Study|Lost to Follow-up|0|||
155367836|NCT01426347|560780509|FG001|Overall Study|Lost to Follow-up|3|||
155367837|NCT01426347|560780508|FG000|Overall Study|Protocol Violation|2|||
155367838|NCT01426347|560780509|FG001|Overall Study|Protocol Violation|0|||
155367839|NCT01426347|560780508|FG000|Overall Study|Withdrawal by Subject|5|||
155367840|NCT01426347|560780509|FG001|Overall Study|Withdrawal by Subject|0|||
155367841|NCT00455741|560780510|FG000|Overall Study|Physician Decision|0|||
155367842|NCT00455741|560780511|FG001|Overall Study|Physician Decision|1|||
155367843|NCT03041792|560780514|FG000|Overall Study|Adverse Event|4|||
155367844|NCT03041792|560780515|FG001|Overall Study|Adverse Event|0|||
155166943|NCT00139477|560047728|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
155166944|NCT00139477|560047727|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
155166945|NCT00139477|560047728|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
155367845|NCT03041792|560780514|FG000|Overall Study|Death in the family|0|||
155367846|NCT03041792|560780515|FG001|Overall Study|Death in the family|2|||
155367847|NCT03041792|560780514|FG000|Overall Study|Randomized but not treated|0|||
155367848|NCT03041792|560780515|FG001|Overall Study|Randomized but not treated|1|||
155367849|NCT04978090|560780516|FG000|Overall Study|unable to adequately fit device|2|||
155367850|NCT02227992|560780521|FG000|Overall Study|Lost to Follow-up|1|||
155367851|NCT02227992|560780522|FG001|Overall Study|Lost to Follow-up|1|||
155367852|NCT01509547|560780525|FG000|Overall Study|Lost to Follow-up|24|||
155367853|NCT01509547|560780526|FG001|Overall Study|Lost to Follow-up|14|||
155367854|NCT01509547|560780525|FG000|Overall Study|Withdrawal by Subject|11|||
155367855|NCT01509547|560780526|FG001|Overall Study|Withdrawal by Subject|24|||
155367856|NCT01509547|560780525|FG000|Overall Study|Physician Decision|0|||
155367857|NCT01509547|560780526|FG001|Overall Study|Physician Decision|1|||
155367858|NCT00935532|560780527|FG000|Overall Study|Adverse Event|11|||
155367859|NCT00935532|560780528|FG001|Overall Study|Adverse Event|6|||
155367860|NCT00935532|560780527|FG000|Overall Study|Death|1|||
155367861|NCT00935532|560780528|FG001|Overall Study|Death|0|||
155367862|NCT00935532|560780527|FG000|Overall Study|Lost to Follow-up|1|||
155367863|NCT00935532|560780528|FG001|Overall Study|Lost to Follow-up|0|||
155367864|NCT00935532|560780527|FG000|Overall Study|Physician Decision|1|||
155367865|NCT00935532|560780528|FG001|Overall Study|Physician Decision|2|||
155367866|NCT00935532|560780527|FG000|Overall Study|Protocol Violation|2|||
155367867|NCT00935532|560780528|FG001|Overall Study|Protocol Violation|1|||
155367868|NCT00935532|560780527|FG000|Overall Study|Subject Decision|2|||
155367869|NCT00935532|560780528|FG001|Overall Study|Subject Decision|1|||
155367870|NCT00935532|560780527|FG000|Overall Study|Sponsor Decision|0|||
155367871|NCT00935532|560780528|FG001|Overall Study|Sponsor Decision|1|||
155367872|NCT00935532|560780527|FG000|Overall Study|Loss Glucose Control|4|||
155166946|NCT00139477|560047727|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
155166947|NCT00139477|560047728|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
155166948|NCT00139477|560047727|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
155367873|NCT00935532|560780528|FG001|Overall Study|Loss Glucose Control|0|||
155367874|NCT01371708|560780531|FG000|Overall Study|Insufficient clinical response|3|||
155367875|NCT01371708|560780532|FG001|Overall Study|Insufficient clinical response|2|||
155367876|NCT01371708|560780533|FG002|Overall Study|Insufficient clinical response|0|||
155367877|NCT01371708|560780531|FG000|Overall Study|Lost to Follow-up|5|||
155367878|NCT01371708|560780532|FG001|Overall Study|Lost to Follow-up|9|||
155367879|NCT01371708|560780533|FG002|Overall Study|Lost to Follow-up|7|||
155367880|NCT01371708|560780531|FG000|Overall Study|Protocol Violation|2|||
155367881|NCT01371708|560780532|FG001|Overall Study|Protocol Violation|1|||
155367882|NCT01371708|560780533|FG002|Overall Study|Protocol Violation|2|||
155367883|NCT01371708|560780531|FG000|Overall Study|No longer willing to participate|7|||
155367884|NCT01371708|560780532|FG001|Overall Study|No longer willing to participate|7|||
155367885|NCT01371708|560780533|FG002|Overall Study|No longer willing to participate|13|||
155367886|NCT01371708|560780531|FG000|Overall Study|Medication error/not related to AE|0|||
155367887|NCT01371708|560780532|FG001|Overall Study|Medication error/not related to AE|1|||
155367888|NCT01371708|560780533|FG002|Overall Study|Medication error/not related to AE|0|||
155367889|NCT01371708|560780531|FG000|Overall Study|Other|3|||
155367890|NCT01371708|560780532|FG001|Overall Study|Other|2|||
155367891|NCT01371708|560780533|FG002|Overall Study|Other|4|||
155367892|NCT01371708|560780531|FG000|Overall Study|Adverse Event|5|||
155367893|NCT01371708|560780532|FG001|Overall Study|Adverse Event|8|||
155367894|NCT01371708|560780533|FG002|Overall Study|Adverse Event|12|||
155367895|NCT01371708|560780531|FG000|Overall Study|Started but did not receive treatment|1|||
155367896|NCT01371708|560780532|FG001|Overall Study|Started but did not receive treatment|0|||
155367897|NCT01371708|560780533|FG002|Overall Study|Started but did not receive treatment|1|||
155367898|NCT02514551|560780534|FG000|Overall Study|Lost to Follow-up|0|||
155367899|NCT02514551|560780535|FG001|Overall Study|Lost to Follow-up|1|||
155367900|NCT02514551|560780534|FG000|Overall Study|Participant Never Treated|0|||
155367901|NCT02514551|560780535|FG001|Overall Study|Participant Never Treated|2|||
155367902|NCT01399918|560780546|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
155367903|NCT03197766|560780547|FG000|Overall Study|Withdrawal by Subject|2|||
155367904|NCT03197766|560780548|FG001|Overall Study|Withdrawal by Subject|0|||
155367905|NCT00632502|560780551|FG000|Overall Study|Adverse Event|0|||
155367906|NCT00632502|560780552|FG001|Overall Study|Adverse Event|1|||
155367907|NCT00632502|560780551|FG000|Overall Study|Randomized not treated|3|||
155367908|NCT00632502|560780552|FG001|Overall Study|Randomized not treated|0|||
155367909|NCT00570908|560780553|FG000|Overall Study|Adverse Event|5|||
155367910|NCT00570908|560780553|FG000|Overall Study|Withdrawal by Subject|2|||
155367911|NCT01213524|560780554|FG000|Baseline|Withdrawal by Subject|5|||
155367912|NCT01213524|560780554|FG000|Baseline|high breath alcohol levels|1|||
155367913|NCT01213524|560780554|FG000|Baseline|Physician Decision|1|||
155367914|NCT01213524|560780554|FG000|Session 2|Withdrawal by Subject|5|||
155367915|NCT01213524|560780554|FG000|Session 3|Withdrawal by Subject|4|||
155367916|NCT01213524|560780554|FG000|Session 4|Physician Decision|1|||
155367917|NCT01213524|560780554|FG000|Session 4|Withdrawal by Subject|2|||
155367918|NCT02519348|560780560|FG000|Overall Study|Death|31|||
155367919|NCT02519348|560780561|FG001|Overall Study|Death|74|||
155367920|NCT02519348|560780562|FG002|Overall Study|Death|47|||
155367921|NCT02519348|560780563|FG003|Overall Study|Death|54|||
155367922|NCT02519348|560780564|FG004|Overall Study|Death|63|||
155367923|NCT02519348|560780565|FG005|Overall Study|Death|18|||
155367924|NCT02519348|560780566|FG006|Overall Study|Death|2|||
155367925|NCT02519348|560780567|FG007|Overall Study|Death|5|||
155367926|NCT02519348|560780568|FG008|Overall Study|Death|5|||
155367927|NCT02519348|560780560|FG000|Overall Study|Withdrawal by Subject|4|||
155367928|NCT02519348|560780561|FG001|Overall Study|Withdrawal by Subject|7|||
155367929|NCT02519348|560780562|FG002|Overall Study|Withdrawal by Subject|4|||
155367930|NCT02519348|560780563|FG003|Overall Study|Withdrawal by Subject|3|||
155367931|NCT02519348|560780564|FG004|Overall Study|Withdrawal by Subject|3|||
155367932|NCT02519348|560780565|FG005|Overall Study|Withdrawal by Subject|2|||
155367933|NCT02519348|560780566|FG006|Overall Study|Withdrawal by Subject|0|||
155367934|NCT02519348|560780567|FG007|Overall Study|Withdrawal by Subject|0|||
155367935|NCT02519348|560780568|FG008|Overall Study|Withdrawal by Subject|1|||
155367936|NCT02519348|560780560|FG000|Overall Study|Lost to Follow-up|0|||
155367937|NCT02519348|560780561|FG001|Overall Study|Lost to Follow-up|0|||
155367938|NCT02519348|560780562|FG002|Overall Study|Lost to Follow-up|1|||
155367939|NCT02519348|560780563|FG003|Overall Study|Lost to Follow-up|0|||
155367940|NCT02519348|560780564|FG004|Overall Study|Lost to Follow-up|2|||
155367941|NCT02519348|560780565|FG005|Overall Study|Lost to Follow-up|1|||
155367942|NCT02519348|560780566|FG006|Overall Study|Lost to Follow-up|1|||
155367943|NCT02519348|560780567|FG007|Overall Study|Lost to Follow-up|0|||
155367944|NCT02519348|560780568|FG008|Overall Study|Lost to Follow-up|0|||
155367945|NCT02519348|560780560|FG000|Overall Study|Other|0|||
154965477|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
155367946|NCT02519348|560780561|FG001|Overall Study|Other|3|||
155367947|NCT02519348|560780562|FG002|Overall Study|Other|0|||
155367948|NCT02519348|560780563|FG003|Overall Study|Other|0|||
155166949|NCT00139477|560047728|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
155166950|NCT00975780|560047731|FG000|Follow Up|Death|88|||
155166951|NCT00975780|560047732|FG001|Follow Up|Death|122|||
155166952|NCT00975780|560047731|FG000|Follow Up|Facility Withdrawal|7|||
155166953|NCT00975780|560047732|FG001|Follow Up|Facility Withdrawal|23|||
155166954|NCT00975780|560047731|FG000|Follow Up|Discharged from Facility|7|||
155166955|NCT00975780|560047732|FG001|Follow Up|Discharged from Facility|12|||
155166956|NCT03962504|560047733|FG000|Overall Study|Other|11|||
155166957|NCT03962504|560047734|FG001|Overall Study|Other|32|||
155166958|NCT01976741|560047735|FG000|Overall Study|Withdrawal by Subject|1|||
155166959|NCT01976741|560047736|FG001|Overall Study|Withdrawal by Subject|0|||
155166960|NCT01976741|560047737|FG002|Overall Study|Withdrawal by Subject|1|||
155166961|NCT01976741|560047738|FG003|Overall Study|Withdrawal by Subject|1|||
155166962|NCT01976741|560047739|FG004|Overall Study|Withdrawal by Subject|0|||
155166963|NCT01976741|560047740|FG005|Overall Study|Withdrawal by Subject|0|||
155166964|NCT01976741|560047741|FG006|Overall Study|Withdrawal by Subject|1|||
155166965|NCT01976741|560047742|FG007|Overall Study|Withdrawal by Subject|4|||
155166966|NCT01976741|560047743|FG008|Overall Study|Withdrawal by Subject|0|||
155166967|NCT01976741|560047744|FG009|Overall Study|Withdrawal by Subject|0|||
155166968|NCT01976741|560047735|FG000|Overall Study|Adverse Event|0|||
155166969|NCT01976741|560047736|FG001|Overall Study|Adverse Event|0|||
155166970|NCT01976741|560047737|FG002|Overall Study|Adverse Event|2|||
155166971|NCT01976741|560047738|FG003|Overall Study|Adverse Event|0|||
155166972|NCT01976741|560047739|FG004|Overall Study|Adverse Event|0|||
155166973|NCT01976741|560047740|FG005|Overall Study|Adverse Event|0|||
155166974|NCT01976741|560047741|FG006|Overall Study|Adverse Event|3|||
155166975|NCT01976741|560047742|FG007|Overall Study|Adverse Event|8|||
155166976|NCT01976741|560047743|FG008|Overall Study|Adverse Event|1|||
155166977|NCT01976741|560047744|FG009|Overall Study|Adverse Event|4|||
155166978|NCT00670306|560047745|FG000|Overall Study|Adverse Event|8|||
155166979|NCT00670306|560047745|FG000|Overall Study|Lack of Efficacy|10|||
155166980|NCT00670306|560047745|FG000|Overall Study|Withdrawal by Subject|9|||
155166981|NCT00670306|560047745|FG000|Overall Study|Physician Decision|1|||
155166982|NCT00670306|560047745|FG000|Overall Study|Lost to Follow-up|8|||
155166983|NCT00670306|560047745|FG000|Overall Study|incl/excl criterias did not meet|19|||
155166984|NCT00067002|560047747|FG000|Overall Study|Early Death|1|||
155166985|NCT00067002|560047748|FG001|Overall Study|Early Death|2|||
155166986|NCT00067002|560047747|FG000|Overall Study|Delayed|1|||
155166987|NCT00067002|560047748|FG001|Overall Study|Delayed|1|||
155166988|NCT00067002|560047747|FG000|Overall Study|Graft Failure|5|||
155166989|NCT00067002|560047748|FG001|Overall Study|Graft Failure|6|||
155166990|NCT03568461|560047772|FG000|Overall Study|Death|7|||
155166991|NCT03568461|560047772|FG000|Overall Study|Physician Decision|5|||
155166992|NCT03568461|560047772|FG000|Overall Study|Subject decision|5|||
155166993|NCT03568461|560047772|FG000|Overall Study|Lost to Follow-up|1|||
155166994|NCT03387085|560047776|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
155166995|NCT04695977|560047777|FG000|Overall Study|Sponsor Decision|9|||
155166996|NCT04695977|560047778|FG001|Overall Study|Sponsor Decision|4|||
155166997|NCT04695977|560047777|FG000|Overall Study|Death|2|||
155166998|NCT04695977|560047778|FG001|Overall Study|Death|5|||
155166999|NCT04549545|560049336|FG000|Initial Period|Withdrawal by Subject|4|||
155167000|NCT04549545|560049337|FG001|Initial Period|Withdrawal by Subject|0|||
155167001|NCT04549545|560049336|FG000|Initial Period|Additional ENT Procedure|3|||
155167002|NCT04549545|560049337|FG001|Initial Period|Additional ENT Procedure|0|||
155167003|NCT04549545|560049336|FG000|Initial Period|Lost to Follow-up|3|||
155367949|NCT02519348|560780564|FG004|Overall Study|Other|1|||
155367950|NCT02519348|560780565|FG005|Overall Study|Other|0|||
155367951|NCT02519348|560780566|FG006|Overall Study|Other|0|||
155367952|NCT02519348|560780567|FG007|Overall Study|Other|0|||
155367953|NCT02519348|560780568|FG008|Overall Study|Other|0|||
155367954|NCT02519348|560780560|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
155367955|NCT02519348|560780561|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
155367956|NCT02519348|560780562|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
155367957|NCT02519348|560780563|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
155367958|NCT02519348|560780564|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
155367959|NCT02519348|560780565|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
155367960|NCT02519348|560780566|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
155167004|NCT04549545|560049337|FG001|Initial Period|Lost to Follow-up|1|||
155167005|NCT04549545|560049336|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
155167006|NCT04549545|560049337|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
155167007|NCT04549545|560049336|FG000|Crossover Period|Additional ENT Procedure|0|||
155167008|NCT04549545|560049337|FG001|Crossover Period|Additional ENT Procedure|6|||
155167009|NCT04549545|560049336|FG000|Crossover Period|Lost to Follow-up|0|||
155167010|NCT04549545|560049337|FG001|Crossover Period|Lost to Follow-up|1|||
155167011|NCT04549545|560049336|FG000|Crossover Period|Withdrawal by Subject|0|||
155167012|NCT04549545|560049337|FG001|Crossover Period|Withdrawal by Subject|4|||
155167013|NCT01865552|560049340|FG000|Period 1|Adverse Event|1|||
155167014|NCT01865552|560049341|FG001|Period 1|Adverse Event|0|||
154965478|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965479|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
154965480|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965481|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
155090384|NCT00619866|559763634|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
155367961|NCT02519348|560780567|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
155367962|NCT02519348|560780568|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
155367963|NCT01110408|560780569|FG000|Overall Study|Protocol Violation|1|||
155367964|NCT01110408|560780570|FG001|Overall Study|Protocol Violation|0|||
155367965|NCT00669877|560780571|FG000|Overall Study|Disease Progression/Death|4|||
155367966|NCT04103892|560780572|FG000|Overall Study|Adverse Event|0|||
155367967|NCT04103892|560780573|FG001|Overall Study|Adverse Event|0|||
155367968|NCT04103892|560780574|FG002|Overall Study|Adverse Event|0|||
155367969|NCT04103892|560780575|FG003|Overall Study|Adverse Event|3|||
155367970|NCT04103892|560780572|FG000|Overall Study|Lost to Follow-up|0|||
155367971|NCT04103892|560780573|FG001|Overall Study|Lost to Follow-up|0|||
155367972|NCT04103892|560780574|FG002|Overall Study|Lost to Follow-up|2|||
155367973|NCT04103892|560780575|FG003|Overall Study|Lost to Follow-up|0|||
155367974|NCT04103892|560780572|FG000|Overall Study|Protocol Violation|0|||
155367975|NCT04103892|560780573|FG001|Overall Study|Protocol Violation|0|||
155367976|NCT04103892|560780574|FG002|Overall Study|Protocol Violation|1|||
155367977|NCT04103892|560780575|FG003|Overall Study|Protocol Violation|1|||
155367978|NCT04103892|560780572|FG000|Overall Study|Withdrawal by Subject|1|||
155367979|NCT04103892|560780573|FG001|Overall Study|Withdrawal by Subject|0|||
155367980|NCT04103892|560780574|FG002|Overall Study|Withdrawal by Subject|2|||
155367981|NCT04103892|560780575|FG003|Overall Study|Withdrawal by Subject|5|||
155367982|NCT04103892|560780572|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
155367983|NCT04103892|560780573|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
155367984|NCT04103892|560780574|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
155367985|NCT04103892|560780575|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
155367986|NCT03008005|560780576|FG000|Overall Study|Physician Decision|1|||
155367987|NCT03008005|560780577|FG001|Overall Study|Physician Decision|0|||
155367988|NCT03008005|560780578|FG002|Overall Study|Physician Decision|0|||
155367989|NCT03008005|560780576|FG000|Overall Study|Withdrawal by Subject|1|||
155090385|NCT00619866|559763630|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
155090386|NCT00619866|559763631|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
155090387|NCT00619866|559763632|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
155090388|NCT00619866|559763633|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
155090389|NCT00619866|559763634|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
155090390|NCT00619866|559763630|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
155090391|NCT00619866|559763631|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
155090392|NCT00619866|559763632|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
155090393|NCT00619866|559763633|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
155090394|NCT00619866|559763634|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
155090395|NCT00619866|559763630|FG000|Weeks 1 - 12|Sponsor Decision|0|||
155090396|NCT00619866|559763631|FG001|Weeks 1 - 12|Sponsor Decision|1|||
155090397|NCT00619866|559763632|FG002|Weeks 1 - 12|Sponsor Decision|0|||
155090398|NCT00619866|559763633|FG003|Weeks 1 - 12|Sponsor Decision|0|||
155090399|NCT00619866|559763634|FG004|Weeks 1 - 12|Sponsor Decision|0|||
155090400|NCT00619866|559763630|FG000|Weeks 13 - 24|Adverse Event|0|||
155090401|NCT00619866|559763631|FG001|Weeks 13 - 24|Adverse Event|0|||
155367990|NCT03008005|560780577|FG001|Overall Study|Withdrawal by Subject|0|||
155367991|NCT03008005|560780578|FG002|Overall Study|Withdrawal by Subject|0|||
155367992|NCT03008005|560780576|FG000|Overall Study|Ineligible|0|||
155090402|NCT00619866|559763632|FG002|Weeks 13 - 24|Adverse Event|2|||
155090403|NCT00619866|559763633|FG003|Weeks 13 - 24|Adverse Event|1|||
155090404|NCT00619866|559763634|FG004|Weeks 13 - 24|Adverse Event|0|||
155090405|NCT00619866|559763630|FG000|Weeks 13 - 24|Protocol Deviation|0|||
155367993|NCT03008005|560780577|FG001|Overall Study|Ineligible|1|||
155367994|NCT03008005|560780578|FG002|Overall Study|Ineligible|0|||
155367995|NCT00975676|560780579|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
155367996|NCT00975676|560780580|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
155367997|NCT02548078|560780581|FG000|Overall Study|Serious adverse event/Adverse event|1|||
155367998|NCT02548078|560780582|FG001|Overall Study|Serious adverse event/Adverse event|0|||
155367999|NCT02548078|560780581|FG000|Overall Study|Moved from study area|3|||
155368000|NCT02548078|560780582|FG001|Overall Study|Moved from study area|3|||
155368001|NCT02548078|560780581|FG000|Overall Study|Lost to Follow-up|1|||
155368002|NCT02548078|560780582|FG001|Overall Study|Lost to Follow-up|3|||
155368003|NCT00862836|560780583|FG000|Overall Study|Withdrawal by Subject|1|||
155368004|NCT05855967|560780584|FG000|Overall Study|Withdrawal by Subject|7|||
155368005|NCT05855967|560780585|FG001|Overall Study|Withdrawal by Subject|5|||
155368006|NCT05855967|560780584|FG000|Overall Study|Lost to Follow-up|2|||
155368007|NCT05855967|560780585|FG001|Overall Study|Lost to Follow-up|1|||
155368008|NCT04147195|560780586|FG000|Overall Study|Adverse Event|0|||
155368009|NCT04147195|560780587|FG001|Overall Study|Adverse Event|3|||
155368010|NCT04147195|560780586|FG000|Overall Study|Study Terminated by Sponsor|4|||
155368011|NCT04147195|560780587|FG001|Overall Study|Study Terminated by Sponsor|2|||
155368012|NCT04147195|560780586|FG000|Overall Study|Withdrawal by Subject|0|||
155368013|NCT04147195|560780587|FG001|Overall Study|Withdrawal by Subject|1|||
155368014|NCT03554629|560783129|FG000|Overall Study|Inadequate data|6|||
155368015|NCT01195948|560783132|FG000|Overall Study|Lost to Follow-up|0|||
155368016|NCT01195948|560783133|FG001|Overall Study|Lost to Follow-up|1|||
155368017|NCT01195948|560783134|FG002|Overall Study|Lost to Follow-up|2|||
155368018|NCT05577715|560783135|FG000|Overall Study|Withdrawal by Subject|1|||
155368019|NCT05577715|560783135|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
155368020|NCT05577715|560783135|FG000|Overall Study|Lost to Follow-up|1|||
155368021|NCT05577715|560783135|FG000|Overall Study|Death|6|||
155368022|NCT05282121|560783140|FG000|Overall Study|Adverse Event|1|||
155368023|NCT05282121|560783141|FG001|Overall Study|Adverse Event|1|||
155368024|NCT05282121|560783142|FG002|Overall Study|Adverse Event|4|||
155368025|NCT05282121|560783143|FG003|Overall Study|Adverse Event|1|||
155368026|NCT05282121|560783140|FG000|Overall Study|Study Terminated by Sponsor|1|||
155368027|NCT05282121|560783141|FG001|Overall Study|Study Terminated by Sponsor|2|||
155368028|NCT05282121|560783142|FG002|Overall Study|Study Terminated by Sponsor|2|||
155368029|NCT05282121|560783143|FG003|Overall Study|Study Terminated by Sponsor|2|||
155368030|NCT05282121|560783140|FG000|Overall Study|Other than listed|0|||
155368031|NCT05282121|560783141|FG001|Overall Study|Other than listed|0|||
155368032|NCT05282121|560783142|FG002|Overall Study|Other than listed|1|||
155368033|NCT05282121|560783143|FG003|Overall Study|Other than listed|0|||
155368034|NCT05282121|560783140|FG000|Overall Study|No reason available|0|||
155368035|NCT05282121|560783141|FG001|Overall Study|No reason available|0|||
155368036|NCT05282121|560783142|FG002|Overall Study|No reason available|1|||
155368037|NCT05282121|560783143|FG003|Overall Study|No reason available|0|||
155368038|NCT03301155|560783146|FG000|Overall Study|Сompliance with exclusion criteria|8|||
155368039|NCT03301155|560783147|FG001|Overall Study|Сompliance with exclusion criteria|7|||
155368040|NCT03510455|560783149|FG000|Overall Study|Physician Decision|1|||
155368041|NCT04958642|560783152|FG000|Overall Study|Transferred to OLEX program|3|||
155368042|NCT04958642|560783153|FG001|Overall Study|Transferred to OLEX program|0|||
155368043|NCT04958642|560783154|FG002|Overall Study|Transferred to OLEX program|5|||
155368044|NCT04958642|560783152|FG000|Overall Study|Death|0|||
155368045|NCT04958642|560783153|FG001|Overall Study|Death|0|||
155368046|NCT04958642|560783154|FG002|Overall Study|Death|1|||
155368047|NCT04958642|560783152|FG000|Overall Study|Withdrawal by Subject|4|||
155368048|NCT04958642|560783153|FG001|Overall Study|Withdrawal by Subject|9|||
155368049|NCT04958642|560783154|FG002|Overall Study|Withdrawal by Subject|13|||
155368050|NCT04958642|560783152|FG000|Overall Study|Investigator's Decision|0|||
155368051|NCT04958642|560783153|FG001|Overall Study|Investigator's Decision|0|||
155368052|NCT04958642|560783154|FG002|Overall Study|Investigator's Decision|1|||
155368053|NCT04958642|560783152|FG000|Overall Study|Adverse Event|1|||
155368054|NCT04958642|560783153|FG001|Overall Study|Adverse Event|0|||
155368055|NCT04958642|560783154|FG002|Overall Study|Adverse Event|1|||
155368056|NCT04958642|560783152|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
155368057|NCT04958642|560783153|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
155368058|NCT04958642|560783154|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
155368059|NCT04958642|560783152|FG000|Overall Study|Lost to Follow-up|1|||
155368060|NCT04958642|560783153|FG001|Overall Study|Lost to Follow-up|0|||
155368061|NCT04958642|560783154|FG002|Overall Study|Lost to Follow-up|0|||
155368062|NCT04958642|560783152|FG000|Overall Study|Transferred to EAP following study termination|0|||
155368063|NCT04958642|560783153|FG001|Overall Study|Transferred to EAP following study termination|0|||
155368064|NCT04958642|560783154|FG002|Overall Study|Transferred to EAP following study termination|1|||
155368065|NCT04958642|560783152|FG000|Overall Study|Transferred to Expanded Access Program|1|||
155368066|NCT04958642|560783153|FG001|Overall Study|Transferred to Expanded Access Program|0|||
155368067|NCT04958642|560783154|FG002|Overall Study|Transferred to Expanded Access Program|0|||
155368068|NCT02942004|560783155|FG000|Overall Study|Withdrawal by Subject|0|||
155368069|NCT02942004|560783156|FG001|Overall Study|Withdrawal by Subject|2|||
155368070|NCT02942004|560783157|FG002|Overall Study|Withdrawal by Subject|3|||
155368071|NCT02942004|560783155|FG000|Overall Study|Lost to Follow-up|1|||
155368072|NCT02942004|560783156|FG001|Overall Study|Lost to Follow-up|1|||
155368073|NCT02942004|560783157|FG002|Overall Study|Lost to Follow-up|2|||
155368074|NCT02942004|560783155|FG000|Overall Study|Randomized but not dosed|3|||
155368075|NCT02942004|560783156|FG001|Overall Study|Randomized but not dosed|9|||
155368076|NCT02942004|560783157|FG002|Overall Study|Randomized but not dosed|4|||
155368077|NCT05627258|560783158|FG000|Overall Study|Lost to Follow-up|1|||
155368078|NCT05627258|560783159|FG001|Overall Study|Lost to Follow-up|0|||
155368079|NCT05627258|560783160|FG002|Overall Study|Lost to Follow-up|0|||
155368080|NCT05627258|560783161|FG003|Overall Study|Lost to Follow-up|0|||
155368081|NCT05627258|560783162|FG004|Overall Study|Lost to Follow-up|0|||
155368082|NCT05627258|560783163|FG005|Overall Study|Lost to Follow-up|0|||
155368083|NCT05627258|560783158|FG000|Overall Study|Withdrawal by Subject|0|||
155368084|NCT05627258|560783159|FG001|Overall Study|Withdrawal by Subject|0|||
155368085|NCT05627258|560783160|FG002|Overall Study|Withdrawal by Subject|0|||
155368086|NCT05627258|560783161|FG003|Overall Study|Withdrawal by Subject|0|||
155368087|NCT05627258|560783162|FG004|Overall Study|Withdrawal by Subject|2|||
155368088|NCT05627258|560783163|FG005|Overall Study|Withdrawal by Subject|0|||
155368089|NCT05627258|560783158|FG000|Overall Study|Enrolled, but product not administered|1|||
155368090|NCT05627258|560783159|FG001|Overall Study|Enrolled, but product not administered|0|||
155368091|NCT05627258|560783160|FG002|Overall Study|Enrolled, but product not administered|0|||
155368092|NCT05627258|560783161|FG003|Overall Study|Enrolled, but product not administered|0|||
155368093|NCT05627258|560783162|FG004|Overall Study|Enrolled, but product not administered|0|||
155368094|NCT05627258|560783163|FG005|Overall Study|Enrolled, but product not administered|0|||
155368095|NCT05627258|560783158|FG000|Overall Study|Other subject illness/injury|1|||
155368096|NCT05627258|560783159|FG001|Overall Study|Other subject illness/injury|0|||
155368097|NCT05627258|560783160|FG002|Overall Study|Other subject illness/injury|0|||
155368098|NCT05627258|560783161|FG003|Overall Study|Other subject illness/injury|0|||
155368099|NCT05627258|560783162|FG004|Overall Study|Other subject illness/injury|0|||
155368100|NCT05627258|560783163|FG005|Overall Study|Other subject illness/injury|0|||
155368101|NCT05627258|560783158|FG000|Overall Study|Subject moved from area|0|||
155368102|NCT05627258|560783159|FG001|Overall Study|Subject moved from area|0|||
155368103|NCT05627258|560783160|FG002|Overall Study|Subject moved from area|1|||
155368104|NCT05627258|560783161|FG003|Overall Study|Subject moved from area|0|||
155368105|NCT05627258|560783162|FG004|Overall Study|Subject moved from area|0|||
155368106|NCT05627258|560783163|FG005|Overall Study|Subject moved from area|0|||
155368107|NCT01923662|560783167|FG000|Overall Study|Withdrawal by Subject|1|||
155368108|NCT01199068|560783168|FG000|Overall Study|Unacceptable toxicity|0|||
155368109|NCT01199068|560783169|FG001|Overall Study|Unacceptable toxicity|0|||
155368110|NCT01199068|560783170|FG002|Overall Study|Unacceptable toxicity|2|||
155368111|NCT01199068|560783168|FG000|Overall Study|Progressive disease|3|||
155368112|NCT01199068|560783169|FG001|Overall Study|Progressive disease|3|||
155368113|NCT01199068|560783170|FG002|Overall Study|Progressive disease|6|||
155368114|NCT01199068|560783168|FG000|Overall Study|Withdrawal by Subject|0|||
155368115|NCT01199068|560783169|FG001|Overall Study|Withdrawal by Subject|0|||
155368116|NCT01199068|560783170|FG002|Overall Study|Withdrawal by Subject|1|||
155368117|NCT01250925|560783171|FG000|Overall Study|Lost to Follow-up|1|||
155368118|NCT01250925|560783172|FG001|Overall Study|Lost to Follow-up|1|||
155368119|NCT01250925|560783173|FG002|Overall Study|Lost to Follow-up|0|||
155368120|NCT01250925|560783171|FG000|Overall Study|Withdrawal by Subject|2|||
155368121|NCT01250925|560783172|FG001|Overall Study|Withdrawal by Subject|0|||
155368122|NCT01250925|560783173|FG002|Overall Study|Withdrawal by Subject|0|||
155368123|NCT01250925|560783171|FG000|Overall Study|Protocol Violation|2|||
155368124|NCT01250925|560783172|FG001|Overall Study|Protocol Violation|0|||
155368125|NCT01250925|560783173|FG002|Overall Study|Protocol Violation|0|||
155368126|NCT01250925|560783171|FG000|Overall Study|Physician Decision|0|||
155368127|NCT01250925|560783172|FG001|Overall Study|Physician Decision|2|||
155368128|NCT01250925|560783173|FG002|Overall Study|Physician Decision|1|||
155368129|NCT01250925|560783171|FG000|Overall Study|Adverse Event|0|||
155368130|NCT01250925|560783172|FG001|Overall Study|Adverse Event|0|||
155368131|NCT01250925|560783173|FG002|Overall Study|Adverse Event|1|||
155368132|NCT00678301|560783174|FG000|Overall Study|Non-compliance with study procedures|0|||
155368133|NCT00678301|560783175|FG001|Overall Study|Non-compliance with study procedures|1|||
155090406|NCT00619866|559763631|FG001|Weeks 13 - 24|Protocol Deviation|0|||
155368134|NCT00678301|560783174|FG000|Overall Study|Adverse Event|1|||
155368135|NCT00678301|560783175|FG001|Overall Study|Adverse Event|0|||
155368136|NCT00678301|560783174|FG000|Overall Study|Withdrawal by Subject|4|||
155368137|NCT00678301|560783175|FG001|Overall Study|Withdrawal by Subject|0|||
155368138|NCT00678301|560783174|FG000|Overall Study|Lost to Follow-up|3|||
155368139|NCT00678301|560783175|FG001|Overall Study|Lost to Follow-up|1|||
155368140|NCT01939353|560783176|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
155368141|NCT01939353|560783176|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
155368142|NCT01939353|560783176|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
155368143|NCT01939353|560783176|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
155368144|NCT01939353|560783176|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
155368145|NCT00335140|560783178|FG000|Overall Study|Ineligible|1|||
155368146|NCT01685229|560783186|FG000|Overall Study|Subjects missing Study Exit form|3|||
155368147|NCT01685229|560783187|FG001|Overall Study|Subjects missing Study Exit form|1|||
155368148|NCT01685229|560783186|FG000|Overall Study|Lost to Follow-up|16|||
155368149|NCT01685229|560783187|FG001|Overall Study|Lost to Follow-up|10|||
155368150|NCT01685229|560783186|FG000|Overall Study|Withdrawal by Subject|6|||
155368151|NCT01685229|560783187|FG001|Overall Study|Withdrawal by Subject|5|||
155368152|NCT01685229|560783186|FG000|Overall Study|Death|1|||
155368153|NCT01685229|560783187|FG001|Overall Study|Death|0|||
155368154|NCT03596762|560783193|FG000|Overall Study|Protocol Violation|0|||
155090407|NCT00619866|559763632|FG002|Weeks 13 - 24|Protocol Deviation|0|||
155090408|NCT00619866|559763633|FG003|Weeks 13 - 24|Protocol Deviation|1|||
155090409|NCT00619866|559763634|FG004|Weeks 13 - 24|Protocol Deviation|0|||
154965482|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965483|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965484|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965485|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965486|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965487|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965488|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
154965489|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965490|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965491|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
155368155|NCT03596762|560783194|FG001|Overall Study|Protocol Violation|0|||
155368156|NCT03596762|560783195|FG002|Overall Study|Protocol Violation|0|||
155368157|NCT03596762|560783196|FG003|Overall Study|Protocol Violation|0|||
155368158|NCT03596762|560783197|FG004|Overall Study|Protocol Violation|1|||
155368159|NCT03596762|560783193|FG000|Overall Study|Adverse Event|2|||
155368160|NCT03596762|560783194|FG001|Overall Study|Adverse Event|0|||
155368161|NCT03596762|560783195|FG002|Overall Study|Adverse Event|1|||
155368162|NCT03596762|560783196|FG003|Overall Study|Adverse Event|0|||
155368163|NCT03596762|560783197|FG004|Overall Study|Adverse Event|5|||
155368164|NCT03596762|560783193|FG000|Overall Study|Withdrawal by Subject|2|||
155368165|NCT03596762|560783194|FG001|Overall Study|Withdrawal by Subject|1|||
155368166|NCT03596762|560783195|FG002|Overall Study|Withdrawal by Subject|0|||
155368167|NCT03596762|560783196|FG003|Overall Study|Withdrawal by Subject|1|||
155368168|NCT03596762|560783197|FG004|Overall Study|Withdrawal by Subject|1|||
155368169|NCT01371825|560783204|FG000|Overall Study|Death|4|||
155368170|NCT00895895|560783205|FG000|Period 1|Adverse Event|7|||
155368171|NCT00895895|560783206|FG001|Period 1|Adverse Event|6|||
154965492|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965493|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965494|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
155368172|NCT00895895|560783207|FG002|Period 1|Adverse Event|4|||
155368173|NCT00895895|560783208|FG003|Period 1|Adverse Event|6|||
155368174|NCT00895895|560783209|FG004|Period 1|Adverse Event|7|||
155167015|NCT01865552|560049342|FG002|Period 1|Adverse Event|0|||
155167016|NCT01865552|560049343|FG003|Period 1|Adverse Event|1|||
155167017|NCT01865552|560049344|FG004|Period 1|Adverse Event|1|||
155167018|NCT01865552|560049345|FG005|Period 1|Adverse Event|1|||
155167019|NCT01865552|560049340|FG000|Period 1|Pathological lab|0|||
155167020|NCT01865552|560049341|FG001|Period 1|Pathological lab|0|||
155167021|NCT01865552|560049342|FG002|Period 1|Pathological lab|0|||
155167022|NCT01865552|560049343|FG003|Period 1|Pathological lab|0|||
155167023|NCT01865552|560049344|FG004|Period 1|Pathological lab|1|||
155167024|NCT01865552|560049345|FG005|Period 1|Pathological lab|0|||
155167025|NCT01865552|560049340|FG000|Period 1|Other|0|||
155167026|NCT01865552|560049341|FG001|Period 1|Other|0|||
155167027|NCT01865552|560049342|FG002|Period 1|Other|0|||
155167028|NCT01865552|560049343|FG003|Period 1|Other|0|||
155167029|NCT01865552|560049344|FG004|Period 1|Other|1|||
155167030|NCT01865552|560049345|FG005|Period 1|Other|0|||
155167031|NCT03083873|560049346|FG000|Overall Study|Death|6|||
155167032|NCT03083873|560049347|FG001|Overall Study|Death|15|||
155368175|NCT00895895|560783205|FG000|Period 1|Death|0|||
155368176|NCT00895895|560783206|FG001|Period 1|Death|0|||
155368177|NCT00895895|560783207|FG002|Period 1|Death|0|||
155368178|NCT00895895|560783208|FG003|Period 1|Death|0|||
155368179|NCT00895895|560783209|FG004|Period 1|Death|1|||
155368180|NCT00895895|560783205|FG000|Period 1|discontinued by sponsor|2|||
155368181|NCT00895895|560783206|FG001|Period 1|discontinued by sponsor|1|||
155368182|NCT00895895|560783207|FG002|Period 1|discontinued by sponsor|2|||
155368183|NCT00895895|560783208|FG003|Period 1|discontinued by sponsor|1|||
155368184|NCT00895895|560783209|FG004|Period 1|discontinued by sponsor|1|||
155368185|NCT00895895|560783205|FG000|Period 1|failed to return|0|||
155368186|NCT00895895|560783206|FG001|Period 1|failed to return|0|||
155368187|NCT00895895|560783207|FG002|Period 1|failed to return|1|||
155368188|NCT00895895|560783208|FG003|Period 1|failed to return|0|||
155368189|NCT00895895|560783209|FG004|Period 1|failed to return|1|||
155368190|NCT00895895|560783205|FG000|Period 1|investigator request|0|||
155368191|NCT00895895|560783206|FG001|Period 1|investigator request|1|||
155368192|NCT00895895|560783207|FG002|Period 1|investigator request|0|||
155368193|NCT00895895|560783208|FG003|Period 1|investigator request|0|||
155368194|NCT00895895|560783209|FG004|Period 1|investigator request|0|||
155368195|NCT00895895|560783205|FG000|Period 1|Lost to Follow-up|2|||
155368196|NCT00895895|560783206|FG001|Period 1|Lost to Follow-up|1|||
155368197|NCT00895895|560783207|FG002|Period 1|Lost to Follow-up|3|||
155368198|NCT00895895|560783208|FG003|Period 1|Lost to Follow-up|2|||
155368199|NCT00895895|560783209|FG004|Period 1|Lost to Follow-up|3|||
155368200|NCT00895895|560783205|FG000|Period 1|Other|1|||
155368201|NCT00895895|560783206|FG001|Period 1|Other|2|||
155368202|NCT00895895|560783207|FG002|Period 1|Other|1|||
155368203|NCT00895895|560783208|FG003|Period 1|Other|1|||
155368204|NCT00895895|560783209|FG004|Period 1|Other|1|||
155368205|NCT00895895|560783205|FG000|Period 1|Protocol Violation|0|||
155368206|NCT00895895|560783206|FG001|Period 1|Protocol Violation|1|||
155368207|NCT00895895|560783207|FG002|Period 1|Protocol Violation|0|||
155368208|NCT00895895|560783208|FG003|Period 1|Protocol Violation|0|||
155368209|NCT00895895|560783209|FG004|Period 1|Protocol Violation|0|||
155368210|NCT00895895|560783205|FG000|Period 1|Withdrawal by Subject|6|||
155368211|NCT00895895|560783206|FG001|Period 1|Withdrawal by Subject|6|||
155368212|NCT00895895|560783207|FG002|Period 1|Withdrawal by Subject|8|||
155368213|NCT00895895|560783208|FG003|Period 1|Withdrawal by Subject|2|||
155368214|NCT00895895|560783209|FG004|Period 1|Withdrawal by Subject|4|||
155368215|NCT00895895|560783205|FG000|Period 1|unsatisfactory response-efficacy|2|||
155368216|NCT00895895|560783206|FG001|Period 1|unsatisfactory response-efficacy|0|||
155368217|NCT00895895|560783207|FG002|Period 1|unsatisfactory response-efficacy|0|||
155368218|NCT00895895|560783208|FG003|Period 1|unsatisfactory response-efficacy|0|||
155368219|NCT00895895|560783209|FG004|Period 1|unsatisfactory response-efficacy|0|||
155368220|NCT00895895|560783205|FG000|Period 1|randomized and not treated|1|||
155368221|NCT00895895|560783206|FG001|Period 1|randomized and not treated|3|||
155368222|NCT00895895|560783207|FG002|Period 1|randomized and not treated|1|||
155368223|NCT00895895|560783208|FG003|Period 1|randomized and not treated|1|||
155368224|NCT00895895|560783209|FG004|Period 1|randomized and not treated|2|||
155368225|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
155368226|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
155368227|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
155368228|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
155368229|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
155368230|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Other|0|||
155368231|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Other|0|||
155368232|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Other|1|||
155368233|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Other|0|||
155368234|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Other|0|||
155368235|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
155368236|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
154965495|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
155368237|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
155368238|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
155368239|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
155368240|NCT00895895|560783205|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368241|NCT00895895|560783206|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368242|NCT00895895|560783207|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368243|NCT00895895|560783208|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
155368244|NCT00895895|560783209|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
155368245|NCT00895895|560783205|FG000|Period 2|Adverse Event|3|||
155368246|NCT00895895|560783206|FG001|Period 2|Adverse Event|3|||
155368247|NCT00895895|560783207|FG002|Period 2|Adverse Event|5|||
155368248|NCT00895895|560783208|FG003|Period 2|Adverse Event|2|||
155368249|NCT00895895|560783209|FG004|Period 2|Adverse Event|5|||
155368250|NCT00895895|560783205|FG000|Period 2|Death|0|||
155368251|NCT00895895|560783206|FG001|Period 2|Death|0|||
155368252|NCT00895895|560783207|FG002|Period 2|Death|1|||
155368253|NCT00895895|560783208|FG003|Period 2|Death|0|||
155368254|NCT00895895|560783209|FG004|Period 2|Death|0|||
155368255|NCT00895895|560783205|FG000|Period 2|discontinued by sponsor|44|||
155368256|NCT00895895|560783206|FG001|Period 2|discontinued by sponsor|44|||
155368257|NCT00895895|560783207|FG002|Period 2|discontinued by sponsor|38|||
155368258|NCT00895895|560783208|FG003|Period 2|discontinued by sponsor|46|||
155368259|NCT00895895|560783209|FG004|Period 2|discontinued by sponsor|37|||
155368260|NCT00895895|560783205|FG000|Period 2|failed to return|2|||
155368261|NCT00895895|560783206|FG001|Period 2|failed to return|0|||
155368262|NCT00895895|560783207|FG002|Period 2|failed to return|0|||
155368263|NCT00895895|560783208|FG003|Period 2|failed to return|0|||
155368264|NCT00895895|560783209|FG004|Period 2|failed to return|0|||
155368265|NCT00895895|560783205|FG000|Period 2|investigator request|2|||
155368266|NCT00895895|560783206|FG001|Period 2|investigator request|0|||
155368267|NCT00895895|560783207|FG002|Period 2|investigator request|0|||
155368268|NCT00895895|560783208|FG003|Period 2|investigator request|0|||
155368269|NCT00895895|560783209|FG004|Period 2|investigator request|0|||
155368270|NCT00895895|560783205|FG000|Period 2|Lost to Follow-up|1|||
155368271|NCT00895895|560783206|FG001|Period 2|Lost to Follow-up|2|||
155368272|NCT00895895|560783207|FG002|Period 2|Lost to Follow-up|1|||
155368273|NCT00895895|560783208|FG003|Period 2|Lost to Follow-up|1|||
155368274|NCT00895895|560783209|FG004|Period 2|Lost to Follow-up|0|||
155368275|NCT00895895|560783205|FG000|Period 2|Other|1|||
155368276|NCT00895895|560783206|FG001|Period 2|Other|1|||
155368277|NCT00895895|560783207|FG002|Period 2|Other|3|||
155368278|NCT00895895|560783208|FG003|Period 2|Other|1|||
155368279|NCT00895895|560783209|FG004|Period 2|Other|1|||
155368280|NCT00895895|560783205|FG000|Period 2|Protocol Violation|1|||
155368281|NCT00895895|560783206|FG001|Period 2|Protocol Violation|0|||
155368282|NCT00895895|560783207|FG002|Period 2|Protocol Violation|1|||
155368283|NCT00895895|560783208|FG003|Period 2|Protocol Violation|1|||
155368284|NCT00895895|560783209|FG004|Period 2|Protocol Violation|1|||
155368285|NCT00895895|560783205|FG000|Period 2|Withdrawal by Subject|0|||
155368286|NCT00895895|560783206|FG001|Period 2|Withdrawal by Subject|2|||
155368287|NCT00895895|560783207|FG002|Period 2|Withdrawal by Subject|0|||
155368288|NCT00895895|560783208|FG003|Period 2|Withdrawal by Subject|3|||
155368289|NCT00895895|560783209|FG004|Period 2|Withdrawal by Subject|5|||
155368290|NCT00895895|560783205|FG000|Period 2|unsatisfactory response-efficacy|2|||
155368291|NCT00895895|560783206|FG001|Period 2|unsatisfactory response-efficacy|1|||
155368292|NCT00895895|560783207|FG002|Period 2|unsatisfactory response-efficacy|0|||
155368293|NCT00895895|560783208|FG003|Period 2|unsatisfactory response-efficacy|0|||
155368294|NCT00895895|560783209|FG004|Period 2|unsatisfactory response-efficacy|0|||
155368295|NCT03019640|560783210|FG000|Overall Study|Screen Failures|4|||
155368296|NCT03019640|560783210|FG000|Overall Study|Adverse Event|3|||
155368297|NCT03019640|560783210|FG000|Overall Study|Participant Relapsed|1|||
155368298|NCT00504777|560783211|FG000|Overall Study|Adverse Event|1|||
155368299|NCT01572740|560783212|FG000|Overall Study|Adverse Event|1|||
155368300|NCT01572740|560783213|FG001|Overall Study|Adverse Event|1|||
155368301|NCT01572740|560783212|FG000|Overall Study|Withdrawal by Subject|1|||
155368302|NCT01572740|560783213|FG001|Overall Study|Withdrawal by Subject|1|||
155368303|NCT01572740|560783212|FG000|Overall Study|unclassified|4|||
155368304|NCT01572740|560783213|FG001|Overall Study|unclassified|3|||
155368305|NCT01818531|560783219|FG000|Overall Study|Withdrawn for case delay after block|1|||
155167033|NCT03083873|560049348|FG002|Overall Study|Death|13|||
155368306|NCT01818531|560783220|FG001|Overall Study|Withdrawn for case delay after block|0|||
155368307|NCT01818531|560783219|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
155368308|NCT01818531|560783220|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
155368309|NCT01818531|560783219|FG000|Overall Study|Withdrawn for failure to place block|0|||
155368310|NCT01818531|560783220|FG001|Overall Study|Withdrawn for failure to place block|1|||
155368311|NCT00214019|560783221|FG000|Overall Study|Lost to Follow-up|11|||
154965496|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965497|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965498|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965499|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965500|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965501|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965502|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965503|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965504|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965505|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
154965506|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965507|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965508|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965509|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965510|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965511|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
154965512|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
154965513|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
154965514|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
154965515|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
155167034|NCT03083873|560049349|FG003|Overall Study|Death|9|||
155167035|NCT03083873|560049350|FG004|Overall Study|Death|0|||
155167036|NCT03083873|560049346|FG000|Overall Study|Sponsor Terminated Study|0|||
155368312|NCT00214019|560783221|FG000|Overall Study|Withdrawal by Subject|2|||
155368313|NCT00214019|560783221|FG000|Overall Study|Screen Failed prior to randomization|17|||
155368314|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
155368315|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
155368316|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
155368317|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
155368318|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
155368319|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
155368320|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
155368321|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
155368322|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
155368323|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
155368324|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368325|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368326|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
155368327|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
155368328|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368329|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368330|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368331|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
155368332|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
155368333|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368334|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368335|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
155167037|NCT03083873|560049347|FG001|Overall Study|Sponsor Terminated Study|1|||
155167038|NCT03083873|560049348|FG002|Overall Study|Sponsor Terminated Study|2|||
155167039|NCT03083873|560049349|FG003|Overall Study|Sponsor Terminated Study|3|||
155167040|NCT03083873|560049350|FG004|Overall Study|Sponsor Terminated Study|0|||
155167041|NCT03083873|560049346|FG000|Overall Study|Lost to Follow-up|0|||
155167042|NCT03083873|560049347|FG001|Overall Study|Lost to Follow-up|1|||
155167043|NCT03083873|560049348|FG002|Overall Study|Lost to Follow-up|1|||
155167044|NCT03083873|560049349|FG003|Overall Study|Lost to Follow-up|0|||
155167045|NCT03083873|560049350|FG004|Overall Study|Lost to Follow-up|0|||
155167046|NCT03083873|560049346|FG000|Overall Study|Withdrawal by Subject|2|||
155167047|NCT03083873|560049347|FG001|Overall Study|Withdrawal by Subject|0|||
155167048|NCT03083873|560049348|FG002|Overall Study|Withdrawal by Subject|0|||
155167049|NCT03083873|560049349|FG003|Overall Study|Withdrawal by Subject|0|||
155167050|NCT03083873|560049350|FG004|Overall Study|Withdrawal by Subject|0|||
155167051|NCT03083873|560049346|FG000|Overall Study|Did Not Receive TIL|2|||
155167052|NCT03083873|560049347|FG001|Overall Study|Did Not Receive TIL|5|||
155167053|NCT03083873|560049348|FG002|Overall Study|Did Not Receive TIL|3|||
155167054|NCT03083873|560049349|FG003|Overall Study|Did Not Receive TIL|1|||
155167055|NCT03083873|560049350|FG004|Overall Study|Did Not Receive TIL|0|||
155167056|NCT00295880|560049351|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
155368336|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
155368337|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368338|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368339|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368340|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
155368341|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
155368342|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
155368343|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
155368344|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
155368345|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
155368346|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368347|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368348|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368349|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
155368350|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
155368351|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
155368352|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
155368353|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
155368354|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
155368355|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368356|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368357|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368358|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
155368359|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
155368360|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
155368361|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
155368362|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
155368363|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
155368364|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
155368365|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
155368366|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
155368367|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
155368368|NCT00477490|560783224|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
155368369|NCT00477490|560783225|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
155368370|NCT00477490|560783226|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
155368371|NCT00477490|560783227|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
155368372|NCT00477490|560783228|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
155368373|NCT00477490|560783229|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
155368374|NCT00477490|560783230|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
155368375|NCT00477490|560783231|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
155368376|NCT00477490|560783232|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
155368377|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
155368378|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
155368379|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
155368380|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
155368381|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
155368382|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
155368383|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
155167057|NCT00295880|560049351|FG000|Overall Study|Unit randomization did not occur|1|||
155167058|NCT03983317|560049354|FG000|Overall Study|Physician Decision|5|||
155167059|NCT00552188|560049359|FG000|Overall Study|Adverse Event|0|||
155167060|NCT00552188|560049360|FG001|Overall Study|Adverse Event|2|||
155167061|NCT00552188|560049359|FG000|Overall Study|Lost to Follow-up|2|||
155368384|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
155368385|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
155368386|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
155368387|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
155368388|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
155368389|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368390|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368391|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368392|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368393|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
155368394|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
155368395|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368396|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
155368397|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
155368398|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368399|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
155368400|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368401|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
155368402|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368403|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
155368404|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368405|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368406|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368407|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368408|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
155368409|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368410|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
155368411|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
155368412|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
155368413|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368414|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
155368415|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368416|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368417|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368418|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368419|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368420|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368421|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
155368422|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
155368423|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
155368424|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
155368425|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
155368426|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
155368427|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
155368428|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
155368429|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
155368430|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
155368431|NCT00477490|560783224|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368432|NCT00477490|560783225|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
155368433|NCT00477490|560783226|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
155368434|NCT00477490|560783227|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368435|NCT00477490|560783228|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
155368436|NCT00477490|560783229|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368437|NCT00477490|560783230|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368438|NCT00477490|560783231|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
155368439|NCT00477490|560783232|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
154965516|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965517|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155368440|NCT01465763|560783233|FG000|Overall Study|Withdrawal by Subject|4|||
155368441|NCT01465763|560783234|FG001|Overall Study|Withdrawal by Subject|0|||
155368442|NCT01465763|560783235|FG002|Overall Study|Withdrawal by Subject|1|||
155368443|NCT01465763|560783233|FG000|Overall Study|Insufficient Clinical Response|11|||
155368444|NCT01465763|560783234|FG001|Overall Study|Insufficient Clinical Response|0|||
155368445|NCT01465763|560783235|FG002|Overall Study|Insufficient Clinical Response|1|||
155368446|NCT01465763|560783233|FG000|Overall Study|Adverse Event|9|||
155368447|NCT01465763|560783234|FG001|Overall Study|Adverse Event|0|||
155368448|NCT01465763|560783235|FG002|Overall Study|Adverse Event|1|||
155368449|NCT01465763|560783233|FG000|Overall Study|Other|2|||
155368450|NCT01465763|560783234|FG001|Overall Study|Other|0|||
155368451|NCT01465763|560783235|FG002|Overall Study|Other|0|||
155368452|NCT01465763|560783233|FG000|Overall Study|Protocol Violation|4|||
155368453|NCT01465763|560783234|FG001|Overall Study|Protocol Violation|1|||
155368454|NCT01465763|560783235|FG002|Overall Study|Protocol Violation|1|||
155368455|NCT01465763|560783233|FG000|Overall Study|Death|1|||
155368456|NCT01465763|560783234|FG001|Overall Study|Death|0|||
155368457|NCT01465763|560783235|FG002|Overall Study|Death|0|||
155368458|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
155368459|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
155368460|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
155368461|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
155368462|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368463|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368464|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368465|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368466|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368467|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368468|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368469|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
155368470|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
155368471|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
155368472|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
155368473|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
155368474|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368475|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368476|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368477|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368478|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368479|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368480|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368481|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
155368482|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
155368483|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
155368484|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
155368485|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
155368486|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368487|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368488|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368489|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368490|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368491|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368492|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368493|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
155368494|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
155368495|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
155368496|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
155368497|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
155368498|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368499|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368500|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368501|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368502|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368503|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368504|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368505|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
155368506|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368507|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368508|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
155368509|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
155368510|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368511|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368512|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368513|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368514|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368515|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368516|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368517|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
155368518|NCT01646177|560783236|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
155368519|NCT01646177|560783237|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
155368520|NCT01646177|560783238|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
155368521|NCT01646177|560783239|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368522|NCT01646177|560783240|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368523|NCT01646177|560783241|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368524|NCT01646177|560783242|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368525|NCT01646177|560783243|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368526|NCT01646177|560783244|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155167062|NCT00552188|560049360|FG001|Overall Study|Lost to Follow-up|1|||
155368527|NCT01646177|560783245|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368528|NCT01646177|560783246|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368529|NCT01646177|560783247|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
155368530|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368531|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368532|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368533|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368534|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
155368535|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
155368536|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
155368537|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
155368538|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368539|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368540|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368541|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
155368542|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368543|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368544|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368545|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368546|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
155368547|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
155167063|NCT00552188|560049359|FG000|Overall Study|Withdrawal of consent|0|||
155167064|NCT00552188|560049360|FG001|Overall Study|Withdrawal of consent|1|||
155368548|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
155368549|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
155368550|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368551|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368552|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368553|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
155368554|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368555|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368556|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368557|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368558|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
155368559|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
155368560|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
155368561|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
155368562|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368563|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368564|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368565|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
155368566|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368567|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368568|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368569|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368570|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
155368571|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
155368572|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
155368573|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
155368574|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368575|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368576|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368577|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
155368578|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368579|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368580|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368581|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368582|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
155368583|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
155368584|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
155368585|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
155368586|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368587|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368588|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368589|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
155368590|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368591|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368592|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368593|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368594|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
155368595|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
155368596|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368597|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
155368598|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368599|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368600|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368601|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
155368602|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368603|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368604|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
154965518|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
155368605|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368606|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
155368607|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
155368608|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
155368609|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
155368610|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368611|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368612|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
155368613|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
154965519|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965520|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965521|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965522|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965523|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965524|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965525|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965526|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965527|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965528|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965529|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965530|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965531|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
154965532|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965533|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965534|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155167065|NCT00552188|560049359|FG000|Overall Study|Subject returned to home country|0|||
155167066|NCT00552188|560049360|FG001|Overall Study|Subject returned to home country|1|||
155167067|NCT01256294|560049361|FG000|Overall Study|Adverse Event|1|||
155167068|NCT01256294|560049362|FG001|Overall Study|Adverse Event|0|||
155167069|NCT01256294|560049361|FG000|Overall Study|Withdrawal by Subject|1|||
155167070|NCT01256294|560049362|FG001|Overall Study|Withdrawal by Subject|1|||
154965535|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965536|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965537|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965538|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155368614|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
155368615|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
155368616|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
155368617|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
155368618|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
155368619|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
155368620|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
155368621|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
155368622|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
155368623|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
155368624|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
155368625|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
155368626|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368627|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368628|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368629|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368630|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
155368631|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
155368632|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
155368633|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
155368634|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368635|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368636|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368637|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
155368638|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368639|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368640|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368641|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368642|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368643|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368644|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368645|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
155368646|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368647|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368648|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368649|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
155368650|NCT01646177|560783236|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368651|NCT01646177|560783237|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368652|NCT01646177|560783238|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368653|NCT01646177|560783239|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368654|NCT01646177|560783240|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368655|NCT01646177|560783241|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
155368656|NCT01646177|560783242|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
155368657|NCT01646177|560783243|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
155368658|NCT01646177|560783244|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368659|NCT01646177|560783245|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368660|NCT01646177|560783246|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368661|NCT01646177|560783247|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
155368662|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368663|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368664|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368665|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368666|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368667|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368668|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368669|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
155368670|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
155368671|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
155368672|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
155368673|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
155368674|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368675|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368676|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368677|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368678|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368679|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368680|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368681|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
155368682|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
155368683|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
155368684|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
155368685|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
155368686|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368687|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368688|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368689|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368690|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368691|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368692|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368693|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
155368694|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
155368695|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
155368696|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
155368697|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
155167071|NCT01256294|560049361|FG000|Overall Study|Protocol deviation|2|||
155368698|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368699|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368700|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368701|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368702|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368703|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368704|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368705|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
155368706|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
155368707|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
155368708|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
155368709|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
155368710|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368711|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368712|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368713|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368714|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368715|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368716|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368717|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
155368718|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
155368719|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
155368720|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
155368721|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
155368722|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368723|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368724|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368725|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368726|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368727|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368728|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368729|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
155368730|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
155368731|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
155368732|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
155368733|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
155368734|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368735|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368736|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368737|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368738|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368739|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368740|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368741|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368742|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
155368743|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
155368744|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
155368745|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
155368746|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368747|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368748|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368749|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368750|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368751|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368752|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368753|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368754|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
155368755|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
155368756|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
155368757|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
155368758|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368759|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368760|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368761|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368762|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368763|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368764|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368765|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368766|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
155368767|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
155368768|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
155368769|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
155368770|NCT01646177|560783236|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368771|NCT01646177|560783237|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368772|NCT01646177|560783238|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368773|NCT01646177|560783239|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368774|NCT01646177|560783240|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368775|NCT01646177|560783241|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368776|NCT01646177|560783242|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368777|NCT01646177|560783243|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368778|NCT01646177|560783244|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368779|NCT01646177|560783245|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
155368780|NCT01646177|560783246|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
155368781|NCT01646177|560783247|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
155368782|NCT00820170|560783250|FG000|Overall Study|Adverse Event|0|||
155368783|NCT00820170|560783251|FG001|Overall Study|Adverse Event|0|||
155368784|NCT00820170|560783252|FG002|Overall Study|Adverse Event|0|||
155368785|NCT00820170|560783253|FG003|Overall Study|Adverse Event|0|||
155368786|NCT00820170|560783254|FG004|Overall Study|Adverse Event|2|||
155368787|NCT00820170|560783250|FG000|Overall Study|Progressive Disease|0|||
155368788|NCT00820170|560783251|FG001|Overall Study|Progressive Disease|0|||
155368789|NCT00820170|560783252|FG002|Overall Study|Progressive Disease|0|||
155368790|NCT00820170|560783253|FG003|Overall Study|Progressive Disease|0|||
155368791|NCT00820170|560783254|FG004|Overall Study|Progressive Disease|2|||
155368792|NCT03995316|560783255|FG000|Overall Study|Lost to Follow-up|10|||
155368793|NCT03995316|560783256|FG001|Overall Study|Lost to Follow-up|3|||
155368794|NCT05479734|560783257|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
155368795|NCT05479734|560783258|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
155368796|NCT05479734|560783257|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
155368797|NCT05479734|560783258|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
155368798|NCT05479734|560783257|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
155368799|NCT05479734|560783258|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
155368800|NCT05479734|560783257|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
155368801|NCT05479734|560783258|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
155368802|NCT00664534|560783261|FG000|Overall Study|Adverse Event|2|||
155368803|NCT00664534|560783262|FG001|Overall Study|Adverse Event|3|||
155368804|NCT00664534|560783261|FG000|Overall Study|Lost to Follow-up|6|||
155368805|NCT00664534|560783262|FG001|Overall Study|Lost to Follow-up|10|||
155368806|NCT00664534|560783261|FG000|Overall Study|Protocol Violation|10|||
155368807|NCT00664534|560783262|FG001|Overall Study|Protocol Violation|8|||
155368808|NCT00664534|560783261|FG000|Overall Study|Withdrawal by Subject|7|||
155368809|NCT00664534|560783262|FG001|Overall Study|Withdrawal by Subject|6|||
155368810|NCT00664534|560783261|FG000|Overall Study|Physician Decision|8|||
155368811|NCT00664534|560783262|FG001|Overall Study|Physician Decision|0|||
155368812|NCT00664534|560783261|FG000|Overall Study|Sponsor decision|8|||
155368813|NCT00664534|560783262|FG001|Overall Study|Sponsor decision|6|||
155368814|NCT00600613|560783263|FG000|Overall Study|Protocol Deviation|1|||
155368815|NCT01436253|560783267|FG000|Overall Study|Lost to Follow-up|182|||
155368816|NCT01436253|560783267|FG000|Overall Study|Not meeting all eligibility criteria|117|||
155368817|NCT01495598|560783268|FG000|Overall Study|Death during follow up period|2|||
155368818|NCT01495598|560783268|FG000|Overall Study|Death on study|1|||
155368819|NCT01495598|560783268|FG000|Overall Study|Lost to Follow-up|3|||
155368820|NCT01495598|560783268|FG000|Overall Study|Physician Decision|8|||
155368821|NCT04844879|560783269|FG000|Overall Study|Death|1|||
155368822|NCT04844879|560783269|FG000|Overall Study|Withdrawal by Subject|1|||
155368823|NCT04844879|560783269|FG000|Overall Study|Adverse Event|1|||
155368824|NCT05576662|560783270|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
155368825|NCT05576662|560783271|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
155368826|NCT05576662|560783270|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
155368827|NCT05576662|560783271|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
155368828|NCT05576662|560783270|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
155368829|NCT05576662|560783271|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
155368830|NCT05576662|560783270|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
155368831|NCT05576662|560783271|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
155368832|NCT05217641|560783276|FG000|Overall Study|Lost to Follow-up|1|||
155368833|NCT05217641|560783277|FG001|Overall Study|Lost to Follow-up|1|||
155368834|NCT05217641|560783278|FG002|Overall Study|Lost to Follow-up|0|||
155368835|NCT05217641|560783279|FG003|Overall Study|Lost to Follow-up|1|||
155368836|NCT05217641|560783280|FG004|Overall Study|Lost to Follow-up|1|||
155368837|NCT05217641|560783281|FG005|Overall Study|Lost to Follow-up|0|||
155368838|NCT05217641|560783276|FG000|Overall Study|Withdrawal by Subject|0|||
155368839|NCT05217641|560783277|FG001|Overall Study|Withdrawal by Subject|0|||
155368840|NCT05217641|560783278|FG002|Overall Study|Withdrawal by Subject|0|||
155368841|NCT05217641|560783279|FG003|Overall Study|Withdrawal by Subject|3|||
155368842|NCT05217641|560783280|FG004|Overall Study|Withdrawal by Subject|1|||
155368843|NCT05217641|560783281|FG005|Overall Study|Withdrawal by Subject|0|||
155368844|NCT05217641|560783276|FG000|Overall Study|Other: participant did not specify reason|0|||
155368845|NCT05217641|560783277|FG001|Overall Study|Other: participant did not specify reason|0|||
155368846|NCT05217641|560783278|FG002|Overall Study|Other: participant did not specify reason|0|||
155368847|NCT05217641|560783279|FG003|Overall Study|Other: participant did not specify reason|0|||
155368848|NCT05217641|560783280|FG004|Overall Study|Other: participant did not specify reason|1|||
155368849|NCT05217641|560783281|FG005|Overall Study|Other: participant did not specify reason|0|||
155368850|NCT05217641|560783276|FG000|Overall Study|Extended Follow up|1|||
155368851|NCT05217641|560783277|FG001|Overall Study|Extended Follow up|1|||
155368852|NCT05217641|560783278|FG002|Overall Study|Extended Follow up|0|||
155368853|NCT05217641|560783279|FG003|Overall Study|Extended Follow up|0|||
155368854|NCT05217641|560783280|FG004|Overall Study|Extended Follow up|1|||
155368855|NCT05217641|560783281|FG005|Overall Study|Extended Follow up|0|||
155368856|NCT05292586|560783282|FG000|Overall Study|Withdrawal by Subject|3|||
155368857|NCT05292586|560783283|FG001|Overall Study|Withdrawal by Subject|10|||
155368858|NCT05292586|560783282|FG000|Overall Study|Randomization error|3|||
155368859|NCT05292586|560783283|FG001|Overall Study|Randomization error|7|||
155368860|NCT05292586|560783282|FG000|Overall Study|Adverse Event|3|||
155368861|NCT05292586|560783283|FG001|Overall Study|Adverse Event|0|||
155368862|NCT05292586|560783282|FG000|Overall Study|Lost to Follow-up|0|||
155368863|NCT05292586|560783283|FG001|Overall Study|Lost to Follow-up|1|||
155368864|NCT05292586|560783282|FG000|Overall Study|Patient refused treatment|1|||
155368865|NCT05292586|560783283|FG001|Overall Study|Patient refused treatment|0|||
155368866|NCT05292586|560783282|FG000|Overall Study|Patient could not travel to the study site|1|||
155368867|NCT05292586|560783283|FG001|Overall Study|Patient could not travel to the study site|0|||
155368868|NCT05292586|560783282|FG000|Overall Study|Technical issues with the masterscope|0|||
155368869|NCT05292586|560783283|FG001|Overall Study|Technical issues with the masterscope|3|||
155368870|NCT05292586|560783282|FG000|Overall Study|Patient moved to a different state|0|||
155368871|NCT05292586|560783283|FG001|Overall Study|Patient moved to a different state|1|||
155368872|NCT01040169|560783297|FG000|Overall Study|Lost to Follow-up|3|||
155368873|NCT01040169|560783298|FG001|Overall Study|Lost to Follow-up|8|||
155368874|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Adverse Event|4|||
155368875|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Adverse Event|0|||
155368876|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Adverse Event|0|||
155368877|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
155368878|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
155368879|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
155368880|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Death|1|||
155368881|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Death|0|||
155368882|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Death|0|||
155368883|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Physician Decision|1|||
155368884|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Physician Decision|0|||
155368885|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Physician Decision|0|||
155368886|NCT00350727|560783299|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
155368887|NCT00350727|560783300|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
155368888|NCT00350727|560783301|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
155368889|NCT00350727|560783299|FG000|Phase II|Disease Progression|0|||
155368890|NCT00350727|560783300|FG001|Phase II|Disease Progression|15|||
155368891|NCT00350727|560783301|FG002|Phase II|Disease Progression|16|||
155368892|NCT00350727|560783299|FG000|Phase II|Clinical Deterioration|0|||
155368893|NCT00350727|560783300|FG001|Phase II|Clinical Deterioration|1|||
155368894|NCT00350727|560783301|FG002|Phase II|Clinical Deterioration|0|||
155368895|NCT00350727|560783299|FG000|Phase II|Withdrawal by Subject|0|||
155368896|NCT00350727|560783300|FG001|Phase II|Withdrawal by Subject|2|||
154965539|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155368897|NCT00350727|560783301|FG002|Phase II|Withdrawal by Subject|1|||
155368898|NCT00350727|560783299|FG000|Phase II|Adverse Event|0|||
155368899|NCT00350727|560783300|FG001|Phase II|Adverse Event|1|||
155368900|NCT00350727|560783301|FG002|Phase II|Adverse Event|1|||
155368901|NCT00350727|560783299|FG000|Phase II|Death|0|||
155368902|NCT00350727|560783300|FG001|Phase II|Death|0|||
155368903|NCT00350727|560783301|FG002|Phase II|Death|2|||
155368904|NCT00350727|560783299|FG000|Phase II|Sponsor Terminated Study|0|||
155368905|NCT00350727|560783300|FG001|Phase II|Sponsor Terminated Study|0|||
155368906|NCT00350727|560783301|FG002|Phase II|Sponsor Terminated Study|1|||
155368907|NCT00350727|560783299|FG000|Phase II|Enrolled in Rollover Study|0|||
155368908|NCT00350727|560783300|FG001|Phase II|Enrolled in Rollover Study|0|||
155368909|NCT00350727|560783301|FG002|Phase II|Enrolled in Rollover Study|1|||
155368910|NCT03633799|560783309|FG000|Overall Study|Adverse Event|349|||
155368911|NCT03633799|560783309|FG000|Overall Study|Withdrawal by Subject|288|||
155368912|NCT03633799|560783309|FG000|Overall Study|Lost to Follow-up|97|||
155368913|NCT03633799|560783309|FG000|Overall Study|Physician Decision|9|||
155368914|NCT03633799|560783309|FG000|Overall Study|Protocol Violation|4|||
155368915|NCT03633799|560783309|FG000|Overall Study|Pregnancy|20|||
155368916|NCT03633799|560783309|FG000|Overall Study|other|39|||
155368917|NCT03633799|560783309|FG000|Overall Study|ongoing within third year of study|106|||
155368918|NCT03633799|560783309|FG000|Overall Study|unsuccessful study drug placement|19|||
155368919|NCT01435772|560783311|FG000|Overall Study|Adverse Event|1|||
155368920|NCT01435772|560783312|FG001|Overall Study|Adverse Event|0|||
155368921|NCT01435772|560783313|FG002|Overall Study|Adverse Event|2|||
155368922|NCT01435772|560783311|FG000|Overall Study|Withdrawal by Subject|0|||
155368923|NCT01435772|560783312|FG001|Overall Study|Withdrawal by Subject|1|||
155368924|NCT01435772|560783313|FG002|Overall Study|Withdrawal by Subject|3|||
155368925|NCT01435772|560783311|FG000|Overall Study|Other - study termination|2|||
155368926|NCT01435772|560783312|FG001|Overall Study|Other - study termination|2|||
155368927|NCT01435772|560783313|FG002|Overall Study|Other - study termination|10|||
155368928|NCT03238963|560783314|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
155368929|NCT03238963|560783315|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
155368930|NCT03238963|560783314|FG000|Overall Study|Withdrawal by Subject|1|||
155368931|NCT03238963|560783315|FG001|Overall Study|Withdrawal by Subject|1|||
155368932|NCT03238963|560783314|FG000|Overall Study|Lost to Follow-up|1|||
155368933|NCT03238963|560783315|FG001|Overall Study|Lost to Follow-up|0|||
155368934|NCT03238963|560783314|FG000|Overall Study|Protocol Violation|1|||
155368935|NCT03238963|560783315|FG001|Overall Study|Protocol Violation|1|||
155368936|NCT03238963|560783314|FG000|Overall Study|Adverse Event|1|||
155368937|NCT03238963|560783315|FG001|Overall Study|Adverse Event|0|||
155368938|NCT05823012|560783316|FG000|Titration Period|Adverse Event|1|||
155368939|NCT05823012|560783316|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
155368940|NCT05823012|560783316|FG000|Maintenance Period|Adverse Event|1|||
155368941|NCT05823012|560783316|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
154965540|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
155368942|NCT05823012|560783316|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
155368943|NCT01424813|560783317|FG000|Overall Study|Withdrawal by Subject|3|||
155368944|NCT01424813|560783318|FG001|Overall Study|Withdrawal by Subject|0|||
155368945|NCT01424813|560783317|FG000|Overall Study|Protocol Violation|1|||
155368946|NCT01424813|560783318|FG001|Overall Study|Protocol Violation|0|||
155368947|NCT01424813|560783317|FG000|Overall Study|Other|1|||
155368948|NCT01424813|560783318|FG001|Overall Study|Other|2|||
155368949|NCT07149155|560783322|FG000|Overall Study|Lost to Follow-up|10|||
155368950|NCT00918879|560785160|FG000|Overall Study|Withdrawal by Subject|4|||
155368951|NCT00918879|560785161|FG001|Overall Study|Withdrawal by Subject|4|||
154965541|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
155368952|NCT00918879|560785160|FG000|Overall Study|Lost to Follow-up|1|||
155368953|NCT00918879|560785161|FG001|Overall Study|Lost to Follow-up|1|||
155368954|NCT00918879|560785160|FG000|Overall Study|Severe non-compliance to protocol|1|||
155368955|NCT00918879|560785161|FG001|Overall Study|Severe non-compliance to protocol|1|||
155368956|NCT04707664|560785162|FG000|Overall Study|Adverse Event|2|||
155368957|NCT04707664|560785163|FG001|Overall Study|Adverse Event|0|||
155368958|NCT04707664|560785162|FG000|Overall Study|Death|1|||
155368959|NCT04707664|560785163|FG001|Overall Study|Death|2|||
155368960|NCT04707664|560785162|FG000|Overall Study|Withdrawal by Subject|13|||
155368961|NCT04707664|560785163|FG001|Overall Study|Withdrawal by Subject|21|||
155368962|NCT04707664|560785162|FG000|Overall Study|Lost to Follow-up|11|||
155368963|NCT04707664|560785163|FG001|Overall Study|Lost to Follow-up|13|||
155368964|NCT04707664|560785162|FG000|Overall Study|Not treated|2|||
155368965|NCT04707664|560785163|FG001|Overall Study|Not treated|0|||
155368966|NCT00357110|560785164|FG000|Overall Study|Early study termination|5|||
155368967|NCT00357110|560785165|FG001|Overall Study|Early study termination|5|||
155368968|NCT01977677|560785169|FG000|Overall Study|Unrelated Adverse Event|0|||
155368969|NCT01977677|560785170|FG001|Overall Study|Unrelated Adverse Event|0|||
155368970|NCT01977677|560785171|FG002|Overall Study|Unrelated Adverse Event|1|||
155368971|NCT01498887|560785172|FG000|Overall Study|Administrative problems|1|||
155368972|NCT01498887|560785173|FG001|Overall Study|Administrative problems|0|||
155368973|NCT01498887|560785172|FG000|Overall Study|Lost to Follow-up|1|||
155368974|NCT01498887|560785173|FG001|Overall Study|Lost to Follow-up|1|||
155368975|NCT01498887|560785172|FG000|Overall Study|Withdrawal by Subject|1|||
155368976|NCT01498887|560785173|FG001|Overall Study|Withdrawal by Subject|0|||
155368977|NCT01498887|560785172|FG000|Overall Study|Protocol Violation|1|||
155368978|NCT01498887|560785173|FG001|Overall Study|Protocol Violation|3|||
155368979|NCT01498887|560785172|FG000|Overall Study|Lack of Efficacy|5|||
155368980|NCT01498887|560785173|FG001|Overall Study|Lack of Efficacy|3|||
155368981|NCT01498887|560785172|FG000|Overall Study|Abnormal result from test procedure|1|||
155368982|NCT01498887|560785173|FG001|Overall Study|Abnormal result from test procedure|1|||
155368983|NCT01498887|560785172|FG000|Overall Study|Abnormal laboratory value|2|||
155368984|NCT01498887|560785173|FG001|Overall Study|Abnormal laboratory value|2|||
155368985|NCT01498887|560785172|FG000|Overall Study|Adverse Event|4|||
155368986|NCT01498887|560785173|FG001|Overall Study|Adverse Event|1|||
155368987|NCT04335591|560785174|FG000|Overall Study|Adverse Event|5|||
155368988|NCT04335591|560785175|FG001|Overall Study|Adverse Event|2|||
155368989|NCT04335591|560785176|FG002|Overall Study|Adverse Event|3|||
155368990|NCT04335591|560785177|FG003|Overall Study|Adverse Event|2|||
155368991|NCT04335591|560785174|FG000|Overall Study|Protocol Violation|1|||
155368992|NCT04335591|560785175|FG001|Overall Study|Protocol Violation|0|||
155368993|NCT04335591|560785176|FG002|Overall Study|Protocol Violation|0|||
155368994|NCT04335591|560785177|FG003|Overall Study|Protocol Violation|0|||
155368995|NCT04335591|560785174|FG000|Overall Study|Withdrawal by Subject|8|||
155368996|NCT04335591|560785175|FG001|Overall Study|Withdrawal by Subject|4|||
155368997|NCT04335591|560785176|FG002|Overall Study|Withdrawal by Subject|4|||
155368998|NCT04335591|560785177|FG003|Overall Study|Withdrawal by Subject|5|||
155368999|NCT04335591|560785174|FG000|Overall Study|Subject planning pregnancy|0|||
155369000|NCT04335591|560785175|FG001|Overall Study|Subject planning pregnancy|1|||
155369001|NCT04335591|560785176|FG002|Overall Study|Subject planning pregnancy|0|||
155369002|NCT04335591|560785177|FG003|Overall Study|Subject planning pregnancy|0|||
155369003|NCT04335591|560785174|FG000|Overall Study|Ukrainian Russian war conflict|4|||
155369004|NCT04335591|560785175|FG001|Overall Study|Ukrainian Russian war conflict|5|||
155369005|NCT04335591|560785176|FG002|Overall Study|Ukrainian Russian war conflict|2|||
155369006|NCT04335591|560785177|FG003|Overall Study|Ukrainian Russian war conflict|0|||
155369007|NCT01077128|560785185|FG000|Overall Study|Adverse Event|8|||
155369008|NCT01077128|560785185|FG000|Overall Study|Lack of Efficacy|1|||
155369009|NCT01077128|560785185|FG000|Overall Study|Disease exacerbation|1|||
155369010|NCT01077128|560785185|FG000|Overall Study|Adverse event and consent withdrawal|1|||
155369011|NCT01077128|560785185|FG000|Overall Study|Adverse event and disease exacerbation|1|||
155369012|NCT01077128|560785185|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
155369013|NCT01077128|560785185|FG000|Overall Study|Other|54|||
155369014|NCT01706705|560785186|FG000|Overall Study|Death|1|||
155369015|NCT01706705|560785186|FG000|Overall Study|Lack of Efficacy|13|||
155369016|NCT01706705|560785186|FG000|Overall Study|Non-clinical|6|||
155369017|NCT02476175|560785190|FG000|Overall Study|Adverse Event|2|||
155369018|NCT04421950|560785193|FG000|Overall Study|Dropped or lost to follow up|4|||
155369019|NCT04421950|560785194|FG001|Overall Study|Dropped or lost to follow up|2|||
155369020|NCT01252355|560785195|FG000|Overall Study|Adverse Event|9|||
155369021|NCT01252355|560785196|FG001|Overall Study|Adverse Event|17|||
155369022|NCT01252355|560785197|FG002|Overall Study|Adverse Event|22|||
155369023|NCT01252355|560785195|FG000|Overall Study|Lack of Efficacy|6|||
155369024|NCT01252355|560785196|FG001|Overall Study|Lack of Efficacy|4|||
155369025|NCT01252355|560785197|FG002|Overall Study|Lack of Efficacy|2|||
155369026|NCT01252355|560785195|FG000|Overall Study|Lost to Follow-up|0|||
155369027|NCT01252355|560785196|FG001|Overall Study|Lost to Follow-up|0|||
155369028|NCT01252355|560785197|FG002|Overall Study|Lost to Follow-up|1|||
155369029|NCT01252355|560785195|FG000|Overall Study|Poor Compliance to Protocol|1|||
155369030|NCT01252355|560785196|FG001|Overall Study|Poor Compliance to Protocol|1|||
155369031|NCT01252355|560785197|FG002|Overall Study|Poor Compliance to Protocol|1|||
155369032|NCT01252355|560785195|FG000|Overall Study|Progressive Disease|2|||
155369033|NCT01252355|560785196|FG001|Overall Study|Progressive Disease|0|||
155369034|NCT01252355|560785197|FG002|Overall Study|Progressive Disease|0|||
155369035|NCT01252355|560785195|FG000|Overall Study|Sponsor Early Termination of Study|149|||
155369036|NCT01252355|560785196|FG001|Overall Study|Sponsor Early Termination of Study|149|||
155369037|NCT01252355|560785197|FG002|Overall Study|Sponsor Early Termination of Study|146|||
155369038|NCT01252355|560785195|FG000|Overall Study|Randomized but not Treated|2|||
155369039|NCT01252355|560785196|FG001|Overall Study|Randomized but not Treated|0|||
155369040|NCT01252355|560785197|FG002|Overall Study|Randomized but not Treated|0|||
155369041|NCT01252355|560785195|FG000|Overall Study|Other Than Above|8|||
155369042|NCT01252355|560785196|FG001|Overall Study|Other Than Above|7|||
155369043|NCT01252355|560785197|FG002|Overall Study|Other Than Above|7|||
155369044|NCT02175641|560785200|FG000|Overall Study|Death|3|||
155369045|NCT02175641|560785201|FG001|Overall Study|Death|4|||
155369046|NCT02175641|560785200|FG000|Overall Study|Lost to Follow-up|4|||
155369047|NCT02175641|560785201|FG001|Overall Study|Lost to Follow-up|4|||
155369048|NCT02175641|560785200|FG000|Overall Study|Withdrawal by Subject|7|||
155369049|NCT02175641|560785201|FG001|Overall Study|Withdrawal by Subject|4|||
155369050|NCT02175641|560785200|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
155369051|NCT02175641|560785201|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
155369052|NCT02175641|560785200|FG000|Overall Study|Developed Contraindicated Condition|8|||
155369053|NCT02175641|560785201|FG001|Overall Study|Developed Contraindicated Condition|0|||
155369054|NCT04546425|560785202|FG000|Overall Study|Protocol Violation|1|||
155369055|NCT04546425|560785203|FG001|Overall Study|Protocol Violation|1|||
155369056|NCT04546425|560785204|FG002|Overall Study|Protocol Violation|0|||
155369057|NCT04546425|560785205|FG003|Overall Study|Protocol Violation|0|||
155369058|NCT04546425|560785202|FG000|Overall Study|Adverse Event|3|||
155369059|NCT04546425|560785203|FG001|Overall Study|Adverse Event|0|||
155369060|NCT04546425|560785204|FG002|Overall Study|Adverse Event|0|||
155369061|NCT04546425|560785205|FG003|Overall Study|Adverse Event|0|||
155369062|NCT04546425|560785202|FG000|Overall Study|Lost to Follow-up|5|||
155369063|NCT04546425|560785203|FG001|Overall Study|Lost to Follow-up|4|||
155369064|NCT04546425|560785204|FG002|Overall Study|Lost to Follow-up|0|||
155369065|NCT04546425|560785205|FG003|Overall Study|Lost to Follow-up|0|||
155369066|NCT04546425|560785202|FG000|Overall Study|No Longer met eligibility criteria|3|||
155369067|NCT04546425|560785203|FG001|Overall Study|No Longer met eligibility criteria|3|||
155369068|NCT04546425|560785204|FG002|Overall Study|No Longer met eligibility criteria|1|||
155369069|NCT04546425|560785205|FG003|Overall Study|No Longer met eligibility criteria|1|||
155369070|NCT04546425|560785202|FG000|Overall Study|Withdrawal by parent/guardian|6|||
155369071|NCT04546425|560785203|FG001|Overall Study|Withdrawal by parent/guardian|5|||
155369072|NCT04546425|560785204|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155369073|NCT04546425|560785205|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155369074|NCT02964325|560785208|FG000|Overall Study|Lost to Follow-up|3|||
155369075|NCT02964325|560785209|FG001|Overall Study|Lost to Follow-up|3|||
155369076|NCT02964325|560785208|FG000|Overall Study|Physician Decision|5|||
155369077|NCT02964325|560785209|FG001|Overall Study|Physician Decision|4|||
155369078|NCT02964325|560785208|FG000|Overall Study|Death|1|||
155369079|NCT02964325|560785209|FG001|Overall Study|Death|3|||
155369080|NCT02964325|560785208|FG000|Overall Study|Withdrawal by Subject|2|||
155369081|NCT02964325|560785209|FG001|Overall Study|Withdrawal by Subject|1|||
155369082|NCT02964325|560785208|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
155369083|NCT02964325|560785209|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
155369084|NCT02195479|560785211|FG000|Overall Study|Lost to Follow-up|18|||
155369085|NCT02195479|560785212|FG001|Overall Study|Lost to Follow-up|15|||
155369086|NCT02195479|560785211|FG000|Overall Study|Death|217|||
155369087|NCT02195479|560785212|FG001|Overall Study|Death|171|||
155369088|NCT02195479|560785211|FG000|Overall Study|Physician Decision|1|||
155369089|NCT02195479|560785212|FG001|Overall Study|Physician Decision|0|||
155369090|NCT02195479|560785211|FG000|Overall Study|Withdrawal by Subject|30|||
155369091|NCT02195479|560785212|FG001|Overall Study|Withdrawal by Subject|30|||
155369092|NCT02195479|560785211|FG000|Overall Study|Other|3|||
155369093|NCT02195479|560785212|FG001|Overall Study|Other|4|||
155369094|NCT02195479|560785211|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
155369095|NCT02195479|560785212|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
155369096|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
155369097|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
155369098|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
155369099|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
155369100|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155369101|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
155369102|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155369103|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
155369104|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155369105|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155369106|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155369107|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155369108|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
155369109|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
155369110|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155369111|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
155369112|NCT01263509|560785213|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
155369113|NCT01263509|560785214|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
155369114|NCT01263509|560785215|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
155369115|NCT01263509|560785216|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
155369116|NCT00967005|560785217|FG000|Overall Study|Lost to Follow-up|7|||
155369117|NCT00967005|560785218|FG001|Overall Study|Lost to Follow-up|10|||
155369118|NCT02593123|560785219|FG000|Overall Study|Physician Decision|2|||
155369119|NCT02593123|560785220|FG001|Overall Study|Physician Decision|1|||
155369120|NCT02593123|560785219|FG000|Overall Study|Relapse|1|||
155369121|NCT02593123|560785220|FG001|Overall Study|Relapse|1|||
155369122|NCT05071053|560785221|FG000|Overall Study|Progressive disease|30|||
155369123|NCT05071053|560785221|FG000|Overall Study|Adverse Event|5|||
155369124|NCT04868539|560785230|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
155369125|NCT04868539|560785231|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
155369126|NCT01401153|560785232|FG000|First Test Day|Learning disabilities; illness|1|||
155369127|NCT01401153|560785233|FG001|First Test Day|Learning disabilities; illness|10|||
155369128|NCT01401153|560785232|FG000|Second Test Day|illness|0|||
155369129|NCT01401153|560785233|FG001|Second Test Day|illness|5|||
155369130|NCT01038427|560785238|FG000|Overall Study|Lost to follow up|1|||
155369131|NCT01038427|560785239|FG001|Overall Study|Lost to follow up|1|||
155369132|NCT01038427|560785240|FG002|Overall Study|Lost to follow up|0|||
155369133|NCT01038427|560785238|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
155369134|NCT01038427|560785239|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
155369135|NCT01038427|560785240|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
155369136|NCT01038427|560785238|FG000|Overall Study|Withdrew consent|0|||
155369137|NCT01038427|560785239|FG001|Overall Study|Withdrew consent|0|||
155369138|NCT01038427|560785240|FG002|Overall Study|Withdrew consent|1|||
155369139|NCT01038427|560785238|FG000|Overall Study|Adverse Event|2|||
155369140|NCT01038427|560785239|FG001|Overall Study|Adverse Event|2|||
155369141|NCT01038427|560785240|FG002|Overall Study|Adverse Event|1|||
155369142|NCT01038427|560785238|FG000|Overall Study|Enrolled in error|0|||
155369143|NCT01038427|560785239|FG001|Overall Study|Enrolled in error|1|||
155369144|NCT01038427|560785240|FG002|Overall Study|Enrolled in error|1|||
155369145|NCT01038427|560785238|FG000|Overall Study|Other|0|||
155369146|NCT01038427|560785239|FG001|Overall Study|Other|2|||
155369147|NCT01038427|560785240|FG002|Overall Study|Other|0|||
155369148|NCT02180243|560785241|FG000|Overall Study|Withdrawal by Subject|12|||
155369149|NCT02180243|560785242|FG001|Overall Study|Withdrawal by Subject|12|||
155369150|NCT02180243|560785241|FG000|Overall Study|Lost to Follow-up|12|||
155369151|NCT02180243|560785242|FG001|Overall Study|Lost to Follow-up|2|||
155369152|NCT01137578|560785243|FG000|Overall Study|Participant requested to Discontinue|3|||
155369153|NCT01137578|560785244|FG001|Overall Study|Participant requested to Discontinue|0|||
155369154|NCT01137578|560785245|FG002|Overall Study|Participant requested to Discontinue|0|||
155369155|NCT01137578|560785243|FG000|Overall Study|Withdrawal by Subject|1|||
155369156|NCT01137578|560785244|FG001|Overall Study|Withdrawal by Subject|0|||
155369157|NCT01137578|560785245|FG002|Overall Study|Withdrawal by Subject|0|||
155369158|NCT01137578|560785243|FG000|Overall Study|Other|12|||
155369159|NCT01137578|560785244|FG001|Overall Study|Other|2|||
155369160|NCT01137578|560785245|FG002|Overall Study|Other|6|||
154965542|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965543|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965544|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965545|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965546|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965547|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965548|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965549|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965550|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965551|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965552|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965553|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965554|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965555|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965556|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965557|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
154965558|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965559|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965560|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965561|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965562|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965563|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965564|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965565|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965566|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965567|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
154965568|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965569|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965570|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965571|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965572|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965573|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965574|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965575|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
155369161|NCT01461005|560785246|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
155369162|NCT04954326|560785247|FG000|Overall Study|Protocol Violation|0|||
155369163|NCT04954326|560785248|FG001|Overall Study|Protocol Violation|1|||
155369164|NCT04954326|560785247|FG000|Overall Study|Death|0|||
155369165|NCT04954326|560785248|FG001|Overall Study|Death|2|||
155369166|NCT04954326|560785247|FG000|Overall Study|Physician Decision|0|||
155369167|NCT04954326|560785248|FG001|Overall Study|Physician Decision|1|||
155369168|NCT03083665|560785250|FG000|Double-Blind Period|Adverse Event|5|||
155369169|NCT03083665|560785251|FG001|Double-Blind Period|Adverse Event|4|||
155369170|NCT03083665|560785252|FG002|Double-Blind Period|Adverse Event|5|||
155369171|NCT03083665|560785253|FG003|Double-Blind Period|Adverse Event|0|||
155369172|NCT03083665|560785254|FG004|Double-Blind Period|Adverse Event|0|||
155369173|NCT03083665|560785255|FG005|Double-Blind Period|Adverse Event|0|||
155369174|NCT03083665|560785250|FG000|Double-Blind Period|Lack of Efficacy|0|||
155369175|NCT03083665|560785251|FG001|Double-Blind Period|Lack of Efficacy|0|||
155369176|NCT03083665|560785252|FG002|Double-Blind Period|Lack of Efficacy|1|||
155369177|NCT03083665|560785253|FG003|Double-Blind Period|Lack of Efficacy|0|||
155369178|NCT03083665|560785254|FG004|Double-Blind Period|Lack of Efficacy|0|||
155369179|NCT03083665|560785255|FG005|Double-Blind Period|Lack of Efficacy|0|||
155369180|NCT03083665|560785250|FG000|Double-Blind Period|Protocol Violation|1|||
155369181|NCT03083665|560785251|FG001|Double-Blind Period|Protocol Violation|0|||
155369182|NCT03083665|560785252|FG002|Double-Blind Period|Protocol Violation|1|||
155369183|NCT03083665|560785253|FG003|Double-Blind Period|Protocol Violation|0|||
155369184|NCT03083665|560785254|FG004|Double-Blind Period|Protocol Violation|0|||
155369185|NCT03083665|560785255|FG005|Double-Blind Period|Protocol Violation|0|||
155369186|NCT03083665|560785250|FG000|Double-Blind Period|Lost to Follow-up|1|||
155369187|NCT03083665|560785251|FG001|Double-Blind Period|Lost to Follow-up|0|||
155369188|NCT03083665|560785252|FG002|Double-Blind Period|Lost to Follow-up|1|||
155369189|NCT03083665|560785253|FG003|Double-Blind Period|Lost to Follow-up|0|||
155369190|NCT03083665|560785254|FG004|Double-Blind Period|Lost to Follow-up|0|||
155369191|NCT03083665|560785255|FG005|Double-Blind Period|Lost to Follow-up|0|||
155369192|NCT03083665|560785250|FG000|Double-Blind Period|Withdrawal by Subject|3|||
155369193|NCT03083665|560785251|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155369194|NCT03083665|560785252|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155369195|NCT03083665|560785253|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155369196|NCT03083665|560785254|FG004|Double-Blind Period|Withdrawal by Subject|0|||
155369197|NCT03083665|560785255|FG005|Double-Blind Period|Withdrawal by Subject|0|||
155369198|NCT03083665|560785250|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
155369199|NCT03083665|560785251|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155369200|NCT03083665|560785252|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155167072|NCT01256294|560049362|FG001|Overall Study|Protocol deviation|1|||
155369201|NCT03083665|560785253|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155167073|NCT03887702|560049363|FG000|Overall Study|Study terminated|0|||
155369202|NCT03083665|560785254|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155369203|NCT03083665|560785255|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
155090410|NCT00619866|559763630|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
155090411|NCT00619866|559763631|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
155090412|NCT00619866|559763632|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
155090413|NCT00619866|559763633|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
155090414|NCT00619866|559763634|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
155090415|NCT00619866|559763630|FG000|Weeks 13 - 24|Non-compliance|0|||
155369204|NCT03083665|560785250|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369205|NCT03083665|560785251|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
155369206|NCT03083665|560785252|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369207|NCT03083665|560785253|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369208|NCT03083665|560785254|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369209|NCT03083665|560785255|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
155369210|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369211|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369212|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369213|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
155369214|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369215|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
155369216|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369217|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369218|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369219|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369220|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
155369221|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
155369222|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
155369223|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
155369224|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
155369225|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
155369226|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
155369227|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
155369228|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369229|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369230|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369231|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369232|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
155369233|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
155369234|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369235|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369236|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369237|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
155369238|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369239|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
155369240|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369241|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369242|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369243|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155090416|NCT00619866|559763631|FG001|Weeks 13 - 24|Non-compliance|1|||
155369244|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
155369245|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
155369246|NCT03083665|560785250|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155369247|NCT03083665|560785251|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155090417|NCT00619866|559763632|FG002|Weeks 13 - 24|Non-compliance|1|||
155090418|NCT00619866|559763633|FG003|Weeks 13 - 24|Non-compliance|0|||
155090419|NCT00619866|559763634|FG004|Weeks 13 - 24|Non-compliance|0|||
155090420|NCT00619866|559763630|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
155090421|NCT00619866|559763631|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
155090422|NCT00619866|559763632|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
155090423|NCT00619866|559763633|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
155369248|NCT03083665|560785252|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155369249|NCT03083665|560785253|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
154965576|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
155090424|NCT00619866|559763634|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
155090425|NCT00265122|559763636|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
155369250|NCT03083665|560785254|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
155369251|NCT03083665|560785255|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
155369252|NCT03635099|560785256|FG000|Period 1|Adverse Event|1|||
155369253|NCT03635099|560785257|FG001|Period 1|Adverse Event|0|||
155369254|NCT03635099|560785258|FG002|Period 1|Adverse Event|0|||
155369255|NCT03635099|560785259|FG003|Period 1|Adverse Event|1|||
155369256|NCT03635099|560785260|FG004|Period 1|Adverse Event|0|||
155369257|NCT03635099|560785261|FG005|Period 1|Adverse Event|0|||
155369258|NCT03635099|560785262|FG006|Period 1|Adverse Event|0|||
155369259|NCT03635099|560785263|FG007|Period 1|Adverse Event|0|||
155369260|NCT03635099|560785256|FG000|Period 1|Protocol Violation|0|||
155369261|NCT03635099|560785257|FG001|Period 1|Protocol Violation|0|||
155369262|NCT03635099|560785258|FG002|Period 1|Protocol Violation|1|||
155369263|NCT03635099|560785259|FG003|Period 1|Protocol Violation|0|||
155369264|NCT03635099|560785260|FG004|Period 1|Protocol Violation|0|||
155369265|NCT03635099|560785261|FG005|Period 1|Protocol Violation|0|||
155369266|NCT03635099|560785262|FG006|Period 1|Protocol Violation|0|||
155369267|NCT03635099|560785263|FG007|Period 1|Protocol Violation|0|||
155369268|NCT03635099|560785256|FG000|Period 1|Lost to Follow-up|0|||
155369269|NCT03635099|560785257|FG001|Period 1|Lost to Follow-up|0|||
155369270|NCT03635099|560785258|FG002|Period 1|Lost to Follow-up|1|||
155369271|NCT03635099|560785259|FG003|Period 1|Lost to Follow-up|2|||
155369272|NCT03635099|560785260|FG004|Period 1|Lost to Follow-up|1|||
155369273|NCT03635099|560785261|FG005|Period 1|Lost to Follow-up|0|||
155369274|NCT03635099|560785262|FG006|Period 1|Lost to Follow-up|1|||
155369275|NCT03635099|560785263|FG007|Period 1|Lost to Follow-up|2|||
155369276|NCT03635099|560785256|FG000|Period 1|Withdrawal by Subject|3|||
155369277|NCT03635099|560785257|FG001|Period 1|Withdrawal by Subject|3|||
155369278|NCT03635099|560785258|FG002|Period 1|Withdrawal by Subject|5|||
155369279|NCT03635099|560785259|FG003|Period 1|Withdrawal by Subject|2|||
155369280|NCT03635099|560785260|FG004|Period 1|Withdrawal by Subject|2|||
155369281|NCT03635099|560785261|FG005|Period 1|Withdrawal by Subject|0|||
155369282|NCT03635099|560785262|FG006|Period 1|Withdrawal by Subject|3|||
155369283|NCT03635099|560785263|FG007|Period 1|Withdrawal by Subject|0|||
155369284|NCT03635099|560785256|FG000|Period 1|History of suicidal ideation|0|||
155369285|NCT03635099|560785257|FG001|Period 1|History of suicidal ideation|0|||
155369286|NCT03635099|560785258|FG002|Period 1|History of suicidal ideation|1|||
155090426|NCT00265122|559763637|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
155090427|NCT00265122|559763638|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
155369287|NCT03635099|560785259|FG003|Period 1|History of suicidal ideation|0|||
155369288|NCT03635099|560785260|FG004|Period 1|History of suicidal ideation|0|||
155369289|NCT03635099|560785261|FG005|Period 1|History of suicidal ideation|0|||
155369290|NCT03635099|560785262|FG006|Period 1|History of suicidal ideation|0|||
155369291|NCT03635099|560785263|FG007|Period 1|History of suicidal ideation|0|||
155369292|NCT03635099|560785256|FG000|Period 1|pursue other treatment options|0|||
155369293|NCT03635099|560785257|FG001|Period 1|pursue other treatment options|0|||
155369294|NCT03635099|560785258|FG002|Period 1|pursue other treatment options|0|||
155369295|NCT03635099|560785259|FG003|Period 1|pursue other treatment options|0|||
155369296|NCT03635099|560785260|FG004|Period 1|pursue other treatment options|0|||
155369297|NCT03635099|560785261|FG005|Period 1|pursue other treatment options|1|||
155369298|NCT03635099|560785262|FG006|Period 1|pursue other treatment options|0|||
155369299|NCT03635099|560785263|FG007|Period 1|pursue other treatment options|0|||
155369300|NCT03635099|560785256|FG000|Not Eligible for Period 2|Pregnancy|0|||
155369301|NCT03635099|560785257|FG001|Not Eligible for Period 2|Pregnancy|0|||
155369302|NCT03635099|560785258|FG002|Not Eligible for Period 2|Pregnancy|0|||
155369303|NCT03635099|560785259|FG003|Not Eligible for Period 2|Pregnancy|1|||
155369304|NCT03635099|560785260|FG004|Not Eligible for Period 2|Pregnancy|0|||
155369305|NCT03635099|560785261|FG005|Not Eligible for Period 2|Pregnancy|0|||
155369306|NCT03635099|560785262|FG006|Not Eligible for Period 2|Pregnancy|0|||
155369307|NCT03635099|560785263|FG007|Not Eligible for Period 2|Pregnancy|0|||
155369308|NCT03635099|560785256|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
155369309|NCT03635099|560785257|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369310|NCT03635099|560785258|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369311|NCT03635099|560785259|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369312|NCT03635099|560785260|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369313|NCT03635099|560785261|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369314|NCT03635099|560785262|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369315|NCT03635099|560785263|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
155369316|NCT03635099|560785256|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369317|NCT03635099|560785257|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369318|NCT03635099|560785258|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369319|NCT03635099|560785259|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369320|NCT03635099|560785260|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
155369321|NCT03635099|560785261|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
155369322|NCT03635099|560785262|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
155369323|NCT03635099|560785263|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
155369324|NCT03635099|560785256|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
155369325|NCT03635099|560785257|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
155369326|NCT03635099|560785258|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
155369327|NCT03635099|560785259|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
155369328|NCT03635099|560785260|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369329|NCT03635099|560785261|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369330|NCT03635099|560785262|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369331|NCT03635099|560785263|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
155369332|NCT03635099|560785256|FG000|Period 2|Adverse Event|0|||
155369333|NCT03635099|560785257|FG001|Period 2|Adverse Event|0|||
155369334|NCT03635099|560785258|FG002|Period 2|Adverse Event|1|||
155369335|NCT03635099|560785259|FG003|Period 2|Adverse Event|0|||
155369336|NCT03635099|560785260|FG004|Period 2|Adverse Event|1|||
155369337|NCT03635099|560785261|FG005|Period 2|Adverse Event|0|||
155369338|NCT03635099|560785262|FG006|Period 2|Adverse Event|0|||
155369339|NCT03635099|560785263|FG007|Period 2|Adverse Event|0|||
155369340|NCT03635099|560785256|FG000|Period 2|Lost to Follow-up|0|||
155369341|NCT03635099|560785257|FG001|Period 2|Lost to Follow-up|0|||
155369342|NCT03635099|560785258|FG002|Period 2|Lost to Follow-up|1|||
155369343|NCT03635099|560785259|FG003|Period 2|Lost to Follow-up|0|||
155369344|NCT03635099|560785260|FG004|Period 2|Lost to Follow-up|4|||
155369345|NCT03635099|560785261|FG005|Period 2|Lost to Follow-up|0|||
155369346|NCT03635099|560785262|FG006|Period 2|Lost to Follow-up|0|||
155369347|NCT03635099|560785263|FG007|Period 2|Lost to Follow-up|0|||
155369348|NCT03635099|560785256|FG000|Period 2|Withdrawal by Subject|0|||
155369349|NCT03635099|560785257|FG001|Period 2|Withdrawal by Subject|0|||
155369350|NCT03635099|560785258|FG002|Period 2|Withdrawal by Subject|7|||
155369351|NCT03635099|560785259|FG003|Period 2|Withdrawal by Subject|4|||
155369352|NCT03635099|560785260|FG004|Period 2|Withdrawal by Subject|7|||
155369353|NCT03635099|560785261|FG005|Period 2|Withdrawal by Subject|0|||
155369354|NCT03635099|560785262|FG006|Period 2|Withdrawal by Subject|0|||
155369355|NCT03635099|560785263|FG007|Period 2|Withdrawal by Subject|0|||
155090428|NCT00265122|559763639|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
155090429|NCT00265122|559763640|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
155090430|NCT00265122|559763641|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
155090431|NCT00265122|559763636|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
155090432|NCT00265122|559763637|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155090433|NCT00265122|559763638|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155090434|NCT00265122|559763639|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
155090435|NCT00265122|559763640|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155090436|NCT00265122|559763641|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
155090437|NCT00265122|559763636|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
155369356|NCT01289210|560785264|FG000|Overall Study|Adverse Event|1|||
155369357|NCT06285240|560785265|FG000|Overall Study|Withdrawal by Subject|2|||
155369358|NCT06285240|560785266|FG001|Overall Study|Withdrawal by Subject|0|||
155369359|NCT06285240|560785267|FG002|Overall Study|Withdrawal by Subject|0|||
155369360|NCT06285240|560785268|FG003|Overall Study|Withdrawal by Subject|0|||
155369361|NCT06285240|560785265|FG000|Overall Study|Serious Adverse Event|0|||
155369362|NCT06285240|560785266|FG001|Overall Study|Serious Adverse Event|0|||
155369363|NCT06285240|560785267|FG002|Overall Study|Serious Adverse Event|1|||
155369364|NCT06285240|560785268|FG003|Overall Study|Serious Adverse Event|0|||
155369365|NCT05140915|560785271|FG000|Overall Study|Lost to Follow-up|2|||
155369366|NCT05140915|560785272|FG001|Overall Study|Lost to Follow-up|1|||
155369367|NCT04520659|560785273|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
155369368|NCT04520659|560785274|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
155369369|NCT04520659|560785275|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
155369370|NCT04520659|560785276|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
155369371|NCT04485611|560785281|FG000|Prehabilitation|Physician Decision|1|||
155369372|NCT04879849|560785282|FG000|Overall Study|Lost to Follow-up|0|||
155369373|NCT04879849|560785283|FG001|Overall Study|Lost to Follow-up|0|||
155369374|NCT04879849|560785284|FG002|Overall Study|Lost to Follow-up|0|||
155369375|NCT04879849|560785285|FG003|Overall Study|Lost to Follow-up|1|||
155369376|NCT04879849|560785286|FG004|Overall Study|Lost to Follow-up|0|||
155369377|NCT04879849|560785287|FG005|Overall Study|Lost to Follow-up|0|||
155369378|NCT04879849|560785288|FG006|Overall Study|Lost to Follow-up|0|||
155369379|NCT04879849|560785289|FG007|Overall Study|Lost to Follow-up|0|||
155369380|NCT04879849|560785282|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
155369381|NCT04879849|560785283|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
155369382|NCT04879849|560785284|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
155369383|NCT04879849|560785285|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
155369384|NCT04879849|560785286|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
155369385|NCT04879849|560785287|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
155369386|NCT04879849|560785288|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
155369387|NCT04879849|560785289|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
155369388|NCT04879849|560785282|FG000|Overall Study|Withdrawal by Subject|0|||
155369389|NCT04879849|560785283|FG001|Overall Study|Withdrawal by Subject|0|||
155369390|NCT04879849|560785284|FG002|Overall Study|Withdrawal by Subject|0|||
155369391|NCT04879849|560785285|FG003|Overall Study|Withdrawal by Subject|0|||
155369392|NCT04879849|560785286|FG004|Overall Study|Withdrawal by Subject|2|||
155369393|NCT04879849|560785287|FG005|Overall Study|Withdrawal by Subject|0|||
155369394|NCT04879849|560785288|FG006|Overall Study|Withdrawal by Subject|1|||
155369395|NCT04879849|560785289|FG007|Overall Study|Withdrawal by Subject|0|||
155369396|NCT04879849|560785282|FG000|Overall Study|Progressive Disease|0|||
155369397|NCT04879849|560785283|FG001|Overall Study|Progressive Disease|0|||
155369398|NCT04879849|560785284|FG002|Overall Study|Progressive Disease|1|||
155369399|NCT04879849|560785285|FG003|Overall Study|Progressive Disease|0|||
155369400|NCT04879849|560785286|FG004|Overall Study|Progressive Disease|0|||
155369401|NCT04879849|560785287|FG005|Overall Study|Progressive Disease|0|||
155369402|NCT04879849|560785288|FG006|Overall Study|Progressive Disease|0|||
155369403|NCT04879849|560785289|FG007|Overall Study|Progressive Disease|0|||
155369404|NCT04879849|560785282|FG000|Overall Study|Death|0|||
155369405|NCT04879849|560785283|FG001|Overall Study|Death|0|||
155369406|NCT04879849|560785284|FG002|Overall Study|Death|1|||
155369407|NCT04879849|560785285|FG003|Overall Study|Death|1|||
155369408|NCT04879849|560785286|FG004|Overall Study|Death|1|||
155369409|NCT04879849|560785287|FG005|Overall Study|Death|2|||
155369410|NCT04879849|560785288|FG006|Overall Study|Death|1|||
155090438|NCT00265122|559763637|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
155369411|NCT04879849|560785289|FG007|Overall Study|Death|2|||
155369412|NCT04879849|560785282|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369413|NCT04879849|560785283|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
154965577|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965578|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965579|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
155090439|NCT00265122|559763638|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
155090440|NCT00265122|559763639|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
155090441|NCT00265122|559763640|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
155090442|NCT00265122|559763641|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
155090443|NCT00265122|559763636|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
155090444|NCT00265122|559763637|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
155090445|NCT00265122|559763638|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
155090446|NCT00265122|559763639|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
155090447|NCT00265122|559763640|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
155090448|NCT00265122|559763641|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
155090449|NCT00265122|559763636|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
155090450|NCT00265122|559763637|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
155369414|NCT04879849|560785284|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369415|NCT04879849|560785285|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
155369416|NCT04879849|560785286|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
155369417|NCT04879849|560785287|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
155369418|NCT04879849|560785288|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369419|NCT04879849|560785289|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
155369420|NCT04879849|560785282|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369421|NCT04879849|560785283|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369422|NCT04879849|560785284|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369423|NCT04879849|560785285|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369424|NCT04879849|560785286|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369425|NCT04879849|560785287|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369426|NCT04879849|560785288|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
155369427|NCT04879849|560785289|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
155369428|NCT04879849|560785282|FG000|Overall Study|Reason Not Specified|1|||
155369429|NCT04879849|560785283|FG001|Overall Study|Reason Not Specified|0|||
155369430|NCT04879849|560785284|FG002|Overall Study|Reason Not Specified|0|||
155369431|NCT04879849|560785285|FG003|Overall Study|Reason Not Specified|0|||
155369432|NCT04879849|560785286|FG004|Overall Study|Reason Not Specified|0|||
155369433|NCT04879849|560785287|FG005|Overall Study|Reason Not Specified|0|||
155369434|NCT04879849|560785288|FG006|Overall Study|Reason Not Specified|0|||
155369435|NCT04879849|560785289|FG007|Overall Study|Reason Not Specified|0|||
155369436|NCT03361865|560785290|FG000|Overall Study|Death|17|||
155369437|NCT03361865|560785291|FG001|Overall Study|Death|18|||
155369438|NCT03361865|560785290|FG000|Overall Study|Physician Decision|1|||
155369439|NCT03361865|560785291|FG001|Overall Study|Physician Decision|9|||
155369440|NCT03361865|560785290|FG000|Overall Study|Withdrawal by Subject|1|||
155369441|NCT03361865|560785291|FG001|Overall Study|Withdrawal by Subject|0|||
155369442|NCT02819024|560785293|FG000|Overall Study|Withdrawal by Subject|1|||
155369443|NCT03551691|560785297|FG000|Overall Study|Withdrawal by Subject|3|||
155369444|NCT03551691|560785298|FG001|Overall Study|Withdrawal by Subject|3|||
155369445|NCT02367040|560785299|FG000|Overall Study|Lost to Follow-up|1|||
155369446|NCT02367040|560785300|FG001|Overall Study|Lost to Follow-up|1|||
155369447|NCT02367040|560785299|FG000|Overall Study|Lack of Efficacy|1|||
155369448|NCT02367040|560785300|FG001|Overall Study|Lack of Efficacy|0|||
155369449|NCT02367040|560785299|FG000|Overall Study|Additional primary malignancy|1|||
155369450|NCT02367040|560785300|FG001|Overall Study|Additional primary malignancy|1|||
155369451|NCT02367040|560785299|FG000|Overall Study|AE not associated with clinical disease progression|117|||
155369452|NCT02367040|560785300|FG001|Overall Study|AE not associated with clinical disease progression|12|||
155369453|NCT02367040|560785299|FG000|Overall Study|AE associated with clinical disease progression|1|||
155369454|NCT02367040|560785300|FG001|Overall Study|AE associated with clinical disease progression|4|||
155369455|NCT02367040|560785299|FG000|Overall Study|Physician Decision|2|||
155369456|NCT02367040|560785300|FG001|Overall Study|Physician Decision|8|||
155369457|NCT02367040|560785299|FG000|Overall Study|Non-compliance to study drug|1|||
155369458|NCT02367040|560785300|FG001|Overall Study|Non-compliance to study drug|0|||
155369459|NCT02367040|560785299|FG000|Overall Study|Failure to meet continuation criteria|1|||
155369460|NCT02367040|560785300|FG001|Overall Study|Failure to meet continuation criteria|0|||
155369461|NCT02367040|560785299|FG000|Overall Study|Switching to other therapy|2|||
155369462|NCT02367040|560785300|FG001|Overall Study|Switching to other therapy|0|||
154965580|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
155369463|NCT02367040|560785299|FG000|Overall Study|Withdrawal by Subject|51|||
155369464|NCT02367040|560785300|FG001|Overall Study|Withdrawal by Subject|16|||
155369465|NCT02367040|560785299|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
155369466|NCT02367040|560785300|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155369467|NCT02367040|560785299|FG000|Overall Study|Patient decision|40|||
155369468|NCT02367040|560785300|FG001|Overall Study|Patient decision|14|||
155369469|NCT02367040|560785299|FG000|Overall Study|Required procedure failed|1|||
155369470|NCT02367040|560785300|FG001|Overall Study|Required procedure failed|0|||
155369471|NCT02367040|560785299|FG000|Overall Study|Randomized by mistake with study treatment|1|||
155369472|NCT02367040|560785300|FG001|Overall Study|Randomized by mistake with study treatment|0|||
155369473|NCT02367040|560785299|FG000|Overall Study|Protocol Violation|1|||
155369474|NCT02367040|560785300|FG001|Overall Study|Protocol Violation|0|||
155369475|NCT02367040|560785299|FG000|Overall Study|Progressive disease - radiological progression|54|||
155369476|NCT02367040|560785300|FG001|Overall Study|Progressive disease - radiological progression|80|||
155369477|NCT02367040|560785299|FG000|Overall Study|Progressive disease - clinical progression|6|||
155369478|NCT02367040|560785300|FG001|Overall Study|Progressive disease - clinical progression|6|||
155369479|NCT02367040|560785299|FG000|Overall Study|Drug not administered|3|||
155369480|NCT02367040|560785300|FG001|Overall Study|Drug not administered|2|||
155369481|NCT02367040|560785299|FG000|Overall Study|Progressive disease|0|||
155369482|NCT02367040|560785300|FG001|Overall Study|Progressive disease|1|||
155369483|NCT02367040|560785299|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
155369484|NCT02367040|560785300|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
155369485|NCT02367040|560785299|FG000|Overall Study|Death|2|||
155369486|NCT02367040|560785300|FG001|Overall Study|Death|0|||
155369487|NCT02367040|560785299|FG000|Overall Study|Study terminated by sponsor|19|||
155369488|NCT02367040|560785300|FG001|Overall Study|Study terminated by sponsor|2|||
155369489|NCT02477618|560785301|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
155369490|NCT02477618|560785302|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
155369491|NCT02477618|560785301|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
155369492|NCT02477618|560785302|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
155369493|NCT02477618|560785301|FG000|Overall Study|Adverse Event|1|||
155369494|NCT02477618|560785302|FG001|Overall Study|Adverse Event|1|||
155369495|NCT02477618|560785301|FG000|Overall Study|Transferred Away from Study Site|1|||
155090451|NCT00265122|559763638|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
155090452|NCT00265122|559763639|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
155090453|NCT00265122|559763640|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
155090454|NCT00265122|559763641|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
155090455|NCT00265122|559763636|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
155090456|NCT00265122|559763637|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
155090457|NCT00265122|559763638|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
155369496|NCT02477618|560785302|FG001|Overall Study|Transferred Away from Study Site|0|||
155369497|NCT02477618|560785301|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
155090458|NCT00265122|559763639|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
155369498|NCT02477618|560785302|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
155369499|NCT02446821|560785303|FG000|Overall Study|Adverse Event|28|||
155369500|NCT02446821|560785303|FG000|Overall Study|Withdrawal by Subject|6|||
155369501|NCT02446821|560785303|FG000|Overall Study|Lost to Follow-up|22|||
155369502|NCT02446821|560785303|FG000|Overall Study|other|9|||
155369503|NCT02446821|560785303|FG000|Overall Study|insertion failure|3|||
155369504|NCT03007420|560785304|FG000|Overall Study|Withdrawal by Subject|0|||
155369505|NCT03007420|560785305|FG001|Overall Study|Withdrawal by Subject|2|||
155369506|NCT03007420|560785304|FG000|Overall Study|Physician Decision|0|||
155369507|NCT03007420|560785305|FG001|Overall Study|Physician Decision|1|||
155369508|NCT02284009|560785309|FG000|Overall Study|Adverse Event|3|||
155369509|NCT02284009|560785310|FG001|Overall Study|Adverse Event|0|||
155369510|NCT02284009|560785309|FG000|Overall Study|Lost to Follow-up|1|||
155369511|NCT02284009|560785310|FG001|Overall Study|Lost to Follow-up|3|||
155369512|NCT02284009|560785309|FG000|Overall Study|Physician Decision|0|||
155369513|NCT02284009|560785310|FG001|Overall Study|Physician Decision|2|||
155369514|NCT02284009|560785309|FG000|Overall Study|Withdrawal by Subject|2|||
155369515|NCT02284009|560785310|FG001|Overall Study|Withdrawal by Subject|5|||
155369516|NCT03841526|560785311|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
155369517|NCT03841526|560785312|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369518|NCT03841526|560785313|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369519|NCT03841526|560785314|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
155369520|NCT03841526|560785315|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369521|NCT03841526|560785316|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
155369522|NCT03841526|560785311|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
155369523|NCT03841526|560785312|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
155369524|NCT03841526|560785313|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
155369525|NCT03841526|560785314|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
155369526|NCT03841526|560785315|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
155369527|NCT03841526|560785316|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
155369528|NCT03841526|560785311|FG000|Outpatient Phase Treatment|Physician Decision|0|||
155369529|NCT03841526|560785312|FG001|Outpatient Phase Treatment|Physician Decision|1|||
155369530|NCT03841526|560785313|FG002|Outpatient Phase Treatment|Physician Decision|0|||
155369531|NCT03841526|560785314|FG003|Outpatient Phase Treatment|Physician Decision|0|||
155369532|NCT03841526|560785315|FG004|Outpatient Phase Treatment|Physician Decision|0|||
155369533|NCT03841526|560785316|FG005|Outpatient Phase Treatment|Physician Decision|0|||
155369534|NCT03841526|560785311|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369535|NCT03841526|560785312|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369536|NCT03841526|560785313|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
155369537|NCT03841526|560785314|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369538|NCT03841526|560785315|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
155369539|NCT03841526|560785316|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
155369540|NCT01876082|560787758|FG000|Overall Study|Withdrawal by Subject|0|||
155369541|NCT01876082|560787759|FG001|Overall Study|Withdrawal by Subject|2|||
155369542|NCT01876082|560787758|FG000|Overall Study|Protocol Violation|1|||
155369543|NCT01876082|560787759|FG001|Overall Study|Protocol Violation|0|||
155369544|NCT01876082|560787758|FG000|Overall Study|Adverse Event|1|||
155369545|NCT01876082|560787759|FG001|Overall Study|Adverse Event|1|||
155369546|NCT01876082|560787758|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
155369547|NCT01876082|560787759|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
155369548|NCT03829501|560787770|FG000|Overall Study|Withdrawal of Consent|2|||
155369549|NCT03829501|560787771|FG001|Overall Study|Withdrawal of Consent|0|||
155369550|NCT03829501|560787772|FG002|Overall Study|Withdrawal of Consent|3|||
155369551|NCT03829501|560787773|FG003|Overall Study|Withdrawal of Consent|0|||
155369552|NCT03829501|560787774|FG004|Overall Study|Withdrawal of Consent|1|||
155369553|NCT03829501|560787775|FG005|Overall Study|Withdrawal of Consent|1|||
155369554|NCT03829501|560787776|FG006|Overall Study|Withdrawal of Consent|0|||
155369555|NCT03829501|560787777|FG007|Overall Study|Withdrawal of Consent|10|||
155369556|NCT03829501|560787778|FG008|Overall Study|Withdrawal of Consent|10|||
155369557|NCT03829501|560787779|FG009|Overall Study|Withdrawal of Consent|3|||
155369558|NCT03829501|560787780|FG010|Overall Study|Withdrawal of Consent|4|||
155369559|NCT03829501|560787781|FG011|Overall Study|Withdrawal of Consent|4|||
155369560|NCT03829501|560787782|FG012|Overall Study|Withdrawal of Consent|4|||
155369561|NCT03829501|560787783|FG013|Overall Study|Withdrawal of Consent|0|||
155369562|NCT03829501|560787784|FG014|Overall Study|Withdrawal of Consent|3|||
155369563|NCT03829501|560787785|FG015|Overall Study|Withdrawal of Consent|0|||
155369564|NCT03829501|560787786|FG016|Overall Study|Withdrawal of Consent|1|||
155090459|NCT00265122|559763640|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
155369565|NCT03829501|560787787|FG017|Overall Study|Withdrawal of Consent|1|||
155369566|NCT03829501|560787788|FG018|Overall Study|Withdrawal of Consent|0|||
155369567|NCT03829501|560787789|FG019|Overall Study|Withdrawal of Consent|0|||
155369568|NCT03829501|560787790|FG020|Overall Study|Withdrawal of Consent|3|||
155369569|NCT03829501|560787791|FG021|Overall Study|Withdrawal of Consent|0|||
155369570|NCT03829501|560787792|FG022|Overall Study|Withdrawal of Consent|1|||
155369571|NCT03829501|560787770|FG000|Overall Study|PD|0|||
155369572|NCT03829501|560787771|FG001|Overall Study|PD|0|||
155369573|NCT03829501|560787772|FG002|Overall Study|PD|0|||
155369574|NCT03829501|560787773|FG003|Overall Study|PD|2|||
155369575|NCT03829501|560787774|FG004|Overall Study|PD|0|||
155369576|NCT03829501|560787775|FG005|Overall Study|PD|0|||
155369577|NCT03829501|560787776|FG006|Overall Study|PD|0|||
155369578|NCT03829501|560787777|FG007|Overall Study|PD|0|||
155369579|NCT03829501|560787778|FG008|Overall Study|PD|0|||
155369580|NCT03829501|560787779|FG009|Overall Study|PD|0|||
155369581|NCT03829501|560787780|FG010|Overall Study|PD|0|||
155369582|NCT03829501|560787781|FG011|Overall Study|PD|0|||
155369583|NCT03829501|560787782|FG012|Overall Study|PD|0|||
155369584|NCT03829501|560787783|FG013|Overall Study|PD|0|||
155369585|NCT03829501|560787784|FG014|Overall Study|PD|0|||
155369586|NCT03829501|560787785|FG015|Overall Study|PD|1|||
155369587|NCT03829501|560787786|FG016|Overall Study|PD|0|||
155369588|NCT03829501|560787787|FG017|Overall Study|PD|0|||
155369589|NCT03829501|560787788|FG018|Overall Study|PD|0|||
155369590|NCT03829501|560787789|FG019|Overall Study|PD|0|||
155369591|NCT03829501|560787790|FG020|Overall Study|PD|1|||
155369592|NCT03829501|560787791|FG021|Overall Study|PD|0|||
155369593|NCT03829501|560787792|FG022|Overall Study|PD|0|||
155369594|NCT03829501|560787770|FG000|Overall Study|Study Terminated by Sponsor|0|||
155369595|NCT03829501|560787771|FG001|Overall Study|Study Terminated by Sponsor|0|||
155369596|NCT03829501|560787772|FG002|Overall Study|Study Terminated by Sponsor|0|||
155369597|NCT03829501|560787773|FG003|Overall Study|Study Terminated by Sponsor|0|||
155369598|NCT03829501|560787774|FG004|Overall Study|Study Terminated by Sponsor|0|||
155369599|NCT03829501|560787775|FG005|Overall Study|Study Terminated by Sponsor|0|||
155369600|NCT03829501|560787776|FG006|Overall Study|Study Terminated by Sponsor|0|||
155369601|NCT03829501|560787777|FG007|Overall Study|Study Terminated by Sponsor|3|||
155369602|NCT03829501|560787778|FG008|Overall Study|Study Terminated by Sponsor|1|||
155369603|NCT03829501|560787779|FG009|Overall Study|Study Terminated by Sponsor|0|||
155369604|NCT03829501|560787780|FG010|Overall Study|Study Terminated by Sponsor|0|||
155369605|NCT03829501|560787781|FG011|Overall Study|Study Terminated by Sponsor|0|||
155369606|NCT03829501|560787782|FG012|Overall Study|Study Terminated by Sponsor|0|||
155369607|NCT03829501|560787783|FG013|Overall Study|Study Terminated by Sponsor|0|||
155369608|NCT03829501|560787784|FG014|Overall Study|Study Terminated by Sponsor|3|||
155369609|NCT03829501|560787785|FG015|Overall Study|Study Terminated by Sponsor|2|||
155369610|NCT03829501|560787786|FG016|Overall Study|Study Terminated by Sponsor|2|||
155369611|NCT03829501|560787787|FG017|Overall Study|Study Terminated by Sponsor|0|||
155369612|NCT03829501|560787788|FG018|Overall Study|Study Terminated by Sponsor|0|||
155369613|NCT03829501|560787789|FG019|Overall Study|Study Terminated by Sponsor|0|||
155369614|NCT03829501|560787790|FG020|Overall Study|Study Terminated by Sponsor|1|||
155369615|NCT03829501|560787791|FG021|Overall Study|Study Terminated by Sponsor|0|||
155090460|NCT00265122|559763641|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
155090461|NCT04716894|559763642|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
155090462|NCT04716894|559763642|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
155090463|NCT05205616|559763649|FG000|Overall Study|Lost to Follow-up|4|||
155090464|NCT05205616|559763650|FG001|Overall Study|Lost to Follow-up|4|||
155090465|NCT01467466|559763659|FG000|Overall Study|Withdrawal by Subject|15|||
155090466|NCT01467466|559763660|FG001|Overall Study|Withdrawal by Subject|18|||
155369616|NCT03829501|560787792|FG022|Overall Study|Study Terminated by Sponsor|3|||
155369617|NCT03829501|560787770|FG000|Overall Study|Lost to Follow Up|0|||
155369618|NCT03829501|560787771|FG001|Overall Study|Lost to Follow Up|0|||
155369619|NCT03829501|560787772|FG002|Overall Study|Lost to Follow Up|0|||
155369620|NCT03829501|560787773|FG003|Overall Study|Lost to Follow Up|0|||
155369621|NCT03829501|560787774|FG004|Overall Study|Lost to Follow Up|1|||
155369622|NCT03829501|560787775|FG005|Overall Study|Lost to Follow Up|0|||
155369623|NCT03829501|560787776|FG006|Overall Study|Lost to Follow Up|0|||
155369624|NCT03829501|560787777|FG007|Overall Study|Lost to Follow Up|2|||
155369625|NCT03829501|560787778|FG008|Overall Study|Lost to Follow Up|2|||
155369626|NCT03829501|560787779|FG009|Overall Study|Lost to Follow Up|0|||
155369627|NCT03829501|560787780|FG010|Overall Study|Lost to Follow Up|2|||
155369628|NCT03829501|560787781|FG011|Overall Study|Lost to Follow Up|1|||
155369629|NCT03829501|560787782|FG012|Overall Study|Lost to Follow Up|0|||
155369630|NCT03829501|560787783|FG013|Overall Study|Lost to Follow Up|1|||
155369631|NCT03829501|560787784|FG014|Overall Study|Lost to Follow Up|1|||
155369632|NCT03829501|560787785|FG015|Overall Study|Lost to Follow Up|0|||
155369633|NCT03829501|560787786|FG016|Overall Study|Lost to Follow Up|0|||
155369634|NCT03829501|560787787|FG017|Overall Study|Lost to Follow Up|0|||
155369635|NCT03829501|560787788|FG018|Overall Study|Lost to Follow Up|0|||
155369636|NCT03829501|560787789|FG019|Overall Study|Lost to Follow Up|0|||
155369637|NCT03829501|560787790|FG020|Overall Study|Lost to Follow Up|0|||
155369638|NCT03829501|560787791|FG021|Overall Study|Lost to Follow Up|0|||
155369639|NCT03829501|560787792|FG022|Overall Study|Lost to Follow Up|1|||
155369640|NCT03829501|560787770|FG000|Overall Study|Death|2|||
155369641|NCT03829501|560787771|FG001|Overall Study|Death|4|||
155369642|NCT03829501|560787772|FG002|Overall Study|Death|5|||
155369643|NCT03829501|560787773|FG003|Overall Study|Death|6|||
155369644|NCT03829501|560787774|FG004|Overall Study|Death|5|||
155369645|NCT03829501|560787775|FG005|Overall Study|Death|4|||
155369646|NCT03829501|560787776|FG006|Overall Study|Death|5|||
155369647|NCT03829501|560787777|FG007|Overall Study|Death|24|||
155369648|NCT03829501|560787778|FG008|Overall Study|Death|22|||
155369649|NCT03829501|560787779|FG009|Overall Study|Death|6|||
155369650|NCT03829501|560787780|FG010|Overall Study|Death|3|||
155369651|NCT03829501|560787781|FG011|Overall Study|Death|10|||
155369652|NCT03829501|560787782|FG012|Overall Study|Death|10|||
155369653|NCT03829501|560787783|FG013|Overall Study|Death|5|||
155369654|NCT03829501|560787784|FG014|Overall Study|Death|7|||
155369655|NCT03829501|560787785|FG015|Overall Study|Death|2|||
155369656|NCT03829501|560787786|FG016|Overall Study|Death|2|||
155369657|NCT03829501|560787787|FG017|Overall Study|Death|1|||
155369658|NCT03829501|560787788|FG018|Overall Study|Death|1|||
155369659|NCT03829501|560787789|FG019|Overall Study|Death|1|||
155369660|NCT03829501|560787790|FG020|Overall Study|Death|1|||
155369661|NCT03829501|560787791|FG021|Overall Study|Death|2|||
155369662|NCT03829501|560787792|FG022|Overall Study|Death|3|||
155369663|NCT03829501|560787770|FG000|Overall Study|Miscellaneous|0|||
155369664|NCT03829501|560787771|FG001|Overall Study|Miscellaneous|0|||
155369665|NCT03829501|560787772|FG002|Overall Study|Miscellaneous|1|||
155369666|NCT03829501|560787773|FG003|Overall Study|Miscellaneous|0|||
155369667|NCT03829501|560787774|FG004|Overall Study|Miscellaneous|0|||
155369668|NCT03829501|560787775|FG005|Overall Study|Miscellaneous|0|||
155369669|NCT03829501|560787776|FG006|Overall Study|Miscellaneous|0|||
155369670|NCT03829501|560787777|FG007|Overall Study|Miscellaneous|1|||
155369671|NCT03829501|560787778|FG008|Overall Study|Miscellaneous|0|||
155369672|NCT03829501|560787779|FG009|Overall Study|Miscellaneous|0|||
155369673|NCT03829501|560787780|FG010|Overall Study|Miscellaneous|0|||
155369674|NCT03829501|560787781|FG011|Overall Study|Miscellaneous|0|||
155369675|NCT03829501|560787782|FG012|Overall Study|Miscellaneous|0|||
155369676|NCT03829501|560787783|FG013|Overall Study|Miscellaneous|0|||
155369677|NCT03829501|560787784|FG014|Overall Study|Miscellaneous|0|||
155369678|NCT03829501|560787785|FG015|Overall Study|Miscellaneous|0|||
155369679|NCT03829501|560787786|FG016|Overall Study|Miscellaneous|0|||
155369680|NCT03829501|560787787|FG017|Overall Study|Miscellaneous|0|||
155090467|NCT01467466|559763661|FG002|Overall Study|Withdrawal by Subject|13|||
155369681|NCT03829501|560787788|FG018|Overall Study|Miscellaneous|0|||
155369682|NCT03829501|560787789|FG019|Overall Study|Miscellaneous|0|||
155369683|NCT03829501|560787790|FG020|Overall Study|Miscellaneous|0|||
155369684|NCT03829501|560787791|FG021|Overall Study|Miscellaneous|0|||
155369685|NCT03829501|560787792|FG022|Overall Study|Miscellaneous|1|||
155369686|NCT02964013|560787793|FG000|Overall Study|Death|58|||
155369687|NCT02964013|560787794|FG001|Overall Study|Death|239|||
155369688|NCT02964013|560787795|FG002|Overall Study|Death|38|||
154965581|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
155369689|NCT02964013|560787796|FG003|Overall Study|Death|10|||
155369690|NCT02964013|560787797|FG004|Overall Study|Death|33|||
155369691|NCT02964013|560787793|FG000|Overall Study|Lost to Follow-up|1|||
155369692|NCT02964013|560787794|FG001|Overall Study|Lost to Follow-up|4|||
155369693|NCT02964013|560787795|FG002|Overall Study|Lost to Follow-up|2|||
155369694|NCT02964013|560787796|FG003|Overall Study|Lost to Follow-up|0|||
155369695|NCT02964013|560787797|FG004|Overall Study|Lost to Follow-up|0|||
155369696|NCT02964013|560787793|FG000|Overall Study|Physician Decision|0|||
155369697|NCT02964013|560787794|FG001|Overall Study|Physician Decision|1|||
155369698|NCT02964013|560787795|FG002|Overall Study|Physician Decision|0|||
155369699|NCT02964013|560787796|FG003|Overall Study|Physician Decision|0|||
155369700|NCT02964013|560787797|FG004|Overall Study|Physician Decision|0|||
155369701|NCT02964013|560787793|FG000|Overall Study|Sponsor Decision|3|||
155369702|NCT02964013|560787794|FG001|Overall Study|Sponsor Decision|22|||
155369703|NCT02964013|560787795|FG002|Overall Study|Sponsor Decision|11|||
155369704|NCT02964013|560787796|FG003|Overall Study|Sponsor Decision|0|||
155369705|NCT02964013|560787797|FG004|Overall Study|Sponsor Decision|7|||
155369706|NCT02964013|560787793|FG000|Overall Study|Withdrawal by Subject|6|||
155369707|NCT02964013|560787794|FG001|Overall Study|Withdrawal by Subject|27|||
155369708|NCT02964013|560787795|FG002|Overall Study|Withdrawal by Subject|9|||
155369709|NCT02964013|560787796|FG003|Overall Study|Withdrawal by Subject|0|||
155369710|NCT02964013|560787797|FG004|Overall Study|Withdrawal by Subject|0|||
155369711|NCT02964013|560787793|FG000|Overall Study|Not Treated|0|||
155369712|NCT02964013|560787794|FG001|Overall Study|Not Treated|2|||
155369713|NCT02964013|560787795|FG002|Overall Study|Not Treated|0|||
155369714|NCT02964013|560787796|FG003|Overall Study|Not Treated|1|||
155369715|NCT02964013|560787797|FG004|Overall Study|Not Treated|0|||
155369716|NCT01123070|560787798|FG000|Part B Double Blind Period|Protocol Violation|0|||
155369717|NCT01123070|560787799|FG001|Part B Double Blind Period|Protocol Violation|0|||
155369718|NCT01123070|560787800|FG002|Part B Double Blind Period|Protocol Violation|0|||
155369719|NCT01123070|560787801|FG003|Part B Double Blind Period|Protocol Violation|1|||
155369720|NCT01123070|560787798|FG000|Part B Double Blind Period|Adverse Event|0|||
155369721|NCT01123070|560787799|FG001|Part B Double Blind Period|Adverse Event|0|||
155369722|NCT01123070|560787800|FG002|Part B Double Blind Period|Adverse Event|2|||
155369723|NCT01123070|560787801|FG003|Part B Double Blind Period|Adverse Event|0|||
155369724|NCT01123070|560787798|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
155369725|NCT01123070|560787799|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
155369726|NCT01123070|560787800|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
155369727|NCT01123070|560787801|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
155369728|NCT04942366|560787802|FG000|Overall Study|Withdrawal by Subject|5|||
155369729|NCT04942366|560787803|FG001|Overall Study|Withdrawal by Subject|5|||
155369730|NCT00747227|560787810|FG000|Overall Study|Death|3|||
155369731|NCT00747227|560787811|FG001|Overall Study|Death|1|||
155369732|NCT00747227|560787810|FG000|Overall Study|Withdrawal by Subject|1|||
155369733|NCT00747227|560787811|FG001|Overall Study|Withdrawal by Subject|0|||
155369734|NCT00747227|560787810|FG000|Overall Study|Lost to Follow-up|1|||
155369735|NCT00747227|560787811|FG001|Overall Study|Lost to Follow-up|2|||
155369736|NCT00747227|560787810|FG000|Overall Study|Illness|1|||
155369737|NCT00747227|560787811|FG001|Overall Study|Illness|1|||
155369738|NCT03284229|560787812|FG000|Overall Study|Lost to Follow-up|3|||
155369739|NCT04325282|560787829|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155167074|NCT03887702|560049364|FG001|Overall Study|Study terminated|0|||
155369740|NCT04325282|560787830|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155369741|NCT04325282|560787829|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
155369742|NCT04325282|560787830|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
155369743|NCT04833127|560787832|FG000|Overall Study|Lost to Follow-up|1|||
155167075|NCT03887702|560049365|FG002|Overall Study|Study terminated|2|||
155167076|NCT03887702|560049366|FG003|Overall Study|Study terminated|2|||
155167077|NCT01643772|560049367|FG000|Overall Study|Protocol Violation|0|||
155167078|NCT01643772|560049368|FG001|Overall Study|Protocol Violation|0|||
155369744|NCT04833127|560787833|FG001|Overall Study|Lost to Follow-up|1|||
154965582|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
154965583|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
155167079|NCT01643772|560049369|FG002|Overall Study|Protocol Violation|0|||
155369745|NCT01499303|560787838|FG000|Overall Study|Ongoing|2|||
155369746|NCT01499303|560787839|FG001|Overall Study|Ongoing|1|||
155369747|NCT01499303|560787838|FG000|Overall Study|Withdrawal by Subject|0|||
155369748|NCT01499303|560787839|FG001|Overall Study|Withdrawal by Subject|1|||
155369749|NCT01499303|560787838|FG000|Overall Study|Adverse Event|1|||
155369750|NCT01499303|560787839|FG001|Overall Study|Adverse Event|4|||
155369751|NCT01499303|560787838|FG000|Overall Study|Other|0|||
155369752|NCT01499303|560787839|FG001|Overall Study|Other|1|||
155369753|NCT00461981|560787840|FG000|Overall Study|Lost to Follow-up|9|||
155369754|NCT00461981|560787841|FG001|Overall Study|Lost to Follow-up|6|||
155369755|NCT00461981|560787840|FG000|Overall Study|Withdrawal by Subject|2|||
155369756|NCT00461981|560787841|FG001|Overall Study|Withdrawal by Subject|3|||
155369757|NCT02242097|560787842|FG000|Ibrutinib Treatment|Adverse Event|16|||
155369758|NCT02242097|560787842|FG000|Ibrutinib Treatment|Physician Decision|1|||
155369759|NCT02242097|560787842|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
155369760|NCT02242097|560787842|FG000|Ibrutinib Treatment|Death|1|||
155369761|NCT02242097|560787842|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
155369762|NCT02242097|560787842|FG000|Post Therapy Follow Up|Death|3|||
155369763|NCT02242097|560787842|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
155369764|NCT03031496|560787844|FG000|Period 1|Adverse Event|2|||
155369765|NCT03031496|560787845|FG001|Period 1|Adverse Event|0|||
155369766|NCT03031496|560787844|FG000|Period 1|Withdrawal by Subject|0|||
155369767|NCT03031496|560787845|FG001|Period 1|Withdrawal by Subject|2|||
155369768|NCT03868787|560787847|FG000|Overall Study|Withdrawal by Subject|2|||
155369769|NCT03868787|560787848|FG001|Overall Study|Withdrawal by Subject|1|||
155369770|NCT01399697|560787849|FG000|Overall Study|Adverse Event|13|||
155369771|NCT01399697|560787850|FG001|Overall Study|Adverse Event|3|||
155369772|NCT01399697|560787851|FG002|Overall Study|Adverse Event|1|||
155369773|NCT01399697|560787849|FG000|Overall Study|Lost to Follow-up|2|||
155369774|NCT01399697|560787850|FG001|Overall Study|Lost to Follow-up|0|||
155369775|NCT01399697|560787851|FG002|Overall Study|Lost to Follow-up|0|||
155369776|NCT01399697|560787849|FG000|Overall Study|Withdrawal by Subject|8|||
155369777|NCT01399697|560787850|FG001|Overall Study|Withdrawal by Subject|0|||
155369778|NCT01399697|560787851|FG002|Overall Study|Withdrawal by Subject|0|||
155369779|NCT01399697|560787849|FG000|Overall Study|Investigator Decisión|1|||
155369780|NCT01399697|560787850|FG001|Overall Study|Investigator Decisión|0|||
155369781|NCT01399697|560787851|FG002|Overall Study|Investigator Decisión|2|||
155369782|NCT01399697|560787849|FG000|Overall Study|Lack of Efficacy|9|||
155369783|NCT01399697|560787850|FG001|Overall Study|Lack of Efficacy|0|||
155369784|NCT01399697|560787851|FG002|Overall Study|Lack of Efficacy|1|||
155369785|NCT01399697|560787849|FG000|Overall Study|Protocol Violation|2|||
155369786|NCT01399697|560787850|FG001|Overall Study|Protocol Violation|0|||
155369787|NCT01399697|560787851|FG002|Overall Study|Protocol Violation|0|||
155369788|NCT01399697|560787849|FG000|Overall Study|Non-Compliant|1|||
155369789|NCT01399697|560787850|FG001|Overall Study|Non-Compliant|0|||
155369790|NCT01399697|560787851|FG002|Overall Study|Non-Compliant|0|||
155369791|NCT01399697|560787849|FG000|Overall Study|Inclusion Error|2|||
155369792|NCT01399697|560787850|FG001|Overall Study|Inclusion Error|0|||
155369793|NCT01399697|560787851|FG002|Overall Study|Inclusion Error|0|||
155369794|NCT01399697|560787849|FG000|Overall Study|Positive result for hepatitis B|1|||
155369795|NCT01399697|560787850|FG001|Overall Study|Positive result for hepatitis B|0|||
155369796|NCT01399697|560787851|FG002|Overall Study|Positive result for hepatitis B|0|||
155369797|NCT01399697|560787849|FG000|Overall Study|Clinical RA remission|1|||
155369798|NCT01399697|560787850|FG001|Overall Study|Clinical RA remission|0|||
155369799|NCT01399697|560787851|FG002|Overall Study|Clinical RA remission|0|||
155369800|NCT01399697|560787849|FG000|Overall Study|Sponsor Decision|1|||
155369801|NCT01399697|560787850|FG001|Overall Study|Sponsor Decision|0|||
155369802|NCT01399697|560787851|FG002|Overall Study|Sponsor Decision|0|||
155369803|NCT03435692|560787852|FG000|Overall Study|Lack of Efficacy|2|||
155369804|NCT03435692|560787853|FG001|Overall Study|Lack of Efficacy|2|||
155369805|NCT03435692|560787854|FG002|Overall Study|Lack of Efficacy|0|||
155369806|NCT04313608|560787855|FG000|Overall Study|Death|12|||
155369807|NCT04313608|560787856|FG001|Overall Study|Death|3|||
155369808|NCT02510040|560787857|FG000|Overall Study|Deemed no longer eligible|18|||
155369809|NCT02510040|560787858|FG001|Overall Study|Deemed no longer eligible|3|||
155369810|NCT02510040|560787859|FG002|Overall Study|Deemed no longer eligible|1|||
155369811|NCT01712061|560787860|FG000|Overall Study|Adverse Event|4|||
155369812|NCT01712061|560787861|FG001|Overall Study|Adverse Event|9|||
155369813|NCT01712061|560787862|FG002|Overall Study|Adverse Event|5|||
155369814|NCT01712061|560787860|FG000|Overall Study|Death|0|||
155369815|NCT01712061|560787861|FG001|Overall Study|Death|0|||
155369816|NCT01712061|560787862|FG002|Overall Study|Death|1|||
155369817|NCT01712061|560787860|FG000|Overall Study|Lost to Follow-up|1|||
155369818|NCT01712061|560787861|FG001|Overall Study|Lost to Follow-up|0|||
155369819|NCT01712061|560787862|FG002|Overall Study|Lost to Follow-up|1|||
155369820|NCT01712061|560787860|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
155369821|NCT01712061|560787861|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
155369822|NCT01712061|560787862|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
155369823|NCT01712061|560787860|FG000|Overall Study|Medication Error Without Associated AE|0|||
155369824|NCT01712061|560787861|FG001|Overall Study|Medication Error Without Associated AE|1|||
155369825|NCT01712061|560787862|FG002|Overall Study|Medication Error Without Associated AE|0|||
155369826|NCT01712061|560787860|FG000|Overall Study|Withdrawal by Subject|1|||
155369827|NCT01712061|560787861|FG001|Overall Study|Withdrawal by Subject|7|||
155369828|NCT01712061|560787862|FG002|Overall Study|Withdrawal by Subject|1|||
155369829|NCT01712061|560787860|FG000|Overall Study|Other|0|||
155369830|NCT01712061|560787861|FG001|Overall Study|Other|3|||
155369831|NCT01712061|560787862|FG002|Overall Study|Other|0|||
155369832|NCT01677767|560787869|FG000|Overall Study|Adverse Event|1|||
155369833|NCT01677767|560787869|FG000|Overall Study|Death|4|||
155369834|NCT01677767|560787869|FG000|Overall Study|Protocol Violation|4|||
155369835|NCT01677767|560787869|FG000|Overall Study|Withdrawal by Subject|10|||
155369836|NCT01677767|560787869|FG000|Overall Study|Non-compliance by the participants|3|||
155369837|NCT00842244|560787870|FG000|Overall Study|Death|3|||
154965584|NCT00112437|559298862|FG000|Year 2 (12-Month Extension)|Moved|0|||
155369838|NCT00842244|560787870|FG000|Overall Study|Withdrawal by Subject|1|||
155369839|NCT00842244|560787870|FG000|Overall Study|Other|17|||
155369840|NCT02807272|560787871|FG000|Overall Study|Death|9|||
155369841|NCT02807272|560787872|FG001|Overall Study|Death|5|||
155369842|NCT02807272|560787873|FG002|Overall Study|Death|2|||
155369843|NCT02807272|560787874|FG003|Overall Study|Death|0|||
155369844|NCT02807272|560787875|FG004|Overall Study|Death|1|||
155369845|NCT02807272|560787871|FG000|Overall Study|Lost to Follow-up|1|||
155369846|NCT02807272|560787872|FG001|Overall Study|Lost to Follow-up|0|||
155369847|NCT02807272|560787873|FG002|Overall Study|Lost to Follow-up|0|||
155369848|NCT02807272|560787874|FG003|Overall Study|Lost to Follow-up|0|||
155369849|NCT02807272|560787875|FG004|Overall Study|Lost to Follow-up|0|||
155369850|NCT02807272|560787871|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
155369851|NCT02807272|560787872|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
155369852|NCT02807272|560787873|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
155369853|NCT02807272|560787874|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
155369854|NCT02807272|560787875|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
155369855|NCT02807272|560787871|FG000|Overall Study|Protocol-defined Disease Progression|0|||
155369856|NCT02807272|560787872|FG001|Overall Study|Protocol-defined Disease Progression|1|||
155369857|NCT02807272|560787873|FG002|Overall Study|Protocol-defined Disease Progression|0|||
155369858|NCT02807272|560787874|FG003|Overall Study|Protocol-defined Disease Progression|0|||
155369859|NCT02807272|560787875|FG004|Overall Study|Protocol-defined Disease Progression|1|||
155369860|NCT02807272|560787871|FG000|Overall Study|Study Terminated by Sponsor|1|||
155369861|NCT02807272|560787872|FG001|Overall Study|Study Terminated by Sponsor|0|||
155369862|NCT02807272|560787873|FG002|Overall Study|Study Terminated by Sponsor|0|||
155369863|NCT02807272|560787874|FG003|Overall Study|Study Terminated by Sponsor|1|||
155369864|NCT02807272|560787875|FG004|Overall Study|Study Terminated by Sponsor|0|||
155369865|NCT02807272|560787871|FG000|Overall Study|Other|1|||
155369866|NCT02807272|560787872|FG001|Overall Study|Other|0|||
155369867|NCT02807272|560787873|FG002|Overall Study|Other|0|||
155369868|NCT02807272|560787874|FG003|Overall Study|Other|0|||
155369869|NCT02807272|560787875|FG004|Overall Study|Other|1|||
155369870|NCT01162863|560787877|FG000|Overall Study|Lack of Efficacy|1|||
155369871|NCT01162863|560787878|FG001|Overall Study|Lack of Efficacy|0|||
155369872|NCT01162863|560787879|FG002|Overall Study|Lack of Efficacy|0|||
155369873|NCT01162863|560787877|FG000|Overall Study|Adverse Event|0|||
155369874|NCT01162863|560787878|FG001|Overall Study|Adverse Event|1|||
155369875|NCT01162863|560787879|FG002|Overall Study|Adverse Event|0|||
155369876|NCT02992691|560787880|FG000|Overall Study|Adverse Event|2|||
155369877|NCT02992691|560787880|FG000|Overall Study|Withdrawal by Subject|1|||
155369878|NCT00588692|560787881|FG000|Overall Study|Withdrawal by Subject|4|||
155369879|NCT00588692|560787882|FG001|Overall Study|Withdrawal by Subject|2|||
155369880|NCT00588692|560787881|FG000|Overall Study|Hip Surgery|0|||
155369881|NCT00588692|560787882|FG001|Overall Study|Hip Surgery|1|||
155369882|NCT00588692|560787881|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
155369883|NCT00588692|560787882|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
155369884|NCT00588692|560787881|FG000|Overall Study|Cancer|1|||
155369885|NCT00588692|560787882|FG001|Overall Study|Cancer|0|||
155369886|NCT00588692|560787881|FG000|Overall Study|Death|1|||
155369887|NCT00588692|560787882|FG001|Overall Study|Death|0|||
155369888|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
155369889|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
155369890|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
155369891|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
155369892|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
155369893|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
155369894|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
155369895|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
155369896|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
155369897|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
155369898|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
155369899|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
155369900|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
155369901|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
155369902|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
155369903|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
155369904|NCT00392925|560787884|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
155369905|NCT00392925|560787885|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
155369906|NCT00392925|560787886|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
155369907|NCT00392925|560787887|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
155369908|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
155369909|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
155369910|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
155369911|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
155369912|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
155369913|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
154965585|NCT00112437|559298863|FG001|Year 2 (12-Month Extension)|Moved|0|||
155369914|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
155369915|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
155369916|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
155369917|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
155369918|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
155369919|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
155369920|NCT00392925|560787884|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
155369921|NCT00392925|560787885|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
155369922|NCT00392925|560787886|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
155369923|NCT00392925|560787887|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
155369924|NCT03538938|560787888|FG000|Overall Study|Death|0|||
155369925|NCT03538938|560787889|FG001|Overall Study|Death|0|||
155369926|NCT03538938|560787890|FG002|Overall Study|Death|2|||
155369927|NCT03538938|560787891|FG003|Overall Study|Death|0|||
155369928|NCT03538938|560787892|FG004|Overall Study|Death|0|||
155369929|NCT03538938|560787893|FG005|Overall Study|Death|1|||
155369930|NCT03538938|560787894|FG006|Overall Study|Death|0|||
155369931|NCT03538938|560787895|FG007|Overall Study|Death|1|||
155369932|NCT03538938|560787896|FG008|Overall Study|Death|1|||
155369933|NCT03538938|560787897|FG009|Overall Study|Death|1|||
155369934|NCT03538938|560787898|FG010|Overall Study|Death|0|||
155369935|NCT03538938|560787899|FG011|Overall Study|Death|0|||
155369936|NCT03538938|560787900|FG012|Overall Study|Death|1|||
155369937|NCT03538938|560787901|FG013|Overall Study|Death|1|||
155369938|NCT03538938|560787902|FG014|Overall Study|Death|0|||
155369939|NCT03538938|560787903|FG015|Overall Study|Death|1|||
155369940|NCT03538938|560787888|FG000|Overall Study|Withdrawal by Subject|4|||
155369941|NCT03538938|560787889|FG001|Overall Study|Withdrawal by Subject|6|||
155369942|NCT03538938|560787890|FG002|Overall Study|Withdrawal by Subject|5|||
155369943|NCT03538938|560787891|FG003|Overall Study|Withdrawal by Subject|3|||
155369944|NCT03538938|560787892|FG004|Overall Study|Withdrawal by Subject|0|||
155369945|NCT03538938|560787893|FG005|Overall Study|Withdrawal by Subject|0|||
155369946|NCT03538938|560787894|FG006|Overall Study|Withdrawal by Subject|3|||
155369947|NCT03538938|560787895|FG007|Overall Study|Withdrawal by Subject|1|||
155369948|NCT03538938|560787896|FG008|Overall Study|Withdrawal by Subject|5|||
155369949|NCT03538938|560787897|FG009|Overall Study|Withdrawal by Subject|1|||
155369950|NCT03538938|560787898|FG010|Overall Study|Withdrawal by Subject|2|||
155369951|NCT03538938|560787899|FG011|Overall Study|Withdrawal by Subject|1|||
155369952|NCT03538938|560787900|FG012|Overall Study|Withdrawal by Subject|3|||
155369953|NCT03538938|560787901|FG013|Overall Study|Withdrawal by Subject|0|||
155369954|NCT03538938|560787902|FG014|Overall Study|Withdrawal by Subject|2|||
155369955|NCT03538938|560787903|FG015|Overall Study|Withdrawal by Subject|4|||
155369956|NCT03538938|560787888|FG000|Overall Study|Incarcerated|0|||
155369957|NCT03538938|560787889|FG001|Overall Study|Incarcerated|0|||
155369958|NCT03538938|560787890|FG002|Overall Study|Incarcerated|0|||
155369959|NCT03538938|560787891|FG003|Overall Study|Incarcerated|0|||
155369960|NCT03538938|560787892|FG004|Overall Study|Incarcerated|0|||
155369961|NCT03538938|560787893|FG005|Overall Study|Incarcerated|0|||
155369962|NCT03538938|560787894|FG006|Overall Study|Incarcerated|0|||
155369963|NCT03538938|560787895|FG007|Overall Study|Incarcerated|0|||
155369964|NCT03538938|560787896|FG008|Overall Study|Incarcerated|0|||
155369965|NCT03538938|560787897|FG009|Overall Study|Incarcerated|0|||
155369966|NCT03538938|560787898|FG010|Overall Study|Incarcerated|0|||
155369967|NCT03538938|560787899|FG011|Overall Study|Incarcerated|1|||
155369968|NCT03538938|560787900|FG012|Overall Study|Incarcerated|0|||
155369969|NCT03538938|560787901|FG013|Overall Study|Incarcerated|0|||
155369970|NCT03538938|560787902|FG014|Overall Study|Incarcerated|0|||
155369971|NCT03538938|560787903|FG015|Overall Study|Incarcerated|0|||
155369972|NCT00755105|560787904|FG000|Overall Study|Withdrawal by Subject|9|||
155369973|NCT00755105|560787905|FG001|Overall Study|Withdrawal by Subject|11|||
155369974|NCT00755105|560787906|FG002|Overall Study|Withdrawal by Subject|4|||
155369975|NCT02202785|560787907|FG000|Overall Study|Study Terminated by Sponsor|1|||
154965586|NCT00112437|559298864|FG002|Year 2 (12-Month Extension)|Moved|0|||
154965587|NCT00112437|559298865|FG003|Year 2 (12-Month Extension)|Moved|0|||
154965588|NCT00112437|559298866|FG004|Year 2 (12-Month Extension)|Moved|0|||
155369976|NCT02202785|560787908|FG001|Overall Study|Study Terminated by Sponsor|6|||
154965589|NCT00112437|559298867|FG005|Year 2 (12-Month Extension)|Moved|0|||
154965590|NCT00112437|559298868|FG006|Year 2 (12-Month Extension)|Moved|0|||
154965591|NCT00112437|559298869|FG007|Year 2 (12-Month Extension)|Moved|0|||
154965592|NCT00112437|559298870|FG008|Year 2 (12-Month Extension)|Moved|0|||
155369977|NCT02202785|560787909|FG002|Overall Study|Study Terminated by Sponsor|4|||
155369978|NCT02202785|560787907|FG000|Overall Study|Withdrawal by Subject|0|||
155369979|NCT02202785|560787908|FG001|Overall Study|Withdrawal by Subject|1|||
155369980|NCT02202785|560787909|FG002|Overall Study|Withdrawal by Subject|0|||
155369981|NCT02202785|560787907|FG000|Overall Study|Lost to Follow-up|0|||
155369982|NCT02202785|560787908|FG001|Overall Study|Lost to Follow-up|1|||
154965593|NCT00112437|559298871|FG009|Year 2 (12-Month Extension)|Moved|1|||
155369983|NCT02202785|560787909|FG002|Overall Study|Lost to Follow-up|0|||
155369984|NCT02202785|560787907|FG000|Overall Study|Reason not Specified|10|||
155369985|NCT02202785|560787908|FG001|Overall Study|Reason not Specified|7|||
155369986|NCT02202785|560787909|FG002|Overall Study|Reason not Specified|13|||
155369987|NCT03945825|560787917|FG000|Overall Study|Enrolled but treatment not administered|0|||
155369988|NCT03945825|560787918|FG001|Overall Study|Enrolled but treatment not administered|0|||
155369989|NCT03945825|560787919|FG002|Overall Study|Enrolled but treatment not administered|0|||
155369990|NCT03945825|560787920|FG003|Overall Study|Enrolled but treatment not administered|0|||
155369991|NCT03945825|560787921|FG004|Overall Study|Enrolled but treatment not administered|1|||
155369992|NCT03945825|560787922|FG005|Overall Study|Enrolled but treatment not administered|0|||
155369993|NCT03945825|560787917|FG000|Overall Study|Lost to Follow-up|1|||
155369994|NCT03945825|560787918|FG001|Overall Study|Lost to Follow-up|5|||
155369995|NCT03945825|560787919|FG002|Overall Study|Lost to Follow-up|0|||
155369996|NCT03945825|560787920|FG003|Overall Study|Lost to Follow-up|1|||
155369997|NCT03945825|560787921|FG004|Overall Study|Lost to Follow-up|2|||
155369998|NCT03945825|560787922|FG005|Overall Study|Lost to Follow-up|2|||
155369999|NCT03945825|560787917|FG000|Overall Study|Withdrawal by Subject|1|||
155370000|NCT03945825|560787918|FG001|Overall Study|Withdrawal by Subject|0|||
155370001|NCT03945825|560787919|FG002|Overall Study|Withdrawal by Subject|1|||
155370002|NCT03945825|560787920|FG003|Overall Study|Withdrawal by Subject|1|||
155370003|NCT03945825|560787921|FG004|Overall Study|Withdrawal by Subject|0|||
155370004|NCT03945825|560787922|FG005|Overall Study|Withdrawal by Subject|1|||
155370005|NCT00203268|560787923|FG000|Early Treatment|only treated one headache|2|||
155370006|NCT00203268|560787923|FG000|Early Treatment|Lost to Follow-up|1|||
155370007|NCT00203268|560787923|FG000|Early Treatment|Withdrawal by Subject|1|||
155370008|NCT04958200|560787925|FG000|Overall Study|Withdrawal by Subject|0|||
155370009|NCT04958200|560787926|FG001|Overall Study|Withdrawal by Subject|2|||
155370010|NCT04958200|560787925|FG000|Overall Study|Lost to Follow-up|3|||
155370011|NCT04958200|560787926|FG001|Overall Study|Lost to Follow-up|2|||
155370012|NCT03852719|560787929|FG000|Overall Study|Withdrawal of consent|8|||
155370013|NCT03852719|560787930|FG001|Overall Study|Withdrawal of consent|8|||
155370014|NCT03852719|560787931|FG002|Overall Study|Withdrawal of consent|9|||
155370015|NCT03852719|560787929|FG000|Overall Study|Physician Decision|5|||
155370016|NCT03852719|560787930|FG001|Overall Study|Physician Decision|4|||
155370017|NCT03852719|560787931|FG002|Overall Study|Physician Decision|1|||
155370018|NCT03852719|560787929|FG000|Overall Study|Pregnancy|2|||
155370019|NCT03852719|560787930|FG001|Overall Study|Pregnancy|1|||
155370020|NCT03852719|560787931|FG002|Overall Study|Pregnancy|0|||
155370021|NCT03852719|560787929|FG000|Overall Study|Death|1|||
155370022|NCT03852719|560787930|FG001|Overall Study|Death|0|||
155370023|NCT03852719|560787931|FG002|Overall Study|Death|0|||
155370024|NCT03852719|560787929|FG000|Overall Study|Reason not Specified|3|||
155370025|NCT03852719|560787930|FG001|Overall Study|Reason not Specified|3|||
155370026|NCT03852719|560787931|FG002|Overall Study|Reason not Specified|5|||
155370027|NCT03852719|560787929|FG000|Overall Study|Adverse Event|2|||
155370028|NCT03852719|560787930|FG001|Overall Study|Adverse Event|1|||
155370029|NCT03852719|560787931|FG002|Overall Study|Adverse Event|4|||
155370030|NCT03852719|560787929|FG000|Overall Study|Progressive disease|1|||
155370031|NCT03852719|560787930|FG001|Overall Study|Progressive disease|4|||
155370032|NCT03852719|560787931|FG002|Overall Study|Progressive disease|1|||
155370033|NCT03852719|560787929|FG000|Overall Study|Lost to Follow-up|1|||
155370034|NCT03852719|560787930|FG001|Overall Study|Lost to Follow-up|0|||
155370035|NCT03852719|560787931|FG002|Overall Study|Lost to Follow-up|0|||
155370036|NCT01647542|560787933|FG000|Overall Study|Major Protocol Deviation|1|||
155370037|NCT01647542|560787934|FG001|Overall Study|Major Protocol Deviation|0|||
155370038|NCT01647542|560787935|FG002|Overall Study|Major Protocol Deviation|0|||
155370039|NCT01647542|560787933|FG000|Overall Study|Adverse Event|4|||
155370040|NCT01647542|560787934|FG001|Overall Study|Adverse Event|5|||
155370041|NCT01647542|560787935|FG002|Overall Study|Adverse Event|4|||
155370042|NCT01647542|560787933|FG000|Overall Study|Lost to Follow-up|0|||
155370043|NCT01647542|560787934|FG001|Overall Study|Lost to Follow-up|2|||
155370044|NCT01647542|560787935|FG002|Overall Study|Lost to Follow-up|2|||
155370045|NCT01647542|560787933|FG000|Overall Study|Withdrawal by Subject|6|||
155370046|NCT01647542|560787934|FG001|Overall Study|Withdrawal by Subject|4|||
155370047|NCT01647542|560787935|FG002|Overall Study|Withdrawal by Subject|0|||
155370048|NCT01647542|560787933|FG000|Overall Study|Study Termination|64|||
155370049|NCT01647542|560787934|FG001|Overall Study|Study Termination|61|||
155370050|NCT01647542|560787935|FG002|Overall Study|Study Termination|65|||
155370051|NCT01647542|560787933|FG000|Overall Study|Lack of Efficacy|1|||
155370052|NCT01647542|560787934|FG001|Overall Study|Lack of Efficacy|1|||
155370053|NCT01647542|560787935|FG002|Overall Study|Lack of Efficacy|0|||
155370054|NCT01647542|560787933|FG000|Overall Study|Death|0|||
155370055|NCT01647542|560787934|FG001|Overall Study|Death|0|||
155370056|NCT01647542|560787935|FG002|Overall Study|Death|1|||
155370057|NCT02397447|560787936|FG000|Overall Study|Lost to Follow-up|2|||
155370058|NCT02397447|560787937|FG001|Overall Study|Lost to Follow-up|2|||
155370059|NCT02994069|560787940|FG000|Overall Study|Death|7|||
155370060|NCT02994069|560787941|FG001|Overall Study|Death|13|||
155370061|NCT02994069|560787940|FG000|Overall Study|Adverse Event|1|||
155370062|NCT02994069|560787941|FG001|Overall Study|Adverse Event|0|||
155370063|NCT02994069|560787940|FG000|Overall Study|Other|2|||
155370064|NCT02994069|560787941|FG001|Overall Study|Other|0|||
155370065|NCT02994069|560787940|FG000|Overall Study|still on follow up/treatment|5|||
155370066|NCT02994069|560787941|FG001|Overall Study|still on follow up/treatment|6|||
155370067|NCT06926673|560787944|FG000|Overall Study|Lost to Follow-up|0|||
155370068|NCT06926673|560787945|FG001|Overall Study|Lost to Follow-up|0|||
155370069|NCT06926673|560787946|FG002|Overall Study|Lost to Follow-up|0|||
155370070|NCT06926673|560787947|FG003|Overall Study|Lost to Follow-up|1|||
155370071|NCT06926673|560787948|FG004|Overall Study|Lost to Follow-up|0|||
155370072|NCT06926673|560787949|FG005|Overall Study|Lost to Follow-up|0|||
155370073|NCT06926673|560787950|FG006|Overall Study|Lost to Follow-up|0|||
155370074|NCT06926673|560787944|FG000|Overall Study|Physician Decision|0|||
155370075|NCT06926673|560787945|FG001|Overall Study|Physician Decision|0|||
155370076|NCT06926673|560787946|FG002|Overall Study|Physician Decision|0|||
155370077|NCT06926673|560787947|FG003|Overall Study|Physician Decision|0|||
155370078|NCT06926673|560787948|FG004|Overall Study|Physician Decision|0|||
155370079|NCT06926673|560787949|FG005|Overall Study|Physician Decision|0|||
155370080|NCT06926673|560787950|FG006|Overall Study|Physician Decision|1|||
155370081|NCT06926673|560787944|FG000|Overall Study|Withdrawal by Subject|0|||
155370082|NCT06926673|560787945|FG001|Overall Study|Withdrawal by Subject|3|||
155370083|NCT06926673|560787946|FG002|Overall Study|Withdrawal by Subject|2|||
155370084|NCT06926673|560787947|FG003|Overall Study|Withdrawal by Subject|1|||
155370085|NCT06926673|560787948|FG004|Overall Study|Withdrawal by Subject|0|||
155370086|NCT06926673|560787949|FG005|Overall Study|Withdrawal by Subject|2|||
155370087|NCT06926673|560787950|FG006|Overall Study|Withdrawal by Subject|0|||
155370088|NCT03345576|560787953|FG000|Overall Study|Withdrawal by Subject|2|||
155370089|NCT03345576|560787954|FG001|Overall Study|Withdrawal by Subject|2|||
155370090|NCT03345576|560787953|FG000|Overall Study|Adverse Event|1|||
155370091|NCT03345576|560787954|FG001|Overall Study|Adverse Event|0|||
155370092|NCT01255631|560789424|FG000|Overall Study|poor enrollment, no data analyzed|9|||
155370093|NCT01255631|560789425|FG001|Overall Study|poor enrollment, no data analyzed|6|||
155370094|NCT00515671|560789426|FG000|Overall Study|Lost to Follow-up|13|||
155370095|NCT00515671|560789427|FG001|Overall Study|Lost to Follow-up|10|||
155370096|NCT00515671|560789426|FG000|Overall Study|Withdrawal by Subject|3|||
155370097|NCT00515671|560789427|FG001|Overall Study|Withdrawal by Subject|5|||
155370098|NCT00515671|560789426|FG000|Overall Study|incarcerated|1|||
155370099|NCT00515671|560789427|FG001|Overall Study|incarcerated|2|||
155370100|NCT00264303|560789428|FG000|Overall Study|Adverse Event|4|||
155370101|NCT00264303|560789429|FG001|Overall Study|Adverse Event|3|||
155370102|NCT00264303|560789428|FG000|Overall Study|Lack of Efficacy|10|||
155370103|NCT00264303|560789429|FG001|Overall Study|Lack of Efficacy|13|||
155370104|NCT00264303|560789428|FG000|Overall Study|Lost to Follow-up|3|||
155370105|NCT00264303|560789429|FG001|Overall Study|Lost to Follow-up|3|||
155370106|NCT00264303|560789428|FG000|Overall Study|Withdrawal by Subject|2|||
155370107|NCT00264303|560789429|FG001|Overall Study|Withdrawal by Subject|3|||
155370108|NCT00264303|560789428|FG000|Overall Study|Various reasons listed in study report|6|||
155370109|NCT00264303|560789429|FG001|Overall Study|Various reasons listed in study report|7|||
155370110|NCT02311673|560789430|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
155370111|NCT02311673|560789431|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
155370112|NCT02311673|560789432|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
155370113|NCT02311673|560789433|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
155370114|NCT04165031|560789439|FG000|Overall Study|Adverse Event|1|||
155370115|NCT04165031|560789440|FG001|Overall Study|Adverse Event|1|||
154965594|NCT00112437|559298872|FG010|Year 2 (12-Month Extension)|Moved|0|||
155370116|NCT04165031|560789441|FG002|Overall Study|Adverse Event|0|||
155370117|NCT04165031|560789442|FG003|Overall Study|Adverse Event|0|||
155370118|NCT04165031|560789443|FG004|Overall Study|Adverse Event|0|||
155370119|NCT04165031|560789444|FG005|Overall Study|Adverse Event|0|||
155370120|NCT04165031|560789439|FG000|Overall Study|Withdrawal by Subject|0|||
155370121|NCT04165031|560789440|FG001|Overall Study|Withdrawal by Subject|0|||
155370122|NCT04165031|560789441|FG002|Overall Study|Withdrawal by Subject|1|||
155370123|NCT04165031|560789442|FG003|Overall Study|Withdrawal by Subject|0|||
155370124|NCT04165031|560789443|FG004|Overall Study|Withdrawal by Subject|0|||
155370125|NCT04165031|560789444|FG005|Overall Study|Withdrawal by Subject|0|||
155370126|NCT00818168|560789445|FG000|Overall Study|Lack of Efficacy|18|||
155370127|NCT00818168|560789445|FG000|Overall Study|Pregnancy|2|||
155370128|NCT00818168|560789445|FG000|Overall Study|Withdrawal by Subject|16|||
155370129|NCT00818168|560789445|FG000|Overall Study|Lost to Follow-up|7|||
155370130|NCT00818168|560789445|FG000|Overall Study|Adverse Event|19|||
155370131|NCT00818168|560789445|FG000|Overall Study|Reason for Non-completion Not reported|6|||
155370132|NCT00818168|560789445|FG000|Overall Study|Participant Moved|2|||
155370133|NCT00667225|560789448|FG000|Overall Study|Subject had no more lesions to treat.|1|||
155370134|NCT00667225|560789449|FG001|Overall Study|Subject had no more lesions to treat.|0|||
155370135|NCT00667225|560789448|FG000|Overall Study|Lost to Follow-up|0|||
155370136|NCT00667225|560789449|FG001|Overall Study|Lost to Follow-up|1|||
155370137|NCT02993406|560789450|FG000|Overall Study|Withdrawal by Subject|170|||
155370138|NCT02993406|560789451|FG001|Overall Study|Withdrawal by Subject|196|||
155370139|NCT02993406|560789450|FG000|Overall Study|Physician Decision|3|||
155370140|NCT02993406|560789451|FG001|Overall Study|Physician Decision|5|||
155370141|NCT02993406|560789450|FG000|Overall Study|Lost to Follow-up|12|||
155370142|NCT02993406|560789451|FG001|Overall Study|Lost to Follow-up|13|||
155370143|NCT02993406|560789450|FG000|Overall Study|Unclassifiable Response|105|||
155167080|NCT01643772|560049370|FG003|Overall Study|Protocol Violation|1|||
155167081|NCT01643772|560049367|FG000|Overall Study|Adverse Event|0|||
155167082|NCT01643772|560049368|FG001|Overall Study|Adverse Event|0|||
155167083|NCT01643772|560049369|FG002|Overall Study|Adverse Event|0|||
155167084|NCT01643772|560049370|FG003|Overall Study|Adverse Event|1|||
155167085|NCT03860818|560049373|FG000|Overall Study|Death|144|||
155167086|NCT03860818|560049374|FG001|Overall Study|Death|195|||
155167087|NCT03860818|560049373|FG000|Overall Study|Graft Loss|32|||
155370144|NCT02993406|560789451|FG001|Overall Study|Unclassifiable Response|139|||
155370145|NCT02993406|560789450|FG000|Overall Study|Administrative decision|1|||
155370146|NCT02993406|560789451|FG001|Overall Study|Administrative decision|0|||
155370147|NCT02993406|560789450|FG000|Overall Study|Sponsor decision|4|||
155370148|NCT02993406|560789451|FG001|Overall Study|Sponsor decision|5|||
155370149|NCT03563157|560789452|FG000|Overall Study|Progressive Disease|2|||
155167088|NCT03860818|560049374|FG001|Overall Study|Graft Loss|45|||
155167089|NCT00792571|560049375|FG000|Overall Study|Death|1|||
155167090|NCT00792571|560049375|FG000|Overall Study|Adverse Event|4|||
155167091|NCT00792571|560049375|FG000|Overall Study|Withdrawal by Subject|1|||
155167092|NCT00792571|560049375|FG000|Overall Study|Other|4|||
155370150|NCT02248818|560789453|FG000|Screening|Protocol Violation|0|||
155370151|NCT02248818|560789454|FG001|Screening|Protocol Violation|0|||
155370152|NCT02248818|560789455|FG002|Screening|Protocol Violation|0|||
155370153|NCT02248818|560789456|FG003|Screening|Protocol Violation|0|||
155370154|NCT02248818|560789457|FG004|Screening|Protocol Violation|0|||
155370155|NCT02248818|560789458|FG005|Screening|Protocol Violation|0|||
155370156|NCT02248818|560789459|FG006|Screening|Protocol Violation|0|||
155370157|NCT02248818|560789460|FG007|Screening|Protocol Violation|0|||
155370158|NCT02248818|560789461|FG008|Screening|Protocol Violation|7|||
155370159|NCT02248818|560789453|FG000|Screening|Study fully enrolled|0|||
155370160|NCT02248818|560789454|FG001|Screening|Study fully enrolled|0|||
155370161|NCT02248818|560789455|FG002|Screening|Study fully enrolled|0|||
155370162|NCT02248818|560789456|FG003|Screening|Study fully enrolled|0|||
155370163|NCT02248818|560789457|FG004|Screening|Study fully enrolled|0|||
155370164|NCT02248818|560789458|FG005|Screening|Study fully enrolled|0|||
155370165|NCT02248818|560789459|FG006|Screening|Study fully enrolled|0|||
155370166|NCT02248818|560789460|FG007|Screening|Study fully enrolled|0|||
155370167|NCT02248818|560789461|FG008|Screening|Study fully enrolled|14|||
155370168|NCT02248818|560789453|FG000|Screening|Physician Decision|0|||
155370169|NCT02248818|560789454|FG001|Screening|Physician Decision|0|||
155370170|NCT02248818|560789455|FG002|Screening|Physician Decision|0|||
155370171|NCT02248818|560789456|FG003|Screening|Physician Decision|0|||
155370172|NCT02248818|560789457|FG004|Screening|Physician Decision|0|||
155370173|NCT02248818|560789458|FG005|Screening|Physician Decision|0|||
155370174|NCT02248818|560789459|FG006|Screening|Physician Decision|0|||
155370175|NCT02248818|560789460|FG007|Screening|Physician Decision|0|||
155370176|NCT02248818|560789461|FG008|Screening|Physician Decision|73|||
155167093|NCT02600819|560049376|FG000|GEN Phase|Adverse Event|2|||
155370177|NCT02248818|560789453|FG000|Screening|Withdrawal by Subject|0|||
155370178|NCT02248818|560789454|FG001|Screening|Withdrawal by Subject|0|||
155370179|NCT02248818|560789455|FG002|Screening|Withdrawal by Subject|0|||
155167094|NCT02600819|560049377|FG001|GEN Phase|Adverse Event|0|||
155370180|NCT02248818|560789456|FG003|Screening|Withdrawal by Subject|0|||
155370181|NCT02248818|560789457|FG004|Screening|Withdrawal by Subject|0|||
155370182|NCT02248818|560789458|FG005|Screening|Withdrawal by Subject|0|||
155370183|NCT02248818|560789459|FG006|Screening|Withdrawal by Subject|0|||
155370184|NCT02248818|560789460|FG007|Screening|Withdrawal by Subject|0|||
155370185|NCT02248818|560789461|FG008|Screening|Withdrawal by Subject|6|||
155370186|NCT02248818|560789453|FG000|Screening|Lost to Follow-up|0|||
155370187|NCT02248818|560789454|FG001|Screening|Lost to Follow-up|0|||
155370188|NCT02248818|560789455|FG002|Screening|Lost to Follow-up|0|||
155167095|NCT02600819|560049376|FG000|GEN Phase|Death|2|||
155167096|NCT02600819|560049377|FG001|GEN Phase|Death|0|||
155167097|NCT02600819|560049376|FG000|GEN Phase|Investigator's Discretion|4|||
155167098|NCT02600819|560049377|FG001|GEN Phase|Investigator's Discretion|0|||
155167099|NCT02600819|560049376|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
155370189|NCT02248818|560789456|FG003|Screening|Lost to Follow-up|0|||
155370190|NCT02248818|560789457|FG004|Screening|Lost to Follow-up|0|||
155370191|NCT02248818|560789458|FG005|Screening|Lost to Follow-up|0|||
155370192|NCT02248818|560789459|FG006|Screening|Lost to Follow-up|0|||
155370193|NCT02248818|560789460|FG007|Screening|Lost to Follow-up|0|||
155370194|NCT02248818|560789461|FG008|Screening|Lost to Follow-up|7|||
155370195|NCT02248818|560789453|FG000|Randomised Study|Administrative - randomization error|0|||
155370196|NCT02248818|560789454|FG001|Randomised Study|Administrative - randomization error|0|||
155370197|NCT02248818|560789455|FG002|Randomised Study|Administrative - randomization error|0|||
155370198|NCT02248818|560789456|FG003|Randomised Study|Administrative - randomization error|0|||
155370199|NCT02248818|560789457|FG004|Randomised Study|Administrative - randomization error|0|||
155370200|NCT02248818|560789458|FG005|Randomised Study|Administrative - randomization error|8|||
155370201|NCT02248818|560789459|FG006|Randomised Study|Administrative - randomization error|0|||
155370202|NCT02248818|560789460|FG007|Randomised Study|Administrative - randomization error|0|||
155370203|NCT02248818|560789461|FG008|Randomised Study|Administrative - randomization error|0|||
155370204|NCT02942277|560789462|FG000|Year 1|Withdrawal by Subject|0|||
155370205|NCT02942277|560789463|FG001|Year 1|Withdrawal by Subject|0|||
155370206|NCT02942277|560789464|FG002|Year 1|Withdrawal by Subject|0|||
155370207|NCT02942277|560789465|FG003|Year 1|Withdrawal by Subject|0|||
155370208|NCT02942277|560789466|FG004|Year 1|Withdrawal by Subject|1|||
155370209|NCT02942277|560789467|FG005|Year 1|Withdrawal by Subject|3|||
155370210|NCT02942277|560789468|FG006|Year 1|Withdrawal by Subject|0|||
155370211|NCT02942277|560789469|FG007|Year 1|Withdrawal by Subject|1|||
155370212|NCT02942277|560789470|FG008|Year 1|Withdrawal by Subject|0|||
155370213|NCT02942277|560789471|FG009|Year 1|Withdrawal by Subject|0|||
155370214|NCT02942277|560789472|FG010|Year 1|Withdrawal by Subject|3|||
155370215|NCT02942277|560789462|FG000|Year 1|Travel|0|||
155370216|NCT02942277|560789463|FG001|Year 1|Travel|1|||
155370217|NCT02942277|560789464|FG002|Year 1|Travel|0|||
155370218|NCT02942277|560789465|FG003|Year 1|Travel|0|||
155370219|NCT02942277|560789466|FG004|Year 1|Travel|4|||
155370220|NCT02942277|560789467|FG005|Year 1|Travel|5|||
155370221|NCT02942277|560789468|FG006|Year 1|Travel|0|||
155370222|NCT02942277|560789469|FG007|Year 1|Travel|0|||
155370223|NCT02942277|560789470|FG008|Year 1|Travel|0|||
155370224|NCT02942277|560789471|FG009|Year 1|Travel|0|||
155370225|NCT02942277|560789472|FG010|Year 1|Travel|8|||
155370226|NCT02942277|560789462|FG000|Year 1|Joined Army|0|||
155370227|NCT02942277|560789463|FG001|Year 1|Joined Army|1|||
155370228|NCT02942277|560789464|FG002|Year 1|Joined Army|0|||
155370229|NCT02942277|560789465|FG003|Year 1|Joined Army|0|||
155370230|NCT02942277|560789466|FG004|Year 1|Joined Army|0|||
155370231|NCT02942277|560789467|FG005|Year 1|Joined Army|0|||
155370232|NCT02942277|560789468|FG006|Year 1|Joined Army|0|||
155370233|NCT02942277|560789469|FG007|Year 1|Joined Army|0|||
155370234|NCT02942277|560789470|FG008|Year 1|Joined Army|0|||
155370235|NCT02942277|560789471|FG009|Year 1|Joined Army|0|||
155370236|NCT02942277|560789472|FG010|Year 1|Joined Army|0|||
155370237|NCT02942277|560789462|FG000|Year 1|Subject met withdrawal criteria|0|||
155370238|NCT02942277|560789463|FG001|Year 1|Subject met withdrawal criteria|0|||
155370239|NCT02942277|560789464|FG002|Year 1|Subject met withdrawal criteria|0|||
155370240|NCT02942277|560789465|FG003|Year 1|Subject met withdrawal criteria|1|||
155370241|NCT02942277|560789466|FG004|Year 1|Subject met withdrawal criteria|0|||
155370242|NCT02942277|560789467|FG005|Year 1|Subject met withdrawal criteria|0|||
155370243|NCT02942277|560789468|FG006|Year 1|Subject met withdrawal criteria|0|||
155370244|NCT02942277|560789469|FG007|Year 1|Subject met withdrawal criteria|0|||
155370245|NCT02942277|560789470|FG008|Year 1|Subject met withdrawal criteria|0|||
155370246|NCT02942277|560789471|FG009|Year 1|Subject met withdrawal criteria|0|||
155370247|NCT02942277|560789472|FG010|Year 1|Subject met withdrawal criteria|0|||
155370248|NCT02942277|560789462|FG000|Year 1|Lost to Follow-up|0|||
155370249|NCT02942277|560789463|FG001|Year 1|Lost to Follow-up|0|||
155370250|NCT02942277|560789464|FG002|Year 1|Lost to Follow-up|0|||
155370251|NCT02942277|560789465|FG003|Year 1|Lost to Follow-up|0|||
155370252|NCT02942277|560789466|FG004|Year 1|Lost to Follow-up|1|||
155370253|NCT02942277|560789467|FG005|Year 1|Lost to Follow-up|0|||
155370254|NCT02942277|560789468|FG006|Year 1|Lost to Follow-up|0|||
155370255|NCT02942277|560789469|FG007|Year 1|Lost to Follow-up|0|||
155370256|NCT02942277|560789470|FG008|Year 1|Lost to Follow-up|0|||
155370257|NCT02942277|560789471|FG009|Year 1|Lost to Follow-up|0|||
155370258|NCT02942277|560789472|FG010|Year 1|Lost to Follow-up|2|||
155370259|NCT02942277|560789462|FG000|Year 1|Protocol Violation|0|||
155370260|NCT02942277|560789463|FG001|Year 1|Protocol Violation|0|||
155370261|NCT02942277|560789464|FG002|Year 1|Protocol Violation|0|||
155370262|NCT02942277|560789465|FG003|Year 1|Protocol Violation|0|||
155370263|NCT02942277|560789466|FG004|Year 1|Protocol Violation|1|||
155167100|NCT02600819|560049377|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
155167101|NCT02600819|560049376|FG000|GEN Phase|Withdrew Consent|5|||
155167102|NCT02600819|560049377|FG001|GEN Phase|Withdrew Consent|0|||
155167103|NCT02600819|560049376|FG000|GEN Phase|Lost to Follow-up|2|||
155167104|NCT02600819|560049377|FG001|GEN Phase|Lost to Follow-up|0|||
155370264|NCT02942277|560789467|FG005|Year 1|Protocol Violation|1|||
155370265|NCT02942277|560789468|FG006|Year 1|Protocol Violation|0|||
155370266|NCT02942277|560789469|FG007|Year 1|Protocol Violation|0|||
155370267|NCT02942277|560789470|FG008|Year 1|Protocol Violation|0|||
155370268|NCT02942277|560789471|FG009|Year 1|Protocol Violation|0|||
155370269|NCT02942277|560789472|FG010|Year 1|Protocol Violation|2|||
155370270|NCT02942277|560789462|FG000|Year 1|Pregnancy|0|||
155370271|NCT02942277|560789463|FG001|Year 1|Pregnancy|0|||
155370272|NCT02942277|560789464|FG002|Year 1|Pregnancy|0|||
155370273|NCT02942277|560789465|FG003|Year 1|Pregnancy|0|||
155370274|NCT02942277|560789466|FG004|Year 1|Pregnancy|0|||
155370275|NCT02942277|560789467|FG005|Year 1|Pregnancy|1|||
155370276|NCT02942277|560789468|FG006|Year 1|Pregnancy|0|||
155370277|NCT02942277|560789469|FG007|Year 1|Pregnancy|0|||
155370278|NCT02942277|560789470|FG008|Year 1|Pregnancy|0|||
155370279|NCT02942277|560789471|FG009|Year 1|Pregnancy|0|||
155370280|NCT02942277|560789472|FG010|Year 1|Pregnancy|0|||
155370281|NCT02942277|560789462|FG000|Year 2|Lost to Follow-up|0|||
155370282|NCT02942277|560789463|FG001|Year 2|Lost to Follow-up|0|||
155370283|NCT02942277|560789464|FG002|Year 2|Lost to Follow-up|0|||
155370284|NCT02942277|560789465|FG003|Year 2|Lost to Follow-up|0|||
155370285|NCT02942277|560789466|FG004|Year 2|Lost to Follow-up|2|||
155370286|NCT02942277|560789467|FG005|Year 2|Lost to Follow-up|1|||
155370287|NCT02942277|560789468|FG006|Year 2|Lost to Follow-up|0|||
155370288|NCT02942277|560789469|FG007|Year 2|Lost to Follow-up|0|||
155370289|NCT02942277|560789470|FG008|Year 2|Lost to Follow-up|0|||
155370290|NCT02942277|560789471|FG009|Year 2|Lost to Follow-up|0|||
155370291|NCT02942277|560789472|FG010|Year 2|Lost to Follow-up|0|||
155370292|NCT02942277|560789462|FG000|Year 2|Did not rescreen|0|||
155370293|NCT02942277|560789463|FG001|Year 2|Did not rescreen|0|||
155370294|NCT02942277|560789464|FG002|Year 2|Did not rescreen|1|||
155370295|NCT02942277|560789465|FG003|Year 2|Did not rescreen|1|||
155370296|NCT02942277|560789466|FG004|Year 2|Did not rescreen|9|||
155370297|NCT02942277|560789467|FG005|Year 2|Did not rescreen|6|||
155370298|NCT02942277|560789468|FG006|Year 2|Did not rescreen|0|||
155370299|NCT02942277|560789469|FG007|Year 2|Did not rescreen|1|||
155370300|NCT02942277|560789470|FG008|Year 2|Did not rescreen|0|||
155370301|NCT02942277|560789471|FG009|Year 2|Did not rescreen|0|||
155370302|NCT02942277|560789472|FG010|Year 2|Did not rescreen|21|||
155370303|NCT02942277|560789462|FG000|Year 2|Met withdrawal criteria|0|||
155370304|NCT02942277|560789463|FG001|Year 2|Met withdrawal criteria|0|||
154965595|NCT00112437|559298873|FG011|Year 2 (12-Month Extension)|Moved|0|||
154965596|NCT00112437|559298874|FG012|Year 2 (12-Month Extension)|Moved|0|||
155167105|NCT01621802|560049379|FG000|Overall Study|Protocol Violation|0|||
155370305|NCT02942277|560789464|FG002|Year 2|Met withdrawal criteria|0|||
155167106|NCT01621802|560049380|FG001|Overall Study|Protocol Violation|0|||
155370306|NCT02942277|560789465|FG003|Year 2|Met withdrawal criteria|0|||
155370307|NCT02942277|560789466|FG004|Year 2|Met withdrawal criteria|1|||
155370308|NCT02942277|560789467|FG005|Year 2|Met withdrawal criteria|2|||
155370309|NCT02942277|560789468|FG006|Year 2|Met withdrawal criteria|0|||
155370310|NCT02942277|560789469|FG007|Year 2|Met withdrawal criteria|0|||
155370311|NCT02942277|560789470|FG008|Year 2|Met withdrawal criteria|0|||
155370312|NCT02942277|560789471|FG009|Year 2|Met withdrawal criteria|0|||
155370313|NCT02942277|560789472|FG010|Year 2|Met withdrawal criteria|1|||
155370314|NCT02942277|560789462|FG000|Year 2|Travel|0|||
155370315|NCT02942277|560789463|FG001|Year 2|Travel|1|||
155370316|NCT02942277|560789464|FG002|Year 2|Travel|0|||
155370317|NCT02942277|560789465|FG003|Year 2|Travel|0|||
155370318|NCT02942277|560789466|FG004|Year 2|Travel|0|||
155370319|NCT02942277|560789467|FG005|Year 2|Travel|1|||
155370320|NCT02942277|560789468|FG006|Year 2|Travel|0|||
155370321|NCT02942277|560789469|FG007|Year 2|Travel|0|||
155370322|NCT02942277|560789470|FG008|Year 2|Travel|0|||
155370323|NCT02942277|560789471|FG009|Year 2|Travel|1|||
155370324|NCT02942277|560789472|FG010|Year 2|Travel|3|||
155370325|NCT02942277|560789462|FG000|Year 2|Non-compliant|0|||
155370326|NCT02942277|560789463|FG001|Year 2|Non-compliant|0|||
155370327|NCT02942277|560789464|FG002|Year 2|Non-compliant|0|||
155370328|NCT02942277|560789465|FG003|Year 2|Non-compliant|0|||
155370329|NCT02942277|560789466|FG004|Year 2|Non-compliant|1|||
155370330|NCT02942277|560789467|FG005|Year 2|Non-compliant|1|||
155370331|NCT02942277|560789468|FG006|Year 2|Non-compliant|0|||
155370332|NCT02942277|560789469|FG007|Year 2|Non-compliant|0|||
155370333|NCT02942277|560789470|FG008|Year 2|Non-compliant|0|||
155370334|NCT02942277|560789471|FG009|Year 2|Non-compliant|0|||
155370335|NCT02942277|560789472|FG010|Year 2|Non-compliant|0|||
155370336|NCT02942277|560789462|FG000|Year 2|Withdrawal by Subject|0|||
155090468|NCT01467466|559763662|FG003|Overall Study|Withdrawal by Subject|11|||
155370337|NCT02942277|560789463|FG001|Year 2|Withdrawal by Subject|0|||
155370338|NCT02942277|560789464|FG002|Year 2|Withdrawal by Subject|0|||
155370339|NCT02942277|560789465|FG003|Year 2|Withdrawal by Subject|0|||
155370340|NCT02942277|560789466|FG004|Year 2|Withdrawal by Subject|0|||
155370341|NCT02942277|560789467|FG005|Year 2|Withdrawal by Subject|0|||
155370342|NCT02942277|560789468|FG006|Year 2|Withdrawal by Subject|1|||
155370343|NCT02942277|560789469|FG007|Year 2|Withdrawal by Subject|0|||
155370344|NCT02942277|560789470|FG008|Year 2|Withdrawal by Subject|0|||
155370345|NCT02942277|560789471|FG009|Year 2|Withdrawal by Subject|0|||
155370346|NCT02942277|560789472|FG010|Year 2|Withdrawal by Subject|0|||
155370347|NCT02187159|560789473|FG000|Overall Study|Protocol Violation|4|||
155370348|NCT02187159|560789474|FG001|Overall Study|Protocol Violation|6|||
155370349|NCT02187159|560789475|FG002|Overall Study|Protocol Violation|3|||
155370350|NCT02187159|560789476|FG003|Overall Study|Protocol Violation|4|||
155370351|NCT02187159|560789473|FG000|Overall Study|Lack of Efficacy|10|||
155370352|NCT02187159|560789474|FG001|Overall Study|Lack of Efficacy|5|||
155370353|NCT02187159|560789475|FG002|Overall Study|Lack of Efficacy|4|||
155370354|NCT02187159|560789476|FG003|Overall Study|Lack of Efficacy|7|||
155370355|NCT02187159|560789473|FG000|Overall Study|Adverse Event|28|||
155370356|NCT02187159|560789474|FG001|Overall Study|Adverse Event|33|||
155370357|NCT02187159|560789475|FG002|Overall Study|Adverse Event|42|||
155370358|NCT02187159|560789476|FG003|Overall Study|Adverse Event|50|||
155370359|NCT02187159|560789473|FG000|Overall Study|Withdrawal by Subject|24|||
155370360|NCT02187159|560789474|FG001|Overall Study|Withdrawal by Subject|28|||
155370361|NCT02187159|560789475|FG002|Overall Study|Withdrawal by Subject|25|||
155370362|NCT02187159|560789476|FG003|Overall Study|Withdrawal by Subject|26|||
155370363|NCT02187159|560789473|FG000|Overall Study|Other|3|||
155370364|NCT02187159|560789474|FG001|Overall Study|Other|7|||
155370365|NCT02187159|560789475|FG002|Overall Study|Other|3|||
155370366|NCT02187159|560789476|FG003|Overall Study|Other|9|||
155370367|NCT01283152|560789479|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
155370368|NCT01283152|560789480|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
155370369|NCT01283152|560789479|FG000|Overall Study|Refused HESA|1|||
155370370|NCT01283152|560789480|FG001|Overall Study|Refused HESA|0|||
155370371|NCT04020185|560789483|FG000|Overall Study|Death|0|||
155370372|NCT04020185|560789484|FG001|Overall Study|Death|0|||
155370373|NCT04020185|560789485|FG002|Overall Study|Death|1|||
155370374|NCT04020185|560789486|FG003|Overall Study|Death|2|||
155370375|NCT04020185|560789487|FG004|Overall Study|Death|1|||
155370376|NCT04020185|560789488|FG005|Overall Study|Death|0|||
155370377|NCT04020185|560789489|FG006|Overall Study|Death|1|||
155370378|NCT04020185|560789490|FG007|Overall Study|Death|0|||
155370379|NCT04020185|560789483|FG000|Overall Study|Consent withdrawn|1|||
155370380|NCT04020185|560789484|FG001|Overall Study|Consent withdrawn|0|||
155370381|NCT04020185|560789485|FG002|Overall Study|Consent withdrawn|0|||
155370382|NCT04020185|560789486|FG003|Overall Study|Consent withdrawn|0|||
155370383|NCT04020185|560789487|FG004|Overall Study|Consent withdrawn|2|||
155370384|NCT04020185|560789488|FG005|Overall Study|Consent withdrawn|0|||
155370385|NCT04020185|560789489|FG006|Overall Study|Consent withdrawn|1|||
155370386|NCT04020185|560789490|FG007|Overall Study|Consent withdrawn|1|||
155370387|NCT04020185|560789483|FG000|Overall Study|Patient in hospice|0|||
155370388|NCT04020185|560789484|FG001|Overall Study|Patient in hospice|1|||
155370389|NCT04020185|560789485|FG002|Overall Study|Patient in hospice|0|||
155370390|NCT04020185|560789486|FG003|Overall Study|Patient in hospice|0|||
155370391|NCT04020185|560789487|FG004|Overall Study|Patient in hospice|0|||
155370392|NCT04020185|560789488|FG005|Overall Study|Patient in hospice|0|||
155370393|NCT04020185|560789489|FG006|Overall Study|Patient in hospice|0|||
155370394|NCT04020185|560789490|FG007|Overall Study|Patient in hospice|0|||
155370395|NCT04020185|560789483|FG000|Overall Study|Continuing on expanded access|0|||
155370396|NCT04020185|560789484|FG001|Overall Study|Continuing on expanded access|0|||
155370397|NCT04020185|560789485|FG002|Overall Study|Continuing on expanded access|0|||
155370398|NCT04020185|560789486|FG003|Overall Study|Continuing on expanded access|0|||
155370399|NCT04020185|560789487|FG004|Overall Study|Continuing on expanded access|0|||
155370400|NCT04020185|560789488|FG005|Overall Study|Continuing on expanded access|0|||
155370401|NCT04020185|560789489|FG006|Overall Study|Continuing on expanded access|1|||
155370402|NCT04020185|560789490|FG007|Overall Study|Continuing on expanded access|1|||
155370403|NCT00527787|560789491|FG000|Overall Study|Adverse Event|14|||
155370404|NCT00527787|560789492|FG001|Overall Study|Adverse Event|24|||
155370405|NCT00527787|560789491|FG000|Overall Study|Withdrawal by Subject|13|||
155370406|NCT00527787|560789492|FG001|Overall Study|Withdrawal by Subject|25|||
155370407|NCT00527787|560789491|FG000|Overall Study|Lost to Follow-up|5|||
155370408|NCT00527787|560789492|FG001|Overall Study|Lost to Follow-up|2|||
155370409|NCT00527787|560789491|FG000|Overall Study|Duodenal Ulcer|1|||
155370410|NCT00527787|560789492|FG001|Overall Study|Duodenal Ulcer|10|||
155370411|NCT00527787|560789491|FG000|Overall Study|misc|5|||
155370412|NCT00527787|560789492|FG001|Overall Study|misc|2|||
155370413|NCT03330405|560789493|FG000|Overall Study|Other|1|||
155370414|NCT03330405|560789494|FG001|Overall Study|Other|3|||
155370415|NCT03330405|560789495|FG002|Overall Study|Other|1|||
155370416|NCT03330405|560789496|FG003|Overall Study|Other|0|||
155370417|NCT03330405|560789497|FG004|Overall Study|Other|2|||
155370418|NCT03330405|560789498|FG005|Overall Study|Other|0|||
155370419|NCT03330405|560789499|FG006|Overall Study|Other|1|||
155370420|NCT03330405|560789500|FG007|Overall Study|Other|0|||
155370421|NCT03330405|560789501|FG008|Overall Study|Other|0|||
155370422|NCT03330405|560789502|FG009|Overall Study|Other|0|||
155370423|NCT03330405|560789503|FG010|Overall Study|Other|0|||
155370424|NCT03330405|560789493|FG000|Overall Study|Progressive disease|8|||
155370425|NCT03330405|560789494|FG001|Overall Study|Progressive disease|27|||
155370426|NCT03330405|560789495|FG002|Overall Study|Progressive disease|4|||
155370427|NCT03330405|560789496|FG003|Overall Study|Progressive disease|18|||
155370428|NCT03330405|560789497|FG004|Overall Study|Progressive disease|16|||
155370429|NCT03330405|560789498|FG005|Overall Study|Progressive disease|14|||
155370430|NCT03330405|560789499|FG006|Overall Study|Progressive disease|7|||
155370431|NCT03330405|560789500|FG007|Overall Study|Progressive disease|29|||
155370432|NCT03330405|560789501|FG008|Overall Study|Progressive disease|9|||
155370433|NCT03330405|560789502|FG009|Overall Study|Progressive disease|11|||
155370434|NCT03330405|560789503|FG010|Overall Study|Progressive disease|5|||
155370435|NCT03330405|560789493|FG000|Overall Study|Withdrawal by Subject|1|||
155370436|NCT03330405|560789494|FG001|Overall Study|Withdrawal by Subject|4|||
155370437|NCT03330405|560789495|FG002|Overall Study|Withdrawal by Subject|0|||
155370438|NCT03330405|560789496|FG003|Overall Study|Withdrawal by Subject|1|||
155370439|NCT03330405|560789497|FG004|Overall Study|Withdrawal by Subject|1|||
155370440|NCT03330405|560789498|FG005|Overall Study|Withdrawal by Subject|1|||
155370441|NCT03330405|560789499|FG006|Overall Study|Withdrawal by Subject|0|||
155370442|NCT03330405|560789500|FG007|Overall Study|Withdrawal by Subject|2|||
155370443|NCT03330405|560789501|FG008|Overall Study|Withdrawal by Subject|2|||
155370444|NCT03330405|560789502|FG009|Overall Study|Withdrawal by Subject|1|||
155370445|NCT03330405|560789503|FG010|Overall Study|Withdrawal by Subject|1|||
155370446|NCT03330405|560789493|FG000|Overall Study|Global deterioration of health status|2|||
155370447|NCT03330405|560789494|FG001|Overall Study|Global deterioration of health status|3|||
155370448|NCT03330405|560789495|FG002|Overall Study|Global deterioration of health status|0|||
155370449|NCT03330405|560789496|FG003|Overall Study|Global deterioration of health status|2|||
155370450|NCT03330405|560789497|FG004|Overall Study|Global deterioration of health status|3|||
155370451|NCT03330405|560789498|FG005|Overall Study|Global deterioration of health status|3|||
155370452|NCT03330405|560789499|FG006|Overall Study|Global deterioration of health status|0|||
155370453|NCT03330405|560789500|FG007|Overall Study|Global deterioration of health status|2|||
155370454|NCT03330405|560789501|FG008|Overall Study|Global deterioration of health status|8|||
155370455|NCT03330405|560789502|FG009|Overall Study|Global deterioration of health status|4|||
155370456|NCT03330405|560789503|FG010|Overall Study|Global deterioration of health status|1|||
155370457|NCT03330405|560789493|FG000|Overall Study|Adverse Event|0|||
155370458|NCT03330405|560789494|FG001|Overall Study|Adverse Event|1|||
155370459|NCT03330405|560789495|FG002|Overall Study|Adverse Event|0|||
155370460|NCT03330405|560789496|FG003|Overall Study|Adverse Event|1|||
155370461|NCT03330405|560789497|FG004|Overall Study|Adverse Event|1|||
155370462|NCT03330405|560789498|FG005|Overall Study|Adverse Event|1|||
155370463|NCT03330405|560789499|FG006|Overall Study|Adverse Event|3|||
155370464|NCT03330405|560789500|FG007|Overall Study|Adverse Event|4|||
155370465|NCT03330405|560789501|FG008|Overall Study|Adverse Event|2|||
155370466|NCT03330405|560789502|FG009|Overall Study|Adverse Event|2|||
155090469|NCT01467466|559763659|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
155090470|NCT01467466|559763660|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
155370467|NCT03330405|560789503|FG010|Overall Study|Adverse Event|2|||
155370468|NCT03330405|560789493|FG000|Overall Study|Death|0|||
155370469|NCT03330405|560789494|FG001|Overall Study|Death|4|||
155370470|NCT03330405|560789495|FG002|Overall Study|Death|0|||
155370471|NCT03330405|560789496|FG003|Overall Study|Death|0|||
155370472|NCT03330405|560789497|FG004|Overall Study|Death|0|||
155370473|NCT03330405|560789498|FG005|Overall Study|Death|1|||
155370474|NCT03330405|560789499|FG006|Overall Study|Death|0|||
155370475|NCT03330405|560789500|FG007|Overall Study|Death|2|||
155370476|NCT03330405|560789501|FG008|Overall Study|Death|0|||
155370477|NCT03330405|560789502|FG009|Overall Study|Death|0|||
155370478|NCT03330405|560789503|FG010|Overall Study|Death|0|||
155370479|NCT03330405|560789493|FG000|Overall Study|Physician Decision|0|||
154965597|NCT00112437|559298875|FG013|Year 2 (12-Month Extension)|Moved|0|||
155370480|NCT03330405|560789494|FG001|Overall Study|Physician Decision|0|||
155370481|NCT03330405|560789495|FG002|Overall Study|Physician Decision|0|||
155370482|NCT03330405|560789496|FG003|Overall Study|Physician Decision|0|||
155370483|NCT03330405|560789497|FG004|Overall Study|Physician Decision|0|||
155370484|NCT03330405|560789498|FG005|Overall Study|Physician Decision|0|||
155370485|NCT03330405|560789499|FG006|Overall Study|Physician Decision|0|||
155370486|NCT03330405|560789500|FG007|Overall Study|Physician Decision|1|||
155370487|NCT03330405|560789501|FG008|Overall Study|Physician Decision|0|||
155370488|NCT03330405|560789502|FG009|Overall Study|Physician Decision|0|||
155370489|NCT03330405|560789503|FG010|Overall Study|Physician Decision|0|||
155370490|NCT01736189|560789506|FG000|Overall Study|Violation of registration criteria|41|||
155370491|NCT01736189|560789506|FG000|Overall Study|Protocol Violation|4|||
155370492|NCT01736189|560789506|FG000|Overall Study|Criteria and protocol violations|1|||
155370493|NCT03809039|560789507|FG000|Part 1|Withdrawal by Subject|1|||
155370494|NCT03809039|560789508|FG001|Part 1|Withdrawal by Subject|0|||
155370495|NCT03809039|560789509|FG002|Part 1|Withdrawal by Subject|0|||
155370496|NCT03809039|560789510|FG003|Part 1|Withdrawal by Subject|1|||
155370497|NCT03809039|560789511|FG004|Part 1|Withdrawal by Subject|0|||
155370498|NCT03809039|560789512|FG005|Part 1|Withdrawal by Subject|0|||
155370499|NCT03809039|560789513|FG006|Part 1|Withdrawal by Subject|0|||
155370500|NCT03809039|560789514|FG007|Part 1|Withdrawal by Subject|0|||
155370501|NCT03809039|560789515|FG008|Part 1|Withdrawal by Subject|0|||
155370502|NCT03809039|560789507|FG000|Part 3|Withdrawn by study termination|0|||
155370503|NCT03809039|560789508|FG001|Part 3|Withdrawn by study termination|0|||
155370504|NCT03809039|560789509|FG002|Part 3|Withdrawn by study termination|0|||
155370505|NCT03809039|560789510|FG003|Part 3|Withdrawn by study termination|0|||
155370506|NCT03809039|560789511|FG004|Part 3|Withdrawn by study termination|0|||
155370507|NCT03809039|560789512|FG005|Part 3|Withdrawn by study termination|0|||
155370508|NCT03809039|560789513|FG006|Part 3|Withdrawn by study termination|0|||
155370509|NCT03809039|560789514|FG007|Part 3|Withdrawn by study termination|2|||
155370510|NCT03809039|560789515|FG008|Part 3|Withdrawn by study termination|6|||
155370511|NCT00702962|560789516|FG000|Overall Study|Progressive disease|0|||
155370512|NCT00702962|560789517|FG001|Overall Study|Progressive disease|1|||
155370513|NCT00702962|560789516|FG000|Overall Study|Hospitalized for other health disorder|1|||
155370514|NCT00702962|560789517|FG001|Overall Study|Hospitalized for other health disorder|0|||
155370515|NCT01923467|560789520|FG000|Overall Study|Lost to Follow-up|62|||
155370516|NCT01923467|560789520|FG000|Overall Study|Subject non-interest|479|||
155370517|NCT01876901|560789521|FG000|Overall Study|Protocol Violation|10|||
155370518|NCT01876901|560789522|FG001|Overall Study|Protocol Violation|2|||
155370519|NCT01876901|560789521|FG000|Overall Study|No or other surgical intervention|7|||
155370520|NCT01876901|560789522|FG001|Overall Study|No or other surgical intervention|5|||
155370521|NCT01145898|560789523|FG000|3-year Treatment|medication change by treating physician|3|||
155370522|NCT01145898|560789524|FG001|3-year Treatment|medication change by treating physician|16|||
155370523|NCT00879775|560789525|FG000|Overall Study|Lost to Follow-up|2|||
155370524|NCT00879775|560789526|FG001|Overall Study|Lost to Follow-up|1|||
155370525|NCT01068665|560789527|FG000|Overall Study|Adverse Event|5|||
155370526|NCT01068665|560789528|FG001|Overall Study|Adverse Event|4|||
155370527|NCT01068665|560789527|FG000|Overall Study|Lack of Efficacy|0|||
155370528|NCT01068665|560789528|FG001|Overall Study|Lack of Efficacy|2|||
155370529|NCT01068665|560789527|FG000|Overall Study|Protocol Violation|5|||
155370530|NCT01068665|560789528|FG001|Overall Study|Protocol Violation|2|||
155370531|NCT01068665|560789527|FG000|Overall Study|Withdrawal Criteria|3|||
155370532|NCT01068665|560789528|FG001|Overall Study|Withdrawal Criteria|9|||
155370533|NCT01068665|560789527|FG000|Overall Study|Other|17|||
155370534|NCT01068665|560789528|FG001|Overall Study|Other|12|||
155370535|NCT03552523|560789530|FG000|Overall Study|Withdrawal by Subject|1|||
155370536|NCT03552523|560789531|FG001|Overall Study|Withdrawal by Subject|1|||
155370537|NCT00694109|560789532|FG000|Overall Study|Physician Decision|3|||
155370538|NCT00694109|560789532|FG000|Overall Study|Adverse Event|74|||
155370539|NCT00694109|560789532|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
155370540|NCT00694109|560789532|FG000|Overall Study|Lack of Efficacy|2|||
155370541|NCT00694109|560789532|FG000|Overall Study|Withdrawal by Subject|13|||
155370542|NCT00694109|560789532|FG000|Overall Study|Pregnancy|1|||
155370543|NCT00694109|560789532|FG000|Overall Study|Enrolled but not treated|1|||
155370544|NCT00694109|560789532|FG000|Overall Study|Other|2|||
155370545|NCT00694109|560789532|FG000|Overall Study|Consented but no additional treatment|3|||
155370546|NCT00846807|560789535|FG000|Overall Study|Adverse Event|270|||
155370547|NCT00846807|560789535|FG000|Overall Study|Lost to Follow-up|94|||
155370548|NCT00846807|560789535|FG000|Overall Study|Withdrawal by Subject|56|||
155370549|NCT00846807|560789535|FG000|Overall Study|Non compliant with European label|7|||
155370550|NCT00846807|560789535|FG000|Overall Study|Switch to other anticoagulants|89|||
155370551|NCT00846807|560789535|FG000|Overall Study|No prescription after hospital discharge|56|||
155370552|NCT00846807|560789535|FG000|Overall Study|Other|60|||
155370553|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
155370554|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
155370555|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
155370556|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
155370557|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
155370558|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
155370559|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
155370560|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
155370561|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
155370562|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
155370563|NCT00245960|560789536|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
155370564|NCT00245960|560789537|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
155370565|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
155370566|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
155370567|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
155370568|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
155370569|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
155370570|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
155370571|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
155370572|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
155370573|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
155370574|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
155370575|NCT00245960|560789536|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
155370576|NCT00245960|560789537|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
155370577|NCT00737698|560789538|FG000|Overall Study|Withdrawal by Subject|6|||
155370578|NCT00737698|560789539|FG001|Overall Study|Withdrawal by Subject|5|||
155370579|NCT00737698|560789540|FG002|Overall Study|Withdrawal by Subject|3|||
155370580|NCT00737698|560789538|FG000|Overall Study|Death|0|||
155370581|NCT00737698|560789539|FG001|Overall Study|Death|0|||
155370582|NCT00737698|560789540|FG002|Overall Study|Death|1|||
155370583|NCT01067846|560789541|FG000|Overall Study|Lost to Follow-up|17|||
155370584|NCT01067846|560789542|FG001|Overall Study|Lost to Follow-up|19|||
155370585|NCT01067846|560789541|FG000|Overall Study|Withdrawal by Subject|1|||
155370586|NCT01067846|560789542|FG001|Overall Study|Withdrawal by Subject|0|||
155370587|NCT01067846|560789541|FG000|Overall Study|participation in other tx study|1|||
155370588|NCT01067846|560789542|FG001|Overall Study|participation in other tx study|0|||
155370589|NCT02817906|560789543|FG000|Overall Study|Adverse Event|3|||
155370590|NCT02817906|560789544|FG001|Overall Study|Adverse Event|0|||
155370591|NCT02817906|560789543|FG000|Overall Study|Lack of Efficacy|1|||
155370592|NCT02817906|560789544|FG001|Overall Study|Lack of Efficacy|0|||
155370593|NCT02817906|560789543|FG000|Overall Study|Protocol Violation|1|||
155370594|NCT02817906|560789544|FG001|Overall Study|Protocol Violation|1|||
155370595|NCT02817906|560789543|FG000|Overall Study|Study Terminated by Sponsor|2|||
155370596|NCT02817906|560789544|FG001|Overall Study|Study Terminated by Sponsor|2|||
155370597|NCT02817906|560789543|FG000|Overall Study|Withdrawal by Subject|7|||
155370598|NCT02817906|560789544|FG001|Overall Study|Withdrawal by Subject|0|||
155370599|NCT02817906|560789543|FG000|Overall Study|Other|2|||
155370600|NCT02817906|560789544|FG001|Overall Study|Other|2|||
155370601|NCT03686423|560789553|FG000|Overall Study|Withdrawal by Subject|9|||
155370602|NCT03686423|560789553|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
155370603|NCT02833077|560789554|FG000|Overall Study|Adverse Event|1|||
155370604|NCT02833077|560789555|FG001|Overall Study|Adverse Event|2|||
155370605|NCT02833077|560789554|FG000|Overall Study|Lost to Follow-up|10|||
155370606|NCT02833077|560789555|FG001|Overall Study|Lost to Follow-up|1|||
155370607|NCT02833077|560789554|FG000|Overall Study|Personal Reasons|6|||
155370608|NCT02833077|560789555|FG001|Overall Study|Personal Reasons|4|||
155370609|NCT02833077|560789554|FG000|Overall Study|Protocol Deviation|0|||
155370610|NCT02833077|560789555|FG001|Overall Study|Protocol Deviation|1|||
155370611|NCT00316017|560789558|FG000|Overall Study|Protocol Violation|11|||
155370612|NCT00316017|560789559|FG001|Overall Study|Protocol Violation|13|||
155370613|NCT00316017|560789560|FG002|Overall Study|Protocol Violation|19|||
155370614|NCT04157400|560789561|FG000|Overall Study|Withdrawal by Subject|1|||
155370615|NCT04157400|560789561|FG000|Overall Study|Lost to Follow-up|3|||
155370616|NCT04201262|560789563|FG000|Primary Treatment Period|Adverse Event|1|||
155370617|NCT04201262|560789564|FG001|Primary Treatment Period|Adverse Event|2|||
155370618|NCT04201262|560789563|FG000|Primary Treatment Period|Physician Decision|1|||
155370619|NCT04201262|560789564|FG001|Primary Treatment Period|Physician Decision|1|||
155370620|NCT04201262|560789563|FG000|Long-term Extension Period|Death|1|||
155370621|NCT04201262|560789564|FG001|Long-term Extension Period|Death|0|||
155370622|NCT05718466|560790417|FG000|Overall Study|Withdrawal by Subject|1|||
155370623|NCT05718466|560790418|FG001|Overall Study|Withdrawal by Subject|2|||
155370624|NCT05718466|560790417|FG000|Overall Study|Death|0|||
155370625|NCT05718466|560790418|FG001|Overall Study|Death|1|||
155370626|NCT01253135|560790419|FG000|Original Protocol|Protocol Amendment|15|||
155370627|NCT01253135|560790419|FG000|Amended Protocol|Non-compliance|1|||
155370628|NCT00833261|560790426|FG000|Overall Study|Withdrawal by Subject|4|||
155370629|NCT03339245|560790436|FG000|Overall Study|Adverse Event|1|||
155370630|NCT03339245|560790437|FG001|Overall Study|Adverse Event|1|||
155370631|NCT03339245|560790436|FG000|Overall Study|Withdrawal by Subject|1|||
155370632|NCT03339245|560790437|FG001|Overall Study|Withdrawal by Subject|0|||
155370633|NCT00288639|560790440|FG000|Overall Study|Adverse Event|5|||
155370634|NCT00288639|560790440|FG000|Overall Study|Lack of Efficacy|4|||
155370635|NCT00288639|560790440|FG000|Overall Study|Withdrawal by Subject|2|||
155370636|NCT00288639|560790440|FG000|Overall Study|Other|1|||
155370637|NCT02815579|560790441|FG000|Overall Study|Non-payment of loan down-payment|16|||
155370638|NCT02815579|560790442|FG001|Overall Study|Non-payment of loan down-payment|0|||
155370639|NCT02815579|560790441|FG000|Overall Study|Withdrawal by Subject|7|||
155370640|NCT02815579|560790442|FG001|Overall Study|Withdrawal by Subject|1|||
155370641|NCT02815579|560790441|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
155370642|NCT02815579|560790442|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
155370643|NCT02815579|560790441|FG000|Overall Study|Lost to Follow-up|7|||
155370644|NCT02815579|560790442|FG001|Overall Study|Lost to Follow-up|4|||
155370645|NCT02815579|560790441|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
155370646|NCT02815579|560790442|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
155370647|NCT02815579|560790441|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
155370648|NCT02815579|560790442|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
155370649|NCT02815579|560790441|FG000|Overall Study|Death|5|||
155370650|NCT02815579|560790442|FG001|Overall Study|Death|4|||
155370651|NCT02815579|560790441|FG000|Overall Study|Imprisoned|0|||
155370652|NCT02815579|560790442|FG001|Overall Study|Imprisoned|2|||
155370653|NCT02815579|560790441|FG000|Overall Study|Did not meet enrollment criteria|0|||
155370654|NCT02815579|560790442|FG001|Overall Study|Did not meet enrollment criteria|1|||
155370655|NCT02389452|560790443|FG000|Overall Study|Lost to Follow-up|13|||
155370656|NCT02389452|560790443|FG000|Overall Study|Adverse Event|1|||
155370657|NCT02389452|560790443|FG000|Overall Study|Withdrawal by Subject|5|||
155370658|NCT02389452|560790443|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
155370659|NCT01014208|560790449|FG000|Overall Study|Lost to Follow-up|2|||
155370660|NCT01014208|560790450|FG001|Overall Study|Lost to Follow-up|5|||
155370661|NCT01014208|560790449|FG000|Overall Study|Participant Withdrew Consent|12|||
155370662|NCT01014208|560790450|FG001|Overall Study|Participant Withdrew Consent|12|||
155370663|NCT01014208|560790449|FG000|Overall Study|Did Not Receive Study Drug|2|||
155370664|NCT01014208|560790450|FG001|Overall Study|Did Not Receive Study Drug|0|||
155370665|NCT01014208|560790449|FG000|Overall Study|Study Closed/terminated|78|||
155370666|NCT01014208|560790450|FG001|Overall Study|Study Closed/terminated|83|||
155370667|NCT00414908|560790453|FG000|Overall Study|Protocol Violation|1|||
155370668|NCT00414908|560790454|FG001|Overall Study|Protocol Violation|1|||
155370669|NCT01076153|560790455|FG000|Overall Study|Symptoms improved/resolved|10|||
155370670|NCT01076153|560790455|FG000|Overall Study|Adverse Event|1|||
155370671|NCT00567567|560790464|FG000|Overall Study|Adverse Event|0|||
155370672|NCT00567567|560790465|FG001|Overall Study|Adverse Event|2|||
155370673|NCT00567567|560790466|FG002|Overall Study|Adverse Event|5|||
155370674|NCT00567567|560790464|FG000|Overall Study|Death|8|||
155370675|NCT00567567|560790465|FG001|Overall Study|Death|1|||
155370676|NCT00567567|560790466|FG002|Overall Study|Death|5|||
155370677|NCT00567567|560790464|FG000|Overall Study|Lack of Efficacy|16|||
155370678|NCT00567567|560790465|FG001|Overall Study|Lack of Efficacy|17|||
155370679|NCT00567567|560790466|FG002|Overall Study|Lack of Efficacy|48|||
155370680|NCT00567567|560790464|FG000|Overall Study|Lost to Follow-up|0|||
155370681|NCT00567567|560790465|FG001|Overall Study|Lost to Follow-up|0|||
155370682|NCT00567567|560790466|FG002|Overall Study|Lost to Follow-up|1|||
155370683|NCT00567567|560790464|FG000|Overall Study|Physician Decision|16|||
155370684|NCT00567567|560790465|FG001|Overall Study|Physician Decision|18|||
155370685|NCT00567567|560790466|FG002|Overall Study|Physician Decision|84|||
155370686|NCT00567567|560790464|FG000|Overall Study|Withdrawal by Subject|0|||
155370687|NCT00567567|560790465|FG001|Overall Study|Withdrawal by Subject|0|||
155167107|NCT01621802|560049381|FG002|Overall Study|Protocol Violation|0|||
155370688|NCT00567567|560790466|FG002|Overall Study|Withdrawal by Subject|2|||
155370689|NCT00567567|560790464|FG000|Overall Study|Ineligible|4|||
155370690|NCT00567567|560790465|FG001|Overall Study|Ineligible|0|||
155370691|NCT00567567|560790466|FG002|Overall Study|Ineligible|9|||
155370692|NCT00567567|560790464|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
155370693|NCT00567567|560790465|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
155370694|NCT00567567|560790466|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
155370695|NCT00567567|560790464|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
155370696|NCT00567567|560790465|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
155370697|NCT00567567|560790466|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
155370698|NCT00567567|560790464|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
155370699|NCT00567567|560790465|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
155370700|NCT00567567|560790466|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
155370701|NCT03433677|560790467|FG000|Period 1|Protocol Violation|1|||
155370702|NCT03433677|560790468|FG001|Period 1|Protocol Violation|0|||
155370703|NCT03433677|560790467|FG000|Period 2|Withdrawal by Subject|1|||
155370704|NCT03433677|560790468|FG001|Period 2|Withdrawal by Subject|1|||
155370705|NCT00608868|560790471|FG000|Overall Study|Withdrawal by Subject|7|||
155370706|NCT00608868|560790471|FG000|Overall Study|Protocol Violation|3|||
155370707|NCT00608868|560790471|FG000|Overall Study|Lost to Follow-up|2|||
155370708|NCT00608868|560790471|FG000|Overall Study|Adverse Event|1|||
155370709|NCT00608868|560790471|FG000|Overall Study|Physician Decision|2|||
155370710|NCT02440425|560790477|FG000|Overall Study|Death likely due to disease progression|1|||
155370711|NCT02440425|560790477|FG000|Overall Study|Withdrawal by Subject|2|||
155370712|NCT02440425|560790477|FG000|Overall Study|Adverse Event|1|||
155370713|NCT02440425|560790477|FG000|Overall Study|Adverse Event/Ineligible|1|||
155370714|NCT04145700|560790482|FG000|Overall Study|Withdrawal by Subject|8|||
155370715|NCT04145700|560790483|FG001|Overall Study|Withdrawal by Subject|3|||
155370716|NCT00780559|560790486|FG000|Overall Study|Lost to Follow-up|2|||
155370717|NCT00780559|560790487|FG001|Overall Study|Lost to Follow-up|7|||
155370718|NCT00780559|560790486|FG000|Overall Study|Death|1|||
155370719|NCT00780559|560790487|FG001|Overall Study|Death|0|||
155370720|NCT01840410|560790492|FG000|Overall Study|Physician Decision|1|||
155370721|NCT01840410|560790493|FG001|Overall Study|Physician Decision|2|||
155370722|NCT01840410|560790492|FG000|Overall Study|Pregnancy|1|||
155370723|NCT01840410|560790493|FG001|Overall Study|Pregnancy|0|||
155370724|NCT01840410|560790492|FG000|Overall Study|Protocol deviation|1|||
155370725|NCT01840410|560790493|FG001|Overall Study|Protocol deviation|0|||
155370726|NCT01840410|560790492|FG000|Overall Study|Lost to Follow-up|1|||
155370727|NCT01840410|560790493|FG001|Overall Study|Lost to Follow-up|0|||
155370728|NCT01840410|560790492|FG000|Overall Study|Withdrawal by Subject|2|||
155370729|NCT01840410|560790493|FG001|Overall Study|Withdrawal by Subject|1|||
155370730|NCT01840410|560790492|FG000|Overall Study|Adverse Event|1|||
155370731|NCT01840410|560790493|FG001|Overall Study|Adverse Event|1|||
155370732|NCT00839956|560790494|FG000|Overall Study|Adverse Event|2|||
155370733|NCT00839956|560790494|FG000|Overall Study|Lack of Efficacy|6|||
155370734|NCT00839956|560790494|FG000|Overall Study|Physician Decision|1|||
155370735|NCT00839956|560790494|FG000|Overall Study|Withdrawal by Subject|3|||
155370736|NCT00972322|560790495|FG000|Overall Study|Adverse Event|2|||
155370737|NCT00972322|560790496|FG001|Overall Study|Adverse Event|1|||
155370738|NCT00972322|560790495|FG000|Overall Study|Positive drug screen|0|||
155370739|NCT00972322|560790496|FG001|Overall Study|Positive drug screen|1|||
155370740|NCT00972322|560790495|FG000|Overall Study|Lost to Follow-up|0|||
155370741|NCT00972322|560790496|FG001|Overall Study|Lost to Follow-up|1|||
155370742|NCT00972322|560790495|FG000|Overall Study|Consistently high glucose values|1|||
155370743|NCT00972322|560790496|FG001|Overall Study|Consistently high glucose values|0|||
155370744|NCT03682185|560790499|FG000|Overall Study|Lost to Follow-up|4|||
155370745|NCT03682185|560790500|FG001|Overall Study|Lost to Follow-up|7|||
155370746|NCT03682185|560790501|FG002|Overall Study|Lost to Follow-up|4|||
155370747|NCT03682185|560790502|FG003|Overall Study|Lost to Follow-up|7|||
155370748|NCT03682185|560790503|FG004|Overall Study|Lost to Follow-up|1|||
155370749|NCT03682185|560790499|FG000|Overall Study|Withdrawal by Subject|7|||
155370750|NCT03682185|560790500|FG001|Overall Study|Withdrawal by Subject|3|||
155370751|NCT03682185|560790501|FG002|Overall Study|Withdrawal by Subject|7|||
155370752|NCT03682185|560790502|FG003|Overall Study|Withdrawal by Subject|3|||
155370753|NCT03682185|560790503|FG004|Overall Study|Withdrawal by Subject|0|||
155370754|NCT03548220|560790505|FG000|Overall Study|Lost to Follow-up|1|||
155370755|NCT03548220|560790506|FG001|Overall Study|Lost to Follow-up|0|||
155370756|NCT03548220|560790507|FG002|Overall Study|Lost to Follow-up|0|||
155370757|NCT03548220|560790508|FG003|Overall Study|Lost to Follow-up|0|||
155370758|NCT03853551|560791914|FG000|Overall Study|Death|2|||
155370759|NCT03853551|560791914|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
155370760|NCT01075958|560791917|FG000|Overall Study|Blood sample could not be obtained|44|||
155370761|NCT01240915|560791920|FG000|Overall Study|Adverse Event|0|||
155370762|NCT01240915|560791921|FG001|Overall Study|Adverse Event|0|||
155370763|NCT01240915|560791922|FG002|Overall Study|Adverse Event|0|||
155370764|NCT01240915|560791923|FG003|Overall Study|Adverse Event|1|||
155370765|NCT01240915|560791924|FG004|Overall Study|Adverse Event|0|||
155370766|NCT01240915|560791925|FG005|Overall Study|Adverse Event|2|||
155370767|NCT01240915|560791926|FG006|Overall Study|Adverse Event|0|||
155370768|NCT01240915|560791927|FG007|Overall Study|Adverse Event|0|||
155370769|NCT01240915|560791928|FG008|Overall Study|Adverse Event|1|||
155370770|NCT01240915|560791920|FG000|Overall Study|Lost to Follow-up|0|||
155370771|NCT01240915|560791921|FG001|Overall Study|Lost to Follow-up|0|||
155370772|NCT01240915|560791922|FG002|Overall Study|Lost to Follow-up|0|||
155370773|NCT01240915|560791923|FG003|Overall Study|Lost to Follow-up|0|||
155370774|NCT01240915|560791924|FG004|Overall Study|Lost to Follow-up|1|||
155370775|NCT01240915|560791925|FG005|Overall Study|Lost to Follow-up|1|||
155370776|NCT01240915|560791926|FG006|Overall Study|Lost to Follow-up|0|||
155370777|NCT01240915|560791927|FG007|Overall Study|Lost to Follow-up|1|||
155370778|NCT01240915|560791928|FG008|Overall Study|Lost to Follow-up|1|||
155370779|NCT01240915|560791920|FG000|Overall Study|Withdrawal by Subject|2|||
155370780|NCT01240915|560791921|FG001|Overall Study|Withdrawal by Subject|1|||
155370781|NCT01240915|560791922|FG002|Overall Study|Withdrawal by Subject|0|||
155370782|NCT01240915|560791923|FG003|Overall Study|Withdrawal by Subject|2|||
155370783|NCT01240915|560791924|FG004|Overall Study|Withdrawal by Subject|0|||
155370784|NCT01240915|560791925|FG005|Overall Study|Withdrawal by Subject|4|||
155370785|NCT01240915|560791926|FG006|Overall Study|Withdrawal by Subject|2|||
155370786|NCT01240915|560791927|FG007|Overall Study|Withdrawal by Subject|3|||
155370787|NCT01240915|560791928|FG008|Overall Study|Withdrawal by Subject|3|||
155370788|NCT01240915|560791920|FG000|Overall Study|Other|0|||
155370789|NCT01240915|560791921|FG001|Overall Study|Other|0|||
155370790|NCT01240915|560791922|FG002|Overall Study|Other|0|||
155370791|NCT01240915|560791923|FG003|Overall Study|Other|0|||
155370792|NCT01240915|560791924|FG004|Overall Study|Other|2|||
155370793|NCT01240915|560791925|FG005|Overall Study|Other|0|||
155370794|NCT01240915|560791926|FG006|Overall Study|Other|0|||
155370795|NCT01240915|560791927|FG007|Overall Study|Other|0|||
155370796|NCT01240915|560791928|FG008|Overall Study|Other|0|||
154965598|NCT00112437|559298876|FG014|Year 2 (12-Month Extension)|Moved|0|||
154965599|NCT00112437|559298877|FG015|Year 2 (12-Month Extension)|Moved|0|||
154965600|NCT00112437|559298878|FG016|Year 2 (12-Month Extension)|Moved|0|||
155370797|NCT01240915|560791920|FG000|Overall Study|Insufficient Clinical Response|0|||
155370798|NCT01240915|560791921|FG001|Overall Study|Insufficient Clinical Response|0|||
155370799|NCT01240915|560791922|FG002|Overall Study|Insufficient Clinical Response|0|||
155370800|NCT01240915|560791923|FG003|Overall Study|Insufficient Clinical Response|0|||
155370801|NCT01240915|560791924|FG004|Overall Study|Insufficient Clinical Response|1|||
155370802|NCT01240915|560791925|FG005|Overall Study|Insufficient Clinical Response|3|||
155370803|NCT01240915|560791926|FG006|Overall Study|Insufficient Clinical Response|6|||
155370804|NCT01240915|560791927|FG007|Overall Study|Insufficient Clinical Response|0|||
155370805|NCT01240915|560791928|FG008|Overall Study|Insufficient Clinical Response|3|||
155370806|NCT02574845|560791932|FG000|Overall Study|Consent withdrawn further participation|0|||
155370807|NCT02574845|560791933|FG001|Overall Study|Consent withdrawn further participation|0|||
155370808|NCT02574845|560791934|FG002|Overall Study|Consent withdrawn further participation|0|||
155370809|NCT02574845|560791935|FG003|Overall Study|Consent withdrawn further participation|0|||
154965601|NCT00112437|559298879|FG017|Year 2 (12-Month Extension)|Moved|0|||
155370810|NCT02574845|560791936|FG004|Overall Study|Consent withdrawn further participation|1|||
155370811|NCT02574845|560791937|FG005|Overall Study|Consent withdrawn further participation|0|||
155370812|NCT02574845|560791932|FG000|Overall Study|Adverse Event|0|||
155370813|NCT02574845|560791933|FG001|Overall Study|Adverse Event|1|||
155370814|NCT02574845|560791934|FG002|Overall Study|Adverse Event|0|||
155370815|NCT02574845|560791935|FG003|Overall Study|Adverse Event|0|||
155370816|NCT02574845|560791936|FG004|Overall Study|Adverse Event|0|||
155370817|NCT02574845|560791937|FG005|Overall Study|Adverse Event|1|||
155370818|NCT01867333|560791940|FG000|Overall Study|Withdrawal by Subject|1|||
155370819|NCT01867333|560791941|FG001|Overall Study|Withdrawal by Subject|0|||
155370820|NCT01867333|560791940|FG000|Overall Study|Adverse Event|1|||
155370821|NCT01867333|560791941|FG001|Overall Study|Adverse Event|0|||
155370822|NCT01867333|560791940|FG000|Overall Study|Participant choice|1|||
155370823|NCT01867333|560791941|FG001|Overall Study|Participant choice|2|||
155370824|NCT01867333|560791940|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
155370825|NCT01867333|560791941|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
155370826|NCT01867333|560791940|FG000|Overall Study|Death|0|||
155370827|NCT01867333|560791941|FG001|Overall Study|Death|1|||
155370828|NCT01867333|560791940|FG000|Overall Study|Physician Decision|3|||
155370829|NCT01867333|560791941|FG001|Overall Study|Physician Decision|2|||
155370830|NCT01867333|560791940|FG000|Overall Study|Switched to alternative treatment|1|||
155370831|NCT01867333|560791941|FG001|Overall Study|Switched to alternative treatment|0|||
155370832|NCT03101462|560791942|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
155370833|NCT03101462|560791943|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
155370834|NCT01696045|560791948|FG000|Overall Study|Study drug toxicity|1|||
155370835|NCT01696045|560791949|FG001|Overall Study|Study drug toxicity|5|||
155370836|NCT01696045|560791948|FG000|Overall Study|Disease progression|2|||
155370837|NCT01696045|560791949|FG001|Overall Study|Disease progression|2|||
155370838|NCT01559129|560791950|FG000|Treatment Phase|Adverse Event|0|||
155370839|NCT01559129|560791951|FG001|Treatment Phase|Adverse Event|2|||
155370840|NCT01559129|560791950|FG000|Treatment Phase|Progressive Disease|1|||
155370841|NCT01559129|560791951|FG001|Treatment Phase|Progressive Disease|1|||
155370842|NCT01559129|560791950|FG000|Treatment Phase|Lack of Efficacy|0|||
155370843|NCT01559129|560791951|FG001|Treatment Phase|Lack of Efficacy|1|||
155370844|NCT01559129|560791950|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
155370845|NCT01559129|560791951|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
155370846|NCT01559129|560791950|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
155370847|NCT01559129|560791951|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
155370848|NCT01559129|560791950|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
155370849|NCT01559129|560791951|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
155370850|NCT01559129|560791950|FG000|Open-label Extension Period|Adverse Event|1|||
155370851|NCT01559129|560791951|FG001|Open-label Extension Period|Adverse Event|0|||
155370852|NCT01559129|560791950|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
155370853|NCT01559129|560791951|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
154965602|NCT00112437|559298880|FG018|Year 2 (12-Month Extension)|Moved|0|||
155370854|NCT03525392|560791952|FG000|Overall Study|Adverse Event|1|||
155370855|NCT03525392|560791953|FG001|Overall Study|Adverse Event|0|||
155370856|NCT03525392|560791954|FG002|Overall Study|Adverse Event|2|||
154965603|NCT00112437|559298881|FG019|Year 2 (12-Month Extension)|Moved|0|||
154965604|NCT00112437|559298882|FG020|Year 2 (12-Month Extension)|Moved|0|||
154965605|NCT00112437|559298883|FG021|Year 2 (12-Month Extension)|Moved|0|||
154965606|NCT00112437|559298884|FG022|Year 2 (12-Month Extension)|Moved|0|||
154965607|NCT00112437|559298885|FG023|Year 2 (12-Month Extension)|Moved|0|||
154965608|NCT00112437|559298886|FG024|Year 2 (12-Month Extension)|Moved|0|||
154965609|NCT00112437|559298887|FG025|Year 2 (12-Month Extension)|Moved|0|||
154965610|NCT00112437|559298862|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
154965611|NCT00112437|559298863|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
154965612|NCT00112437|559298864|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
154965613|NCT00112437|559298865|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
154965614|NCT00112437|559298866|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
154965615|NCT00112437|559298867|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
154965616|NCT00112437|559298868|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
154965617|NCT00112437|559298869|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
154965618|NCT00112437|559298870|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
155090471|NCT01467466|559763661|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
155090472|NCT01467466|559763662|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
155090473|NCT01467466|559763659|FG000|Overall Study|Procedure Cancelled|46|||
155090474|NCT01467466|559763660|FG001|Overall Study|Procedure Cancelled|45|||
155090475|NCT01467466|559763661|FG002|Overall Study|Procedure Cancelled|25|||
155090476|NCT01467466|559763662|FG003|Overall Study|Procedure Cancelled|29|||
155090477|NCT01467466|559763659|FG000|Overall Study|No Endpoint Blood Draw|38|||
155090478|NCT01467466|559763660|FG001|Overall Study|No Endpoint Blood Draw|32|||
155090479|NCT01467466|559763661|FG002|Overall Study|No Endpoint Blood Draw|51|||
155090480|NCT01467466|559763662|FG003|Overall Study|No Endpoint Blood Draw|43|||
155090481|NCT00982280|559763671|FG000|Observation Period|Not eligible to be dosed|19|||
155090482|NCT00982280|559763671|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
155090483|NCT00982280|559763671|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
155370857|NCT03525392|560791955|FG003|Overall Study|Adverse Event|0|||
155370858|NCT03525392|560791956|FG004|Overall Study|Adverse Event|0|||
155370859|NCT03525392|560791952|FG000|Overall Study|Progressive disease|0|||
155370860|NCT03525392|560791953|FG001|Overall Study|Progressive disease|1|||
155370861|NCT03525392|560791954|FG002|Overall Study|Progressive disease|1|||
155167108|NCT01621802|560049382|FG003|Overall Study|Protocol Violation|0|||
155167109|NCT01621802|560049383|FG004|Overall Study|Protocol Violation|0|||
155167110|NCT01621802|560049384|FG005|Overall Study|Protocol Violation|1|||
155167111|NCT01621802|560049379|FG000|Overall Study|Withdrawal by Subject|8|||
155167112|NCT01621802|560049380|FG001|Overall Study|Withdrawal by Subject|4|||
155167113|NCT01621802|560049381|FG002|Overall Study|Withdrawal by Subject|4|||
155167114|NCT01621802|560049382|FG003|Overall Study|Withdrawal by Subject|2|||
155167115|NCT01621802|560049383|FG004|Overall Study|Withdrawal by Subject|2|||
155167116|NCT01621802|560049384|FG005|Overall Study|Withdrawal by Subject|0|||
155167117|NCT01621802|560049379|FG000|Overall Study|Migrated/moved from study area|0|||
155167118|NCT01621802|560049380|FG001|Overall Study|Migrated/moved from study area|0|||
155167119|NCT01621802|560049381|FG002|Overall Study|Migrated/moved from study area|2|||
155167120|NCT01621802|560049382|FG003|Overall Study|Migrated/moved from study area|0|||
155167121|NCT01621802|560049383|FG004|Overall Study|Migrated/moved from study area|1|||
155167122|NCT01621802|560049384|FG005|Overall Study|Migrated/moved from study area|0|||
155167123|NCT01621802|560049379|FG000|Overall Study|Others|3|||
155167124|NCT01621802|560049380|FG001|Overall Study|Others|3|||
155167125|NCT01621802|560049381|FG002|Overall Study|Others|3|||
155167126|NCT01621802|560049382|FG003|Overall Study|Others|2|||
155167127|NCT01621802|560049383|FG004|Overall Study|Others|1|||
155167128|NCT01621802|560049384|FG005|Overall Study|Others|0|||
155167129|NCT01621802|560049379|FG000|Overall Study|Lost to Follow-up|36|||
155167130|NCT01621802|560049380|FG001|Overall Study|Lost to Follow-up|16|||
155167131|NCT01621802|560049381|FG002|Overall Study|Lost to Follow-up|24|||
155167132|NCT01621802|560049382|FG003|Overall Study|Lost to Follow-up|7|||
155167133|NCT01621802|560049383|FG004|Overall Study|Lost to Follow-up|31|||
155167134|NCT01621802|560049384|FG005|Overall Study|Lost to Follow-up|11|||
155167135|NCT01149148|560049385|FG000|Overall Study|Lost to Follow-up|1|||
155167136|NCT01149148|560049386|FG001|Overall Study|Lost to Follow-up|2|||
155167137|NCT01149148|560049385|FG000|Overall Study|Death|1|||
155167138|NCT01149148|560049386|FG001|Overall Study|Death|0|||
155167139|NCT03436082|560049387|FG000|Overall Study|Did not undergo procedure|1|||
155167140|NCT03436082|560049388|FG001|Overall Study|Did not undergo procedure|0|||
155167141|NCT04896086|560049389|FG000|Overall Study|Lost to Follow-up|0|||
155167142|NCT04896086|560049390|FG001|Overall Study|Lost to Follow-up|2|||
155167143|NCT04896086|560049391|FG002|Overall Study|Lost to Follow-up|1|||
155167144|NCT04896086|560049392|FG003|Overall Study|Lost to Follow-up|0|||
155167145|NCT04896086|560049393|FG004|Overall Study|Lost to Follow-up|0|||
155167146|NCT04896086|560049389|FG000|Overall Study|Physician Decision|0|||
155167147|NCT04896086|560049390|FG001|Overall Study|Physician Decision|1|||
155167148|NCT04896086|560049391|FG002|Overall Study|Physician Decision|0|||
155167149|NCT04896086|560049392|FG003|Overall Study|Physician Decision|0|||
155167150|NCT04896086|560049393|FG004|Overall Study|Physician Decision|0|||
155167151|NCT04896086|560049389|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155167152|NCT04896086|560049390|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155167153|NCT04896086|560049391|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155167154|NCT04896086|560049392|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
155167155|NCT04896086|560049393|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
155167156|NCT04896086|560049389|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
155167157|NCT04896086|560049390|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
155167158|NCT04896086|560049391|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
155167159|NCT04896086|560049392|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
155167160|NCT04896086|560049393|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
155167161|NCT02249832|560049396|FG000|Overall Study|Withdrawal by Subject|3|||
155167162|NCT02249832|560049396|FG000|Overall Study|Lost to Follow-up|10|||
155167163|NCT02078960|560049399|FG000|Treatment Period|Other|0|||
155167164|NCT02078960|560049400|FG001|Treatment Period|Other|0|||
155167165|NCT02078960|560049401|FG002|Treatment Period|Other|1|||
155167166|NCT02078960|560049399|FG000|Treatment Period|Lack of Efficacy|0|||
155167167|NCT02078960|560049400|FG001|Treatment Period|Lack of Efficacy|1|||
155167168|NCT02078960|560049401|FG002|Treatment Period|Lack of Efficacy|0|||
155167169|NCT02078960|560049399|FG000|Treatment Period|Disease progression - accelerated phase|0|||
155167170|NCT02078960|560049400|FG001|Treatment Period|Disease progression - accelerated phase|1|||
155167171|NCT02078960|560049401|FG002|Treatment Period|Disease progression - accelerated phase|0|||
155167172|NCT02078960|560049399|FG000|Treatment Period|Disease progression - blast phase|1|||
155167173|NCT02078960|560049400|FG001|Treatment Period|Disease progression - blast phase|0|||
155167174|NCT02078960|560049401|FG002|Treatment Period|Disease progression - blast phase|0|||
155167175|NCT02078960|560049399|FG000|Treatment Period|Withdrawal by Subject|0|||
155167176|NCT02078960|560049400|FG001|Treatment Period|Withdrawal by Subject|1|||
155167177|NCT02078960|560049401|FG002|Treatment Period|Withdrawal by Subject|1|||
155167178|NCT02078960|560049399|FG000|Treatment Period|Adverse Event|1|||
155167179|NCT02078960|560049400|FG001|Treatment Period|Adverse Event|0|||
155167180|NCT02078960|560049401|FG002|Treatment Period|Adverse Event|0|||
155167181|NCT02078960|560049399|FG000|Treatment Period|Death|0|||
155167182|NCT02078960|560049400|FG001|Treatment Period|Death|0|||
155167183|NCT02078960|560049401|FG002|Treatment Period|Death|1|||
155167184|NCT02078960|560049399|FG000|Follow-up Period|Death|2|||
155167185|NCT02078960|560049400|FG001|Follow-up Period|Death|0|||
155167186|NCT02078960|560049401|FG002|Follow-up Period|Death|0|||
155167187|NCT02078960|560049399|FG000|Follow-up Period|Lost to Follow-up|0|||
155167188|NCT02078960|560049400|FG001|Follow-up Period|Lost to Follow-up|1|||
155167189|NCT02078960|560049401|FG002|Follow-up Period|Lost to Follow-up|0|||
155167190|NCT00859638|560049402|FG000|Overall Study|Lost to Follow-up|6|||
155167191|NCT00859638|560049403|FG001|Overall Study|Lost to Follow-up|1|||
155167192|NCT00859638|560049402|FG000|Overall Study|Withdrawal by Subject|3|||
155167193|NCT00859638|560049403|FG001|Overall Study|Withdrawal by Subject|2|||
155167194|NCT00859638|560049402|FG000|Overall Study|Ill health|1|||
155167195|NCT00859638|560049403|FG001|Overall Study|Ill health|1|||
155167196|NCT04643158|560049407|FG000|Overall Study|Study terminated by sponsor|0|||
155167197|NCT04643158|560049408|FG001|Overall Study|Study terminated by sponsor|0|||
155167198|NCT04643158|560049409|FG002|Overall Study|Study terminated by sponsor|1|||
155167199|NCT04643158|560049410|FG003|Overall Study|Study terminated by sponsor|0|||
155167200|NCT04643158|560049411|FG004|Overall Study|Study terminated by sponsor|0|||
155167201|NCT04643158|560049412|FG005|Overall Study|Study terminated by sponsor|1|||
155167202|NCT04643158|560049413|FG006|Overall Study|Study terminated by sponsor|0|||
155167203|NCT04643158|560049407|FG000|Overall Study|Global/country situation|0|||
155167204|NCT04643158|560049408|FG001|Overall Study|Global/country situation|0|||
155167205|NCT04643158|560049409|FG002|Overall Study|Global/country situation|1|||
155167206|NCT04643158|560049410|FG003|Overall Study|Global/country situation|0|||
155167207|NCT04643158|560049411|FG004|Overall Study|Global/country situation|0|||
155167208|NCT04643158|560049412|FG005|Overall Study|Global/country situation|0|||
155167209|NCT04643158|560049413|FG006|Overall Study|Global/country situation|0|||
155167210|NCT04643158|560049407|FG000|Overall Study|Withdrawal by Subject|0|||
155167211|NCT04643158|560049408|FG001|Overall Study|Withdrawal by Subject|0|||
155167212|NCT04643158|560049409|FG002|Overall Study|Withdrawal by Subject|0|||
155167213|NCT04643158|560049410|FG003|Overall Study|Withdrawal by Subject|0|||
155167214|NCT04643158|560049411|FG004|Overall Study|Withdrawal by Subject|0|||
155167215|NCT04643158|560049412|FG005|Overall Study|Withdrawal by Subject|1|||
155167216|NCT04643158|560049413|FG006|Overall Study|Withdrawal by Subject|0|||
155167217|NCT00622440|560049426|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
155167218|NCT00622440|560049427|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
155167219|NCT00622440|560049426|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
155167220|NCT00622440|560049427|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
155167221|NCT00622440|560049426|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
155167222|NCT00622440|560049427|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
155167223|NCT00622440|560049426|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
155167224|NCT00622440|560049427|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
155167225|NCT00771953|560049430|FG000|Overall Study|Adverse Event|5|||
155167226|NCT00771953|560049431|FG001|Overall Study|Adverse Event|3|||
155167227|NCT00771953|560049430|FG000|Overall Study|Death|2|||
155167228|NCT00771953|560049431|FG001|Overall Study|Death|2|||
155167229|NCT00771953|560049430|FG000|Overall Study|Progression before active Tx|1|||
155167230|NCT00771953|560049431|FG001|Overall Study|Progression before active Tx|2|||
155167231|NCT00771953|560049430|FG000|Overall Study|Sponsor decision|1|||
155167232|NCT00771953|560049431|FG001|Overall Study|Sponsor decision|0|||
155167233|NCT00771953|560049430|FG000|Overall Study|Other complicating disease|1|||
155167234|NCT00771953|560049431|FG001|Overall Study|Other complicating disease|0|||
155167235|NCT00771953|560049430|FG000|Overall Study|Withdrawal by Subject|0|||
155167236|NCT00771953|560049431|FG001|Overall Study|Withdrawal by Subject|3|||
155167237|NCT00947193|560049434|FG000|Overall Study|Lost to Follow-up|1|||
155167238|NCT00947193|560049435|FG001|Overall Study|Lost to Follow-up|0|||
155167239|NCT00947193|560049434|FG000|Overall Study|Withdrawal by Subject|1|||
155167240|NCT00947193|560049435|FG001|Overall Study|Withdrawal by Subject|0|||
155167241|NCT00947193|560049434|FG000|Overall Study|Factor VIII >1%|1|||
155167242|NCT00947193|560049435|FG001|Overall Study|Factor VIII >1%|0|||
155167243|NCT04364984|560049436|FG000|Overall Study|Death|2|||
155167244|NCT04364984|560049437|FG001|Overall Study|Death|2|||
155167245|NCT04364984|560049438|FG002|Overall Study|Death|0|||
155167246|NCT01652534|560049439|FG000|Overall Study|Lack of Efficacy|1|||
155167247|NCT01652534|560049440|FG001|Overall Study|Lack of Efficacy|0|||
155167248|NCT02722304|560049444|FG000|Overall Study|Study Terminated by Sponsor|1|||
155167249|NCT02722304|560049445|FG001|Overall Study|Study Terminated by Sponsor|0|||
155167250|NCT02722304|560049446|FG002|Overall Study|Study Terminated by Sponsor|2|||
155167251|NCT02722304|560049447|FG003|Overall Study|Study Terminated by Sponsor|1|||
155167252|NCT02722304|560049448|FG004|Overall Study|Study Terminated by Sponsor|1|||
155167253|NCT02722304|560049444|FG000|Overall Study|Other|0|||
155167254|NCT02722304|560049445|FG001|Overall Study|Other|0|||
155167255|NCT02722304|560049446|FG002|Overall Study|Other|0|||
155167256|NCT02722304|560049447|FG003|Overall Study|Other|1|||
155370862|NCT03525392|560791955|FG003|Overall Study|Progressive disease|3|||
155370863|NCT03525392|560791956|FG004|Overall Study|Progressive disease|1|||
155370864|NCT00831129|560791959|FG000|Overall Study|Adverse Event|0|||
155370865|NCT00831129|560791960|FG001|Overall Study|Adverse Event|1|||
155370866|NCT00831129|560791959|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
155370867|NCT00831129|560791960|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
155370868|NCT01669577|560791961|FG000|Overall Study|Death|22|||
155370869|NCT01669577|560791961|FG000|Overall Study|Lost to Follow-up|78|||
155370870|NCT01669577|560791961|FG000|Overall Study|Physician Decision|34|||
155370871|NCT04462289|560791964|FG000|Overall Study|Lost to Follow-up|4|||
155370872|NCT04462289|560791965|FG001|Overall Study|Lost to Follow-up|5|||
155370873|NCT04462289|560791964|FG000|Overall Study|Death|0|||
155370874|NCT04462289|560791965|FG001|Overall Study|Death|3|||
155370875|NCT04462289|560791964|FG000|Overall Study|Withdrawal by Subject|1|||
155370876|NCT04462289|560791965|FG001|Overall Study|Withdrawal by Subject|3|||
155370877|NCT00818779|560791966|FG000|Overall Study|Protocol Violation|1|||
155370878|NCT00818779|560791967|FG001|Overall Study|Protocol Violation|0|||
155370879|NCT00818779|560791966|FG000|Overall Study|Lost to Follow-up|1|||
155370880|NCT00818779|560791967|FG001|Overall Study|Lost to Follow-up|0|||
155370881|NCT00818779|560791966|FG000|Overall Study|Adverse Event|4|||
155370882|NCT00818779|560791967|FG001|Overall Study|Adverse Event|1|||
155370883|NCT01518153|560791968|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
155370884|NCT01518153|560791969|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
155370885|NCT01518153|560791970|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
155370886|NCT01518153|560791968|FG000|Stem Cell Transplant|Death|2|||
155167257|NCT02722304|560049448|FG004|Overall Study|Other|1|||
155370887|NCT01518153|560791969|FG001|Stem Cell Transplant|Death|0|||
155370888|NCT01518153|560791970|FG002|Stem Cell Transplant|Death|0|||
155370889|NCT01518153|560791968|FG000|Stem Cell Transplant|Secondary graft failure|1|||
155370890|NCT01518153|560791969|FG001|Stem Cell Transplant|Secondary graft failure|0|||
155370891|NCT01518153|560791970|FG002|Stem Cell Transplant|Secondary graft failure|0|||
155370892|NCT01518153|560791968|FG000|Stem Cell Transplant|Adverse Event|1|||
155370893|NCT01518153|560791969|FG001|Stem Cell Transplant|Adverse Event|0|||
155370894|NCT01518153|560791970|FG002|Stem Cell Transplant|Adverse Event|0|||
155370895|NCT01518153|560791968|FG000|Donor Lymphocyte Infusion|Death|0|||
155370896|NCT01518153|560791969|FG001|Donor Lymphocyte Infusion|Death|2|||
155370897|NCT01518153|560791970|FG002|Donor Lymphocyte Infusion|Death|1|||
155370898|NCT00132873|560791971|FG000|Overall Study|Adverse Event|3|||
155370899|NCT00132873|560791971|FG000|Overall Study|Lost to Follow-up|1|||
155370900|NCT00132873|560791971|FG000|Overall Study|Lack of Efficacy|1|||
154965619|NCT00112437|559298871|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
154965620|NCT00112437|559298872|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
155090484|NCT00982280|559763671|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
155090485|NCT00982280|559763671|FG000|Maintenance Period|Adverse Event|1|||
155090486|NCT04724837|559763672|FG000|Overall Study|Other|4|||
155090487|NCT04724837|559763673|FG001|Overall Study|Other|16|||
155090488|NCT04724837|559763674|FG002|Overall Study|Other|0|||
155090489|NCT04724837|559763672|FG000|Overall Study|Withdrawal by Subject|2|||
155090490|NCT04724837|559763673|FG001|Overall Study|Withdrawal by Subject|9|||
155090491|NCT04724837|559763674|FG002|Overall Study|Withdrawal by Subject|9|||
155090492|NCT04724837|559763672|FG000|Overall Study|Adverse Event|2|||
155090493|NCT04724837|559763673|FG001|Overall Study|Adverse Event|7|||
155090494|NCT04724837|559763674|FG002|Overall Study|Adverse Event|4|||
155090495|NCT04724837|559763672|FG000|Overall Study|Lost to Follow-up|0|||
155090496|NCT04724837|559763673|FG001|Overall Study|Lost to Follow-up|1|||
155090497|NCT04724837|559763674|FG002|Overall Study|Lost to Follow-up|3|||
155090498|NCT04724837|559763672|FG000|Overall Study|Physician Decision|1|||
155370901|NCT00132873|560791971|FG000|Overall Study|Withdrawal by Subject|3|||
155370902|NCT00132873|560791971|FG000|Overall Study|Planned Pregnancy|1|||
155370903|NCT04276415|560791972|FG000|Overall Study|Adverse Event|0|||
155370904|NCT04276415|560791973|FG001|Overall Study|Adverse Event|0|||
155370905|NCT04276415|560791974|FG002|Overall Study|Adverse Event|0|||
155370906|NCT04276415|560791975|FG003|Overall Study|Adverse Event|3|||
155370907|NCT04276415|560791976|FG004|Overall Study|Adverse Event|0|||
154965621|NCT00112437|559298873|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
155090499|NCT04724837|559763673|FG001|Overall Study|Physician Decision|2|||
155090500|NCT04724837|559763674|FG002|Overall Study|Physician Decision|0|||
155167258|NCT00934362|560049449|FG000|Overall Study|Adverse Event|1|||
155370908|NCT04276415|560791977|FG005|Overall Study|Adverse Event|0|||
155370909|NCT04276415|560791972|FG000|Overall Study|Clinical progression|1|||
155370910|NCT04276415|560791973|FG001|Overall Study|Clinical progression|1|||
155370911|NCT04276415|560791974|FG002|Overall Study|Clinical progression|0|||
155370912|NCT04276415|560791975|FG003|Overall Study|Clinical progression|0|||
155370913|NCT04276415|560791976|FG004|Overall Study|Clinical progression|1|||
155370914|NCT04276415|560791977|FG005|Overall Study|Clinical progression|0|||
155370915|NCT04276415|560791972|FG000|Overall Study|Other|0|||
155370916|NCT04276415|560791973|FG001|Overall Study|Other|0|||
155370917|NCT04276415|560791974|FG002|Overall Study|Other|0|||
155370918|NCT04276415|560791975|FG003|Overall Study|Other|1|||
155370919|NCT04276415|560791976|FG004|Overall Study|Other|0|||
155370920|NCT04276415|560791977|FG005|Overall Study|Other|0|||
155370921|NCT04276415|560791972|FG000|Overall Study|Physician Decision|0|||
155370922|NCT04276415|560791973|FG001|Overall Study|Physician Decision|0|||
155370923|NCT04276415|560791974|FG002|Overall Study|Physician Decision|1|||
155370924|NCT04276415|560791975|FG003|Overall Study|Physician Decision|3|||
155370925|NCT04276415|560791976|FG004|Overall Study|Physician Decision|2|||
155370926|NCT04276415|560791977|FG005|Overall Study|Physician Decision|0|||
155370927|NCT04276415|560791972|FG000|Overall Study|Progressive disease|3|||
155370928|NCT04276415|560791973|FG001|Overall Study|Progressive disease|3|||
155370929|NCT04276415|560791974|FG002|Overall Study|Progressive disease|4|||
155370930|NCT04276415|560791975|FG003|Overall Study|Progressive disease|5|||
155370931|NCT04276415|560791976|FG004|Overall Study|Progressive disease|1|||
155370932|NCT04276415|560791977|FG005|Overall Study|Progressive disease|2|||
155370933|NCT04276415|560791972|FG000|Overall Study|Withdrawal by patient|0|||
155370934|NCT04276415|560791973|FG001|Overall Study|Withdrawal by patient|0|||
155370935|NCT04276415|560791974|FG002|Overall Study|Withdrawal by patient|0|||
155370936|NCT04276415|560791975|FG003|Overall Study|Withdrawal by patient|1|||
155370937|NCT04276415|560791976|FG004|Overall Study|Withdrawal by patient|2|||
155370938|NCT04276415|560791977|FG005|Overall Study|Withdrawal by patient|0|||
155370939|NCT03309813|560791978|FG000|Main Randomized Study|Withdrawal by Subject|1|||
155370940|NCT03309813|560791979|FG001|Main Randomized Study|Withdrawal by Subject|0|||
155370941|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital status: missing)|1|||
155370942|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital status: missing)|2|||
155370943|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital status: missing)|2|||
155370944|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital status: missing)|1|||
155370945|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
155370946|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
155370947|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
155370948|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
155370949|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
155370950|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
155370951|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
155370952|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
155370953|NCT01327846|560791980|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
155370954|NCT01327846|560791981|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
155370955|NCT01327846|560791982|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
155370956|NCT01327846|560791983|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
155370957|NCT01327846|560791980|FG000|Core Phase|Lost to Follow-up|3|||
155370958|NCT01327846|560791981|FG001|Core Phase|Lost to Follow-up|3|||
155370959|NCT01327846|560791982|FG002|Core Phase|Lost to Follow-up|4|||
155370960|NCT01327846|560791983|FG003|Core Phase|Lost to Follow-up|5|||
155370961|NCT01327846|560791980|FG000|Extension Phase|Study terminated by sponsor|1073|||
155370962|NCT01327846|560791981|FG001|Extension Phase|Study terminated by sponsor|1124|||
155370963|NCT01327846|560791982|FG002|Extension Phase|Study terminated by sponsor|1067|||
155370964|NCT01327846|560791983|FG003|Extension Phase|Study terminated by sponsor|1660|||
155370965|NCT01327846|560791980|FG000|Extension Phase|Withdrawal by Subject|20|||
155370966|NCT01327846|560791981|FG001|Extension Phase|Withdrawal by Subject|13|||
155370967|NCT01327846|560791982|FG002|Extension Phase|Withdrawal by Subject|19|||
155370968|NCT01327846|560791983|FG003|Extension Phase|Withdrawal by Subject|37|||
155370969|NCT01327846|560791980|FG000|Extension Phase|Lost to Follow-up|4|||
155370970|NCT01327846|560791981|FG001|Extension Phase|Lost to Follow-up|3|||
155370971|NCT01327846|560791982|FG002|Extension Phase|Lost to Follow-up|4|||
155370972|NCT01327846|560791983|FG003|Extension Phase|Lost to Follow-up|7|||
155370973|NCT01327846|560791980|FG000|Extension Phase|Technical Problems|2|||
155370974|NCT01327846|560791981|FG001|Extension Phase|Technical Problems|4|||
155370975|NCT01327846|560791982|FG002|Extension Phase|Technical Problems|2|||
155370976|NCT01327846|560791983|FG003|Extension Phase|Technical Problems|2|||
155370977|NCT04343976|560791987|FG000|Overall Study|Withdrawal by Subject|0|||
155370978|NCT04343976|560791988|FG001|Overall Study|Withdrawal by Subject|1|||
155370979|NCT02807883|560791989|FG000|Overall Study|Withdrawal by Subject|2|||
155370980|NCT00594880|560791990|FG000|Overall Study|Withdrawal by Subject|1|||
155370981|NCT00594880|560791991|FG001|Overall Study|Withdrawal by Subject|1|||
155370982|NCT00594880|560791990|FG000|Overall Study|Lost to Follow-up|1|||
155370983|NCT00594880|560791991|FG001|Overall Study|Lost to Follow-up|0|||
155370984|NCT02206061|560791992|FG000|Overall Study|Withdrawal by Subject|4|||
155370985|NCT02206061|560791993|FG001|Overall Study|Withdrawal by Subject|7|||
155370986|NCT02206061|560791994|FG002|Overall Study|Withdrawal by Subject|1|||
155370987|NCT02206061|560791992|FG000|Overall Study|Lost to Follow-up|14|||
155370988|NCT02206061|560791993|FG001|Overall Study|Lost to Follow-up|7|||
155370989|NCT02206061|560791994|FG002|Overall Study|Lost to Follow-up|20|||
155370990|NCT04608773|560791995|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
155370991|NCT04608773|560791996|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
155370992|NCT04608773|560791995|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
155370993|NCT04608773|560791996|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
155370994|NCT04608773|560791995|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
155370995|NCT04608773|560791996|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
155090501|NCT04724837|559763672|FG000|Overall Study|Death|0|||
155090502|NCT04724837|559763673|FG001|Overall Study|Death|0|||
155090503|NCT04724837|559763674|FG002|Overall Study|Death|1|||
155090504|NCT04724837|559763672|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155090505|NCT04724837|559763673|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
155090506|NCT04724837|559763674|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
155090507|NCT04724837|559763672|FG000|Overall Study|Study Terminated by Sponsor|0|||
155370996|NCT04608773|560791995|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
155370997|NCT04608773|560791996|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
155167259|NCT00934362|560049450|FG001|Overall Study|Adverse Event|0|||
155167260|NCT01092117|560049451|FG000|Index Procedure to 1 Month|Death|1|||
155167261|NCT01092117|560049451|FG000|1 Month|Death|1|||
155167262|NCT01092117|560049451|FG000|1 Month|Withdrawal by Subject|1|||
155167263|NCT01092117|560049451|FG000|1 Month|Lost to Follow-up|1|||
155167264|NCT01092117|560049451|FG000|6 Months|Death|2|||
155167265|NCT01092117|560049451|FG000|6 Months|Withdrawal by Subject|3|||
155167266|NCT01092117|560049451|FG000|12 Month|Death|11|||
155167267|NCT01092117|560049451|FG000|12 Month|Withdrawal by Subject|2|||
155167268|NCT01092117|560049451|FG000|12 Month|Lost to Follow-up|1|||
155167269|NCT01092117|560049451|FG000|Year 2|Death|5|||
155167270|NCT01092117|560049451|FG000|Year 2|Withdrawal by Subject|4|||
155167271|NCT01092117|560049451|FG000|Year 2|Lost to Follow-up|1|||
155167272|NCT01092117|560049451|FG000|Year 3|Death|7|||
155167273|NCT01092117|560049451|FG000|Year 3|Withdrawal by Subject|9|||
155167274|NCT01092117|560049451|FG000|Year 3|Lost to Follow-up|3|||
155167275|NCT01092117|560049451|FG000|Year 4|Death|8|||
155167276|NCT01092117|560049451|FG000|Year 4|Withdrawal by Subject|4|||
155167277|NCT01092117|560049451|FG000|Year 4|Lost to Follow-up|4|||
155167278|NCT01191762|560049452|FG000|Overall Study|Adverse Event|1|||
155167279|NCT01191762|560049453|FG001|Overall Study|Adverse Event|0|||
155167280|NCT03865381|560049460|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
155167281|NCT03865381|560049460|FG000|Overall Study|Withdrawal by Subject|2|||
155167282|NCT04999852|560049461|FG000|Overall Study|Withdrawal by Subject|11|||
155167283|NCT04999852|560049462|FG001|Overall Study|Withdrawal by Subject|1|||
155167284|NCT04999852|560049461|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
155167285|NCT04999852|560049462|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
155167286|NCT05626322|560049463|FG000|Overall Study|Death|2|||
155167287|NCT05626322|560049464|FG001|Overall Study|Death|0|||
155167288|NCT05626322|560049465|FG002|Overall Study|Death|0|||
155167289|NCT05626322|560049463|FG000|Overall Study|Physician Decision|1|||
155167290|NCT05626322|560049464|FG001|Overall Study|Physician Decision|0|||
155167291|NCT05626322|560049465|FG002|Overall Study|Physician Decision|0|||
155167292|NCT05626322|560049463|FG000|Overall Study|Progressive Disease|0|||
155167293|NCT05626322|560049464|FG001|Overall Study|Progressive Disease|1|||
155167294|NCT05626322|560049465|FG002|Overall Study|Progressive Disease|1|||
155167295|NCT05626322|560049463|FG000|Overall Study|Study terminated by sponsor|0|||
155167296|NCT05626322|560049464|FG001|Overall Study|Study terminated by sponsor|1|||
155167297|NCT05626322|560049465|FG002|Overall Study|Study terminated by sponsor|0|||
155167298|NCT03776812|560049466|FG000|Overall Study|Death|53|||
155167299|NCT03776812|560049467|FG001|Overall Study|Death|49|||
155167300|NCT03776812|560049468|FG002|Overall Study|Death|56|||
155167301|NCT03776812|560049466|FG000|Overall Study|Withdrawal by Subject|1|||
155167302|NCT03776812|560049467|FG001|Overall Study|Withdrawal by Subject|7|||
155167303|NCT03776812|560049468|FG002|Overall Study|Withdrawal by Subject|2|||
155167304|NCT03776812|560049466|FG000|Overall Study|Lost to Follow-up|1|||
155167305|NCT03776812|560049467|FG001|Overall Study|Lost to Follow-up|1|||
155167306|NCT03776812|560049468|FG002|Overall Study|Lost to Follow-up|0|||
155167307|NCT03776812|560049466|FG000|Overall Study|Did not enter long-term follow-up|3|||
155167308|NCT03776812|560049467|FG001|Overall Study|Did not enter long-term follow-up|3|||
155167309|NCT03776812|560049468|FG002|Overall Study|Did not enter long-term follow-up|2|||
155167310|NCT04758637|560049471|FG000|Overall Study|Lost to Follow-up|0|||
155167311|NCT04758637|560049472|FG001|Overall Study|Lost to Follow-up|1|||
155167312|NCT04758637|560049473|FG002|Overall Study|Lost to Follow-up|0|||
155167313|NCT04758637|560049474|FG003|Overall Study|Lost to Follow-up|0|||
155370998|NCT04608773|560791995|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
155370999|NCT04608773|560791996|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
155371000|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
155371001|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
155371002|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
155371003|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
155371004|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
155371005|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
155371006|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
155371007|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
155167314|NCT03350672|560049477|FG000|Overall Study|Withdrawal by Subject|7|||
155167315|NCT03350672|560049478|FG001|Overall Study|Withdrawal by Subject|0|||
155167316|NCT03350672|560049479|FG002|Overall Study|Withdrawal by Subject|0|||
155167317|NCT00048074|560049480|FG000|Overall Study|Adverse Event|46|||
155167318|NCT00048074|560049481|FG001|Overall Study|Adverse Event|41|||
155167319|NCT00048074|560049482|FG002|Overall Study|Adverse Event|53|||
155167320|NCT00048074|560049480|FG000|Overall Study|Death|3|||
155167321|NCT00048074|560049481|FG001|Overall Study|Death|3|||
155167322|NCT00048074|560049482|FG002|Overall Study|Death|2|||
155167323|NCT00048074|560049480|FG000|Overall Study|Lost to Follow-up|2|||
155167324|NCT00048074|560049481|FG001|Overall Study|Lost to Follow-up|6|||
154965622|NCT00112437|559298874|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
155090508|NCT04724837|559763673|FG001|Overall Study|Study Terminated by Sponsor|1|||
155371008|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
155371009|NCT01077518|560791999|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
155371010|NCT01077518|560792000|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
155371011|NCT01077518|560792001|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
155371012|NCT01077518|560791999|FG000|Optional Ofa Phase|Physician Decision|0|||
155371013|NCT01077518|560792000|FG001|Optional Ofa Phase|Physician Decision|0|||
155371014|NCT01077518|560792001|FG002|Optional Ofa Phase|Physician Decision|1|||
155371015|NCT01077518|560791999|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
155090509|NCT04724837|559763674|FG002|Overall Study|Study Terminated by Sponsor|0|||
155090510|NCT05852470|559763675|FG000|Overall Study|Withdrawal by Subject|0|||
155090511|NCT05852470|559763676|FG001|Overall Study|Withdrawal by Subject|1|||
155090512|NCT06071104|559763677|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
155090513|NCT01344226|559763682|FG000|Overall Study|Protocol Violation|2|||
155371016|NCT01077518|560792000|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
155090514|NCT01344226|559763682|FG000|Overall Study|Withdrawal by Subject|3|||
155371017|NCT01077518|560792001|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
155371018|NCT01077518|560791999|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
155167325|NCT00048074|560049482|FG002|Overall Study|Lost to Follow-up|6|||
155167326|NCT00048074|560049480|FG000|Overall Study|Withdrawal by Subject|28|||
155167327|NCT00048074|560049481|FG001|Overall Study|Withdrawal by Subject|30|||
155167328|NCT00048074|560049482|FG002|Overall Study|Withdrawal by Subject|35|||
155167329|NCT00048074|560049480|FG000|Overall Study|Protocol Violation|1|||
155167330|NCT00048074|560049481|FG001|Overall Study|Protocol Violation|3|||
155371019|NCT01077518|560792000|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
155371020|NCT01077518|560792001|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
155371021|NCT00623805|560792006|FG000|Overall Study|Adverse Event|9|||
155371022|NCT00623805|560792007|FG001|Overall Study|Adverse Event|6|||
155371023|NCT00623805|560792006|FG000|Overall Study|Death|2|||
155167331|NCT00048074|560049482|FG002|Overall Study|Protocol Violation|0|||
155167332|NCT00048074|560049480|FG000|Overall Study|Study participation was terminated|0|||
155167333|NCT00048074|560049481|FG001|Overall Study|Study participation was terminated|1|||
155167334|NCT00048074|560049482|FG002|Overall Study|Study participation was terminated|0|||
155167335|NCT00048074|560049480|FG000|Overall Study|Husband ill|0|||
155167336|NCT00048074|560049481|FG001|Overall Study|Husband ill|1|||
155371024|NCT00623805|560792007|FG001|Overall Study|Death|0|||
155167337|NCT00048074|560049482|FG002|Overall Study|Husband ill|0|||
155167338|NCT00048074|560049480|FG000|Overall Study|Poor compliance|0|||
155167339|NCT00048074|560049481|FG001|Overall Study|Poor compliance|1|||
155167340|NCT00048074|560049482|FG002|Overall Study|Poor compliance|0|||
155167341|NCT00048074|560049480|FG000|Overall Study|Out of station|0|||
155167342|NCT00048074|560049481|FG001|Overall Study|Out of station|1|||
155371025|NCT00623805|560792006|FG000|Overall Study|Lack of Efficacy|3|||
155371026|NCT00623805|560792007|FG001|Overall Study|Lack of Efficacy|7|||
155371027|NCT00623805|560792006|FG000|Overall Study|Lost to Follow-up|2|||
155371028|NCT00623805|560792007|FG001|Overall Study|Lost to Follow-up|2|||
155371029|NCT00623805|560792006|FG000|Overall Study|Protocol Violation|1|||
155371030|NCT00623805|560792007|FG001|Overall Study|Protocol Violation|1|||
155371031|NCT00623805|560792006|FG000|Overall Study|Reason not Specified|3|||
155371032|NCT00623805|560792007|FG001|Overall Study|Reason not Specified|6|||
155371033|NCT01803282|560792012|FG000|Overall Study|Progressive Disease|4|||
155371034|NCT01803282|560792013|FG001|Overall Study|Progressive Disease|3|||
155371035|NCT01803282|560792014|FG002|Overall Study|Progressive Disease|6|||
155371036|NCT01803282|560792015|FG003|Overall Study|Progressive Disease|22|||
155371037|NCT01803282|560792016|FG004|Overall Study|Progressive Disease|5|||
155371038|NCT01803282|560792017|FG005|Overall Study|Progressive Disease|8|||
155371039|NCT01803282|560792018|FG006|Overall Study|Progressive Disease|23|||
155090515|NCT01344226|559763682|FG000|Overall Study|Lack of Efficacy|3|||
155090516|NCT02420717|559763688|FG000|Overall Study|Did not receive all study medication|2|||
155090517|NCT02420717|559763689|FG001|Overall Study|Did not receive all study medication|0|||
155090518|NCT02420717|559763690|FG002|Overall Study|Did not receive all study medication|0|||
155090519|NCT03781570|559763691|FG000|Overall Study|Technical Issues (equipment failure)|31|||
155090520|NCT03781570|559763691|FG000|Overall Study|Withdrawal by Subject|7|||
155090521|NCT03781570|559763691|FG000|Overall Study|Physical Constraints|11|||
155090522|NCT01107496|559763692|FG000|Overall Study|Adverse Event|1|||
155090523|NCT01107496|559763693|FG001|Overall Study|Adverse Event|0|||
155090524|NCT01107496|559763692|FG000|Overall Study|Lack of Efficacy|1|||
155090525|NCT01107496|559763693|FG001|Overall Study|Lack of Efficacy|0|||
155090526|NCT01107496|559763692|FG000|Overall Study|Protocol Violation|0|||
155090527|NCT01107496|559763693|FG001|Overall Study|Protocol Violation|1|||
155090528|NCT01107496|559763692|FG000|Overall Study|Lost to Follow-up|0|||
155090529|NCT01107496|559763693|FG001|Overall Study|Lost to Follow-up|1|||
155090530|NCT03636022|559763697|FG000|Overall Study|Withdrawal by Subject|1|||
155090531|NCT03636022|559763698|FG001|Overall Study|Withdrawal by Subject|3|||
155090532|NCT01587196|559763699|FG000|Overall Study|Lost to Follow-up|50|||
155090533|NCT01587196|559763699|FG000|Overall Study|Withdrawal by Subject|4|||
155090534|NCT01346592|559763700|FG000|Overall Study|Lost to Follow-up|62|||
155090535|NCT01346592|559763701|FG001|Overall Study|Lost to Follow-up|29|||
155371040|NCT01803282|560792019|FG007|Overall Study|Progressive Disease|24|||
155090536|NCT01346592|559763702|FG002|Overall Study|Lost to Follow-up|29|||
155090537|NCT01346592|559763700|FG000|Overall Study|Protocol Violation|2|||
155371041|NCT01803282|560792020|FG008|Overall Study|Progressive Disease|3|||
154965623|NCT00112437|559298875|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
155090538|NCT01346592|559763701|FG001|Overall Study|Protocol Violation|1|||
155090539|NCT01346592|559763702|FG002|Overall Study|Protocol Violation|0|||
155090540|NCT01346592|559763700|FG000|Overall Study|Death|1|||
155090541|NCT01346592|559763701|FG001|Overall Study|Death|3|||
155090542|NCT01346592|559763702|FG002|Overall Study|Death|4|||
155090543|NCT01346592|559763700|FG000|Overall Study|Adverse Event|0|||
155090544|NCT01346592|559763701|FG001|Overall Study|Adverse Event|1|||
155090545|NCT01346592|559763702|FG002|Overall Study|Adverse Event|0|||
155090546|NCT01346592|559763700|FG000|Overall Study|Withdrawal by Subject|77|||
155090547|NCT01346592|559763701|FG001|Overall Study|Withdrawal by Subject|51|||
155090548|NCT01346592|559763702|FG002|Overall Study|Withdrawal by Subject|38|||
155090549|NCT01346592|559763700|FG000|Overall Study|Inappropriate enrollment|3|||
155090550|NCT01346592|559763701|FG001|Overall Study|Inappropriate enrollment|1|||
155090551|NCT01346592|559763702|FG002|Overall Study|Inappropriate enrollment|1|||
155090552|NCT01346592|559763700|FG000|Overall Study|Administrative reason|1|||
155090553|NCT01346592|559763701|FG001|Overall Study|Administrative reason|0|||
155090554|NCT01346592|559763702|FG002|Overall Study|Administrative reason|0|||
155090555|NCT01346592|559763700|FG000|Overall Study|Unable to Classify|7|||
154965624|NCT00112437|559298876|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
155167343|NCT00048074|560049482|FG002|Overall Study|Out of station|1|||
155167344|NCT00048074|560049480|FG000|Overall Study|Social reasons|1|||
155167345|NCT00048074|560049481|FG001|Overall Study|Social reasons|0|||
155167346|NCT00048074|560049482|FG002|Overall Study|Social reasons|0|||
155167347|NCT02873377|560049483|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
155167348|NCT02873377|560049484|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
155167349|NCT02873377|560049483|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
155167350|NCT02873377|560049484|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
155167351|NCT00104520|560049485|FG000|Overall Study|Unrelated adverse event|34|||
155167352|NCT00104520|560049486|FG001|Overall Study|Unrelated adverse event|47|||
155167353|NCT00104520|560049485|FG000|Overall Study|Study drug intolerance|0|||
155167354|NCT00104520|560049486|FG001|Overall Study|Study drug intolerance|1|||
155167355|NCT00104520|560049485|FG000|Overall Study|Related adverse event|13|||
155167356|NCT00104520|560049486|FG001|Overall Study|Related adverse event|15|||
155371042|NCT01803282|560792021|FG009|Overall Study|Progressive Disease|29|||
155371043|NCT01803282|560792022|FG010|Overall Study|Progressive Disease|6|||
155371044|NCT01803282|560792023|FG011|Overall Study|Progressive Disease|11|||
155371045|NCT01803282|560792012|FG000|Overall Study|Death|0|||
155371046|NCT01803282|560792013|FG001|Overall Study|Death|0|||
155371047|NCT01803282|560792014|FG002|Overall Study|Death|0|||
155371048|NCT01803282|560792015|FG003|Overall Study|Death|0|||
155167357|NCT00104520|560049485|FG000|Overall Study|Lost to Follow-up|1|||
155371049|NCT01803282|560792016|FG004|Overall Study|Death|2|||
155371050|NCT01803282|560792017|FG005|Overall Study|Death|1|||
155371051|NCT01803282|560792018|FG006|Overall Study|Death|1|||
155371052|NCT01803282|560792019|FG007|Overall Study|Death|5|||
155371053|NCT01803282|560792020|FG008|Overall Study|Death|1|||
155371054|NCT01803282|560792021|FG009|Overall Study|Death|1|||
155371055|NCT01803282|560792022|FG010|Overall Study|Death|0|||
155090556|NCT01346592|559763701|FG001|Overall Study|Unable to Classify|3|||
155090557|NCT01346592|559763702|FG002|Overall Study|Unable to Classify|6|||
155090558|NCT04890509|559763709|FG000|Overall Study|Death|4|||
155090559|NCT04890509|559763710|FG001|Overall Study|Death|4|||
155090560|NCT02520154|559763714|FG000|Overall Study|Death|1|||
155090561|NCT02520154|559763714|FG000|Overall Study|Withdrawal by Subject|2|||
155090562|NCT02520154|559763714|FG000|Overall Study|Physician Decision|2|||
155090563|NCT06022107|559763715|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
155090564|NCT06022107|559763715|FG000|Overall Study|Dropped out of study for higher level of care|1|||
155090565|NCT06022107|559763715|FG000|Overall Study|Lost to Follow-up|2|||
155090566|NCT05943990|559763716|FG000|Overall Study|Study Terminated by Sponsor|0|||
155090567|NCT05943990|559763717|FG001|Overall Study|Study Terminated by Sponsor|0|||
155090568|NCT05943990|559763718|FG002|Overall Study|Study Terminated by Sponsor|1|||
155090569|NCT02333799|559765028|FG000|Treatment Period|Withdrawal by Subject|1|||
155090570|NCT02333799|559765028|FG000|Treatment Period|Death|6|||
155090571|NCT02333799|559765028|FG000|6 Month Follow Up Period|Physician Decision|1|||
155090572|NCT02333799|559765028|FG000|6 Month Follow Up Period|Death|1|||
155090573|NCT02333799|559765028|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
155090574|NCT02333799|559765028|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
155090575|NCT05847686|559765029|FG000|Overall Study|Withdrawal by Subject|3|||
155090576|NCT03716830|559765030|FG000|Overall Study|Withdrawal by Subject|2|||
155090577|NCT03716830|559765031|FG001|Overall Study|Withdrawal by Subject|2|||
155090578|NCT03716830|559765032|FG002|Overall Study|Withdrawal by Subject|6|||
155090579|NCT03716830|559765033|FG003|Overall Study|Withdrawal by Subject|5|||
155090580|NCT03716830|559765030|FG000|Overall Study|Adverse Event|1|||
155090581|NCT03716830|559765031|FG001|Overall Study|Adverse Event|2|||
155090582|NCT03716830|559765032|FG002|Overall Study|Adverse Event|0|||
155090583|NCT03716830|559765033|FG003|Overall Study|Adverse Event|1|||
155090584|NCT03716830|559765030|FG000|Overall Study|Lost to Follow-up|1|||
155090585|NCT03716830|559765031|FG001|Overall Study|Lost to Follow-up|1|||
155090586|NCT03716830|559765032|FG002|Overall Study|Lost to Follow-up|0|||
155090587|NCT03716830|559765033|FG003|Overall Study|Lost to Follow-up|0|||
155090588|NCT05484895|559765034|FG000|Overall Study|Lost to Follow-up|63|||
155090589|NCT05484895|559765035|FG001|Overall Study|Lost to Follow-up|64|||
155090590|NCT04795531|559765036|FG000|Overall Study|Withdrawal by Subject|4|||
155090591|NCT04795531|559765037|FG001|Overall Study|Withdrawal by Subject|4|||
155090592|NCT04795531|559765036|FG000|Overall Study|Lost to Follow-up|0|||
155090593|NCT04795531|559765037|FG001|Overall Study|Lost to Follow-up|1|||
155090594|NCT04795531|559765036|FG000|Overall Study|Physician Decision|0|||
155090595|NCT04795531|559765037|FG001|Overall Study|Physician Decision|2|||
155090596|NCT04795531|559765036|FG000|Overall Study|Death|2|||
155090597|NCT04795531|559765037|FG001|Overall Study|Death|1|||
155090598|NCT02552225|559765038|FG000|Overall Study|Withdrawal by Subject|1|||
155090599|NCT02552225|559765039|FG001|Overall Study|Withdrawal by Subject|0|||
155090600|NCT01168596|559765040|FG000|Overall Study|Withdrawal by Subject|3|||
155090601|NCT01168596|559765041|FG001|Overall Study|Withdrawal by Subject|1|||
155090602|NCT02829996|559765046|FG000|Overall Study|Withdrawal by Subject|1|||
155090603|NCT02829996|559765047|FG001|Overall Study|Withdrawal by Subject|0|||
155090604|NCT02829996|559765048|FG002|Overall Study|Withdrawal by Subject|0|||
155167358|NCT00104520|560049486|FG001|Overall Study|Lost to Follow-up|0|||
155167359|NCT00104520|560049485|FG000|Overall Study|Noncompliance|0|||
155371056|NCT01803282|560792023|FG011|Overall Study|Death|0|||
155371057|NCT01803282|560792012|FG000|Overall Study|Withdrew Consent|0|||
155371058|NCT01803282|560792013|FG001|Overall Study|Withdrew Consent|0|||
155371059|NCT01803282|560792014|FG002|Overall Study|Withdrew Consent|0|||
155371060|NCT01803282|560792015|FG003|Overall Study|Withdrew Consent|6|||
155371061|NCT01803282|560792016|FG004|Overall Study|Withdrew Consent|1|||
155371062|NCT01803282|560792017|FG005|Overall Study|Withdrew Consent|0|||
155371063|NCT01803282|560792018|FG006|Overall Study|Withdrew Consent|8|||
155371064|NCT01803282|560792019|FG007|Overall Study|Withdrew Consent|3|||
155090605|NCT02829996|559765049|FG003|Overall Study|Withdrawal by Subject|0|||
155090606|NCT02829996|559765050|FG004|Overall Study|Withdrawal by Subject|0|||
155090607|NCT00189423|559765051|FG000|Overall Study|Death|746|||
155090608|NCT00189423|559765052|FG001|Overall Study|Death|747|||
155090609|NCT00189423|559765051|FG000|Overall Study|Withdrawal by Subject|9|||
155090610|NCT00189423|559765052|FG001|Overall Study|Withdrawal by Subject|9|||
155090611|NCT00189423|559765051|FG000|Overall Study|Lost to Follow-up|10|||
155167360|NCT00104520|560049486|FG001|Overall Study|Noncompliance|2|||
155371065|NCT01803282|560792020|FG008|Overall Study|Withdrew Consent|1|||
155371066|NCT01803282|560792021|FG009|Overall Study|Withdrew Consent|5|||
155371067|NCT01803282|560792022|FG010|Overall Study|Withdrew Consent|0|||
155371068|NCT01803282|560792023|FG011|Overall Study|Withdrew Consent|1|||
155371069|NCT01803282|560792012|FG000|Overall Study|Investigator's Discretion|0|||
155167361|NCT00104520|560049485|FG000|Overall Study|Personal/administrative|1|||
155167362|NCT00104520|560049486|FG001|Overall Study|Personal/administrative|1|||
155167363|NCT00104520|560049485|FG000|Overall Study|Other|1|||
155167364|NCT00104520|560049486|FG001|Overall Study|Other|5|||
155167365|NCT04073225|560049487|FG000|Overall Study|Lost to Follow-up|4|||
155167366|NCT04073225|560049488|FG001|Overall Study|Lost to Follow-up|3|||
155167367|NCT00124306|560049490|FG000|Overall Study|Adverse Event|7|||
155167368|NCT00124306|560049491|FG001|Overall Study|Adverse Event|2|||
155167369|NCT00124306|560049490|FG000|Overall Study|Lost to Follow-up|10|||
155167370|NCT00124306|560049491|FG001|Overall Study|Lost to Follow-up|6|||
155167371|NCT00124306|560049490|FG000|Overall Study|Lack of Efficacy|3|||
155167372|NCT00124306|560049491|FG001|Overall Study|Lack of Efficacy|6|||
155167373|NCT00124306|560049490|FG000|Overall Study|Personal constraints|0|||
155167374|NCT00124306|560049491|FG001|Overall Study|Personal constraints|2|||
155167375|NCT00124306|560049490|FG000|Overall Study|Use of unacceptable medication|1|||
155167376|NCT00124306|560049491|FG001|Overall Study|Use of unacceptable medication|0|||
155167377|NCT00124306|560049490|FG000|Overall Study|Abnormal lab result|0|||
155167378|NCT00124306|560049491|FG001|Overall Study|Abnormal lab result|1|||
155167379|NCT00124306|560049490|FG000|Overall Study|Other|2|||
155167380|NCT00124306|560049491|FG001|Overall Study|Other|0|||
155167381|NCT04238819|560049492|FG000|Overall Study|Ongoing Treatment|0|||
155167382|NCT04238819|560049493|FG001|Overall Study|Ongoing Treatment|0|||
155167383|NCT04238819|560049494|FG002|Overall Study|Ongoing Treatment|0|||
155167384|NCT04238819|560049495|FG003|Overall Study|Ongoing Treatment|0|||
155167385|NCT04238819|560049496|FG004|Overall Study|Ongoing Treatment|1|||
155167386|NCT04238819|560049497|FG005|Overall Study|Ongoing Treatment|4|||
155167387|NCT04238819|560049498|FG006|Overall Study|Ongoing Treatment|0|||
155167388|NCT04238819|560049492|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
155167389|NCT04238819|560049493|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
155167390|NCT04238819|560049494|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
155167391|NCT04238819|560049495|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
155167392|NCT04238819|560049496|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
155167393|NCT04238819|560049497|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
155167394|NCT04238819|560049498|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
155167395|NCT05767749|560049499|FG000|Overall Study|Withdrawal by Subject|0|||
155167396|NCT05767749|560049500|FG001|Overall Study|Withdrawal by Subject|0|||
155167397|NCT05767749|560049501|FG002|Overall Study|Withdrawal by Subject|2|||
155167398|NCT05767749|560049502|FG003|Overall Study|Withdrawal by Subject|2|||
155167399|NCT05767749|560049503|FG004|Overall Study|Withdrawal by Subject|2|||
155167400|NCT05767749|560049504|FG005|Overall Study|Withdrawal by Subject|2|||
155167401|NCT00114517|560049505|FG000|Overall Study|Adverse Event|6|||
155167402|NCT00114517|560049506|FG001|Overall Study|Adverse Event|1|||
155167403|NCT00114517|560049507|FG002|Overall Study|Adverse Event|6|||
155167404|NCT00114517|560049508|FG003|Overall Study|Adverse Event|3|||
155167405|NCT00114517|560049505|FG000|Overall Study|Lost to Follow-up|2|||
155167406|NCT00114517|560049506|FG001|Overall Study|Lost to Follow-up|2|||
155167407|NCT00114517|560049507|FG002|Overall Study|Lost to Follow-up|2|||
155167408|NCT00114517|560049508|FG003|Overall Study|Lost to Follow-up|1|||
155167409|NCT00114517|560049505|FG000|Overall Study|Too busy|3|||
155167410|NCT00114517|560049506|FG001|Overall Study|Too busy|1|||
155167411|NCT00114517|560049507|FG002|Overall Study|Too busy|1|||
155167412|NCT00114517|560049508|FG003|Overall Study|Too busy|2|||
155167413|NCT00114517|560049505|FG000|Overall Study|Moved from area|0|||
155167414|NCT00114517|560049506|FG001|Overall Study|Moved from area|3|||
155167415|NCT00114517|560049507|FG002|Overall Study|Moved from area|2|||
155167416|NCT00114517|560049508|FG003|Overall Study|Moved from area|1|||
155167417|NCT00114517|560049505|FG000|Overall Study|Did not want estradiol|1|||
155167418|NCT00114517|560049506|FG001|Overall Study|Did not want estradiol|1|||
155167419|NCT00114517|560049507|FG002|Overall Study|Did not want estradiol|0|||
155167420|NCT00114517|560049508|FG003|Overall Study|Did not want estradiol|0|||
155167421|NCT00114517|560049505|FG000|Overall Study|Armed-services duty|0|||
155167422|NCT00114517|560049506|FG001|Overall Study|Armed-services duty|1|||
155167423|NCT00114517|560049507|FG002|Overall Study|Armed-services duty|0|||
155167424|NCT00114517|560049508|FG003|Overall Study|Armed-services duty|1|||
155167425|NCT00114517|560049505|FG000|Overall Study|Competing family issue|0|||
155167426|NCT00114517|560049506|FG001|Overall Study|Competing family issue|1|||
155371070|NCT01803282|560792013|FG001|Overall Study|Investigator's Discretion|0|||
155371071|NCT01803282|560792014|FG002|Overall Study|Investigator's Discretion|0|||
155167427|NCT00114517|560049507|FG002|Overall Study|Competing family issue|0|||
155167428|NCT00114517|560049508|FG003|Overall Study|Competing family issue|1|||
155167429|NCT00114517|560049505|FG000|Overall Study|Physician Decision|0|||
155167430|NCT00114517|560049506|FG001|Overall Study|Physician Decision|1|||
155167431|NCT00114517|560049507|FG002|Overall Study|Physician Decision|0|||
155167432|NCT00114517|560049508|FG003|Overall Study|Physician Decision|0|||
155167433|NCT00114517|560049505|FG000|Overall Study|Lost interest|0|||
155167434|NCT00114517|560049506|FG001|Overall Study|Lost interest|0|||
155167435|NCT00114517|560049507|FG002|Overall Study|Lost interest|1|||
155167436|NCT00114517|560049508|FG003|Overall Study|Lost interest|0|||
155371072|NCT01803282|560792015|FG003|Overall Study|Investigator's Discretion|7|||
155167437|NCT00114517|560049505|FG000|Overall Study|Weight increase|0|||
155167438|NCT00114517|560049506|FG001|Overall Study|Weight increase|0|||
155167439|NCT00114517|560049507|FG002|Overall Study|Weight increase|1|||
155167440|NCT00114517|560049508|FG003|Overall Study|Weight increase|0|||
155167441|NCT00114517|560049505|FG000|Overall Study|Concern about blood clots|0|||
155167442|NCT00114517|560049506|FG001|Overall Study|Concern about blood clots|0|||
155167443|NCT00114517|560049507|FG002|Overall Study|Concern about blood clots|1|||
155167444|NCT00114517|560049508|FG003|Overall Study|Concern about blood clots|0|||
155167445|NCT00114517|560049505|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
155167446|NCT00114517|560049506|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
155167447|NCT00114517|560049507|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
155167448|NCT00114517|560049508|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
155167449|NCT01243242|560050926|FG000|Overall Study|Adverse Event|1|||
155167450|NCT01243242|560050927|FG001|Overall Study|Adverse Event|1|||
155167451|NCT01243242|560050926|FG000|Overall Study|Withdrawal by Subject|1|||
155167452|NCT01243242|560050927|FG001|Overall Study|Withdrawal by Subject|1|||
155167453|NCT01243242|560050926|FG000|Overall Study|Physician Decision|0|||
155167454|NCT01243242|560050927|FG001|Overall Study|Physician Decision|1|||
155167455|NCT01243242|560050926|FG000|Overall Study|sponsor decision|0|||
155167456|NCT01243242|560050927|FG001|Overall Study|sponsor decision|1|||
155167457|NCT01243242|560050926|FG000|Overall Study|non compliance|1|||
155167458|NCT01243242|560050927|FG001|Overall Study|non compliance|0|||
155167459|NCT04681352|560050932|FG000|Overall Study|Lost to Follow-up|2|||
155167460|NCT04681352|560050932|FG000|Overall Study|Withdrawal by Subject|22|||
155167461|NCT02867384|560050933|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
155167462|NCT02867384|560050934|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
155167463|NCT02867384|560050935|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
155167464|NCT02867384|560050933|FG000|Overall Study|Progression/ Relapse|15|||
155167465|NCT02867384|560050934|FG001|Overall Study|Progression/ Relapse|19|||
155167466|NCT02867384|560050935|FG002|Overall Study|Progression/ Relapse|0|||
155167467|NCT02867384|560050933|FG000|Overall Study|Adverse Event|13|||
155167468|NCT02867384|560050934|FG001|Overall Study|Adverse Event|1|||
155167469|NCT02867384|560050935|FG002|Overall Study|Adverse Event|0|||
155167470|NCT02867384|560050933|FG000|Overall Study|Withdrawal by Subject|6|||
155167471|NCT02867384|560050934|FG001|Overall Study|Withdrawal by Subject|5|||
155167472|NCT02867384|560050935|FG002|Overall Study|Withdrawal by Subject|0|||
155167473|NCT02867384|560050933|FG000|Overall Study|Physician Decision|1|||
155167474|NCT02867384|560050934|FG001|Overall Study|Physician Decision|2|||
155167475|NCT02867384|560050935|FG002|Overall Study|Physician Decision|0|||
155167476|NCT02867384|560050933|FG000|Overall Study|Patient compliance|1|||
155167477|NCT02867384|560050934|FG001|Overall Study|Patient compliance|0|||
155167478|NCT02867384|560050935|FG002|Overall Study|Patient compliance|0|||
155167479|NCT02867384|560050933|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
155167480|NCT02867384|560050934|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
155167481|NCT02867384|560050935|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
155167482|NCT02867384|560050933|FG000|Overall Study|Never start treatment|3|||
155167483|NCT02867384|560050934|FG001|Overall Study|Never start treatment|0|||
155167484|NCT02867384|560050935|FG002|Overall Study|Never start treatment|0|||
155167485|NCT01941186|560050936|FG000|Follow-up|Lost to Follow-up|1|||
155167486|NCT01941186|560050937|FG001|Follow-up|Lost to Follow-up|0|||
155167487|NCT02105961|560050938|FG000|Overall Study|Adverse Event|18|||
155167488|NCT02105961|560050939|FG001|Overall Study|Adverse Event|7|||
155167489|NCT02105961|560050940|FG002|Overall Study|Adverse Event|13|||
155167490|NCT02105961|560050938|FG000|Overall Study|Lack of Efficacy|3|||
155167491|NCT02105961|560050939|FG001|Overall Study|Lack of Efficacy|0|||
155167492|NCT02105961|560050940|FG002|Overall Study|Lack of Efficacy|3|||
155167493|NCT02105961|560050938|FG000|Overall Study|Lost to Follow-up|2|||
155167494|NCT02105961|560050939|FG001|Overall Study|Lost to Follow-up|0|||
155167495|NCT02105961|560050940|FG002|Overall Study|Lost to Follow-up|1|||
155167496|NCT02105961|560050938|FG000|Overall Study|Physician Decision|3|||
155167497|NCT02105961|560050939|FG001|Overall Study|Physician Decision|3|||
155167498|NCT02105961|560050940|FG002|Overall Study|Physician Decision|2|||
155167499|NCT02105961|560050938|FG000|Overall Study|Withdrawal by Subject|15|||
155167500|NCT02105961|560050939|FG001|Overall Study|Withdrawal by Subject|7|||
155167501|NCT02105961|560050940|FG002|Overall Study|Withdrawal by Subject|11|||
155371073|NCT01803282|560792016|FG004|Overall Study|Investigator's Discretion|2|||
155371074|NCT01803282|560792017|FG005|Overall Study|Investigator's Discretion|1|||
155371075|NCT01803282|560792018|FG006|Overall Study|Investigator's Discretion|7|||
155167502|NCT04154189|560050943|FG000|Overall Study|Withdrawal by Subject|4|||
155167503|NCT04154189|560050944|FG001|Overall Study|Withdrawal by Subject|6|||
155167504|NCT04154189|560050943|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
155167505|NCT04154189|560050944|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
155167506|NCT04154189|560050943|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
155167507|NCT04154189|560050944|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
155371076|NCT01803282|560792019|FG007|Overall Study|Investigator's Discretion|10|||
155167508|NCT04154189|560050943|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
155167509|NCT04154189|560050944|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
155167510|NCT04154189|560050943|FG000|Overall Study|Death|25|||
155167511|NCT04154189|560050944|FG001|Overall Study|Death|25|||
155167512|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
155167513|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
155167514|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
155167515|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
155167516|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
155167517|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
155167518|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
155167519|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
155167520|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
155167521|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
155167522|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
155167523|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
155167524|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
155167525|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
155167526|NCT04173494|560050945|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
155167527|NCT04173494|560050946|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
155167528|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
155167529|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
155167530|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
155167531|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
155167532|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
155167533|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
155167534|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
155167535|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
155167536|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
155167537|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
155167538|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
155167539|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
155167540|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
155167541|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
155167542|NCT04173494|560050945|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
155167543|NCT04173494|560050946|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
155167544|NCT01623050|560050947|FG000|Overall Study|Lost to Follow-up|9|||
155167545|NCT02147561|560050950|FG000|Overall Study|Lost to Follow-up|3|||
155167546|NCT02147561|560050950|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
155167547|NCT03023813|560050951|FG000|Overall Study|Lost to Follow-up|1|||
155167548|NCT03023813|560050952|FG001|Overall Study|Lost to Follow-up|2|||
155167549|NCT03023813|560050953|FG002|Overall Study|Lost to Follow-up|0|||
155167550|NCT00393861|560050954|FG000|Overall Study|Adverse Event|2|||
155167551|NCT00393861|560050954|FG000|Overall Study|Disease Progression|24|||
155167552|NCT03710083|560050955|FG000|Overall Study|Withdrawal by Subject|2|||
155167553|NCT03710083|560050955|FG000|Overall Study|Unsuccessful Procedure|1|||
155167554|NCT02123472|560050956|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
155167555|NCT02123472|560050957|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
155167556|NCT03801031|560050958|FG000|Overall Study|Lost to Follow-up|1|||
155167557|NCT03801031|560050959|FG001|Overall Study|Lost to Follow-up|0|||
155167558|NCT03801031|560050958|FG000|Overall Study|Unable to comply|1|||
155167559|NCT03801031|560050959|FG001|Overall Study|Unable to comply|0|||
155167560|NCT03801031|560050958|FG000|Overall Study|Withdrawal by Subject|0|||
155167561|NCT03801031|560050959|FG001|Overall Study|Withdrawal by Subject|1|||
155167562|NCT01598506|560050960|FG000|Overall Study|Withdrawal by Subject|2|||
155167563|NCT02100696|560050961|FG000|Induction Phase|Adverse Event|0|||
155167564|NCT02100696|560050962|FG001|Induction Phase|Adverse Event|0|||
155167565|NCT02100696|560050963|FG002|Induction Phase|Adverse Event|1|||
155167566|NCT02100696|560050964|FG003|Induction Phase|Adverse Event|0|||
155167567|NCT02100696|560050965|FG004|Induction Phase|Adverse Event|0|||
155167568|NCT02100696|560050966|FG005|Induction Phase|Adverse Event|0|||
155167569|NCT02100696|560050961|FG000|Induction Phase|Lost to Follow-up|1|||
155167570|NCT02100696|560050962|FG001|Induction Phase|Lost to Follow-up|0|||
155167571|NCT02100696|560050963|FG002|Induction Phase|Lost to Follow-up|1|||
155167572|NCT02100696|560050964|FG003|Induction Phase|Lost to Follow-up|0|||
155167573|NCT02100696|560050965|FG004|Induction Phase|Lost to Follow-up|0|||
155090612|NCT00189423|559765052|FG001|Overall Study|Lost to Follow-up|10|||
155167574|NCT02100696|560050966|FG005|Induction Phase|Lost to Follow-up|0|||
155167575|NCT02100696|560050961|FG000|Induction Phase|Protocol Violation|0|||
155167576|NCT02100696|560050962|FG001|Induction Phase|Protocol Violation|1|||
155167577|NCT02100696|560050963|FG002|Induction Phase|Protocol Violation|1|||
155167578|NCT02100696|560050964|FG003|Induction Phase|Protocol Violation|0|||
155167579|NCT02100696|560050965|FG004|Induction Phase|Protocol Violation|0|||
155167580|NCT02100696|560050966|FG005|Induction Phase|Protocol Violation|0|||
155167581|NCT02100696|560050961|FG000|Induction Phase|Withdrawal by Subject|8|||
155167582|NCT02100696|560050962|FG001|Induction Phase|Withdrawal by Subject|2|||
155167583|NCT02100696|560050963|FG002|Induction Phase|Withdrawal by Subject|13|||
155167584|NCT02100696|560050964|FG003|Induction Phase|Withdrawal by Subject|0|||
155167585|NCT02100696|560050965|FG004|Induction Phase|Withdrawal by Subject|0|||
155167586|NCT02100696|560050966|FG005|Induction Phase|Withdrawal by Subject|0|||
155167587|NCT02100696|560050961|FG000|Induction Phase|Physician Decision|1|||
155167588|NCT02100696|560050962|FG001|Induction Phase|Physician Decision|0|||
155167589|NCT02100696|560050963|FG002|Induction Phase|Physician Decision|2|||
155167590|NCT02100696|560050964|FG003|Induction Phase|Physician Decision|0|||
155167591|NCT02100696|560050965|FG004|Induction Phase|Physician Decision|0|||
155167592|NCT02100696|560050966|FG005|Induction Phase|Physician Decision|0|||
155167593|NCT02100696|560050961|FG000|Induction Phase|Multiple Reasons|5|||
155167594|NCT02100696|560050962|FG001|Induction Phase|Multiple Reasons|2|||
155167595|NCT02100696|560050963|FG002|Induction Phase|Multiple Reasons|8|||
155167596|NCT02100696|560050964|FG003|Induction Phase|Multiple Reasons|0|||
155167597|NCT02100696|560050965|FG004|Induction Phase|Multiple Reasons|0|||
155167598|NCT02100696|560050966|FG005|Induction Phase|Multiple Reasons|0|||
155167599|NCT02100696|560050961|FG000|Maintenance Phase|Adverse Event|0|||
155167600|NCT02100696|560050962|FG001|Maintenance Phase|Adverse Event|0|||
155167601|NCT02100696|560050963|FG002|Maintenance Phase|Adverse Event|0|||
155167602|NCT02100696|560050964|FG003|Maintenance Phase|Adverse Event|0|||
155167603|NCT02100696|560050965|FG004|Maintenance Phase|Adverse Event|0|||
155167604|NCT02100696|560050966|FG005|Maintenance Phase|Adverse Event|2|||
155167605|NCT02100696|560050961|FG000|Maintenance Phase|Lost to Follow-up|0|||
155167606|NCT02100696|560050962|FG001|Maintenance Phase|Lost to Follow-up|0|||
155167607|NCT02100696|560050963|FG002|Maintenance Phase|Lost to Follow-up|0|||
155167608|NCT02100696|560050964|FG003|Maintenance Phase|Lost to Follow-up|0|||
155167609|NCT02100696|560050965|FG004|Maintenance Phase|Lost to Follow-up|1|||
155167610|NCT02100696|560050966|FG005|Maintenance Phase|Lost to Follow-up|0|||
155167611|NCT02100696|560050961|FG000|Maintenance Phase|Protocol Violation|0|||
155167612|NCT02100696|560050962|FG001|Maintenance Phase|Protocol Violation|0|||
155167613|NCT02100696|560050963|FG002|Maintenance Phase|Protocol Violation|0|||
155167614|NCT02100696|560050964|FG003|Maintenance Phase|Protocol Violation|0|||
155167615|NCT02100696|560050965|FG004|Maintenance Phase|Protocol Violation|1|||
155167616|NCT02100696|560050966|FG005|Maintenance Phase|Protocol Violation|0|||
155167617|NCT02100696|560050961|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155167618|NCT02100696|560050962|FG001|Maintenance Phase|Withdrawal by Subject|0|||
155167619|NCT02100696|560050963|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155167620|NCT02100696|560050964|FG003|Maintenance Phase|Withdrawal by Subject|1|||
155167621|NCT02100696|560050965|FG004|Maintenance Phase|Withdrawal by Subject|4|||
155167622|NCT02100696|560050966|FG005|Maintenance Phase|Withdrawal by Subject|2|||
155167623|NCT02100696|560050961|FG000|Maintenance Phase|Physician Decision|0|||
155167624|NCT02100696|560050962|FG001|Maintenance Phase|Physician Decision|0|||
155167625|NCT02100696|560050963|FG002|Maintenance Phase|Physician Decision|0|||
155167626|NCT02100696|560050964|FG003|Maintenance Phase|Physician Decision|0|||
155167627|NCT02100696|560050965|FG004|Maintenance Phase|Physician Decision|1|||
155167628|NCT02100696|560050966|FG005|Maintenance Phase|Physician Decision|0|||
155167629|NCT02100696|560050961|FG000|Maintenance Phase|Multiple Reasons|0|||
155167630|NCT02100696|560050962|FG001|Maintenance Phase|Multiple Reasons|0|||
155167631|NCT02100696|560050963|FG002|Maintenance Phase|Multiple Reasons|0|||
155167632|NCT02100696|560050964|FG003|Maintenance Phase|Multiple Reasons|0|||
155167633|NCT02100696|560050965|FG004|Maintenance Phase|Multiple Reasons|2|||
155167634|NCT02100696|560050966|FG005|Maintenance Phase|Multiple Reasons|1|||
155167635|NCT01583296|560050971|FG000|Overall Study|Withdrawal by Subject|11|||
155167636|NCT01583296|560050972|FG001|Overall Study|Withdrawal by Subject|10|||
155371077|NCT01803282|560792020|FG008|Overall Study|Investigator's Discretion|6|||
155167637|NCT01063283|560050973|FG000|Cycle 1|Adverse Event|2|||
155167638|NCT01063283|560050974|FG001|Cycle 1|Adverse Event|0|||
155167639|NCT01063283|560050975|FG002|Cycle 1|Adverse Event|0|||
155167640|NCT01063283|560050973|FG000|Cycle 1|Technical failure in data collection|1|||
155167641|NCT01063283|560050974|FG001|Cycle 1|Technical failure in data collection|0|||
155371078|NCT01803282|560792021|FG009|Overall Study|Investigator's Discretion|7|||
155371079|NCT01803282|560792022|FG010|Overall Study|Investigator's Discretion|1|||
155167642|NCT01063283|560050975|FG002|Cycle 1|Technical failure in data collection|0|||
155167643|NCT02504216|560050978|FG000|Overall Study|Lost to Follow-up|3|||
155167644|NCT02504216|560050979|FG001|Overall Study|Lost to Follow-up|3|||
155167645|NCT02504216|560050978|FG000|Overall Study|Withdrawal by Subject|8|||
155167646|NCT02504216|560050979|FG001|Overall Study|Withdrawal by Subject|12|||
155090613|NCT04617860|559765064|FG000|Overall Study|Adverse Event|0|||
155167647|NCT00223080|560050980|FG000|Overall Study|Withdrawal by Subject|253|||
155167648|NCT00223080|560050981|FG001|Overall Study|Withdrawal by Subject|232|||
155167649|NCT00223080|560050980|FG000|Overall Study|Required contraindicated med|0|||
155167650|NCT00223080|560050981|FG001|Overall Study|Required contraindicated med|1|||
155167651|NCT00223080|560050980|FG000|Overall Study|Non-compliant|7|||
155167652|NCT00223080|560050981|FG001|Overall Study|Non-compliant|7|||
155167653|NCT00223080|560050980|FG000|Overall Study|Moved from study area|37|||
155167654|NCT00223080|560050981|FG001|Overall Study|Moved from study area|47|||
155167655|NCT00223080|560050980|FG000|Overall Study|Lost to Follow-up|259|||
155167656|NCT00223080|560050981|FG001|Overall Study|Lost to Follow-up|284|||
155167657|NCT00223080|560050980|FG000|Overall Study|Death|85|||
155167658|NCT00223080|560050981|FG001|Overall Study|Death|74|||
155167659|NCT00223080|560050980|FG000|Overall Study|Other|14|||
155167660|NCT00223080|560050981|FG001|Overall Study|Other|11|||
155167661|NCT00223080|560050980|FG000|Overall Study|Reason not provided|141|||
155167662|NCT00223080|560050981|FG001|Overall Study|Reason not provided|140|||
155167663|NCT00223080|560050980|FG000|Overall Study|Adverse Event|0|||
155167664|NCT00223080|560050981|FG001|Overall Study|Adverse Event|1|||
155167665|NCT02598583|560050982|FG000|Extension Period|Withdrawal by Subject|1|||
155167666|NCT02598583|560050983|FG001|Extension Period|Withdrawal by Subject|0|||
155167667|NCT03237286|560050984|FG000|Overall Study|Withdrawal by Subject|1|||
155167668|NCT03237286|560050985|FG001|Overall Study|Withdrawal by Subject|0|||
155167669|NCT03237286|560050986|FG002|Overall Study|Withdrawal by Subject|2|||
155167670|NCT03237286|560050984|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
155167671|NCT03237286|560050985|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
155167672|NCT03237286|560050986|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
155167673|NCT02792829|560050994|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
154965625|NCT00112437|559298877|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
154965626|NCT00112437|559298878|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
155167674|NCT02792829|560050995|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
155167675|NCT02792829|560050996|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155167676|NCT02792829|560050997|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155167677|NCT02792829|560050998|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155167678|NCT02792829|560050999|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
154965627|NCT00112437|559298879|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
155167679|NCT02792829|560051000|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155167680|NCT02792829|560051001|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
155167681|NCT02792829|560050994|FG000|Treatment Period 2|Adverse Event|0|||
155167682|NCT02792829|560050995|FG001|Treatment Period 2|Adverse Event|0|||
155167683|NCT02792829|560050996|FG002|Treatment Period 2|Adverse Event|0|||
155167684|NCT02792829|560050997|FG003|Treatment Period 2|Adverse Event|0|||
155167685|NCT02792829|560050998|FG004|Treatment Period 2|Adverse Event|1|||
155167686|NCT02792829|560050999|FG005|Treatment Period 2|Adverse Event|0|||
155167687|NCT02792829|560051000|FG006|Treatment Period 2|Adverse Event|1|||
155167688|NCT02792829|560051001|FG007|Treatment Period 2|Adverse Event|1|||
155167689|NCT02792829|560050994|FG000|Treatment Period 2|Use of proscribed medications|0|||
155167690|NCT02792829|560050995|FG001|Treatment Period 2|Use of proscribed medications|0|||
155167691|NCT02792829|560050996|FG002|Treatment Period 2|Use of proscribed medications|0|||
155167692|NCT02792829|560050997|FG003|Treatment Period 2|Use of proscribed medications|0|||
155167693|NCT02792829|560050998|FG004|Treatment Period 2|Use of proscribed medications|0|||
155167694|NCT02792829|560050999|FG005|Treatment Period 2|Use of proscribed medications|0|||
155167695|NCT02792829|560051000|FG006|Treatment Period 2|Use of proscribed medications|0|||
155167696|NCT02792829|560051001|FG007|Treatment Period 2|Use of proscribed medications|1|||
155167697|NCT01010867|560051007|FG000|Overall Study|< 50% adherence to probiotic|1|||
155167698|NCT01668589|560051008|FG000|Overall Study|Lost to Follow-up|29|||
155167699|NCT01668589|560051009|FG001|Overall Study|Lost to Follow-up|37|||
155167700|NCT01668589|560051010|FG002|Overall Study|Lost to Follow-up|15|||
155167701|NCT01668589|560051011|FG003|Overall Study|Lost to Follow-up|5|||
155167702|NCT01668589|560051008|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
155167703|NCT01668589|560051009|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
155167704|NCT01668589|560051010|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
155167705|NCT01668589|560051011|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
155167706|NCT01668589|560051008|FG000|Overall Study|Death|12|||
155167707|NCT01668589|560051009|FG001|Overall Study|Death|3|||
155167708|NCT01668589|560051010|FG002|Overall Study|Death|2|||
155167709|NCT01668589|560051011|FG003|Overall Study|Death|11|||
155167710|NCT01668589|560051008|FG000|Overall Study|Other|44|||
155167711|NCT01668589|560051009|FG001|Overall Study|Other|10|||
155167712|NCT01668589|560051010|FG002|Overall Study|Other|7|||
155167713|NCT01668589|560051011|FG003|Overall Study|Other|15|||
155167714|NCT00233064|560051012|FG000|Overall Study|Lost to Follow-up|7|||
155167715|NCT00233064|560051013|FG001|Overall Study|Lost to Follow-up|7|||
155167716|NCT00233064|560051012|FG000|Overall Study|Withdrawal by Subject|5|||
155167717|NCT00233064|560051013|FG001|Overall Study|Withdrawal by Subject|3|||
155167718|NCT00233064|560051012|FG000|Overall Study|Death|0|||
155167719|NCT00233064|560051013|FG001|Overall Study|Death|1|||
155167720|NCT00233064|560051012|FG000|Overall Study|Relocation|0|||
155167721|NCT00233064|560051013|FG001|Overall Study|Relocation|1|||
155167722|NCT00233064|560051012|FG000|Overall Study|Protocol Violation|1|||
155167723|NCT00233064|560051013|FG001|Overall Study|Protocol Violation|0|||
155167724|NCT00233064|560051012|FG000|Overall Study|Moved to Dom. Republic|1|||
155167725|NCT00233064|560051013|FG001|Overall Study|Moved to Dom. Republic|0|||
155167726|NCT02302339|560051014|FG000|Overall Study|Lost to Follow-up|1|||
155167727|NCT02302339|560051015|FG001|Overall Study|Lost to Follow-up|0|||
155167728|NCT02302339|560051016|FG002|Overall Study|Lost to Follow-up|0|||
155167729|NCT02302339|560051017|FG003|Overall Study|Lost to Follow-up|0|||
155167730|NCT02302339|560051014|FG000|Overall Study|Withdrawal by Subject|0|||
155167731|NCT02302339|560051015|FG001|Overall Study|Withdrawal by Subject|2|||
155167732|NCT02302339|560051016|FG002|Overall Study|Withdrawal by Subject|1|||
155167733|NCT02302339|560051017|FG003|Overall Study|Withdrawal by Subject|0|||
155167734|NCT04393454|560051020|FG000|Overall Study|Death|1|||
155167735|NCT04393454|560051020|FG000|Overall Study|Lost to Follow-up|1|||
155167736|NCT02752165|560051022|FG000|Overall Study|Withdrawal by Subject|6|||
155167737|NCT02752165|560051023|FG001|Overall Study|Withdrawal by Subject|6|||
155167738|NCT02752165|560051022|FG000|Overall Study|Protocol Violation|6|||
155167739|NCT02752165|560051023|FG001|Overall Study|Protocol Violation|5|||
155167740|NCT02752165|560051022|FG000|Overall Study|Lost to Follow-up|33|||
155167741|NCT02752165|560051023|FG001|Overall Study|Lost to Follow-up|38|||
155167742|NCT01120964|560051024|FG000|Overall Study|Did not receive full treatment|1|||
155167743|NCT01120964|560051025|FG001|Overall Study|Did not receive full treatment|0|||
155167744|NCT01704599|560051029|FG000|Overall Study|Adverse Event|1|||
155167745|NCT00912197|560051032|FG000|Overall Study|Withdrawal by Subject|3|||
155167746|NCT00912197|560051033|FG001|Overall Study|Withdrawal by Subject|3|||
155167747|NCT03304249|560051036|FG000|Overall Study|Lost to Follow-up|8|||
155167748|NCT03304249|560051037|FG001|Overall Study|Lost to Follow-up|10|||
155167749|NCT03304249|560051036|FG000|Overall Study|Withdrawal by Subject|12|||
155167750|NCT03304249|560051037|FG001|Overall Study|Withdrawal by Subject|2|||
155167751|NCT03304249|560051036|FG000|Overall Study|Moved Out of District|4|||
155167752|NCT03304249|560051037|FG001|Overall Study|Moved Out of District|2|||
155167753|NCT00494676|560051043|FG000|Allocation|Withdrawal by Subject|2|||
155167754|NCT00494676|560051044|FG001|Allocation|Withdrawal by Subject|4|||
155167755|NCT00494676|560051043|FG000|First Intervention|Withdrawal by Subject|1|||
155167756|NCT00494676|560051044|FG001|First Intervention|Withdrawal by Subject|3|||
155167757|NCT00494676|560051043|FG000|Second Intervention|Withdrawal by Subject|1|||
155167758|NCT00494676|560051044|FG001|Second Intervention|Withdrawal by Subject|1|||
155167759|NCT04976192|560051045|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167760|NCT04976192|560051046|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
155167761|NCT04976192|560051047|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167762|NCT04976192|560051048|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167763|NCT04976192|560051049|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167764|NCT04976192|560051050|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167765|NCT04976192|560051051|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167766|NCT04976192|560051052|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167767|NCT04976192|560051053|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167768|NCT04976192|560051054|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
155167769|NCT04976192|560051045|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
155167770|NCT04976192|560051046|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
155167771|NCT04976192|560051047|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
155167772|NCT04976192|560051048|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155167773|NCT04976192|560051049|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167774|NCT04976192|560051050|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167775|NCT04976192|560051051|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167776|NCT04976192|560051052|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167777|NCT04976192|560051053|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167778|NCT04976192|560051054|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167779|NCT04976192|560051045|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
155167780|NCT04976192|560051046|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167781|NCT04976192|560051047|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
155167782|NCT04976192|560051048|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167783|NCT04976192|560051049|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167784|NCT04976192|560051050|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167785|NCT04976192|560051051|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167786|NCT04976192|560051052|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167787|NCT04976192|560051053|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167788|NCT04976192|560051054|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
155167789|NCT04976192|560051045|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167790|NCT04976192|560051046|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167791|NCT04976192|560051047|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167792|NCT04976192|560051048|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155167793|NCT04976192|560051049|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
155167794|NCT04976192|560051050|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
155167795|NCT04976192|560051051|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155167796|NCT04976192|560051052|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
155167797|NCT04976192|560051053|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
155167798|NCT04976192|560051054|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
155167799|NCT04976192|560051045|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167800|NCT04976192|560051046|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167801|NCT04976192|560051047|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167802|NCT04976192|560051048|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167803|NCT04976192|560051049|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
155167804|NCT04976192|560051050|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167805|NCT04976192|560051051|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167806|NCT04976192|560051052|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167807|NCT04976192|560051053|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167808|NCT04976192|560051054|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
155167809|NCT04976192|560051045|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167810|NCT04976192|560051046|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167811|NCT04976192|560051047|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167812|NCT04976192|560051048|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167813|NCT04976192|560051049|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
154965628|NCT00112437|559298880|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
154965629|NCT00112437|559298881|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
154965630|NCT00112437|559298882|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
155167814|NCT04976192|560051050|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155167815|NCT04976192|560051051|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167816|NCT04976192|560051052|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167817|NCT04976192|560051053|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167818|NCT04976192|560051054|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155167819|NCT02621151|560051055|FG000|Overall Study|Not eligible for trial|6|||
155167820|NCT04198714|560051056|FG000|Overall Study|Physician Decision|0|||
155167821|NCT04198714|560051057|FG001|Overall Study|Physician Decision|1|||
155167822|NCT02529553|560051058|FG000|Overall Study|Progressive Disease|1|||
155167823|NCT02529553|560051059|FG001|Overall Study|Progressive Disease|0|||
155167824|NCT02529553|560051060|FG002|Overall Study|Progressive Disease|1|||
155167825|NCT02529553|560051061|FG003|Overall Study|Progressive Disease|3|||
155167826|NCT02529553|560051062|FG004|Overall Study|Progressive Disease|2|||
155167827|NCT02529553|560051063|FG005|Overall Study|Progressive Disease|3|||
155167828|NCT02529553|560051064|FG006|Overall Study|Progressive Disease|3|||
155167829|NCT02529553|560051065|FG007|Overall Study|Progressive Disease|5|||
155167830|NCT02529553|560051066|FG008|Overall Study|Progressive Disease|3|||
155167831|NCT02529553|560051058|FG000|Overall Study|Physician Decision|0|||
155167832|NCT02529553|560051059|FG001|Overall Study|Physician Decision|1|||
155167833|NCT02529553|560051060|FG002|Overall Study|Physician Decision|0|||
155167834|NCT02529553|560051061|FG003|Overall Study|Physician Decision|0|||
155167835|NCT02529553|560051062|FG004|Overall Study|Physician Decision|1|||
155167836|NCT02529553|560051063|FG005|Overall Study|Physician Decision|0|||
155167837|NCT02529553|560051064|FG006|Overall Study|Physician Decision|0|||
155167838|NCT02529553|560051065|FG007|Overall Study|Physician Decision|0|||
155167839|NCT02529553|560051066|FG008|Overall Study|Physician Decision|0|||
155167840|NCT02529553|560051058|FG000|Overall Study|Withdrawal by Subject|0|||
155167841|NCT02529553|560051059|FG001|Overall Study|Withdrawal by Subject|0|||
155167842|NCT02529553|560051060|FG002|Overall Study|Withdrawal by Subject|0|||
155167843|NCT02529553|560051061|FG003|Overall Study|Withdrawal by Subject|0|||
155167844|NCT02529553|560051062|FG004|Overall Study|Withdrawal by Subject|0|||
155167845|NCT02529553|560051063|FG005|Overall Study|Withdrawal by Subject|1|||
155167846|NCT02529553|560051064|FG006|Overall Study|Withdrawal by Subject|0|||
155167847|NCT02529553|560051065|FG007|Overall Study|Withdrawal by Subject|1|||
155167848|NCT02529553|560051066|FG008|Overall Study|Withdrawal by Subject|0|||
155167849|NCT04236141|560052987|FG000|Overall Study|Death|18|||
155167850|NCT04236141|560052988|FG001|Overall Study|Death|10|||
155167851|NCT04236141|560052987|FG000|Overall Study|Withdrawal by Participant|1|||
155167852|NCT04236141|560052988|FG001|Overall Study|Withdrawal by Participant|0|||
155167853|NCT04236141|560052987|FG000|Overall Study|Reason not Specified|1|||
155167854|NCT04236141|560052988|FG001|Overall Study|Reason not Specified|0|||
155167855|NCT04236141|560052987|FG000|Overall Study|Study terminated by Sponsor|8|||
155167856|NCT04236141|560052988|FG001|Overall Study|Study terminated by Sponsor|4|||
155167857|NCT01925131|560052989|FG000|Overall Study|Death|0|||
155167858|NCT01925131|560052990|FG001|Overall Study|Death|0|||
155167859|NCT01925131|560052991|FG002|Overall Study|Death|1|||
155167860|NCT01925131|560052992|FG003|Overall Study|Death|0|||
155167861|NCT01925131|560052993|FG004|Overall Study|Death|0|||
155167862|NCT01925131|560052994|FG005|Overall Study|Death|0|||
155167863|NCT01925131|560052989|FG000|Overall Study|Progression/Relapse|1|||
155167864|NCT01925131|560052990|FG001|Overall Study|Progression/Relapse|1|||
155167865|NCT01925131|560052991|FG002|Overall Study|Progression/Relapse|4|||
155167866|NCT01925131|560052992|FG003|Overall Study|Progression/Relapse|0|||
155167867|NCT01925131|560052993|FG004|Overall Study|Progression/Relapse|0|||
155167868|NCT01925131|560052994|FG005|Overall Study|Progression/Relapse|1|||
155167869|NCT01925131|560052989|FG000|Overall Study|Patient Refusal|1|||
155167870|NCT01925131|560052990|FG001|Overall Study|Patient Refusal|0|||
155167871|NCT01925131|560052991|FG002|Overall Study|Patient Refusal|0|||
155167872|NCT01925131|560052992|FG003|Overall Study|Patient Refusal|0|||
155167873|NCT01925131|560052993|FG004|Overall Study|Patient Refusal|0|||
155167874|NCT01925131|560052994|FG005|Overall Study|Patient Refusal|0|||
155167875|NCT01925131|560052989|FG000|Overall Study|Adverse Event|0|||
155167876|NCT01925131|560052990|FG001|Overall Study|Adverse Event|0|||
155167877|NCT01925131|560052991|FG002|Overall Study|Adverse Event|2|||
155167878|NCT01925131|560052992|FG003|Overall Study|Adverse Event|0|||
155167879|NCT01925131|560052993|FG004|Overall Study|Adverse Event|1|||
155167880|NCT01925131|560052994|FG005|Overall Study|Adverse Event|3|||
155167881|NCT01925131|560052989|FG000|Overall Study|Other - Not Protocol Specified|3|||
155167882|NCT01925131|560052990|FG001|Overall Study|Other - Not Protocol Specified|1|||
155167883|NCT01925131|560052991|FG002|Overall Study|Other - Not Protocol Specified|2|||
155167884|NCT01925131|560052992|FG003|Overall Study|Other - Not Protocol Specified|5|||
155167885|NCT01925131|560052993|FG004|Overall Study|Other - Not Protocol Specified|10|||
155167886|NCT01925131|560052994|FG005|Overall Study|Other - Not Protocol Specified|6|||
155371080|NCT01803282|560792023|FG011|Overall Study|Investigator's Discretion|0|||
155371081|NCT01803282|560792012|FG000|Overall Study|Adverse Event|0|||
155371082|NCT01803282|560792013|FG001|Overall Study|Adverse Event|0|||
155371083|NCT01803282|560792014|FG002|Overall Study|Adverse Event|0|||
155371084|NCT01803282|560792015|FG003|Overall Study|Adverse Event|0|||
155167887|NCT01395524|560052999|FG000|Overall Study|Non-compliance with study schedule|1|||
155167888|NCT01395524|560053000|FG001|Overall Study|Non-compliance with study schedule|0|||
155167889|NCT01395524|560053001|FG002|Overall Study|Non-compliance with study schedule|1|||
155167890|NCT01395524|560052999|FG000|Overall Study|Lost to Follow-up|3|||
155167891|NCT01395524|560053000|FG001|Overall Study|Lost to Follow-up|1|||
155167892|NCT01395524|560053001|FG002|Overall Study|Lost to Follow-up|1|||
155167893|NCT01395524|560052999|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
155167894|NCT01395524|560053000|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
155167895|NCT01395524|560053001|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
155167896|NCT01395524|560052999|FG000|Overall Study|Severe noncompliance with protocol|1|||
155167897|NCT01395524|560053000|FG001|Overall Study|Severe noncompliance with protocol|0|||
155167898|NCT01395524|560053001|FG002|Overall Study|Severe noncompliance with protocol|0|||
155167899|NCT01395524|560052999|FG000|Overall Study|Adverse Event|4|||
155167900|NCT01395524|560053000|FG001|Overall Study|Adverse Event|4|||
155167901|NCT01395524|560053001|FG002|Overall Study|Adverse Event|3|||
155167902|NCT01395524|560052999|FG000|Overall Study|Death|1|||
155167903|NCT01395524|560053000|FG001|Overall Study|Death|0|||
155167904|NCT01395524|560053001|FG002|Overall Study|Death|0|||
155167905|NCT01395524|560052999|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155167906|NCT01395524|560053000|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155167907|NCT01395524|560053001|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
155167908|NCT01395524|560052999|FG000|Overall Study|Withdrawal by Subject|4|||
155167909|NCT01395524|560053000|FG001|Overall Study|Withdrawal by Subject|8|||
155167910|NCT01395524|560053001|FG002|Overall Study|Withdrawal by Subject|8|||
155167911|NCT01395524|560052999|FG000|Overall Study|Did not receive treatment|1|||
155167912|NCT01395524|560053000|FG001|Overall Study|Did not receive treatment|1|||
155167913|NCT01395524|560053001|FG002|Overall Study|Did not receive treatment|3|||
155167914|NCT01395524|560052999|FG000|Overall Study|Subject had spinal surgery|0|||
155167915|NCT01395524|560053000|FG001|Overall Study|Subject had spinal surgery|0|||
155167916|NCT01395524|560053001|FG002|Overall Study|Subject had spinal surgery|1|||
155167917|NCT01657461|560053002|FG000|Overall Study|Death|9|||
155167918|NCT01657461|560053003|FG001|Overall Study|Death|12|||
155167919|NCT01657461|560053002|FG000|Overall Study|Lost to Follow-up|0|||
155167920|NCT01657461|560053003|FG001|Overall Study|Lost to Follow-up|3|||
155167921|NCT01657461|560053002|FG000|Overall Study|Physician Decision|0|||
155167922|NCT01657461|560053003|FG001|Overall Study|Physician Decision|2|||
155167923|NCT01657461|560053002|FG000|Overall Study|Withdrawal by Subject|1|||
155167924|NCT01657461|560053003|FG001|Overall Study|Withdrawal by Subject|3|||
155167925|NCT00122980|560053011|FG000|Overall Study|Death|0|||
155167926|NCT00122980|560053012|FG001|Overall Study|Death|1|||
155167927|NCT00122980|560053011|FG000|Overall Study|Physician Decision|2|||
155167928|NCT00122980|560053012|FG001|Overall Study|Physician Decision|0|||
155167929|NCT00122980|560053011|FG000|Overall Study|Protocol Violation|5|||
155167930|NCT00122980|560053012|FG001|Overall Study|Protocol Violation|1|||
155167931|NCT00122980|560053011|FG000|Overall Study|Withdrawal by Subject|2|||
155167932|NCT00122980|560053012|FG001|Overall Study|Withdrawal by Subject|3|||
155167933|NCT00122980|560053011|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
155167934|NCT00122980|560053012|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
155167935|NCT00122980|560053011|FG000|Overall Study|Study termination|27|||
155167936|NCT00122980|560053012|FG001|Overall Study|Study termination|35|||
155167937|NCT02175199|560053013|FG000|Overall Study|Withdrawal by Subject|1|||
155167938|NCT02175199|560053014|FG001|Overall Study|Withdrawal by Subject|5|||
155167939|NCT02175199|560053013|FG000|Overall Study|Randomized in Error|1|||
155167940|NCT02175199|560053014|FG001|Overall Study|Randomized in Error|0|||
155167941|NCT02175199|560053013|FG000|Overall Study|Sponsor Decision|1|||
155167942|NCT02175199|560053014|FG001|Overall Study|Sponsor Decision|0|||
155167943|NCT01124864|560053017|FG000|Overall Study|Follow up phase competed as per protocol|18|||
155167944|NCT01124864|560053018|FG001|Overall Study|Follow up phase competed as per protocol|22|||
155167945|NCT01124864|560053019|FG002|Overall Study|Follow up phase competed as per protocol|24|||
155167946|NCT01124864|560053020|FG003|Overall Study|Follow up phase competed as per protocol|18|||
155167947|NCT01124864|560053021|FG004|Overall Study|Follow up phase competed as per protocol|26|||
155167948|NCT01124864|560053022|FG005|Overall Study|Follow up phase competed as per protocol|2|||
155167949|NCT01124864|560053017|FG000|Overall Study|Death|6|||
155167950|NCT01124864|560053018|FG001|Overall Study|Death|9|||
155167951|NCT01124864|560053019|FG002|Overall Study|Death|6|||
155167952|NCT01124864|560053020|FG003|Overall Study|Death|2|||
155167953|NCT01124864|560053021|FG004|Overall Study|Death|1|||
155167954|NCT01124864|560053022|FG005|Overall Study|Death|0|||
155167955|NCT01124864|560053017|FG000|Overall Study|Withdrawal by Subject|2|||
155167956|NCT01124864|560053018|FG001|Overall Study|Withdrawal by Subject|3|||
155371085|NCT01803282|560792016|FG004|Overall Study|Adverse Event|0|||
155371086|NCT01803282|560792017|FG005|Overall Study|Adverse Event|0|||
155167957|NCT01124864|560053019|FG002|Overall Study|Withdrawal by Subject|4|||
155167958|NCT01124864|560053020|FG003|Overall Study|Withdrawal by Subject|0|||
155167959|NCT01124864|560053021|FG004|Overall Study|Withdrawal by Subject|2|||
155167960|NCT01124864|560053022|FG005|Overall Study|Withdrawal by Subject|1|||
155167961|NCT01124864|560053017|FG000|Overall Study|Lost to Follow-up|1|||
155167962|NCT01124864|560053018|FG001|Overall Study|Lost to Follow-up|1|||
155167963|NCT01124864|560053019|FG002|Overall Study|Lost to Follow-up|0|||
155167964|NCT01124864|560053020|FG003|Overall Study|Lost to Follow-up|1|||
155167965|NCT01124864|560053021|FG004|Overall Study|Lost to Follow-up|0|||
155090614|NCT04617860|559765065|FG001|Overall Study|Adverse Event|2|||
155090615|NCT04617860|559765066|FG002|Overall Study|Adverse Event|2|||
155090616|NCT04617860|559765064|FG000|Overall Study|Withdrawal by Subject|0|||
155090617|NCT04617860|559765065|FG001|Overall Study|Withdrawal by Subject|0|||
155090618|NCT04617860|559765066|FG002|Overall Study|Withdrawal by Subject|2|||
155090619|NCT04617860|559765064|FG000|Overall Study|Physician Decision|0|||
155090620|NCT04617860|559765065|FG001|Overall Study|Physician Decision|1|||
155090621|NCT04617860|559765066|FG002|Overall Study|Physician Decision|0|||
155090622|NCT04617860|559765064|FG000|Overall Study|Sponsor Decision|0|||
155090623|NCT04617860|559765065|FG001|Overall Study|Sponsor Decision|3|||
155090624|NCT04617860|559765066|FG002|Overall Study|Sponsor Decision|1|||
155090625|NCT04617860|559765064|FG000|Overall Study|Termination of Study by Sponsor|8|||
155090626|NCT04617860|559765065|FG001|Overall Study|Termination of Study by Sponsor|4|||
155090627|NCT04617860|559765066|FG002|Overall Study|Termination of Study by Sponsor|13|||
155090628|NCT02836249|559765067|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155090629|NCT02836249|559765068|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
155090630|NCT02836249|559765069|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155090631|NCT02836249|559765070|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155090632|NCT02836249|559765067|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
155090633|NCT02836249|559765068|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
155090634|NCT02836249|559765069|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
155090635|NCT02836249|559765070|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
155090636|NCT02836249|559765067|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
155090637|NCT02836249|559765068|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
155090638|NCT02836249|559765069|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
155090639|NCT02836249|559765070|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
155090640|NCT02836249|559765067|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155090641|NCT02836249|559765068|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155090642|NCT02836249|559765069|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155090643|NCT02836249|559765070|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155090644|NCT02836249|559765067|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
155090645|NCT02836249|559765068|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
155090646|NCT02836249|559765069|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
155090647|NCT02836249|559765070|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
155090648|NCT02836249|559765067|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
155090649|NCT02836249|559765068|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155090650|NCT02836249|559765069|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155090651|NCT02836249|559765070|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
155090652|NCT02836249|559765067|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155090653|NCT02836249|559765068|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155090654|NCT02836249|559765069|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
155090655|NCT02836249|559765070|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
155090656|NCT02836249|559765067|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155090657|NCT02836249|559765068|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155090658|NCT02836249|559765069|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
155090659|NCT02836249|559765070|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
155090660|NCT02836249|559765067|FG000|Open-Label TAF Treatment Phase|Death|0|||
155090661|NCT02836249|559765068|FG001|Open-Label TAF Treatment Phase|Death|0|||
155090662|NCT02836249|559765069|FG002|Open-Label TAF Treatment Phase|Death|1|||
155090663|NCT02836249|559765070|FG003|Open-Label TAF Treatment Phase|Death|0|||
155090664|NCT02836249|559765067|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
155090665|NCT02836249|559765068|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
155090666|NCT02836249|559765069|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
155090667|NCT02836249|559765070|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
155090668|NCT02836249|559765067|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
155090669|NCT02836249|559765068|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
155090670|NCT02836249|559765069|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
155090671|NCT02836249|559765070|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
155090672|NCT04752566|559765071|FG000|Overall Study|Protocol Violation|0|||
155090673|NCT04752566|559765072|FG001|Overall Study|Protocol Violation|1|||
155090674|NCT04752566|559765071|FG000|Overall Study|Death|1|||
155090675|NCT04752566|559765072|FG001|Overall Study|Death|0|||
155090676|NCT04752566|559765071|FG000|Overall Study|Adverse Event|1|||
155090677|NCT04752566|559765072|FG001|Overall Study|Adverse Event|0|||
155090678|NCT04752566|559765071|FG000|Overall Study|Withdrawal by Subject|2|||
155090679|NCT04752566|559765072|FG001|Overall Study|Withdrawal by Subject|0|||
155090680|NCT04752566|559765071|FG000|Overall Study|Physician Decision|1|||
155090681|NCT04752566|559765072|FG001|Overall Study|Physician Decision|1|||
155090682|NCT03331354|559765073|FG000|Overall Study|Withdrawal by Subject|1|||
155090683|NCT03331354|559765074|FG001|Overall Study|Withdrawal by Subject|3|||
155090684|NCT03331354|559765073|FG000|Overall Study|Lost to Follow-up|3|||
155090685|NCT03331354|559765074|FG001|Overall Study|Lost to Follow-up|3|||
155090686|NCT03331354|559765073|FG000|Overall Study|Found employment before initiated active intervention|0|||
155090687|NCT03331354|559765074|FG001|Overall Study|Found employment before initiated active intervention|4|||
155090688|NCT01646827|559765075|FG000|Overall Study|Lost to Follow-up|0|||
155090689|NCT01646827|559765076|FG001|Overall Study|Lost to Follow-up|3|||
155090690|NCT01646827|559765075|FG000|Overall Study|Physician Decision|1|||
155090691|NCT01646827|559765076|FG001|Overall Study|Physician Decision|2|||
155090692|NCT01646827|559765075|FG000|Overall Study|Withdrawal by Subject|1|||
155090693|NCT01646827|559765076|FG001|Overall Study|Withdrawal by Subject|0|||
155090694|NCT05134649|559765077|FG000|Overall Study|Lost to Follow-up|12|||
155090695|NCT05134649|559765077|FG000|Overall Study|Withdrawal by Subject|14|||
155090696|NCT05134649|559765077|FG000|Overall Study|Pregnancy|1|||
155090697|NCT05134649|559765077|FG000|Overall Study|Other, not specified|3|||
155090698|NCT03213509|559765093|FG000|Overall Study|Did not consent for verbal autopsy|4|||
155090699|NCT03213509|559765094|FG001|Overall Study|Did not consent for verbal autopsy|5|||
155090700|NCT04251533|559765101|FG000|Overall Study|Progressive disease|33|||
155090701|NCT04251533|559765102|FG001|Overall Study|Progressive disease|29|||
155090702|NCT04251533|559765103|FG002|Overall Study|Progressive disease|22|||
155090703|NCT04251533|559765101|FG000|Overall Study|Death|5|||
155090704|NCT04251533|559765102|FG001|Overall Study|Death|1|||
155090705|NCT04251533|559765103|FG002|Overall Study|Death|3|||
155090706|NCT04251533|559765101|FG000|Overall Study|Physician Decision|3|||
155090707|NCT04251533|559765102|FG001|Overall Study|Physician Decision|2|||
155090708|NCT04251533|559765103|FG002|Overall Study|Physician Decision|4|||
155090709|NCT04251533|559765101|FG000|Overall Study|Participant decision|1|||
155090710|NCT04251533|559765102|FG001|Overall Study|Participant decision|3|||
155090711|NCT04251533|559765103|FG002|Overall Study|Participant decision|1|||
155371087|NCT01803282|560792018|FG006|Overall Study|Adverse Event|1|||
155090712|NCT04251533|559765101|FG000|Overall Study|Adverse Event|2|||
155090713|NCT04251533|559765102|FG001|Overall Study|Adverse Event|1|||
155167966|NCT01124864|560053022|FG005|Overall Study|Lost to Follow-up|0|||
155167967|NCT01124864|560053017|FG000|Overall Study|Protocol Violation|1|||
155167968|NCT01124864|560053018|FG001|Overall Study|Protocol Violation|0|||
155167969|NCT01124864|560053019|FG002|Overall Study|Protocol Violation|0|||
155167970|NCT01124864|560053020|FG003|Overall Study|Protocol Violation|0|||
155167971|NCT01124864|560053021|FG004|Overall Study|Protocol Violation|1|||
155167972|NCT01124864|560053022|FG005|Overall Study|Protocol Violation|0|||
155167973|NCT01761162|560053029|FG000|Overall Study|Withdrawal by Subject|3|||
155167974|NCT00724711|560053034|FG000|Overall Study|Adverse Event|7|||
155167975|NCT00724711|560053035|FG001|Overall Study|Adverse Event|3|||
155167976|NCT00724711|560053034|FG000|Overall Study|Pregnancy|0|||
155167977|NCT00724711|560053035|FG001|Overall Study|Pregnancy|1|||
155167978|NCT00724711|560053034|FG000|Overall Study|Lack of Efficacy|0|||
155167979|NCT00724711|560053035|FG001|Overall Study|Lack of Efficacy|1|||
155167980|NCT00724711|560053034|FG000|Overall Study|Physician Decision|0|||
155167981|NCT00724711|560053035|FG001|Overall Study|Physician Decision|3|||
155167982|NCT00724711|560053034|FG000|Overall Study|Withdrawal by Subject|5|||
155167983|NCT00724711|560053035|FG001|Overall Study|Withdrawal by Subject|4|||
155167984|NCT00724711|560053034|FG000|Overall Study|Lost to Follow-up|4|||
155167985|NCT00724711|560053035|FG001|Overall Study|Lost to Follow-up|5|||
155167986|NCT00724711|560053034|FG000|Overall Study|Protocol Violation|1|||
155167987|NCT00724711|560053035|FG001|Overall Study|Protocol Violation|0|||
155167988|NCT00745849|560053036|FG000|First Intervention|Withdrawal by Subject|0|||
155167989|NCT00745849|560053037|FG001|First Intervention|Withdrawal by Subject|1|||
155167990|NCT00745849|560053036|FG000|First Intervention|Lost to Follow-up|1|||
155167991|NCT00745849|560053037|FG001|First Intervention|Lost to Follow-up|1|||
155167992|NCT00745849|560053036|FG000|Second Intervention|Lost to Follow-up|2|||
155167993|NCT00745849|560053037|FG001|Second Intervention|Lost to Follow-up|1|||
155167994|NCT01139008|560053038|FG000|Overall Study|Withdrawal by Subject|5|||
155167995|NCT01139008|560053038|FG000|Overall Study|Non-compliant, lost product|1|||
155167996|NCT01754727|560053041|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
155167997|NCT02785770|560053042|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
155167998|NCT02785770|560053043|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
155167999|NCT02785770|560053044|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
155168000|NCT02785770|560053045|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
155168001|NCT02785770|560053042|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
155168002|NCT02785770|560053043|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
155168003|NCT02785770|560053044|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
155168004|NCT02785770|560053045|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
155168005|NCT02785770|560053042|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
155168006|NCT02785770|560053043|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
155168007|NCT02785770|560053044|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
155168008|NCT02785770|560053045|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
155168009|NCT04838977|560053049|FG000|Overall Study|Lost to Follow-up|2|||
155168010|NCT04838977|560053050|FG001|Overall Study|Lost to Follow-up|3|||
155168011|NCT04838977|560053049|FG000|Overall Study|Withdrawal by Subject|1|||
155168012|NCT04838977|560053050|FG001|Overall Study|Withdrawal by Subject|1|||
155168013|NCT01088048|560053051|FG000|Overall Study|Adverse Event|7|||
155168014|NCT01088048|560053052|FG001|Overall Study|Adverse Event|9|||
155168015|NCT01088048|560053053|FG002|Overall Study|Adverse Event|7|||
155168016|NCT01088048|560053054|FG003|Overall Study|Adverse Event|5|||
155168017|NCT01088048|560053055|FG004|Overall Study|Adverse Event|6|||
155168018|NCT01088048|560053056|FG005|Overall Study|Adverse Event|3|||
155168019|NCT01088048|560053057|FG006|Overall Study|Adverse Event|3|||
155168020|NCT01088048|560053058|FG007|Overall Study|Adverse Event|0|||
155168021|NCT01088048|560053059|FG008|Overall Study|Adverse Event|2|||
155168022|NCT01088048|560053060|FG009|Overall Study|Adverse Event|2|||
155168023|NCT01088048|560053051|FG000|Overall Study|Withdrew Consent|1|||
155168024|NCT01088048|560053052|FG001|Overall Study|Withdrew Consent|1|||
155168025|NCT01088048|560053053|FG002|Overall Study|Withdrew Consent|1|||
155168026|NCT01088048|560053054|FG003|Overall Study|Withdrew Consent|1|||
155168027|NCT01088048|560053055|FG004|Overall Study|Withdrew Consent|2|||
155168028|NCT01088048|560053056|FG005|Overall Study|Withdrew Consent|1|||
155168029|NCT01088048|560053057|FG006|Overall Study|Withdrew Consent|0|||
155168030|NCT01088048|560053058|FG007|Overall Study|Withdrew Consent|2|||
155168031|NCT01088048|560053059|FG008|Overall Study|Withdrew Consent|2|||
155168032|NCT01088048|560053060|FG009|Overall Study|Withdrew Consent|1|||
155168033|NCT01088048|560053051|FG000|Overall Study|Concomitant Medication Prohibited|1|||
155168034|NCT01088048|560053052|FG001|Overall Study|Concomitant Medication Prohibited|0|||
155168035|NCT01088048|560053053|FG002|Overall Study|Concomitant Medication Prohibited|0|||
155168036|NCT01088048|560053054|FG003|Overall Study|Concomitant Medication Prohibited|0|||
155168037|NCT01088048|560053055|FG004|Overall Study|Concomitant Medication Prohibited|0|||
155168038|NCT01088048|560053056|FG005|Overall Study|Concomitant Medication Prohibited|0|||
155168039|NCT01088048|560053057|FG006|Overall Study|Concomitant Medication Prohibited|0|||
155168040|NCT01088048|560053058|FG007|Overall Study|Concomitant Medication Prohibited|0|||
155168041|NCT01088048|560053059|FG008|Overall Study|Concomitant Medication Prohibited|0|||
155168042|NCT01088048|560053060|FG009|Overall Study|Concomitant Medication Prohibited|0|||
155168043|NCT01088048|560053051|FG000|Overall Study|Investigator Request|2|||
155168044|NCT01088048|560053052|FG001|Overall Study|Investigator Request|2|||
155168045|NCT01088048|560053053|FG002|Overall Study|Investigator Request|0|||
155168046|NCT01088048|560053054|FG003|Overall Study|Investigator Request|0|||
154965631|NCT00112437|559298883|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
154965632|NCT00112437|559298884|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
154965633|NCT00112437|559298885|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
155371088|NCT01803282|560792019|FG007|Overall Study|Adverse Event|2|||
155371089|NCT01803282|560792020|FG008|Overall Study|Adverse Event|0|||
155371090|NCT01803282|560792021|FG009|Overall Study|Adverse Event|1|||
155371091|NCT01803282|560792022|FG010|Overall Study|Adverse Event|0|||
155371092|NCT01803282|560792023|FG011|Overall Study|Adverse Event|3|||
155371093|NCT01803282|560792012|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155371094|NCT01803282|560792013|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155371095|NCT01803282|560792014|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155371096|NCT01803282|560792015|FG003|Overall Study|Non-Compliance with Study Drug|1|||
155168047|NCT01088048|560053055|FG004|Overall Study|Investigator Request|3|||
155168048|NCT01088048|560053056|FG005|Overall Study|Investigator Request|1|||
155168049|NCT01088048|560053057|FG006|Overall Study|Investigator Request|1|||
155168050|NCT01088048|560053058|FG007|Overall Study|Investigator Request|0|||
155168051|NCT01088048|560053059|FG008|Overall Study|Investigator Request|0|||
155168052|NCT01088048|560053060|FG009|Overall Study|Investigator Request|0|||
155168053|NCT01088048|560053051|FG000|Overall Study|Patient Non-compliance|0|||
155168054|NCT01088048|560053052|FG001|Overall Study|Patient Non-compliance|1|||
155168055|NCT01088048|560053053|FG002|Overall Study|Patient Non-compliance|0|||
155168056|NCT01088048|560053054|FG003|Overall Study|Patient Non-compliance|0|||
155168057|NCT01088048|560053055|FG004|Overall Study|Patient Non-compliance|0|||
155168058|NCT01088048|560053056|FG005|Overall Study|Patient Non-compliance|0|||
155168059|NCT01088048|560053057|FG006|Overall Study|Patient Non-compliance|0|||
155168060|NCT01088048|560053058|FG007|Overall Study|Patient Non-compliance|0|||
155168061|NCT01088048|560053059|FG008|Overall Study|Patient Non-compliance|0|||
155168062|NCT01088048|560053060|FG009|Overall Study|Patient Non-compliance|0|||
155168063|NCT01088048|560053051|FG000|Overall Study|Disease Progression|7|||
155168064|NCT01088048|560053052|FG001|Overall Study|Disease Progression|4|||
155168065|NCT01088048|560053053|FG002|Overall Study|Disease Progression|3|||
155168066|NCT01088048|560053054|FG003|Overall Study|Disease Progression|5|||
155168067|NCT01088048|560053055|FG004|Overall Study|Disease Progression|3|||
155168068|NCT01088048|560053056|FG005|Overall Study|Disease Progression|3|||
155168069|NCT01088048|560053057|FG006|Overall Study|Disease Progression|2|||
155168070|NCT01088048|560053058|FG007|Overall Study|Disease Progression|1|||
155168071|NCT01088048|560053059|FG008|Overall Study|Disease Progression|0|||
155168072|NCT01088048|560053060|FG009|Overall Study|Disease Progression|0|||
155168073|NCT01088048|560053051|FG000|Overall Study|Death|1|||
155168074|NCT01088048|560053052|FG001|Overall Study|Death|5|||
155168075|NCT01088048|560053053|FG002|Overall Study|Death|3|||
155168076|NCT01088048|560053054|FG003|Overall Study|Death|3|||
155168077|NCT01088048|560053055|FG004|Overall Study|Death|1|||
155168078|NCT01088048|560053056|FG005|Overall Study|Death|3|||
155168079|NCT01088048|560053057|FG006|Overall Study|Death|0|||
155168080|NCT01088048|560053058|FG007|Overall Study|Death|0|||
155168081|NCT01088048|560053059|FG008|Overall Study|Death|3|||
155168082|NCT01088048|560053060|FG009|Overall Study|Death|1|||
155168083|NCT01088048|560053051|FG000|Overall Study|Other|3|||
155168084|NCT01088048|560053052|FG001|Overall Study|Other|5|||
155168085|NCT01088048|560053053|FG002|Overall Study|Other|0|||
155168086|NCT01088048|560053054|FG003|Overall Study|Other|0|||
155168087|NCT01088048|560053055|FG004|Overall Study|Other|2|||
155168088|NCT01088048|560053056|FG005|Overall Study|Other|0|||
155168089|NCT01088048|560053057|FG006|Overall Study|Other|0|||
155168090|NCT01088048|560053058|FG007|Overall Study|Other|2|||
155168091|NCT01088048|560053059|FG008|Overall Study|Other|0|||
155168092|NCT01088048|560053060|FG009|Overall Study|Other|0|||
155168093|NCT00950859|560053061|FG000|Overall Study|Adverse Event|3|||
155168094|NCT00950859|560053062|FG001|Overall Study|Adverse Event|3|||
155168095|NCT00950859|560053061|FG000|Overall Study|Insufficient Viral Load Response|12|||
155168096|NCT00950859|560053062|FG001|Overall Study|Insufficient Viral Load Response|3|||
155168097|NCT00950859|560053061|FG000|Overall Study|Protocol Violation|1|||
155168098|NCT00950859|560053062|FG001|Overall Study|Protocol Violation|1|||
155168099|NCT00950859|560053061|FG000|Overall Study|Lost to Follow-up|0|||
155168100|NCT00950859|560053062|FG001|Overall Study|Lost to Follow-up|3|||
155168101|NCT00545272|560053066|FG000|Overall Study|Protocol deviation|0|||
155168102|NCT00545272|560053067|FG001|Overall Study|Protocol deviation|1|||
155168103|NCT00545272|560053068|FG002|Overall Study|Protocol deviation|0|||
155168104|NCT00545272|560053069|FG003|Overall Study|Protocol deviation|1|||
155168105|NCT00545272|560053070|FG004|Overall Study|Protocol deviation|0|||
155168106|NCT00545272|560053071|FG005|Overall Study|Protocol deviation|1|||
155168107|NCT00545272|560053066|FG000|Overall Study|Adverse Event|0|||
155168108|NCT00545272|560053067|FG001|Overall Study|Adverse Event|0|||
155168109|NCT00545272|560053068|FG002|Overall Study|Adverse Event|1|||
155168110|NCT00545272|560053069|FG003|Overall Study|Adverse Event|0|||
155168111|NCT00545272|560053070|FG004|Overall Study|Adverse Event|0|||
155371097|NCT01803282|560792016|FG004|Overall Study|Non-Compliance with Study Drug|0|||
155371098|NCT01803282|560792017|FG005|Overall Study|Non-Compliance with Study Drug|0|||
155371099|NCT01803282|560792018|FG006|Overall Study|Non-Compliance with Study Drug|0|||
155371100|NCT01803282|560792019|FG007|Overall Study|Non-Compliance with Study Drug|0|||
155371101|NCT01803282|560792020|FG008|Overall Study|Non-Compliance with Study Drug|0|||
155371102|NCT01803282|560792021|FG009|Overall Study|Non-Compliance with Study Drug|0|||
155371103|NCT01803282|560792022|FG010|Overall Study|Non-Compliance with Study Drug|0|||
155371104|NCT01803282|560792023|FG011|Overall Study|Non-Compliance with Study Drug|0|||
155371105|NCT01803282|560792012|FG000|Overall Study|Unknown Reason|0|||
155371106|NCT01803282|560792013|FG001|Overall Study|Unknown Reason|0|||
155371107|NCT01803282|560792014|FG002|Overall Study|Unknown Reason|0|||
155371108|NCT01803282|560792015|FG003|Overall Study|Unknown Reason|0|||
155371109|NCT01803282|560792016|FG004|Overall Study|Unknown Reason|0|||
155371110|NCT01803282|560792017|FG005|Overall Study|Unknown Reason|0|||
155371111|NCT01803282|560792018|FG006|Overall Study|Unknown Reason|0|||
155371112|NCT01803282|560792019|FG007|Overall Study|Unknown Reason|1|||
155371113|NCT01803282|560792020|FG008|Overall Study|Unknown Reason|0|||
155371114|NCT01803282|560792021|FG009|Overall Study|Unknown Reason|0|||
155371115|NCT01803282|560792022|FG010|Overall Study|Unknown Reason|0|||
155371116|NCT01803282|560792023|FG011|Overall Study|Unknown Reason|0|||
155371117|NCT01803282|560792012|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
155371118|NCT01803282|560792013|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
155371119|NCT01803282|560792014|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
155371120|NCT01803282|560792015|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
155371121|NCT01803282|560792016|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
155371122|NCT01803282|560792017|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
155371123|NCT01803282|560792018|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
155371124|NCT01803282|560792019|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
155371125|NCT01803282|560792020|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
155371126|NCT01803282|560792021|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
155371127|NCT01803282|560792022|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
155371128|NCT01803282|560792023|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
155371129|NCT01803282|560792012|FG000|Overall Study|Enrolled but Never Treated|0|||
155371130|NCT01803282|560792013|FG001|Overall Study|Enrolled but Never Treated|0|||
155371131|NCT01803282|560792014|FG002|Overall Study|Enrolled but Never Treated|0|||
155371132|NCT01803282|560792015|FG003|Overall Study|Enrolled but Never Treated|0|||
155371133|NCT01803282|560792016|FG004|Overall Study|Enrolled but Never Treated|1|||
155371134|NCT01803282|560792017|FG005|Overall Study|Enrolled but Never Treated|0|||
155371135|NCT01803282|560792018|FG006|Overall Study|Enrolled but Never Treated|1|||
155371136|NCT01803282|560792019|FG007|Overall Study|Enrolled but Never Treated|1|||
155371137|NCT01803282|560792020|FG008|Overall Study|Enrolled but Never Treated|0|||
155371138|NCT01803282|560792021|FG009|Overall Study|Enrolled but Never Treated|1|||
155371139|NCT01803282|560792022|FG010|Overall Study|Enrolled but Never Treated|0|||
155371140|NCT01803282|560792023|FG011|Overall Study|Enrolled but Never Treated|0|||
155371141|NCT02671500|560792025|FG000|Overall Study|Lack of Efficacy|12|||
155371142|NCT02671500|560792025|FG000|Overall Study|Lost to Follow-up|2|||
155371143|NCT03086655|560792029|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
155371144|NCT03086655|560792030|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
155371145|NCT03086655|560792029|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
155371146|NCT03086655|560792030|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
155371147|NCT03086655|560792029|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
155371148|NCT03086655|560792030|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
155371149|NCT03086655|560792029|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
155371150|NCT03086655|560792030|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
155371151|NCT03086655|560792029|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
155371152|NCT03086655|560792030|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
155371153|NCT03086655|560792029|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
155371154|NCT03086655|560792030|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
155371155|NCT03086655|560792029|FG000|12 Month Follow-up = Final Assessment|Death|0|||
155371156|NCT03086655|560792030|FG001|12 Month Follow-up = Final Assessment|Death|1|||
155371157|NCT00798434|560792031|FG000|Double-Blind|Adverse Event|22|||
155371158|NCT00798434|560792032|FG001|Double-Blind|Adverse Event|46|||
155090714|NCT04251533|559765103|FG002|Overall Study|Adverse Event|1|||
155371159|NCT00798434|560792031|FG000|Double-Blind|Death|0|||
155090715|NCT02303821|559765106|FG000|Overall Study|Withdrawal by Subject|0|||
155090716|NCT02303821|559765107|FG001|Overall Study|Withdrawal by Subject|0|||
155090717|NCT02303821|559765108|FG002|Overall Study|Withdrawal by Subject|0|||
155371160|NCT00798434|560792032|FG001|Double-Blind|Death|1|||
155371161|NCT00798434|560792031|FG000|Double-Blind|Lost to Follow-up|1|||
155371162|NCT00798434|560792032|FG001|Double-Blind|Lost to Follow-up|0|||
155371163|NCT00798434|560792031|FG000|Double-Blind|Lack of Efficacy|8|||
155371164|NCT00798434|560792032|FG001|Double-Blind|Lack of Efficacy|12|||
155371165|NCT00798434|560792031|FG000|Double-Blind|Withdrawal by Subject|17|||
155371166|NCT00798434|560792032|FG001|Double-Blind|Withdrawal by Subject|14|||
155371167|NCT00798434|560792031|FG000|Double-Blind|Protocol Violation|1|||
155371168|NCT00798434|560792032|FG001|Double-Blind|Protocol Violation|4|||
155371169|NCT00798434|560792031|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
155371170|NCT00798434|560792032|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
155371171|NCT00798434|560792031|FG000|Double-Blind|Other|1|||
155371172|NCT00798434|560792032|FG001|Double-Blind|Other|0|||
155371173|NCT00798434|560792031|FG000|Double-Blind|Not Treated|3|||
155371174|NCT00798434|560792032|FG001|Double-Blind|Not Treated|6|||
155371175|NCT00798434|560792031|FG000|Open-Label|Adverse Event|33|||
155371176|NCT00798434|560792032|FG001|Open-Label|Adverse Event|11|||
155371177|NCT00798434|560792031|FG000|Open-Label|Lack of Efficacy|5|||
155371178|NCT00798434|560792032|FG001|Open-Label|Lack of Efficacy|11|||
155371179|NCT00798434|560792031|FG000|Open-Label|Withdrawal by Subject|2|||
155371180|NCT00798434|560792032|FG001|Open-Label|Withdrawal by Subject|7|||
155371181|NCT00798434|560792031|FG000|Open-Label|Protocol Violation|1|||
155371182|NCT00798434|560792032|FG001|Open-Label|Protocol Violation|0|||
155371183|NCT00798434|560792031|FG000|Open-Label|Other|1|||
155371184|NCT00798434|560792032|FG001|Open-Label|Other|2|||
155371185|NCT00798434|560792031|FG000|Open-Label|Not Treated|0|||
155371186|NCT00798434|560792032|FG001|Open-Label|Not Treated|1|||
155371187|NCT01217437|560792036|FG000|Overall Study|Adverse Event|0|||
155371188|NCT01217437|560792037|FG001|Overall Study|Adverse Event|8|||
155371189|NCT01217437|560792036|FG000|Overall Study|Death|5|||
155371190|NCT01217437|560792037|FG001|Overall Study|Death|0|||
155371191|NCT01217437|560792036|FG000|Overall Study|Lack of Efficacy|29|||
155371192|NCT01217437|560792037|FG001|Overall Study|Lack of Efficacy|25|||
155371193|NCT01217437|560792036|FG000|Overall Study|Physician Decision|8|||
155371194|NCT01217437|560792037|FG001|Overall Study|Physician Decision|5|||
155371195|NCT01217437|560792036|FG000|Overall Study|Withdrawal by Subject|0|||
155371196|NCT01217437|560792037|FG001|Overall Study|Withdrawal by Subject|2|||
155371197|NCT01217437|560792036|FG000|Overall Study|Ineligible|1|||
155371198|NCT01217437|560792037|FG001|Overall Study|Ineligible|1|||
155371199|NCT00387426|560793420|FG000|Overall Study|Lack of Response|7|||
155371200|NCT00387426|560793420|FG000|Overall Study|Toxicities|4|||
155371201|NCT00387426|560793420|FG000|Overall Study|Disease Progression|3|||
155371202|NCT00890695|560793421|FG000|Overall Study|Protocol Violation|1|||
155371203|NCT00890695|560793422|FG001|Overall Study|Protocol Violation|0|||
155371204|NCT02314780|560793425|FG000|Overall Study|organizational reasons|0|||
155371205|NCT02314780|560793426|FG001|Overall Study|organizational reasons|2|||
155371206|NCT02314780|560793427|FG002|Overall Study|organizational reasons|0|||
155371207|NCT02314780|560793425|FG000|Overall Study|Adverse Event|0|||
155371208|NCT02314780|560793426|FG001|Overall Study|Adverse Event|1|||
155371209|NCT02314780|560793427|FG002|Overall Study|Adverse Event|0|||
155371210|NCT03986944|560793430|FG000|Overall Study|Adverse Event|1|||
155371211|NCT03986944|560793431|FG001|Overall Study|Adverse Event|2|||
155371212|NCT03986944|560793432|FG002|Overall Study|Adverse Event|3|||
155371213|NCT03986944|560793430|FG000|Overall Study|Protocol Violation|0|||
155371214|NCT03986944|560793431|FG001|Overall Study|Protocol Violation|1|||
155371215|NCT03986944|560793432|FG002|Overall Study|Protocol Violation|1|||
155371216|NCT03986944|560793430|FG000|Overall Study|Withdrawal by Subject|3|||
155371217|NCT03986944|560793431|FG001|Overall Study|Withdrawal by Subject|5|||
155371218|NCT03986944|560793432|FG002|Overall Study|Withdrawal by Subject|5|||
155371219|NCT03986944|560793430|FG000|Overall Study|Study termination|10|||
155371220|NCT03986944|560793431|FG001|Overall Study|Study termination|10|||
155371221|NCT03986944|560793432|FG002|Overall Study|Study termination|10|||
155371222|NCT03986944|560793430|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
155371223|NCT03986944|560793431|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
155371224|NCT03986944|560793432|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
155371225|NCT03986944|560793430|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
155371226|NCT03986944|560793431|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
155371227|NCT03986944|560793432|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
155371228|NCT03002220|560793433|FG000|Overall Study|Lack of Efficacy|2|||
155371229|NCT03002220|560793433|FG000|Overall Study|Withdrawal by Subject|3|||
155371230|NCT03002220|560793433|FG000|Overall Study|Adverse Event|2|||
155371231|NCT03002220|560793433|FG000|Overall Study|Disease progression|13|||
155371232|NCT03002220|560793433|FG000|Overall Study|Physician Decision|1|||
155371233|NCT01015560|560793434|FG000|Overall Study|Adverse Event|1|||
155371234|NCT01015560|560793434|FG000|Overall Study|Not protocol specified|1|||
155371235|NCT01015560|560793434|FG000|Overall Study|Withdrawal by Subject|1|||
155371236|NCT00837694|560793435|FG000|Overall Study|Lost to Follow-up|2|||
155371237|NCT00837694|560793436|FG001|Overall Study|Lost to Follow-up|0|||
155168112|NCT00545272|560053071|FG005|Overall Study|Adverse Event|1|||
155168113|NCT00545272|560053066|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155168114|NCT00545272|560053067|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155168115|NCT00545272|560053068|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155168116|NCT00545272|560053069|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155168117|NCT00545272|560053070|FG004|Overall Study|Abnormal laboratory value(s)|0|||
155371238|NCT00837694|560793437|FG002|Overall Study|Lost to Follow-up|2|||
155371239|NCT00837694|560793438|FG003|Overall Study|Lost to Follow-up|1|||
155168118|NCT00545272|560053071|FG005|Overall Study|Abnormal laboratory value(s)|1|||
155168119|NCT00545272|560053066|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155168120|NCT00545272|560053067|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155371240|NCT00837694|560793439|FG004|Overall Study|Lost to Follow-up|1|||
155371241|NCT00837694|560793440|FG005|Overall Study|Lost to Follow-up|1|||
155371242|NCT01008410|560793441|FG000|Overall Study|Adverse Event|13|||
155371243|NCT01008410|560793442|FG001|Overall Study|Adverse Event|7|||
155371244|NCT01008410|560793441|FG000|Overall Study|Withdrawal by Subject|6|||
155371245|NCT01008410|560793442|FG001|Overall Study|Withdrawal by Subject|2|||
155371246|NCT01008410|560793441|FG000|Overall Study|Lost to Follow-up|1|||
155371247|NCT01008410|560793442|FG001|Overall Study|Lost to Follow-up|0|||
155371248|NCT01008410|560793441|FG000|Overall Study|Noncompliance|1|||
155371249|NCT01008410|560793442|FG001|Overall Study|Noncompliance|0|||
155371250|NCT01008410|560793441|FG000|Overall Study|Low Cortisol|2|||
155371251|NCT01008410|560793442|FG001|Overall Study|Low Cortisol|0|||
155371252|NCT01008410|560793441|FG000|Overall Study|Lack of Efficacy|2|||
155371253|NCT01008410|560793442|FG001|Overall Study|Lack of Efficacy|6|||
155371254|NCT01008410|560793441|FG000|Overall Study|Met Exclusion Criterion|0|||
155371255|NCT01008410|560793442|FG001|Overall Study|Met Exclusion Criterion|1|||
155371256|NCT00297427|560793443|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
155371257|NCT00297427|560793444|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
155371258|NCT00297427|560793443|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
155371259|NCT00297427|560793444|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
155371260|NCT00297427|560793443|FG000|Phase 1: Initial Intervention|Death|0|||
155371261|NCT00297427|560793444|FG001|Phase 1: Initial Intervention|Death|1|||
155371262|NCT00297427|560793443|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
155371263|NCT00297427|560793444|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
155371264|NCT00297427|560793443|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
155371265|NCT00297427|560793444|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
155371266|NCT00297427|560793443|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
155371267|NCT00297427|560793444|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
155371268|NCT00297427|560793443|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
155371269|NCT00297427|560793444|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
155371270|NCT00297427|560793443|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
155371271|NCT00297427|560793444|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
155371272|NCT01127893|560793445|FG000|Overall Study|Study Termination by the Sponsor|1|||
155371273|NCT01262677|560793446|FG000|Overall Study|Does not meet entrance criteria|0|||
155371274|NCT01262677|560793447|FG001|Overall Study|Does not meet entrance criteria|2|||
155371275|NCT01262677|560793448|FG002|Overall Study|Does not meet entrance criteria|0|||
155371276|NCT01262677|560793446|FG000|Overall Study|Insufficient clinical response|0|||
155371277|NCT01262677|560793447|FG001|Overall Study|Insufficient clinical response|0|||
155371278|NCT01262677|560793448|FG002|Overall Study|Insufficient clinical response|1|||
155371279|NCT01262677|560793446|FG000|Overall Study|Lost to Follow-up|1|||
155371280|NCT01262677|560793447|FG001|Overall Study|Lost to Follow-up|0|||
155371281|NCT01262677|560793448|FG002|Overall Study|Lost to Follow-up|2|||
155371282|NCT01262677|560793446|FG000|Overall Study|No longer willing to participate|3|||
155371283|NCT01262677|560793447|FG001|Overall Study|No longer willing to participate|3|||
155371284|NCT01262677|560793448|FG002|Overall Study|No longer willing to participate|2|||
155371285|NCT01262677|560793446|FG000|Overall Study|Reason not provided|2|||
155371286|NCT01262677|560793447|FG001|Overall Study|Reason not provided|1|||
155371287|NCT01262677|560793448|FG002|Overall Study|Reason not provided|3|||
155371288|NCT01262677|560793446|FG000|Overall Study|Protocol Violation|0|||
155371289|NCT01262677|560793447|FG001|Overall Study|Protocol Violation|1|||
155371290|NCT01262677|560793448|FG002|Overall Study|Protocol Violation|1|||
155371291|NCT01262677|560793446|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
155371292|NCT01262677|560793447|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
155371293|NCT01262677|560793448|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
155371294|NCT02787044|560793452|FG000|Overall Study|Lost to Follow-up|15|||
155371295|NCT02787044|560793453|FG001|Overall Study|Lost to Follow-up|19|||
155371296|NCT01638429|560793454|FG000|Overall Study|Withdrawal by Subject|1|||
155371297|NCT03889704|560793456|FG000|Overall Study|Study terminated due to pandemic|1|||
155371298|NCT03482466|560793457|FG000|Overall Study|Protocol Violation|2|||
155371299|NCT04552899|560793458|FG000|Overall Study|Adverse Event|4|||
155371300|NCT04552899|560793459|FG001|Overall Study|Adverse Event|3|||
155371301|NCT04552899|560793458|FG000|Overall Study|Death|4|||
155168121|NCT00545272|560053068|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155168122|NCT00545272|560053069|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155371302|NCT04552899|560793459|FG001|Overall Study|Death|4|||
155371303|NCT04552899|560793458|FG000|Overall Study|Lost to Follow-up|8|||
155371304|NCT04552899|560793459|FG001|Overall Study|Lost to Follow-up|13|||
155371305|NCT04552899|560793458|FG000|Overall Study|Lung Transplant|4|||
155371306|NCT04552899|560793459|FG001|Overall Study|Lung Transplant|3|||
155371307|NCT04552899|560793458|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
155371308|NCT04552899|560793459|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
155168123|NCT00545272|560053070|FG004|Overall Study|Abnormal test procedure result(s)|1|||
155168124|NCT00545272|560053071|FG005|Overall Study|Abnormal test procedure result(s)|0|||
155168125|NCT00545272|560053066|FG000|Overall Study|Lost to Follow-up|0|||
155168126|NCT00545272|560053067|FG001|Overall Study|Lost to Follow-up|0|||
155168127|NCT00545272|560053068|FG002|Overall Study|Lost to Follow-up|0|||
155168128|NCT00545272|560053069|FG003|Overall Study|Lost to Follow-up|0|||
155168129|NCT00545272|560053070|FG004|Overall Study|Lost to Follow-up|1|||
155168130|NCT00545272|560053071|FG005|Overall Study|Lost to Follow-up|0|||
155168131|NCT02314637|560053072|FG000|Overall Study|Adverse Event|4|||
155168132|NCT02314637|560053073|FG001|Overall Study|Adverse Event|8|||
155168133|NCT02314637|560053072|FG000|Overall Study|Lack of Efficacy|1|||
155168134|NCT02314637|560053073|FG001|Overall Study|Lack of Efficacy|0|||
155168135|NCT02314637|560053072|FG000|Overall Study|Physician Decision|5|||
155168136|NCT02314637|560053073|FG001|Overall Study|Physician Decision|2|||
155168137|NCT02314637|560053072|FG000|Overall Study|Withdrawal by Subject|5|||
155168138|NCT02314637|560053073|FG001|Overall Study|Withdrawal by Subject|4|||
155168139|NCT02314637|560053072|FG000|Overall Study|Other Reason|1|||
155168140|NCT02314637|560053073|FG001|Overall Study|Other Reason|0|||
155168141|NCT02934503|560053074|FG000|Overall Study|progression of disease|3|||
155371309|NCT04552899|560793458|FG000|Overall Study|Physician Decision|3|||
155371310|NCT04552899|560793459|FG001|Overall Study|Physician Decision|4|||
155371311|NCT04552899|560793458|FG000|Overall Study|Study Terminated By Sponsor|237|||
155371312|NCT04552899|560793459|FG001|Overall Study|Study Terminated By Sponsor|239|||
155371313|NCT04552899|560793458|FG000|Overall Study|Withdrawal by Subject|15|||
155168142|NCT02934503|560053074|FG000|Overall Study|Withdrawal by Subject|1|||
155168143|NCT04248491|560053077|FG000|Overall Study|Lost to Follow-up|1|||
155168144|NCT04248491|560053078|FG001|Overall Study|Lost to Follow-up|0|||
155168145|NCT01311024|560053079|FG000|Overall Study|Protocol Violation|35|||
155168146|NCT01311024|560053080|FG001|Overall Study|Protocol Violation|22|||
155168147|NCT01652469|560053084|FG000|Overall Study|Withdrawal by Subject|1|||
155168148|NCT01652469|560053085|FG001|Overall Study|Withdrawal by Subject|4|||
155371314|NCT04552899|560793459|FG001|Overall Study|Withdrawal by Subject|17|||
155371315|NCT02383940|560793462|FG000|Overall Study|Adverse Event|1|||
155090718|NCT02303821|559765109|FG003|Overall Study|Withdrawal by Subject|0|||
155090719|NCT02303821|559765110|FG004|Overall Study|Withdrawal by Subject|0|||
155090720|NCT02303821|559765111|FG005|Overall Study|Withdrawal by Subject|0|||
155168149|NCT01652469|560053084|FG000|Overall Study|Lost to Follow-up|0|||
155168150|NCT01652469|560053085|FG001|Overall Study|Lost to Follow-up|2|||
155168151|NCT01049009|560053086|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155168152|NCT01049009|560053087|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
155168153|NCT01049009|560053086|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155168154|NCT01049009|560053087|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155168155|NCT01049009|560053086|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
155168156|NCT01049009|560053087|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
155168157|NCT01049009|560053086|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
155168158|NCT01049009|560053087|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
155168159|NCT01092546|560053089|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
155168160|NCT03860259|560053090|FG000|Overall Study|Lost to Follow-up|5|||
155168161|NCT03860259|560053091|FG001|Overall Study|Lost to Follow-up|5|||
155168162|NCT03860259|560053090|FG000|Overall Study|Protocol Violation|1|||
155168163|NCT03860259|560053091|FG001|Overall Study|Protocol Violation|0|||
155168164|NCT02280408|560053092|FG000|Overall Study|Lost to Follow-up|0|||
155168165|NCT02280408|560053093|FG001|Overall Study|Lost to Follow-up|2|||
155168166|NCT02280408|560053094|FG002|Overall Study|Lost to Follow-up|0|||
155371316|NCT02383940|560793463|FG001|Overall Study|Adverse Event|0|||
155371317|NCT02383940|560793462|FG000|Overall Study|Lost to Follow-up|2|||
155371318|NCT02383940|560793463|FG001|Overall Study|Lost to Follow-up|2|||
155371319|NCT02383940|560793462|FG000|Overall Study|Physician Decision|2|||
155371320|NCT02383940|560793463|FG001|Overall Study|Physician Decision|0|||
155371321|NCT02383940|560793462|FG000|Overall Study|Withdrawal by Subject|1|||
155371322|NCT02383940|560793463|FG001|Overall Study|Withdrawal by Subject|1|||
155371323|NCT02383940|560793462|FG000|Overall Study|Randomized but not treated|2|||
155371324|NCT02383940|560793463|FG001|Overall Study|Randomized but not treated|0|||
155371325|NCT02383940|560793462|FG000|Overall Study|Other than specified above|1|||
155371326|NCT02383940|560793463|FG001|Overall Study|Other than specified above|0|||
155371327|NCT00565773|560793465|FG000|Overall Study|Withdrawal by Subject|1|||
155371328|NCT00565773|560793465|FG000|Overall Study|Physician Decision|1|||
155371329|NCT01598662|560793466|FG000|Overall Study|Lost to Follow-up|10|||
155371330|NCT01598662|560793467|FG001|Overall Study|Lost to Follow-up|17|||
155371331|NCT01598662|560793466|FG000|Overall Study|Physician Decision|1|||
155371332|NCT01598662|560793467|FG001|Overall Study|Physician Decision|2|||
155371333|NCT01598662|560793466|FG000|Overall Study|IUD expelled before month 6|0|||
155371334|NCT01598662|560793467|FG001|Overall Study|IUD expelled before month 6|2|||
155371335|NCT02530970|560793468|FG000|Overall Study|Adverse Event|8|||
155371336|NCT02530970|560793468|FG000|Overall Study|Lost to Follow-up|88|||
155371337|NCT02530970|560793468|FG000|Overall Study|Physician Decision|5|||
155371338|NCT02530970|560793468|FG000|Overall Study|Withdrawal by Subject|14|||
155371339|NCT02530970|560793468|FG000|Overall Study|Death|6|||
155371340|NCT02530970|560793468|FG000|Overall Study|Hospitalization|1|||
155371341|NCT02530970|560793468|FG000|Overall Study|Insurance|2|||
155371342|NCT02530970|560793468|FG000|Overall Study|Explant|2|||
155371343|NCT02530970|560793468|FG000|Overall Study|Change in Provider|5|||
155371344|NCT02530970|560793468|FG000|Overall Study|Relocation|3|||
155371345|NCT02770612|560793469|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
155371346|NCT02636725|560793470|FG000|Overall Study|Adverse Event|1|||
155371347|NCT00886795|560793472|FG000|Overall Study|Lack of Efficacy|1|||
155371348|NCT01283516|560793473|FG000|Overall Study|Adverse Event|0|||
155371349|NCT01283516|560793474|FG001|Overall Study|Adverse Event|0|||
155371350|NCT01283516|560793475|FG002|Overall Study|Adverse Event|0|||
155371351|NCT01283516|560793476|FG003|Overall Study|Adverse Event|0|||
155371352|NCT01283516|560793477|FG004|Overall Study|Adverse Event|0|||
155371353|NCT01283516|560793478|FG005|Overall Study|Adverse Event|0|||
155371354|NCT01283516|560793479|FG006|Overall Study|Adverse Event|2|||
155371355|NCT01283516|560793480|FG007|Overall Study|Adverse Event|0|||
155371356|NCT01283516|560793481|FG008|Overall Study|Adverse Event|28|||
155371357|NCT01283516|560793473|FG000|Overall Study|Death|0|||
155371358|NCT01283516|560793474|FG001|Overall Study|Death|0|||
155371359|NCT01283516|560793475|FG002|Overall Study|Death|0|||
155371360|NCT01283516|560793476|FG003|Overall Study|Death|0|||
155371361|NCT01283516|560793477|FG004|Overall Study|Death|0|||
155371362|NCT01283516|560793478|FG005|Overall Study|Death|1|||
155371363|NCT01283516|560793479|FG006|Overall Study|Death|0|||
155371364|NCT01283516|560793480|FG007|Overall Study|Death|1|||
155371365|NCT01283516|560793481|FG008|Overall Study|Death|12|||
155371366|NCT01283516|560793473|FG000|Overall Study|Disease Progression|2|||
155371367|NCT01283516|560793474|FG001|Overall Study|Disease Progression|2|||
155371368|NCT01283516|560793475|FG002|Overall Study|Disease Progression|3|||
155371369|NCT01283516|560793476|FG003|Overall Study|Disease Progression|3|||
155371370|NCT01283516|560793477|FG004|Overall Study|Disease Progression|13|||
155371371|NCT01283516|560793478|FG005|Overall Study|Disease Progression|8|||
155371372|NCT01283516|560793479|FG006|Overall Study|Disease Progression|6|||
155371373|NCT01283516|560793480|FG007|Overall Study|Disease Progression|3|||
155371374|NCT01283516|560793481|FG008|Overall Study|Disease Progression|139|||
155371375|NCT01283516|560793473|FG000|Overall Study|Withdrawal by Subject|0|||
155371376|NCT01283516|560793474|FG001|Overall Study|Withdrawal by Subject|0|||
155371377|NCT01283516|560793475|FG002|Overall Study|Withdrawal by Subject|0|||
155371378|NCT01283516|560793476|FG003|Overall Study|Withdrawal by Subject|0|||
155371379|NCT01283516|560793477|FG004|Overall Study|Withdrawal by Subject|1|||
155371380|NCT01283516|560793478|FG005|Overall Study|Withdrawal by Subject|0|||
155371381|NCT01283516|560793479|FG006|Overall Study|Withdrawal by Subject|1|||
155371382|NCT01283516|560793480|FG007|Overall Study|Withdrawal by Subject|0|||
155371383|NCT01283516|560793481|FG008|Overall Study|Withdrawal by Subject|36|||
155371384|NCT01283516|560793473|FG000|Overall Study|Administrative problems|0|||
155371385|NCT01283516|560793474|FG001|Overall Study|Administrative problems|0|||
155371386|NCT01283516|560793475|FG002|Overall Study|Administrative problems|0|||
155371387|NCT01283516|560793476|FG003|Overall Study|Administrative problems|0|||
155371388|NCT01283516|560793477|FG004|Overall Study|Administrative problems|0|||
155090721|NCT02303821|559765112|FG006|Overall Study|Withdrawal by Subject|0|||
155371389|NCT01283516|560793478|FG005|Overall Study|Administrative problems|1|||
155371390|NCT01283516|560793479|FG006|Overall Study|Administrative problems|1|||
155371391|NCT01283516|560793480|FG007|Overall Study|Administrative problems|1|||
155371392|NCT01283516|560793481|FG008|Overall Study|Administrative problems|39|||
155371393|NCT01283516|560793473|FG000|Overall Study|Lost to Follow-up|0|||
155371394|NCT01283516|560793474|FG001|Overall Study|Lost to Follow-up|0|||
155371395|NCT01283516|560793475|FG002|Overall Study|Lost to Follow-up|0|||
155371396|NCT01283516|560793476|FG003|Overall Study|Lost to Follow-up|0|||
155371397|NCT01283516|560793477|FG004|Overall Study|Lost to Follow-up|0|||
155371398|NCT01283516|560793478|FG005|Overall Study|Lost to Follow-up|0|||
155371399|NCT01283516|560793479|FG006|Overall Study|Lost to Follow-up|0|||
155371400|NCT01283516|560793480|FG007|Overall Study|Lost to Follow-up|0|||
155371401|NCT01283516|560793481|FG008|Overall Study|Lost to Follow-up|1|||
155371402|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
155371403|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
155371404|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
154965634|NCT00112437|559298886|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
154965635|NCT00112437|559298887|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
154965636|NCT00112437|559298862|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
155371405|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
155371406|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
155371407|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
155371408|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
155371409|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
155371410|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
155371411|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
155371412|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Adverse Event|0|||
155371413|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Adverse Event|0|||
155371414|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Adverse Event|3|||
155371415|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Adverse Event|2|||
154965637|NCT00112437|559298863|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965638|NCT00112437|559298864|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965639|NCT00112437|559298865|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965640|NCT00112437|559298866|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965641|NCT00112437|559298867|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965642|NCT00112437|559298868|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965643|NCT00112437|559298869|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965644|NCT00112437|559298870|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965645|NCT00112437|559298871|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965646|NCT00112437|559298872|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965647|NCT00112437|559298873|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
154965648|NCT00112437|559298874|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965649|NCT00112437|559298875|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
154965650|NCT00112437|559298876|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965651|NCT00112437|559298877|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
154965652|NCT00112437|559298878|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965653|NCT00112437|559298879|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965654|NCT00112437|559298880|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
154965655|NCT00112437|559298881|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965656|NCT00112437|559298882|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965657|NCT00112437|559298883|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965658|NCT00112437|559298884|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965659|NCT00112437|559298885|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965660|NCT00112437|559298886|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965661|NCT00112437|559298887|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
154965662|NCT00112437|559298862|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965663|NCT00112437|559298863|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965664|NCT00112437|559298864|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965665|NCT00112437|559298865|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965666|NCT00112437|559298866|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965667|NCT00112437|559298867|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155371416|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Adverse Event|13|||
154965668|NCT00112437|559298868|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965669|NCT00112437|559298869|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965670|NCT00112437|559298870|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965671|NCT00112437|559298871|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965672|NCT00112437|559298872|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155371417|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
155371418|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
155371419|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
155371420|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
155371421|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
155371422|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Patient's wish|0|||
155371423|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Patient's wish|0|||
155371424|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Patient's wish|19|||
155371425|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Patient's wish|9|||
155371426|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Patient's wish|20|||
155371427|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
155371428|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
155371429|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
155371430|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
155371431|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
155371432|NCT00444275|560793487|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
155371433|NCT00444275|560793488|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
155371434|NCT00444275|560793489|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
155371435|NCT00444275|560793490|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
155371436|NCT00444275|560793491|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
155371437|NCT00743431|560793495|FG000|Overall Study|Toxicity|6|||
155371438|NCT00743431|560793495|FG000|Overall Study|Tumor progression|56|||
155090722|NCT02303821|559765113|FG007|Overall Study|Withdrawal by Subject|2|||
155090723|NCT02303821|559765106|FG000|Overall Study|Death|0|||
155090724|NCT02303821|559765107|FG001|Overall Study|Death|2|||
155090725|NCT02303821|559765108|FG002|Overall Study|Death|0|||
155090726|NCT02303821|559765109|FG003|Overall Study|Death|0|||
155090727|NCT02303821|559765110|FG004|Overall Study|Death|0|||
155090728|NCT02303821|559765111|FG005|Overall Study|Death|3|||
155090729|NCT02303821|559765112|FG006|Overall Study|Death|41|||
155090730|NCT02303821|559765113|FG007|Overall Study|Death|29|||
155090731|NCT02303821|559765106|FG000|Overall Study|Lost to Follow-up|0|||
155090732|NCT02303821|559765107|FG001|Overall Study|Lost to Follow-up|0|||
155090733|NCT02303821|559765108|FG002|Overall Study|Lost to Follow-up|0|||
155090734|NCT02303821|559765109|FG003|Overall Study|Lost to Follow-up|0|||
155090735|NCT02303821|559765110|FG004|Overall Study|Lost to Follow-up|0|||
155090736|NCT02303821|559765111|FG005|Overall Study|Lost to Follow-up|0|||
155090737|NCT02303821|559765112|FG006|Overall Study|Lost to Follow-up|1|||
155090738|NCT02303821|559765113|FG007|Overall Study|Lost to Follow-up|0|||
155090739|NCT02303821|559765106|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090740|NCT02303821|559765107|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090741|NCT02303821|559765108|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090742|NCT02303821|559765109|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090743|NCT02303821|559765110|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090744|NCT02303821|559765111|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090745|NCT02303821|559765112|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
155090746|NCT02303821|559765113|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
155090747|NCT02303821|559765106|FG000|Overall Study|Decision by sponsor|0|||
155090748|NCT02303821|559765107|FG001|Overall Study|Decision by sponsor|0|||
155090749|NCT02303821|559765108|FG002|Overall Study|Decision by sponsor|0|||
155090750|NCT02303821|559765109|FG003|Overall Study|Decision by sponsor|0|||
155090751|NCT02303821|559765110|FG004|Overall Study|Decision by sponsor|0|||
155090752|NCT02303821|559765111|FG005|Overall Study|Decision by sponsor|1|||
155090753|NCT02303821|559765112|FG006|Overall Study|Decision by sponsor|0|||
155090754|NCT02303821|559765113|FG007|Overall Study|Decision by sponsor|0|||
155090755|NCT02303821|559765106|FG000|Overall Study|Protocol-specified criteria|0|||
155090756|NCT02303821|559765107|FG001|Overall Study|Protocol-specified criteria|1|||
155090757|NCT02303821|559765108|FG002|Overall Study|Protocol-specified criteria|0|||
155090758|NCT02303821|559765109|FG003|Overall Study|Protocol-specified criteria|0|||
155090759|NCT02303821|559765110|FG004|Overall Study|Protocol-specified criteria|0|||
155090760|NCT02303821|559765111|FG005|Overall Study|Protocol-specified criteria|1|||
155090761|NCT02303821|559765112|FG006|Overall Study|Protocol-specified criteria|0|||
155090762|NCT02303821|559765113|FG007|Overall Study|Protocol-specified criteria|0|||
155090763|NCT04116489|559765117|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
155090764|NCT04116489|559765117|FG000|Overall Study|Withdrawal by Subject|1|||
155090765|NCT03138564|559765118|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
155090766|NCT03138564|559765119|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
155090767|NCT03138564|559765118|FG000|Overall Study|Lost to Follow-up|16|||
155090768|NCT03138564|559765119|FG001|Overall Study|Lost to Follow-up|2|||
155090769|NCT03138564|559765118|FG000|Overall Study|Withdrawal by Subject|48|||
155090770|NCT03138564|559765119|FG001|Overall Study|Withdrawal by Subject|4|||
155090771|NCT03138564|559765118|FG000|Overall Study|No longer met eligibility criteria|2|||
155090772|NCT03138564|559765119|FG001|Overall Study|No longer met eligibility criteria|0|||
155090773|NCT03138564|559765118|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
155371439|NCT00743431|560793495|FG000|Overall Study|Withdrawal by Subject|13|||
155371440|NCT00743431|560793495|FG000|Overall Study|Death|9|||
155371441|NCT00743431|560793495|FG000|Overall Study|Reason for discontinuation not specified|29|||
155371442|NCT00743431|560793495|FG000|Overall Study|No documentation available|13|||
155371443|NCT03291288|560793496|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
155371444|NCT03291288|560793497|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
155371445|NCT03291288|560793496|FG000|Drug-drug Interaction Phase|Disease progression|1|||
155371446|NCT03291288|560793497|FG001|Drug-drug Interaction Phase|Disease progression|0|||
155371447|NCT03291288|560793496|FG000|Drug-drug Interaction Phase|Other|3|||
155371448|NCT03291288|560793497|FG001|Drug-drug Interaction Phase|Other|0|||
155371449|NCT03291288|560793496|FG000|Pexidartinib Only|Ongoing|0|||
155371450|NCT03291288|560793497|FG001|Pexidartinib Only|Ongoing|2|||
155371451|NCT04978493|560793498|FG000|Overall Study|No reason available|0|||
155371452|NCT04978493|560793499|FG001|Overall Study|No reason available|1|||
155090774|NCT03138564|559765119|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
155090775|NCT03138564|559765118|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
155090776|NCT03138564|559765119|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
155090777|NCT03138564|559765118|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
155090778|NCT03138564|559765119|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
155090779|NCT03138564|559765118|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
155090780|NCT03138564|559765119|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
155090781|NCT05177354|559765121|FG000|Implant to 30-day Visit|Physician Decision|1|||
155090782|NCT05177354|559765121|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
155090783|NCT05177354|559765121|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
155090784|NCT05177354|559765121|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
155090785|NCT06028464|559765122|FG000|Washout|Positive drug test.|1|||
155090786|NCT03330847|559765125|FG000|Overall Study|Patients ongoing study|62|||
155090787|NCT03330847|559765126|FG001|Overall Study|Patients ongoing study|65|||
155090788|NCT03330847|559765127|FG002|Overall Study|Patients ongoing study|15|||
155090789|NCT02769481|559765130|FG000|Overall Study|Protocol Violation|1|||
155090790|NCT02769481|559765131|FG001|Overall Study|Protocol Violation|0|||
155090791|NCT02769481|559765130|FG000|Overall Study|Adverse Event|3|||
155090792|NCT02769481|559765131|FG001|Overall Study|Adverse Event|6|||
155090793|NCT02769481|559765130|FG000|Overall Study|Entry Criteria Not Met|1|||
155090794|NCT02769481|559765131|FG001|Overall Study|Entry Criteria Not Met|2|||
155090795|NCT02769481|559765130|FG000|Overall Study|Withdrawal by Subject|14|||
155090796|NCT02769481|559765131|FG001|Overall Study|Withdrawal by Subject|16|||
155090797|NCT02769481|559765130|FG000|Overall Study|Lost to Follow-up|9|||
155090798|NCT02769481|559765131|FG001|Overall Study|Lost to Follow-up|9|||
155090799|NCT02769481|559765130|FG000|Overall Study|Physician Decision|0|||
155090800|NCT02769481|559765131|FG001|Overall Study|Physician Decision|1|||
155090801|NCT02769481|559765130|FG000|Overall Study|Terminated by Sponsor|1|||
155090802|NCT02769481|559765131|FG001|Overall Study|Terminated by Sponsor|0|||
155090803|NCT02769481|559765130|FG000|Overall Study|Death|0|||
155090804|NCT02769481|559765131|FG001|Overall Study|Death|1|||
155090805|NCT02769481|559765130|FG000|Overall Study|Undefined|4|||
155090806|NCT02769481|559765131|FG001|Overall Study|Undefined|1|||
155090807|NCT00643279|559765132|FG000|Overall Study|Death|13|||
155090808|NCT00643279|559765133|FG001|Overall Study|Death|11|||
155371453|NCT04978493|560793498|FG000|Overall Study|Adverse Event|1|||
155371454|NCT04978493|560793499|FG001|Overall Study|Adverse Event|0|||
155168167|NCT02280408|560053095|FG003|Overall Study|Lost to Follow-up|0|||
155168168|NCT01068600|560053096|FG000|Overall Study|Withdrawal by Subject|5|||
155168169|NCT01068600|560053097|FG001|Overall Study|Withdrawal by Subject|6|||
155168170|NCT01068600|560053096|FG000|Overall Study|Adverse Event|3|||
155168171|NCT01068600|560053097|FG001|Overall Study|Adverse Event|3|||
155168172|NCT01068600|560053096|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155168173|NCT01068600|560053097|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155168174|NCT01068600|560053096|FG000|Overall Study|Lost to Follow-up|1|||
155168175|NCT01068600|560053097|FG001|Overall Study|Lost to Follow-up|2|||
155168176|NCT01068600|560053096|FG000|Overall Study|Protocol deviation|1|||
155168177|NCT01068600|560053097|FG001|Overall Study|Protocol deviation|1|||
155168178|NCT01068600|560053096|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155168179|NCT01068600|560053097|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155168180|NCT01068600|560053096|FG000|Overall Study|Administrative problems|0|||
155168181|NCT01068600|560053097|FG001|Overall Study|Administrative problems|1|||
155168182|NCT01519869|560053100|FG000|Overall Study|Lost to Follow-up|1|||
155168183|NCT02283762|560053101|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
155168184|NCT02283762|560053102|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
155168185|NCT02283762|560053101|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
155168186|NCT02283762|560053102|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
155168187|NCT02283762|560053101|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
155168188|NCT02283762|560053102|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
155168189|NCT02283762|560053101|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
155168190|NCT02283762|560053102|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
155168191|NCT02283762|560053101|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
155168192|NCT02283762|560053102|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
155168193|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
155168194|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
155168195|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
155168196|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
154965673|NCT00112437|559298873|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965674|NCT00112437|559298874|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155168197|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
155168198|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
155168199|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
155168200|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
155168201|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
155168202|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
155168203|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
155168204|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
155168205|NCT02283762|560053101|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
155168206|NCT02283762|560053102|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
155168207|NCT01474018|560053106|FG000|Overall Study|Lost to Follow-up|0|||
155168208|NCT01474018|560053107|FG001|Overall Study|Lost to Follow-up|1|||
155168209|NCT01474018|560053106|FG000|Overall Study|Withdrawal by Subject|0|||
155168210|NCT01474018|560053107|FG001|Overall Study|Withdrawal by Subject|2|||
155168211|NCT00486291|560053111|FG000|Overall Study|Adverse Event|3|||
155168212|NCT00486291|560053112|FG001|Overall Study|Adverse Event|4|||
155168213|NCT00486291|560053111|FG000|Overall Study|Lost to Follow-up|3|||
155168214|NCT00486291|560053112|FG001|Overall Study|Lost to Follow-up|7|||
155168215|NCT00486291|560053111|FG000|Overall Study|protocol non-compliance|10|||
155168216|NCT00486291|560053112|FG001|Overall Study|protocol non-compliance|15|||
155168217|NCT00486291|560053111|FG000|Overall Study|requirement for restricted medication|0|||
155168218|NCT00486291|560053112|FG001|Overall Study|requirement for restricted medication|3|||
155168219|NCT00126490|560053117|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
155168220|NCT03462511|560053121|FG000|Overall Study|Withdrawal by Subject|2|||
155168221|NCT03462511|560053122|FG001|Overall Study|Withdrawal by Subject|3|||
155168222|NCT00200356|560053123|FG000|Overall Study|Lack of Efficacy|3|||
155168223|NCT00200356|560053124|FG001|Overall Study|Lack of Efficacy|3|||
155168224|NCT00200356|560053123|FG000|Overall Study|Protocol Violation|4|||
154965675|NCT00112437|559298875|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155168225|NCT00200356|560053124|FG001|Overall Study|Protocol Violation|4|||
155168226|NCT00200356|560053123|FG000|Overall Study|Nontreatment|1|||
155371455|NCT01896726|560793500|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
155371456|NCT01896726|560793500|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
155371457|NCT01128114|560793501|FG000|Overall Study|Treatment Withdrawn|6|||
155168227|NCT00200356|560053124|FG001|Overall Study|Nontreatment|0|||
155168228|NCT02367833|560053125|FG000|Overall Study|Withdrawal by Subject|1|||
155168229|NCT02367833|560053126|FG001|Overall Study|Withdrawal by Subject|1|||
155168230|NCT02367833|560053127|FG002|Overall Study|Withdrawal by Subject|0|||
155168231|NCT00035932|560053132|FG000|Overall Study|Adverse Event|10|||
154965676|NCT00112437|559298876|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155371458|NCT01128114|560793501|FG000|Overall Study|Screening Failed|2|||
155371459|NCT00208325|560793502|FG000|Overall Study|Death|18|||
155168232|NCT00035932|560053133|FG001|Overall Study|Adverse Event|9|||
155168233|NCT00035932|560053134|FG002|Overall Study|Adverse Event|9|||
155168234|NCT00035932|560053132|FG000|Overall Study|Death|0|||
155168235|NCT00035932|560053133|FG001|Overall Study|Death|0|||
155168236|NCT00035932|560053134|FG002|Overall Study|Death|1|||
155168237|NCT00035932|560053132|FG000|Overall Study|Disease Progression / Relapse|1|||
155168238|NCT00035932|560053133|FG001|Overall Study|Disease Progression / Relapse|1|||
155371460|NCT00208325|560793503|FG001|Overall Study|Death|19|||
155371461|NCT00208325|560793504|FG002|Overall Study|Death|7|||
155371462|NCT00208325|560793505|FG003|Overall Study|Death|5|||
155371463|NCT00208325|560793502|FG000|Overall Study|Withdrawal by Subject|0|||
155168239|NCT00035932|560053134|FG002|Overall Study|Disease Progression / Relapse|0|||
155168240|NCT00035932|560053132|FG000|Overall Study|Lost to Follow-up|4|||
155168241|NCT00035932|560053133|FG001|Overall Study|Lost to Follow-up|4|||
155168242|NCT00035932|560053134|FG002|Overall Study|Lost to Follow-up|3|||
155168243|NCT00035932|560053132|FG000|Overall Study|Noncompliance|6|||
155168244|NCT00035932|560053133|FG001|Overall Study|Noncompliance|7|||
155371464|NCT00208325|560793503|FG001|Overall Study|Withdrawal by Subject|1|||
155371465|NCT00208325|560793504|FG002|Overall Study|Withdrawal by Subject|0|||
155371466|NCT00208325|560793505|FG003|Overall Study|Withdrawal by Subject|0|||
155371467|NCT00208325|560793502|FG000|Overall Study|Revision|4|||
155371468|NCT00208325|560793503|FG001|Overall Study|Revision|1|||
155371469|NCT00208325|560793504|FG002|Overall Study|Revision|0|||
155371470|NCT00208325|560793505|FG003|Overall Study|Revision|4|||
155371471|NCT00208325|560793502|FG000|Overall Study|Lost to Follow-up|1|||
155371472|NCT00208325|560793503|FG001|Overall Study|Lost to Follow-up|0|||
155371473|NCT00208325|560793504|FG002|Overall Study|Lost to Follow-up|2|||
155371474|NCT00208325|560793505|FG003|Overall Study|Lost to Follow-up|0|||
155371475|NCT00208325|560793502|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
155371476|NCT00208325|560793503|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
155371477|NCT00208325|560793504|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
155371478|NCT00208325|560793505|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
155371479|NCT00208325|560793502|FG000|Overall Study|Does not wish to Continue in Study|5|||
155371480|NCT00208325|560793503|FG001|Overall Study|Does not wish to Continue in Study|8|||
155168245|NCT00035932|560053134|FG002|Overall Study|Noncompliance|6|||
155168246|NCT00035932|560053132|FG000|Overall Study|Protocol Violation While on Study|0|||
155168247|NCT00035932|560053133|FG001|Overall Study|Protocol Violation While on Study|1|||
155168248|NCT00035932|560053134|FG002|Overall Study|Protocol Violation While on Study|2|||
155168249|NCT00035932|560053132|FG000|Overall Study|Withdrawal by Subject|1|||
155168250|NCT00035932|560053133|FG001|Overall Study|Withdrawal by Subject|5|||
155168251|NCT00035932|560053134|FG002|Overall Study|Withdrawal by Subject|0|||
155168252|NCT00035932|560053132|FG000|Overall Study|Study Termination by Sponsor|1|||
155168253|NCT00035932|560053133|FG001|Overall Study|Study Termination by Sponsor|0|||
155168254|NCT00035932|560053134|FG002|Overall Study|Study Termination by Sponsor|0|||
155371481|NCT00208325|560793504|FG002|Overall Study|Does not wish to Continue in Study|3|||
155371482|NCT00208325|560793505|FG003|Overall Study|Does not wish to Continue in Study|2|||
155371483|NCT00208325|560793502|FG000|Overall Study|Other|2|||
155371484|NCT00208325|560793503|FG001|Overall Study|Other|1|||
155371485|NCT00208325|560793504|FG002|Overall Study|Other|1|||
155371486|NCT00208325|560793505|FG003|Overall Study|Other|0|||
155371487|NCT00208325|560793502|FG000|Overall Study|Mis-Randomized|17|||
155371488|NCT00208325|560793503|FG001|Overall Study|Mis-Randomized|20|||
155371489|NCT00208325|560793504|FG002|Overall Study|Mis-Randomized|0|||
155371490|NCT00208325|560793505|FG003|Overall Study|Mis-Randomized|0|||
155371491|NCT04662931|560793506|FG000|Overall Study|Withdrawal by Subject|17|||
155371492|NCT04662931|560793506|FG000|Overall Study|Death|3|||
155168255|NCT00035932|560053132|FG000|Overall Study|Lack of Efficacy|33|||
155168256|NCT00035932|560053133|FG001|Overall Study|Lack of Efficacy|33|||
155168257|NCT00035932|560053134|FG002|Overall Study|Lack of Efficacy|28|||
155168258|NCT00889720|560053137|FG000|Overall Study|Withdrawal by Subject|4|||
155168259|NCT00889720|560053137|FG000|Overall Study|Other|4|||
155371493|NCT04662931|560793506|FG000|Overall Study|Lost to Follow-up|3|||
155371494|NCT04662931|560793506|FG000|Overall Study|Guardian Decision|1|||
155371495|NCT01254747|560793507|FG000|Overall Study|Unacceptable subjective vision|0|||
155371496|NCT01254747|560793508|FG001|Overall Study|Unacceptable subjective vision|0|||
155371497|NCT01254747|560793509|FG002|Overall Study|Unacceptable subjective vision|0|||
155371498|NCT01254747|560793510|FG003|Overall Study|Unacceptable subjective vision|2|||
155371499|NCT01254747|560793507|FG000|Overall Study|Difficult removal handling|0|||
155371500|NCT01254747|560793508|FG001|Overall Study|Difficult removal handling|0|||
155371501|NCT01254747|560793509|FG002|Overall Study|Difficult removal handling|1|||
155371502|NCT01254747|560793510|FG003|Overall Study|Difficult removal handling|0|||
155371503|NCT01254747|560793507|FG000|Overall Study|Symptoms and problems|0|||
155371504|NCT01254747|560793508|FG001|Overall Study|Symptoms and problems|2|||
155371505|NCT01254747|560793509|FG002|Overall Study|Symptoms and problems|1|||
155371506|NCT01254747|560793510|FG003|Overall Study|Symptoms and problems|0|||
155371507|NCT01254747|560793507|FG000|Overall Study|Lost to Follow-up|0|||
155371508|NCT01254747|560793508|FG001|Overall Study|Lost to Follow-up|0|||
155371509|NCT01254747|560793509|FG002|Overall Study|Lost to Follow-up|1|||
155371510|NCT01254747|560793510|FG003|Overall Study|Lost to Follow-up|0|||
155371511|NCT01254747|560793507|FG000|Overall Study|Biomicroscopy|0|||
155371512|NCT01254747|560793508|FG001|Overall Study|Biomicroscopy|0|||
155371513|NCT01254747|560793509|FG002|Overall Study|Biomicroscopy|1|||
155371514|NCT01254747|560793510|FG003|Overall Study|Biomicroscopy|0|||
155371515|NCT01254747|560793507|FG000|Overall Study|Discomfort|0|||
155371516|NCT01254747|560793508|FG001|Overall Study|Discomfort|4|||
155371517|NCT01254747|560793509|FG002|Overall Study|Discomfort|0|||
154965677|NCT00112437|559298877|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
154965678|NCT00112437|559298878|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965679|NCT00112437|559298879|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965680|NCT00112437|559298880|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965681|NCT00112437|559298881|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155371518|NCT01254747|560793510|FG003|Overall Study|Discomfort|0|||
154965682|NCT00112437|559298882|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155371519|NCT04187326|560793511|FG000|Overall Study|Lost to Follow-up|2|||
155371520|NCT04187326|560793512|FG001|Overall Study|Lost to Follow-up|1|||
155371521|NCT04187326|560793511|FG000|Overall Study|Computer error- task was only partially completed.|0|||
155371522|NCT04187326|560793512|FG001|Overall Study|Computer error- task was only partially completed.|1|||
155371523|NCT02406677|560793513|FG000|Overall Study|Death|16|||
155371524|NCT02406677|560793514|FG001|Overall Study|Death|8|||
155371525|NCT02406677|560793513|FG000|Overall Study|Discharged without P2Y12|1|||
155371526|NCT02406677|560793514|FG001|Overall Study|Discharged without P2Y12|3|||
155371527|NCT02406677|560793513|FG000|Overall Study|Discharged on prasugrel|283|||
155371528|NCT02406677|560793514|FG001|Overall Study|Discharged on prasugrel|587|||
155371529|NCT02406677|560793513|FG000|Overall Study|Withdrawal by Subject|1|||
155371530|NCT02406677|560793514|FG001|Overall Study|Withdrawal by Subject|0|||
155371531|NCT02387970|560793517|FG000|Overall Study|Did not complete 1-year follow up|1|||
155371532|NCT02387970|560793518|FG001|Overall Study|Did not complete 1-year follow up|2|||
155371533|NCT04531098|560793521|FG000|Stage I|Adverse Event|0|||
155371534|NCT04531098|560793522|FG001|Stage I|Adverse Event|0|||
155371535|NCT04531098|560793523|FG002|Stage I|Adverse Event|3|||
155371536|NCT04531098|560793521|FG000|Stage I|Protocol Violation|0|||
155371537|NCT04531098|560793522|FG001|Stage I|Protocol Violation|0|||
155371538|NCT04531098|560793523|FG002|Stage I|Protocol Violation|5|||
155371539|NCT04531098|560793521|FG000|Stage I|Withdrawal by Subject|0|||
155371540|NCT04531098|560793522|FG001|Stage I|Withdrawal by Subject|5|||
155371541|NCT04531098|560793523|FG002|Stage I|Withdrawal by Subject|10|||
155371542|NCT04531098|560793521|FG000|Stage II|Adverse Event|1|||
155371543|NCT04531098|560793522|FG001|Stage II|Adverse Event|2|||
155371544|NCT04531098|560793523|FG002|Stage II|Adverse Event|0|||
155371545|NCT04531098|560793521|FG000|Stage II|Protocol Violation|1|||
155371546|NCT04531098|560793522|FG001|Stage II|Protocol Violation|2|||
155371547|NCT04531098|560793523|FG002|Stage II|Protocol Violation|0|||
155371548|NCT04531098|560793521|FG000|Stage II|Withdrawal by Subject|3|||
155168260|NCT04080167|560053138|FG000|Overall Study|Lost to Follow-up-Patients|7|||
155168261|NCT04080167|560053139|FG001|Overall Study|Lost to Follow-up-Patients|14|||
155371549|NCT04531098|560793522|FG001|Stage II|Withdrawal by Subject|1|||
155371550|NCT04531098|560793523|FG002|Stage II|Withdrawal by Subject|0|||
155371551|NCT04531098|560793521|FG000|Stage II|Moved from study area|8|||
155371552|NCT04531098|560793522|FG001|Stage II|Moved from study area|5|||
155371553|NCT04531098|560793523|FG002|Stage II|Moved from study area|0|||
155371554|NCT02145468|560793524|FG000|Overall Study|Withdrawal by Subject|5|||
155371555|NCT02145468|560793525|FG001|Overall Study|Withdrawal by Subject|8|||
155371556|NCT00586612|560793526|FG000|Primary Phase|Protocol Violation|1|||
155371557|NCT00586612|560793527|FG001|Primary Phase|Protocol Violation|0|||
155371558|NCT00586612|560793526|FG000|Primary Phase|Lost to Follow-up|0|||
155371559|NCT00586612|560793527|FG001|Primary Phase|Lost to Follow-up|1|||
155371560|NCT00586612|560793526|FG000|Primary Phase|Withdrawal by Subject|0|||
155371561|NCT00586612|560793527|FG001|Primary Phase|Withdrawal by Subject|2|||
155371562|NCT00586612|560793526|FG000|Booster Phase|Lost to Follow-up|3|||
155371563|NCT00586612|560793527|FG001|Booster Phase|Lost to Follow-up|1|||
155371564|NCT05235269|560793528|FG000|Overall Study|Adverse Event|1|||
155371565|NCT05235269|560793528|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
155371566|NCT05235269|560793528|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
155371567|NCT03810235|560793529|FG000|Overall Study|Withdrawal by Subject|2|||
155371568|NCT03810235|560793530|FG001|Overall Study|Withdrawal by Subject|0|||
155371569|NCT04777864|560793531|FG000|Overall Study|Lost to Follow-up|8|||
155371570|NCT04777864|560793532|FG001|Overall Study|Lost to Follow-up|19|||
155371571|NCT04908631|560793535|FG000|Overall Study|Lost to Follow-up|1|||
155371572|NCT04908631|560793535|FG000|Overall Study|Physician Decision|1|||
155371573|NCT04908631|560793535|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
155371574|NCT06655558|560793536|FG000|Overall Study|Protocol Violation|1|||
155371575|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
155371576|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
155371577|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
155371578|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
155371579|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
155371580|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
155371581|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
155168262|NCT04080167|560053140|FG002|Overall Study|Lost to Follow-up-Patients|0|||
155168263|NCT04080167|560053138|FG000|Overall Study|Lost to Follow-up-Providers|2|||
155168264|NCT04080167|560053139|FG001|Overall Study|Lost to Follow-up-Providers|2|||
155168265|NCT04080167|560053140|FG002|Overall Study|Lost to Follow-up-Providers|0|||
155168266|NCT04080167|560053138|FG000|Overall Study|Withdrawal by Subject|1|||
155168267|NCT04080167|560053139|FG001|Overall Study|Withdrawal by Subject|2|||
155168268|NCT04080167|560053140|FG002|Overall Study|Withdrawal by Subject|0|||
155168269|NCT04080167|560053138|FG000|Overall Study|Withdrawal by Provider|0|||
155168270|NCT04080167|560053139|FG001|Overall Study|Withdrawal by Provider|0|||
155168271|NCT04080167|560053140|FG002|Overall Study|Withdrawal by Provider|4|||
155168272|NCT04080167|560053138|FG000|Overall Study|Death-Patient|2|||
155168273|NCT04080167|560053139|FG001|Overall Study|Death-Patient|1|||
155168274|NCT04080167|560053140|FG002|Overall Study|Death-Patient|0|||
155168275|NCT04080167|560053138|FG000|Overall Study|Hydroxyurea New Starts|0|||
155168276|NCT04080167|560053139|FG001|Overall Study|Hydroxyurea New Starts|0|||
155168277|NCT04080167|560053140|FG002|Overall Study|Hydroxyurea New Starts|1|||
155168278|NCT04080167|560053138|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
155168279|NCT04080167|560053139|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
155168280|NCT04080167|560053140|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
155168281|NCT02167139|560053141|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
155168282|NCT02167139|560053142|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
155371582|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
155371583|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
155371584|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
155371585|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
155168283|NCT02167139|560053143|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
155168284|NCT02167139|560053144|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
155168285|NCT02167139|560053141|FG000|Randomised, Double-blind|Adverse Event|2|||
155168286|NCT02167139|560053142|FG001|Randomised, Double-blind|Adverse Event|9|||
155168287|NCT02167139|560053143|FG002|Randomised, Double-blind|Adverse Event|0|||
155168288|NCT02167139|560053144|FG003|Randomised, Double-blind|Adverse Event|0|||
155168289|NCT02167139|560053141|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
155168290|NCT02167139|560053142|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
155168291|NCT02167139|560053143|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
155168292|NCT02167139|560053144|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
155168293|NCT02167139|560053141|FG000|Randomised, Double-blind|Other|3|||
155168294|NCT02167139|560053142|FG001|Randomised, Double-blind|Other|0|||
155168295|NCT02167139|560053143|FG002|Randomised, Double-blind|Other|0|||
155168296|NCT02167139|560053144|FG003|Randomised, Double-blind|Other|0|||
155168297|NCT02167139|560053141|FG000|Transition-extension|Adverse Event|2|||
155168298|NCT02167139|560053142|FG001|Transition-extension|Adverse Event|0|||
155168299|NCT02167139|560053143|FG002|Transition-extension|Adverse Event|2|||
155168300|NCT02167139|560053144|FG003|Transition-extension|Adverse Event|3|||
155168301|NCT02167139|560053141|FG000|Transition-extension|Withdrawal by Subject|2|||
155168302|NCT02167139|560053142|FG001|Transition-extension|Withdrawal by Subject|0|||
155168303|NCT02167139|560053143|FG002|Transition-extension|Withdrawal by Subject|4|||
155168304|NCT02167139|560053144|FG003|Transition-extension|Withdrawal by Subject|1|||
155168305|NCT02167139|560053141|FG000|Transition-extension|Lack of Efficacy|0|||
155168306|NCT02167139|560053142|FG001|Transition-extension|Lack of Efficacy|0|||
155168307|NCT02167139|560053143|FG002|Transition-extension|Lack of Efficacy|1|||
155168308|NCT02167139|560053144|FG003|Transition-extension|Lack of Efficacy|1|||
155168309|NCT02167139|560053141|FG000|Transition-extension|Other|1|||
155168310|NCT02167139|560053142|FG001|Transition-extension|Other|0|||
155168311|NCT02167139|560053143|FG002|Transition-extension|Other|1|||
155168312|NCT02167139|560053144|FG003|Transition-extension|Other|0|||
155168313|NCT02167139|560053141|FG000|Transition-extension|Lost to Follow-up|1|||
155168314|NCT02167139|560053142|FG001|Transition-extension|Lost to Follow-up|0|||
155168315|NCT02167139|560053143|FG002|Transition-extension|Lost to Follow-up|0|||
155168316|NCT02167139|560053144|FG003|Transition-extension|Lost to Follow-up|0|||
155168317|NCT02067676|560053145|FG000|Overall Study|Withdrawal by Subject|1|||
155168318|NCT02067676|560053146|FG001|Overall Study|Withdrawal by Subject|0|||
155168319|NCT02067676|560053147|FG002|Overall Study|Withdrawal by Subject|0|||
155168320|NCT02067676|560053148|FG003|Overall Study|Withdrawal by Subject|0|||
155168321|NCT02067676|560053149|FG004|Overall Study|Withdrawal by Subject|0|||
155168322|NCT02067676|560053150|FG005|Overall Study|Withdrawal by Subject|0|||
155168323|NCT00996333|560053151|FG000|Overall Study|Screen failure|1|||
155168324|NCT00996333|560053151|FG000|Overall Study|Withdrawal by Subject|1|||
155168325|NCT00996333|560053151|FG000|Overall Study|Death|4|||
155168326|NCT00996333|560053151|FG000|Overall Study|Adverse Event|1|||
155168327|NCT00996333|560053151|FG000|Overall Study|Physician Decision|1|||
155168328|NCT00996333|560053151|FG000|Overall Study|Other|5|||
155168329|NCT00476229|560053152|FG000|Overall Study|Progressive shortness of breath|1|||
155168330|NCT02164461|560053153|FG000|Overall Study|Adverse Event|0|||
155168331|NCT02164461|560053154|FG001|Overall Study|Adverse Event|0|||
155168332|NCT02164461|560053155|FG002|Overall Study|Adverse Event|1|||
155168333|NCT02164461|560053153|FG000|Overall Study|Disease Progression|1|||
155168334|NCT02164461|560053154|FG001|Overall Study|Disease Progression|3|||
155168335|NCT02164461|560053155|FG002|Overall Study|Disease Progression|4|||
155168336|NCT02164461|560053153|FG000|Overall Study|Withdrawal by Subject|0|||
155168337|NCT02164461|560053154|FG001|Overall Study|Withdrawal by Subject|3|||
155168338|NCT02164461|560053155|FG002|Overall Study|Withdrawal by Subject|0|||
155168339|NCT01262820|560053157|FG000|Overall Study|Adverse Event|5|||
155168340|NCT01262820|560053157|FG000|Overall Study|Lack of Efficacy|9|||
155168341|NCT01262820|560053157|FG000|Overall Study|Drug held for 21+ days|1|||
155168342|NCT00452361|560053158|FG000|Overall Study|Adverse Event|8|||
155168343|NCT00452361|560053159|FG001|Overall Study|Adverse Event|0|||
155168344|NCT00452361|560053158|FG000|Overall Study|Withdrawal by Subject|0|||
155168345|NCT00452361|560053159|FG001|Overall Study|Withdrawal by Subject|1|||
155168346|NCT00452361|560053158|FG000|Overall Study|Premature termination|13|||
155168347|NCT00452361|560053159|FG001|Overall Study|Premature termination|9|||
155168348|NCT02954172|560053160|FG000|Overall Study|Protocol Violation|3|||
155168349|NCT02954172|560053161|FG001|Overall Study|Protocol Violation|0|||
155168350|NCT02954172|560053160|FG000|Overall Study|allergic reaction|2|||
155168351|NCT02954172|560053161|FG001|Overall Study|allergic reaction|1|||
155168352|NCT02954172|560053160|FG000|Overall Study|non-measurable lesions at baseline|1|||
155168353|NCT02954172|560053161|FG001|Overall Study|non-measurable lesions at baseline|2|||
155168354|NCT00924027|560053162|FG000|Overall Study|Lost to Further Follow-Up|4|||
155168355|NCT00924027|560053163|FG001|Overall Study|Lost to Further Follow-Up|0|||
155168356|NCT00924027|560053164|FG002|Overall Study|Lost to Further Follow-Up|0|||
155168357|NCT00924027|560053165|FG003|Overall Study|Lost to Further Follow-Up|0|||
155168358|NCT00924027|560053162|FG000|Overall Study|Physician Decision|1|||
155168359|NCT00924027|560053163|FG001|Overall Study|Physician Decision|0|||
155168360|NCT00924027|560053164|FG002|Overall Study|Physician Decision|0|||
155168361|NCT00924027|560053165|FG003|Overall Study|Physician Decision|1|||
155371586|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
155371587|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371588|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
155371589|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371590|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371591|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371592|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
155371593|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371594|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
155371595|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371596|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371597|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371598|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
155371599|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155371600|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155371601|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
155090809|NCT00643279|559765132|FG000|Overall Study|Withdrawal by Subject|3|||
155090810|NCT00643279|559765133|FG001|Overall Study|Withdrawal by Subject|0|||
155090811|NCT00643279|559765132|FG000|Overall Study|Lost to Follow-up|0|||
155090812|NCT00643279|559765133|FG001|Overall Study|Lost to Follow-up|1|||
155090813|NCT00643279|559765132|FG000|Overall Study|Physician Decision|0|||
155090814|NCT00643279|559765133|FG001|Overall Study|Physician Decision|1|||
155090815|NCT06272383|559765134|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
155090816|NCT06272383|559765135|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
155090817|NCT05715827|559765136|FG000|Overall Study|Physician Decision|0|||
155090818|NCT05715827|559765137|FG001|Overall Study|Physician Decision|1|||
155090819|NCT05715827|559765136|FG000|Overall Study|console communication error|0|||
155090820|NCT05715827|559765137|FG001|Overall Study|console communication error|1|||
155090821|NCT04846868|559765138|FG000|Overall Study|Adverse Event|12|||
155090822|NCT04846868|559765139|FG001|Overall Study|Adverse Event|11|||
155090823|NCT04846868|559765138|FG000|Overall Study|Protocol deviation|6|||
155090824|NCT04846868|559765139|FG001|Overall Study|Protocol deviation|2|||
155090825|NCT04846868|559765138|FG000|Overall Study|Perceived lack of efficacy|3|||
155090826|NCT04846868|559765139|FG001|Overall Study|Perceived lack of efficacy|2|||
155090827|NCT04846868|559765138|FG000|Overall Study|Change of residence|2|||
155090828|NCT04846868|559765139|FG001|Overall Study|Change of residence|3|||
155090829|NCT04846868|559765138|FG000|Overall Study|Burden of study procedures|1|||
155090830|NCT04846868|559765139|FG001|Overall Study|Burden of study procedures|1|||
155090831|NCT04846868|559765138|FG000|Overall Study|No reason available|2|||
155090832|NCT04846868|559765139|FG001|Overall Study|No reason available|5|||
155090833|NCT04846868|559765138|FG000|Overall Study|Other reason listed|20|||
155090834|NCT04846868|559765139|FG001|Overall Study|Other reason listed|10|||
155090835|NCT04846868|559765138|FG000|Overall Study|Not treated|0|||
155090836|NCT04846868|559765139|FG001|Overall Study|Not treated|1|||
155090837|NCT05212168|559765140|FG000|Overall Study|Lost to Follow-up|0|||
155090838|NCT05212168|559765141|FG001|Overall Study|Lost to Follow-up|3|||
155090839|NCT05212168|559765140|FG000|Overall Study|Study terminated by sponsor|30|||
155090840|NCT05212168|559765141|FG001|Overall Study|Study terminated by sponsor|27|||
155090841|NCT05212168|559765140|FG000|Overall Study|Other|4|||
155090842|NCT05212168|559765141|FG001|Overall Study|Other|7|||
155090843|NCT03274466|559765142|FG000|Overall Study|Withdrawal by Subject|7|||
155090844|NCT03274466|559765143|FG001|Overall Study|Withdrawal by Subject|3|||
155090845|NCT03274466|559765142|FG000|Overall Study|Protocol Specified Withdrawal|5|||
155090846|NCT03274466|559765143|FG001|Overall Study|Protocol Specified Withdrawal|11|||
155090847|NCT03274466|559765142|FG000|Overall Study|Lost to Follow-up|5|||
155090848|NCT03274466|559765143|FG001|Overall Study|Lost to Follow-up|7|||
155090849|NCT03274466|559765142|FG000|Overall Study|Subject Non-compliance|0|||
155090850|NCT03274466|559765143|FG001|Overall Study|Subject Non-compliance|1|||
155090851|NCT03274466|559765142|FG000|Overall Study|Adverse Event|3|||
155090852|NCT03274466|559765143|FG001|Overall Study|Adverse Event|3|||
155168362|NCT00924027|560053162|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
155168363|NCT00924027|560053163|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
155168364|NCT00924027|560053164|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
155168365|NCT00924027|560053165|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
155168366|NCT00924027|560053162|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
155168367|NCT00924027|560053163|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
155168368|NCT00924027|560053164|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
155168369|NCT00924027|560053165|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
155168370|NCT00924027|560053162|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
155168371|NCT00924027|560053163|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
155168372|NCT00924027|560053164|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
155168373|NCT00924027|560053165|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
155168374|NCT01217307|560054903|FG000|Overall Study|Withdrawal by Subject|0|||
155168375|NCT01217307|560054904|FG001|Overall Study|Withdrawal by Subject|1|||
155168376|NCT01868542|560054905|FG000|Overall Study|Protocol Violation|0|||
155168377|NCT01868542|560054906|FG001|Overall Study|Protocol Violation|1|||
155168378|NCT01868542|560054905|FG000|Overall Study|Unclassified|0|||
155168379|NCT01868542|560054906|FG001|Overall Study|Unclassified|1|||
155168380|NCT00130247|560054907|FG000|Overall Study|Pregnancy|1|||
155168381|NCT00130247|560054908|FG001|Overall Study|Pregnancy|0|||
155168382|NCT00130247|560054907|FG000|Overall Study|Post-randomization exclusion|1|||
155168383|NCT00130247|560054908|FG001|Overall Study|Post-randomization exclusion|2|||
155168384|NCT00130247|560054907|FG000|Overall Study|Not compliant with DOT|0|||
155168385|NCT00130247|560054908|FG001|Overall Study|Not compliant with DOT|2|||
155168386|NCT00843284|560054911|FG000|Overall Study|Adverse Event|39|||
155168387|NCT00843284|560054911|FG000|Overall Study|Lack of Efficacy|5|||
155168388|NCT00843284|560054911|FG000|Overall Study|Lost to Follow-up|11|||
155168389|NCT00843284|560054911|FG000|Overall Study|Other|10|||
155168390|NCT00843284|560054911|FG000|Overall Study|Withdrawal by Subject|4|||
155168391|NCT00843284|560054911|FG000|Overall Study|Death|3|||
155168392|NCT02160899|560054914|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155168393|NCT02160899|560054915|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155168394|NCT02160899|560054916|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
155168395|NCT02160899|560054917|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
155168396|NCT02160899|560054918|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
155168397|NCT02160899|560054919|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
155168398|NCT00727441|560054921|FG000|Overall Study|Disease Progression|11|||
155168399|NCT00727441|560054922|FG001|Overall Study|Disease Progression|14|||
155168400|NCT00727441|560054923|FG002|Overall Study|Disease Progression|17|||
155168401|NCT00727441|560054921|FG000|Overall Study|Eligibility|7|||
155168402|NCT00727441|560054922|FG001|Overall Study|Eligibility|5|||
155168403|NCT00727441|560054923|FG002|Overall Study|Eligibility|7|||
155168404|NCT00727441|560054921|FG000|Overall Study|Death|0|||
155168405|NCT00727441|560054922|FG001|Overall Study|Death|1|||
155168406|NCT00727441|560054923|FG002|Overall Study|Death|1|||
155168407|NCT00727441|560054921|FG000|Overall Study|Physician Decision|0|||
155168408|NCT00727441|560054922|FG001|Overall Study|Physician Decision|1|||
155168409|NCT00727441|560054923|FG002|Overall Study|Physician Decision|0|||
155168410|NCT00727441|560054921|FG000|Overall Study|Withdrawal by Subject|0|||
155168411|NCT00727441|560054922|FG001|Overall Study|Withdrawal by Subject|1|||
155168412|NCT00727441|560054923|FG002|Overall Study|Withdrawal by Subject|0|||
155168413|NCT01239992|560054924|FG000|Overall Study|Withdrawal by Subject|2|||
155168414|NCT00535288|560054925|FG000|Overall Study|Adverse Event|20|||
155168415|NCT00535288|560054926|FG001|Overall Study|Adverse Event|19|||
155168416|NCT00535288|560054927|FG002|Overall Study|Adverse Event|25|||
155168417|NCT00535288|560054928|FG003|Overall Study|Adverse Event|20|||
155168418|NCT00535288|560054929|FG004|Overall Study|Adverse Event|30|||
155168419|NCT00535288|560054925|FG000|Overall Study|Lost to Follow-up|0|||
155168420|NCT00535288|560054926|FG001|Overall Study|Lost to Follow-up|3|||
155168421|NCT00535288|560054927|FG002|Overall Study|Lost to Follow-up|0|||
155168422|NCT00535288|560054928|FG003|Overall Study|Lost to Follow-up|0|||
155168423|NCT00535288|560054929|FG004|Overall Study|Lost to Follow-up|0|||
155168424|NCT00535288|560054925|FG000|Overall Study|Lack of Efficacy|26|||
155168425|NCT00535288|560054926|FG001|Overall Study|Lack of Efficacy|3|||
155168426|NCT00535288|560054927|FG002|Overall Study|Lack of Efficacy|4|||
155168427|NCT00535288|560054928|FG003|Overall Study|Lack of Efficacy|4|||
155168428|NCT00535288|560054929|FG004|Overall Study|Lack of Efficacy|7|||
155168429|NCT00535288|560054925|FG000|Overall Study|Unwilling to cooperate|6|||
155168430|NCT00535288|560054926|FG001|Overall Study|Unwilling to cooperate|6|||
155168431|NCT00535288|560054927|FG002|Overall Study|Unwilling to cooperate|3|||
155168432|NCT00535288|560054928|FG003|Overall Study|Unwilling to cooperate|3|||
155168433|NCT00535288|560054929|FG004|Overall Study|Unwilling to cooperate|4|||
155168434|NCT00535288|560054925|FG000|Overall Study|Other|2|||
155168435|NCT00535288|560054926|FG001|Overall Study|Other|1|||
155168436|NCT00535288|560054927|FG002|Overall Study|Other|1|||
155168437|NCT00535288|560054928|FG003|Overall Study|Other|2|||
155168438|NCT00535288|560054929|FG004|Overall Study|Other|1|||
155168439|NCT02810444|560054930|FG000|Overall Study|Screen Failures|14|||
155168440|NCT02810444|560054930|FG000|Overall Study|Withdrawal by Subject|4|||
155168441|NCT02810444|560054930|FG000|Overall Study|Adverse Event|3|||
155168442|NCT05367492|560054931|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
155168443|NCT05367492|560054932|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
155168444|NCT05367492|560054933|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
155168445|NCT05367492|560054931|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
155168446|NCT05367492|560054932|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
155168447|NCT05367492|560054933|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
155168448|NCT05367492|560054931|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
155168449|NCT05367492|560054932|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
155168450|NCT05367492|560054933|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
155168451|NCT05367492|560054931|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
155168452|NCT05367492|560054932|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
155168453|NCT05367492|560054933|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
155168454|NCT01343693|560054938|FG000|Overall Study|Lost to Follow-up|9|||
155168455|NCT02891070|560054939|FG000|Overall Study|Adverse Event|1|||
155168456|NCT02891070|560054940|FG001|Overall Study|Adverse Event|0|||
155168457|NCT02891070|560054939|FG000|Overall Study|Physician Decision|0|||
155168458|NCT02891070|560054940|FG001|Overall Study|Physician Decision|1|||
155168459|NCT02891070|560054939|FG000|Overall Study|Lost to Follow-up|4|||
155168460|NCT02891070|560054940|FG001|Overall Study|Lost to Follow-up|4|||
155168461|NCT02891070|560054939|FG000|Overall Study|Other|1|||
155168462|NCT02891070|560054940|FG001|Overall Study|Other|0|||
155168463|NCT02891070|560054939|FG000|Overall Study|Protocol Violation|0|||
155168464|NCT02891070|560054940|FG001|Overall Study|Protocol Violation|1|||
155168465|NCT02891070|560054939|FG000|Overall Study|Withdrawal by Subject|1|||
155168466|NCT02891070|560054940|FG001|Overall Study|Withdrawal by Subject|2|||
155168467|NCT02891070|560054939|FG000|Overall Study|Death|3|||
155168468|NCT02891070|560054940|FG001|Overall Study|Death|0|||
155168469|NCT00265148|560054945|FG000|Overall Study|Adverse Event|2|||
155168470|NCT00265148|560054946|FG001|Overall Study|Adverse Event|2|||
155168471|NCT00265148|560054945|FG000|Overall Study|Lack of Efficacy|0|||
155168472|NCT00265148|560054946|FG001|Overall Study|Lack of Efficacy|2|||
155168473|NCT00265148|560054945|FG000|Overall Study|Protocol Violation|3|||
155168474|NCT00265148|560054946|FG001|Overall Study|Protocol Violation|2|||
155168475|NCT00265148|560054945|FG000|Overall Study|Lost to Follow-up|0|||
155090853|NCT03274466|559765142|FG000|Overall Study|Physician Decision|0|||
155090854|NCT03274466|559765143|FG001|Overall Study|Physician Decision|1|||
155090855|NCT03274466|559765142|FG000|Overall Study|Protocol Violation|3|||
155090856|NCT03274466|559765143|FG001|Overall Study|Protocol Violation|3|||
155090857|NCT00618787|559765146|FG000|Overall Study|Adverse Event|0|||
155090858|NCT00618787|559765147|FG001|Overall Study|Adverse Event|1|||
155090859|NCT00618787|559765146|FG000|Overall Study|Withdrawal by Subject|2|||
155090860|NCT00618787|559765147|FG001|Overall Study|Withdrawal by Subject|1|||
155090861|NCT00618787|559765146|FG000|Overall Study|Lost to Follow-up|1|||
155090862|NCT00618787|559765147|FG001|Overall Study|Lost to Follow-up|0|||
155090863|NCT01107886|559765148|FG000|Overall Study|Lost to Follow-up|15|||
155090864|NCT01107886|559765149|FG001|Overall Study|Lost to Follow-up|13|||
155090865|NCT01107886|559765148|FG000|Overall Study|Withdrawal by Subject|180|||
155090866|NCT01107886|559765149|FG001|Overall Study|Withdrawal by Subject|196|||
155090867|NCT01107886|559765148|FG000|Overall Study|Administrative withdrawal of consent|7|||
155090868|NCT01107886|559765149|FG001|Overall Study|Administrative withdrawal of consent|5|||
155090869|NCT05819398|559765150|FG000|Overall Study|Withdrawal by Subject|11|||
155090870|NCT05819398|559765151|FG001|Overall Study|Withdrawal by Subject|7|||
155090871|NCT05819398|559765152|FG002|Overall Study|Withdrawal by Subject|6|||
155090872|NCT05819398|559765153|FG003|Overall Study|Withdrawal by Subject|6|||
155090873|NCT05819398|559765150|FG000|Overall Study|Lost to Follow-up|0|||
155090874|NCT05819398|559765151|FG001|Overall Study|Lost to Follow-up|2|||
155090875|NCT05819398|559765152|FG002|Overall Study|Lost to Follow-up|0|||
155090876|NCT05819398|559765153|FG003|Overall Study|Lost to Follow-up|1|||
155090877|NCT05819398|559765150|FG000|Overall Study|Adverse Event|1|||
155090878|NCT05819398|559765151|FG001|Overall Study|Adverse Event|3|||
155168476|NCT00265148|560054946|FG001|Overall Study|Lost to Follow-up|1|||
155090879|NCT05819398|559765152|FG002|Overall Study|Adverse Event|4|||
155090880|NCT05819398|559765153|FG003|Overall Study|Adverse Event|5|||
155090881|NCT05819398|559765150|FG000|Overall Study|Other than listed|0|||
155090882|NCT05819398|559765151|FG001|Overall Study|Other than listed|2|||
155090883|NCT05819398|559765152|FG002|Overall Study|Other than listed|2|||
155168477|NCT00265148|560054945|FG000|Overall Study|Withdrawal by Subject|2|||
155168478|NCT00265148|560054946|FG001|Overall Study|Withdrawal by Subject|1|||
155168479|NCT00265148|560054945|FG000|Overall Study|Physician Decision|1|||
155168480|NCT00265148|560054946|FG001|Overall Study|Physician Decision|0|||
155168481|NCT00265148|560054945|FG000|Overall Study|Increasing frailty|0|||
155168482|NCT00265148|560054946|FG001|Overall Study|Increasing frailty|1|||
155168483|NCT00265148|560054945|FG000|Overall Study|Subject chose to change of the dose|1|||
155168484|NCT00265148|560054946|FG001|Overall Study|Subject chose to change of the dose|0|||
155168485|NCT01463007|560054947|FG000|Overall Study|Physician Decision|1|||
155168486|NCT03583385|560054948|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155168487|NCT03583385|560054949|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155168488|NCT03583385|560054948|FG000|Treatment Period 2|Adverse Event|1|||
155168489|NCT03583385|560054949|FG001|Treatment Period 2|Adverse Event|0|||
155168490|NCT00724867|560054952|FG000|Overall Study|Adverse Event|25|||
155168491|NCT00724867|560054952|FG000|Overall Study|Lack of Efficacy|14|||
155168492|NCT00724867|560054952|FG000|Overall Study|Lost to Follow-up|12|||
155168493|NCT00724867|560054952|FG000|Overall Study|Non-compliance with study drug|6|||
155168494|NCT00724867|560054952|FG000|Overall Study|Physician Decision|17|||
155168495|NCT00724867|560054952|FG000|Overall Study|Protocol Violation|1|||
155168496|NCT00724867|560054952|FG000|Overall Study|Withdrawal by Subject|31|||
155168497|NCT00724867|560054952|FG000|Overall Study|Sponsor decision to end study|14|||
155168498|NCT00724867|560054952|FG000|Overall Study|Subject incarcerated|1|||
155168499|NCT00724867|560054952|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
155168500|NCT00724867|560054952|FG000|Overall Study|Subject moved out of state|1|||
155168501|NCT00724867|560054952|FG000|Overall Study|Elected to exit due to site closure|2|||
155168502|NCT00436345|560054957|FG000|Overall Study|ICU resident beyond follow-up period|3|||
155168503|NCT00436345|560054958|FG001|Overall Study|ICU resident beyond follow-up period|0|||
155168504|NCT01296672|560054959|FG000|Overall Study|Lost to Follow-up|73|||
155168505|NCT01296672|560054960|FG001|Overall Study|Lost to Follow-up|18|||
155168506|NCT04027608|560054961|FG000|Overall Study|Withdrawal by Subject|13|||
155168507|NCT04027608|560054962|FG001|Overall Study|Withdrawal by Subject|2|||
155168508|NCT04027608|560054961|FG000|Overall Study|Protocol Violation|2|||
155168509|NCT04027608|560054962|FG001|Overall Study|Protocol Violation|1|||
155168510|NCT04027608|560054961|FG000|Overall Study|Physician Decision|1|||
155168511|NCT04027608|560054962|FG001|Overall Study|Physician Decision|0|||
155168512|NCT04027608|560054961|FG000|Overall Study|Lost to Follow-up|20|||
155168513|NCT04027608|560054962|FG001|Overall Study|Lost to Follow-up|4|||
155168514|NCT04605991|560054966|FG000|Overall Study|Adverse Event|5|||
155168515|NCT04605991|560054966|FG000|Overall Study|Lack of Efficacy|1|||
155168516|NCT04605991|560054966|FG000|Overall Study|Lost to Follow-up|8|||
155168517|NCT04605991|560054966|FG000|Overall Study|Physician Decision|4|||
155168518|NCT04605991|560054966|FG000|Overall Study|Withdrawal by Subject|14|||
155168519|NCT04605991|560054966|FG000|Overall Study|Non-compliance with study|1|||
155168520|NCT02597478|560054974|FG000|Overall Study|Withdrawal by Subject|2|||
155168521|NCT02597478|560054975|FG001|Overall Study|Withdrawal by Subject|0|||
155168522|NCT02597478|560054974|FG000|Overall Study|Change of opioid dose|1|||
155168523|NCT02597478|560054975|FG001|Overall Study|Change of opioid dose|0|||
155168524|NCT02597478|560054974|FG000|Overall Study|Insufficient exertional dyspnea|0|||
155168525|NCT02597478|560054975|FG001|Overall Study|Insufficient exertional dyspnea|1|||
155168526|NCT01305577|560054977|FG000|Overall Study|Adverse Event|2|||
155168527|NCT01305577|560054978|FG001|Overall Study|Adverse Event|2|||
155168528|NCT01305577|560054979|FG002|Overall Study|Adverse Event|1|||
155168529|NCT01305577|560054977|FG000|Overall Study|Withdrawal by Subject|7|||
155168530|NCT01305577|560054978|FG001|Overall Study|Withdrawal by Subject|5|||
155168531|NCT01305577|560054979|FG002|Overall Study|Withdrawal by Subject|6|||
155168532|NCT01305577|560054977|FG000|Overall Study|Lost to Follow-up|4|||
155168533|NCT01305577|560054978|FG001|Overall Study|Lost to Follow-up|3|||
155168534|NCT01305577|560054979|FG002|Overall Study|Lost to Follow-up|2|||
155168535|NCT01305577|560054977|FG000|Overall Study|Protocol Deviation|0|||
155168536|NCT01305577|560054978|FG001|Overall Study|Protocol Deviation|1|||
155168537|NCT01305577|560054979|FG002|Overall Study|Protocol Deviation|1|||
155168538|NCT00796978|560054980|FG000|Overall Study|Cardiac adverse event|5|||
155168539|NCT00796978|560054980|FG000|Overall Study|Adverse Event|4|||
155168540|NCT00796978|560054980|FG000|Overall Study|Withdrawal by Subject|3|||
155168541|NCT01256190|560054981|FG000|Overall Study|Lost to Follow-up|2|||
155168542|NCT01256190|560054982|FG001|Overall Study|Lost to Follow-up|0|||
155168543|NCT02834793|560054983|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
155168544|NCT02834793|560054984|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
155168545|NCT02834793|560054985|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
155168546|NCT02834793|560054986|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
155168547|NCT02834793|560054983|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
155168548|NCT02834793|560054984|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
155168549|NCT02834793|560054985|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
155168550|NCT02834793|560054986|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
155168551|NCT02834793|560054983|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
155168552|NCT02834793|560054984|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
155168553|NCT02834793|560054985|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
155168554|NCT02834793|560054986|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
155168555|NCT02834793|560054983|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
155168556|NCT02834793|560054984|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
155168557|NCT02834793|560054985|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
155371602|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155371603|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155168558|NCT02834793|560054986|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
155168559|NCT02834793|560054983|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
155168560|NCT02834793|560054984|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
155168561|NCT02834793|560054985|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
155168562|NCT02834793|560054986|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
155168563|NCT02834793|560054983|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
155168564|NCT02834793|560054984|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
155168565|NCT02834793|560054985|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
155168566|NCT02834793|560054986|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
155168567|NCT02834793|560054983|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
155168568|NCT02834793|560054984|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
155168569|NCT02834793|560054985|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
155168570|NCT02834793|560054986|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
155168571|NCT02834793|560054983|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
155168572|NCT02834793|560054984|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
155168573|NCT02834793|560054985|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
155168574|NCT02834793|560054986|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
155168575|NCT02834793|560054983|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
155168576|NCT02834793|560054984|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
155168577|NCT02834793|560054985|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
155168578|NCT02834793|560054986|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
155168579|NCT02834793|560054983|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
155168580|NCT02834793|560054984|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
155168581|NCT02834793|560054985|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
155168582|NCT02834793|560054986|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
155168583|NCT02834793|560054983|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
155168584|NCT02834793|560054984|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
155168585|NCT02834793|560054985|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
155168586|NCT02834793|560054986|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
155168587|NCT02834793|560054983|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
155168588|NCT02834793|560054984|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
155168589|NCT02834793|560054985|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
155168590|NCT02834793|560054986|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
155168591|NCT02834793|560054983|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
155168592|NCT02834793|560054984|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
155168593|NCT02834793|560054985|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
155168594|NCT02834793|560054986|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
155168595|NCT02834793|560054983|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
155168596|NCT02834793|560054984|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
155168597|NCT02834793|560054985|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
155168598|NCT02834793|560054986|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
155168599|NCT02834793|560054983|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
155168600|NCT02834793|560054984|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
155168601|NCT02834793|560054985|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
155168602|NCT02834793|560054986|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
155168603|NCT02364336|560054987|FG000|Overall Study|Adverse Event|0|||
155168604|NCT02364336|560054988|FG001|Overall Study|Adverse Event|1|||
155168605|NCT01731938|560054989|FG000|Preliminary Part I|Withdrawal by Subject|2|||
155168606|NCT01731938|560054990|FG001|Preliminary Part I|Withdrawal by Subject|2|||
155168607|NCT01731938|560054989|FG000|Preliminary Part I|Physician Decision|1|||
155168608|NCT01731938|560054990|FG001|Preliminary Part I|Physician Decision|0|||
155168609|NCT01731938|560054989|FG000|Preliminary Part I|Lost to Follow-up|0|||
155168610|NCT01731938|560054990|FG001|Preliminary Part I|Lost to Follow-up|3|||
155168611|NCT01731938|560054989|FG000|Preliminary Part I|Missed Week 6 visit|0|||
155168612|NCT01731938|560054990|FG001|Preliminary Part I|Missed Week 6 visit|3|||
155168613|NCT01731938|560054989|FG000|Primary Part II|Withdrawal by Subject|5|||
155168614|NCT01731938|560054990|FG001|Primary Part II|Withdrawal by Subject|4|||
155168615|NCT01731938|560054989|FG000|Primary Part II|Lost to Follow-up|4|||
155168616|NCT01731938|560054990|FG001|Primary Part II|Lost to Follow-up|5|||
155168617|NCT01731938|560054989|FG000|Primary Part II|Death|2|||
155168618|NCT01731938|560054990|FG001|Primary Part II|Death|1|||
155168619|NCT01731938|560054989|FG000|Primary Part II|Missed Week 6 visit|2|||
155168620|NCT01731938|560054990|FG001|Primary Part II|Missed Week 6 visit|3|||
155168621|NCT04931888|560054991|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
155168622|NCT04931888|560054992|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
155168623|NCT04931888|560054993|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
155168624|NCT04931888|560054994|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
155168625|NCT03179202|560054995|FG000|Overall Study|Screen Failure|67|||
155371604|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
155168626|NCT03179202|560054995|FG000|Overall Study|Subject Lost to Follow Up|12|||
155168627|NCT03179202|560054995|FG000|Overall Study|Withdrawal by Subject|7|||
155168628|NCT03179202|560054995|FG000|Overall Study|Adverse Event|3|||
155168629|NCT03179202|560054995|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
155168630|NCT03179202|560054995|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
155168631|NCT00856518|560054996|FG000|Overall Study|Lost to Follow-up|4|||
155168632|NCT00856518|560054997|FG001|Overall Study|Lost to Follow-up|2|||
155168633|NCT02644109|560055004|FG000|Overall Study|Adverse Event|0|||
155168634|NCT02644109|560055005|FG001|Overall Study|Adverse Event|4|||
155168635|NCT02474069|560055006|FG000|Selection Phase (SP)|Adverse Event|8|||
155168636|NCT02474069|560055007|FG001|Selection Phase (SP)|Adverse Event|0|||
155168637|NCT02474069|560055008|FG002|Selection Phase (SP)|Adverse Event|0|||
155168638|NCT02474069|560055006|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
155168639|NCT02474069|560055007|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
155168640|NCT02474069|560055008|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
155168641|NCT02474069|560055006|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
155168642|NCT02474069|560055007|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
155168643|NCT02474069|560055008|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
155168644|NCT02474069|560055006|FG000|Selection Phase (SP)|Physician Decision|1|||
155168645|NCT02474069|560055007|FG001|Selection Phase (SP)|Physician Decision|0|||
155168646|NCT02474069|560055008|FG002|Selection Phase (SP)|Physician Decision|0|||
155168647|NCT02474069|560055006|FG000|Selection Phase (SP)|Protocol Violation|1|||
155168648|NCT02474069|560055007|FG001|Selection Phase (SP)|Protocol Violation|0|||
155168649|NCT02474069|560055008|FG002|Selection Phase (SP)|Protocol Violation|0|||
155168650|NCT02474069|560055006|FG000|Selection Phase (SP)|No longer requires treatment|1|||
155168651|NCT02474069|560055007|FG001|Selection Phase (SP)|No longer requires treatment|0|||
155168652|NCT02474069|560055008|FG002|Selection Phase (SP)|No longer requires treatment|0|||
155168653|NCT02474069|560055006|FG000|Selection Phase (SP)|Technical Problem|1|||
155168654|NCT02474069|560055007|FG001|Selection Phase (SP)|Technical Problem|0|||
155168655|NCT02474069|560055008|FG002|Selection Phase (SP)|Technical Problem|0|||
155168656|NCT02474069|560055006|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
155168657|NCT02474069|560055007|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
155168658|NCT02474069|560055008|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
155168659|NCT02474069|560055006|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
155168660|NCT02474069|560055007|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
155168661|NCT02474069|560055008|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
155168662|NCT02474069|560055006|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
155168663|NCT02474069|560055007|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
155168664|NCT02474069|560055008|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
155168665|NCT02474069|560055006|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
155168666|NCT02474069|560055007|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
155168667|NCT02474069|560055008|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
155168668|NCT02474069|560055006|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
155168669|NCT02474069|560055007|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
155168670|NCT02474069|560055008|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
155168671|NCT02474069|560055006|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
155168672|NCT02474069|560055007|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
155168673|NCT02474069|560055008|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
155168674|NCT00202878|560055011|FG000|Overall Study|Death|964|||
155168675|NCT00202878|560055012|FG001|Overall Study|Death|968|||
155168676|NCT00202878|560055011|FG000|Overall Study|Only Vital Status Known|357|||
155168677|NCT00202878|560055012|FG001|Overall Study|Only Vital Status Known|356|||
155168678|NCT00202878|560055011|FG000|Overall Study|Lost to Follow-up|44|||
155168679|NCT00202878|560055012|FG001|Overall Study|Lost to Follow-up|49|||
155168680|NCT00202878|560055011|FG000|Overall Study|Site Closure|39|||
155168681|NCT00202878|560055012|FG001|Overall Study|Site Closure|36|||
155168682|NCT00202878|560055011|FG000|Overall Study|Withdrawal by Subject|795|||
155168683|NCT00202878|560055012|FG001|Overall Study|Withdrawal by Subject|808|||
155168684|NCT00918736|560055014|FG000|Overall Study|Withdrawal by Subject|4|||
155168685|NCT02433080|560055016|FG000|Overall Study|Lost to Follow-up|1|||
155168686|NCT02433080|560055017|FG001|Overall Study|Lost to Follow-up|2|||
155168687|NCT02433080|560055016|FG000|Overall Study|Withdrawal by Subject|0|||
155168688|NCT02433080|560055017|FG001|Overall Study|Withdrawal by Subject|2|||
155168689|NCT01942733|560055019|FG000|Overall Study|Lost to Follow-up|1|||
155168690|NCT01942733|560055019|FG000|Overall Study|Non-compliance with IMP|1|||
155168691|NCT01942733|560055019|FG000|Overall Study|Administrative|1|||
155168692|NCT02925416|560055021|FG000|Overall Study|Adverse Event|2|||
155168693|NCT02925416|560055022|FG001|Overall Study|Adverse Event|0|||
155168694|NCT01297491|560055025|FG000|Overall Study|Adverse Event|11|||
155168695|NCT01297491|560055026|FG001|Overall Study|Adverse Event|6|||
155168696|NCT01297491|560055025|FG000|Overall Study|Physician Decision|3|||
155168697|NCT01297491|560055026|FG001|Overall Study|Physician Decision|2|||
155168698|NCT01297491|560055025|FG000|Overall Study|Progressive disease|11|||
155168699|NCT01297491|560055026|FG001|Overall Study|Progressive disease|20|||
155168700|NCT01297491|560055025|FG000|Overall Study|Patient/Guardian decision|3|||
155168701|NCT01297491|560055026|FG001|Overall Study|Patient/Guardian decision|4|||
155168702|NCT01297491|560055025|FG000|Overall Study|Death|2|||
155168703|NCT01297491|560055026|FG001|Overall Study|Death|1|||
155168704|NCT02355184|560055032|FG000|Overall Study|Lost to Follow-up|2|||
155168705|NCT02355184|560055032|FG000|Overall Study|Study Terminated|10|||
155168706|NCT04129151|560057156|FG000|Overall Study|Adverse Event|1|||
155168707|NCT04129151|560057156|FG000|Overall Study|Disease Progression|7|||
155168708|NCT04129151|560057156|FG000|Overall Study|Study closure|1|||
155168709|NCT04473235|560057157|FG000|Overall Study|Lost to Follow-up|6|||
155168710|NCT04473235|560057158|FG001|Overall Study|Lost to Follow-up|5|||
155168711|NCT04473235|560057157|FG000|Overall Study|Declined continuation|2|||
155168712|NCT04473235|560057158|FG001|Overall Study|Declined continuation|0|||
155168713|NCT04473235|560057157|FG000|Overall Study|Physician Decision|1|||
155168714|NCT04473235|560057158|FG001|Overall Study|Physician Decision|1|||
155168715|NCT04473235|560057157|FG000|Overall Study|Protocol Violation|10|||
155168716|NCT04473235|560057158|FG001|Overall Study|Protocol Violation|6|||
155168717|NCT00798759|560057161|FG000|Overall Study|Adverse Event|3|||
155168718|NCT00798759|560057162|FG001|Overall Study|Adverse Event|3|||
155168719|NCT00798759|560057161|FG000|Overall Study|Lost to Follow-up|1|||
155168720|NCT00798759|560057162|FG001|Overall Study|Lost to Follow-up|1|||
155168721|NCT00798759|560057161|FG000|Overall Study|Protocol Violation|4|||
155168722|NCT00798759|560057162|FG001|Overall Study|Protocol Violation|8|||
155168723|NCT00798759|560057161|FG000|Overall Study|Other|0|||
155168724|NCT00798759|560057162|FG001|Overall Study|Other|1|||
155168725|NCT03387111|560057163|FG000|Overall Study|Progressive Disease|3|||
155168726|NCT03387111|560057163|FG000|Overall Study|Other|1|||
155168727|NCT01945710|560057164|FG000|Overall Study|Progressive Disease|5|||
154965683|NCT00112437|559298883|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965684|NCT00112437|559298884|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965685|NCT00112437|559298885|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155168728|NCT01945710|560057165|FG001|Overall Study|Progressive Disease|4|||
155168729|NCT01945710|560057166|FG002|Overall Study|Progressive Disease|3|||
155168730|NCT01945710|560057167|FG003|Overall Study|Progressive Disease|2|||
155168731|NCT01945710|560057168|FG004|Overall Study|Progressive Disease|7|||
155168732|NCT01945710|560057169|FG005|Overall Study|Progressive Disease|3|||
155168733|NCT01945710|560057170|FG006|Overall Study|Progressive Disease|19|||
155168734|NCT01945710|560057164|FG000|Overall Study|Adverse Event|0|||
155168735|NCT01945710|560057165|FG001|Overall Study|Adverse Event|1|||
155168736|NCT01945710|560057166|FG002|Overall Study|Adverse Event|0|||
155168737|NCT01945710|560057167|FG003|Overall Study|Adverse Event|0|||
155168738|NCT01945710|560057168|FG004|Overall Study|Adverse Event|0|||
155168739|NCT01945710|560057169|FG005|Overall Study|Adverse Event|0|||
155168740|NCT01945710|560057170|FG006|Overall Study|Adverse Event|0|||
155168741|NCT01945710|560057164|FG000|Overall Study|Other|2|||
155168742|NCT01945710|560057165|FG001|Overall Study|Other|0|||
155168743|NCT01945710|560057166|FG002|Overall Study|Other|3|||
155168744|NCT01945710|560057167|FG003|Overall Study|Other|1|||
155168745|NCT01945710|560057168|FG004|Overall Study|Other|1|||
155168746|NCT01945710|560057169|FG005|Overall Study|Other|0|||
155168747|NCT01945710|560057170|FG006|Overall Study|Other|4|||
155168748|NCT01945710|560057164|FG000|Overall Study|Withdrawal by Subject|0|||
155168749|NCT01945710|560057165|FG001|Overall Study|Withdrawal by Subject|1|||
155168750|NCT01945710|560057166|FG002|Overall Study|Withdrawal by Subject|1|||
155168751|NCT01945710|560057167|FG003|Overall Study|Withdrawal by Subject|0|||
155168752|NCT01945710|560057168|FG004|Overall Study|Withdrawal by Subject|1|||
155168753|NCT01945710|560057169|FG005|Overall Study|Withdrawal by Subject|0|||
155090884|NCT05819398|559765153|FG003|Overall Study|Other than listed|0|||
155090885|NCT05819398|559765150|FG000|Overall Study|Lack of Efficacy|0|||
155090886|NCT05819398|559765151|FG001|Overall Study|Lack of Efficacy|1|||
155090887|NCT05819398|559765152|FG002|Overall Study|Lack of Efficacy|0|||
155090888|NCT05819398|559765153|FG003|Overall Study|Lack of Efficacy|0|||
155090889|NCT05819398|559765150|FG000|Overall Study|Study terminated by sponsor|20|||
155090890|NCT05819398|559765151|FG001|Overall Study|Study terminated by sponsor|18|||
155090891|NCT05819398|559765152|FG002|Overall Study|Study terminated by sponsor|20|||
155090892|NCT05819398|559765153|FG003|Overall Study|Study terminated by sponsor|22|||
155090893|NCT01649869|559765157|FG000|Overall Study|Family member illness|1|||
155090894|NCT01649869|559765158|FG001|Overall Study|Family member illness|0|||
155090895|NCT01649869|559765157|FG000|Overall Study|Required treatment outside protocol|1|||
155090896|NCT01649869|559765158|FG001|Overall Study|Required treatment outside protocol|0|||
155090897|NCT01649869|559765157|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
155090898|NCT01649869|559765158|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
155090899|NCT02776735|559765159|FG000|Overall Study|Adverse Event|0|||
155090900|NCT02776735|559765160|FG001|Overall Study|Adverse Event|0|||
155090901|NCT02776735|559765161|FG002|Overall Study|Adverse Event|0|||
155090902|NCT02776735|559765162|FG003|Overall Study|Adverse Event|1|||
155090903|NCT02776735|559765163|FG004|Overall Study|Adverse Event|0|||
155090904|NCT02776735|559765164|FG005|Overall Study|Adverse Event|1|||
155090905|NCT02776735|559765159|FG000|Overall Study|Lost to Follow-up|0|||
155090906|NCT02776735|559765160|FG001|Overall Study|Lost to Follow-up|0|||
155090907|NCT02776735|559765161|FG002|Overall Study|Lost to Follow-up|0|||
155090908|NCT02776735|559765162|FG003|Overall Study|Lost to Follow-up|1|||
155090909|NCT02776735|559765163|FG004|Overall Study|Lost to Follow-up|0|||
155090910|NCT02776735|559765164|FG005|Overall Study|Lost to Follow-up|0|||
155090911|NCT02776735|559765159|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155090912|NCT02776735|559765160|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155090913|NCT02776735|559765161|FG002|Overall Study|Withdrawal by parent/guardian|2|||
155090914|NCT02776735|559765162|FG003|Overall Study|Withdrawal by parent/guardian|2|||
155168754|NCT01945710|560057170|FG006|Overall Study|Withdrawal by Subject|0|||
155168755|NCT02730195|560057171|FG000|Overall Study|Withdrawal by Subject|1|||
155168756|NCT01368562|560057174|FG000|Overall Study|Adverse Event|1|||
155168757|NCT01368562|560057174|FG000|Overall Study|Disease progression|1|||
155371605|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371606|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
155371607|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
155371608|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371609|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371610|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
155371611|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
155371612|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
155371613|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
155371614|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
155371615|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
155371616|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
155371617|NCT03524092|560793541|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
155371618|NCT03524092|560793542|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
155371619|NCT03524092|560793543|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
155371620|NCT03524092|560793544|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
155371621|NCT03524092|560793545|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
155371622|NCT03524092|560793546|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
155371623|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Adverse Event|0|||
155371624|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Adverse Event|0|||
155371625|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Adverse Event|0|||
155371626|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Adverse Event|2|||
155371627|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Adverse Event|0|||
155371628|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Adverse Event|0|||
155371629|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371630|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371631|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371632|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
155371633|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371634|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
155371635|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Pregnancy|0|||
155371636|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Pregnancy|0|||
155371637|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Pregnancy|0|||
155371638|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Pregnancy|1|||
155371639|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Pregnancy|0|||
155371640|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Pregnancy|0|||
155371641|NCT03524092|560793541|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371642|NCT03524092|560793542|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371643|NCT03524092|560793543|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371644|NCT03524092|560793544|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
155371645|NCT03524092|560793545|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155168758|NCT01368562|560057174|FG000|Overall Study|Lost to Follow-up|1|||
155168759|NCT01368562|560057174|FG000|Overall Study|Death|6|||
155168760|NCT01368562|560057174|FG000|Overall Study|Unresponsive to treatment|5|||
155168761|NCT01368562|560057174|FG000|Overall Study|Other|3|||
155168762|NCT01368562|560057174|FG000|Overall Study|Other than specified|2|||
155168763|NCT02848729|560057177|FG000|Overall Study|Withdrawal by Subject|1|||
155168764|NCT02848729|560057178|FG001|Overall Study|Withdrawal by Subject|0|||
155168765|NCT02848729|560057177|FG000|Overall Study|Emesis|15|||
155168766|NCT02848729|560057178|FG001|Overall Study|Emesis|11|||
155168767|NCT01904773|560057179|FG000|Screen|Screen failure|3|||
155168768|NCT01904773|560057180|FG001|Screen|Screen failure|0|||
155168769|NCT01904773|560057181|FG002|Screen|Screen failure|0|||
155168770|NCT01904773|560057182|FG003|Screen|Screen failure|0|||
155168771|NCT01904773|560057183|FG004|Screen|Screen failure|0|||
155168772|NCT01904773|560057184|FG005|Screen|Screen failure|0|||
155168773|NCT01904773|560057185|FG006|Screen|Screen failure|0|||
155168774|NCT01904773|560057186|FG007|Screen|Screen failure|0|||
155371646|NCT03524092|560793546|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
155371647|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371648|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371649|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371650|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371651|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
155371652|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
155371653|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371654|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371655|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371656|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371657|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
155371658|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
155371659|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371660|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371661|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371662|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371663|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
155371664|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
155371665|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371666|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371667|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371668|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371669|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
155371670|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
155371671|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371672|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155168775|NCT01904773|560057187|FG008|Screen|Screen failure|0|||
155168776|NCT01904773|560057179|FG000|Screen|Withdrawal by Subject|1|||
155168777|NCT01904773|560057180|FG001|Screen|Withdrawal by Subject|0|||
155168778|NCT01904773|560057181|FG002|Screen|Withdrawal by Subject|0|||
155168779|NCT01904773|560057182|FG003|Screen|Withdrawal by Subject|0|||
155168780|NCT01904773|560057183|FG004|Screen|Withdrawal by Subject|0|||
155168781|NCT01904773|560057184|FG005|Screen|Withdrawal by Subject|0|||
155168782|NCT01904773|560057185|FG006|Screen|Withdrawal by Subject|0|||
155168783|NCT01904773|560057186|FG007|Screen|Withdrawal by Subject|0|||
155168784|NCT01904773|560057187|FG008|Screen|Withdrawal by Subject|0|||
155168785|NCT01904773|560057179|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
155168786|NCT01904773|560057180|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168787|NCT01904773|560057181|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168788|NCT01904773|560057182|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168789|NCT01904773|560057183|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155371673|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
154965686|NCT00112437|559298886|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
155168790|NCT01904773|560057184|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168791|NCT01904773|560057185|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168792|NCT01904773|560057186|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168793|NCT01904773|560057187|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
155168794|NCT01904773|560057179|FG000|First Intervention|Adverse Event|0|||
155168795|NCT01904773|560057180|FG001|First Intervention|Adverse Event|0|||
155371674|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371675|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
155371676|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
155371677|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371678|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371679|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371680|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371681|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
155371682|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
155371683|NCT03524092|560793541|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371684|NCT03524092|560793542|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371685|NCT03524092|560793543|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371686|NCT03524092|560793544|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371687|NCT03524092|560793545|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
155371688|NCT03524092|560793546|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
155371689|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371690|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371691|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371692|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371693|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
155371694|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
155371695|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371696|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371697|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371698|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371699|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
155371700|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
155371701|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371702|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371703|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371704|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371705|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
155371706|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
155371707|NCT03524092|560793541|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371708|NCT03524092|560793542|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371709|NCT03524092|560793543|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371710|NCT03524092|560793544|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371711|NCT03524092|560793545|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
155371712|NCT03524092|560793546|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
155371713|NCT04303780|560793547|FG000|Overall Study|Death|104|||
155371714|NCT04303780|560793548|FG001|Overall Study|Death|85|||
155371715|NCT04303780|560793547|FG000|Overall Study|Lost to Follow-up|5|||
155371716|NCT04303780|560793548|FG001|Overall Study|Lost to Follow-up|2|||
155371717|NCT04303780|560793547|FG000|Overall Study|Withdrawal by Subject|12|||
155371718|NCT04303780|560793548|FG001|Overall Study|Withdrawal by Subject|39|||
155371719|NCT04303780|560793547|FG000|Overall Study|Ongoing in study|50|||
155371720|NCT04303780|560793548|FG001|Overall Study|Ongoing in study|45|||
155371721|NCT03826030|560793549|FG000|Overall Study|Withdrawal by Subject|2|||
155371722|NCT03826030|560793550|FG001|Overall Study|Withdrawal by Subject|0|||
155371723|NCT03826030|560793551|FG002|Overall Study|Withdrawal by Subject|1|||
155371724|NCT03826030|560793549|FG000|Overall Study|Lost to Follow-up|1|||
155371725|NCT03826030|560793550|FG001|Overall Study|Lost to Follow-up|1|||
155371726|NCT03826030|560793551|FG002|Overall Study|Lost to Follow-up|1|||
155371727|NCT03826030|560793549|FG000|Overall Study|Too busy to return for visits|1|||
155371728|NCT03826030|560793550|FG001|Overall Study|Too busy to return for visits|0|||
155371729|NCT03826030|560793551|FG002|Overall Study|Too busy to return for visits|0|||
155371730|NCT04893460|560793554|FG000|Overall Study|Lost to Follow-up|18|||
155371731|NCT04500769|560795592|FG000|Overall Study|Withdrawal by Subject|5|||
155371732|NCT01967147|560795593|FG000|Overall Study|Adverse Event|5|||
155371733|NCT01967147|560795594|FG001|Overall Study|Adverse Event|2|||
155371734|NCT01967147|560795593|FG000|Overall Study|Lack of Efficacy|1|||
155371735|NCT01967147|560795594|FG001|Overall Study|Lack of Efficacy|4|||
155371736|NCT01967147|560795593|FG000|Overall Study|Lost to Follow-up|1|||
155371737|NCT01967147|560795594|FG001|Overall Study|Lost to Follow-up|2|||
155371738|NCT01967147|560795593|FG000|Overall Study|Withdrawal by Subject|2|||
155371739|NCT01967147|560795594|FG001|Overall Study|Withdrawal by Subject|4|||
155371740|NCT01967147|560795593|FG000|Overall Study|Non-compliance with Study Drug|0|||
155371741|NCT01967147|560795594|FG001|Overall Study|Non-compliance with Study Drug|3|||
155371742|NCT01967147|560795593|FG000|Overall Study|Other|4|||
155371743|NCT01967147|560795594|FG001|Overall Study|Other|5|||
155371744|NCT03843554|560795595|FG000|Overall Study|Physician Decision|0|||
155371745|NCT03843554|560795596|FG001|Overall Study|Physician Decision|2|||
155371746|NCT02218606|560795598|FG000|Overall Study|Adverse Event|1|||
155371747|NCT02218606|560795599|FG001|Overall Study|Adverse Event|1|||
155371748|NCT02218606|560795598|FG000|Overall Study|Death|15|||
155371749|NCT02218606|560795599|FG001|Overall Study|Death|28|||
155371750|NCT02218606|560795598|FG000|Overall Study|Physician Decision|0|||
155371751|NCT02218606|560795599|FG001|Overall Study|Physician Decision|1|||
155371752|NCT02218606|560795598|FG000|Overall Study|Withdrawal by Subject|4|||
155371753|NCT02218606|560795599|FG001|Overall Study|Withdrawal by Subject|0|||
155371754|NCT02218606|560795598|FG000|Overall Study|Noncompliance|1|||
155371755|NCT02218606|560795599|FG001|Overall Study|Noncompliance|0|||
155371756|NCT02218606|560795598|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
155371757|NCT02218606|560795599|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
155371758|NCT02218606|560795598|FG000|Overall Study|Other|2|||
155371759|NCT02218606|560795599|FG001|Overall Study|Other|1|||
155371760|NCT02218606|560795598|FG000|Overall Study|Never started treatment|0|||
155371761|NCT02218606|560795599|FG001|Overall Study|Never started treatment|1|||
155371762|NCT03203473|560795600|FG000|Induction Phase|Never started primary treatment|2|||
155371763|NCT03203473|560795601|FG001|Induction Phase|Never started primary treatment|0|||
155371764|NCT03203473|560795602|FG002|Induction Phase|Never started primary treatment|0|||
155371765|NCT03203473|560795600|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
155371766|NCT03203473|560795601|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
155371767|NCT03203473|560795602|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
155371768|NCT03203473|560795600|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
155371769|NCT03203473|560795601|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
155371770|NCT03203473|560795602|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
155371771|NCT03203473|560795600|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
155371772|NCT03203473|560795601|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
155371773|NCT03203473|560795602|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
155371774|NCT03203473|560795600|FG000|Arm Allocation Phase|started salvage therapy|0|||
155371775|NCT03203473|560795601|FG001|Arm Allocation Phase|started salvage therapy|5|||
155090915|NCT02776735|559765163|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155090916|NCT02776735|559765164|FG005|Overall Study|Withdrawal by parent/guardian|0|||
155090917|NCT02776735|559765159|FG000|Overall Study|Withdrawal by Subject|1|||
155090918|NCT02776735|559765160|FG001|Overall Study|Withdrawal by Subject|0|||
155090919|NCT02776735|559765161|FG002|Overall Study|Withdrawal by Subject|0|||
155090920|NCT02776735|559765162|FG003|Overall Study|Withdrawal by Subject|0|||
155090921|NCT02776735|559765163|FG004|Overall Study|Withdrawal by Subject|0|||
155090922|NCT02776735|559765164|FG005|Overall Study|Withdrawal by Subject|1|||
155090923|NCT02776735|559765159|FG000|Overall Study|Other|0|||
155090924|NCT02776735|559765160|FG001|Overall Study|Other|0|||
155090925|NCT02776735|559765161|FG002|Overall Study|Other|3|||
155090926|NCT02776735|559765162|FG003|Overall Study|Other|0|||
155090927|NCT02776735|559765163|FG004|Overall Study|Other|0|||
155090928|NCT02776735|559765164|FG005|Overall Study|Other|0|||
155090929|NCT02276040|559767431|FG000|Overall Study|Physician Decision|15|||
155090930|NCT02835690|559767432|FG000|Overall Study|Death|12|||
155090931|NCT02835690|559767433|FG001|Overall Study|Death|11|||
155090932|NCT02835690|559767434|FG002|Overall Study|Death|13|||
155090933|NCT02835690|559767432|FG000|Overall Study|Transferred to Extension Study|2|||
155090934|NCT02835690|559767433|FG001|Overall Study|Transferred to Extension Study|2|||
155090935|NCT02835690|559767434|FG002|Overall Study|Transferred to Extension Study|1|||
155090936|NCT02835690|559767432|FG000|Overall Study|Did Not Continue on Extension Study|0|||
155090937|NCT02835690|559767433|FG001|Overall Study|Did Not Continue on Extension Study|0|||
155090938|NCT02835690|559767434|FG002|Overall Study|Did Not Continue on Extension Study|1|||
155090939|NCT02835690|559767432|FG000|Overall Study|Not Treated|0|||
155090940|NCT02835690|559767433|FG001|Overall Study|Not Treated|2|||
155090941|NCT02835690|559767434|FG002|Overall Study|Not Treated|0|||
155090942|NCT00582907|559767435|FG000|1st Course|Withdrawal by Subject|1|||
155090943|NCT00582907|559767436|FG001|1st Course|Withdrawal by Subject|0|||
155090944|NCT00582907|559767437|FG002|1st Course|Withdrawal by Subject|0|||
155090945|NCT00582907|559767438|FG003|1st Course|Withdrawal by Subject|0|||
155090946|NCT00582907|559767435|FG000|1st Course|Lost to Follow-up|0|||
155090947|NCT00582907|559767436|FG001|1st Course|Lost to Follow-up|0|||
155090948|NCT00582907|559767437|FG002|1st Course|Lost to Follow-up|0|||
155090949|NCT00582907|559767438|FG003|1st Course|Lost to Follow-up|1|||
155090950|NCT00582907|559767435|FG000|2nd Course|Lack of Efficacy|1|||
155090951|NCT00582907|559767436|FG001|2nd Course|Lack of Efficacy|0|||
155090952|NCT00582907|559767437|FG002|2nd Course|Lack of Efficacy|0|||
155090953|NCT00582907|559767438|FG003|2nd Course|Lack of Efficacy|0|||
155090954|NCT04622592|559767439|FG000|Overall Study|Death|0|||
155090955|NCT04622592|559767440|FG001|Overall Study|Death|0|||
155090956|NCT04622592|559767441|FG002|Overall Study|Death|1|||
155371776|NCT03203473|560795602|FG002|Arm Allocation Phase|started salvage therapy|0|||
155371777|NCT03203473|560795600|FG000|Arm Allocation Phase|Disease progression|0|||
155371778|NCT03203473|560795601|FG001|Arm Allocation Phase|Disease progression|0|||
155371779|NCT03203473|560795602|FG002|Arm Allocation Phase|Disease progression|37|||
155371780|NCT03203473|560795600|FG000|Arm Allocation Phase|Adverse Event|0|||
155371781|NCT03203473|560795601|FG001|Arm Allocation Phase|Adverse Event|0|||
155371782|NCT03203473|560795602|FG002|Arm Allocation Phase|Adverse Event|11|||
155371783|NCT03203473|560795600|FG000|Arm Allocation Phase|Physician Decision|0|||
155371784|NCT03203473|560795601|FG001|Arm Allocation Phase|Physician Decision|0|||
155371785|NCT03203473|560795602|FG002|Arm Allocation Phase|Physician Decision|3|||
155371786|NCT03203473|560795600|FG000|Arm Allocation Phase|Death|0|||
155371787|NCT03203473|560795601|FG001|Arm Allocation Phase|Death|0|||
155371788|NCT03203473|560795602|FG002|Arm Allocation Phase|Death|1|||
155371789|NCT03203473|560795600|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
155371790|NCT03203473|560795601|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
155371791|NCT03203473|560795602|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
155371792|NCT03203473|560795600|FG000|Arm Allocation Phase|Intercurrent illness|0|||
155371793|NCT03203473|560795601|FG001|Arm Allocation Phase|Intercurrent illness|0|||
155371794|NCT03203473|560795602|FG002|Arm Allocation Phase|Intercurrent illness|1|||
155371795|NCT03203473|560795600|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
155168796|NCT01904773|560057181|FG002|First Intervention|Adverse Event|0|||
155371796|NCT03203473|560795601|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
155371797|NCT03203473|560795602|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
155371798|NCT01901432|560795607|FG000|Overall Study|Adverse Event|0|||
155371799|NCT01901432|560795608|FG001|Overall Study|Adverse Event|1|||
155371800|NCT01901432|560795609|FG002|Overall Study|Adverse Event|1|||
155371801|NCT01901432|560795610|FG003|Overall Study|Adverse Event|0|||
155371802|NCT01901432|560795611|FG004|Overall Study|Adverse Event|1|||
155371803|NCT01901432|560795607|FG000|Overall Study|Withdrawal by Subject|0|||
155371804|NCT01901432|560795608|FG001|Overall Study|Withdrawal by Subject|0|||
155371805|NCT01901432|560795609|FG002|Overall Study|Withdrawal by Subject|1|||
155371806|NCT01901432|560795610|FG003|Overall Study|Withdrawal by Subject|0|||
155371807|NCT01901432|560795611|FG004|Overall Study|Withdrawal by Subject|5|||
155371808|NCT01901432|560795607|FG000|Overall Study|Physician Decision|0|||
155371809|NCT01901432|560795608|FG001|Overall Study|Physician Decision|0|||
155371810|NCT01901432|560795609|FG002|Overall Study|Physician Decision|0|||
155371811|NCT01901432|560795610|FG003|Overall Study|Physician Decision|0|||
155371812|NCT01901432|560795611|FG004|Overall Study|Physician Decision|2|||
155371813|NCT01901432|560795607|FG000|Overall Study|Patient decision to stop study drug|0|||
155371814|NCT01901432|560795608|FG001|Overall Study|Patient decision to stop study drug|0|||
155371815|NCT01901432|560795609|FG002|Overall Study|Patient decision to stop study drug|0|||
155371816|NCT01901432|560795610|FG003|Overall Study|Patient decision to stop study drug|0|||
155371817|NCT01901432|560795611|FG004|Overall Study|Patient decision to stop study drug|1|||
155371818|NCT00379288|560795612|FG000|Overall Study|Adverse Event|5|||
155371819|NCT00379288|560795613|FG001|Overall Study|Adverse Event|6|||
155371820|NCT00379288|560795614|FG002|Overall Study|Adverse Event|2|||
155371821|NCT00379288|560795615|FG003|Overall Study|Adverse Event|0|||
155371822|NCT00379288|560795612|FG000|Overall Study|Treatment Failure|0|||
155371823|NCT00379288|560795613|FG001|Overall Study|Treatment Failure|1|||
155371824|NCT00379288|560795614|FG002|Overall Study|Treatment Failure|0|||
155371825|NCT00379288|560795615|FG003|Overall Study|Treatment Failure|1|||
155168797|NCT01904773|560057182|FG003|First Intervention|Adverse Event|0|||
155168798|NCT01904773|560057183|FG004|First Intervention|Adverse Event|0|||
155371826|NCT00379288|560795612|FG000|Overall Study|Lost to Follow-up|3|||
155371827|NCT00379288|560795613|FG001|Overall Study|Lost to Follow-up|3|||
155371828|NCT00379288|560795614|FG002|Overall Study|Lost to Follow-up|2|||
155371829|NCT00379288|560795615|FG003|Overall Study|Lost to Follow-up|0|||
155371830|NCT00379288|560795612|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
155371831|NCT00379288|560795613|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
155371832|NCT00379288|560795614|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
155371833|NCT00379288|560795615|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
155168799|NCT01904773|560057184|FG005|First Intervention|Adverse Event|0|||
155168800|NCT01904773|560057185|FG006|First Intervention|Adverse Event|1|||
155168801|NCT01904773|560057186|FG007|First Intervention|Adverse Event|0|||
155371834|NCT00379288|560795612|FG000|Overall Study|Subject withdrew-related to study drug|1|||
155371835|NCT00379288|560795613|FG001|Overall Study|Subject withdrew-related to study drug|0|||
155371836|NCT00379288|560795614|FG002|Overall Study|Subject withdrew-related to study drug|0|||
155371837|NCT00379288|560795615|FG003|Overall Study|Subject withdrew-related to study drug|1|||
155371838|NCT00379288|560795612|FG000|Overall Study|Noncompliance with protocol|8|||
155371839|NCT00379288|560795613|FG001|Overall Study|Noncompliance with protocol|6|||
155371840|NCT00379288|560795614|FG002|Overall Study|Noncompliance with protocol|2|||
155371841|NCT00379288|560795615|FG003|Overall Study|Noncompliance with protocol|1|||
155371842|NCT00379288|560795612|FG000|Overall Study|Did not meet protocol eligibility|0|||
155168802|NCT01904773|560057187|FG008|First Intervention|Adverse Event|0|||
155168803|NCT01904773|560057179|FG000|Placebo Washout First Intervention|Condition worsened|0|||
155371843|NCT00379288|560795613|FG001|Overall Study|Did not meet protocol eligibility|1|||
155371844|NCT00379288|560795614|FG002|Overall Study|Did not meet protocol eligibility|0|||
155371845|NCT00379288|560795615|FG003|Overall Study|Did not meet protocol eligibility|2|||
155371846|NCT00379288|560795612|FG000|Overall Study|Administrative|2|||
155371847|NCT00379288|560795613|FG001|Overall Study|Administrative|2|||
155371848|NCT00379288|560795614|FG002|Overall Study|Administrative|0|||
155371849|NCT00379288|560795615|FG003|Overall Study|Administrative|1|||
155371850|NCT04396366|560795618|FG000|Overall Study|Adverse Event|1|||
155371851|NCT04396366|560795619|FG001|Overall Study|Adverse Event|0|||
155371852|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
155371853|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
155371854|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
155371855|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
155371856|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
155371857|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
155371858|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
155371859|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371860|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371861|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371862|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371863|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
155371864|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Death|1|||
155371865|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Death|2|||
155371866|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Death|2|||
155371867|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Death|0|||
155371868|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Death|0|||
155371869|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Death|0|||
155371870|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155371871|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
155371872|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
155371873|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155371874|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155090957|NCT04622592|559767442|FG003|Overall Study|Death|0|||
155090958|NCT04622592|559767443|FG004|Overall Study|Death|0|||
155090959|NCT04622592|559767444|FG005|Overall Study|Death|0|||
155090960|NCT04622592|559767445|FG006|Overall Study|Death|0|||
155090961|NCT04622592|559767446|FG007|Overall Study|Death|1|||
155090962|NCT04622592|559767439|FG000|Overall Study|Lost to Follow-up|0|||
155090963|NCT04622592|559767440|FG001|Overall Study|Lost to Follow-up|0|||
155090964|NCT04622592|559767441|FG002|Overall Study|Lost to Follow-up|0|||
155090965|NCT04622592|559767442|FG003|Overall Study|Lost to Follow-up|3|||
155090966|NCT04622592|559767443|FG004|Overall Study|Lost to Follow-up|1|||
155090967|NCT04622592|559767444|FG005|Overall Study|Lost to Follow-up|0|||
155090968|NCT04622592|559767445|FG006|Overall Study|Lost to Follow-up|2|||
155090969|NCT04622592|559767446|FG007|Overall Study|Lost to Follow-up|2|||
155090970|NCT04622592|559767439|FG000|Overall Study|Physician Decision|0|||
155090971|NCT04622592|559767440|FG001|Overall Study|Physician Decision|0|||
155090972|NCT04622592|559767441|FG002|Overall Study|Physician Decision|0|||
155090973|NCT04622592|559767442|FG003|Overall Study|Physician Decision|0|||
155090974|NCT04622592|559767443|FG004|Overall Study|Physician Decision|1|||
155090975|NCT04622592|559767444|FG005|Overall Study|Physician Decision|0|||
155090976|NCT04622592|559767445|FG006|Overall Study|Physician Decision|0|||
155090977|NCT04622592|559767446|FG007|Overall Study|Physician Decision|0|||
155090978|NCT04622592|559767439|FG000|Overall Study|Withdrawal by Subject|1|||
155090979|NCT04622592|559767440|FG001|Overall Study|Withdrawal by Subject|0|||
155090980|NCT04622592|559767441|FG002|Overall Study|Withdrawal by Subject|2|||
155090981|NCT04622592|559767442|FG003|Overall Study|Withdrawal by Subject|0|||
155090982|NCT04622592|559767443|FG004|Overall Study|Withdrawal by Subject|0|||
155090983|NCT04622592|559767444|FG005|Overall Study|Withdrawal by Subject|0|||
155090984|NCT04622592|559767445|FG006|Overall Study|Withdrawal by Subject|1|||
155090985|NCT04622592|559767446|FG007|Overall Study|Withdrawal by Subject|4|||
155090986|NCT04622592|559767439|FG000|Overall Study|Other than specified above|0|||
155090987|NCT04622592|559767440|FG001|Overall Study|Other than specified above|0|||
155090988|NCT04622592|559767441|FG002|Overall Study|Other than specified above|1|||
155090989|NCT04622592|559767442|FG003|Overall Study|Other than specified above|0|||
155371875|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
155090990|NCT04622592|559767443|FG004|Overall Study|Other than specified above|0|||
155090991|NCT04622592|559767444|FG005|Overall Study|Other than specified above|0|||
155090992|NCT04622592|559767445|FG006|Overall Study|Other than specified above|0|||
155090993|NCT04622592|559767446|FG007|Overall Study|Other than specified above|0|||
155090994|NCT03309202|559767447|FG000|Overall Study|Lost to Follow-up|1|||
155090995|NCT03309202|559767448|FG001|Overall Study|Lost to Follow-up|0|||
155168804|NCT01904773|560057180|FG001|Placebo Washout First Intervention|Condition worsened|1|||
155090996|NCT03309202|559767449|FG002|Overall Study|Lost to Follow-up|0|||
155371876|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
155371877|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371878|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371879|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371880|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371881|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
155371882|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
155371883|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371884|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371885|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371886|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371887|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
155371888|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
155371889|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371890|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371891|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371892|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371893|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
155371894|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371895|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
155371896|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371897|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371898|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371899|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
155371900|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371901|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371902|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
155371903|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371904|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371905|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
155371906|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371907|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371908|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
155371909|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371910|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371911|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
155371912|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Site closure|0|||
155371913|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Site closure|0|||
155371914|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Site closure|1|||
155371915|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Site closure|0|||
155371916|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Site closure|0|||
155371917|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Site closure|0|||
155371918|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
155371919|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
155371920|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
155371921|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
155371922|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
155371923|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
155371924|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
155371925|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371926|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371927|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371928|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371929|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
155371930|NCT03439254|560795622|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
155371931|NCT03439254|560795623|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
154965687|NCT00112437|559298887|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
154965688|NCT00112437|559298862|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
155090997|NCT03309202|559767450|FG003|Overall Study|Lost to Follow-up|0|||
155371932|NCT03439254|560795624|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
155371933|NCT03439254|560795625|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
155371934|NCT03439254|560795626|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
155371935|NCT03439254|560795627|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
155371936|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
155371937|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
155371938|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
155371939|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
155371940|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
155371941|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
155371942|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371943|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371944|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371945|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
155371946|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
155371947|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
155371948|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371949|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371950|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371951|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371952|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
155371953|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
155371954|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371955|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371956|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371957|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371958|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
155371959|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
155371960|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371961|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371962|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371963|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371964|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
155371965|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
155371966|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371967|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371968|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371969|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371970|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
155371971|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
155371972|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371973|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155168805|NCT01904773|560057181|FG002|Placebo Washout First Intervention|Condition worsened|0|||
155168806|NCT01904773|560057182|FG003|Placebo Washout First Intervention|Condition worsened|0|||
155168807|NCT01904773|560057183|FG004|Placebo Washout First Intervention|Condition worsened|0|||
155168808|NCT01904773|560057184|FG005|Placebo Washout First Intervention|Condition worsened|0|||
155168809|NCT01904773|560057185|FG006|Placebo Washout First Intervention|Condition worsened|0|||
155168810|NCT01904773|560057186|FG007|Placebo Washout First Intervention|Condition worsened|0|||
155168811|NCT01904773|560057187|FG008|Placebo Washout First Intervention|Condition worsened|0|||
155168812|NCT01904773|560057179|FG000|Fifth Intervention|Adverse Event|0|||
155168813|NCT01904773|560057180|FG001|Fifth Intervention|Adverse Event|0|||
155168814|NCT01904773|560057181|FG002|Fifth Intervention|Adverse Event|0|||
155168815|NCT01904773|560057182|FG003|Fifth Intervention|Adverse Event|0|||
155168816|NCT01904773|560057183|FG004|Fifth Intervention|Adverse Event|0|||
155371974|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371975|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
155371976|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371977|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
155371978|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155371979|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155371980|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155168817|NCT01904773|560057184|FG005|Fifth Intervention|Adverse Event|0|||
155168818|NCT01904773|560057185|FG006|Fifth Intervention|Adverse Event|0|||
155168819|NCT01904773|560057186|FG007|Fifth Intervention|Adverse Event|1|||
155168820|NCT01904773|560057187|FG008|Fifth Intervention|Adverse Event|0|||
155168821|NCT01904773|560057179|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168822|NCT01904773|560057180|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
155168823|NCT01904773|560057181|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168824|NCT01904773|560057182|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168825|NCT01904773|560057183|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168826|NCT01904773|560057184|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168827|NCT01904773|560057185|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155371981|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
155371982|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
155371983|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
155371984|NCT03439254|560795622|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
155371985|NCT03439254|560795623|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
155371986|NCT03439254|560795624|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
155371987|NCT03439254|560795625|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
155371988|NCT03439254|560795626|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
155371989|NCT03439254|560795627|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
155168828|NCT01904773|560057186|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168829|NCT01904773|560057187|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
155168830|NCT04518995|560057188|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
155168831|NCT04518995|560057189|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
155168832|NCT04518995|560057190|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
155168833|NCT04518995|560057188|FG000|Overall Study|Lack of Efficacy|2|||
155168834|NCT04518995|560057189|FG001|Overall Study|Lack of Efficacy|1|||
155168835|NCT04518995|560057190|FG002|Overall Study|Lack of Efficacy|0|||
155168836|NCT04518995|560057188|FG000|Overall Study|Non-compliance With Study Drug|0|||
155168837|NCT04518995|560057189|FG001|Overall Study|Non-compliance With Study Drug|3|||
155168838|NCT04518995|560057190|FG002|Overall Study|Non-compliance With Study Drug|2|||
155168839|NCT04518995|560057188|FG000|Overall Study|Pregnancy|0|||
155168840|NCT04518995|560057189|FG001|Overall Study|Pregnancy|0|||
155168841|NCT04518995|560057190|FG002|Overall Study|Pregnancy|1|||
155168842|NCT04518995|560057188|FG000|Overall Study|Protocol Violation|2|||
155168843|NCT04518995|560057189|FG001|Overall Study|Protocol Violation|0|||
155168844|NCT04518995|560057190|FG002|Overall Study|Protocol Violation|1|||
155168845|NCT04518995|560057188|FG000|Overall Study|Reason not Specified|4|||
155168846|NCT04518995|560057189|FG001|Overall Study|Reason not Specified|11|||
155168847|NCT04518995|560057190|FG002|Overall Study|Reason not Specified|2|||
155168848|NCT04518995|560057188|FG000|Overall Study|Lost to Follow-up|1|||
155168849|NCT04518995|560057189|FG001|Overall Study|Lost to Follow-up|10|||
155168850|NCT04518995|560057190|FG002|Overall Study|Lost to Follow-up|6|||
155168851|NCT03390101|560057193|FG000|Weeks 0-12|Withdrawal by Subject|0|||
155168852|NCT03390101|560057194|FG001|Weeks 0-12|Withdrawal by Subject|1|||
155168853|NCT03390101|560057195|FG002|Weeks 0-12|Withdrawal by Subject|1|||
155168854|NCT03390101|560057193|FG000|Weeks 0-12|Lost to Follow-up|0|||
155168855|NCT03390101|560057194|FG001|Weeks 0-12|Lost to Follow-up|1|||
155168856|NCT03390101|560057195|FG002|Weeks 0-12|Lost to Follow-up|0|||
155168857|NCT03390101|560057193|FG000|Weeks 12-54|Withdrawal by Subject|0|||
155168858|NCT03390101|560057194|FG001|Weeks 12-54|Withdrawal by Subject|3|||
155168859|NCT03390101|560057195|FG002|Weeks 12-54|Withdrawal by Subject|1|||
155168860|NCT03390101|560057193|FG000|Weeks 12-54|Pregnancy|1|||
155168861|NCT03390101|560057194|FG001|Weeks 12-54|Pregnancy|0|||
155168862|NCT03390101|560057195|FG002|Weeks 12-54|Pregnancy|0|||
155168863|NCT03390101|560057193|FG000|Weeks 12-54|Adverse Event|2|||
155168864|NCT03390101|560057194|FG001|Weeks 12-54|Adverse Event|1|||
155168865|NCT03390101|560057195|FG002|Weeks 12-54|Adverse Event|1|||
155168866|NCT04590248|560057196|FG000|Overall Study|Lost to Follow-up|1|||
155371990|NCT00128102|560795630|FG000|Overall Study|Site Discontinued|3|||
155371991|NCT00128102|560795631|FG001|Overall Study|Site Discontinued|6|||
155168867|NCT04590248|560057196|FG000|Overall Study|Withdrawal by Subject|16|||
155168868|NCT04590248|560057196|FG000|Overall Study|Other|2|||
155168869|NCT02052414|560057199|FG000|Overall Study|Adverse Event|12|||
155168870|NCT02052414|560057199|FG000|Overall Study|Lack of Efficacy|2|||
155168871|NCT02052414|560057199|FG000|Overall Study|Withdrawal by Subject|3|||
155168872|NCT01716052|560057205|FG000|Overall Study|Withdrawal of funding|1|||
155168873|NCT01716052|560057206|FG001|Overall Study|Withdrawal of funding|1|||
155371992|NCT00128102|560795630|FG000|Overall Study|Other|0|||
155371993|NCT00128102|560795631|FG001|Overall Study|Other|1|||
155371994|NCT00128102|560795630|FG000|Overall Study|Progressive Disease|255|||
155371995|NCT00128102|560795631|FG001|Overall Study|Progressive Disease|285|||
155371996|NCT00128102|560795630|FG000|Overall Study|Adverse Event|34|||
155371997|NCT00128102|560795631|FG001|Overall Study|Adverse Event|11|||
155371998|NCT00128102|560795630|FG000|Overall Study|Death|12|||
155371999|NCT00128102|560795631|FG001|Overall Study|Death|13|||
155372000|NCT00128102|560795630|FG000|Overall Study|Physician Decision|3|||
155372001|NCT00128102|560795631|FG001|Overall Study|Physician Decision|3|||
155372002|NCT00128102|560795630|FG000|Overall Study|Withdrawal by Subject|19|||
155372003|NCT00128102|560795631|FG001|Overall Study|Withdrawal by Subject|11|||
155372004|NCT00128102|560795630|FG000|Overall Study|Protocol Violation|2|||
155372005|NCT00128102|560795631|FG001|Overall Study|Protocol Violation|2|||
155372006|NCT01531673|560795632|FG000|Overall Study|Non-Compliance|0|||
155372007|NCT01531673|560795633|FG001|Overall Study|Non-Compliance|0|||
155372008|NCT01531673|560795634|FG002|Overall Study|Non-Compliance|0|||
155372009|NCT01531673|560795635|FG003|Overall Study|Non-Compliance|0|||
155168874|NCT02969408|560057212|FG000|Overall Study|Adverse Event|2|||
155372010|NCT01531673|560795636|FG004|Overall Study|Non-Compliance|0|||
155372011|NCT01531673|560795637|FG005|Overall Study|Non-Compliance|1|||
155372012|NCT01531673|560795638|FG006|Overall Study|Non-Compliance|0|||
155372013|NCT01531673|560795639|FG007|Overall Study|Non-Compliance|0|||
155372014|NCT01531673|560795640|FG008|Overall Study|Non-Compliance|0|||
155372015|NCT01531673|560795641|FG009|Overall Study|Non-Compliance|0|||
155168875|NCT02969408|560057212|FG000|Overall Study|Withdrawal by Subject|8|||
155168876|NCT02969408|560057212|FG000|Overall Study|Lost to Follow-up|4|||
155168877|NCT02969408|560057212|FG000|Overall Study|Protocol Violation|1|||
155372016|NCT01531673|560795642|FG010|Overall Study|Non-Compliance|0|||
155372017|NCT01531673|560795643|FG011|Overall Study|Non-Compliance|0|||
155372018|NCT01531673|560795644|FG012|Overall Study|Non-Compliance|0|||
155372019|NCT01531673|560795632|FG000|Overall Study|Adverse Event|0|||
155372020|NCT01531673|560795633|FG001|Overall Study|Adverse Event|1|||
155372021|NCT01531673|560795634|FG002|Overall Study|Adverse Event|0|||
155372022|NCT01531673|560795635|FG003|Overall Study|Adverse Event|0|||
155372023|NCT01531673|560795636|FG004|Overall Study|Adverse Event|0|||
155372024|NCT01531673|560795637|FG005|Overall Study|Adverse Event|0|||
155372025|NCT01531673|560795638|FG006|Overall Study|Adverse Event|0|||
155372026|NCT01531673|560795639|FG007|Overall Study|Adverse Event|0|||
155372027|NCT01531673|560795640|FG008|Overall Study|Adverse Event|0|||
155372028|NCT01531673|560795641|FG009|Overall Study|Adverse Event|0|||
155372029|NCT01531673|560795642|FG010|Overall Study|Adverse Event|0|||
155372030|NCT01531673|560795643|FG011|Overall Study|Adverse Event|0|||
155372031|NCT01531673|560795644|FG012|Overall Study|Adverse Event|0|||
155372032|NCT01531673|560795632|FG000|Overall Study|Lost to Follow-up|0|||
155372033|NCT01531673|560795633|FG001|Overall Study|Lost to Follow-up|0|||
155372034|NCT01531673|560795634|FG002|Overall Study|Lost to Follow-up|0|||
155372035|NCT01531673|560795635|FG003|Overall Study|Lost to Follow-up|0|||
155372036|NCT01531673|560795636|FG004|Overall Study|Lost to Follow-up|1|||
155168878|NCT02969408|560057212|FG000|Overall Study|Other than specified|1|||
155168879|NCT02350478|560057213|FG000|Overall Study|Lost to Follow-up|5|||
155372037|NCT01531673|560795637|FG005|Overall Study|Lost to Follow-up|0|||
155372038|NCT01531673|560795638|FG006|Overall Study|Lost to Follow-up|0|||
155372039|NCT01531673|560795639|FG007|Overall Study|Lost to Follow-up|0|||
155372040|NCT01531673|560795640|FG008|Overall Study|Lost to Follow-up|0|||
155372041|NCT01531673|560795641|FG009|Overall Study|Lost to Follow-up|0|||
155372042|NCT01531673|560795642|FG010|Overall Study|Lost to Follow-up|0|||
155372043|NCT01531673|560795643|FG011|Overall Study|Lost to Follow-up|0|||
155372044|NCT01531673|560795644|FG012|Overall Study|Lost to Follow-up|0|||
155168880|NCT02350478|560057214|FG001|Overall Study|Lost to Follow-up|1|||
155372045|NCT01531673|560795632|FG000|Overall Study|Other|0|||
155372046|NCT01531673|560795633|FG001|Overall Study|Other|0|||
155372047|NCT01531673|560795634|FG002|Overall Study|Other|0|||
155372048|NCT01531673|560795635|FG003|Overall Study|Other|1|||
155372049|NCT01531673|560795636|FG004|Overall Study|Other|0|||
155372050|NCT01531673|560795637|FG005|Overall Study|Other|0|||
155372051|NCT01531673|560795638|FG006|Overall Study|Other|0|||
155372052|NCT01531673|560795639|FG007|Overall Study|Other|0|||
155372053|NCT01531673|560795640|FG008|Overall Study|Other|0|||
155372054|NCT01531673|560795641|FG009|Overall Study|Other|1|||
155372055|NCT01531673|560795642|FG010|Overall Study|Other|0|||
155372056|NCT01531673|560795643|FG011|Overall Study|Other|0|||
155372057|NCT01531673|560795644|FG012|Overall Study|Other|0|||
155372058|NCT00568178|560795645|FG000|Double Blind Base Study|Adverse Event|0|||
155372059|NCT00568178|560795646|FG001|Double Blind Base Study|Adverse Event|2|||
155372060|NCT00568178|560795647|FG002|Double Blind Base Study|Adverse Event|1|||
155372061|NCT00568178|560795648|FG003|Double Blind Base Study|Adverse Event|2|||
155372062|NCT00568178|560795649|FG004|Double Blind Base Study|Adverse Event|0|||
155372063|NCT00568178|560795650|FG005|Double Blind Base Study|Adverse Event|0|||
155372064|NCT00568178|560795645|FG000|Double Blind Base Study|Lost to Follow-up|1|||
155372065|NCT00568178|560795646|FG001|Double Blind Base Study|Lost to Follow-up|0|||
155372066|NCT00568178|560795647|FG002|Double Blind Base Study|Lost to Follow-up|0|||
155372067|NCT00568178|560795648|FG003|Double Blind Base Study|Lost to Follow-up|1|||
155372068|NCT00568178|560795649|FG004|Double Blind Base Study|Lost to Follow-up|0|||
155372069|NCT00568178|560795650|FG005|Double Blind Base Study|Lost to Follow-up|0|||
155372070|NCT00568178|560795645|FG000|Double Blind Base Study|Physician Decision|1|||
155372071|NCT00568178|560795646|FG001|Double Blind Base Study|Physician Decision|1|||
155372072|NCT00568178|560795647|FG002|Double Blind Base Study|Physician Decision|0|||
155372073|NCT00568178|560795648|FG003|Double Blind Base Study|Physician Decision|1|||
155372074|NCT00568178|560795649|FG004|Double Blind Base Study|Physician Decision|0|||
155372075|NCT00568178|560795650|FG005|Double Blind Base Study|Physician Decision|0|||
155372076|NCT00568178|560795645|FG000|Double Blind Base Study|Protocol Violation|3|||
155372077|NCT00568178|560795646|FG001|Double Blind Base Study|Protocol Violation|2|||
155372078|NCT00568178|560795647|FG002|Double Blind Base Study|Protocol Violation|0|||
155372079|NCT00568178|560795648|FG003|Double Blind Base Study|Protocol Violation|0|||
155372080|NCT00568178|560795649|FG004|Double Blind Base Study|Protocol Violation|0|||
155372081|NCT00568178|560795650|FG005|Double Blind Base Study|Protocol Violation|0|||
155372082|NCT00568178|560795645|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
155372083|NCT00568178|560795646|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
155372084|NCT00568178|560795647|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
155372085|NCT00568178|560795648|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
155372086|NCT00568178|560795649|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
155372087|NCT00568178|560795650|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
155372088|NCT00568178|560795645|FG000|Double Blind Base Study|Progressive Disease|0|||
155372089|NCT00568178|560795646|FG001|Double Blind Base Study|Progressive Disease|0|||
155372090|NCT00568178|560795647|FG002|Double Blind Base Study|Progressive Disease|0|||
155372091|NCT00568178|560795648|FG003|Double Blind Base Study|Progressive Disease|1|||
155372092|NCT00568178|560795649|FG004|Double Blind Base Study|Progressive Disease|0|||
155372093|NCT00568178|560795650|FG005|Double Blind Base Study|Progressive Disease|0|||
155372094|NCT00568178|560795645|FG000|Open Label Extension|Adverse Event|0|||
155372095|NCT00568178|560795646|FG001|Open Label Extension|Adverse Event|0|||
155372096|NCT00568178|560795647|FG002|Open Label Extension|Adverse Event|0|||
155372097|NCT00568178|560795648|FG003|Open Label Extension|Adverse Event|0|||
155372098|NCT00568178|560795649|FG004|Open Label Extension|Adverse Event|11|||
155372099|NCT00568178|560795650|FG005|Open Label Extension|Adverse Event|8|||
155372100|NCT00568178|560795645|FG000|Open Label Extension|Protocol Violation|0|||
155372101|NCT00568178|560795646|FG001|Open Label Extension|Protocol Violation|0|||
155372102|NCT00568178|560795647|FG002|Open Label Extension|Protocol Violation|0|||
155372103|NCT00568178|560795648|FG003|Open Label Extension|Protocol Violation|0|||
155372104|NCT00568178|560795649|FG004|Open Label Extension|Protocol Violation|1|||
155372105|NCT00568178|560795650|FG005|Open Label Extension|Protocol Violation|0|||
155372106|NCT00568178|560795645|FG000|Open Label Extension|Lost to Follow-up|0|||
155372107|NCT00568178|560795646|FG001|Open Label Extension|Lost to Follow-up|0|||
155372108|NCT00568178|560795647|FG002|Open Label Extension|Lost to Follow-up|0|||
155372109|NCT00568178|560795648|FG003|Open Label Extension|Lost to Follow-up|0|||
155372110|NCT00568178|560795649|FG004|Open Label Extension|Lost to Follow-up|6|||
155372111|NCT00568178|560795650|FG005|Open Label Extension|Lost to Follow-up|11|||
155372112|NCT00568178|560795645|FG000|Open Label Extension|Physician Decision|0|||
155372113|NCT00568178|560795646|FG001|Open Label Extension|Physician Decision|0|||
155372114|NCT00568178|560795647|FG002|Open Label Extension|Physician Decision|0|||
155372115|NCT00568178|560795648|FG003|Open Label Extension|Physician Decision|0|||
155372116|NCT00568178|560795649|FG004|Open Label Extension|Physician Decision|9|||
155372117|NCT00568178|560795650|FG005|Open Label Extension|Physician Decision|8|||
155372118|NCT00568178|560795645|FG000|Open Label Extension|Pregnancy|0|||
155372119|NCT00568178|560795646|FG001|Open Label Extension|Pregnancy|0|||
155372120|NCT00568178|560795647|FG002|Open Label Extension|Pregnancy|0|||
155372121|NCT00568178|560795648|FG003|Open Label Extension|Pregnancy|0|||
155372122|NCT00568178|560795649|FG004|Open Label Extension|Pregnancy|0|||
155372123|NCT00568178|560795650|FG005|Open Label Extension|Pregnancy|1|||
155372124|NCT00568178|560795645|FG000|Open Label Extension|Progressive Disease|0|||
155372125|NCT00568178|560795646|FG001|Open Label Extension|Progressive Disease|0|||
155372126|NCT00568178|560795647|FG002|Open Label Extension|Progressive Disease|0|||
155372127|NCT00568178|560795648|FG003|Open Label Extension|Progressive Disease|0|||
155372128|NCT00568178|560795649|FG004|Open Label Extension|Progressive Disease|3|||
155372129|NCT00568178|560795650|FG005|Open Label Extension|Progressive Disease|1|||
155372130|NCT00568178|560795645|FG000|Open Label Extension|Termination of Trial|0|||
155372131|NCT00568178|560795646|FG001|Open Label Extension|Termination of Trial|0|||
155372132|NCT00568178|560795647|FG002|Open Label Extension|Termination of Trial|0|||
155372133|NCT00568178|560795648|FG003|Open Label Extension|Termination of Trial|0|||
155372134|NCT00568178|560795649|FG004|Open Label Extension|Termination of Trial|45|||
155372135|NCT00568178|560795650|FG005|Open Label Extension|Termination of Trial|47|||
155372136|NCT00568178|560795645|FG000|Open Label Extension|Withdrawal by Subject|0|||
155372137|NCT00568178|560795646|FG001|Open Label Extension|Withdrawal by Subject|0|||
155372138|NCT00568178|560795647|FG002|Open Label Extension|Withdrawal by Subject|0|||
155372139|NCT00568178|560795648|FG003|Open Label Extension|Withdrawal by Subject|0|||
155372140|NCT00568178|560795649|FG004|Open Label Extension|Withdrawal by Subject|4|||
155372141|NCT00568178|560795650|FG005|Open Label Extension|Withdrawal by Subject|4|||
155372142|NCT01332630|560795651|FG000|Overall Study|Withdrawal by Subject|3|||
155372143|NCT04476251|560795654|FG000|Overall Study|Not treated|1|||
155372144|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Physician Decision|2|||
155372145|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Physician Decision|0|||
155372146|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Physician Decision|0|||
155372147|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Adverse Event|33|||
155372148|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Adverse Event|0|||
155372149|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Adverse Event|0|||
155372150|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
155372151|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155372152|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155372153|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
155372154|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
155372155|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
155372156|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
155372157|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155372158|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155372159|NCT01008553|560795662|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
155372160|NCT01008553|560795663|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
155372161|NCT01008553|560795664|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
155372162|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
155372163|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
155372164|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
155372165|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
155372166|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
155372167|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
155372168|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
155372169|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
155372170|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
155372171|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
155372172|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
155372173|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
155372174|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
155372175|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
155372176|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
155372177|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
155372178|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
155372179|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
155372180|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155372181|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
154965689|NCT00112437|559298863|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
155090998|NCT00415636|559767451|FG000|Overall Study|Symptomatic deterioration|1|||
154965690|NCT00112437|559298864|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
155372182|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
155372183|NCT01008553|560795662|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
155372184|NCT01008553|560795663|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
155372185|NCT01008553|560795664|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
155372186|NCT02591953|560795682|FG000|Overall Study|Lost to Follow-up|6|||
155372187|NCT02591953|560795683|FG001|Overall Study|Lost to Follow-up|6|||
155372188|NCT02060370|560795684|FG000|Overall Study|Physician Decision|1|||
155372189|NCT01896557|560795685|FG000|Clopidogrel Alone|Adverse Event|1|||
155372190|NCT01896557|560795686|FG001|Clopidogrel Alone|Adverse Event|0|||
155372191|NCT01896557|560795685|FG000|Clopidogrel + GI Protector|low adherence|1|||
155372192|NCT01896557|560795686|FG001|Clopidogrel + GI Protector|low adherence|1|||
155372193|NCT01896557|560795685|FG000|Clopidogrel + GI Protector|Reading error|1|||
155372194|NCT01896557|560795686|FG001|Clopidogrel + GI Protector|Reading error|3|||
155372195|NCT00731133|560795687|FG000|Overall Study|Withdrawal by Subject|10|||
155372196|NCT01517295|560795692|FG000|Overall Study|Physician Decision|1|||
155372197|NCT01517295|560795693|FG001|Overall Study|Physician Decision|0|||
155372198|NCT02672852|560795694|FG000|Part A1|Disease Worsening|1|||
155372199|NCT02672852|560795695|FG001|Part A1|Disease Worsening|0|||
155372200|NCT02672852|560795696|FG002|Part A1|Disease Worsening|0|||
155372201|NCT02672852|560795697|FG003|Part A1|Disease Worsening|0|||
155372202|NCT02672852|560795698|FG004|Part A1|Disease Worsening|0|||
155372203|NCT02672852|560795699|FG005|Part A1|Disease Worsening|0|||
155372204|NCT02672852|560795700|FG006|Part A1|Disease Worsening|0|||
155372205|NCT02672852|560795694|FG000|Part A1|Adverse Event|0|||
155372206|NCT02672852|560795695|FG001|Part A1|Adverse Event|1|||
155372207|NCT02672852|560795696|FG002|Part A1|Adverse Event|0|||
155372208|NCT02672852|560795697|FG003|Part A1|Adverse Event|0|||
155168881|NCT02779556|560057215|FG000|Baseline|Partial baseline interview completed|1|||
155168882|NCT02779556|560057216|FG001|Baseline|Partial baseline interview completed|0|||
155168883|NCT02779556|560057215|FG000|3 Months|Lost to Follow-up|40|||
155168884|NCT02779556|560057216|FG001|3 Months|Lost to Follow-up|29|||
155168885|NCT02779556|560057215|FG000|3 Months|Missed 3 month clinic visit|27|||
155168886|NCT02779556|560057216|FG001|3 Months|Missed 3 month clinic visit|19|||
155168887|NCT02779556|560057215|FG000|6 Month|Lost to Follow-up|33|||
155168888|NCT02779556|560057216|FG001|6 Month|Lost to Follow-up|39|||
155372209|NCT02672852|560795698|FG004|Part A1|Adverse Event|0|||
155372210|NCT02672852|560795699|FG005|Part A1|Adverse Event|0|||
155372211|NCT02672852|560795700|FG006|Part A1|Adverse Event|0|||
155372212|NCT02672852|560795694|FG000|Part A1|Lost to Follow-up|1|||
155372213|NCT02672852|560795695|FG001|Part A1|Lost to Follow-up|2|||
155372214|NCT02672852|560795696|FG002|Part A1|Lost to Follow-up|0|||
155372215|NCT02672852|560795697|FG003|Part A1|Lost to Follow-up|0|||
155372216|NCT02672852|560795698|FG004|Part A1|Lost to Follow-up|0|||
155372217|NCT02672852|560795699|FG005|Part A1|Lost to Follow-up|0|||
155372218|NCT02672852|560795700|FG006|Part A1|Lost to Follow-up|0|||
155372219|NCT02672852|560795694|FG000|Part A1|Withdrawal by Subject|1|||
155372220|NCT02672852|560795695|FG001|Part A1|Withdrawal by Subject|1|||
155372221|NCT02672852|560795696|FG002|Part A1|Withdrawal by Subject|0|||
155372222|NCT02672852|560795697|FG003|Part A1|Withdrawal by Subject|0|||
155372223|NCT02672852|560795698|FG004|Part A1|Withdrawal by Subject|0|||
155372224|NCT02672852|560795699|FG005|Part A1|Withdrawal by Subject|0|||
155372225|NCT02672852|560795700|FG006|Part A1|Withdrawal by Subject|0|||
155372226|NCT02672852|560795694|FG000|Part A2|Disease worsening|0|||
155372227|NCT02672852|560795695|FG001|Part A2|Disease worsening|0|||
155372228|NCT02672852|560795696|FG002|Part A2|Disease worsening|1|||
155372229|NCT02672852|560795697|FG003|Part A2|Disease worsening|0|||
155372230|NCT02672852|560795698|FG004|Part A2|Disease worsening|0|||
155372231|NCT02672852|560795699|FG005|Part A2|Disease worsening|0|||
155372232|NCT02672852|560795700|FG006|Part A2|Disease worsening|0|||
155372233|NCT02672852|560795694|FG000|Part A2|Adverse Event|0|||
155168889|NCT02779556|560057215|FG000|6 Month HbA1c|No value collected during window|69|||
155168890|NCT02779556|560057216|FG001|6 Month HbA1c|No value collected during window|50|||
155372234|NCT02672852|560795695|FG001|Part A2|Adverse Event|0|||
155372235|NCT02672852|560795696|FG002|Part A2|Adverse Event|3|||
155372236|NCT02672852|560795697|FG003|Part A2|Adverse Event|0|||
155372237|NCT02672852|560795698|FG004|Part A2|Adverse Event|0|||
155372238|NCT02672852|560795699|FG005|Part A2|Adverse Event|0|||
155168891|NCT02779556|560057215|FG000|12 Month HbA1c|No value collected during window|138|||
155372239|NCT02672852|560795700|FG006|Part A2|Adverse Event|0|||
155372240|NCT02672852|560795694|FG000|Part A2|Lost to Follow-up|0|||
155372241|NCT02672852|560795695|FG001|Part A2|Lost to Follow-up|0|||
155372242|NCT02672852|560795696|FG002|Part A2|Lost to Follow-up|2|||
155372243|NCT02672852|560795697|FG003|Part A2|Lost to Follow-up|0|||
155372244|NCT02672852|560795698|FG004|Part A2|Lost to Follow-up|0|||
155372245|NCT02672852|560795699|FG005|Part A2|Lost to Follow-up|0|||
155372246|NCT02672852|560795700|FG006|Part A2|Lost to Follow-up|0|||
155372247|NCT02672852|560795694|FG000|Part A2|Withdrawal by Subject|0|||
155372248|NCT02672852|560795695|FG001|Part A2|Withdrawal by Subject|0|||
155372249|NCT02672852|560795696|FG002|Part A2|Withdrawal by Subject|1|||
155372250|NCT02672852|560795697|FG003|Part A2|Withdrawal by Subject|0|||
155372251|NCT02672852|560795698|FG004|Part A2|Withdrawal by Subject|0|||
155372252|NCT02672852|560795699|FG005|Part A2|Withdrawal by Subject|0|||
155372253|NCT02672852|560795700|FG006|Part A2|Withdrawal by Subject|0|||
155372254|NCT02672852|560795694|FG000|Part A2|Other|0|||
155372255|NCT02672852|560795695|FG001|Part A2|Other|0|||
155372256|NCT02672852|560795696|FG002|Part A2|Other|3|||
155372257|NCT02672852|560795697|FG003|Part A2|Other|0|||
155372258|NCT02672852|560795698|FG004|Part A2|Other|0|||
155372259|NCT02672852|560795699|FG005|Part A2|Other|0|||
155372260|NCT02672852|560795700|FG006|Part A2|Other|0|||
155372261|NCT02672852|560795694|FG000|Part A2|Not entered in Part B|0|||
155372262|NCT02672852|560795695|FG001|Part A2|Not entered in Part B|0|||
155372263|NCT02672852|560795696|FG002|Part A2|Not entered in Part B|0|||
155372264|NCT02672852|560795697|FG003|Part A2|Not entered in Part B|4|||
155372265|NCT02672852|560795698|FG004|Part A2|Not entered in Part B|0|||
155372266|NCT02672852|560795699|FG005|Part A2|Not entered in Part B|0|||
155372267|NCT02672852|560795700|FG006|Part A2|Not entered in Part B|0|||
155372268|NCT02672852|560795694|FG000|Part B|Disease worsening|0|||
155372269|NCT02672852|560795695|FG001|Part B|Disease worsening|0|||
155372270|NCT02672852|560795696|FG002|Part B|Disease worsening|0|||
155372271|NCT02672852|560795697|FG003|Part B|Disease worsening|0|||
155372272|NCT02672852|560795698|FG004|Part B|Disease worsening|1|||
155372273|NCT02672852|560795699|FG005|Part B|Disease worsening|0|||
155372274|NCT02672852|560795700|FG006|Part B|Disease worsening|1|||
155372275|NCT02672852|560795694|FG000|Part B|Worsening pre-existing condition|0|||
155372276|NCT02672852|560795695|FG001|Part B|Worsening pre-existing condition|0|||
155372277|NCT02672852|560795696|FG002|Part B|Worsening pre-existing condition|0|||
155372278|NCT02672852|560795697|FG003|Part B|Worsening pre-existing condition|0|||
155372279|NCT02672852|560795698|FG004|Part B|Worsening pre-existing condition|0|||
155372280|NCT02672852|560795699|FG005|Part B|Worsening pre-existing condition|1|||
155372281|NCT02672852|560795700|FG006|Part B|Worsening pre-existing condition|0|||
155372282|NCT02672852|560795694|FG000|Part B|Other adverse event|0|||
155372283|NCT02672852|560795695|FG001|Part B|Other adverse event|0|||
155372284|NCT02672852|560795696|FG002|Part B|Other adverse event|0|||
155372285|NCT02672852|560795697|FG003|Part B|Other adverse event|0|||
155372286|NCT02672852|560795698|FG004|Part B|Other adverse event|3|||
155372287|NCT02672852|560795699|FG005|Part B|Other adverse event|5|||
155372288|NCT02672852|560795700|FG006|Part B|Other adverse event|1|||
155372289|NCT02672852|560795694|FG000|Part B|Lost to Follow-up|0|||
155372290|NCT02672852|560795695|FG001|Part B|Lost to Follow-up|0|||
155372291|NCT02672852|560795696|FG002|Part B|Lost to Follow-up|0|||
155372292|NCT02672852|560795697|FG003|Part B|Lost to Follow-up|0|||
155372293|NCT02672852|560795698|FG004|Part B|Lost to Follow-up|3|||
155372294|NCT02672852|560795699|FG005|Part B|Lost to Follow-up|4|||
155372295|NCT02672852|560795700|FG006|Part B|Lost to Follow-up|1|||
155372296|NCT02672852|560795694|FG000|Part B|Withdrawal by Subject|0|||
155372297|NCT02672852|560795695|FG001|Part B|Withdrawal by Subject|0|||
155372298|NCT02672852|560795696|FG002|Part B|Withdrawal by Subject|0|||
155372299|NCT02672852|560795697|FG003|Part B|Withdrawal by Subject|0|||
155372300|NCT02672852|560795698|FG004|Part B|Withdrawal by Subject|5|||
155372301|NCT02672852|560795699|FG005|Part B|Withdrawal by Subject|0|||
155372302|NCT02672852|560795700|FG006|Part B|Withdrawal by Subject|7|||
155372303|NCT02672852|560795694|FG000|Part B|Other|0|||
155372304|NCT02672852|560795695|FG001|Part B|Other|0|||
155372305|NCT02672852|560795696|FG002|Part B|Other|0|||
155372306|NCT02672852|560795697|FG003|Part B|Other|0|||
155372307|NCT02672852|560795698|FG004|Part B|Other|4|||
154965691|NCT00112437|559298865|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
155372308|NCT02672852|560795699|FG005|Part B|Other|1|||
154965692|NCT00112437|559298866|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
155090999|NCT00415636|559767452|FG001|Overall Study|Symptomatic deterioration|0|||
155091000|NCT00415636|559767453|FG002|Overall Study|Symptomatic deterioration|1|||
155372309|NCT02672852|560795700|FG006|Part B|Other|2|||
155372310|NCT02182947|560795701|FG000|Overall Study|Withdrawal by Subject|7|||
155372311|NCT02182947|560795701|FG000|Overall Study|Lost to Follow-up|3|||
155372312|NCT02182947|560795701|FG000|Overall Study|Failed screening activities|8|||
154965693|NCT00112437|559298867|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
155372313|NCT03248882|560795702|FG000|Overall Study|Adverse Event|3|||
155372314|NCT03248882|560795703|FG001|Overall Study|Adverse Event|3|||
155372315|NCT03248882|560795704|FG002|Overall Study|Adverse Event|2|||
155372316|NCT03248882|560795705|FG003|Overall Study|Adverse Event|6|||
155372317|NCT03248882|560795706|FG004|Overall Study|Adverse Event|9|||
155372318|NCT03248882|560795702|FG000|Overall Study|Lost to Follow-up|0|||
155372319|NCT03248882|560795703|FG001|Overall Study|Lost to Follow-up|0|||
155372320|NCT03248882|560795704|FG002|Overall Study|Lost to Follow-up|0|||
155372321|NCT03248882|560795705|FG003|Overall Study|Lost to Follow-up|0|||
155372322|NCT03248882|560795706|FG004|Overall Study|Lost to Follow-up|1|||
155372323|NCT03248882|560795702|FG000|Overall Study|Protocol Violation|2|||
155372324|NCT03248882|560795703|FG001|Overall Study|Protocol Violation|0|||
155372325|NCT03248882|560795704|FG002|Overall Study|Protocol Violation|2|||
155372326|NCT03248882|560795705|FG003|Overall Study|Protocol Violation|0|||
155372327|NCT03248882|560795706|FG004|Overall Study|Protocol Violation|1|||
155372328|NCT03248882|560795702|FG000|Overall Study|Withdrawal by Subject|2|||
155372329|NCT03248882|560795703|FG001|Overall Study|Withdrawal by Subject|2|||
155372330|NCT03248882|560795704|FG002|Overall Study|Withdrawal by Subject|3|||
155372331|NCT03248882|560795705|FG003|Overall Study|Withdrawal by Subject|4|||
155372332|NCT03248882|560795706|FG004|Overall Study|Withdrawal by Subject|2|||
155372333|NCT04308590|560795707|FG000|Overall Study|Adverse Event|12|||
155372334|NCT04308590|560795708|FG001|Overall Study|Adverse Event|2|||
155372335|NCT04308590|560795707|FG000|Overall Study|Withdrawal by Subject|10|||
155372336|NCT04308590|560795708|FG001|Overall Study|Withdrawal by Subject|4|||
155372337|NCT04308590|560795707|FG000|Overall Study|Death|1|||
155372338|NCT04308590|560795708|FG001|Overall Study|Death|0|||
155372339|NCT04308590|560795707|FG000|Overall Study|Lost to Follow-up|1|||
155372340|NCT04308590|560795708|FG001|Overall Study|Lost to Follow-up|1|||
155372341|NCT04308590|560795707|FG000|Overall Study|Physician Decision|1|||
155372342|NCT04308590|560795708|FG001|Overall Study|Physician Decision|0|||
155372343|NCT04308590|560795707|FG000|Overall Study|Subject does not want to continue with Pi|0|||
155372344|NCT04308590|560795708|FG001|Overall Study|Subject does not want to continue with Pi|1|||
155372345|NCT01156376|560795710|FG000|Overall Study|Adverse Event|1|||
155372346|NCT01156376|560795711|FG001|Overall Study|Adverse Event|0|||
155372347|NCT01156376|560795712|FG002|Overall Study|Adverse Event|1|||
155372348|NCT01156376|560795710|FG000|Overall Study|Withdrawal by Subject|0|||
155372349|NCT01156376|560795711|FG001|Overall Study|Withdrawal by Subject|0|||
155372350|NCT01156376|560795712|FG002|Overall Study|Withdrawal by Subject|3|||
155372351|NCT01493427|560795713|FG000|Overall Study|Adverse Event|10|||
155372352|NCT01493427|560795713|FG000|Overall Study|Personal Reasons|4|||
155372353|NCT01493427|560795713|FG000|Overall Study|Lost to Follow-up|2|||
155372354|NCT01493427|560795713|FG000|Overall Study|Inability to Follow Instructions|2|||
155372355|NCT01493427|560795713|FG000|Overall Study|Other|2|||
155372356|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
155372357|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
155372358|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
155372359|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
155372360|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
155372361|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
155372362|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
155372363|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
155372364|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
155372365|NCT03846453|560795715|FG000|Placebo Run-in (14 Days)|Other|2|||
155372366|NCT03846453|560795716|FG001|Placebo Run-in (14 Days)|Other|0|||
155372367|NCT03846453|560795717|FG002|Placebo Run-in (14 Days)|Other|0|||
155372368|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
155372369|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
155372370|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
155372371|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
155372372|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
155372373|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
155372374|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
155372375|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
155091001|NCT00415636|559767454|FG003|Overall Study|Symptomatic deterioration|2|||
155091002|NCT00415636|559767455|FG004|Overall Study|Symptomatic deterioration|0|||
155091003|NCT00415636|559767456|FG005|Overall Study|Symptomatic deterioration|1|||
155091004|NCT00415636|559767451|FG000|Overall Study|Adverse Event|0|||
155091005|NCT00415636|559767452|FG001|Overall Study|Adverse Event|0|||
155091006|NCT00415636|559767453|FG002|Overall Study|Adverse Event|0|||
155091007|NCT00415636|559767454|FG003|Overall Study|Adverse Event|1|||
155091008|NCT00415636|559767455|FG004|Overall Study|Adverse Event|1|||
155091009|NCT00415636|559767456|FG005|Overall Study|Adverse Event|0|||
155091010|NCT00415636|559767451|FG000|Overall Study|Withdrawal by Subject|0|||
155091011|NCT00415636|559767452|FG001|Overall Study|Withdrawal by Subject|0|||
155091012|NCT00415636|559767453|FG002|Overall Study|Withdrawal by Subject|0|||
155372376|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
155372377|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
155372378|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
155372379|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
155372380|NCT03846453|560795715|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
155372381|NCT03846453|560795716|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
155091013|NCT00415636|559767454|FG003|Overall Study|Withdrawal by Subject|0|||
155372382|NCT03846453|560795717|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
155372383|NCT02628028|560795720|FG000|Dosing Period|Withdrawal by Subject|0|||
155372384|NCT02628028|560795721|FG001|Dosing Period|Withdrawal by Subject|0|||
155372385|NCT02628028|560795722|FG002|Dosing Period|Withdrawal by Subject|1|||
155372386|NCT02628028|560795723|FG003|Dosing Period|Withdrawal by Subject|0|||
155372387|NCT02628028|560795724|FG004|Dosing Period|Withdrawal by Subject|2|||
155372388|NCT02628028|560795725|FG005|Dosing Period|Withdrawal by Subject|4|||
155372389|NCT02628028|560795726|FG006|Dosing Period|Withdrawal by Subject|1|||
155372390|NCT02628028|560795727|FG007|Dosing Period|Withdrawal by Subject|1|||
155372391|NCT02628028|560795720|FG000|Dosing Period|Adverse Event|0|||
155372392|NCT02628028|560795721|FG001|Dosing Period|Adverse Event|0|||
155372393|NCT02628028|560795722|FG002|Dosing Period|Adverse Event|0|||
155372394|NCT02628028|560795723|FG003|Dosing Period|Adverse Event|0|||
155372395|NCT02628028|560795724|FG004|Dosing Period|Adverse Event|2|||
155372396|NCT02628028|560795725|FG005|Dosing Period|Adverse Event|1|||
155372397|NCT02628028|560795726|FG006|Dosing Period|Adverse Event|3|||
155372398|NCT02628028|560795727|FG007|Dosing Period|Adverse Event|2|||
155372399|NCT02628028|560795720|FG000|Dosing Period|Death|0|||
155372400|NCT02628028|560795721|FG001|Dosing Period|Death|0|||
155372401|NCT02628028|560795722|FG002|Dosing Period|Death|0|||
155372402|NCT02628028|560795723|FG003|Dosing Period|Death|0|||
155372403|NCT02628028|560795724|FG004|Dosing Period|Death|0|||
155372404|NCT02628028|560795725|FG005|Dosing Period|Death|0|||
155372405|NCT02628028|560795726|FG006|Dosing Period|Death|0|||
155372406|NCT02628028|560795727|FG007|Dosing Period|Death|1|||
155372407|NCT02628028|560795720|FG000|Dosing Period|Lack of Efficacy|0|||
155372408|NCT02628028|560795721|FG001|Dosing Period|Lack of Efficacy|0|||
155372409|NCT02628028|560795722|FG002|Dosing Period|Lack of Efficacy|0|||
155372410|NCT02628028|560795723|FG003|Dosing Period|Lack of Efficacy|0|||
155372411|NCT02628028|560795724|FG004|Dosing Period|Lack of Efficacy|3|||
155372412|NCT02628028|560795725|FG005|Dosing Period|Lack of Efficacy|0|||
155372413|NCT02628028|560795726|FG006|Dosing Period|Lack of Efficacy|1|||
155372414|NCT02628028|560795727|FG007|Dosing Period|Lack of Efficacy|0|||
155372415|NCT02628028|560795720|FG000|Dosing Period|Study Terminated by Sponsor|0|||
155372416|NCT02628028|560795721|FG001|Dosing Period|Study Terminated by Sponsor|0|||
155372417|NCT02628028|560795722|FG002|Dosing Period|Study Terminated by Sponsor|0|||
155372418|NCT02628028|560795723|FG003|Dosing Period|Study Terminated by Sponsor|0|||
155372419|NCT02628028|560795724|FG004|Dosing Period|Study Terminated by Sponsor|7|||
155372420|NCT02628028|560795725|FG005|Dosing Period|Study Terminated by Sponsor|6|||
155372421|NCT02628028|560795726|FG006|Dosing Period|Study Terminated by Sponsor|7|||
155372422|NCT02628028|560795727|FG007|Dosing Period|Study Terminated by Sponsor|7|||
155372423|NCT02628028|560795720|FG000|Dosing Period|Physician Decision|0|||
155372424|NCT02628028|560795721|FG001|Dosing Period|Physician Decision|0|||
155372425|NCT02628028|560795722|FG002|Dosing Period|Physician Decision|0|||
155372426|NCT02628028|560795723|FG003|Dosing Period|Physician Decision|0|||
154965694|NCT00112437|559298868|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
155372427|NCT02628028|560795724|FG004|Dosing Period|Physician Decision|0|||
155372428|NCT02628028|560795725|FG005|Dosing Period|Physician Decision|1|||
155372429|NCT02628028|560795726|FG006|Dosing Period|Physician Decision|0|||
155372430|NCT02628028|560795727|FG007|Dosing Period|Physician Decision|0|||
155372431|NCT02628028|560795720|FG000|Dosing Period|Site Terminated by Sponsor|0|||
155372432|NCT02628028|560795721|FG001|Dosing Period|Site Terminated by Sponsor|0|||
155372433|NCT02628028|560795722|FG002|Dosing Period|Site Terminated by Sponsor|0|||
155372434|NCT02628028|560795723|FG003|Dosing Period|Site Terminated by Sponsor|0|||
155372435|NCT02628028|560795724|FG004|Dosing Period|Site Terminated by Sponsor|0|||
155372436|NCT02628028|560795725|FG005|Dosing Period|Site Terminated by Sponsor|1|||
155372437|NCT02628028|560795726|FG006|Dosing Period|Site Terminated by Sponsor|1|||
155372438|NCT02628028|560795727|FG007|Dosing Period|Site Terminated by Sponsor|0|||
155372439|NCT02628028|560795720|FG000|Dosing Period|Lost to Follow-up|0|||
155372440|NCT02628028|560795721|FG001|Dosing Period|Lost to Follow-up|0|||
155372441|NCT02628028|560795722|FG002|Dosing Period|Lost to Follow-up|0|||
155372442|NCT02628028|560795723|FG003|Dosing Period|Lost to Follow-up|0|||
154965695|NCT00112437|559298869|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
155091014|NCT00415636|559767455|FG004|Overall Study|Withdrawal by Subject|1|||
155091015|NCT00415636|559767456|FG005|Overall Study|Withdrawal by Subject|0|||
155091016|NCT00415636|559767451|FG000|Overall Study|Disease progression|0|||
155091017|NCT00415636|559767452|FG001|Overall Study|Disease progression|0|||
155091018|NCT00415636|559767453|FG002|Overall Study|Disease progression|0|||
155091019|NCT00415636|559767454|FG003|Overall Study|Disease progression|3|||
155091020|NCT00415636|559767455|FG004|Overall Study|Disease progression|0|||
155091021|NCT00415636|559767456|FG005|Overall Study|Disease progression|1|||
155091022|NCT02138825|559767457|FG000|Main Study Treatment|Adverse Event|11|||
155091023|NCT02138825|559767458|FG001|Main Study Treatment|Adverse Event|3|||
155091024|NCT02138825|559767457|FG000|Main Study Treatment|Death|1|||
155091025|NCT02138825|559767458|FG001|Main Study Treatment|Death|2|||
155091026|NCT02138825|559767457|FG000|Main Study Treatment|Protocol Violation|2|||
155091027|NCT02138825|559767458|FG001|Main Study Treatment|Protocol Violation|2|||
155091028|NCT02138825|559767457|FG000|Main Study Treatment|Sponsor decision|12|||
155091029|NCT02138825|559767458|FG001|Main Study Treatment|Sponsor decision|18|||
155091030|NCT02138825|559767457|FG000|Main Study Treatment|Study terminated by sponsor|10|||
155091031|NCT02138825|559767458|FG001|Main Study Treatment|Study terminated by sponsor|9|||
155091032|NCT02138825|559767457|FG000|Main Study Treatment|Withdrawal by Subject|3|||
155091033|NCT02138825|559767458|FG001|Main Study Treatment|Withdrawal by Subject|1|||
155091034|NCT02138825|559767457|FG000|Main Study Treatment|Medical decision|1|||
155091035|NCT02138825|559767458|FG001|Main Study Treatment|Medical decision|0|||
155091036|NCT02138825|559767457|FG000|Long-term Extension|Study termination by sponsor|32|||
155091037|NCT02138825|559767458|FG001|Long-term Extension|Study termination by sponsor|38|||
155091038|NCT02138825|559767457|FG000|Safety Follow-up|Adverse Event|4|||
155091039|NCT02138825|559767458|FG001|Safety Follow-up|Adverse Event|3|||
155091040|NCT02138825|559767457|FG000|Safety Follow-up|Death|11|||
155091041|NCT02138825|559767458|FG001|Safety Follow-up|Death|5|||
155091042|NCT02138825|559767457|FG000|Safety Follow-up|Withdrawal by Subject|5|||
155091043|NCT02138825|559767458|FG001|Safety Follow-up|Withdrawal by Subject|3|||
155091044|NCT02138825|559767457|FG000|Safety Follow-up|clinic worsening|1|||
155091045|NCT02138825|559767458|FG001|Safety Follow-up|clinic worsening|0|||
155091046|NCT02138825|559767457|FG000|Safety Follow-up|withdrawal by PI|1|||
155091047|NCT02138825|559767458|FG001|Safety Follow-up|withdrawal by PI|0|||
155091048|NCT02138825|559767457|FG000|Safety Follow-up|logistical difficulties|0|||
155091049|NCT02138825|559767458|FG001|Safety Follow-up|logistical difficulties|1|||
155091050|NCT02138825|559767457|FG000|Safety Follow-up|progressive disease|0|||
155091051|NCT02138825|559767458|FG001|Safety Follow-up|progressive disease|2|||
155091052|NCT02138825|559767457|FG000|Safety Follow-up|too unwell to attend the visit|0|||
155091053|NCT02138825|559767458|FG001|Safety Follow-up|too unwell to attend the visit|1|||
155091054|NCT02138825|559767457|FG000|Safety Follow-up|treatment unblinded|0|||
155091055|NCT02138825|559767458|FG001|Safety Follow-up|treatment unblinded|1|||
155091056|NCT02138825|559767457|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
155091057|NCT02138825|559767458|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
155091058|NCT01702298|559767461|FG000|Overall Study|Withdrawal by Subject|1|||
155091059|NCT01664624|559767467|FG000|Overall Study|Adverse Event|0|||
155091060|NCT01664624|559767468|FG001|Overall Study|Adverse Event|1|||
155091061|NCT01664624|559767469|FG002|Overall Study|Adverse Event|0|||
155372443|NCT02628028|560795724|FG004|Dosing Period|Lost to Follow-up|0|||
155372444|NCT02628028|560795725|FG005|Dosing Period|Lost to Follow-up|0|||
155372445|NCT02628028|560795726|FG006|Dosing Period|Lost to Follow-up|1|||
155091062|NCT01664624|559767470|FG003|Overall Study|Adverse Event|0|||
155372446|NCT02628028|560795727|FG007|Dosing Period|Lost to Follow-up|0|||
155091063|NCT00560508|559767471|FG000|12 Week Double-blind Period|Adverse Event|3|||
155091064|NCT00560508|559767472|FG001|12 Week Double-blind Period|Adverse Event|2|||
155091065|NCT00560508|559767471|FG000|12 Week Double-blind Period|Protocol Violation|1|||
155372447|NCT02628028|560795720|FG000|Dosing Period|Other|0|||
155091066|NCT00560508|559767472|FG001|12 Week Double-blind Period|Protocol Violation|0|||
155372448|NCT02628028|560795721|FG001|Dosing Period|Other|0|||
155372449|NCT02628028|560795722|FG002|Dosing Period|Other|0|||
155372450|NCT02628028|560795723|FG003|Dosing Period|Other|0|||
155372451|NCT02628028|560795724|FG004|Dosing Period|Other|2|||
155372452|NCT02628028|560795725|FG005|Dosing Period|Other|1|||
155372453|NCT02628028|560795726|FG006|Dosing Period|Other|2|||
155372454|NCT02628028|560795727|FG007|Dosing Period|Other|4|||
155372455|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
155372456|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
155372457|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
155372458|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
155372459|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
155372460|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
155372461|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
155372462|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
155372463|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372464|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372465|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372466|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372467|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372468|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
155372469|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
155372470|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
155372471|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372472|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372473|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372474|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372475|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
155372476|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
155372477|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
155372478|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
155372479|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372480|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372481|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372482|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372483|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
155372484|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
155372485|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
155372486|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
155372487|NCT02628028|560795720|FG000|Long-term Extension (LTE) Period|Other|0|||
155372488|NCT02628028|560795721|FG001|Long-term Extension (LTE) Period|Other|0|||
155372489|NCT02628028|560795722|FG002|Long-term Extension (LTE) Period|Other|0|||
155372490|NCT02628028|560795723|FG003|Long-term Extension (LTE) Period|Other|0|||
155372491|NCT02628028|560795724|FG004|Long-term Extension (LTE) Period|Other|0|||
155372492|NCT02628028|560795725|FG005|Long-term Extension (LTE) Period|Other|3|||
155372493|NCT02628028|560795726|FG006|Long-term Extension (LTE) Period|Other|4|||
155372494|NCT02628028|560795727|FG007|Long-term Extension (LTE) Period|Other|3|||
155372495|NCT02738853|560795730|FG000|Enrollment|Inclusion/Exclusion not met|21|||
155372496|NCT02738853|560795730|FG000|Enrollment|Withdrawal by Subject|3|||
155091067|NCT00560508|559767471|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
155372497|NCT02738853|560795730|FG000|Enrollment|Subject treated with commercially available device|6|||
155372498|NCT02738853|560795730|FG000|Enrollment|Study Enrollment Closed|3|||
155372499|NCT02738853|560795730|FG000|Procedure|Death|1|||
155372500|NCT02738853|560795730|FG000|1 Month|Death|2|||
155372501|NCT02738853|560795730|FG000|6 Month|Death|4|||
155372502|NCT02738853|560795730|FG000|6 Month|Withdrawal by Subject|2|||
155372503|NCT02738853|560795730|FG000|1 Year|Death|6|||
155372504|NCT02738853|560795730|FG000|1 Year|Withdrawal by Subject|1|||
155372505|NCT02738853|560795730|FG000|2 Year|Death|2|||
155372506|NCT02738853|560795730|FG000|2 Year|Lost to Follow-up|1|||
155372507|NCT02738853|560795730|FG000|3 Year|Death|2|||
155372508|NCT02738853|560795730|FG000|3 Year|Withdrawal by Subject|1|||
155372509|NCT02738853|560795730|FG000|4 Year|Death|9|||
155372510|NCT02738853|560795730|FG000|5 Year|Lost to Follow-up|4|||
155372511|NCT00653523|560795738|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
155372512|NCT00653523|560795738|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
155372513|NCT00653523|560795738|FG000|Overall Study|Adverse Event|7|||
155372514|NCT00653523|560795738|FG000|Overall Study|Withdrawal by Subject|6|||
155372515|NCT00653523|560795738|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
155091068|NCT00560508|559767472|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
155372516|NCT00653523|560795738|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
155372517|NCT05543707|560795745|FG000|Overall Study|Study drug non-compliance/|5|||
155372518|NCT05543707|560795746|FG001|Overall Study|Study drug non-compliance/|0|||
155372519|NCT05543707|560795745|FG000|Overall Study|Withdrawal by Subject|1|||
155372520|NCT05543707|560795746|FG001|Overall Study|Withdrawal by Subject|1|||
155372521|NCT05543707|560795745|FG000|Overall Study|Adverse Event|1|||
155372522|NCT05543707|560795746|FG001|Overall Study|Adverse Event|0|||
155372523|NCT05543707|560795745|FG000|Overall Study|concurrent illness|0|||
155372524|NCT05543707|560795746|FG001|Overall Study|concurrent illness|1|||
155372525|NCT05543707|560795745|FG000|Overall Study|Pregnancy|1|||
155372526|NCT05543707|560795746|FG001|Overall Study|Pregnancy|1|||
155372527|NCT00186888|560795747|FG000|Overall Study|Toxicity|0|||
155372528|NCT00186888|560795748|FG001|Overall Study|Toxicity|1|||
155372529|NCT00186888|560795749|FG002|Overall Study|Toxicity|0|||
155372530|NCT00186888|560795747|FG000|Overall Study|Relapse or progression of disease|4|||
155372531|NCT00186888|560795748|FG001|Overall Study|Relapse or progression of disease|2|||
155372532|NCT00186888|560795749|FG002|Overall Study|Relapse or progression of disease|0|||
155372533|NCT05511038|560795750|FG000|Overall|Withdrawal by Subject|5|||
155372534|NCT05511038|560795751|FG001|Overall|Withdrawal by Subject|3|||
155372535|NCT05511038|560795750|FG000|Overall|Screen Failure|20|||
155372536|NCT05511038|560795751|FG001|Overall|Screen Failure|1|||
155372537|NCT05511038|560795750|FG000|Overall|Physician Decision|3|||
155372538|NCT05511038|560795751|FG001|Overall|Physician Decision|0|||
155372539|NCT05511038|560795750|FG000|Overall|Lost to Follow-up|3|||
155372540|NCT05511038|560795751|FG001|Overall|Lost to Follow-up|0|||
155372541|NCT05511038|560795750|FG000|Overall|Death|1|||
155372542|NCT05511038|560795751|FG001|Overall|Death|0|||
155372543|NCT05511038|560795750|FG000|Screening|Withdrawal by Subject|1|||
155372544|NCT05511038|560795751|FG001|Screening|Withdrawal by Subject|0|||
155372545|NCT05511038|560795750|FG000|Screening|Lost to Follow Up (1 participant)|1|||
155372546|NCT05511038|560795751|FG001|Screening|Lost to Follow Up (1 participant)|0|||
155372547|NCT05511038|560795750|FG000|Screening|Screen Failure|3|||
155372548|NCT05511038|560795751|FG001|Screening|Screen Failure|0|||
155372549|NCT05511038|560795750|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
155372550|NCT05511038|560795751|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
155372551|NCT05511038|560795750|FG000|Treatment|Withdrawal by Subject|5|||
155372552|NCT05511038|560795751|FG001|Treatment|Withdrawal by Subject|3|||
155372553|NCT05511038|560795750|FG000|Treatment|Physician Decision|4|||
155372554|NCT05511038|560795751|FG001|Treatment|Physician Decision|0|||
155372555|NCT05511038|560795750|FG000|Treatment|Lost to Follow-up|2|||
155372556|NCT05511038|560795751|FG001|Treatment|Lost to Follow-up|0|||
155372557|NCT05511038|560795750|FG000|Treatment|Death|1|||
155372558|NCT05511038|560795751|FG001|Treatment|Death|0|||
155372559|NCT05511038|560795750|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
155372560|NCT05511038|560795751|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
155372561|NCT05511038|560795750|FG000|Treatment|Refuse by subject|1|||
155372562|NCT05511038|560795751|FG001|Treatment|Refuse by subject|0|||
155372563|NCT05511038|560795750|FG000|Treatment|Subject did not go to the site for visit|1|||
155372564|NCT05511038|560795751|FG001|Treatment|Subject did not go to the site for visit|0|||
155372565|NCT02108964|560795752|FG000|Overall Study|Progressive disease|15|||
155372566|NCT02108964|560795753|FG001|Overall Study|Progressive disease|31|||
155372567|NCT02108964|560795754|FG002|Overall Study|Progressive disease|54|||
155372568|NCT02108964|560795755|FG003|Overall Study|Progressive disease|7|||
155372569|NCT02108964|560795756|FG004|Overall Study|Progressive disease|20|||
155372570|NCT02108964|560795757|FG005|Overall Study|Progressive disease|4|||
155372571|NCT02108964|560795758|FG006|Overall Study|Progressive disease|6|||
155372572|NCT02108964|560795759|FG007|Overall Study|Progressive disease|33|||
155372573|NCT02108964|560795752|FG000|Overall Study|Physician Decision|1|||
155372574|NCT02108964|560795753|FG001|Overall Study|Physician Decision|5|||
155372575|NCT02108964|560795754|FG002|Overall Study|Physician Decision|7|||
155372576|NCT02108964|560795755|FG003|Overall Study|Physician Decision|1|||
155372577|NCT02108964|560795756|FG004|Overall Study|Physician Decision|2|||
155372578|NCT02108964|560795757|FG005|Overall Study|Physician Decision|1|||
155372579|NCT02108964|560795758|FG006|Overall Study|Physician Decision|1|||
155372580|NCT02108964|560795759|FG007|Overall Study|Physician Decision|3|||
155372581|NCT02108964|560795752|FG000|Overall Study|Adverse Event|0|||
155372582|NCT02108964|560795753|FG001|Overall Study|Adverse Event|0|||
155372583|NCT02108964|560795754|FG002|Overall Study|Adverse Event|4|||
155372584|NCT02108964|560795755|FG003|Overall Study|Adverse Event|0|||
155372585|NCT02108964|560795756|FG004|Overall Study|Adverse Event|1|||
155372586|NCT02108964|560795757|FG005|Overall Study|Adverse Event|0|||
155372587|NCT02108964|560795758|FG006|Overall Study|Adverse Event|3|||
155372588|NCT02108964|560795759|FG007|Overall Study|Adverse Event|2|||
155372589|NCT02108964|560795752|FG000|Overall Study|Death|1|||
155372590|NCT02108964|560795753|FG001|Overall Study|Death|1|||
155372591|NCT02108964|560795754|FG002|Overall Study|Death|4|||
155372592|NCT02108964|560795755|FG003|Overall Study|Death|0|||
155372593|NCT02108964|560795756|FG004|Overall Study|Death|3|||
155372594|NCT02108964|560795757|FG005|Overall Study|Death|0|||
155372595|NCT02108964|560795758|FG006|Overall Study|Death|0|||
155372596|NCT02108964|560795759|FG007|Overall Study|Death|2|||
155372597|NCT02108964|560795752|FG000|Overall Study|Subject/Guardian decision|0|||
155372598|NCT02108964|560795753|FG001|Overall Study|Subject/Guardian decision|1|||
155372599|NCT02108964|560795754|FG002|Overall Study|Subject/Guardian decision|4|||
155372600|NCT02108964|560795755|FG003|Overall Study|Subject/Guardian decision|0|||
155372601|NCT02108964|560795756|FG004|Overall Study|Subject/Guardian decision|2|||
155372602|NCT02108964|560795757|FG005|Overall Study|Subject/Guardian decision|0|||
155372603|NCT02108964|560795758|FG006|Overall Study|Subject/Guardian decision|1|||
155372604|NCT02108964|560795759|FG007|Overall Study|Subject/Guardian decision|2|||
155372605|NCT02108964|560795752|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372606|NCT02108964|560795753|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372607|NCT02108964|560795754|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372608|NCT02108964|560795755|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372609|NCT02108964|560795756|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
154965696|NCT00112437|559298870|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965697|NCT00112437|559298871|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
155168892|NCT02779556|560057216|FG001|12 Month HbA1c|No value collected during window|102|||
155372610|NCT02108964|560795757|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372611|NCT02108964|560795758|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
155372612|NCT02108964|560795759|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
155372613|NCT03006848|560795760|FG000|Overall Study|Adverse Event|1|||
155372614|NCT03006848|560795760|FG000|Overall Study|Physician Decision|1|||
155372615|NCT03006848|560795760|FG000|Overall Study|Lack of Efficacy|16|||
155372616|NCT05543187|560795761|FG000|Overall Study|Ongoing|3|||
155372617|NCT05543187|560795762|FG001|Overall Study|Ongoing|2|||
155372618|NCT00384397|560795763|FG000|Overall Study|Adverse Event|0|||
155372619|NCT00384397|560795764|FG001|Overall Study|Adverse Event|1|||
155372620|NCT00384397|560795765|FG002|Overall Study|Adverse Event|2|||
155372621|NCT00384397|560795763|FG000|Overall Study|Protocol Violation|7|||
155372622|NCT00384397|560795764|FG001|Overall Study|Protocol Violation|15|||
155372623|NCT00384397|560795765|FG002|Overall Study|Protocol Violation|13|||
155372624|NCT00384397|560795763|FG000|Overall Study|Lost to Follow-up|11|||
155372625|NCT00384397|560795764|FG001|Overall Study|Lost to Follow-up|13|||
155372626|NCT00384397|560795765|FG002|Overall Study|Lost to Follow-up|3|||
155372627|NCT00384397|560795763|FG000|Overall Study|Withdrawal by Subject|14|||
155372628|NCT00384397|560795764|FG001|Overall Study|Withdrawal by Subject|17|||
155372629|NCT00384397|560795765|FG002|Overall Study|Withdrawal by Subject|15|||
155372630|NCT02336451|560795766|FG000|Overall Study|Adverse Event|1|||
155372631|NCT02336451|560795767|FG001|Overall Study|Adverse Event|2|||
155372632|NCT02336451|560795768|FG002|Overall Study|Adverse Event|0|||
155372633|NCT02336451|560795769|FG003|Overall Study|Adverse Event|6|||
155372634|NCT02336451|560795770|FG004|Overall Study|Adverse Event|4|||
155372635|NCT02336451|560795766|FG000|Overall Study|Death|6|||
155372636|NCT02336451|560795767|FG001|Overall Study|Death|2|||
155372637|NCT02336451|560795768|FG002|Overall Study|Death|3|||
155372638|NCT02336451|560795769|FG003|Overall Study|Death|6|||
155372639|NCT02336451|560795770|FG004|Overall Study|Death|6|||
155372640|NCT02336451|560795766|FG000|Overall Study|Physician Decision|9|||
155372641|NCT02336451|560795767|FG001|Overall Study|Physician Decision|6|||
155372642|NCT02336451|560795768|FG002|Overall Study|Physician Decision|7|||
155372643|NCT02336451|560795769|FG003|Overall Study|Physician Decision|16|||
155372644|NCT02336451|560795770|FG004|Overall Study|Physician Decision|3|||
155372645|NCT02336451|560795766|FG000|Overall Study|Progressive disease|23|||
155372646|NCT02336451|560795767|FG001|Overall Study|Progressive disease|26|||
155372647|NCT02336451|560795768|FG002|Overall Study|Progressive disease|2|||
155372648|NCT02336451|560795769|FG003|Overall Study|Progressive disease|14|||
155372649|NCT02336451|560795770|FG004|Overall Study|Progressive disease|4|||
155372650|NCT02336451|560795766|FG000|Overall Study|Protocol Violation|1|||
155372651|NCT02336451|560795767|FG001|Overall Study|Protocol Violation|0|||
155372652|NCT02336451|560795768|FG002|Overall Study|Protocol Violation|0|||
155372653|NCT02336451|560795769|FG003|Overall Study|Protocol Violation|0|||
155372654|NCT02336451|560795770|FG004|Overall Study|Protocol Violation|0|||
155372655|NCT02336451|560795766|FG000|Overall Study|Patient/guardian decision|2|||
155372656|NCT02336451|560795767|FG001|Overall Study|Patient/guardian decision|4|||
155372657|NCT02336451|560795768|FG002|Overall Study|Patient/guardian decision|0|||
155372658|NCT02336451|560795769|FG003|Overall Study|Patient/guardian decision|2|||
155372659|NCT02336451|560795770|FG004|Overall Study|Patient/guardian decision|1|||
155372660|NCT03520712|560795771|FG000|Overall Study|Early termination of the study by Sponsor|2|||
155372661|NCT04531982|560795774|FG000|Overall Study|Withdrawal by Subject|10|||
155372662|NCT04531982|560795775|FG001|Overall Study|Withdrawal by Subject|11|||
155372663|NCT04531982|560795774|FG000|Overall Study|Adverse Event|6|||
155372664|NCT04531982|560795775|FG001|Overall Study|Adverse Event|14|||
155372665|NCT04531982|560795774|FG000|Overall Study|Protocol Violation|6|||
155372666|NCT04531982|560795775|FG001|Overall Study|Protocol Violation|9|||
155372667|NCT04531982|560795774|FG000|Overall Study|Non-compliance with study drug|3|||
155372668|NCT04531982|560795775|FG001|Overall Study|Non-compliance with study drug|2|||
155372669|NCT04531982|560795774|FG000|Overall Study|Use of prohibited medication|2|||
155372670|NCT04531982|560795775|FG001|Overall Study|Use of prohibited medication|0|||
155372671|NCT04531982|560795774|FG000|Overall Study|Lost to Follow-up|0|||
155372672|NCT04531982|560795775|FG001|Overall Study|Lost to Follow-up|1|||
155372673|NCT04531982|560795774|FG000|Overall Study|Geopolitical conflict|2|||
155372674|NCT04531982|560795775|FG001|Overall Study|Geopolitical conflict|0|||
155372675|NCT04531982|560795774|FG000|Overall Study|Lack of Efficacy|3|||
155372676|NCT04531982|560795775|FG001|Overall Study|Lack of Efficacy|1|||
155372677|NCT04998812|560795776|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
155372678|NCT04998812|560795777|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
155372679|NCT04998812|560795776|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
155372680|NCT04998812|560795777|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
155372681|NCT04998812|560795776|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
155372682|NCT04998812|560795777|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
155372683|NCT04998812|560795776|FG000|Vaccination Period|Ongoing in study|23|||
155372684|NCT04998812|560795777|FG001|Vaccination Period|Ongoing in study|23|||
155372685|NCT06748729|560795781|FG000|Overall Study|Withdrawal by Subject|1|||
155372686|NCT03578887|560795782|FG000|Overall Study|Withdrawal by Subject|7|||
155372687|NCT03578887|560795783|FG001|Overall Study|Withdrawal by Subject|2|||
155372688|NCT03578887|560795784|FG002|Overall Study|Withdrawal by Subject|1|||
155372689|NCT03578887|560795782|FG000|Overall Study|Lost to Follow-up|13|||
155372690|NCT03578887|560795783|FG001|Overall Study|Lost to Follow-up|1|||
155372691|NCT03578887|560795784|FG002|Overall Study|Lost to Follow-up|4|||
155372692|NCT03578887|560795782|FG000|Overall Study|Physician Decision|0|||
155372693|NCT03578887|560795783|FG001|Overall Study|Physician Decision|1|||
155372694|NCT03578887|560795784|FG002|Overall Study|Physician Decision|1|||
155372695|NCT01099215|560798430|FG000|Overall Study|Withdrawal by Subject|1|||
155372696|NCT01099215|560798431|FG001|Overall Study|Withdrawal by Subject|0|||
155372697|NCT01099215|560798430|FG000|Overall Study|Adverse Event|0|||
155372698|NCT01099215|560798431|FG001|Overall Study|Adverse Event|1|||
155372699|NCT03333876|560798435|FG000|Screening Period|Screen Failure|4|||
155372700|NCT03333876|560798435|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
155372701|NCT03333876|560798435|FG000|Mandibular Advancement|Adverse Event|2|||
155372702|NCT03333876|560798435|FG000|Mandibular Advancement|Product Damage|2|||
155372703|NCT00095498|560798437|FG000|Overall Study|Physician Decision|9|||
155372704|NCT00095498|560798438|FG001|Overall Study|Physician Decision|10|||
155372705|NCT00095498|560798439|FG002|Overall Study|Physician Decision|8|||
155372706|NCT00095498|560798437|FG000|Overall Study|Adverse Event|1|||
155372707|NCT00095498|560798438|FG001|Overall Study|Adverse Event|0|||
155372708|NCT00095498|560798439|FG002|Overall Study|Adverse Event|1|||
155372709|NCT00095498|560798437|FG000|Overall Study|Withdrawal by Subject|15|||
155372710|NCT00095498|560798438|FG001|Overall Study|Withdrawal by Subject|16|||
155372711|NCT00095498|560798439|FG002|Overall Study|Withdrawal by Subject|15|||
155372712|NCT00095498|560798437|FG000|Overall Study|Disease progression|0|||
155372713|NCT00095498|560798438|FG001|Overall Study|Disease progression|1|||
155372714|NCT00095498|560798439|FG002|Overall Study|Disease progression|1|||
155372715|NCT00095498|560798437|FG000|Overall Study|Ineligibility determined|3|||
155372716|NCT00095498|560798438|FG001|Overall Study|Ineligibility determined|0|||
155372717|NCT00095498|560798439|FG002|Overall Study|Ineligibility determined|2|||
155372718|NCT00095498|560798437|FG000|Overall Study|Lost to Follow-up|1|||
155372719|NCT00095498|560798438|FG001|Overall Study|Lost to Follow-up|1|||
155372720|NCT00095498|560798439|FG002|Overall Study|Lost to Follow-up|2|||
155372721|NCT00095498|560798437|FG000|Overall Study|Noncompliance|1|||
155372722|NCT00095498|560798438|FG001|Overall Study|Noncompliance|0|||
155372723|NCT00095498|560798439|FG002|Overall Study|Noncompliance|1|||
155372724|NCT00095498|560798437|FG000|Overall Study|Other|6|||
155372725|NCT00095498|560798438|FG001|Overall Study|Other|7|||
155372726|NCT00095498|560798439|FG002|Overall Study|Other|6|||
155372727|NCT00095498|560798437|FG000|Overall Study|Protocol Violation|0|||
155372728|NCT00095498|560798438|FG001|Overall Study|Protocol Violation|0|||
155372729|NCT00095498|560798439|FG002|Overall Study|Protocol Violation|1|||
155372730|NCT00095498|560798437|FG000|Overall Study|Requirement for alternative therapy|1|||
155372731|NCT00095498|560798438|FG001|Overall Study|Requirement for alternative therapy|0|||
155372732|NCT00095498|560798439|FG002|Overall Study|Requirement for alternative therapy|2|||
155372733|NCT05020327|560798441|FG000|Overall Study|Physician Decision|3|||
155372734|NCT05020327|560798442|FG001|Overall Study|Physician Decision|0|||
155372735|NCT05020327|560798443|FG002|Overall Study|Physician Decision|0|||
155372736|NCT05020327|560798441|FG000|Overall Study|Withdrawal by Subject|1|||
155372737|NCT05020327|560798442|FG001|Overall Study|Withdrawal by Subject|1|||
155372738|NCT05020327|560798443|FG002|Overall Study|Withdrawal by Subject|0|||
155091069|NCT00560508|559767471|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
155091070|NCT00560508|559767472|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
155091071|NCT00560508|559767471|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
155372739|NCT05020327|560798441|FG000|Overall Study|personal/cultural, ineligible|12|||
155372740|NCT05020327|560798442|FG001|Overall Study|personal/cultural, ineligible|0|||
155372741|NCT05020327|560798443|FG002|Overall Study|personal/cultural, ineligible|0|||
155372742|NCT00166712|560798444|FG000|Overall Study|Death|0|||
155372743|NCT00166712|560798445|FG001|Overall Study|Death|1|||
155372744|NCT00166712|560798444|FG000|Overall Study|Adverse Event|1|||
155372745|NCT00166712|560798445|FG001|Overall Study|Adverse Event|0|||
155372746|NCT00166712|560798444|FG000|Overall Study|Withdrawal by Subject|1|||
155372747|NCT00166712|560798445|FG001|Overall Study|Withdrawal by Subject|2|||
155372748|NCT00166712|560798444|FG000|Overall Study|Physician Decision|0|||
155168893|NCT01667419|560057220|FG000|Overall Study|Reason Not Specified|1|||
155168894|NCT01667419|560057221|FG001|Overall Study|Reason Not Specified|0|||
155168895|NCT01667419|560057222|FG002|Overall Study|Reason Not Specified|0|||
155168896|NCT01667419|560057223|FG003|Overall Study|Reason Not Specified|0|||
155168897|NCT01667419|560057220|FG000|Overall Study|Withdrawal by Subject|16|||
155168898|NCT01667419|560057221|FG001|Overall Study|Withdrawal by Subject|8|||
155168899|NCT01667419|560057222|FG002|Overall Study|Withdrawal by Subject|9|||
155168900|NCT01667419|560057223|FG003|Overall Study|Withdrawal by Subject|8|||
155168901|NCT01667419|560057220|FG000|Overall Study|Non-compliance|0|||
155168902|NCT01667419|560057221|FG001|Overall Study|Non-compliance|0|||
155168903|NCT01667419|560057222|FG002|Overall Study|Non-compliance|0|||
155168904|NCT01667419|560057223|FG003|Overall Study|Non-compliance|1|||
155168905|NCT01667419|560057220|FG000|Overall Study|Protocol Violation|1|||
155168906|NCT01667419|560057221|FG001|Overall Study|Protocol Violation|0|||
155168907|NCT01667419|560057222|FG002|Overall Study|Protocol Violation|0|||
155168908|NCT01667419|560057223|FG003|Overall Study|Protocol Violation|0|||
155168909|NCT01667419|560057220|FG000|Overall Study|Lost to Follow-up|7|||
155168910|NCT01667419|560057221|FG001|Overall Study|Lost to Follow-up|6|||
155168911|NCT01667419|560057222|FG002|Overall Study|Lost to Follow-up|2|||
155168912|NCT01667419|560057223|FG003|Overall Study|Lost to Follow-up|4|||
155168913|NCT01667419|560057220|FG000|Overall Study|Death|18|||
155168914|NCT01667419|560057221|FG001|Overall Study|Death|33|||
155168915|NCT01667419|560057222|FG002|Overall Study|Death|25|||
155168916|NCT01667419|560057223|FG003|Overall Study|Death|26|||
155168917|NCT02082340|560057227|FG000|Overall Study|Lost to Follow-up|1|||
155168918|NCT02082340|560057228|FG001|Overall Study|Lost to Follow-up|1|||
155168919|NCT02625909|560057229|FG000|Overall Study|Death|2|||
155168920|NCT02625909|560057230|FG001|Overall Study|Death|0|||
155168921|NCT02625909|560057229|FG000|Overall Study|Lost to Follow-up|3|||
155168922|NCT02625909|560057230|FG001|Overall Study|Lost to Follow-up|5|||
155168923|NCT02625909|560057229|FG000|Overall Study|Lack of Efficacy|9|||
155168924|NCT02625909|560057230|FG001|Overall Study|Lack of Efficacy|2|||
155168925|NCT02625909|560057229|FG000|Overall Study|Reinfection|3|||
155168926|NCT02625909|560057230|FG001|Overall Study|Reinfection|2|||
155168927|NCT02511106|560057234|FG000|Overall Study|Lost to Follow-up|6|||
155168928|NCT02511106|560057235|FG001|Overall Study|Lost to Follow-up|4|||
154965698|NCT00112437|559298872|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965699|NCT00112437|559298873|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
155168929|NCT02511106|560057234|FG000|Overall Study|Withdrawal by Subject|24|||
155168930|NCT02511106|560057235|FG001|Overall Study|Withdrawal by Subject|21|||
155168931|NCT02511106|560057234|FG000|Overall Study|Death|42|||
155168932|NCT02511106|560057235|FG001|Overall Study|Death|82|||
155168933|NCT02511106|560057234|FG000|Overall Study|Ongoing study at data cut-off|3|||
155168934|NCT02511106|560057235|FG001|Overall Study|Ongoing study at data cut-off|2|||
155168935|NCT02511106|560057234|FG000|Overall Study|Without specified reason|3|||
155168936|NCT02511106|560057235|FG001|Overall Study|Without specified reason|0|||
155168937|NCT01015638|560057236|FG000|Overall Study|Withdrawal by Subject|1|||
155372749|NCT00166712|560798445|FG001|Overall Study|Physician Decision|2|||
155372750|NCT01302080|560798446|FG000|Overall Study|Withdrew Consent|92|||
155372751|NCT01302080|560798447|FG001|Overall Study|Withdrew Consent|39|||
155372752|NCT01302080|560798446|FG000|Overall Study|Patient/Family Moved|28|||
155372753|NCT01302080|560798447|FG001|Overall Study|Patient/Family Moved|3|||
155372754|NCT01302080|560798446|FG000|Overall Study|Lost to Follow-up|192|||
155372755|NCT01302080|560798447|FG001|Overall Study|Lost to Follow-up|93|||
155372756|NCT01302080|560798446|FG000|Overall Study|Death|1|||
155372757|NCT01302080|560798447|FG001|Overall Study|Death|0|||
155372758|NCT01302080|560798446|FG000|Overall Study|Other|52|||
154965700|NCT00112437|559298874|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965701|NCT00112437|559298875|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
155372759|NCT01302080|560798447|FG001|Overall Study|Other|8|||
155372760|NCT01302080|560798446|FG000|Overall Study|Reason Missing For Discontinuation|1|||
155372761|NCT01302080|560798447|FG001|Overall Study|Reason Missing For Discontinuation|0|||
155372762|NCT00503139|560798450|FG000|Overall Study|Case Report Forms were not collected|4|||
155372763|NCT00503139|560798450|FG000|Overall Study|Protocol Violation|4|||
155372764|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372765|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372766|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
155372767|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
155372768|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372769|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
155372770|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
155372771|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
155372772|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
155372773|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
155372774|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372775|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372776|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
155372777|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
155372778|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
155372779|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
155372780|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
154965702|NCT00112437|559298876|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965703|NCT00112437|559298877|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
155372781|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
154965704|NCT00112437|559298878|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
155372782|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
155372783|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
155372784|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
155372785|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
155372786|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
155168938|NCT01015638|560057237|FG001|Overall Study|Withdrawal by Subject|0|||
155168939|NCT00984620|560057238|FG000|Overall Study|Adverse Event|5|||
155168940|NCT00984620|560057239|FG001|Overall Study|Adverse Event|5|||
155168941|NCT00984620|560057238|FG000|Overall Study|Lost to Follow-up|1|||
155168942|NCT00984620|560057239|FG001|Overall Study|Lost to Follow-up|1|||
155168943|NCT00984620|560057238|FG000|Overall Study|Withdrawal by Subject|0|||
155168944|NCT00984620|560057239|FG001|Overall Study|Withdrawal by Subject|2|||
155168945|NCT00984620|560057238|FG000|Overall Study|reason other than listed above|0|||
155372787|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
155372788|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
155372789|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372790|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
155372791|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372792|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372793|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372794|NCT00833833|560798454|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
155372795|NCT00833833|560798455|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
155372796|NCT00833833|560798456|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
155372797|NCT00833833|560798457|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
155372798|NCT00833833|560798458|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
155372799|NCT00833833|560798459|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
155372800|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372801|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372802|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372803|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
155372804|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
155372805|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
155372806|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372807|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372808|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372809|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
155372810|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
155372811|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
155372812|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
155372813|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
155372814|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
155372815|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
155372816|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
155372817|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
155372818|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372819|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372820|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372821|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
155372822|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
155372823|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
155372824|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372825|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372826|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372827|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
155372828|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
155372829|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
155372830|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
155372831|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
155372832|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
155372833|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
155372834|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
155372835|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
155372836|NCT00833833|560798454|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372837|NCT00833833|560798455|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372838|NCT00833833|560798456|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372839|NCT00833833|560798457|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372840|NCT00833833|560798458|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
155372841|NCT00833833|560798459|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
155168946|NCT00984620|560057239|FG001|Overall Study|reason other than listed above|4|||
155168947|NCT00324961|560057243|FG000|Overall Study|Adverse Event|5|||
155168948|NCT00324961|560057243|FG000|Overall Study|Consent Withdrawn|11|||
155372842|NCT02040259|560798460|FG000|Overall Study|Death|280|||
155372843|NCT02040259|560798460|FG000|Overall Study|Lost to Follow-up|76|||
155372844|NCT02040259|560798460|FG000|Overall Study|Assessment not completed|3|||
155372845|NCT02040259|560798460|FG000|Overall Study|Withdrawal by Subject|4|||
155372846|NCT00316602|560798461|FG000|Overall Study|Withdrawal by Subject|3|||
155372847|NCT00316602|560798462|FG001|Overall Study|Withdrawal by Subject|2|||
155372848|NCT00316602|560798461|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
155372849|NCT00316602|560798462|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
155372850|NCT00316602|560798461|FG000|Overall Study|Adverse Event|1|||
155372851|NCT00316602|560798462|FG001|Overall Study|Adverse Event|0|||
155372852|NCT00316602|560798461|FG000|Overall Study|Other|3|||
155372853|NCT00316602|560798462|FG001|Overall Study|Other|6|||
155372854|NCT01142232|560798463|FG000|Overall Study|Adverse Event|1|||
155372855|NCT01142232|560798464|FG001|Overall Study|Adverse Event|2|||
155372856|NCT01142232|560798465|FG002|Overall Study|Adverse Event|1|||
155372857|NCT01142232|560798466|FG003|Overall Study|Adverse Event|0|||
155372858|NCT01142232|560798467|FG004|Overall Study|Adverse Event|4|||
155372859|NCT01142232|560798463|FG000|Overall Study|Death|0|||
155372860|NCT01142232|560798464|FG001|Overall Study|Death|0|||
155372861|NCT01142232|560798465|FG002|Overall Study|Death|0|||
155372862|NCT01142232|560798466|FG003|Overall Study|Death|0|||
155372863|NCT01142232|560798467|FG004|Overall Study|Death|1|||
155372864|NCT01142232|560798463|FG000|Overall Study|Disease Progression|2|||
155372865|NCT01142232|560798464|FG001|Overall Study|Disease Progression|0|||
155372866|NCT01142232|560798465|FG002|Overall Study|Disease Progression|1|||
155372867|NCT01142232|560798466|FG003|Overall Study|Disease Progression|2|||
155372868|NCT01142232|560798467|FG004|Overall Study|Disease Progression|12|||
155372869|NCT01142232|560798463|FG000|Overall Study|Withdrawal by Subject|0|||
155372870|NCT01142232|560798464|FG001|Overall Study|Withdrawal by Subject|0|||
155091072|NCT00560508|559767472|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
155372871|NCT01142232|560798465|FG002|Overall Study|Withdrawal by Subject|0|||
155372872|NCT01142232|560798466|FG003|Overall Study|Withdrawal by Subject|1|||
155091073|NCT00560508|559767471|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
155372873|NCT01142232|560798467|FG004|Overall Study|Withdrawal by Subject|3|||
155372874|NCT01142232|560798463|FG000|Overall Study|Physician Decision|0|||
155372875|NCT01142232|560798464|FG001|Overall Study|Physician Decision|1|||
155372876|NCT01142232|560798465|FG002|Overall Study|Physician Decision|0|||
155372877|NCT01142232|560798466|FG003|Overall Study|Physician Decision|2|||
155372878|NCT01142232|560798467|FG004|Overall Study|Physician Decision|10|||
155372879|NCT01142232|560798463|FG000|Overall Study|Alternative Therapy|0|||
155372880|NCT01142232|560798464|FG001|Overall Study|Alternative Therapy|1|||
155372881|NCT01142232|560798465|FG002|Overall Study|Alternative Therapy|1|||
155372882|NCT01142232|560798466|FG003|Overall Study|Alternative Therapy|0|||
155372883|NCT01142232|560798467|FG004|Overall Study|Alternative Therapy|1|||
155372884|NCT01142232|560798463|FG000|Overall Study|Off Trt for other complicating disease|0|||
155372885|NCT01142232|560798464|FG001|Overall Study|Off Trt for other complicating disease|0|||
155372886|NCT01142232|560798465|FG002|Overall Study|Off Trt for other complicating disease|0|||
155372887|NCT01142232|560798466|FG003|Overall Study|Off Trt for other complicating disease|0|||
155372888|NCT01142232|560798467|FG004|Overall Study|Off Trt for other complicating disease|1|||
155372889|NCT01142232|560798463|FG000|Overall Study|Noncompliance|0|||
155372890|NCT01142232|560798464|FG001|Overall Study|Noncompliance|0|||
155372891|NCT01142232|560798465|FG002|Overall Study|Noncompliance|0|||
155372892|NCT01142232|560798466|FG003|Overall Study|Noncompliance|0|||
155372893|NCT01142232|560798467|FG004|Overall Study|Noncompliance|2|||
155372894|NCT00626990|560798468|FG000|Overall Study|Lack of Efficacy|6|||
155372895|NCT00626990|560798469|FG001|Overall Study|Lack of Efficacy|7|||
155372896|NCT00626990|560798470|FG002|Overall Study|Lack of Efficacy|49|||
155372897|NCT00626990|560798471|FG003|Overall Study|Lack of Efficacy|40|||
155372898|NCT00626990|560798468|FG000|Overall Study|Adverse Event|1|||
155372899|NCT00626990|560798469|FG001|Overall Study|Adverse Event|7|||
155372900|NCT00626990|560798470|FG002|Overall Study|Adverse Event|14|||
155372901|NCT00626990|560798471|FG003|Overall Study|Adverse Event|28|||
155372902|NCT00626990|560798468|FG000|Overall Study|Death|0|||
155372903|NCT00626990|560798469|FG001|Overall Study|Death|1|||
155372904|NCT00626990|560798470|FG002|Overall Study|Death|0|||
155372905|NCT00626990|560798471|FG003|Overall Study|Death|0|||
155372906|NCT00626990|560798468|FG000|Overall Study|Withdrawal by Subject|3|||
155372907|NCT00626990|560798469|FG001|Overall Study|Withdrawal by Subject|1|||
155372908|NCT00626990|560798470|FG002|Overall Study|Withdrawal by Subject|5|||
155372909|NCT00626990|560798471|FG003|Overall Study|Withdrawal by Subject|11|||
155372910|NCT00626990|560798468|FG000|Overall Study|Protocol Violation|0|||
155372911|NCT00626990|560798469|FG001|Overall Study|Protocol Violation|1|||
155372912|NCT00626990|560798470|FG002|Overall Study|Protocol Violation|1|||
155372913|NCT00626990|560798471|FG003|Overall Study|Protocol Violation|0|||
155372914|NCT00626990|560798468|FG000|Overall Study|Various different reasons/missing|4|||
155372915|NCT00626990|560798469|FG001|Overall Study|Various different reasons/missing|8|||
155372916|NCT00626990|560798470|FG002|Overall Study|Various different reasons/missing|8|||
155372917|NCT00626990|560798471|FG003|Overall Study|Various different reasons/missing|16|||
155372918|NCT04138576|560798472|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
155372919|NCT01994837|560798473|FG000|Overall Study|Progressive disease per protocol|23|||
155372920|NCT01994837|560798473|FG000|Overall Study|Adv event related to progressive disease|3|||
155372921|NCT01994837|560798473|FG000|Overall Study|Fatal progressive disease|2|||
155372922|NCT01994837|560798473|FG000|Overall Study|Adverse event not related to progression|1|||
155372923|NCT01994837|560798473|FG000|Overall Study|Chose palliative care|1|||
155372924|NCT01994837|560798473|FG000|Overall Study|Proceeded to transplant|1|||
155372925|NCT01994837|560798473|FG000|Overall Study|Removed from study due to no response|1|||
155372926|NCT00574873|560798474|FG000|Overall Study|Withdrawal by Subject|18|||
155372927|NCT00574873|560798475|FG001|Overall Study|Withdrawal by Subject|19|||
155372928|NCT00574873|560798474|FG000|Overall Study|Investigator request|18|||
155372929|NCT00574873|560798475|FG001|Overall Study|Investigator request|8|||
155372930|NCT00574873|560798474|FG000|Overall Study|Death|15|||
155372931|NCT00574873|560798475|FG001|Overall Study|Death|14|||
155372932|NCT00574873|560798474|FG000|Overall Study|Lost to Follow-up|14|||
155372933|NCT00574873|560798475|FG001|Overall Study|Lost to Follow-up|5|||
155372934|NCT00574873|560798474|FG000|Overall Study|Other|40|||
155372935|NCT00574873|560798475|FG001|Overall Study|Other|4|||
155372936|NCT00574873|560798474|FG000|Overall Study|Discontinuation of study by sponsor|5|||
155372937|NCT00574873|560798475|FG001|Overall Study|Discontinuation of study by sponsor|199|||
155372938|NCT00574873|560798474|FG000|Overall Study|Blank, site closed per local regulations|2|||
155372939|NCT00574873|560798475|FG001|Overall Study|Blank, site closed per local regulations|2|||
155372940|NCT00574873|560798474|FG000|Overall Study|Extension Study|126|||
155372941|NCT00574873|560798475|FG001|Overall Study|Extension Study|0|||
155372942|NCT00581555|560798476|FG000|Overall Study|Adverse Event|4|||
155372943|NCT00581555|560798477|FG001|Overall Study|Adverse Event|3|||
155372944|NCT00581555|560798476|FG000|Overall Study|Physician Decision|3|||
155372945|NCT00581555|560798477|FG001|Overall Study|Physician Decision|2|||
155372946|NCT00581555|560798476|FG000|Overall Study|Withdrawal by Subject|18|||
155372947|NCT00581555|560798477|FG001|Overall Study|Withdrawal by Subject|9|||
155372948|NCT00581555|560798476|FG000|Overall Study|Lost to Follow-up|2|||
155372949|NCT00581555|560798477|FG001|Overall Study|Lost to Follow-up|2|||
155372950|NCT00581555|560798476|FG000|Overall Study|Other reasons|16|||
155372951|NCT00581555|560798477|FG001|Overall Study|Other reasons|4|||
155372952|NCT05816330|560798478|FG000|Overall Study|Withdrawal by Subject|4|||
155372953|NCT05816330|560798479|FG001|Overall Study|Withdrawal by Subject|1|||
155372954|NCT00201643|560798480|FG000|Overall Study|Withdrawal by Subject|5|||
155372955|NCT00201643|560798481|FG001|Overall Study|Withdrawal by Subject|4|||
155372956|NCT03446781|560798482|FG000|Overall Study|Lost to Follow-up|11|||
155372957|NCT03446781|560798483|FG001|Overall Study|Lost to Follow-up|5|||
155372958|NCT03446781|560798482|FG000|Overall Study|Withdrawal by Subject|9|||
155372959|NCT03446781|560798483|FG001|Overall Study|Withdrawal by Subject|7|||
155372960|NCT03446781|560798482|FG000|Overall Study|Adverse Event|8|||
155372961|NCT03446781|560798483|FG001|Overall Study|Adverse Event|2|||
155372962|NCT03446781|560798482|FG000|Overall Study|Protocol Violation|0|||
155372963|NCT03446781|560798483|FG001|Overall Study|Protocol Violation|3|||
155372964|NCT01940939|560798490|FG000|Overall Study|Withdrawal by Subject|2|||
155372965|NCT01940939|560798491|FG001|Overall Study|Withdrawal by Subject|8|||
155372966|NCT01470001|560798492|FG000|Overall Study|Lost to Follow-up|1|||
155372967|NCT01470001|560798493|FG001|Overall Study|Lost to Follow-up|1|||
155372968|NCT01470001|560798492|FG000|Overall Study|Physician Decision|2|||
155372969|NCT01470001|560798493|FG001|Overall Study|Physician Decision|0|||
155372970|NCT01470001|560798492|FG000|Overall Study|Withdrawal by Subject|2|||
155372971|NCT01470001|560798493|FG001|Overall Study|Withdrawal by Subject|1|||
155372972|NCT03268603|560798494|FG000|Overall Study|Withdrawal by Subject|6|||
155372973|NCT03268603|560798494|FG000|Overall Study|Physician Decision|1|||
155372974|NCT03268603|560798494|FG000|Overall Study|Withdrawn due to disease progression|2|||
155372975|NCT01725126|560798495|FG000|Overall Study|Protocol Violation|0|||
155372976|NCT01725126|560798496|FG001|Overall Study|Protocol Violation|1|||
155372977|NCT01725126|560798497|FG002|Overall Study|Protocol Violation|0|||
155372978|NCT01725126|560798498|FG003|Overall Study|Protocol Violation|0|||
155372979|NCT01725126|560798499|FG004|Overall Study|Protocol Violation|0|||
155372980|NCT01725126|560798500|FG005|Overall Study|Protocol Violation|0|||
155372981|NCT01725126|560798495|FG000|Overall Study|Withdrawal by Subject|0|||
155372982|NCT01725126|560798496|FG001|Overall Study|Withdrawal by Subject|0|||
155372983|NCT01725126|560798497|FG002|Overall Study|Withdrawal by Subject|0|||
155372984|NCT01725126|560798498|FG003|Overall Study|Withdrawal by Subject|1|||
155372985|NCT01725126|560798499|FG004|Overall Study|Withdrawal by Subject|0|||
155372986|NCT01725126|560798500|FG005|Overall Study|Withdrawal by Subject|0|||
155372987|NCT03733314|560798501|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
155372988|NCT03733314|560798502|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
155372989|NCT03733314|560798501|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
155372990|NCT03733314|560798502|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
155372991|NCT03733314|560798501|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
155372992|NCT03733314|560798502|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
155372993|NCT03733314|560798501|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
155372994|NCT03733314|560798502|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
155372995|NCT03733314|560798501|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
155372996|NCT03733314|560798502|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
155372997|NCT03733314|560798501|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
155372998|NCT03733314|560798502|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
155372999|NCT03214640|560798503|FG000|Overall Study|Protocol Violation|1|||
155373000|NCT03214640|560798504|FG001|Overall Study|Protocol Violation|2|||
155373001|NCT03214640|560798505|FG002|Overall Study|Protocol Violation|1|||
155373002|NCT03214640|560798506|FG003|Overall Study|Protocol Violation|4|||
155373003|NCT02075073|560798510|FG000|Overall Study|Withdrawal by Subject|0|||
155373004|NCT02075073|560798511|FG001|Overall Study|Withdrawal by Subject|1|||
155373005|NCT02075073|560798512|FG002|Overall Study|Withdrawal by Subject|0|||
155373006|NCT02683785|560798530|FG000|Overall Study|Withdrawal by Subject|1|||
155373007|NCT02683785|560798531|FG001|Overall Study|Withdrawal by Subject|1|||
155373008|NCT02683785|560798530|FG000|Overall Study|Lost to Follow-up|0|||
155373009|NCT02683785|560798531|FG001|Overall Study|Lost to Follow-up|1|||
155373010|NCT02683785|560798530|FG000|Overall Study|Adverse Event|0|||
155373011|NCT02683785|560798531|FG001|Overall Study|Adverse Event|2|||
155373012|NCT01305408|560798532|FG000|Overall Study|Adverse Event|10|||
155373013|NCT01305408|560798533|FG001|Overall Study|Adverse Event|7|||
155373014|NCT01305408|560798532|FG000|Overall Study|Lack of Efficacy|3|||
155373015|NCT01305408|560798533|FG001|Overall Study|Lack of Efficacy|4|||
155373016|NCT01305408|560798532|FG000|Overall Study|Withdrawal by Subject|9|||
155373017|NCT01305408|560798533|FG001|Overall Study|Withdrawal by Subject|9|||
155373018|NCT01305408|560798532|FG000|Overall Study|Protocol Violation|4|||
155373019|NCT01305408|560798533|FG001|Overall Study|Protocol Violation|6|||
155373020|NCT01305408|560798532|FG000|Overall Study|Lost to Follow-up|5|||
155373021|NCT01305408|560798533|FG001|Overall Study|Lost to Follow-up|3|||
155373022|NCT01305408|560798532|FG000|Overall Study|Noncompliance with study medication|0|||
155373023|NCT01305408|560798533|FG001|Overall Study|Noncompliance with study medication|1|||
155373024|NCT01305408|560798532|FG000|Overall Study|Noncompliance with study procedures|0|||
155373025|NCT01305408|560798533|FG001|Overall Study|Noncompliance with study procedures|1|||
155373026|NCT01305408|560798532|FG000|Overall Study|Other|1|||
155373027|NCT01305408|560798533|FG001|Overall Study|Other|0|||
155373028|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
155373029|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
155373030|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
155373031|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
155373032|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
155373033|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
155373034|NCT02233803|560798536|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
155373035|NCT02233803|560798537|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
155373036|NCT02233803|560798536|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
155373037|NCT02233803|560798537|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
155373038|NCT02233803|560798536|FG000|Washout Period (4-Wks)|Physician Decision|1|||
155373039|NCT02233803|560798537|FG001|Washout Period (4-Wks)|Physician Decision|0|||
155373040|NCT02233803|560798536|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
155373041|NCT02233803|560798537|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
155373042|NCT02233803|560798536|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
155373043|NCT02233803|560798537|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
155373044|NCT02233803|560798536|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
155373045|NCT02233803|560798537|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
155373046|NCT00468143|560798538|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
155373047|NCT00468143|560798539|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
155373048|NCT00468143|560798538|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
155373049|NCT00468143|560798539|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
155373050|NCT01204710|560798544|FG000|Randomization Treatment|Lost to Follow-up|1|||
155373051|NCT01204710|560798545|FG001|Randomization Treatment|Lost to Follow-up|0|||
155373052|NCT01204710|560798544|FG000|Randomization Treatment|Withdrawal by Subject|6|||
155373053|NCT01204710|560798545|FG001|Randomization Treatment|Withdrawal by Subject|5|||
155373054|NCT01204710|560798544|FG000|Randomization Treatment|Physician Decision|3|||
155168949|NCT00324961|560057243|FG000|Overall Study|Lost to Follow-up|22|||
155373055|NCT01204710|560798545|FG001|Randomization Treatment|Physician Decision|2|||
155373056|NCT01204710|560798544|FG000|Randomization Treatment|Entry criteria not met|0|||
155373057|NCT01204710|560798545|FG001|Randomization Treatment|Entry criteria not met|1|||
155373058|NCT01204710|560798544|FG000|Randomization Treatment|Adverse Event|4|||
155373059|NCT01204710|560798545|FG001|Randomization Treatment|Adverse Event|2|||
155373060|NCT01204710|560798544|FG000|Randomization Treatment|Sponsor Decision|0|||
155373061|NCT01204710|560798545|FG001|Randomization Treatment|Sponsor Decision|1|||
155373062|NCT01204710|560798544|FG000|Randomization Treatment|Worsening of General condition|0|||
155373063|NCT01204710|560798545|FG001|Randomization Treatment|Worsening of General condition|1|||
155373064|NCT01204710|560798544|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
155373065|NCT01204710|560798545|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
155373066|NCT01204710|560798544|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
155373067|NCT01204710|560798545|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
155373068|NCT01204710|560798544|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
155373069|NCT01204710|560798545|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
155373070|NCT01204710|560798544|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
155373071|NCT01204710|560798545|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
155373072|NCT04531904|560798548|FG000|Overall Study|Lost to Follow-up|1|||
155373073|NCT04531904|560798548|FG000|Overall Study|Death|14|||
155373074|NCT01743989|560798549|FG000|Treatment Phase|Unstable MR4.0|0|||
155373075|NCT01743989|560798550|FG001|Treatment Phase|Unstable MR4.0|6|||
155373076|NCT01743989|560798551|FG002|Treatment Phase|Unstable MR4.0|263|||
155373077|NCT01743989|560798549|FG000|Treatment Phase|Adverse Event|0|||
155373078|NCT01743989|560798550|FG001|Treatment Phase|Adverse Event|4|||
155373079|NCT01743989|560798551|FG002|Treatment Phase|Adverse Event|67|||
155373080|NCT01743989|560798549|FG000|Treatment Phase|Withdrawal by Subject|1|||
155373081|NCT01743989|560798550|FG001|Treatment Phase|Withdrawal by Subject|3|||
155373082|NCT01743989|560798551|FG002|Treatment Phase|Withdrawal by Subject|28|||
155373083|NCT01743989|560798549|FG000|Treatment Phase|Death|0|||
155373084|NCT01743989|560798550|FG001|Treatment Phase|Death|1|||
155373085|NCT01743989|560798551|FG002|Treatment Phase|Death|3|||
155373086|NCT01743989|560798549|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
155373087|NCT01743989|560798550|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
155373088|NCT01743989|560798551|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
155373089|NCT01743989|560798549|FG000|Treatment Phase|Protocol deviation|0|||
155373090|NCT01743989|560798550|FG001|Treatment Phase|Protocol deviation|0|||
155373091|NCT01743989|560798551|FG002|Treatment Phase|Protocol deviation|3|||
155373092|NCT01743989|560798549|FG000|Treatment Phase|Pregnancy|0|||
155373093|NCT01743989|560798550|FG001|Treatment Phase|Pregnancy|0|||
155373094|NCT01743989|560798551|FG002|Treatment Phase|Pregnancy|2|||
155373095|NCT01743989|560798549|FG000|Treatment Phase|Lost to Follow-up|0|||
155373096|NCT01743989|560798550|FG001|Treatment Phase|Lost to Follow-up|0|||
155373097|NCT01743989|560798551|FG002|Treatment Phase|Lost to Follow-up|2|||
155373098|NCT01743989|560798549|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
155373099|NCT01743989|560798550|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
155373100|NCT01743989|560798551|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
155373101|NCT01743989|560798549|FG000|Treatment Phase|Administrative problems|0|||
155373102|NCT01743989|560798550|FG001|Treatment Phase|Administrative problems|0|||
155373103|NCT01743989|560798551|FG002|Treatment Phase|Administrative problems|1|||
155373104|NCT01743989|560798549|FG000|Treatment Phase|New cancer (CML) therapy|0|||
155373105|NCT01743989|560798550|FG001|Treatment Phase|New cancer (CML) therapy|1|||
155373106|NCT01743989|560798551|FG002|Treatment Phase|New cancer (CML) therapy|0|||
155373107|NCT01743989|560798549|FG000|Treatment Phase|Physician Decision|0|||
155373108|NCT01743989|560798550|FG001|Treatment Phase|Physician Decision|0|||
155373109|NCT01743989|560798551|FG002|Treatment Phase|Physician Decision|3|||
155373110|NCT01743989|560798549|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
155373111|NCT01743989|560798550|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
155373112|NCT01743989|560798551|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
155373113|NCT01743989|560798549|FG000|Treatment Phase|Not randomized by mistake|0|||
155373114|NCT01743989|560798550|FG001|Treatment Phase|Not randomized by mistake|0|||
155373115|NCT01743989|560798551|FG002|Treatment Phase|Not randomized by mistake|1|||
155373116|NCT01743989|560798549|FG000|Treatment Phase|Included by mistake|0|||
155373117|NCT01743989|560798550|FG001|Treatment Phase|Included by mistake|0|||
155373118|NCT01743989|560798551|FG002|Treatment Phase|Included by mistake|1|||
155373119|NCT01743989|560798549|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
155373120|NCT01743989|560798550|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
155373121|NCT01743989|560798551|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
155373122|NCT01743989|560798549|FG000|TFR Phase|Adverse Event|0|||
155373123|NCT01743989|560798550|FG001|TFR Phase|Adverse Event|1|||
155373124|NCT01743989|560798551|FG002|TFR Phase|Adverse Event|0|||
155373125|NCT01743989|560798549|FG000|TFR Phase|Lost to Follow-up|0|||
155373126|NCT01743989|560798550|FG001|TFR Phase|Lost to Follow-up|2|||
155373127|NCT01743989|560798551|FG002|TFR Phase|Lost to Follow-up|0|||
155373128|NCT01743989|560798549|FG000|TFR Phase|Physician Decision|0|||
155373129|NCT01743989|560798550|FG001|TFR Phase|Physician Decision|1|||
155373130|NCT01743989|560798551|FG002|TFR Phase|Physician Decision|0|||
155373131|NCT01743989|560798549|FG000|TFR Phase|Logistical problems|0|||
155373132|NCT01743989|560798550|FG001|TFR Phase|Logistical problems|2|||
155373133|NCT01743989|560798551|FG002|TFR Phase|Logistical problems|0|||
155373134|NCT01743989|560798549|FG000|TFR Phase|Protocol deviation|0|||
155373135|NCT01743989|560798550|FG001|TFR Phase|Protocol deviation|1|||
155373136|NCT01743989|560798551|FG002|TFR Phase|Protocol deviation|0|||
155373137|NCT01743989|560798549|FG000|TFR Phase|Withdrawal by Subject|0|||
155373138|NCT01743989|560798550|FG001|TFR Phase|Withdrawal by Subject|2|||
155373139|NCT01743989|560798551|FG002|TFR Phase|Withdrawal by Subject|0|||
155373140|NCT01743989|560798549|FG000|Re-treatment Phase|Adverse Event|8|||
155373141|NCT01743989|560798550|FG001|Re-treatment Phase|Adverse Event|4|||
155373142|NCT01743989|560798551|FG002|Re-treatment Phase|Adverse Event|0|||
155373143|NCT01743989|560798549|FG000|Re-treatment Phase|Death|1|||
155373144|NCT01743989|560798550|FG001|Re-treatment Phase|Death|1|||
155373145|NCT01743989|560798551|FG002|Re-treatment Phase|Death|0|||
155373146|NCT01743989|560798549|FG000|Re-treatment Phase|Administrative problems|1|||
155373147|NCT01743989|560798550|FG001|Re-treatment Phase|Administrative problems|1|||
155373148|NCT01743989|560798551|FG002|Re-treatment Phase|Administrative problems|0|||
155373149|NCT01743989|560798549|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
155373150|NCT01743989|560798550|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
155373151|NCT01743989|560798551|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
155373152|NCT01743989|560798549|FG000|Re-treatment Phase|Unstable MR|1|||
155373153|NCT01743989|560798550|FG001|Re-treatment Phase|Unstable MR|0|||
155373154|NCT01743989|560798551|FG002|Re-treatment Phase|Unstable MR|0|||
155373155|NCT01743989|560798549|FG000|Re-treatment Phase|Physician Decision|0|||
155373156|NCT01743989|560798550|FG001|Re-treatment Phase|Physician Decision|1|||
155373157|NCT01743989|560798551|FG002|Re-treatment Phase|Physician Decision|0|||
155373158|NCT01743989|560798549|FG000|Re-treatment Phase|Lost to Follow-up|0|||
155373159|NCT01743989|560798550|FG001|Re-treatment Phase|Lost to Follow-up|1|||
155373160|NCT01743989|560798551|FG002|Re-treatment Phase|Lost to Follow-up|0|||
155373161|NCT04655027|560798552|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
155373162|NCT04655027|560798553|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
155373163|NCT03519997|560798554|FG000|Overall Study|Adverse Event|4|||
155373164|NCT03519997|560798554|FG000|Overall Study|Withdrawal by Subject|2|||
155373165|NCT03519997|560798554|FG000|Overall Study|Protocol Violation|1|||
155373166|NCT03361605|560798555|FG000|Overall Study|Analyzable data not available|3|||
155373167|NCT02906007|560798556|FG000|Overall Study|Physician Decision|0|||
155373168|NCT02906007|560798557|FG001|Overall Study|Physician Decision|0|||
155373169|NCT02906007|560798558|FG002|Overall Study|Physician Decision|1|||
155373170|NCT02906007|560798556|FG000|Overall Study|Died|1|||
155373171|NCT02906007|560798557|FG001|Overall Study|Died|0|||
155373172|NCT02906007|560798558|FG002|Overall Study|Died|0|||
155373173|NCT04372121|560798568|FG000|Overall Study|Lost to Follow-up|0|||
155373174|NCT04372121|560798569|FG001|Overall Study|Lost to Follow-up|0|||
155373175|NCT04372121|560798570|FG002|Overall Study|Lost to Follow-up|0|||
155373176|NCT04372121|560798571|FG003|Overall Study|Lost to Follow-up|1|||
155373177|NCT04372121|560798568|FG000|Overall Study|Protocol Violation|0|||
155373178|NCT04372121|560798569|FG001|Overall Study|Protocol Violation|0|||
155373179|NCT04372121|560798570|FG002|Overall Study|Protocol Violation|1|||
155373180|NCT04372121|560798571|FG003|Overall Study|Protocol Violation|0|||
155373181|NCT04372121|560798568|FG000|Overall Study|Withdrawal by Subject|3|||
155373182|NCT04372121|560798569|FG001|Overall Study|Withdrawal by Subject|1|||
155373183|NCT04372121|560798570|FG002|Overall Study|Withdrawal by Subject|0|||
155373184|NCT04372121|560798571|FG003|Overall Study|Withdrawal by Subject|0|||
155373185|NCT04372121|560798568|FG000|Overall Study|Study termination|6|||
155373186|NCT04372121|560798569|FG001|Overall Study|Study termination|5|||
155373187|NCT04372121|560798570|FG002|Overall Study|Study termination|1|||
155373188|NCT04372121|560798571|FG003|Overall Study|Study termination|1|||
155373189|NCT04372121|560798568|FG000|Overall Study|Hysterectomy planned|1|||
155373190|NCT04372121|560798569|FG001|Overall Study|Hysterectomy planned|0|||
155373191|NCT04372121|560798570|FG002|Overall Study|Hysterectomy planned|0|||
155373192|NCT04372121|560798571|FG003|Overall Study|Hysterectomy planned|0|||
155373193|NCT02344290|560798577|FG000|Overall Study|Withdrawal by Subject|315|||
155373194|NCT02344290|560798578|FG001|Overall Study|Withdrawal by Subject|324|||
155373195|NCT02344290|560798577|FG000|Overall Study|Lost to Follow-up|258|||
155373196|NCT02344290|560798578|FG001|Overall Study|Lost to Follow-up|249|||
155373197|NCT02344290|560798577|FG000|Overall Study|Unable to get to clinic|69|||
155373198|NCT02344290|560798578|FG001|Overall Study|Unable to get to clinic|60|||
155373199|NCT02344290|560798577|FG000|Overall Study|Physician Decision|25|||
155373200|NCT02344290|560798578|FG001|Overall Study|Physician Decision|25|||
155373201|NCT02344290|560798577|FG000|Overall Study|Site Closure|15|||
155373202|NCT02344290|560798578|FG001|Overall Study|Site Closure|19|||
155373203|NCT02344290|560798577|FG000|Overall Study|Other|5|||
155373204|NCT02344290|560798578|FG001|Overall Study|Other|3|||
155373205|NCT04047862|560798582|FG000|Overall Study|Death|0|||
155373206|NCT04047862|560798583|FG001|Overall Study|Death|0|||
155373207|NCT04047862|560798584|FG002|Overall Study|Death|4|||
155373208|NCT04047862|560798585|FG003|Overall Study|Death|7|||
155373209|NCT04047862|560798586|FG004|Overall Study|Death|2|||
155373210|NCT04047862|560798587|FG005|Overall Study|Death|4|||
155373211|NCT04047862|560798588|FG006|Overall Study|Death|3|||
155373212|NCT04047862|560798589|FG007|Overall Study|Death|24|||
155373213|NCT04047862|560798590|FG008|Overall Study|Death|24|||
155373214|NCT04047862|560798591|FG009|Overall Study|Death|22|||
155373215|NCT04047862|560798592|FG010|Overall Study|Death|35|||
155373216|NCT04047862|560798593|FG011|Overall Study|Death|18|||
155373217|NCT04047862|560798594|FG012|Overall Study|Death|14|||
155373218|NCT04047862|560798595|FG013|Overall Study|Death|6|||
155373219|NCT04047862|560798596|FG014|Overall Study|Death|19|||
155373220|NCT04047862|560798597|FG015|Overall Study|Death|42|||
155373221|NCT04047862|560798598|FG016|Overall Study|Death|9|||
155373222|NCT04047862|560798599|FG017|Overall Study|Death|8|||
155373223|NCT04047862|560798600|FG018|Overall Study|Death|10|||
155373224|NCT04047862|560798582|FG000|Overall Study|Withdrawal by Subject|0|||
155373225|NCT04047862|560798583|FG001|Overall Study|Withdrawal by Subject|0|||
155373226|NCT04047862|560798584|FG002|Overall Study|Withdrawal by Subject|0|||
155373227|NCT04047862|560798585|FG003|Overall Study|Withdrawal by Subject|5|||
155373228|NCT04047862|560798586|FG004|Overall Study|Withdrawal by Subject|2|||
155373229|NCT04047862|560798587|FG005|Overall Study|Withdrawal by Subject|0|||
155373230|NCT04047862|560798588|FG006|Overall Study|Withdrawal by Subject|1|||
155373231|NCT04047862|560798589|FG007|Overall Study|Withdrawal by Subject|0|||
155373232|NCT04047862|560798590|FG008|Overall Study|Withdrawal by Subject|4|||
155373233|NCT04047862|560798591|FG009|Overall Study|Withdrawal by Subject|4|||
155373234|NCT04047862|560798592|FG010|Overall Study|Withdrawal by Subject|4|||
155373235|NCT04047862|560798593|FG011|Overall Study|Withdrawal by Subject|2|||
155373236|NCT04047862|560798594|FG012|Overall Study|Withdrawal by Subject|3|||
155373237|NCT04047862|560798595|FG013|Overall Study|Withdrawal by Subject|0|||
155373238|NCT04047862|560798596|FG014|Overall Study|Withdrawal by Subject|9|||
155373239|NCT04047862|560798597|FG015|Overall Study|Withdrawal by Subject|5|||
155373240|NCT04047862|560798598|FG016|Overall Study|Withdrawal by Subject|1|||
155373241|NCT04047862|560798599|FG017|Overall Study|Withdrawal by Subject|3|||
155373242|NCT04047862|560798600|FG018|Overall Study|Withdrawal by Subject|1|||
155373243|NCT04047862|560798582|FG000|Overall Study|Lost to Follow-up|0|||
155373244|NCT04047862|560798583|FG001|Overall Study|Lost to Follow-up|0|||
155373245|NCT04047862|560798584|FG002|Overall Study|Lost to Follow-up|1|||
155373246|NCT04047862|560798585|FG003|Overall Study|Lost to Follow-up|0|||
155373247|NCT04047862|560798586|FG004|Overall Study|Lost to Follow-up|0|||
155373248|NCT04047862|560798587|FG005|Overall Study|Lost to Follow-up|0|||
155373249|NCT04047862|560798588|FG006|Overall Study|Lost to Follow-up|0|||
155373250|NCT04047862|560798589|FG007|Overall Study|Lost to Follow-up|1|||
155373251|NCT04047862|560798590|FG008|Overall Study|Lost to Follow-up|0|||
155373252|NCT04047862|560798591|FG009|Overall Study|Lost to Follow-up|1|||
155373253|NCT04047862|560798592|FG010|Overall Study|Lost to Follow-up|0|||
155373254|NCT04047862|560798593|FG011|Overall Study|Lost to Follow-up|3|||
155373255|NCT04047862|560798594|FG012|Overall Study|Lost to Follow-up|0|||
155373256|NCT04047862|560798595|FG013|Overall Study|Lost to Follow-up|0|||
155373257|NCT04047862|560798596|FG014|Overall Study|Lost to Follow-up|2|||
155373258|NCT04047862|560798597|FG015|Overall Study|Lost to Follow-up|2|||
155373259|NCT04047862|560798598|FG016|Overall Study|Lost to Follow-up|1|||
155373260|NCT04047862|560798599|FG017|Overall Study|Lost to Follow-up|0|||
155373261|NCT04047862|560798600|FG018|Overall Study|Lost to Follow-up|0|||
155373262|NCT04047862|560798582|FG000|Overall Study|Physician Decision|0|||
155373263|NCT04047862|560798583|FG001|Overall Study|Physician Decision|0|||
155373264|NCT04047862|560798584|FG002|Overall Study|Physician Decision|0|||
155373265|NCT04047862|560798585|FG003|Overall Study|Physician Decision|1|||
155373266|NCT04047862|560798586|FG004|Overall Study|Physician Decision|0|||
155373267|NCT04047862|560798587|FG005|Overall Study|Physician Decision|0|||
155373268|NCT04047862|560798588|FG006|Overall Study|Physician Decision|0|||
155373269|NCT04047862|560798589|FG007|Overall Study|Physician Decision|0|||
155373270|NCT04047862|560798590|FG008|Overall Study|Physician Decision|0|||
155373271|NCT04047862|560798591|FG009|Overall Study|Physician Decision|0|||
155373272|NCT04047862|560798592|FG010|Overall Study|Physician Decision|0|||
155373273|NCT04047862|560798593|FG011|Overall Study|Physician Decision|0|||
155373274|NCT04047862|560798594|FG012|Overall Study|Physician Decision|0|||
155373275|NCT04047862|560798595|FG013|Overall Study|Physician Decision|0|||
155373276|NCT04047862|560798596|FG014|Overall Study|Physician Decision|1|||
155373277|NCT04047862|560798597|FG015|Overall Study|Physician Decision|0|||
155373278|NCT04047862|560798598|FG016|Overall Study|Physician Decision|1|||
155373279|NCT04047862|560798599|FG017|Overall Study|Physician Decision|0|||
155373280|NCT04047862|560798600|FG018|Overall Study|Physician Decision|0|||
155373281|NCT04047862|560798582|FG000|Overall Study|Completed all Assessments|1|||
155373282|NCT04047862|560798583|FG001|Overall Study|Completed all Assessments|3|||
155373283|NCT04047862|560798584|FG002|Overall Study|Completed all Assessments|1|||
155373284|NCT04047862|560798585|FG003|Overall Study|Completed all Assessments|3|||
155373285|NCT04047862|560798586|FG004|Overall Study|Completed all Assessments|2|||
155373286|NCT04047862|560798587|FG005|Overall Study|Completed all Assessments|5|||
155373287|NCT04047862|560798588|FG006|Overall Study|Completed all Assessments|7|||
155373288|NCT04047862|560798589|FG007|Overall Study|Completed all Assessments|0|||
155373289|NCT04047862|560798590|FG008|Overall Study|Completed all Assessments|0|||
155373290|NCT04047862|560798591|FG009|Overall Study|Completed all Assessments|0|||
155373291|NCT04047862|560798592|FG010|Overall Study|Completed all Assessments|0|||
155373292|NCT04047862|560798593|FG011|Overall Study|Completed all Assessments|0|||
155373293|NCT04047862|560798594|FG012|Overall Study|Completed all Assessments|0|||
155373294|NCT04047862|560798595|FG013|Overall Study|Completed all Assessments|0|||
155373295|NCT04047862|560798596|FG014|Overall Study|Completed all Assessments|0|||
155373296|NCT04047862|560798597|FG015|Overall Study|Completed all Assessments|0|||
155373297|NCT04047862|560798598|FG016|Overall Study|Completed all Assessments|0|||
155373298|NCT04047862|560798599|FG017|Overall Study|Completed all Assessments|0|||
155373299|NCT04047862|560798600|FG018|Overall Study|Completed all Assessments|0|||
155373300|NCT04047862|560798582|FG000|Overall Study|Sponsor Decision|0|||
155373301|NCT04047862|560798583|FG001|Overall Study|Sponsor Decision|0|||
155373302|NCT04047862|560798584|FG002|Overall Study|Sponsor Decision|0|||
155373303|NCT04047862|560798585|FG003|Overall Study|Sponsor Decision|0|||
155373304|NCT04047862|560798586|FG004|Overall Study|Sponsor Decision|0|||
155373305|NCT04047862|560798587|FG005|Overall Study|Sponsor Decision|0|||
155373306|NCT04047862|560798588|FG006|Overall Study|Sponsor Decision|0|||
155373307|NCT04047862|560798589|FG007|Overall Study|Sponsor Decision|13|||
155373308|NCT04047862|560798590|FG008|Overall Study|Sponsor Decision|10|||
155373309|NCT04047862|560798591|FG009|Overall Study|Sponsor Decision|18|||
155373310|NCT04047862|560798592|FG010|Overall Study|Sponsor Decision|3|||
155373311|NCT04047862|560798593|FG011|Overall Study|Sponsor Decision|3|||
155373312|NCT04047862|560798594|FG012|Overall Study|Sponsor Decision|4|||
155373313|NCT04047862|560798595|FG013|Overall Study|Sponsor Decision|0|||
155373314|NCT04047862|560798596|FG014|Overall Study|Sponsor Decision|7|||
155373315|NCT04047862|560798597|FG015|Overall Study|Sponsor Decision|8|||
155373316|NCT04047862|560798598|FG016|Overall Study|Sponsor Decision|9|||
155373317|NCT04047862|560798599|FG017|Overall Study|Sponsor Decision|7|||
155373318|NCT04047862|560798600|FG018|Overall Study|Sponsor Decision|8|||
155373319|NCT04047862|560798582|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373320|NCT04047862|560798583|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373321|NCT04047862|560798584|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373322|NCT04047862|560798585|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373323|NCT04047862|560798586|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373324|NCT04047862|560798587|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373325|NCT04047862|560798588|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373326|NCT04047862|560798589|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
155373327|NCT04047862|560798590|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
155373328|NCT04047862|560798591|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373329|NCT04047862|560798592|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
155373330|NCT04047862|560798593|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373331|NCT04047862|560798594|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373332|NCT04047862|560798595|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
155373333|NCT04047862|560798596|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
155373334|NCT04047862|560798597|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
155373335|NCT04047862|560798598|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
155373336|NCT04047862|560798599|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
155373337|NCT04047862|560798600|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
155373338|NCT04047862|560798582|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373339|NCT04047862|560798583|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373340|NCT04047862|560798584|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373341|NCT04047862|560798585|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373342|NCT04047862|560798586|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373343|NCT04047862|560798587|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373344|NCT04047862|560798588|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373345|NCT04047862|560798589|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373346|NCT04047862|560798590|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373347|NCT04047862|560798591|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373348|NCT04047862|560798592|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373349|NCT04047862|560798593|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373350|NCT04047862|560798594|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373351|NCT04047862|560798595|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373352|NCT04047862|560798596|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373353|NCT04047862|560798597|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
155373354|NCT04047862|560798598|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373355|NCT04047862|560798599|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
155373356|NCT04047862|560798600|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
155373357|NCT04047862|560798582|FG000|Overall Study|Other|0|||
155373358|NCT04047862|560798583|FG001|Overall Study|Other|0|||
155373359|NCT04047862|560798584|FG002|Overall Study|Other|0|||
155373360|NCT04047862|560798585|FG003|Overall Study|Other|0|||
155373361|NCT04047862|560798586|FG004|Overall Study|Other|0|||
155373362|NCT04047862|560798587|FG005|Overall Study|Other|0|||
155373363|NCT04047862|560798588|FG006|Overall Study|Other|0|||
155373364|NCT04047862|560798589|FG007|Overall Study|Other|0|||
155373365|NCT04047862|560798590|FG008|Overall Study|Other|0|||
155373366|NCT04047862|560798591|FG009|Overall Study|Other|0|||
155373367|NCT04047862|560798592|FG010|Overall Study|Other|0|||
155373368|NCT04047862|560798593|FG011|Overall Study|Other|0|||
155373369|NCT04047862|560798594|FG012|Overall Study|Other|0|||
155373370|NCT04047862|560798595|FG013|Overall Study|Other|0|||
155373371|NCT04047862|560798596|FG014|Overall Study|Other|2|||
155373372|NCT04047862|560798597|FG015|Overall Study|Other|1|||
155373373|NCT04047862|560798598|FG016|Overall Study|Other|1|||
155373374|NCT04047862|560798599|FG017|Overall Study|Other|1|||
155373375|NCT04047862|560798600|FG018|Overall Study|Other|0|||
155373376|NCT03820947|560798603|FG000|Overall Study|Physician Decision|0|||
155373377|NCT03820947|560798604|FG001|Overall Study|Physician Decision|1|||
155373378|NCT03820947|560798605|FG002|Overall Study|Physician Decision|1|||
155373379|NCT03820947|560798606|FG003|Overall Study|Physician Decision|0|||
155373380|NCT03820947|560798607|FG004|Overall Study|Physician Decision|3|||
155373381|NCT03820947|560798603|FG000|Overall Study|Withdrawal by Subject|6|||
155373382|NCT03820947|560798604|FG001|Overall Study|Withdrawal by Subject|10|||
155373383|NCT03820947|560798605|FG002|Overall Study|Withdrawal by Subject|3|||
155373384|NCT03820947|560798606|FG003|Overall Study|Withdrawal by Subject|8|||
155373385|NCT03820947|560798607|FG004|Overall Study|Withdrawal by Subject|5|||
155373386|NCT03820947|560798603|FG000|Overall Study|Procedure Not Attempted|0|||
155373387|NCT03820947|560798604|FG001|Overall Study|Procedure Not Attempted|2|||
155373388|NCT03820947|560798605|FG002|Overall Study|Procedure Not Attempted|1|||
155373389|NCT03820947|560798606|FG003|Overall Study|Procedure Not Attempted|0|||
155373390|NCT03820947|560798607|FG004|Overall Study|Procedure Not Attempted|0|||
155373391|NCT03820947|560798603|FG000|Overall Study|Other Exit|1|||
155373392|NCT03820947|560798604|FG001|Overall Study|Other Exit|3|||
155373393|NCT03820947|560798605|FG002|Overall Study|Other Exit|3|||
155373394|NCT03820947|560798606|FG003|Overall Study|Other Exit|3|||
155373395|NCT03820947|560798607|FG004|Overall Study|Other Exit|0|||
155373396|NCT03820947|560798603|FG000|Overall Study|Follow-up Not Done|10|||
155373397|NCT03820947|560798604|FG001|Overall Study|Follow-up Not Done|13|||
155373398|NCT03820947|560798605|FG002|Overall Study|Follow-up Not Done|2|||
155373399|NCT03820947|560798606|FG003|Overall Study|Follow-up Not Done|3|||
155373400|NCT03820947|560798607|FG004|Overall Study|Follow-up Not Done|12|||
155373401|NCT03820947|560798603|FG000|Overall Study|Death|0|||
155373402|NCT03820947|560798604|FG001|Overall Study|Death|0|||
155373403|NCT03820947|560798605|FG002|Overall Study|Death|0|||
155373404|NCT03820947|560798606|FG003|Overall Study|Death|0|||
155373405|NCT03820947|560798607|FG004|Overall Study|Death|9|||
155373406|NCT03820947|560798603|FG000|Overall Study|Lost to Follow-up|4|||
155373407|NCT03820947|560798604|FG001|Overall Study|Lost to Follow-up|6|||
155373408|NCT03820947|560798605|FG002|Overall Study|Lost to Follow-up|0|||
155373409|NCT03820947|560798606|FG003|Overall Study|Lost to Follow-up|0|||
155373410|NCT03820947|560798607|FG004|Overall Study|Lost to Follow-up|9|||
155373411|NCT01732822|560800099|FG000|Overall Study|Withdrawal by Subject|123|||
155168950|NCT00324961|560057243|FG000|Overall Study|Protocol Violation|3|||
155168951|NCT00324961|560057243|FG000|Overall Study|Other|2|||
155168952|NCT00344487|560057244|FG000|Overall Study|immunologic failure|1|||
155168953|NCT01703754|560057247|FG000|Overall Study|Clinically significant disease progression|2|||
155168954|NCT01703754|560057248|FG001|Overall Study|Clinically significant disease progression|2|||
155168955|NCT01703754|560057249|FG002|Overall Study|Clinically significant disease progression|1|||
155168956|NCT01703754|560057247|FG000|Overall Study|Adverse Event|1|||
155168957|NCT01703754|560057248|FG001|Overall Study|Adverse Event|1|||
155168958|NCT01703754|560057249|FG002|Overall Study|Adverse Event|0|||
155168959|NCT01703754|560057247|FG000|Overall Study|Withdrawal by Subject|2|||
155168960|NCT01703754|560057248|FG001|Overall Study|Withdrawal by Subject|0|||
155168961|NCT01703754|560057249|FG002|Overall Study|Withdrawal by Subject|0|||
155168962|NCT01459497|560057253|FG000|Overall Study|Inability to meet trial constraints.|1|||
155168963|NCT01459497|560057254|FG001|Overall Study|Inability to meet trial constraints.|0|||
155168964|NCT01459497|560057253|FG000|Overall Study|Physician Decision|1|||
155168965|NCT01459497|560057254|FG001|Overall Study|Physician Decision|1|||
155168966|NCT01459497|560057253|FG000|Overall Study|Hospitalization.|0|||
155168967|NCT01459497|560057254|FG001|Overall Study|Hospitalization.|3|||
155168968|NCT01459497|560057253|FG000|Overall Study|Disease progression.|0|||
155168969|NCT01459497|560057254|FG001|Overall Study|Disease progression.|1|||
155168970|NCT03530124|560057255|FG000|Overall Study|Withdrawal by Subject|0|||
155168971|NCT03530124|560057256|FG001|Overall Study|Withdrawal by Subject|1|||
155168972|NCT03530124|560057255|FG000|Overall Study|Protocol Violation|1|||
155168973|NCT03530124|560057256|FG001|Overall Study|Protocol Violation|0|||
155168974|NCT03530124|560057255|FG000|Overall Study|Discharged prior to study completion|1|||
155168975|NCT03530124|560057256|FG001|Overall Study|Discharged prior to study completion|0|||
155168976|NCT05188053|560057257|FG000|Overall Study|Lost to Follow-up|23|||
155168977|NCT05188053|560057258|FG001|Overall Study|Lost to Follow-up|30|||
155168978|NCT05188053|560057257|FG000|Overall Study|Protocol Violation|16|||
155168979|NCT05188053|560057258|FG001|Overall Study|Protocol Violation|16|||
155168980|NCT05188053|560057257|FG000|Overall Study|Physician Decision|3|||
155168981|NCT05188053|560057258|FG001|Overall Study|Physician Decision|0|||
155168982|NCT05188053|560057257|FG000|Overall Study|Withdrawal by Subject|0|||
155168983|NCT05188053|560057258|FG001|Overall Study|Withdrawal by Subject|1|||
155168984|NCT02379637|560057262|FG000|Overall Study|Protocol Violation|0|||
155168985|NCT02379637|560057263|FG001|Overall Study|Protocol Violation|1|||
155168986|NCT02379637|560057262|FG000|Overall Study|Adverse Event|1|||
155168987|NCT02379637|560057263|FG001|Overall Study|Adverse Event|0|||
155168988|NCT02379637|560057262|FG000|Overall Study|Withdrawal by Subject|1|||
155168989|NCT02379637|560057263|FG001|Overall Study|Withdrawal by Subject|0|||
155168990|NCT01561313|560057272|FG000|Overall Study|Withdrawal by Subject|1|||
155168991|NCT01561313|560057273|FG001|Overall Study|Withdrawal by Subject|0|||
155168992|NCT01561313|560057272|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
155168993|NCT01561313|560057273|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
155168994|NCT04535453|560057274|FG000|Overall Study|Death|0|||
155168995|NCT04535453|560057275|FG001|Overall Study|Death|1|||
155168996|NCT04535453|560057276|FG002|Overall Study|Death|0|||
155168997|NCT04535453|560057277|FG003|Overall Study|Death|0|||
155168998|NCT04535453|560057278|FG004|Overall Study|Death|0|||
155168999|NCT04535453|560057279|FG005|Overall Study|Death|0|||
155169000|NCT04535453|560057280|FG006|Overall Study|Death|0|||
155169001|NCT04535453|560057281|FG007|Overall Study|Death|0|||
155169002|NCT04535453|560057282|FG008|Overall Study|Death|0|||
155169003|NCT04535453|560057283|FG009|Overall Study|Death|0|||
155169004|NCT04535453|560057284|FG010|Overall Study|Death|0|||
155169005|NCT04535453|560057285|FG011|Overall Study|Death|0|||
155169006|NCT04535453|560057274|FG000|Overall Study|Lost to Follow-up|1|||
155169007|NCT04535453|560057275|FG001|Overall Study|Lost to Follow-up|1|||
155373412|NCT01732822|560800100|FG001|Overall Study|Withdrawal by Subject|113|||
155373413|NCT01077271|560800101|FG000|Overall Study|Parental desire|8|||
155373414|NCT01077271|560800101|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
155373415|NCT01077271|560800101|FG000|Overall Study|Noncompliance|2|||
155169008|NCT04535453|560057276|FG002|Overall Study|Lost to Follow-up|1|||
155169009|NCT04535453|560057277|FG003|Overall Study|Lost to Follow-up|0|||
155169010|NCT04535453|560057278|FG004|Overall Study|Lost to Follow-up|3|||
155169011|NCT04535453|560057279|FG005|Overall Study|Lost to Follow-up|1|||
155169012|NCT04535453|560057280|FG006|Overall Study|Lost to Follow-up|0|||
155373416|NCT01077271|560800101|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
155169013|NCT04535453|560057281|FG007|Overall Study|Lost to Follow-up|0|||
155373417|NCT01077271|560800101|FG000|Overall Study|Changed doctors|2|||
155373418|NCT01077271|560800101|FG000|Overall Study|Parents thought too many injections|2|||
155373419|NCT01077271|560800101|FG000|Overall Study|End of RSV season nearly reached|1|||
155373420|NCT01077271|560800101|FG000|Overall Study|Mother unconvinced of the necessity|1|||
155373421|NCT00215137|560800102|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
155373422|NCT00215137|560800103|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
155373423|NCT00215137|560800104|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
155373424|NCT00215137|560800102|FG000|Randomization Period|Lost to Follow-up|0|||
155373425|NCT00215137|560800103|FG001|Randomization Period|Lost to Follow-up|1|||
155373426|NCT00215137|560800104|FG002|Randomization Period|Lost to Follow-up|0|||
155373427|NCT00215137|560800102|FG000|Randomization Period|Withdrawal by Subject|0|||
155373428|NCT00215137|560800103|FG001|Randomization Period|Withdrawal by Subject|1|||
155373429|NCT00215137|560800104|FG002|Randomization Period|Withdrawal by Subject|0|||
155373430|NCT04684394|560800105|FG000|Overall Study|Death|1|||
155373431|NCT04684394|560800106|FG001|Overall Study|Death|2|||
155373432|NCT04684394|560800105|FG000|Overall Study|Lost to Follow-up|1|||
155373433|NCT04684394|560800106|FG001|Overall Study|Lost to Follow-up|0|||
155373434|NCT04684394|560800105|FG000|Overall Study|Withdrawal by Subject|2|||
155373435|NCT04684394|560800106|FG001|Overall Study|Withdrawal by Subject|0|||
155373436|NCT04684394|560800105|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
155373437|NCT04684394|560800106|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
155373438|NCT00591370|560800109|FG000|Overall Study|Not Treated|2|||
155373439|NCT00640133|560800110|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
155373440|NCT00640133|560800111|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
155373441|NCT00640133|560800110|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
155373442|NCT00640133|560800111|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
155373443|NCT00640133|560800110|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
155373444|NCT00640133|560800111|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
155373445|NCT01183260|560800112|FG000|Overall Study|Intraop screen failure|2|||
155373446|NCT01183260|560800113|FG001|Overall Study|Intraop screen failure|0|||
155373447|NCT01183260|560800112|FG000|Overall Study|Withdrawal by Subject|1|||
155373448|NCT01183260|560800113|FG001|Overall Study|Withdrawal by Subject|1|||
155373449|NCT01183260|560800112|FG000|Overall Study|Revised within 30 days|0|||
155373450|NCT01183260|560800113|FG001|Overall Study|Revised within 30 days|1|||
155373451|NCT01183260|560800112|FG000|Overall Study|Death|1|||
155373452|NCT01183260|560800113|FG001|Overall Study|Death|0|||
155373453|NCT01202903|560800115|FG000|Overall Study|Administrative Probelms|1|||
155373454|NCT01202903|560800116|FG001|Overall Study|Administrative Probelms|4|||
155373455|NCT01202903|560800115|FG000|Overall Study|Protocol Violation|0|||
155373456|NCT01202903|560800116|FG001|Overall Study|Protocol Violation|1|||
155373457|NCT01202903|560800115|FG000|Overall Study|Death|1|||
155373458|NCT01202903|560800116|FG001|Overall Study|Death|0|||
155373459|NCT01202903|560800115|FG000|Overall Study|Lost to Follow-up|1|||
155373460|NCT01202903|560800116|FG001|Overall Study|Lost to Follow-up|1|||
155373461|NCT01202903|560800115|FG000|Overall Study|Lack of Efficacy|1|||
155373462|NCT01202903|560800116|FG001|Overall Study|Lack of Efficacy|3|||
155373463|NCT01202903|560800115|FG000|Overall Study|Adverse Event|3|||
155373464|NCT01202903|560800116|FG001|Overall Study|Adverse Event|3|||
155373465|NCT01202903|560800115|FG000|Overall Study|Withdrawal by Subject|4|||
155373466|NCT01202903|560800116|FG001|Overall Study|Withdrawal by Subject|4|||
155373467|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
155373468|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
155373469|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
155373470|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
155373471|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Death|1|||
155373472|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Death|0|||
155373473|NCT00095056|560800117|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
155373474|NCT00095056|560800118|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
154965705|NCT00112437|559298879|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
155373475|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
155373476|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
155373477|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
155373478|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
155373479|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
155373480|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
155373481|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
155373482|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
154965706|NCT00112437|559298880|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
155373483|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Death|3|||
155373484|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Death|1|||
155373485|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
155373486|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
155373487|NCT00095056|560800117|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
155373488|NCT00095056|560800118|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
155373489|NCT00306670|560800119|FG000|Overall Study|patients recruited; Genentech, the st|0|||
155373490|NCT00306670|560800120|FG001|Overall Study|patients recruited; Genentech, the st|2|||
155373491|NCT02735577|560800124|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
155373492|NCT02735577|560800124|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
155373493|NCT02898077|560800129|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
155373494|NCT02898077|560800130|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
155373495|NCT02898077|560800129|FG000|Overall Study|Lost to Follow-up|4|||
155373496|NCT02898077|560800130|FG001|Overall Study|Lost to Follow-up|3|||
155373497|NCT02898077|560800129|FG000|Overall Study|Physician Decision|0|||
155373498|NCT02898077|560800130|FG001|Overall Study|Physician Decision|2|||
155373499|NCT02898077|560800129|FG000|Overall Study|Sponsor Decision|32|||
155373500|NCT02898077|560800130|FG001|Overall Study|Sponsor Decision|13|||
155373501|NCT02898077|560800129|FG000|Overall Study|Withdrawal by Subject|6|||
155373502|NCT02898077|560800130|FG001|Overall Study|Withdrawal by Subject|3|||
155373503|NCT02898077|560800129|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
155373504|NCT02898077|560800130|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
155373505|NCT02898077|560800129|FG000|Overall Study|Ended extension period|3|||
155373506|NCT02898077|560800130|FG001|Overall Study|Ended extension period|0|||
155373507|NCT03896152|560800137|FG000|Overall Study|Patient/guardian decision|1|||
155373508|NCT03896152|560800138|FG001|Overall Study|Patient/guardian decision|1|||
155373509|NCT03896152|560800137|FG000|Overall Study|Adverse Event|0|||
155373510|NCT03896152|560800138|FG001|Overall Study|Adverse Event|1|||
155373511|NCT03896152|560800137|FG000|Overall Study|Physician Decision|1|||
155373512|NCT03896152|560800138|FG001|Overall Study|Physician Decision|0|||
155373513|NCT03896152|560800137|FG000|Overall Study|Technical problems|1|||
155373514|NCT03896152|560800138|FG001|Overall Study|Technical problems|0|||
155373515|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
155373516|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
155373517|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
155373518|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
155373519|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
155373520|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
155373521|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
155373522|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
155373523|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
155373524|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
155373525|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
155373526|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
155373527|NCT04939701|560800139|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
155373528|NCT04939701|560800140|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
155373529|NCT04939701|560800141|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
155373530|NCT04939701|560800139|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
155373531|NCT04939701|560800140|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
155373532|NCT04939701|560800141|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
155373533|NCT04939701|560800139|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
155373534|NCT04939701|560800140|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
155373535|NCT04939701|560800141|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
155373536|NCT01353859|560800144|FG000|Overall Study|Adverse Event|3|||
155373537|NCT01353859|560800144|FG000|Overall Study|Lack of Efficacy|1|||
155373538|NCT01656200|560800145|FG000|Overall Study|Withdrawal by Subject|1|||
155373539|NCT02236988|560800146|FG000|Overall Study|Lost to Follow-up|0|||
155373540|NCT02236988|560800147|FG001|Overall Study|Lost to Follow-up|0|||
155373541|NCT02236988|560800148|FG002|Overall Study|Lost to Follow-up|0|||
155373542|NCT02236988|560800149|FG003|Overall Study|Lost to Follow-up|1|||
155373543|NCT02236988|560800146|FG000|Overall Study|Unable to Comply with Study Visits|0|||
155373544|NCT02236988|560800147|FG001|Overall Study|Unable to Comply with Study Visits|0|||
155373545|NCT02236988|560800148|FG002|Overall Study|Unable to Comply with Study Visits|0|||
155373546|NCT02236988|560800149|FG003|Overall Study|Unable to Comply with Study Visits|2|||
155091074|NCT00560508|559767472|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
155373547|NCT05775991|560800152|FG000|Overall Study|Withdrawal by Subject|0|||
155373548|NCT05775991|560800153|FG001|Overall Study|Withdrawal by Subject|0|||
155373549|NCT05775991|560800154|FG002|Overall Study|Withdrawal by Subject|2|||
155373550|NCT01461811|560800157|FG000|Overall Study|Adverse Event|2|||
155373551|NCT01461811|560800158|FG001|Overall Study|Adverse Event|1|||
155373552|NCT01461811|560800157|FG000|Overall Study|Subject decision unrelated to an AE|1|||
155373553|NCT01461811|560800158|FG001|Overall Study|Subject decision unrelated to an AE|1|||
155373554|NCT01461811|560800157|FG000|Overall Study|Noncompliance|1|||
155373555|NCT01461811|560800158|FG001|Overall Study|Noncompliance|1|||
155373556|NCT01072630|560800159|FG000|Overall Study|Adverse Event|11|||
155373557|NCT01072630|560800160|FG001|Overall Study|Adverse Event|19|||
155373558|NCT01072630|560800161|FG002|Overall Study|Adverse Event|2|||
155373559|NCT01072630|560800159|FG000|Overall Study|Lack of Efficacy|10|||
155373560|NCT01072630|560800160|FG001|Overall Study|Lack of Efficacy|10|||
155373561|NCT01072630|560800161|FG002|Overall Study|Lack of Efficacy|1|||
155373562|NCT01072630|560800159|FG000|Overall Study|Withdrawal by Subject|8|||
155373563|NCT01072630|560800160|FG001|Overall Study|Withdrawal by Subject|7|||
155373564|NCT01072630|560800161|FG002|Overall Study|Withdrawal by Subject|2|||
155373565|NCT01072630|560800159|FG000|Overall Study|Protocol Violation|10|||
155373566|NCT01072630|560800160|FG001|Overall Study|Protocol Violation|8|||
155373567|NCT01072630|560800161|FG002|Overall Study|Protocol Violation|4|||
155373568|NCT01072630|560800159|FG000|Overall Study|Lost to Follow-up|11|||
155373569|NCT01072630|560800160|FG001|Overall Study|Lost to Follow-up|11|||
155373570|NCT01072630|560800161|FG002|Overall Study|Lost to Follow-up|1|||
155373571|NCT01072630|560800159|FG000|Overall Study|Noncompliance with study medication|1|||
155373572|NCT01072630|560800160|FG001|Overall Study|Noncompliance with study medication|1|||
155373573|NCT01072630|560800161|FG002|Overall Study|Noncompliance with study medication|1|||
155373574|NCT01072630|560800159|FG000|Overall Study|Noncompliance with study procedures|1|||
155373575|NCT01072630|560800160|FG001|Overall Study|Noncompliance with study procedures|2|||
155373576|NCT01072630|560800161|FG002|Overall Study|Noncompliance with study procedures|1|||
155373577|NCT01072630|560800159|FG000|Overall Study|Other|3|||
155373578|NCT01072630|560800160|FG001|Overall Study|Other|2|||
155373579|NCT01072630|560800161|FG002|Overall Study|Other|1|||
155373580|NCT03046121|560800162|FG000|Overall Study|Death|32|||
155373581|NCT03046121|560800163|FG001|Overall Study|Death|60|||
155373582|NCT03046121|560800162|FG000|Overall Study|Withdrawal by Subject|14|||
155373583|NCT03046121|560800163|FG001|Overall Study|Withdrawal by Subject|12|||
155373584|NCT04155047|560800164|FG000|Overall Study|Adverse Event|1|||
155373585|NCT04155047|560800165|FG001|Overall Study|Adverse Event|0|||
155373586|NCT04155047|560800164|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
155373587|NCT04155047|560800165|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
155373588|NCT04514510|560800166|FG000|Overall Study|Lost to Follow-up|0|||
155373589|NCT04514510|560800167|FG001|Overall Study|Lost to Follow-up|1|||
155373590|NCT04514510|560800166|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
155373591|NCT04514510|560800167|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
155373592|NCT02781090|560800168|FG000|3-Month Follow-Up|Missed Visit|20|||
155373593|NCT02781090|560800169|FG001|3-Month Follow-Up|Missed Visit|20|||
155373594|NCT02781090|560800168|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
155373595|NCT02781090|560800169|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
155373596|NCT02781090|560800168|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
155373597|NCT02781090|560800169|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
155373598|NCT02781090|560800168|FG000|3-Month Follow-Up|Death|1|||
155373599|NCT02781090|560800169|FG001|3-Month Follow-Up|Death|0|||
155373600|NCT02781090|560800168|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
155373601|NCT02781090|560800169|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
155373602|NCT02781090|560800168|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
155373603|NCT02781090|560800169|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
155373604|NCT02781090|560800168|FG000|6-Month Follow-Up|Death|0|||
155091075|NCT00560508|559767471|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
155373605|NCT02781090|560800169|FG001|6-Month Follow-Up|Death|1|||
155373606|NCT00643617|560800170|FG000|Overall Study|Death|6|||
155373607|NCT00643617|560800171|FG001|Overall Study|Death|9|||
155373608|NCT00643617|560800170|FG000|Overall Study|Lost to Follow-up|42|||
155373609|NCT00643617|560800171|FG001|Overall Study|Lost to Follow-up|51|||
155373610|NCT01208103|560800172|FG000|Overall Study|Adverse Event|1|||
155091076|NCT00560508|559767472|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
155373611|NCT01208103|560800172|FG000|Overall Study|Withdrawal by Subject|1|||
155373612|NCT00416195|560800175|FG000|Overall Study|Adverse Event|1|||
155373613|NCT00416195|560800176|FG001|Overall Study|Adverse Event|2|||
155373614|NCT00416195|560800175|FG000|Overall Study|Protocol Violation|1|||
154965707|NCT00112437|559298881|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965708|NCT00112437|559298882|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
155373615|NCT00416195|560800176|FG001|Overall Study|Protocol Violation|1|||
155373616|NCT00416195|560800175|FG000|Overall Study|Other|0|||
155373617|NCT00416195|560800176|FG001|Overall Study|Other|1|||
155373618|NCT01606670|560800183|FG000|Overall Study|Adverse Event|6|||
155373619|NCT01606670|560800183|FG000|Overall Study|Lack of Efficacy|2|||
155373620|NCT01606670|560800183|FG000|Overall Study|Lost to Follow-up|3|||
155373621|NCT01606670|560800183|FG000|Overall Study|Withdrawal by Subject|3|||
155373622|NCT01606670|560800183|FG000|Overall Study|Other Reason|2|||
155373623|NCT03653208|560800186|FG000|Overall Study|Withdrawal by Subject|0|||
155373624|NCT03653208|560800187|FG001|Overall Study|Withdrawal by Subject|0|||
155373625|NCT03653208|560800188|FG002|Overall Study|Withdrawal by Subject|0|||
155373626|NCT03653208|560800189|FG003|Overall Study|Withdrawal by Subject|0|||
155373627|NCT03653208|560800190|FG004|Overall Study|Withdrawal by Subject|1|||
155373628|NCT03653208|560800191|FG005|Overall Study|Withdrawal by Subject|0|||
155373629|NCT03653208|560800192|FG006|Overall Study|Withdrawal by Subject|0|||
155373630|NCT03653208|560800193|FG007|Overall Study|Withdrawal by Subject|1|||
155373631|NCT03653208|560800194|FG008|Overall Study|Withdrawal by Subject|1|||
155373632|NCT00368927|560800195|FG000|Overall Study|Lost to Follow-up|2|||
155373633|NCT00368927|560800196|FG001|Overall Study|Lost to Follow-up|0|||
155373634|NCT00368927|560800195|FG000|Overall Study|Adverse Event|1|||
155373635|NCT00368927|560800196|FG001|Overall Study|Adverse Event|1|||
155373636|NCT00368927|560800195|FG000|Overall Study|Withdrawal by Subject|1|||
155373637|NCT00368927|560800196|FG001|Overall Study|Withdrawal by Subject|2|||
155373638|NCT00368927|560800195|FG000|Overall Study|Physician Decision|1|||
155373639|NCT00368927|560800196|FG001|Overall Study|Physician Decision|0|||
155373640|NCT01877239|560800197|FG000|Overall Study|Adverse Event|4|||
155373641|NCT01877239|560800197|FG000|Overall Study|Disease Remission|1|||
155373642|NCT01877239|560800197|FG000|Overall Study|Withdrawal by Subject|4|||
155373643|NCT01877239|560800197|FG000|Overall Study|Other|2|||
155373644|NCT01877239|560800197|FG000|Overall Study|Lack of Efficacy|4|||
155373645|NCT01877239|560800197|FG000|Overall Study|Data not available|35|||
155373646|NCT01989169|560800201|FG000|Period 2|Adverse Event|0|||
155373647|NCT01989169|560800202|FG001|Period 2|Adverse Event|1|||
155373648|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
155373649|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
155373650|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
155373651|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
155373652|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
155373653|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
155373654|NCT01114880|560800203|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
155373655|NCT01114880|560800204|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
155373656|NCT01114880|560800203|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
155373657|NCT01114880|560800204|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
155373658|NCT01114880|560800203|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
155373659|NCT01114880|560800204|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
155373660|NCT00283244|560800206|FG000|Overall Study|Adverse Event|0|||
155373661|NCT00283244|560800207|FG001|Overall Study|Adverse Event|8|||
155373662|NCT00283244|560800208|FG002|Overall Study|Adverse Event|11|||
155373663|NCT00283244|560800206|FG000|Overall Study|Death|4|||
155373664|NCT00283244|560800207|FG001|Overall Study|Death|3|||
155373665|NCT00283244|560800208|FG002|Overall Study|Death|2|||
155373666|NCT00283244|560800206|FG000|Overall Study|Lack of Efficacy|8|||
155373667|NCT00283244|560800207|FG001|Overall Study|Lack of Efficacy|32|||
155373668|NCT00283244|560800208|FG002|Overall Study|Lack of Efficacy|26|||
155373669|NCT00283244|560800206|FG000|Overall Study|Withdrawal by Subject|1|||
155373670|NCT00283244|560800207|FG001|Overall Study|Withdrawal by Subject|2|||
155373671|NCT00283244|560800208|FG002|Overall Study|Withdrawal by Subject|2|||
155373672|NCT00283244|560800206|FG000|Overall Study|Physician Decision|0|||
155373673|NCT00283244|560800207|FG001|Overall Study|Physician Decision|0|||
155373674|NCT00283244|560800208|FG002|Overall Study|Physician Decision|1|||
155373675|NCT00283244|560800206|FG000|Overall Study|Medical illness (other complicating dz)|4|||
155373676|NCT00283244|560800207|FG001|Overall Study|Medical illness (other complicating dz)|3|||
155373677|NCT00283244|560800208|FG002|Overall Study|Medical illness (other complicating dz)|6|||
155373678|NCT00283244|560800206|FG000|Overall Study|Clinical deterioration|1|||
155373679|NCT00283244|560800207|FG001|Overall Study|Clinical deterioration|3|||
155373680|NCT00283244|560800208|FG002|Overall Study|Clinical deterioration|3|||
155373681|NCT01585155|560800209|FG000|Overall Study|Adverse Event|1|||
155373682|NCT01585155|560800209|FG000|Overall Study|Lack of Efficacy|2|||
155373683|NCT01585155|560800209|FG000|Overall Study|Worsening ulcerative colitis|2|||
155373684|NCT02235311|560800210|FG000|Overall Study|Lost to Follow-up|0|||
154965709|NCT00112437|559298883|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
155373685|NCT02235311|560800211|FG001|Overall Study|Lost to Follow-up|1|||
155373686|NCT02235311|560800210|FG000|Overall Study|Protocol Violation|0|||
155373687|NCT02235311|560800211|FG001|Overall Study|Protocol Violation|1|||
154965710|NCT00112437|559298884|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965711|NCT00112437|559298885|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965712|NCT00112437|559298886|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965713|NCT00112437|559298887|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
154965714|NCT00112437|559298862|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965715|NCT00112437|559298863|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155373688|NCT00658788|560800212|FG000|Overall Study|Adverse Event|11|||
155373689|NCT00658788|560800212|FG000|Overall Study|Withdrawal by Subject|13|||
155373690|NCT00658788|560800212|FG000|Overall Study|Lost to Follow-up|18|||
155373691|NCT00658788|560800212|FG000|Overall Study|Treatment Discontinuation|32|||
155373692|NCT03898167|560800213|FG000|Overall Study|Terminated phone call early|7|||
155373693|NCT03898167|560800214|FG001|Overall Study|Terminated phone call early|0|||
155373694|NCT03898167|560800215|FG002|Overall Study|Terminated phone call early|0|||
155373695|NCT03898167|560800213|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
155373696|NCT03898167|560800214|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
155373697|NCT03898167|560800215|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
155373698|NCT00091169|560801842|FG000|Overall Study|Disease progression|3|||
155373699|NCT00091169|560801843|FG001|Overall Study|Disease progression|1|||
155373700|NCT00091169|560801842|FG000|Overall Study|Adverse Event|11|||
155373701|NCT00091169|560801843|FG001|Overall Study|Adverse Event|17|||
155373702|NCT00091169|560801842|FG000|Overall Study|Death|4|||
155373703|NCT00091169|560801843|FG001|Overall Study|Death|1|||
155373704|NCT00091169|560801842|FG000|Overall Study|Withdrawal by Subject|10|||
155373705|NCT00091169|560801843|FG001|Overall Study|Withdrawal by Subject|13|||
154965716|NCT00112437|559298864|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155373706|NCT00091169|560801842|FG000|Overall Study|Other|3|||
155373707|NCT00091169|560801843|FG001|Overall Study|Other|4|||
155373708|NCT00091169|560801842|FG000|Overall Study|Not start protocol therapy|26|||
155373709|NCT00091169|560801843|FG001|Overall Study|Not start protocol therapy|17|||
155373710|NCT04410523|560801844|FG000|Overall Study|Study terminated by sponsor|1|||
155373711|NCT04410523|560801845|FG001|Overall Study|Study terminated by sponsor|3|||
155373712|NCT04410523|560801846|FG002|Overall Study|Study terminated by sponsor|2|||
155373713|NCT04410523|560801847|FG003|Overall Study|Study terminated by sponsor|6|||
155373714|NCT04410523|560801848|FG004|Overall Study|Study terminated by sponsor|3|||
155373715|NCT04410523|560801849|FG005|Overall Study|Study terminated by sponsor|4|||
155373716|NCT04410523|560801844|FG000|Overall Study|Adverse Event|1|||
155373717|NCT04410523|560801845|FG001|Overall Study|Adverse Event|0|||
155373718|NCT04410523|560801846|FG002|Overall Study|Adverse Event|0|||
155373719|NCT04410523|560801847|FG003|Overall Study|Adverse Event|0|||
155373720|NCT04410523|560801848|FG004|Overall Study|Adverse Event|0|||
155373721|NCT04410523|560801849|FG005|Overall Study|Adverse Event|2|||
154965717|NCT00112437|559298865|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965718|NCT00112437|559298866|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155169014|NCT04535453|560057282|FG008|Overall Study|Lost to Follow-up|1|||
155169015|NCT04535453|560057283|FG009|Overall Study|Lost to Follow-up|1|||
155169016|NCT04535453|560057284|FG010|Overall Study|Lost to Follow-up|0|||
155169017|NCT04535453|560057285|FG011|Overall Study|Lost to Follow-up|0|||
155169018|NCT04535453|560057274|FG000|Overall Study|Physician Decision|0|||
155169019|NCT04535453|560057275|FG001|Overall Study|Physician Decision|0|||
155169020|NCT04535453|560057276|FG002|Overall Study|Physician Decision|0|||
155169021|NCT04535453|560057277|FG003|Overall Study|Physician Decision|1|||
155169022|NCT04535453|560057278|FG004|Overall Study|Physician Decision|0|||
155169023|NCT04535453|560057279|FG005|Overall Study|Physician Decision|0|||
155169024|NCT04535453|560057280|FG006|Overall Study|Physician Decision|0|||
155169025|NCT04535453|560057281|FG007|Overall Study|Physician Decision|0|||
155169026|NCT04535453|560057282|FG008|Overall Study|Physician Decision|0|||
155169027|NCT04535453|560057283|FG009|Overall Study|Physician Decision|0|||
155169028|NCT04535453|560057284|FG010|Overall Study|Physician Decision|0|||
155169029|NCT04535453|560057285|FG011|Overall Study|Physician Decision|0|||
155169030|NCT04535453|560057274|FG000|Overall Study|Withdrawal by Subject|3|||
155169031|NCT04535453|560057275|FG001|Overall Study|Withdrawal by Subject|6|||
155169032|NCT04535453|560057276|FG002|Overall Study|Withdrawal by Subject|3|||
155169033|NCT04535453|560057277|FG003|Overall Study|Withdrawal by Subject|3|||
155169034|NCT04535453|560057278|FG004|Overall Study|Withdrawal by Subject|2|||
155169035|NCT04535453|560057279|FG005|Overall Study|Withdrawal by Subject|1|||
155169036|NCT04535453|560057280|FG006|Overall Study|Withdrawal by Subject|1|||
155373722|NCT04410523|560801844|FG000|Overall Study|Lost to Follow-up|0|||
155373723|NCT04410523|560801845|FG001|Overall Study|Lost to Follow-up|1|||
155373724|NCT04410523|560801846|FG002|Overall Study|Lost to Follow-up|0|||
155373725|NCT04410523|560801847|FG003|Overall Study|Lost to Follow-up|0|||
155373726|NCT04410523|560801848|FG004|Overall Study|Lost to Follow-up|0|||
155373727|NCT04410523|560801849|FG005|Overall Study|Lost to Follow-up|0|||
155373728|NCT04410523|560801844|FG000|Overall Study|Physician Decision|0|||
155373729|NCT04410523|560801845|FG001|Overall Study|Physician Decision|1|||
155373730|NCT04410523|560801846|FG002|Overall Study|Physician Decision|0|||
155373731|NCT04410523|560801847|FG003|Overall Study|Physician Decision|0|||
155373732|NCT04410523|560801848|FG004|Overall Study|Physician Decision|0|||
155373733|NCT04410523|560801849|FG005|Overall Study|Physician Decision|0|||
155373734|NCT04410523|560801844|FG000|Overall Study|Pregnancy|0|||
155373735|NCT04410523|560801845|FG001|Overall Study|Pregnancy|0|||
155373736|NCT04410523|560801846|FG002|Overall Study|Pregnancy|0|||
155373737|NCT04410523|560801847|FG003|Overall Study|Pregnancy|0|||
155373738|NCT04410523|560801848|FG004|Overall Study|Pregnancy|0|||
155373739|NCT04410523|560801849|FG005|Overall Study|Pregnancy|1|||
155373740|NCT04410523|560801844|FG000|Overall Study|Protocol deviation|0|||
155373741|NCT04410523|560801845|FG001|Overall Study|Protocol deviation|0|||
155373742|NCT04410523|560801846|FG002|Overall Study|Protocol deviation|0|||
155373743|NCT04410523|560801847|FG003|Overall Study|Protocol deviation|0|||
155373744|NCT04410523|560801848|FG004|Overall Study|Protocol deviation|0|||
155373745|NCT04410523|560801849|FG005|Overall Study|Protocol deviation|2|||
155373746|NCT04410523|560801844|FG000|Overall Study|Subject decision|2|||
155373747|NCT04410523|560801845|FG001|Overall Study|Subject decision|0|||
155373748|NCT04410523|560801846|FG002|Overall Study|Subject decision|0|||
155373749|NCT04410523|560801847|FG003|Overall Study|Subject decision|1|||
155373750|NCT04410523|560801848|FG004|Overall Study|Subject decision|0|||
155373751|NCT04410523|560801849|FG005|Overall Study|Subject decision|1|||
155373752|NCT00490490|560801850|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
155373753|NCT00490490|560801850|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
155373754|NCT03207451|560801851|FG000|Overall Study|scheduling conflict|1|||
155373755|NCT03207451|560801852|FG001|Overall Study|scheduling conflict|0|||
155373756|NCT03207451|560801853|FG002|Overall Study|scheduling conflict|2|||
155373757|NCT03207451|560801854|FG003|Overall Study|scheduling conflict|2|||
155169037|NCT04535453|560057281|FG007|Overall Study|Withdrawal by Subject|1|||
155169038|NCT04535453|560057282|FG008|Overall Study|Withdrawal by Subject|1|||
155169039|NCT04535453|560057283|FG009|Overall Study|Withdrawal by Subject|1|||
155169040|NCT04535453|560057284|FG010|Overall Study|Withdrawal by Subject|0|||
155373758|NCT03207451|560801851|FG000|Overall Study|Adverse Event|0|||
155373759|NCT03207451|560801852|FG001|Overall Study|Adverse Event|0|||
155373760|NCT03207451|560801853|FG002|Overall Study|Adverse Event|0|||
155373761|NCT03207451|560801854|FG003|Overall Study|Adverse Event|1|||
155169041|NCT04535453|560057285|FG011|Overall Study|Withdrawal by Subject|1|||
155169042|NCT04535453|560057274|FG000|Overall Study|Other|0|||
155373762|NCT02040584|560801855|FG000|Overall Study|Adverse Event|13|||
155373763|NCT02040584|560801856|FG001|Overall Study|Adverse Event|6|||
155373764|NCT02040584|560801855|FG000|Overall Study|Protocol Violation|9|||
155373765|NCT02040584|560801856|FG001|Overall Study|Protocol Violation|11|||
155373766|NCT02040584|560801855|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155373767|NCT02040584|560801856|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155373768|NCT02040584|560801855|FG000|Overall Study|Death|6|||
155373769|NCT02040584|560801856|FG001|Overall Study|Death|3|||
155373770|NCT02040584|560801855|FG000|Overall Study|Transplant rejection/retransplant|0|||
155373771|NCT02040584|560801856|FG001|Overall Study|Transplant rejection/retransplant|1|||
155373772|NCT02040584|560801855|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
155373773|NCT02040584|560801856|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
155373774|NCT00996476|560801857|FG000|Overall Study|Withdrawal by Subject|1|||
155373775|NCT00996476|560801858|FG001|Overall Study|Withdrawal by Subject|2|||
155373776|NCT00996476|560801859|FG002|Overall Study|Withdrawal by Subject|1|||
155373777|NCT00996476|560801860|FG003|Overall Study|Withdrawal by Subject|0|||
155373778|NCT00996476|560801861|FG004|Overall Study|Withdrawal by Subject|1|||
155373779|NCT00996476|560801857|FG000|Overall Study|Adverse Event|0|||
155373780|NCT00996476|560801858|FG001|Overall Study|Adverse Event|1|||
155373781|NCT00996476|560801859|FG002|Overall Study|Adverse Event|0|||
155373782|NCT00996476|560801860|FG003|Overall Study|Adverse Event|0|||
155373783|NCT00996476|560801861|FG004|Overall Study|Adverse Event|1|||
155373784|NCT01802567|560801862|FG000|Overall Study|Withdrawal by Subject|2|||
155373785|NCT01802567|560801862|FG000|Overall Study|Physician Decision|1|||
155373786|NCT01802567|560801862|FG000|Overall Study|Lack of Efficacy|7|||
155373787|NCT01802567|560801862|FG000|Overall Study|Consented but did not start therapy|7|||
155373788|NCT01802567|560801862|FG000|Overall Study|Protocol Violation|1|||
155373789|NCT01895101|560801863|FG000|Overall Study|OPCAB procedure|1|||
155373790|NCT01895101|560801864|FG001|Overall Study|OPCAB procedure|1|||
155373791|NCT01895101|560801865|FG002|Overall Study|OPCAB procedure|3|||
155373792|NCT01895101|560801863|FG000|Overall Study|Withdrawal by Subject|0|||
155373793|NCT01895101|560801864|FG001|Overall Study|Withdrawal by Subject|1|||
155373794|NCT01895101|560801865|FG002|Overall Study|Withdrawal by Subject|2|||
155373795|NCT01895101|560801863|FG000|Overall Study|another study, enrolled in other study|0|||
155373796|NCT01895101|560801864|FG001|Overall Study|another study, enrolled in other study|1|||
155373797|NCT01895101|560801865|FG002|Overall Study|another study, enrolled in other study|0|||
155373798|NCT01895101|560801863|FG000|Overall Study|Death|0|||
155373799|NCT01895101|560801864|FG001|Overall Study|Death|1|||
155373800|NCT01895101|560801865|FG002|Overall Study|Death|0|||
155373801|NCT01895101|560801863|FG000|Overall Study|coagulation disorder|0|||
155373802|NCT01895101|560801864|FG001|Overall Study|coagulation disorder|1|||
155373803|NCT01895101|560801865|FG002|Overall Study|coagulation disorder|0|||
155373804|NCT00436852|560801866|FG000|Overall Study|Death|23|||
155373805|NCT00436852|560801867|FG001|Overall Study|Death|34|||
155373806|NCT00436852|560801866|FG000|Overall Study|Lack of Efficacy|9|||
155373807|NCT00436852|560801867|FG001|Overall Study|Lack of Efficacy|7|||
155373808|NCT00436852|560801866|FG000|Overall Study|Withdrawal by Subject|2|||
155373809|NCT00436852|560801867|FG001|Overall Study|Withdrawal by Subject|4|||
155373810|NCT00436852|560801866|FG000|Overall Study|Ineligible|1|||
155373811|NCT00436852|560801867|FG001|Overall Study|Ineligible|0|||
155373812|NCT00370682|560801868|FG000|Overall Study|Moved from area|0|||
155373813|NCT00370682|560801869|FG001|Overall Study|Moved from area|2|||
155373814|NCT00370682|560801870|FG002|Overall Study|Moved from area|0|||
155373815|NCT00370682|560801868|FG000|Overall Study|Lost to Follow-up|0|||
155373816|NCT00370682|560801869|FG001|Overall Study|Lost to Follow-up|1|||
155373817|NCT00370682|560801870|FG002|Overall Study|Lost to Follow-up|1|||
155373818|NCT03167359|560801871|FG000|Overall Study|Physician Decision|1|||
155373819|NCT03167359|560801871|FG000|Overall Study|Lost to Follow-up|1|||
155373820|NCT03339583|560801872|FG000|First Intervention (14 Days)|Adverse Event|1|||
155373821|NCT03339583|560801873|FG001|First Intervention (14 Days)|Adverse Event|0|||
155373822|NCT03339583|560801872|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
155373823|NCT03339583|560801873|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
155373824|NCT03339583|560801872|FG000|Second Intervention (14 Days)|Adverse Event|0|||
155373825|NCT03339583|560801873|FG001|Second Intervention (14 Days)|Adverse Event|1|||
155373826|NCT03339583|560801872|FG000|Follow-up (14 Days)|Physician Decision|6|||
155373827|NCT03339583|560801873|FG001|Follow-up (14 Days)|Physician Decision|3|||
155373828|NCT00943852|560801874|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373829|NCT00943852|560801875|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373830|NCT00943852|560801876|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373831|NCT00943852|560801877|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
155373832|NCT00943852|560801878|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373833|NCT00943852|560801879|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373834|NCT00943852|560801880|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373835|NCT00943852|560801881|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373836|NCT00943852|560801882|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373837|NCT00943852|560801883|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
155373838|NCT00943852|560801874|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373839|NCT00943852|560801875|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373840|NCT00943852|560801876|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373841|NCT00943852|560801877|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373842|NCT00943852|560801878|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373843|NCT00943852|560801879|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
155373844|NCT00943852|560801880|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373845|NCT00943852|560801881|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373846|NCT00943852|560801882|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373847|NCT00943852|560801883|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
155373848|NCT00943852|560801874|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373849|NCT00943852|560801875|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373850|NCT00943852|560801876|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373851|NCT00943852|560801877|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373852|NCT00943852|560801878|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
154965719|NCT00112437|559298867|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155373853|NCT00943852|560801879|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373854|NCT00943852|560801880|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
155373855|NCT00943852|560801881|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373856|NCT00943852|560801882|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373857|NCT00943852|560801883|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
155373858|NCT00943852|560801874|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373859|NCT00943852|560801875|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373860|NCT00943852|560801876|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373861|NCT00943852|560801877|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373862|NCT00943852|560801878|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373863|NCT00943852|560801879|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373864|NCT00943852|560801880|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373865|NCT00943852|560801881|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
155373866|NCT00943852|560801882|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373867|NCT00943852|560801883|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
155373868|NCT00943852|560801874|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373869|NCT00943852|560801875|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373870|NCT00943852|560801876|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373871|NCT00943852|560801877|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373872|NCT00943852|560801878|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373873|NCT00943852|560801879|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373874|NCT00943852|560801880|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
155373875|NCT00943852|560801881|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373876|NCT00943852|560801882|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373877|NCT00943852|560801883|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
155373878|NCT02141620|560801884|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
155373879|NCT02141620|560801885|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
155373880|NCT00772330|560801886|FG000|Overall Study|Lost to Follow-up|3|||
155373881|NCT00734591|560801887|FG000|Screening for Prospective Period|Site did not participate|1604|||
155373882|NCT00734591|560801888|FG001|Screening for Prospective Period|Site did not participate|1488|||
155373883|NCT00734591|560801887|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
155373884|NCT00734591|560801888|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
155373885|NCT00734591|560801887|FG000|Prospective Period|Withdrawal by Subject|11|||
155373886|NCT00734591|560801888|FG001|Prospective Period|Withdrawal by Subject|9|||
155373887|NCT00734591|560801887|FG000|Prospective Period|Lost to Follow-up|37|||
155373888|NCT00734591|560801888|FG001|Prospective Period|Lost to Follow-up|33|||
155373889|NCT00734591|560801887|FG000|Prospective Period|Study Terminated|1|||
155373890|NCT00734591|560801888|FG001|Prospective Period|Study Terminated|0|||
155373891|NCT00734591|560801887|FG000|Prospective Period|Other|2|||
155373892|NCT00734591|560801888|FG001|Prospective Period|Other|2|||
155373893|NCT00730275|560801889|FG000|Overall Study|Withdrawal by Subject|0|||
155373894|NCT00730275|560801890|FG001|Overall Study|Withdrawal by Subject|0|||
155373895|NCT00730275|560801891|FG002|Overall Study|Withdrawal by Subject|0|||
155373896|NCT00730275|560801892|FG003|Overall Study|Withdrawal by Subject|1|||
155373897|NCT00356408|560801893|FG000|Overall Study|Adverse Event|9|||
155373898|NCT00356408|560801893|FG000|Overall Study|Lack of Efficacy|36|||
155373899|NCT00356408|560801893|FG000|Overall Study|Lost to Follow-up|2|||
155373900|NCT00356408|560801893|FG000|Overall Study|Withdrawal by Subject|6|||
155373901|NCT00356408|560801893|FG000|Overall Study|Other: Principal investigator discretion|3|||
155373902|NCT00356408|560801893|FG000|Overall Study|Other: Sponsor request|1|||
155373903|NCT00356408|560801893|FG000|Overall Study|Other: Azathioprine stopped|1|||
155373904|NCT00356408|560801893|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
155373905|NCT00356408|560801893|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
155373906|NCT05487586|560801894|FG000|Overall Study|Death|22|||
155373907|NCT05487586|560801894|FG000|Overall Study|Physician Decision|1|||
155373908|NCT05487586|560801894|FG000|Overall Study|Transfer to another hospital|4|||
155373909|NCT05487586|560801894|FG000|Overall Study|Other|1|||
155373910|NCT03921723|560801895|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
155169043|NCT04535453|560057275|FG001|Overall Study|Other|0|||
155169044|NCT04535453|560057276|FG002|Overall Study|Other|1|||
155169045|NCT04535453|560057277|FG003|Overall Study|Other|0|||
155169046|NCT04535453|560057278|FG004|Overall Study|Other|1|||
155169047|NCT04535453|560057279|FG005|Overall Study|Other|0|||
155169048|NCT04535453|560057280|FG006|Overall Study|Other|1|||
155169049|NCT04535453|560057281|FG007|Overall Study|Other|1|||
155169050|NCT04535453|560057282|FG008|Overall Study|Other|1|||
155373911|NCT03921723|560801895|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
155373912|NCT03015129|560801896|FG000|Overall Study|Death|2|||
155373913|NCT03015129|560801897|FG001|Overall Study|Death|2|||
155373914|NCT03015129|560801896|FG000|Overall Study|Lost to Follow-up|0|||
155373915|NCT03015129|560801897|FG001|Overall Study|Lost to Follow-up|1|||
155373916|NCT03015129|560801896|FG000|Overall Study|Progression of disease|38|||
155169051|NCT04535453|560057283|FG009|Overall Study|Other|0|||
155169052|NCT04535453|560057284|FG010|Overall Study|Other|0|||
155169053|NCT04535453|560057285|FG011|Overall Study|Other|0|||
155169054|NCT01742286|560057288|FG000|Escalation Phase|Administrative problems|1|||
155169055|NCT01742286|560057289|FG001|Escalation Phase|Administrative problems|1|||
155169056|NCT01742286|560057290|FG002|Escalation Phase|Administrative problems|0|||
155169057|NCT01742286|560057291|FG003|Escalation Phase|Administrative problems|0|||
155169058|NCT01742286|560057292|FG004|Escalation Phase|Administrative problems|0|||
155169059|NCT01742286|560057293|FG005|Escalation Phase|Administrative problems|0|||
155169060|NCT01742286|560057294|FG006|Escalation Phase|Administrative problems|2|||
155169061|NCT01742286|560057288|FG000|Escalation Phase|Adverse Event|0|||
155169062|NCT01742286|560057289|FG001|Escalation Phase|Adverse Event|1|||
155169063|NCT01742286|560057290|FG002|Escalation Phase|Adverse Event|2|||
155169064|NCT01742286|560057291|FG003|Escalation Phase|Adverse Event|0|||
155169065|NCT01742286|560057292|FG004|Escalation Phase|Adverse Event|0|||
155169066|NCT01742286|560057293|FG005|Escalation Phase|Adverse Event|1|||
155169067|NCT01742286|560057294|FG006|Escalation Phase|Adverse Event|0|||
155169068|NCT01742286|560057288|FG000|Escalation Phase|Disease progression|3|||
155169069|NCT01742286|560057289|FG001|Escalation Phase|Disease progression|7|||
155169070|NCT01742286|560057290|FG002|Escalation Phase|Disease progression|4|||
155169071|NCT01742286|560057291|FG003|Escalation Phase|Disease progression|1|||
155169072|NCT01742286|560057292|FG004|Escalation Phase|Disease progression|4|||
155169073|NCT01742286|560057293|FG005|Escalation Phase|Disease progression|3|||
155169074|NCT01742286|560057294|FG006|Escalation Phase|Disease progression|2|||
155169075|NCT01742286|560057288|FG000|Escalation Phase|Death|0|||
155169076|NCT01742286|560057289|FG001|Escalation Phase|Death|0|||
155169077|NCT01742286|560057290|FG002|Escalation Phase|Death|0|||
155169078|NCT01742286|560057291|FG003|Escalation Phase|Death|0|||
155169079|NCT01742286|560057292|FG004|Escalation Phase|Death|0|||
155373917|NCT03015129|560801897|FG001|Overall Study|Progression of disease|33|||
155373918|NCT03015129|560801896|FG000|Overall Study|Adverse Event|0|||
155373919|NCT03015129|560801897|FG001|Overall Study|Adverse Event|4|||
155373920|NCT00939822|560801903|FG000|Overall Study|Lost to Follow-up|1|||
155373921|NCT00939822|560801904|FG001|Overall Study|Lost to Follow-up|0|||
155373922|NCT00939822|560801903|FG000|Overall Study|withdrew from study due to busy schedule|1|||
155373923|NCT00939822|560801904|FG001|Overall Study|withdrew from study due to busy schedule|1|||
155373924|NCT00939822|560801903|FG000|Overall Study|Mental health issues|0|||
155373925|NCT00939822|560801904|FG001|Overall Study|Mental health issues|2|||
155373926|NCT05032872|560801905|FG000|Overall Study|Adverse Event|1|||
155373927|NCT05032872|560801906|FG001|Overall Study|Adverse Event|0|||
155373928|NCT05032872|560801905|FG000|Overall Study|Lost to Follow-up|2|||
155373929|NCT05032872|560801906|FG001|Overall Study|Lost to Follow-up|4|||
155373930|NCT05032872|560801905|FG000|Overall Study|Withdrawal by Subject|4|||
155373931|NCT05032872|560801906|FG001|Overall Study|Withdrawal by Subject|3|||
155373932|NCT00406692|560801914|FG000|Overall Study|Withdrawal by Subject|4|||
155373933|NCT00406692|560801914|FG000|Overall Study|Physician Decision|1|||
155373934|NCT00406692|560801914|FG000|Overall Study|Adverse Event|1|||
155373935|NCT00406692|560801914|FG000|Overall Study|Lack of Efficacy|1|||
155373936|NCT00821587|560801915|FG000|Overall Study|Physician Decision|0|||
155373937|NCT00821587|560801916|FG001|Overall Study|Physician Decision|1|||
155169080|NCT01742286|560057293|FG005|Escalation Phase|Death|1|||
155169081|NCT01742286|560057294|FG006|Escalation Phase|Death|0|||
155169082|NCT01742286|560057288|FG000|Escalation Phase|Physician Decision|0|||
155169083|NCT01742286|560057289|FG001|Escalation Phase|Physician Decision|3|||
155169084|NCT01742286|560057290|FG002|Escalation Phase|Physician Decision|0|||
155169085|NCT01742286|560057291|FG003|Escalation Phase|Physician Decision|1|||
155169086|NCT01742286|560057292|FG004|Escalation Phase|Physician Decision|0|||
155169087|NCT01742286|560057293|FG005|Escalation Phase|Physician Decision|0|||
155169088|NCT01742286|560057294|FG006|Escalation Phase|Physician Decision|2|||
155169089|NCT01742286|560057288|FG000|Escalation Phase|Subject/guardian decision|1|||
155373938|NCT04488770|560801917|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373939|NCT04488770|560801918|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373940|NCT04488770|560801919|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373941|NCT04488770|560801920|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
155373942|NCT04488770|560801921|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373943|NCT04488770|560801922|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373944|NCT04488770|560801923|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373945|NCT04488770|560801924|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373946|NCT04488770|560801925|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373947|NCT04488770|560801926|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373948|NCT04488770|560801927|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373949|NCT04488770|560801928|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155091077|NCT03493958|559767473|FG000|Overall Study|Withdrawal by Subject|6|||
155373950|NCT04488770|560801929|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
155373951|NCT04488770|560801917|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
155373952|NCT04488770|560801918|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373953|NCT04488770|560801919|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373954|NCT04488770|560801920|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373955|NCT04488770|560801921|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373956|NCT04488770|560801922|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373957|NCT04488770|560801923|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373958|NCT04488770|560801924|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373959|NCT04488770|560801925|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373960|NCT04488770|560801926|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373961|NCT04488770|560801927|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373962|NCT04488770|560801928|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373963|NCT04488770|560801929|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
155373964|NCT04488770|560801917|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373965|NCT04488770|560801918|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373966|NCT04488770|560801919|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373967|NCT04488770|560801920|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373968|NCT04488770|560801921|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373969|NCT04488770|560801922|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
155373970|NCT04488770|560801923|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
155373971|NCT04488770|560801924|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373972|NCT04488770|560801925|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373973|NCT04488770|560801926|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373974|NCT04488770|560801927|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373975|NCT04488770|560801928|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373976|NCT04488770|560801929|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155373977|NCT04488770|560801917|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373978|NCT04488770|560801918|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373979|NCT04488770|560801919|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373980|NCT04488770|560801920|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373981|NCT04488770|560801921|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
155373982|NCT04488770|560801922|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373983|NCT04488770|560801923|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373984|NCT04488770|560801924|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373985|NCT04488770|560801925|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373986|NCT04488770|560801926|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373987|NCT04488770|560801927|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373988|NCT04488770|560801928|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373989|NCT04488770|560801929|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
155373990|NCT03547739|560801930|FG000|Overall Study|Death|0|||
155373991|NCT03547739|560801931|FG001|Overall Study|Death|1|||
155373992|NCT03547739|560801932|FG002|Overall Study|Death|5|||
155373993|NCT03547739|560801930|FG000|Overall Study|Adverse Event|24|||
155373994|NCT03547739|560801931|FG001|Overall Study|Adverse Event|11|||
155373995|NCT03547739|560801932|FG002|Overall Study|Adverse Event|13|||
155373996|NCT03547739|560801930|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
155373997|NCT03547739|560801931|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
155373998|NCT03547739|560801932|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
155373999|NCT03547739|560801930|FG000|Overall Study|Lost to Follow-up|80|||
155374000|NCT03547739|560801931|FG001|Overall Study|Lost to Follow-up|84|||
155374001|NCT03547739|560801932|FG002|Overall Study|Lost to Follow-up|116|||
155374002|NCT01744392|560801937|FG000|Overall Study|Physician Decision|1|||
155374003|NCT01696955|560801941|FG000|Main Study|Protocol Violation|1|||
155374004|NCT01696955|560801942|FG001|Main Study|Protocol Violation|0|||
155374005|NCT01696955|560801941|FG000|Main Study|Withdrawal by Subject|1|||
155374006|NCT01696955|560801942|FG001|Main Study|Withdrawal by Subject|1|||
155374007|NCT00798590|560801949|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
155374008|NCT00798590|560801950|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
155374009|NCT01152814|560801953|FG000|Overall Study|Lost to Follow-up|2|||
155374010|NCT01280357|560801954|FG000|Overall Study|Excluded no internal monitoring|14|||
155374011|NCT01280357|560801954|FG000|Overall Study|IInsufficient data/No data supplied|12|||
155374012|NCT03284203|560801955|FG000|Overall Study|Lost to Follow-up|3|||
155374013|NCT00992225|560801956|FG000|Overall Study|Entry Criteria Not Met|8|||
155374014|NCT00992225|560801956|FG000|Overall Study|Adverse Event|2|||
155374015|NCT03466073|560801957|FG000|Overall Study|Death|1|||
155374016|NCT03466073|560801958|FG001|Overall Study|Death|0|||
155374017|NCT03466073|560801959|FG002|Overall Study|Death|0|||
155374018|NCT03466073|560801960|FG003|Overall Study|Death|0|||
155374019|NCT03466073|560801961|FG004|Overall Study|Death|0|||
155374020|NCT03466073|560801962|FG005|Overall Study|Death|1|||
155374021|NCT00744757|560801963|FG000|Overall Study|Objective disease progression|7|||
155374022|NCT00744757|560801963|FG000|Overall Study|Physician Decision|5|||
155374023|NCT00744757|560801963|FG000|Overall Study|Withdrawal by Subject|1|||
155374024|NCT00744757|560801963|FG000|Overall Study|Death|6|||
155374025|NCT00744757|560801963|FG000|Overall Study|Adverse Event|2|||
155374026|NCT00532493|560801964|FG000|Overall Study|Death|1|||
155374027|NCT00532493|560801965|FG001|Overall Study|Death|1|||
155374028|NCT00532493|560801964|FG000|Overall Study|Lost to Follow-up|10|||
155374029|NCT00532493|560801965|FG001|Overall Study|Lost to Follow-up|7|||
155374030|NCT00532493|560801964|FG000|Overall Study|Withdrawal by Subject|7|||
155374031|NCT00532493|560801965|FG001|Overall Study|Withdrawal by Subject|9|||
155374032|NCT00532493|560801964|FG000|Overall Study|Physician Decision|1|||
155374033|NCT00532493|560801965|FG001|Overall Study|Physician Decision|6|||
155374034|NCT00532493|560801964|FG000|Overall Study|Adverse Event|6|||
155374035|NCT00532493|560801965|FG001|Overall Study|Adverse Event|5|||
155374036|NCT00532493|560801964|FG000|Overall Study|Protocol Deviation|1|||
155374037|NCT00532493|560801965|FG001|Overall Study|Protocol Deviation|0|||
155374038|NCT00532493|560801964|FG000|Overall Study|Subject Moved Away|3|||
155374039|NCT00532493|560801965|FG001|Overall Study|Subject Moved Away|1|||
155374040|NCT00532493|560801964|FG000|Overall Study|Contraindicative Medication|1|||
155374041|NCT00532493|560801965|FG001|Overall Study|Contraindicative Medication|0|||
155374042|NCT02045875|560801969|FG000|Overall Study|Lost to Follow-up|3|||
155374043|NCT02045875|560801970|FG001|Overall Study|Lost to Follow-up|0|||
155374044|NCT02045875|560801969|FG000|Overall Study|Withdrawal by Subject|4|||
155374045|NCT02045875|560801970|FG001|Overall Study|Withdrawal by Subject|3|||
155374046|NCT00775463|560803835|FG000|Overall Study|Withdrawal by Subject|0|||
155374047|NCT00775463|560803836|FG001|Overall Study|Withdrawal by Subject|1|||
155374048|NCT00775463|560803835|FG000|Overall Study|Adverse Event|7|||
155374049|NCT00775463|560803836|FG001|Overall Study|Adverse Event|9|||
155374050|NCT00775463|560803835|FG000|Overall Study|Protocol Violation|2|||
155374051|NCT00775463|560803836|FG001|Overall Study|Protocol Violation|2|||
155374052|NCT00775463|560803835|FG000|Overall Study|Lost to Follow-up|1|||
155374053|NCT00775463|560803836|FG001|Overall Study|Lost to Follow-up|0|||
155374054|NCT00775463|560803835|FG000|Overall Study|Lack of Efficacy|1|||
155374055|NCT00775463|560803836|FG001|Overall Study|Lack of Efficacy|1|||
155374056|NCT02980731|560803837|FG000|Overall Study|Death|63|||
155374057|NCT02980731|560803837|FG000|Overall Study|Withdrawal by Subject|6|||
155374058|NCT02980731|560803837|FG000|Overall Study|Lost to Follow-up|5|||
155374059|NCT02980731|560803837|FG000|Overall Study|Study terminated by Sponsor|4|||
155374060|NCT02980731|560803837|FG000|Overall Study|Completed survival follow-up period|65|||
155374061|NCT02980731|560803837|FG000|Overall Study|COVID-19 infection|1|||
155374062|NCT02980731|560803837|FG000|Overall Study|Other, not specified|66|||
155374063|NCT01789567|560803839|FG000|Overall Study|Death|6|||
155374064|NCT02731690|560803842|FG000|Overall Study|Adverse Event|1|||
155374065|NCT02731690|560803842|FG000|Overall Study|Withdrawal by Subject|3|||
155374066|NCT02731690|560803842|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
155374067|NCT00872989|560803843|FG000|Overall Study|Adverse Event|7|||
155374068|NCT00872989|560803844|FG001|Overall Study|Adverse Event|15|||
155374069|NCT00872989|560803843|FG000|Overall Study|Withdrawal by Subject|8|||
155374070|NCT00872989|560803844|FG001|Overall Study|Withdrawal by Subject|5|||
155374071|NCT00872989|560803843|FG000|Overall Study|Progression/relapse|47|||
155374072|NCT00872989|560803844|FG001|Overall Study|Progression/relapse|35|||
155374073|NCT00872989|560803843|FG000|Overall Study|Not protocol specified|3|||
155374074|NCT00872989|560803844|FG001|Overall Study|Not protocol specified|8|||
155374075|NCT03900416|560803850|FG000|Six Week Follow-up|Lost to Follow-up|1|||
155374076|NCT03900416|560803851|FG001|Six Week Follow-up|Lost to Follow-up|0|||
155374077|NCT03900416|560803850|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
155374078|NCT03900416|560803851|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
155374079|NCT03900416|560803850|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
155374080|NCT03900416|560803851|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
155374081|NCT03900416|560803850|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
155374082|NCT03900416|560803851|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
155374083|NCT03900416|560803850|FG000|Twelve Week Follow-up|Adverse Event|1|||
155374084|NCT03900416|560803851|FG001|Twelve Week Follow-up|Adverse Event|1|||
155374085|NCT03900416|560803850|FG000|Six Month Follow-up|Lost to Follow-up|4|||
155374086|NCT03900416|560803851|FG001|Six Month Follow-up|Lost to Follow-up|3|||
155374087|NCT03900416|560803850|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
155374088|NCT03900416|560803851|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
155374089|NCT00307684|560803852|FG000|Open Label Phase|Lack of Efficacy|0|||
155374090|NCT00307684|560803853|FG001|Open Label Phase|Lack of Efficacy|0|||
155374091|NCT00307684|560803854|FG002|Open Label Phase|Lack of Efficacy|3|||
155374092|NCT00307684|560803852|FG000|Open Label Phase|Adverse Event|0|||
155374093|NCT00307684|560803853|FG001|Open Label Phase|Adverse Event|0|||
155374094|NCT00307684|560803854|FG002|Open Label Phase|Adverse Event|16|||
155374095|NCT00307684|560803852|FG000|Open Label Phase|Withdrawal by Subject|0|||
155374096|NCT00307684|560803853|FG001|Open Label Phase|Withdrawal by Subject|0|||
155374097|NCT00307684|560803854|FG002|Open Label Phase|Withdrawal by Subject|15|||
155374098|NCT00307684|560803852|FG000|Open Label Phase|Lost to Follow-up|0|||
155374099|NCT00307684|560803853|FG001|Open Label Phase|Lost to Follow-up|0|||
155374100|NCT00307684|560803854|FG002|Open Label Phase|Lost to Follow-up|11|||
155374101|NCT00307684|560803852|FG000|Open Label Phase|non compliance|0|||
155374102|NCT00307684|560803853|FG001|Open Label Phase|non compliance|0|||
155374103|NCT00307684|560803854|FG002|Open Label Phase|non compliance|5|||
155374104|NCT00307684|560803852|FG000|Open Label Phase|other|0|||
155374105|NCT00307684|560803853|FG001|Open Label Phase|other|0|||
155374106|NCT00307684|560803854|FG002|Open Label Phase|other|6|||
155374107|NCT00307684|560803852|FG000|Double Blind Phase|Lack of Efficacy|2|||
155374108|NCT00307684|560803853|FG001|Double Blind Phase|Lack of Efficacy|5|||
155374109|NCT00307684|560803854|FG002|Double Blind Phase|Lack of Efficacy|0|||
155374110|NCT00224887|560803855|FG000|Overall Study|Pregnancy|6|||
155374111|NCT00224887|560803856|FG001|Overall Study|Pregnancy|6|||
155374112|NCT00338962|560803857|FG000|Overall Study|Lost to Follow-up|3|||
155374113|NCT00338962|560803858|FG001|Overall Study|Lost to Follow-up|3|||
155374114|NCT00338962|560803859|FG002|Overall Study|Lost to Follow-up|2|||
155374115|NCT00338962|560803860|FG003|Overall Study|Lost to Follow-up|3|||
155374116|NCT00338962|560803857|FG000|Overall Study|Withdrawal by Subject|1|||
155374117|NCT00338962|560803858|FG001|Overall Study|Withdrawal by Subject|0|||
155374118|NCT00338962|560803859|FG002|Overall Study|Withdrawal by Subject|0|||
155374119|NCT00338962|560803860|FG003|Overall Study|Withdrawal by Subject|0|||
155374120|NCT00338962|560803857|FG000|Overall Study|No Transportation|2|||
155374121|NCT00338962|560803858|FG001|Overall Study|No Transportation|0|||
155374122|NCT00338962|560803859|FG002|Overall Study|No Transportation|0|||
155374123|NCT00338962|560803860|FG003|Overall Study|No Transportation|0|||
155374124|NCT00338962|560803857|FG000|Overall Study|Time Constraint|2|||
155374125|NCT00338962|560803858|FG001|Overall Study|Time Constraint|0|||
155374126|NCT00338962|560803859|FG002|Overall Study|Time Constraint|0|||
155374127|NCT00338962|560803860|FG003|Overall Study|Time Constraint|0|||
155374128|NCT00338962|560803857|FG000|Overall Study|Moved|0|||
155374129|NCT00338962|560803858|FG001|Overall Study|Moved|1|||
155374130|NCT00338962|560803859|FG002|Overall Study|Moved|0|||
155374131|NCT00338962|560803860|FG003|Overall Study|Moved|0|||
155374132|NCT00338962|560803857|FG000|Overall Study|Adverse Event|0|||
155374133|NCT00338962|560803858|FG001|Overall Study|Adverse Event|0|||
155091078|NCT03493958|559767473|FG000|Overall Study|Lost to Follow-up|7|||
155091079|NCT03493958|559767473|FG000|Overall Study|Did not complete all required study procedures|2|||
155374134|NCT00338962|560803859|FG002|Overall Study|Adverse Event|2|||
155374135|NCT00338962|560803860|FG003|Overall Study|Adverse Event|0|||
155374136|NCT00338962|560803857|FG000|Overall Study|Poor Compliance|0|||
155374137|NCT00338962|560803858|FG001|Overall Study|Poor Compliance|0|||
155374138|NCT00338962|560803859|FG002|Overall Study|Poor Compliance|2|||
155374139|NCT00338962|560803860|FG003|Overall Study|Poor Compliance|0|||
155374140|NCT00910039|560803861|FG000|Overall Study|Physician Decision|1|||
155091080|NCT02367456|559767474|FG000|Overall Study|Death|8|||
155091081|NCT02367456|559767475|FG001|Overall Study|Death|24|||
155091082|NCT02367456|559767476|FG002|Overall Study|Death|17|||
155091083|NCT02367456|559767474|FG000|Overall Study|Lost to Follow-up|1|||
155374141|NCT00635661|560803879|FG000|Overall Study|Withdrawal by Subject|4|||
155374142|NCT00403767|560803882|FG000|Overall Study|Adverse Event|993|||
155374143|NCT00403767|560803883|FG001|Overall Study|Adverse Event|919|||
155374144|NCT00403767|560803882|FG000|Overall Study|Non-compliant with study medication|134|||
155374145|NCT00403767|560803883|FG001|Overall Study|Non-compliant with study medication|164|||
155091084|NCT02367456|559767475|FG001|Overall Study|Lost to Follow-up|3|||
155374146|NCT00403767|560803882|FG000|Overall Study|Consent withdrawn|671|||
155374147|NCT00403767|560803883|FG001|Overall Study|Consent withdrawn|673|||
155374148|NCT00403767|560803882|FG000|Overall Study|Investigator dec./not protocol-related|191|||
155374149|NCT00403767|560803883|FG001|Overall Study|Investigator dec./not protocol-related|178|||
155374150|NCT00403767|560803882|FG000|Overall Study|Lost to Follow-up|6|||
155374151|NCT00403767|560803883|FG001|Overall Study|Lost to Follow-up|8|||
155374152|NCT00403767|560803882|FG000|Overall Study|Protocol Violation|142|||
155374153|NCT00403767|560803883|FG001|Overall Study|Protocol Violation|124|||
155374154|NCT00403767|560803882|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
155374155|NCT00403767|560803883|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
155374156|NCT00403767|560803882|FG000|Overall Study|Study terminated by sponsor|82|||
155374157|NCT00403767|560803883|FG001|Overall Study|Study terminated by sponsor|69|||
155374158|NCT00403767|560803882|FG000|Overall Study|Missing/incomplete data|1|||
155374159|NCT00403767|560803883|FG001|Overall Study|Missing/incomplete data|1|||
155374160|NCT03192475|560803884|FG000|Overall Study|Death|0|||
155374161|NCT03192475|560803885|FG001|Overall Study|Death|1|||
155374162|NCT03192475|560803884|FG000|Overall Study|Lost to Follow-up|13|||
155374163|NCT03192475|560803885|FG001|Overall Study|Lost to Follow-up|8|||
155374164|NCT01641159|560803886|FG000|Overall Study|Lost to Follow-up|2|||
155374165|NCT01641159|560803887|FG001|Overall Study|Lost to Follow-up|1|||
155374166|NCT01641159|560803886|FG000|Overall Study|Withdrawal by Subject|0|||
155374167|NCT01641159|560803887|FG001|Overall Study|Withdrawal by Subject|1|||
155374168|NCT03980808|560803888|FG000|Overall Study|Lost to Follow-up|2|||
155374169|NCT03980808|560803889|FG001|Overall Study|Lost to Follow-up|2|||
155374170|NCT05330676|560803895|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
155374171|NCT05330676|560803896|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
155374172|NCT00436605|560803897|FG000|Overall Study|Protocol Violation|3|||
155374173|NCT02755818|560803898|FG000|Overall Study|Withdrawal by Subject|0|||
155374174|NCT02755818|560803899|FG001|Overall Study|Withdrawal by Subject|0|||
155374175|NCT02755818|560803900|FG002|Overall Study|Withdrawal by Subject|0|||
155374176|NCT02755818|560803901|FG003|Overall Study|Withdrawal by Subject|2|||
155374177|NCT02755818|560803898|FG000|Overall Study|withdrawal by PI|0|||
155374178|NCT02755818|560803899|FG001|Overall Study|withdrawal by PI|0|||
155374179|NCT02755818|560803900|FG002|Overall Study|withdrawal by PI|1|||
155374180|NCT02755818|560803901|FG003|Overall Study|withdrawal by PI|1|||
155374181|NCT03014011|560803902|FG000|First Intervention|Withdrawal by Subject|1|||
155374182|NCT03014011|560803903|FG001|First Intervention|Withdrawal by Subject|0|||
155374183|NCT03014011|560803902|FG000|Washout|Withdrawal by Subject|1|||
155374184|NCT03014011|560803903|FG001|Washout|Withdrawal by Subject|0|||
155374185|NCT00573859|560803906|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
155374186|NCT00573859|560803906|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
155374187|NCT02416453|560803907|FG000|Overall Study|Adverse Event|0|||
155374188|NCT02416453|560803908|FG001|Overall Study|Adverse Event|0|||
155374189|NCT02416453|560803909|FG002|Overall Study|Adverse Event|0|||
155374190|NCT02416453|560803910|FG003|Overall Study|Adverse Event|2|||
155374191|NCT02416453|560803911|FG004|Overall Study|Adverse Event|0|||
155374192|NCT02416453|560803912|FG005|Overall Study|Adverse Event|1|||
155374193|NCT02416453|560803913|FG006|Overall Study|Adverse Event|0|||
155374194|NCT02416453|560803914|FG007|Overall Study|Adverse Event|0|||
155374195|NCT02416453|560803915|FG008|Overall Study|Adverse Event|0|||
155374196|NCT02416453|560803916|FG009|Overall Study|Adverse Event|0|||
155374197|NCT02416453|560803917|FG010|Overall Study|Adverse Event|0|||
155374198|NCT02416453|560803907|FG000|Overall Study|Lost to Follow-up|1|||
155374199|NCT02416453|560803908|FG001|Overall Study|Lost to Follow-up|3|||
155374200|NCT02416453|560803909|FG002|Overall Study|Lost to Follow-up|0|||
155374201|NCT02416453|560803910|FG003|Overall Study|Lost to Follow-up|8|||
155374202|NCT02416453|560803911|FG004|Overall Study|Lost to Follow-up|0|||
155374203|NCT02416453|560803912|FG005|Overall Study|Lost to Follow-up|5|||
155374204|NCT02416453|560803913|FG006|Overall Study|Lost to Follow-up|1|||
155374205|NCT02416453|560803914|FG007|Overall Study|Lost to Follow-up|3|||
155374206|NCT02416453|560803915|FG008|Overall Study|Lost to Follow-up|1|||
155374207|NCT02416453|560803916|FG009|Overall Study|Lost to Follow-up|0|||
155374208|NCT02416453|560803917|FG010|Overall Study|Lost to Follow-up|0|||
155374209|NCT02416453|560803907|FG000|Overall Study|Physician Decision|0|||
155374210|NCT02416453|560803908|FG001|Overall Study|Physician Decision|0|||
155374211|NCT02416453|560803909|FG002|Overall Study|Physician Decision|0|||
155374212|NCT02416453|560803910|FG003|Overall Study|Physician Decision|0|||
155374213|NCT02416453|560803911|FG004|Overall Study|Physician Decision|0|||
155374214|NCT02416453|560803912|FG005|Overall Study|Physician Decision|1|||
155374215|NCT02416453|560803913|FG006|Overall Study|Physician Decision|1|||
155374216|NCT02416453|560803914|FG007|Overall Study|Physician Decision|1|||
155374217|NCT02416453|560803915|FG008|Overall Study|Physician Decision|0|||
155374218|NCT02416453|560803916|FG009|Overall Study|Physician Decision|0|||
155374219|NCT02416453|560803917|FG010|Overall Study|Physician Decision|0|||
154965720|NCT00112437|559298868|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965721|NCT00112437|559298869|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374220|NCT02416453|560803907|FG000|Overall Study|Withdrawal by Subject|2|||
155374221|NCT02416453|560803908|FG001|Overall Study|Withdrawal by Subject|0|||
155374222|NCT02416453|560803909|FG002|Overall Study|Withdrawal by Subject|0|||
155374223|NCT02416453|560803910|FG003|Overall Study|Withdrawal by Subject|5|||
155374224|NCT02416453|560803911|FG004|Overall Study|Withdrawal by Subject|1|||
155374225|NCT02416453|560803912|FG005|Overall Study|Withdrawal by Subject|8|||
155374226|NCT02416453|560803913|FG006|Overall Study|Withdrawal by Subject|0|||
155374227|NCT02416453|560803914|FG007|Overall Study|Withdrawal by Subject|8|||
155374228|NCT02416453|560803915|FG008|Overall Study|Withdrawal by Subject|4|||
155374229|NCT02416453|560803916|FG009|Overall Study|Withdrawal by Subject|0|||
155374230|NCT02416453|560803917|FG010|Overall Study|Withdrawal by Subject|0|||
155374231|NCT02416453|560803907|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374232|NCT02416453|560803908|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374233|NCT02416453|560803909|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
155374234|NCT02416453|560803910|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374235|NCT02416453|560803911|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374236|NCT02416453|560803912|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374237|NCT02416453|560803913|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374238|NCT02416453|560803914|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374239|NCT02416453|560803915|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374240|NCT02416453|560803916|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374241|NCT02416453|560803917|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
155374242|NCT02416453|560803907|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374243|NCT02416453|560803908|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374244|NCT02416453|560803909|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374245|NCT02416453|560803910|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374246|NCT02416453|560803911|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374247|NCT02416453|560803912|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
155374248|NCT02416453|560803913|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374249|NCT02416453|560803914|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374250|NCT02416453|560803915|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374251|NCT02416453|560803916|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374252|NCT02416453|560803917|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
155374253|NCT03223662|560803922|FG000|Overall Study|Physician Decision|1|||
155374254|NCT03223662|560803922|FG000|Overall Study|Study closure|1|||
155374255|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
155374256|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
155374257|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
155374258|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
155374259|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
155374260|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
155374261|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
155374262|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374263|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
155374264|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374265|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374266|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374267|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374268|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
155374269|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
155374270|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
155374271|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
155374272|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374273|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374274|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374275|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
155374276|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374277|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374278|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
155374279|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
154965722|NCT00112437|559298870|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965723|NCT00112437|559298871|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374280|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374281|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374282|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
155374283|NCT02229851|560803923|FG000|Main Phase (Double-blind Phase)|Death|1|||
154965724|NCT00112437|559298872|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155091085|NCT02367456|559767476|FG002|Overall Study|Lost to Follow-up|1|||
155091086|NCT02367456|559767474|FG000|Overall Study|Other reason|3|||
155374284|NCT02229851|560803924|FG001|Main Phase (Double-blind Phase)|Death|1|||
155374285|NCT02229851|560803925|FG002|Main Phase (Double-blind Phase)|Death|0|||
155374286|NCT02229851|560803926|FG003|Main Phase (Double-blind Phase)|Death|0|||
155374287|NCT02229851|560803927|FG004|Main Phase (Double-blind Phase)|Death|0|||
155374288|NCT02229851|560803928|FG005|Main Phase (Double-blind Phase)|Death|0|||
155374289|NCT02229851|560803929|FG006|Main Phase (Double-blind Phase)|Death|0|||
155374290|NCT02229851|560803923|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374291|NCT02229851|560803924|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374292|NCT02229851|560803925|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374293|NCT02229851|560803926|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
155374294|NCT02229851|560803927|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
155374295|NCT02229851|560803928|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
155374296|NCT02229851|560803929|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
155374297|NCT02229851|560803923|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
155374298|NCT02229851|560803924|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
155374299|NCT02229851|560803925|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
155374300|NCT02229851|560803926|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
155374301|NCT02229851|560803927|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
155374302|NCT02229851|560803928|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
155374303|NCT02229851|560803929|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
155374304|NCT02229851|560803923|FG000|Extension Phase (Open-label Phase)|Death|0|||
155374305|NCT02229851|560803924|FG001|Extension Phase (Open-label Phase)|Death|0|||
155374306|NCT02229851|560803925|FG002|Extension Phase (Open-label Phase)|Death|0|||
155374307|NCT02229851|560803926|FG003|Extension Phase (Open-label Phase)|Death|1|||
155374308|NCT02229851|560803927|FG004|Extension Phase (Open-label Phase)|Death|0|||
155374309|NCT02229851|560803928|FG005|Extension Phase (Open-label Phase)|Death|1|||
155374310|NCT02229851|560803929|FG006|Extension Phase (Open-label Phase)|Death|1|||
155374311|NCT03541200|560803930|FG000|Overall Study|Adverse Event|19|||
155374312|NCT03541200|560803930|FG000|Overall Study|Death|1|||
155374313|NCT03541200|560803930|FG000|Overall Study|Lost to Follow-up|10|||
155374314|NCT03541200|560803930|FG000|Overall Study|Physician Decision|1|||
155374315|NCT03541200|560803930|FG000|Overall Study|Protocol Violation|51|||
155374316|NCT03541200|560803930|FG000|Overall Study|Withdrawal by Subject|23|||
155169090|NCT01742286|560057289|FG001|Escalation Phase|Subject/guardian decision|0|||
155169091|NCT01742286|560057290|FG002|Escalation Phase|Subject/guardian decision|0|||
155169092|NCT01742286|560057291|FG003|Escalation Phase|Subject/guardian decision|0|||
155169093|NCT01742286|560057292|FG004|Escalation Phase|Subject/guardian decision|0|||
155169094|NCT01742286|560057293|FG005|Escalation Phase|Subject/guardian decision|0|||
155169095|NCT01742286|560057294|FG006|Escalation Phase|Subject/guardian decision|0|||
155169096|NCT01742286|560057288|FG000|Expansion Phase|Administrative problems|0|||
155169097|NCT01742286|560057289|FG001|Expansion Phase|Administrative problems|0|||
155169098|NCT01742286|560057290|FG002|Expansion Phase|Administrative problems|0|||
155169099|NCT01742286|560057291|FG003|Expansion Phase|Administrative problems|0|||
155169100|NCT01742286|560057292|FG004|Expansion Phase|Administrative problems|0|||
155169101|NCT01742286|560057293|FG005|Expansion Phase|Administrative problems|0|||
155169102|NCT01742286|560057294|FG006|Expansion Phase|Administrative problems|5|||
155169103|NCT01742286|560057288|FG000|Expansion Phase|Physician Decision|0|||
155169104|NCT01742286|560057289|FG001|Expansion Phase|Physician Decision|0|||
155169105|NCT01742286|560057290|FG002|Expansion Phase|Physician Decision|4|||
155169106|NCT01742286|560057291|FG003|Expansion Phase|Physician Decision|0|||
155169107|NCT01742286|560057292|FG004|Expansion Phase|Physician Decision|0|||
155169108|NCT01742286|560057293|FG005|Expansion Phase|Physician Decision|0|||
155169109|NCT01742286|560057294|FG006|Expansion Phase|Physician Decision|9|||
155169110|NCT01742286|560057288|FG000|Expansion Phase|Adverse Event|0|||
155169111|NCT01742286|560057289|FG001|Expansion Phase|Adverse Event|0|||
155169112|NCT01742286|560057290|FG002|Expansion Phase|Adverse Event|0|||
155169113|NCT01742286|560057291|FG003|Expansion Phase|Adverse Event|0|||
155169114|NCT01742286|560057292|FG004|Expansion Phase|Adverse Event|0|||
155169115|NCT01742286|560057293|FG005|Expansion Phase|Adverse Event|0|||
155169116|NCT01742286|560057294|FG006|Expansion Phase|Adverse Event|6|||
155169117|NCT01742286|560057288|FG000|Expansion Phase|Disease progression|0|||
155169118|NCT01742286|560057289|FG001|Expansion Phase|Disease progression|0|||
155169119|NCT01742286|560057290|FG002|Expansion Phase|Disease progression|3|||
155169120|NCT01742286|560057291|FG003|Expansion Phase|Disease progression|0|||
155169121|NCT01742286|560057292|FG004|Expansion Phase|Disease progression|0|||
155169122|NCT01742286|560057293|FG005|Expansion Phase|Disease progression|0|||
155169123|NCT01742286|560057294|FG006|Expansion Phase|Disease progression|15|||
155169124|NCT01742286|560057288|FG000|Expansion Phase|Withdrawal by Subject|0|||
155169125|NCT01742286|560057289|FG001|Expansion Phase|Withdrawal by Subject|0|||
155169126|NCT01742286|560057290|FG002|Expansion Phase|Withdrawal by Subject|0|||
155169127|NCT01742286|560057291|FG003|Expansion Phase|Withdrawal by Subject|0|||
155169128|NCT01742286|560057292|FG004|Expansion Phase|Withdrawal by Subject|0|||
155169129|NCT01742286|560057293|FG005|Expansion Phase|Withdrawal by Subject|0|||
155169130|NCT01742286|560057294|FG006|Expansion Phase|Withdrawal by Subject|1|||
155169131|NCT02878798|560057295|FG000|Overall Study|Withdrawal by Subject|5|||
155169132|NCT02878798|560057296|FG001|Overall Study|Withdrawal by Subject|4|||
155169133|NCT02878798|560057295|FG000|Overall Study|Lost to Follow-up|2|||
155169134|NCT02878798|560057296|FG001|Overall Study|Lost to Follow-up|2|||
155169135|NCT02878798|560057295|FG000|Overall Study|Protocol Violation|0|||
155169136|NCT02878798|560057296|FG001|Overall Study|Protocol Violation|1|||
155169137|NCT01309282|560057297|FG000|Overall Study|Lost to Follow-up|1|||
155374317|NCT03541200|560803930|FG000|Overall Study|other|8|||
155374318|NCT03459443|560803931|FG000|Overall Study|Lack of Efficacy|3|||
155374319|NCT03459443|560803931|FG000|Overall Study|Adverse Event|1|||
155374320|NCT03459443|560803931|FG000|Overall Study|Sponsor's decision to close the study|18|||
155374321|NCT01276379|560803932|FG000|Overall Study|Screening failure|40|||
155374322|NCT01111240|560803933|FG000|Overall Study|Adverse Event|190|||
155374323|NCT01111240|560803933|FG000|Overall Study|Lack of Efficacy|545|||
155374324|NCT01111240|560803933|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
155169138|NCT02087423|560057298|FG000|Overall Study|Withdrawal by Subject|20|||
155169139|NCT02087423|560057299|FG001|Overall Study|Withdrawal by Subject|20|||
155169140|NCT02087423|560057300|FG002|Overall Study|Withdrawal by Subject|3|||
155169141|NCT02087423|560057298|FG000|Overall Study|Death|68|||
155169142|NCT02087423|560057299|FG001|Overall Study|Death|207|||
155169143|NCT02087423|560057300|FG002|Overall Study|Death|40|||
155169144|NCT02087423|560057298|FG000|Overall Study|Lost to Follow-up|0|||
155169145|NCT02087423|560057299|FG001|Overall Study|Lost to Follow-up|2|||
155169146|NCT02087423|560057300|FG002|Overall Study|Lost to Follow-up|0|||
155169147|NCT02087423|560057298|FG000|Overall Study|Terminated from study at final DCO|23|||
155169148|NCT02087423|560057299|FG001|Overall Study|Terminated from study at final DCO|36|||
155169149|NCT02087423|560057300|FG002|Overall Study|Terminated from study at final DCO|25|||
155169150|NCT01387542|560057301|FG000|Overall Study|Adverse Event|3|||
155169151|NCT01387542|560057301|FG000|Overall Study|Withdrawal by Subject|1|||
155169152|NCT01387542|560057301|FG000|Overall Study|Changed diagnosis|1|||
155169153|NCT01387542|560057301|FG000|Overall Study|Insufficient response|1|||
155374325|NCT01111240|560803933|FG000|Overall Study|Other|312|||
155374326|NCT00680992|560803939|FG000|Overall Study|Complete Resection (as per protocol)|25|||
155374327|NCT00680992|560803940|FG001|Overall Study|Complete Resection (as per protocol)|121|||
155374328|NCT00680992|560803941|FG002|Overall Study|Complete Resection (as per protocol)|0|||
155374329|NCT00680992|560803939|FG000|Overall Study|Administrative Decision|83|||
155374330|NCT00680992|560803940|FG001|Overall Study|Administrative Decision|42|||
155374331|NCT00680992|560803941|FG002|Overall Study|Administrative Decision|5|||
155374332|NCT00680992|560803939|FG000|Overall Study|End of Trial|32|||
155374333|NCT00680992|560803940|FG001|Overall Study|End of Trial|12|||
155374334|NCT00680992|560803941|FG002|Overall Study|End of Trial|3|||
155374335|NCT00680992|560803939|FG000|Overall Study|Withdrawal by Subject|33|||
155374336|NCT00680992|560803940|FG001|Overall Study|Withdrawal by Subject|11|||
155374337|NCT00680992|560803941|FG002|Overall Study|Withdrawal by Subject|1|||
155374338|NCT00680992|560803939|FG000|Overall Study|Adverse Event|21|||
155374339|NCT00680992|560803940|FG001|Overall Study|Adverse Event|19|||
155374340|NCT00680992|560803941|FG002|Overall Study|Adverse Event|1|||
155374341|NCT00680992|560803939|FG000|Overall Study|Other|19|||
155374342|NCT00680992|560803940|FG001|Overall Study|Other|14|||
155374343|NCT00680992|560803941|FG002|Overall Study|Other|1|||
155374344|NCT00680992|560803939|FG000|Overall Study|Disease Progression|21|||
155374345|NCT00680992|560803940|FG001|Overall Study|Disease Progression|9|||
155374346|NCT00680992|560803941|FG002|Overall Study|Disease Progression|0|||
155374347|NCT00680992|560803939|FG000|Overall Study|Lost to Follow-up|12|||
155374348|NCT00680992|560803940|FG001|Overall Study|Lost to Follow-up|14|||
155374349|NCT00680992|560803941|FG002|Overall Study|Lost to Follow-up|0|||
155374350|NCT00680992|560803939|FG000|Overall Study|Noncompliance|4|||
155374351|NCT00680992|560803940|FG001|Overall Study|Noncompliance|6|||
155374352|NCT00680992|560803941|FG002|Overall Study|Noncompliance|0|||
155374353|NCT00680992|560803939|FG000|Overall Study|Requirement for Alternative Therapy|8|||
155374354|NCT00680992|560803940|FG001|Overall Study|Requirement for Alternative Therapy|2|||
155374355|NCT00680992|560803941|FG002|Overall Study|Requirement for Alternative Therapy|0|||
155374356|NCT00680992|560803939|FG000|Overall Study|Pregnancy|5|||
155374357|NCT00680992|560803940|FG001|Overall Study|Pregnancy|0|||
155374358|NCT00680992|560803941|FG002|Overall Study|Pregnancy|1|||
155374359|NCT00680992|560803939|FG000|Overall Study|Death|5|||
155374360|NCT00680992|560803940|FG001|Overall Study|Death|1|||
155374361|NCT00680992|560803941|FG002|Overall Study|Death|0|||
155374362|NCT00680992|560803939|FG000|Overall Study|Ineligibility Determined|0|||
155374363|NCT00680992|560803940|FG001|Overall Study|Ineligibility Determined|1|||
155374364|NCT00680992|560803941|FG002|Overall Study|Ineligibility Determined|0|||
155374365|NCT02425904|560803944|FG000|Overall Study|Lost to Follow-up|1|||
155091087|NCT02367456|559767475|FG001|Overall Study|Other reason|3|||
155091088|NCT02367456|559767476|FG002|Overall Study|Other reason|9|||
155091089|NCT02367456|559767474|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
155091090|NCT02367456|559767475|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
155091091|NCT02367456|559767476|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
155091092|NCT01645176|559767478|FG000|Overall Study|Lack of Efficacy|4|||
155091093|NCT01645176|559767478|FG000|Overall Study|did not complete final MRI|1|||
155091094|NCT04903288|559767481|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
155091095|NCT04903288|559767481|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
155091096|NCT04903288|559767481|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
155091097|NCT04903288|559767481|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
155091098|NCT00573768|559767482|FG000|Overall Study|Adverse Event|1|||
155091099|NCT00573768|559767483|FG001|Overall Study|Adverse Event|1|||
155091100|NCT00573768|559767484|FG002|Overall Study|Adverse Event|2|||
155091101|NCT00573768|559767482|FG000|Overall Study|Protocol Violation|1|||
155091102|NCT00573768|559767483|FG001|Overall Study|Protocol Violation|0|||
155091103|NCT00573768|559767484|FG002|Overall Study|Protocol Violation|1|||
155091104|NCT00573768|559767482|FG000|Overall Study|Withdrawal by Subject|0|||
155091105|NCT00573768|559767483|FG001|Overall Study|Withdrawal by Subject|1|||
155091106|NCT00573768|559767484|FG002|Overall Study|Withdrawal by Subject|0|||
155091107|NCT00573768|559767482|FG000|Overall Study|Lost to Follow-up|0|||
155374366|NCT02425904|560803945|FG001|Overall Study|Lost to Follow-up|0|||
155374367|NCT02425904|560803944|FG000|Overall Study|Withdrawal by Subject|2|||
155091108|NCT00573768|559767483|FG001|Overall Study|Lost to Follow-up|0|||
155091109|NCT00573768|559767484|FG002|Overall Study|Lost to Follow-up|1|||
155091110|NCT00904371|559767485|FG000|Overall Study|Adverse Event|2|||
155374368|NCT02425904|560803945|FG001|Overall Study|Withdrawal by Subject|0|||
155374369|NCT02425904|560803944|FG000|Overall Study|Death|0|||
155374370|NCT02425904|560803945|FG001|Overall Study|Death|3|||
155374371|NCT05384938|560803946|FG000|Overall Study|Withdrawal by Subject|8|||
155374372|NCT05384938|560803946|FG000|Overall Study|Lost to Follow-up|6|||
155374373|NCT05384938|560803946|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
155374374|NCT02626455|560803947|FG000|Overall Study|Other|1|||
154965725|NCT00112437|559298873|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
154965726|NCT00112437|559298874|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965727|NCT00112437|559298875|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965728|NCT00112437|559298876|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
155374375|NCT02626455|560803948|FG001|Overall Study|Other|1|||
155374376|NCT02626455|560803949|FG002|Overall Study|Other|0|||
155374377|NCT02626455|560803950|FG003|Overall Study|Other|0|||
155374378|NCT02626455|560803951|FG004|Overall Study|Other|0|||
155374379|NCT02626455|560803952|FG005|Overall Study|Other|17|||
155374380|NCT02626455|560803953|FG006|Overall Study|Other|23|||
155374381|NCT02626455|560803947|FG000|Overall Study|Withdrawal by Subject|1|||
155374382|NCT02626455|560803948|FG001|Overall Study|Withdrawal by Subject|0|||
155374383|NCT02626455|560803949|FG002|Overall Study|Withdrawal by Subject|0|||
155169154|NCT01387542|560057301|FG000|Overall Study|Non-compliant|1|||
155374384|NCT02626455|560803950|FG003|Overall Study|Withdrawal by Subject|0|||
155169155|NCT01387542|560057301|FG000|Overall Study|Lost to Follow-up|1|||
155374385|NCT02626455|560803951|FG004|Overall Study|Withdrawal by Subject|0|||
155374386|NCT02626455|560803952|FG005|Overall Study|Withdrawal by Subject|10|||
155374387|NCT02626455|560803953|FG006|Overall Study|Withdrawal by Subject|6|||
155374388|NCT02626455|560803947|FG000|Overall Study|Physician Decision|0|||
155374389|NCT02626455|560803948|FG001|Overall Study|Physician Decision|2|||
155374390|NCT02626455|560803949|FG002|Overall Study|Physician Decision|2|||
155374391|NCT02626455|560803950|FG003|Overall Study|Physician Decision|2|||
155374392|NCT02626455|560803951|FG004|Overall Study|Physician Decision|1|||
155374393|NCT02626455|560803952|FG005|Overall Study|Physician Decision|10|||
155374394|NCT02626455|560803953|FG006|Overall Study|Physician Decision|3|||
155374395|NCT02626455|560803947|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374396|NCT02626455|560803948|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374397|NCT02626455|560803949|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374398|NCT02626455|560803950|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374399|NCT02626455|560803951|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374400|NCT02626455|560803952|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
155374401|NCT02626455|560803953|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
155374402|NCT02626455|560803947|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374403|NCT02626455|560803948|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374404|NCT02626455|560803949|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374405|NCT02626455|560803950|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374406|NCT02626455|560803951|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374407|NCT02626455|560803952|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
155374408|NCT02626455|560803953|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
155374409|NCT02626455|560803947|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374410|NCT02626455|560803948|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374411|NCT02626455|560803949|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374412|NCT02626455|560803950|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374413|NCT02626455|560803951|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
155374414|NCT02626455|560803952|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
155374415|NCT02626455|560803953|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
155374416|NCT02626455|560803947|FG000|Overall Study|Patient decision|0|||
155374417|NCT02626455|560803948|FG001|Overall Study|Patient decision|1|||
155374418|NCT02626455|560803949|FG002|Overall Study|Patient decision|0|||
155374419|NCT02626455|560803950|FG003|Overall Study|Patient decision|0|||
155374420|NCT02626455|560803951|FG004|Overall Study|Patient decision|1|||
155374421|NCT02626455|560803952|FG005|Overall Study|Patient decision|36|||
155374422|NCT02626455|560803953|FG006|Overall Study|Patient decision|22|||
155374423|NCT02626455|560803947|FG000|Overall Study|Protocol Violation|0|||
155374424|NCT02626455|560803948|FG001|Overall Study|Protocol Violation|0|||
155374425|NCT02626455|560803949|FG002|Overall Study|Protocol Violation|0|||
155374426|NCT02626455|560803950|FG003|Overall Study|Protocol Violation|0|||
155374427|NCT02626455|560803951|FG004|Overall Study|Protocol Violation|0|||
155374428|NCT02626455|560803952|FG005|Overall Study|Protocol Violation|0|||
155374429|NCT02626455|560803953|FG006|Overall Study|Protocol Violation|1|||
155374430|NCT02626455|560803947|FG000|Overall Study|Progressive disease - radiological progression|0|||
155374431|NCT02626455|560803948|FG001|Overall Study|Progressive disease - radiological progression|0|||
155374432|NCT02626455|560803949|FG002|Overall Study|Progressive disease - radiological progression|0|||
155374433|NCT02626455|560803950|FG003|Overall Study|Progressive disease - radiological progression|0|||
155374434|NCT02626455|560803951|FG004|Overall Study|Progressive disease - radiological progression|0|||
155374435|NCT02626455|560803952|FG005|Overall Study|Progressive disease - radiological progression|11|||
155374436|NCT02626455|560803953|FG006|Overall Study|Progressive disease - radiological progression|22|||
155374437|NCT02626455|560803947|FG000|Overall Study|Progressive disease - clinical progression|0|||
155374438|NCT02626455|560803948|FG001|Overall Study|Progressive disease - clinical progression|0|||
155374439|NCT02626455|560803949|FG002|Overall Study|Progressive disease - clinical progression|0|||
155374440|NCT02626455|560803950|FG003|Overall Study|Progressive disease - clinical progression|0|||
155374441|NCT02626455|560803951|FG004|Overall Study|Progressive disease - clinical progression|0|||
155169156|NCT01761240|560057304|FG000|Overall Study|Progressive disease:radiology assessment|3|||
155374442|NCT02626455|560803952|FG005|Overall Study|Progressive disease - clinical progression|1|||
155374443|NCT02626455|560803953|FG006|Overall Study|Progressive disease - clinical progression|2|||
155374444|NCT02626455|560803947|FG000|Overall Study|Lost to Follow-up|0|||
155169157|NCT01761240|560057305|FG001|Overall Study|Progressive disease:radiology assessment|3|||
155374445|NCT02626455|560803948|FG001|Overall Study|Lost to Follow-up|0|||
155374446|NCT02626455|560803949|FG002|Overall Study|Lost to Follow-up|0|||
155374447|NCT02626455|560803950|FG003|Overall Study|Lost to Follow-up|0|||
155374448|NCT02626455|560803951|FG004|Overall Study|Lost to Follow-up|0|||
155374449|NCT02626455|560803952|FG005|Overall Study|Lost to Follow-up|1|||
155374450|NCT02626455|560803953|FG006|Overall Study|Lost to Follow-up|0|||
155374451|NCT02626455|560803947|FG000|Overall Study|AE not associated with clinical disease progression|1|||
155374452|NCT02626455|560803948|FG001|Overall Study|AE not associated with clinical disease progression|1|||
155374453|NCT02626455|560803949|FG002|Overall Study|AE not associated with clinical disease progression|0|||
155374454|NCT02626455|560803950|FG003|Overall Study|AE not associated with clinical disease progression|2|||
155374455|NCT02626455|560803951|FG004|Overall Study|AE not associated with clinical disease progression|1|||
155374456|NCT02626455|560803952|FG005|Overall Study|AE not associated with clinical disease progression|65|||
155374457|NCT02626455|560803953|FG006|Overall Study|AE not associated with clinical disease progression|21|||
155374458|NCT02626455|560803947|FG000|Overall Study|AE associated with clinical disease progression|0|||
155374459|NCT02626455|560803948|FG001|Overall Study|AE associated with clinical disease progression|0|||
155374460|NCT02626455|560803949|FG002|Overall Study|AE associated with clinical disease progression|0|||
155374461|NCT02626455|560803950|FG003|Overall Study|AE associated with clinical disease progression|0|||
155374462|NCT02626455|560803951|FG004|Overall Study|AE associated with clinical disease progression|0|||
155374463|NCT02626455|560803952|FG005|Overall Study|AE associated with clinical disease progression|1|||
155374464|NCT02626455|560803953|FG006|Overall Study|AE associated with clinical disease progression|2|||
155374465|NCT02626455|560803947|FG000|Overall Study|Study intervention never administered|0|||
155374466|NCT02626455|560803948|FG001|Overall Study|Study intervention never administered|0|||
155374467|NCT02626455|560803949|FG002|Overall Study|Study intervention never administered|0|||
155374468|NCT02626455|560803950|FG003|Overall Study|Study intervention never administered|0|||
155374469|NCT02626455|560803951|FG004|Overall Study|Study intervention never administered|0|||
155374470|NCT02626455|560803952|FG005|Overall Study|Study intervention never administered|1|||
155374471|NCT02626455|560803953|FG006|Overall Study|Study intervention never administered|3|||
155374472|NCT05148962|560803954|FG000|Overall Study|Withdrawal by Subject|1|||
155374473|NCT05148962|560803955|FG001|Overall Study|Withdrawal by Subject|1|||
155374474|NCT05148962|560803956|FG002|Overall Study|Withdrawal by Subject|0|||
155374475|NCT05148962|560803957|FG003|Overall Study|Withdrawal by Subject|1|||
155374476|NCT05148962|560803958|FG004|Overall Study|Withdrawal by Subject|0|||
155374477|NCT05148962|560803954|FG000|Overall Study|Participant was early terminated per protocol|0|||
155374478|NCT05148962|560803955|FG001|Overall Study|Participant was early terminated per protocol|0|||
155374479|NCT05148962|560803956|FG002|Overall Study|Participant was early terminated per protocol|3|||
155374480|NCT05148962|560803957|FG003|Overall Study|Participant was early terminated per protocol|5|||
155374481|NCT05148962|560803958|FG004|Overall Study|Participant was early terminated per protocol|2|||
155374482|NCT05148962|560803954|FG000|Overall Study|Miscellaneous|0|||
155374483|NCT05148962|560803955|FG001|Overall Study|Miscellaneous|0|||
155374484|NCT05148962|560803956|FG002|Overall Study|Miscellaneous|0|||
155374485|NCT05148962|560803957|FG003|Overall Study|Miscellaneous|1|||
155374486|NCT05148962|560803958|FG004|Overall Study|Miscellaneous|0|||
155374487|NCT06665919|560803959|FG000|Overall Study|Withdrawal by Subject|4|||
155374488|NCT06665919|560803960|FG001|Overall Study|Withdrawal by Subject|4|||
155374489|NCT06665919|560803961|FG002|Overall Study|Withdrawal by Subject|4|||
155374490|NCT06665919|560803959|FG000|Overall Study|Non-compliance to Treatment|4|||
155374491|NCT06665919|560803960|FG001|Overall Study|Non-compliance to Treatment|1|||
155374492|NCT06665919|560803961|FG002|Overall Study|Non-compliance to Treatment|6|||
155374493|NCT06665919|560803959|FG000|Overall Study|Lost to Follow-up|3|||
155374494|NCT06665919|560803960|FG001|Overall Study|Lost to Follow-up|0|||
155374495|NCT06665919|560803961|FG002|Overall Study|Lost to Follow-up|2|||
155374496|NCT06665919|560803959|FG000|Overall Study|Physician Decision|4|||
155374497|NCT06665919|560803960|FG001|Overall Study|Physician Decision|0|||
155374498|NCT06665919|560803961|FG002|Overall Study|Physician Decision|1|||
155374499|NCT01144377|560803962|FG000|52 Week Treatment Period|Adverse Event|0|||
155374500|NCT01144377|560803963|FG001|52 Week Treatment Period|Adverse Event|0|||
155374501|NCT01144377|560803964|FG002|52 Week Treatment Period|Adverse Event|3|||
155374502|NCT01144377|560803965|FG003|52 Week Treatment Period|Adverse Event|2|||
155374503|NCT01144377|560803966|FG004|52 Week Treatment Period|Adverse Event|1|||
155374504|NCT01144377|560803962|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
155374505|NCT01144377|560803963|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
155374506|NCT01144377|560803964|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
155374507|NCT01144377|560803965|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
155374508|NCT01144377|560803966|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
155374509|NCT01144377|560803962|FG000|52 Week Treatment Period|Protocol Violation|0|||
155374510|NCT01144377|560803963|FG001|52 Week Treatment Period|Protocol Violation|0|||
155374511|NCT01144377|560803964|FG002|52 Week Treatment Period|Protocol Violation|0|||
155374512|NCT01144377|560803965|FG003|52 Week Treatment Period|Protocol Violation|0|||
155374513|NCT01144377|560803966|FG004|52 Week Treatment Period|Protocol Violation|1|||
155374514|NCT01144377|560803962|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
155374515|NCT01144377|560803963|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
155374516|NCT01144377|560803964|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
155374517|NCT01144377|560803965|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
155374518|NCT01144377|560803966|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
155374519|NCT01144377|560803962|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
155374520|NCT01144377|560803963|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
155374521|NCT01144377|560803964|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
155374522|NCT01144377|560803965|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
155374523|NCT01144377|560803966|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
155374524|NCT01144377|560803962|FG000|52 Week Treatment Period|Sponsor Decision|0|||
155374525|NCT01144377|560803963|FG001|52 Week Treatment Period|Sponsor Decision|0|||
155374526|NCT01144377|560803964|FG002|52 Week Treatment Period|Sponsor Decision|0|||
155374527|NCT01144377|560803965|FG003|52 Week Treatment Period|Sponsor Decision|0|||
155374528|NCT01144377|560803966|FG004|52 Week Treatment Period|Sponsor Decision|1|||
155374529|NCT01144377|560803962|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
155374530|NCT01144377|560803963|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
155374531|NCT01144377|560803964|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
155374532|NCT01144377|560803965|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
155374533|NCT01144377|560803966|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
155374534|NCT01144377|560803962|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374535|NCT01144377|560803963|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374536|NCT01144377|560803964|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374537|NCT01144377|560803965|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
155374538|NCT01144377|560803966|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
155374539|NCT01144377|560803962|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
155374540|NCT01144377|560803963|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374541|NCT01144377|560803964|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374542|NCT01144377|560803965|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374543|NCT01144377|560803966|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
155374544|NCT01525238|560803967|FG000|Overall Study|Withdrawal by Subject|1|||
155374545|NCT01525238|560803968|FG001|Overall Study|Withdrawal by Subject|0|||
155374546|NCT01525238|560803969|FG002|Overall Study|Withdrawal by Subject|0|||
155374547|NCT01214642|560803970|FG000|Overall Study|Progressive Disease|3|||
155374548|NCT01214642|560803971|FG001|Overall Study|Progressive Disease|2|||
155374549|NCT01214642|560803972|FG002|Overall Study|Progressive Disease|3|||
155374550|NCT01214642|560803973|FG003|Overall Study|Progressive Disease|5|||
155374551|NCT01214642|560803974|FG004|Overall Study|Progressive Disease|5|||
155374552|NCT01214642|560803975|FG005|Overall Study|Progressive Disease|3|||
155374553|NCT01214642|560803976|FG006|Overall Study|Progressive Disease|5|||
155374554|NCT01214642|560803977|FG007|Overall Study|Progressive Disease|3|||
155374555|NCT01214642|560803978|FG008|Overall Study|Progressive Disease|10|||
155374556|NCT01214642|560803979|FG009|Overall Study|Progressive Disease|2|||
155374557|NCT01214642|560803980|FG010|Overall Study|Progressive Disease|1|||
155374558|NCT01214642|560803981|FG011|Overall Study|Progressive Disease|4|||
155374559|NCT01214642|560803970|FG000|Overall Study|Adverse Event|0|||
155374560|NCT01214642|560803971|FG001|Overall Study|Adverse Event|1|||
155374561|NCT01214642|560803972|FG002|Overall Study|Adverse Event|0|||
155374562|NCT01214642|560803973|FG003|Overall Study|Adverse Event|0|||
155374563|NCT01214642|560803974|FG004|Overall Study|Adverse Event|0|||
155374564|NCT01214642|560803975|FG005|Overall Study|Adverse Event|0|||
155374565|NCT01214642|560803976|FG006|Overall Study|Adverse Event|1|||
155374566|NCT01214642|560803977|FG007|Overall Study|Adverse Event|0|||
155374567|NCT01214642|560803978|FG008|Overall Study|Adverse Event|0|||
155374568|NCT01214642|560803979|FG009|Overall Study|Adverse Event|1|||
155374569|NCT01214642|560803980|FG010|Overall Study|Adverse Event|1|||
155374570|NCT01214642|560803981|FG011|Overall Study|Adverse Event|0|||
155374571|NCT01214642|560803970|FG000|Overall Study|Death|0|||
155374572|NCT01214642|560803971|FG001|Overall Study|Death|0|||
155374573|NCT01214642|560803972|FG002|Overall Study|Death|1|||
155374574|NCT01214642|560803973|FG003|Overall Study|Death|0|||
155374575|NCT01214642|560803974|FG004|Overall Study|Death|0|||
155374576|NCT01214642|560803975|FG005|Overall Study|Death|0|||
155374577|NCT01214642|560803976|FG006|Overall Study|Death|0|||
155374578|NCT01214642|560803977|FG007|Overall Study|Death|0|||
155374579|NCT01214642|560803978|FG008|Overall Study|Death|0|||
155374580|NCT01214642|560803979|FG009|Overall Study|Death|0|||
155374581|NCT01214642|560803980|FG010|Overall Study|Death|1|||
155374582|NCT01214642|560803981|FG011|Overall Study|Death|0|||
155374583|NCT01214642|560803970|FG000|Overall Study|Withdrawal by Subject|0|||
155374584|NCT01214642|560803971|FG001|Overall Study|Withdrawal by Subject|0|||
155374585|NCT01214642|560803972|FG002|Overall Study|Withdrawal by Subject|1|||
155374586|NCT01214642|560803973|FG003|Overall Study|Withdrawal by Subject|0|||
155374587|NCT01214642|560803974|FG004|Overall Study|Withdrawal by Subject|0|||
155374588|NCT01214642|560803975|FG005|Overall Study|Withdrawal by Subject|0|||
155374589|NCT01214642|560803976|FG006|Overall Study|Withdrawal by Subject|0|||
155374590|NCT01214642|560803977|FG007|Overall Study|Withdrawal by Subject|0|||
155374591|NCT01214642|560803978|FG008|Overall Study|Withdrawal by Subject|3|||
155374592|NCT01214642|560803979|FG009|Overall Study|Withdrawal by Subject|1|||
155374593|NCT01214642|560803980|FG010|Overall Study|Withdrawal by Subject|1|||
155374594|NCT01214642|560803981|FG011|Overall Study|Withdrawal by Subject|0|||
155374595|NCT01214642|560803970|FG000|Overall Study|Physician Decision|0|||
155374596|NCT01214642|560803971|FG001|Overall Study|Physician Decision|0|||
155374597|NCT01214642|560803972|FG002|Overall Study|Physician Decision|1|||
155374598|NCT01214642|560803973|FG003|Overall Study|Physician Decision|1|||
155374599|NCT01214642|560803974|FG004|Overall Study|Physician Decision|1|||
155374600|NCT01214642|560803975|FG005|Overall Study|Physician Decision|0|||
155374601|NCT01214642|560803976|FG006|Overall Study|Physician Decision|0|||
155374602|NCT01214642|560803977|FG007|Overall Study|Physician Decision|0|||
155374603|NCT01214642|560803978|FG008|Overall Study|Physician Decision|0|||
155374604|NCT01214642|560803979|FG009|Overall Study|Physician Decision|0|||
155374605|NCT01214642|560803980|FG010|Overall Study|Physician Decision|0|||
155374606|NCT01214642|560803981|FG011|Overall Study|Physician Decision|2|||
155374607|NCT04696653|560803982|FG000|Overall Study|left organization|18|||
155374608|NCT04696653|560803982|FG000|Overall Study|Lost to Follow-up|3|||
155374609|NCT02075476|560805317|FG000|Overall Study|Death|2|||
155374610|NCT02075476|560805318|FG001|Overall Study|Death|2|||
155374611|NCT02075476|560805317|FG000|Overall Study|Lost to Follow-up|1|||
155374612|NCT02075476|560805318|FG001|Overall Study|Lost to Follow-up|3|||
155374613|NCT02914275|560805321|FG000|Overall Study|Lost to Follow-up|84|||
155374614|NCT02914275|560805322|FG001|Overall Study|Lost to Follow-up|29|||
155374615|NCT02914275|560805321|FG000|Overall Study|Withdrawal by Subject|26|||
155374616|NCT02914275|560805322|FG001|Overall Study|Withdrawal by Subject|10|||
155374617|NCT02914275|560805321|FG000|Overall Study|Protocol Violation|1|||
155374618|NCT02914275|560805322|FG001|Overall Study|Protocol Violation|1|||
155374619|NCT02914275|560805321|FG000|Overall Study|Physician Decision|3|||
155374620|NCT02914275|560805322|FG001|Overall Study|Physician Decision|1|||
155374621|NCT02914275|560805321|FG000|Overall Study|Other|4|||
155374622|NCT02914275|560805322|FG001|Overall Study|Other|1|||
155374623|NCT02914275|560805321|FG000|Overall Study|Excluded due to invalid informed consent|3|||
155374624|NCT02914275|560805322|FG001|Overall Study|Excluded due to invalid informed consent|0|||
155374625|NCT03527550|560805325|FG000|Overall Study|Lost to Follow-up|4|||
155374626|NCT03527550|560805326|FG001|Overall Study|Lost to Follow-up|2|||
154965729|NCT00112437|559298877|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965730|NCT00112437|559298878|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965731|NCT00112437|559298879|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965732|NCT00112437|559298880|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374627|NCT03527550|560805325|FG000|Overall Study|Withdrawal by Subject|4|||
155374628|NCT03527550|560805326|FG001|Overall Study|Withdrawal by Subject|1|||
155374629|NCT03527550|560805325|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
155374630|NCT03527550|560805326|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
155374631|NCT01659853|560805327|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
155374632|NCT01659853|560805328|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
155374633|NCT01659853|560805327|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
155374634|NCT01659853|560805328|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
155374635|NCT03053518|560805331|FG000|Overall Study|Withdrawal by Subject|3|||
155374636|NCT03053518|560805331|FG000|Overall Study|Lost to Follow-up|2|||
155374637|NCT03053518|560805331|FG000|Overall Study|Ineligible|5|||
155374638|NCT02683876|560805332|FG000|Overall Study|samples damaged during shipping|2|||
155374639|NCT02683876|560805333|FG001|Overall Study|samples damaged during shipping|0|||
155374640|NCT00488475|560805336|FG000|Overall Study|Other|1754|||
155374641|NCT02797080|560805340|FG000|Overall Study|Lost to Follow-up|1|||
155374642|NCT02797080|560805340|FG000|Overall Study|Withdrawal by Subject|1|||
155374643|NCT04035499|560805343|FG000|Overall Study|Death|2|||
155374644|NCT04035499|560805343|FG000|Overall Study|Withdrawal by Subject|1|||
155374645|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Adverse Event|1|||
155374646|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Adverse Event|1|||
155374647|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Adverse Event|2|||
155374648|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Adverse Event|5|||
155374649|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Adverse Event|0|||
155374650|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
155374651|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
155374652|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
155374653|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
155374654|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
155374655|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
155374656|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
155374657|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
155374658|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
154965733|NCT00112437|559298881|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374659|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
155374660|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374661|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374662|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374663|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
155374664|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
155374665|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
155374666|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
155374667|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
154965734|NCT00112437|559298882|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374668|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
155374669|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
155374670|NCT00951015|560805344|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
155374671|NCT00951015|560805345|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
155374672|NCT00951015|560805346|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
155374673|NCT00951015|560805347|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
155374674|NCT00951015|560805348|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
155374675|NCT00951015|560805344|FG000|Open-label Phase|Adverse Event|0|||
155374676|NCT00951015|560805345|FG001|Open-label Phase|Adverse Event|0|||
155374677|NCT00951015|560805346|FG002|Open-label Phase|Adverse Event|0|||
155374678|NCT00951015|560805347|FG003|Open-label Phase|Adverse Event|0|||
155374679|NCT00951015|560805348|FG004|Open-label Phase|Adverse Event|3|||
155374680|NCT00951015|560805344|FG000|Open-label Phase|Lack of Efficacy|0|||
155374681|NCT00951015|560805345|FG001|Open-label Phase|Lack of Efficacy|0|||
155374682|NCT00951015|560805346|FG002|Open-label Phase|Lack of Efficacy|0|||
155374683|NCT00951015|560805347|FG003|Open-label Phase|Lack of Efficacy|0|||
155374684|NCT00951015|560805348|FG004|Open-label Phase|Lack of Efficacy|1|||
155374685|NCT00951015|560805344|FG000|Open-label Phase|Protocol Violation|0|||
155374686|NCT00951015|560805345|FG001|Open-label Phase|Protocol Violation|0|||
155374687|NCT00951015|560805346|FG002|Open-label Phase|Protocol Violation|0|||
155374688|NCT00951015|560805347|FG003|Open-label Phase|Protocol Violation|0|||
155374689|NCT00951015|560805348|FG004|Open-label Phase|Protocol Violation|12|||
155374690|NCT00951015|560805344|FG000|Open-label Phase|Lost to Follow-up|0|||
155374691|NCT00951015|560805345|FG001|Open-label Phase|Lost to Follow-up|0|||
155374692|NCT00951015|560805346|FG002|Open-label Phase|Lost to Follow-up|0|||
155374693|NCT00951015|560805347|FG003|Open-label Phase|Lost to Follow-up|0|||
155374694|NCT00951015|560805348|FG004|Open-label Phase|Lost to Follow-up|12|||
155374695|NCT00951015|560805344|FG000|Open-label Phase|Withdrawal by Subject|0|||
155374696|NCT00951015|560805345|FG001|Open-label Phase|Withdrawal by Subject|0|||
155374697|NCT00951015|560805346|FG002|Open-label Phase|Withdrawal by Subject|0|||
155374698|NCT00951015|560805347|FG003|Open-label Phase|Withdrawal by Subject|0|||
155374699|NCT00951015|560805348|FG004|Open-label Phase|Withdrawal by Subject|14|||
155374700|NCT00951015|560805344|FG000|Open-label Phase|Physician Decision|0|||
155374701|NCT00951015|560805345|FG001|Open-label Phase|Physician Decision|0|||
155374702|NCT00951015|560805346|FG002|Open-label Phase|Physician Decision|0|||
155374703|NCT00951015|560805347|FG003|Open-label Phase|Physician Decision|0|||
155374704|NCT00951015|560805348|FG004|Open-label Phase|Physician Decision|8|||
155374705|NCT03819634|560805350|FG000|Overall Study|Physician Decision|2|||
155374706|NCT00299494|560805351|FG000|Overall Study|Withdrawal by Subject|0|||
155374707|NCT00299494|560805352|FG001|Overall Study|Withdrawal by Subject|0|||
155374708|NCT00299494|560805353|FG002|Overall Study|Withdrawal by Subject|0|||
155374709|NCT00299494|560805354|FG003|Overall Study|Withdrawal by Subject|3|||
155374710|NCT00299494|560805355|FG004|Overall Study|Withdrawal by Subject|1|||
155374711|NCT00299494|560805356|FG005|Overall Study|Withdrawal by Subject|4|||
155374712|NCT00299494|560805351|FG000|Overall Study|Physician Decision|0|||
155374713|NCT00299494|560805352|FG001|Overall Study|Physician Decision|0|||
155374714|NCT00299494|560805353|FG002|Overall Study|Physician Decision|0|||
155374715|NCT00299494|560805354|FG003|Overall Study|Physician Decision|0|||
155374716|NCT00299494|560805355|FG004|Overall Study|Physician Decision|1|||
155374717|NCT00299494|560805356|FG005|Overall Study|Physician Decision|0|||
155374718|NCT00299494|560805351|FG000|Overall Study|Death|3|||
155374719|NCT00299494|560805352|FG001|Overall Study|Death|1|||
155374720|NCT00299494|560805353|FG002|Overall Study|Death|4|||
155374721|NCT00299494|560805354|FG003|Overall Study|Death|6|||
155374722|NCT00299494|560805355|FG004|Overall Study|Death|18|||
155374723|NCT00299494|560805356|FG005|Overall Study|Death|19|||
155374724|NCT00299494|560805351|FG000|Overall Study|Lost to Follow-up|0|||
155374725|NCT00299494|560805352|FG001|Overall Study|Lost to Follow-up|0|||
155374726|NCT00299494|560805353|FG002|Overall Study|Lost to Follow-up|0|||
155374727|NCT00299494|560805354|FG003|Overall Study|Lost to Follow-up|0|||
155374728|NCT00299494|560805355|FG004|Overall Study|Lost to Follow-up|3|||
155374729|NCT00299494|560805356|FG005|Overall Study|Lost to Follow-up|1|||
155374730|NCT00299494|560805351|FG000|Overall Study|Other - Unspecified|0|||
155374731|NCT00299494|560805352|FG001|Overall Study|Other - Unspecified|0|||
155374732|NCT00299494|560805353|FG002|Overall Study|Other - Unspecified|0|||
155374733|NCT00299494|560805354|FG003|Overall Study|Other - Unspecified|0|||
155374734|NCT00299494|560805355|FG004|Overall Study|Other - Unspecified|3|||
155374735|NCT00299494|560805356|FG005|Overall Study|Other - Unspecified|1|||
155374736|NCT00299494|560805351|FG000|Overall Study|Other - site closure|0|||
155374737|NCT00299494|560805352|FG001|Overall Study|Other - site closure|0|||
155374738|NCT00299494|560805353|FG002|Overall Study|Other - site closure|0|||
155374739|NCT00299494|560805354|FG003|Overall Study|Other - site closure|1|||
155374740|NCT00299494|560805355|FG004|Overall Study|Other - site closure|1|||
155374741|NCT00299494|560805356|FG005|Overall Study|Other - site closure|1|||
155374742|NCT01417104|560805360|FG000|Overall Study|Withdrawal by Subject|5|||
155374743|NCT01417104|560805361|FG001|Overall Study|Withdrawal by Subject|1|||
155374744|NCT01417104|560805360|FG000|Overall Study|Failure to make contact|0|||
155374745|NCT01417104|560805361|FG001|Overall Study|Failure to make contact|1|||
155374746|NCT01417104|560805360|FG000|Overall Study|Adverse Event|1|||
155374747|NCT01417104|560805361|FG001|Overall Study|Adverse Event|0|||
155374748|NCT01416389|560805362|FG000|Overall Study|Lost to Follow-up|1|||
155374749|NCT01416389|560805363|FG001|Overall Study|Lost to Follow-up|0|||
155374750|NCT01416389|560805362|FG000|Overall Study|Started New Therapy|2|||
155374751|NCT01416389|560805363|FG001|Overall Study|Started New Therapy|0|||
155374752|NCT01365481|560805364|FG000|Overall Study|Adverse Event|6|||
155374753|NCT01365481|560805365|FG001|Overall Study|Adverse Event|9|||
155374754|NCT01365481|560805366|FG002|Overall Study|Adverse Event|0|||
155374755|NCT01365481|560805367|FG003|Overall Study|Adverse Event|2|||
155374756|NCT01365481|560805364|FG000|Overall Study|Withdrawal by Subject|0|||
155374757|NCT01365481|560805365|FG001|Overall Study|Withdrawal by Subject|2|||
155374758|NCT01365481|560805366|FG002|Overall Study|Withdrawal by Subject|1|||
155374759|NCT01365481|560805367|FG003|Overall Study|Withdrawal by Subject|1|||
155374760|NCT01365481|560805364|FG000|Overall Study|Lost to Follow-up|1|||
155374761|NCT01365481|560805365|FG001|Overall Study|Lost to Follow-up|1|||
155374762|NCT01365481|560805366|FG002|Overall Study|Lost to Follow-up|2|||
155374763|NCT01365481|560805367|FG003|Overall Study|Lost to Follow-up|3|||
155374764|NCT01365481|560805364|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155374765|NCT01365481|560805365|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155169158|NCT01761240|560057306|FG002|Overall Study|Progressive disease:radiology assessment|0|||
155169159|NCT01761240|560057307|FG003|Overall Study|Progressive disease:radiology assessment|0|||
155169160|NCT01761240|560057308|FG004|Overall Study|Progressive disease:radiology assessment|0|||
155169161|NCT01761240|560057304|FG000|Overall Study|Progressive disease:clinical assessment|0|||
155169162|NCT01761240|560057305|FG001|Overall Study|Progressive disease:clinical assessment|0|||
155169163|NCT01761240|560057306|FG002|Overall Study|Progressive disease:clinical assessment|3|||
155169164|NCT01761240|560057307|FG003|Overall Study|Progressive disease:clinical assessment|1|||
155169165|NCT01761240|560057308|FG004|Overall Study|Progressive disease:clinical assessment|0|||
155169166|NCT01761240|560057304|FG000|Overall Study|Withdrawal by Subject|0|||
155169167|NCT01761240|560057305|FG001|Overall Study|Withdrawal by Subject|0|||
155169168|NCT01761240|560057306|FG002|Overall Study|Withdrawal by Subject|0|||
155169169|NCT01761240|560057307|FG003|Overall Study|Withdrawal by Subject|3|||
155169170|NCT01761240|560057308|FG004|Overall Study|Withdrawal by Subject|1|||
155169171|NCT01761240|560057304|FG000|Overall Study|Adverse Event|0|||
155169172|NCT01761240|560057305|FG001|Overall Study|Adverse Event|0|||
155169173|NCT01761240|560057306|FG002|Overall Study|Adverse Event|0|||
155169174|NCT01761240|560057307|FG003|Overall Study|Adverse Event|1|||
155169175|NCT01761240|560057308|FG004|Overall Study|Adverse Event|6|||
155169176|NCT01761240|560057304|FG000|Overall Study|Death|0|||
155169177|NCT01761240|560057305|FG001|Overall Study|Death|1|||
155169178|NCT01761240|560057306|FG002|Overall Study|Death|1|||
155169179|NCT01761240|560057307|FG003|Overall Study|Death|2|||
155169180|NCT01761240|560057308|FG004|Overall Study|Death|1|||
155169181|NCT01761240|560057304|FG000|Overall Study|Non-compliance|0|||
155169182|NCT01761240|560057305|FG001|Overall Study|Non-compliance|0|||
155169183|NCT01761240|560057306|FG002|Overall Study|Non-compliance|1|||
155169184|NCT01761240|560057307|FG003|Overall Study|Non-compliance|0|||
155169185|NCT01761240|560057308|FG004|Overall Study|Non-compliance|0|||
155169186|NCT01233232|560057309|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
155169187|NCT01233232|560057310|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
155169188|NCT01233232|560057311|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
155169189|NCT02762370|560057312|FG000|Overall Study|Protocol Violation|1|||
155169190|NCT02762370|560057313|FG001|Overall Study|Protocol Violation|0|||
155169191|NCT01708902|560057320|FG000|Overall Study|Adverse Event|3|||
155169192|NCT01708902|560057321|FG001|Overall Study|Adverse Event|4|||
155169193|NCT01708902|560057322|FG002|Overall Study|Adverse Event|9|||
155169194|NCT01708902|560057323|FG003|Overall Study|Adverse Event|2|||
155169195|NCT01708902|560057324|FG004|Overall Study|Adverse Event|7|||
155169196|NCT01708902|560057325|FG005|Overall Study|Adverse Event|3|||
155169197|NCT01708902|560057326|FG006|Overall Study|Adverse Event|5|||
155169198|NCT01708902|560057320|FG000|Overall Study|Lack of Efficacy|3|||
155169199|NCT01708902|560057321|FG001|Overall Study|Lack of Efficacy|1|||
155169200|NCT01708902|560057322|FG002|Overall Study|Lack of Efficacy|0|||
155169201|NCT01708902|560057323|FG003|Overall Study|Lack of Efficacy|0|||
155169202|NCT01708902|560057324|FG004|Overall Study|Lack of Efficacy|0|||
155169203|NCT01708902|560057325|FG005|Overall Study|Lack of Efficacy|1|||
155169204|NCT01708902|560057326|FG006|Overall Study|Lack of Efficacy|0|||
155169205|NCT01708902|560057320|FG000|Overall Study|Non compliance with protocol|0|||
155169206|NCT01708902|560057321|FG001|Overall Study|Non compliance with protocol|2|||
155169207|NCT01708902|560057322|FG002|Overall Study|Non compliance with protocol|1|||
155169208|NCT01708902|560057323|FG003|Overall Study|Non compliance with protocol|3|||
155169209|NCT01708902|560057324|FG004|Overall Study|Non compliance with protocol|0|||
155169210|NCT01708902|560057325|FG005|Overall Study|Non compliance with protocol|0|||
155169211|NCT01708902|560057326|FG006|Overall Study|Non compliance with protocol|0|||
155169212|NCT01708902|560057320|FG000|Overall Study|Lost to Follow-up|2|||
155169213|NCT01708902|560057321|FG001|Overall Study|Lost to Follow-up|1|||
155169214|NCT01708902|560057322|FG002|Overall Study|Lost to Follow-up|2|||
155169215|NCT01708902|560057323|FG003|Overall Study|Lost to Follow-up|2|||
155374766|NCT01365481|560805366|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155374767|NCT01365481|560805367|FG003|Overall Study|Abnormal laboratory value(s)|0|||
155374768|NCT01365481|560805364|FG000|Overall Study|Administrative problems|0|||
155374769|NCT01365481|560805365|FG001|Overall Study|Administrative problems|1|||
155374770|NCT01365481|560805366|FG002|Overall Study|Administrative problems|0|||
155374771|NCT01365481|560805367|FG003|Overall Study|Administrative problems|0|||
155374772|NCT01365481|560805364|FG000|Overall Study|Protocol deviation|0|||
155374773|NCT01365481|560805365|FG001|Overall Study|Protocol deviation|1|||
155374774|NCT01365481|560805366|FG002|Overall Study|Protocol deviation|0|||
155374775|NCT01365481|560805367|FG003|Overall Study|Protocol deviation|1|||
155374776|NCT01365481|560805364|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155374777|NCT01365481|560805365|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155169216|NCT01708902|560057324|FG004|Overall Study|Lost to Follow-up|0|||
155169217|NCT01708902|560057325|FG005|Overall Study|Lost to Follow-up|0|||
155169218|NCT01708902|560057326|FG006|Overall Study|Lost to Follow-up|1|||
155169219|NCT01708902|560057320|FG000|Overall Study|Refused to continue trial medication|8|||
155169220|NCT01708902|560057321|FG001|Overall Study|Refused to continue trial medication|0|||
155169221|NCT01708902|560057322|FG002|Overall Study|Refused to continue trial medication|4|||
155374778|NCT01365481|560805366|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
155374779|NCT01365481|560805367|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
155374780|NCT00757627|560805368|FG000|Overall Study|Adverse Event|15|||
155374781|NCT00757627|560805368|FG000|Overall Study|Lack of Efficacy|10|||
155374782|NCT00757627|560805368|FG000|Overall Study|Lost to Follow-up|28|||
155374783|NCT00757627|560805368|FG000|Overall Study|Withdrawal by Subject|27|||
155374784|NCT00757627|560805368|FG000|Overall Study|Other|1|||
155374785|NCT00958841|560805371|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155374786|NCT00958841|560805371|FG000|Overall Study|Abnormal test procedure result(s)|3|||
155374787|NCT00958841|560805371|FG000|Overall Study|Administrative problems|1|||
155374788|NCT00958841|560805371|FG000|Overall Study|Adverse Event|8|||
155374789|NCT00958841|560805371|FG000|Overall Study|New cancer therapy|5|||
155374790|NCT00958841|560805371|FG000|Overall Study|Withdrawal by Subject|1|||
155374791|NCT00958841|560805371|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
155374792|NCT00958841|560805371|FG000|Overall Study|Completed M6/did not enter extension|27|||
155374793|NCT00958841|560805371|FG000|Overall Study|Discontinued prior to M*|28|||
155374794|NCT00858364|560805372|FG000|Overall Study|Administrative Decision|3|||
155374795|NCT00858364|560805373|FG001|Overall Study|Administrative Decision|2|||
155374796|NCT00858364|560805372|FG000|Overall Study|Adverse Event|5|||
155374797|NCT00858364|560805373|FG001|Overall Study|Adverse Event|2|||
155374798|NCT00858364|560805372|FG000|Overall Study|Withdrawal by Subject|44|||
154965735|NCT00112437|559298883|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374799|NCT00858364|560805373|FG001|Overall Study|Withdrawal by Subject|118|||
155374800|NCT00858364|560805372|FG000|Overall Study|Ineligibility Determined|1|||
155374801|NCT00858364|560805373|FG001|Overall Study|Ineligibility Determined|10|||
155374802|NCT00858364|560805372|FG000|Overall Study|Lost to Follow-up|24|||
155374803|NCT00858364|560805373|FG001|Overall Study|Lost to Follow-up|54|||
155374804|NCT00858364|560805372|FG000|Overall Study|Noncompliance|3|||
155374805|NCT00858364|560805373|FG001|Overall Study|Noncompliance|4|||
155374806|NCT00858364|560805372|FG000|Overall Study|Protocol Deviation|0|||
155374807|NCT00858364|560805373|FG001|Overall Study|Protocol Deviation|2|||
155374808|NCT00858364|560805372|FG000|Overall Study|Other|9|||
155374809|NCT00858364|560805373|FG001|Overall Study|Other|17|||
155374810|NCT00858364|560805372|FG000|Overall Study|Missing|1|||
155374811|NCT00858364|560805373|FG001|Overall Study|Missing|1|||
155374812|NCT00858364|560805372|FG000|Overall Study|Still on-study|114|||
155374813|NCT00858364|560805373|FG001|Overall Study|Still on-study|247|||
155374814|NCT00688870|560805378|FG000|Infant Series|Parent or legal guardian request|4|||
155374815|NCT00688870|560805379|FG001|Infant Series|Parent or legal guardian request|0|||
155374816|NCT03682302|560805382|FG000|Overall Study|Lost to Follow-up|1|||
155374817|NCT03682302|560805383|FG001|Overall Study|Lost to Follow-up|2|||
155374818|NCT03682302|560805384|FG002|Overall Study|Lost to Follow-up|0|||
155374819|NCT03682302|560805385|FG003|Overall Study|Lost to Follow-up|1|||
155374820|NCT03682302|560805382|FG000|Overall Study|Study drug was not administered|0|||
155374821|NCT03682302|560805383|FG001|Overall Study|Study drug was not administered|0|||
155374822|NCT03682302|560805384|FG002|Overall Study|Study drug was not administered|1|||
155374823|NCT03682302|560805385|FG003|Overall Study|Study drug was not administered|1|||
155374824|NCT01489891|560805387|FG000|Overall Study|Endoscopy failure|1|||
155374825|NCT01489891|560805388|FG001|Overall Study|Endoscopy failure|0|||
155374826|NCT00948766|560805391|FG000|Core Study|Adverse Event|73|||
155374827|NCT00948766|560805392|FG001|Core Study|Adverse Event|51|||
155374828|NCT00948766|560805391|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
155374829|NCT00948766|560805392|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
154965736|NCT00112437|559298884|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965737|NCT00112437|559298885|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
154965738|NCT00112437|559298886|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374830|NCT00948766|560805391|FG000|Core Study|Patient Withdrew Consent|27|||
155374831|NCT00948766|560805392|FG001|Core Study|Patient Withdrew Consent|46|||
155374832|NCT00948766|560805391|FG000|Core Study|Lost to Follow-up|3|||
155374833|NCT00948766|560805392|FG001|Core Study|Lost to Follow-up|2|||
155374834|NCT00948766|560805391|FG000|Core Study|Administrative Problems|2|||
155374835|NCT00948766|560805392|FG001|Core Study|Administrative Problems|2|||
155374836|NCT00948766|560805391|FG000|Core Study|Death|1|||
155374837|NCT00948766|560805392|FG001|Core Study|Death|1|||
155374838|NCT00948766|560805391|FG000|Core Study|Protocol Deviation|8|||
155374839|NCT00948766|560805392|FG001|Core Study|Protocol Deviation|10|||
155374840|NCT00948766|560805391|FG000|Extension Study|Adverse Event|43|||
155374841|NCT00948766|560805392|FG001|Extension Study|Adverse Event|0|||
155374842|NCT00948766|560805391|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
155374843|NCT00948766|560805392|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
155374844|NCT00948766|560805391|FG000|Extension Study|Study Drug No Longer Required|1|||
155374845|NCT00948766|560805392|FG001|Extension Study|Study Drug No Longer Required|0|||
155374846|NCT00948766|560805391|FG000|Extension Study|Patient Withdrew Consent|32|||
155374847|NCT00948766|560805392|FG001|Extension Study|Patient Withdrew Consent|0|||
155374848|NCT00948766|560805391|FG000|Extension Study|Lost to Follow-up|8|||
155374849|NCT00948766|560805392|FG001|Extension Study|Lost to Follow-up|0|||
155374850|NCT00948766|560805391|FG000|Extension Study|Administrative Problems|1|||
155374851|NCT00948766|560805392|FG001|Extension Study|Administrative Problems|0|||
155374852|NCT00948766|560805391|FG000|Extension Study|Death|4|||
155374853|NCT00948766|560805392|FG001|Extension Study|Death|0|||
155374854|NCT01769326|560805393|FG000|Overall Study|Lost to Follow-up|1|||
155374855|NCT01769326|560805394|FG001|Overall Study|Lost to Follow-up|2|||
155374856|NCT01769326|560805395|FG002|Overall Study|Lost to Follow-up|0|||
155374857|NCT01769326|560805396|FG003|Overall Study|Lost to Follow-up|0|||
155374858|NCT01769326|560805393|FG000|Overall Study|unrelated injry|1|||
155374859|NCT01769326|560805394|FG001|Overall Study|unrelated injry|1|||
155374860|NCT01769326|560805395|FG002|Overall Study|unrelated injry|0|||
155374861|NCT01769326|560805396|FG003|Overall Study|unrelated injry|0|||
155374862|NCT01769326|560805393|FG000|Overall Study|got a job|0|||
155374863|NCT01769326|560805394|FG001|Overall Study|got a job|1|||
155374864|NCT01769326|560805395|FG002|Overall Study|got a job|0|||
155374865|NCT01769326|560805396|FG003|Overall Study|got a job|0|||
155374866|NCT01769326|560805393|FG000|Overall Study|Got sick and could not complete study|0|||
155374867|NCT01769326|560805394|FG001|Overall Study|Got sick and could not complete study|0|||
155374868|NCT01769326|560805395|FG002|Overall Study|Got sick and could not complete study|1|||
155374869|NCT01769326|560805396|FG003|Overall Study|Got sick and could not complete study|0|||
155374870|NCT01036438|560805397|FG000|Overall Study|Adverse Event|7|||
155374871|NCT01036438|560805398|FG001|Overall Study|Adverse Event|8|||
155374872|NCT01036438|560805397|FG000|Overall Study|Death|0|||
155374873|NCT01036438|560805398|FG001|Overall Study|Death|1|||
155374874|NCT01036438|560805397|FG000|Overall Study|No effect of study treatment|3|||
155374875|NCT01036438|560805398|FG001|Overall Study|No effect of study treatment|1|||
155374876|NCT00888927|560805399|FG000|Overall Study|Adverse Event|0|||
154965739|NCT00112437|559298887|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
155374877|NCT00888927|560805400|FG001|Overall Study|Adverse Event|0|||
155374878|NCT00888927|560805401|FG002|Overall Study|Adverse Event|0|||
155374879|NCT00888927|560805402|FG003|Overall Study|Adverse Event|1|||
155374880|NCT00888927|560805399|FG000|Overall Study|Withdrawal of consent|0|||
155374881|NCT00888927|560805400|FG001|Overall Study|Withdrawal of consent|0|||
155374882|NCT00888927|560805401|FG002|Overall Study|Withdrawal of consent|0|||
155374883|NCT00888927|560805402|FG003|Overall Study|Withdrawal of consent|1|||
155374884|NCT02153073|560805403|FG000|Overall Study|Case Report Forms Uncollected|230|||
155374885|NCT02153073|560805403|FG000|Overall Study|Protocol Deviation|68|||
155374886|NCT03189745|560805404|FG000|Overall Study|Conflict in work schedule of participant|1|||
155374887|NCT03189745|560805405|FG001|Overall Study|Conflict in work schedule of participant|1|||
155374888|NCT03702231|560805406|FG000|Overall Study|Withdrawal by Subject|1|||
155374889|NCT03702231|560805407|FG001|Overall Study|Withdrawal by Subject|0|||
155374890|NCT03702231|560805408|FG002|Overall Study|Withdrawal by Subject|0|||
155374891|NCT03702231|560805406|FG000|Overall Study|Protocol Violation|0|||
155374892|NCT03702231|560805407|FG001|Overall Study|Protocol Violation|0|||
155374893|NCT03702231|560805408|FG002|Overall Study|Protocol Violation|1|||
155374894|NCT03702231|560805406|FG000|Overall Study|Change in CLL Treatment|0|||
155374895|NCT03702231|560805407|FG001|Overall Study|Change in CLL Treatment|0|||
155374896|NCT03702231|560805408|FG002|Overall Study|Change in CLL Treatment|1|||
155374897|NCT03702231|560805406|FG000|Overall Study|COVID Pandemic|1|||
155374898|NCT03702231|560805407|FG001|Overall Study|COVID Pandemic|4|||
155374899|NCT03702231|560805408|FG002|Overall Study|COVID Pandemic|1|||
155374900|NCT03702231|560805406|FG000|Overall Study|Non-compliance|0|||
155374901|NCT03702231|560805407|FG001|Overall Study|Non-compliance|0|||
155374902|NCT03702231|560805408|FG002|Overall Study|Non-compliance|1|||
155374903|NCT02729831|560805410|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
154965740|NCT00112437|559298862|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965741|NCT00112437|559298863|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965742|NCT00112437|559298864|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965743|NCT00112437|559298865|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965744|NCT00112437|559298866|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965745|NCT00112437|559298867|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965746|NCT00112437|559298868|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965747|NCT00112437|559298869|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965748|NCT00112437|559298870|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965749|NCT00112437|559298871|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965750|NCT00112437|559298872|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
154965751|NCT00112437|559298873|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
154965752|NCT00112437|559298874|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965753|NCT00112437|559298875|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965754|NCT00112437|559298876|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155169222|NCT01708902|560057323|FG003|Overall Study|Refused to continue trial medication|2|||
155169223|NCT01708902|560057324|FG004|Overall Study|Refused to continue trial medication|8|||
155374904|NCT02729831|560805411|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
154965755|NCT00112437|559298877|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965756|NCT00112437|559298878|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965757|NCT00112437|559298879|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965758|NCT00112437|559298880|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965759|NCT00112437|559298881|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965760|NCT00112437|559298882|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965761|NCT00112437|559298883|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965762|NCT00112437|559298884|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
155374905|NCT02729831|560805412|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
155374906|NCT02729831|560805413|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
155374907|NCT02729831|560805410|FG000|1 Week Post-visit|Lost to Follow-up|43|||
155374908|NCT02729831|560805411|FG001|1 Week Post-visit|Lost to Follow-up|40|||
155374909|NCT02729831|560805412|FG002|1 Week Post-visit|Lost to Follow-up|38|||
155374910|NCT02729831|560805413|FG003|1 Week Post-visit|Lost to Follow-up|36|||
155374911|NCT02729831|560805410|FG000|6 Month Follow-up|Lost to Follow-up|54|||
155374912|NCT02729831|560805411|FG001|6 Month Follow-up|Lost to Follow-up|51|||
155374913|NCT02729831|560805412|FG002|6 Month Follow-up|Lost to Follow-up|48|||
155374914|NCT02729831|560805413|FG003|6 Month Follow-up|Lost to Follow-up|42|||
155374915|NCT02729831|560805410|FG000|6 Month Follow-up|Death|1|||
155374916|NCT02729831|560805411|FG001|6 Month Follow-up|Death|3|||
155374917|NCT02729831|560805412|FG002|6 Month Follow-up|Death|0|||
155374918|NCT02729831|560805413|FG003|6 Month Follow-up|Death|1|||
155374919|NCT00864253|560805414|FG000|Overall Study|Adverse Event|56|||
155374920|NCT00864253|560805415|FG001|Overall Study|Adverse Event|11|||
155374921|NCT00864253|560805414|FG000|Overall Study|Unrelated Adverse Event|3|||
155374922|NCT00864253|560805415|FG001|Overall Study|Unrelated Adverse Event|1|||
155374923|NCT00864253|560805414|FG000|Overall Study|Physician Decision|11|||
155374924|NCT00864253|560805415|FG001|Overall Study|Physician Decision|15|||
155374925|NCT00864253|560805414|FG000|Overall Study|Protocol Violation|0|||
155374926|NCT00864253|560805415|FG001|Overall Study|Protocol Violation|2|||
155374927|NCT00864253|560805414|FG000|Overall Study|Lost to Follow-up|1|||
155374928|NCT00864253|560805415|FG001|Overall Study|Lost to Follow-up|1|||
155374929|NCT00864253|560805414|FG000|Overall Study|Withdrawal by Subject|18|||
155374930|NCT00864253|560805415|FG001|Overall Study|Withdrawal by Subject|18|||
155374931|NCT00864253|560805414|FG000|Overall Study|Death|1|||
155374932|NCT00864253|560805415|FG001|Overall Study|Death|0|||
155374933|NCT00864253|560805414|FG000|Overall Study|Ongoing|2|||
155374934|NCT00864253|560805415|FG001|Overall Study|Ongoing|3|||
155374935|NCT00864253|560805414|FG000|Overall Study|Untreated|7|||
155374936|NCT00864253|560805415|FG001|Overall Study|Untreated|7|||
155374937|NCT01747551|560805417|FG000|Overall Study|Progressive Disease|24|||
155374938|NCT01747551|560805418|FG001|Overall Study|Progressive Disease|17|||
155374939|NCT01747551|560805417|FG000|Overall Study|Death|3|||
155374940|NCT01747551|560805418|FG001|Overall Study|Death|1|||
155374941|NCT01747551|560805417|FG000|Overall Study|Adverse Event|7|||
155374942|NCT01747551|560805418|FG001|Overall Study|Adverse Event|1|||
155374943|NCT01747551|560805417|FG000|Overall Study|Prolonged Treatment Delay|2|||
155374944|NCT01747551|560805418|FG001|Overall Study|Prolonged Treatment Delay|0|||
155374945|NCT01747551|560805417|FG000|Overall Study|Withdrawal by Subject|3|||
155374946|NCT01747551|560805418|FG001|Overall Study|Withdrawal by Subject|1|||
155374947|NCT01747551|560805417|FG000|Overall Study|Physician Decision|2|||
155374948|NCT01747551|560805418|FG001|Overall Study|Physician Decision|1|||
155374949|NCT01747551|560805417|FG000|Overall Study|Other|2|||
155374950|NCT01747551|560805418|FG001|Overall Study|Other|0|||
155374951|NCT01607476|560805419|FG000|Overall Study|Withdrawal by Subject|1|||
155374952|NCT01607476|560805420|FG001|Overall Study|Withdrawal by Subject|0|||
155374953|NCT01607476|560805421|FG002|Overall Study|Withdrawal by Subject|1|||
155374954|NCT01607476|560805419|FG000|Overall Study|Lost to Follow-up|0|||
155374955|NCT01607476|560805420|FG001|Overall Study|Lost to Follow-up|0|||
155374956|NCT01607476|560805421|FG002|Overall Study|Lost to Follow-up|2|||
155374957|NCT04445987|560805422|FG000|Overall Study|Adverse Event|0|||
155374958|NCT04445987|560805423|FG001|Overall Study|Adverse Event|0|||
155374959|NCT04445987|560805424|FG002|Overall Study|Adverse Event|1|||
155374960|NCT04445987|560805425|FG003|Overall Study|Adverse Event|0|||
155374961|NCT04445987|560805426|FG004|Overall Study|Adverse Event|4|||
155374962|NCT04445987|560805427|FG005|Overall Study|Adverse Event|0|||
155374963|NCT04445987|560805422|FG000|Overall Study|Lost to Follow-up|4|||
155374964|NCT04445987|560805423|FG001|Overall Study|Lost to Follow-up|3|||
155374965|NCT04445987|560805424|FG002|Overall Study|Lost to Follow-up|1|||
155374966|NCT04445987|560805425|FG003|Overall Study|Lost to Follow-up|1|||
155374967|NCT04445987|560805426|FG004|Overall Study|Lost to Follow-up|29|||
155374968|NCT04445987|560805427|FG005|Overall Study|Lost to Follow-up|0|||
155374969|NCT04445987|560805422|FG000|Overall Study|Physician Decision|0|||
155374970|NCT04445987|560805423|FG001|Overall Study|Physician Decision|0|||
155374971|NCT04445987|560805424|FG002|Overall Study|Physician Decision|0|||
155374972|NCT04445987|560805425|FG003|Overall Study|Physician Decision|0|||
155374973|NCT04445987|560805426|FG004|Overall Study|Physician Decision|1|||
155374974|NCT04445987|560805427|FG005|Overall Study|Physician Decision|0|||
155374975|NCT04445987|560805422|FG000|Overall Study|Protocol Violation|1|||
155374976|NCT04445987|560805423|FG001|Overall Study|Protocol Violation|0|||
155374977|NCT04445987|560805424|FG002|Overall Study|Protocol Violation|0|||
155374978|NCT04445987|560805425|FG003|Overall Study|Protocol Violation|0|||
155374979|NCT04445987|560805426|FG004|Overall Study|Protocol Violation|2|||
155374980|NCT04445987|560805427|FG005|Overall Study|Protocol Violation|0|||
155374981|NCT04445987|560805422|FG000|Overall Study|Withdrawal by Subject|4|||
155374982|NCT04445987|560805423|FG001|Overall Study|Withdrawal by Subject|0|||
155374983|NCT04445987|560805424|FG002|Overall Study|Withdrawal by Subject|1|||
155374984|NCT04445987|560805425|FG003|Overall Study|Withdrawal by Subject|0|||
155374985|NCT04445987|560805426|FG004|Overall Study|Withdrawal by Subject|18|||
155374986|NCT04445987|560805427|FG005|Overall Study|Withdrawal by Subject|1|||
155374987|NCT04445987|560805422|FG000|Overall Study|Other reason|0|||
155374988|NCT04445987|560805423|FG001|Overall Study|Other reason|0|||
155374989|NCT04445987|560805424|FG002|Overall Study|Other reason|1|||
155374990|NCT04445987|560805425|FG003|Overall Study|Other reason|0|||
155374991|NCT04445987|560805426|FG004|Overall Study|Other reason|2|||
155374992|NCT04445987|560805427|FG005|Overall Study|Other reason|0|||
155374993|NCT01609062|560805428|FG000|Extension Phase|Terminated by Sponsor|14|||
155374994|NCT01609062|560805429|FG001|Extension Phase|Terminated by Sponsor|9|||
155374995|NCT01609062|560805428|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
155374996|NCT01609062|560805429|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
155374997|NCT01609062|560805428|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
155374998|NCT01609062|560805429|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
155374999|NCT03772587|560805430|FG000|Overall Study|COVID-19|0|||
155375000|NCT03772587|560805431|FG001|Overall Study|COVID-19|0|||
155375001|NCT03772587|560805432|FG002|Overall Study|COVID-19|1|||
155375002|NCT03772587|560805433|FG003|Overall Study|COVID-19|1|||
155375003|NCT03772587|560805434|FG004|Overall Study|COVID-19|0|||
155375004|NCT03772587|560805430|FG000|Overall Study|Withdrawal by Subject|1|||
155375005|NCT03772587|560805431|FG001|Overall Study|Withdrawal by Subject|0|||
155375006|NCT03772587|560805432|FG002|Overall Study|Withdrawal by Subject|0|||
155375007|NCT03772587|560805433|FG003|Overall Study|Withdrawal by Subject|0|||
155375008|NCT03772587|560805434|FG004|Overall Study|Withdrawal by Subject|0|||
155169224|NCT01708902|560057325|FG005|Overall Study|Refused to continue trial medication|1|||
155375009|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
155375010|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
155375011|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
155375012|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
155375013|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
155375014|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
155375015|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
155375016|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
155375017|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
155375018|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
155375019|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
155375020|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
155375021|NCT05260021|560805437|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
155375022|NCT05260021|560805438|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
155375023|NCT05260021|560805439|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
155375024|NCT03842358|560805440|FG000|Overall Study|Poor DOT probe contact with breast|2|||
155375025|NCT03842358|560805440|FG000|Overall Study|DOT system problem|1|||
155375026|NCT03842358|560805440|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
155375027|NCT03842358|560805440|FG000|Overall Study|No biopsy after physician review|4|||
155375028|NCT03842358|560805440|FG000|Overall Study|Patient withdrew|2|||
155375029|NCT01200290|560805441|FG000|Treatment Period|Adverse Event|1|||
155375030|NCT01200290|560805441|FG000|Post-Treatment Follow-Up Period|Death|2|||
155375031|NCT00607724|560805443|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
155375032|NCT00607724|560805444|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
155375033|NCT00607724|560805445|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
155375034|NCT00607724|560805446|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375035|NCT00607724|560805447|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375036|NCT00607724|560805448|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375037|NCT00607724|560805449|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
155375038|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
155375039|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
155375040|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
155375041|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
155375042|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
155375043|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
155375044|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
155375045|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
155375046|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
155375047|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
155375048|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
155375049|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
155375050|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
155375051|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
155375052|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
155375053|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
155375054|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
155375055|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
155375056|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
155375057|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
155375058|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
155375059|NCT00607724|560805443|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375060|NCT00607724|560805444|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375061|NCT00607724|560805445|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375062|NCT00607724|560805446|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
155375063|NCT00607724|560805447|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375064|NCT00607724|560805448|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375065|NCT00607724|560805449|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
155375066|NCT00151281|560805450|FG000|Overall Study|Not evaluable|3|||
155375067|NCT04349631|560805451|FG000|Overall Study|Lost to Follow-up|3|||
155375068|NCT04349631|560805451|FG000|Overall Study|Withdrawal by Subject|7|||
155375069|NCT03037931|560807348|FG000|Overall Study|Death|354|||
155375070|NCT03037931|560807349|FG001|Overall Study|Death|367|||
155375071|NCT03037931|560807348|FG000|Overall Study|Lost to Follow-up|7|||
155375072|NCT03037931|560807349|FG001|Overall Study|Lost to Follow-up|4|||
155375073|NCT03037931|560807348|FG000|Overall Study|Withdrawal by Subject|48|||
155375074|NCT03037931|560807349|FG001|Overall Study|Withdrawal by Subject|41|||
155375075|NCT02407990|560807350|FG000|Overall Study|Death|2|||
155169225|NCT01708902|560057326|FG006|Overall Study|Refused to continue trial medication|1|||
155169226|NCT01708902|560057320|FG000|Overall Study|Other Reason|1|||
155169227|NCT01708902|560057321|FG001|Overall Study|Other Reason|0|||
155169228|NCT01708902|560057322|FG002|Overall Study|Other Reason|1|||
155169229|NCT01708902|560057323|FG003|Overall Study|Other Reason|1|||
155169230|NCT01708902|560057324|FG004|Overall Study|Other Reason|1|||
155169231|NCT01708902|560057325|FG005|Overall Study|Other Reason|2|||
155169232|NCT01708902|560057326|FG006|Overall Study|Other Reason|0|||
155169233|NCT02633020|560057329|FG000|Overall Study|Adverse Event|1|||
155169234|NCT02633020|560057330|FG001|Overall Study|Adverse Event|0|||
155169235|NCT00934440|560057331|FG000|Overall Study|Lost to Follow-up|1|||
155169236|NCT05661851|560057332|FG000|Overall Study|Protocol Violation|1|||
155169237|NCT05661851|560057333|FG001|Overall Study|Protocol Violation|1|||
155169238|NCT05661851|560057332|FG000|Overall Study|Covid-19 Related|3|||
155169239|NCT05661851|560057333|FG001|Overall Study|Covid-19 Related|4|||
155169240|NCT05661851|560057332|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
155169241|NCT05661851|560057333|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
155169242|NCT05661851|560057332|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
155169243|NCT05661851|560057333|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
155169244|NCT02152956|560057334|FG000|Overall Study|Adverse Event|0|||
155169245|NCT02152956|560057335|FG001|Overall Study|Adverse Event|0|||
155169246|NCT02152956|560057336|FG002|Overall Study|Adverse Event|0|||
155169247|NCT02152956|560057337|FG003|Overall Study|Adverse Event|0|||
155169248|NCT02152956|560057338|FG004|Overall Study|Adverse Event|0|||
155169249|NCT02152956|560057339|FG005|Overall Study|Adverse Event|0|||
155169250|NCT02152956|560057340|FG006|Overall Study|Adverse Event|0|||
155169251|NCT02152956|560057341|FG007|Overall Study|Adverse Event|0|||
155169252|NCT02152956|560057342|FG008|Overall Study|Adverse Event|0|||
155169253|NCT02152956|560057343|FG009|Overall Study|Adverse Event|0|||
155169254|NCT02152956|560057344|FG010|Overall Study|Adverse Event|0|||
155169255|NCT02152956|560057345|FG011|Overall Study|Adverse Event|4|||
155169256|NCT02152956|560057346|FG012|Overall Study|Adverse Event|0|||
155169257|NCT02152956|560057334|FG000|Overall Study|Death|0|||
155169258|NCT02152956|560057335|FG001|Overall Study|Death|3|||
155169259|NCT02152956|560057336|FG002|Overall Study|Death|3|||
155169260|NCT02152956|560057337|FG003|Overall Study|Death|4|||
155169261|NCT02152956|560057338|FG004|Overall Study|Death|1|||
155169262|NCT02152956|560057339|FG005|Overall Study|Death|2|||
155169263|NCT02152956|560057340|FG006|Overall Study|Death|6|||
155169264|NCT02152956|560057341|FG007|Overall Study|Death|6|||
155375076|NCT02407990|560807351|FG001|Overall Study|Death|22|||
155375077|NCT02407990|560807352|FG002|Overall Study|Death|23|||
155375078|NCT02407990|560807353|FG003|Overall Study|Death|7|||
155375079|NCT02407990|560807354|FG004|Overall Study|Death|17|||
155375080|NCT02407990|560807355|FG005|Overall Study|Death|16|||
155375081|NCT02407990|560807356|FG006|Overall Study|Death|10|||
155375082|NCT02407990|560807357|FG007|Overall Study|Death|248|||
155375083|NCT02407990|560807350|FG000|Overall Study|Lost to Follow-up|0|||
155375084|NCT02407990|560807351|FG001|Overall Study|Lost to Follow-up|1|||
155375085|NCT02407990|560807352|FG002|Overall Study|Lost to Follow-up|0|||
155375086|NCT02407990|560807353|FG003|Overall Study|Lost to Follow-up|0|||
155375087|NCT02407990|560807354|FG004|Overall Study|Lost to Follow-up|0|||
155375088|NCT02407990|560807355|FG005|Overall Study|Lost to Follow-up|0|||
155375089|NCT02407990|560807356|FG006|Overall Study|Lost to Follow-up|0|||
155375090|NCT02407990|560807357|FG007|Overall Study|Lost to Follow-up|17|||
155375091|NCT02407990|560807350|FG000|Overall Study|Progressive Disease|0|||
155375092|NCT02407990|560807351|FG001|Overall Study|Progressive Disease|0|||
155375093|NCT02407990|560807352|FG002|Overall Study|Progressive Disease|0|||
155375094|NCT02407990|560807353|FG003|Overall Study|Progressive Disease|0|||
155375095|NCT02407990|560807354|FG004|Overall Study|Progressive Disease|0|||
155375096|NCT02407990|560807355|FG005|Overall Study|Progressive Disease|0|||
155375097|NCT02407990|560807356|FG006|Overall Study|Progressive Disease|0|||
155375098|NCT02407990|560807357|FG007|Overall Study|Progressive Disease|1|||
155169265|NCT02152956|560057342|FG008|Overall Study|Death|4|||
155169266|NCT02152956|560057343|FG009|Overall Study|Death|5|||
155169267|NCT02152956|560057344|FG010|Overall Study|Death|3|||
155169268|NCT02152956|560057345|FG011|Overall Study|Death|143|||
155169269|NCT02152956|560057346|FG012|Overall Study|Death|12|||
155169270|NCT02152956|560057334|FG000|Overall Study|Lost to Follow-up|0|||
155169271|NCT02152956|560057335|FG001|Overall Study|Lost to Follow-up|1|||
155169272|NCT02152956|560057336|FG002|Overall Study|Lost to Follow-up|0|||
155169273|NCT02152956|560057337|FG003|Overall Study|Lost to Follow-up|0|||
155169274|NCT02152956|560057338|FG004|Overall Study|Lost to Follow-up|0|||
155169275|NCT02152956|560057339|FG005|Overall Study|Lost to Follow-up|0|||
155375099|NCT02407990|560807350|FG000|Overall Study|Withdrawal by Subject|0|||
155375100|NCT02407990|560807351|FG001|Overall Study|Withdrawal by Subject|0|||
155375101|NCT02407990|560807352|FG002|Overall Study|Withdrawal by Subject|0|||
154965763|NCT00112437|559298885|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965764|NCT00112437|559298886|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965765|NCT00112437|559298887|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
154965766|NCT00112437|559298862|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965767|NCT00112437|559298863|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965768|NCT00112437|559298864|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965769|NCT00112437|559298865|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965770|NCT00112437|559298866|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965771|NCT00112437|559298867|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965772|NCT00112437|559298868|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965773|NCT00112437|559298869|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965774|NCT00112437|559298870|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965775|NCT00112437|559298871|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965776|NCT00112437|559298872|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965777|NCT00112437|559298873|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965778|NCT00112437|559298874|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965779|NCT00112437|559298875|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965780|NCT00112437|559298876|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965781|NCT00112437|559298877|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965782|NCT00112437|559298878|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965783|NCT00112437|559298879|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965784|NCT00112437|559298880|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965785|NCT00112437|559298881|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965786|NCT00112437|559298882|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
155375102|NCT02407990|560807353|FG003|Overall Study|Withdrawal by Subject|0|||
155375103|NCT02407990|560807354|FG004|Overall Study|Withdrawal by Subject|1|||
155375104|NCT02407990|560807355|FG005|Overall Study|Withdrawal by Subject|0|||
155375105|NCT02407990|560807356|FG006|Overall Study|Withdrawal by Subject|0|||
155375106|NCT02407990|560807357|FG007|Overall Study|Withdrawal by Subject|30|||
155375107|NCT02407990|560807350|FG000|Overall Study|Study Terminated by Sponsor|1|||
155375108|NCT02407990|560807351|FG001|Overall Study|Study Terminated by Sponsor|3|||
155375109|NCT02407990|560807352|FG002|Overall Study|Study Terminated by Sponsor|3|||
155375110|NCT02407990|560807353|FG003|Overall Study|Study Terminated by Sponsor|0|||
155375111|NCT02407990|560807354|FG004|Overall Study|Study Terminated by Sponsor|3|||
155375112|NCT02407990|560807355|FG005|Overall Study|Study Terminated by Sponsor|4|||
155375113|NCT02407990|560807356|FG006|Overall Study|Study Terminated by Sponsor|3|||
155375114|NCT02407990|560807357|FG007|Overall Study|Study Terminated by Sponsor|37|||
155375115|NCT02407990|560807350|FG000|Overall Study|Logistics|0|||
155375116|NCT02407990|560807351|FG001|Overall Study|Logistics|0|||
155375117|NCT02407990|560807352|FG002|Overall Study|Logistics|0|||
155375118|NCT02407990|560807353|FG003|Overall Study|Logistics|0|||
155375119|NCT02407990|560807354|FG004|Overall Study|Logistics|0|||
155375120|NCT02407990|560807355|FG005|Overall Study|Logistics|0|||
155375121|NCT02407990|560807356|FG006|Overall Study|Logistics|0|||
155375122|NCT02407990|560807357|FG007|Overall Study|Logistics|1|||
155375123|NCT02407990|560807350|FG000|Overall Study|Rolled into long-term extension study|0|||
155375124|NCT02407990|560807351|FG001|Overall Study|Rolled into long-term extension study|0|||
155375125|NCT02407990|560807352|FG002|Overall Study|Rolled into long-term extension study|0|||
155375126|NCT02407990|560807353|FG003|Overall Study|Rolled into long-term extension study|0|||
155375127|NCT02407990|560807354|FG004|Overall Study|Rolled into long-term extension study|0|||
155375128|NCT02407990|560807355|FG005|Overall Study|Rolled into long-term extension study|0|||
155375129|NCT02407990|560807356|FG006|Overall Study|Rolled into long-term extension study|0|||
155375130|NCT02407990|560807357|FG007|Overall Study|Rolled into long-term extension study|1|||
155375131|NCT01238900|560807358|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
155375132|NCT01238900|560807358|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
155375133|NCT01198756|560807359|FG000|Overall Study|Adverse Event|0|||
155375134|NCT01198756|560807360|FG001|Overall Study|Adverse Event|0|||
155375135|NCT01198756|560807361|FG002|Overall Study|Adverse Event|0|||
155375136|NCT01198756|560807362|FG003|Overall Study|Adverse Event|1|||
155375137|NCT01198756|560807359|FG000|Overall Study|Protocol Violation|0|||
155375138|NCT01198756|560807360|FG001|Overall Study|Protocol Violation|0|||
155375139|NCT01198756|560807361|FG002|Overall Study|Protocol Violation|0|||
155375140|NCT01198756|560807362|FG003|Overall Study|Protocol Violation|2|||
155375141|NCT01198756|560807359|FG000|Overall Study|Withdrawal by Subject|9|||
155375142|NCT01198756|560807360|FG001|Overall Study|Withdrawal by Subject|4|||
155375143|NCT01198756|560807361|FG002|Overall Study|Withdrawal by Subject|7|||
155375144|NCT01198756|560807362|FG003|Overall Study|Withdrawal by Subject|5|||
155375145|NCT01198756|560807359|FG000|Overall Study|Lost to Follow-up|29|||
155375146|NCT01198756|560807360|FG001|Overall Study|Lost to Follow-up|36|||
155375147|NCT01198756|560807361|FG002|Overall Study|Lost to Follow-up|23|||
155375148|NCT01198756|560807362|FG003|Overall Study|Lost to Follow-up|18|||
155375149|NCT02915302|560807363|FG000|Overall Study|Adverse Event|3|||
155375150|NCT02915302|560807364|FG001|Overall Study|Adverse Event|0|||
155375151|NCT02915302|560807363|FG000|Overall Study|Protocol Violation|20|||
155375152|NCT02915302|560807364|FG001|Overall Study|Protocol Violation|27|||
155375153|NCT02915302|560807363|FG000|Overall Study|Lost to Follow-up|19|||
155375154|NCT02915302|560807364|FG001|Overall Study|Lost to Follow-up|22|||
155375155|NCT02915302|560807363|FG000|Overall Study|Withdrawal by Subject|22|||
155375156|NCT02915302|560807364|FG001|Overall Study|Withdrawal by Subject|29|||
155375157|NCT02915302|560807363|FG000|Overall Study|Other|1|||
155375158|NCT02915302|560807364|FG001|Overall Study|Other|0|||
155375159|NCT04343872|560807367|FG000|Overall Study|Lost to Follow-up|6|||
155375160|NCT04343872|560807368|FG001|Overall Study|Lost to Follow-up|3|||
155375161|NCT02134977|560807369|FG000|Overall Study|Protocol Deviation|102|||
155375162|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Adverse Event|6|||
155375163|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Adverse Event|6|||
155375164|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Death|1|||
155375165|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Death|1|||
155375166|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155375167|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155375168|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
155375169|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
155375170|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Physician Decision|1|||
155375171|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Physician Decision|4|||
155375172|NCT03828747|560807370|FG000|Double-Blind Treatment Period|Various reasons|5|||
155375173|NCT03828747|560807371|FG001|Double-Blind Treatment Period|Various reasons|3|||
155375174|NCT03828747|560807370|FG000|Open-Label Extension|Adverse Event|9|||
155169276|NCT02152956|560057340|FG006|Overall Study|Lost to Follow-up|0|||
155375175|NCT03828747|560807371|FG001|Open-Label Extension|Adverse Event|7|||
155375176|NCT03828747|560807370|FG000|Open-Label Extension|Death|0|||
155169277|NCT02152956|560057341|FG007|Overall Study|Lost to Follow-up|0|||
155169278|NCT02152956|560057342|FG008|Overall Study|Lost to Follow-up|0|||
155169279|NCT02152956|560057343|FG009|Overall Study|Lost to Follow-up|0|||
155375177|NCT03828747|560807371|FG001|Open-Label Extension|Death|2|||
155375178|NCT03828747|560807370|FG000|Open-Label Extension|Lost to Follow-up|4|||
155375179|NCT03828747|560807371|FG001|Open-Label Extension|Lost to Follow-up|0|||
155375180|NCT03828747|560807370|FG000|Open-Label Extension|Withdrawal by Subject|31|||
155375181|NCT03828747|560807371|FG001|Open-Label Extension|Withdrawal by Subject|30|||
155375182|NCT03828747|560807370|FG000|Open-Label Extension|Various reasons|4|||
155375183|NCT03828747|560807371|FG001|Open-Label Extension|Various reasons|4|||
155375184|NCT03828747|560807370|FG000|Open-Label Extension|Physician Decision|6|||
155375185|NCT03828747|560807371|FG001|Open-Label Extension|Physician Decision|2|||
155375186|NCT03646656|560807372|FG000|Overall Study|Lost to Follow-up|1|||
155375187|NCT03646656|560807373|FG001|Overall Study|Lost to Follow-up|0|||
155375188|NCT03646656|560807372|FG000|Overall Study|Withdrawal by Subject|2|||
155375189|NCT03646656|560807373|FG001|Overall Study|Withdrawal by Subject|0|||
155375190|NCT03651622|560807376|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
155375191|NCT03651622|560807377|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
155375192|NCT03651622|560807378|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
155375193|NCT03651622|560807376|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
155375194|NCT03651622|560807377|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
155375195|NCT03651622|560807378|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
155375196|NCT03651622|560807376|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
155375197|NCT03651622|560807377|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
155375198|NCT03651622|560807378|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
155375199|NCT03651622|560807376|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
155375200|NCT03651622|560807377|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
155375201|NCT03651622|560807378|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
155375202|NCT03651622|560807376|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
155375203|NCT03651622|560807377|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
155375204|NCT03651622|560807378|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
155375205|NCT01519089|560807379|FG000|Overall Study|Adverse Event|4|||
155375206|NCT01519089|560807380|FG001|Overall Study|Adverse Event|4|||
155375207|NCT01519089|560807379|FG000|Overall Study|Lack of Efficacy|0|||
155375208|NCT01519089|560807380|FG001|Overall Study|Lack of Efficacy|2|||
155375209|NCT01519089|560807379|FG000|Overall Study|Lost to Follow-up|1|||
155375210|NCT01519089|560807380|FG001|Overall Study|Lost to Follow-up|0|||
155375211|NCT01519089|560807379|FG000|Overall Study|Withdrawal by Subject|0|||
155375212|NCT01519089|560807380|FG001|Overall Study|Withdrawal by Subject|2|||
155375213|NCT01519089|560807379|FG000|Overall Study|Other|2|||
155375214|NCT01519089|560807380|FG001|Overall Study|Other|6|||
155375215|NCT01519089|560807379|FG000|Overall Study|Not received study drug|0|||
155375216|NCT01519089|560807380|FG001|Overall Study|Not received study drug|1|||
155375217|NCT00127205|560807381|FG000|Overall Study|Adverse Event|228|||
155375218|NCT00127205|560807382|FG001|Overall Study|Adverse Event|387|||
155375219|NCT00127205|560807383|FG002|Overall Study|Adverse Event|273|||
155375220|NCT00127205|560807381|FG000|Overall Study|Death|8|||
155375221|NCT00127205|560807382|FG001|Overall Study|Death|6|||
155375222|NCT00127205|560807383|FG002|Overall Study|Death|5|||
155375223|NCT00127205|560807381|FG000|Overall Study|Withdrawal by Subject|318|||
155375224|NCT00127205|560807382|FG001|Overall Study|Withdrawal by Subject|310|||
155375225|NCT00127205|560807383|FG002|Overall Study|Withdrawal by Subject|172|||
155375226|NCT00127205|560807381|FG000|Overall Study|Other-non protocol specified|142|||
155375227|NCT00127205|560807382|FG001|Overall Study|Other-non protocol specified|129|||
155375228|NCT00127205|560807383|FG002|Overall Study|Other-non protocol specified|77|||
155375229|NCT00127205|560807381|FG000|Overall Study|Data not reported|6|||
155375230|NCT00127205|560807382|FG001|Overall Study|Data not reported|10|||
155169280|NCT02152956|560057344|FG010|Overall Study|Lost to Follow-up|0|||
155169281|NCT02152956|560057345|FG011|Overall Study|Lost to Follow-up|3|||
155169282|NCT02152956|560057346|FG012|Overall Study|Lost to Follow-up|0|||
155169283|NCT02152956|560057334|FG000|Overall Study|Withdrawal by Subject|1|||
155375231|NCT00127205|560807383|FG002|Overall Study|Data not reported|1|||
155375232|NCT00127205|560807381|FG000|Overall Study|Progression|127|||
155375233|NCT00127205|560807382|FG001|Overall Study|Progression|131|||
155375234|NCT00127205|560807383|FG002|Overall Study|Progression|84|||
155375235|NCT03377699|560807384|FG000|Overall Study|Withdrawal by Subject|2|||
155375236|NCT03377699|560807385|FG001|Overall Study|Withdrawal by Subject|9|||
155375237|NCT03377699|560807384|FG000|Overall Study|Lost to Follow-up|1|||
155375238|NCT03377699|560807385|FG001|Overall Study|Lost to Follow-up|1|||
155375239|NCT03377699|560807384|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
155375240|NCT03377699|560807385|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
155169284|NCT02152956|560057335|FG001|Overall Study|Withdrawal by Subject|0|||
155169285|NCT02152956|560057336|FG002|Overall Study|Withdrawal by Subject|1|||
155169286|NCT02152956|560057337|FG003|Overall Study|Withdrawal by Subject|0|||
154965787|NCT00112437|559298883|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
154965788|NCT00112437|559298884|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965789|NCT00112437|559298885|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965790|NCT00112437|559298886|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965791|NCT00112437|559298887|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
154965792|NCT00112437|559298862|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965793|NCT00112437|559298863|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155091111|NCT00904371|559767485|FG000|Overall Study|Lost to Follow-up|4|||
155091112|NCT00904371|559767485|FG000|Overall Study|Discontinued at target blood pressure|2|||
155091113|NCT00904371|559767485|FG000|Overall Study|Continued with Tritace|1|||
155091114|NCT01668004|559767488|FG000|Overall Study|Adverse Event|7|||
155091115|NCT01668004|559767488|FG000|Overall Study|Withdrawal by Subject|2|||
155091116|NCT01668004|559767488|FG000|Overall Study|Lost to Follow-up|5|||
155091117|NCT01668004|559767488|FG000|Overall Study|Lack of Efficacy|9|||
155091118|NCT01668004|559767488|FG000|Overall Study|Non-compliance with treatment|2|||
155091119|NCT02090764|559767492|FG000|Overall Study|Adverse Event|1|||
155091120|NCT02090764|559767493|FG001|Overall Study|Adverse Event|3|||
155091121|NCT02090764|559767492|FG000|Overall Study|Lack of Efficacy|0|||
155091122|NCT02090764|559767493|FG001|Overall Study|Lack of Efficacy|13|||
155091123|NCT02090764|559767492|FG000|Overall Study|Withdrawal by Subject|2|||
155091124|NCT02090764|559767493|FG001|Overall Study|Withdrawal by Subject|1|||
155091125|NCT02090764|559767492|FG000|Overall Study|Intercurrent illness and other|1|||
155091126|NCT02090764|559767493|FG001|Overall Study|Intercurrent illness and other|1|||
155091127|NCT02090764|559767492|FG000|Overall Study|Lost to Follow-up|2|||
155091128|NCT02090764|559767493|FG001|Overall Study|Lost to Follow-up|2|||
155091129|NCT00673920|559767504|FG000|Baseline up to Week 48|Withdrew consent|1|||
155091130|NCT00673920|559767505|FG001|Baseline up to Week 48|Withdrew consent|0|||
155091131|NCT00673920|559767506|FG002|Baseline up to Week 48|Withdrew consent|2|||
155375241|NCT03377699|560807384|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
155375242|NCT03377699|560807385|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
155375243|NCT03377699|560807384|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
155091132|NCT00673920|559767507|FG003|Baseline up to Week 48|Withdrew consent|0|||
155091133|NCT00673920|559767508|FG004|Baseline up to Week 48|Withdrew consent|0|||
155091134|NCT00673920|559767509|FG005|Baseline up to Week 48|Withdrew consent|0|||
155091135|NCT00673920|559767510|FG006|Baseline up to Week 48|Withdrew consent|0|||
155091136|NCT00673920|559767511|FG007|Baseline up to Week 48|Withdrew consent|0|||
155169287|NCT02152956|560057338|FG004|Overall Study|Withdrawal by Subject|2|||
155169288|NCT02152956|560057339|FG005|Overall Study|Withdrawal by Subject|2|||
155169289|NCT02152956|560057340|FG006|Overall Study|Withdrawal by Subject|0|||
155169290|NCT02152956|560057341|FG007|Overall Study|Withdrawal by Subject|0|||
155169291|NCT02152956|560057342|FG008|Overall Study|Withdrawal by Subject|1|||
155169292|NCT02152956|560057343|FG009|Overall Study|Withdrawal by Subject|0|||
155169293|NCT02152956|560057344|FG010|Overall Study|Withdrawal by Subject|0|||
155169294|NCT02152956|560057345|FG011|Overall Study|Withdrawal by Subject|4|||
155169295|NCT02152956|560057346|FG012|Overall Study|Withdrawal by Subject|0|||
155169296|NCT02152956|560057334|FG000|Overall Study|Physician Decision|0|||
155169297|NCT02152956|560057335|FG001|Overall Study|Physician Decision|0|||
155169298|NCT02152956|560057336|FG002|Overall Study|Physician Decision|0|||
155169299|NCT02152956|560057337|FG003|Overall Study|Physician Decision|0|||
155169300|NCT02152956|560057338|FG004|Overall Study|Physician Decision|0|||
155169301|NCT02152956|560057339|FG005|Overall Study|Physician Decision|0|||
155169302|NCT02152956|560057340|FG006|Overall Study|Physician Decision|0|||
155169303|NCT02152956|560057341|FG007|Overall Study|Physician Decision|0|||
155169304|NCT02152956|560057342|FG008|Overall Study|Physician Decision|0|||
155169305|NCT02152956|560057343|FG009|Overall Study|Physician Decision|0|||
155169306|NCT02152956|560057344|FG010|Overall Study|Physician Decision|0|||
155169307|NCT02152956|560057345|FG011|Overall Study|Physician Decision|1|||
155169308|NCT02152956|560057346|FG012|Overall Study|Physician Decision|0|||
155169309|NCT02152956|560057334|FG000|Overall Study|Study terminated by sponsor|0|||
155169310|NCT02152956|560057335|FG001|Overall Study|Study terminated by sponsor|0|||
155169311|NCT02152956|560057336|FG002|Overall Study|Study terminated by sponsor|0|||
155169312|NCT02152956|560057337|FG003|Overall Study|Study terminated by sponsor|0|||
155169313|NCT02152956|560057338|FG004|Overall Study|Study terminated by sponsor|0|||
155169314|NCT02152956|560057339|FG005|Overall Study|Study terminated by sponsor|0|||
155169315|NCT02152956|560057340|FG006|Overall Study|Study terminated by sponsor|0|||
155169316|NCT02152956|560057341|FG007|Overall Study|Study terminated by sponsor|0|||
155169317|NCT02152956|560057342|FG008|Overall Study|Study terminated by sponsor|0|||
155169318|NCT02152956|560057343|FG009|Overall Study|Study terminated by sponsor|0|||
155169319|NCT02152956|560057344|FG010|Overall Study|Study terminated by sponsor|0|||
155091137|NCT00673920|559767504|FG000|Baseline up to Week 48|Refused treatment|1|||
155091138|NCT00673920|559767505|FG001|Baseline up to Week 48|Refused treatment|0|||
155091139|NCT00673920|559767506|FG002|Baseline up to Week 48|Refused treatment|0|||
155091140|NCT00673920|559767507|FG003|Baseline up to Week 48|Refused treatment|0|||
155091141|NCT00673920|559767508|FG004|Baseline up to Week 48|Refused treatment|0|||
155091142|NCT00673920|559767509|FG005|Baseline up to Week 48|Refused treatment|0|||
155091143|NCT00673920|559767510|FG006|Baseline up to Week 48|Refused treatment|0|||
155091144|NCT00673920|559767511|FG007|Baseline up to Week 48|Refused treatment|0|||
155091145|NCT00673920|559767504|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
155091146|NCT00673920|559767505|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
155091147|NCT00673920|559767506|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
155091148|NCT00673920|559767507|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
155091149|NCT00673920|559767508|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
155091150|NCT00673920|559767509|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
155091151|NCT00673920|559767510|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
155091152|NCT00673920|559767511|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
155169320|NCT02152956|560057345|FG011|Overall Study|Study terminated by sponsor|29|||
155169321|NCT02152956|560057346|FG012|Overall Study|Study terminated by sponsor|0|||
155169322|NCT02152956|560057334|FG000|Overall Study|progressive disease|0|||
155091153|NCT00673920|559767504|FG000|Baseline up to Week 48|Protocol Violation|0|||
155169323|NCT02152956|560057335|FG001|Overall Study|progressive disease|0|||
155169324|NCT02152956|560057336|FG002|Overall Study|progressive disease|0|||
155169325|NCT02152956|560057337|FG003|Overall Study|progressive disease|0|||
155091154|NCT00673920|559767505|FG001|Baseline up to Week 48|Protocol Violation|0|||
155091155|NCT00673920|559767506|FG002|Baseline up to Week 48|Protocol Violation|1|||
155169326|NCT02152956|560057338|FG004|Overall Study|progressive disease|0|||
155169327|NCT02152956|560057339|FG005|Overall Study|progressive disease|0|||
155169328|NCT02152956|560057340|FG006|Overall Study|progressive disease|0|||
155091156|NCT00673920|559767507|FG003|Baseline up to Week 48|Protocol Violation|0|||
155091157|NCT00673920|559767508|FG004|Baseline up to Week 48|Protocol Violation|0|||
155091158|NCT00673920|559767509|FG005|Baseline up to Week 48|Protocol Violation|0|||
155091159|NCT00673920|559767510|FG006|Baseline up to Week 48|Protocol Violation|0|||
155091160|NCT00673920|559767511|FG007|Baseline up to Week 48|Protocol Violation|0|||
155091161|NCT00673920|559767504|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091162|NCT00673920|559767505|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091163|NCT00673920|559767506|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
155091164|NCT00673920|559767507|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091165|NCT00673920|559767508|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091166|NCT00673920|559767509|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091167|NCT00673920|559767510|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091168|NCT00673920|559767511|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
155091169|NCT00673920|559767504|FG000|Baseline up to Week 48|Administrative/Other|0|||
155091170|NCT00673920|559767505|FG001|Baseline up to Week 48|Administrative/Other|1|||
155091171|NCT00673920|559767506|FG002|Baseline up to Week 48|Administrative/Other|2|||
155091172|NCT00673920|559767507|FG003|Baseline up to Week 48|Administrative/Other|0|||
155091173|NCT00673920|559767508|FG004|Baseline up to Week 48|Administrative/Other|0|||
155091174|NCT00673920|559767509|FG005|Baseline up to Week 48|Administrative/Other|0|||
155091175|NCT00673920|559767510|FG006|Baseline up to Week 48|Administrative/Other|0|||
155091176|NCT00673920|559767511|FG007|Baseline up to Week 48|Administrative/Other|0|||
155091177|NCT00673920|559767504|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155091178|NCT00673920|559767505|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
155091179|NCT00673920|559767506|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
155091180|NCT00673920|559767507|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155091181|NCT00673920|559767508|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155091182|NCT00673920|559767509|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155091183|NCT00673920|559767510|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155091184|NCT00673920|559767511|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
155091185|NCT00673920|559767504|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091186|NCT00673920|559767505|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091187|NCT00673920|559767506|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091188|NCT00673920|559767507|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091189|NCT00673920|559767508|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091190|NCT00673920|559767509|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091191|NCT00673920|559767510|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
155091192|NCT00673920|559767511|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
155091193|NCT00673920|559767504|FG000|Week 24 to Week 48|Failure to return|0|||
155091194|NCT00673920|559767505|FG001|Week 24 to Week 48|Failure to return|0|||
155375244|NCT03377699|560807385|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
155375245|NCT03377699|560807384|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
155375246|NCT03377699|560807385|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
155375247|NCT02580305|560807386|FG000|Overall Study|Adverse Event|15|||
155375248|NCT02580305|560807387|FG001|Overall Study|Adverse Event|19|||
155375249|NCT02580305|560807388|FG002|Overall Study|Adverse Event|10|||
155375250|NCT02580305|560807386|FG000|Overall Study|Lack of Efficacy|5|||
155375251|NCT02580305|560807387|FG001|Overall Study|Lack of Efficacy|0|||
155375252|NCT02580305|560807388|FG002|Overall Study|Lack of Efficacy|2|||
155375253|NCT02580305|560807386|FG000|Overall Study|Protocol Violation|4|||
155375254|NCT02580305|560807387|FG001|Overall Study|Protocol Violation|9|||
155375255|NCT02580305|560807388|FG002|Overall Study|Protocol Violation|6|||
155375256|NCT02580305|560807386|FG000|Overall Study|Lost to Follow-up|4|||
155375257|NCT02580305|560807387|FG001|Overall Study|Lost to Follow-up|4|||
155375258|NCT02580305|560807388|FG002|Overall Study|Lost to Follow-up|2|||
155375259|NCT02580305|560807386|FG000|Overall Study|Withdrawal by Subject|11|||
155375260|NCT02580305|560807387|FG001|Overall Study|Withdrawal by Subject|9|||
155375261|NCT02580305|560807388|FG002|Overall Study|Withdrawal by Subject|7|||
155375262|NCT02580305|560807386|FG000|Overall Study|Randomized in error and never treated|4|||
155375263|NCT02580305|560807387|FG001|Overall Study|Randomized in error and never treated|8|||
155375264|NCT02580305|560807388|FG002|Overall Study|Randomized in error and never treated|5|||
155375265|NCT03582943|560807389|FG000|Allocated to Groups|Withdrawal by Subject|1|||
155375266|NCT03582943|560807390|FG001|Allocated to Groups|Withdrawal by Subject|1|||
155375267|NCT03582943|560807389|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
155375268|NCT03582943|560807390|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
155375269|NCT03582943|560807389|FG000|Analyzed|Protocol Violation|4|||
155375270|NCT03582943|560807390|FG001|Analyzed|Protocol Violation|1|||
155375271|NCT01177800|560807395|FG000|Overall Study|Adverse Event|9|||
155091195|NCT00673920|559767506|FG002|Week 24 to Week 48|Failure to return|0|||
155091196|NCT00673920|559767507|FG003|Week 24 to Week 48|Failure to return|0|||
155375272|NCT01177800|560807396|FG001|Overall Study|Adverse Event|3|||
155375273|NCT01177800|560807395|FG000|Overall Study|Protocol Violation|0|||
155375274|NCT01177800|560807396|FG001|Overall Study|Protocol Violation|1|||
155375275|NCT01177800|560807395|FG000|Overall Study|Physician Decision|1|||
155375276|NCT01177800|560807396|FG001|Overall Study|Physician Decision|0|||
155375277|NCT01177800|560807395|FG000|Overall Study|Withdrawal of informed consent|0|||
155375278|NCT01177800|560807396|FG001|Overall Study|Withdrawal of informed consent|1|||
155375279|NCT02071290|560807397|FG000|Overall Study|Death|1|||
155375280|NCT02071290|560807398|FG001|Overall Study|Death|0|||
155375281|NCT02071290|560807397|FG000|Overall Study|Withdrawal by Subject|0|||
155375282|NCT02071290|560807398|FG001|Overall Study|Withdrawal by Subject|1|||
155375283|NCT02071290|560807397|FG000|Overall Study|Protocol Violation|3|||
155375284|NCT02071290|560807398|FG001|Overall Study|Protocol Violation|5|||
155375285|NCT02071290|560807397|FG000|Overall Study|Physician Decision|0|||
155375286|NCT02071290|560807398|FG001|Overall Study|Physician Decision|1|||
155375287|NCT05560243|560807403|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
155375288|NCT01232738|560807404|FG000|Overall Study|Death|3|||
155375289|NCT01232738|560807404|FG000|Overall Study|Physician Decision|2|||
155375290|NCT01232738|560807404|FG000|Overall Study|Lost to Follow-up|1|||
155375291|NCT01232738|560807404|FG000|Overall Study|Withdrawal by Subject|2|||
155375292|NCT01232738|560807404|FG000|Overall Study|Adverse Event|5|||
155375293|NCT03231800|560807409|FG000|Overall Study|Lost to Follow-up|0|||
155375294|NCT03231800|560807410|FG001|Overall Study|Lost to Follow-up|2|||
155375295|NCT03231800|560807409|FG000|Overall Study|Protocol Violation|1|||
155375296|NCT03231800|560807410|FG001|Overall Study|Protocol Violation|1|||
155375297|NCT03231800|560807409|FG000|Overall Study|reason not provided|2|||
155375298|NCT03231800|560807410|FG001|Overall Study|reason not provided|0|||
155375299|NCT00859222|560807411|FG000|Overall Study|Adverse Event|2|||
155375300|NCT00859222|560807412|FG001|Overall Study|Adverse Event|3|||
155375301|NCT00859222|560807413|FG002|Overall Study|Adverse Event|6|||
155375302|NCT00859222|560807414|FG003|Overall Study|Adverse Event|24|||
155375303|NCT00859222|560807415|FG004|Overall Study|Adverse Event|15|||
155375304|NCT00859222|560807411|FG000|Overall Study|DLT|1|||
155375305|NCT00859222|560807412|FG001|Overall Study|DLT|0|||
155375306|NCT00859222|560807413|FG002|Overall Study|DLT|0|||
155375307|NCT00859222|560807414|FG003|Overall Study|DLT|0|||
155375308|NCT00859222|560807415|FG004|Overall Study|DLT|0|||
155375309|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
155375310|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
155375311|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
155375312|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
155375313|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
155375314|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
155375315|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
155375316|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
155375317|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
155375318|NCT00400725|560807426|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
155375319|NCT00400725|560807427|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
155375320|NCT00400725|560807428|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
155375321|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
155375322|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
155375323|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
155375324|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
155375325|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
155375326|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
155375327|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
155375328|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
155375329|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
155375330|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
155375331|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
155375332|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
155375333|NCT00400725|560807426|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
155375334|NCT00400725|560807427|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
155375335|NCT00400725|560807428|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
155375336|NCT01941719|560807429|FG000|Overall Study|Lost to Follow-up|20|||
155375337|NCT01941719|560807430|FG001|Overall Study|Lost to Follow-up|19|||
155375338|NCT02535091|560807433|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
155375339|NCT02535091|560807434|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
155375340|NCT02535091|560807435|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
155375341|NCT02535091|560807433|FG000|Overall Study|Withdrawal by Subject|14|||
155375342|NCT02535091|560807434|FG001|Overall Study|Withdrawal by Subject|5|||
155375343|NCT02535091|560807435|FG002|Overall Study|Withdrawal by Subject|121|||
155375344|NCT02535091|560807433|FG000|Overall Study|Adverse Event|9|||
155375345|NCT02535091|560807434|FG001|Overall Study|Adverse Event|4|||
155375346|NCT02535091|560807435|FG002|Overall Study|Adverse Event|170|||
155375347|NCT02535091|560807433|FG000|Overall Study|Other|4|||
155375348|NCT02535091|560807434|FG001|Overall Study|Other|3|||
155375349|NCT02535091|560807435|FG002|Overall Study|Other|81|||
155375350|NCT02535091|560807433|FG000|Overall Study|Lost to Follow-up|0|||
155375351|NCT02535091|560807434|FG001|Overall Study|Lost to Follow-up|1|||
155375352|NCT02535091|560807435|FG002|Overall Study|Lost to Follow-up|19|||
155375353|NCT02535091|560807433|FG000|Overall Study|Protocol Violation|0|||
155375354|NCT02535091|560807434|FG001|Overall Study|Protocol Violation|1|||
155375355|NCT02535091|560807435|FG002|Overall Study|Protocol Violation|11|||
155375356|NCT02535091|560807433|FG000|Overall Study|Pregnancy|0|||
155375357|NCT02535091|560807434|FG001|Overall Study|Pregnancy|0|||
155375358|NCT02535091|560807435|FG002|Overall Study|Pregnancy|7|||
155375359|NCT01259089|560807445|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375360|NCT01259089|560807446|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375361|NCT01259089|560807447|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375362|NCT01259089|560807448|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375363|NCT01259089|560807449|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
155375364|NCT01259089|560807450|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
155375365|NCT01259089|560807445|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
155375366|NCT01259089|560807446|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
155375367|NCT01259089|560807447|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
155375368|NCT01259089|560807448|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
155375369|NCT01259089|560807449|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
155375370|NCT01259089|560807450|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
155375371|NCT01259089|560807445|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375372|NCT01259089|560807446|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375373|NCT01259089|560807447|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375374|NCT01259089|560807448|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375375|NCT01259089|560807449|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
155375376|NCT01259089|560807450|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
155375377|NCT01259089|560807445|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375378|NCT01259089|560807446|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375379|NCT01259089|560807447|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375380|NCT01259089|560807448|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
155375381|NCT01259089|560807449|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
155375382|NCT01259089|560807450|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
155375383|NCT01259089|560807445|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
155375384|NCT01259089|560807446|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
155169329|NCT02152956|560057341|FG007|Overall Study|progressive disease|0|||
155375385|NCT01259089|560807447|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
155375386|NCT01259089|560807448|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
155375387|NCT01259089|560807449|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
155375388|NCT01259089|560807450|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
155375389|NCT01259089|560807445|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
155375390|NCT01259089|560807446|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375391|NCT01259089|560807447|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375392|NCT01259089|560807448|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375393|NCT01259089|560807449|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375394|NCT01259089|560807450|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
155375395|NCT01259089|560807445|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375396|NCT01259089|560807446|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375397|NCT01259089|560807447|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375398|NCT01259089|560807448|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
155375399|NCT01259089|560807449|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
155375400|NCT01259089|560807450|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
155375401|NCT01259089|560807445|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375402|NCT01259089|560807446|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375403|NCT01259089|560807447|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375404|NCT01259089|560807448|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
155375405|NCT01259089|560807449|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
155375406|NCT01259089|560807450|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
155375407|NCT01259089|560807445|FG000|Survival Follow up for Two Years|Death|3|||
155375408|NCT01259089|560807446|FG001|Survival Follow up for Two Years|Death|2|||
155375409|NCT01259089|560807447|FG002|Survival Follow up for Two Years|Death|2|||
155375410|NCT01259089|560807448|FG003|Survival Follow up for Two Years|Death|3|||
155375411|NCT01259089|560807449|FG004|Survival Follow up for Two Years|Death|6|||
155375412|NCT01259089|560807450|FG005|Survival Follow up for Two Years|Death|13|||
155375413|NCT01259089|560807445|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375414|NCT01259089|560807446|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375415|NCT01259089|560807447|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375416|NCT01259089|560807448|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375417|NCT01259089|560807449|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
155375418|NCT01259089|560807450|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
155375419|NCT01259089|560807445|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375420|NCT01259089|560807446|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375421|NCT01259089|560807447|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375422|NCT01259089|560807448|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375423|NCT01259089|560807449|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
155375424|NCT01259089|560807450|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
155375425|NCT00548262|560807451|FG000|Overall Study|Death|21|||
155375426|NCT00548262|560807451|FG000|Overall Study|Adverse Event|2|||
155375427|NCT00548262|560807451|FG000|Overall Study|Lack of Efficacy|4|||
155375428|NCT00548262|560807451|FG000|Overall Study|Lost to Follow-up|1|||
155375429|NCT00548262|560807451|FG000|Overall Study|Other|3|||
155375430|NCT00548262|560807451|FG000|Overall Study|Withdrawal by Subject|1|||
155375431|NCT01712659|560807452|FG000|Dose Escalation|Physician Decision|0|||
155375432|NCT01712659|560807453|FG001|Dose Escalation|Physician Decision|1|||
155375433|NCT01712659|560807454|FG002|Dose Escalation|Physician Decision|0|||
155375434|NCT01712659|560807455|FG003|Dose Escalation|Physician Decision|0|||
155375435|NCT01712659|560807456|FG004|Dose Escalation|Physician Decision|0|||
155375436|NCT01712659|560807452|FG000|Dose Escalation|Unable to take study drug|0|||
155375437|NCT01712659|560807453|FG001|Dose Escalation|Unable to take study drug|1|||
155375438|NCT01712659|560807454|FG002|Dose Escalation|Unable to take study drug|0|||
155375439|NCT01712659|560807455|FG003|Dose Escalation|Unable to take study drug|0|||
155375440|NCT01712659|560807456|FG004|Dose Escalation|Unable to take study drug|0|||
155375441|NCT01712659|560807452|FG000|Dose Expansion|Early disease progression|1|||
155375442|NCT01712659|560807453|FG001|Dose Expansion|Early disease progression|0|||
155375443|NCT01712659|560807454|FG002|Dose Expansion|Early disease progression|0|||
155375444|NCT01712659|560807455|FG003|Dose Expansion|Early disease progression|0|||
155375445|NCT01712659|560807456|FG004|Dose Expansion|Early disease progression|0|||
155375446|NCT01712659|560807452|FG000|Dose Expansion|Physician Decision|1|||
155375447|NCT01712659|560807453|FG001|Dose Expansion|Physician Decision|0|||
155375448|NCT01712659|560807454|FG002|Dose Expansion|Physician Decision|0|||
155375449|NCT01712659|560807455|FG003|Dose Expansion|Physician Decision|0|||
155375450|NCT01712659|560807456|FG004|Dose Expansion|Physician Decision|0|||
155375451|NCT01278173|560807460|FG000|Overall Study|Lack of Efficacy|13|||
155375452|NCT01278173|560807460|FG000|Overall Study|Adverse Event|8|||
155375453|NCT01278173|560807460|FG000|Overall Study|Administrative or other reason|4|||
155375454|NCT01278173|560807460|FG000|Overall Study|Protocol Violation|1|||
155169330|NCT02152956|560057342|FG008|Overall Study|progressive disease|1|||
155091197|NCT00673920|559767508|FG004|Week 24 to Week 48|Failure to return|0|||
155091198|NCT00673920|559767509|FG005|Week 24 to Week 48|Failure to return|1|||
155091199|NCT00673920|559767510|FG006|Week 24 to Week 48|Failure to return|0|||
155091200|NCT00673920|559767511|FG007|Week 24 to Week 48|Failure to return|0|||
155091201|NCT00673920|559767504|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
155091202|NCT00673920|559767505|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
155091203|NCT00673920|559767506|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
155091204|NCT00673920|559767507|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
155091205|NCT00673920|559767508|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
155091206|NCT00673920|559767509|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
155091207|NCT00673920|559767510|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
154965794|NCT00112437|559298864|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965795|NCT00112437|559298865|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965796|NCT00112437|559298866|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965797|NCT00112437|559298867|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
155091208|NCT00673920|559767511|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
154965798|NCT00112437|559298868|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965799|NCT00112437|559298869|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965800|NCT00112437|559298870|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965801|NCT00112437|559298871|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965802|NCT00112437|559298872|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965803|NCT00112437|559298873|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965804|NCT00112437|559298874|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965805|NCT00112437|559298875|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965806|NCT00112437|559298876|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965807|NCT00112437|559298877|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965808|NCT00112437|559298878|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965809|NCT00112437|559298879|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965810|NCT00112437|559298880|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965811|NCT00112437|559298881|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965812|NCT00112437|559298882|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
154965813|NCT00112437|559298883|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965814|NCT00112437|559298884|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965815|NCT00112437|559298885|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965816|NCT00112437|559298886|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965817|NCT00112437|559298887|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
154965818|NCT00112437|559298862|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155091209|NCT00673920|559767504|FG000|Week 24 to Week 48|Death|0|||
155091210|NCT00673920|559767505|FG001|Week 24 to Week 48|Death|0|||
155091211|NCT00673920|559767506|FG002|Week 24 to Week 48|Death|0|||
155091212|NCT00673920|559767507|FG003|Week 24 to Week 48|Death|0|||
155091213|NCT00673920|559767508|FG004|Week 24 to Week 48|Death|0|||
155091214|NCT00673920|559767509|FG005|Week 24 to Week 48|Death|1|||
155091215|NCT00673920|559767510|FG006|Week 24 to Week 48|Death|0|||
155091216|NCT00673920|559767511|FG007|Week 24 to Week 48|Death|0|||
155091217|NCT00673920|559767504|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
155091218|NCT00673920|559767505|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
155091219|NCT00673920|559767506|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
155091220|NCT00673920|559767507|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
155091221|NCT00673920|559767508|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
155091222|NCT00673920|559767509|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
155091223|NCT00673920|559767510|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
155091224|NCT00673920|559767511|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
155091225|NCT02300233|559767515|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
155091226|NCT02300233|559767516|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
155091227|NCT02300233|559767517|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
155091228|NCT02300233|559767515|FG000|Overall Study|Withdrawal by Subject|1|||
155091229|NCT02300233|559767516|FG001|Overall Study|Withdrawal by Subject|0|||
155091230|NCT02300233|559767517|FG002|Overall Study|Withdrawal by Subject|3|||
155091231|NCT02300233|559767515|FG000|Overall Study|Investigator Judgement|0|||
155091232|NCT02300233|559767516|FG001|Overall Study|Investigator Judgement|0|||
155091233|NCT02300233|559767517|FG002|Overall Study|Investigator Judgement|1|||
155375455|NCT01278173|560807460|FG000|Overall Study|Withdrawal by Subject|1|||
155375456|NCT02091206|560807462|FG000|Treatment Period|Adverse Event|0|||
155375457|NCT02091206|560807463|FG001|Treatment Period|Adverse Event|1|||
155375458|NCT02091206|560807464|FG002|Treatment Period|Adverse Event|0|||
155375459|NCT02091206|560807465|FG003|Treatment Period|Adverse Event|0|||
155375460|NCT02091206|560807462|FG000|Treatment Period|Met withdrawal criteria|0|||
155375461|NCT02091206|560807463|FG001|Treatment Period|Met withdrawal criteria|0|||
155375462|NCT02091206|560807464|FG002|Treatment Period|Met withdrawal criteria|1|||
155375463|NCT02091206|560807465|FG003|Treatment Period|Met withdrawal criteria|0|||
155375464|NCT02091206|560807462|FG000|Taper Period|Participant refused study drug|1|||
155375465|NCT02091206|560807463|FG001|Taper Period|Participant refused study drug|0|||
155375466|NCT02091206|560807464|FG002|Taper Period|Participant refused study drug|0|||
155375467|NCT02091206|560807465|FG003|Taper Period|Participant refused study drug|1|||
155375468|NCT02091206|560807462|FG000|Taper Period|Lost to Follow-up|0|||
155375469|NCT02091206|560807463|FG001|Taper Period|Lost to Follow-up|0|||
155091234|NCT02300233|559767515|FG000|Overall Study|Reason Not Specified|0|||
155091235|NCT02300233|559767516|FG001|Overall Study|Reason Not Specified|0|||
155091236|NCT02300233|559767517|FG002|Overall Study|Reason Not Specified|5|||
155375470|NCT02091206|560807464|FG002|Taper Period|Lost to Follow-up|0|||
154965819|NCT00112437|559298863|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965820|NCT00112437|559298864|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965821|NCT00112437|559298865|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965822|NCT00112437|559298866|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965823|NCT00112437|559298867|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965824|NCT00112437|559298868|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965825|NCT00112437|559298869|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965826|NCT00112437|559298870|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965827|NCT00112437|559298871|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965828|NCT00112437|559298872|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965829|NCT00112437|559298873|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155091237|NCT00833690|559767518|FG000|Overall Study|Withdrawal by Subject|1|||
155091238|NCT00833690|559767519|FG001|Overall Study|Withdrawal by Subject|0|||
155091239|NCT00833690|559767520|FG002|Overall Study|Withdrawal by Subject|0|||
154965830|NCT00112437|559298874|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155091240|NCT00833690|559767518|FG000|Overall Study|Discontinued study drug|3|||
155091241|NCT00833690|559767519|FG001|Overall Study|Discontinued study drug|2|||
155375471|NCT02091206|560807465|FG003|Taper Period|Lost to Follow-up|1|||
155375472|NCT00293059|560807466|FG000|Overall Study|Adverse Event|12|||
155375473|NCT00293059|560807467|FG001|Overall Study|Adverse Event|4|||
155375474|NCT00293059|560807466|FG000|Overall Study|Lack of Efficacy|2|||
155375475|NCT00293059|560807467|FG001|Overall Study|Lack of Efficacy|0|||
155375476|NCT00293059|560807466|FG000|Overall Study|Lost to Follow-up|2|||
155375477|NCT00293059|560807467|FG001|Overall Study|Lost to Follow-up|3|||
155375478|NCT00293059|560807466|FG000|Overall Study|Pregnancy|1|||
155375479|NCT00293059|560807467|FG001|Overall Study|Pregnancy|1|||
155375480|NCT00293059|560807466|FG000|Overall Study|Protocol Violation|2|||
155375481|NCT00293059|560807467|FG001|Overall Study|Protocol Violation|0|||
155375482|NCT00293059|560807466|FG000|Overall Study|Withdrawal by Subject|11|||
155375483|NCT00293059|560807467|FG001|Overall Study|Withdrawal by Subject|5|||
155375484|NCT00293059|560807466|FG000|Overall Study|Participant moved out of state|1|||
155375485|NCT00293059|560807467|FG001|Overall Study|Participant moved out of state|0|||
155375486|NCT00293059|560807466|FG000|Overall Study|Participant stopped study drug|1|||
155375487|NCT00293059|560807467|FG001|Overall Study|Participant stopped study drug|0|||
155375488|NCT00293059|560807466|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
155375489|NCT00293059|560807467|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
155375490|NCT00293059|560807466|FG000|Overall Study|missing|3|||
155375491|NCT00293059|560807467|FG001|Overall Study|missing|5|||
155375492|NCT02297139|560807470|FG000|Overall Study|Disease progression|0|||
155375493|NCT02297139|560807471|FG001|Overall Study|Disease progression|1|||
155375494|NCT02297139|560807470|FG000|Overall Study|Study drug toxicity|0|||
155375495|NCT02297139|560807471|FG001|Overall Study|Study drug toxicity|4|||
155375496|NCT02297139|560807470|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155375497|NCT02297139|560807471|FG001|Overall Study|Participant request to discontinue study treatment|1|||
155375498|NCT02297139|560807470|FG000|Overall Study|Maximum clinical benefit|1|||
155375499|NCT02297139|560807471|FG001|Overall Study|Maximum clinical benefit|0|||
155375500|NCT02297139|560807470|FG000|Overall Study|Administrative reason by sponsor|0|||
155375501|NCT02297139|560807471|FG001|Overall Study|Administrative reason by sponsor|2|||
155375502|NCT02297139|560807470|FG000|Overall Study|Other reasons|0|||
155375503|NCT02297139|560807471|FG001|Overall Study|Other reasons|8|||
155375504|NCT05051462|560807477|FG000|Overall Study|Lost to Follow-up|1|||
155375505|NCT05051462|560807478|FG001|Overall Study|Lost to Follow-up|8|||
155375506|NCT05051462|560807477|FG000|Overall Study|Withdrawal by Subject|1|||
155375507|NCT05051462|560807478|FG001|Overall Study|Withdrawal by Subject|0|||
155375508|NCT05051462|560807477|FG000|Overall Study|Protocol Violation|0|||
155375509|NCT05051462|560807478|FG001|Overall Study|Protocol Violation|2|||
155375510|NCT05597787|560807479|FG000|Overall Study|Withdrawal by Subject|0|||
155375511|NCT05597787|560807480|FG001|Overall Study|Withdrawal by Subject|0|||
155375512|NCT05597787|560807481|FG002|Overall Study|Withdrawal by Subject|1|||
155375513|NCT01241604|560807482|FG000|Screening Period|Screen Failure|3|||
155375514|NCT01241604|560807483|FG001|Screening Period|Screen Failure|0|||
155375515|NCT01241604|560807484|FG002|Screening Period|Screen Failure|0|||
155375516|NCT01593787|560807485|FG000|Overall Study|Adverse Event|1|||
155375517|NCT01593787|560807486|FG001|Overall Study|Adverse Event|0|||
155375518|NCT01593787|560807487|FG002|Overall Study|Adverse Event|0|||
155375519|NCT01133418|560807490|FG000|Overall Study|Lost to Follow-up|5|||
155375520|NCT01133418|560807491|FG001|Overall Study|Lost to Follow-up|6|||
155375521|NCT04150068|560807497|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
155375522|NCT04150068|560807498|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
155375523|NCT04150068|560807499|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
155375524|NCT04150068|560807497|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
155375525|NCT04150068|560807498|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
155375526|NCT04150068|560807499|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
154965831|NCT00112437|559298875|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965832|NCT00112437|559298876|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965833|NCT00112437|559298877|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965834|NCT00112437|559298878|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965835|NCT00112437|559298879|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965836|NCT00112437|559298880|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965837|NCT00112437|559298881|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155375527|NCT05316701|560807500|FG000|Overall Study|Adverse Event|0|||
155375528|NCT05316701|560807501|FG001|Overall Study|Adverse Event|1|||
155375529|NCT05316701|560807500|FG000|Overall Study|Death|3|||
155375530|NCT05316701|560807501|FG001|Overall Study|Death|9|||
155375531|NCT05316701|560807500|FG000|Overall Study|Lost to Follow-up|1|||
155375532|NCT05316701|560807501|FG001|Overall Study|Lost to Follow-up|0|||
155375533|NCT05316701|560807500|FG000|Overall Study|Physician Decision|1|||
155375534|NCT05316701|560807501|FG001|Overall Study|Physician Decision|4|||
155375535|NCT05316701|560807500|FG000|Overall Study|Withdrawal by Subject|3|||
155375536|NCT05316701|560807501|FG001|Overall Study|Withdrawal by Subject|5|||
155375537|NCT05316701|560807500|FG000|Overall Study|Progression/Relapse|14|||
155375538|NCT05316701|560807501|FG001|Overall Study|Progression/Relapse|9|||
155375539|NCT05316701|560807500|FG000|Overall Study|Received Standard of Care|1|||
155091242|NCT00833690|559767520|FG002|Overall Study|Discontinued study drug|0|||
155091243|NCT03605693|559767526|FG000|Overall Study|Lost to Follow-up|4|||
155091244|NCT03605693|559767527|FG001|Overall Study|Lost to Follow-up|0|||
155091245|NCT03605693|559767526|FG000|Overall Study|Physician Decision|1|||
155091246|NCT03605693|559767527|FG001|Overall Study|Physician Decision|0|||
155091247|NCT04562116|559767528|FG000|Overall Study|Lost to Follow-up|1|||
155091248|NCT04562116|559767528|FG000|Overall Study|Withdrawal by Subject|3|||
155091249|NCT00928668|559767529|FG000|Overall Study|Adverse Event|1|||
155091250|NCT00928668|559767530|FG001|Overall Study|Adverse Event|0|||
155091251|NCT00928668|559767531|FG002|Overall Study|Adverse Event|0|||
155091252|NCT00928668|559767532|FG003|Overall Study|Adverse Event|0|||
155091253|NCT00928668|559767533|FG004|Overall Study|Adverse Event|0|||
155091254|NCT00928668|559767529|FG000|Overall Study|Protocol Violation|0|||
155091255|NCT00928668|559767530|FG001|Overall Study|Protocol Violation|0|||
155091256|NCT00928668|559767531|FG002|Overall Study|Protocol Violation|0|||
155091257|NCT00928668|559767532|FG003|Overall Study|Protocol Violation|0|||
155091258|NCT00928668|559767533|FG004|Overall Study|Protocol Violation|1|||
155091259|NCT00928668|559767529|FG000|Overall Study|Withdrawal by Subject|0|||
155091260|NCT00928668|559767530|FG001|Overall Study|Withdrawal by Subject|1|||
155091261|NCT00928668|559767531|FG002|Overall Study|Withdrawal by Subject|1|||
155091262|NCT00928668|559767532|FG003|Overall Study|Withdrawal by Subject|0|||
155091263|NCT00928668|559767533|FG004|Overall Study|Withdrawal by Subject|0|||
155091264|NCT00928668|559767529|FG000|Overall Study|Other reasons not listed above|0|||
155091265|NCT00928668|559767530|FG001|Overall Study|Other reasons not listed above|0|||
155091266|NCT00928668|559767531|FG002|Overall Study|Other reasons not listed above|0|||
155091267|NCT00928668|559767532|FG003|Overall Study|Other reasons not listed above|1|||
155091268|NCT00928668|559767533|FG004|Overall Study|Other reasons not listed above|0|||
155375540|NCT05316701|560807501|FG001|Overall Study|Received Standard of Care|0|||
155375541|NCT05316701|560807500|FG000|Overall Study|Ongoing|70|||
155375542|NCT05316701|560807501|FG001|Overall Study|Ongoing|64|||
155375543|NCT01946529|560807502|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
155375544|NCT01946529|560807503|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
155375545|NCT01946529|560807504|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
155375546|NCT01946529|560807502|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
155375547|NCT01946529|560807503|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
155375548|NCT01946529|560807504|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
155375549|NCT04679935|560807505|FG000|Overall Study|Death|0|||
155375550|NCT04679935|560807506|FG001|Overall Study|Death|1|||
155375551|NCT04362189|560807507|FG000|Overall Study|Lost to Follow-up|0|||
155375552|NCT04362189|560807508|FG001|Overall Study|Lost to Follow-up|1|||
155375553|NCT04362189|560807507|FG000|Overall Study|Withdrawal by Subject|1|||
155375554|NCT04362189|560807508|FG001|Overall Study|Withdrawal by Subject|0|||
155375555|NCT04362189|560807507|FG000|Overall Study|FDA Clinical Hold|7|||
155375556|NCT04362189|560807508|FG001|Overall Study|FDA Clinical Hold|2|||
155375557|NCT04362189|560807507|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
155375558|NCT04362189|560807508|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
155375559|NCT04362189|560807507|FG000|Overall Study|Adverse Event|0|||
155375560|NCT04362189|560807508|FG001|Overall Study|Adverse Event|2|||
155375561|NCT04362189|560807507|FG000|Overall Study|Death|4|||
155375562|NCT04362189|560807508|FG001|Overall Study|Death|1|||
155375563|NCT02111681|560807509|FG000|Overall Study|Death|5|||
155375564|NCT02111681|560807509|FG000|Overall Study|Lack of Efficacy|2|||
155375565|NCT02111681|560807509|FG000|Overall Study|Progression of disease|4|||
155375566|NCT00923260|560809126|FG000|Overall Study|Lost to Follow-up|1|||
155375567|NCT00923260|560809127|FG001|Overall Study|Lost to Follow-up|1|||
155375568|NCT03241927|560809128|FG000|Overall Study|study terminated|1|||
155375569|NCT03241927|560809129|FG001|Overall Study|study terminated|0|||
155375570|NCT01850446|560809130|FG000|Overall Study|Lack of Efficacy|1|||
155375571|NCT01850446|560809131|FG001|Overall Study|Lack of Efficacy|0|||
155375572|NCT01850446|560809130|FG000|Overall Study|Withdrawal by Subject|4|||
155375573|NCT01850446|560809131|FG001|Overall Study|Withdrawal by Subject|0|||
155091269|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
155169331|NCT02152956|560057343|FG009|Overall Study|progressive disease|0|||
155169332|NCT02152956|560057344|FG010|Overall Study|progressive disease|0|||
155375574|NCT01850446|560809130|FG000|Overall Study|Protocol Violation|0|||
155091270|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
155091271|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
155375575|NCT01850446|560809131|FG001|Overall Study|Protocol Violation|2|||
155375576|NCT00591721|560809132|FG000|Overall Study|Withdrawal by Subject|10|||
155375577|NCT00591721|560809133|FG001|Overall Study|Withdrawal by Subject|10|||
155375578|NCT00591721|560809132|FG000|Overall Study|Lost to Follow-up|1|||
155375579|NCT00591721|560809133|FG001|Overall Study|Lost to Follow-up|4|||
155375580|NCT00591721|560809132|FG000|Overall Study|Intervention not received|10|||
155091272|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
155091273|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
155091274|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
154965838|NCT00112437|559298882|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155375581|NCT00591721|560809133|FG001|Overall Study|Intervention not received|8|||
155375582|NCT03507777|560809134|FG000|Overall Study|Lost to Follow-up|5|||
155375583|NCT03507777|560809135|FG001|Overall Study|Lost to Follow-up|7|||
155375584|NCT03507777|560809134|FG000|Overall Study|Withdrawal by Subject|6|||
155375585|NCT03507777|560809135|FG001|Overall Study|Withdrawal by Subject|11|||
155375586|NCT03507777|560809134|FG000|Overall Study|Death|30|||
155375587|NCT03507777|560809135|FG001|Overall Study|Death|44|||
155375588|NCT03507777|560809134|FG000|Overall Study|Other Reasons|3|||
155375589|NCT03507777|560809135|FG001|Overall Study|Other Reasons|8|||
155375590|NCT01879722|560809136|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155375591|NCT01879722|560809137|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155375592|NCT01879722|560809138|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155375593|NCT01879722|560809139|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
155375594|NCT01879722|560809140|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
155375595|NCT01879722|560809141|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
155375596|NCT01879722|560809142|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
155375597|NCT01879722|560809143|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
155375598|NCT01879722|560809144|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
155375599|NCT01879722|560809145|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
155375600|NCT01879722|560809136|FG000|Overall Study|Voluntary Withdrawal|0|||
155375601|NCT01879722|560809137|FG001|Overall Study|Voluntary Withdrawal|0|||
155375602|NCT01879722|560809138|FG002|Overall Study|Voluntary Withdrawal|0|||
155375603|NCT01879722|560809139|FG003|Overall Study|Voluntary Withdrawal|0|||
155375604|NCT01879722|560809140|FG004|Overall Study|Voluntary Withdrawal|0|||
155375605|NCT01879722|560809141|FG005|Overall Study|Voluntary Withdrawal|0|||
155375606|NCT01879722|560809142|FG006|Overall Study|Voluntary Withdrawal|0|||
155375607|NCT01879722|560809143|FG007|Overall Study|Voluntary Withdrawal|0|||
155375608|NCT01879722|560809144|FG008|Overall Study|Voluntary Withdrawal|1|||
155375609|NCT01879722|560809145|FG009|Overall Study|Voluntary Withdrawal|0|||
155375610|NCT00774930|560809153|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
155375611|NCT00774930|560809154|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
155375612|NCT00774930|560809153|FG000|DB Phase|Adverse Event|1|||
155375613|NCT00774930|560809154|FG001|DB Phase|Adverse Event|2|||
155375614|NCT00774930|560809153|FG000|DB Phase|Subject Decision|1|||
155375615|NCT00774930|560809154|FG001|DB Phase|Subject Decision|5|||
155375616|NCT00774930|560809153|FG000|DB Phase|Sponsor Decision|0|||
155375617|NCT00774930|560809154|FG001|DB Phase|Sponsor Decision|1|||
155375618|NCT00774930|560809153|FG000|DB Phase|Disease Progression|1|||
155375619|NCT00774930|560809154|FG001|DB Phase|Disease Progression|1|||
155375620|NCT00774930|560809153|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
155375621|NCT00774930|560809154|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
155375622|NCT00774930|560809153|FG000|IOL Phase|Adverse Event|1|||
155375623|NCT00774930|560809154|FG001|IOL Phase|Adverse Event|1|||
155375624|NCT00774930|560809153|FG000|IOL Phase|Subject Decision|4|||
155375625|NCT00774930|560809154|FG001|IOL Phase|Subject Decision|3|||
155375626|NCT00774930|560809153|FG000|IOL Phase|Physician Decision|3|||
154965839|NCT00112437|559298883|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
154965840|NCT00112437|559298884|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965841|NCT00112437|559298885|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
155375627|NCT00774930|560809154|FG001|IOL Phase|Physician Decision|2|||
155375628|NCT00774930|560809153|FG000|IOL Phase|Sponsor Decision|1|||
155375629|NCT00774930|560809154|FG001|IOL Phase|Sponsor Decision|0|||
155375630|NCT00774930|560809153|FG000|IOL Phase|Disease Progression|2|||
155375631|NCT00774930|560809154|FG001|IOL Phase|Disease Progression|1|||
155375632|NCT00774930|560809153|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
155375633|NCT00774930|560809154|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
155375634|NCT00774930|560809153|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
155375635|NCT00774930|560809154|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
155375636|NCT00774930|560809153|FG000|IOL Phase|Other|1|||
155375637|NCT00774930|560809154|FG001|IOL Phase|Other|0|||
155375638|NCT00774930|560809153|FG000|IOL Phase|Brain radiation|0|||
155375639|NCT00774930|560809154|FG001|IOL Phase|Brain radiation|1|||
155375640|NCT00774930|560809153|FG000|LTOLE Phase|Adverse Event|7|||
155375641|NCT00774930|560809154|FG001|LTOLE Phase|Adverse Event|3|||
155375642|NCT00774930|560809153|FG000|LTOLE Phase|Subject decision|0|||
155375643|NCT00774930|560809154|FG001|LTOLE Phase|Subject decision|5|||
155375644|NCT00774930|560809153|FG000|LTOLE Phase|Physician Decision|4|||
155375645|NCT00774930|560809154|FG001|LTOLE Phase|Physician Decision|1|||
155375646|NCT00774930|560809153|FG000|LTOLE Phase|Sponsor decision|2|||
155375647|NCT00774930|560809154|FG001|LTOLE Phase|Sponsor decision|1|||
155375648|NCT00774930|560809153|FG000|LTOLE Phase|Disease Progression|2|||
155375649|NCT00774930|560809154|FG001|LTOLE Phase|Disease Progression|5|||
155375650|NCT00774930|560809153|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
155375651|NCT00774930|560809154|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
155375652|NCT00774930|560809153|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
155375653|NCT00774930|560809154|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
155375654|NCT01153321|560809155|FG000|Overall Study|Development of study withdrawal criteria|0|||
155375655|NCT01153321|560809156|FG001|Overall Study|Development of study withdrawal criteria|1|||
155375656|NCT01153321|560809155|FG000|Overall Study|Withdrawal by Subject|0|||
155375657|NCT01153321|560809156|FG001|Overall Study|Withdrawal by Subject|1|||
155375658|NCT01153321|560809155|FG000|Overall Study|Adverse Event|1|||
155375659|NCT01153321|560809156|FG001|Overall Study|Adverse Event|1|||
155375660|NCT04032613|560809157|FG000|Overall Study|Did not complete post-program assessment|5|||
155375661|NCT04032613|560809158|FG001|Overall Study|Did not complete post-program assessment|2|||
155375662|NCT00424385|560809159|FG000|Cohort 0|Withdrawal by Subject|5|||
155375663|NCT00424385|560809159|FG000|Cohort 0|Physician Decision|1|||
155375664|NCT00424385|560809159|FG000|Cohort 1|Withdrawal by Subject|1|||
155375665|NCT00964886|560809164|FG000|Overall Study|Lost to Follow-up|2|||
155375666|NCT00964886|560809165|FG001|Overall Study|Lost to Follow-up|2|||
155375667|NCT00964886|560809166|FG002|Overall Study|Lost to Follow-up|6|||
155375668|NCT00964886|560809167|FG003|Overall Study|Lost to Follow-up|4|||
155375669|NCT00964886|560809164|FG000|Overall Study|Withdrawal by Subject|6|||
155375670|NCT00964886|560809165|FG001|Overall Study|Withdrawal by Subject|2|||
155375671|NCT00964886|560809166|FG002|Overall Study|Withdrawal by Subject|5|||
155375672|NCT00964886|560809167|FG003|Overall Study|Withdrawal by Subject|3|||
155375673|NCT00964886|560809164|FG000|Overall Study|Adverse Event|3|||
155375674|NCT00964886|560809165|FG001|Overall Study|Adverse Event|1|||
155375675|NCT00964886|560809166|FG002|Overall Study|Adverse Event|5|||
155375676|NCT00964886|560809167|FG003|Overall Study|Adverse Event|2|||
155375677|NCT00964886|560809164|FG000|Overall Study|Protocol Violation|0|||
155375678|NCT00964886|560809165|FG001|Overall Study|Protocol Violation|2|||
155375679|NCT00964886|560809166|FG002|Overall Study|Protocol Violation|0|||
155375680|NCT00964886|560809167|FG003|Overall Study|Protocol Violation|0|||
155375681|NCT05870228|560809169|FG000|Overall Study|Lost to Follow-up|2|||
155375682|NCT05870228|560809170|FG001|Overall Study|Lost to Follow-up|0|||
155375683|NCT05870228|560809169|FG000|Overall Study|Withdrawal by Subject|1|||
155375684|NCT05870228|560809170|FG001|Overall Study|Withdrawal by Subject|0|||
155375685|NCT04075994|560809172|FG000|Overall Study|Withdrawal by Subject|8|||
155375686|NCT04075994|560809173|FG001|Overall Study|Withdrawal by Subject|9|||
155375687|NCT04075994|560809172|FG000|Overall Study|Adverse Event|2|||
155375688|NCT04075994|560809173|FG001|Overall Study|Adverse Event|2|||
155375689|NCT04075994|560809172|FG000|Overall Study|Investigator withdrew|3|||
155375690|NCT04075994|560809173|FG001|Overall Study|Investigator withdrew|1|||
155375691|NCT00252577|560809178|FG000|Overall Study|Lost to Follow-up|20|||
155375692|NCT01125514|560809180|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
155375693|NCT01125514|560809180|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
155375694|NCT01125514|560809180|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
155375695|NCT01125514|560809180|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
155375696|NCT01125514|560809180|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
155375697|NCT01125514|560809180|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
155375698|NCT01655693|560809181|FG000|Overall Study|Progression of Disease|92|||
155375699|NCT01655693|560809182|FG001|Overall Study|Progression of Disease|76|||
155375700|NCT01655693|560809183|FG002|Overall Study|Progression of Disease|58|||
155375701|NCT01655693|560809181|FG000|Overall Study|Death|8|||
155375702|NCT01655693|560809182|FG001|Overall Study|Death|9|||
155375703|NCT01655693|560809183|FG002|Overall Study|Death|12|||
155375704|NCT01655693|560809181|FG000|Overall Study|Serious Adverse Event|3|||
155375705|NCT01655693|560809182|FG001|Overall Study|Serious Adverse Event|15|||
155375706|NCT01655693|560809183|FG002|Overall Study|Serious Adverse Event|11|||
155375707|NCT01655693|560809181|FG000|Overall Study|Withdrawal by Subject|3|||
155375708|NCT01655693|560809182|FG001|Overall Study|Withdrawal by Subject|2|||
155169333|NCT02152956|560057345|FG011|Overall Study|progressive disease|1|||
155375709|NCT01655693|560809183|FG002|Overall Study|Withdrawal by Subject|20|||
155375710|NCT01655693|560809181|FG000|Overall Study|Adverse Event|3|||
155375711|NCT01655693|560809182|FG001|Overall Study|Adverse Event|11|||
155375712|NCT01655693|560809183|FG002|Overall Study|Adverse Event|3|||
155375713|NCT01655693|560809181|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
155375714|NCT01655693|560809182|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
155375715|NCT01655693|560809183|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
155375716|NCT01655693|560809181|FG000|Overall Study|Non-Compliance|0|||
155375717|NCT01655693|560809182|FG001|Overall Study|Non-Compliance|0|||
155375718|NCT01655693|560809183|FG002|Overall Study|Non-Compliance|7|||
155375719|NCT01655693|560809181|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
155375720|NCT01655693|560809182|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
155375721|NCT01655693|560809183|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
155375722|NCT01655693|560809181|FG000|Overall Study|Protocol Violation|1|||
155375723|NCT01655693|560809182|FG001|Overall Study|Protocol Violation|0|||
155375724|NCT01655693|560809183|FG002|Overall Study|Protocol Violation|3|||
155375725|NCT01655693|560809181|FG000|Overall Study|Lost to Follow-up|1|||
155375726|NCT01655693|560809182|FG001|Overall Study|Lost to Follow-up|0|||
155375727|NCT01655693|560809183|FG002|Overall Study|Lost to Follow-up|1|||
155375728|NCT01655693|560809181|FG000|Overall Study|Screening Failure|1|||
155375729|NCT01655693|560809182|FG001|Overall Study|Screening Failure|0|||
155375730|NCT01655693|560809183|FG002|Overall Study|Screening Failure|0|||
155375731|NCT01655693|560809181|FG000|Overall Study|Other|8|||
155375732|NCT01655693|560809182|FG001|Overall Study|Other|6|||
155375733|NCT01655693|560809183|FG002|Overall Study|Other|15|||
155375734|NCT00929110|560809186|FG000|Overall Study|Adverse Event|40|||
155375735|NCT00929110|560809187|FG001|Overall Study|Adverse Event|29|||
155375736|NCT00929110|560809188|FG002|Overall Study|Adverse Event|18|||
155375737|NCT00929110|560809186|FG000|Overall Study|Subject withdrew consent|40|||
155375738|NCT00929110|560809187|FG001|Overall Study|Subject withdrew consent|23|||
155375739|NCT00929110|560809188|FG002|Overall Study|Subject withdrew consent|26|||
155375740|NCT00929110|560809186|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
155375741|NCT00929110|560809187|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
155375742|NCT00929110|560809188|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
155375743|NCT00929110|560809186|FG000|Overall Study|Lost to Follow-up|7|||
155375744|NCT00929110|560809187|FG001|Overall Study|Lost to Follow-up|7|||
155375745|NCT00929110|560809188|FG002|Overall Study|Lost to Follow-up|3|||
155375746|NCT00929110|560809186|FG000|Overall Study|Protocol deviation|5|||
155375747|NCT00929110|560809187|FG001|Overall Study|Protocol deviation|2|||
155375748|NCT00929110|560809188|FG002|Overall Study|Protocol deviation|4|||
155375749|NCT00929110|560809186|FG000|Overall Study|Administrative problems|4|||
155375750|NCT00929110|560809187|FG001|Overall Study|Administrative problems|1|||
155375751|NCT00929110|560809188|FG002|Overall Study|Administrative problems|2|||
155375752|NCT00929110|560809186|FG000|Overall Study|Death|2|||
155375753|NCT00929110|560809187|FG001|Overall Study|Death|2|||
155375754|NCT00929110|560809188|FG002|Overall Study|Death|2|||
155375755|NCT00929110|560809186|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155375756|NCT00929110|560809187|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155375757|NCT00929110|560809188|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155375758|NCT00929110|560809186|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155375759|NCT00929110|560809187|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155375760|NCT00929110|560809188|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155375761|NCT00929110|560809186|FG000|Overall Study|Patient inability to use the device|0|||
155091275|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
155091276|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
155091277|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
155091278|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
155091279|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
155375762|NCT00929110|560809187|FG001|Overall Study|Patient inability to use the device|1|||
155375763|NCT00929110|560809188|FG002|Overall Study|Patient inability to use the device|0|||
155375764|NCT01163292|560809192|FG000|Overall Study|Lack of Efficacy|9|||
155375765|NCT01163292|560809193|FG001|Overall Study|Lack of Efficacy|0|||
155375766|NCT01163292|560809192|FG000|Overall Study|Adverse Event|6|||
155375767|NCT01163292|560809193|FG001|Overall Study|Adverse Event|0|||
155169334|NCT02152956|560057346|FG012|Overall Study|progressive disease|0|||
155375768|NCT01163292|560809192|FG000|Overall Study|Initiation of biological therapy|0|||
155375769|NCT01163292|560809193|FG001|Overall Study|Initiation of biological therapy|15|||
155375770|NCT01163292|560809192|FG000|Overall Study|Sufficient response to adalimumab|8|||
155375771|NCT01163292|560809193|FG001|Overall Study|Sufficient response to adalimumab|0|||
155375772|NCT01163292|560809192|FG000|Overall Study|Refusal to receive adalimumab|7|||
155375773|NCT01163292|560809193|FG001|Overall Study|Refusal to receive adalimumab|0|||
155375774|NCT01163292|560809192|FG000|Overall Study|Economic reasons|6|||
155375775|NCT01163292|560809193|FG001|Overall Study|Economic reasons|0|||
155375776|NCT01163292|560809192|FG000|Overall Study|No further visits|5|||
155375777|NCT01163292|560809193|FG001|Overall Study|No further visits|7|||
155375778|NCT02643472|560809194|FG000|Overall Study|Death|2|||
155375779|NCT02643472|560809195|FG001|Overall Study|Death|5|||
155375780|NCT02643472|560809194|FG000|Overall Study|Withdrawal by Subject|3|||
155375781|NCT02643472|560809195|FG001|Overall Study|Withdrawal by Subject|2|||
155375782|NCT02643472|560809194|FG000|Overall Study|Protocol Violation|0|||
155375783|NCT02643472|560809195|FG001|Overall Study|Protocol Violation|1|||
155375784|NCT02643472|560809194|FG000|Overall Study|Lost to Follow-up|22|||
155375785|NCT02643472|560809195|FG001|Overall Study|Lost to Follow-up|26|||
155375786|NCT01258595|560809196|FG000|Overall Study|Lost to Follow-up|1|||
155375787|NCT01258595|560809197|FG001|Overall Study|Lost to Follow-up|0|||
155375788|NCT01258595|560809196|FG000|Overall Study|Withdrawal by Subject|0|||
155375789|NCT01258595|560809197|FG001|Overall Study|Withdrawal by Subject|1|||
155375790|NCT01215188|560809198|FG000|Overall Study|Lost to Follow-up|22|||
155375791|NCT01215188|560809199|FG001|Overall Study|Lost to Follow-up|22|||
155375792|NCT01215188|560809200|FG002|Overall Study|Lost to Follow-up|16|||
155375793|NCT01215188|560809198|FG000|Overall Study|Adverse Event|1|||
155375794|NCT01215188|560809199|FG001|Overall Study|Adverse Event|1|||
155375795|NCT01215188|560809200|FG002|Overall Study|Adverse Event|3|||
155375796|NCT01215188|560809198|FG000|Overall Study|Physician Decision|2|||
155375797|NCT01215188|560809199|FG001|Overall Study|Physician Decision|1|||
155375798|NCT01215188|560809200|FG002|Overall Study|Physician Decision|0|||
155375799|NCT01215188|560809198|FG000|Overall Study|Lack of Efficacy|0|||
155375800|NCT01215188|560809199|FG001|Overall Study|Lack of Efficacy|0|||
155375801|NCT01215188|560809200|FG002|Overall Study|Lack of Efficacy|1|||
155375802|NCT01215188|560809198|FG000|Overall Study|Protocol Violation|1|||
155375803|NCT01215188|560809199|FG001|Overall Study|Protocol Violation|1|||
155375804|NCT01215188|560809200|FG002|Overall Study|Protocol Violation|1|||
155375805|NCT01215188|560809198|FG000|Overall Study|Withdrawal by Subject|32|||
155375806|NCT01215188|560809199|FG001|Overall Study|Withdrawal by Subject|34|||
155375807|NCT01215188|560809200|FG002|Overall Study|Withdrawal by Subject|31|||
155375808|NCT01012414|560809201|FG000|Overall Study|Withdrawal by Subject|2|||
155375809|NCT01012414|560809201|FG000|Overall Study|Lost to Follow-up|1|||
155375810|NCT01012414|560809201|FG000|Overall Study|Trial was stopped before completed|7|||
155375811|NCT02601300|560809202|FG000|Induction Phase|Lack of Efficacy|2|||
155375812|NCT02601300|560809202|FG000|Induction Phase|Protocol Violation|1|||
155375813|NCT02601300|560809202|FG000|Extension Phase|Withdrawal by Subject|3|||
155375814|NCT02601300|560809202|FG000|Extension Phase|Adverse Event|4|||
155375815|NCT02601300|560809202|FG000|Extension Phase|Lack of Efficacy|10|||
155375816|NCT02310100|560809203|FG000|Overall Study|Physician Decision|3|||
155375817|NCT02310100|560809203|FG000|Overall Study|Withdrawal by Subject|10|||
155375818|NCT02310100|560809203|FG000|Overall Study|Enrollment closure|1|||
155375819|NCT02310100|560809203|FG000|Overall Study|Unapproved ablation operator|1|||
155375820|NCT02310100|560809203|FG000|Overall Study|Visit compliance|1|||
155375821|NCT02310100|560809203|FG000|Overall Study|Lost to Follow-up|2|||
155375822|NCT01127763|560809207|FG000|Overall Study|Adverse Event|2|||
155091280|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
155091281|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
155375823|NCT01127763|560809207|FG000|Overall Study|Withdrawal by Subject|1|||
155375824|NCT01127763|560809207|FG000|Overall Study|Physician Decision|2|||
155375825|NCT00528931|560809208|FG000|Overall Study|Lost to Follow-up|1|||
155375826|NCT03122223|560809213|FG000|Overall Study|Withdrawal by Subject|2|||
155375827|NCT03122223|560809214|FG001|Overall Study|Withdrawal by Subject|2|||
155375828|NCT03122223|560809215|FG002|Overall Study|Withdrawal by Subject|1|||
155375829|NCT03122223|560809216|FG003|Overall Study|Withdrawal by Subject|0|||
155375830|NCT03122223|560809213|FG000|Overall Study|Lost to Follow-up|0|||
155375831|NCT03122223|560809214|FG001|Overall Study|Lost to Follow-up|2|||
155375832|NCT03122223|560809215|FG002|Overall Study|Lost to Follow-up|2|||
155375833|NCT03122223|560809216|FG003|Overall Study|Lost to Follow-up|0|||
155375834|NCT03122223|560809213|FG000|Overall Study|Participant unable to adhere|1|||
155375835|NCT03122223|560809214|FG001|Overall Study|Participant unable to adhere|1|||
155375836|NCT03122223|560809215|FG002|Overall Study|Participant unable to adhere|1|||
155375837|NCT03122223|560809216|FG003|Overall Study|Participant unable to adhere|0|||
155375838|NCT01151410|560809219|FG000|Overall Study|Withdrawal by Subject|3|||
155375839|NCT01151410|560809220|FG001|Overall Study|Withdrawal by Subject|5|||
155375840|NCT01151410|560809219|FG000|Overall Study|Lost to Follow-up|3|||
155375841|NCT01151410|560809220|FG001|Overall Study|Lost to Follow-up|4|||
155375842|NCT01151410|560809219|FG000|Overall Study|Adverse Event|1|||
155375843|NCT01151410|560809220|FG001|Overall Study|Adverse Event|2|||
155375844|NCT01151410|560809219|FG000|Overall Study|Protocol deviation|2|||
155375845|NCT01151410|560809220|FG001|Overall Study|Protocol deviation|1|||
155375846|NCT01151410|560809219|FG000|Overall Study|Administrative problems|1|||
155375847|NCT01151410|560809220|FG001|Overall Study|Administrative problems|1|||
155375848|NCT01151410|560809219|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155375849|NCT01151410|560809220|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155375850|NCT01151410|560809219|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155375851|NCT01151410|560809220|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155375852|NCT01253018|560809221|FG000|Overall Study|Lost to Follow-up|1|||
155375853|NCT01253018|560809222|FG001|Overall Study|Lost to Follow-up|1|||
155375854|NCT01253018|560809221|FG000|Overall Study|Robot Repair Issues|2|||
155375855|NCT01253018|560809222|FG001|Overall Study|Robot Repair Issues|0|||
155375856|NCT01253018|560809221|FG000|Overall Study|Withdrawal by Subject|1|||
155375857|NCT01253018|560809222|FG001|Overall Study|Withdrawal by Subject|1|||
155375858|NCT00291642|560809224|FG000|Overall Study|Adverse Event|1|||
155375859|NCT00291642|560809225|FG001|Overall Study|Adverse Event|0|||
155375860|NCT00291642|560809226|FG002|Overall Study|Adverse Event|1|||
155375861|NCT00291642|560809227|FG003|Overall Study|Adverse Event|0|||
155375862|NCT00291642|560809228|FG004|Overall Study|Adverse Event|1|||
155375863|NCT00291642|560809224|FG000|Overall Study|Patient missed visit|0|||
155375864|NCT00291642|560809225|FG001|Overall Study|Patient missed visit|0|||
155375865|NCT00291642|560809226|FG002|Overall Study|Patient missed visit|1|||
155375866|NCT00291642|560809227|FG003|Overall Study|Patient missed visit|0|||
155375867|NCT00291642|560809228|FG004|Overall Study|Patient missed visit|0|||
155375868|NCT00291642|560809224|FG000|Overall Study|Intake of prohibited medication|1|||
155091282|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
155091283|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
155091284|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
155091285|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
155375869|NCT00291642|560809225|FG001|Overall Study|Intake of prohibited medication|0|||
155375870|NCT00291642|560809226|FG002|Overall Study|Intake of prohibited medication|0|||
155375871|NCT00291642|560809227|FG003|Overall Study|Intake of prohibited medication|0|||
155375872|NCT00291642|560809228|FG004|Overall Study|Intake of prohibited medication|0|||
155375873|NCT01820585|560809229|FG000|Overall Study|Adverse Event|9|||
155375874|NCT01820585|560809230|FG001|Overall Study|Adverse Event|13|||
155375875|NCT01820585|560809231|FG002|Overall Study|Adverse Event|23|||
155375876|NCT01820585|560809232|FG003|Overall Study|Adverse Event|34|||
155375877|NCT01820585|560809229|FG000|Overall Study|Lack of Efficacy|9|||
155375878|NCT01820585|560809230|FG001|Overall Study|Lack of Efficacy|7|||
155375879|NCT01820585|560809231|FG002|Overall Study|Lack of Efficacy|5|||
155375880|NCT01820585|560809232|FG003|Overall Study|Lack of Efficacy|1|||
155375881|NCT01820585|560809229|FG000|Overall Study|Withdrawal by Subject|3|||
155375882|NCT01820585|560809230|FG001|Overall Study|Withdrawal by Subject|7|||
155375883|NCT01820585|560809231|FG002|Overall Study|Withdrawal by Subject|3|||
155375884|NCT01820585|560809232|FG003|Overall Study|Withdrawal by Subject|8|||
155375885|NCT01820585|560809229|FG000|Overall Study|Lost to Follow-up|3|||
155375886|NCT01820585|560809230|FG001|Overall Study|Lost to Follow-up|3|||
155375887|NCT01820585|560809231|FG002|Overall Study|Lost to Follow-up|0|||
155375888|NCT01820585|560809232|FG003|Overall Study|Lost to Follow-up|3|||
155375889|NCT01820585|560809229|FG000|Overall Study|Protocol Violation|3|||
155375890|NCT01820585|560809230|FG001|Overall Study|Protocol Violation|1|||
155375891|NCT01820585|560809231|FG002|Overall Study|Protocol Violation|1|||
155375892|NCT01820585|560809232|FG003|Overall Study|Protocol Violation|1|||
155375893|NCT01820585|560809229|FG000|Overall Study|Subject non-compliance|0|||
155375894|NCT01820585|560809230|FG001|Overall Study|Subject non-compliance|0|||
155375895|NCT01820585|560809231|FG002|Overall Study|Subject non-compliance|1|||
155375896|NCT01820585|560809232|FG003|Overall Study|Subject non-compliance|2|||
155375897|NCT01820585|560809229|FG000|Overall Study|at sponsor request|0|||
155375898|NCT01820585|560809230|FG001|Overall Study|at sponsor request|0|||
155375899|NCT01820585|560809231|FG002|Overall Study|at sponsor request|1|||
155375900|NCT01820585|560809232|FG003|Overall Study|at sponsor request|0|||
155375901|NCT01820585|560809229|FG000|Overall Study|Pregnancy|0|||
155375902|NCT01820585|560809230|FG001|Overall Study|Pregnancy|1|||
155375903|NCT01820585|560809231|FG002|Overall Study|Pregnancy|0|||
155375904|NCT01820585|560809232|FG003|Overall Study|Pregnancy|0|||
155375905|NCT02285153|560809233|FG000|Overall Study|Adverse Event|1|||
155375906|NCT02285153|560809234|FG001|Overall Study|Adverse Event|0|||
155375907|NCT03590366|560809239|FG000|Overall Study|Adverse Event|0|||
155375908|NCT03590366|560809240|FG001|Overall Study|Adverse Event|3|||
155375909|NCT03590366|560809239|FG000|Overall Study|Lost to Follow-up|3|||
155375910|NCT03590366|560809240|FG001|Overall Study|Lost to Follow-up|3|||
155375911|NCT03590366|560809239|FG000|Overall Study|Withdrawal by Subject|0|||
155375912|NCT03590366|560809240|FG001|Overall Study|Withdrawal by Subject|2|||
155375913|NCT01413503|560809244|FG000|Overall Study|Lost to Follow-up|1|||
155375914|NCT02001064|560809246|FG000|Overall Study|Withdrawal by Subject|2|||
155375915|NCT02001064|560809247|FG001|Overall Study|Withdrawal by Subject|1|||
155375916|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
155375917|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
155375918|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
155375919|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
155375920|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
155375921|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
155375922|NCT01982448|560809251|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
155375923|NCT01982448|560809252|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
155375924|NCT00969709|560810864|FG000|Overall Study|Adverse Event|3|||
155375925|NCT00969709|560810865|FG001|Overall Study|Adverse Event|13|||
155375926|NCT00969709|560810866|FG002|Overall Study|Adverse Event|26|||
155375927|NCT00969709|560810867|FG003|Overall Study|Adverse Event|12|||
155375928|NCT00969709|560810864|FG000|Overall Study|Lack of Efficacy|7|||
155375929|NCT00969709|560810865|FG001|Overall Study|Lack of Efficacy|4|||
155375930|NCT00969709|560810866|FG002|Overall Study|Lack of Efficacy|1|||
155375931|NCT00969709|560810867|FG003|Overall Study|Lack of Efficacy|3|||
155375932|NCT00969709|560810864|FG000|Overall Study|Protocol Violation|9|||
155375933|NCT00969709|560810865|FG001|Overall Study|Protocol Violation|5|||
155375934|NCT00969709|560810866|FG002|Overall Study|Protocol Violation|9|||
155375935|NCT00969709|560810867|FG003|Overall Study|Protocol Violation|10|||
155375936|NCT00969709|560810864|FG000|Overall Study|Withdrawal by Subject|9|||
155375937|NCT00969709|560810865|FG001|Overall Study|Withdrawal by Subject|12|||
155375938|NCT00969709|560810866|FG002|Overall Study|Withdrawal by Subject|11|||
155375939|NCT00969709|560810867|FG003|Overall Study|Withdrawal by Subject|23|||
155375940|NCT00969709|560810864|FG000|Overall Study|Lost to Follow-up|10|||
155375941|NCT00969709|560810865|FG001|Overall Study|Lost to Follow-up|14|||
155375942|NCT00969709|560810866|FG002|Overall Study|Lost to Follow-up|8|||
155375943|NCT00969709|560810867|FG003|Overall Study|Lost to Follow-up|15|||
155375944|NCT00969709|560810864|FG000|Overall Study|Other reasons|0|||
155375945|NCT00969709|560810865|FG001|Overall Study|Other reasons|0|||
155375946|NCT00969709|560810866|FG002|Overall Study|Other reasons|3|||
155375947|NCT00969709|560810867|FG003|Overall Study|Other reasons|0|||
155375948|NCT03695237|560810868|FG000|Overall Study|Withdrawal by Subject|1|||
155375949|NCT03695237|560810869|FG001|Overall Study|Withdrawal by Subject|3|||
155375950|NCT03695237|560810868|FG000|Overall Study|Lost to Follow-up|1|||
155375951|NCT03695237|560810869|FG001|Overall Study|Lost to Follow-up|2|||
155375952|NCT03695237|560810868|FG000|Overall Study|Other, Not Specified|8|||
155375953|NCT03695237|560810869|FG001|Overall Study|Other, Not Specified|2|||
155375954|NCT00055601|560810870|FG000|Overall Study|Protocol Violation|1|||
155375955|NCT00055601|560810871|FG001|Overall Study|Protocol Violation|1|||
155375956|NCT00055601|560810870|FG000|Overall Study|No protocol treatment received|1|||
155375957|NCT00055601|560810871|FG001|Overall Study|No protocol treatment received|1|||
155375958|NCT02217332|560810878|FG000|Overall Study|Adverse Event|3|||
155375959|NCT02217332|560810878|FG000|Overall Study|Dose interruption >1 month|1|||
155375960|NCT02217332|560810878|FG000|Overall Study|Protocol Violation (eligibility)|1|||
155375961|NCT02217332|560810878|FG000|Overall Study|Withdrawal by Subject|1|||
155375962|NCT02217332|560810878|FG000|Overall Study|Lost to Follow-up|1|||
155375963|NCT03725085|560810882|FG000|Overall Study|Lost to Follow-up|2|||
155375964|NCT02704754|560810883|FG000|Overall Study|Lost to Follow-up|1|||
155375965|NCT02704754|560810884|FG001|Overall Study|Lost to Follow-up|1|||
155375966|NCT02704754|560810883|FG000|Overall Study|Lack of Efficacy|1|||
155375967|NCT02704754|560810884|FG001|Overall Study|Lack of Efficacy|0|||
155375968|NCT02704754|560810883|FG000|Overall Study|Withdrawal by Subject|1|||
155375969|NCT02704754|560810884|FG001|Overall Study|Withdrawal by Subject|0|||
155375970|NCT03809429|560810890|FG000|Overall Study|Withdrawal by Subject|7|||
155375971|NCT03809429|560810891|FG001|Overall Study|Withdrawal by Subject|3|||
155375972|NCT03809429|560810890|FG000|Overall Study|Adverse Event|6|||
155375973|NCT03809429|560810891|FG001|Overall Study|Adverse Event|9|||
155375974|NCT03809429|560810890|FG000|Overall Study|COVID-19|3|||
155091286|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
155091287|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
155169335|NCT00530816|560057347|FG000|Overall Study|Progressive Disease|16|||
155375975|NCT03809429|560810891|FG001|Overall Study|COVID-19|1|||
155375976|NCT03809429|560810890|FG000|Overall Study|Participant was discontinued by investigator|12|||
155375977|NCT03809429|560810891|FG001|Overall Study|Participant was discontinued by investigator|7|||
155375978|NCT02245737|560810895|FG000|Overall Study|Adverse Event|23|||
155375979|NCT02245737|560810896|FG001|Overall Study|Adverse Event|26|||
155375980|NCT02245737|560810897|FG002|Overall Study|Adverse Event|33|||
155375981|NCT02245737|560810895|FG000|Overall Study|Condition Worsened|9|||
155375982|NCT02245737|560810896|FG001|Overall Study|Condition Worsened|10|||
155375983|NCT02245737|560810897|FG002|Overall Study|Condition Worsened|9|||
155375984|NCT02245737|560810895|FG000|Overall Study|Death|2|||
155375985|NCT02245737|560810896|FG001|Overall Study|Death|4|||
155375986|NCT02245737|560810897|FG002|Overall Study|Death|4|||
155375987|NCT02245737|560810895|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
155375988|NCT02245737|560810896|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
155375989|NCT02245737|560810897|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
155375990|NCT02245737|560810895|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
155375991|NCT02245737|560810896|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
155375992|NCT02245737|560810897|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
155375993|NCT02245737|560810895|FG000|Overall Study|Lost to Follow-up|2|||
155375994|NCT02245737|560810896|FG001|Overall Study|Lost to Follow-up|5|||
155375995|NCT02245737|560810897|FG002|Overall Study|Lost to Follow-up|4|||
155375996|NCT02245737|560810895|FG000|Overall Study|Other-determined by Investigator|9|||
155375997|NCT02245737|560810896|FG001|Overall Study|Other-determined by Investigator|10|||
155375998|NCT02245737|560810897|FG002|Overall Study|Other-determined by Investigator|10|||
155375999|NCT02245737|560810895|FG000|Overall Study|Physician Decision|6|||
155376000|NCT02245737|560810896|FG001|Overall Study|Physician Decision|3|||
155376001|NCT02245737|560810897|FG002|Overall Study|Physician Decision|6|||
155376002|NCT02245737|560810895|FG000|Overall Study|Protocol Violation|3|||
155376003|NCT02245737|560810896|FG001|Overall Study|Protocol Violation|2|||
155376004|NCT02245737|560810897|FG002|Overall Study|Protocol Violation|3|||
155376005|NCT02245737|560810895|FG000|Overall Study|Withdrawal by Subject|40|||
155376006|NCT02245737|560810896|FG001|Overall Study|Withdrawal by Subject|41|||
155376007|NCT02245737|560810897|FG002|Overall Study|Withdrawal by Subject|44|||
155376008|NCT02245737|560810895|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
155376009|NCT02245737|560810896|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
155376010|NCT02245737|560810897|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
155376011|NCT02245737|560810895|FG000|Overall Study|Sponsor Decision|445|||
155376012|NCT02245737|560810896|FG001|Overall Study|Sponsor Decision|430|||
155376013|NCT02245737|560810897|FG002|Overall Study|Sponsor Decision|432|||
155376014|NCT00836745|560810901|FG000|Overall Study|Death|2|||
155376015|NCT00836745|560810901|FG000|Overall Study|Lost to Follow-up|10|||
155376016|NCT00836745|560810901|FG000|Overall Study|Adverse Event|3|||
155376017|NCT00836745|560810901|FG000|Overall Study|Objective progression or relapse|4|||
155376018|NCT00836745|560810901|FG000|Overall Study|Other|2|||
155376019|NCT02366468|560810903|FG000|Overall Study|Adverse Event|2|||
155376020|NCT02366468|560810904|FG001|Overall Study|Adverse Event|0|||
155376021|NCT02366468|560810903|FG000|Overall Study|Withdrawal by Subject|1|||
155376022|NCT02366468|560810904|FG001|Overall Study|Withdrawal by Subject|5|||
155376023|NCT02366468|560810903|FG000|Overall Study|Lost to Follow-up|2|||
155376024|NCT02366468|560810904|FG001|Overall Study|Lost to Follow-up|0|||
155376025|NCT02366468|560810903|FG000|Overall Study|Death|1|||
155376026|NCT02366468|560810904|FG001|Overall Study|Death|2|||
155376027|NCT02366468|560810903|FG000|Overall Study|Other|0|||
155376028|NCT02366468|560810904|FG001|Overall Study|Other|2|||
155376029|NCT00446043|560810905|FG000|Overall Study|Adverse Event|9|||
155376030|NCT00446043|560810905|FG000|Overall Study|Withdrawal by Subject|70|||
155376031|NCT00446043|560810905|FG000|Overall Study|Protocol Violation|2|||
155376032|NCT00446043|560810905|FG000|Overall Study|Lost to Follow-up|42|||
155376033|NCT00446043|560810905|FG000|Overall Study|Pregnancy|2|||
155376034|NCT05540717|560810908|FG000|Overall Study|Lost to Follow-up|2|||
155376035|NCT05540717|560810909|FG001|Overall Study|Lost to Follow-up|5|||
155376036|NCT05540717|560810908|FG000|Overall Study|Withdrawal by Subject|6|||
155376037|NCT05540717|560810909|FG001|Overall Study|Withdrawal by Subject|6|||
155376038|NCT05540717|560810908|FG000|Overall Study|Sponsor request|1|||
155376039|NCT05540717|560810909|FG001|Overall Study|Sponsor request|0|||
154965842|NCT00112437|559298886|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965843|NCT00112437|559298887|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
154965844|NCT00112437|559298862|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965845|NCT00112437|559298863|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965846|NCT00112437|559298864|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965847|NCT00112437|559298865|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965848|NCT00112437|559298866|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965849|NCT00112437|559298867|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965850|NCT00112437|559298868|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965851|NCT00112437|559298869|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965852|NCT00112437|559298870|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965853|NCT00112437|559298871|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965854|NCT00112437|559298872|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965855|NCT00112437|559298873|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965856|NCT00112437|559298874|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965857|NCT00112437|559298875|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965858|NCT00112437|559298876|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965859|NCT00112437|559298877|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965860|NCT00112437|559298878|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965861|NCT00112437|559298879|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965862|NCT00112437|559298880|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965863|NCT00112437|559298881|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965864|NCT00112437|559298882|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965865|NCT00112437|559298883|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
154965866|NCT00112437|559298884|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965867|NCT00112437|559298885|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965868|NCT00112437|559298886|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965869|NCT00112437|559298887|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
154965870|NCT00112437|559298862|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965871|NCT00112437|559298863|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965872|NCT00112437|559298864|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965873|NCT00112437|559298865|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965874|NCT00112437|559298866|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965875|NCT00112437|559298867|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965876|NCT00112437|559298868|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965877|NCT00112437|559298869|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965878|NCT00112437|559298870|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965879|NCT00112437|559298871|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965880|NCT00112437|559298872|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965881|NCT00112437|559298873|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155376040|NCT05540717|560810908|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
155376041|NCT05540717|560810909|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
155376042|NCT05540717|560810908|FG000|Overall Study|Other|0|||
155376043|NCT05540717|560810909|FG001|Overall Study|Other|1|||
155376044|NCT00037830|560810910|FG000|Overall Study|Adverse Event|2|||
155376045|NCT00037830|560810911|FG001|Overall Study|Adverse Event|0|||
155376046|NCT00037830|560810912|FG002|Overall Study|Adverse Event|0|||
155376047|NCT00037830|560810910|FG000|Overall Study|Withdrawal by Subject|4|||
155376048|NCT00037830|560810911|FG001|Overall Study|Withdrawal by Subject|5|||
155376049|NCT00037830|560810912|FG002|Overall Study|Withdrawal by Subject|1|||
154965882|NCT00112437|559298874|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965883|NCT00112437|559298875|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965884|NCT00112437|559298876|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155169336|NCT00530816|560057348|FG001|Overall Study|Progressive Disease|24|||
155376050|NCT00037830|560810910|FG000|Overall Study|Protocol Violation|2|||
155376051|NCT00037830|560810911|FG001|Overall Study|Protocol Violation|2|||
155376052|NCT00037830|560810912|FG002|Overall Study|Protocol Violation|0|||
155376053|NCT00037830|560810910|FG000|Overall Study|Unrelated Medical Problem|2|||
155376054|NCT00037830|560810911|FG001|Overall Study|Unrelated Medical Problem|0|||
155376055|NCT00037830|560810912|FG002|Overall Study|Unrelated Medical Problem|0|||
155376056|NCT01327495|560810913|FG000|Overall Study|Adverse Event|2|||
155376057|NCT01327495|560810914|FG001|Overall Study|Adverse Event|1|||
155376058|NCT01327495|560810915|FG002|Overall Study|Adverse Event|1|||
155376059|NCT01327495|560810916|FG003|Overall Study|Adverse Event|0|||
155376060|NCT01327495|560810917|FG004|Overall Study|Adverse Event|0|||
155376061|NCT01327495|560810918|FG005|Overall Study|Adverse Event|2|||
155376062|NCT01327495|560810913|FG000|Overall Study|Withdrawal by Subject|0|||
155376063|NCT01327495|560810914|FG001|Overall Study|Withdrawal by Subject|1|||
155376064|NCT01327495|560810915|FG002|Overall Study|Withdrawal by Subject|1|||
155376065|NCT01327495|560810916|FG003|Overall Study|Withdrawal by Subject|0|||
155376066|NCT01327495|560810917|FG004|Overall Study|Withdrawal by Subject|1|||
155376067|NCT01327495|560810918|FG005|Overall Study|Withdrawal by Subject|0|||
155376068|NCT01327495|560810913|FG000|Overall Study|Physician Decision|0|||
155376069|NCT01327495|560810914|FG001|Overall Study|Physician Decision|0|||
155376070|NCT01327495|560810915|FG002|Overall Study|Physician Decision|0|||
155376071|NCT01327495|560810916|FG003|Overall Study|Physician Decision|0|||
155376072|NCT01327495|560810917|FG004|Overall Study|Physician Decision|2|||
155376073|NCT01327495|560810918|FG005|Overall Study|Physician Decision|0|||
155376074|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
155376075|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376076|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376077|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376078|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
155376079|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
155376080|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376081|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376082|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376083|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
155376084|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
155376085|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376086|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376087|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376088|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
155376089|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
155376090|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376091|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376092|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376093|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
155376094|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
155376095|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376096|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376097|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376098|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
155376099|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
155376100|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376101|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376102|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376103|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
155376104|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
155376105|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376106|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376107|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376108|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
155376109|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
155376110|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376111|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376112|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376113|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
155376114|NCT00700427|560810924|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
155376115|NCT00700427|560810925|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376116|NCT00700427|560810926|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376117|NCT00700427|560810927|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376118|NCT00700427|560810928|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
155376119|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376120|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
155376121|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376122|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376123|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
155376124|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376125|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
155376126|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376127|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376128|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
155376129|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376130|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
155376131|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376132|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376133|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
155376134|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376135|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
155376136|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376137|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376138|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
155376139|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376140|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
155376141|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376142|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376143|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
155376144|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376145|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
155376146|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376147|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376148|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
155376149|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376150|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
155376151|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376152|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376153|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
155376154|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155376155|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
155376156|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155376157|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
155376158|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
154965885|NCT00112437|559298877|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155376159|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376160|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
155376161|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376162|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376163|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
155376164|NCT00700427|560810924|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376165|NCT00700427|560810925|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
155376166|NCT00700427|560810926|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376167|NCT00700427|560810927|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376168|NCT00700427|560810928|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
155376169|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
155376170|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
155376171|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
155376172|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
155376173|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
155376174|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
154965886|NCT00112437|559298878|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
155169337|NCT00530816|560057349|FG002|Overall Study|Progressive Disease|24|||
154965887|NCT00112437|559298879|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965888|NCT00112437|559298880|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965889|NCT00112437|559298881|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965890|NCT00112437|559298882|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
154965891|NCT00112437|559298883|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
154965892|NCT00112437|559298884|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965893|NCT00112437|559298885|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965894|NCT00112437|559298886|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965895|NCT00112437|559298887|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
154965896|NCT00112437|559298862|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965897|NCT00112437|559298863|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965898|NCT00112437|559298864|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965899|NCT00112437|559298865|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965900|NCT00112437|559298866|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965901|NCT00112437|559298867|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965902|NCT00112437|559298868|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965903|NCT00112437|559298869|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965904|NCT00112437|559298870|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965905|NCT00112437|559298871|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965906|NCT00112437|559298872|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965907|NCT00112437|559298873|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965908|NCT00112437|559298874|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965909|NCT00112437|559298875|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965910|NCT00112437|559298876|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965911|NCT00112437|559298877|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965912|NCT00112437|559298878|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965913|NCT00112437|559298879|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965914|NCT00112437|559298880|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965915|NCT00112437|559298881|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965916|NCT00112437|559298882|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965917|NCT00112437|559298883|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965918|NCT00112437|559298884|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
154965919|NCT00112437|559298885|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
154965920|NCT00112437|559298886|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
154965921|NCT00112437|559298887|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
154965922|NCT00112437|559298862|FG000|Years 6-10 (60-Month Extension)|Death|0|||
154965923|NCT00112437|559298863|FG001|Years 6-10 (60-Month Extension)|Death|0|||
154965924|NCT00112437|559298864|FG002|Years 6-10 (60-Month Extension)|Death|0|||
154965925|NCT00112437|559298865|FG003|Years 6-10 (60-Month Extension)|Death|0|||
154965926|NCT00112437|559298866|FG004|Years 6-10 (60-Month Extension)|Death|0|||
154965927|NCT00112437|559298867|FG005|Years 6-10 (60-Month Extension)|Death|0|||
154965928|NCT00112437|559298868|FG006|Years 6-10 (60-Month Extension)|Death|0|||
154965929|NCT00112437|559298869|FG007|Years 6-10 (60-Month Extension)|Death|0|||
154965930|NCT00112437|559298870|FG008|Years 6-10 (60-Month Extension)|Death|0|||
154965931|NCT00112437|559298871|FG009|Years 6-10 (60-Month Extension)|Death|0|||
154965932|NCT00112437|559298872|FG010|Years 6-10 (60-Month Extension)|Death|0|||
154965933|NCT00112437|559298873|FG011|Years 6-10 (60-Month Extension)|Death|0|||
154965934|NCT00112437|559298874|FG012|Years 6-10 (60-Month Extension)|Death|0|||
154965935|NCT00112437|559298875|FG013|Years 6-10 (60-Month Extension)|Death|0|||
154965936|NCT00112437|559298876|FG014|Years 6-10 (60-Month Extension)|Death|0|||
154965937|NCT00112437|559298877|FG015|Years 6-10 (60-Month Extension)|Death|0|||
154965938|NCT00112437|559298878|FG016|Years 6-10 (60-Month Extension)|Death|0|||
154965939|NCT00112437|559298879|FG017|Years 6-10 (60-Month Extension)|Death|0|||
154965940|NCT00112437|559298880|FG018|Years 6-10 (60-Month Extension)|Death|0|||
154965941|NCT00112437|559298881|FG019|Years 6-10 (60-Month Extension)|Death|0|||
154965942|NCT00112437|559298882|FG020|Years 6-10 (60-Month Extension)|Death|0|||
154965943|NCT00112437|559298883|FG021|Years 6-10 (60-Month Extension)|Death|0|||
154965944|NCT00112437|559298884|FG022|Years 6-10 (60-Month Extension)|Death|0|||
154965945|NCT00112437|559298885|FG023|Years 6-10 (60-Month Extension)|Death|2|||
154965946|NCT00112437|559298886|FG024|Years 6-10 (60-Month Extension)|Death|0|||
154965947|NCT00112437|559298887|FG025|Years 6-10 (60-Month Extension)|Death|0|||
155091288|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
155376175|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
155376176|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
155376177|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
155376178|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
155376179|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
155376180|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
155376181|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
155376182|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
155376183|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
155376184|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
155376185|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
155376186|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
155376187|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
155376188|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
155376189|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
155376190|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
155376191|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
155376192|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
155376193|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
155376194|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376195|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376196|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376197|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
155376198|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
155376199|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376200|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376201|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376202|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
155376203|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
155376204|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
155376205|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
155376206|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
155376207|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
155376208|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
155376209|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376210|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376211|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
155376212|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376213|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
155376214|NCT00700427|560810924|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376215|NCT00700427|560810925|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376216|NCT00700427|560810926|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
155376217|NCT00700427|560810927|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376218|NCT00700427|560810928|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
155376219|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376220|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376221|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376222|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
155376223|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
155376224|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
155376225|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
155376226|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
155376227|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
155376228|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
155376229|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376230|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376231|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376232|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
155376233|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
155376234|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376235|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376236|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376237|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
155376238|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
155376239|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376240|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376241|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376242|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
155376243|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
155376244|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376245|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376246|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376247|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
155376248|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
155376249|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376250|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376251|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376252|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
155376253|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
155376254|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376255|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376256|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376257|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
155376258|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
155376259|NCT00700427|560810924|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376260|NCT00700427|560810925|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376261|NCT00700427|560810926|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376262|NCT00700427|560810927|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
155376263|NCT00700427|560810928|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
155376264|NCT02057523|560810931|FG000|Overall Study|Withdrawal by Subject|1|||
155376265|NCT02057523|560810931|FG000|Overall Study|Lack of Efficacy|1|||
155376266|NCT00941070|560810933|FG000|Overall Study|Patient non-compliant|1|||
155376267|NCT03174431|560810934|FG000|Overall Study|Withdrawal by Subject|14|||
155376268|NCT03174431|560810935|FG001|Overall Study|Withdrawal by Subject|11|||
155376269|NCT03174431|560810934|FG000|Overall Study|alternative treatment|2|||
155376270|NCT03174431|560810935|FG001|Overall Study|alternative treatment|0|||
155376271|NCT03174431|560810934|FG000|Overall Study|Lost to Follow-up|1|||
155376272|NCT03174431|560810935|FG001|Overall Study|Lost to Follow-up|5|||
155376273|NCT03500159|560810936|FG000|Overall Study|Study Terminated|2|||
155376274|NCT03500159|560810937|FG001|Overall Study|Study Terminated|1|||
155376275|NCT00560066|560810940|FG000|Overall Study|Death|2|||
155376276|NCT00560066|560810941|FG001|Overall Study|Death|1|||
155376277|NCT00560066|560810940|FG000|Overall Study|Withdrawal by Subject|0|||
155376278|NCT00560066|560810941|FG001|Overall Study|Withdrawal by Subject|3|||
155376279|NCT00560066|560810940|FG000|Overall Study|Lost to Follow-up|4|||
155376280|NCT00560066|560810941|FG001|Overall Study|Lost to Follow-up|10|||
155376281|NCT00560066|560810940|FG000|Overall Study|Protocol Violation|0|||
155376282|NCT00560066|560810941|FG001|Overall Study|Protocol Violation|1|||
155376283|NCT00560066|560810940|FG000|Overall Study|Administrative reason|0|||
155376284|NCT00560066|560810941|FG001|Overall Study|Administrative reason|5|||
155376285|NCT00560066|560810940|FG000|Overall Study|Missing primary reason|0|||
155376286|NCT00560066|560810941|FG001|Overall Study|Missing primary reason|2|||
155376287|NCT00506441|560810942|FG000|Period 1; Open-label Period|Adverse Event|21|||
155376288|NCT00506441|560810943|FG001|Period 1; Open-label Period|Adverse Event|0|||
155376289|NCT00506441|560810942|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
155376290|NCT00506441|560810943|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
155376291|NCT00506441|560810942|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
155376292|NCT00506441|560810943|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
155376293|NCT00506441|560810942|FG000|Period 1; Open-label Period|Physician Decision|5|||
155376294|NCT00506441|560810943|FG001|Period 1; Open-label Period|Physician Decision|0|||
155376295|NCT00506441|560810942|FG000|Period 1; Open-label Period|Protocol Violation|9|||
154965948|NCT00112437|559298862|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965949|NCT00112437|559298863|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965950|NCT00112437|559298864|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965951|NCT00112437|559298865|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965952|NCT00112437|559298866|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965953|NCT00112437|559298867|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965954|NCT00112437|559298868|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965955|NCT00112437|559298869|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965956|NCT00112437|559298870|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965957|NCT00112437|559298871|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965958|NCT00112437|559298872|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965959|NCT00112437|559298873|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965960|NCT00112437|559298874|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155376296|NCT00506441|560810943|FG001|Period 1; Open-label Period|Protocol Violation|0|||
155376297|NCT00506441|560810942|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
155376298|NCT00506441|560810943|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
155376299|NCT00506441|560810942|FG000|Period 1; Open-label Period|Other Reasons|13|||
155376300|NCT00506441|560810943|FG001|Period 1; Open-label Period|Other Reasons|0|||
155376301|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Adverse Event|0|||
155376302|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Adverse Event|1|||
155376303|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
155376304|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
155376305|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Physician Decision|1|||
155376306|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Physician Decision|1|||
155376307|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
155376308|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
155376309|NCT00506441|560810942|FG000|Period 2; Double-blind Period|Other Reason|1|||
155376310|NCT00506441|560810943|FG001|Period 2; Double-blind Period|Other Reason|1|||
155376311|NCT00735475|560810944|FG000|Overall Study|Adverse Event|0|||
155376312|NCT00735475|560810945|FG001|Overall Study|Adverse Event|1|||
155376313|NCT00735475|560810944|FG000|Overall Study|Death|1|||
155376314|NCT00735475|560810945|FG001|Overall Study|Death|1|||
155376315|NCT00735475|560810944|FG000|Overall Study|Lost to Follow-up|3|||
155376316|NCT00735475|560810945|FG001|Overall Study|Lost to Follow-up|3|||
155376317|NCT00735475|560810944|FG000|Overall Study|Physician Decision|0|||
155376318|NCT00735475|560810945|FG001|Overall Study|Physician Decision|1|||
155376319|NCT00735475|560810944|FG000|Overall Study|Withdrawal by Subject|4|||
155376320|NCT00735475|560810945|FG001|Overall Study|Withdrawal by Subject|5|||
155376321|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
155376322|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
155376323|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
155376324|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
155376325|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
155376326|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
155376327|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
155376328|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
155376329|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
155376330|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
155376331|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
155376332|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
155376333|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
155376334|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
155376335|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
155376336|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
155376337|NCT02544451|560810948|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
155376338|NCT02544451|560810949|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
155376339|NCT02544451|560810950|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
155376340|NCT02544451|560810951|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
155376341|NCT02544451|560810948|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
155376342|NCT02544451|560810949|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
155376343|NCT02544451|560810950|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
154965961|NCT00112437|559298875|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155376344|NCT02544451|560810951|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
155376345|NCT00844532|560810953|FG000|Overall Study|Death|16|||
154965962|NCT00112437|559298876|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155376346|NCT00844532|560810953|FG000|Overall Study|Withdrawal by Subject|16|||
155376347|NCT00844532|560810953|FG000|Overall Study|Lost to Follow-up|7|||
155091289|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
155091290|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
155376348|NCT05086276|560810954|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
155376349|NCT05086276|560810955|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
155376350|NCT03592745|560810956|FG000|Overall Study|Adverse Event|0|||
155376351|NCT03592745|560810957|FG001|Overall Study|Adverse Event|2|||
155376352|NCT03592745|560810956|FG000|Overall Study|Lost to Follow-up|2|||
155376353|NCT03592745|560810957|FG001|Overall Study|Lost to Follow-up|0|||
155376354|NCT03592745|560810956|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
155376355|NCT03592745|560810957|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
155376356|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
155376357|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
155376358|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
155376359|NCT02270515|560810958|FG000|Intervention Period 1: 0-6 Months|Death|7|||
155376360|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
155376361|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
155376362|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
155376363|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Death|5|||
155376364|NCT02270515|560810958|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
155376365|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
155376366|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
155376367|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
155376368|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Death|3|||
155376369|NCT02270515|560810958|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
155376370|NCT00738894|560810959|FG000|Overall Study|Lost to Follow-up|23|||
155376371|NCT00738894|560810960|FG001|Overall Study|Lost to Follow-up|13|||
155376372|NCT00738894|560810959|FG000|Overall Study|Withdrawal by Subject|10|||
155376373|NCT00738894|560810960|FG001|Overall Study|Withdrawal by Subject|15|||
155376374|NCT00738894|560810959|FG000|Overall Study|Physician Decision|4|||
155376375|NCT00738894|560810960|FG001|Overall Study|Physician Decision|5|||
155376376|NCT00738894|560810959|FG000|Overall Study|Death|2|||
155376377|NCT00738894|560810960|FG001|Overall Study|Death|0|||
155376378|NCT05017103|560810961|FG000|Overall Study|Death|2|||
155376379|NCT02656329|560810962|FG000|Overall Study|Lost to Follow-up|2|||
155376380|NCT02656329|560810963|FG001|Overall Study|Lost to Follow-up|3|||
155376381|NCT02656329|560810962|FG000|Overall Study|Withdrawal by Subject|7|||
155376382|NCT02656329|560810963|FG001|Overall Study|Withdrawal by Subject|6|||
155376383|NCT02656329|560810962|FG000|Overall Study|Study termination by Sponsor|150|||
155376384|NCT02656329|560810963|FG001|Overall Study|Study termination by Sponsor|142|||
155376385|NCT02656329|560810962|FG000|Overall Study|Other than specified above|5|||
155376386|NCT02656329|560810963|FG001|Overall Study|Other than specified above|6|||
155376387|NCT01081665|560810965|FG000|Overall Study|Death|41|||
155376388|NCT01081665|560810965|FG000|Overall Study|Lost to Follow-up|18|||
155376389|NCT01081665|560810965|FG000|Overall Study|Withdrawal by Subject|17|||
155376390|NCT01081665|560810965|FG000|Overall Study|Change of dialysis unit|10|||
155376391|NCT01081665|560810965|FG000|Overall Study|Regulation of iPTH|5|||
155376392|NCT01081665|560810965|FG000|Overall Study|Change in renal replacement therapy|2|||
155376393|NCT01081665|560810965|FG000|Overall Study|Adverse Event|1|||
155376394|NCT01081665|560810965|FG000|Overall Study|Lack of Efficacy|1|||
155376395|NCT02546921|560810976|FG000|Overall Study|Adverse Event|0|||
155376396|NCT02546921|560810977|FG001|Overall Study|Adverse Event|5|||
155376397|NCT02546921|560810978|FG002|Overall Study|Adverse Event|2|||
155376398|NCT02546921|560810979|FG003|Overall Study|Adverse Event|0|||
155376399|NCT02546921|560810980|FG004|Overall Study|Adverse Event|0|||
155376400|NCT02546921|560810981|FG005|Overall Study|Adverse Event|0|||
155376401|NCT02546921|560810982|FG006|Overall Study|Adverse Event|0|||
155376402|NCT02546921|560810976|FG000|Overall Study|Evidence of Disease Progression|1|||
155376403|NCT02546921|560810977|FG001|Overall Study|Evidence of Disease Progression|0|||
155376404|NCT02546921|560810978|FG002|Overall Study|Evidence of Disease Progression|0|||
155376405|NCT02546921|560810979|FG003|Overall Study|Evidence of Disease Progression|0|||
155376406|NCT02546921|560810980|FG004|Overall Study|Evidence of Disease Progression|1|||
155376407|NCT02546921|560810981|FG005|Overall Study|Evidence of Disease Progression|0|||
155376408|NCT02546921|560810982|FG006|Overall Study|Evidence of Disease Progression|0|||
155376409|NCT02546921|560810976|FG000|Overall Study|Patient Choice|0|||
155376410|NCT02546921|560810977|FG001|Overall Study|Patient Choice|1|||
155376411|NCT02546921|560810978|FG002|Overall Study|Patient Choice|0|||
155376412|NCT02546921|560810979|FG003|Overall Study|Patient Choice|0|||
155376413|NCT02546921|560810980|FG004|Overall Study|Patient Choice|0|||
155376414|NCT02546921|560810981|FG005|Overall Study|Patient Choice|1|||
155376415|NCT02546921|560810982|FG006|Overall Study|Patient Choice|0|||
155376416|NCT01373151|560810983|FG000|Period 1|Lack of Efficacy|3|||
155376417|NCT01373151|560810984|FG001|Period 1|Lack of Efficacy|0|||
155376418|NCT01373151|560810985|FG002|Period 1|Lack of Efficacy|0|||
155376419|NCT01373151|560810986|FG003|Period 1|Lack of Efficacy|0|||
155376420|NCT01373151|560810987|FG004|Period 1|Lack of Efficacy|1|||
155376421|NCT01373151|560810988|FG005|Period 1|Lack of Efficacy|0|||
155376422|NCT01373151|560810989|FG006|Period 1|Lack of Efficacy|0|||
155376423|NCT01373151|560810983|FG000|Period 1|Adverse Event|0|||
155376424|NCT01373151|560810984|FG001|Period 1|Adverse Event|0|||
155376425|NCT01373151|560810985|FG002|Period 1|Adverse Event|1|||
155376426|NCT01373151|560810986|FG003|Period 1|Adverse Event|0|||
155376427|NCT01373151|560810987|FG004|Period 1|Adverse Event|4|||
155376428|NCT01373151|560810988|FG005|Period 1|Adverse Event|3|||
155376429|NCT01373151|560810989|FG006|Period 1|Adverse Event|0|||
155376430|NCT01373151|560810983|FG000|Period 1|Withdrawal by Subject|2|||
155376431|NCT01373151|560810984|FG001|Period 1|Withdrawal by Subject|0|||
155376432|NCT01373151|560810985|FG002|Period 1|Withdrawal by Subject|3|||
155376433|NCT01373151|560810986|FG003|Period 1|Withdrawal by Subject|1|||
155376434|NCT01373151|560810987|FG004|Period 1|Withdrawal by Subject|0|||
155376435|NCT01373151|560810988|FG005|Period 1|Withdrawal by Subject|1|||
155376436|NCT01373151|560810989|FG006|Period 1|Withdrawal by Subject|0|||
155376437|NCT01373151|560810983|FG000|Period 2|Lack of Efficacy|9|||
155376438|NCT01373151|560810984|FG001|Period 2|Lack of Efficacy|0|||
155376439|NCT01373151|560810985|FG002|Period 2|Lack of Efficacy|0|||
155376440|NCT01373151|560810986|FG003|Period 2|Lack of Efficacy|1|||
155376441|NCT01373151|560810987|FG004|Period 2|Lack of Efficacy|2|||
155376442|NCT01373151|560810988|FG005|Period 2|Lack of Efficacy|0|||
155376443|NCT01373151|560810989|FG006|Period 2|Lack of Efficacy|3|||
155376444|NCT01373151|560810983|FG000|Period 2|Adverse Event|0|||
155376445|NCT01373151|560810984|FG001|Period 2|Adverse Event|0|||
155376446|NCT01373151|560810985|FG002|Period 2|Adverse Event|3|||
155376447|NCT01373151|560810986|FG003|Period 2|Adverse Event|3|||
155376448|NCT01373151|560810987|FG004|Period 2|Adverse Event|0|||
155376449|NCT01373151|560810988|FG005|Period 2|Adverse Event|0|||
155376450|NCT01373151|560810989|FG006|Period 2|Adverse Event|1|||
155376451|NCT01373151|560810983|FG000|Period 2|subject request to discontinue|0|||
155376452|NCT01373151|560810984|FG001|Period 2|subject request to discontinue|1|||
155376453|NCT01373151|560810985|FG002|Period 2|subject request to discontinue|0|||
155376454|NCT01373151|560810986|FG003|Period 2|subject request to discontinue|0|||
155376455|NCT01373151|560810987|FG004|Period 2|subject request to discontinue|0|||
155376456|NCT01373151|560810988|FG005|Period 2|subject request to discontinue|0|||
155376457|NCT01373151|560810989|FG006|Period 2|subject request to discontinue|0|||
155376458|NCT01373151|560810983|FG000|Period 2|Withdrawal by Subject|0|||
155376459|NCT01373151|560810984|FG001|Period 2|Withdrawal by Subject|0|||
155376460|NCT01373151|560810985|FG002|Period 2|Withdrawal by Subject|0|||
155376461|NCT01373151|560810986|FG003|Period 2|Withdrawal by Subject|1|||
155376462|NCT01373151|560810987|FG004|Period 2|Withdrawal by Subject|0|||
155376463|NCT01373151|560810988|FG005|Period 2|Withdrawal by Subject|0|||
155376464|NCT01373151|560810989|FG006|Period 2|Withdrawal by Subject|0|||
155376465|NCT01373151|560810983|FG000|Period 2|Other|0|||
155376466|NCT01373151|560810984|FG001|Period 2|Other|0|||
155376467|NCT01373151|560810985|FG002|Period 2|Other|1|||
155376468|NCT01373151|560810986|FG003|Period 2|Other|0|||
155376469|NCT01373151|560810987|FG004|Period 2|Other|0|||
155376470|NCT01373151|560810988|FG005|Period 2|Other|0|||
155376471|NCT01373151|560810989|FG006|Period 2|Other|1|||
155376472|NCT03026075|560810993|FG000|Overall Study|Physician Decision|1|||
155376473|NCT03381339|560810994|FG000|Overall Study|Protocol Violation|4|||
155376474|NCT03381339|560810995|FG001|Overall Study|Protocol Violation|3|||
155376475|NCT03381339|560810994|FG000|Overall Study|Lost to Follow-up|0|||
155376476|NCT03381339|560810995|FG001|Overall Study|Lost to Follow-up|1|||
155376477|NCT01468181|560810996|FG000|Overall Study|Adverse Event|8|||
155376478|NCT01468181|560810997|FG001|Overall Study|Adverse Event|1|||
155376479|NCT01468181|560810998|FG002|Overall Study|Adverse Event|6|||
155376480|NCT01468181|560810999|FG003|Overall Study|Adverse Event|2|||
155376481|NCT01468181|560811000|FG004|Overall Study|Adverse Event|2|||
155376482|NCT01468181|560810996|FG000|Overall Study|Protocol Violation|2|||
155376483|NCT01468181|560810997|FG001|Overall Study|Protocol Violation|0|||
155376484|NCT01468181|560810998|FG002|Overall Study|Protocol Violation|1|||
155376485|NCT01468181|560810999|FG003|Overall Study|Protocol Violation|0|||
155376486|NCT01468181|560811000|FG004|Overall Study|Protocol Violation|1|||
155376487|NCT01468181|560810996|FG000|Overall Study|Physician Decision|0|||
155376488|NCT01468181|560810997|FG001|Overall Study|Physician Decision|0|||
155376489|NCT01468181|560810998|FG002|Overall Study|Physician Decision|0|||
155376490|NCT01468181|560810999|FG003|Overall Study|Physician Decision|1|||
155376491|NCT01468181|560811000|FG004|Overall Study|Physician Decision|1|||
155376492|NCT01468181|560810996|FG000|Overall Study|Lost to Follow-up|0|||
154965963|NCT00112437|559298877|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965964|NCT00112437|559298878|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155376493|NCT01468181|560810997|FG001|Overall Study|Lost to Follow-up|0|||
155376494|NCT01468181|560810998|FG002|Overall Study|Lost to Follow-up|1|||
155376495|NCT01468181|560810999|FG003|Overall Study|Lost to Follow-up|0|||
155376496|NCT01468181|560811000|FG004|Overall Study|Lost to Follow-up|1|||
155376497|NCT01468181|560810996|FG000|Overall Study|Withdrawal by Subject|0|||
155376498|NCT01468181|560810997|FG001|Overall Study|Withdrawal by Subject|1|||
155376499|NCT01468181|560810998|FG002|Overall Study|Withdrawal by Subject|0|||
155376500|NCT01468181|560810999|FG003|Overall Study|Withdrawal by Subject|0|||
155376501|NCT01468181|560811000|FG004|Overall Study|Withdrawal by Subject|0|||
155376502|NCT00513305|560811001|FG000|Overall Study|Adverse Event|6|||
155376503|NCT00513305|560811002|FG001|Overall Study|Adverse Event|2|||
154965965|NCT00112437|559298879|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965966|NCT00112437|559298880|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155376504|NCT00513305|560811001|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
154965967|NCT00112437|559298881|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
155376505|NCT00513305|560811002|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
155376506|NCT00513305|560811001|FG000|Overall Study|Lack of Efficacy|8|||
155376507|NCT00513305|560811002|FG001|Overall Study|Lack of Efficacy|13|||
155376508|NCT00513305|560811001|FG000|Overall Study|Withdrawal by Subject|1|||
155376509|NCT00513305|560811002|FG001|Overall Study|Withdrawal by Subject|2|||
155376510|NCT00513305|560811001|FG000|Overall Study|Disease progression|8|||
155376511|NCT00513305|560811002|FG001|Overall Study|Disease progression|5|||
155376512|NCT00513305|560811001|FG000|Overall Study|Eligible for stem cell transplant|1|||
155376513|NCT00513305|560811002|FG001|Overall Study|Eligible for stem cell transplant|0|||
155376514|NCT00513305|560811001|FG000|Overall Study|Hematologic counts did not recover|1|||
155376515|NCT00513305|560811002|FG001|Overall Study|Hematologic counts did not recover|0|||
155376516|NCT00513305|560811001|FG000|Overall Study|Physician Decision|1|||
155376517|NCT00513305|560811002|FG001|Overall Study|Physician Decision|0|||
155376518|NCT00513305|560811001|FG000|Overall Study|Persistent hypocellularity|0|||
155376519|NCT00513305|560811002|FG001|Overall Study|Persistent hypocellularity|1|||
155376520|NCT00513305|560811001|FG000|Overall Study|Sponsor Decision|0|||
155376521|NCT00513305|560811002|FG001|Overall Study|Sponsor Decision|2|||
155376522|NCT02101385|560811010|FG000|Study Treatment|Disease Progression|9|||
155376523|NCT02101385|560811011|FG001|Study Treatment|Disease Progression|3|||
155376524|NCT02101385|560811010|FG000|Study Treatment|Alternative therapy|0|||
155376525|NCT02101385|560811011|FG001|Study Treatment|Alternative therapy|1|||
155376526|NCT02101385|560811010|FG000|Study Treatment|No treatment, per protocol criteria|0|||
155376527|NCT02101385|560811011|FG001|Study Treatment|No treatment, per protocol criteria|4|||
155376528|NCT02101385|560811010|FG000|Study Treatment|Patient Non compliance|0|||
155376529|NCT02101385|560811011|FG001|Study Treatment|Patient Non compliance|2|||
155376530|NCT02101385|560811010|FG000|Study Treatment|Withdrawal by Subject|5|||
155376531|NCT02101385|560811011|FG001|Study Treatment|Withdrawal by Subject|2|||
155376532|NCT02101385|560811010|FG000|Study Treatment|screen failure|1|||
155376533|NCT02101385|560811011|FG001|Study Treatment|screen failure|0|||
155376534|NCT02101385|560811010|FG000|Study Treatment|AE/Side Effects/Complications|8|||
155376535|NCT02101385|560811011|FG001|Study Treatment|AE/Side Effects/Complications|0|||
155376536|NCT02101385|560811010|FG000|Study Treatment|Lost to Follow-up|1|||
155376537|NCT02101385|560811011|FG001|Study Treatment|Lost to Follow-up|0|||
155376538|NCT02101385|560811010|FG000|Study Treatment|Disease Progression before treatment|1|||
155376539|NCT02101385|560811011|FG001|Study Treatment|Disease Progression before treatment|0|||
155376540|NCT02101385|560811010|FG000|Study Treatment|Death|1|||
155376541|NCT02101385|560811011|FG001|Study Treatment|Death|0|||
155376542|NCT02101385|560811010|FG000|Follow up|Lost to Follow-up|4|||
155376543|NCT02101385|560811011|FG001|Follow up|Lost to Follow-up|9|||
155376544|NCT02101385|560811010|FG000|Follow up|Refused to follow up|5|||
155376545|NCT02101385|560811011|FG001|Follow up|Refused to follow up|4|||
155376546|NCT02101385|560811010|FG000|Follow up|Death|21|||
155376547|NCT02101385|560811011|FG001|Follow up|Death|39|||
155376548|NCT02101385|560811010|FG000|Follow up|study completed|33|||
155376549|NCT02101385|560811011|FG001|Follow up|study completed|52|||
155376550|NCT02101385|560811010|FG000|Follow up|screen failure|2|||
155376551|NCT02101385|560811011|FG001|Follow up|screen failure|0|||
155376552|NCT02101385|560811010|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
155376553|NCT02101385|560811011|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
155376554|NCT02101385|560811010|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
155376555|NCT02101385|560811011|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
155091291|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
155091292|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
155091293|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
155091294|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
155091295|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
155091296|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
155091297|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
155091298|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
155091299|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
155091300|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
155091301|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
155091302|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
155091303|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
155091304|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
155091305|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
155091306|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
155091307|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
155091308|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
155091309|NCT04392154|559767534|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
155091310|NCT04392154|559767535|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
155091311|NCT04392154|559767536|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
155091312|NCT04392154|559767537|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
155091313|NCT04392154|559767534|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
155091314|NCT04392154|559767535|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
155091315|NCT04392154|559767536|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
155091316|NCT04392154|559767537|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
155091317|NCT04392154|559767534|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
155091318|NCT04392154|559767535|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
155091319|NCT04392154|559767536|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
155091320|NCT04392154|559767537|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
155091321|NCT04392154|559767534|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
155376556|NCT02101385|560811010|FG000|Follow up|Withdrawal by Subject|2|||
155376557|NCT02101385|560811011|FG001|Follow up|Withdrawal by Subject|2|||
155376558|NCT02101385|560811010|FG000|Follow up|PI requested closure of site|0|||
155376559|NCT02101385|560811011|FG001|Follow up|PI requested closure of site|5|||
155376560|NCT02516332|560812680|FG000|Overall Study|Withdrawal by Subject|2|||
155376561|NCT02516332|560812681|FG001|Overall Study|Withdrawal by Subject|1|||
155376562|NCT02516332|560812682|FG002|Overall Study|Withdrawal by Subject|2|||
155376563|NCT03573583|560812685|FG000|Overall Study|Lost to Follow-up|1|||
155376564|NCT03573583|560812686|FG001|Overall Study|Lost to Follow-up|0|||
155376565|NCT03573583|560812685|FG000|Overall Study|Withdrawal by Subject|1|||
155376566|NCT03573583|560812686|FG001|Overall Study|Withdrawal by Subject|1|||
155376567|NCT01658150|560812689|FG000|Overall Study|Withdrawal by Subject|1|||
155376568|NCT04187989|560812690|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
155376569|NCT04187989|560812691|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
155376570|NCT04187989|560812690|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
155376571|NCT04187989|560812691|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
155376576|NCT01144052|560812694|FG000|Overall Study|Withdrawal by Subject|1|||
155376577|NCT01144052|560812695|FG001|Overall Study|Withdrawal by Subject|1|||
155376578|NCT03836716|560812699|FG000|Overall Study|Adverse Event|3|||
155376579|NCT03836716|560812699|FG000|Overall Study|Death|22|||
155376580|NCT03836716|560812699|FG000|Overall Study|Withdrawal by Subject|8|||
155376581|NCT03836716|560812699|FG000|Overall Study|Study terminated by sponsor|87|||
155376582|NCT01983254|560812700|FG000|Overall Study|Death|6|||
155376583|NCT01983254|560812701|FG001|Overall Study|Death|6|||
155376584|NCT01983254|560812700|FG000|Overall Study|Lost to Follow-up|17|||
155376585|NCT01983254|560812701|FG001|Overall Study|Lost to Follow-up|16|||
155376586|NCT01983254|560812700|FG000|Overall Study|too ill|11|||
155376587|NCT01983254|560812701|FG001|Overall Study|too ill|8|||
155376588|NCT01631227|560812707|FG000|Overall Study|withdrawn consent|27|||
155376589|NCT01631227|560812708|FG001|Overall Study|withdrawn consent|21|||
155376590|NCT01631227|560812707|FG000|Overall Study|Adverse Event|1|||
155376591|NCT01631227|560812708|FG001|Overall Study|Adverse Event|0|||
155376592|NCT01631227|560812707|FG000|Overall Study|administrative|2|||
155376593|NCT01631227|560812708|FG001|Overall Study|administrative|1|||
155376594|NCT00766363|560812709|FG000|Overall Study|Withdrawal by Subject|1|||
155376595|NCT00766363|560812710|FG001|Overall Study|Withdrawal by Subject|0|||
155376596|NCT00766363|560812711|FG002|Overall Study|Withdrawal by Subject|0|||
155376597|NCT00766363|560812712|FG003|Overall Study|Withdrawal by Subject|0|||
155376598|NCT00766363|560812709|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
155376599|NCT00766363|560812710|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
155376600|NCT00766363|560812711|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
155376601|NCT00766363|560812712|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
155376602|NCT03020576|560812713|FG000|Overall Study|Withdrawal by Subject|1|||
155376603|NCT03020576|560812714|FG001|Overall Study|Withdrawal by Subject|2|||
155376604|NCT03292432|560812715|FG000|Overall Study|Lost to Follow-up|11|||
155376605|NCT03292432|560812716|FG001|Overall Study|Lost to Follow-up|8|||
155376606|NCT03292432|560812715|FG000|Overall Study|Death|2|||
155376607|NCT03292432|560812716|FG001|Overall Study|Death|1|||
155376608|NCT03292432|560812715|FG000|Overall Study|Withdrawal by Subject|1|||
155376609|NCT03292432|560812716|FG001|Overall Study|Withdrawal by Subject|2|||
155376610|NCT03292432|560812715|FG000|Overall Study|Site closed before any data collected|1|||
155376611|NCT03292432|560812716|FG001|Overall Study|Site closed before any data collected|0|||
155376612|NCT01498679|560812717|FG000|Overall Study|Adverse Event|1|||
155376613|NCT01498679|560812718|FG001|Overall Study|Adverse Event|4|||
155376614|NCT01498679|560812717|FG000|Overall Study|Lack of Efficacy|72|||
155376615|NCT01498679|560812718|FG001|Overall Study|Lack of Efficacy|12|||
155376616|NCT01498679|560812717|FG000|Overall Study|Protocol Violation|4|||
155376617|NCT01498679|560812718|FG001|Overall Study|Protocol Violation|0|||
155376618|NCT01498679|560812717|FG000|Overall Study|Physician Decision|0|||
155376619|NCT01498679|560812718|FG001|Overall Study|Physician Decision|2|||
155376620|NCT01498679|560812717|FG000|Overall Study|Withdrawal by Subject|12|||
155376621|NCT01498679|560812718|FG001|Overall Study|Withdrawal by Subject|4|||
155376622|NCT01871805|560812720|FG000|Phase I|Death|7|||
155376623|NCT01871805|560812721|FG001|Phase I|Death|4|||
155376624|NCT01871805|560812722|FG002|Phase I|Death|6|||
155376625|NCT01871805|560812723|FG003|Phase I|Death|2|||
155376626|NCT01871805|560812724|FG004|Phase I|Death|9|||
155376627|NCT01871805|560812725|FG005|Phase I|Death|0|||
155376628|NCT01871805|560812720|FG000|Phase I|Alive in Survival Follow-up|0|||
155376629|NCT01871805|560812721|FG001|Phase I|Alive in Survival Follow-up|2|||
155376630|NCT01871805|560812722|FG002|Phase I|Alive in Survival Follow-up|4|||
155376631|NCT01871805|560812723|FG003|Phase I|Alive in Survival Follow-up|5|||
155376632|NCT01871805|560812724|FG004|Phase I|Alive in Survival Follow-up|4|||
155376633|NCT01871805|560812725|FG005|Phase I|Alive in Survival Follow-up|0|||
155376634|NCT01871805|560812720|FG000|Phase I|Lost to Follow-up|0|||
155376635|NCT01871805|560812721|FG001|Phase I|Lost to Follow-up|1|||
155376636|NCT01871805|560812722|FG002|Phase I|Lost to Follow-up|3|||
155376637|NCT01871805|560812723|FG003|Phase I|Lost to Follow-up|0|||
155376638|NCT01871805|560812724|FG004|Phase I|Lost to Follow-up|0|||
155376639|NCT01871805|560812725|FG005|Phase I|Lost to Follow-up|0|||
155376640|NCT01871805|560812720|FG000|Phase II|Death|0|||
155169338|NCT00530816|560057347|FG000|Overall Study|Adverse Event|6|||
155376641|NCT01871805|560812721|FG001|Phase II|Death|0|||
155376642|NCT01871805|560812722|FG002|Phase II|Death|0|||
155376643|NCT01871805|560812723|FG003|Phase II|Death|0|||
155376644|NCT01871805|560812724|FG004|Phase II|Death|0|||
155376645|NCT01871805|560812725|FG005|Phase II|Death|45|||
155376646|NCT01871805|560812720|FG000|Phase II|Alive in Survival Follow-up|0|||
155376647|NCT01871805|560812721|FG001|Phase II|Alive in Survival Follow-up|0|||
155376648|NCT01871805|560812722|FG002|Phase II|Alive in Survival Follow-up|0|||
155376649|NCT01871805|560812723|FG003|Phase II|Alive in Survival Follow-up|0|||
155376650|NCT01871805|560812724|FG004|Phase II|Alive in Survival Follow-up|0|||
155169339|NCT00530816|560057348|FG001|Overall Study|Adverse Event|13|||
155376651|NCT01871805|560812725|FG005|Phase II|Alive in Survival Follow-up|29|||
155376652|NCT01871805|560812720|FG000|Phase II|Lost to Follow-up|0|||
154965968|NCT00112437|559298882|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965969|NCT00112437|559298883|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965970|NCT00112437|559298884|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965971|NCT00112437|559298885|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965972|NCT00112437|559298886|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
154965973|NCT00112437|559298887|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
154965974|NCT00112437|559298862|FG000|Years 6-10 (60-Month Extension)|Other|0|||
154965975|NCT00112437|559298863|FG001|Years 6-10 (60-Month Extension)|Other|0|||
154965976|NCT00112437|559298864|FG002|Years 6-10 (60-Month Extension)|Other|0|||
154965977|NCT00112437|559298865|FG003|Years 6-10 (60-Month Extension)|Other|0|||
154965978|NCT00112437|559298866|FG004|Years 6-10 (60-Month Extension)|Other|0|||
154965979|NCT00112437|559298867|FG005|Years 6-10 (60-Month Extension)|Other|0|||
154965980|NCT00112437|559298868|FG006|Years 6-10 (60-Month Extension)|Other|0|||
154965981|NCT00112437|559298869|FG007|Years 6-10 (60-Month Extension)|Other|0|||
154965982|NCT00112437|559298870|FG008|Years 6-10 (60-Month Extension)|Other|0|||
154965983|NCT00112437|559298871|FG009|Years 6-10 (60-Month Extension)|Other|0|||
154965984|NCT00112437|559298872|FG010|Years 6-10 (60-Month Extension)|Other|0|||
154965985|NCT00112437|559298873|FG011|Years 6-10 (60-Month Extension)|Other|0|||
154965986|NCT00112437|559298874|FG012|Years 6-10 (60-Month Extension)|Other|0|||
154965987|NCT00112437|559298875|FG013|Years 6-10 (60-Month Extension)|Other|0|||
154965988|NCT00112437|559298876|FG014|Years 6-10 (60-Month Extension)|Other|0|||
154965989|NCT00112437|559298877|FG015|Years 6-10 (60-Month Extension)|Other|0|||
154965990|NCT00112437|559298878|FG016|Years 6-10 (60-Month Extension)|Other|0|||
154965991|NCT00112437|559298879|FG017|Years 6-10 (60-Month Extension)|Other|0|||
154965992|NCT00112437|559298880|FG018|Years 6-10 (60-Month Extension)|Other|0|||
155376653|NCT01871805|560812721|FG001|Phase II|Lost to Follow-up|0|||
155376654|NCT01871805|560812722|FG002|Phase II|Lost to Follow-up|0|||
155376655|NCT01871805|560812723|FG003|Phase II|Lost to Follow-up|0|||
155376656|NCT01871805|560812724|FG004|Phase II|Lost to Follow-up|0|||
155376657|NCT01871805|560812725|FG005|Phase II|Lost to Follow-up|13|||
155376658|NCT03484273|560812734|FG000|Overall Study|Equipment Malfunction|1|||
155376659|NCT03484273|560812734|FG000|Overall Study|Data excluded from analysis|1|||
155376660|NCT00468104|560812740|FG000|First Intervention|Protocol Violation|2|||
155376661|NCT00468104|560812741|FG001|First Intervention|Protocol Violation|1|||
155376662|NCT00468104|560812740|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
155376663|NCT00468104|560812741|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
155376664|NCT00468104|560812740|FG000|First Intervention|died within 3 weeks|1|||
155376665|NCT00468104|560812741|FG001|First Intervention|died within 3 weeks|0|||
155376666|NCT00468104|560812740|FG000|First Intervention|malposition/blocked chest tube tube|2|||
155376667|NCT00468104|560812741|FG001|First Intervention|malposition/blocked chest tube tube|0|||
155376668|NCT00468104|560812740|FG000|First Intervention|large lung mass with minimal effusion|1|||
155376669|NCT00468104|560812741|FG001|First Intervention|large lung mass with minimal effusion|0|||
155376670|NCT00468104|560812740|FG000|First Intervention|associated prolonged pneumothorax|1|||
155376671|NCT00468104|560812741|FG001|First Intervention|associated prolonged pneumothorax|0|||
155376672|NCT00468104|560812740|FG000|First Intervention|trapped lung|1|||
155376673|NCT00468104|560812741|FG001|First Intervention|trapped lung|0|||
155376674|NCT00468104|560812740|FG000|Second Intervention|Withdrawal by Subject|5|||
155376675|NCT00468104|560812741|FG001|Second Intervention|Withdrawal by Subject|2|||
155376676|NCT00468104|560812740|FG000|Second Intervention|discarded for malposition of chest tube|0|||
155376677|NCT00468104|560812741|FG001|Second Intervention|discarded for malposition of chest tube|2|||
155376678|NCT01263665|560812742|FG000|Overall Study|Withdrew Consent|1|||
155376679|NCT01263665|560812742|FG000|Overall Study|Lost to Follow-up|3|||
155376680|NCT01263665|560812742|FG000|Overall Study|Death|2|||
155376681|NCT01263665|560812742|FG000|Overall Study|Amputation above the ankle|1|||
155376682|NCT01263665|560812742|FG000|Overall Study|Surgical Bypass|2|||
155376683|NCT02706899|560812747|FG000|Overall Study|Withdrawal by Subject|1|||
155376684|NCT02706899|560812748|FG001|Overall Study|Withdrawal by Subject|0|||
155376685|NCT02706899|560812747|FG000|Overall Study|Death|8|||
155376686|NCT02706899|560812748|FG001|Overall Study|Death|0|||
155376687|NCT02706899|560812747|FG000|Overall Study|Study Termination by Sponsor|4|||
155376688|NCT02706899|560812748|FG001|Overall Study|Study Termination by Sponsor|6|||
155376689|NCT00324675|560812749|FG000|Overall Study|Adverse Event|1|||
155376690|NCT00324675|560812750|FG001|Overall Study|Adverse Event|0|||
155376691|NCT00381615|560812751|FG000|Overall Study|Withdrawal by Subject|1|||
155376692|NCT00381615|560812752|FG001|Overall Study|Withdrawal by Subject|3|||
155376693|NCT00381615|560812753|FG002|Overall Study|Withdrawal by Subject|0|||
155376694|NCT00381615|560812754|FG003|Overall Study|Withdrawal by Subject|1|||
154965993|NCT00112437|559298881|FG019|Years 6-10 (60-Month Extension)|Other|0|||
155376695|NCT00381615|560812751|FG000|Overall Study|Lost to Follow-up|3|||
154965994|NCT00112437|559298882|FG020|Years 6-10 (60-Month Extension)|Other|0|||
155376696|NCT00381615|560812752|FG001|Overall Study|Lost to Follow-up|2|||
155376697|NCT00381615|560812753|FG002|Overall Study|Lost to Follow-up|0|||
155376698|NCT00381615|560812754|FG003|Overall Study|Lost to Follow-up|1|||
155376699|NCT00381615|560812751|FG000|Overall Study|Protocol Violation|0|||
155376700|NCT00381615|560812752|FG001|Overall Study|Protocol Violation|0|||
155376701|NCT00381615|560812753|FG002|Overall Study|Protocol Violation|1|||
155376702|NCT00381615|560812754|FG003|Overall Study|Protocol Violation|0|||
155376703|NCT04811131|560812766|FG000|Overall Study|Adverse Event|0|||
155376704|NCT04811131|560812767|FG001|Overall Study|Adverse Event|0|||
155376705|NCT04811131|560812768|FG002|Overall Study|Adverse Event|1|||
155376706|NCT04811131|560812769|FG003|Overall Study|Adverse Event|0|||
155376707|NCT04811131|560812766|FG000|Overall Study|Lack of Efficacy|0|||
155376708|NCT04811131|560812767|FG001|Overall Study|Lack of Efficacy|0|||
155376709|NCT04811131|560812768|FG002|Overall Study|Lack of Efficacy|0|||
155376710|NCT04811131|560812769|FG003|Overall Study|Lack of Efficacy|1|||
155376711|NCT04811131|560812766|FG000|Overall Study|Lost to Follow-up|0|||
155376712|NCT04811131|560812767|FG001|Overall Study|Lost to Follow-up|1|||
155376713|NCT04811131|560812768|FG002|Overall Study|Lost to Follow-up|0|||
155376714|NCT04811131|560812769|FG003|Overall Study|Lost to Follow-up|0|||
155376715|NCT04811131|560812766|FG000|Overall Study|Sponsor request|31|||
155376716|NCT04811131|560812767|FG001|Overall Study|Sponsor request|35|||
155376717|NCT04811131|560812768|FG002|Overall Study|Sponsor request|27|||
155376718|NCT04811131|560812769|FG003|Overall Study|Sponsor request|10|||
155376719|NCT04811131|560812766|FG000|Overall Study|Withdrawal by Subject|3|||
155376720|NCT04811131|560812767|FG001|Overall Study|Withdrawal by Subject|1|||
155376721|NCT04811131|560812768|FG002|Overall Study|Withdrawal by Subject|3|||
155376722|NCT04811131|560812769|FG003|Overall Study|Withdrawal by Subject|1|||
155376723|NCT03181789|560812773|FG000|Overall Study|Withdrawal by Subject|0|||
155376724|NCT03181789|560812774|FG001|Overall Study|Withdrawal by Subject|1|||
155376725|NCT03181789|560812775|FG002|Overall Study|Withdrawal by Subject|1|||
155376726|NCT03181789|560812776|FG003|Overall Study|Withdrawal by Subject|0|||
155376727|NCT03181789|560812773|FG000|Overall Study|Lost to Follow-up|7|||
155376728|NCT03181789|560812774|FG001|Overall Study|Lost to Follow-up|1|||
155376729|NCT03181789|560812775|FG002|Overall Study|Lost to Follow-up|0|||
155376730|NCT03181789|560812776|FG003|Overall Study|Lost to Follow-up|0|||
155376731|NCT03181789|560812773|FG000|Overall Study|Participant unable to adhere to visit|0|||
155376732|NCT03181789|560812774|FG001|Overall Study|Participant unable to adhere to visit|1|||
155376733|NCT03181789|560812775|FG002|Overall Study|Participant unable to adhere to visit|0|||
155376734|NCT03181789|560812776|FG003|Overall Study|Participant unable to adhere to visit|0|||
155376735|NCT01131182|560812777|FG000|Overall Study|Withdrawal by Subject|1|||
155376736|NCT01131182|560812778|FG001|Overall Study|Withdrawal by Subject|1|||
155376737|NCT01131182|560812777|FG000|Overall Study|Lost to Follow-up|14|||
155376738|NCT01131182|560812778|FG001|Overall Study|Lost to Follow-up|15|||
155376739|NCT01131182|560812777|FG000|Overall Study|Other Reason|1|||
155376740|NCT01131182|560812778|FG001|Overall Study|Other Reason|0|||
155376741|NCT03001076|560812779|FG000|Overall Study|Withdrawal by patient|2|||
155376742|NCT03001076|560812780|FG001|Overall Study|Withdrawal by patient|0|||
155376743|NCT03001076|560812779|FG000|Overall Study|Other|1|||
155376744|NCT03001076|560812780|FG001|Overall Study|Other|0|||
155376745|NCT03001076|560812779|FG000|Overall Study|Adverse Event|3|||
155376746|NCT03001076|560812780|FG001|Overall Study|Adverse Event|3|||
155376747|NCT03001076|560812779|FG000|Overall Study|Sponsor decision|1|||
155376748|NCT03001076|560812780|FG001|Overall Study|Sponsor decision|0|||
155376749|NCT03001076|560812779|FG000|Overall Study|Lost to Follow-up|0|||
155376750|NCT03001076|560812780|FG001|Overall Study|Lost to Follow-up|2|||
154965995|NCT00112437|559298883|FG021|Years 6-10 (60-Month Extension)|Other|0|||
154965996|NCT00112437|559298884|FG022|Years 6-10 (60-Month Extension)|Other|0|||
155376751|NCT04602221|560812781|FG000|Overall Study|Discontinuation of trial treatment|0|||
154965997|NCT00112437|559298885|FG023|Years 6-10 (60-Month Extension)|Other|0|||
155376752|NCT04602221|560812782|FG001|Overall Study|Discontinuation of trial treatment|0|||
155376753|NCT04602221|560812783|FG002|Overall Study|Discontinuation of trial treatment|1|||
155376754|NCT04602221|560812784|FG003|Overall Study|Discontinuation of trial treatment|0|||
155376755|NCT04602221|560812785|FG004|Overall Study|Discontinuation of trial treatment|0|||
155376756|NCT04602221|560812786|FG005|Overall Study|Discontinuation of trial treatment|0|||
155376757|NCT04602221|560812787|FG006|Overall Study|Discontinuation of trial treatment|0|||
155376758|NCT04602221|560812788|FG007|Overall Study|Discontinuation of trial treatment|0|||
155376759|NCT04602221|560812789|FG008|Overall Study|Discontinuation of trial treatment|0|||
155376760|NCT04602221|560812790|FG009|Overall Study|Discontinuation of trial treatment|0|||
155376761|NCT04602221|560812791|FG010|Overall Study|Discontinuation of trial treatment|0|||
155376762|NCT04602221|560812792|FG011|Overall Study|Discontinuation of trial treatment|0|||
155376763|NCT04602221|560812793|FG012|Overall Study|Discontinuation of trial treatment|0|||
155376764|NCT04602221|560812794|FG013|Overall Study|Discontinuation of trial treatment|0|||
155376765|NCT04602221|560812795|FG014|Overall Study|Discontinuation of trial treatment|0|||
155376766|NCT04602221|560812796|FG015|Overall Study|Discontinuation of trial treatment|0|||
155376767|NCT04602221|560812797|FG016|Overall Study|Discontinuation of trial treatment|0|||
155376768|NCT04602221|560812798|FG017|Overall Study|Discontinuation of trial treatment|0|||
155376769|NCT04602221|560812781|FG000|Overall Study|Other than listed|0|||
155376770|NCT04602221|560812782|FG001|Overall Study|Other than listed|0|||
155376771|NCT04602221|560812783|FG002|Overall Study|Other than listed|0|||
155376772|NCT04602221|560812784|FG003|Overall Study|Other than listed|0|||
155376773|NCT04602221|560812785|FG004|Overall Study|Other than listed|0|||
155376774|NCT04602221|560812786|FG005|Overall Study|Other than listed|0|||
155376775|NCT04602221|560812787|FG006|Overall Study|Other than listed|0|||
155376776|NCT04602221|560812788|FG007|Overall Study|Other than listed|0|||
155376777|NCT04602221|560812789|FG008|Overall Study|Other than listed|0|||
155376778|NCT04602221|560812790|FG009|Overall Study|Other than listed|0|||
155376779|NCT04602221|560812791|FG010|Overall Study|Other than listed|0|||
155376780|NCT04602221|560812792|FG011|Overall Study|Other than listed|0|||
155376781|NCT04602221|560812793|FG012|Overall Study|Other than listed|0|||
155376782|NCT04602221|560812794|FG013|Overall Study|Other than listed|0|||
155376783|NCT04602221|560812795|FG014|Overall Study|Other than listed|0|||
155376784|NCT04602221|560812796|FG015|Overall Study|Other than listed|1|||
155376785|NCT04602221|560812797|FG016|Overall Study|Other than listed|0|||
155376786|NCT04602221|560812798|FG017|Overall Study|Other than listed|1|||
155376787|NCT04602221|560812781|FG000|Overall Study|Withdrawal by Subject|0|||
155376788|NCT04602221|560812782|FG001|Overall Study|Withdrawal by Subject|0|||
155376789|NCT04602221|560812783|FG002|Overall Study|Withdrawal by Subject|0|||
155376790|NCT04602221|560812784|FG003|Overall Study|Withdrawal by Subject|0|||
155376791|NCT04602221|560812785|FG004|Overall Study|Withdrawal by Subject|0|||
155376792|NCT04602221|560812786|FG005|Overall Study|Withdrawal by Subject|0|||
155376793|NCT04602221|560812787|FG006|Overall Study|Withdrawal by Subject|0|||
155376794|NCT04602221|560812788|FG007|Overall Study|Withdrawal by Subject|0|||
155376795|NCT04602221|560812789|FG008|Overall Study|Withdrawal by Subject|0|||
155376796|NCT04602221|560812790|FG009|Overall Study|Withdrawal by Subject|0|||
155376797|NCT04602221|560812791|FG010|Overall Study|Withdrawal by Subject|0|||
155376798|NCT04602221|560812792|FG011|Overall Study|Withdrawal by Subject|0|||
155376799|NCT04602221|560812793|FG012|Overall Study|Withdrawal by Subject|1|||
155376800|NCT04602221|560812794|FG013|Overall Study|Withdrawal by Subject|0|||
155376801|NCT04602221|560812795|FG014|Overall Study|Withdrawal by Subject|0|||
155376802|NCT04602221|560812796|FG015|Overall Study|Withdrawal by Subject|0|||
155376803|NCT04602221|560812797|FG016|Overall Study|Withdrawal by Subject|0|||
155376804|NCT04602221|560812798|FG017|Overall Study|Withdrawal by Subject|0|||
155376805|NCT04602221|560812781|FG000|Overall Study|Lost to Follow-up|0|||
155376806|NCT04602221|560812782|FG001|Overall Study|Lost to Follow-up|0|||
155376807|NCT04602221|560812783|FG002|Overall Study|Lost to Follow-up|0|||
155376808|NCT04602221|560812784|FG003|Overall Study|Lost to Follow-up|0|||
155376809|NCT04602221|560812785|FG004|Overall Study|Lost to Follow-up|0|||
155376810|NCT04602221|560812786|FG005|Overall Study|Lost to Follow-up|1|||
155376811|NCT04602221|560812787|FG006|Overall Study|Lost to Follow-up|0|||
155376812|NCT04602221|560812788|FG007|Overall Study|Lost to Follow-up|0|||
155376813|NCT04602221|560812789|FG008|Overall Study|Lost to Follow-up|0|||
155376814|NCT04602221|560812790|FG009|Overall Study|Lost to Follow-up|0|||
155376815|NCT04602221|560812791|FG010|Overall Study|Lost to Follow-up|0|||
155376816|NCT04602221|560812792|FG011|Overall Study|Lost to Follow-up|0|||
155376817|NCT04602221|560812793|FG012|Overall Study|Lost to Follow-up|0|||
155376818|NCT04602221|560812794|FG013|Overall Study|Lost to Follow-up|0|||
155376819|NCT04602221|560812795|FG014|Overall Study|Lost to Follow-up|0|||
155376820|NCT04602221|560812796|FG015|Overall Study|Lost to Follow-up|0|||
155376821|NCT04602221|560812797|FG016|Overall Study|Lost to Follow-up|0|||
155376822|NCT04602221|560812798|FG017|Overall Study|Lost to Follow-up|0|||
155376823|NCT02576587|560812799|FG000|Baseline|Equipment failure|0|||
155376824|NCT02576587|560812800|FG001|Baseline|Equipment failure|1|||
155376825|NCT02576587|560812799|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
155376826|NCT02576587|560812800|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
155376827|NCT02576587|560812799|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
155376828|NCT02576587|560812800|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
155376829|NCT02576587|560812799|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
155376830|NCT02576587|560812800|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
155376831|NCT01080716|560812801|FG000|Part 1|Physician Decision|1|||
155376832|NCT01080716|560812802|FG001|Part 1|Physician Decision|0|||
155376833|NCT01080716|560812803|FG002|Part 1|Physician Decision|0|||
155376834|NCT01080716|560812804|FG003|Part 1|Physician Decision|0|||
155376835|NCT01056718|560812805|FG000|Overall Study|Withdrawal by Subject|2|||
155376836|NCT01056718|560812805|FG000|Overall Study|Ischemia on baseline stress test|1|||
155376837|NCT00777088|560812806|FG000|Overall Study|PED Treatment not attempted|1|||
155376838|NCT01139580|560812807|FG000|Overall Study|Adverse Event|5|||
155376839|NCT01139580|560812808|FG001|Overall Study|Adverse Event|4|||
155376840|NCT01139580|560812807|FG000|Overall Study|Lost to Follow-up|9|||
155376841|NCT01139580|560812808|FG001|Overall Study|Lost to Follow-up|1|||
155376842|NCT01139580|560812807|FG000|Overall Study|Lack of Efficacy|0|||
155376843|NCT01139580|560812808|FG001|Overall Study|Lack of Efficacy|2|||
155376844|NCT01139580|560812807|FG000|Overall Study|Withdrawal by Subject|6|||
155376845|NCT01139580|560812808|FG001|Overall Study|Withdrawal by Subject|9|||
155376846|NCT01139580|560812807|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
155376847|NCT01139580|560812808|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
155376848|NCT01139580|560812807|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
155376849|NCT01139580|560812808|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
155376850|NCT01139580|560812807|FG000|Overall Study|Misrandomized|1|||
155376851|NCT01139580|560812808|FG001|Overall Study|Misrandomized|0|||
155376852|NCT01139580|560812807|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
155376853|NCT01139580|560812808|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
155376854|NCT01139580|560812807|FG000|Overall Study|Participant Randomization in Error|0|||
155376855|NCT01139580|560812808|FG001|Overall Study|Participant Randomization in Error|1|||
155376856|NCT03117998|560812814|FG000|Overall Study|Adverse Event|1|||
155376857|NCT03117998|560812815|FG001|Overall Study|Adverse Event|0|||
155376858|NCT03117998|560812816|FG002|Overall Study|Adverse Event|0|||
154965998|NCT00112437|559298886|FG024|Years 6-10 (60-Month Extension)|Other|1|||
155376859|NCT03117998|560812817|FG003|Overall Study|Adverse Event|0|||
155376860|NCT03117998|560812818|FG004|Overall Study|Adverse Event|0|||
155376861|NCT03117998|560812819|FG005|Overall Study|Adverse Event|0|||
155376862|NCT03117998|560812814|FG000|Overall Study|Withdrawal by Subject|0|||
155376863|NCT03117998|560812815|FG001|Overall Study|Withdrawal by Subject|0|||
155376864|NCT03117998|560812816|FG002|Overall Study|Withdrawal by Subject|2|||
155376865|NCT03117998|560812817|FG003|Overall Study|Withdrawal by Subject|3|||
155376866|NCT03117998|560812818|FG004|Overall Study|Withdrawal by Subject|3|||
155376867|NCT03117998|560812819|FG005|Overall Study|Withdrawal by Subject|0|||
155376868|NCT03117998|560812814|FG000|Overall Study|Physician Decision|0|||
155376869|NCT03117998|560812815|FG001|Overall Study|Physician Decision|1|||
155376870|NCT03117998|560812816|FG002|Overall Study|Physician Decision|1|||
155376871|NCT03117998|560812817|FG003|Overall Study|Physician Decision|0|||
155376872|NCT03117998|560812818|FG004|Overall Study|Physician Decision|0|||
155376873|NCT03117998|560812819|FG005|Overall Study|Physician Decision|0|||
155376874|NCT03117998|560812814|FG000|Overall Study|Lost to Follow-up|0|||
155376875|NCT03117998|560812815|FG001|Overall Study|Lost to Follow-up|0|||
155376876|NCT03117998|560812816|FG002|Overall Study|Lost to Follow-up|0|||
155376877|NCT03117998|560812817|FG003|Overall Study|Lost to Follow-up|1|||
155376878|NCT03117998|560812818|FG004|Overall Study|Lost to Follow-up|4|||
155376879|NCT03117998|560812819|FG005|Overall Study|Lost to Follow-up|0|||
155376880|NCT03117998|560812814|FG000|Overall Study|Subject noncompliance|0|||
155376881|NCT03117998|560812815|FG001|Overall Study|Subject noncompliance|0|||
155376882|NCT03117998|560812816|FG002|Overall Study|Subject noncompliance|1|||
155376883|NCT03117998|560812817|FG003|Overall Study|Subject noncompliance|0|||
155376884|NCT03117998|560812818|FG004|Overall Study|Subject noncompliance|0|||
155376885|NCT03117998|560812819|FG005|Overall Study|Subject noncompliance|2|||
155376886|NCT03117998|560812814|FG000|Overall Study|Protocol Violation|0|||
155376887|NCT03117998|560812815|FG001|Overall Study|Protocol Violation|0|||
155376888|NCT03117998|560812816|FG002|Overall Study|Protocol Violation|0|||
155169340|NCT00530816|560057349|FG002|Overall Study|Adverse Event|7|||
155376889|NCT03117998|560812817|FG003|Overall Study|Protocol Violation|0|||
155376890|NCT03117998|560812818|FG004|Overall Study|Protocol Violation|0|||
155376891|NCT03117998|560812819|FG005|Overall Study|Protocol Violation|1|||
155376892|NCT00545753|560812824|FG000|Overall Study|Withdrawal by Subject|0|||
155376893|NCT00545753|560812825|FG001|Overall Study|Withdrawal by Subject|1|||
155376894|NCT00545753|560812826|FG002|Overall Study|Withdrawal by Subject|10|||
155376895|NCT00545753|560812824|FG000|Overall Study|Lost to Follow-up|13|||
155376896|NCT00545753|560812825|FG001|Overall Study|Lost to Follow-up|3|||
155376897|NCT00545753|560812826|FG002|Overall Study|Lost to Follow-up|12|||
155376898|NCT00545753|560812824|FG000|Overall Study|Protocol Violation|3|||
155376899|NCT00545753|560812825|FG001|Overall Study|Protocol Violation|1|||
155376900|NCT00545753|560812826|FG002|Overall Study|Protocol Violation|4|||
155376901|NCT01011153|560812828|FG000|Overall Study|Less than 78 cases completed|8|||
155376902|NCT01011153|560812829|FG001|Overall Study|Less than 78 cases completed|11|||
155376903|NCT01011153|560812830|FG002|Overall Study|Less than 78 cases completed|9|||
155376904|NCT03014479|560812831|FG000|Overall Study|Adverse Event|0|||
155376905|NCT03014479|560812832|FG001|Overall Study|Adverse Event|1|||
155376906|NCT03014479|560812831|FG000|Overall Study|Voluntary Withdrawal|0|||
155376907|NCT03014479|560812832|FG001|Overall Study|Voluntary Withdrawal|2|||
155376908|NCT03014479|560812831|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
155376909|NCT03014479|560812832|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
155376910|NCT01081132|560812835|FG000|Overall Study|Lack of Efficacy|25|||
155376911|NCT01081132|560812836|FG001|Overall Study|Lack of Efficacy|9|||
155376912|NCT01081132|560812835|FG000|Overall Study|Withdrawal by Subject|13|||
155376913|NCT01081132|560812836|FG001|Overall Study|Withdrawal by Subject|16|||
155376914|NCT01081132|560812835|FG000|Overall Study|Lost to Follow-up|4|||
155376915|NCT01081132|560812836|FG001|Overall Study|Lost to Follow-up|11|||
155376916|NCT01081132|560812835|FG000|Overall Study|Adverse Event|3|||
155376917|NCT01081132|560812836|FG001|Overall Study|Adverse Event|9|||
155376918|NCT01081132|560812835|FG000|Overall Study|Non Compliance|4|||
155376919|NCT01081132|560812836|FG001|Overall Study|Non Compliance|2|||
155376920|NCT01081132|560812835|FG000|Overall Study|Lack Of Compliance|0|||
155376921|NCT01081132|560812836|FG001|Overall Study|Lack Of Compliance|1|||
155376922|NCT01081132|560812835|FG000|Overall Study|Missed Visits|1|||
155376923|NCT01081132|560812836|FG001|Overall Study|Missed Visits|1|||
155376924|NCT01081132|560812835|FG000|Overall Study|Stopped Taking Meds|2|||
155376925|NCT01081132|560812836|FG001|Overall Study|Stopped Taking Meds|0|||
155376926|NCT01081132|560812835|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
155376927|NCT01081132|560812836|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
155376928|NCT01081132|560812835|FG000|Overall Study|Declined Taper Phase|0|||
155376929|NCT01081132|560812836|FG001|Overall Study|Declined Taper Phase|1|||
155376930|NCT01081132|560812835|FG000|Overall Study|Protocol Violation|3|||
155376931|NCT01081132|560812836|FG001|Overall Study|Protocol Violation|1|||
155376932|NCT02489968|560812839|FG000|Open-label Treatment Period|Adverse Event|14|||
155376933|NCT02489968|560812840|FG001|Open-label Treatment Period|Adverse Event|7|||
155376934|NCT02489968|560812841|FG002|Open-label Treatment Period|Adverse Event|0|||
155376935|NCT02489968|560812842|FG003|Open-label Treatment Period|Adverse Event|0|||
155376936|NCT02489968|560812843|FG004|Open-label Treatment Period|Adverse Event|0|||
155376937|NCT02489968|560812844|FG005|Open-label Treatment Period|Adverse Event|0|||
155376938|NCT02489968|560812839|FG000|Open-label Treatment Period|Protocol Violation|2|||
155376939|NCT02489968|560812840|FG001|Open-label Treatment Period|Protocol Violation|2|||
155376940|NCT02489968|560812841|FG002|Open-label Treatment Period|Protocol Violation|0|||
155376941|NCT02489968|560812842|FG003|Open-label Treatment Period|Protocol Violation|0|||
155169341|NCT00530816|560057347|FG000|Overall Study|Other|3|||
155091322|NCT04392154|559767535|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
155091323|NCT04392154|559767536|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
155376942|NCT02489968|560812843|FG004|Open-label Treatment Period|Protocol Violation|0|||
155376943|NCT02489968|560812844|FG005|Open-label Treatment Period|Protocol Violation|0|||
155376944|NCT02489968|560812839|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155376945|NCT02489968|560812840|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
155376946|NCT02489968|560812841|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155376947|NCT02489968|560812842|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
155376948|NCT02489968|560812843|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
155376949|NCT02489968|560812844|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
155376950|NCT02489968|560812839|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
155376951|NCT02489968|560812840|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
155376952|NCT02489968|560812841|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155376953|NCT02489968|560812842|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
155376954|NCT02489968|560812843|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
155376955|NCT02489968|560812844|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
155376956|NCT02489968|560812839|FG000|Open-label Treatment Period|Other than specified above|204|||
155376957|NCT02489968|560812840|FG001|Open-label Treatment Period|Other than specified above|189|||
155376958|NCT02489968|560812841|FG002|Open-label Treatment Period|Other than specified above|0|||
155376959|NCT02489968|560812842|FG003|Open-label Treatment Period|Other than specified above|0|||
155376960|NCT02489968|560812843|FG004|Open-label Treatment Period|Other than specified above|0|||
155169342|NCT00530816|560057348|FG001|Overall Study|Other|3|||
154965999|NCT00112437|559298887|FG025|Years 6-10 (60-Month Extension)|Other|0|||
154966000|NCT00112437|559298862|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155376961|NCT02489968|560812844|FG005|Open-label Treatment Period|Other than specified above|0|||
155376962|NCT02489968|560812839|FG000|Double-blind Treatment Period|Adverse Event|0|||
155376963|NCT02489968|560812840|FG001|Double-blind Treatment Period|Adverse Event|0|||
155376964|NCT02489968|560812841|FG002|Double-blind Treatment Period|Adverse Event|2|||
155376965|NCT02489968|560812842|FG003|Double-blind Treatment Period|Adverse Event|6|||
155376966|NCT02489968|560812843|FG004|Double-blind Treatment Period|Adverse Event|4|||
155376967|NCT02489968|560812844|FG005|Double-blind Treatment Period|Adverse Event|5|||
155376968|NCT02489968|560812839|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155376969|NCT02489968|560812840|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155376970|NCT02489968|560812841|FG002|Double-blind Treatment Period|Protocol Violation|0|||
155376971|NCT02489968|560812842|FG003|Double-blind Treatment Period|Protocol Violation|0|||
155376972|NCT02489968|560812843|FG004|Double-blind Treatment Period|Protocol Violation|1|||
155376973|NCT02489968|560812844|FG005|Double-blind Treatment Period|Protocol Violation|1|||
155376974|NCT02489968|560812839|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376975|NCT02489968|560812840|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376976|NCT02489968|560812841|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376977|NCT02489968|560812842|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
155376978|NCT02489968|560812843|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
155376979|NCT02489968|560812844|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
155376980|NCT02489968|560812839|FG000|Double-blind Treatment Period|Other than specified above|0|||
155376981|NCT02489968|560812840|FG001|Double-blind Treatment Period|Other than specified above|0|||
155376982|NCT02489968|560812841|FG002|Double-blind Treatment Period|Other than specified above|0|||
155376983|NCT02489968|560812842|FG003|Double-blind Treatment Period|Other than specified above|0|||
155376984|NCT02489968|560812843|FG004|Double-blind Treatment Period|Other than specified above|1|||
155376985|NCT02489968|560812844|FG005|Double-blind Treatment Period|Other than specified above|0|||
155376986|NCT03738423|560812845|FG000|Overall Study|Withdrawal by Subject|9|||
155376987|NCT03738423|560812846|FG001|Overall Study|Withdrawal by Subject|12|||
155376988|NCT03738423|560812847|FG002|Overall Study|Withdrawal by Subject|9|||
155376989|NCT03738423|560812848|FG003|Overall Study|Withdrawal by Subject|12|||
155376990|NCT03738423|560812849|FG004|Overall Study|Withdrawal by Subject|10|||
155376991|NCT03738423|560812845|FG000|Overall Study|Lack of Efficacy|3|||
155376992|NCT03738423|560812846|FG001|Overall Study|Lack of Efficacy|1|||
155376993|NCT03738423|560812847|FG002|Overall Study|Lack of Efficacy|1|||
155376994|NCT03738423|560812848|FG003|Overall Study|Lack of Efficacy|1|||
155376995|NCT03738423|560812849|FG004|Overall Study|Lack of Efficacy|2|||
155376996|NCT03738423|560812845|FG000|Overall Study|Lost to Follow-up|1|||
155376997|NCT03738423|560812846|FG001|Overall Study|Lost to Follow-up|0|||
155376998|NCT03738423|560812847|FG002|Overall Study|Lost to Follow-up|1|||
155376999|NCT03738423|560812848|FG003|Overall Study|Lost to Follow-up|1|||
155377000|NCT03738423|560812849|FG004|Overall Study|Lost to Follow-up|0|||
155377001|NCT03738423|560812845|FG000|Overall Study|Protocol Violation|1|||
155377002|NCT03738423|560812846|FG001|Overall Study|Protocol Violation|0|||
155377003|NCT03738423|560812847|FG002|Overall Study|Protocol Violation|0|||
155377004|NCT03738423|560812848|FG003|Overall Study|Protocol Violation|0|||
155377005|NCT03738423|560812849|FG004|Overall Study|Protocol Violation|1|||
155377006|NCT03738423|560812845|FG000|Overall Study|Physician Decision|0|||
155377007|NCT03738423|560812846|FG001|Overall Study|Physician Decision|0|||
155377008|NCT03738423|560812847|FG002|Overall Study|Physician Decision|1|||
155377009|NCT03738423|560812848|FG003|Overall Study|Physician Decision|0|||
155377010|NCT03738423|560812849|FG004|Overall Study|Physician Decision|1|||
155377011|NCT03738423|560812845|FG000|Overall Study|Death|0|||
155377012|NCT03738423|560812846|FG001|Overall Study|Death|0|||
155377013|NCT03738423|560812847|FG002|Overall Study|Death|0|||
155377014|NCT03738423|560812848|FG003|Overall Study|Death|0|||
155377015|NCT03738423|560812849|FG004|Overall Study|Death|1|||
155377016|NCT03738423|560812845|FG000|Overall Study|Randomized but never treated|0|||
155377017|NCT03738423|560812846|FG001|Overall Study|Randomized but never treated|0|||
155377018|NCT03738423|560812847|FG002|Overall Study|Randomized but never treated|1|||
155377019|NCT03738423|560812848|FG003|Overall Study|Randomized but never treated|1|||
155377020|NCT03738423|560812849|FG004|Overall Study|Randomized but never treated|0|||
155377021|NCT03981861|560812855|FG000|Overall Study|Withdrawal by Subject|3|||
155377022|NCT03973931|560812856|FG000|Overall Study|Lost to Follow-up|47|||
155169343|NCT00530816|560057349|FG002|Overall Study|Other|4|||
155377023|NCT03973931|560812857|FG001|Overall Study|Lost to Follow-up|63|||
155377024|NCT03973931|560812858|FG002|Overall Study|Lost to Follow-up|51|||
155377025|NCT03973931|560812859|FG003|Overall Study|Lost to Follow-up|54|||
155377026|NCT03973931|560812856|FG000|Overall Study|opted out|6|||
155377027|NCT03973931|560812857|FG001|Overall Study|opted out|5|||
155377028|NCT03973931|560812858|FG002|Overall Study|opted out|5|||
155377029|NCT03973931|560812859|FG003|Overall Study|opted out|1|||
155377030|NCT01022112|560812860|FG000|Overall Study|Adverse Event|1|||
155377031|NCT01022112|560812861|FG001|Overall Study|Adverse Event|2|||
155377032|NCT01022112|560812862|FG002|Overall Study|Adverse Event|0|||
155377033|NCT01022112|560812863|FG003|Overall Study|Adverse Event|1|||
155377034|NCT01022112|560812864|FG004|Overall Study|Adverse Event|0|||
155377035|NCT01022112|560812860|FG000|Overall Study|Lack of Efficacy|1|||
155377036|NCT01022112|560812861|FG001|Overall Study|Lack of Efficacy|0|||
155377037|NCT01022112|560812862|FG002|Overall Study|Lack of Efficacy|0|||
155377038|NCT01022112|560812863|FG003|Overall Study|Lack of Efficacy|0|||
155377039|NCT01022112|560812864|FG004|Overall Study|Lack of Efficacy|1|||
155377040|NCT01022112|560812860|FG000|Overall Study|Physician Decision|0|||
155377041|NCT01022112|560812861|FG001|Overall Study|Physician Decision|0|||
155377042|NCT01022112|560812862|FG002|Overall Study|Physician Decision|1|||
155377043|NCT01022112|560812863|FG003|Overall Study|Physician Decision|0|||
155377044|NCT01022112|560812864|FG004|Overall Study|Physician Decision|1|||
155377045|NCT01022112|560812860|FG000|Overall Study|Withdrawal by Subject|0|||
155377046|NCT01022112|560812861|FG001|Overall Study|Withdrawal by Subject|1|||
155377047|NCT01022112|560812862|FG002|Overall Study|Withdrawal by Subject|2|||
155377048|NCT01022112|560812863|FG003|Overall Study|Withdrawal by Subject|2|||
155377049|NCT01022112|560812864|FG004|Overall Study|Withdrawal by Subject|1|||
155377050|NCT01022112|560812860|FG000|Overall Study|Fasting plasma glucose level increased|1|||
155377051|NCT01022112|560812861|FG001|Overall Study|Fasting plasma glucose level increased|0|||
155377052|NCT01022112|560812862|FG002|Overall Study|Fasting plasma glucose level increased|0|||
155377053|NCT01022112|560812863|FG003|Overall Study|Fasting plasma glucose level increased|0|||
155377054|NCT01022112|560812864|FG004|Overall Study|Fasting plasma glucose level increased|7|||
155377055|NCT03541174|560814357|FG000|Part 1 Double-Blind|Adverse Event|6|||
155377056|NCT03541174|560814358|FG001|Part 1 Double-Blind|Adverse Event|5|||
155377057|NCT03541174|560814359|FG002|Part 1 Double-Blind|Adverse Event|2|||
155377058|NCT03541174|560814360|FG003|Part 1 Double-Blind|Adverse Event|0|||
155377059|NCT03541174|560814361|FG004|Part 1 Double-Blind|Adverse Event|0|||
155377060|NCT03541174|560814362|FG005|Part 1 Double-Blind|Adverse Event|0|||
155377061|NCT03541174|560814357|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
155377062|NCT03541174|560814358|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
155377063|NCT03541174|560814359|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
155377064|NCT03541174|560814360|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
155377065|NCT03541174|560814361|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
155377066|NCT03541174|560814362|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
155377067|NCT03541174|560814357|FG000|Part 1 Double-Blind|Other reasons|3|||
155377068|NCT03541174|560814358|FG001|Part 1 Double-Blind|Other reasons|2|||
155377069|NCT03541174|560814359|FG002|Part 1 Double-Blind|Other reasons|3|||
155377070|NCT03541174|560814360|FG003|Part 1 Double-Blind|Other reasons|0|||
155377071|NCT03541174|560814361|FG004|Part 1 Double-Blind|Other reasons|0|||
155377072|NCT03541174|560814362|FG005|Part 1 Double-Blind|Other reasons|0|||
155377073|NCT03541174|560814357|FG000|Part 2 Single-Blind|Adverse Event|0|||
155377074|NCT03541174|560814358|FG001|Part 2 Single-Blind|Adverse Event|0|||
155377075|NCT03541174|560814359|FG002|Part 2 Single-Blind|Adverse Event|0|||
155377076|NCT03541174|560814360|FG003|Part 2 Single-Blind|Adverse Event|25|||
155377077|NCT03541174|560814361|FG004|Part 2 Single-Blind|Adverse Event|0|||
155377078|NCT03541174|560814362|FG005|Part 2 Single-Blind|Adverse Event|0|||
155377079|NCT03541174|560814357|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
155377080|NCT03541174|560814358|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
155377081|NCT03541174|560814359|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
155377082|NCT03541174|560814360|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
155377083|NCT03541174|560814361|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
155377084|NCT03541174|560814362|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
155377085|NCT03541174|560814357|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377086|NCT03541174|560814358|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377087|NCT03541174|560814359|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377088|NCT03541174|560814360|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
155377089|NCT03541174|560814361|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377090|NCT03541174|560814362|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
155377091|NCT03541174|560814357|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
155377092|NCT03541174|560814358|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
155377093|NCT03541174|560814359|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
155377094|NCT03541174|560814360|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
155377095|NCT03541174|560814361|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
155377096|NCT03541174|560814362|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
155377097|NCT03541174|560814357|FG000|Part 2 Single-Blind|Death|0|||
155377098|NCT03541174|560814358|FG001|Part 2 Single-Blind|Death|0|||
155377099|NCT03541174|560814359|FG002|Part 2 Single-Blind|Death|0|||
155377100|NCT03541174|560814360|FG003|Part 2 Single-Blind|Death|5|||
155377101|NCT03541174|560814361|FG004|Part 2 Single-Blind|Death|0|||
155377102|NCT03541174|560814362|FG005|Part 2 Single-Blind|Death|0|||
155377103|NCT03541174|560814357|FG000|Part 2 Single-Blind|Pregnancy|0|||
155377104|NCT03541174|560814358|FG001|Part 2 Single-Blind|Pregnancy|0|||
155377105|NCT03541174|560814359|FG002|Part 2 Single-Blind|Pregnancy|0|||
155377106|NCT03541174|560814360|FG003|Part 2 Single-Blind|Pregnancy|1|||
155377107|NCT03541174|560814361|FG004|Part 2 Single-Blind|Pregnancy|0|||
155377108|NCT03541174|560814362|FG005|Part 2 Single-Blind|Pregnancy|0|||
155377109|NCT03541174|560814357|FG000|Part 2 Single-Blind|Other reasons|0|||
155377110|NCT03541174|560814358|FG001|Part 2 Single-Blind|Other reasons|0|||
155377111|NCT03541174|560814359|FG002|Part 2 Single-Blind|Other reasons|0|||
155377112|NCT03541174|560814360|FG003|Part 2 Single-Blind|Other reasons|32|||
155377113|NCT03541174|560814361|FG004|Part 2 Single-Blind|Other reasons|0|||
155377114|NCT03541174|560814362|FG005|Part 2 Single-Blind|Other reasons|0|||
155377115|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377116|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377117|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377118|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
155377119|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
155377120|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
155377121|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377122|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377123|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377124|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
155377125|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
155377126|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
155377127|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377128|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377129|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377130|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377131|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
155377132|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
155377133|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377134|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377135|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377136|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
155377137|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
155377138|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
155377139|NCT03541174|560814357|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377140|NCT03541174|560814358|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377141|NCT03541174|560814359|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377142|NCT03541174|560814360|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377143|NCT03541174|560814361|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
155377144|NCT03541174|560814362|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
155377145|NCT00275262|560814363|FG000|Overall Study|Adverse Event|2|||
155377146|NCT00275262|560814364|FG001|Overall Study|Adverse Event|0|||
155377147|NCT00275262|560814363|FG000|Overall Study|Disease progression|2|||
155377148|NCT00275262|560814364|FG001|Overall Study|Disease progression|5|||
155377149|NCT00275262|560814363|FG000|Overall Study|Lost to Follow-up|0|||
155377150|NCT00275262|560814364|FG001|Overall Study|Lost to Follow-up|2|||
155377151|NCT00275262|560814363|FG000|Overall Study|Protocol Violation|0|||
155377152|NCT00275262|560814364|FG001|Overall Study|Protocol Violation|2|||
155377153|NCT00275262|560814363|FG000|Overall Study|Death|1|||
155377154|NCT00275262|560814364|FG001|Overall Study|Death|0|||
155377155|NCT00275262|560814363|FG000|Overall Study|Started Chemotherapy|1|||
155377156|NCT00275262|560814364|FG001|Overall Study|Started Chemotherapy|0|||
155377157|NCT02594163|560814367|FG000|Treatment Period|Progressive disease|2|||
155377158|NCT02594163|560814368|FG001|Treatment Period|Progressive disease|3|||
155377159|NCT02594163|560814367|FG000|Treatment Period|Adverse Event|1|||
155377160|NCT02594163|560814368|FG001|Treatment Period|Adverse Event|5|||
155377161|NCT02594163|560814367|FG000|Treatment Period|Physician Decision|1|||
155377162|NCT02594163|560814368|FG001|Treatment Period|Physician Decision|3|||
155377163|NCT02594163|560814367|FG000|Treatment Period|Study termination by sponsor|2|||
155377164|NCT02594163|560814368|FG001|Treatment Period|Study termination by sponsor|1|||
155377165|NCT02594163|560814367|FG000|Treatment Period|Other, Non-AE|1|||
155377166|NCT02594163|560814368|FG001|Treatment Period|Other, Non-AE|0|||
155377167|NCT02594163|560814367|FG000|Follow-up Period|Withdrawal by Subject|0|||
155377168|NCT02594163|560814368|FG001|Follow-up Period|Withdrawal by Subject|1|||
155377169|NCT02594163|560814367|FG000|Follow-up Period|Study Termination by Sponsor|6|||
155377170|NCT02594163|560814368|FG001|Follow-up Period|Study Termination by Sponsor|4|||
155377171|NCT02594163|560814367|FG000|Follow-up Period|Lost to Follow-up|1|||
155377172|NCT02594163|560814368|FG001|Follow-up Period|Lost to Follow-up|0|||
155377173|NCT02594163|560814367|FG000|Follow-up Period|Death|2|||
155377174|NCT02594163|560814368|FG001|Follow-up Period|Death|5|||
155377175|NCT02594163|560814367|FG000|Follow-up Period|Adverse Event|0|||
155377176|NCT02594163|560814368|FG001|Follow-up Period|Adverse Event|1|||
155377177|NCT02594163|560814367|FG000|Follow-up Period|Progressive Disease|2|||
155377178|NCT02594163|560814368|FG001|Follow-up Period|Progressive Disease|0|||
155377179|NCT02594163|560814367|FG000|Follow-up Period|Physician Decision|0|||
155377180|NCT02594163|560814368|FG001|Follow-up Period|Physician Decision|1|||
155377181|NCT01342341|560814369|FG000|Overall Study|Lost to Follow-up|4|||
155377182|NCT01342341|560814370|FG001|Overall Study|Lost to Follow-up|4|||
155377183|NCT02738203|560814373|FG000|Overall Study|Failed IUD Insertion|2|||
155377184|NCT02738203|560814374|FG001|Overall Study|Failed IUD Insertion|2|||
155377185|NCT02738203|560814373|FG000|Overall Study|Protocol Violation|0|||
155377186|NCT02738203|560814374|FG001|Overall Study|Protocol Violation|1|||
155377187|NCT05087979|560814375|FG000|Overall Study|Converted to general anesthesia|1|||
155377188|NCT05087979|560814376|FG001|Overall Study|Converted to general anesthesia|0|||
155377189|NCT02680002|560814382|FG000|Overall Study|Lost to Follow-up|5|||
155377190|NCT02680002|560814383|FG001|Overall Study|Lost to Follow-up|1|||
155377191|NCT02680002|560814384|FG002|Overall Study|Lost to Follow-up|4|||
155377192|NCT02680002|560814385|FG003|Overall Study|Lost to Follow-up|2|||
155377193|NCT02680002|560814386|FG004|Overall Study|Lost to Follow-up|0|||
155377194|NCT02680002|560814387|FG005|Overall Study|Lost to Follow-up|2|||
155377195|NCT02680002|560814382|FG000|Overall Study|Physician Decision|5|||
155377196|NCT02680002|560814383|FG001|Overall Study|Physician Decision|1|||
155377197|NCT02680002|560814384|FG002|Overall Study|Physician Decision|1|||
155377198|NCT02680002|560814385|FG003|Overall Study|Physician Decision|1|||
155377199|NCT02680002|560814386|FG004|Overall Study|Physician Decision|1|||
155377200|NCT02680002|560814387|FG005|Overall Study|Physician Decision|1|||
155377201|NCT02680002|560814382|FG000|Overall Study|Protocol Violation|1|||
155377202|NCT02680002|560814383|FG001|Overall Study|Protocol Violation|0|||
155377203|NCT02680002|560814384|FG002|Overall Study|Protocol Violation|1|||
155377204|NCT02680002|560814385|FG003|Overall Study|Protocol Violation|0|||
155377205|NCT02680002|560814386|FG004|Overall Study|Protocol Violation|1|||
155377206|NCT02680002|560814387|FG005|Overall Study|Protocol Violation|2|||
155377207|NCT02680002|560814382|FG000|Overall Study|Withdrawal by Subject|0|||
155377208|NCT02680002|560814383|FG001|Overall Study|Withdrawal by Subject|0|||
155377209|NCT02680002|560814384|FG002|Overall Study|Withdrawal by Subject|1|||
155377210|NCT02680002|560814385|FG003|Overall Study|Withdrawal by Subject|0|||
155377211|NCT02680002|560814386|FG004|Overall Study|Withdrawal by Subject|2|||
155377212|NCT02680002|560814387|FG005|Overall Study|Withdrawal by Subject|2|||
155377213|NCT02680002|560814382|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
155377214|NCT02680002|560814383|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
155377215|NCT02680002|560814384|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
155377216|NCT02680002|560814385|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
155377217|NCT02680002|560814386|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
155377218|NCT02680002|560814387|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
155377219|NCT02680002|560814382|FG000|Overall Study|Other|0|||
155377220|NCT02680002|560814383|FG001|Overall Study|Other|1|||
155377221|NCT02680002|560814384|FG002|Overall Study|Other|0|||
155377222|NCT02680002|560814385|FG003|Overall Study|Other|0|||
155377223|NCT02680002|560814386|FG004|Overall Study|Other|1|||
155377224|NCT02680002|560814387|FG005|Overall Study|Other|0|||
155377225|NCT02680002|560814382|FG000|Overall Study|Adverse Event|0|||
155377226|NCT02680002|560814383|FG001|Overall Study|Adverse Event|0|||
155377227|NCT02680002|560814384|FG002|Overall Study|Adverse Event|0|||
155377228|NCT02680002|560814385|FG003|Overall Study|Adverse Event|0|||
155377229|NCT02680002|560814386|FG004|Overall Study|Adverse Event|1|||
155377230|NCT02680002|560814387|FG005|Overall Study|Adverse Event|2|||
155377231|NCT00705679|560814388|FG000|Overall Study|Adverse Event|1|||
155377232|NCT00705679|560814389|FG001|Overall Study|Adverse Event|1|||
155377233|NCT00705679|560814390|FG002|Overall Study|Adverse Event|0|||
155377234|NCT00705679|560814391|FG003|Overall Study|Adverse Event|0|||
155377235|NCT00705679|560814392|FG004|Overall Study|Adverse Event|0|||
155377236|NCT00705679|560814388|FG000|Overall Study|Death|0|||
155377237|NCT00705679|560814389|FG001|Overall Study|Death|0|||
155377238|NCT00705679|560814390|FG002|Overall Study|Death|3|||
155377239|NCT00705679|560814391|FG003|Overall Study|Death|2|||
155377240|NCT00705679|560814392|FG004|Overall Study|Death|1|||
155377241|NCT00705679|560814388|FG000|Overall Study|Lost to Follow-up|32|||
155377242|NCT00705679|560814389|FG001|Overall Study|Lost to Follow-up|60|||
155377243|NCT00705679|560814390|FG002|Overall Study|Lost to Follow-up|44|||
155377244|NCT00705679|560814391|FG003|Overall Study|Lost to Follow-up|30|||
155377245|NCT00705679|560814392|FG004|Overall Study|Lost to Follow-up|35|||
155377246|NCT00705679|560814388|FG000|Overall Study|Physician Decision|0|||
155377247|NCT00705679|560814389|FG001|Overall Study|Physician Decision|1|||
154966001|NCT00112437|559298863|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966002|NCT00112437|559298864|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966003|NCT00112437|559298865|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966004|NCT00112437|559298866|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966005|NCT00112437|559298867|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966006|NCT00112437|559298868|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966007|NCT00112437|559298869|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966008|NCT00112437|559298870|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966009|NCT00112437|559298871|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155377248|NCT00705679|560814390|FG002|Overall Study|Physician Decision|0|||
155377249|NCT00705679|560814391|FG003|Overall Study|Physician Decision|1|||
155377250|NCT00705679|560814392|FG004|Overall Study|Physician Decision|0|||
155377251|NCT00705679|560814388|FG000|Overall Study|Withdrawal by Subject|32|||
155377252|NCT00705679|560814389|FG001|Overall Study|Withdrawal by Subject|77|||
155377253|NCT00705679|560814390|FG002|Overall Study|Withdrawal by Subject|68|||
155377254|NCT00705679|560814391|FG003|Overall Study|Withdrawal by Subject|47|||
155377255|NCT00705679|560814392|FG004|Overall Study|Withdrawal by Subject|33|||
155377256|NCT03527173|560814393|FG000|Overall Study|Lost to Follow-up|4|||
155377257|NCT03527173|560814394|FG001|Overall Study|Lost to Follow-up|2|||
155377258|NCT03527173|560814393|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
155377259|NCT03527173|560814394|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
155377260|NCT03527173|560814393|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
155377261|NCT03527173|560814394|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
155377262|NCT03527173|560814393|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155377263|NCT03527173|560814394|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
155377264|NCT00423943|560814397|FG000|Overall Study|Withdrawal by Subject|3|||
155377265|NCT00423943|560814398|FG001|Overall Study|Withdrawal by Subject|1|||
155377266|NCT03730480|560814399|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
155377267|NCT01248780|560814400|FG000|Overall Study|Lack of Efficacy|2|||
155377268|NCT01248780|560814401|FG001|Overall Study|Lack of Efficacy|0|||
155377269|NCT01248780|560814400|FG000|Overall Study|Lost to Follow-up|0|||
155169344|NCT00530816|560057347|FG000|Overall Study|Withdrawal by Subject|1|||
155377270|NCT01248780|560814401|FG001|Overall Study|Lost to Follow-up|1|||
155377271|NCT01248780|560814400|FG000|Overall Study|Death|0|||
155377272|NCT01248780|560814401|FG001|Overall Study|Death|1|||
155377273|NCT01248780|560814400|FG000|Overall Study|Adverse Event|2|||
155377274|NCT01248780|560814401|FG001|Overall Study|Adverse Event|7|||
155377275|NCT01248780|560814400|FG000|Overall Study|Protocol Violation|1|||
155377276|NCT01248780|560814401|FG001|Overall Study|Protocol Violation|1|||
155377277|NCT01248780|560814400|FG000|Overall Study|Withdrawal by Subject|4|||
155377278|NCT01248780|560814401|FG001|Overall Study|Withdrawal by Subject|4|||
155377279|NCT01248780|560814400|FG000|Overall Study|Not treated|0|||
155377280|NCT01248780|560814401|FG001|Overall Study|Not treated|1|||
155377281|NCT04097301|560814402|FG000|Overall Study|Death|1|||
155377282|NCT04097301|560814402|FG000|Overall Study|Withdrawal by Subject|1|||
155377283|NCT04097301|560814402|FG000|Overall Study|Screening Failure|5|||
155377284|NCT01227577|560814403|FG000|Overall Study|Protocol deviation|3|||
155377285|NCT01227577|560814403|FG000|Overall Study|Death|3|||
155377286|NCT01227577|560814403|FG000|Overall Study|Administrative problems|2|||
155377287|NCT01227577|560814403|FG000|Overall Study|Lost to Follow-up|1|||
155377288|NCT01227577|560814403|FG000|Overall Study|Withdrawal by Subject|4|||
155091324|NCT04392154|559767537|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
155091325|NCT02757430|559767544|FG000|Overall Study|Physician Decision|6|||
155377289|NCT01227577|560814403|FG000|Overall Study|Lack of Efficacy|5|||
155377290|NCT01227577|560814403|FG000|Overall Study|Adverse Event|17|||
155377291|NCT00901186|560814404|FG000|Overall Study|Lack of Efficacy|0|||
155377292|NCT00901186|560814405|FG001|Overall Study|Lack of Efficacy|1|||
155377293|NCT00901186|560814404|FG000|Overall Study|Abnormal laboratory values|0|||
155377294|NCT00901186|560814405|FG001|Overall Study|Abnormal laboratory values|1|||
155377295|NCT00901186|560814404|FG000|Overall Study|Lost to Follow-up|2|||
155377296|NCT00901186|560814405|FG001|Overall Study|Lost to Follow-up|0|||
155377297|NCT00901186|560814404|FG000|Overall Study|Adverse Event|2|||
155377298|NCT00901186|560814405|FG001|Overall Study|Adverse Event|4|||
155377299|NCT00901186|560814404|FG000|Overall Study|Administration problems|0|||
155377300|NCT00901186|560814405|FG001|Overall Study|Administration problems|1|||
155377301|NCT00901186|560814404|FG000|Overall Study|Protocol deviations|5|||
155377302|NCT00901186|560814405|FG001|Overall Study|Protocol deviations|4|||
155377303|NCT00107120|560814406|FG000|Overall Study|Adverse Event|4|||
155377304|NCT00107120|560814407|FG001|Overall Study|Adverse Event|1|||
155377305|NCT00107120|560814406|FG000|Overall Study|Lack of Efficacy|5|||
155377306|NCT00107120|560814407|FG001|Overall Study|Lack of Efficacy|5|||
155377307|NCT00107120|560814406|FG000|Overall Study|Protocol Violation|3|||
155377308|NCT00107120|560814407|FG001|Overall Study|Protocol Violation|0|||
155377309|NCT00107120|560814406|FG000|Overall Study|Withdrawal by Subject|8|||
155377310|NCT00107120|560814407|FG001|Overall Study|Withdrawal by Subject|9|||
155377311|NCT00107120|560814406|FG000|Overall Study|Lost to Follow-up|8|||
155377312|NCT00107120|560814407|FG001|Overall Study|Lost to Follow-up|6|||
155377313|NCT00107120|560814406|FG000|Overall Study|Pregnancy|0|||
155377314|NCT00107120|560814407|FG001|Overall Study|Pregnancy|1|||
155377315|NCT00107120|560814406|FG000|Overall Study|moving away from site|1|||
155377316|NCT00107120|560814407|FG001|Overall Study|moving away from site|1|||
155377317|NCT00107120|560814406|FG000|Overall Study|death of parent|0|||
155377318|NCT00107120|560814407|FG001|Overall Study|death of parent|1|||
155377319|NCT01119105|560814408|FG000|Overall Study|Withdrawal by Subject|1|||
155377320|NCT01119105|560814409|FG001|Overall Study|Withdrawal by Subject|1|||
155377321|NCT01119105|560814410|FG002|Overall Study|Withdrawal by Subject|1|||
155377322|NCT01119105|560814408|FG000|Overall Study|Lost to Follow-up|0|||
155377323|NCT01119105|560814409|FG001|Overall Study|Lost to Follow-up|2|||
155377324|NCT01119105|560814410|FG002|Overall Study|Lost to Follow-up|5|||
155377325|NCT01119105|560814408|FG000|Overall Study|Adverse Event|1|||
155377326|NCT01119105|560814409|FG001|Overall Study|Adverse Event|0|||
155377327|NCT01119105|560814410|FG002|Overall Study|Adverse Event|1|||
155377328|NCT01119105|560814408|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
155377329|NCT01119105|560814409|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
155377330|NCT01119105|560814410|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
155377331|NCT01119105|560814408|FG000|Overall Study|Other|1|||
155377332|NCT01119105|560814409|FG001|Overall Study|Other|1|||
155377333|NCT01119105|560814410|FG002|Overall Study|Other|0|||
155377334|NCT01639495|560814411|FG000|Overall Study|Lost to Follow-up|6|||
155377335|NCT01639495|560814411|FG000|Overall Study|Consented but didn't have study catheter|4|||
155377336|NCT01639495|560814411|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
155377337|NCT01639495|560814411|FG000|Overall Study|No radiofrequency energy applied|2|||
155377338|NCT02383056|560814412|FG000|Overall Study|Adverse Event|1|||
155377339|NCT02383056|560814413|FG001|Overall Study|Adverse Event|0|||
155377340|NCT02383056|560814412|FG000|Overall Study|Lost to Follow-up|0|||
155377341|NCT02383056|560814413|FG001|Overall Study|Lost to Follow-up|2|||
155377342|NCT04214600|560814414|FG000|Overall Study|Lost to Follow-up|9|||
155377343|NCT04214600|560814415|FG001|Overall Study|Lost to Follow-up|14|||
155377344|NCT02935452|560814416|FG000|Overall Study|work and life commintment|3|||
155377345|NCT02935452|560814417|FG001|Overall Study|work and life commintment|1|||
155377346|NCT01635920|560814419|FG000|Overall Study|Adverse Event|1|||
155377347|NCT01635920|560814420|FG001|Overall Study|Adverse Event|0|||
155377348|NCT01635920|560814419|FG000|Overall Study|Lost to Follow-up|0|||
155377349|NCT01635920|560814420|FG001|Overall Study|Lost to Follow-up|1|||
155377350|NCT01635920|560814419|FG000|Overall Study|Subject decision|2|||
155377351|NCT01635920|560814420|FG001|Overall Study|Subject decision|0|||
155377352|NCT01813929|560814421|FG000|Overall Study|Withdrawal by Subject|0|||
155377353|NCT01813929|560814422|FG001|Overall Study|Withdrawal by Subject|1|||
155377354|NCT01239043|560814427|FG000|Overall Study|Protocol Violation|2|||
155377355|NCT01239043|560814428|FG001|Overall Study|Protocol Violation|1|||
155377356|NCT02929329|560814429|FG000|Overall Study|Withdrawal by Subject|24|||
155377357|NCT02929329|560814430|FG001|Overall Study|Withdrawal by Subject|21|||
155377358|NCT02929329|560814429|FG000|Overall Study|Lost to Follow-up|26|||
155377359|NCT02929329|560814430|FG001|Overall Study|Lost to Follow-up|20|||
155377360|NCT02929329|560814429|FG000|Overall Study|Death|1054|||
155377361|NCT02929329|560814430|FG001|Overall Study|Death|1051|||
155377362|NCT02121301|560814431|FG000|Overall Study|Protocol Violation|1|||
155377363|NCT02121301|560814432|FG001|Overall Study|Protocol Violation|4|||
155377364|NCT02121301|560814433|FG002|Overall Study|Protocol Violation|1|||
155377365|NCT00434213|560814441|FG000|Overall Study|Adverse Event|12|||
155377366|NCT00434213|560814441|FG000|Overall Study|Lack of Efficacy|9|||
155377367|NCT00434213|560814441|FG000|Overall Study|Lost to Follow-up|14|||
155377368|NCT00434213|560814441|FG000|Overall Study|Withdrawal by Subject|7|||
155377369|NCT00434213|560814441|FG000|Overall Study|Protocol Violation|3|||
155377370|NCT00434213|560814441|FG000|Overall Study|Unable to comply with study visit window|2|||
155377371|NCT00434213|560814441|FG000|Overall Study|Application site reaction|1|||
155377372|NCT00434213|560814441|FG000|Overall Study|Non-compliant to study schedule|1|||
155377373|NCT04988867|560814442|FG000|Overall Study|Study terminated by Sponsor|12|||
155377374|NCT04988867|560814442|FG000|Overall Study|Adverse Event|2|||
155377375|NCT04988867|560814442|FG000|Overall Study|Study drug noncompliance|1|||
155377376|NCT01699503|560814443|FG000|Overall Study|Death|31|||
155377377|NCT01699503|560814444|FG001|Overall Study|Death|40|||
155377378|NCT01699503|560814443|FG000|Overall Study|Withdrawal by Subject|65|||
155377379|NCT01699503|560814444|FG001|Overall Study|Withdrawal by Subject|57|||
155377380|NCT01699503|560814443|FG000|Overall Study|Lost to Follow-up|121|||
155377381|NCT01699503|560814444|FG001|Overall Study|Lost to Follow-up|117|||
155377382|NCT01699503|560814443|FG000|Overall Study|Excluded due to quality|783|||
155377383|NCT01699503|560814444|FG001|Overall Study|Excluded due to quality|791|||
155377384|NCT01639560|560814445|FG000|Overall Study|Withdrawal by Subject|9|||
155377385|NCT01639560|560814446|FG001|Overall Study|Withdrawal by Subject|14|||
155377386|NCT01639560|560814445|FG000|Overall Study|Lack of Efficacy|1|||
155377387|NCT01639560|560814446|FG001|Overall Study|Lack of Efficacy|2|||
155377388|NCT01639560|560814445|FG000|Overall Study|Lost to Follow-up|9|||
155377389|NCT01639560|560814446|FG001|Overall Study|Lost to Follow-up|11|||
155377390|NCT01639560|560814445|FG000|Overall Study|Adverse Event|0|||
155377391|NCT01639560|560814446|FG001|Overall Study|Adverse Event|2|||
155377392|NCT00911937|560814447|FG000|Overall Study|Death|1|||
155377393|NCT00911937|560814448|FG001|Overall Study|Death|0|||
155377394|NCT00911937|560814447|FG000|Overall Study|Lost to Follow-up|8|||
155377395|NCT00911937|560814448|FG001|Overall Study|Lost to Follow-up|5|||
155377396|NCT00911937|560814447|FG000|Overall Study|Withdrawal by Subject|10|||
155377397|NCT00911937|560814448|FG001|Overall Study|Withdrawal by Subject|7|||
155377398|NCT00911937|560814447|FG000|Overall Study|Withdrawn due to pregnancy|1|||
155377399|NCT00911937|560814448|FG001|Overall Study|Withdrawn due to pregnancy|0|||
155377400|NCT00911937|560814447|FG000|Overall Study|Adverse Event|11|||
155377401|NCT00911937|560814448|FG001|Overall Study|Adverse Event|25|||
155377402|NCT00911937|560814447|FG000|Overall Study|Lack of Efficacy|11|||
155377403|NCT00911937|560814448|FG001|Overall Study|Lack of Efficacy|6|||
155377404|NCT00911937|560814447|FG000|Overall Study|Did not meet inclusion criteria|9|||
155377405|NCT00911937|560814448|FG001|Overall Study|Did not meet inclusion criteria|11|||
155377406|NCT00911937|560814447|FG000|Overall Study|Protocol Violation|14|||
155377407|NCT00911937|560814448|FG001|Overall Study|Protocol Violation|23|||
155377408|NCT00911937|560814447|FG000|Overall Study|Randomized but not treated|13|||
155377409|NCT00911937|560814448|FG001|Overall Study|Randomized but not treated|13|||
155377410|NCT00911937|560814447|FG000|Overall Study|Other|9|||
155377411|NCT00911937|560814448|FG001|Overall Study|Other|5|||
155377412|NCT00633880|560814451|FG000|Open Label Titration|Lack of Efficacy|1|||
155377413|NCT00633880|560814452|FG001|Open Label Titration|Lack of Efficacy|0|||
155377414|NCT00633880|560814453|FG002|Open Label Titration|Lack of Efficacy|0|||
155377415|NCT00633880|560814451|FG000|Open Label Titration|Adverse Event|13|||
155377416|NCT00633880|560814452|FG001|Open Label Titration|Adverse Event|0|||
155377417|NCT00633880|560814453|FG002|Open Label Titration|Adverse Event|0|||
155377418|NCT00633880|560814451|FG000|Open Label Titration|Treatment Failure|55|||
155377419|NCT00633880|560814452|FG001|Open Label Titration|Treatment Failure|0|||
155377420|NCT00633880|560814453|FG002|Open Label Titration|Treatment Failure|0|||
155377421|NCT00633880|560814451|FG000|Open Label Titration|Protocol Violation|6|||
155377422|NCT00633880|560814452|FG001|Open Label Titration|Protocol Violation|0|||
155377423|NCT00633880|560814453|FG002|Open Label Titration|Protocol Violation|0|||
155377424|NCT00633880|560814451|FG000|Open Label Titration|Physician Decision|1|||
155377425|NCT00633880|560814452|FG001|Open Label Titration|Physician Decision|0|||
155377426|NCT00633880|560814453|FG002|Open Label Titration|Physician Decision|0|||
155377427|NCT00633880|560814451|FG000|Open Label Titration|Withdrawal by Subject|4|||
155377428|NCT00633880|560814452|FG001|Open Label Titration|Withdrawal by Subject|0|||
155377429|NCT00633880|560814453|FG002|Open Label Titration|Withdrawal by Subject|0|||
155377430|NCT00700778|560814454|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
155377431|NCT04927247|560814456|FG000|Overall Study|Other|2|||
155377432|NCT04927247|560814457|FG001|Overall Study|Other|1|||
155377433|NCT04927247|560814456|FG000|Overall Study|Physician Decision|0|||
155377434|NCT04927247|560814457|FG001|Overall Study|Physician Decision|1|||
155377435|NCT04927247|560814456|FG000|Overall Study|Adverse Event|1|||
155377436|NCT04927247|560814457|FG001|Overall Study|Adverse Event|0|||
155377437|NCT00350103|560814458|FG000|Overall Study|Adverse Event|12|||
155377438|NCT00350103|560814459|FG001|Overall Study|Adverse Event|29|||
155377439|NCT00350103|560814460|FG002|Overall Study|Adverse Event|17|||
155377440|NCT00350103|560814458|FG000|Overall Study|Lack of Efficacy|5|||
155377441|NCT00350103|560814459|FG001|Overall Study|Lack of Efficacy|1|||
155377442|NCT00350103|560814460|FG002|Overall Study|Lack of Efficacy|3|||
155377443|NCT00350103|560814458|FG000|Overall Study|Withdrawal by Subject|6|||
155377444|NCT00350103|560814459|FG001|Overall Study|Withdrawal by Subject|6|||
155377445|NCT00350103|560814460|FG002|Overall Study|Withdrawal by Subject|8|||
155377446|NCT00350103|560814458|FG000|Overall Study|Protocol Violation|0|||
155377447|NCT00350103|560814459|FG001|Overall Study|Protocol Violation|0|||
155377448|NCT00350103|560814460|FG002|Overall Study|Protocol Violation|1|||
155377449|NCT00350103|560814458|FG000|Overall Study|Unsatisfactory Compliance|2|||
155377450|NCT00350103|560814459|FG001|Overall Study|Unsatisfactory Compliance|2|||
155377451|NCT00350103|560814460|FG002|Overall Study|Unsatisfactory Compliance|1|||
155377452|NCT00350103|560814458|FG000|Overall Study|Investigator´s decision|1|||
155377453|NCT00350103|560814459|FG001|Overall Study|Investigator´s decision|1|||
155377454|NCT00350103|560814460|FG002|Overall Study|Investigator´s decision|0|||
155377455|NCT00350103|560814458|FG000|Overall Study|Exclusion criteria met|0|||
155377456|NCT00350103|560814459|FG001|Overall Study|Exclusion criteria met|0|||
155377457|NCT00350103|560814460|FG002|Overall Study|Exclusion criteria met|1|||
155377458|NCT00350103|560814458|FG000|Overall Study|Patient relocated|0|||
155377459|NCT00350103|560814459|FG001|Overall Study|Patient relocated|0|||
155377460|NCT00350103|560814460|FG002|Overall Study|Patient relocated|1|||
155377461|NCT00350103|560814458|FG000|Overall Study|Need for prohibited medication|1|||
155377462|NCT00350103|560814459|FG001|Overall Study|Need for prohibited medication|0|||
155377463|NCT00350103|560814460|FG002|Overall Study|Need for prohibited medication|0|||
155377464|NCT00350103|560814458|FG000|Overall Study|Personal reasons|0|||
155377465|NCT00350103|560814459|FG001|Overall Study|Personal reasons|0|||
155377466|NCT00350103|560814460|FG002|Overall Study|Personal reasons|1|||
155377467|NCT00350103|560814458|FG000|Overall Study|Patient stopped feeling pain|1|||
155377468|NCT00350103|560814459|FG001|Overall Study|Patient stopped feeling pain|0|||
155169345|NCT00530816|560057348|FG001|Overall Study|Withdrawal by Subject|2|||
155377469|NCT00350103|560814460|FG002|Overall Study|Patient stopped feeling pain|0|||
155377470|NCT00350103|560814458|FG000|Overall Study|PR greater than 250ms|0|||
155377471|NCT00350103|560814459|FG001|Overall Study|PR greater than 250ms|0|||
155377472|NCT00350103|560814460|FG002|Overall Study|PR greater than 250ms|1|||
155377473|NCT00350103|560814458|FG000|Overall Study|Wrong calculation of QT interval|0|||
155377474|NCT00350103|560814459|FG001|Overall Study|Wrong calculation of QT interval|0|||
155377475|NCT00350103|560814460|FG002|Overall Study|Wrong calculation of QT interval|1|||
155377476|NCT00350103|560814458|FG000|Overall Study|Sponsor mistake|1|||
155377477|NCT00350103|560814459|FG001|Overall Study|Sponsor mistake|0|||
155377478|NCT00350103|560814460|FG002|Overall Study|Sponsor mistake|0|||
155377479|NCT00350103|560814458|FG000|Overall Study|Randomization mistake|0|||
155377480|NCT00350103|560814459|FG001|Overall Study|Randomization mistake|1|||
155377481|NCT00350103|560814460|FG002|Overall Study|Randomization mistake|1|||
155377482|NCT00350103|560814458|FG000|Overall Study|Sponsor´s decision|0|||
155377483|NCT00350103|560814459|FG001|Overall Study|Sponsor´s decision|1|||
155377484|NCT00350103|560814460|FG002|Overall Study|Sponsor´s decision|0|||
155377485|NCT00350103|560814458|FG000|Overall Study|Lost, Reason unknown|1|||
155377486|NCT00350103|560814459|FG001|Overall Study|Lost, Reason unknown|1|||
155377487|NCT00350103|560814460|FG002|Overall Study|Lost, Reason unknown|0|||
155377488|NCT02842151|560814461|FG000|Overall Study|Adverse Event|1|||
155377489|NCT02842151|560814461|FG000|Overall Study|Subject moved too far away|1|||
155377490|NCT02559895|560814462|FG000|Overall Study|Adverse Event|3|||
155377491|NCT02559895|560814463|FG001|Overall Study|Adverse Event|3|||
155377492|NCT02559895|560814464|FG002|Overall Study|Adverse Event|2|||
155377493|NCT02559895|560814465|FG003|Overall Study|Adverse Event|1|||
155377494|NCT02559895|560814462|FG000|Overall Study|Lack of Efficacy|2|||
155377495|NCT02559895|560814463|FG001|Overall Study|Lack of Efficacy|3|||
155377496|NCT02559895|560814464|FG002|Overall Study|Lack of Efficacy|2|||
155377497|NCT02559895|560814465|FG003|Overall Study|Lack of Efficacy|8|||
155377498|NCT02559895|560814462|FG000|Overall Study|Lost to Follow-up|22|||
155377499|NCT02559895|560814463|FG001|Overall Study|Lost to Follow-up|16|||
155377500|NCT02559895|560814464|FG002|Overall Study|Lost to Follow-up|12|||
155377501|NCT02559895|560814465|FG003|Overall Study|Lost to Follow-up|17|||
155377502|NCT02559895|560814462|FG000|Overall Study|Physician Decision|1|||
155377503|NCT02559895|560814463|FG001|Overall Study|Physician Decision|1|||
155377504|NCT02559895|560814464|FG002|Overall Study|Physician Decision|3|||
155377505|NCT02559895|560814465|FG003|Overall Study|Physician Decision|0|||
155377506|NCT02559895|560814462|FG000|Overall Study|Withdrawal by Subject|16|||
155377507|NCT02559895|560814463|FG001|Overall Study|Withdrawal by Subject|9|||
155377508|NCT02559895|560814464|FG002|Overall Study|Withdrawal by Subject|20|||
155377509|NCT02559895|560814465|FG003|Overall Study|Withdrawal by Subject|9|||
155377510|NCT02559895|560814462|FG000|Overall Study|Study Burden|10|||
155377511|NCT02559895|560814463|FG001|Overall Study|Study Burden|16|||
155377512|NCT02559895|560814464|FG002|Overall Study|Study Burden|12|||
155377513|NCT02559895|560814465|FG003|Overall Study|Study Burden|22|||
155377514|NCT02559895|560814462|FG000|Overall Study|Other|1|||
155377515|NCT02559895|560814463|FG001|Overall Study|Other|5|||
155377516|NCT02559895|560814464|FG002|Overall Study|Other|3|||
155377517|NCT02559895|560814465|FG003|Overall Study|Other|3|||
155377518|NCT00320528|560814466|FG000|Study Period II|Adverse Event|3|||
155377519|NCT00320528|560814467|FG001|Study Period II|Adverse Event|4|||
155377520|NCT00320528|560814468|FG002|Study Period II|Adverse Event|8|||
155377521|NCT00320528|560814466|FG000|Study Period II|Parent/Caregiver Decision|8|||
155377522|NCT00320528|560814467|FG001|Study Period II|Parent/Caregiver Decision|3|||
155377523|NCT00320528|560814468|FG002|Study Period II|Parent/Caregiver Decision|11|||
155377524|NCT00320528|560814466|FG000|Study Period II|Withdrawal by Subject|0|||
155377525|NCT00320528|560814467|FG001|Study Period II|Withdrawal by Subject|1|||
155377526|NCT00320528|560814468|FG002|Study Period II|Withdrawal by Subject|1|||
155377527|NCT00320528|560814466|FG000|Study Period II|Entry Criteria Exclusion|0|||
155377528|NCT00320528|560814467|FG001|Study Period II|Entry Criteria Exclusion|2|||
155377529|NCT00320528|560814468|FG002|Study Period II|Entry Criteria Exclusion|2|||
155377530|NCT00320528|560814466|FG000|Study Period III|Adverse Event|1|||
155377531|NCT00320528|560814467|FG001|Study Period III|Adverse Event|0|||
155377532|NCT00320528|560814468|FG002|Study Period III|Adverse Event|0|||
155377533|NCT00320528|560814466|FG000|Study Period III|Lost to Follow-up|1|||
155377534|NCT00320528|560814467|FG001|Study Period III|Lost to Follow-up|0|||
155377535|NCT00320528|560814468|FG002|Study Period III|Lost to Follow-up|0|||
155377536|NCT00320528|560814466|FG000|Study Period III|Withdrawal by Subject|1|||
155377537|NCT00320528|560814467|FG001|Study Period III|Withdrawal by Subject|1|||
155377538|NCT00320528|560814468|FG002|Study Period III|Withdrawal by Subject|2|||
155377539|NCT00320528|560814466|FG000|Study Period III|Lack of Efficacy|2|||
155377540|NCT00320528|560814467|FG001|Study Period III|Lack of Efficacy|0|||
155377541|NCT00320528|560814468|FG002|Study Period III|Lack of Efficacy|0|||
155377542|NCT00320528|560814466|FG000|Study Period III|Parent/Caregiver Decision|14|||
155377543|NCT00320528|560814467|FG001|Study Period III|Parent/Caregiver Decision|3|||
155377544|NCT00320528|560814468|FG002|Study Period III|Parent/Caregiver Decision|11|||
155377545|NCT00320528|560814466|FG000|Study Period III|Protocol Violation|0|||
155377546|NCT00320528|560814467|FG001|Study Period III|Protocol Violation|1|||
155377547|NCT00320528|560814468|FG002|Study Period III|Protocol Violation|0|||
155377548|NCT00320528|560814466|FG000|Study Period III|Physician Decision|0|||
155377549|NCT00320528|560814467|FG001|Study Period III|Physician Decision|1|||
155377550|NCT00320528|560814468|FG002|Study Period III|Physician Decision|2|||
155377551|NCT00320528|560814466|FG000|Study Period III|Sponsor Decision|0|||
155377552|NCT00320528|560814467|FG001|Study Period III|Sponsor Decision|0|||
155377553|NCT00320528|560814468|FG002|Study Period III|Sponsor Decision|1|||
155377554|NCT00320528|560814466|FG000|Study Period III|Atomoxetine Commercially Available|68|||
155377555|NCT00320528|560814467|FG001|Study Period III|Atomoxetine Commercially Available|25|||
155377556|NCT00320528|560814468|FG002|Study Period III|Atomoxetine Commercially Available|90|||
155377557|NCT04828837|560814469|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
155377558|NCT04828837|560814470|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
155377559|NCT04828837|560814469|FG000|Overall Study|Lost to Follow-up|2|||
155377560|NCT04828837|560814470|FG001|Overall Study|Lost to Follow-up|6|||
155377561|NCT04828837|560814469|FG000|Overall Study|Lack of Efficacy|1|||
155377562|NCT04828837|560814470|FG001|Overall Study|Lack of Efficacy|0|||
155377563|NCT04828837|560814469|FG000|Overall Study|Admitted due to pneumothorax.|1|||
155377564|NCT04828837|560814470|FG001|Overall Study|Admitted due to pneumothorax.|0|||
155377565|NCT04828837|560814469|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
155377566|NCT04828837|560814470|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
155377567|NCT01397422|560814471|FG000|Overall Study|Adverse Event|0|||
155377568|NCT01397422|560814472|FG001|Overall Study|Adverse Event|3|||
155377569|NCT01397422|560814473|FG002|Overall Study|Adverse Event|3|||
155377570|NCT01397422|560814474|FG003|Overall Study|Adverse Event|8|||
155377571|NCT01397422|560814471|FG000|Overall Study|Withdrawal by Subject|1|||
155377572|NCT01397422|560814472|FG001|Overall Study|Withdrawal by Subject|0|||
155377573|NCT01397422|560814473|FG002|Overall Study|Withdrawal by Subject|0|||
155377574|NCT01397422|560814474|FG003|Overall Study|Withdrawal by Subject|0|||
155377575|NCT01397422|560814471|FG000|Overall Study|Increased bradykinesia related to PD|1|||
155377576|NCT01397422|560814472|FG001|Overall Study|Increased bradykinesia related to PD|0|||
155377577|NCT01397422|560814473|FG002|Overall Study|Increased bradykinesia related to PD|0|||
155377578|NCT01397422|560814474|FG003|Overall Study|Increased bradykinesia related to PD|0|||
155377579|NCT00760474|560814475|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
155377580|NCT00760474|560814476|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
155377581|NCT00760474|560814475|FG000|Placebo Washout Period|Other|0|||
155377582|NCT00760474|560814476|FG001|Placebo Washout Period|Other|1|||
155377583|NCT00760474|560814475|FG000|Period 2 (P2)|Lost to Follow-up|1|||
155377584|NCT00760474|560814476|FG001|Period 2 (P2)|Lost to Follow-up|0|||
155377585|NCT00760474|560814475|FG000|Period 2 (P2)|Adverse Event|0|||
155377586|NCT00760474|560814476|FG001|Period 2 (P2)|Adverse Event|1|||
155377587|NCT04664400|560814477|FG000|Overall Study|Withdrawal by Subject|2|||
155377588|NCT01262027|560814478|FG000|Overall Study|Adverse Event|1|||
155377589|NCT01262027|560814478|FG000|Overall Study|Withdrawal by Subject|3|||
155377590|NCT01262027|560814478|FG000|Overall Study|Protocol Violation|1|||
155377591|NCT01905150|560814492|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
155377592|NCT01905150|560814493|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
155377593|NCT01758900|560814500|FG000|Overall Study|difficulty for further intubation|7|||
155377594|NCT01758900|560814501|FG001|Overall Study|difficulty for further intubation|8|||
155377595|NCT03762200|560814503|FG000|Overall Study|Death|2|||
155377596|NCT04577001|560814504|FG000|Overall Study|Subject became ineligible|0|||
155377597|NCT04577001|560814505|FG001|Overall Study|Subject became ineligible|1|||
155377598|NCT01865747|560814508|FG000|Overall Study (ITT)|Adverse Event|32|||
155377599|NCT01865747|560814509|FG001|Overall Study (ITT)|Adverse Event|31|||
155377600|NCT01865747|560814508|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
155377601|NCT01865747|560814509|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
155377602|NCT01865747|560814508|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
155091326|NCT02757430|559767544|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
155377603|NCT01865747|560814509|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
155377604|NCT01865747|560814508|FG000|Overall Study (ITT)|Protocol Violation|1|||
155377605|NCT01865747|560814509|FG001|Overall Study (ITT)|Protocol Violation|1|||
155377606|NCT01865747|560814508|FG000|Overall Study (ITT)|Physician Decision|5|||
155377607|NCT01865747|560814509|FG001|Overall Study (ITT)|Physician Decision|2|||
155377608|NCT01865747|560814508|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
155377609|NCT01865747|560814509|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
154966010|NCT00112437|559298872|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966011|NCT00112437|559298873|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155091327|NCT02757430|559767544|FG000|Overall Study|No informed consent|1|||
155377610|NCT01865747|560814508|FG000|Overall Study (ITT)|Sponsor Decision|0|||
155377611|NCT01865747|560814509|FG001|Overall Study (ITT)|Sponsor Decision|1|||
155377612|NCT01865747|560814508|FG000|Overall Study (ITT)|Progressive Disease|122|||
155377613|NCT01865747|560814509|FG001|Overall Study (ITT)|Progressive Disease|158|||
155377614|NCT01865747|560814508|FG000|Overall Study (ITT)|Reason Not Provided|0|||
155377615|NCT01865747|560814509|FG001|Overall Study (ITT)|Reason Not Provided|1|||
155377616|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
155377617|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
155377618|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
155377619|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
155377620|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
155377621|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
155377622|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
155377623|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
155377624|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
155377625|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
155377626|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
155377627|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
155377628|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
155377629|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
155377630|NCT01865747|560814508|FG000|Primary Intent to Treat (PITT)|Other|0|||
155377631|NCT01865747|560814509|FG001|Primary Intent to Treat (PITT)|Other|1|||
155377632|NCT00611975|560814512|FG000|Overall Study|Withdrawal by Subject|3|||
155377633|NCT00611975|560814513|FG001|Overall Study|Withdrawal by Subject|7|||
155377634|NCT00611975|560814512|FG000|Overall Study|Pregnancy|2|||
155377635|NCT00611975|560814513|FG001|Overall Study|Pregnancy|1|||
155377636|NCT04625413|560814514|FG000|Overall Study|Hospice|2|||
155377637|NCT04625413|560814514|FG000|Overall Study|Distress|1|||
155377638|NCT04625413|560814514|FG000|Overall Study|Not feeling well|1|||
155377639|NCT05618912|560814515|FG000|Overall Study|Lost to Follow-up|14|||
155377640|NCT05618912|560814516|FG001|Overall Study|Lost to Follow-up|19|||
155377641|NCT00432666|560815742|FG000|Main Period|Adverse Event|1|||
155377642|NCT00432666|560815743|FG001|Main Period|Adverse Event|1|||
155377643|NCT00432666|560815742|FG000|Main Period|Consent Withdrawn|1|||
155377644|NCT00432666|560815743|FG001|Main Period|Consent Withdrawn|0|||
155377645|NCT00432666|560815742|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
155377646|NCT00432666|560815743|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
155377647|NCT00432666|560815742|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
155377648|NCT00432666|560815743|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
155377649|NCT00432666|560815742|FG000|Open-Label Extension Period|Adverse Event|5|||
155377650|NCT00432666|560815743|FG001|Open-Label Extension Period|Adverse Event|0|||
155377651|NCT00432666|560815742|FG000|Open-Label Extension Period|Consent withdrawn|10|||
155377652|NCT00432666|560815743|FG001|Open-Label Extension Period|Consent withdrawn|0|||
155377653|NCT00432666|560815742|FG000|Open-Label Extension Period|Physician Decision|3|||
155377654|NCT00432666|560815743|FG001|Open-Label Extension Period|Physician Decision|0|||
155377655|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
155377656|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
155377657|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
155377658|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
155377659|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
155377660|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
155377661|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
155377662|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
155377663|NCT00978627|560815744|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
155377664|NCT00978627|560815745|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
155377665|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
155377666|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
155377667|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
155377668|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
155377669|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
155377670|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
155377671|NCT00978627|560815744|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
155377672|NCT00978627|560815745|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
155377673|NCT01506453|560815746|FG000|Overall Study|Withdrawal prior to treatment|0|||
155377674|NCT01506453|560815747|FG001|Overall Study|Withdrawal prior to treatment|2|||
155377675|NCT00605215|560815750|FG000|Overall Study|Death|0|||
155377676|NCT00605215|560815751|FG001|Overall Study|Death|0|||
155377677|NCT00605215|560815752|FG002|Overall Study|Death|1|||
155377678|NCT00605215|560815750|FG000|Overall Study|Adverse Event|19|||
155377679|NCT00605215|560815751|FG001|Overall Study|Adverse Event|21|||
155377680|NCT00605215|560815752|FG002|Overall Study|Adverse Event|26|||
155377681|NCT00605215|560815750|FG000|Overall Study|Refusal to sign the re-consent form|8|||
155377682|NCT00605215|560815751|FG001|Overall Study|Refusal to sign the re-consent form|3|||
155377683|NCT00605215|560815752|FG002|Overall Study|Refusal to sign the re-consent form|3|||
155377684|NCT00605215|560815750|FG000|Overall Study|Withdrawal by Subject|39|||
155377685|NCT00605215|560815751|FG001|Overall Study|Withdrawal by Subject|37|||
155377686|NCT00605215|560815752|FG002|Overall Study|Withdrawal by Subject|27|||
155377687|NCT00605215|560815750|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
155377688|NCT00605215|560815751|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
155377689|NCT00605215|560815752|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
155377690|NCT00605215|560815750|FG000|Overall Study|Protocol Violation|3|||
155377691|NCT00605215|560815751|FG001|Overall Study|Protocol Violation|4|||
155377692|NCT00605215|560815752|FG002|Overall Study|Protocol Violation|1|||
155377693|NCT00605215|560815750|FG000|Overall Study|Pregnancy|8|||
155377694|NCT00605215|560815751|FG001|Overall Study|Pregnancy|5|||
155377695|NCT00605215|560815752|FG002|Overall Study|Pregnancy|4|||
155377696|NCT00605215|560815750|FG000|Overall Study|Lost to Follow-up|8|||
155377697|NCT00605215|560815751|FG001|Overall Study|Lost to Follow-up|5|||
155377698|NCT00605215|560815752|FG002|Overall Study|Lost to Follow-up|2|||
155377699|NCT00605215|560815750|FG000|Overall Study|Other than specified|0|||
155377700|NCT00605215|560815751|FG001|Overall Study|Other than specified|2|||
155377701|NCT00605215|560815752|FG002|Overall Study|Other than specified|1|||
155377702|NCT04058366|560815753|FG000|Overall Study|Adverse Event|14|||
155377703|NCT04058366|560815753|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
155377704|NCT04058366|560815753|FG000|Overall Study|Commercial drug is available for participants|6|||
155377705|NCT04058366|560815753|FG000|Overall Study|Death|1|||
155377706|NCT04058366|560815753|FG000|Overall Study|Other non-compliance|2|||
155377707|NCT04058366|560815753|FG000|Overall Study|Other|6|||
155377708|NCT01302067|560815756|FG000|Overall Study|Death|0|||
155377709|NCT01302067|560815757|FG001|Overall Study|Death|0|||
155377710|NCT01302067|560815758|FG002|Overall Study|Death|1|||
155377711|NCT01302067|560815756|FG000|Overall Study|Physician Decision|9|||
155377712|NCT01302067|560815757|FG001|Overall Study|Physician Decision|5|||
155377713|NCT01302067|560815758|FG002|Overall Study|Physician Decision|14|||
155377714|NCT01302067|560815756|FG000|Overall Study|Lack of Efficacy|8|||
155377715|NCT01302067|560815757|FG001|Overall Study|Lack of Efficacy|4|||
155377716|NCT01302067|560815758|FG002|Overall Study|Lack of Efficacy|2|||
155377717|NCT01302067|560815756|FG000|Overall Study|Lost to Follow-up|9|||
155377718|NCT01302067|560815757|FG001|Overall Study|Lost to Follow-up|4|||
155377719|NCT01302067|560815758|FG002|Overall Study|Lost to Follow-up|15|||
155377720|NCT01302067|560815756|FG000|Overall Study|Withdrawal by Subject|13|||
155377721|NCT01302067|560815757|FG001|Overall Study|Withdrawal by Subject|6|||
155377722|NCT01302067|560815758|FG002|Overall Study|Withdrawal by Subject|10|||
155377723|NCT01302067|560815756|FG000|Overall Study|Other|1|||
155377724|NCT01302067|560815757|FG001|Overall Study|Other|1|||
155377725|NCT01302067|560815758|FG002|Overall Study|Other|3|||
155377726|NCT01302067|560815756|FG000|Overall Study|Protocol Violation|11|||
155377727|NCT01302067|560815757|FG001|Overall Study|Protocol Violation|0|||
155377728|NCT01302067|560815758|FG002|Overall Study|Protocol Violation|8|||
155377729|NCT01302067|560815756|FG000|Overall Study|Adverse Event|27|||
155377730|NCT01302067|560815757|FG001|Overall Study|Adverse Event|14|||
155377731|NCT01302067|560815758|FG002|Overall Study|Adverse Event|45|||
155377732|NCT01076192|560815759|FG000|Overall Study|Other|197|||
155377733|NCT01034176|560815760|FG000|Overall Study|Physician Decision|2|||
155377734|NCT01034176|560815761|FG001|Overall Study|Physician Decision|0|||
155377735|NCT01034176|560815760|FG000|Overall Study|Withdrawal by Subject|0|||
155377736|NCT01034176|560815761|FG001|Overall Study|Withdrawal by Subject|1|||
155377737|NCT01034176|560815760|FG000|Overall Study|Lost to Follow-up|0|||
155377738|NCT01034176|560815761|FG001|Overall Study|Lost to Follow-up|1|||
155377739|NCT00266227|560815762|FG000|Initial Treatment|Adverse Event|0|||
155377740|NCT00266227|560815763|FG001|Initial Treatment|Adverse Event|0|||
155377741|NCT00266227|560815764|FG002|Initial Treatment|Adverse Event|13|||
155377742|NCT00266227|560815762|FG000|Initial Treatment|Lost to Follow-up|0|||
155377743|NCT00266227|560815763|FG001|Initial Treatment|Lost to Follow-up|0|||
155377744|NCT00266227|560815764|FG002|Initial Treatment|Lost to Follow-up|6|||
155377745|NCT00266227|560815762|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
155377746|NCT00266227|560815763|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
155377747|NCT00266227|560815764|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
155377748|NCT00266227|560815762|FG000|Initial Treatment|Physician decision to withdraw|0|||
155377749|NCT00266227|560815763|FG001|Initial Treatment|Physician decision to withdraw|0|||
155377750|NCT00266227|560815764|FG002|Initial Treatment|Physician decision to withdraw|12|||
155377751|NCT00266227|560815762|FG000|Initial Treatment|Pregnancy|0|||
155377752|NCT00266227|560815763|FG001|Initial Treatment|Pregnancy|0|||
155377753|NCT00266227|560815764|FG002|Initial Treatment|Pregnancy|1|||
155377754|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Death|1|||
155377755|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Death|0|||
155377756|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Death|0|||
155377757|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
155377758|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
155377759|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
155377760|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
155377761|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
155377762|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
155377763|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
155377764|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
155377765|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
155377766|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
155377767|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
155377768|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
155377769|NCT00266227|560815762|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
155377770|NCT00266227|560815763|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
155377771|NCT00266227|560815764|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
155377772|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Death|1|||
155377773|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Death|1|||
155377774|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Death|0|||
155377775|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
155377776|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
155377777|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
155377778|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
155377779|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
155377780|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
155377781|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
155377782|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
155377783|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
155377784|NCT00266227|560815762|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
155377785|NCT00266227|560815763|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
155377786|NCT00266227|560815764|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
155377787|NCT01290315|560815766|FG000|Overall Study|Adverse Event|0|||
155377788|NCT01290315|560815767|FG001|Overall Study|Adverse Event|0|||
155377789|NCT01290315|560815768|FG002|Overall Study|Adverse Event|0|||
155377790|NCT01290315|560815769|FG003|Overall Study|Adverse Event|3|||
155377791|NCT01290315|560815766|FG000|Overall Study|Selection criteria/compliance|2|||
155377792|NCT01290315|560815767|FG001|Overall Study|Selection criteria/compliance|1|||
155377793|NCT01290315|560815768|FG002|Overall Study|Selection criteria/compliance|0|||
155377794|NCT01290315|560815769|FG003|Overall Study|Selection criteria/compliance|2|||
155377795|NCT01290315|560815766|FG000|Overall Study|Lost to Follow-up|0|||
155377796|NCT01290315|560815767|FG001|Overall Study|Lost to Follow-up|1|||
155377797|NCT01290315|560815768|FG002|Overall Study|Lost to Follow-up|0|||
155377798|NCT01290315|560815769|FG003|Overall Study|Lost to Follow-up|0|||
155377799|NCT01290315|560815766|FG000|Overall Study|Withdrawal by Subject|1|||
155377800|NCT01290315|560815767|FG001|Overall Study|Withdrawal by Subject|1|||
155377801|NCT01290315|560815768|FG002|Overall Study|Withdrawal by Subject|0|||
155377802|NCT01290315|560815769|FG003|Overall Study|Withdrawal by Subject|0|||
155377803|NCT00896051|560815773|FG000|Overall Study|Adverse Event|2|||
155377804|NCT00896051|560815774|FG001|Overall Study|Adverse Event|1|||
155377805|NCT00896051|560815773|FG000|Overall Study|Lost to Follow-up|3|||
155377806|NCT00896051|560815774|FG001|Overall Study|Lost to Follow-up|2|||
155377807|NCT00896051|560815773|FG000|Overall Study|Withdrawal by Subject|3|||
155377808|NCT00896051|560815774|FG001|Overall Study|Withdrawal by Subject|2|||
155377809|NCT00896051|560815773|FG000|Overall Study|Subject noncompliant|1|||
155377810|NCT00896051|560815774|FG001|Overall Study|Subject noncompliant|3|||
155377811|NCT00896051|560815773|FG000|Overall Study|Other|1|||
155377812|NCT00896051|560815774|FG001|Overall Study|Other|1|||
155377813|NCT00194987|560815775|FG000|Overall Study|Withdrawal by Subject|0|||
155377814|NCT00194987|560815776|FG001|Overall Study|Withdrawal by Subject|3|||
155377815|NCT01664598|560815777|FG000|Overall Study|Sponsor Decision|1|||
155377816|NCT01664598|560815777|FG000|Overall Study|Withdrawal of Informed Consent|4|||
155377817|NCT01664598|560815777|FG000|Overall Study|Adverse Event|1|||
155377818|NCT02342743|560815778|FG000|Baseline Period|Withdrawal by Subject|3|||
155377819|NCT02342743|560815778|FG000|Baseline Period|Lost to Follow-up|2|||
155377820|NCT02342743|560815778|FG000|Baseline Period|Change in prophylactic medication|3|||
155377821|NCT02342743|560815778|FG000|Baseline Period|Screening failure regarding baseline|7|||
155377822|NCT02342743|560815778|FG000|Treatment Period|Withdrawal by Subject|2|||
155377823|NCT02342743|560815778|FG000|Treatment Period|Lost to Follow-up|8|||
155377824|NCT02342743|560815778|FG000|Treatment Period|Change in prophylactic medication|1|||
155377825|NCT03602066|560815779|FG000|Overall Study|Withdrawal by Subject|2|||
155377826|NCT03602066|560815780|FG001|Overall Study|Withdrawal by Subject|0|||
155377827|NCT03602066|560815779|FG000|Overall Study|Physician Decision|1|||
155377828|NCT03602066|560815780|FG001|Overall Study|Physician Decision|0|||
155377829|NCT00092495|560815781|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
155377830|NCT00092495|560815782|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
155377831|NCT00092495|560815783|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155377832|NCT00092495|560815784|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
155377833|NCT00092495|560815785|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
155377834|NCT00092495|560815781|FG000|Base Study Vaccination Period|Extended|0|||
155377835|NCT00092495|560815782|FG001|Base Study Vaccination Period|Extended|0|||
155377836|NCT00092495|560815783|FG002|Base Study Vaccination Period|Extended|0|||
155377837|NCT00092495|560815784|FG003|Base Study Vaccination Period|Extended|1|||
155377838|NCT00092495|560815785|FG004|Base Study Vaccination Period|Extended|0|||
155377839|NCT00092495|560815781|FG000|Base Study Vaccination Period|*Clinical AE|1|||
155377840|NCT00092495|560815782|FG001|Base Study Vaccination Period|*Clinical AE|0|||
155377841|NCT00092495|560815783|FG002|Base Study Vaccination Period|*Clinical AE|1|||
155377842|NCT00092495|560815784|FG003|Base Study Vaccination Period|*Clinical AE|2|||
155377843|NCT00092495|560815785|FG004|Base Study Vaccination Period|*Clinical AE|0|||
155377844|NCT00092495|560815781|FG000|Base Study Vaccination Period|*Other reasons|1|||
155377845|NCT00092495|560815782|FG001|Base Study Vaccination Period|*Other reasons|0|||
155377846|NCT00092495|560815783|FG002|Base Study Vaccination Period|*Other reasons|0|||
155377847|NCT00092495|560815784|FG003|Base Study Vaccination Period|*Other reasons|1|||
155377848|NCT00092495|560815785|FG004|Base Study Vaccination Period|*Other reasons|0|||
155377849|NCT00092495|560815781|FG000|Base Study Vaccination Period|*Pregnancy|0|||
155377850|NCT00092495|560815782|FG001|Base Study Vaccination Period|*Pregnancy|2|||
155377851|NCT00092495|560815783|FG002|Base Study Vaccination Period|*Pregnancy|5|||
155377852|NCT00092495|560815784|FG003|Base Study Vaccination Period|*Pregnancy|7|||
155377853|NCT00092495|560815785|FG004|Base Study Vaccination Period|*Pregnancy|0|||
155377854|NCT00092495|560815781|FG000|Base Study Vaccination Period|Adverse Event|1|||
155377855|NCT00092495|560815782|FG001|Base Study Vaccination Period|Adverse Event|0|||
155377856|NCT00092495|560815783|FG002|Base Study Vaccination Period|Adverse Event|0|||
155377857|NCT00092495|560815784|FG003|Base Study Vaccination Period|Adverse Event|3|||
155377858|NCT00092495|560815785|FG004|Base Study Vaccination Period|Adverse Event|0|||
155377859|NCT00092495|560815781|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
155377860|NCT00092495|560815782|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
155377861|NCT00092495|560815783|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
155377862|NCT00092495|560815784|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
155377863|NCT00092495|560815785|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155377864|NCT00092495|560815781|FG000|Base Study Vaccination Period|Moved|3|||
155377865|NCT00092495|560815782|FG001|Base Study Vaccination Period|Moved|1|||
155377866|NCT00092495|560815783|FG002|Base Study Vaccination Period|Moved|2|||
155377867|NCT00092495|560815784|FG003|Base Study Vaccination Period|Moved|2|||
155377868|NCT00092495|560815785|FG004|Base Study Vaccination Period|Moved|0|||
155377869|NCT00092495|560815781|FG000|Base Study Vaccination Period|Other|1|||
155377870|NCT00092495|560815782|FG001|Base Study Vaccination Period|Other|1|||
155377871|NCT00092495|560815783|FG002|Base Study Vaccination Period|Other|0|||
155377872|NCT00092495|560815784|FG003|Base Study Vaccination Period|Other|2|||
155377873|NCT00092495|560815785|FG004|Base Study Vaccination Period|Other|0|||
155377874|NCT00092495|560815781|FG000|Base Study Vaccination Period|Pregnancy|2|||
155377875|NCT00092495|560815782|FG001|Base Study Vaccination Period|Pregnancy|0|||
155377876|NCT00092495|560815783|FG002|Base Study Vaccination Period|Pregnancy|0|||
155377877|NCT00092495|560815784|FG003|Base Study Vaccination Period|Pregnancy|0|||
155377878|NCT00092495|560815785|FG004|Base Study Vaccination Period|Pregnancy|0|||
155377879|NCT00092495|560815781|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
155377880|NCT00092495|560815782|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
155377881|NCT00092495|560815783|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
155377882|NCT00092495|560815784|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
155377883|NCT00092495|560815785|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
155377884|NCT00092495|560815781|FG000|Base Study Vaccination Period|Protocol Violation|1|||
155377885|NCT00092495|560815782|FG001|Base Study Vaccination Period|Protocol Violation|0|||
155377886|NCT00092495|560815783|FG002|Base Study Vaccination Period|Protocol Violation|0|||
155377887|NCT00092495|560815784|FG003|Base Study Vaccination Period|Protocol Violation|0|||
155377888|NCT00092495|560815785|FG004|Base Study Vaccination Period|Protocol Violation|0|||
155377889|NCT00092495|560815781|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
155377890|NCT00092495|560815782|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
155377891|NCT00092495|560815783|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
155377892|NCT00092495|560815784|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
155377893|NCT00092495|560815785|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155377894|NCT00092495|560815781|FG000|Base Study Follow-up Period|Extended|0|||
155377895|NCT00092495|560815782|FG001|Base Study Follow-up Period|Extended|0|||
155377896|NCT00092495|560815783|FG002|Base Study Follow-up Period|Extended|1|||
155377897|NCT00092495|560815784|FG003|Base Study Follow-up Period|Extended|2|||
155377898|NCT00092495|560815785|FG004|Base Study Follow-up Period|Extended|0|||
155377899|NCT00092495|560815781|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
155377900|NCT00092495|560815782|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
155377901|NCT00092495|560815783|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
155377902|NCT00092495|560815784|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
155377903|NCT00092495|560815785|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
155377904|NCT00092495|560815781|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
155377905|NCT00092495|560815782|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377906|NCT00092495|560815783|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377907|NCT00092495|560815784|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377908|NCT00092495|560815785|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
155377909|NCT03212989|560815798|FG000|Overall Study|Physician Decision|8|||
155377910|NCT01236534|560815801|FG000|Overall Study|Adverse Event|3|||
155377911|NCT01236534|560815802|FG001|Overall Study|Adverse Event|0|||
155377912|NCT01844687|560815805|FG000|Visit 1|Protocol Violation|3|||
155377913|NCT01844687|560815805|FG000|Visit 1|Lost to Follow-up|5|||
155377914|NCT01844687|560815805|FG000|Visit 2|Withdrawal by Subject|1|||
155377915|NCT01844687|560815805|FG000|Visit 2|Protocol Violation|1|||
155377916|NCT01844687|560815805|FG000|Visit 3|Lost to Follow-up|1|||
155377917|NCT01844687|560815805|FG000|Visit 3|Withdrawal by Subject|3|||
155377918|NCT01844687|560815805|FG000|Visit 3|child care problems|1|||
155377919|NCT01844687|560815805|FG000|Visit 4|Pregnancy|1|||
155377920|NCT01844687|560815805|FG000|Visit 4|Lost to Follow-up|1|||
155377921|NCT01844687|560815805|FG000|Visit 4|Withdrawal by Subject|2|||
155377922|NCT04638920|560815814|FG000|Overall Study|Withdrawal by Subject|5|||
155377923|NCT03775434|560815815|FG000|Overall Study|Adverse Event|2|||
155377924|NCT03775434|560815815|FG000|Overall Study|Withdrawal by Subject|1|||
155377925|NCT01435616|560815816|FG000|Overall Study|Adverse Event|39|||
155377926|NCT01435616|560815817|FG001|Overall Study|Adverse Event|21|||
155377927|NCT01435616|560815816|FG000|Overall Study|Death|7|||
155377928|NCT01435616|560815817|FG001|Overall Study|Death|2|||
155377929|NCT01435616|560815816|FG000|Overall Study|Lost to Follow-up|22|||
155377930|NCT01435616|560815817|FG001|Overall Study|Lost to Follow-up|13|||
155377931|NCT01435616|560815816|FG000|Overall Study|Protocol Violation|16|||
155377932|NCT01435616|560815817|FG001|Overall Study|Protocol Violation|13|||
155377933|NCT01435616|560815816|FG000|Overall Study|Withdrawal by Subject|66|||
155377934|NCT01435616|560815817|FG001|Overall Study|Withdrawal by Subject|24|||
155377935|NCT01435616|560815816|FG000|Overall Study|Physician Decision|20|||
155377936|NCT01435616|560815817|FG001|Overall Study|Physician Decision|7|||
155377937|NCT01435616|560815816|FG000|Overall Study|Sponsor Decision|1|||
155377938|NCT01435616|560815817|FG001|Overall Study|Sponsor Decision|0|||
155377939|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Death|1|||
155377940|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Death|1|||
155377941|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
155377942|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
155377943|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
155377944|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
155377945|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
155377946|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
155377947|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
155377948|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
155377949|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
155377950|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
155377951|NCT00371683|560815818|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
155377952|NCT00371683|560815819|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
155377953|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
155377954|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
155377955|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|Death|0|||
155377956|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|Death|2|||
155377957|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
155377958|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
155377959|NCT00371683|560815818|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
155377960|NCT00371683|560815819|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
154966012|NCT00112437|559298874|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966013|NCT00112437|559298875|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155377961|NCT00438672|560815821|FG000|Overall Study|Lost to Follow-up|7|||
155377962|NCT00438672|560815822|FG001|Overall Study|Lost to Follow-up|9|||
155377963|NCT04540887|560815828|FG000|Overall Study|Withdrawal by Subject|2|||
155377964|NCT01394978|560815834|FG000|Overall Study|Withdrawal by Subject|2|||
155377965|NCT01394978|560815835|FG001|Overall Study|Withdrawal by Subject|4|||
155377966|NCT01394978|560815834|FG000|Overall Study|Lost to Follow-up|13|||
155377967|NCT01394978|560815835|FG001|Overall Study|Lost to Follow-up|20|||
155377968|NCT01394978|560815834|FG000|Overall Study|Death|6|||
155377969|NCT01394978|560815835|FG001|Overall Study|Death|7|||
155377970|NCT03562975|560815836|FG000|Overall Study|Death|1|||
155377971|NCT03562975|560815836|FG000|Overall Study|Lost to Follow-up|1|||
155377972|NCT03562975|560815836|FG000|Overall Study|Withdrawal by Subject|1|||
155377973|NCT00552929|560815837|FG000|Overall Study|Lost to Follow-up|0|||
155377974|NCT00552929|560815838|FG001|Overall Study|Lost to Follow-up|0|||
155377975|NCT00552929|560815839|FG002|Overall Study|Lost to Follow-up|0|||
155377976|NCT00552929|560815840|FG003|Overall Study|Lost to Follow-up|0|||
155377977|NCT00552929|560815841|FG004|Overall Study|Lost to Follow-up|0|||
155377978|NCT00552929|560815842|FG005|Overall Study|Lost to Follow-up|0|||
155377979|NCT00552929|560815843|FG006|Overall Study|Lost to Follow-up|0|||
155377980|NCT00552929|560815844|FG007|Overall Study|Lost to Follow-up|0|||
155377981|NCT00552929|560815845|FG008|Overall Study|Lost to Follow-up|1|||
155377982|NCT00552929|560815846|FG009|Overall Study|Lost to Follow-up|0|||
155377983|NCT00552929|560815837|FG000|Overall Study|Not Eligible|0|||
155377984|NCT00552929|560815838|FG001|Overall Study|Not Eligible|0|||
155377985|NCT00552929|560815839|FG002|Overall Study|Not Eligible|0|||
155377986|NCT00552929|560815840|FG003|Overall Study|Not Eligible|0|||
155377987|NCT00552929|560815841|FG004|Overall Study|Not Eligible|0|||
154966014|NCT00112437|559298876|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155377988|NCT00552929|560815842|FG005|Overall Study|Not Eligible|1|||
155377989|NCT00552929|560815843|FG006|Overall Study|Not Eligible|0|||
155377990|NCT00552929|560815844|FG007|Overall Study|Not Eligible|0|||
155377991|NCT00552929|560815845|FG008|Overall Study|Not Eligible|0|||
155377992|NCT00552929|560815846|FG009|Overall Study|Not Eligible|0|||
155377993|NCT01147536|560815847|FG000|Overall Study|Administrative study close|2|||
155377994|NCT01147536|560815847|FG000|Overall Study|Death|1|||
155377995|NCT02592876|560815850|FG000|Overall Study|Withdrawal by Subject|3|||
155377996|NCT02592876|560815851|FG001|Overall Study|Withdrawal by Subject|3|||
155377997|NCT02592876|560815850|FG000|Overall Study|Study Termination by Sponsor|32|||
155377998|NCT02592876|560815851|FG001|Overall Study|Study Termination by Sponsor|27|||
155377999|NCT02592876|560815850|FG000|Overall Study|Lost to Follow-up|0|||
155378000|NCT02592876|560815851|FG001|Overall Study|Lost to Follow-up|1|||
155378001|NCT02592876|560815850|FG000|Overall Study|Death|6|||
155378002|NCT02592876|560815851|FG001|Overall Study|Death|9|||
155378003|NCT01305200|560815852|FG000|Overall Study|Physician Decision|4|||
155378004|NCT01305200|560815853|FG001|Overall Study|Physician Decision|6|||
155378005|NCT01305200|560815854|FG002|Overall Study|Physician Decision|1|||
155378006|NCT01305200|560815852|FG000|Overall Study|Withdrawal by Subject|24|||
155378007|NCT01305200|560815853|FG001|Overall Study|Withdrawal by Subject|21|||
155378008|NCT01305200|560815854|FG002|Overall Study|Withdrawal by Subject|1|||
155378009|NCT01305200|560815852|FG000|Overall Study|Ineligible|1|||
155378010|NCT01305200|560815853|FG001|Overall Study|Ineligible|2|||
155378011|NCT01305200|560815854|FG002|Overall Study|Ineligible|1|||
155378012|NCT01305200|560815852|FG000|Overall Study|Death|0|||
155378013|NCT01305200|560815853|FG001|Overall Study|Death|2|||
155378014|NCT01305200|560815854|FG002|Overall Study|Death|0|||
155378015|NCT00925353|560815855|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
155378016|NCT03647488|560818170|FG000|Overall Study|Progressive disease|10|||
155378017|NCT03647488|560818171|FG001|Overall Study|Progressive disease|0|||
155378018|NCT03647488|560818172|FG002|Overall Study|Progressive disease|0|||
155378019|NCT03647488|560818170|FG000|Overall Study|Adverse Event|5|||
155378020|NCT03647488|560818171|FG001|Overall Study|Adverse Event|0|||
155378021|NCT03647488|560818172|FG002|Overall Study|Adverse Event|0|||
155378022|NCT03647488|560818170|FG000|Overall Study|Clinical progression|2|||
155378023|NCT03647488|560818171|FG001|Overall Study|Clinical progression|0|||
155378024|NCT03647488|560818172|FG002|Overall Study|Clinical progression|0|||
155378025|NCT03647488|560818170|FG000|Overall Study|Participant refused to take investigational product|1|||
155378026|NCT03647488|560818171|FG001|Overall Study|Participant refused to take investigational product|0|||
155378027|NCT03647488|560818172|FG002|Overall Study|Participant refused to take investigational product|0|||
155378028|NCT00812331|560818173|FG000|Overall Study|Adverse Event|1|||
155378029|NCT00812331|560818174|FG001|Overall Study|Adverse Event|0|||
155378030|NCT00812331|560818175|FG002|Overall Study|Adverse Event|0|||
155378031|NCT00812331|560818176|FG003|Overall Study|Adverse Event|0|||
155378032|NCT00812331|560818177|FG004|Overall Study|Adverse Event|0|||
155378033|NCT00565851|560818178|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
155378034|NCT00565851|560818179|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
155378035|NCT00565851|560818180|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
155378036|NCT00565851|560818181|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
155378037|NCT00565851|560818182|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
155378038|NCT00565851|560818183|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
155378039|NCT00565851|560818184|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
155378040|NCT00565851|560818185|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
155378041|NCT00565851|560818178|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
155378042|NCT00565851|560818179|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
155378043|NCT00565851|560818180|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
155378044|NCT00565851|560818181|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
155378045|NCT00565851|560818182|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
155378046|NCT00565851|560818183|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
155378047|NCT00565851|560818184|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
155378048|NCT00565851|560818185|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
155378049|NCT03694275|560818186|FG000|Overall Study|Adverse Event|0|||
155378050|NCT03694275|560818187|FG001|Overall Study|Adverse Event|1|||
155378051|NCT03694275|560818186|FG000|Overall Study|Reason not Specified|0|||
155378052|NCT03694275|560818187|FG001|Overall Study|Reason not Specified|1|||
155378053|NCT02502799|560818188|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
155378054|NCT02502799|560818189|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
155378055|NCT02502799|560818190|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
155378056|NCT02502799|560818191|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
155378057|NCT02502799|560818188|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
155378058|NCT02502799|560818189|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
155378059|NCT02502799|560818190|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
155378060|NCT02502799|560818191|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
155378061|NCT02502799|560818188|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
155378062|NCT02502799|560818189|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
155378063|NCT02502799|560818190|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
155378064|NCT02502799|560818191|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
155378065|NCT02502799|560818188|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
155378066|NCT02502799|560818189|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
155378067|NCT02502799|560818190|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
155378068|NCT02502799|560818191|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
155378069|NCT02502799|560818188|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
155378070|NCT02502799|560818189|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
155378071|NCT02502799|560818190|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
155378072|NCT02502799|560818191|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
155378073|NCT00153062|560818192|FG000|Overall Study|Death|360|||
155378074|NCT00153062|560818193|FG001|Overall Study|Death|352|||
155378075|NCT00153062|560818194|FG002|Overall Study|Death|369|||
155378076|NCT00153062|560818195|FG003|Overall Study|Death|365|||
155378077|NCT00153062|560818192|FG000|Overall Study|Withdrawal by Subject|14|||
155378078|NCT00153062|560818193|FG001|Overall Study|Withdrawal by Subject|30|||
155378079|NCT00153062|560818194|FG002|Overall Study|Withdrawal by Subject|27|||
155378080|NCT00153062|560818195|FG003|Overall Study|Withdrawal by Subject|28|||
155378081|NCT00153062|560818192|FG000|Overall Study|Lost to Follow-up|12|||
155378082|NCT00153062|560818193|FG001|Overall Study|Lost to Follow-up|20|||
155378083|NCT00153062|560818194|FG002|Overall Study|Lost to Follow-up|15|||
155378084|NCT00153062|560818195|FG003|Overall Study|Lost to Follow-up|16|||
155378085|NCT00153062|560818192|FG000|Overall Study|Adverse Event|0|||
155378086|NCT00153062|560818193|FG001|Overall Study|Adverse Event|1|||
155378087|NCT00153062|560818194|FG002|Overall Study|Adverse Event|1|||
155378088|NCT00153062|560818195|FG003|Overall Study|Adverse Event|0|||
155378089|NCT00153062|560818192|FG000|Overall Study|Protocol Violation|0|||
155378090|NCT00153062|560818193|FG001|Overall Study|Protocol Violation|2|||
155378091|NCT00153062|560818194|FG002|Overall Study|Protocol Violation|1|||
155378092|NCT00153062|560818195|FG003|Overall Study|Protocol Violation|1|||
155378093|NCT00153062|560818192|FG000|Overall Study|No disposition data available|1|||
155378094|NCT00153062|560818193|FG001|Overall Study|No disposition data available|1|||
155378095|NCT00153062|560818194|FG002|Overall Study|No disposition data available|1|||
155378096|NCT00153062|560818195|FG003|Overall Study|No disposition data available|1|||
155378097|NCT00153062|560818192|FG000|Overall Study|Other|0|||
155378098|NCT00153062|560818193|FG001|Overall Study|Other|0|||
155378099|NCT00153062|560818194|FG002|Overall Study|Other|1|||
155378100|NCT00153062|560818195|FG003|Overall Study|Other|0|||
155378101|NCT01589237|560818208|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
155378102|NCT01589237|560818209|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
155378103|NCT01589237|560818210|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
155378104|NCT01589237|560818211|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
155378105|NCT01589237|560818208|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
155378106|NCT01589237|560818209|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
155378107|NCT01589237|560818210|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
155378108|NCT01589237|560818211|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
155378109|NCT01589237|560818208|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
155378110|NCT01589237|560818209|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
155378111|NCT01589237|560818210|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
155378112|NCT01589237|560818211|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
155378113|NCT01589237|560818208|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
155378114|NCT01589237|560818209|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
155378115|NCT01589237|560818210|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
155378116|NCT01589237|560818211|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
155378117|NCT00117845|560818212|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
155091328|NCT02757430|559767544|FG000|Overall Study|No procedure performed|2|||
155091329|NCT03502200|559767545|FG000|Overall Study|Adverse Event|1|||
155378118|NCT01022268|560818213|FG000|Overall Study|Withdrawal by Subject|1|||
155378119|NCT01022268|560818214|FG001|Overall Study|Withdrawal by Subject|0|||
155378120|NCT01022268|560818213|FG000|Overall Study|Withdrawal by Subject|1|||
155378121|NCT01022268|560818214|FG001|Overall Study|Withdrawal by Subject|0|||
155378122|NCT00734097|560818215|FG000|Screening|Protocol Violation|12|||
155378123|NCT00734097|560818215|FG000|Screening|Withdrawal by Subject|5|||
155378124|NCT00734097|560818215|FG000|Screening|Lost to Follow-up|2|||
155378125|NCT00734097|560818215|FG000|Screening|Unconfirmed pregnancy|1|||
155378126|NCT00734097|560818215|FG000|Open Label|Lost to Follow-up|7|||
155091330|NCT03502200|559767546|FG001|Overall Study|Adverse Event|0|||
154966015|NCT00112437|559298877|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
155378127|NCT00734097|560818215|FG000|Open Label|Withdrawal by Subject|5|||
155378128|NCT00734097|560818215|FG000|Open Label|Protocol Violation|4|||
155378129|NCT02233543|560818218|FG000|Period 1|Withdrawal by Subject|1|||
155378130|NCT02233543|560818219|FG001|Period 1|Withdrawal by Subject|0|||
155378131|NCT02233543|560818218|FG000|Period 1|Participants required other treatment.|2|||
155378132|NCT02233543|560818219|FG001|Period 1|Participants required other treatment.|3|||
155378133|NCT02233543|560818218|FG000|Period 2|Adverse Event|1|||
155378134|NCT02233543|560818219|FG001|Period 2|Adverse Event|0|||
155378135|NCT02233543|560818218|FG000|Period 2|Participant required other treatment.|0|||
155378136|NCT02233543|560818219|FG001|Period 2|Participant required other treatment.|1|||
155378137|NCT02233543|560818218|FG000|Period 2|COPD exacerbation|1|||
155378138|NCT02233543|560818219|FG001|Period 2|COPD exacerbation|0|||
155378139|NCT00603304|560818220|FG000|Overall Study|Lost to Follow-up|5|||
155378140|NCT00603304|560818221|FG001|Overall Study|Lost to Follow-up|7|||
155378141|NCT00603304|560818220|FG000|Overall Study|Withdrawal by Subject|8|||
155378142|NCT00603304|560818221|FG001|Overall Study|Withdrawal by Subject|5|||
154966016|NCT00112437|559298878|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966017|NCT00112437|559298879|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966018|NCT00112437|559298880|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966019|NCT00112437|559298881|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966020|NCT00112437|559298882|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966021|NCT00112437|559298883|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966022|NCT00112437|559298884|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966023|NCT00112437|559298885|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
154966024|NCT00112437|559298886|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966025|NCT00112437|559298887|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
154966026|NCT00112437|559298862|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966027|NCT00112437|559298863|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966028|NCT00112437|559298864|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966029|NCT00112437|559298865|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966030|NCT00112437|559298866|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966031|NCT00112437|559298867|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966032|NCT00112437|559298868|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966033|NCT00112437|559298869|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966034|NCT00112437|559298870|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966035|NCT00112437|559298871|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966036|NCT00112437|559298872|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966037|NCT00112437|559298873|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966038|NCT00112437|559298874|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966039|NCT00112437|559298875|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966040|NCT00112437|559298876|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966041|NCT00112437|559298877|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966042|NCT00112437|559298878|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966043|NCT00112437|559298879|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966044|NCT00112437|559298880|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966045|NCT00112437|559298881|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966046|NCT00112437|559298882|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966047|NCT00112437|559298883|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966048|NCT00112437|559298884|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
154966049|NCT00112437|559298885|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
154966050|NCT00112437|559298886|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
154966051|NCT00112437|559298887|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
154966052|NCT03218787|559298893|FG000|Overall Study|Lost to Follow-up|12|||
154966053|NCT03218787|559298893|FG000|Overall Study|Withdrawal by Subject|72|||
154966054|NCT03218787|559298893|FG000|Overall Study|Physician Decision|11|||
154966055|NCT03218787|559298893|FG000|Overall Study|Death|111|||
154966056|NCT00436163|559298894|FG000|Overall Study|Lost to Follow-up|2|||
154966057|NCT00436163|559298894|FG000|Overall Study|Adverse Event|1|||
154966058|NCT03250117|559298896|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
154966059|NCT03250117|559298897|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
154966060|NCT03250117|559298898|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
154966061|NCT03250117|559298899|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
154966062|NCT04063878|559298900|FG000|Overall Study|Withdrawal by Subject|2|||
154966063|NCT04063878|559298900|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
154966064|NCT02751827|559298901|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
154966065|NCT02751827|559298902|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
154966818|NCT00902538|559301138|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
155378143|NCT00603304|560818220|FG000|Overall Study|Protocol Violation|1|||
155378144|NCT00603304|560818221|FG001|Overall Study|Protocol Violation|0|||
155378145|NCT00603304|560818220|FG000|Overall Study|Adverse Event|4|||
155378146|NCT00603304|560818221|FG001|Overall Study|Adverse Event|2|||
155378147|NCT00603304|560818220|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
155378148|NCT00603304|560818221|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
155378149|NCT00603304|560818220|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
155378150|NCT00603304|560818221|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
155378151|NCT00603304|560818220|FG000|Overall Study|Exclusionary Medication|2|||
155378152|NCT00603304|560818221|FG001|Overall Study|Exclusionary Medication|3|||
155378153|NCT00603304|560818220|FG000|Overall Study|Non-Compliant|0|||
155378154|NCT00603304|560818221|FG001|Overall Study|Non-Compliant|1|||
155378155|NCT00603304|560818220|FG000|Overall Study|Moved Away|0|||
155378156|NCT00603304|560818221|FG001|Overall Study|Moved Away|2|||
155378157|NCT00603304|560818220|FG000|Overall Study|Other|2|||
155378158|NCT00603304|560818221|FG001|Overall Study|Other|0|||
155378159|NCT00603304|560818220|FG000|Overall Study|Patient Decision|2|||
155378160|NCT00603304|560818221|FG001|Overall Study|Patient Decision|0|||
155378161|NCT01775475|560818222|FG000|Overall Study|Death|3|||
155378162|NCT01775475|560818223|FG001|Overall Study|Death|3|||
155378163|NCT00007345|560818230|FG000|Overall Study|Refused further treatment|0|||
155378164|NCT00007345|560818231|FG001|Overall Study|Refused further treatment|7|||
155378165|NCT00007345|560818230|FG000|Overall Study|Switched to alternative treatment|0|||
155378166|NCT00007345|560818231|FG001|Overall Study|Switched to alternative treatment|3|||
155378167|NCT00007345|560818230|FG000|Overall Study|Intercurrent illness|1|||
155378168|NCT00007345|560818231|FG001|Overall Study|Intercurrent illness|0|||
155378169|NCT00007345|560818230|FG000|Overall Study|Death on study|1|||
155378170|NCT00007345|560818231|FG001|Overall Study|Death on study|1|||
155378171|NCT04433585|560818232|FG000|Overall Study|Withdrawal by Subject|15|||
155378172|NCT04433585|560818233|FG001|Overall Study|Withdrawal by Subject|3|||
155378173|NCT04433585|560818234|FG002|Overall Study|Withdrawal by Subject|15|||
155378174|NCT04433585|560818235|FG003|Overall Study|Withdrawal by Subject|6|||
155378175|NCT04433585|560818232|FG000|Overall Study|Adverse Event|10|||
155378176|NCT04433585|560818233|FG001|Overall Study|Adverse Event|4|||
155378177|NCT04433585|560818234|FG002|Overall Study|Adverse Event|1|||
155378178|NCT04433585|560818235|FG003|Overall Study|Adverse Event|0|||
155378179|NCT04433585|560818232|FG000|Overall Study|Due to the conflict in Ukraine|2|||
155378180|NCT04433585|560818233|FG001|Overall Study|Due to the conflict in Ukraine|1|||
155378181|NCT04433585|560818234|FG002|Overall Study|Due to the conflict in Ukraine|1|||
155378182|NCT04433585|560818235|FG003|Overall Study|Due to the conflict in Ukraine|2|||
155378183|NCT04433585|560818232|FG000|Overall Study|Physician Decision|1|||
155378184|NCT04433585|560818233|FG001|Overall Study|Physician Decision|2|||
155378185|NCT04433585|560818234|FG002|Overall Study|Physician Decision|0|||
155378186|NCT04433585|560818235|FG003|Overall Study|Physician Decision|0|||
155378187|NCT04433585|560818232|FG000|Overall Study|Lost to Follow-up|1|||
155378188|NCT04433585|560818233|FG001|Overall Study|Lost to Follow-up|1|||
155378189|NCT04433585|560818234|FG002|Overall Study|Lost to Follow-up|1|||
155378190|NCT04433585|560818235|FG003|Overall Study|Lost to Follow-up|0|||
155378191|NCT04433585|560818232|FG000|Overall Study|Lack of Efficacy|0|||
155378192|NCT04433585|560818233|FG001|Overall Study|Lack of Efficacy|1|||
155378193|NCT04433585|560818234|FG002|Overall Study|Lack of Efficacy|1|||
155378194|NCT04433585|560818235|FG003|Overall Study|Lack of Efficacy|1|||
155378195|NCT04433585|560818232|FG000|Overall Study|Death|0|||
155378196|NCT04433585|560818233|FG001|Overall Study|Death|1|||
155378197|NCT04433585|560818234|FG002|Overall Study|Death|0|||
155378198|NCT04433585|560818235|FG003|Overall Study|Death|0|||
155378199|NCT02074553|560818236|FG000|Intervention Period 1|Family Emergency|0|||
155378200|NCT02074553|560818237|FG001|Intervention Period 1|Family Emergency|0|||
155378201|NCT02074553|560818238|FG002|Intervention Period 1|Family Emergency|0|||
155378202|NCT02074553|560818239|FG003|Intervention Period 1|Family Emergency|1|||
155378203|NCT02074553|560818240|FG004|Intervention Period 1|Family Emergency|0|||
155378204|NCT02074553|560818241|FG005|Intervention Period 1|Family Emergency|0|||
155378205|NCT02074553|560818242|FG006|Intervention Period 1|Family Emergency|0|||
155378206|NCT02074553|560818243|FG007|Intervention Period 1|Family Emergency|0|||
155378207|NCT02074553|560818236|FG000|Washout Period 1|Adverse Event|1|||
155378208|NCT02074553|560818237|FG001|Washout Period 1|Adverse Event|0|||
155378209|NCT02074553|560818238|FG002|Washout Period 1|Adverse Event|0|||
155378210|NCT02074553|560818239|FG003|Washout Period 1|Adverse Event|0|||
155378211|NCT02074553|560818240|FG004|Washout Period 1|Adverse Event|0|||
155378212|NCT02074553|560818241|FG005|Washout Period 1|Adverse Event|0|||
155378213|NCT02074553|560818242|FG006|Washout Period 1|Adverse Event|0|||
155378214|NCT02074553|560818243|FG007|Washout Period 1|Adverse Event|0|||
155378215|NCT02074553|560818236|FG000|Washout Period 1|Physician Decision|0|||
155378216|NCT02074553|560818237|FG001|Washout Period 1|Physician Decision|0|||
155378217|NCT02074553|560818238|FG002|Washout Period 1|Physician Decision|0|||
155378218|NCT02074553|560818239|FG003|Washout Period 1|Physician Decision|1|||
155378219|NCT02074553|560818240|FG004|Washout Period 1|Physician Decision|0|||
155378220|NCT02074553|560818241|FG005|Washout Period 1|Physician Decision|0|||
155378221|NCT02074553|560818242|FG006|Washout Period 1|Physician Decision|0|||
155378222|NCT02074553|560818243|FG007|Washout Period 1|Physician Decision|0|||
155378223|NCT02074553|560818236|FG000|Washout Period 1|Other|0|||
155378224|NCT02074553|560818237|FG001|Washout Period 1|Other|0|||
155378225|NCT02074553|560818238|FG002|Washout Period 1|Other|0|||
155378226|NCT02074553|560818239|FG003|Washout Period 1|Other|0|||
155378227|NCT02074553|560818240|FG004|Washout Period 1|Other|0|||
155378228|NCT02074553|560818241|FG005|Washout Period 1|Other|1|||
155378229|NCT02074553|560818242|FG006|Washout Period 1|Other|0|||
155378230|NCT02074553|560818243|FG007|Washout Period 1|Other|0|||
155378231|NCT02074553|560818236|FG000|Washout Period 2|Adverse Event|0|||
155378232|NCT02074553|560818237|FG001|Washout Period 2|Adverse Event|0|||
155378233|NCT02074553|560818238|FG002|Washout Period 2|Adverse Event|0|||
155378234|NCT02074553|560818239|FG003|Washout Period 2|Adverse Event|0|||
155378235|NCT02074553|560818240|FG004|Washout Period 2|Adverse Event|0|||
155378236|NCT02074553|560818241|FG005|Washout Period 2|Adverse Event|0|||
155378237|NCT02074553|560818242|FG006|Washout Period 2|Adverse Event|1|||
155378238|NCT02074553|560818243|FG007|Washout Period 2|Adverse Event|0|||
155378239|NCT02074553|560818236|FG000|Washout Period 2|Physician Decision|0|||
155378240|NCT02074553|560818237|FG001|Washout Period 2|Physician Decision|0|||
155378241|NCT02074553|560818238|FG002|Washout Period 2|Physician Decision|0|||
155378242|NCT02074553|560818239|FG003|Washout Period 2|Physician Decision|0|||
155378243|NCT02074553|560818240|FG004|Washout Period 2|Physician Decision|0|||
155091331|NCT03502200|559767545|FG000|Overall Study|Lost to Follow-up|36|||
155091332|NCT03502200|559767546|FG001|Overall Study|Lost to Follow-up|38|||
155091333|NCT03502200|559767545|FG000|Overall Study|Study Team Decision|1|||
155091334|NCT03502200|559767546|FG001|Overall Study|Study Team Decision|1|||
155091335|NCT03502200|559767545|FG000|Overall Study|Withdrawal by Subject|5|||
155378244|NCT02074553|560818241|FG005|Washout Period 2|Physician Decision|1|||
155378245|NCT02074553|560818242|FG006|Washout Period 2|Physician Decision|0|||
155378246|NCT02074553|560818243|FG007|Washout Period 2|Physician Decision|0|||
155378247|NCT02074553|560818236|FG000|Washout Period 2|Lost to Follow-up|0|||
155378248|NCT02074553|560818237|FG001|Washout Period 2|Lost to Follow-up|0|||
155378249|NCT02074553|560818238|FG002|Washout Period 2|Lost to Follow-up|1|||
155378250|NCT02074553|560818239|FG003|Washout Period 2|Lost to Follow-up|0|||
155378251|NCT02074553|560818240|FG004|Washout Period 2|Lost to Follow-up|0|||
155378252|NCT02074553|560818241|FG005|Washout Period 2|Lost to Follow-up|0|||
155378253|NCT02074553|560818242|FG006|Washout Period 2|Lost to Follow-up|0|||
155378254|NCT02074553|560818243|FG007|Washout Period 2|Lost to Follow-up|0|||
155378255|NCT02074553|560818236|FG000|Washout Period 3|Physician Decision|0|||
155378256|NCT02074553|560818237|FG001|Washout Period 3|Physician Decision|0|||
155378257|NCT02074553|560818238|FG002|Washout Period 3|Physician Decision|0|||
155378258|NCT02074553|560818239|FG003|Washout Period 3|Physician Decision|0|||
155378259|NCT02074553|560818240|FG004|Washout Period 3|Physician Decision|0|||
155378260|NCT02074553|560818241|FG005|Washout Period 3|Physician Decision|0|||
155378261|NCT02074553|560818242|FG006|Washout Period 3|Physician Decision|0|||
155378262|NCT02074553|560818243|FG007|Washout Period 3|Physician Decision|1|||
155378263|NCT00686725|560818244|FG000|Overall Study|Adverse Event|1|||
155378264|NCT00686725|560818245|FG001|Overall Study|Adverse Event|1|||
155378265|NCT00686725|560818244|FG000|Overall Study|Progressive Disease|17|||
155378266|NCT00686725|560818245|FG001|Overall Study|Progressive Disease|23|||
155378267|NCT00686725|560818244|FG000|Overall Study|Lost to Follow-up|7|||
155378268|NCT00686725|560818245|FG001|Overall Study|Lost to Follow-up|5|||
155378269|NCT00686725|560818244|FG000|Overall Study|Death|6|||
155378270|NCT00686725|560818245|FG001|Overall Study|Death|3|||
155378271|NCT00686725|560818244|FG000|Overall Study|Withdrawal by Subject|13|||
155378272|NCT00686725|560818245|FG001|Overall Study|Withdrawal by Subject|4|||
155378273|NCT00686725|560818244|FG000|Overall Study|Protocol Violation|1|||
155378274|NCT00686725|560818245|FG001|Overall Study|Protocol Violation|3|||
155378275|NCT00686725|560818244|FG000|Overall Study|Other|1|||
155378276|NCT00686725|560818245|FG001|Overall Study|Other|3|||
155378277|NCT04875676|560818246|FG000|Overall Study|Lost to Follow-up|1|||
155378278|NCT04875676|560818247|FG001|Overall Study|Lost to Follow-up|0|||
155378279|NCT04875676|560818248|FG002|Overall Study|Lost to Follow-up|0|||
155378280|NCT03103763|560818253|FG000|Overall Study|Death|15|||
155378281|NCT03103763|560818254|FG001|Overall Study|Death|5|||
155378282|NCT03103763|560818255|FG002|Overall Study|Death|5|||
155378283|NCT03103763|560818253|FG000|Overall Study|Withdrawal by Subject|0|||
155378284|NCT03103763|560818254|FG001|Overall Study|Withdrawal by Subject|3|||
155378285|NCT03103763|560818255|FG002|Overall Study|Withdrawal by Subject|2|||
155378286|NCT00938470|560818256|FG000|Overall Study|Disease Progression|3|||
155378287|NCT00938470|560818257|FG001|Overall Study|Disease Progression|0|||
155378288|NCT00938470|560818256|FG000|Overall Study|Alternate Treatment|1|||
155378289|NCT00938470|560818257|FG001|Overall Study|Alternate Treatment|0|||
155378290|NCT00938470|560818256|FG000|Overall Study|Death|3|||
155378291|NCT00938470|560818257|FG001|Overall Study|Death|2|||
155378292|NCT00938470|560818256|FG000|Overall Study|Other Reason|0|||
155378293|NCT00938470|560818257|FG001|Overall Study|Other Reason|1|||
155378294|NCT03245151|560818258|FG000|Overall Study|Withdrawal by Subject|2|||
155378295|NCT03245151|560818259|FG001|Overall Study|Withdrawal by Subject|0|||
155378296|NCT03245151|560818260|FG002|Overall Study|Withdrawal by Subject|0|||
155378297|NCT03245151|560818261|FG003|Overall Study|Withdrawal by Subject|2|||
155378298|NCT03245151|560818262|FG004|Overall Study|Withdrawal by Subject|1|||
155378299|NCT03245151|560818258|FG000|Overall Study|Death|3|||
155378300|NCT03245151|560818259|FG001|Overall Study|Death|14|||
155378301|NCT03245151|560818260|FG002|Overall Study|Death|9|||
155378302|NCT03245151|560818261|FG003|Overall Study|Death|16|||
155378303|NCT03245151|560818262|FG004|Overall Study|Death|7|||
155378304|NCT03245151|560818258|FG000|Overall Study|Sponsor's decision|0|||
155378305|NCT03245151|560818259|FG001|Overall Study|Sponsor's decision|1|||
155378306|NCT03245151|560818260|FG002|Overall Study|Sponsor's decision|0|||
155378307|NCT03245151|560818261|FG003|Overall Study|Sponsor's decision|0|||
155378308|NCT03245151|560818262|FG004|Overall Study|Sponsor's decision|0|||
155378309|NCT01970345|560818263|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
155378310|NCT01970345|560818264|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
155378311|NCT01970345|560818263|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
155378312|NCT01970345|560818264|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
155378313|NCT01346475|560818265|FG000|First Intervention|Lost to Follow-up|4|||
155378314|NCT01346475|560818266|FG001|First Intervention|Lost to Follow-up|3|||
155378315|NCT01552603|560818267|FG000|Overall Study|Physician Decision|1|||
155378316|NCT00618618|560818268|FG000|Overall Study|Patient Request|0|||
155378317|NCT00618618|560818269|FG001|Overall Study|Patient Request|0|||
155378318|NCT00618618|560818270|FG002|Overall Study|Patient Request|2|||
155378319|NCT00618618|560818271|FG003|Overall Study|Patient Request|0|||
155378320|NCT00618618|560818268|FG000|Overall Study|Inability to Complete Study Procedures|0|||
155378321|NCT00618618|560818269|FG001|Overall Study|Inability to Complete Study Procedures|1|||
155378322|NCT00618618|560818270|FG002|Overall Study|Inability to Complete Study Procedures|0|||
155378323|NCT00618618|560818271|FG003|Overall Study|Inability to Complete Study Procedures|0|||
155378324|NCT00618618|560818268|FG000|Overall Study|Lost to Follow-up|3|||
155378325|NCT00618618|560818269|FG001|Overall Study|Lost to Follow-up|0|||
155169346|NCT00530816|560057349|FG002|Overall Study|Withdrawal by Subject|6|||
155169347|NCT01014910|560057350|FG000|Overall Study|Withdrawal by Subject|0|||
155169348|NCT01014910|560057351|FG001|Overall Study|Withdrawal by Subject|2|||
155169349|NCT02445794|560057352|FG000|Overall Study|Adverse Event|0|||
155169350|NCT02445794|560057353|FG001|Overall Study|Adverse Event|0|||
155169351|NCT02445794|560057354|FG002|Overall Study|Adverse Event|2|||
155169352|NCT02445794|560057355|FG003|Overall Study|Adverse Event|0|||
155169353|NCT01136785|560057356|FG000|Overall Study|Protocol Violation|2|||
155169354|NCT01136785|560057357|FG001|Overall Study|Protocol Violation|1|||
155378326|NCT00618618|560818270|FG002|Overall Study|Lost to Follow-up|0|||
155378327|NCT00618618|560818271|FG003|Overall Study|Lost to Follow-up|1|||
155378328|NCT00618618|560818268|FG000|Overall Study|Non-compliance|1|||
155378329|NCT00618618|560818269|FG001|Overall Study|Non-compliance|1|||
155378330|NCT00618618|560818270|FG002|Overall Study|Non-compliance|0|||
155378331|NCT00618618|560818271|FG003|Overall Study|Non-compliance|0|||
155378332|NCT00618618|560818268|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
155378333|NCT00618618|560818269|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
155378334|NCT00618618|560818270|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
155378335|NCT00618618|560818271|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
155378336|NCT00618618|560818268|FG000|Overall Study|Death|0|||
155378337|NCT00618618|560818269|FG001|Overall Study|Death|1|||
155378338|NCT00618618|560818270|FG002|Overall Study|Death|0|||
155378339|NCT00618618|560818271|FG003|Overall Study|Death|0|||
155378340|NCT00621777|560818275|FG000|Open Phase|Adverse Event|20|||
155378341|NCT00621777|560818276|FG001|Open Phase|Adverse Event|0|||
155378342|NCT00621777|560818275|FG000|Open Phase|Did not abstain during open phase|56|||
155378343|NCT00621777|560818276|FG001|Open Phase|Did not abstain during open phase|0|||
155378344|NCT00621777|560818275|FG000|Open Phase|Withdrawal by Subject|17|||
155378345|NCT00621777|560818276|FG001|Open Phase|Withdrawal by Subject|0|||
155378346|NCT00621777|560818275|FG000|Open Phase|administrative|13|||
155378347|NCT00621777|560818276|FG001|Open Phase|administrative|0|||
155378348|NCT00621777|560818275|FG000|Open Phase|Lost to Follow-up|10|||
155378349|NCT00621777|560818276|FG001|Open Phase|Lost to Follow-up|0|||
155378350|NCT00621777|560818275|FG000|Randomized Phase|Adverse Event|3|||
155378351|NCT00621777|560818276|FG001|Randomized Phase|Adverse Event|3|||
155378352|NCT00621777|560818275|FG000|Randomized Phase|Lost to Follow-up|3|||
155378353|NCT00621777|560818276|FG001|Randomized Phase|Lost to Follow-up|3|||
155378354|NCT00621777|560818275|FG000|Randomized Phase|Withdrawal by Subject|1|||
155378355|NCT00621777|560818276|FG001|Randomized Phase|Withdrawal by Subject|9|||
155378356|NCT00621777|560818275|FG000|Randomized Phase|administrative|0|||
155378357|NCT00621777|560818276|FG001|Randomized Phase|administrative|3|||
155378358|NCT00621777|560818275|FG000|Randomized Phase|Death|0|||
155378359|NCT00621777|560818276|FG001|Randomized Phase|Death|1|||
155378360|NCT04797650|560818279|FG000|Overall Study|Reason Not Specified|5|||
155378361|NCT04797650|560818280|FG001|Overall Study|Reason Not Specified|12|||
155378362|NCT04797650|560818281|FG002|Overall Study|Reason Not Specified|5|||
155378363|NCT04797650|560818279|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
155378364|NCT04797650|560818280|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
155378365|NCT04797650|560818281|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
155378366|NCT04797650|560818279|FG000|Overall Study|Lack of Efficacy|1|||
155378367|NCT04797650|560818280|FG001|Overall Study|Lack of Efficacy|0|||
155378368|NCT04797650|560818281|FG002|Overall Study|Lack of Efficacy|1|||
155378369|NCT04797650|560818279|FG000|Overall Study|Non-compliance with Study Drug|0|||
155378370|NCT04797650|560818280|FG001|Overall Study|Non-compliance with Study Drug|0|||
155378371|NCT04797650|560818281|FG002|Overall Study|Non-compliance with Study Drug|2|||
155378372|NCT04797650|560818279|FG000|Overall Study|Lost to Follow-up|4|||
155378373|NCT04797650|560818280|FG001|Overall Study|Lost to Follow-up|6|||
155378374|NCT04797650|560818281|FG002|Overall Study|Lost to Follow-up|1|||
155378375|NCT00309959|560818284|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
155378376|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Death|0|||
155378377|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Death|0|||
155378378|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Death|1|||
155378379|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Death|0|||
155378380|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Death|0|||
155378381|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Death|0|||
155378382|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Death|0|||
155378383|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Death|0|||
155378384|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Death|0|||
155378385|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Death|0|||
155378386|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Death|0|||
155378387|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Death|0|||
155378388|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Death|0|||
155378389|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Death|0|||
155378390|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378391|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378392|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
155169355|NCT01388985|560057358|FG000|Overall Study|Death|0|||
155169356|NCT01388985|560057359|FG001|Overall Study|Death|1|||
154966066|NCT02751827|559298903|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
154966067|NCT01248728|559298904|FG000|Overall Study|Adverse Event|1|||
154966068|NCT01248728|559298905|FG001|Overall Study|Adverse Event|1|||
154966069|NCT01248728|559298904|FG000|Overall Study|Withdrawal by Subject|2|||
154966070|NCT01248728|559298905|FG001|Overall Study|Withdrawal by Subject|1|||
154966071|NCT01248728|559298904|FG000|Overall Study|Lack of Efficacy|1|||
154966072|NCT01248728|559298905|FG001|Overall Study|Lack of Efficacy|0|||
154966073|NCT01841554|559298906|FG000|Overall Study|Death|7|||
154966074|NCT01841554|559298906|FG000|Overall Study|No Implantation|1|||
154966075|NCT01841554|559298906|FG000|Overall Study|Discontinued Follow Up|5|||
154966076|NCT01841554|559298906|FG000|Overall Study|Study exit due to secondary intervention|6|||
154966077|NCT01229150|559298909|FG000|Overall Study|Toxicity|2|||
154966078|NCT01229150|559298910|FG001|Overall Study|Toxicity|2|||
154966079|NCT01229150|559298911|FG002|Overall Study|Toxicity|0|||
154966080|NCT01229150|559298912|FG003|Overall Study|Toxicity|0|||
154966081|NCT00312897|559298913|FG000|Overall Study|Adverse Event|1|||
154966082|NCT00312897|559298914|FG001|Overall Study|Adverse Event|0|||
154966083|NCT00312897|559298913|FG000|Overall Study|Lost to Follow-up|2|||
154966084|NCT00312897|559298914|FG001|Overall Study|Lost to Follow-up|0|||
154966085|NCT00312897|559298913|FG000|Overall Study|Physician Decision|1|||
154966086|NCT00312897|559298914|FG001|Overall Study|Physician Decision|0|||
154966087|NCT00312897|559298913|FG000|Overall Study|Withdrawal by Subject|1|||
154966088|NCT00312897|559298914|FG001|Overall Study|Withdrawal by Subject|3|||
154966089|NCT00312897|559298913|FG000|Overall Study|Pregnancy|1|||
154966090|NCT00312897|559298914|FG001|Overall Study|Pregnancy|0|||
154966091|NCT00312897|559298913|FG000|Overall Study|discontinued prior to getting treatment|0|||
154966092|NCT00312897|559298914|FG001|Overall Study|discontinued prior to getting treatment|3|||
155378393|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378394|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378395|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378396|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378397|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378398|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378399|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378400|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378401|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378402|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378403|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
155378404|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
155378405|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
155378406|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
155378407|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
155378408|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378409|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378410|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378411|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378412|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378413|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378414|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378415|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378416|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378417|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
155378418|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
155378419|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
154966093|NCT04633564|559298915|FG000|Period 1|Adverse Event|28|||
154966094|NCT04633564|559298916|FG001|Period 1|Adverse Event|19|||
154966095|NCT04633564|559298915|FG000|Period 1|Death|8|||
154966096|NCT04633564|559298916|FG001|Period 1|Death|7|||
155169357|NCT01388985|560057358|FG000|Overall Study|Lost to Follow-up|30|||
155378420|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
155378421|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
155378422|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378423|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378424|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378425|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378426|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378427|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378428|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378429|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378430|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378431|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
155378432|NCT02663518|560818285|FG000|Part 1: Phase 1a Escalation|Other|0|||
155378433|NCT02663518|560818286|FG001|Part 1: Phase 1a Escalation|Other|0|||
155378434|NCT02663518|560818287|FG002|Part 1: Phase 1a Escalation|Other|2|||
155378435|NCT02663518|560818288|FG003|Part 1: Phase 1a Escalation|Other|0|||
155378436|NCT02663518|560818289|FG004|Part 1: Phase 1a Escalation|Other|0|||
155378437|NCT02663518|560818290|FG005|Part 1: Phase 1a Escalation|Other|0|||
155378438|NCT02663518|560818291|FG006|Part 1: Phase 1a Escalation|Other|0|||
155378439|NCT02663518|560818292|FG007|Part 1: Phase 1a Escalation|Other|0|||
155378440|NCT02663518|560818293|FG008|Part 1: Phase 1a Escalation|Other|0|||
155378441|NCT02663518|560818294|FG009|Part 1: Phase 1a Escalation|Other|0|||
155378442|NCT02663518|560818295|FG010|Part 1: Phase 1a Escalation|Other|0|||
155378443|NCT02663518|560818296|FG011|Part 1: Phase 1a Escalation|Other|0|||
155378444|NCT02663518|560818297|FG012|Part 1: Phase 1a Escalation|Other|0|||
155378445|NCT02663518|560818298|FG013|Part 1: Phase 1a Escalation|Other|0|||
155378446|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378447|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378448|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378449|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378450|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
155378451|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378452|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
155378453|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
155378454|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378455|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378456|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378457|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378458|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378459|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
155378460|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378461|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378462|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378463|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378464|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
155378465|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378466|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
155378467|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
155378468|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378469|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378470|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378471|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378472|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378473|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
155378474|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378475|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378476|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378477|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378478|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
155378479|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378480|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378481|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378482|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378483|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378484|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378485|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378486|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378487|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
155378488|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378489|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378490|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
154966097|NCT04633564|559298915|FG000|Period 1|Lost to Follow-up|3|||
154966098|NCT04633564|559298916|FG001|Period 1|Lost to Follow-up|5|||
154966099|NCT04633564|559298915|FG000|Period 1|Physician Decision|4|||
154966100|NCT04633564|559298916|FG001|Period 1|Physician Decision|12|||
155091336|NCT03502200|559767546|FG001|Overall Study|Withdrawal by Subject|7|||
154966101|NCT04633564|559298915|FG000|Period 1|Protocol Violation|0|||
154966102|NCT04633564|559298916|FG001|Period 1|Protocol Violation|1|||
154966103|NCT04633564|559298915|FG000|Period 1|Withdrawal by Subject|10|||
154966104|NCT04633564|559298916|FG001|Period 1|Withdrawal by Subject|8|||
155378491|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378492|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
155378493|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
155378494|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
155378495|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
155378496|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378497|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378498|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378499|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378500|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378501|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
155378502|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378503|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378504|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378505|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378506|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
155378507|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378508|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
155378509|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378510|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378511|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378512|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378513|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378514|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378515|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
155378516|NCT02663518|560818285|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378517|NCT02663518|560818286|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378518|NCT02663518|560818287|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378519|NCT02663518|560818288|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378520|NCT02663518|560818289|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378521|NCT02663518|560818290|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378522|NCT02663518|560818291|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
155378523|NCT02663518|560818292|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378524|NCT02663518|560818293|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378525|NCT02663518|560818294|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378526|NCT02663518|560818295|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378527|NCT02663518|560818296|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378528|NCT02663518|560818297|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378529|NCT02663518|560818298|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
155378530|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
155378531|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
155378532|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
155378533|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
155378534|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
155378535|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
155378536|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
155378537|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
155378538|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
155378539|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
155378540|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
155378541|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
155378542|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
155378543|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
155378544|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378545|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378546|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378547|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378548|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378549|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378550|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378551|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378552|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378553|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378554|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378555|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378556|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
155378557|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
155378558|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378559|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378560|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378561|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378562|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378563|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378564|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378565|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378566|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378567|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378568|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378569|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
155169358|NCT01388985|560057359|FG001|Overall Study|Lost to Follow-up|30|||
155378570|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378571|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
155378572|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378573|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378574|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378575|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378576|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378577|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378578|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378579|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378580|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378581|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
155378582|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
155378583|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
155378584|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
155378585|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
155378586|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
155378587|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
155378588|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
155378589|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
155378590|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
155378591|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
155378592|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
155378593|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
155378594|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
155169359|NCT01388985|560057358|FG000|Overall Study|Withdrawal by Subject|13|||
154966105|NCT04633564|559298915|FG000|Period 1|Progressive disease|47|||
155378595|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
155378596|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
155378597|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
155378598|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
155378599|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
155378600|NCT02663518|560818285|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378601|NCT02663518|560818286|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378602|NCT02663518|560818287|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378603|NCT02663518|560818288|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378604|NCT02663518|560818289|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378605|NCT02663518|560818290|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378606|NCT02663518|560818291|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378607|NCT02663518|560818292|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378608|NCT02663518|560818293|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378609|NCT02663518|560818294|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378610|NCT02663518|560818295|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378611|NCT02663518|560818296|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378612|NCT02663518|560818297|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
155378613|NCT02663518|560818298|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
155378614|NCT00006011|560818300|FG000|Overall Study|Disease progression|13|||
155378615|NCT00006011|560818301|FG001|Overall Study|Disease progression|6|||
155378616|NCT00006011|560818302|FG002|Overall Study|Disease progression|26|||
155378617|NCT00006011|560818300|FG000|Overall Study|Refused further treatment|15|||
155378618|NCT00006011|560818301|FG001|Overall Study|Refused further treatment|13|||
155378619|NCT00006011|560818302|FG002|Overall Study|Refused further treatment|26|||
155378620|NCT00006011|560818300|FG000|Overall Study|Adverse Event|15|||
155378621|NCT00006011|560818301|FG001|Overall Study|Adverse Event|39|||
155378622|NCT00006011|560818302|FG002|Overall Study|Adverse Event|5|||
155378623|NCT00006011|560818300|FG000|Overall Study|Death|0|||
155378624|NCT00006011|560818301|FG001|Overall Study|Death|1|||
155378625|NCT00006011|560818302|FG002|Overall Study|Death|2|||
155378626|NCT00006011|560818300|FG000|Overall Study|Other|4|||
155378627|NCT00006011|560818301|FG001|Overall Study|Other|2|||
155378628|NCT00006011|560818302|FG002|Overall Study|Other|5|||
155378629|NCT00006011|560818300|FG000|Overall Study|Ineligible|18|||
155378630|NCT00006011|560818301|FG001|Overall Study|Ineligible|16|||
155378631|NCT00006011|560818302|FG002|Overall Study|Ineligible|9|||
155378632|NCT01097707|560818308|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155378633|NCT01097707|560818309|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
155378634|NCT01097707|560818310|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155378635|NCT01097707|560818311|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155378636|NCT01097707|560818312|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
155378637|NCT01097707|560818308|FG000|Overall Study|Adverse Event|4|||
155378638|NCT01097707|560818309|FG001|Overall Study|Adverse Event|2|||
155378639|NCT01097707|560818310|FG002|Overall Study|Adverse Event|3|||
155378640|NCT01097707|560818311|FG003|Overall Study|Adverse Event|1|||
155378641|NCT01097707|560818312|FG004|Overall Study|Adverse Event|3|||
155378642|NCT01097707|560818308|FG000|Overall Study|Entry Criteria Not Met|2|||
155378643|NCT01097707|560818309|FG001|Overall Study|Entry Criteria Not Met|1|||
155378644|NCT01097707|560818310|FG002|Overall Study|Entry Criteria Not Met|1|||
155378645|NCT01097707|560818311|FG003|Overall Study|Entry Criteria Not Met|0|||
155378646|NCT01097707|560818312|FG004|Overall Study|Entry Criteria Not Met|1|||
155378647|NCT01097707|560818308|FG000|Overall Study|Lack of Efficacy|1|||
155378648|NCT01097707|560818309|FG001|Overall Study|Lack of Efficacy|0|||
155378649|NCT01097707|560818310|FG002|Overall Study|Lack of Efficacy|0|||
155378650|NCT01097707|560818311|FG003|Overall Study|Lack of Efficacy|1|||
155378651|NCT01097707|560818312|FG004|Overall Study|Lack of Efficacy|0|||
155378652|NCT01097707|560818308|FG000|Overall Study|Lost to Follow-up|1|||
155378653|NCT01097707|560818309|FG001|Overall Study|Lost to Follow-up|1|||
155378654|NCT01097707|560818310|FG002|Overall Study|Lost to Follow-up|2|||
155378655|NCT01097707|560818311|FG003|Overall Study|Lost to Follow-up|0|||
155378656|NCT01097707|560818312|FG004|Overall Study|Lost to Follow-up|3|||
155378657|NCT01097707|560818308|FG000|Overall Study|Protocol Violation|2|||
155378658|NCT01097707|560818309|FG001|Overall Study|Protocol Violation|2|||
155378659|NCT01097707|560818310|FG002|Overall Study|Protocol Violation|3|||
155378660|NCT01097707|560818311|FG003|Overall Study|Protocol Violation|2|||
155378661|NCT01097707|560818312|FG004|Overall Study|Protocol Violation|2|||
155378662|NCT01097707|560818308|FG000|Overall Study|Sponsor Decision|31|||
155378663|NCT01097707|560818309|FG001|Overall Study|Sponsor Decision|31|||
155378664|NCT01097707|560818310|FG002|Overall Study|Sponsor Decision|34|||
155378665|NCT01097707|560818311|FG003|Overall Study|Sponsor Decision|35|||
155378666|NCT01097707|560818312|FG004|Overall Study|Sponsor Decision|36|||
155378667|NCT01097707|560818308|FG000|Overall Study|Withdrawal by Subject|3|||
155378668|NCT01097707|560818309|FG001|Overall Study|Withdrawal by Subject|6|||
155378669|NCT01097707|560818310|FG002|Overall Study|Withdrawal by Subject|1|||
155378670|NCT01097707|560818311|FG003|Overall Study|Withdrawal by Subject|4|||
155378671|NCT01097707|560818312|FG004|Overall Study|Withdrawal by Subject|3|||
155378672|NCT01097707|560818308|FG000|Overall Study|Reason unknown|0|||
155378673|NCT01097707|560818309|FG001|Overall Study|Reason unknown|0|||
155378674|NCT01097707|560818310|FG002|Overall Study|Reason unknown|0|||
155378675|NCT01097707|560818311|FG003|Overall Study|Reason unknown|0|||
155378676|NCT01097707|560818312|FG004|Overall Study|Reason unknown|1|||
155378677|NCT00158860|560818319|FG000|Overall Study|Adverse Event|3|||
155378678|NCT00158860|560818320|FG001|Overall Study|Adverse Event|6|||
155378679|NCT00158860|560818319|FG000|Overall Study|Lost to Follow-up|11|||
155378680|NCT00158860|560818320|FG001|Overall Study|Lost to Follow-up|17|||
155378681|NCT00158860|560818319|FG000|Overall Study|Protocol Violation|8|||
155378682|NCT00158860|560818320|FG001|Overall Study|Protocol Violation|23|||
155378683|NCT00158860|560818319|FG000|Overall Study|Withdrawal by Subject|7|||
155378684|NCT00158860|560818320|FG001|Overall Study|Withdrawal by Subject|17|||
155378685|NCT00158860|560818319|FG000|Overall Study|MOVING OUT OF STATE|1|||
155378686|NCT00158860|560818320|FG001|Overall Study|MOVING OUT OF STATE|0|||
155378687|NCT00158860|560818319|FG000|Overall Study|Pregnancy|3|||
155378688|NCT00158860|560818320|FG001|Overall Study|Pregnancy|3|||
155378689|NCT00158860|560818319|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
155378690|NCT00158860|560818320|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
155378691|NCT00158860|560818319|FG000|Overall Study|SPONSOR REQUEST|0|||
155378692|NCT00158860|560818320|FG001|Overall Study|SPONSOR REQUEST|1|||
155378693|NCT00158860|560818319|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
155378694|NCT00158860|560818320|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
155378695|NCT00158860|560818319|FG000|Overall Study|Closed per sponsor|0|||
155378696|NCT00158860|560818320|FG001|Overall Study|Closed per sponsor|1|||
155378697|NCT03047395|560818321|FG000|Overall Study|Adverse Event|142|||
155378698|NCT03047395|560818321|FG000|Overall Study|Withdrawal by Subject|155|||
155378699|NCT03047395|560818321|FG000|Overall Study|Lost to Follow-up|144|||
155378700|NCT03047395|560818321|FG000|Overall Study|COVID-19 Infection|2|||
155378701|NCT03047395|560818321|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
155378702|NCT03047395|560818321|FG000|Overall Study|Other, Not Specified|117|||
155378703|NCT01157676|560818327|FG000|Randomization|Death|1|||
155378704|NCT01157676|560818328|FG001|Randomization|Death|1|||
155378705|NCT01157676|560818327|FG000|Randomization|unresectable|2|||
155378706|NCT01157676|560818328|FG001|Randomization|unresectable|3|||
155378707|NCT01157676|560818327|FG000|Randomization|Withdrawal by Subject|17|||
155378708|NCT01157676|560818328|FG001|Randomization|Withdrawal by Subject|13|||
155378709|NCT01157676|560818327|FG000|Randomization|Physician Decision|1|||
155378710|NCT01157676|560818328|FG001|Randomization|Physician Decision|0|||
155378711|NCT01157676|560818327|FG000|Surgery|underwent open cystectomy|0|||
155378712|NCT01157676|560818328|FG001|Surgery|underwent open cystectomy|4|||
155378713|NCT01157676|560818327|FG000|Surgery|converted to open procedure|0|||
155378714|NCT01157676|560818328|FG001|Surgery|converted to open procedure|5|||
155378715|NCT01157676|560818327|FG000|Surgery|underwent robotic cystectomy|1|||
155378716|NCT01157676|560818328|FG001|Surgery|underwent robotic cystectomy|0|||
155378717|NCT00682890|560818329|FG000|Overall Study|Lost to Follow-up|1|||
155378718|NCT00682890|560818330|FG001|Overall Study|Lost to Follow-up|1|||
155378719|NCT00682890|560818329|FG000|Overall Study|subject moved away|0|||
155378720|NCT00682890|560818330|FG001|Overall Study|subject moved away|1|||
155378721|NCT00682890|560818329|FG000|Overall Study|heavy menstrual bleeding|1|||
155378722|NCT00682890|560818330|FG001|Overall Study|heavy menstrual bleeding|0|||
155378723|NCT02595073|560818333|FG000|Overall Study|Progressive Disease|0|||
155378724|NCT02595073|560818334|FG001|Overall Study|Progressive Disease|1|||
155378725|NCT02595073|560818333|FG000|Overall Study|Protocol Violation|2|||
155378726|NCT02595073|560818334|FG001|Overall Study|Protocol Violation|0|||
155378727|NCT04860297|560818337|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
155378728|NCT04860297|560818338|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
155378729|NCT04860297|560818339|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
155378730|NCT04860297|560818340|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
155378731|NCT04860297|560818341|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
155378732|NCT04860297|560818342|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
155378733|NCT04860297|560818343|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
154966106|NCT04633564|559298916|FG001|Period 1|Progressive disease|51|||
155378734|NCT04860297|560818344|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
155378735|NCT04860297|560818337|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
155378736|NCT04860297|560818338|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
155378737|NCT04860297|560818339|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
154966107|NCT04633564|559298915|FG000|Period 1|Terminated by Sponsor|8|||
155378738|NCT04860297|560818340|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
155378739|NCT04860297|560818341|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
155378740|NCT04860297|560818342|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
155378741|NCT04860297|560818343|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
155378742|NCT04860297|560818344|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
155378743|NCT04860297|560818337|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
155378744|NCT04860297|560818338|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
155378745|NCT04860297|560818339|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
155378746|NCT04860297|560818340|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
155378747|NCT04860297|560818341|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
155378748|NCT04860297|560818342|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
155378749|NCT04860297|560818343|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
155378750|NCT04860297|560818344|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
155378751|NCT04860297|560818337|FG000|Part B (Booster Dose)|Other Than Specified|0|||
155378752|NCT04860297|560818338|FG001|Part B (Booster Dose)|Other Than Specified|0|||
155378753|NCT04860297|560818339|FG002|Part B (Booster Dose)|Other Than Specified|0|||
155378754|NCT04860297|560818340|FG003|Part B (Booster Dose)|Other Than Specified|0|||
155378755|NCT04860297|560818341|FG004|Part B (Booster Dose)|Other Than Specified|0|||
155378756|NCT04860297|560818342|FG005|Part B (Booster Dose)|Other Than Specified|1|||
155378757|NCT04860297|560818343|FG006|Part B (Booster Dose)|Other Than Specified|1|||
155378758|NCT04860297|560818344|FG007|Part B (Booster Dose)|Other Than Specified|0|||
155378759|NCT04860297|560818337|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378760|NCT04860297|560818338|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378761|NCT04860297|560818339|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378762|NCT04860297|560818340|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378763|NCT04860297|560818341|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378764|NCT04860297|560818342|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
155378765|NCT04860297|560818343|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
155378766|NCT04860297|560818344|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
155378767|NCT04860297|560818337|FG000|Part B (Booster Dose)|Death|0|||
155378768|NCT04860297|560818338|FG001|Part B (Booster Dose)|Death|0|||
155378769|NCT04860297|560818339|FG002|Part B (Booster Dose)|Death|0|||
155378770|NCT04860297|560818340|FG003|Part B (Booster Dose)|Death|0|||
155378771|NCT04860297|560818341|FG004|Part B (Booster Dose)|Death|1|||
155378772|NCT04860297|560818342|FG005|Part B (Booster Dose)|Death|2|||
155378773|NCT04860297|560818343|FG006|Part B (Booster Dose)|Death|1|||
155378774|NCT04860297|560818344|FG007|Part B (Booster Dose)|Death|0|||
155378775|NCT04860297|560818337|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
155378776|NCT04860297|560818338|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
155378777|NCT04860297|560818339|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
155378778|NCT04860297|560818340|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
155378779|NCT04860297|560818341|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
155378780|NCT04860297|560818342|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
155378781|NCT04860297|560818343|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
155378782|NCT04860297|560818344|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
155378783|NCT00620282|560818353|FG000|Overall Study|Adverse Event|0|||
155378784|NCT00620282|560818354|FG001|Overall Study|Adverse Event|1|||
155378785|NCT00620282|560818355|FG002|Overall Study|Adverse Event|0|||
155378786|NCT00620282|560818353|FG000|Overall Study|Arterial line unable to be placed|0|||
155378787|NCT00620282|560818354|FG001|Overall Study|Arterial line unable to be placed|0|||
155378788|NCT00620282|560818355|FG002|Overall Study|Arterial line unable to be placed|1|||
155378789|NCT00620282|560818353|FG000|Overall Study|Withdrawal by Subject|0|||
155378790|NCT00620282|560818354|FG001|Overall Study|Withdrawal by Subject|1|||
155378791|NCT00620282|560818355|FG002|Overall Study|Withdrawal by Subject|0|||
155378792|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
155378793|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
155378794|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
155378795|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
155378796|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
155378797|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
155378798|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
155378799|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
155378800|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
155378801|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
155378802|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
155378803|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
155378804|NCT02217475|560818356|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
155378805|NCT02217475|560818357|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
155378806|NCT02217475|560818358|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
154966108|NCT04633564|559298916|FG001|Period 1|Terminated by Sponsor|6|||
154966109|NCT04633564|559298915|FG000|Period 2|Adverse Event|3|||
154966110|NCT04633564|559298916|FG001|Period 2|Adverse Event|4|||
154966111|NCT04633564|559298915|FG000|Period 2|Death|0|||
155378807|NCT02217475|560818356|FG000|Discontinued After Period 1|Adverse Event|1|||
155378808|NCT02217475|560818357|FG001|Discontinued After Period 1|Adverse Event|2|||
155378809|NCT02217475|560818358|FG002|Discontinued After Period 1|Adverse Event|0|||
155378810|NCT02217475|560818356|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
155378811|NCT02217475|560818357|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
155378812|NCT02217475|560818358|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
155378813|NCT02217475|560818356|FG000|Discontinued After Period 1|Physician Decision|0|||
155378814|NCT02217475|560818357|FG001|Discontinued After Period 1|Physician Decision|0|||
155378815|NCT02217475|560818358|FG002|Discontinued After Period 1|Physician Decision|1|||
155378816|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
155378817|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
155378818|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
155378819|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
155378820|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
155378821|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
155378822|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
155378823|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
155378824|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
155378825|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
155378826|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
155378827|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
155378828|NCT02217475|560818356|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
155378829|NCT02217475|560818357|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
155378830|NCT02217475|560818358|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
155378831|NCT04738292|560818363|FG000|Overall Study|Death|1|||
155378832|NCT02971761|560818364|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
155378833|NCT02442336|560818365|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
155378834|NCT02442336|560818365|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
155378835|NCT02442336|560818365|FG000|Overall Study|Lost to Follow-up|11|||
155378836|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
155378837|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
155378838|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
155378839|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
155378840|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
155378841|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
155378842|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
155378843|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
155378844|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
155378845|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
155378846|NCT01237587|560818368|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
155378847|NCT01237587|560818369|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
155378848|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
155378849|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
155378850|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
155378851|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
155378852|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
155378853|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
155378854|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
155378855|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
155378856|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
155378857|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
155378858|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
155378859|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
155378860|NCT01237587|560818368|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
155378861|NCT01237587|560818369|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
155378862|NCT01237587|560818368|FG000|Taper Phase|Adverse Event|0|||
155378863|NCT01237587|560818369|FG001|Taper Phase|Adverse Event|2|||
155378864|NCT01237587|560818368|FG000|Taper Phase|Protocol Violation|2|||
155378865|NCT01237587|560818369|FG001|Taper Phase|Protocol Violation|0|||
155378866|NCT01237587|560818368|FG000|Taper Phase|Lack of Efficacy|2|||
155378867|NCT01237587|560818369|FG001|Taper Phase|Lack of Efficacy|5|||
155378868|NCT01237587|560818368|FG000|Taper Phase|Parent/Guardian Decision|0|||
155378869|NCT01237587|560818369|FG001|Taper Phase|Parent/Guardian Decision|2|||
155378870|NCT01237587|560818368|FG000|Taper Phase|Sponsor Decision|1|||
155378871|NCT01237587|560818369|FG001|Taper Phase|Sponsor Decision|0|||
155378872|NCT01237587|560818368|FG000|Taper Phase|Withdrawal by Subject|0|||
155378873|NCT01237587|560818369|FG001|Taper Phase|Withdrawal by Subject|1|||
155378874|NCT01011387|560818370|FG000|Overall Study|Withdrawal by Subject|3|||
155378875|NCT01011387|560818370|FG000|Overall Study|Adverse Event|2|||
155378876|NCT01011387|560818370|FG000|Overall Study|Protocol Violation|1|||
155378877|NCT01285609|560818371|FG000|Randomized|Progressive Disease|41|||
155378878|NCT01285609|560818372|FG001|Randomized|Progressive Disease|61|||
155378879|NCT01285609|560818371|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
155378880|NCT01285609|560818372|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
155378881|NCT01285609|560818371|FG000|Randomized|Study Drug Toxicity|13|||
155378882|NCT01285609|560818372|FG001|Randomized|Study Drug Toxicity|14|||
155378883|NCT01285609|560818371|FG000|Randomized|Death|5|||
155378884|NCT01285609|560818372|FG001|Randomized|Death|7|||
155378885|NCT01285609|560818371|FG000|Randomized|Withdrawal by Subject|8|||
155378886|NCT01285609|560818372|FG001|Randomized|Withdrawal by Subject|11|||
155378887|NCT01285609|560818371|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
155378888|NCT01285609|560818372|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
155378889|NCT01285609|560818371|FG000|Randomized|Undisclosed Reasons|1|||
155378890|NCT01285609|560818372|FG001|Randomized|Undisclosed Reasons|0|||
155378891|NCT01285609|560818371|FG000|Randomized|Randomized but not Treated|4|||
155378892|NCT01285609|560818372|FG001|Randomized|Randomized but not Treated|4|||
155378893|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
155378894|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
155378895|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
155378896|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
155378897|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
155378898|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
155378899|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
155378900|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
155378901|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Death|11|||
155378902|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Death|3|||
155378903|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
155378904|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
155378905|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Not Reported|0|||
155378906|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Not Reported|2|||
155378907|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
155378908|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
155378909|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
155378910|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
155378911|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
155378912|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
155378913|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
155378914|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
155378915|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
155378916|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
155378917|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
155378918|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
155378919|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
155378920|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
155378921|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
155378922|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
155378923|NCT01285609|560818371|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
155378924|NCT01285609|560818372|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
155378925|NCT01285609|560818371|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
155378926|NCT01285609|560818372|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
155378927|NCT01142115|560818373|FG000|First Intervention|Lack of Efficacy|1|||
155378928|NCT01142115|560818374|FG001|First Intervention|Lack of Efficacy|1|||
155378929|NCT01142115|560818373|FG000|First Intervention|Adverse Event|1|||
155378930|NCT01142115|560818374|FG001|First Intervention|Adverse Event|0|||
155378931|NCT03208036|560818375|FG000|Baseline Assessment|Withdrawal by Subject|1|||
155378932|NCT03208036|560818376|FG001|Baseline Assessment|Withdrawal by Subject|1|||
155378933|NCT03208036|560818375|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
155378934|NCT03208036|560818376|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
155169360|NCT01388985|560057359|FG001|Overall Study|Withdrawal by Subject|4|||
155169361|NCT01388985|560057358|FG000|Overall Study|Subject unavailable|1|||
155378935|NCT03208036|560818375|FG000|Intervention|Withdrawal by Subject|3|||
155378936|NCT03208036|560818376|FG001|Intervention|Withdrawal by Subject|2|||
155378937|NCT03208036|560818375|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
155378938|NCT03208036|560818376|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
155378939|NCT01879553|560818377|FG000|Overall Study|Withdrawal by Subject|1|||
155378940|NCT01879553|560818378|FG001|Overall Study|Withdrawal by Subject|0|||
155378941|NCT02019667|560818379|FG000|First Intervention (6 Months)|Adverse Event|0|||
155378942|NCT02019667|560818380|FG001|First Intervention (6 Months)|Adverse Event|1|||
155378943|NCT02019667|560818379|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
155378944|NCT02019667|560818380|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
155378945|NCT02019667|560818379|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
155378946|NCT02019667|560818380|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
155378947|NCT02432196|560818381|FG000|Overall Study|Exit - did not receive study device|1|||
155378948|NCT02432196|560818381|FG000|Overall Study|Death|2|||
155378949|NCT02432196|560818381|FG000|Overall Study|Reoperation|3|||
155378950|NCT05038163|560818383|FG000|Stage 1|Did not complete survey|374|||
155378951|NCT05038163|560818384|FG001|Stage 1|Did not complete survey|0|||
155378952|NCT05038163|560818385|FG002|Stage 1|Did not complete survey|0|||
155378953|NCT05038163|560818386|FG003|Stage 1|Did not complete survey|0|||
155378954|NCT05038163|560818387|FG004|Stage 1|Did not complete survey|0|||
155378955|NCT05038163|560818388|FG005|Stage 1|Did not complete survey|0|||
155378956|NCT05038163|560818383|FG000|Stage 2|Did not complete Stage 2 survey|0|||
155378957|NCT05038163|560818384|FG001|Stage 2|Did not complete Stage 2 survey|29|||
155378958|NCT05038163|560818385|FG002|Stage 2|Did not complete Stage 2 survey|30|||
155378959|NCT05038163|560818386|FG003|Stage 2|Did not complete Stage 2 survey|24|||
155378960|NCT05038163|560818387|FG004|Stage 2|Did not complete Stage 2 survey|21|||
155378961|NCT05038163|560818388|FG005|Stage 2|Did not complete Stage 2 survey|100|||
155378962|NCT05453201|560818389|FG000|Overall Study|Withdrawal by Subject|1|||
155378963|NCT01934790|560818390|FG000|Treatment|Adverse Event|3|||
155378964|NCT01934790|560818390|FG000|Treatment|Clinical progression|6|||
155378965|NCT01934790|560818390|FG000|Treatment|Radiological progression|4|||
155378966|NCT01934790|560818390|FG000|Treatment|Withdrawal by Subject|2|||
155378967|NCT01934790|560818390|FG000|Treatment|Study drug never administered|1|||
155378968|NCT01934790|560818390|FG000|Active Follow up|Death|20|||
155378969|NCT01934790|560818390|FG000|Active Follow up|Physician Decision|2|||
155378970|NCT01934790|560818390|FG000|Active Follow up|Progressive disease|1|||
155378971|NCT01934790|560818390|FG000|Active Follow up|Other reason|1|||
155378972|NCT00935818|560818391|FG000|Overall Study|Withdrawal by Subject|45|||
155378973|NCT00935818|560818392|FG001|Overall Study|Withdrawal by Subject|50|||
155378974|NCT00935818|560818391|FG000|Overall Study|Lost to Follow-up|40|||
155378975|NCT00935818|560818392|FG001|Overall Study|Lost to Follow-up|42|||
155378976|NCT00935818|560818391|FG000|Overall Study|Adverse Event|6|||
155378977|NCT00935818|560818392|FG001|Overall Study|Adverse Event|7|||
155378978|NCT00935818|560818391|FG000|Overall Study|Physician Decision|0|||
155378979|NCT00935818|560818392|FG001|Overall Study|Physician Decision|1|||
155378980|NCT00867308|560818393|FG000|Overall Study|Death|1|||
155378981|NCT00867308|560818394|FG001|Overall Study|Death|0|||
155378982|NCT00867308|560818393|FG000|Overall Study|Adverse Event|1|||
155378983|NCT00867308|560818394|FG001|Overall Study|Adverse Event|4|||
155378984|NCT00867308|560818393|FG000|Overall Study|Lack of Efficacy|6|||
155378985|NCT00867308|560818394|FG001|Overall Study|Lack of Efficacy|12|||
155378986|NCT00867308|560818393|FG000|Overall Study|Withdrawal by Subject|1|||
155378987|NCT00867308|560818394|FG001|Overall Study|Withdrawal by Subject|2|||
155378988|NCT00604825|560818395|FG000|Overall Study|Adverse Event|2|||
155378989|NCT00604825|560818396|FG001|Overall Study|Adverse Event|6|||
155378990|NCT00604825|560818397|FG002|Overall Study|Adverse Event|7|||
155378991|NCT00604825|560818398|FG003|Overall Study|Adverse Event|4|||
155378992|NCT00604825|560818395|FG000|Overall Study|Lost to Follow-up|0|||
155378993|NCT00604825|560818396|FG001|Overall Study|Lost to Follow-up|3|||
155378994|NCT00604825|560818397|FG002|Overall Study|Lost to Follow-up|1|||
155378995|NCT00604825|560818398|FG003|Overall Study|Lost to Follow-up|0|||
155378996|NCT00604825|560818395|FG000|Overall Study|Protocol Violation|0|||
155378997|NCT00604825|560818396|FG001|Overall Study|Protocol Violation|1|||
155378998|NCT00604825|560818397|FG002|Overall Study|Protocol Violation|0|||
155378999|NCT00604825|560818398|FG003|Overall Study|Protocol Violation|0|||
155379000|NCT00604825|560818395|FG000|Overall Study|Withdrawal by Subject|4|||
155379001|NCT00604825|560818396|FG001|Overall Study|Withdrawal by Subject|3|||
155379002|NCT00604825|560818397|FG002|Overall Study|Withdrawal by Subject|5|||
155379003|NCT00604825|560818398|FG003|Overall Study|Withdrawal by Subject|5|||
155379004|NCT00604825|560818395|FG000|Overall Study|Lack of Efficacy|3|||
155379005|NCT00604825|560818396|FG001|Overall Study|Lack of Efficacy|2|||
155379006|NCT00604825|560818397|FG002|Overall Study|Lack of Efficacy|1|||
155379007|NCT00604825|560818398|FG003|Overall Study|Lack of Efficacy|0|||
155379008|NCT00604825|560818395|FG000|Overall Study|Did not meet eligibility criteria|0|||
155379009|NCT00604825|560818396|FG001|Overall Study|Did not meet eligibility criteria|0|||
155379010|NCT00604825|560818397|FG002|Overall Study|Did not meet eligibility criteria|2|||
155379011|NCT00604825|560818398|FG003|Overall Study|Did not meet eligibility criteria|0|||
155379012|NCT00604825|560818395|FG000|Overall Study|Physician Decision|0|||
155379013|NCT00604825|560818396|FG001|Overall Study|Physician Decision|0|||
155379014|NCT00604825|560818397|FG002|Overall Study|Physician Decision|0|||
155379015|NCT00604825|560818398|FG003|Overall Study|Physician Decision|1|||
155379016|NCT00604825|560818395|FG000|Overall Study|Exclusion criterion met|0|||
155379017|NCT00604825|560818396|FG001|Overall Study|Exclusion criterion met|0|||
155379018|NCT00604825|560818397|FG002|Overall Study|Exclusion criterion met|0|||
155379019|NCT00604825|560818398|FG003|Overall Study|Exclusion criterion met|1|||
155379020|NCT03465904|560818399|FG000|Overall Study|Withdrawal by Subject|9|||
155379021|NCT03465904|560818400|FG001|Overall Study|Withdrawal by Subject|5|||
155379022|NCT03465904|560818399|FG000|Overall Study|Lost to Follow-up|11|||
155379023|NCT03465904|560818400|FG001|Overall Study|Lost to Follow-up|9|||
155379024|NCT03465904|560818399|FG000|Overall Study|Protocol Violation|20|||
155379025|NCT03465904|560818400|FG001|Overall Study|Protocol Violation|15|||
155379026|NCT00616902|560820308|FG000|Overall Study|Termination of study|6|||
155379027|NCT00616902|560820309|FG001|Overall Study|Termination of study|6|||
155379028|NCT03207009|560820310|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
155379029|NCT02924428|560820311|FG000|Overall Study|Adverse Event|1|||
155379030|NCT02924428|560820312|FG001|Overall Study|Adverse Event|0|||
155379031|NCT02924428|560820311|FG000|Overall Study|Physician Decision|1|||
155379032|NCT02924428|560820312|FG001|Overall Study|Physician Decision|0|||
155379033|NCT02924428|560820311|FG000|Overall Study|Lost to Follow-up|2|||
155379034|NCT02924428|560820312|FG001|Overall Study|Lost to Follow-up|4|||
155379035|NCT02924428|560820311|FG000|Overall Study|Pregnancy|0|||
155379036|NCT02924428|560820312|FG001|Overall Study|Pregnancy|1|||
155379037|NCT01877837|560820313|FG000|Overall Study|Lost to Follow-up|1|||
155379038|NCT01877837|560820313|FG000|Overall Study|Ineligible|4|||
155379039|NCT00645801|560820314|FG000|Overall Study|unclear if patient took all the medication.|1|||
155379040|NCT00645801|560820315|FG001|Overall Study|unclear if patient took all the medication.|0|||
155379041|NCT00645801|560820314|FG000|Overall Study|Lost to Follow-up|19|||
155379042|NCT00645801|560820315|FG001|Overall Study|Lost to Follow-up|15|||
155379043|NCT00759915|560820316|FG000|Overall Study|Withdrawal by Subject|1|||
155379044|NCT00759915|560820317|FG001|Overall Study|Withdrawal by Subject|0|||
155379045|NCT00759915|560820316|FG000|Overall Study|Adverse Event|0|||
155379046|NCT00759915|560820317|FG001|Overall Study|Adverse Event|1|||
155379047|NCT00932113|560820320|FG000|Overall Study|Lost to Follow-up|1|||
155379048|NCT00932113|560820321|FG001|Overall Study|Lost to Follow-up|0|||
155379049|NCT01773291|560820324|FG000|Overall Study|Protocol Violation|1|||
155379050|NCT01773291|560820325|FG001|Overall Study|Protocol Violation|0|||
155379051|NCT01773291|560820326|FG002|Overall Study|Protocol Violation|0|||
155379052|NCT01773291|560820324|FG000|Overall Study|Withdrawal by Subject|0|||
155379053|NCT01773291|560820325|FG001|Overall Study|Withdrawal by Subject|0|||
155379054|NCT01773291|560820326|FG002|Overall Study|Withdrawal by Subject|1|||
155379055|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
155379056|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
155379057|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
155379058|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
155379059|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
155379060|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
155379061|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
155379062|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
155379063|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
155379064|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
155379065|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
155379066|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
155379067|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
155379068|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
154966112|NCT04633564|559298916|FG001|Period 2|Death|2|||
154966113|NCT04633564|559298915|FG000|Period 2|Lost to Follow-up|0|||
154966114|NCT04633564|559298916|FG001|Period 2|Lost to Follow-up|1|||
154966115|NCT04633564|559298915|FG000|Period 2|Physician Decision|2|||
154966116|NCT04633564|559298916|FG001|Period 2|Physician Decision|4|||
154966117|NCT04633564|559298915|FG000|Period 2|Withdrawal by Subject|5|||
154966118|NCT04633564|559298916|FG001|Period 2|Withdrawal by Subject|1|||
155379069|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
155379070|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
155379071|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
155379072|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
155379073|NCT02480153|560820327|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
155379074|NCT02480153|560820328|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
154966119|NCT04633564|559298915|FG000|Period 2|Progressive Disease|74|||
154966120|NCT04633564|559298916|FG001|Period 2|Progressive Disease|82|||
155379075|NCT02480153|560820329|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
155379076|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
155379077|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
155379078|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
155379079|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
155379080|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
155379081|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
155379082|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
155379083|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
155379084|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
155379085|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
155379086|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
155379087|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
155379088|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
155379089|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
155379090|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
155379091|NCT02480153|560820327|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
155379092|NCT02480153|560820328|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
155379093|NCT02480153|560820329|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
155379094|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
155379095|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
155379096|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
155379097|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
155379098|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
155379099|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
155379100|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
155379101|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
155379102|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
155379103|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
155379104|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
155379105|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
155379106|NCT02480153|560820327|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
154966121|NCT04633564|559298915|FG000|Period 2|Terminated by Sponsor|9|||
155091337|NCT03502200|559767545|FG000|Overall Study|Death|0|||
155091338|NCT03502200|559767546|FG001|Overall Study|Death|2|||
155091339|NCT03097289|559767548|FG000|Overall Study|Adverse Event|1|||
155091340|NCT03097289|559767548|FG000|Overall Study|Equipment failure|2|||
155379107|NCT02480153|560820328|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
155379108|NCT02480153|560820329|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
155379109|NCT01403610|560820330|FG000|Overall Study|Withdrawal by Subject|2|||
155379110|NCT01403610|560820331|FG001|Overall Study|Withdrawal by Subject|0|||
155379111|NCT01403610|560820332|FG002|Overall Study|Withdrawal by Subject|0|||
155379112|NCT01403610|560820333|FG003|Overall Study|Withdrawal by Subject|0|||
155379113|NCT01403610|560820330|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
155379114|NCT01403610|560820331|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
155379115|NCT01403610|560820332|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
155379116|NCT01403610|560820333|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
155379117|NCT00203476|560820334|FG000|Overall Study|Lost to Follow-up|1|||
155379118|NCT00203476|560820335|FG001|Overall Study|Lost to Follow-up|0|||
155379119|NCT00203476|560820336|FG002|Overall Study|Lost to Follow-up|0|||
155379120|NCT00203476|560820334|FG000|Overall Study|Withdrawal by Subject|0|||
155379121|NCT00203476|560820335|FG001|Overall Study|Withdrawal by Subject|1|||
155379122|NCT00203476|560820336|FG002|Overall Study|Withdrawal by Subject|0|||
155379123|NCT01190514|560820337|FG000|First Intervention (Period 1)|Adverse Event|1|||
155379124|NCT01190514|560820338|FG001|First Intervention (Period 1)|Adverse Event|0|||
155379125|NCT01190514|560820339|FG002|First Intervention (Period 1)|Adverse Event|0|||
155379126|NCT01190514|560820340|FG003|First Intervention (Period 1)|Adverse Event|0|||
155379127|NCT01190514|560820337|FG000|Third Intervention (Period 3)|Adverse Event|1|||
155379128|NCT01190514|560820338|FG001|Third Intervention (Period 3)|Adverse Event|0|||
155379129|NCT01190514|560820339|FG002|Third Intervention (Period 3)|Adverse Event|0|||
155379130|NCT01190514|560820340|FG003|Third Intervention (Period 3)|Adverse Event|0|||
155379131|NCT00512317|560820342|FG000|Overall Study|Insufficient clinical response|36|||
155379132|NCT00512317|560820342|FG000|Overall Study|Withdrawal by Subject|23|||
155379133|NCT00512317|560820342|FG000|Overall Study|Sponsor closure of study|21|||
155379134|NCT00512317|560820342|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
155379135|NCT00512317|560820342|FG000|Overall Study|Adverse Event|13|||
155379136|NCT00512317|560820342|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
155379137|NCT00512317|560820342|FG000|Overall Study|Lost to Follow-up|2|||
155379138|NCT00512317|560820342|FG000|Overall Study|Other|2|||
155379139|NCT01491672|560820343|FG000|Overall Study|Lost to Follow-up|0|||
155379140|NCT01491672|560820344|FG001|Overall Study|Lost to Follow-up|4|||
155379141|NCT01491672|560820345|FG002|Overall Study|Lost to Follow-up|1|||
155379142|NCT01491672|560820343|FG000|Overall Study|Withdrawal by Subject|6|||
155379143|NCT01491672|560820344|FG001|Overall Study|Withdrawal by Subject|7|||
155379144|NCT01491672|560820345|FG002|Overall Study|Withdrawal by Subject|0|||
155379145|NCT01491672|560820343|FG000|Overall Study|Adverse Event|8|||
155379146|NCT01491672|560820344|FG001|Overall Study|Adverse Event|10|||
155379147|NCT01491672|560820345|FG002|Overall Study|Adverse Event|4|||
155379148|NCT01491672|560820343|FG000|Overall Study|Disease progression|42|||
155379149|NCT01491672|560820344|FG001|Overall Study|Disease progression|34|||
155091341|NCT03097289|559767548|FG000|Overall Study|Collected platelet product unusable|3|||
155379150|NCT01491672|560820345|FG002|Overall Study|Disease progression|6|||
155379151|NCT01491672|560820343|FG000|Overall Study|Protocol deviation|0|||
155091342|NCT00049543|559767551|FG000|Overall Study|still on treatment|2|||
155091343|NCT00049543|559767552|FG001|Overall Study|still on treatment|9|||
155379152|NCT01491672|560820344|FG001|Overall Study|Protocol deviation|1|||
155379153|NCT01491672|560820345|FG002|Overall Study|Protocol deviation|0|||
155091344|NCT01656161|559767555|FG000|Overall Study|Death|3|||
155379154|NCT01491672|560820343|FG000|Overall Study|Death|0|||
155379155|NCT01491672|560820344|FG001|Overall Study|Death|4|||
155379156|NCT01491672|560820345|FG002|Overall Study|Death|0|||
155379157|NCT03241225|560820348|FG000|Overall Study|Lost to Follow-up|2|||
155379158|NCT03241225|560820349|FG001|Overall Study|Lost to Follow-up|1|||
155379159|NCT03241225|560820348|FG000|Overall Study|Protocol Violation|4|||
155379160|NCT03241225|560820349|FG001|Overall Study|Protocol Violation|1|||
155379161|NCT03241225|560820348|FG000|Overall Study|Withdrawal by Subject|1|||
155379162|NCT03241225|560820349|FG001|Overall Study|Withdrawal by Subject|0|||
155379163|NCT00852540|560820350|FG000|Overall Study|Adverse Event|10|||
155379164|NCT00852540|560820351|FG001|Overall Study|Adverse Event|3|||
155379165|NCT00852540|560820350|FG000|Overall Study|Lack of Efficacy|15|||
155379166|NCT00852540|560820351|FG001|Overall Study|Lack of Efficacy|3|||
155379167|NCT00852540|560820350|FG000|Overall Study|Protocol Violation|1|||
155379168|NCT00852540|560820351|FG001|Overall Study|Protocol Violation|2|||
155379169|NCT00852540|560820350|FG000|Overall Study|Lost to Follow-up|2|||
155379170|NCT00852540|560820351|FG001|Overall Study|Lost to Follow-up|3|||
155379171|NCT00852540|560820350|FG000|Overall Study|Investigator Discretion|2|||
155379172|NCT00852540|560820351|FG001|Overall Study|Investigator Discretion|3|||
155379173|NCT00852540|560820350|FG000|Overall Study|Withdrawal by Subject|3|||
155379174|NCT00852540|560820351|FG001|Overall Study|Withdrawal by Subject|1|||
155379175|NCT00852540|560820350|FG000|Overall Study|Did Not Receive Study Drug|3|||
155379176|NCT00852540|560820351|FG001|Overall Study|Did Not Receive Study Drug|3|||
155379177|NCT03064035|560820355|FG000|Overall Study|Did not receive allocated intervention|4|||
155379178|NCT03064035|560820356|FG001|Overall Study|Did not receive allocated intervention|2|||
155379179|NCT03064035|560820355|FG000|Overall Study|Lost to Follow-up|1|||
155379180|NCT03064035|560820356|FG001|Overall Study|Lost to Follow-up|1|||
155379181|NCT01253304|560820359|FG000|Overall Study|Adverse Event|0|||
155379182|NCT01253304|560820360|FG001|Overall Study|Adverse Event|0|||
155379183|NCT01253304|560820361|FG002|Overall Study|Adverse Event|0|||
155379184|NCT01253304|560820362|FG003|Overall Study|Adverse Event|1|||
155379185|NCT01004848|560820364|FG000|Overall Study|Lost to Follow-up|55|||
155379186|NCT01004848|560820365|FG001|Overall Study|Lost to Follow-up|45|||
155379187|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
155379188|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379189|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379190|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379191|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379192|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
155379193|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
155379194|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379195|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379196|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379197|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379198|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
155379199|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
155379200|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379201|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379202|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379203|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379204|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
155379205|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
155379206|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379207|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379208|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379209|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379210|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
155379211|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
155379212|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379213|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379214|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379215|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379216|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
155379217|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
155169362|NCT01388985|560057359|FG001|Overall Study|Subject unavailable|1|||
155379218|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379219|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379220|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379221|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379222|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
155379223|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
155379224|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379225|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379226|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379227|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379228|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
155379229|NCT01160289|560820366|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
155379230|NCT01160289|560820367|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379231|NCT01160289|560820368|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379232|NCT01160289|560820369|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379233|NCT01160289|560820370|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379234|NCT01160289|560820371|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
155379235|NCT01160289|560820366|FG000|Post-Randomization Period|Adverse Event|0|||
155379236|NCT01160289|560820367|FG001|Post-Randomization Period|Adverse Event|4|||
155379237|NCT01160289|560820368|FG002|Post-Randomization Period|Adverse Event|4|||
155379238|NCT01160289|560820369|FG003|Post-Randomization Period|Adverse Event|2|||
155379239|NCT01160289|560820370|FG004|Post-Randomization Period|Adverse Event|0|||
155379240|NCT01160289|560820371|FG005|Post-Randomization Period|Adverse Event|0|||
155379241|NCT01160289|560820366|FG000|Post-Randomization Period|Death|0|||
155379242|NCT01160289|560820367|FG001|Post-Randomization Period|Death|0|||
155379243|NCT01160289|560820368|FG002|Post-Randomization Period|Death|0|||
155379244|NCT01160289|560820369|FG003|Post-Randomization Period|Death|1|||
155379245|NCT01160289|560820370|FG004|Post-Randomization Period|Death|0|||
155379246|NCT01160289|560820371|FG005|Post-Randomization Period|Death|0|||
155379247|NCT01160289|560820366|FG000|Post-Randomization Period|Lack of Efficacy|0|||
155379248|NCT01160289|560820367|FG001|Post-Randomization Period|Lack of Efficacy|1|||
155379249|NCT01160289|560820368|FG002|Post-Randomization Period|Lack of Efficacy|0|||
155379250|NCT01160289|560820369|FG003|Post-Randomization Period|Lack of Efficacy|3|||
155379251|NCT01160289|560820370|FG004|Post-Randomization Period|Lack of Efficacy|0|||
155379252|NCT01160289|560820371|FG005|Post-Randomization Period|Lack of Efficacy|0|||
155379253|NCT01160289|560820366|FG000|Post-Randomization Period|Lost to Follow-up|0|||
155379254|NCT01160289|560820367|FG001|Post-Randomization Period|Lost to Follow-up|3|||
155379255|NCT01160289|560820368|FG002|Post-Randomization Period|Lost to Follow-up|2|||
155379256|NCT01160289|560820369|FG003|Post-Randomization Period|Lost to Follow-up|5|||
155379257|NCT01160289|560820370|FG004|Post-Randomization Period|Lost to Follow-up|3|||
155379258|NCT01160289|560820371|FG005|Post-Randomization Period|Lost to Follow-up|4|||
155379259|NCT01160289|560820366|FG000|Post-Randomization Period|Physician Decision|0|||
155379260|NCT01160289|560820367|FG001|Post-Randomization Period|Physician Decision|0|||
155379261|NCT01160289|560820368|FG002|Post-Randomization Period|Physician Decision|1|||
155379262|NCT01160289|560820369|FG003|Post-Randomization Period|Physician Decision|0|||
155379263|NCT01160289|560820370|FG004|Post-Randomization Period|Physician Decision|0|||
155379264|NCT01160289|560820371|FG005|Post-Randomization Period|Physician Decision|0|||
155379265|NCT01160289|560820366|FG000|Post-Randomization Period|Protocol Violation|0|||
155379266|NCT01160289|560820367|FG001|Post-Randomization Period|Protocol Violation|4|||
155379267|NCT01160289|560820368|FG002|Post-Randomization Period|Protocol Violation|2|||
155379268|NCT01160289|560820369|FG003|Post-Randomization Period|Protocol Violation|0|||
155379269|NCT01160289|560820370|FG004|Post-Randomization Period|Protocol Violation|1|||
155379270|NCT01160289|560820371|FG005|Post-Randomization Period|Protocol Violation|3|||
155379271|NCT01160289|560820366|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
155379272|NCT01160289|560820367|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
155379273|NCT01160289|560820368|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
155379274|NCT01160289|560820369|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
155379275|NCT01160289|560820370|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
155379276|NCT01160289|560820371|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
155379277|NCT01160289|560820366|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
155379278|NCT01160289|560820367|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
155379279|NCT01160289|560820368|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
155379280|NCT01160289|560820369|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
155379281|NCT01160289|560820370|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
155379282|NCT01160289|560820371|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
155379283|NCT01160289|560820366|FG000|Post-Randomization Period|Sponsor Decision|0|||
155379284|NCT01160289|560820367|FG001|Post-Randomization Period|Sponsor Decision|1|||
155379285|NCT01160289|560820368|FG002|Post-Randomization Period|Sponsor Decision|0|||
155379286|NCT01160289|560820369|FG003|Post-Randomization Period|Sponsor Decision|0|||
155379287|NCT01160289|560820370|FG004|Post-Randomization Period|Sponsor Decision|0|||
155379288|NCT01160289|560820371|FG005|Post-Randomization Period|Sponsor Decision|0|||
155379289|NCT01156792|560820376|FG000|Overall Study|Adverse Event|1|||
155379290|NCT01156792|560820376|FG000|Overall Study|Lack of Efficacy|36|||
155379291|NCT01156792|560820376|FG000|Overall Study|Protocol Violation|6|||
155379292|NCT01156792|560820376|FG000|Overall Study|Lost to Follow-up|3|||
155379293|NCT01156792|560820376|FG000|Overall Study|Physician Decision|3|||
155379294|NCT01156792|560820376|FG000|Overall Study|Withdrawal by Subject|9|||
155379295|NCT01156792|560820376|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
155379296|NCT00768079|560820377|FG000|Overall Study|Lost to Follow-up|2|||
155379297|NCT00768079|560820378|FG001|Overall Study|Lost to Follow-up|0|||
155379298|NCT00768079|560820379|FG002|Overall Study|Lost to Follow-up|4|||
155379299|NCT00768079|560820377|FG000|Overall Study|Participant incarcerated|0|||
155379300|NCT00768079|560820378|FG001|Overall Study|Participant incarcerated|1|||
155379301|NCT00768079|560820379|FG002|Overall Study|Participant incarcerated|0|||
155379302|NCT00564889|560820382|FG000|Overall Study|Death|7|||
155379303|NCT00564889|560820382|FG000|Overall Study|Adverse Event|12|||
155379304|NCT00564889|560820382|FG000|Overall Study|Alternative treatment|3|||
155379305|NCT00564889|560820382|FG000|Overall Study|Disease progression|3|||
155379306|NCT00564889|560820382|FG000|Overall Study|Other, not specified|4|||
155379307|NCT00141219|560820384|FG000|Overall Study|Protocol violations|5|||
155379308|NCT00141219|560820385|FG001|Overall Study|Protocol violations|4|||
155379309|NCT00141219|560820384|FG000|Overall Study|Adverse Event|8|||
155379310|NCT00141219|560820385|FG001|Overall Study|Adverse Event|6|||
155379311|NCT00141219|560820384|FG000|Overall Study|Lack of Efficacy|5|||
155379312|NCT00141219|560820385|FG001|Overall Study|Lack of Efficacy|4|||
155379313|NCT00141219|560820384|FG000|Overall Study|Withdrawal by Subject|6|||
155379314|NCT00141219|560820385|FG001|Overall Study|Withdrawal by Subject|2|||
155379315|NCT01577745|560820387|FG000|Overall Study|Withdrawal by Subject|0|||
155379316|NCT01577745|560820388|FG001|Overall Study|Withdrawal by Subject|1|||
155379317|NCT01577745|560820389|FG002|Overall Study|Withdrawal by Subject|0|||
155379318|NCT01577745|560820390|FG003|Overall Study|Withdrawal by Subject|3|||
155379319|NCT01577745|560820391|FG004|Overall Study|Withdrawal by Subject|2|||
155379320|NCT01577745|560820392|FG005|Overall Study|Withdrawal by Subject|0|||
155379321|NCT01577745|560820387|FG000|Overall Study|Death|3|||
155379322|NCT01577745|560820388|FG001|Overall Study|Death|2|||
155379323|NCT01577745|560820389|FG002|Overall Study|Death|2|||
155379324|NCT01577745|560820390|FG003|Overall Study|Death|1|||
155379325|NCT01577745|560820391|FG004|Overall Study|Death|1|||
155379326|NCT01577745|560820392|FG005|Overall Study|Death|3|||
155379327|NCT01577745|560820387|FG000|Overall Study|Physician Decision|0|||
155379328|NCT01577745|560820388|FG001|Overall Study|Physician Decision|0|||
155379329|NCT01577745|560820389|FG002|Overall Study|Physician Decision|0|||
155379330|NCT01577745|560820390|FG003|Overall Study|Physician Decision|1|||
155379331|NCT01577745|560820391|FG004|Overall Study|Physician Decision|1|||
155379332|NCT01577745|560820392|FG005|Overall Study|Physician Decision|0|||
155379333|NCT01577745|560820387|FG000|Overall Study|Lost to Follow-up|0|||
155379334|NCT01577745|560820388|FG001|Overall Study|Lost to Follow-up|0|||
155379335|NCT01577745|560820389|FG002|Overall Study|Lost to Follow-up|0|||
155379336|NCT01577745|560820390|FG003|Overall Study|Lost to Follow-up|0|||
155379337|NCT01577745|560820391|FG004|Overall Study|Lost to Follow-up|0|||
155379338|NCT01577745|560820392|FG005|Overall Study|Lost to Follow-up|1|||
155379339|NCT01577745|560820387|FG000|Overall Study|Alternative Therapy|0|||
155379340|NCT01577745|560820388|FG001|Overall Study|Alternative Therapy|0|||
155379341|NCT01577745|560820389|FG002|Overall Study|Alternative Therapy|0|||
155379342|NCT01577745|560820390|FG003|Overall Study|Alternative Therapy|1|||
155379343|NCT01577745|560820391|FG004|Overall Study|Alternative Therapy|1|||
155379344|NCT01577745|560820392|FG005|Overall Study|Alternative Therapy|0|||
155379345|NCT01324440|560820395|FG000|Overall Study|Subject moved|0|||
155379346|NCT01324440|560820396|FG001|Overall Study|Subject moved|1|||
155379347|NCT02884908|560820397|FG000|Overall Study|Lost to Follow-up|13|||
155379348|NCT02884908|560820398|FG001|Overall Study|Lost to Follow-up|18|||
155379349|NCT01801735|560820402|FG000|Overall Study|Adverse Event|79|||
155379350|NCT01801735|560820402|FG000|Overall Study|Lack of Efficacy|28|||
155379351|NCT01801735|560820402|FG000|Overall Study|Withdrawal by Subject|27|||
155379352|NCT01801735|560820402|FG000|Overall Study|Protocol Violation|25|||
155379353|NCT01801735|560820402|FG000|Overall Study|Lost to Follow-up|15|||
155379354|NCT01801735|560820402|FG000|Overall Study|Non-compliance with Trial Drug|13|||
155379355|NCT01801735|560820402|FG000|Overall Study|Physician Decision|3|||
155379356|NCT01801735|560820402|FG000|Overall Study|Death|1|||
155379357|NCT01801735|560820402|FG000|Overall Study|Other, including site closure|19|||
155379358|NCT01293487|560820404|FG000|Overall Study|Lost to Follow-up|0|||
155379359|NCT01293487|560820405|FG001|Overall Study|Lost to Follow-up|0|||
155379360|NCT01293487|560820406|FG002|Overall Study|Lost to Follow-up|0|||
155379361|NCT01293487|560820407|FG003|Overall Study|Lost to Follow-up|1|||
155379362|NCT01293487|560820408|FG004|Overall Study|Lost to Follow-up|0|||
155379363|NCT01293487|560820409|FG005|Overall Study|Lost to Follow-up|0|||
155379364|NCT01293487|560820410|FG006|Overall Study|Lost to Follow-up|0|||
155379365|NCT01293487|560820411|FG007|Overall Study|Lost to Follow-up|0|||
155379366|NCT01293487|560820404|FG000|Overall Study|Withdrawal by Subject|0|||
155379367|NCT01293487|560820405|FG001|Overall Study|Withdrawal by Subject|0|||
155379368|NCT01293487|560820406|FG002|Overall Study|Withdrawal by Subject|0|||
155379369|NCT01293487|560820407|FG003|Overall Study|Withdrawal by Subject|0|||
155379370|NCT01293487|560820408|FG004|Overall Study|Withdrawal by Subject|0|||
155379371|NCT01293487|560820409|FG005|Overall Study|Withdrawal by Subject|0|||
155379372|NCT01293487|560820410|FG006|Overall Study|Withdrawal by Subject|0|||
155379373|NCT01293487|560820411|FG007|Overall Study|Withdrawal by Subject|2|||
155379374|NCT02703259|560820413|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
155379375|NCT02703259|560820414|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
155379376|NCT02703259|560820413|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
155379377|NCT02703259|560820414|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
155379378|NCT02703259|560820413|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
155379379|NCT02703259|560820414|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
155379380|NCT00287690|560820415|FG000|Overall Study|Protocol Violation|20|||
155379381|NCT00287690|560820416|FG001|Overall Study|Protocol Violation|26|||
155379382|NCT01146782|560820417|FG000|Screening Cohort|Screen Failure|187|||
155379383|NCT01146782|560820417|FG000|Screening Cohort|Lost to Follow-up|4|||
155379384|NCT01146782|560820417|FG000|Screening Cohort|Physician Decision|1|||
155379385|NCT01146782|560820417|FG000|Screening Cohort|Withdrawal by Subject|29|||
155379386|NCT01146782|560820417|FG000|Safety Cohort|Screen Failure|61|||
155379387|NCT01146782|560820417|FG000|Safety Cohort|Withdrawal by Subject|4|||
155379388|NCT01146782|560820417|FG000|Safety Cohort|Control AHI <5|4|||
155379389|NCT01146782|560820417|FG000|Safety Cohort|TST <4 hrs|14|||
155379390|NCT01146782|560820417|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
155379391|NCT01146782|560820417|FG000|Primary Endpoint Cohort|Physician Decision|1|||
155379392|NCT02414932|560820418|FG000|Overall Study|Withdrawal by Subject|2|||
155379393|NCT02414932|560820419|FG001|Overall Study|Withdrawal by Subject|3|||
155379394|NCT02414932|560820418|FG000|Overall Study|Adverse Event|1|||
155379395|NCT02414932|560820419|FG001|Overall Study|Adverse Event|0|||
155379396|NCT00470366|560820420|FG000|Overall Study|Adverse Event|3|||
155379397|NCT00470366|560820420|FG000|Overall Study|Poor compliance|1|||
155379398|NCT01021215|560820421|FG000|Overall Study|Lost to Follow-up|3|||
155379399|NCT01021215|560820422|FG001|Overall Study|Lost to Follow-up|0|||
155379400|NCT01688830|560820423|FG000|Overall Study|Lost to Follow-up|0|||
155379401|NCT01688830|560820424|FG001|Overall Study|Lost to Follow-up|0|||
155379402|NCT01688830|560820425|FG002|Overall Study|Lost to Follow-up|0|||
155379403|NCT01688830|560820426|FG003|Overall Study|Lost to Follow-up|0|||
155091345|NCT01656161|559767555|FG000|Overall Study|Adverse Event|2|||
155379404|NCT01688830|560820427|FG004|Overall Study|Lost to Follow-up|0|||
155379405|NCT01688830|560820428|FG005|Overall Study|Lost to Follow-up|0|||
155379406|NCT01688830|560820429|FG006|Overall Study|Lost to Follow-up|0|||
155379407|NCT01688830|560820430|FG007|Overall Study|Lost to Follow-up|0|||
155379408|NCT01688830|560820431|FG008|Overall Study|Lost to Follow-up|0|||
155379409|NCT01688830|560820432|FG009|Overall Study|Lost to Follow-up|0|||
155379410|NCT01688830|560820433|FG010|Overall Study|Lost to Follow-up|1|||
155091346|NCT01656161|559767555|FG000|Overall Study|Protocol Violation|1|||
155379411|NCT01688830|560820434|FG011|Overall Study|Lost to Follow-up|0|||
155379412|NCT01688830|560820435|FG012|Overall Study|Lost to Follow-up|0|||
155091347|NCT01656161|559767555|FG000|Overall Study|Withdrawal by Subject|1|||
155091348|NCT03510273|559767561|FG000|Overall Study|Withdrawal by Subject|2|||
155379413|NCT01688830|560820436|FG013|Overall Study|Lost to Follow-up|0|||
155379414|NCT01688830|560820437|FG014|Overall Study|Lost to Follow-up|0|||
155379415|NCT01688830|560820438|FG015|Overall Study|Lost to Follow-up|0|||
155379416|NCT01688830|560820439|FG016|Overall Study|Lost to Follow-up|0|||
155379417|NCT01688830|560820440|FG017|Overall Study|Lost to Follow-up|0|||
155379418|NCT01688830|560820441|FG018|Overall Study|Lost to Follow-up|0|||
155379419|NCT01688830|560820442|FG019|Overall Study|Lost to Follow-up|0|||
155379420|NCT01688830|560820443|FG020|Overall Study|Lost to Follow-up|0|||
155379421|NCT04822597|560820444|FG000|Overall Study|Withdrawal by Subject|0|||
155379422|NCT04822597|560820445|FG001|Overall Study|Withdrawal by Subject|1|||
155379423|NCT04822597|560820446|FG002|Overall Study|Withdrawal by Subject|1|||
155379424|NCT04822597|560820447|FG003|Overall Study|Withdrawal by Subject|0|||
155379425|NCT04822597|560820444|FG000|Overall Study|Physician Decision|0|||
155379426|NCT04822597|560820445|FG001|Overall Study|Physician Decision|0|||
155379427|NCT04822597|560820446|FG002|Overall Study|Physician Decision|1|||
155379428|NCT04822597|560820447|FG003|Overall Study|Physician Decision|1|||
155379429|NCT04822597|560820444|FG000|Overall Study|Subject withdrawn after enrollment|0|||
155379430|NCT04822597|560820445|FG001|Overall Study|Subject withdrawn after enrollment|1|||
155379431|NCT04822597|560820446|FG002|Overall Study|Subject withdrawn after enrollment|0|||
155379432|NCT04822597|560820447|FG003|Overall Study|Subject withdrawn after enrollment|1|||
155379433|NCT04822597|560820444|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
155379434|NCT04822597|560820445|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
155379435|NCT04822597|560820446|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
155379436|NCT04822597|560820447|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
155379437|NCT00591851|560820448|FG000|Overall Study|Withdrawal by Subject|3|||
155379438|NCT00591851|560820448|FG000|Overall Study|Adverse Event|2|||
155379439|NCT00591851|560820448|FG000|Overall Study|Progressive Disease|1|||
155379440|NCT02217501|560820454|FG000|Overall Study|Death|3|||
155379441|NCT02217501|560820455|FG001|Overall Study|Death|4|||
155379442|NCT01942785|560820459|FG000|Overall Study|Adverse Event|2|||
155379443|NCT01942785|560820459|FG000|Overall Study|Withdrawal by Subject|1|||
155379444|NCT01942785|560820459|FG000|Overall Study|Protocol Violation|1|||
154966122|NCT04633564|559298916|FG001|Period 2|Terminated by Sponsor|3|||
155169363|NCT01388985|560057358|FG000|Overall Study|Other (no reason)|0|||
155169364|NCT01388985|560057359|FG001|Overall Study|Other (no reason)|1|||
155169365|NCT01388985|560057358|FG000|Overall Study|Error of nurse|5|||
155169366|NCT01388985|560057359|FG001|Overall Study|Error of nurse|1|||
154966123|NCT01279486|559298921|FG000|Overall Study|Lost to Follow-up|1|||
155169367|NCT01519167|560057362|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
155169368|NCT01519167|560057363|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
155169369|NCT01519167|560057362|FG000|Overall Study|Adverse Event|0|||
155169370|NCT01519167|560057363|FG001|Overall Study|Adverse Event|1|||
155169371|NCT01519167|560057362|FG000|Overall Study|Lack of Efficacy|0|||
155169372|NCT01519167|560057363|FG001|Overall Study|Lack of Efficacy|1|||
155169373|NCT01519167|560057362|FG000|Overall Study|Medical condition changes&deep sedation|0|||
155169374|NCT01519167|560057363|FG001|Overall Study|Medical condition changes&deep sedation|2|||
155169375|NCT01519167|560057362|FG000|Overall Study|Physician Decision|0|||
155169376|NCT01519167|560057363|FG001|Overall Study|Physician Decision|1|||
154966124|NCT04198363|559298925|FG000|Overall Study|Adverse Event|1|||
154966125|NCT04198363|559298926|FG001|Overall Study|Adverse Event|1|||
154966126|NCT04198363|559298925|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
154966127|NCT04198363|559298926|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
154966128|NCT04198363|559298925|FG000|Overall Study|Reason not Specified|1|||
154966129|NCT04198363|559298926|FG001|Overall Study|Reason not Specified|0|||
154966130|NCT03067987|559298928|FG000|Overall Study|Lost to Follow-up|7|||
154966131|NCT03067987|559298929|FG001|Overall Study|Lost to Follow-up|10|||
154966132|NCT03067987|559298928|FG000|Overall Study|Protocol Violation|1|||
154966133|NCT03067987|559298929|FG001|Overall Study|Protocol Violation|2|||
154966134|NCT03067987|559298928|FG000|Overall Study|Withdrawal by Subject|2|||
154966135|NCT03067987|559298929|FG001|Overall Study|Withdrawal by Subject|1|||
154966136|NCT03500094|559298933|FG000|Overall Study|Withdrawal by Subject|1|||
154966137|NCT03500094|559298933|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
154966138|NCT03500094|559298933|FG000|Overall Study|Lost to Follow-up|1|||
154966139|NCT03506633|559300953|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
154966140|NCT03506633|559300954|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
154966141|NCT02997176|559300955|FG000|Overall Study|Adverse Event|0|||
154966142|NCT02997176|559300956|FG001|Overall Study|Adverse Event|0|||
154966143|NCT02997176|559300957|FG002|Overall Study|Adverse Event|0|||
154966144|NCT02997176|559300958|FG003|Overall Study|Adverse Event|8|||
154966145|NCT02997176|559300955|FG000|Overall Study|Progressive Disease|1|||
154966146|NCT02997176|559300956|FG001|Overall Study|Progressive Disease|0|||
154966147|NCT02997176|559300957|FG002|Overall Study|Progressive Disease|1|||
154966148|NCT02997176|559300958|FG003|Overall Study|Progressive Disease|1|||
154966149|NCT02997176|559300955|FG000|Overall Study|Death|0|||
154966150|NCT02997176|559300956|FG001|Overall Study|Death|0|||
154966151|NCT02997176|559300957|FG002|Overall Study|Death|1|||
154966152|NCT02997176|559300958|FG003|Overall Study|Death|1|||
154966153|NCT02997176|559300955|FG000|Overall Study|Withdrawal by Subject|0|||
154966154|NCT02997176|559300956|FG001|Overall Study|Withdrawal by Subject|2|||
154966155|NCT02997176|559300957|FG002|Overall Study|Withdrawal by Subject|0|||
154966156|NCT02997176|559300958|FG003|Overall Study|Withdrawal by Subject|1|||
154966157|NCT04523480|559300962|FG000|Overall Study|Lost to Follow-up|30|||
154966158|NCT04523480|559300963|FG001|Overall Study|Lost to Follow-up|35|||
154966159|NCT04523480|559300964|FG002|Overall Study|Lost to Follow-up|0|||
154966160|NCT00385736|559300966|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
154966161|NCT00385736|559300967|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
154966162|NCT00385736|559300968|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
154966163|NCT00385736|559300966|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
154966164|NCT00385736|559300967|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
154966165|NCT00385736|559300968|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
154966166|NCT00385736|559300966|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
154966167|NCT00385736|559300967|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
154966168|NCT00385736|559300968|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
154966169|NCT00385736|559300966|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
154966170|NCT00385736|559300967|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
154966171|NCT00385736|559300968|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
154966172|NCT00385736|559300966|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
154966173|NCT00385736|559300967|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
154966174|NCT00385736|559300968|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
154966175|NCT00385736|559300966|FG000|Efficacy Analysis Set - Induction|Other|0|||
154966176|NCT00385736|559300967|FG001|Efficacy Analysis Set - Induction|Other|0|||
154966177|NCT00385736|559300968|FG002|Efficacy Analysis Set - Induction|Other|1|||
154966178|NCT00385736|559300966|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
154966179|NCT00385736|559300967|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
154966180|NCT00385736|559300968|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
154966181|NCT00385736|559300966|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
154966182|NCT00385736|559300967|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
154966183|NCT00385736|559300968|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
154966184|NCT00385736|559300966|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
154966185|NCT00385736|559300967|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
154966186|NCT00385736|559300968|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
154966187|NCT00385736|559300966|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
154966188|NCT00385736|559300967|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
154966189|NCT00385736|559300968|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
154966190|NCT00385736|559300966|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
154966191|NCT00385736|559300967|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
154966192|NCT00385736|559300968|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
154966193|NCT00385736|559300966|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
154966194|NCT00385736|559300967|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
154966195|NCT00385736|559300968|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
154966196|NCT00385736|559300966|FG000|Safety Analysis Set|Adverse Event|23|||
154966197|NCT00385736|559300967|FG001|Safety Analysis Set|Adverse Event|15|||
154966198|NCT00385736|559300968|FG002|Safety Analysis Set|Adverse Event|23|||
154966199|NCT00385736|559300966|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
154966200|NCT00385736|559300967|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
154966201|NCT00385736|559300968|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
154966202|NCT00385736|559300966|FG000|Safety Analysis Set|Lost to Follow-up|0|||
154966203|NCT00385736|559300967|FG001|Safety Analysis Set|Lost to Follow-up|2|||
154966204|NCT00385736|559300968|FG002|Safety Analysis Set|Lost to Follow-up|2|||
154966205|NCT00385736|559300966|FG000|Safety Analysis Set|Lack of Efficacy|38|||
154966206|NCT00385736|559300967|FG001|Safety Analysis Set|Lack of Efficacy|16|||
154966207|NCT00385736|559300968|FG002|Safety Analysis Set|Lack of Efficacy|31|||
154966208|NCT00385736|559300966|FG000|Safety Analysis Set|Protocol Violation|2|||
154966209|NCT00385736|559300967|FG001|Safety Analysis Set|Protocol Violation|1|||
154966210|NCT00385736|559300968|FG002|Safety Analysis Set|Protocol Violation|6|||
154966211|NCT00385736|559300966|FG000|Safety Analysis Set|Other|1|||
154966212|NCT00385736|559300967|FG001|Safety Analysis Set|Other|4|||
154966213|NCT00385736|559300968|FG002|Safety Analysis Set|Other|4|||
154966214|NCT05497557|559300976|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
154966215|NCT05497557|559300977|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
154966216|NCT05497557|559300978|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
154966217|NCT00198133|559300980|FG000|Overall Study|Disease progression|2|||
154966218|NCT00198133|559300981|FG001|Overall Study|Disease progression|5|||
154966219|NCT00198133|559300980|FG000|Overall Study|Adverse Event|1|||
154966220|NCT00198133|559300981|FG001|Overall Study|Adverse Event|3|||
155169377|NCT01516034|560057366|FG000|Overall Study|Physician Decision|1|||
155169378|NCT01516034|560057366|FG000|Overall Study|Lack of Efficacy|7|||
155169379|NCT00870584|560057372|FG000|Overall Study|Adverse Event|3|||
154966221|NCT00198133|559300980|FG000|Overall Study|Withdrawal by Subject|1|||
154966222|NCT00198133|559300981|FG001|Overall Study|Withdrawal by Subject|0|||
154966223|NCT00198133|559300980|FG000|Overall Study|Physician Decision|1|||
154966224|NCT00198133|559300981|FG001|Overall Study|Physician Decision|0|||
154966225|NCT02752074|559300982|FG000|Overall Study|Lost to Follow-up|1|||
154966226|NCT02752074|559300983|FG001|Overall Study|Lost to Follow-up|4|||
154966227|NCT02752074|559300982|FG000|Overall Study|Death|146|||
154966228|NCT02752074|559300983|FG001|Overall Study|Death|129|||
154966229|NCT02752074|559300982|FG000|Overall Study|Withdrawal by Subject|9|||
154966230|NCT02752074|559300983|FG001|Overall Study|Withdrawal by Subject|10|||
154966231|NCT00488774|559300984|FG000|Overall Study|Withdrawal of consent|2|||
154966232|NCT00488774|559300985|FG001|Overall Study|Withdrawal of consent|2|||
154966233|NCT00488774|559300986|FG002|Overall Study|Withdrawal of consent|2|||
154966234|NCT00488774|559300987|FG003|Overall Study|Withdrawal of consent|0|||
154966235|NCT00488774|559300984|FG000|Overall Study|Other|6|||
154966236|NCT00488774|559300985|FG001|Overall Study|Other|3|||
154966237|NCT00488774|559300986|FG002|Overall Study|Other|2|||
154966238|NCT00488774|559300987|FG003|Overall Study|Other|2|||
154966239|NCT00488774|559300984|FG000|Overall Study|Lost to Follow-up|0|||
154966240|NCT00488774|559300985|FG001|Overall Study|Lost to Follow-up|0|||
154966241|NCT00488774|559300986|FG002|Overall Study|Lost to Follow-up|1|||
154966242|NCT00488774|559300987|FG003|Overall Study|Lost to Follow-up|1|||
154966243|NCT05523895|559300988|FG000|Overall Study|Adverse Event|2|||
154966244|NCT05523895|559300989|FG001|Overall Study|Adverse Event|1|||
154966245|NCT05523895|559300990|FG002|Overall Study|Adverse Event|1|||
154966246|NCT05523895|559300988|FG000|Overall Study|Lost to Follow-up|0|||
154966247|NCT05523895|559300989|FG001|Overall Study|Lost to Follow-up|1|||
154966248|NCT05523895|559300990|FG002|Overall Study|Lost to Follow-up|2|||
154966249|NCT05523895|559300988|FG000|Overall Study|Noncompliance with study drug|1|||
154966250|NCT05523895|559300989|FG001|Overall Study|Noncompliance with study drug|1|||
154966251|NCT05523895|559300990|FG002|Overall Study|Noncompliance with study drug|1|||
154966252|NCT05523895|559300988|FG000|Overall Study|Protocol Violation|0|||
154966253|NCT05523895|559300989|FG001|Overall Study|Protocol Violation|2|||
154966254|NCT05523895|559300990|FG002|Overall Study|Protocol Violation|0|||
154966255|NCT05523895|559300988|FG000|Overall Study|Withdrawal by Subject|1|||
154966256|NCT05523895|559300989|FG001|Overall Study|Withdrawal by Subject|3|||
154966257|NCT05523895|559300990|FG002|Overall Study|Withdrawal by Subject|1|||
154966258|NCT05523895|559300988|FG000|Overall Study|Not further specified|0|||
154966259|NCT05523895|559300989|FG001|Overall Study|Not further specified|3|||
154966260|NCT05523895|559300990|FG002|Overall Study|Not further specified|1|||
154966261|NCT01380782|559300991|FG000|Overall Study|Adverse Event|0|||
154966262|NCT01380782|559300992|FG001|Overall Study|Adverse Event|1|||
154966263|NCT01380782|559300993|FG002|Overall Study|Adverse Event|0|||
154966264|NCT01380782|559300994|FG003|Overall Study|Adverse Event|0|||
154966265|NCT01380782|559300991|FG000|Overall Study|Death|1|||
154966266|NCT01380782|559300992|FG001|Overall Study|Death|0|||
154966267|NCT01380782|559300993|FG002|Overall Study|Death|0|||
154966268|NCT01380782|559300994|FG003|Overall Study|Death|0|||
154966269|NCT01380782|559300991|FG000|Overall Study|Lack of Efficacy|10|||
154966270|NCT01380782|559300992|FG001|Overall Study|Lack of Efficacy|9|||
154966271|NCT01380782|559300993|FG002|Overall Study|Lack of Efficacy|10|||
154966272|NCT01380782|559300994|FG003|Overall Study|Lack of Efficacy|3|||
154966273|NCT01380782|559300991|FG000|Overall Study|Physician Decision|1|||
154966274|NCT01380782|559300992|FG001|Overall Study|Physician Decision|0|||
154966275|NCT01380782|559300993|FG002|Overall Study|Physician Decision|0|||
154966276|NCT01380782|559300994|FG003|Overall Study|Physician Decision|0|||
154966277|NCT01380782|559300991|FG000|Overall Study|Withdrawal by Subject|0|||
154966278|NCT01380782|559300992|FG001|Overall Study|Withdrawal by Subject|0|||
154966279|NCT01380782|559300993|FG002|Overall Study|Withdrawal by Subject|1|||
154966280|NCT01380782|559300994|FG003|Overall Study|Withdrawal by Subject|1|||
154966281|NCT01701063|559300995|FG000|Overall Study|Lost to Follow-up|0|||
154966282|NCT01701063|559300996|FG001|Overall Study|Lost to Follow-up|1|||
154966283|NCT01701063|559300997|FG002|Overall Study|Lost to Follow-up|0|||
154966284|NCT01701063|559300995|FG000|Overall Study|Withdrawal by Subject|0|||
154966285|NCT01701063|559300996|FG001|Overall Study|Withdrawal by Subject|0|||
154966286|NCT01701063|559300997|FG002|Overall Study|Withdrawal by Subject|1|||
154966287|NCT01701063|559300995|FG000|Overall Study|Other|0|||
154966288|NCT01701063|559300996|FG001|Overall Study|Other|0|||
154966289|NCT01701063|559300997|FG002|Overall Study|Other|1|||
154966290|NCT01919112|559300998|FG000|Secondary Analysis-day 30|Death|1|||
154966291|NCT01919112|559300999|FG001|Secondary Analysis-day 30|Death|1|||
155169380|NCT00870584|560057373|FG001|Overall Study|Adverse Event|3|||
155169381|NCT00870584|560057372|FG000|Overall Study|Withdrawal by Subject|6|||
154966292|NCT01919112|559301000|FG002|Secondary Analysis-day 30|Death|1|||
154966293|NCT01919112|559300998|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
154966294|NCT01919112|559300999|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
154966295|NCT01919112|559301000|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
154966296|NCT00918645|559301001|FG000|Overall Study|Withdrawal by Subject|1|||
154966297|NCT03446768|559301004|FG000|Overall Study|Withdrawal by Subject|0|||
154966298|NCT03446768|559301005|FG001|Overall Study|Withdrawal by Subject|1|||
154966299|NCT00635648|559301006|FG000|Overall Study|Adverse Event|12|||
154966300|NCT00635648|559301006|FG000|Overall Study|Withdrawal by Subject|9|||
154966301|NCT00635648|559301006|FG000|Overall Study|Physician Decision|4|||
154966302|NCT00635648|559301006|FG000|Overall Study|Rapid progression of baseline disease|4|||
154966303|NCT00635648|559301006|FG000|Overall Study|Use of other antifungal agent needed|1|||
154966304|NCT00635648|559301006|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
154966305|NCT00635648|559301006|FG000|Overall Study|Noncompliance with protocol|1|||
154966306|NCT00635648|559301006|FG000|Overall Study|Other reason|2|||
154966307|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
154966308|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
154966309|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
154966310|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
154966311|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
154966312|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
154966313|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
154966314|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
154966315|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
154966316|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
154966317|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
154966318|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
154966319|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
154966320|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
154966321|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
154966322|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
154966323|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
154966324|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
154966325|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
154966326|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
154966327|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
154966328|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
154966329|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
154966330|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
154966331|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
154966332|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
154966333|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
154966334|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
154966335|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
154966336|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
154966337|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
154966338|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
154966339|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
154966340|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
154966341|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
154966342|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
154966343|NCT04194801|559301007|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
154966344|NCT04194801|559301008|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
154966345|NCT04194801|559301009|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
154966346|NCT04194801|559301007|FG000|Part Ib/II End of Study|Death|2|||
154966347|NCT04194801|559301008|FG001|Part Ib/II End of Study|Death|3|||
154966348|NCT04194801|559301009|FG002|Part Ib/II End of Study|Death|3|||
154966349|NCT04194801|559301007|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
154966350|NCT04194801|559301008|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
154966351|NCT04194801|559301009|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
155091349|NCT03510273|559767561|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
155091350|NCT03510273|559767561|FG000|Overall Study|Moved away from study area|4|||
154966352|NCT04194801|559301007|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
154966353|NCT04194801|559301008|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
154966354|NCT04194801|559301009|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
154966355|NCT04194801|559301007|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
154966356|NCT04194801|559301008|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
154966357|NCT04194801|559301009|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
154966358|NCT04194801|559301007|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
154966359|NCT04194801|559301008|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
154966360|NCT04194801|559301009|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
154966361|NCT03827395|559301013|FG000|Overall Study|Lost to Follow-up|1|||
154966362|NCT03827395|559301014|FG001|Overall Study|Lost to Follow-up|0|||
155091351|NCT00862940|559767562|FG000|Overall Study|Adverse Event|15|||
155091352|NCT00862940|559767563|FG001|Overall Study|Adverse Event|12|||
155091353|NCT00862940|559767562|FG000|Overall Study|Lack of Efficacy|1|||
155091354|NCT00862940|559767563|FG001|Overall Study|Lack of Efficacy|3|||
155091355|NCT00862940|559767562|FG000|Overall Study|Protocol Violation|2|||
155091356|NCT00862940|559767563|FG001|Overall Study|Protocol Violation|5|||
155091357|NCT00862940|559767562|FG000|Overall Study|Withdrawal by Subject|4|||
155091358|NCT00862940|559767563|FG001|Overall Study|Withdrawal by Subject|6|||
155091359|NCT00862940|559767562|FG000|Overall Study|Non-compliance|4|||
155091360|NCT00862940|559767563|FG001|Overall Study|Non-compliance|0|||
155091361|NCT00862940|559767562|FG000|Overall Study|Lost to Follow-up|0|||
154966363|NCT03827395|559301013|FG000|Overall Study|Protocol Violation|1|||
154966364|NCT03827395|559301014|FG001|Overall Study|Protocol Violation|0|||
154966365|NCT03827395|559301013|FG000|Overall Study|Became ineligible after enrollment|1|||
154966366|NCT03827395|559301014|FG001|Overall Study|Became ineligible after enrollment|2|||
154966367|NCT04723693|559301015|FG000|Overall Study|Withdrawal by Subject|2|||
154966368|NCT00294047|559301016|FG000|Month 48|Adverse Event|28|||
154966369|NCT00294047|559301017|FG001|Month 48|Adverse Event|13|||
154966370|NCT00294047|559301016|FG000|Month 48|Protocol Violation|4|||
154966371|NCT00294047|559301017|FG001|Month 48|Protocol Violation|4|||
154966372|NCT00294047|559301016|FG000|Month 48|Withdrawal by Subject|111|||
155091362|NCT00862940|559767563|FG001|Overall Study|Lost to Follow-up|1|||
155091363|NCT00862940|559767562|FG000|Overall Study|Administrative or other reason(s)|4|||
155091364|NCT00862940|559767563|FG001|Overall Study|Administrative or other reason(s)|3|||
155091365|NCT00879398|559767566|FG000|Overall Study|Visit Stop|399|||
155091366|NCT00879398|559767566|FG000|Overall Study|Lack of Efficacy|64|||
155091367|NCT00879398|559767566|FG000|Overall Study|Adverse Event|41|||
155091368|NCT00879398|559767566|FG000|Overall Study|Other Reasons|171|||
155091369|NCT03620981|559767568|FG000|Overall Study|Adverse Event|14|||
155091370|NCT03620981|559767569|FG001|Overall Study|Adverse Event|38|||
155091371|NCT03620981|559767570|FG002|Overall Study|Adverse Event|25|||
155091372|NCT03620981|559767568|FG000|Overall Study|Lack of Efficacy|2|||
155091373|NCT03620981|559767569|FG001|Overall Study|Lack of Efficacy|1|||
155091374|NCT03620981|559767570|FG002|Overall Study|Lack of Efficacy|1|||
155091375|NCT03620981|559767568|FG000|Overall Study|Physician Decision|7|||
155091376|NCT03620981|559767569|FG001|Overall Study|Physician Decision|4|||
155091377|NCT03620981|559767570|FG002|Overall Study|Physician Decision|4|||
155091378|NCT03620981|559767568|FG000|Overall Study|Protocol Violation|1|||
155091379|NCT03620981|559767569|FG001|Overall Study|Protocol Violation|2|||
155091380|NCT03620981|559767570|FG002|Overall Study|Protocol Violation|1|||
155091381|NCT03620981|559767568|FG000|Overall Study|Withdrawal by Legal Representative|2|||
155091382|NCT03620981|559767569|FG001|Overall Study|Withdrawal by Legal Representative|1|||
155091383|NCT03620981|559767570|FG002|Overall Study|Withdrawal by Legal Representative|1|||
155091384|NCT03620981|559767568|FG000|Overall Study|Withdrawal by Care Giver|2|||
155091385|NCT03620981|559767569|FG001|Overall Study|Withdrawal by Care Giver|0|||
155091386|NCT03620981|559767570|FG002|Overall Study|Withdrawal by Care Giver|1|||
155091387|NCT03620981|559767568|FG000|Overall Study|Non-compliance with Study Drug|1|||
155091388|NCT03620981|559767569|FG001|Overall Study|Non-compliance with Study Drug|1|||
154966373|NCT00294047|559301017|FG001|Month 48|Withdrawal by Subject|115|||
155169382|NCT00870584|560057373|FG001|Overall Study|Withdrawal by Subject|7|||
155169383|NCT00870584|560057372|FG000|Overall Study|Lost to Follow-up|5|||
155169384|NCT00870584|560057373|FG001|Overall Study|Lost to Follow-up|1|||
155169385|NCT00870584|560057372|FG000|Overall Study|Protocol Deviation|2|||
155169386|NCT00870584|560057373|FG001|Overall Study|Protocol Deviation|2|||
155169387|NCT01497366|560057374|FG000|Overall Study|Virologic failure|2|||
155169388|NCT01497366|560057375|FG001|Overall Study|Virologic failure|50|||
155169389|NCT01497366|560057374|FG000|Overall Study|Lost to Follow-up|11|||
155169390|NCT01497366|560057375|FG001|Overall Study|Lost to Follow-up|10|||
155169391|NCT01497366|560057374|FG000|Overall Study|Withdrawal by Subject|6|||
155169392|NCT01497366|560057375|FG001|Overall Study|Withdrawal by Subject|6|||
155169393|NCT01497366|560057374|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
154966374|NCT00294047|559301016|FG000|Month 48|Lost to Follow-up|272|||
155169394|NCT01497366|560057375|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
155169395|NCT01497366|560057374|FG000|Overall Study|Other|5|||
155169396|NCT01497366|560057375|FG001|Overall Study|Other|0|||
155169397|NCT01497366|560057374|FG000|Overall Study|Death|1|||
155091389|NCT03620981|559767570|FG002|Overall Study|Non-compliance with Study Drug|0|||
155091390|NCT01994876|559767572|FG000|Test Period 1|Withdrawal by Subject|0|||
155091391|NCT01994876|559767573|FG001|Test Period 1|Withdrawal by Subject|1|||
155091392|NCT01994876|559767572|FG000|Test Period 1|Adverse Event|0|||
155091393|NCT01994876|559767573|FG001|Test Period 1|Adverse Event|1|||
155091394|NCT01994876|559767572|FG000|Test Period 2|Adverse Event|1|||
155091395|NCT01994876|559767573|FG001|Test Period 2|Adverse Event|0|||
155091396|NCT01994876|559767572|FG000|Test Period 2|Protocol Violation|0|||
155091397|NCT01994876|559767573|FG001|Test Period 2|Protocol Violation|1|||
155091398|NCT01346176|559767574|FG000|Recruited|Protocol Violation|1|||
155091399|NCT01346176|559767575|FG001|Recruited|Protocol Violation|0|||
155091400|NCT01346176|559767576|FG002|Recruited|Protocol Violation|0|||
155091401|NCT01346176|559767574|FG000|Completed Advance Directive|Death|3|||
155091402|NCT01346176|559767575|FG001|Completed Advance Directive|Death|2|||
155091403|NCT01346176|559767576|FG002|Completed Advance Directive|Death|2|||
155091404|NCT01346176|559767574|FG000|Completed Advance Directive|Became Ineligible|3|||
155091405|NCT01346176|559767575|FG001|Completed Advance Directive|Became Ineligible|0|||
155091406|NCT01346176|559767576|FG002|Completed Advance Directive|Became Ineligible|1|||
155091407|NCT01346176|559767574|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
155091408|NCT01346176|559767575|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
155091409|NCT01346176|559767576|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
155091410|NCT01346176|559767574|FG000|Completed Satisfaction Survey|Death|3|||
155091411|NCT01346176|559767575|FG001|Completed Satisfaction Survey|Death|0|||
155091412|NCT01346176|559767576|FG002|Completed Satisfaction Survey|Death|2|||
155091413|NCT01346176|559767574|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
155091414|NCT01346176|559767575|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
155091415|NCT01346176|559767576|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
155091416|NCT04522973|559767577|FG000|Overall Study|Lost to Follow-up|4|||
155091417|NCT04522973|559767577|FG000|Overall Study|Could not adhere to study schedule|1|||
155091418|NCT02581930|559767587|FG000|Overall Study|Withdrawal by Subject|1|||
155091419|NCT02581930|559767587|FG000|Overall Study|patient declined further treatment|1|||
155091420|NCT01323192|559769121|FG000|Overall Study|Adverse Event|6|||
155091421|NCT01323192|559769122|FG001|Overall Study|Adverse Event|1|||
155091422|NCT01323192|559769121|FG000|Overall Study|Withdrawal by Subject|3|||
155091423|NCT01323192|559769122|FG001|Overall Study|Withdrawal by Subject|1|||
155091424|NCT01323192|559769121|FG000|Overall Study|Noncompliance with study medication|0|||
155091425|NCT01323192|559769122|FG001|Overall Study|Noncompliance with study medication|3|||
155091426|NCT01323192|559769121|FG000|Overall Study|Nonmedical reasons|0|||
155091427|NCT01323192|559769122|FG001|Overall Study|Nonmedical reasons|1|||
155091428|NCT03698279|559769123|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155091429|NCT03698279|559769124|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155091430|NCT03698279|559769125|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155091431|NCT03698279|559769126|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155091432|NCT03698279|559769127|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155091433|NCT03698279|559769128|FG005|Overall Study|Withdrawal by parent/guardian|0|||
155091434|NCT03698279|559769123|FG000|Overall Study|Protocol deviation|1|||
155091435|NCT03698279|559769124|FG001|Overall Study|Protocol deviation|0|||
155091436|NCT03698279|559769125|FG002|Overall Study|Protocol deviation|1|||
155091437|NCT03698279|559769126|FG003|Overall Study|Protocol deviation|0|||
155091438|NCT03698279|559769127|FG004|Overall Study|Protocol deviation|0|||
155091439|NCT03698279|559769128|FG005|Overall Study|Protocol deviation|0|||
155091440|NCT03698279|559769123|FG000|Overall Study|Withdrawal by Subject|0|||
155091441|NCT03698279|559769124|FG001|Overall Study|Withdrawal by Subject|0|||
155091442|NCT03698279|559769125|FG002|Overall Study|Withdrawal by Subject|1|||
155091443|NCT03698279|559769126|FG003|Overall Study|Withdrawal by Subject|0|||
155091444|NCT03698279|559769127|FG004|Overall Study|Withdrawal by Subject|0|||
155091445|NCT03698279|559769128|FG005|Overall Study|Withdrawal by Subject|0|||
155091446|NCT03698279|559769123|FG000|Overall Study|Lost to Follow-up|3|||
155091447|NCT03698279|559769124|FG001|Overall Study|Lost to Follow-up|1|||
155091448|NCT03698279|559769125|FG002|Overall Study|Lost to Follow-up|4|||
155091449|NCT03698279|559769126|FG003|Overall Study|Lost to Follow-up|5|||
155091450|NCT03698279|559769127|FG004|Overall Study|Lost to Follow-up|0|||
155091451|NCT03698279|559769128|FG005|Overall Study|Lost to Follow-up|0|||
155091452|NCT03728933|559769131|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155091453|NCT03728933|559769132|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155091454|NCT03728933|559769133|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155091455|NCT03728933|559769131|FG000|Overall Study|Withdrawal by Subject|0|||
155091456|NCT03728933|559769132|FG001|Overall Study|Withdrawal by Subject|0|||
155091457|NCT03728933|559769133|FG002|Overall Study|Withdrawal by Subject|1|||
155091458|NCT03728933|559769131|FG000|Overall Study|Lost to Follow-up|0|||
155091459|NCT03728933|559769132|FG001|Overall Study|Lost to Follow-up|1|||
155091460|NCT03728933|559769133|FG002|Overall Study|Lost to Follow-up|0|||
155091461|NCT03728933|559769131|FG000|Overall Study|Adverse Event|1|||
155091462|NCT03728933|559769132|FG001|Overall Study|Adverse Event|0|||
155091463|NCT03728933|559769133|FG002|Overall Study|Adverse Event|0|||
155091464|NCT03674281|559769134|FG000|Overall Study|screen failure|2|||
155091465|NCT03674281|559769135|FG001|Overall Study|screen failure|0|||
155091466|NCT03674281|559769136|FG002|Overall Study|screen failure|0|||
155091467|NCT03674281|559769134|FG000|Overall Study|Withdrawal by Subject|1|||
155091468|NCT03674281|559769135|FG001|Overall Study|Withdrawal by Subject|3|||
155091469|NCT03674281|559769136|FG002|Overall Study|Withdrawal by Subject|3|||
155091470|NCT01441960|559769137|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
155091471|NCT01441960|559769138|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
155091472|NCT01441960|559769137|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
155091473|NCT01441960|559769138|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
155091474|NCT01441960|559769137|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
155091475|NCT01441960|559769138|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
155091476|NCT00276419|559769140|FG000|First Intervention|Adverse Event|1|||
155091477|NCT00276419|559769141|FG001|First Intervention|Adverse Event|0|||
155091478|NCT00276419|559769140|FG000|First Intervention|Withdrawal by Subject|0|||
155091479|NCT00276419|559769141|FG001|First Intervention|Withdrawal by Subject|2|||
155091480|NCT03186638|559769142|FG000|Overall Study|Withdrawal by Subject|4|||
155091481|NCT03186638|559769143|FG001|Overall Study|Withdrawal by Subject|4|||
155091482|NCT03186638|559769142|FG000|Overall Study|Withdrawn due to medical problem|3|||
155091483|NCT03186638|559769143|FG001|Overall Study|Withdrawn due to medical problem|2|||
155091484|NCT03186638|559769142|FG000|Overall Study|Lost to Follow-up|1|||
155091485|NCT03186638|559769143|FG001|Overall Study|Lost to Follow-up|0|||
155091486|NCT03801525|559769144|FG000|Overall Study|Adverse Event|17|||
155091487|NCT03801525|559769145|FG001|Overall Study|Adverse Event|1|||
155091488|NCT03801525|559769146|FG002|Overall Study|Adverse Event|0|||
155091489|NCT03801525|559769144|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
155091490|NCT03801525|559769145|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
155091491|NCT03801525|559769146|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
155091492|NCT03801525|559769144|FG000|Overall Study|Death|29|||
155091493|NCT03801525|559769145|FG001|Overall Study|Death|1|||
155091494|NCT03801525|559769146|FG002|Overall Study|Death|4|||
155091495|NCT03801525|559769144|FG000|Overall Study|Disease Progression|6|||
155169398|NCT01497366|560057375|FG001|Overall Study|Death|1|||
155169399|NCT01497366|560057374|FG000|Overall Study|Randomized but not treated|7|||
155169400|NCT01497366|560057375|FG001|Overall Study|Randomized but not treated|21|||
155169401|NCT02703337|560057376|FG000|Period One (Part A)|Withdrawal by Subject|0|||
155169402|NCT02703337|560057377|FG001|Period One (Part A)|Withdrawal by Subject|0|||
155169403|NCT02703337|560057378|FG002|Period One (Part A)|Withdrawal by Subject|0|||
155169404|NCT02703337|560057379|FG003|Period One (Part A)|Withdrawal by Subject|0|||
155169405|NCT02703337|560057380|FG004|Period One (Part A)|Withdrawal by Subject|1|||
155169406|NCT02703337|560057381|FG005|Period One (Part A)|Withdrawal by Subject|0|||
155169407|NCT02703337|560057382|FG006|Period One (Part A)|Withdrawal by Subject|0|||
155169408|NCT02703337|560057383|FG007|Period One (Part A)|Withdrawal by Subject|0|||
155169409|NCT01888432|560060134|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
155169410|NCT01888432|560060135|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
155169411|NCT01888432|560060134|FG000|12-month Analysis (FAS)|Physician Decision|1|||
155169412|NCT01888432|560060135|FG001|12-month Analysis (FAS)|Physician Decision|1|||
155169413|NCT01888432|560060134|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
155169414|NCT01888432|560060135|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
155169415|NCT01888432|560060134|FG000|12-month Analysis (FAS)|Death|4|||
155169416|NCT01888432|560060135|FG001|12-month Analysis (FAS)|Death|3|||
155169417|NCT01888432|560060134|FG000|24-month Analysis (FAS)|Graft loss|0|||
155169418|NCT01888432|560060135|FG001|24-month Analysis (FAS)|Graft loss|1|||
155169419|NCT01888432|560060134|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
155169420|NCT01888432|560060135|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
155169421|NCT01888432|560060134|FG000|24-month Analysis (FAS)|Physician Decision|2|||
155169422|NCT01888432|560060135|FG001|24-month Analysis (FAS)|Physician Decision|4|||
155169423|NCT01888432|560060134|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
155169424|NCT01888432|560060135|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
155169425|NCT01888432|560060134|FG000|24-month Analysis (FAS)|Death|8|||
155169426|NCT01888432|560060135|FG001|24-month Analysis (FAS)|Death|4|||
155169427|NCT01888432|560060134|FG000|36-month Analysis (Extension)|Death|1|||
155091496|NCT03801525|559769145|FG001|Overall Study|Disease Progression|0|||
155091497|NCT03801525|559769146|FG002|Overall Study|Disease Progression|1|||
154966375|NCT00294047|559301017|FG001|Month 48|Lost to Follow-up|287|||
154966376|NCT00294047|559301016|FG000|Month 48|Other|10|||
155091498|NCT03801525|559769144|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
155169428|NCT01888432|560060135|FG001|36-month Analysis (Extension)|Death|0|||
155169429|NCT03844945|560060136|FG000|Overall Study|Adverse Event|1|||
155169430|NCT03844945|560060137|FG001|Overall Study|Adverse Event|1|||
155169431|NCT03844945|560060138|FG002|Overall Study|Adverse Event|4|||
155169432|NCT03844945|560060139|FG003|Overall Study|Adverse Event|0|||
155169433|NCT03844945|560060136|FG000|Overall Study|Withdrawal by Subject|0|||
155169434|NCT03844945|560060137|FG001|Overall Study|Withdrawal by Subject|0|||
155169435|NCT03844945|560060138|FG002|Overall Study|Withdrawal by Subject|1|||
155169436|NCT03844945|560060139|FG003|Overall Study|Withdrawal by Subject|0|||
155169437|NCT03844945|560060136|FG000|Overall Study|Lack of Efficacy|0|||
155169438|NCT03844945|560060137|FG001|Overall Study|Lack of Efficacy|0|||
155169439|NCT03844945|560060138|FG002|Overall Study|Lack of Efficacy|0|||
155169440|NCT03844945|560060139|FG003|Overall Study|Lack of Efficacy|1|||
155169441|NCT01794338|560060152|FG000|Overall Study|Death|2|||
154966377|NCT00294047|559301017|FG001|Month 48|Other|14|||
155091499|NCT03801525|559769145|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
155091500|NCT03801525|559769146|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
155091501|NCT03801525|559769144|FG000|Overall Study|Investigator Decision|18|||
155091502|NCT03801525|559769145|FG001|Overall Study|Investigator Decision|1|||
155091503|NCT03801525|559769146|FG002|Overall Study|Investigator Decision|0|||
155091504|NCT03801525|559769144|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
155091505|NCT03801525|559769145|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
155091506|NCT03801525|559769146|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
155091507|NCT03801525|559769144|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
155091508|NCT03801525|559769145|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
155091509|NCT03801525|559769146|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
155091510|NCT03801525|559769144|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
155091511|NCT03801525|559769145|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
155091512|NCT03801525|559769146|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
155091513|NCT03801525|559769144|FG000|Overall Study|Withdrawal of Subject Consent|38|||
155091514|NCT03801525|559769145|FG001|Overall Study|Withdrawal of Subject Consent|2|||
155091515|NCT03801525|559769146|FG002|Overall Study|Withdrawal of Subject Consent|1|||
155091516|NCT03801525|559769144|FG000|Overall Study|Reason not Specified|4|||
155091517|NCT03801525|559769145|FG001|Overall Study|Reason not Specified|0|||
155091518|NCT03801525|559769146|FG002|Overall Study|Reason not Specified|4|||
155091519|NCT01263119|559769147|FG000|Period 1|Protocol Violation|2|||
155091520|NCT01263119|559769147|FG000|Period 2|Adverse Event|2|||
155091521|NCT05201807|559769148|FG000|Overall Study|Adverse Event|1|||
155091522|NCT05201807|559769148|FG000|Overall Study|COVID-19 Related|1|||
155091523|NCT01029535|559769154|FG000|Overall Study|Lost to Follow-up|24|||
155091524|NCT01029535|559769154|FG000|Overall Study|Protocol Violation|2|||
155091525|NCT01029535|559769154|FG000|Overall Study|Participant Withdrew Consent|2|||
155091526|NCT01029535|559769154|FG000|Overall Study|Adverse Event|1|||
155091527|NCT01029535|559769154|FG000|Overall Study|Use of Another Treatment|1|||
155091528|NCT01029535|559769154|FG000|Overall Study|Death|1|||
155091529|NCT02862574|559769155|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155091530|NCT02862574|559769156|FG001|Double-Blind Treatment Period|Adverse Event|1|||
155091531|NCT02862574|559769157|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155091532|NCT02862574|559769155|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
155169442|NCT01794338|560060153|FG001|Overall Study|Death|0|||
155091533|NCT02862574|559769156|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
155091534|NCT02862574|559769157|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
155091535|NCT02862574|559769155|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
155091536|NCT02862574|559769156|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
155091537|NCT02862574|559769157|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
155091538|NCT00419744|559769172|FG000|Overall Study|Adverse Event|39|||
155091539|NCT00419744|559769173|FG001|Overall Study|Adverse Event|40|||
154966378|NCT00294047|559301016|FG000|Month 84|Adverse Event|4|||
154966379|NCT00294047|559301017|FG001|Month 84|Adverse Event|2|||
155091540|NCT00419744|559769174|FG002|Overall Study|Adverse Event|50|||
155091541|NCT00419744|559769172|FG000|Overall Study|Withdrawal by Subject|45|||
155091542|NCT00419744|559769173|FG001|Overall Study|Withdrawal by Subject|49|||
155091543|NCT00419744|559769174|FG002|Overall Study|Withdrawal by Subject|52|||
155091544|NCT00419744|559769172|FG000|Overall Study|Lost to Follow-up|8|||
155091545|NCT00419744|559769173|FG001|Overall Study|Lost to Follow-up|10|||
155091546|NCT00419744|559769174|FG002|Overall Study|Lost to Follow-up|6|||
155091547|NCT00419744|559769172|FG000|Overall Study|Protocol Violation|4|||
155091548|NCT00419744|559769173|FG001|Overall Study|Protocol Violation|7|||
155091549|NCT00419744|559769174|FG002|Overall Study|Protocol Violation|8|||
155091550|NCT00419744|559769172|FG000|Overall Study|Randomized in error|9|||
155091551|NCT00419744|559769173|FG001|Overall Study|Randomized in error|6|||
155091552|NCT00419744|559769174|FG002|Overall Study|Randomized in error|7|||
155091553|NCT00419744|559769172|FG000|Overall Study|Moving out of state|2|||
155091554|NCT00419744|559769173|FG001|Overall Study|Moving out of state|0|||
155091555|NCT00419744|559769174|FG002|Overall Study|Moving out of state|1|||
155091556|NCT00419744|559769172|FG000|Overall Study|Physician Decision|10|||
155091557|NCT00419744|559769173|FG001|Overall Study|Physician Decision|5|||
155091558|NCT00419744|559769174|FG002|Overall Study|Physician Decision|6|||
155091559|NCT00419744|559769172|FG000|Overall Study|Spirometry mouthpiece issues|0|||
155169443|NCT01794338|560060152|FG000|Overall Study|Lost to Follow-up|6|||
155169444|NCT01794338|560060153|FG001|Overall Study|Lost to Follow-up|9|||
155169445|NCT01754402|560060154|FG000|Overall Study|Death|0|||
155091560|NCT00419744|559769173|FG001|Overall Study|Spirometry mouthpiece issues|1|||
155091561|NCT00419744|559769174|FG002|Overall Study|Spirometry mouthpiece issues|2|||
155091562|NCT00419744|559769172|FG000|Overall Study|Incorrect medication kit dispensed|0|||
155091563|NCT00419744|559769173|FG001|Overall Study|Incorrect medication kit dispensed|0|||
155091564|NCT00419744|559769174|FG002|Overall Study|Incorrect medication kit dispensed|1|||
155091565|NCT01500317|559769179|FG000|Overall Study|Withdrawal by Subject|3|||
155091566|NCT01500317|559769180|FG001|Overall Study|Withdrawal by Subject|2|||
155091567|NCT01500317|559769181|FG002|Overall Study|Withdrawal by Subject|0|||
155091568|NCT00976456|559769182|FG000|Overall Study|Adverse Event|17|||
155091569|NCT00976456|559769183|FG001|Overall Study|Adverse Event|22|||
155091570|NCT00976456|559769182|FG000|Overall Study|Death|7|||
155091571|NCT00976456|559769183|FG001|Overall Study|Death|9|||
155091572|NCT00976456|559769182|FG000|Overall Study|Lack of Efficacy|5|||
155091573|NCT00976456|559769183|FG001|Overall Study|Lack of Efficacy|2|||
155091574|NCT00976456|559769182|FG000|Overall Study|Withdrawal by Subject|3|||
155091575|NCT00976456|559769183|FG001|Overall Study|Withdrawal by Subject|1|||
155091576|NCT00976456|559769182|FG000|Overall Study|screening failure, unknown|11|||
155091577|NCT00976456|559769183|FG001|Overall Study|screening failure, unknown|4|||
155091578|NCT00335829|559769184|FG000|Overall Study|Withdrawal by Subject|1|||
155091579|NCT00335829|559769184|FG000|Overall Study|Lost to Follow-up|1|||
155091580|NCT00335829|559769184|FG000|Overall Study|Adverse Event|1|||
155091581|NCT00583219|559769185|FG000|Phase 2|Withdrawal by Subject|1|||
155091582|NCT02037529|559769186|FG000|Overall Study|Withdrawal by Subject|1|||
155091583|NCT02037529|559769187|FG001|Overall Study|Withdrawal by Subject|3|||
155091584|NCT02037529|559769186|FG000|Overall Study|Adverse Event|0|||
155091585|NCT02037529|559769187|FG001|Overall Study|Adverse Event|1|||
155091586|NCT02131766|559769188|FG000|Overall Study|Withdrawal by Subject|4|||
155091587|NCT00754572|559769189|FG000|Overall Study|Adverse Event|19|||
155091588|NCT00754572|559769189|FG000|Overall Study|Other|39|||
155091589|NCT00754572|559769189|FG000|Overall Study|Protocol Violation|3|||
155091590|NCT00754572|559769189|FG000|Overall Study|Withdrawal by Subject|3|||
155091591|NCT00754572|559769189|FG000|Overall Study|Lack of Efficacy|2|||
155091592|NCT00754572|559769189|FG000|Overall Study|Death|1|||
155091593|NCT00754572|559769189|FG000|Overall Study|Administrative Reason|3|||
155091594|NCT00754572|559769189|FG000|Overall Study|Lost to Follow-up|1|||
155091595|NCT00718315|559769190|FG000|Overall Study|Adverse Event|1|||
155091596|NCT00718315|559769191|FG001|Overall Study|Adverse Event|2|||
155091597|NCT00718315|559769192|FG002|Overall Study|Adverse Event|3|||
155091598|NCT00718315|559769190|FG000|Overall Study|Death|6|||
155091599|NCT00718315|559769191|FG001|Overall Study|Death|6|||
155091600|NCT00718315|559769192|FG002|Overall Study|Death|5|||
155091601|NCT00718315|559769190|FG000|Overall Study|Lost to Follow-up|2|||
155091602|NCT00718315|559769191|FG001|Overall Study|Lost to Follow-up|3|||
155091603|NCT00718315|559769192|FG002|Overall Study|Lost to Follow-up|4|||
155091604|NCT00718315|559769190|FG000|Overall Study|Protocol Violation|5|||
155091605|NCT00718315|559769191|FG001|Overall Study|Protocol Violation|5|||
155091606|NCT00718315|559769192|FG002|Overall Study|Protocol Violation|3|||
155091607|NCT00718315|559769190|FG000|Overall Study|Erlotinib dose decreased|4|||
155091608|NCT00718315|559769191|FG001|Overall Study|Erlotinib dose decreased|3|||
155091609|NCT00718315|559769192|FG002|Overall Study|Erlotinib dose decreased|1|||
155091610|NCT00718315|559769190|FG000|Overall Study|Use of Minocyclin|1|||
155169446|NCT01754402|560060155|FG001|Overall Study|Death|0|||
155169447|NCT01754402|560060156|FG002|Overall Study|Death|1|||
155169448|NCT01754402|560060154|FG000|Overall Study|Adverse Event|2|||
155169449|NCT01754402|560060155|FG001|Overall Study|Adverse Event|2|||
155169450|NCT01754402|560060156|FG002|Overall Study|Adverse Event|1|||
155169451|NCT01754402|560060154|FG000|Overall Study|Withdrawal by Subject|0|||
155169452|NCT01754402|560060155|FG001|Overall Study|Withdrawal by Subject|0|||
155169453|NCT01754402|560060156|FG002|Overall Study|Withdrawal by Subject|1|||
155169454|NCT01754402|560060154|FG000|Overall Study|Lack of Efficacy|0|||
155169455|NCT01754402|560060155|FG001|Overall Study|Lack of Efficacy|0|||
155169456|NCT01754402|560060156|FG002|Overall Study|Lack of Efficacy|1|||
155169457|NCT01282463|560060157|FG000|Overall Study|Lost to Follow-up|1|||
155169458|NCT01282463|560060158|FG001|Overall Study|Lost to Follow-up|0|||
155091611|NCT00718315|559769191|FG001|Overall Study|Use of Minocyclin|1|||
155091612|NCT00718315|559769192|FG002|Overall Study|Use of Minocyclin|1|||
155091613|NCT00718315|559769190|FG000|Overall Study|Disease progression|0|||
155091614|NCT00718315|559769191|FG001|Overall Study|Disease progression|1|||
155091615|NCT00718315|559769192|FG002|Overall Study|Disease progression|1|||
155091616|NCT00718315|559769190|FG000|Overall Study|Other|0|||
155091617|NCT00718315|559769191|FG001|Overall Study|Other|0|||
155091618|NCT00718315|559769192|FG002|Overall Study|Other|1|||
155091619|NCT00718315|559769190|FG000|Overall Study|Use of ATB and Corticoids|0|||
155091620|NCT00718315|559769191|FG001|Overall Study|Use of ATB and Corticoids|1|||
155169459|NCT01282463|560060159|FG002|Overall Study|Lost to Follow-up|0|||
155169460|NCT01282463|560060157|FG000|Overall Study|Withdrawal by Subject|6|||
155169461|NCT01282463|560060158|FG001|Overall Study|Withdrawal by Subject|2|||
155091621|NCT00718315|559769192|FG002|Overall Study|Use of ATB and Corticoids|2|||
155091622|NCT02271880|559769195|FG000|Overall Study|Premature discontinuation of study|3|||
155091623|NCT02271880|559769196|FG001|Overall Study|Premature discontinuation of study|4|||
155091624|NCT00474903|559769198|FG000|Overall Study|Protocol Violation|1|||
155091625|NCT00474903|559769199|FG001|Overall Study|Protocol Violation|5|||
155091626|NCT00474903|559769200|FG002|Overall Study|Protocol Violation|2|||
155091627|NCT02735200|559769201|FG000|Overall Study|Lost to Follow-up|0|||
155091628|NCT02735200|559769202|FG001|Overall Study|Lost to Follow-up|5|||
155091629|NCT02735200|559769201|FG000|Overall Study|Withdrawal by Subject|8|||
155091630|NCT02735200|559769202|FG001|Overall Study|Withdrawal by Subject|0|||
155091631|NCT01493414|559769207|FG000|Overall Study|Adverse Event|405|||
155091632|NCT01493414|559769207|FG000|Overall Study|Disease progression|204|||
155091633|NCT01493414|559769207|FG000|Overall Study|Death|101|||
155091634|NCT01493414|559769207|FG000|Overall Study|Physician Decision|93|||
155091635|NCT01493414|559769207|FG000|Overall Study|Withdrawal by Subject|79|||
155169462|NCT01282463|560060159|FG002|Overall Study|Withdrawal by Subject|3|||
155169463|NCT01282463|560060157|FG000|Overall Study|"Never Treated Death"|0|||
155169464|NCT01282463|560060158|FG001|Overall Study|"Never Treated Death"|1|||
155169465|NCT01282463|560060159|FG002|Overall Study|"Never Treated Death"|0|||
155169466|NCT01282463|560060157|FG000|Overall Study|"Never Treated PD"|0|||
155169467|NCT01282463|560060158|FG001|Overall Study|"Never Treated PD"|1|||
155169468|NCT01282463|560060159|FG002|Overall Study|"Never Treated PD"|0|||
155169469|NCT01282463|560060157|FG000|Overall Study|Protocol Violation|0|||
155169470|NCT01282463|560060158|FG001|Overall Study|Protocol Violation|0|||
155169471|NCT01282463|560060159|FG002|Overall Study|Protocol Violation|1|||
155169472|NCT01282463|560060157|FG000|Overall Study|Physician Decision|1|||
155169473|NCT01282463|560060158|FG001|Overall Study|Physician Decision|0|||
155169474|NCT01282463|560060159|FG002|Overall Study|Physician Decision|0|||
155169475|NCT01954927|560060160|FG000|Overall Study|Withdrawal by Subject|3|||
155169476|NCT01954927|560060161|FG001|Overall Study|Withdrawal by Subject|1|||
155169477|NCT02156271|560060162|FG000|Overall Study|Physician Decision|4|||
155091636|NCT01493414|559769207|FG000|Overall Study|Protocol deviation|27|||
155091637|NCT01493414|559769207|FG000|Overall Study|Administrative problems|25|||
155091638|NCT01493414|559769207|FG000|Overall Study|Lost to Follow-up|16|||
155091639|NCT05448950|559769208|FG000|Overall Study|Death|2|||
155169478|NCT02156271|560060163|FG001|Overall Study|Physician Decision|3|||
155091640|NCT05448950|559769208|FG000|Overall Study|Withdrawal by Subject|1|||
155091641|NCT05448950|559769208|FG000|Overall Study|AVG abandoned|4|||
155091642|NCT02303262|559769209|FG000|Overall Study|Withdrawal by Subject|2|||
155091643|NCT01143402|559769213|FG000|Overall Study|Rapid clinical decline|1|||
155169479|NCT03320824|560060164|FG000|Overall Study|Withdrawal by Subject|8|||
155169480|NCT03320824|560060165|FG001|Overall Study|Withdrawal by Subject|1|||
154966380|NCT00294047|559301016|FG000|Month 84|Protocol Violation|1|||
154966381|NCT00294047|559301017|FG001|Month 84|Protocol Violation|1|||
154966382|NCT00294047|559301016|FG000|Month 84|Withdrawal by Subject|33|||
154966383|NCT00294047|559301017|FG001|Month 84|Withdrawal by Subject|31|||
154966384|NCT00294047|559301016|FG000|Month 84|Lost to Follow-up|187|||
154966385|NCT00294047|559301017|FG001|Month 84|Lost to Follow-up|190|||
154966386|NCT00294047|559301016|FG000|Month 84|Absent Cervix|2|||
154966387|NCT00294047|559301017|FG001|Month 84|Absent Cervix|0|||
154966388|NCT00294047|559301016|FG000|Month 84|Work related reasons|4|||
154966389|NCT00294047|559301017|FG001|Month 84|Work related reasons|2|||
154966390|NCT00294047|559301016|FG000|Month 84|Center closed, subject did not transfer|1|||
154966391|NCT00294047|559301017|FG001|Month 84|Center closed, subject did not transfer|0|||
154966392|NCT00294047|559301016|FG000|Month 84|Family problems|2|||
154966393|NCT00294047|559301017|FG001|Month 84|Family problems|2|||
154966394|NCT00294047|559301016|FG000|Month 84|Lack of time|3|||
154966395|NCT00294047|559301017|FG001|Month 84|Lack of time|1|||
154966396|NCT00294047|559301016|FG000|Month 84|Personal reason|2|||
154966397|NCT00294047|559301017|FG001|Month 84|Personal reason|4|||
154966398|NCT00294047|559301016|FG000|Month 84|Subject does not want male physician|1|||
154966399|NCT00294047|559301017|FG001|Month 84|Subject does not want male physician|0|||
154966400|NCT00294047|559301016|FG000|Month 84|Transport reimbursement delayed|0|||
154966401|NCT00294047|559301017|FG001|Month 84|Transport reimbursement delayed|1|||
154966402|NCT00294047|559301016|FG000|Month 84|Unable to reach study site|1|||
154966403|NCT00294047|559301017|FG001|Month 84|Unable to reach study site|0|||
154966404|NCT00294047|559301016|FG000|Month 84|Under investigation locally|1|||
154966405|NCT00294047|559301017|FG001|Month 84|Under investigation locally|0|||
154966406|NCT00294047|559301016|FG000|Month 84|Visit missed|0|||
154966407|NCT00294047|559301017|FG001|Month 84|Visit missed|1|||
154966408|NCT00294047|559301016|FG000|Month 84|No consent for Month 84 Follow-up|731|||
154966409|NCT00294047|559301017|FG001|Month 84|No consent for Month 84 Follow-up|754|||
155091644|NCT01143402|559769214|FG001|Overall Study|Rapid clinical decline|1|||
155091645|NCT01143402|559769215|FG002|Overall Study|Rapid clinical decline|0|||
155091646|NCT01143402|559769213|FG000|Overall Study|Not Treated|0|||
155091647|NCT01143402|559769214|FG001|Overall Study|Not Treated|0|||
155091648|NCT01143402|559769215|FG002|Overall Study|Not Treated|1|||
155091649|NCT01968980|559769220|FG000|Overall Study|Death|0|||
155091650|NCT01968980|559769221|FG001|Overall Study|Death|1|||
155091651|NCT01968980|559769220|FG000|Overall Study|Adverse Event|1|||
155091652|NCT01968980|559769221|FG001|Overall Study|Adverse Event|3|||
155091653|NCT01968980|559769220|FG000|Overall Study|Does not meet entry criteria|1|||
155091654|NCT01968980|559769221|FG001|Overall Study|Does not meet entry criteria|3|||
155091655|NCT01968980|559769220|FG000|Overall Study|Withdrawal by Subject|13|||
155091656|NCT01968980|559769221|FG001|Overall Study|Withdrawal by Subject|5|||
155091657|NCT01968980|559769220|FG000|Overall Study|Other unspecified|1|||
155091658|NCT01968980|559769221|FG001|Overall Study|Other unspecified|2|||
155091659|NCT00776230|559769222|FG000|Overall Study|Lost to Follow-up|2|||
155091660|NCT00776230|559769223|FG001|Overall Study|Lost to Follow-up|1|||
155091661|NCT00776230|559769224|FG002|Overall Study|Lost to Follow-up|5|||
155091662|NCT00776230|559769222|FG000|Overall Study|Not vaccinated at Day 0|1|||
155091663|NCT00776230|559769223|FG001|Overall Study|Not vaccinated at Day 0|0|||
155091664|NCT00776230|559769224|FG002|Overall Study|Not vaccinated at Day 0|0|||
155091665|NCT00776230|559769222|FG000|Overall Study|Withdrawal by Subject|0|||
155091666|NCT00776230|559769223|FG001|Overall Study|Withdrawal by Subject|1|||
155091667|NCT00776230|559769224|FG002|Overall Study|Withdrawal by Subject|0|||
155091668|NCT00776230|559769222|FG000|Overall Study|Subject missed Visit 4|0|||
155091669|NCT00776230|559769223|FG001|Overall Study|Subject missed Visit 4|1|||
155091670|NCT00776230|559769224|FG002|Overall Study|Subject missed Visit 4|0|||
154966410|NCT02157974|559301018|FG000|Overall Study|Withdrawal by Subject|0|||
154966411|NCT02157974|559301019|FG001|Overall Study|Withdrawal by Subject|1|||
154966412|NCT02157974|559301020|FG002|Overall Study|Withdrawal by Subject|0|||
154966413|NCT02157974|559301021|FG003|Overall Study|Withdrawal by Subject|0|||
154966414|NCT02157974|559301022|FG004|Overall Study|Withdrawal by Subject|0|||
154966415|NCT02157974|559301018|FG000|Overall Study|Screen Failure|0|||
154966416|NCT02157974|559301019|FG001|Overall Study|Screen Failure|1|||
154966417|NCT02157974|559301020|FG002|Overall Study|Screen Failure|0|||
154966418|NCT02157974|559301021|FG003|Overall Study|Screen Failure|0|||
154966419|NCT02157974|559301022|FG004|Overall Study|Screen Failure|0|||
154966420|NCT02157974|559301018|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
154966421|NCT02157974|559301019|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
154966422|NCT02157974|559301020|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
154966423|NCT02157974|559301021|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
154966424|NCT02157974|559301022|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
154966425|NCT00506831|559301025|FG000|Overall Study|Death|1|||
154966426|NCT00506831|559301025|FG000|Overall Study|Withdrawal by Subject|1|||
155091671|NCT01215851|559769225|FG000|Treatment Period|Adverse Event|1|||
155091672|NCT01215851|559769226|FG001|Treatment Period|Adverse Event|1|||
155091673|NCT01215851|559769227|FG002|Treatment Period|Adverse Event|1|||
155091674|NCT01215851|559769228|FG003|Treatment Period|Adverse Event|3|||
155091675|NCT01215851|559769229|FG004|Treatment Period|Adverse Event|0|||
155091676|NCT01215851|559769230|FG005|Treatment Period|Adverse Event|1|||
155091677|NCT01215851|559769225|FG000|Follow up Period|Lost to Follow-up|0|||
155091678|NCT01215851|559769226|FG001|Follow up Period|Lost to Follow-up|0|||
155091679|NCT01215851|559769227|FG002|Follow up Period|Lost to Follow-up|0|||
155091680|NCT01215851|559769228|FG003|Follow up Period|Lost to Follow-up|0|||
155091681|NCT01215851|559769229|FG004|Follow up Period|Lost to Follow-up|0|||
155091682|NCT01215851|559769230|FG005|Follow up Period|Lost to Follow-up|1|||
155091683|NCT01276106|559769236|FG000|Overall Study|Adverse Event|3|||
155091684|NCT01276106|559769237|FG001|Overall Study|Adverse Event|3|||
155091685|NCT01276106|559769238|FG002|Overall Study|Adverse Event|11|||
155091686|NCT01276106|559769239|FG003|Overall Study|Adverse Event|3|||
155091687|NCT01276106|559769236|FG000|Overall Study|Withdrawal by Subject|6|||
155091688|NCT01276106|559769237|FG001|Overall Study|Withdrawal by Subject|3|||
155091689|NCT01276106|559769238|FG002|Overall Study|Withdrawal by Subject|1|||
155091690|NCT01276106|559769239|FG003|Overall Study|Withdrawal by Subject|6|||
155091691|NCT01276106|559769236|FG000|Overall Study|Lack of Efficacy|0|||
155091692|NCT01276106|559769237|FG001|Overall Study|Lack of Efficacy|1|||
155091693|NCT01276106|559769238|FG002|Overall Study|Lack of Efficacy|0|||
155091694|NCT01276106|559769239|FG003|Overall Study|Lack of Efficacy|1|||
154966427|NCT01410227|559301029|FG000|Overall Study|Adverse Event|1|||
154966428|NCT01410227|559301030|FG001|Overall Study|Adverse Event|0|||
154966429|NCT01410227|559301031|FG002|Overall Study|Adverse Event|0|||
154966430|NCT01410227|559301032|FG003|Overall Study|Adverse Event|0|||
154966431|NCT01410227|559301029|FG000|Overall Study|Withdrawal by Subject|3|||
154966432|NCT01410227|559301030|FG001|Overall Study|Withdrawal by Subject|0|||
154966433|NCT01410227|559301031|FG002|Overall Study|Withdrawal by Subject|1|||
154966434|NCT01410227|559301032|FG003|Overall Study|Withdrawal by Subject|0|||
154966435|NCT01410227|559301029|FG000|Overall Study|Pregnancy|0|||
154966436|NCT01410227|559301030|FG001|Overall Study|Pregnancy|0|||
154966437|NCT01410227|559301031|FG002|Overall Study|Pregnancy|0|||
154966438|NCT01410227|559301032|FG003|Overall Study|Pregnancy|1|||
154966439|NCT01410227|559301029|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
154966440|NCT01410227|559301030|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
154966441|NCT01410227|559301031|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
154966442|NCT01410227|559301032|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
154966443|NCT03497130|559301034|FG000|Overall Study|Lost to Follow-up|1|||
154966444|NCT03497130|559301035|FG001|Overall Study|Lost to Follow-up|1|||
154966445|NCT00829712|559301036|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
154966446|NCT00829712|559301037|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
154966447|NCT01484912|559301038|FG000|Overall Study|Withdrawal by Subject|1|||
154966448|NCT01484912|559301039|FG001|Overall Study|Withdrawal by Subject|0|||
154966449|NCT01484912|559301038|FG000|Overall Study|Physician Decision|0|||
154966450|NCT01484912|559301039|FG001|Overall Study|Physician Decision|1|||
154966451|NCT00606281|559301040|FG000|Overall Study|Adverse Event|11|||
154966452|NCT00606281|559301041|FG001|Overall Study|Adverse Event|12|||
154966453|NCT00606281|559301040|FG000|Overall Study|Death|1|||
154966454|NCT00606281|559301041|FG001|Overall Study|Death|0|||
154966455|NCT00606281|559301040|FG000|Overall Study|Lack of Efficacy|28|||
154966456|NCT00606281|559301041|FG001|Overall Study|Lack of Efficacy|35|||
154966457|NCT00606281|559301040|FG000|Overall Study|Physician Decision|0|||
154966458|NCT00606281|559301041|FG001|Overall Study|Physician Decision|1|||
154966459|NCT00606281|559301040|FG000|Overall Study|Protocol Violation|3|||
154966460|NCT00606281|559301041|FG001|Overall Study|Protocol Violation|3|||
154966461|NCT00606281|559301040|FG000|Overall Study|Withdrawal by Subject|11|||
154966462|NCT00606281|559301041|FG001|Overall Study|Withdrawal by Subject|13|||
154966463|NCT00606281|559301040|FG000|Overall Study|Progression to depressive phase|1|||
154966464|NCT00606281|559301041|FG001|Overall Study|Progression to depressive phase|1|||
154966465|NCT00606281|559301040|FG000|Overall Study|Change of residence or other commitments|1|||
154966466|NCT00606281|559301041|FG001|Overall Study|Change of residence or other commitments|1|||
154966467|NCT03131895|559301043|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
154966468|NCT03131895|559301044|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
154966469|NCT03131895|559301045|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
154966470|NCT03131895|559301046|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
154966471|NCT03131895|559301043|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
154966472|NCT03131895|559301044|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
154966473|NCT03131895|559301045|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
154966474|NCT03131895|559301046|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
154966475|NCT03131895|559301043|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154966476|NCT03131895|559301044|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
155091695|NCT01276106|559769236|FG000|Overall Study|Lost to Follow-up|2|||
155091696|NCT01276106|559769237|FG001|Overall Study|Lost to Follow-up|1|||
155091697|NCT01276106|559769238|FG002|Overall Study|Lost to Follow-up|1|||
155091698|NCT01276106|559769239|FG003|Overall Study|Lost to Follow-up|0|||
155091699|NCT01276106|559769236|FG000|Overall Study|Physician Decision|0|||
155091700|NCT01276106|559769237|FG001|Overall Study|Physician Decision|0|||
155091701|NCT01276106|559769238|FG002|Overall Study|Physician Decision|1|||
154966477|NCT03131895|559301045|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154966478|NCT03131895|559301046|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
154966479|NCT03131895|559301043|FG000|Washout Period (at Least 5 Days)|Other|0|||
154966480|NCT03131895|559301044|FG001|Washout Period (at Least 5 Days)|Other|0|||
154966481|NCT03131895|559301045|FG002|Washout Period (at Least 5 Days)|Other|2|||
155091702|NCT01276106|559769239|FG003|Overall Study|Physician Decision|1|||
155091703|NCT01276106|559769236|FG000|Overall Study|Protocol Violation|1|||
155091704|NCT01276106|559769237|FG001|Overall Study|Protocol Violation|1|||
155091705|NCT01276106|559769238|FG002|Overall Study|Protocol Violation|0|||
155091706|NCT01276106|559769239|FG003|Overall Study|Protocol Violation|2|||
155091707|NCT01276106|559769236|FG000|Overall Study|Insufficient therapeutic effects|0|||
155091708|NCT01276106|559769237|FG001|Overall Study|Insufficient therapeutic effects|0|||
155091709|NCT01276106|559769238|FG002|Overall Study|Insufficient therapeutic effects|2|||
155091710|NCT01276106|559769239|FG003|Overall Study|Insufficient therapeutic effects|0|||
155091711|NCT01242514|559769242|FG000|Overall Study|e.g., project closure|1042|||
155091712|NCT01242514|559769243|FG001|Overall Study|e.g., project closure|305|||
155091713|NCT01242514|559769244|FG002|Overall Study|e.g., project closure|171|||
155091714|NCT01242514|559769242|FG000|Overall Study|Subject decision|33|||
155091715|NCT01242514|559769243|FG001|Overall Study|Subject decision|8|||
155091716|NCT01242514|559769244|FG002|Overall Study|Subject decision|2|||
155091717|NCT01242514|559769242|FG000|Overall Study|Severe non-compliance to protocol|5|||
155091718|NCT01242514|559769243|FG001|Overall Study|Severe non-compliance to protocol|2|||
155091719|NCT01242514|559769244|FG002|Overall Study|Severe non-compliance to protocol|1|||
155091720|NCT01242514|559769242|FG000|Overall Study|Lack of therapeutic response|99|||
155091721|NCT01242514|559769243|FG001|Overall Study|Lack of therapeutic response|16|||
155091722|NCT01242514|559769244|FG002|Overall Study|Lack of therapeutic response|10|||
155091723|NCT01242514|559769242|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
155091724|NCT01242514|559769243|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
155091725|NCT01242514|559769244|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
155091726|NCT01242514|559769242|FG000|Overall Study|Lost to Follow-up|14|||
155091727|NCT01242514|559769243|FG001|Overall Study|Lost to Follow-up|5|||
155091728|NCT01242514|559769244|FG002|Overall Study|Lost to Follow-up|4|||
155091729|NCT01242514|559769242|FG000|Overall Study|Adverse Event|129|||
155091730|NCT01242514|559769243|FG001|Overall Study|Adverse Event|18|||
155091731|NCT01242514|559769244|FG002|Overall Study|Adverse Event|19|||
155091732|NCT00787150|559769246|FG000|Overall Study|Adverse Event|4|||
155091733|NCT00787150|559769247|FG001|Overall Study|Adverse Event|4|||
155091734|NCT00787150|559769248|FG002|Overall Study|Adverse Event|4|||
155091735|NCT00787150|559769246|FG000|Overall Study|Physician Decision|1|||
155091736|NCT00787150|559769247|FG001|Overall Study|Physician Decision|2|||
155091737|NCT00787150|559769248|FG002|Overall Study|Physician Decision|1|||
155091738|NCT00787150|559769246|FG000|Overall Study|Withdrawal by Subject|2|||
155091739|NCT00787150|559769247|FG001|Overall Study|Withdrawal by Subject|1|||
155091740|NCT00787150|559769248|FG002|Overall Study|Withdrawal by Subject|0|||
155091741|NCT00787150|559769246|FG000|Overall Study|Dosing incorrect study durg|2|||
155091742|NCT00787150|559769247|FG001|Overall Study|Dosing incorrect study durg|0|||
155091743|NCT00787150|559769248|FG002|Overall Study|Dosing incorrect study durg|0|||
155091744|NCT01121757|559769249|FG000|First Drug|Death|1|||
155091745|NCT01121757|559769250|FG001|First Drug|Death|0|||
155091746|NCT01121757|559769249|FG000|First Drug|Disease Progression|0|||
155091747|NCT01121757|559769250|FG001|First Drug|Disease Progression|2|||
155091748|NCT01121757|559769249|FG000|Combination|Physician Decision|0|||
155091749|NCT01121757|559769250|FG001|Combination|Physician Decision|1|||
155091750|NCT01121757|559769249|FG000|Combination|Disease Progression|2|||
155091751|NCT01121757|559769250|FG001|Combination|Disease Progression|0|||
155091752|NCT03773484|559769251|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
155091753|NCT04222673|559769252|FG000|Overall Study|Lost to Follow-up|5|||
155091754|NCT05901636|559769265|FG000|Overall Study|Lost to Follow-up|0|||
155091755|NCT05901636|559769266|FG001|Overall Study|Lost to Follow-up|1|||
155091756|NCT05901636|559769267|FG002|Overall Study|Lost to Follow-up|0|||
155091757|NCT05901636|559769268|FG003|Overall Study|Lost to Follow-up|1|||
155091758|NCT05901636|559769269|FG004|Overall Study|Lost to Follow-up|1|||
155091759|NCT05901636|559769270|FG005|Overall Study|Lost to Follow-up|3|||
155091760|NCT05901636|559769271|FG006|Overall Study|Lost to Follow-up|1|||
155091761|NCT05901636|559769265|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
155091762|NCT05901636|559769266|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
155091763|NCT05901636|559769267|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
155091764|NCT05901636|559769268|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
155091765|NCT05901636|559769269|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
155091766|NCT05901636|559769270|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
155091767|NCT05901636|559769271|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
155091768|NCT05901636|559769265|FG000|Overall Study|Withdrawal by Subject|1|||
155091769|NCT05901636|559769266|FG001|Overall Study|Withdrawal by Subject|1|||
154966482|NCT03131895|559301046|FG003|Washout Period (at Least 5 Days)|Other|0|||
154966483|NCT03131895|559301043|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
154966484|NCT03131895|559301044|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
154966485|NCT03131895|559301045|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
154966486|NCT03131895|559301046|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
154966487|NCT03131895|559301043|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
154966488|NCT03131895|559301044|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
155091770|NCT05901636|559769267|FG002|Overall Study|Withdrawal by Subject|0|||
155091771|NCT05901636|559769268|FG003|Overall Study|Withdrawal by Subject|0|||
155169481|NCT03320824|560060164|FG000|Overall Study|Lost to Follow-up|10|||
155169482|NCT03320824|560060165|FG001|Overall Study|Lost to Follow-up|1|||
155169483|NCT03320824|560060164|FG000|Overall Study|moved out of state|0|||
155169484|NCT03320824|560060165|FG001|Overall Study|moved out of state|1|||
155169485|NCT03320824|560060164|FG000|Overall Study|could not complete final visit|0|||
155091772|NCT05901636|559769269|FG004|Overall Study|Withdrawal by Subject|1|||
155091773|NCT05901636|559769270|FG005|Overall Study|Withdrawal by Subject|1|||
155091774|NCT05901636|559769271|FG006|Overall Study|Withdrawal by Subject|0|||
155091775|NCT05901636|559769265|FG000|Overall Study|Other|0|||
155091776|NCT05901636|559769266|FG001|Overall Study|Other|0|||
155091777|NCT05901636|559769267|FG002|Overall Study|Other|1|||
155091778|NCT05901636|559769268|FG003|Overall Study|Other|1|||
155091779|NCT05901636|559769269|FG004|Overall Study|Other|0|||
155091780|NCT05901636|559769270|FG005|Overall Study|Other|0|||
155091781|NCT05901636|559769271|FG006|Overall Study|Other|0|||
155091782|NCT05211596|559769272|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
155091783|NCT05211596|559769272|FG000|Baseline to 6 Months|Death|1|||
155091784|NCT05211596|559769272|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
155091785|NCT05211596|559769272|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
155091786|NCT04398706|559769273|FG000|Overall Study|Adverse Event|0|||
155091787|NCT04398706|559769274|FG001|Overall Study|Adverse Event|0|||
155091788|NCT04398706|559769275|FG002|Overall Study|Adverse Event|0|||
155091789|NCT04398706|559769276|FG003|Overall Study|Adverse Event|0|||
155091790|NCT04398706|559769277|FG004|Overall Study|Adverse Event|0|||
155091791|NCT04398706|559769278|FG005|Overall Study|Adverse Event|1|||
155091792|NCT04398706|559769279|FG006|Overall Study|Adverse Event|1|||
155091793|NCT04398706|559769280|FG007|Overall Study|Adverse Event|0|||
155091794|NCT04398706|559769273|FG000|Overall Study|Lost to Follow-up|0|||
155091795|NCT04398706|559769274|FG001|Overall Study|Lost to Follow-up|1|||
155091796|NCT04398706|559769275|FG002|Overall Study|Lost to Follow-up|2|||
155091797|NCT04398706|559769276|FG003|Overall Study|Lost to Follow-up|1|||
155091798|NCT04398706|559769277|FG004|Overall Study|Lost to Follow-up|6|||
155091799|NCT04398706|559769278|FG005|Overall Study|Lost to Follow-up|3|||
155091800|NCT04398706|559769279|FG006|Overall Study|Lost to Follow-up|8|||
155169486|NCT03320824|560060165|FG001|Overall Study|could not complete final visit|1|||
155169487|NCT00955305|560060166|FG000|Overall Study|Disease progression|39|||
155169488|NCT00955305|560060167|FG001|Overall Study|Disease progression|41|||
155169489|NCT00955305|560060166|FG000|Overall Study|Adverse Event|22|||
155169490|NCT00955305|560060167|FG001|Overall Study|Adverse Event|22|||
155169491|NCT00955305|560060166|FG000|Overall Study|Death|2|||
155169492|NCT00955305|560060167|FG001|Overall Study|Death|1|||
155169493|NCT00955305|560060166|FG000|Overall Study|Withdrawal by Subject|5|||
155169494|NCT00955305|560060167|FG001|Overall Study|Withdrawal by Subject|4|||
155169495|NCT00955305|560060166|FG000|Overall Study|Alternative therapy|4|||
155169496|NCT00955305|560060167|FG001|Overall Study|Alternative therapy|0|||
155169497|NCT00955305|560060166|FG000|Overall Study|Other complicating disease|2|||
155169498|NCT00955305|560060167|FG001|Overall Study|Other complicating disease|4|||
155169499|NCT00955305|560060166|FG000|Overall Study|Physician Decision|1|||
155169500|NCT00955305|560060167|FG001|Overall Study|Physician Decision|0|||
155169501|NCT00955305|560060166|FG000|Overall Study|Continued presence of residual disease|0|||
154966489|NCT03131895|559301045|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
155091801|NCT04398706|559769280|FG007|Overall Study|Lost to Follow-up|2|||
155091802|NCT04398706|559769273|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155091803|NCT04398706|559769274|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155091804|NCT04398706|559769275|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155091805|NCT04398706|559769276|FG003|Overall Study|Withdrawal by parent/guardian|2|||
155091806|NCT04398706|559769277|FG004|Overall Study|Withdrawal by parent/guardian|19|||
155169502|NCT00955305|560060167|FG001|Overall Study|Continued presence of residual disease|1|||
155169503|NCT00955305|560060166|FG000|Overall Study|Functional decline|2|||
155169504|NCT00955305|560060167|FG001|Overall Study|Functional decline|0|||
155169505|NCT00955305|560060166|FG000|Overall Study|Maximum response achieved|0|||
155169506|NCT00955305|560060167|FG001|Overall Study|Maximum response achieved|1|||
155091807|NCT04398706|559769278|FG005|Overall Study|Withdrawal by parent/guardian|23|||
155091808|NCT04398706|559769279|FG006|Overall Study|Withdrawal by parent/guardian|13|||
155091809|NCT04398706|559769280|FG007|Overall Study|Withdrawal by parent/guardian|11|||
155091810|NCT04398706|559769273|FG000|Overall Study|Protocol deviation|0|||
155091811|NCT04398706|559769274|FG001|Overall Study|Protocol deviation|1|||
155169507|NCT00955305|560060166|FG000|Overall Study|Lost to Follow-up|0|||
154966490|NCT03131895|559301046|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
154966491|NCT00540423|559301047|FG000|Double-Blind Treatment Period|Adverse Event|0|||
154966492|NCT00540423|559301048|FG001|Double-Blind Treatment Period|Adverse Event|1|||
154966493|NCT00540423|559301049|FG002|Double-Blind Treatment Period|Adverse Event|0|||
155091812|NCT04398706|559769275|FG002|Overall Study|Protocol deviation|0|||
155091813|NCT04398706|559769276|FG003|Overall Study|Protocol deviation|0|||
155091814|NCT04398706|559769277|FG004|Overall Study|Protocol deviation|6|||
155091815|NCT04398706|559769278|FG005|Overall Study|Protocol deviation|4|||
155091816|NCT04398706|559769279|FG006|Overall Study|Protocol deviation|6|||
155091817|NCT04398706|559769280|FG007|Overall Study|Protocol deviation|3|||
155091818|NCT04116853|559769281|FG000|Overall Study|Adverse Event|1|||
155091819|NCT04116853|559769282|FG001|Overall Study|Adverse Event|3|||
155091820|NCT04116853|559769281|FG000|Overall Study|Lost to Follow-up|2|||
155091821|NCT04116853|559769282|FG001|Overall Study|Lost to Follow-up|0|||
155091822|NCT04116853|559769281|FG000|Overall Study|Incarceration|0|||
155091823|NCT04116853|559769282|FG001|Overall Study|Incarceration|1|||
155091824|NCT04116853|559769281|FG000|Overall Study|Pregnancy|1|||
155091825|NCT04116853|559769282|FG001|Overall Study|Pregnancy|1|||
155091826|NCT04116853|559769281|FG000|Overall Study|Began Other Weight Loss program|4|||
155091827|NCT04116853|559769282|FG001|Overall Study|Began Other Weight Loss program|8|||
155091828|NCT04116853|559769281|FG000|Overall Study|Began Anti-Obesity Medication|3|||
155091829|NCT04116853|559769282|FG001|Overall Study|Began Anti-Obesity Medication|3|||
155091830|NCT04116853|559769281|FG000|Overall Study|Protocol Violation|0|||
155091831|NCT04116853|559769282|FG001|Overall Study|Protocol Violation|1|||
155091832|NCT04696146|559771301|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
155091833|NCT04696146|559771302|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
155091834|NCT04696146|559771301|FG000|Overall Study|Off hours issue with product|1|||
155091835|NCT04696146|559771302|FG001|Overall Study|Off hours issue with product|0|||
155091836|NCT03021486|559771304|FG000|Overall Study|Withdrawal by Subject|1|||
155091837|NCT03021486|559771305|FG001|Overall Study|Withdrawal by Subject|1|||
155091838|NCT03021486|559771306|FG002|Overall Study|Withdrawal by Subject|3|||
155091839|NCT03021486|559771304|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
155091840|NCT03021486|559771305|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
155091841|NCT03021486|559771306|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
155091842|NCT04043286|559771307|FG000|Overall Study|Withdrawal by Subject|2|||
155091843|NCT04043286|559771308|FG001|Overall Study|Withdrawal by Subject|2|||
155091844|NCT01276704|559771312|FG000|Overall Study|Lost to Follow-up|2|||
155091845|NCT01276704|559771313|FG001|Overall Study|Lost to Follow-up|3|||
155091846|NCT01276704|559771312|FG000|Overall Study|Non-compliant|2|||
155091847|NCT01276704|559771313|FG001|Overall Study|Non-compliant|2|||
155091848|NCT01276704|559771312|FG000|Overall Study|Withdrawal by Subject|7|||
155091849|NCT01276704|559771313|FG001|Overall Study|Withdrawal by Subject|1|||
155091850|NCT01276704|559771312|FG000|Overall Study|Physician Decision|3|||
155091851|NCT01276704|559771313|FG001|Overall Study|Physician Decision|5|||
155091852|NCT01359956|559771314|FG000|Overall Study|Death|58|||
155091853|NCT01359956|559771315|FG001|Overall Study|Death|60|||
155091854|NCT01359956|559771316|FG002|Overall Study|Death|66|||
155091855|NCT01359956|559771317|FG003|Overall Study|Death|57|||
155091856|NCT01359956|559771314|FG000|Overall Study|Lost to Follow-up|3|||
155091857|NCT01359956|559771315|FG001|Overall Study|Lost to Follow-up|4|||
155091858|NCT01359956|559771316|FG002|Overall Study|Lost to Follow-up|1|||
155091859|NCT01359956|559771317|FG003|Overall Study|Lost to Follow-up|1|||
155091860|NCT01784029|559771318|FG000|Overall Study|Lost to Follow-up|19|||
155091861|NCT01784029|559771319|FG001|Overall Study|Lost to Follow-up|20|||
155091862|NCT01784029|559771320|FG002|Overall Study|Lost to Follow-up|22|||
155091863|NCT01209767|559771327|FG000|Overall Study|Withdrawal by Subject|1|||
155091864|NCT01209767|559771327|FG000|Overall Study|Lost to Follow-up|3|||
155091865|NCT02410772|559771331|FG000|Overall Study|Death|3|||
155091866|NCT02410772|559771332|FG001|Overall Study|Death|4|||
155091867|NCT02410772|559771333|FG002|Overall Study|Death|8|||
155091868|NCT02410772|559771331|FG000|Overall Study|Lost to Follow-up|31|||
155091869|NCT02410772|559771332|FG001|Overall Study|Lost to Follow-up|23|||
155091870|NCT02410772|559771333|FG002|Overall Study|Lost to Follow-up|22|||
155091871|NCT02410772|559771331|FG000|Overall Study|Pregnancy|8|||
155091872|NCT02410772|559771332|FG001|Overall Study|Pregnancy|4|||
155091873|NCT02410772|559771333|FG002|Overall Study|Pregnancy|5|||
155091874|NCT02410772|559771331|FG000|Overall Study|Protocol Violation|8|||
155091875|NCT02410772|559771332|FG001|Overall Study|Protocol Violation|8|||
155091876|NCT02410772|559771333|FG002|Overall Study|Protocol Violation|4|||
155091877|NCT02410772|559771331|FG000|Overall Study|Baseline Drug Resistance|49|||
155091878|NCT02410772|559771332|FG001|Overall Study|Baseline Drug Resistance|40|||
155091879|NCT02410772|559771333|FG002|Overall Study|Baseline Drug Resistance|51|||
155091880|NCT02410772|559771331|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
155091881|NCT02410772|559771332|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
155091882|NCT02410772|559771333|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
155091883|NCT02410772|559771331|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
155091884|NCT02410772|559771332|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
155091885|NCT02410772|559771333|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
155091886|NCT04573972|559771334|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
155091887|NCT04573972|559771335|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
155091888|NCT01517984|559771336|FG000|Overall Study|Lost to Follow-up|0|||
155091889|NCT01517984|559771337|FG001|Overall Study|Lost to Follow-up|1|||
155091890|NCT01517984|559771338|FG002|Overall Study|Lost to Follow-up|0|||
155091891|NCT01517984|559771339|FG003|Overall Study|Lost to Follow-up|0|||
155091892|NCT01517984|559771336|FG000|Overall Study|Withdrawal by Subject|1|||
155091893|NCT01517984|559771337|FG001|Overall Study|Withdrawal by Subject|8|||
155091894|NCT01517984|559771338|FG002|Overall Study|Withdrawal by Subject|4|||
155091895|NCT01517984|559771339|FG003|Overall Study|Withdrawal by Subject|1|||
155091896|NCT01517984|559771336|FG000|Overall Study|Screen Failure|4|||
155091897|NCT01517984|559771337|FG001|Overall Study|Screen Failure|0|||
155091898|NCT01517984|559771338|FG002|Overall Study|Screen Failure|0|||
155091899|NCT01517984|559771339|FG003|Overall Study|Screen Failure|0|||
155091900|NCT01517984|559771336|FG000|Overall Study|Ineligible for randomization|0|||
155091901|NCT01517984|559771337|FG001|Overall Study|Ineligible for randomization|14|||
155091902|NCT01517984|559771338|FG002|Overall Study|Ineligible for randomization|0|||
155091903|NCT01517984|559771339|FG003|Overall Study|Ineligible for randomization|0|||
155091904|NCT05067335|559771340|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
155091905|NCT05067335|559771341|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
155091906|NCT05067335|559771342|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
155091907|NCT05067335|559771343|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
155091908|NCT05067335|559771340|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
155091909|NCT05067335|559771341|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
155091910|NCT05067335|559771342|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
155091911|NCT05067335|559771343|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
155091912|NCT05067335|559771340|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
155091913|NCT05067335|559771341|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
155091914|NCT05067335|559771342|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
155091915|NCT05067335|559771343|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
155091916|NCT05067335|559771340|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
155091917|NCT05067335|559771341|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
155091918|NCT05067335|559771342|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
155091919|NCT05067335|559771343|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
155091920|NCT05067335|559771340|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
155091921|NCT05067335|559771341|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
155091922|NCT05067335|559771342|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
155091923|NCT05067335|559771343|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
155091924|NCT05067335|559771340|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
155091925|NCT05067335|559771341|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
155091926|NCT05067335|559771342|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
155091927|NCT05067335|559771343|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
155091928|NCT05067335|559771340|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
155091929|NCT05067335|559771341|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
155091930|NCT05067335|559771342|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
155091931|NCT05067335|559771343|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
155091932|NCT05067335|559771340|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
155091933|NCT05067335|559771341|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
155091934|NCT05067335|559771342|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
155091935|NCT05067335|559771343|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
155091936|NCT05067335|559771340|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
155091937|NCT05067335|559771341|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
155091938|NCT05067335|559771342|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
155091939|NCT05067335|559771343|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
155091940|NCT05067335|559771340|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
155091941|NCT05067335|559771341|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
155091942|NCT05067335|559771342|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
155091943|NCT05067335|559771343|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
155091944|NCT02724839|559771344|FG000|Overall Study|Withdrawal by Subject|1|||
155091945|NCT02724839|559771345|FG001|Overall Study|Withdrawal by Subject|1|||
155091946|NCT02724839|559771346|FG002|Overall Study|Withdrawal by Subject|0|||
155091947|NCT02724839|559771344|FG000|Overall Study|Lost to Follow-up|0|||
155091948|NCT02724839|559771345|FG001|Overall Study|Lost to Follow-up|3|||
155091949|NCT02724839|559771346|FG002|Overall Study|Lost to Follow-up|2|||
155091950|NCT02724839|559771344|FG000|Overall Study|Physician Decision|0|||
155091951|NCT02724839|559771345|FG001|Overall Study|Physician Decision|0|||
155091952|NCT02724839|559771346|FG002|Overall Study|Physician Decision|3|||
155091953|NCT00949533|559771348|FG000|Overall Study|Lost to Follow-up|0|||
155091954|NCT00949533|559771349|FG001|Overall Study|Lost to Follow-up|1|||
155091955|NCT01870869|559771352|FG000|Overall Study|Implanted with nonstudy device|1|||
155091956|NCT01870869|559771353|FG001|Overall Study|Implanted with nonstudy device|3|||
155091957|NCT01870869|559771354|FG002|Overall Study|Implanted with nonstudy device|14|||
155091958|NCT01870869|559771355|FG003|Overall Study|Implanted with nonstudy device|4|||
155091959|NCT01870869|559771352|FG000|Overall Study|Death|0|||
155091960|NCT01870869|559771353|FG001|Overall Study|Death|0|||
155091961|NCT01870869|559771354|FG002|Overall Study|Death|7|||
155091962|NCT01870869|559771355|FG003|Overall Study|Death|1|||
155091963|NCT01870869|559771352|FG000|Overall Study|Subject choice|6|||
155091964|NCT01870869|559771353|FG001|Overall Study|Subject choice|2|||
155091965|NCT01870869|559771354|FG002|Overall Study|Subject choice|22|||
155091966|NCT01870869|559771355|FG003|Overall Study|Subject choice|8|||
155091967|NCT01870869|559771352|FG000|Overall Study|Lost to Follow-up|10|||
155091968|NCT01870869|559771353|FG001|Overall Study|Lost to Follow-up|2|||
155091969|NCT01870869|559771354|FG002|Overall Study|Lost to Follow-up|25|||
155091970|NCT01870869|559771355|FG003|Overall Study|Lost to Follow-up|3|||
155091971|NCT01870869|559771352|FG000|Overall Study|Reason not Specified|1|||
155091972|NCT01870869|559771353|FG001|Overall Study|Reason not Specified|2|||
155091973|NCT01870869|559771354|FG002|Overall Study|Reason not Specified|20|||
155091974|NCT01870869|559771355|FG003|Overall Study|Reason not Specified|4|||
155091975|NCT01870869|559771352|FG000|Overall Study|Not evaluable|10|||
155091976|NCT01870869|559771353|FG001|Overall Study|Not evaluable|5|||
155091977|NCT01870869|559771354|FG002|Overall Study|Not evaluable|42|||
155091978|NCT01870869|559771355|FG003|Overall Study|Not evaluable|10|||
155091979|NCT02569853|559771356|FG000|Overall Study|Adverse Event|2|||
155091980|NCT02569853|559771357|FG001|Overall Study|Adverse Event|0|||
155091981|NCT02569853|559771356|FG000|Overall Study|Withdrawal by Subject|3|||
155091982|NCT02569853|559771357|FG001|Overall Study|Withdrawal by Subject|2|||
155091983|NCT02569853|559771356|FG000|Overall Study|Lost to Follow-up|3|||
155091984|NCT02569853|559771357|FG001|Overall Study|Lost to Follow-up|3|||
155091985|NCT02569853|559771356|FG000|Overall Study|Protocol Violation|1|||
155091986|NCT02569853|559771357|FG001|Overall Study|Protocol Violation|1|||
155091987|NCT02569853|559771356|FG000|Overall Study|Did not experience migraine attack|10|||
155091988|NCT02569853|559771357|FG001|Overall Study|Did not experience migraine attack|7|||
155091989|NCT02569853|559771356|FG000|Overall Study|Physician Decision|1|||
155091990|NCT02569853|559771357|FG001|Overall Study|Physician Decision|1|||
155091991|NCT01948427|559771358|FG000|Overall Study|Serious Adverse Event|3|||
155091992|NCT01948427|559771359|FG001|Overall Study|Serious Adverse Event|0|||
155091993|NCT01948427|559771360|FG002|Overall Study|Serious Adverse Event|0|||
155091994|NCT01948427|559771361|FG003|Overall Study|Serious Adverse Event|0|||
155091995|NCT01948427|559771362|FG004|Overall Study|Serious Adverse Event|1|||
155091996|NCT01948427|559771358|FG000|Overall Study|Investigator Request|0|||
155091997|NCT01948427|559771359|FG001|Overall Study|Investigator Request|8|||
155091998|NCT01948427|559771360|FG002|Overall Study|Investigator Request|0|||
155091999|NCT01948427|559771361|FG003|Overall Study|Investigator Request|0|||
155092000|NCT01948427|559771362|FG004|Overall Study|Investigator Request|6|||
155092001|NCT01948427|559771358|FG000|Overall Study|Lost to Follow-up|1|||
155092002|NCT01948427|559771359|FG001|Overall Study|Lost to Follow-up|0|||
155092003|NCT01948427|559771360|FG002|Overall Study|Lost to Follow-up|0|||
155092004|NCT01948427|559771361|FG003|Overall Study|Lost to Follow-up|0|||
155092005|NCT01948427|559771362|FG004|Overall Study|Lost to Follow-up|4|||
155092006|NCT01948427|559771358|FG000|Overall Study|Withdrawal by Subject|2|||
155092007|NCT01948427|559771359|FG001|Overall Study|Withdrawal by Subject|0|||
155092008|NCT01948427|559771360|FG002|Overall Study|Withdrawal by Subject|0|||
155092009|NCT01948427|559771361|FG003|Overall Study|Withdrawal by Subject|0|||
155092010|NCT01948427|559771362|FG004|Overall Study|Withdrawal by Subject|1|||
155092011|NCT01948427|559771358|FG000|Overall Study|Other, Not Specified|1|||
155092012|NCT01948427|559771359|FG001|Overall Study|Other, Not Specified|9|||
155092013|NCT01948427|559771360|FG002|Overall Study|Other, Not Specified|0|||
155092014|NCT01948427|559771361|FG003|Overall Study|Other, Not Specified|0|||
155092015|NCT01948427|559771362|FG004|Overall Study|Other, Not Specified|2|||
155092016|NCT00402987|559771363|FG000|Overall Study|Lack of Efficacy|0|||
155092017|NCT00402987|559771364|FG001|Overall Study|Lack of Efficacy|0|||
155092018|NCT00402987|559771365|FG002|Overall Study|Lack of Efficacy|1|||
155092019|NCT00402987|559771366|FG003|Overall Study|Lack of Efficacy|0|||
155092020|NCT02434081|559771367|FG000|Overall Study|Death (never started treatment)|2|||
155092021|NCT02434081|559771367|FG000|Overall Study|Death|2|||
155092022|NCT02434081|559771367|FG000|Overall Study|Progression|20|||
155092023|NCT02434081|559771367|FG000|Overall Study|Adverse Event|20|||
155092024|NCT02434081|559771367|FG000|Overall Study|Physician Decision|2|||
155092025|NCT02434081|559771367|FG000|Overall Study|Withdrawal by Subject|1|||
155092026|NCT02434081|559771367|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
155092027|NCT02448381|559771374|FG000|Overall Study|Adverse Event|2|||
155092028|NCT02448381|559771375|FG001|Overall Study|Adverse Event|0|||
155092029|NCT02448381|559771374|FG000|Overall Study|Lost to Follow-up|16|||
155092030|NCT02448381|559771375|FG001|Overall Study|Lost to Follow-up|9|||
155092031|NCT02448381|559771374|FG000|Overall Study|Physician Decision|1|||
155092032|NCT02448381|559771375|FG001|Overall Study|Physician Decision|1|||
155092033|NCT02448381|559771374|FG000|Overall Study|Pregnancy|1|||
155092034|NCT02448381|559771375|FG001|Overall Study|Pregnancy|0|||
155092035|NCT02448381|559771374|FG000|Overall Study|Withdrawal by Subject|13|||
155092036|NCT02448381|559771375|FG001|Overall Study|Withdrawal by Subject|9|||
155092037|NCT02448381|559771374|FG000|Overall Study|Noncompliance with Study Procedures|2|||
155092038|NCT02448381|559771375|FG001|Overall Study|Noncompliance with Study Procedures|0|||
155092039|NCT02519842|559771376|FG000|Base Study: Cycle 1|Screening Failure|1|||
155092040|NCT02519842|559771377|FG001|Base Study: Cycle 1|Screening Failure|1|||
155092041|NCT02519842|559771378|FG002|Base Study: Cycle 1|Screening Failure|0|||
155092042|NCT02519842|559771376|FG000|Base Study: Cycle 1|Adverse Event|1|||
155092043|NCT02519842|559771377|FG001|Base Study: Cycle 1|Adverse Event|0|||
155092044|NCT02519842|559771378|FG002|Base Study: Cycle 1|Adverse Event|0|||
155092045|NCT02519842|559771376|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
155092046|NCT02519842|559771377|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
155092047|NCT02519842|559771378|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
155092048|NCT02519842|559771376|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
155169508|NCT00955305|560060167|FG001|Overall Study|Lost to Follow-up|1|||
155092049|NCT02519842|559771377|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
155092050|NCT02519842|559771378|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
155092051|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
155092052|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
155092053|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
155092054|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
155169509|NCT00955305|560060166|FG000|Overall Study|No off-treatment reason submitted|1|||
155092055|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
155092056|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
155092057|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155092058|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
155092059|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
155169510|NCT00955305|560060167|FG001|Overall Study|No off-treatment reason submitted|0|||
155092060|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
155092061|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
155092062|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
155092063|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Death|0|||
155092064|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Death|0|||
155092065|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Death|1|||
155092066|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
155092067|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
155092068|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
155092069|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
155092070|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
155092071|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
155092072|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
155092073|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
155092074|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
155092075|NCT02519842|559771376|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
155092076|NCT02519842|559771377|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
155092077|NCT02519842|559771378|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
155092078|NCT00744861|559771379|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
155092079|NCT00744861|559771380|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
155092080|NCT00744861|559771381|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
155092081|NCT00744861|559771382|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
155092082|NCT00744861|559771379|FG000|Feasibility Stage 1|Pregnancy|0|||
155092083|NCT00744861|559771380|FG001|Feasibility Stage 1|Pregnancy|1|||
155092084|NCT00744861|559771381|FG002|Feasibility Stage 1|Pregnancy|0|||
155092085|NCT00744861|559771382|FG003|Feasibility Stage 1|Pregnancy|0|||
155092086|NCT00744861|559771379|FG000|Pivotal Stage 2|Adverse Event|0|||
155092087|NCT00744861|559771380|FG001|Pivotal Stage 2|Adverse Event|0|||
155092088|NCT00744861|559771381|FG002|Pivotal Stage 2|Adverse Event|6|||
155092089|NCT00744861|559771382|FG003|Pivotal Stage 2|Adverse Event|11|||
155092090|NCT00744861|559771379|FG000|Pivotal Stage 2|Death|0|||
155092091|NCT00744861|559771380|FG001|Pivotal Stage 2|Death|0|||
155092092|NCT00744861|559771381|FG002|Pivotal Stage 2|Death|0|||
155092093|NCT00744861|559771382|FG003|Pivotal Stage 2|Death|1|||
155092094|NCT00744861|559771379|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
155092095|NCT00744861|559771380|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
155092096|NCT00744861|559771381|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
155092097|NCT00744861|559771382|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
155092098|NCT00744861|559771379|FG000|Pivotal Stage 2|Physician Decision|0|||
155092099|NCT00744861|559771380|FG001|Pivotal Stage 2|Physician Decision|0|||
155092100|NCT00744861|559771381|FG002|Pivotal Stage 2|Physician Decision|3|||
155092101|NCT00744861|559771382|FG003|Pivotal Stage 2|Physician Decision|1|||
155092102|NCT00744861|559771379|FG000|Pivotal Stage 2|Protocol Violation|0|||
155092103|NCT00744861|559771380|FG001|Pivotal Stage 2|Protocol Violation|0|||
155092104|NCT00744861|559771381|FG002|Pivotal Stage 2|Protocol Violation|0|||
155092105|NCT00744861|559771382|FG003|Pivotal Stage 2|Protocol Violation|1|||
155092106|NCT00744861|559771379|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
155092107|NCT00744861|559771380|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
155092108|NCT00744861|559771381|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
155092109|NCT00744861|559771382|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
155092110|NCT00744861|559771379|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
155092111|NCT00744861|559771380|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
155092112|NCT00744861|559771381|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
155092113|NCT00744861|559771382|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
155092114|NCT04856527|559771383|FG000|Overall Study|Unable to complete experimental task|2|||
155092115|NCT04856527|559771384|FG001|Overall Study|Unable to complete experimental task|0|||
155092116|NCT02115321|559771385|FG000|Overall Study|Death|1|||
155092117|NCT02115321|559771386|FG001|Overall Study|Death|0|||
155092118|NCT02493764|559771387|FG000|Overall Study|Adverse Event|2|||
155092119|NCT02493764|559771388|FG001|Overall Study|Adverse Event|2|||
155092120|NCT02493764|559771387|FG000|Overall Study|Death|44|||
155092121|NCT02493764|559771388|FG001|Overall Study|Death|58|||
155092122|NCT02493764|559771387|FG000|Overall Study|Lost to Follow-up|2|||
155092123|NCT02493764|559771388|FG001|Overall Study|Lost to Follow-up|1|||
155092124|NCT02493764|559771387|FG000|Overall Study|Protocol Violation|6|||
155092125|NCT02493764|559771388|FG001|Overall Study|Protocol Violation|7|||
155092126|NCT02493764|559771387|FG000|Overall Study|Physician Decision|1|||
155092127|NCT02493764|559771388|FG001|Overall Study|Physician Decision|1|||
155092128|NCT02493764|559771387|FG000|Overall Study|Participant moved|17|||
155092129|NCT02493764|559771388|FG001|Overall Study|Participant moved|5|||
155092130|NCT02493764|559771387|FG000|Overall Study|Withdrawal parent/guardian|0|||
155092131|NCT02493764|559771388|FG001|Overall Study|Withdrawal parent/guardian|1|||
155092132|NCT02493764|559771387|FG000|Overall Study|Withdrawal by Subject|11|||
155092133|NCT02493764|559771388|FG001|Overall Study|Withdrawal by Subject|7|||
155092134|NCT01561976|559771389|FG000|Period 1|Adverse Event|0|||
155092135|NCT01561976|559771390|FG001|Period 1|Adverse Event|0|||
155092136|NCT01561976|559771391|FG002|Period 1|Adverse Event|1|||
155092137|NCT01561976|559771392|FG003|Period 1|Adverse Event|0|||
155092138|NCT01561976|559771393|FG004|Period 1|Adverse Event|0|||
155092139|NCT01561976|559771394|FG005|Period 1|Adverse Event|0|||
155092140|NCT01561976|559771389|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
155092141|NCT01561976|559771390|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
155092142|NCT01561976|559771391|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
155092143|NCT01561976|559771392|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
155092144|NCT01561976|559771393|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
154966494|NCT00540423|559301047|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
154966495|NCT00540423|559301048|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
155092145|NCT01561976|559771394|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
155092146|NCT01561976|559771389|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155092147|NCT01561976|559771390|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155092148|NCT01561976|559771391|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155092149|NCT01561976|559771392|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155092150|NCT01561976|559771393|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
155092151|NCT01561976|559771394|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
155092152|NCT01561976|559771389|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
155092153|NCT01561976|559771390|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
155092154|NCT01561976|559771391|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
155092155|NCT01561976|559771392|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
155092156|NCT01561976|559771393|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
155092157|NCT01561976|559771394|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
155092158|NCT01463527|559771395|FG000|Overall Study|Protocol Violation|1|||
155092159|NCT01463527|559771396|FG001|Overall Study|Protocol Violation|1|||
155092160|NCT01463527|559771395|FG000|Overall Study|Crying >20% of sedation|5|||
155092161|NCT01463527|559771396|FG001|Overall Study|Crying >20% of sedation|6|||
155092162|NCT01977222|559771403|FG000|Overall Study|Withdrawal by Subject|1|||
155092163|NCT04165824|559771404|FG000|Overall Study|Adverse Event|23|||
155092164|NCT04165824|559771404|FG000|Overall Study|Physician Decision|1|||
155092165|NCT04165824|559771404|FG000|Overall Study|Withdrawal by Subject|17|||
155092166|NCT04165824|559771404|FG000|Overall Study|Other|5|||
155092167|NCT04403919|559771405|FG000|Overall Study|Lost to Follow-up|0|||
155092168|NCT04403919|559771406|FG001|Overall Study|Lost to Follow-up|0|||
155092169|NCT04403919|559771407|FG002|Overall Study|Lost to Follow-up|0|||
155092170|NCT04403919|559771408|FG003|Overall Study|Lost to Follow-up|1|||
155092171|NCT04846231|559771412|FG000|Overall Study|Lost to Follow-up|1|||
155092172|NCT04846231|559771413|FG001|Overall Study|Lost to Follow-up|0|||
155092173|NCT04846231|559771414|FG002|Overall Study|Lost to Follow-up|0|||
155092174|NCT04846231|559771415|FG003|Overall Study|Lost to Follow-up|0|||
155092175|NCT04846231|559771416|FG004|Overall Study|Lost to Follow-up|0|||
155092176|NCT04846231|559771417|FG005|Overall Study|Lost to Follow-up|0|||
155092177|NCT04846231|559771418|FG006|Overall Study|Lost to Follow-up|0|||
155092178|NCT04846231|559771419|FG007|Overall Study|Lost to Follow-up|1|||
155092179|NCT04846231|559771412|FG000|Overall Study|Withdrawal by Subject|0|||
155092180|NCT04846231|559771413|FG001|Overall Study|Withdrawal by Subject|1|||
155092181|NCT04846231|559771414|FG002|Overall Study|Withdrawal by Subject|2|||
155092182|NCT04846231|559771415|FG003|Overall Study|Withdrawal by Subject|1|||
155092183|NCT04846231|559771416|FG004|Overall Study|Withdrawal by Subject|0|||
155092184|NCT04846231|559771417|FG005|Overall Study|Withdrawal by Subject|0|||
155092185|NCT04846231|559771418|FG006|Overall Study|Withdrawal by Subject|0|||
155092186|NCT04846231|559771419|FG007|Overall Study|Withdrawal by Subject|0|||
155092187|NCT04846231|559771412|FG000|Overall Study|Protocol Violation|0|||
155092188|NCT04846231|559771413|FG001|Overall Study|Protocol Violation|1|||
155092189|NCT04846231|559771414|FG002|Overall Study|Protocol Violation|0|||
155092190|NCT04846231|559771415|FG003|Overall Study|Protocol Violation|0|||
155092191|NCT04846231|559771416|FG004|Overall Study|Protocol Violation|0|||
155092192|NCT04846231|559771417|FG005|Overall Study|Protocol Violation|0|||
155092193|NCT04846231|559771418|FG006|Overall Study|Protocol Violation|0|||
155092194|NCT04846231|559771419|FG007|Overall Study|Protocol Violation|0|||
154966496|NCT00540423|559301049|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
154966497|NCT02213263|559301054|FG000|Overall Study|Insufficient clinical response|4|||
154966498|NCT02213263|559301055|FG001|Overall Study|Insufficient clinical response|3|||
154966499|NCT02213263|559301054|FG000|Overall Study|Lost to Follow-up|0|||
154966500|NCT02213263|559301055|FG001|Overall Study|Lost to Follow-up|1|||
154966501|NCT02213263|559301054|FG000|Overall Study|No longer willing to participate|3|||
154966502|NCT02213263|559301055|FG001|Overall Study|No longer willing to participate|4|||
154966503|NCT02213263|559301054|FG000|Overall Study|Progressive disease|20|||
154966504|NCT02213263|559301055|FG001|Overall Study|Progressive disease|14|||
154966505|NCT02213263|559301054|FG000|Overall Study|Protocol Violation|0|||
154966506|NCT02213263|559301055|FG001|Overall Study|Protocol Violation|1|||
154966507|NCT02213263|559301054|FG000|Overall Study|Adverse Event|1|||
154966508|NCT02213263|559301055|FG001|Overall Study|Adverse Event|3|||
154966509|NCT01316055|559301057|FG000|Overall Study|Lost to Follow-up|1|||
154966510|NCT01316055|559301058|FG001|Overall Study|Lost to Follow-up|0|||
154966511|NCT01316055|559301059|FG002|Overall Study|Lost to Follow-up|0|||
154966512|NCT00003470|559301060|FG000|Overall Study|Not evaluable|6|||
154966513|NCT02679729|559301062|FG000|Overall Study|Lost to Follow-up|0|||
154966514|NCT02679729|559301063|FG001|Overall Study|Lost to Follow-up|1|||
154966515|NCT02679729|559301064|FG002|Overall Study|Lost to Follow-up|0|||
154966516|NCT02679729|559301065|FG003|Overall Study|Lost to Follow-up|0|||
154966517|NCT02679729|559301066|FG004|Overall Study|Lost to Follow-up|1|||
154966518|NCT02679729|559301067|FG005|Overall Study|Lost to Follow-up|0|||
154966519|NCT02679729|559301068|FG006|Overall Study|Lost to Follow-up|0|||
155169511|NCT00955305|560060166|FG000|Overall Study|Never started protocol treatment|5|||
155169512|NCT00955305|560060167|FG001|Overall Study|Never started protocol treatment|5|||
155169513|NCT00955305|560060166|FG000|Overall Study|Ineligible|5|||
155169514|NCT00955305|560060167|FG001|Overall Study|Ineligible|7|||
155169515|NCT00109590|560060168|FG000|Overall Study|Lost to Follow-up|1|||
155169516|NCT00109590|560060169|FG001|Overall Study|Lost to Follow-up|0|||
155169517|NCT00109590|560060170|FG002|Overall Study|Lost to Follow-up|1|||
155169518|NCT00109590|560060168|FG000|Overall Study|Never Started Treatment|1|||
155169519|NCT00109590|560060169|FG001|Overall Study|Never Started Treatment|2|||
155169520|NCT00109590|560060170|FG002|Overall Study|Never Started Treatment|3|||
155169521|NCT01221285|560060171|FG000|Overall Study|Withdrawal by Subject|1|||
155169522|NCT02123251|560060172|FG000|Overall Study|Death|1|||
155169523|NCT02123251|560060173|FG001|Overall Study|Death|1|||
155169524|NCT02123251|560060172|FG000|Overall Study|Withdrawal by Subject|0|||
155169525|NCT02123251|560060173|FG001|Overall Study|Withdrawal by Subject|3|||
155169526|NCT02123251|560060172|FG000|Overall Study|Lost Medicaid eligibility|29|||
155169527|NCT02123251|560060173|FG001|Overall Study|Lost Medicaid eligibility|22|||
155169528|NCT02123251|560060172|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
155169529|NCT02123251|560060173|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
155169530|NCT00375609|560060177|FG000|Overall Study|Did not receive treatment|1|||
155169531|NCT00375609|560060178|FG001|Overall Study|Did not receive treatment|0|||
155169532|NCT00375609|560060179|FG002|Overall Study|Did not receive treatment|0|||
155169533|NCT00375609|560060177|FG000|Overall Study|Adverse Event|0|||
155169534|NCT00375609|560060178|FG001|Overall Study|Adverse Event|3|||
155169535|NCT00375609|560060179|FG002|Overall Study|Adverse Event|0|||
155169536|NCT00375609|560060177|FG000|Overall Study|Lost to Follow-up|1|||
155169537|NCT00375609|560060178|FG001|Overall Study|Lost to Follow-up|0|||
155169538|NCT00375609|560060179|FG002|Overall Study|Lost to Follow-up|0|||
155169539|NCT00375609|560060177|FG000|Overall Study|Physician Decision|0|||
155169540|NCT00375609|560060178|FG001|Overall Study|Physician Decision|0|||
155169541|NCT00375609|560060179|FG002|Overall Study|Physician Decision|1|||
155169542|NCT00375609|560060177|FG000|Overall Study|Withdrawal by Subject|1|||
155169543|NCT00375609|560060178|FG001|Overall Study|Withdrawal by Subject|4|||
155169544|NCT00375609|560060179|FG002|Overall Study|Withdrawal by Subject|0|||
155169545|NCT00375609|560060177|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
155169546|NCT00375609|560060178|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
155169547|NCT00375609|560060179|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
155169548|NCT03254459|560060180|FG000|Overall Study|Adverse Event|7|||
155169549|NCT03254459|560060181|FG001|Overall Study|Adverse Event|20|||
155169550|NCT03254459|560060180|FG000|Overall Study|Withdrawal by Subject Consent|3|||
155169551|NCT03254459|560060181|FG001|Overall Study|Withdrawal by Subject Consent|1|||
155169552|NCT03254459|560060180|FG000|Overall Study|Lost to Follow-up|0|||
155169553|NCT03254459|560060181|FG001|Overall Study|Lost to Follow-up|1|||
155169554|NCT03254459|560060180|FG000|Overall Study|Miscellaneous|0|||
155169555|NCT03254459|560060181|FG001|Overall Study|Miscellaneous|1|||
155169556|NCT01511055|560060182|FG000|Overall Study|Withdrawal by Subject|6|||
155169557|NCT00669409|560060188|FG000|Part 2|Withdrawal by Subject|0|||
155169558|NCT00669409|560060189|FG001|Part 2|Withdrawal by Subject|0|||
155169559|NCT00669409|560060190|FG002|Part 2|Withdrawal by Subject|0|||
155169560|NCT00669409|560060191|FG003|Part 2|Withdrawal by Subject|0|||
155169561|NCT00669409|560060192|FG004|Part 2|Withdrawal by Subject|0|||
155169562|NCT00669409|560060193|FG005|Part 2|Withdrawal by Subject|0|||
155169563|NCT00669409|560060194|FG006|Part 2|Withdrawal by Subject|0|||
155169564|NCT00669409|560060195|FG007|Part 2|Withdrawal by Subject|0|||
155169565|NCT00669409|560060196|FG008|Part 2|Withdrawal by Subject|0|||
155169566|NCT00669409|560060197|FG009|Part 2|Withdrawal by Subject|1|||
155169567|NCT00669409|560060198|FG010|Part 2|Withdrawal by Subject|0|||
155169568|NCT00813943|560060199|FG000|Overall Study|Ongoing at cut-off date|5|||
155169569|NCT00813943|560060200|FG001|Overall Study|Ongoing at cut-off date|5|||
155169570|NCT00813943|560060201|FG002|Overall Study|Ongoing at cut-off date|3|||
155169571|NCT02704143|560060206|FG000|Overall Study|disease progression|10|||
155169572|NCT01235598|560060207|FG000|Overall Study|Adverse Event|0|||
155169573|NCT01235598|560060208|FG001|Overall Study|Adverse Event|3|||
155169574|NCT01235598|560060207|FG000|Overall Study|Lack of Efficacy|0|||
155169575|NCT01235598|560060208|FG001|Overall Study|Lack of Efficacy|1|||
155169576|NCT01235598|560060207|FG000|Overall Study|Withdrawal by Subject|1|||
155169577|NCT01235598|560060208|FG001|Overall Study|Withdrawal by Subject|0|||
155169578|NCT02551991|560060209|FG000|Overall Study|Death|5|||
155169579|NCT02551991|560060210|FG001|Overall Study|Death|7|||
155169580|NCT02551991|560060211|FG002|Overall Study|Death|8|||
155169581|NCT02551991|560060212|FG003|Overall Study|Death|7|||
155169582|NCT02551991|560060213|FG004|Overall Study|Death|17|||
155169583|NCT02551991|560060209|FG000|Overall Study|Withdrawal by Subject|1|||
155169584|NCT02551991|560060210|FG001|Overall Study|Withdrawal by Subject|0|||
155169585|NCT02551991|560060211|FG002|Overall Study|Withdrawal by Subject|0|||
155169586|NCT02551991|560060212|FG003|Overall Study|Withdrawal by Subject|0|||
155169587|NCT02551991|560060213|FG004|Overall Study|Withdrawal by Subject|2|||
155169588|NCT02551991|560060209|FG000|Overall Study|Lost to Follow-up|0|||
155169589|NCT02551991|560060210|FG001|Overall Study|Lost to Follow-up|0|||
155169590|NCT02551991|560060211|FG002|Overall Study|Lost to Follow-up|1|||
155169591|NCT02551991|560060212|FG003|Overall Study|Lost to Follow-up|0|||
155169592|NCT02551991|560060213|FG004|Overall Study|Lost to Follow-up|0|||
155169593|NCT02551991|560060209|FG000|Overall Study|Sponsor Decision|1|||
155169594|NCT02551991|560060210|FG001|Overall Study|Sponsor Decision|0|||
155169595|NCT02551991|560060211|FG002|Overall Study|Sponsor Decision|1|||
155169596|NCT02551991|560060212|FG003|Overall Study|Sponsor Decision|0|||
155169597|NCT02551991|560060213|FG004|Overall Study|Sponsor Decision|5|||
155092195|NCT04846231|559771412|FG000|Overall Study|Adverse Event|0|||
155092196|NCT04846231|559771413|FG001|Overall Study|Adverse Event|0|||
155092197|NCT04846231|559771414|FG002|Overall Study|Adverse Event|0|||
155092198|NCT04846231|559771415|FG003|Overall Study|Adverse Event|0|||
155092199|NCT04846231|559771416|FG004|Overall Study|Adverse Event|0|||
155092200|NCT04846231|559771417|FG005|Overall Study|Adverse Event|0|||
155092201|NCT04846231|559771418|FG006|Overall Study|Adverse Event|1|||
155092202|NCT04846231|559771419|FG007|Overall Study|Adverse Event|1|||
155092203|NCT02980107|559771420|FG000|Overall Study|Withdrawal by Subject|51|||
155092204|NCT02980107|559771421|FG001|Overall Study|Withdrawal by Subject|62|||
155092205|NCT03746015|559771422|FG000|Overall Study|Withdrawal of Consent|1|||
155092206|NCT03746015|559771423|FG001|Overall Study|Withdrawal of Consent|0|||
155092207|NCT03746015|559771424|FG002|Overall Study|Withdrawal of Consent|0|||
155092208|NCT02412670|559771427|FG000|Overall Study|Adverse Event|4|||
155092209|NCT02412670|559771428|FG001|Overall Study|Adverse Event|1|||
155092210|NCT02412670|559771427|FG000|Overall Study|Physician Decision|1|||
155092211|NCT02412670|559771428|FG001|Overall Study|Physician Decision|0|||
155092212|NCT02412670|559771427|FG000|Overall Study|Withdrawal by Subject|1|||
155092213|NCT02412670|559771428|FG001|Overall Study|Withdrawal by Subject|0|||
155169598|NCT02551991|560060209|FG000|Overall Study|Other|0|||
155169599|NCT02551991|560060210|FG001|Overall Study|Other|0|||
155169600|NCT02551991|560060211|FG002|Overall Study|Other|0|||
155169601|NCT02551991|560060212|FG003|Overall Study|Other|0|||
155169602|NCT02551991|560060213|FG004|Overall Study|Other|1|||
155092214|NCT02412670|559771427|FG000|Overall Study|Ineligible|1|||
155092215|NCT02412670|559771428|FG001|Overall Study|Ineligible|0|||
155169603|NCT00395343|560060214|FG000|Overall Study|Adverse Event|13|||
155092216|NCT01728246|559771432|FG000|Overall Study|Participant needed rescue medication|1|||
155169604|NCT00395343|560060215|FG001|Overall Study|Adverse Event|5|||
155169605|NCT00395343|560060214|FG000|Overall Study|Lack of Efficacy|0|||
155169606|NCT00395343|560060215|FG001|Overall Study|Lack of Efficacy|1|||
155092217|NCT01728246|559771433|FG001|Overall Study|Participant needed rescue medication|5|||
155092218|NCT01728246|559771432|FG000|Overall Study|Protocol Violation|1|||
155092219|NCT01728246|559771433|FG001|Overall Study|Protocol Violation|0|||
155092220|NCT01728246|559771432|FG000|Overall Study|Withdrawal by Subject|2|||
155092221|NCT01728246|559771433|FG001|Overall Study|Withdrawal by Subject|3|||
155092222|NCT01728246|559771432|FG000|Overall Study|Lost to Follow-up|23|||
155092223|NCT01728246|559771433|FG001|Overall Study|Lost to Follow-up|22|||
155092224|NCT01728246|559771432|FG000|Overall Study|Lack of Efficacy|1|||
155092225|NCT01728246|559771433|FG001|Overall Study|Lack of Efficacy|1|||
155092226|NCT01728246|559771432|FG000|Overall Study|Adverse Event|8|||
155092227|NCT01728246|559771433|FG001|Overall Study|Adverse Event|5|||
155092228|NCT05805150|559771434|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
155092229|NCT05805150|559771435|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
155092230|NCT04138056|559771441|FG000|Primary Study|Lost to Follow-up|3|||
155092231|NCT04138056|559771442|FG001|Primary Study|Lost to Follow-up|4|||
155092232|NCT04138056|559771443|FG002|Primary Study|Lost to Follow-up|1|||
155092233|NCT04138056|559771444|FG003|Primary Study|Lost to Follow-up|1|||
155092234|NCT04138056|559771445|FG004|Primary Study|Lost to Follow-up|4|||
155092235|NCT04138056|559771441|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
155092236|NCT04138056|559771442|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
155092237|NCT04138056|559771443|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
155092238|NCT04138056|559771444|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
155092239|NCT04138056|559771445|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
155092240|NCT04138056|559771441|FG000|Extension Study|Lost to Follow-up|1|||
155092241|NCT04138056|559771442|FG001|Extension Study|Lost to Follow-up|2|||
155092242|NCT04138056|559771443|FG002|Extension Study|Lost to Follow-up|1|||
155092243|NCT04138056|559771444|FG003|Extension Study|Lost to Follow-up|0|||
155092244|NCT04138056|559771445|FG004|Extension Study|Lost to Follow-up|1|||
155092245|NCT01959932|559771449|FG000|Overall Study|Withdrawal by Subject|1|||
155092246|NCT01959932|559771450|FG001|Overall Study|Withdrawal by Subject|0|||
155092247|NCT01959932|559771451|FG002|Overall Study|Withdrawal by Subject|0|||
155092248|NCT00397540|559771452|FG000|Overall Study|short follow-up duration < 12 months|1|||
155092249|NCT00397540|559771453|FG001|Overall Study|short follow-up duration < 12 months|0|||
155092250|NCT02589938|559771456|FG000|Overall Study|Withdrawal by Subject|11|||
155092251|NCT02589938|559771457|FG001|Overall Study|Withdrawal by Subject|5|||
155092252|NCT02589938|559771458|FG002|Overall Study|Withdrawal by Subject|6|||
155092253|NCT02589938|559771456|FG000|Overall Study|Lost to Follow-up|3|||
155092254|NCT02589938|559771457|FG001|Overall Study|Lost to Follow-up|3|||
155092255|NCT02589938|559771458|FG002|Overall Study|Lost to Follow-up|3|||
155092256|NCT02589938|559771456|FG000|Overall Study|Death|1|||
155092257|NCT02589938|559771457|FG001|Overall Study|Death|0|||
155092258|NCT02589938|559771458|FG002|Overall Study|Death|1|||
155092259|NCT02589938|559771456|FG000|Overall Study|Protocol Violation|6|||
155092260|NCT02589938|559771457|FG001|Overall Study|Protocol Violation|2|||
155092261|NCT02589938|559771458|FG002|Overall Study|Protocol Violation|3|||
155092262|NCT02589938|559771456|FG000|Overall Study|Physician Decision|1|||
155092263|NCT02589938|559771457|FG001|Overall Study|Physician Decision|0|||
155092264|NCT02589938|559771458|FG002|Overall Study|Physician Decision|0|||
155092265|NCT02589938|559771456|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
155092266|NCT02589938|559771457|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
155092267|NCT02589938|559771458|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
155092268|NCT00485173|559771459|FG000|Overall Study|Death|4|||
155092269|NCT00485173|559771460|FG001|Overall Study|Death|3|||
155092270|NCT00485173|559771459|FG000|Overall Study|Lost to Follow-up|32|||
155092271|NCT00485173|559771460|FG001|Overall Study|Lost to Follow-up|61|||
155092272|NCT00829244|559771467|FG000|Overall Study|Adverse Event|1|||
155092273|NCT00829244|559771468|FG001|Overall Study|Adverse Event|3|||
155092274|NCT00829244|559771467|FG000|Overall Study|Protocol Violation|1|||
155092275|NCT00829244|559771468|FG001|Overall Study|Protocol Violation|0|||
155092276|NCT00829244|559771467|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
155092277|NCT00829244|559771468|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
155092278|NCT00829244|559771467|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
155092279|NCT00829244|559771468|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
155092280|NCT00829244|559771467|FG000|Overall Study|No fertilization|2|||
155092281|NCT00829244|559771468|FG001|Overall Study|No fertilization|2|||
155092282|NCT00829244|559771467|FG000|Overall Study|All embryos discarded|0|||
155092283|NCT00829244|559771468|FG001|Overall Study|All embryos discarded|3|||
155092284|NCT00829244|559771467|FG000|Overall Study|No embryo cleavage|0|||
155092285|NCT00829244|559771468|FG001|Overall Study|No embryo cleavage|2|||
155092286|NCT02297412|559771469|FG000|Overall Study|Canceled|1|||
155092287|NCT02297412|559771470|FG001|Overall Study|Canceled|1|||
155092288|NCT02293551|559771482|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
155092289|NCT02293551|559771483|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
155092290|NCT02293551|559771484|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
155092291|NCT02293551|559771485|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
155092292|NCT02293551|559771486|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
155092293|NCT02293551|559771487|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
155092294|NCT02293551|559771482|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
155092295|NCT02293551|559771483|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
155092296|NCT02293551|559771484|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
155092297|NCT02293551|559771485|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
155092298|NCT02293551|559771486|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
155092299|NCT02293551|559771487|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
155092300|NCT02293551|559771482|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
155092301|NCT02293551|559771483|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
155092302|NCT02293551|559771484|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
155092303|NCT02293551|559771485|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
155092304|NCT02293551|559771486|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
155092305|NCT02293551|559771487|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
155092306|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
155092307|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
155092308|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
155092309|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
155092310|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
155092311|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
155092312|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
155092313|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
155092314|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
155092315|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
155092316|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
155092317|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
155092318|NCT04532749|559771488|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
155092319|NCT04532749|559771489|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
155092320|NCT04532749|559771488|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
155092321|NCT04532749|559771489|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
155092322|NCT04532749|559771488|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
155092323|NCT04532749|559771489|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
155092324|NCT04532749|559771488|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
155092325|NCT04532749|559771489|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
155092326|NCT02936323|559771490|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155092327|NCT02936323|559771491|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155092328|NCT02936323|559771492|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155092329|NCT02936323|559771493|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155092330|NCT02936323|559771494|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155092331|NCT02936323|559771495|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
155092332|NCT02936323|559771496|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155169607|NCT00395343|560060214|FG000|Overall Study|Lost to Follow-up|4|||
154966520|NCT02679729|559301069|FG007|Overall Study|Lost to Follow-up|0|||
155092333|NCT02936323|559771497|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155092334|NCT02936323|559771498|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155092335|NCT02936323|559771499|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
155092336|NCT02936323|559771490|FG000|Phase 1 Dose Escalation|Death|2|||
155092337|NCT02936323|559771491|FG001|Phase 1 Dose Escalation|Death|1|||
155092338|NCT02936323|559771492|FG002|Phase 1 Dose Escalation|Death|3|||
155092339|NCT02936323|559771493|FG003|Phase 1 Dose Escalation|Death|1|||
155092340|NCT02936323|559771494|FG004|Phase 1 Dose Escalation|Death|2|||
154966521|NCT02679729|559301070|FG008|Overall Study|Lost to Follow-up|0|||
155092341|NCT02936323|559771495|FG005|Phase 1 Dose Escalation|Death|3|||
155092342|NCT02936323|559771496|FG006|Phase 1 Dose Escalation|Death|3|||
155092343|NCT02936323|559771497|FG007|Phase 1 Dose Escalation|Death|0|||
155092344|NCT02936323|559771498|FG008|Phase 1 Dose Escalation|Death|0|||
155092345|NCT02936323|559771499|FG009|Phase 1 Dose Escalation|Death|0|||
155092346|NCT02936323|559771490|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092347|NCT02936323|559771491|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092348|NCT02936323|559771492|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092349|NCT02936323|559771493|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092350|NCT02936323|559771494|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092351|NCT02936323|559771495|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
155092352|NCT02936323|559771496|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092353|NCT02936323|559771497|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092354|NCT02936323|559771498|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155169608|NCT00395343|560060215|FG001|Overall Study|Lost to Follow-up|4|||
154966522|NCT02679729|559301062|FG000|Overall Study|Participant decision|0|||
154966523|NCT02679729|559301063|FG001|Overall Study|Participant decision|1|||
154966524|NCT02679729|559301064|FG002|Overall Study|Participant decision|0|||
154966525|NCT02679729|559301065|FG003|Overall Study|Participant decision|0|||
154966526|NCT02679729|559301066|FG004|Overall Study|Participant decision|0|||
154966527|NCT02679729|559301067|FG005|Overall Study|Participant decision|0|||
154966528|NCT02679729|559301068|FG006|Overall Study|Participant decision|1|||
154966529|NCT02679729|559301069|FG007|Overall Study|Participant decision|0|||
154966530|NCT02679729|559301070|FG008|Overall Study|Participant decision|0|||
154966531|NCT00748566|559301071|FG000|Overall Study|Adverse Event|49|||
154966532|NCT00748566|559301071|FG000|Overall Study|Death|1|||
154966533|NCT00748566|559301071|FG000|Overall Study|Lack of Efficacy|12|||
154966534|NCT00748566|559301071|FG000|Overall Study|Lost to Follow-up|1|||
154966535|NCT00748566|559301071|FG000|Overall Study|Protocol Violation|13|||
154966536|NCT00748566|559301071|FG000|Overall Study|Withdrawal by Subject|22|||
154966537|NCT00748566|559301071|FG000|Overall Study|Study terminated by sponsor|5|||
154966538|NCT00748566|559301071|FG000|Overall Study|Other|9|||
154966539|NCT01442376|559301078|FG000|Overall Study|Adverse Event|0|||
154966540|NCT01442376|559301079|FG001|Overall Study|Adverse Event|3|||
154966541|NCT01442376|559301080|FG002|Overall Study|Adverse Event|2|||
154966542|NCT01442376|559301078|FG000|Overall Study|Death|0|||
154966543|NCT01442376|559301079|FG001|Overall Study|Death|1|||
154966544|NCT01442376|559301080|FG002|Overall Study|Death|1|||
154966545|NCT01442376|559301078|FG000|Overall Study|Withdrawal of consent|0|||
154966546|NCT01442376|559301079|FG001|Overall Study|Withdrawal of consent|0|||
154966547|NCT01442376|559301080|FG002|Overall Study|Withdrawal of consent|1|||
154966548|NCT01442376|559301078|FG000|Overall Study|Patients not treated|2|||
154966549|NCT01442376|559301079|FG001|Overall Study|Patients not treated|3|||
154966550|NCT01442376|559301080|FG002|Overall Study|Patients not treated|1|||
154966551|NCT01442376|559301078|FG000|Overall Study|Not eligible for subsequent cycles|1|||
154966552|NCT01442376|559301079|FG001|Overall Study|Not eligible for subsequent cycles|2|||
154966553|NCT01442376|559301080|FG002|Overall Study|Not eligible for subsequent cycles|0|||
154966554|NCT04404725|559301081|FG000|First Intervention|Withdrawal by Subject|0|||
154966555|NCT04404725|559301082|FG001|First Intervention|Withdrawal by Subject|2|||
154966556|NCT04404725|559301081|FG000|Second Intervention|Adverse Event|1|||
154966557|NCT04404725|559301082|FG001|Second Intervention|Adverse Event|1|||
154966558|NCT04404725|559301081|FG000|Second Intervention|Withdrawal by Subject|0|||
154966559|NCT04404725|559301082|FG001|Second Intervention|Withdrawal by Subject|1|||
154966560|NCT01075516|559301083|FG000|Overall Study|Death|5|||
154966561|NCT01075516|559301084|FG001|Overall Study|Death|9|||
154966562|NCT01075516|559301083|FG000|Overall Study|Lost to Follow-up|10|||
154966563|NCT01075516|559301084|FG001|Overall Study|Lost to Follow-up|2|||
154966564|NCT01075516|559301083|FG000|Overall Study|Withdrawal by Subject|3|||
154966565|NCT01075516|559301084|FG001|Overall Study|Withdrawal by Subject|5|||
154966566|NCT01825798|559301085|FG000|Overall Study|Adverse Event|1|||
154966567|NCT01825798|559301086|FG001|Overall Study|Adverse Event|5|||
155169609|NCT00395343|560060214|FG000|Overall Study|Physician Decision|2|||
155169610|NCT00395343|560060215|FG001|Overall Study|Physician Decision|4|||
155169611|NCT00395343|560060214|FG000|Overall Study|Protocol Violation|6|||
154966568|NCT01825798|559301085|FG000|Overall Study|Lost to Follow-up|1|||
154966569|NCT01825798|559301086|FG001|Overall Study|Lost to Follow-up|0|||
154966570|NCT00834873|559301087|FG000|First Intervention|Adverse Event|0|||
154966571|NCT00834873|559301088|FG001|First Intervention|Adverse Event|1|||
155169612|NCT00395343|560060215|FG001|Overall Study|Protocol Violation|8|||
155092355|NCT02936323|559771499|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
155092356|NCT02936323|559771490|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092357|NCT02936323|559771491|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092358|NCT02936323|559771492|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092359|NCT02936323|559771493|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092360|NCT02936323|559771494|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092361|NCT02936323|559771495|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092362|NCT02936323|559771496|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
155092363|NCT02936323|559771497|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
155092364|NCT02936323|559771498|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
155092365|NCT02936323|559771499|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
155092366|NCT02936323|559771490|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
155092367|NCT02936323|559771491|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
155092368|NCT02936323|559771492|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
155092369|NCT02936323|559771493|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
155092370|NCT02936323|559771494|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
155092371|NCT02936323|559771495|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
155092372|NCT02936323|559771496|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
155092373|NCT02936323|559771497|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
155092374|NCT02936323|559771498|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
155092375|NCT02936323|559771499|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
155092376|NCT02936323|559771490|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092377|NCT02936323|559771491|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092378|NCT02936323|559771492|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092379|NCT02936323|559771493|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092380|NCT02936323|559771494|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092381|NCT02936323|559771495|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092382|NCT02936323|559771496|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092383|NCT02936323|559771497|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
155092384|NCT02936323|559771498|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
155092385|NCT02936323|559771499|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
155092386|NCT02936323|559771490|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092387|NCT02936323|559771491|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092388|NCT02936323|559771492|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092389|NCT02936323|559771493|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092390|NCT02936323|559771494|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092391|NCT02936323|559771495|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092392|NCT02936323|559771496|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092393|NCT02936323|559771497|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092394|NCT02936323|559771498|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
155092395|NCT02936323|559771499|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
155092396|NCT02936323|559771490|FG000|Phase 2a Dose Expansion|Death|0|||
155092397|NCT02936323|559771491|FG001|Phase 2a Dose Expansion|Death|0|||
155092398|NCT02936323|559771492|FG002|Phase 2a Dose Expansion|Death|0|||
155092399|NCT02936323|559771493|FG003|Phase 2a Dose Expansion|Death|0|||
155092400|NCT02936323|559771494|FG004|Phase 2a Dose Expansion|Death|0|||
155092401|NCT02936323|559771495|FG005|Phase 2a Dose Expansion|Death|0|||
154966572|NCT02055547|559301089|FG000|Overall Study|Protocol Violation|0|||
154966573|NCT02055547|559301090|FG001|Overall Study|Protocol Violation|0|||
155092402|NCT02936323|559771496|FG006|Phase 2a Dose Expansion|Death|0|||
155092403|NCT02936323|559771497|FG007|Phase 2a Dose Expansion|Death|4|||
155092404|NCT02936323|559771498|FG008|Phase 2a Dose Expansion|Death|8|||
154966574|NCT02055547|559301091|FG002|Overall Study|Protocol Violation|1|||
155092405|NCT02936323|559771499|FG009|Phase 2a Dose Expansion|Death|10|||
155092406|NCT01334918|559773576|FG000|Overall Study|Did not receive study drug|6|||
155092407|NCT01334918|559773577|FG001|Overall Study|Did not receive study drug|0|||
155092408|NCT01334918|559773576|FG000|Overall Study|Adverse Event|2|||
155092409|NCT01334918|559773577|FG001|Overall Study|Adverse Event|0|||
155092410|NCT01334918|559773576|FG000|Overall Study|Withdrawal by Subject|0|||
155092411|NCT01334918|559773577|FG001|Overall Study|Withdrawal by Subject|1|||
155092412|NCT00529633|559773578|FG000|Overall Study|Withdrawal by Subject|1|||
155092413|NCT00529633|559773579|FG001|Overall Study|Withdrawal by Subject|1|||
155092414|NCT01576783|559773583|FG000|Overall Study|Change in Medical Care|1|||
155092415|NCT01576783|559773584|FG001|Overall Study|Change in Medical Care|0|||
155092416|NCT01576783|559773583|FG000|Overall Study|Lost to Follow-up|14|||
155092417|NCT01576783|559773584|FG001|Overall Study|Lost to Follow-up|16|||
155092418|NCT01576783|559773583|FG000|Overall Study|Withdrawal by Subject|5|||
155092419|NCT01576783|559773584|FG001|Overall Study|Withdrawal by Subject|1|||
155092420|NCT05489328|559773586|FG000|Overall Study|Lost to Follow-up|0|||
155092421|NCT05489328|559773587|FG001|Overall Study|Lost to Follow-up|0|||
155092422|NCT05489328|559773588|FG002|Overall Study|Lost to Follow-up|1|||
155092423|NCT05489328|559773589|FG003|Overall Study|Lost to Follow-up|0|||
155092424|NCT05489328|559773590|FG004|Overall Study|Lost to Follow-up|2|||
155092425|NCT05489328|559773591|FG005|Overall Study|Lost to Follow-up|0|||
155092426|NCT05489328|559773592|FG006|Overall Study|Lost to Follow-up|0|||
155092427|NCT05489328|559773593|FG007|Overall Study|Lost to Follow-up|1|||
155092428|NCT05489328|559773594|FG008|Overall Study|Lost to Follow-up|0|||
155092429|NCT05489328|559773586|FG000|Overall Study|Withdrawal by Subject|0|||
155092430|NCT05489328|559773587|FG001|Overall Study|Withdrawal by Subject|0|||
155092431|NCT05489328|559773588|FG002|Overall Study|Withdrawal by Subject|0|||
155092432|NCT05489328|559773589|FG003|Overall Study|Withdrawal by Subject|0|||
155092433|NCT05489328|559773590|FG004|Overall Study|Withdrawal by Subject|0|||
155092434|NCT05489328|559773591|FG005|Overall Study|Withdrawal by Subject|0|||
155092435|NCT05489328|559773592|FG006|Overall Study|Withdrawal by Subject|1|||
155092436|NCT05489328|559773593|FG007|Overall Study|Withdrawal by Subject|1|||
155092437|NCT05489328|559773594|FG008|Overall Study|Withdrawal by Subject|0|||
155092438|NCT05489328|559773586|FG000|Overall Study|Other|0|||
155092439|NCT05489328|559773587|FG001|Overall Study|Other|0|||
155092440|NCT05489328|559773588|FG002|Overall Study|Other|0|||
155092441|NCT05489328|559773589|FG003|Overall Study|Other|0|||
155092442|NCT05489328|559773590|FG004|Overall Study|Other|0|||
155092443|NCT05489328|559773591|FG005|Overall Study|Other|0|||
155092444|NCT05489328|559773592|FG006|Overall Study|Other|0|||
155092445|NCT05489328|559773593|FG007|Overall Study|Other|1|||
155092446|NCT05489328|559773594|FG008|Overall Study|Other|1|||
155092447|NCT01083602|559773595|FG000|Overall Study|Adverse Event|11|||
155092448|NCT01083602|559773595|FG000|Overall Study|New Cancer Therapy|2|||
155092449|NCT01083602|559773595|FG000|Overall Study|Death|1|||
155092450|NCT01083602|559773595|FG000|Overall Study|Withdrawal by Subject|5|||
155092451|NCT01083602|559773595|FG000|Overall Study|Lack of Efficacy|36|||
155092452|NCT01657370|559773597|FG000|Overall Study|Withdrawal by Subject|0|||
155092453|NCT01657370|559773598|FG001|Overall Study|Withdrawal by Subject|0|||
155092454|NCT01657370|559773599|FG002|Overall Study|Withdrawal by Subject|1|||
155092455|NCT01657370|559773600|FG003|Overall Study|Withdrawal by Subject|0|||
155092456|NCT01657370|559773601|FG004|Overall Study|Withdrawal by Subject|0|||
155092457|NCT01657370|559773602|FG005|Overall Study|Withdrawal by Subject|1|||
155092458|NCT01657370|559773597|FG000|Overall Study|Physician Decision|2|||
155092459|NCT01657370|559773598|FG001|Overall Study|Physician Decision|3|||
155092460|NCT01657370|559773599|FG002|Overall Study|Physician Decision|1|||
155092461|NCT01657370|559773600|FG003|Overall Study|Physician Decision|2|||
155092462|NCT01657370|559773601|FG004|Overall Study|Physician Decision|5|||
155092463|NCT01657370|559773602|FG005|Overall Study|Physician Decision|0|||
155092464|NCT01657370|559773597|FG000|Overall Study|Lack of Qualifying Event|1|||
155092465|NCT01657370|559773598|FG001|Overall Study|Lack of Qualifying Event|0|||
155092466|NCT01657370|559773599|FG002|Overall Study|Lack of Qualifying Event|3|||
155092467|NCT01657370|559773600|FG003|Overall Study|Lack of Qualifying Event|2|||
155092468|NCT01657370|559773601|FG004|Overall Study|Lack of Qualifying Event|1|||
155092469|NCT01657370|559773602|FG005|Overall Study|Lack of Qualifying Event|2|||
155092470|NCT01657370|559773597|FG000|Overall Study|Adverse Event|0|||
155092471|NCT01657370|559773598|FG001|Overall Study|Adverse Event|0|||
155092472|NCT01657370|559773599|FG002|Overall Study|Adverse Event|0|||
155092473|NCT01657370|559773600|FG003|Overall Study|Adverse Event|0|||
155092474|NCT01657370|559773601|FG004|Overall Study|Adverse Event|1|||
155092475|NCT01657370|559773602|FG005|Overall Study|Adverse Event|0|||
155092476|NCT01657370|559773597|FG000|Overall Study|Protocol Violation|1|||
155092477|NCT01657370|559773598|FG001|Overall Study|Protocol Violation|1|||
155092478|NCT01657370|559773599|FG002|Overall Study|Protocol Violation|1|||
155092479|NCT01657370|559773600|FG003|Overall Study|Protocol Violation|1|||
155092480|NCT01657370|559773601|FG004|Overall Study|Protocol Violation|0|||
155092481|NCT01657370|559773602|FG005|Overall Study|Protocol Violation|0|||
155092482|NCT01657370|559773597|FG000|Overall Study|Lost to Follow-up|2|||
155092483|NCT01657370|559773598|FG001|Overall Study|Lost to Follow-up|0|||
155092484|NCT01657370|559773599|FG002|Overall Study|Lost to Follow-up|1|||
155092485|NCT01657370|559773600|FG003|Overall Study|Lost to Follow-up|0|||
155092486|NCT01657370|559773601|FG004|Overall Study|Lost to Follow-up|0|||
155092487|NCT01657370|559773602|FG005|Overall Study|Lost to Follow-up|1|||
155092488|NCT02777086|559773603|FG000|Overall Study|Lost to Follow-up|96|||
154966575|NCT02055547|559301092|FG003|Overall Study|Protocol Violation|0|||
154966576|NCT02055547|559301093|FG004|Overall Study|Protocol Violation|0|||
154966577|NCT02055547|559301094|FG005|Overall Study|Protocol Violation|0|||
155169613|NCT00395343|560060214|FG000|Overall Study|Withdrawal by Subject|11|||
155169614|NCT00395343|560060215|FG001|Overall Study|Withdrawal by Subject|12|||
155169615|NCT00395343|560060214|FG000|Overall Study|Other|5|||
155169616|NCT00395343|560060215|FG001|Overall Study|Other|2|||
155169617|NCT00942994|560060219|FG000|Overall Study|Adverse Event|7|||
155169618|NCT00942994|560060220|FG001|Overall Study|Adverse Event|4|||
155169619|NCT00942994|560060219|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155169620|NCT00942994|560060220|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155169621|NCT00942994|560060219|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155169622|NCT00942994|560060220|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155169623|NCT00942994|560060219|FG000|Overall Study|Patient withdrew consent|5|||
155169624|NCT00942994|560060220|FG001|Overall Study|Patient withdrew consent|8|||
155169625|NCT00942994|560060219|FG000|Overall Study|Lost to Follow-up|1|||
155169626|NCT00942994|560060220|FG001|Overall Study|Lost to Follow-up|4|||
155169627|NCT00942994|560060219|FG000|Overall Study|Protocol deviation|1|||
155169628|NCT00942994|560060220|FG001|Overall Study|Protocol deviation|2|||
155169629|NCT00387790|560060221|FG000|Overall Study|Adverse Event|5|||
155169630|NCT00387790|560060221|FG000|Overall Study|Lack of Efficacy|2|||
155169631|NCT00387790|560060221|FG000|Overall Study|Physician Decision|2|||
155169632|NCT00387790|560060221|FG000|Overall Study|Withdrawal by Subject|3|||
155169633|NCT00387790|560060221|FG000|Overall Study|Ineligible for study|2|||
155169634|NCT04491604|560060222|FG000|Overall Study|Withdrawal by Subject|3|||
155169635|NCT01874340|560060225|FG000|Overall Study|Study terminated by Sponsor|6|||
155169636|NCT01874340|560060226|FG001|Overall Study|Study terminated by Sponsor|8|||
155169637|NCT01874340|560060227|FG002|Overall Study|Study terminated by Sponsor|8|||
155169638|NCT01874340|560060228|FG003|Overall Study|Study terminated by Sponsor|4|||
155169639|NCT01874340|560060225|FG000|Overall Study|Withdrawal by Subject|0|||
155169640|NCT01874340|560060226|FG001|Overall Study|Withdrawal by Subject|0|||
155169641|NCT01874340|560060227|FG002|Overall Study|Withdrawal by Subject|0|||
155169642|NCT01874340|560060228|FG003|Overall Study|Withdrawal by Subject|1|||
155169643|NCT03539549|560060230|FG000|Overall Study|Adverse Event|12|||
155169644|NCT03539549|560060230|FG000|Overall Study|Lost to Follow-up|1|||
155169645|NCT03539549|560060230|FG000|Overall Study|Death|2|||
155169646|NCT03539549|560060230|FG000|Overall Study|Progressive Disease|1|||
155169647|NCT03539549|560060230|FG000|Overall Study|Reason not Specified|1|||
155169648|NCT03263702|560060234|FG000|Overall Study|Lost to Follow-up|2|||
155169649|NCT03263702|560060235|FG001|Overall Study|Lost to Follow-up|2|||
155169650|NCT03263702|560060234|FG000|Overall Study|Withdrawal by Subject|1|||
155169651|NCT03263702|560060235|FG001|Overall Study|Withdrawal by Subject|2|||
155169652|NCT03598114|560060236|FG000|Overall Study|Staff turnover/left the program|3|||
155169653|NCT03598114|560060237|FG001|Overall Study|Staff turnover/left the program|39|||
155169654|NCT02527200|560060238|FG000|Overall Study|Withdrawal by Subject|3|||
155169655|NCT02527200|560060239|FG001|Overall Study|Withdrawal by Subject|2|||
155169656|NCT02527200|560060240|FG002|Overall Study|Withdrawal by Subject|1|||
155169657|NCT02527200|560060241|FG003|Overall Study|Withdrawal by Subject|0|||
155169658|NCT02527200|560060238|FG000|Overall Study|Unclassified|0|||
155169659|NCT02527200|560060239|FG001|Overall Study|Unclassified|1|||
155169660|NCT02527200|560060240|FG002|Overall Study|Unclassified|0|||
155169661|NCT02527200|560060241|FG003|Overall Study|Unclassified|0|||
155169662|NCT02527200|560060238|FG000|Overall Study|Lost to Follow-up|0|||
155169663|NCT02527200|560060239|FG001|Overall Study|Lost to Follow-up|0|||
155169664|NCT02527200|560060240|FG002|Overall Study|Lost to Follow-up|1|||
155169665|NCT02527200|560060241|FG003|Overall Study|Lost to Follow-up|0|||
155169666|NCT04540198|560060242|FG000|Overall Study|Lost to Follow-up|25|||
155169667|NCT04540198|560060243|FG001|Overall Study|Lost to Follow-up|23|||
155169668|NCT04540198|560060242|FG000|Overall Study|Withdrawal by Subject|15|||
155169669|NCT04540198|560060243|FG001|Overall Study|Withdrawal by Subject|9|||
155169670|NCT04540198|560060242|FG000|Overall Study|Discontinued|1|||
155169671|NCT04540198|560060243|FG001|Overall Study|Discontinued|0|||
155169672|NCT03110770|560060245|FG000|Overall Study|Death|1|||
155169673|NCT03110770|560060246|FG001|Overall Study|Death|0|||
155169674|NCT03110770|560060247|FG002|Overall Study|Death|0|||
155169675|NCT03110770|560060248|FG003|Overall Study|Death|1|||
155169676|NCT03110770|560060249|FG004|Overall Study|Death|0|||
155169677|NCT03110770|560060245|FG000|Overall Study|Enrolled but did not receive product|0|||
155169678|NCT03110770|560060246|FG001|Overall Study|Enrolled but did not receive product|0|||
155169679|NCT03110770|560060247|FG002|Overall Study|Enrolled but did not receive product|0|||
155169680|NCT03110770|560060248|FG003|Overall Study|Enrolled but did not receive product|8|||
155169681|NCT03110770|560060249|FG004|Overall Study|Enrolled but did not receive product|7|||
155169682|NCT03110770|560060245|FG000|Overall Study|Lost to Follow-up|0|||
155169683|NCT03110770|560060246|FG001|Overall Study|Lost to Follow-up|0|||
155169684|NCT03110770|560060247|FG002|Overall Study|Lost to Follow-up|0|||
155169685|NCT03110770|560060248|FG003|Overall Study|Lost to Follow-up|53|||
155169686|NCT03110770|560060249|FG004|Overall Study|Lost to Follow-up|45|||
155169687|NCT03110770|560060245|FG000|Overall Study|Investigator Decision|0|||
155169688|NCT03110770|560060246|FG001|Overall Study|Investigator Decision|0|||
154966578|NCT02055547|559301095|FG006|Overall Study|Protocol Violation|1|||
154966579|NCT02055547|559301096|FG007|Overall Study|Protocol Violation|0|||
154966580|NCT02055547|559301097|FG008|Overall Study|Protocol Violation|0|||
154966581|NCT02055547|559301098|FG009|Overall Study|Protocol Violation|0|||
154966582|NCT02055547|559301099|FG010|Overall Study|Protocol Violation|0|||
155169689|NCT03110770|560060247|FG002|Overall Study|Investigator Decision|0|||
155169690|NCT03110770|560060248|FG003|Overall Study|Investigator Decision|5|||
155169691|NCT03110770|560060249|FG004|Overall Study|Investigator Decision|3|||
155169692|NCT03110770|560060245|FG000|Overall Study|Withdrawal by Subject|0|||
155169693|NCT03110770|560060246|FG001|Overall Study|Withdrawal by Subject|0|||
155169694|NCT03110770|560060247|FG002|Overall Study|Withdrawal by Subject|0|||
155169695|NCT03110770|560060248|FG003|Overall Study|Withdrawal by Subject|24|||
155169696|NCT03110770|560060249|FG004|Overall Study|Withdrawal by Subject|24|||
155169697|NCT03110770|560060245|FG000|Overall Study|Moved from area|5|||
155169698|NCT03110770|560060246|FG001|Overall Study|Moved from area|0|||
155169699|NCT03110770|560060247|FG002|Overall Study|Moved from area|2|||
155169700|NCT03110770|560060248|FG003|Overall Study|Moved from area|42|||
155169701|NCT03110770|560060249|FG004|Overall Study|Moved from area|43|||
155169702|NCT03110770|560060245|FG000|Overall Study|Illness/Injury unrelated to product|0|||
155169703|NCT03110770|560060246|FG001|Overall Study|Illness/Injury unrelated to product|0|||
155169704|NCT03110770|560060247|FG002|Overall Study|Illness/Injury unrelated to product|0|||
155169705|NCT03110770|560060248|FG003|Overall Study|Illness/Injury unrelated to product|0|||
155169706|NCT03110770|560060249|FG004|Overall Study|Illness/Injury unrelated to product|1|||
155169707|NCT02888119|560060254|FG000|Overall Study|Lost to Follow-up|5|||
155169708|NCT02888119|560060255|FG001|Overall Study|Lost to Follow-up|4|||
155169709|NCT02888119|560060256|FG002|Overall Study|Lost to Follow-up|0|||
155169710|NCT01625260|560060260|FG000|Overall Study|Adverse Event|3|||
155169711|NCT01625260|560060261|FG001|Overall Study|Adverse Event|0|||
155169712|NCT01625260|560060260|FG000|Overall Study|Study Terminated by Investigator|2|||
154966583|NCT02055547|559301100|FG011|Overall Study|Protocol Violation|0|||
154966584|NCT02055547|559301101|FG012|Overall Study|Protocol Violation|0|||
155169713|NCT01625260|560060261|FG001|Overall Study|Study Terminated by Investigator|0|||
155169714|NCT01625260|560060260|FG000|Overall Study|Disease Progression|2|||
155169715|NCT01625260|560060261|FG001|Overall Study|Disease Progression|0|||
155169716|NCT01625260|560060260|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
155169717|NCT01625260|560060261|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
155169718|NCT04195893|560060262|FG000|Second Intervention|Withdrawal by Subject|1|||
154966585|NCT02055547|559301102|FG013|Overall Study|Protocol Violation|0|||
155169719|NCT04195893|560060263|FG001|Second Intervention|Withdrawal by Subject|0|||
155169720|NCT02745145|560060264|FG000|Overall Study|Adverse Event|1|||
155169721|NCT02745145|560060265|FG001|Overall Study|Adverse Event|0|||
155169722|NCT02745145|560060266|FG002|Overall Study|Adverse Event|0|||
155169723|NCT02745145|560060264|FG000|Overall Study|Death|0|||
154966586|NCT02055547|559301103|FG014|Overall Study|Protocol Violation|0|||
155169724|NCT02745145|560060265|FG001|Overall Study|Death|1|||
155169725|NCT02745145|560060266|FG002|Overall Study|Death|0|||
155169726|NCT02745145|560060264|FG000|Overall Study|Progressive disease|0|||
155169727|NCT02745145|560060265|FG001|Overall Study|Progressive disease|0|||
155169728|NCT02745145|560060266|FG002|Overall Study|Progressive disease|1|||
155169729|NCT02745145|560060264|FG000|Overall Study|Withdrew consent|1|||
155169730|NCT02745145|560060265|FG001|Overall Study|Withdrew consent|1|||
155169731|NCT02745145|560060266|FG002|Overall Study|Withdrew consent|1|||
155169732|NCT02745145|560060264|FG000|Overall Study|Study Termination|8|||
155169733|NCT02745145|560060265|FG001|Overall Study|Study Termination|3|||
155169734|NCT02745145|560060266|FG002|Overall Study|Study Termination|7|||
155169735|NCT04413617|560060267|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155169736|NCT04413617|560060268|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155169737|NCT04413617|560060269|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155169738|NCT04413617|560060270|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
155169739|NCT04413617|560060271|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
155169740|NCT04413617|560060267|FG000|Overall Study|Protocol Violation|0|||
155169741|NCT04413617|560060268|FG001|Overall Study|Protocol Violation|1|||
155169742|NCT04413617|560060269|FG002|Overall Study|Protocol Violation|0|||
155169743|NCT04413617|560060270|FG003|Overall Study|Protocol Violation|0|||
155169744|NCT04413617|560060271|FG004|Overall Study|Protocol Violation|1|||
155169745|NCT04413617|560060267|FG000|Overall Study|Lack of Efficacy|2|||
155169746|NCT04413617|560060268|FG001|Overall Study|Lack of Efficacy|0|||
155169747|NCT04413617|560060269|FG002|Overall Study|Lack of Efficacy|2|||
155169748|NCT04413617|560060270|FG003|Overall Study|Lack of Efficacy|1|||
155169749|NCT04413617|560060271|FG004|Overall Study|Lack of Efficacy|0|||
155169750|NCT04413617|560060267|FG000|Overall Study|Withdrawal by Subject|3|||
155169751|NCT04413617|560060268|FG001|Overall Study|Withdrawal by Subject|4|||
155169752|NCT04413617|560060269|FG002|Overall Study|Withdrawal by Subject|2|||
155169753|NCT04413617|560060270|FG003|Overall Study|Withdrawal by Subject|5|||
155169754|NCT04413617|560060271|FG004|Overall Study|Withdrawal by Subject|3|||
155169755|NCT04413617|560060267|FG000|Overall Study|Death|1|||
155169756|NCT04413617|560060268|FG001|Overall Study|Death|0|||
155169757|NCT04413617|560060269|FG002|Overall Study|Death|0|||
155169758|NCT04413617|560060270|FG003|Overall Study|Death|0|||
155169759|NCT04413617|560060271|FG004|Overall Study|Death|0|||
155169760|NCT04413617|560060267|FG000|Overall Study|Adverse Event|1|||
155169761|NCT04413617|560060268|FG001|Overall Study|Adverse Event|0|||
155169762|NCT04413617|560060269|FG002|Overall Study|Adverse Event|0|||
155169763|NCT04413617|560060270|FG003|Overall Study|Adverse Event|1|||
155169764|NCT04413617|560060271|FG004|Overall Study|Adverse Event|1|||
155169765|NCT04413617|560060267|FG000|Overall Study|COVID-19|0|||
155169766|NCT04413617|560060268|FG001|Overall Study|COVID-19|1|||
155169767|NCT04413617|560060269|FG002|Overall Study|COVID-19|0|||
155169768|NCT04413617|560060270|FG003|Overall Study|COVID-19|0|||
155169769|NCT04413617|560060271|FG004|Overall Study|COVID-19|0|||
155169770|NCT00775593|560060272|FG000|Overall Study|Unmet eligibility criteria|6|||
155169771|NCT00775593|560060272|FG000|Overall Study|Death|1|||
155169772|NCT01327482|560060273|FG000|Overall Study|Adverse Event|1|||
155169773|NCT00312195|560060274|FG000|Overall Study|Adverse Event|4|||
155169774|NCT00312195|560060275|FG001|Overall Study|Adverse Event|6|||
155169775|NCT00312195|560060274|FG000|Overall Study|Lost to Follow-up|1|||
155169776|NCT00312195|560060275|FG001|Overall Study|Lost to Follow-up|0|||
155169777|NCT00312195|560060274|FG000|Overall Study|Protocol Violation|1|||
155169778|NCT00312195|560060275|FG001|Overall Study|Protocol Violation|0|||
155169779|NCT01018810|560060278|FG000|Overall Study|Withdrawal by Subject|0|||
155169780|NCT01018810|560060279|FG001|Overall Study|Withdrawal by Subject|1|||
155169781|NCT01018810|560060280|FG002|Overall Study|Withdrawal by Subject|0|||
155169782|NCT01018810|560060281|FG003|Overall Study|Withdrawal by Subject|0|||
155169783|NCT01018810|560060282|FG004|Overall Study|Withdrawal by Subject|0|||
155169784|NCT01018810|560060278|FG000|Overall Study|Sponsor Decision|2|||
155169785|NCT01018810|560060279|FG001|Overall Study|Sponsor Decision|0|||
155169786|NCT01018810|560060280|FG002|Overall Study|Sponsor Decision|1|||
155169787|NCT01018810|560060281|FG003|Overall Study|Sponsor Decision|1|||
155169788|NCT01018810|560060282|FG004|Overall Study|Sponsor Decision|1|||
155169789|NCT02872935|560060283|FG000|Overall Study|Other|0|||
155169790|NCT02872935|560060284|FG001|Overall Study|Other|1|||
155169791|NCT03179319|560060285|FG000|Overall Study|Lost to Follow-up|6|||
155169792|NCT03179319|560060286|FG001|Overall Study|Lost to Follow-up|0|||
155169793|NCT01120717|560060287|FG000|Overall Study|Withdrawal by Subject|11|||
155169794|NCT01120717|560060288|FG001|Overall Study|Withdrawal by Subject|6|||
155169795|NCT01120717|560060287|FG000|Overall Study|Adverse Event|10|||
155169796|NCT01120717|560060288|FG001|Overall Study|Adverse Event|6|||
155169797|NCT01120717|560060287|FG000|Overall Study|Protocol Deviation|2|||
155169798|NCT01120717|560060288|FG001|Overall Study|Protocol Deviation|5|||
155169799|NCT01120717|560060287|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155169800|NCT01120717|560060288|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155169801|NCT01120717|560060287|FG000|Overall Study|Lost to Follow-up|2|||
155169802|NCT01120717|560060288|FG001|Overall Study|Lost to Follow-up|3|||
155169803|NCT01120717|560060287|FG000|Overall Study|Death|3|||
155169804|NCT01120717|560060288|FG001|Overall Study|Death|1|||
155169805|NCT01120717|560060287|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155169806|NCT01120717|560060288|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155169807|NCT00947882|560060293|FG000|Overall Study|Adverse Event|0|||
155169808|NCT00947882|560060294|FG001|Overall Study|Adverse Event|1|||
155169809|NCT00947882|560060295|FG002|Overall Study|Adverse Event|4|||
155169810|NCT00947882|560060296|FG003|Overall Study|Adverse Event|4|||
155169811|NCT00947882|560060293|FG000|Overall Study|Withdrawal by Subject|2|||
155169812|NCT00947882|560060294|FG001|Overall Study|Withdrawal by Subject|0|||
155169813|NCT00947882|560060295|FG002|Overall Study|Withdrawal by Subject|8|||
155169814|NCT00947882|560060296|FG003|Overall Study|Withdrawal by Subject|2|||
155169815|NCT00947882|560060293|FG000|Overall Study|Protocol Violation|0|||
155169816|NCT00947882|560060294|FG001|Overall Study|Protocol Violation|0|||
155169817|NCT00947882|560060295|FG002|Overall Study|Protocol Violation|1|||
155169818|NCT00947882|560060296|FG003|Overall Study|Protocol Violation|0|||
155169819|NCT00947882|560060293|FG000|Overall Study|Lost to Follow-up|0|||
154966587|NCT02055547|559301104|FG015|Overall Study|Protocol Violation|0|||
155169820|NCT00947882|560060294|FG001|Overall Study|Lost to Follow-up|2|||
155169821|NCT00947882|560060295|FG002|Overall Study|Lost to Follow-up|1|||
155169822|NCT00947882|560060296|FG003|Overall Study|Lost to Follow-up|0|||
155169823|NCT00947882|560060293|FG000|Overall Study|Other/Unknown|10|||
155169824|NCT00947882|560060294|FG001|Overall Study|Other/Unknown|13|||
155169825|NCT00947882|560060295|FG002|Overall Study|Other/Unknown|3|||
155169826|NCT00947882|560060296|FG003|Overall Study|Other/Unknown|6|||
155169827|NCT00947882|560060293|FG000|Overall Study|Trial Terminated by Sponsor|62|||
155169828|NCT00947882|560060294|FG001|Overall Study|Trial Terminated by Sponsor|61|||
155169829|NCT00947882|560060295|FG002|Overall Study|Trial Terminated by Sponsor|62|||
155169830|NCT00947882|560060296|FG003|Overall Study|Trial Terminated by Sponsor|70|||
155169831|NCT02695420|560060297|FG000|Overall Study|Death|0|||
155169832|NCT02695420|560060298|FG001|Overall Study|Death|1|||
154966588|NCT02055547|559301105|FG016|Overall Study|Protocol Violation|0|||
154966589|NCT02055547|559301106|FG017|Overall Study|Protocol Violation|0|||
155169833|NCT02695420|560060299|FG002|Overall Study|Death|0|||
155169834|NCT02695420|560060300|FG003|Overall Study|Death|0|||
155169835|NCT02929407|560060301|FG000|Overall Study|Adverse Event|1|||
155169836|NCT04530136|560060302|FG000|Overall Study|Lost to Follow-up|2|||
155169837|NCT04530136|560060303|FG001|Overall Study|Lost to Follow-up|3|||
155169838|NCT04530136|560060302|FG000|Overall Study|Withdrawal by Subject|1|||
155169839|NCT04530136|560060303|FG001|Overall Study|Withdrawal by Subject|0|||
155169840|NCT04530136|560060302|FG000|Overall Study|Death|0|||
155169841|NCT04530136|560060303|FG001|Overall Study|Death|1|||
155169842|NCT02055118|560060304|FG000|Overall Study|Withdrawal by Subject|0|||
155169843|NCT02055118|560060305|FG001|Overall Study|Withdrawal by Subject|2|||
155169844|NCT02055118|560060306|FG002|Overall Study|Withdrawal by Subject|0|||
155169845|NCT02281383|560060308|FG000|Overall Study|Progressive Disease|1|||
155169846|NCT02281383|560060308|FG000|Overall Study|Withdrawal by Subject|6|||
155169847|NCT02281383|560060308|FG000|Overall Study|Protocol Violation|2|||
155169848|NCT02281383|560060308|FG000|Overall Study|Death|1|||
155169849|NCT02281383|560060308|FG000|Overall Study|Adverse Event|2|||
155169850|NCT00472030|560060325|FG000|Overall Study|Physician Decision|1|||
155169851|NCT00472030|560060326|FG001|Overall Study|Physician Decision|0|||
155169852|NCT00829504|560060327|FG000|First Intervention|Adverse Event|1|||
155169853|NCT00829504|560060328|FG001|First Intervention|Adverse Event|0|||
155169854|NCT00829504|560060327|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155169855|NCT00829504|560060328|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155169856|NCT00829504|560060327|FG000|Second Intervention|Physician Decision|1|||
155169857|NCT00829504|560060328|FG001|Second Intervention|Physician Decision|0|||
155169858|NCT01031836|560062353|FG000|Stage I|Adverse Event|1|||
155169859|NCT01031836|560062354|FG001|Stage I|Adverse Event|1|||
155169860|NCT01031836|560062355|FG002|Stage I|Adverse Event|0|||
155169861|NCT01031836|560062356|FG003|Stage I|Adverse Event|0|||
155169862|NCT01031836|560062357|FG004|Stage I|Adverse Event|0|||
155169863|NCT01031836|560062358|FG005|Stage I|Adverse Event|0|||
155169864|NCT01031836|560062353|FG000|Stage I|Other|0|||
155169865|NCT01031836|560062354|FG001|Stage I|Other|1|||
155169866|NCT01031836|560062355|FG002|Stage I|Other|0|||
155169867|NCT01031836|560062356|FG003|Stage I|Other|0|||
155169868|NCT01031836|560062357|FG004|Stage I|Other|0|||
155169869|NCT01031836|560062358|FG005|Stage I|Other|1|||
155169870|NCT01031836|560062353|FG000|Stage II|Adverse Event|0|||
155169871|NCT01031836|560062354|FG001|Stage II|Adverse Event|0|||
155169872|NCT01031836|560062355|FG002|Stage II|Adverse Event|2|||
155169873|NCT01031836|560062356|FG003|Stage II|Adverse Event|2|||
155169874|NCT01031836|560062357|FG004|Stage II|Adverse Event|1|||
155169875|NCT01031836|560062358|FG005|Stage II|Adverse Event|1|||
155169876|NCT01031836|560062353|FG000|Stage II|Other|2|||
155169877|NCT01031836|560062354|FG001|Stage II|Other|0|||
155169878|NCT01031836|560062355|FG002|Stage II|Other|0|||
155169879|NCT01031836|560062356|FG003|Stage II|Other|1|||
155169880|NCT01031836|560062357|FG004|Stage II|Other|1|||
155169881|NCT01031836|560062358|FG005|Stage II|Other|0|||
155169882|NCT01696929|560062361|FG000|Overall Study|Physician Decision|1|||
155169883|NCT02051933|560062362|FG000|Overall Study|Physician Decision|0|||
155169884|NCT02051933|560062363|FG001|Overall Study|Physician Decision|1|||
155169885|NCT00588861|560062367|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
155169886|NCT00588861|560062368|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
155169887|NCT00588861|560062367|FG000|6 Months|Patients did not return for follow-up|98|||
155169888|NCT00588861|560062368|FG001|6 Months|Patients did not return for follow-up|73|||
155169889|NCT00588861|560062367|FG000|1 Year|Patients did not return for follow-up|89|||
155169890|NCT00588861|560062368|FG001|1 Year|Patients did not return for follow-up|82|||
155169891|NCT00588861|560062367|FG000|2 Years|Patients did not return for follow-up|92|||
155169892|NCT00588861|560062368|FG001|2 Years|Patients did not return for follow-up|87|||
155169893|NCT00588861|560062367|FG000|4 Years|Patients did not return for follow-up|91|||
155169894|NCT00588861|560062368|FG001|4 Years|Patients did not return for follow-up|103|||
155169895|NCT00588861|560062367|FG000|6 Years|Patients did not return for follow-up|104|||
155169896|NCT00588861|560062368|FG001|6 Years|Patients did not return for follow-up|109|||
155169897|NCT00588861|560062367|FG000|8 Years|Patients did not return for follow-up|105|||
155169898|NCT00588861|560062368|FG001|8 Years|Patients did not return for follow-up|114|||
155169899|NCT00588861|560062367|FG000|10 Years|Incomplete due to study termination|107|||
155169900|NCT00588861|560062368|FG001|10 Years|Incomplete due to study termination|114|||
155169901|NCT01129583|560062374|FG000|Overall Study|Death|1|||
155169902|NCT01129583|560062375|FG001|Overall Study|Death|0|||
155169903|NCT01129583|560062374|FG000|Overall Study|Lost to Follow-up|1|||
155169904|NCT01129583|560062375|FG001|Overall Study|Lost to Follow-up|1|||
155169905|NCT01129583|560062374|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
155169906|NCT01129583|560062375|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
155169907|NCT02338882|560062376|FG000|Overall Study|Death|1|||
155169908|NCT02338882|560062377|FG001|Overall Study|Death|0|||
155169909|NCT02338882|560062376|FG000|Overall Study|Lost to Follow-up|6|||
155169910|NCT02338882|560062377|FG001|Overall Study|Lost to Follow-up|3|||
155169911|NCT02617485|560062387|FG000|Treatment and Observation Period|Adverse Event|9|||
155169912|NCT02617485|560062388|FG001|Treatment and Observation Period|Adverse Event|1|||
155169913|NCT02617485|560062387|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
155169914|NCT02617485|560062388|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
155169915|NCT02617485|560062387|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
155169916|NCT02617485|560062388|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
155169917|NCT02617485|560062387|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
155169918|NCT02617485|560062388|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
155169919|NCT02617485|560062387|FG000|Treatment and Observation Period|Physician Decision|0|||
155169920|NCT02617485|560062388|FG001|Treatment and Observation Period|Physician Decision|1|||
155169921|NCT02617485|560062387|FG000|Follow-up Period|Adverse Event|1|||
155169922|NCT02617485|560062388|FG001|Follow-up Period|Adverse Event|0|||
155169923|NCT02617485|560062387|FG000|Follow-up Period|Withdrawal by Subject|1|||
155169924|NCT02617485|560062388|FG001|Follow-up Period|Withdrawal by Subject|0|||
154966590|NCT02055547|559301107|FG018|Overall Study|Protocol Violation|0|||
155169925|NCT02617485|560062387|FG000|Follow-up Period|Disease progression|2|||
155169926|NCT02617485|560062388|FG001|Follow-up Period|Disease progression|1|||
155169927|NCT02617485|560062387|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
155169928|NCT02617485|560062388|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
155169929|NCT02617485|560062387|FG000|Follow-up Period|Patient needed radiotherapy|9|||
155169930|NCT02617485|560062388|FG001|Follow-up Period|Patient needed radiotherapy|5|||
155169931|NCT02617485|560062387|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
155169932|NCT02617485|560062388|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
155169933|NCT00220779|560062392|FG000|Overall Study|Adverse Event|1|||
155169934|NCT00220779|560062393|FG001|Overall Study|Adverse Event|0|||
155169935|NCT00220779|560062394|FG002|Overall Study|Adverse Event|0|||
155169936|NCT00220779|560062392|FG000|Overall Study|Withdrawal by Subject|1|||
155169937|NCT00220779|560062393|FG001|Overall Study|Withdrawal by Subject|4|||
155169938|NCT00220779|560062394|FG002|Overall Study|Withdrawal by Subject|1|||
155169939|NCT00220779|560062392|FG000|Overall Study|Non-compliance|1|||
155169940|NCT00220779|560062393|FG001|Overall Study|Non-compliance|0|||
155169941|NCT00220779|560062394|FG002|Overall Study|Non-compliance|0|||
155169942|NCT00220779|560062392|FG000|Overall Study|Too time consuming|1|||
155169943|NCT00220779|560062393|FG001|Overall Study|Too time consuming|0|||
155169944|NCT00220779|560062394|FG002|Overall Study|Too time consuming|0|||
155169945|NCT00220779|560062392|FG000|Overall Study|Pregnancy|0|||
155169946|NCT00220779|560062393|FG001|Overall Study|Pregnancy|0|||
155169947|NCT00220779|560062394|FG002|Overall Study|Pregnancy|2|||
155169948|NCT00220779|560062392|FG000|Overall Study|Lack of Efficacy|3|||
155169949|NCT00220779|560062393|FG001|Overall Study|Lack of Efficacy|0|||
155169950|NCT00220779|560062394|FG002|Overall Study|Lack of Efficacy|1|||
155169951|NCT00791076|560062395|FG000|Overall Study|Study was terminated,PI left institution|8|||
155169952|NCT02248675|560062403|FG000|Overall Study|Lost to Follow-up|3|||
155169953|NCT02248675|560062404|FG001|Overall Study|Lost to Follow-up|1|||
155169954|NCT00830869|560062405|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
155169955|NCT00830869|560062406|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
155169956|NCT00830869|560062407|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
154966591|NCT02055547|559301089|FG000|Overall Study|Physician Decision|0|||
155169957|NCT00830869|560062408|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
155169958|NCT00830869|560062409|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
155169959|NCT00830869|560062410|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
155169960|NCT00830869|560062411|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
155169961|NCT00830869|560062412|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
155169962|NCT00830869|560062413|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
155169963|NCT00830869|560062414|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
155169964|NCT00830869|560062415|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
154966592|NCT02055547|559301090|FG001|Overall Study|Physician Decision|1|||
154966593|NCT02055547|559301091|FG002|Overall Study|Physician Decision|1|||
154966594|NCT02055547|559301092|FG003|Overall Study|Physician Decision|0|||
155169965|NCT00830869|560062416|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
155169966|NCT00830869|560062405|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
155169967|NCT00830869|560062406|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
155169968|NCT00830869|560062407|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
155169969|NCT00830869|560062408|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
155169970|NCT00830869|560062409|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
155169971|NCT00830869|560062410|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
155169972|NCT00830869|560062411|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
155169973|NCT00830869|560062412|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
155169974|NCT00830869|560062413|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
155169975|NCT00830869|560062414|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
155169976|NCT00830869|560062415|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
155169977|NCT00830869|560062416|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
155169978|NCT00830869|560062405|FG000|Period 1: Part 1|Adverse Event|0|||
155169979|NCT00830869|560062406|FG001|Period 1: Part 1|Adverse Event|0|||
155169980|NCT00830869|560062407|FG002|Period 1: Part 1|Adverse Event|0|||
155169981|NCT00830869|560062408|FG003|Period 1: Part 1|Adverse Event|0|||
155169982|NCT00830869|560062409|FG004|Period 1: Part 1|Adverse Event|0|||
155169983|NCT00830869|560062410|FG005|Period 1: Part 1|Adverse Event|1|||
155169984|NCT00830869|560062411|FG006|Period 1: Part 1|Adverse Event|1|||
155169985|NCT00830869|560062412|FG007|Period 1: Part 1|Adverse Event|0|||
155169986|NCT00830869|560062413|FG008|Period 1: Part 1|Adverse Event|0|||
155169987|NCT00830869|560062414|FG009|Period 1: Part 1|Adverse Event|0|||
155169988|NCT00830869|560062415|FG010|Period 1: Part 1|Adverse Event|0|||
155169989|NCT00830869|560062416|FG011|Period 1: Part 1|Adverse Event|0|||
155169990|NCT00830869|560062405|FG000|Period 1: Part 1|Progressive disease|1|||
155169991|NCT00830869|560062406|FG001|Period 1: Part 1|Progressive disease|0|||
155169992|NCT00830869|560062407|FG002|Period 1: Part 1|Progressive disease|1|||
155169993|NCT00830869|560062408|FG003|Period 1: Part 1|Progressive disease|6|||
155169994|NCT00830869|560062409|FG004|Period 1: Part 1|Progressive disease|4|||
155169995|NCT00830869|560062410|FG005|Period 1: Part 1|Progressive disease|4|||
155169996|NCT00830869|560062411|FG006|Period 1: Part 1|Progressive disease|1|||
155169997|NCT00830869|560062412|FG007|Period 1: Part 1|Progressive disease|0|||
155169998|NCT00830869|560062413|FG008|Period 1: Part 1|Progressive disease|0|||
155169999|NCT00830869|560062414|FG009|Period 1: Part 1|Progressive disease|0|||
155170000|NCT00830869|560062415|FG010|Period 1: Part 1|Progressive disease|0|||
155170001|NCT00830869|560062416|FG011|Period 1: Part 1|Progressive disease|0|||
155170002|NCT00830869|560062405|FG000|Period 2: Part 2|Protocol Violation|0|||
155170003|NCT00830869|560062406|FG001|Period 2: Part 2|Protocol Violation|0|||
155170004|NCT00830869|560062407|FG002|Period 2: Part 2|Protocol Violation|0|||
155170005|NCT00830869|560062408|FG003|Period 2: Part 2|Protocol Violation|0|||
155170006|NCT00830869|560062409|FG004|Period 2: Part 2|Protocol Violation|0|||
155170007|NCT00830869|560062410|FG005|Period 2: Part 2|Protocol Violation|0|||
155170042|NCT00830869|560062409|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
155170043|NCT00830869|560062410|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
155170044|NCT00830869|560062411|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
155170045|NCT00830869|560062412|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
155170046|NCT00830869|560062413|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
155170047|NCT00830869|560062414|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
155170048|NCT00830869|560062415|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
155170049|NCT00830869|560062416|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
155170050|NCT00830869|560062405|FG000|Period 2: Part 2|Progressive disease|0|||
155170051|NCT00830869|560062406|FG001|Period 2: Part 2|Progressive disease|0|||
155170052|NCT00830869|560062407|FG002|Period 2: Part 2|Progressive disease|0|||
155170053|NCT00830869|560062408|FG003|Period 2: Part 2|Progressive disease|0|||
155170054|NCT00830869|560062409|FG004|Period 2: Part 2|Progressive disease|0|||
155170055|NCT00830869|560062410|FG005|Period 2: Part 2|Progressive disease|0|||
155170056|NCT00830869|560062411|FG006|Period 2: Part 2|Progressive disease|0|||
155170057|NCT00830869|560062412|FG007|Period 2: Part 2|Progressive disease|14|||
155170058|NCT00830869|560062413|FG008|Period 2: Part 2|Progressive disease|11|||
155170059|NCT00830869|560062414|FG009|Period 2: Part 2|Progressive disease|12|||
155170060|NCT00830869|560062415|FG010|Period 2: Part 2|Progressive disease|8|||
155170061|NCT00830869|560062416|FG011|Period 2: Part 2|Progressive disease|15|||
155170062|NCT00830869|560062405|FG000|Period 2: Part 2|Other|0|||
155170063|NCT00830869|560062406|FG001|Period 2: Part 2|Other|0|||
155170064|NCT00830869|560062407|FG002|Period 2: Part 2|Other|0|||
155170065|NCT00830869|560062408|FG003|Period 2: Part 2|Other|0|||
155170066|NCT00830869|560062409|FG004|Period 2: Part 2|Other|0|||
155170067|NCT00830869|560062410|FG005|Period 2: Part 2|Other|0|||
155170068|NCT00830869|560062411|FG006|Period 2: Part 2|Other|0|||
155170069|NCT00830869|560062412|FG007|Period 2: Part 2|Other|0|||
155170070|NCT00830869|560062413|FG008|Period 2: Part 2|Other|0|||
155170071|NCT00830869|560062414|FG009|Period 2: Part 2|Other|1|||
155170072|NCT00830869|560062415|FG010|Period 2: Part 2|Other|0|||
155170073|NCT00830869|560062416|FG011|Period 2: Part 2|Other|0|||
155170074|NCT00617669|560062417|FG000|Overall Study|Withdrawal by Subject|71|||
155170075|NCT00617669|560062418|FG001|Overall Study|Withdrawal by Subject|77|||
155170076|NCT00617669|560062417|FG000|Overall Study|Lost to Follow-up|3|||
155170077|NCT00617669|560062418|FG001|Overall Study|Lost to Follow-up|2|||
155170078|NCT00617669|560062417|FG000|Overall Study|Adverse Event|87|||
155170079|NCT00617669|560062418|FG001|Overall Study|Adverse Event|76|||
155170080|NCT00617669|560062417|FG000|Overall Study|Protocol Violation|2|||
155170081|NCT00617669|560062418|FG001|Overall Study|Protocol Violation|3|||
155170082|NCT00617669|560062417|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
155170083|NCT00617669|560062418|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
155170084|NCT00617669|560062417|FG000|Overall Study|Patients randomized but not treated|2|||
155170085|NCT00617669|560062418|FG001|Overall Study|Patients randomized but not treated|3|||
155170086|NCT03745820|560062421|FG000|Overall Study|Adverse Event|0|||
155170087|NCT03745820|560062422|FG001|Overall Study|Adverse Event|3|||
155170088|NCT03745820|560062423|FG002|Overall Study|Adverse Event|2|||
155170089|NCT03745820|560062421|FG000|Overall Study|Non-Compliance with Study Drug|4|||
155170090|NCT03745820|560062422|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155170091|NCT03745820|560062423|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155170092|NCT03745820|560062421|FG000|Overall Study|Withdrawal by Subject|4|||
155170093|NCT03745820|560062422|FG001|Overall Study|Withdrawal by Subject|4|||
155170094|NCT03745820|560062423|FG002|Overall Study|Withdrawal by Subject|4|||
155170095|NCT03745820|560062421|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
155170096|NCT03745820|560062422|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
155170097|NCT03745820|560062423|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
155170098|NCT03745820|560062421|FG000|Overall Study|Lost to Follow-up|2|||
155170099|NCT03745820|560062422|FG001|Overall Study|Lost to Follow-up|0|||
155170100|NCT03745820|560062423|FG002|Overall Study|Lost to Follow-up|3|||
155170101|NCT03745820|560062421|FG000|Overall Study|Reason not Specified|2|||
155170102|NCT03745820|560062422|FG001|Overall Study|Reason not Specified|4|||
155170103|NCT03745820|560062423|FG002|Overall Study|Reason not Specified|1|||
155170104|NCT00281658|560062424|FG000|Randomized Phase|Adverse Event|0|||
155170105|NCT00281658|560062425|FG001|Randomized Phase|Adverse Event|2|||
155170106|NCT00281658|560062426|FG002|Randomized Phase|Adverse Event|0|||
155170107|NCT00281658|560062427|FG003|Randomized Phase|Adverse Event|0|||
155170108|NCT00281658|560062424|FG000|Randomized Phase|Lost to Follow-up|34|||
155170109|NCT00281658|560062425|FG001|Randomized Phase|Lost to Follow-up|27|||
155170110|NCT00281658|560062426|FG002|Randomized Phase|Lost to Follow-up|0|||
155170111|NCT00281658|560062427|FG003|Randomized Phase|Lost to Follow-up|0|||
155170112|NCT00281658|560062424|FG000|Randomized Phase|Withdrawal by Subject|8|||
155170113|NCT00281658|560062425|FG001|Randomized Phase|Withdrawal by Subject|7|||
155170114|NCT00281658|560062426|FG002|Randomized Phase|Withdrawal by Subject|0|||
155170115|NCT00281658|560062427|FG003|Randomized Phase|Withdrawal by Subject|0|||
155170116|NCT00281658|560062424|FG000|Randomized Phase|Study closed/terminated|1|||
155170117|NCT00281658|560062425|FG001|Randomized Phase|Study closed/terminated|1|||
155170118|NCT00281658|560062426|FG002|Randomized Phase|Study closed/terminated|0|||
155170119|NCT00281658|560062427|FG003|Randomized Phase|Study closed/terminated|0|||
155170120|NCT00281658|560062424|FG000|Randomized Phase|Disease progression|36|||
155170121|NCT00281658|560062425|FG001|Randomized Phase|Disease progression|27|||
155170122|NCT00281658|560062426|FG002|Randomized Phase|Disease progression|0|||
155170123|NCT00281658|560062427|FG003|Randomized Phase|Disease progression|0|||
155170124|NCT00281658|560062424|FG000|Randomized Phase|Physician Decision|1|||
155170125|NCT00281658|560062425|FG001|Randomized Phase|Physician Decision|1|||
155170126|NCT00281658|560062426|FG002|Randomized Phase|Physician Decision|0|||
155170127|NCT00281658|560062427|FG003|Randomized Phase|Physician Decision|0|||
155170128|NCT00281658|560062424|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
155170129|NCT00281658|560062425|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
155170130|NCT00281658|560062426|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
155170131|NCT00281658|560062427|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
155170132|NCT00281658|560062424|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
155170133|NCT00281658|560062425|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
155170134|NCT00281658|560062426|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
155170135|NCT00281658|560062427|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
155170136|NCT00281658|560062424|FG000|Randomized Phase|Treatment ongoing|1|||
155170137|NCT00281658|560062425|FG001|Randomized Phase|Treatment ongoing|0|||
155170138|NCT00281658|560062426|FG002|Randomized Phase|Treatment ongoing|0|||
155170139|NCT00281658|560062427|FG003|Randomized Phase|Treatment ongoing|0|||
155170140|NCT00281658|560062424|FG000|Open Label Phase|Adverse Event|0|||
155170141|NCT00281658|560062425|FG001|Open Label Phase|Adverse Event|0|||
155170142|NCT00281658|560062426|FG002|Open Label Phase|Adverse Event|1|||
155170143|NCT00281658|560062427|FG003|Open Label Phase|Adverse Event|0|||
155170144|NCT00281658|560062424|FG000|Open Label Phase|Lost to Follow-up|0|||
155170145|NCT00281658|560062425|FG001|Open Label Phase|Lost to Follow-up|0|||
155170146|NCT00281658|560062426|FG002|Open Label Phase|Lost to Follow-up|16|||
155170147|NCT00281658|560062427|FG003|Open Label Phase|Lost to Follow-up|2|||
155170148|NCT00281658|560062424|FG000|Open Label Phase|Withdrawal by Subject|0|||
155170149|NCT00281658|560062425|FG001|Open Label Phase|Withdrawal by Subject|0|||
155170150|NCT00281658|560062426|FG002|Open Label Phase|Withdrawal by Subject|3|||
155170151|NCT00281658|560062427|FG003|Open Label Phase|Withdrawal by Subject|2|||
155170152|NCT00281658|560062424|FG000|Open Label Phase|Disease progression|0|||
155170153|NCT00281658|560062425|FG001|Open Label Phase|Disease progression|0|||
155170154|NCT00281658|560062426|FG002|Open Label Phase|Disease progression|18|||
155170155|NCT00281658|560062427|FG003|Open Label Phase|Disease progression|0|||
155170156|NCT00281658|560062424|FG000|Open Label Phase|Physician Decision|0|||
155170157|NCT00281658|560062425|FG001|Open Label Phase|Physician Decision|0|||
155170158|NCT00281658|560062426|FG002|Open Label Phase|Physician Decision|1|||
155170159|NCT00281658|560062427|FG003|Open Label Phase|Physician Decision|0|||
155170160|NCT00281658|560062424|FG000|Open Label Phase|Relocation of patient|0|||
155170161|NCT00281658|560062425|FG001|Open Label Phase|Relocation of patient|0|||
155170162|NCT00281658|560062426|FG002|Open Label Phase|Relocation of patient|1|||
155170163|NCT00281658|560062427|FG003|Open Label Phase|Relocation of patient|0|||
155170164|NCT00281658|560062424|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
155170165|NCT00281658|560062425|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
155170166|NCT00281658|560062426|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
155170167|NCT00281658|560062427|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
155170168|NCT00507728|560062428|FG000|Randomization to Month 3|Lost to Follow-up|15|||
155170169|NCT00507728|560062429|FG001|Randomization to Month 3|Lost to Follow-up|14|||
155170170|NCT00507728|560062430|FG002|Randomization to Month 3|Lost to Follow-up|20|||
154966819|NCT00902538|559301139|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
154966820|NCT00902538|559301140|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
154966821|NCT00902538|559301141|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
154966822|NCT00902538|559301136|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
154966823|NCT00902538|559301137|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
154966824|NCT00902538|559301138|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
154966825|NCT00902538|559301139|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
154966826|NCT00902538|559301140|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
154966827|NCT00902538|559301141|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
154966828|NCT00902538|559301136|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
154966829|NCT00902538|559301137|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
154966830|NCT00902538|559301138|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155170171|NCT00507728|560062428|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
155170172|NCT00507728|560062429|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
155170173|NCT00507728|560062430|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
155170174|NCT02151773|560062431|FG000|Overall Study|Protocol Deviation|64|||
155170175|NCT00095940|560062435|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
155170176|NCT00095940|560062436|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
155170177|NCT00095940|560062437|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
155170178|NCT00095940|560062438|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
155170179|NCT00095940|560062439|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
155170180|NCT00095940|560062440|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
155170181|NCT00095940|560062441|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
155170182|NCT00095940|560062442|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
155170183|NCT00095940|560062443|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
155170184|NCT00095940|560062435|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155170185|NCT00095940|560062436|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155170186|NCT00095940|560062437|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155170187|NCT00095940|560062438|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155170188|NCT00095940|560062439|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155170189|NCT00095940|560062440|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155170190|NCT00095940|560062441|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155170191|NCT00095940|560062442|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
155170192|NCT00095940|560062443|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
155170193|NCT00095940|560062435|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170194|NCT00095940|560062436|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170195|NCT00095940|560062437|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170196|NCT00095940|560062438|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170197|NCT00095940|560062439|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170198|NCT00095940|560062440|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170199|NCT00095940|560062441|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170200|NCT00095940|560062442|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
155170201|NCT00095940|560062443|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
155170202|NCT02864862|560062446|FG000|Overall Study|Lost to Follow-up|1|||
155170203|NCT02864862|560062447|FG001|Overall Study|Lost to Follow-up|0|||
155170204|NCT02864862|560062448|FG002|Overall Study|Lost to Follow-up|1|||
155170205|NCT02864862|560062446|FG000|Overall Study|Protocol Violation|0|||
155170206|NCT02864862|560062447|FG001|Overall Study|Protocol Violation|0|||
155170207|NCT02864862|560062448|FG002|Overall Study|Protocol Violation|1|||
155170208|NCT01523275|560062449|FG000|Overall Study|Lost to Follow-up|1|||
155170209|NCT01523275|560062450|FG001|Overall Study|Lost to Follow-up|2|||
155170210|NCT01523275|560062449|FG000|Overall Study|Withdrawal by Subject|1|||
155170211|NCT01523275|560062450|FG001|Overall Study|Withdrawal by Subject|0|||
155170212|NCT00966875|560062452|FG000|Part A|Adverse Event|2|||
155170213|NCT00966875|560062453|FG001|Part A|Adverse Event|1|||
155170214|NCT00966875|560062454|FG002|Part A|Adverse Event|0|||
155170215|NCT00966875|560062455|FG003|Part A|Adverse Event|1|||
155170216|NCT00966875|560062456|FG004|Part A|Adverse Event|0|||
155170217|NCT00966875|560062457|FG005|Part A|Adverse Event|1|||
155170218|NCT00966875|560062458|FG006|Part A|Adverse Event|0|||
155170219|NCT00966875|560062459|FG007|Part A|Adverse Event|3|||
155170220|NCT00966875|560062460|FG008|Part A|Adverse Event|3|||
155170221|NCT00966875|560062452|FG000|Part A|Entry Criteria|0|||
155170222|NCT00966875|560062453|FG001|Part A|Entry Criteria|0|||
155170223|NCT00966875|560062454|FG002|Part A|Entry Criteria|0|||
155170224|NCT00966875|560062455|FG003|Part A|Entry Criteria|0|||
155170225|NCT00966875|560062456|FG004|Part A|Entry Criteria|0|||
155170226|NCT00966875|560062457|FG005|Part A|Entry Criteria|2|||
155170227|NCT00966875|560062458|FG006|Part A|Entry Criteria|0|||
155170228|NCT00966875|560062459|FG007|Part A|Entry Criteria|0|||
155170229|NCT00966875|560062460|FG008|Part A|Entry Criteria|0|||
155170230|NCT00966875|560062452|FG000|Part A|Lack of Efficacy|0|||
155170231|NCT00966875|560062453|FG001|Part A|Lack of Efficacy|1|||
155170232|NCT00966875|560062454|FG002|Part A|Lack of Efficacy|0|||
155170233|NCT00966875|560062455|FG003|Part A|Lack of Efficacy|0|||
155170234|NCT00966875|560062456|FG004|Part A|Lack of Efficacy|0|||
155170235|NCT00966875|560062457|FG005|Part A|Lack of Efficacy|0|||
155170236|NCT00966875|560062458|FG006|Part A|Lack of Efficacy|4|||
155170237|NCT00966875|560062459|FG007|Part A|Lack of Efficacy|0|||
155170238|NCT00966875|560062460|FG008|Part A|Lack of Efficacy|0|||
155170239|NCT00966875|560062452|FG000|Part A|Lost to Follow-up|2|||
155170240|NCT00966875|560062453|FG001|Part A|Lost to Follow-up|0|||
155170241|NCT00966875|560062454|FG002|Part A|Lost to Follow-up|0|||
155170242|NCT00966875|560062455|FG003|Part A|Lost to Follow-up|0|||
155170243|NCT00966875|560062456|FG004|Part A|Lost to Follow-up|0|||
155170244|NCT00966875|560062457|FG005|Part A|Lost to Follow-up|1|||
155170245|NCT00966875|560062458|FG006|Part A|Lost to Follow-up|0|||
155170246|NCT00966875|560062459|FG007|Part A|Lost to Follow-up|0|||
155170247|NCT00966875|560062460|FG008|Part A|Lost to Follow-up|0|||
155170248|NCT00966875|560062452|FG000|Part A|Parent/Caregiver Decision|0|||
155170249|NCT00966875|560062453|FG001|Part A|Parent/Caregiver Decision|0|||
155170250|NCT00966875|560062454|FG002|Part A|Parent/Caregiver Decision|0|||
155170251|NCT00966875|560062455|FG003|Part A|Parent/Caregiver Decision|1|||
155170252|NCT00966875|560062456|FG004|Part A|Parent/Caregiver Decision|0|||
155170253|NCT00966875|560062457|FG005|Part A|Parent/Caregiver Decision|0|||
155170254|NCT00966875|560062458|FG006|Part A|Parent/Caregiver Decision|0|||
155170255|NCT00966875|560062459|FG007|Part A|Parent/Caregiver Decision|0|||
155170256|NCT00966875|560062460|FG008|Part A|Parent/Caregiver Decision|0|||
155170257|NCT00966875|560062452|FG000|Part A|Physician Decision|0|||
155170258|NCT00966875|560062453|FG001|Part A|Physician Decision|0|||
155170259|NCT00966875|560062454|FG002|Part A|Physician Decision|0|||
155170260|NCT00966875|560062455|FG003|Part A|Physician Decision|0|||
155170261|NCT00966875|560062456|FG004|Part A|Physician Decision|1|||
155170262|NCT00966875|560062457|FG005|Part A|Physician Decision|0|||
155170263|NCT00966875|560062458|FG006|Part A|Physician Decision|1|||
155170264|NCT00966875|560062459|FG007|Part A|Physician Decision|0|||
155170265|NCT00966875|560062460|FG008|Part A|Physician Decision|2|||
155170266|NCT00966875|560062452|FG000|Part A|Sponsor Decision|0|||
155170267|NCT00966875|560062453|FG001|Part A|Sponsor Decision|0|||
155170268|NCT00966875|560062454|FG002|Part A|Sponsor Decision|1|||
155170269|NCT00966875|560062455|FG003|Part A|Sponsor Decision|0|||
155170270|NCT00966875|560062456|FG004|Part A|Sponsor Decision|1|||
155170271|NCT00966875|560062457|FG005|Part A|Sponsor Decision|0|||
155170272|NCT00966875|560062458|FG006|Part A|Sponsor Decision|0|||
155170273|NCT00966875|560062459|FG007|Part A|Sponsor Decision|2|||
155170274|NCT00966875|560062460|FG008|Part A|Sponsor Decision|1|||
155170275|NCT00966875|560062452|FG000|Part A|Withdrawal by Subject|2|||
155170276|NCT00966875|560062453|FG001|Part A|Withdrawal by Subject|2|||
155170277|NCT00966875|560062454|FG002|Part A|Withdrawal by Subject|1|||
155170278|NCT00966875|560062455|FG003|Part A|Withdrawal by Subject|1|||
155170279|NCT00966875|560062456|FG004|Part A|Withdrawal by Subject|3|||
155170280|NCT00966875|560062457|FG005|Part A|Withdrawal by Subject|0|||
155170281|NCT00966875|560062458|FG006|Part A|Withdrawal by Subject|5|||
155170282|NCT00966875|560062459|FG007|Part A|Withdrawal by Subject|1|||
155170283|NCT00966875|560062460|FG008|Part A|Withdrawal by Subject|1|||
155170284|NCT00966875|560062452|FG000|Part A|Protocol Violation|0|||
155170285|NCT00966875|560062453|FG001|Part A|Protocol Violation|0|||
155170286|NCT00966875|560062454|FG002|Part A|Protocol Violation|0|||
155170287|NCT00966875|560062455|FG003|Part A|Protocol Violation|0|||
155170288|NCT00966875|560062456|FG004|Part A|Protocol Violation|0|||
155170289|NCT00966875|560062457|FG005|Part A|Protocol Violation|0|||
155170290|NCT00966875|560062458|FG006|Part A|Protocol Violation|2|||
155170291|NCT00966875|560062459|FG007|Part A|Protocol Violation|1|||
155170292|NCT00966875|560062460|FG008|Part A|Protocol Violation|1|||
155170293|NCT00966875|560062452|FG000|Part B|Adverse Event|0|||
155170294|NCT00966875|560062453|FG001|Part B|Adverse Event|1|||
155170295|NCT00966875|560062454|FG002|Part B|Adverse Event|1|||
155170296|NCT00966875|560062455|FG003|Part B|Adverse Event|0|||
155170297|NCT00966875|560062456|FG004|Part B|Adverse Event|1|||
155170298|NCT00966875|560062457|FG005|Part B|Adverse Event|0|||
155170299|NCT00966875|560062458|FG006|Part B|Adverse Event|5|||
155170300|NCT00966875|560062459|FG007|Part B|Adverse Event|2|||
155170301|NCT00966875|560062460|FG008|Part B|Adverse Event|2|||
155170302|NCT00966875|560062452|FG000|Part B|Death|0|||
155170303|NCT00966875|560062453|FG001|Part B|Death|0|||
155170304|NCT00966875|560062454|FG002|Part B|Death|1|||
155170305|NCT00966875|560062455|FG003|Part B|Death|0|||
155170306|NCT00966875|560062456|FG004|Part B|Death|0|||
155170307|NCT00966875|560062457|FG005|Part B|Death|0|||
155170308|NCT00966875|560062458|FG006|Part B|Death|0|||
155170309|NCT00966875|560062459|FG007|Part B|Death|1|||
155170310|NCT00966875|560062460|FG008|Part B|Death|0|||
155170311|NCT00966875|560062452|FG000|Part B|Lack of Efficacy|2|||
155170312|NCT00966875|560062453|FG001|Part B|Lack of Efficacy|1|||
155170313|NCT00966875|560062454|FG002|Part B|Lack of Efficacy|1|||
155170314|NCT00966875|560062455|FG003|Part B|Lack of Efficacy|1|||
155170315|NCT00966875|560062456|FG004|Part B|Lack of Efficacy|2|||
155170316|NCT00966875|560062457|FG005|Part B|Lack of Efficacy|3|||
155170317|NCT00966875|560062458|FG006|Part B|Lack of Efficacy|12|||
155170318|NCT00966875|560062459|FG007|Part B|Lack of Efficacy|9|||
155170319|NCT00966875|560062460|FG008|Part B|Lack of Efficacy|6|||
154966831|NCT00902538|559301139|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
154966832|NCT00902538|559301140|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155170320|NCT00966875|560062452|FG000|Part B|Lost to Follow-up|0|||
155170321|NCT00966875|560062453|FG001|Part B|Lost to Follow-up|0|||
155170322|NCT00966875|560062454|FG002|Part B|Lost to Follow-up|0|||
155170323|NCT00966875|560062455|FG003|Part B|Lost to Follow-up|1|||
155170324|NCT00966875|560062456|FG004|Part B|Lost to Follow-up|0|||
155170325|NCT00966875|560062457|FG005|Part B|Lost to Follow-up|0|||
155170326|NCT00966875|560062458|FG006|Part B|Lost to Follow-up|0|||
155170327|NCT00966875|560062459|FG007|Part B|Lost to Follow-up|0|||
155170328|NCT00966875|560062460|FG008|Part B|Lost to Follow-up|1|||
155170329|NCT00966875|560062452|FG000|Part B|Physician Decision|0|||
155170330|NCT00966875|560062453|FG001|Part B|Physician Decision|0|||
155170331|NCT00966875|560062454|FG002|Part B|Physician Decision|1|||
155170332|NCT00966875|560062455|FG003|Part B|Physician Decision|0|||
155170333|NCT00966875|560062456|FG004|Part B|Physician Decision|2|||
155170334|NCT00966875|560062457|FG005|Part B|Physician Decision|1|||
155170335|NCT00966875|560062458|FG006|Part B|Physician Decision|0|||
155170336|NCT00966875|560062459|FG007|Part B|Physician Decision|0|||
155170337|NCT00966875|560062460|FG008|Part B|Physician Decision|2|||
155170338|NCT00966875|560062452|FG000|Part B|Sponsor Decision|1|||
154966833|NCT00902538|559301141|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
155092665|NCT02006927|559773654|FG000|Overall Study|Withdrawal by Subject|1|||
155092666|NCT04583618|559773660|FG000|Overall Study|Adverse Event|0|||
155092667|NCT04583618|559773661|FG001|Overall Study|Adverse Event|0|||
155092668|NCT04583618|559773662|FG002|Overall Study|Adverse Event|1|||
155092669|NCT04583618|559773663|FG003|Overall Study|Adverse Event|0|||
155092670|NCT04583618|559773664|FG004|Overall Study|Adverse Event|0|||
155092671|NCT04583618|559773660|FG000|Overall Study|Protocol deviation|1|||
155092672|NCT04583618|559773661|FG001|Overall Study|Protocol deviation|1|||
155092673|NCT04583618|559773662|FG002|Overall Study|Protocol deviation|1|||
155092674|NCT04583618|559773663|FG003|Overall Study|Protocol deviation|0|||
155092675|NCT04583618|559773664|FG004|Overall Study|Protocol deviation|0|||
155092676|NCT04583618|559773660|FG000|Overall Study|Withdrawal by Subject|2|||
155092677|NCT04583618|559773661|FG001|Overall Study|Withdrawal by Subject|1|||
154966834|NCT00902538|559301136|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
154966835|NCT00902538|559301137|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
154966836|NCT00902538|559301138|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
154966837|NCT00902538|559301139|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
154966838|NCT00902538|559301140|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
154966839|NCT00902538|559301141|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
154966840|NCT00902538|559301136|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
154966841|NCT00902538|559301137|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
154966842|NCT00902538|559301138|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
154966843|NCT00902538|559301139|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
154966844|NCT00902538|559301140|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
155092678|NCT04583618|559773662|FG002|Overall Study|Withdrawal by Subject|3|||
155092679|NCT04583618|559773663|FG003|Overall Study|Withdrawal by Subject|1|||
155092680|NCT04583618|559773664|FG004|Overall Study|Withdrawal by Subject|1|||
155092681|NCT04583618|559773660|FG000|Overall Study|Lost to Follow-up|0|||
155092682|NCT04583618|559773661|FG001|Overall Study|Lost to Follow-up|1|||
155170339|NCT00966875|560062453|FG001|Part B|Sponsor Decision|0|||
155170340|NCT00966875|560062454|FG002|Part B|Sponsor Decision|0|||
155170341|NCT00966875|560062455|FG003|Part B|Sponsor Decision|0|||
155170342|NCT00966875|560062456|FG004|Part B|Sponsor Decision|0|||
155170343|NCT00966875|560062457|FG005|Part B|Sponsor Decision|1|||
155170344|NCT00966875|560062458|FG006|Part B|Sponsor Decision|0|||
155170345|NCT00966875|560062459|FG007|Part B|Sponsor Decision|2|||
155170346|NCT00966875|560062460|FG008|Part B|Sponsor Decision|1|||
155170347|NCT00966875|560062452|FG000|Part B|Withdrawal by Subject|2|||
155170348|NCT00966875|560062453|FG001|Part B|Withdrawal by Subject|1|||
155170349|NCT00966875|560062454|FG002|Part B|Withdrawal by Subject|2|||
155170350|NCT00966875|560062455|FG003|Part B|Withdrawal by Subject|1|||
155170351|NCT00966875|560062456|FG004|Part B|Withdrawal by Subject|2|||
155170352|NCT00966875|560062457|FG005|Part B|Withdrawal by Subject|1|||
155170353|NCT00966875|560062458|FG006|Part B|Withdrawal by Subject|4|||
155170354|NCT00966875|560062459|FG007|Part B|Withdrawal by Subject|5|||
154966845|NCT00902538|559301141|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
155170355|NCT00966875|560062460|FG008|Part B|Withdrawal by Subject|5|||
155170356|NCT00966875|560062452|FG000|Part B|Entry Criteria|0|||
155170357|NCT00966875|560062453|FG001|Part B|Entry Criteria|0|||
155170358|NCT00966875|560062454|FG002|Part B|Entry Criteria|0|||
155170359|NCT00966875|560062455|FG003|Part B|Entry Criteria|0|||
155170360|NCT00966875|560062456|FG004|Part B|Entry Criteria|0|||
155170361|NCT00966875|560062457|FG005|Part B|Entry Criteria|0|||
155170362|NCT00966875|560062458|FG006|Part B|Entry Criteria|1|||
155170363|NCT00966875|560062459|FG007|Part B|Entry Criteria|0|||
155170364|NCT00966875|560062460|FG008|Part B|Entry Criteria|1|||
155170365|NCT01206322|560062461|FG000|Overall Study|Adverse Event|0|||
155170366|NCT01206322|560062462|FG001|Overall Study|Adverse Event|0|||
155170367|NCT01206322|560062463|FG002|Overall Study|Adverse Event|0|||
155170368|NCT01206322|560062464|FG003|Overall Study|Adverse Event|1|||
155170369|NCT00689117|560062465|FG000|Overall Study|Adverse Event|6|||
155170370|NCT00689117|560062466|FG001|Overall Study|Adverse Event|0|||
155170371|NCT00689117|560062467|FG002|Overall Study|Adverse Event|5|||
155170372|NCT00689117|560062468|FG003|Overall Study|Adverse Event|0|||
155170373|NCT00689117|560062465|FG000|Overall Study|Lost to Follow-up|26|||
155170374|NCT00689117|560062466|FG001|Overall Study|Lost to Follow-up|19|||
155170375|NCT00689117|560062467|FG002|Overall Study|Lost to Follow-up|17|||
155170376|NCT00689117|560062468|FG003|Overall Study|Lost to Follow-up|11|||
155170377|NCT00689117|560062465|FG000|Overall Study|Lack of Efficacy|1|||
155170378|NCT00689117|560062466|FG001|Overall Study|Lack of Efficacy|2|||
155170379|NCT00689117|560062467|FG002|Overall Study|Lack of Efficacy|2|||
155170380|NCT00689117|560062468|FG003|Overall Study|Lack of Efficacy|2|||
155170381|NCT00689117|560062465|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
155170382|NCT00689117|560062466|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
155170383|NCT00689117|560062467|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
155170384|NCT00689117|560062468|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
155170385|NCT00689117|560062465|FG000|Overall Study|Withdrawal by Subject|19|||
155170386|NCT00689117|560062466|FG001|Overall Study|Withdrawal by Subject|18|||
155170387|NCT00689117|560062467|FG002|Overall Study|Withdrawal by Subject|26|||
155170388|NCT00689117|560062468|FG003|Overall Study|Withdrawal by Subject|13|||
155170389|NCT00689117|560062465|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
155170390|NCT00689117|560062466|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
155170391|NCT00689117|560062467|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
155170392|NCT00689117|560062468|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
155170393|NCT00689117|560062465|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155170394|NCT00689117|560062466|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
155170395|NCT00689117|560062467|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155170396|NCT00689117|560062468|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155170397|NCT00689117|560062465|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
155170398|NCT00689117|560062466|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
155170399|NCT00689117|560062467|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
155170400|NCT00689117|560062468|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
155170401|NCT00689117|560062465|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
155170402|NCT00689117|560062466|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
155170403|NCT00689117|560062467|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
155170404|NCT00689117|560062468|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
155170405|NCT00689117|560062465|FG000|Overall Study|Use of Prohibitive Medication|2|||
155170406|NCT00689117|560062466|FG001|Overall Study|Use of Prohibitive Medication|1|||
155170407|NCT00689117|560062467|FG002|Overall Study|Use of Prohibitive Medication|3|||
155170408|NCT00689117|560062468|FG003|Overall Study|Use of Prohibitive Medication|0|||
155170409|NCT00689117|560062465|FG000|Overall Study|Pregnancy|0|||
155170410|NCT00689117|560062466|FG001|Overall Study|Pregnancy|2|||
155170411|NCT00689117|560062467|FG002|Overall Study|Pregnancy|0|||
155170412|NCT00689117|560062468|FG003|Overall Study|Pregnancy|2|||
155170413|NCT00689117|560062465|FG000|Overall Study|Incarceration|2|||
155170414|NCT00689117|560062466|FG001|Overall Study|Incarceration|0|||
154966846|NCT00902538|559301136|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
154966847|NCT00902538|559301137|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
154966848|NCT00902538|559301138|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
154966849|NCT00902538|559301139|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
154966850|NCT00902538|559301140|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
154966851|NCT00902538|559301141|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
154966852|NCT03531827|559301142|FG000|Overall Study|Adverse Event|2|||
154966853|NCT03531827|559301143|FG001|Overall Study|Adverse Event|0|||
154966854|NCT03531827|559301142|FG000|Overall Study|Progressive disease|1|||
154966855|NCT03531827|559301143|FG001|Overall Study|Progressive disease|0|||
154966856|NCT00849797|559301146|FG000|First Intervention|bad veins|1|||
154966857|NCT00849797|559301147|FG001|First Intervention|bad veins|0|||
154966858|NCT00849797|559301146|FG000|First Intervention|Adverse Event|0|||
154966859|NCT00849797|559301147|FG001|First Intervention|Adverse Event|1|||
154966860|NCT00849797|559301146|FG000|Washout: One Week|Withdrawal by Subject|0|||
155170415|NCT00689117|560062467|FG002|Overall Study|Incarceration|0|||
155170416|NCT00689117|560062468|FG003|Overall Study|Incarceration|0|||
155170417|NCT00689117|560062465|FG000|Overall Study|Fear of Birth Defects|0|||
155170418|NCT00689117|560062466|FG001|Overall Study|Fear of Birth Defects|0|||
155170419|NCT00689117|560062467|FG002|Overall Study|Fear of Birth Defects|1|||
155170420|NCT00689117|560062468|FG003|Overall Study|Fear of Birth Defects|0|||
155170421|NCT00689117|560062465|FG000|Overall Study|Transportation|1|||
155170422|NCT00689117|560062466|FG001|Overall Study|Transportation|0|||
155170423|NCT00689117|560062467|FG002|Overall Study|Transportation|0|||
155170424|NCT00689117|560062468|FG003|Overall Study|Transportation|0|||
155170425|NCT00689117|560062465|FG000|Overall Study|Patient Withdrew from Study|0|||
155170426|NCT00689117|560062466|FG001|Overall Study|Patient Withdrew from Study|0|||
155170427|NCT00689117|560062467|FG002|Overall Study|Patient Withdrew from Study|0|||
155170428|NCT00689117|560062468|FG003|Overall Study|Patient Withdrew from Study|1|||
155170429|NCT00689117|560062465|FG000|Overall Study|Personal Reason|0|||
155170430|NCT00689117|560062466|FG001|Overall Study|Personal Reason|1|||
155170431|NCT00689117|560062467|FG002|Overall Study|Personal Reason|0|||
155170432|NCT00689117|560062468|FG003|Overall Study|Personal Reason|0|||
155170433|NCT00689117|560062465|FG000|Overall Study|Dispensing Error|0|||
155170434|NCT00689117|560062466|FG001|Overall Study|Dispensing Error|1|||
155170435|NCT00689117|560062467|FG002|Overall Study|Dispensing Error|0|||
155170436|NCT00689117|560062468|FG003|Overall Study|Dispensing Error|0|||
155170437|NCT00444678|560062469|FG000|Overall Study|Toxicity|11|||
155170438|NCT00444678|560062469|FG000|Overall Study|Disease Progression|12|||
155170439|NCT00444678|560062469|FG000|Overall Study|Death|3|||
155170440|NCT00444678|560062469|FG000|Overall Study|Physician Decision|3|||
155170441|NCT00444678|560062469|FG000|Overall Study|Withdrawal by Subject|2|||
155170442|NCT04250077|560062473|FG000|Overall Study|Withdrawal by Subject|0|||
155170443|NCT04250077|560062474|FG001|Overall Study|Withdrawal by Subject|1|||
155170444|NCT04250077|560062475|FG002|Overall Study|Withdrawal by Subject|0|||
155170445|NCT04250077|560062473|FG000|Overall Study|Lost to Follow-up|2|||
155170446|NCT04250077|560062474|FG001|Overall Study|Lost to Follow-up|3|||
155170447|NCT04250077|560062475|FG002|Overall Study|Lost to Follow-up|0|||
155170448|NCT03319745|560062477|FG000|Overall Study|Death|1|||
155170449|NCT03319745|560062477|FG000|Overall Study|Toxicity Precluding Surgery|1|||
155170450|NCT01317550|560062478|FG000|Overall Study|Withdrawal by Subject|1|||
155170451|NCT01317550|560062479|FG001|Overall Study|Withdrawal by Subject|0|||
155170452|NCT01317550|560062480|FG002|Overall Study|Withdrawal by Subject|0|||
155170453|NCT01317550|560062481|FG003|Overall Study|Withdrawal by Subject|0|||
155170454|NCT01317550|560062478|FG000|Overall Study|Lack of compliance study med|1|||
155170455|NCT01317550|560062479|FG001|Overall Study|Lack of compliance study med|0|||
155170456|NCT01317550|560062480|FG002|Overall Study|Lack of compliance study med|0|||
155170457|NCT01317550|560062481|FG003|Overall Study|Lack of compliance study med|0|||
155170458|NCT00870103|560062482|FG000|Overall Study|Physician Decision|2|||
155170459|NCT00870103|560062482|FG000|Overall Study|Lost to Follow-up|2|||
155170460|NCT01767142|560062483|FG000|Overall Study|Lost to Follow-up|3|||
155170461|NCT00926029|560062484|FG000|Overall Study|Lost to Follow-up|2|||
155170462|NCT00926029|560062485|FG001|Overall Study|Lost to Follow-up|1|||
155170463|NCT00926029|560062486|FG002|Overall Study|Lost to Follow-up|1|||
155170464|NCT03206788|560062487|FG000|Overall Study|Withdrawal by Subject|0|||
155170465|NCT03206788|560062488|FG001|Overall Study|Withdrawal by Subject|1|||
155170466|NCT03206788|560062487|FG000|Overall Study|Adverse Event|0|||
155170467|NCT03206788|560062488|FG001|Overall Study|Adverse Event|1|||
155170468|NCT03206788|560062487|FG000|Overall Study|Physician Decision|0|||
155170469|NCT03206788|560062488|FG001|Overall Study|Physician Decision|1|||
155170470|NCT02471612|560062489|FG000|Overall Study|Lost to Follow-up|2|||
155170471|NCT00833417|560062490|FG000|Overall Study|Adverse Event|5|||
155170472|NCT00833417|560062491|FG001|Overall Study|Adverse Event|16|||
155170473|NCT00833417|560062490|FG000|Overall Study|Death|1|||
155170474|NCT00833417|560062491|FG001|Overall Study|Death|3|||
155170475|NCT00833417|560062490|FG000|Overall Study|Lost to Follow-up|1|||
155170476|NCT00833417|560062491|FG001|Overall Study|Lost to Follow-up|2|||
155170477|NCT00833417|560062490|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
155170478|NCT00833417|560062491|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
155170479|NCT00833417|560062490|FG000|Overall Study|Patient Decision to Withdraw|4|||
155170480|NCT00833417|560062491|FG001|Overall Study|Patient Decision to Withdraw|23|||
155170481|NCT00833417|560062490|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
155170482|NCT00833417|560062491|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
155170483|NCT00833417|560062490|FG000|Overall Study|Disease Progression|18|||
155170484|NCT00833417|560062491|FG001|Overall Study|Disease Progression|17|||
155170485|NCT00833417|560062490|FG000|Overall Study|Reason Not Specified|0|||
155170486|NCT00833417|560062491|FG001|Overall Study|Reason Not Specified|1|||
155170487|NCT03330002|560062492|FG000|Overall Study|Lost to Follow-up|15|||
155170488|NCT03330002|560062492|FG000|Overall Study|Death|7|||
155170489|NCT05573386|560062493|FG000|Overall Study|Withdrawal by Subject|3|||
155170490|NCT05573386|560062494|FG001|Overall Study|Withdrawal by Subject|2|||
155170491|NCT03899805|560062495|FG000|Overall Study|Physician Decision|3|||
155170492|NCT03899805|560062496|FG001|Overall Study|Physician Decision|0|||
155170493|NCT03899805|560062497|FG002|Overall Study|Physician Decision|2|||
155170494|NCT03899805|560062495|FG000|Overall Study|Withdrawal by Subject|1|||
155170495|NCT03899805|560062496|FG001|Overall Study|Withdrawal by Subject|0|||
155170496|NCT03899805|560062497|FG002|Overall Study|Withdrawal by Subject|2|||
155170497|NCT03899805|560062495|FG000|Overall Study|Progressive Disease|10|||
155170498|NCT03899805|560062496|FG001|Overall Study|Progressive Disease|18|||
155170499|NCT03899805|560062497|FG002|Overall Study|Progressive Disease|12|||
155170500|NCT03899805|560062495|FG000|Overall Study|Adverse Event|3|||
155170501|NCT03899805|560062496|FG001|Overall Study|Adverse Event|1|||
155170502|NCT03899805|560062497|FG002|Overall Study|Adverse Event|0|||
155170503|NCT03899805|560062495|FG000|Overall Study|Death|2|||
155170504|NCT03899805|560062496|FG001|Overall Study|Death|0|||
155170505|NCT03899805|560062497|FG002|Overall Study|Death|0|||
155170506|NCT03899805|560062495|FG000|Overall Study|Came off for surgery|0|||
155170507|NCT03899805|560062496|FG001|Overall Study|Came off for surgery|0|||
155170508|NCT03899805|560062497|FG002|Overall Study|Came off for surgery|1|||
155170509|NCT05246514|560062498|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
155170510|NCT05246514|560062498|FG000|Overall Study|Withdrawal by Subject|1|||
155170511|NCT05246514|560062498|FG000|Overall Study|Death|13|||
155170512|NCT03646123|560062499|FG000|Overall Study|Withdrawal by Subject|2|||
155170513|NCT03646123|560062500|FG001|Overall Study|Withdrawal by Subject|2|||
155170514|NCT03646123|560062501|FG002|Overall Study|Withdrawal by Subject|3|||
155170515|NCT03646123|560062499|FG000|Overall Study|Study termination by sponsor|0|||
155170516|NCT03646123|560062500|FG001|Overall Study|Study termination by sponsor|45|||
155170517|NCT03646123|560062501|FG002|Overall Study|Study termination by sponsor|139|||
155170518|NCT03646123|560062499|FG000|Overall Study|Lost to Follow-up|4|||
155170519|NCT03646123|560062500|FG001|Overall Study|Lost to Follow-up|10|||
155170520|NCT03646123|560062501|FG002|Overall Study|Lost to Follow-up|10|||
155170521|NCT03646123|560062499|FG000|Overall Study|Death|2|||
155170522|NCT03646123|560062500|FG001|Overall Study|Death|1|||
155170523|NCT03646123|560062501|FG002|Overall Study|Death|1|||
155170524|NCT03646123|560062499|FG000|Overall Study|Other|2|||
155170525|NCT03646123|560062500|FG001|Overall Study|Other|0|||
155170526|NCT03646123|560062501|FG002|Overall Study|Other|2|||
155170527|NCT04075734|560062504|FG000|Overall Study|Lost to Follow-up|1|||
155170528|NCT04075734|560062505|FG001|Overall Study|Lost to Follow-up|1|||
155170529|NCT04075734|560062506|FG002|Overall Study|Lost to Follow-up|0|||
155170530|NCT04075734|560062504|FG000|Overall Study|Withdrawal by Subject|3|||
155170531|NCT04075734|560062505|FG001|Overall Study|Withdrawal by Subject|0|||
155170532|NCT04075734|560062506|FG002|Overall Study|Withdrawal by Subject|0|||
155170533|NCT01802073|560062507|FG000|Overall Study|Lost to Follow-up|0|||
155170534|NCT01802073|560062508|FG001|Overall Study|Lost to Follow-up|1|||
155170535|NCT01802073|560062507|FG000|Overall Study|Non-compliant|4|||
155170536|NCT01802073|560062508|FG001|Overall Study|Non-compliant|2|||
155170537|NCT01802073|560062507|FG000|Overall Study|Withdrawal by Subject|1|||
155170538|NCT01802073|560062508|FG001|Overall Study|Withdrawal by Subject|1|||
155170539|NCT01802073|560062507|FG000|Overall Study|Physician Decision|0|||
155170540|NCT01802073|560062508|FG001|Overall Study|Physician Decision|7|||
155170541|NCT01776307|560062513|FG000|Overall Study|Not dosed|0|||
155170542|NCT01776307|560062514|FG001|Overall Study|Not dosed|0|||
155170543|NCT01776307|560062515|FG002|Overall Study|Not dosed|1|||
155170544|NCT00329797|560062529|FG000|Overall Study|Protocol Violation|1|||
155170545|NCT00329797|560062530|FG001|Overall Study|Protocol Violation|0|||
155170546|NCT00329797|560062529|FG000|Overall Study|Withdrawal by Subject|6|||
155170547|NCT00329797|560062530|FG001|Overall Study|Withdrawal by Subject|6|||
155170548|NCT02447302|560062540|FG000|Overall Study|Physician Decision|1|||
155170549|NCT02447302|560062541|FG001|Overall Study|Physician Decision|0|||
155170550|NCT02447302|560062542|FG002|Overall Study|Physician Decision|0|||
155170551|NCT02447302|560062540|FG000|Overall Study|Adverse Event|4|||
155170552|NCT02447302|560062541|FG001|Overall Study|Adverse Event|3|||
155170553|NCT02447302|560062542|FG002|Overall Study|Adverse Event|0|||
155170554|NCT02447302|560062540|FG000|Overall Study|Withdrawal by Subject|0|||
155170555|NCT02447302|560062541|FG001|Overall Study|Withdrawal by Subject|1|||
155170556|NCT02447302|560062542|FG002|Overall Study|Withdrawal by Subject|5|||
155170557|NCT02447302|560062540|FG000|Overall Study|Sponsor Decision|0|||
155170558|NCT02447302|560062541|FG001|Overall Study|Sponsor Decision|0|||
155170559|NCT02447302|560062542|FG002|Overall Study|Sponsor Decision|1|||
155170560|NCT02791763|560062543|FG000|Overall Study|Protocol Violation|0|||
155170561|NCT02791763|560062544|FG001|Overall Study|Protocol Violation|0|||
155170562|NCT02791763|560062545|FG002|Overall Study|Protocol Violation|1|||
155170563|NCT02791763|560062543|FG000|Overall Study|Withdrawal by Subject|5|||
155170564|NCT02791763|560062544|FG001|Overall Study|Withdrawal by Subject|1|||
155170565|NCT02791763|560062545|FG002|Overall Study|Withdrawal by Subject|0|||
155170566|NCT02791763|560062543|FG000|Overall Study|Physician Decision|0|||
155170567|NCT02791763|560062544|FG001|Overall Study|Physician Decision|1|||
155170568|NCT02791763|560062545|FG002|Overall Study|Physician Decision|0|||
155170569|NCT02791763|560062543|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
154966861|NCT00849797|559301147|FG001|Washout: One Week|Withdrawal by Subject|2|||
154966862|NCT01494532|559301148|FG000|Overall Study|Adverse Event|4|||
154966863|NCT01494532|559301149|FG001|Overall Study|Adverse Event|1|||
154966864|NCT01494532|559301150|FG002|Overall Study|Adverse Event|8|||
154966865|NCT01494532|559301151|FG003|Overall Study|Adverse Event|6|||
154966866|NCT01494532|559301152|FG004|Overall Study|Adverse Event|5|||
154966867|NCT01494532|559301153|FG005|Overall Study|Adverse Event|0|||
154966868|NCT01494532|559301148|FG000|Overall Study|Lack of Efficacy|0|||
154966869|NCT01494532|559301149|FG001|Overall Study|Lack of Efficacy|0|||
154966870|NCT01494532|559301150|FG002|Overall Study|Lack of Efficacy|0|||
154966871|NCT01494532|559301151|FG003|Overall Study|Lack of Efficacy|0|||
154966872|NCT01494532|559301152|FG004|Overall Study|Lack of Efficacy|2|||
154966873|NCT01494532|559301153|FG005|Overall Study|Lack of Efficacy|0|||
154966874|NCT01494532|559301148|FG000|Overall Study|Protocol deviation|2|||
154966875|NCT01494532|559301149|FG001|Overall Study|Protocol deviation|1|||
154966876|NCT01494532|559301150|FG002|Overall Study|Protocol deviation|3|||
154966877|NCT01494532|559301151|FG003|Overall Study|Protocol deviation|2|||
154966878|NCT01494532|559301152|FG004|Overall Study|Protocol deviation|3|||
154966879|NCT01494532|559301153|FG005|Overall Study|Protocol deviation|0|||
154966880|NCT01494532|559301148|FG000|Overall Study|Protocol-defined stopping criteria|0|||
154966881|NCT01494532|559301149|FG001|Overall Study|Protocol-defined stopping criteria|0|||
154966882|NCT01494532|559301150|FG002|Overall Study|Protocol-defined stopping criteria|1|||
154966883|NCT01494532|559301151|FG003|Overall Study|Protocol-defined stopping criteria|0|||
154966884|NCT01494532|559301152|FG004|Overall Study|Protocol-defined stopping criteria|0|||
154966885|NCT01494532|559301153|FG005|Overall Study|Protocol-defined stopping criteria|0|||
154966886|NCT01494532|559301148|FG000|Overall Study|Lost to Follow-up|1|||
154966887|NCT01494532|559301149|FG001|Overall Study|Lost to Follow-up|0|||
154966888|NCT01494532|559301150|FG002|Overall Study|Lost to Follow-up|0|||
154966889|NCT01494532|559301151|FG003|Overall Study|Lost to Follow-up|2|||
154966890|NCT01494532|559301152|FG004|Overall Study|Lost to Follow-up|0|||
154966891|NCT01494532|559301153|FG005|Overall Study|Lost to Follow-up|0|||
154966892|NCT01494532|559301148|FG000|Overall Study|Physician Decision|0|||
154966893|NCT01494532|559301149|FG001|Overall Study|Physician Decision|1|||
154966894|NCT01494532|559301150|FG002|Overall Study|Physician Decision|1|||
154966895|NCT01494532|559301151|FG003|Overall Study|Physician Decision|2|||
154966896|NCT01494532|559301152|FG004|Overall Study|Physician Decision|0|||
154966897|NCT01494532|559301153|FG005|Overall Study|Physician Decision|0|||
154966898|NCT01494532|559301148|FG000|Overall Study|Withdrawal by Subject|3|||
154966899|NCT01494532|559301149|FG001|Overall Study|Withdrawal by Subject|1|||
154966900|NCT01494532|559301150|FG002|Overall Study|Withdrawal by Subject|4|||
154966901|NCT01494532|559301151|FG003|Overall Study|Withdrawal by Subject|3|||
154966902|NCT01494532|559301152|FG004|Overall Study|Withdrawal by Subject|2|||
154966903|NCT01494532|559301153|FG005|Overall Study|Withdrawal by Subject|0|||
154966904|NCT00679081|559301154|FG000|Overall Study|Lost to Follow-up|1|||
155092683|NCT04583618|559773662|FG002|Overall Study|Lost to Follow-up|3|||
155092684|NCT04583618|559773663|FG003|Overall Study|Lost to Follow-up|1|||
155092685|NCT04583618|559773664|FG004|Overall Study|Lost to Follow-up|1|||
155092686|NCT02302222|559773667|FG000|Overall Study|Physician Decision|0|||
155092687|NCT02302222|559773668|FG001|Overall Study|Physician Decision|4|||
155092688|NCT02302222|559773667|FG000|Overall Study|Lost to Follow-up|1|||
155092689|NCT02302222|559773668|FG001|Overall Study|Lost to Follow-up|0|||
155170570|NCT02791763|560062544|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
154966905|NCT01404988|559301155|FG000|Overall Study|Death|2|||
154966906|NCT01404988|559301156|FG001|Overall Study|Death|0|||
154966907|NCT01404988|559301157|FG002|Overall Study|Death|2|||
154966908|NCT01404988|559301155|FG000|Overall Study|Adverse Event|1|||
154966909|NCT01404988|559301156|FG001|Overall Study|Adverse Event|0|||
154966910|NCT01404988|559301157|FG002|Overall Study|Adverse Event|0|||
154966911|NCT01404988|559301155|FG000|Overall Study|Withdrawal by Subject|2|||
154966912|NCT01404988|559301156|FG001|Overall Study|Withdrawal by Subject|2|||
155092690|NCT02302222|559773667|FG000|Overall Study|Treatment discontinued before day 5|0|||
155092691|NCT02302222|559773668|FG001|Overall Study|Treatment discontinued before day 5|1|||
154966913|NCT01404988|559301157|FG002|Overall Study|Withdrawal by Subject|0|||
154966914|NCT01404988|559301155|FG000|Overall Study|Lost to Follow-up|1|||
154966915|NCT01404988|559301156|FG001|Overall Study|Lost to Follow-up|2|||
154966916|NCT01404988|559301157|FG002|Overall Study|Lost to Follow-up|1|||
154966917|NCT00829764|559301158|FG000|First Intervention|Adverse Event|1|||
154966918|NCT00829764|559301159|FG001|First Intervention|Adverse Event|0|||
154966919|NCT00829764|559301158|FG000|First Intervention|Withdrawal by Subject|1|||
154966920|NCT00829764|559301159|FG001|First Intervention|Withdrawal by Subject|1|||
154966921|NCT00754052|559303181|FG000|Overall Study|Study terminated by Sponsor|5|||
154966922|NCT00754052|559303182|FG001|Overall Study|Study terminated by Sponsor|3|||
154966923|NCT02485158|559303187|FG000|Overall Study|Withdrawal by Subject|3|||
154966924|NCT02485158|559303187|FG000|Overall Study|expected drug side effect|1|||
154966925|NCT01098851|559303188|FG000|Overall Study|Equipment failure|1|||
154966926|NCT01098851|559303189|FG001|Overall Study|Equipment failure|0|||
154966927|NCT02316223|559303191|FG000|Overall Study|Lack of Efficacy|0|||
154966928|NCT02316223|559303192|FG001|Overall Study|Lack of Efficacy|1|||
154966929|NCT02316223|559303193|FG002|Overall Study|Lack of Efficacy|1|||
154966930|NCT02316223|559303191|FG000|Overall Study|Lost to Follow-up|27|||
154966931|NCT02316223|559303192|FG001|Overall Study|Lost to Follow-up|34|||
154966932|NCT02316223|559303193|FG002|Overall Study|Lost to Follow-up|36|||
154966933|NCT02316223|559303191|FG000|Overall Study|COPD Diagnosis|3|||
154966934|NCT02316223|559303192|FG001|Overall Study|COPD Diagnosis|2|||
154966935|NCT02316223|559303193|FG002|Overall Study|COPD Diagnosis|3|||
155092692|NCT02302222|559773667|FG000|Overall Study|Withdrawn prior to any treatment|0|||
155092693|NCT02302222|559773668|FG001|Overall Study|Withdrawn prior to any treatment|1|||
155092694|NCT00016354|559773671|FG000|Overall Study|Lack of Efficacy|0|||
155092695|NCT00016354|559773672|FG001|Overall Study|Lack of Efficacy|0|||
155092696|NCT00016354|559773673|FG002|Overall Study|Lack of Efficacy|0|||
155092697|NCT00016354|559773674|FG003|Overall Study|Lack of Efficacy|0|||
155092698|NCT00016354|559773675|FG004|Overall Study|Lack of Efficacy|0|||
155092699|NCT00016354|559773676|FG005|Overall Study|Lack of Efficacy|0|||
155092700|NCT00016354|559773677|FG006|Overall Study|Lack of Efficacy|0|||
155092701|NCT00016354|559773678|FG007|Overall Study|Lack of Efficacy|1|||
155092702|NCT03193801|559773679|FG000|Overall Study|Physician Decision|2|||
155092703|NCT03193801|559773679|FG000|Overall Study|Withdrawal by Subject|1|||
155092704|NCT03110562|559773680|FG000|Initial Treatment Period|Disease Progression|1|||
155092705|NCT03110562|559773681|FG001|Initial Treatment Period|Disease Progression|1|||
155092706|NCT03110562|559773682|FG002|Initial Treatment Period|Disease Progression|0|||
155092707|NCT03110562|559773683|FG003|Initial Treatment Period|Disease Progression|0|||
155092708|NCT03110562|559773680|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
155092709|NCT03110562|559773681|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
155092710|NCT03110562|559773682|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
155092711|NCT03110562|559773683|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
155092712|NCT03110562|559773680|FG000|Initial Treatment Period|Adverse Event|1|||
155092713|NCT03110562|559773681|FG001|Initial Treatment Period|Adverse Event|0|||
155092714|NCT03110562|559773682|FG002|Initial Treatment Period|Adverse Event|0|||
155092715|NCT03110562|559773683|FG003|Initial Treatment Period|Adverse Event|0|||
155092716|NCT03110562|559773680|FG000|Initial Treatment Period|Death|74|||
155092717|NCT03110562|559773681|FG001|Initial Treatment Period|Death|82|||
155092718|NCT03110562|559773682|FG002|Initial Treatment Period|Death|0|||
155092719|NCT03110562|559773683|FG003|Initial Treatment Period|Death|0|||
155092720|NCT03110562|559773680|FG000|Initial Treatment Period|Lost to Follow-up|13|||
155092721|NCT03110562|559773681|FG001|Initial Treatment Period|Lost to Follow-up|8|||
155092722|NCT03110562|559773682|FG002|Initial Treatment Period|Lost to Follow-up|0|||
155092723|NCT03110562|559773683|FG003|Initial Treatment Period|Lost to Follow-up|0|||
155092724|NCT03110562|559773680|FG000|Initial Treatment Period|Protocol Deviation|1|||
155092725|NCT03110562|559773681|FG001|Initial Treatment Period|Protocol Deviation|0|||
155092726|NCT03110562|559773682|FG002|Initial Treatment Period|Protocol Deviation|0|||
155092727|NCT03110562|559773683|FG003|Initial Treatment Period|Protocol Deviation|0|||
155092728|NCT03110562|559773680|FG000|Initial Treatment Period|Physician Decision|2|||
155092729|NCT03110562|559773681|FG001|Initial Treatment Period|Physician Decision|1|||
155092730|NCT03110562|559773682|FG002|Initial Treatment Period|Physician Decision|0|||
155092731|NCT03110562|559773683|FG003|Initial Treatment Period|Physician Decision|0|||
155092732|NCT03110562|559773680|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
155092733|NCT03110562|559773681|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
155092734|NCT03110562|559773682|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
155092735|NCT03110562|559773683|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
155092736|NCT03110562|559773680|FG000|Initial Treatment Period|Other|5|||
155092737|NCT03110562|559773681|FG001|Initial Treatment Period|Other|4|||
155092738|NCT03110562|559773682|FG002|Initial Treatment Period|Other|0|||
155092739|NCT03110562|559773683|FG003|Initial Treatment Period|Other|0|||
155092740|NCT03110562|559773680|FG000|Initial Treatment Period|Randomized but never treated|0|||
154966936|NCT02316223|559303191|FG000|Overall Study|Reside outside study area|1|||
154966937|NCT02316223|559303192|FG001|Overall Study|Reside outside study area|1|||
155092741|NCT03110562|559773681|FG001|Initial Treatment Period|Randomized but never treated|3|||
155092742|NCT03110562|559773682|FG002|Initial Treatment Period|Randomized but never treated|0|||
155092743|NCT03110562|559773683|FG003|Initial Treatment Period|Randomized but never treated|0|||
155092744|NCT03110562|559773680|FG000|Crossover Period|Disease Progression|0|||
155092745|NCT03110562|559773681|FG001|Crossover Period|Disease Progression|0|||
155092746|NCT03110562|559773682|FG002|Crossover Period|Disease Progression|1|||
155092747|NCT03110562|559773683|FG003|Crossover Period|Disease Progression|0|||
155092748|NCT03110562|559773680|FG000|Crossover Period|Withdrawal by Subject|0|||
155092749|NCT03110562|559773681|FG001|Crossover Period|Withdrawal by Subject|0|||
155092750|NCT03110562|559773682|FG002|Crossover Period|Withdrawal by Subject|8|||
155092751|NCT03110562|559773683|FG003|Crossover Period|Withdrawal by Subject|6|||
155092752|NCT03110562|559773680|FG000|Crossover Period|Death|0|||
155092753|NCT03110562|559773681|FG001|Crossover Period|Death|0|||
155092754|NCT03110562|559773682|FG002|Crossover Period|Death|37|||
155092755|NCT03110562|559773683|FG003|Crossover Period|Death|3|||
155092756|NCT03110562|559773680|FG000|Crossover Period|Lost to Follow-up|0|||
155092757|NCT03110562|559773681|FG001|Crossover Period|Lost to Follow-up|0|||
155092758|NCT03110562|559773682|FG002|Crossover Period|Lost to Follow-up|0|||
155092759|NCT03110562|559773683|FG003|Crossover Period|Lost to Follow-up|1|||
155092760|NCT03110562|559773680|FG000|Crossover Period|Other|0|||
155092761|NCT03110562|559773681|FG001|Crossover Period|Other|0|||
155092762|NCT03110562|559773682|FG002|Crossover Period|Other|1|||
155092763|NCT03110562|559773683|FG003|Crossover Period|Other|1|||
155092764|NCT03110562|559773680|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
155092765|NCT03110562|559773681|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
155092766|NCT03110562|559773682|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
155092767|NCT03110562|559773683|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
155092768|NCT03189719|559773689|FG000|Overall Study|Death|325|||
155092769|NCT03189719|559773690|FG001|Overall Study|Death|361|||
155092770|NCT03189719|559773689|FG000|Overall Study|Physician Decision|1|||
155092771|NCT03189719|559773690|FG001|Overall Study|Physician Decision|0|||
155092772|NCT03189719|559773689|FG000|Overall Study|Sponsor Decision|40|||
155092773|NCT03189719|559773690|FG001|Overall Study|Sponsor Decision|12|||
155092774|NCT03189719|559773689|FG000|Overall Study|Withdrawal by Subject|7|||
155092775|NCT03189719|559773690|FG001|Overall Study|Withdrawal by Subject|3|||
155092776|NCT01355627|559773691|FG000|Overall Study|Request By the Patient to Discontinue|5|||
155092777|NCT01355627|559773692|FG001|Overall Study|Request By the Patient to Discontinue|7|||
155092778|NCT01355627|559773691|FG000|Overall Study|Lost to Follow-up|8|||
155092779|NCT01355627|559773692|FG001|Overall Study|Lost to Follow-up|7|||
155092780|NCT01355627|559773691|FG000|Overall Study|Fatal Adverse Event|19|||
155092781|NCT01355627|559773692|FG001|Overall Study|Fatal Adverse Event|23|||
155092782|NCT01355627|559773691|FG000|Overall Study|Other|1|||
155092783|NCT01355627|559773692|FG001|Overall Study|Other|1|||
155092784|NCT04756531|559773693|FG000|Overall Study|Adverse Event|0|||
155092785|NCT04756531|559773694|FG001|Overall Study|Adverse Event|0|||
155092786|NCT04756531|559773695|FG002|Overall Study|Adverse Event|0|||
155092787|NCT04756531|559773696|FG003|Overall Study|Adverse Event|0|||
155092788|NCT04756531|559773697|FG004|Overall Study|Adverse Event|1|||
155092789|NCT04756531|559773698|FG005|Overall Study|Adverse Event|0|||
155092790|NCT04756531|559773699|FG006|Overall Study|Adverse Event|0|||
155092791|NCT04756531|559773700|FG007|Overall Study|Adverse Event|0|||
155092792|NCT04756531|559773701|FG008|Overall Study|Adverse Event|0|||
155092793|NCT04756531|559773702|FG009|Overall Study|Adverse Event|0|||
155092794|NCT04756531|559773703|FG010|Overall Study|Adverse Event|0|||
155092795|NCT04756531|559773704|FG011|Overall Study|Adverse Event|0|||
155092796|NCT04756531|559773705|FG012|Overall Study|Adverse Event|0|||
155092797|NCT04756531|559773706|FG013|Overall Study|Adverse Event|0|||
155092798|NCT04756531|559773707|FG014|Overall Study|Adverse Event|0|||
155092799|NCT04756531|559773708|FG015|Overall Study|Adverse Event|0|||
155092800|NCT04756531|559773709|FG016|Overall Study|Adverse Event|0|||
155092801|NCT04756531|559773710|FG017|Overall Study|Adverse Event|0|||
155092802|NCT04756531|559773693|FG000|Overall Study|Withdrawal by Subject|0|||
155092803|NCT04756531|559773694|FG001|Overall Study|Withdrawal by Subject|0|||
155092804|NCT04756531|559773695|FG002|Overall Study|Withdrawal by Subject|0|||
155092805|NCT04756531|559773696|FG003|Overall Study|Withdrawal by Subject|0|||
155092806|NCT04756531|559773697|FG004|Overall Study|Withdrawal by Subject|0|||
155170571|NCT02791763|560062545|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
155092807|NCT04756531|559773698|FG005|Overall Study|Withdrawal by Subject|0|||
155092808|NCT04756531|559773699|FG006|Overall Study|Withdrawal by Subject|1|||
155092809|NCT04756531|559773700|FG007|Overall Study|Withdrawal by Subject|0|||
155092810|NCT04756531|559773701|FG008|Overall Study|Withdrawal by Subject|0|||
155092811|NCT04756531|559773702|FG009|Overall Study|Withdrawal by Subject|0|||
155092812|NCT04756531|559773703|FG010|Overall Study|Withdrawal by Subject|0|||
155092813|NCT04756531|559773704|FG011|Overall Study|Withdrawal by Subject|0|||
155092814|NCT04756531|559773705|FG012|Overall Study|Withdrawal by Subject|0|||
155092815|NCT04756531|559773706|FG013|Overall Study|Withdrawal by Subject|0|||
155092816|NCT04756531|559773707|FG014|Overall Study|Withdrawal by Subject|0|||
155092817|NCT04756531|559773708|FG015|Overall Study|Withdrawal by Subject|0|||
155092818|NCT04756531|559773709|FG016|Overall Study|Withdrawal by Subject|0|||
155092819|NCT04756531|559773710|FG017|Overall Study|Withdrawal by Subject|0|||
155092820|NCT04237584|559773711|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
155092821|NCT04237584|559773712|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
155092822|NCT04237584|559773713|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
155092823|NCT04237584|559773714|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
155092824|NCT04237584|559773711|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
155092825|NCT04237584|559773712|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
155092826|NCT04237584|559773713|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
155092827|NCT04237584|559773714|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
155092828|NCT04237584|559773711|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
155092829|NCT04237584|559773712|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
155092830|NCT04237584|559773713|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
155092831|NCT04237584|559773714|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
155092832|NCT04237584|559773711|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
155092833|NCT04237584|559773712|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
155092834|NCT04237584|559773713|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
155092835|NCT04237584|559773714|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
155092836|NCT04237584|559773711|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
155092837|NCT04237584|559773712|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
155092838|NCT04237584|559773713|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
155092839|NCT04237584|559773714|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
155092840|NCT05239221|559773715|FG000|Overall Study|Adverse Event|0|||
155092841|NCT05239221|559773716|FG001|Overall Study|Adverse Event|0|||
155092842|NCT05239221|559773717|FG002|Overall Study|Adverse Event|0|||
155092843|NCT05239221|559773718|FG003|Overall Study|Adverse Event|0|||
155092844|NCT05239221|559773719|FG004|Overall Study|Adverse Event|0|||
155092845|NCT05239221|559773720|FG005|Overall Study|Adverse Event|0|||
155092846|NCT05239221|559773721|FG006|Overall Study|Adverse Event|1|||
155092847|NCT05239221|559773722|FG007|Overall Study|Adverse Event|0|||
155092848|NCT05239221|559773723|FG008|Overall Study|Adverse Event|0|||
155092849|NCT05239221|559773724|FG009|Overall Study|Adverse Event|0|||
155092850|NCT05239221|559773725|FG010|Overall Study|Adverse Event|1|||
155092851|NCT05239221|559773726|FG011|Overall Study|Adverse Event|1|||
155092852|NCT05239221|559773727|FG012|Overall Study|Adverse Event|0|||
155092853|NCT05239221|559773728|FG013|Overall Study|Adverse Event|0|||
155092854|NCT05239221|559773729|FG014|Overall Study|Adverse Event|0|||
155092855|NCT05239221|559773730|FG015|Overall Study|Adverse Event|0|||
155092856|NCT05239221|559773715|FG000|Overall Study|Withdrawal by Subject|0|||
155092857|NCT05239221|559773716|FG001|Overall Study|Withdrawal by Subject|0|||
155092858|NCT05239221|559773717|FG002|Overall Study|Withdrawal by Subject|0|||
155092859|NCT05239221|559773718|FG003|Overall Study|Withdrawal by Subject|0|||
155092860|NCT05239221|559773719|FG004|Overall Study|Withdrawal by Subject|0|||
155092861|NCT05239221|559773720|FG005|Overall Study|Withdrawal by Subject|0|||
155092862|NCT05239221|559773721|FG006|Overall Study|Withdrawal by Subject|0|||
155092863|NCT05239221|559773722|FG007|Overall Study|Withdrawal by Subject|0|||
155092864|NCT05239221|559773723|FG008|Overall Study|Withdrawal by Subject|0|||
155092865|NCT05239221|559773724|FG009|Overall Study|Withdrawal by Subject|0|||
155092866|NCT05239221|559773725|FG010|Overall Study|Withdrawal by Subject|1|||
155092867|NCT05239221|559773726|FG011|Overall Study|Withdrawal by Subject|0|||
155092868|NCT05239221|559773727|FG012|Overall Study|Withdrawal by Subject|0|||
155092869|NCT05239221|559773728|FG013|Overall Study|Withdrawal by Subject|0|||
155092870|NCT05239221|559773729|FG014|Overall Study|Withdrawal by Subject|0|||
155092871|NCT05239221|559773730|FG015|Overall Study|Withdrawal by Subject|1|||
155092872|NCT01400412|559773731|FG000|Overall Study|Lost to Follow-up|4|||
155092873|NCT01400412|559773732|FG001|Overall Study|Lost to Follow-up|7|||
155092874|NCT01400412|559773731|FG000|Overall Study|Withdrawal by Subject|3|||
155092875|NCT01400412|559773732|FG001|Overall Study|Withdrawal by Subject|4|||
155092876|NCT01400412|559773731|FG000|Overall Study|Unable to complete|3|||
155092877|NCT01400412|559773732|FG001|Overall Study|Unable to complete|3|||
155092878|NCT01400412|559773731|FG000|Overall Study|Never started study treatment|0|||
155092879|NCT01400412|559773732|FG001|Overall Study|Never started study treatment|3|||
155092880|NCT02114177|559774930|FG000|Overall Study|Lost to Follow-up|1|||
155092881|NCT02114177|559774931|FG001|Overall Study|Lost to Follow-up|2|||
155092882|NCT02114177|559774930|FG000|Overall Study|Withdrawal by Subject|6|||
155092883|NCT02114177|559774931|FG001|Overall Study|Withdrawal by Subject|1|||
155092884|NCT02114177|559774930|FG000|Overall Study|Other|2|||
155092885|NCT02114177|559774931|FG001|Overall Study|Other|1|||
155092886|NCT01897493|559774932|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
155092887|NCT01246960|559774937|FG000|Overall Study|Lost to Follow-up|3|||
155092888|NCT01246960|559774938|FG001|Overall Study|Lost to Follow-up|1|||
155092889|NCT01246960|559774937|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
155092890|NCT01246960|559774938|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
155092891|NCT05111145|559774939|FG000|Overall Study|Commercial drug is available for participant|76|||
155092892|NCT05111145|559774939|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
155092893|NCT00370292|559774940|FG000|Overall Study|Disease Progression|4|||
155092894|NCT00370292|559774940|FG000|Overall Study|Adverse Event|7|||
155092895|NCT00370292|559774940|FG000|Overall Study|Physician Decision|2|||
155092896|NCT02239926|559774943|FG000|Overall Study|Withdrawal by Subject|0|||
155092897|NCT02239926|559774944|FG001|Overall Study|Withdrawal by Subject|1|||
155092898|NCT02415556|559774945|FG000|Overall Study|Adverse Event|3|||
155092899|NCT02415556|559774946|FG001|Overall Study|Adverse Event|4|||
155092900|NCT02415556|559774947|FG002|Overall Study|Adverse Event|2|||
155092901|NCT02415556|559774948|FG003|Overall Study|Adverse Event|4|||
155092902|NCT02415556|559774945|FG000|Overall Study|Lost to Follow-up|4|||
155092903|NCT02415556|559774946|FG001|Overall Study|Lost to Follow-up|5|||
155092904|NCT02415556|559774947|FG002|Overall Study|Lost to Follow-up|4|||
155092905|NCT02415556|559774948|FG003|Overall Study|Lost to Follow-up|1|||
155092906|NCT02415556|559774945|FG000|Overall Study|Withdrawal by Subject|13|||
155092907|NCT02415556|559774946|FG001|Overall Study|Withdrawal by Subject|4|||
155092908|NCT02415556|559774947|FG002|Overall Study|Withdrawal by Subject|14|||
155092909|NCT02415556|559774948|FG003|Overall Study|Withdrawal by Subject|12|||
155092910|NCT02415556|559774945|FG000|Overall Study|Physician Decision|1|||
155092911|NCT02415556|559774946|FG001|Overall Study|Physician Decision|3|||
155092912|NCT02415556|559774947|FG002|Overall Study|Physician Decision|1|||
155092913|NCT02415556|559774948|FG003|Overall Study|Physician Decision|2|||
155092914|NCT02415556|559774945|FG000|Overall Study|Censored - study completion|4|||
155092915|NCT02415556|559774946|FG001|Overall Study|Censored - study completion|5|||
155092916|NCT02415556|559774947|FG002|Overall Study|Censored - study completion|1|||
155092917|NCT02415556|559774948|FG003|Overall Study|Censored - study completion|0|||
155092918|NCT02415556|559774945|FG000|Overall Study|Family-related issues|0|||
155092919|NCT02415556|559774946|FG001|Overall Study|Family-related issues|0|||
155092920|NCT02415556|559774947|FG002|Overall Study|Family-related issues|0|||
154966938|NCT02316223|559303193|FG002|Overall Study|Reside outside study area|1|||
155092921|NCT02415556|559774948|FG003|Overall Study|Family-related issues|1|||
155092922|NCT04102007|559774950|FG000|Overall Study|Adverse Event|4|||
155092923|NCT04102007|559774950|FG000|Overall Study|Lost to Follow-up|3|||
155092924|NCT04102007|559774950|FG000|Overall Study|Withdrawal by Subject|12|||
155092925|NCT04102007|559774950|FG000|Overall Study|Eligibility Violation|5|||
155092926|NCT04102007|559774950|FG000|Overall Study|Lack of Efficacy|6|||
155092927|NCT04102007|559774950|FG000|Overall Study|Protocol Deviation|5|||
155092928|NCT04102007|559774950|FG000|Overall Study|Protocol Compliance|1|||
155092929|NCT04102007|559774950|FG000|Overall Study|Withdrew Treatment|2|||
155092930|NCT04102007|559774950|FG000|Overall Study|Pregnancy|1|||
155092931|NCT05173974|559774951|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
155092932|NCT05173974|559774952|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
155092933|NCT05173974|559774953|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
155092934|NCT05173974|559774954|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
155092935|NCT05173974|559774951|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
155092936|NCT05173974|559774952|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
155092937|NCT05173974|559774953|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
155092938|NCT05173974|559774954|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
155092939|NCT03289143|559774955|FG000|Overall Study|Caregiver Unavailability|1|||
155092940|NCT03289143|559774956|FG001|Overall Study|Caregiver Unavailability|1|||
155092941|NCT03289143|559774957|FG002|Overall Study|Caregiver Unavailability|0|||
155092942|NCT03289143|559774958|FG003|Overall Study|Caregiver Unavailability|0|||
155092943|NCT03289143|559774955|FG000|Overall Study|Research Department Closure|0|||
155092944|NCT03289143|559774956|FG001|Overall Study|Research Department Closure|0|||
155092945|NCT03289143|559774957|FG002|Overall Study|Research Department Closure|1|||
155092946|NCT03289143|559774958|FG003|Overall Study|Research Department Closure|0|||
155092947|NCT03289143|559774955|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
155092948|NCT03289143|559774956|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
155092949|NCT03289143|559774957|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
155092950|NCT03289143|559774958|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
155092951|NCT03289143|559774955|FG000|Overall Study|Medical Monitor Decision|1|||
155092952|NCT03289143|559774956|FG001|Overall Study|Medical Monitor Decision|0|||
155092953|NCT03289143|559774957|FG002|Overall Study|Medical Monitor Decision|0|||
155092954|NCT03289143|559774958|FG003|Overall Study|Medical Monitor Decision|0|||
155092955|NCT03289143|559774955|FG000|Overall Study|Participant Non-Compliance|0|||
155092956|NCT03289143|559774956|FG001|Overall Study|Participant Non-Compliance|0|||
155092957|NCT03289143|559774957|FG002|Overall Study|Participant Non-Compliance|1|||
155092958|NCT03289143|559774958|FG003|Overall Study|Participant Non-Compliance|0|||
155092959|NCT03289143|559774955|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
155092960|NCT03289143|559774956|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
155092961|NCT03289143|559774957|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
155092962|NCT03289143|559774958|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
155092963|NCT03289143|559774955|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
155092964|NCT03289143|559774956|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
155092965|NCT03289143|559774957|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
155092966|NCT03289143|559774958|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
155092967|NCT03289143|559774955|FG000|Overall Study|Caregiver Passed Away|1|||
155092968|NCT03289143|559774956|FG001|Overall Study|Caregiver Passed Away|0|||
155092969|NCT03289143|559774957|FG002|Overall Study|Caregiver Passed Away|0|||
155092970|NCT03289143|559774958|FG003|Overall Study|Caregiver Passed Away|0|||
155092971|NCT03289143|559774955|FG000|Overall Study|Physician Decision|0|||
155170572|NCT02791763|560062543|FG000|Overall Study|Cancer event|1|||
154966939|NCT02316223|559303191|FG000|Overall Study|No asthma|2|||
154966940|NCT02316223|559303192|FG001|Overall Study|No asthma|0|||
154966941|NCT02316223|559303193|FG002|Overall Study|No asthma|0|||
154966942|NCT02316223|559303191|FG000|Overall Study|Discontinued by PI|11|||
154966943|NCT02316223|559303192|FG001|Overall Study|Discontinued by PI|19|||
154966944|NCT02316223|559303193|FG002|Overall Study|Discontinued by PI|3|||
154966945|NCT00529763|559303194|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
154966946|NCT00529763|559303195|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
154966947|NCT00529763|559303196|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
154966948|NCT00529763|559303194|FG000|Overall Study|Death|1|||
154966949|NCT00529763|559303195|FG001|Overall Study|Death|1|||
154966950|NCT00529763|559303196|FG002|Overall Study|Death|1|||
154966951|NCT00529763|559303194|FG000|Overall Study|Disease Progression|10|||
154966952|NCT00529763|559303195|FG001|Overall Study|Disease Progression|16|||
154966953|NCT00529763|559303196|FG002|Overall Study|Disease Progression|11|||
154966954|NCT00529763|559303194|FG000|Overall Study|Lost to Follow-up|1|||
154966955|NCT00529763|559303195|FG001|Overall Study|Lost to Follow-up|2|||
154966956|NCT00529763|559303196|FG002|Overall Study|Lost to Follow-up|3|||
154966957|NCT00529763|559303194|FG000|Overall Study|Stem Cell Transplant|0|||
154966958|NCT00529763|559303195|FG001|Overall Study|Stem Cell Transplant|3|||
154966959|NCT00529763|559303196|FG002|Overall Study|Stem Cell Transplant|1|||
154966960|NCT00529763|559303194|FG000|Overall Study|Study Drug Toxicity|3|||
154966961|NCT00529763|559303195|FG001|Overall Study|Study Drug Toxicity|6|||
154966962|NCT00529763|559303196|FG002|Overall Study|Study Drug Toxicity|4|||
154966963|NCT00529763|559303194|FG000|Overall Study|Participant Withdrew Consent|2|||
154966964|NCT00529763|559303195|FG001|Overall Study|Participant Withdrew Consent|3|||
154966965|NCT00529763|559303196|FG002|Overall Study|Participant Withdrew Consent|4|||
154966966|NCT00529763|559303194|FG000|Overall Study|Other reasons|2|||
154966967|NCT00529763|559303195|FG001|Overall Study|Other reasons|0|||
154966968|NCT00529763|559303196|FG002|Overall Study|Other reasons|2|||
154966969|NCT00529763|559303194|FG000|Overall Study|Participant request to discontinue treatment|1|||
154966970|NCT00529763|559303195|FG001|Overall Study|Participant request to discontinue treatment|1|||
154966971|NCT00529763|559303196|FG002|Overall Study|Participant request to discontinue treatment|3|||
154966972|NCT03669250|559303197|FG000|Overall Study|Adverse Event|0|||
154966973|NCT03669250|559303198|FG001|Overall Study|Adverse Event|0|||
154966974|NCT03669250|559303199|FG002|Overall Study|Adverse Event|0|||
154966975|NCT03669250|559303200|FG003|Overall Study|Adverse Event|0|||
154966976|NCT03669250|559303201|FG004|Overall Study|Adverse Event|1|||
154966977|NCT03669250|559303202|FG005|Overall Study|Adverse Event|0|||
154966978|NCT03669250|559303197|FG000|Overall Study|Withdrawal by Subject|0|||
154966979|NCT03669250|559303198|FG001|Overall Study|Withdrawal by Subject|1|||
154966980|NCT03669250|559303199|FG002|Overall Study|Withdrawal by Subject|0|||
154966981|NCT03669250|559303200|FG003|Overall Study|Withdrawal by Subject|1|||
154966982|NCT03669250|559303201|FG004|Overall Study|Withdrawal by Subject|0|||
154966983|NCT03669250|559303202|FG005|Overall Study|Withdrawal by Subject|0|||
154966984|NCT03234907|559303203|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
154966985|NCT03234907|559303204|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
154966986|NCT03234907|559303205|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
154966987|NCT03234907|559303206|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
154966988|NCT03234907|559303207|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
154966989|NCT03234907|559303208|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
154966990|NCT03234907|559303203|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
154966991|NCT03234907|559303204|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
154966992|NCT03234907|559303205|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
154966993|NCT03234907|559303206|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
154966994|NCT03234907|559303207|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
154966995|NCT03234907|559303208|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
154966996|NCT03234907|559303203|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
154966997|NCT03234907|559303204|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
154966998|NCT03234907|559303205|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
154966999|NCT03234907|559303206|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
154967000|NCT03234907|559303207|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
154967001|NCT03234907|559303208|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
154967002|NCT03234907|559303203|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
154967003|NCT03234907|559303204|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
154967004|NCT03234907|559303205|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
154967005|NCT03234907|559303206|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
154967006|NCT03234907|559303207|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
154967007|NCT03234907|559303208|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
154967008|NCT03234907|559303203|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
154967009|NCT03234907|559303204|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
154967010|NCT03234907|559303205|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
154967011|NCT03234907|559303206|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
154967012|NCT03234907|559303207|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
154967013|NCT03234907|559303208|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
154967014|NCT03234907|559303203|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
154967015|NCT03234907|559303204|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
154967016|NCT03234907|559303205|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
154967017|NCT03234907|559303206|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
154967018|NCT03234907|559303207|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
154967019|NCT03234907|559303208|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
155092972|NCT03289143|559774956|FG001|Overall Study|Physician Decision|2|||
155092973|NCT03289143|559774957|FG002|Overall Study|Physician Decision|2|||
155092974|NCT03289143|559774958|FG003|Overall Study|Physician Decision|2|||
155092975|NCT03289143|559774955|FG000|Overall Study|Protocol Deviation|2|||
155092976|NCT03289143|559774956|FG001|Overall Study|Protocol Deviation|1|||
155092977|NCT03289143|559774957|FG002|Overall Study|Protocol Deviation|3|||
155092978|NCT03289143|559774958|FG003|Overall Study|Protocol Deviation|1|||
155092979|NCT03289143|559774955|FG000|Overall Study|Study Terminated By Sponsor|101|||
155092980|NCT03289143|559774956|FG001|Overall Study|Study Terminated By Sponsor|75|||
155092981|NCT03289143|559774957|FG002|Overall Study|Study Terminated By Sponsor|100|||
155092982|NCT03289143|559774958|FG003|Overall Study|Study Terminated By Sponsor|69|||
155092983|NCT03289143|559774955|FG000|Overall Study|Withdrawal by Subject|14|||
155092984|NCT03289143|559774956|FG001|Overall Study|Withdrawal by Subject|6|||
155092985|NCT03289143|559774957|FG002|Overall Study|Withdrawal by Subject|14|||
155092986|NCT03289143|559774958|FG003|Overall Study|Withdrawal by Subject|12|||
155092987|NCT03289143|559774955|FG000|Overall Study|Adverse Event|10|||
155092988|NCT03289143|559774956|FG001|Overall Study|Adverse Event|7|||
155092989|NCT03289143|559774957|FG002|Overall Study|Adverse Event|6|||
155092990|NCT03289143|559774958|FG003|Overall Study|Adverse Event|5|||
155092991|NCT03289143|559774955|FG000|Overall Study|Death|2|||
155092992|NCT03289143|559774956|FG001|Overall Study|Death|0|||
155092993|NCT03289143|559774957|FG002|Overall Study|Death|2|||
155092994|NCT03289143|559774958|FG003|Overall Study|Death|1|||
155092995|NCT03289143|559774955|FG000|Overall Study|Lost to Follow-up|2|||
155092996|NCT03289143|559774956|FG001|Overall Study|Lost to Follow-up|1|||
155092997|NCT03289143|559774957|FG002|Overall Study|Lost to Follow-up|1|||
155092998|NCT03289143|559774958|FG003|Overall Study|Lost to Follow-up|0|||
155092999|NCT03289143|559774955|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
155093000|NCT03289143|559774956|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
155093001|NCT03289143|559774957|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
155093002|NCT03289143|559774958|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
155093003|NCT03289143|559774955|FG000|Overall Study|Withdrawal by Caregiver|0|||
155093004|NCT03289143|559774956|FG001|Overall Study|Withdrawal by Caregiver|1|||
155093005|NCT03289143|559774957|FG002|Overall Study|Withdrawal by Caregiver|0|||
155093006|NCT03289143|559774958|FG003|Overall Study|Withdrawal by Caregiver|0|||
155093007|NCT03289143|559774955|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
155093008|NCT03289143|559774956|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
155093009|NCT03289143|559774957|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
155093010|NCT03289143|559774958|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
155093011|NCT03289143|559774955|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
155093012|NCT03289143|559774956|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
155093013|NCT03289143|559774957|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
155093014|NCT03289143|559774958|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
155093015|NCT00948688|559774959|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
155093016|NCT00948688|559774960|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
155093017|NCT00948688|559774959|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
155093018|NCT00948688|559774960|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
155093019|NCT00948688|559774959|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
155093020|NCT00948688|559774960|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
155093021|NCT00730756|559774961|FG000|Overall Study|Adverse Event|2|||
155093022|NCT00730756|559774962|FG001|Overall Study|Adverse Event|0|||
155093023|NCT00730756|559774961|FG000|Overall Study|Lack of Efficacy|1|||
155093024|NCT00730756|559774962|FG001|Overall Study|Lack of Efficacy|1|||
155093025|NCT00730756|559774961|FG000|Overall Study|Protocol Deviation|1|||
155093026|NCT00730756|559774962|FG001|Overall Study|Protocol Deviation|2|||
155093027|NCT00730756|559774961|FG000|Overall Study|Lost to Follow-up|0|||
155093028|NCT00730756|559774962|FG001|Overall Study|Lost to Follow-up|1|||
155093029|NCT00730756|559774961|FG000|Overall Study|Withdrew Consent|0|||
155093030|NCT00730756|559774962|FG001|Overall Study|Withdrew Consent|1|||
155093031|NCT04388826|559774963|FG000|Overall Study|Lost to Follow-up|3|||
154967020|NCT03234907|559303203|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
154967021|NCT03234907|559303204|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
154967022|NCT03234907|559303205|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
154967023|NCT03234907|559303206|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
154967024|NCT03234907|559303207|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
154967025|NCT03234907|559303208|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
154967026|NCT00414726|559303211|FG000|Overall Study|Withdrawal by Subject|0|||
154967027|NCT00414726|559303212|FG001|Overall Study|Withdrawal by Subject|1|||
154967028|NCT02107196|559303213|FG000|12-week Treatment Period|Adverse Event|6|||
154967029|NCT02107196|559303214|FG001|12-week Treatment Period|Adverse Event|3|||
154967030|NCT02107196|559303213|FG000|12-week Treatment Period|Lack of Efficacy|2|||
154967031|NCT02107196|559303214|FG001|12-week Treatment Period|Lack of Efficacy|1|||
154967032|NCT02107196|559303213|FG000|12-week Treatment Period|Lost to Follow-up|3|||
154967033|NCT02107196|559303214|FG001|12-week Treatment Period|Lost to Follow-up|6|||
154967034|NCT02107196|559303213|FG000|12-week Treatment Period|Physician Decision|0|||
154967035|NCT02107196|559303214|FG001|12-week Treatment Period|Physician Decision|1|||
154967036|NCT02107196|559303213|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
154967037|NCT02107196|559303214|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
154967038|NCT02107196|559303213|FG000|12-week Treatment Period|Protocol Violation|7|||
154967039|NCT02107196|559303214|FG001|12-week Treatment Period|Protocol Violation|8|||
154967040|NCT02107196|559303213|FG000|12-week Treatment Period|Reason Missing|11|||
154967041|NCT02107196|559303214|FG001|12-week Treatment Period|Reason Missing|8|||
154967042|NCT02107196|559303213|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
154967043|NCT02107196|559303214|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
154967044|NCT02107196|559303213|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
154967045|NCT02107196|559303214|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
154967046|NCT02107196|559303213|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
154967047|NCT02107196|559303214|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
154967048|NCT02107196|559303213|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
154967049|NCT02107196|559303214|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
154967050|NCT01630616|559303215|FG000|Overall Study|Adverse Event|0|||
154967051|NCT01630616|559303216|FG001|Overall Study|Adverse Event|0|||
154967052|NCT01630616|559303217|FG002|Overall Study|Adverse Event|0|||
154967053|NCT01630616|559303218|FG003|Overall Study|Adverse Event|1|||
154967054|NCT01630616|559303219|FG004|Overall Study|Adverse Event|0|||
154967055|NCT01630616|559303220|FG005|Overall Study|Adverse Event|0|||
154967056|NCT01630616|559303215|FG000|Overall Study|Withdrawal by Subject|0|||
154967057|NCT01630616|559303216|FG001|Overall Study|Withdrawal by Subject|0|||
154967058|NCT01630616|559303217|FG002|Overall Study|Withdrawal by Subject|0|||
154967059|NCT01630616|559303218|FG003|Overall Study|Withdrawal by Subject|2|||
154967060|NCT01630616|559303219|FG004|Overall Study|Withdrawal by Subject|0|||
154967061|NCT01630616|559303220|FG005|Overall Study|Withdrawal by Subject|0|||
154967062|NCT00691704|559303221|FG000|Induction Therapy|Disease Progression|1|||
154967063|NCT00691704|559303221|FG000|Induction Therapy|Active Hepatitis|1|||
154967064|NCT00691704|559303221|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
154967065|NCT00691704|559303221|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
154967066|NCT00691704|559303221|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
154967067|NCT01993186|559303222|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
154967068|NCT01993186|559303223|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
154967069|NCT01993186|559303222|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
154967070|NCT01993186|559303223|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
154967071|NCT01993186|559303222|FG000|Open-Label Extension Period|Other, Not Specified|0|||
154967072|NCT01993186|559303223|FG001|Open-Label Extension Period|Other, Not Specified|1|||
154967073|NCT01993186|559303222|FG000|Open-Label Extension Period|Adverse Event|1|||
154967074|NCT01993186|559303223|FG001|Open-Label Extension Period|Adverse Event|0|||
154967075|NCT01993186|559303222|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
154967076|NCT01993186|559303223|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
154967077|NCT01993186|559303222|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
154967078|NCT01993186|559303223|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
154967079|NCT01993186|559303222|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
154967080|NCT01993186|559303223|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
154967081|NCT04158687|559303224|FG000|Overall Study|Adverse Event|2|||
154967082|NCT04158687|559303225|FG001|Overall Study|Adverse Event|3|||
154967083|NCT04158687|559303226|FG002|Overall Study|Adverse Event|0|||
154967084|NCT04158687|559303227|FG003|Overall Study|Adverse Event|3|||
154967085|NCT04158687|559303224|FG000|Overall Study|Lost to Follow-up|5|||
154967086|NCT04158687|559303225|FG001|Overall Study|Lost to Follow-up|12|||
154967087|NCT04158687|559303226|FG002|Overall Study|Lost to Follow-up|4|||
154967088|NCT04158687|559303227|FG003|Overall Study|Lost to Follow-up|5|||
155093032|NCT04388826|559774964|FG001|Overall Study|Lost to Follow-up|2|||
155093033|NCT04388826|559774963|FG000|Overall Study|Adverse Event|1|||
155093034|NCT04388826|559774964|FG001|Overall Study|Adverse Event|0|||
155093035|NCT01146613|559774967|FG000|Overall Study|Lost to Follow-up|3|||
155093036|NCT01146613|559774968|FG001|Overall Study|Lost to Follow-up|8|||
155093037|NCT01146613|559774967|FG000|Overall Study|Lack of Efficacy|0|||
155093038|NCT01146613|559774968|FG001|Overall Study|Lack of Efficacy|1|||
155093039|NCT01146613|559774967|FG000|Overall Study|Death|1|||
155093040|NCT01146613|559774968|FG001|Overall Study|Death|0|||
155093041|NCT01146613|559774967|FG000|Overall Study|Physician Decision|1|||
155093042|NCT01146613|559774968|FG001|Overall Study|Physician Decision|0|||
155093043|NCT01146613|559774967|FG000|Overall Study|Withdrawal by Subject|0|||
155093044|NCT01146613|559774968|FG001|Overall Study|Withdrawal by Subject|3|||
155093045|NCT01146613|559774967|FG000|Overall Study|schedule conflict|1|||
155093046|NCT01146613|559774968|FG001|Overall Study|schedule conflict|0|||
155093047|NCT01146613|559774967|FG000|Overall Study|Outpatient detox|1|||
155093048|NCT01146613|559774968|FG001|Overall Study|Outpatient detox|0|||
155093049|NCT05878067|559774969|FG000|Overall Study|Lost to Follow-up|2|||
155093050|NCT01198587|559774970|FG000|Overall Study|Lost to Follow-up|8|||
155093051|NCT01198587|559774971|FG001|Overall Study|Lost to Follow-up|0|||
155093052|NCT01198587|559774972|FG002|Overall Study|Lost to Follow-up|9|||
155093053|NCT01198587|559774973|FG003|Overall Study|Lost to Follow-up|0|||
155093054|NCT01493089|559774974|FG000|Overall Study|Protocol Violation|2|||
155093055|NCT01493089|559774975|FG001|Overall Study|Protocol Violation|2|||
155093056|NCT01493089|559774974|FG000|Overall Study|Withdrawal by Subject|1|||
155093057|NCT01493089|559774975|FG001|Overall Study|Withdrawal by Subject|0|||
155093058|NCT01493089|559774974|FG000|Overall Study|Physician Decision|0|||
155093059|NCT01493089|559774975|FG001|Overall Study|Physician Decision|1|||
155093060|NCT00652834|559774983|FG000|Overall Study|Withdrawal by Subject|3|||
155093061|NCT00652834|559774983|FG000|Overall Study|Lost to Follow-up|2|||
155093062|NCT00399529|559774985|FG000|Overall Study|Off Study Prior to Treatment|2|||
155093063|NCT01170663|559774986|FG000|Overall Study|Lost to Follow-up|3|||
155093064|NCT01170663|559774987|FG001|Overall Study|Lost to Follow-up|9|||
155093065|NCT01170663|559774986|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
155093066|NCT01170663|559774987|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
155093067|NCT02746809|559774988|FG000|Enrollment|Inclusion Exclusion not met|9|||
155093068|NCT02746809|559774988|FG000|Enrollment|Withdrawal by Subject|1|||
155093069|NCT02746809|559774988|FG000|Enrollment|Expected Enrollment Met|2|||
155093070|NCT02746809|559774988|FG000|Procedure|Death|1|||
155093071|NCT02746809|559774988|FG000|1-Month|Death|5|||
155093072|NCT02746809|559774988|FG000|6-Month|Death|2|||
155093073|NCT02746809|559774988|FG000|6-Month|Withdrawal by Subject|1|||
155093074|NCT02746809|559774988|FG000|12-Month|Death|3|||
155093075|NCT02746809|559774988|FG000|12-Month|Withdrawal by Subject|2|||
155093076|NCT02746809|559774988|FG000|24-Month|Death|1|||
155093077|NCT02746809|559774988|FG000|24-Month|Withdrawal by Subject|1|||
155093078|NCT02746809|559774988|FG000|36-Month|Death|8|||
155093079|NCT02746809|559774988|FG000|36-Month|Withdrawal by Subject|1|||
155093080|NCT02746809|559774988|FG000|48-Month|Death|7|||
155093081|NCT02746809|559774988|FG000|48-Month|Withdrawal by Subject|1|||
155093082|NCT02746809|559774988|FG000|60-Month|Death|1|||
155093083|NCT02746809|559774988|FG000|60-Month|Lost to Follow-up|2|||
155093084|NCT00742625|559774992|FG000|Remission Induction|Progression|6|||
155093085|NCT00742625|559774992|FG000|Remission Induction|Failed induction|8|||
155093086|NCT00742625|559774992|FG000|Remission Induction|Adverse Event|3|||
155093087|NCT00742625|559774992|FG000|Remission Induction|Death|10|||
155093088|NCT00742625|559774992|FG000|Remission Induction|Refusal|5|||
155093089|NCT00742625|559774992|FG000|Remission Induction|Non protocol treatment|17|||
155093090|NCT00742625|559774992|FG000|Remission Induction|Other, not specified|5|||
155093091|NCT00742625|559774992|FG000|Consolidation|Progression|5|||
155093092|NCT00742625|559774992|FG000|Consolidation|Adverse Event|1|||
155093093|NCT00742625|559774992|FG000|Consolidation|Death|1|||
155093094|NCT00742625|559774992|FG000|Consolidation|Refused|1|||
155093095|NCT00742625|559774992|FG000|Consolidation|Non protocol therapy|13|||
155093096|NCT01164007|559774993|FG000|Overall Study|Adverse Event|5|||
155093097|NCT01164007|559774993|FG000|Overall Study|Progression of Disease|30|||
155093098|NCT01164007|559774993|FG000|Overall Study|Protocol Violation|1|||
155093099|NCT01164007|559774993|FG000|Overall Study|Withdrawal by Subject|1|||
155093100|NCT01164007|559774993|FG000|Overall Study|Medical Decision|3|||
155093101|NCT00894387|559774994|FG000|Overall Study|Adverse Event|44|||
155093102|NCT00894387|559774995|FG001|Overall Study|Adverse Event|45|||
155093103|NCT00894387|559774994|FG000|Overall Study|Abnormal Laboratory values|2|||
155093104|NCT00894387|559774995|FG001|Overall Study|Abnormal Laboratory values|2|||
154967089|NCT04158687|559303224|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
154967090|NCT04158687|559303225|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
154967091|NCT04158687|559303226|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
154967092|NCT04158687|559303227|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
154967093|NCT04158687|559303224|FG000|Overall Study|Non-Compliance with Study Medication|2|||
154967094|NCT04158687|559303225|FG001|Overall Study|Non-Compliance with Study Medication|2|||
154967095|NCT04158687|559303226|FG002|Overall Study|Non-Compliance with Study Medication|3|||
154967096|NCT04158687|559303227|FG003|Overall Study|Non-Compliance with Study Medication|0|||
154967097|NCT04158687|559303224|FG000|Overall Study|Investigator Decision|0|||
154967098|NCT04158687|559303225|FG001|Overall Study|Investigator Decision|0|||
154967099|NCT04158687|559303226|FG002|Overall Study|Investigator Decision|2|||
154967100|NCT04158687|559303227|FG003|Overall Study|Investigator Decision|0|||
154967101|NCT04158687|559303224|FG000|Overall Study|Protocol Violation|0|||
154967102|NCT04158687|559303225|FG001|Overall Study|Protocol Violation|2|||
154967103|NCT04158687|559303226|FG002|Overall Study|Protocol Violation|1|||
154967104|NCT04158687|559303227|FG003|Overall Study|Protocol Violation|0|||
154967105|NCT04158687|559303224|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
154967106|NCT04158687|559303225|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
154967107|NCT04158687|559303226|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
154967108|NCT04158687|559303227|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
154967109|NCT04158687|559303224|FG000|Overall Study|Reason not Specified|3|||
154967110|NCT04158687|559303225|FG001|Overall Study|Reason not Specified|2|||
154967111|NCT04158687|559303226|FG002|Overall Study|Reason not Specified|4|||
154967112|NCT04158687|559303227|FG003|Overall Study|Reason not Specified|4|||
154967113|NCT00640393|559303228|FG000|Part 1|Lost to Follow-up|2|||
154967114|NCT00640393|559303229|FG001|Part 1|Lost to Follow-up|0|||
154967115|NCT00640393|559303230|FG002|Part 1|Lost to Follow-up|0|||
154967116|NCT00640393|559303228|FG000|Part 1|Withdrawal by Subject|3|||
154967117|NCT00640393|559303229|FG001|Part 1|Withdrawal by Subject|0|||
154967118|NCT00640393|559303230|FG002|Part 1|Withdrawal by Subject|0|||
154967119|NCT00640393|559303228|FG000|Randomization|Withdrawn per protocol|17|||
154967120|NCT00640393|559303229|FG001|Randomization|Withdrawn per protocol|0|||
154967121|NCT00640393|559303230|FG002|Randomization|Withdrawn per protocol|0|||
154967122|NCT00640393|559303228|FG000|Randomization|Never randomized by site|2|||
154967123|NCT00640393|559303229|FG001|Randomization|Never randomized by site|0|||
154967124|NCT00640393|559303230|FG002|Randomization|Never randomized by site|0|||
154967125|NCT00640393|559303228|FG000|Part 2|Lost to Follow-up|0|||
154967126|NCT00640393|559303229|FG001|Part 2|Lost to Follow-up|2|||
154967127|NCT00640393|559303230|FG002|Part 2|Lost to Follow-up|2|||
154967128|NCT00640393|559303228|FG000|Part 2|Withdrawal by Subject|0|||
154967129|NCT00640393|559303229|FG001|Part 2|Withdrawal by Subject|6|||
154967130|NCT00640393|559303230|FG002|Part 2|Withdrawal by Subject|1|||
154967131|NCT00640393|559303228|FG000|Part 2|Non-adherence|0|||
154967132|NCT00640393|559303229|FG001|Part 2|Non-adherence|1|||
154967133|NCT00640393|559303230|FG002|Part 2|Non-adherence|0|||
154967134|NCT00640393|559303228|FG000|Part 2|Adverse Event|0|||
154967135|NCT00640393|559303229|FG001|Part 2|Adverse Event|1|||
154967136|NCT00640393|559303230|FG002|Part 2|Adverse Event|0|||
154967137|NCT02043132|559303231|FG000|Overall Study|Lost to Follow-up|1|||
154967138|NCT02043132|559303232|FG001|Overall Study|Lost to Follow-up|1|||
154967139|NCT02043132|559303231|FG000|Overall Study|screen failures|4|||
154967140|NCT02043132|559303232|FG001|Overall Study|screen failures|8|||
154967141|NCT02554877|559303233|FG000|Overall Study|Adverse Event|2|||
154967142|NCT02554877|559303234|FG001|Overall Study|Adverse Event|0|||
154967143|NCT02554877|559303235|FG002|Overall Study|Adverse Event|0|||
154967144|NCT02554877|559303236|FG003|Overall Study|Adverse Event|1|||
154967145|NCT02554877|559303233|FG000|Overall Study|Lost to Follow-up|1|||
154967146|NCT02554877|559303234|FG001|Overall Study|Lost to Follow-up|1|||
154967147|NCT02554877|559303235|FG002|Overall Study|Lost to Follow-up|1|||
154967148|NCT02554877|559303236|FG003|Overall Study|Lost to Follow-up|2|||
154967149|NCT02554877|559303233|FG000|Overall Study|Did not meet entrance criteria|0|||
154967150|NCT02554877|559303234|FG001|Overall Study|Did not meet entrance criteria|0|||
154967151|NCT02554877|559303235|FG002|Overall Study|Did not meet entrance criteria|1|||
154967152|NCT02554877|559303236|FG003|Overall Study|Did not meet entrance criteria|0|||
154967153|NCT02554877|559303233|FG000|Overall Study|No longer met eligibility criteria|1|||
154967154|NCT02554877|559303234|FG001|Overall Study|No longer met eligibility criteria|0|||
154967155|NCT02554877|559303235|FG002|Overall Study|No longer met eligibility criteria|1|||
154967156|NCT02554877|559303236|FG003|Overall Study|No longer met eligibility criteria|1|||
154967157|NCT02554877|559303233|FG000|Overall Study|Protocol Violation|3|||
154967158|NCT02554877|559303234|FG001|Overall Study|Protocol Violation|1|||
154967159|NCT02554877|559303235|FG002|Overall Study|Protocol Violation|1|||
154967160|NCT02554877|559303236|FG003|Overall Study|Protocol Violation|0|||
154967161|NCT02554877|559303233|FG000|Overall Study|Other|1|||
154967162|NCT02554877|559303234|FG001|Overall Study|Other|3|||
154967163|NCT02554877|559303235|FG002|Overall Study|Other|0|||
154967164|NCT02554877|559303236|FG003|Overall Study|Other|3|||
154967165|NCT02554877|559303233|FG000|Overall Study|Insufficient clinical response|4|||
154967166|NCT02554877|559303234|FG001|Overall Study|Insufficient clinical response|0|||
154967167|NCT02554877|559303235|FG002|Overall Study|Insufficient clinical response|0|||
155093105|NCT00894387|559774994|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155093106|NCT00894387|559774995|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155093107|NCT00894387|559774994|FG000|Overall Study|Lost to Follow-up|3|||
155093108|NCT00894387|559774995|FG001|Overall Study|Lost to Follow-up|5|||
155093109|NCT00894387|559774994|FG000|Overall Study|Administrative problems|2|||
155093110|NCT00894387|559774995|FG001|Overall Study|Administrative problems|2|||
155093111|NCT00894387|559774994|FG000|Overall Study|Death|77|||
155093112|NCT00894387|559774995|FG001|Overall Study|Death|76|||
155093113|NCT00894387|559774994|FG000|Overall Study|Protocol Deviation|4|||
155093114|NCT00894387|559774995|FG001|Overall Study|Protocol Deviation|0|||
155093115|NCT00894387|559774994|FG000|Overall Study|Patient's request|25|||
155093116|NCT00894387|559774995|FG001|Overall Study|Patient's request|30|||
155093117|NCT00894387|559774994|FG000|Overall Study|Other (Missing)|5|||
155093118|NCT00894387|559774995|FG001|Overall Study|Other (Missing)|3|||
155093119|NCT00894387|559774994|FG000|Overall Study|Mis-randomized|13|||
155093120|NCT00894387|559774995|FG001|Overall Study|Mis-randomized|9|||
155093121|NCT00894387|559774994|FG000|Overall Study|GCP non-compliance|0|||
155093122|NCT00894387|559774995|FG001|Overall Study|GCP non-compliance|2|||
155093123|NCT01076010|559774996|FG000|Overall Study|Death|15|||
155093124|NCT01076010|559774997|FG001|Overall Study|Death|1|||
155093125|NCT01076010|559774998|FG002|Overall Study|Death|0|||
155093126|NCT01076010|559774996|FG000|Overall Study|Adverse Event|7|||
155093127|NCT01076010|559774997|FG001|Overall Study|Adverse Event|2|||
155093128|NCT01076010|559774998|FG002|Overall Study|Adverse Event|0|||
155093129|NCT01076010|559774996|FG000|Overall Study|Progressive disease|90|||
155093130|NCT01076010|559774997|FG001|Overall Study|Progressive disease|30|||
155093131|NCT01076010|559774998|FG002|Overall Study|Progressive disease|1|||
155093132|NCT01076010|559774996|FG000|Overall Study|Lack of Efficacy|4|||
155093133|NCT01076010|559774997|FG001|Overall Study|Lack of Efficacy|0|||
155093134|NCT01076010|559774998|FG002|Overall Study|Lack of Efficacy|0|||
155093135|NCT01076010|559774996|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
155093136|NCT01076010|559774997|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
155093137|NCT01076010|559774998|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
155093138|NCT01076010|559774996|FG000|Overall Study|Significant Surgical Procedure|0|||
155093139|NCT01076010|559774997|FG001|Overall Study|Significant Surgical Procedure|1|||
155093140|NCT01076010|559774998|FG002|Overall Study|Significant Surgical Procedure|0|||
155093141|NCT01076010|559774996|FG000|Overall Study|Protocol Violation|0|||
155093142|NCT01076010|559774997|FG001|Overall Study|Protocol Violation|1|||
155093143|NCT01076010|559774998|FG002|Overall Study|Protocol Violation|0|||
155093144|NCT01076010|559774996|FG000|Overall Study|Noncompliance|1|||
155093145|NCT01076010|559774997|FG001|Overall Study|Noncompliance|1|||
155093146|NCT01076010|559774998|FG002|Overall Study|Noncompliance|0|||
155093147|NCT01076010|559774996|FG000|Overall Study|Withdrawal by Subject|3|||
155093148|NCT01076010|559774997|FG001|Overall Study|Withdrawal by Subject|0|||
155093149|NCT01076010|559774998|FG002|Overall Study|Withdrawal by Subject|1|||
155093150|NCT01076010|559774996|FG000|Overall Study|Other|5|||
155093151|NCT01076010|559774997|FG001|Overall Study|Other|2|||
155093152|NCT01076010|559774998|FG002|Overall Study|Other|0|||
155093153|NCT01612676|559774999|FG000|Overall Study|Adverse Event|2|||
155093154|NCT01612676|559775000|FG001|Overall Study|Adverse Event|3|||
155093155|NCT01612676|559775001|FG002|Overall Study|Adverse Event|1|||
155093156|NCT01612676|559775002|FG003|Overall Study|Adverse Event|3|||
155093157|NCT01612676|559774999|FG000|Overall Study|Protocol Violation|0|||
155093158|NCT01612676|559775000|FG001|Overall Study|Protocol Violation|1|||
155093159|NCT01612676|559775001|FG002|Overall Study|Protocol Violation|0|||
155093160|NCT01612676|559775002|FG003|Overall Study|Protocol Violation|0|||
155093161|NCT05200845|559775006|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
155093162|NCT05200845|559775007|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
155093163|NCT05200845|559775008|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
155170573|NCT02791763|560062544|FG001|Overall Study|Cancer event|3|||
155170574|NCT02791763|560062545|FG002|Overall Study|Cancer event|0|||
155170575|NCT02791763|560062543|FG000|Overall Study|Participant had renal transplant|3|||
155170576|NCT02791763|560062544|FG001|Overall Study|Participant had renal transplant|0|||
155170577|NCT02791763|560062545|FG002|Overall Study|Participant had renal transplant|0|||
155170578|NCT02791763|560062543|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
155170579|NCT02791763|560062544|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
155170580|NCT02791763|560062545|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
155170581|NCT02791763|560062543|FG000|Overall Study|Adverse Event|12|||
155170582|NCT02791763|560062544|FG001|Overall Study|Adverse Event|13|||
155170583|NCT02791763|560062545|FG002|Overall Study|Adverse Event|7|||
155170584|NCT05334212|560062546|FG000|Overall Study|Study terminated prematurely|7|||
155170585|NCT00910299|560062547|FG000|Overall Study|Withdrawal by Subject|16|||
155170586|NCT00910299|560062548|FG001|Overall Study|Withdrawal by Subject|13|||
155170587|NCT00910299|560062547|FG000|Overall Study|Sponsor Decision|58|||
155170588|NCT00910299|560062548|FG001|Overall Study|Sponsor Decision|60|||
155170589|NCT00910299|560062547|FG000|Overall Study|Didn't receive any study drug|2|||
155170590|NCT00910299|560062548|FG001|Overall Study|Didn't receive any study drug|1|||
155170591|NCT01456897|560062549|FG000|Overall Study|Adverse Event|19|||
155170592|NCT01456897|560062550|FG001|Overall Study|Adverse Event|22|||
155170593|NCT01456897|560062549|FG000|Overall Study|Protocol Violation|3|||
155170594|NCT01456897|560062550|FG001|Overall Study|Protocol Violation|4|||
155170595|NCT01456897|560062549|FG000|Overall Study|Physician Decision|5|||
155170596|NCT01456897|560062550|FG001|Overall Study|Physician Decision|3|||
155170597|NCT01456897|560062549|FG000|Overall Study|Withdrawal by Subject|44|||
155170598|NCT01456897|560062550|FG001|Overall Study|Withdrawal by Subject|17|||
155170599|NCT01456897|560062549|FG000|Overall Study|Lack of Efficacy|4|||
155170600|NCT01456897|560062550|FG001|Overall Study|Lack of Efficacy|11|||
155170601|NCT00916929|560062551|FG000|Overall Study|Lost to Follow-up|1|||
155170602|NCT00916929|560062552|FG001|Overall Study|Lost to Follow-up|3|||
155170603|NCT00916929|560062551|FG000|Overall Study|Death|5|||
155170604|NCT00916929|560062552|FG001|Overall Study|Death|10|||
155170605|NCT00916929|560062551|FG000|Overall Study|Withdrawal by Subject|1|||
155170606|NCT00916929|560062552|FG001|Overall Study|Withdrawal by Subject|5|||
155170607|NCT00916929|560062551|FG000|Overall Study|Left ventricular epicardial lead|1|||
155170608|NCT00916929|560062552|FG001|Overall Study|Left ventricular epicardial lead|2|||
155170609|NCT00916929|560062551|FG000|Overall Study|Transferred to hospice care|1|||
155170610|NCT00916929|560062552|FG001|Overall Study|Transferred to hospice care|1|||
155170611|NCT00916929|560062551|FG000|Overall Study|System explant|1|||
155170612|NCT00916929|560062552|FG001|Overall Study|System explant|0|||
155170613|NCT00916929|560062551|FG000|Overall Study|Moved to another state|0|||
155170614|NCT00916929|560062552|FG001|Overall Study|Moved to another state|1|||
155170615|NCT00916929|560062551|FG000|Overall Study|Device unable to process impedance data|0|||
155170616|NCT00916929|560062552|FG001|Overall Study|Device unable to process impedance data|7|||
155170617|NCT01057589|560062557|FG000|Overall Study|Disease Progression|35|||
155170618|NCT01057589|560062557|FG000|Overall Study|Adverse Event|10|||
155170619|NCT01057589|560062557|FG000|Overall Study|Physician Decision|8|||
155170620|NCT01057589|560062557|FG000|Overall Study|Withdrawal by Subject|3|||
155170621|NCT01057589|560062557|FG000|Overall Study|Sponsor Decision|1|||
155170622|NCT01057589|560062557|FG000|Overall Study|Death|8|||
155170623|NCT01057589|560062557|FG000|Overall Study|Lost to Follow-up|1|||
155170624|NCT00490529|560063703|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
155170625|NCT00490529|560063703|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
155170626|NCT00490529|560063703|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
155170627|NCT00490529|560063703|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
155170628|NCT00490529|560063703|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
155170629|NCT00490529|560063703|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
154967168|NCT02554877|559303236|FG003|Overall Study|Insufficient clinical response|0|||
155170630|NCT01589653|560063706|FG000|Overall Study|Protocol Violation|3|||
155170631|NCT01589653|560063707|FG001|Overall Study|Protocol Violation|1|||
155093164|NCT05200845|559775009|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
155093165|NCT05200845|559775006|FG000|Overall Study|Withdrawal by Subject|0|||
155093166|NCT05200845|559775007|FG001|Overall Study|Withdrawal by Subject|1|||
155093167|NCT05200845|559775008|FG002|Overall Study|Withdrawal by Subject|1|||
155093168|NCT05200845|559775009|FG003|Overall Study|Withdrawal by Subject|0|||
155093169|NCT00565409|559775012|FG000|Period 1 Open Label|Adverse Event|17|||
155093170|NCT00565409|559775013|FG001|Period 1 Open Label|Adverse Event|0|||
155093171|NCT00565409|559775014|FG002|Period 1 Open Label|Adverse Event|0|||
155093172|NCT00565409|559775015|FG003|Period 1 Open Label|Adverse Event|0|||
155093173|NCT00565409|559775012|FG000|Period 1 Open Label|Death|2|||
155093174|NCT00565409|559775013|FG001|Period 1 Open Label|Death|0|||
155093175|NCT00565409|559775014|FG002|Period 1 Open Label|Death|0|||
155093176|NCT00565409|559775015|FG003|Period 1 Open Label|Death|0|||
155093177|NCT00565409|559775012|FG000|Period 1 Open Label|Lost to Follow-up|1|||
155093178|NCT00565409|559775013|FG001|Period 1 Open Label|Lost to Follow-up|0|||
155093179|NCT00565409|559775014|FG002|Period 1 Open Label|Lost to Follow-up|0|||
155093180|NCT00565409|559775015|FG003|Period 1 Open Label|Lost to Follow-up|0|||
155093181|NCT00565409|559775012|FG000|Period 1 Open Label|Other|21|||
155093182|NCT00565409|559775013|FG001|Period 1 Open Label|Other|0|||
155093183|NCT00565409|559775014|FG002|Period 1 Open Label|Other|0|||
155093184|NCT00565409|559775015|FG003|Period 1 Open Label|Other|0|||
155093185|NCT00565409|559775012|FG000|Period 1 Open Label|Protocol Violation|14|||
155093186|NCT00565409|559775013|FG001|Period 1 Open Label|Protocol Violation|0|||
155093187|NCT00565409|559775014|FG002|Period 1 Open Label|Protocol Violation|0|||
155093188|NCT00565409|559775015|FG003|Period 1 Open Label|Protocol Violation|0|||
155093189|NCT00565409|559775012|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
155093190|NCT00565409|559775013|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
155093191|NCT00565409|559775014|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
155093192|NCT00565409|559775015|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
155093193|NCT00565409|559775012|FG000|Period 1 Open Label|no conclusion of participation record|1|||
155093194|NCT00565409|559775013|FG001|Period 1 Open Label|no conclusion of participation record|0|||
155093195|NCT00565409|559775014|FG002|Period 1 Open Label|no conclusion of participation record|0|||
155093196|NCT00565409|559775015|FG003|Period 1 Open Label|no conclusion of participation record|0|||
155093197|NCT00565409|559775012|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
155093198|NCT00565409|559775013|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
155093199|NCT00565409|559775014|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
155093200|NCT00565409|559775015|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
155093201|NCT00565409|559775012|FG000|Period 2 Double-Blind|Adverse Event|0|||
155093202|NCT00565409|559775013|FG001|Period 2 Double-Blind|Adverse Event|7|||
155093203|NCT00565409|559775014|FG002|Period 2 Double-Blind|Adverse Event|4|||
155093204|NCT00565409|559775015|FG003|Period 2 Double-Blind|Adverse Event|5|||
155093205|NCT00565409|559775012|FG000|Period 2 Double-Blind|Death|0|||
155093206|NCT00565409|559775013|FG001|Period 2 Double-Blind|Death|2|||
155093207|NCT00565409|559775014|FG002|Period 2 Double-Blind|Death|0|||
155093208|NCT00565409|559775015|FG003|Period 2 Double-Blind|Death|0|||
155093209|NCT00565409|559775012|FG000|Period 2 Double-Blind|Protocol Violation|0|||
155093210|NCT00565409|559775013|FG001|Period 2 Double-Blind|Protocol Violation|4|||
155093211|NCT00565409|559775014|FG002|Period 2 Double-Blind|Protocol Violation|6|||
155093212|NCT00565409|559775015|FG003|Period 2 Double-Blind|Protocol Violation|2|||
155093213|NCT00565409|559775012|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
155093214|NCT00565409|559775013|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
155093215|NCT00565409|559775014|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
155093216|NCT00565409|559775015|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
155093217|NCT00565409|559775012|FG000|Period 2 Double-Blind|Other|0|||
155093218|NCT00565409|559775013|FG001|Period 2 Double-Blind|Other|4|||
155093219|NCT00565409|559775014|FG002|Period 2 Double-Blind|Other|5|||
155093220|NCT00565409|559775015|FG003|Period 2 Double-Blind|Other|9|||
155093221|NCT00565409|559775012|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
155093222|NCT00565409|559775013|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
155093223|NCT00565409|559775014|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
155093224|NCT00565409|559775015|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
155093225|NCT04064905|559775016|FG000|Overall Study|Lost to Follow-up|0|||
155170632|NCT01589653|560063706|FG000|Overall Study|Withdrawal criteria|4|||
155093226|NCT04064905|559775017|FG001|Overall Study|Lost to Follow-up|3|||
155093227|NCT04064905|559775018|FG002|Overall Study|Lost to Follow-up|1|||
155093228|NCT04064905|559775019|FG003|Overall Study|Lost to Follow-up|4|||
155093229|NCT04064905|559775020|FG004|Overall Study|Lost to Follow-up|2|||
155093230|NCT02943473|559775021|FG000|Overall Study|enrolled but not dosed|1|||
155093231|NCT02943473|559775021|FG000|Overall Study|screen failure|1|||
155093232|NCT02943473|559775021|FG000|Overall Study|Physician Decision|4|||
155093233|NCT00431964|559775022|FG000|Overall Study|Adverse Event|1|||
155093234|NCT00431964|559775023|FG001|Overall Study|Adverse Event|0|||
155170633|NCT01589653|560063707|FG001|Overall Study|Withdrawal criteria|7|||
155170634|NCT01589653|560063706|FG000|Overall Study|Unclassified|0|||
155170635|NCT01589653|560063707|FG001|Overall Study|Unclassified|3|||
155170636|NCT01536067|560063708|FG000|Overall Study|Disease Progression|1|||
155170637|NCT00606905|560063711|FG000|Overall Study|No Pregnancy|9|||
155170638|NCT00606905|560063712|FG001|Overall Study|No Pregnancy|6|||
155170639|NCT00606905|560063711|FG000|Overall Study|Non-Index Pregnancy|1|||
155170640|NCT00606905|560063712|FG001|Overall Study|Non-Index Pregnancy|4|||
155170641|NCT00606905|560063711|FG000|Overall Study|Withdrew|5|||
155170642|NCT00606905|560063712|FG001|Overall Study|Withdrew|5|||
155170643|NCT02386189|560063713|FG000|Overall Study|Lost to Follow-up|2|||
155170644|NCT02386189|560063714|FG001|Overall Study|Lost to Follow-up|3|||
155170645|NCT02386189|560063713|FG000|Overall Study|Withdrawal by Subject|1|||
155093235|NCT00431964|559775022|FG000|Overall Study|Lost to Follow-up|1|||
155093236|NCT00431964|559775023|FG001|Overall Study|Lost to Follow-up|2|||
155093237|NCT00431964|559775022|FG000|Overall Study|Physician Decision|2|||
155170646|NCT02386189|560063714|FG001|Overall Study|Withdrawal by Subject|0|||
155170647|NCT02386189|560063713|FG000|Overall Study|Death|1|||
155170648|NCT02386189|560063714|FG001|Overall Study|Death|0|||
155093238|NCT00431964|559775023|FG001|Overall Study|Physician Decision|2|||
155170649|NCT04657666|560063715|FG000|Period 1|Withdrawal of participant consent|2|||
155093239|NCT00431964|559775022|FG000|Overall Study|Withdrawal by Subject|2|||
155093240|NCT00431964|559775023|FG001|Overall Study|Withdrawal by Subject|1|||
155093241|NCT00431964|559775022|FG000|Overall Study|Parental Consent Withdrawn|0|||
155093242|NCT00431964|559775023|FG001|Overall Study|Parental Consent Withdrawn|2|||
155093243|NCT00431964|559775022|FG000|Overall Study|Due to Unstable Health|0|||
155093244|NCT00431964|559775023|FG001|Overall Study|Due to Unstable Health|1|||
155093245|NCT03961308|559775030|FG000|Overall Study|Withdrawal by Subject|1|||
155093246|NCT03961308|559775031|FG001|Overall Study|Withdrawal by Subject|0|||
155093247|NCT03961308|559775030|FG000|Overall Study|Other|1|||
155093248|NCT03961308|559775031|FG001|Overall Study|Other|0|||
155093249|NCT03961308|559775030|FG000|Overall Study|Lost to Follow-up|0|||
155093250|NCT03961308|559775031|FG001|Overall Study|Lost to Follow-up|1|||
155093251|NCT03961308|559775030|FG000|Overall Study|Adverse Event|0|||
155093252|NCT03961308|559775031|FG001|Overall Study|Adverse Event|1|||
155093253|NCT03012880|559775038|FG000|Overall Study|Withdrawal by Subject|1|||
155093254|NCT03012880|559775039|FG001|Overall Study|Withdrawal by Subject|0|||
155093255|NCT03012880|559775038|FG000|Overall Study|Ineligible|1|||
155093256|NCT03012880|559775039|FG001|Overall Study|Ineligible|0|||
155093257|NCT02781558|559775040|FG000|Overall Study|Lost to Follow-up|2|||
155093258|NCT02781558|559775041|FG001|Overall Study|Lost to Follow-up|2|||
155093259|NCT02781558|559775040|FG000|Overall Study|Adverse Event|1|||
155093260|NCT02781558|559775041|FG001|Overall Study|Adverse Event|0|||
155093261|NCT05643495|559775046|FG000|Overall Study|Adverse Event|0|||
155093262|NCT05643495|559775047|FG001|Overall Study|Adverse Event|1|||
155093263|NCT05643495|559775046|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155093264|NCT05643495|559775047|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
155093265|NCT02257528|559775048|FG000|Overall Study|Never received study treatment|1|||
155093266|NCT01729039|559775051|FG000|Overall Study|disqualified|2|||
155093267|NCT01729039|559775052|FG001|Overall Study|disqualified|5|||
155093268|NCT01729039|559775051|FG000|Overall Study|Withdrawal by Subject|8|||
155093269|NCT01729039|559775052|FG001|Overall Study|Withdrawal by Subject|7|||
155093270|NCT00404248|559775055|FG000|Overall Study|pts declining status|0|||
155093271|NCT00404248|559775056|FG001|Overall Study|pts declining status|1|||
155093272|NCT00404248|559775057|FG002|Overall Study|pts declining status|0|||
155093273|NCT00404248|559775058|FG003|Overall Study|pts declining status|0|||
155093274|NCT00404248|559775059|FG004|Overall Study|pts declining status|0|||
155093275|NCT00404248|559775060|FG005|Overall Study|pts declining status|0|||
155093276|NCT00404248|559775061|FG006|Overall Study|pts declining status|0|||
155093277|NCT00404248|559775062|FG007|Overall Study|pts declining status|0|||
155093278|NCT00404248|559775063|FG008|Overall Study|pts declining status|0|||
155093279|NCT00698841|559775064|FG000|Overall Study|Withdrawal by Subject|2|||
155093280|NCT00698841|559775064|FG000|Overall Study|Adverse Event|3|||
155093281|NCT00698841|559775064|FG000|Overall Study|Disease progression|7|||
155093282|NCT00698841|559775064|FG000|Overall Study|Failure to meet eligibility criteria|2|||
155170650|NCT04657666|560063716|FG001|Period 1|Withdrawal of participant consent|1|||
155170651|NCT04657666|560063715|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
155093283|NCT00698841|559775064|FG000|Overall Study|Study drug toxicity|2|||
155093284|NCT00698841|559775064|FG000|Overall Study|Other|2|||
155093285|NCT00789555|559775065|FG000|Overall Study|Protocol Amendment|78|||
154967169|NCT02554877|559303233|FG000|Overall Study|No longer willing to participate|0|||
155170652|NCT04657666|560063716|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
155093286|NCT00789555|559775066|FG001|Overall Study|Protocol Amendment|76|||
155093287|NCT00789555|559775067|FG002|Overall Study|Protocol Amendment|80|||
155093288|NCT00789555|559775065|FG000|Overall Study|Adverse Event|17|||
155093289|NCT00789555|559775066|FG001|Overall Study|Adverse Event|7|||
155093290|NCT00789555|559775067|FG002|Overall Study|Adverse Event|10|||
155093291|NCT00789555|559775065|FG000|Overall Study|Lost to Follow-up|9|||
155093292|NCT00789555|559775066|FG001|Overall Study|Lost to Follow-up|10|||
155093293|NCT00789555|559775067|FG002|Overall Study|Lost to Follow-up|18|||
155093294|NCT00789555|559775065|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
155093295|NCT00789555|559775066|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
155093296|NCT00789555|559775067|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
155093297|NCT00789555|559775065|FG000|Overall Study|Treatment failure|11|||
155093298|NCT00789555|559775066|FG001|Overall Study|Treatment failure|8|||
155093299|NCT00789555|559775067|FG002|Overall Study|Treatment failure|12|||
155093300|NCT00789555|559775065|FG000|Overall Study|Protocol Violation|6|||
155093301|NCT00789555|559775066|FG001|Overall Study|Protocol Violation|9|||
155093302|NCT00789555|559775067|FG002|Overall Study|Protocol Violation|13|||
155093303|NCT04646005|559775071|FG000|Overall Study|Adverse Event|1|||
155093304|NCT04646005|559775071|FG000|Overall Study|Progressive Disease|71|||
155093305|NCT04646005|559775071|FG000|Overall Study|Death|20|||
155093306|NCT04646005|559775071|FG000|Overall Study|Withdrawal by Subject|12|||
155093307|NCT04646005|559775071|FG000|Overall Study|Sponsor Request|9|||
155093308|NCT02661672|559775073|FG000|Overall Study|Lost to Follow-up|1|||
155093309|NCT02661672|559775073|FG000|Overall Study|Death|4|||
155093310|NCT03376516|559776806|FG000|Overall Study|Not treated|1|||
155093311|NCT03376516|559776806|FG000|Overall Study|Consent withdrawn|1|||
155093312|NCT01581684|559776807|FG000|Overall Study|Other reason not defined|0|||
155093313|NCT01581684|559776808|FG001|Overall Study|Other reason not defined|0|||
155093314|NCT01581684|559776809|FG002|Overall Study|Other reason not defined|0|||
155093315|NCT01581684|559776810|FG003|Overall Study|Other reason not defined|0|||
155093316|NCT01581684|559776811|FG004|Overall Study|Other reason not defined|0|||
155093317|NCT01581684|559776812|FG005|Overall Study|Other reason not defined|0|||
155093318|NCT01581684|559776813|FG006|Overall Study|Other reason not defined|0|||
155093319|NCT01581684|559776814|FG007|Overall Study|Other reason not defined|0|||
155093320|NCT01581684|559776815|FG008|Overall Study|Other reason not defined|1|||
155093321|NCT01581684|559776816|FG009|Overall Study|Other reason not defined|0|||
155093322|NCT03235050|559776817|FG000|Overall Study|Adverse Event|0|||
155093323|NCT03235050|559776818|FG001|Overall Study|Adverse Event|0|||
155093324|NCT03235050|559776819|FG002|Overall Study|Adverse Event|1|||
155093325|NCT03235050|559776820|FG003|Overall Study|Adverse Event|4|||
155093326|NCT03235050|559776821|FG004|Overall Study|Adverse Event|1|||
155093327|NCT03235050|559776817|FG000|Overall Study|Death|0|||
155093328|NCT03235050|559776818|FG001|Overall Study|Death|0|||
155093329|NCT03235050|559776819|FG002|Overall Study|Death|0|||
155093330|NCT03235050|559776820|FG003|Overall Study|Death|2|||
155093331|NCT03235050|559776821|FG004|Overall Study|Death|1|||
155093332|NCT03235050|559776817|FG000|Overall Study|Lost to Follow-up|1|||
155093333|NCT03235050|559776818|FG001|Overall Study|Lost to Follow-up|2|||
155093334|NCT03235050|559776819|FG002|Overall Study|Lost to Follow-up|1|||
155093335|NCT03235050|559776820|FG003|Overall Study|Lost to Follow-up|2|||
154967170|NCT02554877|559303234|FG001|Overall Study|No longer willing to participate|2|||
155093336|NCT03235050|559776821|FG004|Overall Study|Lost to Follow-up|0|||
155093337|NCT03235050|559776817|FG000|Overall Study|Withdrawal by Subject|3|||
155093338|NCT03235050|559776818|FG001|Overall Study|Withdrawal by Subject|2|||
155093339|NCT03235050|559776819|FG002|Overall Study|Withdrawal by Subject|2|||
155093340|NCT03235050|559776820|FG003|Overall Study|Withdrawal by Subject|5|||
155093341|NCT03235050|559776821|FG004|Overall Study|Withdrawal by Subject|7|||
155093342|NCT03235050|559776817|FG000|Overall Study|Other reasons|0|||
155093343|NCT03235050|559776818|FG001|Overall Study|Other reasons|1|||
155093344|NCT03235050|559776819|FG002|Overall Study|Other reasons|0|||
154967171|NCT02554877|559303235|FG002|Overall Study|No longer willing to participate|2|||
154967172|NCT02554877|559303236|FG003|Overall Study|No longer willing to participate|0|||
154967173|NCT04474405|559303237|FG000|Overall Study|Withdrawal by Subject|0|||
154967174|NCT04474405|559303238|FG001|Overall Study|Withdrawal by Subject|0|||
154967175|NCT04474405|559303239|FG002|Overall Study|Withdrawal by Subject|1|||
154967176|NCT04474405|559303240|FG003|Overall Study|Withdrawal by Subject|0|||
154967177|NCT04474405|559303241|FG004|Overall Study|Withdrawal by Subject|1|||
154967178|NCT04474405|559303242|FG005|Overall Study|Withdrawal by Subject|0|||
154967179|NCT04474405|559303237|FG000|Overall Study|Other|0|||
154967180|NCT04474405|559303238|FG001|Overall Study|Other|0|||
154967181|NCT04474405|559303239|FG002|Overall Study|Other|0|||
154967182|NCT04474405|559303240|FG003|Overall Study|Other|0|||
154967183|NCT04474405|559303241|FG004|Overall Study|Other|3|||
154967184|NCT04474405|559303242|FG005|Overall Study|Other|0|||
154967185|NCT00835666|559303243|FG000|Washout|Protocol Violation|1|||
154967186|NCT00835666|559303244|FG001|Washout|Protocol Violation|0|||
154967187|NCT00835666|559303243|FG000|Washout|Withdrawal by Subject|1|||
154967188|NCT00835666|559303244|FG001|Washout|Withdrawal by Subject|0|||
154967189|NCT01537887|559303245|FG000|Period 1|Physician Decision|0|||
154967190|NCT01537887|559303246|FG001|Period 1|Physician Decision|0|||
154967191|NCT01537887|559303247|FG002|Period 1|Physician Decision|0|||
154967192|NCT01537887|559303248|FG003|Period 1|Physician Decision|0|||
154967193|NCT01537887|559303249|FG004|Period 1|Physician Decision|1|||
154967194|NCT01537887|559303250|FG005|Period 1|Physician Decision|1|||
154967195|NCT01537887|559303245|FG000|Period 1|Did not receive treatment|0|||
155093345|NCT03235050|559776820|FG003|Overall Study|Other reasons|1|||
155093346|NCT03235050|559776821|FG004|Overall Study|Other reasons|2|||
155093347|NCT02986074|559776822|FG000|First Trial Period|Adverse Event|1|||
155093348|NCT02986074|559776823|FG001|First Trial Period|Adverse Event|0|||
155093349|NCT02986074|559776824|FG002|First Trial Period|Adverse Event|0|||
154967196|NCT01537887|559303246|FG001|Period 1|Did not receive treatment|0|||
154967197|NCT01537887|559303247|FG002|Period 1|Did not receive treatment|1|||
154967198|NCT01537887|559303248|FG003|Period 1|Did not receive treatment|0|||
154967199|NCT01537887|559303249|FG004|Period 1|Did not receive treatment|0|||
154967200|NCT01537887|559303250|FG005|Period 1|Did not receive treatment|0|||
154967201|NCT01537887|559303245|FG000|Period 2|Withdrawal by Subject|0|||
154967202|NCT01537887|559303246|FG001|Period 2|Withdrawal by Subject|1|||
155093350|NCT02986074|559776825|FG003|First Trial Period|Adverse Event|0|||
155093351|NCT02986074|559776822|FG000|Follow up Period|system explant|0|||
155170653|NCT04657666|560063715|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
155170654|NCT04657666|560063716|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
155170655|NCT04657666|560063715|FG000|Period 2|Other|2|||
155170656|NCT04657666|560063716|FG001|Period 2|Other|0|||
155170657|NCT04657666|560063715|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
155170658|NCT04657666|560063716|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
155170659|NCT03120351|560063717|FG000|Overall Study|Physician Decision|1|||
155170660|NCT03120351|560063718|FG001|Overall Study|Physician Decision|1|||
155170661|NCT01022398|560063727|FG000|Overall Study|Study terminated|2|||
155170662|NCT01022398|560063728|FG001|Overall Study|Study terminated|2|||
154967203|NCT01537887|559303247|FG002|Period 2|Withdrawal by Subject|0|||
154967204|NCT01537887|559303248|FG003|Period 2|Withdrawal by Subject|0|||
154967205|NCT01537887|559303249|FG004|Period 2|Withdrawal by Subject|0|||
154967206|NCT01537887|559303250|FG005|Period 2|Withdrawal by Subject|0|||
154967207|NCT01537887|559303245|FG000|Period 3|Adverse Event|0|||
155093352|NCT02986074|559776823|FG001|Follow up Period|system explant|0|||
155093353|NCT02986074|559776824|FG002|Follow up Period|system explant|1|||
154967208|NCT01537887|559303246|FG001|Period 3|Adverse Event|0|||
155093354|NCT02986074|559776825|FG003|Follow up Period|system explant|2|||
154967209|NCT01537887|559303247|FG002|Period 3|Adverse Event|1|||
154967210|NCT01537887|559303248|FG003|Period 3|Adverse Event|0|||
154967211|NCT01537887|559303249|FG004|Period 3|Adverse Event|0|||
154967212|NCT01537887|559303250|FG005|Period 3|Adverse Event|0|||
154967213|NCT01537887|559303245|FG000|Period 3|Withdrawal by Subject|0|||
154967214|NCT01537887|559303246|FG001|Period 3|Withdrawal by Subject|1|||
154967215|NCT01537887|559303247|FG002|Period 3|Withdrawal by Subject|0|||
154967216|NCT01537887|559303248|FG003|Period 3|Withdrawal by Subject|0|||
154967217|NCT01537887|559303249|FG004|Period 3|Withdrawal by Subject|0|||
154967218|NCT01537887|559303250|FG005|Period 3|Withdrawal by Subject|0|||
154967219|NCT01808651|559303251|FG000|Study Period 1|Lost to Follow-up|1|||
154967220|NCT01808651|559303252|FG001|Study Period 1|Lost to Follow-up|3|||
154967221|NCT01808651|559303253|FG002|Study Period 1|Lost to Follow-up|0|||
154967222|NCT01808651|559303251|FG000|Study Period 1|Protocol Violation|1|||
154967223|NCT01808651|559303252|FG001|Study Period 1|Protocol Violation|0|||
154967224|NCT01808651|559303253|FG002|Study Period 1|Protocol Violation|1|||
154967225|NCT01808651|559303251|FG000|Study Period 1|Physician Decision|3|||
154967226|NCT01808651|559303252|FG001|Study Period 1|Physician Decision|2|||
154967227|NCT01808651|559303253|FG002|Study Period 1|Physician Decision|0|||
154967228|NCT01808651|559303251|FG000|Study Period 1|Lack of Efficacy|2|||
154967229|NCT01808651|559303252|FG001|Study Period 1|Lack of Efficacy|1|||
154967230|NCT01808651|559303253|FG002|Study Period 1|Lack of Efficacy|0|||
154967231|NCT01808651|559303251|FG000|Study Period 1|Adverse Event|10|||
154967232|NCT01808651|559303252|FG001|Study Period 1|Adverse Event|4|||
154967233|NCT01808651|559303253|FG002|Study Period 1|Adverse Event|1|||
154967234|NCT01808651|559303251|FG000|Study Period 1|Participant Decision|9|||
154967235|NCT01808651|559303252|FG001|Study Period 1|Participant Decision|7|||
154967236|NCT01808651|559303253|FG002|Study Period 1|Participant Decision|3|||
154967237|NCT00585286|559303254|FG000|Overall Study|Lost to Follow-up|1|||
154967238|NCT00608322|559303258|FG000|Overall Study|Death|2|||
154967239|NCT00608322|559303259|FG001|Overall Study|Death|1|||
154967240|NCT04002648|559303260|FG000|Overall Study|Lost to Follow-up|2|||
154967241|NCT04002648|559303261|FG001|Overall Study|Lost to Follow-up|0|||
154967242|NCT05752721|559303266|FG000|Overall Study|Lost to Follow-up|22|||
154967243|NCT05752721|559303267|FG001|Overall Study|Lost to Follow-up|20|||
154967244|NCT05752721|559303266|FG000|Overall Study|Withdrawal by Subject|15|||
154967245|NCT05752721|559303267|FG001|Overall Study|Withdrawal by Subject|12|||
154967246|NCT00263588|559303268|FG000|Overall Study|Death|54|||
154967247|NCT00263588|559303269|FG001|Overall Study|Death|90|||
154967248|NCT00263588|559303268|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
154967249|NCT00263588|559303269|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
154967250|NCT00263588|559303268|FG000|Overall Study|Lost to Follow-up|7|||
154967251|NCT00263588|559303269|FG001|Overall Study|Lost to Follow-up|10|||
154967252|NCT00263588|559303268|FG000|Overall Study|Withdrawal by Subject|3|||
154967253|NCT00263588|559303269|FG001|Overall Study|Withdrawal by Subject|4|||
154967254|NCT00263588|559303268|FG000|Overall Study|Protocol Violation|0|||
154967255|NCT00263588|559303269|FG001|Overall Study|Protocol Violation|1|||
154967256|NCT00263588|559303268|FG000|Overall Study|Investigator decision|7|||
154967257|NCT00263588|559303269|FG001|Overall Study|Investigator decision|15|||
154967258|NCT00263588|559303268|FG000|Overall Study|Sponsor terminated study|0|||
154967259|NCT00263588|559303269|FG001|Overall Study|Sponsor terminated study|1|||
154967260|NCT00216736|559303276|FG000|Overall Study|Lost to Follow-up|1|||
154967261|NCT00216736|559303277|FG001|Overall Study|Lost to Follow-up|1|||
154967262|NCT00807495|559303279|FG000|Overall Study|Adverse Event|6|||
154967263|NCT00807495|559303280|FG001|Overall Study|Adverse Event|3|||
154967264|NCT00807495|559303281|FG002|Overall Study|Adverse Event|1|||
154967265|NCT00807495|559303282|FG003|Overall Study|Adverse Event|1|||
154967266|NCT00807495|559303283|FG004|Overall Study|Adverse Event|2|||
154967267|NCT00807495|559303279|FG000|Overall Study|Withdrawal by Patient|2|||
154967268|NCT00807495|559303280|FG001|Overall Study|Withdrawal by Patient|0|||
154967269|NCT00807495|559303281|FG002|Overall Study|Withdrawal by Patient|1|||
154967270|NCT00807495|559303282|FG003|Overall Study|Withdrawal by Patient|0|||
154967271|NCT00807495|559303283|FG004|Overall Study|Withdrawal by Patient|0|||
154967272|NCT00807495|559303279|FG000|Overall Study|Reason Not Specified|0|||
154967273|NCT00807495|559303280|FG001|Overall Study|Reason Not Specified|3|||
154967274|NCT00807495|559303281|FG002|Overall Study|Reason Not Specified|2|||
154967275|NCT00807495|559303282|FG003|Overall Study|Reason Not Specified|0|||
154967276|NCT00807495|559303283|FG004|Overall Study|Reason Not Specified|3|||
154967277|NCT00918684|559303284|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
154967278|NCT00918684|559303284|FG000|Treatment Phase|Lack of Efficacy|6|||
154967279|NCT00918684|559303284|FG000|Treatment Phase|Lost to Follow-up|2|||
154967280|NCT00918684|559303284|FG000|Treatment Phase|Physician Decision|8|||
154967281|NCT00918684|559303284|FG000|Treatment Phase|Protocol Violation|1|||
154967282|NCT00918684|559303284|FG000|Treatment Phase|Withdrawal by Subject|8|||
154967283|NCT00841542|559303285|FG000|Period 1|Adverse Event|1|||
154967284|NCT00841542|559303286|FG001|Period 1|Adverse Event|0|||
154967285|NCT01906372|559303287|FG000|Overall Study|Withdrawal by Subject|2|||
154967286|NCT03629054|559303288|FG000|Period 2 (4 Days)|Not treated|0|||
154967287|NCT03629054|559303289|FG001|Period 2 (4 Days)|Not treated|1|||
154967288|NCT02462837|559303290|FG000|Overall Study|pt developed hives|1|||
154967289|NCT02462837|559303291|FG001|Overall Study|pt developed hives|0|||
154967290|NCT02462837|559303290|FG000|Overall Study|Withdrawal by Subject|1|||
154967291|NCT02462837|559303291|FG001|Overall Study|Withdrawal by Subject|0|||
154967292|NCT00924638|559303295|FG000|Overall Study|Death|3|||
154967293|NCT00924638|559303296|FG001|Overall Study|Death|2|||
154967294|NCT00924638|559303295|FG000|Overall Study|Lost to Follow-up|1|||
154967295|NCT00924638|559303296|FG001|Overall Study|Lost to Follow-up|1|||
154967296|NCT00924638|559303295|FG000|Overall Study|Withdrawal by Subject|5|||
154967297|NCT00924638|559303296|FG001|Overall Study|Withdrawal by Subject|7|||
154967298|NCT00924638|559303295|FG000|Overall Study|Physician Decision|3|||
154967299|NCT00924638|559303296|FG001|Overall Study|Physician Decision|3|||
154967300|NCT00906399|559303297|FG000|Year 1|Randomized But Not Treated|0|||
154967301|NCT00906399|559303298|FG001|Year 1|Randomized But Not Treated|1|||
155093355|NCT02986074|559776822|FG000|Follow up Period|Physician Decision|0|||
155093356|NCT02986074|559776823|FG001|Follow up Period|Physician Decision|0|||
155093357|NCT02986074|559776824|FG002|Follow up Period|Physician Decision|0|||
155093358|NCT02986074|559776825|FG003|Follow up Period|Physician Decision|1|||
155093359|NCT04099277|559776826|FG000|Overall Study|Physician Decision|1|||
155093360|NCT04099277|559776826|FG000|Overall Study|Withdrawal by Subject|1|||
155093361|NCT00598650|559776827|FG000|Overall Study|Withdrawal by Subject|3|||
155093362|NCT00598650|559776827|FG000|Overall Study|Adverse Event|18|||
155093363|NCT00598650|559776827|FG000|Overall Study|No treatment for 3 weeks|1|||
155093364|NCT00598650|559776827|FG000|Overall Study|Not eligible|1|||
155093365|NCT00598650|559776827|FG000|Overall Study|Prohibited Concomitant Medication|2|||
155093366|NCT00598650|559776827|FG000|Overall Study|Physician Decision|2|||
155093367|NCT01628913|559776828|FG000|Overall Study|Adverse Event|12|||
155093368|NCT01628913|559776829|FG001|Overall Study|Adverse Event|5|||
155093369|NCT01628913|559776828|FG000|Overall Study|Disease Progression|11|||
155093370|NCT01628913|559776829|FG001|Overall Study|Disease Progression|14|||
155093371|NCT01628913|559776828|FG000|Overall Study|Protocol Violation|1|||
155093372|NCT01628913|559776829|FG001|Overall Study|Protocol Violation|0|||
155093373|NCT01628913|559776828|FG000|Overall Study|Death|1|||
155093374|NCT01628913|559776829|FG001|Overall Study|Death|0|||
155093375|NCT01628913|559776828|FG000|Overall Study|study terminated by Sponsor|4|||
155093376|NCT01628913|559776829|FG001|Overall Study|study terminated by Sponsor|9|||
155093377|NCT01628913|559776828|FG000|Overall Study|Withdrawal by Subject|1|||
155093378|NCT01628913|559776829|FG001|Overall Study|Withdrawal by Subject|0|||
155093379|NCT01628913|559776828|FG000|Overall Study|Physician Decision|1|||
155093380|NCT01628913|559776829|FG001|Overall Study|Physician Decision|3|||
155093381|NCT00105534|559776833|FG000|Overall Study|Adverse Event|2|||
155093382|NCT00105534|559776834|FG001|Overall Study|Adverse Event|5|||
155093383|NCT00105534|559776833|FG000|Overall Study|Protocol Violation|1|||
155093384|NCT00105534|559776834|FG001|Overall Study|Protocol Violation|4|||
155093385|NCT00105534|559776833|FG000|Overall Study|Withdrawal by Subject|6|||
155093386|NCT00105534|559776834|FG001|Overall Study|Withdrawal by Subject|6|||
155093387|NCT00105534|559776833|FG000|Overall Study|Lost to Follow-up|5|||
155093388|NCT00105534|559776834|FG001|Overall Study|Lost to Follow-up|1|||
155093389|NCT00105534|559776833|FG000|Overall Study|Lack of Efficacy|7|||
155093390|NCT00105534|559776834|FG001|Overall Study|Lack of Efficacy|15|||
155093391|NCT00105534|559776833|FG000|Overall Study|Treatment unmasked|1|||
155093392|NCT00105534|559776834|FG001|Overall Study|Treatment unmasked|0|||
155093393|NCT00105534|559776833|FG000|Overall Study|Other Reason|0|||
155093394|NCT00105534|559776834|FG001|Overall Study|Other Reason|2|||
155093395|NCT01621178|559776835|FG000|Overall Study|Adverse Event|5|||
155093396|NCT01621178|559776836|FG001|Overall Study|Adverse Event|2|||
155093397|NCT01621178|559776837|FG002|Overall Study|Adverse Event|8|||
155093398|NCT01621178|559776835|FG000|Overall Study|Death|6|||
155093399|NCT01621178|559776836|FG001|Overall Study|Death|7|||
155093400|NCT01621178|559776837|FG002|Overall Study|Death|2|||
155093401|NCT01621178|559776835|FG000|Overall Study|Lost to Follow-up|1|||
155093402|NCT01621178|559776836|FG001|Overall Study|Lost to Follow-up|2|||
155093403|NCT01621178|559776837|FG002|Overall Study|Lost to Follow-up|1|||
155093404|NCT01621178|559776835|FG000|Overall Study|Withdrawal by Subject|14|||
155093405|NCT01621178|559776836|FG001|Overall Study|Withdrawal by Subject|17|||
155093406|NCT01621178|559776837|FG002|Overall Study|Withdrawal by Subject|18|||
155093407|NCT01621178|559776835|FG000|Overall Study|Physician Decision|5|||
155093408|NCT01621178|559776836|FG001|Overall Study|Physician Decision|2|||
155093409|NCT01621178|559776837|FG002|Overall Study|Physician Decision|7|||
155093410|NCT02935192|559776838|FG000|Overall Study|Withdrawal by Subject|8|||
155093411|NCT02935192|559776839|FG001|Overall Study|Withdrawal by Subject|4|||
155093412|NCT02465931|559776841|FG000|Overall Study|Lost to Follow-up|9|||
155093413|NCT02465931|559776842|FG001|Overall Study|Lost to Follow-up|11|||
155093414|NCT02465931|559776841|FG000|Overall Study|Protocol Violation|1|||
155093415|NCT02465931|559776842|FG001|Overall Study|Protocol Violation|0|||
155093416|NCT02465931|559776841|FG000|Overall Study|Withdrawal by Subject|1|||
155093417|NCT02465931|559776842|FG001|Overall Study|Withdrawal by Subject|0|||
155093418|NCT00492557|559776843|FG000|Overall Study|Subject request|12|||
155093419|NCT00492557|559776844|FG001|Overall Study|Subject request|11|||
155093420|NCT00492557|559776843|FG000|Overall Study|Protocol Violation|7|||
155093421|NCT00492557|559776844|FG001|Overall Study|Protocol Violation|8|||
155093422|NCT00492557|559776843|FG000|Overall Study|Other|2|||
155093423|NCT00492557|559776844|FG001|Overall Study|Other|2|||
155093424|NCT00492557|559776843|FG000|Overall Study|Death|1|||
155093425|NCT00492557|559776844|FG001|Overall Study|Death|1|||
155093426|NCT00492557|559776843|FG000|Overall Study|Adverse Event|1|||
155093427|NCT00492557|559776844|FG001|Overall Study|Adverse Event|0|||
155093428|NCT00492557|559776843|FG000|Overall Study|Failed to return|1|||
155093429|NCT00492557|559776844|FG001|Overall Study|Failed to return|0|||
155093430|NCT00492557|559776843|FG000|Overall Study|Lost to Follow-up|0|||
155093431|NCT00492557|559776844|FG001|Overall Study|Lost to Follow-up|1|||
155170663|NCT03255629|560063729|FG000|Overall Study|Adverse Event|1|||
155170664|NCT03255629|560063730|FG001|Overall Study|Adverse Event|0|||
155093432|NCT04778592|559776849|FG000|Overall Study|Adverse Event|1|||
155093433|NCT04778592|559776850|FG001|Overall Study|Adverse Event|2|||
155093434|NCT04778592|559776849|FG000|Overall Study|Withdrawal by Subject|1|||
155093435|NCT04778592|559776850|FG001|Overall Study|Withdrawal by Subject|2|||
155093436|NCT03423121|559776851|FG000|Overall Study|Lost to Follow-up|2|||
155093437|NCT03423121|559776852|FG001|Overall Study|Lost to Follow-up|6|||
155093438|NCT03423121|559776851|FG000|Overall Study|Adverse Event|1|||
155093439|NCT03423121|559776852|FG001|Overall Study|Adverse Event|0|||
155093440|NCT00524121|559776855|FG000|Overall Study|Disease progression|6|||
155093441|NCT00524121|559776855|FG000|Overall Study|Adverse Event|4|||
155093442|NCT00524121|559776855|FG000|Overall Study|Patient refused|2|||
155093443|NCT00524121|559776855|FG000|Overall Study|Other|1|||
155093444|NCT00524121|559776855|FG000|Overall Study|Death|1|||
155093445|NCT00524121|559776855|FG000|Overall Study|Not treated (became ineligible)|4|||
155093446|NCT00524121|559776855|FG000|Overall Study|Not treated (changed mind)|1|||
155093447|NCT04047446|559776856|FG000|Overall Study|Physician Decision|1|||
155093448|NCT04047446|559776857|FG001|Overall Study|Physician Decision|0|||
155170665|NCT03255629|560063729|FG000|Overall Study|did not experience hypoglycemia|2|||
155170666|NCT03255629|560063730|FG001|Overall Study|did not experience hypoglycemia|1|||
155170667|NCT01086358|560063731|FG000|First Intervention|Lost to Follow-up|9|||
155170668|NCT01086358|560063732|FG001|First Intervention|Lost to Follow-up|4|||
155170669|NCT01086358|560063731|FG000|First Intervention|Withdrawal by Subject|0|||
155170670|NCT01086358|560063732|FG001|First Intervention|Withdrawal by Subject|1|||
155170671|NCT01086358|560063731|FG000|Second Intervention|Lost to Follow-up|4|||
155170672|NCT01086358|560063732|FG001|Second Intervention|Lost to Follow-up|4|||
155170673|NCT03317405|560063733|FG000|Overall Study|Withdrawal by Subject|1|||
155170674|NCT03317405|560063734|FG001|Overall Study|Withdrawal by Subject|0|||
155170675|NCT03317405|560063735|FG002|Overall Study|Withdrawal by Subject|0|||
155170676|NCT03317405|560063733|FG000|Overall Study|Physician Decision|0|||
155170677|NCT03317405|560063734|FG001|Overall Study|Physician Decision|0|||
155170678|NCT03317405|560063735|FG002|Overall Study|Physician Decision|1|||
155170679|NCT03317405|560063733|FG000|Overall Study|Surgery Rescheduled|0|||
155170680|NCT03317405|560063734|FG001|Overall Study|Surgery Rescheduled|1|||
155170681|NCT03317405|560063735|FG002|Overall Study|Surgery Rescheduled|0|||
155170682|NCT01137604|560063736|FG000|Overall Study|Adverse Event|3|||
155170683|NCT01137604|560063737|FG001|Overall Study|Adverse Event|6|||
155170684|NCT01137604|560063738|FG002|Overall Study|Adverse Event|9|||
155170685|NCT01137604|560063739|FG003|Overall Study|Adverse Event|9|||
155170686|NCT01137604|560063736|FG000|Overall Study|Participant Choice|0|||
155170687|NCT01137604|560063737|FG001|Overall Study|Participant Choice|2|||
155170688|NCT01137604|560063738|FG002|Overall Study|Participant Choice|2|||
155170689|NCT01137604|560063739|FG003|Overall Study|Participant Choice|0|||
155170690|NCT01137604|560063736|FG000|Overall Study|Withdrawal of consent|0|||
155170691|NCT01137604|560063737|FG001|Overall Study|Withdrawal of consent|0|||
155170692|NCT01137604|560063738|FG002|Overall Study|Withdrawal of consent|0|||
155170693|NCT01137604|560063739|FG003|Overall Study|Withdrawal of consent|2|||
154967302|NCT00906399|559303299|FG002|Year 1|Randomized But Not Treated|3|||
155170694|NCT01137604|560063736|FG000|Overall Study|Clinical progression/deterioration|1|||
155170695|NCT01137604|560063737|FG001|Overall Study|Clinical progression/deterioration|2|||
155170696|NCT01137604|560063738|FG002|Overall Study|Clinical progression/deterioration|2|||
155170697|NCT01137604|560063739|FG003|Overall Study|Clinical progression/deterioration|0|||
155170698|NCT00591318|560063740|FG000|Overall Study|Lack of Efficacy|2|||
155093449|NCT01840943|559776858|FG000|Overall Study|Withdrawal by Subject|5|||
155093450|NCT01840943|559776859|FG001|Overall Study|Withdrawal by Subject|6|||
155093451|NCT01840943|559776858|FG000|Overall Study|Physician Decision|4|||
155093452|NCT01840943|559776859|FG001|Overall Study|Physician Decision|2|||
155093453|NCT01840943|559776858|FG000|Overall Study|Lost to Follow-up|4|||
155093454|NCT01840943|559776859|FG001|Overall Study|Lost to Follow-up|4|||
155093455|NCT00329420|559776860|FG000|Re-induction Phase|Lack of Efficacy|0|||
155093456|NCT00329420|559776861|FG001|Re-induction Phase|Lack of Efficacy|1|||
155093457|NCT00329420|559776862|FG002|Re-induction Phase|Lack of Efficacy|0|||
155093458|NCT00329420|559776860|FG000|Re-induction Phase|Withdrawal of Consent|0|||
155093459|NCT00329420|559776861|FG001|Re-induction Phase|Withdrawal of Consent|0|||
155093460|NCT00329420|559776862|FG002|Re-induction Phase|Withdrawal of Consent|1|||
155093461|NCT00329420|559776860|FG000|Re-induction Phase|Did not respond to re-induction|6|||
155093462|NCT00329420|559776861|FG001|Re-induction Phase|Did not respond to re-induction|5|||
155093463|NCT00329420|559776862|FG002|Re-induction Phase|Did not respond to re-induction|7|||
155093464|NCT00329420|559776860|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
155093465|NCT00329420|559776861|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
155093466|NCT00329420|559776862|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
155093467|NCT00329420|559776860|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
155093468|NCT00329420|559776861|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
155093469|NCT00329420|559776862|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
155093470|NCT00329420|559776860|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
155093471|NCT00329420|559776861|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
155093472|NCT00329420|559776862|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
155093473|NCT01446874|559776863|FG000|Overall Study|Not eligible|1|||
155093474|NCT01446874|559776864|FG001|Overall Study|Not eligible|0|||
155093475|NCT01446874|559776865|FG002|Overall Study|Not eligible|0|||
155093476|NCT01446874|559776863|FG000|Overall Study|No surgery/No qualifying surgery|1|||
155093477|NCT01446874|559776864|FG001|Overall Study|No surgery/No qualifying surgery|0|||
155093478|NCT01446874|559776865|FG002|Overall Study|No surgery/No qualifying surgery|12|||
155093479|NCT01446874|559776863|FG000|Overall Study|Non-compliance|0|||
155093480|NCT01446874|559776864|FG001|Overall Study|Non-compliance|4|||
155093481|NCT01446874|559776865|FG002|Overall Study|Non-compliance|0|||
155093482|NCT01446874|559776863|FG000|Overall Study|Antibiotics for pre-op infection|0|||
155093483|NCT01446874|559776864|FG001|Overall Study|Antibiotics for pre-op infection|0|||
155093484|NCT01446874|559776865|FG002|Overall Study|Antibiotics for pre-op infection|2|||
155093485|NCT01446874|559776863|FG000|Overall Study|Withdrawal by Subject|0|||
155093486|NCT01446874|559776864|FG001|Overall Study|Withdrawal by Subject|0|||
155093487|NCT01446874|559776865|FG002|Overall Study|Withdrawal by Subject|4|||
155093488|NCT01135992|559776866|FG000|Overall Study|Adverse Event|1|||
155093489|NCT01135992|559776866|FG000|Overall Study|Lack of Efficacy|1|||
155093490|NCT01135992|559776866|FG000|Overall Study|Protocol Violation|2|||
155093491|NCT01135992|559776866|FG000|Overall Study|Withdrawal criteria|10|||
155093492|NCT01135992|559776866|FG000|Overall Study|Unclassified|7|||
155093493|NCT01977898|559776867|FG000|Overall Study|Non functioning catheter|1|||
155093494|NCT01977898|559776868|FG001|Overall Study|Non functioning catheter|1|||
155093495|NCT03386773|559776873|FG000|Overall Study|Lost to Follow-up|24|||
155093496|NCT03386773|559776874|FG001|Overall Study|Lost to Follow-up|33|||
155093497|NCT03386773|559776873|FG000|Overall Study|Withdrawal by Subject|3|||
155093498|NCT03386773|559776874|FG001|Overall Study|Withdrawal by Subject|2|||
155093499|NCT03983421|559776875|FG000|Overall Study|Lost to Follow-up|1|||
155093500|NCT03639610|559776876|FG000|Overall Study|Adverse Event|7|||
155093501|NCT03639610|559776877|FG001|Overall Study|Adverse Event|1|||
155093502|NCT03639610|559776878|FG002|Overall Study|Adverse Event|0|||
155093503|NCT03639610|559776876|FG000|Overall Study|Physician Decision|3|||
155093504|NCT03639610|559776877|FG001|Overall Study|Physician Decision|1|||
155093505|NCT03639610|559776878|FG002|Overall Study|Physician Decision|0|||
155093506|NCT03639610|559776876|FG000|Overall Study|Disease progression|8|||
155093507|NCT03639610|559776877|FG001|Overall Study|Disease progression|5|||
155093508|NCT03639610|559776878|FG002|Overall Study|Disease progression|3|||
155093509|NCT03639610|559776876|FG000|Overall Study|Study terminated by sponsor|2|||
155093510|NCT03639610|559776877|FG001|Overall Study|Study terminated by sponsor|1|||
155093511|NCT03639610|559776878|FG002|Overall Study|Study terminated by sponsor|1|||
155093512|NCT03639610|559776876|FG000|Overall Study|Patient request to stop treatment|1|||
155093513|NCT03639610|559776877|FG001|Overall Study|Patient request to stop treatment|2|||
155093514|NCT03639610|559776878|FG002|Overall Study|Patient request to stop treatment|0|||
155093515|NCT02660229|559776879|FG000|Overall Study|Adverse Event|2|||
155093516|NCT02660229|559776880|FG001|Overall Study|Adverse Event|0|||
155093517|NCT02660229|559776879|FG000|Overall Study|Withdrawal by Subject|0|||
155093518|NCT02660229|559776880|FG001|Overall Study|Withdrawal by Subject|1|||
155093519|NCT01049373|559776884|FG000|Overall Study|Protocol Violation|9|||
155093520|NCT01049373|559776885|FG001|Overall Study|Protocol Violation|9|||
155093521|NCT01049373|559776884|FG000|Overall Study|Withdrawal by Subject|8|||
155093522|NCT01049373|559776885|FG001|Overall Study|Withdrawal by Subject|5|||
155093523|NCT01049373|559776884|FG000|Overall Study|Adverse Event|3|||
154967303|NCT00906399|559303300|FG003|Year 1|Randomized But Not Treated|0|||
155093524|NCT01049373|559776885|FG001|Overall Study|Adverse Event|3|||
154967304|NCT00906399|559303301|FG004|Year 1|Randomized But Not Treated|0|||
155093525|NCT01049373|559776884|FG000|Overall Study|Lost to Follow-up|9|||
155093526|NCT01049373|559776885|FG001|Overall Study|Lost to Follow-up|4|||
155093527|NCT01049373|559776884|FG000|Overall Study|no evaluable study values|9|||
155093528|NCT01049373|559776885|FG001|Overall Study|no evaluable study values|21|||
155093529|NCT01049373|559776884|FG000|Overall Study|Other|1|||
155093530|NCT01049373|559776885|FG001|Overall Study|Other|1|||
155093531|NCT01049373|559776884|FG000|Overall Study|Non-cooperation|0|||
155093532|NCT01049373|559776885|FG001|Overall Study|Non-cooperation|1|||
155093533|NCT03610048|559776886|FG000|Overall Study|Study terminated by sponsor|84|||
155093534|NCT03610048|559776886|FG000|Overall Study|Adverse Event|32|||
155093535|NCT03610048|559776886|FG000|Overall Study|Withdrawal by Subject|31|||
155093536|NCT03610048|559776886|FG000|Overall Study|Lost to Follow-up|8|||
155093537|NCT03610048|559776886|FG000|Overall Study|Other|4|||
155093538|NCT03610048|559776886|FG000|Overall Study|Physician Decision|1|||
155093539|NCT03610048|559776886|FG000|Overall Study|Pregnancy|1|||
155093540|NCT01155050|559776887|FG000|Overall Study|Lost to Follow-up|15|||
155093541|NCT01155050|559776888|FG001|Overall Study|Lost to Follow-up|20|||
155093542|NCT01155050|559776889|FG002|Overall Study|Lost to Follow-up|19|||
155093543|NCT01155050|559776890|FG003|Overall Study|Lost to Follow-up|22|||
155093544|NCT00557193|559776891|FG000|Induction|Adverse Event|2|||
155093545|NCT00557193|559776892|FG001|Induction|Adverse Event|0|||
155093546|NCT00557193|559776893|FG002|Induction|Adverse Event|0|||
155093547|NCT00557193|559776894|FG003|Induction|Adverse Event|0|||
155093548|NCT00557193|559776895|FG004|Induction|Adverse Event|0|||
155093549|NCT00557193|559776896|FG005|Induction|Adverse Event|0|||
155093550|NCT00557193|559776891|FG000|Induction|Death|6|||
155093551|NCT00557193|559776892|FG001|Induction|Death|0|||
155093552|NCT00557193|559776893|FG002|Induction|Death|0|||
155093553|NCT00557193|559776894|FG003|Induction|Death|0|||
155093554|NCT00557193|559776895|FG004|Induction|Death|0|||
155093555|NCT00557193|559776896|FG005|Induction|Death|0|||
155093556|NCT00557193|559776891|FG000|Induction|Physician Decision|3|||
155093557|NCT00557193|559776892|FG001|Induction|Physician Decision|0|||
155093558|NCT00557193|559776893|FG002|Induction|Physician Decision|0|||
155093559|NCT00557193|559776894|FG003|Induction|Physician Decision|0|||
155093560|NCT00557193|559776895|FG004|Induction|Physician Decision|0|||
155093561|NCT00557193|559776896|FG005|Induction|Physician Decision|0|||
155093562|NCT00557193|559776891|FG000|Induction|Withdrawal by Subject|1|||
155093563|NCT00557193|559776892|FG001|Induction|Withdrawal by Subject|0|||
155093564|NCT00557193|559776893|FG002|Induction|Withdrawal by Subject|0|||
155093565|NCT00557193|559776894|FG003|Induction|Withdrawal by Subject|0|||
155093566|NCT00557193|559776895|FG004|Induction|Withdrawal by Subject|0|||
155093567|NCT00557193|559776896|FG005|Induction|Withdrawal by Subject|0|||
155093568|NCT00557193|559776891|FG000|Induction|Refusal of Further Protocol Therapy|2|||
155093569|NCT00557193|559776892|FG001|Induction|Refusal of Further Protocol Therapy|0|||
155093570|NCT00557193|559776893|FG002|Induction|Refusal of Further Protocol Therapy|0|||
155093571|NCT00557193|559776894|FG003|Induction|Refusal of Further Protocol Therapy|0|||
155093572|NCT00557193|559776895|FG004|Induction|Refusal of Further Protocol Therapy|0|||
155093573|NCT00557193|559776896|FG005|Induction|Refusal of Further Protocol Therapy|0|||
155093574|NCT00557193|559776891|FG000|Induction|Ineligible|8|||
155093575|NCT00557193|559776892|FG001|Induction|Ineligible|0|||
155093576|NCT00557193|559776893|FG002|Induction|Ineligible|0|||
155093577|NCT00557193|559776894|FG003|Induction|Ineligible|0|||
155093578|NCT00557193|559776895|FG004|Induction|Ineligible|0|||
155093579|NCT00557193|559776896|FG005|Induction|Ineligible|0|||
155093580|NCT00557193|559776891|FG000|Induction|Inevaluable for post Induction|2|||
155093581|NCT00557193|559776892|FG001|Induction|Inevaluable for post Induction|0|||
155093582|NCT00557193|559776893|FG002|Induction|Inevaluable for post Induction|0|||
155093583|NCT00557193|559776894|FG003|Induction|Inevaluable for post Induction|0|||
155093584|NCT00557193|559776895|FG004|Induction|Inevaluable for post Induction|0|||
155093585|NCT00557193|559776896|FG005|Induction|Inevaluable for post Induction|0|||
155093586|NCT00557193|559776891|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
155093587|NCT00557193|559776892|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155093588|NCT00557193|559776893|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155093589|NCT00557193|559776894|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155093590|NCT00557193|559776895|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155093591|NCT00557193|559776896|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
155093592|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155093593|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
155093594|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
155093595|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
155093596|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
155093597|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
155093598|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
155093599|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
155093600|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
155093601|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
155093602|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
155093603|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
155093604|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
155093605|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
155093606|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
155093607|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
155093608|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
155093609|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
155093610|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
155093611|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
155093612|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
155093613|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
155093614|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
155093615|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
155093616|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
155093617|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
155093618|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
155093619|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
155093620|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
155093621|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
155093622|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155093623|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155093624|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
155093625|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155093626|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155093627|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
155093628|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155093629|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155093630|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
155093631|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155093632|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155093633|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
155093634|NCT00557193|559776891|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155093635|NCT00557193|559776892|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155093636|NCT00557193|559776893|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
155093637|NCT00557193|559776894|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155093638|NCT00557193|559776895|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
155093639|NCT00557193|559776896|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
155093640|NCT01156844|559776899|FG000|Overall Study|Adverse Event|0|||
155093641|NCT01156844|559776900|FG001|Overall Study|Adverse Event|0|||
155093642|NCT01156844|559776901|FG002|Overall Study|Adverse Event|1|||
155093643|NCT01156844|559776902|FG003|Overall Study|Adverse Event|1|||
155093644|NCT01156844|559776899|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155093645|NCT01156844|559776900|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155093646|NCT01156844|559776901|FG002|Overall Study|Abnormal test procedure result(s)|2|||
155093647|NCT01156844|559776902|FG003|Overall Study|Abnormal test procedure result(s)|2|||
155093648|NCT01156844|559776899|FG000|Overall Study|Withdrawal by Subject|0|||
155093649|NCT01156844|559776900|FG001|Overall Study|Withdrawal by Subject|0|||
155093650|NCT01156844|559776901|FG002|Overall Study|Withdrawal by Subject|2|||
155093651|NCT01156844|559776902|FG003|Overall Study|Withdrawal by Subject|2|||
155093652|NCT01156844|559776899|FG000|Overall Study|Lost to Follow-up|0|||
155093653|NCT01156844|559776900|FG001|Overall Study|Lost to Follow-up|0|||
155093654|NCT01156844|559776901|FG002|Overall Study|Lost to Follow-up|1|||
155093655|NCT01156844|559776902|FG003|Overall Study|Lost to Follow-up|0|||
155093656|NCT01156844|559776899|FG000|Overall Study|Administrative problems|0|||
155093657|NCT01156844|559776900|FG001|Overall Study|Administrative problems|1|||
155093658|NCT01156844|559776901|FG002|Overall Study|Administrative problems|0|||
155093659|NCT01156844|559776902|FG003|Overall Study|Administrative problems|1|||
155093660|NCT01156844|559776899|FG000|Overall Study|Protocol deviation|2|||
155093661|NCT01156844|559776900|FG001|Overall Study|Protocol deviation|0|||
155093662|NCT01156844|559776901|FG002|Overall Study|Protocol deviation|0|||
155093663|NCT01156844|559776902|FG003|Overall Study|Protocol deviation|0|||
155093664|NCT01130337|559776904|FG000|Overall Study|Withdrawal by Subject|3|||
155170699|NCT00591318|560063741|FG001|Overall Study|Lack of Efficacy|0|||
155170700|NCT00591318|560063740|FG000|Overall Study|Adverse Event|2|||
155170701|NCT00591318|560063741|FG001|Overall Study|Adverse Event|0|||
155170702|NCT01024309|560063742|FG000|Overall Study|Physician Decision|4|||
155170703|NCT01024309|560063743|FG001|Overall Study|Physician Decision|0|||
155170704|NCT01024309|560063742|FG000|Overall Study|Withdrawal by Subject|4|||
155170705|NCT01024309|560063743|FG001|Overall Study|Withdrawal by Subject|4|||
155170706|NCT00435045|560063744|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
155170707|NCT00435045|560063745|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
155170708|NCT00435045|560063744|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
155170709|NCT00435045|560063745|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
155170710|NCT00435045|560063744|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
155170711|NCT00435045|560063745|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
155170712|NCT00435045|560063744|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
155170713|NCT00435045|560063745|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
155170714|NCT00435045|560063744|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
155170715|NCT00435045|560063745|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
155170716|NCT00435045|560063744|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
155170717|NCT00435045|560063745|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
155170718|NCT00435045|560063744|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
155170719|NCT00435045|560063745|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
155170720|NCT00435045|560063744|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
155170721|NCT00435045|560063745|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
155170722|NCT00435045|560063744|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
155170723|NCT00435045|560063745|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
155170724|NCT00435045|560063744|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
155170725|NCT00435045|560063745|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
155170726|NCT00435045|560063744|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
155170727|NCT00435045|560063745|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
155170728|NCT00567255|560063746|FG000|Overall Study|Adverse Event|241|||
155170729|NCT00567255|560063747|FG001|Overall Study|Adverse Event|68|||
155170730|NCT00567255|560063746|FG000|Overall Study|Lost to Follow-up|77|||
155170731|NCT00567255|560063747|FG001|Overall Study|Lost to Follow-up|48|||
155170732|NCT00567255|560063746|FG000|Overall Study|Withdrawal by Subject|75|||
155170733|NCT00567255|560063747|FG001|Overall Study|Withdrawal by Subject|56|||
155170734|NCT00567255|560063746|FG000|Overall Study|Lack of Efficacy|19|||
155170735|NCT00567255|560063747|FG001|Overall Study|Lack of Efficacy|33|||
155170736|NCT00567255|560063746|FG000|Overall Study|Protocol Violation|20|||
155170737|NCT00567255|560063747|FG001|Overall Study|Protocol Violation|8|||
155170738|NCT00567255|560063746|FG000|Overall Study|Pregnancy|6|||
155170739|NCT00567255|560063747|FG001|Overall Study|Pregnancy|0|||
155170740|NCT00567255|560063746|FG000|Overall Study|Drug noncompliance,moved,other|25|||
155170741|NCT00567255|560063747|FG001|Overall Study|Drug noncompliance,moved,other|15|||
155093665|NCT01130337|559776904|FG000|Overall Study|Principal investigator decision|1|||
155093666|NCT01130337|559776904|FG000|Overall Study|Death|1|||
155093667|NCT01130337|559776904|FG000|Overall Study|Disease progression|1|||
155093668|NCT01130337|559776904|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
155093669|NCT01130337|559776904|FG000|Overall Study|Surgical resection (R2)|1|||
155093670|NCT03886493|559776905|FG000|Overall Study|Adverse Event|1|||
155093671|NCT04661033|559776906|FG000|Overall Study|Adverse Event|0|||
155093672|NCT04661033|559776907|FG001|Overall Study|Adverse Event|0|||
155093673|NCT04661033|559776908|FG002|Overall Study|Adverse Event|1|||
155093674|NCT04661033|559776909|FG003|Overall Study|Adverse Event|0|||
155093675|NCT04661033|559776906|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
155093676|NCT04661033|559776907|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
155093677|NCT04661033|559776908|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
155093678|NCT04661033|559776909|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
155093679|NCT04661033|559776906|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
155093680|NCT04661033|559776907|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
155093681|NCT04661033|559776908|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
155093682|NCT04661033|559776909|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
155170742|NCT01743001|560063750|FG000|Overall Study|Physician Decision|1|||
155170743|NCT01743001|560063751|FG001|Overall Study|Physician Decision|0|||
155170744|NCT01743001|560063750|FG000|Overall Study|Pregnancy|1|||
155170745|NCT01743001|560063751|FG001|Overall Study|Pregnancy|0|||
155170746|NCT01743001|560063750|FG000|Overall Study|Death|1|||
155170747|NCT01743001|560063751|FG001|Overall Study|Death|0|||
155170748|NCT03052426|560063754|FG000|Overall Study|Withdrawal by Subject|0|||
155170749|NCT03052426|560063755|FG001|Overall Study|Withdrawal by Subject|1|||
155170750|NCT03052426|560063756|FG002|Overall Study|Withdrawal by Subject|0|||
155170751|NCT03052426|560063754|FG000|Overall Study|Lost to Follow-up|2|||
155170752|NCT03052426|560063755|FG001|Overall Study|Lost to Follow-up|0|||
155170753|NCT03052426|560063756|FG002|Overall Study|Lost to Follow-up|1|||
155170754|NCT03083990|560063759|FG000|Overall Study|Adverse Event|1|||
155170755|NCT03083990|560063760|FG001|Overall Study|Adverse Event|0|||
155093683|NCT04661033|559776906|FG000|Overall Study|Early discontinuation as per PI|1|||
155093684|NCT04661033|559776907|FG001|Overall Study|Early discontinuation as per PI|0|||
155093685|NCT04661033|559776908|FG002|Overall Study|Early discontinuation as per PI|0|||
155093686|NCT04661033|559776909|FG003|Overall Study|Early discontinuation as per PI|0|||
155093687|NCT00760552|559776913|FG000|Overall Study|Death|2|||
155093688|NCT00760552|559776914|FG001|Overall Study|Death|0|||
155093689|NCT00760552|559776913|FG000|Overall Study|Lost to Follow-up|11|||
155093690|NCT00760552|559776914|FG001|Overall Study|Lost to Follow-up|10|||
155093691|NCT01038323|559776915|FG000|Overall Study|Withdrawal by Subject|3|||
155093692|NCT01038323|559776916|FG001|Overall Study|Withdrawal by Subject|2|||
155093693|NCT01038323|559776917|FG002|Overall Study|Withdrawal by Subject|4|||
155093694|NCT04211363|559776919|FG000|Overall Study|Adverse Event|5|||
155093695|NCT04211363|559776920|FG001|Overall Study|Adverse Event|2|||
155093696|NCT04211363|559776919|FG000|Overall Study|Physician Decision|0|||
155093697|NCT04211363|559776920|FG001|Overall Study|Physician Decision|1|||
155093698|NCT04211363|559776919|FG000|Overall Study|Protocol Violation|1|||
155093699|NCT04211363|559776920|FG001|Overall Study|Protocol Violation|0|||
155093700|NCT04211363|559776919|FG000|Overall Study|Pregnancy|1|||
155093701|NCT04211363|559776920|FG001|Overall Study|Pregnancy|0|||
155093702|NCT04211363|559776919|FG000|Overall Study|Lost to Follow-up|12|||
155093703|NCT04211363|559776920|FG001|Overall Study|Lost to Follow-up|4|||
155093704|NCT04211363|559776919|FG000|Overall Study|Withdrawal by Subject|11|||
155093705|NCT04211363|559776920|FG001|Overall Study|Withdrawal by Subject|11|||
155093706|NCT04211363|559776919|FG000|Overall Study|Other|1|||
155093707|NCT04211363|559776920|FG001|Overall Study|Other|2|||
155093708|NCT01736917|559776925|FG000|Overall Study|Adverse Event|1|||
155093709|NCT01736917|559776925|FG000|Overall Study|Protocol Violation|10|||
155093710|NCT01734902|559776926|FG000|Overall Study|Other than listed|0|||
155093711|NCT01734902|559776927|FG001|Overall Study|Other than listed|2|||
155093712|NCT00060944|559776928|FG000|Overall Study|Adverse Event|12|||
155093713|NCT00060944|559776929|FG001|Overall Study|Adverse Event|10|||
155093714|NCT00060944|559776928|FG000|Overall Study|Death|2|||
155093715|NCT00060944|559776929|FG001|Overall Study|Death|3|||
155093716|NCT00060944|559776928|FG000|Overall Study|Withdrawal by Subject|18|||
155093717|NCT00060944|559776929|FG001|Overall Study|Withdrawal by Subject|5|||
155093718|NCT00060944|559776928|FG000|Overall Study|Disease Progression|93|||
155093719|NCT00060944|559776929|FG001|Overall Study|Disease Progression|94|||
155093720|NCT00060944|559776928|FG000|Overall Study|Lost to Follow-up|1|||
155093721|NCT00060944|559776929|FG001|Overall Study|Lost to Follow-up|0|||
155093722|NCT00060944|559776928|FG000|Overall Study|Subject Ineligible To Continue|2|||
155093723|NCT00060944|559776929|FG001|Overall Study|Subject Ineligible To Continue|1|||
155093724|NCT00060944|559776928|FG000|Overall Study|Treatment Switch|0|||
155093725|NCT00060944|559776929|FG001|Overall Study|Treatment Switch|13|||
155093726|NCT00060944|559776928|FG000|Overall Study|Other|2|||
155093727|NCT00060944|559776929|FG001|Overall Study|Other|4|||
155093728|NCT00060944|559776928|FG000|Overall Study|randomized but not treated|6|||
155093729|NCT00060944|559776929|FG001|Overall Study|randomized but not treated|4|||
155093730|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
155093731|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
155093732|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
155093733|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Death|0|||
155093734|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Death|0|||
155093735|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Death|1|||
155093736|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
155093737|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
155093738|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
155093739|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
155093740|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
155093741|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
155093742|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
155093743|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
155093744|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
155093745|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Graft loss|0|||
155093746|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Graft loss|0|||
155093747|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Graft loss|7|||
155093748|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
155093749|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
155093750|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
155093751|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
155093752|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
155093753|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
155170756|NCT02657408|560063761|FG000|Overall Study|Adverse Event|3|||
155170757|NCT02657408|560063762|FG001|Overall Study|Adverse Event|7|||
155093754|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
155093755|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
155170758|NCT01403948|560063763|FG000|Overall Study|Progressive disease|0|||
155093756|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
155093757|NCT00956293|559776933|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
155093758|NCT00956293|559776934|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
155093759|NCT00956293|559776935|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
155093760|NCT00956293|559776933|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
155093761|NCT00956293|559776934|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
155093762|NCT00956293|559776935|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
155093763|NCT00956293|559776933|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
155093764|NCT00956293|559776934|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
155093765|NCT00956293|559776935|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
155093766|NCT00956293|559776933|FG000|Main Period (Randomization)|Adverse Event|0|||
155093767|NCT00956293|559776934|FG001|Main Period (Randomization)|Adverse Event|15|||
155093768|NCT00956293|559776935|FG002|Main Period (Randomization)|Adverse Event|0|||
155093769|NCT00956293|559776933|FG000|Follow-up Period|Follow-up period was terminated.|20|||
155093770|NCT00956293|559776934|FG001|Follow-up Period|Follow-up period was terminated.|32|||
155093771|NCT00956293|559776935|FG002|Follow-up Period|Follow-up period was terminated.|0|||
155093772|NCT02536664|559776936|FG000|Overall Study|Inadequate completion of documentation|2|||
155093773|NCT02536664|559776937|FG001|Overall Study|Inadequate completion of documentation|4|||
155093774|NCT02536664|559776936|FG000|Overall Study|Progression|13|||
155093775|NCT02536664|559776937|FG001|Overall Study|Progression|18|||
155093776|NCT02536664|559776936|FG000|Overall Study|Death due to lymphoma|2|||
155093777|NCT02536664|559776937|FG001|Overall Study|Death due to lymphoma|1|||
155093778|NCT02536664|559776936|FG000|Overall Study|Death due to other reason|3|||
155093779|NCT02536664|559776937|FG001|Overall Study|Death due to other reason|2|||
155093780|NCT02536664|559776936|FG000|Overall Study|Intolerability|8|||
155093781|NCT02536664|559776937|FG001|Overall Study|Intolerability|6|||
155093782|NCT02536664|559776936|FG000|Overall Study|Withdrawal by Subject|8|||
155093783|NCT02536664|559776937|FG001|Overall Study|Withdrawal by Subject|5|||
155093784|NCT02536664|559776936|FG000|Overall Study|Other|18|||
155093785|NCT02536664|559776937|FG001|Overall Study|Other|24|||
155093786|NCT02536664|559776936|FG000|Overall Study|Missing|53|||
155093787|NCT02536664|559776937|FG001|Overall Study|Missing|20|||
155093788|NCT03383666|559776938|FG000|Overall Study|Withdrawal by Subject|2|||
155093789|NCT03383666|559776938|FG000|Overall Study|Lost to Follow-up|2|||
155093790|NCT03358030|559776940|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
155093791|NCT03358030|559776941|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
155093792|NCT03358030|559776942|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
155093793|NCT03358030|559776943|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
155093794|NCT03358030|559776940|FG000|Overall Study|Ineligibility|0|||
155093795|NCT03358030|559776941|FG001|Overall Study|Ineligibility|0|||
155093796|NCT03358030|559776942|FG002|Overall Study|Ineligibility|0|||
155093797|NCT03358030|559776943|FG003|Overall Study|Ineligibility|2|||
155093798|NCT03358030|559776940|FG000|Overall Study|Voluntary Withdrawal|1|||
155093799|NCT03358030|559776941|FG001|Overall Study|Voluntary Withdrawal|1|||
155093800|NCT03358030|559776942|FG002|Overall Study|Voluntary Withdrawal|3|||
155093801|NCT03358030|559776943|FG003|Overall Study|Voluntary Withdrawal|1|||
155093802|NCT03358030|559776940|FG000|Overall Study|Other|0|||
155093803|NCT03358030|559776941|FG001|Overall Study|Other|0|||
155093804|NCT03358030|559776942|FG002|Overall Study|Other|1|||
155093805|NCT03358030|559776943|FG003|Overall Study|Other|0|||
155093806|NCT03342560|559776944|FG000|Overall Study|Lost to Follow-up|2|||
155093807|NCT03770286|559776945|FG000|Overall Study|Lost to Follow-up|6|||
155093808|NCT03770286|559776946|FG001|Overall Study|Lost to Follow-up|4|||
155170759|NCT01403948|560063764|FG001|Overall Study|Progressive disease|2|||
155093809|NCT03770286|559776947|FG002|Overall Study|Lost to Follow-up|3|||
155093810|NCT03770286|559776945|FG000|Overall Study|Protocol Violation|1|||
155093811|NCT03770286|559776946|FG001|Overall Study|Protocol Violation|0|||
155093812|NCT03770286|559776947|FG002|Overall Study|Protocol Violation|2|||
154967305|NCT00906399|559303302|FG005|Year 1|Randomized But Not Treated|0|||
154967306|NCT00906399|559303303|FG006|Year 1|Randomized But Not Treated|0|||
154967307|NCT00906399|559303297|FG000|Year 1|Adverse Event|4|||
154967308|NCT00906399|559303298|FG001|Year 1|Adverse Event|22|||
154967309|NCT00906399|559303299|FG002|Year 1|Adverse Event|24|||
154967310|NCT00906399|559303300|FG003|Year 1|Adverse Event|0|||
154967311|NCT00906399|559303301|FG004|Year 1|Adverse Event|0|||
154967312|NCT00906399|559303302|FG005|Year 1|Adverse Event|0|||
154967313|NCT00906399|559303303|FG006|Year 1|Adverse Event|0|||
154967314|NCT00906399|559303297|FG000|Year 1|Lost to Follow-up|4|||
154967315|NCT00906399|559303298|FG001|Year 1|Lost to Follow-up|4|||
154967316|NCT00906399|559303299|FG002|Year 1|Lost to Follow-up|2|||
154967317|NCT00906399|559303300|FG003|Year 1|Lost to Follow-up|0|||
154967318|NCT00906399|559303301|FG004|Year 1|Lost to Follow-up|0|||
154967319|NCT00906399|559303302|FG005|Year 1|Lost to Follow-up|0|||
154967320|NCT00906399|559303303|FG006|Year 1|Lost to Follow-up|0|||
154967321|NCT00906399|559303297|FG000|Year 1|Withdrawal by Subject|30|||
154967322|NCT00906399|559303298|FG001|Year 1|Withdrawal by Subject|32|||
154967323|NCT00906399|559303299|FG002|Year 1|Withdrawal by Subject|36|||
154967324|NCT00906399|559303300|FG003|Year 1|Withdrawal by Subject|0|||
154967325|NCT00906399|559303301|FG004|Year 1|Withdrawal by Subject|0|||
154967326|NCT00906399|559303302|FG005|Year 1|Withdrawal by Subject|0|||
154967327|NCT00906399|559303303|FG006|Year 1|Withdrawal by Subject|0|||
154967328|NCT00906399|559303297|FG000|Year 1|Physician Decision|0|||
154967329|NCT00906399|559303298|FG001|Year 1|Physician Decision|1|||
154967330|NCT00906399|559303299|FG002|Year 1|Physician Decision|3|||
154967331|NCT00906399|559303300|FG003|Year 1|Physician Decision|0|||
154967332|NCT00906399|559303301|FG004|Year 1|Physician Decision|0|||
154967333|NCT00906399|559303302|FG005|Year 1|Physician Decision|0|||
154967334|NCT00906399|559303303|FG006|Year 1|Physician Decision|0|||
154967335|NCT00906399|559303297|FG000|Year 1|Death|2|||
154967336|NCT00906399|559303298|FG001|Year 1|Death|1|||
154967337|NCT00906399|559303299|FG002|Year 1|Death|1|||
154967338|NCT00906399|559303300|FG003|Year 1|Death|0|||
154967339|NCT00906399|559303301|FG004|Year 1|Death|0|||
154967340|NCT00906399|559303302|FG005|Year 1|Death|0|||
154967341|NCT00906399|559303303|FG006|Year 1|Death|0|||
154967342|NCT00906399|559303297|FG000|Year 1|Other|4|||
154967343|NCT00906399|559303298|FG001|Year 1|Other|2|||
154967344|NCT00906399|559303299|FG002|Year 1|Other|7|||
154967345|NCT00906399|559303300|FG003|Year 1|Other|0|||
154967346|NCT00906399|559303301|FG004|Year 1|Other|0|||
154967347|NCT00906399|559303302|FG005|Year 1|Other|0|||
155093813|NCT01354223|559778490|FG000|Overall Study|Withdrawal by Subject|3|||
155093814|NCT01354223|559778491|FG001|Overall Study|Withdrawal by Subject|1|||
155093815|NCT01466491|559778499|FG000|Overall Study|Protocol Violation|0|||
155093816|NCT01466491|559778500|FG001|Overall Study|Protocol Violation|3|||
155093817|NCT01466491|559778501|FG002|Overall Study|Protocol Violation|2|||
155093818|NCT01466491|559778502|FG003|Overall Study|Protocol Violation|0|||
155093819|NCT01466491|559778499|FG000|Overall Study|Missing Data|0|||
155093820|NCT01466491|559778500|FG001|Overall Study|Missing Data|0|||
155093821|NCT01466491|559778501|FG002|Overall Study|Missing Data|1|||
155093822|NCT01466491|559778502|FG003|Overall Study|Missing Data|0|||
155093823|NCT00892008|559778503|FG000|Overall Study|Death|5|||
155093824|NCT00892008|559778503|FG000|Overall Study|Lack of Efficacy|3|||
155093825|NCT00892008|559778503|FG000|Overall Study|Lost to Follow-up|142|||
155093826|NCT00892008|559778503|FG000|Overall Study|Other|378|||
155093827|NCT00892008|559778503|FG000|Overall Study|Adverse Event|37|||
155093828|NCT02136914|559778504|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
155093829|NCT02136914|559778505|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
155093830|NCT02136914|559778504|FG000|Overall Study|Withdrawal by Subject|3|||
155093831|NCT02136914|559778505|FG001|Overall Study|Withdrawal by Subject|10|||
155093832|NCT02136914|559778504|FG000|Overall Study|Subject Unwilling to Proceed|7|||
155093833|NCT02136914|559778505|FG001|Overall Study|Subject Unwilling to Proceed|2|||
155093834|NCT02136914|559778504|FG000|Overall Study|Lost to Follow-up|1|||
155093835|NCT02136914|559778505|FG001|Overall Study|Lost to Follow-up|1|||
155093836|NCT02136914|559778504|FG000|Overall Study|Did Not Receive Study Drug|2|||
155093837|NCT02136914|559778505|FG001|Overall Study|Did Not Receive Study Drug|0|||
155093838|NCT02136914|559778504|FG000|Overall Study|Lack of Efficacy|1|||
155093839|NCT02136914|559778505|FG001|Overall Study|Lack of Efficacy|0|||
155093840|NCT02136914|559778504|FG000|Overall Study|Death|0|||
155093841|NCT02136914|559778505|FG001|Overall Study|Death|1|||
155093842|NCT03338400|559778516|FG000|Overall Study|Lost to Follow-up|1|||
155093843|NCT03338400|559778517|FG001|Overall Study|Lost to Follow-up|2|||
155093844|NCT02639390|559778519|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
155093845|NCT02639390|559778520|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
155093846|NCT01531998|559778524|FG000|Overall Study|Withdrawal by Subject|3|||
155093847|NCT02581891|559778525|FG000|Overall Study|Adverse Event|4|||
155093848|NCT02581891|559778526|FG001|Overall Study|Adverse Event|6|||
154967348|NCT00906399|559303303|FG006|Year 1|Other|0|||
155093849|NCT02581891|559778525|FG000|Overall Study|Death|3|||
155093850|NCT02581891|559778526|FG001|Overall Study|Death|4|||
155093851|NCT02581891|559778525|FG000|Overall Study|Lost to Follow-up|1|||
155093852|NCT02581891|559778526|FG001|Overall Study|Lost to Follow-up|2|||
155093853|NCT02581891|559778525|FG000|Overall Study|Physician Decision|0|||
154967349|NCT00906399|559303297|FG000|Year 2|Adverse Event|0|||
155093854|NCT02581891|559778526|FG001|Overall Study|Physician Decision|1|||
155170760|NCT01403948|560063765|FG002|Overall Study|Progressive disease|2|||
155170761|NCT01403948|560063766|FG003|Overall Study|Progressive disease|4|||
154967350|NCT00906399|559303298|FG001|Year 2|Adverse Event|0|||
154967351|NCT00906399|559303299|FG002|Year 2|Adverse Event|0|||
154967352|NCT00906399|559303300|FG003|Year 2|Adverse Event|9|||
154967353|NCT00906399|559303301|FG004|Year 2|Adverse Event|8|||
154967354|NCT00906399|559303302|FG005|Year 2|Adverse Event|11|||
154967355|NCT00906399|559303303|FG006|Year 2|Adverse Event|6|||
154967356|NCT00906399|559303297|FG000|Year 2|Lost to Follow-up|0|||
154967357|NCT00906399|559303298|FG001|Year 2|Lost to Follow-up|0|||
154967358|NCT00906399|559303299|FG002|Year 2|Lost to Follow-up|0|||
154967359|NCT00906399|559303300|FG003|Year 2|Lost to Follow-up|1|||
154967360|NCT00906399|559303301|FG004|Year 2|Lost to Follow-up|4|||
154967361|NCT00906399|559303302|FG005|Year 2|Lost to Follow-up|2|||
154967362|NCT00906399|559303303|FG006|Year 2|Lost to Follow-up|4|||
154967363|NCT00906399|559303297|FG000|Year 2|Withdrawal by Subject|0|||
154967364|NCT00906399|559303298|FG001|Year 2|Withdrawal by Subject|0|||
154967365|NCT00906399|559303299|FG002|Year 2|Withdrawal by Subject|0|||
154967366|NCT00906399|559303300|FG003|Year 2|Withdrawal by Subject|17|||
154967367|NCT00906399|559303301|FG004|Year 2|Withdrawal by Subject|18|||
154967368|NCT00906399|559303302|FG005|Year 2|Withdrawal by Subject|27|||
154967369|NCT00906399|559303303|FG006|Year 2|Withdrawal by Subject|13|||
154967370|NCT00906399|559303297|FG000|Year 2|Physician Decision|0|||
154967371|NCT00906399|559303298|FG001|Year 2|Physician Decision|0|||
154967372|NCT00906399|559303299|FG002|Year 2|Physician Decision|0|||
154967373|NCT00906399|559303300|FG003|Year 2|Physician Decision|0|||
154967374|NCT00906399|559303301|FG004|Year 2|Physician Decision|2|||
154967375|NCT00906399|559303302|FG005|Year 2|Physician Decision|6|||
154967376|NCT00906399|559303303|FG006|Year 2|Physician Decision|3|||
154967377|NCT00906399|559303297|FG000|Year 2|Death|0|||
154967378|NCT00906399|559303298|FG001|Year 2|Death|0|||
154967379|NCT00906399|559303299|FG002|Year 2|Death|0|||
154967380|NCT00906399|559303300|FG003|Year 2|Death|1|||
154967381|NCT00906399|559303301|FG004|Year 2|Death|0|||
154967382|NCT00906399|559303302|FG005|Year 2|Death|0|||
154967383|NCT00906399|559303303|FG006|Year 2|Death|3|||
154967384|NCT00906399|559303297|FG000|Year 2|Other|0|||
154967385|NCT00906399|559303298|FG001|Year 2|Other|0|||
154967386|NCT00906399|559303299|FG002|Year 2|Other|0|||
154967387|NCT00906399|559303300|FG003|Year 2|Other|2|||
154967388|NCT00906399|559303301|FG004|Year 2|Other|3|||
154967389|NCT00906399|559303302|FG005|Year 2|Other|1|||
154967390|NCT00906399|559303303|FG006|Year 2|Other|0|||
154967391|NCT00624286|559303304|FG000|Overall Study|Protocol Deviation|7|||
154967392|NCT00624286|559303305|FG001|Overall Study|Protocol Deviation|9|||
154967393|NCT00624286|559303304|FG000|Overall Study|Adverse Event|6|||
154967394|NCT00624286|559303305|FG001|Overall Study|Adverse Event|3|||
154967395|NCT00624286|559303304|FG000|Overall Study|Withdrawal by Subject|5|||
154967396|NCT00624286|559303305|FG001|Overall Study|Withdrawal by Subject|4|||
154967397|NCT00624286|559303304|FG000|Overall Study|Lost to Follow-up|3|||
154967398|NCT00624286|559303305|FG001|Overall Study|Lost to Follow-up|2|||
154967399|NCT00624286|559303304|FG000|Overall Study|Administrative problems|3|||
154967400|NCT00624286|559303305|FG001|Overall Study|Administrative problems|0|||
155093855|NCT02581891|559778525|FG000|Overall Study|Withdrawal by Subject|4|||
155093856|NCT02581891|559778526|FG001|Overall Study|Withdrawal by Subject|5|||
155093857|NCT02581891|559778525|FG000|Overall Study|Other Reasons|3|||
155093858|NCT02581891|559778526|FG001|Overall Study|Other Reasons|1|||
155093859|NCT02581891|559778525|FG000|Overall Study|Discontinued during followup|1|||
155093860|NCT02581891|559778526|FG001|Overall Study|Discontinued during followup|0|||
155093861|NCT02927795|559778527|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
155093862|NCT02927795|559778527|FG000|Overall Study|Not Treated|4|||
155093863|NCT05525910|559778529|FG000|Period 4|Per sponsor due to study timelines|0|||
155093864|NCT05525910|559778530|FG001|Period 4|Per sponsor due to study timelines|0|||
155093865|NCT05525910|559778531|FG002|Period 4|Per sponsor due to study timelines|1|||
155093866|NCT05525910|559778532|FG003|Period 4|Per sponsor due to study timelines|1|||
155093867|NCT05525910|559778533|FG004|Period 4|Per sponsor due to study timelines|1|||
155093868|NCT00181844|559778535|FG000|Signed Consent|Withdrawal by Subject|5|||
155093869|NCT00181844|559778535|FG000|Signed Consent|Did not meet entrance criteria|7|||
155093870|NCT00181844|559778535|FG000|Exposed to Study Medication|Adverse Event|10|||
155093871|NCT00181844|559778535|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
155093872|NCT00181844|559778535|FG000|Exposed to Study Medication|Non-compliance|2|||
155093873|NCT00181844|559778535|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
155093874|NCT00181844|559778535|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
155093875|NCT00107276|559778537|FG000|Overall Study|Progression|46|||
155093876|NCT00107276|559778537|FG000|Overall Study|Adverse Event|6|||
155093877|NCT00107276|559778537|FG000|Overall Study|M.D. decision|2|||
155093878|NCT00107276|559778537|FG000|Overall Study|Patient refusal|1|||
155093879|NCT00107276|559778537|FG000|Overall Study|Death|1|||
155093880|NCT00107276|559778537|FG000|Overall Study|Ineligible|16|||
155093881|NCT04067011|559778538|FG000|Overall Study|Not Treated|8|||
155093882|NCT04067011|559778539|FG001|Overall Study|Not Treated|7|||
155093883|NCT04067011|559778540|FG002|Overall Study|Not Treated|5|||
155093884|NCT04067011|559778538|FG000|Overall Study|Adverse Event|2|||
155093885|NCT04067011|559778539|FG001|Overall Study|Adverse Event|1|||
155093886|NCT04067011|559778540|FG002|Overall Study|Adverse Event|0|||
155093887|NCT04067011|559778538|FG000|Overall Study|Withdrawal by Subject|6|||
155093888|NCT04067011|559778539|FG001|Overall Study|Withdrawal by Subject|2|||
155093889|NCT04067011|559778540|FG002|Overall Study|Withdrawal by Subject|1|||
155093890|NCT04067011|559778538|FG000|Overall Study|Lost to Follow-up|0|||
155093891|NCT04067011|559778539|FG001|Overall Study|Lost to Follow-up|0|||
155093892|NCT04067011|559778540|FG002|Overall Study|Lost to Follow-up|1|||
155093893|NCT04067011|559778538|FG000|Overall Study|Physician Decision|1|||
155093894|NCT04067011|559778539|FG001|Overall Study|Physician Decision|1|||
155093895|NCT04067011|559778540|FG002|Overall Study|Physician Decision|0|||
155093896|NCT04067011|559778538|FG000|Overall Study|Other Reasons|2|||
155093897|NCT04067011|559778539|FG001|Overall Study|Other Reasons|0|||
155093898|NCT04067011|559778540|FG002|Overall Study|Other Reasons|1|||
155093899|NCT04067011|559778538|FG000|Overall Study|Missing|0|||
155093900|NCT04067011|559778539|FG001|Overall Study|Missing|2|||
155093901|NCT04067011|559778540|FG002|Overall Study|Missing|0|||
155093902|NCT03179761|559778541|FG000|Overall Study|Death|2|||
155093903|NCT03179761|559778542|FG001|Overall Study|Death|5|||
155093904|NCT03179761|559778541|FG000|Overall Study|Lost to Follow-up|2|||
155093905|NCT03179761|559778542|FG001|Overall Study|Lost to Follow-up|2|||
155093906|NCT03179761|559778541|FG000|Overall Study|Protocol Violation|1|||
155093907|NCT03179761|559778542|FG001|Overall Study|Protocol Violation|0|||
155093908|NCT03179761|559778541|FG000|Overall Study|Withdrawal by Subject|1|||
155093909|NCT03179761|559778542|FG001|Overall Study|Withdrawal by Subject|4|||
155093910|NCT03179761|559778541|FG000|Overall Study|Investigator Request|0|||
155093911|NCT03179761|559778542|FG001|Overall Study|Investigator Request|2|||
155093912|NCT03440008|559778546|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
155093913|NCT03440008|559778547|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
155093914|NCT03440008|559778546|FG000|Overall Study|Withdrawal by Subject|1|||
155093915|NCT03440008|559778547|FG001|Overall Study|Withdrawal by Subject|0|||
155093916|NCT02170064|559778550|FG000|Overall Study|Withdrawal by Subject|5|||
155093917|NCT02170064|559778551|FG001|Overall Study|Withdrawal by Subject|1|||
155093918|NCT02170064|559778552|FG002|Overall Study|Withdrawal by Subject|1|||
155093919|NCT02170064|559778550|FG000|Overall Study|Physician Decision|1|||
155093920|NCT02170064|559778551|FG001|Overall Study|Physician Decision|1|||
155093921|NCT02170064|559778552|FG002|Overall Study|Physician Decision|0|||
155093922|NCT02359903|559778553|FG000|Overall Study|Adverse Event|0|||
155093923|NCT02359903|559778554|FG001|Overall Study|Adverse Event|2|||
155093924|NCT03507127|559778562|FG000|Overall Study|Withdrawal by Subject|1|||
155093925|NCT03507127|559778563|FG001|Overall Study|Withdrawal by Subject|0|||
155093926|NCT03507127|559778562|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
155093927|NCT03507127|559778563|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
155093928|NCT01240863|559778564|FG000|Open-label Titration Period|Adverse Event|47|||
155093929|NCT01240863|559778565|FG001|Open-label Titration Period|Adverse Event|0|||
155093930|NCT01240863|559778566|FG002|Open-label Titration Period|Adverse Event|0|||
155093931|NCT01240863|559778564|FG000|Open-label Titration Period|Lack of Efficacy|19|||
155093932|NCT01240863|559778565|FG001|Open-label Titration Period|Lack of Efficacy|0|||
155093933|NCT01240863|559778566|FG002|Open-label Titration Period|Lack of Efficacy|0|||
155093934|NCT01240863|559778564|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
155093935|NCT01240863|559778565|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
155093936|NCT01240863|559778566|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
155093937|NCT01240863|559778564|FG000|Open-label Titration Period|Protocol Violation|7|||
155093938|NCT01240863|559778565|FG001|Open-label Titration Period|Protocol Violation|0|||
155093939|NCT01240863|559778566|FG002|Open-label Titration Period|Protocol Violation|0|||
155093940|NCT01240863|559778564|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
155093941|NCT01240863|559778565|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
155093942|NCT01240863|559778566|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
155093943|NCT01240863|559778564|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
155093944|NCT01240863|559778565|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
155093945|NCT01240863|559778566|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
155093946|NCT01240863|559778564|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
155093947|NCT01240863|559778565|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
155093948|NCT01240863|559778566|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
155093949|NCT01240863|559778564|FG000|Open-label Titration Period|Other|7|||
155093950|NCT01240863|559778565|FG001|Open-label Titration Period|Other|0|||
155093951|NCT01240863|559778566|FG002|Open-label Titration Period|Other|0|||
155093952|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
155093953|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
155093954|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
155093955|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
155093956|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
155093957|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
155093958|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155093959|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
155093960|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
155170762|NCT01403948|560063767|FG004|Overall Study|Progressive disease|2|||
155170763|NCT01403948|560063768|FG005|Overall Study|Progressive disease|6|||
155093961|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
155170764|NCT01403948|560063769|FG006|Overall Study|Progressive disease|2|||
155170765|NCT01403948|560063770|FG007|Overall Study|Progressive disease|4|||
155093962|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
155093963|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
155093964|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
155093965|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
155093966|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
155170766|NCT01403948|560063771|FG008|Overall Study|Progressive disease|5|||
155170767|NCT01403948|560063772|FG009|Overall Study|Progressive disease|5|||
155170768|NCT01403948|560063763|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170769|NCT01403948|560063764|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170770|NCT01403948|560063765|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170771|NCT01403948|560063766|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170772|NCT01403948|560063767|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
155170773|NCT01403948|560063768|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170774|NCT01403948|560063769|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
155093967|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
155093968|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
155170775|NCT01403948|560063770|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170776|NCT01403948|560063771|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
155093969|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
155093970|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
155093971|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
155093972|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
155093973|NCT01240863|559778564|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
155093974|NCT01240863|559778565|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
155093975|NCT01240863|559778566|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
155093976|NCT00746811|559778569|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
155093977|NCT00746811|559778570|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
155093978|NCT00659425|559778571|FG000|Overall Study|Disease progression|1|||
155093979|NCT00659425|559778572|FG001|Overall Study|Disease progression|0|||
155093980|NCT00659425|559778573|FG002|Overall Study|Disease progression|0|||
155093981|NCT00659425|559778574|FG003|Overall Study|Disease progression|1|||
155093982|NCT00659425|559778575|FG004|Overall Study|Disease progression|0|||
155170777|NCT01403948|560063772|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
155170778|NCT01403948|560063763|FG000|Overall Study|Lost to Follow-up|0|||
155170779|NCT01403948|560063764|FG001|Overall Study|Lost to Follow-up|0|||
155170780|NCT01403948|560063765|FG002|Overall Study|Lost to Follow-up|0|||
155170781|NCT01403948|560063766|FG003|Overall Study|Lost to Follow-up|0|||
155170782|NCT01403948|560063767|FG004|Overall Study|Lost to Follow-up|0|||
155170783|NCT01403948|560063768|FG005|Overall Study|Lost to Follow-up|0|||
155170784|NCT01403948|560063769|FG006|Overall Study|Lost to Follow-up|0|||
155170785|NCT01403948|560063770|FG007|Overall Study|Lost to Follow-up|0|||
155170786|NCT01403948|560063771|FG008|Overall Study|Lost to Follow-up|0|||
155170787|NCT01403948|560063772|FG009|Overall Study|Lost to Follow-up|1|||
155170788|NCT01403948|560063763|FG000|Overall Study|Refused cont. medication|0|||
155170789|NCT01403948|560063764|FG001|Overall Study|Refused cont. medication|0|||
155170790|NCT01403948|560063765|FG002|Overall Study|Refused cont. medication|0|||
155170791|NCT01403948|560063766|FG003|Overall Study|Refused cont. medication|0|||
155170792|NCT01403948|560063767|FG004|Overall Study|Refused cont. medication|1|||
155093983|NCT00659425|559778576|FG005|Overall Study|Disease progression|2|||
155093984|NCT00659425|559778577|FG006|Overall Study|Disease progression|4|||
155093985|NCT00659425|559778578|FG007|Overall Study|Disease progression|3|||
155093986|NCT00659425|559778579|FG008|Overall Study|Disease progression|5|||
155093987|NCT00659425|559778580|FG009|Overall Study|Disease progression|3|||
155093988|NCT00659425|559778571|FG000|Overall Study|Death|0|||
155093989|NCT00659425|559778572|FG001|Overall Study|Death|0|||
155093990|NCT00659425|559778573|FG002|Overall Study|Death|0|||
155093991|NCT00659425|559778574|FG003|Overall Study|Death|1|||
155093992|NCT00659425|559778575|FG004|Overall Study|Death|0|||
154967401|NCT00624286|559303304|FG000|Overall Study|Lack of Efficacy|1|||
154967402|NCT00624286|559303305|FG001|Overall Study|Lack of Efficacy|6|||
154967403|NCT00624286|559303304|FG000|Overall Study|Not stated|0|||
154967404|NCT00624286|559303305|FG001|Overall Study|Not stated|1|||
154967405|NCT00624286|559303304|FG000|Overall Study|Abnormal test procedure result(s)|0|||
154967406|NCT00624286|559303305|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155093993|NCT00659425|559778576|FG005|Overall Study|Death|0|||
155093994|NCT00659425|559778577|FG006|Overall Study|Death|1|||
155093995|NCT00659425|559778578|FG007|Overall Study|Death|0|||
155093996|NCT00659425|559778579|FG008|Overall Study|Death|0|||
155093997|NCT00659425|559778580|FG009|Overall Study|Death|0|||
155093998|NCT00659425|559778571|FG000|Overall Study|Adverse Event|0|||
155093999|NCT00659425|559778572|FG001|Overall Study|Adverse Event|0|||
155094000|NCT00659425|559778573|FG002|Overall Study|Adverse Event|0|||
155094001|NCT00659425|559778574|FG003|Overall Study|Adverse Event|0|||
155094002|NCT00659425|559778575|FG004|Overall Study|Adverse Event|0|||
155094003|NCT00659425|559778576|FG005|Overall Study|Adverse Event|1|||
155094004|NCT00659425|559778577|FG006|Overall Study|Adverse Event|0|||
155094005|NCT00659425|559778578|FG007|Overall Study|Adverse Event|3|||
155094006|NCT00659425|559778579|FG008|Overall Study|Adverse Event|1|||
155094007|NCT00659425|559778580|FG009|Overall Study|Adverse Event|4|||
155094008|NCT00659425|559778571|FG000|Overall Study|Investigator Discretion|0|||
155094009|NCT00659425|559778572|FG001|Overall Study|Investigator Discretion|0|||
155094010|NCT00659425|559778573|FG002|Overall Study|Investigator Discretion|0|||
155094011|NCT00659425|559778574|FG003|Overall Study|Investigator Discretion|0|||
155094012|NCT00659425|559778575|FG004|Overall Study|Investigator Discretion|0|||
155094013|NCT00659425|559778576|FG005|Overall Study|Investigator Discretion|1|||
155094014|NCT00659425|559778577|FG006|Overall Study|Investigator Discretion|0|||
155094015|NCT00659425|559778578|FG007|Overall Study|Investigator Discretion|3|||
155094016|NCT00659425|559778579|FG008|Overall Study|Investigator Discretion|0|||
155094017|NCT00659425|559778580|FG009|Overall Study|Investigator Discretion|0|||
155094018|NCT00659425|559778571|FG000|Overall Study|Other|0|||
155094019|NCT00659425|559778572|FG001|Overall Study|Other|1|||
155094020|NCT00659425|559778573|FG002|Overall Study|Other|1|||
155094021|NCT00659425|559778574|FG003|Overall Study|Other|2|||
155094022|NCT00659425|559778575|FG004|Overall Study|Other|4|||
155094023|NCT00659425|559778576|FG005|Overall Study|Other|0|||
155094024|NCT00659425|559778577|FG006|Overall Study|Other|3|||
155094025|NCT00659425|559778578|FG007|Overall Study|Other|2|||
155094026|NCT00659425|559778579|FG008|Overall Study|Other|0|||
155094027|NCT00659425|559778580|FG009|Overall Study|Other|6|||
155094028|NCT02604511|559778581|FG000|Overall Study|Adverse Event|3|||
155094029|NCT02604511|559778581|FG000|Overall Study|Disease Progression|4|||
155094030|NCT02604511|559778581|FG000|Overall Study|Withdrawal by Subject|3|||
155094031|NCT02604511|559778581|FG000|Overall Study|Participant ineligible|1|||
155094032|NCT02604511|559778581|FG000|Overall Study|Intercurrent illness|1|||
155094033|NCT02505425|559778582|FG000|Overall Study|Lost to Follow-up|41|||
155094034|NCT02505425|559778583|FG001|Overall Study|Lost to Follow-up|61|||
155094035|NCT02505425|559778584|FG002|Overall Study|Lost to Follow-up|31|||
155094036|NCT02505425|559778585|FG003|Overall Study|Lost to Follow-up|19|||
155094037|NCT02505425|559778582|FG000|Overall Study|Withdrawal by Subject|39|||
155094038|NCT02505425|559778583|FG001|Overall Study|Withdrawal by Subject|9|||
155094039|NCT02505425|559778584|FG002|Overall Study|Withdrawal by Subject|19|||
155094040|NCT02505425|559778585|FG003|Overall Study|Withdrawal by Subject|7|||
155094041|NCT02505425|559778582|FG000|Overall Study|Death|8|||
155094042|NCT02505425|559778583|FG001|Overall Study|Death|12|||
155094043|NCT02505425|559778584|FG002|Overall Study|Death|0|||
155170793|NCT01403948|560063768|FG005|Overall Study|Refused cont. medication|0|||
155094044|NCT02505425|559778585|FG003|Overall Study|Death|0|||
155094045|NCT00545779|559778591|FG000|Overall Study|Violation of selection criteria at entry|8|||
155094046|NCT00545779|559778591|FG000|Overall Study|Other protocol violation|1|||
155170794|NCT01403948|560063769|FG006|Overall Study|Refused cont. medication|0|||
155170795|NCT01403948|560063770|FG007|Overall Study|Refused cont. medication|0|||
155094047|NCT00545779|559778591|FG000|Overall Study|Did not cooperate|7|||
155094048|NCT00545779|559778591|FG000|Overall Study|Withdrawal by Subject|20|||
155170796|NCT01403948|560063771|FG008|Overall Study|Refused cont. medication|0|||
155170797|NCT01403948|560063772|FG009|Overall Study|Refused cont. medication|1|||
155094049|NCT00545779|559778591|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
155094050|NCT00545779|559778591|FG000|Overall Study|Failure to return|3|||
155094051|NCT01405196|559778592|FG000|Overall Study|Study Terminated by Sponsor|0|||
155094052|NCT01405196|559778593|FG001|Overall Study|Study Terminated by Sponsor|0|||
155094053|NCT01405196|559778594|FG002|Overall Study|Study Terminated by Sponsor|9|||
155094054|NCT01405196|559778595|FG003|Overall Study|Study Terminated by Sponsor|0|||
155094055|NCT01405196|559778592|FG000|Overall Study|Other|2|||
155094056|NCT01405196|559778593|FG001|Overall Study|Other|2|||
155094057|NCT01405196|559778594|FG002|Overall Study|Other|5|||
155094058|NCT01405196|559778595|FG003|Overall Study|Other|0|||
155094059|NCT01405196|559778592|FG000|Overall Study|Withdrawal by Subject|4|||
155094060|NCT01405196|559778593|FG001|Overall Study|Withdrawal by Subject|6|||
155094061|NCT01405196|559778594|FG002|Overall Study|Withdrawal by Subject|3|||
155094062|NCT01405196|559778595|FG003|Overall Study|Withdrawal by Subject|6|||
155094063|NCT01405196|559778592|FG000|Overall Study|Adverse Event|2|||
155094064|NCT01405196|559778593|FG001|Overall Study|Adverse Event|2|||
155094065|NCT01405196|559778594|FG002|Overall Study|Adverse Event|0|||
155094066|NCT01405196|559778595|FG003|Overall Study|Adverse Event|2|||
155094067|NCT01405196|559778592|FG000|Overall Study|Death|1|||
155094068|NCT01405196|559778593|FG001|Overall Study|Death|0|||
155094069|NCT01405196|559778594|FG002|Overall Study|Death|3|||
155094070|NCT01405196|559778595|FG003|Overall Study|Death|0|||
155094071|NCT01405196|559778592|FG000|Overall Study|Lost to Follow-up|2|||
155094072|NCT01405196|559778593|FG001|Overall Study|Lost to Follow-up|2|||
155094073|NCT01405196|559778594|FG002|Overall Study|Lost to Follow-up|3|||
155094074|NCT01405196|559778595|FG003|Overall Study|Lost to Follow-up|1|||
155094075|NCT01542788|559778596|FG000|Overall Study|Randomized but Not Treated|2|||
155094076|NCT01542788|559778597|FG001|Overall Study|Randomized but Not Treated|0|||
155094077|NCT01542788|559778596|FG000|Overall Study|Lack of Efficacy|41|||
155094078|NCT01542788|559778597|FG001|Overall Study|Lack of Efficacy|71|||
155094079|NCT01542788|559778596|FG000|Overall Study|Lost to Follow-up|5|||
155094080|NCT01542788|559778597|FG001|Overall Study|Lost to Follow-up|0|||
155094081|NCT01542788|559778596|FG000|Overall Study|Death|3|||
155094082|NCT01542788|559778597|FG001|Overall Study|Death|0|||
155094083|NCT01542788|559778596|FG000|Overall Study|Protocol Violation|2|||
155094084|NCT01542788|559778597|FG001|Overall Study|Protocol Violation|0|||
155094085|NCT01542788|559778596|FG000|Overall Study|Physician Decision|1|||
155094086|NCT01542788|559778597|FG001|Overall Study|Physician Decision|0|||
155094087|NCT01542788|559778596|FG000|Overall Study|Withdrawal by Subject|1|||
155094088|NCT01542788|559778597|FG001|Overall Study|Withdrawal by Subject|0|||
155094089|NCT03802396|559778598|FG000|Overall Study|Withdrawal by Subject|2|||
155094090|NCT03802396|559778599|FG001|Overall Study|Withdrawal by Subject|0|||
155094091|NCT03802396|559778598|FG000|Overall Study|Surgery Cancelled|1|||
155094092|NCT03802396|559778599|FG001|Overall Study|Surgery Cancelled|0|||
155094093|NCT04577404|559778600|FG000|Overall Study|Adverse Event|31|||
155094094|NCT04577404|559778600|FG000|Overall Study|Death|1|||
155170798|NCT01403948|560063763|FG000|Overall Study|other than above|1|||
155094095|NCT04577404|559778600|FG000|Overall Study|Lack of Efficacy|3|||
155094096|NCT04577404|559778600|FG000|Overall Study|Physician Decision|7|||
155094097|NCT04577404|559778600|FG000|Overall Study|Withdrawal by Subject|21|||
155094098|NCT04577404|559778600|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
155094099|NCT02561962|559778610|FG000|Overall Study|Withdrawal by Subject|1|||
155094100|NCT02561962|559778611|FG001|Overall Study|Withdrawal by Subject|0|||
155094101|NCT02561962|559778612|FG002|Overall Study|Withdrawal by Subject|0|||
155094102|NCT02561962|559778613|FG003|Overall Study|Withdrawal by Subject|0|||
155094103|NCT02561962|559778614|FG004|Overall Study|Withdrawal by Subject|1|||
155094104|NCT02561962|559778615|FG005|Overall Study|Withdrawal by Subject|1|||
155094105|NCT02561962|559778616|FG006|Overall Study|Withdrawal by Subject|2|||
155094106|NCT02561962|559778617|FG007|Overall Study|Withdrawal by Subject|1|||
155094107|NCT02561962|559778618|FG008|Overall Study|Withdrawal by Subject|0|||
155094108|NCT02561962|559778610|FG000|Overall Study|Decision by sponsor|0|||
155094109|NCT02561962|559778611|FG001|Overall Study|Decision by sponsor|0|||
155094110|NCT02561962|559778612|FG002|Overall Study|Decision by sponsor|0|||
155094111|NCT02561962|559778613|FG003|Overall Study|Decision by sponsor|0|||
155094112|NCT02561962|559778614|FG004|Overall Study|Decision by sponsor|1|||
155094113|NCT02561962|559778615|FG005|Overall Study|Decision by sponsor|1|||
155094114|NCT02561962|559778616|FG006|Overall Study|Decision by sponsor|0|||
155094115|NCT02561962|559778617|FG007|Overall Study|Decision by sponsor|3|||
155094116|NCT02561962|559778618|FG008|Overall Study|Decision by sponsor|0|||
155094117|NCT02561962|559778610|FG000|Overall Study|Lost to Follow-up|0|||
155094118|NCT02561962|559778611|FG001|Overall Study|Lost to Follow-up|0|||
155094119|NCT02561962|559778612|FG002|Overall Study|Lost to Follow-up|0|||
155094120|NCT02561962|559778613|FG003|Overall Study|Lost to Follow-up|0|||
155094121|NCT02561962|559778614|FG004|Overall Study|Lost to Follow-up|0|||
155094122|NCT02561962|559778615|FG005|Overall Study|Lost to Follow-up|1|||
155094123|NCT02561962|559778616|FG006|Overall Study|Lost to Follow-up|0|||
155094124|NCT02561962|559778617|FG007|Overall Study|Lost to Follow-up|0|||
155094125|NCT02561962|559778618|FG008|Overall Study|Lost to Follow-up|0|||
155094126|NCT03586973|559778620|FG000|Overall Study|Death|15|||
155094127|NCT03586973|559778621|FG001|Overall Study|Death|8|||
155094128|NCT03586973|559778620|FG000|Overall Study|Site Terminated by Sponsor|3|||
155094129|NCT03586973|559778621|FG001|Overall Study|Site Terminated by Sponsor|6|||
155094130|NCT03586973|559778620|FG000|Overall Study|Withdrawal by Subject|1|||
155094131|NCT03586973|559778621|FG001|Overall Study|Withdrawal by Subject|0|||
155094132|NCT03586973|559778620|FG000|Overall Study|Lost to Follow-up|1|||
155094133|NCT03586973|559778621|FG001|Overall Study|Lost to Follow-up|0|||
155094134|NCT01150357|559778627|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
155094135|NCT01150357|559778628|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
155094136|NCT01150357|559778629|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
155094137|NCT01150357|559778627|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
155094138|NCT01150357|559778628|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
155094139|NCT01150357|559778629|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
155094140|NCT01150357|559778627|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
155094141|NCT01150357|559778628|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
155094142|NCT01150357|559778629|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
155094143|NCT01150357|559778627|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
155094144|NCT01150357|559778628|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
155094145|NCT01150357|559778629|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
155094146|NCT01150357|559778627|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
155094147|NCT01150357|559778628|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
155094148|NCT01150357|559778629|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
155094149|NCT01150357|559778627|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
155094150|NCT01150357|559778628|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
155094151|NCT01150357|559778629|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
155094152|NCT01150357|559778627|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
155094153|NCT01150357|559778628|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
155094154|NCT01150357|559778629|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
155094155|NCT03549338|559780328|FG000|Overall Study|Progressive Disease|1|||
155094156|NCT03549338|559780329|FG001|Overall Study|Progressive Disease|0|||
155094157|NCT03549338|559780330|FG002|Overall Study|Progressive Disease|0|||
155094158|NCT03549338|559780328|FG000|Overall Study|Clinical Progression|0|||
155094159|NCT03549338|559780329|FG001|Overall Study|Clinical Progression|1|||
155094160|NCT03549338|559780330|FG002|Overall Study|Clinical Progression|0|||
155094161|NCT01492426|559780331|FG000|Treatment|Death|0|||
155094162|NCT01492426|559780332|FG001|Treatment|Death|1|||
155094163|NCT01492426|559780331|FG000|Treatment|Other|1|||
155094164|NCT01492426|559780332|FG001|Treatment|Other|0|||
155094165|NCT01492426|559780331|FG000|Treatment|Adverse Event|25|||
155094166|NCT01492426|559780332|FG001|Treatment|Adverse Event|25|||
155094167|NCT01492426|559780331|FG000|Treatment|Lack of Efficacy|38|||
155094168|NCT01492426|559780332|FG001|Treatment|Lack of Efficacy|5|||
155094169|NCT01492426|559780331|FG000|Treatment|Participant withdrew consent|1|||
155094170|NCT01492426|559780332|FG001|Treatment|Participant withdrew consent|2|||
155094171|NCT01492426|559780331|FG000|Treatment|Poor compliance/noncompliance|1|||
154967407|NCT00624286|559303304|FG000|Overall Study|Death|0|||
154967408|NCT00624286|559303305|FG001|Overall Study|Death|1|||
154967409|NCT03488108|559303309|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
154967410|NCT03488108|559303310|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
154967411|NCT03488108|559303309|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
154967412|NCT03488108|559303310|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
154967413|NCT00863330|559303311|FG000|Overall Study|study terminated early due to administra|6|||
154967414|NCT02252016|559303312|FG000|Overall Study|Lost to Follow-up|2|||
154967415|NCT02252016|559303313|FG001|Overall Study|Lost to Follow-up|1|||
154967416|NCT02252016|559303312|FG000|Overall Study|Physician Decision|1|||
154967417|NCT02252016|559303313|FG001|Overall Study|Physician Decision|0|||
154967418|NCT02252016|559303312|FG000|Overall Study|Withdrawal by Subject|0|||
154967419|NCT02252016|559303313|FG001|Overall Study|Withdrawal by Subject|2|||
154967420|NCT00674128|559303314|FG000|Overall Study|Withdrawal by Subject|25|||
154967421|NCT00674128|559303315|FG001|Overall Study|Withdrawal by Subject|23|||
154967422|NCT04631562|559303318|FG000|Overall Study|Withdrawal by Subject|0|||
154967423|NCT04631562|559303319|FG001|Overall Study|Withdrawal by Subject|0|||
154967424|NCT04631562|559303320|FG002|Overall Study|Withdrawal by Subject|0|||
155170799|NCT01403948|560063764|FG001|Overall Study|other than above|2|||
155170800|NCT01403948|560063765|FG002|Overall Study|other than above|1|||
155170801|NCT01403948|560063766|FG003|Overall Study|other than above|0|||
155170802|NCT01403948|560063767|FG004|Overall Study|other than above|1|||
155170803|NCT01403948|560063768|FG005|Overall Study|other than above|1|||
155170804|NCT01403948|560063769|FG006|Overall Study|other than above|2|||
155170805|NCT01403948|560063770|FG007|Overall Study|other than above|0|||
155170806|NCT01403948|560063771|FG008|Overall Study|other than above|0|||
155170807|NCT01403948|560063772|FG009|Overall Study|other than above|0|||
155170808|NCT05498701|560063773|FG000|Period 3|Adverse Event|1|||
155170809|NCT05498701|560063774|FG001|Period 3|Adverse Event|0|||
155170810|NCT02424578|560063775|FG000|Overall Study|Withdrawal by Subject|0|||
155170811|NCT02424578|560063776|FG001|Overall Study|Withdrawal by Subject|1|||
155170812|NCT00862082|560063777|FG000|Overall Study|Sponsor decision to terminate the study|5|||
155170813|NCT00862082|560063778|FG001|Overall Study|Sponsor decision to terminate the study|0|||
155170814|NCT00862082|560063777|FG000|Overall Study|Withdrawal by Subject|0|||
155170815|NCT00862082|560063778|FG001|Overall Study|Withdrawal by Subject|1|||
155170816|NCT03179605|560063781|FG000|Overall Study|Withdrawal by Subject|1|||
155170817|NCT00711477|560063782|FG000|Overall Study|Adverse Event|3|||
155170818|NCT00711477|560063783|FG001|Overall Study|Adverse Event|1|||
155170819|NCT00711477|560063782|FG000|Overall Study|Lost to Follow-up|0|||
155170820|NCT00711477|560063783|FG001|Overall Study|Lost to Follow-up|1|||
155170821|NCT00711477|560063782|FG000|Overall Study|Noncompliance|0|||
155170822|NCT00711477|560063783|FG001|Overall Study|Noncompliance|1|||
155170823|NCT01396070|560063784|FG000|Overall Study|Withdrawal by Subject|2|||
155170824|NCT01396070|560063784|FG000|Overall Study|Death|2|||
155170825|NCT01396070|560063784|FG000|Overall Study|Adverse Event|8|||
155170826|NCT01396070|560063784|FG000|Overall Study|Physician Decision|3|||
155170827|NCT01396070|560063784|FG000|Overall Study|Lack of Efficacy|4|||
155170828|NCT04254913|560063786|FG000|Overall Study|Adverse Event|1|||
155170829|NCT01396057|560063787|FG000|Overall Study|Adverse Event|2|||
155170830|NCT01396057|560063788|FG001|Overall Study|Adverse Event|6|||
155170831|NCT01396057|560063787|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155170832|NCT01396057|560063788|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155170833|NCT01396057|560063787|FG000|Overall Study|Protocol deviation|4|||
155170834|NCT01396057|560063788|FG001|Overall Study|Protocol deviation|4|||
155170835|NCT01396057|560063787|FG000|Overall Study|Consent withdrawn|3|||
155170836|NCT01396057|560063788|FG001|Overall Study|Consent withdrawn|2|||
155170837|NCT01324401|560063789|FG000|Overall Study|Withdrawn before any treatment|0|||
155170838|NCT01324401|560063790|FG001|Overall Study|Withdrawn before any treatment|3|||
155170839|NCT01324401|560063789|FG000|Overall Study|Adverse Event|1|||
155170840|NCT01324401|560063790|FG001|Overall Study|Adverse Event|3|||
155170841|NCT02873429|560063793|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
155170842|NCT02873429|560063794|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
155170843|NCT02873429|560063793|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
155170844|NCT02873429|560063794|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
155170845|NCT02873429|560063793|FG000|16 Weeks|Lost to Follow-up|3|||
155170846|NCT02873429|560063794|FG001|16 Weeks|Lost to Follow-up|0|||
155170847|NCT00744042|560063795|FG000|Overall Study|Withdrawal by Subject|1|||
154967425|NCT04631562|559303321|FG003|Overall Study|Withdrawal by Subject|0|||
155094172|NCT01492426|559780332|FG001|Treatment|Poor compliance/noncompliance|0|||
155094173|NCT01492426|559780331|FG000|Treatment|Subject requested discontinue study drug|7|||
155094174|NCT01492426|559780332|FG001|Treatment|Subject requested discontinue study drug|3|||
155094175|NCT01492426|559780331|FG000|Treatment|Lost to Follow-up|9|||
155094176|NCT01492426|559780332|FG001|Treatment|Lost to Follow-up|4|||
155094177|NCT01492426|559780331|FG000|Treatment|Participant does not meet study criteria|1|||
155094178|NCT01492426|559780332|FG001|Treatment|Participant does not meet study criteria|0|||
155094179|NCT01492426|559780331|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
155094180|NCT01492426|559780332|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
155094181|NCT01492426|559780331|FG000|Follow-Up|Death|1|||
155094182|NCT01492426|559780332|FG001|Follow-Up|Death|0|||
155094183|NCT01492426|559780331|FG000|Follow-Up|Other|4|||
155094184|NCT01492426|559780332|FG001|Follow-Up|Other|2|||
155094185|NCT01492426|559780331|FG000|Follow-Up|Participant Withdrew Consent|6|||
155094186|NCT01492426|559780332|FG001|Follow-Up|Participant Withdrew Consent|1|||
155094187|NCT01492426|559780331|FG000|Follow-Up|Lost to Follow-up|12|||
155094188|NCT01492426|559780332|FG001|Follow-Up|Lost to Follow-up|6|||
155094189|NCT00269113|559780333|FG000|Overall Study|Adverse Event|14|||
155094190|NCT00269113|559780334|FG001|Overall Study|Adverse Event|7|||
155094191|NCT00269113|559780333|FG000|Overall Study|Lack of Efficacy|35|||
155094192|NCT00269113|559780334|FG001|Overall Study|Lack of Efficacy|18|||
155094193|NCT00269113|559780333|FG000|Overall Study|Early Improvement|2|||
155094194|NCT00269113|559780334|FG001|Overall Study|Early Improvement|0|||
155094195|NCT00269113|559780333|FG000|Overall Study|Withdrawal by Subject|0|||
155094196|NCT00269113|559780334|FG001|Overall Study|Withdrawal by Subject|2|||
155094197|NCT00269113|559780333|FG000|Overall Study|Death|6|||
155094198|NCT00269113|559780334|FG001|Overall Study|Death|2|||
155094199|NCT00269113|559780333|FG000|Overall Study|Lost to Follow-up|2|||
155094200|NCT00269113|559780334|FG001|Overall Study|Lost to Follow-up|1|||
155094201|NCT00269113|559780333|FG000|Overall Study|Protocol Violation|15|||
155094202|NCT00269113|559780334|FG001|Overall Study|Protocol Violation|5|||
155094203|NCT00269113|559780333|FG000|Overall Study|Other|0|||
155170848|NCT00853567|560063796|FG000|Overall Study|Study prematurely terminated|71|||
154967426|NCT04631562|559303322|FG004|Overall Study|Withdrawal by Subject|0|||
154967427|NCT04631562|559303323|FG005|Overall Study|Withdrawal by Subject|0|||
155094204|NCT00269113|559780334|FG001|Overall Study|Other|2|||
155094205|NCT01770743|559780335|FG000|Overall Study|Adverse Event|1|||
155094206|NCT01770743|559780336|FG001|Overall Study|Adverse Event|0|||
155094207|NCT01770743|559780337|FG002|Overall Study|Adverse Event|0|||
155094208|NCT01770743|559780338|FG003|Overall Study|Adverse Event|0|||
155094209|NCT01770743|559780339|FG004|Overall Study|Adverse Event|0|||
155094210|NCT01770743|559780335|FG000|Overall Study|Withdrawal by Subject|0|||
155094211|NCT01770743|559780336|FG001|Overall Study|Withdrawal by Subject|0|||
155094212|NCT01770743|559780337|FG002|Overall Study|Withdrawal by Subject|1|||
155094213|NCT01770743|559780338|FG003|Overall Study|Withdrawal by Subject|1|||
155094214|NCT01770743|559780339|FG004|Overall Study|Withdrawal by Subject|1|||
155094215|NCT01770743|559780335|FG000|Overall Study|Lost to Follow-up|0|||
155094216|NCT01770743|559780336|FG001|Overall Study|Lost to Follow-up|2|||
155094217|NCT01770743|559780337|FG002|Overall Study|Lost to Follow-up|0|||
155094218|NCT01770743|559780338|FG003|Overall Study|Lost to Follow-up|0|||
155094219|NCT01770743|559780339|FG004|Overall Study|Lost to Follow-up|1|||
155094220|NCT01770743|559780335|FG000|Overall Study|Sponsor Terminated Subject|1|||
155094221|NCT01770743|559780336|FG001|Overall Study|Sponsor Terminated Subject|0|||
155094222|NCT01770743|559780337|FG002|Overall Study|Sponsor Terminated Subject|0|||
155094223|NCT01770743|559780338|FG003|Overall Study|Sponsor Terminated Subject|1|||
155094224|NCT01770743|559780339|FG004|Overall Study|Sponsor Terminated Subject|0|||
155094225|NCT01770743|559780335|FG000|Overall Study|Moving Out of State|0|||
155094226|NCT01770743|559780336|FG001|Overall Study|Moving Out of State|1|||
155094227|NCT01770743|559780337|FG002|Overall Study|Moving Out of State|0|||
155094228|NCT01770743|559780338|FG003|Overall Study|Moving Out of State|0|||
155094229|NCT01770743|559780339|FG004|Overall Study|Moving Out of State|0|||
155094230|NCT00652743|559780342|FG000|Months 12-18|Lost to Follow-up|1|||
155094231|NCT00652743|559780343|FG001|Months 12-18|Lost to Follow-up|2|||
155094232|NCT00652743|559780344|FG002|Months 12-18|Lost to Follow-up|7|||
155094233|NCT00652743|559780342|FG000|Months 24-30|Other|5|||
155094234|NCT00652743|559780343|FG001|Months 24-30|Other|1|||
155094235|NCT00652743|559780344|FG002|Months 24-30|Other|11|||
155094236|NCT00652743|559780342|FG000|Months 36-42|Serious Adverse Events|0|||
155094237|NCT00652743|559780343|FG001|Months 36-42|Serious Adverse Events|1|||
155094238|NCT00652743|559780344|FG002|Months 36-42|Serious Adverse Events|1|||
155094239|NCT00652743|559780342|FG000|Months 36-42|Withdrawal by Subject|1|||
155094240|NCT00652743|559780343|FG001|Months 36-42|Withdrawal by Subject|1|||
155094241|NCT00652743|559780344|FG002|Months 36-42|Withdrawal by Subject|0|||
155094242|NCT00652743|559780342|FG000|Months 36-42|Lost to Follow-up|0|||
155094243|NCT00652743|559780343|FG001|Months 36-42|Lost to Follow-up|1|||
155094244|NCT00652743|559780344|FG002|Months 36-42|Lost to Follow-up|0|||
155094245|NCT00652743|559780342|FG000|Months 36-42|Migrated/moved from study area|1|||
155094246|NCT00652743|559780343|FG001|Months 36-42|Migrated/moved from study area|0|||
155094247|NCT00652743|559780344|FG002|Months 36-42|Migrated/moved from study area|0|||
155094248|NCT00652743|559780342|FG000|Months 36-42|Other|4|||
155094249|NCT00652743|559780343|FG001|Months 36-42|Other|2|||
155094250|NCT00652743|559780344|FG002|Months 36-42|Other|8|||
155094251|NCT01585025|559780349|FG000|Overall Study|Withdrawal by Subject|0|||
155094252|NCT01585025|559780350|FG001|Overall Study|Withdrawal by Subject|3|||
155094253|NCT01585025|559780351|FG002|Overall Study|Withdrawal by Subject|4|||
155094254|NCT00503984|559780352|FG000|Overall Study|Protocol Violation|0|||
155094255|NCT00503984|559780353|FG001|Overall Study|Protocol Violation|1|||
155094256|NCT00503984|559780354|FG002|Overall Study|Protocol Violation|0|||
155094257|NCT00503984|559780355|FG003|Overall Study|Protocol Violation|0|||
155094258|NCT00503984|559780356|FG004|Overall Study|Protocol Violation|0|||
155094259|NCT00503984|559780357|FG005|Overall Study|Protocol Violation|0|||
155094260|NCT00503984|559780352|FG000|Overall Study|Adverse Event|0|||
155094261|NCT00503984|559780353|FG001|Overall Study|Adverse Event|1|||
155094262|NCT00503984|559780354|FG002|Overall Study|Adverse Event|0|||
155094263|NCT00503984|559780355|FG003|Overall Study|Adverse Event|0|||
155094264|NCT00503984|559780356|FG004|Overall Study|Adverse Event|0|||
155094265|NCT00503984|559780357|FG005|Overall Study|Adverse Event|0|||
155094266|NCT00503984|559780352|FG000|Overall Study|Death|0|||
155094267|NCT00503984|559780353|FG001|Overall Study|Death|0|||
155094268|NCT00503984|559780354|FG002|Overall Study|Death|0|||
155094269|NCT00503984|559780355|FG003|Overall Study|Death|0|||
155170849|NCT02252939|560063800|FG000|Overall Study|Lost to Follow-up|3|||
155170850|NCT01033448|560063801|FG000|Overall Study|Withdrawal by Subject|4|||
155170851|NCT01033448|560063801|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
155170852|NCT01033448|560063801|FG000|Overall Study|Lost to Follow-up|3|||
155094270|NCT00503984|559780356|FG004|Overall Study|Death|1|||
155094271|NCT00503984|559780357|FG005|Overall Study|Death|0|||
155094272|NCT02122380|559780361|FG000|First Intervention (30 Days)|Adverse Event|1|||
155094273|NCT02122380|559780362|FG001|First Intervention (30 Days)|Adverse Event|0|||
155094274|NCT02122380|559780361|FG000|First Intervention (30 Days)|Physician Decision|0|||
155094275|NCT02122380|559780362|FG001|First Intervention (30 Days)|Physician Decision|1|||
155094276|NCT02122380|559780361|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
155094277|NCT02122380|559780362|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
155094278|NCT02122380|559780361|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
155094279|NCT02122380|559780362|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
155094280|NCT02122380|559780361|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
155094281|NCT02122380|559780362|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
155094282|NCT00952705|559780363|FG000|Overall Study|Lost to Follow-up|24|||
155170853|NCT01033448|560063801|FG000|Overall Study|Withdrew due to other reasons|3|||
155170854|NCT01033448|560063801|FG000|Overall Study|Unknown disposition|1|||
155170855|NCT02560025|560063802|FG000|Overall Study|Ineligible after consent/ registration|3|||
155170856|NCT02745080|560063807|FG000|Overall Study|Adverse Event|13|||
155094283|NCT00952705|559780364|FG001|Overall Study|Lost to Follow-up|8|||
155094284|NCT00952705|559780365|FG002|Overall Study|Lost to Follow-up|9|||
155094285|NCT00952705|559780363|FG000|Overall Study|Withdrawal by Subject|2|||
155094286|NCT00952705|559780364|FG001|Overall Study|Withdrawal by Subject|1|||
155094287|NCT00952705|559780365|FG002|Overall Study|Withdrawal by Subject|1|||
155094288|NCT00952705|559780363|FG000|Overall Study|Death|2|||
155094289|NCT00952705|559780364|FG001|Overall Study|Death|0|||
155094290|NCT00952705|559780365|FG002|Overall Study|Death|0|||
155094291|NCT00952705|559780363|FG000|Overall Study|Incarcerated post dose|5|||
155094292|NCT00952705|559780364|FG001|Overall Study|Incarcerated post dose|0|||
155094293|NCT00952705|559780365|FG002|Overall Study|Incarcerated post dose|0|||
154967428|NCT04631562|559303324|FG006|Overall Study|Withdrawal by Subject|0|||
154967429|NCT04631562|559303325|FG007|Overall Study|Withdrawal by Subject|1|||
154967430|NCT04631562|559303326|FG008|Overall Study|Withdrawal by Subject|0|||
155170857|NCT02745080|560063808|FG001|Overall Study|Adverse Event|21|||
155170858|NCT02745080|560063807|FG000|Overall Study|Lack of Efficacy|11|||
155170859|NCT02745080|560063808|FG001|Overall Study|Lack of Efficacy|23|||
155170860|NCT02745080|560063807|FG000|Overall Study|Lost to Follow-up|3|||
154967431|NCT04631562|559303318|FG000|Overall Study|Other|0|||
155094294|NCT00952705|559780363|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
155094295|NCT00952705|559780364|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
154967432|NCT04631562|559303319|FG001|Overall Study|Other|0|||
155094296|NCT00952705|559780365|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
155094297|NCT00140140|559780366|FG000|Overall Study|Unacceptable toxicity|1|||
155170861|NCT02745080|560063808|FG001|Overall Study|Lost to Follow-up|3|||
155094298|NCT00140140|559780367|FG001|Overall Study|Unacceptable toxicity|1|||
155094299|NCT00140140|559780368|FG002|Overall Study|Unacceptable toxicity|2|||
155094300|NCT00140140|559780366|FG000|Overall Study|Physician Decision|1|||
155094301|NCT00140140|559780367|FG001|Overall Study|Physician Decision|1|||
155094302|NCT00140140|559780368|FG002|Overall Study|Physician Decision|0|||
155094303|NCT00639457|559780369|FG000|Overall Study|Withdrawal by Subject|2|||
155094304|NCT00639457|559780370|FG001|Overall Study|Withdrawal by Subject|3|||
155094305|NCT01126190|559780371|FG000|Double-Blind Phase|Death|0|||
155094306|NCT01126190|559780372|FG001|Double-Blind Phase|Death|1|||
155094307|NCT01126190|559780373|FG002|Double-Blind Phase|Death|0|||
155094308|NCT01126190|559780371|FG000|Double-Blind Phase|Adverse Event|1|||
155094309|NCT01126190|559780372|FG001|Double-Blind Phase|Adverse Event|2|||
155094310|NCT01126190|559780373|FG002|Double-Blind Phase|Adverse Event|0|||
155094311|NCT01126190|559780371|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155094312|NCT01126190|559780372|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
155094313|NCT01126190|559780373|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155094314|NCT01126190|559780371|FG000|Double-Blind Phase|Request of Investigator|1|||
155170862|NCT02745080|560063807|FG000|Overall Study|Physician Decision|3|||
155094315|NCT01126190|559780372|FG001|Double-Blind Phase|Request of Investigator|0|||
155094316|NCT01126190|559780373|FG002|Double-Blind Phase|Request of Investigator|0|||
155094317|NCT01126190|559780371|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
155094318|NCT01126190|559780372|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
155094319|NCT01126190|559780373|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
155094320|NCT01126190|559780371|FG000|Double-Blind Phase|Non-compliance|1|||
155094321|NCT01126190|559780372|FG001|Double-Blind Phase|Non-compliance|0|||
155094322|NCT01126190|559780373|FG002|Double-Blind Phase|Non-compliance|0|||
155094323|NCT01126190|559780371|FG000|Double-Blind Phase|Lost to Follow-up|1|||
155094324|NCT01126190|559780372|FG001|Double-Blind Phase|Lost to Follow-up|3|||
155094325|NCT01126190|559780373|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155094326|NCT01126190|559780371|FG000|Open-Label Phase|Death|0|||
155170863|NCT02745080|560063808|FG001|Overall Study|Physician Decision|0|||
155170864|NCT02745080|560063807|FG000|Overall Study|Protocol Violation|3|||
155170865|NCT02745080|560063808|FG001|Overall Study|Protocol Violation|1|||
155094327|NCT01126190|559780372|FG001|Open-Label Phase|Death|0|||
155094328|NCT01126190|559780373|FG002|Open-Label Phase|Death|1|||
155094329|NCT01126190|559780371|FG000|Open-Label Phase|Adverse Event|0|||
155094330|NCT01126190|559780372|FG001|Open-Label Phase|Adverse Event|0|||
155094331|NCT01126190|559780373|FG002|Open-Label Phase|Adverse Event|4|||
155094332|NCT01126190|559780371|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155094333|NCT01126190|559780372|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155094334|NCT01126190|559780373|FG002|Open-Label Phase|Withdrawal by Subject|6|||
155094335|NCT01496287|559780374|FG000|Overall Study|Lost to Follow-up|1|||
155094336|NCT01496287|559780374|FG000|Overall Study|Incomplete anesthesia|5|||
155094337|NCT00329030|559780375|FG000|Overall Study|Withdrawal by Subject|1|||
155094338|NCT00329030|559780376|FG001|Overall Study|Withdrawal by Subject|3|||
155094339|NCT00329030|559780375|FG000|Overall Study|Progressive Disease|6|||
155094340|NCT00329030|559780376|FG001|Overall Study|Progressive Disease|2|||
155094341|NCT00329030|559780375|FG000|Overall Study|Ineligible Pathology|1|||
155094342|NCT00329030|559780376|FG001|Overall Study|Ineligible Pathology|1|||
155094343|NCT03036852|559780377|FG000|Overall Study|Death|2|||
155094344|NCT03036852|559780377|FG000|Overall Study|Lack of Efficacy|2|||
155094345|NCT03036852|559780377|FG000|Overall Study|Adverse Event|1|||
155094346|NCT03036852|559780377|FG000|Overall Study|Lost to Follow-up|1|||
155094347|NCT00399035|559780380|FG000|Overall Study|Death|289|||
155094348|NCT00399035|559780381|FG001|Overall Study|Death|141|||
155094349|NCT00399035|559780382|FG002|Overall Study|Death|234|||
155094350|NCT00399035|559780380|FG000|Overall Study|Lost to Follow-up|2|||
155094351|NCT00399035|559780381|FG001|Overall Study|Lost to Follow-up|1|||
155094352|NCT00399035|559780382|FG002|Overall Study|Lost to Follow-up|5|||
155170866|NCT02745080|560063807|FG000|Overall Study|Withdrawal by Subject|22|||
155170867|NCT02745080|560063808|FG001|Overall Study|Withdrawal by Subject|41|||
155170868|NCT04237116|560063810|FG000|Overall Study|Adverse Event|0|||
155170869|NCT04237116|560063811|FG001|Overall Study|Adverse Event|1|||
155094353|NCT00399035|559780380|FG000|Overall Study|Withdrawal by Subject|19|||
155094354|NCT00399035|559780381|FG001|Overall Study|Withdrawal by Subject|15|||
155094355|NCT00399035|559780382|FG002|Overall Study|Withdrawal by Subject|12|||
155094356|NCT00399035|559780380|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
155094357|NCT00399035|559780381|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
155094358|NCT00399035|559780382|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
155094359|NCT00399035|559780380|FG000|Overall Study|Severe non-compliance with protocol|2|||
155094360|NCT00399035|559780381|FG001|Overall Study|Severe non-compliance with protocol|1|||
155094361|NCT00399035|559780382|FG002|Overall Study|Severe non-compliance with protocol|0|||
155094362|NCT02949011|559780385|FG000|Overall Study|Adverse Event|6|||
155094363|NCT02949011|559780386|FG001|Overall Study|Adverse Event|7|||
155094364|NCT02949011|559780387|FG002|Overall Study|Adverse Event|3|||
155094365|NCT02949011|559780385|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155094366|NCT02949011|559780386|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155094367|NCT02949011|559780387|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
155094368|NCT02949011|559780385|FG000|Overall Study|Protocol Deviation|5|||
155094369|NCT02949011|559780386|FG001|Overall Study|Protocol Deviation|3|||
155094370|NCT02949011|559780387|FG002|Overall Study|Protocol Deviation|3|||
155094371|NCT02949011|559780385|FG000|Overall Study|Lack of Efficacy|0|||
155094372|NCT02949011|559780386|FG001|Overall Study|Lack of Efficacy|2|||
155094373|NCT02949011|559780387|FG002|Overall Study|Lack of Efficacy|0|||
155094374|NCT02949011|559780385|FG000|Overall Study|Withdrawal by Subject|13|||
155094375|NCT02949011|559780386|FG001|Overall Study|Withdrawal by Subject|13|||
155094376|NCT02949011|559780387|FG002|Overall Study|Withdrawal by Subject|21|||
155094377|NCT02949011|559780385|FG000|Overall Study|Lost to Follow-up|7|||
155094378|NCT02949011|559780386|FG001|Overall Study|Lost to Follow-up|5|||
155094379|NCT02949011|559780387|FG002|Overall Study|Lost to Follow-up|5|||
155094380|NCT02949011|559780385|FG000|Overall Study|Death|0|||
155094381|NCT02949011|559780386|FG001|Overall Study|Death|0|||
155094382|NCT02949011|559780387|FG002|Overall Study|Death|1|||
155094383|NCT02949011|559780385|FG000|Overall Study|Miscellaneous|2|||
155094384|NCT02949011|559780386|FG001|Overall Study|Miscellaneous|4|||
155094385|NCT02949011|559780387|FG002|Overall Study|Miscellaneous|6|||
155094386|NCT01541371|559780388|FG000|Overall Study|Withdrawal by Subject|14|||
155094387|NCT01541371|559780388|FG000|Overall Study|Lost to Follow-up|21|||
155094388|NCT01541371|559780388|FG000|Overall Study|Adverse Event|15|||
155094389|NCT01541371|559780388|FG000|Overall Study|Lack of Efficacy|12|||
155094390|NCT01541371|559780388|FG000|Overall Study|Protocol Violation|6|||
155094391|NCT01541371|559780388|FG000|Overall Study|Study medication non-compliance|3|||
155094392|NCT01541371|559780388|FG000|Overall Study|Other|6|||
155094393|NCT02441218|559780389|FG000|Overall Study|Death|503|||
155094394|NCT02441218|559780390|FG001|Overall Study|Death|553|||
155094395|NCT02441218|559780389|FG000|Overall Study|Withdrawal by Subject|73|||
155094396|NCT02441218|559780390|FG001|Overall Study|Withdrawal by Subject|58|||
155094397|NCT02441218|559780389|FG000|Overall Study|Lost to Follow-up|2|||
155094398|NCT02441218|559780390|FG001|Overall Study|Lost to Follow-up|1|||
155094399|NCT00163189|559780393|FG000|Overall Study|Other|6|||
155094400|NCT00163189|559780393|FG000|Overall Study|Lost to Follow-up|1|||
155094401|NCT00163189|559780393|FG000|Overall Study|Protocol Violation|2|||
155094402|NCT00163189|559780393|FG000|Overall Study|Death|3|||
155094403|NCT00163189|559780393|FG000|Overall Study|Adverse Event|6|||
155094404|NCT00163189|559780393|FG000|Overall Study|Lack of Efficacy|7|||
155094405|NCT00163189|559780393|FG000|Overall Study|Study terminated by sponsor|11|||
155094406|NCT00163189|559780393|FG000|Overall Study|Withdrawal by Subject|11|||
155094407|NCT00163189|559780393|FG000|Overall Study|Did not meet continuation criterion|16|||
155094408|NCT03435380|559780394|FG000|Overall Study|Death|1|||
155094409|NCT03435380|559780395|FG001|Overall Study|Death|2|||
155094410|NCT03435380|559780396|FG002|Overall Study|Death|1|||
155094411|NCT03435380|559780394|FG000|Overall Study|Lost to Follow-up|12|||
155094412|NCT03435380|559780395|FG001|Overall Study|Lost to Follow-up|8|||
155094413|NCT03435380|559780396|FG002|Overall Study|Lost to Follow-up|6|||
155094414|NCT03435380|559780394|FG000|Overall Study|Physician Decision|1|||
155094415|NCT03435380|559780395|FG001|Overall Study|Physician Decision|0|||
155094416|NCT03435380|559780396|FG002|Overall Study|Physician Decision|0|||
155094417|NCT03435380|559780394|FG000|Overall Study|Withdrawal by Subject|0|||
155094418|NCT03435380|559780395|FG001|Overall Study|Withdrawal by Subject|1|||
155094419|NCT03435380|559780396|FG002|Overall Study|Withdrawal by Subject|1|||
155094420|NCT03435380|559780394|FG000|Overall Study|Ineligible|0|||
155094421|NCT03435380|559780395|FG001|Overall Study|Ineligible|1|||
155094422|NCT03435380|559780396|FG002|Overall Study|Ineligible|1|||
155094423|NCT02431325|559780397|FG000|Overall Study|Adverse Event|3|||
155094424|NCT02431325|559780398|FG001|Overall Study|Adverse Event|0|||
155094425|NCT02431325|559780397|FG000|Overall Study|Lost to Follow-up|0|||
155094426|NCT02431325|559780398|FG001|Overall Study|Lost to Follow-up|1|||
155094427|NCT02431325|559780397|FG000|Overall Study|Withdrawal by Subject|1|||
155094428|NCT02431325|559780398|FG001|Overall Study|Withdrawal by Subject|2|||
155094429|NCT02431325|559780397|FG000|Overall Study|Declined to take study medication|1|||
155094430|NCT02431325|559780398|FG001|Overall Study|Declined to take study medication|0|||
155094431|NCT02431325|559780397|FG000|Overall Study|Withdrew before starting study medication|1|||
155094432|NCT02431325|559780398|FG001|Overall Study|Withdrew before starting study medication|0|||
155094433|NCT02431325|559780397|FG000|Overall Study|Placebo shortage|2|||
155094434|NCT02431325|559780398|FG001|Overall Study|Placebo shortage|0|||
155094435|NCT01917318|559780399|FG000|First Treatment|Withdrawal by Subject|0|||
155094436|NCT01917318|559780400|FG001|First Treatment|Withdrawal by Subject|1|||
155094437|NCT01008618|559780401|FG000|Period 1 (Titration Period)|Physician Decision|2|||
155094438|NCT01008618|559780402|FG001|Period 1 (Titration Period)|Physician Decision|0|||
155094439|NCT01008618|559780403|FG002|Period 1 (Titration Period)|Physician Decision|0|||
155094440|NCT01008618|559780401|FG000|Period 1 (Titration Period)|Adverse Event|33|||
155094441|NCT01008618|559780402|FG001|Period 1 (Titration Period)|Adverse Event|0|||
155094442|NCT01008618|559780403|FG002|Period 1 (Titration Period)|Adverse Event|0|||
155094443|NCT01008618|559780401|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
155094444|NCT01008618|559780402|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155094445|NCT01008618|559780403|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
155094446|NCT01008618|559780401|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
155094447|NCT01008618|559780402|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155094448|NCT01008618|559780403|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
155094449|NCT01008618|559780401|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
155094450|NCT01008618|559780402|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
155094451|NCT01008618|559780403|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
155094452|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
155094453|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
155094454|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
155094455|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
155094456|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
155094457|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
155094458|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
155094459|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
155094460|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
155094461|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
155094462|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
155094463|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
155094464|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155094465|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
155094466|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
155094467|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
155094468|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
155094469|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
155094470|NCT01008618|559780401|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
155094471|NCT01008618|559780402|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
155094472|NCT01008618|559780403|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
155094473|NCT01128569|559780404|FG000|Washout Period 1|Adverse Event|0|||
155094474|NCT01128569|559780405|FG001|Washout Period 1|Adverse Event|0|||
155094475|NCT01128569|559780406|FG002|Washout Period 1|Adverse Event|1|||
155094476|NCT01128569|559780407|FG003|Washout Period 1|Adverse Event|0|||
155094477|NCT01128569|559780408|FG004|Washout Period 1|Adverse Event|0|||
155094478|NCT01128569|559780409|FG005|Washout Period 1|Adverse Event|0|||
155094479|NCT01128569|559780404|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155094480|NCT01128569|559780405|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155094481|NCT01128569|559780406|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155094482|NCT01128569|559780407|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155094483|NCT01128569|559780408|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155094484|NCT01128569|559780409|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155094485|NCT00487981|559780410|FG000|Overall Study|Hypothyroidism diagnosis|1|||
155094486|NCT01865487|559780413|FG000|Overall Study|Lost to Follow-up|0|||
155094487|NCT01865487|559780414|FG001|Overall Study|Lost to Follow-up|0|||
155094488|NCT01865487|559780415|FG002|Overall Study|Lost to Follow-up|0|||
155094489|NCT01865487|559780416|FG003|Overall Study|Lost to Follow-up|1|||
155094490|NCT01865487|559780417|FG004|Overall Study|Lost to Follow-up|0|||
155094491|NCT01865487|559780418|FG005|Overall Study|Lost to Follow-up|0|||
155094492|NCT01865487|559780419|FG006|Overall Study|Lost to Follow-up|1|||
155094493|NCT01865487|559780420|FG007|Overall Study|Lost to Follow-up|0|||
155094494|NCT01865487|559780421|FG008|Overall Study|Lost to Follow-up|0|||
155094495|NCT01865487|559780422|FG009|Overall Study|Lost to Follow-up|0|||
155094496|NCT01865487|559780413|FG000|Overall Study|Withdrawal by Subject|0|||
155094497|NCT01865487|559780414|FG001|Overall Study|Withdrawal by Subject|0|||
155094498|NCT01865487|559780415|FG002|Overall Study|Withdrawal by Subject|0|||
155094499|NCT01865487|559780416|FG003|Overall Study|Withdrawal by Subject|0|||
155094500|NCT01865487|559780417|FG004|Overall Study|Withdrawal by Subject|1|||
155094501|NCT01865487|559780418|FG005|Overall Study|Withdrawal by Subject|0|||
155094502|NCT01865487|559780419|FG006|Overall Study|Withdrawal by Subject|0|||
155094503|NCT01865487|559780420|FG007|Overall Study|Withdrawal by Subject|0|||
155094504|NCT01865487|559780421|FG008|Overall Study|Withdrawal by Subject|0|||
155094505|NCT01865487|559780422|FG009|Overall Study|Withdrawal by Subject|0|||
155094506|NCT01627691|559780427|FG000|Overall Study|Death|11|||
155094507|NCT01627691|559780427|FG000|Overall Study|Lost to Follow-up|3|||
155094508|NCT01627691|559780427|FG000|Overall Study|Withdrawal by Subject|1|||
155094509|NCT01627691|559780427|FG000|Overall Study|Missed the visit|3|||
155094510|NCT01307449|559780428|FG000|Overall Study|Adverse Event|1|||
155094511|NCT01307449|559780429|FG001|Overall Study|Adverse Event|0|||
155094512|NCT01307449|559780430|FG002|Overall Study|Adverse Event|0|||
155094513|NCT01307449|559780431|FG003|Overall Study|Adverse Event|0|||
155094514|NCT01908140|559780432|FG000|Overall Study|Other or Progressive Disease|5|||
155094515|NCT01908140|559780433|FG001|Overall Study|Other or Progressive Disease|12|||
155094516|NCT01908140|559780432|FG000|Overall Study|Lack of Efficacy|7|||
155094517|NCT01908140|559780433|FG001|Overall Study|Lack of Efficacy|5|||
155094518|NCT01908140|559780432|FG000|Overall Study|Withdrawal by Subject|23|||
155094519|NCT01908140|559780433|FG001|Overall Study|Withdrawal by Subject|24|||
155094520|NCT01908140|559780432|FG000|Overall Study|Lost to Follow-up|1|||
155094521|NCT01908140|559780433|FG001|Overall Study|Lost to Follow-up|6|||
155094522|NCT01908140|559780432|FG000|Overall Study|Protocol Violation|8|||
155094523|NCT01908140|559780433|FG001|Overall Study|Protocol Violation|9|||
155094524|NCT01908140|559780432|FG000|Overall Study|Adverse Event|22|||
155094525|NCT01908140|559780433|FG001|Overall Study|Adverse Event|23|||
155094526|NCT03218917|559780434|FG000|Overall Study|Adverse Event|3|||
155094527|NCT03218917|559780435|FG001|Overall Study|Adverse Event|3|||
155094528|NCT03218917|559780436|FG002|Overall Study|Adverse Event|2|||
155094529|NCT03218917|559780434|FG000|Overall Study|Subject withdrew consent|2|||
155094530|NCT03218917|559780435|FG001|Overall Study|Subject withdrew consent|4|||
155094531|NCT03218917|559780436|FG002|Overall Study|Subject withdrew consent|10|||
155094532|NCT03218917|559780434|FG000|Overall Study|Physician Decision|0|||
155094533|NCT03218917|559780435|FG001|Overall Study|Physician Decision|1|||
155094534|NCT03218917|559780436|FG002|Overall Study|Physician Decision|1|||
155094535|NCT03218917|559780434|FG000|Overall Study|Lost to Follow-up|1|||
155094536|NCT03218917|559780435|FG001|Overall Study|Lost to Follow-up|0|||
155094537|NCT03218917|559780436|FG002|Overall Study|Lost to Follow-up|0|||
155094538|NCT03218917|559780434|FG000|Overall Study|Reason Missing|0|||
155094539|NCT03218917|559780435|FG001|Overall Study|Reason Missing|2|||
155094540|NCT03218917|559780436|FG002|Overall Study|Reason Missing|0|||
155094541|NCT03218917|559780434|FG000|Overall Study|Death|0|||
155094542|NCT03218917|559780435|FG001|Overall Study|Death|1|||
155094543|NCT03218917|559780436|FG002|Overall Study|Death|0|||
155094544|NCT03218917|559780434|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155094545|NCT03218917|559780435|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155094546|NCT03218917|559780436|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155094547|NCT00698828|559780439|FG000|Overall Study|Adverse Event|3|||
155094548|NCT00698828|559780440|FG001|Overall Study|Adverse Event|4|||
155094549|NCT00698828|559780441|FG002|Overall Study|Adverse Event|4|||
155094550|NCT00698828|559780439|FG000|Overall Study|Death|0|||
155094551|NCT00698828|559780440|FG001|Overall Study|Death|0|||
155094552|NCT00698828|559780441|FG002|Overall Study|Death|1|||
155094553|NCT00698828|559780439|FG000|Overall Study|Exacerbation of COPD|1|||
155094554|NCT00698828|559780440|FG001|Overall Study|Exacerbation of COPD|3|||
155094555|NCT00698828|559780441|FG002|Overall Study|Exacerbation of COPD|0|||
155094556|NCT00698828|559780439|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
155094557|NCT00698828|559780440|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
155094558|NCT00698828|559780441|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
155094559|NCT00698828|559780439|FG000|Overall Study|Investigator/Sponsor decision|1|||
155094560|NCT00698828|559780440|FG001|Overall Study|Investigator/Sponsor decision|0|||
155094561|NCT00698828|559780441|FG002|Overall Study|Investigator/Sponsor decision|2|||
155094562|NCT00698828|559780439|FG000|Overall Study|Lost to Follow-up|1|||
155094563|NCT00698828|559780440|FG001|Overall Study|Lost to Follow-up|1|||
155094564|NCT00698828|559780441|FG002|Overall Study|Lost to Follow-up|0|||
155094565|NCT00698828|559780439|FG000|Overall Study|Withdrew consent|0|||
155094566|NCT00698828|559780440|FG001|Overall Study|Withdrew consent|7|||
155094567|NCT00698828|559780441|FG002|Overall Study|Withdrew consent|4|||
155094568|NCT00698828|559780439|FG000|Overall Study|Withdrew consent (not treated)|2|||
155094569|NCT00698828|559780440|FG001|Overall Study|Withdrew consent (not treated)|0|||
155094570|NCT00698828|559780441|FG002|Overall Study|Withdrew consent (not treated)|0|||
155094571|NCT02013609|559780442|FG000|Overall Study|Withdrawal by Subject|9|||
155094572|NCT02013609|559780442|FG000|Overall Study|Lost to Follow-up|3|||
155094573|NCT02013609|559780442|FG000|Overall Study|Adverse Event|3|||
155094574|NCT02013609|559780442|FG000|Overall Study|Met Withdrawal Criteria|3|||
155094575|NCT01816295|559780443|FG000|Double Blind Phase|Adverse Event|11|||
155094576|NCT01816295|559780444|FG001|Double Blind Phase|Adverse Event|8|||
155094577|NCT01816295|559780443|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
155094578|NCT01816295|559780444|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
155094579|NCT01816295|559780443|FG000|Double Blind Phase|Lost to Follow-up|3|||
155094580|NCT01816295|559780444|FG001|Double Blind Phase|Lost to Follow-up|5|||
155094581|NCT01816295|559780443|FG000|Double Blind Phase|Physician Decision|2|||
155094582|NCT01816295|559780444|FG001|Double Blind Phase|Physician Decision|2|||
155094583|NCT01816295|559780443|FG000|Double Blind Phase|Protocol Violation|17|||
155094584|NCT01816295|559780444|FG001|Double Blind Phase|Protocol Violation|11|||
155094585|NCT01816295|559780443|FG000|Double Blind Phase|Sponsor Decision|8|||
155094586|NCT01816295|559780444|FG001|Double Blind Phase|Sponsor Decision|8|||
155094587|NCT01816295|559780443|FG000|Double Blind Phase|Withdrawal by Subject|22|||
155094588|NCT01816295|559780444|FG001|Double Blind Phase|Withdrawal by Subject|20|||
155170870|NCT04237116|560063810|FG000|Overall Study|Study terminated by Sponsor|4|||
155170871|NCT04237116|560063811|FG001|Overall Study|Study terminated by Sponsor|1|||
155170872|NCT01821560|560063812|FG000|Overall Study|Lost to Follow-up|5|||
155170873|NCT01821560|560063813|FG001|Overall Study|Lost to Follow-up|5|||
155170874|NCT01821560|560063812|FG000|Overall Study|Withdrawal by Subject|1|||
155170875|NCT01821560|560063813|FG001|Overall Study|Withdrawal by Subject|1|||
155170876|NCT01821560|560063812|FG000|Overall Study|Protocol Violation|0|||
155170877|NCT01821560|560063813|FG001|Overall Study|Protocol Violation|1|||
155170878|NCT04189224|560063815|FG000|Period 2|Adverse Event|0|||
155170879|NCT04189224|560063816|FG001|Period 2|Adverse Event|1|||
155170880|NCT05688670|560063817|FG000|Overall Study|Change in surgery plan|1|||
155170881|NCT05688670|560063818|FG001|Overall Study|Change in surgery plan|4|||
155170882|NCT05688670|560063817|FG000|Overall Study|Inability to extubate|1|||
155170883|NCT05688670|560063818|FG001|Overall Study|Inability to extubate|2|||
155170884|NCT05688670|560063817|FG000|Overall Study|Day of surgery cancellation|0|||
155170885|NCT05688670|560063818|FG001|Overall Study|Day of surgery cancellation|1|||
155170886|NCT05688670|560063817|FG000|Overall Study|Reintubated on PCICU arrival|0|||
155170887|NCT05688670|560063818|FG001|Overall Study|Reintubated on PCICU arrival|1|||
155170888|NCT00488683|560063819|FG000|Overall Study|Withdrawal by Subject|1|||
155170889|NCT00488683|560063820|FG001|Overall Study|Withdrawal by Subject|2|||
155170890|NCT00488683|560063821|FG002|Overall Study|Withdrawal by Subject|2|||
155170891|NCT00488683|560063819|FG000|Overall Study|Lost to Follow-up|5|||
155170892|NCT00488683|560063820|FG001|Overall Study|Lost to Follow-up|3|||
155170893|NCT00488683|560063821|FG002|Overall Study|Lost to Follow-up|0|||
155170894|NCT00488683|560063819|FG000|Overall Study|Protocol Violation|5|||
155170895|NCT00488683|560063820|FG001|Overall Study|Protocol Violation|1|||
155170896|NCT00488683|560063821|FG002|Overall Study|Protocol Violation|0|||
155170897|NCT00488683|560063819|FG000|Overall Study|Unable to Classify|1|||
155170898|NCT00488683|560063820|FG001|Overall Study|Unable to Classify|0|||
155170899|NCT00488683|560063821|FG002|Overall Study|Unable to Classify|0|||
155170900|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
155170901|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
155170902|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
155170903|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
155170904|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
155170905|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
155170906|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
155170907|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
155170908|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
155170909|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
155170910|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
155170911|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
155170912|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
155170913|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
155170914|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
155170915|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
155170916|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
155170917|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
155170918|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
155170919|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
155094589|NCT01816295|559780443|FG000|OLE Phase|Adverse Event|17|||
155094590|NCT01816295|559780444|FG001|OLE Phase|Adverse Event|15|||
155094591|NCT01816295|559780443|FG000|OLE Phase|Death|1|||
155094592|NCT01816295|559780444|FG001|OLE Phase|Death|0|||
155094593|NCT01816295|559780443|FG000|OLE Phase|Entry Criteria Not Met|3|||
155094594|NCT01816295|559780444|FG001|OLE Phase|Entry Criteria Not Met|5|||
155094595|NCT01816295|559780443|FG000|OLE Phase|Lost to Follow-up|5|||
155094596|NCT01816295|559780444|FG001|OLE Phase|Lost to Follow-up|5|||
154967433|NCT04631562|559303320|FG002|Overall Study|Other|0|||
155094597|NCT01816295|559780443|FG000|OLE Phase|Physician Decision|3|||
155094598|NCT01816295|559780444|FG001|OLE Phase|Physician Decision|1|||
155094599|NCT01816295|559780443|FG000|OLE Phase|Protocol Violation|4|||
155094600|NCT01816295|559780444|FG001|OLE Phase|Protocol Violation|4|||
155094601|NCT01816295|559780443|FG000|OLE Phase|Sponsor Decision|7|||
155170920|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
155170921|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
155170922|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
155094602|NCT01816295|559780444|FG001|OLE Phase|Sponsor Decision|9|||
155094603|NCT01816295|559780443|FG000|OLE Phase|Withdrawal by Subject|10|||
155170923|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
155170924|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
155170925|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
155170926|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
155170927|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
155094604|NCT01816295|559780444|FG001|OLE Phase|Withdrawal by Subject|10|||
155094605|NCT01816295|559780443|FG000|OLE Phase|Lack of Efficacy|3|||
155094606|NCT01816295|559780444|FG001|OLE Phase|Lack of Efficacy|7|||
155094607|NCT01119287|559780445|FG000|Overall Study|Patient Decision, not related to AE|0|||
155094608|NCT01119287|559780446|FG001|Overall Study|Patient Decision, not related to AE|0|||
155094609|NCT01119287|559780447|FG002|Overall Study|Patient Decision, not related to AE|2|||
155094610|NCT01119287|559780448|FG003|Overall Study|Patient Decision, not related to AE|2|||
155094611|NCT01119287|559780449|FG004|Overall Study|Patient Decision, not related to AE|1|||
155094612|NCT01119287|559780450|FG005|Overall Study|Patient Decision, not related to AE|0|||
155094613|NCT01534481|559780460|FG000|Overall Study|Lost to Follow-up|29|||
155094614|NCT01534481|559780461|FG001|Overall Study|Lost to Follow-up|24|||
155094615|NCT01534481|559780460|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
155094616|NCT01534481|559780461|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
155094617|NCT00945659|559780462|FG000|Overall Study|Lost to Follow-up|7|||
155094618|NCT00945659|559780463|FG001|Overall Study|Lost to Follow-up|20|||
155094619|NCT00945659|559780464|FG002|Overall Study|Lost to Follow-up|17|||
155094620|NCT05209386|559780465|FG000|Overall Study|Withdrawal by Subject|8|||
155094621|NCT05209386|559780465|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
155094622|NCT03498716|559780475|FG000|Overall Study|Withdrawal by Subject|88|||
155094623|NCT03498716|559780476|FG001|Overall Study|Withdrawal by Subject|73|||
155094624|NCT03498716|559780475|FG000|Overall Study|Study Terminated By Sponsor|933|||
155094625|NCT03498716|559780476|FG001|Overall Study|Study Terminated By Sponsor|927|||
155094626|NCT03498716|559780475|FG000|Overall Study|Lost to Follow-up|15|||
155094627|NCT03498716|559780476|FG001|Overall Study|Lost to Follow-up|26|||
155094628|NCT03498716|559780475|FG000|Overall Study|Disease Relapse|0|||
155094629|NCT03498716|559780476|FG001|Overall Study|Disease Relapse|1|||
155094630|NCT03498716|559780475|FG000|Overall Study|Death|58|||
155094631|NCT03498716|559780476|FG001|Overall Study|Death|72|||
155094632|NCT03498716|559780475|FG000|Overall Study|Physician Decision|4|||
155094633|NCT03498716|559780476|FG001|Overall Study|Physician Decision|2|||
155094634|NCT02284191|559780477|FG000|Overall Study|Withdrawal by Subject|1|||
155094635|NCT02284191|559780478|FG001|Overall Study|Withdrawal by Subject|3|||
155094636|NCT02284191|559780477|FG000|Overall Study|Lost to Follow-up|1|||
155094637|NCT02284191|559780478|FG001|Overall Study|Lost to Follow-up|0|||
155094638|NCT02257684|559780481|FG000|Overall Study|Adverse Event|2|||
155094639|NCT02257684|559780481|FG000|Overall Study|Lack of Efficacy|1|||
155094640|NCT02257684|559780481|FG000|Overall Study|Sponsor's Decision|1|||
155094641|NCT01448616|559780485|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
155094642|NCT01448616|559780486|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
155094643|NCT01448616|559780487|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
155094644|NCT01448616|559780488|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
155094645|NCT01448616|559780485|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
155094646|NCT01448616|559780486|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
155094647|NCT01448616|559780487|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
155094648|NCT01448616|559780488|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
155094649|NCT01448616|559780485|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
155094650|NCT01448616|559780486|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
155094651|NCT01448616|559780487|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
155094652|NCT01448616|559780488|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
155094653|NCT01448616|559780485|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
155094654|NCT01448616|559780486|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
155094655|NCT01448616|559780487|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
155094656|NCT01448616|559780488|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
155094657|NCT01448616|559780485|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
155094658|NCT01448616|559780486|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
155094659|NCT01448616|559780487|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
155094660|NCT01448616|559780488|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
155094661|NCT05788991|559780489|FG000|Overall Study|Not treated with study medication|1|||
155094662|NCT05788991|559780490|FG001|Overall Study|Not treated with study medication|3|||
155094663|NCT05788991|559780489|FG000|Overall Study|Withdrawal by Subject|1|||
155094664|NCT05788991|559780490|FG001|Overall Study|Withdrawal by Subject|0|||
155094665|NCT05788991|559780489|FG000|Overall Study|Lack of Efficacy|0|||
155094666|NCT05788991|559780490|FG001|Overall Study|Lack of Efficacy|1|||
155094667|NCT05788991|559780489|FG000|Overall Study|Protocol Violation|1|||
155094668|NCT05788991|559780490|FG001|Overall Study|Protocol Violation|2|||
155094669|NCT04712669|559780491|FG000|Double Blind Phase|Adverse Event|4|||
155094670|NCT04712669|559780492|FG001|Double Blind Phase|Adverse Event|4|||
155094671|NCT04712669|559780493|FG002|Double Blind Phase|Adverse Event|3|||
155094672|NCT04712669|559780494|FG003|Double Blind Phase|Adverse Event|0|||
155094673|NCT04712669|559780495|FG004|Double Blind Phase|Adverse Event|0|||
155094674|NCT04712669|559780496|FG005|Double Blind Phase|Adverse Event|0|||
155094675|NCT04712669|559780497|FG006|Double Blind Phase|Adverse Event|0|||
155094676|NCT04712669|559780498|FG007|Double Blind Phase|Adverse Event|0|||
155094677|NCT04712669|559780491|FG000|Double Blind Phase|Physician Decision|1|||
155094678|NCT04712669|559780492|FG001|Double Blind Phase|Physician Decision|0|||
155094679|NCT04712669|559780493|FG002|Double Blind Phase|Physician Decision|0|||
155094680|NCT04712669|559780494|FG003|Double Blind Phase|Physician Decision|0|||
155094681|NCT04712669|559780495|FG004|Double Blind Phase|Physician Decision|0|||
155094682|NCT04712669|559780496|FG005|Double Blind Phase|Physician Decision|0|||
155094683|NCT04712669|559780497|FG006|Double Blind Phase|Physician Decision|0|||
155094684|NCT04712669|559780498|FG007|Double Blind Phase|Physician Decision|0|||
155094685|NCT04712669|559780491|FG000|Double Blind Phase|Withdrawal by Subject|3|||
155094686|NCT04712669|559780492|FG001|Double Blind Phase|Withdrawal by Subject|6|||
155094687|NCT04712669|559780493|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155094688|NCT04712669|559780494|FG003|Double Blind Phase|Withdrawal by Subject|0|||
155094689|NCT04712669|559780495|FG004|Double Blind Phase|Withdrawal by Subject|0|||
155094690|NCT04712669|559780496|FG005|Double Blind Phase|Withdrawal by Subject|0|||
155094691|NCT04712669|559780497|FG006|Double Blind Phase|Withdrawal by Subject|0|||
155094692|NCT04712669|559780498|FG007|Double Blind Phase|Withdrawal by Subject|0|||
155094693|NCT04712669|559780491|FG000|Double Blind Phase|Termination by Sponsor|0|||
155094694|NCT04712669|559780492|FG001|Double Blind Phase|Termination by Sponsor|0|||
155094695|NCT04712669|559780493|FG002|Double Blind Phase|Termination by Sponsor|1|||
155094696|NCT04712669|559780494|FG003|Double Blind Phase|Termination by Sponsor|0|||
155094697|NCT04712669|559780495|FG004|Double Blind Phase|Termination by Sponsor|0|||
155094698|NCT04712669|559780496|FG005|Double Blind Phase|Termination by Sponsor|0|||
155094699|NCT04712669|559780497|FG006|Double Blind Phase|Termination by Sponsor|0|||
155094700|NCT04712669|559780498|FG007|Double Blind Phase|Termination by Sponsor|0|||
155094701|NCT04712669|559780491|FG000|Open Label Phase|Adverse Event|0|||
155094702|NCT04712669|559780492|FG001|Open Label Phase|Adverse Event|0|||
155094703|NCT04712669|559780493|FG002|Open Label Phase|Adverse Event|0|||
155094704|NCT04712669|559780494|FG003|Open Label Phase|Adverse Event|1|||
155094705|NCT04712669|559780495|FG004|Open Label Phase|Adverse Event|1|||
155094706|NCT04712669|559780496|FG005|Open Label Phase|Adverse Event|3|||
155094707|NCT04712669|559780497|FG006|Open Label Phase|Adverse Event|1|||
155094708|NCT04712669|559780498|FG007|Open Label Phase|Adverse Event|2|||
155094709|NCT04712669|559780491|FG000|Open Label Phase|Death|0|||
155094710|NCT04712669|559780492|FG001|Open Label Phase|Death|0|||
155094711|NCT04712669|559780493|FG002|Open Label Phase|Death|0|||
155094712|NCT04712669|559780494|FG003|Open Label Phase|Death|1|||
155094713|NCT04712669|559780495|FG004|Open Label Phase|Death|0|||
155094714|NCT04712669|559780496|FG005|Open Label Phase|Death|0|||
155094715|NCT04712669|559780497|FG006|Open Label Phase|Death|0|||
155094716|NCT04712669|559780498|FG007|Open Label Phase|Death|0|||
155094717|NCT04712669|559780491|FG000|Open Label Phase|Lack of Efficacy|0|||
155094718|NCT04712669|559780492|FG001|Open Label Phase|Lack of Efficacy|0|||
155094719|NCT04712669|559780493|FG002|Open Label Phase|Lack of Efficacy|0|||
155094720|NCT04712669|559780494|FG003|Open Label Phase|Lack of Efficacy|0|||
155094721|NCT04712669|559780495|FG004|Open Label Phase|Lack of Efficacy|1|||
155094722|NCT04712669|559780496|FG005|Open Label Phase|Lack of Efficacy|0|||
155094723|NCT04712669|559780497|FG006|Open Label Phase|Lack of Efficacy|0|||
155094724|NCT04712669|559780498|FG007|Open Label Phase|Lack of Efficacy|0|||
155094725|NCT04712669|559780491|FG000|Open Label Phase|Lost to Follow-up|0|||
155094726|NCT04712669|559780492|FG001|Open Label Phase|Lost to Follow-up|0|||
155094727|NCT04712669|559780493|FG002|Open Label Phase|Lost to Follow-up|0|||
155094728|NCT04712669|559780494|FG003|Open Label Phase|Lost to Follow-up|0|||
155094729|NCT04712669|559780495|FG004|Open Label Phase|Lost to Follow-up|0|||
155094730|NCT04712669|559780496|FG005|Open Label Phase|Lost to Follow-up|0|||
155094731|NCT04712669|559780497|FG006|Open Label Phase|Lost to Follow-up|1|||
155094732|NCT04712669|559780498|FG007|Open Label Phase|Lost to Follow-up|1|||
155094733|NCT04712669|559780491|FG000|Open Label Phase|Physician Decision|0|||
154967434|NCT04631562|559303321|FG003|Overall Study|Other|0|||
155094734|NCT04712669|559780492|FG001|Open Label Phase|Physician Decision|0|||
155094735|NCT04712669|559780493|FG002|Open Label Phase|Physician Decision|0|||
155094736|NCT04712669|559780494|FG003|Open Label Phase|Physician Decision|1|||
155094737|NCT04712669|559780495|FG004|Open Label Phase|Physician Decision|0|||
155094738|NCT04712669|559780496|FG005|Open Label Phase|Physician Decision|0|||
155094739|NCT04712669|559780497|FG006|Open Label Phase|Physician Decision|0|||
155094740|NCT04712669|559780498|FG007|Open Label Phase|Physician Decision|0|||
154967435|NCT04631562|559303322|FG004|Overall Study|Other|0|||
155094741|NCT04712669|559780491|FG000|Open Label Phase|Withdrawal by Subject|0|||
155170928|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
155170929|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
155170930|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
155170931|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
155170932|NCT03818035|560063822|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
155170933|NCT03818035|560063823|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
155170934|NCT03818035|560063824|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
155170935|NCT03818035|560063825|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
155170936|NCT03818035|560063822|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
155170937|NCT03818035|560063823|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
155170938|NCT03818035|560063824|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
155170939|NCT03818035|560063825|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
155170940|NCT03818035|560063822|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
155170941|NCT03818035|560063823|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
155170942|NCT03818035|560063824|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
155170943|NCT03818035|560063825|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
155170944|NCT03818035|560063822|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
155170945|NCT03818035|560063823|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
155170946|NCT03818035|560063824|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
155170947|NCT03818035|560063825|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
154967436|NCT04631562|559303323|FG005|Overall Study|Other|0|||
154967437|NCT04631562|559303324|FG006|Overall Study|Other|0|||
155094742|NCT04712669|559780492|FG001|Open Label Phase|Withdrawal by Subject|0|||
155094743|NCT04712669|559780493|FG002|Open Label Phase|Withdrawal by Subject|0|||
155094744|NCT04712669|559780494|FG003|Open Label Phase|Withdrawal by Subject|1|||
155094745|NCT04712669|559780495|FG004|Open Label Phase|Withdrawal by Subject|5|||
155094746|NCT04712669|559780496|FG005|Open Label Phase|Withdrawal by Subject|5|||
155094747|NCT04712669|559780497|FG006|Open Label Phase|Withdrawal by Subject|0|||
155094748|NCT04712669|559780498|FG007|Open Label Phase|Withdrawal by Subject|4|||
155094749|NCT04712669|559780491|FG000|Open Label Phase|Termination by Sponsor|0|||
155094750|NCT04712669|559780492|FG001|Open Label Phase|Termination by Sponsor|0|||
155094751|NCT04712669|559780493|FG002|Open Label Phase|Termination by Sponsor|0|||
155094752|NCT04712669|559780494|FG003|Open Label Phase|Termination by Sponsor|11|||
155094753|NCT04712669|559780495|FG004|Open Label Phase|Termination by Sponsor|9|||
155094754|NCT04712669|559780496|FG005|Open Label Phase|Termination by Sponsor|14|||
155094755|NCT04712669|559780497|FG006|Open Label Phase|Termination by Sponsor|0|||
155094756|NCT04712669|559780498|FG007|Open Label Phase|Termination by Sponsor|14|||
155094757|NCT04464473|559780499|FG000|Overall Study|New piercing could not be removed for scanning|0|||
155094758|NCT04464473|559780500|FG001|Overall Study|New piercing could not be removed for scanning|0|||
155094759|NCT04464473|559780501|FG002|Overall Study|New piercing could not be removed for scanning|0|||
155094760|NCT04464473|559780502|FG003|Overall Study|New piercing could not be removed for scanning|1|||
155094761|NCT04464473|559780503|FG004|Overall Study|New piercing could not be removed for scanning|0|||
155094762|NCT04464473|559780504|FG005|Overall Study|New piercing could not be removed for scanning|0|||
155094763|NCT04464473|559780499|FG000|Overall Study|Adverse Event|0|||
155094764|NCT04464473|559780500|FG001|Overall Study|Adverse Event|0|||
155094765|NCT04464473|559780501|FG002|Overall Study|Adverse Event|0|||
155094766|NCT04464473|559780502|FG003|Overall Study|Adverse Event|1|||
155094767|NCT04464473|559780503|FG004|Overall Study|Adverse Event|0|||
155094768|NCT04464473|559780504|FG005|Overall Study|Adverse Event|0|||
155094769|NCT04464473|559780499|FG000|Overall Study|Lost to Follow-up|0|||
155094770|NCT04464473|559780500|FG001|Overall Study|Lost to Follow-up|0|||
155094771|NCT04464473|559780501|FG002|Overall Study|Lost to Follow-up|0|||
155094772|NCT04464473|559780502|FG003|Overall Study|Lost to Follow-up|1|||
155094773|NCT04464473|559780503|FG004|Overall Study|Lost to Follow-up|0|||
155094774|NCT04464473|559780504|FG005|Overall Study|Lost to Follow-up|0|||
155094775|NCT01114737|559782043|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
155094776|NCT01114737|559782044|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
155094777|NCT01114737|559782043|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
155094778|NCT01114737|559782044|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
155094779|NCT01114737|559782043|FG000|Randomized Treatment Period|Pregnancy|1|||
155094780|NCT01114737|559782044|FG001|Randomized Treatment Period|Pregnancy|0|||
155094781|NCT01114737|559782043|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
155094782|NCT01114737|559782044|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
155094783|NCT01114737|559782043|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
155094784|NCT01114737|559782044|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
155094785|NCT01114737|559782043|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
155094786|NCT01114737|559782044|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
155094787|NCT02727322|559782047|FG000|Overall Study|Withdrawal by Subject|1|||
155094788|NCT02727322|559782048|FG001|Overall Study|Withdrawal by Subject|1|||
155094789|NCT02727322|559782047|FG000|Overall Study|Protocol Violation|1|||
155094790|NCT02727322|559782048|FG001|Overall Study|Protocol Violation|0|||
155094791|NCT01123148|559782049|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
155094792|NCT01123148|559782049|FG000|Overall Study|Didn't meet milestone criteria|1|||
155094793|NCT01693367|559782050|FG000|Overall Study|Withdrawal by Subject|1|||
155094794|NCT01693367|559782051|FG001|Overall Study|Withdrawal by Subject|1|||
155094795|NCT01693367|559782050|FG000|Overall Study|Physician Decision|0|||
155094796|NCT01693367|559782051|FG001|Overall Study|Physician Decision|1|||
155094797|NCT00325143|559782052|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
155094798|NCT00325143|559782052|FG000|Overall Study|Migrated/moved from study area|1|||
155094799|NCT00325143|559782052|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
155094800|NCT00325143|559782052|FG000|Overall Study|Withdrawal by Subject|8|||
155094801|NCT02286895|559782053|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
155170948|NCT03818035|560063822|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
155170949|NCT03818035|560063823|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
155170950|NCT03818035|560063824|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
155170951|NCT03818035|560063825|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
154967438|NCT04631562|559303325|FG007|Overall Study|Other|0|||
154967439|NCT04631562|559303326|FG008|Overall Study|Other|1|||
155094802|NCT02286895|559782054|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
155094803|NCT02286895|559782053|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
155094804|NCT02286895|559782054|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
155094805|NCT02286895|559782053|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
155094806|NCT02286895|559782054|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
155094807|NCT00256126|559782055|FG000|Overall Study|Adverse Event|1|||
155094808|NCT00256126|559782056|FG001|Overall Study|Adverse Event|0|||
155094809|NCT00256126|559782055|FG000|Overall Study|Other|1|||
155094810|NCT00256126|559782056|FG001|Overall Study|Other|2|||
155094811|NCT04108273|559782058|FG000|Overall Study|COVID Pandemic|1|||
155094812|NCT04108273|559782059|FG001|Overall Study|COVID Pandemic|0|||
155094813|NCT02154061|559782061|FG000|Overall Study|Pregnancy|1|||
155094814|NCT02154061|559782062|FG001|Overall Study|Pregnancy|0|||
155094815|NCT02154061|559782061|FG000|Overall Study|enrolled but not vaccinated|1|||
155094816|NCT02154061|559782062|FG001|Overall Study|enrolled but not vaccinated|0|||
155094817|NCT00506142|559782063|FG000|Overall Study|Adverse Event|8|||
155094818|NCT00506142|559782064|FG001|Overall Study|Adverse Event|7|||
155094819|NCT00506142|559782063|FG000|Overall Study|Lack of Efficacy|21|||
155094820|NCT00506142|559782064|FG001|Overall Study|Lack of Efficacy|7|||
155094821|NCT00506142|559782063|FG000|Overall Study|Withdrawal by Subject|4|||
155094822|NCT00506142|559782064|FG001|Overall Study|Withdrawal by Subject|5|||
155094823|NCT00506142|559782063|FG000|Overall Study|Physician Decision|1|||
155094824|NCT00506142|559782064|FG001|Overall Study|Physician Decision|0|||
155094825|NCT00506142|559782063|FG000|Overall Study|New health condition|1|||
155094826|NCT00506142|559782064|FG001|Overall Study|New health condition|0|||
155094827|NCT01936831|559782070|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094828|NCT01936831|559782071|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094829|NCT01936831|559782072|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094830|NCT01936831|559782073|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094831|NCT01936831|559782074|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094832|NCT01936831|559782075|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
155094833|NCT01936831|559782076|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094834|NCT01936831|559782077|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094835|NCT01936831|559782078|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
155094836|NCT00454116|559782079|FG000|Overall Study|Adverse Event|5|||
155094837|NCT00454116|559782080|FG001|Overall Study|Adverse Event|11|||
155094838|NCT00454116|559782081|FG002|Overall Study|Adverse Event|9|||
155094839|NCT00454116|559782079|FG000|Overall Study|Condition under investigation worsened|17|||
155094840|NCT00454116|559782080|FG001|Overall Study|Condition under investigation worsened|13|||
155094841|NCT00454116|559782081|FG002|Overall Study|Condition under investigation worsened|18|||
155094842|NCT00454116|559782079|FG000|Overall Study|Withdrawal by Subject|3|||
155094843|NCT00454116|559782080|FG001|Overall Study|Withdrawal by Subject|3|||
155094844|NCT00454116|559782081|FG002|Overall Study|Withdrawal by Subject|1|||
155094845|NCT00454116|559782079|FG000|Overall Study|Other|2|||
155094846|NCT00454116|559782080|FG001|Overall Study|Other|2|||
155094847|NCT00454116|559782081|FG002|Overall Study|Other|0|||
155094848|NCT03500211|559782086|FG000|Overall Study|Withdrawal by Subject|1|||
155094849|NCT03500211|559782087|FG001|Overall Study|Withdrawal by Subject|1|||
155094850|NCT04460183|559782088|FG000|Overall Study|Lost to Follow-up|3|||
155094851|NCT04460183|559782089|FG001|Overall Study|Lost to Follow-up|1|||
155094852|NCT04460183|559782088|FG000|Overall Study|Withdrawal by Subject|1|||
155094853|NCT04460183|559782089|FG001|Overall Study|Withdrawal by Subject|0|||
155094854|NCT01213082|559782090|FG000|Overall Study|Lost to Follow-up|6|||
155094855|NCT01213082|559782091|FG001|Overall Study|Lost to Follow-up|7|||
155094856|NCT01213082|559782092|FG002|Overall Study|Lost to Follow-up|4|||
155094857|NCT01213082|559782090|FG000|Overall Study|Physician Decision|0|||
155094858|NCT01213082|559782091|FG001|Overall Study|Physician Decision|0|||
155094859|NCT01213082|559782092|FG002|Overall Study|Physician Decision|1|||
155094860|NCT01570387|559782110|FG000|Overall Study|Adverse Event|1|||
155094861|NCT01570387|559782111|FG001|Overall Study|Adverse Event|0|||
155094862|NCT01570387|559782112|FG002|Overall Study|Adverse Event|0|||
155094863|NCT01570387|559782113|FG003|Overall Study|Adverse Event|0|||
155094864|NCT01570387|559782110|FG000|Overall Study|Death|0|||
155094865|NCT01570387|559782111|FG001|Overall Study|Death|0|||
155094866|NCT01570387|559782112|FG002|Overall Study|Death|0|||
155094867|NCT01570387|559782113|FG003|Overall Study|Death|1|||
155094868|NCT01570387|559782110|FG000|Overall Study|Withdrawal by Subject|0|||
155094869|NCT01570387|559782111|FG001|Overall Study|Withdrawal by Subject|0|||
155170952|NCT03818035|560063822|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
155170953|NCT03818035|560063823|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
155170954|NCT03818035|560063824|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
155170955|NCT03818035|560063825|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
155170956|NCT03818035|560063822|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
155170957|NCT03818035|560063823|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
155170958|NCT03818035|560063824|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
155170959|NCT03818035|560063825|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
155170960|NCT03700684|560065285|FG000|Overall Study|COVID-19|0|||
155170961|NCT03700684|560065286|FG001|Overall Study|COVID-19|0|||
155170962|NCT03700684|560065287|FG002|Overall Study|COVID-19|2|||
155170963|NCT01120782|560065288|FG000|Overall Study|Test article shipping error|11|||
155170964|NCT04140227|560065289|FG000|Overall Study|Withdrawal by Subject|26|||
155170965|NCT04140227|560065289|FG000|Overall Study|Lost to Follow-up|8|||
155170966|NCT04140227|560065289|FG000|Overall Study|Adverse Event|8|||
155170967|NCT04140227|560065289|FG000|Overall Study|Death|1|||
155170968|NCT04140227|560065289|FG000|Overall Study|Other|3|||
155170969|NCT04140227|560065289|FG000|Overall Study|Protocol Violation|2|||
155170970|NCT04145219|560065290|FG000|Overall Study|Adverse Event|18|||
155170971|NCT04145219|560065291|FG001|Overall Study|Adverse Event|6|||
155170972|NCT04145219|560065290|FG000|Overall Study|Lost to Follow-up|2|||
155170973|NCT04145219|560065291|FG001|Overall Study|Lost to Follow-up|3|||
155170974|NCT04145219|560065290|FG000|Overall Study|Physician Decision|0|||
155170975|NCT04145219|560065291|FG001|Overall Study|Physician Decision|2|||
155170976|NCT04145219|560065290|FG000|Overall Study|Withdrawal by Subject|12|||
155170977|NCT04145219|560065291|FG001|Overall Study|Withdrawal by Subject|8|||
155170978|NCT04145219|560065290|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
155170979|NCT04145219|560065291|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
155170980|NCT01640314|560065292|FG000|Overall Study|Protocol Violation|0|||
155170981|NCT01640314|560065293|FG001|Overall Study|Protocol Violation|1|||
155170982|NCT03672097|560065294|FG000|Period 1|Withdrawal by Subject|2|||
155170983|NCT03672097|560065294|FG000|Period 1|Adverse Event|1|||
155170984|NCT03672097|560065294|FG000|Period 1|Did not receive treatment|1|||
155170985|NCT03672097|560065294|FG000|Period 2|Withdrawal by Subject|3|||
155094870|NCT01570387|559782112|FG002|Overall Study|Withdrawal by Subject|0|||
155094871|NCT01570387|559782113|FG003|Overall Study|Withdrawal by Subject|1|||
155094872|NCT03139448|559782114|FG000|Overall Study|Lack of Efficacy|6|||
155094873|NCT03139448|559782115|FG001|Overall Study|Lack of Efficacy|7|||
155094874|NCT03139448|559782114|FG000|Overall Study|Location of procedure changed|2|||
155094875|NCT03139448|559782115|FG001|Overall Study|Location of procedure changed|8|||
155094876|NCT03139448|559782114|FG000|Overall Study|Withdrawal by Subject|3|||
155094877|NCT03139448|559782115|FG001|Overall Study|Withdrawal by Subject|6|||
155094878|NCT03139448|559782114|FG000|Overall Study|Screen fail|1|||
155094879|NCT03139448|559782115|FG001|Overall Study|Screen fail|3|||
155094880|NCT03139448|559782114|FG000|Overall Study|Physician Decision|0|||
155094881|NCT03139448|559782115|FG001|Overall Study|Physician Decision|2|||
155094882|NCT01987557|559782116|FG000|Overall Study|Protocol Violation|1|||
155094883|NCT01987557|559782117|FG001|Overall Study|Protocol Violation|0|||
155094884|NCT01987557|559782118|FG002|Overall Study|Protocol Violation|1|||
155094885|NCT01987557|559782116|FG000|Overall Study|Withdrawal by Subject|2|||
155094886|NCT01987557|559782117|FG001|Overall Study|Withdrawal by Subject|1|||
155094887|NCT01987557|559782118|FG002|Overall Study|Withdrawal by Subject|2|||
155094888|NCT01987557|559782116|FG000|Overall Study|Adverse Event|0|||
155094889|NCT01987557|559782117|FG001|Overall Study|Adverse Event|2|||
155094890|NCT01987557|559782118|FG002|Overall Study|Adverse Event|0|||
155094891|NCT01832727|559782126|FG000|Overall Study|Adverse Event|4|||
155094892|NCT01832727|559782127|FG001|Overall Study|Adverse Event|6|||
155170986|NCT03672097|560065294|FG000|Period 2|Other|1|||
155094893|NCT01832727|559782128|FG002|Overall Study|Adverse Event|1|||
155094894|NCT01832727|559782129|FG003|Overall Study|Adverse Event|0|||
155094895|NCT01832727|559782130|FG004|Overall Study|Adverse Event|1|||
155094896|NCT01832727|559782131|FG005|Overall Study|Adverse Event|1|||
155094897|NCT01832727|559782132|FG006|Overall Study|Adverse Event|2|||
155094898|NCT01832727|559782133|FG007|Overall Study|Adverse Event|1|||
155094899|NCT01832727|559782134|FG008|Overall Study|Adverse Event|9|||
155094900|NCT01832727|559782126|FG000|Overall Study|Disease progression|3|||
155094901|NCT01832727|559782127|FG001|Overall Study|Disease progression|0|||
155094902|NCT01832727|559782128|FG002|Overall Study|Disease progression|2|||
155094903|NCT01832727|559782129|FG003|Overall Study|Disease progression|1|||
155094904|NCT01832727|559782130|FG004|Overall Study|Disease progression|3|||
155094905|NCT01832727|559782131|FG005|Overall Study|Disease progression|3|||
155094906|NCT01832727|559782132|FG006|Overall Study|Disease progression|6|||
155094907|NCT01832727|559782133|FG007|Overall Study|Disease progression|2|||
155094908|NCT01832727|559782134|FG008|Overall Study|Disease progression|7|||
155094909|NCT01832727|559782126|FG000|Overall Study|Lost to Follow-up|0|||
155094910|NCT01832727|559782127|FG001|Overall Study|Lost to Follow-up|0|||
155094911|NCT01832727|559782128|FG002|Overall Study|Lost to Follow-up|0|||
155094912|NCT01832727|559782129|FG003|Overall Study|Lost to Follow-up|1|||
155094913|NCT01832727|559782130|FG004|Overall Study|Lost to Follow-up|0|||
155094914|NCT01832727|559782131|FG005|Overall Study|Lost to Follow-up|0|||
155094915|NCT01832727|559782132|FG006|Overall Study|Lost to Follow-up|0|||
155094916|NCT01832727|559782133|FG007|Overall Study|Lost to Follow-up|0|||
155094917|NCT01832727|559782134|FG008|Overall Study|Lost to Follow-up|0|||
155094918|NCT01832727|559782126|FG000|Overall Study|Physician Decision|1|||
155094919|NCT01832727|559782127|FG001|Overall Study|Physician Decision|0|||
155094920|NCT01832727|559782128|FG002|Overall Study|Physician Decision|0|||
155094921|NCT01832727|559782129|FG003|Overall Study|Physician Decision|1|||
155094922|NCT01832727|559782130|FG004|Overall Study|Physician Decision|0|||
155094923|NCT01832727|559782131|FG005|Overall Study|Physician Decision|1|||
155094924|NCT01832727|559782132|FG006|Overall Study|Physician Decision|0|||
155094925|NCT01832727|559782133|FG007|Overall Study|Physician Decision|0|||
155094926|NCT01832727|559782134|FG008|Overall Study|Physician Decision|0|||
155094927|NCT01832727|559782126|FG000|Overall Study|Withdrawal by Subject|1|||
155094928|NCT01832727|559782127|FG001|Overall Study|Withdrawal by Subject|1|||
155094929|NCT01832727|559782128|FG002|Overall Study|Withdrawal by Subject|0|||
155094930|NCT01832727|559782129|FG003|Overall Study|Withdrawal by Subject|1|||
155094931|NCT01832727|559782130|FG004|Overall Study|Withdrawal by Subject|0|||
155094932|NCT01832727|559782131|FG005|Overall Study|Withdrawal by Subject|1|||
155094933|NCT01832727|559782132|FG006|Overall Study|Withdrawal by Subject|0|||
155094934|NCT01832727|559782133|FG007|Overall Study|Withdrawal by Subject|2|||
155094935|NCT01832727|559782134|FG008|Overall Study|Withdrawal by Subject|1|||
155094936|NCT01832727|559782126|FG000|Overall Study|Study terminated by sponsor|0|||
155094937|NCT01832727|559782127|FG001|Overall Study|Study terminated by sponsor|0|||
155094938|NCT01832727|559782128|FG002|Overall Study|Study terminated by sponsor|0|||
155170987|NCT01290796|560065295|FG000|Overall Study|Lost to Follow-up|21|||
155170988|NCT01290796|560065295|FG000|Overall Study|Withdrawal by Subject|4|||
155094939|NCT01832727|559782129|FG003|Overall Study|Study terminated by sponsor|0|||
155094940|NCT01832727|559782130|FG004|Overall Study|Study terminated by sponsor|0|||
155094941|NCT01832727|559782131|FG005|Overall Study|Study terminated by sponsor|0|||
155094942|NCT01832727|559782132|FG006|Overall Study|Study terminated by sponsor|0|||
155094943|NCT01832727|559782133|FG007|Overall Study|Study terminated by sponsor|1|||
155094944|NCT01832727|559782134|FG008|Overall Study|Study terminated by sponsor|1|||
155094945|NCT03323164|559782135|FG000|Overall Study|Poor quality imaging/scans|2|||
155094946|NCT03323164|559782136|FG001|Overall Study|Poor quality imaging/scans|2|||
155094947|NCT00461708|559782139|FG000|Overall Study|Adverse Event|17|||
155094948|NCT00461708|559782140|FG001|Overall Study|Adverse Event|7|||
154967440|NCT04631562|559303318|FG000|Overall Study|Lost to Follow-up|0|||
154967441|NCT04631562|559303319|FG001|Overall Study|Lost to Follow-up|0|||
154967442|NCT04631562|559303320|FG002|Overall Study|Lost to Follow-up|0|||
155094949|NCT00461708|559782139|FG000|Overall Study|Lack of Efficacy|68|||
155094950|NCT00461708|559782140|FG001|Overall Study|Lack of Efficacy|20|||
155094951|NCT00461708|559782139|FG000|Overall Study|Physician Decision|10|||
155094952|NCT00461708|559782140|FG001|Overall Study|Physician Decision|4|||
155094953|NCT00461708|559782139|FG000|Overall Study|Withdrawal by Subject|8|||
155094954|NCT00461708|559782140|FG001|Overall Study|Withdrawal by Subject|2|||
155094955|NCT00461708|559782139|FG000|Overall Study|Other|4|||
155094956|NCT00461708|559782140|FG001|Overall Study|Other|4|||
155094957|NCT00461708|559782139|FG000|Overall Study|Death|8|||
155094958|NCT00461708|559782140|FG001|Overall Study|Death|1|||
155094959|NCT02394561|559782141|FG000|CORE Phase|Adverse Event|7|||
155094960|NCT02394561|559782142|FG001|CORE Phase|Adverse Event|9|||
155094961|NCT02394561|559782141|FG000|CORE Phase|Death|0|||
155094962|NCT02394561|559782142|FG001|CORE Phase|Death|1|||
155094963|NCT02394561|559782141|FG000|CORE Phase|Pregnancy|1|||
155094964|NCT02394561|559782142|FG001|CORE Phase|Pregnancy|0|||
155094965|NCT02394561|559782141|FG000|CORE Phase|Lost to Follow-up|1|||
155094966|NCT02394561|559782142|FG001|CORE Phase|Lost to Follow-up|0|||
155094967|NCT02394561|559782141|FG000|CORE Phase|Physician Decision|1|||
155094968|NCT02394561|559782142|FG001|CORE Phase|Physician Decision|1|||
155094969|NCT02394561|559782141|FG000|CORE Phase|Withdrawal by Subject|2|||
155094970|NCT02394561|559782142|FG001|CORE Phase|Withdrawal by Subject|2|||
155094971|NCT02394561|559782141|FG000|CORE Phase|Lack of Efficacy|1|||
155094972|NCT02394561|559782142|FG001|CORE Phase|Lack of Efficacy|6|||
155094973|NCT02394561|559782141|FG000|Extension Phase|Adverse Event|6|||
155094974|NCT02394561|559782142|FG001|Extension Phase|Adverse Event|1|||
155094975|NCT02394561|559782141|FG000|Extension Phase|Death|0|||
155094976|NCT02394561|559782142|FG001|Extension Phase|Death|1|||
155094977|NCT02394561|559782141|FG000|Extension Phase|Protocol Violation|1|||
155094978|NCT02394561|559782142|FG001|Extension Phase|Protocol Violation|0|||
155094979|NCT02394561|559782141|FG000|Extension Phase|Lost to Follow-up|1|||
155094980|NCT02394561|559782142|FG001|Extension Phase|Lost to Follow-up|0|||
155094981|NCT02394561|559782141|FG000|Extension Phase|Physician Decision|0|||
155094982|NCT02394561|559782142|FG001|Extension Phase|Physician Decision|2|||
155094983|NCT02394561|559782141|FG000|Extension Phase|Withdrawal by Subject|0|||
155094984|NCT02394561|559782142|FG001|Extension Phase|Withdrawal by Subject|5|||
155094985|NCT02394561|559782141|FG000|Extension Phase|Lack of Efficacy|3|||
155094986|NCT02394561|559782142|FG001|Extension Phase|Lack of Efficacy|3|||
155094987|NCT00501644|559782143|FG000|Overall Study|Adverse Event|4|||
155094988|NCT00501644|559782143|FG000|Overall Study|Withdrawal by Subject|1|||
155094989|NCT02553629|559782144|FG000|Overall Study|Logistic reasons|3|||
155094990|NCT02553629|559782145|FG001|Overall Study|Logistic reasons|6|||
155094991|NCT01812057|559782153|FG000|Overall Study|Protocol Violation|1|||
155094992|NCT01812057|559782154|FG001|Overall Study|Protocol Violation|0|||
155094993|NCT01812057|559782153|FG000|Overall Study|Physician Decision|1|||
155094994|NCT01812057|559782154|FG001|Overall Study|Physician Decision|0|||
155094995|NCT00654732|559782157|FG000|Overall Study|Adverse Event|4|||
155094996|NCT00654732|559782158|FG001|Overall Study|Adverse Event|6|||
155094997|NCT03710889|559782173|FG000|Overall Study|Adverse Event|2|||
155094998|NCT03710889|559782173|FG000|Overall Study|Protocol Deviation|1|||
155094999|NCT00421148|559782174|FG000|Overall Study|Lost to Follow-up|0|||
155095000|NCT00421148|559782175|FG001|Overall Study|Lost to Follow-up|0|||
155095001|NCT00421148|559782176|FG002|Overall Study|Lost to Follow-up|0|||
155095002|NCT00421148|559782177|FG003|Overall Study|Lost to Follow-up|0|||
155095003|NCT00421148|559782178|FG004|Overall Study|Lost to Follow-up|0|||
155095004|NCT00421148|559782179|FG005|Overall Study|Lost to Follow-up|0|||
155095005|NCT00421148|559782180|FG006|Overall Study|Lost to Follow-up|0|||
155095006|NCT00421148|559782181|FG007|Overall Study|Lost to Follow-up|0|||
155095007|NCT00421148|559782182|FG008|Overall Study|Lost to Follow-up|0|||
155095008|NCT00421148|559782183|FG009|Overall Study|Lost to Follow-up|0|||
155095009|NCT00421148|559782184|FG010|Overall Study|Lost to Follow-up|0|||
155095010|NCT00421148|559782185|FG011|Overall Study|Lost to Follow-up|0|||
155095011|NCT00421148|559782186|FG012|Overall Study|Lost to Follow-up|0|||
155095012|NCT00421148|559782187|FG013|Overall Study|Lost to Follow-up|0|||
155095013|NCT00421148|559782188|FG014|Overall Study|Lost to Follow-up|0|||
155095014|NCT00421148|559782189|FG015|Overall Study|Lost to Follow-up|0|||
155095015|NCT00421148|559782190|FG016|Overall Study|Lost to Follow-up|0|||
155095016|NCT00421148|559782191|FG017|Overall Study|Lost to Follow-up|1|||
155095017|NCT00421148|559782192|FG018|Overall Study|Lost to Follow-up|0|||
155095018|NCT00421148|559782193|FG019|Overall Study|Lost to Follow-up|0|||
155095019|NCT00421148|559782174|FG000|Overall Study|Withdrawal by Subject|0|||
155095020|NCT00421148|559782175|FG001|Overall Study|Withdrawal by Subject|0|||
155095021|NCT00421148|559782176|FG002|Overall Study|Withdrawal by Subject|0|||
155095022|NCT00421148|559782177|FG003|Overall Study|Withdrawal by Subject|0|||
155095023|NCT00421148|559782178|FG004|Overall Study|Withdrawal by Subject|0|||
155095024|NCT00421148|559782179|FG005|Overall Study|Withdrawal by Subject|0|||
155095025|NCT00421148|559782180|FG006|Overall Study|Withdrawal by Subject|0|||
155095026|NCT00421148|559782181|FG007|Overall Study|Withdrawal by Subject|0|||
155095027|NCT00421148|559782182|FG008|Overall Study|Withdrawal by Subject|0|||
155095028|NCT00421148|559782183|FG009|Overall Study|Withdrawal by Subject|0|||
155095029|NCT00421148|559782184|FG010|Overall Study|Withdrawal by Subject|0|||
155095030|NCT00421148|559782185|FG011|Overall Study|Withdrawal by Subject|0|||
155095031|NCT00421148|559782186|FG012|Overall Study|Withdrawal by Subject|0|||
155095032|NCT00421148|559782187|FG013|Overall Study|Withdrawal by Subject|0|||
155095033|NCT00421148|559782188|FG014|Overall Study|Withdrawal by Subject|0|||
155095034|NCT00421148|559782189|FG015|Overall Study|Withdrawal by Subject|0|||
155095035|NCT00421148|559782190|FG016|Overall Study|Withdrawal by Subject|0|||
155095036|NCT00421148|559782191|FG017|Overall Study|Withdrawal by Subject|1|||
155095037|NCT00421148|559782192|FG018|Overall Study|Withdrawal by Subject|0|||
155095038|NCT00421148|559782193|FG019|Overall Study|Withdrawal by Subject|0|||
155095039|NCT00421148|559782174|FG000|Overall Study|Protocol Violation|0|||
155095040|NCT00421148|559782175|FG001|Overall Study|Protocol Violation|0|||
155095041|NCT00421148|559782176|FG002|Overall Study|Protocol Violation|0|||
155095042|NCT00421148|559782177|FG003|Overall Study|Protocol Violation|0|||
155095043|NCT00421148|559782178|FG004|Overall Study|Protocol Violation|0|||
155095044|NCT00421148|559782179|FG005|Overall Study|Protocol Violation|1|||
155170989|NCT01290796|560065295|FG000|Overall Study|Physician Decision|2|||
154967443|NCT04631562|559303321|FG003|Overall Study|Lost to Follow-up|1|||
155095045|NCT00421148|559782180|FG006|Overall Study|Protocol Violation|0|||
155095046|NCT00421148|559782181|FG007|Overall Study|Protocol Violation|0|||
155095047|NCT00421148|559782182|FG008|Overall Study|Protocol Violation|0|||
155095048|NCT00421148|559782183|FG009|Overall Study|Protocol Violation|0|||
155095049|NCT00421148|559782184|FG010|Overall Study|Protocol Violation|0|||
155095050|NCT00421148|559782185|FG011|Overall Study|Protocol Violation|0|||
155095051|NCT00421148|559782186|FG012|Overall Study|Protocol Violation|0|||
155095052|NCT00421148|559782187|FG013|Overall Study|Protocol Violation|0|||
155095053|NCT00421148|559782188|FG014|Overall Study|Protocol Violation|0|||
155095054|NCT00421148|559782189|FG015|Overall Study|Protocol Violation|0|||
155095055|NCT00421148|559782190|FG016|Overall Study|Protocol Violation|0|||
155095056|NCT00421148|559782191|FG017|Overall Study|Protocol Violation|0|||
155095057|NCT00421148|559782192|FG018|Overall Study|Protocol Violation|1|||
155095058|NCT00421148|559782193|FG019|Overall Study|Protocol Violation|0|||
155095059|NCT01538199|559782194|FG000|Overall Study|Lost to Follow-up|1|||
155095060|NCT01538199|559782195|FG001|Overall Study|Lost to Follow-up|2|||
155095061|NCT01538199|559782196|FG002|Overall Study|Lost to Follow-up|1|||
155095062|NCT01538199|559782197|FG003|Overall Study|Lost to Follow-up|0|||
155095063|NCT01538199|559782194|FG000|Overall Study|participant did not have time|1|||
155095064|NCT01538199|559782195|FG001|Overall Study|participant did not have time|0|||
155095065|NCT01538199|559782196|FG002|Overall Study|participant did not have time|0|||
155095066|NCT01538199|559782197|FG003|Overall Study|participant did not have time|2|||
155095067|NCT01538199|559782194|FG000|Overall Study|Lack of Efficacy|0|||
155095068|NCT01538199|559782195|FG001|Overall Study|Lack of Efficacy|1|||
155095069|NCT01538199|559782196|FG002|Overall Study|Lack of Efficacy|0|||
155095070|NCT01538199|559782197|FG003|Overall Study|Lack of Efficacy|0|||
155095071|NCT00636181|559782200|FG000|Overall Study|Withdrawal by Subject|8|||
155095072|NCT00636181|559782201|FG001|Overall Study|Withdrawal by Subject|6|||
155095073|NCT00636181|559782202|FG002|Overall Study|Withdrawal by Subject|10|||
155095074|NCT04549454|559782203|FG000|T1 to T2|Lost to Follow-up|22|||
155095075|NCT04549454|559782204|FG001|T1 to T2|Lost to Follow-up|26|||
155095076|NCT04549454|559782203|FG000|T1 to T3|Lost to Follow-up|31|||
155095077|NCT04549454|559782204|FG001|T1 to T3|Lost to Follow-up|36|||
155095078|NCT05270863|559782220|FG000|Visit 2 First Intervention|Randomization error|0|||
155095079|NCT05270863|559782221|FG001|Visit 2 First Intervention|Randomization error|0|||
155095080|NCT05270863|559782222|FG002|Visit 2 First Intervention|Randomization error|0|||
155095081|NCT05270863|559782223|FG003|Visit 2 First Intervention|Randomization error|1|||
155095082|NCT05270863|559782224|FG004|Visit 2 First Intervention|Randomization error|0|||
155095083|NCT05270863|559782225|FG005|Visit 2 First Intervention|Randomization error|0|||
155095084|NCT05270863|559782220|FG000|First Washout|Withdrawal by Subject|0|||
155095085|NCT05270863|559782221|FG001|First Washout|Withdrawal by Subject|0|||
155095086|NCT05270863|559782222|FG002|First Washout|Withdrawal by Subject|0|||
155095087|NCT05270863|559782223|FG003|First Washout|Withdrawal by Subject|0|||
155095088|NCT05270863|559782224|FG004|First Washout|Withdrawal by Subject|1|||
155095089|NCT05270863|559782225|FG005|First Washout|Withdrawal by Subject|1|||
155095090|NCT05270863|559782220|FG000|First Washout|Lost to Follow-up|0|||
155095091|NCT05270863|559782221|FG001|First Washout|Lost to Follow-up|0|||
155095092|NCT05270863|559782222|FG002|First Washout|Lost to Follow-up|0|||
155095093|NCT05270863|559782223|FG003|First Washout|Lost to Follow-up|0|||
155095094|NCT05270863|559782224|FG004|First Washout|Lost to Follow-up|0|||
155095095|NCT05270863|559782225|FG005|First Washout|Lost to Follow-up|1|||
155095096|NCT05270863|559782220|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
155095097|NCT05270863|559782221|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
155095098|NCT05270863|559782222|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
155095099|NCT05270863|559782223|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
155095100|NCT05270863|559782224|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
155095101|NCT05270863|559782225|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
155095102|NCT05270863|559782220|FG000|Second Washout|Withdrawal by Subject|1|||
155095103|NCT05270863|559782221|FG001|Second Washout|Withdrawal by Subject|1|||
155095104|NCT05270863|559782222|FG002|Second Washout|Withdrawal by Subject|0|||
155095105|NCT05270863|559782223|FG003|Second Washout|Withdrawal by Subject|0|||
155095106|NCT05270863|559782224|FG004|Second Washout|Withdrawal by Subject|0|||
155095107|NCT05270863|559782225|FG005|Second Washout|Withdrawal by Subject|0|||
155095108|NCT05270863|559782220|FG000|Second Washout|Lost to Follow-up|0|||
155095109|NCT05270863|559782221|FG001|Second Washout|Lost to Follow-up|0|||
155095110|NCT05270863|559782222|FG002|Second Washout|Lost to Follow-up|0|||
155095111|NCT05270863|559782223|FG003|Second Washout|Lost to Follow-up|1|||
155095112|NCT05270863|559782224|FG004|Second Washout|Lost to Follow-up|0|||
155095113|NCT05270863|559782225|FG005|Second Washout|Lost to Follow-up|0|||
155095114|NCT02735421|559783610|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
155095115|NCT02735421|559783610|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
155095116|NCT02735421|559783610|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
155095117|NCT02735421|559783610|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
155095118|NCT02735421|559783610|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
155095119|NCT02735421|559783610|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
155095120|NCT02735421|559783610|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
155095121|NCT01978145|559783612|FG000|Treatment Period 1|Adverse Event|1|||
155095122|NCT01978145|559783613|FG001|Treatment Period 1|Adverse Event|9|||
155095123|NCT01978145|559783612|FG000|Treatment Period 1|Physician Decision|1|||
155095124|NCT01978145|559783613|FG001|Treatment Period 1|Physician Decision|0|||
155095125|NCT01978145|559783612|FG000|Treatment Period 1|Withdrawal by Subject|5|||
155095126|NCT01978145|559783613|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155095127|NCT01978145|559783612|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
155095128|NCT01978145|559783613|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
155095129|NCT01978145|559783612|FG000|Washout Period 1|Adverse Event|0|||
155095130|NCT01978145|559783613|FG001|Washout Period 1|Adverse Event|1|||
155095131|NCT01978145|559783612|FG000|Washout Period 1|Withdrawal by Subject|1|||
155095132|NCT01978145|559783613|FG001|Washout Period 1|Withdrawal by Subject|1|||
155095133|NCT01978145|559783612|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
155095134|NCT01978145|559783613|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
155095135|NCT01978145|559783612|FG000|Treatment Period 2|Adverse Event|3|||
154967444|NCT04631562|559303322|FG004|Overall Study|Lost to Follow-up|0|||
155095136|NCT01978145|559783613|FG001|Treatment Period 2|Adverse Event|3|||
155095137|NCT01978145|559783612|FG000|Treatment Period 2|Protocol Violation|0|||
155095138|NCT01978145|559783613|FG001|Treatment Period 2|Protocol Violation|1|||
155095139|NCT01978145|559783612|FG000|Treatment Period 2|Lost to Follow-up|1|||
155095140|NCT01978145|559783613|FG001|Treatment Period 2|Lost to Follow-up|1|||
155095141|NCT01978145|559783612|FG000|Treatment Period 2|Withdrawal by Subject|7|||
155095142|NCT01978145|559783613|FG001|Treatment Period 2|Withdrawal by Subject|4|||
155095143|NCT01978145|559783612|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
155095144|NCT01978145|559783613|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
155095145|NCT00322049|559783614|FG000|Overall Study|Moved out of area|0|||
155095146|NCT00322049|559783615|FG001|Overall Study|Moved out of area|0|||
155095147|NCT00322049|559783616|FG002|Overall Study|Moved out of area|0|||
155095148|NCT00322049|559783617|FG003|Overall Study|Moved out of area|1|||
155095149|NCT00322049|559783614|FG000|Overall Study|Infected with Dengue during study|0|||
155095150|NCT00322049|559783615|FG001|Overall Study|Infected with Dengue during study|1|||
155095151|NCT00322049|559783616|FG002|Overall Study|Infected with Dengue during study|0|||
155095152|NCT00322049|559783617|FG003|Overall Study|Infected with Dengue during study|0|||
155095153|NCT01250054|559783618|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
155095154|NCT01250054|559783619|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
155095155|NCT00755807|559783622|FG000|Acute Phase|Adverse Event|16|||
155095156|NCT00755807|559783623|FG001|Acute Phase|Adverse Event|5|||
155095157|NCT00755807|559783622|FG000|Acute Phase|Protocol Violation|1|||
155095158|NCT00755807|559783623|FG001|Acute Phase|Protocol Violation|3|||
155095159|NCT00755807|559783622|FG000|Acute Phase|Withdrawal by Subject|1|||
155095160|NCT00755807|559783623|FG001|Acute Phase|Withdrawal by Subject|2|||
155095161|NCT00755807|559783622|FG000|Acute Phase|Lack of Efficacy|0|||
155095162|NCT00755807|559783623|FG001|Acute Phase|Lack of Efficacy|1|||
155095163|NCT00755807|559783622|FG000|Acute Phase|Physician Decision|0|||
155095164|NCT00755807|559783623|FG001|Acute Phase|Physician Decision|1|||
155095165|NCT00755807|559783622|FG000|Open-label Extension Phase|Adverse Event|7|||
155095166|NCT00755807|559783623|FG001|Open-label Extension Phase|Adverse Event|7|||
155095167|NCT00755807|559783622|FG000|Open-label Extension Phase|Protocol Violation|5|||
155095168|NCT00755807|559783623|FG001|Open-label Extension Phase|Protocol Violation|2|||
155095169|NCT00755807|559783622|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
155095170|NCT00755807|559783623|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
155095171|NCT00755807|559783622|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
155095172|NCT00755807|559783623|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
155095173|NCT00755807|559783622|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
155095174|NCT00755807|559783623|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
155095175|NCT00755807|559783622|FG000|Open-label Extension Phase|Sponsor Decision|0|||
155095176|NCT00755807|559783623|FG001|Open-label Extension Phase|Sponsor Decision|1|||
155095177|NCT00939107|559783624|FG000|Overall Study|Lost to Follow-up|14|||
155095178|NCT00939107|559783625|FG001|Overall Study|Lost to Follow-up|12|||
155095179|NCT00427011|559783628|FG000|Overall Study|Adverse Event|10|||
155095180|NCT00427011|559783628|FG000|Overall Study|Withdrawal by Subject|1|||
155095181|NCT00427011|559783628|FG000|Overall Study|Lack of Efficacy|2|||
155095182|NCT00427011|559783628|FG000|Overall Study|Other|12|||
155095183|NCT02921789|559783629|FG000|Overall Study|Adverse Event|0|||
155095184|NCT02921789|559783630|FG001|Overall Study|Adverse Event|1|||
155095185|NCT02921789|559783629|FG000|Overall Study|Lost to Follow-up|1|||
155095186|NCT02921789|559783630|FG001|Overall Study|Lost to Follow-up|0|||
155095187|NCT02921789|559783629|FG000|Overall Study|Protocol Deviation|2|||
155095188|NCT02921789|559783630|FG001|Overall Study|Protocol Deviation|0|||
155095189|NCT02921789|559783629|FG000|Overall Study|Withdrawal by Subject|2|||
155095190|NCT02921789|559783630|FG001|Overall Study|Withdrawal by Subject|1|||
155095191|NCT02921789|559783629|FG000|Overall Study|Miscellaneous|3|||
155095192|NCT02921789|559783630|FG001|Overall Study|Miscellaneous|2|||
155095193|NCT01192126|559783631|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
155095194|NCT01192126|559783632|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
155095195|NCT01192126|559783631|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
155095196|NCT01192126|559783632|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
155095197|NCT01248793|559783633|FG000|Overall Study|Lost to Follow-up|0|||
155095198|NCT01248793|559783634|FG001|Overall Study|Lost to Follow-up|1|||
155095199|NCT01248793|559783633|FG000|Overall Study|Adverse Event|1|||
155095200|NCT01248793|559783634|FG001|Overall Study|Adverse Event|1|||
155095201|NCT01248793|559783633|FG000|Overall Study|Protocol Violation|0|||
155095202|NCT01248793|559783634|FG001|Overall Study|Protocol Violation|1|||
155095203|NCT01248793|559783633|FG000|Overall Study|Withdrawal by Subject|3|||
155095204|NCT01248793|559783634|FG001|Overall Study|Withdrawal by Subject|3|||
155095205|NCT00517699|559783635|FG000|Overall Study|Withdrawal by Subject|1|||
155095206|NCT00517699|559783635|FG000|Overall Study|Lack of Efficacy|1|||
155095207|NCT00517699|559783635|FG000|Overall Study|Administrative error|1|||
155095208|NCT00517699|559783635|FG000|Overall Study|Study terminated by Sponsor|2|||
155095209|NCT02332187|559783636|FG000|Overall Study|Withdrawal by Subject|2|||
155095210|NCT02332187|559783637|FG001|Overall Study|Withdrawal by Subject|2|||
155095211|NCT02332187|559783636|FG000|Overall Study|Adverse Event|0|||
155095212|NCT02332187|559783637|FG001|Overall Study|Adverse Event|1|||
155095213|NCT02580877|559783638|FG000|Overall Study|Withdrawal by Subject|1|||
155095214|NCT02580877|559783639|FG001|Overall Study|Withdrawal by Subject|3|||
155095215|NCT02580877|559783638|FG000|Overall Study|Adverse Event|0|||
154967445|NCT04631562|559303323|FG005|Overall Study|Lost to Follow-up|0|||
154967446|NCT04631562|559303324|FG006|Overall Study|Lost to Follow-up|0|||
154967447|NCT04631562|559303325|FG007|Overall Study|Lost to Follow-up|0|||
154967448|NCT04631562|559303326|FG008|Overall Study|Lost to Follow-up|0|||
154967449|NCT04631562|559303318|FG000|Overall Study|Adverse Event|0|||
154967450|NCT04631562|559303319|FG001|Overall Study|Adverse Event|0|||
154967451|NCT04631562|559303320|FG002|Overall Study|Adverse Event|0|||
155095216|NCT02580877|559783639|FG001|Overall Study|Adverse Event|1|||
155095217|NCT00355030|559783640|FG000|Study Period 1 Treatment|Adverse Event|1|||
155095218|NCT00355030|559783641|FG001|Study Period 1 Treatment|Adverse Event|1|||
155095219|NCT00355030|559783640|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
155095220|NCT00355030|559783641|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
155095221|NCT00355030|559783640|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
155095222|NCT00355030|559783641|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
155095223|NCT00355030|559783640|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
155095224|NCT00355030|559783641|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
155095225|NCT00355030|559783640|FG000|Study Period 1 Treatment|Physician Decision|0|||
155095226|NCT00355030|559783641|FG001|Study Period 1 Treatment|Physician Decision|1|||
155095227|NCT00355030|559783640|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
155095228|NCT00355030|559783641|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
155095229|NCT00355030|559783640|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
155095230|NCT00355030|559783641|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
155095231|NCT00355030|559783640|FG000|Study Period 1 Treatment|Other|2|||
155095232|NCT00355030|559783641|FG001|Study Period 1 Treatment|Other|6|||
155095233|NCT00355030|559783640|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
155095234|NCT00355030|559783641|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
155095235|NCT00355030|559783640|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
155095236|NCT00355030|559783641|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
155095237|NCT00339040|559783642|FG000|Stage I|Not able to attend clinic|1|||
155095238|NCT00339040|559783643|FG001|Stage I|Not able to attend clinic|0|||
155095239|NCT00339040|559783642|FG000|Stage I|Protocol Violation|1|||
155095240|NCT00339040|559783643|FG001|Stage I|Protocol Violation|1|||
155095241|NCT00339040|559783642|FG000|Stage II|Lost to Follow-up|3|||
155095242|NCT00339040|559783643|FG001|Stage II|Lost to Follow-up|0|||
155095243|NCT00339040|559783642|FG000|Stage II|Withdrawal by Subject|1|||
155095244|NCT00339040|559783643|FG001|Stage II|Withdrawal by Subject|2|||
155095245|NCT00339040|559783642|FG000|Stage II|Protocol Violation|3|||
155095246|NCT00339040|559783643|FG001|Stage II|Protocol Violation|0|||
155095247|NCT00339040|559783642|FG000|Stage II|Not able to attend clinic|1|||
155095248|NCT00339040|559783643|FG001|Stage II|Not able to attend clinic|0|||
155095249|NCT00339040|559783642|FG000|Stage II|Site closing|2|||
155095250|NCT00339040|559783643|FG001|Stage II|Site closing|0|||
155095251|NCT01462929|559783644|FG000|Overall Study|Adverse Event|3|||
155095252|NCT01462929|559783645|FG001|Overall Study|Adverse Event|3|||
155095253|NCT01462929|559783646|FG002|Overall Study|Adverse Event|4|||
155095254|NCT01462929|559783644|FG000|Overall Study|Withdrawal by Subject|2|||
155095255|NCT01462929|559783645|FG001|Overall Study|Withdrawal by Subject|1|||
155095256|NCT01462929|559783646|FG002|Overall Study|Withdrawal by Subject|0|||
155095257|NCT01462929|559783644|FG000|Overall Study|Lack of Efficacy|0|||
155095258|NCT01462929|559783645|FG001|Overall Study|Lack of Efficacy|0|||
155095259|NCT01462929|559783646|FG002|Overall Study|Lack of Efficacy|1|||
154967452|NCT04631562|559303321|FG003|Overall Study|Adverse Event|0|||
155095260|NCT02808897|559783649|FG000|Overall Study|Lost to Follow-up|9|||
155095261|NCT02808897|559783650|FG001|Overall Study|Lost to Follow-up|11|||
155095262|NCT02133573|559783656|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
154967453|NCT04631562|559303322|FG004|Overall Study|Adverse Event|0|||
154967454|NCT04631562|559303323|FG005|Overall Study|Adverse Event|0|||
154967455|NCT04631562|559303324|FG006|Overall Study|Adverse Event|1|||
155095263|NCT02133573|559783657|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
155095264|NCT02133573|559783656|FG000|Overall Study|Child Deaths|3|||
155095265|NCT02133573|559783657|FG001|Overall Study|Child Deaths|5|||
155095266|NCT02133573|559783656|FG000|Overall Study|Child Declined Follow Ups|2|||
155095267|NCT02133573|559783657|FG001|Overall Study|Child Declined Follow Ups|1|||
155095268|NCT02133573|559783656|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
155095269|NCT02133573|559783657|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
155095270|NCT02808429|559783661|FG000|Overall Study|Lost to Follow-up|1|||
155095271|NCT02808429|559783662|FG001|Overall Study|Lost to Follow-up|0|||
155170990|NCT01290796|560065295|FG000|Overall Study|Secondary Surgical Intervention|2|||
155170991|NCT01290796|560065295|FG000|Overall Study|Withdrawal by Sponsor|1|||
155170992|NCT02709538|560065297|FG000|Overall Study|Adverse Event|13|||
155170993|NCT02709538|560065298|FG001|Overall Study|Adverse Event|2|||
155170994|NCT02709538|560065299|FG002|Overall Study|Adverse Event|3|||
155170995|NCT02709538|560065297|FG000|Overall Study|Lack of Efficacy|1|||
155170996|NCT02709538|560065298|FG001|Overall Study|Lack of Efficacy|0|||
155170997|NCT02709538|560065299|FG002|Overall Study|Lack of Efficacy|0|||
155170998|NCT02709538|560065297|FG000|Overall Study|Lost to Follow-up|24|||
155170999|NCT02709538|560065298|FG001|Overall Study|Lost to Follow-up|8|||
155171000|NCT02709538|560065299|FG002|Overall Study|Lost to Follow-up|4|||
155171001|NCT02709538|560065297|FG000|Overall Study|Physician Decision|1|||
155171002|NCT02709538|560065298|FG001|Overall Study|Physician Decision|0|||
155171003|NCT02709538|560065299|FG002|Overall Study|Physician Decision|0|||
155171004|NCT02709538|560065297|FG000|Overall Study|Withdrawal by Subject|40|||
155171005|NCT02709538|560065298|FG001|Overall Study|Withdrawal by Subject|7|||
155171006|NCT02709538|560065299|FG002|Overall Study|Withdrawal by Subject|4|||
154967456|NCT04631562|559303325|FG007|Overall Study|Adverse Event|0|||
155095272|NCT02808429|559783663|FG002|Overall Study|Lost to Follow-up|0|||
155095273|NCT02808429|559783661|FG000|Overall Study|Protocol Violation|0|||
155095274|NCT02808429|559783662|FG001|Overall Study|Protocol Violation|1|||
155095275|NCT02808429|559783663|FG002|Overall Study|Protocol Violation|0|||
155095276|NCT02808429|559783661|FG000|Overall Study|Premature study termination by sponsor|2|||
155095277|NCT02808429|559783662|FG001|Overall Study|Premature study termination by sponsor|0|||
155095278|NCT02808429|559783663|FG002|Overall Study|Premature study termination by sponsor|1|||
155095279|NCT02808429|559783661|FG000|Overall Study|Relocation|0|||
155095280|NCT02808429|559783662|FG001|Overall Study|Relocation|0|||
155095281|NCT02808429|559783663|FG002|Overall Study|Relocation|1|||
155095282|NCT01788943|559783667|FG000|Overall Study|Withdrawal by Subject|1|||
155095283|NCT01788943|559783668|FG001|Overall Study|Withdrawal by Subject|0|||
155095284|NCT01567722|559783677|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
155095285|NCT01567722|559783678|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
155095286|NCT01567722|559783679|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
155095287|NCT01567722|559783677|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
155095288|NCT01567722|559783678|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
155095289|NCT01567722|559783679|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
155095290|NCT01567722|559783677|FG000|Overall Study|Protocol closure by the OCG|2|||
155095291|NCT01567722|559783678|FG001|Overall Study|Protocol closure by the OCG|0|||
155095292|NCT01567722|559783679|FG002|Overall Study|Protocol closure by the OCG|0|||
155095293|NCT01567722|559783677|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
155095294|NCT01567722|559783678|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
155095295|NCT01567722|559783679|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
155095296|NCT03434834|559783680|FG000|Overall Study|unable to swallow OCT probe|16|||
155095297|NCT01823289|559783681|FG000|Overall Study|Lost to Follow-up|5|||
155095298|NCT01823289|559783681|FG000|Overall Study|Adverse Event|5|||
155095299|NCT01823289|559783681|FG000|Overall Study|Lack of Efficacy|1|||
155095300|NCT01823289|559783681|FG000|Overall Study|Physician Decision|9|||
155095301|NCT01823289|559783681|FG000|Overall Study|Administered contraindicated medicine|1|||
155095302|NCT01823289|559783681|FG000|Overall Study|Transaminase increased more than 3 times|1|||
155095303|NCT01823289|559783681|FG000|Overall Study|Drug affected efficacy and safety|1|||
155095304|NCT01823289|559783681|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
155095305|NCT01911260|559783682|FG000|Supplementation Period|transference or evasion of school|7|||
155095306|NCT01911260|559783683|FG001|Supplementation Period|transference or evasion of school|9|||
155095307|NCT01911260|559783684|FG002|Supplementation Period|transference or evasion of school|7|||
155095308|NCT01911260|559783685|FG003|Supplementation Period|transference or evasion of school|6|||
155095309|NCT01911260|559783682|FG000|Supplementation Period|Adverse Event|2|||
155095310|NCT01911260|559783683|FG001|Supplementation Period|Adverse Event|0|||
155095311|NCT01911260|559783684|FG002|Supplementation Period|Adverse Event|1|||
155095312|NCT01911260|559783685|FG003|Supplementation Period|Adverse Event|0|||
155095313|NCT01911260|559783682|FG000|Supplementation Period|refused to receive supplement|1|||
155095314|NCT01911260|559783683|FG001|Supplementation Period|refused to receive supplement|0|||
155095315|NCT01911260|559783684|FG002|Supplementation Period|refused to receive supplement|1|||
155171007|NCT02709538|560065297|FG000|Overall Study|Non-compliance with study procedures|5|||
155171008|NCT02709538|560065298|FG001|Overall Study|Non-compliance with study procedures|0|||
154967457|NCT04631562|559303326|FG008|Overall Study|Adverse Event|0|||
155171009|NCT02709538|560065299|FG002|Overall Study|Non-compliance with study procedures|0|||
155171010|NCT02709538|560065297|FG000|Overall Study|Non-compliance with study drug|2|||
155171011|NCT02709538|560065298|FG001|Overall Study|Non-compliance with study drug|0|||
155171012|NCT02709538|560065299|FG002|Overall Study|Non-compliance with study drug|0|||
155171013|NCT02709538|560065297|FG000|Overall Study|Protocol deviation|10|||
155171014|NCT02709538|560065298|FG001|Overall Study|Protocol deviation|4|||
155171015|NCT02709538|560065299|FG002|Overall Study|Protocol deviation|4|||
155171016|NCT02709538|560065297|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
155171017|NCT02709538|560065298|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
155171018|NCT02709538|560065299|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
155171019|NCT02709538|560065297|FG000|Overall Study|Other|16|||
155171020|NCT02709538|560065298|FG001|Overall Study|Other|7|||
155171021|NCT02709538|560065299|FG002|Overall Study|Other|5|||
155171022|NCT00835211|560065301|FG000|First Intervention|Withdrawal by Subject|0|||
155171023|NCT00835211|560065302|FG001|First Intervention|Withdrawal by Subject|1|||
155171024|NCT00835211|560065301|FG000|Washout: 7 Days|Adverse Event|2|||
155171025|NCT00835211|560065302|FG001|Washout: 7 Days|Adverse Event|1|||
155171026|NCT00835211|560065301|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
155171027|NCT00835211|560065302|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
155171028|NCT02343549|560065303|FG000|Overall Study|Death|11|||
155171029|NCT02343549|560065303|FG000|Overall Study|Withdrawal by Subject|2|||
155171030|NCT03087617|560065304|FG000|Overall Study|Lost to Follow-up|32|||
155171031|NCT03087617|560065305|FG001|Overall Study|Lost to Follow-up|30|||
155171032|NCT03087617|560065306|FG002|Overall Study|Lost to Follow-up|30|||
155171033|NCT03087617|560065307|FG003|Overall Study|Lost to Follow-up|39|||
155171034|NCT02160041|560065310|FG000|Overall Study|Adverse Event|11|||
155171035|NCT02160041|560065310|FG000|Overall Study|Death|2|||
155171036|NCT02160041|560065310|FG000|Overall Study|disease progression|57|||
155171037|NCT02160041|560065310|FG000|Overall Study|Protocol Violation|1|||
155171038|NCT02160041|560065310|FG000|Overall Study|non-compliance with study|1|||
155171039|NCT02160041|560065310|FG000|Overall Study|Physician Decision|3|||
155171040|NCT02160041|560065310|FG000|Overall Study|Withdrawal by Subject|8|||
155171041|NCT02160041|560065310|FG000|Overall Study|study terminated by by sponsor|1|||
155171042|NCT04450381|560065311|FG000|Overall Study|Protocol Violation|4|||
155171043|NCT04450381|560065311|FG000|Overall Study|Wrong device setting|2|||
155171044|NCT01090323|560065312|FG000|Overall Study|Adverse Event|12|||
155171045|NCT01090323|560065313|FG001|Overall Study|Adverse Event|2|||
155171046|NCT01090323|560065312|FG000|Overall Study|Abnormal Lab Values|3|||
155171047|NCT01090323|560065313|FG001|Overall Study|Abnormal Lab Values|1|||
155171048|NCT01090323|560065312|FG000|Overall Study|Abnormal Test Procedure Results|2|||
155171049|NCT01090323|560065313|FG001|Overall Study|Abnormal Test Procedure Results|0|||
155171050|NCT01090323|560065312|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155171051|NCT01090323|560065313|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155171052|NCT01090323|560065312|FG000|Overall Study|Condition no longer requires drug|5|||
155171053|NCT01090323|560065313|FG001|Overall Study|Condition no longer requires drug|4|||
155171054|NCT01090323|560065312|FG000|Overall Study|Protocol Violation|2|||
155171055|NCT01090323|560065313|FG001|Overall Study|Protocol Violation|1|||
155171056|NCT01090323|560065312|FG000|Overall Study|Withdrew consent|33|||
155171057|NCT01090323|560065313|FG001|Overall Study|Withdrew consent|11|||
155171058|NCT01090323|560065312|FG000|Overall Study|Lost to Follow-up|11|||
155171059|NCT01090323|560065313|FG001|Overall Study|Lost to Follow-up|6|||
155171060|NCT01090323|560065312|FG000|Overall Study|Administrative problems|6|||
155171061|NCT01090323|560065313|FG001|Overall Study|Administrative problems|4|||
155171062|NCT01090323|560065312|FG000|Overall Study|Death|1|||
155171063|NCT01090323|560065313|FG001|Overall Study|Death|2|||
155095316|NCT01911260|559783685|FG003|Supplementation Period|refused to receive supplement|0|||
155095317|NCT01911260|559783682|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
155095318|NCT01911260|559783683|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
155095319|NCT01911260|559783684|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
155095320|NCT01911260|559783685|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
155095321|NCT01911260|559783682|FG000|Follow-up Period|transference or evasion of school|13|||
155095322|NCT01911260|559783683|FG001|Follow-up Period|transference or evasion of school|20|||
155095323|NCT01911260|559783684|FG002|Follow-up Period|transference or evasion of school|15|||
155095324|NCT01911260|559783685|FG003|Follow-up Period|transference or evasion of school|12|||
155095325|NCT04436744|559783689|FG000|Overall Study|Adverse Event|1|||
155095326|NCT04436744|559783690|FG001|Overall Study|Adverse Event|1|||
155095327|NCT04436744|559783689|FG000|Overall Study|Death|1|||
155095328|NCT04436744|559783690|FG001|Overall Study|Death|0|||
155095329|NCT04436744|559783689|FG000|Overall Study|Lost to Follow-up|0|||
155095330|NCT04436744|559783690|FG001|Overall Study|Lost to Follow-up|2|||
155095331|NCT04436744|559783689|FG000|Overall Study|Physician Decision|0|||
155171064|NCT01090323|560065312|FG000|Overall Study|Stopped end of core|7|||
155171065|NCT01090323|560065313|FG001|Overall Study|Stopped end of core|0|||
155171066|NCT01090323|560065312|FG000|Overall Study|Stopped end of extension 1#|3|||
155171067|NCT01090323|560065313|FG001|Overall Study|Stopped end of extension 1#|1|||
155171068|NCT01864005|560065314|FG000|Overall Study|Protocol Violation|0|||
155171069|NCT01864005|560065315|FG001|Overall Study|Protocol Violation|1|||
155171070|NCT01864005|560065314|FG000|Overall Study|Withdrawal by Subject|0|||
155095332|NCT04436744|559783690|FG001|Overall Study|Physician Decision|1|||
155095333|NCT04436744|559783689|FG000|Overall Study|Progressive Disease|0|||
155095334|NCT04436744|559783690|FG001|Overall Study|Progressive Disease|4|||
155095335|NCT04436744|559783689|FG000|Overall Study|Protocol Deviation|1|||
155095336|NCT04436744|559783690|FG001|Overall Study|Protocol Deviation|1|||
155095337|NCT04436744|559783689|FG000|Overall Study|Withdrawal by Subject|1|||
155095338|NCT04436744|559783690|FG001|Overall Study|Withdrawal by Subject|2|||
155095339|NCT01133847|559783691|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
155095340|NCT01133847|559783692|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
155095341|NCT01133847|559783693|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
155095342|NCT01133847|559783691|FG000|Follow-Up Phase|Lost to Follow-up|1|||
155095343|NCT01133847|559783692|FG001|Follow-Up Phase|Lost to Follow-up|3|||
155095344|NCT01133847|559783693|FG002|Follow-Up Phase|Lost to Follow-up|7|||
155095345|NCT01880957|559783694|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
155095346|NCT01880957|559783695|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
155095347|NCT01880957|559783694|FG000|Overall Study|Lost to Follow-up|11|||
155095348|NCT01880957|559783695|FG001|Overall Study|Lost to Follow-up|0|||
155095349|NCT01880957|559783694|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
155095350|NCT01880957|559783695|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
155095351|NCT01378117|559783696|FG000|Overall Study|withdrawal|2|||
155095352|NCT01378117|559783697|FG001|Overall Study|withdrawal|1|||
155095353|NCT01378117|559783698|FG002|Overall Study|withdrawal|2|||
155095354|NCT01378117|559783696|FG000|Overall Study|discharged before med given|2|||
155095355|NCT01378117|559783697|FG001|Overall Study|discharged before med given|0|||
155095356|NCT01378117|559783698|FG002|Overall Study|discharged before med given|1|||
155095357|NCT01463033|559783699|FG000|Overall Study|Lost to Follow-up|4|||
155095358|NCT01463033|559783700|FG001|Overall Study|Lost to Follow-up|4|||
155095359|NCT01463033|559783699|FG000|Overall Study|Death|3|||
155095360|NCT01463033|559783700|FG001|Overall Study|Death|2|||
155095361|NCT01854528|559783701|FG000|Overall Study|Adverse Event|0|||
155095362|NCT01854528|559783702|FG001|Overall Study|Adverse Event|4|||
155095363|NCT01854528|559783701|FG000|Overall Study|Withdrawal by Subject|0|||
155095364|NCT01854528|559783702|FG001|Overall Study|Withdrawal by Subject|2|||
155095365|NCT01854528|559783701|FG000|Overall Study|Virologic Failure|0|||
155095366|NCT01854528|559783702|FG001|Overall Study|Virologic Failure|9|||
155095367|NCT02951780|559783703|FG000|Period 1|Adverse Event|0|||
155095368|NCT02951780|559783704|FG001|Period 1|Adverse Event|0|||
155095369|NCT02951780|559783705|FG002|Period 1|Adverse Event|0|||
155095370|NCT02951780|559783706|FG003|Period 1|Adverse Event|1|||
155095371|NCT02951780|559783707|FG004|Period 1|Adverse Event|0|||
155095372|NCT02951780|559783708|FG005|Period 1|Adverse Event|0|||
155095373|NCT02951780|559783709|FG006|Period 1|Adverse Event|0|||
155095374|NCT02951780|559783710|FG007|Period 1|Adverse Event|0|||
155095375|NCT02951780|559783711|FG008|Period 1|Adverse Event|0|||
155095376|NCT02951780|559783703|FG000|Period 1|Scheduling Conflicts|0|||
155095377|NCT02951780|559783704|FG001|Period 1|Scheduling Conflicts|0|||
155095378|NCT02951780|559783705|FG002|Period 1|Scheduling Conflicts|0|||
155095379|NCT02951780|559783706|FG003|Period 1|Scheduling Conflicts|0|||
155095380|NCT02951780|559783707|FG004|Period 1|Scheduling Conflicts|0|||
155095381|NCT02951780|559783708|FG005|Period 1|Scheduling Conflicts|0|||
155095382|NCT02951780|559783709|FG006|Period 1|Scheduling Conflicts|0|||
155095383|NCT02951780|559783710|FG007|Period 1|Scheduling Conflicts|1|||
155095384|NCT02951780|559783711|FG008|Period 1|Scheduling Conflicts|0|||
155095385|NCT02951780|559783703|FG000|Period 2|Scheduling Conflicts|0|||
155095386|NCT02951780|559783704|FG001|Period 2|Scheduling Conflicts|0|||
155095387|NCT02951780|559783705|FG002|Period 2|Scheduling Conflicts|0|||
155095388|NCT02951780|559783706|FG003|Period 2|Scheduling Conflicts|0|||
155095389|NCT02951780|559783707|FG004|Period 2|Scheduling Conflicts|0|||
155095390|NCT02951780|559783708|FG005|Period 2|Scheduling Conflicts|0|||
155095391|NCT02951780|559783709|FG006|Period 2|Scheduling Conflicts|0|||
155095392|NCT02951780|559783710|FG007|Period 2|Scheduling Conflicts|1|||
155095393|NCT02951780|559783711|FG008|Period 2|Scheduling Conflicts|0|||
155095394|NCT01082614|559783712|FG000|Overall Study|Adverse Event|1|||
155095395|NCT01082614|559783713|FG001|Overall Study|Adverse Event|4|||
155095396|NCT01082614|559783712|FG000|Overall Study|Equipment Malfunction|0|||
155095397|NCT01082614|559783713|FG001|Overall Study|Equipment Malfunction|1|||
155095398|NCT01082614|559783712|FG000|Overall Study|Physician Decision|2|||
155095399|NCT01082614|559783713|FG001|Overall Study|Physician Decision|0|||
155095400|NCT00811720|559783714|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
155095401|NCT00811720|559783715|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
155095402|NCT00811720|559783714|FG000|All Treated Patients|Adverse Event|20|||
155095403|NCT00811720|559783715|FG001|All Treated Patients|Adverse Event|62|||
155095404|NCT00811720|559783714|FG000|All Treated Patients|Lack of Efficacy|22|||
155095405|NCT00811720|559783715|FG001|All Treated Patients|Lack of Efficacy|18|||
155095406|NCT00811720|559783714|FG000|All Treated Patients|Non-compliance|0|||
155095407|NCT00811720|559783715|FG001|All Treated Patients|Non-compliance|14|||
155095408|NCT00811720|559783714|FG000|All Treated Patients|Protocol Violation|9|||
155095409|NCT00811720|559783715|FG001|All Treated Patients|Protocol Violation|16|||
155095410|NCT00811720|559783714|FG000|All Treated Patients|Withdrawal by Subject|28|||
155171071|NCT01864005|560065315|FG001|Overall Study|Withdrawal by Subject|1|||
155171072|NCT01864005|560065314|FG000|Overall Study|Incorrect enrolment|1|||
155171073|NCT01864005|560065315|FG001|Overall Study|Incorrect enrolment|0|||
155171074|NCT01864005|560065314|FG000|Overall Study|Disease need|1|||
155171075|NCT01864005|560065315|FG001|Overall Study|Disease need|1|||
155171076|NCT01864005|560065314|FG000|Overall Study|Need GP IIb/IIIa|1|||
155171077|NCT01864005|560065315|FG001|Overall Study|Need GP IIb/IIIa|3|||
155171078|NCT00763698|560065323|FG000|Overall Study|Unsuccessful Implant|5|||
155171079|NCT00763698|560065323|FG000|Overall Study|Death|4|||
155171080|NCT00763698|560065323|FG000|Overall Study|Withdrawal by Subject|1|||
155171081|NCT02184572|560065324|FG000|Overall Study|Lost to Follow-up|29|||
155171082|NCT02184572|560065325|FG001|Overall Study|Lost to Follow-up|21|||
155171083|NCT02184572|560065324|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
155171084|NCT02184572|560065325|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
155171085|NCT02184572|560065324|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
155171086|NCT02184572|560065325|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
155171087|NCT02184572|560065324|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
155171088|NCT02184572|560065325|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
155171089|NCT02184572|560065324|FG000|Overall Study|Traveling Outside The Country|1|||
155171090|NCT02184572|560065325|FG001|Overall Study|Traveling Outside The Country|0|||
155171091|NCT02184572|560065324|FG000|Overall Study|Withdrawal by Subject|14|||
155171092|NCT02184572|560065325|FG001|Overall Study|Withdrawal by Subject|9|||
155171093|NCT00006409|560065329|FG000|Baseline|Protocol Violation|48|||
155171094|NCT00006409|560065330|FG001|Baseline|Protocol Violation|70|||
155171095|NCT00006409|560065331|FG002|Baseline|Protocol Violation|0|||
155171096|NCT00006409|560065332|FG003|Baseline|Protocol Violation|0|||
155171097|NCT00006409|560065333|FG004|Baseline|Protocol Violation|0|||
155171098|NCT00006409|560065334|FG005|Baseline|Protocol Violation|0|||
155171099|NCT00006409|560065329|FG000|Post-2 Year Intervention|Protocol Violation|0|||
155171100|NCT00006409|560065330|FG001|Post-2 Year Intervention|Protocol Violation|0|||
155171101|NCT00006409|560065331|FG002|Post-2 Year Intervention|Protocol Violation|251|||
155171102|NCT00006409|560065332|FG003|Post-2 Year Intervention|Protocol Violation|168|||
155171103|NCT00006409|560065333|FG004|Post-2 Year Intervention|Protocol Violation|0|||
155171104|NCT00006409|560065334|FG005|Post-2 Year Intervention|Protocol Violation|0|||
155171105|NCT00006409|560065329|FG000|Post-3 Year Intervention|Protocol Violation|0|||
155171106|NCT00006409|560065330|FG001|Post-3 Year Intervention|Protocol Violation|0|||
154967458|NCT05098743|559303334|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
154967459|NCT05098743|559303335|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
155095411|NCT00811720|559783715|FG001|All Treated Patients|Withdrawal by Subject|34|||
155095412|NCT00811720|559783714|FG000|All Treated Patients|Lost to Follow-up|10|||
155095413|NCT00811720|559783715|FG001|All Treated Patients|Lost to Follow-up|16|||
155095414|NCT00811720|559783714|FG000|All Treated Patients|Other Reason|7|||
155095415|NCT00811720|559783715|FG001|All Treated Patients|Other Reason|4|||
155095416|NCT03768427|559783716|FG000|Overall Study|Death|0|||
155095417|NCT03768427|559783717|FG001|Overall Study|Death|0|||
155095418|NCT03768427|559783718|FG002|Overall Study|Death|1|||
155095419|NCT03768427|559783719|FG003|Overall Study|Death|0|||
155095420|NCT03768427|559783716|FG000|Overall Study|Lost to Follow-up|2|||
155095421|NCT03768427|559783717|FG001|Overall Study|Lost to Follow-up|0|||
155095422|NCT03768427|559783718|FG002|Overall Study|Lost to Follow-up|0|||
155095423|NCT03768427|559783719|FG003|Overall Study|Lost to Follow-up|0|||
155095424|NCT03768427|559783716|FG000|Overall Study|Physician Decision|3|||
155095425|NCT03768427|559783717|FG001|Overall Study|Physician Decision|2|||
155095426|NCT03768427|559783718|FG002|Overall Study|Physician Decision|4|||
155095427|NCT03768427|559783719|FG003|Overall Study|Physician Decision|4|||
155095428|NCT03768427|559783716|FG000|Overall Study|Withdrawal by Subject|7|||
155095429|NCT03768427|559783717|FG001|Overall Study|Withdrawal by Subject|2|||
155095430|NCT03768427|559783718|FG002|Overall Study|Withdrawal by Subject|6|||
155095431|NCT03768427|559783719|FG003|Overall Study|Withdrawal by Subject|7|||
155095432|NCT02850978|559783721|FG000|Overall Study|Uncollectable CRF|27|||
155095433|NCT02850978|559783721|FG000|Overall Study|No visit since the first visit|35|||
155095434|NCT02850978|559783721|FG000|Overall Study|Adverse Event|81|||
155095435|NCT02850978|559783721|FG000|Overall Study|Lack of Efficacy|40|||
155095436|NCT02850978|559783721|FG000|Overall Study|Improvement in condition|34|||
155095437|NCT02850978|559783721|FG000|Overall Study|Lost to Follow-up|121|||
155095438|NCT02850978|559783721|FG000|Overall Study|Reason not listed|88|||
155095439|NCT04881760|559783722|FG000|Overall Study|Adverse Event|0|||
155095440|NCT04881760|559783723|FG001|Overall Study|Adverse Event|1|||
155095441|NCT04881760|559783724|FG002|Overall Study|Adverse Event|1|||
155095442|NCT04881760|559783725|FG003|Overall Study|Adverse Event|0|||
155095443|NCT04881760|559783726|FG004|Overall Study|Adverse Event|1|||
155095444|NCT04881760|559783727|FG005|Overall Study|Adverse Event|1|||
155095445|NCT04881760|559783728|FG006|Overall Study|Adverse Event|2|||
155095446|NCT04881760|559783722|FG000|Overall Study|Death|0|||
154967460|NCT05098743|559303334|FG000|Overall Study|Lost to Follow-up|1|||
154967461|NCT05098743|559303335|FG001|Overall Study|Lost to Follow-up|2|||
154967462|NCT01456221|559303336|FG000|Overall Study|Withdrawal by Subject|56|||
154967463|NCT01456221|559303337|FG001|Overall Study|Withdrawal by Subject|49|||
154967464|NCT01456221|559303336|FG000|Overall Study|Lost to Follow-up|1|||
154967465|NCT01456221|559303337|FG001|Overall Study|Lost to Follow-up|4|||
154967466|NCT01456221|559303336|FG000|Overall Study|Received medication|3|||
154967467|NCT01456221|559303337|FG001|Overall Study|Received medication|2|||
154967468|NCT01456221|559303336|FG000|Overall Study|Incomplete data|4|||
155171107|NCT00006409|560065331|FG002|Post-3 Year Intervention|Protocol Violation|0|||
154967469|NCT01456221|559303337|FG001|Overall Study|Incomplete data|2|||
154967470|NCT02272803|559303338|FG000|Overall Study|Disease progression|16|||
154967471|NCT02272803|559303339|FG001|Overall Study|Disease progression|8|||
154967472|NCT02272803|559303338|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
154967473|NCT02272803|559303339|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
154967474|NCT02272803|559303338|FG000|Overall Study|Study drug toxicity|4|||
154967475|NCT02272803|559303339|FG001|Overall Study|Study drug toxicity|9|||
154967476|NCT02272803|559303338|FG000|Overall Study|Participant request to discontinue study treatment|3|||
154967477|NCT02272803|559303339|FG001|Overall Study|Participant request to discontinue study treatment|7|||
154967478|NCT02272803|559303338|FG000|Overall Study|Maximum clinical benefit|4|||
154967479|NCT02272803|559303339|FG001|Overall Study|Maximum clinical benefit|2|||
154967480|NCT02272803|559303338|FG000|Overall Study|Poor/non-compliance|2|||
154967481|NCT02272803|559303339|FG001|Overall Study|Poor/non-compliance|2|||
154967482|NCT02272803|559303338|FG000|Overall Study|Withdrawal by Subject|2|||
154967483|NCT02272803|559303339|FG001|Overall Study|Withdrawal by Subject|1|||
154967484|NCT02272803|559303338|FG000|Overall Study|Death|0|||
154967485|NCT02272803|559303339|FG001|Overall Study|Death|1|||
154967486|NCT02272803|559303338|FG000|Overall Study|Other reasons|1|||
154967487|NCT02272803|559303339|FG001|Overall Study|Other reasons|3|||
154967488|NCT02272803|559303338|FG000|Overall Study|Administrative reason by sponsor|5|||
154967489|NCT02272803|559303339|FG001|Overall Study|Administrative reason by sponsor|4|||
154967490|NCT02611323|559303340|FG000|Overall Study|Death|3|||
154967491|NCT02611323|559303341|FG001|Overall Study|Death|1|||
154967492|NCT02611323|559303342|FG002|Overall Study|Death|0|||
154967493|NCT02611323|559303343|FG003|Overall Study|Death|0|||
154967494|NCT02611323|559303344|FG004|Overall Study|Death|1|||
154967495|NCT02611323|559303345|FG005|Overall Study|Death|1|||
154967496|NCT02611323|559303346|FG006|Overall Study|Death|8|||
154967497|NCT02611323|559303347|FG007|Overall Study|Death|0|||
154967498|NCT02611323|559303348|FG008|Overall Study|Death|4|||
154967499|NCT02611323|559303349|FG009|Overall Study|Death|6|||
154967500|NCT02611323|559303350|FG010|Overall Study|Death|26|||
154967501|NCT02611323|559303340|FG000|Overall Study|Lost to Follow-up|1|||
154967502|NCT02611323|559303341|FG001|Overall Study|Lost to Follow-up|0|||
154967503|NCT02611323|559303342|FG002|Overall Study|Lost to Follow-up|0|||
154967504|NCT02611323|559303343|FG003|Overall Study|Lost to Follow-up|0|||
154967505|NCT02611323|559303344|FG004|Overall Study|Lost to Follow-up|0|||
154967506|NCT02611323|559303345|FG005|Overall Study|Lost to Follow-up|0|||
154967507|NCT02611323|559303346|FG006|Overall Study|Lost to Follow-up|3|||
154967508|NCT02611323|559303347|FG007|Overall Study|Lost to Follow-up|0|||
154967509|NCT02611323|559303348|FG008|Overall Study|Lost to Follow-up|0|||
154967510|NCT02611323|559303349|FG009|Overall Study|Lost to Follow-up|0|||
154967511|NCT02611323|559303350|FG010|Overall Study|Lost to Follow-up|2|||
154967512|NCT02611323|559303340|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967513|NCT02611323|559303341|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967514|NCT02611323|559303342|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967515|NCT02611323|559303343|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967516|NCT02611323|559303344|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967517|NCT02611323|559303345|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
155095447|NCT04881760|559783723|FG001|Overall Study|Death|0|||
155095448|NCT04881760|559783724|FG002|Overall Study|Death|0|||
155095449|NCT04881760|559783725|FG003|Overall Study|Death|1|||
155095450|NCT04881760|559783726|FG004|Overall Study|Death|0|||
155095451|NCT04881760|559783727|FG005|Overall Study|Death|0|||
155095452|NCT04881760|559783728|FG006|Overall Study|Death|0|||
155095453|NCT04881760|559783722|FG000|Overall Study|Lost to Follow-up|5|||
155095454|NCT04881760|559783723|FG001|Overall Study|Lost to Follow-up|7|||
155095455|NCT04881760|559783724|FG002|Overall Study|Lost to Follow-up|5|||
155095456|NCT04881760|559783725|FG003|Overall Study|Lost to Follow-up|1|||
155095457|NCT04881760|559783726|FG004|Overall Study|Lost to Follow-up|2|||
155095458|NCT04881760|559783727|FG005|Overall Study|Lost to Follow-up|4|||
155095459|NCT04881760|559783728|FG006|Overall Study|Lost to Follow-up|4|||
155095460|NCT04881760|559783722|FG000|Overall Study|Withdrawal by Subject|13|||
155095461|NCT04881760|559783723|FG001|Overall Study|Withdrawal by Subject|1|||
155095462|NCT04881760|559783724|FG002|Overall Study|Withdrawal by Subject|1|||
155095463|NCT04881760|559783725|FG003|Overall Study|Withdrawal by Subject|4|||
155095464|NCT04881760|559783726|FG004|Overall Study|Withdrawal by Subject|2|||
155095465|NCT04881760|559783727|FG005|Overall Study|Withdrawal by Subject|1|||
155095466|NCT04881760|559783728|FG006|Overall Study|Withdrawal by Subject|2|||
155095467|NCT04881760|559783722|FG000|Overall Study|Randomized but Never Treated|0|||
155095468|NCT04881760|559783723|FG001|Overall Study|Randomized but Never Treated|0|||
155095469|NCT04881760|559783724|FG002|Overall Study|Randomized but Never Treated|0|||
155095470|NCT04881760|559783725|FG003|Overall Study|Randomized but Never Treated|1|||
155095471|NCT04881760|559783726|FG004|Overall Study|Randomized but Never Treated|0|||
155095472|NCT04881760|559783727|FG005|Overall Study|Randomized but Never Treated|0|||
155095473|NCT04881760|559783728|FG006|Overall Study|Randomized but Never Treated|0|||
155095474|NCT04881760|559783722|FG000|Overall Study|Inadvertent Enrollment|2|||
155095475|NCT04881760|559783723|FG001|Overall Study|Inadvertent Enrollment|0|||
155095476|NCT04881760|559783724|FG002|Overall Study|Inadvertent Enrollment|0|||
155095477|NCT04881760|559783725|FG003|Overall Study|Inadvertent Enrollment|0|||
155095478|NCT04881760|559783726|FG004|Overall Study|Inadvertent Enrollment|0|||
155095479|NCT04881760|559783727|FG005|Overall Study|Inadvertent Enrollment|0|||
155095480|NCT04881760|559783728|FG006|Overall Study|Inadvertent Enrollment|0|||
155095481|NCT04881760|559783722|FG000|Overall Study|Site Closure|0|||
155095482|NCT04881760|559783723|FG001|Overall Study|Site Closure|0|||
155095483|NCT04881760|559783724|FG002|Overall Study|Site Closure|0|||
155095484|NCT04881760|559783725|FG003|Overall Study|Site Closure|1|||
155095485|NCT04881760|559783726|FG004|Overall Study|Site Closure|0|||
155095486|NCT04881760|559783727|FG005|Overall Study|Site Closure|0|||
155095487|NCT04881760|559783728|FG006|Overall Study|Site Closure|0|||
155095488|NCT02081586|559783729|FG000|Overall Study|Lost to Follow-up|0|||
155095489|NCT02081586|559783730|FG001|Overall Study|Lost to Follow-up|1|||
155095490|NCT02081586|559783731|FG002|Overall Study|Lost to Follow-up|0|||
155095491|NCT02081586|559783732|FG003|Overall Study|Lost to Follow-up|1|||
155095492|NCT02081586|559783729|FG000|Overall Study|Head injury not related to study|0|||
155095493|NCT02081586|559783730|FG001|Overall Study|Head injury not related to study|0|||
155095494|NCT02081586|559783731|FG002|Overall Study|Head injury not related to study|1|||
155095495|NCT02081586|559783732|FG003|Overall Study|Head injury not related to study|0|||
155095496|NCT04540367|559783743|FG000|Overall Study|Withdrawal by Subject|0|||
155095497|NCT04540367|559783744|FG001|Overall Study|Withdrawal by Subject|0|||
155095498|NCT04540367|559783745|FG002|Overall Study|Withdrawal by Subject|0|||
155095499|NCT04540367|559783746|FG003|Overall Study|Withdrawal by Subject|2|||
155095500|NCT04540367|559783743|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
155095501|NCT04540367|559783744|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
155095502|NCT04540367|559783745|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
155095503|NCT04540367|559783746|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
155095504|NCT04540367|559783743|FG000|Overall Study|Adverse Event|0|||
155095505|NCT04540367|559783744|FG001|Overall Study|Adverse Event|0|||
155095506|NCT04540367|559783745|FG002|Overall Study|Adverse Event|1|||
155095507|NCT04540367|559783746|FG003|Overall Study|Adverse Event|1|||
155095508|NCT02121509|559783752|FG000|Washout Period (35 Days)|Adverse Event|1|||
155095509|NCT02121509|559783753|FG001|Washout Period (35 Days)|Adverse Event|1|||
155095510|NCT02121509|559783754|FG002|Washout Period (35 Days)|Adverse Event|0|||
155095511|NCT02121509|559783755|FG003|Washout Period (35 Days)|Adverse Event|0|||
155095512|NCT02121509|559783752|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
155095513|NCT02121509|559783753|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
155095514|NCT02121509|559783754|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
155095515|NCT02121509|559783755|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
155095516|NCT02121509|559783752|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
155095517|NCT02121509|559783753|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
155095518|NCT02121509|559783754|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
155095519|NCT02121509|559783755|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
155095520|NCT00867035|559783758|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
154967518|NCT02611323|559303346|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
155095521|NCT00867035|559783759|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
155095522|NCT00867035|559783758|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
155095523|NCT00867035|559783759|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
155095524|NCT05076045|559783760|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
155095525|NCT05076045|559783761|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
155095526|NCT02993263|559783766|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
155095527|NCT04704193|559783769|FG000|Overall Study|Withdrawal by Subject|1|||
155095528|NCT00542178|559783770|FG000|Overall Study|did not complete year 4 follow-up|75|||
155095529|NCT00542178|559783771|FG001|Overall Study|did not complete year 4 follow-up|80|||
155095530|NCT00542178|559783772|FG002|Overall Study|did not complete year 4 follow-up|74|||
155095531|NCT00542178|559783773|FG003|Overall Study|did not complete year 4 follow-up|62|||
155095532|NCT00542178|559783774|FG004|Overall Study|did not complete year 4 follow-up|64|||
155095533|NCT00542178|559783775|FG005|Overall Study|did not complete year 4 follow-up|89|||
155095534|NCT00542178|559783776|FG006|Overall Study|did not complete year 4 follow-up|87|||
155095535|NCT00542178|559783777|FG007|Overall Study|did not complete year 4 follow-up|85|||
155095536|NCT00829998|559783778|FG000|Washout|Adverse Event|0|||
155095537|NCT00829998|559783779|FG001|Washout|Adverse Event|1|||
155095538|NCT03384875|559783780|FG000|Overall Study|Death|1|||
155095539|NCT03384875|559783781|FG001|Overall Study|Death|1|||
155095540|NCT03384875|559783782|FG002|Overall Study|Death|0|||
155095541|NCT03384875|559783780|FG000|Overall Study|Reason not provided|1|||
155095542|NCT03384875|559783781|FG001|Overall Study|Reason not provided|0|||
155095543|NCT03384875|559783782|FG002|Overall Study|Reason not provided|0|||
155150911|NCT00556894|559985828|FG000|Overall Study|Withdrawal by Subject|1|||
155150912|NCT00556894|559985829|FG001|Overall Study|Withdrawal by Subject|1|||
155150913|NCT00556894|559985830|FG002|Overall Study|Withdrawal by Subject|1|||
155150914|NCT03883581|559985831|FG000|Overall Study|Withdrawal by Subject|4|||
155150915|NCT00740220|559988122|FG000|Overall Study|screen failures (non-COPD patients)|9|||
155150916|NCT01602224|559988123|FG000|Overall Study|Adverse Event|0|||
155150917|NCT01602224|559988124|FG001|Overall Study|Adverse Event|1|||
155150918|NCT01602224|559988125|FG002|Overall Study|Adverse Event|0|||
155150919|NCT01602224|559988123|FG000|Overall Study|Investigator Decison|1|||
155150920|NCT01602224|559988124|FG001|Overall Study|Investigator Decison|0|||
155150921|NCT01602224|559988125|FG002|Overall Study|Investigator Decison|0|||
155150922|NCT01602224|559988123|FG000|Overall Study|Lost to Follow-up|0|||
155150923|NCT01602224|559988124|FG001|Overall Study|Lost to Follow-up|0|||
155150924|NCT01602224|559988125|FG002|Overall Study|Lost to Follow-up|1|||
155150925|NCT01602224|559988123|FG000|Overall Study|Protocol Violation|0|||
155150926|NCT01602224|559988124|FG001|Overall Study|Protocol Violation|1|||
155150927|NCT01602224|559988125|FG002|Overall Study|Protocol Violation|0|||
155150928|NCT01602224|559988123|FG000|Overall Study|Sponsor Decision|2|||
155150929|NCT01602224|559988124|FG001|Overall Study|Sponsor Decision|3|||
155150930|NCT01602224|559988125|FG002|Overall Study|Sponsor Decision|2|||
155150931|NCT01602224|559988123|FG000|Overall Study|Withdrawal by Subject|5|||
155150932|NCT01602224|559988124|FG001|Overall Study|Withdrawal by Subject|3|||
155150933|NCT01602224|559988125|FG002|Overall Study|Withdrawal by Subject|3|||
154967519|NCT02611323|559303347|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
155095544|NCT02026011|559785585|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
155095545|NCT02026011|559785586|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
155095546|NCT02026011|559785585|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
155095547|NCT02026011|559785586|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
155095548|NCT02026011|559785585|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
155095549|NCT02026011|559785586|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
155095550|NCT02026011|559785585|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
155095551|NCT02026011|559785586|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
155095552|NCT05010070|559785587|FG000|Overall Study|Lost to Follow-up|1|||
155095553|NCT05010070|559785587|FG000|Overall Study|Withdrawal by Subject|1|||
155095554|NCT00529243|559785589|FG000|Overall Study|Adverse Event|1|||
155095555|NCT00529243|559785589|FG000|Overall Study|Death|1|||
155095556|NCT00529243|559785589|FG000|Overall Study|Relocated|1|||
155095557|NCT02896257|559785590|FG000|Providers|Without eligible patients|21|||
155095558|NCT02896257|559785591|FG001|Providers|Without eligible patients|28|||
155095559|NCT02896257|559785590|FG000|Patients|PFT entry criteria not met|43|||
155095560|NCT02896257|559785591|FG001|Patients|PFT entry criteria not met|50|||
155095561|NCT02896257|559785590|FG000|Patients|No capacity to review|8|||
155095562|NCT02896257|559785591|FG001|Patients|No capacity to review|11|||
155095563|NCT02896257|559785590|FG000|Patients|Appointment rescheduled/cancelled|5|||
155095564|NCT02896257|559785591|FG001|Patients|Appointment rescheduled/cancelled|7|||
155095565|NCT02896257|559785590|FG000|Patients|PCP not assigned a clinic|4|||
155095566|NCT02896257|559785591|FG001|Patients|PCP not assigned a clinic|0|||
155095567|NCT02896257|559785590|FG000|Patients|No history of COPD|0|||
155095568|NCT02896257|559785591|FG001|Patients|No history of COPD|1|||
155095569|NCT02896257|559785590|FG000|Patients|Deceased between review and index date|0|||
155095570|NCT02896257|559785591|FG001|Patients|Deceased between review and index date|1|||
155095571|NCT02896257|559785590|FG000|Patients|No ICS Rx upon review|1|||
155095572|NCT02896257|559785591|FG001|Patients|No ICS Rx upon review|1|||
155095573|NCT02896257|559785590|FG000|Patients|Protocol Violation|2|||
155095574|NCT02896257|559785591|FG001|Patients|Protocol Violation|1|||
155095575|NCT02896257|559785590|FG000|Patients|Hospice care|0|||
155095576|NCT02896257|559785591|FG001|Patients|Hospice care|1|||
155095577|NCT03759600|559785596|FG000|Overall Study|Adverse Event|2|||
155095578|NCT03759600|559785596|FG000|Overall Study|Progressive Disease|15|||
155095579|NCT03759600|559785596|FG000|Overall Study|Site Terminated by Sponsor|3|||
155171108|NCT00006409|560065332|FG003|Post-3 Year Intervention|Protocol Violation|0|||
155171109|NCT00006409|560065333|FG004|Post-3 Year Intervention|Protocol Violation|62|||
155171110|NCT00006409|560065334|FG005|Post-3 Year Intervention|Protocol Violation|62|||
155171111|NCT03679754|560065336|FG000|Overall Study|Investigator request|1|||
155171112|NCT00964171|560065337|FG000|Overall Study|Death|5|||
155171113|NCT00080899|560065338|FG000|Overall Study|Adverse Event|1|||
155171114|NCT05343624|560065340|FG000|Overall Study|Chart review not completed|1|||
155171115|NCT02640508|560065341|FG000|Overall Study|Death|19|||
155171116|NCT02640508|560065341|FG000|Overall Study|Withdrawal by Subject|8|||
155171117|NCT02640508|560065341|FG000|Overall Study|Physician Decision|1|||
155171118|NCT02640508|560065341|FG000|Overall Study|Lost to Follow-up|1|||
155171119|NCT05405257|560065342|FG000|Overall Study|Withdrawal by Subject|1|||
155171120|NCT00776919|560065343|FG000|Overall Study|Withdrawal by Subject|16|||
155171121|NCT00776919|560065344|FG001|Overall Study|Withdrawal by Subject|14|||
155171122|NCT00776919|560065345|FG002|Overall Study|Withdrawal by Subject|15|||
155171123|NCT00776919|560065346|FG003|Overall Study|Withdrawal by Subject|26|||
155171124|NCT00776919|560065343|FG000|Overall Study|Lost to Follow-up|8|||
155171125|NCT00776919|560065344|FG001|Overall Study|Lost to Follow-up|12|||
155171126|NCT00776919|560065345|FG002|Overall Study|Lost to Follow-up|11|||
155171127|NCT00776919|560065346|FG003|Overall Study|Lost to Follow-up|8|||
155171128|NCT00776919|560065343|FG000|Overall Study|Adverse Event|1|||
155171129|NCT00776919|560065344|FG001|Overall Study|Adverse Event|0|||
155171130|NCT00776919|560065345|FG002|Overall Study|Adverse Event|2|||
155171131|NCT00776919|560065346|FG003|Overall Study|Adverse Event|2|||
155171132|NCT00776919|560065343|FG000|Overall Study|Protocol Violation|1|||
155171133|NCT00776919|560065344|FG001|Overall Study|Protocol Violation|2|||
155171134|NCT00776919|560065345|FG002|Overall Study|Protocol Violation|0|||
155171135|NCT00776919|560065346|FG003|Overall Study|Protocol Violation|1|||
155171136|NCT00776919|560065343|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
155171137|NCT00776919|560065344|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
155171138|NCT00776919|560065345|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
155171139|NCT00776919|560065346|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
155171140|NCT03091348|560065355|FG000|Overall Study|Lost to Follow-up|2|||
155171141|NCT03091348|560065356|FG001|Overall Study|Lost to Follow-up|1|||
155171142|NCT04534686|560065357|FG000|Baseline Measurement|Lost to Follow-up|4|||
155171143|NCT04534686|560065358|FG001|Baseline Measurement|Lost to Follow-up|6|||
155171144|NCT04534686|560065357|FG000|Baseline Measurement|Withdrawal by Subject|3|||
155171145|NCT04534686|560065358|FG001|Baseline Measurement|Withdrawal by Subject|1|||
155171146|NCT04534686|560065357|FG000|Intervention|Withdrawal by Subject|2|||
155171147|NCT04534686|560065358|FG001|Intervention|Withdrawal by Subject|2|||
155171148|NCT00635999|560065359|FG000|Overall Study|Withdrawal by Subject|4|||
155171149|NCT00635999|560065360|FG001|Overall Study|Withdrawal by Subject|2|||
155171150|NCT00635999|560065361|FG002|Overall Study|Withdrawal by Subject|1|||
155171151|NCT02636361|560065362|FG000|Period 4|Physician Decision|0|||
155171152|NCT02636361|560065363|FG001|Period 4|Physician Decision|0|||
155171153|NCT02636361|560065364|FG002|Period 4|Physician Decision|0|||
155171154|NCT02636361|560065365|FG003|Period 4|Physician Decision|1|||
155171155|NCT02636361|560065366|FG004|Period 4|Physician Decision|0|||
155171156|NCT03037580|560065373|FG000|Overall Study|Withdrawal by Subject|3|||
155171157|NCT03037580|560065374|FG001|Overall Study|Withdrawal by Subject|0|||
155171158|NCT03037580|560065373|FG000|Overall Study|Adverse Event|1|||
155171159|NCT03037580|560065374|FG001|Overall Study|Adverse Event|0|||
155171160|NCT03037580|560065373|FG000|Overall Study|Study Terminated by Sponsor|12|||
155171161|NCT03037580|560065374|FG001|Overall Study|Study Terminated by Sponsor|15|||
155171162|NCT03037580|560065373|FG000|Overall Study|Death|0|||
155171163|NCT03037580|560065374|FG001|Overall Study|Death|1|||
155171164|NCT02036853|560065375|FG000|Overall Study|Adverse Event|0|||
155171165|NCT02036853|560065376|FG001|Overall Study|Adverse Event|2|||
155171166|NCT02036853|560065375|FG000|Overall Study|Lack of Efficacy|0|||
155171167|NCT02036853|560065376|FG001|Overall Study|Lack of Efficacy|2|||
155171168|NCT02036853|560065375|FG000|Overall Study|Physician Decision|0|||
155171169|NCT02036853|560065376|FG001|Overall Study|Physician Decision|1|||
155171170|NCT02036853|560065375|FG000|Overall Study|Withdrawal by Subject|0|||
155171171|NCT02036853|560065376|FG001|Overall Study|Withdrawal by Subject|1|||
155171172|NCT00228553|560065377|FG000|Overall Study|Adverse Event|112|||
155171173|NCT00228553|560065377|FG000|Overall Study|Lack of Efficacy|34|||
155171174|NCT00228553|560065377|FG000|Overall Study|Lost to Follow-up|67|||
155171175|NCT00228553|560065377|FG000|Overall Study|Physician Decision|48|||
155171176|NCT00228553|560065377|FG000|Overall Study|Protocol Violation|6|||
155171177|NCT00228553|560065377|FG000|Overall Study|Withdrawal by Subject|115|||
155171178|NCT00228553|560065377|FG000|Overall Study|Pregnancy|2|||
155171179|NCT00228553|560065377|FG000|Overall Study|Miscellaneous|46|||
155171180|NCT03500224|560065381|FG000|Overall Study|Withdrawal by Subject|2|||
155171181|NCT00335764|560065382|FG000|Overall Study|wrong histology|1|||
155171182|NCT00335764|560065383|FG001|Overall Study|wrong histology|0|||
155171183|NCT00335764|560065384|FG002|Overall Study|wrong histology|0|||
155171184|NCT00335764|560065385|FG003|Overall Study|wrong histology|0|||
155171185|NCT00335764|560065386|FG004|Overall Study|wrong histology|1|||
155171186|NCT00499590|560065387|FG000|Overall Study|Study Terminated|112|||
155171187|NCT00499590|560065388|FG001|Overall Study|Study Terminated|112|||
155171188|NCT00499590|560065389|FG002|Overall Study|Study Terminated|112|||
155171189|NCT00499590|560065387|FG000|Overall Study|Not treated|1|||
155171190|NCT00499590|560065388|FG001|Overall Study|Not treated|0|||
155171191|NCT00499590|560065389|FG002|Overall Study|Not treated|1|||
155171192|NCT00612807|560065391|FG000|Overall Study|Withdrawal by Subject|2|||
155171193|NCT00612807|560065392|FG001|Overall Study|Withdrawal by Subject|0|||
155171194|NCT00782834|560065401|FG000|Treatment Phase|fibrous tumor not GIST|1|||
155171195|NCT01215097|560065403|FG000|Overall Study|Adverse Event|1|||
155171196|NCT01215097|560065404|FG001|Overall Study|Adverse Event|3|||
155171197|NCT01215097|560065403|FG000|Overall Study|Protocol Violation|0|||
155171198|NCT01215097|560065404|FG001|Overall Study|Protocol Violation|2|||
155171199|NCT01215097|560065403|FG000|Overall Study|Lost to Follow-up|2|||
155171200|NCT01215097|560065404|FG001|Overall Study|Lost to Follow-up|0|||
155171201|NCT01215097|560065403|FG000|Overall Study|Withdrawal by Subject|6|||
155171202|NCT01215097|560065404|FG001|Overall Study|Withdrawal by Subject|3|||
155171203|NCT01215097|560065403|FG000|Overall Study|Lack of Efficacy|0|||
155171204|NCT01215097|560065404|FG001|Overall Study|Lack of Efficacy|3|||
155171205|NCT01215097|560065403|FG000|Overall Study|patient's refusal to come|2|||
155171206|NCT01215097|560065404|FG001|Overall Study|patient's refusal to come|2|||
155171207|NCT01215097|560065403|FG000|Overall Study|patient's private reason|1|||
155171208|NCT01215097|560065404|FG001|Overall Study|patient's private reason|1|||
155171209|NCT02259088|560065405|FG000|Overall Study|Adverse Event|6|||
155171210|NCT02259088|560065406|FG001|Overall Study|Adverse Event|4|||
155171211|NCT02259088|560065405|FG000|Overall Study|Lost to Follow-up|2|||
155171212|NCT02259088|560065406|FG001|Overall Study|Lost to Follow-up|0|||
155171213|NCT02259088|560065405|FG000|Overall Study|Death|2|||
155171214|NCT02259088|560065406|FG001|Overall Study|Death|0|||
155171215|NCT02259088|560065405|FG000|Overall Study|Physician Decision|5|||
155171216|NCT02259088|560065406|FG001|Overall Study|Physician Decision|2|||
155171217|NCT02259088|560065405|FG000|Overall Study|Protocol deviation|5|||
155095580|NCT03257358|559785597|FG000|Overall Study|Adverse Event|25|||
155095581|NCT03257358|559785598|FG001|Overall Study|Adverse Event|12|||
155095582|NCT03257358|559785597|FG000|Overall Study|Lack of Efficacy|1|||
155095583|NCT03257358|559785598|FG001|Overall Study|Lack of Efficacy|1|||
155095584|NCT03257358|559785597|FG000|Overall Study|Lost to Follow-up|12|||
155095585|NCT03257358|559785598|FG001|Overall Study|Lost to Follow-up|4|||
155095586|NCT03257358|559785597|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
155095587|NCT03257358|559785598|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
155095588|NCT03257358|559785597|FG000|Overall Study|Physician Decision|2|||
155095589|NCT03257358|559785598|FG001|Overall Study|Physician Decision|2|||
155095590|NCT03257358|559785597|FG000|Overall Study|Protocol Violation|5|||
155095591|NCT03257358|559785598|FG001|Overall Study|Protocol Violation|3|||
155095592|NCT03257358|559785597|FG000|Overall Study|Technical problems|4|||
155171218|NCT02259088|560065406|FG001|Overall Study|Protocol deviation|0|||
155171219|NCT02259088|560065405|FG000|Overall Study|Subject/guardian decision|8|||
155171220|NCT02259088|560065406|FG001|Overall Study|Subject/guardian decision|8|||
154967520|NCT02611323|559303348|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967521|NCT02611323|559303349|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
155171221|NCT01818752|560065408|FG000|Overall Study|Adverse Event|64|||
155171222|NCT01818752|560065409|FG001|Overall Study|Adverse Event|74|||
155171223|NCT01818752|560065408|FG000|Overall Study|Death|14|||
155171224|NCT01818752|560065409|FG001|Overall Study|Death|18|||
155171225|NCT01818752|560065408|FG000|Overall Study|Non-compliance|16|||
155171226|NCT01818752|560065409|FG001|Overall Study|Non-compliance|20|||
155171227|NCT01818752|560065408|FG000|Overall Study|Withdrawal by Subject|15|||
155171228|NCT01818752|560065409|FG001|Overall Study|Withdrawal by Subject|14|||
155095593|NCT03257358|559785598|FG001|Overall Study|Technical problems|1|||
155095594|NCT03257358|559785597|FG000|Overall Study|Withdrawal by Subject|8|||
155095595|NCT03257358|559785598|FG001|Overall Study|Withdrawal by Subject|3|||
155171229|NCT01818752|560065408|FG000|Overall Study|Physician Decision|9|||
155095596|NCT03257358|559785597|FG000|Overall Study|Withdrawal of informed consent|9|||
155095597|NCT03257358|559785598|FG001|Overall Study|Withdrawal of informed consent|5|||
155095598|NCT03257358|559785597|FG000|Overall Study|New therapy for study indication|1|||
155095599|NCT03257358|559785598|FG001|Overall Study|New therapy for study indication|0|||
155095600|NCT03257358|559785597|FG000|Overall Study|No longer requires treatment|0|||
155095601|NCT03257358|559785598|FG001|Overall Study|No longer requires treatment|1|||
155095602|NCT01669902|559785599|FG000|Overall Study|Adverse Event|11|||
155095603|NCT01669902|559785599|FG000|Overall Study|Lack of Efficacy|10|||
155095604|NCT01669902|559785599|FG000|Overall Study|Other|8|||
155095605|NCT02903823|559785600|FG000|Overall Study|Physician Decision|5|||
155095606|NCT02903823|559785600|FG000|Overall Study|Could not advance catheter|1|||
155095607|NCT02903823|559785600|FG000|Overall Study|Catheter dislodgement|1|||
155095608|NCT02852967|559785601|FG000|Overall Study|Adverse Event|3|||
155095609|NCT02852967|559785602|FG001|Overall Study|Adverse Event|1|||
155095610|NCT02852967|559785603|FG002|Overall Study|Adverse Event|0|||
155095611|NCT02852967|559785604|FG003|Overall Study|Adverse Event|1|||
155095612|NCT02852967|559785605|FG004|Overall Study|Adverse Event|0|||
155095613|NCT02852967|559785601|FG000|Overall Study|Death|1|||
155095614|NCT02852967|559785602|FG001|Overall Study|Death|0|||
155095615|NCT02852967|559785603|FG002|Overall Study|Death|0|||
155095616|NCT02852967|559785604|FG003|Overall Study|Death|0|||
155095617|NCT02852967|559785605|FG004|Overall Study|Death|0|||
155095618|NCT02852967|559785601|FG000|Overall Study|Lost to Follow-up|1|||
155095619|NCT02852967|559785602|FG001|Overall Study|Lost to Follow-up|2|||
155095620|NCT02852967|559785603|FG002|Overall Study|Lost to Follow-up|3|||
155095621|NCT02852967|559785604|FG003|Overall Study|Lost to Follow-up|4|||
155095622|NCT02852967|559785605|FG004|Overall Study|Lost to Follow-up|4|||
155095623|NCT02852967|559785601|FG000|Overall Study|Withdrawal by Subject|6|||
155095624|NCT02852967|559785602|FG001|Overall Study|Withdrawal by Subject|12|||
155095625|NCT02852967|559785603|FG002|Overall Study|Withdrawal by Subject|7|||
155095626|NCT02852967|559785604|FG003|Overall Study|Withdrawal by Subject|10|||
155095627|NCT02852967|559785605|FG004|Overall Study|Withdrawal by Subject|10|||
155095628|NCT02852967|559785601|FG000|Overall Study|SAE|0|||
155095629|NCT02852967|559785602|FG001|Overall Study|SAE|0|||
155095630|NCT02852967|559785603|FG002|Overall Study|SAE|0|||
155095631|NCT02852967|559785604|FG003|Overall Study|SAE|3|||
155095632|NCT02852967|559785605|FG004|Overall Study|SAE|0|||
155095633|NCT02852967|559785601|FG000|Overall Study|Elevated Liver Enzymes|2|||
155095634|NCT02852967|559785602|FG001|Overall Study|Elevated Liver Enzymes|0|||
155095635|NCT02852967|559785603|FG002|Overall Study|Elevated Liver Enzymes|0|||
155095636|NCT02852967|559785604|FG003|Overall Study|Elevated Liver Enzymes|2|||
155095637|NCT02852967|559785605|FG004|Overall Study|Elevated Liver Enzymes|2|||
155095638|NCT02852967|559785601|FG000|Overall Study|Physician Decision|0|||
155095639|NCT02852967|559785602|FG001|Overall Study|Physician Decision|0|||
155095640|NCT02852967|559785603|FG002|Overall Study|Physician Decision|0|||
155095641|NCT02852967|559785604|FG003|Overall Study|Physician Decision|1|||
155095642|NCT02852967|559785605|FG004|Overall Study|Physician Decision|0|||
155095643|NCT02852967|559785601|FG000|Overall Study|Lack of Efficacy|0|||
155095644|NCT02852967|559785602|FG001|Overall Study|Lack of Efficacy|1|||
155095645|NCT02852967|559785603|FG002|Overall Study|Lack of Efficacy|0|||
155095646|NCT02852967|559785604|FG003|Overall Study|Lack of Efficacy|0|||
155095647|NCT02852967|559785605|FG004|Overall Study|Lack of Efficacy|0|||
155095648|NCT02852967|559785601|FG000|Overall Study|Non-compliance|0|||
155095649|NCT02852967|559785602|FG001|Overall Study|Non-compliance|0|||
155095650|NCT02852967|559785603|FG002|Overall Study|Non-compliance|1|||
155095651|NCT02852967|559785604|FG003|Overall Study|Non-compliance|1|||
155095652|NCT02852967|559785605|FG004|Overall Study|Non-compliance|0|||
154967522|NCT02611323|559303350|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
154967523|NCT02611323|559303340|FG000|Overall Study|Progressive Disease|0|||
154967524|NCT02611323|559303341|FG001|Overall Study|Progressive Disease|0|||
154967525|NCT02611323|559303342|FG002|Overall Study|Progressive Disease|0|||
154967526|NCT02611323|559303343|FG003|Overall Study|Progressive Disease|0|||
155095653|NCT02852967|559785601|FG000|Overall Study|Dispensing Drug Violation|0|||
155095654|NCT02852967|559785602|FG001|Overall Study|Dispensing Drug Violation|0|||
155095655|NCT02852967|559785603|FG002|Overall Study|Dispensing Drug Violation|1|||
155095656|NCT02852967|559785604|FG003|Overall Study|Dispensing Drug Violation|0|||
155095657|NCT02852967|559785605|FG004|Overall Study|Dispensing Drug Violation|0|||
155095658|NCT02852967|559785601|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
155095659|NCT02852967|559785602|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
155095660|NCT02852967|559785603|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
155095661|NCT02852967|559785604|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
155095662|NCT02852967|559785605|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
155095663|NCT00887159|559785612|FG000|Overall Study|Disease progression|6|||
155095664|NCT00887159|559785613|FG001|Overall Study|Disease progression|39|||
155095665|NCT00887159|559785614|FG002|Overall Study|Disease progression|33|||
154967527|NCT02611323|559303344|FG004|Overall Study|Progressive Disease|0|||
154967528|NCT02611323|559303345|FG005|Overall Study|Progressive Disease|0|||
155095666|NCT00887159|559785612|FG000|Overall Study|Adverse Event|3|||
155095667|NCT00887159|559785613|FG001|Overall Study|Adverse Event|4|||
155095668|NCT00887159|559785614|FG002|Overall Study|Adverse Event|17|||
155095669|NCT00887159|559785612|FG000|Overall Study|Death|2|||
155095670|NCT00887159|559785613|FG001|Overall Study|Death|2|||
155095671|NCT00887159|559785614|FG002|Overall Study|Death|0|||
155095672|NCT00887159|559785612|FG000|Overall Study|Withdrawal by Subject|4|||
155095673|NCT00887159|559785613|FG001|Overall Study|Withdrawal by Subject|4|||
155095674|NCT00887159|559785614|FG002|Overall Study|Withdrawal by Subject|2|||
155095675|NCT00887159|559785612|FG000|Overall Study|Alternative therapy|2|||
155095676|NCT00887159|559785613|FG001|Overall Study|Alternative therapy|0|||
155095677|NCT00887159|559785614|FG002|Overall Study|Alternative therapy|0|||
155095678|NCT00887159|559785612|FG000|Overall Study|Physician Decision|1|||
155095679|NCT00887159|559785613|FG001|Overall Study|Physician Decision|1|||
155095680|NCT00887159|559785614|FG002|Overall Study|Physician Decision|0|||
155095681|NCT00887159|559785612|FG000|Overall Study|Sympomatic deterioration|1|||
155095682|NCT00887159|559785613|FG001|Overall Study|Sympomatic deterioration|0|||
155095683|NCT00887159|559785614|FG002|Overall Study|Sympomatic deterioration|0|||
155095684|NCT00887159|559785612|FG000|Overall Study|Treatment delayed|1|||
155095685|NCT00887159|559785613|FG001|Overall Study|Treatment delayed|1|||
155095686|NCT00887159|559785614|FG002|Overall Study|Treatment delayed|0|||
155095687|NCT00887159|559785612|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
155095688|NCT00887159|559785613|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
155095689|NCT00887159|559785614|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
155095690|NCT00887159|559785612|FG000|Overall Study|Received more tx instead of observation|1|||
155095691|NCT00887159|559785613|FG001|Overall Study|Received more tx instead of observation|0|||
155095692|NCT00887159|559785614|FG002|Overall Study|Received more tx instead of observation|0|||
155095693|NCT00887159|559785612|FG000|Overall Study|Ineligible|5|||
155095694|NCT00887159|559785613|FG001|Overall Study|Ineligible|1|||
155095695|NCT00887159|559785614|FG002|Overall Study|Ineligible|0|||
155095696|NCT00887159|559785612|FG000|Overall Study|Never started assigned therapy|3|||
155095697|NCT00887159|559785613|FG001|Overall Study|Never started assigned therapy|3|||
155095698|NCT00887159|559785614|FG002|Overall Study|Never started assigned therapy|4|||
155095699|NCT00688467|559785615|FG000|Treatment Period 1|Adverse Event|2|||
155095700|NCT00688467|559785616|FG001|Treatment Period 1|Adverse Event|1|||
155095701|NCT00688467|559785615|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
155095702|NCT00688467|559785616|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
155095703|NCT00688467|559785615|FG000|Treatment Period 2|Protocol Violation|0|||
155095704|NCT00688467|559785616|FG001|Treatment Period 2|Protocol Violation|1|||
155095705|NCT00688467|559785615|FG000|Treatment Period 2|Adverse Event|0|||
155095706|NCT00688467|559785616|FG001|Treatment Period 2|Adverse Event|1|||
155095707|NCT00690794|559785617|FG000|Overall Study|Adverse Event|12|||
155095708|NCT00690794|559785618|FG001|Overall Study|Adverse Event|10|||
155095709|NCT00690794|559785617|FG000|Overall Study|Lost to Follow-up|1|||
155095710|NCT00690794|559785618|FG001|Overall Study|Lost to Follow-up|4|||
155095711|NCT00690794|559785617|FG000|Overall Study|Withdrawal by Subject|0|||
155095712|NCT00690794|559785618|FG001|Overall Study|Withdrawal by Subject|9|||
155095713|NCT00690794|559785617|FG000|Overall Study|Protocol Violation|6|||
155095714|NCT00690794|559785618|FG001|Overall Study|Protocol Violation|7|||
155095715|NCT00690794|559785617|FG000|Overall Study|Noncompliance|1|||
155095716|NCT00690794|559785618|FG001|Overall Study|Noncompliance|2|||
155095717|NCT00690794|559785617|FG000|Overall Study|Other not specified|1|||
155095718|NCT00690794|559785618|FG001|Overall Study|Other not specified|3|||
155095719|NCT03848416|559785619|FG000|Overall Study|Withdrawal by Subject|1|||
155095720|NCT03848416|559785620|FG001|Overall Study|Withdrawal by Subject|0|||
155095721|NCT03848416|559785621|FG002|Overall Study|Withdrawal by Subject|0|||
155095722|NCT03848416|559785619|FG000|Overall Study|Death|0|||
155095723|NCT03848416|559785620|FG001|Overall Study|Death|0|||
155095724|NCT03848416|559785621|FG002|Overall Study|Death|1|||
155095725|NCT00856609|559785622|FG000|Overall Study|Adverse Event|1|||
155095726|NCT00856609|559785623|FG001|Overall Study|Adverse Event|0|||
155095727|NCT00783432|559785624|FG000|Overall Study|Adverse Event|22|||
155095728|NCT00783432|559785625|FG001|Overall Study|Adverse Event|17|||
155095729|NCT00783432|559785624|FG000|Overall Study|Lack of Efficacy|20|||
155095730|NCT00783432|559785625|FG001|Overall Study|Lack of Efficacy|21|||
155095731|NCT00783432|559785624|FG000|Overall Study|Lost to Follow-up|11|||
155095732|NCT00783432|559785625|FG001|Overall Study|Lost to Follow-up|6|||
155095733|NCT00783432|559785624|FG000|Overall Study|Withdrawal by Subject|23|||
155095734|NCT00783432|559785625|FG001|Overall Study|Withdrawal by Subject|20|||
155095735|NCT00783432|559785624|FG000|Overall Study|subject moved|3|||
155095736|NCT00783432|559785625|FG001|Overall Study|subject moved|5|||
155095737|NCT00783432|559785624|FG000|Overall Study|Protocol Violation|6|||
155095738|NCT00783432|559785625|FG001|Overall Study|Protocol Violation|9|||
155095739|NCT01436110|559785626|FG000|Overall Study|Lack of Efficacy|23|||
155095740|NCT01436110|559785627|FG001|Overall Study|Lack of Efficacy|14|||
155095741|NCT01436110|559785628|FG002|Overall Study|Lack of Efficacy|9|||
155095742|NCT01436110|559785626|FG000|Overall Study|Withdrawal by Subject|6|||
155095743|NCT01436110|559785627|FG001|Overall Study|Withdrawal by Subject|8|||
155095744|NCT01436110|559785628|FG002|Overall Study|Withdrawal by Subject|4|||
155095745|NCT01436110|559785626|FG000|Overall Study|Adverse Event|2|||
155095746|NCT01436110|559785627|FG001|Overall Study|Adverse Event|1|||
155095747|NCT01436110|559785628|FG002|Overall Study|Adverse Event|2|||
155095748|NCT01436110|559785626|FG000|Overall Study|Physician Decision|3|||
155095749|NCT01436110|559785627|FG001|Overall Study|Physician Decision|1|||
155095750|NCT01436110|559785628|FG002|Overall Study|Physician Decision|1|||
155095751|NCT01436110|559785626|FG000|Overall Study|Lost to Follow-up|1|||
155095752|NCT01436110|559785627|FG001|Overall Study|Lost to Follow-up|1|||
155095753|NCT01436110|559785628|FG002|Overall Study|Lost to Follow-up|3|||
155095754|NCT01436110|559785626|FG000|Overall Study|Protocol Violation|3|||
155095755|NCT01436110|559785627|FG001|Overall Study|Protocol Violation|1|||
155095756|NCT01436110|559785628|FG002|Overall Study|Protocol Violation|1|||
155095757|NCT01436110|559785626|FG000|Overall Study|Did Not Receive Trial Medication|1|||
155095758|NCT01436110|559785627|FG001|Overall Study|Did Not Receive Trial Medication|0|||
155095759|NCT01436110|559785628|FG002|Overall Study|Did Not Receive Trial Medication|3|||
155095760|NCT03273907|559785629|FG000|Overall Study|Death|1|||
155095761|NCT03273907|559785629|FG000|Overall Study|Lost to Follow-up|4|||
155095762|NCT03273907|559785629|FG000|Overall Study|Withdrawal by Subject|2|||
155095763|NCT03273907|559785629|FG000|Overall Study|COVID 19|2|||
155095764|NCT01088503|559785630|FG000|Overall Study|Withdrawal by Subject|118|||
155095765|NCT01088503|559785631|FG001|Overall Study|Withdrawal by Subject|327|||
155095766|NCT01088503|559785632|FG002|Overall Study|Withdrawal by Subject|10|||
155095767|NCT01088503|559785630|FG000|Overall Study|Death|64|||
155095768|NCT01088503|559785631|FG001|Overall Study|Death|358|||
155095769|NCT01088503|559785632|FG002|Overall Study|Death|7|||
155095770|NCT00110214|559785633|FG000|Overall Study|Never started treatment|21|||
155095771|NCT00110214|559785634|FG001|Overall Study|Never started treatment|20|||
155095772|NCT00110214|559785633|FG000|Overall Study|Disease progression or death|260|||
155095773|NCT00110214|559785634|FG001|Overall Study|Disease progression or death|151|||
155095774|NCT00110214|559785633|FG000|Overall Study|Adverse Event|115|||
155095775|NCT00110214|559785634|FG001|Overall Study|Adverse Event|192|||
155095776|NCT00110214|559785633|FG000|Overall Study|Refused further treatment|52|||
155095777|NCT00110214|559785634|FG001|Overall Study|Refused further treatment|65|||
155095778|NCT00110214|559785633|FG000|Overall Study|Other (not specified)|61|||
155095779|NCT00110214|559785634|FG001|Overall Study|Other (not specified)|75|||
155095780|NCT01847092|559785635|FG000|Overall Study|Adverse Event|12|||
155095781|NCT01847092|559785636|FG001|Overall Study|Adverse Event|3|||
155095782|NCT01847092|559785635|FG000|Overall Study|Withdrawal by Subject|5|||
155095783|NCT01847092|559785636|FG001|Overall Study|Withdrawal by Subject|5|||
155095784|NCT01847092|559785635|FG000|Overall Study|Protocol Specified|8|||
155095785|NCT01847092|559785636|FG001|Overall Study|Protocol Specified|0|||
155095786|NCT01847092|559785635|FG000|Overall Study|Physician Decision|1|||
155095787|NCT01847092|559785636|FG001|Overall Study|Physician Decision|1|||
155095788|NCT01847092|559785635|FG000|Overall Study|Protocol Violation|0|||
155095789|NCT01847092|559785636|FG001|Overall Study|Protocol Violation|2|||
155095790|NCT03604497|559785638|FG000|Overall Study|Protocol Violation|52|||
155095791|NCT00811954|559785639|FG000|Overall Study|Death|10|||
155095792|NCT00811954|559785640|FG001|Overall Study|Death|6|||
155095793|NCT00811954|559785641|FG002|Overall Study|Death|13|||
155095794|NCT00811954|559785639|FG000|Overall Study|Lost to Follow-up|29|||
155095795|NCT00811954|559785640|FG001|Overall Study|Lost to Follow-up|23|||
155095796|NCT00811954|559785641|FG002|Overall Study|Lost to Follow-up|34|||
155095797|NCT00811954|559785639|FG000|Overall Study|Not able to get to clinic|28|||
155095798|NCT00811954|559785640|FG001|Overall Study|Not able to get to clinic|35|||
155095799|NCT00811954|559785641|FG002|Overall Study|Not able to get to clinic|30|||
155095800|NCT00811954|559785639|FG000|Overall Study|Not willing to adhere to requirements|12|||
154967529|NCT02611323|559303346|FG006|Overall Study|Progressive Disease|0|||
155095801|NCT00811954|559785640|FG001|Overall Study|Not willing to adhere to requirements|2|||
155095802|NCT00811954|559785641|FG002|Overall Study|Not willing to adhere to requirements|16|||
155150934|NCT00633477|559988126|FG000|Overall Study|Death|1|||
155150935|NCT00633477|559988127|FG001|Overall Study|Death|0|||
155171230|NCT01818752|560065409|FG001|Overall Study|Physician Decision|8|||
155171231|NCT01818752|560065408|FG000|Overall Study|Disease Progression|54|||
155171232|NCT01818752|560065409|FG001|Overall Study|Disease Progression|48|||
155171233|NCT01818752|560065408|FG000|Overall Study|Other|7|||
155171234|NCT01818752|560065409|FG001|Overall Study|Other|8|||
155171235|NCT01818752|560065408|FG000|Overall Study|Continuing Treatment|1|||
155171236|NCT01818752|560065409|FG001|Overall Study|Continuing Treatment|4|||
155171237|NCT01818752|560065408|FG000|Overall Study|Randomized but not Dosed|7|||
155171238|NCT01818752|560065409|FG001|Overall Study|Randomized but not Dosed|4|||
155171239|NCT04270370|560065410|FG000|Overall Study|Lost to Follow-up|1|||
155171240|NCT04270370|560065411|FG001|Overall Study|Lost to Follow-up|0|||
155171241|NCT04270370|560065412|FG002|Overall Study|Lost to Follow-up|0|||
155171242|NCT04270370|560065413|FG003|Overall Study|Lost to Follow-up|0|||
155171243|NCT04270370|560065414|FG004|Overall Study|Lost to Follow-up|0|||
155171244|NCT04270370|560065415|FG005|Overall Study|Lost to Follow-up|0|||
155171245|NCT04270370|560065416|FG006|Overall Study|Lost to Follow-up|0|||
155171246|NCT04270370|560065417|FG007|Overall Study|Lost to Follow-up|0|||
155171247|NCT04270370|560065418|FG008|Overall Study|Lost to Follow-up|1|||
155171248|NCT04270370|560065419|FG009|Overall Study|Lost to Follow-up|0|||
155171249|NCT04270370|560065420|FG010|Overall Study|Lost to Follow-up|0|||
155171250|NCT04270370|560065421|FG011|Overall Study|Lost to Follow-up|0|||
155171251|NCT01324141|560065422|FG000|Overall Study|Declined to participate before treatment started|1|||
155171252|NCT01324141|560065422|FG000|Overall Study|Disease progression on study|1|||
155171253|NCT00282308|560065423|FG000|Treatment Period|Lost to Follow-up|1|||
155171254|NCT00282308|560065424|FG001|Treatment Period|Lost to Follow-up|0|||
155171255|NCT00282308|560065425|FG002|Treatment Period|Lost to Follow-up|0|||
155171256|NCT00282308|560065423|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
155171257|NCT00282308|560065424|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
155171258|NCT00282308|560065425|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
155171259|NCT00282308|560065423|FG000|Treatment Period|Adverse Event|0|||
155171260|NCT00282308|560065424|FG001|Treatment Period|Adverse Event|2|||
155171261|NCT00282308|560065425|FG002|Treatment Period|Adverse Event|0|||
155171262|NCT00282308|560065423|FG000|Treatment Period|Not Treated with Study Drug|1|||
155171263|NCT00282308|560065424|FG001|Treatment Period|Not Treated with Study Drug|0|||
155171264|NCT00282308|560065425|FG002|Treatment Period|Not Treated with Study Drug|0|||
155171265|NCT00282308|560065423|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
155171266|NCT00282308|560065424|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
155171267|NCT00282308|560065425|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
155171268|NCT00282308|560065423|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
155171269|NCT00282308|560065424|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
155171270|NCT00282308|560065425|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
155171271|NCT00282308|560065423|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
155171272|NCT00282308|560065424|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
155171273|NCT00282308|560065425|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
155171274|NCT00282308|560065423|FG000|Safety Follow-up Period|Adverse Event|0|||
155171275|NCT00282308|560065424|FG001|Safety Follow-up Period|Adverse Event|0|||
155171276|NCT00282308|560065425|FG002|Safety Follow-up Period|Adverse Event|1|||
155171277|NCT00282308|560065423|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
155171278|NCT00282308|560065424|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
155171279|NCT00282308|560065425|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
155171280|NCT00282308|560065423|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
155171281|NCT00282308|560065424|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
155171282|NCT00282308|560065425|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
155171283|NCT00282308|560065423|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
155171284|NCT00282308|560065424|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
155171285|NCT00282308|560065425|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
155171286|NCT01001325|560065426|FG000|Overall Study|Lost to Follow-up|16|||
155171287|NCT01001325|560065427|FG001|Overall Study|Lost to Follow-up|10|||
155171288|NCT01001325|560065426|FG000|Overall Study|Protocol Violation|2|||
155171289|NCT01001325|560065427|FG001|Overall Study|Protocol Violation|0|||
155171290|NCT01584440|560065430|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
155171291|NCT01584440|560065431|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155171292|NCT01584440|560065432|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155171293|NCT01584440|560065433|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155171294|NCT01584440|560065434|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
155171295|NCT01584440|560065430|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
155171296|NCT01584440|560065431|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
155171297|NCT01584440|560065432|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
155171298|NCT01584440|560065433|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
155171299|NCT01584440|560065434|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
155171300|NCT01584440|560065430|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
155171301|NCT01584440|560065431|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155095803|NCT00811954|559785639|FG000|Overall Study|Withdraw consent prior study completion|4|||
155095804|NCT00811954|559785640|FG001|Overall Study|Withdraw consent prior study completion|6|||
155095805|NCT00811954|559785641|FG002|Overall Study|Withdraw consent prior study completion|5|||
155095806|NCT00811954|559785639|FG000|Overall Study|Site Closure|4|||
155095807|NCT00811954|559785640|FG001|Overall Study|Site Closure|0|||
154967530|NCT02611323|559303347|FG007|Overall Study|Progressive Disease|0|||
154967531|NCT02611323|559303348|FG008|Overall Study|Progressive Disease|0|||
154967532|NCT02611323|559303349|FG009|Overall Study|Progressive Disease|0|||
155095808|NCT00811954|559785641|FG002|Overall Study|Site Closure|1|||
155095809|NCT00811954|559785639|FG000|Overall Study|Severe Debilitation|2|||
155095810|NCT00811954|559785640|FG001|Overall Study|Severe Debilitation|0|||
155095811|NCT00811954|559785641|FG002|Overall Study|Severe Debilitation|1|||
155095812|NCT00811954|559785639|FG000|Overall Study|Complete Protocol: No follow-up|0|||
155095813|NCT00811954|559785640|FG001|Overall Study|Complete Protocol: No follow-up|0|||
155095814|NCT00811954|559785641|FG002|Overall Study|Complete Protocol: No follow-up|1|||
155095815|NCT01016067|559785642|FG000|Overall Study|Lost to Follow-up|1|||
155095816|NCT01016067|559785643|FG001|Overall Study|Lost to Follow-up|2|||
155095817|NCT01016067|559785642|FG000|Overall Study|Physician Decision|1|||
155095818|NCT01016067|559785643|FG001|Overall Study|Physician Decision|1|||
155095819|NCT01016067|559785642|FG000|Overall Study|Withdrew due to Relocation|0|||
155095820|NCT01016067|559785643|FG001|Overall Study|Withdrew due to Relocation|1|||
155095821|NCT00186628|559785645|FG000|Overall Study|Death|2|||
155095822|NCT00186628|559785645|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
155095823|NCT00658541|559785651|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
155095824|NCT00658541|559785652|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155095825|NCT00658541|559785651|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
155095826|NCT00658541|559785652|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
155095827|NCT04828707|559785653|FG000|Overall Study|Lost to Follow-up|3|||
155095828|NCT04828707|559785654|FG001|Overall Study|Lost to Follow-up|2|||
155095829|NCT04828707|559785653|FG000|Overall Study|Withdrawal by Subject|2|||
155095830|NCT04828707|559785654|FG001|Overall Study|Withdrawal by Subject|1|||
155095831|NCT01188967|559785659|FG000|Overall Study|Withdrawal by Subject|1|||
155095832|NCT01188967|559785660|FG001|Overall Study|Withdrawal by Subject|1|||
155095833|NCT01188967|559785659|FG000|Overall Study|Physician Decision|1|||
155095834|NCT01188967|559785660|FG001|Overall Study|Physician Decision|1|||
155095835|NCT01188967|559785659|FG000|Overall Study|Lost to Follow-up|3|||
155095836|NCT01188967|559785660|FG001|Overall Study|Lost to Follow-up|2|||
155095837|NCT01876381|559785661|FG000|Overall Study|Lack of Efficacy|5|||
155095838|NCT01876381|559785661|FG000|Overall Study|Physician Decision|1|||
155095839|NCT01876381|559785661|FG000|Overall Study|Withdrawal by Subject|1|||
155095840|NCT00523978|559785662|FG000|Overall Study|Withdrawal by Subject|3|||
155095841|NCT00523978|559785663|FG001|Overall Study|Withdrawal by Subject|7|||
155095842|NCT00523978|559785662|FG000|Overall Study|Screen Failures|5|||
155095843|NCT00523978|559785663|FG001|Overall Study|Screen Failures|1|||
155095844|NCT00523978|559785662|FG000|Overall Study|Death|1|||
155095845|NCT00523978|559785663|FG001|Overall Study|Death|0|||
155095846|NCT01464879|559785664|FG000|Overall Study|Physician Decision|1|||
155095847|NCT01464879|559785664|FG000|Overall Study|Non-compliance|1|||
155095848|NCT01657305|559785665|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
155095849|NCT01657305|559785665|FG000|Overall Study|Withdrawal by Subject|4|||
155095850|NCT01657305|559785665|FG000|Overall Study|Adverse Event|1|||
155095851|NCT01657305|559785665|FG000|Overall Study|Lost to Follow-up|1|||
155095852|NCT01657305|559785665|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
155095853|NCT04103450|559785666|FG000|Overall Study|Adverse Event|4|||
155095854|NCT04103450|559785667|FG001|Overall Study|Adverse Event|2|||
155095855|NCT04103450|559785666|FG000|Overall Study|Lack of Efficacy|3|||
155095856|NCT04103450|559785667|FG001|Overall Study|Lack of Efficacy|0|||
155095857|NCT04103450|559785666|FG000|Overall Study|Withdrawal by Subject|5|||
155095858|NCT04103450|559785667|FG001|Overall Study|Withdrawal by Subject|3|||
155095859|NCT04103450|559785666|FG000|Overall Study|Lost to Follow-up|1|||
155095860|NCT04103450|559785667|FG001|Overall Study|Lost to Follow-up|2|||
155095861|NCT04103450|559785666|FG000|Overall Study|Physician Decision|1|||
155095862|NCT04103450|559785667|FG001|Overall Study|Physician Decision|2|||
155095863|NCT04103450|559785666|FG000|Overall Study|Protocol Violation|1|||
155095864|NCT04103450|559785667|FG001|Overall Study|Protocol Violation|0|||
155095865|NCT04103450|559785666|FG000|Overall Study|Other|1|||
155095866|NCT04103450|559785667|FG001|Overall Study|Other|1|||
155095867|NCT00696878|559785668|FG000|Overall Study|Adverse Event|8|||
155095868|NCT00696878|559785668|FG000|Overall Study|Withdrawal by Subject|87|||
155095869|NCT00696878|559785668|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
155095870|NCT00696878|559785668|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
154967533|NCT02611323|559303350|FG010|Overall Study|Progressive Disease|1|||
154967534|NCT02611323|559303340|FG000|Overall Study|Withdrawal by Subject|1|||
155095871|NCT00696878|559785668|FG000|Overall Study|Trial stopped|32|||
155095872|NCT00696878|559785668|FG000|Overall Study|Other reason (not specified)|55|||
155095873|NCT02259114|559785673|FG000|Overall Study|Progressive Disease|14|||
155095874|NCT02259114|559785674|FG001|Overall Study|Progressive Disease|2|||
155095875|NCT02259114|559785675|FG002|Overall Study|Progressive Disease|10|||
155095876|NCT02259114|559785676|FG003|Overall Study|Progressive Disease|2|||
155095877|NCT02259114|559785677|FG004|Overall Study|Progressive Disease|5|||
155095878|NCT02259114|559785673|FG000|Overall Study|Adverse Event|2|||
155095879|NCT02259114|559785674|FG001|Overall Study|Adverse Event|1|||
155095880|NCT02259114|559785675|FG002|Overall Study|Adverse Event|0|||
155171302|NCT01584440|560065432|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155171303|NCT01584440|560065433|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155171304|NCT01584440|560065434|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
155171305|NCT01584440|560065430|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
155171306|NCT01584440|560065431|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
155171307|NCT01584440|560065432|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
155171308|NCT01584440|560065433|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
155171309|NCT01584440|560065434|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
155171310|NCT01584440|560065430|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
155171311|NCT01584440|560065431|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155171312|NCT01584440|560065432|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155171313|NCT01584440|560065433|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155171314|NCT01584440|560065434|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
155171315|NCT01584440|560065430|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155171316|NCT01584440|560065431|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
155171317|NCT01584440|560065432|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155171318|NCT01584440|560065433|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155171319|NCT01584440|560065434|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
155171320|NCT01584440|560065430|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
155171321|NCT01584440|560065431|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
155171322|NCT01584440|560065432|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
155171323|NCT01584440|560065433|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
155171324|NCT01584440|560065434|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
155171325|NCT01584440|560065430|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
155171326|NCT01584440|560065431|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
155171327|NCT01584440|560065432|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
155171328|NCT01584440|560065433|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
155171329|NCT01584440|560065434|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
155171330|NCT01584440|560065430|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155171331|NCT01584440|560065431|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155171332|NCT01584440|560065432|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
155171333|NCT01584440|560065433|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155171334|NCT01584440|560065434|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
155171335|NCT00899431|560065435|FG000|Overall Study|Physician Decision|1|||
155171336|NCT00899431|560065436|FG001|Overall Study|Physician Decision|0|||
155171337|NCT00899431|560065437|FG002|Overall Study|Physician Decision|0|||
155171338|NCT03212144|560065438|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
155171339|NCT03212144|560065439|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
155171340|NCT03212144|560065438|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
155171341|NCT03212144|560065439|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
155171342|NCT00661427|560065440|FG000|Overall Study|Adverse Event|5|||
155171343|NCT00661427|560065441|FG001|Overall Study|Adverse Event|5|||
155171344|NCT00661427|560065440|FG000|Overall Study|Patient not treated|0|||
155171345|NCT00661427|560065441|FG001|Overall Study|Patient not treated|2|||
155171346|NCT00599339|560065442|FG000|Overall Study|Adverse Event|79|||
155171347|NCT00599339|560065442|FG000|Overall Study|Withdrawal by Subject|137|||
155171348|NCT00599339|560065442|FG000|Overall Study|Other Reason|179|||
155171349|NCT00599339|560065442|FG000|Overall Study|Lost to Follow-up|221|||
155171350|NCT00599339|560065442|FG000|Overall Study|No valid data consent|36|||
155171351|NCT00599339|560065442|FG000|Overall Study|Study Termination Status Unknown|12|||
155171352|NCT05564052|560065443|FG000|Overall Study|Withdrawal by Subject|0|||
155171353|NCT05564052|560065444|FG001|Overall Study|Withdrawal by Subject|0|||
155171354|NCT05564052|560065445|FG002|Overall Study|Withdrawal by Subject|0|||
155171355|NCT05564052|560065446|FG003|Overall Study|Withdrawal by Subject|1|||
155171356|NCT01338298|560065447|FG000|Overall Study|Withdrawal by Subject|1|||
155171357|NCT01338298|560065448|FG001|Overall Study|Withdrawal by Subject|1|||
155171358|NCT01338298|560065447|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
155171359|NCT01338298|560065448|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
155171360|NCT01338298|560065447|FG000|Overall Study|Administrative error|0|||
155171361|NCT01338298|560065448|FG001|Overall Study|Administrative error|1|||
155171362|NCT01338298|560065447|FG000|Overall Study|Positive symptom worsening|1|||
155171363|NCT01338298|560065448|FG001|Overall Study|Positive symptom worsening|0|||
155171364|NCT01338298|560065447|FG000|Overall Study|Depressive symptoms and nausea|1|||
155171365|NCT01338298|560065448|FG001|Overall Study|Depressive symptoms and nausea|0|||
155171366|NCT01338298|560065447|FG000|Overall Study|Non-adherence|1|||
155095881|NCT02259114|559785676|FG003|Overall Study|Adverse Event|0|||
155095882|NCT02259114|559785677|FG004|Overall Study|Adverse Event|1|||
155171367|NCT01338298|560065448|FG001|Overall Study|Non-adherence|0|||
155171368|NCT02872285|560065449|FG000|Overall Study|Withdrawal by Subject|2|||
155095883|NCT02259114|559785673|FG000|Overall Study|Death|3|||
155095884|NCT02259114|559785674|FG001|Overall Study|Death|0|||
155095885|NCT02259114|559785675|FG002|Overall Study|Death|1|||
155095886|NCT02259114|559785676|FG003|Overall Study|Death|0|||
155095887|NCT02259114|559785677|FG004|Overall Study|Death|0|||
155095888|NCT02259114|559785673|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155095889|NCT02259114|559785674|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155095890|NCT02259114|559785675|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
155095891|NCT02259114|559785676|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155095892|NCT02259114|559785677|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
155095893|NCT02259114|559785673|FG000|Overall Study|Withdrawal by Subject|0|||
155095894|NCT02259114|559785674|FG001|Overall Study|Withdrawal by Subject|0|||
155095895|NCT02259114|559785675|FG002|Overall Study|Withdrawal by Subject|1|||
155095896|NCT02259114|559785676|FG003|Overall Study|Withdrawal by Subject|1|||
155095897|NCT02259114|559785677|FG004|Overall Study|Withdrawal by Subject|0|||
155095898|NCT02259114|559785673|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
155095899|NCT02259114|559785674|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
155095900|NCT02259114|559785675|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
155095901|NCT02259114|559785676|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
155095902|NCT02259114|559785677|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
155095903|NCT02259114|559785673|FG000|Overall Study|Not Treated|1|||
155095904|NCT02259114|559785674|FG001|Overall Study|Not Treated|0|||
155095905|NCT02259114|559785675|FG002|Overall Study|Not Treated|0|||
155095906|NCT02259114|559785676|FG003|Overall Study|Not Treated|0|||
155095907|NCT02259114|559785677|FG004|Overall Study|Not Treated|0|||
155095908|NCT03937479|559785678|FG000|Overall Study|Adverse Event|2|||
155095909|NCT03937479|559785679|FG001|Overall Study|Adverse Event|3|||
155095910|NCT03937479|559785680|FG002|Overall Study|Adverse Event|0|||
155095911|NCT03937479|559785681|FG003|Overall Study|Adverse Event|0|||
155095912|NCT03937479|559785682|FG004|Overall Study|Adverse Event|1|||
155095913|NCT03937479|559785678|FG000|Overall Study|Withdrawal by Subject|3|||
155095914|NCT03937479|559785679|FG001|Overall Study|Withdrawal by Subject|5|||
155095915|NCT03937479|559785680|FG002|Overall Study|Withdrawal by Subject|2|||
155095916|NCT03937479|559785681|FG003|Overall Study|Withdrawal by Subject|2|||
155095917|NCT03937479|559785682|FG004|Overall Study|Withdrawal by Subject|1|||
155095918|NCT03937479|559785678|FG000|Overall Study|Protocol Violation|5|||
155095919|NCT03937479|559785679|FG001|Overall Study|Protocol Violation|6|||
155095920|NCT03937479|559785680|FG002|Overall Study|Protocol Violation|4|||
155095921|NCT03937479|559785681|FG003|Overall Study|Protocol Violation|3|||
155095922|NCT03937479|559785682|FG004|Overall Study|Protocol Violation|2|||
155095923|NCT03937479|559785678|FG000|Overall Study|Lost to Follow-up|0|||
155095924|NCT03937479|559785679|FG001|Overall Study|Lost to Follow-up|1|||
155095925|NCT03937479|559785680|FG002|Overall Study|Lost to Follow-up|0|||
155095926|NCT03937479|559785681|FG003|Overall Study|Lost to Follow-up|1|||
155095927|NCT03937479|559785682|FG004|Overall Study|Lost to Follow-up|0|||
155095928|NCT03937479|559785678|FG000|Overall Study|Physician Decision|0|||
155095929|NCT03937479|559785679|FG001|Overall Study|Physician Decision|0|||
155095930|NCT03937479|559785680|FG002|Overall Study|Physician Decision|1|||
155095931|NCT03937479|559785681|FG003|Overall Study|Physician Decision|0|||
155095932|NCT03937479|559785682|FG004|Overall Study|Physician Decision|1|||
155095933|NCT02712788|559785685|FG000|Overall Study|Physician Decision|1|||
155095934|NCT02712788|559785686|FG001|Overall Study|Physician Decision|0|||
155095935|NCT02712788|559785685|FG000|Overall Study|Protocol Violation|1|||
155095936|NCT02712788|559785686|FG001|Overall Study|Protocol Violation|0|||
155095937|NCT00940602|559785690|FG000|Overall Study|Administrative problems|1|||
155095938|NCT00940602|559785691|FG001|Overall Study|Administrative problems|1|||
155095939|NCT00940602|559785690|FG000|Overall Study|Patient/guardian decision|13|||
155095940|NCT00940602|559785691|FG001|Overall Study|Patient/guardian decision|28|||
155095941|NCT00940602|559785690|FG000|Overall Study|Physician Decision|8|||
155095942|NCT00940602|559785691|FG001|Overall Study|Physician Decision|5|||
155095943|NCT00940602|559785690|FG000|Overall Study|Pregnancy|1|||
155095944|NCT00940602|559785691|FG001|Overall Study|Pregnancy|0|||
155095945|NCT00940602|559785690|FG000|Overall Study|Protocol Deviation (untreated)|1|||
155095946|NCT00940602|559785691|FG001|Overall Study|Protocol Deviation (untreated)|0|||
155095947|NCT00940602|559785690|FG000|Overall Study|Disease progression|8|||
155095948|NCT00940602|559785691|FG001|Overall Study|Disease progression|2|||
155095949|NCT00940602|559785690|FG000|Overall Study|Death|38|||
155095950|NCT00940602|559785691|FG001|Overall Study|Death|19|||
155095951|NCT00940602|559785690|FG000|Overall Study|Lost to Follow-up|3|||
155095952|NCT00940602|559785691|FG001|Overall Study|Lost to Follow-up|1|||
155095953|NCT00940602|559785690|FG000|Overall Study|Patient withdrew consent|26|||
155095954|NCT00940602|559785691|FG001|Overall Study|Patient withdrew consent|13|||
155095955|NCT00940602|559785690|FG000|Overall Study|Adverse Event|7|||
155095956|NCT00940602|559785691|FG001|Overall Study|Adverse Event|2|||
155095957|NCT00940602|559785690|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
155095958|NCT00940602|559785691|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
155095959|NCT02961244|559785693|FG000|Overall Study|Protocol Violation|0|||
154967535|NCT02611323|559303341|FG001|Overall Study|Withdrawal by Subject|0|||
154967536|NCT02611323|559303342|FG002|Overall Study|Withdrawal by Subject|0|||
155095960|NCT02961244|559785694|FG001|Overall Study|Protocol Violation|1|||
155095961|NCT02961244|559785693|FG000|Overall Study|Withdrawal by Subject|1|||
155095962|NCT02961244|559785694|FG001|Overall Study|Withdrawal by Subject|2|||
155095963|NCT02961244|559785693|FG000|Overall Study|Surgery plan change after study approval|0|||
155095964|NCT02961244|559785694|FG001|Overall Study|Surgery plan change after study approval|2|||
155095965|NCT02961244|559785693|FG000|Overall Study|Lost to Follow-up|0|||
155095966|NCT02961244|559785694|FG001|Overall Study|Lost to Follow-up|2|||
155095967|NCT02961244|559785693|FG000|Overall Study|İnadequate data|0|||
155095968|NCT02961244|559785694|FG001|Overall Study|İnadequate data|2|||
155095969|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
155095970|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
155095971|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
155095972|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
155095973|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
155095974|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
155095975|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
155095976|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
155095977|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
155095978|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
155095979|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
155095980|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
155095981|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
155095982|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
155095983|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
155095984|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
155095985|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
155095986|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
155095987|NCT03789292|559785695|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
155095988|NCT03789292|559785696|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
155095989|NCT03789292|559785697|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
155095990|NCT03789292|559785695|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
155095991|NCT03789292|559785696|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
155095992|NCT03789292|559785697|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
155095993|NCT03789292|559785695|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
155095994|NCT03789292|559785696|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
155095995|NCT03789292|559785697|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
155095996|NCT03789292|559785695|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
155095997|NCT03789292|559785696|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
155095998|NCT03789292|559785697|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
155095999|NCT03789292|559785695|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
155096000|NCT03789292|559785696|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
155096001|NCT03789292|559785697|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
155096002|NCT03789292|559785695|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
155096003|NCT03789292|559785696|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
155096004|NCT03789292|559785697|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
155096005|NCT03789292|559785695|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
155096006|NCT03789292|559785696|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
155096007|NCT03789292|559785697|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
155096008|NCT01696643|559785698|FG000|Overall Study|Adverse Event|15|||
155096009|NCT01696643|559785699|FG001|Overall Study|Adverse Event|7|||
155096010|NCT01696643|559785698|FG000|Overall Study|Death|1|||
155096011|NCT01696643|559785699|FG001|Overall Study|Death|2|||
155096012|NCT01696643|559785698|FG000|Overall Study|Lack of Efficacy|3|||
155096013|NCT01696643|559785699|FG001|Overall Study|Lack of Efficacy|0|||
155096014|NCT01696643|559785698|FG000|Overall Study|Lost to Follow-up|67|||
155096015|NCT01696643|559785699|FG001|Overall Study|Lost to Follow-up|67|||
155096016|NCT01696643|559785698|FG000|Overall Study|Physician Decision|3|||
155096017|NCT01696643|559785699|FG001|Overall Study|Physician Decision|2|||
155096018|NCT01696643|559785698|FG000|Overall Study|Pregnancy|0|||
155096019|NCT01696643|559785699|FG001|Overall Study|Pregnancy|1|||
155096020|NCT01696643|559785698|FG000|Overall Study|Protocol Violation|7|||
155096021|NCT01696643|559785699|FG001|Overall Study|Protocol Violation|7|||
155096022|NCT01696643|559785698|FG000|Overall Study|Study Terminated by Sponsor|286|||
155096023|NCT01696643|559785699|FG001|Overall Study|Study Terminated by Sponsor|294|||
155096024|NCT01696643|559785698|FG000|Overall Study|Withdrawal by Subject|142|||
155096025|NCT01696643|559785699|FG001|Overall Study|Withdrawal by Subject|149|||
155171369|NCT02872285|560065450|FG001|Overall Study|Withdrawal by Subject|0|||
155171370|NCT02872285|560065449|FG000|Overall Study|Lost to Follow-up|2|||
155171371|NCT02872285|560065450|FG001|Overall Study|Lost to Follow-up|2|||
155171372|NCT02872285|560065449|FG000|Overall Study|Discontinued due to back surgery|1|||
155171373|NCT02872285|560065450|FG001|Overall Study|Discontinued due to back surgery|0|||
155171374|NCT00531427|560065451|FG000|Overall Study|Withdrawal by Subject|7|||
155171375|NCT00531427|560065452|FG001|Overall Study|Withdrawal by Subject|13|||
155171376|NCT00531427|560065451|FG000|Overall Study|Adverse Event|44|||
155171377|NCT00531427|560065452|FG001|Overall Study|Adverse Event|30|||
155171378|NCT00531427|560065451|FG000|Overall Study|Lost to Follow-up|4|||
155171379|NCT00531427|560065452|FG001|Overall Study|Lost to Follow-up|3|||
155171380|NCT00531427|560065451|FG000|Overall Study|Lack of Efficacy|14|||
155171381|NCT00531427|560065452|FG001|Overall Study|Lack of Efficacy|39|||
155171382|NCT00531427|560065451|FG000|Overall Study|Administrative|4|||
155171383|NCT00531427|560065452|FG001|Overall Study|Administrative|9|||
155171384|NCT01253577|560065455|FG000|Overall Study|Lost to Follow-up|3|||
155171385|NCT00721968|560065456|FG000|Overall Study|Lost to Follow-up|2|||
155171386|NCT00721968|560065457|FG001|Overall Study|Lost to Follow-up|0|||
155171387|NCT02894502|560067289|FG000|Baseline|Withdrawal by Subject|24|||
155171388|NCT02894502|560067290|FG001|Baseline|Withdrawal by Subject|31|||
155171389|NCT02894502|560067291|FG002|Baseline|Withdrawal by Subject|36|||
155171390|NCT02894502|560067289|FG000|Baseline|Death|3|||
155171391|NCT02894502|560067290|FG001|Baseline|Death|1|||
155171392|NCT02894502|560067291|FG002|Baseline|Death|9|||
155171393|NCT02894502|560067289|FG000|First Follow up|Withdrawal by Subject|32|||
155171394|NCT02894502|560067290|FG001|First Follow up|Withdrawal by Subject|29|||
155171395|NCT02894502|560067291|FG002|First Follow up|Withdrawal by Subject|37|||
155171396|NCT02894502|560067289|FG000|First Follow up|Death|2|||
155171397|NCT02894502|560067290|FG001|First Follow up|Death|2|||
155171398|NCT02894502|560067291|FG002|First Follow up|Death|3|||
155171399|NCT02894502|560067289|FG000|Second Follow up|Withdrawal by Subject|13|||
155171400|NCT02894502|560067290|FG001|Second Follow up|Withdrawal by Subject|15|||
155171401|NCT02894502|560067291|FG002|Second Follow up|Withdrawal by Subject|13|||
155171402|NCT02894502|560067289|FG000|Second Follow up|Death|2|||
155171403|NCT02894502|560067290|FG001|Second Follow up|Death|3|||
155171404|NCT02894502|560067291|FG002|Second Follow up|Death|1|||
155171405|NCT02894502|560067289|FG000|Third Follow up|Withdrawal by Subject|5|||
155171406|NCT02894502|560067290|FG001|Third Follow up|Withdrawal by Subject|6|||
155171407|NCT02894502|560067291|FG002|Third Follow up|Withdrawal by Subject|3|||
155171408|NCT02894502|560067289|FG000|Third Follow up|Death|1|||
155171409|NCT02894502|560067290|FG001|Third Follow up|Death|1|||
155171410|NCT02894502|560067291|FG002|Third Follow up|Death|0|||
155171411|NCT01410357|560067292|FG000|Overall Study|Death|2|||
155171412|NCT01410357|560067293|FG001|Overall Study|Death|1|||
155171413|NCT01410357|560067292|FG000|Overall Study|Withdrawal by Subject|1|||
155171414|NCT01410357|560067293|FG001|Overall Study|Withdrawal by Subject|2|||
155171415|NCT01410357|560067292|FG000|Overall Study|Lost to Follow-up|23|||
155171416|NCT01410357|560067293|FG001|Overall Study|Lost to Follow-up|21|||
155171417|NCT00615901|560067294|FG000|Overall Study|Withdrawal by Subject|2|||
155171418|NCT00615901|560067294|FG000|Overall Study|Adverse Event|7|||
155171419|NCT00668733|560067301|FG000|Overall Study|Lost to Follow-up|2|||
155171420|NCT00668733|560067302|FG001|Overall Study|Lost to Follow-up|3|||
155171421|NCT00668733|560067301|FG000|Overall Study|Withdrawal by Subject|0|||
155171422|NCT00668733|560067302|FG001|Overall Study|Withdrawal by Subject|4|||
155171423|NCT03467152|560067303|FG000|Overall Study|Adverse Event|4|||
155171424|NCT03467152|560067304|FG001|Overall Study|Adverse Event|5|||
155171425|NCT03467152|560067305|FG002|Overall Study|Adverse Event|0|||
155171426|NCT03467152|560067303|FG000|Overall Study|Subject Choice|1|||
155171427|NCT03467152|560067304|FG001|Overall Study|Subject Choice|3|||
155171428|NCT03467152|560067305|FG002|Overall Study|Subject Choice|0|||
155171429|NCT03467152|560067303|FG000|Overall Study|Lost to Follow-up|1|||
155171430|NCT03467152|560067304|FG001|Overall Study|Lost to Follow-up|0|||
155171431|NCT03467152|560067305|FG002|Overall Study|Lost to Follow-up|0|||
155171432|NCT03467152|560067303|FG000|Overall Study|Withdrawal by Subject|4|||
155171433|NCT03467152|560067304|FG001|Overall Study|Withdrawal by Subject|2|||
155171434|NCT03467152|560067305|FG002|Overall Study|Withdrawal by Subject|0|||
155171435|NCT03467152|560067303|FG000|Overall Study|Others|3|||
155171436|NCT03467152|560067304|FG001|Overall Study|Others|0|||
155171437|NCT03467152|560067305|FG002|Overall Study|Others|0|||
155171438|NCT03467152|560067303|FG000|Overall Study|Not treated|3|||
155171439|NCT03467152|560067304|FG001|Overall Study|Not treated|1|||
155171440|NCT03467152|560067305|FG002|Overall Study|Not treated|6|||
155171441|NCT00945906|560067307|FG000|Overall Study|Withdrawal by Subject|1|||
155171442|NCT00945906|560067307|FG000|Overall Study|Did not want to return for last visit|2|||
155171443|NCT00945906|560067307|FG000|Overall Study|Unable to return for last visit|2|||
155171444|NCT00945906|560067307|FG000|Overall Study|Moved to another country|2|||
155171445|NCT00361634|560067312|FG000|Overall Study|Lost to Follow-up|1|||
155171446|NCT00361634|560067312|FG000|Overall Study|Withdrawal by Subject|1|||
155171447|NCT00635219|560067313|FG000|Overall Study|Adverse Event|12|||
155171448|NCT00635219|560067314|FG001|Overall Study|Adverse Event|10|||
154967537|NCT02611323|559303343|FG003|Overall Study|Withdrawal by Subject|0|||
154967538|NCT02611323|559303344|FG004|Overall Study|Withdrawal by Subject|0|||
154967539|NCT02611323|559303345|FG005|Overall Study|Withdrawal by Subject|0|||
155096026|NCT01696643|559785698|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
155096027|NCT01696643|559785699|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
155096028|NCT01696643|559785698|FG000|Overall Study|Site Error|2|||
155096029|NCT01696643|559785699|FG001|Overall Study|Site Error|1|||
155096030|NCT01696643|559785698|FG000|Overall Study|Participant Incarcerated|0|||
155096031|NCT01696643|559785699|FG001|Overall Study|Participant Incarcerated|1|||
155096032|NCT01696643|559785698|FG000|Overall Study|Medical Monitor Decision|0|||
155096033|NCT01696643|559785699|FG001|Overall Study|Medical Monitor Decision|2|||
155096034|NCT01696643|559785698|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
155096035|NCT01696643|559785699|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
155096036|NCT01368614|559785704|FG000|Screening Period|Screen Failure|58|||
155096037|NCT01368614|559785705|FG001|Screening Period|Screen Failure|0|||
155096038|NCT01368614|559785706|FG002|Screening Period|Screen Failure|0|||
155096039|NCT01368614|559785707|FG003|Screening Period|Screen Failure|0|||
155096040|NCT01368614|559785704|FG000|Study Period|Withdrawal by Subject|0|||
155096041|NCT01368614|559785705|FG001|Study Period|Withdrawal by Subject|1|||
155096042|NCT01368614|559785706|FG002|Study Period|Withdrawal by Subject|1|||
155096043|NCT01368614|559785707|FG003|Study Period|Withdrawal by Subject|3|||
155096044|NCT01368614|559785704|FG000|Study Period|Lost to Follow-up|0|||
155096045|NCT01368614|559785705|FG001|Study Period|Lost to Follow-up|0|||
155096046|NCT01368614|559785706|FG002|Study Period|Lost to Follow-up|1|||
155096047|NCT01368614|559785707|FG003|Study Period|Lost to Follow-up|0|||
155096048|NCT00518180|559785708|FG000|Overall Study|Withdrawal by Subject|29|||
155096049|NCT00518180|559785709|FG001|Overall Study|Withdrawal by Subject|30|||
155096050|NCT00518180|559785710|FG002|Overall Study|Withdrawal by Subject|42|||
155096051|NCT00518180|559785708|FG000|Overall Study|Lost to Follow-up|30|||
155096052|NCT00518180|559785709|FG001|Overall Study|Lost to Follow-up|28|||
155096053|NCT00518180|559785710|FG002|Overall Study|Lost to Follow-up|34|||
155096054|NCT00518180|559785708|FG000|Overall Study|Administrative reason|0|||
155096055|NCT00518180|559785709|FG001|Overall Study|Administrative reason|2|||
155096056|NCT00518180|559785710|FG002|Overall Study|Administrative reason|2|||
155096057|NCT00518180|559785708|FG000|Overall Study|Protocol Violation|5|||
155096058|NCT00518180|559785709|FG001|Overall Study|Protocol Violation|7|||
155096059|NCT00518180|559785710|FG002|Overall Study|Protocol Violation|4|||
155096060|NCT00518180|559785708|FG000|Overall Study|Unable to classify|0|||
155096061|NCT00518180|559785709|FG001|Overall Study|Unable to classify|2|||
155096062|NCT00518180|559785710|FG002|Overall Study|Unable to classify|0|||
155096063|NCT00518180|559785708|FG000|Overall Study|Adverse Event|1|||
155096064|NCT00518180|559785709|FG001|Overall Study|Adverse Event|0|||
155096065|NCT00518180|559785710|FG002|Overall Study|Adverse Event|0|||
155096066|NCT00508482|559785711|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
155096067|NCT00508482|559785712|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
155096068|NCT00508482|559785713|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
155096069|NCT00508482|559785711|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
155096070|NCT00508482|559785712|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
155096071|NCT00508482|559785713|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
155096072|NCT00508482|559785711|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
155096073|NCT00508482|559785712|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
155096074|NCT00508482|559785713|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
155096075|NCT00546481|559785714|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
154967540|NCT02611323|559303346|FG006|Overall Study|Withdrawal by Subject|0|||
154967541|NCT02611323|559303347|FG007|Overall Study|Withdrawal by Subject|1|||
154967542|NCT02611323|559303348|FG008|Overall Study|Withdrawal by Subject|0|||
155171449|NCT00635219|560067315|FG002|Overall Study|Adverse Event|18|||
155171450|NCT00635219|560067316|FG003|Overall Study|Adverse Event|15|||
155171451|NCT00635219|560067317|FG004|Overall Study|Adverse Event|19|||
155171452|NCT00635219|560067313|FG000|Overall Study|Lack of Efficacy|5|||
155171453|NCT00635219|560067314|FG001|Overall Study|Lack of Efficacy|6|||
155171454|NCT00635219|560067315|FG002|Overall Study|Lack of Efficacy|3|||
155171455|NCT00635219|560067316|FG003|Overall Study|Lack of Efficacy|4|||
155171456|NCT00635219|560067317|FG004|Overall Study|Lack of Efficacy|6|||
155171457|NCT00635219|560067313|FG000|Overall Study|Non-compliance With Study Product|0|||
155171458|NCT00635219|560067314|FG001|Overall Study|Non-compliance With Study Product|0|||
155171459|NCT00635219|560067315|FG002|Overall Study|Non-compliance With Study Product|0|||
155171460|NCT00635219|560067316|FG003|Overall Study|Non-compliance With Study Product|2|||
155171461|NCT00635219|560067317|FG004|Overall Study|Non-compliance With Study Product|1|||
155171462|NCT00635219|560067313|FG000|Overall Study|Protocol Violation|0|||
155171463|NCT00635219|560067314|FG001|Overall Study|Protocol Violation|2|||
155171464|NCT00635219|560067315|FG002|Overall Study|Protocol Violation|3|||
155171465|NCT00635219|560067316|FG003|Overall Study|Protocol Violation|2|||
155171466|NCT00635219|560067317|FG004|Overall Study|Protocol Violation|4|||
155171467|NCT00635219|560067313|FG000|Overall Study|Withdrawal of Consent|8|||
155171468|NCT00635219|560067314|FG001|Overall Study|Withdrawal of Consent|6|||
155171469|NCT00635219|560067315|FG002|Overall Study|Withdrawal of Consent|8|||
155171470|NCT00635219|560067316|FG003|Overall Study|Withdrawal of Consent|11|||
155171471|NCT00635219|560067317|FG004|Overall Study|Withdrawal of Consent|8|||
155171472|NCT00635219|560067313|FG000|Overall Study|Lost to Follow-up|0|||
155171473|NCT00635219|560067314|FG001|Overall Study|Lost to Follow-up|0|||
155171474|NCT00635219|560067315|FG002|Overall Study|Lost to Follow-up|2|||
155171475|NCT00635219|560067316|FG003|Overall Study|Lost to Follow-up|0|||
155171476|NCT00635219|560067317|FG004|Overall Study|Lost to Follow-up|3|||
155171477|NCT00635219|560067313|FG000|Overall Study|Administrative or Other Reasons|0|||
155171478|NCT00635219|560067314|FG001|Overall Study|Administrative or Other Reasons|1|||
155171479|NCT00635219|560067315|FG002|Overall Study|Administrative or Other Reasons|1|||
155171480|NCT00635219|560067316|FG003|Overall Study|Administrative or Other Reasons|0|||
155171481|NCT00635219|560067317|FG004|Overall Study|Administrative or Other Reasons|1|||
155171482|NCT01989208|560067323|FG000|200 mg (7 Days)|Protocol Violation|0|||
155171483|NCT01989208|560067324|FG001|200 mg (7 Days)|Protocol Violation|1|||
155171484|NCT04343235|560067328|FG000|Overall Study|Lost to Follow-up|3|||
155171485|NCT04343235|560067329|FG001|Overall Study|Lost to Follow-up|2|||
155171486|NCT00787267|560067330|FG000|Overall Study|Screen failure/Ineligible|10|||
155171487|NCT00787267|560067330|FG000|Overall Study|No Reason Provided|1|||
155171488|NCT00787267|560067330|FG000|Overall Study|Withdrawal by Subject|1|||
155171489|NCT01763996|560067331|FG000|Treatment Period 2|Adverse Event|0|||
155171490|NCT01763996|560067332|FG001|Treatment Period 2|Adverse Event|1|||
155171491|NCT00865280|560067333|FG000|Overall Study|Withdrawal by Subject|4|||
155171492|NCT00865280|560067334|FG001|Overall Study|Withdrawal by Subject|1|||
155171493|NCT00865280|560067333|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
155171494|NCT00865280|560067334|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
155171495|NCT00865280|560067333|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
155171496|NCT00865280|560067334|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
155171497|NCT00865280|560067333|FG000|Overall Study|Exclusion Condition|1|||
155171498|NCT00865280|560067334|FG001|Overall Study|Exclusion Condition|0|||
155171499|NCT00865280|560067333|FG000|Overall Study|Adverse Event|0|||
155171500|NCT00865280|560067334|FG001|Overall Study|Adverse Event|1|||
155171501|NCT01788215|560067337|FG000|Overall Study|Withdrawal by Subject|0|||
155171502|NCT01788215|560067338|FG001|Overall Study|Withdrawal by Subject|1|||
155171503|NCT01788215|560067337|FG000|Overall Study|Lost to Follow-up|2|||
155171504|NCT01788215|560067338|FG001|Overall Study|Lost to Follow-up|0|||
155171505|NCT03116152|560067339|FG000|Overall Study|Disease Progression|49|||
155171506|NCT03116152|560067340|FG001|Overall Study|Disease Progression|47|||
155171507|NCT03116152|560067339|FG000|Overall Study|Death|5|||
155171508|NCT03116152|560067340|FG001|Overall Study|Death|2|||
155171509|NCT03116152|560067339|FG000|Overall Study|Adverse Event|21|||
155171510|NCT03116152|560067340|FG001|Overall Study|Adverse Event|7|||
155171511|NCT03116152|560067339|FG000|Overall Study|Protocol Violation|2|||
155171512|NCT03116152|560067340|FG001|Overall Study|Protocol Violation|2|||
155171513|NCT03116152|560067339|FG000|Overall Study|Withdrawal by Subject|0|||
155171514|NCT03116152|560067340|FG001|Overall Study|Withdrawal by Subject|1|||
155171515|NCT03116152|560067339|FG000|Overall Study|Physician Decision|3|||
155171516|NCT03116152|560067340|FG001|Overall Study|Physician Decision|2|||
155171517|NCT03116152|560067339|FG000|Overall Study|other|11|||
155171518|NCT03116152|560067340|FG001|Overall Study|other|34|||
155171519|NCT00862641|560067343|FG000|Overall Study|Randomized, but drug not received|1|||
155171520|NCT00862641|560067344|FG001|Overall Study|Randomized, but drug not received|4|||
155171521|NCT00862641|560067345|FG002|Overall Study|Randomized, but drug not received|1|||
155171522|NCT00862641|560067346|FG003|Overall Study|Randomized, but drug not received|4|||
155096076|NCT00546481|559785715|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
155096077|NCT00546481|559785716|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
155096078|NCT00546481|559785714|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
155096079|NCT00546481|559785715|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
155096080|NCT00546481|559785716|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
155096081|NCT00546481|559785714|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
155096082|NCT00546481|559785715|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
155096083|NCT00546481|559785716|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
155096084|NCT00546481|559785714|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
155096085|NCT00546481|559785715|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
155096086|NCT00546481|559785716|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
155096087|NCT00546481|559785714|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
155096088|NCT00546481|559785715|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
155096089|NCT00546481|559785716|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
155096090|NCT00546481|559785714|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
155096091|NCT00546481|559785715|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
155096092|NCT00546481|559785716|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
155096093|NCT00546481|559785714|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
155096094|NCT00546481|559785715|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
155096095|NCT00546481|559785716|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
155096096|NCT00546481|559785714|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
155096097|NCT00546481|559785715|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
155096098|NCT00546481|559785716|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
155096099|NCT00546481|559785714|FG000|Maintenance Phase (CERA)|Other Reason|0|||
155096100|NCT00546481|559785715|FG001|Maintenance Phase (CERA)|Other Reason|0|||
155096101|NCT00546481|559785716|FG002|Maintenance Phase (CERA)|Other Reason|1|||
155096102|NCT00244621|559785717|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155096103|NCT00244621|559785718|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155096104|NCT00244621|559785719|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
155096105|NCT00244621|559785717|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155096106|NCT00244621|559785718|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155096107|NCT00244621|559785719|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155096108|NCT00244621|559785717|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155096109|NCT00244621|559785718|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
155096110|NCT00244621|559785719|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
155096111|NCT00244621|559785717|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
155096112|NCT00244621|559785718|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
155096113|NCT00244621|559785719|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
155096114|NCT00244621|559785717|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155096115|NCT00244621|559785718|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
155096116|NCT00244621|559785719|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155096117|NCT00244621|559785717|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
155096118|NCT00244621|559785718|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155096119|NCT00244621|559785719|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155096120|NCT00244621|559785717|FG000|Open-label Treatment Period|Adverse Event|0|||
155096121|NCT00244621|559785718|FG001|Open-label Treatment Period|Adverse Event|0|||
155096122|NCT00244621|559785719|FG002|Open-label Treatment Period|Adverse Event|1|||
155096123|NCT00244621|559785717|FG000|Open-label Treatment Period|Moved abroad|0|||
155096124|NCT00244621|559785718|FG001|Open-label Treatment Period|Moved abroad|0|||
155096125|NCT00244621|559785719|FG002|Open-label Treatment Period|Moved abroad|1|||
155096126|NCT01193101|559785725|FG000|Overall Study|Adverse Event|0|||
155096127|NCT01193101|559785726|FG001|Overall Study|Adverse Event|1|||
155096128|NCT01193101|559785727|FG002|Overall Study|Adverse Event|1|||
155096129|NCT01193101|559785728|FG003|Overall Study|Adverse Event|3|||
155096130|NCT01193101|559785725|FG000|Overall Study|Lack of Efficacy|3|||
155096131|NCT01193101|559785726|FG001|Overall Study|Lack of Efficacy|1|||
155096132|NCT01193101|559785727|FG002|Overall Study|Lack of Efficacy|0|||
155096133|NCT01193101|559785728|FG003|Overall Study|Lack of Efficacy|8|||
155096134|NCT01193101|559785725|FG000|Overall Study|Withdrawal by Subject|2|||
155096135|NCT01193101|559785726|FG001|Overall Study|Withdrawal by Subject|4|||
155096136|NCT01193101|559785727|FG002|Overall Study|Withdrawal by Subject|1|||
155096137|NCT01193101|559785728|FG003|Overall Study|Withdrawal by Subject|1|||
155096138|NCT01193101|559785725|FG000|Overall Study|Administrative problems|0|||
155096139|NCT01193101|559785726|FG001|Overall Study|Administrative problems|0|||
155096140|NCT01193101|559785727|FG002|Overall Study|Administrative problems|1|||
155096141|NCT01193101|559785728|FG003|Overall Study|Administrative problems|0|||
155096142|NCT01193101|559785725|FG000|Overall Study|Abnormal test procedure results|0|||
155096143|NCT01193101|559785726|FG001|Overall Study|Abnormal test procedure results|1|||
155096144|NCT01193101|559785727|FG002|Overall Study|Abnormal test procedure results|0|||
155096145|NCT01193101|559785728|FG003|Overall Study|Abnormal test procedure results|0|||
155096146|NCT02347085|559785729|FG000|Overall Study|Adverse Event|2|||
155096147|NCT02347085|559785729|FG000|Overall Study|Lack of Efficacy|1|||
155096148|NCT02347085|559785729|FG000|Overall Study|Withdrawal by Subject|4|||
155096149|NCT02347085|559785729|FG000|Overall Study|Lost to Follow-up|1|||
155096150|NCT02347085|559785729|FG000|Overall Study|Protocol Criteria|2|||
155096151|NCT02271529|559785730|FG000|Overall Study|Withdrawal by Subject|1|||
155096152|NCT03508050|559785732|FG000|Overall Study|Pleural adhesions|1|||
155096153|NCT03508050|559785733|FG001|Overall Study|Pleural adhesions|0|||
155096154|NCT03508050|559785732|FG000|Overall Study|Mucus plug|1|||
155096155|NCT03508050|559785733|FG001|Overall Study|Mucus plug|0|||
155096156|NCT03508050|559785732|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
155096157|NCT03508050|559785733|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
155096158|NCT03508050|559785732|FG000|Overall Study|Sustained desaturation|0|||
155096159|NCT03508050|559785733|FG001|Overall Study|Sustained desaturation|1|||
155096160|NCT01957865|559785734|FG000|Overall Study|Found HIV negative|0|||
155096161|NCT01957865|559785735|FG001|Overall Study|Found HIV negative|0|||
155096162|NCT01957865|559785736|FG002|Overall Study|Found HIV negative|1|||
155096163|NCT01957865|559785734|FG000|Overall Study|Lost to Follow-up|0|||
155096164|NCT01957865|559785735|FG001|Overall Study|Lost to Follow-up|2|||
155096165|NCT01957865|559785736|FG002|Overall Study|Lost to Follow-up|2|||
155096166|NCT03783780|559785737|FG000|Overall Study|Withdrawn prior to completion|1|||
155096167|NCT00165789|559785744|FG000|Overall Study|Adverse Event|0|||
155096168|NCT00165789|559785745|FG001|Overall Study|Adverse Event|3|||
155096169|NCT00165789|559785746|FG002|Overall Study|Adverse Event|0|||
155096170|NCT00165789|559785747|FG003|Overall Study|Adverse Event|12|||
155096171|NCT00165789|559785744|FG000|Overall Study|Withdrawal by Subject|0|||
155096172|NCT00165789|559785745|FG001|Overall Study|Withdrawal by Subject|1|||
155096173|NCT00165789|559785746|FG002|Overall Study|Withdrawal by Subject|1|||
155096174|NCT00165789|559785747|FG003|Overall Study|Withdrawal by Subject|2|||
155096175|NCT01816048|559785748|FG000|Overall Study|Adverse Event|1|||
155096176|NCT01816048|559785748|FG000|Overall Study|Death|1|||
155096177|NCT01816048|559785748|FG000|Overall Study|Withdrawal by Subject|1|||
155096178|NCT01816048|559785748|FG000|Overall Study|Disease Progression|3|||
155096179|NCT02031302|559785749|FG000|Overall Study|Death|115|||
155096180|NCT02031302|559785750|FG001|Overall Study|Death|0|||
155096181|NCT02031302|559785749|FG000|Overall Study|Not treated with study valve system|18|||
155096182|NCT02031302|559785750|FG001|Overall Study|Not treated with study valve system|0|||
155096183|NCT02031302|559785749|FG000|Overall Study|Missed Follow Up|27|||
155096184|NCT02031302|559785750|FG001|Overall Study|Missed Follow Up|0|||
155096185|NCT02031302|559785749|FG000|Overall Study|Lost to Follow-up|4|||
155096186|NCT02031302|559785750|FG001|Overall Study|Lost to Follow-up|0|||
155096187|NCT01816984|559785751|FG000|Overall Study|declining health status|1|||
155096188|NCT05899829|559785752|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
155096189|NCT05899829|559785753|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
155096190|NCT05899829|559785752|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
155096191|NCT05899829|559785753|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
155096192|NCT01173679|559787446|FG000|Overall Study|Death|1|||
155096193|NCT03247829|559787451|FG000|Overall Study|Death|3|||
155096194|NCT03247829|559787452|FG001|Overall Study|Death|4|||
155096195|NCT03247829|559787451|FG000|Overall Study|Enter Hospice Care|1|||
155096196|NCT03247829|559787452|FG001|Overall Study|Enter Hospice Care|0|||
155096197|NCT03247829|559787451|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
155096198|NCT03247829|559787452|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
155096199|NCT03247829|559787451|FG000|Overall Study|LVAD Explant|1|||
155096200|NCT03247829|559787452|FG001|Overall Study|LVAD Explant|1|||
155096201|NCT03247829|559787451|FG000|Overall Study|Transplant|1|||
155096202|NCT03247829|559787452|FG001|Overall Study|Transplant|1|||
155096203|NCT01783444|559787453|FG000|Treatment Phase|Adverse Event|9|||
155096204|NCT01783444|559787454|FG001|Treatment Phase|Adverse Event|20|||
155096205|NCT01783444|559787455|FG002|Treatment Phase|Adverse Event|19|||
155096206|NCT01783444|559787453|FG000|Treatment Phase|Disease Progression|76|||
155096207|NCT01783444|559787454|FG001|Treatment Phase|Disease Progression|66|||
155096208|NCT01783444|559787455|FG002|Treatment Phase|Disease Progression|64|||
155096209|NCT01783444|559787453|FG000|Treatment Phase|Death|2|||
155096210|NCT01783444|559787454|FG001|Treatment Phase|Death|2|||
155096211|NCT01783444|559787455|FG002|Treatment Phase|Death|2|||
155096212|NCT01783444|559787453|FG000|Treatment Phase|Protocol Violation|1|||
155096213|NCT01783444|559787454|FG001|Treatment Phase|Protocol Violation|1|||
155096214|NCT01783444|559787455|FG002|Treatment Phase|Protocol Violation|2|||
155096215|NCT01783444|559787453|FG000|Treatment Phase|Withdrawal by Subject|6|||
155096216|NCT01783444|559787454|FG001|Treatment Phase|Withdrawal by Subject|8|||
155096217|NCT01783444|559787455|FG002|Treatment Phase|Withdrawal by Subject|9|||
155096218|NCT01783444|559787453|FG000|Treatment Phase|Administrative problems|2|||
155096219|NCT01783444|559787454|FG001|Treatment Phase|Administrative problems|0|||
155096220|NCT01783444|559787455|FG002|Treatment Phase|Administrative problems|1|||
155096221|NCT01783444|559787453|FG000|Treatment Phase|Physician Decision|8|||
155096222|NCT01783444|559787454|FG001|Treatment Phase|Physician Decision|6|||
155096223|NCT01783444|559787455|FG002|Treatment Phase|Physician Decision|5|||
155096224|NCT01783444|559787453|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
155096225|NCT01783444|559787454|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
155096226|NCT01783444|559787455|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
155096227|NCT01783444|559787453|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
155096228|NCT01783444|559787454|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
155096229|NCT01783444|559787455|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
155096230|NCT01783444|559787453|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
155096231|NCT01783444|559787454|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
155096232|NCT01783444|559787455|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
155096233|NCT01783444|559787453|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
155096234|NCT01783444|559787454|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
155096235|NCT01783444|559787455|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
155096236|NCT01783444|559787453|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
155096237|NCT01783444|559787454|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
155096238|NCT01783444|559787455|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
155096239|NCT01783444|559787453|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
155096240|NCT01783444|559787454|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
155096241|NCT01783444|559787455|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
155096242|NCT00441272|559787456|FG000|Overall Study|Study terminated prior to enrollment|25|||
155096243|NCT00441272|559787457|FG001|Overall Study|Study terminated prior to enrollment|25|||
155096244|NCT00443703|559787458|FG000|Overall Study|Never Treated|3|||
155096245|NCT00443703|559787459|FG001|Overall Study|Never Treated|1|||
155096246|NCT00443703|559787458|FG000|Overall Study|Adverse Event|7|||
155096247|NCT00443703|559787459|FG001|Overall Study|Adverse Event|3|||
155096248|NCT00443703|559787458|FG000|Overall Study|Lack of Efficacy|3|||
155096249|NCT00443703|559787459|FG001|Overall Study|Lack of Efficacy|1|||
155096250|NCT00443703|559787458|FG000|Overall Study|Lost to Follow-up|0|||
155096251|NCT00443703|559787459|FG001|Overall Study|Lost to Follow-up|4|||
155171523|NCT00145977|560067355|FG000|Overall Study|Lack of Efficacy|0|||
155171524|NCT00145977|560067356|FG001|Overall Study|Lack of Efficacy|4|||
155171525|NCT00145977|560067355|FG000|Overall Study|Lost to Follow-up|1|||
155171526|NCT00145977|560067356|FG001|Overall Study|Lost to Follow-up|0|||
155171527|NCT00145977|560067355|FG000|Overall Study|Withdrawal by Subject|1|||
154967543|NCT02611323|559303349|FG009|Overall Study|Withdrawal by Subject|1|||
154967544|NCT02611323|559303350|FG010|Overall Study|Withdrawal by Subject|0|||
155096252|NCT00443703|559787458|FG000|Overall Study|Physician Decision|4|||
155171528|NCT00145977|560067356|FG001|Overall Study|Withdrawal by Subject|0|||
155171529|NCT01578850|560067359|FG000|Period 1|Insufficient Clinical Response|1|||
155096253|NCT00443703|559787459|FG001|Overall Study|Physician Decision|2|||
155096254|NCT00443703|559787458|FG000|Overall Study|Protocol Violation|1|||
155096255|NCT00443703|559787459|FG001|Overall Study|Protocol Violation|1|||
155096256|NCT00443703|559787458|FG000|Overall Study|Withdrawal by Subject|9|||
155096257|NCT00443703|559787459|FG001|Overall Study|Withdrawal by Subject|6|||
155096258|NCT00443703|559787458|FG000|Overall Study|Progressive Disease|1|||
155096259|NCT00443703|559787459|FG001|Overall Study|Progressive Disease|0|||
155096260|NCT01047007|559787460|FG000|Overall Study|Adverse Event|0|||
155096261|NCT01047007|559787461|FG001|Overall Study|Adverse Event|2|||
155096262|NCT01047007|559787462|FG002|Overall Study|Adverse Event|1|||
154967545|NCT01899053|559303352|FG000|Overall Study|Progressive Disease|4|||
154967546|NCT01899053|559303353|FG001|Overall Study|Progressive Disease|0|||
155096263|NCT01047007|559787463|FG003|Overall Study|Adverse Event|0|||
154967547|NCT01899053|559303354|FG002|Overall Study|Progressive Disease|3|||
154967548|NCT01899053|559303355|FG003|Overall Study|Progressive Disease|0|||
155096264|NCT01047007|559787460|FG000|Overall Study|Progressive Disease|2|||
155096265|NCT01047007|559787461|FG001|Overall Study|Progressive Disease|4|||
155096266|NCT01047007|559787462|FG002|Overall Study|Progressive Disease|1|||
155096267|NCT01047007|559787463|FG003|Overall Study|Progressive Disease|0|||
155096268|NCT03423602|559787465|FG000|Overall Study|Death|1|||
155096269|NCT03423602|559787465|FG000|Overall Study|Lost to Follow-up|6|||
155096270|NCT03423602|559787465|FG000|Overall Study|Protocol Violation|1|||
155096271|NCT03423602|559787465|FG000|Overall Study|Withdrawal by Subject|4|||
155096272|NCT03046446|559787473|FG000|Overall Study|Lack of Efficacy|7|||
155096273|NCT03046446|559787473|FG000|Overall Study|Adverse Event|6|||
155096274|NCT03046446|559787473|FG000|Overall Study|Lost to Follow-up|3|||
155096275|NCT03046446|559787473|FG000|Overall Study|Withdrawal by Subject|14|||
155171530|NCT01578850|560067360|FG001|Period 1|Insufficient Clinical Response|0|||
155171531|NCT01578850|560067361|FG002|Period 1|Insufficient Clinical Response|0|||
155171532|NCT01578850|560067359|FG000|Period 1|Adverse Event|11|||
155171533|NCT01578850|560067360|FG001|Period 1|Adverse Event|0|||
155171534|NCT01578850|560067361|FG002|Period 1|Adverse Event|0|||
155171535|NCT01578850|560067359|FG000|Period 1|Death|1|||
155171536|NCT01578850|560067360|FG001|Period 1|Death|0|||
155171537|NCT01578850|560067361|FG002|Period 1|Death|0|||
155171538|NCT01578850|560067359|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
155096276|NCT03046446|559787473|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
155096277|NCT03046446|559787473|FG000|Overall Study|Disease Progression (see caveats)|25|||
155096278|NCT03046446|559787473|FG000|Overall Study|Non OA related knee surgery|1|||
155096279|NCT00558636|559787481|FG000|Treatment|Adverse Event|9|||
155096280|NCT00558636|559787482|FG001|Treatment|Adverse Event|2|||
155096281|NCT00558636|559787481|FG000|Treatment|Withdrawal by Subject|2|||
155096282|NCT00558636|559787482|FG001|Treatment|Withdrawal by Subject|0|||
155096283|NCT00558636|559787481|FG000|Treatment|Premature termination of the study|35|||
155171539|NCT01578850|560067360|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
155171540|NCT01578850|560067361|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
155171541|NCT01578850|560067359|FG000|Period 1|Withdrawal by Subject|9|||
155171542|NCT01578850|560067360|FG001|Period 1|Withdrawal by Subject|0|||
155171543|NCT01578850|560067361|FG002|Period 1|Withdrawal by Subject|0|||
155096284|NCT00558636|559787482|FG001|Treatment|Premature termination of the study|37|||
155096285|NCT00558636|559787481|FG000|Treatment|Disease progression|1|||
155096286|NCT00558636|559787482|FG001|Treatment|Disease progression|5|||
155096287|NCT00558636|559787481|FG000|Follow-up|Premature termination of the study|12|||
155096288|NCT00558636|559787482|FG001|Follow-up|Premature termination of the study|7|||
155171544|NCT01578850|560067359|FG000|Period 1|Study Terminated by Sponsor|3|||
155171545|NCT01578850|560067360|FG001|Period 1|Study Terminated by Sponsor|0|||
155171546|NCT01578850|560067361|FG002|Period 1|Study Terminated by Sponsor|0|||
155171547|NCT01578850|560067359|FG000|Period 2|Insufficient Clinical Response|0|||
155096289|NCT03443687|559787483|FG000|Overall Study|Lost to Follow-up|3|||
155096290|NCT03443687|559787484|FG001|Overall Study|Lost to Follow-up|5|||
155096291|NCT03443687|559787483|FG000|Overall Study|Withdrawal by Subject|1|||
154967549|NCT01899053|559303356|FG004|Overall Study|Progressive Disease|3|||
154967550|NCT01899053|559303357|FG005|Overall Study|Progressive Disease|1|||
154967551|NCT01899053|559303358|FG006|Overall Study|Progressive Disease|1|||
154967552|NCT01899053|559303359|FG007|Overall Study|Progressive Disease|1|||
154967553|NCT01899053|559303360|FG008|Overall Study|Progressive Disease|4|||
154967554|NCT01899053|559303361|FG009|Overall Study|Progressive Disease|3|||
154967555|NCT01899053|559303362|FG010|Overall Study|Progressive Disease|12|||
154967556|NCT01899053|559303363|FG011|Overall Study|Progressive Disease|5|||
154967557|NCT01899053|559303364|FG012|Overall Study|Progressive Disease|8|||
154967558|NCT01899053|559303365|FG013|Overall Study|Progressive Disease|17|||
155096292|NCT03443687|559787484|FG001|Overall Study|Withdrawal by Subject|0|||
155096293|NCT03443687|559787483|FG000|Overall Study|Discontinued intervention|1|||
155096294|NCT03443687|559787484|FG001|Overall Study|Discontinued intervention|1|||
155096295|NCT01331681|559787489|FG000|Overall Study|Adverse Event|10|||
155096296|NCT01331681|559787490|FG001|Overall Study|Adverse Event|13|||
155096297|NCT01331681|559787491|FG002|Overall Study|Adverse Event|10|||
155096298|NCT01331681|559787489|FG000|Overall Study|Death|6|||
155096299|NCT01331681|559787490|FG001|Overall Study|Death|6|||
155096300|NCT01331681|559787491|FG002|Overall Study|Death|2|||
155096301|NCT01331681|559787489|FG000|Overall Study|Lack of Efficacy|0|||
155096302|NCT01331681|559787490|FG001|Overall Study|Lack of Efficacy|1|||
155096303|NCT01331681|559787491|FG002|Overall Study|Lack of Efficacy|0|||
155096304|NCT01331681|559787489|FG000|Overall Study|Withdrawal by Subject|12|||
155096305|NCT01331681|559787490|FG001|Overall Study|Withdrawal by Subject|8|||
155096306|NCT01331681|559787491|FG002|Overall Study|Withdrawal by Subject|15|||
155096307|NCT01331681|559787489|FG000|Overall Study|Protocol Violation|1|||
155096308|NCT01331681|559787490|FG001|Overall Study|Protocol Violation|1|||
155096309|NCT01331681|559787491|FG002|Overall Study|Protocol Violation|0|||
155096310|NCT01331681|559787489|FG000|Overall Study|Lost to Follow-up|2|||
155096311|NCT01331681|559787490|FG001|Overall Study|Lost to Follow-up|4|||
155096312|NCT01331681|559787491|FG002|Overall Study|Lost to Follow-up|1|||
155096313|NCT01331681|559787489|FG000|Overall Study|Physician Decision|2|||
155096314|NCT01331681|559787490|FG001|Overall Study|Physician Decision|0|||
155096315|NCT01331681|559787491|FG002|Overall Study|Physician Decision|4|||
155096316|NCT01331681|559787489|FG000|Overall Study|Therapeutic procedure required|1|||
155096317|NCT01331681|559787490|FG001|Overall Study|Therapeutic procedure required|0|||
155096318|NCT01331681|559787491|FG002|Overall Study|Therapeutic procedure required|0|||
155096319|NCT01331681|559787489|FG000|Overall Study|Sponsor decision|1|||
155096320|NCT01331681|559787490|FG001|Overall Study|Sponsor decision|1|||
155096321|NCT01331681|559787491|FG002|Overall Study|Sponsor decision|0|||
155096322|NCT01331681|559787489|FG000|Overall Study|Switching to other therapy|0|||
155096323|NCT01331681|559787490|FG001|Overall Study|Switching to other therapy|0|||
155096324|NCT01331681|559787491|FG002|Overall Study|Switching to other therapy|1|||
155096325|NCT01331681|559787489|FG000|Overall Study|Not Received Study Treatment|0|||
155096326|NCT01331681|559787490|FG001|Overall Study|Not Received Study Treatment|0|||
155096327|NCT01331681|559787491|FG002|Overall Study|Not Received Study Treatment|2|||
155096328|NCT01664247|559787493|FG000|Overall Study|Adverse Event|5|||
155096329|NCT01664247|559787494|FG001|Overall Study|Adverse Event|3|||
155096330|NCT01664247|559787493|FG000|Overall Study|Protocol Violation|3|||
155096331|NCT01664247|559787494|FG001|Overall Study|Protocol Violation|5|||
155096332|NCT01664247|559787493|FG000|Overall Study|Withdrawal Criteria|1|||
155096333|NCT01664247|559787494|FG001|Overall Study|Withdrawal Criteria|4|||
155096334|NCT01664247|559787493|FG000|Overall Study|Unclassified|5|||
155096335|NCT01664247|559787494|FG001|Overall Study|Unclassified|29|||
155096336|NCT00382174|559787495|FG000|Overall Study|Lost to Follow-up|1|||
155096337|NCT00382174|559787496|FG001|Overall Study|Lost to Follow-up|4|||
155096338|NCT00382174|559787497|FG002|Overall Study|Lost to Follow-up|5|||
155096339|NCT00382174|559787495|FG000|Overall Study|Adverse Event|1|||
155096340|NCT00382174|559787496|FG001|Overall Study|Adverse Event|4|||
155096341|NCT00382174|559787497|FG002|Overall Study|Adverse Event|5|||
155096342|NCT00382174|559787495|FG000|Overall Study|Withdrawal by Subject|1|||
155096343|NCT00382174|559787496|FG001|Overall Study|Withdrawal by Subject|4|||
155096344|NCT00382174|559787497|FG002|Overall Study|Withdrawal by Subject|5|||
155096345|NCT00382174|559787495|FG000|Overall Study|Non compliance|1|||
155096346|NCT00382174|559787496|FG001|Overall Study|Non compliance|0|||
155096347|NCT00382174|559787497|FG002|Overall Study|Non compliance|1|||
155096348|NCT00382174|559787495|FG000|Overall Study|Physician Decision|0|||
155096349|NCT00382174|559787496|FG001|Overall Study|Physician Decision|2|||
155096350|NCT00382174|559787497|FG002|Overall Study|Physician Decision|2|||
155096351|NCT00382174|559787495|FG000|Overall Study|Failed to meet criteria|0|||
155096352|NCT00382174|559787496|FG001|Overall Study|Failed to meet criteria|1|||
155096353|NCT00382174|559787497|FG002|Overall Study|Failed to meet criteria|1|||
155096354|NCT00382174|559787495|FG000|Overall Study|Wounds merged|0|||
155096355|NCT00382174|559787496|FG001|Overall Study|Wounds merged|2|||
155096356|NCT00382174|559787497|FG002|Overall Study|Wounds merged|2|||
154967559|NCT01899053|559303352|FG000|Overall Study|Adverse Event|1|||
154967560|NCT01899053|559303353|FG001|Overall Study|Adverse Event|1|||
154967561|NCT01899053|559303354|FG002|Overall Study|Adverse Event|1|||
154967562|NCT01899053|559303355|FG003|Overall Study|Adverse Event|3|||
154967563|NCT01899053|559303356|FG004|Overall Study|Adverse Event|1|||
155096357|NCT04577781|559787500|FG000|Overall Study|Adverse Event|2|||
155096358|NCT04577781|559787501|FG001|Overall Study|Adverse Event|2|||
155096359|NCT04577781|559787500|FG000|Overall Study|Physician Decision|1|||
155096360|NCT04577781|559787501|FG001|Overall Study|Physician Decision|0|||
155096361|NCT00967616|559787507|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
155096362|NCT00967616|559787508|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
154967564|NCT01899053|559303357|FG005|Overall Study|Adverse Event|1|||
155096363|NCT00967616|559787507|FG000|Overall Study|Death|0|||
155096364|NCT00967616|559787508|FG001|Overall Study|Death|3|||
155096365|NCT00967616|559787507|FG000|Overall Study|Withdrawal by Subject|8|||
155096366|NCT00967616|559787508|FG001|Overall Study|Withdrawal by Subject|4|||
155096367|NCT00967616|559787507|FG000|Overall Study|Progressive Disease|31|||
155096368|NCT00967616|559787508|FG001|Overall Study|Progressive Disease|18|||
155096369|NCT00967616|559787507|FG000|Overall Study|Other|8|||
155096370|NCT00967616|559787508|FG001|Overall Study|Other|8|||
155096371|NCT00967616|559787507|FG000|Overall Study|Protocol Violation|1|||
155096372|NCT00967616|559787508|FG001|Overall Study|Protocol Violation|0|||
155096373|NCT00575666|559787509|FG000|Overall Study|Withdrawal by Subject|3|||
155096374|NCT00575666|559787510|FG001|Overall Study|Withdrawal by Subject|2|||
155096375|NCT00575666|559787509|FG000|Overall Study|Physician Decision|1|||
155096376|NCT00575666|559787510|FG001|Overall Study|Physician Decision|1|||
155096377|NCT01374425|559787511|FG000|Overall Study|Radiographic Disease Progression|86|||
154967565|NCT01899053|559303358|FG006|Overall Study|Adverse Event|1|||
155096378|NCT01374425|559787512|FG001|Overall Study|Radiographic Disease Progression|81|||
155096379|NCT01374425|559787511|FG000|Overall Study|Clinical Disease Progression|9|||
154967566|NCT01899053|559303359|FG007|Overall Study|Adverse Event|0|||
154967567|NCT01899053|559303360|FG008|Overall Study|Adverse Event|2|||
154967568|NCT01899053|559303361|FG009|Overall Study|Adverse Event|0|||
154967569|NCT01899053|559303362|FG010|Overall Study|Adverse Event|3|||
154967570|NCT01899053|559303363|FG011|Overall Study|Adverse Event|1|||
154967571|NCT01899053|559303364|FG012|Overall Study|Adverse Event|2|||
154967572|NCT01899053|559303365|FG013|Overall Study|Adverse Event|2|||
154967573|NCT01899053|559303352|FG000|Overall Study|Reason Not Specified|0|||
154967574|NCT01899053|559303353|FG001|Overall Study|Reason Not Specified|0|||
154967575|NCT01899053|559303354|FG002|Overall Study|Reason Not Specified|0|||
154967576|NCT01899053|559303355|FG003|Overall Study|Reason Not Specified|0|||
155096380|NCT01374425|559787512|FG001|Overall Study|Clinical Disease Progression|6|||
155096381|NCT01374425|559787511|FG000|Overall Study|Adverse Event|29|||
155096382|NCT01374425|559787512|FG001|Overall Study|Adverse Event|18|||
154967577|NCT01899053|559303356|FG004|Overall Study|Reason Not Specified|0|||
154967578|NCT01899053|559303357|FG005|Overall Study|Reason Not Specified|0|||
155096383|NCT01374425|559787511|FG000|Overall Study|Death (Progression of Disease)|1|||
155096384|NCT01374425|559787512|FG001|Overall Study|Death (Progression of Disease)|0|||
154967579|NCT01899053|559303358|FG006|Overall Study|Reason Not Specified|1|||
154967580|NCT01899053|559303359|FG007|Overall Study|Reason Not Specified|0|||
154967581|NCT01899053|559303360|FG008|Overall Study|Reason Not Specified|0|||
155096385|NCT01374425|559787511|FG000|Overall Study|Death (Adverse Event)|2|||
155096386|NCT01374425|559787512|FG001|Overall Study|Death (Adverse Event)|4|||
155096387|NCT01374425|559787511|FG000|Overall Study|Withdrawal by Subject|6|||
155096388|NCT01374425|559787512|FG001|Overall Study|Withdrawal by Subject|7|||
155096389|NCT01374425|559787511|FG000|Overall Study|Refused Treatment|10|||
155096390|NCT01374425|559787512|FG001|Overall Study|Refused Treatment|24|||
155096391|NCT01374425|559787511|FG000|Overall Study|Protocol Violation|2|||
155096392|NCT01374425|559787512|FG001|Overall Study|Protocol Violation|3|||
155096393|NCT01374425|559787511|FG000|Overall Study|Sponsor Decision|0|||
155096394|NCT01374425|559787512|FG001|Overall Study|Sponsor Decision|1|||
155096395|NCT01374425|559787511|FG000|Overall Study|Lost to Follow-up|2|||
155096396|NCT01374425|559787512|FG001|Overall Study|Lost to Follow-up|1|||
155096397|NCT01374425|559787511|FG000|Overall Study|Other|41|||
155096398|NCT01374425|559787512|FG001|Overall Study|Other|43|||
155096399|NCT02289469|559787513|FG000|Overall Study|Unable to match a control|6|||
155096400|NCT02289469|559787514|FG001|Overall Study|Unable to match a control|0|||
155096401|NCT02750930|559787516|FG000|Overall Study|Study closed/terminated|8|||
155096402|NCT00553631|559787520|FG000|Overall Study|Withdrawal by Subject|0|||
155171548|NCT01578850|560067360|FG001|Period 2|Insufficient Clinical Response|1|||
155171549|NCT01578850|560067361|FG002|Period 2|Insufficient Clinical Response|0|||
155171550|NCT01578850|560067359|FG000|Period 2|Adverse Event|0|||
155096403|NCT00553631|559787521|FG001|Overall Study|Withdrawal by Subject|1|||
155096404|NCT00553631|559787520|FG000|Overall Study|Lost to Follow-up|1|||
155096405|NCT00553631|559787521|FG001|Overall Study|Lost to Follow-up|0|||
155096406|NCT00950651|559787522|FG000|Overall Study|Adverse Event|17|||
155171551|NCT01578850|560067360|FG001|Period 2|Adverse Event|3|||
155171552|NCT01578850|560067361|FG002|Period 2|Adverse Event|6|||
155171553|NCT01578850|560067359|FG000|Period 2|Lost to Follow-up|0|||
155171554|NCT01578850|560067360|FG001|Period 2|Lost to Follow-up|1|||
155171555|NCT01578850|560067361|FG002|Period 2|Lost to Follow-up|2|||
155171556|NCT01578850|560067359|FG000|Period 2|Withdrawal by Subject|0|||
155171557|NCT01578850|560067360|FG001|Period 2|Withdrawal by Subject|2|||
155171558|NCT01578850|560067361|FG002|Period 2|Withdrawal by Subject|2|||
155171559|NCT01578850|560067359|FG000|Period 2|Study Terminated by Sponsor|0|||
155171560|NCT01578850|560067360|FG001|Period 2|Study Terminated by Sponsor|5|||
155171561|NCT01578850|560067361|FG002|Period 2|Study Terminated by Sponsor|4|||
155171562|NCT01578850|560067359|FG000|Period 2|Unspecified Reasons|0|||
155171563|NCT01578850|560067360|FG001|Period 2|Unspecified Reasons|1|||
155171564|NCT01578850|560067361|FG002|Period 2|Unspecified Reasons|0|||
155171565|NCT01711216|560067366|FG000|Overall Study|Adverse Event|4|||
155171566|NCT01711216|560067366|FG000|Overall Study|Pregnancy|56|||
155096407|NCT00950651|559787523|FG001|Overall Study|Adverse Event|20|||
155096408|NCT00950651|559787522|FG000|Overall Study|Death|1|||
155096409|NCT00950651|559787523|FG001|Overall Study|Death|0|||
155096410|NCT00950651|559787522|FG000|Overall Study|Lack of Efficacy|2|||
155096411|NCT00950651|559787523|FG001|Overall Study|Lack of Efficacy|2|||
155096412|NCT00950651|559787522|FG000|Overall Study|Protocol Violation|3|||
155171567|NCT01711216|560067366|FG000|Overall Study|Withdrawal by Subject|6|||
155171568|NCT01711216|560067366|FG000|Overall Study|Lost to Follow-up|46|||
155096413|NCT00950651|559787523|FG001|Overall Study|Protocol Violation|4|||
155096414|NCT00950651|559787522|FG000|Overall Study|Withdrawal by Subject|8|||
155171569|NCT01711216|560067366|FG000|Overall Study|variety of other minor reasons|83|||
155171570|NCT01711216|560067366|FG000|Overall Study|no reason specified|22|||
155171571|NCT03060551|560067367|FG000|Overall Study|Withdrawal by Subject|1|||
155171572|NCT03060551|560067367|FG000|Overall Study|Adverse Event|1|||
155096415|NCT00950651|559787523|FG001|Overall Study|Withdrawal by Subject|9|||
155096416|NCT02761642|559787524|FG000|Overall Study|Did not Receive Study Treatment|3|||
155096417|NCT02761642|559787524|FG000|Overall Study|Adverse Event|13|||
155096418|NCT02761642|559787524|FG000|Overall Study|Withdrawal by Subject|2|||
155096419|NCT02761642|559787524|FG000|Overall Study|Non-compliant|7|||
155096420|NCT02761642|559787524|FG000|Overall Study|Death|3|||
155096421|NCT02761642|559787524|FG000|Overall Study|Lack of Efficacy|20|||
155096422|NCT02761642|559787524|FG000|Overall Study|Physician Decision|1|||
155096423|NCT02761642|559787524|FG000|Overall Study|Reason Unspecified|21|||
155096424|NCT00776789|559787527|FG000|Overall Study|Consent refusal|2|||
155096425|NCT00776789|559787528|FG001|Overall Study|Consent refusal|2|||
155096426|NCT00776789|559787527|FG000|Overall Study|Poor quality video|1|||
155096427|NCT00776789|559787528|FG001|Overall Study|Poor quality video|1|||
155096428|NCT04940130|559787531|FG000|Overall Study|Travel|1|||
155096429|NCT04940130|559787532|FG001|Overall Study|Travel|0|||
155096430|NCT04940130|559787533|FG002|Overall Study|Travel|2|||
155096431|NCT04940130|559787531|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
155096432|NCT04940130|559787532|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
155096433|NCT04940130|559787533|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
155096434|NCT04940130|559787531|FG000|Overall Study|Adverse Event|0|||
155096435|NCT04940130|559787532|FG001|Overall Study|Adverse Event|0|||
155096436|NCT04940130|559787533|FG002|Overall Study|Adverse Event|2|||
155096437|NCT04940130|559787531|FG000|Overall Study|Disease progression/treatment failure|0|||
155096438|NCT04940130|559787532|FG001|Overall Study|Disease progression/treatment failure|0|||
155096439|NCT04940130|559787533|FG002|Overall Study|Disease progression/treatment failure|1|||
155096440|NCT04940130|559787531|FG000|Overall Study|Participant refusal|0|||
155096441|NCT04940130|559787532|FG001|Overall Study|Participant refusal|0|||
155096442|NCT04940130|559787533|FG002|Overall Study|Participant refusal|1|||
155096443|NCT00114127|559787534|FG000|Overall Study|Adverse Event|2|||
155096444|NCT00114127|559787535|FG001|Overall Study|Adverse Event|1|||
155096445|NCT00114127|559787534|FG000|Overall Study|Lost to Follow-up|1|||
155096446|NCT00114127|559787535|FG001|Overall Study|Lost to Follow-up|0|||
155096447|NCT00114127|559787534|FG000|Overall Study|Withdrawal by Subject|1|||
155096448|NCT00114127|559787535|FG001|Overall Study|Withdrawal by Subject|3|||
155096449|NCT00570713|559787536|FG000|Overall Study|Adverse Event|16|||
155096450|NCT00570713|559787537|FG001|Overall Study|Adverse Event|9|||
155096451|NCT00570713|559787536|FG000|Overall Study|Death|7|||
155096452|NCT00570713|559787537|FG001|Overall Study|Death|7|||
155096453|NCT00570713|559787536|FG000|Overall Study|Lack of Efficacy|40|||
155096454|NCT00570713|559787537|FG001|Overall Study|Lack of Efficacy|49|||
155096455|NCT00570713|559787536|FG000|Overall Study|Physician Decision|2|||
155096456|NCT00570713|559787537|FG001|Overall Study|Physician Decision|2|||
155096457|NCT00570713|559787536|FG000|Overall Study|Withdrawal by Subject|3|||
155096458|NCT00570713|559787537|FG001|Overall Study|Withdrawal by Subject|3|||
155096459|NCT00570713|559787536|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
155096460|NCT00570713|559787537|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
155096461|NCT00469833|559787538|FG000|Overall Study|No IV access|2|||
155096462|NCT03289533|559787539|FG000|Overall Study|Death|12|||
155096463|NCT03289533|559787539|FG000|Overall Study|Terminated from study by sponsor|10|||
155096464|NCT00539240|559787540|FG000|Overall Study|Withdrawal by Subject|0|||
155171573|NCT04629066|560067370|FG000|Overall Study|Lost to Follow-up|3|||
155171574|NCT04629066|560067371|FG001|Overall Study|Lost to Follow-up|2|||
155171575|NCT02660983|560067377|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
155171576|NCT02660983|560067378|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
155171577|NCT02660983|560067377|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
155171578|NCT02660983|560067378|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
155171579|NCT02660983|560067377|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
155171580|NCT02660983|560067378|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
155171581|NCT02660983|560067377|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
155171582|NCT02660983|560067378|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
155171583|NCT02660983|560067377|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
155171584|NCT02660983|560067378|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
155171585|NCT02660983|560067377|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
155096465|NCT00539240|559787541|FG001|Overall Study|Withdrawal by Subject|2|||
155096466|NCT00539240|559787542|FG002|Overall Study|Withdrawal by Subject|0|||
155096467|NCT00539240|559787540|FG000|Overall Study|Protocol Violation|1|||
155096468|NCT00539240|559787541|FG001|Overall Study|Protocol Violation|1|||
155096469|NCT00539240|559787542|FG002|Overall Study|Protocol Violation|4|||
155096470|NCT00539240|559787540|FG000|Overall Study|Lost to Follow-up|2|||
155096471|NCT00539240|559787541|FG001|Overall Study|Lost to Follow-up|3|||
155096472|NCT00539240|559787542|FG002|Overall Study|Lost to Follow-up|1|||
155096473|NCT00539240|559787540|FG000|Overall Study|Adverse Event|3|||
155096474|NCT00539240|559787541|FG001|Overall Study|Adverse Event|1|||
155096475|NCT00539240|559787542|FG002|Overall Study|Adverse Event|10|||
155096476|NCT00902330|559787547|FG000|Overall Study|Too overwhelmed by treatment|2|||
155096477|NCT00902330|559787548|FG001|Overall Study|Too overwhelmed by treatment|5|||
155096478|NCT00902330|559787547|FG000|Overall Study|Adverse Event|1|||
155096479|NCT00902330|559787548|FG001|Overall Study|Adverse Event|0|||
155096480|NCT00902330|559787547|FG000|Overall Study|No post baseline data|1|||
155096481|NCT00902330|559787548|FG001|Overall Study|No post baseline data|0|||
155096482|NCT01847443|559787549|FG000|Study Period 1|Withdrawal by Subject|0|||
155096483|NCT01847443|559787550|FG001|Study Period 1|Withdrawal by Subject|1|||
155096484|NCT01847443|559787551|FG002|Study Period 1|Withdrawal by Subject|0|||
155096485|NCT01847443|559787552|FG003|Study Period 1|Withdrawal by Subject|0|||
155096486|NCT01847443|559787549|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
155096487|NCT01847443|559787550|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
155096488|NCT01847443|559787551|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
155096489|NCT01847443|559787552|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
155096490|NCT01847443|559787549|FG000|Washout Period Before Study Period 2|Other reason|1|||
155096491|NCT01847443|559787550|FG001|Washout Period Before Study Period 2|Other reason|0|||
155096492|NCT01847443|559787551|FG002|Washout Period Before Study Period 2|Other reason|0|||
155096493|NCT01847443|559787552|FG003|Washout Period Before Study Period 2|Other reason|0|||
155096494|NCT01847443|559787549|FG000|Washout Period Before Study Period 3|Other reason|1|||
155096495|NCT01847443|559787550|FG001|Washout Period Before Study Period 3|Other reason|0|||
155096496|NCT01847443|559787551|FG002|Washout Period Before Study Period 3|Other reason|0|||
155096497|NCT01847443|559787552|FG003|Washout Period Before Study Period 3|Other reason|0|||
155096498|NCT01847443|559787549|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
155096499|NCT01847443|559787550|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
155096500|NCT01847443|559787551|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
155096501|NCT01847443|559787552|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
155096502|NCT01847443|559787549|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
155096503|NCT01847443|559787550|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
155096504|NCT01847443|559787551|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
155096505|NCT01847443|559787552|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
155096506|NCT03571971|559787553|FG000|Overall Study|Lost to Follow-up|2|||
155096507|NCT03571971|559787554|FG001|Overall Study|Lost to Follow-up|2|||
155096508|NCT03571971|559787553|FG000|Overall Study|Protocol Violation|2|||
155096509|NCT03571971|559787554|FG001|Overall Study|Protocol Violation|3|||
155096510|NCT03571971|559787553|FG000|Overall Study|Withdrawal by Subject|2|||
155096511|NCT03571971|559787554|FG001|Overall Study|Withdrawal by Subject|0|||
155096512|NCT03571971|559787553|FG000|Overall Study|Incomplete primary outcome data|2|||
155096513|NCT03571971|559787554|FG001|Overall Study|Incomplete primary outcome data|0|||
155096514|NCT04067492|559787555|FG000|Overall Study|Lost to Follow-up|0|||
155096515|NCT04067492|559787556|FG001|Overall Study|Lost to Follow-up|0|||
155096516|NCT04067492|559787557|FG002|Overall Study|Lost to Follow-up|0|||
155096517|NCT04067492|559787558|FG003|Overall Study|Lost to Follow-up|0|||
155096518|NCT04067492|559787559|FG004|Overall Study|Lost to Follow-up|0|||
155171586|NCT02660983|560067378|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
155171587|NCT02660983|560067377|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
155171588|NCT02660983|560067378|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
155171589|NCT05601544|560067383|FG000|Phase 2 Period 1|Adverse Event|0|||
155171590|NCT05601544|560067384|FG001|Phase 2 Period 1|Adverse Event|1|||
155171591|NCT05601544|560067385|FG002|Phase 2 Period 1|Adverse Event|0|||
155171592|NCT05601544|560067386|FG003|Phase 2 Period 1|Adverse Event|0|||
155171593|NCT05601544|560067387|FG004|Phase 2 Period 1|Adverse Event|0|||
155171594|NCT05601544|560067388|FG005|Phase 2 Period 1|Adverse Event|0|||
155171595|NCT04303195|560067389|FG000|Overall Study|Adverse Event|1|||
155171596|NCT04303195|560067390|FG001|Overall Study|Adverse Event|3|||
155171597|NCT04303195|560067391|FG002|Overall Study|Adverse Event|7|||
155171598|NCT04303195|560067392|FG003|Overall Study|Adverse Event|0|||
155171599|NCT04303195|560067389|FG000|Overall Study|Lost to Follow-up|1|||
155171600|NCT04303195|560067390|FG001|Overall Study|Lost to Follow-up|0|||
155171601|NCT04303195|560067391|FG002|Overall Study|Lost to Follow-up|1|||
155171602|NCT04303195|560067392|FG003|Overall Study|Lost to Follow-up|4|||
155171603|NCT04303195|560067389|FG000|Overall Study|Withdrawal by Subject|3|||
155171604|NCT04303195|560067390|FG001|Overall Study|Withdrawal by Subject|1|||
155171605|NCT04303195|560067391|FG002|Overall Study|Withdrawal by Subject|1|||
155171606|NCT04303195|560067392|FG003|Overall Study|Withdrawal by Subject|1|||
155171607|NCT04303195|560067389|FG000|Overall Study|No study drug administered or protocol deviation|0|||
155171608|NCT04303195|560067390|FG001|Overall Study|No study drug administered or protocol deviation|2|||
155171609|NCT04303195|560067391|FG002|Overall Study|No study drug administered or protocol deviation|0|||
155171610|NCT04303195|560067392|FG003|Overall Study|No study drug administered or protocol deviation|2|||
155171611|NCT01064947|560067393|FG000|Overall Study|negative culture|41|||
155171612|NCT02970942|560067394|FG000|Overall Study|Death|0|||
155171613|NCT02970942|560067395|FG001|Overall Study|Death|1|||
155171614|NCT02970942|560067396|FG002|Overall Study|Death|0|||
155171615|NCT02970942|560067397|FG003|Overall Study|Death|0|||
155171616|NCT02970942|560067394|FG000|Overall Study|Lost to Follow-up|1|||
155171617|NCT02970942|560067395|FG001|Overall Study|Lost to Follow-up|0|||
155171618|NCT02970942|560067396|FG002|Overall Study|Lost to Follow-up|2|||
155171619|NCT02970942|560067397|FG003|Overall Study|Lost to Follow-up|1|||
155171620|NCT02970942|560067394|FG000|Overall Study|Withdrawal by Subject|3|||
155171621|NCT02970942|560067395|FG001|Overall Study|Withdrawal by Subject|5|||
155171622|NCT02970942|560067396|FG002|Overall Study|Withdrawal by Subject|3|||
155171623|NCT02970942|560067397|FG003|Overall Study|Withdrawal by Subject|2|||
155171624|NCT06457204|560067398|FG000|Washout|Adverse Event|0|||
155171625|NCT06457204|560067399|FG001|Washout|Adverse Event|2|||
155171626|NCT01065454|560067402|FG000|Treatment|Adverse Event|7|||
155171627|NCT01065454|560067403|FG001|Treatment|Adverse Event|4|||
155171628|NCT01065454|560067404|FG002|Treatment|Adverse Event|3|||
155171629|NCT01065454|560067405|FG003|Treatment|Adverse Event|6|||
155171630|NCT01065454|560067402|FG000|Treatment|Death|1|||
155171631|NCT01065454|560067403|FG001|Treatment|Death|0|||
155171632|NCT01065454|560067404|FG002|Treatment|Death|0|||
155171633|NCT01065454|560067405|FG003|Treatment|Death|0|||
155171634|NCT01065454|560067402|FG000|Treatment|Non-compliance|1|||
155171635|NCT01065454|560067403|FG001|Treatment|Non-compliance|0|||
155171636|NCT01065454|560067404|FG002|Treatment|Non-compliance|0|||
155171637|NCT01065454|560067405|FG003|Treatment|Non-compliance|1|||
155171638|NCT01065454|560067402|FG000|Treatment|Protocol Decision|0|||
155171639|NCT01065454|560067403|FG001|Treatment|Protocol Decision|0|||
155171640|NCT01065454|560067404|FG002|Treatment|Protocol Decision|3|||
155171641|NCT01065454|560067405|FG003|Treatment|Protocol Decision|2|||
155171642|NCT01065454|560067402|FG000|Treatment|Protocol Violation|1|||
155171643|NCT01065454|560067403|FG001|Treatment|Protocol Violation|0|||
155171644|NCT01065454|560067404|FG002|Treatment|Protocol Violation|1|||
155171645|NCT01065454|560067405|FG003|Treatment|Protocol Violation|0|||
155171646|NCT01065454|560067402|FG000|Treatment|Withdrawal by Subject|3|||
155171647|NCT01065454|560067403|FG001|Treatment|Withdrawal by Subject|1|||
155171648|NCT01065454|560067404|FG002|Treatment|Withdrawal by Subject|2|||
155171649|NCT01065454|560067405|FG003|Treatment|Withdrawal by Subject|3|||
155171650|NCT01065454|560067402|FG000|Follow up|Adverse Event|1|||
155171651|NCT01065454|560067403|FG001|Follow up|Adverse Event|0|||
155171652|NCT01065454|560067404|FG002|Follow up|Adverse Event|0|||
155171653|NCT01065454|560067405|FG003|Follow up|Adverse Event|1|||
155171654|NCT01065454|560067402|FG000|Follow up|Death|0|||
155171655|NCT01065454|560067403|FG001|Follow up|Death|1|||
155171656|NCT01065454|560067404|FG002|Follow up|Death|1|||
155171657|NCT01065454|560067405|FG003|Follow up|Death|0|||
155171658|NCT01065454|560067402|FG000|Follow up|Lost to Follow-up|0|||
155171659|NCT01065454|560067403|FG001|Follow up|Lost to Follow-up|0|||
155171660|NCT01065454|560067404|FG002|Follow up|Lost to Follow-up|0|||
155171661|NCT01065454|560067405|FG003|Follow up|Lost to Follow-up|1|||
155171662|NCT01065454|560067402|FG000|Follow up|Progressive disease|0|||
155171663|NCT01065454|560067403|FG001|Follow up|Progressive disease|0|||
155171664|NCT01065454|560067404|FG002|Follow up|Progressive disease|0|||
155171665|NCT01065454|560067405|FG003|Follow up|Progressive disease|1|||
155171666|NCT01065454|560067402|FG000|Follow up|Withdrawal by Subject|1|||
155096519|NCT04067492|559787560|FG005|Overall Study|Lost to Follow-up|1|||
155096520|NCT04067492|559787555|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155096521|NCT04067492|559787556|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
155096522|NCT04067492|559787557|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155096523|NCT04067492|559787558|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155096524|NCT04067492|559787559|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155096525|NCT04067492|559787560|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
155096526|NCT04067492|559787555|FG000|Overall Study|COVID-19 epidemiological situation|0|||
155096527|NCT04067492|559787556|FG001|Overall Study|COVID-19 epidemiological situation|0|||
155096528|NCT04067492|559787557|FG002|Overall Study|COVID-19 epidemiological situation|0|||
155096529|NCT04067492|559787558|FG003|Overall Study|COVID-19 epidemiological situation|1|||
155096530|NCT04067492|559787559|FG004|Overall Study|COVID-19 epidemiological situation|0|||
155096531|NCT04067492|559787560|FG005|Overall Study|COVID-19 epidemiological situation|0|||
155096532|NCT03950856|559787568|FG000|Overall Study|Death|1|||
155096533|NCT03950856|559787569|FG001|Overall Study|Death|2|||
155096534|NCT03950856|559787570|FG002|Overall Study|Death|0|||
155096535|NCT03950856|559787571|FG003|Overall Study|Death|0|||
155096536|NCT03950856|559787568|FG000|Overall Study|Lost to Follow-up|5|||
155096537|NCT03950856|559787569|FG001|Overall Study|Lost to Follow-up|6|||
155096538|NCT03950856|559787570|FG002|Overall Study|Lost to Follow-up|8|||
155096539|NCT03950856|559787571|FG003|Overall Study|Lost to Follow-up|2|||
155096540|NCT03950856|559787568|FG000|Overall Study|Protocol Violation|2|||
155096541|NCT03950856|559787569|FG001|Overall Study|Protocol Violation|0|||
155096542|NCT03950856|559787570|FG002|Overall Study|Protocol Violation|0|||
155096543|NCT03950856|559787571|FG003|Overall Study|Protocol Violation|1|||
155096544|NCT03950856|559787568|FG000|Overall Study|Withdrawal by Subject|4|||
155096545|NCT03950856|559787569|FG001|Overall Study|Withdrawal by Subject|1|||
155096546|NCT03950856|559787570|FG002|Overall Study|Withdrawal by Subject|3|||
155096547|NCT03950856|559787571|FG003|Overall Study|Withdrawal by Subject|1|||
155096548|NCT03950856|559787568|FG000|Overall Study|Unable to phone|7|||
155096549|NCT03950856|559787569|FG001|Overall Study|Unable to phone|6|||
155096550|NCT03950856|559787570|FG002|Overall Study|Unable to phone|7|||
155096551|NCT03950856|559787571|FG003|Overall Study|Unable to phone|2|||
155096552|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
155096553|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
155096554|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
155096555|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
155096556|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
155096557|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
155096558|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
155096559|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
155096560|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
155096561|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
155096562|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
155096563|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
155096564|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
155096565|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
155096566|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
155096567|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
155096568|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
155096569|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
155096570|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
155096571|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
155096572|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
155096573|NCT04021290|559787574|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
155096574|NCT04021290|559787575|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
155096575|NCT04021290|559787576|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
155096576|NCT04021290|559787574|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
155096577|NCT04021290|559787575|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
155096578|NCT04021290|559787576|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
155096579|NCT04021290|559787574|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
155096580|NCT04021290|559787575|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
155096581|NCT04021290|559787576|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
155096582|NCT04021290|559787574|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
155171667|NCT01065454|560067403|FG001|Follow up|Withdrawal by Subject|1|||
155171668|NCT01065454|560067404|FG002|Follow up|Withdrawal by Subject|1|||
155171669|NCT01065454|560067405|FG003|Follow up|Withdrawal by Subject|0|||
155171670|NCT01065454|560067402|FG000|Follow up|study ongoing|37|||
155171671|NCT01065454|560067403|FG001|Follow up|study ongoing|22|||
155096583|NCT04021290|559787575|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
155096584|NCT04021290|559787576|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
155096585|NCT04021290|559787574|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
155096586|NCT04021290|559787575|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
155096587|NCT04021290|559787576|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
155096588|NCT03391882|559787577|FG000|Study Overall|Adverse Event|3|||
155096589|NCT03391882|559787578|FG001|Study Overall|Adverse Event|6|||
155096590|NCT03391882|559787579|FG002|Study Overall|Adverse Event|1|||
155096591|NCT03391882|559787580|FG003|Study Overall|Adverse Event|1|||
155096592|NCT03391882|559787581|FG004|Study Overall|Adverse Event|3|||
155096593|NCT03391882|559787582|FG005|Study Overall|Adverse Event|1|||
155096594|NCT03391882|559787577|FG000|Study Overall|Lack of Efficacy|13|||
155096595|NCT03391882|559787578|FG001|Study Overall|Lack of Efficacy|9|||
155096596|NCT03391882|559787579|FG002|Study Overall|Lack of Efficacy|0|||
155096597|NCT03391882|559787580|FG003|Study Overall|Lack of Efficacy|0|||
155096598|NCT03391882|559787581|FG004|Study Overall|Lack of Efficacy|0|||
155096599|NCT03391882|559787582|FG005|Study Overall|Lack of Efficacy|0|||
155096600|NCT03391882|559787577|FG000|Study Overall|Withdrawal by Subject|3|||
155096601|NCT03391882|559787578|FG001|Study Overall|Withdrawal by Subject|3|||
155096602|NCT03391882|559787579|FG002|Study Overall|Withdrawal by Subject|2|||
155096603|NCT03391882|559787580|FG003|Study Overall|Withdrawal by Subject|2|||
155096604|NCT03391882|559787581|FG004|Study Overall|Withdrawal by Subject|1|||
155096605|NCT03391882|559787582|FG005|Study Overall|Withdrawal by Subject|3|||
155096606|NCT03391882|559787577|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155096607|NCT03391882|559787578|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
155096608|NCT03391882|559787579|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155096609|NCT03391882|559787580|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155096610|NCT03391882|559787581|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155096611|NCT03391882|559787582|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
155096612|NCT03391882|559787577|FG000|Study Overall|Protocol Violation|1|||
155096613|NCT03391882|559787578|FG001|Study Overall|Protocol Violation|0|||
155096614|NCT03391882|559787579|FG002|Study Overall|Protocol Violation|0|||
155096615|NCT03391882|559787580|FG003|Study Overall|Protocol Violation|0|||
155096616|NCT03391882|559787581|FG004|Study Overall|Protocol Violation|0|||
155096617|NCT03391882|559787582|FG005|Study Overall|Protocol Violation|0|||
155096618|NCT03391882|559787577|FG000|Part A - Titration Phase|Adverse Event|3|||
155096619|NCT03391882|559787578|FG001|Part A - Titration Phase|Adverse Event|6|||
155096620|NCT03391882|559787579|FG002|Part A - Titration Phase|Adverse Event|0|||
155096621|NCT03391882|559787580|FG003|Part A - Titration Phase|Adverse Event|0|||
155096622|NCT03391882|559787581|FG004|Part A - Titration Phase|Adverse Event|0|||
155096623|NCT03391882|559787582|FG005|Part A - Titration Phase|Adverse Event|0|||
155096624|NCT03391882|559787577|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
155096625|NCT03391882|559787578|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
155096626|NCT03391882|559787579|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
155096627|NCT03391882|559787580|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
155096628|NCT03391882|559787581|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
155096629|NCT03391882|559787582|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
155096630|NCT03391882|559787577|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
155096631|NCT03391882|559787578|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
155096632|NCT03391882|559787579|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
155096633|NCT03391882|559787580|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
155096634|NCT03391882|559787581|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
155096635|NCT03391882|559787582|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
155096636|NCT03391882|559787577|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155096637|NCT03391882|559787578|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
155096638|NCT03391882|559787579|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155096639|NCT03391882|559787580|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155096640|NCT03391882|559787581|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155096641|NCT03391882|559787582|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
155096642|NCT03391882|559787577|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
155096643|NCT03391882|559787578|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
155096644|NCT03391882|559787579|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
155096645|NCT03391882|559787580|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
155096646|NCT03391882|559787581|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
155096647|NCT03391882|559787582|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
155096648|NCT03391882|559787577|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
155096649|NCT03391882|559787578|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
155096650|NCT03391882|559787579|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
155096651|NCT03391882|559787580|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
155096652|NCT03391882|559787581|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
155096653|NCT03391882|559787582|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
155096654|NCT03391882|559787577|FG000|Part B - Treatment Phase|Adverse Event|0|||
155096655|NCT03391882|559787578|FG001|Part B - Treatment Phase|Adverse Event|0|||
155096656|NCT03391882|559787579|FG002|Part B - Treatment Phase|Adverse Event|1|||
155096657|NCT03391882|559787580|FG003|Part B - Treatment Phase|Adverse Event|1|||
155096658|NCT03391882|559787581|FG004|Part B - Treatment Phase|Adverse Event|3|||
155096659|NCT03391882|559787582|FG005|Part B - Treatment Phase|Adverse Event|1|||
155096660|NCT03391882|559787577|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
155096661|NCT03391882|559787578|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
155096662|NCT03391882|559787579|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
155096663|NCT03391882|559787580|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
155096664|NCT03391882|559787581|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
155096665|NCT03391882|559787582|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
155096666|NCT03092479|559787583|FG000|Overall Study|Lost to Follow-up|3|||
155096667|NCT03092479|559787584|FG001|Overall Study|Lost to Follow-up|2|||
155096668|NCT03092479|559787583|FG000|Overall Study|Withdrawal by Subject|4|||
155096669|NCT03092479|559787584|FG001|Overall Study|Withdrawal by Subject|0|||
155096670|NCT04422431|559787587|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
154967582|NCT01899053|559303361|FG009|Overall Study|Reason Not Specified|0|||
154967583|NCT01899053|559303362|FG010|Overall Study|Reason Not Specified|0|||
155096671|NCT04422431|559787587|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
155096672|NCT04422431|559787587|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
155096673|NCT04422431|559787587|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
155096674|NCT04422431|559787587|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
155096675|NCT04422431|559787587|FG000|Extension Period (48 Weeks)|Other than specified|2|||
155096676|NCT03913130|559787588|FG000|Overall Study|Sponsor Decision|1|||
155096677|NCT01174563|559787591|FG000|Overall Study|Progressive Disease|45|||
155096678|NCT01174563|559787591|FG000|Overall Study|Death|5|||
155096679|NCT01174563|559787591|FG000|Overall Study|Investigator's Discretion|5|||
155096680|NCT01174563|559787591|FG000|Overall Study|Participant Withdrew Consent|3|||
155096681|NCT01174563|559787591|FG000|Overall Study|Rash Adverse Event|1|||
155096682|NCT01174563|559787591|FG000|Overall Study|Sponsor's decision|1|||
155096683|NCT03402841|559787592|FG000|Overall Study|Withdrawal by Subject|3|||
155096684|NCT03402841|559787592|FG000|Overall Study|Lost to Follow-up|2|||
155096685|NCT03402841|559787592|FG000|Overall Study|Death|146|||
155096686|NCT00444106|559787593|FG000|Overall Study|Lost to Follow-up|2|||
155096687|NCT00444106|559787594|FG001|Overall Study|Lost to Follow-up|1|||
155096688|NCT00444106|559787595|FG002|Overall Study|Lost to Follow-up|0|||
155096689|NCT00444106|559787593|FG000|Overall Study|Abnormal Test Procedure Results|0|||
155096690|NCT00444106|559787594|FG001|Overall Study|Abnormal Test Procedure Results|0|||
155096691|NCT00444106|559787595|FG002|Overall Study|Abnormal Test Procedure Results|1|||
155096692|NCT02317627|559787598|FG000|Overall Study|Withdrawal by Subject|0|||
155096693|NCT02317627|559787599|FG001|Overall Study|Withdrawal by Subject|1|||
155096694|NCT02317627|559787600|FG002|Overall Study|Withdrawal by Subject|1|||
155096695|NCT02317627|559787598|FG000|Overall Study|Lost to Follow-up|2|||
155096696|NCT02317627|559787599|FG001|Overall Study|Lost to Follow-up|0|||
155096697|NCT02317627|559787600|FG002|Overall Study|Lost to Follow-up|0|||
155096698|NCT02317627|559787598|FG000|Overall Study|Stopped by Investigator|0|||
155096699|NCT02317627|559787599|FG001|Overall Study|Stopped by Investigator|1|||
154967584|NCT01899053|559303363|FG011|Overall Study|Reason Not Specified|0|||
154967585|NCT01899053|559303364|FG012|Overall Study|Reason Not Specified|1|||
155096700|NCT02317627|559787600|FG002|Overall Study|Stopped by Investigator|0|||
155096701|NCT02317627|559787598|FG000|Overall Study|Adverse Event|0|||
155096702|NCT02317627|559787599|FG001|Overall Study|Adverse Event|2|||
155096703|NCT02317627|559787600|FG002|Overall Study|Adverse Event|3|||
155171672|NCT01065454|560067404|FG002|Follow up|study ongoing|15|||
155171673|NCT01065454|560067405|FG003|Follow up|study ongoing|41|||
155171674|NCT01601652|560067407|FG000|Overall Study|Death|1|||
155171675|NCT03374202|560067423|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
155171676|NCT03374202|560067424|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
155171677|NCT03374202|560067425|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
155171678|NCT03374202|560067423|FG000|Five Year Long Term Follow Up|Death|0|||
155171679|NCT03374202|560067424|FG001|Five Year Long Term Follow Up|Death|1|||
155171680|NCT03374202|560067425|FG002|Five Year Long Term Follow Up|Death|0|||
155171681|NCT01948193|560069454|FG000|Overall Study|Serious event|2|||
155171682|NCT01948193|560069454|FG000|Overall Study|Lost to Follow-up|7|||
155171683|NCT00843778|560069455|FG000|Overall Study|Adverse Event|15|||
155171684|NCT00843778|560069455|FG000|Overall Study|Lack of Efficacy|14|||
155171685|NCT00843778|560069455|FG000|Overall Study|Loss of efficacy|2|||
155171686|NCT00843778|560069455|FG000|Overall Study|Withdrawal by Subject|4|||
155171687|NCT03338959|560069456|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
155171688|NCT03338959|560069456|FG000|Overall Study|Physician Decision|1|||
155171689|NCT00409331|560069457|FG000|Overall Study|Physician Decision|1|||
155171690|NCT02184455|560069458|FG000|Overall Study|Lost to Follow-up|1|||
155171691|NCT00730028|560069462|FG000|Overall Study|Adverse Event|23|||
155171692|NCT00730028|560069463|FG001|Overall Study|Adverse Event|26|||
155171693|NCT00730028|560069464|FG002|Overall Study|Adverse Event|16|||
155171694|NCT00730028|560069465|FG003|Overall Study|Adverse Event|20|||
155171695|NCT00730028|560069466|FG004|Overall Study|Adverse Event|43|||
155171696|NCT00730028|560069462|FG000|Overall Study|Lost to Follow-up|13|||
155171697|NCT00730028|560069463|FG001|Overall Study|Lost to Follow-up|26|||
155171698|NCT00730028|560069464|FG002|Overall Study|Lost to Follow-up|22|||
155171699|NCT00730028|560069465|FG003|Overall Study|Lost to Follow-up|26|||
155171700|NCT00730028|560069466|FG004|Overall Study|Lost to Follow-up|25|||
155171701|NCT00730028|560069462|FG000|Overall Study|Protocol Violation|6|||
155171702|NCT00730028|560069463|FG001|Overall Study|Protocol Violation|1|||
155171703|NCT00730028|560069464|FG002|Overall Study|Protocol Violation|1|||
155171704|NCT00730028|560069465|FG003|Overall Study|Protocol Violation|2|||
155171705|NCT00730028|560069466|FG004|Overall Study|Protocol Violation|0|||
155171706|NCT00730028|560069462|FG000|Overall Study|Withdrawal by Subject|9|||
155171707|NCT00730028|560069463|FG001|Overall Study|Withdrawal by Subject|5|||
155171708|NCT00730028|560069464|FG002|Overall Study|Withdrawal by Subject|4|||
155171709|NCT00730028|560069465|FG003|Overall Study|Withdrawal by Subject|5|||
155171710|NCT00730028|560069466|FG004|Overall Study|Withdrawal by Subject|9|||
155171711|NCT00730028|560069462|FG000|Overall Study|Physician Decision|3|||
155171712|NCT00730028|560069463|FG001|Overall Study|Physician Decision|3|||
155171713|NCT00730028|560069464|FG002|Overall Study|Physician Decision|2|||
155171714|NCT00730028|560069465|FG003|Overall Study|Physician Decision|3|||
155171715|NCT00730028|560069466|FG004|Overall Study|Physician Decision|2|||
155171716|NCT00730028|560069462|FG000|Overall Study|Treatment Failure|5|||
155171717|NCT00730028|560069463|FG001|Overall Study|Treatment Failure|5|||
155171718|NCT00730028|560069464|FG002|Overall Study|Treatment Failure|0|||
155171719|NCT00730028|560069465|FG003|Overall Study|Treatment Failure|0|||
155171720|NCT00730028|560069466|FG004|Overall Study|Treatment Failure|1|||
155171721|NCT00730028|560069462|FG000|Overall Study|Randomization Error|1|||
155171722|NCT00730028|560069463|FG001|Overall Study|Randomization Error|0|||
155171723|NCT00730028|560069464|FG002|Overall Study|Randomization Error|0|||
155171724|NCT00730028|560069465|FG003|Overall Study|Randomization Error|0|||
155171725|NCT00730028|560069466|FG004|Overall Study|Randomization Error|2|||
155171726|NCT03680742|560069467|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
155171727|NCT01250496|560069470|FG000|Overall Study|Study terminated|124|||
155171728|NCT01250496|560069471|FG001|Overall Study|Study terminated|124|||
155171729|NCT00003590|560069472|FG000|Overall Study|Ineligible Patient|1|||
155171730|NCT00003590|560069472|FG000|Overall Study|Adverse Event|7|||
155171731|NCT00003590|560069472|FG000|Overall Study|Withdrawal by Subject|1|||
155171732|NCT00003590|560069472|FG000|Overall Study|Lack of Efficacy|11|||
155171733|NCT00003590|560069472|FG000|Overall Study|Death|1|||
155171734|NCT00003590|560069472|FG000|Overall Study|Physician Decision|1|||
155171735|NCT01425463|560069478|FG000|Overall Study|Adverse Event|5|||
155171736|NCT01425463|560069479|FG001|Overall Study|Adverse Event|7|||
155171737|NCT01425463|560069478|FG000|Overall Study|Lack of Efficacy|1|||
155171738|NCT01425463|560069479|FG001|Overall Study|Lack of Efficacy|1|||
155171739|NCT01425463|560069478|FG000|Overall Study|Protocol Violation|2|||
155171740|NCT01425463|560069479|FG001|Overall Study|Protocol Violation|2|||
155171741|NCT01425463|560069478|FG000|Overall Study|Lost to Follow-up|5|||
155171742|NCT01425463|560069479|FG001|Overall Study|Lost to Follow-up|2|||
155171743|NCT01425463|560069478|FG000|Overall Study|Withdrawal by Subject|7|||
155171744|NCT01425463|560069479|FG001|Overall Study|Withdrawal by Subject|5|||
155171745|NCT01425463|560069478|FG000|Overall Study|Unknown Reason|4|||
155171746|NCT01425463|560069479|FG001|Overall Study|Unknown Reason|7|||
155171747|NCT01236547|560069480|FG000|Overall Study|Protocol Violation|0|||
155171748|NCT01236547|560069481|FG001|Overall Study|Protocol Violation|1|||
155171749|NCT01236547|560069482|FG002|Overall Study|Protocol Violation|1|||
155171750|NCT01236547|560069483|FG003|Overall Study|Protocol Violation|6|||
155171751|NCT01236547|560069484|FG004|Overall Study|Protocol Violation|12|||
155171752|NCT00538785|560069485|FG000|Overall Study|Death|9|||
155171753|NCT00538785|560069486|FG001|Overall Study|Death|10|||
155171754|NCT00538785|560069485|FG000|Overall Study|Withdrawal of consent|9|||
155171755|NCT00538785|560069486|FG001|Overall Study|Withdrawal of consent|7|||
155171756|NCT00538785|560069485|FG000|Overall Study|Lost to Follow-up|1|||
155171757|NCT00538785|560069486|FG001|Overall Study|Lost to Follow-up|0|||
155171758|NCT01598129|560069487|FG000|Overall Study|Disease progression|6|||
155096704|NCT02317627|559787598|FG000|Overall Study|Non-compliance with study drug|0|||
155096705|NCT02317627|559787599|FG001|Overall Study|Non-compliance with study drug|1|||
155096706|NCT02317627|559787600|FG002|Overall Study|Non-compliance with study drug|0|||
155096707|NCT00279214|559787601|FG000|Overall Study|Physician Decision|3|||
155096708|NCT00279214|559787602|FG001|Overall Study|Physician Decision|2|||
155096709|NCT01280968|559787603|FG000|Overall Study|Lost to Follow-up|8|||
155096710|NCT01280968|559787604|FG001|Overall Study|Lost to Follow-up|2|||
155096711|NCT01280968|559787603|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
155096712|NCT01280968|559787604|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
155096713|NCT01280968|559787603|FG000|Overall Study|Commuting Problems|2|||
155096714|NCT01280968|559787604|FG001|Overall Study|Commuting Problems|0|||
155096715|NCT01280968|559787603|FG000|Overall Study|Anxiety|2|||
155096716|NCT01280968|559787604|FG001|Overall Study|Anxiety|0|||
155096717|NCT01280968|559787603|FG000|Overall Study|Adverse Event|1|||
155096718|NCT01280968|559787604|FG001|Overall Study|Adverse Event|0|||
155096719|NCT01280968|559787603|FG000|Overall Study|Scheduling Conflicts|1|||
155096720|NCT01280968|559787604|FG001|Overall Study|Scheduling Conflicts|1|||
155096721|NCT01280968|559787603|FG000|Overall Study|Pre-existing Neurological Condition|1|||
155096722|NCT01280968|559787604|FG001|Overall Study|Pre-existing Neurological Condition|0|||
155096723|NCT01280968|559787603|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
155096724|NCT01280968|559787604|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
155096725|NCT00038948|559787605|FG000|Overall Study|Adverse Event|131|||
155096726|NCT00038948|559787606|FG001|Overall Study|Adverse Event|43|||
155096727|NCT00038948|559787605|FG000|Overall Study|Lost to Follow-up|4|||
155096728|NCT00038948|559787606|FG001|Overall Study|Lost to Follow-up|4|||
155096729|NCT00038948|559787605|FG000|Overall Study|Nonmedical event|5|||
155096730|NCT00038948|559787606|FG001|Overall Study|Nonmedical event|7|||
155096731|NCT00038948|559787605|FG000|Overall Study|Withdrawal by Subject|23|||
155096732|NCT00038948|559787606|FG001|Overall Study|Withdrawal by Subject|10|||
155096733|NCT00038948|559787605|FG000|Overall Study|Protocol Violation|3|||
155096734|NCT00038948|559787606|FG001|Overall Study|Protocol Violation|7|||
155096735|NCT00038948|559787605|FG000|Overall Study|Lack of Efficacy|3|||
155096736|NCT00038948|559787606|FG001|Overall Study|Lack of Efficacy|6|||
155096737|NCT03984188|559787609|FG000|Overall Study|Death|2|||
155096738|NCT03984188|559787610|FG001|Overall Study|Death|4|||
155096739|NCT03984188|559787609|FG000|Overall Study|Physician Decision|0|||
155096740|NCT03984188|559787610|FG001|Overall Study|Physician Decision|2|||
155096741|NCT03984188|559787609|FG000|Overall Study|Lost to Follow-up|3|||
155096742|NCT03984188|559787610|FG001|Overall Study|Lost to Follow-up|2|||
155096743|NCT03984188|559787609|FG000|Overall Study|Withdrawal by Subject|6|||
155096744|NCT03984188|559787610|FG001|Overall Study|Withdrawal by Subject|0|||
155096745|NCT01747915|559789503|FG000|Overall Study|Other|1|||
155096746|NCT01747915|559789504|FG001|Overall Study|Other|1|||
155096747|NCT01747915|559789505|FG002|Overall Study|Other|1|||
155096748|NCT01747915|559789503|FG000|Overall Study|Adverse Event|8|||
155096749|NCT01747915|559789504|FG001|Overall Study|Adverse Event|5|||
155096750|NCT01747915|559789505|FG002|Overall Study|Adverse Event|2|||
155096751|NCT01747915|559789503|FG000|Overall Study|Death|0|||
155096752|NCT01747915|559789504|FG001|Overall Study|Death|0|||
155096753|NCT01747915|559789505|FG002|Overall Study|Death|1|||
155096754|NCT01747915|559789503|FG000|Overall Study|Lack of Efficacy|0|||
155096755|NCT01747915|559789504|FG001|Overall Study|Lack of Efficacy|1|||
155096756|NCT01747915|559789505|FG002|Overall Study|Lack of Efficacy|0|||
155096757|NCT01747915|559789503|FG000|Overall Study|Lost to Follow-up|1|||
155096758|NCT01747915|559789504|FG001|Overall Study|Lost to Follow-up|0|||
155096759|NCT01747915|559789505|FG002|Overall Study|Lost to Follow-up|0|||
155096760|NCT01747915|559789503|FG000|Overall Study|Withdrawal by Subject|4|||
155096761|NCT01747915|559789504|FG001|Overall Study|Withdrawal by Subject|4|||
154967586|NCT01899053|559303365|FG013|Overall Study|Reason Not Specified|0|||
155096762|NCT01747915|559789505|FG002|Overall Study|Withdrawal by Subject|1|||
155096763|NCT01747915|559789503|FG000|Overall Study|Protocol Violation|1|||
155096764|NCT01747915|559789504|FG001|Overall Study|Protocol Violation|0|||
155096765|NCT01747915|559789505|FG002|Overall Study|Protocol Violation|0|||
155096766|NCT01747915|559789503|FG000|Overall Study|Pregnancy|0|||
155096767|NCT01747915|559789504|FG001|Overall Study|Pregnancy|0|||
155096768|NCT01747915|559789505|FG002|Overall Study|Pregnancy|1|||
155096769|NCT03341637|559789506|FG000|Overall Study|Lost to Follow-up|1|||
155096770|NCT03341637|559789507|FG001|Overall Study|Lost to Follow-up|0|||
155096771|NCT03341637|559789506|FG000|Overall Study|Withdrawal by Subject|3|||
155096772|NCT03341637|559789507|FG001|Overall Study|Withdrawal by Subject|3|||
155096773|NCT03341637|559789506|FG000|Overall Study|Reason not Specified|1|||
155096774|NCT03341637|559789507|FG001|Overall Study|Reason not Specified|1|||
155096775|NCT02391311|559789508|FG000|Overall Study|Lost to Follow-up|2|||
155096776|NCT02391311|559789509|FG001|Overall Study|Lost to Follow-up|1|||
155096777|NCT02391311|559789508|FG000|Overall Study|deemed ineligible after baseline|1|||
155096778|NCT02391311|559789509|FG001|Overall Study|deemed ineligible after baseline|1|||
155096779|NCT03012334|559789512|FG000|Period 1|Withdrawal by Subject|0|||
155096780|NCT03012334|559789513|FG001|Period 1|Withdrawal by Subject|0|||
155096781|NCT03012334|559789514|FG002|Period 1|Withdrawal by Subject|0|||
155096782|NCT03012334|559789515|FG003|Period 1|Withdrawal by Subject|0|||
155096783|NCT03012334|559789516|FG004|Period 1|Withdrawal by Subject|0|||
155096784|NCT03012334|559789517|FG005|Period 1|Withdrawal by Subject|0|||
155096785|NCT03012334|559789518|FG006|Period 1|Withdrawal by Subject|0|||
155096786|NCT03012334|559789519|FG007|Period 1|Withdrawal by Subject|0|||
155096787|NCT03012334|559789520|FG008|Period 1|Withdrawal by Subject|0|||
155096788|NCT03012334|559789521|FG009|Period 1|Withdrawal by Subject|1|||
155096789|NCT03012334|559789512|FG000|Period 2|Withdrawal by Subject|0|||
155096790|NCT03012334|559789513|FG001|Period 2|Withdrawal by Subject|1|||
155096791|NCT03012334|559789514|FG002|Period 2|Withdrawal by Subject|0|||
155096792|NCT03012334|559789515|FG003|Period 2|Withdrawal by Subject|0|||
155096793|NCT03012334|559789516|FG004|Period 2|Withdrawal by Subject|0|||
155096794|NCT03012334|559789517|FG005|Period 2|Withdrawal by Subject|0|||
155096795|NCT03012334|559789518|FG006|Period 2|Withdrawal by Subject|0|||
155096796|NCT03012334|559789519|FG007|Period 2|Withdrawal by Subject|0|||
154967587|NCT01899053|559303352|FG000|Overall Study|Withdrawal by Subject|1|||
154967588|NCT01899053|559303353|FG001|Overall Study|Withdrawal by Subject|1|||
155096797|NCT03012334|559789520|FG008|Period 2|Withdrawal by Subject|0|||
155096798|NCT03012334|559789521|FG009|Period 2|Withdrawal by Subject|0|||
155096799|NCT03012334|559789512|FG000|Period 2|Protocol Violation|0|||
155096800|NCT03012334|559789513|FG001|Period 2|Protocol Violation|0|||
155096801|NCT03012334|559789514|FG002|Period 2|Protocol Violation|1|||
155096802|NCT03012334|559789515|FG003|Period 2|Protocol Violation|0|||
155096803|NCT03012334|559789516|FG004|Period 2|Protocol Violation|0|||
155096804|NCT03012334|559789517|FG005|Period 2|Protocol Violation|0|||
155171759|NCT01598129|560069487|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
155171760|NCT01598129|560069487|FG000|Overall Study|Withdrawal by Subject|1|||
155171761|NCT00505076|560069488|FG000|Overall Study|Adverse Event|1|||
155171762|NCT00505076|560069489|FG001|Overall Study|Adverse Event|0|||
155171763|NCT00505076|560069490|FG002|Overall Study|Adverse Event|1|||
155171764|NCT00505076|560069488|FG000|Overall Study|Protocol Violation|2|||
155171765|NCT00505076|560069489|FG001|Overall Study|Protocol Violation|1|||
155171766|NCT00505076|560069490|FG002|Overall Study|Protocol Violation|2|||
155171767|NCT00505076|560069488|FG000|Overall Study|Withdrawal by Subject|0|||
155171768|NCT00505076|560069489|FG001|Overall Study|Withdrawal by Subject|1|||
155171769|NCT00505076|560069490|FG002|Overall Study|Withdrawal by Subject|2|||
155171770|NCT04093024|560069493|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
155171771|NCT04093024|560069494|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
155171772|NCT04093024|560069493|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
155171773|NCT04093024|560069494|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
155171774|NCT04093024|560069493|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
155171775|NCT04093024|560069494|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
155171776|NCT04093024|560069493|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
155171777|NCT04093024|560069494|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
155171778|NCT00647270|560069499|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
155171779|NCT00647270|560069500|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
155171780|NCT00647270|560069501|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
155171781|NCT00647270|560069499|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
155171782|NCT00647270|560069500|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
155171783|NCT00647270|560069501|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
155096805|NCT03012334|559789518|FG006|Period 2|Protocol Violation|0|||
155096806|NCT03012334|559789519|FG007|Period 2|Protocol Violation|1|||
155096807|NCT03012334|559789520|FG008|Period 2|Protocol Violation|0|||
155096808|NCT03012334|559789521|FG009|Period 2|Protocol Violation|0|||
155096809|NCT03012334|559789512|FG000|Period 4|Non-Compliance|0|||
155096810|NCT03012334|559789513|FG001|Period 4|Non-Compliance|0|||
155096811|NCT03012334|559789514|FG002|Period 4|Non-Compliance|0|||
155096812|NCT03012334|559789515|FG003|Period 4|Non-Compliance|0|||
155096813|NCT03012334|559789516|FG004|Period 4|Non-Compliance|0|||
155096814|NCT03012334|559789517|FG005|Period 4|Non-Compliance|0|||
155096815|NCT03012334|559789518|FG006|Period 4|Non-Compliance|1|||
155096816|NCT03012334|559789519|FG007|Period 4|Non-Compliance|0|||
155096817|NCT03012334|559789520|FG008|Period 4|Non-Compliance|0|||
155096818|NCT03012334|559789521|FG009|Period 4|Non-Compliance|0|||
155096819|NCT03012334|559789512|FG000|Period 4|Adverse Event|0|||
155096820|NCT03012334|559789513|FG001|Period 4|Adverse Event|0|||
155096821|NCT03012334|559789514|FG002|Period 4|Adverse Event|0|||
155096822|NCT03012334|559789515|FG003|Period 4|Adverse Event|0|||
155096823|NCT03012334|559789516|FG004|Period 4|Adverse Event|0|||
155096824|NCT03012334|559789517|FG005|Period 4|Adverse Event|0|||
155096825|NCT03012334|559789518|FG006|Period 4|Adverse Event|0|||
155096826|NCT03012334|559789519|FG007|Period 4|Adverse Event|0|||
155096827|NCT03012334|559789520|FG008|Period 4|Adverse Event|1|||
155096828|NCT03012334|559789521|FG009|Period 4|Adverse Event|0|||
155096829|NCT01823107|559789522|FG000|Overall Study|Withdrawal by Subject|1|||
155096830|NCT01073293|559789523|FG000|Overall Study|Lost to Follow-up|0|||
155096831|NCT01073293|559789524|FG001|Overall Study|Lost to Follow-up|1|||
155096832|NCT01073293|559789523|FG000|Overall Study|Withdrawal by Subject|5|||
155096833|NCT01073293|559789524|FG001|Overall Study|Withdrawal by Subject|10|||
155096834|NCT00305448|559789525|FG000|Overall Study|Protocol Violation|0|||
155096835|NCT00305448|559789526|FG001|Overall Study|Protocol Violation|1|||
155096836|NCT00305448|559789527|FG002|Overall Study|Protocol Violation|0|||
155096837|NCT00305448|559789525|FG000|Overall Study|Withdrawal by Subject|2|||
155096838|NCT00305448|559789526|FG001|Overall Study|Withdrawal by Subject|0|||
155096839|NCT00305448|559789527|FG002|Overall Study|Withdrawal by Subject|1|||
155096840|NCT00305448|559789525|FG000|Overall Study|Adverse Event|1|||
155096841|NCT00305448|559789526|FG001|Overall Study|Adverse Event|0|||
155096842|NCT00305448|559789527|FG002|Overall Study|Adverse Event|1|||
155096843|NCT00305448|559789525|FG000|Overall Study|Disease Progression|27|||
155096844|NCT00305448|559789526|FG001|Overall Study|Disease Progression|31|||
155096845|NCT00305448|559789527|FG002|Overall Study|Disease Progression|28|||
155096846|NCT00305448|559789525|FG000|Overall Study|Subjective Disease Progression|1|||
155096847|NCT00305448|559789526|FG001|Overall Study|Subjective Disease Progression|2|||
155096848|NCT00305448|559789527|FG002|Overall Study|Subjective Disease Progression|2|||
155096849|NCT00305448|559789525|FG000|Overall Study|Tumor Marker Elevation|0|||
155096850|NCT00305448|559789526|FG001|Overall Study|Tumor Marker Elevation|0|||
155096851|NCT00305448|559789527|FG002|Overall Study|Tumor Marker Elevation|1|||
155096852|NCT00002766|559789530|FG000|Overall Study|Withdrawal by Subject|0|||
155096853|NCT00002766|559789531|FG001|Overall Study|Withdrawal by Subject|1|||
155096854|NCT00002766|559789530|FG000|Overall Study|Patient Not Treated|1|||
155096855|NCT00002766|559789531|FG001|Overall Study|Patient Not Treated|2|||
155096856|NCT00002766|559789530|FG000|Overall Study|Adverse Event|1|||
155096857|NCT00002766|559789531|FG001|Overall Study|Adverse Event|1|||
155096858|NCT00002766|559789530|FG000|Overall Study|Protocol Violation|1|||
155096859|NCT00002766|559789531|FG001|Overall Study|Protocol Violation|0|||
155096860|NCT00328172|559789532|FG000|Overall Study|Adverse Event|3|||
155096861|NCT00328172|559789533|FG001|Overall Study|Adverse Event|2|||
155096862|NCT00328172|559789534|FG002|Overall Study|Adverse Event|1|||
155096863|NCT00328172|559789535|FG003|Overall Study|Adverse Event|2|||
155096864|NCT00328172|559789536|FG004|Overall Study|Adverse Event|1|||
155096865|NCT00328172|559789532|FG000|Overall Study|Protocol Violation|0|||
155096866|NCT00328172|559789533|FG001|Overall Study|Protocol Violation|1|||
155096867|NCT00328172|559789534|FG002|Overall Study|Protocol Violation|1|||
155096868|NCT00328172|559789535|FG003|Overall Study|Protocol Violation|0|||
155096869|NCT00328172|559789536|FG004|Overall Study|Protocol Violation|0|||
155096870|NCT00328172|559789532|FG000|Overall Study|Lost to Follow-up|1|||
155096871|NCT00328172|559789533|FG001|Overall Study|Lost to Follow-up|1|||
155096872|NCT00328172|559789534|FG002|Overall Study|Lost to Follow-up|2|||
155096873|NCT00328172|559789535|FG003|Overall Study|Lost to Follow-up|1|||
155096874|NCT00328172|559789536|FG004|Overall Study|Lost to Follow-up|1|||
155096875|NCT00328172|559789532|FG000|Overall Study|Withdrawal by Subject|1|||
155096876|NCT00328172|559789533|FG001|Overall Study|Withdrawal by Subject|1|||
155096877|NCT00328172|559789534|FG002|Overall Study|Withdrawal by Subject|1|||
155096878|NCT00328172|559789535|FG003|Overall Study|Withdrawal by Subject|6|||
155096879|NCT00328172|559789536|FG004|Overall Study|Withdrawal by Subject|0|||
155096880|NCT00328172|559789532|FG000|Overall Study|Lack of Efficacy|14|||
155096881|NCT00328172|559789533|FG001|Overall Study|Lack of Efficacy|9|||
155096882|NCT00328172|559789534|FG002|Overall Study|Lack of Efficacy|4|||
155096883|NCT00328172|559789535|FG003|Overall Study|Lack of Efficacy|4|||
155096884|NCT00328172|559789536|FG004|Overall Study|Lack of Efficacy|3|||
155096885|NCT00328172|559789532|FG000|Overall Study|Other reason (not specified)|3|||
155096886|NCT00328172|559789533|FG001|Overall Study|Other reason (not specified)|0|||
155096887|NCT00328172|559789534|FG002|Overall Study|Other reason (not specified)|1|||
155171784|NCT00647270|560069499|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
155171785|NCT00647270|560069500|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
155171786|NCT00647270|560069501|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
155171787|NCT00647270|560069499|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
155171788|NCT00647270|560069500|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
155171789|NCT00647270|560069501|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
155171790|NCT00647270|560069499|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
155171791|NCT00647270|560069500|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
155171792|NCT00647270|560069501|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
155171793|NCT00647270|560069499|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
155171794|NCT00647270|560069500|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
155171795|NCT00647270|560069501|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
155171796|NCT00647270|560069499|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
155171797|NCT00647270|560069500|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
155171798|NCT00647270|560069501|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
155171799|NCT03615040|560069504|FG000|Overall Study|Withdrawal by Subject|2|||
155171800|NCT03615040|560069505|FG001|Overall Study|Withdrawal by Subject|1|||
155171801|NCT03615040|560069504|FG000|Overall Study|Physician Decision|2|||
155171802|NCT03615040|560069505|FG001|Overall Study|Physician Decision|2|||
155171803|NCT03615040|560069504|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
155171804|NCT03615040|560069505|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
155171805|NCT03615040|560069504|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
155171806|NCT03615040|560069505|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
155171807|NCT03615040|560069504|FG000|Overall Study|Death|0|||
155171808|NCT03615040|560069505|FG001|Overall Study|Death|2|||
155171809|NCT01541397|560069506|FG000|Overall Study|Study ended prior to data collection|4|||
155171810|NCT01541397|560069507|FG001|Overall Study|Study ended prior to data collection|2|||
155171811|NCT01128621|560069508|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
155171812|NCT01128621|560069509|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
155171813|NCT00388583|560069514|FG000|Overall Study|Protocol Violation|1|||
155171814|NCT00388583|560069515|FG001|Overall Study|Protocol Violation|0|||
155171815|NCT00388583|560069514|FG000|Overall Study|Withdrawal by Subject|3|||
155171816|NCT00388583|560069515|FG001|Overall Study|Withdrawal by Subject|3|||
155171817|NCT00388583|560069514|FG000|Overall Study|Serious Adverse Event|2|||
155171818|NCT00388583|560069515|FG001|Overall Study|Serious Adverse Event|0|||
155096888|NCT00328172|559789535|FG003|Overall Study|Other reason (not specified)|0|||
155096889|NCT00328172|559789536|FG004|Overall Study|Other reason (not specified)|0|||
155096890|NCT00077974|559789537|FG000|Overall Study|Adverse Event|22|||
155096891|NCT00077974|559789537|FG000|Overall Study|Protocol Violation|1|||
155096892|NCT00077974|559789537|FG000|Overall Study|Withdrawal by Subject|3|||
155096893|NCT00077974|559789537|FG000|Overall Study|Lack of Efficacy|76|||
155096894|NCT00077974|559789537|FG000|Overall Study|Decision of Sponsor|2|||
155096895|NCT01343888|559789538|FG000|Overall Study|Adverse Event|12|||
155096896|NCT01343888|559789539|FG001|Overall Study|Adverse Event|22|||
155096897|NCT01343888|559789540|FG002|Overall Study|Adverse Event|5|||
155096898|NCT01343888|559789538|FG000|Overall Study|Lack of Efficacy|9|||
155096899|NCT01343888|559789539|FG001|Overall Study|Lack of Efficacy|9|||
155096900|NCT01343888|559789540|FG002|Overall Study|Lack of Efficacy|13|||
155096901|NCT01343888|559789538|FG000|Overall Study|Lost to Follow-up|0|||
155096902|NCT01343888|559789539|FG001|Overall Study|Lost to Follow-up|2|||
155096903|NCT01343888|559789540|FG002|Overall Study|Lost to Follow-up|1|||
155096904|NCT01343888|559789538|FG000|Overall Study|Protocol Violation|0|||
155096905|NCT01343888|559789539|FG001|Overall Study|Protocol Violation|2|||
155096906|NCT01343888|559789540|FG002|Overall Study|Protocol Violation|0|||
155096907|NCT01343888|559789538|FG000|Overall Study|Withdrawal by Subject|4|||
155096908|NCT01343888|559789539|FG001|Overall Study|Withdrawal by Subject|4|||
155096909|NCT01343888|559789540|FG002|Overall Study|Withdrawal by Subject|2|||
155096910|NCT01343888|559789538|FG000|Overall Study|other than stated above|0|||
155096911|NCT01343888|559789539|FG001|Overall Study|other than stated above|0|||
155096912|NCT01343888|559789540|FG002|Overall Study|other than stated above|1|||
155096913|NCT00387088|559789541|FG000|Overall Study|Adverse Event|143|||
155096914|NCT00387088|559789542|FG001|Overall Study|Adverse Event|156|||
155096915|NCT00387088|559789541|FG000|Overall Study|Protocol Violation|47|||
155096916|NCT00387088|559789542|FG001|Overall Study|Protocol Violation|35|||
155096917|NCT00387088|559789541|FG000|Overall Study|Withdrawal by Subject|20|||
155096918|NCT00387088|559789542|FG001|Overall Study|Withdrawal by Subject|35|||
155096919|NCT00387088|559789541|FG000|Overall Study|Lack of Efficacy|28|||
155096920|NCT00387088|559789542|FG001|Overall Study|Lack of Efficacy|67|||
155096921|NCT00387088|559789541|FG000|Overall Study|Lost to Follow-up|22|||
155096922|NCT00387088|559789542|FG001|Overall Study|Lost to Follow-up|28|||
155096923|NCT00387088|559789541|FG000|Overall Study|Other|58|||
155096924|NCT00387088|559789542|FG001|Overall Study|Other|52|||
155096925|NCT01990742|559789543|FG000|Overall Study|Withdrawal by facility|407|||
155096926|NCT01990742|559789544|FG001|Overall Study|Withdrawal by facility|1083|||
155096927|NCT01990742|559789543|FG000|Overall Study|Facility closed|0|||
155096928|NCT01990742|559789544|FG001|Overall Study|Facility closed|270|||
155096929|NCT00800735|559789547|FG000|Overall Study|Administrative/Other|2|||
155096930|NCT00800735|559789547|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155096931|NCT00800735|559789547|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
155096932|NCT00800735|559789547|FG000|Overall Study|Withdrew Consent|3|||
155096933|NCT02805790|559789548|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
155096934|NCT02805790|559789549|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
155096935|NCT02897115|559789556|FG000|Overall Study|Early termination of study by sponsor|11|||
155096936|NCT02897115|559789557|FG001|Overall Study|Early termination of study by sponsor|8|||
155096937|NCT02071771|559789558|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
155096938|NCT02071771|559789559|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
155096939|NCT02071771|559789558|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
155096940|NCT02071771|559789559|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
155096941|NCT02078752|559789560|FG000|Overall Study|Death|0|||
155096942|NCT02078752|559789561|FG001|Overall Study|Death|3|||
155096943|NCT02078752|559789562|FG002|Overall Study|Death|0|||
155096944|NCT02078752|559789563|FG003|Overall Study|Death|0|||
155096945|NCT02078752|559789564|FG004|Overall Study|Death|0|||
155096946|NCT02078752|559789565|FG005|Overall Study|Death|1|||
155096947|NCT02078752|559789566|FG006|Overall Study|Death|0|||
155096948|NCT02078752|559789567|FG007|Overall Study|Death|1|||
155096949|NCT02078752|559789568|FG008|Overall Study|Death|0|||
155096950|NCT02078752|559789569|FG009|Overall Study|Death|4|||
155096951|NCT02078752|559789560|FG000|Overall Study|Lost to Follow-up|1|||
155171819|NCT00388583|560069514|FG000|Overall Study|Did not receive vaccine|0|||
155171820|NCT00388583|560069515|FG001|Overall Study|Did not receive vaccine|1|||
155171821|NCT05194579|560069516|FG000|Overall Study|Lost to Follow-up|2|||
155171822|NCT05194579|560069517|FG001|Overall Study|Lost to Follow-up|3|||
155171823|NCT05194579|560069516|FG000|Overall Study|Withdrawal by Subject|3|||
155171824|NCT05194579|560069517|FG001|Overall Study|Withdrawal by Subject|4|||
155171825|NCT05194579|560069516|FG000|Overall Study|Refused further study procedures|0|||
155171826|NCT05194579|560069517|FG001|Overall Study|Refused further study procedures|1|||
155171827|NCT05194579|560069516|FG000|Overall Study|Protocol deviation|1|||
155171828|NCT05194579|560069517|FG001|Overall Study|Protocol deviation|0|||
155171829|NCT03595228|560069522|FG000|Overall Study|Death|2|||
155096952|NCT02078752|559789561|FG001|Overall Study|Lost to Follow-up|0|||
155096953|NCT02078752|559789562|FG002|Overall Study|Lost to Follow-up|0|||
155096954|NCT02078752|559789563|FG003|Overall Study|Lost to Follow-up|1|||
155096955|NCT02078752|559789564|FG004|Overall Study|Lost to Follow-up|0|||
155096956|NCT02078752|559789565|FG005|Overall Study|Lost to Follow-up|0|||
155096957|NCT02078752|559789566|FG006|Overall Study|Lost to Follow-up|0|||
155096958|NCT02078752|559789567|FG007|Overall Study|Lost to Follow-up|0|||
155096959|NCT02078752|559789568|FG008|Overall Study|Lost to Follow-up|0|||
155096960|NCT02078752|559789569|FG009|Overall Study|Lost to Follow-up|0|||
155096961|NCT02078752|559789560|FG000|Overall Study|Withdrawal by Subject|1|||
155096962|NCT02078752|559789561|FG001|Overall Study|Withdrawal by Subject|1|||
155096963|NCT02078752|559789562|FG002|Overall Study|Withdrawal by Subject|1|||
155096964|NCT02078752|559789563|FG003|Overall Study|Withdrawal by Subject|1|||
155096965|NCT02078752|559789564|FG004|Overall Study|Withdrawal by Subject|0|||
155096966|NCT02078752|559789565|FG005|Overall Study|Withdrawal by Subject|3|||
155096967|NCT02078752|559789566|FG006|Overall Study|Withdrawal by Subject|2|||
155096968|NCT02078752|559789567|FG007|Overall Study|Withdrawal by Subject|1|||
155096969|NCT02078752|559789568|FG008|Overall Study|Withdrawal by Subject|0|||
155096970|NCT02078752|559789569|FG009|Overall Study|Withdrawal by Subject|1|||
155096971|NCT02078752|559789560|FG000|Overall Study|Other|0|||
155096972|NCT02078752|559789561|FG001|Overall Study|Other|3|||
155096973|NCT02078752|559789562|FG002|Overall Study|Other|0|||
155171830|NCT03595228|560069522|FG000|Overall Study|Lack of Efficacy|13|||
155171831|NCT03595228|560069522|FG000|Overall Study|Withdrawal by Subject|3|||
155096974|NCT02078752|559789563|FG003|Overall Study|Other|0|||
155171832|NCT03595228|560069522|FG000|Overall Study|Withdrawal by Sponsor|1|||
155096975|NCT02078752|559789564|FG004|Overall Study|Other|1|||
155096976|NCT02078752|559789565|FG005|Overall Study|Other|0|||
155171833|NCT01639729|560069523|FG000|Overall Study|Withdrawal by Subject|1|||
155171834|NCT01639729|560069524|FG001|Overall Study|Withdrawal by Subject|0|||
155171835|NCT01639729|560069525|FG002|Overall Study|Withdrawal by Subject|1|||
155171836|NCT01639729|560069526|FG003|Overall Study|Withdrawal by Subject|1|||
155171837|NCT01639729|560069527|FG004|Overall Study|Withdrawal by Subject|0|||
155171838|NCT01639729|560069528|FG005|Overall Study|Withdrawal by Subject|0|||
155171839|NCT03232333|560069529|FG000|Overall Study|Infection or Osteomyelitis|9|||
155171840|NCT03232333|560069529|FG000|Overall Study|Lost to Follow-up|4|||
155171841|NCT03232333|560069529|FG000|Overall Study|Withdrawal by Subject|2|||
155171842|NCT01253811|560069530|FG000|Overall Study|Withdrawal criteria|1|||
155171843|NCT00759564|560069531|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
155171844|NCT00759564|560069532|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
155171845|NCT00759564|560069533|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
155171846|NCT00759564|560069534|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
155171847|NCT00759564|560069535|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
155171848|NCT04975438|560069540|FG000|Overall Study|Lost to Follow-up|1|||
155171849|NCT04975438|560069541|FG001|Overall Study|Lost to Follow-up|0|||
155171850|NCT04975438|560069542|FG002|Overall Study|Lost to Follow-up|1|||
155171851|NCT04975438|560069543|FG003|Overall Study|Lost to Follow-up|0|||
155171852|NCT04975438|560069540|FG000|Overall Study|Withdrawal by Subject|1|||
155171853|NCT04975438|560069541|FG001|Overall Study|Withdrawal by Subject|0|||
155171854|NCT04975438|560069542|FG002|Overall Study|Withdrawal by Subject|0|||
155171855|NCT04975438|560069543|FG003|Overall Study|Withdrawal by Subject|0|||
155171856|NCT04973436|560069544|FG000|Overall Study|Lost to Follow-up|3|||
155171857|NCT04973436|560069544|FG000|Overall Study|Withdrawal by Subject|1|||
155171858|NCT04973436|560069544|FG000|Overall Study|Death|2|||
155171859|NCT01276054|560069545|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
155171860|NCT01276054|560069546|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
155171861|NCT01419197|560069550|FG000|Overall Study|Death|247|||
155171862|NCT01419197|560069551|FG001|Overall Study|Death|122|||
155171863|NCT01419197|560069550|FG000|Overall Study|Physician Decision|4|||
155171864|NCT01419197|560069551|FG001|Overall Study|Physician Decision|4|||
155171865|NCT01419197|560069550|FG000|Overall Study|Non-compliance|3|||
155171866|NCT01419197|560069551|FG001|Overall Study|Non-compliance|1|||
155171867|NCT01419197|560069550|FG000|Overall Study|Withdrawal by Subject|33|||
155171868|NCT01419197|560069551|FG001|Overall Study|Withdrawal by Subject|32|||
155171869|NCT01419197|560069550|FG000|Overall Study|Study Completed by Sponsor|103|||
155171870|NCT01419197|560069551|FG001|Overall Study|Study Completed by Sponsor|34|||
155171871|NCT01419197|560069550|FG000|Overall Study|Reason Not Specified|0|||
155171872|NCT01419197|560069551|FG001|Overall Study|Reason Not Specified|1|||
155171873|NCT01419197|560069550|FG000|Overall Study|Lost to Follow-up|14|||
155171874|NCT01419197|560069551|FG001|Overall Study|Lost to Follow-up|4|||
155171875|NCT00146848|560069552|FG000|Pre-randomization|Death|19|||
155171876|NCT00146848|560069553|FG001|Pre-randomization|Death|0|||
155171877|NCT00146848|560069554|FG002|Pre-randomization|Death|0|||
155171878|NCT00146848|560069552|FG000|Pre-randomization|Lost to Follow-up|70|||
155171879|NCT00146848|560069553|FG001|Pre-randomization|Lost to Follow-up|0|||
155171880|NCT00146848|560069554|FG002|Pre-randomization|Lost to Follow-up|0|||
155171881|NCT00146848|560069552|FG000|Pre-randomization|Physician Decision|8|||
155171882|NCT00146848|560069553|FG001|Pre-randomization|Physician Decision|0|||
155171883|NCT00146848|560069554|FG002|Pre-randomization|Physician Decision|0|||
155171884|NCT00146848|560069552|FG000|Pre-randomization|Protocol Violation|172|||
155171885|NCT00146848|560069553|FG001|Pre-randomization|Protocol Violation|0|||
155171886|NCT00146848|560069554|FG002|Pre-randomization|Protocol Violation|0|||
155171887|NCT00146848|560069552|FG000|Pre-randomization|Withdrawal by Subject|40|||
155171888|NCT00146848|560069553|FG001|Pre-randomization|Withdrawal by Subject|0|||
155171889|NCT00146848|560069554|FG002|Pre-randomization|Withdrawal by Subject|0|||
155171890|NCT00146848|560069552|FG000|Post-randomization|Lost to Follow-up|12|||
155171891|NCT00146848|560069553|FG001|Post-randomization|Lost to Follow-up|15|||
155171892|NCT00146848|560069554|FG002|Post-randomization|Lost to Follow-up|12|||
155171893|NCT00146848|560069552|FG000|Post-randomization|Withdrawn|26|||
155171894|NCT00146848|560069553|FG001|Post-randomization|Withdrawn|32|||
155171895|NCT00146848|560069554|FG002|Post-randomization|Withdrawn|27|||
155171896|NCT01798849|560069555|FG000|Overall Study|Physician Decision|0|||
155171897|NCT01798849|560069556|FG001|Overall Study|Physician Decision|0|||
155171898|NCT01798849|560069557|FG002|Overall Study|Physician Decision|1|||
155171899|NCT00717236|560069558|FG000|Double-Blind Period|Adverse Event|33|||
155171900|NCT00717236|560069559|FG001|Double-Blind Period|Adverse Event|6|||
155171901|NCT00717236|560069558|FG000|Double-Blind Period|Lack of Efficacy|6|||
155171902|NCT00717236|560069559|FG001|Double-Blind Period|Lack of Efficacy|6|||
155171903|NCT00717236|560069558|FG000|Double-Blind Period|Lost to Follow-up|3|||
155171904|NCT00717236|560069559|FG001|Double-Blind Period|Lost to Follow-up|5|||
155171905|NCT00717236|560069558|FG000|Double-Blind Period|Withdrawal by Subject|10|||
155096977|NCT02078752|559789566|FG006|Overall Study|Other|0|||
155096978|NCT02078752|559789567|FG007|Overall Study|Other|1|||
155096979|NCT02078752|559789568|FG008|Overall Study|Other|0|||
155096980|NCT02078752|559789569|FG009|Overall Study|Other|0|||
155096981|NCT02078752|559789560|FG000|Overall Study|Study terminated by sponsor|0|||
155096982|NCT02078752|559789561|FG001|Overall Study|Study terminated by sponsor|0|||
155096983|NCT02078752|559789562|FG002|Overall Study|Study terminated by sponsor|0|||
155096984|NCT02078752|559789563|FG003|Overall Study|Study terminated by sponsor|0|||
155096985|NCT02078752|559789564|FG004|Overall Study|Study terminated by sponsor|0|||
155096986|NCT02078752|559789565|FG005|Overall Study|Study terminated by sponsor|0|||
155096987|NCT02078752|559789566|FG006|Overall Study|Study terminated by sponsor|0|||
155096988|NCT02078752|559789567|FG007|Overall Study|Study terminated by sponsor|0|||
155096989|NCT02078752|559789568|FG008|Overall Study|Study terminated by sponsor|0|||
155096990|NCT02078752|559789569|FG009|Overall Study|Study terminated by sponsor|5|||
155096991|NCT02776683|559789577|FG000|Pre-switch Period|Protocol Violation|1|||
155096992|NCT02776683|559789578|FG001|Pre-switch Period|Protocol Violation|0|||
155096993|NCT02776683|559789577|FG000|Pre-switch Period|Adverse Event|21|||
155096994|NCT02776683|559789578|FG001|Pre-switch Period|Adverse Event|0|||
155096995|NCT02776683|559789577|FG000|Pre-switch Period|Withdrawal by Subject|9|||
155096996|NCT02776683|559789578|FG001|Pre-switch Period|Withdrawal by Subject|0|||
155171906|NCT00717236|560069559|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155171907|NCT00717236|560069558|FG000|Double-Blind Period|Loss of efficacy|3|||
155171908|NCT00717236|560069559|FG001|Double-Blind Period|Loss of efficacy|0|||
155096997|NCT02776683|559789577|FG000|Pre-switch Period|Physician Decision|7|||
155096998|NCT02776683|559789578|FG001|Pre-switch Period|Physician Decision|0|||
155096999|NCT02776683|559789577|FG000|Pre-switch Period|Progressive disease|39|||
155097000|NCT02776683|559789578|FG001|Pre-switch Period|Progressive disease|0|||
155171909|NCT00717236|560069558|FG000|Double-Blind Period|Other: Death|1|||
155097001|NCT02776683|559789577|FG000|Pre-switch Period|Other than listed|3|||
155097002|NCT02776683|559789578|FG001|Pre-switch Period|Other than listed|0|||
155097003|NCT02776683|559789577|FG000|Post-switch Period|Adverse Event|0|||
155097004|NCT02776683|559789578|FG001|Post-switch Period|Adverse Event|3|||
155097005|NCT02776683|559789577|FG000|Post-switch Period|Withdrawal by Subject|0|||
155097006|NCT02776683|559789578|FG001|Post-switch Period|Withdrawal by Subject|2|||
155097007|NCT02776683|559789577|FG000|Post-switch Period|Physician Decision|0|||
155097008|NCT02776683|559789578|FG001|Post-switch Period|Physician Decision|3|||
155097009|NCT02776683|559789577|FG000|Post-switch Period|Progressive disease|0|||
155097010|NCT02776683|559789578|FG001|Post-switch Period|Progressive disease|20|||
155097011|NCT02776683|559789577|FG000|Post-switch Period|Other than listed|0|||
155097012|NCT02776683|559789578|FG001|Post-switch Period|Other than listed|15|||
155097013|NCT00616642|559789579|FG000|Overall Study|Withdrawal by Subject|0|||
155097014|NCT00616642|559789580|FG001|Overall Study|Withdrawal by Subject|1|||
155097015|NCT01023217|559789582|FG000|Overall Study|Withdrawal by Subject|1|||
155097016|NCT01023217|559789583|FG001|Overall Study|Withdrawal by Subject|0|||
155097017|NCT01673646|559789584|FG000|Overall Study|Adverse Event|2|||
155097018|NCT01673646|559789585|FG001|Overall Study|Adverse Event|1|||
155097019|NCT01673646|559789586|FG002|Overall Study|Adverse Event|1|||
155097020|NCT01673646|559789584|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155097021|NCT01673646|559789585|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155097022|NCT01673646|559789586|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155097023|NCT01673646|559789584|FG000|Overall Study|Condition no longer requires study drug|0|||
155097024|NCT01673646|559789585|FG001|Overall Study|Condition no longer requires study drug|1|||
155097025|NCT01673646|559789586|FG002|Overall Study|Condition no longer requires study drug|0|||
155097026|NCT01673646|559789584|FG000|Overall Study|Withdrawal by Subject|0|||
155097027|NCT01673646|559789585|FG001|Overall Study|Withdrawal by Subject|2|||
155097028|NCT01673646|559789586|FG002|Overall Study|Withdrawal by Subject|2|||
155097029|NCT01673646|559789584|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
155097030|NCT01673646|559789585|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
155097031|NCT01673646|559789586|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
155097032|NCT01000506|559789587|FG000|Overall Study|Adverse Event|6|||
155097033|NCT01000506|559789588|FG001|Overall Study|Adverse Event|5|||
155097034|NCT01000506|559789589|FG002|Overall Study|Adverse Event|8|||
155097035|NCT01000506|559789590|FG003|Overall Study|Adverse Event|9|||
155097036|NCT01000506|559789587|FG000|Overall Study|Lack of Efficacy|8|||
155097037|NCT01000506|559789588|FG001|Overall Study|Lack of Efficacy|6|||
155097038|NCT01000506|559789589|FG002|Overall Study|Lack of Efficacy|4|||
155097039|NCT01000506|559789590|FG003|Overall Study|Lack of Efficacy|4|||
155097040|NCT01000506|559789587|FG000|Overall Study|Protocol Violation|1|||
155097041|NCT01000506|559789588|FG001|Overall Study|Protocol Violation|1|||
155097042|NCT01000506|559789589|FG002|Overall Study|Protocol Violation|0|||
155097043|NCT01000506|559789590|FG003|Overall Study|Protocol Violation|0|||
155097044|NCT01000506|559789587|FG000|Overall Study|Lost to Follow-up|1|||
155097045|NCT01000506|559789588|FG001|Overall Study|Lost to Follow-up|1|||
155097046|NCT01000506|559789589|FG002|Overall Study|Lost to Follow-up|4|||
155097047|NCT01000506|559789590|FG003|Overall Study|Lost to Follow-up|0|||
155097048|NCT01000506|559789587|FG000|Overall Study|Physician Decision|1|||
155097049|NCT01000506|559789588|FG001|Overall Study|Physician Decision|3|||
155097050|NCT01000506|559789589|FG002|Overall Study|Physician Decision|3|||
155097051|NCT01000506|559789590|FG003|Overall Study|Physician Decision|3|||
155097052|NCT01000506|559789587|FG000|Overall Study|Withdrawal by Subject|11|||
155097053|NCT01000506|559789588|FG001|Overall Study|Withdrawal by Subject|8|||
155097054|NCT01000506|559789589|FG002|Overall Study|Withdrawal by Subject|2|||
155097055|NCT01000506|559789590|FG003|Overall Study|Withdrawal by Subject|7|||
155097056|NCT03064074|559789591|FG000|Overall Study|Physician Decision|0|||
155097057|NCT03064074|559789592|FG001|Overall Study|Physician Decision|0|||
155097058|NCT03064074|559789593|FG002|Overall Study|Physician Decision|0|||
155097059|NCT03064074|559789594|FG003|Overall Study|Physician Decision|1|||
155097060|NCT05518461|559789596|FG000|Overall Study|Lost to Follow-up|25|||
155097061|NCT00269087|559789597|FG000|Overall Study|Adverse Event|20|||
155097062|NCT00269087|559789597|FG000|Overall Study|Withdrawal by Subject|1|||
155097063|NCT00269087|559789597|FG000|Overall Study|Exacerbation of COPD|13|||
155097064|NCT00332696|559789600|FG000|Overall Study|Death|24|||
155097065|NCT00332696|559789601|FG001|Overall Study|Death|14|||
155097066|NCT00332696|559789600|FG000|Overall Study|Insufficient therapeutic effect|4|||
155097067|NCT00332696|559789601|FG001|Overall Study|Insufficient therapeutic effect|11|||
155097068|NCT00332696|559789600|FG000|Overall Study|Adverse Event|1|||
155097069|NCT00332696|559789601|FG001|Overall Study|Adverse Event|2|||
155097070|NCT00332696|559789600|FG000|Overall Study|Condition does not justify treatment|0|||
155097071|NCT00332696|559789601|FG001|Overall Study|Condition does not justify treatment|2|||
155097072|NCT00332696|559789600|FG000|Overall Study|Lost to Follow-up|0|||
155097073|NCT00332696|559789601|FG001|Overall Study|Lost to Follow-up|1|||
155097074|NCT00332696|559789600|FG000|Overall Study|Withdrawal by Subject|1|||
155097075|NCT00332696|559789601|FG001|Overall Study|Withdrawal by Subject|0|||
155097076|NCT02230189|559789604|FG000|Overall Study|Withdrawal by Subject|3|||
155097077|NCT02230189|559789605|FG001|Overall Study|Withdrawal by Subject|0|||
155097078|NCT02230189|559789606|FG002|Overall Study|Withdrawal by Subject|1|||
155097079|NCT02230189|559789604|FG000|Overall Study|Lost to Follow-up|1|||
155097080|NCT02230189|559789605|FG001|Overall Study|Lost to Follow-up|0|||
155097081|NCT02230189|559789606|FG002|Overall Study|Lost to Follow-up|0|||
155097082|NCT02230189|559789604|FG000|Overall Study|Physician Decision|1|||
155097083|NCT02230189|559789605|FG001|Overall Study|Physician Decision|0|||
155097084|NCT02230189|559789606|FG002|Overall Study|Physician Decision|0|||
155097085|NCT03824392|559789607|FG000|Overall Study|Adverse Event|1|||
155097086|NCT03824392|559789608|FG001|Overall Study|Adverse Event|0|||
155097087|NCT03824392|559789609|FG002|Overall Study|Adverse Event|0|||
155097088|NCT03824392|559789610|FG003|Overall Study|Adverse Event|0|||
155097089|NCT03824392|559789607|FG000|Overall Study|Investigator Decision|0|||
155097090|NCT03824392|559789608|FG001|Overall Study|Investigator Decision|1|||
155097091|NCT03824392|559789609|FG002|Overall Study|Investigator Decision|0|||
155097092|NCT03824392|559789610|FG003|Overall Study|Investigator Decision|0|||
155097093|NCT03824392|559789607|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
155097094|NCT03824392|559789608|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
155097095|NCT03824392|559789609|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
155097096|NCT03824392|559789610|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
155097097|NCT01847755|559789611|FG000|Overall Study|Adverse Event|2|||
155097098|NCT01847755|559789611|FG000|Overall Study|Withdrawal by Subject|2|||
155097099|NCT01847755|559789611|FG000|Overall Study|Physician Decision|1|||
155097100|NCT01904721|559789614|FG000|Overall Study|Other Reasons|0|||
155097101|NCT01904721|559789615|FG001|Overall Study|Other Reasons|0|||
155097102|NCT01904721|559789616|FG002|Overall Study|Other Reasons|1|||
155097103|NCT01904721|559789617|FG003|Overall Study|Other Reasons|1|||
155097104|NCT01904721|559789618|FG004|Overall Study|Other Reasons|2|||
155097105|NCT01904721|559789619|FG005|Overall Study|Other Reasons|2|||
155097106|NCT01904721|559789620|FG006|Overall Study|Other Reasons|2|||
155097107|NCT01904721|559789614|FG000|Overall Study|Personal Reasons|0|||
155097108|NCT01904721|559789615|FG001|Overall Study|Personal Reasons|0|||
155097109|NCT01904721|559789616|FG002|Overall Study|Personal Reasons|0|||
155097110|NCT01904721|559789617|FG003|Overall Study|Personal Reasons|0|||
155097111|NCT01904721|559789618|FG004|Overall Study|Personal Reasons|2|||
155097112|NCT01904721|559789619|FG005|Overall Study|Personal Reasons|3|||
155097113|NCT01904721|559789620|FG006|Overall Study|Personal Reasons|3|||
155097114|NCT01904721|559789614|FG000|Overall Study|Lost to Follow-up|0|||
155097115|NCT01904721|559789615|FG001|Overall Study|Lost to Follow-up|0|||
155097116|NCT01904721|559789616|FG002|Overall Study|Lost to Follow-up|0|||
155097117|NCT01904721|559789617|FG003|Overall Study|Lost to Follow-up|0|||
155097118|NCT01904721|559789618|FG004|Overall Study|Lost to Follow-up|1|||
155097119|NCT01904721|559789619|FG005|Overall Study|Lost to Follow-up|3|||
155097120|NCT01904721|559789620|FG006|Overall Study|Lost to Follow-up|1|||
155097121|NCT01904721|559789614|FG000|Overall Study|Lack of Efficacy|0|||
155097122|NCT01904721|559789615|FG001|Overall Study|Lack of Efficacy|0|||
155097123|NCT01904721|559789616|FG002|Overall Study|Lack of Efficacy|0|||
155097124|NCT01904721|559789617|FG003|Overall Study|Lack of Efficacy|0|||
155097125|NCT01904721|559789618|FG004|Overall Study|Lack of Efficacy|0|||
155097126|NCT01904721|559789619|FG005|Overall Study|Lack of Efficacy|0|||
155097127|NCT01904721|559789620|FG006|Overall Study|Lack of Efficacy|1|||
155097128|NCT01904721|559789614|FG000|Overall Study|Adverse Event|0|||
155097129|NCT01904721|559789615|FG001|Overall Study|Adverse Event|0|||
155097130|NCT01904721|559789616|FG002|Overall Study|Adverse Event|0|||
155097131|NCT01904721|559789617|FG003|Overall Study|Adverse Event|0|||
155097132|NCT01904721|559789618|FG004|Overall Study|Adverse Event|3|||
155097133|NCT01904721|559789619|FG005|Overall Study|Adverse Event|1|||
155097134|NCT01904721|559789620|FG006|Overall Study|Adverse Event|0|||
155097135|NCT01077063|559789622|FG000|Overall Study|Adverse Event|3|||
155097136|NCT01077063|559789623|FG001|Overall Study|Adverse Event|0|||
155097137|NCT01077063|559789622|FG000|Overall Study|Death|1|||
155097138|NCT01077063|559789623|FG001|Overall Study|Death|1|||
155097139|NCT01077063|559789622|FG000|Overall Study|Withdrawal by Subject|0|||
155097140|NCT01077063|559789623|FG001|Overall Study|Withdrawal by Subject|2|||
155097141|NCT02967679|559789624|FG000|Overall Study|Adverse Event|1|||
155097142|NCT03188263|559789625|FG000|Overall Study|Withdrawal by Subject|3|||
155097143|NCT03188263|559789626|FG001|Overall Study|Withdrawal by Subject|0|||
155097144|NCT03188263|559789625|FG000|Overall Study|Physician Decision|1|||
155097145|NCT03188263|559789626|FG001|Overall Study|Physician Decision|0|||
155097146|NCT00699413|559789627|FG000|Overall Study|Withdrawal by Subject|0|||
155097147|NCT00699413|559789628|FG001|Overall Study|Withdrawal by Subject|2|||
155097148|NCT00699413|559789627|FG000|Overall Study|Study terminated by sponsor|4|||
155097149|NCT00699413|559789628|FG001|Overall Study|Study terminated by sponsor|2|||
155097150|NCT02779777|559789629|FG000|Overall Study|Disease Progression|1|||
155097151|NCT02779777|559789630|FG001|Overall Study|Disease Progression|0|||
155097152|NCT02779777|559789631|FG002|Overall Study|Disease Progression|0|||
155097153|NCT02779777|559789629|FG000|Overall Study|Adverse Event|3|||
155097154|NCT02779777|559789630|FG001|Overall Study|Adverse Event|1|||
155097155|NCT02779777|559789631|FG002|Overall Study|Adverse Event|0|||
155097156|NCT02779777|559789629|FG000|Overall Study|Physician Decision|9|||
155097157|NCT02779777|559789630|FG001|Overall Study|Physician Decision|0|||
155097158|NCT02779777|559789631|FG002|Overall Study|Physician Decision|1|||
155097159|NCT02779777|559789629|FG000|Overall Study|Withdrawal by Subject|1|||
155097160|NCT02779777|559789630|FG001|Overall Study|Withdrawal by Subject|0|||
155171910|NCT00717236|560069559|FG001|Double-Blind Period|Other: Death|0|||
155097161|NCT02779777|559789631|FG002|Overall Study|Withdrawal by Subject|0|||
155097162|NCT00251693|559789632|FG000|Overall Study|Adverse Event|17|||
155097163|NCT00251693|559789633|FG001|Overall Study|Adverse Event|9|||
155097164|NCT00251693|559789634|FG002|Overall Study|Adverse Event|9|||
155097165|NCT00251693|559789632|FG000|Overall Study|Protocol Violation|2|||
155097166|NCT00251693|559789633|FG001|Overall Study|Protocol Violation|0|||
155097167|NCT00251693|559789634|FG002|Overall Study|Protocol Violation|2|||
155097168|NCT00251693|559789632|FG000|Overall Study|Lost to Follow-up|12|||
155097169|NCT00251693|559789633|FG001|Overall Study|Lost to Follow-up|7|||
155097170|NCT00251693|559789634|FG002|Overall Study|Lost to Follow-up|8|||
155097171|NCT00251693|559789632|FG000|Overall Study|Withdrawal by Subject|11|||
155097172|NCT00251693|559789633|FG001|Overall Study|Withdrawal by Subject|17|||
155097173|NCT00251693|559789634|FG002|Overall Study|Withdrawal by Subject|14|||
155097174|NCT00251693|559789632|FG000|Overall Study|Lack of Efficacy|0|||
155097175|NCT00251693|559789633|FG001|Overall Study|Lack of Efficacy|1|||
155097176|NCT00251693|559789634|FG002|Overall Study|Lack of Efficacy|0|||
155097177|NCT00251693|559789632|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
155097178|NCT00251693|559789633|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
155097179|NCT00251693|559789634|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
155097180|NCT00251693|559789632|FG000|Overall Study|Noncompliant|0|||
155097181|NCT00251693|559789633|FG001|Overall Study|Noncompliant|0|||
155097182|NCT00251693|559789634|FG002|Overall Study|Noncompliant|2|||
155097183|NCT00251693|559789632|FG000|Overall Study|Possible Barrett's esophagus|3|||
155097184|NCT00251693|559789633|FG001|Overall Study|Possible Barrett's esophagus|5|||
155097185|NCT00251693|559789634|FG002|Overall Study|Possible Barrett's esophagus|2|||
155097186|NCT00251693|559789632|FG000|Overall Study|Subject request/subject unavailable|1|||
155097187|NCT00251693|559789633|FG001|Overall Study|Subject request/subject unavailable|2|||
155097188|NCT00251693|559789634|FG002|Overall Study|Subject request/subject unavailable|0|||
155097189|NCT00251693|559789632|FG000|Overall Study|Abnormal laboratory findings|0|||
155097190|NCT00251693|559789633|FG001|Overall Study|Abnormal laboratory findings|0|||
155097191|NCT00251693|559789634|FG002|Overall Study|Abnormal laboratory findings|1|||
155097192|NCT01030822|559789636|FG000|Overall Study|Moved/migrated from study area|6|||
155097193|NCT01030822|559789637|FG001|Overall Study|Moved/migrated from study area|7|||
155097194|NCT01030822|559789638|FG002|Overall Study|Moved/migrated from study area|3|||
155171911|NCT00717236|560069558|FG000|Double-Blind Period|Other: Pregnancy|1|||
155171912|NCT00717236|560069559|FG001|Double-Blind Period|Other: Pregnancy|0|||
155171913|NCT00717236|560069558|FG000|Double-Blind Period|Other: Protocol Violation|2|||
155171914|NCT00717236|560069559|FG001|Double-Blind Period|Other: Protocol Violation|0|||
155171915|NCT00717236|560069558|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
155171916|NCT00717236|560069559|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
155171917|NCT00717236|560069558|FG000|Double-Blind Period|Other: Site withdrew|2|||
155171918|NCT00717236|560069559|FG001|Double-Blind Period|Other: Site withdrew|0|||
155171919|NCT00717236|560069558|FG000|Double-Blind Period|Other: Screening failure|1|||
155171920|NCT00717236|560069559|FG001|Double-Blind Period|Other: Screening failure|0|||
155171921|NCT00717236|560069558|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
155171922|NCT00717236|560069559|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
155171923|NCT00717236|560069558|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
155171924|NCT00717236|560069559|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
155171925|NCT00717236|560069558|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
155171926|NCT00717236|560069559|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
155171927|NCT00717236|560069558|FG000|Double-Blind Period|Other: History of cancer|1|||
155171928|NCT00717236|560069559|FG001|Double-Blind Period|Other: History of cancer|0|||
155171929|NCT00717236|560069558|FG000|Double-Blind Period|Other: Sponsor request|1|||
155171930|NCT00717236|560069559|FG001|Double-Blind Period|Other: Sponsor request|0|||
155171931|NCT00717236|560069558|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
155171932|NCT00717236|560069559|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
155171933|NCT00717236|560069558|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
155171934|NCT00717236|560069559|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
155171935|NCT00717236|560069558|FG000|Double-Blind Period|Other: Subject moved|1|||
155171936|NCT00717236|560069559|FG001|Double-Blind Period|Other: Subject moved|1|||
155171937|NCT00717236|560069558|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
155171938|NCT00717236|560069559|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
155171939|NCT00717236|560069558|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
155171940|NCT00717236|560069559|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
155171941|NCT00717236|560069558|FG000|Double-Blind Period|Other: Transportation problems|0|||
155171942|NCT00717236|560069559|FG001|Double-Blind Period|Other: Transportation problems|1|||
155171943|NCT00717236|560069558|FG000|Double-Blind Period|Other: Investigator Decision|0|||
155171944|NCT00717236|560069559|FG001|Double-Blind Period|Other: Investigator Decision|1|||
155171945|NCT00717236|560069558|FG000|Open-Label Period|Adverse Event|29|||
155171946|NCT00717236|560069559|FG001|Open-Label Period|Adverse Event|4|||
155171947|NCT00717236|560069558|FG000|Open-Label Period|Lack of Efficacy|30|||
155171948|NCT00717236|560069559|FG001|Open-Label Period|Lack of Efficacy|8|||
155171949|NCT00717236|560069558|FG000|Open-Label Period|Lost to Follow-up|28|||
155171950|NCT00717236|560069559|FG001|Open-Label Period|Lost to Follow-up|4|||
155171951|NCT00717236|560069558|FG000|Open-Label Period|Withdrawal by Subject|20|||
155171952|NCT00717236|560069559|FG001|Open-Label Period|Withdrawal by Subject|2|||
155171953|NCT00717236|560069558|FG000|Open-Label Period|Loss of Efficacy|6|||
155171954|NCT00717236|560069559|FG001|Open-Label Period|Loss of Efficacy|1|||
155171955|NCT00717236|560069558|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
155171956|NCT00717236|560069559|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
155171957|NCT00717236|560069558|FG000|Open-Label Period|Other: Lack of Compliance|1|||
155171958|NCT00717236|560069559|FG001|Open-Label Period|Other: Lack of Compliance|1|||
155171959|NCT00717236|560069558|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
155171960|NCT00717236|560069559|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
155097195|NCT01030822|559789636|FG000|Overall Study|Withdrawal by Subject|16|||
155097196|NCT01030822|559789637|FG001|Overall Study|Withdrawal by Subject|13|||
155097197|NCT01030822|559789638|FG002|Overall Study|Withdrawal by Subject|16|||
155097198|NCT01030822|559789636|FG000|Overall Study|Lost to Follow-up|9|||
155097199|NCT01030822|559789637|FG001|Overall Study|Lost to Follow-up|4|||
155097200|NCT01030822|559789638|FG002|Overall Study|Lost to Follow-up|7|||
155097201|NCT01284959|559789640|FG000|Overall Study|Withdrawal by Subject|1|||
155097202|NCT01284959|559789641|FG001|Overall Study|Withdrawal by Subject|0|||
155097203|NCT01284959|559789642|FG002|Overall Study|Withdrawal by Subject|0|||
155097204|NCT01284959|559789640|FG000|Overall Study|Adverse Event|0|||
155097205|NCT01284959|559789641|FG001|Overall Study|Adverse Event|0|||
155097206|NCT01284959|559789642|FG002|Overall Study|Adverse Event|1|||
155171961|NCT00717236|560069558|FG000|Open-Label Period|Other: Moved|1|||
155171962|NCT00717236|560069559|FG001|Open-Label Period|Other: Moved|0|||
155171963|NCT00717236|560069558|FG000|Open-Label Period|Other: Investigator Decision|1|||
155171964|NCT00717236|560069559|FG001|Open-Label Period|Other: Investigator Decision|0|||
155171965|NCT00717236|560069558|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
155097207|NCT01055613|559789643|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
155097208|NCT01055613|559789644|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155097209|NCT01055613|559789643|FG000|Overall Study|Unacceptable lens fit|1|||
155171966|NCT00717236|560069559|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
155171967|NCT00717236|560069558|FG000|Open-Label Period|Other: Sponsor Request|3|||
155171968|NCT00717236|560069559|FG001|Open-Label Period|Other: Sponsor Request|0|||
155171969|NCT00717236|560069558|FG000|Open-Label Period|Other: Cataract Surgery|1|||
155171970|NCT00717236|560069559|FG001|Open-Label Period|Other: Cataract Surgery|0|||
155171971|NCT00717236|560069558|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
155171972|NCT00717236|560069559|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
155171973|NCT00717236|560069558|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
155171974|NCT00717236|560069559|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
155171975|NCT00717236|560069558|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
155171976|NCT00717236|560069559|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
155171977|NCT00743106|560069560|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
155171978|NCT00743106|560069561|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
155171979|NCT04556383|560069562|FG000|PCP|Lack of Efficacy|28|||
155171980|NCT04556383|560069563|FG001|PCP|Lack of Efficacy|23|||
155171981|NCT04556383|560069564|FG002|PCP|Lack of Efficacy|23|||
155171982|NCT04556383|560069565|FG003|PCP|Lack of Efficacy|0|||
155171983|NCT04556383|560069562|FG000|PCP|Study terminated by sponsor|15|||
155171984|NCT04556383|560069563|FG001|PCP|Study terminated by sponsor|13|||
155171985|NCT04556383|560069564|FG002|PCP|Study terminated by sponsor|16|||
155171986|NCT04556383|560069565|FG003|PCP|Study terminated by sponsor|0|||
155171987|NCT04556383|560069562|FG000|PCP|Withdrawal by Subject|8|||
155171988|NCT04556383|560069563|FG001|PCP|Withdrawal by Subject|6|||
155171989|NCT04556383|560069564|FG002|PCP|Withdrawal by Subject|6|||
155171990|NCT04556383|560069565|FG003|PCP|Withdrawal by Subject|0|||
155171991|NCT04556383|560069562|FG000|PCP|Adverse Event|1|||
155171992|NCT04556383|560069563|FG001|PCP|Adverse Event|7|||
155171993|NCT04556383|560069564|FG002|PCP|Adverse Event|7|||
155171994|NCT04556383|560069565|FG003|PCP|Adverse Event|0|||
155171995|NCT04556383|560069562|FG000|PCP|Other, Not Specified|1|||
155171996|NCT04556383|560069563|FG001|PCP|Other, Not Specified|2|||
155171997|NCT04556383|560069564|FG002|PCP|Other, Not Specified|1|||
155171998|NCT04556383|560069565|FG003|PCP|Other, Not Specified|0|||
155171999|NCT04556383|560069562|FG000|PCP|Protocol Violation|1|||
155172000|NCT04556383|560069563|FG001|PCP|Protocol Violation|0|||
155172001|NCT04556383|560069564|FG002|PCP|Protocol Violation|1|||
155172002|NCT04556383|560069565|FG003|PCP|Protocol Violation|0|||
155172003|NCT04556383|560069562|FG000|PCP|Lost to Follow-up|1|||
155172004|NCT04556383|560069563|FG001|PCP|Lost to Follow-up|0|||
155172005|NCT04556383|560069564|FG002|PCP|Lost to Follow-up|0|||
155172006|NCT04556383|560069565|FG003|PCP|Lost to Follow-up|0|||
155172007|NCT04556383|560069562|FG000|PCP|Physician Decision|0|||
155172008|NCT04556383|560069563|FG001|PCP|Physician Decision|1|||
155172009|NCT04556383|560069564|FG002|PCP|Physician Decision|0|||
155172010|NCT04556383|560069565|FG003|PCP|Physician Decision|0|||
155172011|NCT04556383|560069562|FG000|PCP|Site terminated by sponsor|0|||
155172012|NCT04556383|560069563|FG001|PCP|Site terminated by sponsor|1|||
155172013|NCT04556383|560069564|FG002|PCP|Site terminated by sponsor|0|||
155172014|NCT04556383|560069565|FG003|PCP|Site terminated by sponsor|0|||
155172015|NCT04556383|560069562|FG000|OLE|Study terminated by sponsor|0|||
155172016|NCT04556383|560069563|FG001|OLE|Study terminated by sponsor|0|||
155172017|NCT04556383|560069564|FG002|OLE|Study terminated by sponsor|0|||
155172018|NCT04556383|560069565|FG003|OLE|Study terminated by sponsor|68|||
155172019|NCT04556383|560069562|FG000|OLE|Withdrawal by Subject|0|||
155172020|NCT04556383|560069563|FG001|OLE|Withdrawal by Subject|0|||
155172021|NCT04556383|560069564|FG002|OLE|Withdrawal by Subject|0|||
155172022|NCT04556383|560069565|FG003|OLE|Withdrawal by Subject|10|||
155172023|NCT04556383|560069562|FG000|OLE|Lack of Efficacy|0|||
155172024|NCT04556383|560069563|FG001|OLE|Lack of Efficacy|0|||
155172025|NCT04556383|560069564|FG002|OLE|Lack of Efficacy|0|||
155172026|NCT04556383|560069565|FG003|OLE|Lack of Efficacy|7|||
155172027|NCT04556383|560069562|FG000|OLE|Adverse Event|0|||
155172028|NCT04556383|560069563|FG001|OLE|Adverse Event|0|||
155172029|NCT04556383|560069564|FG002|OLE|Adverse Event|0|||
155172030|NCT04556383|560069565|FG003|OLE|Adverse Event|2|||
155172031|NCT04556383|560069562|FG000|OLE|Other, Not Specified|0|||
155172032|NCT04556383|560069563|FG001|OLE|Other, Not Specified|0|||
155172033|NCT04556383|560069564|FG002|OLE|Other, Not Specified|0|||
155172034|NCT04556383|560069565|FG003|OLE|Other, Not Specified|2|||
155172035|NCT04556383|560069562|FG000|OLE|Death|0|||
155172036|NCT04556383|560069563|FG001|OLE|Death|0|||
155172037|NCT04556383|560069564|FG002|OLE|Death|0|||
155172038|NCT04556383|560069565|FG003|OLE|Death|1|||
155172039|NCT04556383|560069562|FG000|OLE|Lost to Follow-up|0|||
155172040|NCT04556383|560069563|FG001|OLE|Lost to Follow-up|0|||
155172041|NCT04556383|560069564|FG002|OLE|Lost to Follow-up|0|||
155172042|NCT04556383|560069565|FG003|OLE|Lost to Follow-up|1|||
155172043|NCT00884741|560069566|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
155172044|NCT00884741|560069567|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
155172045|NCT00884741|560069568|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
155172046|NCT00884741|560069569|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
155172047|NCT00884741|560069566|FG000|Step 1 Registration: Tissue Screening|Death|3|||
155172048|NCT00884741|560069567|FG001|Step 1 Registration: Tissue Screening|Death|0|||
155172049|NCT00884741|560069568|FG002|Step 1 Registration: Tissue Screening|Death|0|||
155097210|NCT01055613|559789644|FG001|Overall Study|Unacceptable lens fit|0|||
155097211|NCT01055613|559789643|FG000|Overall Study|Discomfort|2|||
155097212|NCT01055613|559789644|FG001|Overall Study|Discomfort|1|||
155097213|NCT01055613|559789643|FG000|Overall Study|Lost to Follow-up|1|||
155097214|NCT01055613|559789644|FG001|Overall Study|Lost to Follow-up|1|||
155097215|NCT01055613|559789643|FG000|Overall Study|Protocol Violation|1|||
155097216|NCT01055613|559789644|FG001|Overall Study|Protocol Violation|1|||
155097217|NCT01055613|559789643|FG000|Overall Study|Subject Disinterest|1|||
155097218|NCT01055613|559789644|FG001|Overall Study|Subject Disinterest|1|||
155097219|NCT02765399|559789645|FG000|Overall Study|Nausea|1|||
155097220|NCT02765399|559789646|FG001|Overall Study|Nausea|0|||
155097221|NCT00363311|559789651|FG000|Overall Study|Adverse Event|6|||
155097222|NCT00363311|559789652|FG001|Overall Study|Adverse Event|4|||
155097223|NCT00363311|559789651|FG000|Overall Study|Lost to Follow-up|3|||
155097224|NCT00363311|559789652|FG001|Overall Study|Lost to Follow-up|0|||
155097225|NCT00363311|559789651|FG000|Overall Study|Protocol Violation|1|||
155097226|NCT00363311|559789652|FG001|Overall Study|Protocol Violation|2|||
155097227|NCT00363311|559789651|FG000|Overall Study|Withdrawal by Subject|12|||
155097228|NCT00363311|559789652|FG001|Overall Study|Withdrawal by Subject|6|||
155097229|NCT00363311|559789651|FG000|Overall Study|Physician Decision|1|||
155097230|NCT00363311|559789652|FG001|Overall Study|Physician Decision|1|||
155097231|NCT00363311|559789651|FG000|Overall Study|Sponsor Terminated Study|2|||
155097232|NCT00363311|559789652|FG001|Overall Study|Sponsor Terminated Study|2|||
155097233|NCT00363311|559789651|FG000|Overall Study|Disease Progression|46|||
155097234|NCT00363311|559789652|FG001|Overall Study|Disease Progression|26|||
155097235|NCT00363311|559789651|FG000|Overall Study|Non-Compliance|1|||
155097236|NCT00363311|559789652|FG001|Overall Study|Non-Compliance|1|||
155097237|NCT00363311|559789651|FG000|Overall Study|Participant Refused Biopsy|1|||
155097238|NCT00363311|559789652|FG001|Overall Study|Participant Refused Biopsy|0|||
155097239|NCT00363311|559789651|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
155097240|NCT00363311|559789652|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
155097241|NCT00363311|559789651|FG000|Overall Study|Participant Opted for Treatment|1|||
155097242|NCT00363311|559789652|FG001|Overall Study|Participant Opted for Treatment|0|||
155097243|NCT00363311|559789651|FG000|Overall Study|Participant Moved to Another Country|1|||
155097244|NCT00363311|559789652|FG001|Overall Study|Participant Moved to Another Country|0|||
155097245|NCT00363311|559789651|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
155097246|NCT00363311|559789652|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
155097247|NCT00363311|559789651|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
155097248|NCT00363311|559789652|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
155097249|NCT00363311|559789651|FG000|Overall Study|Participant Moved to Louisiana|0|||
155097250|NCT00363311|559789652|FG001|Overall Study|Participant Moved to Louisiana|1|||
155097251|NCT00401843|559789653|FG000|Overall Study|Achieved Complete Response|1|||
155097252|NCT00401843|559789654|FG001|Overall Study|Achieved Complete Response|5|||
155097253|NCT00401843|559789655|FG002|Overall Study|Achieved Complete Response|11|||
155097254|NCT00401843|559789653|FG000|Overall Study|Adverse Event|7|||
155097255|NCT00401843|559789654|FG001|Overall Study|Adverse Event|26|||
155097256|NCT00401843|559789655|FG002|Overall Study|Adverse Event|27|||
155097257|NCT00401843|559789653|FG000|Overall Study|Death|0|||
155097258|NCT00401843|559789654|FG001|Overall Study|Death|8|||
155097259|NCT00401843|559789655|FG002|Overall Study|Death|10|||
155097260|NCT00401843|559789653|FG000|Overall Study|Disease progression|10|||
155097261|NCT00401843|559789654|FG001|Overall Study|Disease progression|60|||
155097262|NCT00401843|559789655|FG002|Overall Study|Disease progression|49|||
155097263|NCT00401843|559789653|FG000|Overall Study|End of Study|1|||
155097264|NCT00401843|559789654|FG001|Overall Study|End of Study|1|||
155097265|NCT00401843|559789655|FG002|Overall Study|End of Study|2|||
155097266|NCT00401843|559789653|FG000|Overall Study|Lost to Follow-up|0|||
155097267|NCT00401843|559789654|FG001|Overall Study|Lost to Follow-up|0|||
155097268|NCT00401843|559789655|FG002|Overall Study|Lost to Follow-up|2|||
155097269|NCT00401843|559789653|FG000|Overall Study|Other Unspecified|0|||
155097270|NCT00401843|559789654|FG001|Overall Study|Other Unspecified|3|||
155097271|NCT00401843|559789655|FG002|Overall Study|Other Unspecified|5|||
155097272|NCT00401843|559789653|FG000|Overall Study|Physician Decision|0|||
155097273|NCT00401843|559789654|FG001|Overall Study|Physician Decision|16|||
155097274|NCT00401843|559789655|FG002|Overall Study|Physician Decision|10|||
155097275|NCT00401843|559789653|FG000|Overall Study|Protocol Violation|0|||
155097276|NCT00401843|559789654|FG001|Overall Study|Protocol Violation|0|||
155172050|NCT00884741|560069569|FG003|Step 1 Registration: Tissue Screening|Death|0|||
155172051|NCT00884741|560069566|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
155172052|NCT00884741|560069567|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
155172053|NCT00884741|560069568|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
155172054|NCT00884741|560069569|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
155172055|NCT00884741|560069566|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
155172056|NCT00884741|560069567|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
155172057|NCT00884741|560069568|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
155172058|NCT00884741|560069569|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
155172059|NCT00884741|560069566|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
155172060|NCT00884741|560069567|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
155172061|NCT00884741|560069568|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
155172062|NCT00884741|560069569|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
155172063|NCT00884741|560069566|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
155172064|NCT00884741|560069567|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
155172065|NCT00884741|560069568|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
155172066|NCT00884741|560069569|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
155172067|NCT00884741|560069566|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
155172068|NCT00884741|560069567|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
155172069|NCT00884741|560069568|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
155172070|NCT00884741|560069569|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
155172071|NCT00884741|560069566|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
155172072|NCT00884741|560069567|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
155172073|NCT00884741|560069568|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
155172074|NCT00884741|560069569|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
155172075|NCT00884741|560069566|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
155172076|NCT00884741|560069567|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
155172077|NCT00884741|560069568|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
155172078|NCT00884741|560069569|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
155172079|NCT00884741|560069566|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
155172080|NCT00884741|560069567|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
155172081|NCT00884741|560069568|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
155172082|NCT00884741|560069569|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
155172083|NCT00884741|560069566|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
155172084|NCT00884741|560069567|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
155172085|NCT00884741|560069568|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
155172086|NCT00884741|560069569|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
155172087|NCT00884741|560069566|FG000|Randomization|Protocol Violation|0|||
155172088|NCT00884741|560069567|FG001|Randomization|Protocol Violation|0|||
155172089|NCT00884741|560069568|FG002|Randomization|Protocol Violation|8|||
155172090|NCT00884741|560069569|FG003|Randomization|Protocol Violation|8|||
155172091|NCT03753789|560069571|FG000|Overall Study|Withdrawal by Subject|2|||
155172092|NCT05477108|560069572|FG000|Overall Study|Participants randomized, not treated|1|||
155172093|NCT05477108|560069573|FG001|Overall Study|Participants randomized, not treated|1|||
155172094|NCT05477108|560069574|FG002|Overall Study|Participants randomized, not treated|1|||
155172095|NCT05477108|560069572|FG000|Overall Study|Physician Decision|0|||
155172096|NCT05477108|560069573|FG001|Overall Study|Physician Decision|0|||
155172097|NCT05477108|560069574|FG002|Overall Study|Physician Decision|1|||
155097277|NCT00401843|559789655|FG002|Overall Study|Protocol Violation|1|||
155097278|NCT00401843|559789653|FG000|Overall Study|Withdrawal by Subject|1|||
155172098|NCT05477108|560069572|FG000|Overall Study|withdrawn from study|0|||
155172099|NCT05477108|560069573|FG001|Overall Study|withdrawn from study|0|||
155097279|NCT00401843|559789654|FG001|Overall Study|Withdrawal by Subject|5|||
155097280|NCT00401843|559789655|FG002|Overall Study|Withdrawal by Subject|5|||
155097281|NCT00401843|559789653|FG000|Overall Study|Withdrawal of consent to study agent|1|||
155097282|NCT00401843|559789654|FG001|Overall Study|Withdrawal of consent to study agent|15|||
155172100|NCT05477108|560069574|FG002|Overall Study|withdrawn from study|1|||
155172101|NCT00334113|560069575|FG000|Overall Study|Lost to Follow-up|2|||
155172102|NCT00334113|560069576|FG001|Overall Study|Lost to Follow-up|2|||
155172103|NCT00334113|560069575|FG000|Overall Study|Withdrawal by Subject|0|||
155172104|NCT00334113|560069576|FG001|Overall Study|Withdrawal by Subject|1|||
155172105|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
155172106|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
155172107|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
155172108|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
155172109|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Other|2|||
155172110|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
155172111|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
155172112|NCT02509026|560069579|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
155172113|NCT02509026|560069579|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
155172114|NCT02509026|560069579|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
155172115|NCT02509026|560069579|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
155172116|NCT02509026|560069579|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
155172117|NCT02509026|560069579|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
155172118|NCT00243841|560069582|FG000|Overall Study|Physician Decision|0|||
155172119|NCT00243841|560069583|FG001|Overall Study|Physician Decision|0|||
155172120|NCT00243841|560069584|FG002|Overall Study|Physician Decision|1|||
155172121|NCT00243841|560069585|FG003|Overall Study|Physician Decision|0|||
155172122|NCT00243841|560069586|FG004|Overall Study|Physician Decision|0|||
155172123|NCT00243841|560069587|FG005|Overall Study|Physician Decision|2|||
155172124|NCT02537015|560069588|FG000|Overall Study|Adverse Event|3|||
155172125|NCT02537015|560069588|FG000|Overall Study|Withdrawal by Subject|2|||
155172126|NCT02537015|560069588|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155172127|NCT01808092|560069589|FG000|Overall Study|Death|39|||
155172128|NCT01808092|560069590|FG001|Overall Study|Death|29|||
155172129|NCT01808092|560069589|FG000|Overall Study|Lost to Follow-up|3|||
155097283|NCT00401843|559789655|FG002|Overall Study|Withdrawal of consent to study agent|17|||
155097284|NCT00401843|559789653|FG000|Overall Study|Randomized but not Treated|0|||
155097285|NCT00401843|559789654|FG001|Overall Study|Randomized but not Treated|2|||
155097286|NCT00401843|559789655|FG002|Overall Study|Randomized but not Treated|3|||
155097287|NCT00401843|559789653|FG000|Overall Study|Received incorrect treatment|0|||
155097288|NCT00401843|559789654|FG001|Overall Study|Received incorrect treatment|3|||
155097289|NCT00401843|559789655|FG002|Overall Study|Received incorrect treatment|0|||
155097290|NCT00120627|559789660|FG000|Overall Study|Withdrawal by Subject|5|||
155097291|NCT00120627|559789661|FG001|Overall Study|Withdrawal by Subject|5|||
155097292|NCT01182298|559789662|FG000|Overall Study|Lack of Efficacy|4|||
155097293|NCT01182298|559789662|FG000|Overall Study|Withdrawal by Subject|2|||
155097294|NCT01508910|559789663|FG000|Treatment|Death|2|||
155097295|NCT01508910|559789664|FG001|Treatment|Death|3|||
155097296|NCT01508910|559789665|FG002|Treatment|Death|2|||
155097297|NCT01508910|559789666|FG003|Treatment|Death|0|||
155097298|NCT01508910|559789663|FG000|Treatment|Lost to Follow-up|0|||
155097299|NCT01508910|559789664|FG001|Treatment|Lost to Follow-up|0|||
155097300|NCT01508910|559789665|FG002|Treatment|Lost to Follow-up|2|||
155097301|NCT01508910|559789666|FG003|Treatment|Lost to Follow-up|1|||
155097302|NCT01508910|559789663|FG000|Treatment|Withdrawal by Subject|0|||
155097303|NCT01508910|559789664|FG001|Treatment|Withdrawal by Subject|1|||
155097304|NCT01508910|559789665|FG002|Treatment|Withdrawal by Subject|6|||
155097305|NCT01508910|559789666|FG003|Treatment|Withdrawal by Subject|1|||
155097306|NCT01508910|559789663|FG000|Treatment|Sponsor Decision|0|||
155097307|NCT01508910|559789664|FG001|Treatment|Sponsor Decision|0|||
155097308|NCT01508910|559789665|FG002|Treatment|Sponsor Decision|0|||
155097309|NCT01508910|559789666|FG003|Treatment|Sponsor Decision|1|||
155097310|NCT01595529|559789667|FG000|Overall Study|Adverse Event|2|||
155097311|NCT01595529|559789668|FG001|Overall Study|Adverse Event|0|||
155097312|NCT01595529|559789667|FG000|Overall Study|Subject Non-Compliant|2|||
155097313|NCT01595529|559789668|FG001|Overall Study|Subject Non-Compliant|0|||
155097314|NCT01595529|559789667|FG000|Overall Study|Lost to Follow-up|8|||
155097315|NCT01595529|559789668|FG001|Overall Study|Lost to Follow-up|14|||
155172130|NCT01808092|560069590|FG001|Overall Study|Lost to Follow-up|7|||
155172131|NCT01808092|560069589|FG000|Overall Study|Withdrawal by Subject|9|||
155172132|NCT01808092|560069590|FG001|Overall Study|Withdrawal by Subject|4|||
155172133|NCT01808092|560069589|FG000|Overall Study|Other Eligibility criteria|3|||
155172134|NCT01808092|560069590|FG001|Overall Study|Other Eligibility criteria|5|||
155172135|NCT01097005|560069596|FG000|Overall Study|Case Report Form not collected|18|||
155172136|NCT01097005|560069596|FG000|Overall Study|Subjects cannot visit the hospital|1|||
155172137|NCT01097005|560069596|FG000|Overall Study|Poor medication compliance|1|||
155172138|NCT01097005|560069596|FG000|Overall Study|No examination data available|244|||
155172139|NCT01097005|560069596|FG000|Overall Study|Deviation from exclusion criteria|37|||
155097316|NCT01595529|559789667|FG000|Overall Study|Protocol Violation|1|||
155097317|NCT01595529|559789668|FG001|Overall Study|Protocol Violation|2|||
155097318|NCT01595529|559789667|FG000|Overall Study|Physician Decision|1|||
155097319|NCT01595529|559789668|FG001|Overall Study|Physician Decision|0|||
155097320|NCT01595529|559789667|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
155097321|NCT01595529|559789668|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
155097322|NCT01595529|559789667|FG000|Overall Study|Administrative Decision|1|||
155097323|NCT01595529|559789668|FG001|Overall Study|Administrative Decision|0|||
155097324|NCT01595529|559789667|FG000|Overall Study|Entry Failure/Screening Failure|6|||
155097325|NCT01595529|559789668|FG001|Overall Study|Entry Failure/Screening Failure|1|||
155097326|NCT04016714|559789669|FG000|Overall Study|Death|1|||
155097327|NCT04016714|559789670|FG001|Overall Study|Death|0|||
155097328|NCT04016714|559789669|FG000|Overall Study|Lost to Follow-up|3|||
155097329|NCT04016714|559789670|FG001|Overall Study|Lost to Follow-up|1|||
155097330|NCT04016714|559789669|FG000|Overall Study|Physician Decision|3|||
155097331|NCT04016714|559789670|FG001|Overall Study|Physician Decision|3|||
155097332|NCT04016714|559789669|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
155097333|NCT04016714|559789670|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
155097334|NCT01677988|559789671|FG000|Overall Study|Lack of Efficacy|2|||
155097335|NCT01822665|559789672|FG000|Overall Study|Adverse Event|3|||
155097336|NCT01822665|559789672|FG000|Overall Study|Other Reason|5|||
155097337|NCT00271544|559789673|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
155097338|NCT00271544|559789673|FG000|Overall Study|Model 4196 lead not attempted|9|||
155097339|NCT00271544|559789673|FG000|Overall Study|Implant not attempted|4|||
155097340|NCT00907621|559789674|FG000|Overall Study|Lost to Follow-up|6|||
155097341|NCT00907621|559789675|FG001|Overall Study|Lost to Follow-up|3|||
155097342|NCT00907621|559789674|FG000|Overall Study|intercurrent febrile illness|1|||
155097343|NCT00907621|559789675|FG001|Overall Study|intercurrent febrile illness|1|||
155097344|NCT00730886|559789676|FG000|Overall Study|Lost to Follow-up|1|||
155097345|NCT00730886|559789677|FG001|Overall Study|Lost to Follow-up|0|||
155097346|NCT00730886|559789676|FG000|Overall Study|Physician Decision|1|||
155097347|NCT00730886|559789677|FG001|Overall Study|Physician Decision|0|||
155097348|NCT04290624|559789678|FG000|Overall Study|Adverse Event|1|||
155097349|NCT04290624|559789679|FG001|Overall Study|Adverse Event|0|||
155097350|NCT00656370|559789680|FG000|Overall Study|Screen Failures|7|||
155097351|NCT00656370|559789680|FG000|Overall Study|Alternates|3|||
155097352|NCT00552071|559791388|FG000|Overall Study|Adverse Event|1|||
155097353|NCT00552071|559791389|FG001|Overall Study|Adverse Event|0|||
155097354|NCT00552071|559791388|FG000|Overall Study|Lack of Efficacy|1|||
155097355|NCT00552071|559791389|FG001|Overall Study|Lack of Efficacy|0|||
155097356|NCT00552071|559791388|FG000|Overall Study|Physician Decision|1|||
155097357|NCT00552071|559791389|FG001|Overall Study|Physician Decision|0|||
155097358|NCT00552071|559791388|FG000|Overall Study|Pregnancy|1|||
155097359|NCT00552071|559791389|FG001|Overall Study|Pregnancy|0|||
155097360|NCT00552071|559791388|FG000|Overall Study|Death|0|||
155097361|NCT00552071|559791389|FG001|Overall Study|Death|1|||
155097362|NCT00552071|559791388|FG000|Overall Study|Withdrawal by Subject|0|||
155097363|NCT00552071|559791389|FG001|Overall Study|Withdrawal by Subject|1|||
155097364|NCT00272792|559791390|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
155097365|NCT00272792|559791391|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
155097366|NCT00272792|559791390|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
155097367|NCT00272792|559791391|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
155097368|NCT00272792|559791390|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
155097369|NCT00272792|559791391|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
155097370|NCT00272792|559791390|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
155097371|NCT00272792|559791391|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
155097372|NCT00937495|559791398|FG000|Overall Study|Protocol Violation|2|||
155097373|NCT01856322|559791399|FG000|Overall Study|off study due to lack of accrual|0|||
155097374|NCT01856322|559791400|FG001|Overall Study|off study due to lack of accrual|0|||
155097375|NCT01856322|559791401|FG002|Overall Study|off study due to lack of accrual|3|||
155097376|NCT00288015|559791402|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
155097377|NCT00288015|559791402|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
155097378|NCT00288015|559791402|FG000|First Response Assessment|Withdrawal by Subject|1|||
155097379|NCT00288015|559791402|FG000|First Response Assessment|Death|1|||
155097380|NCT00288015|559791402|FG000|First Response Assessment|Physician Decision|2|||
155097381|NCT00288015|559791402|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
155097382|NCT00288015|559791402|FG000|Follow up for Survival x 2 Years|Death|13|||
155097383|NCT00288015|559791402|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
155097384|NCT00288015|559791402|FG000|Follow up for Survival x 2 Years|Other|9|||
155097385|NCT04592341|559791405|FG000|Overall Study|Physician Decision|5|||
155097386|NCT04592341|559791405|FG000|Overall Study|Study Terminated by Sponsor|5|||
155097387|NCT04592341|559791405|FG000|Overall Study|Withdrawal by Subject|53|||
155097388|NCT04592341|559791405|FG000|Overall Study|Lost to Follow-up|3|||
155097389|NCT04592341|559791405|FG000|Overall Study|Death|1|||
155097390|NCT04592341|559791405|FG000|Overall Study|Adverse Event|5|||
155097391|NCT04592341|559791405|FG000|Overall Study|other|4|||
155097392|NCT01944020|559791406|FG000|Overall Study|Withdrawal by Subject|5|||
155097393|NCT01944020|559791407|FG001|Overall Study|Withdrawal by Subject|0|||
155097394|NCT00692003|559791408|FG000|Overall Study|Sponsor Decision|5|||
155097395|NCT00692003|559791409|FG001|Overall Study|Sponsor Decision|1|||
155097396|NCT00305877|559791410|FG000|Overall Study|Lack of Efficacy|6|||
155097397|NCT00305877|559791411|FG001|Overall Study|Lack of Efficacy|9|||
155097398|NCT00305877|559791410|FG000|Overall Study|Adverse Event|9|||
155097399|NCT00305877|559791411|FG001|Overall Study|Adverse Event|14|||
155097400|NCT00305877|559791410|FG000|Overall Study|Death|0|||
155097401|NCT00305877|559791411|FG001|Overall Study|Death|1|||
155097402|NCT00305877|559791410|FG000|Overall Study|Withdrawal by Subject|4|||
155097403|NCT00305877|559791411|FG001|Overall Study|Withdrawal by Subject|2|||
155097404|NCT00305877|559791410|FG000|Overall Study|Physician Decision|1|||
155097405|NCT00305877|559791411|FG001|Overall Study|Physician Decision|1|||
155097406|NCT00305877|559791410|FG000|Overall Study|Never start treatment|2|||
155097407|NCT00305877|559791411|FG001|Overall Study|Never start treatment|5|||
155097408|NCT00305877|559791410|FG000|Overall Study|Ineligible|2|||
155097409|NCT00305877|559791411|FG001|Overall Study|Ineligible|1|||
155097410|NCT00305877|559791410|FG000|Overall Study|Transportation issue with daily RT|0|||
155097411|NCT00305877|559791411|FG001|Overall Study|Transportation issue with daily RT|1|||
155097412|NCT01535287|559791412|FG000|Overall Study|drug not prepared in time|5|||
155097413|NCT01535287|559791413|FG001|Overall Study|drug not prepared in time|6|||
155097414|NCT00457392|559791414|FG000|Overall Study|Objective Progression or Relapse|229|||
155097415|NCT00457392|559791415|FG001|Overall Study|Objective Progression or Relapse|296|||
155097416|NCT00457392|559791414|FG000|Overall Study|Death|106|||
155097417|NCT00457392|559791415|FG001|Overall Study|Death|106|||
155097418|NCT00457392|559791414|FG000|Overall Study|Adverse Event|84|||
155097419|NCT00457392|559791415|FG001|Overall Study|Adverse Event|41|||
155097420|NCT00457392|559791414|FG000|Overall Study|Global Deterioration of Health Status|22|||
155097421|NCT00457392|559791415|FG001|Overall Study|Global Deterioration of Health Status|8|||
155097422|NCT00457392|559791414|FG000|Overall Study|Withdrawal by Subject|14|||
155097423|NCT00457392|559791415|FG001|Overall Study|Withdrawal by Subject|8|||
155172140|NCT01097005|560069596|FG000|Overall Study|Adverse Event|14|||
155172141|NCT01097005|560069596|FG000|Overall Study|Discontinuance by complication|50|||
155097424|NCT00457392|559791414|FG000|Overall Study|Lost to Follow-up|6|||
155172142|NCT03425253|560069599|FG000|Overall Study|Adverse Event|2|||
155097425|NCT00457392|559791415|FG001|Overall Study|Lost to Follow-up|7|||
155097426|NCT00457392|559791414|FG000|Overall Study|Protocol Violation|4|||
155172143|NCT03425253|560069599|FG000|Overall Study|Lost to Follow-up|3|||
155097427|NCT00457392|559791415|FG001|Overall Study|Protocol Violation|3|||
155097428|NCT00457392|559791414|FG000|Overall Study|Other|7|||
155097429|NCT00457392|559791415|FG001|Overall Study|Other|4|||
155097430|NCT00457392|559791414|FG000|Overall Study|Study Terminated by Sponsor|1|||
155097431|NCT00457392|559791415|FG001|Overall Study|Study Terminated by Sponsor|4|||
155097432|NCT00457392|559791414|FG000|Overall Study|Randomized, Not Treated|7|||
155097433|NCT00457392|559791415|FG001|Overall Study|Randomized, Not Treated|3|||
155097434|NCT00980148|559791416|FG000|Overall Study|Discharged from facility|89|||
155097435|NCT00980148|559791417|FG001|Overall Study|Discharged from facility|96|||
155172144|NCT03425253|560069599|FG000|Overall Study|Withdrew Consent|6|||
155172145|NCT03425253|560069599|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
155172146|NCT04614324|560069600|FG000|Overall Study|Lost to Follow-up|3|||
155097436|NCT00980148|559791416|FG000|Overall Study|Received other antichlamydia treatment|20|||
155097437|NCT00980148|559791417|FG001|Overall Study|Received other antichlamydia treatment|14|||
155097438|NCT00980148|559791416|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
155172147|NCT04614324|560069600|FG000|Overall Study|Physician Decision|1|||
155172148|NCT04614324|560069600|FG000|Overall Study|Withdrawal by Subject|2|||
155172149|NCT04614324|560069600|FG000|Overall Study|Remaining in Follow up|123|||
155172150|NCT04627285|560069601|FG000|Overall Study|Adverse Event|0|||
155172151|NCT04627285|560069602|FG001|Overall Study|Adverse Event|2|||
155172152|NCT04627285|560069601|FG000|Overall Study|Lost to Follow-up|1|||
155172153|NCT04627285|560069602|FG001|Overall Study|Lost to Follow-up|0|||
155172154|NCT04627285|560069601|FG000|Overall Study|Withdrawal by Subject|1|||
155172155|NCT04627285|560069602|FG001|Overall Study|Withdrawal by Subject|1|||
155172156|NCT04627285|560069601|FG000|Overall Study|Sponsor decision|5|||
155172157|NCT04627285|560069602|FG001|Overall Study|Sponsor decision|0|||
155172158|NCT04627285|560069601|FG000|Overall Study|Participant left country; aunt informed the site|0|||
155172159|NCT04627285|560069602|FG001|Overall Study|Participant left country; aunt informed the site|1|||
155172160|NCT00336856|560071729|FG000|Overall Study|Withdrawal by Subject|3|||
155172161|NCT00336856|560071729|FG000|Overall Study|Found ineligible at time of analysis|1|||
155172162|NCT01325337|560071730|FG000|Overall Study|Adverse Event|0|||
155172163|NCT01325337|560071731|FG001|Overall Study|Adverse Event|2|||
155172164|NCT01325337|560071732|FG002|Overall Study|Adverse Event|2|||
155172165|NCT01325337|560071733|FG003|Overall Study|Adverse Event|1|||
155172166|NCT01325337|560071734|FG004|Overall Study|Adverse Event|2|||
155172167|NCT01325337|560071730|FG000|Overall Study|Lost to Follow-up|2|||
155172168|NCT01325337|560071731|FG001|Overall Study|Lost to Follow-up|2|||
155172169|NCT01325337|560071732|FG002|Overall Study|Lost to Follow-up|2|||
155172170|NCT01325337|560071733|FG003|Overall Study|Lost to Follow-up|1|||
155172171|NCT01325337|560071734|FG004|Overall Study|Lost to Follow-up|2|||
155172172|NCT01325337|560071730|FG000|Overall Study|Personal Reasons|2|||
155172173|NCT01325337|560071731|FG001|Overall Study|Personal Reasons|5|||
155172174|NCT01325337|560071732|FG002|Overall Study|Personal Reasons|4|||
155172175|NCT01325337|560071733|FG003|Overall Study|Personal Reasons|8|||
155172176|NCT01325337|560071734|FG004|Overall Study|Personal Reasons|3|||
155172177|NCT01325337|560071730|FG000|Overall Study|Withdrawal by Subject|1|||
155172178|NCT01325337|560071731|FG001|Overall Study|Withdrawal by Subject|0|||
155172179|NCT01325337|560071732|FG002|Overall Study|Withdrawal by Subject|1|||
155172180|NCT01325337|560071733|FG003|Overall Study|Withdrawal by Subject|0|||
155172181|NCT01325337|560071734|FG004|Overall Study|Withdrawal by Subject|1|||
155172182|NCT01332799|560071751|FG000|Overall Study|Insufficient funding|10|||
155172183|NCT01332799|560071752|FG001|Overall Study|Insufficient funding|10|||
154967589|NCT01899053|559303354|FG002|Overall Study|Withdrawal by Subject|2|||
154967590|NCT01899053|559303355|FG003|Overall Study|Withdrawal by Subject|0|||
154967591|NCT01899053|559303356|FG004|Overall Study|Withdrawal by Subject|2|||
154967592|NCT01899053|559303357|FG005|Overall Study|Withdrawal by Subject|0|||
154967593|NCT01899053|559303358|FG006|Overall Study|Withdrawal by Subject|0|||
154967594|NCT01899053|559303359|FG007|Overall Study|Withdrawal by Subject|1|||
154967595|NCT01899053|559303360|FG008|Overall Study|Withdrawal by Subject|0|||
154967596|NCT01899053|559303361|FG009|Overall Study|Withdrawal by Subject|0|||
154967597|NCT01899053|559303362|FG010|Overall Study|Withdrawal by Subject|0|||
154967598|NCT01899053|559303363|FG011|Overall Study|Withdrawal by Subject|0|||
154967599|NCT01899053|559303364|FG012|Overall Study|Withdrawal by Subject|1|||
154967600|NCT01899053|559303365|FG013|Overall Study|Withdrawal by Subject|1|||
154967601|NCT01899053|559303352|FG000|Overall Study|Protocol Violation|0|||
155097439|NCT00980148|559791417|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
155097440|NCT00980148|559791416|FG000|Overall Study|Various other reasons|8|||
155097441|NCT00980148|559791417|FG001|Overall Study|Various other reasons|9|||
155097442|NCT06164691|559791426|FG000|Overall Study|Withdrawal by Subject|2|||
154967602|NCT01899053|559303353|FG001|Overall Study|Protocol Violation|0|||
154967603|NCT01899053|559303354|FG002|Overall Study|Protocol Violation|1|||
155097443|NCT06164691|559791427|FG001|Overall Study|Withdrawal by Subject|0|||
155097444|NCT06164691|559791428|FG002|Overall Study|Withdrawal by Subject|0|||
155097445|NCT00812955|559791429|FG000|Overall Study|Adverse Event|7|||
155097446|NCT00812955|559791430|FG001|Overall Study|Adverse Event|6|||
154967604|NCT01899053|559303355|FG003|Overall Study|Protocol Violation|0|||
155097447|NCT00812955|559791431|FG002|Overall Study|Adverse Event|3|||
155097448|NCT00812955|559791432|FG003|Overall Study|Adverse Event|4|||
155097449|NCT00812955|559791429|FG000|Overall Study|Lost to Follow-up|2|||
155097450|NCT00812955|559791430|FG001|Overall Study|Lost to Follow-up|1|||
155097451|NCT00812955|559791431|FG002|Overall Study|Lost to Follow-up|1|||
154967605|NCT01899053|559303356|FG004|Overall Study|Protocol Violation|0|||
154967606|NCT01899053|559303357|FG005|Overall Study|Protocol Violation|0|||
154967607|NCT01899053|559303358|FG006|Overall Study|Protocol Violation|0|||
154967608|NCT01899053|559303359|FG007|Overall Study|Protocol Violation|0|||
154967609|NCT01899053|559303360|FG008|Overall Study|Protocol Violation|0|||
154967610|NCT01899053|559303361|FG009|Overall Study|Protocol Violation|0|||
155097452|NCT00812955|559791432|FG003|Overall Study|Lost to Follow-up|2|||
155097453|NCT00812955|559791429|FG000|Overall Study|Withdrawal by Subject|1|||
155097454|NCT00812955|559791430|FG001|Overall Study|Withdrawal by Subject|0|||
155097455|NCT00812955|559791431|FG002|Overall Study|Withdrawal by Subject|1|||
155097456|NCT00812955|559791432|FG003|Overall Study|Withdrawal by Subject|2|||
155097457|NCT00812955|559791429|FG000|Overall Study|randomized in error|0|||
155097458|NCT00812955|559791430|FG001|Overall Study|randomized in error|0|||
155097459|NCT00812955|559791431|FG002|Overall Study|randomized in error|1|||
155097460|NCT00812955|559791432|FG003|Overall Study|randomized in error|0|||
154967611|NCT01899053|559303362|FG010|Overall Study|Protocol Violation|0|||
155097461|NCT01309204|559791433|FG000|Overall Study|Adverse Event|48|||
155097462|NCT01309204|559791434|FG001|Overall Study|Adverse Event|58|||
155097463|NCT01309204|559791433|FG000|Overall Study|Lost to Follow-up|2|||
154967612|NCT01899053|559303363|FG011|Overall Study|Protocol Violation|0|||
154967613|NCT01899053|559303364|FG012|Overall Study|Protocol Violation|0|||
154967614|NCT01899053|559303365|FG013|Overall Study|Protocol Violation|0|||
155097464|NCT01309204|559791434|FG001|Overall Study|Lost to Follow-up|2|||
154967615|NCT01899053|559303352|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
154967616|NCT01899053|559303353|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
154967617|NCT01899053|559303354|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155172184|NCT04022733|560071755|FG000|Overall Study|conversion to open surgery|3|||
155172185|NCT04022733|560071756|FG001|Overall Study|conversion to open surgery|2|||
155172186|NCT04022733|560071755|FG000|Overall Study|bradycardia|0|||
155172187|NCT04022733|560071756|FG001|Overall Study|bradycardia|1|||
155172188|NCT05315908|560071764|FG000|Overall Study|Lost to Follow-up|4477|||
155172189|NCT05315908|560071765|FG001|Overall Study|Lost to Follow-up|4606|||
155172190|NCT00294762|560071766|FG000|Overall Study|Did not receive study treatment|3|||
155172191|NCT00294762|560071767|FG001|Overall Study|Did not receive study treatment|3|||
155172192|NCT02937584|560071768|FG000|Period 1|Adverse Event|1|||
155172193|NCT02937584|560071769|FG001|Period 1|Adverse Event|2|||
155172194|NCT02937584|560071768|FG000|Washout|Adverse Event|0|||
155172195|NCT02937584|560071769|FG001|Washout|Adverse Event|1|||
155172196|NCT02238080|560071770|FG000|Overall Study|Death|13|||
155172197|NCT02238080|560071770|FG000|Overall Study|Treatment interrupted|6|||
155172198|NCT02238080|560071770|FG000|Overall Study|Withdrawal by Subject|2|||
155172199|NCT02238080|560071770|FG000|Overall Study|Other|4|||
155172200|NCT00233454|560071779|FG000|Overall Study|Death|6|||
155172201|NCT04224688|560071783|FG000|Overall Study|Withdrawal by Subject|1|||
155172202|NCT04224688|560071784|FG001|Overall Study|Withdrawal by Subject|3|||
155172203|NCT04224688|560071783|FG000|Overall Study|Lack of Efficacy|1|||
155172204|NCT04224688|560071784|FG001|Overall Study|Lack of Efficacy|1|||
155172205|NCT04224688|560071783|FG000|Overall Study|Adverse event, not fatal|0|||
155172206|NCT04224688|560071784|FG001|Overall Study|Adverse event, not fatal|2|||
155172207|NCT04224688|560071783|FG000|Overall Study|COVID-19|0|||
155172208|NCT04224688|560071784|FG001|Overall Study|COVID-19|1|||
155172209|NCT04074161|560071785|FG000|Overall Study|Withdrawal by Subject|2|||
155172210|NCT04074161|560071786|FG001|Overall Study|Withdrawal by Subject|4|||
155172211|NCT04074161|560071787|FG002|Overall Study|Withdrawal by Subject|1|||
155172212|NCT04074161|560071785|FG000|Overall Study|Lost to Follow-up|4|||
155172213|NCT04074161|560071786|FG001|Overall Study|Lost to Follow-up|5|||
155097465|NCT01309204|559791433|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
155097466|NCT01309204|559791434|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
155097467|NCT01309204|559791433|FG000|Overall Study|Inadequate control of IOP|4|||
155097468|NCT01309204|559791434|FG001|Overall Study|Inadequate control of IOP|4|||
155097469|NCT01309204|559791433|FG000|Overall Study|Other|4|||
155097470|NCT01309204|559791434|FG001|Overall Study|Other|1|||
155097471|NCT03183063|559791435|FG000|Overall Study|Withdrawal by Subject|2|||
155097472|NCT03183063|559791436|FG001|Overall Study|Withdrawal by Subject|0|||
155097473|NCT03183063|559791437|FG002|Overall Study|Withdrawal by Subject|0|||
155097474|NCT03183063|559791435|FG000|Overall Study|Physician Decision|3|||
155097475|NCT03183063|559791436|FG001|Overall Study|Physician Decision|4|||
155172214|NCT04074161|560071787|FG002|Overall Study|Lost to Follow-up|3|||
155172215|NCT00796445|560071790|FG000|Overall Study|Protocol Violation|5|||
155172216|NCT00796445|560071791|FG001|Overall Study|Protocol Violation|3|||
155172217|NCT00796445|560071790|FG000|Overall Study|Adverse event, serious fatal|10|||
155172218|NCT00796445|560071791|FG001|Overall Study|Adverse event, serious fatal|5|||
155172219|NCT00796445|560071790|FG000|Overall Study|Adverse event, non-fatal|4|||
155172220|NCT00796445|560071791|FG001|Overall Study|Adverse event, non-fatal|0|||
155172221|NCT00796445|560071790|FG000|Overall Study|Disease progression/recurrence|537|||
155172222|NCT00796445|560071791|FG001|Overall Study|Disease progression/recurrence|268|||
155172223|NCT00796445|560071790|FG000|Overall Study|Other|10|||
155172224|NCT00796445|560071791|FG001|Overall Study|Other|7|||
155172225|NCT00796445|560071790|FG000|Overall Study|Withdrawal by Subject|18|||
155172226|NCT00796445|560071791|FG001|Overall Study|Withdrawal by Subject|9|||
155172227|NCT00796445|560071790|FG000|Overall Study|Invalid Informed Consent Form|1|||
155172228|NCT00796445|560071791|FG001|Overall Study|Invalid Informed Consent Form|0|||
155172229|NCT02500056|560071792|FG000|Overall Study|Lost to Follow-up|3|||
155172230|NCT02500056|560071793|FG001|Overall Study|Lost to Follow-up|7|||
155172231|NCT02500056|560071792|FG000|Overall Study|Recurrence|1|||
155172232|NCT02500056|560071793|FG001|Overall Study|Recurrence|0|||
155172233|NCT02500056|560071792|FG000|Overall Study|Death|3|||
155172234|NCT02500056|560071793|FG001|Overall Study|Death|1|||
155172235|NCT01087736|560071794|FG000|Overall Study|Lost to Follow-up|1|||
155172236|NCT01087736|560071795|FG001|Overall Study|Lost to Follow-up|0|||
155172237|NCT01087736|560071794|FG000|Overall Study|Death|0|||
155172238|NCT01087736|560071795|FG001|Overall Study|Death|1|||
155172239|NCT01087736|560071794|FG000|Overall Study|Withdrawal by Subject|0|||
155172240|NCT01087736|560071795|FG001|Overall Study|Withdrawal by Subject|1|||
155172241|NCT01565343|560071797|FG000|Overall Study|Administrative decision/technical issues|1|||
155172242|NCT01565343|560071798|FG001|Overall Study|Administrative decision/technical issues|0|||
155172243|NCT01565343|560071799|FG002|Overall Study|Administrative decision/technical issues|0|||
155172244|NCT00638183|560071801|FG000|Overall Study|Adverse Event|23|||
155172245|NCT00638183|560071801|FG000|Overall Study|Lack of Efficacy|14|||
155172246|NCT00638183|560071801|FG000|Overall Study|Physician Decision|9|||
155172247|NCT00638183|560071801|FG000|Overall Study|Lost to Follow-up|46|||
155172248|NCT00638183|560071801|FG000|Overall Study|Other reason not defined above|27|||
155097476|NCT03183063|559791437|FG002|Overall Study|Physician Decision|4|||
155097477|NCT00925002|559791438|FG000|Overall Study|Other|1|||
155097478|NCT00925002|559791439|FG001|Overall Study|Other|4|||
155172249|NCT02059291|560071802|FG000|Epoch 2|Lack of Efficacy|0|||
155172250|NCT02059291|560071803|FG001|Epoch 2|Lack of Efficacy|0|||
155172251|NCT02059291|560071804|FG002|Epoch 2|Lack of Efficacy|0|||
155172252|NCT02059291|560071805|FG003|Epoch 2|Lack of Efficacy|1|||
155172253|NCT02059291|560071806|FG004|Epoch 2|Lack of Efficacy|0|||
155172254|NCT02059291|560071807|FG005|Epoch 2|Lack of Efficacy|1|||
155097479|NCT00925002|559791440|FG002|Overall Study|Other|0|||
155097480|NCT00925002|559791438|FG000|Overall Study|Death|1|||
155172255|NCT02059291|560071808|FG006|Epoch 2|Lack of Efficacy|0|||
155172256|NCT02059291|560071809|FG007|Epoch 2|Lack of Efficacy|0|||
155172257|NCT02059291|560071810|FG008|Epoch 2|Lack of Efficacy|0|||
155172258|NCT02059291|560071811|FG009|Epoch 2|Lack of Efficacy|0|||
155172259|NCT02059291|560071812|FG010|Epoch 2|Lack of Efficacy|0|||
155172260|NCT02059291|560071813|FG011|Epoch 2|Lack of Efficacy|0|||
155172261|NCT02059291|560071814|FG012|Epoch 2|Lack of Efficacy|0|||
155172262|NCT02059291|560071815|FG013|Epoch 2|Lack of Efficacy|0|||
155172263|NCT02059291|560071816|FG014|Epoch 2|Lack of Efficacy|0|||
155172264|NCT02059291|560071817|FG015|Epoch 2|Lack of Efficacy|0|||
155172265|NCT02059291|560071818|FG016|Epoch 2|Lack of Efficacy|0|||
155172266|NCT02059291|560071819|FG017|Epoch 2|Lack of Efficacy|0|||
155172267|NCT02059291|560071820|FG018|Epoch 2|Lack of Efficacy|0|||
155172268|NCT02059291|560071821|FG019|Epoch 2|Lack of Efficacy|0|||
155172269|NCT02059291|560071822|FG020|Epoch 2|Lack of Efficacy|0|||
155172270|NCT02059291|560071823|FG021|Epoch 2|Lack of Efficacy|0|||
155172271|NCT02059291|560071824|FG022|Epoch 2|Lack of Efficacy|0|||
155172272|NCT02059291|560071825|FG023|Epoch 2|Lack of Efficacy|0|||
155172273|NCT02059291|560071826|FG024|Epoch 2|Lack of Efficacy|0|||
155172274|NCT02059291|560071802|FG000|Epoch 2|Adverse Event|0|||
155172275|NCT02059291|560071803|FG001|Epoch 2|Adverse Event|0|||
155172276|NCT02059291|560071804|FG002|Epoch 2|Adverse Event|1|||
155172277|NCT02059291|560071805|FG003|Epoch 2|Adverse Event|1|||
155172278|NCT02059291|560071806|FG004|Epoch 2|Adverse Event|0|||
155172279|NCT02059291|560071807|FG005|Epoch 2|Adverse Event|0|||
155172280|NCT02059291|560071808|FG006|Epoch 2|Adverse Event|0|||
155172281|NCT02059291|560071809|FG007|Epoch 2|Adverse Event|1|||
155172282|NCT02059291|560071810|FG008|Epoch 2|Adverse Event|1|||
155172283|NCT02059291|560071811|FG009|Epoch 2|Adverse Event|0|||
155172284|NCT02059291|560071812|FG010|Epoch 2|Adverse Event|0|||
155172285|NCT02059291|560071813|FG011|Epoch 2|Adverse Event|0|||
155172286|NCT02059291|560071814|FG012|Epoch 2|Adverse Event|0|||
155172287|NCT02059291|560071815|FG013|Epoch 2|Adverse Event|0|||
155172288|NCT02059291|560071816|FG014|Epoch 2|Adverse Event|0|||
155172289|NCT02059291|560071817|FG015|Epoch 2|Adverse Event|0|||
155172290|NCT02059291|560071818|FG016|Epoch 2|Adverse Event|0|||
155172291|NCT02059291|560071819|FG017|Epoch 2|Adverse Event|0|||
155172292|NCT02059291|560071820|FG018|Epoch 2|Adverse Event|0|||
155172293|NCT02059291|560071821|FG019|Epoch 2|Adverse Event|0|||
155172294|NCT02059291|560071822|FG020|Epoch 2|Adverse Event|0|||
155172295|NCT02059291|560071823|FG021|Epoch 2|Adverse Event|0|||
155172296|NCT02059291|560071824|FG022|Epoch 2|Adverse Event|0|||
155172297|NCT02059291|560071825|FG023|Epoch 2|Adverse Event|0|||
155172298|NCT02059291|560071826|FG024|Epoch 2|Adverse Event|0|||
155172299|NCT02059291|560071802|FG000|Epoch 2|Withdrawal by Subject|0|||
155172300|NCT02059291|560071803|FG001|Epoch 2|Withdrawal by Subject|1|||
155172301|NCT02059291|560071804|FG002|Epoch 2|Withdrawal by Subject|0|||
155172302|NCT02059291|560071805|FG003|Epoch 2|Withdrawal by Subject|0|||
155172303|NCT02059291|560071806|FG004|Epoch 2|Withdrawal by Subject|0|||
155172304|NCT02059291|560071807|FG005|Epoch 2|Withdrawal by Subject|1|||
155172305|NCT02059291|560071808|FG006|Epoch 2|Withdrawal by Subject|0|||
155172306|NCT02059291|560071809|FG007|Epoch 2|Withdrawal by Subject|0|||
155172307|NCT02059291|560071810|FG008|Epoch 2|Withdrawal by Subject|1|||
155172308|NCT02059291|560071811|FG009|Epoch 2|Withdrawal by Subject|0|||
155172309|NCT02059291|560071812|FG010|Epoch 2|Withdrawal by Subject|0|||
155172310|NCT02059291|560071813|FG011|Epoch 2|Withdrawal by Subject|0|||
155172311|NCT02059291|560071814|FG012|Epoch 2|Withdrawal by Subject|0|||
155172312|NCT02059291|560071815|FG013|Epoch 2|Withdrawal by Subject|0|||
155172313|NCT02059291|560071816|FG014|Epoch 2|Withdrawal by Subject|0|||
155172314|NCT02059291|560071817|FG015|Epoch 2|Withdrawal by Subject|0|||
155172315|NCT02059291|560071818|FG016|Epoch 2|Withdrawal by Subject|0|||
155172316|NCT02059291|560071819|FG017|Epoch 2|Withdrawal by Subject|0|||
155172317|NCT02059291|560071820|FG018|Epoch 2|Withdrawal by Subject|0|||
155172318|NCT02059291|560071821|FG019|Epoch 2|Withdrawal by Subject|0|||
155172319|NCT02059291|560071822|FG020|Epoch 2|Withdrawal by Subject|0|||
155172320|NCT02059291|560071823|FG021|Epoch 2|Withdrawal by Subject|0|||
155172321|NCT02059291|560071824|FG022|Epoch 2|Withdrawal by Subject|0|||
155172322|NCT02059291|560071825|FG023|Epoch 2|Withdrawal by Subject|0|||
155172323|NCT02059291|560071826|FG024|Epoch 2|Withdrawal by Subject|0|||
155172324|NCT02059291|560071802|FG000|Epoch 3|Physician Decision|0|||
155172325|NCT02059291|560071803|FG001|Epoch 3|Physician Decision|0|||
155172326|NCT02059291|560071804|FG002|Epoch 3|Physician Decision|0|||
155172327|NCT02059291|560071805|FG003|Epoch 3|Physician Decision|0|||
155172328|NCT02059291|560071806|FG004|Epoch 3|Physician Decision|0|||
155172329|NCT02059291|560071807|FG005|Epoch 3|Physician Decision|0|||
155172330|NCT02059291|560071808|FG006|Epoch 3|Physician Decision|0|||
155172331|NCT02059291|560071809|FG007|Epoch 3|Physician Decision|0|||
155172332|NCT02059291|560071810|FG008|Epoch 3|Physician Decision|0|||
155172333|NCT02059291|560071811|FG009|Epoch 3|Physician Decision|0|||
155172334|NCT02059291|560071812|FG010|Epoch 3|Physician Decision|0|||
155172335|NCT02059291|560071813|FG011|Epoch 3|Physician Decision|0|||
155172336|NCT02059291|560071814|FG012|Epoch 3|Physician Decision|0|||
155172337|NCT02059291|560071815|FG013|Epoch 3|Physician Decision|1|||
155172338|NCT02059291|560071816|FG014|Epoch 3|Physician Decision|0|||
155172339|NCT02059291|560071817|FG015|Epoch 3|Physician Decision|1|||
155172340|NCT02059291|560071818|FG016|Epoch 3|Physician Decision|0|||
155172341|NCT02059291|560071819|FG017|Epoch 3|Physician Decision|0|||
155172342|NCT02059291|560071820|FG018|Epoch 3|Physician Decision|0|||
155172343|NCT02059291|560071821|FG019|Epoch 3|Physician Decision|0|||
155172344|NCT02059291|560071822|FG020|Epoch 3|Physician Decision|0|||
155172345|NCT02059291|560071823|FG021|Epoch 3|Physician Decision|0|||
155172346|NCT02059291|560071824|FG022|Epoch 3|Physician Decision|0|||
155172347|NCT02059291|560071825|FG023|Epoch 3|Physician Decision|0|||
155172348|NCT02059291|560071826|FG024|Epoch 3|Physician Decision|0|||
155172349|NCT02059291|560071802|FG000|Epoch 3|Adverse Event|0|||
155097481|NCT00925002|559791439|FG001|Overall Study|Death|1|||
155097482|NCT00925002|559791440|FG002|Overall Study|Death|5|||
155097483|NCT00925002|559791438|FG000|Overall Study|Adverse Event|3|||
155097484|NCT00925002|559791439|FG001|Overall Study|Adverse Event|1|||
155097485|NCT00925002|559791440|FG002|Overall Study|Adverse Event|2|||
155097486|NCT00925002|559791438|FG000|Overall Study|Participant withdrew consent|1|||
155097487|NCT00925002|559791439|FG001|Overall Study|Participant withdrew consent|3|||
154967618|NCT01899053|559303355|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967619|NCT01899053|559303356|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967620|NCT01899053|559303357|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967621|NCT01899053|559303358|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967622|NCT01899053|559303359|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967623|NCT01899053|559303360|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967624|NCT01899053|559303361|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967625|NCT01899053|559303362|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
154967626|NCT01899053|559303363|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967627|NCT01899053|559303364|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
155097488|NCT00925002|559791440|FG002|Overall Study|Participant withdrew consent|3|||
155097489|NCT04512001|559791444|FG000|Week 0 to Week 24|Adverse Event|14|||
155097490|NCT04512001|559791445|FG001|Week 0 to Week 24|Adverse Event|10|||
155097491|NCT04512001|559791446|FG002|Week 0 to Week 24|Adverse Event|0|||
155097492|NCT04512001|559791447|FG003|Week 0 to Week 24|Adverse Event|0|||
155097493|NCT04512001|559791448|FG004|Week 0 to Week 24|Adverse Event|0|||
155097494|NCT04512001|559791444|FG000|Week 0 to Week 24|Death|0|||
155097495|NCT04512001|559791445|FG001|Week 0 to Week 24|Death|2|||
155097496|NCT04512001|559791446|FG002|Week 0 to Week 24|Death|0|||
155097497|NCT04512001|559791447|FG003|Week 0 to Week 24|Death|0|||
154967628|NCT01899053|559303365|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
154967629|NCT01899053|559303352|FG000|Overall Study|Symptomatic Deterioration|0|||
154967630|NCT01899053|559303353|FG001|Overall Study|Symptomatic Deterioration|0|||
154967631|NCT01899053|559303354|FG002|Overall Study|Symptomatic Deterioration|0|||
154967632|NCT01899053|559303355|FG003|Overall Study|Symptomatic Deterioration|0|||
154967633|NCT01899053|559303356|FG004|Overall Study|Symptomatic Deterioration|0|||
154967634|NCT01899053|559303357|FG005|Overall Study|Symptomatic Deterioration|1|||
155172350|NCT02059291|560071803|FG001|Epoch 3|Adverse Event|0|||
155172351|NCT02059291|560071804|FG002|Epoch 3|Adverse Event|0|||
155172352|NCT02059291|560071805|FG003|Epoch 3|Adverse Event|0|||
154967635|NCT01899053|559303358|FG006|Overall Study|Symptomatic Deterioration|0|||
154967636|NCT01899053|559303359|FG007|Overall Study|Symptomatic Deterioration|1|||
154967637|NCT01899053|559303360|FG008|Overall Study|Symptomatic Deterioration|0|||
154967638|NCT01899053|559303361|FG009|Overall Study|Symptomatic Deterioration|0|||
154967639|NCT01899053|559303362|FG010|Overall Study|Symptomatic Deterioration|0|||
154967640|NCT01899053|559303363|FG011|Overall Study|Symptomatic Deterioration|1|||
154967641|NCT01899053|559303364|FG012|Overall Study|Symptomatic Deterioration|2|||
154967642|NCT01899053|559303365|FG013|Overall Study|Symptomatic Deterioration|0|||
154967643|NCT02452463|559303367|FG000|Overall Study|Death|1|||
155172353|NCT02059291|560071806|FG004|Epoch 3|Adverse Event|0|||
155172354|NCT02059291|560071807|FG005|Epoch 3|Adverse Event|0|||
155172355|NCT02059291|560071808|FG006|Epoch 3|Adverse Event|0|||
154967644|NCT02452463|559303368|FG001|Overall Study|Death|0|||
154967645|NCT02452463|559303369|FG002|Overall Study|Death|0|||
154967646|NCT02452463|559303367|FG000|Overall Study|Study Suspended|1|||
154967647|NCT02452463|559303368|FG001|Overall Study|Study Suspended|0|||
154967648|NCT02452463|559303369|FG002|Overall Study|Study Suspended|0|||
154967649|NCT02452463|559303367|FG000|Overall Study|Recommended by DSMB|0|||
154967650|NCT02452463|559303368|FG001|Overall Study|Recommended by DSMB|1|||
154967651|NCT02452463|559303369|FG002|Overall Study|Recommended by DSMB|0|||
154967652|NCT02452463|559303367|FG000|Overall Study|Withdrawal by Subject|0|||
154967653|NCT02452463|559303368|FG001|Overall Study|Withdrawal by Subject|1|||
154967654|NCT02452463|559303369|FG002|Overall Study|Withdrawal by Subject|0|||
154967655|NCT01073631|559303370|FG000|Overall Study|Death|82|||
154967656|NCT01073631|559303370|FG000|Overall Study|Adverse Event|24|||
154967657|NCT01073631|559303370|FG000|Overall Study|Other|63|||
155172356|NCT02059291|560071809|FG007|Epoch 3|Adverse Event|0|||
155172357|NCT02059291|560071810|FG008|Epoch 3|Adverse Event|0|||
155172358|NCT02059291|560071811|FG009|Epoch 3|Adverse Event|0|||
155172359|NCT02059291|560071812|FG010|Epoch 3|Adverse Event|0|||
155172360|NCT02059291|560071813|FG011|Epoch 3|Adverse Event|0|||
155172361|NCT02059291|560071814|FG012|Epoch 3|Adverse Event|0|||
155172362|NCT02059291|560071815|FG013|Epoch 3|Adverse Event|0|||
155172363|NCT02059291|560071816|FG014|Epoch 3|Adverse Event|0|||
154967658|NCT04594252|559303376|FG000|Overall Study|Adverse Event|0|||
154967659|NCT04594252|559303377|FG001|Overall Study|Adverse Event|2|||
154967660|NCT00477594|559303378|FG000|Year 1 and Year 2|Adverse Event|4|||
154967661|NCT00477594|559303379|FG001|Year 1 and Year 2|Adverse Event|2|||
154967662|NCT00477594|559303378|FG000|Year 1 and Year 2|Physician Decision|2|||
155097498|NCT04512001|559791448|FG004|Week 0 to Week 24|Death|0|||
155097499|NCT04512001|559791444|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
155097500|NCT04512001|559791445|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
155097501|NCT04512001|559791446|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
155097502|NCT04512001|559791447|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
155097503|NCT04512001|559791448|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
155097504|NCT04512001|559791444|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
155097505|NCT04512001|559791445|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
155097506|NCT04512001|559791446|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
155097507|NCT04512001|559791447|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
154967663|NCT00477594|559303379|FG001|Year 1 and Year 2|Physician Decision|1|||
154967664|NCT00477594|559303378|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
154967665|NCT00477594|559303379|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
155097508|NCT04512001|559791448|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
155097509|NCT04512001|559791444|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
154967666|NCT00477594|559303378|FG000|Year 1 and Year 2|Other|1|||
155097510|NCT04512001|559791445|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155172364|NCT02059291|560071817|FG015|Epoch 3|Adverse Event|1|||
154967667|NCT00477594|559303379|FG001|Year 1 and Year 2|Other|0|||
155097511|NCT04512001|559791446|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155097512|NCT04512001|559791447|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155097513|NCT04512001|559791448|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
155097514|NCT04512001|559791444|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155097515|NCT04512001|559791445|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
155097516|NCT04512001|559791446|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155097517|NCT04512001|559791447|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155172365|NCT02059291|560071818|FG016|Epoch 3|Adverse Event|0|||
154967668|NCT00477594|559303378|FG000|Year 3|Adverse Event|1|||
155097518|NCT04512001|559791448|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
155097519|NCT04512001|559791444|FG000|Week 24 to Week 63|Adverse Event|0|||
155097520|NCT04512001|559791445|FG001|Week 24 to Week 63|Adverse Event|0|||
155097521|NCT04512001|559791446|FG002|Week 24 to Week 63|Adverse Event|13|||
155097522|NCT04512001|559791447|FG003|Week 24 to Week 63|Adverse Event|8|||
155097523|NCT04512001|559791448|FG004|Week 24 to Week 63|Adverse Event|6|||
155097524|NCT04512001|559791444|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
155097525|NCT04512001|559791445|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
155097526|NCT04512001|559791446|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
155097527|NCT04512001|559791447|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
155097528|NCT04512001|559791448|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
155097529|NCT04512001|559791444|FG000|Week 24 to Week 63|Death|0|||
155097530|NCT04512001|559791445|FG001|Week 24 to Week 63|Death|0|||
155097531|NCT04512001|559791446|FG002|Week 24 to Week 63|Death|0|||
155097532|NCT04512001|559791447|FG003|Week 24 to Week 63|Death|1|||
155097533|NCT04512001|559791448|FG004|Week 24 to Week 63|Death|1|||
154967669|NCT00477594|559303379|FG001|Year 3|Adverse Event|0|||
154967670|NCT00477594|559303378|FG000|Year 3|Withdrawal by Subject|1|||
154967671|NCT00477594|559303379|FG001|Year 3|Withdrawal by Subject|0|||
154967672|NCT00477594|559303378|FG000|Follow-up Period|Withdrawal by Subject|2|||
154967673|NCT00477594|559303379|FG001|Follow-up Period|Withdrawal by Subject|1|||
154967674|NCT00477594|559303378|FG000|Follow-up Period|Other|1|||
154967675|NCT00477594|559303379|FG001|Follow-up Period|Other|0|||
154967676|NCT01109849|559305229|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
154967677|NCT01109849|559305230|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
154967678|NCT01109849|559305231|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
154967679|NCT01109849|559305232|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
154967680|NCT01109849|559305233|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
154967681|NCT01109849|559305229|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
154967682|NCT01109849|559305230|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
154967683|NCT01109849|559305231|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
154967684|NCT01109849|559305232|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
154967685|NCT01109849|559305233|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
154967686|NCT01109849|559305229|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
154967687|NCT01109849|559305230|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
154967688|NCT01109849|559305231|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
154967689|NCT01109849|559305232|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
154967690|NCT01109849|559305233|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
154967691|NCT01109849|559305229|FG000|Initial Randomization: ADHD Treatment|move away|2|||
154967692|NCT01109849|559305230|FG001|Initial Randomization: ADHD Treatment|move away|7|||
155097534|NCT04512001|559791444|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
155097535|NCT04512001|559791445|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
155097536|NCT04512001|559791446|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
155097537|NCT04512001|559791447|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
155097538|NCT04512001|559791448|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
155097539|NCT04512001|559791444|FG000|Week 24 to Week 63|Miscellaneous|0|||
154967693|NCT01109849|559305231|FG002|Initial Randomization: ADHD Treatment|move away|0|||
154967694|NCT01109849|559305232|FG003|Initial Randomization: ADHD Treatment|move away|0|||
155097540|NCT04512001|559791445|FG001|Week 24 to Week 63|Miscellaneous|0|||
154967695|NCT01109849|559305233|FG004|Initial Randomization: ADHD Treatment|move away|0|||
155097541|NCT04512001|559791446|FG002|Week 24 to Week 63|Miscellaneous|3|||
155097542|NCT04512001|559791447|FG003|Week 24 to Week 63|Miscellaneous|2|||
155097543|NCT04512001|559791448|FG004|Week 24 to Week 63|Miscellaneous|1|||
155172366|NCT02059291|560071819|FG017|Epoch 3|Adverse Event|0|||
155172367|NCT02059291|560071820|FG018|Epoch 3|Adverse Event|0|||
155172368|NCT02059291|560071821|FG019|Epoch 3|Adverse Event|0|||
155172369|NCT02059291|560071822|FG020|Epoch 3|Adverse Event|0|||
155172370|NCT02059291|560071823|FG021|Epoch 3|Adverse Event|0|||
155097544|NCT03389308|559791449|FG000|Overall Study|Withdrawal by Subject|5|||
155097545|NCT03389308|559791449|FG000|Overall Study|Lost to Follow-up|3|||
155097546|NCT03389308|559791449|FG000|Overall Study|Adverse Event|2|||
155097547|NCT03389308|559791449|FG000|Overall Study|Sponsor Request|2|||
155172371|NCT02059291|560071824|FG022|Epoch 3|Adverse Event|0|||
155172372|NCT02059291|560071825|FG023|Epoch 3|Adverse Event|0|||
155172373|NCT02059291|560071826|FG024|Epoch 3|Adverse Event|0|||
155172374|NCT02059291|560071802|FG000|Epoch 3|Lack of Efficacy|0|||
155172375|NCT02059291|560071803|FG001|Epoch 3|Lack of Efficacy|0|||
155172376|NCT02059291|560071804|FG002|Epoch 3|Lack of Efficacy|0|||
155172377|NCT02059291|560071805|FG003|Epoch 3|Lack of Efficacy|0|||
155097548|NCT00570323|559791451|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
155097549|NCT00570323|559791452|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
155097550|NCT00570323|559791451|FG000|Started Treatment After Randomization|Protocol Violation|1|||
155172378|NCT02059291|560071806|FG004|Epoch 3|Lack of Efficacy|0|||
155172379|NCT02059291|560071807|FG005|Epoch 3|Lack of Efficacy|0|||
155097551|NCT00570323|559791452|FG001|Started Treatment After Randomization|Protocol Violation|0|||
155172380|NCT02059291|560071808|FG006|Epoch 3|Lack of Efficacy|0|||
155172381|NCT02059291|560071809|FG007|Epoch 3|Lack of Efficacy|0|||
155172382|NCT02059291|560071810|FG008|Epoch 3|Lack of Efficacy|0|||
155172383|NCT02059291|560071811|FG009|Epoch 3|Lack of Efficacy|0|||
155172384|NCT02059291|560071812|FG010|Epoch 3|Lack of Efficacy|0|||
155097552|NCT00570323|559791451|FG000|Started Treatment After Randomization|Physician Decision|1|||
155097553|NCT00570323|559791452|FG001|Started Treatment After Randomization|Physician Decision|0|||
155097554|NCT00570323|559791451|FG000|Complete Study After Start|Lost to Follow-up|0|||
155097555|NCT00570323|559791452|FG001|Complete Study After Start|Lost to Follow-up|1|||
155097556|NCT00570323|559791451|FG000|Complete Study After Start|Withdrawal by Subject|2|||
155097557|NCT00570323|559791452|FG001|Complete Study After Start|Withdrawal by Subject|0|||
155097558|NCT00570323|559791451|FG000|Complete Study After Start|Physician Decision|1|||
155097559|NCT00570323|559791452|FG001|Complete Study After Start|Physician Decision|0|||
155097560|NCT04263766|559791453|FG000|Overall Study|Withdrawal by Subject|6|||
155097561|NCT04263766|559791454|FG001|Overall Study|Withdrawal by Subject|4|||
155097562|NCT04263766|559791453|FG000|Overall Study|Lack of Efficacy|1|||
155097563|NCT04263766|559791454|FG001|Overall Study|Lack of Efficacy|3|||
155097564|NCT04232943|559791457|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
155097565|NCT04232943|559791458|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
155097566|NCT04232943|559791459|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
155097567|NCT04232943|559791457|FG000|Overall Study|Withdrawal by Subject|1|||
155097568|NCT04232943|559791458|FG001|Overall Study|Withdrawal by Subject|1|||
155097569|NCT04232943|559791459|FG002|Overall Study|Withdrawal by Subject|0|||
155097570|NCT02639247|559791460|FG000|Overall Study|Lost to Follow-up|2|||
155097571|NCT02639247|559791461|FG001|Overall Study|Lost to Follow-up|1|||
155097572|NCT02639247|559791460|FG000|Overall Study|Death|2|||
155097573|NCT02639247|559791461|FG001|Overall Study|Death|0|||
155097574|NCT02639247|559791460|FG000|Overall Study|Withdrew Consent|0|||
155097575|NCT02639247|559791461|FG001|Overall Study|Withdrew Consent|1|||
155097576|NCT02639247|559791460|FG000|Overall Study|Protocol Violation|1|||
155097577|NCT02639247|559791461|FG001|Overall Study|Protocol Violation|0|||
155097578|NCT01891396|559791462|FG000|Overall Study|Withdrawal by Subject|4|||
155097579|NCT01891396|559791463|FG001|Overall Study|Withdrawal by Subject|4|||
155097580|NCT01891396|559791464|FG002|Overall Study|Withdrawal by Subject|3|||
155097581|NCT01891396|559791462|FG000|Overall Study|Lost to Follow-up|0|||
155097582|NCT01891396|559791463|FG001|Overall Study|Lost to Follow-up|1|||
155097583|NCT01891396|559791464|FG002|Overall Study|Lost to Follow-up|0|||
155097584|NCT02266147|559791466|FG000|PART 1: Dose Escalation|Physician Decision|0|||
155097585|NCT02266147|559791467|FG001|PART 1: Dose Escalation|Physician Decision|0|||
155097586|NCT02266147|559791468|FG002|PART 1: Dose Escalation|Physician Decision|1|||
155097587|NCT02266147|559791469|FG003|PART 1: Dose Escalation|Physician Decision|0|||
155097588|NCT02266147|559791466|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
155097589|NCT02266147|559791467|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
155097590|NCT02266147|559791468|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
155097591|NCT02266147|559791469|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
155097592|NCT02266147|559791466|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
155097593|NCT02266147|559791467|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
155097594|NCT02266147|559791468|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
155097595|NCT02266147|559791469|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
155097596|NCT02266147|559791466|FG000|PART 1: Dose Escalation|Other|1|||
155097597|NCT02266147|559791467|FG001|PART 1: Dose Escalation|Other|1|||
155097598|NCT02266147|559791468|FG002|PART 1: Dose Escalation|Other|0|||
155097599|NCT02266147|559791469|FG003|PART 1: Dose Escalation|Other|0|||
155097600|NCT02266147|559791466|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
155097601|NCT02266147|559791467|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
155097602|NCT02266147|559791468|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
155097603|NCT02266147|559791469|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
155097604|NCT02266147|559791466|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
155097605|NCT02266147|559791467|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
155172385|NCT02059291|560071813|FG011|Epoch 3|Lack of Efficacy|0|||
155172386|NCT02059291|560071814|FG012|Epoch 3|Lack of Efficacy|0|||
155172387|NCT02059291|560071815|FG013|Epoch 3|Lack of Efficacy|0|||
155172388|NCT02059291|560071816|FG014|Epoch 3|Lack of Efficacy|0|||
155172389|NCT02059291|560071817|FG015|Epoch 3|Lack of Efficacy|3|||
155172390|NCT02059291|560071818|FG016|Epoch 3|Lack of Efficacy|0|||
155172391|NCT02059291|560071819|FG017|Epoch 3|Lack of Efficacy|0|||
155172392|NCT02059291|560071820|FG018|Epoch 3|Lack of Efficacy|0|||
155172393|NCT02059291|560071821|FG019|Epoch 3|Lack of Efficacy|0|||
155172394|NCT02059291|560071822|FG020|Epoch 3|Lack of Efficacy|0|||
155172395|NCT02059291|560071823|FG021|Epoch 3|Lack of Efficacy|0|||
155172396|NCT02059291|560071824|FG022|Epoch 3|Lack of Efficacy|0|||
155172397|NCT02059291|560071825|FG023|Epoch 3|Lack of Efficacy|0|||
155172398|NCT02059291|560071826|FG024|Epoch 3|Lack of Efficacy|0|||
155172399|NCT02059291|560071802|FG000|Epoch 3|Withdrawal by Subject|0|||
155172400|NCT02059291|560071803|FG001|Epoch 3|Withdrawal by Subject|0|||
155097606|NCT02266147|559791468|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
155097607|NCT02266147|559791469|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
155097608|NCT00573391|559791473|FG000|Overall Study|study stopped|2|||
155097609|NCT00573391|559791474|FG001|Overall Study|study stopped|2|||
155097610|NCT00573391|559791473|FG000|Overall Study|Death|1|||
155097611|NCT00573391|559791474|FG001|Overall Study|Death|0|||
155097612|NCT03896477|559791477|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
155097613|NCT03896477|559791478|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
155097614|NCT03896477|559791479|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
155097615|NCT03896477|559791477|FG000|Overall Study|Parent Requested Withdrawal|8|||
155172401|NCT02059291|560071804|FG002|Epoch 3|Withdrawal by Subject|0|||
155097616|NCT03896477|559791478|FG001|Overall Study|Parent Requested Withdrawal|12|||
155097617|NCT03896477|559791479|FG002|Overall Study|Parent Requested Withdrawal|9|||
155097618|NCT03896477|559791477|FG000|Overall Study|Adverse Event|0|||
155097619|NCT03896477|559791478|FG001|Overall Study|Adverse Event|0|||
155172402|NCT02059291|560071805|FG003|Epoch 3|Withdrawal by Subject|0|||
155172403|NCT02059291|560071806|FG004|Epoch 3|Withdrawal by Subject|0|||
155172404|NCT02059291|560071807|FG005|Epoch 3|Withdrawal by Subject|0|||
155172405|NCT02059291|560071808|FG006|Epoch 3|Withdrawal by Subject|0|||
154967696|NCT01109849|559305229|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
155097620|NCT03896477|559791479|FG002|Overall Study|Adverse Event|1|||
155097621|NCT03896477|559791477|FG000|Overall Study|Death|1|||
155097622|NCT03896477|559791478|FG001|Overall Study|Death|0|||
155097623|NCT03896477|559791479|FG002|Overall Study|Death|0|||
155097624|NCT03896477|559791477|FG000|Overall Study|Other|5|||
155097625|NCT03896477|559791478|FG001|Overall Study|Other|6|||
154967697|NCT01109849|559305230|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
155097626|NCT03896477|559791479|FG002|Overall Study|Other|7|||
155097627|NCT03896477|559791477|FG000|Overall Study|Lost to Follow-up|2|||
154967698|NCT01109849|559305231|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
154967699|NCT01109849|559305232|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
154967700|NCT01109849|559305233|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
155097628|NCT03896477|559791478|FG001|Overall Study|Lost to Follow-up|1|||
155097629|NCT03896477|559791479|FG002|Overall Study|Lost to Follow-up|1|||
155097630|NCT01882465|559791482|FG000|Period 1|Lens Discomfort|0|||
154967701|NCT01109849|559305229|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
154967702|NCT01109849|559305230|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
154967703|NCT01109849|559305231|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
154967704|NCT01109849|559305232|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
155097631|NCT01882465|559791483|FG001|Period 1|Lens Discomfort|0|||
155097632|NCT01882465|559791484|FG002|Period 1|Lens Discomfort|0|||
154967705|NCT01109849|559305233|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
154967706|NCT03969641|559305234|FG000|Overall Study|Lost to Follow-up|5|||
154967707|NCT03969641|559305235|FG001|Overall Study|Lost to Follow-up|3|||
155097633|NCT01882465|559791485|FG003|Period 1|Lens Discomfort|1|||
155097634|NCT01882465|559791486|FG004|Period 1|Lens Discomfort|0|||
155097635|NCT01882465|559791487|FG005|Period 1|Lens Discomfort|0|||
155097636|NCT01882465|559791488|FG006|Period 1|Lens Discomfort|0|||
155097637|NCT01882465|559791482|FG000|Period 1|Withdrawal by Subject|0|||
155097638|NCT01882465|559791483|FG001|Period 1|Withdrawal by Subject|0|||
155097639|NCT01882465|559791484|FG002|Period 1|Withdrawal by Subject|0|||
155097640|NCT01882465|559791485|FG003|Period 1|Withdrawal by Subject|0|||
155097641|NCT01882465|559791486|FG004|Period 1|Withdrawal by Subject|0|||
155097642|NCT01882465|559791487|FG005|Period 1|Withdrawal by Subject|0|||
155097643|NCT01882465|559791488|FG006|Period 1|Withdrawal by Subject|1|||
154967708|NCT03969641|559305234|FG000|Overall Study|Withdrawal by Subject|1|||
154967709|NCT03969641|559305235|FG001|Overall Study|Withdrawal by Subject|2|||
155097644|NCT01882465|559791482|FG000|Period 2|Protocol Violation|0|||
154967710|NCT03969641|559305234|FG000|Overall Study|Found to be ineligible|1|||
154967711|NCT03969641|559305235|FG001|Overall Study|Found to be ineligible|1|||
154967712|NCT03969641|559305234|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
154967713|NCT03969641|559305235|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
154967714|NCT03969641|559305234|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
154967715|NCT03969641|559305235|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
154967716|NCT03969641|559305234|FG000|Overall Study|Elective termination|0|||
154967717|NCT03969641|559305235|FG001|Overall Study|Elective termination|1|||
154967718|NCT02658019|559305243|FG000|Overall Study|Adverse Event|1|||
154967719|NCT03087786|559305244|FG000|Overall Study|Withdrawal by Subject|2|||
154967720|NCT03087786|559305245|FG001|Overall Study|Withdrawal by Subject|0|||
154967721|NCT00660660|559305246|FG000|Overall Study|Adverse Event|1|||
154967722|NCT00660660|559305247|FG001|Overall Study|Adverse Event|0|||
154967723|NCT00660660|559305246|FG000|Overall Study|Lost to Follow-up|0|||
154967724|NCT00660660|559305247|FG001|Overall Study|Lost to Follow-up|6|||
154967725|NCT00660660|559305246|FG000|Overall Study|Lack of Efficacy|0|||
154967726|NCT00660660|559305247|FG001|Overall Study|Lack of Efficacy|2|||
154967727|NCT00660660|559305246|FG000|Overall Study|Withdrawal by Subject|3|||
154967728|NCT00660660|559305247|FG001|Overall Study|Withdrawal by Subject|0|||
154967729|NCT00660660|559305246|FG000|Overall Study|Incorrect enrollment and other|0|||
154967730|NCT00660660|559305247|FG001|Overall Study|Incorrect enrollment and other|1|||
154967731|NCT00660660|559305246|FG000|Overall Study|New medication after randomization|1|||
154967732|NCT00660660|559305247|FG001|Overall Study|New medication after randomization|0|||
154967733|NCT02450539|559305251|FG000|Overall Study|Withdrawal by Subject|12|||
154967734|NCT02450539|559305252|FG001|Overall Study|Withdrawal by Subject|6|||
154967735|NCT02450539|559305251|FG000|Overall Study|Lost to Follow-up|4|||
154967736|NCT02450539|559305252|FG001|Overall Study|Lost to Follow-up|1|||
154967737|NCT00731939|559305263|FG000|Overall Study|Adverse Event|6|||
154967738|NCT00731939|559305263|FG000|Overall Study|Lost to Follow-up|15|||
154967739|NCT00731939|559305263|FG000|Overall Study|Not implanted with study device|9|||
154967740|NCT00731939|559305263|FG000|Overall Study|Withdrawal by Subject|2|||
154967741|NCT00731939|559305263|FG000|Overall Study|Did not meet enrollment criteria|2|||
154967742|NCT02280863|559305264|FG000|Integrated Platform|Met stopping criteria|0|||
154967743|NCT02280863|559305265|FG001|Integrated Platform|Met stopping criteria|1|||
154967744|NCT02622386|559305268|FG000|First Assignment|Withdrawal by Subject|3|||
154967745|NCT02622386|559305269|FG001|First Assignment|Withdrawal by Subject|2|||
154967746|NCT02622386|559305268|FG000|Washout|Withdrawal by Subject|4|||
154967747|NCT02622386|559305269|FG001|Washout|Withdrawal by Subject|4|||
154967748|NCT02622386|559305268|FG000|Second Assignment|Withdrawal by Subject|0|||
154967749|NCT02622386|559305269|FG001|Second Assignment|Withdrawal by Subject|2|||
154967750|NCT02890992|559305270|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
154967751|NCT02890992|559305271|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
154967752|NCT02890992|559305272|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
154967753|NCT02890992|559305273|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155097645|NCT01882465|559791483|FG001|Period 2|Protocol Violation|0|||
155097646|NCT01882465|559791484|FG002|Period 2|Protocol Violation|0|||
155097647|NCT01882465|559791485|FG003|Period 2|Protocol Violation|0|||
155097648|NCT01882465|559791486|FG004|Period 2|Protocol Violation|1|||
155097649|NCT01882465|559791487|FG005|Period 2|Protocol Violation|0|||
155097650|NCT01882465|559791488|FG006|Period 2|Protocol Violation|0|||
155097651|NCT00532844|559791494|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
155097652|NCT00532844|559791495|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
155097653|NCT00532844|559791494|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
155097654|NCT00532844|559791495|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
155172406|NCT02059291|560071809|FG007|Epoch 3|Withdrawal by Subject|0|||
155097655|NCT00532844|559791494|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
155097656|NCT00532844|559791495|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
155097657|NCT00532844|559791494|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
155097658|NCT00532844|559791495|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
155097659|NCT00532844|559791494|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
155097660|NCT00532844|559791495|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
155097661|NCT03894891|559791496|FG000|Overall Study|Withdrawal by Subject|1|||
154967754|NCT02890992|559305274|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155097662|NCT03894891|559791496|FG000|Overall Study|Completed protocol treatment per protocol|5|||
155097663|NCT04389866|559791497|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
154967755|NCT02890992|559305275|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
154967756|NCT02890992|559305276|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
155172407|NCT02059291|560071810|FG008|Epoch 3|Withdrawal by Subject|0|||
154967757|NCT02890992|559305277|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
154967758|NCT02890992|559305270|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
154967759|NCT02890992|559305271|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
154967760|NCT02890992|559305272|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
154967761|NCT02890992|559305273|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
154967762|NCT02890992|559305274|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
154967763|NCT02890992|559305275|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
154967764|NCT02890992|559305276|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
154967765|NCT02890992|559305277|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
155097664|NCT04389866|559791498|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
155097665|NCT00800982|559791502|FG000|Overall Study|Lost to Follow-up|1|||
155097666|NCT00800982|559791503|FG001|Overall Study|Lost to Follow-up|2|||
155097667|NCT00800982|559791502|FG000|Overall Study|Withdrawal by Subject|0|||
155097668|NCT00800982|559791503|FG001|Overall Study|Withdrawal by Subject|1|||
155097669|NCT00800982|559791502|FG000|Overall Study|Patient moved out of state|1|||
155097670|NCT00800982|559791503|FG001|Overall Study|Patient moved out of state|0|||
155097671|NCT02756403|559791504|FG000|Overall Study|Unable to swallow medication|0|||
155097672|NCT02756403|559791505|FG001|Overall Study|Unable to swallow medication|1|||
155172408|NCT02059291|560071811|FG009|Epoch 3|Withdrawal by Subject|0|||
155172409|NCT02059291|560071812|FG010|Epoch 3|Withdrawal by Subject|0|||
154967766|NCT02890992|559305270|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
155097673|NCT02756403|559791506|FG002|Overall Study|Unable to swallow medication|1|||
155097674|NCT02756403|559791507|FG003|Overall Study|Unable to swallow medication|1|||
155097675|NCT02756403|559791504|FG000|Overall Study|Did not complete Procedure|0|||
155097676|NCT02756403|559791505|FG001|Overall Study|Did not complete Procedure|1|||
155097677|NCT02756403|559791506|FG002|Overall Study|Did not complete Procedure|0|||
155097678|NCT02756403|559791507|FG003|Overall Study|Did not complete Procedure|0|||
155097679|NCT02756403|559791504|FG000|Overall Study|Changed Mind About Procedure|0|||
155097680|NCT02756403|559791505|FG001|Overall Study|Changed Mind About Procedure|0|||
155097681|NCT02756403|559791506|FG002|Overall Study|Changed Mind About Procedure|1|||
155097682|NCT02756403|559791507|FG003|Overall Study|Changed Mind About Procedure|0|||
155097683|NCT02756403|559791504|FG000|Overall Study|Protocol Violation|0|||
155097684|NCT02756403|559791505|FG001|Overall Study|Protocol Violation|1|||
155097685|NCT02756403|559791506|FG002|Overall Study|Protocol Violation|0|||
155097686|NCT02756403|559791507|FG003|Overall Study|Protocol Violation|1|||
155097687|NCT01644643|559791508|FG000|Overall Study|Death|1|||
155097688|NCT01644643|559791509|FG001|Overall Study|Death|0|||
155097689|NCT01644643|559791510|FG002|Overall Study|Death|3|||
155097690|NCT01644643|559791511|FG003|Overall Study|Death|3|||
155097691|NCT01644643|559791508|FG000|Overall Study|Lost to Follow-up|0|||
155097692|NCT01644643|559791509|FG001|Overall Study|Lost to Follow-up|0|||
155097693|NCT01644643|559791510|FG002|Overall Study|Lost to Follow-up|0|||
155097694|NCT01644643|559791511|FG003|Overall Study|Lost to Follow-up|4|||
155097695|NCT01644643|559791508|FG000|Overall Study|Withdrawal by Subject|1|||
155097696|NCT01644643|559791509|FG001|Overall Study|Withdrawal by Subject|0|||
155097697|NCT01644643|559791510|FG002|Overall Study|Withdrawal by Subject|2|||
155097698|NCT01644643|559791511|FG003|Overall Study|Withdrawal by Subject|1|||
155097699|NCT01644643|559791508|FG000|Overall Study|Other Eligibility criteria|0|||
155097700|NCT01644643|559791509|FG001|Overall Study|Other Eligibility criteria|0|||
155097701|NCT01644643|559791510|FG002|Overall Study|Other Eligibility criteria|0|||
155097702|NCT01644643|559791511|FG003|Overall Study|Other Eligibility criteria|2|||
155097703|NCT00527618|559791512|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
155097704|NCT00527618|559791513|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
155097705|NCT00527618|559791512|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
155097706|NCT00527618|559791513|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
155097707|NCT00527618|559791512|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
155097708|NCT00527618|559791513|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
155097709|NCT00527618|559791512|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
155097710|NCT00527618|559791513|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
155097711|NCT00527618|559791512|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
155097712|NCT00527618|559791513|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
155097713|NCT00527618|559791512|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
155097714|NCT00527618|559791513|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
155097715|NCT01490918|559791516|FG000|Overall Study|Lost to Follow-up|2|||
155097716|NCT01490918|559791517|FG001|Overall Study|Lost to Follow-up|1|||
155097717|NCT01490918|559791518|FG002|Overall Study|Lost to Follow-up|0|||
155097718|NCT01490918|559791516|FG000|Overall Study|Withdrawal by Subject|7|||
155097719|NCT01490918|559791517|FG001|Overall Study|Withdrawal by Subject|8|||
155172410|NCT02059291|560071813|FG011|Epoch 3|Withdrawal by Subject|0|||
155097720|NCT01490918|559791518|FG002|Overall Study|Withdrawal by Subject|3|||
155097721|NCT01490918|559791516|FG000|Overall Study|Adverse Event|0|||
155097722|NCT01490918|559791517|FG001|Overall Study|Adverse Event|0|||
155097723|NCT01490918|559791518|FG002|Overall Study|Adverse Event|1|||
155097724|NCT01490918|559791516|FG000|Overall Study|other cause|4|||
155097725|NCT01490918|559791517|FG001|Overall Study|other cause|5|||
155097726|NCT01490918|559791518|FG002|Overall Study|other cause|8|||
155097727|NCT00648037|559791521|FG000|Overall Study|Not Treated|1|||
155097728|NCT00648037|559791521|FG000|Overall Study|Withdrawal by Subject|1|||
155097729|NCT00648037|559791521|FG000|Overall Study|Adverse Event|11|||
155097730|NCT00648037|559791521|FG000|Overall Study|Relapse|2|||
155097731|NCT00648037|559791521|FG000|Overall Study|Other|1|||
155097732|NCT00846846|559791522|FG000|Overall Study|Death|56|||
155097733|NCT00846846|559791522|FG000|Overall Study|Withdrawal by Subject|19|||
155097734|NCT02103062|559791541|FG000|Overall Study|Adverse Event|1|||
155097735|NCT02103062|559791542|FG001|Overall Study|Adverse Event|2|||
155097736|NCT02103062|559791541|FG000|Overall Study|Progressive Disease|17|||
155097737|NCT02103062|559791542|FG001|Overall Study|Progressive Disease|20|||
155097738|NCT02103062|559791541|FG000|Overall Study|Death|0|||
155097739|NCT02103062|559791542|FG001|Overall Study|Death|1|||
155097740|NCT02629861|559791556|FG000|Overall Study|Adverse Event|7|||
155097741|NCT02629861|559791557|FG001|Overall Study|Adverse Event|5|||
155097742|NCT02629861|559791558|FG002|Overall Study|Adverse Event|4|||
155097743|NCT02629861|559791556|FG000|Overall Study|Withdrawal by Subject|5|||
155097744|NCT02629861|559791557|FG001|Overall Study|Withdrawal by Subject|8|||
155097745|NCT02629861|559791558|FG002|Overall Study|Withdrawal by Subject|13|||
155097746|NCT02629861|559791556|FG000|Overall Study|Protocol Violation|2|||
155097747|NCT02629861|559791557|FG001|Overall Study|Protocol Violation|3|||
155097748|NCT02629861|559791558|FG002|Overall Study|Protocol Violation|7|||
155097749|NCT02629861|559791556|FG000|Overall Study|Lost to Follow-up|12|||
155097750|NCT02629861|559791557|FG001|Overall Study|Lost to Follow-up|9|||
155097751|NCT02629861|559791558|FG002|Overall Study|Lost to Follow-up|4|||
155097752|NCT02629861|559791556|FG000|Overall Study|Other|1|||
155097753|NCT02629861|559791557|FG001|Overall Study|Other|1|||
155097754|NCT02629861|559791558|FG002|Overall Study|Other|0|||
155097755|NCT02629861|559791556|FG000|Overall Study|Pregnancy|2|||
155097756|NCT02629861|559791557|FG001|Overall Study|Pregnancy|1|||
155097757|NCT02629861|559791558|FG002|Overall Study|Pregnancy|0|||
155097758|NCT00959907|559791559|FG000|Overall Study|Protocol Violation|0|||
155097759|NCT00959907|559791560|FG001|Overall Study|Protocol Violation|1|||
155097760|NCT00959907|559791559|FG000|Overall Study|Adverse Event|1|||
155097761|NCT00959907|559791560|FG001|Overall Study|Adverse Event|0|||
155097762|NCT00959907|559791559|FG000|Overall Study|Withdrawal by Subject|2|||
155097763|NCT00959907|559791560|FG001|Overall Study|Withdrawal by Subject|0|||
155097764|NCT03958331|559791561|FG000|Overall Study|Withdrawal by Subject|3|||
155097765|NCT03958331|559791562|FG001|Overall Study|Withdrawal by Subject|1|||
155097766|NCT03958331|559791563|FG002|Overall Study|Withdrawal by Subject|5|||
155097767|NCT03958331|559791561|FG000|Overall Study|Weaned from medicine|2|||
155097768|NCT03958331|559791562|FG001|Overall Study|Weaned from medicine|0|||
155097769|NCT03958331|559791563|FG002|Overall Study|Weaned from medicine|0|||
155097770|NCT03958331|559791561|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
155097771|NCT03958331|559791562|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
155097772|NCT03958331|559791563|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
155097773|NCT01991483|559791564|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
155097774|NCT01991483|559791565|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
155097775|NCT01991483|559791566|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
155097776|NCT01991483|559791567|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
155097777|NCT01991483|559791564|FG000|Dose Level 600 mg|Physician Decision|0|||
155097778|NCT01991483|559791565|FG001|Dose Level 600 mg|Physician Decision|0|||
155097779|NCT01991483|559791566|FG002|Dose Level 600 mg|Physician Decision|1|||
155097780|NCT01991483|559791567|FG003|Dose Level 600 mg|Physician Decision|0|||
155097781|NCT01991483|559791564|FG000|Dose Level 1000 mg|Protocol Violation|0|||
155097782|NCT01991483|559791565|FG001|Dose Level 1000 mg|Protocol Violation|0|||
154967767|NCT02890992|559305271|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
155172411|NCT02059291|560071814|FG012|Epoch 3|Withdrawal by Subject|0|||
155097783|NCT01991483|559791566|FG002|Dose Level 1000 mg|Protocol Violation|0|||
155097784|NCT01991483|559791567|FG003|Dose Level 1000 mg|Protocol Violation|1|||
155097785|NCT02030821|559791570|FG000|Overall Study|Physician Decision|2|||
155097786|NCT02030821|559791571|FG001|Overall Study|Physician Decision|2|||
155097787|NCT02030821|559791572|FG002|Overall Study|Physician Decision|5|||
155097788|NCT02030821|559791573|FG003|Overall Study|Physician Decision|2|||
155097789|NCT02549989|559793083|FG000|Overall Study|Adverse Event|4|||
155097790|NCT02549989|559793083|FG000|Overall Study|Death|1|||
155097791|NCT02549989|559793083|FG000|Overall Study|Lack of Efficacy|19|||
155097792|NCT02549989|559793083|FG000|Overall Study|Withdrawal by Subject|3|||
155097793|NCT01772550|559793087|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
155097794|NCT01772550|559793088|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
155097795|NCT01772550|559793089|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
155097796|NCT01772550|559793087|FG000|Overall Study|Adverse Event|0|||
155097797|NCT01772550|559793088|FG001|Overall Study|Adverse Event|0|||
155097798|NCT01772550|559793089|FG002|Overall Study|Adverse Event|1|||
155097799|NCT00559104|559793090|FG000|Overall Study|Lack of Efficacy|9|||
154967768|NCT02890992|559305272|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
155097800|NCT00559104|559793091|FG001|Overall Study|Lack of Efficacy|0|||
155097801|NCT04723355|559793092|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
154967769|NCT02890992|559305273|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
154967770|NCT02890992|559305274|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
154967771|NCT02890992|559305275|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
155097802|NCT04723355|559793092|FG000|Overall Study|Errors in the informed consent form|2|||
155097803|NCT03374358|559793093|FG000|Overall Study|Withdrawal by Subject|0|||
155172412|NCT02059291|560071815|FG013|Epoch 3|Withdrawal by Subject|0|||
155097804|NCT03374358|559793094|FG001|Overall Study|Withdrawal by Subject|2|||
155097805|NCT01127633|559793095|FG000|Overall Study|Adverse Event|74|||
154967772|NCT02890992|559305276|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
155172413|NCT02059291|560071816|FG014|Epoch 3|Withdrawal by Subject|0|||
155172414|NCT02059291|560071817|FG015|Epoch 3|Withdrawal by Subject|1|||
154967773|NCT02890992|559305277|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
154967774|NCT03236311|559305278|FG000|Overall Study|Study terminated by sponsor|0|||
154967775|NCT03236311|559305279|FG001|Overall Study|Study terminated by sponsor|2|||
154967776|NCT03236311|559305278|FG000|Overall Study|Adverse Event|0|||
154967777|NCT03236311|559305279|FG001|Overall Study|Adverse Event|1|||
154967778|NCT00669162|559305280|FG000|Overall Study|Withdrawal by Subject|1|||
154967779|NCT02704091|559305281|FG000|Overall Study|Adverse Event|4|||
154967780|NCT02704091|559305282|FG001|Overall Study|Adverse Event|3|||
154967781|NCT02704091|559305281|FG000|Overall Study|Protocol Violation|5|||
154967782|NCT02704091|559305282|FG001|Overall Study|Protocol Violation|3|||
154967783|NCT02704091|559305281|FG000|Overall Study|Consent withdrawn|4|||
154967784|NCT02704091|559305282|FG001|Overall Study|Consent withdrawn|4|||
154967785|NCT02704091|559305281|FG000|Overall Study|Lost to Follow-up|13|||
154967786|NCT02704091|559305282|FG001|Overall Study|Lost to Follow-up|5|||
154967787|NCT02704091|559305281|FG000|Overall Study|Other|2|||
154967788|NCT02704091|559305282|FG001|Overall Study|Other|8|||
154967789|NCT05274763|559305283|FG000|Overall Study|Lost to Follow-up|1|||
154967790|NCT01174186|559305284|FG000|Overall Study|Lost to Follow-up|0|||
154967791|NCT01174186|559305285|FG001|Overall Study|Lost to Follow-up|1|||
154967792|NCT01174186|559305284|FG000|Overall Study|Withdrawal by Subject|0|||
154967793|NCT01174186|559305285|FG001|Overall Study|Withdrawal by Subject|2|||
154967794|NCT01051349|559305286|FG000|Overall Study|Adverse Event|88|||
154967795|NCT01051349|559305286|FG000|Overall Study|Consent Withdrawn|54|||
154967796|NCT01051349|559305286|FG000|Overall Study|Investigator Decision|6|||
154967797|NCT01051349|559305286|FG000|Overall Study|Lost to Follow-up|6|||
154967798|NCT01051349|559305286|FG000|Overall Study|Subject non-compliance|7|||
154967799|NCT01051349|559305286|FG000|Overall Study|Reason not Specified|12|||
154967800|NCT00484679|559305287|FG000|Overall Study|Withdrawal by Subject|3|||
154967801|NCT00402103|559305288|FG000|Overall Study|Adverse Event|60|||
154967802|NCT00402103|559305289|FG001|Overall Study|Adverse Event|7|||
154967803|NCT00402103|559305288|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154967804|NCT00402103|559305289|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
154967805|NCT00402103|559305288|FG000|Overall Study|Condition no longer requires study drug|2|||
154967806|NCT00402103|559305289|FG001|Overall Study|Condition no longer requires study drug|0|||
154967807|NCT00402103|559305288|FG000|Overall Study|Protocol Deviation|8|||
154967808|NCT00402103|559305289|FG001|Overall Study|Protocol Deviation|0|||
154967809|NCT00402103|559305288|FG000|Overall Study|Patient withdrew consent|12|||
154967810|NCT00402103|559305289|FG001|Overall Study|Patient withdrew consent|1|||
154967811|NCT00402103|559305288|FG000|Overall Study|Lost to Follow-up|6|||
155097806|NCT01127633|559793096|FG001|Overall Study|Adverse Event|73|||
155097807|NCT01127633|559793095|FG000|Overall Study|Death|40|||
154967812|NCT00402103|559305289|FG001|Overall Study|Lost to Follow-up|3|||
154967813|NCT00402103|559305288|FG000|Overall Study|Administrative problems|2|||
154967814|NCT00402103|559305289|FG001|Overall Study|Administrative problems|0|||
154967815|NCT00418145|559305292|FG000|Overall Study|study terminated|6|||
154967816|NCT00425308|559305293|FG000|Overall Study|Adverse Event|2|||
155097808|NCT01127633|559793096|FG001|Overall Study|Death|43|||
155097809|NCT01127633|559793095|FG000|Overall Study|Lost to Follow-up|4|||
155097810|NCT01127633|559793096|FG001|Overall Study|Lost to Follow-up|0|||
155097811|NCT01127633|559793095|FG000|Overall Study|Parent/Caregiver Decision|246|||
155097812|NCT01127633|559793096|FG001|Overall Study|Parent/Caregiver Decision|228|||
155097813|NCT01127633|559793095|FG000|Overall Study|Physician Decision|60|||
155097814|NCT01127633|559793096|FG001|Overall Study|Physician Decision|45|||
155097815|NCT01127633|559793095|FG000|Overall Study|Withdrawal by Subject|57|||
155097816|NCT01127633|559793096|FG001|Overall Study|Withdrawal by Subject|72|||
155097817|NCT01127633|559793095|FG000|Overall Study|Sponsor Decision|163|||
155097818|NCT01127633|559793096|FG001|Overall Study|Sponsor Decision|195|||
155097819|NCT01127633|559793095|FG000|Overall Study|Protocol Violation|8|||
155097820|NCT01127633|559793096|FG001|Overall Study|Protocol Violation|16|||
155097821|NCT01127633|559793095|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
155097822|NCT01127633|559793096|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
155097823|NCT01127633|559793095|FG000|Overall Study|Not treated|1|||
155172415|NCT02059291|560071818|FG016|Epoch 3|Withdrawal by Subject|0|||
154967817|NCT00425308|559305294|FG001|Overall Study|Adverse Event|1|||
154967818|NCT00425308|559305293|FG000|Overall Study|Withdrawal by Subject|1|||
154967819|NCT00425308|559305294|FG001|Overall Study|Withdrawal by Subject|0|||
154967820|NCT00425308|559305293|FG000|Overall Study|Death|1|||
155172416|NCT02059291|560071819|FG017|Epoch 3|Withdrawal by Subject|0|||
155172417|NCT02059291|560071820|FG018|Epoch 3|Withdrawal by Subject|0|||
155172418|NCT02059291|560071821|FG019|Epoch 3|Withdrawal by Subject|0|||
155172419|NCT02059291|560071822|FG020|Epoch 3|Withdrawal by Subject|0|||
155172420|NCT02059291|560071823|FG021|Epoch 3|Withdrawal by Subject|0|||
155172421|NCT02059291|560071824|FG022|Epoch 3|Withdrawal by Subject|0|||
155172422|NCT02059291|560071825|FG023|Epoch 3|Withdrawal by Subject|0|||
155172423|NCT02059291|560071826|FG024|Epoch 3|Withdrawal by Subject|0|||
155172424|NCT02059291|560071802|FG000|Epoch 4|Adverse Event|0|||
155172425|NCT02059291|560071803|FG001|Epoch 4|Adverse Event|0|||
155172426|NCT02059291|560071804|FG002|Epoch 4|Adverse Event|0|||
155172427|NCT02059291|560071805|FG003|Epoch 4|Adverse Event|0|||
155172428|NCT02059291|560071806|FG004|Epoch 4|Adverse Event|0|||
155172429|NCT02059291|560071807|FG005|Epoch 4|Adverse Event|0|||
154967821|NCT00425308|559305294|FG001|Overall Study|Death|0|||
154967822|NCT00463684|559305299|FG000|Overall Study|Withdrawal by Subject|1|||
155172430|NCT02059291|560071808|FG006|Epoch 4|Adverse Event|0|||
155172431|NCT02059291|560071809|FG007|Epoch 4|Adverse Event|0|||
155172432|NCT02059291|560071810|FG008|Epoch 4|Adverse Event|0|||
155172433|NCT02059291|560071811|FG009|Epoch 4|Adverse Event|0|||
155172434|NCT02059291|560071812|FG010|Epoch 4|Adverse Event|0|||
154967823|NCT00463684|559305299|FG000|Overall Study|Lost to Follow-up|3|||
154967824|NCT01075282|559305301|FG000|Overall Study|Withdrawal by Subject|11|||
154967825|NCT01075282|559305302|FG001|Overall Study|Withdrawal by Subject|7|||
154967826|NCT01075282|559305303|FG002|Overall Study|Withdrawal by Subject|11|||
154967827|NCT01075282|559305301|FG000|Overall Study|Adverse Event|9|||
154967828|NCT01075282|559305302|FG001|Overall Study|Adverse Event|8|||
154967829|NCT01075282|559305303|FG002|Overall Study|Adverse Event|5|||
154967830|NCT01075282|559305301|FG000|Overall Study|Entry Criteria Not Met|3|||
155097824|NCT01127633|559793096|FG001|Overall Study|Not treated|0|||
155097825|NCT00399568|559793098|FG000|Overall Study|Adverse Event|1|||
155097826|NCT00399568|559793099|FG001|Overall Study|Adverse Event|2|||
155097827|NCT00399568|559793098|FG000|Overall Study|Withdrawal by Subject|7|||
155097828|NCT00399568|559793099|FG001|Overall Study|Withdrawal by Subject|3|||
155097829|NCT00399568|559793098|FG000|Overall Study|Protocol non-compliance|2|||
155097830|NCT00399568|559793099|FG001|Overall Study|Protocol non-compliance|2|||
155097831|NCT00399568|559793098|FG000|Overall Study|Lost to Follow-up|2|||
155097832|NCT00399568|559793099|FG001|Overall Study|Lost to Follow-up|2|||
155097833|NCT00420381|559793105|FG000|Overall Study|Protocol Violation|1|||
155097834|NCT03432494|559793106|FG000|Overall Study|Death|1|||
155097835|NCT03432494|559793106|FG000|Overall Study|Noncompliance|1|||
155097836|NCT00775268|559793107|FG000|Baseline|Drug not synthesize dose|1|||
155097837|NCT00775268|559793108|FG001|Baseline|Drug not synthesize dose|0|||
155097838|NCT00775268|559793107|FG000|Baseline|Not treated-ineligible per CT|0|||
155097839|NCT00775268|559793108|FG001|Baseline|Not treated-ineligible per CT|1|||
155097840|NCT00775268|559793107|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
155097841|NCT00775268|559793108|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
155097842|NCT00775268|559793107|FG000|After Completion|Participant missed scan appointment|1|||
155097843|NCT00775268|559793108|FG001|After Completion|Participant missed scan appointment|0|||
155172435|NCT02059291|560071813|FG011|Epoch 4|Adverse Event|0|||
155172436|NCT02059291|560071814|FG012|Epoch 4|Adverse Event|0|||
154967831|NCT01075282|559305302|FG001|Overall Study|Entry Criteria Not Met|2|||
155097844|NCT00592631|559793109|FG000|Overall Study|Lost to Follow-up|0|||
155097845|NCT00592631|559793110|FG001|Overall Study|Lost to Follow-up|2|||
155097846|NCT01244035|559793111|FG000|Part 1: Period 1|Adverse Event|0|||
155097847|NCT01244035|559793112|FG001|Part 1: Period 1|Adverse Event|0|||
155097848|NCT01244035|559793113|FG002|Part 1: Period 1|Adverse Event|0|||
155097849|NCT01244035|559793114|FG003|Part 1: Period 1|Adverse Event|0|||
155097850|NCT01244035|559793115|FG004|Part 1: Period 1|Adverse Event|0|||
155172437|NCT02059291|560071815|FG013|Epoch 4|Adverse Event|0|||
155097851|NCT01244035|559793116|FG005|Part 1: Period 1|Adverse Event|1|||
155097852|NCT01244035|559793111|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
155097853|NCT01244035|559793112|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
155097854|NCT01244035|559793113|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
154967832|NCT01075282|559305303|FG002|Overall Study|Entry Criteria Not Met|0|||
155097855|NCT01244035|559793114|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
155097856|NCT01244035|559793115|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
155097857|NCT01244035|559793116|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
155097858|NCT01244035|559793111|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
155097859|NCT01244035|559793112|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
155097860|NCT01244035|559793113|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
155097861|NCT01244035|559793114|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
155097862|NCT01244035|559793115|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
155097863|NCT01244035|559793116|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
155097864|NCT01244035|559793111|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155097865|NCT01244035|559793112|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
154967833|NCT01075282|559305301|FG000|Overall Study|Lost to Follow-up|3|||
155172438|NCT02059291|560071816|FG014|Epoch 4|Adverse Event|0|||
155097866|NCT01244035|559793113|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
155097867|NCT01244035|559793114|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155097868|NCT01244035|559793115|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155172439|NCT02059291|560071817|FG015|Epoch 4|Adverse Event|0|||
155097869|NCT01244035|559793116|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
155097870|NCT01244035|559793111|FG000|Part 1: Period 3|Adverse Event|0|||
155097871|NCT01244035|559793112|FG001|Part 1: Period 3|Adverse Event|0|||
155097872|NCT01244035|559793113|FG002|Part 1: Period 3|Adverse Event|0|||
155097873|NCT01244035|559793114|FG003|Part 1: Period 3|Adverse Event|0|||
155097874|NCT01244035|559793115|FG004|Part 1: Period 3|Adverse Event|0|||
155097875|NCT01244035|559793116|FG005|Part 1: Period 3|Adverse Event|1|||
155172440|NCT02059291|560071818|FG016|Epoch 4|Adverse Event|1|||
154967834|NCT01075282|559305302|FG001|Overall Study|Lost to Follow-up|3|||
154967835|NCT01075282|559305303|FG002|Overall Study|Lost to Follow-up|3|||
154967836|NCT01075282|559305301|FG000|Overall Study|Physician Decision|3|||
155097876|NCT01244035|559793111|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
155097877|NCT01244035|559793112|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
155097878|NCT01244035|559793113|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
155097879|NCT01244035|559793114|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
155097880|NCT01244035|559793115|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
155172441|NCT02059291|560071819|FG017|Epoch 4|Adverse Event|0|||
155172442|NCT02059291|560071820|FG018|Epoch 4|Adverse Event|0|||
155172443|NCT02059291|560071821|FG019|Epoch 4|Adverse Event|0|||
155172444|NCT02059291|560071822|FG020|Epoch 4|Adverse Event|0|||
155097881|NCT01244035|559793116|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
155097882|NCT01244035|559793111|FG000|Part 1: Period 3|Protocol Deviation|0|||
155097883|NCT01244035|559793112|FG001|Part 1: Period 3|Protocol Deviation|1|||
155097884|NCT01244035|559793113|FG002|Part 1: Period 3|Protocol Deviation|0|||
155097885|NCT01244035|559793114|FG003|Part 1: Period 3|Protocol Deviation|0|||
155097886|NCT01244035|559793115|FG004|Part 1: Period 3|Protocol Deviation|0|||
155097887|NCT01244035|559793116|FG005|Part 1: Period 3|Protocol Deviation|0|||
155097888|NCT00374595|559793117|FG000|Overall Study|Death|23|||
155097889|NCT00374595|559793117|FG000|Overall Study|Withdrawal by Subject|39|||
155097890|NCT00374595|559793117|FG000|Overall Study|Lost to Follow-up|3|||
155097891|NCT00374595|559793117|FG000|Overall Study|too much time commitment|1|||
155097892|NCT00374595|559793117|FG000|Overall Study|transfer care to other clinical site|1|||
155097893|NCT00374595|559793117|FG000|Overall Study|relocation|3|||
155097894|NCT03745768|559793119|FG000|Overall Study|discontinued study|2|||
155097895|NCT03745768|559793120|FG001|Overall Study|discontinued study|0|||
155097896|NCT00443118|559793121|FG000|Overall Study|unknown primary outcome|3|||
155097897|NCT00443118|559793122|FG001|Overall Study|unknown primary outcome|1|||
155097898|NCT00443118|559793123|FG002|Overall Study|unknown primary outcome|0|||
155097899|NCT00443118|559793121|FG000|Overall Study|Withdrawal by Subject|1|||
155097900|NCT00443118|559793122|FG001|Overall Study|Withdrawal by Subject|0|||
155097901|NCT00443118|559793123|FG002|Overall Study|Withdrawal by Subject|0|||
155097902|NCT00400517|559793131|FG000|Overall Study|Withdrawal by Subject|1|||
155097903|NCT00400517|559793131|FG000|Overall Study|Physician Decision|1|||
155097904|NCT01106157|559793132|FG000|Overall Study|Withdrawal by Subject|1|||
155097905|NCT01106157|559793133|FG001|Overall Study|Withdrawal by Subject|0|||
155097906|NCT01881009|559793137|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
155097907|NCT01881009|559793138|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
155097908|NCT02298868|559793139|FG000|Overall Study|Adverse Event|1|||
155097909|NCT02298868|559793139|FG000|Overall Study|Death|1|||
155097910|NCT02298868|559793139|FG000|Overall Study|Patient underwent transplant|1|||
155097911|NCT01063348|559793140|FG000|Overall Study|Lost to Follow-up|3|||
155097912|NCT01063348|559793141|FG001|Overall Study|Lost to Follow-up|10|||
155097913|NCT01194245|559793142|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
155097914|NCT01194245|559793143|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155097915|NCT01194245|559793144|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155097916|NCT01194245|559793145|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155097917|NCT01194245|559793146|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
155097918|NCT01194245|559793142|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
155097919|NCT01194245|559793143|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155097920|NCT01194245|559793144|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155097921|NCT01194245|559793145|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155097922|NCT01194245|559793146|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
155097923|NCT01194245|559793142|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
155097924|NCT01194245|559793143|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155097925|NCT01194245|559793144|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155097926|NCT01194245|559793145|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155097927|NCT01194245|559793146|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
155097928|NCT01194245|559793142|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
154967837|NCT01075282|559305302|FG001|Overall Study|Physician Decision|3|||
154967838|NCT01075282|559305303|FG002|Overall Study|Physician Decision|3|||
155097929|NCT01194245|559793143|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155097930|NCT01194245|559793144|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155172445|NCT02059291|560071823|FG021|Epoch 4|Adverse Event|0|||
154967839|NCT01075282|559305301|FG000|Overall Study|Lack of Efficacy|1|||
155097931|NCT01194245|559793145|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155097932|NCT01194245|559793146|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
155097933|NCT01194245|559793142|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155097934|NCT01194245|559793143|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155097935|NCT01194245|559793144|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155097936|NCT01194245|559793145|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155097937|NCT01194245|559793146|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
155097938|NCT01194245|559793142|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155097939|NCT01194245|559793143|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155097940|NCT01194245|559793144|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
155097941|NCT01194245|559793145|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
155097942|NCT01194245|559793146|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
155097943|NCT01118780|559793147|FG000|Overall Study|Adverse Event|15|||
155097944|NCT01118780|559793148|FG001|Overall Study|Adverse Event|15|||
155097945|NCT01118780|559793147|FG000|Overall Study|Death|1|||
155097946|NCT01118780|559793148|FG001|Overall Study|Death|0|||
155097947|NCT01118780|559793147|FG000|Overall Study|Lack of Efficacy|2|||
155097948|NCT01118780|559793148|FG001|Overall Study|Lack of Efficacy|6|||
155097949|NCT01118780|559793147|FG000|Overall Study|Physician Decision|2|||
155097950|NCT01118780|559793148|FG001|Overall Study|Physician Decision|0|||
155097951|NCT01118780|559793147|FG000|Overall Study|Protocol Violation|3|||
155097952|NCT01118780|559793148|FG001|Overall Study|Protocol Violation|6|||
155097953|NCT01118780|559793147|FG000|Overall Study|Withdrawal by Subject|13|||
155097954|NCT01118780|559793148|FG001|Overall Study|Withdrawal by Subject|8|||
155097955|NCT03962855|559793151|FG000|Overall Study|Death|0|||
155097956|NCT03962855|559793152|FG001|Overall Study|Death|1|||
155097957|NCT03962855|559793151|FG000|Overall Study|Lost to Follow-up|0|||
155172446|NCT02059291|560071824|FG022|Epoch 4|Adverse Event|1|||
155172447|NCT02059291|560071825|FG023|Epoch 4|Adverse Event|0|||
155172448|NCT02059291|560071826|FG024|Epoch 4|Adverse Event|0|||
155172449|NCT02059291|560071802|FG000|Epoch 4|Pregnancy|0|||
154967840|NCT01075282|559305302|FG001|Overall Study|Lack of Efficacy|1|||
155172450|NCT02059291|560071803|FG001|Epoch 4|Pregnancy|0|||
155172451|NCT02059291|560071804|FG002|Epoch 4|Pregnancy|0|||
155172452|NCT02059291|560071805|FG003|Epoch 4|Pregnancy|0|||
155172453|NCT02059291|560071806|FG004|Epoch 4|Pregnancy|0|||
155172454|NCT02059291|560071807|FG005|Epoch 4|Pregnancy|0|||
155172455|NCT02059291|560071808|FG006|Epoch 4|Pregnancy|0|||
154967841|NCT01075282|559305303|FG002|Overall Study|Lack of Efficacy|0|||
155097958|NCT03962855|559793152|FG001|Overall Study|Lost to Follow-up|1|||
155097959|NCT03962855|559793151|FG000|Overall Study|Adverse Event|0|||
155097960|NCT03962855|559793152|FG001|Overall Study|Adverse Event|1|||
155097961|NCT03962855|559793151|FG000|Overall Study|Physician Decision|0|||
155097962|NCT03962855|559793152|FG001|Overall Study|Physician Decision|2|||
155097963|NCT02457247|559793153|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
155097964|NCT02457247|559793154|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
155097965|NCT02457247|559793155|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
155097966|NCT02457247|559793156|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
155097967|NCT02457247|559793153|FG000|Period 1|Significant Protocol Deviation|1|||
155097968|NCT02457247|559793154|FG001|Period 1|Significant Protocol Deviation|1|||
155097969|NCT02457247|559793155|FG002|Period 1|Significant Protocol Deviation|0|||
155097970|NCT02457247|559793156|FG003|Period 1|Significant Protocol Deviation|0|||
155097971|NCT02457247|559793153|FG000|Period 1|Voluntary Withdrawal|1|||
155097972|NCT02457247|559793154|FG001|Period 1|Voluntary Withdrawal|0|||
155097973|NCT02457247|559793155|FG002|Period 1|Voluntary Withdrawal|0|||
155097974|NCT02457247|559793156|FG003|Period 1|Voluntary Withdrawal|0|||
155097975|NCT02457247|559793153|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
155097976|NCT02457247|559793154|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
155097977|NCT02457247|559793155|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
155097978|NCT02457247|559793156|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
155097979|NCT02457247|559793153|FG000|Period 2|Significant Protocol Deviation|1|||
155097980|NCT02457247|559793154|FG001|Period 2|Significant Protocol Deviation|0|||
155097981|NCT02457247|559793155|FG002|Period 2|Significant Protocol Deviation|0|||
155172456|NCT02059291|560071809|FG007|Epoch 4|Pregnancy|0|||
155172457|NCT02059291|560071810|FG008|Epoch 4|Pregnancy|0|||
155097982|NCT02457247|559793156|FG003|Period 2|Significant Protocol Deviation|0|||
155097983|NCT02457247|559793153|FG000|Period 2|Lost to Follow-up|0|||
155097984|NCT02457247|559793154|FG001|Period 2|Lost to Follow-up|1|||
155172458|NCT02059291|560071811|FG009|Epoch 4|Pregnancy|0|||
155097985|NCT02457247|559793155|FG002|Period 2|Lost to Follow-up|0|||
155097986|NCT02457247|559793156|FG003|Period 2|Lost to Follow-up|0|||
155097987|NCT02457247|559793153|FG000|Period 2|Voluntary Withdrawal|1|||
155097988|NCT02457247|559793154|FG001|Period 2|Voluntary Withdrawal|1|||
155097989|NCT02457247|559793155|FG002|Period 2|Voluntary Withdrawal|0|||
155097990|NCT02457247|559793156|FG003|Period 2|Voluntary Withdrawal|0|||
155097991|NCT03326063|559793157|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
155097992|NCT03326063|559793158|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
155097993|NCT02216526|559793161|FG000|Overall Study|Adverse Event|1|||
155097994|NCT02216526|559793162|FG001|Overall Study|Adverse Event|1|||
155097995|NCT02216526|559793163|FG002|Overall Study|Adverse Event|0|||
155097996|NCT02216526|559793161|FG000|Overall Study|Death|0|||
155097997|NCT02216526|559793162|FG001|Overall Study|Death|1|||
155097998|NCT02216526|559793163|FG002|Overall Study|Death|3|||
155097999|NCT02216526|559793161|FG000|Overall Study|Protocol Violation|2|||
155098000|NCT02216526|559793162|FG001|Overall Study|Protocol Violation|0|||
155098001|NCT02216526|559793163|FG002|Overall Study|Protocol Violation|2|||
155098002|NCT02216526|559793161|FG000|Overall Study|Hospitalization|2|||
155098003|NCT02216526|559793162|FG001|Overall Study|Hospitalization|1|||
155098004|NCT02216526|559793163|FG002|Overall Study|Hospitalization|3|||
155098005|NCT02750514|559793164|FG000|Track 1|Disease progression|20|||
155098006|NCT02750514|559793165|FG001|Track 1|Disease progression|1|||
155098007|NCT02750514|559793166|FG002|Track 1|Disease progression|0|||
155098008|NCT02750514|559793167|FG003|Track 1|Disease progression|1|||
155098009|NCT02750514|559793168|FG004|Track 1|Disease progression|0|||
155098010|NCT02750514|559793164|FG000|Track 1|Adverse event unrelated to study drug|1|||
155098011|NCT02750514|559793165|FG001|Track 1|Adverse event unrelated to study drug|0|||
155098012|NCT02750514|559793166|FG002|Track 1|Adverse event unrelated to study drug|0|||
155098013|NCT02750514|559793167|FG003|Track 1|Adverse event unrelated to study drug|0|||
155098014|NCT02750514|559793168|FG004|Track 1|Adverse event unrelated to study drug|0|||
155098015|NCT02750514|559793164|FG000|Track 1|Study drug toxicity|4|||
154967842|NCT01075282|559305301|FG000|Overall Study|Treatment Non-compliance|1|||
155098016|NCT02750514|559793165|FG001|Track 1|Study drug toxicity|1|||
155098017|NCT02750514|559793166|FG002|Track 1|Study drug toxicity|0|||
155098018|NCT02750514|559793167|FG003|Track 1|Study drug toxicity|1|||
155098019|NCT02750514|559793168|FG004|Track 1|Study drug toxicity|0|||
155098020|NCT02750514|559793164|FG000|Track 1|Participant request to discontinue|1|||
155098021|NCT02750514|559793165|FG001|Track 1|Participant request to discontinue|0|||
155098022|NCT02750514|559793166|FG002|Track 1|Participant request to discontinue|0|||
154967843|NCT01075282|559305302|FG001|Overall Study|Treatment Non-compliance|2|||
155098023|NCT02750514|559793167|FG003|Track 1|Participant request to discontinue|0|||
155172459|NCT02059291|560071812|FG010|Epoch 4|Pregnancy|0|||
154967844|NCT01075282|559305303|FG002|Overall Study|Treatment Non-compliance|2|||
155098024|NCT02750514|559793168|FG004|Track 1|Participant request to discontinue|0|||
155098025|NCT02750514|559793164|FG000|Track 1|Other reasons|1|||
155098026|NCT02750514|559793165|FG001|Track 1|Other reasons|0|||
155098027|NCT02750514|559793166|FG002|Track 1|Other reasons|0|||
155098028|NCT02750514|559793167|FG003|Track 1|Other reasons|0|||
155098029|NCT02750514|559793168|FG004|Track 1|Other reasons|0|||
154967845|NCT01075282|559305301|FG000|Overall Study|Protocol Violation|0|||
155098030|NCT02750514|559793164|FG000|Track 2|Disease progression|4|||
155098031|NCT02750514|559793165|FG001|Track 2|Disease progression|5|||
155098032|NCT02750514|559793166|FG002|Track 2|Disease progression|2|||
155098033|NCT02750514|559793167|FG003|Track 2|Disease progression|5|||
155098034|NCT02750514|559793168|FG004|Track 2|Disease progression|0|||
155098035|NCT02750514|559793164|FG000|Track 2|Adverse event unrelated to study drug|1|||
155098036|NCT02750514|559793165|FG001|Track 2|Adverse event unrelated to study drug|0|||
155098037|NCT02750514|559793166|FG002|Track 2|Adverse event unrelated to study drug|0|||
155098038|NCT02750514|559793167|FG003|Track 2|Adverse event unrelated to study drug|0|||
155098039|NCT02750514|559793168|FG004|Track 2|Adverse event unrelated to study drug|0|||
155098040|NCT02750514|559793164|FG000|Track 2|Study drug toxicity|1|||
155098041|NCT02750514|559793165|FG001|Track 2|Study drug toxicity|2|||
155098042|NCT02750514|559793166|FG002|Track 2|Study drug toxicity|0|||
155098043|NCT02750514|559793167|FG003|Track 2|Study drug toxicity|2|||
155098044|NCT02750514|559793168|FG004|Track 2|Study drug toxicity|0|||
155098045|NCT02750514|559793164|FG000|Track 2|Participant withdrew consent|0|||
155098046|NCT02750514|559793165|FG001|Track 2|Participant withdrew consent|1|||
155098047|NCT02750514|559793166|FG002|Track 2|Participant withdrew consent|0|||
155098048|NCT02750514|559793167|FG003|Track 2|Participant withdrew consent|0|||
155098049|NCT02750514|559793168|FG004|Track 2|Participant withdrew consent|0|||
155098050|NCT02750514|559793164|FG000|Track 3|Disease progression|0|||
155172460|NCT02059291|560071813|FG011|Epoch 4|Pregnancy|0|||
154967846|NCT01075282|559305302|FG001|Overall Study|Protocol Violation|2|||
155098051|NCT02750514|559793165|FG001|Track 3|Disease progression|24|||
155098052|NCT02750514|559793166|FG002|Track 3|Disease progression|13|||
155172461|NCT02059291|560071814|FG012|Epoch 4|Pregnancy|0|||
155098053|NCT02750514|559793167|FG003|Track 3|Disease progression|14|||
155098054|NCT02750514|559793168|FG004|Track 3|Disease progression|0|||
155098055|NCT02750514|559793164|FG000|Track 3|Adverse event unrelated to study drug|0|||
155098056|NCT02750514|559793165|FG001|Track 3|Adverse event unrelated to study drug|1|||
155098057|NCT02750514|559793166|FG002|Track 3|Adverse event unrelated to study drug|1|||
155098058|NCT02750514|559793167|FG003|Track 3|Adverse event unrelated to study drug|1|||
155098059|NCT02750514|559793168|FG004|Track 3|Adverse event unrelated to study drug|0|||
155098060|NCT02750514|559793164|FG000|Track 3|Study drug toxicity|0|||
155098061|NCT02750514|559793165|FG001|Track 3|Study drug toxicity|3|||
155098062|NCT02750514|559793166|FG002|Track 3|Study drug toxicity|0|||
155098063|NCT02750514|559793167|FG003|Track 3|Study drug toxicity|1|||
155098064|NCT02750514|559793168|FG004|Track 3|Study drug toxicity|0|||
155098065|NCT02750514|559793164|FG000|Track 3|Participant request to discontinue|0|||
155098066|NCT02750514|559793165|FG001|Track 3|Participant request to discontinue|2|||
155098067|NCT02750514|559793166|FG002|Track 3|Participant request to discontinue|0|||
155098068|NCT02750514|559793167|FG003|Track 3|Participant request to discontinue|0|||
155098069|NCT02750514|559793168|FG004|Track 3|Participant request to discontinue|0|||
155098070|NCT02750514|559793164|FG000|Track 3|Participant withdrew consent|0|||
155098071|NCT02750514|559793165|FG001|Track 3|Participant withdrew consent|3|||
155098072|NCT02750514|559793166|FG002|Track 3|Participant withdrew consent|1|||
155098073|NCT02750514|559793167|FG003|Track 3|Participant withdrew consent|0|||
154967847|NCT01075282|559305303|FG002|Overall Study|Protocol Violation|1|||
155098074|NCT02750514|559793168|FG004|Track 3|Participant withdrew consent|0|||
155098075|NCT02750514|559793164|FG000|Track 3|Other reasons|0|||
155098076|NCT02750514|559793165|FG001|Track 3|Other reasons|3|||
155098077|NCT02750514|559793166|FG002|Track 3|Other reasons|0|||
155098078|NCT02750514|559793167|FG003|Track 3|Other reasons|0|||
155098079|NCT02750514|559793168|FG004|Track 3|Other reasons|0|||
155098080|NCT02750514|559793164|FG000|Track 4|Study drug toxicity|0|||
154967848|NCT01075282|559305301|FG000|Overall Study|Death|0|||
154967849|NCT01075282|559305302|FG001|Overall Study|Death|1|||
154967850|NCT01075282|559305303|FG002|Overall Study|Death|2|||
154967851|NCT00367133|559305304|FG000|2 Years|Death|20|||
154967852|NCT00367133|559305305|FG001|2 Years|Death|12|||
154967853|NCT00367133|559305306|FG002|2 Years|Death|12|||
154967854|NCT00367133|559305304|FG000|2 Years|Dropped|34|||
154967855|NCT00367133|559305305|FG001|2 Years|Dropped|19|||
154967856|NCT00367133|559305306|FG002|2 Years|Dropped|33|||
154967857|NCT00367133|559305304|FG000|2 Years|Missed visit|4|||
154967858|NCT00367133|559305305|FG001|2 Years|Missed visit|5|||
154967859|NCT00367133|559305306|FG002|2 Years|Missed visit|4|||
154967860|NCT00847535|559305307|FG000|Overall Study|Withdrawal by Subject|2|||
154967861|NCT00847535|559305308|FG001|Overall Study|Withdrawal by Subject|1|||
154967862|NCT00847535|559305309|FG002|Overall Study|Withdrawal by Subject|1|||
154967863|NCT00847535|559305307|FG000|Overall Study|Lost to Follow-up|0|||
154967864|NCT00847535|559305308|FG001|Overall Study|Lost to Follow-up|1|||
154967865|NCT00847535|559305309|FG002|Overall Study|Lost to Follow-up|0|||
154967866|NCT01252953|559305310|FG000|Overall Study|Withdrawal by Subject|16|||
154967867|NCT01252953|559305311|FG001|Overall Study|Withdrawal by Subject|17|||
155098081|NCT02750514|559793165|FG001|Track 4|Study drug toxicity|6|||
155098082|NCT02750514|559793166|FG002|Track 4|Study drug toxicity|0|||
155098083|NCT02750514|559793167|FG003|Track 4|Study drug toxicity|5|||
154967868|NCT01252953|559305310|FG000|Overall Study|Lost to Follow-up|22|||
154967869|NCT01252953|559305311|FG001|Overall Study|Lost to Follow-up|21|||
154967870|NCT00840203|559305312|FG000|First Intervention|Protocol Violation|1|||
154967871|NCT00840203|559305313|FG001|First Intervention|Protocol Violation|1|||
154967872|NCT00840203|559305312|FG000|Washout|Protocol Violation|1|||
154967873|NCT00840203|559305313|FG001|Washout|Protocol Violation|0|||
154967874|NCT00989950|559305318|FG000|Randomized Phase|Protocol Violation|1|||
154967875|NCT00989950|559305319|FG001|Randomized Phase|Protocol Violation|0|||
155098084|NCT02750514|559793168|FG004|Track 4|Study drug toxicity|0|||
155098085|NCT02750514|559793164|FG000|Track 4|Participant request to discontinue|0|||
154967876|NCT00989950|559305320|FG002|Randomized Phase|Protocol Violation|0|||
154967877|NCT00989950|559305321|FG003|Randomized Phase|Protocol Violation|0|||
154967878|NCT00989950|559305318|FG000|Randomized Phase|Adverse Event|0|||
154967879|NCT00989950|559305319|FG001|Randomized Phase|Adverse Event|1|||
154967880|NCT00989950|559305320|FG002|Randomized Phase|Adverse Event|0|||
154967881|NCT00989950|559305321|FG003|Randomized Phase|Adverse Event|0|||
154967882|NCT00101439|559305322|FG000|Period 2|Withdrawal by Subject|0|||
154967883|NCT00101439|559305323|FG001|Period 2|Withdrawal by Subject|2|||
154967884|NCT02845336|559305327|FG000|Overall Study|Lost to Follow-up|3|||
154967885|NCT02845336|559305328|FG001|Overall Study|Lost to Follow-up|1|||
154967886|NCT02845336|559305327|FG000|Overall Study|Inability to get medication|2|||
154967887|NCT02845336|559305328|FG001|Overall Study|Inability to get medication|0|||
154967888|NCT02615249|559305338|FG000|Overall Study|Withdrawal by Subject|1|||
154967889|NCT02471807|559305343|FG000|Overall Study|Death|14|||
154967890|NCT02471807|559305343|FG000|Overall Study|Withdrawal by Subject|2|||
155172462|NCT02059291|560071815|FG013|Epoch 4|Pregnancy|0|||
155098086|NCT02750514|559793165|FG001|Track 4|Participant request to discontinue|1|||
155098087|NCT02750514|559793166|FG002|Track 4|Participant request to discontinue|0|||
155172463|NCT02059291|560071816|FG014|Epoch 4|Pregnancy|0|||
155172464|NCT02059291|560071817|FG015|Epoch 4|Pregnancy|0|||
155172465|NCT02059291|560071818|FG016|Epoch 4|Pregnancy|1|||
155172466|NCT02059291|560071819|FG017|Epoch 4|Pregnancy|0|||
155172467|NCT02059291|560071820|FG018|Epoch 4|Pregnancy|0|||
155172468|NCT02059291|560071821|FG019|Epoch 4|Pregnancy|0|||
155172469|NCT02059291|560071822|FG020|Epoch 4|Pregnancy|0|||
155172470|NCT02059291|560071823|FG021|Epoch 4|Pregnancy|0|||
155172471|NCT02059291|560071824|FG022|Epoch 4|Pregnancy|0|||
155172472|NCT02059291|560071825|FG023|Epoch 4|Pregnancy|0|||
155172473|NCT02059291|560071826|FG024|Epoch 4|Pregnancy|0|||
155172474|NCT02059291|560071802|FG000|Epoch 4|Withdrawal by Subject|0|||
155172475|NCT02059291|560071803|FG001|Epoch 4|Withdrawal by Subject|0|||
155172476|NCT02059291|560071804|FG002|Epoch 4|Withdrawal by Subject|0|||
155172477|NCT02059291|560071805|FG003|Epoch 4|Withdrawal by Subject|0|||
155172478|NCT02059291|560071806|FG004|Epoch 4|Withdrawal by Subject|0|||
155172479|NCT02059291|560071807|FG005|Epoch 4|Withdrawal by Subject|0|||
155172480|NCT02059291|560071808|FG006|Epoch 4|Withdrawal by Subject|0|||
155172481|NCT02059291|560071809|FG007|Epoch 4|Withdrawal by Subject|0|||
155172482|NCT02059291|560071810|FG008|Epoch 4|Withdrawal by Subject|0|||
155172483|NCT02059291|560071811|FG009|Epoch 4|Withdrawal by Subject|0|||
155098088|NCT02750514|559793167|FG003|Track 4|Participant request to discontinue|1|||
155098089|NCT02750514|559793168|FG004|Track 4|Participant request to discontinue|0|||
154967891|NCT02471807|559305343|FG000|Overall Study|Explant|5|||
154967892|NCT02471807|559305343|FG000|Overall Study|Lost to Follow-up|1|||
154967893|NCT01559363|559305344|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
154967894|NCT01559363|559305345|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
155172484|NCT02059291|560071812|FG010|Epoch 4|Withdrawal by Subject|0|||
155172485|NCT02059291|560071813|FG011|Epoch 4|Withdrawal by Subject|0|||
155172486|NCT02059291|560071814|FG012|Epoch 4|Withdrawal by Subject|0|||
155172487|NCT02059291|560071815|FG013|Epoch 4|Withdrawal by Subject|0|||
155172488|NCT02059291|560071816|FG014|Epoch 4|Withdrawal by Subject|0|||
155172489|NCT02059291|560071817|FG015|Epoch 4|Withdrawal by Subject|0|||
155098090|NCT02750514|559793164|FG000|Track 4|Participant withdrew consent|0|||
155172490|NCT02059291|560071818|FG016|Epoch 4|Withdrawal by Subject|0|||
155172491|NCT02059291|560071819|FG017|Epoch 4|Withdrawal by Subject|0|||
155172492|NCT02059291|560071820|FG018|Epoch 4|Withdrawal by Subject|0|||
155172493|NCT02059291|560071821|FG019|Epoch 4|Withdrawal by Subject|0|||
155098091|NCT02750514|559793165|FG001|Track 4|Participant withdrew consent|1|||
155098092|NCT02750514|559793166|FG002|Track 4|Participant withdrew consent|0|||
155098093|NCT02750514|559793167|FG003|Track 4|Participant withdrew consent|0|||
155098094|NCT02750514|559793168|FG004|Track 4|Participant withdrew consent|0|||
155098095|NCT02750514|559793164|FG000|Track 4|Other reasons|0|||
154967895|NCT01559363|559305346|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
155172494|NCT02059291|560071822|FG020|Epoch 4|Withdrawal by Subject|1|||
155098096|NCT02750514|559793165|FG001|Track 4|Other reasons|5|||
155098097|NCT02750514|559793166|FG002|Track 4|Other reasons|0|||
155098098|NCT02750514|559793167|FG003|Track 4|Other reasons|3|||
155098099|NCT02750514|559793168|FG004|Track 4|Other reasons|0|||
155098100|NCT02750514|559793164|FG000|Track 4|Disease progression|0|||
155098101|NCT02750514|559793165|FG001|Track 4|Disease progression|33|||
155098102|NCT02750514|559793166|FG002|Track 4|Disease progression|0|||
155098103|NCT02750514|559793167|FG003|Track 4|Disease progression|32|||
155098104|NCT02750514|559793168|FG004|Track 4|Disease progression|0|||
155098105|NCT02750514|559793164|FG000|Track 4|Adverse event unrelated to study drug|0|||
155098106|NCT02750514|559793165|FG001|Track 4|Adverse event unrelated to study drug|5|||
155098107|NCT02750514|559793166|FG002|Track 4|Adverse event unrelated to study drug|0|||
155098108|NCT02750514|559793167|FG003|Track 4|Adverse event unrelated to study drug|0|||
155098109|NCT02750514|559793168|FG004|Track 4|Adverse event unrelated to study drug|0|||
155098110|NCT02750514|559793164|FG000|Track 4|Death|0|||
155098111|NCT02750514|559793165|FG001|Track 4|Death|0|||
155098112|NCT02750514|559793166|FG002|Track 4|Death|0|||
155098113|NCT02750514|559793167|FG003|Track 4|Death|1|||
155098114|NCT02750514|559793168|FG004|Track 4|Death|0|||
154967896|NCT01559363|559305347|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
154967897|NCT01559363|559305348|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
154967898|NCT01559363|559305349|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
154967899|NCT01559363|559305344|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
155098115|NCT02750514|559793164|FG000|Track 5|Disease progression|0|||
155098116|NCT02750514|559793165|FG001|Track 5|Disease progression|0|||
155098117|NCT02750514|559793166|FG002|Track 5|Disease progression|0|||
155098118|NCT02750514|559793167|FG003|Track 5|Disease progression|0|||
154967900|NCT01559363|559305345|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
155098119|NCT02750514|559793168|FG004|Track 5|Disease progression|34|||
155172495|NCT02059291|560071823|FG021|Epoch 4|Withdrawal by Subject|0|||
155098120|NCT02750514|559793164|FG000|Track 5|Adverse event unrelated to study drug|0|||
155098121|NCT02750514|559793165|FG001|Track 5|Adverse event unrelated to study drug|0|||
155098122|NCT02750514|559793166|FG002|Track 5|Adverse event unrelated to study drug|0|||
155098123|NCT02750514|559793167|FG003|Track 5|Adverse event unrelated to study drug|0|||
155098124|NCT02750514|559793168|FG004|Track 5|Adverse event unrelated to study drug|2|||
155098125|NCT02750514|559793164|FG000|Track 5|Study drug toxicity|0|||
155098126|NCT02750514|559793165|FG001|Track 5|Study drug toxicity|0|||
155098127|NCT02750514|559793166|FG002|Track 5|Study drug toxicity|0|||
155098128|NCT02750514|559793167|FG003|Track 5|Study drug toxicity|0|||
155098129|NCT02750514|559793168|FG004|Track 5|Study drug toxicity|2|||
155098130|NCT02750514|559793164|FG000|Track 5|Participant request to discontinue|0|||
155098131|NCT02750514|559793165|FG001|Track 5|Participant request to discontinue|0|||
155098132|NCT02750514|559793166|FG002|Track 5|Participant request to discontinue|0|||
154967901|NCT01559363|559305346|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
154967902|NCT01559363|559305347|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
154967903|NCT01559363|559305348|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
154967904|NCT01559363|559305349|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
154967905|NCT01559363|559305344|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
154967906|NCT01559363|559305345|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
154967907|NCT01559363|559305346|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
154967908|NCT01559363|559305347|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
154967909|NCT01559363|559305348|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
154967910|NCT01559363|559305349|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
154967911|NCT01559363|559305344|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
154967912|NCT01559363|559305345|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
154967913|NCT01559363|559305346|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
154967914|NCT01559363|559305347|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
154967915|NCT01559363|559305348|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
154967916|NCT01559363|559305349|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
154967917|NCT01559363|559305344|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
154967918|NCT01559363|559305345|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
154967919|NCT01559363|559305346|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
154967920|NCT01559363|559305347|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
154967921|NCT01559363|559305348|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
154967922|NCT01559363|559305349|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
154967923|NCT01559363|559305344|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
154967924|NCT01559363|559305345|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
154967925|NCT01559363|559305346|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
154967926|NCT01559363|559305347|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
154967927|NCT01559363|559305348|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
154967928|NCT01559363|559305349|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
154967929|NCT01559363|559305344|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
154967930|NCT01559363|559305345|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
154967931|NCT01559363|559305346|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
154967932|NCT01559363|559305347|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
154967933|NCT01559363|559305348|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
154967934|NCT01559363|559305349|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
154967935|NCT04025021|559305353|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
154967936|NCT04025021|559305354|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
154967937|NCT01986647|559305355|FG000|Overall Study|Lost to Follow-up|4|||
154967938|NCT01986647|559305356|FG001|Overall Study|Lost to Follow-up|1|||
154967939|NCT01986647|559305357|FG002|Overall Study|Lost to Follow-up|4|||
154967940|NCT01986647|559305358|FG003|Overall Study|Lost to Follow-up|4|||
154967941|NCT01986647|559305355|FG000|Overall Study|Withdrawal by Subject|1|||
154967942|NCT01986647|559305356|FG001|Overall Study|Withdrawal by Subject|3|||
154967943|NCT01986647|559305357|FG002|Overall Study|Withdrawal by Subject|2|||
154967944|NCT01986647|559305358|FG003|Overall Study|Withdrawal by Subject|3|||
154967945|NCT01986647|559305355|FG000|Overall Study|Health|5|||
155172496|NCT02059291|560071824|FG022|Epoch 4|Withdrawal by Subject|0|||
155172497|NCT02059291|560071825|FG023|Epoch 4|Withdrawal by Subject|0|||
155172498|NCT02059291|560071826|FG024|Epoch 4|Withdrawal by Subject|0|||
155172499|NCT02059291|560071802|FG000|Epoch 4|Lack of Efficacy|0|||
155172500|NCT02059291|560071803|FG001|Epoch 4|Lack of Efficacy|0|||
155098133|NCT02750514|559793167|FG003|Track 5|Participant request to discontinue|0|||
155098134|NCT02750514|559793168|FG004|Track 5|Participant request to discontinue|3|||
155098135|NCT02750514|559793164|FG000|Track 5|Other reasons|0|||
155098136|NCT02750514|559793165|FG001|Track 5|Other reasons|0|||
155098137|NCT02750514|559793166|FG002|Track 5|Other reasons|0|||
155098138|NCT02750514|559793167|FG003|Track 5|Other reasons|0|||
155098139|NCT02750514|559793168|FG004|Track 5|Other reasons|2|||
155098140|NCT01824290|559793172|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
155098141|NCT01824290|559793173|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
154967946|NCT01986647|559305356|FG001|Overall Study|Health|3|||
154967947|NCT01986647|559305357|FG002|Overall Study|Health|6|||
155098142|NCT01824290|559793174|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
154967948|NCT01986647|559305358|FG003|Overall Study|Health|4|||
155098143|NCT01824290|559793175|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
154967949|NCT00868998|559305360|FG000|Overall Study|Screen Failure|1|||
154967950|NCT00868998|559305360|FG000|Overall Study|Withdrawal by Subject|1|||
155098144|NCT01824290|559793172|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
155098145|NCT01824290|559793173|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
155098146|NCT01824290|559793174|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
155098147|NCT01824290|559793175|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
155098148|NCT01824290|559793172|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
154967951|NCT00868998|559305360|FG000|Overall Study|Progression of disease|2|||
155098149|NCT01824290|559793173|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
155098150|NCT01824290|559793174|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
155098151|NCT01824290|559793175|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
155098152|NCT01824290|559793172|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
155098153|NCT01824290|559793173|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
155098154|NCT01824290|559793174|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
155172501|NCT02059291|560071804|FG002|Epoch 4|Lack of Efficacy|0|||
155172502|NCT02059291|560071805|FG003|Epoch 4|Lack of Efficacy|0|||
155098155|NCT01824290|559793175|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
155098156|NCT01824290|559793172|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
155098157|NCT01824290|559793173|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
155098158|NCT01824290|559793174|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
154967952|NCT00868998|559305360|FG000|Overall Study|Death|1|||
154967953|NCT01483820|559305361|FG000|Overall Study|Lack of Efficacy|6|||
154967954|NCT01483820|559305361|FG000|Overall Study|Adverse Event|1|||
154967955|NCT01483820|559305361|FG000|Overall Study|Death|1|||
154967956|NCT01507662|559305366|FG000|Overall Study|Death|26|||
155172503|NCT02059291|560071806|FG004|Epoch 4|Lack of Efficacy|0|||
154967957|NCT01507662|559305367|FG001|Overall Study|Death|18|||
154967958|NCT01507662|559305366|FG000|Overall Study|Withdrawal by Subject|290|||
154967959|NCT01507662|559305367|FG001|Overall Study|Withdrawal by Subject|287|||
154967960|NCT01507662|559305366|FG000|Overall Study|Lost to Follow-up|498|||
154967961|NCT01507662|559305367|FG001|Overall Study|Lost to Follow-up|523|||
154967962|NCT01507662|559305366|FG000|Overall Study|Proxy interview done|2|||
154967963|NCT01507662|559305367|FG001|Overall Study|Proxy interview done|3|||
154967964|NCT03541252|559305374|FG000|Overall Study|Withdrawal by Subject|1|||
154967965|NCT01960296|559305381|FG000|Overall Study|Postponed surgery|1|||
154967966|NCT01960296|559305382|FG001|Overall Study|Postponed surgery|0|||
154967967|NCT01960296|559305381|FG000|Overall Study|Received different procedure|1|||
154967968|NCT01960296|559305382|FG001|Overall Study|Received different procedure|3|||
154967969|NCT02003391|559305383|FG000|Overall Study|Withdrawal by Subject|2|||
154967970|NCT02003391|559305384|FG001|Overall Study|Withdrawal by Subject|1|||
154967971|NCT02003391|559305383|FG000|Overall Study|Protocol Violation|0|||
154967972|NCT02003391|559305384|FG001|Overall Study|Protocol Violation|1|||
154967973|NCT02003391|559305383|FG000|Overall Study|Adverse Event|1|||
154967974|NCT02003391|559305384|FG001|Overall Study|Adverse Event|0|||
154967975|NCT00858403|559305385|FG000|Overall Study|Withdrawal by Subject|1|||
154967976|NCT00858403|559305385|FG000|Overall Study|Death|3|||
154967977|NCT00858403|559305385|FG000|Overall Study|Disease Progression|1|||
154967978|NCT02264977|559305386|FG000|Overall Study|Death|3|||
154967979|NCT02264977|559305386|FG000|Overall Study|Physician Decision|1|||
154967980|NCT02264977|559305386|FG000|Overall Study|Refuse to return|1|||
154967981|NCT00243347|559305387|FG000|Overall Study|Lack of Efficacy|4|||
154967982|NCT00243347|559305387|FG000|Overall Study|Adverse Event|2|||
154967983|NCT00243347|559305387|FG000|Overall Study|Death|1|||
154967984|NCT00243347|559305387|FG000|Overall Study|Withdrawal by Subject|5|||
154967985|NCT00243347|559305387|FG000|Overall Study|Condition worsened|7|||
154967986|NCT03573544|559305388|FG000|Overall Study|Adverse Event|0|||
154967987|NCT03573544|559305389|FG001|Overall Study|Adverse Event|0|||
154967988|NCT03573544|559305390|FG002|Overall Study|Adverse Event|0|||
154967989|NCT03573544|559305391|FG003|Overall Study|Adverse Event|3|||
154967990|NCT03573544|559305392|FG004|Overall Study|Adverse Event|1|||
154967991|NCT03573544|559305393|FG005|Overall Study|Adverse Event|0|||
154967992|NCT03573544|559305394|FG006|Overall Study|Adverse Event|2|||
154967993|NCT03573544|559305395|FG007|Overall Study|Adverse Event|0|||
154967994|NCT03573544|559305388|FG000|Overall Study|Physician Decision|0|||
154967995|NCT03573544|559305389|FG001|Overall Study|Physician Decision|0|||
154967996|NCT03573544|559305390|FG002|Overall Study|Physician Decision|0|||
154967997|NCT03573544|559305391|FG003|Overall Study|Physician Decision|0|||
154967998|NCT03573544|559305392|FG004|Overall Study|Physician Decision|0|||
155098159|NCT01824290|559793175|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
155098160|NCT01824290|559793172|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
154967999|NCT03573544|559305393|FG005|Overall Study|Physician Decision|0|||
154968000|NCT03573544|559305394|FG006|Overall Study|Physician Decision|1|||
154968001|NCT03573544|559305395|FG007|Overall Study|Physician Decision|0|||
154968002|NCT03573544|559305388|FG000|Overall Study|Withdrawal by Subject|2|||
155098161|NCT01824290|559793173|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
155098162|NCT01824290|559793174|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
155098163|NCT01824290|559793175|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
155098164|NCT02240121|559793176|FG000|Overall Study|Protocol Violation|1|||
155098165|NCT02240121|559793177|FG001|Overall Study|Protocol Violation|2|||
155098166|NCT02240121|559793176|FG000|Overall Study|Physician Decision|0|||
155098167|NCT02240121|559793177|FG001|Overall Study|Physician Decision|1|||
155098168|NCT02240121|559793176|FG000|Overall Study|Change in protocol interpretation|1|||
155098169|NCT02240121|559793177|FG001|Overall Study|Change in protocol interpretation|0|||
155098170|NCT02240121|559793176|FG000|Overall Study|Lack of Efficacy|2|||
155098171|NCT02240121|559793177|FG001|Overall Study|Lack of Efficacy|3|||
155098172|NCT02240121|559793176|FG000|Overall Study|Site closed|1|||
155098173|NCT02240121|559793177|FG001|Overall Study|Site closed|1|||
155098174|NCT02240121|559793176|FG000|Overall Study|Pregnancy|1|||
155098175|NCT02240121|559793177|FG001|Overall Study|Pregnancy|0|||
155098176|NCT02240121|559793176|FG000|Overall Study|Adverse Event|2|||
155098177|NCT02240121|559793177|FG001|Overall Study|Adverse Event|4|||
155098178|NCT02240121|559793176|FG000|Overall Study|Withdrawal by Subject|6|||
155098179|NCT02240121|559793177|FG001|Overall Study|Withdrawal by Subject|2|||
155098180|NCT02240121|559793176|FG000|Overall Study|Lost to Follow-up|3|||
155098181|NCT02240121|559793177|FG001|Overall Study|Lost to Follow-up|4|||
155098182|NCT02240121|559793176|FG000|Overall Study|Other than specified|1|||
154968003|NCT03573544|559305389|FG001|Overall Study|Withdrawal by Subject|0|||
154968004|NCT03573544|559305390|FG002|Overall Study|Withdrawal by Subject|0|||
154968005|NCT03573544|559305391|FG003|Overall Study|Withdrawal by Subject|1|||
154968006|NCT03573544|559305392|FG004|Overall Study|Withdrawal by Subject|1|||
154968007|NCT03573544|559305393|FG005|Overall Study|Withdrawal by Subject|1|||
154968008|NCT03573544|559305394|FG006|Overall Study|Withdrawal by Subject|0|||
154968009|NCT03573544|559305395|FG007|Overall Study|Withdrawal by Subject|1|||
154968010|NCT03573544|559305388|FG000|Overall Study|Disease progression|3|||
154968011|NCT03573544|559305389|FG001|Overall Study|Disease progression|3|||
154968012|NCT03573544|559305390|FG002|Overall Study|Disease progression|6|||
154968013|NCT03573544|559305391|FG003|Overall Study|Disease progression|4|||
154968014|NCT03573544|559305392|FG004|Overall Study|Disease progression|5|||
155172504|NCT02059291|560071807|FG005|Epoch 4|Lack of Efficacy|0|||
155172505|NCT02059291|560071808|FG006|Epoch 4|Lack of Efficacy|0|||
154968015|NCT03573544|559305393|FG005|Overall Study|Disease progression|7|||
155172506|NCT02059291|560071809|FG007|Epoch 4|Lack of Efficacy|0|||
154968016|NCT03573544|559305394|FG006|Overall Study|Disease progression|6|||
155172507|NCT02059291|560071810|FG008|Epoch 4|Lack of Efficacy|0|||
154968017|NCT03573544|559305395|FG007|Overall Study|Disease progression|7|||
154968018|NCT03846193|559305398|FG000|Overall Study|Physician Decision|0|||
154968019|NCT03846193|559305399|FG001|Overall Study|Physician Decision|0|||
154968020|NCT03846193|559305400|FG002|Overall Study|Physician Decision|1|||
154968021|NCT03846193|559305401|FG003|Overall Study|Physician Decision|0|||
154968022|NCT03846193|559305402|FG004|Overall Study|Physician Decision|0|||
154968023|NCT03846193|559305398|FG000|Overall Study|Lost to Follow-up|0|||
155098183|NCT02240121|559793177|FG001|Overall Study|Other than specified|3|||
154968024|NCT03846193|559305399|FG001|Overall Study|Lost to Follow-up|0|||
155098184|NCT00881894|559793178|FG000|Overall Study|Consent withdrawn|0|||
155098185|NCT00881894|559793179|FG001|Overall Study|Consent withdrawn|1|||
155098186|NCT00881894|559793178|FG000|Overall Study|Other reasons for premature termination|1|||
155098187|NCT00881894|559793179|FG001|Overall Study|Other reasons for premature termination|2|||
155098188|NCT01253369|559793180|FG000|Overall Study|Adverse Event|4|||
155098189|NCT01253369|559793180|FG000|Overall Study|Withdrawal by Subject|2|||
155098190|NCT01253369|559793180|FG000|Overall Study|Death|1|||
155098191|NCT01253369|559793180|FG000|Overall Study|Progressive disease|23|||
154968025|NCT03846193|559305400|FG002|Overall Study|Lost to Follow-up|0|||
154968026|NCT03846193|559305401|FG003|Overall Study|Lost to Follow-up|0|||
155172508|NCT02059291|560071811|FG009|Epoch 4|Lack of Efficacy|0|||
155172509|NCT02059291|560071812|FG010|Epoch 4|Lack of Efficacy|0|||
155172510|NCT02059291|560071813|FG011|Epoch 4|Lack of Efficacy|0|||
155172511|NCT02059291|560071814|FG012|Epoch 4|Lack of Efficacy|0|||
155172512|NCT02059291|560071815|FG013|Epoch 4|Lack of Efficacy|0|||
155172513|NCT02059291|560071816|FG014|Epoch 4|Lack of Efficacy|0|||
155172514|NCT02059291|560071817|FG015|Epoch 4|Lack of Efficacy|0|||
155172515|NCT02059291|560071818|FG016|Epoch 4|Lack of Efficacy|0|||
154968027|NCT03846193|559305402|FG004|Overall Study|Lost to Follow-up|1|||
155098192|NCT01253369|559793180|FG000|Overall Study|Not Evaluable|3|||
155098193|NCT01932788|559793182|FG000|Overall Study|Protocol Violation|18|||
155098194|NCT01932788|559793183|FG001|Overall Study|Protocol Violation|0|||
155098195|NCT01932788|559793182|FG000|Overall Study|Lost to Follow-up|18|||
155098196|NCT01932788|559793183|FG001|Overall Study|Lost to Follow-up|46|||
155098197|NCT01932788|559793182|FG000|Overall Study|Lack of Efficacy|2|||
155098198|NCT01932788|559793183|FG001|Overall Study|Lack of Efficacy|0|||
155098199|NCT01932788|559793182|FG000|Overall Study|Withdrawal by Subject|0|||
155098200|NCT01932788|559793183|FG001|Overall Study|Withdrawal by Subject|5|||
155172516|NCT02059291|560071819|FG017|Epoch 4|Lack of Efficacy|0|||
155172517|NCT02059291|560071820|FG018|Epoch 4|Lack of Efficacy|0|||
155098201|NCT00543985|559793197|FG000|Overall Study|Withdrawal by Subject|4|||
155172518|NCT02059291|560071821|FG019|Epoch 4|Lack of Efficacy|0|||
155172519|NCT02059291|560071822|FG020|Epoch 4|Lack of Efficacy|0|||
155172520|NCT02059291|560071823|FG021|Epoch 4|Lack of Efficacy|0|||
155172521|NCT02059291|560071824|FG022|Epoch 4|Lack of Efficacy|0|||
154968028|NCT03846193|559305398|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
154968029|NCT03846193|559305399|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
154968030|NCT03846193|559305400|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
154968031|NCT03846193|559305401|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
154968032|NCT03846193|559305402|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
154968033|NCT02986139|559307335|FG000|Overall Study|Sponsor Decision|1|||
154968034|NCT02986139|559307336|FG001|Overall Study|Sponsor Decision|2|||
154968035|NCT02986139|559307335|FG000|Overall Study|Withdrawal by Subject|0|||
154968036|NCT02986139|559307336|FG001|Overall Study|Withdrawal by Subject|1|||
154968037|NCT02986139|559307335|FG000|Overall Study|Lost to Follow-up|0|||
154968038|NCT02986139|559307336|FG001|Overall Study|Lost to Follow-up|1|||
154968039|NCT02313558|559307341|FG000|Overall Study|Withdrawal by Subject|2|||
155172522|NCT02059291|560071825|FG023|Epoch 4|Lack of Efficacy|1|||
155172523|NCT02059291|560071826|FG024|Epoch 4|Lack of Efficacy|0|||
155172524|NCT03180619|560071827|FG000|Overall Study|Withdrew Consent|5|||
155172525|NCT03180619|560071828|FG001|Overall Study|Withdrew Consent|0|||
155172526|NCT03180619|560071829|FG002|Overall Study|Withdrew Consent|2|||
155172527|NCT03180619|560071827|FG000|Overall Study|Death|2|||
155172528|NCT03180619|560071828|FG001|Overall Study|Death|1|||
155172529|NCT03180619|560071829|FG002|Overall Study|Death|2|||
155172530|NCT03180619|560071827|FG000|Overall Study|Adverse Event|2|||
155172531|NCT03180619|560071828|FG001|Overall Study|Adverse Event|0|||
155172532|NCT03180619|560071829|FG002|Overall Study|Adverse Event|1|||
155172533|NCT03180619|560071827|FG000|Overall Study|Investigator's discretion|2|||
154968040|NCT02313558|559307342|FG001|Overall Study|Withdrawal by Subject|0|||
154968041|NCT02313558|559307341|FG000|Overall Study|Lost to Follow-up|4|||
154968042|NCT02313558|559307342|FG001|Overall Study|Lost to Follow-up|4|||
154968043|NCT01911429|559307343|FG000|Overall Study|Adverse Event|5|||
154968044|NCT01911429|559307344|FG001|Overall Study|Adverse Event|3|||
154968045|NCT01911429|559307345|FG002|Overall Study|Adverse Event|9|||
154968046|NCT01911429|559307343|FG000|Overall Study|Lack of Efficacy|1|||
154968047|NCT01911429|559307344|FG001|Overall Study|Lack of Efficacy|2|||
154968048|NCT01911429|559307345|FG002|Overall Study|Lack of Efficacy|4|||
154968049|NCT01911429|559307343|FG000|Overall Study|Lost to Follow-up|0|||
154968050|NCT01911429|559307344|FG001|Overall Study|Lost to Follow-up|0|||
154968051|NCT01911429|559307345|FG002|Overall Study|Lost to Follow-up|1|||
154968052|NCT01911429|559307343|FG000|Overall Study|Protocol Violation|0|||
154968053|NCT01911429|559307344|FG001|Overall Study|Protocol Violation|0|||
154968054|NCT01911429|559307345|FG002|Overall Study|Protocol Violation|1|||
154968055|NCT01911429|559307343|FG000|Overall Study|Withdrawal by Subject|5|||
154968056|NCT01911429|559307344|FG001|Overall Study|Withdrawal by Subject|5|||
155098202|NCT01634152|559793198|FG000|Overall Study|Adverse Event|2|||
154968057|NCT01911429|559307345|FG002|Overall Study|Withdrawal by Subject|4|||
154968058|NCT01911429|559307343|FG000|Overall Study|Accidental randomization|0|||
154968059|NCT01911429|559307344|FG001|Overall Study|Accidental randomization|0|||
154968060|NCT01911429|559307345|FG002|Overall Study|Accidental randomization|1|||
154968061|NCT01911429|559307343|FG000|Overall Study|subject left study|1|||
154968062|NCT01911429|559307344|FG001|Overall Study|subject left study|0|||
154968063|NCT01911429|559307345|FG002|Overall Study|subject left study|0|||
154968064|NCT03540160|559307346|FG000|Overall Study|Protocol Violation|1|||
154968065|NCT03540160|559307346|FG000|Overall Study|Physician Decision|8|||
154968066|NCT03540160|559307346|FG000|Overall Study|Lack of Efficacy|60|||
154968067|NCT03540160|559307346|FG000|Overall Study|Pregnancy|1|||
154968068|NCT03540160|559307346|FG000|Overall Study|Adverse Event|20|||
154968069|NCT03540160|559307346|FG000|Overall Study|Withdrawal by Subject|68|||
154968070|NCT03540160|559307346|FG000|Overall Study|COVID-19|2|||
154968071|NCT03540160|559307346|FG000|Overall Study|Study Closure|10|||
154968072|NCT03540160|559307346|FG000|Overall Study|Lost to Follow-up|18|||
154968073|NCT03540160|559307346|FG000|Overall Study|Sponsor decision|191|||
154968074|NCT01923740|559307349|FG000|Overall Study|Lost to Follow-up|4|||
154968075|NCT01923740|559307350|FG001|Overall Study|Lost to Follow-up|9|||
154968076|NCT01923740|559307349|FG000|Overall Study|Withdrawal by Subject|2|||
154968077|NCT01923740|559307350|FG001|Overall Study|Withdrawal by Subject|0|||
154968078|NCT03707587|559307351|FG000|Overall Study|Death|0|||
154968079|NCT03707587|559307352|FG001|Overall Study|Death|1|||
154968080|NCT01370083|559307353|FG000|Overall Study|Lost to Follow-up|2|||
154968081|NCT01370083|559307354|FG001|Overall Study|Lost to Follow-up|0|||
154968082|NCT01370083|559307353|FG000|Overall Study|Adverse Event|0|||
154968083|NCT01370083|559307354|FG001|Overall Study|Adverse Event|1|||
154968084|NCT00834444|559307355|FG000|First Intervention|Adverse Event|1|||
154968085|NCT00834444|559307356|FG001|First Intervention|Adverse Event|0|||
154968086|NCT00834444|559307355|FG000|First Intervention|Intolerance to Venopuncture|0|||
154968087|NCT00834444|559307356|FG001|First Intervention|Intolerance to Venopuncture|1|||
154968088|NCT00834444|559307355|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
154968089|NCT00834444|559307356|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
154968090|NCT00834444|559307355|FG000|Second Intervention|Adverse Event|1|||
154968091|NCT00834444|559307356|FG001|Second Intervention|Adverse Event|0|||
154968092|NCT03158727|559307359|FG000|Overall Study|Withdrawal by Subject|2|||
154968093|NCT03158727|559307360|FG001|Overall Study|Withdrawal by Subject|6|||
154968094|NCT03158727|559307359|FG000|Overall Study|Death|11|||
154968095|NCT03158727|559307360|FG001|Overall Study|Death|12|||
154968096|NCT03158727|559307359|FG000|Overall Study|Lost to Follow-up|1|||
154968097|NCT03158727|559307360|FG001|Overall Study|Lost to Follow-up|0|||
154968098|NCT03158727|559307359|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
154968099|NCT03158727|559307360|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
154968100|NCT03158727|559307359|FG000|Overall Study|Visit 11 not done by mistake|0|||
154968101|NCT03158727|559307360|FG001|Overall Study|Visit 11 not done by mistake|1|||
154968102|NCT03158727|559307359|FG000|Overall Study|Enrolled, not treated|1|||
154968103|NCT03158727|559307360|FG001|Overall Study|Enrolled, not treated|0|||
154968104|NCT02412852|559307361|FG000|Overall Study|Withdrawal by Subject|0|||
154968105|NCT02412852|559307362|FG001|Overall Study|Withdrawal by Subject|1|||
154968106|NCT02412852|559307363|FG002|Overall Study|Withdrawal by Subject|0|||
154968107|NCT02412852|559307364|FG003|Overall Study|Withdrawal by Subject|0|||
154968108|NCT02412852|559307361|FG000|Overall Study|Physician Decision|0|||
154968109|NCT02412852|559307362|FG001|Overall Study|Physician Decision|0|||
154968110|NCT02412852|559307363|FG002|Overall Study|Physician Decision|0|||
154968111|NCT02412852|559307364|FG003|Overall Study|Physician Decision|1|||
154968112|NCT00985439|559307365|FG000|Overall Study|Adverse Event|0|||
154968113|NCT00985439|559307366|FG001|Overall Study|Adverse Event|0|||
154968114|NCT00985439|559307367|FG002|Overall Study|Adverse Event|1|||
154968115|NCT00985439|559307368|FG003|Overall Study|Adverse Event|0|||
154968116|NCT00472212|559307369|FG000|Overall Study|Lost to Follow-up|6|||
154968117|NCT00472212|559307370|FG001|Overall Study|Lost to Follow-up|4|||
154968118|NCT02336074|559307376|FG000|Overall Study|Adverse Event|0|||
154968119|NCT02336074|559307377|FG001|Overall Study|Adverse Event|2|||
154968120|NCT00958724|559307378|FG000|Overall Study|Disease Progression|6|||
154968121|NCT05604014|559307396|FG000|Overall Study|Lost to Follow-up|13|||
154968122|NCT02121184|559307398|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
154968123|NCT02121184|559307399|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
154968124|NCT02121184|559307398|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
154968125|NCT02121184|559307399|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
154968126|NCT02121184|559307398|FG000|Overall Study|Emergency cesarean section required|0|||
154968127|NCT02121184|559307399|FG001|Overall Study|Emergency cesarean section required|2|||
154968128|NCT02121184|559307398|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
154968129|NCT02121184|559307399|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
154968130|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Refused|1|||
154968131|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Refused|3|||
154968132|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Medical|0|||
154968133|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Medical|1|||
154968134|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
154968135|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
154968136|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
154968137|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
154968138|NCT02054715|559307402|FG000|Baseline/Follow-up 1|No Reason|0|||
154968139|NCT02054715|559307403|FG001|Baseline/Follow-up 1|No Reason|1|||
155098203|NCT01634152|559793199|FG001|Overall Study|Adverse Event|0|||
155098204|NCT01634152|559793200|FG002|Overall Study|Adverse Event|2|||
155098205|NCT01634152|559793198|FG000|Overall Study|Consent withdrawn not due to AE|1|||
155098206|NCT01634152|559793199|FG001|Overall Study|Consent withdrawn not due to AE|0|||
155098207|NCT01634152|559793200|FG002|Overall Study|Consent withdrawn not due to AE|1|||
154968140|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
154968141|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
154968142|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Ineligible|3|||
154968143|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Ineligible|0|||
154968144|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Hospitalization|1|||
154968145|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Hospitalization|0|||
154968146|NCT02054715|559307402|FG000|Baseline/Follow-up 1|Changed Mind|1|||
154968147|NCT02054715|559307403|FG001|Baseline/Follow-up 1|Changed Mind|0|||
154968148|NCT02054715|559307402|FG000|Follow-up 2|Lost to Followup|3|||
154968149|NCT02054715|559307403|FG001|Follow-up 2|Lost to Followup|1|||
154968150|NCT02054715|559307402|FG000|Follow-up 2|Refused|3|||
154968151|NCT02054715|559307403|FG001|Follow-up 2|Refused|2|||
155172534|NCT03180619|560071828|FG001|Overall Study|Investigator's discretion|0|||
154968152|NCT02054715|559307402|FG000|Follow-up 2|Followup Not Completed|3|||
155172535|NCT03180619|560071829|FG002|Overall Study|Investigator's discretion|1|||
155172536|NCT01433289|560071830|FG000|Overall Study|Pregnancy|0|||
155172537|NCT01433289|560071831|FG001|Overall Study|Pregnancy|1|||
155172538|NCT01433289|560071832|FG002|Overall Study|Pregnancy|0|||
155172539|NCT01433289|560071833|FG003|Overall Study|Pregnancy|0|||
155172540|NCT02410343|560071840|FG000|Core Period (24 Weeks)|Adverse Event|1|||
155172541|NCT02410343|560071841|FG001|Core Period (24 Weeks)|Adverse Event|0|||
155172542|NCT02410343|560071840|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
155172543|NCT02410343|560071841|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
155172544|NCT02410343|560071840|FG000|Extension Period (12 Months)|Adverse Event|1|||
155172545|NCT02410343|560071841|FG001|Extension Period (12 Months)|Adverse Event|0|||
155172546|NCT02410343|560071840|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
155172547|NCT02410343|560071841|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
155172548|NCT04784442|560071844|FG000|Overall Study|Adverse Event|1|||
155172549|NCT04784442|560071845|FG001|Overall Study|Adverse Event|0|||
155172550|NCT04784442|560071846|FG002|Overall Study|Adverse Event|2|||
155172551|NCT04784442|560071847|FG003|Overall Study|Adverse Event|1|||
155172552|NCT04784442|560071844|FG000|Overall Study|Protocol Violation|1|||
155172553|NCT04784442|560071845|FG001|Overall Study|Protocol Violation|0|||
155172554|NCT04784442|560071846|FG002|Overall Study|Protocol Violation|0|||
155172555|NCT04784442|560071847|FG003|Overall Study|Protocol Violation|0|||
155172556|NCT04784442|560071844|FG000|Overall Study|Non-compliance with study drug|1|||
155172557|NCT04784442|560071845|FG001|Overall Study|Non-compliance with study drug|0|||
155172558|NCT04784442|560071846|FG002|Overall Study|Non-compliance with study drug|0|||
155098208|NCT01634152|559793198|FG000|Overall Study|Not treated|0|||
155098209|NCT01634152|559793199|FG001|Overall Study|Not treated|1|||
155098210|NCT01634152|559793200|FG002|Overall Study|Not treated|0|||
155098211|NCT01634152|559793198|FG000|Overall Study|Other reason not defined above|1|||
155098212|NCT01634152|559793199|FG001|Overall Study|Other reason not defined above|0|||
155098213|NCT01634152|559793200|FG002|Overall Study|Other reason not defined above|1|||
155098214|NCT01900665|559793202|FG000|Placebo Controlled Period|Death|9|||
155098215|NCT01900665|559793203|FG001|Placebo Controlled Period|Death|16|||
155098216|NCT01900665|559793202|FG000|Placebo Controlled Period|Adverse Event|48|||
155098217|NCT01900665|559793203|FG001|Placebo Controlled Period|Adverse Event|39|||
155098218|NCT01900665|559793202|FG000|Placebo Controlled Period|Protocol Violation|1|||
155098219|NCT01900665|559793203|FG001|Placebo Controlled Period|Protocol Violation|7|||
155098220|NCT01900665|559793202|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
155098221|NCT01900665|559793203|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
155098222|NCT01900665|559793202|FG000|Placebo Controlled Period|Physician Decision|11|||
155098223|NCT01900665|559793203|FG001|Placebo Controlled Period|Physician Decision|7|||
155098224|NCT01900665|559793202|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
155098225|NCT01900665|559793203|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
155098226|NCT01900665|559793202|FG000|Placebo Controlled Period|Caregiver Decision|33|||
154833815|NCT00388973|558826577|FG000|Overall Study|Adverse Event|16|||
154833816|NCT00388973|558826578|FG001|Overall Study|Adverse Event|6|||
154833817|NCT00388973|558826577|FG000|Overall Study|Lack of Efficacy|1|||
154833818|NCT00388973|558826578|FG001|Overall Study|Lack of Efficacy|12|||
154833819|NCT00388973|558826577|FG000|Overall Study|Protocol Violation|3|||
154833820|NCT00388973|558826578|FG001|Overall Study|Protocol Violation|0|||
154833821|NCT00388973|558826577|FG000|Overall Study|Withdrawal by Subject|14|||
154833822|NCT00388973|558826578|FG001|Overall Study|Withdrawal by Subject|17|||
154833823|NCT00388973|558826577|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
154833824|NCT00388973|558826578|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
154833825|NCT00388973|558826577|FG000|Overall Study|Did not complete 61 days of treatment|5|||
154833826|NCT00388973|558826578|FG001|Overall Study|Did not complete 61 days of treatment|4|||
154833827|NCT00388973|558826577|FG000|Overall Study|Left region|0|||
154833828|NCT00388973|558826578|FG001|Overall Study|Left region|1|||
154833829|NCT00388973|558826577|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
154833830|NCT00388973|558826578|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
154833831|NCT00075400|558826579|FG000|Overall Study|Ineligible: wrong primary|1|||
154833832|NCT00075400|558826579|FG000|Overall Study|Never treated|2|||
154833833|NCT01652885|558826580|FG000|Overall Study|Adverse Event|1|||
154833834|NCT03723707|558826582|FG000|Overall Study|Death|32|||
154833835|NCT03723707|558826583|FG001|Overall Study|Death|32|||
154833836|NCT03723707|558826582|FG000|Overall Study|Admitted to long term care|12|||
154833837|NCT03723707|558826583|FG001|Overall Study|Admitted to long term care|12|||
154833838|NCT03723707|558826582|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
154833839|NCT03723707|558826583|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
154833840|NCT03723707|558826582|FG000|Overall Study|Lost to Follow-up|40|||
154833841|NCT03723707|558826583|FG001|Overall Study|Lost to Follow-up|22|||
154968153|NCT02054715|559307403|FG001|Follow-up 2|Followup Not Completed|4|||
154833842|NCT03723707|558826582|FG000|Overall Study|Discontinued after study closure|24|||
154833843|NCT03723707|558826583|FG001|Overall Study|Discontinued after study closure|12|||
154833844|NCT00075023|558826584|FG000|Pilot Study|Physician Decision|1|||
154833845|NCT00075023|558826585|FG001|Pilot Study|Physician Decision|2|||
154833846|NCT00075023|558826584|FG000|Pilot Study|Withdrawal by Subject|1|||
154833847|NCT00075023|558826585|FG001|Pilot Study|Withdrawal by Subject|0|||
154968154|NCT02054715|559307402|FG000|Follow-up 2|Ineligible|4|||
154968155|NCT02054715|559307403|FG001|Follow-up 2|Ineligible|5|||
154968156|NCT02054715|559307402|FG000|Follow-up 2|Death|3|||
154968157|NCT02054715|559307403|FG001|Follow-up 2|Death|3|||
154968158|NCT02054715|559307402|FG000|Follow-up 2|Hospitalization|0|||
154968159|NCT02054715|559307403|FG001|Follow-up 2|Hospitalization|2|||
154968160|NCT02054715|559307402|FG000|Follow-up 2|Changed MD/Facility|0|||
154968161|NCT02054715|559307403|FG001|Follow-up 2|Changed MD/Facility|1|||
154968162|NCT02054715|559307402|FG000|Follow-up 2|Changed Mind|0|||
154968163|NCT02054715|559307403|FG001|Follow-up 2|Changed Mind|1|||
154968164|NCT02054715|559307402|FG000|Follow-up 2|No Reason|2|||
154968165|NCT02054715|559307403|FG001|Follow-up 2|No Reason|0|||
154968166|NCT02054715|559307402|FG000|Follow-up 2|Treatment Change or Delay|1|||
154968167|NCT02054715|559307403|FG001|Follow-up 2|Treatment Change or Delay|0|||
154968168|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
154968169|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
154968170|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
154968171|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
154968172|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
154968173|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
154968174|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
154968175|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
154968176|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
154968177|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
154968178|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
154968179|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
154968180|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
154968181|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
154968182|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
154968183|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
154968184|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
154968185|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
154968186|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
154968187|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
154968188|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
154968189|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
154968190|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
154968191|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
154968192|NCT00073307|559307406|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
154968193|NCT00073307|559307407|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
154968194|NCT00073307|559307408|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
154968195|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
154968196|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
154968197|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
154968198|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
154968199|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
154968200|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
154968201|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
154968202|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
154968203|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
154968204|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
154968205|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
154968206|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
154968207|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
154968208|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
154968209|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
154968210|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
154968211|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
154968212|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
155098227|NCT01900665|559793203|FG001|Placebo Controlled Period|Caregiver Decision|41|||
154968213|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
154968214|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
154833848|NCT04342871|558826586|FG000|Overall Study|Death|4|||
154833849|NCT04342871|558826586|FG000|Overall Study|Clinical deterioration/illness progression|2|||
154833850|NCT04342871|558826586|FG000|Overall Study|Did not complete baseline assessments|5|||
154833851|NCT04342871|558826586|FG000|Overall Study|Lost to Follow-up|13|||
154833852|NCT00666458|558826588|FG000|Overall Study|Adverse Event|8|||
154833853|NCT00666458|558826589|FG001|Overall Study|Adverse Event|7|||
154833854|NCT00666458|558826588|FG000|Overall Study|Withdrawal by Subject|5|||
154833855|NCT00666458|558826589|FG001|Overall Study|Withdrawal by Subject|4|||
154833856|NCT00666458|558826588|FG000|Overall Study|Lost to Follow-up|0|||
154833857|NCT00666458|558826589|FG001|Overall Study|Lost to Follow-up|3|||
154833858|NCT00666458|558826588|FG000|Overall Study|Administrative reason by sponsor|1|||
154833859|NCT00666458|558826589|FG001|Overall Study|Administrative reason by sponsor|1|||
154833860|NCT00666458|558826588|FG000|Overall Study|Incorrect enrollment|7|||
154833861|NCT00666458|558826589|FG001|Overall Study|Incorrect enrollment|1|||
154833862|NCT00666458|558826588|FG000|Overall Study|Study specific discontinuation criteria|14|||
154833863|NCT00666458|558826589|FG001|Overall Study|Study specific discontinuation criteria|7|||
154833864|NCT00666458|558826588|FG000|Overall Study|Severe non-compliance to the protocol|1|||
154833865|NCT00666458|558826589|FG001|Overall Study|Severe non-compliance to the protocol|1|||
154833866|NCT00666458|558826588|FG000|Overall Study|Safety reasons|1|||
154833867|NCT00666458|558826589|FG001|Overall Study|Safety reasons|0|||
154833868|NCT00666458|558826588|FG000|Overall Study|Medical history of anemia|1|||
154833869|NCT00666458|558826589|FG001|Overall Study|Medical history of anemia|0|||
154833870|NCT01429584|558826593|FG000|Overall Study|Withdrawal by Subject|1|||
155098228|NCT01900665|559793202|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
155098229|NCT01900665|559793203|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
154833871|NCT01429584|558826594|FG001|Overall Study|Withdrawal by Subject|0|||
154833872|NCT01429584|558826593|FG000|Overall Study|Protocol Violation|0|||
154968215|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
154833873|NCT01429584|558826594|FG001|Overall Study|Protocol Violation|1|||
154833874|NCT00750698|558826595|FG000|Overall Study|Withdrawal by Subject|1|||
154833875|NCT00750698|558826596|FG001|Overall Study|Withdrawal by Subject|0|||
154833876|NCT00750698|558826595|FG000|Overall Study|Progressive disease|5|||
154833877|NCT00750698|558826596|FG001|Overall Study|Progressive disease|2|||
154833878|NCT00402649|558826597|FG000|Overall Study|Lost to Follow-up|1|||
154833879|NCT00402649|558826597|FG000|Overall Study|Withdrawal by Subject|1|||
154833880|NCT01999465|558826598|FG000|Overall Study|Lost to Follow-up|0|||
154833881|NCT01999465|558826599|FG001|Overall Study|Lost to Follow-up|2|||
154833882|NCT01999465|558826598|FG000|Overall Study|Protocol Violation|0|||
154833883|NCT01999465|558826599|FG001|Overall Study|Protocol Violation|1|||
154833884|NCT02325219|558826600|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
154833885|NCT02325219|558826601|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
154833886|NCT02325219|558826602|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
154833887|NCT02325219|558826603|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
154833888|NCT02325219|558826604|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
154833889|NCT02325219|558826600|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
154833890|NCT02325219|558826601|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
154833891|NCT02325219|558826602|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
154833892|NCT02325219|558826603|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
154833893|NCT02325219|558826604|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
154833894|NCT02325219|558826600|FG000|Controlled Period (Week 0 - 16)|Other|0|||
154833895|NCT02325219|558826601|FG001|Controlled Period (Week 0 - 16)|Other|0|||
154833896|NCT02325219|558826602|FG002|Controlled Period (Week 0 - 16)|Other|1|||
154968216|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
154968217|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
154968218|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
154833897|NCT02325219|558826603|FG003|Controlled Period (Week 0 - 16)|Other|0|||
154833898|NCT02325219|558826604|FG004|Controlled Period (Week 0 - 16)|Other|0|||
154833899|NCT02325219|558826600|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
155098230|NCT01900665|559793202|FG000|Open Label Period|Adverse Event|16|||
155098231|NCT01900665|559793203|FG001|Open Label Period|Adverse Event|20|||
155098232|NCT01900665|559793202|FG000|Open Label Period|Death|5|||
155098233|NCT01900665|559793203|FG001|Open Label Period|Death|6|||
154968219|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
154968220|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
154833900|NCT02325219|558826601|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
154968221|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
154968222|NCT00073307|559307406|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
154968223|NCT00073307|559307407|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
154968224|NCT00073307|559307408|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
154968225|NCT00858780|559307409|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
154968226|NCT00858780|559307410|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
154968227|NCT00858780|559307411|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
155172559|NCT04784442|560071847|FG003|Overall Study|Non-compliance with study drug|0|||
155172560|NCT00509145|560071848|FG000|Overall Study|Death|0|||
155172561|NCT00509145|560071849|FG001|Overall Study|Death|2|||
154833901|NCT02325219|558826602|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
154833902|NCT02325219|558826603|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
154833903|NCT02325219|558826604|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
155172562|NCT00509145|560071848|FG000|Overall Study|Adverse Event|42|||
155172563|NCT00509145|560071849|FG001|Overall Study|Adverse Event|28|||
155172564|NCT00509145|560071848|FG000|Overall Study|Withdrawal by Subject|32|||
155172565|NCT00509145|560071849|FG001|Overall Study|Withdrawal by Subject|38|||
154968228|NCT00858780|559307412|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
154968229|NCT00858780|559307413|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
154968230|NCT00858780|559307409|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
154968231|NCT00858780|559307410|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
154968232|NCT00858780|559307411|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
154968233|NCT00858780|559307412|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
154968234|NCT00858780|559307413|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
154968235|NCT00858780|559307409|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
154968236|NCT00858780|559307410|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
154968237|NCT00858780|559307411|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
154968238|NCT00858780|559307412|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
154968239|NCT00858780|559307413|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
154968240|NCT00858780|559307409|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
154968241|NCT00858780|559307410|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
154968242|NCT00858780|559307411|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
154968243|NCT00858780|559307412|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
154968244|NCT00858780|559307413|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
154968245|NCT00858780|559307409|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
154968246|NCT00858780|559307410|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
154968247|NCT00858780|559307411|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
154968248|NCT00858780|559307412|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
154968249|NCT00858780|559307413|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
154968250|NCT00858780|559307409|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
154968251|NCT00858780|559307410|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
154968252|NCT00858780|559307411|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
154968253|NCT00858780|559307412|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
154968254|NCT00858780|559307413|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
154968255|NCT01964950|559307414|FG000|Overall Study|Protocol Violation|25|||
154968256|NCT01149057|559307415|FG000|Overall Study|Lack of Efficacy|16|||
154968257|NCT01149057|559307415|FG000|Overall Study|Adverse Event|13|||
154968258|NCT01149057|559307415|FG000|Overall Study|Withdrawal by Subject|9|||
154968259|NCT01149057|559307415|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
154968260|NCT01149057|559307415|FG000|Overall Study|B Cell Depletion|4|||
154968261|NCT01149057|559307415|FG000|Overall Study|Participant Non-Compliance|2|||
154968262|NCT01149057|559307415|FG000|Overall Study|Lost to Follow-up|1|||
154968263|NCT01149057|559307415|FG000|Overall Study|High Parathyroid Hormone Value|1|||
154968264|NCT01149057|559307415|FG000|Overall Study|Other|6|||
154968265|NCT03499873|559307416|FG000|Overall Study|Withdrawal by Subject|4|||
154968266|NCT03499873|559307417|FG001|Overall Study|Withdrawal by Subject|6|||
154968267|NCT03499873|559307418|FG002|Overall Study|Withdrawal by Subject|1|||
154968268|NCT03499873|559307416|FG000|Overall Study|Subjects condition worsened|0|||
154968269|NCT03499873|559307417|FG001|Overall Study|Subjects condition worsened|3|||
154968270|NCT03499873|559307418|FG002|Overall Study|Subjects condition worsened|11|||
154968271|NCT03499873|559307416|FG000|Overall Study|Adverse Event|8|||
154968272|NCT03499873|559307417|FG001|Overall Study|Adverse Event|3|||
154968273|NCT03499873|559307418|FG002|Overall Study|Adverse Event|6|||
154968274|NCT03499873|559307416|FG000|Overall Study|Physician Decision|1|||
154968275|NCT03499873|559307417|FG001|Overall Study|Physician Decision|0|||
154968276|NCT03499873|559307418|FG002|Overall Study|Physician Decision|0|||
154968277|NCT03499873|559307416|FG000|Overall Study|Administrative reasons|0|||
154968278|NCT03499873|559307417|FG001|Overall Study|Administrative reasons|1|||
154968279|NCT03499873|559307418|FG002|Overall Study|Administrative reasons|0|||
154968280|NCT03499873|559307416|FG000|Overall Study|Concomitant therapy|5|||
154968281|NCT03499873|559307417|FG001|Overall Study|Concomitant therapy|4|||
154968282|NCT03499873|559307418|FG002|Overall Study|Concomitant therapy|7|||
154968283|NCT03499873|559307416|FG000|Overall Study|Miscellaneous|1|||
154968284|NCT03499873|559307417|FG001|Overall Study|Miscellaneous|2|||
154968285|NCT03499873|559307418|FG002|Overall Study|Miscellaneous|2|||
154968286|NCT03499873|559307416|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
154968287|NCT03499873|559307417|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
154968288|NCT03499873|559307418|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
154968289|NCT03602339|559307419|FG000|Overall Study|Withdrawal by Subject|9|||
154968290|NCT03602339|559307419|FG000|Overall Study|Physician Decision|2|||
154968291|NCT03602339|559307419|FG000|Overall Study|Other reason|4|||
154968292|NCT01297504|559307420|FG000|Overall Study|Invalid Consent|1|||
154968293|NCT01297504|559307420|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
154968294|NCT01297504|559307420|FG000|Overall Study|No Study Visits|4|||
154968295|NCT01297504|559307420|FG000|Overall Study|Death|3|||
154968296|NCT01297504|559307420|FG000|Overall Study|Lost to Follow-up|43|||
154968297|NCT01297504|559307420|FG000|Overall Study|Withdrawal by Subject|9|||
154968298|NCT01297504|559307420|FG000|Overall Study|Site Closure|3|||
154968299|NCT01297504|559307420|FG000|Overall Study|Protocol Violation|3|||
154968300|NCT01190865|559307429|FG000|Overall Study|Withdrawal by Subject|1|||
154968301|NCT01190865|559307429|FG000|Overall Study|Non-compliance|2|||
154968302|NCT00574847|559307431|FG000|Overall Study|Adverse Event|2|||
154968303|NCT00574847|559307432|FG001|Overall Study|Adverse Event|0|||
154968304|NCT00574847|559307431|FG000|Overall Study|Death|1|||
154968305|NCT00574847|559307432|FG001|Overall Study|Death|0|||
154968306|NCT00574847|559307431|FG000|Overall Study|Withdrawal by Subject|2|||
154968307|NCT00574847|559307432|FG001|Overall Study|Withdrawal by Subject|2|||
154968308|NCT00574847|559307431|FG000|Overall Study|Physician Decision|1|||
154968309|NCT00574847|559307432|FG001|Overall Study|Physician Decision|0|||
154968310|NCT00574847|559307431|FG000|Overall Study|Did not receive medication (declined)|2|||
154968311|NCT00574847|559307432|FG001|Overall Study|Did not receive medication (declined)|5|||
154968312|NCT00881751|559307433|FG000|Overall Study|Physician Decision|0|||
154968313|NCT00881751|559307434|FG001|Overall Study|Physician Decision|1|||
154968314|NCT00881751|559307433|FG000|Overall Study|Adverse Event|0|||
154968315|NCT00881751|559307434|FG001|Overall Study|Adverse Event|2|||
154968316|NCT00881751|559307433|FG000|Overall Study|Withdrawal by Subject|0|||
154968317|NCT00881751|559307434|FG001|Overall Study|Withdrawal by Subject|2|||
154968318|NCT00957021|559307435|FG000|Overall Study|Death|5|||
154968319|NCT00957021|559307435|FG000|Overall Study|Lost to Follow-up|8|||
154968320|NCT00957021|559307435|FG000|Overall Study|Withdrawal by Subject|34|||
154968321|NCT00957021|559307435|FG000|Overall Study|No 2 yr ROM data|35|||
154968322|NCT00957021|559307435|FG000|Overall Study|Revised study component by 2 yr visit|8|||
154968323|NCT00957021|559307435|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
154968324|NCT00957021|559307435|FG000|Overall Study|Surgery Cancelled|9|||
154968325|NCT00957021|559307435|FG000|Overall Study|Termination due to language issue|2|||
154968326|NCT01087502|559307448|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
154968327|NCT01087502|559307449|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
154968328|NCT01087502|559307448|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
154968329|NCT01087502|559307449|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
154833904|NCT02325219|558826600|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
154833905|NCT02325219|558826601|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
154833906|NCT02325219|558826602|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
154833907|NCT02325219|558826603|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
155172566|NCT00509145|560071848|FG000|Overall Study|Physician Decision|11|||
154833908|NCT02325219|558826604|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
154833909|NCT02325219|558826600|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
154833910|NCT02325219|558826601|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
154833911|NCT02325219|558826602|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
154833912|NCT02325219|558826603|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
155098234|NCT01900665|559793202|FG000|Open Label Period|Lost to Follow-up|1|||
155098235|NCT01900665|559793203|FG001|Open Label Period|Lost to Follow-up|1|||
155098236|NCT01900665|559793202|FG000|Open Label Period|Parent/Caregiver Decision|33|||
155098237|NCT01900665|559793203|FG001|Open Label Period|Parent/Caregiver Decision|34|||
155098238|NCT01900665|559793202|FG000|Open Label Period|Physician Decision|4|||
155098239|NCT01900665|559793203|FG001|Open Label Period|Physician Decision|4|||
155098240|NCT01900665|559793202|FG000|Open Label Period|Protocol Violation|0|||
155098241|NCT01900665|559793203|FG001|Open Label Period|Protocol Violation|1|||
155098242|NCT01900665|559793202|FG000|Open Label Period|Sponsor Decision|802|||
155098243|NCT01900665|559793203|FG001|Open Label Period|Sponsor Decision|765|||
155098244|NCT01900665|559793202|FG000|Open Label Period|Withdrawal by Subject|20|||
155098245|NCT01900665|559793203|FG001|Open Label Period|Withdrawal by Subject|28|||
155098246|NCT04749914|559793204|FG000|Period 1|Adverse Event|1|||
155098247|NCT04749914|559793205|FG001|Period 1|Adverse Event|0|||
155098248|NCT04749914|559793206|FG002|Period 1|Adverse Event|0|||
155098249|NCT04749914|559793207|FG003|Period 1|Adverse Event|0|||
155098250|NCT04749914|559793204|FG000|Period 1|Withdrawal by Subject|1|||
155098251|NCT04749914|559793205|FG001|Period 1|Withdrawal by Subject|0|||
155098252|NCT04749914|559793206|FG002|Period 1|Withdrawal by Subject|1|||
155098253|NCT04749914|559793207|FG003|Period 1|Withdrawal by Subject|0|||
155098254|NCT04046939|559793208|FG000|Primary Assessment Period|Adverse Event|1|||
155098255|NCT04046939|559793209|FG001|Primary Assessment Period|Adverse Event|0|||
155098256|NCT04046939|559793210|FG002|Primary Assessment Period|Adverse Event|0|||
155098257|NCT04046939|559793211|FG003|Primary Assessment Period|Adverse Event|0|||
155098258|NCT04046939|559793208|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
155098259|NCT04046939|559793209|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
155098260|NCT04046939|559793210|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
155098261|NCT04046939|559793211|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
155098262|NCT04046939|559793208|FG000|Primary Assessment Period|Physician Decision|0|||
155098263|NCT04046939|559793209|FG001|Primary Assessment Period|Physician Decision|0|||
155098264|NCT04046939|559793210|FG002|Primary Assessment Period|Physician Decision|1|||
155098265|NCT04046939|559793211|FG003|Primary Assessment Period|Physician Decision|0|||
154833913|NCT02325219|558826604|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
154833914|NCT02187172|558826605|FG000|Overall Study|Lost to Follow-up|1|||
155098266|NCT04046939|559793208|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
155098267|NCT04046939|559793209|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
155098268|NCT04046939|559793210|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
155098269|NCT04046939|559793211|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
155098270|NCT01897532|559793213|FG000|Discontinuation From Treatment|Not Treated|7|||
155098271|NCT01897532|559793214|FG001|Discontinuation From Treatment|Not Treated|5|||
155098272|NCT01897532|559793213|FG000|Discontinuation From Treatment|Other reason than specified|196|||
155098273|NCT01897532|559793214|FG001|Discontinuation From Treatment|Other reason than specified|176|||
155172567|NCT00509145|560071849|FG001|Overall Study|Physician Decision|14|||
154833915|NCT02187172|558826606|FG001|Overall Study|Lost to Follow-up|2|||
155098274|NCT01897532|559793213|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
155098275|NCT01897532|559793214|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
155098276|NCT01897532|559793213|FG000|Discontinuation From Treatment|Non compliance|24|||
155098277|NCT01897532|559793214|FG001|Discontinuation From Treatment|Non compliance|15|||
155098278|NCT01897532|559793213|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
155098279|NCT01897532|559793214|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
155098280|NCT01897532|559793213|FG000|Discontinuation From Trial|Not Treated|7|||
155098281|NCT01897532|559793214|FG001|Discontinuation From Trial|Not Treated|5|||
155098282|NCT01897532|559793213|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
155098283|NCT01897532|559793214|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
155098284|NCT00953706|559793221|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
155098285|NCT00953706|559793222|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
155098286|NCT00953706|559793223|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
155098287|NCT00953706|559793224|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
154833916|NCT02187172|558826605|FG000|Overall Study|Lack of Efficacy|1|||
154833917|NCT02187172|558826606|FG001|Overall Study|Lack of Efficacy|2|||
154833918|NCT02187172|558826605|FG000|Overall Study|Adverse Event|0|||
154833919|NCT02187172|558826606|FG001|Overall Study|Adverse Event|1|||
154833920|NCT02187172|558826605|FG000|Overall Study|Physician Decision|1|||
154833921|NCT02187172|558826606|FG001|Overall Study|Physician Decision|1|||
154833922|NCT01549275|558826612|FG000|Overall Study|Lost to Follow-up|1|||
154833923|NCT01549275|558826613|FG001|Overall Study|Lost to Follow-up|0|||
154833924|NCT03179891|558826618|FG000|First Intervention|Withdrawal by Subject|1|||
154833925|NCT03179891|558826619|FG001|First Intervention|Withdrawal by Subject|1|||
154833926|NCT03179891|558826618|FG000|First Intervention|Unspecified reason|1|||
154833927|NCT03179891|558826619|FG001|First Intervention|Unspecified reason|0|||
154833928|NCT03179891|558826618|FG000|First Intervention|Protocol Violation|0|||
154833929|NCT03179891|558826619|FG001|First Intervention|Protocol Violation|1|||
154833930|NCT02969187|558826624|FG000|Overall Study|Physician Decision|12|||
154833931|NCT02969187|558826625|FG001|Overall Study|Physician Decision|13|||
154833932|NCT03719690|558826630|FG000|Overall Study|Withdrawal by Subject|5|||
154833933|NCT03719690|558826631|FG001|Overall Study|Withdrawal by Subject|10|||
154833934|NCT03719690|558826630|FG000|Overall Study|Death|40|||
154833935|NCT03719690|558826631|FG001|Overall Study|Death|149|||
154833936|NCT03719690|558826630|FG000|Overall Study|Miscellaneous|12|||
154833937|NCT03719690|558826631|FG001|Overall Study|Miscellaneous|56|||
154833938|NCT03719690|558826630|FG000|Overall Study|Lost to Follow-up|2|||
154833939|NCT03719690|558826631|FG001|Overall Study|Lost to Follow-up|18|||
154833940|NCT03719690|558826630|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
155172568|NCT00509145|560071848|FG000|Overall Study|Protocol Violation|1|||
155172569|NCT00509145|560071849|FG001|Overall Study|Protocol Violation|6|||
154833941|NCT03719690|558826631|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
154833942|NCT04416555|558826632|FG000|Overall Study|Withdrawal by Subject|0|||
154833943|NCT04416555|558826633|FG001|Overall Study|Withdrawal by Subject|3|||
155098288|NCT00953706|559793221|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
154833944|NCT00530270|558826636|FG000|Overall Study|Protocol Violation|1|||
154833945|NCT00530270|558826637|FG001|Overall Study|Protocol Violation|0|||
154833946|NCT03374189|558826639|FG000|Overall Study|Lost to Follow-up|1|||
154833947|NCT03374189|558826640|FG001|Overall Study|Lost to Follow-up|0|||
154833948|NCT02375724|558826641|FG000|Overall Study|Lack of Efficacy|1|||
154833949|NCT02375724|558826642|FG001|Overall Study|Lack of Efficacy|1|||
154833950|NCT02375724|558826641|FG000|Overall Study|Withdrawal by Subject|1|||
154833951|NCT02375724|558826642|FG001|Overall Study|Withdrawal by Subject|1|||
154833952|NCT02375724|558826641|FG000|Overall Study|Lost to Follow-up|1|||
154833953|NCT02375724|558826642|FG001|Overall Study|Lost to Follow-up|0|||
154833954|NCT02375724|558826641|FG000|Overall Study|Protocol Violation|1|||
154833955|NCT02375724|558826642|FG001|Overall Study|Protocol Violation|0|||
154833956|NCT02375724|558826641|FG000|Overall Study|Adverse Event|2|||
154833957|NCT02375724|558826642|FG001|Overall Study|Adverse Event|4|||
154833958|NCT04712110|558826645|FG000|Overall Study|Lost to Follow-up|0|||
154833959|NCT04712110|558826646|FG001|Overall Study|Lost to Follow-up|1|||
154833960|NCT04712110|558826645|FG000|Overall Study|Withdrawal by Subject|0|||
154833961|NCT04712110|558826646|FG001|Overall Study|Withdrawal by Subject|4|||
154833962|NCT04712110|558826645|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
154833963|NCT04712110|558826646|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
154833964|NCT01197521|558826647|FG000|Overall Study|Not reported|24|||
154833965|NCT01197521|558826648|FG001|Overall Study|Not reported|25|||
154833966|NCT01197521|558826649|FG002|Overall Study|Not reported|21|||
154833967|NCT01197521|558826647|FG000|Overall Study|Enrolment in long term extension|42|||
154833968|NCT01197521|558826648|FG001|Overall Study|Enrolment in long term extension|36|||
154833969|NCT01197521|558826649|FG002|Overall Study|Enrolment in long term extension|87|||
154833970|NCT01197521|558826647|FG000|Overall Study|Severe non-compliance to protocol|1|||
154833971|NCT01197521|558826648|FG001|Overall Study|Severe non-compliance to protocol|3|||
154833972|NCT01197521|558826649|FG002|Overall Study|Severe non-compliance to protocol|3|||
154833973|NCT01197521|558826647|FG000|Overall Study|Lack of therapeutic response|2|||
154833974|NCT01197521|558826648|FG001|Overall Study|Lack of therapeutic response|3|||
154833975|NCT01197521|558826649|FG002|Overall Study|Lack of therapeutic response|4|||
154833976|NCT01197521|558826647|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
154833977|NCT01197521|558826648|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
154833978|NCT01197521|558826649|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
155098289|NCT00953706|559793222|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
155098290|NCT00953706|559793223|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
155098291|NCT00953706|559793224|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
155098292|NCT00953706|559793221|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
155172570|NCT00509145|560071848|FG000|Overall Study|Pregnancy|3|||
154833979|NCT01197521|558826647|FG000|Overall Study|Lost to Follow-up|3|||
154833980|NCT01197521|558826648|FG001|Overall Study|Lost to Follow-up|2|||
155098293|NCT00953706|559793222|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
154968330|NCT01087502|559307448|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
154968331|NCT01087502|559307449|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
154968332|NCT01087502|559307448|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
154968333|NCT01087502|559307449|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
154968334|NCT01087502|559307448|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
154968335|NCT01087502|559307449|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
154968336|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
154968337|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
154968338|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
154968339|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
154968340|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
154968341|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
154968342|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
155172571|NCT00509145|560071849|FG001|Overall Study|Pregnancy|8|||
154968343|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
154968344|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
154968345|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
154968346|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
154968347|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
155172572|NCT00509145|560071848|FG000|Overall Study|Lost to Follow-up|6|||
154968348|NCT01087502|559307448|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
154968349|NCT01087502|559307449|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
154968350|NCT01653704|559307450|FG000|Overall Study|Technical failure during recording|1|||
154968351|NCT01653704|559307451|FG001|Overall Study|Technical failure during recording|1|||
154968352|NCT01653704|559307450|FG000|Overall Study|Performance not reflective of training|1|||
154968353|NCT01653704|559307451|FG001|Overall Study|Performance not reflective of training|0|||
154968354|NCT02705716|559307452|FG000|Overall Study|Adverse Event|0|||
154968355|NCT02705716|559307453|FG001|Overall Study|Adverse Event|1|||
154968356|NCT02705716|559307452|FG000|Overall Study|Protocol Violation|3|||
154968357|NCT02705716|559307453|FG001|Overall Study|Protocol Violation|0|||
154968358|NCT02705716|559307452|FG000|Overall Study|Withdrawal of Consent|1|||
154968359|NCT02705716|559307453|FG001|Overall Study|Withdrawal of Consent|1|||
154968360|NCT00562718|559307454|FG000|Overall Study|Death|1|||
154968361|NCT00562718|559307454|FG000|Overall Study|Withdrawal by Subject|3|||
154968362|NCT00562718|559307454|FG000|Overall Study|Adverse Event|4|||
154968363|NCT00562718|559307454|FG000|Overall Study|Lack of Efficacy|2|||
154968364|NCT00562718|559307454|FG000|Overall Study|not stated|1|||
154968365|NCT01151618|559307455|FG000|Overall Study|Adverse Event|2|||
154968366|NCT01151618|559307455|FG000|Overall Study|Withdrawal by Subject|7|||
154968367|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
154968368|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
154968369|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
154968370|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
154968371|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
154968372|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
154968373|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
154968374|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
154968375|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
154968376|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
154968377|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
154968378|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
154968379|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
154968380|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
154968381|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
154968382|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
154968383|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
154968384|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
155172573|NCT00509145|560071849|FG001|Overall Study|Lost to Follow-up|5|||
155172574|NCT00509145|560071848|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
154968385|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
154968386|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
155172575|NCT00509145|560071849|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
154968387|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
154968388|NCT02227238|559307456|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
154968389|NCT02227238|559307457|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
154968390|NCT02227238|559307458|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
154968391|NCT02227238|559307456|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
154968392|NCT02227238|559307457|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
154968393|NCT02227238|559307458|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
154968394|NCT02227238|559307456|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
154968395|NCT02227238|559307457|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
154968396|NCT02227238|559307458|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
154968397|NCT02227238|559307456|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
154968398|NCT02227238|559307457|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
154968399|NCT02227238|559307458|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
154968400|NCT02227238|559307456|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
154968401|NCT02227238|559307457|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
154968402|NCT02227238|559307458|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
154968403|NCT02227238|559307456|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
154968404|NCT02227238|559307457|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
154968405|NCT02227238|559307458|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
154968406|NCT02227238|559307456|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
154968407|NCT02227238|559307457|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
154968408|NCT02227238|559307458|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
154968409|NCT03966911|559307460|FG000|Overall Study|Adverse Event|1|||
154968410|NCT03966911|559307461|FG001|Overall Study|Adverse Event|1|||
154968411|NCT03966911|559307460|FG000|Overall Study|Withdrawal by Subject|8|||
154968412|NCT03966911|559307461|FG001|Overall Study|Withdrawal by Subject|2|||
154968413|NCT03966911|559307460|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
154968414|NCT03966911|559307461|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
154968415|NCT00985751|559307462|FG000|Overall Study|Adverse Event|0|||
154968416|NCT00985751|559307463|FG001|Overall Study|Adverse Event|0|||
154968417|NCT00985751|559307464|FG002|Overall Study|Adverse Event|0|||
154968418|NCT00985751|559307465|FG003|Overall Study|Adverse Event|0|||
154968419|NCT00985751|559307466|FG004|Overall Study|Adverse Event|1|||
154968420|NCT01663896|559307467|FG000|Overall Study|Various reasons|43|||
154968421|NCT00474188|559307470|FG000|Overall Study|Withdrawal by Subject|1|||
155098294|NCT00953706|559793223|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
155098295|NCT00953706|559793224|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
155098296|NCT00953706|559793221|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
155098297|NCT00953706|559793222|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
155098298|NCT00953706|559793223|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
155098299|NCT00953706|559793224|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
155098300|NCT00953706|559793221|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
155098301|NCT00953706|559793222|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
155098302|NCT00953706|559793223|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
155098303|NCT00953706|559793224|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
155098304|NCT00953706|559793221|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
155172576|NCT00509145|560071848|FG000|Overall Study|Other|6|||
155172577|NCT00509145|560071849|FG001|Overall Study|Other|6|||
155172578|NCT00246740|560071850|FG000|Initial Enrollment|Death|1|||
155172579|NCT00246740|560071851|FG001|Initial Enrollment|Death|0|||
155172580|NCT00246740|560071850|FG000|Initial Enrollment|Additional surgery scheduled|0|||
155172581|NCT00246740|560071851|FG001|Initial Enrollment|Additional surgery scheduled|2|||
155172582|NCT00246740|560071850|FG000|Initial Enrollment|Surgery schedule change|4|||
154968422|NCT00474188|559307470|FG000|Overall Study|Study discontinued by sponsor|5|||
154968423|NCT05412121|559307473|FG000|Overall Study|Withdrawal by Subject|4|||
154968424|NCT05412121|559307473|FG000|Overall Study|Physician Decision|1|||
155098305|NCT00953706|559793222|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
155098306|NCT00953706|559793223|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
155098307|NCT00953706|559793224|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
155098308|NCT00953706|559793221|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
155098309|NCT00953706|559793222|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
155098310|NCT00953706|559793223|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
154833981|NCT01197521|558826649|FG002|Overall Study|Lost to Follow-up|2|||
154833982|NCT01197521|558826647|FG000|Overall Study|Adverse Event|25|||
154833983|NCT01197521|558826648|FG001|Overall Study|Adverse Event|28|||
154833984|NCT01197521|558826649|FG002|Overall Study|Adverse Event|24|||
154833985|NCT02018822|558826650|FG000|Overall Study|filling replaced by crown|0|||
154833986|NCT02018822|558826651|FG001|Overall Study|filling replaced by crown|1|||
154833987|NCT02018822|558826652|FG002|Overall Study|filling replaced by crown|0|||
154833988|NCT02018822|558826650|FG000|Overall Study|Physician Decision|0|||
154833989|NCT02018822|558826651|FG001|Overall Study|Physician Decision|1|||
154833990|NCT02018822|558826652|FG002|Overall Study|Physician Decision|1|||
154833991|NCT02018822|558826650|FG000|Overall Study|Lost to Follow-up|6|||
154833992|NCT02018822|558826651|FG001|Overall Study|Lost to Follow-up|6|||
154833993|NCT02018822|558826652|FG002|Overall Study|Lost to Follow-up|5|||
154833994|NCT02285777|558826653|FG000|Overall Study|Withdrawal by Subject|1|||
154833995|NCT02285777|558826654|FG001|Overall Study|Withdrawal by Subject|1|||
154833996|NCT02285777|558826653|FG000|Overall Study|Lost to Follow-up|4|||
154833997|NCT02285777|558826654|FG001|Overall Study|Lost to Follow-up|2|||
154833998|NCT03201458|558826655|FG000|Overall Study|No longer eligible|2|||
154833999|NCT03201458|558826656|FG001|Overall Study|No longer eligible|5|||
154834000|NCT03201458|558826655|FG000|Overall Study|Health event before starting|1|||
154834001|NCT03201458|558826656|FG001|Overall Study|Health event before starting|0|||
154834002|NCT03201458|558826655|FG000|Overall Study|Physician Decision|1|||
154834003|NCT03201458|558826656|FG001|Overall Study|Physician Decision|0|||
154834004|NCT00715026|558826659|FG000|Overall Study|Withdrawal by Subject|5|||
154968425|NCT05412121|559307473|FG000|Overall Study|Lost to Follow-up|5|||
154968426|NCT01962298|559307474|FG000|Overall Study|Protocol Violation|1|||
154968427|NCT01962298|559307475|FG001|Overall Study|Protocol Violation|0|||
154968428|NCT01962298|559307476|FG002|Overall Study|Protocol Violation|1|||
154968429|NCT01962298|559307477|FG003|Overall Study|Protocol Violation|1|||
154968430|NCT01962298|559307478|FG004|Overall Study|Protocol Violation|0|||
154968431|NCT01962298|559307474|FG000|Overall Study|Data quality insufficient|2|||
154968432|NCT01962298|559307475|FG001|Overall Study|Data quality insufficient|0|||
154968433|NCT01962298|559307476|FG002|Overall Study|Data quality insufficient|3|||
154968434|NCT01962298|559307477|FG003|Overall Study|Data quality insufficient|1|||
154834005|NCT00715026|558826659|FG000|Overall Study|Lost to Follow-up|3|||
154968435|NCT01962298|559307478|FG004|Overall Study|Data quality insufficient|4|||
154968436|NCT01962298|559307474|FG000|Overall Study|Insufficient data|0|||
154968437|NCT01962298|559307475|FG001|Overall Study|Insufficient data|2|||
155172583|NCT00246740|560071851|FG001|Initial Enrollment|Surgery schedule change|4|||
155172584|NCT00246740|560071850|FG000|Initial Enrollment|Other|1|||
155172585|NCT00246740|560071851|FG001|Initial Enrollment|Other|2|||
155172586|NCT00101452|560071854|FG000|Overall Study|Adverse Event|2|||
155172587|NCT00101452|560071855|FG001|Overall Study|Adverse Event|0|||
155172588|NCT00101452|560071856|FG002|Overall Study|Adverse Event|1|||
155172589|NCT00101452|560071854|FG000|Overall Study|Lost to Follow-up|13|||
155172590|NCT00101452|560071855|FG001|Overall Study|Lost to Follow-up|8|||
155172591|NCT00101452|560071856|FG002|Overall Study|Lost to Follow-up|14|||
155172592|NCT00101452|560071854|FG000|Overall Study|Withdrawal by Subject|10|||
155172593|NCT00101452|560071855|FG001|Overall Study|Withdrawal by Subject|14|||
155172594|NCT00101452|560071856|FG002|Overall Study|Withdrawal by Subject|9|||
155172595|NCT00101452|560071854|FG000|Overall Study|Baseline Fail|2|||
155098311|NCT00953706|559793224|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
155098312|NCT00953706|559793221|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
155098313|NCT00953706|559793222|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
155098314|NCT00953706|559793223|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
155098315|NCT00953706|559793224|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
155098316|NCT00953706|559793221|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
155098317|NCT00953706|559793222|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
155098318|NCT00953706|559793223|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
155098319|NCT00953706|559793224|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
155098320|NCT00953706|559793221|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
155098321|NCT00953706|559793222|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
155098322|NCT00953706|559793223|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
155098323|NCT00953706|559793224|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
155098324|NCT00953706|559793221|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
155098325|NCT00953706|559793222|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
155098326|NCT00953706|559793223|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
155098327|NCT00953706|559793224|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
155098328|NCT01214837|559793225|FG000|Overall Study|Death|0|||
155098329|NCT01214837|559793226|FG001|Overall Study|Death|0|||
155098330|NCT01214837|559793227|FG002|Overall Study|Death|1|||
155098331|NCT01214837|559793225|FG000|Overall Study|Adverse Event|1|||
155098332|NCT01214837|559793226|FG001|Overall Study|Adverse Event|2|||
155098333|NCT01214837|559793227|FG002|Overall Study|Adverse Event|1|||
155098334|NCT01214837|559793225|FG000|Overall Study|Withdrawal by Subject|27|||
155098335|NCT01214837|559793226|FG001|Overall Study|Withdrawal by Subject|36|||
155098336|NCT01214837|559793227|FG002|Overall Study|Withdrawal by Subject|28|||
155098337|NCT01214837|559793225|FG000|Overall Study|Lost to Follow-up|20|||
155098338|NCT01214837|559793226|FG001|Overall Study|Lost to Follow-up|15|||
155098339|NCT01214837|559793227|FG002|Overall Study|Lost to Follow-up|21|||
155098340|NCT01214837|559793225|FG000|Overall Study|Inappropriate Enrolment|0|||
155098341|NCT01214837|559793226|FG001|Overall Study|Inappropriate Enrolment|1|||
155098342|NCT01214837|559793227|FG002|Overall Study|Inappropriate Enrolment|2|||
154968438|NCT01962298|559307476|FG002|Overall Study|Insufficient data|1|||
154968439|NCT01962298|559307477|FG003|Overall Study|Insufficient data|0|||
154968440|NCT01962298|559307478|FG004|Overall Study|Insufficient data|1|||
154968441|NCT01962298|559307474|FG000|Overall Study|Incorrect data recorded|0|||
154968442|NCT01962298|559307475|FG001|Overall Study|Incorrect data recorded|1|||
154968443|NCT01962298|559307476|FG002|Overall Study|Incorrect data recorded|0|||
155098343|NCT01214837|559793225|FG000|Overall Study|Administrative Reason|2|||
155098344|NCT01214837|559793226|FG001|Overall Study|Administrative Reason|6|||
154968444|NCT01962298|559307477|FG003|Overall Study|Incorrect data recorded|0|||
155098345|NCT01214837|559793227|FG002|Overall Study|Administrative Reason|4|||
155098346|NCT01214837|559793225|FG000|Overall Study|Protocol Violation|3|||
154968445|NCT01962298|559307478|FG004|Overall Study|Incorrect data recorded|0|||
155098347|NCT01214837|559793226|FG001|Overall Study|Protocol Violation|1|||
155098348|NCT01214837|559793227|FG002|Overall Study|Protocol Violation|5|||
155098349|NCT01214837|559793225|FG000|Overall Study|Unable to Classify|1|||
155098350|NCT01214837|559793226|FG001|Overall Study|Unable to Classify|3|||
155098351|NCT01214837|559793227|FG002|Overall Study|Unable to Classify|0|||
155098352|NCT05414175|559793228|FG000|Overall Study|Withdrawal by Subject|1|||
155098353|NCT05414175|559793228|FG000|Overall Study|Other Reasons|1|||
155098354|NCT00027560|559793229|FG000|Overall Study|Withdrawal by Subject|1|||
155098355|NCT03559270|559793231|FG000|Overall Study|Adverse Event|6|||
155098356|NCT03559270|559793232|FG001|Overall Study|Adverse Event|5|||
155098357|NCT03559270|559793233|FG002|Overall Study|Adverse Event|3|||
155098358|NCT03559270|559793234|FG003|Overall Study|Adverse Event|0|||
155098359|NCT03559270|559793231|FG000|Overall Study|Lack of Efficacy|34|||
155098360|NCT03559270|559793232|FG001|Overall Study|Lack of Efficacy|52|||
155098361|NCT03559270|559793233|FG002|Overall Study|Lack of Efficacy|37|||
155098362|NCT03559270|559793234|FG003|Overall Study|Lack of Efficacy|2|||
155098363|NCT03559270|559793231|FG000|Overall Study|Death|0|||
155098364|NCT03559270|559793232|FG001|Overall Study|Death|2|||
155098365|NCT03559270|559793233|FG002|Overall Study|Death|0|||
155098366|NCT03559270|559793234|FG003|Overall Study|Death|0|||
155098367|NCT03559270|559793231|FG000|Overall Study|Lost to Follow-up|16|||
155098368|NCT03559270|559793232|FG001|Overall Study|Lost to Follow-up|4|||
155098369|NCT03559270|559793233|FG002|Overall Study|Lost to Follow-up|12|||
155098370|NCT03559270|559793234|FG003|Overall Study|Lost to Follow-up|3|||
155098371|NCT03559270|559793231|FG000|Overall Study|Sponsor Decision|38|||
155098372|NCT03559270|559793232|FG001|Overall Study|Sponsor Decision|31|||
155098373|NCT03559270|559793233|FG002|Overall Study|Sponsor Decision|35|||
155098374|NCT03559270|559793234|FG003|Overall Study|Sponsor Decision|18|||
155098375|NCT03559270|559793231|FG000|Overall Study|Withdrawal by Subject|19|||
155098376|NCT03559270|559793232|FG001|Overall Study|Withdrawal by Subject|21|||
155098377|NCT03559270|559793233|FG002|Overall Study|Withdrawal by Subject|18|||
155098378|NCT03559270|559793234|FG003|Overall Study|Withdrawal by Subject|7|||
155098379|NCT03559270|559793231|FG000|Overall Study|Physician Decision|3|||
155098380|NCT03559270|559793232|FG001|Overall Study|Physician Decision|2|||
154968446|NCT01962298|559307474|FG000|Overall Study|Physician Decision|0|||
154968447|NCT01962298|559307475|FG001|Overall Study|Physician Decision|1|||
154968448|NCT01962298|559307476|FG002|Overall Study|Physician Decision|0|||
154968449|NCT01962298|559307477|FG003|Overall Study|Physician Decision|0|||
154968450|NCT01962298|559307478|FG004|Overall Study|Physician Decision|1|||
154968451|NCT04476277|559307479|FG000|Overall Study|Withdrawal by Subject|0|||
154968452|NCT04476277|559307480|FG001|Overall Study|Withdrawal by Subject|0|||
154968453|NCT04476277|559307481|FG002|Overall Study|Withdrawal by Subject|1|||
154968454|NCT04476277|559307482|FG003|Overall Study|Withdrawal by Subject|0|||
154968455|NCT01576705|559307483|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
154968456|NCT01576705|559307484|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
154968457|NCT01576705|559307485|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
154968458|NCT01576705|559307486|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
155098381|NCT03559270|559793233|FG002|Overall Study|Physician Decision|1|||
155098382|NCT03559270|559793234|FG003|Overall Study|Physician Decision|0|||
155172596|NCT00101452|560071855|FG001|Overall Study|Baseline Fail|1|||
155098383|NCT03559270|559793231|FG000|Overall Study|Pregnancy|0|||
155098384|NCT03559270|559793232|FG001|Overall Study|Pregnancy|1|||
155098385|NCT03559270|559793233|FG002|Overall Study|Pregnancy|0|||
155098386|NCT03559270|559793234|FG003|Overall Study|Pregnancy|0|||
155098387|NCT03559270|559793231|FG000|Overall Study|Protocol Violation|1|||
155098388|NCT03559270|559793232|FG001|Overall Study|Protocol Violation|0|||
155098389|NCT03559270|559793233|FG002|Overall Study|Protocol Violation|2|||
155098390|NCT03559270|559793234|FG003|Overall Study|Protocol Violation|0|||
155098391|NCT04790279|559795182|FG000|Overall Study|Did not meet medication start criteria|27|||
155098392|NCT04790279|559795183|FG001|Overall Study|Did not meet medication start criteria|15|||
155098393|NCT04790279|559795182|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
155098394|NCT04790279|559795183|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
155098395|NCT04790279|559795182|FG000|Overall Study|Protocol Violation|8|||
155098396|NCT04790279|559795183|FG001|Overall Study|Protocol Violation|3|||
155098397|NCT04790279|559795182|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
155098398|NCT04790279|559795183|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
155098399|NCT00784368|559795189|FG000|Overall Study|Physician Decision|0|||
155098400|NCT00784368|559795190|FG001|Overall Study|Physician Decision|0|||
155098401|NCT00784368|559795191|FG002|Overall Study|Physician Decision|6|||
155098402|NCT00784368|559795189|FG000|Overall Study|Lack of Efficacy|2|||
155098403|NCT00784368|559795190|FG001|Overall Study|Lack of Efficacy|0|||
155098404|NCT00784368|559795191|FG002|Overall Study|Lack of Efficacy|1|||
155098405|NCT00784368|559795189|FG000|Overall Study|Adverse Event|6|||
155098406|NCT00784368|559795190|FG001|Overall Study|Adverse Event|9|||
155098407|NCT00784368|559795191|FG002|Overall Study|Adverse Event|2|||
155098408|NCT00784368|559795189|FG000|Overall Study|Diagnosis of fever|0|||
155098409|NCT00784368|559795190|FG001|Overall Study|Diagnosis of fever|0|||
155098410|NCT00784368|559795191|FG002|Overall Study|Diagnosis of fever|1|||
155098411|NCT00784368|559795189|FG000|Overall Study|Worsening of complications|0|||
155098412|NCT00784368|559795190|FG001|Overall Study|Worsening of complications|0|||
155098413|NCT00784368|559795191|FG002|Overall Study|Worsening of complications|1|||
155098414|NCT00784368|559795189|FG000|Overall Study|Worsening of symptoms|0|||
155098415|NCT00784368|559795190|FG001|Overall Study|Worsening of symptoms|1|||
155098416|NCT00784368|559795191|FG002|Overall Study|Worsening of symptoms|0|||
155098417|NCT00784368|559795189|FG000|Overall Study|Withdrawal of informed consent|0|||
155098418|NCT00784368|559795190|FG001|Overall Study|Withdrawal of informed consent|1|||
155098419|NCT00784368|559795191|FG002|Overall Study|Withdrawal of informed consent|0|||
155098420|NCT00720356|559795194|FG000|Registration to Study|Determined to have methylated MGMT|67|||
155098421|NCT00720356|559795194|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
155098422|NCT00720356|559795194|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
155098423|NCT00720356|559795194|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
155098424|NCT00720356|559795194|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
155098425|NCT00720356|559795194|FG000|Follow up Until Death|Withdrawal by Subject|1|||
155098426|NCT00720356|559795194|FG000|Follow up Until Death|Alive at last data collection|4|||
155098427|NCT01713582|559795197|FG000|Overall Study|Disease progression|3|||
155098428|NCT01713582|559795198|FG001|Overall Study|Disease progression|3|||
155098429|NCT01713582|559795199|FG002|Overall Study|Disease progression|3|||
155172597|NCT00101452|560071856|FG002|Overall Study|Baseline Fail|2|||
154968459|NCT01576705|559307483|FG000|Overall Study|invalid ICF|0|||
155098430|NCT01713582|559795200|FG003|Overall Study|Disease progression|2|||
155098431|NCT01713582|559795201|FG004|Overall Study|Disease progression|3|||
155098432|NCT01713582|559795202|FG005|Overall Study|Disease progression|3|||
155098433|NCT01713582|559795203|FG006|Overall Study|Disease progression|3|||
155098434|NCT01713582|559795204|FG007|Overall Study|Disease progression|3|||
155098435|NCT01713582|559795205|FG008|Overall Study|Disease progression|3|||
155098436|NCT01713582|559795206|FG009|Overall Study|Disease progression|11|||
155098437|NCT01713582|559795207|FG010|Overall Study|Disease progression|10|||
155098438|NCT01713582|559795208|FG011|Overall Study|Disease progression|5|||
154968460|NCT01576705|559307484|FG001|Overall Study|invalid ICF|1|||
154968461|NCT01576705|559307485|FG002|Overall Study|invalid ICF|0|||
154968462|NCT01576705|559307486|FG003|Overall Study|invalid ICF|0|||
154968463|NCT03727139|559307487|FG000|Overall Study|Protocol Violation|60|||
154968464|NCT00566722|559307488|FG000|Overall Study|Adverse Event|0|||
154968465|NCT00566722|559307489|FG001|Overall Study|Adverse Event|1|||
154968466|NCT00566722|559307490|FG002|Overall Study|Adverse Event|0|||
154968467|NCT00566722|559307488|FG000|Overall Study|Withdrawal by Subject|0|||
154968468|NCT00566722|559307489|FG001|Overall Study|Withdrawal by Subject|0|||
154968469|NCT00566722|559307490|FG002|Overall Study|Withdrawal by Subject|1|||
154968470|NCT00566722|559307488|FG000|Overall Study|Lost to Follow-up|1|||
154968471|NCT00566722|559307489|FG001|Overall Study|Lost to Follow-up|1|||
154968472|NCT00566722|559307490|FG002|Overall Study|Lost to Follow-up|1|||
154968473|NCT00566722|559307488|FG000|Overall Study|Lack of Efficacy|1|||
154968474|NCT00566722|559307489|FG001|Overall Study|Lack of Efficacy|2|||
154968475|NCT00566722|559307490|FG002|Overall Study|Lack of Efficacy|4|||
154968476|NCT00566722|559307488|FG000|Overall Study|Did not meet exclusion criteria|0|||
154968477|NCT00566722|559307489|FG001|Overall Study|Did not meet exclusion criteria|0|||
154968478|NCT00566722|559307490|FG002|Overall Study|Did not meet exclusion criteria|2|||
154968479|NCT00566722|559307488|FG000|Overall Study|Serious adverse event|0|||
154968480|NCT00566722|559307489|FG001|Overall Study|Serious adverse event|1|||
155098439|NCT01713582|559795209|FG012|Overall Study|Disease progression|3|||
155098440|NCT01713582|559795210|FG013|Overall Study|Disease progression|3|||
154968481|NCT00566722|559307490|FG002|Overall Study|Serious adverse event|0|||
154968482|NCT00566722|559307488|FG000|Overall Study|Noncompliant with drug administration|0|||
154968483|NCT00566722|559307489|FG001|Overall Study|Noncompliant with drug administration|0|||
154968484|NCT00566722|559307490|FG002|Overall Study|Noncompliant with drug administration|1|||
154968485|NCT03961204|559307491|FG000|Overall Study|Withdrawal by Subject|2|||
154968486|NCT03961204|559307491|FG000|Overall Study|Lost to Follow-up|3|||
154968487|NCT03961204|559307491|FG000|Overall Study|Other|1|||
155098441|NCT01713582|559795211|FG014|Overall Study|Disease progression|6|||
155098442|NCT01713582|559795212|FG015|Overall Study|Disease progression|6|||
154968488|NCT03961204|559307491|FG000|Overall Study|Missing|1|||
154968489|NCT02218216|559307492|FG000|Overall Study|Study terminated before completed|6|||
154968490|NCT02218216|559307493|FG001|Overall Study|Study terminated before completed|0|||
154968491|NCT02218216|559307494|FG002|Overall Study|Study terminated before completed|0|||
154968492|NCT05740098|559307499|FG000|Overall Study|Lost to Follow-up|26|||
154968493|NCT05740098|559307500|FG001|Overall Study|Lost to Follow-up|17|||
154968494|NCT05740098|559307501|FG002|Overall Study|Lost to Follow-up|21|||
155098443|NCT01713582|559795213|FG016|Overall Study|Disease progression|5|||
155098444|NCT01713582|559795214|FG017|Overall Study|Disease progression|2|||
155098445|NCT01713582|559795215|FG018|Overall Study|Disease progression|3|||
155098446|NCT01713582|559795216|FG019|Overall Study|Disease progression|5|||
155098447|NCT01713582|559795217|FG020|Overall Study|Disease progression|15|||
155098448|NCT01713582|559795197|FG000|Overall Study|Death|0|||
155098449|NCT01713582|559795198|FG001|Overall Study|Death|0|||
155098450|NCT01713582|559795199|FG002|Overall Study|Death|0|||
155098451|NCT01713582|559795200|FG003|Overall Study|Death|1|||
155098452|NCT01713582|559795201|FG004|Overall Study|Death|1|||
155098453|NCT01713582|559795202|FG005|Overall Study|Death|3|||
155098454|NCT01713582|559795203|FG006|Overall Study|Death|3|||
155098455|NCT01713582|559795204|FG007|Overall Study|Death|2|||
155098456|NCT01713582|559795205|FG008|Overall Study|Death|3|||
154834006|NCT00715026|558826659|FG000|Overall Study|Protocol Violation|1|||
154834007|NCT00715026|558826659|FG000|Overall Study|Surgery done on non-study consented hip|1|||
155098457|NCT01713582|559795206|FG009|Overall Study|Death|4|||
155098458|NCT01713582|559795207|FG010|Overall Study|Death|3|||
155098459|NCT01713582|559795208|FG011|Overall Study|Death|0|||
155098460|NCT01713582|559795209|FG012|Overall Study|Death|0|||
155098461|NCT01713582|559795210|FG013|Overall Study|Death|0|||
155098462|NCT01713582|559795211|FG014|Overall Study|Death|0|||
155098463|NCT01713582|559795212|FG015|Overall Study|Death|0|||
155098464|NCT01713582|559795213|FG016|Overall Study|Death|0|||
155098465|NCT01713582|559795214|FG017|Overall Study|Death|0|||
154968495|NCT01131260|559307502|FG000|Overall Study|Randomization error|5|||
155098466|NCT01713582|559795215|FG018|Overall Study|Death|0|||
155098467|NCT01713582|559795216|FG019|Overall Study|Death|0|||
155098468|NCT01713582|559795217|FG020|Overall Study|Death|0|||
155098469|NCT01713582|559795197|FG000|Overall Study|Adverse event-related|0|||
155098470|NCT01713582|559795198|FG001|Overall Study|Adverse event-related|0|||
155098471|NCT01713582|559795199|FG002|Overall Study|Adverse event-related|0|||
155098472|NCT01713582|559795200|FG003|Overall Study|Adverse event-related|0|||
154834008|NCT00750737|558826667|FG000|Overall Study|Withdrawal by Subject|3|||
154834009|NCT00750737|558826668|FG001|Overall Study|Withdrawal by Subject|3|||
154834010|NCT03625687|558826669|FG000|Overall Study|Death|1|||
154834011|NCT01543828|558826670|FG000|Treatment 2|Lost to Follow-up|1|||
154834012|NCT01543828|558826671|FG001|Treatment 2|Lost to Follow-up|0|||
154834013|NCT01069172|558826674|FG000|Overall Study|Withdrawal by Subject|1|||
154834014|NCT01069172|558826675|FG001|Overall Study|Withdrawal by Subject|0|||
154834015|NCT00711425|558826678|FG000|Overall Study|Protocol Violation|1|||
154834016|NCT00711425|558826678|FG000|Overall Study|Death|2|||
154834017|NCT00711425|558826678|FG000|Overall Study|Lost to Follow-up|1|||
154834018|NCT03901079|558826679|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
154834019|NCT00916149|558826680|FG000|Overall Study|Lost to Follow-up|3|||
154834020|NCT00916149|558826681|FG001|Overall Study|Lost to Follow-up|2|||
154834021|NCT00916149|558826682|FG002|Overall Study|Lost to Follow-up|0|||
154834022|NCT00916149|558826680|FG000|Overall Study|Unable to place scalp EEG leads|1|||
154834023|NCT00916149|558826681|FG001|Overall Study|Unable to place scalp EEG leads|0|||
154834024|NCT00916149|558826682|FG002|Overall Study|Unable to place scalp EEG leads|0|||
154834025|NCT00912028|558826685|FG000|Overall Study|Lost to Follow-up|2|||
154834026|NCT00912028|558826686|FG001|Overall Study|Lost to Follow-up|3|||
154834027|NCT00912028|558826687|FG002|Overall Study|Lost to Follow-up|0|||
154834028|NCT00912028|558826688|FG003|Overall Study|Lost to Follow-up|1|||
154834029|NCT00912028|558826689|FG004|Overall Study|Lost to Follow-up|3|||
154834030|NCT00912028|558826685|FG000|Overall Study|Withdrawal by Subject|3|||
154834031|NCT00912028|558826686|FG001|Overall Study|Withdrawal by Subject|0|||
154834032|NCT00912028|558826687|FG002|Overall Study|Withdrawal by Subject|0|||
154834033|NCT00912028|558826688|FG003|Overall Study|Withdrawal by Subject|0|||
154834034|NCT00912028|558826689|FG004|Overall Study|Withdrawal by Subject|0|||
154834035|NCT00841568|558826690|FG000|Overall Study|Adverse Event|1|||
154834036|NCT00841568|558826690|FG000|Overall Study|Death|1|||
154834037|NCT00841568|558826690|FG000|Overall Study|Withdrawal by Subject|2|||
154834038|NCT00841568|558826690|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
154834039|NCT03002155|558826691|FG000|Overall Study|Lost to Follow-up|1|||
154834040|NCT03002155|558826692|FG001|Overall Study|Lost to Follow-up|2|||
154834041|NCT03002155|558826691|FG000|Overall Study|Withdrawal by Subject|1|||
154834042|NCT03002155|558826692|FG001|Overall Study|Withdrawal by Subject|0|||
154834043|NCT03002155|558826691|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
154834044|NCT03002155|558826692|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
154834045|NCT00545298|558826693|FG000|Overall Study|Issues with Standard of Care|2|||
154968496|NCT01131260|559307503|FG001|Overall Study|Randomization error|1|||
154968497|NCT01131260|559307502|FG000|Overall Study|Declined to continue participation|8|||
154968498|NCT01131260|559307503|FG001|Overall Study|Declined to continue participation|13|||
154968499|NCT01131260|559307502|FG000|Overall Study|Physician Decision|22|||
154968500|NCT01131260|559307503|FG001|Overall Study|Physician Decision|24|||
154968501|NCT01131260|559307502|FG000|Overall Study|Technical problems|7|||
154968502|NCT01131260|559307503|FG001|Overall Study|Technical problems|6|||
154968503|NCT01131260|559307502|FG000|Overall Study|Staff error|2|||
154968504|NCT01131260|559307503|FG001|Overall Study|Staff error|1|||
154968505|NCT01131260|559307502|FG000|Overall Study|Ineligible|0|||
155098473|NCT01713582|559795201|FG004|Overall Study|Adverse event-related|0|||
155098474|NCT01713582|559795202|FG005|Overall Study|Adverse event-related|0|||
154834046|NCT00545298|558826694|FG001|Overall Study|Issues with Standard of Care|0|||
154834047|NCT00545298|558826695|FG002|Overall Study|Issues with Standard of Care|1|||
154834048|NCT00978029|558826696|FG000|Overall Study|Adverse Event|1|||
154834049|NCT00978029|558826697|FG001|Overall Study|Adverse Event|2|||
154968506|NCT01131260|559307503|FG001|Overall Study|Ineligible|2|||
155172598|NCT00101452|560071854|FG000|Overall Study|Physician Decision|0|||
155172599|NCT00101452|560071855|FG001|Overall Study|Physician Decision|3|||
155172600|NCT00101452|560071856|FG002|Overall Study|Physician Decision|2|||
155172601|NCT00101452|560071854|FG000|Overall Study|Protocol Violation|2|||
155172602|NCT00101452|560071855|FG001|Overall Study|Protocol Violation|1|||
155172603|NCT00101452|560071856|FG002|Overall Study|Protocol Violation|3|||
155172604|NCT00101452|560071854|FG000|Overall Study|Other|15|||
155172605|NCT00101452|560071855|FG001|Overall Study|Other|16|||
155172606|NCT00101452|560071856|FG002|Overall Study|Other|12|||
155172607|NCT01994889|560071857|FG000|Overall Study|Adverse Event|5|||
154834050|NCT00978029|558826698|FG002|Overall Study|Adverse Event|5|||
155172608|NCT01994889|560071858|FG001|Overall Study|Adverse Event|12|||
155172609|NCT01994889|560071859|FG002|Overall Study|Adverse Event|11|||
155172610|NCT01994889|560071857|FG000|Overall Study|Cardiac Device Implantation|0|||
155172611|NCT01994889|560071858|FG001|Overall Study|Cardiac Device Implantation|2|||
155172612|NCT01994889|560071859|FG002|Overall Study|Cardiac Device Implantation|0|||
155172613|NCT01994889|560071857|FG000|Overall Study|Organ Transplantation|1|||
155172614|NCT01994889|560071858|FG001|Overall Study|Organ Transplantation|5|||
154834051|NCT00978029|558826696|FG000|Overall Study|Withdrawal by Subject|0|||
154834052|NCT00978029|558826697|FG001|Overall Study|Withdrawal by Subject|0|||
154834053|NCT00978029|558826698|FG002|Overall Study|Withdrawal by Subject|1|||
155098475|NCT01713582|559795203|FG006|Overall Study|Adverse event-related|0|||
154834054|NCT00978029|558826696|FG000|Overall Study|Protocol Violation|0|||
154834055|NCT00978029|558826697|FG001|Overall Study|Protocol Violation|1|||
154834056|NCT00978029|558826698|FG002|Overall Study|Protocol Violation|0|||
154834057|NCT01820364|558826699|FG000|Part I: LGX818|Death|1|||
154834058|NCT01820364|558826700|FG001|Part I: LGX818|Death|0|||
154834059|NCT01820364|558826699|FG000|Part I: LGX818|Administrative Problems|3|||
154834060|NCT01820364|558826700|FG001|Part I: LGX818|Administrative Problems|0|||
154834061|NCT01820364|558826699|FG000|Part I: LGX818|Adverse Event|6|||
154834062|NCT01820364|558826700|FG001|Part I: LGX818|Adverse Event|0|||
154834063|NCT01820364|558826699|FG000|Part I: LGX818|Disease Progression|4|||
154834064|NCT01820364|558826700|FG001|Part I: LGX818|Disease Progression|0|||
154834065|NCT01820364|558826699|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
154834066|NCT01820364|558826700|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
154834067|NCT01793142|558826701|FG000|Overall Study|Randomized not treated|7|||
154834068|NCT01087775|558826702|FG000|Overall Study|failed inclusion criteria|2|||
154834069|NCT00974675|558826703|FG000|Overall Study|Adverse Event|2|||
154834070|NCT00974675|558826704|FG001|Overall Study|Adverse Event|1|||
154834071|NCT00974675|558826705|FG002|Overall Study|Adverse Event|1|||
154834072|NCT00974675|558826706|FG003|Overall Study|Adverse Event|1|||
154834073|NCT00974675|558826703|FG000|Overall Study|Physician Decision|0|||
154834074|NCT00974675|558826704|FG001|Overall Study|Physician Decision|0|||
154834075|NCT00974675|558826705|FG002|Overall Study|Physician Decision|1|||
154834076|NCT00974675|558826706|FG003|Overall Study|Physician Decision|0|||
154834077|NCT00974675|558826703|FG000|Overall Study|Participant on holiday; unable to attend|0|||
154834078|NCT00974675|558826704|FG001|Overall Study|Participant on holiday; unable to attend|0|||
154834079|NCT00974675|558826705|FG002|Overall Study|Participant on holiday; unable to attend|0|||
154834080|NCT00974675|558826706|FG003|Overall Study|Participant on holiday; unable to attend|1|||
154834081|NCT04744207|558826707|FG000|Treatment|Withdrawal by Subject|2|||
154834082|NCT04744207|558826708|FG001|Treatment|Withdrawal by Subject|0|||
154834083|NCT04744207|558826707|FG000|Treatment|Adverse Event|1|||
154834084|NCT04744207|558826708|FG001|Treatment|Adverse Event|2|||
154834085|NCT00825162|558826709|FG000|Overall Study|Withdrawal by Subject|11|||
154834086|NCT00825162|558826710|FG001|Overall Study|Withdrawal by Subject|13|||
154834087|NCT00825162|558826711|FG002|Overall Study|Withdrawal by Subject|3|||
154834088|NCT00825162|558826709|FG000|Overall Study|Lost to Follow-up|9|||
154834089|NCT00825162|558826710|FG001|Overall Study|Lost to Follow-up|6|||
154834090|NCT00825162|558826711|FG002|Overall Study|Lost to Follow-up|3|||
154834091|NCT00825162|558826709|FG000|Overall Study|Physician Decision|2|||
154834092|NCT00825162|558826710|FG001|Overall Study|Physician Decision|0|||
155098476|NCT01713582|559795204|FG007|Overall Study|Adverse event-related|0|||
155098477|NCT01713582|559795205|FG008|Overall Study|Adverse event-related|0|||
154834093|NCT00825162|558826711|FG002|Overall Study|Physician Decision|0|||
154834094|NCT00825162|558826709|FG000|Overall Study|Move away from the study area|1|||
154834095|NCT00825162|558826710|FG001|Overall Study|Move away from the study area|0|||
154834096|NCT00825162|558826711|FG002|Overall Study|Move away from the study area|0|||
154834097|NCT00825162|558826709|FG000|Overall Study|Unable to attend the study visit|5|||
154834098|NCT00825162|558826710|FG001|Overall Study|Unable to attend the study visit|2|||
154834099|NCT00825162|558826711|FG002|Overall Study|Unable to attend the study visit|0|||
154834100|NCT01744665|558826712|FG000|Monitoring Phase|Adverse Event|4|||
154834101|NCT01744665|558826712|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
154834102|NCT01744665|558826712|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
154968507|NCT01968031|559307513|FG000|Overall Study|Adverse Event|13|||
154834103|NCT01744665|558826712|FG000|Monitoring Phase|Withdrawal by Subject|5|||
154834104|NCT01744665|558826712|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
155098478|NCT01713582|559795206|FG009|Overall Study|Adverse event-related|1|||
155098479|NCT01713582|559795207|FG010|Overall Study|Adverse event-related|1|||
155098480|NCT01713582|559795208|FG011|Overall Study|Adverse event-related|0|||
155098481|NCT01713582|559795209|FG012|Overall Study|Adverse event-related|0|||
155098482|NCT01713582|559795210|FG013|Overall Study|Adverse event-related|0|||
155098483|NCT01713582|559795211|FG014|Overall Study|Adverse event-related|0|||
155098484|NCT01713582|559795212|FG015|Overall Study|Adverse event-related|0|||
155098485|NCT01713582|559795213|FG016|Overall Study|Adverse event-related|0|||
155098486|NCT01713582|559795214|FG017|Overall Study|Adverse event-related|0|||
155098487|NCT01713582|559795215|FG018|Overall Study|Adverse event-related|1|||
155098488|NCT01713582|559795216|FG019|Overall Study|Adverse event-related|0|||
155098489|NCT01713582|559795217|FG020|Overall Study|Adverse event-related|0|||
155098490|NCT01713582|559795197|FG000|Overall Study|Adverse event-unrelated|0|||
155098491|NCT01713582|559795198|FG001|Overall Study|Adverse event-unrelated|0|||
155098492|NCT01713582|559795199|FG002|Overall Study|Adverse event-unrelated|0|||
155098493|NCT01713582|559795200|FG003|Overall Study|Adverse event-unrelated|0|||
155098494|NCT01713582|559795201|FG004|Overall Study|Adverse event-unrelated|0|||
155098495|NCT01713582|559795202|FG005|Overall Study|Adverse event-unrelated|1|||
155098496|NCT01713582|559795203|FG006|Overall Study|Adverse event-unrelated|1|||
155098497|NCT01713582|559795204|FG007|Overall Study|Adverse event-unrelated|1|||
155098498|NCT01713582|559795205|FG008|Overall Study|Adverse event-unrelated|0|||
155098499|NCT01713582|559795206|FG009|Overall Study|Adverse event-unrelated|0|||
155098500|NCT01713582|559795207|FG010|Overall Study|Adverse event-unrelated|0|||
155098501|NCT01713582|559795208|FG011|Overall Study|Adverse event-unrelated|0|||
155098502|NCT01713582|559795209|FG012|Overall Study|Adverse event-unrelated|0|||
155098503|NCT01713582|559795210|FG013|Overall Study|Adverse event-unrelated|1|||
155098504|NCT01713582|559795211|FG014|Overall Study|Adverse event-unrelated|1|||
155098505|NCT01713582|559795212|FG015|Overall Study|Adverse event-unrelated|0|||
155098506|NCT01713582|559795213|FG016|Overall Study|Adverse event-unrelated|0|||
155098507|NCT01713582|559795214|FG017|Overall Study|Adverse event-unrelated|0|||
155098508|NCT01713582|559795215|FG018|Overall Study|Adverse event-unrelated|0|||
155098509|NCT01713582|559795216|FG019|Overall Study|Adverse event-unrelated|0|||
155098510|NCT01713582|559795217|FG020|Overall Study|Adverse event-unrelated|0|||
155098511|NCT01713582|559795197|FG000|Overall Study|Withdrawal of consent|0|||
155098512|NCT01713582|559795198|FG001|Overall Study|Withdrawal of consent|0|||
155098513|NCT01713582|559795199|FG002|Overall Study|Withdrawal of consent|1|||
155098514|NCT01713582|559795200|FG003|Overall Study|Withdrawal of consent|0|||
155098515|NCT01713582|559795201|FG004|Overall Study|Withdrawal of consent|0|||
155098516|NCT01713582|559795202|FG005|Overall Study|Withdrawal of consent|1|||
155098517|NCT01713582|559795203|FG006|Overall Study|Withdrawal of consent|0|||
155098518|NCT01713582|559795204|FG007|Overall Study|Withdrawal of consent|0|||
155098519|NCT01713582|559795205|FG008|Overall Study|Withdrawal of consent|0|||
155098520|NCT01713582|559795206|FG009|Overall Study|Withdrawal of consent|1|||
155098521|NCT01713582|559795207|FG010|Overall Study|Withdrawal of consent|0|||
155098522|NCT01713582|559795208|FG011|Overall Study|Withdrawal of consent|0|||
155098523|NCT01713582|559795209|FG012|Overall Study|Withdrawal of consent|0|||
155098524|NCT01713582|559795210|FG013|Overall Study|Withdrawal of consent|0|||
155172615|NCT01994889|560071859|FG002|Overall Study|Organ Transplantation|5|||
155172616|NCT01994889|560071857|FG000|Overall Study|No longer willing to participate|8|||
155172617|NCT01994889|560071858|FG001|Overall Study|No longer willing to participate|17|||
155172618|NCT01994889|560071859|FG002|Overall Study|No longer willing to participate|37|||
155098525|NCT01713582|559795211|FG014|Overall Study|Withdrawal of consent|0|||
155098526|NCT01713582|559795212|FG015|Overall Study|Withdrawal of consent|0|||
155098527|NCT01713582|559795213|FG016|Overall Study|Withdrawal of consent|0|||
155098528|NCT01713582|559795214|FG017|Overall Study|Withdrawal of consent|0|||
155098529|NCT01713582|559795215|FG018|Overall Study|Withdrawal of consent|1|||
155098530|NCT01713582|559795216|FG019|Overall Study|Withdrawal of consent|0|||
155172619|NCT01994889|560071857|FG000|Overall Study|Lost to Follow-up|0|||
155172620|NCT01994889|560071858|FG001|Overall Study|Lost to Follow-up|1|||
155098531|NCT01713582|559795217|FG020|Overall Study|Withdrawal of consent|0|||
155172621|NCT01994889|560071859|FG002|Overall Study|Lost to Follow-up|0|||
155098532|NCT01713582|559795197|FG000|Overall Study|Lack of Efficacy|0|||
155098533|NCT01713582|559795198|FG001|Overall Study|Lack of Efficacy|0|||
155098534|NCT01713582|559795199|FG002|Overall Study|Lack of Efficacy|0|||
155098535|NCT01713582|559795200|FG003|Overall Study|Lack of Efficacy|0|||
155098536|NCT01713582|559795201|FG004|Overall Study|Lack of Efficacy|0|||
155098537|NCT01713582|559795202|FG005|Overall Study|Lack of Efficacy|0|||
155098538|NCT01713582|559795203|FG006|Overall Study|Lack of Efficacy|0|||
155098539|NCT01713582|559795204|FG007|Overall Study|Lack of Efficacy|0|||
155098540|NCT01713582|559795205|FG008|Overall Study|Lack of Efficacy|0|||
155098541|NCT01713582|559795206|FG009|Overall Study|Lack of Efficacy|1|||
154968508|NCT01968031|559307514|FG001|Overall Study|Adverse Event|10|||
154968509|NCT01968031|559307515|FG002|Overall Study|Adverse Event|22|||
154968510|NCT01968031|559307513|FG000|Overall Study|Withdrawal by Subject|3|||
154968511|NCT01968031|559307514|FG001|Overall Study|Withdrawal by Subject|7|||
155098542|NCT01713582|559795207|FG010|Overall Study|Lack of Efficacy|2|||
154834105|NCT01744665|558826712|FG000|Consolidation Phase|Adverse Event|2|||
154834106|NCT01744665|558826712|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
154834107|NCT01744665|558826712|FG000|Consolidation Phase|Withdrawal by Subject|4|||
154834108|NCT01744665|558826712|FG000|Consolidation Phase|Administrative problems|9|||
154834109|NCT01744665|558826712|FG000|Re-initiation Phase|Administrative problems|10|||
154834110|NCT01744665|558826712|FG000|Re-initiation Phase|Adverse Event|1|||
154834111|NCT01744665|558826712|FG000|Re-initiation Phase|No longer required treatment|1|||
155172622|NCT01994889|560071857|FG000|Overall Study|Protocol Violation|0|||
154834112|NCT01744665|558826712|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
154834113|NCT03803059|558826713|FG000|Overall Study|Protocol Violation|2|||
155172623|NCT01994889|560071858|FG001|Overall Study|Protocol Violation|1|||
155172624|NCT01994889|560071859|FG002|Overall Study|Protocol Violation|1|||
155172625|NCT01994889|560071857|FG000|Overall Study|Death|14|||
155172626|NCT01994889|560071858|FG001|Overall Study|Death|25|||
155172627|NCT01994889|560071859|FG002|Overall Study|Death|38|||
155172628|NCT02969655|560071860|FG000|Overall Study|Withdrawal by Subject|3|||
155172629|NCT02969655|560071861|FG001|Overall Study|Withdrawal by Subject|2|||
155172630|NCT02969655|560071860|FG000|Overall Study|Physician Decision|4|||
155172631|NCT02969655|560071861|FG001|Overall Study|Physician Decision|3|||
155172632|NCT02969655|560071860|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
155172633|NCT02969655|560071861|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
155172634|NCT02969655|560071860|FG000|Overall Study|Adverse Event|10|||
155172635|NCT02969655|560071861|FG001|Overall Study|Adverse Event|8|||
155172636|NCT00929643|560071864|FG000|Overall Study|Protocol Violation|2|||
154834114|NCT03803059|558826713|FG000|Overall Study|Lost to Follow-up|1|||
154834115|NCT01293968|558826716|FG000|Overall Study|non-cooperation|3|||
154834116|NCT01293968|558826717|FG001|Overall Study|non-cooperation|3|||
154834117|NCT03996876|558826720|FG000|Overall Study|Incomplete Data|2|||
154834118|NCT03996876|558826721|FG001|Overall Study|Incomplete Data|4|||
154834119|NCT00121108|558826722|FG000|Overall Study|Lost to Follow-up|10|||
154834120|NCT00121108|558826723|FG001|Overall Study|Lost to Follow-up|22|||
154834121|NCT00121108|558826722|FG000|Overall Study|Withdrawal by Subject|106|||
154834122|NCT00121108|558826723|FG001|Overall Study|Withdrawal by Subject|195|||
154834123|NCT00121108|558826722|FG000|Overall Study|Death|5|||
154834124|NCT00121108|558826723|FG001|Overall Study|Death|8|||
154834125|NCT00747643|558828216|FG000|Overall Study|Withdrawal by Subject|36|||
154968512|NCT01968031|559307515|FG002|Overall Study|Withdrawal by Subject|3|||
154968513|NCT01968031|559307513|FG000|Overall Study|Did not meet entry criteria|1|||
154968514|NCT01968031|559307514|FG001|Overall Study|Did not meet entry criteria|1|||
155098543|NCT01713582|559795208|FG011|Overall Study|Lack of Efficacy|0|||
155098544|NCT01713582|559795209|FG012|Overall Study|Lack of Efficacy|0|||
155098545|NCT01713582|559795210|FG013|Overall Study|Lack of Efficacy|0|||
155098546|NCT01713582|559795211|FG014|Overall Study|Lack of Efficacy|0|||
155098547|NCT01713582|559795212|FG015|Overall Study|Lack of Efficacy|0|||
155098548|NCT01713582|559795213|FG016|Overall Study|Lack of Efficacy|0|||
155098549|NCT01713582|559795214|FG017|Overall Study|Lack of Efficacy|0|||
155098550|NCT01713582|559795215|FG018|Overall Study|Lack of Efficacy|0|||
155098551|NCT01713582|559795216|FG019|Overall Study|Lack of Efficacy|0|||
155098552|NCT01713582|559795217|FG020|Overall Study|Lack of Efficacy|0|||
155172637|NCT01536392|560071865|FG000|Overall Study|Adverse Event|2|||
155172638|NCT01536392|560071866|FG001|Overall Study|Adverse Event|2|||
154968515|NCT01968031|559307515|FG002|Overall Study|Did not meet entry criteria|1|||
155172639|NCT01536392|560071865|FG000|Overall Study|Physician Decision|2|||
155172640|NCT01536392|560071866|FG001|Overall Study|Physician Decision|3|||
155172641|NCT01536392|560071865|FG000|Overall Study|Withdrawal by Subject|3|||
155172642|NCT01536392|560071866|FG001|Overall Study|Withdrawal by Subject|6|||
155172643|NCT01536392|560071865|FG000|Overall Study|Non Compliance|3|||
155172644|NCT01536392|560071866|FG001|Overall Study|Non Compliance|4|||
154968516|NCT01968031|559307513|FG000|Overall Study|Noncompliance|0|||
154968517|NCT01968031|559307514|FG001|Overall Study|Noncompliance|0|||
155098553|NCT01713582|559795197|FG000|Overall Study|Withdrawal by Subject|0|||
155098554|NCT01713582|559795198|FG001|Overall Study|Withdrawal by Subject|0|||
155172645|NCT01536392|560071865|FG000|Overall Study|Completed therapy early|3|||
155098555|NCT01713582|559795199|FG002|Overall Study|Withdrawal by Subject|0|||
155098556|NCT01713582|559795200|FG003|Overall Study|Withdrawal by Subject|0|||
155098557|NCT01713582|559795201|FG004|Overall Study|Withdrawal by Subject|0|||
155098558|NCT01713582|559795202|FG005|Overall Study|Withdrawal by Subject|0|||
155098559|NCT01713582|559795203|FG006|Overall Study|Withdrawal by Subject|0|||
155098560|NCT01713582|559795204|FG007|Overall Study|Withdrawal by Subject|0|||
155098561|NCT01713582|559795205|FG008|Overall Study|Withdrawal by Subject|0|||
155098562|NCT01713582|559795206|FG009|Overall Study|Withdrawal by Subject|0|||
155098563|NCT01713582|559795207|FG010|Overall Study|Withdrawal by Subject|0|||
155098564|NCT01713582|559795208|FG011|Overall Study|Withdrawal by Subject|0|||
155098565|NCT01713582|559795209|FG012|Overall Study|Withdrawal by Subject|0|||
155098566|NCT01713582|559795210|FG013|Overall Study|Withdrawal by Subject|0|||
155098567|NCT01713582|559795211|FG014|Overall Study|Withdrawal by Subject|0|||
155098568|NCT01713582|559795212|FG015|Overall Study|Withdrawal by Subject|0|||
155098569|NCT01713582|559795213|FG016|Overall Study|Withdrawal by Subject|0|||
155098570|NCT01713582|559795214|FG017|Overall Study|Withdrawal by Subject|1|||
155098571|NCT01713582|559795215|FG018|Overall Study|Withdrawal by Subject|0|||
155098572|NCT01713582|559795216|FG019|Overall Study|Withdrawal by Subject|0|||
155098573|NCT01713582|559795217|FG020|Overall Study|Withdrawal by Subject|0|||
155098574|NCT01713582|559795197|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
155098575|NCT01713582|559795198|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
155098576|NCT01713582|559795199|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
155098577|NCT01713582|559795200|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
155098578|NCT01713582|559795201|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
155098579|NCT01713582|559795202|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
155098580|NCT01713582|559795203|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
155098581|NCT01713582|559795204|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
155098582|NCT01713582|559795205|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
155098583|NCT01713582|559795206|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
155098584|NCT01713582|559795207|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
155098585|NCT01713582|559795208|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
155098586|NCT01713582|559795209|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
155098587|NCT01713582|559795210|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
155098588|NCT01713582|559795211|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
155098589|NCT01713582|559795212|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
155098590|NCT01713582|559795213|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
155098591|NCT01713582|559795214|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
154834126|NCT00747643|558828217|FG001|Overall Study|Withdrawal by Subject|27|||
154834127|NCT00390546|558828220|FG000|Overall Study|Renal impairment|1|||
154834128|NCT00390546|558828221|FG001|Overall Study|Renal impairment|0|||
154834129|NCT00390546|558828220|FG000|Overall Study|Physician Decision|5|||
154834130|NCT00390546|558828221|FG001|Overall Study|Physician Decision|5|||
154834131|NCT01308008|558828222|FG000|4 Weeks|Illness, disinterest, time|9|||
154834132|NCT01308008|558828223|FG001|4 Weeks|Illness, disinterest, time|2|||
154834133|NCT01417195|558828224|FG000|Overall Study|Stimulation failure|1|||
154834134|NCT01417195|558828225|FG001|Overall Study|Stimulation failure|0|||
154834135|NCT01417195|558828224|FG000|Overall Study|No embryos for transfer|0|||
154834136|NCT01417195|558828225|FG001|Overall Study|No embryos for transfer|1|||
154834137|NCT01417195|558828224|FG000|Overall Study|No transfer due to risk of OHSS|1|||
154834138|NCT01417195|558828225|FG001|Overall Study|No transfer due to risk of OHSS|0|||
154834139|NCT01417195|558828224|FG000|Overall Study|No transfer due to elevated progesterone|1|||
154834140|NCT01417195|558828225|FG001|Overall Study|No transfer due to elevated progesterone|0|||
154834141|NCT01239342|558828226|FG000|Overall Study|Adverse Event|1|||
154834142|NCT01239342|558828227|FG001|Overall Study|Adverse Event|0|||
154834143|NCT01239342|558828226|FG000|Overall Study|Withdrawal by Subject|1|||
154834144|NCT01239342|558828227|FG001|Overall Study|Withdrawal by Subject|5|||
155098592|NCT01713582|559795215|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
155098593|NCT01713582|559795216|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
155098594|NCT01713582|559795217|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
155098595|NCT01713582|559795197|FG000|Overall Study|Disease progression and adverse event|0|||
155098596|NCT01713582|559795198|FG001|Overall Study|Disease progression and adverse event|0|||
155098597|NCT01713582|559795199|FG002|Overall Study|Disease progression and adverse event|0|||
155098598|NCT01713582|559795200|FG003|Overall Study|Disease progression and adverse event|0|||
155098599|NCT01713582|559795201|FG004|Overall Study|Disease progression and adverse event|0|||
155098600|NCT01713582|559795202|FG005|Overall Study|Disease progression and adverse event|0|||
155098601|NCT01713582|559795203|FG006|Overall Study|Disease progression and adverse event|0|||
155098602|NCT01713582|559795204|FG007|Overall Study|Disease progression and adverse event|0|||
155098603|NCT01713582|559795205|FG008|Overall Study|Disease progression and adverse event|0|||
155098604|NCT01713582|559795206|FG009|Overall Study|Disease progression and adverse event|0|||
155098605|NCT01713582|559795207|FG010|Overall Study|Disease progression and adverse event|0|||
155098606|NCT01713582|559795208|FG011|Overall Study|Disease progression and adverse event|0|||
155098607|NCT01713582|559795209|FG012|Overall Study|Disease progression and adverse event|0|||
155098608|NCT01713582|559795210|FG013|Overall Study|Disease progression and adverse event|0|||
155098609|NCT01713582|559795211|FG014|Overall Study|Disease progression and adverse event|0|||
155098610|NCT01713582|559795212|FG015|Overall Study|Disease progression and adverse event|0|||
155098611|NCT01713582|559795213|FG016|Overall Study|Disease progression and adverse event|1|||
155098612|NCT01713582|559795214|FG017|Overall Study|Disease progression and adverse event|0|||
155098613|NCT01713582|559795215|FG018|Overall Study|Disease progression and adverse event|0|||
155098614|NCT01713582|559795216|FG019|Overall Study|Disease progression and adverse event|0|||
155098615|NCT01713582|559795217|FG020|Overall Study|Disease progression and adverse event|0|||
155098616|NCT04776161|559795219|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
155098617|NCT04776161|559795220|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
155098618|NCT04776161|559795221|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
155098619|NCT04776161|559795219|FG000|Overall Study|Withdrawal by Subject|1|||
155098620|NCT04776161|559795220|FG001|Overall Study|Withdrawal by Subject|0|||
155098621|NCT04776161|559795221|FG002|Overall Study|Withdrawal by Subject|1|||
155098622|NCT04776161|559795219|FG000|Overall Study|Adverse Event|0|||
155098623|NCT04776161|559795220|FG001|Overall Study|Adverse Event|1|||
155098624|NCT04776161|559795221|FG002|Overall Study|Adverse Event|1|||
155098625|NCT00342628|559795222|FG000|Overall Study|Withdrawal by Subject|19|||
155098626|NCT00342628|559795223|FG001|Overall Study|Withdrawal by Subject|19|||
155098627|NCT00342628|559795224|FG002|Overall Study|Withdrawal by Subject|18|||
155098628|NCT00342628|559795222|FG000|Overall Study|Death|1|||
155098629|NCT00342628|559795223|FG001|Overall Study|Death|1|||
155098630|NCT00342628|559795224|FG002|Overall Study|Death|0|||
155098631|NCT00342628|559795222|FG000|Overall Study|moved residence|0|||
155098632|NCT00342628|559795223|FG001|Overall Study|moved residence|1|||
155098633|NCT00342628|559795224|FG002|Overall Study|moved residence|1|||
155098634|NCT03846427|559795225|FG000|Overall Study|Death|13|||
155098635|NCT03846427|559795225|FG000|Overall Study|Withdrawal by Subject|3|||
155098636|NCT03846427|559795225|FG000|Overall Study|Physician Decision|1|||
155098637|NCT01334554|559795226|FG000|Overall Study|Adverse Event|4|||
155098638|NCT01334554|559795227|FG001|Overall Study|Adverse Event|2|||
155098639|NCT02393859|559795229|FG000|Overall Study|Decision by Sponsor|2|||
155098640|NCT02393859|559795230|FG001|Overall Study|Decision by Sponsor|4|||
155098641|NCT02393859|559795229|FG000|Overall Study|Withdrawal by Subject|11|||
155098642|NCT02393859|559795230|FG001|Overall Study|Withdrawal by Subject|6|||
155098643|NCT02393859|559795229|FG000|Overall Study|Death|27|||
155098644|NCT02393859|559795230|FG001|Overall Study|Death|10|||
155098645|NCT02393859|559795229|FG000|Overall Study|Lost to Follow-up|1|||
155098646|NCT02393859|559795230|FG001|Overall Study|Lost to Follow-up|1|||
155098647|NCT00954447|559795231|FG000|Overall Study|Adverse Event|33|||
155098648|NCT00954447|559795232|FG001|Overall Study|Adverse Event|25|||
155098649|NCT00954447|559795231|FG000|Overall Study|Lack of Efficacy|17|||
155098650|NCT00954447|559795232|FG001|Overall Study|Lack of Efficacy|3|||
155098651|NCT00954447|559795231|FG000|Overall Study|Protocol Violation|5|||
155098652|NCT00954447|559795232|FG001|Overall Study|Protocol Violation|7|||
155098653|NCT00954447|559795231|FG000|Overall Study|Lost to Follow-up|8|||
155098654|NCT00954447|559795232|FG001|Overall Study|Lost to Follow-up|14|||
155098655|NCT00954447|559795231|FG000|Overall Study|Withdrawal by Subject|26|||
155098656|NCT00954447|559795232|FG001|Overall Study|Withdrawal by Subject|21|||
155098657|NCT00954447|559795231|FG000|Overall Study|Other|21|||
155098658|NCT00954447|559795232|FG001|Overall Study|Other|18|||
155098659|NCT00488514|559795233|FG000|Overall Study|Adverse Event|41|||
155098660|NCT00488514|559795233|FG000|Overall Study|Lost to Follow-up|44|||
155098661|NCT00488514|559795233|FG000|Overall Study|Protocol Violation|32|||
154968518|NCT01968031|559307515|FG002|Overall Study|Noncompliance|2|||
155098662|NCT00488514|559795233|FG000|Overall Study|Withdrawal by Subject|106|||
155098663|NCT00488514|559795233|FG000|Overall Study|Lack of Efficacy|28|||
155098664|NCT00488514|559795233|FG000|Overall Study|Did not meet criteria for treatment|30|||
155098665|NCT00488514|559795233|FG000|Overall Study|Postive drug screen|1|||
155098666|NCT00488514|559795233|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
155098667|NCT00488514|559795233|FG000|Overall Study|Investigator decision|1|||
155098668|NCT00488514|559795233|FG000|Overall Study|Participant had too few migraines|5|||
155098669|NCT00488514|559795233|FG000|Overall Study|Increase in number of migraines|2|||
154834145|NCT01239342|558828226|FG000|Overall Study|Reason Unknown|1|||
154834146|NCT01239342|558828227|FG001|Overall Study|Reason Unknown|1|||
154834147|NCT02918864|558828228|FG000|Overall Study|Withdrawal by Subject|1|||
154834148|NCT02918864|558828229|FG001|Overall Study|Withdrawal by Subject|1|||
154834149|NCT02918864|558828228|FG000|Overall Study|Lost to Follow-up|3|||
154834150|NCT02918864|558828229|FG001|Overall Study|Lost to Follow-up|2|||
154834151|NCT02257372|558828235|FG000|Overall Study|Adverse Event|3|||
154834152|NCT02257372|558828236|FG001|Overall Study|Adverse Event|7|||
154834153|NCT02257372|558828235|FG000|Overall Study|Lack of Efficacy|2|||
154834154|NCT02257372|558828236|FG001|Overall Study|Lack of Efficacy|1|||
154834155|NCT02257372|558828235|FG000|Overall Study|Protocol Violation|1|||
154834156|NCT02257372|558828236|FG001|Overall Study|Protocol Violation|1|||
154834157|NCT02257372|558828235|FG000|Overall Study|Lost to Follow-up|0|||
154834158|NCT02257372|558828236|FG001|Overall Study|Lost to Follow-up|1|||
154834159|NCT02257372|558828235|FG000|Overall Study|Withdrew consent|1|||
154834160|NCT02257372|558828236|FG001|Overall Study|Withdrew consent|0|||
154834161|NCT00880399|558828239|FG000|Overall Study|Adverse Event|4|||
154834162|NCT00880399|558828240|FG001|Overall Study|Adverse Event|6|||
154834163|NCT00880399|558828241|FG002|Overall Study|Adverse Event|5|||
154834164|NCT00880399|558828239|FG000|Overall Study|Lack of Efficacy|1|||
154834165|NCT00880399|558828240|FG001|Overall Study|Lack of Efficacy|4|||
154834166|NCT00880399|558828241|FG002|Overall Study|Lack of Efficacy|2|||
154834167|NCT00880399|558828239|FG000|Overall Study|Protocol Violation|4|||
154834168|NCT00880399|558828240|FG001|Overall Study|Protocol Violation|4|||
154834169|NCT00880399|558828241|FG002|Overall Study|Protocol Violation|6|||
154834170|NCT00880399|558828239|FG000|Overall Study|Study closed/terminated|3|||
154834171|NCT00880399|558828240|FG001|Overall Study|Study closed/terminated|7|||
154834172|NCT00880399|558828241|FG002|Overall Study|Study closed/terminated|4|||
154834173|NCT00880399|558828239|FG000|Overall Study|Lost to Follow-up|8|||
154834174|NCT00880399|558828240|FG001|Overall Study|Lost to Follow-up|5|||
154834175|NCT00880399|558828241|FG002|Overall Study|Lost to Follow-up|3|||
154834176|NCT00880399|558828239|FG000|Overall Study|Physician Decision|5|||
154834177|NCT00880399|558828240|FG001|Overall Study|Physician Decision|0|||
155098670|NCT00488514|559795233|FG000|Overall Study|Increased use of concomitant medication|1|||
155098671|NCT00628446|559795236|FG000|Overall Study|Lost to Follow-up|3|||
155098672|NCT00628446|559795236|FG000|Overall Study|Withdrawal by Subject|1|||
155098673|NCT00628446|559795236|FG000|Overall Study|Protocol Violation|3|||
155098674|NCT00756275|559795237|FG000|Overall Study|Lost to Follow-up|25|||
155098675|NCT00756275|559795238|FG001|Overall Study|Lost to Follow-up|21|||
155098676|NCT00756275|559795237|FG000|Overall Study|Withdrawal by Subject|4|||
155098677|NCT00756275|559795238|FG001|Overall Study|Withdrawal by Subject|7|||
155098678|NCT04971967|559795241|FG000|Overall Study|Lost to Follow-up|6|||
155098679|NCT04971967|559795242|FG001|Overall Study|Lost to Follow-up|7|||
155098680|NCT00682929|559795247|FG000|Overall Study|Adverse Event|4|||
155098681|NCT00682929|559795248|FG001|Overall Study|Adverse Event|1|||
155098682|NCT00682929|559795249|FG002|Overall Study|Adverse Event|1|||
155098683|NCT00682929|559795247|FG000|Overall Study|Withdrawal by Subject|1|||
155098684|NCT00682929|559795248|FG001|Overall Study|Withdrawal by Subject|2|||
155098685|NCT00682929|559795249|FG002|Overall Study|Withdrawal by Subject|1|||
155098686|NCT00682929|559795247|FG000|Overall Study|dosing compliance < 80%|0|||
155098687|NCT00682929|559795248|FG001|Overall Study|dosing compliance < 80%|2|||
155098688|NCT00682929|559795249|FG002|Overall Study|dosing compliance < 80%|0|||
155098689|NCT00682929|559795247|FG000|Overall Study|lag in DEA renewal|1|||
155098690|NCT00682929|559795248|FG001|Overall Study|lag in DEA renewal|0|||
155098691|NCT00682929|559795249|FG002|Overall Study|lag in DEA renewal|0|||
155098692|NCT00938912|559795250|FG000|Overall Study|Withdrawal by Subject|28|||
155098693|NCT00938912|559795250|FG000|Overall Study|Lost to Follow-up|4|||
155098694|NCT00938912|559795250|FG000|Overall Study|Lack of Efficacy|43|||
155098695|NCT00938912|559795250|FG000|Overall Study|Adverse event, non-fatal|24|||
155098696|NCT00938912|559795250|FG000|Overall Study|Adverse event, fatal|1|||
155098697|NCT00938912|559795250|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
155098698|NCT00938912|559795250|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
155098699|NCT00938912|559795250|FG000|Overall Study|Participant needed prohibit medication|1|||
155098700|NCT00938912|559795250|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
155172646|NCT01536392|560071866|FG001|Overall Study|Completed therapy early|0|||
154834178|NCT00880399|558828241|FG002|Overall Study|Physician Decision|3|||
154834179|NCT00880399|558828239|FG000|Overall Study|Withdrawal by Subject|6|||
154834180|NCT00880399|558828240|FG001|Overall Study|Withdrawal by Subject|3|||
154834181|NCT00880399|558828241|FG002|Overall Study|Withdrawal by Subject|3|||
154834182|NCT04353284|558828242|FG000|Overall Study|Adverse Event|1|||
154834183|NCT04353284|558828243|FG001|Overall Study|Adverse Event|1|||
154834184|NCT04353284|558828242|FG000|Overall Study|Lost to Follow-up|1|||
155098701|NCT00938912|559795250|FG000|Overall Study|Did not meet Eligibility criteria|1|||
155098702|NCT00938912|559795250|FG000|Overall Study|Participant relocated not related to AE|1|||
155098703|NCT00938912|559795250|FG000|Overall Study|Participant moved to another city|1|||
155098704|NCT00938912|559795250|FG000|Overall Study|Participant experienced break through seizures|1|||
155098705|NCT00938912|559795250|FG000|Overall Study|No longer wished to participate in the study|1|||
155098706|NCT00938912|559795250|FG000|Overall Study|Protocol Deviation|2|||
155098707|NCT01475721|559795256|FG000|Overall Study|Death|3|||
155098708|NCT01475721|559795257|FG001|Overall Study|Death|6|||
155098709|NCT01475721|559795256|FG000|Overall Study|Withdrawal by Subject|8|||
155098710|NCT01475721|559795257|FG001|Overall Study|Withdrawal by Subject|8|||
155098711|NCT00803738|559795258|FG000|Overall Study|Adverse Event|3|||
155098712|NCT00803738|559795259|FG001|Overall Study|Adverse Event|5|||
155098713|NCT00803738|559795258|FG000|Overall Study|Lost to Follow-up|4|||
155098714|NCT00803738|559795259|FG001|Overall Study|Lost to Follow-up|4|||
155098715|NCT00803738|559795258|FG000|Overall Study|Protocol Violation|18|||
155098716|NCT00803738|559795259|FG001|Overall Study|Protocol Violation|10|||
155098717|NCT00803738|559795258|FG000|Overall Study|Withdrawal by Subject|1|||
155098718|NCT00803738|559795259|FG001|Overall Study|Withdrawal by Subject|4|||
155098719|NCT00803738|559795258|FG000|Overall Study|Lack of Efficacy|10|||
155098720|NCT00803738|559795259|FG001|Overall Study|Lack of Efficacy|16|||
155098721|NCT00803738|559795258|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
155098722|NCT00803738|559795259|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
155098723|NCT00803738|559795258|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
155098724|NCT00803738|559795259|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
155098725|NCT01048242|559795260|FG000|Overall Study|See study flow chart|4|||
155098726|NCT01048242|559795261|FG001|Overall Study|See study flow chart|2|||
155098727|NCT02364037|559795262|FG000|Overall Study|Withdrawal by Subject|7|||
155098728|NCT02364037|559795263|FG001|Overall Study|Withdrawal by Subject|4|||
155098729|NCT02364037|559795262|FG000|Overall Study|Lost to Follow-up|37|||
155098730|NCT02364037|559795263|FG001|Overall Study|Lost to Follow-up|49|||
155098731|NCT01453036|559795265|FG000|Overall Study|Lost to Follow-up|26|||
155098732|NCT01453036|559795266|FG001|Overall Study|Lost to Follow-up|115|||
155098733|NCT01453036|559795267|FG002|Overall Study|Lost to Follow-up|31|||
155098734|NCT01815424|559795268|FG000|Week 0 to 16|Adverse Event|1|||
155098735|NCT01815424|559795269|FG001|Week 0 to 16|Adverse Event|3|||
155098736|NCT01815424|559795270|FG002|Week 0 to 16|Adverse Event|3|||
155098737|NCT01815424|559795271|FG003|Week 0 to 16|Adverse Event|0|||
155098738|NCT01815424|559795272|FG004|Week 0 to 16|Adverse Event|0|||
155098739|NCT01815424|559795268|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
155098740|NCT01815424|559795269|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155098741|NCT01815424|559795270|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155172647|NCT02874144|560071867|FG000|Overall Study|Lost to Follow-up|3|||
154834185|NCT04353284|558828243|FG001|Overall Study|Lost to Follow-up|0|||
154834186|NCT04773106|558828250|FG000|Overall Study|Withdrawal by Subject|3|||
154834187|NCT04773106|558828250|FG000|Overall Study|Death|1|||
154834188|NCT00530894|558828252|FG000|Overall Study|Death|84|||
154834189|NCT00530894|558828253|FG001|Overall Study|Death|89|||
154834190|NCT00530894|558828254|FG002|Overall Study|Death|55|||
154834191|NCT00530894|558828255|FG003|Overall Study|Death|89|||
154834192|NCT00530894|558828252|FG000|Overall Study|Lost to Follow-up|1|||
154834193|NCT00530894|558828253|FG001|Overall Study|Lost to Follow-up|3|||
154834194|NCT00530894|558828254|FG002|Overall Study|Lost to Follow-up|0|||
154834195|NCT00530894|558828255|FG003|Overall Study|Lost to Follow-up|0|||
154968519|NCT01968031|559307513|FG000|Overall Study|Failed inclusion criteria|0|||
155098742|NCT01815424|559795271|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155098743|NCT01815424|559795272|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
155098744|NCT01815424|559795268|FG000|Week 0 to 16|Lost to Follow-up|0|||
155098745|NCT01815424|559795269|FG001|Week 0 to 16|Lost to Follow-up|1|||
155098746|NCT01815424|559795270|FG002|Week 0 to 16|Lost to Follow-up|0|||
155098747|NCT01815424|559795271|FG003|Week 0 to 16|Lost to Follow-up|0|||
155098748|NCT01815424|559795272|FG004|Week 0 to 16|Lost to Follow-up|0|||
155098749|NCT01815424|559795268|FG000|Week 0 to 16|Withdrawal by Subject|0|||
154834196|NCT00530894|558828252|FG000|Overall Study|Withdrawal by Subject|1|||
154834197|NCT00530894|558828253|FG001|Overall Study|Withdrawal by Subject|23|||
154834198|NCT00530894|558828254|FG002|Overall Study|Withdrawal by Subject|0|||
155098750|NCT01815424|559795269|FG001|Week 0 to 16|Withdrawal by Subject|0|||
155098751|NCT01815424|559795270|FG002|Week 0 to 16|Withdrawal by Subject|1|||
154834199|NCT00530894|558828255|FG003|Overall Study|Withdrawal by Subject|5|||
154834200|NCT00530894|558828252|FG000|Overall Study|Alive and censored prior to 1 year|2|||
154834201|NCT00530894|558828253|FG001|Overall Study|Alive and censored prior to 1 year|0|||
154834202|NCT00530894|558828254|FG002|Overall Study|Alive and censored prior to 1 year|0|||
154834203|NCT00530894|558828255|FG003|Overall Study|Alive and censored prior to 1 year|0|||
154834204|NCT01349465|558828256|FG000|Overall Study|Adverse Event|1|||
154834205|NCT01349465|558828257|FG001|Overall Study|Adverse Event|0|||
154834206|NCT01349465|558828256|FG000|Overall Study|Death|3|||
154834207|NCT01349465|558828257|FG001|Overall Study|Death|0|||
154834208|NCT01349465|558828256|FG000|Overall Study|Lost to Follow-up|10|||
154834209|NCT01349465|558828257|FG001|Overall Study|Lost to Follow-up|1|||
154834210|NCT01349465|558828256|FG000|Overall Study|Withdrawal by Subject|4|||
154834211|NCT01349465|558828257|FG001|Overall Study|Withdrawal by Subject|2|||
154834212|NCT01349465|558828256|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
154834213|NCT01349465|558828257|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
154834214|NCT01230242|558828258|FG000|Overall Study|Physician Decision|2|||
154834215|NCT01230242|558828258|FG000|Overall Study|Withdrawal by Subject|1|||
154834216|NCT04329702|558828261|FG000|Overall Study|illness|3|||
154834217|NCT04329702|558828262|FG001|Overall Study|illness|4|||
154834218|NCT04329702|558828263|FG002|Overall Study|illness|0|||
154834219|NCT04329702|558828261|FG000|Overall Study|Lost to Follow-up|0|||
154834220|NCT04329702|558828262|FG001|Overall Study|Lost to Follow-up|0|||
154834221|NCT04329702|558828263|FG002|Overall Study|Lost to Follow-up|2|||
154834222|NCT04329702|558828261|FG000|Overall Study|Death|0|||
155098752|NCT01815424|559795271|FG003|Week 0 to 16|Withdrawal by Subject|0|||
155098753|NCT01815424|559795272|FG004|Week 0 to 16|Withdrawal by Subject|0|||
155098754|NCT01815424|559795268|FG000|Week 0 to 16|Other|1|||
155098755|NCT01815424|559795269|FG001|Week 0 to 16|Other|0|||
155098756|NCT01815424|559795270|FG002|Week 0 to 16|Other|3|||
155098757|NCT01815424|559795271|FG003|Week 0 to 16|Other|0|||
155098758|NCT01815424|559795272|FG004|Week 0 to 16|Other|0|||
155098759|NCT01815424|559795268|FG000|Week 0 to 16|Protocol Violation|1|||
155098760|NCT01815424|559795269|FG001|Week 0 to 16|Protocol Violation|0|||
155098761|NCT01815424|559795270|FG002|Week 0 to 16|Protocol Violation|0|||
155098762|NCT01815424|559795271|FG003|Week 0 to 16|Protocol Violation|0|||
155098763|NCT01815424|559795272|FG004|Week 0 to 16|Protocol Violation|0|||
155098764|NCT01815424|559795268|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
155098765|NCT01815424|559795269|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
155098766|NCT01815424|559795270|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
155098767|NCT01815424|559795271|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
155098768|NCT01815424|559795272|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
155098769|NCT01815424|559795268|FG000|Week 16 to 52|Other|0|||
155098770|NCT01815424|559795269|FG001|Week 16 to 52|Other|1|||
155098771|NCT01815424|559795270|FG002|Week 16 to 52|Other|0|||
155098772|NCT01815424|559795271|FG003|Week 16 to 52|Other|0|||
155098773|NCT01815424|559795272|FG004|Week 16 to 52|Other|0|||
155098774|NCT01815424|559795268|FG000|Week 16 to 52|Adverse Event|0|||
155098775|NCT01815424|559795269|FG001|Week 16 to 52|Adverse Event|0|||
155098776|NCT01815424|559795270|FG002|Week 16 to 52|Adverse Event|0|||
155098777|NCT01815424|559795271|FG003|Week 16 to 52|Adverse Event|0|||
155098778|NCT01815424|559795272|FG004|Week 16 to 52|Adverse Event|1|||
155098779|NCT01815424|559795268|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
155098780|NCT01815424|559795269|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
155098781|NCT01815424|559795270|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
155098782|NCT01815424|559795271|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
154834223|NCT04329702|558828262|FG001|Overall Study|Death|2|||
154834224|NCT04329702|558828263|FG002|Overall Study|Death|0|||
154834225|NCT00766532|558828264|FG000|Overall Study|Protocol Violation|2|||
155098783|NCT01815424|559795272|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
155098784|NCT01815424|559795268|FG000|Week 16 to 52|Lost to Follow-up|0|||
155098785|NCT01815424|559795269|FG001|Week 16 to 52|Lost to Follow-up|2|||
154834226|NCT01438489|558828265|FG000|Overall Study|Lost to Follow-up|4|||
154834227|NCT01438489|558828266|FG001|Overall Study|Lost to Follow-up|2|||
154834228|NCT01438489|558828267|FG002|Overall Study|Lost to Follow-up|2|||
154834229|NCT01438489|558828265|FG000|Overall Study|Withdrawal by Subject|11|||
154834230|NCT01438489|558828266|FG001|Overall Study|Withdrawal by Subject|3|||
154834231|NCT01438489|558828267|FG002|Overall Study|Withdrawal by Subject|8|||
154834232|NCT01438489|558828265|FG000|Overall Study|Death|0|||
155098786|NCT01815424|559795270|FG002|Week 16 to 52|Lost to Follow-up|0|||
155098787|NCT01815424|559795271|FG003|Week 16 to 52|Lost to Follow-up|2|||
155098788|NCT01815424|559795272|FG004|Week 16 to 52|Lost to Follow-up|1|||
155098789|NCT01815424|559795268|FG000|Week 16 to 52|Withdrawal by Subject|1|||
155098790|NCT01815424|559795269|FG001|Week 16 to 52|Withdrawal by Subject|2|||
155098791|NCT01815424|559795270|FG002|Week 16 to 52|Withdrawal by Subject|0|||
155098792|NCT01815424|559795271|FG003|Week 16 to 52|Withdrawal by Subject|0|||
155098793|NCT01815424|559795272|FG004|Week 16 to 52|Withdrawal by Subject|0|||
155098794|NCT04072835|559795273|FG000|Overall Study|Overall trial ended|603|||
155098795|NCT04072835|559795273|FG000|Overall Study|Ablation|97|||
155098796|NCT04072835|559795273|FG000|Overall Study|Withdrawal of consent|66|||
155098797|NCT04072835|559795273|FG000|Overall Study|Physician Decision|50|||
155098798|NCT04072835|559795273|FG000|Overall Study|Lost to Follow-up|39|||
155098799|NCT04072835|559795273|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
155098800|NCT04072835|559795273|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
155098801|NCT04072835|559795273|FG000|Overall Study|Adverse Event|25|||
155098802|NCT04072835|559795273|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
155098803|NCT04072835|559795273|FG000|Overall Study|Death|11|||
155098804|NCT04072835|559795273|FG000|Overall Study|Participant felt the drug did not work|8|||
155098805|NCT04072835|559795273|FG000|Overall Study|Participant tolerability|5|||
155098806|NCT04072835|559795273|FG000|Overall Study|Missing|5|||
155098807|NCT04072835|559795273|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
155098808|NCT04072835|559795273|FG000|Overall Study|Pregnancy|3|||
155098809|NCT00856323|559795274|FG000|Overall Study|Withdrawal by Subject|2|||
155098810|NCT01119443|559795278|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
155098811|NCT01119443|559795279|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
155098812|NCT02329743|559795280|FG000|Overall Study|Adverse Event|1|||
155098813|NCT02329743|559795281|FG001|Overall Study|Adverse Event|1|||
155098814|NCT02329743|559795282|FG002|Overall Study|Adverse Event|3|||
154834233|NCT01438489|558828266|FG001|Overall Study|Death|0|||
154834234|NCT01438489|558828267|FG002|Overall Study|Death|1|||
154834235|NCT01438489|558828265|FG000|Overall Study|Sponsor decision|4|||
154834236|NCT01438489|558828266|FG001|Overall Study|Sponsor decision|1|||
154834237|NCT01438489|558828267|FG002|Overall Study|Sponsor decision|4|||
154834238|NCT01438489|558828265|FG000|Overall Study|Subject choice/Subject moved|2|||
154834239|NCT01438489|558828266|FG001|Overall Study|Subject choice/Subject moved|1|||
154834240|NCT01438489|558828267|FG002|Overall Study|Subject choice/Subject moved|1|||
154834241|NCT01438489|558828265|FG000|Overall Study|Investigator decision|0|||
154834242|NCT01438489|558828266|FG001|Overall Study|Investigator decision|1|||
154834243|NCT01438489|558828267|FG002|Overall Study|Investigator decision|0|||
155098815|NCT02329743|559795280|FG000|Overall Study|Lost to Follow-up|1|||
155098816|NCT02329743|559795281|FG001|Overall Study|Lost to Follow-up|0|||
155098817|NCT02329743|559795282|FG002|Overall Study|Lost to Follow-up|1|||
155098818|NCT02329743|559795280|FG000|Overall Study|Withdrawal by Subject|4|||
155098819|NCT02329743|559795281|FG001|Overall Study|Withdrawal by Subject|4|||
155098820|NCT02329743|559795282|FG002|Overall Study|Withdrawal by Subject|1|||
154834244|NCT01438489|558828265|FG000|Overall Study|AE/SAEs|2|||
154834245|NCT01438489|558828266|FG001|Overall Study|AE/SAEs|1|||
154834246|NCT01438489|558828267|FG002|Overall Study|AE/SAEs|1|||
154834247|NCT01438489|558828265|FG000|Overall Study|Received prohibited medication|1|||
154834248|NCT01438489|558828266|FG001|Overall Study|Received prohibited medication|0|||
154834249|NCT01438489|558828267|FG002|Overall Study|Received prohibited medication|0|||
154834250|NCT01438489|558828265|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
154834251|NCT01438489|558828266|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
154834252|NCT01438489|558828267|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
154834253|NCT01438489|558828265|FG000|Overall Study|Inadequate venous access|0|||
154834254|NCT01438489|558828266|FG001|Overall Study|Inadequate venous access|2|||
154834255|NCT01438489|558828267|FG002|Overall Study|Inadequate venous access|0|||
154834256|NCT01372384|558828269|FG000|Overall Study|Progression of disease|3|||
154834257|NCT01471015|558828276|FG000|Overall Study|Death|0|||
154834258|NCT01471015|558828277|FG001|Overall Study|Death|1|||
154834259|NCT01471015|558828278|FG002|Overall Study|Death|1|||
154968520|NCT01968031|559307514|FG001|Overall Study|Failed inclusion criteria|2|||
154968521|NCT01968031|559307515|FG002|Overall Study|Failed inclusion criteria|0|||
154834260|NCT02576444|558828279|FG000|Overall Study|Death|1|||
154834261|NCT02576444|558828280|FG001|Overall Study|Death|1|||
154834262|NCT02576444|558828281|FG002|Overall Study|Death|0|||
154834263|NCT02576444|558828282|FG003|Overall Study|Death|0|||
154834264|NCT02576444|558828279|FG000|Overall Study|Withdrawal by Subject|0|||
154834265|NCT02576444|558828280|FG001|Overall Study|Withdrawal by Subject|0|||
154834266|NCT02576444|558828281|FG002|Overall Study|Withdrawal by Subject|2|||
154834267|NCT02576444|558828282|FG003|Overall Study|Withdrawal by Subject|0|||
154834268|NCT02576444|558828279|FG000|Overall Study|Adverse Event|0|||
154834269|NCT02576444|558828280|FG001|Overall Study|Adverse Event|0|||
154834270|NCT02576444|558828281|FG002|Overall Study|Adverse Event|1|||
154834271|NCT02576444|558828282|FG003|Overall Study|Adverse Event|0|||
155098821|NCT02329743|559795280|FG000|Overall Study|Other|0|||
155098822|NCT02329743|559795281|FG001|Overall Study|Other|2|||
155098823|NCT02329743|559795282|FG002|Overall Study|Other|3|||
155098824|NCT01428219|559795283|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
155098825|NCT00825994|559795296|FG000|Overall Study|Withdrawal by Subject|2|||
155098826|NCT00825994|559795296|FG000|Overall Study|Lost to Follow-up|1|||
155098827|NCT00825994|559795296|FG000|Overall Study|Protocol Violation|1|||
155098828|NCT00825994|559795296|FG000|Overall Study|Placebo Responder at V2|1|||
155098829|NCT01833494|559795300|FG000|Overall Study|Adverse Event|24|||
155098830|NCT01833494|559795300|FG000|Overall Study|Physician Decision|6|||
155098831|NCT01833494|559795300|FG000|Overall Study|Withdrawal by Subject|6|||
155098832|NCT01833494|559795300|FG000|Overall Study|Decrease in serum phosphorus|4|||
155098833|NCT01833494|559795300|FG000|Overall Study|Decrease in serum calcium|4|||
155098834|NCT01833494|559795300|FG000|Overall Study|Increase in serum ferritin|1|||
155098835|NCT01694433|559795305|FG000|Overall Study|Adverse Event|7|||
155098836|NCT01694433|559795306|FG001|Overall Study|Adverse Event|0|||
155098837|NCT01694433|559795305|FG000|Overall Study|Physician Decision|1|||
155098838|NCT01694433|559795306|FG001|Overall Study|Physician Decision|0|||
155098839|NCT01694433|559795305|FG000|Overall Study|Withdrawal by Subject|3|||
155098840|NCT01694433|559795306|FG001|Overall Study|Withdrawal by Subject|4|||
155098841|NCT04571060|559795311|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
155098842|NCT04571060|559795312|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
155098843|NCT04571060|559795311|FG000|Overall Study|Never treated migraine|47|||
155098844|NCT04571060|559795312|FG001|Overall Study|Never treated migraine|36|||
155098845|NCT04571060|559795311|FG000|Overall Study|Protocol Violation|4|||
155098846|NCT04571060|559795312|FG001|Overall Study|Protocol Violation|2|||
155098847|NCT04571060|559795311|FG000|Overall Study|Withdrawal by Subject|6|||
155098848|NCT04571060|559795312|FG001|Overall Study|Withdrawal by Subject|2|||
154834272|NCT02576444|558828279|FG000|Overall Study|Physician Decision|0|||
154834273|NCT02576444|558828280|FG001|Overall Study|Physician Decision|0|||
154834274|NCT02576444|558828281|FG002|Overall Study|Physician Decision|1|||
154834275|NCT02576444|558828282|FG003|Overall Study|Physician Decision|0|||
154834276|NCT03370120|558828289|FG000|Overall Study|Adverse event, non-fatal|24|||
154834277|NCT03370120|558828289|FG000|Overall Study|Withdrawal by Subject|6|||
154968522|NCT01968031|559307513|FG000|Overall Study|Death|0|||
154968523|NCT01968031|559307514|FG001|Overall Study|Death|0|||
154968524|NCT01968031|559307515|FG002|Overall Study|Death|1|||
154968525|NCT01968031|559307513|FG000|Overall Study|Prohibited concomitant medication|1|||
154968526|NCT01968031|559307514|FG001|Overall Study|Prohibited concomitant medication|0|||
155098849|NCT04571060|559795311|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
154834278|NCT03370120|558828289|FG000|Overall Study|Lost to Follow-up|1|||
154834279|NCT03370120|558828289|FG000|Overall Study|Lack of Efficacy|37|||
154968527|NCT01968031|559307515|FG002|Overall Study|Prohibited concomitant medication|0|||
154968528|NCT01891357|559307516|FG000|Overall Study|Protocol Violation|3|||
154968529|NCT03733145|559307517|FG000|Overall Study|screenfail|3|||
155098850|NCT04571060|559795312|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
155098851|NCT01220401|559795317|FG000|Overall Study|Withdrawal by Subject|2|||
155098852|NCT01220401|559795317|FG000|Overall Study|Protocol Violation|1|||
155098853|NCT01853462|559795320|FG000|Overall Study|Withdrawal by Subject|1|||
154968530|NCT03733145|559307518|FG001|Overall Study|screenfail|3|||
154968531|NCT03733145|559307519|FG002|Overall Study|screenfail|2|||
154834280|NCT03370120|558828289|FG000|Overall Study|Per sponsor's instructions|1|||
154834281|NCT03370120|558828289|FG000|Overall Study|Study was terminated by parent company UCB|2|||
154834282|NCT03370120|558828289|FG000|Overall Study|The study was ended by the promoter|3|||
154834283|NCT03370120|558828289|FG000|Overall Study|Discontinuation of drug development|3|||
154834284|NCT03370120|558828289|FG000|Overall Study|End of project|2|||
154834285|NCT03370120|558828289|FG000|Overall Study|Premature study closure|2|||
154834286|NCT03370120|558828289|FG000|Overall Study|Premature program termination|1|||
154834287|NCT03370120|558828289|FG000|Overall Study|Premature study termination|7|||
154834288|NCT03370120|558828289|FG000|Overall Study|Trial terminated by sponsor|2|||
154834289|NCT03370120|558828289|FG000|Overall Study|Trial discontinued by sponsor|2|||
154834290|NCT03370120|558828289|FG000|Overall Study|Study ended|15|||
154834291|NCT03370120|558828289|FG000|Overall Study|Clinical trial has been cancelled|1|||
154834292|NCT03370120|558828289|FG000|Overall Study|End of study per sponsor decision|2|||
154834293|NCT03370120|558828289|FG000|Overall Study|Promoter's decision|2|||
154834294|NCT03370120|558828289|FG000|Overall Study|The trial has been suspended|3|||
154834295|NCT03370120|558828289|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
154834296|NCT03370120|558828289|FG000|Overall Study|Early termination by order of sponsor|2|||
154834297|NCT03370120|558828289|FG000|Overall Study|Discontinuation of the study|5|||
154834298|NCT03370120|558828289|FG000|Overall Study|End of clinical trial discontinuation|1|||
154834299|NCT03370120|558828289|FG000|Overall Study|Because the clinical trial ended halfway|4|||
154834300|NCT03370120|558828289|FG000|Overall Study|Development discontinued|5|||
154834301|NCT03370120|558828289|FG000|Overall Study|Padsenovil program closed|3|||
154834302|NCT03370120|558828289|FG000|Overall Study|End of project|2|||
154834303|NCT03370120|558828289|FG000|Overall Study|Termination of project|1|||
154834304|NCT03370120|558828289|FG000|Overall Study|The study was interrupted by sponsor|4|||
154834305|NCT03370120|558828289|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
154834306|NCT03370120|558828289|FG000|Overall Study|End of sponsor decision|1|||
154834307|NCT03370120|558828289|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
154834308|NCT03370120|558828289|FG000|Overall Study|Early termination of studies|5|||
154834309|NCT03370120|558828289|FG000|Overall Study|This study is ended early|1|||
154834310|NCT03370120|558828289|FG000|Overall Study|End of padsevonil program|2|||
154834311|NCT03370120|558828289|FG000|Overall Study|Decision of sponsor|6|||
154834312|NCT03370120|558828289|FG000|Overall Study|Asked by the sponsor|3|||
154834313|NCT03370120|558828289|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
154834314|NCT03370120|558828289|FG000|Overall Study|PI decision poor compliance from participant|1|||
154834315|NCT03370120|558828289|FG000|Overall Study|Promoter ended the study|3|||
154834316|NCT03370120|558828289|FG000|Overall Study|Premature study close by sponsor's decision|4|||
154834317|NCT03370120|558828289|FG000|Overall Study|Study terminated by sponsor|33|||
154834318|NCT03370120|558828289|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
154834319|NCT03370120|558828289|FG000|Overall Study|Sponsor decision to terminate study|63|||
154834320|NCT03370120|558828289|FG000|Overall Study|Program closure|3|||
154834321|NCT03370120|558828289|FG000|Overall Study|Study ended prematurely|1|||
154834322|NCT03370120|558828289|FG000|Overall Study|Study stopped by sponsor|2|||
154834323|NCT03370120|558828289|FG000|Overall Study|Program termination|55|||
154834324|NCT03370120|558828289|FG000|Overall Study|Sponsor decision|62|||
154834325|NCT03370120|558828289|FG000|Overall Study|Sponsor study closure|10|||
154834326|NCT02700412|558828293|FG000|Overall Study|Adverse Event|6|||
154834327|NCT02700412|558828293|FG000|Overall Study|Death|1|||
154834328|NCT02700412|558828293|FG000|Overall Study|Lack of Efficacy|19|||
154834329|NCT02700412|558828293|FG000|Overall Study|Protocol Violation|5|||
154834330|NCT02700412|558828293|FG000|Overall Study|Withdrawal by Subject|2|||
154834331|NCT00928889|558828294|FG000|Overall Study|Lost to Follow-up|3|||
155098854|NCT01853462|559795321|FG001|Overall Study|Withdrawal by Subject|1|||
154834332|NCT00928889|558828295|FG001|Overall Study|Lost to Follow-up|1|||
154834333|NCT00928889|558828294|FG000|Overall Study|Protocol Violation|0|||
154834334|NCT00928889|558828295|FG001|Overall Study|Protocol Violation|1|||
154834335|NCT00928889|558828294|FG000|Overall Study|Adverse Event|1|||
154834336|NCT00928889|558828295|FG001|Overall Study|Adverse Event|0|||
154834337|NCT00928889|558828294|FG000|Overall Study|Other|1|||
155098855|NCT03386435|559795322|FG000|Overall Study|Protocol Violation|5|||
154834338|NCT00928889|558828295|FG001|Overall Study|Other|0|||
154834339|NCT01923285|558828307|FG000|Overall Study|Withdrawal by Subject|7|||
154834340|NCT01923285|558828308|FG001|Overall Study|Withdrawal by Subject|6|||
154834341|NCT01356407|558828309|FG000|Overall Study|Lost to Follow-up|2|||
155098856|NCT03386435|559795323|FG001|Overall Study|Protocol Violation|7|||
155098857|NCT04068922|559795324|FG000|Overall Study|Lost to Follow-up|5|||
155098858|NCT04068922|559795324|FG000|Overall Study|Withdrawal by Subject|7|||
155098859|NCT04068922|559795324|FG000|Overall Study|Adverse Event|1|||
155098860|NCT00625586|559795325|FG000|Overall Study|Adverse Event|1|||
155098861|NCT00625586|559795325|FG000|Overall Study|Progressive disease|1|||
155098862|NCT03192137|559795328|FG000|Overall Study|Adverse Event|10|||
155098863|NCT03192137|559795329|FG001|Overall Study|Adverse Event|11|||
155098864|NCT03192137|559795328|FG000|Overall Study|Physician Decision|1|||
155098865|NCT03192137|559795329|FG001|Overall Study|Physician Decision|0|||
155098866|NCT03192137|559795328|FG000|Overall Study|Lack of Efficacy|20|||
155098867|NCT03192137|559795329|FG001|Overall Study|Lack of Efficacy|37|||
155098868|NCT03192137|559795328|FG000|Overall Study|Withdrawal by Subject|3|||
155098869|NCT03192137|559795329|FG001|Overall Study|Withdrawal by Subject|3|||
155098870|NCT03192137|559795328|FG000|Overall Study|Protocol Violation|4|||
155098871|NCT03192137|559795329|FG001|Overall Study|Protocol Violation|3|||
155098872|NCT03192137|559795328|FG000|Overall Study|Surgery Cancelled|4|||
155098873|NCT03192137|559795329|FG001|Overall Study|Surgery Cancelled|1|||
155098874|NCT03192137|559795328|FG000|Overall Study|Other - Various Administrative Reasons|8|||
155098875|NCT03192137|559795329|FG001|Overall Study|Other - Various Administrative Reasons|3|||
155098876|NCT01261975|559795335|FG000|Overall Study|Surgical complication|1|||
155098877|NCT00716274|559795337|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
155098878|NCT00716274|559795338|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155098879|NCT00716274|559795339|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155098880|NCT00716274|559795340|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155098881|NCT00716274|559795341|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155098882|NCT00716274|559795342|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
155098883|NCT00716274|559795337|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
155098884|NCT00716274|559795338|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
155098885|NCT00716274|559795339|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
155098886|NCT00716274|559795340|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
155098887|NCT00716274|559795341|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
155098888|NCT00716274|559795342|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
155098889|NCT00716274|559795337|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
155098890|NCT00716274|559795338|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155098891|NCT00716274|559795339|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155098892|NCT00716274|559795340|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155098893|NCT00716274|559795341|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155098894|NCT00716274|559795342|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
155098895|NCT00716274|559795337|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
155098896|NCT00716274|559795338|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
155098897|NCT00716274|559795339|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
155098898|NCT00716274|559795340|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
155098899|NCT00716274|559795341|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
155098900|NCT00716274|559795342|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
155098901|NCT00716274|559795337|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
155098902|NCT00716274|559795338|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
155098903|NCT00716274|559795339|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155098904|NCT00716274|559795340|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155172648|NCT02874144|560071868|FG001|Overall Study|Lost to Follow-up|5|||
155172649|NCT00852371|560071873|FG000|Overall Study|Lost to Follow-up|2|||
155172650|NCT00852371|560071874|FG001|Overall Study|Lost to Follow-up|3|||
155172651|NCT00852371|560071875|FG002|Overall Study|Lost to Follow-up|4|||
155172652|NCT00852371|560071876|FG003|Overall Study|Lost to Follow-up|2|||
155172653|NCT04525885|560071877|FG000|Overall Study|Screen Failure|1|||
155172654|NCT04525885|560071878|FG001|Overall Study|Screen Failure|0|||
154834342|NCT01356407|558828310|FG001|Overall Study|Lost to Follow-up|0|||
154834343|NCT01356407|558828309|FG000|Overall Study|Patient Withdrew Consent|2|||
154834344|NCT01356407|558828310|FG001|Overall Study|Patient Withdrew Consent|1|||
154834345|NCT01356407|558828309|FG000|Overall Study|Could not afford IMP administration|0|||
154834346|NCT01356407|558828310|FG001|Overall Study|Could not afford IMP administration|1|||
154834347|NCT01356407|558828309|FG000|Overall Study|Not complete Endoscopy|2|||
154834348|NCT01356407|558828310|FG001|Overall Study|Not complete Endoscopy|2|||
154834349|NCT01309659|558828311|FG000|Overall Study|Protocol Violation|0|||
154834350|NCT01309659|558828312|FG001|Overall Study|Protocol Violation|1|||
154834351|NCT02184195|558828314|FG000|Overall Study|Patient decision|5|||
154834352|NCT02184195|558828315|FG001|Overall Study|Patient decision|2|||
154834353|NCT02184195|558828314|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155098905|NCT00716274|559795341|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155098906|NCT00716274|559795342|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
155098907|NCT00716274|559795337|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155098908|NCT00716274|559795338|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
155098909|NCT00716274|559795339|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155098910|NCT00716274|559795340|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155098911|NCT00716274|559795341|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155098912|NCT00716274|559795342|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
155098913|NCT00716274|559795337|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155098914|NCT00716274|559795338|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155098915|NCT00716274|559795339|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
155098916|NCT00716274|559795340|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155098917|NCT00716274|559795341|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155098918|NCT00716274|559795342|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
155098919|NCT00716274|559795337|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
155098920|NCT00716274|559795338|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
155098921|NCT00716274|559795339|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
155098922|NCT00716274|559795340|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
155098923|NCT00716274|559795341|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
155098924|NCT00716274|559795342|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
155098925|NCT00716274|559795337|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155098926|NCT00716274|559795338|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155098927|NCT00716274|559795339|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155098928|NCT00716274|559795340|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
155098929|NCT00716274|559795341|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
155098930|NCT00716274|559795342|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
155098931|NCT00716274|559795337|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
155098932|NCT00716274|559795338|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
155098933|NCT00716274|559795339|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
155098934|NCT00716274|559795340|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
155098935|NCT00716274|559795341|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
155098936|NCT00716274|559795342|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
155098937|NCT01171677|559795343|FG000|Overall Study|Withdrawal by Subject|0|||
155098938|NCT01171677|559795344|FG001|Overall Study|Withdrawal by Subject|3|||
155098939|NCT01171677|559795343|FG000|Overall Study|Adverse Event|1|||
154834354|NCT02184195|558828315|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
154834355|NCT02184195|558828314|FG000|Overall Study|Death|67|||
154834356|NCT02184195|558828315|FG001|Overall Study|Death|44|||
154834357|NCT02184195|558828314|FG000|Overall Study|Lost to Follow-up|1|||
154834358|NCT02184195|558828315|FG001|Overall Study|Lost to Follow-up|5|||
154834359|NCT02184195|558828314|FG000|Overall Study|Other|0|||
154968532|NCT04573309|559308946|FG000|Overall Study|Protocol Violation|1|||
155098940|NCT01171677|559795344|FG001|Overall Study|Adverse Event|0|||
155098941|NCT01171677|559795343|FG000|Overall Study|completed <70% IntenSati classes|5|||
155098942|NCT01171677|559795344|FG001|Overall Study|completed <70% IntenSati classes|0|||
155098943|NCT02015039|559795355|FG000|Overall Study|Not eligible|0|||
155098944|NCT02015039|559795356|FG001|Overall Study|Not eligible|1|||
155172655|NCT04525885|560071879|FG002|Overall Study|Screen Failure|0|||
155172656|NCT04525885|560071877|FG000|Overall Study|Withdrawal by Subject|14|||
155172657|NCT04525885|560071878|FG001|Overall Study|Withdrawal by Subject|6|||
155172658|NCT04525885|560071879|FG002|Overall Study|Withdrawal by Subject|20|||
155172659|NCT04525885|560071877|FG000|Overall Study|Physician Decision|1|||
154834360|NCT02184195|558828315|FG001|Overall Study|Other|3|||
154834361|NCT02716987|558828318|FG000|Overall Study|Ligand synthesis failure|0|||
154968533|NCT04573309|559308947|FG001|Overall Study|Protocol Violation|0|||
155098945|NCT00403130|559795360|FG000|2 Years From Start of Treatment|Not Eligible|3|||
155172660|NCT04525885|560071878|FG001|Overall Study|Physician Decision|0|||
155172661|NCT04525885|560071879|FG002|Overall Study|Physician Decision|1|||
154834362|NCT02716987|558828319|FG001|Overall Study|Ligand synthesis failure|0|||
154834363|NCT02716987|558828320|FG002|Overall Study|Ligand synthesis failure|1|||
154834364|NCT02716987|558828321|FG003|Overall Study|Ligand synthesis failure|0|||
154834365|NCT02716987|558828322|FG004|Overall Study|Ligand synthesis failure|0|||
155172662|NCT02717832|560071880|FG000|Overall Study|Inability to place IV|3|||
154834366|NCT02716987|558828323|FG005|Overall Study|Ligand synthesis failure|0|||
154834367|NCT02716987|558828318|FG000|Overall Study|Withdrawal by Subject|0|||
154834368|NCT02716987|558828319|FG001|Overall Study|Withdrawal by Subject|0|||
154834369|NCT02716987|558828320|FG002|Overall Study|Withdrawal by Subject|0|||
154834370|NCT02716987|558828321|FG003|Overall Study|Withdrawal by Subject|0|||
154834371|NCT02716987|558828322|FG004|Overall Study|Withdrawal by Subject|1|||
154834372|NCT02716987|558828323|FG005|Overall Study|Withdrawal by Subject|1|||
154834373|NCT02829138|558828324|FG000|Overall Study|Withdrawal by Subject|1|||
154834374|NCT02829138|558828325|FG001|Overall Study|Withdrawal by Subject|0|||
154834375|NCT00808236|558828333|FG000|Overall Study|Was not resuscitated|50|||
154968534|NCT01691430|559308950|FG000|Overall Study|Death|17|||
154968535|NCT01691430|559308951|FG001|Overall Study|Death|16|||
154968536|NCT01691430|559308950|FG000|Overall Study|Withdrawal by Subject|5|||
154968537|NCT01691430|559308951|FG001|Overall Study|Withdrawal by Subject|1|||
154968538|NCT01691430|559308950|FG000|Overall Study|Lost to Follow-up|0|||
154968539|NCT01691430|559308951|FG001|Overall Study|Lost to Follow-up|3|||
154968540|NCT01894230|559308952|FG000|Overall Study|Lost to Follow-up|2|||
154968541|NCT01894230|559308953|FG001|Overall Study|Lost to Follow-up|2|||
154968542|NCT01894230|559308952|FG000|Overall Study|Withdrawal by Subject|4|||
154968543|NCT01894230|559308953|FG001|Overall Study|Withdrawal by Subject|4|||
154968544|NCT01894230|559308952|FG000|Overall Study|Non-adherent|0|||
154968545|NCT01894230|559308953|FG001|Overall Study|Non-adherent|1|||
154968546|NCT01894230|559308952|FG000|Overall Study|Death|1|||
154968547|NCT01894230|559308953|FG001|Overall Study|Death|0|||
154968548|NCT00660387|559308956|FG000|Overall Study|Adverse Event|1|||
154968549|NCT00660387|559308957|FG001|Overall Study|Adverse Event|2|||
154968550|NCT00660387|559308956|FG000|Overall Study|Lack of Efficacy|0|||
154968551|NCT00660387|559308957|FG001|Overall Study|Lack of Efficacy|1|||
154968552|NCT00660387|559308956|FG000|Overall Study|Protocol Violation|1|||
154968553|NCT00660387|559308957|FG001|Overall Study|Protocol Violation|0|||
154968554|NCT02259348|559308958|FG000|Overall Study|Donors|6|||
154968555|NCT02259348|559308958|FG000|Overall Study|Death|4|||
154968556|NCT01622660|559308959|FG000|Overall Study|Adverse Event|1|||
154968557|NCT04211766|559308960|FG000|Overall Study|Withdrawal by Subject|5|||
154968558|NCT04211766|559308961|FG001|Overall Study|Withdrawal by Subject|1|||
154968559|NCT00642993|559308962|FG000|Overall Study|Adverse Event|85|||
154968560|NCT00642993|559308963|FG001|Overall Study|Adverse Event|4|||
154968561|NCT00642993|559308962|FG000|Overall Study|Lost to Follow-up|8|||
154968562|NCT00642993|559308963|FG001|Overall Study|Lost to Follow-up|4|||
154968563|NCT00642993|559308962|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
154968564|NCT00642993|559308963|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
154968565|NCT00642993|559308962|FG000|Overall Study|Protocol Violation|1|||
154968566|NCT00642993|559308963|FG001|Overall Study|Protocol Violation|4|||
154968567|NCT00642993|559308962|FG000|Overall Study|Did not meet protocol eligibility|0|||
154968568|NCT00642993|559308963|FG001|Overall Study|Did not meet protocol eligibility|1|||
154968569|NCT00642993|559308962|FG000|Overall Study|Administrative|1|||
154968570|NCT00642993|559308963|FG001|Overall Study|Administrative|0|||
154968571|NCT02583048|559308964|FG000|Overall Study|Withdrawal by Subject|0|||
154968572|NCT02583048|559308965|FG001|Overall Study|Withdrawal by Subject|1|||
154968573|NCT02583048|559308966|FG002|Overall Study|Withdrawal by Subject|0|||
154968574|NCT02583048|559308964|FG000|Overall Study|Failed to meet eligibility criterion|0|||
154968575|NCT02583048|559308965|FG001|Overall Study|Failed to meet eligibility criterion|0|||
154834376|NCT00808236|558828334|FG001|Overall Study|Was not resuscitated|56|||
154834377|NCT00808236|558828333|FG000|Overall Study|Pre-defined exclusion|13|||
154968576|NCT02583048|559308966|FG002|Overall Study|Failed to meet eligibility criterion|1|||
154968577|NCT00516295|559308970|FG000|Overall Study|Lack of Efficacy|2|||
154968578|NCT00516295|559308971|FG001|Overall Study|Lack of Efficacy|0|||
155098946|NCT00403130|559795360|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
155098947|NCT00403130|559795360|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
155098948|NCT00403130|559795360|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
155098949|NCT01404234|559795361|FG000|Overall Study|Withdrawal by Subject|2|||
155098950|NCT02670473|559795362|FG000|Overall Study|Withdrawal by Subject|1|||
155098951|NCT00810277|559797476|FG000|Overall Study|Adverse Event|1|||
155098952|NCT00678288|559797479|FG000|Overall Study|Adverse Event|0|||
155098953|NCT00678288|559797480|FG001|Overall Study|Adverse Event|2|||
155098954|NCT00678288|559797479|FG000|Overall Study|Withdrawal by Subject|1|||
155098955|NCT00678288|559797480|FG001|Overall Study|Withdrawal by Subject|1|||
155098956|NCT00678288|559797479|FG000|Overall Study|Study terminated by the sponsor|2|||
155098957|NCT00678288|559797480|FG001|Overall Study|Study terminated by the sponsor|0|||
155098958|NCT00678288|559797479|FG000|Overall Study|Not compliant with study medication|0|||
155098959|NCT00678288|559797480|FG001|Overall Study|Not compliant with study medication|1|||
155098960|NCT00678288|559797479|FG000|Overall Study|Switch to commercial drug|0|||
155098961|NCT00678288|559797480|FG001|Overall Study|Switch to commercial drug|1|||
155098962|NCT00678288|559797479|FG000|Overall Study|Reason not reported|1|||
155098963|NCT00678288|559797480|FG001|Overall Study|Reason not reported|0|||
155098964|NCT00678288|559797479|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
155098965|NCT00678288|559797480|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
155098966|NCT04472650|559797491|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
155098967|NCT04472650|559797492|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
155098968|NCT02628444|559797495|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
155098969|NCT02628444|559797496|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098970|NCT02628444|559797497|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098971|NCT02628444|559797498|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098972|NCT02628444|559797499|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098973|NCT02628444|559797500|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098974|NCT02628444|559797501|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098975|NCT02628444|559797502|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098976|NCT02628444|559797503|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
155098977|NCT02628444|559797495|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098978|NCT02628444|559797496|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
155098979|NCT02628444|559797497|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
155098980|NCT02628444|559797498|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098981|NCT02628444|559797499|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098982|NCT02628444|559797500|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098983|NCT02628444|559797501|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098984|NCT02628444|559797502|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098985|NCT02628444|559797503|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
155098986|NCT02628444|559797495|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
155098987|NCT02628444|559797496|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
155098988|NCT02628444|559797497|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
155098989|NCT02628444|559797498|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155098990|NCT02628444|559797499|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155098991|NCT02628444|559797500|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155098992|NCT02628444|559797501|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155098993|NCT02628444|559797502|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155098994|NCT02628444|559797503|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
155098995|NCT02628444|559797495|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
155098996|NCT02628444|559797496|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
155098997|NCT02628444|559797497|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
155098998|NCT02628444|559797498|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155098999|NCT02628444|559797499|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155099000|NCT02628444|559797500|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155099001|NCT02628444|559797501|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155099002|NCT02628444|559797502|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155099003|NCT02628444|559797503|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
155099004|NCT02628444|559797495|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
155099005|NCT02628444|559797496|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
155099006|NCT02628444|559797497|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
155099007|NCT02628444|559797498|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155099008|NCT02628444|559797499|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155099009|NCT02628444|559797500|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155099010|NCT02628444|559797501|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155099011|NCT02628444|559797502|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155099012|NCT02628444|559797503|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
155099013|NCT02628444|559797495|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099014|NCT02628444|559797496|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099015|NCT02628444|559797497|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099016|NCT02628444|559797498|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
155099017|NCT02628444|559797499|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099018|NCT02628444|559797500|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099019|NCT02628444|559797501|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099020|NCT02628444|559797502|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099021|NCT02628444|559797503|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
155099022|NCT02628444|559797495|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
155099023|NCT02628444|559797496|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
155099024|NCT02628444|559797497|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
155099025|NCT02628444|559797498|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
155099026|NCT02628444|559797499|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
155099027|NCT02628444|559797500|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
155099028|NCT02628444|559797501|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
155099029|NCT02628444|559797502|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
155099030|NCT02628444|559797503|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
155099031|NCT02628444|559797495|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
154834378|NCT00808236|558828334|FG001|Overall Study|Pre-defined exclusion|3|||
154834379|NCT00808236|558828333|FG000|Overall Study|Lost to Follow-up|1|||
154834380|NCT00808236|558828334|FG001|Overall Study|Lost to Follow-up|1|||
154834381|NCT00808236|558828333|FG000|Overall Study|Physician Decision|0|||
155099032|NCT02628444|559797496|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
155099033|NCT02628444|559797497|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
155099034|NCT02628444|559797498|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
155099035|NCT02628444|559797499|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
155099036|NCT02628444|559797500|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
155099037|NCT02628444|559797501|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
155099038|NCT02628444|559797502|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
155099039|NCT02628444|559797503|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
155099040|NCT02628444|559797495|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155099041|NCT02628444|559797496|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155099042|NCT02628444|559797497|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155099043|NCT02628444|559797498|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155099044|NCT02628444|559797499|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
155099045|NCT02628444|559797500|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
155099046|NCT02628444|559797501|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
154834382|NCT00808236|558828334|FG001|Overall Study|Physician Decision|1|||
154834383|NCT00808236|558828333|FG000|Overall Study|Death|18|||
154834384|NCT00808236|558828334|FG001|Overall Study|Death|30|||
154834385|NCT00961220|558828335|FG000|Overall Study|Adverse Event|3|||
154834386|NCT00961220|558828335|FG000|Overall Study|Lack of Efficacy|1|||
154968579|NCT00516295|559308972|FG002|Overall Study|Lack of Efficacy|0|||
155172663|NCT03158285|560071881|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
155172664|NCT03158285|560071882|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
154968580|NCT00516295|559308970|FG000|Overall Study|Ineligible|1|||
154968581|NCT00516295|559308971|FG001|Overall Study|Ineligible|0|||
154968582|NCT00516295|559308972|FG002|Overall Study|Ineligible|0|||
154968583|NCT04661202|559308973|FG000|Overall Study|Withdrawal by Subject|1|||
154968584|NCT04661202|559308974|FG001|Overall Study|Withdrawal by Subject|1|||
154968585|NCT04661202|559308973|FG000|Overall Study|Lack of Efficacy|2|||
154968586|NCT04661202|559308974|FG001|Overall Study|Lack of Efficacy|0|||
154968587|NCT01944722|559308977|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
154968588|NCT01944722|559308977|FG000|Overall Study|Specimen Shipping Issues|34|||
154968589|NCT01944722|559308977|FG000|Overall Study|Improper Storage/Transport|5|||
154968590|NCT01944722|559308977|FG000|Overall Study|Insufficient Volume for Test|1|||
154968591|NCT01944722|559308977|FG000|Overall Study|Missing Specimens|3|||
154968592|NCT01944722|559308977|FG000|Overall Study|Specimens Mislabeled|2|||
154968593|NCT01944722|559308977|FG000|Overall Study|Withdrawal by Subject|8|||
154968594|NCT01944722|559308977|FG000|Overall Study|NILM Subjects <30 years old|8106|||
154968595|NCT01944722|559308977|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
154968596|NCT01944722|559308977|FG000|Overall Study|>ASCUS Cytology|1122|||
154968597|NCT02906917|559308981|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
154968598|NCT02906917|559308982|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
154968599|NCT02906917|559308981|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
154968600|NCT02906917|559308982|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
154968601|NCT02906917|559308981|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
154968602|NCT02906917|559308982|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
154968603|NCT02906917|559308981|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
154968604|NCT02906917|559308982|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
154968605|NCT02906917|559308981|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
154968606|NCT02906917|559308982|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
154968607|NCT02906917|559308981|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
154968608|NCT02906917|559308982|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
154968609|NCT02906917|559308981|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
154968610|NCT02906917|559308982|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
154968611|NCT02906917|559308981|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
154968612|NCT02906917|559308982|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
154968613|NCT00687739|559308983|FG000|Overall Study|Lost to Follow-up|2|||
154968614|NCT00687739|559308984|FG001|Overall Study|Lost to Follow-up|2|||
154968615|NCT00687739|559308985|FG002|Overall Study|Lost to Follow-up|1|||
154968616|NCT00687739|559308986|FG003|Overall Study|Lost to Follow-up|2|||
154968617|NCT00687739|559308983|FG000|Overall Study|Adverse Event|0|||
154968618|NCT00687739|559308984|FG001|Overall Study|Adverse Event|1|||
154968619|NCT00687739|559308985|FG002|Overall Study|Adverse Event|1|||
154968620|NCT00687739|559308986|FG003|Overall Study|Adverse Event|0|||
154968621|NCT03599362|559308991|FG000|Overall Study|Screen Failure|3|||
154968622|NCT02072096|559308993|FG000|Overall Study|Lack of Efficacy|18|||
154968623|NCT02072096|559308994|FG001|Overall Study|Lack of Efficacy|29|||
154968624|NCT02072096|559308993|FG000|Overall Study|Protocol Violation|7|||
154968625|NCT02072096|559308994|FG001|Overall Study|Protocol Violation|7|||
154968626|NCT02072096|559308993|FG000|Overall Study|Withdrawal by Subject|5|||
154968627|NCT02072096|559308994|FG001|Overall Study|Withdrawal by Subject|7|||
154968628|NCT02072096|559308993|FG000|Overall Study|Adverse Event|5|||
154968629|NCT02072096|559308994|FG001|Overall Study|Adverse Event|2|||
154968630|NCT02072096|559308993|FG000|Overall Study|No Reason Provided|4|||
154968631|NCT02072096|559308994|FG001|Overall Study|No Reason Provided|2|||
154968632|NCT02072096|559308993|FG000|Overall Study|Death|2|||
154968633|NCT02072096|559308994|FG001|Overall Study|Death|0|||
154968634|NCT02072096|559308993|FG000|Overall Study|Physician Decision|0|||
154968635|NCT02072096|559308994|FG001|Overall Study|Physician Decision|1|||
154968636|NCT02072096|559308993|FG000|Overall Study|Study Terminated by Sponsor|43|||
154968637|NCT02072096|559308994|FG001|Overall Study|Study Terminated by Sponsor|30|||
154968638|NCT02072096|559308993|FG000|Overall Study|Lost to Follow-up|1|||
155172665|NCT03158285|560071883|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
154968639|NCT02072096|559308994|FG001|Overall Study|Lost to Follow-up|0|||
154968640|NCT04567329|559309012|FG000|Overall Study|Withdrawal by Subject|5|||
155099047|NCT02628444|559797502|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
155099048|NCT02628444|559797503|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
155099049|NCT02628444|559797495|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
155099050|NCT02628444|559797496|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
155099051|NCT02628444|559797497|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
155099052|NCT02628444|559797498|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
155099053|NCT02628444|559797499|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
155099054|NCT02628444|559797500|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
155099055|NCT02628444|559797501|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
155099056|NCT02628444|559797502|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
155099057|NCT02628444|559797503|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
155099058|NCT01333722|559797504|FG000|Overall Study|Lack of Efficacy|0|||
155099059|NCT01333722|559797505|FG001|Overall Study|Lack of Efficacy|2|||
155099060|NCT01333722|559797504|FG000|Overall Study|Withdrawal by Subject|0|||
155099061|NCT01333722|559797505|FG001|Overall Study|Withdrawal by Subject|1|||
155099062|NCT02079909|559797508|FG000|Overall Study|Adverse Event|23|||
155099063|NCT02079909|559797509|FG001|Overall Study|Adverse Event|23|||
155099064|NCT02079909|559797510|FG002|Overall Study|Adverse Event|7|||
155099065|NCT02079909|559797508|FG000|Overall Study|Withdrawal by Subject|9|||
155099066|NCT02079909|559797509|FG001|Overall Study|Withdrawal by Subject|17|||
155099067|NCT02079909|559797510|FG002|Overall Study|Withdrawal by Subject|4|||
155099068|NCT02079909|559797508|FG000|Overall Study|Lost to Follow-up|2|||
155099069|NCT02079909|559797509|FG001|Overall Study|Lost to Follow-up|3|||
155099070|NCT02079909|559797510|FG002|Overall Study|Lost to Follow-up|1|||
155099071|NCT02079909|559797508|FG000|Overall Study|Death|2|||
155099072|NCT02079909|559797509|FG001|Overall Study|Death|2|||
155099073|NCT02079909|559797510|FG002|Overall Study|Death|0|||
155099074|NCT02079909|559797508|FG000|Overall Study|Lack of Efficacy|0|||
155099075|NCT02079909|559797509|FG001|Overall Study|Lack of Efficacy|0|||
155099076|NCT02079909|559797510|FG002|Overall Study|Lack of Efficacy|1|||
155099077|NCT02079909|559797508|FG000|Overall Study|Protocol Violation|0|||
155099078|NCT02079909|559797509|FG001|Overall Study|Protocol Violation|1|||
155099079|NCT02079909|559797510|FG002|Overall Study|Protocol Violation|1|||
155099080|NCT02079909|559797508|FG000|Overall Study|Physician Decision|0|||
155099081|NCT02079909|559797509|FG001|Overall Study|Physician Decision|1|||
155099082|NCT02079909|559797510|FG002|Overall Study|Physician Decision|1|||
155099083|NCT02079909|559797508|FG000|Overall Study|Relocation etc.|2|||
155099084|NCT02079909|559797509|FG001|Overall Study|Relocation etc.|2|||
155099085|NCT02079909|559797510|FG002|Overall Study|Relocation etc.|3|||
155099086|NCT02237001|559797513|FG000|Overall Study|Lost to Follow-up|2|||
155099087|NCT02237001|559797513|FG000|Overall Study|Withdrawal by Subject|1|||
155099088|NCT02237001|559797513|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
155099089|NCT02237001|559797513|FG000|Overall Study|Re-operation|4|||
155099090|NCT02237001|559797513|FG000|Overall Study|Incarceration|1|||
155099091|NCT04551898|559797514|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
155099092|NCT04551898|559797515|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
155099093|NCT04551898|559797516|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
155099094|NCT04551898|559797517|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
155099095|NCT04551898|559797514|FG000|Overall Study|Withdrawal by Subject|5|||
155099096|NCT04551898|559797515|FG001|Overall Study|Withdrawal by Subject|1|||
155099097|NCT04551898|559797516|FG002|Overall Study|Withdrawal by Subject|2|||
155099098|NCT04551898|559797517|FG003|Overall Study|Withdrawal by Subject|2|||
155099099|NCT04551898|559797514|FG000|Overall Study|Lost to Follow-up|2|||
155099100|NCT04551898|559797515|FG001|Overall Study|Lost to Follow-up|1|||
155099101|NCT04551898|559797516|FG002|Overall Study|Lost to Follow-up|2|||
155099102|NCT04551898|559797517|FG003|Overall Study|Lost to Follow-up|2|||
155099103|NCT04551898|559797514|FG000|Overall Study|Death|1|||
155099104|NCT04551898|559797515|FG001|Overall Study|Death|0|||
155099105|NCT04551898|559797516|FG002|Overall Study|Death|0|||
155099106|NCT04551898|559797517|FG003|Overall Study|Death|0|||
155099107|NCT04551898|559797514|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
155099108|NCT04551898|559797515|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
155099109|NCT04551898|559797516|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
155099110|NCT04551898|559797517|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
155099111|NCT03427814|559797518|FG000|Overall Study|Withdrawal by Subject|4|||
155099112|NCT03427814|559797519|FG001|Overall Study|Withdrawal by Subject|4|||
154968641|NCT04567329|559309013|FG001|Overall Study|Withdrawal by Subject|6|||
154968642|NCT04567329|559309012|FG000|Overall Study|Protocol Violation|2|||
154968643|NCT04567329|559309013|FG001|Overall Study|Protocol Violation|3|||
154968644|NCT04567329|559309012|FG000|Overall Study|Discontinued|2|||
154968645|NCT04567329|559309013|FG001|Overall Study|Discontinued|2|||
154968646|NCT04567329|559309012|FG000|Overall Study|Lost to Follow-up|0|||
154968647|NCT04567329|559309013|FG001|Overall Study|Lost to Follow-up|1|||
154968648|NCT04567329|559309012|FG000|Overall Study|Lack of Efficacy|0|||
154968649|NCT04567329|559309013|FG001|Overall Study|Lack of Efficacy|1|||
154968650|NCT02933060|559309014|FG000|Overall Study|Withdrawal by Subject|0|||
154968651|NCT02933060|559309015|FG001|Overall Study|Withdrawal by Subject|1|||
154968652|NCT01945580|559309016|FG000|Overall Study|Withdrawal by Subject|13|||
154968653|NCT01945580|559309017|FG001|Overall Study|Withdrawal by Subject|35|||
154968654|NCT01945580|559309016|FG000|Overall Study|Physician Decision|3|||
154968655|NCT01945580|559309017|FG001|Overall Study|Physician Decision|2|||
154968656|NCT01945580|559309016|FG000|Overall Study|Lost to Follow-up|26|||
154968657|NCT01945580|559309017|FG001|Overall Study|Lost to Follow-up|39|||
154968658|NCT01945580|559309016|FG000|Overall Study|Death|7|||
154968659|NCT01945580|559309017|FG001|Overall Study|Death|2|||
154968660|NCT01945580|559309016|FG000|Overall Study|Patient moved out of state|0|||
154968661|NCT01945580|559309017|FG001|Overall Study|Patient moved out of state|1|||
154968662|NCT01945580|559309016|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
154968663|NCT01945580|559309017|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
154968664|NCT01945580|559309016|FG000|Overall Study|Family illness - unable to return|0|||
154968665|NCT01945580|559309017|FG001|Overall Study|Family illness - unable to return|1|||
154968666|NCT01945580|559309016|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
154968667|NCT01945580|559309017|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
154968668|NCT01945580|559309016|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
154968669|NCT01945580|559309017|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
154968670|NCT01945580|559309016|FG000|Overall Study|Noncompliance with 36 month visit|1|||
154968671|NCT01945580|559309017|FG001|Overall Study|Noncompliance with 36 month visit|0|||
154968672|NCT01945580|559309016|FG000|Overall Study|The patient moved.|1|||
154968673|NCT01945580|559309017|FG001|Overall Study|The patient moved.|0|||
154968674|NCT01945580|559309016|FG000|Overall Study|No data available|0|||
154968675|NCT01945580|559309017|FG001|Overall Study|No data available|2|||
154968676|NCT04411680|559309018|FG000|Treatment Period|Adverse Event|3|||
154968677|NCT04411680|559309019|FG001|Treatment Period|Adverse Event|0|||
154968678|NCT04411680|559309018|FG000|Treatment Period|Discharged from hospital|18|||
155099113|NCT03427814|559797518|FG000|Overall Study|Lost to Follow-up|0|||
155099114|NCT03427814|559797519|FG001|Overall Study|Lost to Follow-up|2|||
155099115|NCT03427814|559797518|FG000|Overall Study|Death|42|||
154968679|NCT04411680|559309019|FG001|Treatment Period|Discharged from hospital|7|||
154968680|NCT04411680|559309018|FG000|Treatment Period|Missed 1 or more doses|8|||
154834387|NCT00961220|558828335|FG000|Overall Study|No IV access for O6BG|1|||
154834388|NCT00961220|558828335|FG000|Overall Study|O6BG no longer supplied|1|||
154834389|NCT00961220|558828335|FG000|Overall Study|Complete Response prior to 12 courses|1|||
154834390|NCT04041284|558828338|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
154834391|NCT04041284|558828339|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
154834392|NCT04041284|558828338|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
155099116|NCT03427814|559797519|FG001|Overall Study|Death|31|||
155099117|NCT03427814|559797518|FG000|Overall Study|Sponsor's Decision|1|||
155099118|NCT03427814|559797519|FG001|Overall Study|Sponsor's Decision|0|||
155099119|NCT03427814|559797518|FG000|Overall Study|Investigator's Decision|1|||
155099120|NCT03427814|559797519|FG001|Overall Study|Investigator's Decision|2|||
155099121|NCT03427814|559797518|FG000|Overall Study|Disease progression|1|||
155099122|NCT03427814|559797519|FG001|Overall Study|Disease progression|0|||
155099123|NCT03427814|559797518|FG000|Overall Study|Treatment Completed|0|||
155099124|NCT03427814|559797519|FG001|Overall Study|Treatment Completed|1|||
155099125|NCT03427814|559797518|FG000|Overall Study|Sponsor's Decision to End study|21|||
155099126|NCT03427814|559797519|FG001|Overall Study|Sponsor's Decision to End study|25|||
155099127|NCT03427814|559797518|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
155099128|NCT03427814|559797519|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
155099129|NCT01979614|559797520|FG000|Overall Study|Adverse Event|1|||
155099130|NCT01979614|559797521|FG001|Overall Study|Adverse Event|1|||
155099131|NCT00456755|559797526|FG000|Overall Study|Lost to Follow-up|2|||
155099132|NCT00456755|559797527|FG001|Overall Study|Lost to Follow-up|1|||
155099133|NCT03073525|559797531|FG000|Overall Study|Withdrawal by Subject|0|||
155099134|NCT03073525|559797532|FG001|Overall Study|Withdrawal by Subject|0|||
155099135|NCT03073525|559797533|FG002|Overall Study|Withdrawal by Subject|3|||
154834393|NCT04041284|558828339|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
154834394|NCT04041284|558828338|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
154834395|NCT04041284|558828339|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
154834396|NCT04041284|558828338|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
154834397|NCT04041284|558828339|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
154834398|NCT04041284|558828338|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
154834399|NCT04041284|558828339|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
154834400|NCT04041284|558828338|FG000|DB Phase (12 Weeks)|Other than specified|1|||
154834401|NCT04041284|558828339|FG001|DB Phase (12 Weeks)|Other than specified|0|||
154834402|NCT04041284|558828338|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
154834403|NCT04041284|558828339|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
154834404|NCT04041284|558828338|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
154834405|NCT04041284|558828339|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
154834406|NCT04041284|558828338|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
154834407|NCT04041284|558828339|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
154834408|NCT04041284|558828338|FG000|OL Phase (12 Weeks)|Other than specified|6|||
154834409|NCT04041284|558828339|FG001|OL Phase (12 Weeks)|Other than specified|2|||
154834410|NCT00258674|558828346|FG000|Overall Study|Death|32|||
155099136|NCT02477527|559797534|FG000|Overall Study|Lost to Follow-up|2|||
155099137|NCT02477527|559797534|FG000|Overall Study|Withdrawal by Subject|1|||
155099138|NCT02477527|559797534|FG000|Overall Study|Screen Failure|3|||
155099139|NCT01976299|559797535|FG000|Overall Study|Withdrawal by Subject|3|||
155099140|NCT01976299|559797536|FG001|Overall Study|Withdrawal by Subject|1|||
155099141|NCT01976299|559797535|FG000|Overall Study|Death|4|||
155099142|NCT01976299|559797536|FG001|Overall Study|Death|2|||
155099143|NCT01976299|559797535|FG000|Overall Study|Lost to Follow-up|7|||
155099144|NCT01976299|559797536|FG001|Overall Study|Lost to Follow-up|1|||
155099145|NCT01976299|559797535|FG000|Overall Study|See clarification above in comments|9|||
155099146|NCT01976299|559797536|FG001|Overall Study|See clarification above in comments|2|||
155099147|NCT03692403|559797537|FG000|Overall Study|Withdrawal by Subject|1|||
155099148|NCT03692403|559797538|FG001|Overall Study|Withdrawal by Subject|0|||
155099149|NCT03692403|559797539|FG002|Overall Study|Withdrawal by Subject|1|||
155099150|NCT03692403|559797540|FG003|Overall Study|Withdrawal by Subject|0|||
155099151|NCT03692403|559797537|FG000|Overall Study|Adverse Event|0|||
155099152|NCT03692403|559797538|FG001|Overall Study|Adverse Event|0|||
155099153|NCT03692403|559797539|FG002|Overall Study|Adverse Event|0|||
155099154|NCT03692403|559797540|FG003|Overall Study|Adverse Event|1|||
155099155|NCT03692403|559797537|FG000|Overall Study|Pregnancy|0|||
155099156|NCT03692403|559797538|FG001|Overall Study|Pregnancy|1|||
155099157|NCT03692403|559797539|FG002|Overall Study|Pregnancy|0|||
155099158|NCT03692403|559797540|FG003|Overall Study|Pregnancy|0|||
154834411|NCT00258674|558828347|FG001|Overall Study|Death|53|||
154834412|NCT00258674|558828348|FG002|Overall Study|Death|34|||
155099159|NCT03692403|559797537|FG000|Overall Study|Other|0|||
154834413|NCT00432042|558828353|FG000|Overall Study|Protocol Violation|2|||
154834414|NCT00432042|558828354|FG001|Overall Study|Protocol Violation|0|||
154834415|NCT00432042|558828355|FG002|Overall Study|Protocol Violation|0|||
154834416|NCT00432042|558828353|FG000|Overall Study|Withdrawal by Subject|0|||
155099160|NCT03692403|559797538|FG001|Overall Study|Other|0|||
155099161|NCT03692403|559797539|FG002|Overall Study|Other|1|||
155099162|NCT03692403|559797540|FG003|Overall Study|Other|0|||
155099163|NCT04567524|559797541|FG000|Overall Study|Adverse Event|1|||
155099164|NCT04567524|559797542|FG001|Overall Study|Adverse Event|1|||
155099165|NCT04567524|559797543|FG002|Overall Study|Adverse Event|0|||
155099166|NCT04567524|559797544|FG003|Overall Study|Adverse Event|0|||
154834417|NCT00432042|558828354|FG001|Overall Study|Withdrawal by Subject|0|||
155099167|NCT04567524|559797541|FG000|Overall Study|Withdrawal by Subject|2|||
155099168|NCT04567524|559797542|FG001|Overall Study|Withdrawal by Subject|0|||
155099169|NCT04567524|559797543|FG002|Overall Study|Withdrawal by Subject|0|||
155099170|NCT04567524|559797544|FG003|Overall Study|Withdrawal by Subject|1|||
155099171|NCT02848092|559797546|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
155099172|NCT02848092|559797547|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
155099173|NCT02848092|559797546|FG000|1-month Post-training Follow-up|Adverse Event|2|||
155099174|NCT02848092|559797547|FG001|1-month Post-training Follow-up|Adverse Event|1|||
155099175|NCT02848092|559797546|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
155099176|NCT02848092|559797547|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
155099177|NCT02848092|559797546|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
155099178|NCT02848092|559797547|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
155099179|NCT02848092|559797546|FG000|1-month Post-training Follow-up|fatigue|0|||
155099180|NCT02848092|559797547|FG001|1-month Post-training Follow-up|fatigue|1|||
155099181|NCT02848092|559797546|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
155099182|NCT02848092|559797547|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
155099183|NCT02848092|559797546|FG000|6-month Post-training Follow-up|Adverse Event|1|||
155099184|NCT02848092|559797547|FG001|6-month Post-training Follow-up|Adverse Event|1|||
155099185|NCT02848092|559797546|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
155099186|NCT02848092|559797547|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
155099187|NCT02848092|559797546|FG000|6-month Post-training Follow-up|frustrated with task|1|||
155099188|NCT02848092|559797547|FG001|6-month Post-training Follow-up|frustrated with task|0|||
155099189|NCT02848092|559797546|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
155099190|NCT02848092|559797547|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
155099191|NCT02848092|559797546|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
155099192|NCT02848092|559797547|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
155099193|NCT01639469|559797549|FG000|Overall Study|Death|4|||
155099194|NCT01639469|559797550|FG001|Overall Study|Death|2|||
155099195|NCT01639469|559797549|FG000|Overall Study|Lost to Follow-up|1|||
155099196|NCT01639469|559797550|FG001|Overall Study|Lost to Follow-up|1|||
155099197|NCT01147393|559797559|FG000|Dose Level 1|Dose limiting Toxicity|2|||
155099198|NCT01147393|559797559|FG000|Dose Level -1|Dose Limited Toxicity|1|||
155099199|NCT02383862|559797566|FG000|3 Month Follow up|Lost to Follow-up|23|||
155099200|NCT02383862|559797567|FG001|3 Month Follow up|Lost to Follow-up|21|||
155099201|NCT01665911|559797568|FG000|Overall Study|Protocol Violation|4|||
155099202|NCT01665911|559797568|FG000|Overall Study|Withdrawal by Subject|1|||
155099203|NCT01665911|559797568|FG000|Overall Study|Adverse Event|1|||
155099204|NCT00506779|559797569|FG000|Overall Study|Withdrawal by Subject|1|||
155099205|NCT00506779|559797570|FG001|Overall Study|Withdrawal by Subject|0|||
154834418|NCT00432042|558828355|FG002|Overall Study|Withdrawal by Subject|2|||
154834419|NCT00432042|558828353|FG000|Overall Study|Lost to Follow-up|5|||
154834420|NCT00432042|558828354|FG001|Overall Study|Lost to Follow-up|1|||
154834421|NCT00432042|558828355|FG002|Overall Study|Lost to Follow-up|0|||
154834422|NCT00492752|558828357|FG000|Double Blind Treatment|Death|13|||
154834423|NCT00492752|558828358|FG001|Double Blind Treatment|Death|0|||
154834424|NCT00492752|558828359|FG002|Double Blind Treatment|Death|2|||
154834425|NCT00492752|558828360|FG003|Double Blind Treatment|Death|0|||
154834426|NCT00492752|558828357|FG000|Double Blind Treatment|Adverse Event|1|||
154834427|NCT00492752|558828358|FG001|Double Blind Treatment|Adverse Event|0|||
154834428|NCT00492752|558828359|FG002|Double Blind Treatment|Adverse Event|0|||
154834429|NCT00492752|558828360|FG003|Double Blind Treatment|Adverse Event|0|||
154834430|NCT00492752|558828357|FG000|Double Blind Treatment|Protocol Violation|0|||
154834431|NCT00492752|558828358|FG001|Double Blind Treatment|Protocol Violation|0|||
154834432|NCT00492752|558828359|FG002|Double Blind Treatment|Protocol Violation|1|||
154834433|NCT00492752|558828360|FG003|Double Blind Treatment|Protocol Violation|0|||
154834434|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
154834435|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
154834436|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
154834437|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
154834438|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
154834439|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
154834440|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
154834441|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
154834442|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
154834443|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
154834444|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
154834445|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
154834446|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
154834447|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
154834448|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
154834449|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
154834450|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
154834451|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
154834452|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
154834453|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
154834454|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
154834455|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
154834456|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
154834457|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
154834458|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
154834459|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
154834460|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
154834461|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
154834462|NCT00492752|558828357|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
154834463|NCT00492752|558828358|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
154834464|NCT00492752|558828359|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
154834465|NCT00492752|558828360|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
154834466|NCT02222207|558829835|FG000|Overall Study|Death|1|||
155099206|NCT00506779|559797571|FG002|Overall Study|Withdrawal by Subject|1|||
155099207|NCT00506779|559797572|FG003|Overall Study|Withdrawal by Subject|0|||
155099208|NCT00506779|559797569|FG000|Overall Study|Adverse Event|0|||
155099209|NCT00506779|559797570|FG001|Overall Study|Adverse Event|1|||
155099210|NCT00506779|559797571|FG002|Overall Study|Adverse Event|1|||
155099211|NCT00506779|559797572|FG003|Overall Study|Adverse Event|1|||
155099212|NCT03198767|559797573|FG000|Overall Study|Protocol Violation|0|||
155099213|NCT03198767|559797574|FG001|Overall Study|Protocol Violation|0|||
155099214|NCT03198767|559797575|FG002|Overall Study|Protocol Violation|0|||
155099215|NCT03198767|559797576|FG003|Overall Study|Protocol Violation|6|||
155099216|NCT03198767|559797577|FG004|Overall Study|Protocol Violation|0|||
154968681|NCT04411680|559309019|FG001|Treatment Period|Missed 1 or more doses|0|||
154834467|NCT02222207|558829835|FG000|Overall Study|Other reasons|2|||
154834468|NCT02222207|558829835|FG000|Overall Study|Adverse Event|1|||
154834469|NCT04682405|558829836|FG000|Overall Study|Adverse Event|0|||
154834470|NCT04682405|558829837|FG001|Overall Study|Adverse Event|1|||
154834471|NCT03557281|558829838|FG000|Overall Study|Investigator discretion|0|||
154834472|NCT03557281|558829839|FG001|Overall Study|Investigator discretion|0|||
154834473|NCT03557281|558829840|FG002|Overall Study|Investigator discretion|1|||
154834474|NCT03557281|558829841|FG003|Overall Study|Investigator discretion|0|||
154834475|NCT03557281|558829842|FG004|Overall Study|Investigator discretion|0|||
154834476|NCT03557281|558829838|FG000|Overall Study|Withdrawal by Subject|0|||
154834477|NCT03557281|558829839|FG001|Overall Study|Withdrawal by Subject|1|||
154834478|NCT03557281|558829840|FG002|Overall Study|Withdrawal by Subject|1|||
154834479|NCT03557281|558829841|FG003|Overall Study|Withdrawal by Subject|1|||
154834480|NCT03557281|558829842|FG004|Overall Study|Withdrawal by Subject|2|||
154834481|NCT03557281|558829838|FG000|Overall Study|Randomized, but did not receive treatment|0|||
154834482|NCT03557281|558829839|FG001|Overall Study|Randomized, but did not receive treatment|0|||
154834483|NCT03557281|558829840|FG002|Overall Study|Randomized, but did not receive treatment|0|||
154834484|NCT03557281|558829841|FG003|Overall Study|Randomized, but did not receive treatment|0|||
154834485|NCT03557281|558829842|FG004|Overall Study|Randomized, but did not receive treatment|1|||
154834486|NCT01199042|558829843|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
154834487|NCT01199042|558829843|FG000|At Home (3 Months)|Lost to Follow-up|1|||
154834488|NCT03357731|558829846|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
154834489|NCT03357731|558829847|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
154834490|NCT03357731|558829848|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
154834491|NCT03357731|558829849|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
154834492|NCT03357731|558829850|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
154834493|NCT03357731|558829851|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
154834494|NCT03357731|558829846|FG000|Overall Study|Acute bradycardia and hypotension|0|||
154834495|NCT03357731|558829847|FG001|Overall Study|Acute bradycardia and hypotension|0|||
154834496|NCT03357731|558829848|FG002|Overall Study|Acute bradycardia and hypotension|0|||
154834497|NCT03357731|558829849|FG003|Overall Study|Acute bradycardia and hypotension|1|||
154834498|NCT03357731|558829850|FG004|Overall Study|Acute bradycardia and hypotension|0|||
154834499|NCT03357731|558829851|FG005|Overall Study|Acute bradycardia and hypotension|0|||
154834500|NCT03357731|558829846|FG000|Overall Study|Adverse Event|0|||
154834501|NCT03357731|558829847|FG001|Overall Study|Adverse Event|0|||
154834502|NCT03357731|558829848|FG002|Overall Study|Adverse Event|0|||
154834503|NCT03357731|558829849|FG003|Overall Study|Adverse Event|0|||
154834504|NCT03357731|558829850|FG004|Overall Study|Adverse Event|0|||
154834505|NCT03357731|558829851|FG005|Overall Study|Adverse Event|1|||
154834506|NCT03357731|558829846|FG000|Overall Study|Hypotension|0|||
154834507|NCT03357731|558829847|FG001|Overall Study|Hypotension|0|||
154834508|NCT03357731|558829848|FG002|Overall Study|Hypotension|1|||
154834509|NCT03357731|558829849|FG003|Overall Study|Hypotension|1|||
155099217|NCT03198767|559797578|FG005|Overall Study|Protocol Violation|0|||
155099218|NCT03198767|559797579|FG006|Overall Study|Protocol Violation|0|||
154834510|NCT03357731|558829850|FG004|Overall Study|Hypotension|0|||
154834511|NCT03357731|558829851|FG005|Overall Study|Hypotension|0|||
154834512|NCT03357731|558829846|FG000|Overall Study|Lost to Follow-up|0|||
154834513|NCT03357731|558829847|FG001|Overall Study|Lost to Follow-up|0|||
154834514|NCT03357731|558829848|FG002|Overall Study|Lost to Follow-up|0|||
154834515|NCT03357731|558829849|FG003|Overall Study|Lost to Follow-up|1|||
154834516|NCT03357731|558829850|FG004|Overall Study|Lost to Follow-up|0|||
154834517|NCT03357731|558829851|FG005|Overall Study|Lost to Follow-up|0|||
154834518|NCT01773109|558829852|FG000|Overall Study|Symptomatic Progression|2|||
154834519|NCT01773109|558829852|FG000|Overall Study|Death|1|||
154834520|NCT04036708|558829855|FG000|Overall Study|Lost to Follow-up|14|||
154834521|NCT04036708|558829856|FG001|Overall Study|Lost to Follow-up|4|||
154834522|NCT04036708|558829857|FG002|Overall Study|Lost to Follow-up|14|||
154834523|NCT04036708|558829858|FG003|Overall Study|Lost to Follow-up|4|||
154834524|NCT04766021|558829859|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
154834525|NCT04766021|558829859|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
154834526|NCT01849874|558829861|FG000|Overall Study|Death|89|||
154834527|NCT01849874|558829862|FG001|Overall Study|Death|42|||
154834528|NCT01849874|558829861|FG000|Overall Study|Withdrawal by Subject|17|||
154834529|NCT01849874|558829862|FG001|Overall Study|Withdrawal by Subject|16|||
154834530|NCT01849874|558829861|FG000|Overall Study|Lost to Follow-up|3|||
154834531|NCT01849874|558829862|FG001|Overall Study|Lost to Follow-up|2|||
154834532|NCT01849874|558829861|FG000|Overall Study|Study Termination By Sponsor|93|||
154834533|NCT01849874|558829862|FG001|Overall Study|Study Termination By Sponsor|48|||
154834534|NCT01849874|558829861|FG000|Overall Study|Completed as per protocol amendment 6|3|||
154834535|NCT01849874|558829862|FG001|Overall Study|Completed as per protocol amendment 6|0|||
154834536|NCT01849874|558829861|FG000|Overall Study|Physician Decision|7|||
154834537|NCT01849874|558829862|FG001|Overall Study|Physician Decision|1|||
154834538|NCT01849874|558829861|FG000|Overall Study|Other|16|||
154834539|NCT01849874|558829862|FG001|Overall Study|Other|4|||
154834540|NCT02104583|558829863|FG000|Overall Study|New ICD or CRT-D implanted|2|||
154834541|NCT02104583|558829864|FG001|Overall Study|New ICD or CRT-D implanted|0|||
154834542|NCT02104583|558829865|FG002|Overall Study|New ICD or CRT-D implanted|1|||
154834543|NCT02104583|558829866|FG003|Overall Study|New ICD or CRT-D implanted|0|||
154834544|NCT02104583|558829867|FG004|Overall Study|New ICD or CRT-D implanted|0|||
154834545|NCT02104583|558829863|FG000|Overall Study|Death|2|||
154834546|NCT02104583|558829864|FG001|Overall Study|Death|1|||
154834547|NCT02104583|558829865|FG002|Overall Study|Death|3|||
154834548|NCT02104583|558829866|FG003|Overall Study|Death|3|||
154834549|NCT02104583|558829867|FG004|Overall Study|Death|5|||
154834550|NCT02104583|558829863|FG000|Overall Study|Subject required cardiac ablation|6|||
154834551|NCT02104583|558829864|FG001|Overall Study|Subject required cardiac ablation|4|||
154834552|NCT02104583|558829865|FG002|Overall Study|Subject required cardiac ablation|4|||
154834553|NCT02104583|558829866|FG003|Overall Study|Subject required cardiac ablation|5|||
154834554|NCT02104583|558829867|FG004|Overall Study|Subject required cardiac ablation|4|||
154834555|NCT02104583|558829863|FG000|Overall Study|Subject required prohibited medication|0|||
154834556|NCT02104583|558829864|FG001|Overall Study|Subject required prohibited medication|1|||
154834557|NCT02104583|558829865|FG002|Overall Study|Subject required prohibited medication|1|||
154834558|NCT02104583|558829866|FG003|Overall Study|Subject required prohibited medication|0|||
154834559|NCT02104583|558829867|FG004|Overall Study|Subject required prohibited medication|1|||
154834560|NCT02104583|558829863|FG000|Overall Study|Withdrew Consent|3|||
154834561|NCT02104583|558829864|FG001|Overall Study|Withdrew Consent|2|||
154834562|NCT02104583|558829865|FG002|Overall Study|Withdrew Consent|0|||
154834563|NCT02104583|558829866|FG003|Overall Study|Withdrew Consent|2|||
154834564|NCT02104583|558829867|FG004|Overall Study|Withdrew Consent|1|||
154834565|NCT02104583|558829863|FG000|Overall Study|Investigator's Discretion|1|||
154834566|NCT02104583|558829864|FG001|Overall Study|Investigator's Discretion|0|||
154834567|NCT02104583|558829865|FG002|Overall Study|Investigator's Discretion|0|||
154834568|NCT02104583|558829866|FG003|Overall Study|Investigator's Discretion|0|||
154834569|NCT02104583|558829867|FG004|Overall Study|Investigator's Discretion|0|||
154834570|NCT02104583|558829863|FG000|Overall Study|Protocol Violation|0|||
154834571|NCT02104583|558829864|FG001|Overall Study|Protocol Violation|0|||
154834572|NCT02104583|558829865|FG002|Overall Study|Protocol Violation|1|||
154834573|NCT02104583|558829866|FG003|Overall Study|Protocol Violation|0|||
154834574|NCT02104583|558829867|FG004|Overall Study|Protocol Violation|0|||
154834575|NCT02104583|558829863|FG000|Overall Study|Adverse Event|3|||
154834576|NCT02104583|558829864|FG001|Overall Study|Adverse Event|3|||
154834577|NCT02104583|558829865|FG002|Overall Study|Adverse Event|6|||
154834578|NCT02104583|558829866|FG003|Overall Study|Adverse Event|6|||
154834579|NCT02104583|558829867|FG004|Overall Study|Adverse Event|1|||
154834580|NCT02104583|558829863|FG000|Overall Study|Lost to Follow-up|1|||
154834581|NCT02104583|558829864|FG001|Overall Study|Lost to Follow-up|0|||
154834582|NCT02104583|558829865|FG002|Overall Study|Lost to Follow-up|0|||
154834583|NCT02104583|558829866|FG003|Overall Study|Lost to Follow-up|0|||
154834584|NCT02104583|558829867|FG004|Overall Study|Lost to Follow-up|0|||
154834585|NCT02104583|558829863|FG000|Overall Study|Randomized but Never Treated|0|||
154834586|NCT02104583|558829864|FG001|Overall Study|Randomized but Never Treated|0|||
155172666|NCT03158285|560071881|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
155172667|NCT03158285|560071882|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
155172668|NCT03158285|560071883|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
155172669|NCT03158285|560071881|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
155172670|NCT03158285|560071882|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
155172671|NCT03158285|560071883|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
155172672|NCT03158285|560071881|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155172673|NCT03158285|560071882|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
155172674|NCT03158285|560071883|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155172675|NCT03158285|560071881|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
155172676|NCT03158285|560071882|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
155172677|NCT03158285|560071883|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
155172678|NCT03158285|560071881|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
155172679|NCT03158285|560071882|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
155172680|NCT03158285|560071883|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
155172681|NCT03158285|560071881|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
155172682|NCT03158285|560071882|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
155172683|NCT03158285|560071883|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
155172684|NCT03158285|560071881|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
155172685|NCT03158285|560071882|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
155172686|NCT03158285|560071883|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
154834587|NCT02104583|558829865|FG002|Overall Study|Randomized but Never Treated|0|||
154834588|NCT02104583|558829866|FG003|Overall Study|Randomized but Never Treated|1|||
154834589|NCT02104583|558829867|FG004|Overall Study|Randomized but Never Treated|0|||
154834590|NCT04640272|558829868|FG000|Overall Study|Subject moved out of area|1|||
154834591|NCT02535715|558829872|FG000|Overall Study|Withdrawal by Subject|0|||
154834592|NCT02535715|558829873|FG001|Overall Study|Withdrawal by Subject|0|||
154834593|NCT02535715|558829874|FG002|Overall Study|Withdrawal by Subject|1|||
155172687|NCT03158285|560071881|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
155172688|NCT03158285|560071882|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
155172689|NCT03158285|560071883|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
155172690|NCT03158285|560071881|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
154834594|NCT03709654|558829875|FG000|Overall Study|Lost to Follow-up|1|||
154834595|NCT03709654|558829876|FG001|Overall Study|Lost to Follow-up|1|||
154834596|NCT03709654|558829875|FG000|Overall Study|Withdrawal by Subject|1|||
154834597|NCT03709654|558829876|FG001|Overall Study|Withdrawal by Subject|1|||
154834598|NCT03709654|558829875|FG000|Overall Study|Adverse Event|1|||
154834599|NCT03709654|558829876|FG001|Overall Study|Adverse Event|0|||
154834600|NCT01902966|558829877|FG000|Overall Study|Death|1|||
154834601|NCT01902966|558829877|FG000|Overall Study|Physician Decision|1|||
154834602|NCT01902966|558829877|FG000|Overall Study|Withdrawal by Subject|1|||
155099219|NCT02820844|559797580|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
155099220|NCT02820844|559797581|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
155099221|NCT02820844|559797582|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155099222|NCT02820844|559797583|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155099223|NCT02820844|559797584|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
155099224|NCT02820844|559797585|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
154834603|NCT01040351|558829878|FG000|Overall Study|poor ovarian response|1|||
155099225|NCT02820844|559797580|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
155099226|NCT02820844|559797581|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
155099227|NCT02820844|559797582|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155099228|NCT02820844|559797583|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155099229|NCT02820844|559797584|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155099230|NCT02820844|559797585|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
155099231|NCT02820844|559797580|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
154834604|NCT01040351|558829879|FG001|Overall Study|poor ovarian response|2|||
154834605|NCT01230307|558829880|FG000|Overall Study|LVAD Placement|0|||
154834606|NCT01230307|558829881|FG001|Overall Study|LVAD Placement|2|||
154834607|NCT02256540|558829883|FG000|Overall Study|Withdrawal by Subject|0|||
154834608|NCT02256540|558829884|FG001|Overall Study|Withdrawal by Subject|1|||
154834609|NCT02256540|558829885|FG002|Overall Study|Withdrawal by Subject|1|||
154834610|NCT02256540|558829883|FG000|Overall Study|Back pain preventing exercise|0|||
154834611|NCT02256540|558829884|FG001|Overall Study|Back pain preventing exercise|0|||
154834612|NCT02256540|558829885|FG002|Overall Study|Back pain preventing exercise|1|||
154834613|NCT03923426|558829886|FG000|Overall Study|Other|19|||
154834614|NCT03923426|558829886|FG000|Overall Study|Lost to Follow-up|16|||
154834615|NCT03923426|558829886|FG000|Overall Study|Death|107|||
155099232|NCT02820844|559797581|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
155099233|NCT02820844|559797582|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155099234|NCT02820844|559797583|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155099235|NCT02820844|559797584|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155099236|NCT02820844|559797585|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
155099237|NCT02820844|559797580|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
155099238|NCT02820844|559797581|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
155099239|NCT02820844|559797582|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
155099240|NCT02820844|559797583|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
155099241|NCT02820844|559797584|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
154834616|NCT03923426|558829886|FG000|Overall Study|Incomplete response to question|13|||
154834617|NCT00751400|558829890|FG000|Overall Study|Lost to Follow-up|10|||
154834618|NCT01918007|558829891|FG000|Overall Study|Baseline oximetry not acceptable|11|||
154834619|NCT01918007|558829892|FG001|Overall Study|Baseline oximetry not acceptable|7|||
154834620|NCT01918007|558829891|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
154834621|NCT01918007|558829892|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
154834622|NCT01918007|558829891|FG000|Overall Study|Lost to Follow-up|4|||
154834623|NCT01918007|558829892|FG001|Overall Study|Lost to Follow-up|7|||
154834624|NCT04206020|558829894|FG000|Overall Study|Adverse Event|1|||
154834625|NCT04206020|558829895|FG001|Overall Study|Adverse Event|4|||
155099242|NCT02820844|559797585|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
154834626|NCT04206020|558829894|FG000|Overall Study|Protocol Violation|2|||
154834627|NCT04206020|558829895|FG001|Overall Study|Protocol Violation|0|||
154834628|NCT04206020|558829894|FG000|Overall Study|Withdrawal by Subject|2|||
154834629|NCT04206020|558829895|FG001|Overall Study|Withdrawal by Subject|0|||
154834630|NCT04206020|558829894|FG000|Overall Study|Lost to Follow-up|2|||
155099243|NCT02820844|559797580|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
155099244|NCT02820844|559797581|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155099245|NCT02820844|559797582|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155099246|NCT02820844|559797583|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
154834631|NCT04206020|558829895|FG001|Overall Study|Lost to Follow-up|0|||
154834632|NCT04206020|558829894|FG000|Overall Study|Pregnancy|0|||
154834633|NCT04206020|558829895|FG001|Overall Study|Pregnancy|1|||
154834634|NCT04206020|558829894|FG000|Overall Study|Unable to attend visits|1|||
154834635|NCT04206020|558829895|FG001|Overall Study|Unable to attend visits|2|||
154834636|NCT04962022|558829896|FG000|Period 1|Withdrawal by Subject|1|||
154834637|NCT04962022|558829897|FG001|Period 1|Withdrawal by Subject|0|||
154834638|NCT03962101|558829900|FG000|Overall Study|Adverse Event|1|||
154834639|NCT03962101|558829900|FG000|Overall Study|Physician Decision|2|||
154834640|NCT03962101|558829900|FG000|Overall Study|Not related to medical events|1|||
154834641|NCT00552175|558829901|FG000|Overall Study|Lack of Efficacy|2|||
154834642|NCT00552175|558829902|FG001|Overall Study|Lack of Efficacy|0|||
154834643|NCT00552175|558829903|FG002|Overall Study|Lack of Efficacy|1|||
154834644|NCT00552175|558829901|FG000|Overall Study|Adverse Event|9|||
154834645|NCT00552175|558829902|FG001|Overall Study|Adverse Event|9|||
154834646|NCT00552175|558829903|FG002|Overall Study|Adverse Event|10|||
154834647|NCT00552175|558829901|FG000|Overall Study|Withdrawal by Subject|2|||
154834648|NCT00552175|558829902|FG001|Overall Study|Withdrawal by Subject|2|||
154834649|NCT00552175|558829903|FG002|Overall Study|Withdrawal by Subject|1|||
154834650|NCT00552175|558829901|FG000|Overall Study|Lost to Follow-up|0|||
154834651|NCT00552175|558829902|FG001|Overall Study|Lost to Follow-up|0|||
154834652|NCT00552175|558829903|FG002|Overall Study|Lost to Follow-up|1|||
154834653|NCT00552175|558829901|FG000|Overall Study|Entry Criteria Not Met|1|||
154834654|NCT00552175|558829902|FG001|Overall Study|Entry Criteria Not Met|1|||
154834655|NCT00552175|558829903|FG002|Overall Study|Entry Criteria Not Met|0|||
154834656|NCT00552175|558829901|FG000|Overall Study|Reason Not Specified|3|||
154834657|NCT00552175|558829902|FG001|Overall Study|Reason Not Specified|1|||
154834658|NCT00552175|558829903|FG002|Overall Study|Reason Not Specified|1|||
154834659|NCT03972969|558829905|FG000|3-month Follow-up|Death|1|||
154834660|NCT03972969|558829906|FG001|3-month Follow-up|Death|1|||
154834661|NCT03972969|558829907|FG002|3-month Follow-up|Death|0|||
154834662|NCT03972969|558829905|FG000|6-month Follow-up|Death|1|||
154834663|NCT03972969|558829906|FG001|6-month Follow-up|Death|1|||
154834664|NCT03972969|558829907|FG002|6-month Follow-up|Death|1|||
154834665|NCT03972969|558829905|FG000|6-month Follow-up|Lost to Follow-up|2|||
154834666|NCT03972969|558829906|FG001|6-month Follow-up|Lost to Follow-up|2|||
154834667|NCT03972969|558829907|FG002|6-month Follow-up|Lost to Follow-up|2|||
154834668|NCT02919436|558829908|FG000|Overall Study|Did not undergo surgery|16|||
154834669|NCT02919436|558829909|FG001|Overall Study|Did not undergo surgery|20|||
154834670|NCT02919436|558829908|FG000|Overall Study|Enrolled before trial registration|44|||
154834671|NCT02919436|558829909|FG001|Overall Study|Enrolled before trial registration|33|||
154834672|NCT00283595|558829910|FG000|Overall Study|Withdrawal by Subject|1|||
155099247|NCT02820844|559797584|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155099248|NCT02820844|559797585|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
155099249|NCT02820844|559797580|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155099250|NCT02820844|559797581|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155099251|NCT02820844|559797582|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
155099252|NCT02820844|559797583|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
155099253|NCT02820844|559797584|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155099254|NCT02820844|559797585|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
155099255|NCT02820844|559797580|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155099256|NCT02820844|559797581|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155099257|NCT02820844|559797582|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
155099258|NCT02820844|559797583|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155099259|NCT02820844|559797584|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155099260|NCT02820844|559797585|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
155099261|NCT02820844|559797580|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099262|NCT02820844|559797581|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099263|NCT02820844|559797582|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
155099264|NCT02820844|559797583|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
155099265|NCT02820844|559797584|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
154834673|NCT00283595|558829911|FG001|Overall Study|Withdrawal by Subject|2|||
154834674|NCT02409290|558829912|FG000|Overall Study|Protocol Violation|3|||
154834675|NCT02409290|558829913|FG001|Overall Study|Protocol Violation|6|||
154834676|NCT02409290|558829914|FG002|Overall Study|Protocol Violation|9|||
154834677|NCT02409290|558829915|FG003|Overall Study|Protocol Violation|4|||
154834678|NCT02409290|558829912|FG000|Overall Study|No positive culture/no baseline sample|3|||
154834679|NCT02409290|558829913|FG001|Overall Study|No positive culture/no baseline sample|9|||
154834680|NCT02409290|558829914|FG002|Overall Study|No positive culture/no baseline sample|6|||
154834681|NCT02409290|558829915|FG003|Overall Study|No positive culture/no baseline sample|5|||
154834682|NCT02409290|558829912|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
154834683|NCT02409290|558829913|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
154834684|NCT02409290|558829914|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
154834685|NCT02409290|558829915|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
154834686|NCT04607148|558829916|FG000|Overall Study|Withdrawal by Subject|0|||
154834687|NCT04607148|558829917|FG001|Overall Study|Withdrawal by Subject|4|||
154834688|NCT04607148|558829918|FG002|Overall Study|Withdrawal by Subject|2|||
154834689|NCT04607148|558829919|FG003|Overall Study|Withdrawal by Subject|8|||
154834690|NCT04607148|558829916|FG000|Overall Study|Study Terminated by Sponsor|14|||
154834691|NCT04607148|558829917|FG001|Overall Study|Study Terminated by Sponsor|59|||
154834692|NCT04607148|558829918|FG002|Overall Study|Study Terminated by Sponsor|9|||
154834693|NCT04607148|558829919|FG003|Overall Study|Study Terminated by Sponsor|39|||
154834694|NCT04607148|558829916|FG000|Overall Study|Sponsor Decision|0|||
154834695|NCT04607148|558829917|FG001|Overall Study|Sponsor Decision|0|||
154834696|NCT04607148|558829918|FG002|Overall Study|Sponsor Decision|1|||
154834697|NCT04607148|558829919|FG003|Overall Study|Sponsor Decision|0|||
154834698|NCT04607148|558829916|FG000|Overall Study|Non-Compliance With Study Drug|0|||
154834699|NCT04607148|558829917|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154834700|NCT04607148|558829918|FG002|Overall Study|Non-Compliance With Study Drug|0|||
154834701|NCT04607148|558829919|FG003|Overall Study|Non-Compliance With Study Drug|0|||
154834702|NCT04607148|558829916|FG000|Overall Study|Lost to Follow-up|0|||
154834703|NCT04607148|558829917|FG001|Overall Study|Lost to Follow-up|2|||
154834704|NCT04607148|558829918|FG002|Overall Study|Lost to Follow-up|0|||
154834705|NCT04607148|558829919|FG003|Overall Study|Lost to Follow-up|0|||
154834706|NCT04607148|558829916|FG000|Overall Study|Death|0|||
154834707|NCT04607148|558829917|FG001|Overall Study|Death|3|||
154834708|NCT04607148|558829918|FG002|Overall Study|Death|0|||
155099266|NCT02820844|559797585|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099267|NCT02820844|559797580|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155099268|NCT02820844|559797581|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155099269|NCT02820844|559797582|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155099270|NCT02820844|559797583|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
155099271|NCT02820844|559797584|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
155099272|NCT02820844|559797585|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
154834709|NCT04607148|558829919|FG003|Overall Study|Death|1|||
154834710|NCT04607148|558829916|FG000|Overall Study|Adverse Event|0|||
155099273|NCT02820844|559797580|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099274|NCT02820844|559797581|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
154834711|NCT04607148|558829917|FG001|Overall Study|Adverse Event|1|||
154834712|NCT04607148|558829918|FG002|Overall Study|Adverse Event|0|||
154834713|NCT04607148|558829919|FG003|Overall Study|Adverse Event|0|||
154834714|NCT00804570|558829920|FG000|Overall Study|Adverse Event|14|||
155099275|NCT02820844|559797582|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099276|NCT02820844|559797583|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099277|NCT02820844|559797584|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
155099278|NCT02820844|559797585|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
155099279|NCT02954887|559797586|FG000|Overall Study|Withdrawal by Subject|3|||
155099280|NCT02954887|559797586|FG000|Overall Study|Lack of Efficacy|3|||
155099281|NCT02954887|559797586|FG000|Overall Study|Other|1|||
155099282|NCT00920556|559797587|FG000|Overall Study|Adverse Event|16|||
155099283|NCT00920556|559797587|FG000|Overall Study|Physician Decision|7|||
155099284|NCT00920556|559797587|FG000|Overall Study|Withdrawal by Subject|1|||
155099285|NCT03637491|559797588|FG000|Overall Study|Death|9|||
155099286|NCT03637491|559797589|FG001|Overall Study|Death|9|||
155099287|NCT03637491|559797590|FG002|Overall Study|Death|5|||
154834715|NCT00804570|558829921|FG001|Overall Study|Adverse Event|7|||
154834716|NCT00804570|558829920|FG000|Overall Study|Lack of Efficacy|0|||
154834717|NCT00804570|558829921|FG001|Overall Study|Lack of Efficacy|1|||
154834718|NCT00804570|558829920|FG000|Overall Study|Lost to Follow-up|18|||
154834719|NCT00804570|558829921|FG001|Overall Study|Lost to Follow-up|21|||
154834720|NCT00804570|558829920|FG000|Overall Study|Entry criteria not met|5|||
154834721|NCT00804570|558829921|FG001|Overall Study|Entry criteria not met|5|||
154834722|NCT00804570|558829920|FG000|Overall Study|Protocol Violation|12|||
154834723|NCT00804570|558829921|FG001|Overall Study|Protocol Violation|16|||
154834724|NCT00804570|558829920|FG000|Overall Study|Physician Decision|1|||
154834725|NCT00804570|558829921|FG001|Overall Study|Physician Decision|2|||
154834726|NCT00804570|558829920|FG000|Overall Study|Sponsor decision|1|||
154834727|NCT00804570|558829921|FG001|Overall Study|Sponsor decision|4|||
154834728|NCT00804570|558829920|FG000|Overall Study|Withdrawal by Subject|21|||
154834729|NCT00804570|558829921|FG001|Overall Study|Withdrawal by Subject|38|||
154834730|NCT00290342|558829922|FG000|Overall Study|Other|0|||
154834731|NCT00290342|558829923|FG001|Overall Study|Other|1|||
154834732|NCT00290342|558829922|FG000|Overall Study|Withdrawal by Subject|6|||
154834733|NCT00290342|558829923|FG001|Overall Study|Withdrawal by Subject|4|||
154834734|NCT00290342|558829922|FG000|Overall Study|Lost to Follow-up|1|||
154834735|NCT00290342|558829923|FG001|Overall Study|Lost to Follow-up|0|||
154834736|NCT01056510|558829926|FG000|Overall Study|Dropout Before Start of Treatment|1|||
154834737|NCT01056510|558829927|FG001|Overall Study|Dropout Before Start of Treatment|1|||
154834738|NCT01056510|558829926|FG000|Overall Study|Withdrawal by Subject|4|||
154834739|NCT01056510|558829927|FG001|Overall Study|Withdrawal by Subject|2|||
154834740|NCT01056510|558829926|FG000|Overall Study|Death|29|||
154834741|NCT01056510|558829927|FG001|Overall Study|Death|34|||
154834742|NCT01056510|558829926|FG000|Overall Study|Noncompliance|1|||
154834743|NCT01056510|558829927|FG001|Overall Study|Noncompliance|3|||
155099288|NCT03637491|559797591|FG003|Overall Study|Death|3|||
155099289|NCT03637491|559797588|FG000|Overall Study|Lost to Follow-up|0|||
154834744|NCT01056510|558829926|FG000|Overall Study|Physician Decision|4|||
154834745|NCT01056510|558829927|FG001|Overall Study|Physician Decision|5|||
154834746|NCT01056510|558829926|FG000|Overall Study|Lost to Follow-up|5|||
154834747|NCT01056510|558829927|FG001|Overall Study|Lost to Follow-up|6|||
154834748|NCT01056510|558829926|FG000|Overall Study|Other|10|||
154834749|NCT01056510|558829927|FG001|Overall Study|Other|12|||
154834750|NCT01056510|558829926|FG000|Overall Study|Missing|0|||
154834751|NCT01056510|558829927|FG001|Overall Study|Missing|1|||
155099290|NCT03637491|559797589|FG001|Overall Study|Lost to Follow-up|1|||
154968682|NCT04411680|559309018|FG000|Treatment Period|Transferred to another hospital|0|||
154968683|NCT04411680|559309019|FG001|Treatment Period|Transferred to another hospital|1|||
154968684|NCT04411680|559309018|FG000|Follow up Period|Withdrawal by Subject|2|||
154968685|NCT04411680|559309019|FG001|Follow up Period|Withdrawal by Subject|0|||
154834752|NCT02285998|558829928|FG000|Overall Study|Adverse Event|9|||
154834753|NCT02285998|558829929|FG001|Overall Study|Adverse Event|8|||
154834754|NCT02285998|558829928|FG000|Overall Study|Physician Decision|1|||
154834755|NCT02285998|558829929|FG001|Overall Study|Physician Decision|2|||
154834756|NCT02285998|558829928|FG000|Overall Study|Lost to Follow-up|176|||
154834757|NCT02285998|558829929|FG001|Overall Study|Lost to Follow-up|172|||
154834758|NCT02285998|558829928|FG000|Overall Study|Withdrawal by Subject|53|||
154834759|NCT02285998|558829929|FG001|Overall Study|Withdrawal by Subject|61|||
154834760|NCT02285998|558829928|FG000|Overall Study|Other Reasons|7|||
154834761|NCT02285998|558829929|FG001|Overall Study|Other Reasons|10|||
154834762|NCT02830776|558829930|FG000|Overall Study|Lost to Follow-up|1|||
154834763|NCT03029143|558829931|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
154834764|NCT03029143|558829932|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
154834765|NCT03029143|558829933|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
154834766|NCT03029143|558829931|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
154834767|NCT03029143|558829932|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
154834768|NCT03029143|558829933|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
154834769|NCT03029143|558829931|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
154834770|NCT03029143|558829932|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
154834771|NCT03029143|558829933|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
154834772|NCT03029143|558829931|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
154834773|NCT03029143|558829932|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
154834774|NCT03029143|558829933|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
154834775|NCT03029143|558829931|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
154834776|NCT03029143|558829932|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
154834777|NCT03029143|558829933|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
154834778|NCT03029143|558829931|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
154834779|NCT03029143|558829932|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
154834780|NCT03029143|558829933|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
154834781|NCT03029143|558829931|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
154834782|NCT03029143|558829932|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
154834783|NCT03029143|558829933|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
154834784|NCT03029143|558829931|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155099291|NCT03637491|559797590|FG002|Overall Study|Lost to Follow-up|0|||
154834785|NCT03029143|558829932|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154834786|NCT03029143|558829933|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
154834787|NCT03029143|558829931|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
154834788|NCT03029143|558829932|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
154834789|NCT03029143|558829933|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
154834790|NCT03029143|558829931|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
154834791|NCT03029143|558829932|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
154834792|NCT03029143|558829933|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
154834793|NCT03029143|558829931|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
154834794|NCT03029143|558829932|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
154834795|NCT03029143|558829933|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
154834796|NCT01394627|558829935|FG000|First Intervention (1 Day)|poor intravenous access|0|||
154834797|NCT01394627|558829936|FG001|First Intervention (1 Day)|poor intravenous access|1|||
154834798|NCT01394627|558829935|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
154834799|NCT01394627|558829936|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
154834800|NCT01617070|558829937|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
154834801|NCT03223428|558829942|FG000|Overall Study|No longer taking Xermelo|27|||
154834802|NCT03223428|558829942|FG000|Overall Study|Declined Consent|1|||
154834803|NCT03223428|558829942|FG000|Overall Study|Non-responders|56|||
154834804|NCT03223428|558829942|FG000|Overall Study|Withdrawal by Subject|14|||
154834805|NCT02230384|558829944|FG000|Phase 1|Lost to Follow-up|1|||
155099292|NCT03637491|559797591|FG003|Overall Study|Lost to Follow-up|1|||
155099293|NCT03637491|559797588|FG000|Overall Study|Study Terminated By Sponsor|0|||
154834806|NCT02230384|558829945|FG001|Phase 1|Lost to Follow-up|0|||
154834807|NCT02230384|558829944|FG000|Phase 1|Physician Decision|0|||
155099294|NCT03637491|559797589|FG001|Overall Study|Study Terminated By Sponsor|2|||
155099295|NCT03637491|559797590|FG002|Overall Study|Study Terminated By Sponsor|1|||
154834808|NCT02230384|558829945|FG001|Phase 1|Physician Decision|1|||
154834809|NCT02230384|558829944|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
154834810|NCT02230384|558829945|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
154834811|NCT02230384|558829944|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
154834812|NCT02230384|558829945|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
154834813|NCT02230384|558829944|FG000|Phase 2 - Switch|Adverse Event|2|||
154834814|NCT02230384|558829945|FG001|Phase 2 - Switch|Adverse Event|0|||
154834815|NCT00777101|558829946|FG000|Overall Study|Death|48|||
154834816|NCT00777101|558829947|FG001|Overall Study|Death|43|||
154834817|NCT00777101|558829946|FG000|Overall Study|Withdrawal by Subject|11|||
154834818|NCT00777101|558829947|FG001|Overall Study|Withdrawal by Subject|6|||
154834819|NCT00777101|558829946|FG000|Overall Study|Lost to Follow-up|2|||
154834820|NCT00777101|558829947|FG001|Overall Study|Lost to Follow-up|1|||
154834821|NCT00777101|558829946|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
154834822|NCT00777101|558829947|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
154834823|NCT00777101|558829946|FG000|Overall Study|Failed to Return|0|||
154834824|NCT00777101|558829947|FG001|Overall Study|Failed to Return|1|||
154834825|NCT05376215|558829948|FG000|Overall Study|Withdrawal by Subject|2|||
154834826|NCT05376215|558829949|FG001|Overall Study|Withdrawal by Subject|1|||
154834827|NCT05376215|558829948|FG000|Overall Study|Lost to Follow-up|0|||
154834828|NCT05376215|558829949|FG001|Overall Study|Lost to Follow-up|1|||
154834829|NCT00282334|558829951|FG000|Overall Study|Withdrawal by Subject|8|||
154834830|NCT00282334|558829952|FG001|Overall Study|Withdrawal by Subject|5|||
154834831|NCT01301950|558829958|FG000|Overall Study|Surgery was cancelled by patient|0|||
154834832|NCT01301950|558829959|FG001|Overall Study|Surgery was cancelled by patient|1|||
155099296|NCT03637491|559797591|FG003|Overall Study|Study Terminated By Sponsor|0|||
155099297|NCT03637491|559797588|FG000|Overall Study|Withdrawal by Subject|1|||
155099298|NCT03637491|559797589|FG001|Overall Study|Withdrawal by Subject|0|||
155099299|NCT03637491|559797590|FG002|Overall Study|Withdrawal by Subject|1|||
155099300|NCT03637491|559797591|FG003|Overall Study|Withdrawal by Subject|2|||
155099301|NCT04819113|559797599|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155099302|NCT04819113|559797599|FG000|Overall Study|Lost to Follow-up|1|||
155099303|NCT04819113|559797599|FG000|Overall Study|Withdrawn before vaccination|2|||
155099304|NCT00437268|559797600|FG000|Overall Study|Adverse Event|1|||
155099305|NCT00437268|559797601|FG001|Overall Study|Adverse Event|1|||
155099306|NCT00437268|559797600|FG000|Overall Study|Withdrawal by Subject|2|||
155099307|NCT00437268|559797601|FG001|Overall Study|Withdrawal by Subject|2|||
155099308|NCT00437268|559797600|FG000|Overall Study|Progressive disease|9|||
155099309|NCT00437268|559797601|FG001|Overall Study|Progressive disease|9|||
155099310|NCT00437268|559797600|FG000|Overall Study|Physician Decision|1|||
155099311|NCT00437268|559797601|FG001|Overall Study|Physician Decision|0|||
155099312|NCT00437268|559797600|FG000|Overall Study|Death|0|||
155099313|NCT00437268|559797601|FG001|Overall Study|Death|1|||
155099314|NCT00833027|559797606|FG000|Overall Study|Adverse Event|33|||
155099315|NCT00833027|559797606|FG000|Overall Study|Death|1|||
155099316|NCT00833027|559797606|FG000|Overall Study|Lack of Efficacy|12|||
155099317|NCT00833027|559797606|FG000|Overall Study|Lost to Follow-up|24|||
155099318|NCT00833027|559797606|FG000|Overall Study|Protocol Violation|115|||
155099319|NCT00833027|559797606|FG000|Overall Study|Withdrawal by Subject|16|||
155099320|NCT00833027|559797606|FG000|Overall Study|Missing|10|||
155099321|NCT00444925|559797607|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
155099322|NCT00444925|559797608|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
155099323|NCT00444925|559797609|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
155099324|NCT00444925|559797607|FG000|Double-blind Treatment Period|Death|2|||
155099325|NCT00444925|559797608|FG001|Double-blind Treatment Period|Death|0|||
155099326|NCT00444925|559797609|FG002|Double-blind Treatment Period|Death|0|||
155099327|NCT00444925|559797607|FG000|Double-blind Treatment Period|Adverse Event|6|||
155099328|NCT00444925|559797608|FG001|Double-blind Treatment Period|Adverse Event|28|||
155099329|NCT00444925|559797609|FG002|Double-blind Treatment Period|Adverse Event|44|||
155099330|NCT00444925|559797607|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
155099331|NCT00444925|559797608|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
155099332|NCT00444925|559797609|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
155099333|NCT00444925|559797607|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
155099334|NCT00444925|559797608|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
155099335|NCT00444925|559797609|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
155099336|NCT00444925|559797607|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
155099337|NCT00444925|559797608|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
155099338|NCT00444925|559797609|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
155099339|NCT00444925|559797607|FG000|Double-blind Treatment Period|Other|7|||
155099340|NCT00444925|559797608|FG001|Double-blind Treatment Period|Other|7|||
155099341|NCT00444925|559797609|FG002|Double-blind Treatment Period|Other|12|||
155099342|NCT01342094|559797612|FG000|Overall Study|Adverse Event|5|||
155099343|NCT01342094|559797613|FG001|Overall Study|Adverse Event|0|||
155099344|NCT01342094|559797612|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
155099345|NCT01342094|559797613|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
155099346|NCT01342094|559797612|FG000|Overall Study|Withdrawal by Subject|0|||
155099347|NCT01342094|559797613|FG001|Overall Study|Withdrawal by Subject|2|||
155099348|NCT02806414|559797614|FG000|Overall Study|Lost to Follow-up|2|||
155099349|NCT05653700|559797619|FG000|Overall Study|Non Responders|9|||
155099350|NCT05653700|559797620|FG001|Overall Study|Non Responders|0|||
155099351|NCT01085214|559797623|FG000|Overall Study|Alternate treatment required|1|||
155099352|NCT01985022|559797637|FG000|Overall Study|Lost to Follow-up|0|||
155099353|NCT01985022|559797638|FG001|Overall Study|Lost to Follow-up|1|||
155099354|NCT01985022|559797637|FG000|Overall Study|Protocol Violation|0|||
155099355|NCT01985022|559797638|FG001|Overall Study|Protocol Violation|1|||
155099356|NCT01985022|559797637|FG000|Overall Study|Withdrawal by Subject|4|||
155099357|NCT01985022|559797638|FG001|Overall Study|Withdrawal by Subject|1|||
155099358|NCT01152437|559797639|FG000|Overall Study|Other Adverse Event|8|||
155099359|NCT01152437|559797640|FG001|Overall Study|Other Adverse Event|1|||
155099360|NCT01152437|559797641|FG002|Overall Study|Other Adverse Event|7|||
155099361|NCT01152437|559797639|FG000|Overall Study|Not treated|0|||
155099362|NCT01152437|559797640|FG001|Overall Study|Not treated|1|||
155099363|NCT01152437|559797641|FG002|Overall Study|Not treated|2|||
155099364|NCT01152437|559797639|FG000|Overall Study|Progressive disease|27|||
155099365|NCT01152437|559797640|FG001|Overall Study|Progressive disease|13|||
154834833|NCT01066585|558829960|FG000|Overall Study|Protocol Violation|1|||
154968686|NCT04411680|559309018|FG000|Follow up Period|Lost to Follow-up|5|||
154968687|NCT04411680|559309019|FG001|Follow up Period|Lost to Follow-up|6|||
154968688|NCT04411680|559309018|FG000|Follow up Period|Death|11|||
154968689|NCT04411680|559309019|FG001|Follow up Period|Death|8|||
154968690|NCT05034874|559309020|FG000|Overall Study|Withdrawal by Subject|6|||
154834834|NCT01066585|558829961|FG001|Overall Study|Protocol Violation|0|||
154968691|NCT05034874|559309021|FG001|Overall Study|Withdrawal by Subject|6|||
154968692|NCT05034874|559309020|FG000|Overall Study|Lost to Follow-up|18|||
154968693|NCT05034874|559309021|FG001|Overall Study|Lost to Follow-up|8|||
154968694|NCT05034874|559309020|FG000|Overall Study|Physician Decision|0|||
155099366|NCT01152437|559797641|FG002|Overall Study|Progressive disease|32|||
155099367|NCT01152437|559797639|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
155099368|NCT01152437|559797640|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
155099369|NCT01152437|559797641|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
155099370|NCT00806260|559797645|FG000|Period 1 (1 Day)|Adverse Event|0|||
155099371|NCT00806260|559797646|FG001|Period 1 (1 Day)|Adverse Event|0|||
155099372|NCT00806260|559797647|FG002|Period 1 (1 Day)|Adverse Event|0|||
155099373|NCT00806260|559797648|FG003|Period 1 (1 Day)|Adverse Event|0|||
155172691|NCT03158285|560071882|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
155099374|NCT00806260|559797649|FG004|Period 1 (1 Day)|Adverse Event|3|||
154834835|NCT01066585|558829960|FG000|Overall Study|Withdrawal by Subject|0|||
155099375|NCT00806260|559797650|FG005|Period 1 (1 Day)|Adverse Event|0|||
155099376|NCT00806260|559797645|FG000|Period 2|Adverse Event|0|||
155099377|NCT00806260|559797646|FG001|Period 2|Adverse Event|0|||
155099378|NCT00806260|559797647|FG002|Period 2|Adverse Event|0|||
155099379|NCT00806260|559797648|FG003|Period 2|Adverse Event|1|||
155099380|NCT00806260|559797649|FG004|Period 2|Adverse Event|0|||
154834836|NCT01066585|558829961|FG001|Overall Study|Withdrawal by Subject|3|||
154834837|NCT02424253|558829965|FG000|Overall Study|Other, unspecified|1|||
155099381|NCT00806260|559797650|FG005|Period 2|Adverse Event|0|||
155099382|NCT00806260|559797645|FG000|Period 2|Protocol Violation|1|||
155099383|NCT00806260|559797646|FG001|Period 2|Protocol Violation|0|||
154968695|NCT05034874|559309021|FG001|Overall Study|Physician Decision|1|||
154968696|NCT05034874|559309020|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
155099384|NCT00806260|559797647|FG002|Period 2|Protocol Violation|1|||
155172692|NCT03158285|560071883|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
155099385|NCT00806260|559797648|FG003|Period 2|Protocol Violation|0|||
155099386|NCT00806260|559797649|FG004|Period 2|Protocol Violation|0|||
155099387|NCT00806260|559797650|FG005|Period 2|Protocol Violation|0|||
155099388|NCT00806260|559797645|FG000|Period 2|Need to take concomitant medication|1|||
155099389|NCT00806260|559797646|FG001|Period 2|Need to take concomitant medication|0|||
155099390|NCT00806260|559797647|FG002|Period 2|Need to take concomitant medication|0|||
155099391|NCT00806260|559797648|FG003|Period 2|Need to take concomitant medication|0|||
155099392|NCT00806260|559797649|FG004|Period 2|Need to take concomitant medication|0|||
155099393|NCT00806260|559797650|FG005|Period 2|Need to take concomitant medication|0|||
155099394|NCT00806260|559797645|FG000|Period 2|sponsor request|0|||
155099395|NCT00806260|559797646|FG001|Period 2|sponsor request|0|||
155099396|NCT00806260|559797647|FG002|Period 2|sponsor request|1|||
155099397|NCT00806260|559797648|FG003|Period 2|sponsor request|1|||
155099398|NCT00806260|559797649|FG004|Period 2|sponsor request|0|||
155099399|NCT00806260|559797650|FG005|Period 2|sponsor request|0|||
155099400|NCT00806260|559797645|FG000|Period 3|Protocol Violation|0|||
155099401|NCT00806260|559797646|FG001|Period 3|Protocol Violation|1|||
155099402|NCT00806260|559797647|FG002|Period 3|Protocol Violation|1|||
155099403|NCT00806260|559797648|FG003|Period 3|Protocol Violation|0|||
155099404|NCT00806260|559797649|FG004|Period 3|Protocol Violation|0|||
155099405|NCT00806260|559797650|FG005|Period 3|Protocol Violation|0|||
155099406|NCT00806260|559797645|FG000|Period 3|Pregnancy|1|||
155099407|NCT00806260|559797646|FG001|Period 3|Pregnancy|0|||
155099408|NCT00806260|559797647|FG002|Period 3|Pregnancy|0|||
155099409|NCT00806260|559797648|FG003|Period 3|Pregnancy|0|||
155099410|NCT00806260|559797649|FG004|Period 3|Pregnancy|0|||
155099411|NCT00806260|559797650|FG005|Period 3|Pregnancy|0|||
155099412|NCT01074931|559797651|FG000|Overall Study|Economic reasons|1|||
155099413|NCT01074931|559797651|FG000|Overall Study|Death|5|||
155099414|NCT05223673|559797652|FG000|Overall Study|Protocol Violation|1|||
155099415|NCT05223673|559797652|FG000|Overall Study|Study termination|6|||
155099416|NCT01088906|559797653|FG000|Overall Study|Inclusion error|1|||
155099417|NCT01088906|559797653|FG000|Overall Study|Did not receive study treatment|3|||
155099418|NCT01088906|559797653|FG000|Overall Study|Missing data|1|||
155099419|NCT00457626|559797654|FG000|Overall Study|Adverse Event|3|||
155099420|NCT00457626|559797654|FG000|Overall Study|Administrative Problems|2|||
155099421|NCT00457626|559797654|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
155099422|NCT00532129|559799175|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
155099423|NCT00532129|559799175|FG000|Treatment Period|Physician Decision|15|||
155099424|NCT00532129|559799175|FG000|Treatment Period|Disease progression|3|||
155099425|NCT00532129|559799175|FG000|Treatment Period|Protocol Violation|1|||
155099426|NCT00532129|559799175|FG000|Treatment Period|Other|5|||
155099427|NCT00532129|559799175|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
155099428|NCT00532129|559799175|FG000|Follow-up Period|Disease progression|57|||
155099429|NCT00532129|559799175|FG000|Follow-up Period|Lost to Follow-up|1|||
155099430|NCT00532129|559799175|FG000|Follow-up Period|Other|6|||
155099431|NCT03145064|559799176|FG000|Overall Study|Death|24|||
155099432|NCT03145064|559799176|FG000|Overall Study|Lost to Follow-up|3|||
155099433|NCT03145064|559799176|FG000|Overall Study|Withdrawal by Subject|6|||
155099434|NCT03145064|559799176|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
155099435|NCT03145064|559799176|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
155099436|NCT00661830|559799177|FG000|Overall Study|Death|37|||
155099437|NCT00661830|559799178|FG001|Overall Study|Death|33|||
155099438|NCT00661830|559799177|FG000|Overall Study|Lost to Follow-up|1|||
155099439|NCT00661830|559799178|FG001|Overall Study|Lost to Follow-up|3|||
155099440|NCT00661830|559799177|FG000|Overall Study|Withdrawal by Subject|1|||
155099441|NCT00661830|559799178|FG001|Overall Study|Withdrawal by Subject|1|||
155099442|NCT00661830|559799177|FG000|Overall Study|Other reason|1|||
155099443|NCT00661830|559799178|FG001|Overall Study|Other reason|5|||
155099444|NCT00551031|559799182|FG000|Overall Study|Adverse Event|0|||
155099445|NCT00551031|559799183|FG001|Overall Study|Adverse Event|1|||
155099446|NCT00551031|559799184|FG002|Overall Study|Adverse Event|0|||
155099447|NCT00551031|559799185|FG003|Overall Study|Adverse Event|0|||
155099448|NCT00551031|559799186|FG004|Overall Study|Adverse Event|0|||
155099449|NCT00551031|559799182|FG000|Overall Study|Protocol Violation|1|||
155099450|NCT00551031|559799183|FG001|Overall Study|Protocol Violation|1|||
155099451|NCT00551031|559799184|FG002|Overall Study|Protocol Violation|0|||
155099452|NCT00551031|559799185|FG003|Overall Study|Protocol Violation|0|||
155099453|NCT00551031|559799186|FG004|Overall Study|Protocol Violation|0|||
155099454|NCT00551031|559799182|FG000|Overall Study|Lost to Follow-up|0|||
155099455|NCT00551031|559799183|FG001|Overall Study|Lost to Follow-up|1|||
155099456|NCT00551031|559799184|FG002|Overall Study|Lost to Follow-up|0|||
155099457|NCT00551031|559799185|FG003|Overall Study|Lost to Follow-up|1|||
155099458|NCT00551031|559799186|FG004|Overall Study|Lost to Follow-up|1|||
155099459|NCT00551031|559799182|FG000|Overall Study|Withdrawal by Subject|0|||
155099460|NCT00551031|559799183|FG001|Overall Study|Withdrawal by Subject|4|||
155099461|NCT00551031|559799184|FG002|Overall Study|Withdrawal by Subject|1|||
155099462|NCT00551031|559799185|FG003|Overall Study|Withdrawal by Subject|2|||
155099463|NCT00551031|559799186|FG004|Overall Study|Withdrawal by Subject|0|||
155099464|NCT00551031|559799182|FG000|Overall Study|Serious Adverse Event|0|||
155099465|NCT00551031|559799183|FG001|Overall Study|Serious Adverse Event|2|||
155099466|NCT00551031|559799184|FG002|Overall Study|Serious Adverse Event|1|||
155099467|NCT00551031|559799185|FG003|Overall Study|Serious Adverse Event|0|||
155099468|NCT00551031|559799186|FG004|Overall Study|Serious Adverse Event|0|||
155099469|NCT00551031|559799182|FG000|Overall Study|Did not receive vaccine|1|||
155099470|NCT00551031|559799183|FG001|Overall Study|Did not receive vaccine|2|||
155099471|NCT00551031|559799184|FG002|Overall Study|Did not receive vaccine|0|||
155099472|NCT00551031|559799185|FG003|Overall Study|Did not receive vaccine|0|||
155099473|NCT00551031|559799186|FG004|Overall Study|Did not receive vaccine|0|||
155099474|NCT01650831|559799190|FG000|Overall Study|Screen failure|1|||
155099475|NCT00856635|559799191|FG000|Overall Study|Lost to Follow-up|2|||
155099476|NCT00856635|559799192|FG001|Overall Study|Lost to Follow-up|5|||
155099477|NCT00856635|559799191|FG000|Overall Study|Pregnancy|1|||
155099478|NCT00856635|559799192|FG001|Overall Study|Pregnancy|0|||
155099479|NCT00856635|559799191|FG000|Overall Study|Withdrawal by Subject|3|||
155099480|NCT00856635|559799192|FG001|Overall Study|Withdrawal by Subject|1|||
155099481|NCT00856635|559799191|FG000|Overall Study|Serious Adverse Event|1|||
155099482|NCT00856635|559799192|FG001|Overall Study|Serious Adverse Event|0|||
155099483|NCT00856635|559799191|FG000|Overall Study|Other|1|||
155099484|NCT00856635|559799192|FG001|Overall Study|Other|0|||
155099485|NCT00856635|559799191|FG000|Overall Study|Discontinued at Randomization|2|||
155099486|NCT00856635|559799192|FG001|Overall Study|Discontinued at Randomization|2|||
155099487|NCT03462758|559799193|FG000|Overall Study|Chose no or other method of contraception|20|||
154968697|NCT05034874|559309021|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
154968698|NCT02426918|559309022|FG000|Overall Study|Adverse Event|2|||
154968699|NCT02426918|559309023|FG001|Overall Study|Adverse Event|2|||
154968700|NCT02426918|559309024|FG002|Overall Study|Adverse Event|0|||
154968701|NCT02426918|559309022|FG000|Overall Study|Physician Decision|1|||
154968702|NCT02426918|559309023|FG001|Overall Study|Physician Decision|1|||
154968703|NCT02426918|559309024|FG002|Overall Study|Physician Decision|1|||
154968704|NCT02426918|559309022|FG000|Overall Study|Withdrawal by Subject|5|||
154968705|NCT02426918|559309023|FG001|Overall Study|Withdrawal by Subject|5|||
154968706|NCT02426918|559309024|FG002|Overall Study|Withdrawal by Subject|4|||
154968707|NCT02426918|559309022|FG000|Overall Study|Other|9|||
154968708|NCT02426918|559309023|FG001|Overall Study|Other|11|||
154968709|NCT02426918|559309024|FG002|Overall Study|Other|9|||
154968710|NCT01496118|559309025|FG000|Overall Study|Disease progression|3|||
154968711|NCT01496118|559309026|FG001|Overall Study|Disease progression|2|||
154968712|NCT01496118|559309027|FG002|Overall Study|Disease progression|3|||
154968713|NCT01496118|559309028|FG003|Overall Study|Disease progression|1|||
154968714|NCT01496118|559309029|FG004|Overall Study|Disease progression|2|||
154968715|NCT01496118|559309030|FG005|Overall Study|Disease progression|2|||
154968716|NCT01496118|559309031|FG006|Overall Study|Disease progression|14|||
154968717|NCT01496118|559309032|FG007|Overall Study|Disease progression|10|||
154968718|NCT01496118|559309025|FG000|Overall Study|Physician Decision|0|||
155099488|NCT03462758|559799194|FG001|Overall Study|Chose no or other method of contraception|23|||
155099489|NCT03462758|559799193|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
154834838|NCT02424253|558829966|FG001|Overall Study|Other, unspecified|0|||
154834839|NCT02424253|558829965|FG000|Overall Study|Compliance problems|1|||
154834840|NCT02424253|558829966|FG001|Overall Study|Compliance problems|0|||
154834841|NCT02424253|558829965|FG000|Overall Study|Physician Decision|2|||
154834842|NCT02424253|558829966|FG001|Overall Study|Physician Decision|0|||
154834843|NCT02424253|558829965|FG000|Overall Study|Lack of Efficacy|0|||
154834844|NCT02424253|558829966|FG001|Overall Study|Lack of Efficacy|7|||
154834845|NCT02424253|558829965|FG000|Overall Study|Adverse Event|2|||
154834846|NCT02424253|558829966|FG001|Overall Study|Adverse Event|0|||
154968719|NCT01496118|559309026|FG001|Overall Study|Physician Decision|0|||
155099490|NCT03462758|559799194|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
154968720|NCT01496118|559309027|FG002|Overall Study|Physician Decision|0|||
154968721|NCT01496118|559309028|FG003|Overall Study|Physician Decision|0|||
154968722|NCT01496118|559309029|FG004|Overall Study|Physician Decision|1|||
154968723|NCT01496118|559309030|FG005|Overall Study|Physician Decision|0|||
155099491|NCT03462758|559799193|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
154834847|NCT02424253|558829965|FG000|Overall Study|Consent withdrawn by subject|4|||
154834848|NCT02424253|558829966|FG001|Overall Study|Consent withdrawn by subject|1|||
154834849|NCT02424253|558829965|FG000|Overall Study|Lost to Follow-up|1|||
154968724|NCT01496118|559309031|FG006|Overall Study|Physician Decision|3|||
154834850|NCT02424253|558829966|FG001|Overall Study|Lost to Follow-up|1|||
154834851|NCT00884273|558829967|FG000|Overall Study|Adverse Event|0|||
154834852|NCT00884273|558829968|FG001|Overall Study|Adverse Event|2|||
154834853|NCT00884273|558829967|FG000|Overall Study|Protocol Violation|1|||
154834854|NCT00884273|558829968|FG001|Overall Study|Protocol Violation|3|||
154834855|NCT00884273|558829967|FG000|Overall Study|Practical reasons|1|||
154834856|NCT00884273|558829968|FG001|Overall Study|Practical reasons|0|||
154834857|NCT03715153|558829969|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
154834858|NCT03715153|558829970|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
154834859|NCT03715153|558829969|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
154834860|NCT03715153|558829970|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
154834861|NCT03715153|558829969|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
154834862|NCT03715153|558829970|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
154834863|NCT03715153|558829969|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
154834864|NCT03715153|558829970|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
154834865|NCT03715153|558829969|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
154834866|NCT03715153|558829970|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
154834867|NCT03715153|558829969|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
154834868|NCT03715153|558829970|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
154834869|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
154834870|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
154834871|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
154834872|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
154834873|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
154834874|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
154834875|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
154834876|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
154834877|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to death|4|||
154834878|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to death|3|||
154834879|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
154834880|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
154834881|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
154834882|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
154834883|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
154834884|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
154834885|NCT02258451|558829974|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
154834886|NCT02258451|558829975|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
154834887|NCT02258451|558829974|FG000|Overall Study|Other reason|1|||
154834888|NCT02258451|558829975|FG001|Overall Study|Other reason|1|||
154834889|NCT02258451|558829974|FG000|Overall Study|Never treated|2|||
154834890|NCT02258451|558829975|FG001|Overall Study|Never treated|3|||
154834891|NCT03021499|558829980|FG000|Overall Study|Adverse Event|1|||
154834892|NCT03021499|558829981|FG001|Overall Study|Adverse Event|0|||
154834893|NCT03021499|558829980|FG000|Overall Study|Death|1|||
154834894|NCT03021499|558829981|FG001|Overall Study|Death|5|||
154834895|NCT03021499|558829980|FG000|Overall Study|Lack of Efficacy|0|||
154834896|NCT03021499|558829981|FG001|Overall Study|Lack of Efficacy|1|||
154834897|NCT03021499|558829980|FG000|Overall Study|Lost to Follow-up|1|||
154834898|NCT03021499|558829981|FG001|Overall Study|Lost to Follow-up|3|||
154834899|NCT03021499|558829980|FG000|Overall Study|Physician Decision|2|||
154834900|NCT03021499|558829981|FG001|Overall Study|Physician Decision|3|||
154834901|NCT03021499|558829980|FG000|Overall Study|Pregnancy|1|||
155099492|NCT03462758|559799194|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
155099493|NCT03462758|559799193|FG000|Overall Study|Medical contraindication|2|||
155099494|NCT03462758|559799194|FG001|Overall Study|Medical contraindication|2|||
155099495|NCT03462758|559799193|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
155099496|NCT03462758|559799194|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
155099497|NCT00413660|559799195|FG000|Up To Week 12|Adverse Event|1|||
155099498|NCT00413660|559799196|FG001|Up To Week 12|Adverse Event|3|||
155099499|NCT00413660|559799197|FG002|Up To Week 12|Adverse Event|1|||
155099500|NCT00413660|559799198|FG003|Up To Week 12|Adverse Event|4|||
155099501|NCT00413660|559799199|FG004|Up To Week 12|Adverse Event|6|||
155099502|NCT00413660|559799200|FG005|Up To Week 12|Adverse Event|4|||
155099503|NCT00413660|559799201|FG006|Up To Week 12|Adverse Event|1|||
155099504|NCT00413660|559799202|FG007|Up To Week 12|Adverse Event|0|||
155099505|NCT00413660|559799203|FG008|Up To Week 12|Adverse Event|0|||
155099506|NCT00413660|559799204|FG009|Up To Week 12|Adverse Event|0|||
155099507|NCT00413660|559799205|FG010|Up To Week 12|Adverse Event|0|||
155099508|NCT00413660|559799195|FG000|Up To Week 12|Lack of Efficacy|2|||
155099509|NCT00413660|559799196|FG001|Up To Week 12|Lack of Efficacy|0|||
155099510|NCT00413660|559799197|FG002|Up To Week 12|Lack of Efficacy|0|||
155099511|NCT00413660|559799198|FG003|Up To Week 12|Lack of Efficacy|0|||
155099512|NCT00413660|559799199|FG004|Up To Week 12|Lack of Efficacy|0|||
155099513|NCT00413660|559799200|FG005|Up To Week 12|Lack of Efficacy|0|||
155099514|NCT00413660|559799201|FG006|Up To Week 12|Lack of Efficacy|5|||
155099515|NCT00413660|559799202|FG007|Up To Week 12|Lack of Efficacy|0|||
155099516|NCT00413660|559799203|FG008|Up To Week 12|Lack of Efficacy|0|||
155099517|NCT00413660|559799204|FG009|Up To Week 12|Lack of Efficacy|0|||
155099518|NCT00413660|559799205|FG010|Up To Week 12|Lack of Efficacy|0|||
155099519|NCT00413660|559799195|FG000|Up To Week 12|Lost to Follow-up|0|||
155099520|NCT00413660|559799196|FG001|Up To Week 12|Lost to Follow-up|1|||
155099521|NCT00413660|559799197|FG002|Up To Week 12|Lost to Follow-up|0|||
155099522|NCT00413660|559799198|FG003|Up To Week 12|Lost to Follow-up|0|||
154968725|NCT01496118|559309032|FG007|Overall Study|Physician Decision|6|||
154968726|NCT01496118|559309025|FG000|Overall Study|Adverse Event|1|||
154968727|NCT01496118|559309026|FG001|Overall Study|Adverse Event|1|||
154968728|NCT01496118|559309027|FG002|Overall Study|Adverse Event|0|||
154968729|NCT01496118|559309028|FG003|Overall Study|Adverse Event|0|||
154968730|NCT01496118|559309029|FG004|Overall Study|Adverse Event|0|||
154968731|NCT01496118|559309030|FG005|Overall Study|Adverse Event|0|||
154968732|NCT01496118|559309031|FG006|Overall Study|Adverse Event|6|||
154968733|NCT01496118|559309032|FG007|Overall Study|Adverse Event|10|||
154968734|NCT01496118|559309025|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968735|NCT01496118|559309026|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968736|NCT01496118|559309027|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968737|NCT01496118|559309028|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968738|NCT01496118|559309029|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968739|NCT01496118|559309030|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968740|NCT01496118|559309031|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
154968741|NCT01496118|559309032|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
154968742|NCT01496118|559309025|FG000|Overall Study|Death|0|||
154968743|NCT01496118|559309026|FG001|Overall Study|Death|0|||
154968744|NCT01496118|559309027|FG002|Overall Study|Death|0|||
154968745|NCT01496118|559309028|FG003|Overall Study|Death|0|||
154968746|NCT01496118|559309029|FG004|Overall Study|Death|0|||
154968747|NCT01496118|559309030|FG005|Overall Study|Death|0|||
154968748|NCT01496118|559309031|FG006|Overall Study|Death|1|||
154968749|NCT01496118|559309032|FG007|Overall Study|Death|1|||
154968750|NCT01496118|559309025|FG000|Overall Study|Withdrawal by Subject|0|||
154968751|NCT01496118|559309026|FG001|Overall Study|Withdrawal by Subject|0|||
154834902|NCT03021499|558829981|FG001|Overall Study|Pregnancy|0|||
154834903|NCT03021499|558829980|FG000|Overall Study|Withdrawal by Subject|7|||
154834904|NCT03021499|558829981|FG001|Overall Study|Withdrawal by Subject|14|||
154834905|NCT03021499|558829980|FG000|Overall Study|Prohibited medication required|1|||
154834906|NCT03021499|558829981|FG001|Overall Study|Prohibited medication required|0|||
154968752|NCT01496118|559309027|FG002|Overall Study|Withdrawal by Subject|0|||
154968753|NCT01496118|559309028|FG003|Overall Study|Withdrawal by Subject|2|||
154968754|NCT01496118|559309029|FG004|Overall Study|Withdrawal by Subject|0|||
154968755|NCT01496118|559309030|FG005|Overall Study|Withdrawal by Subject|1|||
154968756|NCT01496118|559309031|FG006|Overall Study|Withdrawal by Subject|6|||
154968757|NCT01496118|559309032|FG007|Overall Study|Withdrawal by Subject|3|||
154968758|NCT01438060|559309036|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
155099523|NCT00413660|559799199|FG004|Up To Week 12|Lost to Follow-up|1|||
154834907|NCT03021499|558829980|FG000|Overall Study|Protocol non-compliance|1|||
154834908|NCT03021499|558829981|FG001|Overall Study|Protocol non-compliance|1|||
154834909|NCT03021499|558829980|FG000|Overall Study|None of the above|0|||
154834910|NCT03021499|558829981|FG001|Overall Study|None of the above|4|||
154834911|NCT03021499|558829980|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
154834912|NCT03021499|558829981|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
155099524|NCT00413660|559799200|FG005|Up To Week 12|Lost to Follow-up|0|||
154834913|NCT02581202|558829985|FG000|Overall Study|Lack of Efficacy|2|||
154834914|NCT02581202|558829985|FG000|Overall Study|Withdrawal by Subject|4|||
154834915|NCT02581202|558829985|FG000|Overall Study|Lost to Follow-up|5|||
155099525|NCT00413660|559799201|FG006|Up To Week 12|Lost to Follow-up|0|||
155099526|NCT00413660|559799202|FG007|Up To Week 12|Lost to Follow-up|0|||
154834916|NCT02581202|558829985|FG000|Overall Study|Pregnancy|3|||
155099527|NCT00413660|559799203|FG008|Up To Week 12|Lost to Follow-up|0|||
155099528|NCT00413660|559799204|FG009|Up To Week 12|Lost to Follow-up|0|||
155099529|NCT00413660|559799205|FG010|Up To Week 12|Lost to Follow-up|0|||
155099530|NCT00413660|559799195|FG000|Up To Week 12|Withdrawal by Subject|0|||
155099531|NCT00413660|559799196|FG001|Up To Week 12|Withdrawal by Subject|2|||
154834917|NCT04050982|558829986|FG000|Overall Study|Did not meet eligibility criteria|0|||
154834918|NCT04050982|558829987|FG001|Overall Study|Did not meet eligibility criteria|1|||
154834919|NCT04050982|558829988|FG002|Overall Study|Did not meet eligibility criteria|0|||
154834920|NCT04050982|558829986|FG000|Overall Study|Withdrawal by Subject|1|||
154834921|NCT04050982|558829987|FG001|Overall Study|Withdrawal by Subject|0|||
154834922|NCT04050982|558829988|FG002|Overall Study|Withdrawal by Subject|0|||
154834923|NCT04050982|558829986|FG000|Overall Study|Unable to enroll on platform|1|||
154968759|NCT01438060|559309037|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
154968760|NCT01438060|559309036|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
154968761|NCT01438060|559309037|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
154968762|NCT01438060|559309036|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
154968763|NCT01438060|559309037|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
154968764|NCT01438060|559309036|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
154968765|NCT01438060|559309037|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
154968766|NCT01438060|559309036|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
154968767|NCT01438060|559309037|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
154968768|NCT01438060|559309036|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
154968769|NCT01438060|559309037|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
154968770|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
154968771|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
154968772|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
154968773|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
154968774|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
154968775|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
154968776|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
154968777|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
154968778|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
154968779|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
154968780|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
154968781|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
154968782|NCT01438060|559309036|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
154968783|NCT01438060|559309037|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
154968784|NCT01438060|559309036|FG000|On Study Beyond Week 140|Adverse Event|0|||
154968785|NCT01438060|559309037|FG001|On Study Beyond Week 140|Adverse Event|2|||
154968786|NCT01438060|559309036|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
154968787|NCT01438060|559309037|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
154968788|NCT01438060|559309036|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
154834924|NCT04050982|558829987|FG001|Overall Study|Unable to enroll on platform|0|||
154834925|NCT04050982|558829988|FG002|Overall Study|Unable to enroll on platform|0|||
154834926|NCT00609791|558831722|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
155099532|NCT00413660|559799197|FG002|Up To Week 12|Withdrawal by Subject|0|||
155099533|NCT00413660|559799198|FG003|Up To Week 12|Withdrawal by Subject|2|||
155099534|NCT00413660|559799199|FG004|Up To Week 12|Withdrawal by Subject|0|||
155099535|NCT00413660|559799200|FG005|Up To Week 12|Withdrawal by Subject|2|||
155099536|NCT00413660|559799201|FG006|Up To Week 12|Withdrawal by Subject|2|||
155099537|NCT00413660|559799202|FG007|Up To Week 12|Withdrawal by Subject|0|||
155099538|NCT00413660|559799203|FG008|Up To Week 12|Withdrawal by Subject|0|||
155099539|NCT00413660|559799204|FG009|Up To Week 12|Withdrawal by Subject|0|||
155099540|NCT00413660|559799205|FG010|Up To Week 12|Withdrawal by Subject|0|||
155099541|NCT00413660|559799195|FG000|Up To Week 12|Randomized, Not Treated|1|||
155099542|NCT00413660|559799196|FG001|Up To Week 12|Randomized, Not Treated|0|||
155099543|NCT00413660|559799197|FG002|Up To Week 12|Randomized, Not Treated|0|||
155099544|NCT00413660|559799198|FG003|Up To Week 12|Randomized, Not Treated|1|||
155099545|NCT00413660|559799199|FG004|Up To Week 12|Randomized, Not Treated|0|||
155099546|NCT00413660|559799200|FG005|Up To Week 12|Randomized, Not Treated|0|||
155099547|NCT00413660|559799201|FG006|Up To Week 12|Randomized, Not Treated|0|||
155099548|NCT00413660|559799202|FG007|Up To Week 12|Randomized, Not Treated|0|||
155099549|NCT00413660|559799203|FG008|Up To Week 12|Randomized, Not Treated|0|||
155099550|NCT00413660|559799204|FG009|Up To Week 12|Randomized, Not Treated|0|||
155099551|NCT00413660|559799205|FG010|Up To Week 12|Randomized, Not Treated|0|||
155099552|NCT00413660|559799195|FG000|Up To Week 12|Other|3|||
155099553|NCT00413660|559799196|FG001|Up To Week 12|Other|1|||
154834927|NCT04218201|558831723|FG000|Overall Study|Death|0|||
154834928|NCT04218201|558831724|FG001|Overall Study|Death|0|||
154834929|NCT04218201|558831725|FG002|Overall Study|Death|2|||
154834930|NCT04218201|558831726|FG003|Overall Study|Death|0|||
154834931|NCT04218201|558831723|FG000|Overall Study|Unable to contact participant|4|||
154834932|NCT04218201|558831724|FG001|Overall Study|Unable to contact participant|0|||
154834933|NCT04218201|558831725|FG002|Overall Study|Unable to contact participant|3|||
154834934|NCT04218201|558831726|FG003|Overall Study|Unable to contact participant|0|||
154834935|NCT04218201|558831723|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
155099554|NCT00413660|559799197|FG002|Up To Week 12|Other|6|||
155099555|NCT00413660|559799198|FG003|Up To Week 12|Other|1|||
155099556|NCT00413660|559799199|FG004|Up To Week 12|Other|2|||
155099557|NCT00413660|559799200|FG005|Up To Week 12|Other|4|||
155099558|NCT00413660|559799201|FG006|Up To Week 12|Other|3|||
155099559|NCT00413660|559799202|FG007|Up To Week 12|Other|0|||
155099560|NCT00413660|559799203|FG008|Up To Week 12|Other|0|||
154834936|NCT04218201|558831724|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
154834937|NCT04218201|558831725|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
154834938|NCT04218201|558831726|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
155099561|NCT00413660|559799204|FG009|Up To Week 12|Other|0|||
155099562|NCT00413660|559799205|FG010|Up To Week 12|Other|0|||
155099563|NCT00413660|559799195|FG000|Post Week 12|Adverse Event|2|||
155099564|NCT00413660|559799196|FG001|Post Week 12|Adverse Event|0|||
155099565|NCT00413660|559799197|FG002|Post Week 12|Adverse Event|2|||
155099566|NCT00413660|559799198|FG003|Post Week 12|Adverse Event|1|||
155099567|NCT00413660|559799199|FG004|Post Week 12|Adverse Event|4|||
155099568|NCT00413660|559799200|FG005|Post Week 12|Adverse Event|2|||
155099569|NCT00413660|559799201|FG006|Post Week 12|Adverse Event|2|||
155099570|NCT00413660|559799202|FG007|Post Week 12|Adverse Event|0|||
155099571|NCT00413660|559799203|FG008|Post Week 12|Adverse Event|0|||
155099572|NCT00413660|559799204|FG009|Post Week 12|Adverse Event|0|||
154834939|NCT04218201|558831723|FG000|Overall Study|Withdrawal by Subject|2|||
154834940|NCT04218201|558831724|FG001|Overall Study|Withdrawal by Subject|0|||
154834941|NCT04218201|558831725|FG002|Overall Study|Withdrawal by Subject|0|||
154834942|NCT04218201|558831726|FG003|Overall Study|Withdrawal by Subject|0|||
154834943|NCT04218201|558831723|FG000|Overall Study|PCP plans to leave practice|0|||
154834944|NCT04218201|558831724|FG001|Overall Study|PCP plans to leave practice|8|||
154834945|NCT04218201|558831725|FG002|Overall Study|PCP plans to leave practice|0|||
154834946|NCT04218201|558831726|FG003|Overall Study|PCP plans to leave practice|5|||
154834947|NCT04218201|558831723|FG000|Overall Study|Reduced panel|0|||
154834948|NCT04218201|558831724|FG001|Overall Study|Reduced panel|0|||
154834949|NCT04218201|558831725|FG002|Overall Study|Reduced panel|0|||
155099573|NCT00413660|559799205|FG010|Post Week 12|Adverse Event|0|||
155099574|NCT00413660|559799195|FG000|Post Week 12|Lack of Efficacy|0|||
155099575|NCT00413660|559799196|FG001|Post Week 12|Lack of Efficacy|0|||
154834950|NCT04218201|558831726|FG003|Overall Study|Reduced panel|1|||
155099576|NCT00413660|559799197|FG002|Post Week 12|Lack of Efficacy|1|||
155099577|NCT00413660|559799198|FG003|Post Week 12|Lack of Efficacy|0|||
155099578|NCT00413660|559799199|FG004|Post Week 12|Lack of Efficacy|0|||
155099579|NCT00413660|559799200|FG005|Post Week 12|Lack of Efficacy|0|||
155099580|NCT00413660|559799201|FG006|Post Week 12|Lack of Efficacy|0|||
155099581|NCT00413660|559799202|FG007|Post Week 12|Lack of Efficacy|0|||
155099582|NCT00413660|559799203|FG008|Post Week 12|Lack of Efficacy|0|||
155099583|NCT00413660|559799204|FG009|Post Week 12|Lack of Efficacy|1|||
155099584|NCT00413660|559799205|FG010|Post Week 12|Lack of Efficacy|0|||
155099585|NCT00413660|559799195|FG000|Post Week 12|Lost to Follow-up|0|||
155099586|NCT00413660|559799196|FG001|Post Week 12|Lost to Follow-up|1|||
155099587|NCT00413660|559799197|FG002|Post Week 12|Lost to Follow-up|1|||
155099588|NCT00413660|559799198|FG003|Post Week 12|Lost to Follow-up|0|||
155099589|NCT00413660|559799199|FG004|Post Week 12|Lost to Follow-up|0|||
155099590|NCT00413660|559799200|FG005|Post Week 12|Lost to Follow-up|0|||
155099591|NCT00413660|559799201|FG006|Post Week 12|Lost to Follow-up|0|||
155099592|NCT00413660|559799202|FG007|Post Week 12|Lost to Follow-up|0|||
155099593|NCT00413660|559799203|FG008|Post Week 12|Lost to Follow-up|0|||
155099594|NCT00413660|559799204|FG009|Post Week 12|Lost to Follow-up|0|||
155099595|NCT00413660|559799205|FG010|Post Week 12|Lost to Follow-up|0|||
155099596|NCT00413660|559799195|FG000|Post Week 12|Withdrawal by Subject|0|||
155099597|NCT00413660|559799196|FG001|Post Week 12|Withdrawal by Subject|1|||
155099598|NCT00413660|559799197|FG002|Post Week 12|Withdrawal by Subject|1|||
155099599|NCT00413660|559799198|FG003|Post Week 12|Withdrawal by Subject|0|||
155099600|NCT00413660|559799199|FG004|Post Week 12|Withdrawal by Subject|1|||
155099601|NCT00413660|559799200|FG005|Post Week 12|Withdrawal by Subject|0|||
155099602|NCT00413660|559799201|FG006|Post Week 12|Withdrawal by Subject|0|||
155099603|NCT00413660|559799202|FG007|Post Week 12|Withdrawal by Subject|0|||
155099604|NCT00413660|559799203|FG008|Post Week 12|Withdrawal by Subject|0|||
155099605|NCT00413660|559799204|FG009|Post Week 12|Withdrawal by Subject|0|||
155099606|NCT00413660|559799205|FG010|Post Week 12|Withdrawal by Subject|1|||
155099607|NCT00413660|559799195|FG000|Post Week 12|Other|1|||
155099608|NCT00413660|559799196|FG001|Post Week 12|Other|2|||
155099609|NCT00413660|559799197|FG002|Post Week 12|Other|3|||
155099610|NCT00413660|559799198|FG003|Post Week 12|Other|0|||
155099611|NCT00413660|559799199|FG004|Post Week 12|Other|1|||
155099612|NCT00413660|559799200|FG005|Post Week 12|Other|1|||
155099613|NCT00413660|559799201|FG006|Post Week 12|Other|1|||
155099614|NCT00413660|559799202|FG007|Post Week 12|Other|0|||
155099615|NCT00413660|559799203|FG008|Post Week 12|Other|0|||
155099616|NCT00413660|559799204|FG009|Post Week 12|Other|0|||
155099617|NCT00413660|559799205|FG010|Post Week 12|Other|0|||
155099618|NCT01791517|559799206|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
155099619|NCT01791517|559799207|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
155099620|NCT01791517|559799208|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
155099621|NCT01791517|559799209|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
155099622|NCT01791517|559799210|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
155099623|NCT01791517|559799211|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
155099624|NCT01791517|559799212|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
155099625|NCT01791517|559799213|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
155099626|NCT01791517|559799214|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
155099627|NCT01791517|559799215|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
155099628|NCT01791517|559799216|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
155099629|NCT01791517|559799217|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
155099630|NCT01791517|559799206|FG000|Phase I: Period 1|Adverse Event|0|||
155099631|NCT01791517|559799207|FG001|Phase I: Period 1|Adverse Event|0|||
155099632|NCT01791517|559799208|FG002|Phase I: Period 1|Adverse Event|1|||
155099633|NCT01791517|559799209|FG003|Phase I: Period 1|Adverse Event|1|||
155099634|NCT01791517|559799210|FG004|Phase I: Period 1|Adverse Event|0|||
155099635|NCT01791517|559799211|FG005|Phase I: Period 1|Adverse Event|0|||
155099636|NCT01791517|559799212|FG006|Phase I: Period 1|Adverse Event|0|||
155099637|NCT01791517|559799213|FG007|Phase I: Period 1|Adverse Event|0|||
155099638|NCT01791517|559799214|FG008|Phase I: Period 1|Adverse Event|0|||
155099639|NCT01791517|559799215|FG009|Phase I: Period 1|Adverse Event|0|||
155099640|NCT01791517|559799216|FG010|Phase I: Period 1|Adverse Event|0|||
155099641|NCT01791517|559799217|FG011|Phase I: Period 1|Adverse Event|0|||
155099642|NCT01791517|559799206|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
155099643|NCT01791517|559799207|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099644|NCT01791517|559799208|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099645|NCT01791517|559799209|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099646|NCT01791517|559799210|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099647|NCT01791517|559799211|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099648|NCT01791517|559799212|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099649|NCT01791517|559799213|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099650|NCT01791517|559799214|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099651|NCT01791517|559799215|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099652|NCT01791517|559799216|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099653|NCT01791517|559799217|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
155099654|NCT01791517|559799206|FG000|Phase I: Period 1|Protocol Violation|0|||
155099655|NCT01791517|559799207|FG001|Phase I: Period 1|Protocol Violation|1|||
155099656|NCT01791517|559799208|FG002|Phase I: Period 1|Protocol Violation|0|||
154834951|NCT04218201|558831723|FG000|Overall Study|No longer interested in participating|0|||
154834952|NCT04218201|558831724|FG001|Overall Study|No longer interested in participating|1|||
154834953|NCT04218201|558831725|FG002|Overall Study|No longer interested in participating|0|||
154834954|NCT04218201|558831726|FG003|Overall Study|No longer interested in participating|0|||
154834955|NCT04649255|558831727|FG000|Overall Study|Death|9|||
154834956|NCT04649255|558831727|FG000|Overall Study|Withdrawal by Subject|1|||
154834957|NCT00122681|558831735|FG000|Overall Study|Adverse Event|20|||
155099657|NCT01791517|559799209|FG003|Phase I: Period 1|Protocol Violation|0|||
155099658|NCT01791517|559799210|FG004|Phase I: Period 1|Protocol Violation|0|||
155099659|NCT01791517|559799211|FG005|Phase I: Period 1|Protocol Violation|0|||
155099660|NCT01791517|559799212|FG006|Phase I: Period 1|Protocol Violation|0|||
155099661|NCT01791517|559799213|FG007|Phase I: Period 1|Protocol Violation|0|||
155099662|NCT01791517|559799214|FG008|Phase I: Period 1|Protocol Violation|0|||
155099663|NCT01791517|559799215|FG009|Phase I: Period 1|Protocol Violation|0|||
155099664|NCT01791517|559799216|FG010|Phase I: Period 1|Protocol Violation|0|||
155099665|NCT01791517|559799217|FG011|Phase I: Period 1|Protocol Violation|0|||
155099666|NCT01791517|559799206|FG000|Phase I: Period 1|Lost to Follow-up|0|||
155099667|NCT01791517|559799207|FG001|Phase I: Period 1|Lost to Follow-up|0|||
155099668|NCT01791517|559799208|FG002|Phase I: Period 1|Lost to Follow-up|0|||
155099669|NCT01791517|559799209|FG003|Phase I: Period 1|Lost to Follow-up|1|||
155099670|NCT01791517|559799210|FG004|Phase I: Period 1|Lost to Follow-up|0|||
155099671|NCT01791517|559799211|FG005|Phase I: Period 1|Lost to Follow-up|0|||
155099672|NCT01791517|559799212|FG006|Phase I: Period 1|Lost to Follow-up|1|||
155099673|NCT01791517|559799213|FG007|Phase I: Period 1|Lost to Follow-up|0|||
155099674|NCT01791517|559799214|FG008|Phase I: Period 1|Lost to Follow-up|1|||
155099675|NCT01791517|559799215|FG009|Phase I: Period 1|Lost to Follow-up|1|||
154834958|NCT00122681|558831736|FG001|Overall Study|Adverse Event|16|||
155099676|NCT01791517|559799216|FG010|Phase I: Period 1|Lost to Follow-up|0|||
155099677|NCT01791517|559799217|FG011|Phase I: Period 1|Lost to Follow-up|0|||
155099678|NCT01791517|559799206|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099679|NCT01791517|559799207|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099680|NCT01791517|559799208|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099681|NCT01791517|559799209|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099682|NCT01791517|559799210|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099683|NCT01791517|559799211|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099684|NCT01791517|559799212|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099685|NCT01791517|559799213|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099686|NCT01791517|559799214|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099687|NCT01791517|559799215|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
155099688|NCT01791517|559799216|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
154968789|NCT01438060|559309037|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
154968790|NCT01438060|559309036|FG000|On Study Beyond Week 140|Death|0|||
154968791|NCT01438060|559309037|FG001|On Study Beyond Week 140|Death|1|||
154968792|NCT01438060|559309036|FG000|On Study Beyond Week 140|Other Reason|0|||
154968793|NCT01438060|559309037|FG001|On Study Beyond Week 140|Other Reason|3|||
154968794|NCT04608448|559309038|FG000|Overall Study|Withdrawal by Subject|1|||
154968795|NCT04608448|559309038|FG000|Overall Study|Adverse Event|1|||
154968796|NCT04060251|559309042|FG000|Overall Study|Study terminated due to low enrollment.|7|||
154968797|NCT04060251|559309043|FG001|Overall Study|Study terminated due to low enrollment.|5|||
154968798|NCT04060251|559309044|FG002|Overall Study|Study terminated due to low enrollment.|7|||
154968799|NCT04060251|559309042|FG000|Overall Study|Adverse Event|1|||
154968800|NCT04060251|559309043|FG001|Overall Study|Adverse Event|1|||
154968801|NCT04060251|559309044|FG002|Overall Study|Adverse Event|0|||
154968802|NCT00487435|559309045|FG000|Overall Study|Adverse Event|146|||
154968803|NCT00487435|559309045|FG000|Overall Study|Death|2|||
154968804|NCT00487435|559309045|FG000|Overall Study|Lack of Efficacy|33|||
154968805|NCT00487435|559309045|FG000|Overall Study|Lost to Follow-up|54|||
154968806|NCT00487435|559309045|FG000|Overall Study|Pregnancy|2|||
154968807|NCT00487435|559309045|FG000|Overall Study|Withdrawal by Subject|132|||
154968808|NCT00487435|559309045|FG000|Overall Study|Resolution Of Pain|1|||
154968809|NCT00487435|559309045|FG000|Overall Study|Study Medication Non-Compliant|32|||
154968810|NCT00487435|559309045|FG000|Overall Study|Other|83|||
154968811|NCT01155531|559309046|FG000|Overall Study|Adverse Event|0|||
154968812|NCT01155531|559309047|FG001|Overall Study|Adverse Event|0|||
154968813|NCT01155531|559309048|FG002|Overall Study|Adverse Event|1|||
154968814|NCT01155531|559309049|FG003|Overall Study|Adverse Event|0|||
154968815|NCT01155531|559309046|FG000|Overall Study|Lost to Follow-up|0|||
154968816|NCT01155531|559309047|FG001|Overall Study|Lost to Follow-up|0|||
154968817|NCT01155531|559309048|FG002|Overall Study|Lost to Follow-up|0|||
154968818|NCT01155531|559309049|FG003|Overall Study|Lost to Follow-up|1|||
154968819|NCT01155531|559309046|FG000|Overall Study|Withdrawal by Subject|1|||
154968820|NCT01155531|559309047|FG001|Overall Study|Withdrawal by Subject|0|||
154968821|NCT01155531|559309048|FG002|Overall Study|Withdrawal by Subject|1|||
154968822|NCT01155531|559309049|FG003|Overall Study|Withdrawal by Subject|0|||
154968823|NCT00999687|559309052|FG000|First Intervention|Withdrawal by Subject|1|||
154968824|NCT00999687|559309052|FG000|Second Intervention|Withdrawal by Subject|2|||
154968825|NCT00999687|559309052|FG000|Second Intervention|Lack of Efficacy|1|||
154968826|NCT03614728|559309053|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
154968827|NCT03614728|559309054|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
154968828|NCT03614728|559309055|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
154968829|NCT03614728|559309056|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
154968830|NCT03614728|559309053|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
154968831|NCT03614728|559309054|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
154968832|NCT03614728|559309055|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
154968833|NCT03614728|559309056|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
154968834|NCT00842309|559309059|FG000|Overall Study|Withdrawal by Subject|3|||
154968835|NCT00842309|559309060|FG001|Overall Study|Withdrawal by Subject|1|||
154968836|NCT03105297|559309061|FG000|Baseline Phase (Day 1)|Other|21|||
154968837|NCT03105297|559309061|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
154968838|NCT03105297|559309061|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
154968839|NCT01390948|559309062|FG000|Overall Study|End of Study|1|||
154968840|NCT01390948|559309063|FG001|Overall Study|End of Study|0|||
154968841|NCT01390948|559309064|FG002|Overall Study|End of Study|0|||
154968842|NCT01390948|559309062|FG000|Overall Study|Withdrew consent|2|||
154968843|NCT01390948|559309063|FG001|Overall Study|Withdrew consent|2|||
154968844|NCT01390948|559309064|FG002|Overall Study|Withdrew consent|0|||
154968845|NCT01390948|559309062|FG000|Overall Study|Progressive Disease|2|||
154968846|NCT01390948|559309063|FG001|Overall Study|Progressive Disease|5|||
154968847|NCT01390948|559309064|FG002|Overall Study|Progressive Disease|0|||
154968848|NCT01390948|559309062|FG000|Overall Study|Death during follow-up|10|||
154968849|NCT01390948|559309063|FG001|Overall Study|Death during follow-up|11|||
154968850|NCT01390948|559309064|FG002|Overall Study|Death during follow-up|1|||
154968851|NCT03867760|559309069|FG000|Overall Study|Lost to Follow-up|2|||
154968852|NCT03867760|559309070|FG001|Overall Study|Lost to Follow-up|3|||
154968853|NCT03867760|559309069|FG000|Overall Study|Withdrawal by Subject|1|||
154968854|NCT03867760|559309070|FG001|Overall Study|Withdrawal by Subject|2|||
154968855|NCT03867760|559309069|FG000|Overall Study|subject could not meet study logistics|3|||
154968856|NCT03867760|559309070|FG001|Overall Study|subject could not meet study logistics|3|||
154968857|NCT01401062|559309073|FG000|Overall Study|Death|9|||
154968858|NCT01401062|559309074|FG001|Overall Study|Death|7|||
154968859|NCT01401062|559309073|FG000|Overall Study|Physician Decision|1|||
154968860|NCT01401062|559309074|FG001|Overall Study|Physician Decision|0|||
154968861|NCT01401062|559309073|FG000|Overall Study|Withdrawal by Subject|1|||
154968862|NCT01401062|559309074|FG001|Overall Study|Withdrawal by Subject|1|||
154834959|NCT00122681|558831735|FG000|Overall Study|Lost to Follow-up|1080|||
154834960|NCT00122681|558831736|FG001|Overall Study|Lost to Follow-up|1097|||
154834961|NCT00122681|558831735|FG000|Overall Study|Protocol Violation|7|||
154834962|NCT00122681|558831736|FG001|Overall Study|Protocol Violation|10|||
154834963|NCT00122681|558831735|FG000|Overall Study|Withdrawal by Subject|257|||
154834964|NCT00122681|558831736|FG001|Overall Study|Withdrawal by Subject|251|||
154834965|NCT00122681|558831735|FG000|Overall Study|Personal reasons|150|||
154834966|NCT00122681|558831736|FG001|Overall Study|Personal reasons|147|||
154834967|NCT02819635|558831737|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
154834968|NCT02819635|558831738|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
154834969|NCT02819635|558831739|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
154834970|NCT02819635|558831740|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
154834971|NCT02819635|558831741|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
154834972|NCT02819635|558831742|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
154834973|NCT02819635|558831743|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
154834974|NCT02819635|558831744|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
154834975|NCT02819635|558831745|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
154834976|NCT02819635|558831746|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
154834977|NCT02819635|558831747|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
154834978|NCT02819635|558831748|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
154834979|NCT02819635|558831737|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834980|NCT02819635|558831738|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834981|NCT02819635|558831739|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834982|NCT02819635|558831740|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834983|NCT02819635|558831741|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
154834984|NCT02819635|558831742|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
154834985|NCT02819635|558831743|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
154834986|NCT02819635|558831744|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834987|NCT02819635|558831745|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834988|NCT02819635|558831746|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834989|NCT02819635|558831747|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834990|NCT02819635|558831748|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
154834991|NCT02819635|558831737|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154834992|NCT02819635|558831738|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154834993|NCT02819635|558831739|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154834994|NCT02819635|558831740|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154834995|NCT02819635|558831741|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154834996|NCT02819635|558831742|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
154834997|NCT02819635|558831743|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
154834998|NCT02819635|558831744|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154834999|NCT02819635|558831745|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154835000|NCT02819635|558831746|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154835001|NCT02819635|558831747|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154835002|NCT02819635|558831748|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
154835003|NCT02819635|558831737|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835004|NCT02819635|558831738|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835005|NCT02819635|558831739|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835006|NCT02819635|558831740|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835007|NCT02819635|558831741|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835008|NCT02819635|558831742|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154968863|NCT03684928|559309080|FG000|First Intervention|Lost to Follow-up|0|||
154835009|NCT02819635|558831743|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
154968864|NCT03684928|559309081|FG001|First Intervention|Lost to Follow-up|1|||
155099689|NCT01791517|559799217|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
155099690|NCT01791517|559799206|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
154835010|NCT02819635|558831744|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835011|NCT02819635|558831745|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835012|NCT02819635|558831746|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835013|NCT02819635|558831747|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835014|NCT02819635|558831748|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
154835015|NCT02819635|558831737|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
154835016|NCT02819635|558831738|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
154835017|NCT02819635|558831739|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
154835018|NCT02819635|558831740|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
154835019|NCT02819635|558831741|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
154835020|NCT02819635|558831742|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
154835021|NCT02819635|558831743|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
154835022|NCT02819635|558831744|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
154835023|NCT02819635|558831745|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
154835024|NCT02819635|558831746|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
154835025|NCT02819635|558831747|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
154835026|NCT02819635|558831748|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
155099691|NCT01791517|559799207|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099692|NCT01791517|559799208|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099693|NCT01791517|559799209|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099694|NCT01791517|559799210|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099695|NCT01791517|559799211|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099696|NCT01791517|559799212|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099697|NCT01791517|559799213|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099698|NCT01791517|559799214|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099699|NCT01791517|559799215|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099700|NCT01791517|559799216|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099701|NCT01791517|559799217|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
155099702|NCT01791517|559799206|FG000|Phase I: Period 2|Protocol Violation|0|||
155099703|NCT01791517|559799207|FG001|Phase I: Period 2|Protocol Violation|0|||
155099704|NCT01791517|559799208|FG002|Phase I: Period 2|Protocol Violation|0|||
155099705|NCT01791517|559799209|FG003|Phase I: Period 2|Protocol Violation|1|||
155099706|NCT01791517|559799210|FG004|Phase I: Period 2|Protocol Violation|0|||
155099707|NCT01791517|559799211|FG005|Phase I: Period 2|Protocol Violation|0|||
155099708|NCT01791517|559799212|FG006|Phase I: Period 2|Protocol Violation|0|||
155099709|NCT01791517|559799213|FG007|Phase I: Period 2|Protocol Violation|0|||
155099710|NCT01791517|559799214|FG008|Phase I: Period 2|Protocol Violation|0|||
155099711|NCT01791517|559799215|FG009|Phase I: Period 2|Protocol Violation|0|||
155099712|NCT01791517|559799216|FG010|Phase I: Period 2|Protocol Violation|0|||
155099713|NCT01791517|559799217|FG011|Phase I: Period 2|Protocol Violation|0|||
155099714|NCT01791517|559799206|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
155099715|NCT01791517|559799207|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
155099716|NCT01791517|559799208|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
155099717|NCT01791517|559799209|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
155099718|NCT01791517|559799210|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
155099719|NCT01791517|559799211|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
154835027|NCT02819635|558831737|FG000|Substudy 2, Part 2|Adverse Event|0|||
154835028|NCT02819635|558831738|FG001|Substudy 2, Part 2|Adverse Event|0|||
154835029|NCT02819635|558831739|FG002|Substudy 2, Part 2|Adverse Event|0|||
154835030|NCT02819635|558831740|FG003|Substudy 2, Part 2|Adverse Event|0|||
154835031|NCT02819635|558831741|FG004|Substudy 2, Part 2|Adverse Event|0|||
154835032|NCT02819635|558831742|FG005|Substudy 2, Part 2|Adverse Event|4|||
154835033|NCT02819635|558831743|FG006|Substudy 2, Part 2|Adverse Event|0|||
155099720|NCT01791517|559799212|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
155099721|NCT01791517|559799213|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
155099722|NCT01791517|559799214|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
155099723|NCT01791517|559799215|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
154835034|NCT02819635|558831744|FG007|Substudy 2, Part 2|Adverse Event|0|||
155099724|NCT01791517|559799216|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
155099725|NCT01791517|559799217|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
155099726|NCT01791517|559799206|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099727|NCT01791517|559799207|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099728|NCT01791517|559799208|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
154968865|NCT03684928|559309080|FG000|First Intervention|Withdrawal by Subject|0|||
154968866|NCT03684928|559309081|FG001|First Intervention|Withdrawal by Subject|2|||
154835035|NCT02819635|558831745|FG008|Substudy 2, Part 2|Adverse Event|0|||
154835036|NCT02819635|558831746|FG009|Substudy 2, Part 2|Adverse Event|0|||
154835037|NCT02819635|558831747|FG010|Substudy 2, Part 2|Adverse Event|0|||
154835038|NCT02819635|558831748|FG011|Substudy 2, Part 2|Adverse Event|0|||
154835039|NCT02819635|558831737|FG000|Substudy 2, Part 2|Withdrew consent|0|||
154835040|NCT02819635|558831738|FG001|Substudy 2, Part 2|Withdrew consent|0|||
154835041|NCT02819635|558831739|FG002|Substudy 2, Part 2|Withdrew consent|0|||
154835042|NCT02819635|558831740|FG003|Substudy 2, Part 2|Withdrew consent|0|||
154835043|NCT02819635|558831741|FG004|Substudy 2, Part 2|Withdrew consent|0|||
154835044|NCT02819635|558831742|FG005|Substudy 2, Part 2|Withdrew consent|3|||
154835045|NCT02819635|558831743|FG006|Substudy 2, Part 2|Withdrew consent|1|||
155099729|NCT01791517|559799209|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099730|NCT01791517|559799210|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099731|NCT01791517|559799211|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099732|NCT01791517|559799212|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099733|NCT01791517|559799213|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099734|NCT01791517|559799214|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099735|NCT01791517|559799215|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099736|NCT01791517|559799216|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
155099737|NCT01791517|559799217|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
155099738|NCT01791517|559799206|FG000|Phase I: Period 2|Lens Discomfort|0|||
155099739|NCT01791517|559799207|FG001|Phase I: Period 2|Lens Discomfort|0|||
155099740|NCT01791517|559799208|FG002|Phase I: Period 2|Lens Discomfort|0|||
155099741|NCT01791517|559799209|FG003|Phase I: Period 2|Lens Discomfort|0|||
155099742|NCT01791517|559799210|FG004|Phase I: Period 2|Lens Discomfort|0|||
155099743|NCT01791517|559799211|FG005|Phase I: Period 2|Lens Discomfort|1|||
155099744|NCT01791517|559799212|FG006|Phase I: Period 2|Lens Discomfort|0|||
155099745|NCT01791517|559799213|FG007|Phase I: Period 2|Lens Discomfort|0|||
155099746|NCT01791517|559799214|FG008|Phase I: Period 2|Lens Discomfort|0|||
155099747|NCT01791517|559799215|FG009|Phase I: Period 2|Lens Discomfort|0|||
155099748|NCT01791517|559799216|FG010|Phase I: Period 2|Lens Discomfort|0|||
155099749|NCT01791517|559799217|FG011|Phase I: Period 2|Lens Discomfort|0|||
155099750|NCT01791517|559799206|FG000|Phase I: Period 2|Lost to Follow-up|0|||
155099751|NCT01791517|559799207|FG001|Phase I: Period 2|Lost to Follow-up|3|||
155099752|NCT01791517|559799208|FG002|Phase I: Period 2|Lost to Follow-up|2|||
155099753|NCT01791517|559799209|FG003|Phase I: Period 2|Lost to Follow-up|0|||
155099754|NCT01791517|559799210|FG004|Phase I: Period 2|Lost to Follow-up|0|||
155099755|NCT01791517|559799211|FG005|Phase I: Period 2|Lost to Follow-up|0|||
155099756|NCT01791517|559799212|FG006|Phase I: Period 2|Lost to Follow-up|0|||
155099757|NCT01791517|559799213|FG007|Phase I: Period 2|Lost to Follow-up|0|||
155099758|NCT01791517|559799214|FG008|Phase I: Period 2|Lost to Follow-up|0|||
155099759|NCT01791517|559799215|FG009|Phase I: Period 2|Lost to Follow-up|0|||
155099760|NCT01791517|559799216|FG010|Phase I: Period 2|Lost to Follow-up|0|||
155099761|NCT01791517|559799217|FG011|Phase I: Period 2|Lost to Follow-up|0|||
155099762|NCT01791517|559799206|FG000|Phase I: Period 3|Lens Discomfort|0|||
155099763|NCT01791517|559799207|FG001|Phase I: Period 3|Lens Discomfort|0|||
155099764|NCT01791517|559799208|FG002|Phase I: Period 3|Lens Discomfort|0|||
155099765|NCT01791517|559799209|FG003|Phase I: Period 3|Lens Discomfort|0|||
155099766|NCT01791517|559799210|FG004|Phase I: Period 3|Lens Discomfort|0|||
155099767|NCT01791517|559799211|FG005|Phase I: Period 3|Lens Discomfort|0|||
155099768|NCT01791517|559799212|FG006|Phase I: Period 3|Lens Discomfort|0|||
155099769|NCT01791517|559799213|FG007|Phase I: Period 3|Lens Discomfort|0|||
155099770|NCT01791517|559799214|FG008|Phase I: Period 3|Lens Discomfort|0|||
155099771|NCT01791517|559799215|FG009|Phase I: Period 3|Lens Discomfort|0|||
155099772|NCT01791517|559799216|FG010|Phase I: Period 3|Lens Discomfort|0|||
154835046|NCT02819635|558831744|FG007|Substudy 2, Part 2|Withdrew consent|0|||
154835047|NCT02819635|558831745|FG008|Substudy 2, Part 2|Withdrew consent|0|||
154835048|NCT02819635|558831746|FG009|Substudy 2, Part 2|Withdrew consent|0|||
154835049|NCT02819635|558831747|FG010|Substudy 2, Part 2|Withdrew consent|0|||
154835050|NCT02819635|558831748|FG011|Substudy 2, Part 2|Withdrew consent|0|||
154835051|NCT02819635|558831737|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
154835052|NCT02819635|558831738|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
154835053|NCT02819635|558831739|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
155099773|NCT01791517|559799217|FG011|Phase I: Period 3|Lens Discomfort|1|||
155099774|NCT01791517|559799206|FG000|Phase I: Period 3|Lost to Follow-up|0|||
155099775|NCT01791517|559799207|FG001|Phase I: Period 3|Lost to Follow-up|1|||
155099776|NCT01791517|559799208|FG002|Phase I: Period 3|Lost to Follow-up|0|||
155099777|NCT01791517|559799209|FG003|Phase I: Period 3|Lost to Follow-up|0|||
155099778|NCT01791517|559799210|FG004|Phase I: Period 3|Lost to Follow-up|1|||
155099779|NCT01791517|559799211|FG005|Phase I: Period 3|Lost to Follow-up|0|||
154835054|NCT02819635|558831740|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
155099780|NCT01791517|559799212|FG006|Phase I: Period 3|Lost to Follow-up|0|||
155099781|NCT01791517|559799213|FG007|Phase I: Period 3|Lost to Follow-up|0|||
155099782|NCT01791517|559799214|FG008|Phase I: Period 3|Lost to Follow-up|0|||
155099783|NCT01791517|559799215|FG009|Phase I: Period 3|Lost to Follow-up|0|||
155099784|NCT01791517|559799216|FG010|Phase I: Period 3|Lost to Follow-up|0|||
155099785|NCT01791517|559799217|FG011|Phase I: Period 3|Lost to Follow-up|0|||
155099786|NCT01791517|559799206|FG000|Phase I: Period 3|Adverse Event|0|||
155099787|NCT01791517|559799207|FG001|Phase I: Period 3|Adverse Event|0|||
155099788|NCT01791517|559799208|FG002|Phase I: Period 3|Adverse Event|0|||
155099789|NCT01791517|559799209|FG003|Phase I: Period 3|Adverse Event|1|||
155099790|NCT01791517|559799210|FG004|Phase I: Period 3|Adverse Event|0|||
155099791|NCT01791517|559799211|FG005|Phase I: Period 3|Adverse Event|0|||
155099792|NCT01791517|559799212|FG006|Phase I: Period 3|Adverse Event|0|||
155099793|NCT01791517|559799213|FG007|Phase I: Period 3|Adverse Event|0|||
155099794|NCT01791517|559799214|FG008|Phase I: Period 3|Adverse Event|0|||
155099795|NCT01791517|559799215|FG009|Phase I: Period 3|Adverse Event|0|||
155099796|NCT01791517|559799216|FG010|Phase I: Period 3|Adverse Event|0|||
155099797|NCT01791517|559799217|FG011|Phase I: Period 3|Adverse Event|0|||
155099798|NCT01791517|559799206|FG000|Phase II|Lost to Follow-up|1|||
155099799|NCT01791517|559799207|FG001|Phase II|Lost to Follow-up|0|||
155099800|NCT01791517|559799208|FG002|Phase II|Lost to Follow-up|1|||
155099801|NCT01791517|559799209|FG003|Phase II|Lost to Follow-up|0|||
155099802|NCT01791517|559799210|FG004|Phase II|Lost to Follow-up|1|||
155099803|NCT01791517|559799211|FG005|Phase II|Lost to Follow-up|2|||
155099804|NCT01791517|559799212|FG006|Phase II|Lost to Follow-up|0|||
155099805|NCT01791517|559799213|FG007|Phase II|Lost to Follow-up|1|||
155099806|NCT01791517|559799214|FG008|Phase II|Lost to Follow-up|1|||
155099807|NCT01791517|559799215|FG009|Phase II|Lost to Follow-up|1|||
155099808|NCT01791517|559799216|FG010|Phase II|Lost to Follow-up|0|||
155099809|NCT01791517|559799217|FG011|Phase II|Lost to Follow-up|0|||
155099810|NCT01791517|559799206|FG000|Phase II|Withdrawal by Subject|1|||
155099811|NCT01791517|559799207|FG001|Phase II|Withdrawal by Subject|0|||
155099812|NCT01791517|559799208|FG002|Phase II|Withdrawal by Subject|0|||
155099813|NCT01791517|559799209|FG003|Phase II|Withdrawal by Subject|0|||
155099814|NCT01791517|559799210|FG004|Phase II|Withdrawal by Subject|0|||
155099815|NCT01791517|559799211|FG005|Phase II|Withdrawal by Subject|2|||
155099816|NCT01791517|559799212|FG006|Phase II|Withdrawal by Subject|0|||
155099817|NCT01791517|559799213|FG007|Phase II|Withdrawal by Subject|1|||
155099818|NCT01791517|559799214|FG008|Phase II|Withdrawal by Subject|0|||
154835055|NCT02819635|558831741|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
154835056|NCT02819635|558831742|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
154835057|NCT02819635|558831743|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
154835058|NCT02819635|558831744|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
155099819|NCT01791517|559799215|FG009|Phase II|Withdrawal by Subject|0|||
155099820|NCT01791517|559799216|FG010|Phase II|Withdrawal by Subject|1|||
155099821|NCT01791517|559799217|FG011|Phase II|Withdrawal by Subject|0|||
155099822|NCT01791517|559799206|FG000|Phase II|Lack of Efficacy|0|||
155099823|NCT01791517|559799207|FG001|Phase II|Lack of Efficacy|0|||
154968867|NCT03684928|559309080|FG000|Second Intervention|Soft Tissue Injury|1|||
154968868|NCT03684928|559309081|FG001|Second Intervention|Soft Tissue Injury|0|||
154968869|NCT01018862|559309082|FG000|Overall Study|Adverse Event|2|||
154968870|NCT01018862|559309083|FG001|Overall Study|Adverse Event|0|||
154968871|NCT01018862|559309084|FG002|Overall Study|Adverse Event|6|||
154968872|NCT01018862|559309082|FG000|Overall Study|Lack of Efficacy|1|||
154968873|NCT01018862|559309083|FG001|Overall Study|Lack of Efficacy|0|||
154968874|NCT01018862|559309084|FG002|Overall Study|Lack of Efficacy|2|||
154968875|NCT01018862|559309082|FG000|Overall Study|Lost to Follow-up|3|||
154968876|NCT01018862|559309083|FG001|Overall Study|Lost to Follow-up|1|||
154968877|NCT01018862|559309084|FG002|Overall Study|Lost to Follow-up|0|||
154968878|NCT01018862|559309082|FG000|Overall Study|Protocol Violation|1|||
154968879|NCT01018862|559309083|FG001|Overall Study|Protocol Violation|3|||
154968880|NCT01018862|559309084|FG002|Overall Study|Protocol Violation|3|||
154968881|NCT01018862|559309082|FG000|Overall Study|Withdrawal by Subject|1|||
154968882|NCT01018862|559309083|FG001|Overall Study|Withdrawal by Subject|2|||
154968883|NCT01018862|559309084|FG002|Overall Study|Withdrawal by Subject|1|||
154968884|NCT01018862|559309082|FG000|Overall Study|administrative problems|5|||
154968885|NCT01018862|559309083|FG001|Overall Study|administrative problems|4|||
154968886|NCT01018862|559309084|FG002|Overall Study|administrative problems|4|||
154968887|NCT00840879|559309085|FG000|Second Intervention|Withdrawal by Subject|1|||
154968888|NCT00840879|559309086|FG001|Second Intervention|Withdrawal by Subject|0|||
154968889|NCT02219009|559310362|FG000|Overall Study|Withdrawal by Subject|5|||
154968890|NCT02219009|559310363|FG001|Overall Study|Withdrawal by Subject|1|||
154968891|NCT02219009|559310362|FG000|Overall Study|Adverse Event|2|||
154968892|NCT02219009|559310363|FG001|Overall Study|Adverse Event|4|||
154968893|NCT02219009|559310362|FG000|Overall Study|Lost to Follow-up|2|||
154968894|NCT02219009|559310363|FG001|Overall Study|Lost to Follow-up|2|||
154968895|NCT02219009|559310362|FG000|Overall Study|Protocol deviation|1|||
154968896|NCT02219009|559310363|FG001|Overall Study|Protocol deviation|0|||
154968897|NCT02219009|559310362|FG000|Overall Study|Physician Decision|0|||
154968898|NCT02219009|559310363|FG001|Overall Study|Physician Decision|1|||
154968899|NCT03086135|559310364|FG000|Overall Study|Adverse Event|1|||
154968900|NCT03086135|559310364|FG000|Overall Study|Lost to Follow-up|2|||
154968901|NCT00960154|559310365|FG000|Overall Study|Study termination|25|||
154968902|NCT00960154|559310366|FG001|Overall Study|Study termination|25|||
154968903|NCT00757705|559310367|FG000|Overall Study|Adverse Event|19|||
154968904|NCT00757705|559310367|FG000|Overall Study|Lost to Follow-up|16|||
154968905|NCT00757705|559310367|FG000|Overall Study|Withdrawal by Subject|25|||
154968906|NCT00757705|559310367|FG000|Overall Study|Insufficient Response|26|||
154968907|NCT00757705|559310367|FG000|Overall Study|Ineligible to continue|8|||
154968908|NCT00757705|559310367|FG000|Overall Study|Non-compliant|9|||
154968909|NCT00757705|559310367|FG000|Overall Study|Other|18|||
154968910|NCT02651987|559310371|FG000|Overall Study|Adverse Event|2|||
154968911|NCT02651987|559310372|FG001|Overall Study|Adverse Event|2|||
154968912|NCT02651987|559310371|FG000|Overall Study|Consent Withdrawn|2|||
154968913|NCT02651987|559310372|FG001|Overall Study|Consent Withdrawn|0|||
154968914|NCT02651987|559310371|FG000|Overall Study|Local PD|0|||
154968915|NCT02651987|559310372|FG001|Overall Study|Local PD|2|||
154968916|NCT02651987|559310371|FG000|Overall Study|Investigator Decision|1|||
154968917|NCT02651987|559310372|FG001|Overall Study|Investigator Decision|1|||
154968918|NCT04408924|559310373|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
154968919|NCT04408924|559310373|FG000|Overall Study|Lost to Follow-up|3|||
154968920|NCT04408924|559310373|FG000|Overall Study|Withdrawal by Subject|5|||
154968921|NCT04408924|559310373|FG000|Overall Study|Sponsor Decision|2|||
155099824|NCT01791517|559799208|FG002|Phase II|Lack of Efficacy|0|||
155099825|NCT01791517|559799209|FG003|Phase II|Lack of Efficacy|0|||
155099826|NCT01791517|559799210|FG004|Phase II|Lack of Efficacy|1|||
155099827|NCT01791517|559799211|FG005|Phase II|Lack of Efficacy|0|||
155099828|NCT01791517|559799212|FG006|Phase II|Lack of Efficacy|0|||
155099829|NCT01791517|559799213|FG007|Phase II|Lack of Efficacy|0|||
155099830|NCT01791517|559799214|FG008|Phase II|Lack of Efficacy|0|||
155099831|NCT01791517|559799215|FG009|Phase II|Lack of Efficacy|0|||
155099832|NCT01791517|559799216|FG010|Phase II|Lack of Efficacy|0|||
155099833|NCT01791517|559799217|FG011|Phase II|Lack of Efficacy|0|||
155099834|NCT01791517|559799206|FG000|Phase II|Adverse Event|0|||
155099835|NCT01791517|559799207|FG001|Phase II|Adverse Event|0|||
155099836|NCT01791517|559799208|FG002|Phase II|Adverse Event|0|||
155099837|NCT01791517|559799209|FG003|Phase II|Adverse Event|0|||
154835059|NCT02819635|558831745|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
155099838|NCT01791517|559799210|FG004|Phase II|Adverse Event|0|||
155099839|NCT01791517|559799211|FG005|Phase II|Adverse Event|0|||
155099840|NCT01791517|559799212|FG006|Phase II|Adverse Event|2|||
155099841|NCT01791517|559799213|FG007|Phase II|Adverse Event|1|||
155099842|NCT01791517|559799214|FG008|Phase II|Adverse Event|0|||
155099843|NCT01791517|559799215|FG009|Phase II|Adverse Event|1|||
155099844|NCT01791517|559799216|FG010|Phase II|Adverse Event|0|||
155099845|NCT01791517|559799217|FG011|Phase II|Adverse Event|0|||
155099846|NCT01791517|559799206|FG000|Phase II|Lens Handling Difficulties|0|||
155099847|NCT01791517|559799207|FG001|Phase II|Lens Handling Difficulties|0|||
155099848|NCT01791517|559799208|FG002|Phase II|Lens Handling Difficulties|0|||
155099849|NCT01791517|559799209|FG003|Phase II|Lens Handling Difficulties|0|||
155099850|NCT01791517|559799210|FG004|Phase II|Lens Handling Difficulties|0|||
155099851|NCT01791517|559799211|FG005|Phase II|Lens Handling Difficulties|0|||
155099852|NCT01791517|559799212|FG006|Phase II|Lens Handling Difficulties|0|||
155099853|NCT01791517|559799213|FG007|Phase II|Lens Handling Difficulties|0|||
155099854|NCT01791517|559799214|FG008|Phase II|Lens Handling Difficulties|1|||
155099855|NCT01791517|559799215|FG009|Phase II|Lens Handling Difficulties|0|||
155099856|NCT01791517|559799216|FG010|Phase II|Lens Handling Difficulties|0|||
155099857|NCT01791517|559799217|FG011|Phase II|Lens Handling Difficulties|0|||
155099858|NCT01791517|559799206|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
155099859|NCT01791517|559799207|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
155099860|NCT01791517|559799208|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
155099861|NCT01791517|559799209|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
155099862|NCT01791517|559799210|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
155099863|NCT01791517|559799211|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
155099864|NCT01791517|559799212|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
155099865|NCT01791517|559799213|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
155099866|NCT01791517|559799214|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
155099867|NCT01791517|559799215|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
155099868|NCT01791517|559799216|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
155099869|NCT01791517|559799217|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
155099870|NCT01791517|559799206|FG000|Phase II|Pre-Existing Ocular Issue|0|||
155099871|NCT01791517|559799207|FG001|Phase II|Pre-Existing Ocular Issue|0|||
155099872|NCT01791517|559799208|FG002|Phase II|Pre-Existing Ocular Issue|0|||
155099873|NCT01791517|559799209|FG003|Phase II|Pre-Existing Ocular Issue|0|||
155099874|NCT01791517|559799210|FG004|Phase II|Pre-Existing Ocular Issue|0|||
155099875|NCT01791517|559799211|FG005|Phase II|Pre-Existing Ocular Issue|0|||
155099876|NCT01791517|559799212|FG006|Phase II|Pre-Existing Ocular Issue|0|||
155099877|NCT01791517|559799213|FG007|Phase II|Pre-Existing Ocular Issue|0|||
155099878|NCT01791517|559799214|FG008|Phase II|Pre-Existing Ocular Issue|0|||
155099879|NCT01791517|559799215|FG009|Phase II|Pre-Existing Ocular Issue|0|||
155099880|NCT01791517|559799216|FG010|Phase II|Pre-Existing Ocular Issue|0|||
155099881|NCT01791517|559799217|FG011|Phase II|Pre-Existing Ocular Issue|1|||
155099882|NCT03230318|559799219|FG000|Overall Study|Radiographic disease progression|72|||
155099883|NCT03230318|559799220|FG001|Overall Study|Radiographic disease progression|19|||
155099884|NCT03230318|559799219|FG000|Overall Study|Clinical progression|17|||
155099885|NCT03230318|559799220|FG001|Overall Study|Clinical progression|7|||
155099886|NCT03230318|559799219|FG000|Overall Study|Adverse Event|5|||
155099887|NCT03230318|559799220|FG001|Overall Study|Adverse Event|3|||
155099888|NCT03230318|559799219|FG000|Overall Study|Physician Decision|2|||
155099889|NCT03230318|559799220|FG001|Overall Study|Physician Decision|3|||
155099890|NCT03230318|559799219|FG000|Overall Study|Death|3|||
155099891|NCT03230318|559799220|FG001|Overall Study|Death|2|||
155099892|NCT03230318|559799219|FG000|Overall Study|Lost to Follow-up|1|||
155099893|NCT03230318|559799220|FG001|Overall Study|Lost to Follow-up|0|||
155099894|NCT03230318|559799219|FG000|Overall Study|Withdrawal by Subject|1|||
155099895|NCT03230318|559799220|FG001|Overall Study|Withdrawal by Subject|3|||
155099896|NCT03230318|559799219|FG000|Overall Study|Other|3|||
155099897|NCT03230318|559799220|FG001|Overall Study|Other|7|||
155099898|NCT02141672|559799221|FG000|Overall Study|Adverse Event|0|||
155099899|NCT02141672|559799222|FG001|Overall Study|Adverse Event|1|||
155099900|NCT02141672|559799223|FG002|Overall Study|Adverse Event|0|||
155099901|NCT02141672|559799221|FG000|Overall Study|Death|10|||
155099902|NCT02141672|559799222|FG001|Overall Study|Death|2|||
155099903|NCT02141672|559799223|FG002|Overall Study|Death|1|||
155099904|NCT02141672|559799221|FG000|Overall Study|Lack of Efficacy|0|||
155099905|NCT02141672|559799222|FG001|Overall Study|Lack of Efficacy|0|||
155099906|NCT02141672|559799223|FG002|Overall Study|Lack of Efficacy|2|||
155099907|NCT02141672|559799221|FG000|Overall Study|Lost to Follow-up|1|||
155099908|NCT02141672|559799222|FG001|Overall Study|Lost to Follow-up|1|||
155099909|NCT02141672|559799223|FG002|Overall Study|Lost to Follow-up|3|||
155099910|NCT02141672|559799221|FG000|Overall Study|Physician Decision|1|||
155099911|NCT02141672|559799222|FG001|Overall Study|Physician Decision|2|||
155099912|NCT02141672|559799223|FG002|Overall Study|Physician Decision|5|||
155099913|NCT02141672|559799221|FG000|Overall Study|Protocol Violation|0|||
155099914|NCT02141672|559799222|FG001|Overall Study|Protocol Violation|0|||
154835060|NCT02819635|558831746|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
155099915|NCT02141672|559799223|FG002|Overall Study|Protocol Violation|1|||
155099916|NCT02141672|559799221|FG000|Overall Study|Withdrawal by Subject|3|||
155099917|NCT02141672|559799222|FG001|Overall Study|Withdrawal by Subject|2|||
155099918|NCT02141672|559799223|FG002|Overall Study|Withdrawal by Subject|5|||
155099919|NCT02141672|559799221|FG000|Overall Study|refused to follow-up|1|||
155099920|NCT02141672|559799222|FG001|Overall Study|refused to follow-up|0|||
155099921|NCT02141672|559799223|FG002|Overall Study|refused to follow-up|1|||
155099922|NCT00075764|559799224|FG000|Overall Study|Adverse Event|5|||
155099923|NCT00075764|559799225|FG001|Overall Study|Adverse Event|12|||
155099924|NCT00075764|559799224|FG000|Overall Study|Death|4|||
155099925|NCT00075764|559799225|FG001|Overall Study|Death|8|||
155099926|NCT00075764|559799224|FG000|Overall Study|Withdrawal by Subject|28|||
155099927|NCT00075764|559799225|FG001|Overall Study|Withdrawal by Subject|18|||
155099928|NCT00075764|559799224|FG000|Overall Study|Progression|269|||
155099929|NCT00075764|559799225|FG001|Overall Study|Progression|274|||
155099930|NCT00075764|559799224|FG000|Overall Study|Still on treatment|8|||
155099931|NCT00075764|559799225|FG001|Overall Study|Still on treatment|15|||
155099932|NCT00075764|559799224|FG000|Overall Study|Delinquent|4|||
155099933|NCT00075764|559799225|FG001|Overall Study|Delinquent|2|||
155099934|NCT00075764|559799224|FG000|Overall Study|Not protocol specified|27|||
155099935|NCT00075764|559799225|FG001|Overall Study|Not protocol specified|19|||
155099936|NCT00075764|559799224|FG000|Overall Study|Under review|0|||
155099937|NCT00075764|559799225|FG001|Overall Study|Under review|1|||
155099938|NCT02817594|559799229|FG000|Overall Study|Withdrawal by Subject|1|||
155099939|NCT02817594|559799229|FG000|Overall Study|Other|1|||
155099940|NCT02817594|559799229|FG000|Overall Study|Did Not Receive Treatment|1|||
155099941|NCT02010593|559799230|FG000|Overall Study|Lost to Follow-up|1|||
155099942|NCT02010593|559799231|FG001|Overall Study|Lost to Follow-up|0|||
155099943|NCT02010593|559799230|FG000|Overall Study|Physician Decision|1|||
155099944|NCT02010593|559799231|FG001|Overall Study|Physician Decision|0|||
155099945|NCT02010593|559799230|FG000|Overall Study|Unable to adhere to visit schedule|0|||
155099946|NCT02010593|559799231|FG001|Overall Study|Unable to adhere to visit schedule|2|||
155099947|NCT01773967|559799232|FG000|Overall Study|Lost to Follow-up|15|||
155099948|NCT01773967|559799233|FG001|Overall Study|Lost to Follow-up|13|||
155099949|NCT00739310|559799238|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
155099950|NCT00739310|559799238|FG000|Overall Study|Withdrawal by Subject|1|||
155099951|NCT00739310|559799238|FG000|Overall Study|Lost to Follow-up|2|||
155099952|NCT01492088|559799239|FG000|Overall Study|Withdrawal by Patient|0|||
155099953|NCT01492088|559799240|FG001|Overall Study|Withdrawal by Patient|2|||
155099954|NCT01492088|559799241|FG002|Overall Study|Withdrawal by Patient|0|||
154835061|NCT02819635|558831747|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
155099955|NCT01492088|559799239|FG000|Overall Study|Death|1|||
155099956|NCT01492088|559799240|FG001|Overall Study|Death|6|||
155099957|NCT01492088|559799241|FG002|Overall Study|Death|2|||
155099958|NCT01492088|559799239|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
155099959|NCT01492088|559799240|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
155099960|NCT01492088|559799241|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
154835062|NCT02819635|558831748|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
155099961|NCT01492088|559799239|FG000|Overall Study|Alive at Last Follow-up|0|||
155099962|NCT01492088|559799240|FG001|Overall Study|Alive at Last Follow-up|6|||
155099963|NCT01492088|559799241|FG002|Overall Study|Alive at Last Follow-up|11|||
155099964|NCT02803203|559799242|FG000|Overall Study|Adverse Event|4|||
155099965|NCT02803203|559799242|FG000|Overall Study|Death|4|||
155099966|NCT02803203|559799242|FG000|Overall Study|Progressive disease|29|||
155099967|NCT02803203|559799242|FG000|Overall Study|Withdrawal by Subject|8|||
155099968|NCT02803203|559799242|FG000|Overall Study|Complete resection of target disease|2|||
155099969|NCT02803203|559799242|FG000|Overall Study|Switched to commercial Osi|1|||
155099970|NCT02803203|559799242|FG000|Overall Study|Participant moved away|1|||
155099971|NCT00590967|559799243|FG000|Overall Study|Withdrawal by Subject|1|||
155099972|NCT00590967|559799244|FG001|Overall Study|Withdrawal by Subject|1|||
154835063|NCT02819635|558831737|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835064|NCT02819635|558831738|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835065|NCT02819635|558831739|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835066|NCT02819635|558831740|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835067|NCT02819635|558831741|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835068|NCT02819635|558831742|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835069|NCT02819635|558831743|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
154835070|NCT02819635|558831744|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
155099973|NCT00590967|559799243|FG000|Overall Study|Ineligible|1|||
155099974|NCT00590967|559799244|FG001|Overall Study|Ineligible|0|||
155099975|NCT00590967|559799243|FG000|Overall Study|Poor performance status|0|||
155099976|NCT00590967|559799244|FG001|Overall Study|Poor performance status|1|||
155099977|NCT00590967|559799243|FG000|Overall Study|Non-compliant|0|||
155099978|NCT00590967|559799244|FG001|Overall Study|Non-compliant|2|||
154835071|NCT02819635|558831745|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835072|NCT02819635|558831746|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835073|NCT02819635|558831747|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835074|NCT02819635|558831748|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
154835075|NCT02819635|558831737|FG000|Substudy 2, Part 2|Other, not specified|0|||
154835076|NCT02819635|558831738|FG001|Substudy 2, Part 2|Other, not specified|0|||
154835077|NCT02819635|558831739|FG002|Substudy 2, Part 2|Other, not specified|0|||
154835078|NCT02819635|558831740|FG003|Substudy 2, Part 2|Other, not specified|0|||
154835079|NCT02819635|558831741|FG004|Substudy 2, Part 2|Other, not specified|0|||
154835080|NCT02819635|558831742|FG005|Substudy 2, Part 2|Other, not specified|4|||
154835081|NCT02819635|558831743|FG006|Substudy 2, Part 2|Other, not specified|8|||
154835082|NCT02819635|558831744|FG007|Substudy 2, Part 2|Other, not specified|0|||
154835083|NCT02819635|558831745|FG008|Substudy 2, Part 2|Other, not specified|0|||
154835084|NCT02819635|558831746|FG009|Substudy 2, Part 2|Other, not specified|0|||
154835085|NCT02819635|558831747|FG010|Substudy 2, Part 2|Other, not specified|0|||
154835086|NCT02819635|558831748|FG011|Substudy 2, Part 2|Other, not specified|0|||
154835087|NCT02819635|558831737|FG000|Substudy 3|Adverse Event|0|||
154835088|NCT02819635|558831738|FG001|Substudy 3|Adverse Event|0|||
154835089|NCT02819635|558831739|FG002|Substudy 3|Adverse Event|0|||
154835090|NCT02819635|558831740|FG003|Substudy 3|Adverse Event|0|||
154835091|NCT02819635|558831741|FG004|Substudy 3|Adverse Event|0|||
154835092|NCT02819635|558831742|FG005|Substudy 3|Adverse Event|0|||
154835093|NCT02819635|558831743|FG006|Substudy 3|Adverse Event|0|||
154835094|NCT02819635|558831744|FG007|Substudy 3|Adverse Event|0|||
154835095|NCT02819635|558831745|FG008|Substudy 3|Adverse Event|32|||
154835096|NCT02819635|558831746|FG009|Substudy 3|Adverse Event|3|||
154835097|NCT02819635|558831747|FG010|Substudy 3|Adverse Event|12|||
154835098|NCT02819635|558831748|FG011|Substudy 3|Adverse Event|18|||
154835099|NCT02819635|558831737|FG000|Substudy 3|Withdrew consent|0|||
154835100|NCT02819635|558831738|FG001|Substudy 3|Withdrew consent|0|||
154835101|NCT02819635|558831739|FG002|Substudy 3|Withdrew consent|0|||
154835102|NCT02819635|558831740|FG003|Substudy 3|Withdrew consent|0|||
155099979|NCT00590967|559799243|FG000|Overall Study|Did not sign consent form|0|||
155099980|NCT00590967|559799244|FG001|Overall Study|Did not sign consent form|1|||
155099981|NCT00590967|559799243|FG000|Overall Study|Did not receive chemo per protocol|1|||
155099982|NCT00590967|559799244|FG001|Overall Study|Did not receive chemo per protocol|0|||
155099983|NCT01881789|559799245|FG000|Overall Study|Withdrawal by Subject|0|||
155099984|NCT01881789|559799246|FG001|Overall Study|Withdrawal by Subject|2|||
155099985|NCT01881789|559799247|FG002|Overall Study|Withdrawal by Subject|1|||
155099986|NCT01881789|559799248|FG003|Overall Study|Withdrawal by Subject|0|||
155099987|NCT01881789|559799249|FG004|Overall Study|Withdrawal by Subject|1|||
155099988|NCT01881789|559799250|FG005|Overall Study|Withdrawal by Subject|1|||
155099989|NCT01881789|559799245|FG000|Overall Study|Study Terminated by Sponsor|0|||
155099990|NCT01881789|559799246|FG001|Overall Study|Study Terminated by Sponsor|0|||
155099991|NCT01881789|559799247|FG002|Overall Study|Study Terminated by Sponsor|0|||
155099992|NCT01881789|559799248|FG003|Overall Study|Study Terminated by Sponsor|0|||
155099993|NCT01881789|559799249|FG004|Overall Study|Study Terminated by Sponsor|0|||
155099994|NCT01881789|559799250|FG005|Overall Study|Study Terminated by Sponsor|1|||
155099995|NCT01881789|559799245|FG000|Overall Study|Other|3|||
155099996|NCT01881789|559799246|FG001|Overall Study|Other|5|||
155099997|NCT01881789|559799247|FG002|Overall Study|Other|2|||
155099998|NCT01881789|559799248|FG003|Overall Study|Other|3|||
155099999|NCT01881789|559799249|FG004|Overall Study|Other|1|||
155100000|NCT01881789|559799250|FG005|Overall Study|Other|1|||
154835103|NCT02819635|558831741|FG004|Substudy 3|Withdrew consent|0|||
154835104|NCT02819635|558831742|FG005|Substudy 3|Withdrew consent|0|||
155100001|NCT01887717|559799251|FG000|Overall Study|Withdrawal by Subject|1|||
154835105|NCT02819635|558831743|FG006|Substudy 3|Withdrew consent|0|||
154835106|NCT02819635|558831744|FG007|Substudy 3|Withdrew consent|0|||
154835107|NCT02819635|558831745|FG008|Substudy 3|Withdrew consent|11|||
154835108|NCT02819635|558831746|FG009|Substudy 3|Withdrew consent|1|||
155100002|NCT01887717|559799252|FG001|Overall Study|Withdrawal by Subject|7|||
155100003|NCT01887717|559799251|FG000|Overall Study|Physician Decision|0|||
155100004|NCT01887717|559799252|FG001|Overall Study|Physician Decision|2|||
155100005|NCT01887717|559799251|FG000|Overall Study|Administrative reasons|5|||
154835109|NCT02819635|558831747|FG010|Substudy 3|Withdrew consent|4|||
154835110|NCT02819635|558831748|FG011|Substudy 3|Withdrew consent|9|||
154835111|NCT02819635|558831737|FG000|Substudy 3|Lost to Follow-up|0|||
154835112|NCT02819635|558831738|FG001|Substudy 3|Lost to Follow-up|0|||
154835113|NCT02819635|558831739|FG002|Substudy 3|Lost to Follow-up|0|||
154835114|NCT02819635|558831740|FG003|Substudy 3|Lost to Follow-up|0|||
154835115|NCT02819635|558831741|FG004|Substudy 3|Lost to Follow-up|0|||
154835116|NCT02819635|558831742|FG005|Substudy 3|Lost to Follow-up|0|||
154835117|NCT02819635|558831743|FG006|Substudy 3|Lost to Follow-up|0|||
154835118|NCT02819635|558831744|FG007|Substudy 3|Lost to Follow-up|0|||
154835119|NCT02819635|558831745|FG008|Substudy 3|Lost to Follow-up|1|||
154835120|NCT02819635|558831746|FG009|Substudy 3|Lost to Follow-up|0|||
154835121|NCT02819635|558831747|FG010|Substudy 3|Lost to Follow-up|1|||
154835122|NCT02819635|558831748|FG011|Substudy 3|Lost to Follow-up|1|||
154835123|NCT02819635|558831737|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835124|NCT02819635|558831738|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835125|NCT02819635|558831739|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835126|NCT02819635|558831740|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835127|NCT02819635|558831741|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835128|NCT02819635|558831742|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835129|NCT02819635|558831743|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835130|NCT02819635|558831744|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835131|NCT02819635|558831745|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835132|NCT02819635|558831746|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835133|NCT02819635|558831747|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
154835134|NCT02819635|558831748|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
154835135|NCT02819635|558831737|FG000|Substudy 3|Other, not specified|0|||
154835136|NCT02819635|558831738|FG001|Substudy 3|Other, not specified|0|||
154835137|NCT02819635|558831739|FG002|Substudy 3|Other, not specified|0|||
154835138|NCT02819635|558831740|FG003|Substudy 3|Other, not specified|0|||
154968922|NCT00486434|559310374|FG000|Overall Study|Withdrawal by Subject|34|||
154968923|NCT00486434|559310375|FG001|Overall Study|Withdrawal by Subject|39|||
154835139|NCT02819635|558831741|FG004|Substudy 3|Other, not specified|0|||
154835140|NCT02819635|558831742|FG005|Substudy 3|Other, not specified|0|||
154835141|NCT02819635|558831743|FG006|Substudy 3|Other, not specified|0|||
154835142|NCT02819635|558831744|FG007|Substudy 3|Other, not specified|0|||
154835143|NCT02819635|558831745|FG008|Substudy 3|Other, not specified|202|||
154835144|NCT02819635|558831746|FG009|Substudy 3|Other, not specified|5|||
155100006|NCT01887717|559799252|FG001|Overall Study|Administrative reasons|2|||
155100007|NCT01299389|559799253|FG000|Double-blind|Adverse Event|45|||
155100008|NCT01299389|559799254|FG001|Double-blind|Adverse Event|27|||
155100009|NCT01299389|559799255|FG002|Double-blind|Adverse Event|0|||
155100010|NCT01299389|559799256|FG003|Double-blind|Adverse Event|0|||
155100011|NCT01299389|559799253|FG000|Double-blind|Lack of Efficacy|45|||
155100012|NCT01299389|559799254|FG001|Double-blind|Lack of Efficacy|21|||
155100013|NCT01299389|559799255|FG002|Double-blind|Lack of Efficacy|0|||
155100014|NCT01299389|559799256|FG003|Double-blind|Lack of Efficacy|0|||
155100015|NCT01299389|559799253|FG000|Double-blind|Lost to Follow-up|2|||
155100016|NCT01299389|559799254|FG001|Double-blind|Lost to Follow-up|1|||
155100017|NCT01299389|559799255|FG002|Double-blind|Lost to Follow-up|0|||
155100018|NCT01299389|559799256|FG003|Double-blind|Lost to Follow-up|0|||
155100019|NCT01299389|559799253|FG000|Double-blind|Withdrawal by Subject|16|||
155100020|NCT01299389|559799254|FG001|Double-blind|Withdrawal by Subject|13|||
155100021|NCT01299389|559799255|FG002|Double-blind|Withdrawal by Subject|0|||
155100022|NCT01299389|559799256|FG003|Double-blind|Withdrawal by Subject|0|||
155100023|NCT01299389|559799253|FG000|Double-blind|Other|1|||
155100024|NCT01299389|559799254|FG001|Double-blind|Other|1|||
155100025|NCT01299389|559799255|FG002|Double-blind|Other|0|||
155100026|NCT01299389|559799256|FG003|Double-blind|Other|0|||
155100027|NCT01299389|559799253|FG000|Double-blind|"fail to meet study population criteria"|0|||
155100028|NCT01299389|559799254|FG001|Double-blind|"fail to meet study population criteria"|1|||
155100029|NCT01299389|559799255|FG002|Double-blind|"fail to meet study population criteria"|0|||
155100030|NCT01299389|559799256|FG003|Double-blind|"fail to meet study population criteria"|0|||
155100031|NCT01299389|559799253|FG000|Post-observational|Other|0|||
155100032|NCT01299389|559799254|FG001|Post-observational|Other|0|||
155100033|NCT01299389|559799255|FG002|Post-observational|Other|12|||
155100034|NCT01299389|559799256|FG003|Post-observational|Other|6|||
155100035|NCT00889707|559799258|FG000|Overall Study|Adverse Event|1|||
155100036|NCT00889707|559799259|FG001|Overall Study|Adverse Event|0|||
155100037|NCT00889707|559799258|FG000|Overall Study|Withdrawal by Subject|4|||
155100038|NCT00889707|559799259|FG001|Overall Study|Withdrawal by Subject|3|||
155100039|NCT00889707|559799258|FG000|Overall Study|Lost to Follow-up|0|||
155100040|NCT00889707|559799259|FG001|Overall Study|Lost to Follow-up|2|||
155100041|NCT00889707|559799258|FG000|Overall Study|Lack of Efficacy|2|||
155100042|NCT00889707|559799259|FG001|Overall Study|Lack of Efficacy|5|||
155100043|NCT02185534|559799260|FG000|First Period|Withdrawal by Subject|0|||
155100044|NCT02185534|559799261|FG001|First Period|Withdrawal by Subject|0|||
155100045|NCT02185534|559799262|FG002|First Period|Withdrawal by Subject|0|||
155100046|NCT02185534|559799263|FG003|First Period|Withdrawal by Subject|1|||
155100047|NCT02185534|559799264|FG004|First Period|Withdrawal by Subject|0|||
155100048|NCT02185534|559799265|FG005|First Period|Withdrawal by Subject|0|||
155100049|NCT02185534|559799260|FG000|First Washout Period|Withdrawal by Subject|1|||
155100050|NCT02185534|559799261|FG001|First Washout Period|Withdrawal by Subject|0|||
155100051|NCT02185534|559799262|FG002|First Washout Period|Withdrawal by Subject|0|||
155100052|NCT02185534|559799263|FG003|First Washout Period|Withdrawal by Subject|0|||
155100053|NCT02185534|559799264|FG004|First Washout Period|Withdrawal by Subject|1|||
155100054|NCT02185534|559799265|FG005|First Washout Period|Withdrawal by Subject|0|||
155100055|NCT02185534|559799260|FG000|First Washout Period|Protocol Violation|0|||
155100056|NCT02185534|559799261|FG001|First Washout Period|Protocol Violation|0|||
155100057|NCT02185534|559799262|FG002|First Washout Period|Protocol Violation|0|||
155100058|NCT02185534|559799263|FG003|First Washout Period|Protocol Violation|0|||
155100059|NCT02185534|559799264|FG004|First Washout Period|Protocol Violation|0|||
155100060|NCT02185534|559799265|FG005|First Washout Period|Protocol Violation|1|||
155100061|NCT01151020|559799266|FG000|Overall Study|Death|25|||
155100062|NCT01151020|559799266|FG000|Overall Study|Conversion to open repair|1|||
154835145|NCT02819635|558831747|FG010|Substudy 3|Other, not specified|89|||
155100063|NCT01151020|559799266|FG000|Overall Study|Lost to Follow-up|4|||
155100064|NCT01151020|559799266|FG000|Overall Study|Withdrawal by Subject|22|||
155100065|NCT01151020|559799266|FG000|Overall Study|Patients did not receive the device|2|||
155100066|NCT01635998|559799267|FG000|Overall Study|Death|1|||
155100067|NCT01635998|559799268|FG001|Overall Study|Death|1|||
155100068|NCT01635998|559799267|FG000|Overall Study|Lost to Follow-up|2|||
155100069|NCT01635998|559799268|FG001|Overall Study|Lost to Follow-up|1|||
155100070|NCT01635998|559799267|FG000|Overall Study|Withdrawal by Subject|1|||
155100071|NCT01635998|559799268|FG001|Overall Study|Withdrawal by Subject|5|||
155100072|NCT04419467|559799269|FG000|Overall Study|Not treated with IP|0|||
155100073|NCT04419467|559799270|FG001|Overall Study|Not treated with IP|0|||
155100074|NCT04419467|559799271|FG002|Overall Study|Not treated with IP|2|||
155100075|NCT04419467|559799269|FG000|Overall Study|Adverse Event|0|||
155100076|NCT04419467|559799270|FG001|Overall Study|Adverse Event|2|||
155100077|NCT04419467|559799271|FG002|Overall Study|Adverse Event|0|||
155100078|NCT04419467|559799269|FG000|Overall Study|Death|1|||
155100079|NCT04419467|559799270|FG001|Overall Study|Death|0|||
155100080|NCT04419467|559799271|FG002|Overall Study|Death|0|||
155100081|NCT04419467|559799269|FG000|Overall Study|Lost to Follow-up|0|||
155100082|NCT04419467|559799270|FG001|Overall Study|Lost to Follow-up|1|||
155100083|NCT04419467|559799271|FG002|Overall Study|Lost to Follow-up|2|||
155100084|NCT04419467|559799269|FG000|Overall Study|Withdrawal by Subject|0|||
155100085|NCT04419467|559799270|FG001|Overall Study|Withdrawal by Subject|0|||
155100086|NCT04419467|559799271|FG002|Overall Study|Withdrawal by Subject|4|||
155100087|NCT04419467|559799269|FG000|Overall Study|Pandemic related|0|||
155100088|NCT04419467|559799270|FG001|Overall Study|Pandemic related|0|||
155100089|NCT04419467|559799271|FG002|Overall Study|Pandemic related|1|||
155100090|NCT04419467|559799269|FG000|Overall Study|Reason not known|1|||
155100091|NCT04419467|559799270|FG001|Overall Study|Reason not known|0|||
155100092|NCT04419467|559799271|FG002|Overall Study|Reason not known|0|||
155100093|NCT00600067|559799276|FG000|Overall Study|Adverse Event|0|||
155100094|NCT00600067|559799277|FG001|Overall Study|Adverse Event|1|||
155100095|NCT00600067|559799276|FG000|Overall Study|Lost to Follow-up|2|||
155100096|NCT00600067|559799277|FG001|Overall Study|Lost to Follow-up|3|||
155100097|NCT00600067|559799276|FG000|Overall Study|protocol non-compliance|0|||
155100098|NCT00600067|559799277|FG001|Overall Study|protocol non-compliance|3|||
155100099|NCT00600067|559799276|FG000|Overall Study|Lack of Efficacy|1|||
155100100|NCT00600067|559799277|FG001|Overall Study|Lack of Efficacy|0|||
155100101|NCT00003631|559799278|FG000|Overall Study|Patient not treated|1|||
155100102|NCT00003631|559799279|FG001|Overall Study|Patient not treated|0|||
155100103|NCT00003631|559799280|FG002|Overall Study|Patient not treated|1|||
155100104|NCT00003631|559799278|FG000|Overall Study|Protocol Violation|1|||
155100105|NCT00003631|559799279|FG001|Overall Study|Protocol Violation|0|||
155100106|NCT00003631|559799280|FG002|Overall Study|Protocol Violation|0|||
155100107|NCT00003631|559799278|FG000|Overall Study|Adverse Event|1|||
155100108|NCT00003631|559799279|FG001|Overall Study|Adverse Event|1|||
155100109|NCT00003631|559799280|FG002|Overall Study|Adverse Event|5|||
155100110|NCT00003631|559799278|FG000|Overall Study|Death|0|||
155100111|NCT00003631|559799279|FG001|Overall Study|Death|0|||
155100112|NCT00003631|559799280|FG002|Overall Study|Death|1|||
155100113|NCT00003631|559799278|FG000|Overall Study|Evaluable for toxicity only|0|||
155100114|NCT00003631|559799279|FG001|Overall Study|Evaluable for toxicity only|0|||
155100115|NCT00003631|559799280|FG002|Overall Study|Evaluable for toxicity only|2|||
155100116|NCT03943290|559799291|FG000|Overall Study|Sponsor Terminated Study|6|||
155100117|NCT03943290|559799292|FG001|Overall Study|Sponsor Terminated Study|1|||
155100118|NCT03943290|559799293|FG002|Overall Study|Sponsor Terminated Study|11|||
155100119|NCT03943290|559799294|FG003|Overall Study|Sponsor Terminated Study|6|||
155100120|NCT03943290|559799295|FG004|Overall Study|Sponsor Terminated Study|7|||
155100121|NCT03943290|559799296|FG005|Overall Study|Sponsor Terminated Study|6|||
155100122|NCT03943290|559799297|FG006|Overall Study|Sponsor Terminated Study|6|||
155100123|NCT03943290|559799298|FG007|Overall Study|Sponsor Terminated Study|7|||
155100124|NCT03943290|559799299|FG008|Overall Study|Sponsor Terminated Study|8|||
155100125|NCT03943290|559799291|FG000|Overall Study|Lost to Follow-up|1|||
155100126|NCT03943290|559799292|FG001|Overall Study|Lost to Follow-up|0|||
155100127|NCT03943290|559799293|FG002|Overall Study|Lost to Follow-up|1|||
155100128|NCT03943290|559799294|FG003|Overall Study|Lost to Follow-up|0|||
155100129|NCT03943290|559799295|FG004|Overall Study|Lost to Follow-up|0|||
155100130|NCT03943290|559799296|FG005|Overall Study|Lost to Follow-up|0|||
155100131|NCT03943290|559799297|FG006|Overall Study|Lost to Follow-up|0|||
155100132|NCT03943290|559799298|FG007|Overall Study|Lost to Follow-up|1|||
155100133|NCT03943290|559799299|FG008|Overall Study|Lost to Follow-up|0|||
155100134|NCT03943290|559799291|FG000|Overall Study|Withdrawal by Subject|0|||
155100135|NCT03943290|559799292|FG001|Overall Study|Withdrawal by Subject|0|||
155100136|NCT03943290|559799293|FG002|Overall Study|Withdrawal by Subject|1|||
155100137|NCT03943290|559799294|FG003|Overall Study|Withdrawal by Subject|0|||
155100138|NCT03943290|559799295|FG004|Overall Study|Withdrawal by Subject|0|||
155100139|NCT03943290|559799296|FG005|Overall Study|Withdrawal by Subject|0|||
155100140|NCT03943290|559799297|FG006|Overall Study|Withdrawal by Subject|0|||
155100141|NCT03943290|559799298|FG007|Overall Study|Withdrawal by Subject|0|||
155100142|NCT03943290|559799299|FG008|Overall Study|Withdrawal by Subject|0|||
155100143|NCT00657267|559799307|FG000|Overall Study|Progressive disease|45|||
155100144|NCT00657267|559799307|FG000|Overall Study|Adverse Event|9|||
155100145|NCT02737501|559799308|FG000|Randomized Phase|Died|41|||
155100146|NCT02737501|559799309|FG001|Randomized Phase|Died|29|||
155100147|NCT02737501|559799310|FG002|Randomized Phase|Died|0|||
155100148|NCT02737501|559799308|FG000|Randomized Phase|Withdrawal by Subject|16|||
155100149|NCT02737501|559799309|FG001|Randomized Phase|Withdrawal by Subject|6|||
155100150|NCT02737501|559799310|FG002|Randomized Phase|Withdrawal by Subject|0|||
155100151|NCT02737501|559799308|FG000|Randomized Phase|Lost to Follow-up|0|||
155100152|NCT02737501|559799309|FG001|Randomized Phase|Lost to Follow-up|1|||
155100153|NCT02737501|559799310|FG002|Randomized Phase|Lost to Follow-up|0|||
155100154|NCT02737501|559799308|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
155100155|NCT02737501|559799309|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
155100156|NCT02737501|559799310|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
155100157|NCT02737501|559799308|FG000|Randomized Phase|Reason not Specified|1|||
155100158|NCT02737501|559799309|FG001|Randomized Phase|Reason not Specified|1|||
155100159|NCT02737501|559799310|FG002|Randomized Phase|Reason not Specified|0|||
155100160|NCT02737501|559799308|FG000|Randomized Phase|Never Treated|1|||
155100161|NCT02737501|559799309|FG001|Randomized Phase|Never Treated|1|||
155100162|NCT02737501|559799310|FG002|Randomized Phase|Never Treated|0|||
155100163|NCT02737501|559799308|FG000|Crossover Phase|Died|0|||
155100164|NCT02737501|559799309|FG001|Crossover Phase|Died|0|||
155100165|NCT02737501|559799310|FG002|Crossover Phase|Died|22|||
155100166|NCT02737501|559799308|FG000|Crossover Phase|Withdrew Consent|0|||
154968924|NCT00486434|559310374|FG000|Overall Study|Adverse Event|118|||
154968925|NCT00486434|559310375|FG001|Overall Study|Adverse Event|44|||
154968926|NCT00486434|559310374|FG000|Overall Study|Protocol Violation|22|||
154968927|NCT00486434|559310375|FG001|Overall Study|Protocol Violation|21|||
154968928|NCT00486434|559310374|FG000|Overall Study|Lack of Efficacy|12|||
154968929|NCT00486434|559310375|FG001|Overall Study|Lack of Efficacy|19|||
154968930|NCT00486434|559310374|FG000|Overall Study|Lost to Follow-up|2|||
154968931|NCT00486434|559310375|FG001|Overall Study|Lost to Follow-up|3|||
154968932|NCT00486434|559310374|FG000|Overall Study|Death|1|||
154968933|NCT00486434|559310375|FG001|Overall Study|Death|2|||
154968934|NCT00486434|559310374|FG000|Overall Study|Personal reasons|5|||
154968935|NCT00486434|559310375|FG001|Overall Study|Personal reasons|6|||
155100167|NCT02737501|559799309|FG001|Crossover Phase|Withdrew Consent|0|||
155100168|NCT02737501|559799310|FG002|Crossover Phase|Withdrew Consent|9|||
155100169|NCT02737501|559799308|FG000|Crossover Phase|Physician Decision|0|||
155100170|NCT02737501|559799309|FG001|Crossover Phase|Physician Decision|0|||
155100171|NCT02737501|559799310|FG002|Crossover Phase|Physician Decision|1|||
155100172|NCT02737501|559799308|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
155100173|NCT02737501|559799309|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
155100174|NCT02737501|559799310|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
154968936|NCT02218541|559310376|FG000|Overall Study|Lost to Follow-up|2|||
154968937|NCT02218541|559310377|FG001|Overall Study|Lost to Follow-up|1|||
154968938|NCT02218541|559310376|FG000|Overall Study|Implant Failure|4|||
155100175|NCT03069716|559799313|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
155100176|NCT03069716|559799314|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
155100177|NCT03069716|559799315|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
155100178|NCT03069716|559799313|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
155100179|NCT03069716|559799314|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
155100180|NCT03069716|559799315|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
155100181|NCT03069716|559799313|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
155100182|NCT03069716|559799314|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
155100183|NCT03069716|559799315|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
154835146|NCT02819635|558831748|FG011|Substudy 3|Other, not specified|39|||
155100184|NCT03069716|559799313|FG000|Randomized Treatment|Withdrawal by Subject|0|||
154835147|NCT01476475|558831749|FG000|Overall Study|Adverse Event|6|||
154835148|NCT01476475|558831750|FG001|Overall Study|Adverse Event|0|||
154835149|NCT01476475|558831749|FG000|Overall Study|Poor compliance to protocol|1|||
154835150|NCT01476475|558831750|FG001|Overall Study|Poor compliance to protocol|1|||
154835151|NCT01476475|558831749|FG000|Overall Study|Other reasons|4|||
154835152|NCT01476475|558831750|FG001|Overall Study|Other reasons|2|||
154835153|NCT00441974|558831751|FG000|Overall Study|Adverse Event|6|||
154835154|NCT00441974|558831751|FG000|Overall Study|Consent Withdrawn|35|||
154835155|NCT00441974|558831751|FG000|Overall Study|Lost to Follow-up|80|||
154835156|NCT00441974|558831751|FG000|Overall Study|Protocol Violation|7|||
154835157|NCT01146873|558831759|FG000|Overall Study|Transfer out|0|||
154835158|NCT01146873|558831760|FG001|Overall Study|Transfer out|6|||
154835159|NCT02055820|558831763|FG000|Phase I: Dose-Finding|Death|1|||
154968939|NCT02218541|559310377|FG001|Overall Study|Implant Failure|1|||
154968940|NCT02578641|559310378|FG000|Overall Study|Adverse Event|5|||
155100185|NCT03069716|559799314|FG001|Randomized Treatment|Withdrawal by Subject|2|||
155100186|NCT03069716|559799315|FG002|Randomized Treatment|Withdrawal by Subject|0|||
154835160|NCT02055820|558831764|FG001|Phase I: Dose-Finding|Death|0|||
154835161|NCT02055820|558831765|FG002|Phase I: Dose-Finding|Death|1|||
154968941|NCT02578641|559310379|FG001|Overall Study|Adverse Event|15|||
154968942|NCT02578641|559310378|FG000|Overall Study|Death|16|||
154968943|NCT02578641|559310379|FG001|Overall Study|Death|8|||
154968944|NCT02578641|559310378|FG000|Overall Study|Lost to Follow-up|0|||
154968945|NCT02578641|559310379|FG001|Overall Study|Lost to Follow-up|1|||
154968946|NCT02578641|559310378|FG000|Overall Study|Withdrawal by Subject|14|||
154968947|NCT02578641|559310379|FG001|Overall Study|Withdrawal by Subject|7|||
154968948|NCT02578641|559310378|FG000|Overall Study|Progressive Disease|69|||
154968949|NCT02578641|559310379|FG001|Overall Study|Progressive Disease|21|||
154968950|NCT02578641|559310378|FG000|Overall Study|No Study Drug|2|||
154968951|NCT02578641|559310379|FG001|Overall Study|No Study Drug|0|||
154968952|NCT02578641|559310378|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
154968953|NCT02578641|559310379|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
154968954|NCT02578641|559310378|FG000|Overall Study|Non-compliance with Study Schedule|1|||
154968955|NCT02578641|559310379|FG001|Overall Study|Non-compliance with Study Schedule|0|||
154968956|NCT02578641|559310378|FG000|Overall Study|Other|1|||
154835162|NCT02055820|558831766|FG003|Phase I: Dose-Finding|Death|2|||
154968957|NCT02578641|559310379|FG001|Overall Study|Other|10|||
155100187|NCT01673126|559799316|FG000|Overall Study|change of diagnosis|4|||
154968958|NCT02578641|559310378|FG000|Overall Study|Not treated|1|||
154968959|NCT02578641|559310379|FG001|Overall Study|Not treated|4|||
154968960|NCT00856349|559310380|FG000|Overall Study|Death|418|||
154968961|NCT00856349|559310380|FG000|Overall Study|Withdrawal by Subject|116|||
154968962|NCT00856349|559310380|FG000|Overall Study|Lost to Follow-up|91|||
154968963|NCT00856349|559310380|FG000|Overall Study|Protocol Violation|38|||
154968964|NCT00856349|559310380|FG000|Overall Study|Physician Decision|13|||
154968965|NCT00856349|559310380|FG000|Overall Study|Subject relocation|104|||
154968966|NCT00856349|559310380|FG000|Overall Study|Device explant|33|||
154968967|NCT00856349|559310380|FG000|Overall Study|Site closure|78|||
154968968|NCT00856349|559310380|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
154968969|NCT02725515|559310381|FG000|Overall Study|Refused infusion (no study treatment)|1|||
154968970|NCT02725515|559310382|FG001|Overall Study|Refused infusion (no study treatment)|0|||
154968971|NCT02725515|559310381|FG000|Overall Study|Loss of Improvement per Protocol|14|||
154968972|NCT02725515|559310382|FG001|Overall Study|Loss of Improvement per Protocol|25|||
154968973|NCT02725515|559310381|FG000|Overall Study|Withdrawal by Subject|2|||
154968974|NCT02725515|559310382|FG001|Overall Study|Withdrawal by Subject|1|||
154968975|NCT02725515|559310381|FG000|Overall Study|Non-Compliance With Study Drug|0|||
154968976|NCT02725515|559310382|FG001|Overall Study|Non-Compliance With Study Drug|3|||
154968977|NCT02725515|559310381|FG000|Overall Study|Lost to Follow-up|1|||
154968978|NCT02725515|559310382|FG001|Overall Study|Lost to Follow-up|1|||
154968979|NCT02725515|559310381|FG000|Overall Study|Adverse Event|7|||
154968980|NCT02725515|559310382|FG001|Overall Study|Adverse Event|2|||
154968981|NCT02725515|559310381|FG000|Overall Study|No Documented Disease Improvement|0|||
154968982|NCT02725515|559310382|FG001|Overall Study|No Documented Disease Improvement|1|||
154968983|NCT02725515|559310381|FG000|Overall Study|Completed Study Under Original Protocol|0|||
154968984|NCT02725515|559310382|FG001|Overall Study|Completed Study Under Original Protocol|1|||
154968985|NCT02725515|559310381|FG000|Overall Study|Lack of Response|0|||
154968986|NCT02725515|559310382|FG001|Overall Study|Lack of Response|1|||
154968987|NCT00183196|559310388|FG000|Overall Study|Withdrawal by Subject|18|||
154968988|NCT00183196|559310389|FG001|Overall Study|Withdrawal by Subject|11|||
154968989|NCT00183196|559310390|FG002|Overall Study|Withdrawal by Subject|13|||
154968990|NCT00183196|559310388|FG000|Overall Study|Adverse Event|1|||
154968991|NCT00183196|559310389|FG001|Overall Study|Adverse Event|2|||
154968992|NCT00183196|559310390|FG002|Overall Study|Adverse Event|2|||
154968993|NCT00183196|559310388|FG000|Overall Study|Legal event|1|||
154968994|NCT00183196|559310389|FG001|Overall Study|Legal event|1|||
155100188|NCT01673126|559799317|FG001|Overall Study|change of diagnosis|3|||
155100189|NCT00237042|559799320|FG000|Treatment|Became ineligible post-randomization|0|||
155100190|NCT00237042|559799321|FG001|Treatment|Became ineligible post-randomization|1|||
155100191|NCT00237042|559799322|FG002|Treatment|Became ineligible post-randomization|16|||
155100192|NCT00237042|559799320|FG000|Treatment|Moved out of state|1|||
155100193|NCT00237042|559799321|FG001|Treatment|Moved out of state|1|||
155100194|NCT00237042|559799322|FG002|Treatment|Moved out of state|1|||
155100195|NCT00237042|559799320|FG000|Treatment|Completed no treatment|5|||
155100196|NCT00237042|559799321|FG001|Treatment|Completed no treatment|5|||
155100197|NCT00237042|559799322|FG002|Treatment|Completed no treatment|21|||
155100198|NCT00237042|559799320|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
155100199|NCT00237042|559799321|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
155100200|NCT00237042|559799322|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
155100201|NCT00237042|559799320|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
155100202|NCT00237042|559799321|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
155100203|NCT00237042|559799322|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
155100204|NCT01913327|559799325|FG000|Overall Study|Withdrawal by Subject|0|||
155100205|NCT01913327|559799326|FG001|Overall Study|Withdrawal by Subject|1|||
155100206|NCT03132467|559799327|FG000|Overall Study|Adverse Event|2|||
155100207|NCT03132467|559799327|FG000|Overall Study|Withdrawal by Subject|2|||
154968995|NCT00183196|559310390|FG002|Overall Study|Legal event|1|||
154968996|NCT00183196|559310388|FG000|Overall Study|Required more intensive care|0|||
154968997|NCT00183196|559310389|FG001|Overall Study|Required more intensive care|1|||
154968998|NCT00183196|559310390|FG002|Overall Study|Required more intensive care|2|||
154968999|NCT02694536|559310391|FG000|Overall Study|Progressive Disease|40|||
154969000|NCT02694536|559310391|FG000|Overall Study|Lost to Follow-up|1|||
155100208|NCT02964273|559800624|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
154969001|NCT02694536|559310391|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
154969002|NCT02694536|559310391|FG000|Overall Study|Withdrawal by Subject|8|||
154969003|NCT02694536|559310391|FG000|Overall Study|Death|8|||
154969004|NCT02694536|559310391|FG000|Overall Study|Other|22|||
155100209|NCT02964273|559800625|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
155100210|NCT02964273|559800626|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
155100211|NCT02964273|559800627|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
155100212|NCT02964273|559800624|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
155100213|NCT02964273|559800625|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
155100214|NCT02964273|559800626|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
155100215|NCT02964273|559800627|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
155100216|NCT02964273|559800624|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
155100217|NCT02964273|559800625|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
155100218|NCT02964273|559800626|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
155100219|NCT02964273|559800627|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
155100220|NCT02964273|559800624|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
155100221|NCT02964273|559800625|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
155100222|NCT02964273|559800626|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
155100223|NCT02964273|559800627|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
154835163|NCT02055820|558831767|FG004|Phase I: Dose-Finding|Death|0|||
154835164|NCT02055820|558831768|FG005|Phase I: Dose-Finding|Death|1|||
154835165|NCT02055820|558831769|FG006|Phase I: Dose-Finding|Death|1|||
154835166|NCT02055820|558831770|FG007|Phase I: Dose-Finding|Death|0|||
154835167|NCT02055820|558831771|FG008|Phase I: Dose-Finding|Death|0|||
154835168|NCT02055820|558831772|FG009|Phase I: Dose-Finding|Death|0|||
155100224|NCT02964273|559800624|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
155100225|NCT02964273|559800625|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
155100226|NCT02964273|559800626|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
155100227|NCT02964273|559800627|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
155100228|NCT02964273|559800624|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
155100229|NCT02964273|559800625|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
155100230|NCT02964273|559800626|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
155100231|NCT02964273|559800627|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
154835169|NCT02055820|558831763|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835170|NCT02055820|558831764|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835171|NCT02055820|558831765|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835172|NCT02055820|558831766|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835173|NCT02055820|558831767|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835174|NCT02055820|558831768|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
154835175|NCT02055820|558831769|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835176|NCT02055820|558831770|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835177|NCT02055820|558831771|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835178|NCT02055820|558831772|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
154835179|NCT02055820|558831763|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835180|NCT02055820|558831764|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835181|NCT02055820|558831765|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835182|NCT02055820|558831766|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
154835183|NCT02055820|558831767|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835184|NCT02055820|558831768|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835185|NCT02055820|558831769|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
154835186|NCT02055820|558831770|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835187|NCT02055820|558831771|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835188|NCT02055820|558831772|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
154835189|NCT02055820|558831763|FG000|Phase II: Expansion|Death|0|||
154835190|NCT02055820|558831764|FG001|Phase II: Expansion|Death|0|||
154835191|NCT02055820|558831765|FG002|Phase II: Expansion|Death|0|||
154835192|NCT02055820|558831766|FG003|Phase II: Expansion|Death|0|||
154835193|NCT02055820|558831767|FG004|Phase II: Expansion|Death|33|||
154835194|NCT02055820|558831768|FG005|Phase II: Expansion|Death|0|||
154835195|NCT02055820|558831769|FG006|Phase II: Expansion|Death|0|||
154835196|NCT02055820|558831770|FG007|Phase II: Expansion|Death|0|||
154835197|NCT02055820|558831771|FG008|Phase II: Expansion|Death|0|||
154835198|NCT02055820|558831772|FG009|Phase II: Expansion|Death|0|||
154835199|NCT02055820|558831763|FG000|Phase II: Expansion|Lost to Follow-up|0|||
154969005|NCT03358147|559310393|FG000|Overall Study|Withdrawal by Subject|13|||
155100232|NCT01336712|559800629|FG000|Overall Study|Death|2|||
155172693|NCT03158285|560071881|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
154835200|NCT02055820|558831764|FG001|Phase II: Expansion|Lost to Follow-up|0|||
154835201|NCT02055820|558831765|FG002|Phase II: Expansion|Lost to Follow-up|0|||
154835202|NCT02055820|558831766|FG003|Phase II: Expansion|Lost to Follow-up|0|||
154835203|NCT02055820|558831767|FG004|Phase II: Expansion|Lost to Follow-up|4|||
154835204|NCT02055820|558831768|FG005|Phase II: Expansion|Lost to Follow-up|0|||
154835205|NCT02055820|558831769|FG006|Phase II: Expansion|Lost to Follow-up|0|||
154835206|NCT02055820|558831770|FG007|Phase II: Expansion|Lost to Follow-up|0|||
154835207|NCT02055820|558831771|FG008|Phase II: Expansion|Lost to Follow-up|0|||
154835208|NCT02055820|558831772|FG009|Phase II: Expansion|Lost to Follow-up|0|||
154835209|NCT02055820|558831763|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
154835210|NCT02055820|558831764|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
154835211|NCT02055820|558831765|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
154835212|NCT02055820|558831766|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
154835213|NCT02055820|558831767|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
154835214|NCT02055820|558831768|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
154835215|NCT02055820|558831769|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
154835216|NCT02055820|558831770|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
154835217|NCT02055820|558831771|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
154835218|NCT02055820|558831772|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
154835219|NCT00631020|558831775|FG000|Overall Study|Lost to Follow-up|7|||
154835220|NCT00631020|558831775|FG000|Overall Study|Incarcerated|1|||
154835221|NCT02614859|558831777|FG000|Overall Study|Physician Decision|0|||
154835222|NCT02614859|558831778|FG001|Overall Study|Physician Decision|1|||
154835223|NCT03548935|558831779|FG000|Overall Study|Withdrawal by Subject|26|||
154835224|NCT03548935|558831780|FG001|Overall Study|Withdrawal by Subject|17|||
154835225|NCT03548935|558831779|FG000|Overall Study|Lost to Follow-up|39|||
154835226|NCT03548935|558831780|FG001|Overall Study|Lost to Follow-up|28|||
154835227|NCT03548935|558831779|FG000|Overall Study|Death|1|||
154835228|NCT03548935|558831780|FG001|Overall Study|Death|1|||
154835229|NCT04677959|558831781|FG000|Overall Study|Adverse Event|1|||
154835230|NCT04677959|558831782|FG001|Overall Study|Adverse Event|9|||
154835231|NCT04677959|558831781|FG000|Overall Study|Withdrawal by Subject|2|||
154835232|NCT04677959|558831782|FG001|Overall Study|Withdrawal by Subject|15|||
154835233|NCT04677959|558831781|FG000|Overall Study|Withdrawal by parent/guardian|0|||
154835234|NCT04677959|558831782|FG001|Overall Study|Withdrawal by parent/guardian|1|||
154835235|NCT04677959|558831781|FG000|Overall Study|Non-compliance with study drug|0|||
154835236|NCT04677959|558831782|FG001|Overall Study|Non-compliance with study drug|2|||
154835237|NCT04677959|558831781|FG000|Overall Study|Protocol deviation|0|||
154835238|NCT04677959|558831782|FG001|Overall Study|Protocol deviation|11|||
154835239|NCT04677959|558831781|FG000|Overall Study|Lost to Follow-up|9|||
154835240|NCT04677959|558831782|FG001|Overall Study|Lost to Follow-up|13|||
154835241|NCT04677959|558831781|FG000|Overall Study|Other than specified|0|||
155100233|NCT01336712|559800629|FG000|Overall Study|Lack of Efficacy|1|||
155100234|NCT00841776|559800631|FG000|Overall Study|Lack of Efficacy|0|||
155100235|NCT00841776|559800632|FG001|Overall Study|Lack of Efficacy|1|||
155100236|NCT00841776|559800631|FG000|Overall Study|Lost to Follow-up|2|||
155100237|NCT00841776|559800632|FG001|Overall Study|Lost to Follow-up|1|||
155100238|NCT00841776|559800631|FG000|Overall Study|Withdrawal by Subject|0|||
155100239|NCT00841776|559800632|FG001|Overall Study|Withdrawal by Subject|1|||
155100240|NCT04245449|559800633|FG000|Overall Study|COVID shutdown|7|||
155100241|NCT01349673|559800634|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
155100242|NCT01349673|559800634|FG000|Overall Study|No Longer Qualified For Study|1|||
155100243|NCT01349673|559800634|FG000|Overall Study|Site Closure|10|||
155100244|NCT01349673|559800634|FG000|Overall Study|Withdrawal by Subject|21|||
155100245|NCT01349673|559800634|FG000|Overall Study|Lost to Follow-up|6|||
155100246|NCT01349673|559800634|FG000|Overall Study|Adverse Event|17|||
155100247|NCT01349673|559800634|FG000|Overall Study|Study Terminated By Sponsor|50|||
155100248|NCT01349673|559800634|FG000|Overall Study|Lack of Efficacy|8|||
155100249|NCT00347932|559800637|FG000|Overall Study|Adverse Event|4|||
155100250|NCT00347932|559800638|FG001|Overall Study|Adverse Event|5|||
155100251|NCT00347932|559800637|FG000|Overall Study|Lack of Efficacy|3|||
155100252|NCT00347932|559800638|FG001|Overall Study|Lack of Efficacy|14|||
155100253|NCT00347932|559800637|FG000|Overall Study|Lost to Follow-up|10|||
155100254|NCT00347932|559800638|FG001|Overall Study|Lost to Follow-up|9|||
155100255|NCT00347932|559800637|FG000|Overall Study|Withdrawal by Subject|10|||
155100256|NCT00347932|559800638|FG001|Overall Study|Withdrawal by Subject|16|||
155100257|NCT00347932|559800637|FG000|Overall Study|Did not meet inclusion criteria|4|||
154835242|NCT04677959|558831782|FG001|Overall Study|Other than specified|8|||
154835243|NCT00732303|558831783|FG000|Overall Study|Study Terminated|2|||
154835244|NCT01074190|558831790|FG000|Overall Study|Emergency Cesarean Delivery|1|||
154835245|NCT01074190|558831791|FG001|Overall Study|Emergency Cesarean Delivery|2|||
154835246|NCT01074190|558831792|FG002|Overall Study|Emergency Cesarean Delivery|1|||
154835247|NCT01074190|558831790|FG000|Overall Study|Protocol Violation|2|||
154835248|NCT01074190|558831791|FG001|Overall Study|Protocol Violation|1|||
154835249|NCT01074190|558831792|FG002|Overall Study|Protocol Violation|0|||
154835250|NCT01074190|558831790|FG000|Overall Study|Delivered in under 90 minutes|0|||
154835251|NCT01074190|558831791|FG001|Overall Study|Delivered in under 90 minutes|2|||
154835252|NCT01074190|558831792|FG002|Overall Study|Delivered in under 90 minutes|1|||
154835253|NCT01074190|558831790|FG000|Overall Study|Subject withdrew consent|1|||
154835254|NCT01074190|558831791|FG001|Overall Study|Subject withdrew consent|1|||
154835255|NCT01074190|558831792|FG002|Overall Study|Subject withdrew consent|1|||
154835256|NCT01399788|558831793|FG000|First Intervention Period|Adverse Event|1|||
154835257|NCT01399788|558831794|FG001|First Intervention Period|Adverse Event|0|||
155100258|NCT00347932|559800638|FG001|Overall Study|Did not meet inclusion criteria|8|||
155100259|NCT00589797|559800647|FG000|Overall Study|Death|1|||
155100260|NCT00589797|559800648|FG001|Overall Study|Death|0|||
155100261|NCT00589797|559800647|FG000|Overall Study|Lost to Follow-up|12|||
155100262|NCT00589797|559800648|FG001|Overall Study|Lost to Follow-up|9|||
155100263|NCT00589797|559800647|FG000|Overall Study|Physician Decision|8|||
155100264|NCT00589797|559800648|FG001|Overall Study|Physician Decision|3|||
155100265|NCT00589797|559800647|FG000|Overall Study|Withdrawal by Subject|6|||
155100266|NCT00589797|559800648|FG001|Overall Study|Withdrawal by Subject|5|||
155100267|NCT00589797|559800647|FG000|Overall Study|Non-Randomized Training Subjects|46|||
155100268|NCT00589797|559800648|FG001|Overall Study|Non-Randomized Training Subjects|6|||
155100269|NCT04011735|559800652|FG000|Overall Study|Withdrawal by Subject|1|||
155100270|NCT04011735|559800653|FG001|Overall Study|Withdrawal by Subject|0|||
155100271|NCT04011735|559800654|FG002|Overall Study|Withdrawal by Subject|1|||
155100272|NCT04011735|559800652|FG000|Overall Study|Met exclusion criteria after study entry|0|||
155100273|NCT04011735|559800653|FG001|Overall Study|Met exclusion criteria after study entry|1|||
155100274|NCT04011735|559800654|FG002|Overall Study|Met exclusion criteria after study entry|0|||
155100275|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
155100276|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
155100277|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
155100278|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
155100279|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
155100280|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
155100281|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
155100282|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
155100283|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
155100284|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
155100285|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
155100286|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
155100287|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
155100288|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
155100289|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
155100290|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
155100291|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
155100292|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
155100293|NCT02831855|559800656|FG000|Open Label Phase (24 Weeks)|Other|4|||
155100294|NCT02831855|559800657|FG001|Open Label Phase (24 Weeks)|Other|0|||
155100295|NCT02831855|559800658|FG002|Open Label Phase (24 Weeks)|Other|0|||
155100296|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
155100297|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
155100298|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
155100299|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Death|0|||
155100300|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Death|0|||
155100301|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Death|2|||
155100302|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
155100303|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
155100304|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
155100305|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
155100306|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
155100307|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
154969006|NCT03358147|559310394|FG001|Overall Study|Withdrawal by Subject|19|||
154969007|NCT03358147|559310395|FG002|Overall Study|Withdrawal by Subject|16|||
154969008|NCT03358147|559310396|FG003|Overall Study|Withdrawal by Subject|10|||
154969009|NCT03358147|559310397|FG004|Overall Study|Withdrawal by Subject|5|||
154969010|NCT03358147|559310393|FG000|Overall Study|Adverse Event|3|||
155100308|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
155100309|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
155100310|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
155100311|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Other|0|||
155100312|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Other|2|||
155100313|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Other|5|||
155100314|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
155100315|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
155100316|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
155100317|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
155100318|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
155100319|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
155100320|NCT02831855|559800656|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
155100321|NCT02831855|559800657|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
155100322|NCT02831855|559800658|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
155100323|NCT02688192|559800660|FG000|Overall Study|Lost to Follow-up|11|||
155100324|NCT02688192|559800661|FG001|Overall Study|Lost to Follow-up|5|||
155100325|NCT02688192|559800660|FG000|Overall Study|Physician Decision|1|||
155100326|NCT02688192|559800661|FG001|Overall Study|Physician Decision|0|||
155100327|NCT01459666|559800666|FG000|Overall Study|PI left institution|5|||
155100328|NCT01459666|559800667|FG001|Overall Study|PI left institution|4|||
155100329|NCT01061385|559800669|FG000|Overall Study|Lost to Follow-up|1|||
155100330|NCT01061385|559800670|FG001|Overall Study|Lost to Follow-up|0|||
155100331|NCT01061385|559800669|FG000|Overall Study|subject decision not related to AE|0|||
155100332|NCT01061385|559800670|FG001|Overall Study|subject decision not related to AE|1|||
155100333|NCT00533429|559800671|FG000|Overall Study|Adverse Event|3|||
155100334|NCT00533429|559800672|FG001|Overall Study|Adverse Event|1|||
155100335|NCT00533429|559800671|FG000|Overall Study|Death|1|||
155100336|NCT00533429|559800672|FG001|Overall Study|Death|0|||
155100337|NCT00533429|559800671|FG000|Overall Study|Withdrawal by Subject|2|||
155100338|NCT00533429|559800672|FG001|Overall Study|Withdrawal by Subject|0|||
155100339|NCT00533429|559800671|FG000|Overall Study|Progressive Disease|12|||
155100340|NCT00533429|559800672|FG001|Overall Study|Progressive Disease|13|||
155100341|NCT00533429|559800671|FG000|Overall Study|Symptomatic deterioration|1|||
155100342|NCT00533429|559800672|FG001|Overall Study|Symptomatic deterioration|2|||
155100343|NCT02379052|559800679|FG000|Overall Study|Protocol Violation|0|||
155100344|NCT02379052|559800680|FG001|Overall Study|Protocol Violation|1|||
155100345|NCT02379052|559800679|FG000|Overall Study|Adverse Event|0|||
155100346|NCT02379052|559800680|FG001|Overall Study|Adverse Event|1|||
155100347|NCT02379052|559800679|FG000|Overall Study|Physician Decision|1|||
155100348|NCT02379052|559800680|FG001|Overall Study|Physician Decision|1|||
155100349|NCT02379052|559800679|FG000|Overall Study|Withdrawal by Subject|2|||
155100350|NCT02379052|559800680|FG001|Overall Study|Withdrawal by Subject|0|||
155100351|NCT02379052|559800679|FG000|Overall Study|Lost to Follow-up|2|||
155100352|NCT02379052|559800680|FG001|Overall Study|Lost to Follow-up|1|||
155100353|NCT02379052|559800679|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
155100354|NCT02379052|559800680|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
155100355|NCT02379052|559800679|FG000|Overall Study|Subject was Incarcerated|0|||
155100356|NCT02379052|559800680|FG001|Overall Study|Subject was Incarcerated|1|||
155100357|NCT00127855|559800681|FG000|Primary Vaccination Course|Adverse Event|0|||
155100358|NCT00127855|559800682|FG001|Primary Vaccination Course|Adverse Event|0|||
155100359|NCT00127855|559800683|FG002|Primary Vaccination Course|Adverse Event|1|||
155100360|NCT00127855|559800684|FG003|Primary Vaccination Course|Adverse Event|0|||
155100361|NCT00127855|559800685|FG004|Primary Vaccination Course|Adverse Event|0|||
155100362|NCT00127855|559800681|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
155100363|NCT00127855|559800682|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
155100364|NCT00127855|559800683|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
155100365|NCT00127855|559800684|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
155100366|NCT00127855|559800685|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
155100367|NCT00127855|559800681|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
155100368|NCT00127855|559800682|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
155100369|NCT00127855|559800683|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
155100370|NCT00127855|559800684|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
155172694|NCT03158285|560071882|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
154969011|NCT03358147|559310394|FG001|Overall Study|Adverse Event|9|||
155100371|NCT00127855|559800685|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
155100372|NCT00127855|559800681|FG000|Primary Vaccination Course|Other|0|||
155100373|NCT00127855|559800682|FG001|Primary Vaccination Course|Other|0|||
155100374|NCT00127855|559800683|FG002|Primary Vaccination Course|Other|0|||
155100375|NCT00127855|559800684|FG003|Primary Vaccination Course|Other|0|||
155100376|NCT00127855|559800685|FG004|Primary Vaccination Course|Other|1|||
155100377|NCT02343302|559800686|FG000|Overall Study|Physician Decision|1|||
155100378|NCT02343302|559800687|FG001|Overall Study|Physician Decision|1|||
155100379|NCT02655887|559800690|FG000|Overall Study|Lost to Follow-up|3|||
155100380|NCT02655887|559800690|FG000|Overall Study|Death|4|||
155100381|NCT02655887|559800690|FG000|Overall Study|Withdrawal by Subject|3|||
155100382|NCT02655887|559800690|FG000|Overall Study|Missed 12-month follow-up visit|4|||
155100383|NCT02834819|559800691|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
155100384|NCT02834819|559800692|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
155100385|NCT04245709|559800693|FG000|Overall Study|Adverse Event|13|||
155100386|NCT04245709|559800693|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
155100387|NCT02041299|559800702|FG000|Overall Study|Adverse Event|9|||
155100388|NCT02041299|559800703|FG001|Overall Study|Adverse Event|3|||
155100389|NCT02041299|559800702|FG000|Overall Study|Lost to Follow-up|4|||
155100390|NCT02041299|559800703|FG001|Overall Study|Lost to Follow-up|1|||
155100391|NCT02041299|559800702|FG000|Overall Study|Physician Decision|1|||
155100392|NCT02041299|559800703|FG001|Overall Study|Physician Decision|1|||
155100393|NCT02041299|559800702|FG000|Overall Study|Withdrawal by Subject|13|||
155100394|NCT02041299|559800703|FG001|Overall Study|Withdrawal by Subject|7|||
155100395|NCT02041299|559800702|FG000|Overall Study|Protocol Violation|11|||
155100396|NCT02041299|559800703|FG001|Overall Study|Protocol Violation|4|||
155100397|NCT02041299|559800702|FG000|Overall Study|Termination of the study|7|||
155100398|NCT02041299|559800703|FG001|Overall Study|Termination of the study|3|||
155100399|NCT02041299|559800702|FG000|Overall Study|Required bone marrow transplant|0|||
155100400|NCT02041299|559800703|FG001|Overall Study|Required bone marrow transplant|1|||
155100401|NCT02041299|559800702|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
155100402|NCT02041299|559800703|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
155100403|NCT02389465|559800704|FG000|Overall Study|Lost to Follow-up|1|||
155100404|NCT02389465|559800705|FG001|Overall Study|Lost to Follow-up|3|||
155100405|NCT02389465|559800706|FG002|Overall Study|Lost to Follow-up|3|||
155100406|NCT02389465|559800707|FG003|Overall Study|Lost to Follow-up|0|||
155100407|NCT02389465|559800704|FG000|Overall Study|Physician Decision|0|||
155100408|NCT02389465|559800705|FG001|Overall Study|Physician Decision|0|||
155100409|NCT02389465|559800706|FG002|Overall Study|Physician Decision|0|||
155100410|NCT02389465|559800707|FG003|Overall Study|Physician Decision|1|||
155100411|NCT02389465|559800704|FG000|Overall Study|Withdrawal by Subject|0|||
155100412|NCT02389465|559800705|FG001|Overall Study|Withdrawal by Subject|1|||
155100413|NCT02389465|559800706|FG002|Overall Study|Withdrawal by Subject|2|||
155100414|NCT02389465|559800707|FG003|Overall Study|Withdrawal by Subject|2|||
155100415|NCT01925768|559800708|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155100416|NCT01925768|559800709|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155100417|NCT01925768|559800708|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155100418|NCT01925768|559800709|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
155100419|NCT01925768|559800708|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
155100420|NCT01925768|559800709|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
155100421|NCT01925768|559800708|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
155100422|NCT01925768|559800709|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
155100423|NCT01925768|559800708|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
155100424|NCT01925768|559800709|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
155100425|NCT01925768|559800708|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
155100426|NCT01925768|559800709|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
155100427|NCT01925768|559800708|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
155100428|NCT01925768|559800709|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
155100429|NCT01925768|559800708|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
155100430|NCT01925768|559800709|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
155100431|NCT01925768|559800708|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
155100432|NCT01925768|559800709|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
155100433|NCT01925768|559800708|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
155100434|NCT01925768|559800709|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
155172695|NCT03158285|560071883|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
155100435|NCT01925768|559800708|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
155100436|NCT01925768|559800709|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
155100437|NCT04339413|559800710|FG000|Overall Study|Reason Not Specified|2|||
155100438|NCT04339413|559800711|FG001|Overall Study|Reason Not Specified|7|||
155100439|NCT04339413|559800710|FG000|Overall Study|Study Terminated by Sponsor|30|||
155100440|NCT04339413|559800711|FG001|Overall Study|Study Terminated by Sponsor|33|||
155100441|NCT04339413|559800710|FG000|Overall Study|Progressive Disease|9|||
155100442|NCT04339413|559800711|FG001|Overall Study|Progressive Disease|6|||
155100443|NCT04339413|559800710|FG000|Overall Study|Withdrawal by Subject|9|||
155100444|NCT04339413|559800711|FG001|Overall Study|Withdrawal by Subject|10|||
155100445|NCT04339413|559800710|FG000|Overall Study|Physician Decision|3|||
155100446|NCT04339413|559800711|FG001|Overall Study|Physician Decision|1|||
155100447|NCT04339413|559800710|FG000|Overall Study|Death|2|||
155100448|NCT04339413|559800711|FG001|Overall Study|Death|0|||
155100449|NCT04339413|559800710|FG000|Overall Study|Adverse Event|3|||
155100450|NCT04339413|559800711|FG001|Overall Study|Adverse Event|0|||
155100451|NCT00087698|559800717|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
155100452|NCT00087698|559800717|FG000|Overall Study|Death from Other Causes|3|||
155100453|NCT00087698|559800717|FG000|Overall Study|Adverse Event|4|||
155100454|NCT00087698|559800717|FG000|Overall Study|Withdrawal by Subject|4|||
155100455|NCT00087698|559800717|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
155100456|NCT00087698|559800717|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
155100457|NCT00087698|559800717|FG000|Overall Study|Clinical Relapse|1|||
155100458|NCT00087698|559800717|FG000|Overall Study|Death from Study Disease|2|||
155100459|NCT00087698|559800717|FG000|Overall Study|Death from Study Drug Toxicity|2|||
155100460|NCT00087698|559800717|FG000|Overall Study|Protocol Violation|1|||
155100461|NCT04179305|559800718|FG000|Overall Study|Death|1|||
155100462|NCT04179305|559800719|FG001|Overall Study|Death|1|||
155100463|NCT04179305|559800720|FG002|Overall Study|Death|0|||
155100464|NCT04179305|559800721|FG003|Overall Study|Death|0|||
155100465|NCT04179305|559800718|FG000|Overall Study|Lost to Follow-up|1|||
155100466|NCT04179305|559800719|FG001|Overall Study|Lost to Follow-up|1|||
155100467|NCT04179305|559800720|FG002|Overall Study|Lost to Follow-up|0|||
155100468|NCT04179305|559800721|FG003|Overall Study|Lost to Follow-up|0|||
155100469|NCT04179305|559800718|FG000|Overall Study|Withdrawal by Subject|0|||
155100470|NCT04179305|559800719|FG001|Overall Study|Withdrawal by Subject|1|||
155100471|NCT04179305|559800720|FG002|Overall Study|Withdrawal by Subject|0|||
155100472|NCT04179305|559800721|FG003|Overall Study|Withdrawal by Subject|0|||
155100473|NCT04179305|559800718|FG000|Overall Study|Did not have scan|1|||
155100474|NCT04179305|559800719|FG001|Overall Study|Did not have scan|0|||
155100475|NCT04179305|559800720|FG002|Overall Study|Did not have scan|0|||
155100476|NCT04179305|559800721|FG003|Overall Study|Did not have scan|0|||
155100477|NCT04179305|559800718|FG000|Overall Study|In hospice care|3|||
155100478|NCT04179305|559800719|FG001|Overall Study|In hospice care|0|||
155100479|NCT04179305|559800720|FG002|Overall Study|In hospice care|0|||
155100480|NCT04179305|559800721|FG003|Overall Study|In hospice care|0|||
155100481|NCT01737762|559800724|FG000|Overall Study|Adverse Event|2|||
155100482|NCT01737762|559800725|FG001|Overall Study|Adverse Event|2|||
155100483|NCT01737762|559800724|FG000|Overall Study|Lost to Follow-up|1|||
155100484|NCT01737762|559800725|FG001|Overall Study|Lost to Follow-up|0|||
155100485|NCT01737762|559800724|FG000|Overall Study|Withdrawal by Subject|2|||
155100486|NCT01737762|559800725|FG001|Overall Study|Withdrawal by Subject|2|||
155100487|NCT01737762|559800724|FG000|Overall Study|Progressive disease|1|||
155100488|NCT01737762|559800725|FG001|Overall Study|Progressive disease|2|||
155100489|NCT01737762|559800724|FG000|Overall Study|Physician Decision|1|||
155100490|NCT01737762|559800725|FG001|Overall Study|Physician Decision|1|||
155100491|NCT01737762|559800724|FG000|Overall Study|Moved from area|2|||
155100492|NCT01737762|559800725|FG001|Overall Study|Moved from area|1|||
155100493|NCT01737762|559800724|FG000|Overall Study|Trial termination|11|||
155100494|NCT01737762|559800725|FG001|Overall Study|Trial termination|9|||
155100495|NCT01964378|559800726|FG000|Overall Study|Disc. due to death before first dosing|0|||
155100496|NCT01964378|559800727|FG001|Overall Study|Disc. due to death before first dosing|1|||
155100497|NCT01964378|559800726|FG000|Overall Study|Disc. due to AE before first dosing|1|||
155100498|NCT01964378|559800727|FG001|Overall Study|Disc. due to AE before first dosing|0|||
155100499|NCT01964378|559800726|FG000|Overall Study|Death|3|||
155100500|NCT01964378|559800727|FG001|Overall Study|Death|2|||
155100501|NCT01964378|559800726|FG000|Overall Study|Adverse Event|12|||
155100502|NCT01964378|559800727|FG001|Overall Study|Adverse Event|5|||
155100503|NCT01964378|559800726|FG000|Overall Study|Lack of Efficacy|0|||
155100504|NCT01964378|559800727|FG001|Overall Study|Lack of Efficacy|1|||
155100505|NCT01964378|559800726|FG000|Overall Study|Protocol Violation|0|||
155100506|NCT01964378|559800727|FG001|Overall Study|Protocol Violation|1|||
155100507|NCT01964378|559800726|FG000|Overall Study|Lost to Follow-up|0|||
155100508|NCT01964378|559800727|FG001|Overall Study|Lost to Follow-up|1|||
155100509|NCT01964378|559800726|FG000|Overall Study|Withdrawal by Subject|7|||
154835258|NCT03699007|558831798|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
154835259|NCT03699007|558831799|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
155100510|NCT01964378|559800727|FG001|Overall Study|Withdrawal by Subject|5|||
154835260|NCT03699007|558831798|FG000|6-month Follow Up|Lost to Follow-up|2|||
155100511|NCT01964378|559800726|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
155100512|NCT01964378|559800727|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
155100513|NCT01964378|559800726|FG000|Overall Study|Other|1|||
155100514|NCT01964378|559800727|FG001|Overall Study|Other|2|||
155100515|NCT00326599|559800728|FG000|Overall Study|Withdrawal by Subject|1|||
155100516|NCT00326599|559800729|FG001|Overall Study|Withdrawal by Subject|0|||
155100517|NCT00326599|559800730|FG002|Overall Study|Withdrawal by Subject|5|||
155100518|NCT00326599|559800731|FG003|Overall Study|Withdrawal by Subject|2|||
155100519|NCT00326599|559800728|FG000|Overall Study|Adverse Event|1|||
155100520|NCT00326599|559800729|FG001|Overall Study|Adverse Event|0|||
155100521|NCT00326599|559800730|FG002|Overall Study|Adverse Event|32|||
155100522|NCT00326599|559800731|FG003|Overall Study|Adverse Event|3|||
155100523|NCT00326599|559800728|FG000|Overall Study|Disease Progression|3|||
155100524|NCT00326599|559800729|FG001|Overall Study|Disease Progression|1|||
155100525|NCT00326599|559800730|FG002|Overall Study|Disease Progression|13|||
155100526|NCT00326599|559800731|FG003|Overall Study|Disease Progression|11|||
155100527|NCT00326599|559800728|FG000|Overall Study|Alternate Treatment|1|||
155100528|NCT00326599|559800729|FG001|Overall Study|Alternate Treatment|0|||
155100529|NCT00326599|559800730|FG002|Overall Study|Alternate Treatment|0|||
155100530|NCT00326599|559800731|FG003|Overall Study|Alternate Treatment|0|||
155100531|NCT00326599|559800728|FG000|Overall Study|Death|0|||
155100532|NCT00326599|559800729|FG001|Overall Study|Death|0|||
155100533|NCT00326599|559800730|FG002|Overall Study|Death|1|||
155100534|NCT00326599|559800731|FG003|Overall Study|Death|2|||
155100535|NCT00326599|559800728|FG000|Overall Study|Other Unspecified Reason|0|||
155100536|NCT00326599|559800729|FG001|Overall Study|Other Unspecified Reason|0|||
155100537|NCT00326599|559800730|FG002|Overall Study|Other Unspecified Reason|2|||
155100538|NCT00326599|559800731|FG003|Overall Study|Other Unspecified Reason|1|||
155100539|NCT03542266|559800732|FG000|Treatment Phase|Withdrawal by Subject|1|||
155100540|NCT03542266|559800732|FG000|Treatment Phase|Adverse Event|1|||
155100541|NCT03542266|559800732|FG000|Treatment Phase|PD|1|||
155100542|NCT01070979|559800742|FG000|Overall Study|Adverse Event|2|||
155100543|NCT01070979|559800743|FG001|Overall Study|Adverse Event|3|||
155100544|NCT01070979|559800744|FG002|Overall Study|Adverse Event|3|||
155100545|NCT01070979|559800742|FG000|Overall Study|Lost to Follow-up|2|||
155100546|NCT01070979|559800743|FG001|Overall Study|Lost to Follow-up|1|||
155100547|NCT01070979|559800744|FG002|Overall Study|Lost to Follow-up|1|||
155100548|NCT01070979|559800742|FG000|Overall Study|Protocol Violation|0|||
155100549|NCT01070979|559800743|FG001|Overall Study|Protocol Violation|2|||
155100550|NCT01070979|559800744|FG002|Overall Study|Protocol Violation|6|||
155100551|NCT01070979|559800742|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
155100552|NCT01070979|559800743|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
155100553|NCT01070979|559800744|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
155100554|NCT01070979|559800742|FG000|Overall Study|Withdrawal by Subject|3|||
155100555|NCT01070979|559800743|FG001|Overall Study|Withdrawal by Subject|1|||
155100556|NCT01070979|559800744|FG002|Overall Study|Withdrawal by Subject|1|||
155100557|NCT01070979|559800742|FG000|Overall Study|No study drug taken|0|||
155100558|NCT01070979|559800743|FG001|Overall Study|No study drug taken|1|||
155100559|NCT01070979|559800744|FG002|Overall Study|No study drug taken|0|||
155100560|NCT00142792|559800745|FG000|Overall Study|Death|0|||
155100561|NCT00142792|559800746|FG001|Overall Study|Death|0|||
155100562|NCT00142792|559800747|FG002|Overall Study|Death|1|||
155100563|NCT00142792|559800745|FG000|Overall Study|Withdrawal by Subject|3|||
155100564|NCT00142792|559800746|FG001|Overall Study|Withdrawal by Subject|2|||
155100565|NCT00142792|559800747|FG002|Overall Study|Withdrawal by Subject|3|||
155100566|NCT00142792|559800745|FG000|Overall Study|Lost to Follow-up|8|||
154835261|NCT03699007|558831799|FG001|6-month Follow Up|Lost to Follow-up|3|||
154835262|NCT04718974|558831800|FG000|Overall Study|Death|0|||
154835263|NCT04718974|558831801|FG001|Overall Study|Death|2|||
154835264|NCT04718974|558831800|FG000|Overall Study|Lost to Follow-up|10|||
154835265|NCT04718974|558831801|FG001|Overall Study|Lost to Follow-up|20|||
154835266|NCT04718974|558831800|FG000|Overall Study|Transferred out|2|||
154835267|NCT04718974|558831801|FG001|Overall Study|Transferred out|4|||
154835268|NCT00845728|558831802|FG000|Overall Study|Abnormal laboratory value (s)|2|||
154835269|NCT00845728|558831803|FG001|Overall Study|Abnormal laboratory value (s)|2|||
154835270|NCT00845728|558831802|FG000|Overall Study|Patient's inability to use the device|4|||
154835271|NCT00845728|558831803|FG001|Overall Study|Patient's inability to use the device|6|||
154835272|NCT00845728|558831802|FG000|Overall Study|Abnormal test procedure result (s)|7|||
154835273|NCT00845728|558831803|FG001|Overall Study|Abnormal test procedure result (s)|2|||
154835274|NCT00845728|558831802|FG000|Overall Study|Lost to Follow-up|22|||
154835275|NCT00845728|558831803|FG001|Overall Study|Lost to Follow-up|13|||
154835276|NCT00845728|558831802|FG000|Overall Study|Death|24|||
155100567|NCT00142792|559800746|FG001|Overall Study|Lost to Follow-up|11|||
155100568|NCT00142792|559800747|FG002|Overall Study|Lost to Follow-up|7|||
155100569|NCT00142792|559800745|FG000|Overall Study|No category|1|||
155100570|NCT00142792|559800746|FG001|Overall Study|No category|2|||
155100571|NCT00142792|559800747|FG002|Overall Study|No category|1|||
155100572|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Death|2|||
155100573|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
155100574|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
155100575|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Physician Decision|1|||
155100576|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
155100577|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
155100578|NCT00786422|559800749|FG000|Rivaroxaban Treatment|Adverse Event|2|||
155100579|NCT00786422|559800749|FG000|Follow-up Period|Death|1|||
155100580|NCT00786422|559800749|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
155100581|NCT04466384|559800750|FG000|First Phase|Protocol Violation|1|||
155100582|NCT04466384|559800751|FG001|First Phase|Protocol Violation|0|||
155100583|NCT04466384|559800750|FG000|First Phase|Missing data|1|||
155100584|NCT04466384|559800751|FG001|First Phase|Missing data|0|||
155100585|NCT04466384|559800750|FG000|Cross Over Phase|Physician Decision|1|||
155100586|NCT04466384|559800751|FG001|Cross Over Phase|Physician Decision|0|||
155100587|NCT04466384|559800750|FG000|Cross Over Phase|Withdrawal by Subject|0|||
155100588|NCT04466384|559800751|FG001|Cross Over Phase|Withdrawal by Subject|1|||
155100589|NCT02454530|559800758|FG000|Overall Study|Other|8|||
155100590|NCT02454530|559800759|FG001|Overall Study|Other|13|||
155100591|NCT02454530|559800758|FG000|Overall Study|Missing information|56|||
155100592|NCT02454530|559800759|FG001|Overall Study|Missing information|69|||
155100593|NCT02454530|559800758|FG000|Overall Study|Death|2|||
155100594|NCT02454530|559800759|FG001|Overall Study|Death|41|||
155100595|NCT02454530|559800758|FG000|Overall Study|Lost to Follow-up|4|||
155100596|NCT02454530|559800759|FG001|Overall Study|Lost to Follow-up|4|||
155100597|NCT00326001|559800760|FG000|Overall Study|Adverse Event|4|||
155100598|NCT00326001|559800761|FG001|Overall Study|Adverse Event|5|||
155100599|NCT00326001|559800760|FG000|Overall Study|Physician Decision|3|||
155100600|NCT00326001|559800761|FG001|Overall Study|Physician Decision|3|||
155100601|NCT01898286|559801880|FG000|Overall Study|Withdrawal by Subject|1|||
155100602|NCT01898286|559801880|FG000|Overall Study|Protocol Violation|1|||
155100603|NCT01898286|559801880|FG000|Overall Study|Lost to Follow-up|1|||
155100604|NCT00355368|559801883|FG000|Overall Study|Protocol Violation|8|||
155100605|NCT00355368|559801884|FG001|Overall Study|Protocol Violation|7|||
155100606|NCT00355368|559801883|FG000|Overall Study|cardiac arrest prior to intubation|2|||
155100607|NCT00355368|559801884|FG001|Overall Study|cardiac arrest prior to intubation|2|||
155100608|NCT01408277|559801885|FG000|Overall Study|Adverse Event|3|||
155100609|NCT01408277|559801886|FG001|Overall Study|Adverse Event|4|||
155100610|NCT01408277|559801885|FG000|Overall Study|Lost to Follow-up|1|||
155100611|NCT01408277|559801886|FG001|Overall Study|Lost to Follow-up|0|||
155100612|NCT01408277|559801885|FG000|Overall Study|Withdrawal by Subject|2|||
155172696|NCT03158285|560071881|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
155172697|NCT03158285|560071882|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
155172698|NCT03158285|560071883|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
155100613|NCT01408277|559801886|FG001|Overall Study|Withdrawal by Subject|0|||
155100614|NCT01408277|559801885|FG000|Overall Study|Protocol Violation|2|||
155100615|NCT01408277|559801886|FG001|Overall Study|Protocol Violation|0|||
155172699|NCT03158285|560071881|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
155100616|NCT01645735|559801891|FG000|Overall Study|Physician Decision|2|||
155172700|NCT03158285|560071882|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
154835277|NCT00845728|558831803|FG001|Overall Study|Death|26|||
154835278|NCT00845728|558831802|FG000|Overall Study|Administrative Problems|34|||
154835279|NCT00845728|558831803|FG001|Overall Study|Administrative Problems|26|||
155100617|NCT01645735|559801892|FG001|Overall Study|Physician Decision|0|||
155100618|NCT01645735|559801891|FG000|Overall Study|Withdrawal by Subject|1|||
155100619|NCT01645735|559801892|FG001|Overall Study|Withdrawal by Subject|0|||
154835280|NCT00845728|558831802|FG000|Overall Study|Protocol Violation|36|||
154835281|NCT00845728|558831803|FG001|Overall Study|Protocol Violation|24|||
154835282|NCT00845728|558831802|FG000|Overall Study|Lack of Efficacy|51|||
154835283|NCT00845728|558831803|FG001|Overall Study|Lack of Efficacy|39|||
154835284|NCT00845728|558831802|FG000|Overall Study|Adverse Event|101|||
154835285|NCT00845728|558831803|FG001|Overall Study|Adverse Event|96|||
154835286|NCT00845728|558831802|FG000|Overall Study|Withdrawal by Subject|105|||
154835287|NCT00845728|558831803|FG001|Overall Study|Withdrawal by Subject|108|||
154835288|NCT01389752|558831804|FG000|Study Period 1|Sponsor decision|0|||
154835289|NCT01389752|558831805|FG001|Study Period 1|Sponsor decision|2|||
154835290|NCT01389752|558831804|FG000|Study Period 2|Sponsor decision|1|||
154835291|NCT01389752|558831805|FG001|Study Period 2|Sponsor decision|0|||
154835292|NCT03259074|558831806|FG000|Overall Study|Adverse Event|9|||
154835293|NCT03259074|558831807|FG001|Overall Study|Adverse Event|12|||
154835294|NCT03259074|558831808|FG002|Overall Study|Adverse Event|8|||
154835295|NCT03259074|558831806|FG000|Overall Study|Death|1|||
154835296|NCT03259074|558831807|FG001|Overall Study|Death|1|||
154835297|NCT03259074|558831808|FG002|Overall Study|Death|3|||
154835298|NCT03259074|558831806|FG000|Overall Study|Lost to Follow-up|2|||
154835299|NCT03259074|558831807|FG001|Overall Study|Lost to Follow-up|4|||
154835300|NCT03259074|558831808|FG002|Overall Study|Lost to Follow-up|3|||
154835301|NCT03259074|558831806|FG000|Overall Study|New Therapy For Study Indication|1|||
154835302|NCT03259074|558831807|FG001|Overall Study|New Therapy For Study Indication|2|||
154835303|NCT03259074|558831808|FG002|Overall Study|New Therapy For Study Indication|2|||
154835304|NCT03259074|558831806|FG000|Overall Study|Physician Decision|4|||
154835305|NCT03259074|558831807|FG001|Overall Study|Physician Decision|12|||
154835306|NCT03259074|558831808|FG002|Overall Study|Physician Decision|10|||
154835307|NCT03259074|558831806|FG000|Overall Study|Pregnancy|1|||
154835308|NCT03259074|558831807|FG001|Overall Study|Pregnancy|1|||
154835309|NCT03259074|558831808|FG002|Overall Study|Pregnancy|0|||
154835310|NCT03259074|558831806|FG000|Overall Study|Progressive Disease|1|||
154835311|NCT03259074|558831807|FG001|Overall Study|Progressive Disease|0|||
154835312|NCT03259074|558831808|FG002|Overall Study|Progressive Disease|0|||
154835313|NCT03259074|558831806|FG000|Overall Study|Protocol Deviation|1|||
154835314|NCT03259074|558831807|FG001|Overall Study|Protocol Deviation|1|||
154835315|NCT03259074|558831808|FG002|Overall Study|Protocol Deviation|3|||
154835316|NCT03259074|558831806|FG000|Overall Study|Subject/Guardian Decision|13|||
154835317|NCT03259074|558831807|FG001|Overall Study|Subject/Guardian Decision|16|||
154835318|NCT03259074|558831808|FG002|Overall Study|Subject/Guardian Decision|14|||
154835319|NCT00053417|558831819|FG000|Overall Study|Adverse Event|1|||
154835320|NCT00053417|558831820|FG001|Overall Study|Adverse Event|0|||
154835321|NCT00053417|558831821|FG002|Overall Study|Adverse Event|1|||
154835322|NCT00053417|558831822|FG003|Overall Study|Adverse Event|5|||
154835323|NCT00053417|558831819|FG000|Overall Study|Non-Compliance|0|||
154835324|NCT00053417|558831820|FG001|Overall Study|Non-Compliance|0|||
154835325|NCT00053417|558831821|FG002|Overall Study|Non-Compliance|0|||
154835326|NCT00053417|558831822|FG003|Overall Study|Non-Compliance|1|||
154835327|NCT00053417|558831819|FG000|Overall Study|Withdrawal by Subject|0|||
154835328|NCT00053417|558831820|FG001|Overall Study|Withdrawal by Subject|1|||
154835329|NCT00053417|558831821|FG002|Overall Study|Withdrawal by Subject|0|||
154835330|NCT00053417|558831822|FG003|Overall Study|Withdrawal by Subject|0|||
154835331|NCT00053417|558831819|FG000|Overall Study|Lost to Follow-up|1|||
154835332|NCT00053417|558831820|FG001|Overall Study|Lost to Follow-up|1|||
154835333|NCT00053417|558831821|FG002|Overall Study|Lost to Follow-up|0|||
154835334|NCT00053417|558831822|FG003|Overall Study|Lost to Follow-up|0|||
154835335|NCT04251910|558831828|FG000|Overall Study|Covid 19 lockdown|0|||
154835336|NCT04251910|558831829|FG001|Overall Study|Covid 19 lockdown|5|||
154835337|NCT04251910|558831830|FG002|Overall Study|Covid 19 lockdown|0|||
154835338|NCT04251910|558831831|FG003|Overall Study|Covid 19 lockdown|4|||
154835339|NCT04251910|558831832|FG004|Overall Study|Covid 19 lockdown|0|||
154969012|NCT03358147|559310395|FG002|Overall Study|Adverse Event|7|||
154969013|NCT03358147|559310396|FG003|Overall Study|Adverse Event|5|||
154969014|NCT03358147|559310397|FG004|Overall Study|Adverse Event|2|||
154969015|NCT03358147|559310393|FG000|Overall Study|Lost to Follow-up|4|||
154969016|NCT03358147|559310394|FG001|Overall Study|Lost to Follow-up|3|||
154969017|NCT03358147|559310395|FG002|Overall Study|Lost to Follow-up|7|||
154969018|NCT03358147|559310396|FG003|Overall Study|Lost to Follow-up|6|||
154969019|NCT03358147|559310397|FG004|Overall Study|Lost to Follow-up|4|||
154969020|NCT03358147|559310393|FG000|Overall Study|Major Protocol Deviation|11|||
154969021|NCT03358147|559310394|FG001|Overall Study|Major Protocol Deviation|3|||
154969022|NCT03358147|559310395|FG002|Overall Study|Major Protocol Deviation|2|||
154969023|NCT03358147|559310396|FG003|Overall Study|Major Protocol Deviation|3|||
154969024|NCT03358147|559310397|FG004|Overall Study|Major Protocol Deviation|1|||
154969025|NCT03358147|559310393|FG000|Overall Study|Protocol specified criteria|2|||
154969026|NCT03358147|559310394|FG001|Overall Study|Protocol specified criteria|3|||
154969027|NCT03358147|559310395|FG002|Overall Study|Protocol specified criteria|0|||
154835340|NCT04251910|558831833|FG005|Overall Study|Covid 19 lockdown|0|||
154835341|NCT04251910|558831828|FG000|Overall Study|Assisted living facility was closed|0|||
154835342|NCT04251910|558831829|FG001|Overall Study|Assisted living facility was closed|0|||
155100620|NCT01645735|559801891|FG000|Overall Study|Protocol Violation|1|||
155100621|NCT01645735|559801892|FG001|Overall Study|Protocol Violation|0|||
155100622|NCT01645735|559801891|FG000|Overall Study|Adverse Event|0|||
155100623|NCT01645735|559801892|FG001|Overall Study|Adverse Event|1|||
155100624|NCT00041470|559801902|FG000|Overall Study|Loss of Funding|38|||
155100625|NCT03465722|559801905|FG000|Overall Study|Withdrawal by Subject|21|||
155100626|NCT03465722|559801906|FG001|Overall Study|Withdrawal by Subject|14|||
155100627|NCT03465722|559801905|FG000|Overall Study|Death|89|||
155100628|NCT03465722|559801906|FG001|Overall Study|Death|87|||
155100629|NCT03465722|559801905|FG000|Overall Study|Lost to Follow-up|5|||
155100630|NCT03465722|559801906|FG001|Overall Study|Lost to Follow-up|3|||
155100631|NCT03465722|559801905|FG000|Overall Study|Administrative/Other|33|||
155100632|NCT03465722|559801906|FG001|Overall Study|Administrative/Other|32|||
155100633|NCT03465722|559801905|FG000|Overall Study|Not treated|1|||
155100634|NCT03465722|559801906|FG001|Overall Study|Not treated|2|||
155100635|NCT03465722|559801905|FG000|Overall Study|Sponsor decision|91|||
155100636|NCT03465722|559801906|FG001|Overall Study|Sponsor decision|98|||
155100637|NCT02948582|559801909|FG000|Washout Period 1|Adverse Event|0|||
155100638|NCT02948582|559801910|FG001|Washout Period 1|Adverse Event|2|||
155100639|NCT02948582|559801911|FG002|Washout Period 1|Adverse Event|0|||
155100640|NCT02948582|559801912|FG003|Washout Period 1|Adverse Event|0|||
155100641|NCT02948582|559801913|FG004|Washout Period 1|Adverse Event|0|||
155100642|NCT02948582|559801914|FG005|Washout Period 1|Adverse Event|0|||
155100643|NCT02948582|559801909|FG000|Washout Period 1|Protocol Violation|0|||
155100644|NCT02948582|559801910|FG001|Washout Period 1|Protocol Violation|0|||
155100645|NCT02948582|559801911|FG002|Washout Period 1|Protocol Violation|0|||
155100646|NCT02948582|559801912|FG003|Washout Period 1|Protocol Violation|0|||
155100647|NCT02948582|559801913|FG004|Washout Period 1|Protocol Violation|0|||
155100648|NCT02948582|559801914|FG005|Washout Period 1|Protocol Violation|1|||
155100649|NCT02948582|559801909|FG000|Washout Period 2|Adverse Event|0|||
155100650|NCT02948582|559801910|FG001|Washout Period 2|Adverse Event|1|||
155100651|NCT02948582|559801911|FG002|Washout Period 2|Adverse Event|0|||
155100652|NCT02948582|559801912|FG003|Washout Period 2|Adverse Event|0|||
155100653|NCT02948582|559801913|FG004|Washout Period 2|Adverse Event|0|||
155100654|NCT02948582|559801914|FG005|Washout Period 2|Adverse Event|0|||
155100655|NCT02948582|559801909|FG000|Washout Period 2|personal reasons|0|||
155100656|NCT02948582|559801910|FG001|Washout Period 2|personal reasons|0|||
155100657|NCT02948582|559801911|FG002|Washout Period 2|personal reasons|0|||
155100658|NCT02948582|559801912|FG003|Washout Period 2|personal reasons|1|||
155100659|NCT02948582|559801913|FG004|Washout Period 2|personal reasons|0|||
155100660|NCT02948582|559801914|FG005|Washout Period 2|personal reasons|0|||
155100661|NCT02948582|559801909|FG000|Washout Period 4|Adverse Event|1|||
155100662|NCT02948582|559801910|FG001|Washout Period 4|Adverse Event|0|||
155100663|NCT02948582|559801911|FG002|Washout Period 4|Adverse Event|1|||
155100664|NCT02948582|559801912|FG003|Washout Period 4|Adverse Event|0|||
155100665|NCT02948582|559801913|FG004|Washout Period 4|Adverse Event|0|||
155100666|NCT02948582|559801914|FG005|Washout Period 4|Adverse Event|0|||
155100667|NCT00955474|559801920|FG000|Overall Study|Physician Decision|7|||
155100668|NCT00955474|559801921|FG001|Overall Study|Physician Decision|5|||
155100669|NCT02012218|559801923|FG000|Overall Study|Withdrawal by Subject|1|||
155100670|NCT02012218|559801924|FG001|Overall Study|Withdrawal by Subject|0|||
155100671|NCT02012218|559801925|FG002|Overall Study|Withdrawal by Subject|1|||
155100672|NCT02012218|559801926|FG003|Overall Study|Withdrawal by Subject|1|||
155100673|NCT02012218|559801927|FG004|Overall Study|Withdrawal by Subject|1|||
155100674|NCT02012218|559801923|FG000|Overall Study|Adverse Event|1|||
155100675|NCT02012218|559801924|FG001|Overall Study|Adverse Event|0|||
155100676|NCT02012218|559801925|FG002|Overall Study|Adverse Event|0|||
155100677|NCT02012218|559801926|FG003|Overall Study|Adverse Event|1|||
155100678|NCT02012218|559801927|FG004|Overall Study|Adverse Event|0|||
155100679|NCT02012218|559801923|FG000|Overall Study|Lost to Follow-up|0|||
155100680|NCT02012218|559801924|FG001|Overall Study|Lost to Follow-up|1|||
155100681|NCT02012218|559801925|FG002|Overall Study|Lost to Follow-up|1|||
155100682|NCT02012218|559801926|FG003|Overall Study|Lost to Follow-up|0|||
155100683|NCT02012218|559801927|FG004|Overall Study|Lost to Follow-up|0|||
155100684|NCT02012218|559801923|FG000|Overall Study|Protocol Specified|1|||
155100685|NCT02012218|559801924|FG001|Overall Study|Protocol Specified|0|||
155100686|NCT02012218|559801925|FG002|Overall Study|Protocol Specified|0|||
155100687|NCT02012218|559801926|FG003|Overall Study|Protocol Specified|0|||
155100688|NCT02012218|559801927|FG004|Overall Study|Protocol Specified|0|||
155100689|NCT02012218|559801923|FG000|Overall Study|Protocol Deviation|1|||
155100690|NCT02012218|559801924|FG001|Overall Study|Protocol Deviation|0|||
155100691|NCT02012218|559801925|FG002|Overall Study|Protocol Deviation|0|||
155100692|NCT02012218|559801926|FG003|Overall Study|Protocol Deviation|0|||
155100693|NCT02012218|559801927|FG004|Overall Study|Protocol Deviation|0|||
155100694|NCT02382991|559801928|FG000|Overall Study|Adverse Event|1|||
155100695|NCT02382991|559801929|FG001|Overall Study|Adverse Event|2|||
155100696|NCT02382991|559801928|FG000|Overall Study|Lost to Follow-up|1|||
154835343|NCT04251910|558831830|FG002|Overall Study|Assisted living facility was closed|0|||
154835344|NCT04251910|558831831|FG003|Overall Study|Assisted living facility was closed|0|||
154835345|NCT04251910|558831832|FG004|Overall Study|Assisted living facility was closed|1|||
154835346|NCT04251910|558831833|FG005|Overall Study|Assisted living facility was closed|0|||
154835347|NCT03451084|558831836|FG000|Overall Study|Withdrawal by Subject|2|||
154835348|NCT03451084|558831837|FG001|Overall Study|Withdrawal by Subject|1|||
154835349|NCT03451084|558831838|FG002|Overall Study|Withdrawal by Subject|2|||
154835350|NCT03451084|558831839|FG003|Overall Study|Withdrawal by Subject|1|||
154835351|NCT03451084|558831836|FG000|Overall Study|Disease recurrence|0|||
154835352|NCT03451084|558831837|FG001|Overall Study|Disease recurrence|2|||
155100697|NCT02382991|559801929|FG001|Overall Study|Lost to Follow-up|0|||
155100698|NCT02382991|559801928|FG000|Overall Study|Withdrawal by Subject|0|||
155100699|NCT02382991|559801929|FG001|Overall Study|Withdrawal by Subject|1|||
155100700|NCT04417257|559801930|FG000|Pilot Phase 2|Adverse Event|2|||
155100701|NCT04417257|559801931|FG001|Pilot Phase 2|Adverse Event|0|||
155100702|NCT04417257|559801930|FG000|Pilot Phase 2|Death|14|||
155100703|NCT04417257|559801931|FG001|Pilot Phase 2|Death|11|||
155100704|NCT04417257|559801930|FG000|Pilot Phase 2|Lost to Follow-up|3|||
155100705|NCT04417257|559801931|FG001|Pilot Phase 2|Lost to Follow-up|5|||
155100706|NCT04417257|559801930|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
155100707|NCT04417257|559801931|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
155100708|NCT04417257|559801930|FG000|Pilot Phase 2|Hepatic impairment|1|||
155100709|NCT04417257|559801931|FG001|Pilot Phase 2|Hepatic impairment|0|||
155100710|NCT04417257|559801930|FG000|Pilot Phase 2|Unblinding|1|||
155100711|NCT04417257|559801931|FG001|Pilot Phase 2|Unblinding|0|||
155100712|NCT04417257|559801930|FG000|Pilot Phase 2|All other|0|||
155100713|NCT04417257|559801931|FG001|Pilot Phase 2|All other|2|||
155100714|NCT04417257|559801930|FG000|Phase 3 Extension|Death|3|||
155100715|NCT04417257|559801931|FG001|Phase 3 Extension|Death|1|||
155100716|NCT04417257|559801930|FG000|Phase 3 Extension|Lost to Follow-up|4|||
155100717|NCT04417257|559801931|FG001|Phase 3 Extension|Lost to Follow-up|2|||
155100718|NCT04417257|559801930|FG000|Phase 3 Extension|Patient withdrawal|2|||
155100719|NCT04417257|559801931|FG001|Phase 3 Extension|Patient withdrawal|2|||
155100720|NCT04417257|559801930|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
155100721|NCT04417257|559801931|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
155100722|NCT03484429|559801932|FG000|Overall Study|Withdrawal by Subject|1|||
155100723|NCT03484429|559801933|FG001|Overall Study|Withdrawal by Subject|0|||
155100724|NCT03484429|559801932|FG000|Overall Study|Adverse Event|2|||
155100725|NCT03484429|559801933|FG001|Overall Study|Adverse Event|0|||
155100726|NCT00714948|559801936|FG000|Overall Study|Adverse Event|2|||
155100727|NCT04570384|559801943|FG000|Overall Study|Adverse Event|2|||
155100728|NCT04570384|559801944|FG001|Overall Study|Adverse Event|1|||
155100729|NCT04570384|559801943|FG000|Overall Study|Death|2|||
155100730|NCT04570384|559801944|FG001|Overall Study|Death|5|||
155100731|NCT04570384|559801943|FG000|Overall Study|Lost to Follow-up|1|||
155100732|NCT04570384|559801944|FG001|Overall Study|Lost to Follow-up|0|||
155100733|NCT04570384|559801943|FG000|Overall Study|Other|1|||
155100734|NCT04570384|559801944|FG001|Overall Study|Other|0|||
155100735|NCT04570384|559801943|FG000|Overall Study|Protocol Violation|0|||
155100736|NCT04570384|559801944|FG001|Overall Study|Protocol Violation|1|||
155100737|NCT04570384|559801943|FG000|Overall Study|Sponsor Decision|1|||
155100738|NCT04570384|559801944|FG001|Overall Study|Sponsor Decision|0|||
155100739|NCT04570384|559801943|FG000|Overall Study|Withdrawal by Subject|4|||
155100740|NCT04570384|559801944|FG001|Overall Study|Withdrawal by Subject|2|||
155100741|NCT02573948|559801945|FG000|Longitudinal Cohort|Death|9|||
155100742|NCT02573948|559801945|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
154835353|NCT03451084|558831838|FG002|Overall Study|Disease recurrence|0|||
155100743|NCT02573948|559801945|FG000|Longitudinal Cohort|Incarcerated|25|||
155100744|NCT03654274|559801950|FG000|Overall Study|Adverse Event|19|||
155100745|NCT03654274|559801951|FG001|Overall Study|Adverse Event|23|||
155100746|NCT03654274|559801952|FG002|Overall Study|Adverse Event|24|||
155100747|NCT03654274|559801950|FG000|Overall Study|Protocol Deviation|0|||
155100748|NCT03654274|559801951|FG001|Overall Study|Protocol Deviation|2|||
155100749|NCT03654274|559801952|FG002|Overall Study|Protocol Deviation|0|||
154835354|NCT03451084|558831839|FG003|Overall Study|Disease recurrence|0|||
155100750|NCT03654274|559801950|FG000|Overall Study|Lost to Follow-up|8|||
155100751|NCT03654274|559801951|FG001|Overall Study|Lost to Follow-up|6|||
155100752|NCT03654274|559801952|FG002|Overall Study|Lost to Follow-up|5|||
154835355|NCT03451084|558831836|FG000|Overall Study|Lack of Efficacy|0|||
155100753|NCT03654274|559801950|FG000|Overall Study|Withdrawal by Subject|46|||
155100754|NCT03654274|559801951|FG001|Overall Study|Withdrawal by Subject|25|||
155100755|NCT03654274|559801952|FG002|Overall Study|Withdrawal by Subject|33|||
154835356|NCT03451084|558831837|FG001|Overall Study|Lack of Efficacy|3|||
154835357|NCT03451084|558831838|FG002|Overall Study|Lack of Efficacy|0|||
154835358|NCT03451084|558831839|FG003|Overall Study|Lack of Efficacy|1|||
154835359|NCT03451084|558831836|FG000|Overall Study|Death|1|||
155100756|NCT03654274|559801950|FG000|Overall Study|Lack of Efficacy|4|||
155100757|NCT03654274|559801951|FG001|Overall Study|Lack of Efficacy|5|||
155100758|NCT03654274|559801952|FG002|Overall Study|Lack of Efficacy|7|||
154969028|NCT03358147|559310396|FG003|Overall Study|Protocol specified criteria|3|||
154969029|NCT03358147|559310397|FG004|Overall Study|Protocol specified criteria|1|||
154969030|NCT03358147|559310393|FG000|Overall Study|Physician Decision|1|||
155172701|NCT03158285|560071883|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
154969031|NCT03358147|559310394|FG001|Overall Study|Physician Decision|0|||
154969032|NCT03358147|559310395|FG002|Overall Study|Physician Decision|1|||
154969033|NCT03358147|559310396|FG003|Overall Study|Physician Decision|6|||
154969034|NCT03358147|559310397|FG004|Overall Study|Physician Decision|1|||
154969035|NCT03358147|559310393|FG000|Overall Study|Administrative reasons|0|||
154969036|NCT03358147|559310394|FG001|Overall Study|Administrative reasons|1|||
154969037|NCT03358147|559310395|FG002|Overall Study|Administrative reasons|0|||
154969038|NCT03358147|559310396|FG003|Overall Study|Administrative reasons|3|||
154969039|NCT03358147|559310397|FG004|Overall Study|Administrative reasons|0|||
154969040|NCT03358147|559310393|FG000|Overall Study|Lack of Efficacy|0|||
154969041|NCT03358147|559310394|FG001|Overall Study|Lack of Efficacy|1|||
154969042|NCT03358147|559310395|FG002|Overall Study|Lack of Efficacy|1|||
154969043|NCT03358147|559310396|FG003|Overall Study|Lack of Efficacy|0|||
154969044|NCT03358147|559310397|FG004|Overall Study|Lack of Efficacy|0|||
154969045|NCT01634139|559310398|FG000|Overall Study|Non compliant with protocol|1|||
154969046|NCT01634139|559310399|FG001|Overall Study|Non compliant with protocol|0|||
154969047|NCT01634139|559310400|FG002|Overall Study|Non compliant with protocol|0|||
154969048|NCT01634139|559310398|FG000|Overall Study|Consent withdrawn not due to AE|4|||
154969049|NCT01634139|559310399|FG001|Overall Study|Consent withdrawn not due to AE|3|||
154969050|NCT01634139|559310400|FG002|Overall Study|Consent withdrawn not due to AE|2|||
154969051|NCT01634139|559310398|FG000|Overall Study|Other|4|||
155172702|NCT03158285|560071881|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
154969052|NCT01634139|559310399|FG001|Overall Study|Other|0|||
154969053|NCT01634139|559310400|FG002|Overall Study|Other|3|||
154969054|NCT01634139|559310398|FG000|Overall Study|Lost to Follow-up|0|||
154969055|NCT01634139|559310399|FG001|Overall Study|Lost to Follow-up|2|||
154969056|NCT01634139|559310400|FG002|Overall Study|Lost to Follow-up|0|||
154969057|NCT01634139|559310398|FG000|Overall Study|Not treated|1|||
154969058|NCT01634139|559310399|FG001|Overall Study|Not treated|1|||
154969059|NCT01634139|559310400|FG002|Overall Study|Not treated|0|||
154969060|NCT01168856|559310407|FG000|Overall Study|Lost to Follow-up|4|||
154969061|NCT01168856|559310408|FG001|Overall Study|Lost to Follow-up|34|||
154969062|NCT01168856|559310407|FG000|Overall Study|Withdrawal by Subject|6|||
154969063|NCT01168856|559310408|FG001|Overall Study|Withdrawal by Subject|8|||
154969064|NCT01168856|559310407|FG000|Overall Study|Physician Decision|2|||
154969065|NCT01168856|559310408|FG001|Overall Study|Physician Decision|1|||
154969066|NCT01168856|559310407|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
154969067|NCT01168856|559310408|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
154969068|NCT01168856|559310407|FG000|Overall Study|Participant received anti-HCV treatment|1|||
154969069|NCT01168856|559310408|FG001|Overall Study|Participant received anti-HCV treatment|0|||
154969070|NCT01168856|559310407|FG000|Overall Study|Death|0|||
154969071|NCT01168856|559310408|FG001|Overall Study|Death|2|||
154969072|NCT01168856|559310407|FG000|Overall Study|Other|1|||
154969073|NCT01168856|559310408|FG001|Overall Study|Other|291|||
154969074|NCT01168856|559310407|FG000|Overall Study|Protocol Violation|4|||
154969075|NCT01168856|559310408|FG001|Overall Study|Protocol Violation|6|||
155100759|NCT03654274|559801950|FG000|Overall Study|Pregnancy|2|||
155100760|NCT03654274|559801951|FG001|Overall Study|Pregnancy|2|||
155100761|NCT03654274|559801952|FG002|Overall Study|Pregnancy|1|||
155100762|NCT03654274|559801950|FG000|Overall Study|Other|27|||
155100763|NCT03654274|559801951|FG001|Overall Study|Other|29|||
155100764|NCT03654274|559801952|FG002|Overall Study|Other|32|||
155100765|NCT03654274|559801950|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
155100766|NCT03654274|559801951|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
155100767|NCT03654274|559801952|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
155100768|NCT01102491|559801953|FG000|Overall Study|Protocol Violation|11|||
155100769|NCT01102491|559801954|FG001|Overall Study|Protocol Violation|12|||
155100770|NCT01265992|559801955|FG000|Overall Study|Lost to Follow-up|1|||
155100771|NCT01265992|559801955|FG000|Overall Study|Withdrawal by Subject|1|||
155100772|NCT01265992|559801955|FG000|Overall Study|Adverse Event|1|||
155100773|NCT01265992|559801955|FG000|Overall Study|Administrative reasons|2|||
155100774|NCT01265992|559801955|FG000|Overall Study|Stopped treatment|3|||
155100775|NCT01265992|559801955|FG000|Overall Study|Did not receive treatment|1|||
155100776|NCT01837680|559801956|FG000|Overall Study|Lost to Follow-up|2|||
155100777|NCT01837680|559801957|FG001|Overall Study|Lost to Follow-up|2|||
155100778|NCT01837680|559801956|FG000|Overall Study|lack of insurance|0|||
155100779|NCT01837680|559801957|FG001|Overall Study|lack of insurance|2|||
155100780|NCT01837680|559801956|FG000|Overall Study|allergic reaction|6|||
155100781|NCT01837680|559801957|FG001|Overall Study|allergic reaction|0|||
155100782|NCT01837680|559801956|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
155100783|NCT01837680|559801957|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
155100784|NCT05005273|559801958|FG000|Overall Study|Study Terminated|1|||
155100785|NCT05005273|559801959|FG001|Overall Study|Study Terminated|0|||
155100786|NCT03265145|559801960|FG000|Overall Study|Protocol Violation|2|||
155100787|NCT03265145|559801961|FG001|Overall Study|Protocol Violation|0|||
155100788|NCT03265145|559801960|FG000|Overall Study|Adverse Event|1|||
155100789|NCT03265145|559801961|FG001|Overall Study|Adverse Event|0|||
155100790|NCT03265145|559801960|FG000|Overall Study|Withdrawal by Subject|23|||
155100791|NCT03265145|559801961|FG001|Overall Study|Withdrawal by Subject|19|||
154835360|NCT03451084|558831837|FG001|Overall Study|Death|0|||
154835361|NCT03451084|558831838|FG002|Overall Study|Death|2|||
154835362|NCT03451084|558831839|FG003|Overall Study|Death|0|||
154835363|NCT03451084|558831836|FG000|Overall Study|Physician Decision|0|||
154835364|NCT03451084|558831837|FG001|Overall Study|Physician Decision|0|||
154835365|NCT03451084|558831838|FG002|Overall Study|Physician Decision|2|||
154835366|NCT03451084|558831839|FG003|Overall Study|Physician Decision|2|||
154835367|NCT03451084|558831836|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
154835368|NCT03451084|558831837|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
154835369|NCT03451084|558831838|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
154835370|NCT03451084|558831839|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
154835371|NCT02121262|558831847|FG000|Overall Study|Adverse Event|6|||
154835372|NCT02121262|558831848|FG001|Overall Study|Adverse Event|3|||
154835373|NCT02121262|558831847|FG000|Overall Study|Lack of Efficacy|3|||
154835374|NCT02121262|558831848|FG001|Overall Study|Lack of Efficacy|0|||
154835375|NCT02121262|558831847|FG000|Overall Study|Personal Reasons|19|||
154835376|NCT02121262|558831848|FG001|Overall Study|Personal Reasons|5|||
154835377|NCT02121262|558831847|FG000|Overall Study|Protocol Violation|1|||
154835378|NCT02121262|558831848|FG001|Overall Study|Protocol Violation|1|||
154835379|NCT02121262|558831847|FG000|Overall Study|Participant Dropped-out|0|||
154835380|NCT02121262|558831848|FG001|Overall Study|Participant Dropped-out|1|||
154835381|NCT02121262|558831847|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
154835382|NCT02121262|558831848|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
154835383|NCT02121262|558831847|FG000|Overall Study|Consent Withdrawn|1|||
154835384|NCT02121262|558831848|FG001|Overall Study|Consent Withdrawn|0|||
154835385|NCT01553188|558831851|FG000|Overall Study|Patient choice|1|||
154835386|NCT01553188|558831852|FG001|Overall Study|Patient choice|0|||
154835387|NCT01553188|558831853|FG002|Overall Study|Patient choice|0|||
154835388|NCT01553188|558831854|FG003|Overall Study|Patient choice|0|||
154835389|NCT01553188|558831851|FG000|Overall Study|Intercurrent illness and adverse event|0|||
154835390|NCT01553188|558831852|FG001|Overall Study|Intercurrent illness and adverse event|1|||
154835391|NCT01553188|558831853|FG002|Overall Study|Intercurrent illness and adverse event|2|||
154835392|NCT01553188|558831854|FG003|Overall Study|Intercurrent illness and adverse event|0|||
154835393|NCT05289570|558831855|FG000|Overall Study|Physician Decision|1|||
154835394|NCT04544475|558831856|FG000|Overall Study|Withdrawal by Subject|1|||
154835395|NCT04544475|558831857|FG001|Overall Study|Withdrawal by Subject|3|||
154835396|NCT00964743|558831862|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
154835397|NCT03317795|558831863|FG000|Overall Study|IUD Expulsion|1|||
154835398|NCT03317795|558831864|FG001|Overall Study|IUD Expulsion|0|||
154835399|NCT03317795|558831863|FG000|Overall Study|Lost to Follow-up|1|||
154835400|NCT03317795|558831864|FG001|Overall Study|Lost to Follow-up|3|||
154835401|NCT03317795|558831863|FG000|Overall Study|Treatment change|0|||
154835402|NCT03317795|558831864|FG001|Overall Study|Treatment change|3|||
154835403|NCT03317795|558831863|FG000|Overall Study|Intolerance of medication|0|||
154835404|NCT03317795|558831864|FG001|Overall Study|Intolerance of medication|1|||
154835405|NCT00886600|558831865|FG000|Double-blind Monotherapy|Adverse Event|1|||
154835406|NCT00886600|558831866|FG001|Double-blind Monotherapy|Adverse Event|1|||
154835407|NCT00886600|558831867|FG002|Double-blind Monotherapy|Adverse Event|1|||
154835408|NCT00886600|558831868|FG003|Double-blind Monotherapy|Adverse Event|1|||
154835409|NCT00886600|558831865|FG000|Double-blind Monotherapy|Protocol Violation|0|||
154835410|NCT00886600|558831866|FG001|Double-blind Monotherapy|Protocol Violation|0|||
154835411|NCT00886600|558831867|FG002|Double-blind Monotherapy|Protocol Violation|0|||
154835412|NCT00886600|558831868|FG003|Double-blind Monotherapy|Protocol Violation|1|||
154835413|NCT00886600|558831865|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
154835414|NCT00886600|558831866|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
154835415|NCT00886600|558831867|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
154835416|NCT00886600|558831868|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
154835417|NCT00886600|558831865|FG000|Combination Therapy Period|Adverse Event|0|||
154835418|NCT00886600|558831866|FG001|Combination Therapy Period|Adverse Event|0|||
154835419|NCT00886600|558831867|FG002|Combination Therapy Period|Adverse Event|1|||
154835420|NCT00886600|558831868|FG003|Combination Therapy Period|Adverse Event|0|||
154835421|NCT00886600|558831865|FG000|Combination Therapy Period|Protocol Violation|0|||
154835422|NCT00886600|558831866|FG001|Combination Therapy Period|Protocol Violation|0|||
154835423|NCT00886600|558831867|FG002|Combination Therapy Period|Protocol Violation|1|||
154835424|NCT00886600|558831868|FG003|Combination Therapy Period|Protocol Violation|0|||
154835425|NCT00501007|558831869|FG000|Overall Study|Inclusion criteria not met.|29|||
154835426|NCT00501007|558831870|FG001|Overall Study|Inclusion criteria not met.|25|||
154835427|NCT03917823|558831872|FG000|Overall Study|Lost to Follow-up|1|||
154835428|NCT03917823|558831873|FG001|Overall Study|Lost to Follow-up|1|||
154835429|NCT03917823|558831872|FG000|Overall Study|Withdrawal by Subject|0|||
154835430|NCT03917823|558831873|FG001|Overall Study|Withdrawal by Subject|1|||
154835431|NCT02016820|558831874|FG000|Overall Study|Lost to Follow-up|2|||
154835432|NCT02016820|558831875|FG001|Overall Study|Lost to Follow-up|4|||
154835433|NCT00135668|558831876|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
155100792|NCT03265145|559801960|FG000|Overall Study|Death|12|||
154835434|NCT00135668|558831877|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
154835435|NCT00135668|558831878|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
154835436|NCT00135668|558831879|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
155100793|NCT03265145|559801961|FG001|Overall Study|Death|12|||
155100794|NCT03265145|559801960|FG000|Overall Study|Lost to Follow-up|13|||
155100795|NCT03265145|559801961|FG001|Overall Study|Lost to Follow-up|9|||
155100796|NCT03265145|559801960|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
155100797|NCT03265145|559801961|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
155100798|NCT03265145|559801960|FG000|Overall Study|Switched back to previous medication|1|||
155100799|NCT03265145|559801961|FG001|Overall Study|Switched back to previous medication|0|||
155100800|NCT03265145|559801960|FG000|Overall Study|Did not want to take medication|1|||
155100801|NCT03265145|559801961|FG001|Overall Study|Did not want to take medication|0|||
155100802|NCT03265145|559801960|FG000|Overall Study|Subject could not afford medication|0|||
155100803|NCT03265145|559801961|FG001|Overall Study|Subject could not afford medication|1|||
155100804|NCT03265145|559801960|FG000|Overall Study|Site closed|2|||
155100805|NCT03265145|559801961|FG001|Overall Study|Site closed|3|||
155100806|NCT03265145|559801960|FG000|Overall Study|Incorrectly randomized|16|||
155100807|NCT03265145|559801961|FG001|Overall Study|Incorrectly randomized|6|||
155100808|NCT03265145|559801960|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
155100809|NCT03265145|559801961|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
155100810|NCT03265145|559801960|FG000|Overall Study|Physician Decision|0|||
155100811|NCT03265145|559801961|FG001|Overall Study|Physician Decision|3|||
155100812|NCT03265145|559801960|FG000|Overall Study|Subject transferred to another facility|0|||
155100813|NCT03265145|559801961|FG001|Overall Study|Subject transferred to another facility|1|||
155100814|NCT04409834|559801962|FG000|Overall Study|Death|55|||
155100815|NCT04409834|559801963|FG001|Overall Study|Death|62|||
155100816|NCT02137070|559801964|FG000|Overall Study|Adverse Event|12|||
155100817|NCT02137070|559801965|FG001|Overall Study|Adverse Event|3|||
155100818|NCT02137070|559801964|FG000|Overall Study|Death|2|||
155100819|NCT02137070|559801965|FG001|Overall Study|Death|0|||
155100820|NCT02137070|559801964|FG000|Overall Study|Lost to Follow-up|24|||
155100821|NCT02137070|559801965|FG001|Overall Study|Lost to Follow-up|9|||
155100822|NCT02137070|559801964|FG000|Overall Study|Physician Decision|0|||
155100823|NCT02137070|559801965|FG001|Overall Study|Physician Decision|1|||
155100824|NCT02137070|559801964|FG000|Overall Study|Protocol Violation|18|||
155100825|NCT02137070|559801965|FG001|Overall Study|Protocol Violation|4|||
155100826|NCT02137070|559801964|FG000|Overall Study|Withdrawal by Subject|18|||
155100827|NCT02137070|559801965|FG001|Overall Study|Withdrawal by Subject|1|||
155100828|NCT02151786|559801966|FG000|Overall Study|Unavailability of Case Report Form|26|||
155100829|NCT02151786|559801966|FG000|Overall Study|Outside the Contract Period|1|||
155100830|NCT02151786|559801966|FG000|Overall Study|Randomized, not Treated|1|||
155100831|NCT02151786|559801966|FG000|Overall Study|Unavailability of Information|8|||
155100832|NCT02112656|559801970|FG000|Overall Study|Death|78|||
155100833|NCT02112656|559801971|FG001|Overall Study|Death|82|||
155100834|NCT02112656|559801970|FG000|Overall Study|Withdrawal by Subject|9|||
155100835|NCT02112656|559801971|FG001|Overall Study|Withdrawal by Subject|11|||
155100836|NCT02112656|559801970|FG000|Overall Study|Lost to Follow-up|2|||
155100837|NCT02112656|559801971|FG001|Overall Study|Lost to Follow-up|4|||
155100838|NCT02112656|559801970|FG000|Overall Study|Noncompliance|1|||
155100839|NCT02112656|559801971|FG001|Overall Study|Noncompliance|2|||
155100840|NCT03761056|559801972|FG000|Overall Study|Death|8|||
155100841|NCT03761056|559801972|FG000|Overall Study|Enrolled but never treated|2|||
155100842|NCT03761056|559801972|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
155100843|NCT03761056|559801972|FG000|Overall Study|Investigator decision|1|||
155100844|NCT01365455|559801978|FG000|Induction Period|Adverse Event|5|||
155100845|NCT01365455|559801979|FG001|Induction Period|Adverse Event|3|||
155100846|NCT01365455|559801980|FG002|Induction Period|Adverse Event|4|||
155100847|NCT01365455|559801981|FG003|Induction Period|Adverse Event|0|||
154835437|NCT00473343|558831882|FG000|Overall Study|Adverse Event|9|||
154835438|NCT00473343|558831882|FG000|Overall Study|Lost to Follow-up|8|||
154835439|NCT00473343|558831882|FG000|Overall Study|Treatment failure|27|||
154835440|NCT00473343|558831882|FG000|Overall Study|Withdrew consent|3|||
154835441|NCT00473343|558831882|FG000|Overall Study|Other un-specified reason|3|||
154835442|NCT02290873|558831883|FG000|Overall Study|Withdrawal by Subject|0|||
154835443|NCT02290873|558831884|FG001|Overall Study|Withdrawal by Subject|1|||
154835444|NCT02290873|558831885|FG002|Overall Study|Withdrawal by Subject|1|||
154835445|NCT02290873|558831883|FG000|Overall Study|Nellcor device error|1|||
154835446|NCT02290873|558831884|FG001|Overall Study|Nellcor device error|0|||
154835447|NCT02290873|558831885|FG002|Overall Study|Nellcor device error|0|||
154835448|NCT02290873|558831883|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
154835449|NCT02290873|558831884|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
154835450|NCT02290873|558831885|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
154835451|NCT02290873|558831883|FG000|Overall Study|Protocol Violation|0|||
154835452|NCT02290873|558831884|FG001|Overall Study|Protocol Violation|0|||
154835453|NCT02290873|558831885|FG002|Overall Study|Protocol Violation|1|||
154835454|NCT01519765|558831888|FG000|Overall Study|Adverse Event|0|||
154835455|NCT01519765|558831889|FG001|Overall Study|Adverse Event|1|||
154835456|NCT01519765|558831888|FG000|Overall Study|Lack of Efficacy|2|||
154835457|NCT01519765|558831889|FG001|Overall Study|Lack of Efficacy|0|||
154835458|NCT01519765|558831888|FG000|Overall Study|Protocol Violation|1|||
154835459|NCT01519765|558831889|FG001|Overall Study|Protocol Violation|0|||
154835460|NCT01519765|558831888|FG000|Overall Study|Withdrawal by Subject|0|||
154835461|NCT01519765|558831889|FG001|Overall Study|Withdrawal by Subject|1|||
154835462|NCT04126083|558831890|FG000|Overall Study|Withdrawal by Subject|1|||
154835463|NCT02437864|558831897|FG000|Overall Study|Protocol Violation|4|||
154835464|NCT02437864|558831898|FG001|Overall Study|Protocol Violation|0|||
154835465|NCT00645593|558831900|FG000|Overall Study|Later found to be ineligible|1|||
154835466|NCT00645593|558831901|FG001|Overall Study|Later found to be ineligible|0|||
154835467|NCT01585272|558831902|FG000|Overall Study|Adverse Event|22|||
154835468|NCT01585272|558831902|FG000|Overall Study|Protocol Violation|7|||
154835469|NCT01585272|558831902|FG000|Overall Study|Withdrawal by Subject|10|||
154835470|NCT02577146|558831903|FG000|Overall Study|Lost to Follow-up|8|||
154835471|NCT02577146|558831903|FG000|Overall Study|Physician Decision|3|||
154835472|NCT02577146|558831903|FG000|Overall Study|Screen Failure|17|||
154835473|NCT00781911|558831906|FG000|Overall Study|Adverse Event|4|||
154835474|NCT00781911|558831907|FG001|Overall Study|Adverse Event|4|||
154835475|NCT00781911|558831906|FG000|Overall Study|Withdrawal by Subject|1|||
154835476|NCT00781911|558831907|FG001|Overall Study|Withdrawal by Subject|2|||
154835477|NCT00781911|558831906|FG000|Overall Study|Physician Decision|0|||
154835478|NCT00781911|558831907|FG001|Overall Study|Physician Decision|2|||
154835479|NCT00781911|558831906|FG000|Overall Study|Sponsor Decision|1|||
154835480|NCT00781911|558831907|FG001|Overall Study|Sponsor Decision|0|||
154835481|NCT01357655|558831908|FG000|Overall Study|Administrative Reason by Sponsor|45|||
154969076|NCT01266902|559310409|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
154835482|NCT01357655|558831909|FG001|Overall Study|Administrative Reason by Sponsor|0|||
154835483|NCT01357655|558831908|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
154835484|NCT01357655|558831909|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
154969077|NCT01266902|559310410|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
154969078|NCT01266902|559310411|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
154835485|NCT01357655|558831908|FG000|Overall Study|Disease Progression|1|||
154835486|NCT01357655|558831909|FG001|Overall Study|Disease Progression|0|||
154835487|NCT01357655|558831908|FG000|Overall Study|Lost to Follow-up|2|||
154835488|NCT01357655|558831909|FG001|Overall Study|Lost to Follow-up|0|||
154835489|NCT01357655|558831908|FG000|Overall Study|Maximum Clinical Benefit|2|||
154835490|NCT01357655|558831909|FG001|Overall Study|Maximum Clinical Benefit|0|||
154835491|NCT01357655|558831908|FG000|Overall Study|Reason Unspecified|1|||
154835492|NCT01357655|558831909|FG001|Overall Study|Reason Unspecified|0|||
154835493|NCT01357655|558831908|FG000|Overall Study|Study Drug Toxicity|11|||
154835494|NCT01357655|558831909|FG001|Overall Study|Study Drug Toxicity|0|||
154835495|NCT01357655|558831908|FG000|Overall Study|Subject Withdrew Consent|1|||
154835496|NCT01357655|558831909|FG001|Overall Study|Subject Withdrew Consent|0|||
154835497|NCT05003622|558831910|FG000|Overall Study|Progressive disease|2|||
155100848|NCT01365455|559801982|FG004|Induction Period|Adverse Event|0|||
155100849|NCT01365455|559801978|FG000|Induction Period|Lack of Efficacy|1|||
155100850|NCT01365455|559801979|FG001|Induction Period|Lack of Efficacy|1|||
155100851|NCT01365455|559801980|FG002|Induction Period|Lack of Efficacy|0|||
155100852|NCT01365455|559801981|FG003|Induction Period|Lack of Efficacy|0|||
155172703|NCT03158285|560071882|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
155172704|NCT03158285|560071883|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
155172705|NCT03158285|560071881|FG000|Active Treatment Period: Week 52-100|Death|1|||
155100853|NCT01365455|559801982|FG004|Induction Period|Lack of Efficacy|0|||
155100854|NCT01365455|559801978|FG000|Induction Period|Pregnancy|0|||
155100855|NCT01365455|559801979|FG001|Induction Period|Pregnancy|1|||
155100856|NCT01365455|559801980|FG002|Induction Period|Pregnancy|0|||
155100857|NCT01365455|559801981|FG003|Induction Period|Pregnancy|0|||
155100858|NCT01365455|559801982|FG004|Induction Period|Pregnancy|0|||
155100859|NCT01365455|559801978|FG000|Induction Period|Protocol deviation|0|||
155100860|NCT01365455|559801979|FG001|Induction Period|Protocol deviation|1|||
155100861|NCT01365455|559801980|FG002|Induction Period|Protocol deviation|1|||
155100862|NCT01365455|559801981|FG003|Induction Period|Protocol deviation|0|||
155100863|NCT01365455|559801982|FG004|Induction Period|Protocol deviation|0|||
155100864|NCT01365455|559801978|FG000|Induction Period|Subject/guardian decision|9|||
155100865|NCT01365455|559801979|FG001|Induction Period|Subject/guardian decision|1|||
155100866|NCT01365455|559801980|FG002|Induction Period|Subject/guardian decision|8|||
155100867|NCT01365455|559801981|FG003|Induction Period|Subject/guardian decision|0|||
155172706|NCT03158285|560071882|FG001|Active Treatment Period: Week 52-100|Death|0|||
155172707|NCT03158285|560071883|FG002|Active Treatment Period: Week 52-100|Death|0|||
154835498|NCT05003622|558831910|FG000|Overall Study|Withdrawal by Subject|1|||
155100868|NCT01365455|559801982|FG004|Induction Period|Subject/guardian decision|0|||
155100869|NCT01365455|559801978|FG000|Induction Period|Lost to Follow-up|0|||
154835499|NCT00129766|558833261|FG000|Overall Study|Death|3|||
155100870|NCT01365455|559801979|FG001|Induction Period|Lost to Follow-up|0|||
155100871|NCT01365455|559801980|FG002|Induction Period|Lost to Follow-up|3|||
155100872|NCT01365455|559801981|FG003|Induction Period|Lost to Follow-up|0|||
155100873|NCT01365455|559801982|FG004|Induction Period|Lost to Follow-up|0|||
155100874|NCT01365455|559801978|FG000|Maintenance Period|Adverse Event|12|||
155100875|NCT01365455|559801979|FG001|Maintenance Period|Adverse Event|5|||
155100876|NCT01365455|559801980|FG002|Maintenance Period|Adverse Event|1|||
155100877|NCT01365455|559801981|FG003|Maintenance Period|Adverse Event|2|||
155100878|NCT01365455|559801982|FG004|Maintenance Period|Adverse Event|4|||
155100879|NCT01365455|559801978|FG000|Maintenance Period|Lack of Efficacy|10|||
155100880|NCT01365455|559801979|FG001|Maintenance Period|Lack of Efficacy|2|||
155100881|NCT01365455|559801980|FG002|Maintenance Period|Lack of Efficacy|0|||
155100882|NCT01365455|559801981|FG003|Maintenance Period|Lack of Efficacy|2|||
155100883|NCT01365455|559801982|FG004|Maintenance Period|Lack of Efficacy|2|||
155100884|NCT01365455|559801978|FG000|Maintenance Period|Lost to Follow-up|2|||
155100885|NCT01365455|559801979|FG001|Maintenance Period|Lost to Follow-up|4|||
155100886|NCT01365455|559801980|FG002|Maintenance Period|Lost to Follow-up|0|||
155100887|NCT01365455|559801981|FG003|Maintenance Period|Lost to Follow-up|0|||
155100888|NCT01365455|559801982|FG004|Maintenance Period|Lost to Follow-up|3|||
155100889|NCT01365455|559801978|FG000|Maintenance Period|Non-compliance with study treatment|0|||
155100890|NCT01365455|559801979|FG001|Maintenance Period|Non-compliance with study treatment|0|||
155100891|NCT01365455|559801980|FG002|Maintenance Period|Non-compliance with study treatment|0|||
155100892|NCT01365455|559801981|FG003|Maintenance Period|Non-compliance with study treatment|1|||
155100893|NCT01365455|559801982|FG004|Maintenance Period|Non-compliance with study treatment|0|||
155100894|NCT01365455|559801978|FG000|Maintenance Period|Physician Decision|0|||
155100895|NCT01365455|559801979|FG001|Maintenance Period|Physician Decision|1|||
155100896|NCT01365455|559801980|FG002|Maintenance Period|Physician Decision|0|||
155100897|NCT01365455|559801981|FG003|Maintenance Period|Physician Decision|0|||
155100898|NCT01365455|559801982|FG004|Maintenance Period|Physician Decision|1|||
155100899|NCT01365455|559801978|FG000|Maintenance Period|Pregnancy|0|||
155100900|NCT01365455|559801979|FG001|Maintenance Period|Pregnancy|4|||
155100901|NCT01365455|559801980|FG002|Maintenance Period|Pregnancy|0|||
154835500|NCT00129766|558833262|FG001|Overall Study|Death|8|||
155100902|NCT01365455|559801981|FG003|Maintenance Period|Pregnancy|0|||
155100903|NCT01365455|559801982|FG004|Maintenance Period|Pregnancy|2|||
155100904|NCT01365455|559801978|FG000|Maintenance Period|Protocol deviation|1|||
155100905|NCT01365455|559801979|FG001|Maintenance Period|Protocol deviation|1|||
155100906|NCT01365455|559801980|FG002|Maintenance Period|Protocol deviation|0|||
154969079|NCT01266902|559310409|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
154969080|NCT01266902|559310410|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
154969081|NCT01266902|559310411|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
154969082|NCT01266902|559310409|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
154969083|NCT01266902|559310410|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
154969084|NCT01266902|559310411|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
154969085|NCT01266902|559310409|FG000|Period 1 (Main Study)|Adverse Event|3|||
154969086|NCT01266902|559310410|FG001|Period 1 (Main Study)|Adverse Event|11|||
154969087|NCT01266902|559310411|FG002|Period 1 (Main Study)|Adverse Event|0|||
154969088|NCT01266902|559310409|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
154969089|NCT01266902|559310410|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
154969090|NCT01266902|559310411|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
154969091|NCT01266902|559310409|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
154969092|NCT01266902|559310410|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
154969093|NCT01266902|559310411|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
154969094|NCT01266902|559310409|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
154969095|NCT01266902|559310410|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
154969096|NCT01266902|559310411|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
154969097|NCT01266902|559310409|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
154969098|NCT01266902|559310410|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
154969099|NCT01266902|559310411|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
154969100|NCT01266902|559310409|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
154969101|NCT01266902|559310410|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
154969102|NCT01266902|559310411|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
154969103|NCT01266902|559310409|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
154969104|NCT01266902|559310410|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
154969105|NCT01266902|559310411|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
154969106|NCT05562011|559310418|FG000|Overall Study|Withdrawal by Subject|3|||
154969107|NCT05562011|559310418|FG000|Overall Study|Lost to Follow-up|1|||
154969108|NCT05562011|559310418|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
154969109|NCT05562011|559310418|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
154969110|NCT05562011|559310418|FG000|Overall Study|Device malfunction|13|||
154969111|NCT00387153|559310419|FG000|Overall Study|Adverse Event|1|||
154969112|NCT00387153|559310419|FG000|Overall Study|Disease Progression|3|||
155100907|NCT01365455|559801981|FG003|Maintenance Period|Protocol deviation|0|||
155100908|NCT01365455|559801982|FG004|Maintenance Period|Protocol deviation|0|||
155100909|NCT01365455|559801978|FG000|Maintenance Period|Subject/guardian decision|4|||
154969113|NCT00387153|559310419|FG000|Overall Study|Lack of Response|4|||
155100910|NCT01365455|559801979|FG001|Maintenance Period|Subject/guardian decision|6|||
155100911|NCT01365455|559801980|FG002|Maintenance Period|Subject/guardian decision|2|||
155100912|NCT01365455|559801981|FG003|Maintenance Period|Subject/guardian decision|4|||
155100913|NCT01365455|559801982|FG004|Maintenance Period|Subject/guardian decision|1|||
155100914|NCT03965403|559801983|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
155100915|NCT04267926|559803400|FG000|Overall Study|abnormal labs. No longer eligible|0|||
155100916|NCT04267926|559803401|FG001|Overall Study|abnormal labs. No longer eligible|0|||
155100917|NCT04267926|559803402|FG002|Overall Study|abnormal labs. No longer eligible|1|||
155100918|NCT04267926|559803400|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
155100919|NCT04267926|559803401|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
155100920|NCT04267926|559803402|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
155100921|NCT03718325|559803403|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
155100922|NCT03718325|559803404|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
155100923|NCT03718325|559803405|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
155100924|NCT03718325|559803403|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
155100925|NCT03718325|559803404|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
155100926|NCT03718325|559803405|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
155100927|NCT00972023|559803408|FG000|Overall Study|Withdrawal by Subject|1|||
155100928|NCT03052608|559803410|FG000|Treatment Phase|Adverse Event|10|||
155100929|NCT03052608|559803411|FG001|Treatment Phase|Adverse Event|12|||
155100930|NCT03052608|559803410|FG000|Treatment Phase|Death|6|||
155100931|NCT03052608|559803411|FG001|Treatment Phase|Death|4|||
155100932|NCT03052608|559803410|FG000|Treatment Phase|Withdrawal by Subject|4|||
155100933|NCT03052608|559803411|FG001|Treatment Phase|Withdrawal by Subject|12|||
155100934|NCT03052608|559803410|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
155172708|NCT03158285|560071881|FG000|Active Treatment Period: Week 52-100|Other|4|||
154835501|NCT00129766|558833261|FG000|Overall Study|Withdrawal of consent|31|||
154835502|NCT00129766|558833262|FG001|Overall Study|Withdrawal of consent|30|||
154835503|NCT00129766|558833261|FG000|Overall Study|Lost to Follow-up|26|||
154835504|NCT00129766|558833262|FG001|Overall Study|Lost to Follow-up|21|||
154835505|NCT01081912|558833263|FG000|Conversion/Titration|Adverse Event|47|||
154835506|NCT01081912|558833264|FG001|Conversion/Titration|Adverse Event|0|||
154835507|NCT01081912|558833265|FG002|Conversion/Titration|Adverse Event|0|||
154835508|NCT01081912|558833263|FG000|Conversion/Titration|Lack of Efficacy|17|||
154835509|NCT01081912|558833264|FG001|Conversion/Titration|Lack of Efficacy|0|||
154835510|NCT01081912|558833265|FG002|Conversion/Titration|Lack of Efficacy|0|||
155172709|NCT03158285|560071882|FG001|Active Treatment Period: Week 52-100|Other|1|||
155100935|NCT03052608|559803411|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
155100936|NCT03052608|559803410|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
155100937|NCT03052608|559803411|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
155100938|NCT03052608|559803410|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
155100939|NCT03052608|559803411|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
155100940|NCT03052608|559803410|FG000|Treatment Phase|Ongoing|103|||
155100941|NCT03052608|559803411|FG001|Treatment Phase|Ongoing|31|||
155100942|NCT03052608|559803410|FG000|Long-Term Follow-up Phase|Death|23|||
155100943|NCT03052608|559803411|FG001|Long-Term Follow-up Phase|Death|28|||
155100944|NCT03052608|559803410|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
155100945|NCT03052608|559803411|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
155100946|NCT03052608|559803410|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
155100947|NCT03052608|559803411|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
155100948|NCT03052608|559803410|FG000|Long-Term Follow-up Phase|Ongoing|122|||
155100949|NCT03052608|559803411|FG001|Long-Term Follow-up Phase|Ongoing|99|||
155100950|NCT02595879|559803412|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
155100951|NCT02595879|559803413|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
155100952|NCT01396187|559803414|FG000|Overall Study|Adverse Event|0|||
155100953|NCT01396187|559803415|FG001|Overall Study|Adverse Event|1|||
155100954|NCT01396187|559803416|FG002|Overall Study|Adverse Event|0|||
155100955|NCT01396187|559803417|FG003|Overall Study|Adverse Event|0|||
155100956|NCT01396187|559803418|FG004|Overall Study|Adverse Event|0|||
155100957|NCT01396187|559803414|FG000|Overall Study|Withdrawal by Subject|0|||
155100958|NCT01396187|559803415|FG001|Overall Study|Withdrawal by Subject|1|||
155100959|NCT01396187|559803416|FG002|Overall Study|Withdrawal by Subject|1|||
155100960|NCT01396187|559803417|FG003|Overall Study|Withdrawal by Subject|0|||
155100961|NCT01396187|559803418|FG004|Overall Study|Withdrawal by Subject|0|||
155100962|NCT01396187|559803414|FG000|Overall Study|Other|1|||
155100963|NCT01396187|559803415|FG001|Overall Study|Other|1|||
155100964|NCT01396187|559803416|FG002|Overall Study|Other|0|||
155100965|NCT01396187|559803417|FG003|Overall Study|Other|0|||
155100966|NCT01396187|559803418|FG004|Overall Study|Other|1|||
155100967|NCT05554146|559803419|FG000|Overall Study|Adverse Event|0|||
155100968|NCT05554146|559803420|FG001|Overall Study|Adverse Event|1|||
155100969|NCT05554146|559803421|FG002|Overall Study|Adverse Event|0|||
155100970|NCT05554146|559803422|FG003|Overall Study|Adverse Event|0|||
155100971|NCT05554146|559803419|FG000|Overall Study|Protocol Violation|0|||
155100972|NCT05554146|559803420|FG001|Overall Study|Protocol Violation|1|||
155100973|NCT05554146|559803421|FG002|Overall Study|Protocol Violation|0|||
155100974|NCT05554146|559803422|FG003|Overall Study|Protocol Violation|0|||
155100975|NCT05554146|559803419|FG000|Overall Study|No longer interested in participating|0|||
155100976|NCT05554146|559803420|FG001|Overall Study|No longer interested in participating|0|||
155172710|NCT03158285|560071883|FG002|Active Treatment Period: Week 52-100|Other|0|||
155172711|NCT00750152|560071886|FG000|Overall Study|Adverse Event|2|||
155172712|NCT00750152|560071887|FG001|Overall Study|Adverse Event|1|||
155172713|NCT00750152|560071886|FG000|Overall Study|Lost to Follow-up|8|||
155172714|NCT00750152|560071887|FG001|Overall Study|Lost to Follow-up|13|||
155172715|NCT00750152|560071886|FG000|Overall Study|Withdrawal by Subject|3|||
155172716|NCT00750152|560071887|FG001|Overall Study|Withdrawal by Subject|3|||
155172717|NCT00750152|560071886|FG000|Overall Study|Physician Decision|1|||
155172718|NCT00750152|560071887|FG001|Overall Study|Physician Decision|1|||
155172719|NCT00750152|560071886|FG000|Overall Study|Non-compliance|0|||
155172720|NCT00750152|560071887|FG001|Overall Study|Non-compliance|1|||
155172721|NCT00750152|560071886|FG000|Overall Study|Termination by sponsor|1|||
155172722|NCT00750152|560071887|FG001|Overall Study|Termination by sponsor|0|||
155172723|NCT00750152|560071886|FG000|Overall Study|Other|7|||
155172724|NCT00750152|560071887|FG001|Overall Study|Other|8|||
155172725|NCT01165216|560071896|FG000|Overall Study|Adverse Event|6|||
155172726|NCT01165216|560071897|FG001|Overall Study|Adverse Event|3|||
155172727|NCT01165216|560071896|FG000|Overall Study|Withdrawal by Subject|1|||
155172728|NCT01165216|560071897|FG001|Overall Study|Withdrawal by Subject|1|||
155172729|NCT01165216|560071896|FG000|Overall Study|Disease progression|1|||
155172730|NCT01165216|560071897|FG001|Overall Study|Disease progression|3|||
155100977|NCT05554146|559803421|FG002|Overall Study|No longer interested in participating|1|||
155100978|NCT05554146|559803422|FG003|Overall Study|No longer interested in participating|0|||
155100979|NCT05554146|559803419|FG000|Overall Study|Lost to Follow-up|1|||
155100980|NCT05554146|559803420|FG001|Overall Study|Lost to Follow-up|0|||
155100981|NCT05554146|559803421|FG002|Overall Study|Lost to Follow-up|0|||
155100982|NCT05554146|559803422|FG003|Overall Study|Lost to Follow-up|0|||
155100983|NCT00620373|559803423|FG000|Overall Study|Unverified cancer status|33|||
155100984|NCT01897727|559803424|FG000|Overall Study|Exclusion: central sleep apnea|0|||
155100985|NCT01897727|559803425|FG001|Overall Study|Exclusion: central sleep apnea|1|||
155100986|NCT01273038|559803430|FG000|Second Intervention (14 Days)|Adverse Event|0|||
155100987|NCT01273038|559803431|FG001|Second Intervention (14 Days)|Adverse Event|1|||
155100988|NCT01273038|559803430|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155100989|NCT01273038|559803431|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155100990|NCT02197572|559803432|FG000|Overall Study|Progressive Disease|28|||
155100991|NCT02197572|559803432|FG000|Overall Study|Withdrawal by Subject|9|||
155100992|NCT02197572|559803432|FG000|Overall Study|Adverse Event|3|||
155100993|NCT02197572|559803432|FG000|Overall Study|Reason Not Specified|4|||
155100994|NCT01306643|559803433|FG000|Overall Study|Adverse Event|5|||
155100995|NCT01306643|559803433|FG000|Overall Study|Disease Progression|7|||
155100996|NCT01306643|559803433|FG000|Overall Study|Other: Change in Eligibility Status|1|||
155100997|NCT01465386|559803434|FG000|Overall Study|Lack of Efficacy|3|||
155100998|NCT01465386|559803434|FG000|Overall Study|Adverse Event|1|||
155100999|NCT02479880|559803437|FG000|Overall Study|Study Terminated by Sponsor|13|||
155101000|NCT02479880|559803438|FG001|Overall Study|Study Terminated by Sponsor|12|||
155101001|NCT02479880|559803437|FG000|Overall Study|Pregnancy|0|||
155101002|NCT02479880|559803438|FG001|Overall Study|Pregnancy|1|||
155101003|NCT01279044|559803439|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
155101004|NCT01279044|559803440|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
155101005|NCT01279044|559803441|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
155101006|NCT01279044|559803439|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
155101007|NCT01279044|559803440|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
155101008|NCT01279044|559803441|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
155101009|NCT01279044|559803439|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
155101010|NCT01279044|559803440|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
155101011|NCT01279044|559803441|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
155172731|NCT03255083|560071898|FG000|Overall Study|Clinical progression|1|||
155172732|NCT03255083|560071899|FG001|Overall Study|Clinical progression|0|||
155172733|NCT03255083|560071900|FG002|Overall Study|Clinical progression|0|||
155101012|NCT02840253|559803444|FG000|Overall Study|Unsuccessful block|4|||
155172734|NCT03255083|560071901|FG003|Overall Study|Clinical progression|0|||
155172735|NCT03255083|560071898|FG000|Overall Study|Adverse Event|0|||
155172736|NCT03255083|560071899|FG001|Overall Study|Adverse Event|1|||
155101013|NCT03801928|559803447|FG000|Overall Study|Adverse Event|1|||
155101014|NCT03801928|559803448|FG001|Overall Study|Adverse Event|0|||
155101015|NCT03801928|559803449|FG002|Overall Study|Adverse Event|1|||
155101016|NCT03801928|559803450|FG003|Overall Study|Adverse Event|2|||
155172737|NCT03255083|560071900|FG002|Overall Study|Adverse Event|0|||
155172738|NCT03255083|560071901|FG003|Overall Study|Adverse Event|0|||
155172739|NCT03255083|560071898|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
155172740|NCT03255083|560071899|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
155172741|NCT03255083|560071900|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
155101017|NCT03801928|559803451|FG004|Overall Study|Adverse Event|0|||
155101018|NCT03801928|559803452|FG005|Overall Study|Adverse Event|2|||
155101019|NCT03801928|559803447|FG000|Overall Study|Lack of Efficacy|0|||
155101020|NCT03801928|559803448|FG001|Overall Study|Lack of Efficacy|0|||
155101021|NCT03801928|559803449|FG002|Overall Study|Lack of Efficacy|1|||
155101022|NCT03801928|559803450|FG003|Overall Study|Lack of Efficacy|0|||
155101023|NCT03801928|559803451|FG004|Overall Study|Lack of Efficacy|0|||
155101024|NCT03801928|559803452|FG005|Overall Study|Lack of Efficacy|0|||
155101025|NCT03801928|559803447|FG000|Overall Study|Lost to Follow-up|5|||
155101026|NCT03801928|559803448|FG001|Overall Study|Lost to Follow-up|1|||
155101027|NCT03801928|559803449|FG002|Overall Study|Lost to Follow-up|1|||
155101028|NCT03801928|559803450|FG003|Overall Study|Lost to Follow-up|4|||
155101029|NCT03801928|559803451|FG004|Overall Study|Lost to Follow-up|4|||
155101030|NCT03801928|559803452|FG005|Overall Study|Lost to Follow-up|2|||
155101031|NCT03801928|559803447|FG000|Overall Study|Withdrawal by Subject|0|||
155101032|NCT03801928|559803448|FG001|Overall Study|Withdrawal by Subject|0|||
155101033|NCT03801928|559803449|FG002|Overall Study|Withdrawal by Subject|2|||
155101034|NCT03801928|559803450|FG003|Overall Study|Withdrawal by Subject|1|||
155101035|NCT03801928|559803451|FG004|Overall Study|Withdrawal by Subject|0|||
155101036|NCT03801928|559803452|FG005|Overall Study|Withdrawal by Subject|0|||
155101037|NCT03801928|559803447|FG000|Overall Study|Other|0|||
155101038|NCT03801928|559803448|FG001|Overall Study|Other|2|||
155101039|NCT03801928|559803449|FG002|Overall Study|Other|0|||
155101040|NCT03801928|559803450|FG003|Overall Study|Other|1|||
155101041|NCT03801928|559803451|FG004|Overall Study|Other|0|||
155101042|NCT03801928|559803452|FG005|Overall Study|Other|1|||
155101043|NCT03688919|559803453|FG000|Overall Study|Lost to Follow-up|2|||
155101044|NCT03688919|559803454|FG001|Overall Study|Lost to Follow-up|1|||
155101045|NCT03688919|559803453|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
155101046|NCT03688919|559803454|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
155101047|NCT00564733|559803455|FG000|Overall Study|Withdrawal by Subject|4|||
155101048|NCT00564733|559803455|FG000|Overall Study|Ineligible|5|||
155101049|NCT01484496|559803458|FG000|Period 1|Protocol Violation|3|||
155101050|NCT01484496|559803459|FG001|Period 1|Protocol Violation|4|||
155101051|NCT01484496|559803460|FG002|Period 1|Protocol Violation|0|||
155101052|NCT01484496|559803461|FG003|Period 1|Protocol Violation|0|||
155101053|NCT01484496|559803458|FG000|Period 1|Physician Decision|5|||
155101054|NCT01484496|559803459|FG001|Period 1|Physician Decision|1|||
155101055|NCT01484496|559803460|FG002|Period 1|Physician Decision|0|||
155101056|NCT01484496|559803461|FG003|Period 1|Physician Decision|0|||
155101057|NCT01484496|559803458|FG000|Period 1|Lack of Efficacy|10|||
155101058|NCT01484496|559803459|FG001|Period 1|Lack of Efficacy|15|||
155101059|NCT01484496|559803460|FG002|Period 1|Lack of Efficacy|0|||
155101060|NCT01484496|559803461|FG003|Period 1|Lack of Efficacy|0|||
155101061|NCT01484496|559803458|FG000|Period 1|Adverse Event|25|||
155101062|NCT01484496|559803459|FG001|Period 1|Adverse Event|40|||
155101063|NCT01484496|559803460|FG002|Period 1|Adverse Event|0|||
155101064|NCT01484496|559803461|FG003|Period 1|Adverse Event|0|||
155101065|NCT01484496|559803458|FG000|Period 1|Withdrawal by Subject|15|||
155101066|NCT01484496|559803459|FG001|Period 1|Withdrawal by Subject|12|||
155101067|NCT01484496|559803460|FG002|Period 1|Withdrawal by Subject|0|||
155101068|NCT01484496|559803461|FG003|Period 1|Withdrawal by Subject|0|||
155101069|NCT01484496|559803458|FG000|Period 1|Lost to Follow-up|2|||
155101070|NCT01484496|559803459|FG001|Period 1|Lost to Follow-up|6|||
155101071|NCT01484496|559803460|FG002|Period 1|Lost to Follow-up|0|||
155101072|NCT01484496|559803461|FG003|Period 1|Lost to Follow-up|0|||
155101073|NCT01484496|559803458|FG000|Period 1|Positive Pregnancy|1|||
155101074|NCT01484496|559803459|FG001|Period 1|Positive Pregnancy|6|||
155101075|NCT01484496|559803460|FG002|Period 1|Positive Pregnancy|0|||
155101076|NCT01484496|559803461|FG003|Period 1|Positive Pregnancy|0|||
155101077|NCT01484496|559803458|FG000|Period 1|Treatment Failure|3|||
155101078|NCT01484496|559803459|FG001|Period 1|Treatment Failure|6|||
155101079|NCT01484496|559803460|FG002|Period 1|Treatment Failure|0|||
155101080|NCT01484496|559803461|FG003|Period 1|Treatment Failure|0|||
155101081|NCT01484496|559803458|FG000|Period 1|Lack of Compliance|2|||
155172742|NCT03255083|560071901|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
155101082|NCT01484496|559803459|FG001|Period 1|Lack of Compliance|1|||
155101083|NCT01484496|559803460|FG002|Period 1|Lack of Compliance|0|||
155101084|NCT01484496|559803461|FG003|Period 1|Lack of Compliance|0|||
155101085|NCT01484496|559803458|FG000|Period 1|Unable to Visit Site|0|||
155101086|NCT01484496|559803459|FG001|Period 1|Unable to Visit Site|2|||
155101087|NCT01484496|559803460|FG002|Period 1|Unable to Visit Site|0|||
155101088|NCT01484496|559803461|FG003|Period 1|Unable to Visit Site|0|||
155101089|NCT01484496|559803458|FG000|Period 2|Lack of Efficacy|0|||
155101090|NCT01484496|559803459|FG001|Period 2|Lack of Efficacy|0|||
155101091|NCT01484496|559803460|FG002|Period 2|Lack of Efficacy|1|||
154969114|NCT01867658|559310424|FG000|Overall Study|Withdrawal by Subject|6|||
155101092|NCT01484496|559803461|FG003|Period 2|Lack of Efficacy|3|||
155101093|NCT01484496|559803458|FG000|Period 2|Adverse Event|0|||
155101094|NCT01484496|559803459|FG001|Period 2|Adverse Event|0|||
155101095|NCT01484496|559803460|FG002|Period 2|Adverse Event|5|||
155101096|NCT01484496|559803461|FG003|Period 2|Adverse Event|13|||
155101097|NCT01484496|559803458|FG000|Period 2|Other|0|||
155101098|NCT01484496|559803459|FG001|Period 2|Other|0|||
155101099|NCT01484496|559803460|FG002|Period 2|Other|9|||
155101100|NCT01484496|559803461|FG003|Period 2|Other|6|||
155101101|NCT01456130|559803462|FG000|Overall Study|Adverse Event|4|||
155101102|NCT01456130|559803462|FG000|Overall Study|Voluntary Withdrawal|1|||
155101103|NCT01456130|559803462|FG000|Overall Study|Lack of Efficacy|4|||
155101104|NCT01456130|559803462|FG000|Overall Study|Other|1|||
155101105|NCT01135459|559803463|FG000|Overall Study|Adverse Event|8|||
155101106|NCT01135459|559803464|FG001|Overall Study|Adverse Event|10|||
155101107|NCT01135459|559803463|FG000|Overall Study|Lack of Efficacy|3|||
155101108|NCT01135459|559803464|FG001|Overall Study|Lack of Efficacy|1|||
155101109|NCT01135459|559803463|FG000|Overall Study|Withdrawal by Subject|2|||
155101110|NCT01135459|559803464|FG001|Overall Study|Withdrawal by Subject|3|||
155101111|NCT01135459|559803463|FG000|Overall Study|Protocol Violation|5|||
155101112|NCT01135459|559803464|FG001|Overall Study|Protocol Violation|3|||
155101113|NCT01135459|559803463|FG000|Overall Study|Lost to Follow-up|2|||
155101114|NCT01135459|559803464|FG001|Overall Study|Lost to Follow-up|1|||
155101115|NCT01135459|559803463|FG000|Overall Study|Non-compliance to study procedures|0|||
155101116|NCT01135459|559803464|FG001|Overall Study|Non-compliance to study procedures|1|||
155101117|NCT01135459|559803463|FG000|Overall Study|Other than specified|1|||
155101118|NCT01135459|559803464|FG001|Overall Study|Other than specified|1|||
155101119|NCT02236572|559803466|FG000|Overall Study|Withdrawal by Subject|1|||
155101120|NCT02236572|559803466|FG000|Overall Study|Protocol Violation|1|||
155101121|NCT02236572|559803466|FG000|Overall Study|Lost to Follow-up|1|||
155101122|NCT02959463|559803467|FG000|Overall Study|Adverse Event|1|||
155101123|NCT02959463|559803468|FG001|Overall Study|Adverse Event|1|||
155101124|NCT02959463|559803467|FG000|Overall Study|Death|1|||
155101125|NCT02959463|559803468|FG001|Overall Study|Death|0|||
155101126|NCT02959463|559803467|FG000|Overall Study|Withdrawal by Subject|1|||
155101127|NCT02959463|559803468|FG001|Overall Study|Withdrawal by Subject|0|||
155101128|NCT00709319|559803469|FG000|Overall Study|Death|4|||
155101129|NCT00709319|559803469|FG000|Overall Study|Withdrawal by Subject|2|||
155101130|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
155101131|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
155101132|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
155101133|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
155101134|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
155101135|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
155101136|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
155101137|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
155101138|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
155101139|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
155101140|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
155101141|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
155101142|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
155101143|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
155101144|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
155101145|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
155101146|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
155101147|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
154969115|NCT01867658|559310424|FG000|Overall Study|Death|2|||
155101148|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
155101149|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
155101150|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
155101151|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
155101152|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
155101153|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
155101154|NCT01672879|559803470|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
154969116|NCT01867658|559310424|FG000|Overall Study|Subject could not be contacted|1|||
154969117|NCT03101358|559310425|FG000|Overall Study|Non-compliance with study schedule|1|||
154969118|NCT03101358|559310426|FG001|Overall Study|Non-compliance with study schedule|0|||
155101155|NCT01672879|559803471|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
155101156|NCT01672879|559803472|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
155101157|NCT01672879|559803470|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
155101158|NCT01672879|559803471|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
155101159|NCT01672879|559803472|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
155101160|NCT01672879|559803470|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
155101161|NCT01672879|559803471|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
155101162|NCT01672879|559803472|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
155101163|NCT01672879|559803470|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
155101164|NCT01672879|559803471|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
155101165|NCT01672879|559803472|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
155101166|NCT01672879|559803470|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
155101167|NCT01672879|559803471|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
155101168|NCT01672879|559803472|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
155101169|NCT04860869|559803473|FG000|Overall Study|Withdrawal by Subject|1|||
155101170|NCT04860869|559803474|FG001|Overall Study|Withdrawal by Subject|0|||
155101171|NCT02651116|559803475|FG000|Overall Study|Adverse Event|0|||
155101172|NCT02651116|559803476|FG001|Overall Study|Adverse Event|1|||
155101173|NCT02651116|559803475|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
155101174|NCT02651116|559803476|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
155101175|NCT03810014|559803482|FG000|Overall Study|Pregnancy|2|||
155101176|NCT03810014|559803483|FG001|Overall Study|Pregnancy|2|||
155101177|NCT03810014|559803484|FG002|Overall Study|Pregnancy|0|||
155101178|NCT03810014|559803485|FG003|Overall Study|Pregnancy|2|||
155101179|NCT03606486|559803486|FG000|Overall Study|Unable to collect sample|5|||
155101180|NCT00442416|559803492|FG000|Overall Study|Adverse Event|4|||
155101181|NCT00442416|559803493|FG001|Overall Study|Adverse Event|1|||
155101182|NCT00442416|559803492|FG000|Overall Study|Death|1|||
155101183|NCT00442416|559803493|FG001|Overall Study|Death|0|||
155101184|NCT00442416|559803492|FG000|Overall Study|Lack of Efficacy|2|||
155101185|NCT00442416|559803493|FG001|Overall Study|Lack of Efficacy|0|||
155101186|NCT00442416|559803492|FG000|Overall Study|Protocol Violation|2|||
155101187|NCT00442416|559803493|FG001|Overall Study|Protocol Violation|3|||
155101188|NCT00442416|559803492|FG000|Overall Study|Withdrew consent|1|||
155101189|NCT00442416|559803493|FG001|Overall Study|Withdrew consent|2|||
155101190|NCT00442416|559803492|FG000|Overall Study|Administrative/Other|27|||
155101191|NCT00442416|559803493|FG001|Overall Study|Administrative/Other|33|||
155101192|NCT00503425|559803503|FG000|Overall Study|Participant files lost|6|||
155101193|NCT00503425|559803503|FG000|Overall Study|Adverse Event|5|||
155101194|NCT00503425|559803503|FG000|Overall Study|Lack of Efficacy|25|||
155101195|NCT00503425|559803503|FG000|Overall Study|Withdrawal by Subject|8|||
155101196|NCT00503425|559803503|FG000|Overall Study|Lost to Follow-up|3|||
155101197|NCT00503425|559803503|FG000|Overall Study|Death|3|||
155101198|NCT00503425|559803503|FG000|Overall Study|Missing Data/Unknown|4|||
154835511|NCT01081912|558833263|FG000|Conversion/Titration|Lost to Follow-up|5|||
154835512|NCT01081912|558833264|FG001|Conversion/Titration|Lost to Follow-up|0|||
154835513|NCT01081912|558833265|FG002|Conversion/Titration|Lost to Follow-up|0|||
154835514|NCT01081912|558833263|FG000|Conversion/Titration|Physician Decision|2|||
155101199|NCT02148263|559803504|FG000|Overall Study|Withdrawal by Subject|3|||
155101200|NCT02148263|559803505|FG001|Overall Study|Withdrawal by Subject|2|||
155101201|NCT00003869|559803506|FG000|Overall Study|Adverse Event|14|||
155101202|NCT00003869|559803507|FG001|Overall Study|Adverse Event|3|||
155101203|NCT00003869|559803506|FG000|Overall Study|Withdrawal by Subject|21|||
155101204|NCT00003869|559803507|FG001|Overall Study|Withdrawal by Subject|3|||
155101205|NCT00003869|559803506|FG000|Overall Study|Death|1|||
155101206|NCT00003869|559803507|FG001|Overall Study|Death|2|||
155101207|NCT00003869|559803506|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
155101208|NCT00003869|559803507|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
155101209|NCT03364231|559803508|FG000|Overall Study|Adverse Event|1|||
155101210|NCT03364231|559803509|FG001|Overall Study|Adverse Event|4|||
155101211|NCT03364231|559803508|FG000|Overall Study|Death|1|||
155101212|NCT03364231|559803509|FG001|Overall Study|Death|0|||
155101213|NCT03364231|559803508|FG000|Overall Study|Investigator Decision|2|||
155101214|NCT03364231|559803509|FG001|Overall Study|Investigator Decision|2|||
155101215|NCT03364231|559803508|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
155101216|NCT03364231|559803509|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
155101217|NCT03364231|559803508|FG000|Overall Study|Withdrawal of Subject Consent|1|||
155101218|NCT03364231|559803509|FG001|Overall Study|Withdrawal of Subject Consent|0|||
155101219|NCT03364231|559803508|FG000|Overall Study|Reason Not Specified|1|||
155101220|NCT03364231|559803509|FG001|Overall Study|Reason Not Specified|0|||
155101221|NCT03364231|559803508|FG000|Overall Study|Disease Progression|0|||
155101222|NCT03364231|559803509|FG001|Overall Study|Disease Progression|6|||
155101223|NCT02708680|559803516|FG000|Overall Study|Withdrawal by Subject|4|||
155101224|NCT02708680|559803517|FG001|Overall Study|Withdrawal by Subject|12|||
155101225|NCT02708680|559803518|FG002|Overall Study|Withdrawal by Subject|12|||
155101226|NCT02708680|559803516|FG000|Overall Study|Death|4|||
154835515|NCT01081912|558833264|FG001|Conversion/Titration|Physician Decision|0|||
154835516|NCT01081912|558833265|FG002|Conversion/Titration|Physician Decision|0|||
154835517|NCT01081912|558833263|FG000|Conversion/Titration|Protocol Violation|67|||
154835518|NCT01081912|558833264|FG001|Conversion/Titration|Protocol Violation|0|||
154835519|NCT01081912|558833265|FG002|Conversion/Titration|Protocol Violation|0|||
154835520|NCT01081912|558833263|FG000|Conversion/Titration|Withdrawal by Subject|23|||
154835521|NCT01081912|558833264|FG001|Conversion/Titration|Withdrawal by Subject|0|||
154835522|NCT01081912|558833265|FG002|Conversion/Titration|Withdrawal by Subject|0|||
154835523|NCT01081912|558833263|FG000|Conversion/Titration|Non-Compliance|47|||
154835524|NCT01081912|558833264|FG001|Conversion/Titration|Non-Compliance|0|||
154835525|NCT01081912|558833265|FG002|Conversion/Titration|Non-Compliance|0|||
154835526|NCT01081912|558833263|FG000|Maintenance Treatment|Adverse Event|0|||
154835527|NCT01081912|558833264|FG001|Maintenance Treatment|Adverse Event|2|||
154835528|NCT01081912|558833265|FG002|Maintenance Treatment|Adverse Event|12|||
154835529|NCT01081912|558833263|FG000|Maintenance Treatment|Lack of Efficacy|0|||
154835530|NCT01081912|558833264|FG001|Maintenance Treatment|Lack of Efficacy|14|||
154835531|NCT01081912|558833265|FG002|Maintenance Treatment|Lack of Efficacy|64|||
154835532|NCT01081912|558833263|FG000|Maintenance Treatment|Lost to Follow-up|0|||
154835533|NCT01081912|558833264|FG001|Maintenance Treatment|Lost to Follow-up|1|||
154835534|NCT01081912|558833265|FG002|Maintenance Treatment|Lost to Follow-up|0|||
154835535|NCT01081912|558833263|FG000|Maintenance Treatment|Physician Decision|0|||
154835536|NCT01081912|558833264|FG001|Maintenance Treatment|Physician Decision|0|||
155101227|NCT02708680|559803517|FG001|Overall Study|Death|19|||
155101228|NCT02708680|559803518|FG002|Overall Study|Death|21|||
154835537|NCT01081912|558833265|FG002|Maintenance Treatment|Physician Decision|1|||
154835538|NCT01081912|558833263|FG000|Maintenance Treatment|Protocol Violation|0|||
154835539|NCT01081912|558833264|FG001|Maintenance Treatment|Protocol Violation|1|||
155101229|NCT02708680|559803516|FG000|Overall Study|Lost to Follow-up|0|||
155101230|NCT02708680|559803517|FG001|Overall Study|Lost to Follow-up|3|||
155101231|NCT02708680|559803518|FG002|Overall Study|Lost to Follow-up|3|||
155101232|NCT02708680|559803516|FG000|Overall Study|Study Terminated By Sponsor|0|||
155101233|NCT02708680|559803517|FG001|Overall Study|Study Terminated By Sponsor|5|||
155101234|NCT02708680|559803518|FG002|Overall Study|Study Terminated By Sponsor|4|||
155101235|NCT02708680|559803516|FG000|Overall Study|Other than Specified|0|||
155101236|NCT02708680|559803517|FG001|Overall Study|Other than Specified|0|||
155101237|NCT02708680|559803518|FG002|Overall Study|Other than Specified|1|||
155101238|NCT02708680|559803516|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
155101239|NCT02708680|559803517|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
155101240|NCT02708680|559803518|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
155101241|NCT04162470|559803519|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
155101242|NCT03929913|559803522|FG000|Overall Study|Death|4|||
155101243|NCT03929913|559803522|FG000|Overall Study|Lost to Follow-up|1|||
155101244|NCT03929913|559803522|FG000|Overall Study|Failed Procedure|2|||
155101245|NCT03919929|559803523|FG000|Overall Study|Withdrawal by Subject|0|||
155101246|NCT03919929|559803524|FG001|Overall Study|Withdrawal by Subject|4|||
155101247|NCT03919929|559803523|FG000|Overall Study|Screen Failure|0|||
155101248|NCT03919929|559803524|FG001|Overall Study|Screen Failure|5|||
155101249|NCT03941483|559803525|FG000|Overall Study|Miscellaneous|2|||
155101250|NCT03941483|559803526|FG001|Overall Study|Miscellaneous|3|||
155101251|NCT03941483|559803527|FG002|Overall Study|Miscellaneous|0|||
155101252|NCT03941483|559803525|FG000|Overall Study|Study Terminated by Sponsor|1|||
155101253|NCT03941483|559803526|FG001|Overall Study|Study Terminated by Sponsor|0|||
155101254|NCT03941483|559803527|FG002|Overall Study|Study Terminated by Sponsor|0|||
155101255|NCT03941483|559803525|FG000|Overall Study|Withdrawal by Subject|1|||
155101256|NCT03941483|559803526|FG001|Overall Study|Withdrawal by Subject|4|||
155101257|NCT03941483|559803527|FG002|Overall Study|Withdrawal by Subject|1|||
155101258|NCT03941483|559803525|FG000|Overall Study|Lost to Follow-up|2|||
155101259|NCT03941483|559803526|FG001|Overall Study|Lost to Follow-up|1|||
155101260|NCT03941483|559803527|FG002|Overall Study|Lost to Follow-up|8|||
155101261|NCT03941483|559803525|FG000|Overall Study|Death|3|||
155101262|NCT03941483|559803526|FG001|Overall Study|Death|2|||
155101263|NCT03941483|559803527|FG002|Overall Study|Death|6|||
155101264|NCT04749745|559803528|FG000|Overall Study|Withdrawal by Subject|1|||
155101265|NCT04749745|559803529|FG001|Overall Study|Withdrawal by Subject|0|||
155101266|NCT01234480|559804993|FG000|Overall Study|Pregnancy|88|||
155101267|NCT01234480|559804993|FG000|Overall Study|>36/Normal History|50|||
155101268|NCT01234480|559804993|FG000|Overall Study|Age|3|||
155101269|NCT01234480|559804993|FG000|Overall Study|HPV Vaccine History|28|||
155101270|NCT01234480|559804993|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
155101271|NCT01234480|559804993|FG000|Overall Study|Hysterectomy|2|||
155101272|NCT01234480|559804993|FG000|Overall Study|Hysterectomy post enrollment|1|||
154835540|NCT01081912|558833265|FG002|Maintenance Treatment|Protocol Violation|2|||
155101273|NCT01234480|559804993|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
155101274|NCT01234480|559804993|FG000|Overall Study|Informed Consent Form Violation|30|||
155101275|NCT01234480|559804993|FG000|Overall Study|Incorrect Visit|3|||
155101276|NCT01234480|559804993|FG000|Overall Study|No Florida Lab License|20|||
155101277|NCT01234480|559804993|FG000|Overall Study|Out of Window|42|||
154835541|NCT01081912|558833263|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
155101278|NCT01234480|559804993|FG000|Overall Study|Sample Processing/Storage|92|||
155101279|NCT01234480|559804993|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
155101280|NCT01234480|559804993|FG000|Overall Study|Site/Subject non-compliance|44|||
155101281|NCT01234480|559804993|FG000|Overall Study|Missing Sample|9|||
155101282|NCT00617084|559804994|FG000|Overall Study|Withdrawal by Subject|5|||
155101283|NCT00617084|559804995|FG001|Overall Study|Withdrawal by Subject|7|||
155101284|NCT00617084|559804994|FG000|Overall Study|Missed 12 Months visit|16|||
155101285|NCT00617084|559804995|FG001|Overall Study|Missed 12 Months visit|19|||
155101286|NCT03370419|559804996|FG000|Overall Study|Lost to Follow-up|16|||
155101287|NCT01693250|559805001|FG000|Overall Study|Lost to Follow-up|2|||
155101288|NCT01693250|559805002|FG001|Overall Study|Lost to Follow-up|2|||
155101289|NCT01147965|559805003|FG000|Overall Study|Progressive Disease|3|||
155101290|NCT01147965|559805004|FG001|Overall Study|Progressive Disease|3|||
155101291|NCT01147965|559805005|FG002|Overall Study|Progressive Disease|5|||
155101292|NCT01147965|559805006|FG003|Overall Study|Progressive Disease|9|||
155101293|NCT01147965|559805007|FG004|Overall Study|Progressive Disease|5|||
155101294|NCT01147965|559805008|FG005|Overall Study|Progressive Disease|5|||
155101295|NCT01147965|559805003|FG000|Overall Study|Death|0|||
155101296|NCT01147965|559805004|FG001|Overall Study|Death|0|||
155101297|NCT01147965|559805005|FG002|Overall Study|Death|1|||
155101298|NCT01147965|559805006|FG003|Overall Study|Death|1|||
155101299|NCT01147965|559805007|FG004|Overall Study|Death|0|||
154969119|NCT03101358|559310427|FG002|Overall Study|Non-compliance with study schedule|0|||
155101300|NCT01147965|559805008|FG005|Overall Study|Death|2|||
155101301|NCT01147965|559805003|FG000|Overall Study|Withdrawal by Subject|0|||
155101302|NCT01147965|559805004|FG001|Overall Study|Withdrawal by Subject|0|||
155101303|NCT01147965|559805005|FG002|Overall Study|Withdrawal by Subject|1|||
155101304|NCT01147965|559805006|FG003|Overall Study|Withdrawal by Subject|1|||
155101305|NCT01147965|559805007|FG004|Overall Study|Withdrawal by Subject|0|||
155101306|NCT01147965|559805008|FG005|Overall Study|Withdrawal by Subject|0|||
155101307|NCT01147965|559805003|FG000|Overall Study|Administration Of Alternative Therapy|0|||
155101308|NCT01147965|559805004|FG001|Overall Study|Administration Of Alternative Therapy|0|||
155101309|NCT01147965|559805005|FG002|Overall Study|Administration Of Alternative Therapy|0|||
155101310|NCT01147965|559805006|FG003|Overall Study|Administration Of Alternative Therapy|0|||
155101311|NCT01147965|559805007|FG004|Overall Study|Administration Of Alternative Therapy|0|||
155101312|NCT01147965|559805008|FG005|Overall Study|Administration Of Alternative Therapy|1|||
155101313|NCT01147965|559805003|FG000|Overall Study|Other|0|||
155101314|NCT01147965|559805004|FG001|Overall Study|Other|0|||
155101315|NCT01147965|559805005|FG002|Overall Study|Other|0|||
155101316|NCT01147965|559805006|FG003|Overall Study|Other|3|||
155101317|NCT01147965|559805007|FG004|Overall Study|Other|1|||
155101318|NCT01147965|559805008|FG005|Overall Study|Other|0|||
155101319|NCT02257242|559805009|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
155101320|NCT02257242|559805010|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101321|NCT02257242|559805011|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101322|NCT02257242|559805012|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101323|NCT02257242|559805013|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101324|NCT02257242|559805014|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101325|NCT02257242|559805015|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101326|NCT02257242|559805016|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101327|NCT02257242|559805017|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
155101328|NCT04667949|559805018|FG000|Overall Study|Adverse Event|0|||
155101329|NCT04667949|559805019|FG001|Overall Study|Adverse Event|2|||
155101330|NCT04667949|559805018|FG000|Overall Study|Lost to Follow-up|0|||
155172743|NCT03255083|560071898|FG000|Overall Study|Withdrawal by Subject|1|||
155172744|NCT03255083|560071899|FG001|Overall Study|Withdrawal by Subject|1|||
155172745|NCT03255083|560071900|FG002|Overall Study|Withdrawal by Subject|1|||
155101331|NCT04667949|559805019|FG001|Overall Study|Lost to Follow-up|1|||
155101332|NCT04667949|559805018|FG000|Overall Study|Physician Decision|0|||
155101333|NCT04667949|559805019|FG001|Overall Study|Physician Decision|2|||
155101334|NCT04667949|559805018|FG000|Overall Study|Subject decision|1|||
155101335|NCT04667949|559805019|FG001|Overall Study|Subject decision|7|||
155101336|NCT03783962|559805021|FG000|Overall Study|Lost to Follow-up|3|||
155101337|NCT03783962|559805022|FG001|Overall Study|Lost to Follow-up|6|||
155101338|NCT03783962|559805021|FG000|Overall Study|Protocol Violation|0|||
155101339|NCT03783962|559805022|FG001|Overall Study|Protocol Violation|1|||
155101340|NCT04423939|559805025|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
155101341|NCT04423939|559805026|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
155101342|NCT04423939|559805025|FG000|Overall Study|Death|3|||
155101343|NCT04423939|559805026|FG001|Overall Study|Death|0|||
155101344|NCT04423939|559805025|FG000|Overall Study|Withdrawal by Subject|3|||
155101345|NCT04423939|559805026|FG001|Overall Study|Withdrawal by Subject|0|||
155101346|NCT04423939|559805025|FG000|Overall Study|Caregiver to patient who died|0|||
155101347|NCT04423939|559805026|FG001|Overall Study|Caregiver to patient who died|3|||
155101348|NCT04423939|559805025|FG000|Overall Study|Caregiver to patient who withdrew|0|||
155101349|NCT04423939|559805026|FG001|Overall Study|Caregiver to patient who withdrew|3|||
155101350|NCT00540592|559805027|FG000|Overall Study|Adverse Event|0|||
155101351|NCT00540592|559805028|FG001|Overall Study|Adverse Event|1|||
155101352|NCT00540592|559805029|FG002|Overall Study|Adverse Event|0|||
155101353|NCT00540592|559805030|FG003|Overall Study|Adverse Event|0|||
155101354|NCT00540592|559805031|FG004|Overall Study|Adverse Event|1|||
155101355|NCT00540592|559805032|FG005|Overall Study|Adverse Event|0|||
155101356|NCT00540592|559805033|FG006|Overall Study|Adverse Event|0|||
155101357|NCT00540592|559805034|FG007|Overall Study|Adverse Event|1|||
155101358|NCT00540592|559805035|FG008|Overall Study|Adverse Event|1|||
155101359|NCT00540592|559805036|FG009|Overall Study|Adverse Event|2|||
155101360|NCT00540592|559805027|FG000|Overall Study|Lost to Follow-up|2|||
155101361|NCT00540592|559805028|FG001|Overall Study|Lost to Follow-up|0|||
155101362|NCT00540592|559805029|FG002|Overall Study|Lost to Follow-up|0|||
155101363|NCT00540592|559805030|FG003|Overall Study|Lost to Follow-up|0|||
155101364|NCT00540592|559805031|FG004|Overall Study|Lost to Follow-up|0|||
155101365|NCT00540592|559805032|FG005|Overall Study|Lost to Follow-up|0|||
155101366|NCT00540592|559805033|FG006|Overall Study|Lost to Follow-up|0|||
155101367|NCT00540592|559805034|FG007|Overall Study|Lost to Follow-up|0|||
155101368|NCT00540592|559805035|FG008|Overall Study|Lost to Follow-up|0|||
155101369|NCT00540592|559805036|FG009|Overall Study|Lost to Follow-up|0|||
155101370|NCT00540592|559805027|FG000|Overall Study|Withdrawal by Subject|0|||
155101371|NCT00540592|559805028|FG001|Overall Study|Withdrawal by Subject|0|||
155101372|NCT00540592|559805029|FG002|Overall Study|Withdrawal by Subject|1|||
155101373|NCT00540592|559805030|FG003|Overall Study|Withdrawal by Subject|1|||
155101374|NCT00540592|559805031|FG004|Overall Study|Withdrawal by Subject|0|||
155101375|NCT00540592|559805032|FG005|Overall Study|Withdrawal by Subject|0|||
155101376|NCT00540592|559805033|FG006|Overall Study|Withdrawal by Subject|0|||
155101377|NCT00540592|559805034|FG007|Overall Study|Withdrawal by Subject|0|||
155101378|NCT00540592|559805035|FG008|Overall Study|Withdrawal by Subject|0|||
155101379|NCT00540592|559805036|FG009|Overall Study|Withdrawal by Subject|0|||
155101380|NCT03369665|559805040|FG000|Overall Study|Adverse Event|3|||
155101381|NCT03369665|559805040|FG000|Overall Study|Lost to Follow-up|7|||
155101382|NCT03369665|559805040|FG000|Overall Study|Withdrawal by Subject|15|||
155101383|NCT03369665|559805040|FG000|Overall Study|Progression Disease|2|||
155101384|NCT03369665|559805040|FG000|Overall Study|Not classified|3|||
155101385|NCT04908683|559805041|FG000|Overall Study|Failure to meet continuation criteria|34|||
155101386|NCT04908683|559805042|FG001|Overall Study|Failure to meet continuation criteria|22|||
155101387|NCT04908683|559805041|FG000|Overall Study|Initiated prohibited medication|3|||
155101388|NCT04908683|559805042|FG001|Overall Study|Initiated prohibited medication|0|||
155101389|NCT04908683|559805041|FG000|Overall Study|Randomized by mistake|1|||
155101390|NCT04908683|559805042|FG001|Overall Study|Randomized by mistake|0|||
155101391|NCT04908683|559805041|FG000|Overall Study|Lost to Follow-up|679|||
155101392|NCT04908683|559805042|FG001|Overall Study|Lost to Follow-up|341|||
155101393|NCT04908683|559805041|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
155101394|NCT04908683|559805042|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
155101395|NCT04908683|559805041|FG000|Overall Study|Physician Decision|44|||
155101396|NCT04908683|559805042|FG001|Overall Study|Physician Decision|35|||
155101397|NCT04908683|559805041|FG000|Overall Study|Technical problems|12|||
155101398|NCT04908683|559805042|FG001|Overall Study|Technical problems|9|||
155101399|NCT04908683|559805041|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
155172746|NCT03255083|560071901|FG003|Overall Study|Withdrawal by Subject|0|||
155172747|NCT01457352|560071906|FG000|Period 1|Adverse Event|2|||
155172748|NCT01457352|560071907|FG001|Period 1|Adverse Event|0|||
155172749|NCT01457352|560071906|FG000|Period 1|Withdrawal by Subject|2|||
155172750|NCT01457352|560071907|FG001|Period 1|Withdrawal by Subject|0|||
155172751|NCT01457352|560071906|FG000|Period 1|Physician Decision|2|||
155172752|NCT01457352|560071907|FG001|Period 1|Physician Decision|0|||
155172753|NCT01457352|560071906|FG000|Period 1|MS related disease progression|1|||
155172754|NCT01457352|560071907|FG001|Period 1|MS related disease progression|0|||
155172755|NCT01457352|560071906|FG000|Period 1|Withdrawn|1|||
155172756|NCT01457352|560071907|FG001|Period 1|Withdrawn|0|||
155172757|NCT01457352|560071906|FG000|Period 1|withdrew per sponsor|1|||
155172758|NCT01457352|560071907|FG001|Period 1|withdrew per sponsor|0|||
155172759|NCT01457352|560071906|FG000|Period 1|Protocol Violation|4|||
155172760|NCT01457352|560071907|FG001|Period 1|Protocol Violation|0|||
155172761|NCT01457352|560071906|FG000|Period 1|Did not meet eligibility criteria|3|||
154969120|NCT03101358|559310428|FG003|Overall Study|Non-compliance with study schedule|1|||
155172762|NCT01457352|560071907|FG001|Period 1|Did not meet eligibility criteria|0|||
155172763|NCT01457352|560071906|FG000|Period 2|Withdrawal by Subject|23|||
155172764|NCT01457352|560071907|FG001|Period 2|Withdrawal by Subject|0|||
155172765|NCT01457352|560071906|FG000|Period 2|Adverse Event|22|||
155172766|NCT01457352|560071907|FG001|Period 2|Adverse Event|0|||
155101400|NCT04908683|559805042|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
155101401|NCT04908683|559805041|FG000|Overall Study|Protocol Violation|2|||
155101402|NCT04908683|559805042|FG001|Overall Study|Protocol Violation|0|||
155101403|NCT04908683|559805041|FG000|Overall Study|Withdrawal by Subject|1188|||
155101404|NCT04908683|559805042|FG001|Overall Study|Withdrawal by Subject|570|||
155101405|NCT04908683|559805041|FG000|Overall Study|Site Closure by Sponsor|6|||
155101406|NCT04908683|559805042|FG001|Overall Study|Site Closure by Sponsor|3|||
155101407|NCT04908683|559805041|FG000|Overall Study|Adverse Event|21|||
155101408|NCT04908683|559805042|FG001|Overall Study|Adverse Event|11|||
155101409|NCT04908683|559805041|FG000|Overall Study|Death|101|||
155101410|NCT04908683|559805042|FG001|Overall Study|Death|61|||
155101411|NCT04908683|559805041|FG000|Overall Study|Sponsor's decision|14398|||
155101412|NCT04908683|559805042|FG001|Overall Study|Sponsor's decision|7205|||
155101413|NCT04908683|559805041|FG000|Overall Study|Other|92|||
155101414|NCT04908683|559805042|FG001|Overall Study|Other|50|||
155101415|NCT04908683|559805041|FG000|Overall Study|Randomized not vaccinated|108|||
155101416|NCT04908683|559805042|FG001|Overall Study|Randomized not vaccinated|52|||
155101417|NCT02168101|559805043|FG000|Overall Study|Death|2|||
155101418|NCT02168101|559805044|FG001|Overall Study|Death|2|||
155101419|NCT02168101|559805045|FG002|Overall Study|Death|1|||
155101420|NCT05507567|559805046|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
155101421|NCT05507567|559805047|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
155101422|NCT05507567|559805048|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
155101423|NCT05507567|559805046|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
155101424|NCT05507567|559805047|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
155101425|NCT05507567|559805048|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
155101426|NCT05507567|559805046|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
155101427|NCT05507567|559805047|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
155101428|NCT05507567|559805048|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
155101429|NCT05507567|559805046|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
155101430|NCT05507567|559805047|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
155101431|NCT05507567|559805048|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
155101432|NCT01206140|559805052|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
155101433|NCT01206140|559805053|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
154969121|NCT03101358|559310425|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
154969122|NCT03101358|559310426|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
155101434|NCT01766037|559805055|FG000|Overall Study|Adverse Event|1|||
155101435|NCT01766037|559805056|FG001|Overall Study|Adverse Event|0|||
155101436|NCT01766037|559805055|FG000|Overall Study|Lack of Efficacy|1|||
155101437|NCT01766037|559805056|FG001|Overall Study|Lack of Efficacy|0|||
155101438|NCT01766037|559805055|FG000|Overall Study|Lost to Follow-up|0|||
154835542|NCT01081912|558833264|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
154835543|NCT01081912|558833265|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
154835544|NCT01081912|558833263|FG000|Maintenance Treatment|Non-Compliance|0|||
154835545|NCT01081912|558833264|FG001|Maintenance Treatment|Non-Compliance|4|||
154835546|NCT01081912|558833265|FG002|Maintenance Treatment|Non-Compliance|7|||
154835547|NCT01081912|558833263|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
154835548|NCT01081912|558833264|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
154835549|NCT01081912|558833265|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
154969123|NCT03101358|559310427|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
154969124|NCT03101358|559310428|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
155101439|NCT01766037|559805056|FG001|Overall Study|Lost to Follow-up|10|||
154835550|NCT02037295|558833266|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
155101440|NCT01766037|559805055|FG000|Overall Study|Physician Decision|0|||
154969125|NCT03101358|559310425|FG000|Overall Study|Physician Decision|1|||
155172767|NCT01457352|560071906|FG000|Period 2|no analysis|10|||
154835551|NCT02037295|558833267|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
154835552|NCT02037295|558833268|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
154835553|NCT02037295|558833269|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
154835554|NCT01140451|558833270|FG000|Overall Study|Withdrawal by Subject|26|||
154835555|NCT01140451|558833271|FG001|Overall Study|Withdrawal by Subject|33|||
154835556|NCT01140451|558833270|FG000|Overall Study|Adverse Event|2|||
154835557|NCT01140451|558833271|FG001|Overall Study|Adverse Event|6|||
154835558|NCT01140451|558833270|FG000|Overall Study|Physician Decision|5|||
154835559|NCT01140451|558833271|FG001|Overall Study|Physician Decision|3|||
154835560|NCT01140451|558833270|FG000|Overall Study|Lost to Follow-up|2|||
154835561|NCT01140451|558833271|FG001|Overall Study|Lost to Follow-up|0|||
154835562|NCT01140451|558833270|FG000|Overall Study|Participants Planning Pregnancy|3|||
154835563|NCT01140451|558833271|FG001|Overall Study|Participants Planning Pregnancy|0|||
154835564|NCT00661531|558833277|FG000|Overall Study|Withdrawal by Subject|3|||
154835565|NCT03134599|558833278|FG000|Week 1|Lost to Follow-up|0|||
154835566|NCT03134599|558833279|FG001|Week 1|Lost to Follow-up|0|||
154835567|NCT03134599|558833280|FG002|Week 1|Lost to Follow-up|0|||
154835568|NCT03134599|558833281|FG003|Week 1|Lost to Follow-up|0|||
154835569|NCT03134599|558833282|FG004|Week 1|Lost to Follow-up|1|||
154835570|NCT03134599|558833283|FG005|Week 1|Lost to Follow-up|0|||
154835571|NCT03134599|558833278|FG000|Week 2|Lost to Follow-up|1|||
154835572|NCT03134599|558833279|FG001|Week 2|Lost to Follow-up|0|||
154835573|NCT03134599|558833280|FG002|Week 2|Lost to Follow-up|0|||
154835574|NCT03134599|558833281|FG003|Week 2|Lost to Follow-up|1|||
154835575|NCT03134599|558833282|FG004|Week 2|Lost to Follow-up|1|||
154835576|NCT03134599|558833283|FG005|Week 2|Lost to Follow-up|0|||
154835577|NCT03134599|558833278|FG000|Week 3|Lost to Follow-up|0|||
154835578|NCT03134599|558833279|FG001|Week 3|Lost to Follow-up|0|||
154835579|NCT03134599|558833280|FG002|Week 3|Lost to Follow-up|0|||
154835580|NCT03134599|558833281|FG003|Week 3|Lost to Follow-up|1|||
154835581|NCT03134599|558833282|FG004|Week 3|Lost to Follow-up|0|||
154835582|NCT03134599|558833283|FG005|Week 3|Lost to Follow-up|1|||
154835583|NCT00705783|558833295|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
154835584|NCT00705783|558833296|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
154835585|NCT00705783|558833297|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
154835586|NCT00705783|558833295|FG000|Conversion Phase|Lost to Follow-up|13|||
154835587|NCT00705783|558833296|FG001|Conversion Phase|Lost to Follow-up|0|||
154835588|NCT00705783|558833297|FG002|Conversion Phase|Lost to Follow-up|0|||
154835589|NCT00705783|558833295|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
154835590|NCT00705783|558833296|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
154835591|NCT00705783|558833297|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
154835592|NCT00705783|558833295|FG000|Conversion Phase|Withdrawn by Investigator|4|||
154835593|NCT00705783|558833296|FG001|Conversion Phase|Withdrawn by Investigator|0|||
154835594|NCT00705783|558833297|FG002|Conversion Phase|Withdrawn by Investigator|0|||
154835595|NCT00705783|558833295|FG000|Conversion Phase|Withdrew Consent|24|||
154835596|NCT00705783|558833296|FG001|Conversion Phase|Withdrew Consent|0|||
154835597|NCT00705783|558833297|FG002|Conversion Phase|Withdrew Consent|0|||
154835598|NCT00705783|558833295|FG000|Conversion Phase|Protocol Deviation|2|||
154835599|NCT00705783|558833296|FG001|Conversion Phase|Protocol Deviation|0|||
154835600|NCT00705783|558833297|FG002|Conversion Phase|Protocol Deviation|0|||
154835601|NCT00705783|558833295|FG000|Conversion Phase|Adverse Event|11|||
154835602|NCT00705783|558833296|FG001|Conversion Phase|Adverse Event|0|||
154835603|NCT00705783|558833297|FG002|Conversion Phase|Adverse Event|0|||
154835604|NCT00705783|558833295|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
154835605|NCT00705783|558833296|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
154835606|NCT00705783|558833297|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
154835607|NCT00705783|558833295|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
154835608|NCT00705783|558833296|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
154835609|NCT00705783|558833297|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
154835610|NCT00705783|558833295|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
154835611|NCT00705783|558833296|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
154835612|NCT00705783|558833297|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
154835613|NCT00705783|558833295|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
154835614|NCT00705783|558833296|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
154969126|NCT03101358|559310426|FG001|Overall Study|Physician Decision|0|||
154835615|NCT00705783|558833297|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
154969127|NCT03101358|559310427|FG002|Overall Study|Physician Decision|0|||
154969128|NCT03101358|559310428|FG003|Overall Study|Physician Decision|3|||
154969129|NCT03101358|559310425|FG000|Overall Study|Adverse Event|0|||
154969130|NCT03101358|559310426|FG001|Overall Study|Adverse Event|0|||
154969131|NCT03101358|559310427|FG002|Overall Study|Adverse Event|1|||
154969132|NCT03101358|559310428|FG003|Overall Study|Adverse Event|0|||
154969133|NCT03101358|559310425|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
154969134|NCT03101358|559310426|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
154969135|NCT03101358|559310427|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
154969136|NCT03101358|559310428|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
154969137|NCT03101358|559310425|FG000|Overall Study|Lost to Follow-up|1|||
154969138|NCT03101358|559310426|FG001|Overall Study|Lost to Follow-up|0|||
154969139|NCT03101358|559310427|FG002|Overall Study|Lost to Follow-up|0|||
154969140|NCT03101358|559310428|FG003|Overall Study|Lost to Follow-up|1|||
154969141|NCT00474058|559310429|FG000|Overall Study|Adverse Event|11|||
154969142|NCT00474058|559310430|FG001|Overall Study|Adverse Event|6|||
154969143|NCT00474058|559310429|FG000|Overall Study|Lack of Efficacy|0|||
154969144|NCT00474058|559310430|FG001|Overall Study|Lack of Efficacy|4|||
155101441|NCT01766037|559805056|FG001|Overall Study|Physician Decision|1|||
155101442|NCT01766037|559805055|FG000|Overall Study|Withdrawal by Subject|18|||
155101443|NCT01766037|559805056|FG001|Overall Study|Withdrawal by Subject|16|||
155101444|NCT01766037|559805055|FG000|Overall Study|Moved from area|5|||
155101445|NCT01766037|559805056|FG001|Overall Study|Moved from area|0|||
155101446|NCT01766037|559805055|FG000|Overall Study|medical - unrelated|1|||
155101447|NCT01766037|559805056|FG001|Overall Study|medical - unrelated|2|||
155101448|NCT01766037|559805055|FG000|Overall Study|nausea / discomfort|3|||
155101449|NCT01766037|559805056|FG001|Overall Study|nausea / discomfort|0|||
155101450|NCT05226598|559805057|FG000|Overall Study|Death|186|||
155101451|NCT05226598|559805058|FG001|Overall Study|Death|191|||
155101452|NCT05226598|559805057|FG000|Overall Study|Withdrawal by Subject|6|||
155101453|NCT05226598|559805058|FG001|Overall Study|Withdrawal by Subject|6|||
155101454|NCT05226598|559805057|FG000|Overall Study|Ongoing|174|||
155101455|NCT05226598|559805058|FG001|Overall Study|Ongoing|176|||
155101456|NCT01057693|559805059|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
155101457|NCT01057693|559805060|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
155101458|NCT01057693|559805061|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
155101459|NCT01057693|559805059|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
155101460|NCT01057693|559805060|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
155101461|NCT01057693|559805061|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
155101462|NCT01057693|559805059|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
155101463|NCT01057693|559805060|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
155101464|NCT01057693|559805061|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
155101465|NCT01057693|559805059|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
155101466|NCT01057693|559805060|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
155101467|NCT01057693|559805061|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
155101468|NCT01057693|559805059|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
155101469|NCT01057693|559805060|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
155101470|NCT01057693|559805061|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
155101471|NCT01057693|559805059|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
155101472|NCT01057693|559805060|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
155101473|NCT01057693|559805061|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
155101474|NCT01057693|559805059|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
155101475|NCT01057693|559805060|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
155101476|NCT01057693|559805061|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
155101477|NCT01057693|559805059|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
155101478|NCT01057693|559805060|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
155101479|NCT01057693|559805061|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
155101480|NCT01057693|559805059|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
155101481|NCT01057693|559805060|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
155101482|NCT01057693|559805061|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
155101483|NCT01057693|559805059|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
155101484|NCT01057693|559805060|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
155101485|NCT01057693|559805061|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
155101486|NCT01057693|559805059|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
155101487|NCT01057693|559805060|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
155101488|NCT01057693|559805061|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
155101489|NCT01057693|559805059|FG000|Between Single-Blind and Double-Blind|Other|6|||
155101490|NCT01057693|559805060|FG001|Between Single-Blind and Double-Blind|Other|0|||
155101491|NCT01057693|559805061|FG002|Between Single-Blind and Double-Blind|Other|0|||
155101492|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
155101493|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
155101494|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
155101495|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
155101496|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
155101497|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
155101498|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
155101499|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
155101500|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
155101501|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
155101502|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
155101503|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
155101504|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
155101505|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
155101506|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
155101507|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
155101508|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
155101509|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
155101510|NCT01057693|559805059|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
155101511|NCT01057693|559805060|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
155101512|NCT01057693|559805061|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
155101513|NCT02413996|559805062|FG000|Overall Study|not comfortable with the intervention|9|||
155101514|NCT02413996|559805063|FG001|Overall Study|not comfortable with the intervention|2|||
155101515|NCT00579553|559805067|FG000|Overall Study|Lost to Follow-up|16|||
154835616|NCT00705783|558833295|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
154969145|NCT00474058|559310429|FG000|Overall Study|Withdrawal by Subject|11|||
155101516|NCT00579553|559805068|FG001|Overall Study|Lost to Follow-up|13|||
155101517|NCT00090779|559805069|FG000|Step 1|Withdrawal by Subject|4|||
155101518|NCT00090779|559805070|FG001|Step 1|Withdrawal by Subject|2|||
155101519|NCT00090779|559805069|FG000|Step 1|Lost to Follow-up|3|||
155101520|NCT00090779|559805070|FG001|Step 1|Lost to Follow-up|2|||
155101521|NCT00090779|559805069|FG000|Step 1|Death|0|||
155101522|NCT00090779|559805070|FG001|Step 1|Death|2|||
155101523|NCT00090779|559805069|FG000|Step 1|Physician Decision|1|||
155101524|NCT00090779|559805070|FG001|Step 1|Physician Decision|0|||
155101525|NCT00090779|559805069|FG000|Step 1|Pregnancy|1|||
155101526|NCT00090779|559805070|FG001|Step 1|Pregnancy|0|||
155101527|NCT00090779|559805069|FG000|Step 1|Non-compliance to study requirements|0|||
155101528|NCT00090779|559805070|FG001|Step 1|Non-compliance to study requirements|1|||
155101529|NCT00090779|559805069|FG000|Step 1|Subject relocated|2|||
155101530|NCT00090779|559805070|FG001|Step 1|Subject relocated|8|||
155101531|NCT00090779|559805069|FG000|Step 2|Off study per study closure|6|||
155101532|NCT00090779|559805070|FG001|Step 2|Off study per study closure|16|||
155101533|NCT00090779|559805069|FG000|Step 2|Subject relocated|0|||
155101534|NCT00090779|559805070|FG001|Step 2|Subject relocated|1|||
155101535|NCT00090779|559805069|FG000|Step 2|Non-compliance to study requirements|0|||
155101536|NCT00090779|559805070|FG001|Step 2|Non-compliance to study requirements|1|||
155101537|NCT00090779|559805069|FG000|Step 3|Initiation of ART and off extended study|3|||
155101538|NCT00090779|559805070|FG001|Step 3|Initiation of ART and off extended study|2|||
155101539|NCT00090779|559805069|FG000|Step 3|Off extended study due to study closure|4|||
155101540|NCT00090779|559805070|FG001|Step 3|Off extended study due to study closure|3|||
155101541|NCT01775553|559805075|FG000|Overall Study|Adverse Event|1|||
155101542|NCT01775553|559805075|FG000|Overall Study|Disease Progression|12|||
155101543|NCT03951766|559805076|FG000|Treatment Phase|Lost to Follow-up|1|||
155101544|NCT03951766|559805076|FG000|Follow-up Phase|Lost to Follow-up|10|||
155101545|NCT04834726|559805080|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
155101546|NCT04834726|559805081|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
155101547|NCT04834726|559805082|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
155101548|NCT04834726|559805083|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
155101549|NCT04834726|559805084|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
155101550|NCT04834726|559805085|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
155101551|NCT04834726|559805086|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
155101552|NCT04834726|559805087|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
155101553|NCT04834726|559805088|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
155101554|NCT01162473|559805090|FG000|Overall Study|Adverse Event|2|||
155101555|NCT01162473|559805091|FG001|Overall Study|Adverse Event|1|||
155101556|NCT01162473|559805090|FG000|Overall Study|Withdrawal by Subject|0|||
155101557|NCT01162473|559805091|FG001|Overall Study|Withdrawal by Subject|4|||
155101558|NCT01144416|559805092|FG000|Intervention Period|Adverse Event|5|||
155172768|NCT01457352|560071907|FG001|Period 2|no analysis|0|||
155101559|NCT01144416|559805093|FG001|Intervention Period|Adverse Event|6|||
155101560|NCT01144416|559805092|FG000|Intervention Period|Insufficient ovarian response|11|||
155101561|NCT01144416|559805093|FG001|Intervention Period|Insufficient ovarian response|17|||
155101562|NCT01144416|559805092|FG000|Intervention Period|Risk of OHSS|0|||
155172769|NCT01457352|560071906|FG000|Period 2|Lack of Efficacy|8|||
155101563|NCT01144416|559805093|FG001|Intervention Period|Risk of OHSS|1|||
155101564|NCT01144416|559805092|FG000|Intervention Period|Too high ovarian response|4|||
155101565|NCT01144416|559805093|FG001|Intervention Period|Too high ovarian response|2|||
155101566|NCT01144416|559805092|FG000|Intervention Period|No/too few/bad oocytes|7|||
155101567|NCT01144416|559805093|FG001|Intervention Period|No/too few/bad oocytes|5|||
155101568|NCT01144416|559805092|FG000|Intervention Period|No or abnormal fertilization|25|||
155101569|NCT01144416|559805093|FG001|Intervention Period|No or abnormal fertilization|10|||
154969146|NCT00474058|559310430|FG001|Overall Study|Withdrawal by Subject|7|||
154969147|NCT00474058|559310429|FG000|Overall Study|Other|2|||
154969148|NCT00474058|559310430|FG001|Overall Study|Other|0|||
154969149|NCT02640235|559310431|FG000|Overall Study|Withdrawal by Subject|7|||
154969150|NCT02640235|559310432|FG001|Overall Study|Withdrawal by Subject|6|||
155101570|NCT01144416|559805092|FG000|Intervention Period|No/too few/bad quality embryos|3|||
155101571|NCT01144416|559805093|FG001|Intervention Period|No/too few/bad quality embryos|3|||
155101572|NCT01144416|559805092|FG000|Intervention Period|Other|7|||
155101573|NCT01144416|559805093|FG001|Intervention Period|Other|5|||
155101574|NCT02534883|559805094|FG000|Overall Study|Early Termination|8|||
155101575|NCT02534883|559805095|FG001|Overall Study|Early Termination|3|||
155172770|NCT01457352|560071907|FG001|Period 2|Lack of Efficacy|0|||
155101576|NCT00886769|559805096|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155101577|NCT00886769|559805097|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
155101578|NCT03328832|559805098|FG000|Overall Study|Lost to Follow-up|0|||
155101579|NCT03328832|559805099|FG001|Overall Study|Lost to Follow-up|1|||
155101580|NCT00414076|559805100|FG000|Overall Study|Progression|1|||
154835617|NCT00705783|558833296|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
155101581|NCT00414076|559805101|FG001|Overall Study|Progression|2|||
155101582|NCT00414076|559805100|FG000|Overall Study|Withdrawal by Subject|1|||
155101583|NCT00414076|559805101|FG001|Overall Study|Withdrawal by Subject|3|||
155101584|NCT00414076|559805100|FG000|Overall Study|Adverse Event|1|||
155101585|NCT00414076|559805101|FG001|Overall Study|Adverse Event|0|||
155101586|NCT00778336|559805104|FG000|Index Procedure-Discharge|Death|6|||
154969151|NCT02640235|559310431|FG000|Overall Study|Lost to Follow-up|4|||
154969152|NCT02640235|559310432|FG001|Overall Study|Lost to Follow-up|3|||
154969153|NCT02640235|559310431|FG000|Overall Study|Death|2|||
155101587|NCT00778336|559805105|FG001|Index Procedure-Discharge|Death|3|||
154835618|NCT00705783|558833297|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
154835619|NCT00705783|558833295|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
154835620|NCT00705783|558833296|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
154835621|NCT00705783|558833297|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
154835622|NCT00705783|558833295|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
154835623|NCT00705783|558833296|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
154835624|NCT00705783|558833297|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
154835625|NCT00705783|558833295|FG000|Oral Stabilization Phase|Adverse Event|14|||
154835626|NCT00705783|558833296|FG001|Oral Stabilization Phase|Adverse Event|0|||
154835627|NCT00705783|558833297|FG002|Oral Stabilization Phase|Adverse Event|0|||
154835628|NCT00705783|558833295|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
154835629|NCT00705783|558833296|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
154835630|NCT00705783|558833297|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
154835631|NCT00705783|558833295|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
154835632|NCT00705783|558833296|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
154835633|NCT00705783|558833297|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
154835634|NCT00705783|558833295|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
154835635|NCT00705783|558833296|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
154835636|NCT00705783|558833297|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
154835637|NCT00705783|558833295|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
154835638|NCT00705783|558833296|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
154835639|NCT00705783|558833297|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
154835640|NCT00705783|558833295|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
154835641|NCT00705783|558833296|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
154835642|NCT00705783|558833297|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
154835643|NCT00705783|558833295|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
154835644|NCT00705783|558833296|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
154835645|NCT00705783|558833297|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
154835646|NCT00705783|558833295|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
154835647|NCT00705783|558833296|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
154835648|NCT00705783|558833297|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
154835649|NCT00705783|558833295|FG000|Depot Stabilization Phase|Adverse Event|17|||
154835650|NCT00705783|558833296|FG001|Depot Stabilization Phase|Adverse Event|0|||
154835651|NCT00705783|558833297|FG002|Depot Stabilization Phase|Adverse Event|0|||
154969154|NCT02640235|559310432|FG001|Overall Study|Death|3|||
154969155|NCT02640235|559310431|FG000|Overall Study|Other|1|||
154835652|NCT00705783|558833295|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
154835653|NCT00705783|558833296|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
154835654|NCT00705783|558833297|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
154835655|NCT00705783|558833295|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
154835656|NCT00705783|558833296|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
154835657|NCT00705783|558833297|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
154835658|NCT00705783|558833295|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
154835659|NCT00705783|558833296|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
154835660|NCT00705783|558833297|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
154835661|NCT00705783|558833295|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
154835662|NCT00705783|558833296|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
154835663|NCT00705783|558833297|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
154835664|NCT00705783|558833295|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
154835665|NCT00705783|558833296|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
154835666|NCT00705783|558833297|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
154835667|NCT00705783|558833295|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
154835668|NCT00705783|558833296|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
154835669|NCT00705783|558833297|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
154835670|NCT00705783|558833295|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
154835671|NCT00705783|558833296|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
154835672|NCT00705783|558833297|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
154835673|NCT00705783|558833295|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
154835674|NCT00705783|558833296|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
154835675|NCT00705783|558833297|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
154835676|NCT00705783|558833295|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
154835677|NCT00705783|558833296|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
154835678|NCT00705783|558833297|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
154835679|NCT00705783|558833295|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
154835680|NCT00705783|558833296|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
154835681|NCT00705783|558833297|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
154835682|NCT00705783|558833295|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
154835683|NCT00705783|558833296|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
154835684|NCT00705783|558833297|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
154835685|NCT01549002|558833307|FG000|Overall Study|Excessive pain|0|||
154835686|NCT01549002|558833308|FG001|Overall Study|Excessive pain|2|||
154835687|NCT01549002|558833307|FG000|Overall Study|Moderate sedation required|0|||
154835688|NCT01549002|558833308|FG001|Overall Study|Moderate sedation required|2|||
154835689|NCT01251367|558833309|FG000|Overall Study|Protocol Violation|1|||
154835690|NCT01251367|558833309|FG000|Overall Study|Lack of Efficacy|2|||
154835691|NCT01251367|558833309|FG000|Overall Study|Adverse Event|19|||
154835692|NCT01251367|558833309|FG000|Overall Study|Withdrawal by Subject|36|||
154835693|NCT01251367|558833309|FG000|Overall Study|Lost to Follow-up|5|||
154835694|NCT01251367|558833309|FG000|Overall Study|Subject Required Alternative Treatment|7|||
154835695|NCT01251367|558833309|FG000|Overall Study|No Study Drug Available|1|||
154835696|NCT01251367|558833309|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
154835697|NCT01251367|558833309|FG000|Overall Study|End of Study Visit Performed in Error|1|||
154835698|NCT02370615|558833314|FG000|Overall Study|Adverse Event|1|||
154835699|NCT02370615|558833315|FG001|Overall Study|Adverse Event|0|||
154835700|NCT00506883|558833318|FG000|Overall Study|Lost to Follow-up|1|||
154835701|NCT00506883|558833319|FG001|Overall Study|Lost to Follow-up|1|||
154835702|NCT00506883|558833320|FG002|Overall Study|Lost to Follow-up|1|||
154835703|NCT00506883|558833318|FG000|Overall Study|Withdrawal by Subject|1|||
154835704|NCT00506883|558833319|FG001|Overall Study|Withdrawal by Subject|0|||
154835705|NCT00506883|558833320|FG002|Overall Study|Withdrawal by Subject|1|||
154835706|NCT00506883|558833318|FG000|Overall Study|Lack of Efficacy|0|||
154835707|NCT00506883|558833319|FG001|Overall Study|Lack of Efficacy|1|||
154835708|NCT00506883|558833320|FG002|Overall Study|Lack of Efficacy|1|||
154835709|NCT00506883|558833318|FG000|Overall Study|Other|5|||
154835710|NCT00506883|558833319|FG001|Overall Study|Other|1|||
154835711|NCT00506883|558833320|FG002|Overall Study|Other|1|||
155101588|NCT00778336|559805106|FG002|Index Procedure-Discharge|Death|2|||
155101589|NCT00778336|559805107|FG003|Index Procedure-Discharge|Death|0|||
154835712|NCT00078325|558833321|FG000|Overall Study|Adverse Event|15|||
154835713|NCT00078325|558833322|FG001|Overall Study|Adverse Event|10|||
154835714|NCT00078325|558833323|FG002|Overall Study|Adverse Event|5|||
155101590|NCT00778336|559805104|FG000|3 Month Follow Up|Lost to Follow-up|15|||
155101591|NCT00778336|559805105|FG001|3 Month Follow Up|Lost to Follow-up|20|||
154835715|NCT00078325|558833321|FG000|Overall Study|Protocol Violation|2|||
154835716|NCT00078325|558833322|FG001|Overall Study|Protocol Violation|2|||
154835717|NCT00078325|558833323|FG002|Overall Study|Protocol Violation|0|||
154835718|NCT00078325|558833321|FG000|Overall Study|Withdrawal by Subject|1|||
154835719|NCT00078325|558833322|FG001|Overall Study|Withdrawal by Subject|5|||
155101592|NCT00778336|559805106|FG002|3 Month Follow Up|Lost to Follow-up|3|||
155101593|NCT00778336|559805107|FG003|3 Month Follow Up|Lost to Follow-up|0|||
155101594|NCT00778336|559805104|FG000|3 Month Follow Up|Death|8|||
155101595|NCT00778336|559805105|FG001|3 Month Follow Up|Death|3|||
155101596|NCT00778336|559805106|FG002|3 Month Follow Up|Death|2|||
155101597|NCT00778336|559805107|FG003|3 Month Follow Up|Death|0|||
155101598|NCT00049257|559805108|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
155101599|NCT00049257|559805108|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
155101600|NCT00049257|559805108|FG000|Carboplatin, Paclitaxel|Death|2|||
155101601|NCT00049257|559805108|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
155101602|NCT04721158|559805109|FG000|Overall Study|Lost to Follow-up|4|||
155172771|NCT01457352|560071906|FG000|Period 2|Protocol Violation|4|||
155172772|NCT01457352|560071907|FG001|Period 2|Protocol Violation|0|||
154835720|NCT00078325|558833323|FG002|Overall Study|Withdrawal by Subject|3|||
154835721|NCT00078325|558833321|FG000|Overall Study|Lost to Follow-up|0|||
155101603|NCT04721158|559805109|FG000|Overall Study|Device did not connect|1|||
155101604|NCT00132301|559805113|FG000|Overall Study|Death|7|||
155172773|NCT01457352|560071906|FG000|Period 2|Sponsor's withdrawal|7|||
155101605|NCT00132301|559805114|FG001|Overall Study|Death|6|||
155101606|NCT00132301|559805113|FG000|Overall Study|Withdrawal by Subject|5|||
154969156|NCT02640235|559310432|FG001|Overall Study|Other|2|||
154969157|NCT00841659|559310437|FG000|Washout: 2 Weeks|Protocol Violation|1|||
154969158|NCT00841659|559310438|FG001|Washout: 2 Weeks|Protocol Violation|0|||
154969159|NCT01024855|559310444|FG000|Overall Study|Inclusion/exclusion criteria|1|||
154969160|NCT03306277|559310445|FG000|Overall Study|Death|1|||
154969161|NCT03306277|559310445|FG000|Overall Study|Adverse Event|1|||
154969162|NCT03306277|559310445|FG000|Overall Study|Withdrawal by Subject|1|||
154969163|NCT00829452|559310448|FG000|First Intervention|Withdrawal by Subject|0|||
154969164|NCT00829452|559310449|FG001|First Intervention|Withdrawal by Subject|1|||
154969165|NCT00829452|559310448|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
154969166|NCT00829452|559310449|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
154969167|NCT00829452|559310448|FG000|Second Intervention|Physician Decision|0|||
154969168|NCT00829452|559310449|FG001|Second Intervention|Physician Decision|1|||
154969169|NCT02436200|559310458|FG000|Overall Study|Significant outlier|1|||
154969170|NCT00819169|559310463|FG000|Overall Study|Withdrawal by Subject|2|||
154969171|NCT00819169|559310464|FG001|Overall Study|Withdrawal by Subject|0|||
154969172|NCT00819169|559310465|FG002|Overall Study|Withdrawal by Subject|0|||
154969173|NCT00819169|559310466|FG003|Overall Study|Withdrawal by Subject|1|||
154969174|NCT00819169|559310467|FG004|Overall Study|Withdrawal by Subject|1|||
154969175|NCT00819169|559310468|FG005|Overall Study|Withdrawal by Subject|1|||
154969176|NCT00819169|559310469|FG006|Overall Study|Withdrawal by Subject|5|||
154969177|NCT00819169|559310470|FG007|Overall Study|Withdrawal by Subject|1|||
154969178|NCT00819169|559310471|FG008|Overall Study|Withdrawal by Subject|4|||
154969179|NCT00819169|559310463|FG000|Overall Study|Lost to Follow-up|0|||
154969180|NCT00819169|559310464|FG001|Overall Study|Lost to Follow-up|2|||
154969181|NCT00819169|559310465|FG002|Overall Study|Lost to Follow-up|0|||
154969182|NCT00819169|559310466|FG003|Overall Study|Lost to Follow-up|1|||
154969183|NCT00819169|559310467|FG004|Overall Study|Lost to Follow-up|0|||
154969184|NCT00819169|559310468|FG005|Overall Study|Lost to Follow-up|6|||
154969185|NCT00819169|559310469|FG006|Overall Study|Lost to Follow-up|2|||
154969186|NCT00819169|559310470|FG007|Overall Study|Lost to Follow-up|2|||
154969187|NCT00819169|559310471|FG008|Overall Study|Lost to Follow-up|1|||
154969188|NCT00819169|559310463|FG000|Overall Study|Death|1|||
154969189|NCT00819169|559310464|FG001|Overall Study|Death|1|||
155101607|NCT00132301|559805114|FG001|Overall Study|Withdrawal by Subject|2|||
155101608|NCT00132301|559805113|FG000|Overall Study|Physician Decision|1|||
155101609|NCT00132301|559805114|FG001|Overall Study|Physician Decision|1|||
155101610|NCT00132301|559805113|FG000|Overall Study|Lost to Follow-up|5|||
154835722|NCT00078325|558833322|FG001|Overall Study|Lost to Follow-up|1|||
154835723|NCT00078325|558833323|FG002|Overall Study|Lost to Follow-up|1|||
154969190|NCT00819169|559310465|FG002|Overall Study|Death|3|||
154969191|NCT00819169|559310466|FG003|Overall Study|Death|8|||
154969192|NCT00819169|559310467|FG004|Overall Study|Death|5|||
154969193|NCT00819169|559310468|FG005|Overall Study|Death|7|||
154969194|NCT00819169|559310469|FG006|Overall Study|Death|9|||
154969195|NCT00819169|559310470|FG007|Overall Study|Death|4|||
154969196|NCT00819169|559310471|FG008|Overall Study|Death|7|||
154969197|NCT00819169|559310463|FG000|Overall Study|Ineligibility determined|0|||
154969198|NCT00819169|559310464|FG001|Overall Study|Ineligibility determined|0|||
154969199|NCT00819169|559310465|FG002|Overall Study|Ineligibility determined|0|||
154969200|NCT00819169|559310466|FG003|Overall Study|Ineligibility determined|2|||
155101611|NCT00132301|559805114|FG001|Overall Study|Lost to Follow-up|3|||
155101612|NCT00132301|559805113|FG000|Overall Study|Other|1|||
155101613|NCT00132301|559805114|FG001|Overall Study|Other|1|||
155101614|NCT00132301|559805113|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
155101615|NCT00132301|559805114|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
155101616|NCT00996658|559805115|FG000|Overall Study|Adverse Event|2|||
155101617|NCT00996658|559805116|FG001|Overall Study|Adverse Event|5|||
155101618|NCT00996658|559805115|FG000|Overall Study|Protocol Violation|0|||
155101619|NCT00996658|559805116|FG001|Overall Study|Protocol Violation|1|||
155101620|NCT00996658|559805115|FG000|Overall Study|Lost to Follow-up|2|||
155101621|NCT00996658|559805116|FG001|Overall Study|Lost to Follow-up|5|||
155101622|NCT00996658|559805115|FG000|Overall Study|Non-compliance issues|3|||
155101623|NCT00996658|559805116|FG001|Overall Study|Non-compliance issues|3|||
155101624|NCT00996658|559805115|FG000|Overall Study|Other|9|||
155101625|NCT00996658|559805116|FG001|Overall Study|Other|7|||
155101626|NCT02685826|559805121|FG000|Overall Study|Adverse Event|2|||
155101627|NCT02685826|559805122|FG001|Overall Study|Adverse Event|0|||
155101628|NCT02685826|559805123|FG002|Overall Study|Adverse Event|1|||
155101629|NCT02685826|559805121|FG000|Overall Study|Progressive Disease|2|||
155101630|NCT02685826|559805122|FG001|Overall Study|Progressive Disease|1|||
155101631|NCT02685826|559805123|FG002|Overall Study|Progressive Disease|0|||
155101632|NCT02685826|559805121|FG000|Overall Study|Withdrawal by Subject|2|||
155101633|NCT02685826|559805122|FG001|Overall Study|Withdrawal by Subject|0|||
155101634|NCT02685826|559805123|FG002|Overall Study|Withdrawal by Subject|0|||
155101635|NCT02685826|559805121|FG000|Overall Study|Full Clinical Hold by FDA|19|||
155101636|NCT02685826|559805122|FG001|Overall Study|Full Clinical Hold by FDA|9|||
155101637|NCT02685826|559805123|FG002|Overall Study|Full Clinical Hold by FDA|20|||
155101638|NCT03154476|559805124|FG000|Overall Study|Lost to Follow-up|4|||
155101639|NCT03154476|559805125|FG001|Overall Study|Lost to Follow-up|4|||
155101640|NCT01444430|559805126|FG000|Overall Study|Withdrawal by Subject|53|||
155101641|NCT01444430|559805127|FG001|Overall Study|Withdrawal by Subject|72|||
155101642|NCT01444430|559805126|FG000|Overall Study|Death|6|||
155101643|NCT01444430|559805127|FG001|Overall Study|Death|8|||
155101644|NCT01444430|559805126|FG000|Overall Study|Lost to Follow-up|2|||
155101645|NCT01444430|559805127|FG001|Overall Study|Lost to Follow-up|0|||
155101646|NCT01444430|559805126|FG000|Overall Study|CRF termination module not completed.|0|||
155101647|NCT01444430|559805127|FG001|Overall Study|CRF termination module not completed.|1|||
155101648|NCT02522429|559806448|FG000|Overall Study|Lost to Follow-up|8|||
155101649|NCT02522429|559806448|FG000|Overall Study|Adverse Event|2|||
155101650|NCT02522429|559806448|FG000|Overall Study|Death|1|||
155101651|NCT02522429|559806448|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
155101652|NCT00600106|559806449|FG000|Overall Study|Withdrawal by Subject|1|||
155101653|NCT00600106|559806450|FG001|Overall Study|Withdrawal by Subject|1|||
155101654|NCT02763059|559806457|FG000|Overall Study|Lost to Follow-up|4|||
155101655|NCT02763059|559806458|FG001|Overall Study|Lost to Follow-up|1|||
155101656|NCT02763059|559806459|FG002|Overall Study|Lost to Follow-up|6|||
155101657|NCT02763059|559806457|FG000|Overall Study|Withdrawal by Subject|1|||
155101658|NCT02763059|559806458|FG001|Overall Study|Withdrawal by Subject|0|||
155101659|NCT02763059|559806459|FG002|Overall Study|Withdrawal by Subject|3|||
155101660|NCT02370368|559806460|FG000|Overall Study|Adverse Event|1|||
155101661|NCT02370368|559806461|FG001|Overall Study|Adverse Event|2|||
155101662|NCT02370368|559806460|FG000|Overall Study|Withdrawal by Subject|5|||
155101663|NCT02370368|559806461|FG001|Overall Study|Withdrawal by Subject|4|||
155101664|NCT01724216|559806462|FG000|Overall Study|Scan was not completed|1|||
155101665|NCT00175916|559806463|FG000|Overall Study|Death|19|||
155101666|NCT00175916|559806463|FG000|Overall Study|Adverse Event|81|||
155101667|NCT00175916|559806463|FG000|Overall Study|Lack of Efficacy|354|||
155101668|NCT00175916|559806463|FG000|Overall Study|Lost to Follow-up|17|||
155101669|NCT00175916|559806463|FG000|Overall Study|Subject Choice|98|||
155101670|NCT00175916|559806463|FG000|Overall Study|Lack of compliance|8|||
155101671|NCT00175916|559806463|FG000|Overall Study|Patient cannot record seizures|1|||
155101672|NCT00175916|559806463|FG000|Overall Study|Sponsor decision|17|||
155101673|NCT00175916|559806463|FG000|Overall Study|Vigabatrin intake|1|||
155172774|NCT01457352|560071907|FG001|Period 2|Sponsor's withdrawal|0|||
155172775|NCT01457352|560071906|FG000|Period 2|Lost to Follow-up|1|||
155101674|NCT00175916|559806463|FG000|Overall Study|Suicidal behaviour|1|||
155101675|NCT00175916|559806463|FG000|Overall Study|Withdrawal by Subject|1|||
155101676|NCT00175916|559806463|FG000|Overall Study|Seizure - free|4|||
155101677|NCT00175916|559806463|FG000|Overall Study|Administrative reason|1|||
155101678|NCT00175916|559806463|FG000|Overall Study|Pregnancy|1|||
155101679|NCT00175916|559806463|FG000|Overall Study|Patient's request|2|||
155101680|NCT00175916|559806463|FG000|Overall Study|Treating physiciant's choice|1|||
155101681|NCT00175916|559806463|FG000|Overall Study|Moved overseas|1|||
155101682|NCT00175916|559806463|FG000|Overall Study|Loss of job and economic burden|1|||
155101683|NCT00175916|559806463|FG000|Overall Study|Site was closed|9|||
155101684|NCT00175916|559806463|FG000|Overall Study|Patient went to prison|1|||
155101685|NCT04024436|559806464|FG000|Overall Study|Death|10|||
155101686|NCT04024436|559806465|FG001|Overall Study|Death|14|||
155101687|NCT04024436|559806466|FG002|Overall Study|Death|2|||
155101688|NCT04024436|559806467|FG003|Overall Study|Death|7|||
155101689|NCT04024436|559806464|FG000|Overall Study|Loss to follow up|1|||
155101690|NCT04024436|559806465|FG001|Overall Study|Loss to follow up|0|||
155101691|NCT04024436|559806466|FG002|Overall Study|Loss to follow up|0|||
155101692|NCT04024436|559806467|FG003|Overall Study|Loss to follow up|1|||
155101693|NCT04024436|559806464|FG000|Overall Study|Withdrawal of consent|2|||
155101694|NCT04024436|559806465|FG001|Overall Study|Withdrawal of consent|0|||
155101695|NCT04024436|559806466|FG002|Overall Study|Withdrawal of consent|0|||
155101696|NCT04024436|559806467|FG003|Overall Study|Withdrawal of consent|1|||
155101697|NCT04024436|559806464|FG000|Overall Study|Study termination by sponsor|4|||
155101698|NCT04024436|559806465|FG001|Overall Study|Study termination by sponsor|6|||
155101699|NCT04024436|559806466|FG002|Overall Study|Study termination by sponsor|2|||
155101700|NCT04024436|559806467|FG003|Overall Study|Study termination by sponsor|11|||
155101701|NCT04024436|559806464|FG000|Overall Study|Reason Not Specified|0|||
155101702|NCT04024436|559806465|FG001|Overall Study|Reason Not Specified|1|||
155101703|NCT04024436|559806466|FG002|Overall Study|Reason Not Specified|0|||
155101704|NCT04024436|559806467|FG003|Overall Study|Reason Not Specified|2|||
155101705|NCT01169337|559806468|FG000|Overall Study|Lack of Efficacy|5|||
155101706|NCT01169337|559806469|FG001|Overall Study|Lack of Efficacy|7|||
155101707|NCT01169337|559806470|FG002|Overall Study|Lack of Efficacy|0|||
155101708|NCT01169337|559806468|FG000|Overall Study|Adverse Event|12|||
155101709|NCT01169337|559806469|FG001|Overall Study|Adverse Event|18|||
155101710|NCT01169337|559806470|FG002|Overall Study|Adverse Event|0|||
155101711|NCT01169337|559806468|FG000|Overall Study|Death|2|||
155101712|NCT01169337|559806469|FG001|Overall Study|Death|0|||
155101713|NCT01169337|559806470|FG002|Overall Study|Death|0|||
155101714|NCT01169337|559806468|FG000|Overall Study|Withdrawal by Subject|11|||
155101715|NCT01169337|559806469|FG001|Overall Study|Withdrawal by Subject|11|||
155101716|NCT01169337|559806470|FG002|Overall Study|Withdrawal by Subject|6|||
155101717|NCT01169337|559806468|FG000|Overall Study|Noncompliance|2|||
155101718|NCT01169337|559806469|FG001|Overall Study|Noncompliance|0|||
155101719|NCT01169337|559806470|FG002|Overall Study|Noncompliance|0|||
155101720|NCT01169337|559806468|FG000|Overall Study|Other complicating disease|1|||
155101721|NCT01169337|559806469|FG001|Overall Study|Other complicating disease|1|||
154835724|NCT00078325|558833321|FG000|Overall Study|Physician Decision|2|||
154835725|NCT00078325|558833322|FG001|Overall Study|Physician Decision|0|||
154835726|NCT00078325|558833323|FG002|Overall Study|Physician Decision|1|||
154835727|NCT00078325|558833321|FG000|Overall Study|Miscellaneous|1|||
154835728|NCT00078325|558833322|FG001|Overall Study|Miscellaneous|1|||
154835729|NCT00078325|558833323|FG002|Overall Study|Miscellaneous|1|||
154835730|NCT00578136|558833324|FG000|Overall Study|Not given intervention|1|||
154835731|NCT00578136|558833325|FG001|Overall Study|Not given intervention|1|||
155101722|NCT01169337|559806470|FG002|Overall Study|Other complicating disease|0|||
155101723|NCT01169337|559806468|FG000|Overall Study|Physician Decision|1|||
155101724|NCT01169337|559806469|FG001|Overall Study|Physician Decision|5|||
155101725|NCT01169337|559806470|FG002|Overall Study|Physician Decision|0|||
155101726|NCT01169337|559806468|FG000|Overall Study|Alternative therapy|0|||
155172776|NCT01457352|560071907|FG001|Period 2|Lost to Follow-up|0|||
155101727|NCT01169337|559806469|FG001|Overall Study|Alternative therapy|2|||
155172777|NCT01457352|560071906|FG000|Period 2|dose change|1|||
155172778|NCT01457352|560071907|FG001|Period 2|dose change|0|||
155172779|NCT01457352|560071906|FG000|Period 2|Physician Decision|1|||
155172780|NCT01457352|560071907|FG001|Period 2|Physician Decision|0|||
155172781|NCT01457352|560071906|FG000|Period 2|Did not meet eligibility criteria|3|||
155172782|NCT01457352|560071907|FG001|Period 2|Did not meet eligibility criteria|0|||
155172783|NCT01457352|560071906|FG000|Period 3|Adverse Event|1|||
155172784|NCT01457352|560071907|FG001|Period 3|Adverse Event|1|||
155172785|NCT01457352|560071906|FG000|Period 3|Withdrawal by Subject|0|||
155172786|NCT01457352|560071907|FG001|Period 3|Withdrawal by Subject|2|||
155172787|NCT01457352|560071906|FG000|Period 3|incorrect treatment|0|||
155172788|NCT01457352|560071907|FG001|Period 3|incorrect treatment|1|||
154835732|NCT00754793|558833329|FG000|Overall Study|voluntary withdrawn from study|0|||
154835733|NCT00754793|558833330|FG001|Overall Study|voluntary withdrawn from study|1|||
154835734|NCT00932360|558833331|FG000|Washout (One Week)|Withdrawal by Subject|0|||
154835735|NCT00932360|558833332|FG001|Washout (One Week)|Withdrawal by Subject|0|||
154835736|NCT00932360|558833333|FG002|Washout (One Week)|Withdrawal by Subject|0|||
154835737|NCT00932360|558833334|FG003|Washout (One Week)|Withdrawal by Subject|0|||
154835738|NCT00932360|558833335|FG004|Washout (One Week)|Withdrawal by Subject|2|||
155101728|NCT01169337|559806470|FG002|Overall Study|Alternative therapy|0|||
155101729|NCT01169337|559806468|FG000|Overall Study|Changed hospital|0|||
155101730|NCT01169337|559806469|FG001|Overall Study|Changed hospital|1|||
155101731|NCT01169337|559806470|FG002|Overall Study|Changed hospital|0|||
155101732|NCT01169337|559806468|FG000|Overall Study|Never started treatment|0|||
155101733|NCT01169337|559806469|FG001|Overall Study|Never started treatment|2|||
155101734|NCT01169337|559806470|FG002|Overall Study|Never started treatment|0|||
155101735|NCT01169337|559806468|FG000|Overall Study|Reason not reported|1|||
155101736|NCT01169337|559806469|FG001|Overall Study|Reason not reported|0|||
155101737|NCT01169337|559806470|FG002|Overall Study|Reason not reported|0|||
155101738|NCT01169337|559806468|FG000|Overall Study|Continuing lenalidomide|9|||
155101739|NCT01169337|559806469|FG001|Overall Study|Continuing lenalidomide|43|||
155101740|NCT01169337|559806470|FG002|Overall Study|Continuing lenalidomide|0|||
155101741|NCT01134614|559806471|FG000|Overall Study|Still on treatment as of March 2013|21|||
155101742|NCT01134614|559806472|FG001|Overall Study|Still on treatment as of March 2013|13|||
155101743|NCT01134614|559806471|FG000|Overall Study|Progressive disease|60|||
155101744|NCT01134614|559806472|FG001|Overall Study|Progressive disease|54|||
155101745|NCT01134614|559806471|FG000|Overall Study|Adverse Event|26|||
155101746|NCT01134614|559806472|FG001|Overall Study|Adverse Event|39|||
155101747|NCT01134614|559806471|FG000|Overall Study|Death|5|||
155101748|NCT01134614|559806472|FG001|Overall Study|Death|8|||
155101749|NCT01134614|559806471|FG000|Overall Study|Withdrawal by Subject|3|||
155101750|NCT01134614|559806472|FG001|Overall Study|Withdrawal by Subject|2|||
155101751|NCT01134614|559806471|FG000|Overall Study|Alternative therapy|2|||
155101752|NCT01134614|559806472|FG001|Overall Study|Alternative therapy|0|||
155101753|NCT01134614|559806471|FG000|Overall Study|Complicating disease|2|||
155172789|NCT01457352|560071906|FG000|Period 3|Sponsor's withdrawal|0|||
155101754|NCT01134614|559806472|FG001|Overall Study|Complicating disease|1|||
155172790|NCT01457352|560071907|FG001|Period 3|Sponsor's withdrawal|1|||
154835739|NCT00932360|558833336|FG005|Washout (One Week)|Withdrawal by Subject|0|||
154835740|NCT01892163|558833339|FG000|Overall Study|Death|1|||
154835741|NCT01892163|558833340|FG001|Overall Study|Death|1|||
154835742|NCT01892163|558833339|FG000|Overall Study|Lost to Follow-up|1|||
154835743|NCT01892163|558833340|FG001|Overall Study|Lost to Follow-up|0|||
155101755|NCT01134614|559806471|FG000|Overall Study|Physician's decision|0|||
155101756|NCT01134614|559806472|FG001|Overall Study|Physician's decision|1|||
155101757|NCT01134614|559806471|FG000|Overall Study|Never started treatment|4|||
155101758|NCT01134614|559806472|FG001|Overall Study|Never started treatment|1|||
155101759|NCT01134614|559806471|FG000|Overall Study|Pt received tx not allowed on study|0|||
155101760|NCT01134614|559806472|FG001|Overall Study|Pt received tx not allowed on study|1|||
155101761|NCT01134614|559806471|FG000|Overall Study|Symptomatic deterioration|0|||
155101762|NCT01134614|559806472|FG001|Overall Study|Symptomatic deterioration|1|||
155101763|NCT01134614|559806471|FG000|Overall Study|Patient in hospice care|0|||
155101764|NCT01134614|559806472|FG001|Overall Study|Patient in hospice care|1|||
155101765|NCT01722994|559806475|FG000|Overall Study|Missing data|25|||
155101766|NCT01722994|559806476|FG001|Overall Study|Missing data|17|||
155101767|NCT01803880|559806477|FG000|Overall Study|Adverse Event|1|||
155101768|NCT01803880|559806478|FG001|Overall Study|Adverse Event|0|||
155101769|NCT01803880|559806479|FG002|Overall Study|Adverse Event|0|||
155101770|NCT01803880|559806477|FG000|Overall Study|Withdrawal by Subject|1|||
155101771|NCT01803880|559806478|FG001|Overall Study|Withdrawal by Subject|1|||
155101772|NCT01803880|559806479|FG002|Overall Study|Withdrawal by Subject|4|||
155101773|NCT01803880|559806477|FG000|Overall Study|Physician Decision|0|||
155101774|NCT01803880|559806478|FG001|Overall Study|Physician Decision|0|||
155101775|NCT01803880|559806479|FG002|Overall Study|Physician Decision|1|||
155101776|NCT01803880|559806477|FG000|Overall Study|Unable to return for follow-up visits|0|||
155101777|NCT01803880|559806478|FG001|Overall Study|Unable to return for follow-up visits|1|||
155101778|NCT01803880|559806479|FG002|Overall Study|Unable to return for follow-up visits|2|||
155101779|NCT01803880|559806477|FG000|Overall Study|Lost to Follow-up|1|||
155101780|NCT01803880|559806478|FG001|Overall Study|Lost to Follow-up|2|||
155101781|NCT01803880|559806479|FG002|Overall Study|Lost to Follow-up|3|||
155101782|NCT01803880|559806477|FG000|Overall Study|Protocol Violation|1|||
155101783|NCT01803880|559806478|FG001|Overall Study|Protocol Violation|0|||
155101784|NCT01803880|559806479|FG002|Overall Study|Protocol Violation|0|||
155101785|NCT01803880|559806477|FG000|Overall Study|Early study termination|0|||
155101786|NCT01803880|559806478|FG001|Overall Study|Early study termination|6|||
155101787|NCT01803880|559806479|FG002|Overall Study|Early study termination|5|||
155101788|NCT01803880|559806477|FG000|Overall Study|Incomplete data entry by sites|2|||
155101789|NCT01803880|559806478|FG001|Overall Study|Incomplete data entry by sites|0|||
155101790|NCT01803880|559806479|FG002|Overall Study|Incomplete data entry by sites|0|||
155101791|NCT05338710|559806482|FG000|Overall Study|Withdrawal by Subject|3|||
155101792|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
155101793|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
155101794|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101795|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101796|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101797|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101798|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101799|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101800|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101801|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
155101802|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
155101803|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
155101804|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101805|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101806|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101807|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101808|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101809|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101810|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101811|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
155101812|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
155101813|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155172791|NCT02626624|560071908|FG000|Overall Study|Adverse Event|1|||
155172792|NCT02626624|560071908|FG000|Overall Study|Lost to Follow-up|3|||
155101814|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101815|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101816|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101817|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101818|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101819|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101820|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101821|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
155101822|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
155101823|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
155101824|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101825|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101826|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101827|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101828|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101829|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101830|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101831|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
155101832|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155101833|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
155101834|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
154969201|NCT00819169|559310467|FG004|Overall Study|Ineligibility determined|0|||
154969202|NCT00819169|559310468|FG005|Overall Study|Ineligibility determined|0|||
154969203|NCT00819169|559310469|FG006|Overall Study|Ineligibility determined|0|||
154969204|NCT00819169|559310470|FG007|Overall Study|Ineligibility determined|0|||
154969205|NCT00819169|559310471|FG008|Overall Study|Ineligibility determined|1|||
154969206|NCT00819169|559310463|FG000|Overall Study|Adverse Event|0|||
154969207|NCT00819169|559310464|FG001|Overall Study|Adverse Event|0|||
154969208|NCT00819169|559310465|FG002|Overall Study|Adverse Event|0|||
154969209|NCT00819169|559310466|FG003|Overall Study|Adverse Event|0|||
154969210|NCT00819169|559310467|FG004|Overall Study|Adverse Event|1|||
154969211|NCT00819169|559310468|FG005|Overall Study|Adverse Event|0|||
154969212|NCT00819169|559310469|FG006|Overall Study|Adverse Event|0|||
154969213|NCT00819169|559310470|FG007|Overall Study|Adverse Event|0|||
154969214|NCT00819169|559310471|FG008|Overall Study|Adverse Event|0|||
154969215|NCT00819169|559310463|FG000|Overall Study|Administrative Decision|0|||
154969216|NCT00819169|559310464|FG001|Overall Study|Administrative Decision|0|||
154969217|NCT00819169|559310465|FG002|Overall Study|Administrative Decision|0|||
154969218|NCT00819169|559310466|FG003|Overall Study|Administrative Decision|0|||
154969219|NCT00819169|559310467|FG004|Overall Study|Administrative Decision|1|||
154969220|NCT00819169|559310468|FG005|Overall Study|Administrative Decision|2|||
154969221|NCT00819169|559310469|FG006|Overall Study|Administrative Decision|0|||
154969222|NCT00819169|559310470|FG007|Overall Study|Administrative Decision|2|||
154969223|NCT00819169|559310471|FG008|Overall Study|Administrative Decision|0|||
154969224|NCT00380588|559310475|FG000|Overall Study|Unequivocal Disease Progression|25|||
154969225|NCT00380588|559310476|FG001|Overall Study|Unequivocal Disease Progression|34|||
154969226|NCT00380588|559310475|FG000|Overall Study|Next Cycle Not Started|4|||
154969227|NCT00380588|559310476|FG001|Overall Study|Next Cycle Not Started|0|||
154969228|NCT00380588|559310475|FG000|Overall Study|Adverse Event|7|||
154969229|NCT00380588|559310476|FG001|Overall Study|Adverse Event|3|||
154969230|NCT00380588|559310475|FG000|Overall Study|Withdrawal by Subject|1|||
154969231|NCT00380588|559310476|FG001|Overall Study|Withdrawal by Subject|3|||
154969232|NCT00380588|559310475|FG000|Overall Study|Physician Decision|2|||
154969233|NCT00380588|559310476|FG001|Overall Study|Physician Decision|0|||
154969234|NCT02096705|559310477|FG000|Treatment|Adverse Event|6|||
154969235|NCT02096705|559310478|FG001|Treatment|Adverse Event|3|||
154969236|NCT02096705|559310477|FG000|Treatment|Subject request to discontinue treatment|1|||
154969237|NCT02096705|559310478|FG001|Treatment|Subject request to discontinue treatment|1|||
154969238|NCT02096705|559310477|FG000|Treatment|Withdrawal by Subject|1|||
154969239|NCT02096705|559310478|FG001|Treatment|Withdrawal by Subject|0|||
154969240|NCT02096705|559310477|FG000|Treatment|Other|1|||
154969241|NCT02096705|559310478|FG001|Treatment|Other|1|||
154969242|NCT02096705|559310477|FG000|Follow-up|Withdrawal by Subject|1|||
154969243|NCT02096705|559310478|FG001|Follow-up|Withdrawal by Subject|0|||
154969244|NCT02096705|559310477|FG000|Follow-up|Adverse Event|2|||
154969245|NCT02096705|559310478|FG001|Follow-up|Adverse Event|2|||
154969246|NCT02096705|559310477|FG000|Follow-up|Subjects not reporting status|1|||
154969247|NCT02096705|559310478|FG001|Follow-up|Subjects not reporting status|2|||
154969248|NCT02905435|559310479|FG000|Overall Study|Death|2|||
154969249|NCT02905435|559310479|FG000|Overall Study|Physician Decision|1|||
154969250|NCT02905435|559310479|FG000|Overall Study|Lost to Follow-up|4|||
154969251|NCT02377349|559310483|FG000|Overall Study|Serious Adverse Event|1|||
154969252|NCT02377349|559310484|FG001|Overall Study|Serious Adverse Event|0|||
154969253|NCT02377349|559310483|FG000|Overall Study|Protocol Violation|3|||
154969254|NCT02377349|559310484|FG001|Overall Study|Protocol Violation|2|||
154969255|NCT02377349|559310483|FG000|Overall Study|Withdrawal by Subject|5|||
155101835|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155101836|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155101837|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155101838|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
154969256|NCT02377349|559310484|FG001|Overall Study|Withdrawal by Subject|3|||
154969257|NCT02377349|559310483|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
154969258|NCT02377349|559310484|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
154969259|NCT02377349|559310483|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
154969260|NCT02377349|559310484|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
154969261|NCT02377349|559310483|FG000|Overall Study|Other|0|||
155101839|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155101840|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
154969262|NCT02377349|559310484|FG001|Overall Study|Other|1|||
154969263|NCT01395017|559310487|FG000|Overall Study|Lost to Follow-up|1|||
154969264|NCT01395017|559310488|FG001|Overall Study|Lost to Follow-up|0|||
154969265|NCT01395017|559310487|FG000|Overall Study|Adverse Event|26|||
154969266|NCT01395017|559310488|FG001|Overall Study|Adverse Event|12|||
154969267|NCT01395017|559310487|FG000|Overall Study|Physician Decision|11|||
154969268|NCT01395017|559310488|FG001|Overall Study|Physician Decision|15|||
154969269|NCT01395017|559310487|FG000|Overall Study|Withdrawal by Subject|14|||
154969270|NCT01395017|559310488|FG001|Overall Study|Withdrawal by Subject|8|||
154969271|NCT01395017|559310487|FG000|Overall Study|Protocol deviation|1|||
154969272|NCT01395017|559310488|FG001|Overall Study|Protocol deviation|2|||
154835744|NCT01624662|558833344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
154835745|NCT01624662|558833345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
154835746|NCT01624662|558833346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
154835747|NCT01624662|558833347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
154835748|NCT01624662|558833344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
154835749|NCT01624662|558833345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
154835750|NCT01624662|558833346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
154835751|NCT01624662|558833347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
154835752|NCT01624662|558833344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
154835753|NCT01624662|558833345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
154835754|NCT01624662|558833346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
154835755|NCT01624662|558833347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
154835756|NCT01624662|558833344|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
154835757|NCT01624662|558833345|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
154835758|NCT01624662|558833346|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
154835759|NCT01624662|558833347|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
154835760|NCT01624662|558833344|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
154835761|NCT01624662|558833345|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
154835762|NCT01624662|558833346|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
154835763|NCT01624662|558833347|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
154835764|NCT01624662|558833344|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
154835765|NCT01624662|558833345|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
154835766|NCT01624662|558833346|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
154835767|NCT01624662|558833347|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
154835768|NCT01624662|558833344|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
154835769|NCT01624662|558833345|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
154835770|NCT01624662|558833346|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
154835771|NCT01624662|558833347|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
154835772|NCT00361270|558833348|FG000|Overall Study|Death|0|||
154835773|NCT00361270|558833349|FG001|Overall Study|Death|0|||
154835774|NCT00361270|558833350|FG002|Overall Study|Death|0|||
154835775|NCT00361270|558833351|FG003|Overall Study|Death|2|||
154835776|NCT00361270|558833348|FG000|Overall Study|Lost to Follow-up|4|||
154835777|NCT00361270|558833349|FG001|Overall Study|Lost to Follow-up|1|||
154835778|NCT00361270|558833350|FG002|Overall Study|Lost to Follow-up|0|||
154835779|NCT00361270|558833351|FG003|Overall Study|Lost to Follow-up|0|||
154835780|NCT00361270|558833348|FG000|Overall Study|Physician Decision|0|||
154835781|NCT00361270|558833349|FG001|Overall Study|Physician Decision|0|||
154835782|NCT00361270|558833350|FG002|Overall Study|Physician Decision|1|||
154835783|NCT00361270|558833351|FG003|Overall Study|Physician Decision|0|||
154835784|NCT00361270|558833348|FG000|Overall Study|Protocol Violation|9|||
154835785|NCT00361270|558833349|FG001|Overall Study|Protocol Violation|4|||
154835786|NCT00361270|558833350|FG002|Overall Study|Protocol Violation|5|||
154835787|NCT00361270|558833351|FG003|Overall Study|Protocol Violation|4|||
154835788|NCT00361270|558833348|FG000|Overall Study|Withdrawal by Subject|6|||
154835789|NCT00361270|558833349|FG001|Overall Study|Withdrawal by Subject|6|||
154835790|NCT00361270|558833350|FG002|Overall Study|Withdrawal by Subject|3|||
154835791|NCT00361270|558833351|FG003|Overall Study|Withdrawal by Subject|7|||
154835792|NCT00361270|558833348|FG000|Overall Study|Afraid of Hypnosis|1|||
154835793|NCT00361270|558833349|FG001|Overall Study|Afraid of Hypnosis|2|||
154835794|NCT00361270|558833350|FG002|Overall Study|Afraid of Hypnosis|0|||
154835795|NCT00361270|558833351|FG003|Overall Study|Afraid of Hypnosis|0|||
154835796|NCT00361270|558833348|FG000|Overall Study|Problems with Transportation|4|||
154835797|NCT00361270|558833349|FG001|Overall Study|Problems with Transportation|0|||
154835798|NCT00361270|558833350|FG002|Overall Study|Problems with Transportation|0|||
154835799|NCT00361270|558833351|FG003|Overall Study|Problems with Transportation|0|||
154835800|NCT00361270|558833348|FG000|Overall Study|Adverse Event|0|||
154835801|NCT00361270|558833349|FG001|Overall Study|Adverse Event|1|||
154835802|NCT00361270|558833350|FG002|Overall Study|Adverse Event|1|||
154835803|NCT00361270|558833351|FG003|Overall Study|Adverse Event|0|||
154835804|NCT04013529|558833353|FG000|Overall Study|Withdrawal by Subject|1|||
154835805|NCT04013529|558833354|FG001|Overall Study|Withdrawal by Subject|1|||
154835806|NCT00517751|558833360|FG000|Overall Study|Death|3|||
154835807|NCT00517751|558833360|FG000|Overall Study|Withdrawal by Subject|37|||
154835808|NCT00517751|558833360|FG000|Overall Study|Lost to Follow-up|4|||
154835809|NCT00517751|558833360|FG000|Overall Study|patient not over due|6|||
154835810|NCT00517751|558833360|FG000|Overall Study|Patient not due for visit|76|||
154835811|NCT00517751|558833360|FG000|Overall Study|Missing|3|||
154835812|NCT00495820|558833363|FG000|Overall Study|Adverse Event|1|||
154835813|NCT00495820|558833364|FG001|Overall Study|Adverse Event|1|||
154835814|NCT00820950|558833365|FG000|Overall Study|Scheduling Conflict|0|||
154835815|NCT00820950|558833366|FG001|Overall Study|Scheduling Conflict|0|||
154835816|NCT00820950|558833367|FG002|Overall Study|Scheduling Conflict|0|||
154835817|NCT00820950|558833368|FG003|Overall Study|Scheduling Conflict|0|||
154835818|NCT00820950|558833369|FG004|Overall Study|Scheduling Conflict|0|||
154835819|NCT00820950|558833370|FG005|Overall Study|Scheduling Conflict|0|||
154835820|NCT00820950|558833371|FG006|Overall Study|Scheduling Conflict|1|||
154835821|NCT00820950|558833372|FG007|Overall Study|Scheduling Conflict|1|||
154835822|NCT00820950|558833373|FG008|Overall Study|Scheduling Conflict|0|||
154835823|NCT00820950|558833374|FG009|Overall Study|Scheduling Conflict|0|||
154835824|NCT00820950|558833365|FG000|Overall Study|Protocol Violation|1|||
154835825|NCT00820950|558833366|FG001|Overall Study|Protocol Violation|1|||
154835826|NCT00820950|558833367|FG002|Overall Study|Protocol Violation|0|||
154835827|NCT00820950|558833368|FG003|Overall Study|Protocol Violation|0|||
154835828|NCT00820950|558833369|FG004|Overall Study|Protocol Violation|0|||
154835829|NCT00820950|558833370|FG005|Overall Study|Protocol Violation|0|||
154835830|NCT00820950|558833371|FG006|Overall Study|Protocol Violation|0|||
154835831|NCT00820950|558833372|FG007|Overall Study|Protocol Violation|0|||
154835832|NCT00820950|558833373|FG008|Overall Study|Protocol Violation|0|||
154835833|NCT00820950|558833374|FG009|Overall Study|Protocol Violation|0|||
154835834|NCT01246583|558833377|FG000|Overall Study|Lost to Follow-up|0|||
154835835|NCT01246583|558833378|FG001|Overall Study|Lost to Follow-up|0|||
154835836|NCT01246583|558833379|FG002|Overall Study|Lost to Follow-up|0|||
154835837|NCT01246583|558833380|FG003|Overall Study|Lost to Follow-up|1|||
154835838|NCT01246583|558833377|FG000|Overall Study|Protocol Violation|0|||
154835839|NCT01246583|558833378|FG001|Overall Study|Protocol Violation|0|||
155101841|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
155101842|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
155101843|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
155101844|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155101845|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
154835840|NCT01246583|558833379|FG002|Overall Study|Protocol Violation|1|||
154835841|NCT01246583|558833380|FG003|Overall Study|Protocol Violation|0|||
154835842|NCT01246583|558833377|FG000|Overall Study|Withdrawal by Subject|1|||
155101846|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155101847|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155101848|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155101849|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
154835843|NCT01246583|558833378|FG001|Overall Study|Withdrawal by Subject|0|||
154835844|NCT01246583|558833379|FG002|Overall Study|Withdrawal by Subject|0|||
155101850|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
154835845|NCT01246583|558833380|FG003|Overall Study|Withdrawal by Subject|0|||
154835846|NCT05264740|558833381|FG000|Baseline|Withdrawal by Subject|0|||
154835847|NCT05264740|558833382|FG001|Baseline|Withdrawal by Subject|1|||
154835848|NCT05264740|558833381|FG000|Follow Up 1|Lost to Follow-up|1|||
154835849|NCT05264740|558833382|FG001|Follow Up 1|Lost to Follow-up|1|||
154835850|NCT05264740|558833381|FG000|Follow Up 1|Withdrawal by Subject|0|||
154835851|NCT05264740|558833382|FG001|Follow Up 1|Withdrawal by Subject|1|||
154835852|NCT05264740|558833381|FG000|Follow Up 2|Lost to Follow-up|1|||
154835853|NCT05264740|558833382|FG001|Follow Up 2|Lost to Follow-up|4|||
154835854|NCT05264740|558833381|FG000|Follow Up 3|Lost to Follow-up|7|||
154835855|NCT05264740|558833382|FG001|Follow Up 3|Lost to Follow-up|4|||
154835856|NCT01423851|558833383|FG000|Whole Study|Disease progression|2|||
154835857|NCT01423851|558833384|FG001|Whole Study|Disease progression|1|||
154835858|NCT01423851|558833385|FG002|Whole Study|Disease progression|1|||
154835859|NCT01423851|558833386|FG003|Whole Study|Disease progression|4|||
154835860|NCT01423851|558833387|FG004|Whole Study|Disease progression|1|||
154835861|NCT01423851|558833388|FG005|Whole Study|Disease progression|3|||
154835862|NCT01423851|558833389|FG006|Whole Study|Disease progression|1|||
154835863|NCT01423851|558833390|FG007|Whole Study|Disease progression|4|||
154835864|NCT01423851|558833391|FG008|Whole Study|Disease progression|0|||
154835865|NCT01423851|558833392|FG009|Whole Study|Disease progression|2|||
154835866|NCT01423851|558833393|FG010|Whole Study|Disease progression|10|||
154835867|NCT01423851|558833383|FG000|Whole Study|Physician Decision|0|||
154835868|NCT01423851|558833384|FG001|Whole Study|Physician Decision|1|||
154835869|NCT01423851|558833385|FG002|Whole Study|Physician Decision|2|||
154835870|NCT01423851|558833386|FG003|Whole Study|Physician Decision|0|||
154835871|NCT01423851|558833387|FG004|Whole Study|Physician Decision|2|||
154835872|NCT01423851|558833388|FG005|Whole Study|Physician Decision|0|||
154835873|NCT01423851|558833389|FG006|Whole Study|Physician Decision|2|||
154835874|NCT01423851|558833390|FG007|Whole Study|Physician Decision|1|||
154835875|NCT01423851|558833391|FG008|Whole Study|Physician Decision|3|||
154835876|NCT01423851|558833392|FG009|Whole Study|Physician Decision|4|||
154835877|NCT01423851|558833393|FG010|Whole Study|Physician Decision|12|||
154835878|NCT01423851|558833383|FG000|Whole Study|Withdrawal by Subject|1|||
154835879|NCT01423851|558833384|FG001|Whole Study|Withdrawal by Subject|1|||
154835880|NCT01423851|558833385|FG002|Whole Study|Withdrawal by Subject|0|||
154835881|NCT01423851|558833386|FG003|Whole Study|Withdrawal by Subject|0|||
154835882|NCT01423851|558833387|FG004|Whole Study|Withdrawal by Subject|0|||
154835883|NCT01423851|558833388|FG005|Whole Study|Withdrawal by Subject|0|||
154835884|NCT01423851|558833389|FG006|Whole Study|Withdrawal by Subject|0|||
154835885|NCT01423851|558833390|FG007|Whole Study|Withdrawal by Subject|0|||
154835886|NCT01423851|558833391|FG008|Whole Study|Withdrawal by Subject|2|||
154835887|NCT01423851|558833392|FG009|Whole Study|Withdrawal by Subject|0|||
154835888|NCT01423851|558833393|FG010|Whole Study|Withdrawal by Subject|4|||
154835889|NCT01423851|558833383|FG000|Whole Study|Adverse Event|0|||
154835890|NCT01423851|558833384|FG001|Whole Study|Adverse Event|0|||
154835891|NCT01423851|558833385|FG002|Whole Study|Adverse Event|0|||
154835892|NCT01423851|558833386|FG003|Whole Study|Adverse Event|2|||
154835893|NCT01423851|558833387|FG004|Whole Study|Adverse Event|0|||
154835894|NCT01423851|558833388|FG005|Whole Study|Adverse Event|0|||
154835895|NCT01423851|558833389|FG006|Whole Study|Adverse Event|0|||
154835896|NCT01423851|558833390|FG007|Whole Study|Adverse Event|3|||
154835897|NCT01423851|558833391|FG008|Whole Study|Adverse Event|3|||
154835898|NCT01423851|558833392|FG009|Whole Study|Adverse Event|2|||
154835899|NCT01423851|558833393|FG010|Whole Study|Adverse Event|3|||
154835900|NCT05885737|558833397|FG000|DB Period|Adverse Event|4|||
154835901|NCT05885737|558833398|FG001|DB Period|Adverse Event|4|||
154835902|NCT05885737|558833397|FG000|DB Period|Lost to Follow-up|0|||
154835903|NCT05885737|558833398|FG001|DB Period|Lost to Follow-up|1|||
154835904|NCT05885737|558833397|FG000|DB Period|Physician Decision|2|||
154835905|NCT05885737|558833398|FG001|DB Period|Physician Decision|0|||
154835906|NCT05885737|558833397|FG000|DB Period|Withdrawal by Subject|12|||
154835907|NCT05885737|558833398|FG001|DB Period|Withdrawal by Subject|6|||
154835908|NCT05885737|558833397|FG000|DB Period|Other: Unspecified|2|||
154835909|NCT05885737|558833398|FG001|DB Period|Other: Unspecified|2|||
154835910|NCT05885737|558833397|FG000|OLE Period|Adverse Event|3|||
154835911|NCT05885737|558833398|FG001|OLE Period|Adverse Event|2|||
154835912|NCT05885737|558833397|FG000|OLE Period|Physician Decision|1|||
154835913|NCT05885737|558833398|FG001|OLE Period|Physician Decision|0|||
154835914|NCT05885737|558833397|FG000|OLE Period|Withdrawal by Subject|5|||
154835915|NCT05885737|558833398|FG001|OLE Period|Withdrawal by Subject|5|||
154835916|NCT05885737|558833397|FG000|OLE Period|Other: Unspecified|2|||
154835917|NCT05885737|558833398|FG001|OLE Period|Other: Unspecified|1|||
154835918|NCT02484911|558834914|FG000|Overall Study|Withdrawal by Subject|2|||
154835919|NCT02484911|558834915|FG001|Overall Study|Withdrawal by Subject|1|||
154835920|NCT02484911|558834914|FG000|Overall Study|Protocol Violation|2|||
154835921|NCT02484911|558834915|FG001|Overall Study|Protocol Violation|1|||
154835922|NCT04129528|558834916|FG000|Overall Study|Adverse Event|1|||
154835923|NCT04129528|558834917|FG001|Overall Study|Adverse Event|0|||
154835924|NCT04129528|558834916|FG000|Overall Study|Physician Decision|1|||
154835925|NCT04129528|558834917|FG001|Overall Study|Physician Decision|1|||
154835926|NCT04129528|558834916|FG000|Overall Study|Withdrawal by Subject|1|||
154835927|NCT04129528|558834917|FG001|Overall Study|Withdrawal by Subject|1|||
154835928|NCT00490568|558834923|FG000|Overall Study|Adverse Event|116|||
154835929|NCT00490568|558834923|FG000|Overall Study|Lost to Follow-up|13|||
154835930|NCT00490568|558834923|FG000|Overall Study|Protocol Violation|45|||
154835931|NCT00490568|558834923|FG000|Overall Study|Withdrawal by Subject|135|||
154835932|NCT00490568|558834923|FG000|Overall Study|Still in the study at termination|974|||
154835933|NCT00490568|558834923|FG000|Overall Study|Other|1|||
154835934|NCT00490568|558834923|FG000|Overall Study|Exclusion criteria met|1|||
154835935|NCT00490568|558834923|FG000|Overall Study|Caregiver related|20|||
154835936|NCT00490568|558834923|FG000|Overall Study|Abnormal ECG|25|||
154835937|NCT00490568|558834923|FG000|Overall Study|Participant refused follow-up|9|||
154835938|NCT00490568|558834923|FG000|Overall Study|Legal representative withdrew consent|1|||
154835939|NCT00490568|558834923|FG000|Overall Study|Disease progression|4|||
154835940|NCT00490568|558834923|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
154835941|NCT00490568|558834923|FG000|Overall Study|Investigator decision|3|||
154835942|NCT00490568|558834923|FG000|Overall Study|Non-Compliance|7|||
154835943|NCT00490568|558834923|FG000|Overall Study|Efficacy related|3|||
154835944|NCT00490568|558834923|FG000|Overall Study|Participant died|1|||
154835945|NCT00490568|558834923|FG000|Overall Study|Participant withdrawal due to surgery|1|||
154835946|NCT01351389|558834927|FG000|Overall Study|Withdrawal by Subject|7|||
154835947|NCT01351389|558834928|FG001|Overall Study|Withdrawal by Subject|0|||
154835948|NCT01351389|558834927|FG000|Overall Study|did not complete intervention|23|||
154835949|NCT01351389|558834928|FG001|Overall Study|did not complete intervention|15|||
154835950|NCT03776175|558834930|FG000|Treatment Period (42 Days)|Adverse Event|0|||
154835951|NCT03776175|558834931|FG001|Treatment Period (42 Days)|Adverse Event|1|||
154835952|NCT03776175|558834932|FG002|Treatment Period (42 Days)|Adverse Event|1|||
154835953|NCT03776175|558834933|FG003|Treatment Period (42 Days)|Adverse Event|0|||
154835954|NCT03776175|558834930|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
154835955|NCT03776175|558834931|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
154835956|NCT03776175|558834932|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
154835957|NCT03776175|558834933|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
154835958|NCT03776175|558834930|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
154835959|NCT03776175|558834931|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
154835960|NCT03776175|558834932|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
154835961|NCT03776175|558834933|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
154835962|NCT03776175|558834930|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
154835963|NCT03776175|558834931|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
154835964|NCT03776175|558834932|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
154835965|NCT03776175|558834933|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
154835966|NCT03776175|558834930|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
154835967|NCT03776175|558834931|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
154835968|NCT03776175|558834932|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
154835969|NCT03776175|558834933|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
154835970|NCT03776175|558834930|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
154835971|NCT03776175|558834931|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
154835972|NCT03776175|558834932|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
154835973|NCT03776175|558834933|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
154835974|NCT02770547|558834937|FG000|Overall Study|Patient non-compliant|1|||
154835975|NCT02770547|558834938|FG001|Overall Study|Patient non-compliant|0|||
154835976|NCT02770547|558834937|FG000|Overall Study|Adverse Event|0|||
154835977|NCT02770547|558834938|FG001|Overall Study|Adverse Event|1|||
154969273|NCT01395017|559310487|FG000|Overall Study|Death|4|||
154835978|NCT01324232|558834939|FG000|Overall Study|Protocol Violation|0|||
154835979|NCT01324232|558834940|FG001|Overall Study|Protocol Violation|0|||
154835980|NCT01324232|558834941|FG002|Overall Study|Protocol Violation|0|||
154835981|NCT01324232|558834942|FG003|Overall Study|Protocol Violation|2|||
154835982|NCT01324232|558834939|FG000|Overall Study|Missing|0|||
154835983|NCT01324232|558834940|FG001|Overall Study|Missing|0|||
154835984|NCT01324232|558834941|FG002|Overall Study|Missing|1|||
154969274|NCT01395017|559310488|FG001|Overall Study|Death|3|||
154835985|NCT01324232|558834942|FG003|Overall Study|Missing|0|||
154969275|NCT01395017|559310487|FG000|Overall Study|Disease progression|42|||
154835986|NCT01324232|558834939|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
154835987|NCT01324232|558834940|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
154835988|NCT01324232|558834941|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
154835989|NCT01324232|558834942|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
154835990|NCT01324232|558834939|FG000|Overall Study|Lack of Efficacy|2|||
154835991|NCT01324232|558834940|FG001|Overall Study|Lack of Efficacy|1|||
154835992|NCT01324232|558834941|FG002|Overall Study|Lack of Efficacy|2|||
154835993|NCT01324232|558834942|FG003|Overall Study|Lack of Efficacy|2|||
154835994|NCT01324232|558834939|FG000|Overall Study|Participant Refused Medication|0|||
154835995|NCT01324232|558834940|FG001|Overall Study|Participant Refused Medication|1|||
154835996|NCT01324232|558834941|FG002|Overall Study|Participant Refused Medication|0|||
154835997|NCT01324232|558834942|FG003|Overall Study|Participant Refused Medication|0|||
154835998|NCT01324232|558834939|FG000|Overall Study|Intercurrent illness|0|||
154835999|NCT01324232|558834940|FG001|Overall Study|Intercurrent illness|0|||
154836000|NCT01324232|558834941|FG002|Overall Study|Intercurrent illness|0|||
154836001|NCT01324232|558834942|FG003|Overall Study|Intercurrent illness|1|||
154836002|NCT01324232|558834939|FG000|Overall Study|Adverse Event|2|||
154836003|NCT01324232|558834940|FG001|Overall Study|Adverse Event|5|||
154836004|NCT01324232|558834941|FG002|Overall Study|Adverse Event|6|||
154836005|NCT01324232|558834942|FG003|Overall Study|Adverse Event|6|||
154836006|NCT01324232|558834939|FG000|Overall Study|Withdrawal by Subject|0|||
154836007|NCT01324232|558834940|FG001|Overall Study|Withdrawal by Subject|3|||
154836008|NCT01324232|558834941|FG002|Overall Study|Withdrawal by Subject|4|||
154836009|NCT01324232|558834942|FG003|Overall Study|Withdrawal by Subject|0|||
154836010|NCT01324232|558834939|FG000|Overall Study|Lost to Follow-up|1|||
154836011|NCT01324232|558834940|FG001|Overall Study|Lost to Follow-up|0|||
154836012|NCT01324232|558834941|FG002|Overall Study|Lost to Follow-up|0|||
154836013|NCT01324232|558834942|FG003|Overall Study|Lost to Follow-up|0|||
154836014|NCT00393887|558834943|FG000|Overall Study|Physician Decision|5|||
154836015|NCT00393887|558834944|FG001|Overall Study|Physician Decision|0|||
154836016|NCT00393887|558834943|FG000|Overall Study|Lost to Follow-up|11|||
154836017|NCT00393887|558834944|FG001|Overall Study|Lost to Follow-up|9|||
154836018|NCT01265615|558834945|FG000|Overall Study|Protocol Violation|2|||
154836019|NCT01265615|558834946|FG001|Overall Study|Protocol Violation|2|||
154836020|NCT01265615|558834947|FG002|Overall Study|Protocol Violation|4|||
154836021|NCT01265615|558834948|FG003|Overall Study|Protocol Violation|3|||
154836022|NCT01732796|558834949|FG000|Overall Study|Adverse Event|16|||
154836023|NCT01732796|558834950|FG001|Overall Study|Adverse Event|16|||
154836024|NCT01732796|558834951|FG002|Overall Study|Adverse Event|4|||
154836025|NCT01732796|558834949|FG000|Overall Study|Lack of Efficacy|21|||
154836026|NCT01732796|558834950|FG001|Overall Study|Lack of Efficacy|18|||
154836027|NCT01732796|558834951|FG002|Overall Study|Lack of Efficacy|5|||
154836028|NCT01732796|558834949|FG000|Overall Study|Lost to Follow-up|2|||
154836029|NCT01732796|558834950|FG001|Overall Study|Lost to Follow-up|0|||
154836030|NCT01732796|558834951|FG002|Overall Study|Lost to Follow-up|0|||
154836031|NCT01732796|558834949|FG000|Overall Study|Withdrawal by Subject|6|||
154836032|NCT01732796|558834950|FG001|Overall Study|Withdrawal by Subject|8|||
154836033|NCT01732796|558834951|FG002|Overall Study|Withdrawal by Subject|2|||
154836034|NCT01732796|558834949|FG000|Overall Study|Other reason not defined above|1|||
154836035|NCT01732796|558834950|FG001|Overall Study|Other reason not defined above|0|||
154836036|NCT01732796|558834951|FG002|Overall Study|Other reason not defined above|2|||
154836037|NCT00876187|558834953|FG000|Overall Study|Adverse Event|14|||
154836038|NCT00876187|558834954|FG001|Overall Study|Adverse Event|12|||
154836039|NCT00876187|558834955|FG002|Overall Study|Adverse Event|19|||
154836040|NCT00876187|558834956|FG003|Overall Study|Adverse Event|29|||
154836041|NCT00876187|558834957|FG004|Overall Study|Adverse Event|10|||
154969276|NCT01395017|559310488|FG001|Overall Study|Disease progression|58|||
154969277|NCT01395017|559310487|FG000|Overall Study|Sponsor discontinued study|1|||
154969278|NCT01395017|559310488|FG001|Overall Study|Sponsor discontinued study|4|||
154969279|NCT03366428|559310491|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
154969280|NCT03366428|559310491|FG000|Overall Study|Adverse Event|12|||
154969281|NCT03366428|559310491|FG000|Overall Study|Clinical progression|2|||
154969282|NCT03366428|559310491|FG000|Overall Study|Withdrawal by Subject|4|||
154969283|NCT01046084|559310495|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
154969284|NCT01046084|559310496|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
154969285|NCT02166606|559310497|FG000|Overall Study|Adverse Event|3|||
154969286|NCT02166606|559310497|FG000|Overall Study|Death|31|||
154969287|NCT02166606|559310497|FG000|Overall Study|Protocol Violation|7|||
154969288|NCT02166606|559310497|FG000|Overall Study|Lost to Follow-up|30|||
154969289|NCT02166606|559310497|FG000|Overall Study|Withdrawal by Subject|1|||
154969290|NCT02166606|559310497|FG000|Overall Study|Physician Decision|1|||
154969291|NCT02166606|559310497|FG000|Overall Study|Device upgrade|1|||
154969292|NCT02166606|559310497|FG000|Overall Study|Enrolled after End of Enrollment|4|||
154969293|NCT01958476|559310500|FG000|Overall Study|Parent requested exclusion from analysis|1|||
154969294|NCT01958476|559310501|FG001|Overall Study|Parent requested exclusion from analysis|0|||
154969295|NCT02670551|559310502|FG000|Overall Study|Adverse Event|4|||
154969296|NCT02670551|559310503|FG001|Overall Study|Adverse Event|7|||
154969297|NCT02670551|559310504|FG002|Overall Study|Adverse Event|9|||
154969298|NCT02670551|559310502|FG000|Overall Study|Lack of Efficacy|2|||
154969299|NCT02670551|559310503|FG001|Overall Study|Lack of Efficacy|0|||
154969300|NCT02670551|559310504|FG002|Overall Study|Lack of Efficacy|3|||
154969301|NCT02670551|559310502|FG000|Overall Study|Withdrawal of Consent|6|||
154969302|NCT02670551|559310503|FG001|Overall Study|Withdrawal of Consent|3|||
154969303|NCT02670551|559310504|FG002|Overall Study|Withdrawal of Consent|8|||
154969304|NCT02670551|559310502|FG000|Overall Study|Lost to Follow-up|5|||
154969305|NCT02670551|559310503|FG001|Overall Study|Lost to Follow-up|7|||
154969306|NCT02670551|559310504|FG002|Overall Study|Lost to Follow-up|6|||
154969307|NCT02670551|559310502|FG000|Overall Study|Protocol Violation|1|||
154969308|NCT02670551|559310503|FG001|Overall Study|Protocol Violation|0|||
154969309|NCT02670551|559310504|FG002|Overall Study|Protocol Violation|0|||
154969310|NCT02670551|559310502|FG000|Overall Study|Noncompliance with study drug|3|||
154969311|NCT02670551|559310503|FG001|Overall Study|Noncompliance with study drug|3|||
154969312|NCT02670551|559310504|FG002|Overall Study|Noncompliance with study drug|2|||
154969313|NCT02670551|559310502|FG000|Overall Study|Other Miscellaneous Reasons|2|||
154969314|NCT02670551|559310503|FG001|Overall Study|Other Miscellaneous Reasons|3|||
154969315|NCT02670551|559310504|FG002|Overall Study|Other Miscellaneous Reasons|3|||
154969316|NCT02670551|559310502|FG000|Overall Study|Did Not Receive Treatment|5|||
154969317|NCT02670551|559310503|FG001|Overall Study|Did Not Receive Treatment|3|||
154969318|NCT02670551|559310504|FG002|Overall Study|Did Not Receive Treatment|0|||
154969319|NCT01971645|559310505|FG000|Overall Study|Adverse Event|1|||
154969320|NCT01971645|559310506|FG001|Overall Study|Adverse Event|0|||
154969321|NCT01971645|559310507|FG002|Overall Study|Adverse Event|0|||
154969322|NCT01971645|559310505|FG000|Overall Study|Lost to Follow-up|1|||
154969323|NCT01971645|559310506|FG001|Overall Study|Lost to Follow-up|0|||
154969324|NCT01971645|559310507|FG002|Overall Study|Lost to Follow-up|1|||
154969325|NCT01971645|559310505|FG000|Overall Study|Protocol Violation|0|||
154969326|NCT01971645|559310506|FG001|Overall Study|Protocol Violation|0|||
154969327|NCT01971645|559310507|FG002|Overall Study|Protocol Violation|1|||
154969328|NCT00714051|559310508|FG000|Overall Study|Withdrawal by Subject|1|||
154969329|NCT00714051|559310509|FG001|Overall Study|Withdrawal by Subject|0|||
154969330|NCT00714051|559310508|FG000|Overall Study|Death|0|||
154969331|NCT00714051|559310509|FG001|Overall Study|Death|1|||
154969332|NCT03868631|559310510|FG000|Baseline to Week 6|Adverse Event|0|||
154969333|NCT03868631|559310511|FG001|Baseline to Week 6|Adverse Event|3|||
154969334|NCT03868631|559310510|FG000|Baseline to Week 6|Protocol Violation|1|||
154969335|NCT03868631|559310511|FG001|Baseline to Week 6|Protocol Violation|1|||
154969336|NCT03868631|559310510|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
155172793|NCT02626624|560071908|FG000|Overall Study|Protocol Violation|4|||
155172794|NCT02626624|560071908|FG000|Overall Study|Death|2|||
155172795|NCT04174365|560071909|FG000|Overall Study|Lost to Follow-up|1|||
155172796|NCT04174365|560071910|FG001|Overall Study|Lost to Follow-up|2|||
154969337|NCT03868631|559310511|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
154969338|NCT03868631|559310510|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
154969339|NCT03868631|559310511|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
154969340|NCT03868631|559310510|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
154969341|NCT03868631|559310511|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
154969342|NCT03868631|559310510|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
154969343|NCT03868631|559310511|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
154969344|NCT02286466|559310512|FG000|Overall Study|Death|1|||
154969345|NCT02286466|559310513|FG001|Overall Study|Death|3|||
154969346|NCT02286466|559310512|FG000|Overall Study|Withdrawal by Subject|5|||
154969347|NCT02286466|559310513|FG001|Overall Study|Withdrawal by Subject|2|||
154969348|NCT02286466|559310512|FG000|Overall Study|Lost to Follow-up|1|||
155172797|NCT04174365|560071909|FG000|Overall Study|Adverse Event|2|||
154836042|NCT00876187|558834953|FG000|Overall Study|Lack of Efficacy|59|||
154836043|NCT00876187|558834954|FG001|Overall Study|Lack of Efficacy|34|||
154836044|NCT00876187|558834955|FG002|Overall Study|Lack of Efficacy|45|||
155172798|NCT04174365|560071910|FG001|Overall Study|Adverse Event|1|||
154836045|NCT00876187|558834956|FG003|Overall Study|Lack of Efficacy|34|||
154836046|NCT00876187|558834957|FG004|Overall Study|Lack of Efficacy|59|||
154836047|NCT00876187|558834953|FG000|Overall Study|Lost to Follow-up|9|||
154836048|NCT00876187|558834954|FG001|Overall Study|Lost to Follow-up|10|||
154969349|NCT02286466|559310513|FG001|Overall Study|Lost to Follow-up|4|||
154969350|NCT02286466|559310512|FG000|Overall Study|Declined Clinician Assessment|0|||
154969351|NCT02286466|559310513|FG001|Overall Study|Declined Clinician Assessment|1|||
154969352|NCT00835081|559310514|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
154969353|NCT00835081|559310515|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
154969354|NCT01675596|559310516|FG000|Overall Study|Death|6|||
154969355|NCT01675596|559310516|FG000|Overall Study|Exit with other reason|1|||
154969356|NCT01675596|559310516|FG000|Overall Study|Missed Visit|1|||
154969357|NCT01520987|559312181|FG000|Overall Study|Withdrawal by Subject|1|||
154969358|NCT01520987|559312182|FG001|Overall Study|Withdrawal by Subject|0|||
154969359|NCT01520987|559312183|FG002|Overall Study|Withdrawal by Subject|0|||
154969360|NCT01520987|559312184|FG003|Overall Study|Withdrawal by Subject|0|||
154969361|NCT01520987|559312185|FG004|Overall Study|Withdrawal by Subject|0|||
154969362|NCT01520987|559312186|FG005|Overall Study|Withdrawal by Subject|1|||
154969363|NCT01520987|559312187|FG006|Overall Study|Withdrawal by Subject|0|||
154969364|NCT01520987|559312188|FG007|Overall Study|Withdrawal by Subject|0|||
154969365|NCT02005562|559312189|FG000|Overall Study|Death|2|||
154969366|NCT02005562|559312190|FG001|Overall Study|Death|2|||
154969367|NCT02005562|559312189|FG000|Overall Study|Graft loss|7|||
154969368|NCT02005562|559312190|FG001|Overall Study|Graft loss|6|||
154969369|NCT02005562|559312189|FG000|Overall Study|Withdrawal by Subject|2|||
154969370|NCT02005562|559312190|FG001|Overall Study|Withdrawal by Subject|2|||
154969371|NCT02005562|559312189|FG000|Overall Study|No transplant|1|||
154969372|NCT02005562|559312190|FG001|Overall Study|No transplant|4|||
154969373|NCT02005562|559312189|FG000|Overall Study|Physician Decision|0|||
154969374|NCT02005562|559312190|FG001|Overall Study|Physician Decision|1|||
154969375|NCT02300987|559312191|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
154969376|NCT02300987|559312192|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
154969377|NCT02300987|559312191|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
154969378|NCT02300987|559312192|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
154969379|NCT02300987|559312191|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
154969380|NCT02300987|559312192|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
154969381|NCT02300987|559312191|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
154969382|NCT02300987|559312192|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
154969383|NCT02300987|559312191|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
154969384|NCT02300987|559312192|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
154969385|NCT01023061|559312193|FG000|Overall Study|Withdrawal prior to treatment|2|||
154969386|NCT02966340|559312194|FG000|Overall Study|Adverse Event|0|||
154969387|NCT02966340|559312195|FG001|Overall Study|Adverse Event|1|||
154969388|NCT02966340|559312194|FG000|Overall Study|Lost to Follow-up|0|||
154969389|NCT02966340|559312195|FG001|Overall Study|Lost to Follow-up|1|||
154969390|NCT02966340|559312194|FG000|Overall Study|Withdrawal by Subject|1|||
154969391|NCT02966340|559312195|FG001|Overall Study|Withdrawal by Subject|0|||
154969392|NCT02966340|559312194|FG000|Overall Study|data acquisition error|1|||
154969393|NCT02966340|559312195|FG001|Overall Study|data acquisition error|0|||
154969394|NCT02966340|559312194|FG000|Overall Study|startle non-responder|1|||
154969395|NCT02966340|559312195|FG001|Overall Study|startle non-responder|1|||
154969396|NCT02664415|559312197|FG000|Overall Study|Adverse Event|1|||
154969397|NCT02664415|559312198|FG001|Overall Study|Adverse Event|0|||
154969398|NCT02034513|559312202|FG000|Overall Study|Adverse Event|11|||
154969399|NCT02034513|559312203|FG001|Overall Study|Adverse Event|10|||
154969400|NCT02034513|559312202|FG000|Overall Study|Lack of Efficacy|0|||
154969401|NCT02034513|559312203|FG001|Overall Study|Lack of Efficacy|1|||
154969402|NCT02034513|559312202|FG000|Overall Study|Lost to Follow-up|6|||
154969403|NCT02034513|559312203|FG001|Overall Study|Lost to Follow-up|7|||
154969404|NCT02034513|559312202|FG000|Overall Study|Pregnancy|0|||
154969405|NCT02034513|559312203|FG001|Overall Study|Pregnancy|3|||
154969406|NCT02034513|559312202|FG000|Overall Study|Protocol Violation|7|||
154969407|NCT02034513|559312203|FG001|Overall Study|Protocol Violation|10|||
154969408|NCT02034513|559312202|FG000|Overall Study|Withdrawal by Subject|25|||
154969409|NCT02034513|559312203|FG001|Overall Study|Withdrawal by Subject|25|||
154969410|NCT02034513|559312202|FG000|Overall Study|Unclassified|0|||
154969411|NCT02034513|559312203|FG001|Overall Study|Unclassified|1|||
154969412|NCT02308241|559312204|FG000|Overall Study|Withdrawal by Subject|3|||
154969413|NCT00659815|559312205|FG000|Overall Study|Study related symptoms and complaints|2|||
154969414|NCT00659815|559312206|FG001|Overall Study|Study related symptoms and complaints|1|||
154969415|NCT00659815|559312205|FG000|Overall Study|Inability to maintain wearing schedule|1|||
154969416|NCT00659815|559312206|FG001|Overall Study|Inability to maintain wearing schedule|2|||
155101851|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
155101852|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
155101853|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
154836049|NCT00876187|558834955|FG002|Overall Study|Lost to Follow-up|8|||
154836050|NCT00876187|558834956|FG003|Overall Study|Lost to Follow-up|8|||
154836051|NCT00876187|558834957|FG004|Overall Study|Lost to Follow-up|11|||
154836052|NCT00876187|558834953|FG000|Overall Study|Protocol Violation|6|||
154836053|NCT00876187|558834954|FG001|Overall Study|Protocol Violation|7|||
154836054|NCT00876187|558834955|FG002|Overall Study|Protocol Violation|7|||
155172799|NCT04174365|560071909|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
154836055|NCT00876187|558834956|FG003|Overall Study|Protocol Violation|6|||
155101854|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101855|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101856|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101857|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101858|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101859|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101860|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101861|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
155101862|NCT01194219|559806483|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
155101863|NCT01194219|559806484|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
155101864|NCT01194219|559806485|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155101865|NCT01194219|559806486|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155172800|NCT04174365|560071910|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
155172801|NCT04174365|560071909|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
155172802|NCT04174365|560071910|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
155172803|NCT04174365|560071909|FG000|Overall Study|Protocol Deviation|1|||
155172804|NCT04174365|560071910|FG001|Overall Study|Protocol Deviation|0|||
155172805|NCT04174365|560071909|FG000|Overall Study|Lack of Efficacy|0|||
154836056|NCT00876187|558834957|FG004|Overall Study|Protocol Violation|3|||
154836057|NCT00876187|558834953|FG000|Overall Study|Withdrawal by Subject|16|||
154836058|NCT00876187|558834954|FG001|Overall Study|Withdrawal by Subject|26|||
154836059|NCT00876187|558834955|FG002|Overall Study|Withdrawal by Subject|32|||
154836060|NCT00876187|558834956|FG003|Overall Study|Withdrawal by Subject|38|||
154836061|NCT00876187|558834957|FG004|Overall Study|Withdrawal by Subject|37|||
154836062|NCT00876187|558834953|FG000|Overall Study|Entered extension study|101|||
154836063|NCT00876187|558834954|FG001|Overall Study|Entered extension study|120|||
154836064|NCT00876187|558834955|FG002|Overall Study|Entered extension study|156|||
154836065|NCT00876187|558834956|FG003|Overall Study|Entered extension study|151|||
154836066|NCT00876187|558834957|FG004|Overall Study|Entered extension study|144|||
154836067|NCT00876187|558834953|FG000|Overall Study|Randomized but not treated|3|||
154836068|NCT00876187|558834954|FG001|Overall Study|Randomized but not treated|1|||
154836069|NCT00876187|558834955|FG002|Overall Study|Randomized but not treated|3|||
154836070|NCT00876187|558834956|FG003|Overall Study|Randomized but not treated|2|||
154836071|NCT00876187|558834957|FG004|Overall Study|Randomized but not treated|3|||
154836072|NCT00876187|558834953|FG000|Overall Study|Other|2|||
154836073|NCT00876187|558834954|FG001|Overall Study|Other|5|||
154836074|NCT00876187|558834955|FG002|Overall Study|Other|9|||
154836075|NCT00876187|558834956|FG003|Overall Study|Other|7|||
154836076|NCT00876187|558834957|FG004|Overall Study|Other|4|||
154836077|NCT00838331|558834958|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
154836078|NCT01379274|558834959|FG000|Overall Study|funding withdrawn|1|||
154836079|NCT03200366|558834960|FG000|Patient Navigation Intervention Given|Death|0|||
154836080|NCT03200366|558834961|FG001|Patient Navigation Intervention Given|Death|2|||
154836081|NCT03200366|558834962|FG002|Patient Navigation Intervention Given|Death|0|||
154836082|NCT03200366|558834960|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
154836083|NCT03200366|558834961|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
154836084|NCT03200366|558834962|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
154836085|NCT03200366|558834960|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
154836086|NCT03200366|558834961|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
154924061|NCT04668066|559146371|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924062|NCT04668066|559146372|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924063|NCT04668066|559146373|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
154836087|NCT03200366|558834962|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
154836088|NCT03200366|558834960|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
154836089|NCT03200366|558834961|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
154836090|NCT03200366|558834962|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
154836091|NCT03200366|558834960|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
154836092|NCT03200366|558834961|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
154836093|NCT03200366|558834962|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
154836094|NCT03200366|558834960|FG000|6 Month Post-Baseline Interview|Death|1|||
154836095|NCT03200366|558834961|FG001|6 Month Post-Baseline Interview|Death|1|||
154836096|NCT03200366|558834962|FG002|6 Month Post-Baseline Interview|Death|1|||
154836097|NCT03200366|558834960|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
154836098|NCT03200366|558834961|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
154836099|NCT03200366|558834962|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
154969417|NCT00659815|559312205|FG000|Overall Study|Withdrawal by Subject|1|||
154969418|NCT00659815|559312206|FG001|Overall Study|Withdrawal by Subject|1|||
154969419|NCT02998541|559312212|FG000|Overall Study|Adverse Event|4|||
154969420|NCT02998541|559312213|FG001|Overall Study|Adverse Event|5|||
154969421|NCT02998541|559312214|FG002|Overall Study|Adverse Event|1|||
154969422|NCT02998541|559312212|FG000|Overall Study|Protocol Violation|1|||
154969423|NCT02998541|559312213|FG001|Overall Study|Protocol Violation|0|||
154969424|NCT02998541|559312214|FG002|Overall Study|Protocol Violation|0|||
154969425|NCT02998541|559312212|FG000|Overall Study|Withdrawal by Subject|3|||
154969426|NCT02998541|559312213|FG001|Overall Study|Withdrawal by Subject|1|||
154969427|NCT02998541|559312214|FG002|Overall Study|Withdrawal by Subject|0|||
154969428|NCT02998541|559312212|FG000|Overall Study|Lost to Follow-up|0|||
154969429|NCT02998541|559312213|FG001|Overall Study|Lost to Follow-up|3|||
154969430|NCT02998541|559312214|FG002|Overall Study|Lost to Follow-up|1|||
154969431|NCT02998541|559312212|FG000|Overall Study|Physician Decision|0|||
154969432|NCT02998541|559312213|FG001|Overall Study|Physician Decision|0|||
154969433|NCT02998541|559312214|FG002|Overall Study|Physician Decision|3|||
154969434|NCT02998541|559312212|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154969435|NCT02998541|559312213|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154969436|NCT02998541|559312214|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
154969437|NCT01513239|559312222|FG000|Period 1: Main Phase|Adverse Event|1|||
154969438|NCT01513239|559312223|FG001|Period 1: Main Phase|Adverse Event|1|||
154969439|NCT01513239|559312224|FG002|Period 1: Main Phase|Adverse Event|2|||
154969440|NCT01513239|559312225|FG003|Period 1: Main Phase|Adverse Event|0|||
154969441|NCT01513239|559312226|FG004|Period 1: Main Phase|Adverse Event|0|||
154969442|NCT01513239|559312227|FG005|Period 1: Main Phase|Adverse Event|0|||
154969443|NCT01513239|559312222|FG000|Period 1: Main Phase|Death|29|||
154969444|NCT01513239|559312223|FG001|Period 1: Main Phase|Death|22|||
154969445|NCT01513239|559312224|FG002|Period 1: Main Phase|Death|32|||
154969446|NCT01513239|559312225|FG003|Period 1: Main Phase|Death|0|||
154969447|NCT01513239|559312226|FG004|Period 1: Main Phase|Death|0|||
154969448|NCT01513239|559312227|FG005|Period 1: Main Phase|Death|0|||
154969449|NCT01513239|559312222|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
154969450|NCT01513239|559312223|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
154969451|NCT01513239|559312224|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
154969452|NCT01513239|559312225|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
154969453|NCT01513239|559312226|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
154969454|NCT01513239|559312227|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
154969455|NCT01513239|559312222|FG000|Period 1: Main Phase|Physician Decision|4|||
154969456|NCT01513239|559312223|FG001|Period 1: Main Phase|Physician Decision|4|||
154969457|NCT01513239|559312224|FG002|Period 1: Main Phase|Physician Decision|4|||
154969458|NCT01513239|559312225|FG003|Period 1: Main Phase|Physician Decision|0|||
154969459|NCT01513239|559312226|FG004|Period 1: Main Phase|Physician Decision|0|||
155172806|NCT04174365|560071910|FG001|Overall Study|Lack of Efficacy|2|||
154969460|NCT01513239|559312227|FG005|Period 1: Main Phase|Physician Decision|0|||
154969461|NCT01513239|559312222|FG000|Period 1: Main Phase|Protocol Violation|2|||
154969462|NCT01513239|559312223|FG001|Period 1: Main Phase|Protocol Violation|2|||
154969463|NCT01513239|559312224|FG002|Period 1: Main Phase|Protocol Violation|2|||
154969464|NCT01513239|559312225|FG003|Period 1: Main Phase|Protocol Violation|0|||
154969465|NCT01513239|559312226|FG004|Period 1: Main Phase|Protocol Violation|0|||
154969466|NCT01513239|559312227|FG005|Period 1: Main Phase|Protocol Violation|0|||
154969467|NCT01513239|559312222|FG000|Period 1: Main Phase|Technical Problems|1|||
154969468|NCT01513239|559312223|FG001|Period 1: Main Phase|Technical Problems|2|||
154836100|NCT03200366|558834960|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
154836101|NCT03200366|558834961|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
154836102|NCT03200366|558834962|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
154836103|NCT03200366|558834960|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
154836104|NCT03200366|558834961|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
154836105|NCT03200366|558834962|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
154836106|NCT03200366|558834960|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
154836107|NCT03200366|558834961|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
154836108|NCT03200366|558834962|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
154836109|NCT03200366|558834960|FG000|9 Month Post-Baseline Interview|Death|1|||
154836110|NCT03200366|558834961|FG001|9 Month Post-Baseline Interview|Death|1|||
154836111|NCT03200366|558834962|FG002|9 Month Post-Baseline Interview|Death|1|||
154836112|NCT03200366|558834960|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
154836113|NCT03200366|558834961|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
154836114|NCT03200366|558834962|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
154836115|NCT03200366|558834960|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
154836116|NCT03200366|558834961|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
154836117|NCT03200366|558834962|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
154836118|NCT03200366|558834960|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
154836119|NCT03200366|558834961|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
154836120|NCT03200366|558834962|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
154836121|NCT00405067|558834963|FG000|Overall Study|Adverse Event|4|||
154836122|NCT00405067|558834964|FG001|Overall Study|Adverse Event|9|||
154836123|NCT00405067|558834965|FG002|Overall Study|Adverse Event|4|||
154836124|NCT00405067|558834963|FG000|Overall Study|Lost to Follow-up|0|||
154836125|NCT00405067|558834964|FG001|Overall Study|Lost to Follow-up|0|||
154836126|NCT00405067|558834965|FG002|Overall Study|Lost to Follow-up|1|||
154969469|NCT01513239|559312224|FG002|Period 1: Main Phase|Technical Problems|0|||
154969470|NCT01513239|559312225|FG003|Period 1: Main Phase|Technical Problems|0|||
154836127|NCT03287219|558834966|FG000|Overall Study|Protocol Violation|0|||
154836128|NCT03287219|558834967|FG001|Overall Study|Protocol Violation|2|||
154969471|NCT01513239|559312226|FG004|Period 1: Main Phase|Technical Problems|0|||
154969472|NCT01513239|559312227|FG005|Period 1: Main Phase|Technical Problems|0|||
155101866|NCT01194219|559806487|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
154969473|NCT01513239|559312222|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
154969474|NCT01513239|559312223|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
154969475|NCT01513239|559312224|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
154969476|NCT01513239|559312225|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
154969477|NCT01513239|559312226|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
154969478|NCT01513239|559312227|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
154969479|NCT01513239|559312222|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
154969480|NCT01513239|559312223|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
154969481|NCT01513239|559312224|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
154969482|NCT01513239|559312225|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
154969483|NCT01513239|559312226|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
154969484|NCT01513239|559312227|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
154969485|NCT01513239|559312222|FG000|Period 2: 9 Month Extension Phase|Death|0|||
154969486|NCT01513239|559312223|FG001|Period 2: 9 Month Extension Phase|Death|0|||
154969487|NCT01513239|559312224|FG002|Period 2: 9 Month Extension Phase|Death|0|||
154969488|NCT01513239|559312225|FG003|Period 2: 9 Month Extension Phase|Death|2|||
154969489|NCT01513239|559312226|FG004|Period 2: 9 Month Extension Phase|Death|5|||
154969490|NCT01513239|559312227|FG005|Period 2: 9 Month Extension Phase|Death|2|||
154969491|NCT01513239|559312222|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
154969492|NCT01513239|559312223|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
154969493|NCT01513239|559312224|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
154969494|NCT01513239|559312225|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
154969495|NCT01513239|559312226|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
154969496|NCT01513239|559312227|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
154969497|NCT01513239|559312222|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
154969498|NCT01513239|559312223|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
154969499|NCT01513239|559312224|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
154969500|NCT01513239|559312225|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
154969501|NCT01513239|559312226|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
154969502|NCT01513239|559312227|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
154969503|NCT01513239|559312222|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
154969504|NCT01513239|559312223|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
154969505|NCT01513239|559312224|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
154969506|NCT01513239|559312225|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
154969507|NCT01513239|559312226|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
154969508|NCT01513239|559312227|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
154969509|NCT00396162|559312228|FG000|Overall Study|Withdrawal by Subject|2|||
154969510|NCT00396162|559312229|FG001|Overall Study|Withdrawal by Subject|3|||
154969511|NCT01741545|559312233|FG000|Treatment Period|Lack of Efficacy|0|||
154969512|NCT01741545|559312234|FG001|Treatment Period|Lack of Efficacy|1|||
154969513|NCT01741545|559312233|FG000|Treatment Period|Adverse event, non-fatal|1|||
154969514|NCT01741545|559312234|FG001|Treatment Period|Adverse event, non-fatal|3|||
154969515|NCT01741545|559312233|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
154969516|NCT01741545|559312234|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
154969517|NCT01741545|559312233|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
154969518|NCT01741545|559312234|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
154969519|NCT01456962|559312235|FG000|Overall Study|Lost to Follow-up|2|||
154969520|NCT01456962|559312236|FG001|Overall Study|Lost to Follow-up|1|||
154969521|NCT03387462|559312237|FG000|Overall Study|Lost to Follow-up|1|||
154969522|NCT01460628|559312238|FG000|Overall Study|Adverse Event|3|||
154969523|NCT01460628|559312238|FG000|Overall Study|Withdrawal by Subject|2|||
154969524|NCT01664039|559312242|FG000|Overall Study|Adverse Event|3|||
154969525|NCT01664039|559312243|FG001|Overall Study|Adverse Event|4|||
154969526|NCT01664039|559312242|FG000|Overall Study|Lost to Follow-up|1|||
154969527|NCT01664039|559312243|FG001|Overall Study|Lost to Follow-up|1|||
154969528|NCT01664039|559312242|FG000|Overall Study|Withdrawal by Subject|1|||
155101867|NCT01194219|559806488|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155101868|NCT01194219|559806489|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
154969529|NCT01664039|559312243|FG001|Overall Study|Withdrawal by Subject|3|||
154969530|NCT01664039|559312242|FG000|Overall Study|Noncompliance|1|||
154969531|NCT01664039|559312243|FG001|Overall Study|Noncompliance|1|||
154969532|NCT01853176|559312244|FG000|Overall Study|Study terminated|4|||
154969533|NCT01853176|559312245|FG001|Overall Study|Study terminated|0|||
155101869|NCT01194219|559806490|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155101870|NCT01194219|559806491|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
154969534|NCT00874822|559312247|FG000|Overall Study|excluded by criteria|8|||
154969535|NCT02854800|559312248|FG000|Overall Study|Protocol Violation|16|||
154969536|NCT02854800|559312249|FG001|Overall Study|Protocol Violation|11|||
154969537|NCT02854800|559312250|FG002|Overall Study|Protocol Violation|3|||
154969538|NCT02854800|559312248|FG000|Overall Study|Withdrawal by Subject|4|||
154969539|NCT02854800|559312249|FG001|Overall Study|Withdrawal by Subject|2|||
154969540|NCT02854800|559312250|FG002|Overall Study|Withdrawal by Subject|3|||
154969541|NCT04442503|559312251|FG000|Overall Study|Adverse Event|1|||
154969542|NCT04442503|559312252|FG001|Overall Study|Adverse Event|1|||
154969543|NCT04442503|559312251|FG000|Overall Study|Lost to Follow-up|8|||
154969544|NCT04442503|559312252|FG001|Overall Study|Lost to Follow-up|6|||
154969545|NCT04442503|559312251|FG000|Overall Study|Physician Decision|0|||
154969546|NCT04442503|559312252|FG001|Overall Study|Physician Decision|2|||
154969547|NCT04442503|559312251|FG000|Overall Study|Withdrawal by Subject|3|||
154969548|NCT04442503|559312252|FG001|Overall Study|Withdrawal by Subject|4|||
154969549|NCT04442503|559312251|FG000|Overall Study|Reason not Specified|0|||
154969550|NCT04442503|559312252|FG001|Overall Study|Reason not Specified|1|||
154969551|NCT04442503|559312251|FG000|Overall Study|Randomized but not Treated|3|||
154969552|NCT04442503|559312252|FG001|Overall Study|Randomized but not Treated|1|||
154969553|NCT02420353|559312263|FG000|Overall Study|Withdrawal by Subject|0|||
154969554|NCT02420353|559312264|FG001|Overall Study|Withdrawal by Subject|1|||
154969555|NCT00503867|559312265|FG000|Overall Study|Lost to Follow-up|1|||
154969556|NCT00503867|559312265|FG000|Overall Study|Adverse Event|1|||
154969557|NCT00654186|559312266|FG000|Overall Study|Withdrawal by Subject|5|||
154969558|NCT05616728|559312267|FG000|Overall Study|Lost to Follow-up|0|||
154969559|NCT05616728|559312268|FG001|Overall Study|Lost to Follow-up|0|||
154969560|NCT05616728|559312269|FG002|Overall Study|Lost to Follow-up|1|||
154969561|NCT05616728|559312267|FG000|Overall Study|Withdrawal by Subject|1|||
154969562|NCT05616728|559312268|FG001|Overall Study|Withdrawal by Subject|1|||
154969563|NCT05616728|559312269|FG002|Overall Study|Withdrawal by Subject|0|||
154969564|NCT05616728|559312267|FG000|Overall Study|Physician Decision|1|||
154969565|NCT05616728|559312268|FG001|Overall Study|Physician Decision|1|||
154969566|NCT05616728|559312269|FG002|Overall Study|Physician Decision|1|||
154969567|NCT05616728|559312267|FG000|Overall Study|Other|0|||
154969568|NCT05616728|559312268|FG001|Overall Study|Other|2|||
154969569|NCT05616728|559312269|FG002|Overall Study|Other|0|||
154969570|NCT00577655|559312270|FG000|Overall Study|Patient Request|0|||
154969571|NCT00577655|559312271|FG001|Overall Study|Patient Request|2|||
154969572|NCT00577655|559312270|FG000|Overall Study|Protocol Violation|0|||
154969573|NCT00577655|559312271|FG001|Overall Study|Protocol Violation|1|||
154969574|NCT00577655|559312270|FG000|Overall Study|Lost to Follow-up|1|||
154969575|NCT00577655|559312271|FG001|Overall Study|Lost to Follow-up|1|||
154969576|NCT00875524|559312277|FG000|Overall Study|Serious adverse event|0|||
154969577|NCT00875524|559312278|FG001|Overall Study|Serious adverse event|1|||
154969578|NCT00875524|559312277|FG000|Overall Study|Protocol Violation|4|||
154969579|NCT00875524|559312278|FG001|Overall Study|Protocol Violation|0|||
154969580|NCT00875524|559312277|FG000|Overall Study|Lost to Follow-up|1|||
154969581|NCT00875524|559312278|FG001|Overall Study|Lost to Follow-up|0|||
154969582|NCT00875524|559312277|FG000|Overall Study|Withdrawal by Subject|3|||
154969583|NCT00875524|559312278|FG001|Overall Study|Withdrawal by Subject|5|||
154969584|NCT01370863|559312282|FG000|Overall Study|Adverse Event|1|||
154969585|NCT01370863|559312283|FG001|Overall Study|Adverse Event|1|||
154969586|NCT01370863|559312282|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
154969587|NCT01370863|559312283|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
154969588|NCT01370863|559312282|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
154969589|NCT01370863|559312283|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
154969590|NCT02761915|559312285|FG000|Overall Study|Death|3|||
154969591|NCT02761915|559312286|FG001|Overall Study|Death|1|||
154969592|NCT02761915|559312287|FG002|Overall Study|Death|1|||
154969593|NCT02761915|559312288|FG003|Overall Study|Death|1|||
154969594|NCT02761915|559312289|FG004|Overall Study|Death|0|||
154969595|NCT02761915|559312290|FG005|Overall Study|Death|1|||
154969596|NCT02761915|559312285|FG000|Overall Study|Withdrawal by Subject|1|||
154969597|NCT02761915|559312286|FG001|Overall Study|Withdrawal by Subject|0|||
154969598|NCT02761915|559312287|FG002|Overall Study|Withdrawal by Subject|0|||
154969599|NCT02761915|559312288|FG003|Overall Study|Withdrawal by Subject|0|||
154969600|NCT02761915|559312289|FG004|Overall Study|Withdrawal by Subject|1|||
154969601|NCT02761915|559312290|FG005|Overall Study|Withdrawal by Subject|2|||
154969602|NCT02761915|559312285|FG000|Overall Study|Disease Progression|0|||
154969603|NCT02761915|559312286|FG001|Overall Study|Disease Progression|0|||
154969604|NCT02761915|559312287|FG002|Overall Study|Disease Progression|0|||
154836129|NCT00930761|558834968|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
154969605|NCT02761915|559312288|FG003|Overall Study|Disease Progression|2|||
154969606|NCT02761915|559312289|FG004|Overall Study|Disease Progression|2|||
154969607|NCT02761915|559312290|FG005|Overall Study|Disease Progression|2|||
154969608|NCT01926119|559312300|FG000|Overall Study|Withdrawal by Subject|1|||
154969609|NCT00672984|559312301|FG000|First Intervention|Adverse Event|5|||
154969610|NCT00672984|559312302|FG001|First Intervention|Adverse Event|0|||
154969611|NCT00672984|559312303|FG002|First Intervention|Adverse Event|0|||
154969612|NCT00672984|559312301|FG000|First Intervention|Withdrawal by Subject|1|||
154969613|NCT00672984|559312302|FG001|First Intervention|Withdrawal by Subject|2|||
154969614|NCT00672984|559312303|FG002|First Intervention|Withdrawal by Subject|2|||
154969615|NCT00672984|559312301|FG000|First Intervention|Sponsor decision|3|||
154969616|NCT00672984|559312302|FG001|First Intervention|Sponsor decision|0|||
154969617|NCT00672984|559312303|FG002|First Intervention|Sponsor decision|0|||
154836130|NCT00930761|558834969|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
154836131|NCT00930761|558834968|FG000|Overall Study|less than 3 music therapy sessions|0|||
154836132|NCT00930761|558834969|FG001|Overall Study|less than 3 music therapy sessions|3|||
154836133|NCT03571646|558834970|FG000|Overall Study|Adverse Event|1|||
154836134|NCT03571646|558834971|FG001|Overall Study|Adverse Event|0|||
154836135|NCT03571646|558834970|FG000|Overall Study|Withdrawal by Subject|1|||
154836136|NCT03571646|558834971|FG001|Overall Study|Withdrawal by Subject|1|||
154836137|NCT01576549|558834972|FG000|Overall Study|Sponsor Decision|2|||
154836138|NCT04081363|558834973|FG000|Overall Study|Withdrawal by Subject|1|||
154836139|NCT04081363|558834974|FG001|Overall Study|Withdrawal by Subject|0|||
154836140|NCT01765920|558834976|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
154836141|NCT01765920|558834977|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
154836142|NCT01765920|558834976|FG000|Overall Study|Patient code disclosure|0|||
154836143|NCT01765920|558834977|FG001|Overall Study|Patient code disclosure|1|||
154836144|NCT02025907|558834978|FG000|Overall Study|Lack of Efficacy|1|||
154836145|NCT02025907|558834979|FG001|Overall Study|Lack of Efficacy|0|||
154836146|NCT02025907|558834978|FG000|Overall Study|Withdrawal by Subject|15|||
154836147|NCT02025907|558834979|FG001|Overall Study|Withdrawal by Subject|8|||
154836148|NCT02025907|558834978|FG000|Overall Study|Protocol Violation|2|||
154836149|NCT02025907|558834979|FG001|Overall Study|Protocol Violation|0|||
154836150|NCT02025907|558834978|FG000|Overall Study|Physician Decision|2|||
154836151|NCT02025907|558834979|FG001|Overall Study|Physician Decision|0|||
154836152|NCT02025907|558834978|FG000|Overall Study|Lost to Follow-up|2|||
154836153|NCT02025907|558834979|FG001|Overall Study|Lost to Follow-up|2|||
154836154|NCT02025907|558834978|FG000|Overall Study|Adverse Event|3|||
154836155|NCT02025907|558834979|FG001|Overall Study|Adverse Event|1|||
154836156|NCT02025907|558834978|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
154836157|NCT02025907|558834979|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
154836158|NCT02411539|558834983|FG000|Overall Study|Lost to Follow-up|2|||
154836159|NCT02411539|558834984|FG001|Overall Study|Lost to Follow-up|0|||
154836160|NCT02411539|558834983|FG000|Overall Study|Confounding medical condition|0|||
154836161|NCT02411539|558834984|FG001|Overall Study|Confounding medical condition|1|||
154836162|NCT00939783|558834987|FG000|Overall Study|Death|6|||
154836163|NCT00939783|558834987|FG000|Overall Study|Adverse Event|39|||
154836164|NCT00939783|558834987|FG000|Overall Study|Study Terminated by Sponsor|498|||
154836165|NCT00939783|558834987|FG000|Overall Study|Withdrawal by Subject|78|||
154836166|NCT00939783|558834987|FG000|Overall Study|Other|16|||
154836167|NCT00939783|558834987|FG000|Overall Study|Lost to Follow-up|8|||
154836168|NCT00939783|558834987|FG000|Overall Study|Protocol Violation|3|||
154836169|NCT00939783|558834987|FG000|Overall Study|Enrolled but not treated|1|||
154836170|NCT03631732|558834993|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
154836171|NCT03631732|558834994|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
154836172|NCT03631732|558834993|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
154836173|NCT03631732|558834994|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
154836174|NCT03631732|558834993|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
154836175|NCT03631732|558834994|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
154836176|NCT03631732|558834993|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
154836177|NCT03631732|558834994|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
154836178|NCT03631732|558834993|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
154836179|NCT03631732|558834994|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
154836180|NCT03631732|558834993|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
154836181|NCT03631732|558834994|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
154836182|NCT03631732|558834993|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
154969618|NCT00672984|559312301|FG000|Second Intervention|Non-compliance with facility policies|0|||
155172807|NCT04174365|560071909|FG000|Overall Study|Disease Relapse|1|||
155172808|NCT04174365|560071910|FG001|Overall Study|Disease Relapse|0|||
154836183|NCT03631732|558834994|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
154836184|NCT03631732|558834993|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
154836185|NCT03631732|558834994|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
154836186|NCT03631732|558834993|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
154836187|NCT03631732|558834994|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
154836188|NCT03631732|558834993|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
154836189|NCT03631732|558834994|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
154836190|NCT01439204|558834995|FG000|Overall Study|Withdrawal by Subject|0|||
154836191|NCT01439204|558834996|FG001|Overall Study|Withdrawal by Subject|1|||
154836192|NCT01439204|558834995|FG000|Overall Study|Lost to Follow-up|0|||
154836193|NCT01439204|558834996|FG001|Overall Study|Lost to Follow-up|2|||
154836194|NCT01439204|558834995|FG000|Overall Study|No longer meets study criteria|1|||
154836195|NCT01439204|558834996|FG001|Overall Study|No longer meets study criteria|0|||
154836196|NCT01439204|558834995|FG000|Overall Study|poor/non-compliance|3|||
154836197|NCT01439204|558834996|FG001|Overall Study|poor/non-compliance|0|||
154836198|NCT02255409|558834997|FG000|Overall Study|Administrative Reason|3|||
154836199|NCT02255409|558834998|FG001|Overall Study|Administrative Reason|7|||
154836200|NCT02255409|558834997|FG000|Overall Study|Withdrawal by Subject|1|||
154836201|NCT02255409|558834998|FG001|Overall Study|Withdrawal by Subject|5|||
154836202|NCT02255409|558834997|FG000|Overall Study|Lost to Follow-up|10|||
154836203|NCT02255409|558834998|FG001|Overall Study|Lost to Follow-up|19|||
154836204|NCT03775421|558835000|FG000|Overall Study|Lost to Follow-up|2|||
154836205|NCT03775421|558835000|FG000|Overall Study|Withdrawal by Subject|10|||
154836206|NCT03775421|558835000|FG000|Overall Study|Physician Decision|3|||
154836207|NCT03775421|558835000|FG000|Overall Study|Death|1|||
154836208|NCT03775421|558835000|FG000|Overall Study|Study Terminated by Sponsor|94|||
154836209|NCT02287623|558835008|FG000|Overall Study|Protocol Violation|0|||
154836210|NCT02287623|558835009|FG001|Overall Study|Protocol Violation|1|||
154836211|NCT02700997|558835010|FG000|Overall Study|Did not undergo CT imaging|1|||
154836212|NCT02700997|558835010|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
154836213|NCT00455013|558835014|FG000|Short Term Period|Adverse Event|2|||
154836214|NCT00455013|558835015|FG001|Short Term Period|Adverse Event|5|||
154836215|NCT00455013|558835016|FG002|Short Term Period|Adverse Event|0|||
154836216|NCT00455013|558835014|FG000|Short Term Period|Withdrawal by Subject|0|||
154836217|NCT00455013|558835015|FG001|Short Term Period|Withdrawal by Subject|0|||
154836218|NCT00455013|558835016|FG002|Short Term Period|Withdrawal by Subject|1|||
154836219|NCT00455013|558835014|FG000|Short Term Period|Lack of Efficacy|4|||
154836220|NCT00455013|558835015|FG001|Short Term Period|Lack of Efficacy|0|||
154836221|NCT00455013|558835016|FG002|Short Term Period|Lack of Efficacy|0|||
154836222|NCT00455013|558835014|FG000|Short Term Period|Other|0|||
154836223|NCT00455013|558835015|FG001|Short Term Period|Other|0|||
154836224|NCT00455013|558835016|FG002|Short Term Period|Other|1|||
154836225|NCT00455013|558835014|FG000|Long Term Extension (LTE)|Adverse Event|0|||
154836226|NCT00455013|558835015|FG001|Long Term Extension (LTE)|Adverse Event|1|||
154836227|NCT00455013|558835016|FG002|Long Term Extension (LTE)|Adverse Event|1|||
154836228|NCT00455013|558835014|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
154836229|NCT00455013|558835015|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
154836230|NCT00455013|558835016|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
154836231|NCT00455013|558835014|FG000|Long Term Extension (LTE)|Death|1|||
154836232|NCT00455013|558835015|FG001|Long Term Extension (LTE)|Death|1|||
154836233|NCT00455013|558835016|FG002|Long Term Extension (LTE)|Death|0|||
154836234|NCT00455013|558835014|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
154836235|NCT00455013|558835015|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
154836236|NCT00455013|558835016|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
154836237|NCT00455013|558835014|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
154836238|NCT00455013|558835015|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
154836239|NCT00455013|558835016|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
155101871|NCT01194219|559806492|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
155101872|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
155101873|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
155101874|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
155101875|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
155101876|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
155101877|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
155172809|NCT04174365|560071909|FG000|Overall Study|Reason Not Specified|0|||
154836240|NCT00455013|558835014|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
154836241|NCT00455013|558835015|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
154836242|NCT00455013|558835016|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
154836243|NCT00455013|558835014|FG000|Long Term Extension (LTE)|non-specified|0|||
154836244|NCT00455013|558835015|FG001|Long Term Extension (LTE)|non-specified|0|||
154836245|NCT00455013|558835016|FG002|Long Term Extension (LTE)|non-specified|1|||
154836246|NCT01445951|558835017|FG000|Overall Study|Adverse Event|16|||
154836247|NCT01445951|558835018|FG001|Overall Study|Adverse Event|9|||
154836248|NCT01445951|558835019|FG002|Overall Study|Adverse Event|0|||
154836249|NCT01445951|558835017|FG000|Overall Study|Protocol Violation|2|||
154836250|NCT01445951|558835018|FG001|Overall Study|Protocol Violation|2|||
154836251|NCT01445951|558835019|FG002|Overall Study|Protocol Violation|2|||
154836252|NCT01445951|558835017|FG000|Overall Study|Withdrawal by Subject|21|||
154836253|NCT01445951|558835018|FG001|Overall Study|Withdrawal by Subject|16|||
154836254|NCT01445951|558835019|FG002|Overall Study|Withdrawal by Subject|8|||
154836255|NCT01445951|558835017|FG000|Overall Study|Physician Decision|3|||
154836256|NCT01445951|558835018|FG001|Overall Study|Physician Decision|1|||
154836257|NCT01445951|558835019|FG002|Overall Study|Physician Decision|0|||
154836258|NCT01445951|558835017|FG000|Overall Study|Lost to Follow-up|1|||
154836259|NCT01445951|558835018|FG001|Overall Study|Lost to Follow-up|2|||
154836260|NCT01445951|558835019|FG002|Overall Study|Lost to Follow-up|4|||
154836261|NCT01445951|558835017|FG000|Overall Study|Pregnancy|0|||
154836262|NCT01445951|558835018|FG001|Overall Study|Pregnancy|1|||
154836263|NCT01445951|558835019|FG002|Overall Study|Pregnancy|4|||
154969619|NCT00672984|559312302|FG001|Second Intervention|Non-compliance with facility policies|2|||
154836264|NCT01445951|558835017|FG000|Overall Study|Death|0|||
154836265|NCT01445951|558835018|FG001|Overall Study|Death|0|||
154836266|NCT01445951|558835019|FG002|Overall Study|Death|1|||
154969620|NCT00672984|559312303|FG002|Second Intervention|Non-compliance with facility policies|0|||
154969621|NCT00672984|559312301|FG000|Second Intervention|Withdrawal by Subject|0|||
154969622|NCT00672984|559312302|FG001|Second Intervention|Withdrawal by Subject|3|||
154969623|NCT00672984|559312303|FG002|Second Intervention|Withdrawal by Subject|0|||
154969624|NCT00672984|559312301|FG000|Second Intervention|Protocol Violation|0|||
154969625|NCT00672984|559312302|FG001|Second Intervention|Protocol Violation|1|||
154969626|NCT00672984|559312303|FG002|Second Intervention|Protocol Violation|1|||
154969627|NCT00672984|559312301|FG000|Third Intervention|Adverse Event|1|||
154969628|NCT00672984|559312302|FG001|Third Intervention|Adverse Event|0|||
154836267|NCT01445951|558835017|FG000|Overall Study|Non-compliance with study drug|1|||
154836268|NCT01445951|558835018|FG001|Overall Study|Non-compliance with study drug|2|||
154969629|NCT00672984|559312303|FG002|Third Intervention|Adverse Event|1|||
154969630|NCT02654145|559312304|FG000|Overall Study|Lack of Efficacy|1|||
154969631|NCT02654145|559312304|FG000|Overall Study|Protocol Violation|1|||
154969632|NCT02654145|559312304|FG000|Overall Study|Withdrawal by Subject|5|||
154969633|NCT00009945|559312305|FG000|Overall Study|no follow up data|7|||
154969634|NCT00009945|559312306|FG001|Overall Study|no follow up data|5|||
154969635|NCT00354835|559312307|FG000|Overall Study|Death|1|||
154969636|NCT00354835|559312308|FG001|Overall Study|Death|1|||
154969637|NCT00354835|559312307|FG000|Overall Study|Physician Decision|8|||
154969638|NCT00354835|559312308|FG001|Overall Study|Physician Decision|13|||
154969639|NCT00354835|559312307|FG000|Overall Study|Withdrawal by Subject|2|||
154969640|NCT00354835|559312308|FG001|Overall Study|Withdrawal by Subject|1|||
154969641|NCT00354835|559312307|FG000|Overall Study|Ineligible|17|||
154969642|NCT00354835|559312308|FG001|Overall Study|Ineligible|16|||
155101878|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
155101879|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
154969643|NCT00354835|559312307|FG000|Overall Study|Disease progression or relapse|15|||
155101880|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
155101881|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
155101882|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155101883|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155101884|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
154969644|NCT00354835|559312308|FG001|Overall Study|Disease progression or relapse|22|||
154969645|NCT00354835|559312307|FG000|Overall Study|Adverse Event|6|||
154969646|NCT00354835|559312308|FG001|Overall Study|Adverse Event|0|||
154969647|NCT00354835|559312307|FG000|Overall Study|Refusal of further therapy|3|||
154969648|NCT00354835|559312308|FG001|Overall Study|Refusal of further therapy|8|||
154969649|NCT01968551|559312309|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
155172810|NCT04174365|560071910|FG001|Overall Study|Reason Not Specified|1|||
154836269|NCT01445951|558835019|FG002|Overall Study|Non-compliance with study drug|0|||
154836270|NCT01445951|558835017|FG000|Overall Study|Non-compliance with protocol|0|||
154836271|NCT01445951|558835018|FG001|Overall Study|Non-compliance with protocol|1|||
154836272|NCT01445951|558835019|FG002|Overall Study|Non-compliance with protocol|0|||
154836273|NCT01445951|558835017|FG000|Overall Study|Sponsor decision - subject travel|0|||
154836274|NCT01445951|558835018|FG001|Overall Study|Sponsor decision - subject travel|1|||
154836275|NCT01445951|558835019|FG002|Overall Study|Sponsor decision - subject travel|0|||
154836276|NCT01445951|558835017|FG000|Overall Study|Cough|0|||
154836277|NCT01445951|558835018|FG001|Overall Study|Cough|1|||
154836278|NCT01445951|558835019|FG002|Overall Study|Cough|0|||
154836279|NCT01473563|558835020|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
154836280|NCT03610724|558835021|FG000|Overall Study|Death|17|||
154836281|NCT03610724|558835021|FG000|Overall Study|Lost to Follow-up|1|||
154836282|NCT03610724|558835021|FG000|Overall Study|Physician Decision|1|||
154836283|NCT03610724|558835021|FG000|Overall Study|Died prior to infusion|1|||
154836284|NCT00786565|558835025|FG000|Enrollment Prior to Surgery|Site Closed|3|||
154836285|NCT00786565|558835025|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
154836286|NCT00786565|558835025|FG000|Post Surgery|Abnormal macular pucker|1|||
154836287|NCT00786565|558835025|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
154836288|NCT05513625|558835026|FG000|Overall Study|Withdrawal by Subject|1|||
154836289|NCT02943564|558835028|FG000|Overall Study|Miscellaneous Reasons|0|||
154836290|NCT02943564|558835029|FG001|Overall Study|Miscellaneous Reasons|0|||
154836291|NCT02943564|558835030|FG002|Overall Study|Miscellaneous Reasons|3|||
154836292|NCT02943564|558835028|FG000|Overall Study|Site terminated by sponsor|0|||
154836293|NCT02943564|558835029|FG001|Overall Study|Site terminated by sponsor|1|||
154836294|NCT02943564|558835030|FG002|Overall Study|Site terminated by sponsor|0|||
154836295|NCT02943564|558835028|FG000|Overall Study|Non-compliance with study drug|0|||
154836296|NCT02943564|558835029|FG001|Overall Study|Non-compliance with study drug|1|||
154836297|NCT02943564|558835030|FG002|Overall Study|Non-compliance with study drug|0|||
154836298|NCT02943564|558835028|FG000|Overall Study|Pregnancy|0|||
154836299|NCT02943564|558835029|FG001|Overall Study|Pregnancy|1|||
154836300|NCT02943564|558835030|FG002|Overall Study|Pregnancy|1|||
154836301|NCT02943564|558835028|FG000|Overall Study|Protocol Violation|2|||
154836302|NCT02943564|558835029|FG001|Overall Study|Protocol Violation|2|||
154836303|NCT02943564|558835030|FG002|Overall Study|Protocol Violation|2|||
154836304|NCT02943564|558835028|FG000|Overall Study|Lost to Follow-up|1|||
154836305|NCT02943564|558835029|FG001|Overall Study|Lost to Follow-up|0|||
154836306|NCT02943564|558835030|FG002|Overall Study|Lost to Follow-up|0|||
154836307|NCT02943564|558835028|FG000|Overall Study|Withdrawal by Subject|6|||
154836308|NCT02943564|558835029|FG001|Overall Study|Withdrawal by Subject|5|||
154836309|NCT02943564|558835030|FG002|Overall Study|Withdrawal by Subject|2|||
154836310|NCT02943564|558835028|FG000|Overall Study|Adverse Event|1|||
154836311|NCT02943564|558835029|FG001|Overall Study|Adverse Event|2|||
154836312|NCT02943564|558835030|FG002|Overall Study|Adverse Event|1|||
154836313|NCT02943564|558835028|FG000|Overall Study|Lack of Efficacy|0|||
154836314|NCT02943564|558835029|FG001|Overall Study|Lack of Efficacy|1|||
154836315|NCT02943564|558835030|FG002|Overall Study|Lack of Efficacy|0|||
154836316|NCT04143009|558835031|FG000|Pilot Trial|Lost to Follow-up|0|||
154836317|NCT04143009|558835032|FG001|Pilot Trial|Lost to Follow-up|1|||
154836318|NCT04143009|558835033|FG002|Pilot Trial|Lost to Follow-up|1|||
154836319|NCT03116698|558835040|FG000|Overall Study|Adverse Event|1|||
154836320|NCT03116698|558835041|FG001|Overall Study|Adverse Event|1|||
154836321|NCT03116698|558835042|FG002|Overall Study|Adverse Event|1|||
154836322|NCT03116698|558835043|FG003|Overall Study|Adverse Event|0|||
154836323|NCT03116698|558835040|FG000|Overall Study|Withdrawal by Subject|1|||
154836324|NCT03116698|558835041|FG001|Overall Study|Withdrawal by Subject|4|||
154836325|NCT03116698|558835042|FG002|Overall Study|Withdrawal by Subject|5|||
154836326|NCT03116698|558835043|FG003|Overall Study|Withdrawal by Subject|2|||
154836327|NCT03116698|558835040|FG000|Overall Study|Lost to Follow-up|2|||
154836328|NCT03116698|558835041|FG001|Overall Study|Lost to Follow-up|0|||
154836329|NCT03116698|558835042|FG002|Overall Study|Lost to Follow-up|0|||
154836330|NCT03116698|558835043|FG003|Overall Study|Lost to Follow-up|0|||
154836331|NCT03116698|558835040|FG000|Overall Study|Physician Decision|1|||
154836332|NCT03116698|558835041|FG001|Overall Study|Physician Decision|1|||
154836333|NCT03116698|558835042|FG002|Overall Study|Physician Decision|0|||
154836334|NCT03116698|558835043|FG003|Overall Study|Physician Decision|0|||
154836335|NCT03116698|558835040|FG000|Overall Study|Protocol Violation|1|||
154836336|NCT03116698|558835041|FG001|Overall Study|Protocol Violation|0|||
154836337|NCT03116698|558835042|FG002|Overall Study|Protocol Violation|0|||
154836338|NCT03116698|558835043|FG003|Overall Study|Protocol Violation|0|||
154836339|NCT03116698|558835040|FG000|Overall Study|Death|0|||
154836340|NCT03116698|558835041|FG001|Overall Study|Death|0|||
154836341|NCT03116698|558835042|FG002|Overall Study|Death|2|||
154836342|NCT03116698|558835043|FG003|Overall Study|Death|0|||
154836343|NCT00788372|558835044|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
154836344|NCT00788372|558835044|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
154836345|NCT00788372|558835044|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
154836346|NCT00788372|558835044|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
155101885|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
154836347|NCT00788372|558835044|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
154836348|NCT00788372|558835044|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
154836349|NCT00788372|558835044|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
154836350|NCT03099187|558835053|FG000|Double-blind Treatment|Adverse Event|19|||
154969650|NCT01968551|559312310|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
154969651|NCT01968551|559312311|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
154969652|NCT01968551|559312309|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
154969653|NCT01968551|559312310|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
154969654|NCT01968551|559312311|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
154969655|NCT01968551|559312309|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
154969656|NCT01968551|559312310|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
154969657|NCT01968551|559312311|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
154969658|NCT01968551|559312309|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
154969659|NCT01968551|559312310|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
154969660|NCT01968551|559312311|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
154969661|NCT01968551|559312309|FG000|Extension Phase|Adverse Event|0|||
154969662|NCT01968551|559312310|FG001|Extension Phase|Adverse Event|0|||
154969663|NCT01968551|559312311|FG002|Extension Phase|Adverse Event|2|||
154969664|NCT01968551|559312309|FG000|Extension Phase|Death|0|||
154836351|NCT03099187|558835054|FG001|Double-blind Treatment|Adverse Event|1|||
154836352|NCT03099187|558835055|FG002|Double-blind Treatment|Adverse Event|0|||
154836353|NCT03099187|558835056|FG003|Double-blind Treatment|Adverse Event|0|||
154836354|NCT03099187|558835053|FG000|Double-blind Treatment|Death|1|||
154836355|NCT03099187|558835054|FG001|Double-blind Treatment|Death|3|||
154836356|NCT03099187|558835055|FG002|Double-blind Treatment|Death|0|||
154836357|NCT03099187|558835056|FG003|Double-blind Treatment|Death|0|||
154836358|NCT03099187|558835053|FG000|Double-blind Treatment|Lack of Efficacy|1|||
154836359|NCT03099187|558835054|FG001|Double-blind Treatment|Lack of Efficacy|0|||
154836360|NCT03099187|558835055|FG002|Double-blind Treatment|Lack of Efficacy|0|||
154836361|NCT03099187|558835056|FG003|Double-blind Treatment|Lack of Efficacy|0|||
154836362|NCT03099187|558835053|FG000|Double-blind Treatment|Physician Decision|2|||
154836363|NCT03099187|558835054|FG001|Double-blind Treatment|Physician Decision|1|||
154836364|NCT03099187|558835055|FG002|Double-blind Treatment|Physician Decision|0|||
154836365|NCT03099187|558835056|FG003|Double-blind Treatment|Physician Decision|0|||
154836366|NCT03099187|558835053|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
154836367|NCT03099187|558835054|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
154836368|NCT03099187|558835055|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
154836369|NCT03099187|558835056|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
154836370|NCT03099187|558835053|FG000|Double-blind Treatment|Lung transplantation|0|||
154836371|NCT03099187|558835054|FG001|Double-blind Treatment|Lung transplantation|1|||
154836372|NCT03099187|558835055|FG002|Double-blind Treatment|Lung transplantation|0|||
154836373|NCT03099187|558835056|FG003|Double-blind Treatment|Lung transplantation|0|||
154836374|NCT03099187|558835053|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
154836375|NCT03099187|558835054|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
154969665|NCT01968551|559312310|FG001|Extension Phase|Death|1|||
154969666|NCT01968551|559312311|FG002|Extension Phase|Death|0|||
154969667|NCT01968551|559312309|FG000|Extension Phase|Withdrew Consent|0|||
154969668|NCT01968551|559312310|FG001|Extension Phase|Withdrew Consent|0|||
154969669|NCT01968551|559312311|FG002|Extension Phase|Withdrew Consent|1|||
154836376|NCT03099187|558835055|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
154969670|NCT01968551|559312309|FG000|Extension Phase|Lost to Follow-up|1|||
154969671|NCT01968551|559312310|FG001|Extension Phase|Lost to Follow-up|0|||
154969672|NCT01968551|559312311|FG002|Extension Phase|Lost to Follow-up|1|||
154969673|NCT00645853|559312312|FG000|Overall Study|Adverse Event|18|||
154969674|NCT00645853|559312313|FG001|Overall Study|Adverse Event|7|||
154969675|NCT00645853|559312312|FG000|Overall Study|AZ study closure in Hungary|60|||
154969676|NCT00645853|559312313|FG001|Overall Study|AZ study closure in Hungary|40|||
154836377|NCT03099187|558835056|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
154836378|NCT03099187|558835053|FG000|Double-blind Treatment|Disease progression|0|||
154969677|NCT00645853|559312312|FG000|Overall Study|Withdrawal by Subject|5|||
154969678|NCT00645853|559312313|FG001|Overall Study|Withdrawal by Subject|2|||
154969679|NCT00645853|559312312|FG000|Overall Study|Protocol Violation|0|||
154969680|NCT00645853|559312313|FG001|Overall Study|Protocol Violation|2|||
154969681|NCT00645853|559312312|FG000|Overall Study|Discontinuation criteria|2|||
154969682|NCT00645853|559312313|FG001|Overall Study|Discontinuation criteria|2|||
154836379|NCT03099187|558835054|FG001|Double-blind Treatment|Disease progression|1|||
154836380|NCT03099187|558835055|FG002|Double-blind Treatment|Disease progression|0|||
154969683|NCT00645853|559312312|FG000|Overall Study|recall of ICF, planned operation, death|7|||
155101886|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
154836381|NCT03099187|558835056|FG003|Double-blind Treatment|Disease progression|0|||
155101887|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155101888|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
154836382|NCT03099187|558835053|FG000|Double-blind Treatment|Randomization error|0|||
154836383|NCT03099187|558835054|FG001|Double-blind Treatment|Randomization error|2|||
154836384|NCT03099187|558835055|FG002|Double-blind Treatment|Randomization error|0|||
154836385|NCT03099187|558835056|FG003|Double-blind Treatment|Randomization error|0|||
154836386|NCT03099187|558835053|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
154836387|NCT03099187|558835054|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
154836388|NCT03099187|558835055|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
154836389|NCT03099187|558835056|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
154836390|NCT03099187|558835053|FG000|12-month Safety Follow-up|Adverse Event|0|||
154836391|NCT03099187|558835054|FG001|12-month Safety Follow-up|Adverse Event|0|||
154836392|NCT03099187|558835055|FG002|12-month Safety Follow-up|Adverse Event|5|||
154836393|NCT03099187|558835056|FG003|12-month Safety Follow-up|Adverse Event|12|||
154836394|NCT03099187|558835053|FG000|12-month Safety Follow-up|Death|0|||
154836395|NCT03099187|558835054|FG001|12-month Safety Follow-up|Death|0|||
154836396|NCT03099187|558835055|FG002|12-month Safety Follow-up|Death|7|||
154836397|NCT03099187|558835056|FG003|12-month Safety Follow-up|Death|9|||
154836398|NCT03099187|558835053|FG000|12-month Safety Follow-up|Lung transplantation|0|||
154836399|NCT03099187|558835054|FG001|12-month Safety Follow-up|Lung transplantation|0|||
154969684|NCT00645853|559312313|FG001|Overall Study|recall of ICF, planned operation, death|4|||
154836400|NCT03099187|558835055|FG002|12-month Safety Follow-up|Lung transplantation|2|||
154969685|NCT02637141|559312316|FG000|Overall Study|Adverse Event|1|||
154969686|NCT02637141|559312317|FG001|Overall Study|Adverse Event|1|||
154969687|NCT02637141|559312318|FG002|Overall Study|Adverse Event|0|||
154969688|NCT02637141|559312316|FG000|Overall Study|Withdrawal by Subject|1|||
154969689|NCT02637141|559312317|FG001|Overall Study|Withdrawal by Subject|1|||
154969690|NCT02637141|559312318|FG002|Overall Study|Withdrawal by Subject|1|||
154969691|NCT00406393|559312320|FG000|Overall Study|Did not undergo transplantation|2|||
154969692|NCT00406393|559312321|FG001|Overall Study|Did not undergo transplantation|1|||
154969693|NCT03885934|559312322|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
154969694|NCT03885934|559312323|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
154969695|NCT03885934|559312324|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
154969696|NCT03885934|559312325|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
154969697|NCT03885934|559312326|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
154969698|NCT03885934|559312327|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
154969699|NCT00570128|559312328|FG000|Overall Study|Adverse Event|1|||
154969700|NCT00570128|559312329|FG001|Overall Study|Adverse Event|0|||
154969701|NCT00570128|559312328|FG000|Overall Study|Lost to Follow-up|1|||
154969702|NCT00570128|559312329|FG001|Overall Study|Lost to Follow-up|0|||
154969703|NCT00570128|559312328|FG000|Overall Study|Withdrawal by Subject|2|||
154969704|NCT00570128|559312329|FG001|Overall Study|Withdrawal by Subject|0|||
154969705|NCT01139762|559312330|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
154969706|NCT01139762|559312331|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
154969707|NCT01139762|559312332|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
154969708|NCT01139762|559312330|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
154969709|NCT01139762|559312331|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
154836401|NCT03099187|558835056|FG003|12-month Safety Follow-up|Lung transplantation|1|||
154836402|NCT03099187|558835053|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
154836403|NCT03099187|558835054|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
155101889|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155101890|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
154836404|NCT03099187|558835055|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
154836405|NCT03099187|558835056|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
154836406|NCT03099187|558835053|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
154836407|NCT03099187|558835054|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
154836408|NCT03099187|558835055|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
154836409|NCT03099187|558835056|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
154836410|NCT03099187|558835053|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
154836411|NCT03099187|558835054|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
154836412|NCT03099187|558835055|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
154836413|NCT03099187|558835056|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
154836414|NCT03099187|558835053|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
154836415|NCT03099187|558835054|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
154836416|NCT03099187|558835055|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
154836417|NCT03099187|558835056|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
154836418|NCT01210690|558835059|FG000|Overall Study|Adverse Event|7|||
154836419|NCT01210690|558835059|FG000|Overall Study|Lack of Efficacy|12|||
154836420|NCT01210690|558835059|FG000|Overall Study|Lost to Follow-up|3|||
154836421|NCT01210690|558835059|FG000|Overall Study|Disease Remission|1|||
154836422|NCT01210690|558835059|FG000|Overall Study|Withdrawal by Subject|1|||
154836423|NCT01210690|558835059|FG000|Overall Study|Patient refused to swallow|1|||
154836424|NCT01210690|558835059|FG000|Overall Study|Patient could not take glucose|1|||
154836425|NCT00470054|558835060|FG000|Overall Study|Ineligible|1|||
154836426|NCT00528021|558835064|FG000|Overall Study|Lack of Efficacy|17|||
154836427|NCT00528021|558835065|FG001|Overall Study|Lack of Efficacy|13|||
154836428|NCT00528021|558835066|FG002|Overall Study|Lack of Efficacy|7|||
154836429|NCT00528021|558835067|FG003|Overall Study|Lack of Efficacy|9|||
154836430|NCT01395394|558836664|FG000|Baseline Study Visit|Protocol Violation|1|||
154836431|NCT01395394|558836665|FG001|Baseline Study Visit|Protocol Violation|0|||
154836432|NCT01395394|558836666|FG002|Baseline Study Visit|Protocol Violation|0|||
154836433|NCT05121480|558836667|FG000|Overall Study|Lack of Efficacy|2|||
154836434|NCT05121480|558836668|FG001|Overall Study|Lack of Efficacy|2|||
154836435|NCT05121480|558836669|FG002|Overall Study|Lack of Efficacy|1|||
154836436|NCT05121480|558836670|FG003|Overall Study|Lack of Efficacy|4|||
154836437|NCT05121480|558836671|FG004|Overall Study|Lack of Efficacy|0|||
154836438|NCT05121480|558836672|FG005|Overall Study|Lack of Efficacy|1|||
154836439|NCT05121480|558836673|FG006|Overall Study|Lack of Efficacy|0|||
154836440|NCT05121480|558836674|FG007|Overall Study|Lack of Efficacy|2|||
154836441|NCT05121480|558836667|FG000|Overall Study|Treatment Failure|0|||
154836442|NCT05121480|558836668|FG001|Overall Study|Treatment Failure|2|||
155101891|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
155101892|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155101893|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
154836443|NCT05121480|558836669|FG002|Overall Study|Treatment Failure|0|||
154836444|NCT05121480|558836670|FG003|Overall Study|Treatment Failure|1|||
154836445|NCT05121480|558836671|FG004|Overall Study|Treatment Failure|0|||
154836446|NCT05121480|558836672|FG005|Overall Study|Treatment Failure|0|||
154836447|NCT05121480|558836673|FG006|Overall Study|Treatment Failure|0|||
154836448|NCT05121480|558836674|FG007|Overall Study|Treatment Failure|0|||
154969710|NCT01139762|559312332|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
154969711|NCT01139762|559312330|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
154969712|NCT01139762|559312331|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
154969713|NCT01139762|559312332|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
154969714|NCT01139762|559312330|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
154969715|NCT01139762|559312331|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
154969716|NCT01139762|559312332|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
154969717|NCT01139762|559312330|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
154969718|NCT01139762|559312331|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
154969719|NCT01139762|559312332|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
154969720|NCT01139762|559312330|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
154969721|NCT01139762|559312331|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
154969722|NCT01139762|559312332|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
154969723|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
154969724|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
154969725|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
154969726|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Death|0|||
154969727|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Death|1|||
154969728|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Death|1|||
154969729|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
154969730|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
154969731|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
154969732|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
154969733|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
154969734|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
154969735|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
154969736|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
154969737|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
154969738|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
154969739|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
154969740|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
154969741|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
154969742|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
154969743|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
154969744|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
154969745|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
154969746|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
154969747|NCT01139762|559312330|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
154969748|NCT01139762|559312331|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
154969749|NCT01139762|559312332|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
154969750|NCT00874276|559312333|FG000|Overall Study|Withdrawal by Subject|1|||
154969751|NCT00874276|559312334|FG001|Overall Study|Withdrawal by Subject|1|||
154969752|NCT04236596|559312335|FG000|Overall Study|Withdrawal by Subject|1|||
154969753|NCT04236596|559312335|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
154969754|NCT04236596|559312335|FG000|Overall Study|Participants did not receive implant at all|4|||
154969755|NCT02588339|559312339|FG000|Overall Study|Withdrawal by Subject|1|||
154969756|NCT02588339|559312339|FG000|Overall Study|GVHD Progression prior to treatment|2|||
154969757|NCT04590781|559313403|FG000|Overall Study|Death|0|||
154969758|NCT04590781|559313404|FG001|Overall Study|Death|2|||
154969759|NCT04590781|559313403|FG000|Overall Study|Withdrawal by Subject|2|||
154969760|NCT04590781|559313404|FG001|Overall Study|Withdrawal by Subject|0|||
154969761|NCT01120899|559313410|FG000|Overall Study|Withdrawal by Subject|3|||
154969762|NCT00452348|559313411|FG000|Overall Study|Adverse Event|6|||
154969763|NCT00452348|559313412|FG001|Overall Study|Adverse Event|9|||
154969764|NCT00452348|559313411|FG000|Overall Study|Lack of Efficacy|10|||
154969765|NCT00452348|559313412|FG001|Overall Study|Lack of Efficacy|9|||
154969766|NCT00452348|559313411|FG000|Overall Study|Lost to Follow-up|14|||
154969767|NCT00452348|559313412|FG001|Overall Study|Lost to Follow-up|8|||
154969768|NCT00452348|559313411|FG000|Overall Study|Protocol Violation|22|||
154969769|NCT00452348|559313412|FG001|Overall Study|Protocol Violation|28|||
154969770|NCT00452348|559313411|FG000|Overall Study|Withdrawal by Subject|18|||
154969771|NCT00452348|559313412|FG001|Overall Study|Withdrawal by Subject|21|||
154969772|NCT00452348|559313411|FG000|Overall Study|Other|9|||
154969773|NCT00452348|559313412|FG001|Overall Study|Other|9|||
154969774|NCT01490190|559313413|FG000|Overall Study|Withdrawal by Subject|9|||
154969775|NCT01490190|559313413|FG000|Overall Study|Adverse Event|17|||
154969776|NCT01490190|559313413|FG000|Overall Study|Protocol Violation|5|||
154969777|NCT01490190|559313413|FG000|Overall Study|Lost to Follow-up|13|||
154969778|NCT01490190|559313413|FG000|Overall Study|Relocation|1|||
154969779|NCT01490190|559313413|FG000|Overall Study|Inconvenience|1|||
154969780|NCT01490190|559313413|FG000|Overall Study|Ring expulsion|2|||
154969781|NCT03119662|559313414|FG000|Overall Study|Withdrawal by Subject|0|||
154969782|NCT03119662|559313415|FG001|Overall Study|Withdrawal by Subject|1|||
154969783|NCT02817828|559313416|FG000|Overall Study|Lost to Follow-up|41|||
154969784|NCT02817828|559313416|FG000|Overall Study|Adverse event not related to bleeding|104|||
154969785|NCT02817828|559313416|FG000|Overall Study|Adverse event related to bleeding|53|||
154969786|NCT02817828|559313416|FG000|Overall Study|Protocol Violation|11|||
154969787|NCT02817828|559313416|FG000|Overall Study|Pregnancy|7|||
154969788|NCT02817828|559313416|FG000|Overall Study|Pregnancy wish|15|||
154969789|NCT02817828|559313416|FG000|Overall Study|Withdrawal by Subject|78|||
154969790|NCT02817828|559313416|FG000|Overall Study|Other|26|||
154969791|NCT04697173|559313422|FG000|Overall Study|Withdrawal by Subject|34|||
154969792|NCT04697173|559313423|FG001|Overall Study|Withdrawal by Subject|38|||
154969793|NCT05004649|559313425|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
154969794|NCT05004649|559313425|FG000|Overall Study|Lost to Follow-up|1|||
154969795|NCT05004649|559313425|FG000|Overall Study|Withdrawal by Subject|2|||
154969796|NCT05004649|559313425|FG000|Overall Study|COVID-19|1|||
154969797|NCT02385708|559313426|FG000|Overall Study|Withdrawal by Subject|0|||
154969798|NCT02385708|559313427|FG001|Overall Study|Withdrawal by Subject|2|||
154969799|NCT02385708|559313426|FG000|Overall Study|Withdrawn - surgery canceled|2|||
154969800|NCT02385708|559313427|FG001|Overall Study|Withdrawn - surgery canceled|5|||
154969801|NCT02385708|559313426|FG000|Overall Study|Investigator decision|5|||
154969802|NCT02385708|559313427|FG001|Overall Study|Investigator decision|7|||
154969803|NCT02385708|559313426|FG000|Overall Study|Protocol Violation|1|||
154969804|NCT02385708|559313427|FG001|Overall Study|Protocol Violation|1|||
154969805|NCT03504085|559313429|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
154969806|NCT03504085|559313430|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
154969807|NCT03504085|559313429|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
154969808|NCT03504085|559313430|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
154836449|NCT05121480|558836667|FG000|Overall Study|Adverse Event|0|||
154836450|NCT05121480|558836668|FG001|Overall Study|Adverse Event|1|||
154836451|NCT05121480|558836669|FG002|Overall Study|Adverse Event|0|||
154836452|NCT05121480|558836670|FG003|Overall Study|Adverse Event|5|||
154836453|NCT05121480|558836671|FG004|Overall Study|Adverse Event|3|||
154836454|NCT05121480|558836672|FG005|Overall Study|Adverse Event|2|||
154836455|NCT05121480|558836673|FG006|Overall Study|Adverse Event|0|||
154836456|NCT05121480|558836674|FG007|Overall Study|Adverse Event|4|||
154836457|NCT05121480|558836667|FG000|Overall Study|Withdrawal by Subject|4|||
154836458|NCT05121480|558836668|FG001|Overall Study|Withdrawal by Subject|9|||
154836459|NCT05121480|558836669|FG002|Overall Study|Withdrawal by Subject|1|||
154836460|NCT05121480|558836670|FG003|Overall Study|Withdrawal by Subject|8|||
154969809|NCT04133311|559313431|FG000|Period 1 Double Masked Treatment Period|Death|1|||
154969810|NCT04133311|559313432|FG001|Period 1 Double Masked Treatment Period|Death|0|||
154969811|NCT04133311|559313433|FG002|Period 1 Double Masked Treatment Period|Death|0|||
154969812|NCT04133311|559313434|FG003|Period 1 Double Masked Treatment Period|Death|0|||
154969813|NCT04133311|559313431|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
154969814|NCT04133311|559313432|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
154969815|NCT04133311|559313433|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
154969816|NCT04133311|559313434|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
154969817|NCT04133311|559313431|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
154969818|NCT04133311|559313432|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
154969819|NCT04133311|559313433|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
154969820|NCT04133311|559313434|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
154969821|NCT04133311|559313431|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
154969822|NCT04133311|559313432|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
154969823|NCT04133311|559313433|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
154969824|NCT04133311|559313434|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
154969825|NCT04133311|559313431|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
154969826|NCT04133311|559313432|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
154969827|NCT04133311|559313433|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
155101894|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
155101895|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
155101896|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155101897|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155101898|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155101899|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155101900|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
155101901|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
154969828|NCT04133311|559313434|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
154969829|NCT04133311|559313431|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
154969830|NCT04133311|559313432|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
155172811|NCT05141448|560071911|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
154969831|NCT04133311|559313433|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
154969832|NCT04133311|559313434|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
154969833|NCT04133311|559313431|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
154969834|NCT04133311|559313432|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
154969835|NCT04133311|559313433|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
154969836|NCT04133311|559313434|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
154969837|NCT04133311|559313431|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
154969838|NCT04133311|559313432|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
154969839|NCT04133311|559313433|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
154969840|NCT04133311|559313434|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
154969841|NCT01143337|559313435|FG000|Overall Study|Adverse Event|3|||
154969842|NCT01143337|559313436|FG001|Overall Study|Adverse Event|9|||
154969843|NCT01143337|559313437|FG002|Overall Study|Adverse Event|5|||
154969844|NCT01143337|559313435|FG000|Overall Study|Lack of Efficacy|6|||
154969845|NCT01143337|559313436|FG001|Overall Study|Lack of Efficacy|2|||
154969846|NCT01143337|559313437|FG002|Overall Study|Lack of Efficacy|1|||
154969847|NCT01143337|559313435|FG000|Overall Study|Protocol Violation|1|||
154969848|NCT01143337|559313436|FG001|Overall Study|Protocol Violation|0|||
154969849|NCT01143337|559313437|FG002|Overall Study|Protocol Violation|0|||
154969850|NCT01143337|559313435|FG000|Overall Study|Withdrawal by Subject|0|||
154969851|NCT01143337|559313436|FG001|Overall Study|Withdrawal by Subject|0|||
154969852|NCT01143337|559313437|FG002|Overall Study|Withdrawal by Subject|1|||
154969853|NCT01143337|559313435|FG000|Overall Study|Other reason|0|||
154969854|NCT01143337|559313436|FG001|Overall Study|Other reason|0|||
155101902|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155101903|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155101904|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
155101905|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
155101906|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155101907|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155101908|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155101909|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
154969855|NCT01143337|559313437|FG002|Overall Study|Other reason|5|||
154969856|NCT00728754|559313446|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
154969857|NCT00728754|559313447|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
154969858|NCT00728754|559313446|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
154969859|NCT00728754|559313447|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
154969860|NCT00728754|559313446|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
154969861|NCT00728754|559313447|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
154969862|NCT01859598|559313448|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
154969863|NCT00573313|559313453|FG000|Overall Study|Protocol Violation|5|||
154969864|NCT00573313|559313454|FG001|Overall Study|Protocol Violation|0|||
154969865|NCT00573313|559313455|FG002|Overall Study|Protocol Violation|6|||
154969866|NCT00573313|559313456|FG003|Overall Study|Protocol Violation|0|||
154969867|NCT03255980|559313459|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
154969868|NCT03255980|559313460|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
154969869|NCT03255980|559313461|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
154969870|NCT03255980|559313462|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
154969871|NCT03255980|559313459|FG000|Overall Study|Adverse Event|1|||
154969872|NCT03255980|559313460|FG001|Overall Study|Adverse Event|1|||
154969873|NCT03255980|559313461|FG002|Overall Study|Adverse Event|0|||
154969874|NCT03255980|559313462|FG003|Overall Study|Adverse Event|1|||
154969875|NCT03255980|559313459|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
154969876|NCT03255980|559313460|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
154969877|NCT03255980|559313461|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
154969878|NCT03255980|559313462|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
154969879|NCT03255980|559313459|FG000|Overall Study|Lost to Follow-up|1|||
154969880|NCT03255980|559313460|FG001|Overall Study|Lost to Follow-up|1|||
154969881|NCT03255980|559313461|FG002|Overall Study|Lost to Follow-up|0|||
154969882|NCT03255980|559313462|FG003|Overall Study|Lost to Follow-up|3|||
155101910|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155101911|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
155172812|NCT05141448|560071912|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
155172813|NCT05141448|560071913|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155172814|NCT05141448|560071914|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
154969883|NCT03255980|559313459|FG000|Overall Study|Withdrawal by Subject|0|||
154969884|NCT03255980|559313460|FG001|Overall Study|Withdrawal by Subject|1|||
154969885|NCT03255980|559313461|FG002|Overall Study|Withdrawal by Subject|0|||
154969886|NCT03255980|559313462|FG003|Overall Study|Withdrawal by Subject|3|||
154969887|NCT01597791|559313463|FG000|Overall Study|Physician Decision|2|||
154969888|NCT01597791|559313464|FG001|Overall Study|Physician Decision|1|||
154969889|NCT01597791|559313463|FG000|Overall Study|Cesarean Section|6|||
154969890|NCT01597791|559313464|FG001|Overall Study|Cesarean Section|7|||
154969891|NCT01597791|559313463|FG000|Overall Study|Subject withdrawal|0|||
154969892|NCT01597791|559313464|FG001|Overall Study|Subject withdrawal|1|||
154969893|NCT01597791|559313463|FG000|Overall Study|Protocol Violation|0|||
154969894|NCT01597791|559313464|FG001|Overall Study|Protocol Violation|1|||
154969895|NCT00354159|559313465|FG000|Randomized Study Period|Withdrawal by Subject|5|||
154969896|NCT00354159|559313466|FG001|Randomized Study Period|Withdrawal by Subject|3|||
154969897|NCT00354159|559313465|FG000|Randomized Study Period|Physician Decision|6|||
154969898|NCT00354159|559313466|FG001|Randomized Study Period|Physician Decision|10|||
154969899|NCT00354159|559313465|FG000|Randomized Study Period|Lost to Follow-up|4|||
154969900|NCT00354159|559313466|FG001|Randomized Study Period|Lost to Follow-up|0|||
154969901|NCT00354159|559313465|FG000|Randomized Study Period|Death|7|||
154969902|NCT00354159|559313466|FG001|Randomized Study Period|Death|9|||
154969903|NCT00354159|559313465|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
154969904|NCT00354159|559313466|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
154969905|NCT00354159|559313465|FG000|Long-term Follow-up|Physician Decision|127|||
154969906|NCT00354159|559313466|FG001|Long-term Follow-up|Physician Decision|122|||
154969907|NCT00354159|559313465|FG000|Long-term Follow-up|Lost to Follow-up|1|||
154969908|NCT00354159|559313466|FG001|Long-term Follow-up|Lost to Follow-up|0|||
154969909|NCT00354159|559313465|FG000|Long-term Follow-up|Death|14|||
154969910|NCT00354159|559313466|FG001|Long-term Follow-up|Death|11|||
154969911|NCT00354159|559313465|FG000|Long-term Follow-up|Study Closed|29|||
154969912|NCT00354159|559313466|FG001|Long-term Follow-up|Study Closed|34|||
154969913|NCT02229084|559313467|FG000|Overall Study|Adverse Event|1|||
154969914|NCT02229084|559313468|FG001|Overall Study|Adverse Event|0|||
154969915|NCT02229084|559313469|FG002|Overall Study|Adverse Event|0|||
154969916|NCT02229084|559313470|FG003|Overall Study|Adverse Event|0|||
154969917|NCT02229084|559313471|FG004|Overall Study|Adverse Event|0|||
154969918|NCT02229084|559313472|FG005|Overall Study|Adverse Event|0|||
154969919|NCT02229084|559313473|FG006|Overall Study|Adverse Event|0|||
154969920|NCT02229084|559313467|FG000|Overall Study|Lost to Follow-up|0|||
154969921|NCT02229084|559313468|FG001|Overall Study|Lost to Follow-up|0|||
154969922|NCT02229084|559313469|FG002|Overall Study|Lost to Follow-up|1|||
154969923|NCT02229084|559313470|FG003|Overall Study|Lost to Follow-up|1|||
154969924|NCT02229084|559313471|FG004|Overall Study|Lost to Follow-up|0|||
154969925|NCT02229084|559313472|FG005|Overall Study|Lost to Follow-up|0|||
154969926|NCT02229084|559313473|FG006|Overall Study|Lost to Follow-up|1|||
154969927|NCT02229084|559313467|FG000|Overall Study|Physician Decision|0|||
154969928|NCT02229084|559313468|FG001|Overall Study|Physician Decision|0|||
154969929|NCT02229084|559313469|FG002|Overall Study|Physician Decision|0|||
154969930|NCT02229084|559313470|FG003|Overall Study|Physician Decision|1|||
154969931|NCT02229084|559313471|FG004|Overall Study|Physician Decision|3|||
154969932|NCT02229084|559313472|FG005|Overall Study|Physician Decision|0|||
154969933|NCT02229084|559313473|FG006|Overall Study|Physician Decision|1|||
154969934|NCT02229084|559313467|FG000|Overall Study|Withdrawal by Subject|0|||
154969935|NCT02229084|559313468|FG001|Overall Study|Withdrawal by Subject|0|||
154969936|NCT02229084|559313469|FG002|Overall Study|Withdrawal by Subject|1|||
155101912|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101913|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101914|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
155101915|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101916|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101917|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101918|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101919|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101920|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101921|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
155101922|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155101923|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155101924|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
154969937|NCT02229084|559313470|FG003|Overall Study|Withdrawal by Subject|0|||
154969938|NCT02229084|559313471|FG004|Overall Study|Withdrawal by Subject|1|||
155101925|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
154969939|NCT02229084|559313472|FG005|Overall Study|Withdrawal by Subject|1|||
154969940|NCT02229084|559313473|FG006|Overall Study|Withdrawal by Subject|1|||
154969941|NCT02229084|559313467|FG000|Overall Study|Death|0|||
154969942|NCT02229084|559313468|FG001|Overall Study|Death|0|||
154969943|NCT02229084|559313469|FG002|Overall Study|Death|0|||
154969944|NCT02229084|559313470|FG003|Overall Study|Death|0|||
154969945|NCT02229084|559313471|FG004|Overall Study|Death|0|||
154969946|NCT02229084|559313472|FG005|Overall Study|Death|0|||
154969947|NCT02229084|559313473|FG006|Overall Study|Death|1|||
154969948|NCT01728116|559313476|FG000|Overall Study|Sponsor Terminated Study|106|||
154969949|NCT01728116|559313477|FG001|Overall Study|Sponsor Terminated Study|35|||
154969950|NCT01728116|559313476|FG000|Overall Study|Withdrawal by Subject|16|||
154836461|NCT05121480|558836671|FG004|Overall Study|Withdrawal by Subject|0|||
154836462|NCT05121480|558836672|FG005|Overall Study|Withdrawal by Subject|9|||
154836463|NCT05121480|558836673|FG006|Overall Study|Withdrawal by Subject|0|||
154836464|NCT05121480|558836674|FG007|Overall Study|Withdrawal by Subject|4|||
154836465|NCT05121480|558836667|FG000|Overall Study|Non-compliance with the protocol|0|||
154836466|NCT05121480|558836668|FG001|Overall Study|Non-compliance with the protocol|0|||
154836467|NCT05121480|558836669|FG002|Overall Study|Non-compliance with the protocol|0|||
154836468|NCT05121480|558836670|FG003|Overall Study|Non-compliance with the protocol|0|||
154836469|NCT05121480|558836671|FG004|Overall Study|Non-compliance with the protocol|1|||
154836470|NCT05121480|558836672|FG005|Overall Study|Non-compliance with the protocol|6|||
154836471|NCT05121480|558836673|FG006|Overall Study|Non-compliance with the protocol|0|||
154836472|NCT05121480|558836674|FG007|Overall Study|Non-compliance with the protocol|1|||
154836473|NCT05121480|558836667|FG000|Overall Study|Lost to Follow-up|0|||
154836474|NCT05121480|558836668|FG001|Overall Study|Lost to Follow-up|4|||
154836475|NCT05121480|558836669|FG002|Overall Study|Lost to Follow-up|1|||
154836476|NCT05121480|558836670|FG003|Overall Study|Lost to Follow-up|3|||
154836477|NCT05121480|558836671|FG004|Overall Study|Lost to Follow-up|1|||
154836478|NCT05121480|558836672|FG005|Overall Study|Lost to Follow-up|1|||
154836479|NCT05121480|558836673|FG006|Overall Study|Lost to Follow-up|1|||
154836480|NCT05121480|558836674|FG007|Overall Study|Lost to Follow-up|4|||
154836481|NCT05121480|558836667|FG000|Overall Study|Physician Decision|0|||
154836482|NCT05121480|558836668|FG001|Overall Study|Physician Decision|0|||
154836483|NCT05121480|558836669|FG002|Overall Study|Physician Decision|0|||
154836484|NCT05121480|558836670|FG003|Overall Study|Physician Decision|0|||
154836485|NCT05121480|558836671|FG004|Overall Study|Physician Decision|0|||
154836486|NCT05121480|558836672|FG005|Overall Study|Physician Decision|1|||
154836487|NCT05121480|558836673|FG006|Overall Study|Physician Decision|0|||
154836488|NCT05121480|558836674|FG007|Overall Study|Physician Decision|1|||
154836489|NCT05121480|558836667|FG000|Overall Study|Other Reason|0|||
154836490|NCT05121480|558836668|FG001|Overall Study|Other Reason|0|||
154836491|NCT05121480|558836669|FG002|Overall Study|Other Reason|0|||
154836492|NCT05121480|558836670|FG003|Overall Study|Other Reason|0|||
154836493|NCT05121480|558836671|FG004|Overall Study|Other Reason|0|||
154836494|NCT05121480|558836672|FG005|Overall Study|Other Reason|1|||
154836495|NCT05121480|558836673|FG006|Overall Study|Other Reason|1|||
154836496|NCT05121480|558836674|FG007|Overall Study|Other Reason|1|||
154836497|NCT02356562|558836675|FG000|Overall Study|Withdrawal by Subject|0|||
154836498|NCT02356562|558836676|FG001|Overall Study|Withdrawal by Subject|1|||
154836499|NCT02356562|558836675|FG000|Overall Study|Re-entered treatment in a previous study|1|||
154836500|NCT02356562|558836676|FG001|Overall Study|Re-entered treatment in a previous study|0|||
154836501|NCT02356562|558836675|FG000|Overall Study|site closure|1|||
154836502|NCT02356562|558836676|FG001|Overall Study|site closure|0|||
154836503|NCT00412750|558836677|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154836504|NCT00412750|558836678|FG001|Overall Study|Abnormal laboratory value(s)|0|||
154836505|NCT00412750|558836679|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155101926|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155101927|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
154836506|NCT00412750|558836677|FG000|Overall Study|Administrative problems|21|||
154836507|NCT00412750|558836678|FG001|Overall Study|Administrative problems|17|||
154836508|NCT00412750|558836679|FG002|Overall Study|Administrative problems|14|||
154836509|NCT00412750|558836677|FG000|Overall Study|Adverse Event|8|||
154836510|NCT00412750|558836678|FG001|Overall Study|Adverse Event|3|||
154836511|NCT00412750|558836679|FG002|Overall Study|Adverse Event|3|||
154836512|NCT00412750|558836677|FG000|Overall Study|Lost to Follow-up|1|||
154836513|NCT00412750|558836678|FG001|Overall Study|Lost to Follow-up|0|||
154836514|NCT00412750|558836679|FG002|Overall Study|Lost to Follow-up|1|||
154836515|NCT00412750|558836677|FG000|Overall Study|Withdrawal by Subject|0|||
154836516|NCT00412750|558836678|FG001|Overall Study|Withdrawal by Subject|1|||
154836517|NCT00412750|558836679|FG002|Overall Study|Withdrawal by Subject|2|||
154836518|NCT00412750|558836677|FG000|Overall Study|Lack of Efficacy|0|||
154836519|NCT00412750|558836678|FG001|Overall Study|Lack of Efficacy|0|||
154836520|NCT00412750|558836679|FG002|Overall Study|Lack of Efficacy|3|||
154836521|NCT01157078|558836680|FG000|Overall Study|Withdrawal by Subject|12|||
154836522|NCT01157078|558836681|FG001|Overall Study|Withdrawal by Subject|14|||
154836523|NCT01157078|558836680|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
154836524|NCT01157078|558836681|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
154836525|NCT01157078|558836680|FG000|Overall Study|Adverse Event|6|||
154836526|NCT01157078|558836681|FG001|Overall Study|Adverse Event|6|||
154836527|NCT01157078|558836680|FG000|Overall Study|Severe non-compliance to protocol|2|||
154836528|NCT01157078|558836681|FG001|Overall Study|Severe non-compliance to protocol|4|||
154836529|NCT01157078|558836680|FG000|Overall Study|Condition under investigation worsened|0|||
154836530|NCT01157078|558836681|FG001|Overall Study|Condition under investigation worsened|1|||
154836531|NCT01157078|558836680|FG000|Overall Study|Lack of Efficacy|2|||
154836532|NCT01157078|558836681|FG001|Overall Study|Lack of Efficacy|0|||
154836533|NCT01157078|558836680|FG000|Overall Study|Study-specific withdrawal criteria|2|||
154836534|NCT01157078|558836681|FG001|Overall Study|Study-specific withdrawal criteria|2|||
154836535|NCT01157078|558836680|FG000|Overall Study|Lost to Follow-up|7|||
154836536|NCT01157078|558836681|FG001|Overall Study|Lost to Follow-up|5|||
154836537|NCT01157078|558836680|FG000|Overall Study|Other|2|||
154836538|NCT01157078|558836681|FG001|Overall Study|Other|4|||
154836539|NCT01623271|558836684|FG000|Overall Study|Withdrawal by Subject|2|||
154836540|NCT01611974|558836685|FG000|Overall Study|Death|10|||
154836541|NCT01611974|558836686|FG001|Overall Study|Death|12|||
154836542|NCT01611974|558836687|FG002|Overall Study|Death|10|||
154836543|NCT01611974|558836685|FG000|Overall Study|Lost to Follow-up|0|||
154836544|NCT01611974|558836686|FG001|Overall Study|Lost to Follow-up|1|||
154836545|NCT01611974|558836687|FG002|Overall Study|Lost to Follow-up|0|||
154836546|NCT01611974|558836685|FG000|Overall Study|Physician Decision|5|||
154836547|NCT01611974|558836686|FG001|Overall Study|Physician Decision|1|||
154836548|NCT01611974|558836687|FG002|Overall Study|Physician Decision|2|||
154836549|NCT01611974|558836685|FG000|Overall Study|Withdrawal by Subject|0|||
154836550|NCT01611974|558836686|FG001|Overall Study|Withdrawal by Subject|1|||
154836551|NCT01611974|558836687|FG002|Overall Study|Withdrawal by Subject|4|||
154836552|NCT00522431|558836688|FG000|Overall Study|Adverse Event|5|||
154836553|NCT00522431|558836688|FG000|Overall Study|Protocol Violation|2|||
154836554|NCT00522431|558836688|FG000|Overall Study|Withdrawal by Subject|2|||
154836555|NCT00522431|558836688|FG000|Overall Study|Subject non-compliance|1|||
154836556|NCT00522431|558836688|FG000|Overall Study|Other/unknown|1|||
154836557|NCT03927105|558836689|FG000|Overall Study|Death|1|||
154836558|NCT03927105|558836689|FG000|Overall Study|In observation for potential re-treatment|2|||
154836559|NCT03927105|558836689|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
154836560|NCT00789529|558836690|FG000|Overall Study|Withdrawal by Subject|0|||
154836561|NCT00789529|558836691|FG001|Overall Study|Withdrawal by Subject|1|||
154836562|NCT00789529|558836690|FG000|Overall Study|Other Reason|1|||
154836563|NCT00789529|558836691|FG001|Overall Study|Other Reason|0|||
154836564|NCT01870401|558836692|FG000|Overall Study|Death|48|||
154836565|NCT01870401|558836693|FG001|Overall Study|Death|24|||
154836566|NCT01870401|558836692|FG000|Overall Study|Withdrawal by Subject|39|||
154836567|NCT01870401|558836693|FG001|Overall Study|Withdrawal by Subject|26|||
154836568|NCT01870401|558836692|FG000|Overall Study|Lost to Follow-up|19|||
154836569|NCT01870401|558836693|FG001|Overall Study|Lost to Follow-up|14|||
154836570|NCT01870401|558836692|FG000|Overall Study|Other|9|||
154836571|NCT01870401|558836693|FG001|Overall Study|Other|7|||
154836572|NCT01870401|558836692|FG000|Overall Study|On-going in the Study|35|||
154836573|NCT01870401|558836693|FG001|Overall Study|On-going in the Study|25|||
154836574|NCT01135498|558836694|FG000|Overall Study|Adverse Event|20|||
154836575|NCT01135498|558836694|FG000|Overall Study|Progressive disease|38|||
154836576|NCT01135498|558836694|FG000|Overall Study|Investigator judgement|25|||
154836577|NCT01135498|558836694|FG000|Overall Study|Withdrawal by Subject|4|||
154836578|NCT01135498|558836694|FG000|Overall Study|Death|1|||
154836579|NCT01135498|558836694|FG000|Overall Study|Ongoing at time of analysis|2|||
154836580|NCT01192022|558836695|FG000|Overall Study|Withdrawal of Consent|3|||
154836581|NCT01192022|558836696|FG001|Overall Study|Withdrawal of Consent|1|||
154836582|NCT01192022|558836697|FG002|Overall Study|Withdrawal of Consent|0|||
154836583|NCT01192022|558836698|FG003|Overall Study|Withdrawal of Consent|0|||
154836584|NCT01192022|558836699|FG004|Overall Study|Withdrawal of Consent|0|||
154836585|NCT01192022|558836695|FG000|Overall Study|Lost to Follow-up|4|||
154836586|NCT01192022|558836696|FG001|Overall Study|Lost to Follow-up|2|||
154836587|NCT01192022|558836697|FG002|Overall Study|Lost to Follow-up|1|||
154836588|NCT01192022|558836698|FG003|Overall Study|Lost to Follow-up|1|||
154836589|NCT01192022|558836699|FG004|Overall Study|Lost to Follow-up|0|||
154836590|NCT01192022|558836695|FG000|Overall Study|Adverse Event|1|||
154836591|NCT01192022|558836696|FG001|Overall Study|Adverse Event|0|||
154969951|NCT01728116|559313477|FG001|Overall Study|Withdrawal by Subject|9|||
154969952|NCT01728116|559313476|FG000|Overall Study|Adverse Event|13|||
154969953|NCT01728116|559313477|FG001|Overall Study|Adverse Event|0|||
154969954|NCT01728116|559313476|FG000|Overall Study|Procedure/device failure|7|||
154969955|NCT01728116|559313477|FG001|Overall Study|Procedure/device failure|0|||
154969956|NCT01728116|559313476|FG000|Overall Study|Lost to Follow-up|9|||
154969957|NCT01728116|559313477|FG001|Overall Study|Lost to Follow-up|2|||
154969958|NCT01728116|559313476|FG000|Overall Study|Physician Decision|2|||
154969959|NCT01728116|559313477|FG001|Overall Study|Physician Decision|0|||
154969960|NCT01728116|559313476|FG000|Overall Study|Subject Non-Compliance|2|||
154969961|NCT01728116|559313477|FG001|Overall Study|Subject Non-Compliance|0|||
154969962|NCT01728116|559313476|FG000|Overall Study|Inter-current finding at procedure|1|||
154969963|NCT01728116|559313477|FG001|Overall Study|Inter-current finding at procedure|0|||
154969964|NCT01728116|559313476|FG000|Overall Study|Incorrectly enrolled in Study|0|||
154969965|NCT01728116|559313477|FG001|Overall Study|Incorrectly enrolled in Study|1|||
154969966|NCT01728116|559313476|FG000|Overall Study|various not noted previously|5|||
154969967|NCT01728116|559313477|FG001|Overall Study|various not noted previously|0|||
154969968|NCT03277248|559313478|FG000|Overall Study|Adverse Event|3|||
154969969|NCT03277248|559313479|FG001|Overall Study|Adverse Event|1|||
154969970|NCT03277248|559313478|FG000|Overall Study|Subject Withdrawal of Consent|6|||
154969971|NCT03277248|559313479|FG001|Overall Study|Subject Withdrawal of Consent|23|||
154969972|NCT03277248|559313478|FG000|Overall Study|Investigator/Sponsor Decision|2|||
154969973|NCT03277248|559313479|FG001|Overall Study|Investigator/Sponsor Decision|2|||
154969974|NCT03277248|559313478|FG000|Overall Study|Pregnancy|4|||
154969975|NCT03277248|559313479|FG001|Overall Study|Pregnancy|1|||
154969976|NCT03277248|559313478|FG000|Overall Study|Lost to Follow-up|0|||
154969977|NCT03277248|559313479|FG001|Overall Study|Lost to Follow-up|2|||
154969978|NCT03277248|559313478|FG000|Overall Study|Lack of Efficacy|0|||
154969979|NCT03277248|559313479|FG001|Overall Study|Lack of Efficacy|2|||
154969980|NCT03277248|559313478|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
154969981|NCT03277248|559313479|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
154969982|NCT01451541|559313486|FG000|Overall Study|Adverse Event|4|||
154969983|NCT01451541|559313487|FG001|Overall Study|Adverse Event|3|||
154969984|NCT01451541|559313488|FG002|Overall Study|Adverse Event|6|||
154969985|NCT01451541|559313486|FG000|Overall Study|Lack of Efficacy|2|||
154969986|NCT01451541|559313487|FG001|Overall Study|Lack of Efficacy|0|||
154969987|NCT01451541|559313488|FG002|Overall Study|Lack of Efficacy|0|||
154969988|NCT01451541|559313486|FG000|Overall Study|Lost to Follow-up|4|||
154969989|NCT01451541|559313487|FG001|Overall Study|Lost to Follow-up|4|||
154969990|NCT01451541|559313488|FG002|Overall Study|Lost to Follow-up|7|||
154969991|NCT01451541|559313486|FG000|Overall Study|Withdrawal by Subject|15|||
154969992|NCT01451541|559313487|FG001|Overall Study|Withdrawal by Subject|8|||
154969993|NCT01451541|559313488|FG002|Overall Study|Withdrawal by Subject|6|||
154969994|NCT01451541|559313486|FG000|Overall Study|randomization error, noncompliance|11|||
154969995|NCT01451541|559313487|FG001|Overall Study|randomization error, noncompliance|10|||
154969996|NCT01451541|559313488|FG002|Overall Study|randomization error, noncompliance|8|||
154969997|NCT04164758|559313489|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
154969998|NCT04164758|559313490|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
154969999|NCT04164758|559313491|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
154970000|NCT04164758|559313489|FG000|Overall Study|Adverse Event|0|||
154970001|NCT04164758|559313490|FG001|Overall Study|Adverse Event|1|||
154970002|NCT04164758|559313491|FG002|Overall Study|Adverse Event|0|||
154970003|NCT00379353|559313494|FG000|Overall Study|Hospitalization|3|||
154970004|NCT00379353|559313495|FG001|Overall Study|Hospitalization|3|||
154970005|NCT00379353|559313494|FG000|Overall Study|Withdrawal by Subject|5|||
155101928|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155101929|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
155101930|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
154970006|NCT00379353|559313495|FG001|Overall Study|Withdrawal by Subject|2|||
154970007|NCT00379353|559313494|FG000|Overall Study|Death|1|||
154970008|NCT00379353|559313495|FG001|Overall Study|Death|0|||
154970009|NCT00379353|559313494|FG000|Overall Study|Cardiac Tamponade|1|||
154970010|NCT00379353|559313495|FG001|Overall Study|Cardiac Tamponade|0|||
155101931|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
154970011|NCT00379353|559313494|FG000|Overall Study|Non-compliance|1|||
154970012|NCT00379353|559313495|FG001|Overall Study|Non-compliance|0|||
154836592|NCT01192022|558836697|FG002|Overall Study|Adverse Event|0|||
154970013|NCT00379353|559313494|FG000|Overall Study|Conflicting drug treatment|0|||
154970014|NCT00379353|559313495|FG001|Overall Study|Conflicting drug treatment|1|||
154970015|NCT00533507|559313499|FG000|Overall Study|Withdrawal by Subject|1|||
154970016|NCT02943096|559313502|FG000|Overall Study|Lack of Efficacy|0|||
154970017|NCT02943096|559313503|FG001|Overall Study|Lack of Efficacy|1|||
154970018|NCT05065619|559313504|FG000|Up to Day 42|Lost to Follow-up|1|||
154970019|NCT05065619|559313505|FG001|Up to Day 42|Lost to Follow-up|0|||
154970020|NCT05065619|559313504|FG000|Up to Day 42|Withdrawal by Subject|1|||
154970021|NCT05065619|559313505|FG001|Up to Day 42|Withdrawal by Subject|0|||
154970022|NCT05065619|559313504|FG000|After Day 43|Lost to Follow-up|1|||
154970023|NCT05065619|559313505|FG001|After Day 43|Lost to Follow-up|0|||
154970024|NCT05065619|559313504|FG000|After Day 43|Physician Decision|3|||
154970025|NCT05065619|559313505|FG001|After Day 43|Physician Decision|0|||
154970026|NCT05065619|559313504|FG000|After Day 43|Withdrawal by Subject|1|||
155101932|NCT01194219|559806483|FG000|Maintenance Phase Weeks16-32|Other|0|||
155101933|NCT01194219|559806484|FG001|Maintenance Phase Weeks16-32|Other|0|||
154970027|NCT05065619|559313505|FG001|After Day 43|Withdrawal by Subject|2|||
154970028|NCT05065619|559313504|FG000|After Day 43|Public vaccination|6|||
154970029|NCT05065619|559313505|FG001|After Day 43|Public vaccination|8|||
154970030|NCT05065619|559313504|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
154970031|NCT05065619|559313505|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
154970032|NCT05065619|559313504|FG000|After Day 43|Study Terminated by Sponsor|88|||
154970033|NCT05065619|559313505|FG001|After Day 43|Study Terminated by Sponsor|16|||
154970034|NCT01050764|559313506|FG000|Overall Study|Death, before HSCT|1|||
154970035|NCT01050764|559313506|FG000|Overall Study|Donor mobilization failure, death|1|||
154970036|NCT01050764|559313506|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
154970037|NCT01426854|559313520|FG000|Overall Study|Adverse Event|1|||
154970038|NCT01426854|559313521|FG001|Overall Study|Adverse Event|5|||
154970039|NCT01426854|559313520|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
154970040|NCT01426854|559313521|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
154970041|NCT01426854|559313520|FG000|Overall Study|Lost to Follow-up|3|||
154970042|NCT01426854|559313521|FG001|Overall Study|Lost to Follow-up|0|||
154970043|NCT01426854|559313520|FG000|Overall Study|Noncompliance|0|||
154970044|NCT01426854|559313521|FG001|Overall Study|Noncompliance|1|||
154970045|NCT01426854|559313520|FG000|Overall Study|Treatment Failure|0|||
154970046|NCT01426854|559313521|FG001|Overall Study|Treatment Failure|16|||
154970047|NCT01426854|559313520|FG000|Overall Study|Protocol Deviation|0|||
154970048|NCT01426854|559313521|FG001|Overall Study|Protocol Deviation|1|||
154970049|NCT01426854|559313520|FG000|Overall Study|Other|3|||
154970050|NCT01426854|559313521|FG001|Overall Study|Other|2|||
154970051|NCT03555695|559313524|FG000|Overall Study|Withdrawal by Subject|1|||
154970052|NCT03555695|559313524|FG000|Overall Study|Lost to Follow-up|1|||
154970053|NCT03555695|559313524|FG000|Overall Study|appendicitis (unrelated)|1|||
154970054|NCT03555695|559313524|FG000|Overall Study|pre-existing sciatica|1|||
154970055|NCT04203823|559313527|FG000|Overall Study|Withdrawal by Subject|2|||
154970056|NCT04203823|559313528|FG001|Overall Study|Withdrawal by Subject|2|||
154970057|NCT04203823|559313527|FG000|Overall Study|Adverse Event|1|||
154970058|NCT04203823|559313528|FG001|Overall Study|Adverse Event|1|||
154970059|NCT04203823|559313527|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154970060|NCT04203823|559313528|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
154970061|NCT03193021|559313529|FG000|Overall Study|Lost to Follow-up|1|||
154970062|NCT03193021|559313530|FG001|Overall Study|Lost to Follow-up|1|||
154970063|NCT00685334|559313536|FG000|Overall Study|Withdrawal by Subject|5|||
154970064|NCT00685334|559313537|FG001|Overall Study|Withdrawal by Subject|6|||
154970065|NCT00685334|559313536|FG000|Overall Study|Lost to Follow-up|4|||
154970066|NCT00685334|559313537|FG001|Overall Study|Lost to Follow-up|0|||
154970067|NCT00685334|559313536|FG000|Overall Study|Chose to enter hospital|1|||
154970068|NCT00685334|559313537|FG001|Overall Study|Chose to enter hospital|1|||
154970069|NCT02957331|559313538|FG000|Overall Study|Protocol Violation|1|||
154970070|NCT02957331|559313539|FG001|Overall Study|Protocol Violation|0|||
154970071|NCT00820599|559315121|FG000|Overall Study|Death|129|||
154970072|NCT00820599|559315121|FG000|Overall Study|Withdrawal by Subject|2|||
154970073|NCT03686215|559315122|FG000|Overall Study|Adverse Event|0|||
154970074|NCT03686215|559315123|FG001|Overall Study|Adverse Event|0|||
154970075|NCT03686215|559315124|FG002|Overall Study|Adverse Event|7|||
154970076|NCT03686215|559315122|FG000|Overall Study|Physician Decision|0|||
154970077|NCT03686215|559315123|FG001|Overall Study|Physician Decision|0|||
154970078|NCT03686215|559315124|FG002|Overall Study|Physician Decision|1|||
154970079|NCT03686215|559315122|FG000|Overall Study|Protocol Violation|0|||
154970080|NCT03686215|559315123|FG001|Overall Study|Protocol Violation|0|||
154970081|NCT03686215|559315124|FG002|Overall Study|Protocol Violation|4|||
154836593|NCT01192022|558836698|FG003|Overall Study|Adverse Event|0|||
154836594|NCT01192022|558836699|FG004|Overall Study|Adverse Event|0|||
154836595|NCT01192022|558836695|FG000|Overall Study|Fatal Adverse Event|4|||
154836596|NCT01192022|558836696|FG001|Overall Study|Fatal Adverse Event|6|||
154970082|NCT03686215|559315122|FG000|Overall Study|Device issue|1|||
154970083|NCT03686215|559315123|FG001|Overall Study|Device issue|0|||
154970084|NCT03686215|559315124|FG002|Overall Study|Device issue|2|||
154970085|NCT00202839|559315125|FG000|Overall Study|Adverse Event|1|||
154970086|NCT00202839|559315126|FG001|Overall Study|Adverse Event|5|||
154970087|NCT00202839|559315125|FG000|Overall Study|Physician Decision|12|||
154970088|NCT00202839|559315126|FG001|Overall Study|Physician Decision|0|||
154970089|NCT00202839|559315125|FG000|Overall Study|Withdrawal by Subject|6|||
154970090|NCT00202839|559315126|FG001|Overall Study|Withdrawal by Subject|2|||
154970091|NCT00202839|559315125|FG000|Overall Study|Protocol Violation|2|||
154970092|NCT00202839|559315126|FG001|Overall Study|Protocol Violation|1|||
154970093|NCT00202839|559315125|FG000|Overall Study|Lost to Follow-up|3|||
154970094|NCT00202839|559315126|FG001|Overall Study|Lost to Follow-up|2|||
154970095|NCT04768296|559315127|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
154970096|NCT04768296|559315128|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
154970097|NCT00522041|559315129|FG000|Overall Study|Adverse Event|9|||
154970098|NCT00522041|559315130|FG001|Overall Study|Adverse Event|3|||
154970099|NCT00522041|559315129|FG000|Overall Study|Protocol Violation|2|||
154970100|NCT00522041|559315130|FG001|Overall Study|Protocol Violation|0|||
154970101|NCT00522041|559315129|FG000|Overall Study|Lost to Follow-up|1|||
154970102|NCT00522041|559315130|FG001|Overall Study|Lost to Follow-up|4|||
154970103|NCT00522041|559315129|FG000|Overall Study|Voluntary withdrawal|5|||
154970104|NCT00522041|559315130|FG001|Overall Study|Voluntary withdrawal|4|||
154970105|NCT00522041|559315129|FG000|Overall Study|Did not receive treatment|0|||
154970106|NCT00522041|559315130|FG001|Overall Study|Did not receive treatment|1|||
154970107|NCT00874549|559315131|FG000|Overall Study|Adverse Event|0|||
154970108|NCT00874549|559315132|FG001|Overall Study|Adverse Event|0|||
154970109|NCT00874549|559315133|FG002|Overall Study|Adverse Event|1|||
154970110|NCT00874549|559315134|FG003|Overall Study|Adverse Event|0|||
154970111|NCT00874549|559315131|FG000|Overall Study|Protocol Violation|1|||
154970112|NCT00874549|559315132|FG001|Overall Study|Protocol Violation|0|||
154970113|NCT00874549|559315133|FG002|Overall Study|Protocol Violation|2|||
154970114|NCT00874549|559315134|FG003|Overall Study|Protocol Violation|1|||
154970115|NCT00874549|559315131|FG000|Overall Study|Lost to Follow-up|0|||
154970116|NCT00874549|559315132|FG001|Overall Study|Lost to Follow-up|0|||
154970117|NCT00874549|559315133|FG002|Overall Study|Lost to Follow-up|1|||
154970118|NCT00874549|559315134|FG003|Overall Study|Lost to Follow-up|0|||
154970119|NCT00874549|559315131|FG000|Overall Study|Withdrawal by Subject|0|||
154970120|NCT00874549|559315132|FG001|Overall Study|Withdrawal by Subject|1|||
154970121|NCT00874549|559315133|FG002|Overall Study|Withdrawal by Subject|0|||
154970122|NCT00874549|559315134|FG003|Overall Study|Withdrawal by Subject|1|||
154970123|NCT02754492|559315135|FG000|Overall Study|Protocol Violation|2|||
154970124|NCT02754492|559315136|FG001|Overall Study|Protocol Violation|2|||
154970125|NCT02754492|559315137|FG002|Overall Study|Protocol Violation|0|||
154970126|NCT02754492|559315138|FG003|Overall Study|Protocol Violation|1|||
154970127|NCT02754492|559315135|FG000|Overall Study|Withdrawal by Subject|2|||
154970128|NCT02754492|559315136|FG001|Overall Study|Withdrawal by Subject|0|||
154970129|NCT02754492|559315137|FG002|Overall Study|Withdrawal by Subject|0|||
154970130|NCT02754492|559315138|FG003|Overall Study|Withdrawal by Subject|0|||
154970131|NCT02754492|559315135|FG000|Overall Study|Equipment malfuntion|0|||
154970132|NCT02754492|559315136|FG001|Overall Study|Equipment malfuntion|0|||
154970133|NCT02754492|559315137|FG002|Overall Study|Equipment malfuntion|2|||
154970134|NCT02754492|559315138|FG003|Overall Study|Equipment malfuntion|5|||
154970135|NCT02754492|559315135|FG000|Overall Study|Adverse Event|0|||
154970136|NCT02754492|559315136|FG001|Overall Study|Adverse Event|0|||
154970137|NCT02754492|559315137|FG002|Overall Study|Adverse Event|0|||
154970138|NCT02754492|559315138|FG003|Overall Study|Adverse Event|13|||
154970139|NCT02754492|559315135|FG000|Overall Study|Venous access issues not resulting in AE|0|||
154970140|NCT02754492|559315136|FG001|Overall Study|Venous access issues not resulting in AE|0|||
154970141|NCT02754492|559315137|FG002|Overall Study|Venous access issues not resulting in AE|0|||
154970142|NCT02754492|559315138|FG003|Overall Study|Venous access issues not resulting in AE|4|||
154970143|NCT05387408|559315141|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
154970144|NCT02786953|559315152|FG000|Overall Study|Withdrawal by Subject|3|||
154970145|NCT02786953|559315153|FG001|Overall Study|Withdrawal by Subject|0|||
154970146|NCT02786953|559315152|FG000|Overall Study|Physician Decision|0|||
154970147|NCT02786953|559315153|FG001|Overall Study|Physician Decision|1|||
154970148|NCT02627963|559315159|FG000|Overall Study|Randomized but not treated|2|||
154836597|NCT01192022|558836697|FG002|Overall Study|Fatal Adverse Event|0|||
154836598|NCT01192022|558836698|FG003|Overall Study|Fatal Adverse Event|0|||
154836599|NCT01192022|558836699|FG004|Overall Study|Fatal Adverse Event|1|||
154836600|NCT01192022|558836695|FG000|Overall Study|Physician withdrew-patient hardship|1|||
154836601|NCT01192022|558836696|FG001|Overall Study|Physician withdrew-patient hardship|0|||
154836602|NCT01192022|558836697|FG002|Overall Study|Physician withdrew-patient hardship|0|||
154836603|NCT01192022|558836698|FG003|Overall Study|Physician withdrew-patient hardship|0|||
154836604|NCT01192022|558836699|FG004|Overall Study|Physician withdrew-patient hardship|0|||
154836605|NCT01192022|558836695|FG000|Overall Study|Patient too sick from chemotherapy|0|||
154836606|NCT01192022|558836696|FG001|Overall Study|Patient too sick from chemotherapy|1|||
154836607|NCT01192022|558836697|FG002|Overall Study|Patient too sick from chemotherapy|0|||
154836608|NCT01192022|558836698|FG003|Overall Study|Patient too sick from chemotherapy|0|||
154836609|NCT01192022|558836699|FG004|Overall Study|Patient too sick from chemotherapy|0|||
154836610|NCT01192022|558836695|FG000|Overall Study|Patient needed surgery|0|||
154836611|NCT01192022|558836696|FG001|Overall Study|Patient needed surgery|1|||
154836612|NCT01192022|558836697|FG002|Overall Study|Patient needed surgery|0|||
154836613|NCT01192022|558836698|FG003|Overall Study|Patient needed surgery|0|||
154836614|NCT01192022|558836699|FG004|Overall Study|Patient needed surgery|0|||
154836615|NCT01192022|558836695|FG000|Overall Study|Parents did not allow all follow up|0|||
154836616|NCT01192022|558836696|FG001|Overall Study|Parents did not allow all follow up|0|||
154836617|NCT01192022|558836697|FG002|Overall Study|Parents did not allow all follow up|0|||
154836618|NCT01192022|558836698|FG003|Overall Study|Parents did not allow all follow up|1|||
154836619|NCT01192022|558836699|FG004|Overall Study|Parents did not allow all follow up|0|||
154836620|NCT04839978|558836700|FG000|Overall Study|Lost to Follow-up|135|||
154836621|NCT04839978|558836701|FG001|Overall Study|Lost to Follow-up|147|||
154836622|NCT03551509|558836702|FG000|Overall Study|Lost to Follow-up|0|||
154836623|NCT03551509|558836703|FG001|Overall Study|Lost to Follow-up|1|||
154970149|NCT02627963|559315160|FG001|Overall Study|Randomized but not treated|6|||
154970150|NCT03073798|559315161|FG000|Overall Study|Adverse Event|1|||
154970151|NCT03073798|559315161|FG000|Overall Study|Withdrawal by Subject|1|||
154836624|NCT03551509|558836704|FG002|Overall Study|Lost to Follow-up|0|||
154836625|NCT05440539|558836711|FG000|Overall Study|Lost to Follow-up|4|||
154836626|NCT05440539|558836712|FG001|Overall Study|Lost to Follow-up|4|||
154836627|NCT05440539|558836711|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
154836628|NCT05440539|558836712|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
154836629|NCT02004262|558836715|FG000|Overall Study|Death|67|||
154836630|NCT02004262|558836716|FG001|Overall Study|Death|64|||
154836631|NCT02004262|558836717|FG002|Overall Study|Death|66|||
154836632|NCT02004262|558836718|FG003|Overall Study|Death|28|||
154836633|NCT02004262|558836719|FG004|Overall Study|Death|29|||
154836634|NCT02004262|558836720|FG005|Overall Study|Death|22|||
154970152|NCT01186458|559315162|FG000|Overall Study|Adverse Event|1|||
154970153|NCT04281472|559315163|FG000|Stage A|Lack of Efficacy|8|||
154970154|NCT04281472|559315164|FG001|Stage A|Lack of Efficacy|0|||
154970155|NCT04281472|559315165|FG002|Stage A|Lack of Efficacy|0|||
154970156|NCT04281472|559315163|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
154970157|NCT04281472|559315164|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
154970158|NCT04281472|559315165|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
154970159|NCT04281472|559315163|FG000|Stage A|Adverse Event|20|||
154970160|NCT04281472|559315164|FG001|Stage A|Adverse Event|0|||
154970161|NCT04281472|559315165|FG002|Stage A|Adverse Event|0|||
154970162|NCT04281472|559315163|FG000|Stage A|Death|1|||
154970163|NCT04281472|559315164|FG001|Stage A|Death|0|||
154970164|NCT04281472|559315165|FG002|Stage A|Death|0|||
154970165|NCT04281472|559315163|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
154836635|NCT02004262|558836715|FG000|Overall Study|Withdrawal by Subject|1|||
154836636|NCT02004262|558836716|FG001|Overall Study|Withdrawal by Subject|0|||
154836637|NCT02004262|558836717|FG002|Overall Study|Withdrawal by Subject|4|||
154836638|NCT02004262|558836718|FG003|Overall Study|Withdrawal by Subject|0|||
154836639|NCT02004262|558836719|FG004|Overall Study|Withdrawal by Subject|1|||
154836640|NCT02004262|558836720|FG005|Overall Study|Withdrawal by Subject|3|||
154836641|NCT02004262|558836715|FG000|Overall Study|Lost to Follow-up|1|||
154836642|NCT02004262|558836716|FG001|Overall Study|Lost to Follow-up|1|||
154836643|NCT02004262|558836717|FG002|Overall Study|Lost to Follow-up|0|||
154836644|NCT02004262|558836718|FG003|Overall Study|Lost to Follow-up|0|||
154836645|NCT02004262|558836719|FG004|Overall Study|Lost to Follow-up|0|||
154970166|NCT04281472|559315164|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
154970167|NCT04281472|559315165|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
154970168|NCT04281472|559315163|FG000|Stage A|Lost to Follow-up|2|||
154970169|NCT04281472|559315164|FG001|Stage A|Lost to Follow-up|0|||
154970170|NCT04281472|559315165|FG002|Stage A|Lost to Follow-up|0|||
154970171|NCT04281472|559315163|FG000|Stage A|Non-compliance with study drug|1|||
154970172|NCT04281472|559315164|FG001|Stage A|Non-compliance with study drug|0|||
154970173|NCT04281472|559315165|FG002|Stage A|Non-compliance with study drug|0|||
154836646|NCT02004262|558836720|FG005|Overall Study|Lost to Follow-up|0|||
154836647|NCT02004262|558836715|FG000|Overall Study|Study Terminated by Sponsor|4|||
154836648|NCT02004262|558836716|FG001|Overall Study|Study Terminated by Sponsor|3|||
155101934|NCT01194219|559806485|FG002|Maintenance Phase Weeks16-32|Other|2|||
155101935|NCT01194219|559806486|FG003|Maintenance Phase Weeks16-32|Other|1|||
155101936|NCT01194219|559806487|FG004|Maintenance Phase Weeks16-32|Other|0|||
155101937|NCT01194219|559806488|FG005|Maintenance Phase Weeks16-32|Other|0|||
155101938|NCT01194219|559806489|FG006|Maintenance Phase Weeks16-32|Other|0|||
155101939|NCT01194219|559806490|FG007|Maintenance Phase Weeks16-32|Other|0|||
155101940|NCT01194219|559806491|FG008|Maintenance Phase Weeks16-32|Other|0|||
155101941|NCT01194219|559806492|FG009|Maintenance Phase Weeks16-32|Other|0|||
154836649|NCT02004262|558836717|FG002|Overall Study|Study Terminated by Sponsor|2|||
155101942|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
154970174|NCT04281472|559315163|FG000|Stage A|Physician Decision|1|||
155101943|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
154836650|NCT02004262|558836718|FG003|Overall Study|Study Terminated by Sponsor|1|||
154836651|NCT02004262|558836719|FG004|Overall Study|Study Terminated by Sponsor|1|||
154836652|NCT02004262|558836720|FG005|Overall Study|Study Terminated by Sponsor|5|||
154836653|NCT01967628|558836721|FG000|Overall Study|Withdrawal by Subject|2|||
154836654|NCT01967628|558836722|FG001|Overall Study|Withdrawal by Subject|0|||
154836655|NCT01967628|558836721|FG000|Overall Study|Unable to complete bronchoscopy|4|||
154836656|NCT01967628|558836722|FG001|Overall Study|Unable to complete bronchoscopy|6|||
154836657|NCT01967628|558836721|FG000|Overall Study|Lost to Follow-up|1|||
154836658|NCT01967628|558836722|FG001|Overall Study|Lost to Follow-up|0|||
154836659|NCT01967628|558836721|FG000|Overall Study|Low protein concentration in sample|20|||
154836660|NCT01967628|558836722|FG001|Overall Study|Low protein concentration in sample|25|||
154836661|NCT00957008|558836723|FG000|Overall Study|Withdrawal by Subject|13|||
154836662|NCT00957008|558836724|FG001|Overall Study|Withdrawal by Subject|10|||
154836663|NCT00957008|558836725|FG002|Overall Study|Withdrawal by Subject|12|||
154836664|NCT00957008|558836726|FG003|Overall Study|Withdrawal by Subject|16|||
154836665|NCT00957008|558836723|FG000|Overall Study|Lost to Follow-up|3|||
154836666|NCT00957008|558836724|FG001|Overall Study|Lost to Follow-up|1|||
154836667|NCT00957008|558836725|FG002|Overall Study|Lost to Follow-up|3|||
155101944|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155101945|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155101946|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155101947|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
154836668|NCT00957008|558836726|FG003|Overall Study|Lost to Follow-up|4|||
154836669|NCT00957008|558836723|FG000|Overall Study|Physician Decision|1|||
154836670|NCT00957008|558836724|FG001|Overall Study|Physician Decision|0|||
154836671|NCT00957008|558836725|FG002|Overall Study|Physician Decision|1|||
154836672|NCT00957008|558836726|FG003|Overall Study|Physician Decision|1|||
154836673|NCT00957008|558836723|FG000|Overall Study|Relocated; Family conflict|4|||
154836674|NCT00957008|558836724|FG001|Overall Study|Relocated; Family conflict|1|||
154836675|NCT00957008|558836725|FG002|Overall Study|Relocated; Family conflict|1|||
154836676|NCT00957008|558836726|FG003|Overall Study|Relocated; Family conflict|3|||
154836677|NCT01157364|558836733|FG000|Overall Study|Other Reasons|1|||
154836678|NCT01157364|558836734|FG001|Overall Study|Other Reasons|1|||
154836679|NCT01157364|558836735|FG002|Overall Study|Other Reasons|2|||
154836680|NCT01157364|558836736|FG003|Overall Study|Other Reasons|1|||
154836681|NCT01157364|558836737|FG004|Overall Study|Other Reasons|0|||
154836682|NCT01157364|558836738|FG005|Overall Study|Other Reasons|0|||
154970175|NCT04281472|559315164|FG001|Stage A|Physician Decision|0|||
154836683|NCT01157364|558836733|FG000|Overall Study|Personal Reasons|0|||
154836684|NCT01157364|558836734|FG001|Overall Study|Personal Reasons|2|||
154836685|NCT01157364|558836735|FG002|Overall Study|Personal Reasons|0|||
154836686|NCT01157364|558836736|FG003|Overall Study|Personal Reasons|0|||
154970176|NCT04281472|559315165|FG002|Stage A|Physician Decision|0|||
154970177|NCT04281472|559315163|FG000|Stage A|Prohibited medications|2|||
154970178|NCT04281472|559315164|FG001|Stage A|Prohibited medications|0|||
154970179|NCT04281472|559315165|FG002|Stage A|Prohibited medications|0|||
154970180|NCT04281472|559315163|FG000|Stage A|Withdrawal by Subject|11|||
154970181|NCT04281472|559315164|FG001|Stage A|Withdrawal by Subject|0|||
154970182|NCT04281472|559315165|FG002|Stage A|Withdrawal by Subject|0|||
154970183|NCT04281472|559315163|FG000|Stage A|Other|5|||
154970184|NCT04281472|559315164|FG001|Stage A|Other|0|||
154970185|NCT04281472|559315165|FG002|Stage A|Other|0|||
154970186|NCT04281472|559315163|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
154970187|NCT04281472|559315164|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
155101948|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
155101949|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
155101950|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
155101951|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
154836687|NCT01157364|558836737|FG004|Overall Study|Personal Reasons|1|||
154836688|NCT01157364|558836738|FG005|Overall Study|Personal Reasons|1|||
154836689|NCT01157364|558836733|FG000|Overall Study|Lost to Follow-up|1|||
154970188|NCT04281472|559315165|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
154836690|NCT01157364|558836734|FG001|Overall Study|Lost to Follow-up|0|||
154836691|NCT01157364|558836735|FG002|Overall Study|Lost to Follow-up|1|||
154836692|NCT01157364|558836736|FG003|Overall Study|Lost to Follow-up|0|||
154970189|NCT04281472|559315163|FG000|Stage B|Adverse Event|0|||
154970190|NCT04281472|559315164|FG001|Stage B|Adverse Event|3|||
154836693|NCT01157364|558836737|FG004|Overall Study|Lost to Follow-up|0|||
154836694|NCT01157364|558836738|FG005|Overall Study|Lost to Follow-up|0|||
154836695|NCT01157364|558836733|FG000|Overall Study|Lack of Efficacy|0|||
154836696|NCT01157364|558836734|FG001|Overall Study|Lack of Efficacy|0|||
154836697|NCT01157364|558836735|FG002|Overall Study|Lack of Efficacy|0|||
154836698|NCT01157364|558836736|FG003|Overall Study|Lack of Efficacy|1|||
154836699|NCT01157364|558836737|FG004|Overall Study|Lack of Efficacy|0|||
154836700|NCT01157364|558836738|FG005|Overall Study|Lack of Efficacy|0|||
154836701|NCT01157364|558836733|FG000|Overall Study|Adverse Event|0|||
154836702|NCT01157364|558836734|FG001|Overall Study|Adverse Event|1|||
154836703|NCT01157364|558836735|FG002|Overall Study|Adverse Event|1|||
154836704|NCT01157364|558836736|FG003|Overall Study|Adverse Event|0|||
154836705|NCT01157364|558836737|FG004|Overall Study|Adverse Event|1|||
154836706|NCT01157364|558836738|FG005|Overall Study|Adverse Event|0|||
154836707|NCT01709435|558836739|FG000|Overall Study|Adverse Event|1|||
154836708|NCT01709435|558836740|FG001|Overall Study|Adverse Event|1|||
154836709|NCT01709435|558836741|FG002|Overall Study|Adverse Event|1|||
154836710|NCT01709435|558836742|FG003|Overall Study|Adverse Event|0|||
154836711|NCT01709435|558836743|FG004|Overall Study|Adverse Event|0|||
154970191|NCT04281472|559315165|FG002|Stage B|Adverse Event|0|||
154970192|NCT04281472|559315163|FG000|Stage B|Death|0|||
154970193|NCT04281472|559315164|FG001|Stage B|Death|0|||
154970194|NCT04281472|559315165|FG002|Stage B|Death|1|||
154970195|NCT04281472|559315163|FG000|Stage B|Lack of Efficacy|0|||
154970196|NCT04281472|559315164|FG001|Stage B|Lack of Efficacy|0|||
154970197|NCT04281472|559315165|FG002|Stage B|Lack of Efficacy|1|||
154970198|NCT04281472|559315163|FG000|Stage B|Lost to Follow-up|0|||
154970199|NCT04281472|559315164|FG001|Stage B|Lost to Follow-up|0|||
154970200|NCT04281472|559315165|FG002|Stage B|Lost to Follow-up|2|||
154836712|NCT01709435|558836744|FG005|Overall Study|Adverse Event|1|||
154836713|NCT01709435|558836739|FG000|Overall Study|Lack of Efficacy|5|||
154836714|NCT01709435|558836740|FG001|Overall Study|Lack of Efficacy|7|||
154836715|NCT01709435|558836741|FG002|Overall Study|Lack of Efficacy|2|||
154836716|NCT01709435|558836742|FG003|Overall Study|Lack of Efficacy|2|||
154970201|NCT04281472|559315163|FG000|Stage B|Prohibited medications|0|||
154836717|NCT01709435|558836743|FG004|Overall Study|Lack of Efficacy|6|||
154836718|NCT01709435|558836744|FG005|Overall Study|Lack of Efficacy|3|||
154836719|NCT01709435|558836739|FG000|Overall Study|Physician Decision|0|||
154970202|NCT04281472|559315164|FG001|Stage B|Prohibited medications|2|||
154970203|NCT04281472|559315165|FG002|Stage B|Prohibited medications|1|||
154970204|NCT04281472|559315163|FG000|Stage B|Protocol Violation|0|||
155101952|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
154970205|NCT04281472|559315164|FG001|Stage B|Protocol Violation|1|||
155101953|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155101954|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
154836720|NCT01709435|558836740|FG001|Overall Study|Physician Decision|1|||
154836721|NCT01709435|558836741|FG002|Overall Study|Physician Decision|0|||
154836722|NCT01709435|558836742|FG003|Overall Study|Physician Decision|1|||
154836723|NCT01709435|558836743|FG004|Overall Study|Physician Decision|2|||
154836724|NCT01709435|558836744|FG005|Overall Study|Physician Decision|0|||
154836725|NCT01709435|558836739|FG000|Overall Study|Withdrawal by Subject|0|||
154836726|NCT01709435|558836740|FG001|Overall Study|Withdrawal by Subject|0|||
154836727|NCT01709435|558836741|FG002|Overall Study|Withdrawal by Subject|3|||
154836728|NCT01709435|558836742|FG003|Overall Study|Withdrawal by Subject|0|||
154836729|NCT01709435|558836743|FG004|Overall Study|Withdrawal by Subject|2|||
154836730|NCT01709435|558836744|FG005|Overall Study|Withdrawal by Subject|2|||
154836731|NCT01780662|558836745|FG000|Overall Study|Adverse Event|1|||
154836732|NCT01780662|558836746|FG001|Overall Study|Adverse Event|0|||
154836733|NCT01780662|558836747|FG002|Overall Study|Adverse Event|2|||
154836734|NCT01780662|558836745|FG000|Overall Study|Physician Decision|0|||
154836735|NCT01780662|558836746|FG001|Overall Study|Physician Decision|5|||
154836736|NCT01780662|558836747|FG002|Overall Study|Physician Decision|7|||
154836737|NCT01780662|558836745|FG000|Overall Study|Protocol Violation|0|||
154836738|NCT01780662|558836746|FG001|Overall Study|Protocol Violation|1|||
154836739|NCT01780662|558836747|FG002|Overall Study|Protocol Violation|0|||
154836740|NCT01780662|558836745|FG000|Overall Study|Ineligible|0|||
154970206|NCT04281472|559315165|FG002|Stage B|Protocol Violation|1|||
154970207|NCT04281472|559315163|FG000|Stage B|Sponsor decision|0|||
154836741|NCT01780662|558836746|FG001|Overall Study|Ineligible|0|||
154836742|NCT01780662|558836747|FG002|Overall Study|Ineligible|1|||
154836743|NCT02182687|558836749|FG000|Overall Study|Withdrawal by Subject|4|||
154836744|NCT02182687|558836750|FG001|Overall Study|Withdrawal by Subject|0|||
154836745|NCT02182687|558836749|FG000|Overall Study|Adverse Event|1|||
154836746|NCT02182687|558836750|FG001|Overall Study|Adverse Event|0|||
154836747|NCT02182687|558836749|FG000|Overall Study|Lost to Follow-up|0|||
154836748|NCT02182687|558836750|FG001|Overall Study|Lost to Follow-up|1|||
155101955|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155101956|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
155101957|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
154836749|NCT01265797|558836753|FG000|Run-in Month|Withdrawal by Subject|0|||
154836750|NCT01265797|558836754|FG001|Run-in Month|Withdrawal by Subject|4|||
154836751|NCT01265797|558836753|FG000|Run-in Month|1st seizure during run-in month|0|||
154836752|NCT01265797|558836754|FG001|Run-in Month|1st seizure during run-in month|1|||
154836753|NCT01265797|558836753|FG000|Blinded Month|Lack of Efficacy|5|||
154836754|NCT01265797|558836754|FG001|Blinded Month|Lack of Efficacy|0|||
154836755|NCT01265797|558836753|FG000|Blinded Month|Lost to Follow-up|1|||
154836756|NCT01265797|558836754|FG001|Blinded Month|Lost to Follow-up|0|||
154836757|NCT01265797|558836753|FG000|Blinded Month|Protocol Violation|2|||
154836758|NCT01265797|558836754|FG001|Blinded Month|Protocol Violation|1|||
154970208|NCT04281472|559315164|FG001|Stage B|Sponsor decision|0|||
154836759|NCT01265797|558836753|FG000|Blinded Month|Adverse Event|2|||
154836760|NCT01265797|558836754|FG001|Blinded Month|Adverse Event|0|||
154970209|NCT04281472|559315165|FG002|Stage B|Sponsor decision|1|||
154836761|NCT01265797|558836753|FG000|Blinded Month|Diary data incomplete|0|||
154970210|NCT04281472|559315163|FG000|Stage B|Withdrawal by Subject|0|||
154970211|NCT04281472|559315164|FG001|Stage B|Withdrawal by Subject|3|||
154836762|NCT01265797|558836754|FG001|Blinded Month|Diary data incomplete|1|||
154836763|NCT01265797|558836753|FG000|Open Label Month|Lost to Follow-up|0|||
154836764|NCT01265797|558836754|FG001|Open Label Month|Lost to Follow-up|1|||
154836765|NCT01422915|558836755|FG000|Overall Study|Adverse Event|1|||
154836766|NCT01378104|558836756|FG000|Overall Study|Adverse Event|8|||
154836767|NCT01378104|558836757|FG001|Overall Study|Adverse Event|8|||
154836768|NCT01378104|558836756|FG000|Overall Study|Lack of Efficacy|7|||
154836769|NCT01378104|558836757|FG001|Overall Study|Lack of Efficacy|5|||
154836770|NCT01378104|558836756|FG000|Overall Study|Withdrawal by Subject|12|||
154836771|NCT01378104|558836757|FG001|Overall Study|Withdrawal by Subject|13|||
154836772|NCT02354222|558836768|FG000|Overall Study|Adverse Event|0|||
154836773|NCT02354222|558836769|FG001|Overall Study|Adverse Event|3|||
154836774|NCT02354222|558836768|FG000|Overall Study|Physician Decision|1|||
154836775|NCT02354222|558836769|FG001|Overall Study|Physician Decision|1|||
154836776|NCT02354222|558836768|FG000|Overall Study|Pregnancy|1|||
154836777|NCT02354222|558836769|FG001|Overall Study|Pregnancy|0|||
154970212|NCT04281472|559315165|FG002|Stage B|Withdrawal by Subject|3|||
154970213|NCT04281472|559315163|FG000|Stage B|Other|0|||
154970214|NCT04281472|559315164|FG001|Stage B|Other|3|||
154970215|NCT04281472|559315165|FG002|Stage B|Other|0|||
154970216|NCT05278858|559315166|FG000|Overall Study|Withdrawal by Subject|1|||
155101958|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
155101959|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
155101960|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
155101961|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
154836778|NCT02354222|558836768|FG000|Overall Study|Withdrawal by Subject|2|||
154836779|NCT02354222|558836769|FG001|Overall Study|Withdrawal by Subject|3|||
154970217|NCT00840658|559315167|FG000|Overall Study|Death|2|||
154836780|NCT02354222|558836768|FG000|Overall Study|Conflict with the stopping criteria|0|||
154836781|NCT02354222|558836769|FG001|Overall Study|Conflict with the stopping criteria|4|||
154836782|NCT02739620|558836770|FG000|Overall Study|Lost to Follow-up|3|||
154836783|NCT02739620|558836771|FG001|Overall Study|Lost to Follow-up|1|||
154836784|NCT02739620|558836770|FG000|Overall Study|Adverse Event|0|||
154836785|NCT02739620|558836771|FG001|Overall Study|Adverse Event|1|||
154836786|NCT02536313|558836772|FG000|Overall Study|Lack of Efficacy|0|||
154836787|NCT02536313|558836773|FG001|Overall Study|Lack of Efficacy|1|||
154836788|NCT01924182|558836774|FG000|Overall Study|Withdrawal by Subject|1|||
155101962|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101963|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101964|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101965|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101966|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
155101967|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101968|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
155101969|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101970|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
154836789|NCT01924182|558836775|FG001|Overall Study|Withdrawal by Subject|0|||
154970218|NCT00840658|559315168|FG001|Overall Study|Death|2|||
154836790|NCT00993265|558836777|FG000|Overall Study|Adverse Event|1|||
154836791|NCT00993265|558836778|FG001|Overall Study|Adverse Event|0|||
154836792|NCT00993265|558836777|FG000|Overall Study|Changed dose of concomitant drug|2|||
154836793|NCT00993265|558836778|FG001|Overall Study|Changed dose of concomitant drug|0|||
155101971|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
155101972|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155101973|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155101974|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155101975|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155101976|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
155101977|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155101978|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
155101979|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
155101980|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
154836794|NCT00993265|558836777|FG000|Overall Study|Non-compliant with study medication|1|||
154836795|NCT00993265|558836778|FG001|Overall Study|Non-compliant with study medication|0|||
154970219|NCT00840658|559315169|FG002|Overall Study|Death|3|||
154970220|NCT00840658|559315170|FG003|Overall Study|Death|3|||
154924064|NCT04668066|559146374|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
154836796|NCT03885089|558836779|FG000|Overall Study|No informed consent for publication of study results|2|||
154836797|NCT03349099|558836780|FG000|Overall Study|Physician Decision|3|||
154836798|NCT03349099|558836781|FG001|Overall Study|Physician Decision|4|||
154836799|NCT03349099|558836780|FG000|Overall Study|Stone migrated from the kidney|1|||
154836800|NCT03349099|558836781|FG001|Overall Study|Stone migrated from the kidney|0|||
154836801|NCT04869345|558836782|FG000|Overall Study|Lost to Follow-up|8|||
155101981|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
155101982|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
154836802|NCT04869345|558836783|FG001|Overall Study|Lost to Follow-up|3|||
154836803|NCT04194528|558836792|FG000|Overall Study|Adverse Event|1|||
154836804|NCT03077685|558836803|FG000|Overall Study|Lost to Follow-up|0|||
154836805|NCT03077685|558836804|FG001|Overall Study|Lost to Follow-up|0|||
154836806|NCT03077685|558836805|FG002|Overall Study|Lost to Follow-up|0|||
154836807|NCT03077685|558836806|FG003|Overall Study|Lost to Follow-up|0|||
154836808|NCT03077685|558836807|FG004|Overall Study|Lost to Follow-up|1|||
154836809|NCT03077685|558836803|FG000|Overall Study|Death|0|||
154836810|NCT03077685|558836804|FG001|Overall Study|Death|0|||
154836811|NCT03077685|558836805|FG002|Overall Study|Death|1|||
154836812|NCT03077685|558836806|FG003|Overall Study|Death|1|||
154836813|NCT03077685|558836807|FG004|Overall Study|Death|3|||
154836814|NCT03077685|558836803|FG000|Overall Study|Withdrawal by Subject|0|||
154836815|NCT03077685|558836804|FG001|Overall Study|Withdrawal by Subject|0|||
154836816|NCT03077685|558836805|FG002|Overall Study|Withdrawal by Subject|0|||
154836817|NCT03077685|558836806|FG003|Overall Study|Withdrawal by Subject|2|||
154836818|NCT03077685|558836807|FG004|Overall Study|Withdrawal by Subject|1|||
154836819|NCT03077685|558836803|FG000|Overall Study|Physician Decision|0|||
154836820|NCT03077685|558836804|FG001|Overall Study|Physician Decision|0|||
154836821|NCT03077685|558836805|FG002|Overall Study|Physician Decision|1|||
154836822|NCT03077685|558836806|FG003|Overall Study|Physician Decision|0|||
154836823|NCT03077685|558836807|FG004|Overall Study|Physician Decision|3|||
154836824|NCT03077685|558836803|FG000|Overall Study|Disease Progression|1|||
154836825|NCT03077685|558836804|FG001|Overall Study|Disease Progression|0|||
154836826|NCT03077685|558836805|FG002|Overall Study|Disease Progression|0|||
154836827|NCT03077685|558836806|FG003|Overall Study|Disease Progression|2|||
154836828|NCT03077685|558836807|FG004|Overall Study|Disease Progression|1|||
154970221|NCT00840658|559315167|FG000|Overall Study|Lost to Follow-up|3|||
154836829|NCT03077685|558836803|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
154836830|NCT03077685|558836804|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
154836831|NCT03077685|558836805|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
154836832|NCT03077685|558836806|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
154836833|NCT03077685|558836807|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
154970222|NCT00840658|559315168|FG001|Overall Study|Lost to Follow-up|1|||
155101983|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155101984|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155101985|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
154970223|NCT00840658|559315169|FG002|Overall Study|Lost to Follow-up|2|||
154970224|NCT00840658|559315170|FG003|Overall Study|Lost to Follow-up|1|||
154970225|NCT02372006|559315173|FG000|Overall Study|Progressive disease|8|||
154970226|NCT02372006|559315174|FG001|Overall Study|Progressive disease|7|||
154970227|NCT02372006|559315175|FG002|Overall Study|Progressive disease|34|||
154970228|NCT02372006|559315173|FG000|Overall Study|Dose limiting toxicity|0|||
154970229|NCT02372006|559315174|FG001|Overall Study|Dose limiting toxicity|1|||
154970230|NCT02372006|559315175|FG002|Overall Study|Dose limiting toxicity|0|||
154970231|NCT02372006|559315173|FG000|Overall Study|Adverse Event|0|||
154970232|NCT02372006|559315174|FG001|Overall Study|Adverse Event|0|||
154970233|NCT02372006|559315175|FG002|Overall Study|Adverse Event|3|||
154970234|NCT02372006|559315173|FG000|Overall Study|Withdrawal by Subject|0|||
155101986|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
154970235|NCT02372006|559315174|FG001|Overall Study|Withdrawal by Subject|1|||
154970236|NCT02372006|559315175|FG002|Overall Study|Withdrawal by Subject|1|||
154970237|NCT02372006|559315173|FG000|Overall Study|Other reason for not completing|0|||
154970238|NCT02372006|559315174|FG001|Overall Study|Other reason for not completing|0|||
154836834|NCT03077685|558836803|FG000|Overall Study|Subject entered hospice care|0|||
154836835|NCT03077685|558836804|FG001|Overall Study|Subject entered hospice care|0|||
154836836|NCT03077685|558836805|FG002|Overall Study|Subject entered hospice care|0|||
154836837|NCT03077685|558836806|FG003|Overall Study|Subject entered hospice care|0|||
155101987|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
155101988|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
155101989|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
154836838|NCT03077685|558836807|FG004|Overall Study|Subject entered hospice care|1|||
154836839|NCT02116777|558836808|FG000|Overall Study|Adverse Event|0|||
154836840|NCT02116777|558836809|FG001|Overall Study|Adverse Event|0|||
154836841|NCT02116777|558836810|FG002|Overall Study|Adverse Event|0|||
154836842|NCT02116777|558836811|FG003|Overall Study|Adverse Event|0|||
154836843|NCT02116777|558836812|FG004|Overall Study|Adverse Event|2|||
154836844|NCT02116777|558836813|FG005|Overall Study|Adverse Event|2|||
154836845|NCT02116777|558836814|FG006|Overall Study|Adverse Event|0|||
154970239|NCT02372006|559315175|FG002|Overall Study|Other reason for not completing|1|||
154970240|NCT01055834|559315178|FG000|Treatment Period I|Adverse Event|1|||
154970241|NCT01055834|559315179|FG001|Treatment Period I|Adverse Event|0|||
155172815|NCT05141448|560071915|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
154836846|NCT02116777|558836808|FG000|Overall Study|Death|0|||
154836847|NCT02116777|558836809|FG001|Overall Study|Death|0|||
154836848|NCT02116777|558836810|FG002|Overall Study|Death|0|||
155101990|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155101991|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
155101992|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155101993|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
154836849|NCT02116777|558836811|FG003|Overall Study|Death|1|||
154836850|NCT02116777|558836812|FG004|Overall Study|Death|0|||
154836851|NCT02116777|558836813|FG005|Overall Study|Death|0|||
154836852|NCT02116777|558836814|FG006|Overall Study|Death|0|||
154970242|NCT01717313|559315180|FG000|Phase A (Weeks 0 to 24)|Death|0|||
154970243|NCT01717313|559315181|FG001|Phase A (Weeks 0 to 24)|Death|1|||
154836853|NCT02116777|558836808|FG000|Overall Study|Lack of Efficacy|3|||
155172816|NCT05141448|560071916|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
154970244|NCT01717313|559315180|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
154970245|NCT01717313|559315181|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
154836854|NCT02116777|558836809|FG001|Overall Study|Lack of Efficacy|3|||
154836855|NCT02116777|558836810|FG002|Overall Study|Lack of Efficacy|3|||
154836856|NCT02116777|558836811|FG003|Overall Study|Lack of Efficacy|8|||
154836857|NCT02116777|558836812|FG004|Overall Study|Lack of Efficacy|4|||
154836858|NCT02116777|558836813|FG005|Overall Study|Lack of Efficacy|1|||
154836859|NCT02116777|558836814|FG006|Overall Study|Lack of Efficacy|9|||
154836860|NCT02116777|558836808|FG000|Overall Study|Physician Decision|0|||
154836861|NCT02116777|558836809|FG001|Overall Study|Physician Decision|0|||
154836862|NCT02116777|558836810|FG002|Overall Study|Physician Decision|0|||
154836863|NCT02116777|558836811|FG003|Overall Study|Physician Decision|2|||
154836864|NCT02116777|558836812|FG004|Overall Study|Physician Decision|0|||
154836865|NCT02116777|558836813|FG005|Overall Study|Physician Decision|0|||
155172817|NCT05141448|560071911|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
154836866|NCT02116777|558836814|FG006|Overall Study|Physician Decision|0|||
155101994|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155101995|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155172818|NCT05141448|560071912|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155172819|NCT05141448|560071913|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155172820|NCT05141448|560071914|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155172821|NCT05141448|560071915|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
154970246|NCT01717313|559315180|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
154970247|NCT01717313|559315181|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
154970248|NCT01717313|559315180|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
154970249|NCT01717313|559315181|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
154970250|NCT01717313|559315180|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
154970251|NCT01717313|559315181|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
154836867|NCT02116777|558836808|FG000|Overall Study|Protocol Violation|0|||
154970252|NCT01717313|559315180|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
154970253|NCT01717313|559315181|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
154970254|NCT01717313|559315180|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
154970255|NCT01717313|559315181|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
154970256|NCT01717313|559315180|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
154970257|NCT01717313|559315181|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
154970258|NCT01717313|559315180|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
155101996|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155101997|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155101998|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155101999|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
155102000|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155102001|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
155102002|NCT01194219|559806483|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102003|NCT01194219|559806484|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
154836868|NCT02116777|558836809|FG001|Overall Study|Protocol Violation|0|||
155102004|NCT01194219|559806485|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
154836869|NCT02116777|558836810|FG002|Overall Study|Protocol Violation|0|||
155102005|NCT01194219|559806486|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102006|NCT01194219|559806487|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102007|NCT01194219|559806488|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102008|NCT01194219|559806489|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
155102009|NCT01194219|559806490|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102010|NCT01194219|559806491|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102011|NCT01194219|559806492|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
155102012|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102013|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102014|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102015|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102016|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102017|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102018|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102019|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
155102020|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
154836870|NCT02116777|558836811|FG003|Overall Study|Protocol Violation|1|||
154836871|NCT02116777|558836812|FG004|Overall Study|Protocol Violation|0|||
154836872|NCT02116777|558836813|FG005|Overall Study|Protocol Violation|0|||
154836873|NCT02116777|558836814|FG006|Overall Study|Protocol Violation|0|||
154836874|NCT02116777|558836808|FG000|Overall Study|Withdrawal by Subject|0|||
154836875|NCT02116777|558836809|FG001|Overall Study|Withdrawal by Subject|0|||
154836876|NCT02116777|558836810|FG002|Overall Study|Withdrawal by Subject|0|||
154836877|NCT02116777|558836811|FG003|Overall Study|Withdrawal by Subject|1|||
155102021|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
155102022|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102023|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
154836878|NCT02116777|558836812|FG004|Overall Study|Withdrawal by Subject|0|||
154836879|NCT02116777|558836813|FG005|Overall Study|Withdrawal by Subject|0|||
154836880|NCT02116777|558836814|FG006|Overall Study|Withdrawal by Subject|0|||
154836881|NCT00102960|558836817|FG000|Overall Study|Death|23|||
154836882|NCT00102960|558836818|FG001|Overall Study|Death|11|||
154836883|NCT00102960|558836819|FG002|Overall Study|Death|11|||
154836884|NCT00102960|558836817|FG000|Overall Study|Lost to Follow-up|6|||
154836885|NCT00102960|558836818|FG001|Overall Study|Lost to Follow-up|12|||
154836886|NCT00102960|558836819|FG002|Overall Study|Lost to Follow-up|16|||
154836887|NCT00102960|558836817|FG000|Overall Study|Withdrawal by Subject|1|||
154836888|NCT00102960|558836818|FG001|Overall Study|Withdrawal by Subject|0|||
155102024|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102025|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102026|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102027|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102028|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102029|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
155102030|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
155102031|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
155102032|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102033|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102034|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102035|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155172822|NCT05141448|560071916|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
154836889|NCT00102960|558836819|FG002|Overall Study|Withdrawal by Subject|1|||
154970259|NCT01717313|559315181|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
155102036|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102037|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102038|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102039|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
155102040|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
154970260|NCT00301964|559315182|FG000|Overall Study|Second primary|2|||
154970261|NCT00301964|559315182|FG000|Overall Study|Wrong primary|1|||
154970262|NCT00301964|559315182|FG000|Overall Study|Inadequate pathology|1|||
154970263|NCT00295490|559315183|FG000|Overall Study|Protocol Violation|0|||
154970264|NCT00295490|559315184|FG001|Overall Study|Protocol Violation|0|||
154970265|NCT00295490|559315185|FG002|Overall Study|Protocol Violation|3|||
154970266|NCT00295490|559315186|FG003|Overall Study|Protocol Violation|3|||
154970267|NCT00295490|559315183|FG000|Overall Study|Withdrawal by Subject|0|||
154970268|NCT00295490|559315184|FG001|Overall Study|Withdrawal by Subject|2|||
154970269|NCT00295490|559315185|FG002|Overall Study|Withdrawal by Subject|0|||
154970270|NCT00295490|559315186|FG003|Overall Study|Withdrawal by Subject|1|||
154970271|NCT00295490|559315183|FG000|Overall Study|Lost to Follow-up|0|||
154970272|NCT00295490|559315184|FG001|Overall Study|Lost to Follow-up|0|||
154970273|NCT00295490|559315185|FG002|Overall Study|Lost to Follow-up|1|||
154970274|NCT00295490|559315186|FG003|Overall Study|Lost to Follow-up|0|||
154970275|NCT00295490|559315183|FG000|Overall Study|Adverse Event|1|||
154970276|NCT00295490|559315184|FG001|Overall Study|Adverse Event|0|||
155102041|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
154970277|NCT00295490|559315185|FG002|Overall Study|Adverse Event|0|||
154970278|NCT00295490|559315186|FG003|Overall Study|Adverse Event|0|||
154970279|NCT00295490|559315183|FG000|Overall Study|Other|0|||
154970280|NCT00295490|559315184|FG001|Overall Study|Other|2|||
155102042|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102043|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
154836890|NCT00733954|558836820|FG000|Overall Study|Lost to Follow-up|5|||
154836891|NCT00733954|558836821|FG001|Overall Study|Lost to Follow-up|2|||
154970281|NCT00295490|559315185|FG002|Overall Study|Other|0|||
154970282|NCT00295490|559315186|FG003|Overall Study|Other|1|||
154970283|NCT02611362|559315187|FG000|Overall Study|Withdrawal by Subject|7|||
154970284|NCT02611362|559315188|FG001|Overall Study|Withdrawal by Subject|2|||
154970285|NCT02611362|559315187|FG000|Overall Study|Lost to Follow-up|2|||
154970286|NCT02611362|559315188|FG001|Overall Study|Lost to Follow-up|4|||
155102044|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102045|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102046|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102047|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102048|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102049|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
155102050|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
154836892|NCT00733954|558836820|FG000|Overall Study|Protocol Violation|1|||
154836893|NCT00733954|558836821|FG001|Overall Study|Protocol Violation|0|||
154970287|NCT01532908|559315202|FG000|Overall Study|Not Transplanted|1|||
154970288|NCT01532908|559315203|FG001|Overall Study|Not Transplanted|0|||
154970289|NCT01559116|559315204|FG000|Overall Study|Adverse Event|10|||
154970290|NCT01559116|559315204|FG000|Overall Study|Lack of Efficacy|1|||
154970291|NCT01559116|559315204|FG000|Overall Study|Lost to Follow-up|1|||
154970292|NCT01559116|559315204|FG000|Overall Study|Protocol Violation|1|||
154970293|NCT01559116|559315204|FG000|Overall Study|Withdrawal by Subject|4|||
154970294|NCT01559116|559315204|FG000|Overall Study|other than stated above|9|||
154970295|NCT01868243|559315205|FG000|Overall Study|Death|0|||
154970296|NCT01868243|559315206|FG001|Overall Study|Death|1|||
154970297|NCT01632306|559315207|FG000|Overall Study|Protocol Violation|1|||
154970298|NCT01632306|559315208|FG001|Overall Study|Protocol Violation|0|||
154970299|NCT01632306|559315209|FG002|Overall Study|Protocol Violation|0|||
154970300|NCT00467597|559315211|FG000|Overall Study|Withdrawal by Subject|2|||
154970301|NCT00467597|559315212|FG001|Overall Study|Withdrawal by Subject|0|||
154970302|NCT01745094|559315215|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
154970303|NCT01745094|559315216|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
154970304|NCT01745094|559315217|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
154970305|NCT01745094|559315218|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
154970306|NCT01745094|559315215|FG000|Overall Study|Adverse Event|0|||
154970307|NCT01745094|559315216|FG001|Overall Study|Adverse Event|0|||
154970308|NCT01745094|559315217|FG002|Overall Study|Adverse Event|3|||
154970309|NCT01745094|559315218|FG003|Overall Study|Adverse Event|0|||
154970310|NCT01745094|559315215|FG000|Overall Study|Withdrawal by Subject|2|||
154970311|NCT01745094|559315216|FG001|Overall Study|Withdrawal by Subject|0|||
154970312|NCT01745094|559315217|FG002|Overall Study|Withdrawal by Subject|1|||
154970313|NCT01745094|559315218|FG003|Overall Study|Withdrawal by Subject|2|||
154970314|NCT01745094|559315215|FG000|Overall Study|Protocol Violation|1|||
154970315|NCT01745094|559315216|FG001|Overall Study|Protocol Violation|0|||
154970316|NCT01745094|559315217|FG002|Overall Study|Protocol Violation|3|||
154970317|NCT01745094|559315218|FG003|Overall Study|Protocol Violation|1|||
154970318|NCT01745094|559315215|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
154970319|NCT01745094|559315216|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
155102051|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
155102052|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
155102053|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
155102054|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
155102055|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
154970320|NCT01745094|559315217|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
154970321|NCT01745094|559315218|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
154970322|NCT01745094|559315215|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
154970323|NCT01745094|559315216|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
154970324|NCT01745094|559315217|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
154970325|NCT01745094|559315218|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
154970326|NCT01745094|559315215|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
155102056|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
154970327|NCT01745094|559315216|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
154970328|NCT01745094|559315217|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
154970329|NCT01745094|559315218|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
154970330|NCT04610580|559315219|FG000|Two-way Crossover Period|Adverse Event|1|||
154970331|NCT04610580|559315220|FG001|Two-way Crossover Period|Adverse Event|0|||
154970332|NCT04610580|559315221|FG002|Two-way Crossover Period|Adverse Event|0|||
154970333|NCT04610580|559315222|FG003|Two-way Crossover Period|Adverse Event|0|||
155102057|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
155102058|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
155102059|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
155102060|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
155102061|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
155102062|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102063|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102064|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102065|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102066|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102067|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102068|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102069|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
155102070|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
155102071|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
155102072|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102073|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102074|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102075|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102076|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102077|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102078|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102079|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102080|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
155102081|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
155102082|NCT01194219|559806483|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102083|NCT01194219|559806484|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102084|NCT01194219|559806485|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102085|NCT01194219|559806486|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102086|NCT01194219|559806487|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102087|NCT01194219|559806488|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102088|NCT01194219|559806489|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102089|NCT01194219|559806490|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
155102090|NCT01194219|559806491|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
154970334|NCT04610580|559315223|FG004|Two-way Crossover Period|Adverse Event|0|||
154970335|NCT04610580|559315224|FG005|Two-way Crossover Period|Adverse Event|0|||
154970336|NCT04610580|559315219|FG000|Two-way Crossover Period|Physician Decision|1|||
154970337|NCT04610580|559315220|FG001|Two-way Crossover Period|Physician Decision|0|||
154836894|NCT00733954|558836820|FG000|Overall Study|Withdrawal by Subject|2|||
154836895|NCT00733954|558836821|FG001|Overall Study|Withdrawal by Subject|0|||
154836896|NCT02663453|558836822|FG000|Overall Study|Death|4|||
154836897|NCT02663453|558836823|FG001|Overall Study|Death|4|||
154836898|NCT02663453|558836822|FG000|Overall Study|Withdrawal by Subject|1|||
154836899|NCT02663453|558836823|FG001|Overall Study|Withdrawal by Subject|0|||
154836900|NCT01964352|558838465|FG000|Overall Study|Adverse Event|13|||
154836901|NCT01964352|558838466|FG001|Overall Study|Adverse Event|3|||
154836902|NCT01964352|558838467|FG002|Overall Study|Adverse Event|4|||
154836903|NCT01964352|558838468|FG003|Overall Study|Adverse Event|3|||
154836904|NCT01964352|558838465|FG000|Overall Study|Lack of Efficacy|6|||
154836905|NCT01964352|558838466|FG001|Overall Study|Lack of Efficacy|0|||
154836906|NCT01964352|558838467|FG002|Overall Study|Lack of Efficacy|0|||
154836907|NCT01964352|558838468|FG003|Overall Study|Lack of Efficacy|0|||
154836908|NCT01964352|558838465|FG000|Overall Study|Protocol Violation|2|||
154836909|NCT01964352|558838466|FG001|Overall Study|Protocol Violation|4|||
154836910|NCT01964352|558838467|FG002|Overall Study|Protocol Violation|0|||
154836911|NCT01964352|558838468|FG003|Overall Study|Protocol Violation|2|||
154836912|NCT01964352|558838465|FG000|Overall Study|Lost to Follow-up|1|||
154836913|NCT01964352|558838466|FG001|Overall Study|Lost to Follow-up|0|||
154836914|NCT01964352|558838467|FG002|Overall Study|Lost to Follow-up|0|||
154836915|NCT01964352|558838468|FG003|Overall Study|Lost to Follow-up|1|||
154836916|NCT01964352|558838465|FG000|Overall Study|Withdrawal by Subject|4|||
154836917|NCT01964352|558838466|FG001|Overall Study|Withdrawal by Subject|2|||
154836918|NCT01964352|558838467|FG002|Overall Study|Withdrawal by Subject|1|||
154836919|NCT01964352|558838468|FG003|Overall Study|Withdrawal by Subject|0|||
154836920|NCT01964352|558838465|FG000|Overall Study|Other than stated above|0|||
154836921|NCT01964352|558838466|FG001|Overall Study|Other than stated above|2|||
154836922|NCT01964352|558838467|FG002|Overall Study|Other than stated above|1|||
154836923|NCT01964352|558838468|FG003|Overall Study|Other than stated above|2|||
155172823|NCT05141448|560071911|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
154836924|NCT00874120|558838474|FG000|First Intervention|Adverse Event|0|||
154836925|NCT00874120|558838475|FG001|First Intervention|Adverse Event|1|||
154970338|NCT04610580|559315221|FG002|Two-way Crossover Period|Physician Decision|0|||
154836926|NCT00874120|558838474|FG000|First Intervention|Withdrawal by Subject|2|||
154836927|NCT00874120|558838475|FG001|First Intervention|Withdrawal by Subject|0|||
154836928|NCT00874120|558838474|FG000|First Intervention|Lost to Follow-up|0|||
154836929|NCT00874120|558838475|FG001|First Intervention|Lost to Follow-up|1|||
154836930|NCT00874120|558838474|FG000|First Intervention|Protocol Violation|3|||
154970339|NCT04610580|559315222|FG003|Two-way Crossover Period|Physician Decision|0|||
154970340|NCT04610580|559315223|FG004|Two-way Crossover Period|Physician Decision|0|||
154970341|NCT04610580|559315224|FG005|Two-way Crossover Period|Physician Decision|0|||
154970342|NCT04610580|559315219|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
154970343|NCT04610580|559315220|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
154970344|NCT04610580|559315221|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
154970345|NCT04610580|559315222|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
154970346|NCT04610580|559315223|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
154970347|NCT04610580|559315224|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
154970348|NCT04610580|559315219|FG000|Two-way Crossover Period|Other than specified|0|||
154970349|NCT04610580|559315220|FG001|Two-way Crossover Period|Other than specified|1|||
154970350|NCT04610580|559315221|FG002|Two-way Crossover Period|Other than specified|0|||
154970351|NCT04610580|559315222|FG003|Two-way Crossover Period|Other than specified|0|||
155172824|NCT05141448|560071912|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
154836931|NCT00874120|558838475|FG001|First Intervention|Protocol Violation|0|||
154836932|NCT00874120|558838474|FG000|First Intervention|positive drug test|1|||
154836933|NCT00874120|558838475|FG001|First Intervention|positive drug test|0|||
154836934|NCT00874120|558838474|FG000|Second Intervention|Withdrawal by Subject|1|||
154836935|NCT00874120|558838475|FG001|Second Intervention|Withdrawal by Subject|0|||
154836936|NCT00874120|558838474|FG000|Second Intervention|Protocol Violation|1|||
154836937|NCT00874120|558838475|FG001|Second Intervention|Protocol Violation|0|||
155102091|NCT01194219|559806492|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
155102092|NCT01081951|559806493|FG000|Overall Study|Death|54|||
155102093|NCT01081951|559806494|FG001|Overall Study|Death|47|||
155102094|NCT01081951|559806493|FG000|Overall Study|Withdrawal by Subject|2|||
155102095|NCT01081951|559806494|FG001|Overall Study|Withdrawal by Subject|6|||
155102096|NCT01081951|559806493|FG000|Overall Study|Allocated treatment but did not take it|0|||
155102097|NCT01081951|559806494|FG001|Overall Study|Allocated treatment but did not take it|1|||
155102098|NCT01081951|559806493|FG000|Overall Study|Lost to Follow-up|0|||
154836938|NCT00477165|558838476|FG000|Overall Study|Adverse Event|7|||
154836939|NCT00477165|558838477|FG001|Overall Study|Adverse Event|2|||
154836940|NCT01823679|558838478|FG000|Overall Study|Death|1|||
154836941|NCT00105443|558838482|FG000|Double-Blind Treatment|Adverse Event|1|||
154836942|NCT00105443|558838483|FG001|Double-Blind Treatment|Adverse Event|0|||
154836943|NCT00105443|558838484|FG002|Double-Blind Treatment|Adverse Event|0|||
155172825|NCT05141448|560071913|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
154836944|NCT00105443|558838485|FG003|Double-Blind Treatment|Adverse Event|0|||
154836945|NCT00105443|558838482|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
154836946|NCT00105443|558838483|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
154836947|NCT00105443|558838484|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
154836948|NCT00105443|558838485|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
154836949|NCT00105443|558838482|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
154836950|NCT00105443|558838483|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
154836951|NCT00105443|558838484|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
154836952|NCT00105443|558838485|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
154836953|NCT00105443|558838482|FG000|Double-Blind Treatment|Physician Decision|1|||
154836954|NCT00105443|558838483|FG001|Double-Blind Treatment|Physician Decision|0|||
154836955|NCT00105443|558838484|FG002|Double-Blind Treatment|Physician Decision|2|||
154836956|NCT00105443|558838485|FG003|Double-Blind Treatment|Physician Decision|0|||
154836957|NCT00105443|558838482|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
154836958|NCT00105443|558838483|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
154836959|NCT00105443|558838484|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
154836960|NCT00105443|558838485|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
154836961|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
154836962|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
154836963|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
154836964|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
154836965|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
154836966|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
154836967|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
154836968|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
154836969|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
154836970|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
154836971|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
154836972|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
154836973|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
155102099|NCT01081951|559806494|FG001|Overall Study|Lost to Follow-up|1|||
155102100|NCT05384834|559806503|FG000|Overall Study|Lost to Follow-up|43|||
155102101|NCT05384834|559806503|FG000|Overall Study|Withdrawal by Subject|5|||
155102102|NCT01871545|559806504|FG000|Overall Study|Death|2|||
154836974|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
154836975|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
154836976|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
155102103|NCT01871545|559806505|FG001|Overall Study|Death|0|||
155102104|NCT01871545|559806504|FG000|Overall Study|Lack of Efficacy|11|||
155102105|NCT01871545|559806505|FG001|Overall Study|Lack of Efficacy|2|||
154836977|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
154836978|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
154836979|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
154836980|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
155102106|NCT01871545|559806504|FG000|Overall Study|Physician Decision|4|||
155102107|NCT01871545|559806505|FG001|Overall Study|Physician Decision|0|||
154836981|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
154836982|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
154836983|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
154836984|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
155102108|NCT01871545|559806504|FG000|Overall Study|Withdrawal by Subject|0|||
155102109|NCT01871545|559806505|FG001|Overall Study|Withdrawal by Subject|1|||
155102110|NCT05710640|559806508|FG000|Overall Study|Physician Decision|0|||
155102111|NCT05710640|559806509|FG001|Overall Study|Physician Decision|1|||
155102112|NCT05710640|559806508|FG000|Overall Study|Withdrawal by Subject|1|||
155102113|NCT05710640|559806509|FG001|Overall Study|Withdrawal by Subject|0|||
155102114|NCT05710640|559806508|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
155102115|NCT05710640|559806509|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
155102116|NCT04188509|559806510|FG000|Overall Study|Adverse Event|2|||
155102117|NCT04188509|559806510|FG000|Overall Study|Lost to Follow-up|1|||
155102118|NCT04188509|559806510|FG000|Overall Study|Withdrawal of Consent|1|||
155102119|NCT04188509|559806510|FG000|Overall Study|Discretion of Investigator|1|||
155102120|NCT04188509|559806510|FG000|Overall Study|Noncompliance|3|||
155102121|NCT04188509|559806510|FG000|Overall Study|Sponsor Decision|127|||
155102122|NCT04188509|559806510|FG000|Overall Study|Other|2|||
155102123|NCT04158375|559806511|FG000|Overall Study|Withdrawal by Subject|0|||
155102124|NCT04158375|559806512|FG001|Overall Study|Withdrawal by Subject|3|||
155102125|NCT04158375|559806513|FG002|Overall Study|Withdrawal by Subject|0|||
155102126|NCT04847843|559806514|FG000|Overall Study|Scheduling Conflicts|6|||
155102127|NCT04847843|559806515|FG001|Overall Study|Scheduling Conflicts|9|||
155102128|NCT04847843|559806514|FG000|Overall Study|Withdrawal by Subject|1|||
155102129|NCT04847843|559806515|FG001|Overall Study|Withdrawal by Subject|0|||
155102130|NCT04847843|559806514|FG000|Overall Study|Lost to Follow-up|1|||
155102131|NCT04847843|559806515|FG001|Overall Study|Lost to Follow-up|1|||
154836985|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
154836986|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
155102132|NCT04847843|559806514|FG000|Overall Study|Pregnancy|0|||
155102133|NCT04847843|559806515|FG001|Overall Study|Pregnancy|2|||
155102134|NCT04847843|559806514|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
155102135|NCT04847843|559806515|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
155102136|NCT02734004|559806516|FG000|Overall Study|Death|36|||
155102137|NCT02734004|559806517|FG001|Overall Study|Death|24|||
155102138|NCT02734004|559806518|FG002|Overall Study|Death|26|||
155102139|NCT02734004|559806519|FG003|Overall Study|Death|35|||
155102140|NCT02734004|559806520|FG004|Overall Study|Death|13|||
155102141|NCT02734004|559806521|FG005|Overall Study|Death|17|||
155102142|NCT02734004|559806522|FG006|Overall Study|Death|20|||
155102143|NCT02734004|559806516|FG000|Overall Study|Lost to Follow-up|1|||
155102144|NCT02734004|559806517|FG001|Overall Study|Lost to Follow-up|1|||
155102145|NCT02734004|559806518|FG002|Overall Study|Lost to Follow-up|0|||
155102146|NCT02734004|559806519|FG003|Overall Study|Lost to Follow-up|0|||
155102147|NCT02734004|559806520|FG004|Overall Study|Lost to Follow-up|1|||
155102148|NCT02734004|559806521|FG005|Overall Study|Lost to Follow-up|0|||
155102149|NCT02734004|559806522|FG006|Overall Study|Lost to Follow-up|0|||
155102150|NCT02734004|559806516|FG000|Overall Study|Withdrawal by Subject|3|||
155102151|NCT02734004|559806517|FG001|Overall Study|Withdrawal by Subject|1|||
155102152|NCT02734004|559806518|FG002|Overall Study|Withdrawal by Subject|1|||
155102153|NCT02734004|559806519|FG003|Overall Study|Withdrawal by Subject|1|||
155102154|NCT02734004|559806520|FG004|Overall Study|Withdrawal by Subject|3|||
155102155|NCT02734004|559806521|FG005|Overall Study|Withdrawal by Subject|0|||
155102156|NCT02734004|559806522|FG006|Overall Study|Withdrawal by Subject|2|||
155102157|NCT02734004|559806516|FG000|Overall Study|Other|0|||
154836987|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
154836988|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
154836989|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
154836990|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
154836991|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
154836992|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
154836993|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
154970352|NCT04610580|559315223|FG004|Two-way Crossover Period|Other than specified|0|||
154970353|NCT04610580|559315224|FG005|Two-way Crossover Period|Other than specified|0|||
154970354|NCT04610580|559315219|FG000|Washout Before Extension Period|Other than specified|0|||
154970355|NCT04610580|559315220|FG001|Washout Before Extension Period|Other than specified|1|||
154970356|NCT04610580|559315221|FG002|Washout Before Extension Period|Other than specified|0|||
154970357|NCT04610580|559315222|FG003|Washout Before Extension Period|Other than specified|0|||
154970358|NCT04610580|559315223|FG004|Washout Before Extension Period|Other than specified|0|||
154970359|NCT04610580|559315224|FG005|Washout Before Extension Period|Other than specified|0|||
154970360|NCT04610580|559315219|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
154970361|NCT04610580|559315220|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
154970362|NCT04610580|559315221|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
154970363|NCT04610580|559315222|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
154970364|NCT04610580|559315223|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
154970365|NCT04610580|559315224|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
154970366|NCT04610580|559315219|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
154970367|NCT04610580|559315220|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
154970368|NCT04610580|559315221|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
154970369|NCT04610580|559315222|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
154970370|NCT04610580|559315223|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
154970371|NCT04610580|559315224|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
154970372|NCT03480022|559315226|FG000|Overall Study|Pregnancy|2|||
154970373|NCT03480022|559315227|FG001|Overall Study|Pregnancy|0|||
154970374|NCT03480022|559315226|FG000|Overall Study|Adverse Event|6|||
154970375|NCT03480022|559315227|FG001|Overall Study|Adverse Event|0|||
154970376|NCT03480022|559315226|FG000|Overall Study|Lack of Efficacy|0|||
154970377|NCT03480022|559315227|FG001|Overall Study|Lack of Efficacy|2|||
154970378|NCT03480022|559315226|FG000|Overall Study|Physician Decision|0|||
154970379|NCT03480022|559315227|FG001|Overall Study|Physician Decision|1|||
154970380|NCT03480022|559315226|FG000|Overall Study|Withdrawal by Subject|2|||
154970381|NCT03480022|559315227|FG001|Overall Study|Withdrawal by Subject|0|||
154970382|NCT03480022|559315226|FG000|Overall Study|Medication concerns|1|||
154970383|NCT03480022|559315227|FG001|Overall Study|Medication concerns|0|||
154970384|NCT03480022|559315226|FG000|Overall Study|Family member COVID exposure|0|||
154970385|NCT03480022|559315227|FG001|Overall Study|Family member COVID exposure|1|||
154970386|NCT00881569|559315228|FG000|Overall Study|Disease progression|1|||
154970387|NCT00881569|559315229|FG001|Overall Study|Disease progression|1|||
154970388|NCT01993940|559315234|FG000|Overall Study|Adverse Event|16|||
154970389|NCT01993940|559315235|FG001|Overall Study|Adverse Event|11|||
154836994|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
154836995|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
154836996|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
154836997|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
154836998|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
154970390|NCT01993940|559315234|FG000|Overall Study|Withdrawal by Subject|15|||
154970391|NCT01993940|559315235|FG001|Overall Study|Withdrawal by Subject|19|||
154970392|NCT01993940|559315234|FG000|Overall Study|Lost to Follow-up|2|||
154970393|NCT01993940|559315235|FG001|Overall Study|Lost to Follow-up|5|||
155102158|NCT02734004|559806517|FG001|Overall Study|Other|8|||
155102159|NCT02734004|559806518|FG002|Overall Study|Other|7|||
154970394|NCT01993940|559315234|FG000|Overall Study|Protocol Violation|5|||
154970395|NCT01993940|559315235|FG001|Overall Study|Protocol Violation|8|||
154836999|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
154837000|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
154924065|NCT04668066|559146375|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924066|NCT04668066|559146376|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924067|NCT04668066|559146377|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924068|NCT04668066|559146378|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924069|NCT04668066|559146379|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924070|NCT04668066|559146380|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924071|NCT04668066|559146381|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924072|NCT04668066|559146382|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924073|NCT04668066|559146383|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924074|NCT04668066|559146384|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
154924075|NCT04668066|559146366|FG000|Part 2: Treatment Phase|Other|0|||
154924076|NCT04668066|559146367|FG001|Part 2: Treatment Phase|Other|0|||
154924077|NCT04668066|559146368|FG002|Part 2: Treatment Phase|Other|0|||
154924078|NCT04668066|559146369|FG003|Part 2: Treatment Phase|Other|0|||
154924079|NCT04668066|559146370|FG004|Part 2: Treatment Phase|Other|0|||
154924080|NCT04668066|559146371|FG005|Part 2: Treatment Phase|Other|0|||
154924081|NCT04668066|559146372|FG006|Part 2: Treatment Phase|Other|0|||
154924082|NCT04668066|559146373|FG007|Part 2: Treatment Phase|Other|0|||
154924083|NCT04668066|559146374|FG008|Part 2: Treatment Phase|Other|0|||
154924084|NCT04668066|559146375|FG009|Part 2: Treatment Phase|Other|0|||
154924085|NCT04668066|559146376|FG010|Part 2: Treatment Phase|Other|0|||
154924086|NCT04668066|559146377|FG011|Part 2: Treatment Phase|Other|0|||
154924087|NCT04668066|559146378|FG012|Part 2: Treatment Phase|Other|0|||
154924088|NCT04668066|559146379|FG013|Part 2: Treatment Phase|Other|0|||
154924089|NCT04668066|559146380|FG014|Part 2: Treatment Phase|Other|0|||
154924090|NCT04668066|559146381|FG015|Part 2: Treatment Phase|Other|0|||
154924091|NCT04668066|559146382|FG016|Part 2: Treatment Phase|Other|0|||
154924092|NCT04668066|559146383|FG017|Part 2: Treatment Phase|Other|0|||
154924093|NCT04668066|559146384|FG018|Part 2: Treatment Phase|Other|1|||
154924094|NCT04668066|559146366|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924095|NCT04668066|559146367|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
154970396|NCT01993940|559315234|FG000|Overall Study|Death|1|||
154970397|NCT01993940|559315235|FG001|Overall Study|Death|0|||
154970398|NCT01993940|559315234|FG000|Overall Study|Other - Miscellaneous|1|||
154970399|NCT01993940|559315235|FG001|Overall Study|Other - Miscellaneous|1|||
154970400|NCT03922750|559315236|FG000|Overall Study|Unclassified|0|||
154970401|NCT03922750|559315237|FG001|Overall Study|Unclassified|0|||
154970402|NCT03922750|559315238|FG002|Overall Study|Unclassified|1|||
154970403|NCT03922750|559315236|FG000|Overall Study|Adverse Event|0|||
154970404|NCT03922750|559315237|FG001|Overall Study|Adverse Event|1|||
154970405|NCT03922750|559315238|FG002|Overall Study|Adverse Event|0|||
154970406|NCT00668395|559315239|FG000|Overall Study|Withdrawal by Subject|4|||
154837001|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
154837002|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
154837003|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
154837004|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
155102160|NCT02734004|559806519|FG003|Overall Study|Other|4|||
155102161|NCT02734004|559806520|FG004|Overall Study|Other|34|||
155102162|NCT02734004|559806521|FG005|Overall Study|Other|14|||
155102163|NCT02734004|559806522|FG006|Overall Study|Other|10|||
155102164|NCT01282866|559806529|FG000|Overall Study|Adverse Event|1|||
155102165|NCT01541865|559806531|FG000|Overall Study|Lost to Follow-up|11|||
155102166|NCT01541865|559806531|FG000|Overall Study|Withdrawal by Subject|9|||
155102167|NCT01541865|559806531|FG000|Overall Study|Adverse Event|1|||
154837005|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
154837006|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
154837007|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
154837008|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
154837009|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
154837010|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
154837011|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
154837012|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
154837013|NCT00105443|558838482|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
154837014|NCT00105443|558838483|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
154837015|NCT00105443|558838484|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
154837016|NCT00105443|558838485|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
154837017|NCT02135692|558838486|FG000|Overall Study|Adverse Event|3|||
154837018|NCT02135692|558838486|FG000|Overall Study|Lack of Efficacy|2|||
154837019|NCT02135692|558838486|FG000|Overall Study|Protocol Violation|2|||
154837020|NCT02135692|558838486|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
154837021|NCT02135692|558838486|FG000|Overall Study|Product commercially available|159|||
154837022|NCT02135692|558838486|FG000|Overall Study|Study closed/terminated|153|||
154837023|NCT02135692|558838486|FG000|Overall Study|Lost to Follow-up|4|||
154837024|NCT02135692|558838486|FG000|Overall Study|Withdrawal by Subject|15|||
154837025|NCT01097746|558838487|FG000|Overall Study|Adverse Event|4|||
154837026|NCT01097746|558838487|FG000|Overall Study|taken off study before any treatment given|1|||
154837027|NCT00772954|558838488|FG000|Overall Study|Adverse Event|0|||
154837028|NCT00772954|558838489|FG001|Overall Study|Adverse Event|0|||
154837029|NCT00772954|558838490|FG002|Overall Study|Adverse Event|1|||
154837030|NCT02495844|558838494|FG000|Overall Study|Lack of Efficacy|1|||
154837031|NCT02495844|558838495|FG001|Overall Study|Lack of Efficacy|2|||
154837032|NCT02495844|558838494|FG000|Overall Study|AE, non-fatal|0|||
154837033|NCT02495844|558838495|FG001|Overall Study|AE, non-fatal|1|||
154837034|NCT02495844|558838494|FG000|Overall Study|Hepatitis Positivity|0|||
154837035|NCT02495844|558838495|FG001|Overall Study|Hepatitis Positivity|1|||
155102168|NCT01541865|559806531|FG000|Overall Study|Protocol Violation|1|||
155102169|NCT00049322|559806532|FG000|Overall Study|disease burden|0|||
155102170|NCT00049322|559806533|FG001|Overall Study|disease burden|3|||
155102171|NCT00049322|559806532|FG000|Overall Study|Adverse Event|1|||
155102172|NCT00049322|559806533|FG001|Overall Study|Adverse Event|0|||
155102173|NCT00049322|559806532|FG000|Overall Study|refused angio|0|||
154837036|NCT00623480|558838499|FG000|Overall Study|Lost to Follow-up|0|||
154837037|NCT00623480|558838500|FG001|Overall Study|Lost to Follow-up|1|||
154837038|NCT00623480|558838499|FG000|Overall Study|Withdrawal by Subject|2|||
154837039|NCT00623480|558838500|FG001|Overall Study|Withdrawal by Subject|4|||
154837040|NCT00623480|558838499|FG000|Overall Study|Lack of Efficacy|1|||
154837041|NCT00623480|558838500|FG001|Overall Study|Lack of Efficacy|0|||
154837042|NCT00623480|558838499|FG000|Overall Study|Non-compliant with study medication|4|||
154837043|NCT00623480|558838500|FG001|Overall Study|Non-compliant with study medication|0|||
154837044|NCT00623480|558838499|FG000|Overall Study|Protocol Violation|0|||
154837045|NCT00623480|558838500|FG001|Overall Study|Protocol Violation|1|||
154837046|NCT00623480|558838499|FG000|Overall Study|Site closed by sponsor|0|||
154837047|NCT00623480|558838500|FG001|Overall Study|Site closed by sponsor|1|||
154837048|NCT01594853|558838501|FG000|Overall Study|Withdrawal by Subject|1|||
154837049|NCT01594853|558838502|FG001|Overall Study|Withdrawal by Subject|1|||
154837050|NCT01594853|558838501|FG000|Overall Study|Lost to Follow-up|1|||
154837051|NCT01594853|558838502|FG001|Overall Study|Lost to Follow-up|1|||
154837052|NCT01594853|558838501|FG000|Overall Study|noncompliance with exercise|0|||
154837053|NCT01594853|558838502|FG001|Overall Study|noncompliance with exercise|1|||
154837054|NCT00711100|558838503|FG000|Overall Study|Lack of Efficacy|5|||
154837055|NCT00711100|558838503|FG000|Overall Study|Withdrawal by Subject|8|||
154837056|NCT00783094|558838504|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
154837057|NCT00783094|558838505|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
154837058|NCT00783094|558838506|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
154970407|NCT00668395|559315240|FG001|Overall Study|Withdrawal by Subject|4|||
154837059|NCT00783094|558838504|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
154837060|NCT00783094|558838505|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
154837061|NCT00783094|558838506|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
154837062|NCT00783094|558838504|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
154837063|NCT00783094|558838505|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
154837064|NCT00783094|558838506|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
154837065|NCT00783094|558838504|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
154837066|NCT00783094|558838505|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
154837067|NCT00783094|558838506|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
154837068|NCT00783094|558838504|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
154837069|NCT00783094|558838505|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
154837070|NCT00783094|558838506|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
154837071|NCT00783094|558838504|FG000|Open-Label Extension Period|Adverse Event|12|||
154970408|NCT00668395|559315241|FG002|Overall Study|Withdrawal by Subject|1|||
154970409|NCT00668395|559315239|FG000|Overall Study|Adverse Event|1|||
154970410|NCT00668395|559315240|FG001|Overall Study|Adverse Event|1|||
154970411|NCT00668395|559315241|FG002|Overall Study|Adverse Event|0|||
155172826|NCT05141448|560071914|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
154970412|NCT00668395|559315239|FG000|Overall Study|Physician Decision|1|||
154970413|NCT00668395|559315240|FG001|Overall Study|Physician Decision|1|||
154970414|NCT00668395|559315241|FG002|Overall Study|Physician Decision|0|||
154970415|NCT01670097|559315246|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
154970416|NCT01670097|559315247|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
154970417|NCT01670097|559315246|FG000|Overall Study|Study burden|1|||
154970418|NCT01670097|559315247|FG001|Overall Study|Study burden|0|||
154970419|NCT01670097|559315246|FG000|Overall Study|COPD exacerbation|0|||
154970420|NCT01670097|559315247|FG001|Overall Study|COPD exacerbation|1|||
155172827|NCT05141448|560071915|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
154970421|NCT01670097|559315246|FG000|Overall Study|Neutropenia|0|||
154970422|NCT01670097|559315247|FG001|Overall Study|Neutropenia|1|||
154970423|NCT01670097|559315246|FG000|Overall Study|Clinical deterioration|0|||
154970424|NCT01670097|559315247|FG001|Overall Study|Clinical deterioration|1|||
154970425|NCT01670097|559315246|FG000|Overall Study|Disease progression|0|||
154970426|NCT01670097|559315247|FG001|Overall Study|Disease progression|1|||
154970427|NCT01949532|559315248|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
154970428|NCT01949532|559315249|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
154970429|NCT05665387|559315250|FG000|Overall Study|Withdrawal by Subject|1|||
154970430|NCT05665387|559315251|FG001|Overall Study|Withdrawal by Subject|0|||
154970431|NCT05665387|559315252|FG002|Overall Study|Withdrawal by Subject|1|||
154970432|NCT01824498|559315253|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
154970433|NCT01824498|559315254|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
154970434|NCT01824498|559315255|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
154970435|NCT01824498|559315256|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
154970436|NCT01824498|559315257|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
154970437|NCT01824498|559315258|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
154970438|NCT01567527|559315259|FG000|Conversion Phase.|Protocol deviation|3|||
154970439|NCT01567527|559315260|FG001|Conversion Phase.|Protocol deviation|0|||
154970440|NCT01567527|559315261|FG002|Conversion Phase.|Protocol deviation|0|||
154970441|NCT01567527|559315262|FG003|Conversion Phase.|Protocol deviation|0|||
154970442|NCT01567527|559315263|FG004|Conversion Phase.|Protocol deviation|0|||
154970443|NCT01567527|559315259|FG000|Conversion Phase.|Met withdrawal criteria|10|||
154970444|NCT01567527|559315260|FG001|Conversion Phase.|Met withdrawal criteria|0|||
154970445|NCT01567527|559315261|FG002|Conversion Phase.|Met withdrawal criteria|0|||
154970446|NCT01567527|559315262|FG003|Conversion Phase.|Met withdrawal criteria|0|||
154837072|NCT00783094|558838505|FG001|Open-Label Extension Period|Adverse Event|7|||
154837073|NCT00783094|558838506|FG002|Open-Label Extension Period|Adverse Event|16|||
154837074|NCT00783094|558838504|FG000|Open-Label Extension Period|Death|0|||
154837075|NCT00783094|558838505|FG001|Open-Label Extension Period|Death|0|||
154837076|NCT00783094|558838506|FG002|Open-Label Extension Period|Death|1|||
154837077|NCT00783094|558838504|FG000|Open-Label Extension Period|Protocol Violation|4|||
154837078|NCT00783094|558838505|FG001|Open-Label Extension Period|Protocol Violation|5|||
154837079|NCT00783094|558838506|FG002|Open-Label Extension Period|Protocol Violation|7|||
154837080|NCT00783094|558838504|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
154837081|NCT00783094|558838505|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
154837082|NCT00783094|558838506|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
154970447|NCT01567527|559315263|FG004|Conversion Phase.|Met withdrawal criteria|0|||
154837083|NCT00783094|558838504|FG000|Open-Label Extension Period|Physician Decision|4|||
154837084|NCT00783094|558838505|FG001|Open-Label Extension Period|Physician Decision|2|||
154837085|NCT00783094|558838506|FG002|Open-Label Extension Period|Physician Decision|3|||
154837086|NCT00783094|558838504|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
154837087|NCT00783094|558838505|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
154837088|NCT00783094|558838506|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
154837089|NCT02513329|558838507|FG000|Overall Study|Lost to Follow-up|5|||
154837090|NCT02513329|558838508|FG001|Overall Study|Lost to Follow-up|2|||
154837091|NCT03808077|558838509|FG000|Overall Study|Physician Decision|2|||
154837092|NCT03808077|558838510|FG001|Overall Study|Physician Decision|3|||
154837093|NCT03808077|558838509|FG000|Overall Study|Withdrawal by Subject|1|||
154837094|NCT03808077|558838510|FG001|Overall Study|Withdrawal by Subject|0|||
154837095|NCT03808077|558838509|FG000|Overall Study|Equipment Issues|2|||
154837096|NCT03808077|558838510|FG001|Overall Study|Equipment Issues|1|||
154837097|NCT03703102|558838513|FG000|Overall Study|Adverse Event|4|||
154837098|NCT03703102|558838514|FG001|Overall Study|Adverse Event|3|||
154837099|NCT03703102|558838515|FG002|Overall Study|Adverse Event|7|||
154837100|NCT03703102|558838516|FG003|Overall Study|Adverse Event|3|||
154837101|NCT03703102|558838517|FG004|Overall Study|Adverse Event|13|||
154837102|NCT03703102|558838513|FG000|Overall Study|Lack of Efficacy|4|||
154837103|NCT03703102|558838514|FG001|Overall Study|Lack of Efficacy|0|||
154837104|NCT03703102|558838515|FG002|Overall Study|Lack of Efficacy|1|||
154837105|NCT03703102|558838516|FG003|Overall Study|Lack of Efficacy|4|||
154837106|NCT03703102|558838517|FG004|Overall Study|Lack of Efficacy|1|||
154837107|NCT03703102|558838513|FG000|Overall Study|Lost to Follow-up|0|||
154837108|NCT03703102|558838514|FG001|Overall Study|Lost to Follow-up|0|||
154837109|NCT03703102|558838515|FG002|Overall Study|Lost to Follow-up|1|||
154837110|NCT03703102|558838516|FG003|Overall Study|Lost to Follow-up|2|||
154837111|NCT03703102|558838517|FG004|Overall Study|Lost to Follow-up|2|||
154837112|NCT03703102|558838513|FG000|Overall Study|Physician Decision|2|||
154837113|NCT03703102|558838514|FG001|Overall Study|Physician Decision|2|||
154837114|NCT03703102|558838515|FG002|Overall Study|Physician Decision|2|||
154837115|NCT03703102|558838516|FG003|Overall Study|Physician Decision|2|||
154837116|NCT03703102|558838517|FG004|Overall Study|Physician Decision|4|||
154837117|NCT03703102|558838513|FG000|Overall Study|Withdrawal by Subject|7|||
154837118|NCT03703102|558838514|FG001|Overall Study|Withdrawal by Subject|5|||
154837119|NCT03703102|558838515|FG002|Overall Study|Withdrawal by Subject|5|||
154837120|NCT03703102|558838516|FG003|Overall Study|Withdrawal by Subject|5|||
154837121|NCT03703102|558838517|FG004|Overall Study|Withdrawal by Subject|9|||
154837122|NCT03703102|558838513|FG000|Overall Study|Ineligibility|0|||
154837123|NCT03703102|558838514|FG001|Overall Study|Ineligibility|0|||
154837124|NCT03703102|558838515|FG002|Overall Study|Ineligibility|1|||
154970448|NCT01567527|559315259|FG000|Conversion Phase.|Withdrawal by Subject|32|||
154970449|NCT01567527|559315260|FG001|Conversion Phase.|Withdrawal by Subject|0|||
154837125|NCT03703102|558838516|FG003|Overall Study|Ineligibility|0|||
154837126|NCT03703102|558838517|FG004|Overall Study|Ineligibility|0|||
154837127|NCT03703102|558838513|FG000|Overall Study|Protocol Deviation|4|||
154837128|NCT03703102|558838514|FG001|Overall Study|Protocol Deviation|4|||
154837129|NCT03703102|558838515|FG002|Overall Study|Protocol Deviation|3|||
154837130|NCT03703102|558838516|FG003|Overall Study|Protocol Deviation|0|||
154837131|NCT03703102|558838517|FG004|Overall Study|Protocol Deviation|0|||
154837132|NCT03703102|558838513|FG000|Overall Study|Non-Compliance with Study Drug|1|||
154837133|NCT03703102|558838514|FG001|Overall Study|Non-Compliance with Study Drug|1|||
154837134|NCT03703102|558838515|FG002|Overall Study|Non-Compliance with Study Drug|2|||
154837135|NCT03703102|558838516|FG003|Overall Study|Non-Compliance with Study Drug|1|||
154837136|NCT03703102|558838517|FG004|Overall Study|Non-Compliance with Study Drug|4|||
154837137|NCT02311153|558838518|FG000|Overall Study|Lost to Follow-up|5|||
154837138|NCT02311153|558838519|FG001|Overall Study|Lost to Follow-up|7|||
154837139|NCT01650636|558838524|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
154837140|NCT01650636|558838525|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
154837141|NCT01650636|558838524|FG000|Washout up to 5 Months|Physician Decision|2|||
154837142|NCT01650636|558838525|FG001|Washout up to 5 Months|Physician Decision|2|||
154837143|NCT01650636|558838524|FG000|Washout up to 5 Months|Death|1|||
154837144|NCT01650636|558838525|FG001|Washout up to 5 Months|Death|0|||
154837145|NCT01650636|558838524|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
154837146|NCT01650636|558838525|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
154837147|NCT01650636|558838524|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
154970450|NCT01567527|559315261|FG002|Conversion Phase.|Withdrawal by Subject|0|||
154970451|NCT01567527|559315262|FG003|Conversion Phase.|Withdrawal by Subject|0|||
154970452|NCT01567527|559315263|FG004|Conversion Phase.|Withdrawal by Subject|0|||
154970453|NCT01567527|559315259|FG000|Conversion Phase.|Lost to Follow-up|16|||
154970454|NCT01567527|559315260|FG001|Conversion Phase.|Lost to Follow-up|0|||
154970455|NCT01567527|559315261|FG002|Conversion Phase.|Lost to Follow-up|0|||
154837148|NCT01650636|558838525|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
154837149|NCT01650636|558838524|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
154837150|NCT01650636|558838525|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
154837151|NCT01560780|558838526|FG000|Overall Study|Death|2|||
154970456|NCT01567527|559315262|FG003|Conversion Phase.|Lost to Follow-up|0|||
154970457|NCT01567527|559315263|FG004|Conversion Phase.|Lost to Follow-up|0|||
154837152|NCT01560780|558838527|FG001|Overall Study|Death|1|||
154837153|NCT01560780|558838526|FG000|Overall Study|Patient Preference|11|||
154970458|NCT01567527|559315259|FG000|Conversion Phase.|Lack of Efficacy|2|||
155102174|NCT00049322|559806533|FG001|Overall Study|refused angio|3|||
155102175|NCT04872569|559806536|FG000|Overall Study|Withdrawal by Subject|2|||
155172828|NCT05141448|560071916|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155172829|NCT05141448|560071911|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155172830|NCT05141448|560071912|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155172831|NCT05141448|560071913|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155172832|NCT05141448|560071914|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155172833|NCT05141448|560071915|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155172834|NCT05141448|560071916|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
155172835|NCT05141448|560071911|FG000|Period 2|COVID-19 Related|0|||
155172836|NCT05141448|560071912|FG001|Period 2|COVID-19 Related|0|||
155172837|NCT05141448|560071913|FG002|Period 2|COVID-19 Related|0|||
155172838|NCT05141448|560071914|FG003|Period 2|COVID-19 Related|1|||
155172839|NCT05141448|560071915|FG004|Period 2|COVID-19 Related|0|||
155172840|NCT05141448|560071916|FG005|Period 2|COVID-19 Related|1|||
155172841|NCT05141448|560071911|FG000|3|Covid-19 related|2|||
155172842|NCT05141448|560071912|FG001|3|Covid-19 related|0|||
155172843|NCT05141448|560071913|FG002|3|Covid-19 related|0|||
155172844|NCT05141448|560071914|FG003|3|Covid-19 related|0|||
155172845|NCT05141448|560071915|FG004|3|Covid-19 related|0|||
155172846|NCT05141448|560071916|FG005|3|Covid-19 related|1|||
155172847|NCT05141448|560071911|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
155172848|NCT05141448|560071912|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
155172849|NCT05141448|560071913|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
155172850|NCT05141448|560071914|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
155172851|NCT05141448|560071915|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
155172852|NCT05141448|560071916|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
155172853|NCT02238067|560073212|FG000|Overall Study|Not completed survey at Month 6|45|||
155172854|NCT01853839|560073213|FG000|Overall Study|Violated inclusion criteria|2|||
155172855|NCT01853839|560073213|FG000|Overall Study|Not meet ITT population definition|58|||
155172856|NCT01853839|560073213|FG000|Overall Study|End of treatment visit too early|33|||
154837154|NCT01560780|558838527|FG001|Overall Study|Patient Preference|11|||
154970459|NCT01567527|559315260|FG001|Conversion Phase.|Lack of Efficacy|0|||
154970460|NCT01567527|559315261|FG002|Conversion Phase.|Lack of Efficacy|0|||
155172857|NCT01853839|560073213|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
155172858|NCT02743611|560073216|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
155172859|NCT02743611|560073217|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
155172860|NCT02743611|560073218|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
155172861|NCT02743611|560073219|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
155172862|NCT00600119|560073220|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
155172863|NCT00600119|560073221|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
155172864|NCT00600119|560073222|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
155172865|NCT00600119|560073223|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
155172866|NCT00600119|560073224|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
155172867|NCT00600119|560073225|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
155172868|NCT00600119|560073220|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155172869|NCT00600119|560073221|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
155172870|NCT00600119|560073222|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
155172871|NCT00600119|560073223|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155172872|NCT00600119|560073224|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155172873|NCT00600119|560073225|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155172874|NCT00600119|560073220|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155172875|NCT00600119|560073221|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155172876|NCT00600119|560073222|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
155172877|NCT00600119|560073223|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155172878|NCT00600119|560073224|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
155172879|NCT00600119|560073225|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
155172880|NCT00600119|560073220|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
155172881|NCT00600119|560073221|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155172882|NCT00600119|560073222|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155172883|NCT00600119|560073223|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155172884|NCT00600119|560073224|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155172885|NCT00600119|560073225|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
155172886|NCT00600119|560073220|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
155172887|NCT00600119|560073221|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
155172888|NCT00600119|560073222|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
155172889|NCT00600119|560073223|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
155172890|NCT00600119|560073224|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
155172891|NCT00600119|560073225|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
155172892|NCT00600119|560073220|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
155172893|NCT00600119|560073221|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
155172894|NCT00600119|560073222|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155172895|NCT00600119|560073223|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155172896|NCT00600119|560073224|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155172897|NCT00600119|560073225|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
155172898|NCT00600119|560073220|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
155172899|NCT00600119|560073221|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155172900|NCT00600119|560073222|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155172901|NCT00600119|560073223|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
155172902|NCT00600119|560073224|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
155172903|NCT00600119|560073225|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
155172904|NCT00600119|560073220|FG000|Double-blind Treatment Period|Other|0|||
155172905|NCT00600119|560073221|FG001|Double-blind Treatment Period|Other|0|||
155172906|NCT00600119|560073222|FG002|Double-blind Treatment Period|Other|0|||
155172907|NCT00600119|560073223|FG003|Double-blind Treatment Period|Other|0|||
155172908|NCT00600119|560073224|FG004|Double-blind Treatment Period|Other|2|||
155172909|NCT00600119|560073225|FG005|Double-blind Treatment Period|Other|1|||
155172910|NCT00600119|560073220|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155172911|NCT00600119|560073221|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
155172912|NCT00600119|560073222|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155172913|NCT00600119|560073223|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155172914|NCT00600119|560073224|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
155172915|NCT00600119|560073225|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
155172916|NCT00600119|560073220|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155172917|NCT00600119|560073221|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
155172918|NCT00600119|560073222|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155172919|NCT00600119|560073223|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155172920|NCT00600119|560073224|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155172921|NCT00600119|560073225|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
155172922|NCT00600119|560073220|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
155172923|NCT00600119|560073221|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
155172924|NCT00600119|560073222|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
155172925|NCT00600119|560073223|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
155172926|NCT00600119|560073224|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
155172927|NCT00600119|560073225|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
155172928|NCT00600119|560073220|FG000|Double-blind Treatment Period|Physician Decision|2|||
155172929|NCT00600119|560073221|FG001|Double-blind Treatment Period|Physician Decision|0|||
155172930|NCT00600119|560073222|FG002|Double-blind Treatment Period|Physician Decision|0|||
155172931|NCT00600119|560073223|FG003|Double-blind Treatment Period|Physician Decision|0|||
155172932|NCT00600119|560073224|FG004|Double-blind Treatment Period|Physician Decision|0|||
155172933|NCT00600119|560073225|FG005|Double-blind Treatment Period|Physician Decision|0|||
155172934|NCT00600119|560073220|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
154837155|NCT02797808|558838528|FG000|Overall Study|Withdrawal by Subject|1|||
155172935|NCT00600119|560073221|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
155172936|NCT00600119|560073222|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155172937|NCT00600119|560073223|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155172938|NCT00600119|560073224|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
155172939|NCT00600119|560073225|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
155172940|NCT00600119|560073220|FG000|Double-blind Treatment Period|Adverse Event|1|||
155172941|NCT00600119|560073221|FG001|Double-blind Treatment Period|Adverse Event|1|||
155172942|NCT00600119|560073222|FG002|Double-blind Treatment Period|Adverse Event|0|||
155172943|NCT00600119|560073223|FG003|Double-blind Treatment Period|Adverse Event|1|||
155172944|NCT00600119|560073224|FG004|Double-blind Treatment Period|Adverse Event|2|||
155172945|NCT00600119|560073225|FG005|Double-blind Treatment Period|Adverse Event|10|||
155172946|NCT00600119|560073220|FG000|Follow-up Period|Adverse Event|0|||
155172947|NCT00600119|560073221|FG001|Follow-up Period|Adverse Event|0|||
155172948|NCT00600119|560073222|FG002|Follow-up Period|Adverse Event|0|||
155172949|NCT00600119|560073223|FG003|Follow-up Period|Adverse Event|0|||
155172950|NCT00600119|560073224|FG004|Follow-up Period|Adverse Event|0|||
155172951|NCT00600119|560073225|FG005|Follow-up Period|Adverse Event|1|||
155172952|NCT00600119|560073220|FG000|Follow-up Period|Other|1|||
155172953|NCT00600119|560073221|FG001|Follow-up Period|Other|0|||
155172954|NCT00600119|560073222|FG002|Follow-up Period|Other|0|||
155172955|NCT00600119|560073223|FG003|Follow-up Period|Other|0|||
155172956|NCT00600119|560073224|FG004|Follow-up Period|Other|0|||
155172957|NCT00600119|560073225|FG005|Follow-up Period|Other|0|||
155172958|NCT00729469|560073226|FG000|Overall Study|Adverse Event|14|||
155172959|NCT00729469|560073227|FG001|Overall Study|Adverse Event|25|||
155172960|NCT00729469|560073226|FG000|Overall Study|Lost to Follow-up|9|||
155172961|NCT00729469|560073227|FG001|Overall Study|Lost to Follow-up|9|||
155172962|NCT00729469|560073226|FG000|Overall Study|Protocol Violation|2|||
155172963|NCT00729469|560073227|FG001|Overall Study|Protocol Violation|1|||
155172964|NCT00729469|560073226|FG000|Overall Study|Withdrawal by Subject|19|||
155172965|NCT00729469|560073227|FG001|Overall Study|Withdrawal by Subject|8|||
155172966|NCT00729469|560073226|FG000|Overall Study|Other-Not mentioned|9|||
155172967|NCT00729469|560073227|FG001|Overall Study|Other-Not mentioned|4|||
155172968|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
155172969|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
155172970|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Adverse Event|7|||
155172971|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Adverse Event|6|||
155172972|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
155172973|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
155172974|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Physician Decision|4|||
155172975|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Physician Decision|4|||
155172976|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
155172977|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
155172978|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
155172979|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
155172980|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
155102176|NCT01890265|559806543|FG000|Overall Study|Other (Unspecified reason)|0|||
155102177|NCT01890265|559806544|FG001|Overall Study|Other (Unspecified reason)|1|||
155102178|NCT01890265|559806545|FG002|Overall Study|Other (Unspecified reason)|0|||
155102179|NCT01890265|559806546|FG003|Overall Study|Other (Unspecified reason)|0|||
155102180|NCT01890265|559806547|FG004|Overall Study|Other (Unspecified reason)|0|||
155102181|NCT01890265|559806548|FG005|Overall Study|Other (Unspecified reason)|0|||
155102182|NCT01890265|559806543|FG000|Overall Study|Progressive disease|6|||
155102183|NCT01890265|559806544|FG001|Overall Study|Progressive disease|6|||
155102184|NCT01890265|559806545|FG002|Overall Study|Progressive disease|0|||
155102185|NCT01890265|559806546|FG003|Overall Study|Progressive disease|0|||
155102186|NCT01890265|559806547|FG004|Overall Study|Progressive disease|0|||
155102187|NCT01890265|559806548|FG005|Overall Study|Progressive disease|0|||
155102188|NCT01890265|559806543|FG000|Overall Study|Adverse Event|2|||
155102189|NCT01890265|559806544|FG001|Overall Study|Adverse Event|1|||
155102190|NCT01890265|559806545|FG002|Overall Study|Adverse Event|0|||
155102191|NCT01890265|559806546|FG003|Overall Study|Adverse Event|0|||
155102192|NCT01890265|559806547|FG004|Overall Study|Adverse Event|0|||
155102193|NCT01890265|559806548|FG005|Overall Study|Adverse Event|0|||
155102194|NCT01890265|559806543|FG000|Overall Study|Death|2|||
155102195|NCT01890265|559806544|FG001|Overall Study|Death|3|||
155172981|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
155172982|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Non-compliance|1|||
155172983|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Non-compliance|0|||
155172984|NCT00470834|560073228|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
155172985|NCT00470834|560073229|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
155172986|NCT00470834|560073228|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
155172987|NCT00470834|560073229|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
155172988|NCT00470834|560073228|FG000|Extension Period (24 Months)|Adverse Event|3|||
155172989|NCT00470834|560073229|FG001|Extension Period (24 Months)|Adverse Event|4|||
155172990|NCT00470834|560073228|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
155172991|NCT00470834|560073229|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
155172992|NCT00470834|560073228|FG000|Extension Period (24 Months)|Physician Decision|4|||
155172993|NCT00470834|560073229|FG001|Extension Period (24 Months)|Physician Decision|3|||
155172994|NCT00470834|560073228|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
154837156|NCT02797808|558838529|FG001|Overall Study|Withdrawal by Subject|1|||
155172995|NCT00470834|560073229|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
155172996|NCT00470834|560073228|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
155172997|NCT00470834|560073229|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
155172998|NCT00470834|560073228|FG000|Extension Period (24 Months)|Non-compliance|0|||
155172999|NCT00470834|560073229|FG001|Extension Period (24 Months)|Non-compliance|1|||
155173000|NCT00470834|560073228|FG000|Extension Period (24 Months)|Disease Progression|0|||
155173001|NCT00470834|560073229|FG001|Extension Period (24 Months)|Disease Progression|1|||
155173002|NCT00561977|560073230|FG000|Overall Study|Withdrawal by Subject|0|||
155173003|NCT00561977|560073231|FG001|Overall Study|Withdrawal by Subject|2|||
155173004|NCT00561977|560073232|FG002|Overall Study|Withdrawal by Subject|1|||
155173005|NCT00561977|560073230|FG000|Overall Study|Pregnancy|0|||
155173006|NCT00561977|560073231|FG001|Overall Study|Pregnancy|1|||
155173007|NCT00561977|560073232|FG002|Overall Study|Pregnancy|1|||
155173008|NCT00566696|560073233|FG000|Overall Study|Met Exclusion Criteria|2|||
155173009|NCT00566696|560073233|FG000|Overall Study|Muromonab not available|1|||
155173010|NCT00566696|560073233|FG000|Overall Study|Health Status Change|1|||
155173011|NCT00566696|560073233|FG000|Overall Study|Physician Decision|1|||
155173012|NCT00566696|560073233|FG000|Overall Study|Non-Patient Donors|37|||
155173013|NCT00275340|560073237|FG000|Overall Study|Lost to Follow-up|2|||
155173014|NCT00275340|560073238|FG001|Overall Study|Lost to Follow-up|4|||
155173015|NCT01950013|560073239|FG000|Overall Study|Withdrawal by Subject|0|||
155173016|NCT01950013|560073240|FG001|Overall Study|Withdrawal by Subject|2|||
155173017|NCT01950013|560073241|FG002|Overall Study|Withdrawal by Subject|0|||
155173018|NCT02365480|560073242|FG000|Overall Study|Withdrawal by Subject|2|||
155173019|NCT02365480|560073243|FG001|Overall Study|Withdrawal by Subject|0|||
155173020|NCT00706342|560073244|FG000|Overall Study|Adverse Event|3|||
155173021|NCT00706342|560073244|FG000|Overall Study|Not responding to treatment|2|||
155173022|NCT00706342|560073244|FG000|Overall Study|Withdrawn due to failure to respond|1|||
155173023|NCT00706342|560073244|FG000|Overall Study|Death|1|||
154837157|NCT02797808|558838528|FG000|Overall Study|Physician Decision|6|||
154837158|NCT02797808|558838529|FG001|Overall Study|Physician Decision|2|||
154837159|NCT02192827|558838530|FG000|Overall Study|Lost to Follow-up|25|||
154837160|NCT02192827|558838531|FG001|Overall Study|Lost to Follow-up|27|||
154837161|NCT02192827|558838530|FG000|Overall Study|Given additional steroids with admission|13|||
154837162|NCT02192827|558838531|FG001|Overall Study|Given additional steroids with admission|11|||
154837163|NCT00535132|558838536|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
154837164|NCT00535132|558838537|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
154837165|NCT00535132|558838536|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
154970461|NCT01567527|559315262|FG003|Conversion Phase.|Lack of Efficacy|0|||
155173024|NCT00706342|560073244|FG000|Overall Study|Withdrew from the study on his own.|1|||
155173025|NCT00706342|560073244|FG000|Overall Study|Investigator discretion|2|||
155173026|NCT00706342|560073244|FG000|Overall Study|Non-responder Week 12|1|||
155173027|NCT00706342|560073244|FG000|Overall Study|Ongoing|6|||
155173028|NCT00706342|560073244|FG000|Overall Study|WIthdrawal of consent|1|||
155173029|NCT01781299|560073249|FG000|Overall Study|Withdrawal by Subject|0|||
155173030|NCT01781299|560073250|FG001|Overall Study|Withdrawal by Subject|1|||
154970462|NCT01567527|559315263|FG004|Conversion Phase.|Lack of Efficacy|0|||
155173031|NCT02395172|560073255|FG000|Overall Study|Participants randomized but not treated|3|||
155173032|NCT02395172|560073256|FG001|Overall Study|Participants randomized but not treated|31|||
155173033|NCT02032238|560073257|FG000|Overall Study|Lost to Follow-up|2|||
155173034|NCT02032238|560073258|FG001|Overall Study|Lost to Follow-up|0|||
155173035|NCT00653939|560073259|FG000|Overall Study|Adverse Event|1|||
155173036|NCT00653939|560073260|FG001|Overall Study|Adverse Event|3|||
155173037|NCT00653939|560073259|FG000|Overall Study|Withdrawal by Subject|3|||
155173038|NCT00653939|560073260|FG001|Overall Study|Withdrawal by Subject|3|||
155173039|NCT00653939|560073259|FG000|Overall Study|Physician Decision|4|||
155173040|NCT00653939|560073260|FG001|Overall Study|Physician Decision|0|||
155173041|NCT00653939|560073259|FG000|Overall Study|Disease Progression|2|||
155173042|NCT00653939|560073260|FG001|Overall Study|Disease Progression|3|||
155173043|NCT00653939|560073259|FG000|Overall Study|Other|2|||
155173044|NCT00653939|560073260|FG001|Overall Study|Other|6|||
155173045|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
155173046|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
155173047|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
155173048|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
155173049|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
155173050|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
155173051|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
155173052|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
155173053|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
155173054|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
155173055|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
155173056|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
155173057|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
155173058|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
155173059|NCT00612105|560073261|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
155173060|NCT00612105|560073262|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
155173061|NCT00612105|560073261|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
155173062|NCT00612105|560073262|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
155173063|NCT00612105|560073261|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
155173064|NCT00612105|560073262|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
155173065|NCT00612105|560073261|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
155173066|NCT00612105|560073262|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
154837166|NCT00535132|558838537|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
154837167|NCT00264875|558838538|FG000|Overall Study|Adverse Event|6|||
154837168|NCT00264875|558838538|FG000|Overall Study|Lost to Follow-up|6|||
154837169|NCT00264875|558838538|FG000|Overall Study|Protocol Violation|11|||
154837170|NCT00264875|558838538|FG000|Overall Study|Withdrawal by Subject|7|||
154837171|NCT01500278|558838540|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
154837172|NCT01500278|558838541|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
154837173|NCT01500278|558838540|FG000|Week 0 - Week 12|Protocol Violation|10|||
154837174|NCT01500278|558838541|FG001|Week 0 - Week 12|Protocol Violation|16|||
154837175|NCT01500278|558838540|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
154837176|NCT01500278|558838541|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
154837177|NCT01500278|558838540|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
154837178|NCT01500278|558838541|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
154837179|NCT01500278|558838540|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
154837180|NCT01500278|558838541|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
154837181|NCT01500278|558838540|FG000|Week 0 - Week 12|Patient decision|1|||
154837182|NCT01500278|558838541|FG001|Week 0 - Week 12|Patient decision|0|||
154837183|NCT01500278|558838540|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
154837184|NCT01500278|558838541|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
155102196|NCT01890265|559806545|FG002|Overall Study|Death|1|||
155102197|NCT01890265|559806546|FG003|Overall Study|Death|0|||
155102198|NCT01890265|559806547|FG004|Overall Study|Death|0|||
155102199|NCT01890265|559806548|FG005|Overall Study|Death|0|||
155102200|NCT01890265|559806543|FG000|Overall Study|Withdrawal by Subject|0|||
155102201|NCT01890265|559806544|FG001|Overall Study|Withdrawal by Subject|2|||
155102202|NCT01890265|559806545|FG002|Overall Study|Withdrawal by Subject|3|||
155102203|NCT01890265|559806546|FG003|Overall Study|Withdrawal by Subject|0|||
155102204|NCT01890265|559806547|FG004|Overall Study|Withdrawal by Subject|2|||
155102205|NCT01890265|559806548|FG005|Overall Study|Withdrawal by Subject|0|||
155102206|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
155102207|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
155102208|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
155102209|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
155102210|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
155102211|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
155102212|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
155102213|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
155102214|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
155102215|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
155102216|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
155102217|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
155102218|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
154837185|NCT01500278|558838540|FG000|Week 0 - Week 12|Investigator decision|1|||
154837186|NCT01500278|558838541|FG001|Week 0 - Week 12|Investigator decision|0|||
154837187|NCT01500278|558838540|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
155173067|NCT00612105|560073261|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
155173068|NCT00612105|560073262|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
155173069|NCT00475982|560073263|FG000|Overall Study|surgery rescheduled|7|||
155173070|NCT00475982|560073264|FG001|Overall Study|surgery rescheduled|3|||
155173071|NCT01105767|560073265|FG000|Overall Study|Lost to Follow-up|1160|||
155173072|NCT01105767|560073266|FG001|Overall Study|Lost to Follow-up|1614|||
155173073|NCT01105767|560073267|FG002|Overall Study|Lost to Follow-up|1184|||
155173074|NCT00783198|560073276|FG000|Overall Study|Adverse Event|15|||
154970463|NCT01567527|559315259|FG000|Conversion Phase.|Adverse Event|33|||
155173075|NCT00783198|560073277|FG001|Overall Study|Adverse Event|19|||
155173076|NCT00783198|560073278|FG002|Overall Study|Adverse Event|3|||
154970464|NCT01567527|559315260|FG001|Conversion Phase.|Adverse Event|0|||
155173077|NCT00783198|560073276|FG000|Overall Study|Lost to Follow-up|11|||
154837188|NCT01500278|558838541|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
154837189|NCT01500278|558838540|FG000|Week 0 - Week 12|Sponsor decision|1|||
154837190|NCT01500278|558838541|FG001|Week 0 - Week 12|Sponsor decision|0|||
154837191|NCT01500278|558838540|FG000|Week 0 - Week 12|Personal reason|0|||
154837192|NCT01500278|558838541|FG001|Week 0 - Week 12|Personal reason|1|||
154837193|NCT01500278|558838540|FG000|Week 0 - Week 12|Other serious disease|0|||
154837194|NCT01500278|558838541|FG001|Week 0 - Week 12|Other serious disease|1|||
154837195|NCT01500278|558838540|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
154837196|NCT01500278|558838541|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
154837197|NCT01500278|558838540|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
154837198|NCT01500278|558838541|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
154837199|NCT01500278|558838540|FG000|Week 13 - Week 104|Protocol Violation|6|||
154837200|NCT01500278|558838541|FG001|Week 13 - Week 104|Protocol Violation|6|||
154837201|NCT01500278|558838540|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
154837202|NCT01500278|558838541|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
154837203|NCT01500278|558838540|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
154837204|NCT01500278|558838541|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
154837205|NCT01500278|558838540|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
154837206|NCT01500278|558838541|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
154837207|NCT01500278|558838540|FG000|Week 13 - Week 104|Non/bad compliance|7|||
154837208|NCT01500278|558838541|FG001|Week 13 - Week 104|Non/bad compliance|5|||
154837209|NCT01500278|558838540|FG000|Week 13 - Week 104|Recurrent infections|1|||
154837210|NCT01500278|558838541|FG001|Week 13 - Week 104|Recurrent infections|0|||
154837211|NCT01500278|558838540|FG000|Week 13 - Week 104|False positive test|1|||
154837212|NCT01500278|558838541|FG001|Week 13 - Week 104|False positive test|2|||
154837213|NCT01500278|558838540|FG000|Week 13 - Week 104|Sponsor request|4|||
154837214|NCT01500278|558838541|FG001|Week 13 - Week 104|Sponsor request|0|||
154837215|NCT01500278|558838540|FG000|Week 13 - Week 104|Withdrawn in error|1|||
154837216|NCT01500278|558838541|FG001|Week 13 - Week 104|Withdrawn in error|0|||
154837217|NCT01500278|558838540|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
154837218|NCT01500278|558838541|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
154837219|NCT01500278|558838540|FG000|Week 13 - Week 104|Protocol deviation|1|||
154837220|NCT01500278|558838541|FG001|Week 13 - Week 104|Protocol deviation|0|||
154837221|NCT01500278|558838540|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
154837222|NCT01500278|558838541|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
154837223|NCT01500278|558838540|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
154837224|NCT01500278|558838541|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
154837225|NCT01500278|558838540|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
154837226|NCT01500278|558838541|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
154837227|NCT01500278|558838540|FG000|Week 13 - Week 104|Relocation|0|||
154837228|NCT01500278|558838541|FG001|Week 13 - Week 104|Relocation|1|||
154837229|NCT01500278|558838540|FG000|Week 13 - Week 104|Sponsor decision|0|||
154837230|NCT01500278|558838541|FG001|Week 13 - Week 104|Sponsor decision|2|||
154837231|NCT01500278|558838540|FG000|Week 13 - Week 104|Medical monitor decision|0|||
154837232|NCT01500278|558838541|FG001|Week 13 - Week 104|Medical monitor decision|2|||
154837233|NCT01500278|558838540|FG000|Week 13 - Week 104|Personal reason|0|||
154837234|NCT01500278|558838541|FG001|Week 13 - Week 104|Personal reason|1|||
154837235|NCT01500278|558838540|FG000|Week 13 - Week 104|Not completed|0|||
154837236|NCT01500278|558838541|FG001|Week 13 - Week 104|Not completed|1|||
154837237|NCT01500278|558838540|FG000|Week 13 - Week 104|Death|2|||
154837238|NCT01500278|558838541|FG001|Week 13 - Week 104|Death|4|||
154970465|NCT01567527|559315261|FG002|Conversion Phase.|Adverse Event|0|||
154970466|NCT01567527|559315262|FG003|Conversion Phase.|Adverse Event|0|||
154970467|NCT01567527|559315263|FG004|Conversion Phase.|Adverse Event|0|||
154970468|NCT01567527|559315259|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
154970469|NCT01567527|559315260|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
154970470|NCT01567527|559315261|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
154970471|NCT01567527|559315262|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
154970472|NCT01567527|559315263|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
154970473|NCT01567527|559315259|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
154970474|NCT01567527|559315260|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
154970475|NCT01567527|559315261|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
154970476|NCT01567527|559315262|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
154970477|NCT01567527|559315263|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
154970478|NCT01567527|559315259|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
154970479|NCT01567527|559315260|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
154837239|NCT01500278|558838540|FG000|Week 13 - Week 104|Adverse Event|54|||
154837240|NCT01500278|558838541|FG001|Week 13 - Week 104|Adverse Event|54|||
154970480|NCT01567527|559315261|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
155102219|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
155102220|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
155102221|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155102222|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
155102223|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155102224|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155102225|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
155102226|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
155102227|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
155102228|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
155102229|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
155102230|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
155102231|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155102232|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
155102233|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155102234|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155102235|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
155102236|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
155102237|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155102238|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155102239|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
155102240|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
154970481|NCT01567527|559315262|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
154970482|NCT01567527|559315263|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
155173078|NCT00783198|560073277|FG001|Overall Study|Lost to Follow-up|1|||
155173079|NCT00783198|560073278|FG002|Overall Study|Lost to Follow-up|7|||
155173080|NCT00783198|560073276|FG000|Overall Study|Withdrawal by Subject|22|||
155173081|NCT00783198|560073277|FG001|Overall Study|Withdrawal by Subject|14|||
155173082|NCT00783198|560073278|FG002|Overall Study|Withdrawal by Subject|20|||
155173083|NCT00783198|560073276|FG000|Overall Study|Noncompliance with protocol|7|||
155173084|NCT00783198|560073277|FG001|Overall Study|Noncompliance with protocol|7|||
155173085|NCT00783198|560073278|FG002|Overall Study|Noncompliance with protocol|10|||
155173086|NCT00783198|560073276|FG000|Overall Study|Did not meet protocol eligibility|0|||
155173087|NCT00783198|560073277|FG001|Overall Study|Did not meet protocol eligibility|1|||
155173088|NCT00783198|560073278|FG002|Overall Study|Did not meet protocol eligibility|0|||
155173089|NCT00783198|560073276|FG000|Overall Study|Administrative|2|||
155173090|NCT00783198|560073277|FG001|Overall Study|Administrative|1|||
155173091|NCT00783198|560073278|FG002|Overall Study|Administrative|2|||
155173092|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
155173093|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
155173094|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
155173095|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
155173096|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
155173097|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
155173098|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
155173099|NCT00946985|560073279|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
155173100|NCT00946985|560073279|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
155173101|NCT00271505|560073280|FG000|Overall Study|Screen Failure|3|||
155173102|NCT00271505|560073280|FG000|Overall Study|Adverse Event|1|||
155173103|NCT00271505|560073280|FG000|Overall Study|Death|1|||
155173104|NCT00119678|560073281|FG000|Double-blind Treatment Period|Death|1|||
155173105|NCT00119678|560073282|FG001|Double-blind Treatment Period|Death|0|||
155173106|NCT00119678|560073281|FG000|Double-blind Treatment Period|Adverse Event|7|||
155173107|NCT00119678|560073282|FG001|Double-blind Treatment Period|Adverse Event|1|||
155173108|NCT00119678|560073281|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
155173109|NCT00119678|560073282|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
155173110|NCT00119678|560073281|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155173111|NCT00119678|560073282|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
155173112|NCT00119678|560073281|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
155173113|NCT00119678|560073282|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
155173114|NCT00119678|560073281|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
155173115|NCT00119678|560073282|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
155173116|NCT00119678|560073281|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
155173117|NCT00119678|560073282|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
155173118|NCT00119678|560073281|FG000|Double-blind Treatment Period|Pregnancy|0|||
155173119|NCT00119678|560073282|FG001|Double-blind Treatment Period|Pregnancy|2|||
155173120|NCT00119678|560073281|FG000|Double-blind Treatment Period|Not treated|1|||
155173121|NCT00119678|560073282|FG001|Double-blind Treatment Period|Not treated|2|||
155173122|NCT00119678|560073281|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
155173123|NCT00119678|560073282|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
155173124|NCT00119678|560073281|FG000|Open-label Treatment Period|Death|1|||
155173125|NCT00119678|560073282|FG001|Open-label Treatment Period|Death|0|||
155173126|NCT00119678|560073281|FG000|Open-label Treatment Period|Adverse Event|3|||
155173127|NCT00119678|560073282|FG001|Open-label Treatment Period|Adverse Event|0|||
155173128|NCT00119678|560073281|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
155173129|NCT00119678|560073282|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
155173130|NCT00119678|560073281|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
155173131|NCT00119678|560073282|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155173132|NCT00119678|560073281|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
155173133|NCT00119678|560073282|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
155173134|NCT00119678|560073281|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
155173135|NCT00119678|560073282|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
155173136|NCT00119678|560073281|FG000|Open-label Treatment Period|Pregnancy|1|||
155173137|NCT00119678|560073282|FG001|Open-label Treatment Period|Pregnancy|0|||
155173138|NCT00119678|560073281|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
155173139|NCT00119678|560073282|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
155173140|NCT03704636|560073283|FG000|Overall Study|Inadequate Venous Flow|3|||
155173141|NCT02720042|560073284|FG000|Overall Study|Death|3|||
155173142|NCT02720042|560073284|FG000|Overall Study|Lost to Follow-up|4|||
155173143|NCT02720042|560073284|FG000|Overall Study|Withdrawal by Subject|1|||
155173144|NCT02720042|560073284|FG000|Overall Study|Physician Decision|3|||
155173145|NCT02720042|560073284|FG000|Overall Study|Phasix Mesh explanted|1|||
155173146|NCT02720042|560073284|FG000|Overall Study|unable due to non-study-related illness|3|||
155173147|NCT00539188|560073287|FG000|Overall Study|Withdrawal by Subject|1|||
155173148|NCT00539188|560073288|FG001|Overall Study|Withdrawal by Subject|0|||
154837241|NCT01970995|558838542|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
155173149|NCT00539188|560073287|FG000|Overall Study|Lost to Follow-up|2|||
155173150|NCT00539188|560073288|FG001|Overall Study|Lost to Follow-up|1|||
155173151|NCT01134705|560073291|FG000|Overall Study|Adverse Event|1|||
155173152|NCT01134705|560073292|FG001|Overall Study|Adverse Event|7|||
155173153|NCT01134705|560073291|FG000|Overall Study|Withdrawal by Subject|6|||
155173154|NCT01134705|560073292|FG001|Overall Study|Withdrawal by Subject|6|||
155173155|NCT01134705|560073291|FG000|Overall Study|Pregnancy|1|||
155173156|NCT01134705|560073292|FG001|Overall Study|Pregnancy|0|||
155173157|NCT01134705|560073291|FG000|Overall Study|Lost to Follow-up|5|||
155173158|NCT01134705|560073292|FG001|Overall Study|Lost to Follow-up|2|||
155173159|NCT01134705|560073291|FG000|Overall Study|Protocol Violation|1|||
155173160|NCT01134705|560073292|FG001|Overall Study|Protocol Violation|1|||
155173161|NCT01134705|560073291|FG000|Overall Study|Other|1|||
155173162|NCT01134705|560073292|FG001|Overall Study|Other|6|||
155173163|NCT01510769|560073293|FG000|Overall Study|Adverse Event|7|||
155173164|NCT01510769|560073294|FG001|Overall Study|Adverse Event|6|||
155173165|NCT01510769|560073295|FG002|Overall Study|Adverse Event|4|||
155173166|NCT01510769|560073293|FG000|Overall Study|Gout Flare|0|||
155173167|NCT01510769|560073294|FG001|Overall Study|Gout Flare|3|||
155173168|NCT01510769|560073295|FG002|Overall Study|Gout Flare|1|||
155173169|NCT01510769|560073293|FG000|Overall Study|Protocol Violation|11|||
155173170|NCT01510769|560073294|FG001|Overall Study|Protocol Violation|10|||
155173171|NCT01510769|560073295|FG002|Overall Study|Protocol Violation|9|||
155173172|NCT01510769|560073293|FG000|Overall Study|Lost to Follow-up|5|||
155173173|NCT01510769|560073294|FG001|Overall Study|Lost to Follow-up|1|||
155173174|NCT01510769|560073295|FG002|Overall Study|Lost to Follow-up|5|||
155173175|NCT01510769|560073293|FG000|Overall Study|Withdrawal by Subject|3|||
155173176|NCT01510769|560073294|FG001|Overall Study|Withdrawal by Subject|4|||
155173177|NCT01510769|560073295|FG002|Overall Study|Withdrawal by Subject|3|||
155173178|NCT01510769|560073293|FG000|Overall Study|Death|1|||
155173179|NCT01510769|560073294|FG001|Overall Study|Death|1|||
155173180|NCT01510769|560073295|FG002|Overall Study|Death|0|||
155173181|NCT02674204|560073296|FG000|Overall Study|Adverse Event|1|||
155173182|NCT02674204|560073297|FG001|Overall Study|Adverse Event|0|||
155173183|NCT01642615|560073298|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
155173184|NCT01642615|560073299|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155173185|NCT01642615|560073300|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155173186|NCT01642615|560073298|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
154837242|NCT01970995|558838543|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
154837243|NCT01970995|558838544|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
154837244|NCT01970995|558838542|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
155102241|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
155102242|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155102243|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155102244|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155102245|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
155102246|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
155102247|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155102248|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155102249|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155102250|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
155102251|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155102252|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
155102253|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155102254|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155102255|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
155173187|NCT01642615|560073299|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
155173188|NCT01642615|560073300|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
155173189|NCT01642615|560073298|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
154970483|NCT01567527|559315259|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
154970484|NCT01567527|559315260|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
154970485|NCT01567527|559315261|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
154970486|NCT01567527|559315262|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
154970487|NCT01567527|559315263|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
154970488|NCT01567527|559315259|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
154970489|NCT01567527|559315260|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
154970490|NCT01567527|559315261|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
154970491|NCT01567527|559315262|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
154970492|NCT01567527|559315263|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
154970493|NCT01567527|559315259|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
155102256|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
155102257|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155102258|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155102259|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155102260|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
155102261|NCT04951622|559806549|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155102262|NCT04951622|559806550|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
155102263|NCT04951622|559806551|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155102264|NCT04951622|559806552|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155102265|NCT04951622|559806553|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
155102266|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
155102267|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
155102268|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
155102269|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
155102270|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
155102271|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
155102272|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
155102273|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
155102274|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
155102275|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
155102276|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
155102277|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
155102278|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
155102279|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
155102280|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
155102281|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
155102282|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
155102283|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
154837245|NCT01970995|558838543|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
154837246|NCT01970995|558838544|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
154837247|NCT00414453|558838547|FG000|Overall Study|Abnormal lab work|16|||
154837248|NCT01263639|558838548|FG000|Overall Study|Lost to Follow-up|66|||
154837249|NCT01263639|558838549|FG001|Overall Study|Lost to Follow-up|70|||
154837250|NCT01263639|558838548|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
154837251|NCT01263639|558838549|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
154837252|NCT03975920|558838552|FG000|Overall Study|Lost to Follow-up|1|||
154837253|NCT03975920|558838553|FG001|Overall Study|Lost to Follow-up|2|||
154837254|NCT03975920|558838552|FG000|Overall Study|Protocol Violation|1|||
154837255|NCT03975920|558838553|FG001|Overall Study|Protocol Violation|1|||
154837256|NCT03975920|558838552|FG000|Overall Study|Did not complete survey|2|||
154837257|NCT03975920|558838553|FG001|Overall Study|Did not complete survey|1|||
154837258|NCT00586495|558838554|FG000|Treatment Period|Adverse Event|11|||
154837259|NCT00586495|558838554|FG000|Treatment Period|Death|1|||
154837260|NCT00586495|558838554|FG000|Treatment Period|Protocol Violation|1|||
154837261|NCT00586495|558838554|FG000|Treatment Period|Withdrawal by Subject|1|||
154837262|NCT00586495|558838554|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
154970494|NCT01567527|559315260|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
154837263|NCT00586495|558838554|FG000|Treatment Period|Switch to commercial drug|10|||
154837264|NCT00586495|558838554|FG000|Follow-up|Death|40|||
154837265|NCT00586495|558838554|FG000|Follow-up|Lost to Follow-up|1|||
154837266|NCT00586495|558838554|FG000|Follow-up|Withdrawal by Subject|4|||
154837267|NCT00586495|558838554|FG000|Follow-up|Protocol driven decision point|37|||
154837268|NCT00586495|558838554|FG000|Follow-up|Switch to commercial drug|10|||
155102284|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
155102285|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
155102286|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
154837269|NCT01081249|558838555|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
154837270|NCT01081249|558838556|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
154970495|NCT01567527|559315261|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
155102287|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155102288|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
155102289|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155102290|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
155102291|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
155102292|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
155102293|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
155102294|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
155102295|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
155102296|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
155102297|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
155102298|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
155102299|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
155102300|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
155102301|NCT04951622|559806549|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155102302|NCT04951622|559806550|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155102303|NCT04951622|559806551|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155102304|NCT04951622|559806552|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
155102305|NCT04951622|559806553|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
155102306|NCT03517436|559806555|FG000|Overall Study|Death|3|||
155102307|NCT03517436|559806555|FG000|Overall Study|Withdrawal by Subject|4|||
155102308|NCT03517436|559806555|FG000|Overall Study|Did not receive study valve.|1|||
155102309|NCT04271540|559806556|FG000|Overall Study|Lost to Follow-up|1|||
155102310|NCT04271540|559806556|FG000|Overall Study|Screen Fail|5|||
155102311|NCT04587869|559806559|FG000|Overall Study|Death|1|||
155102312|NCT04587869|559806560|FG001|Overall Study|Death|0|||
155102313|NCT04587869|559806559|FG000|Overall Study|Lost to Follow-up|27|||
155102314|NCT04587869|559806560|FG001|Overall Study|Lost to Follow-up|34|||
155102315|NCT04587869|559806559|FG000|Overall Study|Grant Termination|13|||
155102316|NCT04587869|559806560|FG001|Overall Study|Grant Termination|25|||
155102317|NCT04587869|559806559|FG000|Overall Study|too busy|2|||
155102318|NCT04587869|559806560|FG001|Overall Study|too busy|0|||
155102319|NCT04587869|559806559|FG000|Overall Study|Withdrawal by Subject|2|||
155102320|NCT04587869|559806560|FG001|Overall Study|Withdrawal by Subject|2|||
155102321|NCT04587869|559806559|FG000|Overall Study|Other|1|||
155102322|NCT04587869|559806560|FG001|Overall Study|Other|0|||
155102323|NCT02268383|559806563|FG000|Overall Study|Death|12|||
155102324|NCT02268383|559806563|FG000|Overall Study|Lost to Follow-up|2|||
155102325|NCT02268383|559806563|FG000|Overall Study|Withdrawal by Subject|9|||
155102326|NCT02268383|559806563|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
155102327|NCT02268383|559806563|FG000|Overall Study|Protocol deviation|3|||
155102328|NCT02268383|559806563|FG000|Overall Study|Sponsor decision|22|||
155102329|NCT02268383|559806563|FG000|Overall Study|Not reported|12|||
155102330|NCT00943761|559806564|FG000|Overall Study|Lost to Follow-up|2|||
155102331|NCT00943761|559806565|FG001|Overall Study|Lost to Follow-up|0|||
155102332|NCT00943761|559806564|FG000|Overall Study|Withdrawal by Subject|2|||
155102333|NCT00943761|559806565|FG001|Overall Study|Withdrawal by Subject|1|||
155173190|NCT01642615|560073299|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
155173191|NCT01642615|560073300|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
155173192|NCT01642615|560073298|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
155173193|NCT01642615|560073299|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
155173194|NCT01642615|560073300|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
155173195|NCT01642615|560073298|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
155173196|NCT01642615|560073299|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
155173197|NCT01642615|560073300|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
155173198|NCT01642615|560073298|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
155173199|NCT01642615|560073299|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
155173200|NCT01642615|560073300|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
155173201|NCT01642615|560073298|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
155173202|NCT01642615|560073299|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
155173203|NCT01642615|560073300|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
155173204|NCT01642615|560073298|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155173205|NCT01642615|560073299|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
155102334|NCT01342926|559806568|FG000|Overall Study|Adverse Event|5|||
155102335|NCT01342926|559806569|FG001|Overall Study|Adverse Event|8|||
155102336|NCT01342926|559806570|FG002|Overall Study|Adverse Event|10|||
155102337|NCT01342926|559806571|FG003|Overall Study|Adverse Event|7|||
155102338|NCT01342926|559806568|FG000|Overall Study|Lost to Follow-up|0|||
155102339|NCT01342926|559806569|FG001|Overall Study|Lost to Follow-up|1|||
155102340|NCT01342926|559806570|FG002|Overall Study|Lost to Follow-up|1|||
155102341|NCT01342926|559806571|FG003|Overall Study|Lost to Follow-up|0|||
155102342|NCT01342926|559806568|FG000|Overall Study|Investigator Discretion|2|||
155102343|NCT01342926|559806569|FG001|Overall Study|Investigator Discretion|2|||
155102344|NCT01342926|559806570|FG002|Overall Study|Investigator Discretion|0|||
155102345|NCT01342926|559806571|FG003|Overall Study|Investigator Discretion|0|||
155102346|NCT01342926|559806568|FG000|Overall Study|Withdrawal by Subject|2|||
155102347|NCT01342926|559806569|FG001|Overall Study|Withdrawal by Subject|4|||
155102348|NCT01342926|559806570|FG002|Overall Study|Withdrawal by Subject|3|||
155102349|NCT01342926|559806571|FG003|Overall Study|Withdrawal by Subject|5|||
155102350|NCT03382912|559806572|FG000|Overall Study|Physician Decision|0|||
155102351|NCT03382912|559806573|FG001|Overall Study|Physician Decision|1|||
155102352|NCT03382912|559806572|FG000|Overall Study|Sponsor Decision|6|||
155102353|NCT03382912|559806573|FG001|Overall Study|Sponsor Decision|6|||
155102354|NCT03382912|559806572|FG000|Overall Study|Withdrawal by Subject|0|||
155102355|NCT03382912|559806573|FG001|Overall Study|Withdrawal by Subject|5|||
155102356|NCT01402869|559806574|FG000|Overall Study|Required Tooth Extraction|0|||
155102357|NCT01402869|559806575|FG001|Overall Study|Required Tooth Extraction|0|||
155102358|NCT01402869|559806576|FG002|Overall Study|Required Tooth Extraction|1|||
155102359|NCT01544348|559806577|FG000|Overall Study|Lost to Follow-up|1|||
155102360|NCT01544348|559806578|FG001|Overall Study|Lost to Follow-up|0|||
155102361|NCT01544348|559806579|FG002|Overall Study|Lost to Follow-up|0|||
155102362|NCT01544348|559806580|FG003|Overall Study|Lost to Follow-up|0|||
155102363|NCT01544348|559806581|FG004|Overall Study|Lost to Follow-up|0|||
155102364|NCT01544348|559806582|FG005|Overall Study|Lost to Follow-up|0|||
155102365|NCT01544348|559806583|FG006|Overall Study|Lost to Follow-up|1|||
155102366|NCT01544348|559806584|FG007|Overall Study|Lost to Follow-up|0|||
155102367|NCT01544348|559806577|FG000|Overall Study|Withdrawal by Subject|1|||
155102368|NCT01544348|559806578|FG001|Overall Study|Withdrawal by Subject|0|||
155102369|NCT01544348|559806579|FG002|Overall Study|Withdrawal by Subject|0|||
155102370|NCT01544348|559806580|FG003|Overall Study|Withdrawal by Subject|0|||
155102371|NCT01544348|559806581|FG004|Overall Study|Withdrawal by Subject|1|||
155102372|NCT01544348|559806582|FG005|Overall Study|Withdrawal by Subject|2|||
155102373|NCT01544348|559806583|FG006|Overall Study|Withdrawal by Subject|1|||
155102374|NCT01544348|559806584|FG007|Overall Study|Withdrawal by Subject|0|||
155102375|NCT01544348|559806577|FG000|Overall Study|Physician Decision|0|||
155102376|NCT01544348|559806578|FG001|Overall Study|Physician Decision|0|||
155102377|NCT01544348|559806579|FG002|Overall Study|Physician Decision|0|||
155102378|NCT01544348|559806580|FG003|Overall Study|Physician Decision|0|||
155102379|NCT01544348|559806581|FG004|Overall Study|Physician Decision|0|||
155102380|NCT01544348|559806582|FG005|Overall Study|Physician Decision|1|||
155102381|NCT01544348|559806583|FG006|Overall Study|Physician Decision|0|||
155102382|NCT01544348|559806584|FG007|Overall Study|Physician Decision|0|||
155102383|NCT00642707|559806585|FG000|Overall Study|Adverse Event|0|||
155102384|NCT00642707|559806586|FG001|Overall Study|Adverse Event|0|||
155102385|NCT00642707|559806587|FG002|Overall Study|Adverse Event|0|||
155102386|NCT00642707|559806588|FG003|Overall Study|Adverse Event|2|||
155102387|NCT00642707|559806585|FG000|Overall Study|Withdrawal by Subject|1|||
155102388|NCT00642707|559806586|FG001|Overall Study|Withdrawal by Subject|0|||
155102389|NCT00642707|559806587|FG002|Overall Study|Withdrawal by Subject|0|||
155102390|NCT00642707|559806588|FG003|Overall Study|Withdrawal by Subject|0|||
155102391|NCT02891226|559806589|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
155102392|NCT02891226|559806590|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
155102393|NCT02891226|559806591|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
155102394|NCT02891226|559806592|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102395|NCT02891226|559806593|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102396|NCT02891226|559806594|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102397|NCT02891226|559806595|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102398|NCT02891226|559806596|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102399|NCT02891226|559806597|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102400|NCT02891226|559806598|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102401|NCT02891226|559806599|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102402|NCT02891226|559806600|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102403|NCT02891226|559806601|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102404|NCT02891226|559806602|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102405|NCT02891226|559806603|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102406|NCT02891226|559806604|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
155102407|NCT02891226|559806589|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
155102408|NCT02891226|559806590|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
155102409|NCT02891226|559806591|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102410|NCT02891226|559806592|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102411|NCT02891226|559806593|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102412|NCT02891226|559806594|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102413|NCT02891226|559806595|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102414|NCT02891226|559806596|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102415|NCT02891226|559806597|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102416|NCT02891226|559806598|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102417|NCT02891226|559806599|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102418|NCT02891226|559806600|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102419|NCT02891226|559806601|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102420|NCT02891226|559806602|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102421|NCT02891226|559806603|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102422|NCT02891226|559806604|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
155102423|NCT02891226|559806589|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102424|NCT02891226|559806590|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102425|NCT02891226|559806591|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155173206|NCT01642615|560073300|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
155173207|NCT01642615|560073298|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
155173208|NCT01642615|560073299|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
155173209|NCT01642615|560073300|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
155173210|NCT02744040|560073301|FG000|Overall Study|Withdrawal by Subject|3|||
155173211|NCT02744040|560073302|FG001|Overall Study|Withdrawal by Subject|2|||
155173212|NCT02744040|560073303|FG002|Overall Study|Withdrawal by Subject|2|||
155173213|NCT02744040|560073301|FG000|Overall Study|Physician Decision|0|||
155173214|NCT02744040|560073302|FG001|Overall Study|Physician Decision|8|||
155173215|NCT02744040|560073303|FG002|Overall Study|Physician Decision|13|||
155173216|NCT02744040|560073301|FG000|Overall Study|Lost to Follow-up|3|||
155173217|NCT02744040|560073302|FG001|Overall Study|Lost to Follow-up|1|||
155173218|NCT02744040|560073303|FG002|Overall Study|Lost to Follow-up|7|||
155173219|NCT01008423|560073304|FG000|Overall Study|Adverse Event|13|||
155173220|NCT01008423|560073305|FG001|Overall Study|Adverse Event|6|||
155173221|NCT01008423|560073304|FG000|Overall Study|Withdrawal by Subject|4|||
155173222|NCT01008423|560073305|FG001|Overall Study|Withdrawal by Subject|7|||
155173223|NCT01008423|560073304|FG000|Overall Study|Lost to Follow-up|0|||
155173224|NCT01008423|560073305|FG001|Overall Study|Lost to Follow-up|2|||
155173225|NCT01008423|560073304|FG000|Overall Study|Low Cortisol|0|||
155173226|NCT01008423|560073305|FG001|Overall Study|Low Cortisol|1|||
155173227|NCT01008423|560073304|FG000|Overall Study|Lack of Efficacy|0|||
154837271|NCT00205855|558838559|FG000|Overall Study|Only received temporary implants|16|||
155173228|NCT01008423|560073305|FG001|Overall Study|Lack of Efficacy|5|||
155173229|NCT01008423|560073304|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
155173230|NCT01008423|560073305|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
155173231|NCT01008423|560073304|FG000|Overall Study|Personal Conflict|1|||
155173232|NCT01008423|560073305|FG001|Overall Study|Personal Conflict|0|||
155173233|NCT01008423|560073304|FG000|Overall Study|Other|0|||
155173234|NCT01008423|560073305|FG001|Overall Study|Other|1|||
155173235|NCT00978757|560073311|FG000|Overall Study|Physician Decision|1|||
155173236|NCT00978757|560073312|FG001|Overall Study|Physician Decision|3|||
155173237|NCT01028300|560073315|FG000|Overall Study|Study Terminated|4|||
155173238|NCT00402740|560073316|FG000|Overall Study|Withdrawal by Subject|18|||
155173239|NCT00402740|560073316|FG000|Overall Study|Death|50|||
155173240|NCT00402740|560073316|FG000|Overall Study|Lost to Follow-up|6|||
155173241|NCT00402740|560073316|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
155173242|NCT00402740|560073316|FG000|Overall Study|Subject disposition unknown.|1|||
155173243|NCT01214395|560073319|FG000|Overall Study|All patients had infection|5|||
155173244|NCT00715910|560073323|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
155173245|NCT00715910|560073324|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
155173246|NCT00715910|560073325|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
155173247|NCT00715910|560073326|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
155173248|NCT00715910|560073327|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
155173249|NCT00715910|560073328|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
155173250|NCT00715910|560073323|FG000|Booster and ESFU Phase|Other|0|||
155173251|NCT00715910|560073324|FG001|Booster and ESFU Phase|Other|0|||
155173252|NCT00715910|560073325|FG002|Booster and ESFU Phase|Other|0|||
155173253|NCT00715910|560073326|FG003|Booster and ESFU Phase|Other|5|||
154837272|NCT00205855|558838559|FG000|Overall Study|Withdrawal by Subject|5|||
154837273|NCT02039375|558838560|FG000|Overall Study|Lost to Follow-up|2|||
155173254|NCT00715910|560073327|FG004|Booster and ESFU Phase|Other|1|||
154837274|NCT00219284|558838562|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
154837275|NCT00219284|558838563|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
154837276|NCT00219284|558838562|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
155173255|NCT00715910|560073328|FG005|Booster and ESFU Phase|Other|0|||
155173256|NCT01185353|560073329|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
154837277|NCT00219284|558838563|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
155173257|NCT01185353|560073330|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155173258|NCT01185353|560073331|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155173259|NCT01185353|560073332|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
155173260|NCT01185353|560073333|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
155173261|NCT01185353|560073334|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155173262|NCT01185353|560073335|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155173263|NCT01185353|560073336|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155173264|NCT01185353|560073337|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155173265|NCT01185353|560073338|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
155173266|NCT01185353|560073329|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173267|NCT01185353|560073330|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173268|NCT01185353|560073331|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173269|NCT01185353|560073332|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173270|NCT01185353|560073333|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
155173271|NCT01185353|560073334|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173272|NCT01185353|560073335|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173273|NCT01185353|560073336|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173274|NCT01185353|560073337|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173275|NCT01185353|560073338|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
155173276|NCT01185353|560073329|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
155173277|NCT01185353|560073330|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173278|NCT01185353|560073331|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173279|NCT01185353|560073332|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173280|NCT01185353|560073333|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
155173281|NCT01185353|560073334|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173282|NCT01185353|560073335|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173283|NCT01185353|560073336|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173284|NCT01185353|560073337|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173285|NCT01185353|560073338|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
155173286|NCT01185353|560073329|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173287|NCT01185353|560073330|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173288|NCT01185353|560073331|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
155173289|NCT01185353|560073332|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173290|NCT01185353|560073333|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
155173291|NCT01185353|560073334|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173292|NCT01185353|560073335|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173293|NCT01185353|560073336|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173294|NCT01185353|560073337|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173295|NCT01185353|560073338|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
155173296|NCT01185353|560073329|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173297|NCT01185353|560073330|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173298|NCT01185353|560073331|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173299|NCT01185353|560073332|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173300|NCT01185353|560073333|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
155173301|NCT01185353|560073334|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173302|NCT01185353|560073335|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173303|NCT01185353|560073336|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173304|NCT01185353|560073337|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173305|NCT01185353|560073338|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
155173306|NCT01185353|560073329|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
155173307|NCT01185353|560073330|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173308|NCT01185353|560073331|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173309|NCT01185353|560073332|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173310|NCT01185353|560073333|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
155173311|NCT01185353|560073334|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173312|NCT01185353|560073335|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
154837278|NCT00219284|558838562|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
154837279|NCT00219284|558838563|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
154837280|NCT00219284|558838562|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
154837281|NCT00219284|558838563|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
154837282|NCT00219284|558838562|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
154837283|NCT00219284|558838563|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
154837284|NCT00219284|558838562|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
154837285|NCT00219284|558838563|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
154837286|NCT00219284|558838562|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
154837287|NCT00219284|558838563|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
154837288|NCT00219284|558838562|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
154837289|NCT00219284|558838563|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
154837290|NCT00219284|558838562|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
155173313|NCT01185353|560073336|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173314|NCT01185353|560073337|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173315|NCT01185353|560073338|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
155173316|NCT01185353|560073329|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
154837291|NCT00219284|558838563|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
154837292|NCT01692275|558838564|FG000|Overall Study|Lost to Follow-up|57|||
154837293|NCT01692275|558838565|FG001|Overall Study|Lost to Follow-up|48|||
154837294|NCT01692275|558838564|FG000|Overall Study|Withdrawal by Subject|9|||
154837295|NCT01692275|558838565|FG001|Overall Study|Withdrawal by Subject|11|||
155102426|NCT02891226|559806592|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
155102427|NCT02891226|559806593|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102428|NCT02891226|559806594|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102429|NCT02891226|559806595|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102430|NCT02891226|559806596|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102431|NCT02891226|559806597|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102432|NCT02891226|559806598|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102433|NCT02891226|559806599|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102434|NCT02891226|559806600|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102435|NCT02891226|559806601|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102436|NCT02891226|559806602|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102437|NCT02891226|559806603|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102438|NCT02891226|559806604|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
155102439|NCT02891226|559806589|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102440|NCT02891226|559806590|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102441|NCT02891226|559806591|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
155102442|NCT02891226|559806592|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102443|NCT02891226|559806593|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102444|NCT02891226|559806594|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102445|NCT02891226|559806595|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102446|NCT02891226|559806596|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102447|NCT02891226|559806597|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102448|NCT02891226|559806598|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102449|NCT02891226|559806599|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102450|NCT02891226|559806600|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102451|NCT02891226|559806601|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102452|NCT02891226|559806602|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102453|NCT02891226|559806603|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102454|NCT02891226|559806604|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
155102455|NCT02891226|559806589|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102456|NCT02891226|559806590|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102457|NCT02891226|559806591|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102458|NCT02891226|559806592|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
155102459|NCT02891226|559806593|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102460|NCT02891226|559806594|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102461|NCT02891226|559806595|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102462|NCT02891226|559806596|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102463|NCT02891226|559806597|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102464|NCT02891226|559806598|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102465|NCT02891226|559806599|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102466|NCT02891226|559806600|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102467|NCT02891226|559806601|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102468|NCT02891226|559806602|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102469|NCT02891226|559806603|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102470|NCT02891226|559806604|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
155102471|NCT02891226|559806589|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102472|NCT02891226|559806590|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102473|NCT02891226|559806591|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102474|NCT02891226|559806592|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
155102475|NCT02891226|559806593|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102476|NCT02891226|559806594|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102477|NCT02891226|559806595|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102478|NCT02891226|559806596|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102479|NCT02891226|559806597|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102480|NCT02891226|559806598|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102481|NCT02891226|559806599|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102482|NCT02891226|559806600|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102483|NCT02891226|559806601|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102484|NCT02891226|559806602|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102485|NCT02891226|559806603|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102486|NCT02891226|559806604|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
155102487|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102488|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102489|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102490|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102491|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102492|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102493|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
155173317|NCT01185353|560073330|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173318|NCT01185353|560073331|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
155173319|NCT01185353|560073332|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173320|NCT01185353|560073333|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173321|NCT01185353|560073334|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
155173322|NCT01185353|560073335|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173323|NCT01185353|560073336|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173324|NCT01185353|560073337|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173325|NCT01185353|560073338|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
155173326|NCT01185353|560073329|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173327|NCT01185353|560073330|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
155173328|NCT01185353|560073331|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173329|NCT01185353|560073332|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
155173330|NCT01185353|560073333|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173331|NCT01185353|560073334|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173332|NCT01185353|560073335|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173333|NCT01185353|560073336|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173334|NCT01185353|560073337|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173335|NCT01185353|560073338|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
155173336|NCT01185353|560073329|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173337|NCT01185353|560073330|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173338|NCT01185353|560073331|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173339|NCT01185353|560073332|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
155173340|NCT01185353|560073333|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173341|NCT01185353|560073334|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173342|NCT01185353|560073335|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
155173343|NCT01185353|560073336|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173344|NCT01185353|560073337|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173345|NCT01185353|560073338|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
155173346|NCT01185353|560073329|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155173347|NCT01185353|560073330|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155173348|NCT01185353|560073331|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
155173349|NCT01185353|560073332|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
155173350|NCT01185353|560073333|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155173351|NCT01185353|560073334|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
155173352|NCT01185353|560073335|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
155173353|NCT01185353|560073336|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155173354|NCT01185353|560073337|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155173355|NCT01185353|560073338|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
155173356|NCT01185353|560073329|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173357|NCT01185353|560073330|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173358|NCT01185353|560073331|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173359|NCT01185353|560073332|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173360|NCT01185353|560073333|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173361|NCT01185353|560073334|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173362|NCT01185353|560073335|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
155173363|NCT01185353|560073336|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
154837296|NCT00640328|558838571|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
154837297|NCT00640328|558838572|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
154837298|NCT00640328|558838573|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
154837299|NCT00640328|558838574|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
154837300|NCT00640328|558838575|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
154837301|NCT00640328|558838576|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
154837302|NCT00640328|558838571|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
154837303|NCT00640328|558838572|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
154837304|NCT00640328|558838573|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
154837305|NCT00640328|558838574|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
154837306|NCT00640328|558838575|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
154837307|NCT00640328|558838576|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
154837308|NCT00640328|558838571|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
154837309|NCT00640328|558838572|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155173364|NCT01185353|560073337|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
154837310|NCT00640328|558838573|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
154837311|NCT00640328|558838574|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
154837312|NCT00640328|558838575|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
154837313|NCT00640328|558838576|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
155173365|NCT01185353|560073338|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
155173366|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173367|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173368|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173369|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173370|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173371|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173372|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
155173373|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
155173374|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
155173375|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
155173376|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173377|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173378|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173379|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173380|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173381|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173382|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
155173383|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
155173384|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
155173385|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
155173386|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173387|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173388|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173389|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173390|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173391|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173392|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
155173393|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
155173394|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
155173395|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
155173396|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173397|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173398|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173399|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173400|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173401|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173402|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173403|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173404|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
155173405|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
155173406|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Death|0|||
155173407|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Death|0|||
155173408|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Death|0|||
155173409|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Death|0|||
155173410|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Death|0|||
154970496|NCT01567527|559315262|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
154970497|NCT01567527|559315263|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
154970498|NCT01567527|559315259|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
154970499|NCT01567527|559315260|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
154970500|NCT01567527|559315261|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
154970501|NCT01567527|559315262|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
154970502|NCT01567527|559315263|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
154970503|NCT01567527|559315259|FG000|IM Depot Stabilization.|Protocol deviation|0|||
154970504|NCT01567527|559315260|FG001|IM Depot Stabilization.|Protocol deviation|0|||
154970505|NCT01567527|559315261|FG002|IM Depot Stabilization.|Protocol deviation|5|||
154970506|NCT01567527|559315262|FG003|IM Depot Stabilization.|Protocol deviation|0|||
154970507|NCT01567527|559315263|FG004|IM Depot Stabilization.|Protocol deviation|0|||
154970508|NCT01567527|559315259|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
154970509|NCT01567527|559315260|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
154970510|NCT01567527|559315261|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
154970511|NCT01567527|559315262|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
154970512|NCT01567527|559315263|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
154970513|NCT01567527|559315259|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
154970514|NCT01567527|559315260|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
154970515|NCT01567527|559315261|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
154970516|NCT01567527|559315262|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
154970517|NCT01567527|559315263|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
154970518|NCT01567527|559315259|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
154970519|NCT01567527|559315260|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
154970520|NCT01567527|559315261|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
154970521|NCT01567527|559315262|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
154970522|NCT01567527|559315263|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
154970523|NCT01567527|559315259|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
155102494|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
155102495|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
155102496|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
155102497|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102498|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102499|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102500|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102501|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102502|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
155102503|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102504|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102505|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102506|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102507|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102508|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
155102509|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102510|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102511|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102512|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
155102513|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102514|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102515|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102516|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102517|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102518|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
155102519|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102520|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102521|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102522|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102523|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102524|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
154970524|NCT01567527|559315260|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
154970525|NCT01567527|559315261|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
154970526|NCT01567527|559315262|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
154970527|NCT01567527|559315263|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
154970528|NCT01567527|559315259|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
155173411|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Death|0|||
155173412|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Death|0|||
155173413|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Death|0|||
155173414|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Death|0|||
155173415|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Death|1|||
155173416|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173417|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173418|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173419|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173420|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173421|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173422|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173423|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173424|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
155173425|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
155173426|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173427|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173428|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173429|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173430|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173431|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173432|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173433|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173434|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
155173435|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
155173436|NCT01185353|560073329|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173437|NCT01185353|560073330|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173438|NCT01185353|560073331|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173439|NCT01185353|560073332|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173440|NCT01185353|560073333|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173441|NCT01185353|560073334|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173442|NCT01185353|560073335|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173443|NCT01185353|560073336|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173444|NCT01185353|560073337|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
155173445|NCT01185353|560073338|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
155173446|NCT01185353|560073329|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173447|NCT01185353|560073330|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173448|NCT01185353|560073331|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173449|NCT01185353|560073332|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173450|NCT01185353|560073333|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173451|NCT01185353|560073334|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173452|NCT01185353|560073335|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
154970529|NCT01567527|559315260|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
154970530|NCT01567527|559315261|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
154970531|NCT01567527|559315262|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
154970532|NCT01567527|559315263|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
154970533|NCT01567527|559315259|FG000|IM Depot Stabilization.|Adverse Event|0|||
154970534|NCT01567527|559315260|FG001|IM Depot Stabilization.|Adverse Event|0|||
154970535|NCT01567527|559315261|FG002|IM Depot Stabilization.|Adverse Event|37|||
154970536|NCT01567527|559315262|FG003|IM Depot Stabilization.|Adverse Event|0|||
155102525|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
155102526|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
155102527|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
155102528|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
155102529|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102530|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102531|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102532|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
154970537|NCT01567527|559315263|FG004|IM Depot Stabilization.|Adverse Event|0|||
155102533|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
154970538|NCT01567527|559315259|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
155102534|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
155102535|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102536|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102537|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102538|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102539|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
155102540|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102541|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102542|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
154837314|NCT00640328|558838571|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
154837315|NCT00640328|558838572|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
154837316|NCT00640328|558838573|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
154837317|NCT00640328|558838574|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
154837318|NCT00640328|558838575|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
154837319|NCT00640328|558838576|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
154837320|NCT02374099|558838577|FG000|Overall Study|Adverse Event|1|||
154837321|NCT02374099|558838578|FG001|Overall Study|Adverse Event|0|||
154837322|NCT02374099|558838577|FG000|Overall Study|Progressive Disease|35|||
154837323|NCT02374099|558838578|FG001|Overall Study|Progressive Disease|40|||
154837324|NCT02374099|558838577|FG000|Overall Study|Withdrawal by Subject|5|||
154837325|NCT02374099|558838578|FG001|Overall Study|Withdrawal by Subject|1|||
154837326|NCT02374099|558838577|FG000|Overall Study|Miscellaneous|2|||
154837327|NCT02374099|558838578|FG001|Overall Study|Miscellaneous|3|||
154837328|NCT02374099|558838577|FG000|Overall Study|Randomized, but not treated|2|||
154837329|NCT02374099|558838578|FG001|Overall Study|Randomized, but not treated|1|||
154837330|NCT02374099|558838577|FG000|Overall Study|Study Terminated by Sponsor|3|||
154837331|NCT02374099|558838578|FG001|Overall Study|Study Terminated by Sponsor|4|||
154837332|NCT01033825|558838579|FG000|Overall Study|Withdrawal by Subject|2|||
154837333|NCT01033825|558838580|FG001|Overall Study|Withdrawal by Subject|3|||
154837334|NCT01033825|558838581|FG002|Overall Study|Withdrawal by Subject|2|||
154837335|NCT01033825|558838582|FG003|Overall Study|Withdrawal by Subject|1|||
154837336|NCT01033825|558838583|FG004|Overall Study|Withdrawal by Subject|1|||
154837337|NCT01033825|558838584|FG005|Overall Study|Withdrawal by Subject|0|||
154837338|NCT01033825|558838585|FG006|Overall Study|Withdrawal by Subject|0|||
154837339|NCT01033825|558838579|FG000|Overall Study|Adverse Event|0|||
154837340|NCT01033825|558838580|FG001|Overall Study|Adverse Event|0|||
154837341|NCT01033825|558838581|FG002|Overall Study|Adverse Event|0|||
154837342|NCT01033825|558838582|FG003|Overall Study|Adverse Event|1|||
154837343|NCT01033825|558838583|FG004|Overall Study|Adverse Event|0|||
154837344|NCT01033825|558838584|FG005|Overall Study|Adverse Event|0|||
154837345|NCT01033825|558838585|FG006|Overall Study|Adverse Event|0|||
154837346|NCT01033825|558838579|FG000|Overall Study|Protocol Violation|1|||
154837347|NCT01033825|558838580|FG001|Overall Study|Protocol Violation|0|||
154837348|NCT01033825|558838581|FG002|Overall Study|Protocol Violation|0|||
154837349|NCT01033825|558838582|FG003|Overall Study|Protocol Violation|0|||
154837350|NCT01033825|558838583|FG004|Overall Study|Protocol Violation|0|||
154837351|NCT01033825|558838584|FG005|Overall Study|Protocol Violation|0|||
154837352|NCT01033825|558838585|FG006|Overall Study|Protocol Violation|0|||
154837353|NCT01033825|558838579|FG000|Overall Study|Other|0|||
154837354|NCT01033825|558838580|FG001|Overall Study|Other|0|||
154837355|NCT01033825|558838581|FG002|Overall Study|Other|0|||
154837356|NCT01033825|558838582|FG003|Overall Study|Other|0|||
154837357|NCT01033825|558838583|FG004|Overall Study|Other|1|||
154837358|NCT01033825|558838584|FG005|Overall Study|Other|0|||
154837359|NCT01033825|558838585|FG006|Overall Study|Other|0|||
154837360|NCT04294719|558838586|FG000|Overall Study|Withdrawal by Subject|1|||
154970539|NCT01567527|559315260|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
154970540|NCT01567527|559315261|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
154970541|NCT01567527|559315262|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
154970542|NCT01567527|559315263|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
154970543|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
154970544|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
154970545|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
154837361|NCT01714687|558838587|FG000|Overall Study|Withdrawal by Subject|1|||
154837362|NCT01714687|558838588|FG001|Overall Study|Withdrawal by Subject|0|||
154837363|NCT01714687|558838587|FG000|Overall Study|Lost to Follow-up|2|||
154837364|NCT01714687|558838588|FG001|Overall Study|Lost to Follow-up|4|||
154837365|NCT00278993|558838589|FG000|Overall Study|Adverse Event|24|||
154837366|NCT00278993|558838589|FG000|Overall Study|Withdrawal by Subject|5|||
154837367|NCT00278993|558838589|FG000|Overall Study|Progressive Disease|65|||
154837368|NCT00278993|558838589|FG000|Overall Study|Physician Decision|9|||
154837369|NCT00278993|558838589|FG000|Overall Study|Not Otherwise Specified|4|||
154837370|NCT01439555|558838591|FG000|Overall Study|Protocol Violation|1|||
154837371|NCT03921424|558838600|FG000|Overall Study|Lost to Follow-up|0|||
154837372|NCT03921424|558838601|FG001|Overall Study|Lost to Follow-up|1|||
154970546|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
154970547|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
154837373|NCT03921424|558838600|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
154837374|NCT03921424|558838601|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
154970548|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
154970549|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
154837375|NCT01934556|558838605|FG000|Overall Study|Withdrawal by Subject|0|||
154837376|NCT01934556|558838606|FG001|Overall Study|Withdrawal by Subject|1|||
154837377|NCT01934556|558838607|FG002|Overall Study|Withdrawal by Subject|1|||
154837378|NCT01934556|558838605|FG000|Overall Study|Lost to Follow-up|4|||
154837379|NCT01934556|558838606|FG001|Overall Study|Lost to Follow-up|10|||
154837380|NCT01934556|558838607|FG002|Overall Study|Lost to Follow-up|7|||
154837381|NCT01934556|558838605|FG000|Overall Study|Death|1|||
154837382|NCT01934556|558838606|FG001|Overall Study|Death|5|||
154837383|NCT01934556|558838607|FG002|Overall Study|Death|2|||
154837384|NCT05038020|558838609|FG000|Overall Study|Early Termination|3|||
154837385|NCT05038020|558838610|FG001|Overall Study|Early Termination|0|||
154837386|NCT03416153|558838612|FG000|Overall Study|Physician Decision|1|||
154837387|NCT03416153|558838613|FG001|Overall Study|Physician Decision|1|||
154837388|NCT03416153|558838612|FG000|Overall Study|Withdrawal by Subject|1|||
154837389|NCT03416153|558838613|FG001|Overall Study|Withdrawal by Subject|0|||
154837390|NCT03770260|558840187|FG000|Overall Study|Disease progression|0|||
154837391|NCT03770260|558840188|FG001|Overall Study|Disease progression|1|||
154837392|NCT03770260|558840189|FG002|Overall Study|Disease progression|0|||
154837393|NCT03770260|558840190|FG003|Overall Study|Disease progression|0|||
154837394|NCT01908101|558840197|FG000|Overall Study|Physician Decision|1|||
154837395|NCT01908101|558840197|FG000|Overall Study|Withdrawal by Subject|1|||
154837396|NCT01908101|558840197|FG000|Overall Study|Incorrect Diagnosis|2|||
154837397|NCT01908101|558840197|FG000|Overall Study|Incorrect Starting Dose|1|||
154837398|NCT01908101|558840197|FG000|Overall Study|Did not complete the first cycle|4|||
154837399|NCT01394939|558840198|FG000|Overall Study|Adverse Event|1|||
154837400|NCT01394939|558840199|FG001|Overall Study|Adverse Event|3|||
154837401|NCT01394939|558840200|FG002|Overall Study|Adverse Event|0|||
154837402|NCT01394939|558840201|FG003|Overall Study|Adverse Event|2|||
154837403|NCT01394939|558840198|FG000|Overall Study|Death|0|||
154837404|NCT01394939|558840199|FG001|Overall Study|Death|2|||
154837405|NCT01394939|558840200|FG002|Overall Study|Death|0|||
154837406|NCT01394939|558840201|FG003|Overall Study|Death|0|||
154837407|NCT01394939|558840198|FG000|Overall Study|Physician Decision|0|||
154837408|NCT01394939|558840199|FG001|Overall Study|Physician Decision|1|||
154837409|NCT01394939|558840200|FG002|Overall Study|Physician Decision|0|||
154837410|NCT01394939|558840201|FG003|Overall Study|Physician Decision|0|||
154970550|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
154970551|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
154970552|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
154970553|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
154970554|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
154970555|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
154970556|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
154970557|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
154970558|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
154970559|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
155102543|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
154837411|NCT01394939|558840198|FG000|Overall Study|Withdrawal by Subject|0|||
155102544|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102545|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102546|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102547|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
154837412|NCT01394939|558840199|FG001|Overall Study|Withdrawal by Subject|2|||
154837413|NCT01394939|558840200|FG002|Overall Study|Withdrawal by Subject|0|||
154837414|NCT01394939|558840201|FG003|Overall Study|Withdrawal by Subject|2|||
154837415|NCT01394939|558840198|FG000|Overall Study|Others|0|||
155102548|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
154837416|NCT01394939|558840199|FG001|Overall Study|Others|2|||
154837417|NCT01394939|558840200|FG002|Overall Study|Others|0|||
154837418|NCT01394939|558840201|FG003|Overall Study|Others|3|||
154837419|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
154837420|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
154837421|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
155173453|NCT01185353|560073336|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
154970560|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
154837422|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
154837423|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
154837424|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
154837425|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
154837426|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
154837427|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
154837428|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
155102549|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
154837429|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
154837430|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
154837431|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
154837432|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
154837433|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
154837434|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
155102550|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
155102551|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
154837435|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
154837436|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
154837437|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
154837438|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
154837439|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
154837440|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
154837441|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
154837442|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
154837443|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
154970561|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
154970562|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
154970563|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
154970564|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
154970565|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
154970566|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
154970567|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
154970568|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
154970569|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
154970570|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
154970571|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
154970572|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
154970573|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
154970574|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
154970575|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
154970576|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
154970577|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
154970578|NCT01567527|559315259|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
154970579|NCT01567527|559315260|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
154970580|NCT01567527|559315261|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
154970581|NCT01567527|559315262|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
154970582|NCT01567527|559315263|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
154970583|NCT02311894|559315264|FG000|Overall Study|Discontinued in error|1|||
154970584|NCT02311894|559315264|FG000|Overall Study|Lost to Follow-up|1|||
154970585|NCT02311894|559315264|FG000|Overall Study|Adverse Event|1|||
154970586|NCT02311894|559315264|FG000|Overall Study|Withdrawal by Subject|1|||
154970587|NCT00939523|559315265|FG000|Overall Study|Lack of Efficacy|1|||
154970588|NCT00939523|559315265|FG000|Overall Study|Physician Decision|2|||
154970589|NCT02119936|559315270|FG000|Overall Study|Lost to Follow-up|10|||
154970590|NCT00757172|559315272|FG000|Overall Study|Withdrawal by Subject|4|||
154970591|NCT00757172|559315272|FG000|Overall Study|Physician Decision|3|||
154970592|NCT00757172|559315272|FG000|Overall Study|Progression|4|||
154970593|NCT01971554|559315273|FG000|Overall Study|Lost to Follow-up|1|||
154970594|NCT01971554|559315274|FG001|Overall Study|Lost to Follow-up|0|||
154970595|NCT01971554|559315275|FG002|Overall Study|Lost to Follow-up|0|||
154970596|NCT01971554|559315276|FG003|Overall Study|Lost to Follow-up|0|||
154970597|NCT01942135|559315278|FG000|Overall Study|Adverse Event|21|||
154970598|NCT01942135|559315279|FG001|Overall Study|Adverse Event|7|||
154970599|NCT01942135|559315278|FG000|Overall Study|Global Deterioration of Health Status|9|||
154970600|NCT01942135|559315279|FG001|Overall Study|Global Deterioration of Health Status|6|||
154970601|NCT01942135|559315278|FG000|Overall Study|Randomized Not Treated|2|||
154970602|NCT01942135|559315279|FG001|Overall Study|Randomized Not Treated|2|||
154970603|NCT01942135|559315278|FG000|Overall Study|Death|2|||
154970604|NCT01942135|559315279|FG001|Overall Study|Death|1|||
154970605|NCT01942135|559315278|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
154970606|NCT01942135|559315279|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
154970607|NCT01942135|559315278|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
154970608|NCT01942135|559315279|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
154970609|NCT01942135|559315278|FG000|Overall Study|Withdrawal by Subject|4|||
154970610|NCT01942135|559315279|FG001|Overall Study|Withdrawal by Subject|3|||
154970611|NCT01942135|559315278|FG000|Overall Study|Protocol Violation|1|||
154970612|NCT01942135|559315279|FG001|Overall Study|Protocol Violation|0|||
154970613|NCT01942135|559315278|FG000|Overall Study|Other|19|||
154970614|NCT01942135|559315279|FG001|Overall Study|Other|4|||
154970615|NCT01499043|559315280|FG000|Overall Study|Progressive disease (radiographic)|2|||
154970616|NCT01499043|559315280|FG000|Overall Study|Progressive disease (clinical)|1|||
154837444|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
154837445|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
154970617|NCT01499043|559315280|FG000|Overall Study|Withdrawal by Subject|2|||
154970618|NCT01499043|559315280|FG000|Overall Study|Adverse Event|1|||
154970619|NCT04750239|559315281|FG000|Overall Study|Withdrawal by Subject|2|||
154970620|NCT04750239|559315281|FG000|Overall Study|Trial terminated by sponsor|1|||
154970621|NCT01912807|559315282|FG000|Overall Study|Did not meet elegibility criteria|6|||
154970622|NCT01912807|559315283|FG001|Overall Study|Did not meet elegibility criteria|4|||
154970623|NCT01912807|559315282|FG000|Overall Study|Lost to Follow-up|36|||
154970624|NCT01912807|559315283|FG001|Overall Study|Lost to Follow-up|37|||
154970625|NCT00903877|559315284|FG000|Overall Study|Did not meet study criteria|33|||
154970626|NCT00903877|559315284|FG000|Overall Study|Withdrawal by Subject|3|||
154970627|NCT00903877|559315284|FG000|Overall Study|Adverse Event|2|||
155102552|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102553|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
154837446|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
154837447|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
154837448|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
154837449|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
154837450|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
154837451|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
154837452|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
154837453|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
154837454|NCT02831673|558840203|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
154837455|NCT02831673|558840204|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
154837456|NCT02831673|558840205|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
154837457|NCT02831673|558840206|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
154837458|NCT02831673|558840207|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
154837459|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
154837460|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
154837461|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
154837462|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
154837463|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
154837464|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
154837465|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
154837466|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
154837467|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
154837468|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
154837469|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
154837470|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
154837471|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
154837472|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
154837473|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
154837474|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
154837475|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
154837476|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
154837477|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
154837478|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
154837479|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
154837480|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155102554|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102555|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102556|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
154837481|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
154970628|NCT00903877|559315284|FG000|Overall Study|Lost to Follow-up|1|||
154970629|NCT00903877|559315284|FG000|Overall Study|Participation put on hold|4|||
154970630|NCT02535923|559315285|FG000|Overall Study|Lost to Follow-up|5|||
154970631|NCT02535923|559315286|FG001|Overall Study|Lost to Follow-up|5|||
155102557|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
154970632|NCT02535923|559315285|FG000|Overall Study|Withdrawal by Subject|4|||
155102558|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
154970633|NCT02535923|559315286|FG001|Overall Study|Withdrawal by Subject|3|||
154970634|NCT04264819|559316789|FG000|Overall Study|Physician Decision|19|||
154970635|NCT04264819|559316789|FG000|Overall Study|Adverse Event|12|||
154970636|NCT04264819|559316789|FG000|Overall Study|Withdrawal by Subject|11|||
154970637|NCT04264819|559316789|FG000|Overall Study|Lost to Follow-up|2|||
154970638|NCT04264819|559316789|FG000|Overall Study|Death|2|||
154970639|NCT01662024|559316796|FG000|Overall Study|Pregnancy|2|||
154837482|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
154837483|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
154837484|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
154837485|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
154837486|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
154837487|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
154837488|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
154837489|NCT02831673|558840203|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
154837490|NCT02831673|558840204|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
154837491|NCT02831673|558840205|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
154837492|NCT02831673|558840206|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
154837493|NCT02831673|558840207|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
154837494|NCT02831673|558840203|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
154970640|NCT01662024|559316796|FG000|Overall Study|Withdrawal by Subject|3|||
154970641|NCT00108628|559316797|FG000|Overall Study|Withdrawal by Subject|17|||
154970642|NCT00108628|559316798|FG001|Overall Study|Withdrawal by Subject|9|||
154970643|NCT00108628|559316797|FG000|Overall Study|Lack of Efficacy|2|||
154970644|NCT00108628|559316798|FG001|Overall Study|Lack of Efficacy|1|||
154970645|NCT00108628|559316797|FG000|Overall Study|Death|1|||
154970646|NCT00108628|559316798|FG001|Overall Study|Death|0|||
154970647|NCT01151280|559316801|FG000|Overall Study|Adverse Event|1|||
154970648|NCT01151280|559316801|FG000|Overall Study|Lack of Efficacy|3|||
154970649|NCT02435433|559316802|FG000|Overall Study|Withdrawal by Subject|2|||
154970650|NCT02435433|559316803|FG001|Overall Study|Withdrawal by Subject|3|||
154970651|NCT02435433|559316804|FG002|Overall Study|Withdrawal by Subject|1|||
154970652|NCT02435433|559316805|FG003|Overall Study|Withdrawal by Subject|0|||
155173454|NCT01185353|560073337|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
154970653|NCT02435433|559316806|FG004|Overall Study|Withdrawal by Subject|0|||
154970654|NCT02435433|559316802|FG000|Overall Study|Lost to Follow-up|2|||
154970655|NCT02435433|559316803|FG001|Overall Study|Lost to Follow-up|2|||
154970656|NCT02435433|559316804|FG002|Overall Study|Lost to Follow-up|4|||
154837495|NCT02831673|558840204|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
154837496|NCT02831673|558840205|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
154837497|NCT02831673|558840206|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
154837498|NCT02831673|558840207|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
154837499|NCT02831673|558840203|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
154837500|NCT02831673|558840204|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
154837501|NCT02831673|558840205|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
154837502|NCT02831673|558840206|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
154837503|NCT02831673|558840207|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
155102559|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102560|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
154970657|NCT02435433|559316805|FG003|Overall Study|Lost to Follow-up|1|||
154970658|NCT02435433|559316806|FG004|Overall Study|Lost to Follow-up|0|||
154970659|NCT00544167|559316807|FG000|Overall Study|Adverse Event|21|||
154970660|NCT00544167|559316807|FG000|Overall Study|Physician Decision|8|||
154970661|NCT03343639|559316812|FG000|Overall Study|Withdrawal by Subject|10|||
154970662|NCT03343639|559316813|FG001|Overall Study|Withdrawal by Subject|6|||
154970663|NCT03343639|559316812|FG000|Overall Study|Lost to Follow-up|4|||
154970664|NCT03343639|559316813|FG001|Overall Study|Lost to Follow-up|5|||
154970665|NCT03343639|559316812|FG000|Overall Study|Protocol Violation|0|||
154970666|NCT03343639|559316813|FG001|Overall Study|Protocol Violation|1|||
154970667|NCT00735696|559316818|FG000|Overall Study|Withdrawal by Subject|1|||
154970668|NCT00735696|559316818|FG000|Overall Study|Enrolled but never Treated|1|||
154970669|NCT00084864|559316819|FG000|Overall Study|Adverse Event|1|||
154970670|NCT00084864|559316820|FG001|Overall Study|Adverse Event|0|||
154970671|NCT00084864|559316821|FG002|Overall Study|Adverse Event|0|||
154970672|NCT00084864|559316822|FG003|Overall Study|Adverse Event|0|||
155102561|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102562|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102563|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102564|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
154970673|NCT02460835|559316826|FG000|Overall Study|Disease progression prior to treatment|3|||
154970674|NCT02460835|559316826|FG000|Overall Study|Unable to complete planning scans|2|||
155102565|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102566|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
155102567|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102568|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102569|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102570|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102571|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102572|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102573|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102574|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
155102575|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
155102576|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
155102577|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102578|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102579|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102580|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102581|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102582|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
155102583|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102584|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102585|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102586|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102587|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102588|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102589|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102590|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
155102591|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102592|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102593|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102594|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102595|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102596|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102597|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102598|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
155102599|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102600|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102601|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102602|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102603|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
154837504|NCT02831673|558840203|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155102604|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102605|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102606|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102607|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
155102608|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102609|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102610|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102611|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102612|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102613|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102614|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
155102615|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102616|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102617|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102618|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102619|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102620|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102621|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102622|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102623|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102624|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
155102625|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102626|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102627|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102628|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102629|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102630|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
155102631|NCT02891226|559806589|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102632|NCT02891226|559806590|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102633|NCT02891226|559806591|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102634|NCT02891226|559806592|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102635|NCT02891226|559806593|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102636|NCT02891226|559806594|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102637|NCT02891226|559806595|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102638|NCT02891226|559806596|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102639|NCT02891226|559806597|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102640|NCT02891226|559806598|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
155102641|NCT02891226|559806599|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102642|NCT02891226|559806600|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102643|NCT02891226|559806601|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102644|NCT02891226|559806602|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102645|NCT02891226|559806603|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102646|NCT02891226|559806604|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
155102647|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102648|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102649|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102650|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102651|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102652|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102653|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155173455|NCT01185353|560073338|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
155173456|NCT01185353|560073329|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
154837505|NCT02831673|558840204|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
154837506|NCT02831673|558840205|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155102654|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102655|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102656|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102657|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
155102658|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102659|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102660|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102661|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102662|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
155102663|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102664|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102665|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102666|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102667|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102668|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102669|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102670|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102671|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102672|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102673|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
155102674|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102675|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102676|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102677|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102678|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
155102679|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102680|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102681|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102682|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102683|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102684|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102685|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102686|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102687|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102688|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102689|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
155102690|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102691|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102692|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102693|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102694|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
155102695|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102696|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102697|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102698|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102699|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102700|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102701|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102702|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102703|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102704|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102705|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
155102706|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102707|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102708|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155173457|NCT01185353|560073330|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
154970675|NCT02460835|559316826|FG000|Overall Study|Decrease in performance status|1|||
154970676|NCT02460835|559316826|FG000|Overall Study|Withdrawal by Subject|3|||
155102709|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102710|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
155102711|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102712|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102713|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102714|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102715|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102716|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102717|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102718|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102719|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102720|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102721|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
155102722|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102723|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102724|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102725|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102726|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
155102727|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102728|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102729|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102730|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102731|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102732|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102733|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102734|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102735|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102736|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102737|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
155102738|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102739|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102740|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102741|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102742|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
155102743|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
154837507|NCT02831673|558840206|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
154837508|NCT02831673|558840207|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
154837509|NCT02831673|558840203|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155102744|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102745|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102746|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102747|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102748|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102749|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102750|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102751|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102752|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102753|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
155102754|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102755|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102756|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102757|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102758|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
155102759|NCT02891226|559806589|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102760|NCT02891226|559806590|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102761|NCT02891226|559806591|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102762|NCT02891226|559806592|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102763|NCT02891226|559806593|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102764|NCT02891226|559806594|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102765|NCT02891226|559806595|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102766|NCT02891226|559806596|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102767|NCT02891226|559806597|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102768|NCT02891226|559806598|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102769|NCT02891226|559806599|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
155102770|NCT02891226|559806600|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102771|NCT02891226|559806601|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102772|NCT02891226|559806602|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102773|NCT02891226|559806603|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102774|NCT02891226|559806604|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
155102775|NCT02891226|559806589|FG000|Follow-up Period|Withdrawal by Subject|0|||
155102776|NCT02891226|559806590|FG001|Follow-up Period|Withdrawal by Subject|0|||
155102777|NCT02891226|559806591|FG002|Follow-up Period|Withdrawal by Subject|0|||
155102778|NCT02891226|559806592|FG003|Follow-up Period|Withdrawal by Subject|0|||
155102779|NCT02891226|559806593|FG004|Follow-up Period|Withdrawal by Subject|0|||
155102780|NCT02891226|559806594|FG005|Follow-up Period|Withdrawal by Subject|0|||
155102781|NCT02891226|559806595|FG006|Follow-up Period|Withdrawal by Subject|0|||
155102782|NCT02891226|559806596|FG007|Follow-up Period|Withdrawal by Subject|0|||
155102783|NCT02891226|559806597|FG008|Follow-up Period|Withdrawal by Subject|0|||
155102784|NCT02891226|559806598|FG009|Follow-up Period|Withdrawal by Subject|0|||
155102785|NCT02891226|559806599|FG010|Follow-up Period|Withdrawal by Subject|0|||
155102786|NCT02891226|559806600|FG011|Follow-up Period|Withdrawal by Subject|1|||
155102787|NCT02891226|559806601|FG012|Follow-up Period|Withdrawal by Subject|0|||
155102788|NCT02891226|559806602|FG013|Follow-up Period|Withdrawal by Subject|0|||
155102789|NCT02891226|559806603|FG014|Follow-up Period|Withdrawal by Subject|1|||
155102790|NCT02891226|559806604|FG015|Follow-up Period|Withdrawal by Subject|1|||
155102791|NCT01445847|559806605|FG000|Overall Study|Protocol Violation|13|||
155102792|NCT01445847|559806606|FG001|Overall Study|Protocol Violation|14|||
155102793|NCT01445847|559806605|FG000|Overall Study|Missed Data|1|||
155102794|NCT01445847|559806606|FG001|Overall Study|Missed Data|0|||
155102795|NCT00707993|559806607|FG000|Overall Study|Adverse Event|16|||
155102796|NCT00707993|559806608|FG001|Overall Study|Adverse Event|20|||
155102797|NCT00707993|559806607|FG000|Overall Study|Protocol Violation|4|||
155102798|NCT00707993|559806608|FG001|Overall Study|Protocol Violation|7|||
155102799|NCT00707993|559806607|FG000|Overall Study|Lost to Follow-up|0|||
155102800|NCT00707993|559806608|FG001|Overall Study|Lost to Follow-up|4|||
155102801|NCT00707993|559806607|FG000|Overall Study|Withdrawal by Subject|12|||
155102802|NCT00707993|559806608|FG001|Overall Study|Withdrawal by Subject|16|||
155102803|NCT00707993|559806607|FG000|Overall Study|Hyperglycemic Rescue|55|||
155102804|NCT00707993|559806608|FG001|Overall Study|Hyperglycemic Rescue|47|||
155102805|NCT00707993|559806607|FG000|Overall Study|Other|2|||
155102806|NCT00707993|559806608|FG001|Overall Study|Other|0|||
155102807|NCT03008070|559806609|FG000|Overall Study|Adverse Event|3|||
155102808|NCT03008070|559806610|FG001|Overall Study|Adverse Event|3|||
155102809|NCT03008070|559806611|FG002|Overall Study|Adverse Event|3|||
155102810|NCT03008070|559806609|FG000|Overall Study|Lost to Follow-up|1|||
155102811|NCT03008070|559806610|FG001|Overall Study|Lost to Follow-up|1|||
155102812|NCT03008070|559806611|FG002|Overall Study|Lost to Follow-up|0|||
155102813|NCT03008070|559806609|FG000|Overall Study|Non compliance|0|||
155102814|NCT03008070|559806610|FG001|Overall Study|Non compliance|1|||
155102815|NCT03008070|559806611|FG002|Overall Study|Non compliance|1|||
155102816|NCT03008070|559806609|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
155102817|NCT03008070|559806610|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
155102818|NCT03008070|559806611|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
155102819|NCT03008070|559806609|FG000|Overall Study|Withdrawal by Subject|2|||
155102820|NCT03008070|559806610|FG001|Overall Study|Withdrawal by Subject|0|||
155102821|NCT03008070|559806611|FG002|Overall Study|Withdrawal by Subject|1|||
155102822|NCT03008070|559806609|FG000|Overall Study|Use of prohibited drug|0|||
155102823|NCT03008070|559806610|FG001|Overall Study|Use of prohibited drug|0|||
155102824|NCT03008070|559806611|FG002|Overall Study|Use of prohibited drug|2|||
154837510|NCT02831673|558840204|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
154837511|NCT02831673|558840205|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
154837512|NCT02831673|558840206|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155102825|NCT03960684|559806612|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
155102826|NCT03533660|559806613|FG000|Overall Study|Withdrawal by Subject|2|||
155102827|NCT03533660|559806614|FG001|Overall Study|Withdrawal by Subject|2|||
155102828|NCT03533660|559806613|FG000|Overall Study|Death|2|||
155102829|NCT03533660|559806614|FG001|Overall Study|Death|4|||
155102830|NCT03533660|559806613|FG000|Overall Study|Adverse Event|0|||
155102831|NCT03533660|559806614|FG001|Overall Study|Adverse Event|2|||
155102832|NCT03816176|559806615|FG000|Overall Study|Miscellaneous|5|||
155102833|NCT03816176|559806615|FG000|Overall Study|Lack of Efficacy|4|||
155102834|NCT03816176|559806615|FG000|Overall Study|Adverse Event|3|||
155102835|NCT03640325|559808505|FG000|Overall Study|Withdrawal by Subject|4|||
155102836|NCT03640325|559808506|FG001|Overall Study|Withdrawal by Subject|1|||
155102837|NCT03640325|559808507|FG002|Overall Study|Withdrawal by Subject|0|||
155102838|NCT03640325|559808505|FG000|Overall Study|Lost to Follow-up|4|||
155102839|NCT03640325|559808506|FG001|Overall Study|Lost to Follow-up|5|||
155102840|NCT03640325|559808507|FG002|Overall Study|Lost to Follow-up|21|||
155102841|NCT03640325|559808505|FG000|Overall Study|Death|5|||
154970677|NCT02460835|559316826|FG000|Overall Study|Underwent fractionated RT|10|||
154970678|NCT02460835|559316826|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
154970679|NCT02655224|559316827|FG000|Overall Study|Adverse Event|1|||
154970680|NCT02655224|559316828|FG001|Overall Study|Adverse Event|1|||
155102842|NCT03640325|559808506|FG001|Overall Study|Death|5|||
155102843|NCT03640325|559808507|FG002|Overall Study|Death|0|||
155102844|NCT05265728|559808508|FG000|Overall Study|Adverse Event|1|||
155102845|NCT05265728|559808508|FG000|Overall Study|Study Terminated by Sponsor|5|||
155102846|NCT05265728|559808508|FG000|Overall Study|Withdrawal by Subject|2|||
155102847|NCT03493451|559808509|FG000|Overall Study|Death|11|||
155102848|NCT03493451|559808510|FG001|Overall Study|Death|26|||
155102849|NCT03493451|559808511|FG002|Overall Study|Death|3|||
155102850|NCT03493451|559808509|FG000|Overall Study|Lost to Follow-up|1|||
155102851|NCT03493451|559808510|FG001|Overall Study|Lost to Follow-up|4|||
155102852|NCT03493451|559808511|FG002|Overall Study|Lost to Follow-up|1|||
155102853|NCT03493451|559808509|FG000|Overall Study|Withdrawal by Subject|1|||
155102854|NCT03493451|559808510|FG001|Overall Study|Withdrawal by Subject|1|||
155102855|NCT03493451|559808511|FG002|Overall Study|Withdrawal by Subject|2|||
155102856|NCT03493451|559808509|FG000|Overall Study|Progressive Disease|1|||
155102857|NCT03493451|559808510|FG001|Overall Study|Progressive Disease|0|||
155102858|NCT03493451|559808511|FG002|Overall Study|Progressive Disease|0|||
155102859|NCT03493451|559808509|FG000|Overall Study|Transferred to long term extension study|8|||
155102860|NCT03493451|559808510|FG001|Overall Study|Transferred to long term extension study|13|||
155102861|NCT03493451|559808511|FG002|Overall Study|Transferred to long term extension study|5|||
155102862|NCT01566149|559808514|FG000|Overall Study|Adverse Event|0|||
155102863|NCT01566149|559808515|FG001|Overall Study|Adverse Event|1|||
155102864|NCT01566149|559808514|FG000|Overall Study|Non-compliance with study medication|2|||
155102865|NCT01566149|559808515|FG001|Overall Study|Non-compliance with study medication|0|||
154970681|NCT00063258|559316838|FG000|Overall Study|Physician Decision|2|||
154970682|NCT00063258|559316839|FG001|Overall Study|Physician Decision|0|||
154970683|NCT00063258|559316838|FG000|Overall Study|Lack of Efficacy|2|||
154970684|NCT00063258|559316839|FG001|Overall Study|Lack of Efficacy|0|||
154970685|NCT02483416|559316842|FG000|Overall Study|Other reason|0|||
154970686|NCT02483416|559316843|FG001|Overall Study|Other reason|1|||
154970687|NCT02483416|559316842|FG000|Overall Study|Treatment stop|3|||
154970688|NCT02483416|559316843|FG001|Overall Study|Treatment stop|0|||
154970689|NCT02587143|559316845|FG000|Overall Study|Adverse Event|1|||
154970690|NCT02587143|559316846|FG001|Overall Study|Adverse Event|0|||
154970691|NCT01119625|559316847|FG000|Overall Study|Lost to Follow-up|1|||
154970692|NCT01119625|559316848|FG001|Overall Study|Lost to Follow-up|2|||
154970693|NCT01119625|559316847|FG000|Overall Study|Withdrawal by Subject|2|||
154970694|NCT01119625|559316848|FG001|Overall Study|Withdrawal by Subject|1|||
155102866|NCT01566149|559808514|FG000|Overall Study|Protocol Violation|0|||
155102867|NCT01566149|559808515|FG001|Overall Study|Protocol Violation|1|||
155102868|NCT01566149|559808514|FG000|Overall Study|Withdrawal by Subject|1|||
154970695|NCT01119625|559316847|FG000|Overall Study|Other|0|||
154970696|NCT01119625|559316848|FG001|Overall Study|Other|1|||
154970697|NCT01721772|559316853|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
154970698|NCT01721772|559316854|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
154970699|NCT01721772|559316853|FG000|Pre-Treatment|Poor/non-compliance|0|||
154970700|NCT01721772|559316854|FG001|Pre-Treatment|Poor/non-compliance|1|||
154970701|NCT01721772|559316853|FG000|Pre-Treatment|Participant withdrew consent|0|||
154970702|NCT01721772|559316854|FG001|Pre-Treatment|Participant withdrew consent|1|||
154970703|NCT01721772|559316853|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
154970704|NCT01721772|559316854|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
154970705|NCT01721772|559316853|FG000|Treatment|Disease progression|119|||
154970706|NCT01721772|559316854|FG001|Treatment|Disease progression|168|||
154970707|NCT01721772|559316853|FG000|Treatment|Study drug toxicity|19|||
154970708|NCT01721772|559316854|FG001|Treatment|Study drug toxicity|10|||
154970709|NCT01721772|559316853|FG000|Treatment|Adverse event unrelated to study drug|7|||
155102869|NCT01566149|559808515|FG001|Overall Study|Withdrawal by Subject|0|||
155102870|NCT03687957|559808520|FG000|Overall Study|Withdrawal by Subject|0|||
154970710|NCT01721772|559316854|FG001|Treatment|Adverse event unrelated to study drug|7|||
155102871|NCT03687957|559808521|FG001|Overall Study|Withdrawal by Subject|0|||
155102872|NCT03687957|559808522|FG002|Overall Study|Withdrawal by Subject|0|||
155102873|NCT03687957|559808523|FG003|Overall Study|Withdrawal by Subject|2|||
155102874|NCT03687957|559808524|FG004|Overall Study|Withdrawal by Subject|0|||
155102875|NCT03687957|559808525|FG005|Overall Study|Withdrawal by Subject|0|||
155102876|NCT03687957|559808526|FG006|Overall Study|Withdrawal by Subject|3|||
155102877|NCT03687957|559808527|FG007|Overall Study|Withdrawal by Subject|1|||
154970711|NCT01721772|559316853|FG000|Treatment|Maximum clinical benefit|16|||
154970712|NCT01721772|559316854|FG001|Treatment|Maximum clinical benefit|4|||
154970713|NCT01721772|559316853|FG000|Treatment|Other|19|||
154970714|NCT01721772|559316854|FG001|Treatment|Other|2|||
154970715|NCT01721772|559316853|FG000|Treatment|Participant withdrew consent|2|||
154970716|NCT01721772|559316854|FG001|Treatment|Participant withdrew consent|5|||
155102878|NCT03687957|559808528|FG008|Overall Study|Withdrawal by Subject|1|||
155102879|NCT03687957|559808529|FG009|Overall Study|Withdrawal by Subject|0|||
155102880|NCT03687957|559808520|FG000|Overall Study|Disease progression|0|||
155102881|NCT03687957|559808521|FG001|Overall Study|Disease progression|1|||
155102882|NCT03687957|559808522|FG002|Overall Study|Disease progression|1|||
154837513|NCT02831673|558840207|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
154837514|NCT02831673|558840203|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
154837515|NCT02831673|558840204|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
154837516|NCT02831673|558840205|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
154837517|NCT02831673|558840206|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
154837518|NCT02831673|558840207|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
154837519|NCT00150592|558840208|FG000|Overall Study|Adverse Event|4|||
154837520|NCT00150592|558840209|FG001|Overall Study|Adverse Event|1|||
154837521|NCT00150592|558840208|FG000|Overall Study|Protocol Violation|1|||
154837522|NCT00150592|558840209|FG001|Overall Study|Protocol Violation|0|||
154837523|NCT00150592|558840208|FG000|Overall Study|Withdrawal by Subject|1|||
154837524|NCT00150592|558840209|FG001|Overall Study|Withdrawal by Subject|2|||
154837525|NCT00150592|558840208|FG000|Overall Study|Non-compliance|1|||
154837526|NCT00150592|558840209|FG001|Overall Study|Non-compliance|0|||
154837527|NCT01659320|558840225|FG000|Overall Study|Withdrawal by Subject|2|||
154837528|NCT01659320|558840225|FG000|Overall Study|Physician Decision|1|||
154837529|NCT01514682|558840226|FG000|Overall Study|Withdrawal by Subject|2|||
154837530|NCT01514682|558840227|FG001|Overall Study|Withdrawal by Subject|3|||
154837531|NCT01514682|558840226|FG000|Overall Study|Physician Decision|4|||
154837532|NCT01514682|558840227|FG001|Overall Study|Physician Decision|3|||
154837533|NCT00590590|558840228|FG000|Overall Study|Lack of Efficacy|1|||
154837534|NCT00590590|558840229|FG001|Overall Study|Lack of Efficacy|2|||
154837535|NCT00590590|558840230|FG002|Overall Study|Lack of Efficacy|0|||
154837536|NCT00590590|558840228|FG000|Overall Study|Adverse Event|1|||
154837537|NCT00590590|558840229|FG001|Overall Study|Adverse Event|0|||
154837538|NCT00590590|558840230|FG002|Overall Study|Adverse Event|0|||
154837539|NCT00590590|558840228|FG000|Overall Study|Protocol Violation|0|||
154837540|NCT00590590|558840229|FG001|Overall Study|Protocol Violation|0|||
154837541|NCT00590590|558840230|FG002|Overall Study|Protocol Violation|2|||
154837542|NCT00590590|558840228|FG000|Overall Study|Lost to Follow-up|4|||
154837543|NCT00590590|558840229|FG001|Overall Study|Lost to Follow-up|1|||
154837544|NCT00590590|558840230|FG002|Overall Study|Lost to Follow-up|2|||
154837545|NCT00590590|558840228|FG000|Overall Study|Withdrawal by Subject|0|||
154837546|NCT00590590|558840229|FG001|Overall Study|Withdrawal by Subject|1|||
154837547|NCT00590590|558840230|FG002|Overall Study|Withdrawal by Subject|1|||
154837548|NCT00590590|558840228|FG000|Overall Study|Did not complete due to study closure|1|||
154837549|NCT00590590|558840229|FG001|Overall Study|Did not complete due to study closure|1|||
154837550|NCT00590590|558840230|FG002|Overall Study|Did not complete due to study closure|1|||
154837551|NCT00590590|558840228|FG000|Overall Study|Did not complete study|0|||
154837552|NCT00590590|558840229|FG001|Overall Study|Did not complete study|1|||
154837553|NCT00590590|558840230|FG002|Overall Study|Did not complete study|0|||
154837554|NCT00132132|558840231|FG000|Overall Study|Lost to Follow-up|7|||
154837555|NCT00132132|558840232|FG001|Overall Study|Lost to Follow-up|2|||
154837556|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
154837557|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
154837558|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
154837559|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
154837560|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
154837561|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
154837562|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
154837563|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
154837564|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
154837565|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
154837566|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
154837567|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
154837568|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
154837569|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
154837570|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
154837571|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
154837572|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
154837573|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
154837574|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
154837575|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
154837576|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
154837577|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
154837578|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
154837579|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
154837580|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
154837581|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
154837582|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
154837583|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
155102883|NCT03687957|559808523|FG003|Overall Study|Disease progression|2|||
155102884|NCT03687957|559808524|FG004|Overall Study|Disease progression|2|||
155102885|NCT03687957|559808525|FG005|Overall Study|Disease progression|0|||
155102886|NCT03687957|559808526|FG006|Overall Study|Disease progression|2|||
155102887|NCT03687957|559808527|FG007|Overall Study|Disease progression|1|||
155102888|NCT03687957|559808528|FG008|Overall Study|Disease progression|0|||
155102889|NCT03687957|559808529|FG009|Overall Study|Disease progression|0|||
155102890|NCT03687957|559808520|FG000|Overall Study|Physician Decision|0|||
155102891|NCT03687957|559808521|FG001|Overall Study|Physician Decision|0|||
155102892|NCT03687957|559808522|FG002|Overall Study|Physician Decision|0|||
155102893|NCT03687957|559808523|FG003|Overall Study|Physician Decision|2|||
155102894|NCT03687957|559808524|FG004|Overall Study|Physician Decision|1|||
155102895|NCT03687957|559808525|FG005|Overall Study|Physician Decision|0|||
155102896|NCT03687957|559808526|FG006|Overall Study|Physician Decision|1|||
155102897|NCT03687957|559808527|FG007|Overall Study|Physician Decision|0|||
155102898|NCT03687957|559808528|FG008|Overall Study|Physician Decision|0|||
155102899|NCT03687957|559808529|FG009|Overall Study|Physician Decision|0|||
155102900|NCT03687957|559808520|FG000|Overall Study|New malignancy|0|||
155102901|NCT03687957|559808521|FG001|Overall Study|New malignancy|0|||
155102902|NCT03687957|559808522|FG002|Overall Study|New malignancy|0|||
155102903|NCT03687957|559808523|FG003|Overall Study|New malignancy|0|||
155102904|NCT03687957|559808524|FG004|Overall Study|New malignancy|1|||
155102905|NCT03687957|559808525|FG005|Overall Study|New malignancy|0|||
155102906|NCT03687957|559808526|FG006|Overall Study|New malignancy|0|||
155102907|NCT03687957|559808527|FG007|Overall Study|New malignancy|0|||
155102908|NCT03687957|559808528|FG008|Overall Study|New malignancy|0|||
155102909|NCT03687957|559808529|FG009|Overall Study|New malignancy|0|||
155102910|NCT03687957|559808520|FG000|Overall Study|Adverse Event|0|||
155102911|NCT03687957|559808521|FG001|Overall Study|Adverse Event|0|||
155102912|NCT03687957|559808522|FG002|Overall Study|Adverse Event|0|||
155102913|NCT03687957|559808523|FG003|Overall Study|Adverse Event|0|||
155102914|NCT03687957|559808524|FG004|Overall Study|Adverse Event|0|||
155102915|NCT03687957|559808525|FG005|Overall Study|Adverse Event|2|||
155102916|NCT03687957|559808526|FG006|Overall Study|Adverse Event|0|||
155102917|NCT03687957|559808527|FG007|Overall Study|Adverse Event|3|||
155102918|NCT03687957|559808528|FG008|Overall Study|Adverse Event|0|||
155102919|NCT03687957|559808529|FG009|Overall Study|Adverse Event|0|||
155102920|NCT03687957|559808520|FG000|Overall Study|Patient went on hospice|0|||
155102921|NCT03687957|559808521|FG001|Overall Study|Patient went on hospice|0|||
155102922|NCT03687957|559808522|FG002|Overall Study|Patient went on hospice|0|||
155102923|NCT03687957|559808523|FG003|Overall Study|Patient went on hospice|0|||
155102924|NCT03687957|559808524|FG004|Overall Study|Patient went on hospice|0|||
155102925|NCT03687957|559808525|FG005|Overall Study|Patient went on hospice|0|||
155102926|NCT03687957|559808526|FG006|Overall Study|Patient went on hospice|1|||
155102927|NCT03687957|559808527|FG007|Overall Study|Patient went on hospice|0|||
155102928|NCT03687957|559808528|FG008|Overall Study|Patient went on hospice|0|||
155102929|NCT03687957|559808529|FG009|Overall Study|Patient went on hospice|0|||
155102930|NCT03687957|559808520|FG000|Overall Study|Death|0|||
155102931|NCT03687957|559808521|FG001|Overall Study|Death|0|||
155102932|NCT03687957|559808522|FG002|Overall Study|Death|0|||
155102933|NCT03687957|559808523|FG003|Overall Study|Death|0|||
155102934|NCT03687957|559808524|FG004|Overall Study|Death|0|||
155102935|NCT03687957|559808525|FG005|Overall Study|Death|0|||
155102936|NCT03687957|559808526|FG006|Overall Study|Death|0|||
155102937|NCT03687957|559808527|FG007|Overall Study|Death|1|||
155102938|NCT03687957|559808528|FG008|Overall Study|Death|0|||
155102939|NCT03687957|559808529|FG009|Overall Study|Death|0|||
155102940|NCT03276728|559808530|FG000|Overall Study|Lost to Follow-up|0|||
155102941|NCT03276728|559808531|FG001|Overall Study|Lost to Follow-up|0|||
155102942|NCT03276728|559808532|FG002|Overall Study|Lost to Follow-up|2|||
155102943|NCT03276728|559808533|FG003|Overall Study|Lost to Follow-up|2|||
155102944|NCT03276728|559808534|FG004|Overall Study|Lost to Follow-up|0|||
155102945|NCT03276728|559808535|FG005|Overall Study|Lost to Follow-up|0|||
155102946|NCT03276728|559808536|FG006|Overall Study|Lost to Follow-up|0|||
155102947|NCT03276728|559808537|FG007|Overall Study|Lost to Follow-up|0|||
154837584|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
154837585|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
154837586|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
154837587|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
154837588|NCT03605680|558840235|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
154837589|NCT03605680|558840236|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
154837590|NCT03605680|558840237|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
154837591|NCT03605680|558840238|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
154837592|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
154837593|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
154837594|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
154837595|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
154837596|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
154837597|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
154837598|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
154837599|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
154837600|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
154837601|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
154837602|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
154837603|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
154837604|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
154837605|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
154837606|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
154837607|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
154837608|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
154837609|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
154837610|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
154837611|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
154837612|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
154837613|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
154837614|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
154837615|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
154837616|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
154837617|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
154837618|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
154837619|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
154837620|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
154837621|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
154837622|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
154837623|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
154837624|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
154837625|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
154837626|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
154837627|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
154837628|NCT03605680|558840235|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
154837629|NCT03605680|558840236|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
154837630|NCT03605680|558840237|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
154837631|NCT03605680|558840238|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
154837632|NCT00647556|558840239|FG000|Overall Study|Adverse Event|0|||
155102948|NCT03276728|559808530|FG000|Overall Study|Withdrawal by Subject|0|||
155102949|NCT03276728|559808531|FG001|Overall Study|Withdrawal by Subject|0|||
155102950|NCT03276728|559808532|FG002|Overall Study|Withdrawal by Subject|0|||
155102951|NCT03276728|559808533|FG003|Overall Study|Withdrawal by Subject|3|||
155102952|NCT03276728|559808534|FG004|Overall Study|Withdrawal by Subject|0|||
155102953|NCT03276728|559808535|FG005|Overall Study|Withdrawal by Subject|0|||
155102954|NCT03276728|559808536|FG006|Overall Study|Withdrawal by Subject|0|||
155102955|NCT03276728|559808537|FG007|Overall Study|Withdrawal by Subject|0|||
155102956|NCT03276728|559808530|FG000|Overall Study|Decision by sponsor|0|||
155102957|NCT03276728|559808531|FG001|Overall Study|Decision by sponsor|0|||
155102958|NCT03276728|559808532|FG002|Overall Study|Decision by sponsor|0|||
155102959|NCT03276728|559808533|FG003|Overall Study|Decision by sponsor|0|||
155102960|NCT03276728|559808534|FG004|Overall Study|Decision by sponsor|1|||
154837633|NCT00647556|558840240|FG001|Overall Study|Adverse Event|1|||
154837634|NCT00647556|558840239|FG000|Overall Study|Lost to Follow-up|1|||
154837635|NCT00647556|558840240|FG001|Overall Study|Lost to Follow-up|0|||
154837636|NCT00647556|558840239|FG000|Overall Study|Protocol Violation|0|||
154837637|NCT00647556|558840240|FG001|Overall Study|Protocol Violation|1|||
154837638|NCT00647556|558840239|FG000|Overall Study|Withdrawal by Subject|1|||
154837639|NCT00647556|558840240|FG001|Overall Study|Withdrawal by Subject|0|||
154837640|NCT00647556|558840239|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
154837641|NCT00647556|558840240|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
154837642|NCT02145741|558840241|FG000|Overall Study|Progressive disease|3|||
154837643|NCT02145741|558840242|FG001|Overall Study|Progressive disease|6|||
154837644|NCT02145741|558840243|FG002|Overall Study|Progressive disease|6|||
154837645|NCT02145741|558840241|FG000|Overall Study|quality issue with the administered drug|3|||
154837646|NCT02145741|558840242|FG001|Overall Study|quality issue with the administered drug|0|||
154837647|NCT02145741|558840243|FG002|Overall Study|quality issue with the administered drug|0|||
154837648|NCT03865706|558840246|FG000|Overall Study|Death|0|||
154837649|NCT03865706|558840247|FG001|Overall Study|Death|3|||
154837650|NCT03865706|558840248|FG002|Overall Study|Death|1|||
154837651|NCT02095535|558840249|FG000|Recruitment|Protocol Violation|2|||
154837652|NCT02646982|558840250|FG000|Overall Study|Adverse Event|1|||
154837653|NCT02646982|558840251|FG001|Overall Study|Adverse Event|1|||
154837654|NCT02646982|558840250|FG000|Overall Study|Withdrawal by Subject|2|||
154837655|NCT02646982|558840251|FG001|Overall Study|Withdrawal by Subject|1|||
154837656|NCT00769002|558840254|FG000|Overall Study|Study was not completed, no data|9|||
154837657|NCT00769002|558840255|FG001|Overall Study|Study was not completed, no data|9|||
154837658|NCT00960661|558840256|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
154837659|NCT00960661|558840257|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
154837660|NCT00960661|558840258|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
154837661|NCT00960661|558840256|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
154837662|NCT00960661|558840257|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
154837663|NCT00960661|558840258|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
154837664|NCT00960661|558840256|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
154837665|NCT00960661|558840257|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
154837666|NCT00960661|558840258|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
154837667|NCT00960661|558840256|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
154837668|NCT00960661|558840257|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
154837669|NCT00960661|558840258|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
154837670|NCT00960661|558840256|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
154837671|NCT00960661|558840257|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
154837672|NCT00960661|558840258|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
154837673|NCT00960661|558840256|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
154837674|NCT00960661|558840257|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
154837675|NCT00960661|558840258|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
154837676|NCT00960661|558840256|FG000|Interventional Phase|Adverse Event|0|||
154837677|NCT00960661|558840257|FG001|Interventional Phase|Adverse Event|17|||
154837678|NCT00960661|558840258|FG002|Interventional Phase|Adverse Event|8|||
154837679|NCT00960661|558840256|FG000|Interventional Phase|Death|0|||
154837680|NCT00960661|558840257|FG001|Interventional Phase|Death|1|||
154837681|NCT00960661|558840258|FG002|Interventional Phase|Death|0|||
154837682|NCT00960661|558840256|FG000|Interventional Phase|Lost to Follow-up|0|||
154837683|NCT00960661|558840257|FG001|Interventional Phase|Lost to Follow-up|0|||
154837684|NCT00960661|558840258|FG002|Interventional Phase|Lost to Follow-up|2|||
154837685|NCT00960661|558840256|FG000|Interventional Phase|entry criteria not met|0|||
155102961|NCT03276728|559808535|FG005|Overall Study|Decision by sponsor|0|||
154837686|NCT00960661|558840257|FG001|Interventional Phase|entry criteria not met|3|||
154837687|NCT00960661|558840258|FG002|Interventional Phase|entry criteria not met|0|||
154837688|NCT00960661|558840256|FG000|Interventional Phase|Protocol Violation|0|||
154837689|NCT00960661|558840257|FG001|Interventional Phase|Protocol Violation|7|||
154837690|NCT00960661|558840258|FG002|Interventional Phase|Protocol Violation|2|||
154837691|NCT00960661|558840256|FG000|Interventional Phase|Withdrawal by Subject|0|||
154837692|NCT00960661|558840257|FG001|Interventional Phase|Withdrawal by Subject|18|||
154837693|NCT00960661|558840258|FG002|Interventional Phase|Withdrawal by Subject|29|||
154837694|NCT00960661|558840256|FG000|Interventional Phase|Physician Decision|0|||
154837695|NCT00960661|558840257|FG001|Interventional Phase|Physician Decision|3|||
154837696|NCT00960661|558840258|FG002|Interventional Phase|Physician Decision|5|||
154837697|NCT00960661|558840256|FG000|Interventional Phase|sponsor decision|0|||
155102962|NCT03276728|559808536|FG006|Overall Study|Decision by sponsor|2|||
155102963|NCT03276728|559808537|FG007|Overall Study|Decision by sponsor|1|||
155102964|NCT02213926|559808538|FG000|Overall Study|Death|59|||
155102965|NCT02213926|559808538|FG000|Overall Study|Withdrawal by Subject|10|||
155102966|NCT02213926|559808538|FG000|Overall Study|study terminated by sponsor|51|||
155102967|NCT02213926|559808538|FG000|Overall Study|Lost to Follow-up|3|||
155102968|NCT02213926|559808538|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
155102969|NCT01188551|559808539|FG000|Overall Study|Pharmacy issues|1|||
155102970|NCT01188551|559808540|FG001|Overall Study|Pharmacy issues|0|||
155102971|NCT01188551|559808541|FG002|Overall Study|Pharmacy issues|0|||
155102972|NCT01188551|559808542|FG003|Overall Study|Pharmacy issues|0|||
155102973|NCT03458325|559808550|FG000|Overall Study|Withdrawal by Subject|1|||
155102974|NCT02630693|559808551|FG000|Overall Study|No receive treatment|0|||
155102975|NCT02630693|559808552|FG001|Overall Study|No receive treatment|1|||
155102976|NCT00310375|559808553|FG000|Primary Reporting Phase|Adverse Event|28|||
155102977|NCT00310375|559808554|FG001|Primary Reporting Phase|Adverse Event|22|||
155102978|NCT00310375|559808555|FG002|Primary Reporting Phase|Adverse Event|0|||
155102979|NCT00310375|559808553|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
155102980|NCT00310375|559808554|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
155102981|NCT00310375|559808555|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
155102982|NCT00310375|559808553|FG000|Primary Reporting Phase|Pregnancy|2|||
155102983|NCT00310375|559808554|FG001|Primary Reporting Phase|Pregnancy|2|||
155102984|NCT00310375|559808555|FG002|Primary Reporting Phase|Pregnancy|0|||
155102985|NCT00310375|559808553|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
155102986|NCT00310375|559808554|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
155102987|NCT00310375|559808555|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
155102988|NCT00310375|559808553|FG000|Primary Reporting Phase|Protocol Violation|8|||
155102989|NCT00310375|559808554|FG001|Primary Reporting Phase|Protocol Violation|5|||
155102990|NCT00310375|559808555|FG002|Primary Reporting Phase|Protocol Violation|0|||
155102991|NCT00310375|559808553|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
155102992|NCT00310375|559808554|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
155102993|NCT00310375|559808555|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
155102994|NCT00310375|559808553|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
155102995|NCT00310375|559808554|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
155102996|NCT00310375|559808555|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
155102997|NCT00310375|559808553|FG000|Primary Reporting Phase|Physician Decision|5|||
155102998|NCT00310375|559808554|FG001|Primary Reporting Phase|Physician Decision|3|||
155102999|NCT00310375|559808555|FG002|Primary Reporting Phase|Physician Decision|0|||
155103000|NCT00310375|559808553|FG000|Primary Reporting Phase|Request of the sponsor|2|||
155103001|NCT00310375|559808554|FG001|Primary Reporting Phase|Request of the sponsor|2|||
155103002|NCT00310375|559808555|FG002|Primary Reporting Phase|Request of the sponsor|0|||
155103003|NCT00310375|559808553|FG000|Primary Reporting Phase|Failed to return|1|||
155103004|NCT00310375|559808554|FG001|Primary Reporting Phase|Failed to return|3|||
155103005|NCT00310375|559808555|FG002|Primary Reporting Phase|Failed to return|0|||
155103006|NCT00310375|559808553|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
155103007|NCT00310375|559808554|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
155103008|NCT00310375|559808555|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
155103009|NCT00310375|559808553|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
155103010|NCT00310375|559808554|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
155103011|NCT00310375|559808555|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
154837698|NCT00960661|558840257|FG001|Interventional Phase|sponsor decision|1|||
155103012|NCT00310375|559808553|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
155103013|NCT00310375|559808554|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
155103014|NCT00310375|559808555|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
155103015|NCT00310375|559808553|FG000|Primary Reporting Phase|Site closure|3|||
155103016|NCT00310375|559808554|FG001|Primary Reporting Phase|Site closure|0|||
155103017|NCT00310375|559808555|FG002|Primary Reporting Phase|Site closure|0|||
155103018|NCT00310375|559808553|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
155103019|NCT00310375|559808554|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
155103020|NCT00310375|559808555|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
155103021|NCT00310375|559808553|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
155103022|NCT00310375|559808554|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
154837699|NCT00960661|558840258|FG002|Interventional Phase|sponsor decision|0|||
154837700|NCT00960661|558840256|FG000|Interventional Phase|Lack of Efficacy|0|||
154837701|NCT00960661|558840257|FG001|Interventional Phase|Lack of Efficacy|2|||
154837702|NCT00960661|558840258|FG002|Interventional Phase|Lack of Efficacy|0|||
154837703|NCT02699892|558840259|FG000|Overall Study|Other|36|||
154837704|NCT04677712|558840260|FG000|Overall Study|Lost to Follow-up|0|||
154837705|NCT04677712|558840261|FG001|Overall Study|Lost to Follow-up|1|||
154837706|NCT04677712|558840262|FG002|Overall Study|Lost to Follow-up|0|||
154837707|NCT04677712|558840263|FG003|Overall Study|Lost to Follow-up|0|||
154837708|NCT04677712|558840264|FG004|Overall Study|Lost to Follow-up|0|||
154837709|NCT04677712|558840265|FG005|Overall Study|Lost to Follow-up|0|||
154837710|NCT00847912|558840266|FG000|Overall Study|Protocol Violation|6|||
154837711|NCT00847912|558840267|FG001|Overall Study|Protocol Violation|7|||
154837712|NCT00847912|558840266|FG000|Overall Study|Withdrawal by Subject|3|||
154837713|NCT00847912|558840267|FG001|Overall Study|Withdrawal by Subject|6|||
154837714|NCT02083380|558840269|FG000|Overall Study|Lack of Efficacy|68|||
154837715|NCT02083380|558840270|FG001|Overall Study|Lack of Efficacy|79|||
154837716|NCT02083380|558840271|FG002|Overall Study|Lack of Efficacy|64|||
154837717|NCT02083380|558840269|FG000|Overall Study|Withdrawal by Subject|9|||
154837718|NCT02083380|558840270|FG001|Overall Study|Withdrawal by Subject|3|||
154837719|NCT02083380|558840271|FG002|Overall Study|Withdrawal by Subject|7|||
154837720|NCT02083380|558840269|FG000|Overall Study|Physician Decision|1|||
154837721|NCT02083380|558840270|FG001|Overall Study|Physician Decision|6|||
154837722|NCT02083380|558840271|FG002|Overall Study|Physician Decision|3|||
154837723|NCT02083380|558840269|FG000|Overall Study|Adverse Event|0|||
154837724|NCT02083380|558840270|FG001|Overall Study|Adverse Event|0|||
154837725|NCT02083380|558840271|FG002|Overall Study|Adverse Event|1|||
154837726|NCT02083380|558840269|FG000|Overall Study|Lost to Follow-up|5|||
154837727|NCT02083380|558840270|FG001|Overall Study|Lost to Follow-up|3|||
154837728|NCT02083380|558840271|FG002|Overall Study|Lost to Follow-up|3|||
154837729|NCT02083380|558840269|FG000|Overall Study|Other|8|||
154837730|NCT02083380|558840270|FG001|Overall Study|Other|4|||
154837731|NCT02083380|558840271|FG002|Overall Study|Other|6|||
154837732|NCT04091087|558840272|FG000|Overall Study|Not treated|1|||
154837733|NCT04091087|558840273|FG001|Overall Study|Not treated|0|||
154837734|NCT04091087|558840272|FG000|Overall Study|Adverse Event|4|||
154837735|NCT04091087|558840273|FG001|Overall Study|Adverse Event|4|||
154837736|NCT04091087|558840272|FG000|Overall Study|Protocol Violation|0|||
154837737|NCT04091087|558840273|FG001|Overall Study|Protocol Violation|1|||
154837738|NCT04091087|558840272|FG000|Overall Study|Withdrawal by Subject|5|||
154837739|NCT04091087|558840273|FG001|Overall Study|Withdrawal by Subject|2|||
154837740|NCT02412787|558840274|FG000|Overall Study|Withdrawal by Subject|9|||
154837741|NCT02412787|558840274|FG000|Overall Study|Participation Terminated by Investigator|1|||
154837742|NCT02412787|558840274|FG000|Overall Study|Site Terminated by Sponsor|21|||
154837743|NCT02412787|558840274|FG000|Overall Study|Technical Problems|1|||
154837744|NCT02412787|558840274|FG000|Overall Study|Reason Not Specified|1|||
154837745|NCT00001379|558840275|FG000|Initial Treatment|Disease progression|21|||
154837746|NCT00001379|558840276|FG001|Initial Treatment|Disease progression|3|||
154837747|NCT00001379|558840277|FG002|Initial Treatment|Disease progression|0|||
154837748|NCT00001379|558840278|FG003|Initial Treatment|Disease progression|0|||
154837749|NCT00001379|558840275|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
154837750|NCT00001379|558840276|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
154837751|NCT00001379|558840277|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
154837752|NCT00001379|558840278|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
154837753|NCT00001379|558840275|FG000|Initial Treatment|Received alternative treatment|2|||
155103023|NCT00310375|559808555|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
155103024|NCT00310375|559808553|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
154837754|NCT00001379|558840276|FG001|Initial Treatment|Received alternative treatment|1|||
154837755|NCT00001379|558840277|FG002|Initial Treatment|Received alternative treatment|0|||
155103025|NCT00310375|559808554|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
154837756|NCT00001379|558840278|FG003|Initial Treatment|Received alternative treatment|0|||
154837757|NCT00001379|558840275|FG000|Initial Treatment|Refused further treatment|2|||
154837758|NCT00001379|558840276|FG001|Initial Treatment|Refused further treatment|0|||
154837759|NCT00001379|558840277|FG002|Initial Treatment|Refused further treatment|0|||
154837760|NCT00001379|558840278|FG003|Initial Treatment|Refused further treatment|0|||
154837761|NCT00001379|558840275|FG000|Initial Treatment|Did not receive protocol treatment|0|||
154837762|NCT00001379|558840276|FG001|Initial Treatment|Did not receive protocol treatment|0|||
154837763|NCT00001379|558840277|FG002|Initial Treatment|Did not receive protocol treatment|5|||
154837764|NCT00001379|558840278|FG003|Initial Treatment|Did not receive protocol treatment|0|||
155103026|NCT00310375|559808555|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
155103027|NCT00310375|559808553|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
155103028|NCT00310375|559808554|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
155103029|NCT00310375|559808555|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
155103030|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
155103031|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
155103032|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
155103033|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
155103034|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
155103035|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
155103036|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
155103037|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
155103038|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
155103039|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
155103040|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
155103041|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
155103042|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
155103043|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
155103044|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
155103045|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
155103046|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
155103047|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
155103048|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
155103049|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
155103050|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
155103051|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
155103052|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
155103053|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
155103054|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Other|6|||
155103055|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Other|0|||
155103056|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Other|0|||
155103057|NCT05615220|559808556|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
155103058|NCT05615220|559808557|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
155103059|NCT05615220|559808558|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
155103060|NCT05615220|559808556|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
155103061|NCT05615220|559808557|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
155103062|NCT05615220|559808558|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
155103063|NCT05615220|559808556|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
155103064|NCT05615220|559808557|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
155103065|NCT05615220|559808558|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
155103066|NCT05615220|559808556|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
155103067|NCT05615220|559808557|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
155103068|NCT05615220|559808558|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
155103069|NCT05615220|559808556|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
155103070|NCT05615220|559808557|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
155103071|NCT05615220|559808558|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
155103072|NCT05615220|559808556|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
155103073|NCT05615220|559808557|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
155103074|NCT05615220|559808558|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
155103075|NCT00703963|559808563|FG000|Overall Study|Withdrawal by Subject|7|||
155103076|NCT00703963|559808564|FG001|Overall Study|Withdrawal by Subject|13|||
155103077|NCT00703963|559808563|FG000|Overall Study|Physician Decision|0|||
155103078|NCT00703963|559808564|FG001|Overall Study|Physician Decision|1|||
155103079|NCT03994211|559808571|FG000|Core Phase|Adverse Event|0|||
155103080|NCT03994211|559808572|FG001|Core Phase|Adverse Event|1|||
155103081|NCT03994211|559808573|FG002|Core Phase|Adverse Event|0|||
155103082|NCT03994211|559808571|FG000|Extension Phase|Adverse Event|0|||
155103083|NCT03994211|559808572|FG001|Extension Phase|Adverse Event|0|||
155103084|NCT03994211|559808573|FG002|Extension Phase|Adverse Event|1|||
155103085|NCT03994211|559808571|FG000|Extension Phase|Physician Decision|0|||
155103086|NCT03994211|559808572|FG001|Extension Phase|Physician Decision|0|||
155103087|NCT03994211|559808573|FG002|Extension Phase|Physician Decision|1|||
155173458|NCT01185353|560073331|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
154970717|NCT01721772|559316853|FG000|Treatment|Participant request to discontinue study treatment|21|||
155103088|NCT03994211|559808571|FG000|Extension Phase|Progressive Disease|0|||
155103089|NCT03994211|559808572|FG001|Extension Phase|Progressive Disease|0|||
155103090|NCT03994211|559808573|FG002|Extension Phase|Progressive Disease|20|||
155103091|NCT03994211|559808571|FG000|Extension Phase|Withdrawal by Subject|0|||
155103092|NCT03994211|559808572|FG001|Extension Phase|Withdrawal by Subject|0|||
155103093|NCT03994211|559808573|FG002|Extension Phase|Withdrawal by Subject|2|||
155103094|NCT02528942|559808574|FG000|Overall Study|Did not meet imaging criteria|9|||
155103095|NCT02528942|559808574|FG000|Overall Study|Lost to Follow-up|25|||
155103096|NCT00881530|559808575|FG000|Overall Study|Adverse Event|5|||
155103097|NCT00881530|559808576|FG001|Overall Study|Adverse Event|1|||
155103098|NCT00881530|559808577|FG002|Overall Study|Adverse Event|1|||
155103099|NCT00881530|559808578|FG003|Overall Study|Adverse Event|4|||
155103100|NCT00881530|559808579|FG004|Overall Study|Adverse Event|10|||
155103101|NCT00881530|559808580|FG005|Overall Study|Adverse Event|2|||
155103102|NCT00881530|559808575|FG000|Overall Study|Lack of Efficacy|1|||
155103103|NCT00881530|559808576|FG001|Overall Study|Lack of Efficacy|0|||
155103104|NCT00881530|559808577|FG002|Overall Study|Lack of Efficacy|0|||
155103105|NCT00881530|559808578|FG003|Overall Study|Lack of Efficacy|0|||
155103106|NCT00881530|559808579|FG004|Overall Study|Lack of Efficacy|1|||
155103107|NCT00881530|559808580|FG005|Overall Study|Lack of Efficacy|1|||
155103108|NCT00881530|559808575|FG000|Overall Study|Not compliant with the protocol|0|||
155103109|NCT00881530|559808576|FG001|Overall Study|Not compliant with the protocol|0|||
155103110|NCT00881530|559808577|FG002|Overall Study|Not compliant with the protocol|0|||
155103111|NCT00881530|559808578|FG003|Overall Study|Not compliant with the protocol|0|||
155103112|NCT00881530|559808579|FG004|Overall Study|Not compliant with the protocol|2|||
155103113|NCT00881530|559808580|FG005|Overall Study|Not compliant with the protocol|0|||
154970718|NCT01721772|559316854|FG001|Treatment|Participant request to discontinue study treatment|8|||
154970719|NCT01721772|559316853|FG000|Treatment|Death|1|||
154970720|NCT01721772|559316854|FG001|Treatment|Death|0|||
155173459|NCT01185353|560073332|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155103114|NCT00881530|559808575|FG000|Overall Study|Lost to Follow-up|0|||
155103115|NCT00881530|559808576|FG001|Overall Study|Lost to Follow-up|1|||
155103116|NCT00881530|559808577|FG002|Overall Study|Lost to Follow-up|1|||
155103117|NCT00881530|559808578|FG003|Overall Study|Lost to Follow-up|3|||
155103118|NCT00881530|559808579|FG004|Overall Study|Lost to Follow-up|1|||
155103119|NCT00881530|559808580|FG005|Overall Study|Lost to Follow-up|0|||
155173460|NCT01185353|560073333|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155103120|NCT00881530|559808575|FG000|Overall Study|Refused to continue medication|7|||
155173461|NCT01185353|560073334|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155173462|NCT01185353|560073335|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
155173463|NCT01185353|560073336|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
155173464|NCT01185353|560073337|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
154970721|NCT01721772|559316853|FG000|Treatment|Not reported|1|||
155173465|NCT01185353|560073338|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
155173466|NCT01185353|560073329|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173467|NCT01185353|560073330|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173468|NCT01185353|560073331|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173469|NCT01185353|560073332|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173470|NCT01185353|560073333|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173471|NCT01185353|560073334|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173472|NCT01185353|560073335|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173473|NCT01185353|560073336|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
155173474|NCT01185353|560073337|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
155173475|NCT01185353|560073338|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
155173476|NCT00946153|560073339|FG000|Phase 2|Adverse Event|0|||
155173477|NCT00946153|560073340|FG001|Phase 2|Adverse Event|0|||
155173478|NCT00946153|560073341|FG002|Phase 2|Adverse Event|0|||
155173479|NCT00946153|560073342|FG003|Phase 2|Adverse Event|0|||
155173480|NCT00946153|560073343|FG004|Phase 2|Adverse Event|6|||
155173481|NCT00946153|560073339|FG000|Phase 2|Need more reduction of dose|0|||
155173482|NCT00946153|560073340|FG001|Phase 2|Need more reduction of dose|0|||
155173483|NCT00946153|560073341|FG002|Phase 2|Need more reduction of dose|0|||
155173484|NCT00946153|560073342|FG003|Phase 2|Need more reduction of dose|0|||
155173485|NCT00946153|560073343|FG004|Phase 2|Need more reduction of dose|2|||
155173486|NCT00946153|560073339|FG000|Phase 2|Physician Decision|0|||
155173487|NCT00946153|560073340|FG001|Phase 2|Physician Decision|0|||
154970722|NCT01721772|559316854|FG001|Treatment|Not reported|0|||
154970723|NCT01721772|559316853|FG000|Treatment|Poor/non-compliance|1|||
154970724|NCT01721772|559316854|FG001|Treatment|Poor/non-compliance|0|||
154970725|NCT01721772|559316853|FG000|Treatment|Lost to Follow-up|0|||
154970726|NCT01721772|559316854|FG001|Treatment|Lost to Follow-up|1|||
154970727|NCT04542694|559316855|FG000|Overall Study|The need for prohibited therapy|2|||
154970728|NCT04542694|559316856|FG001|Overall Study|The need for prohibited therapy|0|||
154970729|NCT04542694|559316855|FG000|Overall Study|Adverse Event|1|||
154970730|NCT04542694|559316856|FG001|Overall Study|Adverse Event|0|||
154970731|NCT04542694|559316855|FG000|Overall Study|Protocol Violation|1|||
154970732|NCT04542694|559316856|FG001|Overall Study|Protocol Violation|0|||
154970733|NCT00969124|559316857|FG000|Overall Study|Protocol Violation|2|||
154970734|NCT00969124|559316857|FG000|Overall Study|Inadequate bowel preparation|15|||
154970735|NCT00969124|559316857|FG000|Overall Study|Inability to reach cecum|9|||
154970736|NCT00969124|559316857|FG000|Overall Study|Previously unrecognized disease|3|||
154970737|NCT00969124|559316857|FG000|Overall Study|Technical error|1|||
154970738|NCT00210639|559316858|FG000|Overall Study|Lost to Follow-up|37|||
154970739|NCT00210639|559316859|FG001|Overall Study|Lost to Follow-up|29|||
154970740|NCT00210639|559316858|FG000|Overall Study|Withdrawal by Subject|8|||
154970741|NCT00210639|559316859|FG001|Overall Study|Withdrawal by Subject|1|||
154970742|NCT00210639|559316858|FG000|Overall Study|Other|18|||
154970743|NCT00210639|559316859|FG001|Overall Study|Other|12|||
154970744|NCT00743145|559316862|FG000|Overall Study|Withdrawal by Subject|1|||
154970745|NCT00743145|559316862|FG000|Overall Study|Adverse Event|2|||
154970746|NCT00743145|559316862|FG000|Overall Study|Pregnancy|1|||
154970747|NCT00884390|559316863|FG000|Overall Study|Adverse Event|0|||
154970748|NCT00884390|559316864|FG001|Overall Study|Adverse Event|1|||
154970749|NCT00884390|559316863|FG000|Overall Study|Lost to Follow-up|0|||
154970750|NCT00884390|559316864|FG001|Overall Study|Lost to Follow-up|1|||
154970751|NCT00884390|559316863|FG000|Overall Study|Physician Decision|2|||
154970752|NCT00884390|559316864|FG001|Overall Study|Physician Decision|1|||
155103121|NCT00881530|559808576|FG001|Overall Study|Refused to continue medication|2|||
155103122|NCT00881530|559808577|FG002|Overall Study|Refused to continue medication|1|||
155103123|NCT00881530|559808578|FG003|Overall Study|Refused to continue medication|2|||
155103124|NCT00881530|559808579|FG004|Overall Study|Refused to continue medication|0|||
155103125|NCT00881530|559808580|FG005|Overall Study|Refused to continue medication|0|||
155103126|NCT00881530|559808575|FG000|Overall Study|Other reason not defined above|1|||
155103127|NCT00881530|559808576|FG001|Overall Study|Other reason not defined above|1|||
155103128|NCT00881530|559808577|FG002|Overall Study|Other reason not defined above|2|||
155103129|NCT00881530|559808578|FG003|Overall Study|Other reason not defined above|0|||
155103130|NCT00881530|559808579|FG004|Overall Study|Other reason not defined above|0|||
155103131|NCT00881530|559808580|FG005|Overall Study|Other reason not defined above|2|||
155103132|NCT03900728|559808581|FG000|Overall Study|No text responses|0|||
155103133|NCT03900728|559808582|FG001|Overall Study|No text responses|0|||
155103134|NCT03900728|559808583|FG002|Overall Study|No text responses|4|||
155103135|NCT00763256|559808585|FG000|Overall Study|Didn't return for appointments|7|||
155103136|NCT00763256|559808586|FG001|Overall Study|Didn't return for appointments|10|||
155103137|NCT01272037|559808590|FG000|Overall Study|Death|25|||
155103138|NCT01272037|559808591|FG001|Overall Study|Death|28|||
155103139|NCT01272037|559808590|FG000|Overall Study|Adverse Event|12|||
155103140|NCT01272037|559808591|FG001|Overall Study|Adverse Event|7|||
155103141|NCT01272037|559808590|FG000|Overall Study|Withdrawal by Subject|175|||
155103142|NCT01272037|559808591|FG001|Overall Study|Withdrawal by Subject|93|||
155103143|NCT01272037|559808590|FG000|Overall Study|Disease progression|70|||
155103144|NCT01272037|559808591|FG001|Overall Study|Disease progression|111|||
155103145|NCT01272037|559808590|FG000|Overall Study|Other reason|42|||
155103146|NCT01272037|559808591|FG001|Overall Study|Other reason|41|||
155103147|NCT01272037|559808590|FG000|Overall Study|Delinquent data|24|||
155103148|NCT01272037|559808591|FG001|Overall Study|Delinquent data|19|||
155103149|NCT01272037|559808590|FG000|Overall Study|Reason under review|33|||
155103150|NCT01272037|559808591|FG001|Overall Study|Reason under review|29|||
155103151|NCT01272037|559808590|FG000|Overall Study|On treatment|626|||
155103152|NCT01272037|559808591|FG001|Overall Study|On treatment|632|||
155103153|NCT01393899|559808594|FG000|Overall Study|Study terminated by sponsor|1|||
155103154|NCT01393899|559808595|FG001|Overall Study|Study terminated by sponsor|0|||
155103155|NCT01393899|559808596|FG002|Overall Study|Study terminated by sponsor|1|||
155103156|NCT01393899|559808594|FG000|Overall Study|Other|1|||
155103157|NCT01393899|559808595|FG001|Overall Study|Other|0|||
155103158|NCT01393899|559808596|FG002|Overall Study|Other|0|||
155103159|NCT01393899|559808594|FG000|Overall Study|Withdrawal by Subject|2|||
155103160|NCT01393899|559808595|FG001|Overall Study|Withdrawal by Subject|2|||
155103161|NCT01393899|559808596|FG002|Overall Study|Withdrawal by Subject|1|||
155103162|NCT01393899|559808594|FG000|Overall Study|Lost to Follow-up|0|||
155103163|NCT01393899|559808595|FG001|Overall Study|Lost to Follow-up|0|||
155103164|NCT01393899|559808596|FG002|Overall Study|Lost to Follow-up|1|||
154970753|NCT00884390|559316863|FG000|Overall Study|Protocol Violation|4|||
154970754|NCT00884390|559316864|FG001|Overall Study|Protocol Violation|1|||
154970755|NCT00884390|559316863|FG000|Overall Study|Withdrawal by Subject|4|||
154970756|NCT00884390|559316864|FG001|Overall Study|Withdrawal by Subject|1|||
155103165|NCT01393899|559808594|FG000|Overall Study|Does not meet entrance criteria|1|||
155103166|NCT01393899|559808595|FG001|Overall Study|Does not meet entrance criteria|0|||
155103167|NCT01393899|559808596|FG002|Overall Study|Does not meet entrance criteria|1|||
155103168|NCT01393899|559808594|FG000|Overall Study|Lack of Efficacy|26|||
155103169|NCT01393899|559808595|FG001|Overall Study|Lack of Efficacy|21|||
155103170|NCT01393899|559808596|FG002|Overall Study|Lack of Efficacy|16|||
155103171|NCT01393899|559808594|FG000|Overall Study|Adverse Event|1|||
155103172|NCT01393899|559808595|FG001|Overall Study|Adverse Event|5|||
155103173|NCT01393899|559808596|FG002|Overall Study|Adverse Event|3|||
155103174|NCT02503085|559808597|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
155103175|NCT02503085|559808598|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
154924096|NCT04668066|559146368|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924097|NCT04668066|559146369|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924098|NCT04668066|559146370|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924099|NCT04668066|559146371|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924100|NCT04668066|559146372|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924101|NCT04668066|559146373|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924102|NCT04668066|559146374|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924103|NCT04668066|559146375|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924104|NCT04668066|559146376|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
155173488|NCT00946153|560073341|FG002|Phase 2|Physician Decision|0|||
155173489|NCT00946153|560073342|FG003|Phase 2|Physician Decision|0|||
154837765|NCT00001379|558840275|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
154837766|NCT00001379|558840276|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
154837767|NCT00001379|558840277|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
154837768|NCT00001379|558840278|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
154837769|NCT00001379|558840275|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
154837770|NCT00001379|558840276|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
154837771|NCT00001379|558840277|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
154837772|NCT00001379|558840278|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
154837773|NCT00001379|558840275|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
154837774|NCT00001379|558840276|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
154837775|NCT00001379|558840277|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
154837776|NCT00001379|558840278|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
154837777|NCT00001379|558840275|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
155103176|NCT02503085|559808599|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
155103177|NCT02503085|559808600|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
155103178|NCT00124072|559808604|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
155103179|NCT00124072|559808605|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
155103180|NCT00124072|559808606|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
155103181|NCT00124072|559808607|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
155103182|NCT00124072|559808604|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
155103183|NCT00124072|559808605|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
155103184|NCT00124072|559808606|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
155103185|NCT00124072|559808607|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
155103186|NCT00124072|559808604|FG000|Overall Study|Death|499|||
155103187|NCT00124072|559808605|FG001|Overall Study|Death|484|||
155103188|NCT00124072|559808606|FG002|Overall Study|Death|471|||
155103189|NCT00124072|559808607|FG003|Overall Study|Death|480|||
155103190|NCT04585269|559808608|FG000|Intervention|Withdrawal by Subject|9|||
155103191|NCT04585269|559808609|FG001|Intervention|Withdrawal by Subject|0|||
155103192|NCT04585269|559808608|FG000|Intervention|Unable to schedule|15|||
155103193|NCT04585269|559808609|FG001|Intervention|Unable to schedule|0|||
155103194|NCT04585269|559808608|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
155103195|NCT04585269|559808609|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
155103196|NCT04585269|559808608|FG000|FU Time 2 (3 months)|Death|2|||
155103197|NCT04585269|559808609|FG001|FU Time 2 (3 months)|Death|2|||
155103198|NCT04585269|559808608|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
155103199|NCT04585269|559808609|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
155103200|NCT04585269|559808608|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
155103201|NCT04585269|559808609|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
155103202|NCT04585269|559808608|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
155103203|NCT04585269|559808609|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
155103204|NCT04585269|559808608|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
155103205|NCT04585269|559808609|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
155103206|NCT04585269|559808608|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
155103207|NCT04585269|559808609|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
155103208|NCT03670355|559808613|FG000|Overall Study|Adverse Event|1|||
155103209|NCT03670355|559808614|FG001|Overall Study|Adverse Event|0|||
155103210|NCT03670355|559808613|FG000|Overall Study|Unable to comply with study procedures|0|||
155103211|NCT03670355|559808614|FG001|Overall Study|Unable to comply with study procedures|1|||
155103212|NCT03670355|559808613|FG000|Overall Study|Participant refused|0|||
155103213|NCT03670355|559808614|FG001|Overall Study|Participant refused|1|||
155103214|NCT03307785|559808615|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
155103215|NCT03307785|559808616|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103216|NCT03307785|559808617|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103217|NCT03307785|559808618|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103218|NCT03307785|559808619|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103219|NCT03307785|559808620|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103220|NCT03307785|559808621|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103221|NCT03307785|559808622|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103222|NCT03307785|559808623|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103223|NCT03307785|559808624|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103224|NCT03307785|559808625|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
154837778|NCT00001379|558840276|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
154837779|NCT00001379|558840277|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
154837780|NCT00001379|558840278|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
154837781|NCT00001379|558840275|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
154837782|NCT00001379|558840276|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
154837783|NCT00001379|558840277|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
155103225|NCT03307785|559808626|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103226|NCT03307785|559808627|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
155103227|NCT03307785|559808615|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
155103228|NCT03307785|559808616|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
155103229|NCT03307785|559808617|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103230|NCT03307785|559808618|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103231|NCT03307785|559808619|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103232|NCT03307785|559808620|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103233|NCT03307785|559808621|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103234|NCT03307785|559808622|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103235|NCT03307785|559808623|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103236|NCT03307785|559808624|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103237|NCT03307785|559808625|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103238|NCT03307785|559808626|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103239|NCT03307785|559808627|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
155103240|NCT03307785|559808615|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
155103241|NCT03307785|559808616|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
155103242|NCT03307785|559808617|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103243|NCT03307785|559808618|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103244|NCT03307785|559808619|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103245|NCT03307785|559808620|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103246|NCT03307785|559808621|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103247|NCT03307785|559808622|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103248|NCT03307785|559808623|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103249|NCT03307785|559808624|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103250|NCT03307785|559808625|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103251|NCT03307785|559808626|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103252|NCT03307785|559808627|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
155103253|NCT03307785|559808615|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
155103254|NCT03307785|559808616|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
155103255|NCT03307785|559808617|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103256|NCT03307785|559808618|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103257|NCT03307785|559808619|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103258|NCT03307785|559808620|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103259|NCT03307785|559808621|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103260|NCT03307785|559808622|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103261|NCT03307785|559808623|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155173490|NCT00946153|560073343|FG004|Phase 2|Physician Decision|1|||
155173491|NCT00946153|560073339|FG000|Phase 2|14 days washout for recovery due to AE|0|||
155173492|NCT00946153|560073340|FG001|Phase 2|14 days washout for recovery due to AE|0|||
155173493|NCT00946153|560073341|FG002|Phase 2|14 days washout for recovery due to AE|0|||
155103262|NCT03307785|559808624|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103263|NCT03307785|559808625|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155173494|NCT00946153|560073342|FG003|Phase 2|14 days washout for recovery due to AE|0|||
154837784|NCT00001379|558840278|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
154837785|NCT03246958|558840279|FG000|Overall Study|Withdrawal by Subject|0|||
154837786|NCT03246958|558840280|FG001|Overall Study|Withdrawal by Subject|1|||
154837787|NCT03246958|558840281|FG002|Overall Study|Withdrawal by Subject|0|||
154837788|NCT03246958|558840282|FG003|Overall Study|Withdrawal by Subject|0|||
154837789|NCT03246958|558840283|FG004|Overall Study|Withdrawal by Subject|0|||
154837790|NCT03246958|558840284|FG005|Overall Study|Withdrawal by Subject|1|||
154837791|NCT03246958|558840285|FG006|Overall Study|Withdrawal by Subject|0|||
154837792|NCT03246958|558840279|FG000|Overall Study|Progression|13|||
154837793|NCT03246958|558840280|FG001|Overall Study|Progression|9|||
154837794|NCT03246958|558840281|FG002|Overall Study|Progression|3|||
154837795|NCT03246958|558840282|FG003|Overall Study|Progression|2|||
154837796|NCT03246958|558840283|FG004|Overall Study|Progression|1|||
154837797|NCT03246958|558840284|FG005|Overall Study|Progression|2|||
154837798|NCT03246958|558840285|FG006|Overall Study|Progression|1|||
154837799|NCT03246958|558840279|FG000|Overall Study|Adverse Event|2|||
155103264|NCT03307785|559808626|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103265|NCT03307785|559808627|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
155103266|NCT03307785|559808615|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103267|NCT03307785|559808616|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103268|NCT03307785|559808617|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
155103269|NCT03307785|559808618|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103270|NCT03307785|559808619|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103271|NCT03307785|559808620|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103272|NCT03307785|559808621|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103273|NCT03307785|559808622|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103274|NCT03307785|559808623|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103275|NCT03307785|559808624|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103276|NCT03307785|559808625|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103277|NCT03307785|559808626|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103278|NCT03307785|559808627|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
155103279|NCT03307785|559808615|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103280|NCT03307785|559808616|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103281|NCT03307785|559808617|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
155103282|NCT03307785|559808618|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103283|NCT03307785|559808619|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103284|NCT03307785|559808620|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103285|NCT03307785|559808621|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103286|NCT03307785|559808622|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103287|NCT03307785|559808623|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103288|NCT03307785|559808624|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103289|NCT03307785|559808625|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103290|NCT03307785|559808626|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103291|NCT03307785|559808627|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
155103292|NCT03307785|559808615|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103293|NCT03307785|559808616|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103294|NCT03307785|559808617|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
155103295|NCT03307785|559808618|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103296|NCT03307785|559808619|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103297|NCT03307785|559808620|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103298|NCT03307785|559808621|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103299|NCT03307785|559808622|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103300|NCT03307785|559808623|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103301|NCT03307785|559808624|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103302|NCT03307785|559808625|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103303|NCT03307785|559808626|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103304|NCT03307785|559808627|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
155103305|NCT03307785|559808615|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103306|NCT03307785|559808616|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103307|NCT03307785|559808617|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
155103308|NCT03307785|559808618|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103309|NCT03307785|559808619|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103310|NCT03307785|559808620|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103311|NCT03307785|559808621|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103312|NCT03307785|559808622|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103313|NCT03307785|559808623|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103314|NCT03307785|559808624|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103315|NCT03307785|559808625|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103316|NCT03307785|559808626|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103317|NCT03307785|559808627|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
155103318|NCT03307785|559808615|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
154970757|NCT00884390|559316863|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
154970758|NCT00884390|559316864|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
154970759|NCT00884390|559316863|FG000|Overall Study|Other|11|||
154970760|NCT00884390|559316864|FG001|Overall Study|Other|1|||
154970761|NCT01691612|559316867|FG000|Overall Study|deemed ineligible after 1st visit|6|||
154970762|NCT01691612|559316867|FG000|Overall Study|Adverse Event|1|||
154970763|NCT01211262|559316871|FG000|Overall Study|Progressive Disease|18|||
154970764|NCT01211262|559316872|FG001|Overall Study|Progressive Disease|9|||
154970765|NCT01211262|559316871|FG000|Overall Study|Adverse Event|4|||
154970766|NCT01211262|559316872|FG001|Overall Study|Adverse Event|0|||
154970767|NCT01211262|559316871|FG000|Overall Study|Withdrawal of Consent|1|||
154970768|NCT01211262|559316872|FG001|Overall Study|Withdrawal of Consent|0|||
154970769|NCT01211262|559316871|FG000|Overall Study|Other|0|||
154970770|NCT01211262|559316872|FG001|Overall Study|Other|1|||
154970771|NCT01277510|559316873|FG000|Double-blind Phase|Non-compliance|0|||
154970772|NCT01277510|559316874|FG001|Double-blind Phase|Non-compliance|1|||
154837800|NCT03246958|558840280|FG001|Overall Study|Adverse Event|2|||
154837801|NCT03246958|558840281|FG002|Overall Study|Adverse Event|0|||
154837802|NCT03246958|558840282|FG003|Overall Study|Adverse Event|1|||
154837803|NCT03246958|558840283|FG004|Overall Study|Adverse Event|1|||
154837804|NCT03246958|558840284|FG005|Overall Study|Adverse Event|0|||
154837805|NCT03246958|558840285|FG006|Overall Study|Adverse Event|2|||
154837806|NCT03246958|558840279|FG000|Overall Study|Death|0|||
154837807|NCT03246958|558840280|FG001|Overall Study|Death|1|||
154837808|NCT03246958|558840281|FG002|Overall Study|Death|0|||
154837809|NCT03246958|558840282|FG003|Overall Study|Death|0|||
154837810|NCT03246958|558840283|FG004|Overall Study|Death|0|||
154837811|NCT03246958|558840284|FG005|Overall Study|Death|0|||
154837812|NCT03246958|558840285|FG006|Overall Study|Death|0|||
154837813|NCT03246958|558840279|FG000|Overall Study|Physician Decision|0|||
154837814|NCT03246958|558840280|FG001|Overall Study|Physician Decision|0|||
154837815|NCT03246958|558840281|FG002|Overall Study|Physician Decision|0|||
154837816|NCT03246958|558840282|FG003|Overall Study|Physician Decision|1|||
154837817|NCT03246958|558840283|FG004|Overall Study|Physician Decision|0|||
154837818|NCT03246958|558840284|FG005|Overall Study|Physician Decision|0|||
154837819|NCT03246958|558840285|FG006|Overall Study|Physician Decision|0|||
154837820|NCT03246958|558840279|FG000|Overall Study|Never start treatment|1|||
154837821|NCT03246958|558840280|FG001|Overall Study|Never start treatment|0|||
154837822|NCT03246958|558840281|FG002|Overall Study|Never start treatment|0|||
154837823|NCT03246958|558840282|FG003|Overall Study|Never start treatment|0|||
154837824|NCT03246958|558840283|FG004|Overall Study|Never start treatment|0|||
154837825|NCT03246958|558840284|FG005|Overall Study|Never start treatment|0|||
154837826|NCT03246958|558840285|FG006|Overall Study|Never start treatment|0|||
154837827|NCT03246958|558840279|FG000|Overall Study|Over enrollment|0|||
154837828|NCT03246958|558840280|FG001|Overall Study|Over enrollment|2|||
154837829|NCT03246958|558840281|FG002|Overall Study|Over enrollment|0|||
154837830|NCT03246958|558840282|FG003|Overall Study|Over enrollment|0|||
154837831|NCT03246958|558840283|FG004|Overall Study|Over enrollment|0|||
154837832|NCT03246958|558840284|FG005|Overall Study|Over enrollment|0|||
154837833|NCT03246958|558840285|FG006|Overall Study|Over enrollment|0|||
154837834|NCT01032915|558840291|FG000|Overall Study|Adverse Event|2|||
154837835|NCT01032915|558840292|FG001|Overall Study|Adverse Event|2|||
154837836|NCT01032915|558840293|FG002|Overall Study|Adverse Event|1|||
154970773|NCT01277510|559316873|FG000|Double-blind Phase|Adverse Event|1|||
155103319|NCT03307785|559808616|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103320|NCT03307785|559808617|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
155103321|NCT03307785|559808618|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103322|NCT03307785|559808619|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
154837837|NCT01032915|558840294|FG003|Overall Study|Adverse Event|1|||
154837838|NCT01032915|558840291|FG000|Overall Study|Abnormal test procedure result|0|||
154837839|NCT01032915|558840292|FG001|Overall Study|Abnormal test procedure result|0|||
154837840|NCT01032915|558840293|FG002|Overall Study|Abnormal test procedure result|1|||
154837841|NCT01032915|558840294|FG003|Overall Study|Abnormal test procedure result|0|||
154837842|NCT01032915|558840291|FG000|Overall Study|Withdrawal by Subject|0|||
154837843|NCT01032915|558840292|FG001|Overall Study|Withdrawal by Subject|3|||
154837844|NCT01032915|558840293|FG002|Overall Study|Withdrawal by Subject|1|||
154837845|NCT01032915|558840294|FG003|Overall Study|Withdrawal by Subject|1|||
154837846|NCT01032915|558840291|FG000|Overall Study|Administrative reasons|5|||
154837847|NCT01032915|558840292|FG001|Overall Study|Administrative reasons|6|||
154837848|NCT01032915|558840293|FG002|Overall Study|Administrative reasons|4|||
155103323|NCT03307785|559808620|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103324|NCT03307785|559808621|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
154837849|NCT01032915|558840294|FG003|Overall Study|Administrative reasons|4|||
154837850|NCT01032915|558840291|FG000|Overall Study|Protocol Violation|1|||
154837851|NCT01032915|558840292|FG001|Overall Study|Protocol Violation|0|||
154837852|NCT01032915|558840293|FG002|Overall Study|Protocol Violation|0|||
154837853|NCT01032915|558840294|FG003|Overall Study|Protocol Violation|1|||
154837854|NCT01577186|558840295|FG000|Overall Study|Adverse Event|23|||
154837855|NCT01577186|558840295|FG000|Overall Study|Death|1|||
154837856|NCT01577186|558840295|FG000|Overall Study|Lost to Follow-up|28|||
154837857|NCT01577186|558840295|FG000|Overall Study|Withdrawal by Subject|35|||
154837858|NCT01577186|558840295|FG000|Overall Study|Insufficient Response|18|||
154837859|NCT01577186|558840295|FG000|Overall Study|Ineligible to Continue|15|||
154837860|NCT01577186|558840295|FG000|Overall Study|Non-Compliant|8|||
154837861|NCT01577186|558840295|FG000|Overall Study|Other|2|||
154837862|NCT00811135|558840296|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
154837863|NCT00811135|558840296|FG000|Overall Study|Death|3|||
154837864|NCT00811135|558840296|FG000|Overall Study|Protocol Violation|2|||
154837865|NCT00811135|558840296|FG000|Overall Study|Violation of Selection Criteria|1|||
154837866|NCT00811135|558840296|FG000|Overall Study|Refused Treatment|1|||
154837867|NCT00811135|558840296|FG000|Overall Study|Withdrawal by Subject|3|||
154837868|NCT00811135|558840296|FG000|Overall Study|Administrative/Other Unspecified|11|||
155103325|NCT03307785|559808622|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103326|NCT03307785|559808623|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103327|NCT03307785|559808624|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
154837869|NCT00811135|558840296|FG000|Overall Study|Ongoing|59|||
154837870|NCT01118351|558840297|FG000|Overall Study|Adverse Event|3|||
154837871|NCT01118351|558840297|FG000|Overall Study|Withdrawal by Subject|1|||
154837872|NCT00183274|558840303|FG000|Phase 1: Open-Label|Adverse Event|31|||
154837873|NCT00183274|558840304|FG001|Phase 1: Open-Label|Adverse Event|0|||
154837874|NCT00183274|558840305|FG002|Phase 1: Open-Label|Adverse Event|0|||
154837875|NCT00183274|558840306|FG003|Phase 1: Open-Label|Adverse Event|0|||
154837876|NCT00183274|558840307|FG004|Phase 1: Open-Label|Adverse Event|0|||
154970774|NCT01277510|559316874|FG001|Double-blind Phase|Adverse Event|0|||
155103328|NCT03307785|559808625|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
154837877|NCT00183274|558840308|FG005|Phase 1: Open-Label|Adverse Event|0|||
154837878|NCT00183274|558840303|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
154837879|NCT00183274|558840304|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
154837880|NCT00183274|558840305|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
154837881|NCT00183274|558840306|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
154837882|NCT00183274|558840307|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
154837883|NCT00183274|558840308|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
154837884|NCT00183274|558840303|FG000|Phase 1: Open-Label|Protocol Violation|11|||
154837885|NCT00183274|558840304|FG001|Phase 1: Open-Label|Protocol Violation|0|||
154837886|NCT00183274|558840305|FG002|Phase 1: Open-Label|Protocol Violation|0|||
155103329|NCT03307785|559808626|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103330|NCT03307785|559808627|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
155103331|NCT03307785|559808615|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103332|NCT03307785|559808616|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
154970775|NCT01277510|559316873|FG000|Double-blind Phase|Withdrawal by Subject|2|||
154837887|NCT00183274|558840306|FG003|Phase 1: Open-Label|Protocol Violation|0|||
154837888|NCT00183274|558840307|FG004|Phase 1: Open-Label|Protocol Violation|0|||
154837889|NCT00183274|558840308|FG005|Phase 1: Open-Label|Protocol Violation|0|||
154837890|NCT00183274|558840303|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
154837891|NCT00183274|558840304|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
154837892|NCT00183274|558840305|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
154837893|NCT00183274|558840306|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
154837894|NCT00183274|558840307|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
154837895|NCT00183274|558840308|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
154837896|NCT00183274|558840303|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
154837897|NCT00183274|558840304|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
154837898|NCT00183274|558840305|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
154837899|NCT00183274|558840306|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
154837900|NCT00183274|558840307|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
154837901|NCT00183274|558840308|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
154837902|NCT00183274|558840303|FG000|Phase 1: Open-Label|Other|9|||
154837903|NCT00183274|558840304|FG001|Phase 1: Open-Label|Other|0|||
154837904|NCT00183274|558840305|FG002|Phase 1: Open-Label|Other|0|||
154837905|NCT00183274|558840306|FG003|Phase 1: Open-Label|Other|0|||
154837906|NCT00183274|558840307|FG004|Phase 1: Open-Label|Other|0|||
155103333|NCT03307785|559808617|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103334|NCT03307785|559808618|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
155103335|NCT03307785|559808619|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
155103336|NCT03307785|559808620|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103337|NCT03307785|559808621|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103338|NCT03307785|559808622|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103339|NCT03307785|559808623|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103340|NCT03307785|559808624|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103341|NCT03307785|559808625|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103342|NCT03307785|559808626|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103343|NCT03307785|559808627|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
155103344|NCT03307785|559808615|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103345|NCT03307785|559808616|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103346|NCT03307785|559808617|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103347|NCT03307785|559808618|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
155103348|NCT03307785|559808619|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
154837907|NCT00183274|558840308|FG005|Phase 1: Open-Label|Other|0|||
154837908|NCT00183274|558840303|FG000|Phase 2: Double-Blind|Relapsed|0|||
154837909|NCT00183274|558840304|FG001|Phase 2: Double-Blind|Relapsed|8|||
154837910|NCT00183274|558840305|FG002|Phase 2: Double-Blind|Relapsed|29|||
154837911|NCT00183274|558840306|FG003|Phase 2: Double-Blind|Relapsed|0|||
154837912|NCT00183274|558840307|FG004|Phase 2: Double-Blind|Relapsed|0|||
154837913|NCT00183274|558840308|FG005|Phase 2: Double-Blind|Relapsed|0|||
155103349|NCT03307785|559808620|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103350|NCT03307785|559808621|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
154837914|NCT00183274|558840303|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
154837915|NCT00183274|558840304|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
154837916|NCT00183274|558840305|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
155103351|NCT03307785|559808622|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103352|NCT03307785|559808623|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103353|NCT03307785|559808624|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103354|NCT03307785|559808625|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103355|NCT03307785|559808626|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103356|NCT03307785|559808627|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
155103357|NCT03307785|559808615|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103358|NCT03307785|559808616|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103359|NCT03307785|559808617|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103360|NCT03307785|559808618|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
155103361|NCT03307785|559808619|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103362|NCT03307785|559808620|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103363|NCT03307785|559808621|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103364|NCT03307785|559808622|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103365|NCT03307785|559808623|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103366|NCT03307785|559808624|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103367|NCT03307785|559808625|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103368|NCT03307785|559808626|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103369|NCT03307785|559808627|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
155103370|NCT03307785|559808615|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103371|NCT03307785|559808616|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103372|NCT03307785|559808617|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103373|NCT03307785|559808618|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103374|NCT03307785|559808619|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
155103375|NCT03307785|559808620|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103376|NCT03307785|559808621|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103377|NCT03307785|559808622|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103378|NCT03307785|559808623|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103379|NCT03307785|559808624|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103380|NCT03307785|559808625|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103381|NCT03307785|559808626|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103382|NCT03307785|559808627|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
155103383|NCT03307785|559808615|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103384|NCT03307785|559808616|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103385|NCT03307785|559808617|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103386|NCT03307785|559808618|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103387|NCT03307785|559808619|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103388|NCT03307785|559808620|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
155103389|NCT03307785|559808621|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103390|NCT03307785|559808622|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103391|NCT03307785|559808623|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103392|NCT03307785|559808624|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103393|NCT03307785|559808625|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103394|NCT03307785|559808626|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103395|NCT03307785|559808627|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
155103396|NCT03307785|559808615|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103397|NCT03307785|559808616|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103398|NCT03307785|559808617|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103399|NCT03307785|559808618|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103400|NCT03307785|559808619|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103401|NCT03307785|559808620|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
155103402|NCT03307785|559808621|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103403|NCT03307785|559808622|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
154837917|NCT00183274|558840306|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
154837918|NCT00183274|558840307|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
155103404|NCT03307785|559808623|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103405|NCT03307785|559808624|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103406|NCT03307785|559808625|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103407|NCT03307785|559808626|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103408|NCT03307785|559808627|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
155103409|NCT03307785|559808615|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103410|NCT03307785|559808616|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103411|NCT03307785|559808617|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103412|NCT03307785|559808618|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103413|NCT03307785|559808619|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103414|NCT03307785|559808620|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
155173495|NCT00946153|560073343|FG004|Phase 2|14 days washout for recovery due to AE|4|||
154837919|NCT00183274|558840308|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
154837920|NCT00183274|558840303|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
154970776|NCT01277510|559316874|FG001|Double-blind Phase|Withdrawal by Subject|0|||
154837921|NCT00183274|558840304|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
154837922|NCT00183274|558840305|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
155103415|NCT03307785|559808621|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103416|NCT03307785|559808622|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103417|NCT03307785|559808623|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103418|NCT03307785|559808624|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103419|NCT03307785|559808625|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103420|NCT03307785|559808626|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103421|NCT03307785|559808627|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
155103422|NCT03307785|559808615|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103423|NCT03307785|559808616|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103424|NCT03307785|559808617|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103425|NCT03307785|559808618|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103426|NCT03307785|559808619|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103427|NCT03307785|559808620|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
155103428|NCT03307785|559808621|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103429|NCT03307785|559808622|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103430|NCT03307785|559808623|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103431|NCT03307785|559808624|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103432|NCT03307785|559808625|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103433|NCT03307785|559808626|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103434|NCT03307785|559808627|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
155103435|NCT03307785|559808615|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103436|NCT03307785|559808616|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103437|NCT03307785|559808617|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103438|NCT03307785|559808618|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103439|NCT03307785|559808619|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103440|NCT03307785|559808620|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
155103441|NCT03307785|559808621|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103442|NCT03307785|559808622|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103443|NCT03307785|559808623|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103444|NCT03307785|559808624|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103445|NCT03307785|559808625|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103446|NCT03307785|559808626|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103447|NCT03307785|559808627|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
155103448|NCT03307785|559808615|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103449|NCT03307785|559808616|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103450|NCT03307785|559808617|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103451|NCT03307785|559808618|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103452|NCT03307785|559808619|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103453|NCT03307785|559808620|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103454|NCT03307785|559808621|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
155103455|NCT03307785|559808622|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103456|NCT03307785|559808623|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103457|NCT03307785|559808624|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103458|NCT03307785|559808625|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103459|NCT03307785|559808626|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103460|NCT03307785|559808627|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
155103461|NCT03307785|559808615|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103462|NCT03307785|559808616|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103463|NCT03307785|559808617|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103464|NCT03307785|559808618|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103465|NCT03307785|559808619|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103466|NCT03307785|559808620|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103467|NCT03307785|559808621|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
155103468|NCT03307785|559808622|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103469|NCT03307785|559808623|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103470|NCT03307785|559808624|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155173496|NCT01030666|560073344|FG000|Overall Study|Lost to Follow-up|3|||
154837923|NCT00183274|558840306|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
154837924|NCT00183274|558840307|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
154837925|NCT00183274|558840308|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
154970777|NCT01277510|559316873|FG000|Double-blind Phase|Administrative decision|7|||
154837926|NCT00183274|558840303|FG000|Phase 3: Double-Blind|Relapsed|0|||
155103471|NCT03307785|559808625|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103472|NCT03307785|559808626|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103473|NCT03307785|559808627|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
155103474|NCT03307785|559808615|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103475|NCT03307785|559808616|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103476|NCT03307785|559808617|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103477|NCT03307785|559808618|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103478|NCT03307785|559808619|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103479|NCT03307785|559808620|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103480|NCT03307785|559808621|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103481|NCT03307785|559808622|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
155103482|NCT03307785|559808623|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103483|NCT03307785|559808624|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103484|NCT03307785|559808625|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103485|NCT03307785|559808626|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103486|NCT03307785|559808627|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
155103487|NCT03307785|559808615|FG000|PACT Phase: Up to 19 Months|Death|0|||
155103488|NCT03307785|559808616|FG001|PACT Phase: Up to 19 Months|Death|0|||
155103489|NCT03307785|559808617|FG002|PACT Phase: Up to 19 Months|Death|0|||
155103490|NCT03307785|559808618|FG003|PACT Phase: Up to 19 Months|Death|0|||
155103491|NCT03307785|559808619|FG004|PACT Phase: Up to 19 Months|Death|0|||
155103492|NCT03307785|559808620|FG005|PACT Phase: Up to 19 Months|Death|0|||
155103493|NCT03307785|559808621|FG006|PACT Phase: Up to 19 Months|Death|0|||
155103494|NCT03307785|559808622|FG007|PACT Phase: Up to 19 Months|Death|0|||
155103495|NCT03307785|559808623|FG008|PACT Phase: Up to 19 Months|Death|0|||
155103496|NCT03307785|559808624|FG009|PACT Phase: Up to 19 Months|Death|0|||
155103497|NCT03307785|559808625|FG010|PACT Phase: Up to 19 Months|Death|0|||
155103498|NCT03307785|559808626|FG011|PACT Phase: Up to 19 Months|Death|0|||
155103499|NCT03307785|559808627|FG012|PACT Phase: Up to 19 Months|Death|1|||
155103500|NCT03666988|559808628|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
155103501|NCT03666988|559808629|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
155103502|NCT03666988|559808630|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
155103503|NCT03666988|559808631|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
155103504|NCT03666988|559808632|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
155103505|NCT03666988|559808633|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
155103506|NCT03666988|559808628|FG000|Part 1 (Up to 28 Months)|Other|0|||
155103507|NCT03666988|559808629|FG001|Part 1 (Up to 28 Months)|Other|1|||
155103508|NCT03666988|559808630|FG002|Part 1 (Up to 28 Months)|Other|1|||
155103509|NCT03666988|559808631|FG003|Part 1 (Up to 28 Months)|Other|0|||
155103510|NCT03666988|559808632|FG004|Part 1 (Up to 28 Months)|Other|0|||
155103511|NCT03666988|559808633|FG005|Part 1 (Up to 28 Months)|Other|0|||
155103512|NCT03666988|559808628|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
155103513|NCT03666988|559808629|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
155103514|NCT03666988|559808630|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
155103515|NCT03666988|559808631|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
155103516|NCT03666988|559808632|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
155103517|NCT03666988|559808633|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
155103518|NCT03666988|559808628|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
155103519|NCT03666988|559808629|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
155103520|NCT03666988|559808630|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
155103521|NCT03666988|559808631|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
155103522|NCT03666988|559808632|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
155103523|NCT03666988|559808633|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
155103524|NCT03666988|559808628|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
155103525|NCT03666988|559808629|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
154837927|NCT00183274|558840304|FG001|Phase 3: Double-Blind|Relapsed|0|||
154837928|NCT00183274|558840305|FG002|Phase 3: Double-Blind|Relapsed|0|||
154837929|NCT00183274|558840306|FG003|Phase 3: Double-Blind|Relapsed|1|||
154837930|NCT00183274|558840307|FG004|Phase 3: Double-Blind|Relapsed|11|||
154837931|NCT00183274|558840308|FG005|Phase 3: Double-Blind|Relapsed|2|||
154837932|NCT00708500|558840309|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
154837933|NCT00708500|558840310|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
154970778|NCT01277510|559316874|FG001|Double-blind Phase|Administrative decision|9|||
154970779|NCT01277510|559316873|FG000|Double-blind Phase|Death|0|||
155103526|NCT03666988|559808630|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155103527|NCT03666988|559808631|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155103528|NCT03666988|559808632|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155103529|NCT03666988|559808633|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
155103530|NCT05526521|559808639|FG000|Overall Study|Withdrawal by Subject|0|||
155103531|NCT05526521|559808640|FG001|Overall Study|Withdrawal by Subject|1|||
155103532|NCT05526521|559808641|FG002|Overall Study|Withdrawal by Subject|0|||
155103533|NCT05526521|559808642|FG003|Overall Study|Withdrawal by Subject|0|||
154837934|NCT00708500|558840311|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
155103534|NCT00436436|559808648|FG000|Overall Study|Progression|4|||
155103535|NCT00436436|559808648|FG000|Overall Study|Adverse Event|2|||
155103536|NCT00436436|559808648|FG000|Overall Study|Death|6|||
155103537|NCT03381287|559808653|FG000|Overall Study|Withdrawal by Subject|0|||
155103538|NCT03381287|559808654|FG001|Overall Study|Withdrawal by Subject|1|||
155103539|NCT03381287|559808655|FG002|Overall Study|Withdrawal by Subject|0|||
155103540|NCT03381287|559808656|FG003|Overall Study|Withdrawal by Subject|0|||
155103541|NCT03381287|559808653|FG000|Overall Study|Adverse Event|0|||
155103542|NCT03381287|559808654|FG001|Overall Study|Adverse Event|0|||
155103543|NCT03381287|559808655|FG002|Overall Study|Adverse Event|0|||
155103544|NCT03381287|559808656|FG003|Overall Study|Adverse Event|1|||
155103545|NCT03381287|559808653|FG000|Overall Study|Physician Decision|0|||
155103546|NCT03381287|559808654|FG001|Overall Study|Physician Decision|0|||
155103547|NCT03381287|559808655|FG002|Overall Study|Physician Decision|0|||
155103548|NCT03381287|559808656|FG003|Overall Study|Physician Decision|1|||
155103549|NCT00325130|559808690|FG000|Overall Study|Lost to Follow-up|6|||
155103550|NCT00325130|559808691|FG001|Overall Study|Lost to Follow-up|14|||
155103551|NCT00325130|559808690|FG000|Overall Study|Withdrawal by Subject|12|||
155103552|NCT00325130|559808691|FG001|Overall Study|Withdrawal by Subject|14|||
155103553|NCT00325130|559808690|FG000|Overall Study|Protocol Deviation|0|||
155103554|NCT00325130|559808691|FG001|Overall Study|Protocol Deviation|1|||
155103555|NCT00325130|559808690|FG000|Overall Study|Moved|0|||
155103556|NCT00325130|559808691|FG001|Overall Study|Moved|1|||
155103557|NCT00325130|559808690|FG000|Overall Study|Patient Discontinued for Other|1|||
155103558|NCT00325130|559808691|FG001|Overall Study|Patient Discontinued for Other|0|||
155103559|NCT01671956|559808694|FG000|Overall Study|Disease progression|0|||
155103560|NCT01671956|559808695|FG001|Overall Study|Disease progression|1|||
155103561|NCT01671956|559808694|FG000|Overall Study|Withdrawal by Subject|1|||
154970780|NCT01277510|559316874|FG001|Double-blind Phase|Death|1|||
154970781|NCT01277510|559316873|FG000|Double-blind Phase|Protocol-specified criteria|2|||
154970782|NCT01277510|559316874|FG001|Double-blind Phase|Protocol-specified criteria|6|||
155103562|NCT01671956|559808695|FG001|Overall Study|Withdrawal by Subject|1|||
155103563|NCT01671956|559808694|FG000|Overall Study|Adverse Event|1|||
155103564|NCT01671956|559808695|FG001|Overall Study|Adverse Event|0|||
155103565|NCT04266912|559808701|FG000|Overall Study|Withdrawal by Subject|1|||
155103566|NCT04266912|559808702|FG001|Overall Study|Withdrawal by Subject|0|||
155103567|NCT04266912|559808703|FG002|Overall Study|Withdrawal by Subject|0|||
155103568|NCT04266912|559808704|FG003|Overall Study|Withdrawal by Subject|0|||
155103569|NCT04266912|559808701|FG000|Overall Study|Progression|6|||
155103570|NCT04266912|559808702|FG001|Overall Study|Progression|6|||
155103571|NCT04266912|559808703|FG002|Overall Study|Progression|0|||
155103572|NCT04266912|559808704|FG003|Overall Study|Progression|10|||
155103573|NCT03581292|559808711|FG000|Overall Study|Physician Decision|9|||
155103574|NCT03581292|559808712|FG001|Overall Study|Physician Decision|5|||
155103575|NCT03581292|559808711|FG000|Overall Study|Withdrawal by Subject|3|||
155103576|NCT03581292|559808712|FG001|Overall Study|Withdrawal by Subject|0|||
155103577|NCT03581292|559808711|FG000|Overall Study|Withdrawal before Therapy Start|1|||
155103578|NCT03581292|559808712|FG001|Overall Study|Withdrawal before Therapy Start|0|||
155103579|NCT01142388|559810220|FG000|Overall Study|Lack of Efficacy|21|||
155103580|NCT01142388|559810221|FG001|Overall Study|Lack of Efficacy|31|||
155103581|NCT01142388|559810220|FG000|Overall Study|Adverse Event|9|||
155103582|NCT01142388|559810221|FG001|Overall Study|Adverse Event|5|||
155103583|NCT01142388|559810220|FG000|Overall Study|Death|3|||
155103584|NCT01142388|559810221|FG001|Overall Study|Death|2|||
155103585|NCT01142388|559810220|FG000|Overall Study|Withdrawal by Subject|5|||
155103586|NCT01142388|559810221|FG001|Overall Study|Withdrawal by Subject|3|||
155103587|NCT01142388|559810220|FG000|Overall Study|Alternative therapy|1|||
155103588|NCT01142388|559810221|FG001|Overall Study|Alternative therapy|0|||
155103589|NCT01142388|559810220|FG000|Overall Study|Other complications|0|||
155103590|NCT01142388|559810221|FG001|Overall Study|Other complications|2|||
155103591|NCT01142388|559810220|FG000|Overall Study|Other|1|||
155103592|NCT01142388|559810221|FG001|Overall Study|Other|1|||
155103593|NCT01142388|559810220|FG000|Overall Study|Never started therapy|7|||
155103594|NCT01142388|559810221|FG001|Overall Study|Never started therapy|3|||
155103595|NCT03419897|559810227|FG000|Overall Study|Death|180|||
155103596|NCT03419897|559810227|FG000|Overall Study|Lost to Follow-up|1|||
155103597|NCT03419897|559810227|FG000|Overall Study|Withdrawal by Subject|6|||
155103598|NCT03419897|559810227|FG000|Overall Study|Sponsor Decision|61|||
155103599|NCT03419897|559810227|FG000|Overall Study|Physician Decision|1|||
155103600|NCT01945216|559810230|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
155103601|NCT01945216|559810230|FG000|Overall Study|Protocol Violation|42|||
155103602|NCT01945216|559810230|FG000|Overall Study|CRF not assured by investigators|5|||
155103603|NCT03941873|559810231|FG000|Overall Study|Death|0|||
155103604|NCT03941873|559810232|FG001|Overall Study|Death|12|||
155103605|NCT03941873|559810233|FG002|Overall Study|Death|2|||
155103606|NCT03941873|559810234|FG003|Overall Study|Death|53|||
155103607|NCT03941873|559810231|FG000|Overall Study|Withdrawal by Subject|1|||
155103608|NCT03941873|559810232|FG001|Overall Study|Withdrawal by Subject|1|||
155103609|NCT03941873|559810233|FG002|Overall Study|Withdrawal by Subject|0|||
155103610|NCT03941873|559810234|FG003|Overall Study|Withdrawal by Subject|5|||
155103611|NCT03941873|559810231|FG000|Overall Study|Lost to Follow-up|1|||
155103612|NCT03941873|559810232|FG001|Overall Study|Lost to Follow-up|2|||
155103613|NCT03941873|559810233|FG002|Overall Study|Lost to Follow-up|0|||
155103614|NCT03941873|559810234|FG003|Overall Study|Lost to Follow-up|0|||
155103615|NCT03941873|559810231|FG000|Overall Study|Sponsor Decision|0|||
155103616|NCT03941873|559810232|FG001|Overall Study|Sponsor Decision|6|||
155103617|NCT03941873|559810233|FG002|Overall Study|Sponsor Decision|0|||
155103618|NCT03941873|559810234|FG003|Overall Study|Sponsor Decision|15|||
155103619|NCT02982772|559810238|FG000|Intervention|Lost to Follow-up|19|||
155103620|NCT02982772|559810239|FG001|Intervention|Lost to Follow-up|13|||
155103621|NCT02982772|559810238|FG000|1M Follow-Up|Lost to Follow-up|21|||
155103622|NCT02982772|559810239|FG001|1M Follow-Up|Lost to Follow-up|18|||
155103623|NCT02982772|559810238|FG000|3M Follow-Up|Lost to Follow-up|17|||
155103624|NCT02982772|559810239|FG001|3M Follow-Up|Lost to Follow-up|11|||
155103625|NCT02982772|559810238|FG000|6M Follow-Up|Lost to Follow-up|11|||
155103626|NCT02982772|559810239|FG001|6M Follow-Up|Lost to Follow-up|9|||
155103627|NCT02982772|559810238|FG000|12M Follow-Up|Lost to Follow-up|11|||
155103628|NCT02982772|559810239|FG001|12M Follow-Up|Lost to Follow-up|5|||
155103629|NCT02974140|559810240|FG000|Overall Study|Adverse Event|2|||
155103630|NCT02974140|559810240|FG000|Overall Study|Lost to Follow-up|1|||
155103631|NCT02974140|559810240|FG000|Overall Study|Study Terminated by Sponsor|36|||
155103632|NCT02297815|559810243|FG000|Overall Study|Lost to Follow-up|236|||
155103633|NCT02297815|559810244|FG001|Overall Study|Lost to Follow-up|140|||
155103634|NCT00293813|559810249|FG000|Overall Study|Physician Decision|0|||
155103635|NCT00293813|559810250|FG001|Overall Study|Physician Decision|1|||
155103636|NCT00293813|559810251|FG002|Overall Study|Physician Decision|0|||
155103637|NCT00293813|559810249|FG000|Overall Study|Adverse Event|3|||
155103638|NCT00293813|559810250|FG001|Overall Study|Adverse Event|1|||
155103639|NCT00293813|559810251|FG002|Overall Study|Adverse Event|1|||
155103640|NCT00293813|559810249|FG000|Overall Study|Withdrawal by Subject|7|||
155103641|NCT00293813|559810250|FG001|Overall Study|Withdrawal by Subject|4|||
155103642|NCT00293813|559810251|FG002|Overall Study|Withdrawal by Subject|4|||
155103643|NCT00293813|559810249|FG000|Overall Study|Lost to Follow-up|3|||
155103644|NCT00293813|559810250|FG001|Overall Study|Lost to Follow-up|2|||
155103645|NCT00293813|559810251|FG002|Overall Study|Lost to Follow-up|3|||
155103646|NCT00293813|559810249|FG000|Overall Study|Noncompliance|0|||
155103647|NCT00293813|559810250|FG001|Overall Study|Noncompliance|1|||
155103648|NCT00293813|559810251|FG002|Overall Study|Noncompliance|0|||
155103649|NCT00460655|559810252|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
155103650|NCT00460655|559810253|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155103651|NCT00460655|559810254|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155103652|NCT00460655|559810255|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
155103653|NCT00460655|559810252|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
155103654|NCT00460655|559810253|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155103655|NCT00460655|559810254|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155103656|NCT00460655|559810255|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
155103657|NCT00460655|559810252|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
155103658|NCT00460655|559810253|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
155103659|NCT00460655|559810254|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
155103660|NCT00460655|559810255|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
154837935|NCT00708500|558840309|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
154837936|NCT00708500|558840310|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
154837937|NCT00708500|558840311|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
155103661|NCT00460655|559810252|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155103662|NCT00460655|559810253|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
155103663|NCT00460655|559810254|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
154837938|NCT00708500|558840309|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
155103664|NCT00460655|559810255|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
155103665|NCT00460655|559810252|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155103666|NCT00460655|559810253|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
155103667|NCT00460655|559810254|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
155103668|NCT00460655|559810255|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
155103669|NCT00460655|559810252|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
155103670|NCT00460655|559810253|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
155103671|NCT00460655|559810254|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
155103672|NCT00460655|559810255|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
155103673|NCT03650413|559810256|FG000|Overall Study|Adverse Event|1|||
155103674|NCT03650413|559810256|FG000|Overall Study|Lack of Efficacy|17|||
155103675|NCT03650413|559810256|FG000|Overall Study|Other|9|||
155103676|NCT03650413|559810256|FG000|Overall Study|Physician Decision|2|||
155103677|NCT03650413|559810256|FG000|Overall Study|Study Terminated By Sponsor|16|||
155103678|NCT03650413|559810256|FG000|Overall Study|Withdrawal by Subject|16|||
155103679|NCT02553928|559810257|FG000|Overall Study|Adverse Event|2|||
155103680|NCT02553928|559810258|FG001|Overall Study|Adverse Event|1|||
155103681|NCT02553928|559810257|FG000|Overall Study|Lost to Follow-up|0|||
155103682|NCT02553928|559810258|FG001|Overall Study|Lost to Follow-up|1|||
155103683|NCT02553928|559810257|FG000|Overall Study|Administrative reason(s)|0|||
155103684|NCT02553928|559810258|FG001|Overall Study|Administrative reason(s)|1|||
155103685|NCT00910910|559810259|FG000|Overall Study|Adverse Event|63|||
155103686|NCT00910910|559810260|FG001|Overall Study|Adverse Event|35|||
155103687|NCT00910910|559810259|FG000|Overall Study|PD without histologic change|27|||
155103688|NCT00910910|559810260|FG001|Overall Study|PD without histologic change|23|||
155103689|NCT00910910|559810259|FG000|Overall Study|PD with histologic change|0|||
155103690|NCT00910910|559810260|FG001|Overall Study|PD with histologic change|2|||
155103691|NCT00910910|559810259|FG000|Overall Study|Withdrawal by Subject|7|||
155103692|NCT00910910|559810260|FG001|Overall Study|Withdrawal by Subject|5|||
155103693|NCT00910910|559810259|FG000|Overall Study|Lost to Follow-up|2|||
155103694|NCT00910910|559810260|FG001|Overall Study|Lost to Follow-up|2|||
155103695|NCT00910910|559810259|FG000|Overall Study|Death|9|||
155103696|NCT00910910|559810260|FG001|Overall Study|Death|3|||
155103697|NCT00910910|559810259|FG000|Overall Study|Protocol Violation|2|||
155103698|NCT00910910|559810260|FG001|Overall Study|Protocol Violation|2|||
155103699|NCT00910910|559810259|FG000|Overall Study|Completed 13 cycles of treatment|0|||
155103700|NCT00910910|559810260|FG001|Overall Study|Completed 13 cycles of treatment|118|||
155103701|NCT00910910|559810259|FG000|Overall Study|Other|114|||
155103702|NCT00910910|559810260|FG001|Overall Study|Other|32|||
155103703|NCT00910910|559810259|FG000|Overall Study|Untreated before cycle 1|1|||
155103704|NCT00910910|559810260|FG001|Overall Study|Untreated before cycle 1|2|||
155103705|NCT01973231|559810261|FG000|Overall Study|Protocol Violation|1|||
155103706|NCT01973231|559810262|FG001|Overall Study|Protocol Violation|1|||
155103707|NCT01973231|559810261|FG000|Overall Study|Lost to Follow-up|1|||
155103708|NCT01973231|559810262|FG001|Overall Study|Lost to Follow-up|1|||
155103709|NCT01973231|559810261|FG000|Overall Study|unclassified|2|||
155103710|NCT01973231|559810262|FG001|Overall Study|unclassified|1|||
155103711|NCT01973231|559810261|FG000|Overall Study|Withdrawal by Subject|7|||
155103712|NCT01973231|559810262|FG001|Overall Study|Withdrawal by Subject|9|||
155103713|NCT01485796|559810263|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
155103714|NCT01485796|559810263|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
155103715|NCT01485796|559810263|FG000|Period 2: Epoch 2|Adverse Event|3|||
155103716|NCT01485796|559810263|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
155103717|NCT01485796|559810263|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
155103718|NCT01485796|559810263|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
155103719|NCT01485796|559810263|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
155103720|NCT01485796|559810263|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
155103721|NCT04830215|559810264|FG000|Overall Study|Adverse Event|6|||
155103722|NCT04830215|559810264|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
155103723|NCT04830215|559810264|FG000|Overall Study|Withdrawal by Subject|3|||
155103724|NCT04830215|559810264|FG000|Overall Study|Protocol Deviation|1|||
155103725|NCT00770562|559810270|FG000|Overall Study|Did not take treatment|1|||
155103726|NCT00770562|559810271|FG001|Overall Study|Did not take treatment|1|||
155103727|NCT01643408|559810272|FG000|Overall Study|Adverse Event|12|||
155103728|NCT01643408|559810272|FG000|Overall Study|Other|2|||
155103729|NCT00292045|559810276|FG000|Core Study (Through Week 13)|Adverse Event|1|||
155103730|NCT00292045|559810276|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
155103731|NCT00606411|559810277|FG000|Overall Study|Adverse Event|1|||
155103732|NCT00606411|559810278|FG001|Overall Study|Adverse Event|2|||
155103733|NCT00606411|559810277|FG000|Overall Study|Lack of Adherence|1|||
155103734|NCT00606411|559810278|FG001|Overall Study|Lack of Adherence|1|||
155103735|NCT00606411|559810277|FG000|Overall Study|Lack of Efficacy|1|||
155103736|NCT00606411|559810278|FG001|Overall Study|Lack of Efficacy|1|||
155103737|NCT00606411|559810277|FG000|Overall Study|Withdrawal by Subject|2|||
155103738|NCT00606411|559810278|FG001|Overall Study|Withdrawal by Subject|0|||
155103739|NCT00606411|559810277|FG000|Overall Study|Lost to Follow-up|1|||
155103740|NCT00606411|559810278|FG001|Overall Study|Lost to Follow-up|2|||
155103741|NCT00606411|559810277|FG000|Overall Study|Move out of state|0|||
155103742|NCT00606411|559810278|FG001|Overall Study|Move out of state|1|||
155103743|NCT04503551|559810279|FG000|Overall Study|Withdrawal by Subject|5|||
155103744|NCT04503551|559810280|FG001|Overall Study|Withdrawal by Subject|3|||
155103745|NCT04503551|559810279|FG000|Overall Study|Physician Decision|1|||
155103746|NCT04503551|559810280|FG001|Overall Study|Physician Decision|0|||
155103747|NCT04503551|559810279|FG000|Overall Study|Death|0|||
155103748|NCT04503551|559810280|FG001|Overall Study|Death|1|||
155103749|NCT04503551|559810279|FG000|Overall Study|Lost to Follow-up|1|||
155103750|NCT04503551|559810280|FG001|Overall Study|Lost to Follow-up|2|||
155103751|NCT04503551|559810279|FG000|Overall Study|Ongoing at Week 52|99|||
155103752|NCT04503551|559810280|FG001|Overall Study|Ongoing at Week 52|62|||
155103753|NCT03726658|559810281|FG000|Overall Study|Lost to Follow-up|0|||
155103754|NCT03726658|559810282|FG001|Overall Study|Lost to Follow-up|0|||
155103755|NCT03726658|559810283|FG002|Overall Study|Lost to Follow-up|2|||
155103756|NCT03726658|559810284|FG003|Overall Study|Lost to Follow-up|0|||
155103757|NCT03726658|559810285|FG004|Overall Study|Lost to Follow-up|0|||
155103758|NCT03726658|559810286|FG005|Overall Study|Lost to Follow-up|1|||
155103759|NCT03726658|559810287|FG006|Overall Study|Lost to Follow-up|1|||
155103760|NCT03726658|559810281|FG000|Overall Study|Withdrawal by Subject|1|||
155103761|NCT03726658|559810282|FG001|Overall Study|Withdrawal by Subject|0|||
155103762|NCT03726658|559810283|FG002|Overall Study|Withdrawal by Subject|0|||
155103763|NCT03726658|559810284|FG003|Overall Study|Withdrawal by Subject|0|||
154837939|NCT00708500|558840310|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
154837940|NCT00708500|558840311|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
154837941|NCT00708500|558840309|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
154837942|NCT00708500|558840310|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
154837943|NCT00708500|558840311|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
154837944|NCT00708500|558840309|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
154837945|NCT00708500|558840310|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
154837946|NCT00708500|558840311|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
154837947|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
154837948|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
154970783|NCT01277510|559316873|FG000|Double-blind Phase|Other|1|||
154970784|NCT01277510|559316874|FG001|Double-blind Phase|Other|1|||
154970785|NCT01277510|559316873|FG000|Open-label Phase|Administrative decision|4|||
154970786|NCT01277510|559316874|FG001|Open-label Phase|Administrative decision|3|||
154970787|NCT01277510|559316873|FG000|Open-label Phase|Protocol-specified criteria|1|||
155103764|NCT03726658|559810285|FG004|Overall Study|Withdrawal by Subject|6|||
155103765|NCT03726658|559810286|FG005|Overall Study|Withdrawal by Subject|4|||
155103766|NCT03726658|559810287|FG006|Overall Study|Withdrawal by Subject|2|||
155103767|NCT03726658|559810281|FG000|Overall Study|Pregnancy|0|||
155103768|NCT03726658|559810282|FG001|Overall Study|Pregnancy|0|||
155103769|NCT03726658|559810283|FG002|Overall Study|Pregnancy|0|||
155103770|NCT03726658|559810284|FG003|Overall Study|Pregnancy|0|||
155103771|NCT03726658|559810285|FG004|Overall Study|Pregnancy|0|||
155103772|NCT03726658|559810286|FG005|Overall Study|Pregnancy|0|||
155103773|NCT03726658|559810287|FG006|Overall Study|Pregnancy|1|||
155103774|NCT03726658|559810281|FG000|Overall Study|Not Reported|0|||
155103775|NCT03726658|559810282|FG001|Overall Study|Not Reported|0|||
155103776|NCT03726658|559810283|FG002|Overall Study|Not Reported|0|||
155103777|NCT03726658|559810284|FG003|Overall Study|Not Reported|0|||
155103778|NCT03726658|559810285|FG004|Overall Study|Not Reported|0|||
155103779|NCT03726658|559810286|FG005|Overall Study|Not Reported|0|||
154970788|NCT01277510|559316874|FG001|Open-label Phase|Protocol-specified criteria|0|||
154970789|NCT01277510|559316873|FG000|Open-label Phase|Never received investigational product|2|||
155103780|NCT03726658|559810287|FG006|Overall Study|Not Reported|1|||
155103781|NCT00412958|559810288|FG000|Overall Study|Withdrawal by Subject|3|||
155103782|NCT00412958|559810289|FG001|Overall Study|Withdrawal by Subject|0|||
155103783|NCT00412958|559810290|FG002|Overall Study|Withdrawal by Subject|0|||
155103784|NCT00412958|559810291|FG003|Overall Study|Withdrawal by Subject|1|||
155103785|NCT00412958|559810288|FG000|Overall Study|Adverse Event|0|||
155103786|NCT00412958|559810289|FG001|Overall Study|Adverse Event|1|||
155103787|NCT00412958|559810290|FG002|Overall Study|Adverse Event|0|||
154837949|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
155103788|NCT00412958|559810291|FG003|Overall Study|Adverse Event|0|||
155103789|NCT00412958|559810288|FG000|Overall Study|Lost to Follow-up|0|||
155103790|NCT00412958|559810289|FG001|Overall Study|Lost to Follow-up|1|||
155103791|NCT00412958|559810290|FG002|Overall Study|Lost to Follow-up|0|||
155103792|NCT00412958|559810291|FG003|Overall Study|Lost to Follow-up|0|||
155103793|NCT00412958|559810288|FG000|Overall Study|Death|0|||
155103794|NCT00412958|559810289|FG001|Overall Study|Death|1|||
155103795|NCT00412958|559810290|FG002|Overall Study|Death|0|||
155103796|NCT00412958|559810291|FG003|Overall Study|Death|0|||
155103797|NCT00412958|559810288|FG000|Overall Study|Transport issue|0|||
155103798|NCT00412958|559810289|FG001|Overall Study|Transport issue|1|||
155103799|NCT00412958|559810290|FG002|Overall Study|Transport issue|0|||
155103800|NCT00412958|559810291|FG003|Overall Study|Transport issue|0|||
155103801|NCT01318135|559810292|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
155103802|NCT01318135|559810293|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155103803|NCT01318135|559810294|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155103804|NCT01318135|559810295|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155103805|NCT01318135|559810296|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155103806|NCT01318135|559810297|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155103807|NCT01318135|559810298|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
155103808|NCT01318135|559810299|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
154837950|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
154837951|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
154837952|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
154837953|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
154837954|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
154837955|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
154837956|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
154837957|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
154837958|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
154837959|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
154837960|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
154837961|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
154837962|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
154837963|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
154837964|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
154837965|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
154837966|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
154837967|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
154837968|NCT00708500|558840309|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
154837969|NCT00708500|558840310|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
154837970|NCT00708500|558840311|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
154837971|NCT00708500|558840309|FG000|FOLLOWUP|Adverse Event|0|||
154837972|NCT00708500|558840310|FG001|FOLLOWUP|Adverse Event|1|||
154837973|NCT00708500|558840311|FG002|FOLLOWUP|Adverse Event|0|||
154837974|NCT00708500|558840309|FG000|FOLLOWUP|Lost to Follow-up|1|||
154837975|NCT00708500|558840310|FG001|FOLLOWUP|Lost to Follow-up|6|||
154837976|NCT00708500|558840311|FG002|FOLLOWUP|Lost to Follow-up|4|||
154837977|NCT00708500|558840309|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
154837978|NCT00708500|558840310|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
154837979|NCT00708500|558840311|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
154837980|NCT00708500|558840309|FG000|FOLLOWUP|Subject withdrew consent|31|||
154837981|NCT00708500|558840310|FG001|FOLLOWUP|Subject withdrew consent|4|||
154837982|NCT00708500|558840311|FG002|FOLLOWUP|Subject withdrew consent|5|||
154837983|NCT00708500|558840309|FG000|FOLLOWUP|Non-compliance with protocol|5|||
154837984|NCT00708500|558840310|FG001|FOLLOWUP|Non-compliance with protocol|0|||
154837985|NCT00708500|558840311|FG002|FOLLOWUP|Non-compliance with protocol|1|||
154837986|NCT00794677|558840323|FG000|First Intervention|Withdrawal by Subject|2|||
154837987|NCT00794677|558840324|FG001|First Intervention|Withdrawal by Subject|0|||
154837988|NCT03882970|558840325|FG000|Overall Study|Adverse Event|5|||
154837989|NCT03882970|558840326|FG001|Overall Study|Adverse Event|7|||
154837990|NCT03882970|558840327|FG002|Overall Study|Adverse Event|3|||
154837991|NCT03882970|558840328|FG003|Overall Study|Adverse Event|1|||
154970790|NCT01277510|559316874|FG001|Open-label Phase|Never received investigational product|0|||
154970791|NCT00537095|559316876|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
155103809|NCT01318135|559810292|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
155103810|NCT01318135|559810293|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155103811|NCT01318135|559810294|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
154837992|NCT03882970|558840325|FG000|Overall Study|Death|1|||
154837993|NCT03882970|558840326|FG001|Overall Study|Death|2|||
154837994|NCT03882970|558840327|FG002|Overall Study|Death|1|||
154837995|NCT03882970|558840328|FG003|Overall Study|Death|1|||
154837996|NCT03882970|558840325|FG000|Overall Study|Lost to Follow-up|8|||
154837997|NCT03882970|558840326|FG001|Overall Study|Lost to Follow-up|9|||
154837998|NCT03882970|558840327|FG002|Overall Study|Lost to Follow-up|5|||
154837999|NCT03882970|558840328|FG003|Overall Study|Lost to Follow-up|5|||
154838000|NCT03882970|558840325|FG000|Overall Study|Physician Decision|0|||
154838001|NCT03882970|558840326|FG001|Overall Study|Physician Decision|2|||
155103812|NCT01318135|559810295|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155103813|NCT01318135|559810296|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155103814|NCT01318135|559810297|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155103815|NCT01318135|559810298|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155103816|NCT01318135|559810299|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
155103817|NCT01318135|559810292|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
155103818|NCT01318135|559810293|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
155103819|NCT01318135|559810294|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
155103820|NCT01318135|559810295|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
155103821|NCT01318135|559810296|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
155103822|NCT01318135|559810297|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
155103823|NCT01318135|559810298|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
155103824|NCT01318135|559810299|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
155103825|NCT01318135|559810292|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
155103826|NCT01318135|559810293|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
155103827|NCT01318135|559810294|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
155103828|NCT01318135|559810295|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
155103829|NCT01318135|559810296|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
155103830|NCT01318135|559810297|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
155103831|NCT01318135|559810298|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
155103832|NCT01318135|559810299|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
155103833|NCT01318135|559810292|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155103834|NCT01318135|559810293|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155103835|NCT01318135|559810294|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155103836|NCT01318135|559810295|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155103837|NCT01318135|559810296|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
155103838|NCT01318135|559810297|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155103839|NCT01318135|559810298|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
155103840|NCT01318135|559810299|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
155103841|NCT01318135|559810292|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
155103842|NCT01318135|559810293|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
155103843|NCT01318135|559810294|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155103844|NCT01318135|559810295|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
155103845|NCT01318135|559810296|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155103846|NCT01318135|559810297|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
155103847|NCT01318135|559810298|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155103848|NCT01318135|559810299|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
155103849|NCT01318135|559810292|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103850|NCT01318135|559810293|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103851|NCT01318135|559810294|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103852|NCT01318135|559810295|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103853|NCT01318135|559810296|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103854|NCT01318135|559810297|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103855|NCT01318135|559810298|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
155103856|NCT01318135|559810299|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
155103857|NCT01523743|559810303|FG000|Period 1|Adverse Event|1|||
155103858|NCT01523743|559810304|FG001|Period 1|Adverse Event|0|||
155103859|NCT01523743|559810303|FG000|Period 1|Withdrawal by Subject|6|||
155103860|NCT01523743|559810304|FG001|Period 1|Withdrawal by Subject|2|||
155103861|NCT01523743|559810303|FG000|Period 1|Lost to Follow-up|1|||
155103862|NCT01523743|559810304|FG001|Period 1|Lost to Follow-up|0|||
155103863|NCT01523743|559810303|FG000|Period 1|Lack of Efficacy|1|||
155103864|NCT01523743|559810304|FG001|Period 1|Lack of Efficacy|0|||
155103865|NCT01523743|559810303|FG000|Period 1|Felt unable to empty bladder|1|||
155103866|NCT01523743|559810304|FG001|Period 1|Felt unable to empty bladder|0|||
155103867|NCT01523743|559810303|FG000|Period 2|Withdrawal by Subject|0|||
155103868|NCT01523743|559810304|FG001|Period 2|Withdrawal by Subject|2|||
155103869|NCT01523743|559810303|FG000|Period 2|Adverse Event|1|||
155103870|NCT01523743|559810304|FG001|Period 2|Adverse Event|0|||
155103871|NCT02569476|559810305|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
155103872|NCT02569476|559810305|FG000|Overall Study|Death|33|||
155103873|NCT02569476|559810305|FG000|Overall Study|Withdrawal by Subject|9|||
155103874|NCT02569476|559810305|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
155103875|NCT02569476|559810305|FG000|Overall Study|Palliative care|1|||
155103876|NCT02569476|559810305|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
155103877|NCT02569476|559810305|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
155103878|NCT01071954|559810306|FG000|Overall Study|Noncompliance|4|||
155103879|NCT01071954|559810306|FG000|Overall Study|Adverse Event|1|||
155103880|NCT01071954|559810306|FG000|Overall Study|Withdrawal by Subject|11|||
155103881|NCT01071954|559810306|FG000|Overall Study|Requirement for Alternative Therapy|5|||
155103882|NCT01071954|559810306|FG000|Overall Study|Administrative Decision|5|||
155103883|NCT01071954|559810306|FG000|Overall Study|Protocol Specified Criteria|1|||
155103884|NCT01152788|559810307|FG000|Overall Study|Withdrawal by Subject|0|||
155103885|NCT01152788|559810308|FG001|Overall Study|Withdrawal by Subject|3|||
155103886|NCT01152788|559810307|FG000|Overall Study|No treatment|0|||
155103887|NCT01152788|559810308|FG001|Overall Study|No treatment|1|||
155103888|NCT01434654|559810310|FG000|Overall Study|Withdrawal by Subject|1|||
155103889|NCT01434654|559810311|FG001|Overall Study|Withdrawal by Subject|0|||
155103890|NCT01434654|559810310|FG000|Overall Study|Lost to Follow-up|1|||
155103891|NCT01434654|559810311|FG001|Overall Study|Lost to Follow-up|0|||
155103892|NCT03782064|559810314|FG000|Overall Study|Lack of Efficacy|2|||
155103893|NCT03782064|559810314|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
155103894|NCT00363142|559810315|FG000|Overall Study|Adverse Event|2|||
155103895|NCT00363142|559810316|FG001|Overall Study|Adverse Event|0|||
155103896|NCT00363142|559810315|FG000|Overall Study|Lack of Efficacy|0|||
155103897|NCT00363142|559810316|FG001|Overall Study|Lack of Efficacy|1|||
155103898|NCT00363142|559810315|FG000|Overall Study|Lost to Follow-up|1|||
155103899|NCT00363142|559810316|FG001|Overall Study|Lost to Follow-up|0|||
155103900|NCT00363142|559810315|FG000|Overall Study|Non-compliance|1|||
155103901|NCT00363142|559810316|FG001|Overall Study|Non-compliance|1|||
155103902|NCT00363142|559810315|FG000|Overall Study|Withdrawal by Subject|3|||
155103903|NCT00363142|559810316|FG001|Overall Study|Withdrawal by Subject|1|||
155103904|NCT02625220|559810318|FG000|Overall Study|Adverse Event|2|||
155103905|NCT02625220|559810318|FG000|Overall Study|Lost to Follow-up|2|||
155103906|NCT02625220|559810318|FG000|Overall Study|Protocol Violation|1|||
155103907|NCT02625220|559810318|FG000|Overall Study|Study discontinued at site|2|||
155103908|NCT01140867|559810319|FG000|Overall Study|Adverse Event|22|||
155103909|NCT01140867|559810319|FG000|Overall Study|Lack of Efficacy|3|||
155103910|NCT01140867|559810319|FG000|Overall Study|Lost to Follow-up|2|||
155103911|NCT01140867|559810319|FG000|Overall Study|Withdrawal by Subject|1|||
155103912|NCT01140867|559810319|FG000|Overall Study|Protocol Violation|1|||
155103913|NCT01140867|559810319|FG000|Overall Study|Uncooperative patient|2|||
155103914|NCT01140867|559810319|FG000|Overall Study|Medication Noncompliance|2|||
155103915|NCT01926444|559810320|FG000|Overall Study|Colonoscopy not performed|0|||
155103916|NCT01926444|559810321|FG001|Overall Study|Colonoscopy not performed|0|||
155103917|NCT01926444|559810322|FG002|Overall Study|Colonoscopy not performed|4|||
155103918|NCT01926444|559810323|FG003|Overall Study|Colonoscopy not performed|2|||
155103919|NCT00995436|559810326|FG000|Overall Study|Withdrawal by Subject|2|||
155103920|NCT00995436|559810327|FG001|Overall Study|Withdrawal by Subject|5|||
155103921|NCT00995436|559810328|FG002|Overall Study|Withdrawal by Subject|0|||
155103922|NCT03035864|559810330|FG000|Treatment Period|Adverse Event|1|||
155103923|NCT03035864|559810331|FG001|Treatment Period|Adverse Event|0|||
155103924|NCT03035864|559810330|FG000|Treatment Period|Other|3|||
155103925|NCT03035864|559810331|FG001|Treatment Period|Other|1|||
155103926|NCT03035864|559810330|FG000|Follow-up Period|Adverse Event|1|||
155103927|NCT03035864|559810331|FG001|Follow-up Period|Adverse Event|0|||
155103928|NCT03035864|559810330|FG000|Follow-up Period|Lost to Follow-up|6|||
155103929|NCT03035864|559810331|FG001|Follow-up Period|Lost to Follow-up|2|||
155103930|NCT03035864|559810330|FG000|Follow-up Period|Physician Decision|1|||
155103931|NCT03035864|559810331|FG001|Follow-up Period|Physician Decision|0|||
155103932|NCT03035864|559810330|FG000|Follow-up Period|Other|3|||
155103933|NCT03035864|559810331|FG001|Follow-up Period|Other|2|||
155103934|NCT02720523|559810332|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
155103935|NCT02720523|559810333|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
155103936|NCT02720523|559810334|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
155103937|NCT02720523|559810335|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
155103938|NCT02720523|559810336|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
155103939|NCT02720523|559810337|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
155103940|NCT02720523|559810338|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
155103941|NCT02720523|559810332|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
155103942|NCT02720523|559810333|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155173497|NCT01030666|560073345|FG001|Overall Study|Lost to Follow-up|2|||
155103943|NCT02720523|559810334|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155103944|NCT02720523|559810335|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155103945|NCT02720523|559810336|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155103946|NCT02720523|559810337|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155103947|NCT02720523|559810338|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
155103948|NCT02720523|559810332|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
155103949|NCT02720523|559810333|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155103950|NCT02720523|559810334|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155103951|NCT02720523|559810335|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155103952|NCT02720523|559810336|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155103953|NCT02720523|559810337|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155103954|NCT02720523|559810338|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
155103955|NCT02720523|559810332|FG000|Period 1: Placebo-controlled Period|Other|0|||
155103956|NCT02720523|559810333|FG001|Period 1: Placebo-controlled Period|Other|0|||
155103957|NCT02720523|559810334|FG002|Period 1: Placebo-controlled Period|Other|1|||
155103958|NCT02720523|559810335|FG003|Period 1: Placebo-controlled Period|Other|1|||
155103959|NCT02720523|559810336|FG004|Period 1: Placebo-controlled Period|Other|0|||
155103960|NCT02720523|559810337|FG005|Period 1: Placebo-controlled Period|Other|0|||
155103961|NCT02720523|559810338|FG006|Period 1: Placebo-controlled Period|Other|0|||
155103962|NCT02720523|559810332|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
155103963|NCT02720523|559810333|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
155103964|NCT02720523|559810334|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
155103965|NCT02720523|559810335|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
155103966|NCT02720523|559810336|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
154838002|NCT03882970|558840327|FG002|Overall Study|Physician Decision|2|||
155103967|NCT02720523|559810337|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
155103968|NCT02720523|559810338|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
155103969|NCT02720523|559810332|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
155103970|NCT02720523|559810333|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
155103971|NCT02720523|559810334|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
155103972|NCT02720523|559810335|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
155103973|NCT02720523|559810336|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
155103974|NCT02720523|559810337|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
155103975|NCT02720523|559810338|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
155103976|NCT02720523|559810332|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155103977|NCT02720523|559810333|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155103978|NCT02720523|559810334|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155103979|NCT02720523|559810335|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
155103980|NCT02720523|559810336|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
155103981|NCT02720523|559810337|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
155103982|NCT02720523|559810338|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
155103983|NCT02720523|559810332|FG000|Period 2: Long-term Extension Period|Other|0|||
155103984|NCT02720523|559810333|FG001|Period 2: Long-term Extension Period|Other|0|||
155103985|NCT02720523|559810334|FG002|Period 2: Long-term Extension Period|Other|0|||
155103986|NCT02720523|559810335|FG003|Period 2: Long-term Extension Period|Other|0|||
155103987|NCT02720523|559810336|FG004|Period 2: Long-term Extension Period|Other|2|||
155103988|NCT02720523|559810337|FG005|Period 2: Long-term Extension Period|Other|0|||
155103989|NCT02720523|559810338|FG006|Period 2: Long-term Extension Period|Other|3|||
155103990|NCT03146663|559810345|FG000|Overall Study|Did not receive study treatment|1|||
155103991|NCT03146663|559810346|FG001|Overall Study|Did not receive study treatment|1|||
155103992|NCT02842086|559810348|FG000|Overall Study|Randomized but Never Treated|6|||
155103993|NCT02842086|559810349|FG001|Overall Study|Randomized but Never Treated|6|||
154838003|NCT03882970|558840328|FG003|Overall Study|Physician Decision|2|||
155103994|NCT02842086|559810348|FG000|Overall Study|Still in Double-Blind Phase|7|||
155103995|NCT02842086|559810349|FG001|Overall Study|Still in Double-Blind Phase|3|||
155103996|NCT02842086|559810348|FG000|Overall Study|Adverse Event|18|||
155103997|NCT02842086|559810349|FG001|Overall Study|Adverse Event|20|||
155103998|NCT02842086|559810348|FG000|Overall Study|Death|3|||
155103999|NCT02842086|559810349|FG001|Overall Study|Death|3|||
155104000|NCT02842086|559810348|FG000|Overall Study|Investigator's Discretion|9|||
155104001|NCT02842086|559810349|FG001|Overall Study|Investigator's Discretion|13|||
155104002|NCT02842086|559810348|FG000|Overall Study|Non-Compliance with Study Drug|9|||
155104003|NCT02842086|559810349|FG001|Overall Study|Non-Compliance with Study Drug|8|||
155104004|NCT02842086|559810348|FG000|Overall Study|Protocol Violation|8|||
155104005|NCT02842086|559810349|FG001|Overall Study|Protocol Violation|4|||
155104006|NCT02842086|559810348|FG000|Overall Study|Withdrew Consent|205|||
155104007|NCT02842086|559810349|FG001|Overall Study|Withdrew Consent|194|||
155104008|NCT02842086|559810348|FG000|Overall Study|Lost to Follow-up|274|||
155104009|NCT02842086|559810349|FG001|Overall Study|Lost to Follow-up|236|||
154838004|NCT03882970|558840325|FG000|Overall Study|Protocol Violation|2|||
154838005|NCT03882970|558840326|FG001|Overall Study|Protocol Violation|0|||
154838006|NCT03882970|558840327|FG002|Overall Study|Protocol Violation|0|||
154838007|NCT03882970|558840328|FG003|Overall Study|Protocol Violation|0|||
154838008|NCT03882970|558840325|FG000|Overall Study|Withdrawal by Subject|8|||
154838009|NCT03882970|558840326|FG001|Overall Study|Withdrawal by Subject|17|||
154838010|NCT03882970|558840327|FG002|Overall Study|Withdrawal by Subject|7|||
154838011|NCT03882970|558840328|FG003|Overall Study|Withdrawal by Subject|22|||
154838012|NCT03882970|558840325|FG000|Overall Study|Personal Reason|2|||
154838013|NCT03882970|558840326|FG001|Overall Study|Personal Reason|3|||
154838014|NCT03882970|558840327|FG002|Overall Study|Personal Reason|1|||
155104010|NCT02842086|559810348|FG000|Overall Study|HIV-1 Infection|5|||
155104011|NCT02842086|559810349|FG001|Overall Study|HIV-1 Infection|6|||
155104012|NCT07214935|559810355|FG000|Overall Study|Adverse Event|1|||
155104013|NCT07214935|559810356|FG001|Overall Study|Adverse Event|1|||
155104014|NCT07214935|559810357|FG002|Overall Study|Adverse Event|1|||
155104015|NCT07214935|559810358|FG003|Overall Study|Adverse Event|0|||
155104016|NCT07214935|559810355|FG000|Overall Study|Lost to Follow-up|0|||
155104017|NCT07214935|559810356|FG001|Overall Study|Lost to Follow-up|1|||
155104018|NCT07214935|559810357|FG002|Overall Study|Lost to Follow-up|0|||
155104019|NCT07214935|559810358|FG003|Overall Study|Lost to Follow-up|0|||
155104020|NCT07214935|559810355|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
155104021|NCT07214935|559810356|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
155104022|NCT07214935|559810357|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
155104023|NCT07214935|559810358|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
155104024|NCT07214935|559810355|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
155104025|NCT07214935|559810356|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
155104026|NCT07214935|559810357|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
155104027|NCT07214935|559810358|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
155104028|NCT05823974|559812412|FG000|Overall Study|Lost to Follow-up|0|||
155104029|NCT05823974|559812413|FG001|Overall Study|Lost to Follow-up|3|||
155104030|NCT05823974|559812414|FG002|Overall Study|Lost to Follow-up|1|||
154838015|NCT03882970|558840328|FG003|Overall Study|Personal Reason|3|||
154838016|NCT02863809|558840341|FG000|Overall Study|Adverse Event|8|||
154838017|NCT02863809|558840342|FG001|Overall Study|Adverse Event|8|||
155104031|NCT05823974|559812415|FG003|Overall Study|Lost to Follow-up|0|||
155104032|NCT05823974|559812416|FG004|Overall Study|Lost to Follow-up|1|||
155104033|NCT05823974|559812417|FG005|Overall Study|Lost to Follow-up|0|||
155104034|NCT05823974|559812418|FG006|Overall Study|Lost to Follow-up|1|||
155104035|NCT05823974|559812419|FG007|Overall Study|Lost to Follow-up|0|||
155104036|NCT05823974|559812420|FG008|Overall Study|Lost to Follow-up|0|||
155104037|NCT05823974|559812421|FG009|Overall Study|Lost to Follow-up|1|||
155104038|NCT05823974|559812422|FG010|Overall Study|Lost to Follow-up|1|||
155104039|NCT05823974|559812423|FG011|Overall Study|Lost to Follow-up|0|||
154970792|NCT00537095|559316877|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
155173498|NCT03698591|560073346|FG000|Overall Study|Withdrawal by Subject|2|||
155173499|NCT03698591|560073347|FG001|Overall Study|Withdrawal by Subject|2|||
155104040|NCT05823974|559812424|FG012|Overall Study|Lost to Follow-up|1|||
154838018|NCT02863809|558840341|FG000|Overall Study|Withdrawal by Subject|0|||
154838019|NCT02863809|558840342|FG001|Overall Study|Withdrawal by Subject|1|||
155104041|NCT05823974|559812425|FG013|Overall Study|Lost to Follow-up|2|||
155104042|NCT05823974|559812426|FG014|Overall Study|Lost to Follow-up|1|||
154838020|NCT02863809|558840341|FG000|Overall Study|Lost to Follow-up|1|||
155104043|NCT05823974|559812427|FG015|Overall Study|Lost to Follow-up|1|||
155104044|NCT05823974|559812428|FG016|Overall Study|Lost to Follow-up|1|||
155104045|NCT05823974|559812429|FG017|Overall Study|Lost to Follow-up|0|||
155104046|NCT05823974|559812430|FG018|Overall Study|Lost to Follow-up|0|||
155104047|NCT05823974|559812431|FG019|Overall Study|Lost to Follow-up|2|||
155173500|NCT03698591|560073346|FG000|Overall Study|Failed drug screen|1|||
155104048|NCT05823974|559812432|FG020|Overall Study|Lost to Follow-up|0|||
155104049|NCT05823974|559812412|FG000|Overall Study|Physician Decision|0|||
155104050|NCT05823974|559812413|FG001|Overall Study|Physician Decision|0|||
155104051|NCT05823974|559812414|FG002|Overall Study|Physician Decision|0|||
155104052|NCT05823974|559812415|FG003|Overall Study|Physician Decision|0|||
155104053|NCT05823974|559812416|FG004|Overall Study|Physician Decision|0|||
155104054|NCT05823974|559812417|FG005|Overall Study|Physician Decision|0|||
154838021|NCT02863809|558840342|FG001|Overall Study|Lost to Follow-up|1|||
154838022|NCT02863809|558840341|FG000|Overall Study|Death|1|||
154838023|NCT02863809|558840342|FG001|Overall Study|Death|0|||
154838024|NCT00607386|558840343|FG000|Overall Study|Physician Decision|1|||
154838025|NCT02980224|558840353|FG000|Overall Study|Adverse Event|4|||
154838026|NCT02980224|558840354|FG001|Overall Study|Adverse Event|1|||
154838027|NCT02980224|558840353|FG000|Overall Study|Withdrawal by Subject|0|||
154838028|NCT02980224|558840354|FG001|Overall Study|Withdrawal by Subject|2|||
154838029|NCT00606320|558840355|FG000|Overall Study|Adverse Event|3|||
155104055|NCT05823974|559812418|FG006|Overall Study|Physician Decision|0|||
154838030|NCT00606320|558840355|FG000|Overall Study|Lack of Efficacy|5|||
154838031|NCT00606320|558840355|FG000|Overall Study|Physician Decision|7|||
154838032|NCT00606320|558840355|FG000|Overall Study|Protocol Violation|8|||
155104056|NCT05823974|559812419|FG007|Overall Study|Physician Decision|0|||
154838033|NCT00606320|558840355|FG000|Overall Study|Withdrawal by Subject|10|||
154838034|NCT00606320|558840355|FG000|Overall Study|Progression to depressive phase|4|||
155104057|NCT05823974|559812420|FG008|Overall Study|Physician Decision|0|||
155104058|NCT05823974|559812421|FG009|Overall Study|Physician Decision|0|||
155104059|NCT05823974|559812422|FG010|Overall Study|Physician Decision|0|||
155104060|NCT05823974|559812423|FG011|Overall Study|Physician Decision|0|||
155104061|NCT05823974|559812424|FG012|Overall Study|Physician Decision|0|||
155104062|NCT05823974|559812425|FG013|Overall Study|Physician Decision|0|||
155104063|NCT05823974|559812426|FG014|Overall Study|Physician Decision|0|||
154970793|NCT00537095|559316876|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
155104064|NCT05823974|559812427|FG015|Overall Study|Physician Decision|1|||
155104065|NCT05823974|559812428|FG016|Overall Study|Physician Decision|0|||
155104066|NCT05823974|559812429|FG017|Overall Study|Physician Decision|1|||
155104067|NCT05823974|559812430|FG018|Overall Study|Physician Decision|1|||
155104068|NCT05823974|559812431|FG019|Overall Study|Physician Decision|0|||
155104069|NCT05823974|559812432|FG020|Overall Study|Physician Decision|0|||
155104070|NCT05823974|559812412|FG000|Overall Study|Withdrawal by Subject|1|||
155104071|NCT05823974|559812413|FG001|Overall Study|Withdrawal by Subject|1|||
155104072|NCT05823974|559812414|FG002|Overall Study|Withdrawal by Subject|2|||
155104073|NCT05823974|559812415|FG003|Overall Study|Withdrawal by Subject|0|||
155104074|NCT05823974|559812416|FG004|Overall Study|Withdrawal by Subject|2|||
155104075|NCT05823974|559812417|FG005|Overall Study|Withdrawal by Subject|3|||
155104076|NCT05823974|559812418|FG006|Overall Study|Withdrawal by Subject|1|||
155104077|NCT05823974|559812419|FG007|Overall Study|Withdrawal by Subject|1|||
155104078|NCT05823974|559812420|FG008|Overall Study|Withdrawal by Subject|2|||
155104079|NCT05823974|559812421|FG009|Overall Study|Withdrawal by Subject|1|||
155104080|NCT05823974|559812422|FG010|Overall Study|Withdrawal by Subject|1|||
155104081|NCT05823974|559812423|FG011|Overall Study|Withdrawal by Subject|0|||
155104082|NCT05823974|559812424|FG012|Overall Study|Withdrawal by Subject|0|||
155104083|NCT05823974|559812425|FG013|Overall Study|Withdrawal by Subject|1|||
155104084|NCT05823974|559812426|FG014|Overall Study|Withdrawal by Subject|1|||
155104085|NCT05823974|559812427|FG015|Overall Study|Withdrawal by Subject|3|||
155104086|NCT05823974|559812428|FG016|Overall Study|Withdrawal by Subject|0|||
155104087|NCT05823974|559812429|FG017|Overall Study|Withdrawal by Subject|2|||
155104088|NCT05823974|559812430|FG018|Overall Study|Withdrawal by Subject|2|||
155104089|NCT05823974|559812431|FG019|Overall Study|Withdrawal by Subject|0|||
155104090|NCT05823974|559812432|FG020|Overall Study|Withdrawal by Subject|1|||
155104091|NCT05823974|559812412|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104092|NCT05823974|559812413|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104093|NCT05823974|559812414|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155104094|NCT05823974|559812415|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104095|NCT05823974|559812416|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104096|NCT05823974|559812417|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104097|NCT05823974|559812418|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104098|NCT05823974|559812419|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104099|NCT05823974|559812420|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104100|NCT05823974|559812421|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104101|NCT05823974|559812422|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104102|NCT05823974|559812423|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104103|NCT05823974|559812424|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104104|NCT05823974|559812425|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104105|NCT05823974|559812426|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155104106|NCT05823974|559812427|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104107|NCT05823974|559812428|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104108|NCT05823974|559812429|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104109|NCT05823974|559812430|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104110|NCT05823974|559812431|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104111|NCT05823974|559812432|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155104112|NCT05823974|559812412|FG000|Overall Study|Other|0|||
155104113|NCT05823974|559812413|FG001|Overall Study|Other|1|||
155104114|NCT05823974|559812414|FG002|Overall Study|Other|1|||
155104115|NCT05823974|559812415|FG003|Overall Study|Other|1|||
155104116|NCT05823974|559812416|FG004|Overall Study|Other|0|||
155104117|NCT05823974|559812417|FG005|Overall Study|Other|1|||
155104118|NCT05823974|559812418|FG006|Overall Study|Other|1|||
155104119|NCT05823974|559812419|FG007|Overall Study|Other|1|||
155104120|NCT05823974|559812420|FG008|Overall Study|Other|1|||
155104121|NCT05823974|559812421|FG009|Overall Study|Other|0|||
155104122|NCT05823974|559812422|FG010|Overall Study|Other|0|||
155104123|NCT05823974|559812423|FG011|Overall Study|Other|0|||
155104124|NCT05823974|559812424|FG012|Overall Study|Other|2|||
155104125|NCT05823974|559812425|FG013|Overall Study|Other|1|||
155104126|NCT05823974|559812426|FG014|Overall Study|Other|0|||
155104127|NCT05823974|559812427|FG015|Overall Study|Other|1|||
155104128|NCT05823974|559812428|FG016|Overall Study|Other|0|||
155104129|NCT05823974|559812429|FG017|Overall Study|Other|0|||
155104130|NCT05823974|559812430|FG018|Overall Study|Other|0|||
155104131|NCT05823974|559812431|FG019|Overall Study|Other|0|||
154970794|NCT00537095|559316877|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
154970795|NCT00537095|559316876|FG000|Randomized Treatment Period (433 Days)|Death|3|||
155104132|NCT05823974|559812432|FG020|Overall Study|Other|0|||
155104133|NCT02744612|559812433|FG000|Overall Study|Withdrawal by Subject|0|||
155104134|NCT02744612|559812434|FG001|Overall Study|Withdrawal by Subject|2|||
155104135|NCT00316706|559812435|FG000|Overall Study|Lost to Follow-up|38|||
155104136|NCT00316706|559812436|FG001|Overall Study|Lost to Follow-up|48|||
155104137|NCT00283803|559812438|FG000|Overall Study|Physician Decision|9|||
155104138|NCT00283803|559812438|FG000|Overall Study|Withdrawal by Subject|4|||
155104139|NCT01127607|559812439|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
155104140|NCT01127607|559812440|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
155104141|NCT01127607|559812439|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
155104142|NCT01127607|559812440|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
155104143|NCT02220855|559812441|FG000|Overall Study|Adverse Event|8|||
155104144|NCT02220855|559812441|FG000|Overall Study|Disease Progression|5|||
155104145|NCT02220855|559812441|FG000|Overall Study|Withdrawal by Subject|1|||
155104146|NCT05730725|559812442|FG000|Overall Study|Withdrawal by Subject|3|||
155104147|NCT05730725|559812443|FG001|Overall Study|Withdrawal by Subject|0|||
155104148|NCT05730725|559812444|FG002|Overall Study|Withdrawal by Subject|0|||
155104149|NCT05730725|559812445|FG003|Overall Study|Withdrawal by Subject|1|||
155104150|NCT05730725|559812442|FG000|Overall Study|Not Reported|1|||
155104151|NCT05730725|559812443|FG001|Overall Study|Not Reported|1|||
155104152|NCT05730725|559812444|FG002|Overall Study|Not Reported|1|||
155104153|NCT05730725|559812445|FG003|Overall Study|Not Reported|1|||
155104154|NCT01133756|559812447|FG000|Overall Study|Adverse Event|1|||
155104155|NCT01133756|559812448|FG001|Overall Study|Adverse Event|2|||
155104156|NCT01133756|559812449|FG002|Overall Study|Adverse Event|1|||
155104157|NCT01133756|559812447|FG000|Overall Study|Investigator Decision|1|||
155104158|NCT01133756|559812448|FG001|Overall Study|Investigator Decision|0|||
155104159|NCT01133756|559812449|FG002|Overall Study|Investigator Decision|0|||
155104160|NCT01133756|559812447|FG000|Overall Study|Withdrawal by Subject|0|||
155104161|NCT01133756|559812448|FG001|Overall Study|Withdrawal by Subject|1|||
155104162|NCT01133756|559812449|FG002|Overall Study|Withdrawal by Subject|0|||
155104163|NCT01133756|559812447|FG000|Overall Study|Progression of Disease|0|||
155104164|NCT01133756|559812448|FG001|Overall Study|Progression of Disease|0|||
155104165|NCT01133756|559812449|FG002|Overall Study|Progression of Disease|1|||
155104166|NCT01905943|559812463|FG000|Overall Study|Withdrawal of consent|90|||
155104167|NCT01905943|559812463|FG000|Overall Study|Lost to Follow-up|16|||
155104168|NCT01905943|559812463|FG000|Overall Study|Investigator discretion|7|||
155104169|NCT01905943|559812463|FG000|Overall Study|Death|186|||
155104170|NCT01905943|559812463|FG000|Overall Study|Adverse Event|3|||
155104171|NCT01905943|559812463|FG000|Overall Study|Other|12|||
155104172|NCT01238991|559812466|FG000|Overall Study|Adverse Event|1|||
155104173|NCT01238991|559812467|FG001|Overall Study|Adverse Event|0|||
155104174|NCT01238991|559812468|FG002|Overall Study|Adverse Event|3|||
155104175|NCT01238991|559812469|FG003|Overall Study|Adverse Event|1|||
155104176|NCT01238991|559812470|FG004|Overall Study|Adverse Event|1|||
155104177|NCT01238991|559812471|FG005|Overall Study|Adverse Event|0|||
155104178|NCT01238991|559812472|FG006|Overall Study|Adverse Event|1|||
155104179|NCT01238991|559812473|FG007|Overall Study|Adverse Event|1|||
155104180|NCT01238991|559812474|FG008|Overall Study|Adverse Event|0|||
155104181|NCT01238991|559812475|FG009|Overall Study|Adverse Event|0|||
155104182|NCT01238991|559812466|FG000|Overall Study|Death|0|||
155104183|NCT01238991|559812467|FG001|Overall Study|Death|0|||
155104184|NCT01238991|559812468|FG002|Overall Study|Death|0|||
155104185|NCT01238991|559812469|FG003|Overall Study|Death|1|||
155104186|NCT01238991|559812470|FG004|Overall Study|Death|0|||
155104187|NCT01238991|559812471|FG005|Overall Study|Death|0|||
155104188|NCT01238991|559812472|FG006|Overall Study|Death|0|||
155104189|NCT01238991|559812473|FG007|Overall Study|Death|0|||
155104190|NCT01238991|559812474|FG008|Overall Study|Death|0|||
155104191|NCT01238991|559812475|FG009|Overall Study|Death|0|||
155104192|NCT01238991|559812466|FG000|Overall Study|Lack of Efficacy|0|||
155104193|NCT01238991|559812467|FG001|Overall Study|Lack of Efficacy|0|||
155104194|NCT01238991|559812468|FG002|Overall Study|Lack of Efficacy|1|||
155104195|NCT01238991|559812469|FG003|Overall Study|Lack of Efficacy|0|||
155104196|NCT01238991|559812470|FG004|Overall Study|Lack of Efficacy|0|||
155104197|NCT01238991|559812471|FG005|Overall Study|Lack of Efficacy|0|||
155104198|NCT01238991|559812472|FG006|Overall Study|Lack of Efficacy|0|||
155104199|NCT01238991|559812473|FG007|Overall Study|Lack of Efficacy|0|||
155104200|NCT01238991|559812474|FG008|Overall Study|Lack of Efficacy|1|||
155104201|NCT01238991|559812475|FG009|Overall Study|Lack of Efficacy|0|||
155104202|NCT01238991|559812466|FG000|Overall Study|Withdrawal by Subject|0|||
155104203|NCT01238991|559812467|FG001|Overall Study|Withdrawal by Subject|0|||
155104204|NCT01238991|559812468|FG002|Overall Study|Withdrawal by Subject|1|||
155104205|NCT01238991|559812469|FG003|Overall Study|Withdrawal by Subject|0|||
155104206|NCT01238991|559812470|FG004|Overall Study|Withdrawal by Subject|0|||
155104207|NCT01238991|559812471|FG005|Overall Study|Withdrawal by Subject|0|||
155104208|NCT01238991|559812472|FG006|Overall Study|Withdrawal by Subject|0|||
155104209|NCT01238991|559812473|FG007|Overall Study|Withdrawal by Subject|0|||
155104210|NCT01238991|559812474|FG008|Overall Study|Withdrawal by Subject|0|||
155104211|NCT01238991|559812475|FG009|Overall Study|Withdrawal by Subject|0|||
155104212|NCT01238991|559812466|FG000|Overall Study|Study Terminated by Sponsor|0|||
155104213|NCT01238991|559812467|FG001|Overall Study|Study Terminated by Sponsor|0|||
155104214|NCT01238991|559812468|FG002|Overall Study|Study Terminated by Sponsor|0|||
155104215|NCT01238991|559812469|FG003|Overall Study|Study Terminated by Sponsor|0|||
155104216|NCT01238991|559812470|FG004|Overall Study|Study Terminated by Sponsor|1|||
155104217|NCT01238991|559812471|FG005|Overall Study|Study Terminated by Sponsor|0|||
155104218|NCT01238991|559812472|FG006|Overall Study|Study Terminated by Sponsor|7|||
155104219|NCT01238991|559812473|FG007|Overall Study|Study Terminated by Sponsor|4|||
155104220|NCT01238991|559812474|FG008|Overall Study|Study Terminated by Sponsor|2|||
155104221|NCT01238991|559812475|FG009|Overall Study|Study Terminated by Sponsor|2|||
155104222|NCT01238991|559812466|FG000|Overall Study|Caregiver's request|0|||
155104223|NCT01238991|559812467|FG001|Overall Study|Caregiver's request|0|||
155104224|NCT01238991|559812468|FG002|Overall Study|Caregiver's request|0|||
155104225|NCT01238991|559812469|FG003|Overall Study|Caregiver's request|0|||
155104226|NCT01238991|559812470|FG004|Overall Study|Caregiver's request|0|||
155104227|NCT01238991|559812471|FG005|Overall Study|Caregiver's request|0|||
155104228|NCT01238991|559812472|FG006|Overall Study|Caregiver's request|0|||
155104229|NCT01238991|559812473|FG007|Overall Study|Caregiver's request|0|||
155104230|NCT01238991|559812474|FG008|Overall Study|Caregiver's request|1|||
155104231|NCT01238991|559812475|FG009|Overall Study|Caregiver's request|0|||
155104232|NCT01238991|559812466|FG000|Overall Study|Admission to a nursing home|1|||
155104233|NCT01238991|559812467|FG001|Overall Study|Admission to a nursing home|0|||
155104234|NCT01238991|559812468|FG002|Overall Study|Admission to a nursing home|1|||
154970796|NCT00537095|559316877|FG001|Randomized Treatment Period (433 Days)|Death|1|||
154970797|NCT00537095|559316876|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
155104235|NCT01238991|559812469|FG003|Overall Study|Admission to a nursing home|0|||
155104236|NCT01238991|559812470|FG004|Overall Study|Admission to a nursing home|0|||
155104237|NCT01238991|559812471|FG005|Overall Study|Admission to a nursing home|0|||
155104238|NCT01238991|559812472|FG006|Overall Study|Admission to a nursing home|0|||
155104239|NCT01238991|559812473|FG007|Overall Study|Admission to a nursing home|0|||
154970798|NCT00537095|559316877|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
154838035|NCT04839380|558840356|FG000|Overall Study|Withdrawal by Subject|2|||
155104240|NCT01238991|559812474|FG008|Overall Study|Admission to a nursing home|0|||
155173501|NCT03698591|560073347|FG001|Overall Study|Failed drug screen|1|||
154838036|NCT04839380|558840356|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
154838037|NCT00879645|558840357|FG000|Overall Study|Adverse Event|1|||
155104241|NCT01238991|559812475|FG009|Overall Study|Admission to a nursing home|0|||
155104242|NCT02574078|559812477|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104243|NCT02574078|559812478|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104244|NCT02574078|559812479|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104245|NCT02574078|559812480|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104246|NCT02574078|559812481|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154838038|NCT00879645|558840358|FG001|Overall Study|Adverse Event|0|||
155104247|NCT02574078|559812482|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155104248|NCT02574078|559812483|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
155104249|NCT02574078|559812484|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104250|NCT02574078|559812485|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
154838039|NCT00879645|558840359|FG002|Overall Study|Adverse Event|0|||
154838040|NCT00879645|558840360|FG003|Overall Study|Adverse Event|0|||
154838041|NCT00513500|558840361|FG000|Overall Study|Lost to Follow-up|35|||
154838042|NCT00513500|558840362|FG001|Overall Study|Lost to Follow-up|39|||
154838043|NCT00513500|558840361|FG000|Overall Study|Death|2|||
154838044|NCT00513500|558840362|FG001|Overall Study|Death|1|||
154838045|NCT00513500|558840361|FG000|Overall Study|Hospitalized|4|||
155104251|NCT02574078|559812486|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104252|NCT02574078|559812487|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104253|NCT02574078|559812488|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155104254|NCT02574078|559812489|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154838046|NCT00513500|558840362|FG001|Overall Study|Hospitalized|14|||
154838047|NCT00749996|558840363|FG000|Overall Study|Lost to Follow-up|7|||
154838048|NCT00749996|558840364|FG001|Overall Study|Lost to Follow-up|4|||
154838049|NCT00749996|558840363|FG000|Overall Study|Withdrawal by Subject|5|||
154838050|NCT00749996|558840364|FG001|Overall Study|Withdrawal by Subject|4|||
154838051|NCT00749996|558840363|FG000|Overall Study|Protocol Violation|2|||
154838052|NCT00749996|558840364|FG001|Overall Study|Protocol Violation|3|||
154838053|NCT00749996|558840363|FG000|Overall Study|Physician Decision|2|||
154838054|NCT00749996|558840364|FG001|Overall Study|Physician Decision|0|||
154838055|NCT00749996|558840363|FG000|Overall Study|Pregnancy|0|||
154838056|NCT00749996|558840364|FG001|Overall Study|Pregnancy|2|||
154838057|NCT00749996|558840363|FG000|Overall Study|Adverse Event|1|||
154838058|NCT00749996|558840364|FG001|Overall Study|Adverse Event|0|||
154838059|NCT00749996|558840363|FG000|Overall Study|Death|1|||
154838060|NCT00749996|558840364|FG001|Overall Study|Death|0|||
154838061|NCT01227044|558840365|FG000|Overall Study|Lost to Follow-up|5|||
154838062|NCT01227044|558840366|FG001|Overall Study|Lost to Follow-up|7|||
154838063|NCT01227044|558840365|FG000|Overall Study|Discontinued Intervention|1|||
155104255|NCT02574078|559812477|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
155104256|NCT02574078|559812478|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155104257|NCT02574078|559812479|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
155104258|NCT02574078|559812480|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
155104259|NCT02574078|559812481|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
154838064|NCT01227044|558840366|FG001|Overall Study|Discontinued Intervention|2|||
154924105|NCT04668066|559146377|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924106|NCT04668066|559146378|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924107|NCT04668066|559146379|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924108|NCT04668066|559146380|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924109|NCT04668066|559146381|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
154924110|NCT04668066|559146382|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
154970799|NCT00537095|559316876|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
154970800|NCT00537095|559316877|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
154970801|NCT00537095|559316876|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
154970802|NCT00537095|559316877|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
154970803|NCT00537095|559316876|FG000|Open-label Period (590 Days)|Adverse Event|2|||
155104260|NCT02574078|559812482|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
155104261|NCT02574078|559812483|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
155104262|NCT02574078|559812484|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
155104263|NCT02574078|559812485|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
155104264|NCT02574078|559812486|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
155104265|NCT02574078|559812487|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
155104266|NCT02574078|559812488|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
155104267|NCT02574078|559812489|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
155104268|NCT02574078|559812477|FG000|Pre-Treatment Period|Other reasons|0|||
155104269|NCT02574078|559812478|FG001|Pre-Treatment Period|Other reasons|0|||
155104270|NCT02574078|559812479|FG002|Pre-Treatment Period|Other reasons|0|||
155173502|NCT03698591|560073346|FG000|Overall Study|Failed health screen|0|||
155173503|NCT03698591|560073347|FG001|Overall Study|Failed health screen|1|||
155173504|NCT03698591|560073346|FG000|Overall Study|Ineligible for financial compensation|1|||
154970804|NCT00537095|559316877|FG001|Open-label Period (590 Days)|Adverse Event|11|||
155104271|NCT02574078|559812480|FG003|Pre-Treatment Period|Other reasons|0|||
155104272|NCT02574078|559812481|FG004|Pre-Treatment Period|Other reasons|0|||
155104273|NCT02574078|559812482|FG005|Pre-Treatment Period|Other reasons|0|||
155104274|NCT02574078|559812483|FG006|Pre-Treatment Period|Other reasons|2|||
155104275|NCT02574078|559812484|FG007|Pre-Treatment Period|Other reasons|0|||
155104276|NCT02574078|559812485|FG008|Pre-Treatment Period|Other reasons|0|||
155104277|NCT02574078|559812486|FG009|Pre-Treatment Period|Other reasons|0|||
155104278|NCT02574078|559812487|FG010|Pre-Treatment Period|Other reasons|2|||
155104279|NCT02574078|559812488|FG011|Pre-Treatment Period|Other reasons|0|||
155104280|NCT02574078|559812489|FG012|Pre-Treatment Period|Other reasons|0|||
155104281|NCT02574078|559812477|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
155104282|NCT02574078|559812478|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
155104283|NCT02574078|559812479|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
155104284|NCT02574078|559812480|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
155104285|NCT02574078|559812481|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
155104286|NCT02574078|559812482|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
155104287|NCT02574078|559812483|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
155104288|NCT02574078|559812484|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
155104289|NCT02574078|559812485|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
155104290|NCT02574078|559812486|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
155104291|NCT02574078|559812487|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
155104292|NCT02574078|559812488|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
154838065|NCT04247061|558840367|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
154838066|NCT04247061|558840367|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
154970805|NCT00537095|559316876|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
154970806|NCT00537095|559316877|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
154970807|NCT00537095|559316876|FG000|Open-label Period (590 Days)|Death|2|||
154970808|NCT00537095|559316877|FG001|Open-label Period (590 Days)|Death|2|||
154970809|NCT00537095|559316876|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
154970810|NCT00537095|559316877|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
154970811|NCT00537095|559316876|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
154970812|NCT00537095|559316877|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
154970813|NCT00021541|559316878|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
154838067|NCT04247061|558840367|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
154838068|NCT00917150|558840368|FG000|Overall Study|Adverse Event|12|||
154838069|NCT00917150|558840369|FG001|Overall Study|Adverse Event|7|||
154838070|NCT00917150|558840370|FG002|Overall Study|Adverse Event|12|||
154838071|NCT00917150|558840371|FG003|Overall Study|Adverse Event|11|||
154838072|NCT00917150|558840368|FG000|Overall Study|Death|1|||
154838073|NCT00917150|558840369|FG001|Overall Study|Death|4|||
154838074|NCT00917150|558840370|FG002|Overall Study|Death|3|||
154838075|NCT00917150|558840371|FG003|Overall Study|Death|2|||
154838076|NCT00917150|558840368|FG000|Overall Study|Lost to Follow-up|1|||
154838077|NCT00917150|558840369|FG001|Overall Study|Lost to Follow-up|0|||
154838078|NCT00917150|558840370|FG002|Overall Study|Lost to Follow-up|4|||
154838079|NCT00917150|558840371|FG003|Overall Study|Lost to Follow-up|2|||
154838080|NCT00917150|558840368|FG000|Overall Study|Physician Decision|0|||
154838081|NCT00917150|558840369|FG001|Overall Study|Physician Decision|2|||
154838082|NCT00917150|558840370|FG002|Overall Study|Physician Decision|0|||
154838083|NCT00917150|558840371|FG003|Overall Study|Physician Decision|1|||
154838084|NCT00917150|558840368|FG000|Overall Study|Protocol Violation|5|||
154838085|NCT00917150|558840369|FG001|Overall Study|Protocol Violation|5|||
154838086|NCT00917150|558840370|FG002|Overall Study|Protocol Violation|3|||
154838087|NCT00917150|558840371|FG003|Overall Study|Protocol Violation|5|||
154838088|NCT00917150|558840368|FG000|Overall Study|Withdrawal by Subject|15|||
154838089|NCT00917150|558840369|FG001|Overall Study|Withdrawal by Subject|16|||
154838090|NCT00917150|558840370|FG002|Overall Study|Withdrawal by Subject|18|||
154838091|NCT00917150|558840371|FG003|Overall Study|Withdrawal by Subject|11|||
154838092|NCT00917150|558840368|FG000|Overall Study|Other than specified|3|||
154838093|NCT00917150|558840369|FG001|Overall Study|Other than specified|3|||
154838094|NCT00917150|558840370|FG002|Overall Study|Other than specified|2|||
154838095|NCT00917150|558840371|FG003|Overall Study|Other than specified|2|||
154838096|NCT03891264|558840372|FG000|Overall Study|Adverse Event|1|||
154838097|NCT03891264|558840372|FG000|Overall Study|Withdrawal by Subject|2|||
154838098|NCT03891264|558840372|FG000|Overall Study|Physician Decision|2|||
154838099|NCT01979536|558840373|FG000|Overall Study|Physician Decision|2|||
154838100|NCT01979536|558840374|FG001|Overall Study|Physician Decision|3|||
154838101|NCT01979536|558840373|FG000|Overall Study|Withdrawal by Subject|0|||
154838102|NCT01979536|558840374|FG001|Overall Study|Withdrawal by Subject|1|||
154838103|NCT01979536|558840373|FG000|Overall Study|Refusal|0|||
154838104|NCT01979536|558840374|FG001|Overall Study|Refusal|1|||
154838105|NCT01979536|558840373|FG000|Overall Study|Relapse|0|||
154838106|NCT01979536|558840374|FG001|Overall Study|Relapse|1|||
154838107|NCT01979536|558840373|FG000|Overall Study|Study terminated by Sponsor|0|||
154838108|NCT01979536|558840374|FG001|Overall Study|Study terminated by Sponsor|1|||
154838109|NCT01979536|558840373|FG000|Overall Study|Did not start treatment|0|||
154838110|NCT01979536|558840374|FG001|Overall Study|Did not start treatment|1|||
154838111|NCT05054114|558840379|FG000|Overall Study|Protocol Violation|13|||
154838112|NCT05054114|558840380|FG001|Overall Study|Protocol Violation|1|||
154838113|NCT05054114|558840379|FG000|Overall Study|Pregnancy|0|||
154838114|NCT05054114|558840380|FG001|Overall Study|Pregnancy|1|||
154838115|NCT01806779|558840381|FG000|Overall Study|Physician Decision|2|||
154838116|NCT01806779|558840382|FG001|Overall Study|Physician Decision|0|||
154838117|NCT01806779|558840383|FG002|Overall Study|Physician Decision|1|||
154838118|NCT01806779|558840381|FG000|Overall Study|Lack of Efficacy|1|||
154838119|NCT01806779|558840382|FG001|Overall Study|Lack of Efficacy|1|||
154838120|NCT01806779|558840383|FG002|Overall Study|Lack of Efficacy|0|||
154838121|NCT01806779|558840381|FG000|Overall Study|Lost to Follow-up|19|||
154838122|NCT01806779|558840382|FG001|Overall Study|Lost to Follow-up|20|||
154838123|NCT01806779|558840383|FG002|Overall Study|Lost to Follow-up|0|||
154838124|NCT01806779|558840381|FG000|Overall Study|Withdrawal by Subject|20|||
154838125|NCT01806779|558840382|FG001|Overall Study|Withdrawal by Subject|23|||
154838126|NCT01806779|558840383|FG002|Overall Study|Withdrawal by Subject|22|||
154838127|NCT00805480|558840384|FG000|Overall Study|Withdrawal by Subject|13|||
154838128|NCT00805480|558840385|FG001|Overall Study|Withdrawal by Subject|5|||
154838129|NCT00805480|558840386|FG002|Overall Study|Withdrawal by Subject|11|||
154838130|NCT00805480|558840387|FG003|Overall Study|Withdrawal by Subject|5|||
154838131|NCT00805480|558840384|FG000|Overall Study|Lost to Follow-up|1|||
154838132|NCT00805480|558840385|FG001|Overall Study|Lost to Follow-up|2|||
154838133|NCT00805480|558840386|FG002|Overall Study|Lost to Follow-up|0|||
154838134|NCT00805480|558840387|FG003|Overall Study|Lost to Follow-up|0|||
154838135|NCT00805480|558840384|FG000|Overall Study|Adverse Event|0|||
154838136|NCT00805480|558840385|FG001|Overall Study|Adverse Event|0|||
154838137|NCT00805480|558840386|FG002|Overall Study|Adverse Event|1|||
154838138|NCT00805480|558840387|FG003|Overall Study|Adverse Event|0|||
154838139|NCT02595450|558840390|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
154838140|NCT02595450|558840390|FG000|Overall Study|Enrolled, but not treated|8|||
154838141|NCT04294901|558840391|FG000|Overall Study|Death|86|||
154838142|NCT04294901|558840392|FG001|Overall Study|Death|110|||
154838143|NCT04294901|558840391|FG000|Overall Study|Provider did not have historical control patients|581|||
154838144|NCT04294901|558840392|FG001|Overall Study|Provider did not have historical control patients|0|||
154838145|NCT04294901|558840391|FG000|Overall Study|Provider did not have intervention patients|0|||
154838146|NCT04294901|558840392|FG001|Overall Study|Provider did not have intervention patients|98|||
154838147|NCT02239939|558842162|FG000|Overall Study|Adverse Event|1|||
154838148|NCT02239939|558842163|FG001|Overall Study|Adverse Event|0|||
154838149|NCT02239939|558842162|FG000|Overall Study|Withdrawal by Subject|1|||
154838150|NCT02239939|558842163|FG001|Overall Study|Withdrawal by Subject|1|||
154838151|NCT02239939|558842162|FG000|Overall Study|Lost to Follow-up|0|||
154838152|NCT02239939|558842163|FG001|Overall Study|Lost to Follow-up|1|||
154838153|NCT05634577|558842164|FG000|Overall Study|Lost to Follow-up|1|||
154838154|NCT05634577|558842164|FG000|Overall Study|Withdrawal by Subject|1|||
154838155|NCT02631200|558842165|FG000|First Period|Death|1|||
154838156|NCT02631200|558842166|FG001|First Period|Death|2|||
154838157|NCT02631200|558842165|FG000|First Period|Patient ill-health|2|||
154838158|NCT02631200|558842166|FG001|First Period|Patient ill-health|4|||
154838159|NCT02631200|558842165|FG000|First Period|Withdrawal by Subject|4|||
154838160|NCT02631200|558842166|FG001|First Period|Withdrawal by Subject|1|||
154838161|NCT02631200|558842165|FG000|Deferred Period|Death|0|||
154838162|NCT02631200|558842166|FG001|Deferred Period|Death|1|||
154838163|NCT02631200|558842165|FG000|Deferred Period|Received kidney transplant|0|||
154838164|NCT02631200|558842166|FG001|Deferred Period|Received kidney transplant|1|||
154838165|NCT02631200|558842165|FG000|Deferred Period|Withdrawal by Subject|0|||
154838166|NCT02631200|558842166|FG001|Deferred Period|Withdrawal by Subject|2|||
154838167|NCT02631200|558842165|FG000|Deferred Period|Lost to Follow-up|0|||
154838168|NCT02631200|558842166|FG001|Deferred Period|Lost to Follow-up|1|||
154838169|NCT01496885|558842168|FG000|Overall Study|Lost to Follow-up|13|||
154838170|NCT01496885|558842168|FG000|Overall Study|Withdrawal by Subject|7|||
154838171|NCT01496885|558842168|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
154838172|NCT01496885|558842168|FG000|Overall Study|Death|1|||
154838173|NCT03273166|558842169|FG000|Overall Study|Withdrawn prior to Completion|31|||
154838174|NCT01294670|558842170|FG000|Overall Study|Not treated|1|||
154838175|NCT01294670|558842171|FG001|Overall Study|Not treated|0|||
154838176|NCT01294670|558842172|FG002|Overall Study|Not treated|0|||
154838177|NCT01294670|558842173|FG003|Overall Study|Not treated|0|||
154838178|NCT01294670|558842174|FG004|Overall Study|Not treated|0|||
154838179|NCT04152161|558842177|FG000|Overall Study|Death|0|||
154838180|NCT04152161|558842178|FG001|Overall Study|Death|1|||
154838181|NCT04152161|558842177|FG000|Overall Study|Physician Decision|0|||
154970814|NCT00021541|559316879|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
154838182|NCT04152161|558842178|FG001|Overall Study|Physician Decision|1|||
154838183|NCT04152161|558842177|FG000|Overall Study|Lost to Follow-up|9|||
154838184|NCT04152161|558842178|FG001|Overall Study|Lost to Follow-up|3|||
154838185|NCT04152161|558842177|FG000|Overall Study|Protocol Violation|1|||
154838186|NCT04152161|558842178|FG001|Overall Study|Protocol Violation|0|||
154838187|NCT04152161|558842177|FG000|Overall Study|Withdrawal by Subject|29|||
154838188|NCT04152161|558842178|FG001|Overall Study|Withdrawal by Subject|28|||
154838189|NCT04152161|558842177|FG000|Overall Study|Sponsor termination of study|750|||
154838190|NCT04152161|558842178|FG001|Overall Study|Sponsor termination of study|755|||
154838191|NCT04152161|558842177|FG000|Overall Study|Other|20|||
154838192|NCT04152161|558842178|FG001|Overall Study|Other|18|||
154838193|NCT03363321|558842179|FG000|Overall Study|Withdrawal by Subject|0|||
154838194|NCT03363321|558842180|FG001|Overall Study|Withdrawal by Subject|1|||
154838195|NCT03363321|558842181|FG002|Overall Study|Withdrawal by Subject|0|||
154838196|NCT03363321|558842182|FG003|Overall Study|Withdrawal by Subject|1|||
154838197|NCT03363321|558842183|FG004|Overall Study|Withdrawal by Subject|0|||
154838198|NCT02915523|558842185|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
154838199|NCT02915523|558842186|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
154838200|NCT02915523|558842187|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
154838201|NCT02915523|558842188|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
154838202|NCT02915523|558842185|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
154838203|NCT02915523|558842186|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
154838204|NCT02915523|558842187|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
154838205|NCT02915523|558842188|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
154838206|NCT02915523|558842185|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
154838207|NCT02915523|558842186|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
154838208|NCT02915523|558842187|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
154838209|NCT02915523|558842188|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
154838210|NCT02915523|558842185|FG000|Expansion Phase (Phase 2)|Death|0|||
154838211|NCT02915523|558842186|FG001|Expansion Phase (Phase 2)|Death|0|||
154838212|NCT02915523|558842187|FG002|Expansion Phase (Phase 2)|Death|26|||
154838213|NCT02915523|558842188|FG003|Expansion Phase (Phase 2)|Death|53|||
154838214|NCT02915523|558842185|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
154838215|NCT02915523|558842186|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
154838216|NCT02915523|558842187|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
154838217|NCT02915523|558842188|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
154838218|NCT02915523|558842185|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
154838219|NCT02915523|558842186|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
154838220|NCT02915523|558842187|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
154838221|NCT02915523|558842188|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
154838222|NCT02915523|558842185|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
154838223|NCT02915523|558842186|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
154838224|NCT02915523|558842187|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
154838225|NCT02915523|558842188|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
154838226|NCT02590588|558842191|FG000|Overall Study|Adverse Event|1|||
154838227|NCT01780831|558842199|FG000|Overall Study|Withdrawal by Subject|0|||
154838228|NCT01780831|558842200|FG001|Overall Study|Withdrawal by Subject|0|||
154838229|NCT01780831|558842201|FG002|Overall Study|Withdrawal by Subject|4|||
154838230|NCT01780831|558842202|FG003|Overall Study|Withdrawal by Subject|0|||
154838231|NCT01780831|558842199|FG000|Overall Study|Lost to Follow-up|0|||
154838232|NCT01780831|558842200|FG001|Overall Study|Lost to Follow-up|0|||
154838233|NCT01780831|558842201|FG002|Overall Study|Lost to Follow-up|0|||
154838234|NCT01780831|558842202|FG003|Overall Study|Lost to Follow-up|1|||
154838235|NCT01784861|558842206|FG000|Overall Study|Adverse Event|0|||
154838236|NCT01784861|558842207|FG001|Overall Study|Adverse Event|0|||
154838237|NCT01784861|558842208|FG002|Overall Study|Adverse Event|1|||
154838238|NCT01784861|558842209|FG003|Overall Study|Adverse Event|2|||
154838239|NCT01784861|558842210|FG004|Overall Study|Adverse Event|1|||
154838240|NCT01784861|558842211|FG005|Overall Study|Adverse Event|0|||
154838241|NCT01784861|558842206|FG000|Overall Study|Withdrawal by Subject|0|||
154838242|NCT01784861|558842207|FG001|Overall Study|Withdrawal by Subject|0|||
154838243|NCT01784861|558842208|FG002|Overall Study|Withdrawal by Subject|0|||
154838244|NCT01784861|558842209|FG003|Overall Study|Withdrawal by Subject|1|||
154838245|NCT01784861|558842210|FG004|Overall Study|Withdrawal by Subject|0|||
154838246|NCT01784861|558842211|FG005|Overall Study|Withdrawal by Subject|0|||
154838247|NCT01784861|558842206|FG000|Overall Study|Physician Decision|0|||
155104293|NCT02574078|559812489|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
155104294|NCT02574078|559812477|FG000|Treatment Period|Disease progression|6|||
155104295|NCT02574078|559812478|FG001|Treatment Period|Disease progression|4|||
155104296|NCT02574078|559812479|FG002|Treatment Period|Disease progression|7|||
154838248|NCT01784861|558842207|FG001|Overall Study|Physician Decision|0|||
155104297|NCT02574078|559812480|FG003|Treatment Period|Disease progression|18|||
154838249|NCT01784861|558842208|FG002|Overall Study|Physician Decision|0|||
154838250|NCT01784861|558842209|FG003|Overall Study|Physician Decision|2|||
154838251|NCT01784861|558842210|FG004|Overall Study|Physician Decision|0|||
154838252|NCT01784861|558842211|FG005|Overall Study|Physician Decision|1|||
154838253|NCT01965262|558842220|FG000|Second Intervention (7 Days)|Discontinued|0|||
154838254|NCT01965262|558842221|FG001|Second Intervention (7 Days)|Discontinued|1|||
154838255|NCT01965262|558842220|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
154838256|NCT01965262|558842221|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
154838257|NCT01965262|558842220|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
154838258|NCT01965262|558842221|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
154838259|NCT01029366|558842222|FG000|Overall Study|Withdrawal by Subject|1|||
154838260|NCT01029366|558842223|FG001|Overall Study|Withdrawal by Subject|0|||
154838261|NCT01029366|558842222|FG000|Overall Study|Death|1|||
154838262|NCT01029366|558842223|FG001|Overall Study|Death|1|||
154838263|NCT01029366|558842222|FG000|Overall Study|disease progression|2|||
154838264|NCT01029366|558842223|FG001|Overall Study|disease progression|0|||
154838265|NCT01029366|558842222|FG000|Overall Study|manufacturing failure|0|||
154838266|NCT01029366|558842223|FG001|Overall Study|manufacturing failure|1|||
154838267|NCT00440947|558842224|FG000|36-Week Induction Phase|Adverse Event|16|||
154838268|NCT00440947|558842225|FG001|36-Week Induction Phase|Adverse Event|0|||
154838269|NCT00440947|558842226|FG002|36-Week Induction Phase|Adverse Event|0|||
154838270|NCT00440947|558842227|FG003|36-Week Induction Phase|Adverse Event|0|||
154838271|NCT00440947|558842228|FG004|36-Week Induction Phase|Adverse Event|0|||
154838272|NCT00440947|558842224|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
154838273|NCT00440947|558842225|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
154838274|NCT00440947|558842226|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
154838275|NCT00440947|558842227|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
154838276|NCT00440947|558842228|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
154970815|NCT00021541|559316878|FG000|Period 1-First Treatment|Adverse Event|2|||
154970816|NCT00021541|559316879|FG001|Period 1-First Treatment|Adverse Event|1|||
154970817|NCT00021541|559316878|FG000|Period 1-First Treatment|non-adherence|3|||
154970818|NCT00021541|559316879|FG001|Period 1-First Treatment|non-adherence|0|||
154970819|NCT00021541|559316878|FG000|Period 1-First Treatment|Death|1|||
154838277|NCT00440947|558842224|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
154838278|NCT00440947|558842225|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
154838279|NCT00440947|558842226|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
154838280|NCT00440947|558842227|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
154838281|NCT00440947|558842228|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
154838282|NCT00440947|558842224|FG000|36-Week Induction Phase|Non-compliance|10|||
154838283|NCT00440947|558842225|FG001|36-Week Induction Phase|Non-compliance|0|||
154838284|NCT00440947|558842226|FG002|36-Week Induction Phase|Non-compliance|0|||
154838285|NCT00440947|558842227|FG003|36-Week Induction Phase|Non-compliance|0|||
155104298|NCT02574078|559812481|FG004|Treatment Period|Disease progression|16|||
155104299|NCT02574078|559812482|FG005|Treatment Period|Disease progression|26|||
155104300|NCT02574078|559812483|FG006|Treatment Period|Disease progression|5|||
155104301|NCT02574078|559812484|FG007|Treatment Period|Disease progression|9|||
155104302|NCT02574078|559812485|FG008|Treatment Period|Disease progression|8|||
155104303|NCT02574078|559812486|FG009|Treatment Period|Disease progression|5|||
155104304|NCT02574078|559812487|FG010|Treatment Period|Disease progression|20|||
155104305|NCT02574078|559812488|FG011|Treatment Period|Disease progression|29|||
155104306|NCT02574078|559812489|FG012|Treatment Period|Disease progression|2|||
155104307|NCT02574078|559812477|FG000|Treatment Period|Study drug toxicity|1|||
155104308|NCT02574078|559812478|FG001|Treatment Period|Study drug toxicity|1|||
155104309|NCT02574078|559812479|FG002|Treatment Period|Study drug toxicity|0|||
155104310|NCT02574078|559812480|FG003|Treatment Period|Study drug toxicity|5|||
155104311|NCT02574078|559812481|FG004|Treatment Period|Study drug toxicity|3|||
155104312|NCT02574078|559812482|FG005|Treatment Period|Study drug toxicity|1|||
155104313|NCT02574078|559812483|FG006|Treatment Period|Study drug toxicity|2|||
154838286|NCT00440947|558842228|FG004|36-Week Induction Phase|Non-compliance|0|||
154838287|NCT00440947|558842224|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
154838288|NCT00440947|558842225|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
154838289|NCT00440947|558842226|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
154838290|NCT00440947|558842227|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
154838291|NCT00440947|558842228|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
154838292|NCT00440947|558842224|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
154838293|NCT00440947|558842225|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
154838294|NCT00440947|558842226|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
154838295|NCT00440947|558842227|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
155104314|NCT02574078|559812484|FG007|Treatment Period|Study drug toxicity|0|||
155104315|NCT02574078|559812485|FG008|Treatment Period|Study drug toxicity|2|||
155104316|NCT02574078|559812486|FG009|Treatment Period|Study drug toxicity|1|||
155104317|NCT02574078|559812487|FG010|Treatment Period|Study drug toxicity|16|||
155104318|NCT02574078|559812488|FG011|Treatment Period|Study drug toxicity|2|||
154838296|NCT00440947|558842228|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
154838297|NCT00440947|558842224|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
154970820|NCT00021541|559316879|FG001|Period 1-First Treatment|Death|0|||
154970821|NCT00021541|559316878|FG000|Period 1-First Treatment|Pts that did not progress|2|||
154838298|NCT00440947|558842225|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
154838299|NCT00440947|558842226|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
154838300|NCT00440947|558842227|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
154838301|NCT00440947|558842228|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
154838302|NCT00440947|558842224|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
154838303|NCT00440947|558842225|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
154838304|NCT00440947|558842226|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
154838305|NCT00440947|558842227|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
154838306|NCT00440947|558842228|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
154838307|NCT00440947|558842224|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
154838308|NCT00440947|558842225|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
154838309|NCT00440947|558842226|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
154970822|NCT00021541|559316879|FG001|Period 1-First Treatment|Pts that did not progress|2|||
154970823|NCT00021541|559316878|FG000|Period 1-First Treatment|Ineligible|0|||
155104319|NCT02574078|559812489|FG012|Treatment Period|Study drug toxicity|4|||
155104320|NCT02574078|559812477|FG000|Treatment Period|Death|2|||
155104321|NCT02574078|559812478|FG001|Treatment Period|Death|0|||
154838310|NCT00440947|558842227|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
154838311|NCT00440947|558842228|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
154838312|NCT00440947|558842224|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
155104322|NCT02574078|559812479|FG002|Treatment Period|Death|0|||
155104323|NCT02574078|559812480|FG003|Treatment Period|Death|0|||
154970824|NCT00021541|559316879|FG001|Period 1-First Treatment|Ineligible|2|||
154970825|NCT00021541|559316878|FG000|Period 2-crossover|refused phase B|2|||
154970826|NCT00021541|559316879|FG001|Period 2-crossover|refused phase B|2|||
154970827|NCT00021541|559316878|FG000|Period 2-crossover|Withdrawal by Subject|3|||
154838313|NCT00440947|558842225|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
154838314|NCT00440947|558842226|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
154838315|NCT00440947|558842227|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
154838316|NCT00440947|558842228|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
154838317|NCT00440947|558842224|FG000|36-Week Induction Phase|Incarceration|3|||
154838318|NCT00440947|558842225|FG001|36-Week Induction Phase|Incarceration|0|||
154838319|NCT00440947|558842226|FG002|36-Week Induction Phase|Incarceration|0|||
154838320|NCT00440947|558842227|FG003|36-Week Induction Phase|Incarceration|0|||
154838321|NCT00440947|558842228|FG004|36-Week Induction Phase|Incarceration|0|||
154838322|NCT00440947|558842224|FG000|36-Week Induction Phase|Pregnancy|1|||
154838323|NCT00440947|558842225|FG001|36-Week Induction Phase|Pregnancy|0|||
154838324|NCT00440947|558842226|FG002|36-Week Induction Phase|Pregnancy|0|||
154838325|NCT00440947|558842227|FG003|36-Week Induction Phase|Pregnancy|0|||
154838326|NCT00440947|558842228|FG004|36-Week Induction Phase|Pregnancy|0|||
154838327|NCT00440947|558842224|FG000|48-Week Randomization Phase|Adverse Event|0|||
154838328|NCT00440947|558842225|FG001|48-Week Randomization Phase|Adverse Event|2|||
154838329|NCT00440947|558842226|FG002|48-Week Randomization Phase|Adverse Event|5|||
154838330|NCT00440947|558842227|FG003|48-Week Randomization Phase|Adverse Event|0|||
154838331|NCT00440947|558842228|FG004|48-Week Randomization Phase|Adverse Event|0|||
154838332|NCT00440947|558842224|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
154838333|NCT00440947|558842225|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
154838334|NCT00440947|558842226|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
154838335|NCT00440947|558842227|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
154838336|NCT00440947|558842228|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
154838337|NCT00440947|558842224|FG000|48-Week Randomization Phase|Non-compliance|0|||
154838338|NCT00440947|558842225|FG001|48-Week Randomization Phase|Non-compliance|3|||
154838339|NCT00440947|558842226|FG002|48-Week Randomization Phase|Non-compliance|4|||
154838340|NCT00440947|558842227|FG003|48-Week Randomization Phase|Non-compliance|0|||
154838341|NCT00440947|558842228|FG004|48-Week Randomization Phase|Non-compliance|0|||
154838342|NCT00440947|558842224|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
154838343|NCT00440947|558842225|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
154838344|NCT00440947|558842226|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
154838345|NCT00440947|558842227|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
154838346|NCT00440947|558842228|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
154838347|NCT00440947|558842224|FG000|48-Week Randomization Phase|Protocol Violation|0|||
154838348|NCT00440947|558842225|FG001|48-Week Randomization Phase|Protocol Violation|0|||
154838349|NCT00440947|558842226|FG002|48-Week Randomization Phase|Protocol Violation|1|||
154838350|NCT00440947|558842227|FG003|48-Week Randomization Phase|Protocol Violation|0|||
154838351|NCT00440947|558842228|FG004|48-Week Randomization Phase|Protocol Violation|0|||
154838352|NCT00440947|558842224|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
154838353|NCT00440947|558842225|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
154838354|NCT00440947|558842226|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
154838355|NCT00440947|558842227|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
154838356|NCT00440947|558842228|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
154838357|NCT00440947|558842224|FG000|48-Week Randomization Phase|Pregnancy|0|||
154838358|NCT00440947|558842225|FG001|48-Week Randomization Phase|Pregnancy|0|||
154838359|NCT00440947|558842226|FG002|48-Week Randomization Phase|Pregnancy|1|||
154838360|NCT00440947|558842227|FG003|48-Week Randomization Phase|Pregnancy|0|||
154838361|NCT00440947|558842228|FG004|48-Week Randomization Phase|Pregnancy|0|||
154838362|NCT00440947|558842224|FG000|48-Week Randomization Phase|Incarceration|0|||
154838363|NCT00440947|558842225|FG001|48-Week Randomization Phase|Incarceration|3|||
154838364|NCT00440947|558842226|FG002|48-Week Randomization Phase|Incarceration|0|||
154838365|NCT00440947|558842227|FG003|48-Week Randomization Phase|Incarceration|0|||
154838366|NCT00440947|558842228|FG004|48-Week Randomization Phase|Incarceration|0|||
154838367|NCT00440947|558842224|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
154838368|NCT00440947|558842225|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
154838369|NCT00440947|558842226|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
154838370|NCT00440947|558842227|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
154838371|NCT00440947|558842228|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
154838372|NCT00440947|558842224|FG000|48-Week Randomization Phase|Physician Decision|0|||
154838373|NCT00440947|558842225|FG001|48-Week Randomization Phase|Physician Decision|2|||
154838374|NCT00440947|558842226|FG002|48-Week Randomization Phase|Physician Decision|0|||
154838375|NCT00440947|558842227|FG003|48-Week Randomization Phase|Physician Decision|0|||
154838376|NCT00440947|558842228|FG004|48-Week Randomization Phase|Physician Decision|0|||
154838377|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
154838378|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
154838379|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
154970828|NCT00021541|559316879|FG001|Period 2-crossover|Withdrawal by Subject|4|||
154838380|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
154970829|NCT00021541|559316878|FG000|Period 2-crossover|Adverse Event|2|||
154838381|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
154838382|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
154838383|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
154970830|NCT00021541|559316879|FG001|Period 2-crossover|Adverse Event|2|||
154970831|NCT00021541|559316878|FG000|Period 2-crossover|non-adherence|1|||
154970832|NCT00021541|559316879|FG001|Period 2-crossover|non-adherence|0|||
154970833|NCT00021541|559316878|FG000|Period 2-crossover|Pts that did not progress|2|||
154970834|NCT00021541|559316879|FG001|Period 2-crossover|Pts that did not progress|3|||
154970835|NCT01874535|559316880|FG000|Overall Study|Lost to Follow-up|10|||
154970836|NCT01874535|559316881|FG001|Overall Study|Lost to Follow-up|9|||
154970837|NCT01874535|559316880|FG000|Overall Study|incomplete symptom resolution|45|||
154970838|NCT01874535|559316881|FG001|Overall Study|incomplete symptom resolution|35|||
155104324|NCT02574078|559812481|FG004|Treatment Period|Death|1|||
154970839|NCT05263505|559316882|FG000|Overall Study|Adverse Event|0|||
155104325|NCT02574078|559812482|FG005|Treatment Period|Death|1|||
155104326|NCT02574078|559812483|FG006|Treatment Period|Death|1|||
155104327|NCT02574078|559812484|FG007|Treatment Period|Death|1|||
155104328|NCT02574078|559812485|FG008|Treatment Period|Death|7|||
155104329|NCT02574078|559812486|FG009|Treatment Period|Death|1|||
155104330|NCT02574078|559812487|FG010|Treatment Period|Death|0|||
155104331|NCT02574078|559812488|FG011|Treatment Period|Death|2|||
155104332|NCT02574078|559812489|FG012|Treatment Period|Death|1|||
155104333|NCT02574078|559812477|FG000|Treatment Period|Adverse event unrelated to drug|0|||
154970840|NCT05263505|559316883|FG001|Overall Study|Adverse Event|1|||
154970841|NCT02616380|559316884|FG000|Overall Study|Lost to Follow-up|1|||
154970842|NCT02616380|559316884|FG000|Overall Study|Other|2|||
155104334|NCT02574078|559812478|FG001|Treatment Period|Adverse event unrelated to drug|0|||
155104335|NCT02574078|559812479|FG002|Treatment Period|Adverse event unrelated to drug|1|||
155104336|NCT02574078|559812480|FG003|Treatment Period|Adverse event unrelated to drug|0|||
155104337|NCT02574078|559812481|FG004|Treatment Period|Adverse event unrelated to drug|2|||
155104338|NCT02574078|559812482|FG005|Treatment Period|Adverse event unrelated to drug|3|||
155104339|NCT02574078|559812483|FG006|Treatment Period|Adverse event unrelated to drug|0|||
155104340|NCT02574078|559812484|FG007|Treatment Period|Adverse event unrelated to drug|0|||
154970843|NCT01929681|559316885|FG000|Overall Study|Withdrawal by Subject|1|||
154970844|NCT01929681|559316886|FG001|Overall Study|Withdrawal by Subject|0|||
154970845|NCT01929681|559316885|FG000|Overall Study|Physician Decision|1|||
154970846|NCT01929681|559316886|FG001|Overall Study|Physician Decision|1|||
155104341|NCT02574078|559812485|FG008|Treatment Period|Adverse event unrelated to drug|1|||
154838384|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
154838385|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
154838386|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
154838387|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
154838388|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
154924111|NCT04668066|559146383|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
155104342|NCT02574078|559812486|FG009|Treatment Period|Adverse event unrelated to drug|2|||
154838389|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
154838390|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
154838391|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
154838392|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
154838393|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
154838394|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
154838395|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
154838396|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
155173505|NCT03698591|560073347|FG001|Overall Study|Ineligible for financial compensation|0|||
154970847|NCT05315713|559316887|FG000|Overall Study|Death|5|||
154838397|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
154838398|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
154838399|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
154838400|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
154838401|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
154838402|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
154838403|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
154838404|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
154838405|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
154838406|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
154838407|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
154838408|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
154838409|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
154838410|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
154838411|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
154838412|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
154838413|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
154838414|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
154838415|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
154838416|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
154838417|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
154838418|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
154838419|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
154970848|NCT05315713|559316887|FG000|Overall Study|Progressive disease|1|||
154970849|NCT05315713|559316887|FG000|Overall Study|Withdrawal by Subject|1|||
154970850|NCT05315713|559316887|FG000|Overall Study|Study terminated by sponsor|1|||
154838420|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
154970851|NCT00556673|559316888|FG000|Overall Study|Protocol deviation|3|||
154970852|NCT00556673|559316889|FG001|Overall Study|Protocol deviation|2|||
154970853|NCT01528735|559316890|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
154970854|NCT01528735|559316891|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
154970855|NCT01528735|559316890|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
154970856|NCT01528735|559316891|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
154970857|NCT01717040|559316892|FG000|Overall Study|Lost to Follow-up|2|||
154970858|NCT01717040|559316893|FG001|Overall Study|Lost to Follow-up|3|||
154970859|NCT01717040|559316892|FG000|Overall Study|Lack of Efficacy|1|||
154970860|NCT01717040|559316893|FG001|Overall Study|Lack of Efficacy|1|||
154838421|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
155104343|NCT02574078|559812487|FG010|Treatment Period|Adverse event unrelated to drug|4|||
155104344|NCT02574078|559812488|FG011|Treatment Period|Adverse event unrelated to drug|1|||
155104345|NCT02574078|559812489|FG012|Treatment Period|Adverse event unrelated to drug|0|||
155104346|NCT02574078|559812477|FG000|Treatment Period|Administrative reason by Sponsor|0|||
155104347|NCT02574078|559812478|FG001|Treatment Period|Administrative reason by Sponsor|1|||
155104348|NCT02574078|559812479|FG002|Treatment Period|Administrative reason by Sponsor|0|||
155104349|NCT02574078|559812480|FG003|Treatment Period|Administrative reason by Sponsor|0|||
155104350|NCT02574078|559812481|FG004|Treatment Period|Administrative reason by Sponsor|0|||
155104351|NCT02574078|559812482|FG005|Treatment Period|Administrative reason by Sponsor|0|||
155104352|NCT02574078|559812483|FG006|Treatment Period|Administrative reason by Sponsor|1|||
155104353|NCT02574078|559812484|FG007|Treatment Period|Administrative reason by Sponsor|0|||
155104354|NCT02574078|559812485|FG008|Treatment Period|Administrative reason by Sponsor|0|||
155104355|NCT02574078|559812486|FG009|Treatment Period|Administrative reason by Sponsor|0|||
154838422|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
155104356|NCT02574078|559812487|FG010|Treatment Period|Administrative reason by Sponsor|0|||
155104357|NCT02574078|559812488|FG011|Treatment Period|Administrative reason by Sponsor|0|||
155104358|NCT02574078|559812489|FG012|Treatment Period|Administrative reason by Sponsor|3|||
155104359|NCT02574078|559812477|FG000|Treatment Period|Other reasons|1|||
155104360|NCT02574078|559812478|FG001|Treatment Period|Other reasons|0|||
155104361|NCT02574078|559812479|FG002|Treatment Period|Other reasons|1|||
154970861|NCT01717040|559316892|FG000|Overall Study|Adverse Event|1|||
154838423|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
154838424|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
154838425|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
154838426|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
154838427|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
154838428|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
154838429|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
154970862|NCT01717040|559316893|FG001|Overall Study|Adverse Event|0|||
154970863|NCT01717040|559316892|FG000|Overall Study|Required Medication Change|0|||
154970864|NCT01717040|559316893|FG001|Overall Study|Required Medication Change|1|||
154970865|NCT01717040|559316892|FG000|Overall Study|New Substance Use Disorder|1|||
154970866|NCT01717040|559316893|FG001|Overall Study|New Substance Use Disorder|0|||
154970867|NCT01596127|559316894|FG000|Overall Study|Patient Ineligible|1|||
154838430|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
154838431|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
154838432|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Other|0|||
154838433|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Other|0|||
154838434|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Other|0|||
154838435|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Other|1|||
154838436|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Other|0|||
154838437|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
154838438|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
154838439|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
154838440|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
154838441|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
154838442|NCT00440947|558842224|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
154838443|NCT00440947|558842225|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
154838444|NCT00440947|558842226|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
154838445|NCT00440947|558842227|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
154838446|NCT00440947|558842228|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
154838447|NCT01827670|558842239|FG000|Overall Study|Withdrawal of Consent|3|||
154838448|NCT01827670|558842240|FG001|Overall Study|Withdrawal of Consent|2|||
154838449|NCT01827670|558842239|FG000|Overall Study|Lost to Follow-up|0|||
154838450|NCT01827670|558842240|FG001|Overall Study|Lost to Follow-up|1|||
154838451|NCT02813694|558842251|FG000|Overall Study|Physician Decision|0|||
154838452|NCT02813694|558842252|FG001|Overall Study|Physician Decision|1|||
154838453|NCT02813694|558842251|FG000|Overall Study|Withdrawal by Subject|10|||
154838454|NCT02813694|558842252|FG001|Overall Study|Withdrawal by Subject|9|||
154838455|NCT02813694|558842251|FG000|Overall Study|Lost to Follow-up|1|||
154838456|NCT02813694|558842252|FG001|Overall Study|Lost to Follow-up|1|||
154838457|NCT02813694|558842251|FG000|Overall Study|Death|3|||
154970868|NCT01566435|559316895|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
154970869|NCT00438633|559316896|FG000|Overall Study|Withdrawal by Subject|1|||
155104362|NCT02574078|559812480|FG003|Treatment Period|Other reasons|3|||
155104363|NCT02574078|559812481|FG004|Treatment Period|Other reasons|3|||
154838458|NCT02813694|558842252|FG001|Overall Study|Death|3|||
154838459|NCT02813694|558842251|FG000|Overall Study|Randomized- did not receive study drug|2|||
154838460|NCT02813694|558842252|FG001|Overall Study|Randomized- did not receive study drug|0|||
155104364|NCT02574078|559812482|FG005|Treatment Period|Other reasons|1|||
155104365|NCT02574078|559812483|FG006|Treatment Period|Other reasons|2|||
155104366|NCT02574078|559812484|FG007|Treatment Period|Other reasons|1|||
155104367|NCT02574078|559812485|FG008|Treatment Period|Other reasons|3|||
155104368|NCT02574078|559812486|FG009|Treatment Period|Other reasons|1|||
155104369|NCT02574078|559812487|FG010|Treatment Period|Other reasons|1|||
155104370|NCT02574078|559812488|FG011|Treatment Period|Other reasons|3|||
155104371|NCT02574078|559812489|FG012|Treatment Period|Other reasons|1|||
154970870|NCT00438633|559316897|FG001|Overall Study|Withdrawal by Subject|0|||
155104372|NCT02574078|559812477|FG000|Treatment Period|Participant request to stop drug|0|||
155104373|NCT02574078|559812478|FG001|Treatment Period|Participant request to stop drug|0|||
155104374|NCT02574078|559812479|FG002|Treatment Period|Participant request to stop drug|0|||
154970871|NCT00438633|559316896|FG000|Overall Study|Lost to Follow-up|15|||
154970872|NCT00438633|559316897|FG001|Overall Study|Lost to Follow-up|17|||
154970873|NCT00421304|559316898|FG000|Overall Study|Lost to Follow-up|5|||
154970874|NCT00421304|559316899|FG001|Overall Study|Lost to Follow-up|2|||
154970875|NCT00421304|559316900|FG002|Overall Study|Lost to Follow-up|5|||
154970876|NCT00421304|559316898|FG000|Overall Study|Withdrawal by Subject|2|||
154970877|NCT00421304|559316899|FG001|Overall Study|Withdrawal by Subject|2|||
154970878|NCT00421304|559316900|FG002|Overall Study|Withdrawal by Subject|2|||
154970879|NCT00421304|559316898|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
154970880|NCT00421304|559316899|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
154970881|NCT00421304|559316900|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
154970882|NCT00421304|559316898|FG000|Overall Study|Did not attend Day 360 visit|0|||
154970883|NCT00421304|559316899|FG001|Overall Study|Did not attend Day 360 visit|0|||
154970884|NCT00421304|559316900|FG002|Overall Study|Did not attend Day 360 visit|1|||
154970885|NCT03196284|559316901|FG000|Main Part|Withdrawal by Subject|0|||
154970886|NCT03196284|559316902|FG001|Main Part|Withdrawal by Subject|1|||
154970887|NCT03196284|559316903|FG002|Main Part|Withdrawal by Subject|0|||
154970888|NCT03196284|559316901|FG000|Extension Part|Lack of Efficacy|0|||
154970889|NCT03196284|559316902|FG001|Extension Part|Lack of Efficacy|0|||
154970890|NCT03196284|559316903|FG002|Extension Part|Lack of Efficacy|1|||
154970891|NCT03196284|559316901|FG000|Extension Part|Withdrawal by Subject|0|||
154970892|NCT03196284|559316902|FG001|Extension Part|Withdrawal by Subject|0|||
154970893|NCT03196284|559316903|FG002|Extension Part|Withdrawal by Subject|1|||
154970894|NCT03196284|559316901|FG000|Extension Part|Physician Decision|0|||
154970895|NCT03196284|559316902|FG001|Extension Part|Physician Decision|0|||
154970896|NCT03196284|559316903|FG002|Extension Part|Physician Decision|1|||
154970897|NCT00919711|559316904|FG000|Overall Study|Withdrawal by Subject|15|||
154970898|NCT00919711|559316905|FG001|Overall Study|Withdrawal by Subject|7|||
154970899|NCT00919711|559316904|FG000|Overall Study|Adverse Event|13|||
154970900|NCT00919711|559316905|FG001|Overall Study|Adverse Event|3|||
155173506|NCT03698591|560073346|FG000|Overall Study|Equipment Error|1|||
154970901|NCT00919711|559316904|FG000|Overall Study|Other|1|||
154970902|NCT00919711|559316905|FG001|Overall Study|Other|2|||
154970903|NCT00919711|559316904|FG000|Overall Study|Administrative Decision|0|||
154970904|NCT00919711|559316905|FG001|Overall Study|Administrative Decision|1|||
154970905|NCT00919711|559316904|FG000|Overall Study|Lost to Follow-up|2|||
154970906|NCT00919711|559316905|FG001|Overall Study|Lost to Follow-up|0|||
155104375|NCT02574078|559812480|FG003|Treatment Period|Participant request to stop drug|2|||
155104376|NCT02574078|559812481|FG004|Treatment Period|Participant request to stop drug|4|||
155104377|NCT02574078|559812482|FG005|Treatment Period|Participant request to stop drug|0|||
155104378|NCT02574078|559812483|FG006|Treatment Period|Participant request to stop drug|1|||
155104379|NCT02574078|559812484|FG007|Treatment Period|Participant request to stop drug|0|||
155104380|NCT02574078|559812485|FG008|Treatment Period|Participant request to stop drug|3|||
155104381|NCT02574078|559812486|FG009|Treatment Period|Participant request to stop drug|2|||
155104382|NCT02574078|559812487|FG010|Treatment Period|Participant request to stop drug|2|||
154838461|NCT02813694|558842251|FG000|Overall Study|Patient hospitalized|1|||
154838462|NCT02813694|558842252|FG001|Overall Study|Patient hospitalized|0|||
154838463|NCT00563186|558842256|FG000|Overall Study|LOS<48 hours|97|||
154838464|NCT00563186|558842257|FG001|Overall Study|LOS<48 hours|74|||
154838465|NCT00563186|558842256|FG000|Overall Study|Incomplete data|1|||
154838466|NCT00563186|558842257|FG001|Overall Study|Incomplete data|1|||
154838467|NCT01152021|558842258|FG000|Overall Study|Adverse Event|4|||
154838468|NCT01152021|558842259|FG001|Overall Study|Adverse Event|4|||
154838469|NCT01152021|558842258|FG000|Overall Study|Study drug had expired|1|||
154838470|NCT01152021|558842259|FG001|Overall Study|Study drug had expired|0|||
154838471|NCT01152021|558842258|FG000|Overall Study|Physician Decision|1|||
154838472|NCT01152021|558842259|FG001|Overall Study|Physician Decision|1|||
154838473|NCT01152021|558842258|FG000|Overall Study|No access to study drug in Pharmacy|0|||
154838474|NCT01152021|558842259|FG001|Overall Study|No access to study drug in Pharmacy|1|||
154838475|NCT00996944|558842260|FG000|Double-blind Treatment Period|Adverse Event|2|||
154838476|NCT00996944|558842261|FG001|Double-blind Treatment Period|Adverse Event|1|||
154970907|NCT00919711|559316904|FG000|Overall Study|Death|1|||
154970908|NCT00919711|559316905|FG001|Overall Study|Death|0|||
155104383|NCT02574078|559812488|FG011|Treatment Period|Participant request to stop drug|4|||
154838477|NCT00996944|558842260|FG000|Double-blind Treatment Period|Protocol Violation|1|||
154838478|NCT00996944|558842261|FG001|Double-blind Treatment Period|Protocol Violation|0|||
154838479|NCT00996944|558842260|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
154838480|NCT00996944|558842261|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
154838481|NCT00996944|558842260|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155104384|NCT02574078|559812489|FG012|Treatment Period|Participant request to stop drug|1|||
154838482|NCT00996944|558842261|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
154838483|NCT00996944|558842260|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
155104385|NCT02574078|559812477|FG000|Treatment Period|Participant withdrew consent|0|||
155104386|NCT02574078|559812478|FG001|Treatment Period|Participant withdrew consent|0|||
155104387|NCT02574078|559812479|FG002|Treatment Period|Participant withdrew consent|0|||
155104388|NCT02574078|559812480|FG003|Treatment Period|Participant withdrew consent|0|||
155104389|NCT02574078|559812481|FG004|Treatment Period|Participant withdrew consent|1|||
154838484|NCT00996944|558842261|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
154838485|NCT00769184|558842262|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
154838486|NCT00769184|558842263|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
154838487|NCT00769184|558842262|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
154838488|NCT00769184|558842263|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
154838489|NCT00769184|558842262|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
154838490|NCT00769184|558842263|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
155104390|NCT02574078|559812482|FG005|Treatment Period|Participant withdrew consent|1|||
155104391|NCT02574078|559812483|FG006|Treatment Period|Participant withdrew consent|0|||
154838491|NCT00517829|558842264|FG000|Overall Study|Adverse Event|22|||
154838492|NCT00517829|558842265|FG001|Overall Study|Adverse Event|34|||
154838493|NCT00517829|558842264|FG000|Overall Study|Disease Progression|39|||
154838494|NCT00517829|558842265|FG001|Overall Study|Disease Progression|32|||
155173507|NCT03698591|560073347|FG001|Overall Study|Equipment Error|0|||
155104392|NCT02574078|559812484|FG007|Treatment Period|Participant withdrew consent|1|||
155104393|NCT02574078|559812485|FG008|Treatment Period|Participant withdrew consent|0|||
155104394|NCT02574078|559812486|FG009|Treatment Period|Participant withdrew consent|2|||
155104395|NCT02574078|559812487|FG010|Treatment Period|Participant withdrew consent|1|||
155104396|NCT02574078|559812488|FG011|Treatment Period|Participant withdrew consent|4|||
155104397|NCT02574078|559812489|FG012|Treatment Period|Participant withdrew consent|1|||
155104398|NCT02574078|559812477|FG000|Treatment Period|Participant no longer meets criteria|0|||
155104399|NCT02574078|559812478|FG001|Treatment Period|Participant no longer meets criteria|0|||
154838495|NCT00517829|558842264|FG000|Overall Study|Patient Request|6|||
154838496|NCT00517829|558842265|FG001|Overall Study|Patient Request|5|||
154838497|NCT00517829|558842264|FG000|Overall Study|Investigator Request|5|||
154838498|NCT00517829|558842265|FG001|Overall Study|Investigator Request|3|||
154838499|NCT00517829|558842264|FG000|Overall Study|Other|3|||
155173508|NCT03698591|560073346|FG000|Overall Study|Could not establish TMS dosage|0|||
155104400|NCT02574078|559812479|FG002|Treatment Period|Participant no longer meets criteria|0|||
155104401|NCT02574078|559812480|FG003|Treatment Period|Participant no longer meets criteria|0|||
155104402|NCT02574078|559812481|FG004|Treatment Period|Participant no longer meets criteria|1|||
155104403|NCT02574078|559812482|FG005|Treatment Period|Participant no longer meets criteria|0|||
155104404|NCT02574078|559812483|FG006|Treatment Period|Participant no longer meets criteria|0|||
155104405|NCT02574078|559812484|FG007|Treatment Period|Participant no longer meets criteria|0|||
154838500|NCT00517829|558842265|FG001|Overall Study|Other|1|||
155104406|NCT02574078|559812485|FG008|Treatment Period|Participant no longer meets criteria|0|||
155104407|NCT02574078|559812486|FG009|Treatment Period|Participant no longer meets criteria|1|||
155104408|NCT02574078|559812487|FG010|Treatment Period|Participant no longer meets criteria|1|||
155104409|NCT02574078|559812488|FG011|Treatment Period|Participant no longer meets criteria|1|||
155104410|NCT02574078|559812489|FG012|Treatment Period|Participant no longer meets criteria|0|||
155104411|NCT02574078|559812477|FG000|Treatment Period|Lost to Follow-up|0|||
155104412|NCT02574078|559812478|FG001|Treatment Period|Lost to Follow-up|0|||
154838501|NCT02250274|558842267|FG000|Overall Study|Insufficient blood draw amount|7|||
154970909|NCT00919711|559316904|FG000|Overall Study|Noncompliance|1|||
154838502|NCT02250274|558842268|FG001|Overall Study|Insufficient blood draw amount|6|||
154838503|NCT00583362|558842269|FG000|Overall Study|Adverse Event|44|||
154838504|NCT00583362|558842269|FG000|Overall Study|Lack of Efficacy|22|||
154838505|NCT00583362|558842269|FG000|Overall Study|Lost to Follow-up|4|||
154838506|NCT00583362|558842269|FG000|Overall Study|Non-compliance with study drug|28|||
154838507|NCT00583362|558842269|FG000|Overall Study|Pregnancy|7|||
154838508|NCT00583362|558842269|FG000|Overall Study|Miscommunication of visit window|5|||
154838509|NCT00583362|558842269|FG000|Overall Study|Current site closed|7|||
154838510|NCT00583362|558842269|FG000|Overall Study|Subject not dosed in LBSL99|1|||
154838511|NCT00583362|558842269|FG000|Overall Study|Subject moved out of the country/state|2|||
154838512|NCT00583362|558842269|FG000|Overall Study|Missed visits due to staff changes|1|||
154838513|NCT00583362|558842269|FG000|Overall Study|Misunderstanding of protocol|1|||
154838514|NCT00583362|558842269|FG000|Overall Study|Behavioral problems and non-compliance|1|||
154838515|NCT00583362|558842269|FG000|Overall Study|Sponsor request due to missed doses|1|||
154838516|NCT00583362|558842269|FG000|Overall Study|Physician Decision|19|||
154838517|NCT00583362|558842269|FG000|Overall Study|Protocol Violation|2|||
154838518|NCT00583362|558842269|FG000|Overall Study|Withdrawal by Subject|57|||
154838519|NCT00446511|558842270|FG000|Overall Study|Adverse Event|7|||
154838520|NCT00446511|558842271|FG001|Overall Study|Adverse Event|2|||
154838521|NCT00446511|558842272|FG002|Overall Study|Adverse Event|3|||
154838522|NCT00446511|558842273|FG003|Overall Study|Adverse Event|1|||
154838523|NCT00446511|558842270|FG000|Overall Study|Protocol Violation|0|||
154838524|NCT00446511|558842271|FG001|Overall Study|Protocol Violation|0|||
154838525|NCT00446511|558842272|FG002|Overall Study|Protocol Violation|0|||
154838526|NCT00446511|558842273|FG003|Overall Study|Protocol Violation|1|||
154838527|NCT00446511|558842270|FG000|Overall Study|Withdrawal by Subject|0|||
154838528|NCT00446511|558842271|FG001|Overall Study|Withdrawal by Subject|0|||
154838529|NCT00446511|558842272|FG002|Overall Study|Withdrawal by Subject|0|||
154838530|NCT00446511|558842273|FG003|Overall Study|Withdrawal by Subject|3|||
154970910|NCT00919711|559316905|FG001|Overall Study|Noncompliance|0|||
154970911|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Adverse Event|8|||
154970912|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Adverse Event|5|||
154970913|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Adverse Event|9|||
154970914|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Adverse Event|0|||
154970915|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Adverse Event|0|||
154970916|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Adverse Event|0|||
154970917|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
154970918|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
154970919|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
154970920|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
154838531|NCT00446511|558842270|FG000|Overall Study|Administrative Problems|3|||
154838532|NCT00446511|558842271|FG001|Overall Study|Administrative Problems|0|||
154838533|NCT00446511|558842272|FG002|Overall Study|Administrative Problems|4|||
154838534|NCT00446511|558842273|FG003|Overall Study|Administrative Problems|1|||
154838535|NCT01136655|558842278|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
154838536|NCT01136655|558842278|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
154838537|NCT01136655|558842278|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
154838538|NCT01136655|558842278|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
154838539|NCT04770389|558842286|FG000|Overall Study|Adverse Event|1|||
154838540|NCT04770389|558842287|FG001|Overall Study|Adverse Event|2|||
154838541|NCT04770389|558842288|FG002|Overall Study|Adverse Event|0|||
154838542|NCT04770389|558842289|FG003|Overall Study|Adverse Event|1|||
154970921|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
154838543|NCT04770389|558842286|FG000|Overall Study|Withdrawal by Subject|0|||
154838544|NCT04770389|558842287|FG001|Overall Study|Withdrawal by Subject|2|||
154838545|NCT04770389|558842288|FG002|Overall Study|Withdrawal by Subject|1|||
154838546|NCT04770389|558842289|FG003|Overall Study|Withdrawal by Subject|0|||
154838547|NCT04770389|558842286|FG000|Overall Study|Failed attempt to draw blood|1|||
154838548|NCT04770389|558842287|FG001|Overall Study|Failed attempt to draw blood|0|||
154838549|NCT04770389|558842288|FG002|Overall Study|Failed attempt to draw blood|0|||
154838550|NCT04770389|558842289|FG003|Overall Study|Failed attempt to draw blood|0|||
154838551|NCT04770389|558842286|FG000|Overall Study|Left the country|0|||
154838552|NCT04770389|558842287|FG001|Overall Study|Left the country|0|||
154838553|NCT04770389|558842288|FG002|Overall Study|Left the country|1|||
154838554|NCT04770389|558842289|FG003|Overall Study|Left the country|2|||
154838555|NCT04770389|558842286|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
154838556|NCT04770389|558842287|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
154838557|NCT04770389|558842288|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
154838558|NCT04770389|558842289|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
154838559|NCT04770389|558842286|FG000|Overall Study|Lost to Follow-up|0|||
154838560|NCT04770389|558842287|FG001|Overall Study|Lost to Follow-up|0|||
154838561|NCT04770389|558842288|FG002|Overall Study|Lost to Follow-up|0|||
154838562|NCT04770389|558842289|FG003|Overall Study|Lost to Follow-up|1|||
154838563|NCT04770389|558842286|FG000|Overall Study|Moved away from study site|0|||
154838564|NCT04770389|558842287|FG001|Overall Study|Moved away from study site|1|||
154838565|NCT04770389|558842288|FG002|Overall Study|Moved away from study site|0|||
154838566|NCT04770389|558842289|FG003|Overall Study|Moved away from study site|0|||
154838567|NCT03765138|558842290|FG000|Overall Study|Lost to Follow-up|1|||
154838568|NCT00794157|558842291|FG000|Overall Study|Adverse Event|4|||
154838569|NCT00794157|558842292|FG001|Overall Study|Adverse Event|1|||
154838570|NCT00794157|558842293|FG002|Overall Study|Adverse Event|8|||
154838571|NCT00794157|558842291|FG000|Overall Study|Subject withdrew consent|2|||
154838572|NCT00794157|558842292|FG001|Overall Study|Subject withdrew consent|0|||
154838573|NCT00794157|558842293|FG002|Overall Study|Subject withdrew consent|3|||
154838574|NCT00794157|558842291|FG000|Overall Study|Lost to Follow-up|2|||
154838575|NCT00794157|558842292|FG001|Overall Study|Lost to Follow-up|0|||
154838576|NCT00794157|558842293|FG002|Overall Study|Lost to Follow-up|1|||
154838577|NCT00794157|558842291|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154838578|NCT00794157|558842292|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154838579|NCT00794157|558842293|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
154838580|NCT00794157|558842291|FG000|Overall Study|Administrative problems|1|||
154838581|NCT00794157|558842292|FG001|Overall Study|Administrative problems|7|||
154838582|NCT00794157|558842293|FG002|Overall Study|Administrative problems|4|||
154838583|NCT00794157|558842291|FG000|Overall Study|Abnormal test procedure result(s)|0|||
154838584|NCT00794157|558842292|FG001|Overall Study|Abnormal test procedure result(s)|1|||
154970922|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
154970923|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
154970924|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
154970925|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
154970926|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
154970927|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
155104413|NCT02574078|559812479|FG002|Treatment Period|Lost to Follow-up|0|||
155104414|NCT02574078|559812480|FG003|Treatment Period|Lost to Follow-up|0|||
155104415|NCT02574078|559812481|FG004|Treatment Period|Lost to Follow-up|0|||
155104416|NCT02574078|559812482|FG005|Treatment Period|Lost to Follow-up|0|||
155104417|NCT02574078|559812483|FG006|Treatment Period|Lost to Follow-up|0|||
155104418|NCT02574078|559812484|FG007|Treatment Period|Lost to Follow-up|0|||
155104419|NCT02574078|559812485|FG008|Treatment Period|Lost to Follow-up|0|||
155104420|NCT02574078|559812486|FG009|Treatment Period|Lost to Follow-up|1|||
155104421|NCT02574078|559812487|FG010|Treatment Period|Lost to Follow-up|0|||
155104422|NCT02574078|559812488|FG011|Treatment Period|Lost to Follow-up|1|||
155104423|NCT02574078|559812489|FG012|Treatment Period|Lost to Follow-up|0|||
155104424|NCT02574078|559812477|FG000|Treatment Period|Maximum clinical benefit|0|||
155104425|NCT02574078|559812478|FG001|Treatment Period|Maximum clinical benefit|0|||
154838585|NCT00794157|558842293|FG002|Overall Study|Abnormal test procedure result(s)|0|||
154838586|NCT00794157|558842291|FG000|Overall Study|Protocol deviation|0|||
154838587|NCT00794157|558842292|FG001|Overall Study|Protocol deviation|1|||
154838588|NCT00794157|558842293|FG002|Overall Study|Protocol deviation|1|||
154838589|NCT01970501|558842294|FG000|Overall Study|Discontinuation of study by sponsor|16|||
154838590|NCT01970501|558842295|FG001|Overall Study|Discontinuation of study by sponsor|14|||
154838591|NCT01970501|558842294|FG000|Overall Study|Withdrawal by Subject|6|||
154838592|NCT01970501|558842295|FG001|Overall Study|Withdrawal by Subject|7|||
154838593|NCT01970501|558842294|FG000|Overall Study|Adverse Event|2|||
154838594|NCT01970501|558842295|FG001|Overall Study|Adverse Event|4|||
154838595|NCT01970501|558842294|FG000|Overall Study|Death|1|||
154838596|NCT01970501|558842295|FG001|Overall Study|Death|3|||
154838597|NCT01970501|558842294|FG000|Overall Study|Physician Decision|2|||
154838598|NCT01970501|558842295|FG001|Overall Study|Physician Decision|0|||
154838599|NCT00708123|558842296|FG000|Period 1|Protocol Violation|0|||
154838600|NCT00708123|558842297|FG001|Period 1|Protocol Violation|1|||
154838601|NCT00708123|558842298|FG002|Period 1|Protocol Violation|0|||
154838602|NCT00708123|558842299|FG003|Period 1|Protocol Violation|1|||
154838603|NCT00708123|558842300|FG004|Period 1|Protocol Violation|0|||
154838604|NCT00708123|558842296|FG000|Period 1|Adverse Event|0|||
154838605|NCT00708123|558842297|FG001|Period 1|Adverse Event|0|||
154838606|NCT00708123|558842298|FG002|Period 1|Adverse Event|1|||
154838607|NCT00708123|558842299|FG003|Period 1|Adverse Event|0|||
154838608|NCT00708123|558842300|FG004|Period 1|Adverse Event|0|||
154838609|NCT00708123|558842296|FG000|Period 2|Protocol Violation|0|||
154838610|NCT00708123|558842297|FG001|Period 2|Protocol Violation|0|||
154838611|NCT00708123|558842298|FG002|Period 2|Protocol Violation|0|||
154838612|NCT00708123|558842299|FG003|Period 2|Protocol Violation|1|||
154838613|NCT00708123|558842300|FG004|Period 2|Protocol Violation|0|||
154838614|NCT00708123|558842296|FG000|Period 2|Other Reason|1|||
154838615|NCT00708123|558842297|FG001|Period 2|Other Reason|0|||
154838616|NCT00708123|558842298|FG002|Period 2|Other Reason|0|||
154838617|NCT00708123|558842299|FG003|Period 2|Other Reason|0|||
154838618|NCT00708123|558842300|FG004|Period 2|Other Reason|0|||
154838619|NCT00708123|558842296|FG000|Period 3|Lost to Follow-up|0|||
154838620|NCT00708123|558842297|FG001|Period 3|Lost to Follow-up|0|||
154838621|NCT00708123|558842298|FG002|Period 3|Lost to Follow-up|1|||
154838622|NCT00708123|558842299|FG003|Period 3|Lost to Follow-up|1|||
154838623|NCT00708123|558842300|FG004|Period 3|Lost to Follow-up|0|||
154838624|NCT00708123|558842296|FG000|Period 4|Protocol Violation|0|||
154838625|NCT00708123|558842297|FG001|Period 4|Protocol Violation|1|||
154838626|NCT00708123|558842298|FG002|Period 4|Protocol Violation|0|||
154838627|NCT00708123|558842299|FG003|Period 4|Protocol Violation|0|||
154838628|NCT00708123|558842300|FG004|Period 4|Protocol Violation|0|||
154838629|NCT02970292|558842301|FG000|Overall Study|Physician Decision|1|||
154838630|NCT02970292|558842302|FG001|Overall Study|Physician Decision|1|||
154838631|NCT02970292|558842301|FG000|Overall Study|Withdrawal by Subject|11|||
154838632|NCT02970292|558842302|FG001|Overall Study|Withdrawal by Subject|5|||
154838633|NCT02970292|558842301|FG000|Overall Study|Noncompliance with study drug|2|||
154838634|NCT02970292|558842302|FG001|Overall Study|Noncompliance with study drug|2|||
154838635|NCT02970292|558842301|FG000|Overall Study|Adverse Event|5|||
154838636|NCT02970292|558842302|FG001|Overall Study|Adverse Event|0|||
154838637|NCT02970292|558842301|FG000|Overall Study|Lack of Efficacy|1|||
154838638|NCT02970292|558842302|FG001|Overall Study|Lack of Efficacy|0|||
154838639|NCT02970292|558842301|FG000|Overall Study|Lost to Follow-up|1|||
154838640|NCT02970292|558842302|FG001|Overall Study|Lost to Follow-up|0|||
154838641|NCT02970292|558842301|FG000|Overall Study|Protocol Violation|2|||
154838642|NCT02970292|558842302|FG001|Overall Study|Protocol Violation|0|||
154838643|NCT02970292|558842301|FG000|Overall Study|Other|1|||
154838644|NCT02970292|558842302|FG001|Overall Study|Other|0|||
154838645|NCT00814892|558842303|FG000|Overall Study|Disease Progression|1|||
154838646|NCT00814892|558842303|FG000|Overall Study|Study Termination|1|||
154838647|NCT04486950|558842305|FG000|Overall Study|Lost to Follow-up|0|||
154838648|NCT04486950|558842306|FG001|Overall Study|Lost to Follow-up|0|||
154838649|NCT04486950|558842307|FG002|Overall Study|Lost to Follow-up|0|||
154838650|NCT04486950|558842308|FG003|Overall Study|Lost to Follow-up|0|||
154838651|NCT04486950|558842309|FG004|Overall Study|Lost to Follow-up|0|||
154838652|NCT04486950|558842310|FG005|Overall Study|Lost to Follow-up|1|||
154838653|NCT04486950|558842311|FG006|Overall Study|Lost to Follow-up|0|||
154838654|NCT00401375|558842312|FG000|Overall Study|Protocol Violation|2|||
154838655|NCT00401375|558842313|FG001|Overall Study|Protocol Violation|2|||
154838656|NCT00401375|558842314|FG002|Overall Study|Protocol Violation|1|||
154838657|NCT00401375|558842312|FG000|Overall Study|Adverse Event|6|||
154838658|NCT00401375|558842313|FG001|Overall Study|Adverse Event|11|||
154838659|NCT00401375|558842314|FG002|Overall Study|Adverse Event|10|||
154838660|NCT00401375|558842312|FG000|Overall Study|Withdrawal by Subject|9|||
154838661|NCT00401375|558842313|FG001|Overall Study|Withdrawal by Subject|7|||
154838662|NCT00401375|558842314|FG002|Overall Study|Withdrawal by Subject|7|||
154838663|NCT00401375|558842312|FG000|Overall Study|Lost to Follow-up|0|||
154838664|NCT00401375|558842313|FG001|Overall Study|Lost to Follow-up|1|||
154838665|NCT00401375|558842314|FG002|Overall Study|Lost to Follow-up|1|||
154838666|NCT00401375|558842312|FG000|Overall Study|Other than specified|2|||
154970928|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
154970929|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Physician Decision|4|||
154970930|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Physician Decision|0|||
154970931|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Physician Decision|2|||
154970932|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Physician Decision|0|||
154970933|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Physician Decision|0|||
154970934|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Physician Decision|0|||
154970935|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Pregnancy|1|||
154970936|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Pregnancy|2|||
154970937|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Pregnancy|0|||
154970938|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Pregnancy|0|||
154970939|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Pregnancy|0|||
154970940|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Pregnancy|0|||
154970941|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
154970942|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
154970943|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
154970944|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
154970945|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
154970946|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
154970947|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
154970948|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
154970949|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
154970950|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
154970951|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
154970952|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
154970953|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
154970954|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
154970955|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
154970956|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
155104426|NCT02574078|559812479|FG002|Treatment Period|Maximum clinical benefit|0|||
155104427|NCT02574078|559812480|FG003|Treatment Period|Maximum clinical benefit|0|||
155104428|NCT02574078|559812481|FG004|Treatment Period|Maximum clinical benefit|0|||
155104429|NCT02574078|559812482|FG005|Treatment Period|Maximum clinical benefit|0|||
155104430|NCT02574078|559812483|FG006|Treatment Period|Maximum clinical benefit|0|||
155104431|NCT02574078|559812484|FG007|Treatment Period|Maximum clinical benefit|0|||
155104432|NCT02574078|559812485|FG008|Treatment Period|Maximum clinical benefit|0|||
155104433|NCT02574078|559812486|FG009|Treatment Period|Maximum clinical benefit|1|||
154838667|NCT00401375|558842313|FG001|Overall Study|Other than specified|1|||
155104434|NCT02574078|559812487|FG010|Treatment Period|Maximum clinical benefit|0|||
155104435|NCT02574078|559812488|FG011|Treatment Period|Maximum clinical benefit|0|||
155104436|NCT02574078|559812489|FG012|Treatment Period|Maximum clinical benefit|0|||
155104437|NCT02222688|559812490|FG000|Overall Study|Withdrawal by Subject|0|||
155104438|NCT02222688|559812491|FG001|Overall Study|Withdrawal by Subject|0|||
155104439|NCT02222688|559812492|FG002|Overall Study|Withdrawal by Subject|0|||
155104440|NCT02222688|559812493|FG003|Overall Study|Withdrawal by Subject|2|||
155104441|NCT02222688|559812494|FG004|Overall Study|Withdrawal by Subject|1|||
154970957|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
154970958|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
154970959|NCT02614196|559316906|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
154970960|NCT02614196|559316907|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
155104442|NCT02222688|559812495|FG005|Overall Study|Withdrawal by Subject|0|||
155104443|NCT02222688|559812496|FG006|Overall Study|Withdrawal by Subject|1|||
155104444|NCT02222688|559812490|FG000|Overall Study|Disease progression|1|||
155104445|NCT02222688|559812491|FG001|Overall Study|Disease progression|0|||
155104446|NCT02222688|559812492|FG002|Overall Study|Disease progression|0|||
155104447|NCT02222688|559812493|FG003|Overall Study|Disease progression|0|||
155104448|NCT02222688|559812494|FG004|Overall Study|Disease progression|0|||
155104449|NCT02222688|559812495|FG005|Overall Study|Disease progression|0|||
155104450|NCT02222688|559812496|FG006|Overall Study|Disease progression|0|||
155104451|NCT05935878|559812503|FG000|Overall Study|Death|1|||
155104452|NCT05935878|559812504|FG001|Overall Study|Death|2|||
155104453|NCT05935878|559812503|FG000|Overall Study|Withdrawal by Subject|5|||
155104454|NCT05935878|559812504|FG001|Overall Study|Withdrawal by Subject|5|||
155104455|NCT05935878|559812503|FG000|Overall Study|Revision of implant|1|||
155104456|NCT05935878|559812504|FG001|Overall Study|Revision of implant|1|||
155104457|NCT05935878|559812503|FG000|Overall Study|Mobile bearing dislocation|0|||
155104458|NCT05935878|559812504|FG001|Overall Study|Mobile bearing dislocation|1|||
155104459|NCT00662831|559812518|FG000|Overall Study|Death|4|||
155104460|NCT00662831|559812519|FG001|Overall Study|Death|1|||
155104461|NCT00662831|559812518|FG000|Overall Study|Lack of Efficacy|6|||
155104462|NCT00662831|559812519|FG001|Overall Study|Lack of Efficacy|6|||
155104463|NCT00662831|559812518|FG000|Overall Study|Lost to Follow-up|1|||
155104464|NCT00662831|559812519|FG001|Overall Study|Lost to Follow-up|0|||
155104465|NCT00662831|559812518|FG000|Overall Study|Withdrawal by Subject|2|||
155104466|NCT00662831|559812519|FG001|Overall Study|Withdrawal by Subject|1|||
155104467|NCT00662831|559812518|FG000|Overall Study|Other|62|||
155104468|NCT00662831|559812519|FG001|Overall Study|Other|31|||
155104469|NCT00662831|559812518|FG000|Overall Study|Protocol Violation|8|||
155104470|NCT00662831|559812519|FG001|Overall Study|Protocol Violation|4|||
155104471|NCT00662831|559812518|FG000|Overall Study|Adverse Event|23|||
155104472|NCT00662831|559812519|FG001|Overall Study|Adverse Event|16|||
155104473|NCT00294671|559812520|FG000|Overall Study|Lack of Efficacy|11|||
155104474|NCT00294671|559812521|FG001|Overall Study|Lack of Efficacy|23|||
155104475|NCT00294671|559812520|FG000|Overall Study|Liver transplant|7|||
155104476|NCT00294671|559812521|FG001|Overall Study|Liver transplant|9|||
155104477|NCT00294671|559812520|FG000|Overall Study|Drug related adverse event (AE)|4|||
155104478|NCT00294671|559812521|FG001|Overall Study|Drug related adverse event (AE)|2|||
155104479|NCT00294671|559812520|FG000|Overall Study|Non-drug related AE|3|||
155104480|NCT00294671|559812521|FG001|Overall Study|Non-drug related AE|2|||
154970961|NCT02614196|559316908|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
155104481|NCT00294671|559812520|FG000|Overall Study|Lost to Follow-up|1|||
155104482|NCT00294671|559812521|FG001|Overall Study|Lost to Follow-up|3|||
155104483|NCT00294671|559812520|FG000|Overall Study|Non-compliance|1|||
154838668|NCT00401375|558842314|FG002|Overall Study|Other than specified|3|||
154838669|NCT00401375|558842312|FG000|Overall Study|Randomized but not treated|3|||
154838670|NCT00401375|558842313|FG001|Overall Study|Randomized but not treated|3|||
154838671|NCT00401375|558842314|FG002|Overall Study|Randomized but not treated|3|||
154838672|NCT02821715|558842315|FG000|Overall Study|Protocol Violation|1|||
154838673|NCT02821715|558842316|FG001|Overall Study|Protocol Violation|0|||
154838674|NCT02821715|558842317|FG002|Overall Study|Protocol Violation|0|||
154838675|NCT02821715|558842318|FG003|Overall Study|Protocol Violation|0|||
154838676|NCT02821715|558842319|FG004|Overall Study|Protocol Violation|0|||
154838677|NCT02821715|558842320|FG005|Overall Study|Protocol Violation|0|||
154838678|NCT00923130|558842328|FG000|Overall Study|Stopped treatment due to progression|17|||
154838679|NCT00923130|558842328|FG000|Overall Study|Death|1|||
154838680|NCT00923130|558842328|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
154838681|NCT00923130|558842328|FG000|Overall Study|Switched to alternative treatment|2|||
154838682|NCT00923130|558842328|FG000|Overall Study|Refused further treatment|2|||
154838683|NCT01187953|558842329|FG000|Overall Study|Death|11|||
154838684|NCT01187953|558842330|FG001|Overall Study|Death|13|||
154838685|NCT01187953|558842329|FG000|Overall Study|Adverse Event|1|||
154838686|NCT01187953|558842330|FG001|Overall Study|Adverse Event|2|||
154838687|NCT01187953|558842329|FG000|Overall Study|Lost to Follow-up|0|||
154838688|NCT01187953|558842330|FG001|Overall Study|Lost to Follow-up|3|||
154838689|NCT01187953|558842329|FG000|Overall Study|Withdrawal by Subject|3|||
154838690|NCT01187953|558842330|FG001|Overall Study|Withdrawal by Subject|3|||
154838691|NCT02457637|558842335|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
154838692|NCT00159861|558842336|FG000|Core Study - 16 Weeks|Death|3|||
154838693|NCT00159861|558842337|FG001|Core Study - 16 Weeks|Death|0|||
154838694|NCT00159861|558842336|FG000|Core Study - 16 Weeks|Adverse Event|12|||
154838695|NCT00159861|558842337|FG001|Core Study - 16 Weeks|Adverse Event|6|||
154838696|NCT00159861|558842336|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
154838697|NCT00159861|558842337|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
154838698|NCT00159861|558842336|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
154838699|NCT00159861|558842337|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
154838700|NCT00159861|558842336|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
154838701|NCT00159861|558842337|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
154838702|NCT00159861|558842336|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
154838703|NCT00159861|558842337|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
154838704|NCT00159861|558842336|FG000|Extension Study - up to 3 Years|Death|24|||
154838705|NCT00159861|558842337|FG001|Extension Study - up to 3 Years|Death|28|||
154838706|NCT00159861|558842336|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
154838707|NCT00159861|558842337|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
154838708|NCT00159861|558842336|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
154838709|NCT00159861|558842337|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
154838710|NCT00159861|558842336|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
154838711|NCT00159861|558842337|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
154838712|NCT00159861|558842336|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
154838713|NCT00159861|558842337|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
154838714|NCT01553136|558842339|FG000|Overall Study|Adverse Event|3|||
154838715|NCT01553136|558842340|FG001|Overall Study|Adverse Event|2|||
154838716|NCT01553136|558842339|FG000|Overall Study|Withdrawal by Subject|2|||
154838717|NCT01553136|558842340|FG001|Overall Study|Withdrawal by Subject|3|||
154838718|NCT01553136|558842339|FG000|Overall Study|Lost to Follow-up|4|||
154838719|NCT01553136|558842340|FG001|Overall Study|Lost to Follow-up|10|||
154838720|NCT01553136|558842339|FG000|Overall Study|Physician Decision|2|||
154838721|NCT01553136|558842340|FG001|Overall Study|Physician Decision|3|||
154838722|NCT01553136|558842339|FG000|Overall Study|Scheduling Difficulties|5|||
154838723|NCT01553136|558842340|FG001|Overall Study|Scheduling Difficulties|4|||
154838724|NCT03451773|558843993|FG000|Overall Study|Death on study|1|||
154838725|NCT03451773|558843994|FG001|Overall Study|Death on study|5|||
154838726|NCT03451773|558843993|FG000|Overall Study|Death during follow-up period|0|||
154838727|NCT03451773|558843994|FG001|Overall Study|Death during follow-up period|1|||
154838728|NCT02068547|558843995|FG000|Overall Study|Lost to Follow-up|3|||
154838729|NCT02068547|558843996|FG001|Overall Study|Lost to Follow-up|3|||
154838730|NCT02068547|558843995|FG000|Overall Study|Physician Decision|1|||
154838731|NCT02068547|558843996|FG001|Overall Study|Physician Decision|0|||
154838732|NCT03657043|558843997|FG000|Overall Study|Withdrawal by Subject|1|||
154838733|NCT03657043|558843998|FG001|Overall Study|Withdrawal by Subject|1|||
154838734|NCT03657043|558843999|FG002|Overall Study|Withdrawal by Subject|0|||
154838735|NCT03657043|558844000|FG003|Overall Study|Withdrawal by Subject|0|||
154838736|NCT03657043|558844001|FG004|Overall Study|Withdrawal by Subject|4|||
154838737|NCT03657043|558843997|FG000|Overall Study|Study closure by Sponsor|0|||
154838738|NCT03657043|558843998|FG001|Overall Study|Study closure by Sponsor|2|||
154838739|NCT03657043|558843999|FG002|Overall Study|Study closure by Sponsor|0|||
154838740|NCT03657043|558844000|FG003|Overall Study|Study closure by Sponsor|0|||
154838741|NCT03657043|558844001|FG004|Overall Study|Study closure by Sponsor|17|||
154838742|NCT03657043|558843997|FG000|Overall Study|Lost to Follow-up|0|||
154838743|NCT03657043|558843998|FG001|Overall Study|Lost to Follow-up|0|||
155104484|NCT00294671|559812521|FG001|Overall Study|Non-compliance|0|||
155104485|NCT00294671|559812520|FG000|Overall Study|Death|0|||
154838744|NCT03657043|558843999|FG002|Overall Study|Lost to Follow-up|0|||
154838745|NCT03657043|558844000|FG003|Overall Study|Lost to Follow-up|0|||
154838746|NCT03657043|558844001|FG004|Overall Study|Lost to Follow-up|4|||
154838747|NCT03657043|558843997|FG000|Overall Study|Death|6|||
154838748|NCT03657043|558843998|FG001|Overall Study|Death|5|||
154838749|NCT03657043|558843999|FG002|Overall Study|Death|0|||
154838750|NCT03657043|558844000|FG003|Overall Study|Death|0|||
154838751|NCT03657043|558844001|FG004|Overall Study|Death|53|||
154838752|NCT03657043|558843997|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
154838753|NCT03657043|558843998|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
154838754|NCT03657043|558843999|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
154838755|NCT03657043|558844000|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
154838756|NCT03657043|558844001|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
154838757|NCT03657043|558843997|FG000|Overall Study|Adverse Event|0|||
154838758|NCT03657043|558843998|FG001|Overall Study|Adverse Event|0|||
154838759|NCT03657043|558843999|FG002|Overall Study|Adverse Event|0|||
154838760|NCT03657043|558844000|FG003|Overall Study|Adverse Event|0|||
154838761|NCT03657043|558844001|FG004|Overall Study|Adverse Event|2|||
154838762|NCT03657043|558843997|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
154838763|NCT03657043|558843998|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
154838764|NCT03657043|558843999|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
154838765|NCT03657043|558844000|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
154838766|NCT03657043|558844001|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
154838767|NCT03657043|558843997|FG000|Overall Study|Withdrawal - declined follow-up|0|||
154838768|NCT03657043|558843998|FG001|Overall Study|Withdrawal - declined follow-up|0|||
154838769|NCT03657043|558843999|FG002|Overall Study|Withdrawal - declined follow-up|0|||
154838770|NCT03657043|558844000|FG003|Overall Study|Withdrawal - declined follow-up|0|||
154838771|NCT03657043|558844001|FG004|Overall Study|Withdrawal - declined follow-up|1|||
154838772|NCT01979523|558844002|FG000|Overall Study|Withdrawal by Subject|1|||
154838773|NCT01979523|558844003|FG001|Overall Study|Withdrawal by Subject|0|||
154838774|NCT00631371|558844011|FG000|Overall Study|Lost to Follow-up|24|||
154838775|NCT00631371|558844012|FG001|Overall Study|Lost to Follow-up|19|||
154838776|NCT00631371|558844011|FG000|Overall Study|Other reason|5|||
154838777|NCT00631371|558844012|FG001|Overall Study|Other reason|12|||
154838778|NCT00631371|558844011|FG000|Overall Study|subject request|38|||
154838779|NCT00631371|558844012|FG001|Overall Study|subject request|45|||
154838780|NCT00631371|558844011|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
154838781|NCT00631371|558844012|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
154838782|NCT00631371|558844011|FG000|Overall Study|Death|263|||
154838783|NCT00631371|558844012|FG001|Overall Study|Death|239|||
154838784|NCT01661140|558844013|FG000|Open-Label Period|Adverse Event|44|||
154838785|NCT01661140|558844014|FG001|Open-Label Period|Adverse Event|0|||
154838786|NCT01661140|558844015|FG002|Open-Label Period|Adverse Event|0|||
154838787|NCT01661140|558844013|FG000|Open-Label Period|Protocol Violation|3|||
154838788|NCT01661140|558844014|FG001|Open-Label Period|Protocol Violation|0|||
154838789|NCT01661140|558844015|FG002|Open-Label Period|Protocol Violation|0|||
154838790|NCT01661140|558844013|FG000|Open-Label Period|Withdrawal by Subject|5|||
154838791|NCT01661140|558844014|FG001|Open-Label Period|Withdrawal by Subject|0|||
154838792|NCT01661140|558844015|FG002|Open-Label Period|Withdrawal by Subject|0|||
154838793|NCT01661140|558844013|FG000|Open-Label Period|Investigator Decision|3|||
154838794|NCT01661140|558844014|FG001|Open-Label Period|Investigator Decision|0|||
154838795|NCT01661140|558844015|FG002|Open-Label Period|Investigator Decision|0|||
154838796|NCT01661140|558844013|FG000|Open-Label Period|Death|1|||
154838797|NCT01661140|558844014|FG001|Open-Label Period|Death|0|||
154838798|NCT01661140|558844015|FG002|Open-Label Period|Death|0|||
154838799|NCT01661140|558844013|FG000|Open-Label Period|Administrative/Other|1|||
154838800|NCT01661140|558844014|FG001|Open-Label Period|Administrative/Other|0|||
154838801|NCT01661140|558844015|FG002|Open-Label Period|Administrative/Other|0|||
154838802|NCT01661140|558844013|FG000|Open-Label Period|Sponsor termination|16|||
154838803|NCT01661140|558844014|FG001|Open-Label Period|Sponsor termination|0|||
154838804|NCT01661140|558844015|FG002|Open-Label Period|Sponsor termination|0|||
154838805|NCT01661140|558844013|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
154838806|NCT01661140|558844014|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
154838807|NCT01661140|558844015|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
154838808|NCT01661140|558844013|FG000|Open-Label Period|Lost to Follow-up|2|||
154838809|NCT01661140|558844014|FG001|Open-Label Period|Lost to Follow-up|0|||
154838810|NCT01661140|558844015|FG002|Open-Label Period|Lost to Follow-up|0|||
154838811|NCT01661140|558844013|FG000|Double-Blind Period|Refused Treatment|0|||
154838812|NCT01661140|558844014|FG001|Double-Blind Period|Refused Treatment|0|||
154838813|NCT01661140|558844015|FG002|Double-Blind Period|Refused Treatment|1|||
154838814|NCT01661140|558844013|FG000|Double-Blind Period|Adverse Event|0|||
154838815|NCT01661140|558844014|FG001|Double-Blind Period|Adverse Event|16|||
154838816|NCT01661140|558844015|FG002|Double-Blind Period|Adverse Event|18|||
154838817|NCT01661140|558844013|FG000|Double-Blind Period|Protocol Violation|0|||
154838818|NCT01661140|558844014|FG001|Double-Blind Period|Protocol Violation|2|||
154838819|NCT01661140|558844015|FG002|Double-Blind Period|Protocol Violation|3|||
154838820|NCT01661140|558844013|FG000|Double-Blind Period|Withdrawal by Subject|0|||
154838821|NCT01661140|558844014|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155104486|NCT00294671|559812521|FG001|Overall Study|Death|1|||
155104487|NCT01061723|559812522|FG000|Overall Study|Adverse Event|0|||
155104488|NCT01061723|559812523|FG001|Overall Study|Adverse Event|2|||
155104489|NCT01061723|559812524|FG002|Overall Study|Adverse Event|5|||
155104490|NCT01061723|559812525|FG003|Overall Study|Adverse Event|5|||
155104491|NCT01061723|559812526|FG004|Overall Study|Adverse Event|2|||
154838822|NCT01661140|558844015|FG002|Double-Blind Period|Withdrawal by Subject|3|||
154838823|NCT01661140|558844013|FG000|Double-Blind Period|Investigator's Decision|0|||
154838824|NCT01661140|558844014|FG001|Double-Blind Period|Investigator's Decision|1|||
154838825|NCT01661140|558844015|FG002|Double-Blind Period|Investigator's Decision|2|||
154838826|NCT01661140|558844013|FG000|Double-Blind Period|Sponsor Termination|0|||
154838827|NCT01661140|558844014|FG001|Double-Blind Period|Sponsor Termination|14|||
154838828|NCT01661140|558844015|FG002|Double-Blind Period|Sponsor Termination|17|||
154838829|NCT01661140|558844013|FG000|Double-Blind Period|Administrative/Other|0|||
154838830|NCT01661140|558844014|FG001|Double-Blind Period|Administrative/Other|7|||
154838831|NCT01661140|558844015|FG002|Double-Blind Period|Administrative/Other|6|||
154838832|NCT00713700|558844016|FG000|Overall Study|Lost to Follow-up|3|||
154838833|NCT00713700|558844016|FG000|Overall Study|Withdrawal by Subject|1|||
154838834|NCT00781456|558844017|FG000|Overall Study|Adverse Event|3|||
154838835|NCT00781456|558844018|FG001|Overall Study|Adverse Event|3|||
154838836|NCT00781456|558844017|FG000|Overall Study|Withdrawal by Subject|3|||
154838837|NCT00781456|558844018|FG001|Overall Study|Withdrawal by Subject|5|||
154838838|NCT00781456|558844017|FG000|Overall Study|Protocol Violation|4|||
154838839|NCT00781456|558844018|FG001|Overall Study|Protocol Violation|1|||
154838840|NCT00781456|558844017|FG000|Overall Study|Noncompliance With Protocol|1|||
154838841|NCT00781456|558844018|FG001|Overall Study|Noncompliance With Protocol|1|||
154838842|NCT00781456|558844017|FG000|Overall Study|Lost to Follow-up|10|||
154838843|NCT00781456|558844018|FG001|Overall Study|Lost to Follow-up|5|||
154838844|NCT00781456|558844017|FG000|Overall Study|Other Reason, Unknown|0|||
154838845|NCT00781456|558844018|FG001|Overall Study|Other Reason, Unknown|1|||
154838846|NCT01877187|558844020|FG000|Overall Study|Death|2|||
154838847|NCT01877187|558844020|FG000|Overall Study|Withdrawal by Subject|4|||
154838848|NCT01877187|558844020|FG000|Overall Study|Lost to Follow-up|3|||
154838849|NCT01877187|558844020|FG000|Overall Study|Declining clinical status|11|||
154838850|NCT01877187|558844020|FG000|Overall Study|Liver transplant|2|||
154838851|NCT05098041|558844022|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
154838852|NCT00618410|558844023|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
154838853|NCT00618410|558844024|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
154838854|NCT01297270|558844030|FG000|Overall Study|Adverse Event|19|||
154838855|NCT01297270|558844031|FG001|Overall Study|Adverse Event|32|||
154838856|NCT01297270|558844032|FG002|Overall Study|Adverse Event|5|||
154838857|NCT01297270|558844030|FG000|Overall Study|Lack of Efficacy|15|||
154838858|NCT01297270|558844031|FG001|Overall Study|Lack of Efficacy|17|||
154838859|NCT01297270|558844032|FG002|Overall Study|Lack of Efficacy|15|||
154838860|NCT01297270|558844030|FG000|Overall Study|Lost to Follow-up|1|||
154838861|NCT01297270|558844031|FG001|Overall Study|Lost to Follow-up|2|||
154838862|NCT01297270|558844032|FG002|Overall Study|Lost to Follow-up|1|||
154838863|NCT01297270|558844030|FG000|Overall Study|Protocol Violation|0|||
154838864|NCT01297270|558844031|FG001|Overall Study|Protocol Violation|2|||
154838865|NCT01297270|558844032|FG002|Overall Study|Protocol Violation|0|||
154838866|NCT01297270|558844030|FG000|Overall Study|Withdrawal by Subject|7|||
154838867|NCT01297270|558844031|FG001|Overall Study|Withdrawal by Subject|15|||
154838868|NCT01297270|558844032|FG002|Overall Study|Withdrawal by Subject|7|||
154838869|NCT01297270|558844030|FG000|Overall Study|Other reason not defined above|3|||
154838870|NCT01297270|558844031|FG001|Overall Study|Other reason not defined above|3|||
155104492|NCT01061723|559812527|FG005|Overall Study|Adverse Event|6|||
155104493|NCT01061723|559812522|FG000|Overall Study|Lack of Efficacy|2|||
155104494|NCT01061723|559812523|FG001|Overall Study|Lack of Efficacy|3|||
155104495|NCT01061723|559812524|FG002|Overall Study|Lack of Efficacy|4|||
155104496|NCT01061723|559812525|FG003|Overall Study|Lack of Efficacy|2|||
155104497|NCT01061723|559812526|FG004|Overall Study|Lack of Efficacy|1|||
155104498|NCT01061723|559812527|FG005|Overall Study|Lack of Efficacy|1|||
155104499|NCT01061723|559812522|FG000|Overall Study|Randomized but not treated|0|||
154838871|NCT01297270|558844032|FG002|Overall Study|Other reason not defined above|1|||
154838872|NCT01297270|558844030|FG000|Overall Study|Not treated|0|||
154838873|NCT01297270|558844031|FG001|Overall Study|Not treated|1|||
155104500|NCT01061723|559812523|FG001|Overall Study|Randomized but not treated|0|||
155104501|NCT01061723|559812524|FG002|Overall Study|Randomized but not treated|0|||
154838874|NCT01297270|558844032|FG002|Overall Study|Not treated|0|||
154838875|NCT00382993|558844035|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
154838876|NCT00382993|558844036|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
154838877|NCT00382993|558844035|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
154838878|NCT00382993|558844036|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
154838879|NCT00382993|558844035|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
154838880|NCT00382993|558844036|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
154838881|NCT00382993|558844035|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
154838882|NCT00382993|558844036|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
154838883|NCT00382993|558844035|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
155104502|NCT01061723|559812525|FG003|Overall Study|Randomized but not treated|0|||
155104503|NCT01061723|559812526|FG004|Overall Study|Randomized but not treated|0|||
155104504|NCT01061723|559812527|FG005|Overall Study|Randomized but not treated|1|||
155104505|NCT01061723|559812522|FG000|Overall Study|Other than specified above|2|||
154838884|NCT00382993|558844036|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
154838885|NCT00382993|558844035|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
154838886|NCT00382993|558844036|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
154838887|NCT00382993|558844035|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
154838888|NCT00382993|558844036|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
154838889|NCT00382993|558844035|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
154838890|NCT00382993|558844036|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
154838891|NCT00382993|558844035|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
154838892|NCT00382993|558844036|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
154838893|NCT00382993|558844035|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
154838894|NCT00382993|558844036|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
154838895|NCT00906087|558844046|FG000|Initial Washout|Withdrawal by Subject|1|||
154838896|NCT00906087|558844046|FG000|Initial Washout|Physician Decision|1|||
154838897|NCT02898259|558844047|FG000|Overall Study|Adverse Event|0|||
154838898|NCT02898259|558844048|FG001|Overall Study|Adverse Event|0|||
154838899|NCT02898259|558844049|FG002|Overall Study|Adverse Event|1|||
154838900|NCT02898259|558844050|FG003|Overall Study|Adverse Event|0|||
154838901|NCT02898259|558844051|FG004|Overall Study|Adverse Event|0|||
154838902|NCT02898259|558844047|FG000|Overall Study|Lack of Efficacy|1|||
154838903|NCT02898259|558844048|FG001|Overall Study|Lack of Efficacy|1|||
154838904|NCT02898259|558844049|FG002|Overall Study|Lack of Efficacy|3|||
154838905|NCT02898259|558844050|FG003|Overall Study|Lack of Efficacy|0|||
154838906|NCT02898259|558844051|FG004|Overall Study|Lack of Efficacy|0|||
154838907|NCT02898259|558844047|FG000|Overall Study|Lost to Follow-up|0|||
154838908|NCT02898259|558844048|FG001|Overall Study|Lost to Follow-up|0|||
154838909|NCT02898259|558844049|FG002|Overall Study|Lost to Follow-up|1|||
154838910|NCT02898259|558844050|FG003|Overall Study|Lost to Follow-up|0|||
154838911|NCT02898259|558844051|FG004|Overall Study|Lost to Follow-up|0|||
154838912|NCT02898259|558844047|FG000|Overall Study|Transformation before study began|0|||
154838913|NCT02898259|558844048|FG001|Overall Study|Transformation before study began|0|||
154838914|NCT02898259|558844049|FG002|Overall Study|Transformation before study began|0|||
154838915|NCT02898259|558844050|FG003|Overall Study|Transformation before study began|1|||
154838916|NCT02898259|558844051|FG004|Overall Study|Transformation before study began|0|||
154838917|NCT03016325|558844054|FG000|Treatment Period|Participant withdrew consent|0|||
154838918|NCT03016325|558844055|FG001|Treatment Period|Participant withdrew consent|1|||
154838919|NCT03016325|558844056|FG002|Treatment Period|Participant withdrew consent|0|||
154838920|NCT03016325|558844057|FG003|Treatment Period|Participant withdrew consent|0|||
154838921|NCT03016325|558844058|FG004|Treatment Period|Participant withdrew consent|0|||
154838922|NCT03016325|558844059|FG005|Treatment Period|Participant withdrew consent|0|||
154838923|NCT03016325|558844060|FG006|Treatment Period|Participant withdrew consent|0|||
154838924|NCT03016325|558844061|FG007|Treatment Period|Participant withdrew consent|0|||
154838925|NCT03016325|558844054|FG000|Treatment Period|Death|0|||
154838926|NCT03016325|558844055|FG001|Treatment Period|Death|0|||
154838927|NCT03016325|558844056|FG002|Treatment Period|Death|0|||
154838928|NCT03016325|558844057|FG003|Treatment Period|Death|0|||
154838929|NCT03016325|558844058|FG004|Treatment Period|Death|2|||
154838930|NCT03016325|558844059|FG005|Treatment Period|Death|0|||
154838931|NCT03016325|558844060|FG006|Treatment Period|Death|0|||
154838932|NCT03016325|558844061|FG007|Treatment Period|Death|0|||
155104506|NCT01061723|559812523|FG001|Overall Study|Other than specified above|1|||
154838933|NCT03016325|558844054|FG000|Treatment Period|Participant refuses assessments|0|||
154838934|NCT03016325|558844055|FG001|Treatment Period|Participant refuses assessments|0|||
154838935|NCT03016325|558844056|FG002|Treatment Period|Participant refuses assessments|1|||
154838936|NCT03016325|558844057|FG003|Treatment Period|Participant refuses assessments|0|||
154838937|NCT03016325|558844058|FG004|Treatment Period|Participant refuses assessments|0|||
154838938|NCT03016325|558844059|FG005|Treatment Period|Participant refuses assessments|0|||
154838939|NCT03016325|558844060|FG006|Treatment Period|Participant refuses assessments|0|||
154838940|NCT03016325|558844061|FG007|Treatment Period|Participant refuses assessments|0|||
154838941|NCT03016325|558844054|FG000|32-Day Follow-Up Period|Death|2|||
154838942|NCT03016325|558844055|FG001|32-Day Follow-Up Period|Death|0|||
154838943|NCT03016325|558844056|FG002|32-Day Follow-Up Period|Death|5|||
154838944|NCT03016325|558844057|FG003|32-Day Follow-Up Period|Death|6|||
154838945|NCT03016325|558844058|FG004|32-Day Follow-Up Period|Death|3|||
154838946|NCT03016325|558844059|FG005|32-Day Follow-Up Period|Death|0|||
154970962|NCT02614196|559316909|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
154838947|NCT03016325|558844060|FG006|32-Day Follow-Up Period|Death|0|||
154838948|NCT03016325|558844061|FG007|32-Day Follow-Up Period|Death|0|||
154970963|NCT02614196|559316910|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
155104507|NCT01061723|559812524|FG002|Overall Study|Other than specified above|1|||
155104508|NCT01061723|559812525|FG003|Overall Study|Other than specified above|1|||
155104509|NCT01061723|559812526|FG004|Overall Study|Other than specified above|0|||
155104510|NCT01061723|559812527|FG005|Overall Study|Other than specified above|1|||
155104511|NCT01734785|559812528|FG000|Open-Label Period|Adverse Event|0|||
155104512|NCT01734785|559812529|FG001|Open-Label Period|Adverse Event|0|||
155104513|NCT01734785|559812530|FG002|Open-Label Period|Adverse Event|0|||
155104514|NCT01734785|559812531|FG003|Open-Label Period|Adverse Event|9|||
155104515|NCT01734785|559812528|FG000|Open-Label Period|Lack of Efficacy|0|||
155104516|NCT01734785|559812529|FG001|Open-Label Period|Lack of Efficacy|0|||
155104517|NCT01734785|559812530|FG002|Open-Label Period|Lack of Efficacy|0|||
155104518|NCT01734785|559812531|FG003|Open-Label Period|Lack of Efficacy|1|||
155104519|NCT01734785|559812528|FG000|Open-Label Period|Protocol Violation|0|||
155104520|NCT01734785|559812529|FG001|Open-Label Period|Protocol Violation|0|||
155104521|NCT01734785|559812530|FG002|Open-Label Period|Protocol Violation|0|||
154838949|NCT03016325|558844054|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
154838950|NCT03016325|558844055|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
154838951|NCT03016325|558844056|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
154838952|NCT03016325|558844057|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
154838953|NCT03016325|558844058|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
154838954|NCT03016325|558844059|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
154838955|NCT03016325|558844060|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
154838956|NCT03016325|558844061|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
154838957|NCT03016325|558844054|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
154838958|NCT03016325|558844055|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
154838959|NCT03016325|558844056|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
154838960|NCT03016325|558844057|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
154838961|NCT03016325|558844058|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
154838962|NCT03016325|558844059|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
154838963|NCT03016325|558844060|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
154838964|NCT03016325|558844061|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
154838965|NCT03016325|558844054|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
154838966|NCT03016325|558844055|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
154838967|NCT03016325|558844056|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
154838968|NCT03016325|558844057|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
154838969|NCT03016325|558844058|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
154838970|NCT03016325|558844059|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
154838971|NCT03016325|558844060|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
154838972|NCT03016325|558844061|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
154838973|NCT03016325|558844054|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
154838974|NCT03016325|558844055|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
154838975|NCT03016325|558844056|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
154838976|NCT03016325|558844057|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
154838977|NCT03016325|558844058|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
154838978|NCT03016325|558844059|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
154838979|NCT03016325|558844060|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
154838980|NCT03016325|558844061|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
154838981|NCT03016325|558844054|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838982|NCT03016325|558844055|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838983|NCT03016325|558844056|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
154838984|NCT03016325|558844057|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838985|NCT03016325|558844058|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838986|NCT03016325|558844059|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838987|NCT03016325|558844060|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838988|NCT03016325|558844061|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
154838989|NCT03016325|558844054|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838990|NCT03016325|558844055|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
154838991|NCT03016325|558844056|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838992|NCT03016325|558844057|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838993|NCT03016325|558844058|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838994|NCT03016325|558844059|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838995|NCT03016325|558844060|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838996|NCT03016325|558844061|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
154838997|NCT03016325|558844054|FG000|182-Day Follow-Up Period|Death|3|||
154838998|NCT03016325|558844055|FG001|182-Day Follow-Up Period|Death|3|||
154838999|NCT03016325|558844056|FG002|182-Day Follow-Up Period|Death|11|||
154839000|NCT03016325|558844057|FG003|182-Day Follow-Up Period|Death|12|||
154839001|NCT03016325|558844058|FG004|182-Day Follow-Up Period|Death|9|||
154839002|NCT03016325|558844059|FG005|182-Day Follow-Up Period|Death|0|||
154839003|NCT03016325|558844060|FG006|182-Day Follow-Up Period|Death|0|||
154839004|NCT03016325|558844061|FG007|182-Day Follow-Up Period|Death|1|||
154839005|NCT03016325|558844054|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
154839006|NCT03016325|558844055|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
154839007|NCT03016325|558844056|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
154839008|NCT03016325|558844057|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
154970964|NCT02614196|559316911|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
154970965|NCT02614196|559316906|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
154970966|NCT02614196|559316907|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
154839009|NCT03016325|558844058|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
155173509|NCT03698591|560073347|FG001|Overall Study|Could not establish TMS dosage|1|||
154839010|NCT03016325|558844059|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
154839011|NCT03016325|558844060|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
154839012|NCT03016325|558844061|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
154839013|NCT03016325|558844054|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
154839014|NCT03016325|558844055|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
154839015|NCT03016325|558844056|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
154839016|NCT03016325|558844057|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
154839017|NCT03016325|558844058|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
154839018|NCT03016325|558844059|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
154839019|NCT03016325|558844060|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
154839020|NCT03016325|558844061|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
154839021|NCT03016325|558844054|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839022|NCT03016325|558844055|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839023|NCT03016325|558844056|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839024|NCT03016325|558844057|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839025|NCT03016325|558844058|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
154839026|NCT03016325|558844059|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839027|NCT03016325|558844060|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839028|NCT03016325|558844061|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
154839029|NCT03016325|558844054|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839030|NCT03016325|558844055|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839031|NCT03016325|558844056|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839032|NCT03016325|558844057|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839033|NCT03016325|558844058|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
154839034|NCT03016325|558844059|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839035|NCT03016325|558844060|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839036|NCT03016325|558844061|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
154839037|NCT03016325|558844054|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839038|NCT03016325|558844055|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839039|NCT03016325|558844056|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839040|NCT03016325|558844057|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
154839041|NCT03016325|558844058|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839042|NCT03016325|558844059|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839043|NCT03016325|558844060|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839044|NCT03016325|558844061|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
154839045|NCT03016325|558844054|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
154839046|NCT03016325|558844055|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
154839047|NCT03016325|558844056|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
154839048|NCT03016325|558844057|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
155173510|NCT03952039|560073354|FG000|Overall Study|Adverse Event|22|||
155173511|NCT03952039|560073355|FG001|Overall Study|Adverse Event|8|||
155173512|NCT03952039|560073354|FG000|Overall Study|Withdrawal by Participant|17|||
154839049|NCT03016325|558844058|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
154839050|NCT03016325|558844059|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
154839051|NCT03016325|558844060|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
154839052|NCT03016325|558844061|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
154839053|NCT03016325|558844054|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
154839054|NCT03016325|558844055|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
154839055|NCT03016325|558844056|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
154839056|NCT03016325|558844057|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
154839057|NCT03016325|558844058|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
154839058|NCT03016325|558844059|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
154839059|NCT03016325|558844060|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
154839060|NCT03016325|558844061|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
154839061|NCT02941627|558844062|FG000|Overall Study|Death|1|||
154839062|NCT02941627|558844062|FG000|Overall Study|Surgical failure|1|||
154839063|NCT02941627|558844062|FG000|Overall Study|cholesteatoma prevented implantation|1|||
154839064|NCT02595723|558844063|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
154839065|NCT02595723|558844064|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
154839066|NCT02595723|558844065|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
154839067|NCT02595723|558844063|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
154839068|NCT02595723|558844064|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
154839069|NCT02595723|558844065|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
154839070|NCT01087905|558844066|FG000|Overall Study|Lost to Follow-up|24|||
154839071|NCT01087905|558844067|FG001|Overall Study|Lost to Follow-up|28|||
154839072|NCT01087905|558844068|FG002|Overall Study|Lost to Follow-up|18|||
154839073|NCT01087905|558844069|FG003|Overall Study|Lost to Follow-up|31|||
154839074|NCT01087905|558844070|FG004|Overall Study|Lost to Follow-up|27|||
154839075|NCT01087905|558844071|FG005|Overall Study|Lost to Follow-up|25|||
154839076|NCT01087905|558844072|FG006|Overall Study|Lost to Follow-up|20|||
154839077|NCT01087905|558844073|FG007|Overall Study|Lost to Follow-up|24|||
154839078|NCT01087905|558844066|FG000|Overall Study|Withdrawal by Subject|5|||
154839079|NCT01087905|558844067|FG001|Overall Study|Withdrawal by Subject|4|||
154839080|NCT01087905|558844068|FG002|Overall Study|Withdrawal by Subject|4|||
154839081|NCT01087905|558844069|FG003|Overall Study|Withdrawal by Subject|5|||
154839082|NCT01087905|558844070|FG004|Overall Study|Withdrawal by Subject|4|||
154839083|NCT01087905|558844071|FG005|Overall Study|Withdrawal by Subject|3|||
154839084|NCT01087905|558844072|FG006|Overall Study|Withdrawal by Subject|3|||
154839085|NCT01087905|558844073|FG007|Overall Study|Withdrawal by Subject|5|||
154839086|NCT01902290|558844079|FG000|Overall Study|Withdrawal by Subject|19|||
154839087|NCT01902290|558844080|FG001|Overall Study|Withdrawal by Subject|27|||
154839088|NCT01902290|558844079|FG000|Overall Study|Lost to Follow-up|2|||
154839089|NCT01902290|558844080|FG001|Overall Study|Lost to Follow-up|2|||
154839090|NCT01902290|558844079|FG000|Overall Study|Death|1|||
154839091|NCT01902290|558844080|FG001|Overall Study|Death|0|||
154839092|NCT01902290|558844079|FG000|Overall Study|Sponsor Decision|26|||
154839093|NCT01902290|558844080|FG001|Overall Study|Sponsor Decision|24|||
154839094|NCT00385255|558844081|FG000|Overall Study|Serious Adverse Event|1|||
154839095|NCT00385255|558844082|FG001|Overall Study|Serious Adverse Event|2|||
154839096|NCT00385255|558844081|FG000|Overall Study|Protocol Violation|0|||
154839097|NCT00385255|558844082|FG001|Overall Study|Protocol Violation|4|||
154839098|NCT00385255|558844081|FG000|Overall Study|Withdrawal by Subject|0|||
154839099|NCT00385255|558844082|FG001|Overall Study|Withdrawal by Subject|8|||
154839100|NCT00385255|558844081|FG000|Overall Study|Migrated/moved from study area|0|||
154839101|NCT00385255|558844082|FG001|Overall Study|Migrated/moved from study area|1|||
154839102|NCT00385255|558844081|FG000|Overall Study|Lost to Follow-up|20|||
154839103|NCT00385255|558844082|FG001|Overall Study|Lost to Follow-up|58|||
154839104|NCT01265550|558844083|FG000|Pre Randomization|Withdrawal by Subject|0|||
154839105|NCT01265550|558844084|FG001|Pre Randomization|Withdrawal by Subject|0|||
154839106|NCT01265550|558844085|FG002|Pre Randomization|Withdrawal by Subject|0|||
154839107|NCT01265550|558844086|FG003|Pre Randomization|Withdrawal by Subject|70|||
154839108|NCT01265550|558844083|FG000|Pre Randomization|Technical Exclusions|0|||
154839109|NCT01265550|558844084|FG001|Pre Randomization|Technical Exclusions|0|||
154839110|NCT01265550|558844085|FG002|Pre Randomization|Technical Exclusions|0|||
154839111|NCT01265550|558844086|FG003|Pre Randomization|Technical Exclusions|54|||
154839112|NCT01265550|558844083|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
154839113|NCT01265550|558844084|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
154839114|NCT01265550|558844085|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
154839115|NCT01265550|558844086|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
154839116|NCT01265550|558844083|FG000|Pre Randomization|Non-GERD organic disorders|0|||
155104522|NCT01734785|559812531|FG003|Open-Label Period|Protocol Violation|13|||
155104523|NCT01734785|559812528|FG000|Open-Label Period|Lost to Follow-up|0|||
155104524|NCT01734785|559812529|FG001|Open-Label Period|Lost to Follow-up|0|||
155104525|NCT01734785|559812530|FG002|Open-Label Period|Lost to Follow-up|0|||
154839117|NCT01265550|558844084|FG001|Pre Randomization|Non-GERD organic disorders|0|||
154839118|NCT01265550|558844085|FG002|Pre Randomization|Non-GERD organic disorders|0|||
154839119|NCT01265550|558844086|FG003|Pre Randomization|Non-GERD organic disorders|23|||
154839120|NCT01265550|558844083|FG000|Pre Randomization|Functional heartburn|0|||
154839121|NCT01265550|558844084|FG001|Pre Randomization|Functional heartburn|0|||
154839122|NCT01265550|558844085|FG002|Pre Randomization|Functional heartburn|0|||
154839123|NCT01265550|558844086|FG003|Pre Randomization|Functional heartburn|99|||
154839124|NCT01929408|558844088|FG000|Overall Study|received HCT as initial treatment|8|||
154839125|NCT01015768|558844093|FG000|Overall Study|Some subject data unuseable|4|||
154839126|NCT01015768|558844094|FG001|Overall Study|Some subject data unuseable|4|||
154839127|NCT01073267|558844095|FG000|Overall Study|Disease Progression|3|||
155104526|NCT01734785|559812531|FG003|Open-Label Period|Lost to Follow-up|14|||
154839128|NCT01225731|558844096|FG000|Part 1|Did not meet eligibility criteria|1|||
154839129|NCT01225731|558844097|FG001|Part 1|Did not meet eligibility criteria|0|||
154839130|NCT01225731|558844098|FG002|Part 1|Did not meet eligibility criteria|0|||
155104527|NCT01734785|559812528|FG000|Open-Label Period|Withdrawal by Subject|0|||
155104528|NCT01734785|559812529|FG001|Open-Label Period|Withdrawal by Subject|0|||
155104529|NCT01734785|559812530|FG002|Open-Label Period|Withdrawal by Subject|0|||
155104530|NCT01734785|559812531|FG003|Open-Label Period|Withdrawal by Subject|12|||
155104531|NCT01734785|559812528|FG000|Open-Label Period|Other Reasons|0|||
155104532|NCT01734785|559812529|FG001|Open-Label Period|Other Reasons|0|||
155104533|NCT01734785|559812530|FG002|Open-Label Period|Other Reasons|0|||
154839131|NCT01225731|558844099|FG003|Part 1|Did not meet eligibility criteria|0|||
154839132|NCT01225731|558844100|FG004|Part 1|Did not meet eligibility criteria|1|||
154839133|NCT01225731|558844101|FG005|Part 1|Did not meet eligibility criteria|0|||
154839134|NCT01225731|558844102|FG006|Part 1|Did not meet eligibility criteria|0|||
154839135|NCT01225731|558844103|FG007|Part 1|Did not meet eligibility criteria|0|||
154839136|NCT01225731|558844104|FG008|Part 1|Did not meet eligibility criteria|0|||
154839137|NCT01225731|558844105|FG009|Part 1|Did not meet eligibility criteria|0|||
154839138|NCT01225731|558844106|FG010|Part 1|Did not meet eligibility criteria|0|||
154839139|NCT01225731|558844107|FG011|Part 1|Did not meet eligibility criteria|0|||
154839140|NCT01225731|558844108|FG012|Part 1|Did not meet eligibility criteria|0|||
154839141|NCT01225731|558844096|FG000|Part 1|Adverse Event|1|||
154839142|NCT01225731|558844097|FG001|Part 1|Adverse Event|2|||
154839143|NCT01225731|558844098|FG002|Part 1|Adverse Event|1|||
154839144|NCT01225731|558844099|FG003|Part 1|Adverse Event|1|||
154839145|NCT01225731|558844100|FG004|Part 1|Adverse Event|1|||
154839146|NCT01225731|558844101|FG005|Part 1|Adverse Event|0|||
154839147|NCT01225731|558844102|FG006|Part 1|Adverse Event|0|||
154839148|NCT01225731|558844103|FG007|Part 1|Adverse Event|0|||
154839149|NCT01225731|558844104|FG008|Part 1|Adverse Event|0|||
154839150|NCT01225731|558844105|FG009|Part 1|Adverse Event|0|||
154839151|NCT01225731|558844106|FG010|Part 1|Adverse Event|0|||
154839152|NCT01225731|558844107|FG011|Part 1|Adverse Event|0|||
154839153|NCT01225731|558844108|FG012|Part 1|Adverse Event|0|||
154839154|NCT01225731|558844096|FG000|Part 1|Withdrawal by Subject|0|||
154839155|NCT01225731|558844097|FG001|Part 1|Withdrawal by Subject|3|||
154839156|NCT01225731|558844098|FG002|Part 1|Withdrawal by Subject|0|||
154839157|NCT01225731|558844099|FG003|Part 1|Withdrawal by Subject|0|||
154839158|NCT01225731|558844100|FG004|Part 1|Withdrawal by Subject|4|||
154839159|NCT01225731|558844101|FG005|Part 1|Withdrawal by Subject|0|||
154839160|NCT01225731|558844102|FG006|Part 1|Withdrawal by Subject|0|||
154839161|NCT01225731|558844103|FG007|Part 1|Withdrawal by Subject|0|||
154839162|NCT01225731|558844104|FG008|Part 1|Withdrawal by Subject|0|||
154839163|NCT01225731|558844105|FG009|Part 1|Withdrawal by Subject|0|||
154839164|NCT01225731|558844106|FG010|Part 1|Withdrawal by Subject|0|||
154839165|NCT01225731|558844107|FG011|Part 1|Withdrawal by Subject|0|||
154839166|NCT01225731|558844108|FG012|Part 1|Withdrawal by Subject|0|||
154839167|NCT01225731|558844096|FG000|Part 1|Protocol Violation|0|||
154839168|NCT01225731|558844097|FG001|Part 1|Protocol Violation|0|||
154839169|NCT01225731|558844098|FG002|Part 1|Protocol Violation|0|||
154839170|NCT01225731|558844099|FG003|Part 1|Protocol Violation|1|||
154839171|NCT01225731|558844100|FG004|Part 1|Protocol Violation|0|||
154839172|NCT01225731|558844101|FG005|Part 1|Protocol Violation|0|||
154839173|NCT01225731|558844102|FG006|Part 1|Protocol Violation|0|||
154839174|NCT01225731|558844103|FG007|Part 1|Protocol Violation|0|||
154970967|NCT02614196|559316908|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
154970968|NCT02614196|559316909|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
155104534|NCT01734785|559812531|FG003|Open-Label Period|Other Reasons|224|||
155104535|NCT01734785|559812528|FG000|Double-Blind Period|Adverse Event|0|||
155104536|NCT01734785|559812529|FG001|Double-Blind Period|Adverse Event|3|||
155104537|NCT01734785|559812530|FG002|Double-Blind Period|Adverse Event|2|||
155104538|NCT01734785|559812531|FG003|Double-Blind Period|Adverse Event|0|||
154839175|NCT01225731|558844104|FG008|Part 1|Protocol Violation|0|||
154839176|NCT01225731|558844105|FG009|Part 1|Protocol Violation|0|||
154839177|NCT01225731|558844106|FG010|Part 1|Protocol Violation|0|||
154839178|NCT01225731|558844107|FG011|Part 1|Protocol Violation|0|||
154839179|NCT01225731|558844108|FG012|Part 1|Protocol Violation|0|||
154839180|NCT01225731|558844096|FG000|Part 2|Protocol Violation|0|||
154839181|NCT01225731|558844097|FG001|Part 2|Protocol Violation|0|||
154839182|NCT01225731|558844098|FG002|Part 2|Protocol Violation|0|||
154839183|NCT01225731|558844099|FG003|Part 2|Protocol Violation|0|||
154839184|NCT01225731|558844100|FG004|Part 2|Protocol Violation|0|||
154839185|NCT01225731|558844101|FG005|Part 2|Protocol Violation|1|||
154839186|NCT01225731|558844102|FG006|Part 2|Protocol Violation|0|||
154839187|NCT01225731|558844103|FG007|Part 2|Protocol Violation|0|||
154839188|NCT01225731|558844104|FG008|Part 2|Protocol Violation|1|||
155104539|NCT01734785|559812528|FG000|Double-Blind Period|Lack of Efficacy|0|||
154839189|NCT01225731|558844105|FG009|Part 2|Protocol Violation|0|||
154839190|NCT01225731|558844106|FG010|Part 2|Protocol Violation|0|||
154839191|NCT01225731|558844107|FG011|Part 2|Protocol Violation|0|||
155104540|NCT01734785|559812529|FG001|Double-Blind Period|Lack of Efficacy|1|||
154839192|NCT01225731|558844108|FG012|Part 2|Protocol Violation|0|||
154839193|NCT01225731|558844096|FG000|Part 2|Adverse Event|0|||
154839194|NCT01225731|558844097|FG001|Part 2|Adverse Event|0|||
154839195|NCT01225731|558844098|FG002|Part 2|Adverse Event|0|||
154839196|NCT01225731|558844099|FG003|Part 2|Adverse Event|0|||
155104541|NCT01734785|559812530|FG002|Double-Blind Period|Lack of Efficacy|0|||
155104542|NCT01734785|559812531|FG003|Double-Blind Period|Lack of Efficacy|0|||
155104543|NCT01734785|559812528|FG000|Double-Blind Period|Protocol Violation|0|||
155104544|NCT01734785|559812529|FG001|Double-Blind Period|Protocol Violation|1|||
155104545|NCT01734785|559812530|FG002|Double-Blind Period|Protocol Violation|1|||
155104546|NCT01734785|559812531|FG003|Double-Blind Period|Protocol Violation|0|||
155104547|NCT01734785|559812528|FG000|Double-Blind Period|Lost to Follow-up|2|||
154970969|NCT02614196|559316910|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
154970970|NCT02614196|559316911|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
154970971|NCT02614196|559316906|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
155104548|NCT01734785|559812529|FG001|Double-Blind Period|Lost to Follow-up|4|||
155104549|NCT01734785|559812530|FG002|Double-Blind Period|Lost to Follow-up|2|||
154839197|NCT01225731|558844100|FG004|Part 2|Adverse Event|0|||
154839198|NCT01225731|558844101|FG005|Part 2|Adverse Event|0|||
154839199|NCT01225731|558844102|FG006|Part 2|Adverse Event|4|||
154839200|NCT01225731|558844103|FG007|Part 2|Adverse Event|4|||
154839201|NCT01225731|558844104|FG008|Part 2|Adverse Event|2|||
154839202|NCT01225731|558844105|FG009|Part 2|Adverse Event|0|||
154839203|NCT01225731|558844106|FG010|Part 2|Adverse Event|0|||
154839204|NCT01225731|558844107|FG011|Part 2|Adverse Event|0|||
154839205|NCT01225731|558844108|FG012|Part 2|Adverse Event|0|||
154839206|NCT01225731|558844096|FG000|Part 2|Lack of Efficacy|0|||
154839207|NCT01225731|558844097|FG001|Part 2|Lack of Efficacy|0|||
154839208|NCT01225731|558844098|FG002|Part 2|Lack of Efficacy|0|||
154839209|NCT01225731|558844099|FG003|Part 2|Lack of Efficacy|0|||
154839210|NCT01225731|558844100|FG004|Part 2|Lack of Efficacy|0|||
154839211|NCT01225731|558844101|FG005|Part 2|Lack of Efficacy|1|||
154839212|NCT01225731|558844102|FG006|Part 2|Lack of Efficacy|0|||
154839213|NCT01225731|558844103|FG007|Part 2|Lack of Efficacy|12|||
154839214|NCT01225731|558844104|FG008|Part 2|Lack of Efficacy|3|||
154839215|NCT01225731|558844105|FG009|Part 2|Lack of Efficacy|0|||
154839216|NCT01225731|558844106|FG010|Part 2|Lack of Efficacy|0|||
154839217|NCT01225731|558844107|FG011|Part 2|Lack of Efficacy|0|||
154839218|NCT01225731|558844108|FG012|Part 2|Lack of Efficacy|0|||
154839219|NCT01225731|558844096|FG000|Part 2|Pregnancy|0|||
154839220|NCT01225731|558844097|FG001|Part 2|Pregnancy|0|||
154839221|NCT01225731|558844098|FG002|Part 2|Pregnancy|0|||
154839222|NCT01225731|558844099|FG003|Part 2|Pregnancy|0|||
154839223|NCT01225731|558844100|FG004|Part 2|Pregnancy|0|||
154839224|NCT01225731|558844101|FG005|Part 2|Pregnancy|0|||
154839225|NCT01225731|558844102|FG006|Part 2|Pregnancy|1|||
154839226|NCT01225731|558844103|FG007|Part 2|Pregnancy|0|||
154839227|NCT01225731|558844104|FG008|Part 2|Pregnancy|1|||
154839228|NCT01225731|558844105|FG009|Part 2|Pregnancy|0|||
154839229|NCT01225731|558844106|FG010|Part 2|Pregnancy|0|||
154839230|NCT01225731|558844107|FG011|Part 2|Pregnancy|0|||
154839231|NCT01225731|558844108|FG012|Part 2|Pregnancy|0|||
154839232|NCT01225731|558844096|FG000|Part 2|Lost to Follow-up|0|||
154839233|NCT01225731|558844097|FG001|Part 2|Lost to Follow-up|0|||
154839234|NCT01225731|558844098|FG002|Part 2|Lost to Follow-up|0|||
154839235|NCT01225731|558844099|FG003|Part 2|Lost to Follow-up|0|||
154839236|NCT01225731|558844100|FG004|Part 2|Lost to Follow-up|0|||
154839237|NCT01225731|558844101|FG005|Part 2|Lost to Follow-up|0|||
154839238|NCT01225731|558844102|FG006|Part 2|Lost to Follow-up|0|||
154839239|NCT01225731|558844103|FG007|Part 2|Lost to Follow-up|3|||
154839240|NCT01225731|558844104|FG008|Part 2|Lost to Follow-up|1|||
154839241|NCT01225731|558844105|FG009|Part 2|Lost to Follow-up|0|||
154839242|NCT01225731|558844106|FG010|Part 2|Lost to Follow-up|0|||
154839243|NCT01225731|558844107|FG011|Part 2|Lost to Follow-up|0|||
154839244|NCT01225731|558844108|FG012|Part 2|Lost to Follow-up|0|||
154839245|NCT01225731|558844096|FG000|Part 2|Physician Decision|0|||
155104550|NCT01734785|559812531|FG003|Double-Blind Period|Lost to Follow-up|0|||
155104551|NCT01734785|559812528|FG000|Double-Blind Period|Withdrawal by Subject|2|||
154839246|NCT01225731|558844097|FG001|Part 2|Physician Decision|0|||
154839247|NCT01225731|558844098|FG002|Part 2|Physician Decision|0|||
154839248|NCT01225731|558844099|FG003|Part 2|Physician Decision|0|||
154839249|NCT01225731|558844100|FG004|Part 2|Physician Decision|0|||
155104552|NCT01734785|559812529|FG001|Double-Blind Period|Withdrawal by Subject|0|||
155104553|NCT01734785|559812530|FG002|Double-Blind Period|Withdrawal by Subject|0|||
155104554|NCT01734785|559812531|FG003|Double-Blind Period|Withdrawal by Subject|0|||
154839250|NCT01225731|558844101|FG005|Part 2|Physician Decision|0|||
154839251|NCT01225731|558844102|FG006|Part 2|Physician Decision|0|||
154839252|NCT01225731|558844103|FG007|Part 2|Physician Decision|2|||
154839253|NCT01225731|558844104|FG008|Part 2|Physician Decision|2|||
154839254|NCT01225731|558844105|FG009|Part 2|Physician Decision|0|||
154839255|NCT01225731|558844106|FG010|Part 2|Physician Decision|0|||
154839256|NCT01225731|558844107|FG011|Part 2|Physician Decision|0|||
154839257|NCT01225731|558844108|FG012|Part 2|Physician Decision|0|||
154839258|NCT01225731|558844096|FG000|Part 2|Withdrawal by Subject|0|||
154839259|NCT01225731|558844097|FG001|Part 2|Withdrawal by Subject|0|||
154839260|NCT01225731|558844098|FG002|Part 2|Withdrawal by Subject|0|||
154839261|NCT01225731|558844099|FG003|Part 2|Withdrawal by Subject|0|||
154839262|NCT01225731|558844100|FG004|Part 2|Withdrawal by Subject|0|||
154839263|NCT01225731|558844101|FG005|Part 2|Withdrawal by Subject|1|||
154839264|NCT01225731|558844102|FG006|Part 2|Withdrawal by Subject|3|||
154839265|NCT01225731|558844103|FG007|Part 2|Withdrawal by Subject|4|||
154839266|NCT01225731|558844104|FG008|Part 2|Withdrawal by Subject|1|||
154839267|NCT01225731|558844105|FG009|Part 2|Withdrawal by Subject|0|||
154839268|NCT01225731|558844106|FG010|Part 2|Withdrawal by Subject|0|||
154839269|NCT01225731|558844107|FG011|Part 2|Withdrawal by Subject|0|||
154839270|NCT01225731|558844108|FG012|Part 2|Withdrawal by Subject|0|||
154839271|NCT01225731|558844096|FG000|Part 3|Adverse Event|0|||
154839272|NCT01225731|558844097|FG001|Part 3|Adverse Event|0|||
154839273|NCT01225731|558844098|FG002|Part 3|Adverse Event|0|||
154839274|NCT01225731|558844099|FG003|Part 3|Adverse Event|0|||
154839275|NCT01225731|558844100|FG004|Part 3|Adverse Event|0|||
154839276|NCT01225731|558844101|FG005|Part 3|Adverse Event|0|||
154839277|NCT01225731|558844102|FG006|Part 3|Adverse Event|0|||
154839278|NCT01225731|558844103|FG007|Part 3|Adverse Event|0|||
154839279|NCT01225731|558844104|FG008|Part 3|Adverse Event|0|||
154839280|NCT01225731|558844105|FG009|Part 3|Adverse Event|0|||
154839281|NCT01225731|558844106|FG010|Part 3|Adverse Event|1|||
154839282|NCT01225731|558844107|FG011|Part 3|Adverse Event|1|||
154839283|NCT01225731|558844108|FG012|Part 3|Adverse Event|0|||
154839284|NCT01225731|558844096|FG000|Part 3|Lost to Follow-up|0|||
154839285|NCT01225731|558844097|FG001|Part 3|Lost to Follow-up|0|||
154839286|NCT01225731|558844098|FG002|Part 3|Lost to Follow-up|0|||
154839287|NCT01225731|558844099|FG003|Part 3|Lost to Follow-up|0|||
154839288|NCT01225731|558844100|FG004|Part 3|Lost to Follow-up|0|||
154839289|NCT01225731|558844101|FG005|Part 3|Lost to Follow-up|0|||
154839290|NCT01225731|558844102|FG006|Part 3|Lost to Follow-up|0|||
154839291|NCT01225731|558844103|FG007|Part 3|Lost to Follow-up|0|||
154839292|NCT01225731|558844104|FG008|Part 3|Lost to Follow-up|0|||
154839293|NCT01225731|558844105|FG009|Part 3|Lost to Follow-up|0|||
154839294|NCT01225731|558844106|FG010|Part 3|Lost to Follow-up|1|||
154839295|NCT01225731|558844107|FG011|Part 3|Lost to Follow-up|2|||
154839296|NCT01225731|558844108|FG012|Part 3|Lost to Follow-up|1|||
154839297|NCT01225731|558844096|FG000|Part 3|Physician Decision|0|||
154839298|NCT01225731|558844097|FG001|Part 3|Physician Decision|0|||
154839299|NCT01225731|558844098|FG002|Part 3|Physician Decision|0|||
154839300|NCT01225731|558844099|FG003|Part 3|Physician Decision|0|||
154839301|NCT01225731|558844100|FG004|Part 3|Physician Decision|0|||
154839302|NCT01225731|558844101|FG005|Part 3|Physician Decision|0|||
154839303|NCT01225731|558844102|FG006|Part 3|Physician Decision|0|||
154839304|NCT01225731|558844103|FG007|Part 3|Physician Decision|0|||
154839305|NCT01225731|558844104|FG008|Part 3|Physician Decision|0|||
154839306|NCT01225731|558844105|FG009|Part 3|Physician Decision|0|||
154839307|NCT01225731|558844106|FG010|Part 3|Physician Decision|0|||
154839308|NCT01225731|558844107|FG011|Part 3|Physician Decision|1|||
154839309|NCT01225731|558844108|FG012|Part 3|Physician Decision|2|||
154970972|NCT02614196|559316907|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
154970973|NCT02614196|559316908|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
154970974|NCT02614196|559316909|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
154839310|NCT01225731|558844096|FG000|Part 3|Withdrawal by Subject|0|||
154839311|NCT01225731|558844097|FG001|Part 3|Withdrawal by Subject|0|||
154839312|NCT01225731|558844098|FG002|Part 3|Withdrawal by Subject|0|||
154839313|NCT01225731|558844099|FG003|Part 3|Withdrawal by Subject|0|||
154839314|NCT01225731|558844100|FG004|Part 3|Withdrawal by Subject|0|||
154839315|NCT01225731|558844101|FG005|Part 3|Withdrawal by Subject|0|||
154839316|NCT01225731|558844102|FG006|Part 3|Withdrawal by Subject|0|||
154839317|NCT01225731|558844103|FG007|Part 3|Withdrawal by Subject|0|||
154839318|NCT01225731|558844104|FG008|Part 3|Withdrawal by Subject|0|||
154839319|NCT01225731|558844105|FG009|Part 3|Withdrawal by Subject|0|||
154839320|NCT01225731|558844106|FG010|Part 3|Withdrawal by Subject|4|||
154839321|NCT01225731|558844107|FG011|Part 3|Withdrawal by Subject|6|||
154839322|NCT01225731|558844108|FG012|Part 3|Withdrawal by Subject|4|||
154839323|NCT00577642|558844109|FG000|Overall Study|Clinical Disease Progression|1|||
154839324|NCT01505634|558844115|FG000|Overall Study|Withdrawal by Subject|2|||
154839325|NCT01505634|558844116|FG001|Overall Study|Withdrawal by Subject|5|||
154839326|NCT01505634|558844117|FG002|Overall Study|Withdrawal by Subject|1|||
154839327|NCT01505634|558844115|FG000|Overall Study|Physician Decision|1|||
154839328|NCT01505634|558844116|FG001|Overall Study|Physician Decision|1|||
154839329|NCT01505634|558844117|FG002|Overall Study|Physician Decision|0|||
154839330|NCT01505634|558844115|FG000|Overall Study|Adverse Event|1|||
154839331|NCT01505634|558844116|FG001|Overall Study|Adverse Event|0|||
154970975|NCT02614196|559316910|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
154970976|NCT02614196|559316911|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
154970977|NCT02614196|559316906|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
154839332|NCT01505634|558844117|FG002|Overall Study|Adverse Event|0|||
154839333|NCT01505634|558844115|FG000|Overall Study|Insufficient supply of drug at site|1|||
154839334|NCT01505634|558844116|FG001|Overall Study|Insufficient supply of drug at site|0|||
154839335|NCT01505634|558844117|FG002|Overall Study|Insufficient supply of drug at site|0|||
154839336|NCT01505634|558844115|FG000|Overall Study|Protocol Violation|2|||
155104555|NCT01734785|559812528|FG000|Double-Blind Period|Not treated|1|||
154839337|NCT01505634|558844116|FG001|Overall Study|Protocol Violation|0|||
154839338|NCT01505634|558844117|FG002|Overall Study|Protocol Violation|0|||
154839339|NCT01505634|558844115|FG000|Overall Study|Lost to Follow-up|1|||
154839340|NCT01505634|558844116|FG001|Overall Study|Lost to Follow-up|4|||
154839341|NCT01505634|558844117|FG002|Overall Study|Lost to Follow-up|4|||
154970978|NCT02614196|559316907|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
154839342|NCT01505634|558844115|FG000|Overall Study|Death|1|||
154839343|NCT01505634|558844116|FG001|Overall Study|Death|0|||
154839344|NCT01505634|558844117|FG002|Overall Study|Death|0|||
154839345|NCT01505634|558844115|FG000|Overall Study|In a conflict zone|0|||
154839346|NCT01505634|558844116|FG001|Overall Study|In a conflict zone|0|||
154839347|NCT01505634|558844117|FG002|Overall Study|In a conflict zone|1|||
154839348|NCT00542269|558844121|FG000|Overall Study|Adverse Event|10|||
154839349|NCT00542269|558844122|FG001|Overall Study|Adverse Event|4|||
155173513|NCT03952039|560073355|FG001|Overall Study|Withdrawal by Participant|12|||
154970979|NCT02614196|559316908|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
154839350|NCT00542269|558844123|FG002|Overall Study|Adverse Event|5|||
154839351|NCT00542269|558844121|FG000|Overall Study|Protocol Violation|1|||
154839352|NCT00542269|558844122|FG001|Overall Study|Protocol Violation|1|||
154839353|NCT00542269|558844123|FG002|Overall Study|Protocol Violation|0|||
154839354|NCT00542269|558844121|FG000|Overall Study|Withdrawal by Subject|1|||
154839355|NCT00542269|558844122|FG001|Overall Study|Withdrawal by Subject|0|||
154839356|NCT00542269|558844123|FG002|Overall Study|Withdrawal by Subject|0|||
154839357|NCT00542269|558844121|FG000|Overall Study|Administrative problems|1|||
154839358|NCT00542269|558844122|FG001|Overall Study|Administrative problems|1|||
154839359|NCT00542269|558844123|FG002|Overall Study|Administrative problems|1|||
154839360|NCT03873714|558844124|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
154839361|NCT00845650|558844125|FG000|Overall Study|Withdrawal by Subject|0|||
154839362|NCT00845650|558844126|FG001|Overall Study|Withdrawal by Subject|0|||
154839363|NCT00845650|558844127|FG002|Overall Study|Withdrawal by Subject|0|||
154839364|NCT00845650|558844128|FG003|Overall Study|Withdrawal by Subject|0|||
154839365|NCT00845650|558844129|FG004|Overall Study|Withdrawal by Subject|2|||
154839366|NCT00845650|558844130|FG005|Overall Study|Withdrawal by Subject|0|||
154839367|NCT00845650|558844125|FG000|Overall Study|Lost to Follow-up|0|||
154839368|NCT00845650|558844126|FG001|Overall Study|Lost to Follow-up|0|||
154839369|NCT00845650|558844127|FG002|Overall Study|Lost to Follow-up|3|||
154839370|NCT00845650|558844128|FG003|Overall Study|Lost to Follow-up|1|||
154839371|NCT00845650|558844129|FG004|Overall Study|Lost to Follow-up|0|||
154839372|NCT00845650|558844130|FG005|Overall Study|Lost to Follow-up|1|||
154839373|NCT00845650|558844125|FG000|Overall Study|Sponsor hold on dosing|0|||
154839374|NCT00845650|558844126|FG001|Overall Study|Sponsor hold on dosing|0|||
154839375|NCT00845650|558844127|FG002|Overall Study|Sponsor hold on dosing|0|||
154839376|NCT00845650|558844128|FG003|Overall Study|Sponsor hold on dosing|0|||
154839377|NCT00845650|558844129|FG004|Overall Study|Sponsor hold on dosing|1|||
154839378|NCT00845650|558844130|FG005|Overall Study|Sponsor hold on dosing|1|||
154839379|NCT00845650|558844125|FG000|Overall Study|Unable to access IV line|1|||
154839380|NCT00845650|558844126|FG001|Overall Study|Unable to access IV line|0|||
154839381|NCT00845650|558844127|FG002|Overall Study|Unable to access IV line|0|||
154839382|NCT00845650|558844128|FG003|Overall Study|Unable to access IV line|0|||
154839383|NCT00845650|558844129|FG004|Overall Study|Unable to access IV line|0|||
154839384|NCT00845650|558844130|FG005|Overall Study|Unable to access IV line|0|||
154839385|NCT00531752|558844133|FG000|First Double-blind Intervention Period|Adverse Event|2|||
154839386|NCT00531752|558844134|FG001|First Double-blind Intervention Period|Adverse Event|0|||
154839387|NCT00531752|558844135|FG002|First Double-blind Intervention Period|Adverse Event|1|||
154839388|NCT00531752|558844136|FG003|First Double-blind Intervention Period|Adverse Event|1|||
154839389|NCT00531752|558844133|FG000|First Double-blind Intervention Period|Other|1|||
154839390|NCT00531752|558844134|FG001|First Double-blind Intervention Period|Other|4|||
154839391|NCT00531752|558844135|FG002|First Double-blind Intervention Period|Other|4|||
154839392|NCT00531752|558844136|FG003|First Double-blind Intervention Period|Other|0|||
154839393|NCT00531752|558844133|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
154839394|NCT00531752|558844134|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
154839395|NCT00531752|558844135|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
154839396|NCT00531752|558844136|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
154839397|NCT00531752|558844133|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
154839398|NCT00531752|558844134|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
154839399|NCT00531752|558844135|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
154839400|NCT00531752|558844136|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
154839401|NCT00531752|558844133|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
154839402|NCT00531752|558844134|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
154839403|NCT00531752|558844135|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
154839404|NCT00531752|558844136|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
154839405|NCT00531752|558844133|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
154839406|NCT00531752|558844134|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
154839407|NCT00531752|558844135|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
154839408|NCT00531752|558844136|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
154839409|NCT00531752|558844133|FG000|Second Double-blind Intervention Period|Other|1|||
154839410|NCT00531752|558844134|FG001|Second Double-blind Intervention Period|Other|1|||
154839411|NCT00531752|558844135|FG002|Second Double-blind Intervention Period|Other|0|||
154839412|NCT00531752|558844136|FG003|Second Double-blind Intervention Period|Other|0|||
155104556|NCT01734785|559812529|FG001|Double-Blind Period|Not treated|0|||
155104557|NCT01734785|559812530|FG002|Double-Blind Period|Not treated|0|||
155104558|NCT01734785|559812531|FG003|Double-Blind Period|Not treated|0|||
155104559|NCT02397915|559812532|FG000|Period 1|Protocol Violation|0|||
154839413|NCT00531752|558844133|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
154839414|NCT00531752|558844134|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
154839415|NCT00531752|558844135|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
155104560|NCT02397915|559812533|FG001|Period 1|Protocol Violation|1|||
154839416|NCT00531752|558844136|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
154839417|NCT00531752|558844133|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
154839418|NCT00531752|558844134|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
154839419|NCT00531752|558844135|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
154839420|NCT00531752|558844136|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
154839421|NCT01181011|558844138|FG000|Overall Study|Adverse Event|2|||
154839422|NCT01181011|558844138|FG000|Overall Study|Lost to Follow-up|1|||
154839423|NCT00950664|558844139|FG000|First Intervention|Lost to Follow-up|1|||
154839424|NCT00950664|558844140|FG001|First Intervention|Lost to Follow-up|3|||
154839425|NCT00950664|558844139|FG000|First Intervention|Withdrawal by Subject|2|||
154839426|NCT00950664|558844140|FG001|First Intervention|Withdrawal by Subject|2|||
154839427|NCT00677014|558844141|FG000|Overall Study|Lost to Follow-up|20|||
154839428|NCT00677014|558844142|FG001|Overall Study|Lost to Follow-up|12|||
154839429|NCT00677014|558844143|FG002|Overall Study|Lost to Follow-up|24|||
154839430|NCT00677014|558844141|FG000|Overall Study|Death|6|||
154839431|NCT00677014|558844142|FG001|Overall Study|Death|15|||
154839432|NCT00677014|558844143|FG002|Overall Study|Death|7|||
154839433|NCT00677014|558844141|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
154839434|NCT00677014|558844142|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
154839435|NCT00677014|558844143|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
154839436|NCT01326546|558844144|FG000|Overall Study|Lost to Follow-up|8|||
154839437|NCT01326546|558844145|FG001|Overall Study|Lost to Follow-up|7|||
154839438|NCT01326546|558844144|FG000|Overall Study|Protocol Violation|3|||
154839439|NCT01326546|558844145|FG001|Overall Study|Protocol Violation|4|||
154839440|NCT01326546|558844144|FG000|Overall Study|Pregnancy|0|||
154839441|NCT01326546|558844145|FG001|Overall Study|Pregnancy|1|||
154839442|NCT01326546|558844144|FG000|Overall Study|Adverse Event|1|||
154839443|NCT01326546|558844145|FG001|Overall Study|Adverse Event|0|||
154839444|NCT01326546|558844144|FG000|Overall Study|Withdrawal by Subject|5|||
154839445|NCT01326546|558844145|FG001|Overall Study|Withdrawal by Subject|1|||
154839446|NCT03152019|558844146|FG000|Overall Study|Adverse Event|0|||
154839447|NCT03152019|558844147|FG001|Overall Study|Adverse Event|1|||
154839448|NCT00081159|558844148|FG000|Overall Study|Withdrawal by Subject|0|||
154839449|NCT00081159|558844149|FG001|Overall Study|Withdrawal by Subject|3|||
154839450|NCT00081159|558844148|FG000|Overall Study|Myelosuppression prior to treatment|0|||
154839451|NCT00081159|558844149|FG001|Overall Study|Myelosuppression prior to treatment|1|||
154839452|NCT00081159|558844148|FG000|Overall Study|Lost to Follow-up|2|||
154839453|NCT00081159|558844149|FG001|Overall Study|Lost to Follow-up|1|||
154839454|NCT03693625|558844150|FG000|Overall Study|Adverse Event|2|||
154839455|NCT03693625|558844151|FG001|Overall Study|Adverse Event|0|||
154839456|NCT03693625|558844150|FG000|Overall Study|Study Terminated By Sponsor|20|||
154839457|NCT03693625|558844151|FG001|Overall Study|Study Terminated By Sponsor|7|||
154839458|NCT03693625|558844150|FG000|Overall Study|Withdrawal by Subject|1|||
154839459|NCT03693625|558844151|FG001|Overall Study|Withdrawal by Subject|1|||
154839460|NCT01883635|558844153|FG000|Overall Study|Withdrawal by Subject|4|||
154839461|NCT01883635|558844154|FG001|Overall Study|Withdrawal by Subject|0|||
154839462|NCT01464307|558844155|FG000|Main Period|Death|0|||
154839463|NCT01464307|558844156|FG001|Main Period|Death|1|||
154839464|NCT01464307|558844155|FG000|Main Period|Adverse Event|6|||
154839465|NCT01464307|558844156|FG001|Main Period|Adverse Event|1|||
154839466|NCT01464307|558844155|FG000|Main Period|Lack of Efficacy|2|||
154839467|NCT01464307|558844156|FG001|Main Period|Lack of Efficacy|0|||
154839468|NCT01464307|558844155|FG000|Main Period|Withdrawal by Subject|5|||
154839469|NCT01464307|558844156|FG001|Main Period|Withdrawal by Subject|2|||
154839470|NCT01464307|558844155|FG000|Main Period|Predefined discontinuation criteria|2|||
154839471|NCT01464307|558844156|FG001|Main Period|Predefined discontinuation criteria|1|||
154839472|NCT01464307|558844155|FG000|Open-Label Extension Period|Adverse Event|15|||
154839473|NCT01464307|558844156|FG001|Open-Label Extension Period|Adverse Event|0|||
154839474|NCT01464307|558844155|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
154839475|NCT01464307|558844156|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
154839476|NCT01464307|558844155|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
154839477|NCT01464307|558844156|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
154839478|NCT01464307|558844155|FG000|Open-Label Extension Period|Death|1|||
154839479|NCT01464307|558844156|FG001|Open-Label Extension Period|Death|0|||
154839480|NCT01464307|558844155|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
154839481|NCT01464307|558844156|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
154839482|NCT01464307|558844155|FG000|Open-Label Extension Period|Non-compliance|9|||
154839483|NCT01464307|558844156|FG001|Open-Label Extension Period|Non-compliance|0|||
154839484|NCT01464307|558844155|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
154839485|NCT01464307|558844156|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
154839486|NCT00761514|558844157|FG000|Overall Study|Adverse Event|1|||
154839487|NCT00761514|558844157|FG000|Overall Study|Withdrawal by Subject|2|||
154839488|NCT00761514|558844157|FG000|Overall Study|Lost to Follow-up|1|||
154839489|NCT00761514|558844157|FG000|Overall Study|Health insurance didn't cover study drug|1|||
154839490|NCT00761514|558844157|FG000|Overall Study|Problem complying with study visit|1|||
154839491|NCT00761514|558844157|FG000|Overall Study|Unable to pay for medications|1|||
154970980|NCT02614196|559316909|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
154970981|NCT02614196|559316910|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
154970982|NCT02614196|559316911|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
154970983|NCT02614196|559316906|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
154970984|NCT02614196|559316907|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
154970985|NCT02614196|559316908|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
154839492|NCT01035905|558844159|FG000|Overall Study|Lack of Efficacy|1|||
154839493|NCT01035905|558844160|FG001|Overall Study|Lack of Efficacy|1|||
154839494|NCT01273883|558844161|FG000|First Intervention|Adverse Event|2|||
154839495|NCT01273883|558844162|FG001|First Intervention|Adverse Event|1|||
154839496|NCT01273883|558844161|FG000|Second Intervention|Lost to Follow-up|1|||
154839497|NCT01273883|558844162|FG001|Second Intervention|Lost to Follow-up|1|||
154839498|NCT01273883|558844161|FG000|Second Intervention|Lack of Efficacy|1|||
154839499|NCT01273883|558844162|FG001|Second Intervention|Lack of Efficacy|0|||
154839500|NCT00894556|558844163|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
154839501|NCT00894556|558844164|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
154839502|NCT00894556|558844165|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
154839503|NCT00894556|558844166|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
154839504|NCT00894556|558844163|FG000|Treatment Phase|Lost to Follow-up|2|||
154839505|NCT00894556|558844164|FG001|Treatment Phase|Lost to Follow-up|3|||
154839506|NCT00894556|558844165|FG002|Treatment Phase|Lost to Follow-up|1|||
154839507|NCT00894556|558844166|FG003|Treatment Phase|Lost to Follow-up|0|||
154839508|NCT00894556|558844163|FG000|Treatment Phase|Lack of Qualifying Event|2|||
154839509|NCT00894556|558844164|FG001|Treatment Phase|Lack of Qualifying Event|1|||
154839510|NCT00894556|558844165|FG002|Treatment Phase|Lack of Qualifying Event|0|||
154839511|NCT00894556|558844166|FG003|Treatment Phase|Lack of Qualifying Event|0|||
154924112|NCT04668066|559146384|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
154924113|NCT02369874|559146385|FG000|Overall Study|Lost to Follow-up|2|||
154924114|NCT02369874|559146386|FG001|Overall Study|Lost to Follow-up|2|||
154924115|NCT02369874|559146387|FG002|Overall Study|Lost to Follow-up|2|||
154924116|NCT02369874|559146385|FG000|Overall Study|Withdrawal by Subject|7|||
154924117|NCT02369874|559146386|FG001|Overall Study|Withdrawal by Subject|9|||
154924118|NCT02369874|559146387|FG002|Overall Study|Withdrawal by Subject|27|||
154924119|NCT02369874|559146385|FG000|Overall Study|Miscellaneous|1|||
154924120|NCT02369874|559146386|FG001|Overall Study|Miscellaneous|1|||
154924121|NCT02369874|559146387|FG002|Overall Study|Miscellaneous|0|||
154924122|NCT02369874|559146385|FG000|Overall Study|On Treatment/Off Study|34|||
154924123|NCT02369874|559146386|FG001|Overall Study|On Treatment/Off Study|45|||
154924124|NCT02369874|559146387|FG002|Overall Study|On Treatment/Off Study|32|||
154924125|NCT02219477|559146388|FG000|Overall Study|Adverse Event|0|||
154924126|NCT02219477|559146389|FG001|Overall Study|Adverse Event|1|||
154924127|NCT02219477|559146390|FG002|Overall Study|Adverse Event|1|||
154924128|NCT02219477|559146388|FG000|Overall Study|Withdrawal by Subject|0|||
154924129|NCT02219477|559146389|FG001|Overall Study|Withdrawal by Subject|1|||
154924130|NCT02219477|559146390|FG002|Overall Study|Withdrawal by Subject|0|||
154924131|NCT00596466|559146391|FG000|Overall Study|Lack of Efficacy|5|||
154924132|NCT00596466|559146391|FG000|Overall Study|Adverse Event|4|||
154924133|NCT00596466|559146391|FG000|Overall Study|Withdrawal by Subject|2|||
154924134|NCT00596466|559146391|FG000|Overall Study|Protocol Violation|2|||
154924135|NCT00596466|559146391|FG000|Overall Study|Unpecified|2|||
154924136|NCT00596466|559146391|FG000|Overall Study|Enrolled, not treated|2|||
154924137|NCT01891669|559146392|FG000|Overall Study|Death|0|||
154924138|NCT01891669|559146393|FG001|Overall Study|Death|0|||
154924139|NCT01891669|559146394|FG002|Overall Study|Death|0|||
154924140|NCT01891669|559146395|FG003|Overall Study|Death|0|||
154924141|NCT01891669|559146396|FG004|Overall Study|Death|0|||
154924142|NCT01891669|559146397|FG005|Overall Study|Death|0|||
154924143|NCT01891669|559146398|FG006|Overall Study|Death|0|||
154924144|NCT01891669|559146399|FG007|Overall Study|Death|1|||
154924145|NCT01891669|559146400|FG008|Overall Study|Death|0|||
154924146|NCT01891669|559146401|FG009|Overall Study|Death|1|||
154924147|NCT01891669|559146392|FG000|Overall Study|Withdrawal by Subject|1|||
154924148|NCT01891669|559146393|FG001|Overall Study|Withdrawal by Subject|1|||
154924149|NCT01891669|559146394|FG002|Overall Study|Withdrawal by Subject|0|||
154924150|NCT01891669|559146395|FG003|Overall Study|Withdrawal by Subject|0|||
154924151|NCT01891669|559146396|FG004|Overall Study|Withdrawal by Subject|0|||
154924152|NCT01891669|559146397|FG005|Overall Study|Withdrawal by Subject|0|||
154924153|NCT01891669|559146398|FG006|Overall Study|Withdrawal by Subject|1|||
154924154|NCT01891669|559146399|FG007|Overall Study|Withdrawal by Subject|2|||
154924155|NCT01891669|559146400|FG008|Overall Study|Withdrawal by Subject|1|||
154924156|NCT01891669|559146401|FG009|Overall Study|Withdrawal by Subject|1|||
154924157|NCT01891669|559146392|FG000|Overall Study|Other|1|||
154924158|NCT01891669|559146393|FG001|Overall Study|Other|0|||
154924159|NCT01891669|559146394|FG002|Overall Study|Other|0|||
154924160|NCT01891669|559146395|FG003|Overall Study|Other|0|||
154924161|NCT01891669|559146396|FG004|Overall Study|Other|0|||
154924162|NCT01891669|559146397|FG005|Overall Study|Other|0|||
154924163|NCT01891669|559146398|FG006|Overall Study|Other|0|||
154924164|NCT01891669|559146399|FG007|Overall Study|Other|1|||
154924165|NCT01891669|559146400|FG008|Overall Study|Other|0|||
154924166|NCT01891669|559146401|FG009|Overall Study|Other|0|||
154924167|NCT01015118|559146402|FG000|Overall Study|Protocol Violation|5|||
154924168|NCT01015118|559146403|FG001|Overall Study|Protocol Violation|6|||
154924169|NCT01015118|559146402|FG000|Overall Study|Withdrawal by Subject|103|||
155173514|NCT03952039|560073354|FG000|Overall Study|Death|13|||
155173515|NCT03952039|560073355|FG001|Overall Study|Death|6|||
154839512|NCT04311502|558845488|FG000|Overall Study|Death|1|||
154839513|NCT04311502|558845489|FG001|Overall Study|Death|1|||
154839514|NCT04311502|558845490|FG002|Overall Study|Death|1|||
154839515|NCT04311502|558845488|FG000|Overall Study|Lost to Follow-up|2|||
154839516|NCT04311502|558845489|FG001|Overall Study|Lost to Follow-up|3|||
154839517|NCT04311502|558845490|FG002|Overall Study|Lost to Follow-up|0|||
154839518|NCT04311502|558845488|FG000|Overall Study|Participant is in prison|1|||
154839519|NCT04311502|558845489|FG001|Overall Study|Participant is in prison|0|||
154839520|NCT04311502|558845490|FG002|Overall Study|Participant is in prison|0|||
154839521|NCT04311502|558845488|FG000|Overall Study|Participant moved out of country|1|||
154839522|NCT04311502|558845489|FG001|Overall Study|Participant moved out of country|0|||
154839523|NCT04311502|558845490|FG002|Overall Study|Participant moved out of country|0|||
154839524|NCT04311502|558845488|FG000|Overall Study|Withdrawal by Subject|2|||
154839525|NCT04311502|558845489|FG001|Overall Study|Withdrawal by Subject|0|||
154839526|NCT04311502|558845490|FG002|Overall Study|Withdrawal by Subject|0|||
154839527|NCT04311502|558845488|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
154839528|NCT04311502|558845489|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
154839529|NCT04311502|558845490|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
154839530|NCT03040999|558845491|FG000|Overall Study|Lost to Follow-up|2|||
154839531|NCT03040999|558845492|FG001|Overall Study|Lost to Follow-up|2|||
154839532|NCT03040999|558845491|FG000|Overall Study|Withdrawal by Subject|12|||
154839533|NCT03040999|558845492|FG001|Overall Study|Withdrawal by Subject|13|||
154839534|NCT03040999|558845491|FG000|Overall Study|Death|155|||
154839535|NCT03040999|558845492|FG001|Overall Study|Death|171|||
154839536|NCT03040999|558845491|FG000|Overall Study|Physician Decision|0|||
154839537|NCT03040999|558845492|FG001|Overall Study|Physician Decision|3|||
154839538|NCT03468855|558845493|FG000|Overall Study|Adverse Event|2|||
154839539|NCT03468855|558845493|FG000|Overall Study|Lost to Follow-up|5|||
154839540|NCT03468855|558845493|FG000|Overall Study|Withdrawal by Subject|3|||
154839541|NCT03468855|558845493|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
154839542|NCT02627495|558845494|FG000|Overall Study|Withdrawal by Subject|4|||
154839543|NCT02404103|558845500|FG000|Overall Study|Adverse Event|1|||
154839544|NCT02404103|558845501|FG001|Overall Study|Adverse Event|0|||
154839545|NCT02404103|558845500|FG000|Overall Study|Lost to Follow-up|3|||
154839546|NCT02404103|558845501|FG001|Overall Study|Lost to Follow-up|3|||
154839547|NCT01995071|558845502|FG000|Overall Study|Adverse Event|0|||
154839548|NCT01995071|558845503|FG001|Overall Study|Adverse Event|0|||
154839549|NCT01995071|558845504|FG002|Overall Study|Adverse Event|0|||
154839550|NCT01995071|558845505|FG003|Overall Study|Adverse Event|0|||
154839551|NCT01995071|558845506|FG004|Overall Study|Adverse Event|0|||
154839552|NCT01995071|558845507|FG005|Overall Study|Adverse Event|0|||
154839553|NCT01995071|558845508|FG006|Overall Study|Adverse Event|1|||
154839554|NCT01995071|558845509|FG007|Overall Study|Adverse Event|0|||
154839555|NCT01995071|558845510|FG008|Overall Study|Adverse Event|0|||
154839556|NCT01995071|558845511|FG009|Overall Study|Adverse Event|0|||
154839557|NCT01995071|558845512|FG010|Overall Study|Adverse Event|0|||
154839558|NCT01995071|558845513|FG011|Overall Study|Adverse Event|0|||
154839559|NCT01995071|558845502|FG000|Overall Study|Moved|0|||
154839560|NCT01995071|558845503|FG001|Overall Study|Moved|0|||
154839561|NCT01995071|558845504|FG002|Overall Study|Moved|1|||
154839562|NCT01995071|558845505|FG003|Overall Study|Moved|0|||
154839563|NCT01995071|558845506|FG004|Overall Study|Moved|1|||
154839564|NCT01995071|558845507|FG005|Overall Study|Moved|0|||
154839565|NCT01995071|558845508|FG006|Overall Study|Moved|0|||
154839566|NCT01995071|558845509|FG007|Overall Study|Moved|0|||
154839567|NCT01995071|558845510|FG008|Overall Study|Moved|0|||
154839568|NCT01995071|558845511|FG009|Overall Study|Moved|0|||
154839569|NCT01995071|558845512|FG010|Overall Study|Moved|1|||
154839570|NCT01995071|558845513|FG011|Overall Study|Moved|0|||
154839571|NCT01995071|558845502|FG000|Overall Study|Lost to Follow-up|1|||
154839572|NCT01995071|558845503|FG001|Overall Study|Lost to Follow-up|0|||
154839573|NCT01995071|558845504|FG002|Overall Study|Lost to Follow-up|0|||
154839574|NCT01995071|558845505|FG003|Overall Study|Lost to Follow-up|0|||
155104561|NCT02397915|559812534|FG002|Period 1|Protocol Violation|0|||
154839575|NCT01995071|558845506|FG004|Overall Study|Lost to Follow-up|0|||
154839576|NCT01995071|558845507|FG005|Overall Study|Lost to Follow-up|0|||
154839577|NCT01995071|558845508|FG006|Overall Study|Lost to Follow-up|0|||
154839578|NCT01995071|558845509|FG007|Overall Study|Lost to Follow-up|1|||
154839579|NCT01995071|558845510|FG008|Overall Study|Lost to Follow-up|1|||
154839580|NCT01995071|558845511|FG009|Overall Study|Lost to Follow-up|0|||
154839581|NCT01995071|558845512|FG010|Overall Study|Lost to Follow-up|0|||
154839582|NCT01995071|558845513|FG011|Overall Study|Lost to Follow-up|0|||
154839583|NCT01995071|558845502|FG000|Overall Study|Incarcerated|0|||
154839584|NCT01995071|558845503|FG001|Overall Study|Incarcerated|0|||
154839585|NCT01995071|558845504|FG002|Overall Study|Incarcerated|0|||
154839586|NCT01995071|558845505|FG003|Overall Study|Incarcerated|0|||
154839587|NCT01995071|558845506|FG004|Overall Study|Incarcerated|0|||
154839588|NCT01995071|558845507|FG005|Overall Study|Incarcerated|0|||
154839589|NCT01995071|558845508|FG006|Overall Study|Incarcerated|0|||
155104562|NCT02397915|559812535|FG003|Period 1|Protocol Violation|0|||
155104563|NCT02397915|559812532|FG000|Period 1|Physician Decision|1|||
155104564|NCT02397915|559812533|FG001|Period 1|Physician Decision|0|||
155104565|NCT02397915|559812534|FG002|Period 1|Physician Decision|0|||
155104566|NCT02397915|559812535|FG003|Period 1|Physician Decision|0|||
155104567|NCT00368745|559812536|FG000|Double-blind Treatment Period|Adverse Event|6|||
155104568|NCT00368745|559812537|FG001|Double-blind Treatment Period|Adverse Event|6|||
155104569|NCT00368745|559812536|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
155104570|NCT00368745|559812537|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
155104571|NCT00368745|559812536|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155104572|NCT00368745|559812537|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
155104573|NCT00368745|559812536|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
155104574|NCT00368745|559812537|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
155104575|NCT00368745|559812536|FG000|Double-blind Treatment Period|Other|7|||
155104576|NCT00368745|559812537|FG001|Double-blind Treatment Period|Other|6|||
155104577|NCT03292874|559812538|FG000|Overall Study|Due to pandemic|5|||
155104578|NCT01582009|559812544|FG000|Overall Study|Withdrawal by Subject|1|||
155104579|NCT01582009|559812544|FG000|Overall Study|Physician Decision|1|||
155104580|NCT04556591|559812545|FG000|Overall Study|Lost to Follow-up|1|||
155104581|NCT04556591|559812546|FG001|Overall Study|Lost to Follow-up|0|||
154839590|NCT01995071|558845509|FG007|Overall Study|Incarcerated|1|||
154839591|NCT01995071|558845510|FG008|Overall Study|Incarcerated|0|||
155104582|NCT04556591|559812545|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
155104583|NCT04556591|559812546|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
154839592|NCT01995071|558845511|FG009|Overall Study|Incarcerated|0|||
154839593|NCT01995071|558845512|FG010|Overall Study|Incarcerated|0|||
154839594|NCT01995071|558845513|FG011|Overall Study|Incarcerated|0|||
154839595|NCT02543528|558845514|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
154839596|NCT02543528|558845515|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
154839597|NCT02543528|558845516|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
154839598|NCT02543528|558845517|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
154839599|NCT02543528|558845518|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
154839600|NCT02543528|558845514|FG000|Adaptation Period|Lens Handling Difficultes|0|||
154839601|NCT02543528|558845515|FG001|Adaptation Period|Lens Handling Difficultes|0|||
154839602|NCT02543528|558845516|FG002|Adaptation Period|Lens Handling Difficultes|0|||
154839603|NCT02543528|558845517|FG003|Adaptation Period|Lens Handling Difficultes|0|||
154839604|NCT02543528|558845518|FG004|Adaptation Period|Lens Handling Difficultes|8|||
154839605|NCT02543528|558845514|FG000|Adaptation Period|Lost to Follow-up|0|||
154839606|NCT02543528|558845515|FG001|Adaptation Period|Lost to Follow-up|0|||
154839607|NCT02543528|558845516|FG002|Adaptation Period|Lost to Follow-up|0|||
154839608|NCT02543528|558845517|FG003|Adaptation Period|Lost to Follow-up|0|||
154839609|NCT02543528|558845518|FG004|Adaptation Period|Lost to Follow-up|14|||
154839610|NCT02543528|558845514|FG000|Adaptation Period|Adverse Event|0|||
154839611|NCT02543528|558845515|FG001|Adaptation Period|Adverse Event|0|||
154839612|NCT02543528|558845516|FG002|Adaptation Period|Adverse Event|0|||
154839613|NCT02543528|558845517|FG003|Adaptation Period|Adverse Event|0|||
154839614|NCT02543528|558845518|FG004|Adaptation Period|Adverse Event|2|||
155173516|NCT03952039|560073354|FG000|Overall Study|Lack of Efficacy|12|||
154839615|NCT02543528|558845514|FG000|Extended Wear Period|Adverse Event|17|||
154839616|NCT02543528|558845515|FG001|Extended Wear Period|Adverse Event|11|||
154839617|NCT02543528|558845516|FG002|Extended Wear Period|Adverse Event|16|||
155173517|NCT03952039|560073355|FG001|Overall Study|Lack of Efficacy|2|||
155173518|NCT03952039|560073354|FG000|Overall Study|Physician Decision|9|||
155104584|NCT03332173|559812547|FG000|Overall Study|Death|7|||
155104585|NCT03332173|559812547|FG000|Overall Study|Withdrawal by Subject|6|||
155104586|NCT03332173|559812547|FG000|Overall Study|Lost to Follow-up|2|||
155104587|NCT03332173|559812547|FG000|Overall Study|Transferred to long-term extension study|29|||
155104588|NCT00211172|559812548|FG000|Overall Study|Died or lost health plan eligibility|39|||
155104589|NCT00211172|559812549|FG001|Overall Study|Died or lost health plan eligibility|32|||
155104590|NCT04474197|559812550|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
155104591|NCT04474197|559812551|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
155104592|NCT04474197|559812552|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
155104593|NCT04474197|559812553|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
155104594|NCT00624468|559812555|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
155104595|NCT00624468|559812556|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
155104596|NCT00624468|559812557|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
155104597|NCT00624468|559812558|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
155104598|NCT00624468|559812555|FG000|Double-blind Period|Withdrew Prematurely|1|||
155104599|NCT00624468|559812556|FG001|Double-blind Period|Withdrew Prematurely|1|||
155104600|NCT00624468|559812557|FG002|Double-blind Period|Withdrew Prematurely|0|||
155104601|NCT00624468|559812558|FG003|Double-blind Period|Withdrew Prematurely|0|||
155104602|NCT00624468|559812555|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
155104603|NCT00624468|559812556|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
155104604|NCT00624468|559812557|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
155104605|NCT00624468|559812558|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
155104606|NCT00624468|559812555|FG000|Safety Follow-up (SFU) Period|Other|0|||
155104607|NCT00624468|559812556|FG001|Safety Follow-up (SFU) Period|Other|0|||
154839618|NCT02543528|558845517|FG003|Extended Wear Period|Adverse Event|3|||
154839619|NCT02543528|558845518|FG004|Extended Wear Period|Adverse Event|0|||
154839620|NCT02543528|558845514|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
154839621|NCT02543528|558845515|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
154839622|NCT02543528|558845516|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
154970986|NCT02614196|559316909|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
154970987|NCT02614196|559316910|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
154970988|NCT02614196|559316911|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
154970989|NCT00087529|559316913|FG000|Overall Study|Death|1|||
154970990|NCT00087529|559316914|FG001|Overall Study|Death|0|||
154970991|NCT00087529|559316913|FG000|Overall Study|Adverse Event|0|||
154970992|NCT00087529|559316914|FG001|Overall Study|Adverse Event|8|||
154970993|NCT00087529|559316913|FG000|Overall Study|Pregnancy|0|||
154970994|NCT00087529|559316914|FG001|Overall Study|Pregnancy|1|||
154970995|NCT00087529|559316913|FG000|Overall Study|Lost to Follow-up|2|||
154970996|NCT00087529|559316914|FG001|Overall Study|Lost to Follow-up|3|||
154970997|NCT00087529|559316913|FG000|Overall Study|Participant Decision|14|||
154970998|NCT00087529|559316914|FG001|Overall Study|Participant Decision|37|||
154970999|NCT00087529|559316913|FG000|Overall Study|Physician Decision|4|||
154971000|NCT00087529|559316914|FG001|Overall Study|Physician Decision|8|||
154971001|NCT00087529|559316913|FG000|Overall Study|Initiation of Excluded Therapy|0|||
154971002|NCT00087529|559316914|FG001|Overall Study|Initiation of Excluded Therapy|1|||
154971003|NCT00087529|559316913|FG000|Overall Study|Participant Noncompliance|0|||
154971004|NCT00087529|559316914|FG001|Overall Study|Participant Noncompliance|1|||
154971005|NCT00087529|559316913|FG000|Overall Study|Disease Progression|5|||
154971006|NCT00087529|559316914|FG001|Overall Study|Disease Progression|4|||
154971007|NCT00087529|559316913|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
154971008|NCT00087529|559316914|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
154971009|NCT01562613|559316915|FG000|Overall Study|Lost to Follow-up|2|||
154971010|NCT01562613|559316915|FG000|Overall Study|Withdrawal by Subject|2|||
154971011|NCT04388787|559316916|FG000|Blinded Period|Patient could not follow instructions|1|||
154971012|NCT04388787|559316916|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
154971013|NCT00663234|559316917|FG000|Overall Study|Not willing to adhere to requirements|1|||
154971014|NCT01253564|559316920|FG000|Overall Study|Disease Progression|22|||
155104608|NCT00624468|559812557|FG002|Safety Follow-up (SFU) Period|Other|1|||
155104609|NCT00624468|559812558|FG003|Safety Follow-up (SFU) Period|Other|1|||
155104610|NCT03072043|559812567|FG000|Overall Study|Death|0|||
155104611|NCT03072043|559812568|FG001|Overall Study|Death|0|||
155104612|NCT03072043|559812569|FG002|Overall Study|Death|3|||
155104613|NCT03072043|559812567|FG000|Overall Study|Adverse Event|0|||
154839623|NCT02543528|558845517|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
154839624|NCT02543528|558845518|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
154839625|NCT02543528|558845514|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
154839626|NCT02543528|558845515|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
154839627|NCT02543528|558845516|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
154839628|NCT02543528|558845517|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
154839629|NCT02543528|558845518|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
154839630|NCT02543528|558845514|FG000|Extended Wear Period|Lost to Follow-up|0|||
154839631|NCT02543528|558845515|FG001|Extended Wear Period|Lost to Follow-up|1|||
154839632|NCT02543528|558845516|FG002|Extended Wear Period|Lost to Follow-up|2|||
154839633|NCT02543528|558845517|FG003|Extended Wear Period|Lost to Follow-up|1|||
154971015|NCT01253564|559316920|FG000|Overall Study|Withdrawal by Subject|1|||
154971016|NCT01253564|559316920|FG000|Overall Study|Serious Adverse Event|1|||
154971017|NCT03694197|559316923|FG000|Overall Study|Adverse Event|9|||
155104614|NCT03072043|559812568|FG001|Overall Study|Adverse Event|0|||
155104615|NCT03072043|559812569|FG002|Overall Study|Adverse Event|2|||
154971018|NCT03694197|559316923|FG000|Overall Study|Protocol became inconvenient to participate|1|||
154971019|NCT03694197|559316923|FG000|Overall Study|Physician Decision|4|||
154971020|NCT03694197|559316923|FG000|Overall Study|Study terminated by sponsor|1350|||
154971021|NCT03694197|559316923|FG000|Overall Study|Participant moved|5|||
155104616|NCT03072043|559812567|FG000|Overall Study|Withdrawal by Subject|0|||
155104617|NCT03072043|559812568|FG001|Overall Study|Withdrawal by Subject|0|||
154971022|NCT03694197|559316923|FG000|Overall Study|Participant withdrew consent|10|||
154839634|NCT02543528|558845518|FG004|Extended Wear Period|Lost to Follow-up|0|||
154839635|NCT02543528|558845514|FG000|Extended Wear Period|Withdrawal by Subject|10|||
154839636|NCT02543528|558845515|FG001|Extended Wear Period|Withdrawal by Subject|9|||
154839637|NCT02543528|558845516|FG002|Extended Wear Period|Withdrawal by Subject|4|||
154839638|NCT02543528|558845517|FG003|Extended Wear Period|Withdrawal by Subject|5|||
154839639|NCT02543528|558845518|FG004|Extended Wear Period|Withdrawal by Subject|0|||
154839640|NCT01339559|558845528|FG000|Overall Study|Adverse Event|92|||
154839641|NCT01339559|558845528|FG000|Overall Study|Death|5|||
154839642|NCT01339559|558845528|FG000|Overall Study|Lack of Efficacy|164|||
154839643|NCT01339559|558845528|FG000|Overall Study|Lost to Follow-up|22|||
154839644|NCT01339559|558845528|FG000|Overall Study|Subject choice|89|||
154839645|NCT01339559|558845528|FG000|Overall Study|Protocol Violation|15|||
154839646|NCT01339559|558845528|FG000|Overall Study|Study closure at site|1|||
154839647|NCT01339559|558845528|FG000|Overall Study|Incarcerated|2|||
154839648|NCT01339559|558845528|FG000|Overall Study|Epilepsy surgery|1|||
154839649|NCT01339559|558845528|FG000|Overall Study|Pregnancy planned|2|||
154839650|NCT01339559|558845528|FG000|Overall Study|Left the country|1|||
154839651|NCT01339559|558845528|FG000|Overall Study|Investigator decision|2|||
154839652|NCT01339559|558845528|FG000|Overall Study|Patient didn't wish to continue|1|||
154839653|NCT01339559|558845528|FG000|Overall Study|PI decision|1|||
154839654|NCT00971945|558845529|FG000|Overall Study|Progressive Disease|3|||
154839655|NCT00971945|558845529|FG000|Overall Study|Change in treatment policy|1|||
154839656|NCT00971945|558845529|FG000|Overall Study|Other reasons|2|||
154839657|NCT03354663|558845530|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
154839658|NCT03354663|558845530|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
154839659|NCT03354663|558845530|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
154839660|NCT03354663|558845530|FG000|Completed 30-day Visit|Missed Visit|1|||
154839661|NCT00513409|558845536|FG000|Overall Study|Adverse Event|0|||
154839662|NCT00513409|558845537|FG001|Overall Study|Adverse Event|1|||
154839663|NCT00513409|558845536|FG000|Overall Study|Withdrawal by Subject|0|||
154839664|NCT00513409|558845537|FG001|Overall Study|Withdrawal by Subject|2|||
154839665|NCT00513409|558845536|FG000|Overall Study|Lost to Follow-up|0|||
154839666|NCT00513409|558845537|FG001|Overall Study|Lost to Follow-up|1|||
154839667|NCT00513409|558845536|FG000|Overall Study|Physician Decision|1|||
154839668|NCT00513409|558845537|FG001|Overall Study|Physician Decision|0|||
154839669|NCT00513409|558845536|FG000|Overall Study|Visit 3 not done|1|||
154839670|NCT00513409|558845537|FG001|Overall Study|Visit 3 not done|2|||
154839671|NCT03548051|558845538|FG000|Overall Study|Death|1|||
154839672|NCT03548051|558845539|FG001|Overall Study|Death|1|||
154839673|NCT03548051|558845538|FG000|Overall Study|Withdrawal by Subject|1|||
154839674|NCT03548051|558845539|FG001|Overall Study|Withdrawal by Subject|0|||
154839675|NCT00817531|558845541|FG000|Overall Study|Adverse Event|1|||
154839676|NCT00817531|558845541|FG000|Overall Study|Lack of Efficacy|1|||
154839677|NCT00812214|558845542|FG000|Overall Study|Lost to Follow-up|3|||
154839678|NCT00812214|558845543|FG001|Overall Study|Lost to Follow-up|1|||
154839679|NCT03325673|558845544|FG000|Overall Study|Adverse Event|4|||
154839680|NCT03325673|558845545|FG001|Overall Study|Adverse Event|0|||
154839681|NCT00883337|558845546|FG000|Core Treatment Period|Adverse Event|9|||
154839682|NCT00883337|558845547|FG001|Core Treatment Period|Adverse Event|12|||
154839683|NCT00883337|558845548|FG002|Core Treatment Period|Adverse Event|22|||
154839684|NCT00883337|558845546|FG000|Core Treatment Period|Lack of Efficacy|7|||
154839685|NCT00883337|558845547|FG001|Core Treatment Period|Lack of Efficacy|4|||
154839686|NCT00883337|558845548|FG002|Core Treatment Period|Lack of Efficacy|2|||
154839687|NCT00883337|558845546|FG000|Core Treatment Period|Lost to Follow-up|1|||
154839688|NCT00883337|558845547|FG001|Core Treatment Period|Lost to Follow-up|1|||
154971023|NCT03694197|559316923|FG000|Overall Study|Related to IMP administration|1|||
154971024|NCT03694197|559316923|FG000|Overall Study|Not disclosed|5|||
154971025|NCT04729101|559318514|FG000|Overall Study|Adverse Event|1|||
154971026|NCT04729101|559318515|FG001|Overall Study|Adverse Event|0|||
154971027|NCT04729101|559318514|FG000|Overall Study|Physician Decision|1|||
154839689|NCT00883337|558845548|FG002|Core Treatment Period|Lost to Follow-up|0|||
154971028|NCT04729101|559318515|FG001|Overall Study|Physician Decision|0|||
154971029|NCT04729101|559318514|FG000|Overall Study|Withdrawal by Subject|1|||
154971030|NCT04729101|559318515|FG001|Overall Study|Withdrawal by Subject|0|||
155104618|NCT03072043|559812569|FG002|Overall Study|Withdrawal by Subject|4|||
154839690|NCT00883337|558845546|FG000|Core Treatment Period|Withdrawal by Subject|2|||
154839691|NCT00883337|558845547|FG001|Core Treatment Period|Withdrawal by Subject|2|||
154839692|NCT00883337|558845548|FG002|Core Treatment Period|Withdrawal by Subject|6|||
154839693|NCT00883337|558845546|FG000|Core Treatment Period|Wish to be pregnant|1|||
154839694|NCT00883337|558845547|FG001|Core Treatment Period|Wish to be pregnant|2|||
154839695|NCT00883337|558845548|FG002|Core Treatment Period|Wish to be pregnant|1|||
154839696|NCT00883337|558845546|FG000|Core Treatment Period|Poor compliance to protocol|0|||
154839697|NCT00883337|558845547|FG001|Core Treatment Period|Poor compliance to protocol|0|||
154839698|NCT00883337|558845548|FG002|Core Treatment Period|Poor compliance to protocol|1|||
154839699|NCT00883337|558845546|FG000|Core Treatment Period|Other than above|0|||
154839700|NCT00883337|558845547|FG001|Core Treatment Period|Other than above|1|||
155104619|NCT01340664|559812570|FG000|Overall Study|Adverse Event|0|||
154839701|NCT00883337|558845548|FG002|Core Treatment Period|Other than above|1|||
154839702|NCT00883337|558845546|FG000|Extension Treatment Period|Adverse Event|8|||
154839703|NCT00883337|558845547|FG001|Extension Treatment Period|Adverse Event|5|||
154839704|NCT00883337|558845548|FG002|Extension Treatment Period|Adverse Event|5|||
154839705|NCT00883337|558845546|FG000|Extension Treatment Period|Lack of Efficacy|8|||
154839706|NCT00883337|558845547|FG001|Extension Treatment Period|Lack of Efficacy|8|||
154839707|NCT00883337|558845548|FG002|Extension Treatment Period|Lack of Efficacy|8|||
154839708|NCT00883337|558845546|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
154839709|NCT00883337|558845547|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
154839710|NCT00883337|558845548|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
154839711|NCT00883337|558845546|FG000|Extension Treatment Period|Lost to Follow-up|1|||
154839712|NCT00883337|558845547|FG001|Extension Treatment Period|Lost to Follow-up|0|||
154839713|NCT00883337|558845548|FG002|Extension Treatment Period|Lost to Follow-up|0|||
154839714|NCT00883337|558845546|FG000|Extension Treatment Period|Other than above|10|||
154839715|NCT00883337|558845547|FG001|Extension Treatment Period|Other than above|9|||
154839716|NCT00883337|558845548|FG002|Extension Treatment Period|Other than above|5|||
154839717|NCT00763139|558845549|FG000|Overall Study|Adverse Event|4|||
154839718|NCT00763139|558845550|FG001|Overall Study|Adverse Event|2|||
154839719|NCT00763139|558845549|FG000|Overall Study|Withdrawal by Subject|0|||
154839720|NCT00763139|558845550|FG001|Overall Study|Withdrawal by Subject|1|||
154839721|NCT00763139|558845549|FG000|Overall Study|med change not allowed by protocol|1|||
154839722|NCT00763139|558845550|FG001|Overall Study|med change not allowed by protocol|0|||
154839723|NCT02669017|558845551|FG000|Overall Study|Death|1|||
154839724|NCT02669017|558845552|FG001|Overall Study|Death|2|||
154839725|NCT02669017|558845553|FG002|Overall Study|Death|2|||
154839726|NCT02669017|558845554|FG003|Overall Study|Death|3|||
154839727|NCT02669017|558845555|FG004|Overall Study|Death|8|||
154839728|NCT02669017|558845556|FG005|Overall Study|Death|18|||
154839729|NCT02669017|558845557|FG006|Overall Study|Death|10|||
154839730|NCT02669017|558845558|FG007|Overall Study|Death|47|||
154839731|NCT02669017|558845559|FG008|Overall Study|Death|20|||
154839732|NCT02669017|558845551|FG000|Overall Study|Withdrawal by Subject|0|||
154839733|NCT02669017|558845552|FG001|Overall Study|Withdrawal by Subject|0|||
154839734|NCT02669017|558845553|FG002|Overall Study|Withdrawal by Subject|0|||
154839735|NCT02669017|558845554|FG003|Overall Study|Withdrawal by Subject|1|||
154839736|NCT02669017|558845555|FG004|Overall Study|Withdrawal by Subject|2|||
154839737|NCT02669017|558845556|FG005|Overall Study|Withdrawal by Subject|0|||
154839738|NCT02669017|558845557|FG006|Overall Study|Withdrawal by Subject|0|||
154839739|NCT02669017|558845558|FG007|Overall Study|Withdrawal by Subject|2|||
154839740|NCT02669017|558845559|FG008|Overall Study|Withdrawal by Subject|2|||
154839741|NCT02669017|558845551|FG000|Overall Study|Lost to Follow-up|0|||
154839742|NCT02669017|558845552|FG001|Overall Study|Lost to Follow-up|0|||
154839743|NCT02669017|558845553|FG002|Overall Study|Lost to Follow-up|0|||
154839744|NCT02669017|558845554|FG003|Overall Study|Lost to Follow-up|0|||
154839745|NCT02669017|558845555|FG004|Overall Study|Lost to Follow-up|0|||
154839746|NCT02669017|558845556|FG005|Overall Study|Lost to Follow-up|0|||
154839747|NCT02669017|558845557|FG006|Overall Study|Lost to Follow-up|0|||
154839748|NCT02669017|558845558|FG007|Overall Study|Lost to Follow-up|0|||
154839749|NCT02669017|558845559|FG008|Overall Study|Lost to Follow-up|1|||
154839750|NCT02669017|558845551|FG000|Overall Study|Miscellaneous|0|||
154839751|NCT02669017|558845552|FG001|Overall Study|Miscellaneous|0|||
154839752|NCT02669017|558845553|FG002|Overall Study|Miscellaneous|0|||
154839753|NCT02669017|558845554|FG003|Overall Study|Miscellaneous|0|||
154839754|NCT02669017|558845555|FG004|Overall Study|Miscellaneous|2|||
154839755|NCT02669017|558845556|FG005|Overall Study|Miscellaneous|1|||
154839756|NCT02669017|558845557|FG006|Overall Study|Miscellaneous|1|||
154839757|NCT02669017|558845558|FG007|Overall Study|Miscellaneous|13|||
154839758|NCT02669017|558845559|FG008|Overall Study|Miscellaneous|2|||
154839759|NCT00915681|558845564|FG000|Overall Study|Screening failures|46|||
154839760|NCT03221751|558845567|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
154839761|NCT03221751|558845568|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
154839762|NCT02559687|558845569|FG000|Overall Study|Death|112|||
154839763|NCT02559687|558845569|FG000|Overall Study|Sponsor Decision|5|||
154839764|NCT02559687|558845569|FG000|Overall Study|Withdrawal by Subject|4|||
154839765|NCT03245450|558845571|FG000|Overall Study|Radiological disease progression|3|||
154839766|NCT03245450|558845572|FG001|Overall Study|Radiological disease progression|3|||
154971031|NCT00274625|559318516|FG000|Overall Study|Lost to Follow-up|46|||
155173519|NCT03952039|560073355|FG001|Overall Study|Physician Decision|3|||
154839767|NCT03245450|558845573|FG002|Overall Study|Radiological disease progression|2|||
154839768|NCT03245450|558845574|FG003|Overall Study|Radiological disease progression|2|||
154971032|NCT00274625|559318517|FG001|Overall Study|Lost to Follow-up|54|||
155173520|NCT03952039|560073354|FG000|Overall Study|Progressive Disease|6|||
154839769|NCT03245450|558845575|FG004|Overall Study|Radiological disease progression|7|||
154839770|NCT03245450|558845576|FG005|Overall Study|Radiological disease progression|6|||
154839771|NCT03245450|558845577|FG006|Overall Study|Radiological disease progression|6|||
154839772|NCT03245450|558845571|FG000|Overall Study|Clinical disease progression|0|||
154839773|NCT03245450|558845572|FG001|Overall Study|Clinical disease progression|0|||
154839774|NCT03245450|558845573|FG002|Overall Study|Clinical disease progression|1|||
154839775|NCT03245450|558845574|FG003|Overall Study|Clinical disease progression|0|||
154839776|NCT03245450|558845575|FG004|Overall Study|Clinical disease progression|0|||
154839777|NCT03245450|558845576|FG005|Overall Study|Clinical disease progression|2|||
154839778|NCT03245450|558845577|FG006|Overall Study|Clinical disease progression|0|||
154839779|NCT03245450|558845571|FG000|Overall Study|Other|0|||
154839780|NCT03245450|558845572|FG001|Overall Study|Other|0|||
154839781|NCT03245450|558845573|FG002|Overall Study|Other|0|||
154839782|NCT03245450|558845574|FG003|Overall Study|Other|1|||
154839783|NCT03245450|558845575|FG004|Overall Study|Other|1|||
154839784|NCT03245450|558845576|FG005|Overall Study|Other|1|||
154839785|NCT03245450|558845577|FG006|Overall Study|Other|1|||
154839786|NCT03245450|558845571|FG000|Overall Study|Withdrawal by Subject|0|||
154839787|NCT03245450|558845572|FG001|Overall Study|Withdrawal by Subject|1|||
154839788|NCT03245450|558845573|FG002|Overall Study|Withdrawal by Subject|0|||
154839789|NCT03245450|558845574|FG003|Overall Study|Withdrawal by Subject|0|||
154839790|NCT03245450|558845575|FG004|Overall Study|Withdrawal by Subject|0|||
154839791|NCT03245450|558845576|FG005|Overall Study|Withdrawal by Subject|0|||
154839792|NCT03245450|558845577|FG006|Overall Study|Withdrawal by Subject|0|||
154839793|NCT03245450|558845571|FG000|Overall Study|Adverse Event|0|||
154839794|NCT03245450|558845572|FG001|Overall Study|Adverse Event|0|||
154839795|NCT03245450|558845573|FG002|Overall Study|Adverse Event|0|||
154839796|NCT03245450|558845574|FG003|Overall Study|Adverse Event|0|||
154839797|NCT03245450|558845575|FG004|Overall Study|Adverse Event|1|||
154839798|NCT03245450|558845576|FG005|Overall Study|Adverse Event|0|||
154839799|NCT03245450|558845577|FG006|Overall Study|Adverse Event|2|||
154839800|NCT02599961|558845581|FG000|Overall Study|Withdrawal by Subject|1|||
154839801|NCT02599961|558845581|FG000|Overall Study|Subject Non-Compliance|2|||
154839802|NCT02599961|558845581|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
154839803|NCT02599961|558845581|FG000|Overall Study|Other, Not Specified|3|||
154839804|NCT00401752|558845582|FG000|Overall Study|Adverse Event|2|||
154839805|NCT00401752|558845583|FG001|Overall Study|Adverse Event|5|||
154839806|NCT00401752|558845582|FG000|Overall Study|Withdrawal by Subject|2|||
154839807|NCT00401752|558845583|FG001|Overall Study|Withdrawal by Subject|6|||
154839808|NCT00401752|558845582|FG000|Overall Study|Lost to Follow-up|1|||
154839809|NCT00401752|558845583|FG001|Overall Study|Lost to Follow-up|4|||
154839810|NCT00401752|558845582|FG000|Overall Study|Development of any exclusion criteria|4|||
154839811|NCT00401752|558845583|FG001|Overall Study|Development of any exclusion criteria|2|||
154839812|NCT00401752|558845582|FG000|Overall Study|Physician Decision|1|||
154839813|NCT00401752|558845583|FG001|Overall Study|Physician Decision|1|||
154839814|NCT00143312|558845586|FG000|Overall Study|Death|11|||
154839815|NCT00143312|558845586|FG000|Overall Study|Adverse Event|2|||
154839816|NCT00143312|558845586|FG000|Overall Study|Lost to Follow-up|1|||
154839817|NCT00143312|558845586|FG000|Overall Study|Other|1|||
154839818|NCT00143312|558845586|FG000|Overall Study|Withdrawal by Subject|1|||
154839819|NCT01046877|558845590|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
154839820|NCT01046877|558845590|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
154839821|NCT01834274|558845591|FG000|Overall Study|Study Termination|41|||
154839822|NCT01834274|558845592|FG001|Overall Study|Study Termination|38|||
154839823|NCT01834274|558845591|FG000|Overall Study|Withdrawal by Subject|1|||
154839824|NCT01834274|558845592|FG001|Overall Study|Withdrawal by Subject|1|||
154839825|NCT01834274|558845591|FG000|Overall Study|Lost to Follow-up|3|||
154839826|NCT01834274|558845592|FG001|Overall Study|Lost to Follow-up|1|||
154839827|NCT01834274|558845591|FG000|Overall Study|Other|2|||
154839828|NCT01834274|558845592|FG001|Overall Study|Other|1|||
154839829|NCT03681119|558845597|FG000|Overall Study|No specific reason|4|||
154839830|NCT03681119|558845598|FG001|Overall Study|No specific reason|0|||
154839831|NCT03681119|558845597|FG000|Overall Study|Sickness|2|||
154839832|NCT03681119|558845598|FG001|Overall Study|Sickness|0|||
154839833|NCT04288154|558845602|FG000|Overall Study|Withdrawal by Subject|9|||
154839834|NCT04288154|558845603|FG001|Overall Study|Withdrawal by Subject|9|||
154839835|NCT00774345|558845604|FG000|Pre-treatment|Other reasons|2|||
154839836|NCT00774345|558845605|FG001|Pre-treatment|Other reasons|0|||
154839837|NCT00774345|558845604|FG000|Treatment|Adverse Event|61|||
154839838|NCT00774345|558845605|FG001|Treatment|Adverse Event|15|||
154839839|NCT00774345|558845604|FG000|Treatment|Progressive Disease without histologic transformation|51|||
155173521|NCT03952039|560073355|FG001|Overall Study|Progressive Disease|4|||
154839840|NCT00774345|558845605|FG001|Treatment|Progressive Disease without histologic transformation|111|||
154839841|NCT00774345|558845604|FG000|Treatment|Progressive Disease with histologic transformation|4|||
154839842|NCT00774345|558845605|FG001|Treatment|Progressive Disease with histologic transformation|2|||
154839843|NCT00774345|558845604|FG000|Treatment|Withdrawal by Subject|5|||
154839844|NCT00774345|558845605|FG001|Treatment|Withdrawal by Subject|2|||
154839845|NCT00774345|558845604|FG000|Treatment|Lost to Follow-up|1|||
154839846|NCT00774345|558845605|FG001|Treatment|Lost to Follow-up|1|||
154839847|NCT00774345|558845604|FG000|Treatment|Death|4|||
154839848|NCT00774345|558845605|FG001|Treatment|Death|0|||
154971033|NCT00274625|559318516|FG000|Overall Study|Excluded from analysis|14|||
155104620|NCT01340664|559812571|FG001|Overall Study|Adverse Event|1|||
155104621|NCT01340664|559812572|FG002|Overall Study|Adverse Event|7|||
155104622|NCT01340664|559812570|FG000|Overall Study|Lost to Follow-up|2|||
155104623|NCT01340664|559812571|FG001|Overall Study|Lost to Follow-up|0|||
155104624|NCT01340664|559812572|FG002|Overall Study|Lost to Follow-up|2|||
155104625|NCT01340664|559812570|FG000|Overall Study|Withdrawal by Subject|2|||
155104626|NCT01340664|559812571|FG001|Overall Study|Withdrawal by Subject|4|||
155104627|NCT01340664|559812572|FG002|Overall Study|Withdrawal by Subject|0|||
155104628|NCT01340664|559812570|FG000|Overall Study|Glycemic withdrawal criteria|2|||
155104629|NCT01340664|559812571|FG001|Overall Study|Glycemic withdrawal criteria|0|||
155104630|NCT01340664|559812572|FG002|Overall Study|Glycemic withdrawal criteria|0|||
155173522|NCT03952039|560073354|FG000|Overall Study|Other Reasons|12|||
154839849|NCT00774345|558845604|FG000|Treatment|Other Reasons|32|||
154839850|NCT00774345|558845605|FG001|Treatment|Other Reasons|26|||
154839851|NCT00835237|558845606|FG000|Overall Study|Lost to Follow-up|4|||
154839852|NCT00835237|558845607|FG001|Overall Study|Lost to Follow-up|0|||
154839853|NCT00835237|558845606|FG000|Overall Study|Withdrawal by Subject|2|||
154839854|NCT00835237|558845607|FG001|Overall Study|Withdrawal by Subject|0|||
154839855|NCT00606086|558845610|FG000|Overall Study|Adverse Event|1|||
154839856|NCT00606086|558845611|FG001|Overall Study|Adverse Event|1|||
154839857|NCT00606086|558845610|FG000|Overall Study|Lost to Follow-up|4|||
154839858|NCT00606086|558845611|FG001|Overall Study|Lost to Follow-up|8|||
154839859|NCT00606086|558845610|FG000|Overall Study|Protocol Violation|1|||
154839860|NCT00606086|558845611|FG001|Overall Study|Protocol Violation|0|||
154839861|NCT00606086|558845610|FG000|Overall Study|Withdrawal by Subject|5|||
154839862|NCT00606086|558845611|FG001|Overall Study|Withdrawal by Subject|3|||
154839863|NCT00606086|558845610|FG000|Overall Study|Non-compliance|0|||
154839864|NCT00606086|558845611|FG001|Overall Study|Non-compliance|1|||
154839865|NCT00606086|558845610|FG000|Overall Study|Randomized, not treated|1|||
154839866|NCT00606086|558845611|FG001|Overall Study|Randomized, not treated|2|||
154839867|NCT00391222|558845617|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
154839868|NCT00391222|558845618|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
154839869|NCT00391222|558845619|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
154839870|NCT00391222|558845620|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
154839871|NCT00391222|558845617|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
154839872|NCT00391222|558845618|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
154839873|NCT00391222|558845619|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
154839874|NCT00391222|558845620|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
154839875|NCT00391222|558845617|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
154839876|NCT00391222|558845618|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
154839877|NCT00391222|558845619|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
154839878|NCT00391222|558845620|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
154839879|NCT00391222|558845617|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
154839880|NCT00391222|558845618|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
154839881|NCT00391222|558845619|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
154839882|NCT00391222|558845620|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
154839883|NCT00391222|558845617|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
154839884|NCT00391222|558845618|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
154839885|NCT00391222|558845619|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
154839886|NCT00391222|558845620|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
154839887|NCT00391222|558845617|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
154839888|NCT00391222|558845618|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
154839889|NCT00391222|558845619|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
154839890|NCT00391222|558845620|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
154839891|NCT00391222|558845617|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
154839892|NCT00391222|558845618|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
154839893|NCT00391222|558845619|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
154839894|NCT00391222|558845620|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
154839895|NCT00391222|558845617|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
154839896|NCT00391222|558845618|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
154839897|NCT00391222|558845619|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
154839898|NCT00391222|558845620|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
155173523|NCT03952039|560073355|FG001|Overall Study|Other Reasons|4|||
154839899|NCT00391222|558845617|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
154839900|NCT00391222|558845618|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
154839901|NCT00391222|558845619|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
154839902|NCT00391222|558845620|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
154839903|NCT00391222|558845617|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
154839904|NCT00391222|558845618|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
154839905|NCT00391222|558845619|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
154839906|NCT00391222|558845620|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
154839907|NCT00391222|558845617|FG000|Period III (Double-Blind Treatment)|Other|6|||
154839908|NCT00391222|558845618|FG001|Period III (Double-Blind Treatment)|Other|1|||
154839909|NCT00391222|558845619|FG002|Period III (Double-Blind Treatment)|Other|6|||
154839910|NCT00391222|558845620|FG003|Period III (Double-Blind Treatment)|Other|0|||
154839911|NCT01627860|558845621|FG000|Overall Study|Adverse Event|9|||
154839912|NCT01627860|558845622|FG001|Overall Study|Adverse Event|4|||
154839913|NCT01627860|558845621|FG000|Overall Study|Withdrawal by Subject|2|||
154839914|NCT01627860|558845622|FG001|Overall Study|Withdrawal by Subject|1|||
154839915|NCT01627860|558845621|FG000|Overall Study|Seizure frequency doubled|0|||
154839916|NCT01627860|558845622|FG001|Overall Study|Seizure frequency doubled|1|||
154839917|NCT01627860|558845621|FG000|Overall Study|Protocol Violation|1|||
154839918|NCT01627860|558845622|FG001|Overall Study|Protocol Violation|0|||
154839919|NCT01014689|558845625|FG000|Overall Study|Lack of Efficacy|0|||
154839920|NCT01014689|558845626|FG001|Overall Study|Lack of Efficacy|1|||
154839921|NCT01014689|558845625|FG000|Overall Study|Adverse Event|3|||
154839922|NCT01014689|558845626|FG001|Overall Study|Adverse Event|0|||
154839923|NCT01014689|558845625|FG000|Overall Study|Withdrawal by Subject|5|||
154839924|NCT01014689|558845626|FG001|Overall Study|Withdrawal by Subject|4|||
154839925|NCT01014689|558845625|FG000|Overall Study|Protocol Violation|1|||
154839926|NCT01014689|558845626|FG001|Overall Study|Protocol Violation|1|||
154839927|NCT01014689|558845625|FG000|Overall Study|Lost to Follow-up|3|||
154839928|NCT01014689|558845626|FG001|Overall Study|Lost to Follow-up|7|||
154839929|NCT01014689|558845625|FG000|Overall Study|Pregnancy|1|||
154839930|NCT01014689|558845626|FG001|Overall Study|Pregnancy|0|||
154839931|NCT00333359|558845632|FG000|Overall Study|Adverse Event|29|||
154839932|NCT00333359|558845633|FG001|Overall Study|Adverse Event|35|||
154839933|NCT00333359|558845632|FG000|Overall Study|Withdrawal by Subject|19|||
154839934|NCT00333359|558845633|FG001|Overall Study|Withdrawal by Subject|37|||
154839935|NCT00333359|558845632|FG000|Overall Study|Physician Decision|2|||
154839936|NCT00333359|558845633|FG001|Overall Study|Physician Decision|2|||
154839937|NCT00333359|558845632|FG000|Overall Study|Protocol Non-compliance|2|||
154839938|NCT00333359|558845633|FG001|Overall Study|Protocol Non-compliance|8|||
154839939|NCT00333359|558845632|FG000|Overall Study|Lost to Follow-up|15|||
154839940|NCT00333359|558845633|FG001|Overall Study|Lost to Follow-up|25|||
154839941|NCT00333359|558845632|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
154839942|NCT00333359|558845633|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
154839943|NCT00333359|558845632|FG000|Overall Study|Treatment Failure|3|||
154839944|NCT00333359|558845633|FG001|Overall Study|Treatment Failure|8|||
154839945|NCT00333359|558845632|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
154839946|NCT00333359|558845633|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
154839947|NCT01534533|558845637|FG000|Overall Study|Lost to Follow-up|3|||
154839948|NCT01534533|558845638|FG001|Overall Study|Lost to Follow-up|0|||
154839949|NCT01534533|558845639|FG002|Overall Study|Lost to Follow-up|4|||
154839950|NCT01534533|558845640|FG003|Overall Study|Lost to Follow-up|3|||
154839951|NCT01534533|558845637|FG000|Overall Study|Withdrawal by Subject|5|||
154839952|NCT01534533|558845638|FG001|Overall Study|Withdrawal by Subject|3|||
154839953|NCT01534533|558845639|FG002|Overall Study|Withdrawal by Subject|4|||
154839954|NCT01534533|558845640|FG003|Overall Study|Withdrawal by Subject|1|||
154839955|NCT05032157|558847570|FG000|Overall Study|Adverse Event|12|||
154839956|NCT05032157|558847571|FG001|Overall Study|Adverse Event|7|||
154839957|NCT05032157|558847570|FG000|Overall Study|Pregnancy|0|||
154839958|NCT05032157|558847571|FG001|Overall Study|Pregnancy|2|||
154839959|NCT05032157|558847570|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154839960|NCT05032157|558847571|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
154839961|NCT05032157|558847570|FG000|Overall Study|Protocol Deviation|8|||
154839962|NCT05032157|558847571|FG001|Overall Study|Protocol Deviation|4|||
154839963|NCT05032157|558847570|FG000|Overall Study|Lost to Follow-up|1|||
154839964|NCT05032157|558847571|FG001|Overall Study|Lost to Follow-up|3|||
154839965|NCT05032157|558847570|FG000|Overall Study|Physician Decision|7|||
154839966|NCT05032157|558847571|FG001|Overall Study|Physician Decision|2|||
154839967|NCT05032157|558847570|FG000|Overall Study|Patient Decision|38|||
154839968|NCT05032157|558847571|FG001|Overall Study|Patient Decision|19|||
154839969|NCT00880893|558847574|FG000|Overall Study|Protocol Violation|13|||
154839970|NCT00880893|558847575|FG001|Overall Study|Protocol Violation|1|||
154839971|NCT00880893|558847574|FG000|Overall Study|Withdrawal by Subject|15|||
154839972|NCT00880893|558847575|FG001|Overall Study|Withdrawal by Subject|11|||
154839973|NCT00880893|558847574|FG000|Overall Study|Lost to Follow-up|76|||
154839974|NCT00880893|558847575|FG001|Overall Study|Lost to Follow-up|33|||
154839975|NCT00880893|558847574|FG000|Overall Study|Serious adverse event|3|||
154839976|NCT00880893|558847575|FG001|Overall Study|Serious adverse event|0|||
154839977|NCT01736579|558847576|FG000|Overall Study|Termination of Study by Sponsor|2|||
154839978|NCT01736579|558847577|FG001|Overall Study|Termination of Study by Sponsor|2|||
154839979|NCT01783678|558847582|FG000|Overall Study|Randomized but Not Treated|0|||
154839980|NCT01783678|558847583|FG001|Overall Study|Randomized but Not Treated|0|||
154839981|NCT01783678|558847584|FG002|Overall Study|Randomized but Not Treated|0|||
154839982|NCT01783678|558847585|FG003|Overall Study|Randomized but Not Treated|1|||
154839983|NCT01783678|558847586|FG004|Overall Study|Randomized but Not Treated|0|||
154839984|NCT01783678|558847587|FG005|Overall Study|Randomized but Not Treated|0|||
154839985|NCT01783678|558847582|FG000|Overall Study|Lack of Efficacy|1|||
154839986|NCT01783678|558847583|FG001|Overall Study|Lack of Efficacy|13|||
154839987|NCT01783678|558847584|FG002|Overall Study|Lack of Efficacy|1|||
154839988|NCT01783678|558847585|FG003|Overall Study|Lack of Efficacy|3|||
154839989|NCT01783678|558847586|FG004|Overall Study|Lack of Efficacy|6|||
154839990|NCT01783678|558847587|FG005|Overall Study|Lack of Efficacy|5|||
154839991|NCT01783678|558847582|FG000|Overall Study|Lost to Follow-up|0|||
154839992|NCT01783678|558847583|FG001|Overall Study|Lost to Follow-up|4|||
154839993|NCT01783678|558847584|FG002|Overall Study|Lost to Follow-up|0|||
154839994|NCT01783678|558847585|FG003|Overall Study|Lost to Follow-up|2|||
154839995|NCT01783678|558847586|FG004|Overall Study|Lost to Follow-up|1|||
154839996|NCT01783678|558847587|FG005|Overall Study|Lost to Follow-up|0|||
154839997|NCT01783678|558847582|FG000|Overall Study|Withdrew Consent|1|||
154839998|NCT01783678|558847583|FG001|Overall Study|Withdrew Consent|1|||
154839999|NCT01783678|558847584|FG002|Overall Study|Withdrew Consent|0|||
154840000|NCT01783678|558847585|FG003|Overall Study|Withdrew Consent|2|||
154840001|NCT01783678|558847586|FG004|Overall Study|Withdrew Consent|0|||
154840002|NCT01783678|558847587|FG005|Overall Study|Withdrew Consent|0|||
154840003|NCT01408147|558847588|FG000|Overall Study|Withdrawal by Subject|0|||
154840004|NCT01408147|558847589|FG001|Overall Study|Withdrawal by Subject|1|||
154840005|NCT01042600|558847590|FG000|Overall Study|Ineligible|1|||
154840006|NCT01042600|558847591|FG001|Overall Study|Ineligible|0|||
154840007|NCT03445000|558847592|FG000|Overall Study|Disease progression|8|||
154840008|NCT03445000|558847592|FG000|Overall Study|Adverse Event|3|||
154840009|NCT03445000|558847592|FG000|Overall Study|Death|2|||
154840010|NCT03445000|558847592|FG000|Overall Study|Physician Decision|1|||
154840011|NCT03311711|558847593|FG000|Overall Study|Death|1|||
154840012|NCT03311711|558847594|FG001|Overall Study|Death|0|||
154840013|NCT03311711|558847595|FG002|Overall Study|Death|0|||
154840014|NCT03311711|558847596|FG003|Overall Study|Death|0|||
154840015|NCT03311711|558847597|FG004|Overall Study|Death|0|||
154840016|NCT03311711|558847598|FG005|Overall Study|Death|0|||
154840017|NCT03311711|558847599|FG006|Overall Study|Death|1|||
154840018|NCT03311711|558847600|FG007|Overall Study|Death|0|||
154840019|NCT03311711|558847601|FG008|Overall Study|Death|1|||
154840020|NCT03311711|558847602|FG009|Overall Study|Death|0|||
154840021|NCT03311711|558847593|FG000|Overall Study|Death of dyad partner|0|||
154840022|NCT03311711|558847594|FG001|Overall Study|Death of dyad partner|1|||
154840023|NCT03311711|558847595|FG002|Overall Study|Death of dyad partner|0|||
154840024|NCT03311711|558847596|FG003|Overall Study|Death of dyad partner|0|||
154840025|NCT03311711|558847597|FG004|Overall Study|Death of dyad partner|0|||
154840026|NCT03311711|558847598|FG005|Overall Study|Death of dyad partner|0|||
154840027|NCT03311711|558847599|FG006|Overall Study|Death of dyad partner|0|||
154840028|NCT03311711|558847600|FG007|Overall Study|Death of dyad partner|1|||
154840029|NCT03311711|558847601|FG008|Overall Study|Death of dyad partner|0|||
154840030|NCT03311711|558847602|FG009|Overall Study|Death of dyad partner|1|||
154840031|NCT03311711|558847593|FG000|Overall Study|Lost to Follow-up|2|||
154840032|NCT03311711|558847594|FG001|Overall Study|Lost to Follow-up|2|||
154840033|NCT03311711|558847595|FG002|Overall Study|Lost to Follow-up|0|||
154840034|NCT03311711|558847596|FG003|Overall Study|Lost to Follow-up|0|||
154840035|NCT03311711|558847597|FG004|Overall Study|Lost to Follow-up|0|||
154840036|NCT03311711|558847598|FG005|Overall Study|Lost to Follow-up|0|||
154840037|NCT03311711|558847599|FG006|Overall Study|Lost to Follow-up|1|||
154840038|NCT03311711|558847600|FG007|Overall Study|Lost to Follow-up|1|||
154840039|NCT03311711|558847601|FG008|Overall Study|Lost to Follow-up|0|||
154840040|NCT03311711|558847602|FG009|Overall Study|Lost to Follow-up|0|||
154840041|NCT03311711|558847593|FG000|Overall Study|Withdrawal by Subject|1|||
154840042|NCT03311711|558847594|FG001|Overall Study|Withdrawal by Subject|1|||
154840043|NCT03311711|558847595|FG002|Overall Study|Withdrawal by Subject|0|||
154840044|NCT03311711|558847596|FG003|Overall Study|Withdrawal by Subject|0|||
154840045|NCT03311711|558847597|FG004|Overall Study|Withdrawal by Subject|0|||
154840046|NCT03311711|558847598|FG005|Overall Study|Withdrawal by Subject|0|||
154840047|NCT03311711|558847599|FG006|Overall Study|Withdrawal by Subject|3|||
154840048|NCT03311711|558847600|FG007|Overall Study|Withdrawal by Subject|3|||
154840049|NCT03311711|558847601|FG008|Overall Study|Withdrawal by Subject|0|||
154840050|NCT03311711|558847602|FG009|Overall Study|Withdrawal by Subject|0|||
154840051|NCT01982292|558847603|FG000|Overall Study|Adverse Event|2|||
154840052|NCT01982292|558847604|FG001|Overall Study|Adverse Event|0|||
154840053|NCT01982292|558847603|FG000|Overall Study|Death|1|||
154840054|NCT01982292|558847604|FG001|Overall Study|Death|0|||
155104631|NCT01340664|559812570|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
155104632|NCT01340664|559812571|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
155104633|NCT01340664|559812572|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
154840055|NCT01982292|558847603|FG000|Overall Study|Lost to Follow-up|2|||
154840056|NCT01982292|558847604|FG001|Overall Study|Lost to Follow-up|0|||
154840057|NCT01982292|558847603|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
154840058|NCT01982292|558847604|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
154840059|NCT01982292|558847603|FG000|Overall Study|Protocol Deviation|1|||
154840060|NCT01982292|558847604|FG001|Overall Study|Protocol Deviation|0|||
154840061|NCT01982292|558847603|FG000|Overall Study|Patient/Guardian Decision|3|||
154840062|NCT01982292|558847604|FG001|Overall Study|Patient/Guardian Decision|1|||
154840063|NCT01982292|558847603|FG000|Overall Study|Technical Problems|2|||
154840064|NCT01982292|558847604|FG001|Overall Study|Technical Problems|0|||
154840065|NCT01049035|558847605|FG000|Overall Study|Serious adverse event|0|||
154971034|NCT00274625|559318517|FG001|Overall Study|Excluded from analysis|8|||
154971035|NCT02940522|559318518|FG000|Overall Study|Lost to Follow-up|1|||
154971036|NCT02940522|559318519|FG001|Overall Study|Lost to Follow-up|2|||
154840066|NCT01049035|558847606|FG001|Overall Study|Serious adverse event|1|||
154840067|NCT01049035|558847607|FG002|Overall Study|Serious adverse event|1|||
154840068|NCT01049035|558847608|FG003|Overall Study|Serious adverse event|2|||
154840069|NCT01049035|558847609|FG004|Overall Study|Serious adverse event|0|||
154840070|NCT01049035|558847610|FG005|Overall Study|Serious adverse event|0|||
154840071|NCT01049035|558847611|FG006|Overall Study|Serious adverse event|0|||
154840072|NCT01049035|558847605|FG000|Overall Study|Other adverse event (AE)|0|||
154840073|NCT01049035|558847606|FG001|Overall Study|Other adverse event (AE)|0|||
154840074|NCT01049035|558847607|FG002|Overall Study|Other adverse event (AE)|0|||
154840075|NCT01049035|558847608|FG003|Overall Study|Other adverse event (AE)|1|||
154840076|NCT01049035|558847609|FG004|Overall Study|Other adverse event (AE)|0|||
154840077|NCT01049035|558847610|FG005|Overall Study|Other adverse event (AE)|0|||
154840078|NCT01049035|558847611|FG006|Overall Study|Other adverse event (AE)|0|||
154840079|NCT01049035|558847605|FG000|Overall Study|Non-compliance with the protocol|12|||
154840080|NCT01049035|558847606|FG001|Overall Study|Non-compliance with the protocol|6|||
154840081|NCT01049035|558847607|FG002|Overall Study|Non-compliance with the protocol|14|||
154840082|NCT01049035|558847608|FG003|Overall Study|Non-compliance with the protocol|5|||
154840083|NCT01049035|558847609|FG004|Overall Study|Non-compliance with the protocol|3|||
154840084|NCT01049035|558847610|FG005|Overall Study|Non-compliance with the protocol|4|||
154840085|NCT01049035|558847611|FG006|Overall Study|Non-compliance with the protocol|10|||
154840086|NCT01049035|558847605|FG000|Overall Study|Lost to Follow-up|5|||
154840087|NCT01049035|558847606|FG001|Overall Study|Lost to Follow-up|4|||
154840088|NCT01049035|558847607|FG002|Overall Study|Lost to Follow-up|4|||
154840089|NCT01049035|558847608|FG003|Overall Study|Lost to Follow-up|1|||
154840090|NCT01049035|558847609|FG004|Overall Study|Lost to Follow-up|0|||
154840091|NCT01049035|558847610|FG005|Overall Study|Lost to Follow-up|3|||
154840092|NCT01049035|558847611|FG006|Overall Study|Lost to Follow-up|3|||
154840093|NCT01049035|558847605|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
154840094|NCT01049035|558847606|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
154840095|NCT01049035|558847607|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
154840096|NCT01049035|558847608|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
154840097|NCT01049035|558847609|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
154840098|NCT01049035|558847610|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
154840099|NCT01049035|558847611|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
154840100|NCT01137773|558847612|FG000|Overall Study|Death|3|||
154840101|NCT01137773|558847613|FG001|Overall Study|Death|3|||
154840102|NCT01137773|558847612|FG000|Overall Study|Lost to Follow-up|6|||
154840103|NCT01137773|558847613|FG001|Overall Study|Lost to Follow-up|0|||
154840104|NCT00493870|558847617|FG000|Overall Study|Lost to Follow-up|12|||
154840105|NCT00493870|558847618|FG001|Overall Study|Lost to Follow-up|15|||
154840106|NCT05594173|558847621|FG000|Overall Study|Adverse Event|1|||
154840107|NCT05594173|558847621|FG000|Overall Study|COVID-19 Pandemic|2|||
154840108|NCT01485627|558847624|FG000|Overall Study|Patient withdrew|6|||
154840109|NCT01485627|558847625|FG001|Overall Study|Patient withdrew|5|||
154840110|NCT01485627|558847624|FG000|Overall Study|Patient died|3|||
154840111|NCT01485627|558847625|FG001|Overall Study|Patient died|1|||
154840112|NCT01485627|558847624|FG000|Overall Study|Patient lost to followup|0|||
154840113|NCT01485627|558847625|FG001|Overall Study|Patient lost to followup|1|||
154840114|NCT01485627|558847624|FG000|Overall Study|Caregiver withdrew|3|||
154840115|NCT01485627|558847625|FG001|Overall Study|Caregiver withdrew|3|||
154840116|NCT01485627|558847624|FG000|Overall Study|Caregiver lost to follow up|11|||
154840117|NCT01485627|558847625|FG001|Overall Study|Caregiver lost to follow up|12|||
154840118|NCT01485627|558847624|FG000|Overall Study|Caregiver died|1|||
154840119|NCT01485627|558847625|FG001|Overall Study|Caregiver died|0|||
154840120|NCT01485627|558847624|FG000|Overall Study|caregiver was not bereaved|42|||
154840121|NCT01485627|558847625|FG001|Overall Study|caregiver was not bereaved|35|||
154840122|NCT01709149|558847626|FG000|Open-label Lead-in Phase|Adverse Event|109|||
154840123|NCT01709149|558847627|FG001|Open-label Lead-in Phase|Adverse Event|0|||
154840124|NCT01709149|558847628|FG002|Open-label Lead-in Phase|Adverse Event|0|||
154840125|NCT01709149|558847626|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
154840126|NCT01709149|558847627|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
154840127|NCT01709149|558847628|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
154840128|NCT01709149|558847626|FG000|Open-label Lead-in Phase|Death|1|||
154840129|NCT01709149|558847627|FG001|Open-label Lead-in Phase|Death|0|||
154840130|NCT01709149|558847628|FG002|Open-label Lead-in Phase|Death|0|||
154840131|NCT01709149|558847626|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
154840132|NCT01709149|558847627|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
154971037|NCT02940522|559318518|FG000|Overall Study|Withdrawal by Subject|1|||
154971038|NCT02940522|559318519|FG001|Overall Study|Withdrawal by Subject|0|||
154971039|NCT00762411|559318522|FG000|Initial Treatment|Death|7|||
154840133|NCT01709149|558847628|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
154840134|NCT01709149|558847626|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
154840135|NCT01709149|558847627|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
154840136|NCT01709149|558847628|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
154840137|NCT01709149|558847626|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
154840138|NCT01709149|558847627|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
154840139|NCT01709149|558847628|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
154840140|NCT01709149|558847626|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
154840141|NCT01709149|558847627|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
154840142|NCT01709149|558847628|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
154840143|NCT01709149|558847626|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
154840144|NCT01709149|558847627|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
154840145|NCT01709149|558847628|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
154840146|NCT01709149|558847626|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
154840147|NCT01709149|558847627|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
154840148|NCT01709149|558847628|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
154840149|NCT01709149|558847626|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
154840150|NCT01709149|558847627|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
154840151|NCT01709149|558847628|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
154840152|NCT00763815|558847629|FG000|Overall Study|Adverse Event|14|||
154840153|NCT00763815|558847630|FG001|Overall Study|Adverse Event|29|||
154840154|NCT00763815|558847629|FG000|Overall Study|Lack of Efficacy|10|||
154840155|NCT00763815|558847630|FG001|Overall Study|Lack of Efficacy|11|||
154840156|NCT00763815|558847629|FG000|Overall Study|Poor Compliance to Protocol|6|||
154840157|NCT00763815|558847630|FG001|Overall Study|Poor Compliance to Protocol|6|||
154840158|NCT00763815|558847629|FG000|Overall Study|Lost to Follow-up|2|||
154840159|NCT00763815|558847630|FG001|Overall Study|Lost to Follow-up|4|||
154840160|NCT00763815|558847629|FG000|Overall Study|Early Termination|1|||
154840161|NCT00763815|558847630|FG001|Overall Study|Early Termination|0|||
154840162|NCT00763815|558847629|FG000|Overall Study|Familial and Personal Reasons|9|||
154840163|NCT00763815|558847630|FG001|Overall Study|Familial and Personal Reasons|16|||
154840164|NCT00763815|558847629|FG000|Overall Study|Physician Decision|1|||
154840165|NCT00763815|558847630|FG001|Overall Study|Physician Decision|0|||
154840166|NCT00763815|558847629|FG000|Overall Study|Withdrawal by Subject|7|||
154840167|NCT00763815|558847630|FG001|Overall Study|Withdrawal by Subject|12|||
154840168|NCT00763815|558847629|FG000|Overall Study|Protocol Violation|2|||
154840169|NCT00763815|558847630|FG001|Overall Study|Protocol Violation|5|||
154840170|NCT00763815|558847629|FG000|Overall Study|Sponsor's Decision|0|||
154840171|NCT00763815|558847630|FG001|Overall Study|Sponsor's Decision|1|||
154840172|NCT04951037|558847631|FG000|Overall Study|Lost to Follow-up|16|||
154840173|NCT04951037|558847631|FG000|Overall Study|Withdrawal by Subject|5|||
154840174|NCT04951037|558847631|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
154840175|NCT05630937|558847632|FG000|Overall Study|Study terminated by sponsor|1|||
154840176|NCT05630937|558847633|FG001|Overall Study|Study terminated by sponsor|1|||
154840177|NCT05630937|558847634|FG002|Overall Study|Study terminated by sponsor|8|||
154840178|NCT05630937|558847635|FG003|Overall Study|Study terminated by sponsor|0|||
154840179|NCT05630937|558847632|FG000|Overall Study|Lost to Follow-up|0|||
154840180|NCT05630937|558847633|FG001|Overall Study|Lost to Follow-up|0|||
154840181|NCT05630937|558847634|FG002|Overall Study|Lost to Follow-up|1|||
154840182|NCT05630937|558847635|FG003|Overall Study|Lost to Follow-up|0|||
154840183|NCT05630937|558847632|FG000|Overall Study|Enrolled but not treated|0|||
154840184|NCT05630937|558847633|FG001|Overall Study|Enrolled but not treated|0|||
154840185|NCT05630937|558847634|FG002|Overall Study|Enrolled but not treated|0|||
154840186|NCT05630937|558847635|FG003|Overall Study|Enrolled but not treated|1|||
154840187|NCT00267748|558847637|FG000|Non-randomized Period|Progressive disease|10|||
154840188|NCT00267748|558847638|FG001|Non-randomized Period|Progressive disease|0|||
154840189|NCT00267748|558847639|FG002|Non-randomized Period|Progressive disease|0|||
154840190|NCT00267748|558847637|FG000|Non-randomized Period|Adverse Event|8|||
154840191|NCT00267748|558847638|FG001|Non-randomized Period|Adverse Event|0|||
154840192|NCT00267748|558847639|FG002|Non-randomized Period|Adverse Event|0|||
154840193|NCT00267748|558847637|FG000|Non-randomized Period|Death|1|||
154840194|NCT00267748|558847638|FG001|Non-randomized Period|Death|0|||
154840195|NCT00267748|558847639|FG002|Non-randomized Period|Death|0|||
154840196|NCT00267748|558847637|FG000|Non-randomized Period|Participant not willing to participate|1|||
154840197|NCT00267748|558847638|FG001|Non-randomized Period|Participant not willing to participate|0|||
154840198|NCT00267748|558847639|FG002|Non-randomized Period|Participant not willing to participate|0|||
154840199|NCT00267748|558847637|FG000|Non-randomized Period|Other|3|||
154840200|NCT00267748|558847638|FG001|Non-randomized Period|Other|0|||
154840201|NCT00267748|558847639|FG002|Non-randomized Period|Other|0|||
154840202|NCT00267748|558847637|FG000|Randomized Period|Death|0|||
154840203|NCT00267748|558847638|FG001|Randomized Period|Death|2|||
154840204|NCT00267748|558847639|FG002|Randomized Period|Death|3|||
154840205|NCT00267748|558847637|FG000|Randomized Period|Adverse Event|0|||
154840206|NCT00267748|558847638|FG001|Randomized Period|Adverse Event|23|||
154840207|NCT00267748|558847639|FG002|Randomized Period|Adverse Event|25|||
154840208|NCT00267748|558847637|FG000|Randomized Period|Global deterioration of health status|0|||
154840209|NCT00267748|558847638|FG001|Randomized Period|Global deterioration of health status|6|||
154840210|NCT00267748|558847639|FG002|Randomized Period|Global deterioration of health status|7|||
154840211|NCT00267748|558847637|FG000|Randomized Period|Lost to Follow-up|0|||
154840212|NCT00267748|558847638|FG001|Randomized Period|Lost to Follow-up|1|||
154840213|NCT00267748|558847639|FG002|Randomized Period|Lost to Follow-up|0|||
154840214|NCT00267748|558847637|FG000|Randomized Period|Objective progression or relapse|0|||
154971040|NCT00762411|559318523|FG001|Initial Treatment|Death|6|||
154840215|NCT00267748|558847638|FG001|Randomized Period|Objective progression or relapse|77|||
154840216|NCT00267748|558847639|FG002|Randomized Period|Objective progression or relapse|86|||
154840217|NCT00267748|558847637|FG000|Randomized Period|Withdrawal by Subject|0|||
154840218|NCT00267748|558847638|FG001|Randomized Period|Withdrawal by Subject|9|||
154840219|NCT00267748|558847639|FG002|Randomized Period|Withdrawal by Subject|2|||
154840220|NCT00267748|558847637|FG000|Randomized Period|Other|0|||
154840221|NCT00267748|558847638|FG001|Randomized Period|Other|9|||
154840222|NCT00267748|558847639|FG002|Randomized Period|Other|6|||
154840223|NCT00267748|558847637|FG000|Randomized Period|randomized but not treated|0|||
154840224|NCT00267748|558847638|FG001|Randomized Period|randomized but not treated|0|||
154840225|NCT00267748|558847639|FG002|Randomized Period|randomized but not treated|3|||
154840226|NCT02429414|558847640|FG000|Overall Study|Physician Decision|0|||
154840227|NCT02429414|558847641|FG001|Overall Study|Physician Decision|1|||
154840228|NCT01098071|558847654|FG000|Overall Study|Surgery (adenoidectomy)|2|||
154840229|NCT01098071|558847654|FG000|Overall Study|Lost to Follow-up|13|||
154840230|NCT01604265|558847655|FG000|Overall Study|Adverse Event|1|||
154840231|NCT01604265|558847656|FG001|Overall Study|Adverse Event|0|||
154840232|NCT01604265|558847655|FG000|Overall Study|Withdrawal by Subject|1|||
154840233|NCT01604265|558847656|FG001|Overall Study|Withdrawal by Subject|0|||
154840234|NCT01903837|558847657|FG000|Part A|Withdrawal by Subject|4|||
154840235|NCT01903837|558847658|FG001|Part A|Withdrawal by Subject|9|||
154840236|NCT01903837|558847659|FG002|Part A|Withdrawal by Subject|8|||
154840237|NCT01903837|558847660|FG003|Part A|Withdrawal by Subject|5|||
154840238|NCT01903837|558847657|FG000|Part A|Adverse Event|3|||
154840239|NCT01903837|558847658|FG001|Part A|Adverse Event|6|||
154840240|NCT01903837|558847659|FG002|Part A|Adverse Event|9|||
154840241|NCT01903837|558847660|FG003|Part A|Adverse Event|6|||
154840242|NCT01903837|558847657|FG000|Part A|Lost to Follow-up|9|||
154840243|NCT01903837|558847658|FG001|Part A|Lost to Follow-up|7|||
154840244|NCT01903837|558847659|FG002|Part A|Lost to Follow-up|7|||
154840245|NCT01903837|558847660|FG003|Part A|Lost to Follow-up|2|||
154840246|NCT01903837|558847657|FG000|Part A|Non-compliance with study drug|1|||
154840247|NCT01903837|558847658|FG001|Part A|Non-compliance with study drug|4|||
154840248|NCT01903837|558847659|FG002|Part A|Non-compliance with study drug|4|||
154840249|NCT01903837|558847660|FG003|Part A|Non-compliance with study drug|0|||
154840250|NCT01903837|558847657|FG000|Part A|Physician Decision|1|||
154840251|NCT01903837|558847658|FG001|Part A|Physician Decision|1|||
154840252|NCT01903837|558847659|FG002|Part A|Physician Decision|0|||
154840253|NCT01903837|558847660|FG003|Part A|Physician Decision|0|||
154840254|NCT01903837|558847657|FG000|Part A|Protocol Violation|1|||
154840255|NCT01903837|558847658|FG001|Part A|Protocol Violation|1|||
154840256|NCT01903837|558847659|FG002|Part A|Protocol Violation|0|||
154840257|NCT01903837|558847660|FG003|Part A|Protocol Violation|0|||
154840258|NCT01903837|558847657|FG000|Part B|Lost to Follow-up|0|||
154840259|NCT01903837|558847658|FG001|Part B|Lost to Follow-up|3|||
154840260|NCT01903837|558847659|FG002|Part B|Lost to Follow-up|3|||
154840261|NCT01903837|558847660|FG003|Part B|Lost to Follow-up|4|||
154840262|NCT01903837|558847657|FG000|Part B|Withdrawal by Subject|1|||
154840263|NCT01903837|558847658|FG001|Part B|Withdrawal by Subject|2|||
154840264|NCT01903837|558847659|FG002|Part B|Withdrawal by Subject|0|||
154840265|NCT01903837|558847660|FG003|Part B|Withdrawal by Subject|3|||
154840266|NCT01903837|558847657|FG000|Part B|Adverse Event|3|||
154840267|NCT01903837|558847658|FG001|Part B|Adverse Event|0|||
154840268|NCT01903837|558847659|FG002|Part B|Adverse Event|2|||
154840269|NCT01903837|558847660|FG003|Part B|Adverse Event|0|||
154840270|NCT01903837|558847657|FG000|Part B|Non-compliance with study drug|2|||
154840271|NCT01903837|558847658|FG001|Part B|Non-compliance with study drug|0|||
154840272|NCT01903837|558847659|FG002|Part B|Non-compliance with study drug|0|||
154840273|NCT01903837|558847660|FG003|Part B|Non-compliance with study drug|1|||
155104634|NCT01340664|559812570|FG000|Overall Study|Other|1|||
155104635|NCT01340664|559812571|FG001|Overall Study|Other|2|||
155104636|NCT01340664|559812572|FG002|Overall Study|Other|2|||
155104637|NCT02923531|559812573|FG000|Overall Study|Adverse Event|4|||
154840274|NCT01903837|558847657|FG000|Part B|Incarceration|2|||
155104638|NCT02923531|559812573|FG000|Overall Study|Clinical Deterioration|1|||
154840275|NCT01903837|558847658|FG001|Part B|Incarceration|0|||
154840276|NCT01903837|558847659|FG002|Part B|Incarceration|0|||
154840277|NCT01903837|558847660|FG003|Part B|Incarceration|1|||
154840278|NCT01903837|558847657|FG000|Part B|Physician Decision|1|||
154840279|NCT01903837|558847658|FG001|Part B|Physician Decision|0|||
154840280|NCT01903837|558847659|FG002|Part B|Physician Decision|0|||
154840281|NCT01903837|558847660|FG003|Part B|Physician Decision|2|||
154840282|NCT01903837|558847657|FG000|Part B|Lack of Efficacy|0|||
154840283|NCT01903837|558847658|FG001|Part B|Lack of Efficacy|1|||
154840284|NCT01903837|558847659|FG002|Part B|Lack of Efficacy|0|||
155104639|NCT02923531|559812573|FG000|Overall Study|Disease Progression|3|||
155104640|NCT02923531|559812573|FG000|Overall Study|Study Termination|1|||
154840285|NCT01903837|558847660|FG003|Part B|Lack of Efficacy|0|||
154840286|NCT02706873|558847661|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
154840287|NCT02706873|558847662|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
154840288|NCT02706873|558847663|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
154840289|NCT02706873|558847664|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
154840290|NCT02706873|558847661|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
154840291|NCT02706873|558847662|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
155104641|NCT01823198|559812575|FG000|Overall Study|Physician Decision|0|||
155104642|NCT01823198|559812576|FG001|Overall Study|Physician Decision|1|||
154840292|NCT02706873|558847663|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
154840293|NCT02706873|558847664|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
154840294|NCT02706873|558847661|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
154840295|NCT02706873|558847662|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
154840296|NCT02706873|558847663|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
154840297|NCT02706873|558847664|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
154840298|NCT02706873|558847661|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
154840299|NCT02706873|558847662|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
154840300|NCT02706873|558847663|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
154840301|NCT02706873|558847664|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
154840302|NCT02706873|558847661|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
154840303|NCT02706873|558847662|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
154840304|NCT02706873|558847663|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
154840305|NCT02706873|558847664|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
154840306|NCT02706873|558847661|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
154840307|NCT02706873|558847662|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
154840308|NCT02706873|558847663|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
154840309|NCT02706873|558847664|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
154840310|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
154840311|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
154840312|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
154840313|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
154840314|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
154840315|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
154840316|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
154840317|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
154840318|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
154840319|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
154840320|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
154840321|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
154840322|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
154840323|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
154840324|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
154840325|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
154840326|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
154840327|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
154840328|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
154840329|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
154840330|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
154840331|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
154840332|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
154840333|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
154840334|NCT02706873|558847661|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
154840335|NCT02706873|558847662|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
154840336|NCT02706873|558847663|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
154840337|NCT02706873|558847664|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
154840338|NCT00705939|558847667|FG000|Overall Study|Protocol Violation|0|||
154840339|NCT00705939|558847668|FG001|Overall Study|Protocol Violation|0|||
154840340|NCT00705939|558847669|FG002|Overall Study|Protocol Violation|1|||
154840341|NCT00705939|558847667|FG000|Overall Study|Withdrawal by Subject|0|||
154840342|NCT00705939|558847668|FG001|Overall Study|Withdrawal by Subject|1|||
154840343|NCT00705939|558847669|FG002|Overall Study|Withdrawal by Subject|3|||
154840344|NCT00705939|558847667|FG000|Overall Study|Physician Decision|0|||
154840345|NCT00705939|558847668|FG001|Overall Study|Physician Decision|1|||
155104643|NCT01823198|559812577|FG002|Overall Study|Physician Decision|0|||
155104644|NCT01823198|559812578|FG003|Overall Study|Physician Decision|0|||
155104645|NCT01823198|559812579|FG004|Overall Study|Physician Decision|0|||
155104646|NCT01823198|559812580|FG005|Overall Study|Physician Decision|3|||
155104647|NCT01823198|559812581|FG006|Overall Study|Physician Decision|3|||
154840346|NCT00705939|558847669|FG002|Overall Study|Physician Decision|0|||
154840347|NCT00464334|558847675|FG000|Overall Study|Adverse Event|0|||
154840348|NCT00464334|558847676|FG001|Overall Study|Adverse Event|0|||
154840349|NCT00464334|558847677|FG002|Overall Study|Adverse Event|0|||
154840350|NCT00464334|558847678|FG003|Overall Study|Adverse Event|1|||
154840351|NCT00464334|558847679|FG004|Overall Study|Adverse Event|1|||
154840352|NCT00464334|558847680|FG005|Overall Study|Adverse Event|1|||
154840353|NCT00464334|558847681|FG006|Overall Study|Adverse Event|0|||
155104648|NCT05588440|559812589|FG000|Overall Study|Sponsor Decision|2|||
155104649|NCT05588440|559812590|FG001|Overall Study|Sponsor Decision|0|||
155104650|NCT05588440|559812591|FG002|Overall Study|Sponsor Decision|1|||
154840354|NCT00464334|558847682|FG007|Overall Study|Adverse Event|0|||
154840355|NCT00464334|558847683|FG008|Overall Study|Adverse Event|2|||
154840356|NCT00464334|558847684|FG009|Overall Study|Adverse Event|1|||
154840357|NCT00464334|558847685|FG010|Overall Study|Adverse Event|2|||
154840358|NCT00464334|558847675|FG000|Overall Study|Lack of Efficacy|0|||
154840359|NCT00464334|558847676|FG001|Overall Study|Lack of Efficacy|1|||
154840360|NCT00464334|558847677|FG002|Overall Study|Lack of Efficacy|0|||
154840361|NCT00464334|558847678|FG003|Overall Study|Lack of Efficacy|0|||
154840362|NCT00464334|558847679|FG004|Overall Study|Lack of Efficacy|0|||
154840363|NCT00464334|558847680|FG005|Overall Study|Lack of Efficacy|0|||
154840364|NCT00464334|558847681|FG006|Overall Study|Lack of Efficacy|0|||
154840365|NCT00464334|558847682|FG007|Overall Study|Lack of Efficacy|0|||
154840366|NCT00464334|558847683|FG008|Overall Study|Lack of Efficacy|0|||
154840367|NCT00464334|558847684|FG009|Overall Study|Lack of Efficacy|0|||
154840368|NCT00464334|558847685|FG010|Overall Study|Lack of Efficacy|0|||
154840369|NCT00464334|558847675|FG000|Overall Study|Lost to Follow-up|0|||
154840370|NCT00464334|558847676|FG001|Overall Study|Lost to Follow-up|0|||
154840371|NCT00464334|558847677|FG002|Overall Study|Lost to Follow-up|1|||
154971041|NCT00762411|559318522|FG000|Initial Treatment|Adverse Event|132|||
154971042|NCT00762411|559318523|FG001|Initial Treatment|Adverse Event|40|||
154971043|NCT00762411|559318522|FG000|Initial Treatment|Protocol Violation|4|||
154971044|NCT00762411|559318523|FG001|Initial Treatment|Protocol Violation|1|||
154971045|NCT00762411|559318522|FG000|Initial Treatment|Withdrawal by Subject|65|||
154971046|NCT00762411|559318523|FG001|Initial Treatment|Withdrawal by Subject|52|||
154971047|NCT00762411|559318522|FG000|Initial Treatment|Physician Decision|1|||
154971048|NCT00762411|559318523|FG001|Initial Treatment|Physician Decision|0|||
154971049|NCT00762411|559318522|FG000|Initial Treatment|Sponsor Decision|293|||
154971050|NCT00762411|559318523|FG001|Initial Treatment|Sponsor Decision|401|||
154971051|NCT00762411|559318522|FG000|Initial Treatment|Lost to Follow-up|5|||
154971052|NCT00762411|559318523|FG001|Initial Treatment|Lost to Follow-up|0|||
154971053|NCT00762411|559318522|FG000|Initial Treatment|Caregiver Decision|21|||
154971054|NCT00762411|559318523|FG001|Initial Treatment|Caregiver Decision|16|||
154971055|NCT00762411|559318522|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
154971056|NCT00762411|559318523|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
154971057|NCT00762411|559318522|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
154971058|NCT00762411|559318523|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
154971059|NCT00762411|559318522|FG000|Delayed Start|Adverse Event|0|||
154971060|NCT00762411|559318523|FG001|Delayed Start|Adverse Event|4|||
154971061|NCT00762411|559318522|FG000|Delayed Start|Protocol Violation|0|||
154971062|NCT00762411|559318523|FG001|Delayed Start|Protocol Violation|1|||
154971063|NCT00762411|559318522|FG000|Delayed Start|Sponsor Decision|16|||
154971064|NCT00762411|559318523|FG001|Delayed Start|Sponsor Decision|20|||
154971065|NCT00762411|559318522|FG000|Delayed Start|Caregiver Decision|1|||
154971066|NCT00762411|559318523|FG001|Delayed Start|Caregiver Decision|1|||
154971067|NCT00762411|559318522|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
154971068|NCT00762411|559318523|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
154971069|NCT00762411|559318522|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
154971070|NCT00762411|559318523|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
154971071|NCT00762411|559318522|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
154971072|NCT00762411|559318523|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
154971073|NCT00762411|559318522|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
154971074|NCT00762411|559318523|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
154971075|NCT00762411|559318522|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
154971076|NCT00762411|559318523|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
154971077|NCT00762411|559318522|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
154971078|NCT00762411|559318523|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
154971079|NCT02710214|559318527|FG000|Overall Study|Lost to Follow-up|1|||
154971080|NCT02710214|559318528|FG001|Overall Study|Lost to Follow-up|0|||
154971081|NCT02710214|559318527|FG000|Overall Study|Lack of Efficacy|0|||
154971082|NCT02710214|559318528|FG001|Overall Study|Lack of Efficacy|1|||
154971083|NCT02710214|559318527|FG000|Overall Study|Death|0|||
154971084|NCT02710214|559318528|FG001|Overall Study|Death|1|||
154971085|NCT02832167|559318529|FG000|Treatment Period 1|Disease progression|90|||
154971086|NCT02832167|559318529|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
154971087|NCT02832167|559318529|FG000|Treatment Period 1|Death|2|||
154971088|NCT02832167|559318529|FG000|Treatment Period 1|Study Drug Toxicity|6|||
154971089|NCT02832167|559318529|FG000|Treatment Period 1|Participant request to discontinue|9|||
154971090|NCT02832167|559318529|FG000|Treatment Period 1|No longer meet study criteria|1|||
154971091|NCT02832167|559318529|FG000|Treatment Period 1|Participant withdrew consent|3|||
154971092|NCT02832167|559318529|FG000|Treatment Period 1|Other reasons|6|||
154971093|NCT02832167|559318529|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
154971094|NCT02832167|559318529|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
154971095|NCT02832167|559318529|FG000|Transition From Period 1 to Period 2|Death|2|||
154840372|NCT00464334|558847678|FG003|Overall Study|Lost to Follow-up|0|||
154840373|NCT00464334|558847679|FG004|Overall Study|Lost to Follow-up|1|||
154840374|NCT00464334|558847680|FG005|Overall Study|Lost to Follow-up|0|||
154840375|NCT00464334|558847681|FG006|Overall Study|Lost to Follow-up|1|||
154840376|NCT00464334|558847682|FG007|Overall Study|Lost to Follow-up|0|||
154840377|NCT00464334|558847683|FG008|Overall Study|Lost to Follow-up|0|||
154840378|NCT00464334|558847684|FG009|Overall Study|Lost to Follow-up|0|||
154840379|NCT00464334|558847685|FG010|Overall Study|Lost to Follow-up|2|||
154840380|NCT00464334|558847675|FG000|Overall Study|Progressive Disease|0|||
154840381|NCT00464334|558847676|FG001|Overall Study|Progressive Disease|0|||
154840382|NCT00464334|558847677|FG002|Overall Study|Progressive Disease|0|||
154840383|NCT00464334|558847678|FG003|Overall Study|Progressive Disease|0|||
154840384|NCT00464334|558847679|FG004|Overall Study|Progressive Disease|0|||
154840385|NCT00464334|558847680|FG005|Overall Study|Progressive Disease|1|||
154840386|NCT00464334|558847681|FG006|Overall Study|Progressive Disease|0|||
154840387|NCT00464334|558847682|FG007|Overall Study|Progressive Disease|0|||
154840388|NCT00464334|558847683|FG008|Overall Study|Progressive Disease|1|||
154840389|NCT00464334|558847684|FG009|Overall Study|Progressive Disease|0|||
154840390|NCT00464334|558847685|FG010|Overall Study|Progressive Disease|0|||
154840391|NCT00464334|558847675|FG000|Overall Study|Study Terminated by Sponsor|0|||
154840392|NCT00464334|558847676|FG001|Overall Study|Study Terminated by Sponsor|0|||
154840393|NCT00464334|558847677|FG002|Overall Study|Study Terminated by Sponsor|0|||
154840394|NCT00464334|558847678|FG003|Overall Study|Study Terminated by Sponsor|1|||
154840395|NCT00464334|558847679|FG004|Overall Study|Study Terminated by Sponsor|0|||
154840396|NCT00464334|558847680|FG005|Overall Study|Study Terminated by Sponsor|0|||
154840397|NCT00464334|558847681|FG006|Overall Study|Study Terminated by Sponsor|0|||
154840398|NCT00464334|558847682|FG007|Overall Study|Study Terminated by Sponsor|0|||
154840399|NCT00464334|558847683|FG008|Overall Study|Study Terminated by Sponsor|0|||
154840400|NCT00464334|558847684|FG009|Overall Study|Study Terminated by Sponsor|0|||
154840401|NCT00464334|558847685|FG010|Overall Study|Study Terminated by Sponsor|0|||
154840402|NCT00464334|558847675|FG000|Overall Study|Withdrawal by Subject|1|||
154840403|NCT00464334|558847676|FG001|Overall Study|Withdrawal by Subject|7|||
154840404|NCT00464334|558847677|FG002|Overall Study|Withdrawal by Subject|4|||
154840405|NCT00464334|558847678|FG003|Overall Study|Withdrawal by Subject|2|||
154840406|NCT00464334|558847679|FG004|Overall Study|Withdrawal by Subject|2|||
154840407|NCT00464334|558847680|FG005|Overall Study|Withdrawal by Subject|2|||
154840408|NCT00464334|558847681|FG006|Overall Study|Withdrawal by Subject|2|||
154840409|NCT00464334|558847682|FG007|Overall Study|Withdrawal by Subject|1|||
154840410|NCT00464334|558847683|FG008|Overall Study|Withdrawal by Subject|3|||
154840411|NCT00464334|558847684|FG009|Overall Study|Withdrawal by Subject|0|||
154840412|NCT00464334|558847685|FG010|Overall Study|Withdrawal by Subject|0|||
154840413|NCT03948178|558847686|FG000|Overall Study|Protocol Violation|1|||
154840414|NCT03948178|558847686|FG000|Overall Study|Lost to Follow-up|2|||
154840415|NCT03948178|558847686|FG000|Overall Study|Withdrawal by Subject|2|||
154840416|NCT03948178|558847686|FG000|Overall Study|Reason not known|2|||
154840417|NCT03948178|558847686|FG000|Overall Study|Personal reason|14|||
154840418|NCT03948178|558847686|FG000|Overall Study|Disease progression|30|||
154840419|NCT03948178|558847686|FG000|Overall Study|Adverse Event|12|||
154840420|NCT03948178|558847686|FG000|Overall Study|Sponsor terminated study|164|||
154840421|NCT02432235|558847689|FG000|Overall Study|Death|1|||
154840422|NCT02432235|558847690|FG001|Overall Study|Death|1|||
154840423|NCT02432235|558847691|FG002|Overall Study|Death|2|||
154840424|NCT02432235|558847692|FG003|Overall Study|Death|2|||
154840425|NCT02432235|558847693|FG004|Overall Study|Death|1|||
154840426|NCT02432235|558847694|FG005|Overall Study|Death|3|||
154840427|NCT02432235|558847695|FG006|Overall Study|Death|11|||
154840428|NCT02432235|558847696|FG007|Overall Study|Death|15|||
154840429|NCT02432235|558847697|FG008|Overall Study|Death|15|||
154840430|NCT02432235|558847698|FG009|Overall Study|Death|3|||
154840431|NCT02432235|558847699|FG010|Overall Study|Death|1|||
154840432|NCT02432235|558847700|FG011|Overall Study|Death|0|||
154840433|NCT02432235|558847689|FG000|Overall Study|Withdrawal by Subject|0|||
154840434|NCT02432235|558847690|FG001|Overall Study|Withdrawal by Subject|1|||
154840435|NCT02432235|558847691|FG002|Overall Study|Withdrawal by Subject|0|||
155104651|NCT05588440|559812589|FG000|Overall Study|Death|1|||
154840436|NCT02432235|558847692|FG003|Overall Study|Withdrawal by Subject|0|||
154840437|NCT02432235|558847693|FG004|Overall Study|Withdrawal by Subject|0|||
154840438|NCT02432235|558847694|FG005|Overall Study|Withdrawal by Subject|2|||
154840439|NCT02432235|558847695|FG006|Overall Study|Withdrawal by Subject|5|||
154840440|NCT02432235|558847696|FG007|Overall Study|Withdrawal by Subject|3|||
154840441|NCT02432235|558847697|FG008|Overall Study|Withdrawal by Subject|1|||
154840442|NCT02432235|558847698|FG009|Overall Study|Withdrawal by Subject|0|||
154840443|NCT02432235|558847699|FG010|Overall Study|Withdrawal by Subject|0|||
154840444|NCT02432235|558847700|FG011|Overall Study|Withdrawal by Subject|0|||
154840445|NCT02432235|558847689|FG000|Overall Study|Lost to Follow-up|0|||
154840446|NCT02432235|558847690|FG001|Overall Study|Lost to Follow-up|0|||
154840447|NCT02432235|558847691|FG002|Overall Study|Lost to Follow-up|0|||
155104652|NCT05588440|559812590|FG001|Overall Study|Death|1|||
154840448|NCT02432235|558847692|FG003|Overall Study|Lost to Follow-up|0|||
154840449|NCT02432235|558847693|FG004|Overall Study|Lost to Follow-up|0|||
154840450|NCT02432235|558847694|FG005|Overall Study|Lost to Follow-up|1|||
154840451|NCT02432235|558847695|FG006|Overall Study|Lost to Follow-up|0|||
155104653|NCT05588440|559812591|FG002|Overall Study|Death|1|||
154840452|NCT02432235|558847696|FG007|Overall Study|Lost to Follow-up|0|||
154840453|NCT02432235|558847697|FG008|Overall Study|Lost to Follow-up|1|||
154840454|NCT02432235|558847698|FG009|Overall Study|Lost to Follow-up|0|||
154840455|NCT02432235|558847699|FG010|Overall Study|Lost to Follow-up|0|||
154840456|NCT02432235|558847700|FG011|Overall Study|Lost to Follow-up|0|||
154840457|NCT02432235|558847689|FG000|Overall Study|Miscellaneous|0|||
154840458|NCT02432235|558847690|FG001|Overall Study|Miscellaneous|0|||
154840459|NCT02432235|558847691|FG002|Overall Study|Miscellaneous|0|||
154840460|NCT02432235|558847692|FG003|Overall Study|Miscellaneous|0|||
154840461|NCT02432235|558847693|FG004|Overall Study|Miscellaneous|1|||
154840462|NCT02432235|558847694|FG005|Overall Study|Miscellaneous|6|||
154840463|NCT02432235|558847695|FG006|Overall Study|Miscellaneous|2|||
154840464|NCT02432235|558847696|FG007|Overall Study|Miscellaneous|2|||
154840465|NCT02432235|558847697|FG008|Overall Study|Miscellaneous|4|||
154840466|NCT02432235|558847698|FG009|Overall Study|Miscellaneous|0|||
154840467|NCT02432235|558847699|FG010|Overall Study|Miscellaneous|0|||
154840468|NCT02432235|558847700|FG011|Overall Study|Miscellaneous|1|||
154840469|NCT01895322|558847701|FG000|Overall Study|Adverse Event|1|||
154840470|NCT01895322|558847701|FG000|Overall Study|Withdrawal by Subject|2|||
154840471|NCT01895322|558847701|FG000|Overall Study|Protocol Violation|10|||
154840472|NCT02728830|558847712|FG000|Overall Study|Exclusionary Surgery|9|||
154840473|NCT02728830|558847712|FG000|Overall Study|Exclusionary Pathology|6|||
154840474|NCT02728830|558847712|FG000|Overall Study|Physician Decision|3|||
154840475|NCT02728830|558847712|FG000|Overall Study|Withdrawal by Subject|2|||
154840476|NCT02728830|558847712|FG000|Overall Study|Lost to Follow-up|1|||
154840477|NCT02728830|558847712|FG000|Overall Study|Exclusionary Lab Values|1|||
154840478|NCT02728830|558847712|FG000|Overall Study|Contraindicated Illness|1|||
154840479|NCT02728830|558847712|FG000|Overall Study|Language Barrier|1|||
154840480|NCT01347554|558847713|FG000|Overall Study|Lack of Efficacy|7|||
154840481|NCT01347554|558847714|FG001|Overall Study|Lack of Efficacy|11|||
154840482|NCT03603496|558847715|FG000|Overall Study|Death|19|||
154840483|NCT03603496|558847716|FG001|Overall Study|Death|24|||
154840484|NCT03603496|558847715|FG000|Overall Study|Lost to Follow-up|141|||
154840485|NCT03603496|558847716|FG001|Overall Study|Lost to Follow-up|141|||
154840486|NCT03603496|558847715|FG000|Overall Study|Withdrawal by Subject|26|||
154840487|NCT03603496|558847716|FG001|Overall Study|Withdrawal by Subject|20|||
154840488|NCT00004259|558847718|FG000|Overall Study|Protocol Violation|1|||
154840489|NCT00004259|558847719|FG001|Overall Study|Protocol Violation|2|||
154840490|NCT00004259|558847720|FG002|Overall Study|Protocol Violation|0|||
154840491|NCT00004259|558847721|FG003|Overall Study|Protocol Violation|0|||
154840492|NCT00004259|558847718|FG000|Overall Study|Withdrawal by Subject|0|||
154840493|NCT00004259|558847719|FG001|Overall Study|Withdrawal by Subject|2|||
154840494|NCT00004259|558847720|FG002|Overall Study|Withdrawal by Subject|0|||
154840495|NCT00004259|558847721|FG003|Overall Study|Withdrawal by Subject|0|||
154840496|NCT03594227|558847722|FG000|Overall Study|Adverse Event|2|||
154840497|NCT03594227|558847723|FG001|Overall Study|Adverse Event|1|||
154840498|NCT03594227|558847724|FG002|Overall Study|Adverse Event|0|||
154840499|NCT03594227|558847725|FG003|Overall Study|Adverse Event|2|||
154840500|NCT03594227|558847722|FG000|Overall Study|Lost to Follow-up|1|||
154840501|NCT03594227|558847723|FG001|Overall Study|Lost to Follow-up|1|||
154840502|NCT03594227|558847724|FG002|Overall Study|Lost to Follow-up|1|||
154840503|NCT03594227|558847725|FG003|Overall Study|Lost to Follow-up|0|||
154840504|NCT03594227|558847722|FG000|Overall Study|Withdrawal by Subject|1|||
154840505|NCT03594227|558847723|FG001|Overall Study|Withdrawal by Subject|1|||
154840506|NCT03594227|558847724|FG002|Overall Study|Withdrawal by Subject|1|||
154840507|NCT03594227|558847725|FG003|Overall Study|Withdrawal by Subject|1|||
154840508|NCT03594227|558847722|FG000|Overall Study|Pregnancy|0|||
154840509|NCT03594227|558847723|FG001|Overall Study|Pregnancy|1|||
154840510|NCT03594227|558847724|FG002|Overall Study|Pregnancy|0|||
154840511|NCT03594227|558847725|FG003|Overall Study|Pregnancy|0|||
154840512|NCT03594227|558847722|FG000|Overall Study|Sponsor Decision|0|||
154840513|NCT03594227|558847723|FG001|Overall Study|Sponsor Decision|0|||
154840514|NCT03594227|558847724|FG002|Overall Study|Sponsor Decision|0|||
154840515|NCT03594227|558847725|FG003|Overall Study|Sponsor Decision|1|||
154840516|NCT03594227|558847722|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
154840517|NCT03594227|558847723|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
154840518|NCT03594227|558847724|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
154840519|NCT03594227|558847725|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
154840520|NCT00790907|558847726|FG000|Overall Study|Adverse Event|9|||
154840521|NCT00790907|558847727|FG001|Overall Study|Adverse Event|7|||
154840522|NCT00790907|558847728|FG002|Overall Study|Adverse Event|6|||
154840523|NCT00790907|558847726|FG000|Overall Study|Physician Decision|304|||
154840524|NCT00790907|558847727|FG001|Overall Study|Physician Decision|271|||
154840525|NCT00790907|558847728|FG002|Overall Study|Physician Decision|255|||
154840526|NCT00790907|558847726|FG000|Overall Study|Withdrawal by Subject|1|||
154840527|NCT00790907|558847727|FG001|Overall Study|Withdrawal by Subject|7|||
154840528|NCT00790907|558847728|FG002|Overall Study|Withdrawal by Subject|5|||
154840529|NCT00790907|558847726|FG000|Overall Study|Bleeding Event|11|||
154840530|NCT00790907|558847727|FG001|Overall Study|Bleeding Event|16|||
154840531|NCT00790907|558847728|FG002|Overall Study|Bleeding Event|21|||
155104654|NCT05588440|559812589|FG000|Overall Study|Screen Fail|0|||
155104655|NCT05588440|559812590|FG001|Overall Study|Screen Fail|1|||
155104656|NCT05588440|559812591|FG002|Overall Study|Screen Fail|1|||
155104657|NCT05588440|559812589|FG000|Overall Study|Withdrawal by Subject|0|||
155104658|NCT05588440|559812590|FG001|Overall Study|Withdrawal by Subject|0|||
155104659|NCT05588440|559812591|FG002|Overall Study|Withdrawal by Subject|1|||
155104660|NCT00100802|559812596|FG000|Overall Study|Adverse Event|9|||
155104661|NCT00100802|559812596|FG000|Overall Study|Death|1|||
154840532|NCT00790907|558847726|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
154840533|NCT00790907|558847727|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
154840534|NCT00790907|558847728|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
154840535|NCT00790907|558847726|FG000|Overall Study|Qualifying Condition Not Present|29|||
154840536|NCT00790907|558847727|FG001|Overall Study|Qualifying Condition Not Present|14|||
154840537|NCT00790907|558847728|FG002|Overall Study|Qualifying Condition Not Present|16|||
154840538|NCT00790907|558847726|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
154840539|NCT00790907|558847727|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
154840540|NCT00790907|558847728|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
154840541|NCT00790907|558847726|FG000|Overall Study|Did Not Receive Study Drug|10|||
154840542|NCT00790907|558847727|FG001|Overall Study|Did Not Receive Study Drug|0|||
154840543|NCT00790907|558847728|FG002|Overall Study|Did Not Receive Study Drug|0|||
154840544|NCT03436862|558847734|FG000|Overall Study|Adverse Event|4|||
154840545|NCT03436862|558847734|FG000|Overall Study|Progressive Disease|2|||
154840546|NCT02054897|558847736|FG000|Overall Study|Withdrawal by Subject|2|||
154840547|NCT02054897|558847737|FG001|Overall Study|Withdrawal by Subject|0|||
154840548|NCT02054897|558847738|FG002|Overall Study|Withdrawal by Subject|2|||
154840549|NCT02054897|558847736|FG000|Overall Study|Missing follow-up information|3|||
154840550|NCT02054897|558847737|FG001|Overall Study|Missing follow-up information|5|||
154840551|NCT02054897|558847738|FG002|Overall Study|Missing follow-up information|3|||
154840552|NCT02054897|558847736|FG000|Overall Study|Lost to Follow-up|4|||
154840553|NCT02054897|558847737|FG001|Overall Study|Lost to Follow-up|2|||
154840554|NCT02054897|558847738|FG002|Overall Study|Lost to Follow-up|7|||
154840555|NCT02054897|558847736|FG000|Overall Study|Randomized but not exposed|1|||
154840556|NCT02054897|558847737|FG001|Overall Study|Randomized but not exposed|0|||
154840557|NCT02054897|558847738|FG002|Overall Study|Randomized but not exposed|0|||
154840558|NCT00960843|558847739|FG000|Overall Study|Lost to Follow-up|2|||
154840559|NCT00960843|558847740|FG001|Overall Study|Lost to Follow-up|0|||
154840560|NCT00960843|558847739|FG000|Overall Study|Protocol Violation|0|||
154840561|NCT00960843|558847740|FG001|Overall Study|Protocol Violation|4|||
154840562|NCT00960843|558847739|FG000|Overall Study|Repeated needle dislodgment|0|||
154840563|NCT00960843|558847740|FG001|Overall Study|Repeated needle dislodgment|1|||
154840564|NCT00652366|558847741|FG000|Overall Study|Adverse Event|8|||
154840565|NCT00652366|558847742|FG001|Overall Study|Adverse Event|4|||
154840566|NCT00652366|558847743|FG002|Overall Study|Adverse Event|7|||
154840567|NCT00652366|558847744|FG003|Overall Study|Adverse Event|17|||
154840568|NCT00652366|558847745|FG004|Overall Study|Adverse Event|13|||
154840569|NCT00652366|558847741|FG000|Overall Study|Death|5|||
154840570|NCT00652366|558847742|FG001|Overall Study|Death|4|||
154840571|NCT00652366|558847743|FG002|Overall Study|Death|1|||
154840572|NCT00652366|558847744|FG003|Overall Study|Death|8|||
154840573|NCT00652366|558847745|FG004|Overall Study|Death|5|||
154840574|NCT00652366|558847741|FG000|Overall Study|Lack of Efficacy|84|||
154840575|NCT00652366|558847742|FG001|Overall Study|Lack of Efficacy|58|||
154840576|NCT00652366|558847743|FG002|Overall Study|Lack of Efficacy|53|||
154840577|NCT00652366|558847744|FG003|Overall Study|Lack of Efficacy|133|||
154840578|NCT00652366|558847745|FG004|Overall Study|Lack of Efficacy|13|||
154840579|NCT00652366|558847741|FG000|Overall Study|Violation of Selection Criteria|0|||
154840580|NCT00652366|558847742|FG001|Overall Study|Violation of Selection Criteria|0|||
154840581|NCT00652366|558847743|FG002|Overall Study|Violation of Selection Criteria|1|||
154840582|NCT00652366|558847744|FG003|Overall Study|Violation of Selection Criteria|0|||
154840583|NCT00652366|558847745|FG004|Overall Study|Violation of Selection Criteria|0|||
154840584|NCT00652366|558847741|FG000|Overall Study|Protocol Violation|1|||
154840585|NCT00652366|558847742|FG001|Overall Study|Protocol Violation|0|||
154840586|NCT00652366|558847743|FG002|Overall Study|Protocol Violation|0|||
154840587|NCT00652366|558847744|FG003|Overall Study|Protocol Violation|0|||
154840588|NCT00652366|558847745|FG004|Overall Study|Protocol Violation|0|||
154840589|NCT00652366|558847741|FG000|Overall Study|Refused treatment|3|||
154840590|NCT00652366|558847742|FG001|Overall Study|Refused treatment|7|||
155104662|NCT00100802|559812596|FG000|Overall Study|Lack of Efficacy|47|||
154840591|NCT00652366|558847743|FG002|Overall Study|Refused treatment|6|||
154840592|NCT00652366|558847744|FG003|Overall Study|Refused treatment|17|||
154840593|NCT00652366|558847745|FG004|Overall Study|Refused treatment|5|||
154840594|NCT00652366|558847741|FG000|Overall Study|Other|5|||
154840595|NCT00652366|558847742|FG001|Overall Study|Other|2|||
154840596|NCT00652366|558847743|FG002|Overall Study|Other|3|||
154840597|NCT00652366|558847744|FG003|Overall Study|Other|4|||
154840598|NCT00652366|558847745|FG004|Overall Study|Other|0|||
154840599|NCT02069899|558847746|FG000|Overall Study|Adverse Event|6|||
155104663|NCT00100802|559812596|FG000|Overall Study|Physician Decision|5|||
154840600|NCT02069899|558847747|FG001|Overall Study|Adverse Event|0|||
154840601|NCT02069899|558847748|FG002|Overall Study|Adverse Event|1|||
154840602|NCT02069899|558847746|FG000|Overall Study|Withdrawal by Participant|2|||
154840603|NCT02069899|558847747|FG001|Overall Study|Withdrawal by Participant|0|||
154840604|NCT02069899|558847748|FG002|Overall Study|Withdrawal by Participant|0|||
154840605|NCT02069899|558847746|FG000|Overall Study|Lost to Follow-up|1|||
154840606|NCT02069899|558847747|FG001|Overall Study|Lost to Follow-up|0|||
154840607|NCT02069899|558847748|FG002|Overall Study|Lost to Follow-up|1|||
154840608|NCT02069899|558847746|FG000|Overall Study|Other|4|||
154840609|NCT02069899|558847747|FG001|Overall Study|Other|0|||
154840610|NCT02069899|558847748|FG002|Overall Study|Other|0|||
154840611|NCT02069899|558847746|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
154840612|NCT02069899|558847747|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
154840613|NCT02069899|558847748|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
154840614|NCT02069899|558847746|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
154840615|NCT02069899|558847747|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
154840616|NCT02069899|558847748|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
154840617|NCT01967537|558847749|FG000|Overall Study|Withdrawal by Subject|52|||
154840618|NCT01967537|558847749|FG000|Overall Study|Refuse treatment|2|||
154840619|NCT01967537|558847749|FG000|Overall Study|Lost to Follow-up|6|||
154840620|NCT04703075|558847750|FG000|Overall Study|Adverse Event|11|||
154840621|NCT04703075|558847751|FG001|Overall Study|Adverse Event|7|||
154840622|NCT04703075|558847750|FG000|Overall Study|Lost to Follow-up|6|||
154840623|NCT04703075|558847751|FG001|Overall Study|Lost to Follow-up|12|||
155104664|NCT00100802|559812596|FG000|Overall Study|Protocol Violation|1|||
155104665|NCT00100802|559812596|FG000|Overall Study|Withdrawal by Subject|5|||
155104666|NCT00100802|559812596|FG000|Overall Study|Ineligible|12|||
154840624|NCT04703075|558847750|FG000|Overall Study|Physician Decision|3|||
154840625|NCT04703075|558847751|FG001|Overall Study|Physician Decision|0|||
154840626|NCT04703075|558847750|FG000|Overall Study|Moved|0|||
154840627|NCT04703075|558847751|FG001|Overall Study|Moved|2|||
154840628|NCT04703075|558847750|FG000|Overall Study|Index INH Resistant|0|||
154840629|NCT04703075|558847751|FG001|Overall Study|Index INH Resistant|1|||
154840630|NCT04703075|558847750|FG000|Overall Study|Lack of Efficacy|6|||
154840631|NCT04703075|558847751|FG001|Overall Study|Lack of Efficacy|18|||
154840632|NCT00550680|558847754|FG000|Overall Study|Administrative Reasons|1|||
154840633|NCT00550680|558847754|FG000|Overall Study|Adverse Event|5|||
154840634|NCT00550680|558847754|FG000|Overall Study|Death|3|||
154840635|NCT00550680|558847754|FG000|Overall Study|Early Improvement|1|||
154840636|NCT00550680|558847754|FG000|Overall Study|Lost to Follow-up|3|||
154840637|NCT00550680|558847754|FG000|Overall Study|Lack of Efficacy|1|||
154840638|NCT00550680|558847754|FG000|Overall Study|Other|10|||
154840639|NCT00550680|558847754|FG000|Overall Study|Protocol Violation|7|||
154840640|NCT00550680|558847754|FG000|Overall Study|Refused Treatment|19|||
154840641|NCT00550680|558847754|FG000|Overall Study|Screen Failure|6|||
154840642|NCT01119248|558847755|FG000|Overall Study|Physician Decision|5|||
154840643|NCT01967550|558847756|FG000|Overall Study|Withdrawal by Subject|1|||
154840644|NCT01967550|558847757|FG001|Overall Study|Withdrawal by Subject|0|||
154840645|NCT01967550|558847756|FG000|Overall Study|Adverse Event|2|||
154840646|NCT01967550|558847757|FG001|Overall Study|Adverse Event|0|||
154840647|NCT01967550|558847756|FG000|Overall Study|Protocol Violation|2|||
154840648|NCT01967550|558847757|FG001|Overall Study|Protocol Violation|1|||
154840649|NCT01967550|558847756|FG000|Overall Study|Non Compliance|0|||
154840650|NCT01967550|558847757|FG001|Overall Study|Non Compliance|1|||
154840651|NCT00250835|558847758|FG000|Overall Study|Withdrawal by Subject|1|||
154840652|NCT01836783|558847762|FG000|Overall Study|Withdrawal by Subject|0|||
154840653|NCT01836783|558847763|FG001|Overall Study|Withdrawal by Subject|2|||
154840654|NCT01100437|558847764|FG000|Titration/Stabilization|Adverse Event|0|||
155104667|NCT02709720|559812597|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
154840655|NCT01100437|558847765|FG001|Titration/Stabilization|Adverse Event|0|||
154840656|NCT01100437|558847766|FG002|Titration/Stabilization|Adverse Event|4|||
154840657|NCT01100437|558847764|FG000|Titration/Stabilization|Non-compliance|0|||
154840658|NCT01100437|558847765|FG001|Titration/Stabilization|Non-compliance|0|||
154840659|NCT01100437|558847766|FG002|Titration/Stabilization|Non-compliance|1|||
154840660|NCT01100437|558847764|FG000|Titration/Stabilization|Sponsor canceled study|0|||
155104668|NCT02709720|559812597|FG000|Overall Study|Protocol Violation|1|||
155104669|NCT02709720|559812597|FG000|Overall Study|Not take study medication|1|||
154840661|NCT01100437|558847765|FG001|Titration/Stabilization|Sponsor canceled study|0|||
154840662|NCT01100437|558847766|FG002|Titration/Stabilization|Sponsor canceled study|1|||
154840663|NCT01100437|558847764|FG000|Maintenance|Withdrawal by Subject|0|||
154840664|NCT01100437|558847765|FG001|Maintenance|Withdrawal by Subject|0|||
155104670|NCT00928187|559812608|FG000|Overall Study|Death|1|||
155104671|NCT00928187|559812609|FG001|Overall Study|Death|2|||
155104672|NCT00928187|559812610|FG002|Overall Study|Death|3|||
154840665|NCT01100437|558847766|FG002|Maintenance|Withdrawal by Subject|1|||
154840666|NCT01100437|558847764|FG000|Maintenance|Sponsor termination of study|0|||
154840667|NCT01100437|558847765|FG001|Maintenance|Sponsor termination of study|0|||
154840668|NCT01100437|558847766|FG002|Maintenance|Sponsor termination of study|1|||
154840669|NCT04099251|558849060|FG000|Pre-Treatment|Other reasons|1|||
154840670|NCT04099251|558849061|FG001|Pre-Treatment|Other reasons|0|||
154840671|NCT04099251|558849060|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
154840672|NCT04099251|558849061|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
154840673|NCT04099251|558849060|FG000|Blinded Treatment Phase|Other reasons|16|||
154840674|NCT04099251|558849061|FG001|Blinded Treatment Phase|Other reasons|7|||
154840675|NCT04099251|558849060|FG000|Blinded Treatment Phase|Disease recurrence|26|||
154840676|NCT04099251|558849061|FG001|Blinded Treatment Phase|Disease recurrence|41|||
154840677|NCT04099251|558849060|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
154840678|NCT04099251|558849061|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
154840679|NCT04099251|558849060|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
154840680|NCT04099251|558849061|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
154840681|NCT04099251|558849060|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
154840682|NCT04099251|558849061|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
154840683|NCT04099251|558849060|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
154840684|NCT04099251|558849061|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
154840685|NCT04099251|558849060|FG000|Blinded Treatment Phase|Death|6|||
154840686|NCT04099251|558849061|FG001|Blinded Treatment Phase|Death|2|||
154840687|NCT04099251|558849060|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
154840688|NCT04099251|558849061|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
154840689|NCT04099251|558849060|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
154840690|NCT04099251|558849061|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
154840691|NCT04099251|558849060|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
154840692|NCT04099251|558849061|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
154840693|NCT04099251|558849060|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
154840694|NCT04099251|558849061|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
154840695|NCT04099251|558849060|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
154840696|NCT04099251|558849061|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
154840697|NCT04099251|558849060|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
154840698|NCT04099251|558849061|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
154840699|NCT04099251|558849060|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
154840700|NCT04099251|558849061|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
154840701|NCT04099251|558849060|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
154840702|NCT04099251|558849061|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
154840703|NCT04099251|558849060|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
154840704|NCT04099251|558849061|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
154840705|NCT00621504|558849068|FG000|Overall Study|Adverse Event|1|||
155104673|NCT00928187|559812608|FG000|Overall Study|Lost to Follow-up|1|||
155104674|NCT00928187|559812609|FG001|Overall Study|Lost to Follow-up|2|||
155104675|NCT00928187|559812610|FG002|Overall Study|Lost to Follow-up|1|||
155104676|NCT00928187|559812608|FG000|Overall Study|Withdrawal by Subject|0|||
155104677|NCT00928187|559812609|FG001|Overall Study|Withdrawal by Subject|1|||
155104678|NCT00928187|559812610|FG002|Overall Study|Withdrawal by Subject|1|||
155104679|NCT00928187|559812608|FG000|Overall Study|Protocol Violation|0|||
155104680|NCT00928187|559812609|FG001|Overall Study|Protocol Violation|1|||
155173524|NCT03472547|560073358|FG000|Overall Study|Withdrawal by Subject|30|||
154840706|NCT00621504|558849069|FG001|Overall Study|Adverse Event|3|||
154840707|NCT00621504|558849068|FG000|Overall Study|At the request of sponsor/investigator|1|||
154840708|NCT00621504|558849069|FG001|Overall Study|At the request of sponsor/investigator|0|||
154840709|NCT00621504|558849068|FG000|Overall Study|Withdrew consent|9|||
154840710|NCT00621504|558849069|FG001|Overall Study|Withdrew consent|6|||
154840711|NCT00621504|558849068|FG000|Overall Study|Lost to Follow-up|8|||
154840712|NCT00621504|558849069|FG001|Overall Study|Lost to Follow-up|10|||
155173525|NCT02043899|560074803|FG000|Overall Study|Adverse Event|3|||
154840713|NCT00621504|558849068|FG000|Overall Study|Other|1|||
154840714|NCT00621504|558849069|FG001|Overall Study|Other|0|||
154840715|NCT00621504|558849068|FG000|Overall Study|Death|6|||
154840716|NCT00621504|558849069|FG001|Overall Study|Death|6|||
154840717|NCT00706134|558849071|FG000|Overall Study|Adverse Event|8|||
154840718|NCT00706134|558849072|FG001|Overall Study|Adverse Event|7|||
154840719|NCT00706134|558849073|FG002|Overall Study|Adverse Event|2|||
154840720|NCT00706134|558849074|FG003|Overall Study|Adverse Event|3|||
154840721|NCT00706134|558849071|FG000|Overall Study|Lost to Follow-up|0|||
154840722|NCT00706134|558849072|FG001|Overall Study|Lost to Follow-up|1|||
154840723|NCT00706134|558849073|FG002|Overall Study|Lost to Follow-up|0|||
155104681|NCT00928187|559812610|FG002|Overall Study|Protocol Violation|0|||
155104682|NCT02524145|559812611|FG000|Overall Study|Withdrawal by Subject|2|||
155104683|NCT02524145|559812612|FG001|Overall Study|Withdrawal by Subject|2|||
154840724|NCT00706134|558849074|FG003|Overall Study|Lost to Follow-up|0|||
154840725|NCT00706134|558849071|FG000|Overall Study|Protocol Violation|0|||
154840726|NCT00706134|558849072|FG001|Overall Study|Protocol Violation|6|||
154840727|NCT00706134|558849073|FG002|Overall Study|Protocol Violation|0|||
154840728|NCT00706134|558849074|FG003|Overall Study|Protocol Violation|3|||
154840729|NCT00706134|558849071|FG000|Overall Study|Withdrawal by Subject|1|||
154840730|NCT00706134|558849072|FG001|Overall Study|Withdrawal by Subject|2|||
154840731|NCT00706134|558849073|FG002|Overall Study|Withdrawal by Subject|1|||
154840732|NCT00706134|558849074|FG003|Overall Study|Withdrawal by Subject|0|||
154840733|NCT00706134|558849071|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
154840734|NCT00706134|558849072|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
154840735|NCT00706134|558849073|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
154840736|NCT00706134|558849074|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
154840737|NCT00706134|558849071|FG000|Overall Study|Did not meet study criteria|2|||
154840738|NCT00706134|558849072|FG001|Overall Study|Did not meet study criteria|0|||
154840739|NCT00706134|558849073|FG002|Overall Study|Did not meet study criteria|0|||
154840740|NCT00706134|558849074|FG003|Overall Study|Did not meet study criteria|0|||
154840741|NCT00264004|558849076|FG000|Overall Study|Adverse Event|2|||
154840742|NCT00264004|558849077|FG001|Overall Study|Adverse Event|3|||
154840743|NCT00264004|558849078|FG002|Overall Study|Adverse Event|6|||
154840744|NCT00264004|558849079|FG003|Overall Study|Adverse Event|4|||
154840745|NCT00264004|558849076|FG000|Overall Study|Withdrawal by Subject|0|||
154840746|NCT00264004|558849077|FG001|Overall Study|Withdrawal by Subject|1|||
154840747|NCT00264004|558849078|FG002|Overall Study|Withdrawal by Subject|2|||
154840748|NCT00264004|558849079|FG003|Overall Study|Withdrawal by Subject|2|||
154840749|NCT00264004|558849076|FG000|Overall Study|Other|2|||
154840750|NCT00264004|558849077|FG001|Overall Study|Other|2|||
154840751|NCT00264004|558849078|FG002|Overall Study|Other|0|||
154840752|NCT00264004|558849079|FG003|Overall Study|Other|3|||
154840753|NCT00264004|558849076|FG000|Overall Study|Development study specific disc. crit.|1|||
154840754|NCT00264004|558849077|FG001|Overall Study|Development study specific disc. crit.|0|||
154840755|NCT00264004|558849078|FG002|Overall Study|Development study specific disc. crit.|1|||
154840756|NCT00264004|558849079|FG003|Overall Study|Development study specific disc. crit.|0|||
154840757|NCT00264004|558849076|FG000|Overall Study|Cond. under inv. worsened|9|||
154840758|NCT00264004|558849077|FG001|Overall Study|Cond. under inv. worsened|5|||
154840759|NCT00264004|558849078|FG002|Overall Study|Cond. under inv. worsened|3|||
154840760|NCT00264004|558849079|FG003|Overall Study|Cond. under inv. worsened|4|||
154840761|NCT00264004|558849076|FG000|Overall Study|Not treated|3|||
154840762|NCT00264004|558849077|FG001|Overall Study|Not treated|0|||
154840763|NCT00264004|558849078|FG002|Overall Study|Not treated|2|||
154840764|NCT00264004|558849079|FG003|Overall Study|Not treated|2|||
154840765|NCT03691974|558849080|FG000|Overall Study|Physician Decision|1|||
154840766|NCT03691974|558849081|FG001|Overall Study|Physician Decision|0|||
154840767|NCT03691974|558849080|FG000|Overall Study|Adverse Event|1|||
154840768|NCT03691974|558849081|FG001|Overall Study|Adverse Event|0|||
154840769|NCT03691974|558849080|FG000|Overall Study|Withdrawal by Subject|11|||
154840770|NCT03691974|558849081|FG001|Overall Study|Withdrawal by Subject|9|||
154840771|NCT03691974|558849080|FG000|Overall Study|Protocol Violation|1|||
154840772|NCT03691974|558849081|FG001|Overall Study|Protocol Violation|0|||
154840773|NCT03691974|558849080|FG000|Overall Study|Lost to Follow-up|8|||
154840774|NCT03691974|558849081|FG001|Overall Study|Lost to Follow-up|7|||
154840775|NCT00691483|558849082|FG000|Overall Study|Adverse Event|14|||
154840776|NCT00691483|558849083|FG001|Overall Study|Adverse Event|6|||
154840777|NCT00691483|558849082|FG000|Overall Study|Lost to Follow-up|17|||
154840778|NCT00691483|558849083|FG001|Overall Study|Lost to Follow-up|10|||
154840779|NCT00691483|558849082|FG000|Overall Study|Withdrawal by Subject|24|||
154840780|NCT00691483|558849083|FG001|Overall Study|Withdrawal by Subject|7|||
154840781|NCT00691483|558849082|FG000|Overall Study|Other known cause|6|||
154840782|NCT00691483|558849083|FG001|Overall Study|Other known cause|1|||
154840783|NCT00691483|558849082|FG000|Overall Study|Randomized by not treated|7|||
154840784|NCT00691483|558849083|FG001|Overall Study|Randomized by not treated|1|||
154840785|NCT00746252|558849084|FG000|Overall Study|weight gain >7.5 %|1|||
154840786|NCT00746252|558849085|FG001|Overall Study|weight gain >7.5 %|2|||
154840787|NCT01391000|558849087|FG000|Overall Study|Lost to Follow-up|2|||
154840788|NCT01391000|558849088|FG001|Overall Study|Lost to Follow-up|0|||
154840789|NCT00082888|558849089|FG000|Overall Study|Ineligible|1|||
155104684|NCT02524145|559812613|FG002|Overall Study|Withdrawal by Subject|3|||
155104685|NCT01961297|559813829|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
155104686|NCT01961297|559813830|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
154840790|NCT00082888|558849090|FG001|Overall Study|Ineligible|0|||
154840791|NCT00082888|558849091|FG002|Overall Study|Ineligible|0|||
154840792|NCT03860961|558849092|FG000|Overall Study|Withdrawal by Subject|6|||
154840793|NCT03860961|558849093|FG001|Overall Study|Withdrawal by Subject|11|||
154840794|NCT03860961|558849092|FG000|Overall Study|Death|10|||
154840795|NCT03860961|558849093|FG001|Overall Study|Death|6|||
154840796|NCT03860961|558849092|FG000|Overall Study|Incomplete two-year data|4|||
154840797|NCT03860961|558849093|FG001|Overall Study|Incomplete two-year data|0|||
154840798|NCT00272038|558849094|FG000|Overall Study|withdrew before they received 2 cycles|7|||
154840799|NCT03189446|558849095|FG000|Overall Study|Adverse Event|2|||
154840800|NCT03189446|558849095|FG000|Overall Study|Withdrawal by Subject|2|||
154840801|NCT03189446|558849095|FG000|Overall Study|Physician Decision|1|||
154840802|NCT00527605|558849096|FG000|Overall Study|Adverse Event|3|||
154840803|NCT00527605|558849097|FG001|Overall Study|Adverse Event|0|||
154840804|NCT00527605|558849096|FG000|Overall Study|Withdrawal by Subject|3|||
154840805|NCT00527605|558849097|FG001|Overall Study|Withdrawal by Subject|7|||
154840806|NCT00527605|558849096|FG000|Overall Study|Lost to Follow-up|6|||
154840807|NCT00527605|558849097|FG001|Overall Study|Lost to Follow-up|2|||
154840808|NCT00527605|558849096|FG000|Overall Study|Protocol Violation|1|||
154840809|NCT00527605|558849097|FG001|Overall Study|Protocol Violation|2|||
154840810|NCT04312009|558849101|FG000|Overall Study|Withdrawal by Subject|2|||
154840811|NCT04312009|558849102|FG001|Overall Study|Withdrawal by Subject|1|||
154840812|NCT01268293|558849104|FG000|Overall Study|Disease progression|7|||
154840813|NCT01268293|558849104|FG000|Overall Study|Adverse Event|1|||
154840814|NCT01268293|558849104|FG000|Overall Study|Subject choice|1|||
154840815|NCT03468309|558849105|FG000|Overall Study|Lost to Follow-up|4|||
154840816|NCT03468309|558849105|FG000|Overall Study|Withdrawal by Subject|2|||
154840817|NCT03548558|558849107|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
154840818|NCT03548558|558849108|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
154840819|NCT03548558|558849109|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
154840820|NCT03548558|558849110|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
154840821|NCT03548558|558849111|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
154840822|NCT03548558|558849112|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
154840823|NCT03548558|558849113|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
154840824|NCT03548558|558849107|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
154840825|NCT03548558|558849108|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
154840826|NCT03548558|558849109|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
154840827|NCT03548558|558849110|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
154840828|NCT03548558|558849111|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
154840829|NCT03548558|558849112|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
154840830|NCT03548558|558849113|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
154840831|NCT03548558|558849107|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
154840832|NCT03548558|558849108|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
154840833|NCT03548558|558849109|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
154840834|NCT03548558|558849110|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
154840835|NCT03548558|558849111|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
154840836|NCT03548558|558849112|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
154840837|NCT03548558|558849113|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
154840838|NCT03548558|558849107|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
154840839|NCT03548558|558849108|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
154840840|NCT03548558|558849109|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
154840841|NCT03548558|558849110|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
154840842|NCT03548558|558849111|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
154840843|NCT03548558|558849112|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
154840844|NCT03548558|558849113|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
154840845|NCT03548558|558849107|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
154840846|NCT03548558|558849108|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
154840847|NCT03548558|558849109|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
154840848|NCT03548558|558849110|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
154840849|NCT03548558|558849111|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
154840850|NCT03548558|558849112|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
154840851|NCT03548558|558849113|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
154840852|NCT03548558|558849107|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
154840853|NCT03548558|558849108|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
154840854|NCT03548558|558849109|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
154840855|NCT03548558|558849110|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
154840856|NCT03548558|558849111|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
154840857|NCT03548558|558849112|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
154840858|NCT03548558|558849113|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
154840859|NCT03509350|558849115|FG000|Overall Study|Withdrawal by Subject|0|||
154840860|NCT03509350|558849116|FG001|Overall Study|Withdrawal by Subject|2|||
154840861|NCT00797732|558849119|FG000|Overall Study|Withdrawal by Subject|3|||
154840862|NCT00797732|558849120|FG001|Overall Study|Withdrawal by Subject|3|||
154840863|NCT00797732|558849121|FG002|Overall Study|Withdrawal by Subject|0|||
154840864|NCT00797732|558849119|FG000|Overall Study|Lost to Follow-up|1|||
155104687|NCT02482298|559813831|FG000|Overall Study|Withdrawal by Subject|2|||
154840865|NCT00797732|558849120|FG001|Overall Study|Lost to Follow-up|0|||
154840866|NCT00797732|558849121|FG002|Overall Study|Lost to Follow-up|0|||
154840867|NCT00797732|558849119|FG000|Overall Study|Death|1|||
154840868|NCT00797732|558849120|FG001|Overall Study|Death|0|||
155104688|NCT02482298|559813832|FG001|Overall Study|Withdrawal by Subject|1|||
154840869|NCT00797732|558849121|FG002|Overall Study|Death|0|||
154840870|NCT00797732|558849119|FG000|Overall Study|Not meet inclusion criteria|0|||
154840871|NCT00797732|558849120|FG001|Overall Study|Not meet inclusion criteria|0|||
154840872|NCT00797732|558849121|FG002|Overall Study|Not meet inclusion criteria|7|||
154840873|NCT00797732|558849119|FG000|Overall Study|Excluded due to time constraints|0|||
154840874|NCT00797732|558849120|FG001|Overall Study|Excluded due to time constraints|0|||
154840875|NCT00797732|558849121|FG002|Overall Study|Excluded due to time constraints|24|||
154840876|NCT00797732|558849119|FG000|Overall Study|Refused to Participate|0|||
154840877|NCT00797732|558849120|FG001|Overall Study|Refused to Participate|0|||
154840878|NCT00797732|558849121|FG002|Overall Study|Refused to Participate|123|||
154840879|NCT01857869|558849122|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
154840880|NCT01857869|558849123|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
154840881|NCT01857869|558849124|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
154840882|NCT01857869|558849125|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
154840883|NCT01857869|558849126|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
154840884|NCT01857869|558849127|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
154840885|NCT01857869|558849128|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
154840886|NCT01857869|558849129|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
154840887|NCT01857869|558849130|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
154840888|NCT01857869|558849131|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
154840889|NCT01857869|558849122|FG000|Primary/Challenge Phase|Pregnancy|1|||
154840890|NCT01857869|558849123|FG001|Primary/Challenge Phase|Pregnancy|0|||
154840891|NCT01857869|558849124|FG002|Primary/Challenge Phase|Pregnancy|0|||
154840892|NCT01857869|558849125|FG003|Primary/Challenge Phase|Pregnancy|0|||
154840893|NCT01857869|558849126|FG004|Primary/Challenge Phase|Pregnancy|0|||
154840894|NCT01857869|558849127|FG005|Primary/Challenge Phase|Pregnancy|0|||
154840895|NCT01857869|558849128|FG006|Primary/Challenge Phase|Pregnancy|0|||
154840896|NCT01857869|558849129|FG007|Primary/Challenge Phase|Pregnancy|0|||
154840897|NCT01857869|558849130|FG008|Primary/Challenge Phase|Pregnancy|0|||
154840898|NCT01857869|558849131|FG009|Primary/Challenge Phase|Pregnancy|0|||
154840899|NCT01857869|558849122|FG000|Primary/Challenge Phase|Protocol Violation|1|||
154840900|NCT01857869|558849123|FG001|Primary/Challenge Phase|Protocol Violation|0|||
154840901|NCT01857869|558849124|FG002|Primary/Challenge Phase|Protocol Violation|0|||
154840902|NCT01857869|558849125|FG003|Primary/Challenge Phase|Protocol Violation|0|||
154840903|NCT01857869|558849126|FG004|Primary/Challenge Phase|Protocol Violation|0|||
154840904|NCT01857869|558849127|FG005|Primary/Challenge Phase|Protocol Violation|0|||
154840905|NCT01857869|558849128|FG006|Primary/Challenge Phase|Protocol Violation|0|||
154840906|NCT01857869|558849129|FG007|Primary/Challenge Phase|Protocol Violation|0|||
154840907|NCT01857869|558849130|FG008|Primary/Challenge Phase|Protocol Violation|0|||
154840908|NCT01857869|558849131|FG009|Primary/Challenge Phase|Protocol Violation|0|||
154840909|NCT01857869|558849122|FG000|Primary/Challenge Phase|Other|1|||
154840910|NCT01857869|558849123|FG001|Primary/Challenge Phase|Other|1|||
154840911|NCT01857869|558849124|FG002|Primary/Challenge Phase|Other|0|||
154840912|NCT01857869|558849125|FG003|Primary/Challenge Phase|Other|0|||
154840913|NCT01857869|558849126|FG004|Primary/Challenge Phase|Other|0|||
154840914|NCT01857869|558849127|FG005|Primary/Challenge Phase|Other|0|||
154840915|NCT01857869|558849128|FG006|Primary/Challenge Phase|Other|0|||
154840916|NCT01857869|558849129|FG007|Primary/Challenge Phase|Other|0|||
154840917|NCT01857869|558849130|FG008|Primary/Challenge Phase|Other|0|||
154840918|NCT01857869|558849131|FG009|Primary/Challenge Phase|Other|0|||
154840919|NCT01857869|558849122|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840920|NCT01857869|558849123|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840921|NCT01857869|558849124|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840922|NCT01857869|558849125|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
154840923|NCT01857869|558849126|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840924|NCT01857869|558849127|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840925|NCT01857869|558849128|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840926|NCT01857869|558849129|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840927|NCT01857869|558849130|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840928|NCT01857869|558849131|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
154840929|NCT01857869|558849122|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840930|NCT01857869|558849123|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155104689|NCT02482298|559813833|FG002|Overall Study|Withdrawal by Subject|2|||
154840931|NCT01857869|558849124|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840932|NCT01857869|558849125|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
154840933|NCT01857869|558849126|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840934|NCT01857869|558849127|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840935|NCT01857869|558849128|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
155104690|NCT02482298|559813831|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
154840936|NCT01857869|558849129|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840937|NCT01857869|558849130|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840938|NCT01857869|558849131|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
154840939|NCT02199080|558849135|FG000|Overall Study|Protocol Violation|12|||
155104691|NCT02482298|559813832|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
154840940|NCT02443883|558849136|FG000|Overall Study|Adverse Event|0|||
154840941|NCT02443883|558849137|FG001|Overall Study|Adverse Event|1|||
154840942|NCT02443883|558849138|FG002|Overall Study|Adverse Event|0|||
154840943|NCT02443883|558849139|FG003|Overall Study|Adverse Event|0|||
154840944|NCT02443883|558849136|FG000|Overall Study|Lost to Follow-up|3|||
154840945|NCT02443883|558849137|FG001|Overall Study|Lost to Follow-up|2|||
154840946|NCT02443883|558849138|FG002|Overall Study|Lost to Follow-up|1|||
154840947|NCT02443883|558849139|FG003|Overall Study|Lost to Follow-up|0|||
154840948|NCT02443883|558849136|FG000|Overall Study|Physician Decision|1|||
154840949|NCT02443883|558849137|FG001|Overall Study|Physician Decision|1|||
154840950|NCT02443883|558849138|FG002|Overall Study|Physician Decision|0|||
154840951|NCT02443883|558849139|FG003|Overall Study|Physician Decision|3|||
154840952|NCT02443883|558849136|FG000|Overall Study|Withdrawal by Subject|1|||
154840953|NCT02443883|558849137|FG001|Overall Study|Withdrawal by Subject|0|||
154840954|NCT02443883|558849138|FG002|Overall Study|Withdrawal by Subject|0|||
154840955|NCT02443883|558849139|FG003|Overall Study|Withdrawal by Subject|2|||
154840956|NCT02443883|558849136|FG000|Overall Study|Randomized, but never treated|1|||
154840957|NCT02443883|558849137|FG001|Overall Study|Randomized, but never treated|0|||
154840958|NCT02443883|558849138|FG002|Overall Study|Randomized, but never treated|0|||
154840959|NCT02443883|558849139|FG003|Overall Study|Randomized, but never treated|0|||
154840960|NCT02937818|558849144|FG000|Overall Study|Participants decision|2|||
154840961|NCT02937818|558849145|FG001|Overall Study|Participants decision|1|||
154840962|NCT02937818|558849146|FG002|Overall Study|Participants decision|1|||
154840963|NCT02937818|558849147|FG003|Overall Study|Participants decision|1|||
154840964|NCT02937818|558849144|FG000|Overall Study|Adverse Event|2|||
154840965|NCT02937818|558849145|FG001|Overall Study|Adverse Event|4|||
154840966|NCT02937818|558849146|FG002|Overall Study|Adverse Event|1|||
154840967|NCT02937818|558849147|FG003|Overall Study|Adverse Event|1|||
154840968|NCT02937818|558849144|FG000|Overall Study|Disease progression|17|||
154840969|NCT02937818|558849145|FG001|Overall Study|Disease progression|15|||
154840970|NCT02937818|558849146|FG002|Overall Study|Disease progression|7|||
154840971|NCT02937818|558849147|FG003|Overall Study|Disease progression|19|||
154840972|NCT02937818|558849144|FG000|Overall Study|Condition under investigation worsened|0|||
154840973|NCT02937818|558849145|FG001|Overall Study|Condition under investigation worsened|0|||
154840974|NCT02937818|558849146|FG002|Overall Study|Condition under investigation worsened|1|||
154840975|NCT02937818|558849147|FG003|Overall Study|Condition under investigation worsened|0|||
154840976|NCT02873936|558849150|FG000|Overall Study|Withdrew Consent|4|||
154840977|NCT02873936|558849151|FG001|Overall Study|Withdrew Consent|11|||
154840978|NCT02873936|558849152|FG002|Overall Study|Withdrew Consent|20|||
154840979|NCT02873936|558849150|FG000|Overall Study|Investigator's Discretion|3|||
154840980|NCT02873936|558849151|FG001|Overall Study|Investigator's Discretion|5|||
154840981|NCT02873936|558849152|FG002|Overall Study|Investigator's Discretion|4|||
154840982|NCT02873936|558849150|FG000|Overall Study|Adverse Event|3|||
154840983|NCT02873936|558849151|FG001|Overall Study|Adverse Event|5|||
154840984|NCT02873936|558849152|FG002|Overall Study|Adverse Event|3|||
154840985|NCT02873936|558849150|FG000|Overall Study|Protocol Violation|0|||
154840986|NCT02873936|558849151|FG001|Overall Study|Protocol Violation|1|||
154840987|NCT02873936|558849152|FG002|Overall Study|Protocol Violation|3|||
154840988|NCT02873936|558849150|FG000|Overall Study|Lost to Follow-up|1|||
154840989|NCT02873936|558849151|FG001|Overall Study|Lost to Follow-up|1|||
154840990|NCT02873936|558849152|FG002|Overall Study|Lost to Follow-up|1|||
154840991|NCT02873936|558849150|FG000|Overall Study|Non-compliance With Study Drug|1|||
154840992|NCT02873936|558849151|FG001|Overall Study|Non-compliance With Study Drug|0|||
154840993|NCT02873936|558849152|FG002|Overall Study|Non-compliance With Study Drug|1|||
154840994|NCT02873936|558849150|FG000|Overall Study|Randomized but not Dosed|1|||
154840995|NCT02873936|558849151|FG001|Overall Study|Randomized but not Dosed|0|||
154840996|NCT02873936|558849152|FG002|Overall Study|Randomized but not Dosed|0|||
154840997|NCT00490451|558849153|FG000|Overall Study|Adverse Event|3|||
154840998|NCT00490451|558849154|FG001|Overall Study|Adverse Event|3|||
154840999|NCT00490451|558849153|FG000|Overall Study|Death|3|||
155104692|NCT02482298|559813833|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
155104693|NCT02482298|559813831|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
154841000|NCT00490451|558849154|FG001|Overall Study|Death|1|||
154841001|NCT00490451|558849153|FG000|Overall Study|Withdrawal by Subject|2|||
154841002|NCT00490451|558849154|FG001|Overall Study|Withdrawal by Subject|0|||
155104694|NCT02482298|559813832|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
155104695|NCT02482298|559813833|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
154841003|NCT00490451|558849153|FG000|Overall Study|Investigator Decision|1|||
154841004|NCT00490451|558849154|FG001|Overall Study|Investigator Decision|0|||
154841005|NCT00490451|558849153|FG000|Overall Study|Protocol Violation|1|||
154841006|NCT00490451|558849154|FG001|Overall Study|Protocol Violation|0|||
154841007|NCT00490451|558849153|FG000|Overall Study|Progressive Disease|53|||
154841008|NCT00490451|558849154|FG001|Overall Study|Progressive Disease|34|||
154841009|NCT00254501|558849157|FG000|Overall Study|Lost to Follow-up|1|||
154841010|NCT00254501|558849158|FG001|Overall Study|Lost to Follow-up|1|||
154841011|NCT01508702|558849163|FG000|Overall Study|Adverse Event|7|||
155104696|NCT02482298|559813831|FG000|Overall Study|Lost to Follow-up|0|||
155104697|NCT02482298|559813832|FG001|Overall Study|Lost to Follow-up|1|||
154841012|NCT01508702|558849164|FG001|Overall Study|Adverse Event|3|||
154841013|NCT01508702|558849163|FG000|Overall Study|Gout flare|2|||
154841014|NCT01508702|558849164|FG001|Overall Study|Gout flare|0|||
154841015|NCT01508702|558849163|FG000|Overall Study|Protocol Violation|2|||
154841016|NCT01508702|558849164|FG001|Overall Study|Protocol Violation|1|||
154841017|NCT01508702|558849163|FG000|Overall Study|Lost to Follow-up|1|||
154841018|NCT01508702|558849164|FG001|Overall Study|Lost to Follow-up|2|||
154841019|NCT01508702|558849163|FG000|Overall Study|Withdrawal by Subject|11|||
154841020|NCT01508702|558849164|FG001|Overall Study|Withdrawal by Subject|7|||
154841021|NCT03861559|558849165|FG000|Overall Study|Adverse Event|0|||
154841022|NCT03861559|558849166|FG001|Overall Study|Adverse Event|2|||
154841023|NCT03861559|558849165|FG000|Overall Study|Treatment failure|0|||
154841024|NCT03861559|558849166|FG001|Overall Study|Treatment failure|2|||
154841025|NCT03861559|558849165|FG000|Overall Study|Noncompliance|1|||
154841026|NCT03861559|558849166|FG001|Overall Study|Noncompliance|1|||
154841027|NCT03861559|558849165|FG000|Overall Study|Did not meet eligibility requirements|1|||
154841028|NCT03861559|558849166|FG001|Overall Study|Did not meet eligibility requirements|0|||
154841029|NCT00879697|558849169|FG000|Overall Study|Physician Decision|2|||
154841030|NCT00879697|558849170|FG001|Overall Study|Physician Decision|2|||
154841031|NCT02500121|558849171|FG000|Overall Study|Lost to Follow-up|0|||
154841032|NCT02500121|558849172|FG001|Overall Study|Lost to Follow-up|1|||
154841033|NCT02500121|558849171|FG000|Overall Study|Withdrawal by Subject|1|||
154841034|NCT02500121|558849172|FG001|Overall Study|Withdrawal by Subject|1|||
154841035|NCT02500121|558849171|FG000|Overall Study|Death|26|||
154841036|NCT02500121|558849172|FG001|Overall Study|Death|24|||
154841037|NCT02124564|558849176|FG000|Treatment Period|Adverse Event|2|||
154841038|NCT02124564|558849176|FG000|Treatment Period|Lack of Efficacy|3|||
154841039|NCT02124564|558849176|FG000|Treatment Period|Withdrawal by Subject|2|||
154841040|NCT04489888|558849177|FG000|Overall Study|Death|75|||
154841041|NCT04489888|558849177|FG000|Overall Study|Sponsor Decision|26|||
154841042|NCT03829657|558849185|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
154841043|NCT03829657|558849186|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
154841044|NCT03829657|558849187|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
154841045|NCT03829657|558849188|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
154841046|NCT03829657|558849189|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
154841047|NCT03829657|558849185|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
154841048|NCT03829657|558849186|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
154841049|NCT03829657|558849187|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
154841050|NCT03829657|558849188|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
154841051|NCT03829657|558849189|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
154841052|NCT03829657|558849185|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
154841053|NCT03829657|558849186|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
154841054|NCT03829657|558849187|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
154841055|NCT03829657|558849188|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
154841056|NCT03829657|558849189|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
154841057|NCT03829657|558849185|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
154841058|NCT03829657|558849186|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
154841059|NCT03829657|558849187|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
154841060|NCT03829657|558849188|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
154841061|NCT03829657|558849189|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
154841062|NCT03829657|558849185|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
154841063|NCT03829657|558849186|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
154841064|NCT03829657|558849187|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
154841065|NCT03829657|558849188|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
154841066|NCT03829657|558849189|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
154841067|NCT03829657|558849185|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
154841068|NCT03829657|558849186|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
154841069|NCT03829657|558849187|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
154841070|NCT03829657|558849188|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
154841071|NCT03829657|558849189|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
154841072|NCT03829657|558849185|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
154841073|NCT03829657|558849186|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
155104698|NCT02482298|559813833|FG002|Overall Study|Lost to Follow-up|0|||
154841074|NCT03829657|558849187|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
154841075|NCT03829657|558849188|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
154971096|NCT02832167|559318529|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
154971097|NCT02832167|559318529|FG000|Treatment Period 2|Disease progression|69|||
155104699|NCT03053440|559813838|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
155104700|NCT03053440|559813839|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
155104701|NCT03053440|559813838|FG000|Overall Study|Death|18|||
155104702|NCT03053440|559813839|FG001|Overall Study|Death|14|||
155104703|NCT03053440|559813838|FG000|Overall Study|Withdrawal by Subject|9|||
155104704|NCT03053440|559813839|FG001|Overall Study|Withdrawal by Subject|8|||
155104705|NCT03053440|559813838|FG000|Overall Study|Lost to Follow-up|1|||
155104706|NCT03053440|559813839|FG001|Overall Study|Lost to Follow-up|0|||
154841076|NCT03829657|558849189|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
154841077|NCT03829657|558849185|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
154841078|NCT03829657|558849186|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
154841079|NCT03829657|558849187|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
154841080|NCT03829657|558849188|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
154841081|NCT03829657|558849189|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
154841082|NCT03829657|558849185|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
154841083|NCT03829657|558849186|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
154841084|NCT03829657|558849187|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
154841085|NCT03829657|558849188|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
154841086|NCT03829657|558849189|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
154841087|NCT03829657|558849185|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
154841088|NCT03829657|558849186|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
154841089|NCT03829657|558849187|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
154841090|NCT03829657|558849188|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
154841091|NCT03829657|558849189|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
154841092|NCT04418076|558849190|FG000|Overall Study|Death|1|||
154841093|NCT04418076|558849191|FG001|Overall Study|Death|0|||
154841094|NCT04418076|558849192|FG002|Overall Study|Death|0|||
154841095|NCT04418076|558849193|FG003|Overall Study|Death|0|||
154841096|NCT04418076|558849190|FG000|Overall Study|Lost to Follow-up|2|||
154841097|NCT04418076|558849191|FG001|Overall Study|Lost to Follow-up|5|||
154841098|NCT04418076|558849192|FG002|Overall Study|Lost to Follow-up|1|||
154841099|NCT04418076|558849193|FG003|Overall Study|Lost to Follow-up|2|||
154841100|NCT04418076|558849190|FG000|Overall Study|Withdrawal by Subject|1|||
154841101|NCT04418076|558849191|FG001|Overall Study|Withdrawal by Subject|0|||
154841102|NCT04418076|558849192|FG002|Overall Study|Withdrawal by Subject|1|||
154841103|NCT04418076|558849193|FG003|Overall Study|Withdrawal by Subject|1|||
154841104|NCT04418076|558849190|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
154841105|NCT04418076|558849191|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
154841106|NCT04418076|558849192|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
154841107|NCT04418076|558849193|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
154841108|NCT01452152|558849197|FG000|Overall Study|Study termination by sponsor|5|||
154841109|NCT01452152|558849198|FG001|Overall Study|Study termination by sponsor|0|||
154841110|NCT01452152|558849199|FG002|Overall Study|Study termination by sponsor|4|||
154841111|NCT02867995|558849201|FG000|Overall Study|Withdrawal by Subject|0|||
154841112|NCT02867995|558849202|FG001|Overall Study|Withdrawal by Subject|1|||
154841113|NCT02867995|558849201|FG000|Overall Study|Lost to Follow-up|0|||
154841114|NCT02867995|558849202|FG001|Overall Study|Lost to Follow-up|2|||
154841115|NCT03368170|558850790|FG000|Overall Study|Adverse Event|2|||
154841116|NCT03368170|558850791|FG001|Overall Study|Adverse Event|1|||
154841117|NCT03047980|558850792|FG000|Overall Study|Adverse Event|1|||
154841118|NCT02164981|558850793|FG000|Started|Withdrawal by Subject|2|||
154841119|NCT02164981|558850794|FG001|Started|Withdrawal by Subject|1|||
154841120|NCT02164981|558850795|FG002|Started|Withdrawal by Subject|0|||
154841121|NCT02164981|558850793|FG000|Started|Protocol Violation|2|||
154841122|NCT02164981|558850794|FG001|Started|Protocol Violation|0|||
154841123|NCT02164981|558850795|FG002|Started|Protocol Violation|0|||
154841124|NCT02164981|558850793|FG000|Started|Adverse Event|1|||
154841125|NCT02164981|558850794|FG001|Started|Adverse Event|2|||
154841126|NCT02164981|558850795|FG002|Started|Adverse Event|0|||
154841127|NCT02164981|558850793|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
154841128|NCT02164981|558850794|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
154841129|NCT02164981|558850795|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
154841130|NCT02164981|558850793|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
154841131|NCT02164981|558850794|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
154841132|NCT02164981|558850795|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
154841133|NCT02164981|558850793|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
154841134|NCT02164981|558850794|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
154841135|NCT02164981|558850795|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
154841136|NCT01765673|558850801|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
154841137|NCT02600507|558850802|FG000|Overall Study|Adverse Event|3|||
154841138|NCT02600507|558850803|FG001|Overall Study|Adverse Event|15|||
154841139|NCT02600507|558850804|FG002|Overall Study|Adverse Event|5|||
154841140|NCT02600507|558850802|FG000|Overall Study|Lack of Efficacy|3|||
154841141|NCT02600507|558850803|FG001|Overall Study|Lack of Efficacy|8|||
154841142|NCT02600507|558850804|FG002|Overall Study|Lack of Efficacy|5|||
154841143|NCT02600507|558850802|FG000|Overall Study|Lost to Follow-up|3|||
154841144|NCT02600507|558850803|FG001|Overall Study|Lost to Follow-up|5|||
154841145|NCT02600507|558850804|FG002|Overall Study|Lost to Follow-up|2|||
154841146|NCT02600507|558850802|FG000|Overall Study|Protocol Violation|12|||
154841147|NCT02600507|558850803|FG001|Overall Study|Protocol Violation|4|||
154841148|NCT02600507|558850804|FG002|Overall Study|Protocol Violation|4|||
154841149|NCT02600507|558850802|FG000|Overall Study|Physician Decision|1|||
154841150|NCT02600507|558850803|FG001|Overall Study|Physician Decision|0|||
154841151|NCT02600507|558850804|FG002|Overall Study|Physician Decision|1|||
154841152|NCT02600507|558850802|FG000|Overall Study|Withdrawal by Subject|7|||
154841153|NCT02600507|558850803|FG001|Overall Study|Withdrawal by Subject|11|||
154841154|NCT02600507|558850804|FG002|Overall Study|Withdrawal by Subject|7|||
154841155|NCT02600507|558850802|FG000|Overall Study|Other|0|||
154841156|NCT02600507|558850803|FG001|Overall Study|Other|1|||
154841157|NCT02600507|558850804|FG002|Overall Study|Other|1|||
154841158|NCT05048719|558850805|FG000|Overall Study|Withdrawal by Subject|2|||
154841159|NCT05048719|558850806|FG001|Overall Study|Withdrawal by Subject|1|||
154841160|NCT05048719|558850807|FG002|Overall Study|Withdrawal by Subject|3|||
154841161|NCT05048719|558850808|FG003|Overall Study|Withdrawal by Subject|1|||
154841162|NCT05048719|558850809|FG004|Overall Study|Withdrawal by Subject|0|||
154841163|NCT05048719|558850810|FG005|Overall Study|Withdrawal by Subject|2|||
154841164|NCT05048719|558850811|FG006|Overall Study|Withdrawal by Subject|1|||
154841165|NCT05048719|558850812|FG007|Overall Study|Withdrawal by Subject|1|||
154841166|NCT05048719|558850813|FG008|Overall Study|Withdrawal by Subject|0|||
154841167|NCT05048719|558850805|FG000|Overall Study|Death|1|||
154841168|NCT05048719|558850806|FG001|Overall Study|Death|0|||
154841169|NCT05048719|558850807|FG002|Overall Study|Death|0|||
154841170|NCT05048719|558850808|FG003|Overall Study|Death|0|||
154841171|NCT05048719|558850809|FG004|Overall Study|Death|0|||
154841172|NCT05048719|558850810|FG005|Overall Study|Death|0|||
154841173|NCT05048719|558850811|FG006|Overall Study|Death|0|||
154841174|NCT05048719|558850812|FG007|Overall Study|Death|0|||
154841175|NCT05048719|558850813|FG008|Overall Study|Death|0|||
154841176|NCT05048719|558850805|FG000|Overall Study|Adverse Event|0|||
154841177|NCT05048719|558850806|FG001|Overall Study|Adverse Event|1|||
154841178|NCT05048719|558850807|FG002|Overall Study|Adverse Event|2|||
154841179|NCT05048719|558850808|FG003|Overall Study|Adverse Event|0|||
154841180|NCT05048719|558850809|FG004|Overall Study|Adverse Event|1|||
154841181|NCT05048719|558850810|FG005|Overall Study|Adverse Event|0|||
154841182|NCT05048719|558850811|FG006|Overall Study|Adverse Event|0|||
154841183|NCT05048719|558850812|FG007|Overall Study|Adverse Event|0|||
154841184|NCT05048719|558850813|FG008|Overall Study|Adverse Event|0|||
154841185|NCT05048719|558850805|FG000|Overall Study|Lost to Follow-up|0|||
154841186|NCT05048719|558850806|FG001|Overall Study|Lost to Follow-up|0|||
154841187|NCT05048719|558850807|FG002|Overall Study|Lost to Follow-up|1|||
154841188|NCT05048719|558850808|FG003|Overall Study|Lost to Follow-up|3|||
154841189|NCT05048719|558850809|FG004|Overall Study|Lost to Follow-up|1|||
154841190|NCT05048719|558850810|FG005|Overall Study|Lost to Follow-up|1|||
154841191|NCT05048719|558850811|FG006|Overall Study|Lost to Follow-up|1|||
154841192|NCT05048719|558850812|FG007|Overall Study|Lost to Follow-up|1|||
154841193|NCT05048719|558850813|FG008|Overall Study|Lost to Follow-up|0|||
154841194|NCT05048719|558850805|FG000|Overall Study|Physician Decision|0|||
154841195|NCT05048719|558850806|FG001|Overall Study|Physician Decision|0|||
154841196|NCT05048719|558850807|FG002|Overall Study|Physician Decision|0|||
154841197|NCT05048719|558850808|FG003|Overall Study|Physician Decision|0|||
154841198|NCT05048719|558850809|FG004|Overall Study|Physician Decision|0|||
154841199|NCT05048719|558850810|FG005|Overall Study|Physician Decision|0|||
154841200|NCT05048719|558850811|FG006|Overall Study|Physician Decision|0|||
154841201|NCT05048719|558850812|FG007|Overall Study|Physician Decision|1|||
154841202|NCT05048719|558850813|FG008|Overall Study|Physician Decision|1|||
154841203|NCT05048719|558850805|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
154841204|NCT05048719|558850806|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841205|NCT05048719|558850807|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841206|NCT05048719|558850808|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841207|NCT05048719|558850809|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841208|NCT05048719|558850810|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841209|NCT05048719|558850811|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841210|NCT05048719|558850812|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841211|NCT05048719|558850813|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
154841212|NCT05048719|558850805|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155104707|NCT03053440|559813838|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
155104708|NCT03053440|559813839|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
155104709|NCT03053440|559813838|FG000|Overall Study|Physician Decision|2|||
154841213|NCT05048719|558850806|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
154841214|NCT05048719|558850807|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
154841215|NCT05048719|558850808|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
154841216|NCT05048719|558850809|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
154841217|NCT05048719|558850810|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
154841218|NCT05048719|558850811|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
155104710|NCT03053440|559813839|FG001|Overall Study|Physician Decision|1|||
154841219|NCT05048719|558850812|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
154841220|NCT05048719|558850813|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
154841221|NCT05048719|558850805|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841222|NCT05048719|558850806|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
154841223|NCT05048719|558850807|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841224|NCT05048719|558850808|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841225|NCT05048719|558850809|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841226|NCT05048719|558850810|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841227|NCT05048719|558850811|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841228|NCT05048719|558850812|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841229|NCT05048719|558850813|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
154841230|NCT05048719|558850805|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841231|NCT05048719|558850806|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841232|NCT05048719|558850807|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841233|NCT05048719|558850808|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
154841234|NCT05048719|558850809|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841235|NCT05048719|558850810|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841236|NCT05048719|558850811|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841237|NCT05048719|558850812|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841238|NCT05048719|558850813|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
154841239|NCT05048719|558850805|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841240|NCT05048719|558850806|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841241|NCT05048719|558850807|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841242|NCT05048719|558850808|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841243|NCT05048719|558850809|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841244|NCT05048719|558850810|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
154841245|NCT05048719|558850811|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841246|NCT05048719|558850812|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841247|NCT05048719|558850813|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
154841248|NCT03257267|558850814|FG000|Overall Study|Adverse Event|17|||
154841249|NCT03257267|558850815|FG001|Overall Study|Adverse Event|7|||
154841250|NCT03257267|558850814|FG000|Overall Study|Death|96|||
154841251|NCT03257267|558850815|FG001|Overall Study|Death|98|||
154841252|NCT03257267|558850814|FG000|Overall Study|Lost to Follow-up|2|||
154841253|NCT03257267|558850815|FG001|Overall Study|Lost to Follow-up|2|||
154841254|NCT03257267|558850814|FG000|Overall Study|Non-compliance with Study Drug|0|||
154841255|NCT03257267|558850815|FG001|Overall Study|Non-compliance with Study Drug|2|||
154841256|NCT03257267|558850814|FG000|Overall Study|Participant Decision|35|||
154841257|NCT03257267|558850815|FG001|Overall Study|Participant Decision|43|||
154841258|NCT03257267|558850814|FG000|Overall Study|Sponsor Decision|1|||
154841259|NCT03257267|558850815|FG001|Overall Study|Sponsor Decision|0|||
154841260|NCT03257267|558850814|FG000|Overall Study|Physician Decision|1|||
154841261|NCT03257267|558850815|FG001|Overall Study|Physician Decision|3|||
154841262|NCT03257267|558850814|FG000|Overall Study|Disease Progression|109|||
154841263|NCT03257267|558850815|FG001|Overall Study|Disease Progression|121|||
154841264|NCT03257267|558850814|FG000|Overall Study|Withdrawal by Subject|8|||
154841265|NCT03257267|558850815|FG001|Overall Study|Withdrawal by Subject|26|||
154841266|NCT03257267|558850814|FG000|Overall Study|Other|0|||
154841267|NCT03257267|558850815|FG001|Overall Study|Other|2|||
154841268|NCT04872101|558850816|FG000|Overall Study|Withdrawal by Subject|10|||
154841269|NCT04872101|558850817|FG001|Overall Study|Withdrawal by Subject|16|||
154841270|NCT04872101|558850816|FG000|Overall Study|Lack of Efficacy|6|||
154841271|NCT04872101|558850817|FG001|Overall Study|Lack of Efficacy|14|||
154841272|NCT04872101|558850816|FG000|Overall Study|Adverse Event|1|||
154841273|NCT04872101|558850817|FG001|Overall Study|Adverse Event|6|||
154841274|NCT04872101|558850816|FG000|Overall Study|Lost to Follow-up|2|||
154841275|NCT04872101|558850817|FG001|Overall Study|Lost to Follow-up|1|||
154841276|NCT04872101|558850816|FG000|Overall Study|Pregnancy|2|||
154841277|NCT04872101|558850817|FG001|Overall Study|Pregnancy|0|||
154841278|NCT04872101|558850816|FG000|Overall Study|Prohibited Medication|1|||
154841279|NCT04872101|558850817|FG001|Overall Study|Prohibited Medication|0|||
154841280|NCT04872101|558850816|FG000|Overall Study|Not dosed|1|||
154841281|NCT04872101|558850817|FG001|Overall Study|Not dosed|0|||
154841282|NCT02684981|558850826|FG000|Overall Study|Permanently discontinued the treatment|157|||
154841283|NCT02684981|558850827|FG001|Overall Study|Permanently discontinued the treatment|161|||
154841284|NCT02684981|558850828|FG002|Overall Study|Permanently discontinued the treatment|110|||
154841285|NCT02684981|558850826|FG000|Overall Study|Other|83|||
155104711|NCT03053440|559813838|FG000|Overall Study|Participant Randomized but died before dosing|1|||
155104712|NCT03053440|559813839|FG001|Overall Study|Participant Randomized but died before dosing|0|||
155104713|NCT05002985|559813840|FG000|Overall Study|Withdrawal by Subject|1|||
155104714|NCT02705105|559813841|FG000|Treatment|Objective Disease Progression|1|||
154841286|NCT02684981|558850827|FG001|Overall Study|Other|49|||
154841287|NCT02684981|558850828|FG002|Overall Study|Other|17|||
154841288|NCT04623242|558850829|FG000|Overall Study|Withdrawal by Subject|7|||
154841289|NCT04623242|558850830|FG001|Overall Study|Withdrawal by Subject|12|||
154841290|NCT04623242|558850831|FG002|Overall Study|Withdrawal by Subject|5|||
154841291|NCT04623242|558850832|FG003|Overall Study|Withdrawal by Subject|7|||
154841292|NCT04623242|558850833|FG004|Overall Study|Withdrawal by Subject|0|||
154841293|NCT04623242|558850829|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
154841294|NCT04623242|558850830|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
154841295|NCT04623242|558850831|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
154841296|NCT04623242|558850832|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
154841297|NCT04623242|558850833|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
154841298|NCT04623242|558850829|FG000|Overall Study|Subject unblinded to mutation status|0|||
154841299|NCT04623242|558850830|FG001|Overall Study|Subject unblinded to mutation status|0|||
154841300|NCT04623242|558850831|FG002|Overall Study|Subject unblinded to mutation status|0|||
154841301|NCT04623242|558850832|FG003|Overall Study|Subject unblinded to mutation status|13|||
154841302|NCT04623242|558850833|FG004|Overall Study|Subject unblinded to mutation status|0|||
154841303|NCT00820898|558850838|FG000|Overall Study|Inelgible - wrong primary site|1|||
154841304|NCT00452699|558850841|FG000|Overall Study|Adverse Event|10|||
154841305|NCT00452699|558850842|FG001|Overall Study|Adverse Event|3|||
154841306|NCT00452699|558850841|FG000|Overall Study|Lack of Efficacy|6|||
154841307|NCT00452699|558850842|FG001|Overall Study|Lack of Efficacy|4|||
154841308|NCT00452699|558850841|FG000|Overall Study|Lost to Follow-up|6|||
154841309|NCT00452699|558850842|FG001|Overall Study|Lost to Follow-up|9|||
154841310|NCT00452699|558850841|FG000|Overall Study|Protocol Violation|21|||
154841311|NCT00452699|558850842|FG001|Overall Study|Protocol Violation|25|||
154841312|NCT00452699|558850841|FG000|Overall Study|Withdrawal by Subject|26|||
154841313|NCT00452699|558850842|FG001|Overall Study|Withdrawal by Subject|25|||
154841314|NCT00452699|558850841|FG000|Overall Study|Other|12|||
154841315|NCT00452699|558850842|FG001|Overall Study|Other|7|||
154841316|NCT02921971|558850843|FG000|Overall Study|Adverse Event|1|||
154841317|NCT02921971|558850844|FG001|Overall Study|Adverse Event|2|||
154841318|NCT02921971|558850843|FG000|Overall Study|Lack of Efficacy|3|||
154841319|NCT02921971|558850844|FG001|Overall Study|Lack of Efficacy|1|||
154841320|NCT02921971|558850843|FG000|Overall Study|Other than specified above|2|||
154841321|NCT02921971|558850844|FG001|Overall Study|Other than specified above|1|||
154841322|NCT02105454|558850847|FG000|Overall Study|Withdrawal by Subject|1|||
154841323|NCT00326898|558850848|FG000|Overall Study|Disease progression|52|||
154841324|NCT00326898|558850849|FG001|Overall Study|Disease progression|54|||
154841325|NCT00326898|558850850|FG002|Overall Study|Disease progression|102|||
154841326|NCT00326898|558850848|FG000|Overall Study|Adverse Event|124|||
154841327|NCT00326898|558850849|FG001|Overall Study|Adverse Event|128|||
154841328|NCT00326898|558850850|FG002|Overall Study|Adverse Event|33|||
154841329|NCT00326898|558850848|FG000|Overall Study|Death|2|||
154841330|NCT00326898|558850849|FG001|Overall Study|Death|0|||
154841331|NCT00326898|558850850|FG002|Overall Study|Death|0|||
154841332|NCT00326898|558850848|FG000|Overall Study|Withdrawal by Subject|134|||
154841333|NCT00326898|558850849|FG001|Overall Study|Withdrawal by Subject|128|||
154841334|NCT00326898|558850850|FG002|Overall Study|Withdrawal by Subject|32|||
154841335|NCT00326898|558850848|FG000|Overall Study|Alternative therapy|1|||
154841336|NCT00326898|558850849|FG001|Overall Study|Alternative therapy|0|||
154841337|NCT00326898|558850850|FG002|Overall Study|Alternative therapy|0|||
154841338|NCT00326898|558850848|FG000|Overall Study|Other complicating disease|5|||
154841339|NCT00326898|558850849|FG001|Overall Study|Other complicating disease|5|||
154841340|NCT00326898|558850850|FG002|Overall Study|Other complicating disease|4|||
154841341|NCT00326898|558850848|FG000|Overall Study|Other/Missing/Unknown|33|||
154841342|NCT00326898|558850849|FG001|Overall Study|Other/Missing/Unknown|28|||
154841343|NCT00326898|558850850|FG002|Overall Study|Other/Missing/Unknown|32|||
154841344|NCT03847987|558850851|FG000|Overall Study|Lost to Follow-up|1|||
154841345|NCT03847987|558850852|FG001|Overall Study|Lost to Follow-up|0|||
154841346|NCT03847987|558850851|FG000|Overall Study|Adverse Event|2|||
154841347|NCT03847987|558850852|FG001|Overall Study|Adverse Event|0|||
155104715|NCT02705105|559813842|FG001|Treatment|Objective Disease Progression|50|||
154841348|NCT02721355|558850853|FG000|Overall Study|Lost to Follow-up|6|||
154841349|NCT02721355|558850854|FG001|Overall Study|Lost to Follow-up|1|||
154841350|NCT00356278|558850855|FG000|Overall Study|Withdrawal by Subject|25|||
154841351|NCT00356278|558850856|FG001|Overall Study|Withdrawal by Subject|15|||
154841352|NCT00356278|558850857|FG002|Overall Study|Withdrawal by Subject|19|||
154841353|NCT01592760|558850864|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
154841354|NCT01592760|558850865|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
154841355|NCT01592760|558850866|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
154841356|NCT01363986|558850869|FG000|Overall Study|Disease progression|1|||
154841357|NCT01637142|558850870|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
154841358|NCT02111564|558850871|FG000|Overall Study|Death|109|||
154841359|NCT02111564|558850872|FG001|Overall Study|Death|120|||
154841360|NCT02111564|558850871|FG000|Overall Study|Lost to Follow-up|2|||
154841361|NCT02111564|558850872|FG001|Overall Study|Lost to Follow-up|3|||
154841362|NCT02111564|558850871|FG000|Overall Study|Withdrawal by Subject|20|||
154841363|NCT02111564|558850872|FG001|Overall Study|Withdrawal by Subject|20|||
154841364|NCT00687362|558850873|FG000|Overall Study|Protocol Violation|2|||
154841365|NCT00687362|558850873|FG000|Overall Study|Withdrawal by Subject|1|||
154841366|NCT00925015|558850874|FG000|Overall Study|Adverse Event|1|||
154841367|NCT00925015|558850875|FG001|Overall Study|Adverse Event|2|||
154841368|NCT00925015|558850876|FG002|Overall Study|Adverse Event|1|||
154841369|NCT00925015|558850874|FG000|Overall Study|Physician Decision|0|||
154841370|NCT00925015|558850875|FG001|Overall Study|Physician Decision|1|||
154841371|NCT00925015|558850876|FG002|Overall Study|Physician Decision|0|||
154841372|NCT00925015|558850874|FG000|Overall Study|Progressive Disease|7|||
154841373|NCT00925015|558850875|FG001|Overall Study|Progressive Disease|3|||
154841374|NCT00925015|558850876|FG002|Overall Study|Progressive Disease|4|||
154841375|NCT00925015|558850874|FG000|Overall Study|Withdrawal by Subject|0|||
154841376|NCT00925015|558850875|FG001|Overall Study|Withdrawal by Subject|0|||
154841377|NCT00925015|558850876|FG002|Overall Study|Withdrawal by Subject|1|||
154841378|NCT04986202|558850877|FG000|Overall Study|Death|10|||
154841379|NCT04986202|558850878|FG001|Overall Study|Death|3|||
154841380|NCT04986202|558850879|FG002|Overall Study|Death|10|||
154841381|NCT04986202|558850877|FG000|Overall Study|Physician Decision|3|||
154841382|NCT04986202|558850878|FG001|Overall Study|Physician Decision|1|||
154841383|NCT04986202|558850879|FG002|Overall Study|Physician Decision|2|||
155104716|NCT02705105|559813841|FG000|Treatment|Withdrawal by Subject|3|||
155104717|NCT02705105|559813842|FG001|Treatment|Withdrawal by Subject|5|||
154841384|NCT04986202|558850877|FG000|Overall Study|Withdrawal by Subject|4|||
154841385|NCT04986202|558850878|FG001|Overall Study|Withdrawal by Subject|2|||
154841386|NCT04986202|558850879|FG002|Overall Study|Withdrawal by Subject|4|||
154841387|NCT01289015|558850882|FG000|Overall Study|Protocol Violation|12|||
154841388|NCT01289015|558850883|FG001|Overall Study|Protocol Violation|9|||
154841389|NCT01289015|558850882|FG000|Overall Study|Adverse Event|3|||
154841390|NCT01289015|558850883|FG001|Overall Study|Adverse Event|0|||
154841391|NCT01289015|558850882|FG000|Overall Study|Lost to Follow-up|33|||
154841392|NCT01289015|558850883|FG001|Overall Study|Lost to Follow-up|17|||
154841393|NCT01289015|558850882|FG000|Overall Study|Withdrawal by Subject|17|||
154841394|NCT01289015|558850883|FG001|Overall Study|Withdrawal by Subject|8|||
154841395|NCT01289015|558850882|FG000|Overall Study|Disease progression|1|||
154841396|NCT01289015|558850883|FG001|Overall Study|Disease progression|0|||
154841397|NCT01289015|558850882|FG000|Overall Study|Negative baseline culture and others|33|||
154841398|NCT01289015|558850883|FG001|Overall Study|Negative baseline culture and others|20|||
154841399|NCT01425203|558850886|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
154841400|NCT01425203|558850887|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
154841401|NCT01425203|558850888|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
154841402|NCT01425203|558850886|FG000|Treatment Phase|Failure at futility timepoint|8|||
154841403|NCT01425203|558850887|FG001|Treatment Phase|Failure at futility timepoint|27|||
154841404|NCT01425203|558850888|FG002|Treatment Phase|Failure at futility timepoint|0|||
154841405|NCT01425203|558850886|FG000|Treatment Phase|Other virologic failure criteria|5|||
154841406|NCT01425203|558850887|FG001|Treatment Phase|Other virologic failure criteria|3|||
154841407|NCT01425203|558850888|FG002|Treatment Phase|Other virologic failure criteria|0|||
154841408|NCT01425203|558850886|FG000|Treatment Phase|Unidentified reasons|11|||
154841409|NCT01425203|558850887|FG001|Treatment Phase|Unidentified reasons|5|||
154841410|NCT01425203|558850888|FG002|Treatment Phase|Unidentified reasons|0|||
154841411|NCT01425203|558850886|FG000|Treatment Phase|Did not receive treatment|0|||
154841412|NCT01425203|558850887|FG001|Treatment Phase|Did not receive treatment|1|||
154841413|NCT01425203|558850888|FG002|Treatment Phase|Did not receive treatment|0|||
154841414|NCT01425203|558850886|FG000|Crossover Phase|Failure at futility timepoint|0|||
154841415|NCT01425203|558850887|FG001|Crossover Phase|Failure at futility timepoint|0|||
154841416|NCT01425203|558850888|FG002|Crossover Phase|Failure at futility timepoint|3|||
154841417|NCT01425203|558850886|FG000|Crossover Phase|Other virologic failure criteria|0|||
154841418|NCT01425203|558850887|FG001|Crossover Phase|Other virologic failure criteria|0|||
154841419|NCT01425203|558850888|FG002|Crossover Phase|Other virologic failure criteria|3|||
154841420|NCT00290433|558850895|FG000|Overall Study|Disease Progression|13|||
154841421|NCT00290433|558850895|FG000|Overall Study|Adverse Event|14|||
154841422|NCT00290433|558850895|FG000|Overall Study|Withdrawal by Subject|1|||
154841423|NCT00290433|558850895|FG000|Overall Study|Non-Compliance|1|||
154841424|NCT00290433|558850895|FG000|Overall Study|Congestive Heart Failure|1|||
154841425|NCT00290433|558850895|FG000|Overall Study|Transplant in CR|5|||
154841426|NCT00290433|558850895|FG000|Overall Study|Unrelated Infection/Death|1|||
154841427|NCT01888640|558850904|FG000|Overall Study|Lost to Follow-up|1|||
154841428|NCT01888640|558850905|FG001|Overall Study|Lost to Follow-up|2|||
154841429|NCT01888640|558850906|FG002|Overall Study|Lost to Follow-up|0|||
154841430|NCT01888640|558850904|FG000|Overall Study|Withdrawal by Subject|15|||
154841431|NCT01888640|558850905|FG001|Overall Study|Withdrawal by Subject|11|||
154841432|NCT01888640|558850906|FG002|Overall Study|Withdrawal by Subject|4|||
154841433|NCT01888640|558850904|FG000|Overall Study|Minimum dose not met|10|||
154841434|NCT01888640|558850905|FG001|Overall Study|Minimum dose not met|16|||
154841435|NCT01888640|558850906|FG002|Overall Study|Minimum dose not met|0|||
154841436|NCT01888640|558850904|FG000|Overall Study|Given wrong unit (placebo)|1|||
154841437|NCT01888640|558850905|FG001|Overall Study|Given wrong unit (placebo)|0|||
154841438|NCT01888640|558850906|FG002|Overall Study|Given wrong unit (placebo)|0|||
154841439|NCT01888640|558850904|FG000|Overall Study|Excluded for prior TENS|0|||
154841440|NCT01888640|558850905|FG001|Overall Study|Excluded for prior TENS|1|||
154841441|NCT01888640|558850906|FG002|Overall Study|Excluded for prior TENS|0|||
154841442|NCT01888640|558850904|FG000|Overall Study|Researcher Termination of Participant|0|||
154841443|NCT01888640|558850905|FG001|Overall Study|Researcher Termination of Participant|1|||
154841444|NCT01888640|558850906|FG002|Overall Study|Researcher Termination of Participant|1|||
154841445|NCT00109707|558850907|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
154841446|NCT00109707|558850908|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
154841447|NCT00109707|558850909|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
154841448|NCT00109707|558850907|FG000|Overall Study|Abnormal laboratory values|1|||
154841449|NCT00109707|558850908|FG001|Overall Study|Abnormal laboratory values|0|||
154841450|NCT00109707|558850909|FG002|Overall Study|Abnormal laboratory values|0|||
154841451|NCT00109707|558850907|FG000|Overall Study|Administrative problems|2|||
154841452|NCT00109707|558850908|FG001|Overall Study|Administrative problems|0|||
154841453|NCT00109707|558850909|FG002|Overall Study|Administrative problems|1|||
154841454|NCT00109707|558850907|FG000|Overall Study|Adverse Event|10|||
154841455|NCT00109707|558850908|FG001|Overall Study|Adverse Event|2|||
154841456|NCT00109707|558850909|FG002|Overall Study|Adverse Event|3|||
154841457|NCT00109707|558850907|FG000|Overall Study|Death|4|||
154841458|NCT00109707|558850908|FG001|Overall Study|Death|0|||
154841459|NCT00109707|558850909|FG002|Overall Study|Death|0|||
154841460|NCT00109707|558850907|FG000|Overall Study|Disease progression|12|||
154971098|NCT02832167|559318529|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
154841461|NCT00109707|558850908|FG001|Overall Study|Disease progression|4|||
154971099|NCT02832167|559318529|FG000|Treatment Period 2|Maximum clinical benefit|1|||
154841462|NCT00109707|558850909|FG002|Overall Study|Disease progression|3|||
154841463|NCT00109707|558850907|FG000|Overall Study|Lost to Follow-up|3|||
154841464|NCT00109707|558850908|FG001|Overall Study|Lost to Follow-up|0|||
154841465|NCT00109707|558850909|FG002|Overall Study|Lost to Follow-up|0|||
154841466|NCT00109707|558850907|FG000|Overall Study|Protocol Violation|1|||
154841467|NCT00109707|558850908|FG001|Overall Study|Protocol Violation|0|||
154841468|NCT00109707|558850909|FG002|Overall Study|Protocol Violation|0|||
154841469|NCT00109707|558850907|FG000|Overall Study|Patient withdrew consent|6|||
154841470|NCT00109707|558850908|FG001|Overall Study|Patient withdrew consent|1|||
154841471|NCT00109707|558850909|FG002|Overall Study|Patient withdrew consent|0|||
154841472|NCT01277549|558850910|FG000|Overall Study|Failed to meet eligibility criteria|13|||
154841473|NCT01277549|558850911|FG001|Overall Study|Failed to meet eligibility criteria|9|||
154841474|NCT01277549|558850910|FG000|Overall Study|Withdrawal by Subject|1|||
154841475|NCT01277549|558850911|FG001|Overall Study|Withdrawal by Subject|3|||
154841476|NCT01277549|558850910|FG000|Overall Study|Protocol Violation|10|||
154841477|NCT01277549|558850911|FG001|Overall Study|Protocol Violation|1|||
154841478|NCT01277549|558850910|FG000|Overall Study|Physician Decision|2|||
154841479|NCT01277549|558850911|FG001|Overall Study|Physician Decision|1|||
154841480|NCT01618214|558850912|FG000|Overall Study|Adverse Event|3|||
154841481|NCT01618214|558850913|FG001|Overall Study|Adverse Event|1|||
154841482|NCT01618214|558850912|FG000|Overall Study|Lack of Efficacy|1|||
154841483|NCT01618214|558850913|FG001|Overall Study|Lack of Efficacy|1|||
154841484|NCT01618214|558850912|FG000|Overall Study|Protocol Violation|1|||
154841485|NCT01618214|558850913|FG001|Overall Study|Protocol Violation|4|||
154841486|NCT01618214|558850912|FG000|Overall Study|Withdrawal Criteria|1|||
154841487|NCT01618214|558850913|FG001|Overall Study|Withdrawal Criteria|2|||
154841488|NCT01618214|558850912|FG000|Overall Study|Unclassified|4|||
154841489|NCT01618214|558850913|FG001|Overall Study|Unclassified|5|||
154841490|NCT02228590|558850914|FG000|Overall Study|Withdrawal by Subject|1|||
154841491|NCT02109484|558850915|FG000|Overall Study|Lost to Follow-up|0|||
154841492|NCT02109484|558850916|FG001|Overall Study|Lost to Follow-up|0|||
154841493|NCT02109484|558850917|FG002|Overall Study|Lost to Follow-up|0|||
154841494|NCT02109484|558850918|FG003|Overall Study|Lost to Follow-up|1|||
154841495|NCT02109484|558850919|FG004|Overall Study|Lost to Follow-up|1|||
154841496|NCT02109484|558850920|FG005|Overall Study|Lost to Follow-up|0|||
154841497|NCT02109484|558850921|FG006|Overall Study|Lost to Follow-up|1|||
154841498|NCT02109484|558850922|FG007|Overall Study|Lost to Follow-up|0|||
154841499|NCT02109484|558850915|FG000|Overall Study|Withdrawal by Subject|0|||
154841500|NCT02109484|558850916|FG001|Overall Study|Withdrawal by Subject|0|||
154841501|NCT02109484|558850917|FG002|Overall Study|Withdrawal by Subject|0|||
154841502|NCT02109484|558850918|FG003|Overall Study|Withdrawal by Subject|0|||
154841503|NCT02109484|558850919|FG004|Overall Study|Withdrawal by Subject|1|||
154841504|NCT02109484|558850920|FG005|Overall Study|Withdrawal by Subject|1|||
154841505|NCT02109484|558850921|FG006|Overall Study|Withdrawal by Subject|1|||
154841506|NCT02109484|558850922|FG007|Overall Study|Withdrawal by Subject|0|||
154841507|NCT02109484|558850915|FG000|Overall Study|Physician Decision|0|||
154841508|NCT02109484|558850916|FG001|Overall Study|Physician Decision|0|||
154841509|NCT02109484|558850917|FG002|Overall Study|Physician Decision|0|||
154841510|NCT02109484|558850918|FG003|Overall Study|Physician Decision|0|||
154841511|NCT02109484|558850919|FG004|Overall Study|Physician Decision|2|||
154841512|NCT02109484|558850920|FG005|Overall Study|Physician Decision|0|||
154841513|NCT02109484|558850921|FG006|Overall Study|Physician Decision|0|||
154841514|NCT02109484|558850922|FG007|Overall Study|Physician Decision|0|||
154841515|NCT02109484|558850915|FG000|Overall Study|Death|0|||
154841516|NCT02109484|558850916|FG001|Overall Study|Death|0|||
154841517|NCT02109484|558850917|FG002|Overall Study|Death|0|||
154841518|NCT02109484|558850918|FG003|Overall Study|Death|0|||
154841519|NCT02109484|558850919|FG004|Overall Study|Death|0|||
154841520|NCT02109484|558850920|FG005|Overall Study|Death|0|||
154841521|NCT02109484|558850921|FG006|Overall Study|Death|0|||
154841522|NCT02109484|558850922|FG007|Overall Study|Death|2|||
154841523|NCT02109484|558850915|FG000|Overall Study|Moved away from study area|0|||
154841524|NCT02109484|558850916|FG001|Overall Study|Moved away from study area|0|||
154841525|NCT02109484|558850917|FG002|Overall Study|Moved away from study area|0|||
154841526|NCT02109484|558850918|FG003|Overall Study|Moved away from study area|0|||
154841527|NCT02109484|558850919|FG004|Overall Study|Moved away from study area|0|||
154841528|NCT02109484|558850920|FG005|Overall Study|Moved away from study area|0|||
154841529|NCT02109484|558850921|FG006|Overall Study|Moved away from study area|1|||
154841530|NCT02109484|558850922|FG007|Overall Study|Moved away from study area|1|||
154841531|NCT02111993|558850923|FG000|Overall Study|Physician Decision|5|||
154841532|NCT02111993|558850924|FG001|Overall Study|Physician Decision|4|||
154841533|NCT01097863|558850925|FG000|Overall Study|Discomfort|1|||
154841534|NCT01097863|558850926|FG001|Overall Study|Discomfort|0|||
154841535|NCT01097863|558850927|FG002|Overall Study|Discomfort|1|||
154841536|NCT01097863|558850925|FG000|Overall Study|Did not return for final visit|0|||
154841537|NCT01097863|558850926|FG001|Overall Study|Did not return for final visit|0|||
154841538|NCT01097863|558850927|FG002|Overall Study|Did not return for final visit|1|||
154841539|NCT00419380|558850928|FG000|Overall Study|Lack of Efficacy|1|||
154841540|NCT00419380|558850929|FG001|Overall Study|Lack of Efficacy|7|||
154841541|NCT00419380|558850928|FG000|Overall Study|Physician Decision|0|||
154841542|NCT00419380|558850929|FG001|Overall Study|Physician Decision|1|||
154841543|NCT00419380|558850928|FG000|Overall Study|Lost to Follow-up|0|||
154841544|NCT00419380|558850929|FG001|Overall Study|Lost to Follow-up|1|||
154841545|NCT00419380|558850928|FG000|Overall Study|Withdrawal by Subject|0|||
154841546|NCT00419380|558850929|FG001|Overall Study|Withdrawal by Subject|1|||
154841547|NCT00796315|558850930|FG000|Overall Study|Protocol Violation|0|||
154841548|NCT00796315|558850931|FG001|Overall Study|Protocol Violation|1|||
154841549|NCT00796315|558850932|FG002|Overall Study|Protocol Violation|0|||
154841550|NCT01400451|558850941|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
154841551|NCT01400451|558850942|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
154841552|NCT01400451|558850943|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
154841553|NCT01400451|558850941|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
154841554|NCT01400451|558850942|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
154841555|NCT01400451|558850943|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
154841556|NCT01400451|558850941|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
154841557|NCT01400451|558850942|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
154841558|NCT01400451|558850943|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
154841559|NCT01400451|558850941|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
154841560|NCT01400451|558850942|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
154841561|NCT01400451|558850943|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
154841562|NCT01400451|558850941|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
154841563|NCT01400451|558850942|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
154841564|NCT01400451|558850943|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
154841565|NCT00574275|558850944|FG000|Overall Study|Randomized but not treated|2|||
154841566|NCT00574275|558850945|FG001|Overall Study|Randomized but not treated|3|||
154841567|NCT00574275|558850944|FG000|Overall Study|Adverse Event|32|||
154841568|NCT00574275|558850945|FG001|Overall Study|Adverse Event|76|||
154841569|NCT00574275|558850944|FG000|Overall Study|Disease progression|160|||
154841570|NCT00574275|558850945|FG001|Overall Study|Disease progression|146|||
154841571|NCT00574275|558850944|FG000|Overall Study|Lost to Follow-up|2|||
154841572|NCT00574275|558850945|FG001|Overall Study|Lost to Follow-up|1|||
154841573|NCT00574275|558850944|FG000|Overall Study|Study stopped based on DMC decision|62|||
154841574|NCT00574275|558850945|FG001|Overall Study|Study stopped based on DMC decision|23|||
154841575|NCT00574275|558850944|FG000|Overall Study|Withdrawal by Subject|15|||
154841576|NCT00574275|558850945|FG001|Overall Study|Withdrawal by Subject|17|||
154841577|NCT00574275|558850944|FG000|Overall Study|Error calculating tumor measurement|1|||
154841578|NCT00574275|558850945|FG001|Overall Study|Error calculating tumor measurement|0|||
154841579|NCT00574275|558850944|FG000|Overall Study|Physician Decision|1|||
154841580|NCT00574275|558850945|FG001|Overall Study|Physician Decision|1|||
154841581|NCT00574275|558850944|FG000|Overall Study|Protocol Violation|0|||
154841582|NCT00574275|558850945|FG001|Overall Study|Protocol Violation|1|||
154971100|NCT02832167|559318529|FG000|Treatment Period 2|Study Drug Toxicity|5|||
154841583|NCT00574275|558850944|FG000|Overall Study|Patient and Investigator decision|0|||
154841584|NCT00574275|558850945|FG001|Overall Study|Patient and Investigator decision|1|||
154841585|NCT00574275|558850944|FG000|Overall Study|Insurance change|0|||
154841586|NCT00574275|558850945|FG001|Overall Study|Insurance change|1|||
154841587|NCT00574275|558850944|FG000|Overall Study|Operation for curative intent|0|||
154841588|NCT00574275|558850945|FG001|Overall Study|Operation for curative intent|1|||
154841589|NCT00889265|558850953|FG000|Overall Study|Adverse Event|1|||
154841590|NCT00889265|558850953|FG000|Overall Study|Lost to Follow-up|5|||
154841591|NCT00889265|558850953|FG000|Overall Study|Protocol Violation|1|||
154971101|NCT02832167|559318529|FG000|Treatment Period 2|Participant request to discontinue|2|||
154841592|NCT03028870|558850954|FG000|Overall Study|Adverse Event|7|||
154841593|NCT03028870|558850955|FG001|Overall Study|Adverse Event|4|||
154841594|NCT03028870|558850956|FG002|Overall Study|Adverse Event|3|||
154841595|NCT03028870|558850957|FG003|Overall Study|Adverse Event|3|||
154841596|NCT03028870|558850954|FG000|Overall Study|Withdrawal by Subject|1|||
154841597|NCT03028870|558850955|FG001|Overall Study|Withdrawal by Subject|1|||
154841598|NCT03028870|558850956|FG002|Overall Study|Withdrawal by Subject|1|||
154841599|NCT03028870|558850957|FG003|Overall Study|Withdrawal by Subject|2|||
154841600|NCT03028870|558850954|FG000|Overall Study|Lost to Follow-up|1|||
154841601|NCT03028870|558850955|FG001|Overall Study|Lost to Follow-up|0|||
154841602|NCT03028870|558850956|FG002|Overall Study|Lost to Follow-up|0|||
154841603|NCT03028870|558850957|FG003|Overall Study|Lost to Follow-up|0|||
154841604|NCT03028870|558850954|FG000|Overall Study|Lack of Efficacy|3|||
154841605|NCT03028870|558850955|FG001|Overall Study|Lack of Efficacy|0|||
154841606|NCT03028870|558850956|FG002|Overall Study|Lack of Efficacy|0|||
154841607|NCT03028870|558850957|FG003|Overall Study|Lack of Efficacy|0|||
154841608|NCT03028870|558850954|FG000|Overall Study|Administrative|5|||
154841609|NCT03028870|558850955|FG001|Overall Study|Administrative|5|||
154841610|NCT03028870|558850956|FG002|Overall Study|Administrative|12|||
154841611|NCT03028870|558850957|FG003|Overall Study|Administrative|4|||
154841612|NCT00317109|558850960|FG000|Overall Study|Withdrawal by Subject|2|||
154841613|NCT00317109|558850961|FG001|Overall Study|Withdrawal by Subject|0|||
154841614|NCT00317109|558850960|FG000|Overall Study|Migated/moved from study area|1|||
154841615|NCT00317109|558850961|FG001|Overall Study|Migated/moved from study area|0|||
154841616|NCT03461757|558850963|FG000|Overall Study|Adverse Event|1|||
154841617|NCT03461757|558850964|FG001|Overall Study|Adverse Event|0|||
154841618|NCT03461757|558850963|FG000|Overall Study|Lost to Follow-up|13|||
154841619|NCT03461757|558850964|FG001|Overall Study|Lost to Follow-up|7|||
154841620|NCT03461757|558850963|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
154841621|NCT03461757|558850964|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
154841622|NCT03461757|558850963|FG000|Overall Study|Non-compliance with study treatment|0|||
154841623|NCT03461757|558850964|FG001|Overall Study|Non-compliance with study treatment|1|||
154841624|NCT03461757|558850963|FG000|Overall Study|Pregnancy|2|||
154841625|NCT03461757|558850964|FG001|Overall Study|Pregnancy|0|||
154841626|NCT03461757|558850963|FG000|Overall Study|Protocol Violation|1|||
154841627|NCT03461757|558850964|FG001|Overall Study|Protocol Violation|1|||
154841628|NCT03461757|558850963|FG000|Overall Study|Withdrawal by Subject|7|||
154841629|NCT03461757|558850964|FG001|Overall Study|Withdrawal by Subject|7|||
154841630|NCT03461757|558850963|FG000|Overall Study|Other Reasons|1|||
154841631|NCT03461757|558850964|FG001|Overall Study|Other Reasons|4|||
154841632|NCT03315871|558850968|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
154841633|NCT03315871|558850969|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
154841634|NCT03315871|558850970|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
154841635|NCT03315871|558850968|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
154841636|NCT03315871|558850969|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
154841637|NCT03315871|558850970|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
154841638|NCT03315871|558850968|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
154841639|NCT03315871|558850969|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
154841640|NCT03315871|558850970|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
154841641|NCT03315871|558850968|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
154841642|NCT03315871|558850969|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
154841643|NCT03315871|558850970|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
154841644|NCT03315871|558850968|FG000|PROSTVAC + CV301|Progressive disease|0|||
154841645|NCT03315871|558850969|FG001|PROSTVAC + CV301|Progressive disease|0|||
154841646|NCT03315871|558850970|FG002|PROSTVAC + CV301|Progressive disease|1|||
154841647|NCT03315871|558850968|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
154841648|NCT03315871|558850969|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
154841649|NCT03315871|558850970|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
154841650|NCT00328627|558854240|FG000|Overall Study|Hyperglycemic Rescue|41|||
154841651|NCT00328627|558854241|FG001|Overall Study|Hyperglycemic Rescue|18|||
154841652|NCT00328627|558854242|FG002|Overall Study|Hyperglycemic Rescue|16|||
154841653|NCT00328627|558854243|FG003|Overall Study|Hyperglycemic Rescue|13|||
154841654|NCT00328627|558854244|FG004|Overall Study|Hyperglycemic Rescue|6|||
154841655|NCT00328627|558854245|FG005|Overall Study|Hyperglycemic Rescue|5|||
154841656|NCT00328627|558854246|FG006|Overall Study|Hyperglycemic Rescue|19|||
154841657|NCT00328627|558854247|FG007|Overall Study|Hyperglycemic Rescue|6|||
154841658|NCT00328627|558854248|FG008|Overall Study|Hyperglycemic Rescue|6|||
154841659|NCT00328627|558854249|FG009|Overall Study|Hyperglycemic Rescue|11|||
154841660|NCT00328627|558854250|FG010|Overall Study|Hyperglycemic Rescue|3|||
154841661|NCT00328627|558854251|FG011|Overall Study|Hyperglycemic Rescue|2|||
154841662|NCT00328627|558854240|FG000|Overall Study|Adverse Event|3|||
154841663|NCT00328627|558854241|FG001|Overall Study|Adverse Event|1|||
154841664|NCT00328627|558854242|FG002|Overall Study|Adverse Event|2|||
154841665|NCT00328627|558854243|FG003|Overall Study|Adverse Event|3|||
154841666|NCT00328627|558854244|FG004|Overall Study|Adverse Event|1|||
154841667|NCT00328627|558854245|FG005|Overall Study|Adverse Event|2|||
154841668|NCT00328627|558854246|FG006|Overall Study|Adverse Event|1|||
154841669|NCT00328627|558854247|FG007|Overall Study|Adverse Event|2|||
154841670|NCT00328627|558854248|FG008|Overall Study|Adverse Event|0|||
154841671|NCT00328627|558854249|FG009|Overall Study|Adverse Event|7|||
154841672|NCT00328627|558854250|FG010|Overall Study|Adverse Event|5|||
154841673|NCT00328627|558854251|FG011|Overall Study|Adverse Event|4|||
154841674|NCT00328627|558854240|FG000|Overall Study|Protocol Violation|2|||
154841675|NCT00328627|558854241|FG001|Overall Study|Protocol Violation|2|||
154841676|NCT00328627|558854242|FG002|Overall Study|Protocol Violation|2|||
154841677|NCT00328627|558854243|FG003|Overall Study|Protocol Violation|8|||
154841678|NCT00328627|558854244|FG004|Overall Study|Protocol Violation|5|||
154841679|NCT00328627|558854245|FG005|Overall Study|Protocol Violation|5|||
154841680|NCT00328627|558854246|FG006|Overall Study|Protocol Violation|6|||
154841681|NCT00328627|558854247|FG007|Overall Study|Protocol Violation|2|||
154841682|NCT00328627|558854248|FG008|Overall Study|Protocol Violation|1|||
154841683|NCT00328627|558854249|FG009|Overall Study|Protocol Violation|4|||
154841684|NCT00328627|558854250|FG010|Overall Study|Protocol Violation|6|||
154841685|NCT00328627|558854251|FG011|Overall Study|Protocol Violation|2|||
154841686|NCT00328627|558854240|FG000|Overall Study|Lost to Follow-up|4|||
154841687|NCT00328627|558854241|FG001|Overall Study|Lost to Follow-up|2|||
154841688|NCT00328627|558854242|FG002|Overall Study|Lost to Follow-up|2|||
154841689|NCT00328627|558854243|FG003|Overall Study|Lost to Follow-up|4|||
154841690|NCT00328627|558854244|FG004|Overall Study|Lost to Follow-up|0|||
154841691|NCT00328627|558854245|FG005|Overall Study|Lost to Follow-up|2|||
154841692|NCT00328627|558854246|FG006|Overall Study|Lost to Follow-up|3|||
154841693|NCT00328627|558854247|FG007|Overall Study|Lost to Follow-up|0|||
154841694|NCT00328627|558854248|FG008|Overall Study|Lost to Follow-up|3|||
154841695|NCT00328627|558854249|FG009|Overall Study|Lost to Follow-up|2|||
154841696|NCT00328627|558854250|FG010|Overall Study|Lost to Follow-up|0|||
154841697|NCT00328627|558854251|FG011|Overall Study|Lost to Follow-up|1|||
154841698|NCT00328627|558854240|FG000|Overall Study|Withdrawal by Subject|5|||
154841699|NCT00328627|558854241|FG001|Overall Study|Withdrawal by Subject|4|||
154841700|NCT00328627|558854242|FG002|Overall Study|Withdrawal by Subject|5|||
154841701|NCT00328627|558854243|FG003|Overall Study|Withdrawal by Subject|6|||
154841702|NCT00328627|558854244|FG004|Overall Study|Withdrawal by Subject|2|||
154841703|NCT00328627|558854245|FG005|Overall Study|Withdrawal by Subject|5|||
154841704|NCT00328627|558854246|FG006|Overall Study|Withdrawal by Subject|4|||
154841705|NCT00328627|558854247|FG007|Overall Study|Withdrawal by Subject|4|||
154841706|NCT00328627|558854248|FG008|Overall Study|Withdrawal by Subject|4|||
154841707|NCT00328627|558854249|FG009|Overall Study|Withdrawal by Subject|5|||
154841708|NCT00328627|558854250|FG010|Overall Study|Withdrawal by Subject|2|||
154841709|NCT00328627|558854251|FG011|Overall Study|Withdrawal by Subject|7|||
154841710|NCT00328627|558854240|FG000|Overall Study|Pregnancy|0|||
154841711|NCT00328627|558854241|FG001|Overall Study|Pregnancy|1|||
154841712|NCT00328627|558854242|FG002|Overall Study|Pregnancy|0|||
154841713|NCT00328627|558854243|FG003|Overall Study|Pregnancy|0|||
154841714|NCT00328627|558854244|FG004|Overall Study|Pregnancy|0|||
154841715|NCT00328627|558854245|FG005|Overall Study|Pregnancy|0|||
154841716|NCT00328627|558854246|FG006|Overall Study|Pregnancy|0|||
154841717|NCT00328627|558854247|FG007|Overall Study|Pregnancy|0|||
154841718|NCT00328627|558854248|FG008|Overall Study|Pregnancy|0|||
154841719|NCT00328627|558854249|FG009|Overall Study|Pregnancy|0|||
154841720|NCT00328627|558854250|FG010|Overall Study|Pregnancy|0|||
154841721|NCT00328627|558854251|FG011|Overall Study|Pregnancy|0|||
154841722|NCT00328627|558854240|FG000|Overall Study|Physician Decision|4|||
154841723|NCT00328627|558854241|FG001|Overall Study|Physician Decision|3|||
154841724|NCT00328627|558854242|FG002|Overall Study|Physician Decision|1|||
154841725|NCT00328627|558854243|FG003|Overall Study|Physician Decision|2|||
154841726|NCT00328627|558854244|FG004|Overall Study|Physician Decision|1|||
154841727|NCT00328627|558854245|FG005|Overall Study|Physician Decision|1|||
154841728|NCT00328627|558854246|FG006|Overall Study|Physician Decision|1|||
154841729|NCT00328627|558854247|FG007|Overall Study|Physician Decision|0|||
155173526|NCT02043899|560074803|FG000|Overall Study|Physician Decision|1|||
154841730|NCT00328627|558854248|FG008|Overall Study|Physician Decision|3|||
154841731|NCT00328627|558854249|FG009|Overall Study|Physician Decision|2|||
154841732|NCT00328627|558854250|FG010|Overall Study|Physician Decision|1|||
154841733|NCT00328627|558854251|FG011|Overall Study|Physician Decision|0|||
154841734|NCT00328627|558854240|FG000|Overall Study|Other|0|||
154841735|NCT00328627|558854241|FG001|Overall Study|Other|0|||
154841736|NCT00328627|558854242|FG002|Overall Study|Other|0|||
154841737|NCT00328627|558854243|FG003|Overall Study|Other|1|||
154841738|NCT00328627|558854244|FG004|Overall Study|Other|0|||
154841739|NCT00328627|558854245|FG005|Overall Study|Other|0|||
154841740|NCT00328627|558854246|FG006|Overall Study|Other|1|||
154841741|NCT00328627|558854247|FG007|Overall Study|Other|0|||
154841742|NCT00328627|558854248|FG008|Overall Study|Other|0|||
155173527|NCT02043899|560074803|FG000|Overall Study|Withdrawal by Subject|2|||
154841743|NCT00328627|558854249|FG009|Overall Study|Other|1|||
154841744|NCT00328627|558854250|FG010|Overall Study|Other|1|||
154841745|NCT00328627|558854251|FG011|Overall Study|Other|0|||
154841746|NCT02049944|558854252|FG000|Overall Study|Protocol Violation|2|||
155104718|NCT02705105|559813841|FG000|Treatment|Adverse Event|0|||
155104719|NCT02705105|559813842|FG001|Treatment|Adverse Event|17|||
155104720|NCT02705105|559813841|FG000|Treatment|Clinical Disease Progression|0|||
154841747|NCT01761266|558854253|FG000|Overall Study|Death|415|||
154841748|NCT01761266|558854254|FG001|Overall Study|Death|402|||
154841749|NCT01761266|558854253|FG000|Overall Study|Lost to Follow-up|8|||
154841750|NCT01761266|558854254|FG001|Overall Study|Lost to Follow-up|12|||
154841751|NCT01761266|558854253|FG000|Overall Study|Withdrawal by Subject|14|||
154841752|NCT01761266|558854254|FG001|Overall Study|Withdrawal by Subject|10|||
154841753|NCT01761266|558854253|FG000|Overall Study|Sponsor Decision|41|||
154841754|NCT01761266|558854254|FG001|Overall Study|Sponsor Decision|52|||
154841755|NCT01662440|558854255|FG000|Overall Study|Adverse Event|1|||
154841756|NCT01662440|558854256|FG001|Overall Study|Adverse Event|0|||
154841757|NCT01662440|558854257|FG002|Overall Study|Adverse Event|0|||
154841758|NCT01662440|558854258|FG003|Overall Study|Adverse Event|1|||
154841759|NCT01662440|558854255|FG000|Overall Study|Death|0|||
154841760|NCT01662440|558854256|FG001|Overall Study|Death|1|||
154841761|NCT01662440|558854257|FG002|Overall Study|Death|0|||
154841762|NCT01662440|558854258|FG003|Overall Study|Death|0|||
154841763|NCT01662440|558854255|FG000|Overall Study|Lost to Follow-up|2|||
154841764|NCT01662440|558854256|FG001|Overall Study|Lost to Follow-up|2|||
154841765|NCT01662440|558854257|FG002|Overall Study|Lost to Follow-up|4|||
154841766|NCT01662440|558854258|FG003|Overall Study|Lost to Follow-up|1|||
154841767|NCT01662440|558854255|FG000|Overall Study|Subject moved to another country.|0|||
154841768|NCT01662440|558854256|FG001|Overall Study|Subject moved to another country.|1|||
154841769|NCT01662440|558854257|FG002|Overall Study|Subject moved to another country.|0|||
154841770|NCT01662440|558854258|FG003|Overall Study|Subject moved to another country.|0|||
154841771|NCT01662440|558854255|FG000|Overall Study|Protocol Violation|1|||
154841772|NCT01662440|558854256|FG001|Overall Study|Protocol Violation|0|||
154841773|NCT01662440|558854257|FG002|Overall Study|Protocol Violation|0|||
154841774|NCT01662440|558854258|FG003|Overall Study|Protocol Violation|0|||
154841775|NCT01662440|558854255|FG000|Overall Study|Withdrawal by Subject|5|||
154841776|NCT01662440|558854256|FG001|Overall Study|Withdrawal by Subject|2|||
154841777|NCT01662440|558854257|FG002|Overall Study|Withdrawal by Subject|2|||
154841778|NCT01662440|558854258|FG003|Overall Study|Withdrawal by Subject|2|||
154841779|NCT00112905|558854259|FG000|Overall Study|Adverse Event|4|||
154841780|NCT00112905|558854259|FG000|Overall Study|Death|1|||
154841781|NCT00112905|558854259|FG000|Overall Study|Ineligibility|5|||
154841782|NCT00112905|558854259|FG000|Overall Study|Alternative treatment|1|||
154841783|NCT00112905|558854259|FG000|Overall Study|performance status was deteiorating|1|||
154841784|NCT04541004|558854264|FG000|Overall Study|Adverse Event|2|||
154841785|NCT00605085|558854265|FG000|Overall Study|Withdrawal by Subject|8|||
154841786|NCT00605085|558854266|FG001|Overall Study|Withdrawal by Subject|5|||
154841787|NCT00605085|558854265|FG000|Overall Study|Adverse Event|9|||
154841788|NCT00605085|558854266|FG001|Overall Study|Adverse Event|5|||
154841789|NCT00605085|558854265|FG000|Overall Study|Pregnancy|2|||
154841790|NCT00605085|558854266|FG001|Overall Study|Pregnancy|0|||
154841791|NCT00605085|558854265|FG000|Overall Study|Protocol Violation|3|||
154841792|NCT00605085|558854266|FG001|Overall Study|Protocol Violation|2|||
154841793|NCT00605085|558854265|FG000|Overall Study|Lost to Follow-up|10|||
154841794|NCT00605085|558854266|FG001|Overall Study|Lost to Follow-up|5|||
154841795|NCT00605085|558854265|FG000|Overall Study|administrative reasons|18|||
154841796|NCT00605085|558854266|FG001|Overall Study|administrative reasons|8|||
154841797|NCT02229552|558854269|FG000|Baseline|Withdrawal by Subject|6|||
154841798|NCT02229552|558854269|FG000|1-year Follow up|Withdrawal by Subject|7|||
154841799|NCT02229552|558854269|FG000|1-year Follow up|Lost to Follow-up|18|||
154841800|NCT02229552|558854269|FG000|2-Year Follow up|Withdrawal by Subject|9|||
154841801|NCT02229552|558854269|FG000|2-Year Follow up|Lost to Follow-up|17|||
154841802|NCT00879229|558854270|FG000|Overall Study|Study terminated by Sponsor|13|||
154841803|NCT00879229|558854271|FG001|Overall Study|Study terminated by Sponsor|12|||
154841804|NCT00879229|558854270|FG000|Overall Study|Death|4|||
154841805|NCT00879229|558854271|FG001|Overall Study|Death|2|||
154841806|NCT00879229|558854270|FG000|Overall Study|Adverse Event|2|||
154841807|NCT00879229|558854271|FG001|Overall Study|Adverse Event|0|||
154841808|NCT00879229|558854270|FG000|Overall Study|Withdrawal by Subject|1|||
154841809|NCT00879229|558854271|FG001|Overall Study|Withdrawal by Subject|0|||
154841810|NCT00879229|558854270|FG000|Overall Study|Clinical status did not improve|1|||
154841811|NCT00879229|558854271|FG001|Overall Study|Clinical status did not improve|0|||
154841812|NCT00879229|558854270|FG000|Overall Study|Other|1|||
154841813|NCT00879229|558854271|FG001|Overall Study|Other|0|||
154841814|NCT02475681|558854272|FG000|Overall Study|Death|16|||
154841815|NCT02475681|558854273|FG001|Overall Study|Death|6|||
154841816|NCT02475681|558854274|FG002|Overall Study|Death|9|||
154841817|NCT02475681|558854272|FG000|Overall Study|Physician Decision|0|||
154841818|NCT02475681|558854273|FG001|Overall Study|Physician Decision|3|||
154841819|NCT02475681|558854274|FG002|Overall Study|Physician Decision|1|||
154841820|NCT02475681|558854272|FG000|Overall Study|Withdrawal by Subject|12|||
154841821|NCT02475681|558854273|FG001|Overall Study|Withdrawal by Subject|6|||
154841822|NCT02475681|558854274|FG002|Overall Study|Withdrawal by Subject|9|||
155104721|NCT02705105|559813842|FG001|Treatment|Clinical Disease Progression|32|||
155104722|NCT02705105|559813841|FG000|Treatment|Physician Decision|0|||
155104723|NCT02705105|559813842|FG001|Treatment|Physician Decision|3|||
155104724|NCT02705105|559813841|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
155104725|NCT02705105|559813842|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
155104726|NCT02705105|559813841|FG000|Follow-Up|Death|3|||
155104727|NCT02705105|559813842|FG001|Follow-Up|Death|68|||
155104728|NCT02705105|559813841|FG000|Follow-Up|Withdrawal by Subject|1|||
155104729|NCT02705105|559813842|FG001|Follow-Up|Withdrawal by Subject|14|||
155104730|NCT02705105|559813841|FG000|Follow-Up|Study Terminated|0|||
154841823|NCT02475681|558854272|FG000|Overall Study|Lost to Follow-up|2|||
155104731|NCT02705105|559813842|FG001|Follow-Up|Study Terminated|26|||
154841824|NCT02475681|558854273|FG001|Overall Study|Lost to Follow-up|1|||
154841825|NCT02475681|558854274|FG002|Overall Study|Lost to Follow-up|3|||
154841826|NCT02475681|558854272|FG000|Overall Study|Ongoing in Study|0|||
154841827|NCT02475681|558854273|FG001|Overall Study|Ongoing in Study|163|||
154841828|NCT02475681|558854274|FG002|Overall Study|Ongoing in Study|157|||
154841829|NCT02475681|558854272|FG000|Overall Study|Reasons other than above listed|2|||
154841830|NCT02475681|558854273|FG001|Overall Study|Reasons other than above listed|0|||
154841831|NCT02475681|558854274|FG002|Overall Study|Reasons other than above listed|0|||
154841832|NCT01652287|558854277|FG000|Overall Study|Withdrawal by Subject|2|||
154841833|NCT01652287|558854278|FG001|Overall Study|Withdrawal by Subject|0|||
154841834|NCT02605642|558854283|FG000|Overall Study|Other|11|||
154841835|NCT02605642|558854284|FG001|Overall Study|Other|1|||
154841836|NCT02605642|558854283|FG000|Overall Study|Participant non-compliance|2|||
154841837|NCT02605642|558854284|FG001|Overall Study|Participant non-compliance|4|||
154841838|NCT02605642|558854283|FG000|Overall Study|Physician Decision|10|||
154841839|NCT02605642|558854284|FG001|Overall Study|Physician Decision|0|||
154841840|NCT02605642|558854283|FG000|Overall Study|Lost to Follow-up|12|||
154841841|NCT02605642|558854284|FG001|Overall Study|Lost to Follow-up|1|||
154841842|NCT02605642|558854283|FG000|Overall Study|Adverse Event|14|||
154841843|NCT02605642|558854284|FG001|Overall Study|Adverse Event|2|||
154841844|NCT02605642|558854283|FG000|Overall Study|Withdrawal by Subject|23|||
154841845|NCT02605642|558854284|FG001|Overall Study|Withdrawal by Subject|2|||
154841846|NCT02605642|558854283|FG000|Overall Study|Lack of response|24|||
154841847|NCT02605642|558854284|FG001|Overall Study|Lack of response|11|||
154841848|NCT02354703|558854293|FG000|Overall Study|Withdrawal by Subject|1|||
154841849|NCT02354703|558854294|FG001|Overall Study|Withdrawal by Subject|1|||
154841850|NCT02354703|558854295|FG002|Overall Study|Withdrawal by Subject|1|||
154841851|NCT02354703|558854296|FG003|Overall Study|Withdrawal by Subject|1|||
154841852|NCT02354703|558854293|FG000|Overall Study|Lost to Follow-up|2|||
154841853|NCT02354703|558854294|FG001|Overall Study|Lost to Follow-up|7|||
154841854|NCT02354703|558854295|FG002|Overall Study|Lost to Follow-up|9|||
154841855|NCT02354703|558854296|FG003|Overall Study|Lost to Follow-up|2|||
154841856|NCT02354703|558854293|FG000|Overall Study|Adverse Event|0|||
154841857|NCT02354703|558854294|FG001|Overall Study|Adverse Event|0|||
154841858|NCT02354703|558854295|FG002|Overall Study|Adverse Event|1|||
154841859|NCT02354703|558854296|FG003|Overall Study|Adverse Event|0|||
154841860|NCT02597855|558854302|FG000|Overall Study|Lost to Follow-up|2|||
154841861|NCT02597855|558854303|FG001|Overall Study|Lost to Follow-up|1|||
154841862|NCT03704194|558854307|FG000|Overall Study|Withdrawal by Subject|0|||
154841863|NCT03704194|558854308|FG001|Overall Study|Withdrawal by Subject|1|||
154841864|NCT00179309|558854313|FG000|Treatment|Toxicity|2|||
154841865|NCT00179309|558854314|FG001|Treatment|Toxicity|3|||
154841866|NCT00179309|558854313|FG000|Treatment|Withdrawal by Subject|1|||
154841867|NCT00179309|558854314|FG001|Treatment|Withdrawal by Subject|2|||
154841868|NCT00179309|558854313|FG000|Treatment|Allergy|1|||
154841869|NCT00179309|558854314|FG001|Treatment|Allergy|0|||
154841870|NCT04681170|558854315|FG000|Stratified Enrolment & run-in|Death|1|||
154841871|NCT04681170|558854316|FG001|Stratified Enrolment & run-in|Death|0|||
154841872|NCT04681170|558854315|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
154841873|NCT04681170|558854316|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
154841874|NCT04681170|558854315|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
154841875|NCT04681170|558854316|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
154841876|NCT04681170|558854315|FG000|Open Label Efficacy Phase|Adverse Event|0|||
154841877|NCT04681170|558854316|FG001|Open Label Efficacy Phase|Adverse Event|2|||
154841878|NCT04681170|558854315|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
154841879|NCT04681170|558854316|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
154841880|NCT04681170|558854315|FG000|Open Label Safety Phase|AEs and none compliance|0|||
154841881|NCT04681170|558854316|FG001|Open Label Safety Phase|AEs and none compliance|1|||
154841882|NCT01407926|558854321|FG000|Overall Study|Lost to Follow-up|55|||
154971102|NCT02832167|559318529|FG000|Treatment Period 2|Participant withdrew consent|3|||
154841883|NCT05131204|558854322|FG000|Overall Study|Sponsor request|2|||
154841884|NCT05131204|558854323|FG001|Overall Study|Sponsor request|1|||
154841885|NCT00488982|558854324|FG000|Course 1|Physician Decision|0|||
154841886|NCT00488982|558854325|FG001|Course 1|Physician Decision|2|||
154841887|NCT00488982|558854326|FG002|Course 1|Physician Decision|4|||
154841888|NCT00488982|558854324|FG000|Course 1|Withdrawal by Subject|0|||
154841889|NCT00488982|558854325|FG001|Course 1|Withdrawal by Subject|8|||
154841890|NCT00488982|558854326|FG002|Course 1|Withdrawal by Subject|2|||
154841891|NCT00488982|558854324|FG000|Course 1|nonprotocol therapy|0|||
154841892|NCT00488982|558854325|FG001|Course 1|nonprotocol therapy|2|||
154841893|NCT00488982|558854326|FG002|Course 1|nonprotocol therapy|2|||
154841894|NCT00488982|558854324|FG000|Course 1|Adverse Event|0|||
154841895|NCT00488982|558854325|FG001|Course 1|Adverse Event|0|||
154841896|NCT00488982|558854326|FG002|Course 1|Adverse Event|6|||
154841897|NCT01368835|558854327|FG000|Overall Study|Inclusion criteria/photography quality|22|||
154841898|NCT01368835|558854327|FG000|Overall Study|Lost to Follow-up|11|||
154971103|NCT02832167|559318529|FG000|Treatment Period 2|Other reasons|3|||
154841899|NCT01885000|558854328|FG000|Overall Study|Adverse Event|1|||
154841900|NCT01885000|558854329|FG001|Overall Study|Adverse Event|0|||
154841901|NCT01885000|558854328|FG000|Overall Study|Withdrawal by Subject|1|||
154841902|NCT01885000|558854329|FG001|Overall Study|Withdrawal by Subject|1|||
154841903|NCT01885000|558854328|FG000|Overall Study|Protocol Violation|0|||
154841904|NCT01885000|558854329|FG001|Overall Study|Protocol Violation|1|||
154841905|NCT02363686|558854333|FG000|Overall Study|Withdrawal by Subject|22|||
154841906|NCT02363686|558854333|FG000|Overall Study|incomplete FEES examinations|13|||
154841907|NCT02469090|558854339|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
154841908|NCT02469090|558854340|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
154841909|NCT02469090|558854341|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
154841910|NCT02469090|558854339|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
154841911|NCT02469090|558854340|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
154841912|NCT02469090|558854341|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
154841913|NCT02469090|558854339|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
154841914|NCT02469090|558854340|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
154841915|NCT02469090|558854341|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
154841916|NCT02469090|558854339|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
154841917|NCT02469090|558854340|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
154841918|NCT02469090|558854341|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
154841919|NCT02469090|558854339|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
154841920|NCT02469090|558854340|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
154841921|NCT02469090|558854341|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
154841922|NCT02469090|558854339|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
154841923|NCT02469090|558854340|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
154841924|NCT02469090|558854341|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
154841925|NCT02469090|558854339|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
154841926|NCT02469090|558854340|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
154841927|NCT02469090|558854341|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
154841928|NCT02469090|558854339|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
154841929|NCT02469090|558854340|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
154841930|NCT02469090|558854341|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
154841931|NCT03806127|558854343|FG000|Overall Study|Withdrawal by Subject|4|||
154841932|NCT03806127|558854344|FG001|Overall Study|Withdrawal by Subject|5|||
154841933|NCT03806127|558854343|FG000|Overall Study|Protocol Violation|3|||
154841934|NCT03806127|558854344|FG001|Overall Study|Protocol Violation|1|||
154841935|NCT03806127|558854343|FG000|Overall Study|Adverse Event|3|||
154841936|NCT03806127|558854344|FG001|Overall Study|Adverse Event|0|||
154841937|NCT03806127|558854343|FG000|Overall Study|Unable to Complete Procedures|0|||
154841938|NCT03806127|558854344|FG001|Overall Study|Unable to Complete Procedures|1|||
154841939|NCT03806127|558854343|FG000|Overall Study|Pregnancy|0|||
154841940|NCT03806127|558854344|FG001|Overall Study|Pregnancy|1|||
154841941|NCT03806127|558854343|FG000|Overall Study|Lost to Follow-up|5|||
154841942|NCT03806127|558854344|FG001|Overall Study|Lost to Follow-up|1|||
154841943|NCT03806127|558854343|FG000|Overall Study|Physician Decision|1|||
154841944|NCT03806127|558854344|FG001|Overall Study|Physician Decision|1|||
154841945|NCT03806127|558854343|FG000|Overall Study|Could Not Come Due to Covid|1|||
154841946|NCT03806127|558854344|FG001|Overall Study|Could Not Come Due to Covid|0|||
154841947|NCT03806127|558854343|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
154841948|NCT03806127|558854344|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
154841949|NCT03806127|558854343|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
154841950|NCT03806127|558854344|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
154841951|NCT03806127|558854343|FG000|Overall Study|Covid 19 Restrictions|2|||
154841952|NCT03806127|558854344|FG001|Overall Study|Covid 19 Restrictions|0|||
154841953|NCT03806127|558854343|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
154841954|NCT03806127|558854344|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
154841955|NCT03806127|558854343|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
154841956|NCT03806127|558854344|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
154841957|NCT03446885|558854346|FG000|Overall Study|Lost to Follow-up|1|||
154841958|NCT03446885|558854347|FG001|Overall Study|Lost to Follow-up|0|||
154841959|NCT03446885|558854346|FG000|Overall Study|Did not complete entire visit|1|||
154841960|NCT03446885|558854347|FG001|Overall Study|Did not complete entire visit|0|||
154841961|NCT05882318|558854356|FG000|Overall Study|Withdrawal by Subject|1|||
154841962|NCT05882318|558854357|FG001|Overall Study|Withdrawal by Subject|0|||
154841963|NCT05882318|558854356|FG000|Overall Study|Protocol Violation|0|||
154841964|NCT05882318|558854357|FG001|Overall Study|Protocol Violation|1|||
154841965|NCT05030311|558854358|FG000|Overall Study|Technical problems|0|||
154841966|NCT05030311|558854359|FG001|Overall Study|Technical problems|1|||
154841967|NCT05030311|558854358|FG000|Overall Study|Withdrawal by Subject|31|||
154841968|NCT05030311|558854359|FG001|Overall Study|Withdrawal by Subject|17|||
154841969|NCT05030311|558854358|FG000|Overall Study|Adverse Event|13|||
154841970|NCT05030311|558854359|FG001|Overall Study|Adverse Event|5|||
155104732|NCT02705105|559813841|FG000|Follow-Up|Discontinued per Amendment 3|0|||
154841971|NCT05030311|558854358|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154841972|NCT05030311|558854359|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
154841973|NCT05030311|558854358|FG000|Overall Study|Physician Decision|5|||
154841974|NCT05030311|558854359|FG001|Overall Study|Physician Decision|2|||
154841975|NCT05030311|558854358|FG000|Overall Study|Lost to Follow-up|5|||
154841976|NCT05030311|558854359|FG001|Overall Study|Lost to Follow-up|1|||
154841977|NCT05030311|558854358|FG000|Overall Study|Protocol Violation|4|||
154841978|NCT05030311|558854359|FG001|Overall Study|Protocol Violation|4|||
154841979|NCT03042468|558854360|FG000|Overall Study|Death|0|||
154841980|NCT03042468|558854361|FG001|Overall Study|Death|1|||
154841981|NCT03042468|558854362|FG002|Overall Study|Death|1|||
154841982|NCT03042468|558854363|FG003|Overall Study|Death|0|||
154841983|NCT03042468|558854364|FG004|Overall Study|Death|0|||
154841984|NCT03042468|558854365|FG005|Overall Study|Death|0|||
154841985|NCT03042468|558854360|FG000|Overall Study|Withdrawal by Subject|0|||
154841986|NCT03042468|558854361|FG001|Overall Study|Withdrawal by Subject|0|||
154841987|NCT03042468|558854362|FG002|Overall Study|Withdrawal by Subject|0|||
154841988|NCT03042468|558854363|FG003|Overall Study|Withdrawal by Subject|0|||
154841989|NCT03042468|558854364|FG004|Overall Study|Withdrawal by Subject|0|||
154841990|NCT03042468|558854365|FG005|Overall Study|Withdrawal by Subject|1|||
154841991|NCT03042468|558854360|FG000|Overall Study|Lost to Follow-up|0|||
154841992|NCT03042468|558854361|FG001|Overall Study|Lost to Follow-up|0|||
154841993|NCT03042468|558854362|FG002|Overall Study|Lost to Follow-up|0|||
154841994|NCT03042468|558854363|FG003|Overall Study|Lost to Follow-up|0|||
154841995|NCT03042468|558854364|FG004|Overall Study|Lost to Follow-up|1|||
154841996|NCT03042468|558854365|FG005|Overall Study|Lost to Follow-up|1|||
154841997|NCT01662895|558854366|FG000|Overall Study|Lost to Follow-up|0|||
154841998|NCT01662895|558854367|FG001|Overall Study|Lost to Follow-up|1|||
154841999|NCT02275338|558854368|FG000|Overall Study|Adverse Event|15|||
154842000|NCT02275338|558854368|FG000|Overall Study|Lack of Efficacy|3|||
154842001|NCT02275338|558854368|FG000|Overall Study|Withdrawal by Subject|4|||
154842002|NCT02275338|558854368|FG000|Overall Study|Disease progression (death)|1|||
154842003|NCT02275338|558854368|FG000|Overall Study|Ineligible to start Phase 2|4|||
154842004|NCT02275338|558854368|FG000|Overall Study|Reason not specified|5|||
154842005|NCT02275338|558854368|FG000|Overall Study|Does not meet entry criteria|1|||
154842006|NCT01665807|558854369|FG000|Overall Study|Withdrawal by Subject|2|||
154842007|NCT01665807|558854370|FG001|Overall Study|Withdrawal by Subject|0|||
154842008|NCT01665807|558854371|FG002|Overall Study|Withdrawal by Subject|1|||
154842009|NCT00623428|558854372|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
154842010|NCT00623428|558854373|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
154842011|NCT00623428|558854372|FG000|Treatment Period|Death|0|||
154842012|NCT00623428|558854373|FG001|Treatment Period|Death|1|||
154842013|NCT00623428|558854372|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
154842014|NCT00623428|558854373|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
154842015|NCT00623428|558854372|FG000|Treatment Period|Insufficient therapeutic response|0|||
154842016|NCT00623428|558854373|FG001|Treatment Period|Insufficient therapeutic response|2|||
154842017|NCT00623428|558854372|FG000|Treatment Period|Other|0|||
154842018|NCT00623428|558854373|FG001|Treatment Period|Other|1|||
154842019|NCT00623428|558854372|FG000|Treatment Period|Withdrawal by Subject|0|||
154842020|NCT00623428|558854373|FG001|Treatment Period|Withdrawal by Subject|1|||
154842021|NCT00623428|558854372|FG000|Follow-up Period|Relapse post-treatment|11|||
154842022|NCT00623428|558854373|FG001|Follow-up Period|Relapse post-treatment|3|||
154842023|NCT00623428|558854372|FG000|Follow-up Period|Failure to return|10|||
154842024|NCT00623428|558854373|FG001|Follow-up Period|Failure to return|2|||
154842025|NCT00623428|558854372|FG000|Follow-up Period|Patient withdrew consent|5|||
154842026|NCT00623428|558854373|FG001|Follow-up Period|Patient withdrew consent|4|||
154842027|NCT00623428|558854372|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
154842028|NCT00623428|558854373|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
154842029|NCT00623428|558854372|FG000|Follow-up Period|Did not cooperate|0|||
154842030|NCT00623428|558854373|FG001|Follow-up Period|Did not cooperate|3|||
154842031|NCT00623428|558854372|FG000|Follow-up Period|Reason not specified|1|||
154842032|NCT00623428|558854373|FG001|Follow-up Period|Reason not specified|1|||
154842033|NCT00623428|558854372|FG000|Follow-up Period|Death|0|||
154842034|NCT00623428|558854373|FG001|Follow-up Period|Death|1|||
155104733|NCT02705105|559813842|FG001|Follow-Up|Discontinued per Amendment 3|2|||
154842035|NCT01692301|558854374|FG000|Overall Study|Adverse Event|15|||
154842036|NCT01692301|558854375|FG001|Overall Study|Adverse Event|12|||
154842037|NCT01692301|558854374|FG000|Overall Study|Death|1|||
154842038|NCT01692301|558854375|FG001|Overall Study|Death|2|||
154842039|NCT01692301|558854374|FG000|Overall Study|Lack of Efficacy|0|||
154842040|NCT01692301|558854375|FG001|Overall Study|Lack of Efficacy|5|||
154842041|NCT01692301|558854374|FG000|Overall Study|Non-compliance with study treatment|1|||
154842042|NCT01692301|558854375|FG001|Overall Study|Non-compliance with study treatment|2|||
154842043|NCT01692301|558854374|FG000|Overall Study|Protocol deviation|9|||
154842044|NCT01692301|558854375|FG001|Overall Study|Protocol deviation|2|||
154842045|NCT01692301|558854374|FG000|Overall Study|Patient/guardian decision|16|||
154842046|NCT01692301|558854375|FG001|Overall Study|Patient/guardian decision|15|||
154842047|NCT01692301|558854374|FG000|Overall Study|Technical problems|0|||
154842048|NCT01692301|558854375|FG001|Overall Study|Technical problems|1|||
154842049|NCT01692301|558854374|FG000|Overall Study|Physician Decision|2|||
155104734|NCT00485758|559813845|FG000|Overall Study|Adverse Event|102|||
155104735|NCT00485758|559813846|FG001|Overall Study|Adverse Event|31|||
154842050|NCT01692301|558854375|FG001|Overall Study|Physician Decision|2|||
154842051|NCT01692301|558854374|FG000|Overall Study|Lost to Follow-up|1|||
154842052|NCT01692301|558854375|FG001|Overall Study|Lost to Follow-up|1|||
154842053|NCT01142726|558854376|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
154842054|NCT01142726|558854377|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
154842055|NCT01142726|558854378|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
154842056|NCT01142726|558854376|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
154842057|NCT01142726|558854377|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
154842058|NCT01142726|558854378|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
154842059|NCT01142726|558854376|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
154842060|NCT01142726|558854377|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
154842061|NCT01142726|558854378|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
154842062|NCT01142726|558854376|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
154842063|NCT01142726|558854377|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
154842064|NCT01142726|558854378|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
154842065|NCT01142726|558854376|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
154842066|NCT01142726|558854377|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
154842067|NCT01142726|558854378|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
154842068|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
154842069|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
154842070|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
154842071|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
154842072|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
154842073|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
154842074|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
154842075|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
154842076|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
154842077|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
154842078|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
154842079|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
154842080|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
154842081|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
154842082|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
154842083|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
154842084|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
154842085|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
154842086|NCT01142726|558854376|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
154842087|NCT01142726|558854377|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
154842088|NCT01142726|558854378|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
154842089|NCT01142726|558854376|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
154842090|NCT01142726|558854377|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
154842091|NCT01142726|558854378|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
154842092|NCT01142726|558854376|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
154842093|NCT01142726|558854377|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
154842094|NCT01142726|558854378|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
154842095|NCT01142726|558854376|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
154842096|NCT01142726|558854377|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
154842097|NCT01142726|558854378|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
154842098|NCT01142726|558854376|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
154842099|NCT01142726|558854377|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
154971104|NCT01754376|559318530|FG000|Overall Study|Adverse Event|1|||
155104736|NCT00485758|559813845|FG000|Overall Study|Death|0|||
155104737|NCT00485758|559813846|FG001|Overall Study|Death|1|||
155104738|NCT00485758|559813845|FG000|Overall Study|Lost to Follow-up|5|||
155104739|NCT00485758|559813846|FG001|Overall Study|Lost to Follow-up|1|||
155104740|NCT00485758|559813845|FG000|Overall Study|Physician Decision|3|||
155104741|NCT00485758|559813846|FG001|Overall Study|Physician Decision|3|||
155104742|NCT00485758|559813845|FG000|Overall Study|Protocol Violation|11|||
154842100|NCT01142726|558854378|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
154842101|NCT01568593|558854379|FG000|Overall Study|Lack of Efficacy|4|||
154842102|NCT01568593|558854380|FG001|Overall Study|Lack of Efficacy|1|||
154842103|NCT01568593|558854379|FG000|Overall Study|Adverse Event|3|||
155104743|NCT00485758|559813846|FG001|Overall Study|Protocol Violation|2|||
155104744|NCT00485758|559813845|FG000|Overall Study|Withdrawal by Subject|32|||
154842104|NCT01568593|558854380|FG001|Overall Study|Adverse Event|2|||
154842105|NCT02788747|558854385|FG000|Overall Study|Adverse Event|1|||
154842106|NCT02788747|558854386|FG001|Overall Study|Adverse Event|0|||
154842107|NCT02788747|558854387|FG002|Overall Study|Adverse Event|0|||
154842108|NCT01079182|558854388|FG000|Overall Study|Lost to Follow-up|1634|||
154842109|NCT01079182|558854388|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
154842110|NCT01079182|558854388|FG000|Overall Study|Lack of Efficacy|514|||
154842111|NCT01079182|558854388|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
154842112|NCT01079182|558854388|FG000|Overall Study|Reasons not Evaluated|271|||
154842113|NCT01026831|558854389|FG000|Overall Study|Adverse Event|4|||
154842114|NCT01026831|558854390|FG001|Overall Study|Adverse Event|3|||
154842115|NCT01026831|558854389|FG000|Overall Study|Lost to Follow-up|2|||
154842116|NCT01026831|558854390|FG001|Overall Study|Lost to Follow-up|0|||
154842117|NCT01026831|558854389|FG000|Overall Study|Physician Decision|1|||
154842118|NCT01026831|558854390|FG001|Overall Study|Physician Decision|1|||
154842119|NCT01026831|558854389|FG000|Overall Study|Protocol Violation|0|||
154842120|NCT01026831|558854390|FG001|Overall Study|Protocol Violation|2|||
154842121|NCT01026831|558854389|FG000|Overall Study|Withdrawal by Subject|7|||
154842122|NCT01026831|558854390|FG001|Overall Study|Withdrawal by Subject|5|||
154842123|NCT04417894|558854391|FG000|Overall Study|Lost to Follow-up|3|||
154842124|NCT04417894|558854392|FG001|Overall Study|Lost to Follow-up|0|||
154842125|NCT04417894|558854391|FG000|Overall Study|Withdrawal by Subject|7|||
154842126|NCT04417894|558854392|FG001|Overall Study|Withdrawal by Subject|6|||
154842127|NCT04417894|558854391|FG000|Overall Study|Lack of Efficacy|3|||
154842128|NCT04417894|558854392|FG001|Overall Study|Lack of Efficacy|1|||
154842129|NCT04472429|558854393|FG000|Randomized Period|Ongoing|90|||
154842130|NCT04472429|558854394|FG001|Randomized Period|Ongoing|40|||
154842131|NCT04472429|558854395|FG002|Randomized Period|Ongoing|0|||
154842132|NCT04472429|558854393|FG000|Randomized Period|Death|52|||
154842133|NCT04472429|558854394|FG001|Randomized Period|Death|37|||
155104745|NCT00485758|559813846|FG001|Overall Study|Withdrawal by Subject|27|||
155104746|NCT00485758|559813845|FG000|Overall Study|Study Terminated by Sponsor|3|||
155104747|NCT00485758|559813846|FG001|Overall Study|Study Terminated by Sponsor|0|||
154842134|NCT04472429|558854395|FG002|Randomized Period|Death|0|||
154842135|NCT04472429|558854393|FG000|Randomized Period|Lost to Follow-up|4|||
154842136|NCT04472429|558854394|FG001|Randomized Period|Lost to Follow-up|0|||
154842137|NCT04472429|558854395|FG002|Randomized Period|Lost to Follow-up|0|||
154842138|NCT04472429|558854393|FG000|Randomized Period|Physician Decision|1|||
154842139|NCT04472429|558854394|FG001|Randomized Period|Physician Decision|2|||
154842140|NCT04472429|558854395|FG002|Randomized Period|Physician Decision|0|||
154842141|NCT04472429|558854393|FG000|Randomized Period|Withdrawal by Subject|6|||
154842142|NCT04472429|558854394|FG001|Randomized Period|Withdrawal by Subject|5|||
154842143|NCT04472429|558854395|FG002|Randomized Period|Withdrawal by Subject|0|||
154842144|NCT04472429|558854393|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
154842145|NCT04472429|558854394|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
154842146|NCT04472429|558854395|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
154842147|NCT04472429|558854393|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
154842148|NCT04472429|558854394|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
155104748|NCT02526212|559813854|FG000|Overall Study|Incarceration|1|||
155104749|NCT02526212|559813855|FG001|Overall Study|Incarceration|0|||
154842149|NCT04472429|558854395|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
154842150|NCT04472429|558854393|FG000|Open-label Monotherapy Period|Ongoing|0|||
155104750|NCT02526212|559813854|FG000|Overall Study|Lost to Follow-up|1|||
155104751|NCT02526212|559813855|FG001|Overall Study|Lost to Follow-up|0|||
155104752|NCT02526212|559813854|FG000|Overall Study|Death|0|||
155104753|NCT02526212|559813855|FG001|Overall Study|Death|1|||
155104754|NCT02096952|559813862|FG000|Overall Study|Adverse Event|1|||
155104755|NCT00635349|559813864|FG000|Overall Study|Other|8|||
155104756|NCT00635349|559813865|FG001|Overall Study|Other|6|||
155104757|NCT00635349|559813864|FG000|Overall Study|Protocol Violation|18|||
155104758|NCT00635349|559813865|FG001|Overall Study|Protocol Violation|22|||
155104759|NCT00635349|559813864|FG000|Overall Study|Withdrawal by Subject|3|||
155104760|NCT00635349|559813865|FG001|Overall Study|Withdrawal by Subject|8|||
154842151|NCT04472429|558854394|FG001|Open-label Monotherapy Period|Ongoing|0|||
154842152|NCT04472429|558854395|FG002|Open-label Monotherapy Period|Ongoing|32|||
154842153|NCT04472429|558854393|FG000|Open-label Monotherapy Period|Death|0|||
154842154|NCT04472429|558854394|FG001|Open-label Monotherapy Period|Death|0|||
154842155|NCT04472429|558854395|FG002|Open-label Monotherapy Period|Death|35|||
154842156|NCT04472429|558854393|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
154842157|NCT04472429|558854394|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
154842158|NCT04472429|558854395|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
154842159|NCT01180660|558854396|FG000|Overall Study|Changed to open surgery|1|||
154971105|NCT01754376|559318530|FG000|Overall Study|Lack of Efficacy|2|||
154971106|NCT04556734|559318531|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
155104761|NCT00635349|559813864|FG000|Overall Study|Lost to Follow-up|4|||
155104762|NCT00635349|559813865|FG001|Overall Study|Lost to Follow-up|3|||
155104763|NCT00635349|559813864|FG000|Overall Study|Adverse Event|11|||
155104764|NCT00635349|559813865|FG001|Overall Study|Adverse Event|9|||
155104765|NCT02446769|559813868|FG000|Screening Period|Screen Failure|11|||
155104766|NCT02446769|559813869|FG001|Screening Period|Screen Failure|0|||
155104767|NCT02446769|559813870|FG002|Screening Period|Screen Failure|0|||
155104768|NCT02446769|559813868|FG000|Study Period|Randomized in Error|0|||
155104769|NCT02446769|559813869|FG001|Study Period|Randomized in Error|2|||
155104770|NCT02446769|559813870|FG002|Study Period|Randomized in Error|0|||
154842160|NCT01180660|558854397|FG001|Overall Study|Changed to open surgery|0|||
154842161|NCT02425826|558854398|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
155104771|NCT04482439|559813871|FG000|Overall Study|Lost to Follow-up|1|||
155104772|NCT04482439|559813871|FG000|Overall Study|Unrelated illness|1|||
154842162|NCT02425826|558854399|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
154842163|NCT02425826|558854400|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
154842164|NCT02425826|558854398|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
154842165|NCT02425826|558854399|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
154842166|NCT02425826|558854400|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
154842167|NCT02425826|558854398|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
154842168|NCT02425826|558854399|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
154842169|NCT02425826|558854400|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
154842170|NCT02425826|558854398|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
154842171|NCT02425826|558854399|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
154842172|NCT02425826|558854400|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
154842173|NCT02425826|558854398|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
154842174|NCT02425826|558854399|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
154842175|NCT02425826|558854400|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
154842176|NCT02425826|558854398|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
154842177|NCT02425826|558854399|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
154842178|NCT02425826|558854400|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
154842179|NCT02425826|558854398|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
154842180|NCT02425826|558854399|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
154842181|NCT02425826|558854400|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
154842182|NCT02425826|558854398|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
154842183|NCT02425826|558854399|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
154842184|NCT02425826|558854400|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
154842185|NCT02425826|558854398|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
154842186|NCT02425826|558854399|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
154842187|NCT02425826|558854400|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
154842188|NCT02425826|558854398|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
154842189|NCT02425826|558854399|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
154971107|NCT04556734|559318532|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
154971108|NCT04556734|559318533|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
154971109|NCT04556734|559318534|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154971110|NCT04556734|559318535|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154971111|NCT04556734|559318536|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154971112|NCT04556734|559318537|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154971113|NCT04556734|559318538|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154971114|NCT04556734|559318531|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
154971115|NCT04556734|559318532|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971116|NCT04556734|559318533|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971117|NCT04556734|559318534|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971118|NCT04556734|559318535|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971119|NCT04556734|559318536|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971120|NCT04556734|559318537|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971121|NCT04556734|559318538|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
154971122|NCT04556734|559318531|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154971123|NCT04556734|559318532|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154971124|NCT04556734|559318533|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154971125|NCT04556734|559318534|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154971126|NCT04556734|559318535|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154971127|NCT04556734|559318536|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154971128|NCT04556734|559318537|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154971129|NCT04556734|559318538|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154971130|NCT04556734|559318531|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
154971131|NCT04556734|559318532|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971132|NCT04556734|559318533|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971133|NCT04556734|559318534|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971134|NCT04556734|559318535|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971135|NCT04556734|559318536|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971136|NCT04556734|559318537|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971137|NCT04556734|559318538|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154971138|NCT04556734|559318531|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154971139|NCT04556734|559318532|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154971140|NCT04556734|559318533|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
154971141|NCT04556734|559318534|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154971142|NCT04556734|559318535|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154971143|NCT04556734|559318536|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154842190|NCT02425826|558854400|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
154842191|NCT04942925|558854407|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
154842192|NCT04942925|558854408|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
154842193|NCT04942925|558854407|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
154842194|NCT04942925|558854408|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
154842195|NCT02043548|558854411|FG000|Overall Study|Lack of Efficacy|1|||
154842196|NCT02043548|558854412|FG001|Overall Study|Lack of Efficacy|0|||
154842197|NCT02043548|558854411|FG000|Overall Study|Adverse Event|0|||
154842198|NCT02043548|558854412|FG001|Overall Study|Adverse Event|1|||
154842199|NCT01344876|558854413|FG000|Overall Study|Adverse Event|0|||
154842200|NCT01344876|558854414|FG001|Overall Study|Adverse Event|0|||
154842201|NCT01344876|558854415|FG002|Overall Study|Adverse Event|0|||
154842202|NCT01344876|558854416|FG003|Overall Study|Adverse Event|0|||
154842203|NCT01344876|558854417|FG004|Overall Study|Adverse Event|1|||
154842204|NCT01344876|558854413|FG000|Overall Study|Withdrawal by Subject|0|||
154842205|NCT01344876|558854414|FG001|Overall Study|Withdrawal by Subject|0|||
154842206|NCT01344876|558854415|FG002|Overall Study|Withdrawal by Subject|1|||
154842207|NCT01344876|558854416|FG003|Overall Study|Withdrawal by Subject|0|||
154842208|NCT01344876|558854417|FG004|Overall Study|Withdrawal by Subject|0|||
154842209|NCT01344876|558854413|FG000|Overall Study|Definite progression of primary disease|1|||
154842210|NCT01344876|558854414|FG001|Overall Study|Definite progression of primary disease|0|||
154842211|NCT01344876|558854415|FG002|Overall Study|Definite progression of primary disease|0|||
154842212|NCT01344876|558854416|FG003|Overall Study|Definite progression of primary disease|3|||
154842213|NCT01344876|558854417|FG004|Overall Study|Definite progression of primary disease|0|||
154842214|NCT05107765|558854418|FG000|Overall Study|Lost to Follow-up|4|||
154842215|NCT05107765|558854419|FG001|Overall Study|Lost to Follow-up|1|||
154842216|NCT05107765|558854418|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
154842217|NCT05107765|558854419|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
154842218|NCT05107765|558854418|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
154842219|NCT05107765|558854419|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
154842220|NCT00562588|558854420|FG000|Overall Study|Adverse Event|40|||
154842221|NCT00562588|558854421|FG001|Overall Study|Adverse Event|58|||
154842222|NCT00562588|558854420|FG000|Overall Study|Protocol Violation|30|||
154842223|NCT00562588|558854421|FG001|Overall Study|Protocol Violation|26|||
154842224|NCT00562588|558854420|FG000|Overall Study|Lost to Follow-up|12|||
154842225|NCT00562588|558854421|FG001|Overall Study|Lost to Follow-up|4|||
154842226|NCT00562588|558854420|FG000|Overall Study|Withdrawal by Subject|10|||
154842227|NCT00562588|558854421|FG001|Overall Study|Withdrawal by Subject|9|||
154842228|NCT00562588|558854420|FG000|Overall Study|Other|0|||
154842229|NCT00562588|558854421|FG001|Overall Study|Other|2|||
154842230|NCT01777152|558855830|FG000|Overall Study|Withdrawal by Subject|22|||
154842231|NCT01777152|558855831|FG001|Overall Study|Withdrawal by Subject|16|||
154842232|NCT01777152|558855830|FG000|Overall Study|Lost to Follow-up|3|||
154842233|NCT01777152|558855831|FG001|Overall Study|Lost to Follow-up|5|||
154842234|NCT01777152|558855830|FG000|Overall Study|Death|68|||
154842235|NCT01777152|558855831|FG001|Overall Study|Death|89|||
154842236|NCT01777152|558855830|FG000|Overall Study|Not eligible, no study drug received|1|||
154842237|NCT01777152|558855831|FG001|Overall Study|Not eligible, no study drug received|0|||
154842238|NCT01777152|558855830|FG000|Overall Study|Change of diagnosis|1|||
154842239|NCT01777152|558855831|FG001|Overall Study|Change of diagnosis|0|||
154842240|NCT03823391|558855836|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
154842241|NCT03823391|558855837|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
154842242|NCT03823391|558855836|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
154842243|NCT03823391|558855837|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
154842244|NCT03557359|558855843|FG000|Dose 1: 240 mg|Adverse Event|1|||
154842245|NCT03557359|558855844|FG001|Dose 1: 240 mg|Adverse Event|0|||
154842246|NCT05980299|558855849|FG000|Overall Study|Death|28|||
154842247|NCT05980299|558855850|FG001|Overall Study|Death|0|||
154842248|NCT05980299|558855849|FG000|Overall Study|Discharged from Nursing Home|9|||
154842249|NCT05980299|558855850|FG001|Overall Study|Discharged from Nursing Home|0|||
154842250|NCT05980299|558855849|FG000|Overall Study|Lost to Follow-up|0|||
154842251|NCT05980299|558855850|FG001|Overall Study|Lost to Follow-up|10|||
154842252|NCT02264990|558855851|FG000|Overall Study|Death|255|||
154842253|NCT02264990|558855852|FG001|Overall Study|Death|250|||
154842254|NCT02264990|558855851|FG000|Overall Study|Withdrawal by Subject|4|||
154842255|NCT02264990|558855852|FG001|Overall Study|Withdrawal by Subject|5|||
154842256|NCT02264990|558855851|FG000|Overall Study|Lost to Follow-up|1|||
154842257|NCT02264990|558855852|FG001|Overall Study|Lost to Follow-up|3|||
154842258|NCT02264990|558855851|FG000|Overall Study|Other|0|||
154842259|NCT02264990|558855852|FG001|Overall Study|Other|1|||
154842260|NCT03031301|558855854|FG000|Overall Study|Protocol Violation|4|||
154842261|NCT03031301|558855855|FG001|Overall Study|Protocol Violation|8|||
154842262|NCT03031301|558855854|FG000|Overall Study|Withdrawal by Subject|7|||
154842263|NCT03031301|558855855|FG001|Overall Study|Withdrawal by Subject|4|||
154842264|NCT03031301|558855854|FG000|Overall Study|Lost to Follow-up|4|||
154842265|NCT03031301|558855855|FG001|Overall Study|Lost to Follow-up|12|||
154842266|NCT03031301|558855854|FG000|Overall Study|Noncompliance|1|||
154842267|NCT03031301|558855855|FG001|Overall Study|Noncompliance|3|||
154842268|NCT03031301|558855854|FG000|Overall Study|Technical issue|1|||
154842269|NCT03031301|558855855|FG001|Overall Study|Technical issue|1|||
154842270|NCT03031301|558855854|FG000|Overall Study|Adverse Event|1|||
154842271|NCT03031301|558855855|FG001|Overall Study|Adverse Event|0|||
154842272|NCT01294800|558855856|FG000|Overall Study|Adverse Event|7|||
154842273|NCT01294800|558855857|FG001|Overall Study|Adverse Event|6|||
154842274|NCT01294800|558855858|FG002|Overall Study|Adverse Event|12|||
154842275|NCT01294800|558855859|FG003|Overall Study|Adverse Event|5|||
154842276|NCT01294800|558855856|FG000|Overall Study|Subject Withdrew Consent|2|||
154842277|NCT01294800|558855857|FG001|Overall Study|Subject Withdrew Consent|2|||
154842278|NCT01294800|558855858|FG002|Overall Study|Subject Withdrew Consent|2|||
154842279|NCT01294800|558855859|FG003|Overall Study|Subject Withdrew Consent|11|||
154842280|NCT01294800|558855856|FG000|Overall Study|Lost to Follow-up|0|||
154842281|NCT01294800|558855857|FG001|Overall Study|Lost to Follow-up|0|||
154842282|NCT01294800|558855858|FG002|Overall Study|Lost to Follow-up|1|||
154842283|NCT01294800|558855859|FG003|Overall Study|Lost to Follow-up|0|||
154842284|NCT01294800|558855856|FG000|Overall Study|Non-compliance With Protocol|0|||
154842285|NCT01294800|558855857|FG001|Overall Study|Non-compliance With Protocol|1|||
154842286|NCT01294800|558855858|FG002|Overall Study|Non-compliance With Protocol|1|||
154842287|NCT01294800|558855859|FG003|Overall Study|Non-compliance With Protocol|0|||
154842288|NCT01294800|558855856|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
154842289|NCT01294800|558855857|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
154842290|NCT01294800|558855858|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
154842291|NCT01294800|558855859|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
154842292|NCT05048342|558855861|FG000|Overall Study|Adverse Event|1|||
154842293|NCT05048342|558855861|FG000|Overall Study|Subject decision|2|||
154842294|NCT00493038|558855862|FG000|Treatment|Adverse Event|8|||
154842295|NCT00493038|558855863|FG001|Treatment|Adverse Event|4|||
154842296|NCT00493038|558855862|FG000|Treatment|Lost to Follow-up|5|||
154842297|NCT00493038|558855863|FG001|Treatment|Lost to Follow-up|3|||
154842298|NCT00493038|558855862|FG000|Treatment|Withdrawal by Subject|11|||
154842299|NCT00493038|558855863|FG001|Treatment|Withdrawal by Subject|12|||
154842300|NCT00493038|558855862|FG000|Treatment|Other|0|||
154842301|NCT00493038|558855863|FG001|Treatment|Other|1|||
154842302|NCT00493038|558855862|FG000|Follow-up|Lost to Follow-up|1|||
154842303|NCT00493038|558855863|FG001|Follow-up|Lost to Follow-up|0|||
154842304|NCT01441063|558855864|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
154842305|NCT01441063|558855864|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
154842306|NCT03345472|558855869|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
154842307|NCT03345472|558855869|FG000|Implant to 3 Months|Physician Decision|1|||
154842308|NCT03345472|558855869|FG000|Implant to 3 Months|Adverse Event|1|||
154842309|NCT03345472|558855869|FG000|3 Months to 12 Months|Physician Decision|3|||
154842310|NCT03345472|558855869|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
154842311|NCT03345472|558855869|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
155104773|NCT00645840|559813872|FG000|Overall Study|Protocol Violation|3|||
155104774|NCT00402324|559813873|FG000|Overall Study|Lost to Follow-up|11|||
155104775|NCT00402324|559813874|FG001|Overall Study|Lost to Follow-up|11|||
155104776|NCT00402324|559813873|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
155104777|NCT00402324|559813874|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
155104778|NCT00402324|559813873|FG000|Overall Study|Protocol Violation|8|||
155104779|NCT00402324|559813874|FG001|Overall Study|Protocol Violation|7|||
155104780|NCT00402324|559813873|FG000|Overall Study|Withdrawal by Subject|5|||
155104781|NCT00402324|559813874|FG001|Overall Study|Withdrawal by Subject|2|||
155104782|NCT00402324|559813873|FG000|Overall Study|Physician Decision|2|||
155104783|NCT00402324|559813874|FG001|Overall Study|Physician Decision|4|||
155104784|NCT00402324|559813873|FG000|Overall Study|Sponsor Decision|4|||
155104785|NCT00402324|559813874|FG001|Overall Study|Sponsor Decision|5|||
154842312|NCT03345472|558855869|FG000|3 Months to 12 Months|Adverse Event|1|||
154842313|NCT03345472|558855869|FG000|3 Months to 12 Months|Death|1|||
154842314|NCT01926782|558855870|FG000|Overall Study|Participant moved|2|||
154842315|NCT01926782|558855871|FG001|Overall Study|Participant moved|0|||
154842316|NCT01926782|558855872|FG002|Overall Study|Participant moved|1|||
154842317|NCT01926782|558855873|FG003|Overall Study|Participant moved|1|||
155104786|NCT00402324|559813873|FG000|Overall Study|Lack of Efficacy|1|||
155104787|NCT00402324|559813874|FG001|Overall Study|Lack of Efficacy|4|||
155104788|NCT00402324|559813873|FG000|Overall Study|Adverse Event|6|||
155104789|NCT00402324|559813874|FG001|Overall Study|Adverse Event|4|||
155104790|NCT00402324|559813873|FG000|Overall Study|Death|1|||
155104791|NCT00402324|559813874|FG001|Overall Study|Death|0|||
155104792|NCT01277822|559813875|FG000|Overall Study|Adverse Event|2|||
155104793|NCT01277822|559813876|FG001|Overall Study|Adverse Event|1|||
155104794|NCT01277822|559813875|FG000|Overall Study|Withdrawal by Subject|6|||
155104795|NCT01277822|559813876|FG001|Overall Study|Withdrawal by Subject|7|||
155104796|NCT01277822|559813875|FG000|Overall Study|Physician Decision|1|||
155104797|NCT01277822|559813876|FG001|Overall Study|Physician Decision|1|||
154842318|NCT01926782|558855874|FG004|Overall Study|Participant moved|0|||
154842319|NCT01926782|558855875|FG005|Overall Study|Participant moved|3|||
154842320|NCT01926782|558855870|FG000|Overall Study|Physician Decision|0|||
154842321|NCT01926782|558855871|FG001|Overall Study|Physician Decision|2|||
154842322|NCT01926782|558855872|FG002|Overall Study|Physician Decision|1|||
154842323|NCT01926782|558855873|FG003|Overall Study|Physician Decision|1|||
154842324|NCT01926782|558855874|FG004|Overall Study|Physician Decision|0|||
154842325|NCT01926782|558855875|FG005|Overall Study|Physician Decision|0|||
154842326|NCT01926782|558855870|FG000|Overall Study|Other than specified|2|||
154842327|NCT01926782|558855871|FG001|Overall Study|Other than specified|3|||
154842328|NCT01926782|558855872|FG002|Overall Study|Other than specified|5|||
154842329|NCT01926782|558855873|FG003|Overall Study|Other than specified|12|||
154842330|NCT01926782|558855874|FG004|Overall Study|Other than specified|4|||
154842331|NCT01926782|558855875|FG005|Overall Study|Other than specified|11|||
154842332|NCT01926782|558855870|FG000|Overall Study|Adverse Event|13|||
154842333|NCT01926782|558855871|FG001|Overall Study|Adverse Event|4|||
154842334|NCT01926782|558855872|FG002|Overall Study|Adverse Event|17|||
154842335|NCT01926782|558855873|FG003|Overall Study|Adverse Event|4|||
154842336|NCT01926782|558855874|FG004|Overall Study|Adverse Event|3|||
154842337|NCT01926782|558855875|FG005|Overall Study|Adverse Event|14|||
154842338|NCT01926782|558855870|FG000|Overall Study|Poor compliance to protocol|5|||
154842339|NCT01926782|558855871|FG001|Overall Study|Poor compliance to protocol|3|||
154842340|NCT01926782|558855872|FG002|Overall Study|Poor compliance to protocol|8|||
154842341|NCT01926782|558855873|FG003|Overall Study|Poor compliance to protocol|0|||
154842342|NCT01926782|558855874|FG004|Overall Study|Poor compliance to protocol|1|||
154842343|NCT01926782|558855875|FG005|Overall Study|Poor compliance to protocol|6|||
154842344|NCT01926782|558855870|FG000|Overall Study|Randomized and not treated|0|||
154842345|NCT01926782|558855871|FG001|Overall Study|Randomized and not treated|0|||
154842346|NCT01926782|558855872|FG002|Overall Study|Randomized and not treated|0|||
154842347|NCT01926782|558855873|FG003|Overall Study|Randomized and not treated|1|||
154842348|NCT01926782|558855874|FG004|Overall Study|Randomized and not treated|0|||
154842349|NCT01926782|558855875|FG005|Overall Study|Randomized and not treated|0|||
154842350|NCT01926782|558855870|FG000|Overall Study|Withdrawal by Subject|6|||
154842351|NCT01926782|558855871|FG001|Overall Study|Withdrawal by Subject|1|||
154842352|NCT01926782|558855872|FG002|Overall Study|Withdrawal by Subject|8|||
154842353|NCT01926782|558855873|FG003|Overall Study|Withdrawal by Subject|1|||
154842354|NCT01926782|558855874|FG004|Overall Study|Withdrawal by Subject|0|||
154842355|NCT01926782|558855875|FG005|Overall Study|Withdrawal by Subject|5|||
154842356|NCT01926782|558855870|FG000|Overall Study|Related to study drug administration|0|||
154842357|NCT01926782|558855871|FG001|Overall Study|Related to study drug administration|0|||
154842358|NCT01926782|558855872|FG002|Overall Study|Related to study drug administration|0|||
154842359|NCT01926782|558855873|FG003|Overall Study|Related to study drug administration|0|||
154842360|NCT01926782|558855874|FG004|Overall Study|Related to study drug administration|0|||
154842361|NCT01926782|558855875|FG005|Overall Study|Related to study drug administration|2|||
154842362|NCT01100944|558855880|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
154842363|NCT01100944|558855881|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
154842364|NCT01100944|558855882|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
154842365|NCT01100944|558855880|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
154842366|NCT01100944|558855881|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
154842367|NCT01100944|558855882|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
154842368|NCT01100944|558855880|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
154842369|NCT01100944|558855881|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
154842370|NCT01100944|558855882|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
154842371|NCT01100944|558855880|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
154842372|NCT01100944|558855881|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
154842373|NCT01100944|558855882|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
154842374|NCT04607733|558855885|FG000|Overall Study|Lost to Follow-up|1|||
154842375|NCT04607733|558855886|FG001|Overall Study|Lost to Follow-up|0|||
154842376|NCT04607733|558855887|FG002|Overall Study|Lost to Follow-up|0|||
154842377|NCT04607733|558855888|FG003|Overall Study|Lost to Follow-up|1|||
155104798|NCT01277822|559813875|FG000|Overall Study|Protocol Violation|1|||
155104799|NCT01277822|559813876|FG001|Overall Study|Protocol Violation|0|||
154842378|NCT04607733|558855889|FG004|Overall Study|Lost to Follow-up|1|||
154842379|NCT04607733|558855890|FG005|Overall Study|Lost to Follow-up|0|||
154842380|NCT04607733|558855885|FG000|Overall Study|Withdrawal by Subject|0|||
154842381|NCT04607733|558855886|FG001|Overall Study|Withdrawal by Subject|0|||
154842382|NCT04607733|558855887|FG002|Overall Study|Withdrawal by Subject|0|||
154842383|NCT04607733|558855888|FG003|Overall Study|Withdrawal by Subject|0|||
154842384|NCT04607733|558855889|FG004|Overall Study|Withdrawal by Subject|1|||
154842385|NCT04607733|558855890|FG005|Overall Study|Withdrawal by Subject|0|||
154842386|NCT01639833|558855916|FG000|Overall Study|Death|4|||
154842387|NCT01639833|558855917|FG001|Overall Study|Death|2|||
154842388|NCT01639833|558855916|FG000|Overall Study|Withdrawal by Subject|2|||
154842389|NCT01639833|558855917|FG001|Overall Study|Withdrawal by Subject|2|||
154842390|NCT00070941|558855919|FG000|Overall Study|Adverse Event|10|||
154842391|NCT00070941|558855920|FG001|Overall Study|Adverse Event|8|||
154842392|NCT00070941|558855921|FG002|Overall Study|Adverse Event|4|||
154842393|NCT00075504|558855925|FG000|Overall Study|Withdrawal by Subject|9|||
154842394|NCT00075504|558855926|FG001|Overall Study|Withdrawal by Subject|7|||
154842395|NCT01290692|558855927|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
154842396|NCT03099707|558855935|FG000|Overall Study|Withdrawal by Subject|0|||
154842397|NCT03099707|558855936|FG001|Overall Study|Withdrawal by Subject|3|||
154842398|NCT03099707|558855935|FG000|Overall Study|Lost to Follow-up|0|||
154842399|NCT03099707|558855936|FG001|Overall Study|Lost to Follow-up|1|||
154842400|NCT03167073|558855937|FG000|Overall Study|Stillbirth|1|||
154842401|NCT03167073|558855938|FG001|Overall Study|Stillbirth|0|||
154842402|NCT00689871|558855942|FG000|Overall Study|Lost to Follow-up|123|||
154842403|NCT00689871|558855943|FG001|Overall Study|Lost to Follow-up|13|||
154842404|NCT00689871|558855944|FG002|Overall Study|Lost to Follow-up|37|||
154842405|NCT00689871|558855945|FG003|Overall Study|Lost to Follow-up|1|||
154842406|NCT00689871|558855942|FG000|Overall Study|Explanted of All Study Devices|36|||
154842407|NCT00689871|558855943|FG001|Overall Study|Explanted of All Study Devices|25|||
154842408|NCT00689871|558855944|FG002|Overall Study|Explanted of All Study Devices|29|||
154842409|NCT00689871|558855945|FG003|Overall Study|Explanted of All Study Devices|3|||
154842410|NCT00689871|558855942|FG000|Overall Study|Withdrawal by Subject|13|||
154842411|NCT00689871|558855943|FG001|Overall Study|Withdrawal by Subject|3|||
154842412|NCT00689871|558855944|FG002|Overall Study|Withdrawal by Subject|4|||
154842413|NCT00689871|558855945|FG003|Overall Study|Withdrawal by Subject|1|||
154842414|NCT00689871|558855942|FG000|Overall Study|Death|1|||
154842415|NCT00689871|558855943|FG001|Overall Study|Death|10|||
154842416|NCT00689871|558855944|FG002|Overall Study|Death|2|||
154842417|NCT00689871|558855945|FG003|Overall Study|Death|2|||
154842418|NCT00689871|558855942|FG000|Overall Study|Physician Decision|2|||
154842419|NCT00689871|558855943|FG001|Overall Study|Physician Decision|1|||
154842420|NCT00689871|558855944|FG002|Overall Study|Physician Decision|1|||
154842421|NCT00689871|558855945|FG003|Overall Study|Physician Decision|0|||
154842422|NCT00562354|558855946|FG000|Overall Study|Physician Decision|0|||
154842423|NCT00562354|558855947|FG001|Overall Study|Physician Decision|1|||
154842424|NCT00562354|558855946|FG000|Overall Study|Lost to Follow-up|0|||
154842425|NCT00562354|558855947|FG001|Overall Study|Lost to Follow-up|1|||
154842426|NCT00371865|558855952|FG000|Overall Study|Lack of Efficacy|0|||
154842427|NCT00371865|558855953|FG001|Overall Study|Lack of Efficacy|2|||
154842428|NCT00371865|558855952|FG000|Overall Study|Protocol Violation|3|||
154842429|NCT00371865|558855953|FG001|Overall Study|Protocol Violation|2|||
154842430|NCT00371865|558855952|FG000|Overall Study|Withdrawal by Subject|12|||
154842431|NCT00371865|558855953|FG001|Overall Study|Withdrawal by Subject|10|||
154842432|NCT01430455|558855962|FG000|Overall Study|Withdrawal by Subject|1|||
154842433|NCT01430455|558855962|FG000|Overall Study|Switched to follow-up phase|1|||
154842434|NCT01425008|558855965|FG000|Dose Escalation Phase|Progressive Disease|2|||
154842435|NCT01425008|558855966|FG001|Dose Escalation Phase|Progressive Disease|3|||
154842436|NCT01425008|558855967|FG002|Dose Escalation Phase|Progressive Disease|2|||
154842437|NCT01425008|558855968|FG003|Dose Escalation Phase|Progressive Disease|3|||
154842438|NCT01425008|558855969|FG004|Dose Escalation Phase|Progressive Disease|5|||
154971144|NCT04556734|559318537|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154971145|NCT04556734|559318538|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
154971146|NCT04556734|559318531|FG000|OLE Period (28 Weeks)|Not reported|0|||
154842439|NCT01425008|558855970|FG005|Dose Escalation Phase|Progressive Disease|4|||
154842440|NCT01425008|558855971|FG006|Dose Escalation Phase|Progressive Disease|0|||
154842441|NCT01425008|558855972|FG007|Dose Escalation Phase|Progressive Disease|2|||
154842442|NCT01425008|558855973|FG008|Dose Escalation Phase|Progressive Disease|6|||
154842443|NCT01425008|558855974|FG009|Dose Escalation Phase|Progressive Disease|2|||
154842444|NCT01425008|558855975|FG010|Dose Escalation Phase|Progressive Disease|0|||
154842445|NCT01425008|558855976|FG011|Dose Escalation Phase|Progressive Disease|0|||
154842446|NCT01425008|558855977|FG012|Dose Escalation Phase|Progressive Disease|0|||
154842447|NCT01425008|558855978|FG013|Dose Escalation Phase|Progressive Disease|0|||
154842448|NCT01425008|558855979|FG014|Dose Escalation Phase|Progressive Disease|0|||
154842449|NCT01425008|558855980|FG015|Dose Escalation Phase|Progressive Disease|0|||
154842450|NCT01425008|558855981|FG016|Dose Escalation Phase|Progressive Disease|0|||
154842451|NCT01425008|558855982|FG017|Dose Escalation Phase|Progressive Disease|0|||
155104800|NCT01277822|559813875|FG000|Overall Study|Lost to Follow-up|2|||
155104801|NCT01277822|559813876|FG001|Overall Study|Lost to Follow-up|1|||
155104802|NCT01277822|559813875|FG000|Overall Study|Contraindicated medication used|2|||
155104803|NCT01277822|559813876|FG001|Overall Study|Contraindicated medication used|1|||
155104804|NCT01277822|559813875|FG000|Overall Study|Participant moved|1|||
154842452|NCT01425008|558855983|FG018|Dose Escalation Phase|Progressive Disease|0|||
154842453|NCT01425008|558855965|FG000|Dose Escalation Phase|Adverse Event|2|||
154842454|NCT01425008|558855966|FG001|Dose Escalation Phase|Adverse Event|0|||
154842455|NCT01425008|558855967|FG002|Dose Escalation Phase|Adverse Event|0|||
154842456|NCT01425008|558855968|FG003|Dose Escalation Phase|Adverse Event|0|||
154842457|NCT01425008|558855969|FG004|Dose Escalation Phase|Adverse Event|0|||
154842458|NCT01425008|558855970|FG005|Dose Escalation Phase|Adverse Event|2|||
154842459|NCT01425008|558855971|FG006|Dose Escalation Phase|Adverse Event|0|||
154842460|NCT01425008|558855972|FG007|Dose Escalation Phase|Adverse Event|0|||
154842461|NCT01425008|558855973|FG008|Dose Escalation Phase|Adverse Event|2|||
154842462|NCT01425008|558855974|FG009|Dose Escalation Phase|Adverse Event|0|||
154842463|NCT01425008|558855975|FG010|Dose Escalation Phase|Adverse Event|0|||
154842464|NCT01425008|558855976|FG011|Dose Escalation Phase|Adverse Event|0|||
154842465|NCT01425008|558855977|FG012|Dose Escalation Phase|Adverse Event|0|||
154842466|NCT01425008|558855978|FG013|Dose Escalation Phase|Adverse Event|0|||
154842467|NCT01425008|558855979|FG014|Dose Escalation Phase|Adverse Event|0|||
154842468|NCT01425008|558855980|FG015|Dose Escalation Phase|Adverse Event|0|||
154842469|NCT01425008|558855981|FG016|Dose Escalation Phase|Adverse Event|0|||
154842470|NCT01425008|558855982|FG017|Dose Escalation Phase|Adverse Event|0|||
154842471|NCT01425008|558855983|FG018|Dose Escalation Phase|Adverse Event|0|||
154842472|NCT01425008|558855965|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842473|NCT01425008|558855966|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842474|NCT01425008|558855967|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842475|NCT01425008|558855968|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842476|NCT01425008|558855969|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
154842477|NCT01425008|558855970|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842478|NCT01425008|558855971|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
154842479|NCT01425008|558855972|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
154842480|NCT01425008|558855973|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
154842481|NCT01425008|558855974|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842482|NCT01425008|558855975|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842483|NCT01425008|558855976|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842484|NCT01425008|558855977|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842485|NCT01425008|558855978|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842486|NCT01425008|558855979|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842487|NCT01425008|558855980|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842488|NCT01425008|558855981|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842489|NCT01425008|558855982|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842490|NCT01425008|558855983|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154842491|NCT01425008|558855965|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
154842492|NCT01425008|558855966|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
154842493|NCT01425008|558855967|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
154842494|NCT01425008|558855968|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
154842495|NCT01425008|558855969|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
154842496|NCT01425008|558855970|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
154842497|NCT01425008|558855971|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
154842498|NCT01425008|558855972|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
154842499|NCT01425008|558855973|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
154842500|NCT01425008|558855974|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
154842501|NCT01425008|558855975|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
154842502|NCT01425008|558855976|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
154842503|NCT01425008|558855977|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
154842504|NCT01425008|558855978|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
154842505|NCT01425008|558855979|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
154842506|NCT01425008|558855980|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
154842507|NCT01425008|558855981|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
154842508|NCT01425008|558855982|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
154842509|NCT01425008|558855983|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
154842510|NCT01425008|558855965|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842511|NCT01425008|558855966|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842512|NCT01425008|558855967|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
154842513|NCT01425008|558855968|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842514|NCT01425008|558855969|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842515|NCT01425008|558855970|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842516|NCT01425008|558855971|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842517|NCT01425008|558855972|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842518|NCT01425008|558855973|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
154842519|NCT01425008|558855974|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
154842520|NCT01425008|558855975|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842521|NCT01425008|558855976|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842522|NCT01425008|558855977|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842523|NCT01425008|558855978|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842524|NCT01425008|558855979|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842525|NCT01425008|558855980|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842526|NCT01425008|558855981|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842527|NCT01425008|558855982|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842528|NCT01425008|558855983|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
154842529|NCT01425008|558855965|FG000|Dose Escalation Phase|Other|0|||
154842530|NCT01425008|558855966|FG001|Dose Escalation Phase|Other|0|||
154842531|NCT01425008|558855967|FG002|Dose Escalation Phase|Other|0|||
154842532|NCT01425008|558855968|FG003|Dose Escalation Phase|Other|0|||
154842533|NCT01425008|558855969|FG004|Dose Escalation Phase|Other|0|||
154842534|NCT01425008|558855970|FG005|Dose Escalation Phase|Other|0|||
154842535|NCT01425008|558855971|FG006|Dose Escalation Phase|Other|0|||
154842536|NCT01425008|558855972|FG007|Dose Escalation Phase|Other|0|||
154842537|NCT01425008|558855973|FG008|Dose Escalation Phase|Other|1|||
154842538|NCT01425008|558855974|FG009|Dose Escalation Phase|Other|0|||
154842539|NCT01425008|558855975|FG010|Dose Escalation Phase|Other|0|||
154842540|NCT01425008|558855976|FG011|Dose Escalation Phase|Other|0|||
154842541|NCT01425008|558855977|FG012|Dose Escalation Phase|Other|0|||
154842542|NCT01425008|558855978|FG013|Dose Escalation Phase|Other|0|||
154842543|NCT01425008|558855979|FG014|Dose Escalation Phase|Other|0|||
154842544|NCT01425008|558855980|FG015|Dose Escalation Phase|Other|0|||
154842545|NCT01425008|558855981|FG016|Dose Escalation Phase|Other|0|||
154842546|NCT01425008|558855982|FG017|Dose Escalation Phase|Other|0|||
154842547|NCT01425008|558855983|FG018|Dose Escalation Phase|Other|0|||
154842548|NCT01425008|558855965|FG000|Dose Expansion Phase|Progressive Disease|0|||
154842549|NCT01425008|558855966|FG001|Dose Expansion Phase|Progressive Disease|0|||
154842550|NCT01425008|558855967|FG002|Dose Expansion Phase|Progressive Disease|0|||
154842551|NCT01425008|558855968|FG003|Dose Expansion Phase|Progressive Disease|0|||
154842552|NCT01425008|558855969|FG004|Dose Expansion Phase|Progressive Disease|0|||
154842553|NCT01425008|558855970|FG005|Dose Expansion Phase|Progressive Disease|0|||
154842554|NCT01425008|558855971|FG006|Dose Expansion Phase|Progressive Disease|0|||
154842555|NCT01425008|558855972|FG007|Dose Expansion Phase|Progressive Disease|0|||
154842556|NCT01425008|558855973|FG008|Dose Expansion Phase|Progressive Disease|0|||
154842557|NCT01425008|558855974|FG009|Dose Expansion Phase|Progressive Disease|0|||
154842558|NCT01425008|558855975|FG010|Dose Expansion Phase|Progressive Disease|10|||
154842559|NCT01425008|558855976|FG011|Dose Expansion Phase|Progressive Disease|4|||
154842560|NCT01425008|558855977|FG012|Dose Expansion Phase|Progressive Disease|12|||
154842561|NCT01425008|558855978|FG013|Dose Expansion Phase|Progressive Disease|1|||
154842562|NCT01425008|558855979|FG014|Dose Expansion Phase|Progressive Disease|5|||
154842563|NCT01425008|558855980|FG015|Dose Expansion Phase|Progressive Disease|8|||
154842564|NCT01425008|558855981|FG016|Dose Expansion Phase|Progressive Disease|9|||
154842565|NCT01425008|558855982|FG017|Dose Expansion Phase|Progressive Disease|2|||
154842566|NCT01425008|558855983|FG018|Dose Expansion Phase|Progressive Disease|10|||
154842567|NCT01425008|558855965|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
154842568|NCT01425008|558855966|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
154842569|NCT01425008|558855967|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
154842570|NCT01425008|558855968|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
154842571|NCT01425008|558855969|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
154842572|NCT01425008|558855970|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
154842573|NCT01425008|558855971|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
154842574|NCT01425008|558855972|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
154842575|NCT01425008|558855973|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
154842576|NCT01425008|558855974|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
154842577|NCT01425008|558855975|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
154842578|NCT01425008|558855976|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
154842579|NCT01425008|558855977|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
154842580|NCT01425008|558855978|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
154842581|NCT01425008|558855979|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
154842582|NCT01425008|558855980|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
154842583|NCT01425008|558855981|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
154842584|NCT01425008|558855982|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
154842585|NCT01425008|558855983|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
154842586|NCT01425008|558855965|FG000|Dose Expansion Phase|Other|0|||
154842587|NCT01425008|558855966|FG001|Dose Expansion Phase|Other|0|||
154842588|NCT01425008|558855967|FG002|Dose Expansion Phase|Other|0|||
154842589|NCT01425008|558855968|FG003|Dose Expansion Phase|Other|0|||
154842590|NCT01425008|558855969|FG004|Dose Expansion Phase|Other|0|||
154842591|NCT01425008|558855970|FG005|Dose Expansion Phase|Other|0|||
154842592|NCT01425008|558855971|FG006|Dose Expansion Phase|Other|0|||
154842593|NCT01425008|558855972|FG007|Dose Expansion Phase|Other|0|||
154842594|NCT01425008|558855973|FG008|Dose Expansion Phase|Other|0|||
154842595|NCT01425008|558855974|FG009|Dose Expansion Phase|Other|0|||
154842596|NCT01425008|558855975|FG010|Dose Expansion Phase|Other|0|||
155104805|NCT01277822|559813876|FG001|Overall Study|Participant moved|0|||
155104806|NCT00997984|559813877|FG000|Overall Study|Adverse Event|1|||
155104807|NCT00997984|559813878|FG001|Overall Study|Adverse Event|8|||
155104808|NCT00997984|559813879|FG002|Overall Study|Adverse Event|8|||
155104809|NCT00997984|559813877|FG000|Overall Study|Protocol Violation|1|||
155104810|NCT00997984|559813878|FG001|Overall Study|Protocol Violation|3|||
155104811|NCT00997984|559813879|FG002|Overall Study|Protocol Violation|0|||
155104812|NCT00997984|559813877|FG000|Overall Study|Withdrawal by Subject|6|||
154842597|NCT01425008|558855976|FG011|Dose Expansion Phase|Other|0|||
154842598|NCT01425008|558855977|FG012|Dose Expansion Phase|Other|1|||
154842599|NCT01425008|558855978|FG013|Dose Expansion Phase|Other|0|||
154842600|NCT01425008|558855979|FG014|Dose Expansion Phase|Other|0|||
154842601|NCT01425008|558855980|FG015|Dose Expansion Phase|Other|0|||
154842602|NCT01425008|558855981|FG016|Dose Expansion Phase|Other|2|||
154842603|NCT01425008|558855982|FG017|Dose Expansion Phase|Other|0|||
154842604|NCT01425008|558855983|FG018|Dose Expansion Phase|Other|4|||
154842605|NCT01425008|558855965|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842606|NCT01425008|558855966|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842607|NCT01425008|558855967|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842608|NCT01425008|558855968|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842609|NCT01425008|558855969|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842610|NCT01425008|558855970|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842611|NCT01425008|558855971|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842612|NCT01425008|558855972|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842613|NCT01425008|558855973|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842614|NCT01425008|558855974|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842615|NCT01425008|558855975|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
154842616|NCT01425008|558855976|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
154842617|NCT01425008|558855977|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842618|NCT01425008|558855978|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842619|NCT01425008|558855979|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842620|NCT01425008|558855980|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
154842621|NCT01425008|558855981|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
154842622|NCT01425008|558855982|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
154842623|NCT01425008|558855983|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
154842624|NCT01425008|558855965|FG000|Dose Expansion Phase|Adverse Event|0|||
154842625|NCT01425008|558855966|FG001|Dose Expansion Phase|Adverse Event|0|||
154842626|NCT01425008|558855967|FG002|Dose Expansion Phase|Adverse Event|0|||
154842627|NCT01425008|558855968|FG003|Dose Expansion Phase|Adverse Event|0|||
154842628|NCT01425008|558855969|FG004|Dose Expansion Phase|Adverse Event|0|||
154842629|NCT01425008|558855970|FG005|Dose Expansion Phase|Adverse Event|0|||
154842630|NCT01425008|558855971|FG006|Dose Expansion Phase|Adverse Event|0|||
154842631|NCT01425008|558855972|FG007|Dose Expansion Phase|Adverse Event|0|||
154842632|NCT01425008|558855973|FG008|Dose Expansion Phase|Adverse Event|0|||
154842633|NCT01425008|558855974|FG009|Dose Expansion Phase|Adverse Event|0|||
154842634|NCT01425008|558855975|FG010|Dose Expansion Phase|Adverse Event|2|||
154842635|NCT01425008|558855976|FG011|Dose Expansion Phase|Adverse Event|3|||
154842636|NCT01425008|558855977|FG012|Dose Expansion Phase|Adverse Event|3|||
154842637|NCT01425008|558855978|FG013|Dose Expansion Phase|Adverse Event|0|||
154842638|NCT01425008|558855979|FG014|Dose Expansion Phase|Adverse Event|1|||
154842639|NCT01425008|558855980|FG015|Dose Expansion Phase|Adverse Event|1|||
154842640|NCT01425008|558855981|FG016|Dose Expansion Phase|Adverse Event|5|||
154842641|NCT01425008|558855982|FG017|Dose Expansion Phase|Adverse Event|0|||
154842642|NCT01425008|558855983|FG018|Dose Expansion Phase|Adverse Event|3|||
154842643|NCT01425008|558855965|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
154842644|NCT01425008|558855966|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
154842645|NCT01425008|558855967|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
154842646|NCT01425008|558855968|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
155104813|NCT00997984|559813878|FG001|Overall Study|Withdrawal by Subject|9|||
155104814|NCT00997984|559813879|FG002|Overall Study|Withdrawal by Subject|5|||
155104815|NCT00997984|559813877|FG000|Overall Study|Lost to Follow-up|8|||
155104816|NCT00997984|559813878|FG001|Overall Study|Lost to Follow-up|5|||
154842647|NCT01425008|558855969|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
154842648|NCT01425008|558855970|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
154842649|NCT01425008|558855971|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
154842650|NCT01425008|558855972|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
154842651|NCT01425008|558855973|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
155104817|NCT00997984|559813879|FG002|Overall Study|Lost to Follow-up|4|||
155104818|NCT00997984|559813877|FG000|Overall Study|Lack of Efficacy|20|||
154842652|NCT01425008|558855974|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
155104819|NCT00997984|559813878|FG001|Overall Study|Lack of Efficacy|6|||
155104820|NCT00997984|559813879|FG002|Overall Study|Lack of Efficacy|3|||
154842653|NCT01425008|558855975|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
154842654|NCT01425008|558855976|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
154842655|NCT01425008|558855977|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
154842656|NCT01425008|558855978|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
154842657|NCT01425008|558855979|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
154842658|NCT01425008|558855980|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
154842659|NCT01425008|558855981|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
154842660|NCT01425008|558855982|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
154842661|NCT01425008|558855983|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
154842662|NCT01425008|558855965|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842663|NCT01425008|558855966|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842664|NCT01425008|558855967|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842665|NCT01425008|558855968|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842666|NCT01425008|558855969|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842667|NCT01425008|558855970|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842668|NCT01425008|558855971|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842669|NCT01425008|558855972|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842670|NCT01425008|558855973|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842671|NCT01425008|558855974|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842672|NCT01425008|558855975|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842673|NCT01425008|558855976|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842674|NCT01425008|558855977|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842675|NCT01425008|558855978|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842676|NCT01425008|558855979|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842677|NCT01425008|558855980|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842678|NCT01425008|558855981|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842679|NCT01425008|558855982|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154842680|NCT01425008|558855983|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
154842681|NCT00264238|558855984|FG000|Overall Study|Protocol Violation|1|||
154842682|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
154842683|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
154842684|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
154842685|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
154842686|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
154842687|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
154842688|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
154842689|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
154842690|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
154842691|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
154842692|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
154842693|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
154842694|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
154842695|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
154842696|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
154842697|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
154842698|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
154842699|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
154842700|NCT02600494|558855985|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
154842701|NCT02600494|558855986|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
154842702|NCT02600494|558855987|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
154842703|NCT02600494|558855985|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
154842704|NCT02600494|558855986|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
154842705|NCT02600494|558855987|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
154842706|NCT02600494|558855985|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
154842707|NCT02600494|558855986|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
154842708|NCT02600494|558855987|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
154842709|NCT02600494|558855985|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
154842710|NCT02600494|558855986|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
154842711|NCT02600494|558855987|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
154842712|NCT02600494|558855985|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
154842713|NCT02600494|558855986|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
154842714|NCT02600494|558855987|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
154842715|NCT02600494|558855985|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
155104821|NCT00997984|559813877|FG000|Overall Study|Met exclusion criteria|1|||
155104822|NCT00997984|559813878|FG001|Overall Study|Met exclusion criteria|0|||
155104823|NCT00997984|559813879|FG002|Overall Study|Met exclusion criteria|0|||
154842716|NCT02600494|558855986|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
155104824|NCT00997984|559813877|FG000|Overall Study|non-compliance|0|||
155104825|NCT00997984|559813878|FG001|Overall Study|non-compliance|2|||
155104826|NCT00997984|559813879|FG002|Overall Study|non-compliance|3|||
155104827|NCT00997984|559813877|FG000|Overall Study|Wrong medication dispensed|0|||
155104828|NCT00997984|559813878|FG001|Overall Study|Wrong medication dispensed|1|||
155104829|NCT00997984|559813879|FG002|Overall Study|Wrong medication dispensed|0|||
155104830|NCT00997984|559813877|FG000|Overall Study|Suicidal ideation|0|||
155104831|NCT00997984|559813878|FG001|Overall Study|Suicidal ideation|0|||
155104832|NCT00997984|559813879|FG002|Overall Study|Suicidal ideation|1|||
155104833|NCT00997984|559813877|FG000|Overall Study|Work schedule|0|||
155104834|NCT00997984|559813878|FG001|Overall Study|Work schedule|0|||
155104835|NCT00997984|559813879|FG002|Overall Study|Work schedule|2|||
155104836|NCT01232127|559813880|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
155104837|NCT01232127|559813881|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
155104838|NCT01232127|559813882|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
155104839|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
155104840|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
155104841|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
155104842|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
155104843|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
155104844|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
155104845|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
155104846|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
155104847|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
155104848|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
154971147|NCT04556734|559318532|FG001|OLE Period (28 Weeks)|Not reported|0|||
154842717|NCT02600494|558855987|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
154842718|NCT02600494|558855985|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
154842719|NCT02600494|558855986|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
154842720|NCT02600494|558855987|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
154842721|NCT03124563|558855988|FG000|Overall Study|Lost to Follow-up|1|||
154842722|NCT03124563|558855989|FG001|Overall Study|Lost to Follow-up|1|||
154842723|NCT03124563|558855988|FG000|Overall Study|Withdrawal by Subject|1|||
154842724|NCT03124563|558855989|FG001|Overall Study|Withdrawal by Subject|1|||
154842725|NCT05061719|558855992|FG000|Overall Study|Adverse Event|60|||
154842726|NCT05061719|558855992|FG000|Overall Study|Death|1|||
154842727|NCT05061719|558855992|FG000|Overall Study|Lack of Efficacy|7|||
154842728|NCT05061719|558855992|FG000|Overall Study|Lost to Follow-up|5|||
154842729|NCT05061719|558855992|FG000|Overall Study|Pregnancy|1|||
154842730|NCT05061719|558855992|FG000|Overall Study|Protocol Violation|8|||
154842731|NCT05061719|558855992|FG000|Overall Study|Withdrawal by Subject|41|||
154842732|NCT05061719|558855992|FG000|Overall Study|Site Closure|2|||
154842733|NCT05804877|558857548|FG000|Overall Study|Lost to Follow-up|1|||
154842734|NCT05804877|558857549|FG001|Overall Study|Lost to Follow-up|3|||
154842735|NCT05804877|558857548|FG000|Overall Study|Withdrawal by Subject|1|||
154842736|NCT05804877|558857549|FG001|Overall Study|Withdrawal by Subject|0|||
154842737|NCT05804877|558857548|FG000|Overall Study|Withdrawal by Subject|1|||
154842738|NCT05804877|558857549|FG001|Overall Study|Withdrawal by Subject|0|||
154842739|NCT01745146|558857551|FG000|Overall Study|Withdrawal by Subject|1|||
154842740|NCT01745146|558857552|FG001|Overall Study|Withdrawal by Subject|3|||
154842741|NCT01745146|558857551|FG000|Overall Study|Lost to Follow-up|2|||
154842742|NCT01745146|558857552|FG001|Overall Study|Lost to Follow-up|0|||
154842743|NCT01262365|558857553|FG000|Overall Study|Lack of Efficacy|35|||
154842744|NCT01262365|558857554|FG001|Overall Study|Lack of Efficacy|30|||
154842745|NCT01262365|558857555|FG002|Overall Study|Lack of Efficacy|47|||
154842746|NCT01262365|558857553|FG000|Overall Study|Protocol Violation|3|||
154842747|NCT01262365|558857554|FG001|Overall Study|Protocol Violation|1|||
154842748|NCT01262365|558857555|FG002|Overall Study|Protocol Violation|1|||
154842749|NCT01262365|558857553|FG000|Overall Study|Lost to Follow-up|3|||
154842750|NCT01262365|558857554|FG001|Overall Study|Lost to Follow-up|7|||
154842751|NCT01262365|558857555|FG002|Overall Study|Lost to Follow-up|6|||
154842752|NCT01262365|558857553|FG000|Overall Study|Withdrawal by Subject|17|||
154842753|NCT01262365|558857554|FG001|Overall Study|Withdrawal by Subject|22|||
154842754|NCT01262365|558857555|FG002|Overall Study|Withdrawal by Subject|22|||
154842755|NCT01262365|558857553|FG000|Overall Study|Death|1|||
154842756|NCT01262365|558857554|FG001|Overall Study|Death|2|||
154842757|NCT01262365|558857555|FG002|Overall Study|Death|1|||
154842758|NCT01262365|558857553|FG000|Overall Study|Adverse Event|26|||
154842759|NCT01262365|558857554|FG001|Overall Study|Adverse Event|16|||
154842760|NCT01262365|558857555|FG002|Overall Study|Adverse Event|11|||
155104849|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155104850|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
155104851|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
155104852|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
155104853|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
154842761|NCT01262365|558857553|FG000|Overall Study|sponsor decision|1|||
154842762|NCT01262365|558857554|FG001|Overall Study|sponsor decision|1|||
154842763|NCT01262365|558857555|FG002|Overall Study|sponsor decision|0|||
154842764|NCT01262365|558857553|FG000|Overall Study|Randomization error|1|||
154842765|NCT01262365|558857554|FG001|Overall Study|Randomization error|0|||
154842766|NCT01262365|558857555|FG002|Overall Study|Randomization error|2|||
154842767|NCT01262365|558857553|FG000|Overall Study|Non-compliance|1|||
154842768|NCT01262365|558857554|FG001|Overall Study|Non-compliance|0|||
154842769|NCT01262365|558857555|FG002|Overall Study|Non-compliance|2|||
154842770|NCT01262365|558857553|FG000|Overall Study|Suspected pregnancy|1|||
154842771|NCT01262365|558857554|FG001|Overall Study|Suspected pregnancy|0|||
154842772|NCT01262365|558857555|FG002|Overall Study|Suspected pregnancy|0|||
154842773|NCT01262365|558857553|FG000|Overall Study|Patient pregnant|1|||
154842774|NCT01262365|558857554|FG001|Overall Study|Patient pregnant|0|||
154842775|NCT01262365|558857555|FG002|Overall Study|Patient pregnant|1|||
154842776|NCT01262365|558857553|FG000|Overall Study|Toxicity related to study drug|0|||
154842777|NCT01262365|558857554|FG001|Overall Study|Toxicity related to study drug|1|||
154842778|NCT01262365|558857555|FG002|Overall Study|Toxicity related to study drug|0|||
154842779|NCT01262365|558857553|FG000|Overall Study|Cannot tolerate the protocol|0|||
154842780|NCT01262365|558857554|FG001|Overall Study|Cannot tolerate the protocol|1|||
154842781|NCT01262365|558857555|FG002|Overall Study|Cannot tolerate the protocol|0|||
154842782|NCT01262365|558857553|FG000|Overall Study|Patient unavailable|0|||
154842783|NCT01262365|558857554|FG001|Overall Study|Patient unavailable|0|||
154842784|NCT01262365|558857555|FG002|Overall Study|Patient unavailable|1|||
154842785|NCT00130832|558857559|FG000|Overall Study|Adverse Event|1|||
154842786|NCT00130832|558857560|FG001|Overall Study|Adverse Event|1|||
154842787|NCT00130832|558857559|FG000|Overall Study|Lost to Follow-up|1|||
154842788|NCT00130832|558857560|FG001|Overall Study|Lost to Follow-up|2|||
154842789|NCT00130832|558857559|FG000|Overall Study|Protocol Violation|6|||
154842790|NCT00130832|558857560|FG001|Overall Study|Protocol Violation|8|||
154842791|NCT00130832|558857559|FG000|Overall Study|Withdrawal by Subject|6|||
154842792|NCT00130832|558857560|FG001|Overall Study|Withdrawal by Subject|1|||
154842793|NCT00130832|558857559|FG000|Overall Study|Moved|2|||
154842794|NCT00130832|558857560|FG001|Overall Study|Moved|2|||
154842795|NCT00130832|558857559|FG000|Overall Study|Other|0|||
154842796|NCT00130832|558857560|FG001|Overall Study|Other|3|||
154842797|NCT00699348|558857562|FG000|Overall Study|Death|6|||
154842798|NCT00699348|558857562|FG000|Overall Study|Adverse Event|15|||
154842799|NCT00699348|558857562|FG000|Overall Study|Withdrawal by Subject|11|||
154842800|NCT00699348|558857562|FG000|Overall Study|Protocol Violation|10|||
154842801|NCT00699348|558857562|FG000|Overall Study|Lack of Efficacy|8|||
154842802|NCT00699348|558857562|FG000|Overall Study|Failure to return|1|||
154842803|NCT00699348|558857562|FG000|Overall Study|Blood transfusion|24|||
154842804|NCT00699348|558857562|FG000|Overall Study|Renal transplantation|10|||
154842805|NCT00699348|558857562|FG000|Overall Study|Other|5|||
154842806|NCT04478708|558857563|FG000|Overall Study|Lost to Follow-up|0|||
154842807|NCT04478708|558857564|FG001|Overall Study|Lost to Follow-up|0|||
154842808|NCT04478708|558857565|FG002|Overall Study|Lost to Follow-up|0|||
154842809|NCT04478708|558857566|FG003|Overall Study|Lost to Follow-up|0|||
154842810|NCT04478708|558857567|FG004|Overall Study|Lost to Follow-up|0|||
154842811|NCT04478708|558857568|FG005|Overall Study|Lost to Follow-up|0|||
154842812|NCT04478708|558857569|FG006|Overall Study|Lost to Follow-up|0|||
154842813|NCT04478708|558857570|FG007|Overall Study|Lost to Follow-up|0|||
154842814|NCT04478708|558857571|FG008|Overall Study|Lost to Follow-up|1|||
154842815|NCT04478708|558857572|FG009|Overall Study|Lost to Follow-up|1|||
154842816|NCT04478708|558857573|FG010|Overall Study|Lost to Follow-up|1|||
154842817|NCT04478708|558857574|FG011|Overall Study|Lost to Follow-up|2|||
154842818|NCT04478708|558857575|FG012|Overall Study|Lost to Follow-up|1|||
154842819|NCT04478708|558857576|FG013|Overall Study|Lost to Follow-up|0|||
154842820|NCT04478708|558857577|FG014|Overall Study|Lost to Follow-up|0|||
154842821|NCT04478708|558857578|FG015|Overall Study|Lost to Follow-up|0|||
154842822|NCT04478708|558857579|FG016|Overall Study|Lost to Follow-up|0|||
154842823|NCT04478708|558857563|FG000|Overall Study|Withdrawal of consent from study|0|||
154842824|NCT04478708|558857564|FG001|Overall Study|Withdrawal of consent from study|1|||
154842825|NCT04478708|558857565|FG002|Overall Study|Withdrawal of consent from study|2|||
154842826|NCT04478708|558857566|FG003|Overall Study|Withdrawal of consent from study|0|||
154842827|NCT04478708|558857567|FG004|Overall Study|Withdrawal of consent from study|1|||
154842828|NCT04478708|558857568|FG005|Overall Study|Withdrawal of consent from study|1|||
154842829|NCT04478708|558857569|FG006|Overall Study|Withdrawal of consent from study|1|||
154842830|NCT04478708|558857570|FG007|Overall Study|Withdrawal of consent from study|0|||
154842831|NCT04478708|558857571|FG008|Overall Study|Withdrawal of consent from study|0|||
154842832|NCT04478708|558857572|FG009|Overall Study|Withdrawal of consent from study|0|||
154842833|NCT04478708|558857573|FG010|Overall Study|Withdrawal of consent from study|4|||
154842834|NCT04478708|558857574|FG011|Overall Study|Withdrawal of consent from study|3|||
154842835|NCT04478708|558857575|FG012|Overall Study|Withdrawal of consent from study|0|||
154842836|NCT04478708|558857576|FG013|Overall Study|Withdrawal of consent from study|0|||
154842837|NCT04478708|558857577|FG014|Overall Study|Withdrawal of consent from study|1|||
154842838|NCT04478708|558857578|FG015|Overall Study|Withdrawal of consent from study|0|||
154842839|NCT04478708|558857579|FG016|Overall Study|Withdrawal of consent from study|4|||
154842840|NCT01869114|558857582|FG000|Overall Study|Death|19|||
154842841|NCT01869114|558857583|FG001|Overall Study|Death|18|||
154842842|NCT01869114|558857584|FG002|Overall Study|Death|8|||
154842843|NCT01869114|558857582|FG000|Overall Study|Adverse Event/Side Effects/Complications|0|||
154842844|NCT01869114|558857583|FG001|Overall Study|Adverse Event/Side Effects/Complications|1|||
154842845|NCT01869114|558857584|FG002|Overall Study|Adverse Event/Side Effects/Complications|0|||
154842846|NCT01869114|558857582|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
154842847|NCT01869114|558857583|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
154842848|NCT01869114|558857584|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
154842849|NCT01869114|558857582|FG000|Overall Study|Withdrawal by Subject|0|||
154842850|NCT01869114|558857583|FG001|Overall Study|Withdrawal by Subject|3|||
154842851|NCT01869114|558857584|FG002|Overall Study|Withdrawal by Subject|0|||
154842852|NCT01869114|558857582|FG000|Overall Study|Disease Progression|0|||
154842853|NCT01869114|558857583|FG001|Overall Study|Disease Progression|1|||
154842854|NCT01869114|558857584|FG002|Overall Study|Disease Progression|0|||
154842855|NCT00559507|558857585|FG000|Overall Study|Not treated, patient ineligible|3|||
154842856|NCT02468648|558857586|FG000|Overall Study|Death|1|||
154842857|NCT02118792|558857587|FG000|Overall Study|Withdrawal by Subject|6|||
154842858|NCT02118792|558857588|FG001|Overall Study|Withdrawal by Subject|3|||
154842859|NCT02118792|558857587|FG000|Overall Study|Lost to Follow-up|4|||
154842860|NCT02118792|558857588|FG001|Overall Study|Lost to Follow-up|4|||
154842861|NCT02118792|558857587|FG000|Overall Study|Adverse Event|5|||
154842862|NCT02118792|558857588|FG001|Overall Study|Adverse Event|4|||
154842863|NCT02118792|558857587|FG000|Overall Study|Withdrawal by parent/guardian|14|||
154842864|NCT02118792|558857588|FG001|Overall Study|Withdrawal by parent/guardian|20|||
154842865|NCT02118792|558857587|FG000|Overall Study|Other|1|||
154842866|NCT02118792|558857588|FG001|Overall Study|Other|6|||
154842867|NCT02118792|558857587|FG000|Overall Study|Randomised but not treated|1|||
154842868|NCT02118792|558857588|FG001|Overall Study|Randomised but not treated|0|||
154842869|NCT04232696|558857590|FG000|Overall Study|Implant attempted but not completed|5|||
154842870|NCT04232696|558857591|FG001|Overall Study|Implant attempted but not completed|2|||
154842871|NCT04232696|558857590|FG000|Overall Study|Not satisfied with therapy outcome|0|||
154842872|NCT04232696|558857591|FG001|Overall Study|Not satisfied with therapy outcome|8|||
154842873|NCT04232696|558857590|FG000|Overall Study|Adverse Event|0|||
154842874|NCT04232696|558857591|FG001|Overall Study|Adverse Event|3|||
154842875|NCT04232696|558857590|FG000|Overall Study|Withdrawal by Subject|0|||
154842876|NCT04232696|558857591|FG001|Overall Study|Withdrawal by Subject|3|||
154842877|NCT04232696|558857590|FG000|Overall Study|Missed Visit|0|||
154842878|NCT04232696|558857591|FG001|Overall Study|Missed Visit|2|||
154842879|NCT04232696|558857590|FG000|Overall Study|Other reason|0|||
154842880|NCT04232696|558857591|FG001|Overall Study|Other reason|1|||
154842881|NCT01678144|558857592|FG000|Stage 1: MAR Classic|Adverse Event|1|||
154842882|NCT03118297|558857593|FG000|Overall Study|Lost to Follow-up|0|||
154842883|NCT03118297|558857594|FG001|Overall Study|Lost to Follow-up|2|||
154842884|NCT04227899|558857595|FG000|Overall Study|Withdrawal by Subject|6|||
154842885|NCT04227899|558857596|FG001|Overall Study|Withdrawal by Subject|3|||
154842886|NCT04227899|558857595|FG000|Overall Study|Death|12|||
154842887|NCT04227899|558857596|FG001|Overall Study|Death|6|||
154842888|NCT04227899|558857595|FG000|Overall Study|Lost to Follow-up|2|||
154842889|NCT04227899|558857596|FG001|Overall Study|Lost to Follow-up|1|||
154842890|NCT02754726|558857597|FG000|Overall Study|Progressive Disease by RECIST|13|||
154842891|NCT02754726|558857597|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
154842892|NCT02754726|558857597|FG000|Overall Study|Clinical Disease Progression|5|||
154842893|NCT02754726|558857597|FG000|Overall Study|Adverse Event|3|||
154842894|NCT02754726|558857597|FG000|Overall Study|Withdrawal by Subject|1|||
154842895|NCT02754726|558857597|FG000|Overall Study|Tolerability|1|||
154842896|NCT05587296|558857602|FG000|Overall Study|Adverse Event|15|||
154842897|NCT05587296|558857603|FG001|Overall Study|Adverse Event|7|||
154842898|NCT05587296|558857602|FG000|Overall Study|Lack of Efficacy|2|||
154842899|NCT05587296|558857603|FG001|Overall Study|Lack of Efficacy|0|||
154842900|NCT05587296|558857602|FG000|Overall Study|Lost to Follow-up|1|||
154842901|NCT05587296|558857603|FG001|Overall Study|Lost to Follow-up|0|||
155104854|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
155104855|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
155104856|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
155104857|NCT03162796|559813888|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
155104858|NCT03162796|559813889|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
155104859|NCT03162796|559813890|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
154842902|NCT05587296|558857602|FG000|Overall Study|Withdrawal by Subject|14|||
154842903|NCT05587296|558857603|FG001|Overall Study|Withdrawal by Subject|4|||
154842904|NCT05587296|558857602|FG000|Overall Study|miscellaneous|3|||
154842905|NCT05587296|558857603|FG001|Overall Study|miscellaneous|6|||
154842906|NCT05587296|558857602|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
154842907|NCT05587296|558857603|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
154842908|NCT05617911|558857606|FG000|Overall Study|Withdrawal by Subject|1|||
154842909|NCT05617911|558857607|FG001|Overall Study|Withdrawal by Subject|0|||
154842910|NCT04868903|558857608|FG000|Overall Study|Adverse Event|0|||
154842911|NCT04868903|558857609|FG001|Overall Study|Adverse Event|0|||
154842912|NCT04868903|558857610|FG002|Overall Study|Adverse Event|0|||
154842913|NCT04868903|558857611|FG003|Overall Study|Adverse Event|1|||
154842914|NCT04868903|558857608|FG000|Overall Study|Withdrawal by Subject|29|||
154842915|NCT04868903|558857609|FG001|Overall Study|Withdrawal by Subject|44|||
154842916|NCT04868903|558857610|FG002|Overall Study|Withdrawal by Subject|17|||
154842917|NCT04868903|558857611|FG003|Overall Study|Withdrawal by Subject|12|||
154842918|NCT04868903|558857608|FG000|Overall Study|Hyperparathyroidism|3|||
154842919|NCT04868903|558857609|FG001|Overall Study|Hyperparathyroidism|5|||
154842920|NCT04868903|558857610|FG002|Overall Study|Hyperparathyroidism|2|||
154842921|NCT04868903|558857611|FG003|Overall Study|Hyperparathyroidism|3|||
154842922|NCT03092726|558857614|FG000|Overall Study|Adverse Event|3|||
154842923|NCT03092726|558857615|FG001|Overall Study|Adverse Event|10|||
154842924|NCT03092726|558857614|FG000|Overall Study|Lack of Efficacy|0|||
154842925|NCT03092726|558857615|FG001|Overall Study|Lack of Efficacy|1|||
154842926|NCT03092726|558857614|FG000|Overall Study|Lost to Follow-up|1|||
154842927|NCT03092726|558857615|FG001|Overall Study|Lost to Follow-up|0|||
154842928|NCT03092726|558857614|FG000|Overall Study|Withdrawal by Subject|5|||
154842929|NCT03092726|558857615|FG001|Overall Study|Withdrawal by Subject|3|||
154842930|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
154842931|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
154842932|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
154842933|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
154842934|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
154842935|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
154842936|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
154842937|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
154842938|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
154842939|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
154842940|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
154842941|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
154842942|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
154842943|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
154842944|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
154842945|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
154842946|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
154842947|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
154842948|NCT04418765|558857617|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
154842949|NCT04418765|558857618|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
154842950|NCT04418765|558857619|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
154842951|NCT04418765|558857617|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
154842952|NCT04418765|558857618|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
154842953|NCT04418765|558857619|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
154842954|NCT04418765|558857617|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
154842955|NCT04418765|558857618|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
154842956|NCT04418765|558857619|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
154842957|NCT04418765|558857617|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
154842958|NCT04418765|558857618|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
154842959|NCT04418765|558857619|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
154842960|NCT04418765|558857617|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
154842961|NCT04418765|558857618|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
154842962|NCT04418765|558857619|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
154842963|NCT04418765|558857617|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
154842964|NCT04418765|558857618|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
154842965|NCT04418765|558857619|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
154842966|NCT04418765|558857617|FG000|Extension Period (48 Weeks)|Other than specified|0|||
154842967|NCT04418765|558857618|FG001|Extension Period (48 Weeks)|Other than specified|5|||
154842968|NCT04418765|558857619|FG002|Extension Period (48 Weeks)|Other than specified|2|||
154842969|NCT02296242|558857620|FG000|Overall Study|Death|1|||
155104860|NCT03162796|559813888|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
155104861|NCT03162796|559813889|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
155104862|NCT03162796|559813890|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
155104863|NCT03162796|559813888|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
154842970|NCT02296242|558857621|FG001|Overall Study|Death|1|||
154971148|NCT04556734|559318533|FG002|OLE Period (28 Weeks)|Not reported|0|||
154842971|NCT02296242|558857622|FG002|Overall Study|Death|1|||
154842972|NCT02296242|558857623|FG003|Overall Study|Death|1|||
154842973|NCT02296242|558857624|FG004|Overall Study|Death|1|||
154842974|NCT02296242|558857620|FG000|Overall Study|Withdrawal by Subject|0|||
154842975|NCT02296242|558857621|FG001|Overall Study|Withdrawal by Subject|0|||
154842976|NCT02296242|558857622|FG002|Overall Study|Withdrawal by Subject|1|||
154842977|NCT02296242|558857623|FG003|Overall Study|Withdrawal by Subject|1|||
154842978|NCT02296242|558857624|FG004|Overall Study|Withdrawal by Subject|3|||
154842979|NCT02296242|558857620|FG000|Overall Study|Disease Progression|1|||
154842980|NCT02296242|558857621|FG001|Overall Study|Disease Progression|3|||
154842981|NCT02296242|558857622|FG002|Overall Study|Disease Progression|2|||
154842982|NCT02296242|558857623|FG003|Overall Study|Disease Progression|8|||
154842983|NCT02296242|558857624|FG004|Overall Study|Disease Progression|11|||
154842984|NCT02296242|558857620|FG000|Overall Study|Unacceptable Toxicity|0|||
154842985|NCT02296242|558857621|FG001|Overall Study|Unacceptable Toxicity|0|||
154842986|NCT02296242|558857622|FG002|Overall Study|Unacceptable Toxicity|0|||
155173528|NCT02043899|560074803|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
155173529|NCT02043899|560074803|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
154842987|NCT02296242|558857623|FG003|Overall Study|Unacceptable Toxicity|0|||
154842988|NCT02296242|558857624|FG004|Overall Study|Unacceptable Toxicity|1|||
154842989|NCT02296242|558857620|FG000|Overall Study|Patient Condition Changed|0|||
154842990|NCT02296242|558857621|FG001|Overall Study|Patient Condition Changed|0|||
154842991|NCT02296242|558857622|FG002|Overall Study|Patient Condition Changed|2|||
154842992|NCT02296242|558857623|FG003|Overall Study|Patient Condition Changed|0|||
154842993|NCT02296242|558857624|FG004|Overall Study|Patient Condition Changed|1|||
154842994|NCT02296242|558857620|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
154842995|NCT02296242|558857621|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
154842996|NCT02296242|558857622|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
154842997|NCT02296242|558857623|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
154842998|NCT02296242|558857624|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
154842999|NCT02296242|558857620|FG000|Overall Study|Lost to Follow-up|1|||
154843000|NCT02296242|558857621|FG001|Overall Study|Lost to Follow-up|0|||
154843001|NCT02296242|558857622|FG002|Overall Study|Lost to Follow-up|0|||
154843002|NCT02296242|558857623|FG003|Overall Study|Lost to Follow-up|0|||
154843003|NCT02296242|558857624|FG004|Overall Study|Lost to Follow-up|0|||
154843004|NCT02296242|558857620|FG000|Overall Study|Need for Hydroxyurea|2|||
154843005|NCT02296242|558857621|FG001|Overall Study|Need for Hydroxyurea|0|||
154843006|NCT02296242|558857622|FG002|Overall Study|Need for Hydroxyurea|0|||
154843007|NCT02296242|558857623|FG003|Overall Study|Need for Hydroxyurea|0|||
154843008|NCT02296242|558857624|FG004|Overall Study|Need for Hydroxyurea|0|||
154843009|NCT02296242|558857620|FG000|Overall Study|Screened for Other Protocol|0|||
154843010|NCT02296242|558857621|FG001|Overall Study|Screened for Other Protocol|1|||
154843011|NCT02296242|558857622|FG002|Overall Study|Screened for Other Protocol|0|||
154843012|NCT02296242|558857623|FG003|Overall Study|Screened for Other Protocol|0|||
154843013|NCT02296242|558857624|FG004|Overall Study|Screened for Other Protocol|0|||
154843014|NCT02296242|558857620|FG000|Overall Study|Physician Decision|0|||
154843015|NCT02296242|558857621|FG001|Overall Study|Physician Decision|1|||
154843016|NCT02296242|558857622|FG002|Overall Study|Physician Decision|0|||
154843017|NCT02296242|558857623|FG003|Overall Study|Physician Decision|1|||
154843018|NCT02296242|558857624|FG004|Overall Study|Physician Decision|0|||
154843019|NCT02296242|558857620|FG000|Overall Study|Alternative Treatment|0|||
154843020|NCT02296242|558857621|FG001|Overall Study|Alternative Treatment|0|||
154843021|NCT02296242|558857622|FG002|Overall Study|Alternative Treatment|0|||
154843022|NCT02296242|558857623|FG003|Overall Study|Alternative Treatment|1|||
154843023|NCT02296242|558857624|FG004|Overall Study|Alternative Treatment|0|||
154843024|NCT02296242|558857620|FG000|Overall Study|Adverse Event|0|||
154843025|NCT02296242|558857621|FG001|Overall Study|Adverse Event|0|||
154843026|NCT02296242|558857622|FG002|Overall Study|Adverse Event|0|||
154843027|NCT02296242|558857623|FG003|Overall Study|Adverse Event|1|||
154843028|NCT02296242|558857624|FG004|Overall Study|Adverse Event|0|||
154843029|NCT02296242|558857620|FG000|Overall Study|Lack of Efficacy|0|||
154843030|NCT02296242|558857621|FG001|Overall Study|Lack of Efficacy|0|||
154843031|NCT02296242|558857622|FG002|Overall Study|Lack of Efficacy|0|||
154843032|NCT02296242|558857623|FG003|Overall Study|Lack of Efficacy|0|||
154843033|NCT02296242|558857624|FG004|Overall Study|Lack of Efficacy|3|||
154843034|NCT02217566|558857625|FG000|Overall Study|Lost to Follow-up|2|||
154843035|NCT02217566|558857625|FG000|Overall Study|Death|3|||
154843036|NCT02217566|558857625|FG000|Overall Study|Early study termination|6|||
154843037|NCT03504397|558857626|FG000|Overall Study|Progressive Disease|151|||
154843038|NCT03504397|558857627|FG001|Overall Study|Progressive Disease|199|||
154843039|NCT03504397|558857626|FG000|Overall Study|Withdrawal by Subject|29|||
154843040|NCT03504397|558857627|FG001|Overall Study|Withdrawal by Subject|17|||
154843041|NCT03504397|558857626|FG000|Overall Study|Lost to Follow-up|1|||
154843042|NCT03504397|558857627|FG001|Overall Study|Lost to Follow-up|0|||
154843043|NCT03504397|558857626|FG000|Overall Study|Death|14|||
154843044|NCT03504397|558857627|FG001|Overall Study|Death|16|||
154843045|NCT03504397|558857626|FG000|Overall Study|Adverse Event|40|||
154843046|NCT03504397|558857627|FG001|Overall Study|Adverse Event|14|||
154843047|NCT03504397|558857626|FG000|Overall Study|miscellaneous|17|||
154843048|NCT03504397|558857627|FG001|Overall Study|miscellaneous|15|||
154843049|NCT03504397|558857626|FG000|Overall Study|Protocol deviation|1|||
154843050|NCT03504397|558857627|FG001|Overall Study|Protocol deviation|0|||
154843051|NCT03504397|558857626|FG000|Overall Study|Participants who did not take the study drug|4|||
154843052|NCT03504397|558857627|FG001|Overall Study|Participants who did not take the study drug|4|||
154843053|NCT02064387|558857628|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843054|NCT02064387|558857629|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843055|NCT02064387|558857630|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843056|NCT02064387|558857631|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843057|NCT02064387|558857632|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843058|NCT02064387|558857633|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843059|NCT02064387|558857634|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843060|NCT02064387|558857635|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
154843061|NCT02064387|558857636|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843062|NCT02064387|558857637|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
154843063|NCT02064387|558857638|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843064|NCT02064387|558857639|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
154843065|NCT02064387|558857628|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843066|NCT02064387|558857629|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843067|NCT02064387|558857630|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843068|NCT02064387|558857631|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843069|NCT02064387|558857632|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843070|NCT02064387|558857633|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843071|NCT02064387|558857634|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843072|NCT02064387|558857635|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
154843073|NCT02064387|558857636|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843074|NCT02064387|558857637|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843075|NCT02064387|558857638|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843076|NCT02064387|558857639|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
154843077|NCT02064387|558857628|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843078|NCT02064387|558857629|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843079|NCT02064387|558857630|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843080|NCT02064387|558857631|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843081|NCT02064387|558857632|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843082|NCT02064387|558857633|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843083|NCT02064387|558857634|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843084|NCT02064387|558857635|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843085|NCT02064387|558857636|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
154843086|NCT02064387|558857637|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843087|NCT02064387|558857638|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843088|NCT02064387|558857639|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
154843089|NCT02064387|558857628|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
154843090|NCT02064387|558857629|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
154843091|NCT02064387|558857630|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
154843092|NCT02064387|558857631|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
154843093|NCT02064387|558857632|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
154843094|NCT02064387|558857633|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
154843095|NCT02064387|558857634|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
154843096|NCT02064387|558857635|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
154843097|NCT02064387|558857636|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
154843098|NCT02064387|558857637|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
154843099|NCT02064387|558857638|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
154843100|NCT02064387|558857639|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
154843101|NCT02064387|558857628|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843102|NCT02064387|558857629|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843103|NCT02064387|558857630|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843104|NCT02064387|558857631|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843105|NCT02064387|558857632|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843106|NCT02064387|558857633|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843107|NCT02064387|558857634|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843108|NCT02064387|558857635|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843109|NCT02064387|558857636|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843110|NCT02064387|558857637|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843111|NCT02064387|558857638|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
154843112|NCT02064387|558857639|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
154843113|NCT02436876|558857643|FG000|Overall Study|Lost to Follow-up|0|||
154843114|NCT02436876|558857644|FG001|Overall Study|Lost to Follow-up|1|||
154843115|NCT02436876|558857645|FG002|Overall Study|Lost to Follow-up|1|||
154843116|NCT02436876|558857646|FG003|Overall Study|Lost to Follow-up|1|||
154843117|NCT02436876|558857643|FG000|Overall Study|Withdrawal by Subject|1|||
154843118|NCT02436876|558857644|FG001|Overall Study|Withdrawal by Subject|0|||
154843119|NCT02436876|558857645|FG002|Overall Study|Withdrawal by Subject|0|||
154843120|NCT02436876|558857646|FG003|Overall Study|Withdrawal by Subject|1|||
154843121|NCT02436876|558857643|FG000|Overall Study|Physician Decision|0|||
154843122|NCT02436876|558857644|FG001|Overall Study|Physician Decision|2|||
155104864|NCT03162796|559813889|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
155104865|NCT03162796|559813890|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
155104866|NCT03162796|559813888|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
155104867|NCT03162796|559813889|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
155104868|NCT03162796|559813890|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
155104869|NCT03162796|559813888|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
155104870|NCT03162796|559813889|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
154843123|NCT02436876|558857645|FG002|Overall Study|Physician Decision|1|||
154843124|NCT02436876|558857646|FG003|Overall Study|Physician Decision|0|||
154843125|NCT02436876|558857643|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
154843126|NCT02436876|558857644|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
154843127|NCT02436876|558857645|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
154843128|NCT02436876|558857646|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
154843129|NCT01276236|558857647|FG000|Overall Study|Lack of Efficacy|2|||
155104871|NCT03162796|559813890|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
154843130|NCT01276236|558857647|FG000|Overall Study|Withdrawal by Subject|4|||
154843131|NCT03215771|558857648|FG000|Overall Study|Withdrawal by Subject|2|||
154843132|NCT03215771|558857648|FG000|Overall Study|Physician Decision|1|||
154843133|NCT03127384|558857653|FG000|Overall Study|Lost to Follow-up|4|||
154843134|NCT03127384|558857653|FG000|Overall Study|Subject request|2|||
154843135|NCT02703311|558857654|FG000|Overall Study|Death|5|||
154843136|NCT02703311|558857654|FG000|Overall Study|Withdrawal by Subject|3|||
154843137|NCT00343889|558857662|FG000|Overall Study|Lost to Follow-up|2|||
154843138|NCT00343889|558857663|FG001|Overall Study|Lost to Follow-up|0|||
154843139|NCT00343889|558857662|FG000|Overall Study|Withdrawal by Subject|0|||
154843140|NCT00343889|558857663|FG001|Overall Study|Withdrawal by Subject|1|||
154843141|NCT00343889|558857662|FG000|Overall Study|Protocol Violation|1|||
154843142|NCT00343889|558857663|FG001|Overall Study|Protocol Violation|0|||
154843143|NCT01294579|558857668|FG000|Overall Study|Disease progression|12|||
154843144|NCT01294579|558857668|FG000|Overall Study|Adverse Event|11|||
154843145|NCT01294579|558857668|FG000|Overall Study|Study closed/terminated|3|||
154843146|NCT01294579|558857668|FG000|Overall Study|Lost to Follow-up|1|||
154843147|NCT01294579|558857668|FG000|Overall Study|Physician Decision|3|||
154843148|NCT01294579|558857668|FG000|Overall Study|Withdrawal by Subject|5|||
154843149|NCT00137111|558857669|FG000|Total Therapy|Death|35|||
154843150|NCT00137111|558857670|FG001|Total Therapy|Death|0|||
154843151|NCT00137111|558857671|FG002|Total Therapy|Death|0|||
154843152|NCT00137111|558857672|FG003|Total Therapy|Death|0|||
154843153|NCT00137111|558857669|FG000|Total Therapy|Non Compliance|5|||
154843154|NCT00137111|558857670|FG001|Total Therapy|Non Compliance|0|||
154843155|NCT00137111|558857671|FG002|Total Therapy|Non Compliance|0|||
154843156|NCT00137111|558857672|FG003|Total Therapy|Non Compliance|0|||
154843157|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
154843158|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
154843159|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
154843160|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
154843161|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
154843162|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
154843163|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
154843164|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
154843165|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
154843166|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
154843167|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
154843168|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
154843169|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
154843170|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
154843171|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
154843172|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
154843173|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
154843174|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
154843175|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
154843176|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
154843177|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
154843178|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
154843179|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
154843180|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
154843181|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
154843182|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
154843183|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
154843184|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
154843185|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
154843186|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
154843187|NCT00784654|558857673|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
154843188|NCT00784654|558857674|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
154843189|NCT00784654|558857675|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
154843190|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
154843191|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
154843192|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
154843193|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
154843194|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
154843195|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
154843196|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154843197|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
155104872|NCT02725476|559813892|FG000|Overall Study|Physician Decision|2|||
154843198|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
154843199|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
154843200|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
154843201|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
154843202|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Adverse Event|0|||
154843203|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Adverse Event|1|||
154843204|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Adverse Event|1|||
154843205|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
154843206|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
154843207|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
154843208|NCT00784654|558857673|FG000|Randomized Withdrawal Period|Family reasons|0|||
154843209|NCT00784654|558857674|FG001|Randomized Withdrawal Period|Family reasons|0|||
154843210|NCT00784654|558857675|FG002|Randomized Withdrawal Period|Family reasons|1|||
154843211|NCT00844753|558857676|FG000|Overall Study|Lack of Efficacy|1|||
154843212|NCT00844753|558857677|FG001|Overall Study|Lack of Efficacy|0|||
154843213|NCT00844753|558857678|FG002|Overall Study|Lack of Efficacy|2|||
154843214|NCT00844753|558857679|FG003|Overall Study|Lack of Efficacy|2|||
154843215|NCT00844753|558857676|FG000|Overall Study|Adverse Event|3|||
154843216|NCT00844753|558857677|FG001|Overall Study|Adverse Event|2|||
154843217|NCT00844753|558857678|FG002|Overall Study|Adverse Event|5|||
154843218|NCT00844753|558857679|FG003|Overall Study|Adverse Event|5|||
154843219|NCT00844753|558857676|FG000|Overall Study|Lost to Follow-up|1|||
154843220|NCT00844753|558857677|FG001|Overall Study|Lost to Follow-up|1|||
154843221|NCT00844753|558857678|FG002|Overall Study|Lost to Follow-up|0|||
154843222|NCT00844753|558857679|FG003|Overall Study|Lost to Follow-up|1|||
154843223|NCT00844753|558857676|FG000|Overall Study|could not swallow medication|2|||
154843224|NCT00844753|558857677|FG001|Overall Study|could not swallow medication|0|||
154843225|NCT00844753|558857678|FG002|Overall Study|could not swallow medication|0|||
154843226|NCT00844753|558857679|FG003|Overall Study|could not swallow medication|0|||
154843227|NCT00844753|558857676|FG000|Overall Study|Withdrawal by Subject|1|||
154843228|NCT00844753|558857677|FG001|Overall Study|Withdrawal by Subject|0|||
154843229|NCT00844753|558857678|FG002|Overall Study|Withdrawal by Subject|0|||
154843230|NCT00844753|558857679|FG003|Overall Study|Withdrawal by Subject|3|||
154843231|NCT00903175|558857680|FG000|Period 1 - First Line|Adverse Event|36|||
154843232|NCT00903175|558857681|FG001|Period 1 - First Line|Adverse Event|50|||
154843233|NCT00903175|558857680|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
154843234|NCT00903175|558857681|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
154843235|NCT00903175|558857680|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
154843236|NCT00903175|558857681|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
154843237|NCT00903175|558857680|FG000|Period 1 - First Line|Protocol Violation|3|||
154843238|NCT00903175|558857681|FG001|Period 1 - First Line|Protocol Violation|3|||
154843239|NCT00903175|558857680|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
154843240|NCT00903175|558857681|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
154843241|NCT00903175|558857680|FG000|Period 1 - First Line|Administrative problems|12|||
154843242|NCT00903175|558857681|FG001|Period 1 - First Line|Administrative problems|13|||
154843243|NCT00903175|558857680|FG000|Period 1 - First Line|Death|17|||
154843244|NCT00903175|558857681|FG001|Period 1 - First Line|Death|10|||
154843245|NCT00903175|558857680|FG000|Period 2 - Second Line|Missing|1|||
154843246|NCT00903175|558857681|FG001|Period 2 - Second Line|Missing|0|||
154843247|NCT00903175|558857680|FG000|Period 2 - Second Line|Adverse Event|16|||
154843248|NCT00903175|558857681|FG001|Period 2 - Second Line|Adverse Event|20|||
154843249|NCT00903175|558857680|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
154843250|NCT00903175|558857681|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
154843251|NCT00903175|558857680|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
154843252|NCT00903175|558857681|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
154843253|NCT00903175|558857680|FG000|Period 2 - Second Line|Administrative problems|19|||
154843254|NCT00903175|558857681|FG001|Period 2 - Second Line|Administrative problems|9|||
154843255|NCT00903175|558857680|FG000|Period 2 - Second Line|Death|5|||
154843256|NCT00903175|558857681|FG001|Period 2 - Second Line|Death|2|||
154843257|NCT03074474|558857682|FG000|Overall Study|Lost to Follow-up|10|||
154843258|NCT03074474|558857682|FG000|Overall Study|Withdrawal by Subject|10|||
154843259|NCT03074474|558857682|FG000|Overall Study|Death|4|||
154843260|NCT03074474|558857682|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
154843261|NCT05073458|558857687|FG000|24-week Double-blind Period|Adverse Event|1|||
154843262|NCT05073458|558857688|FG001|24-week Double-blind Period|Adverse Event|0|||
154843263|NCT05073458|558857687|FG000|24-week Double-blind Period|Physician Decision|1|||
154843264|NCT05073458|558857688|FG001|24-week Double-blind Period|Physician Decision|0|||
154843265|NCT05073458|558857687|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
154843266|NCT05073458|558857688|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
154843267|NCT05073458|558857687|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
154843268|NCT05073458|558857688|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
154843269|NCT05073458|558857687|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
154843270|NCT05073458|558857688|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
154843271|NCT05073458|558857687|FG000|24-week Open-label Period|Adverse Event|1|||
154843272|NCT05073458|558857688|FG001|24-week Open-label Period|Adverse Event|2|||
154843273|NCT01627899|558857697|FG000|Overall Study|Study terminated early by sponsor.|5|||
154843274|NCT04818593|558857699|FG000|Overall Study|Low Oocyte Yield|8|||
154843275|NCT04818593|558857700|FG001|Overall Study|Low Oocyte Yield|8|||
154843276|NCT04818593|558857699|FG000|Overall Study|Not ICSI Insemination|7|||
154843277|NCT04818593|558857700|FG001|Overall Study|Not ICSI Insemination|7|||
154843278|NCT04818593|558857699|FG000|Overall Study|Poor Sperm Quality|2|||
154843279|NCT04818593|558857700|FG001|Overall Study|Poor Sperm Quality|2|||
154843280|NCT04818593|558857699|FG000|Overall Study|Withdrawal by Subject|2|||
154843281|NCT04818593|558857700|FG001|Overall Study|Withdrawal by Subject|2|||
154843282|NCT04818593|558857699|FG000|Overall Study|Conversion to IUI due to low response|1|||
154843283|NCT04818593|558857700|FG001|Overall Study|Conversion to IUI due to low response|1|||
154843284|NCT03809611|558857701|FG000|Overall Study|Withdrawal by Subject|1|||
154843285|NCT03809611|558857702|FG001|Overall Study|Withdrawal by Subject|1|||
154843286|NCT04179175|558859227|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
154843287|NCT04179175|558859228|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
154843288|NCT04179175|558859229|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
154843289|NCT04179175|558859230|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
154843290|NCT04179175|558859231|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
154843291|NCT04179175|558859232|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
154843292|NCT04179175|558859227|FG000|Overall Study|Adverse Event|5|||
154843293|NCT04179175|558859228|FG001|Overall Study|Adverse Event|3|||
154843294|NCT04179175|558859229|FG002|Overall Study|Adverse Event|3|||
154843295|NCT04179175|558859230|FG003|Overall Study|Adverse Event|4|||
154843296|NCT04179175|558859231|FG004|Overall Study|Adverse Event|6|||
154843297|NCT04179175|558859232|FG005|Overall Study|Adverse Event|6|||
154843298|NCT04179175|558859227|FG000|Overall Study|Lack of Efficacy|5|||
154843299|NCT04179175|558859228|FG001|Overall Study|Lack of Efficacy|1|||
154843300|NCT04179175|558859229|FG002|Overall Study|Lack of Efficacy|3|||
154843301|NCT04179175|558859230|FG003|Overall Study|Lack of Efficacy|2|||
154843302|NCT04179175|558859231|FG004|Overall Study|Lack of Efficacy|18|||
154843303|NCT04179175|558859232|FG005|Overall Study|Lack of Efficacy|7|||
154843304|NCT04179175|558859227|FG000|Overall Study|Lost to Follow-up|5|||
154843305|NCT04179175|558859228|FG001|Overall Study|Lost to Follow-up|3|||
154843306|NCT04179175|558859229|FG002|Overall Study|Lost to Follow-up|2|||
154843307|NCT04179175|558859230|FG003|Overall Study|Lost to Follow-up|2|||
154843308|NCT04179175|558859231|FG004|Overall Study|Lost to Follow-up|4|||
154843309|NCT04179175|558859232|FG005|Overall Study|Lost to Follow-up|5|||
154843310|NCT04179175|558859227|FG000|Overall Study|Physician Decision|2|||
154843311|NCT04179175|558859228|FG001|Overall Study|Physician Decision|0|||
154843312|NCT04179175|558859229|FG002|Overall Study|Physician Decision|2|||
154843313|NCT04179175|558859230|FG003|Overall Study|Physician Decision|3|||
154843314|NCT04179175|558859231|FG004|Overall Study|Physician Decision|1|||
154843315|NCT04179175|558859232|FG005|Overall Study|Physician Decision|1|||
154843316|NCT04179175|558859227|FG000|Overall Study|Pregnancy|3|||
154843317|NCT04179175|558859228|FG001|Overall Study|Pregnancy|0|||
154843318|NCT04179175|558859229|FG002|Overall Study|Pregnancy|3|||
154843319|NCT04179175|558859230|FG003|Overall Study|Pregnancy|0|||
154843320|NCT04179175|558859231|FG004|Overall Study|Pregnancy|1|||
154843321|NCT04179175|558859232|FG005|Overall Study|Pregnancy|2|||
154843322|NCT04179175|558859227|FG000|Overall Study|Withdrawal by Subject|22|||
154843323|NCT04179175|558859228|FG001|Overall Study|Withdrawal by Subject|10|||
154843324|NCT04179175|558859229|FG002|Overall Study|Withdrawal by Subject|12|||
154843325|NCT04179175|558859230|FG003|Overall Study|Withdrawal by Subject|8|||
154843326|NCT04179175|558859231|FG004|Overall Study|Withdrawal by Subject|23|||
154843327|NCT04179175|558859232|FG005|Overall Study|Withdrawal by Subject|31|||
154843328|NCT04179175|558859227|FG000|Overall Study|Technical problems|0|||
154843329|NCT04179175|558859228|FG001|Overall Study|Technical problems|0|||
154843330|NCT04179175|558859229|FG002|Overall Study|Technical problems|1|||
154843331|NCT04179175|558859230|FG003|Overall Study|Technical problems|1|||
154843332|NCT04179175|558859231|FG004|Overall Study|Technical problems|0|||
154843333|NCT04179175|558859232|FG005|Overall Study|Technical problems|0|||
154971149|NCT04556734|559318534|FG003|OLE Period (28 Weeks)|Not reported|0|||
154971150|NCT04556734|559318535|FG004|OLE Period (28 Weeks)|Not reported|0|||
154971151|NCT04556734|559318536|FG005|OLE Period (28 Weeks)|Not reported|1|||
154843334|NCT03215030|558859241|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
154843335|NCT03215030|558859242|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
154843336|NCT03215030|558859243|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843337|NCT03215030|558859244|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
154843338|NCT03215030|558859245|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843339|NCT03215030|558859246|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843340|NCT03215030|558859247|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843341|NCT03215030|558859248|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843342|NCT03215030|558859249|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
154971152|NCT04556734|559318537|FG006|OLE Period (28 Weeks)|Not reported|0|||
154971153|NCT04556734|559318538|FG007|OLE Period (28 Weeks)|Not reported|0|||
154843343|NCT03215030|558859250|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843344|NCT03215030|558859251|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843345|NCT03215030|558859252|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
154843346|NCT03215030|558859241|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
154843347|NCT03215030|558859242|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843348|NCT03215030|558859243|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843349|NCT03215030|558859244|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
154843350|NCT03215030|558859245|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843351|NCT03215030|558859246|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843352|NCT03215030|558859247|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843353|NCT03215030|558859248|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843354|NCT03215030|558859249|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843355|NCT03215030|558859250|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843356|NCT03215030|558859251|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843357|NCT03215030|558859252|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154843358|NCT03215030|558859241|FG000|Part 1: Dose Escalation|Death|15|||
154843359|NCT03215030|558859242|FG001|Part 1: Dose Escalation|Death|6|||
154843360|NCT03215030|558859243|FG002|Part 1: Dose Escalation|Death|6|||
154843361|NCT03215030|558859244|FG003|Part 1: Dose Escalation|Death|8|||
154843362|NCT03215030|558859245|FG004|Part 1: Dose Escalation|Death|0|||
154843363|NCT03215030|558859246|FG005|Part 1: Dose Escalation|Death|0|||
154843364|NCT03215030|558859247|FG006|Part 1: Dose Escalation|Death|0|||
154843365|NCT03215030|558859248|FG007|Part 1: Dose Escalation|Death|0|||
154843366|NCT03215030|558859249|FG008|Part 1: Dose Escalation|Death|0|||
154843367|NCT03215030|558859250|FG009|Part 1: Dose Escalation|Death|0|||
154843368|NCT03215030|558859251|FG010|Part 1: Dose Escalation|Death|0|||
154843369|NCT03215030|558859252|FG011|Part 1: Dose Escalation|Death|0|||
154843370|NCT03215030|558859241|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
154843371|NCT03215030|558859242|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
154843372|NCT03215030|558859243|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
154843373|NCT03215030|558859244|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
154843374|NCT03215030|558859245|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
154843375|NCT03215030|558859246|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
154843376|NCT03215030|558859247|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
154843377|NCT03215030|558859248|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
154843378|NCT03215030|558859249|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
154843379|NCT03215030|558859250|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
154843380|NCT03215030|558859251|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
154843381|NCT03215030|558859252|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
154843382|NCT03215030|558859241|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843383|NCT03215030|558859242|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843384|NCT03215030|558859243|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843385|NCT03215030|558859244|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843386|NCT03215030|558859245|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843387|NCT03215030|558859246|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843388|NCT03215030|558859247|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843389|NCT03215030|558859248|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
154843390|NCT03215030|558859249|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843391|NCT03215030|558859250|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843392|NCT03215030|558859251|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843393|NCT03215030|558859252|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
154843394|NCT03215030|558859241|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843395|NCT03215030|558859242|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843396|NCT03215030|558859243|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843397|NCT03215030|558859244|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843398|NCT03215030|558859245|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
154843399|NCT03215030|558859246|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
154843400|NCT03215030|558859247|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
154843401|NCT03215030|558859248|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
154971154|NCT04556734|559318531|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155104873|NCT02725476|559813893|FG001|Overall Study|Physician Decision|0|||
155104874|NCT02725476|559813892|FG000|Overall Study|Adverse Event|1|||
155104875|NCT02725476|559813893|FG001|Overall Study|Adverse Event|1|||
154843402|NCT03215030|558859249|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843403|NCT03215030|558859250|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843404|NCT03215030|558859251|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843405|NCT03215030|558859252|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154843406|NCT03215030|558859241|FG000|Part 2: Dose Expansion|Death|0|||
154843407|NCT03215030|558859242|FG001|Part 2: Dose Expansion|Death|0|||
154843408|NCT03215030|558859243|FG002|Part 2: Dose Expansion|Death|0|||
154971155|NCT04556734|559318532|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
155104876|NCT00289289|559813894|FG000|Overall Study|Withdrawal by Subject|5|||
154843409|NCT03215030|558859244|FG003|Part 2: Dose Expansion|Death|0|||
154843410|NCT03215030|558859245|FG004|Part 2: Dose Expansion|Death|3|||
154843411|NCT03215030|558859246|FG005|Part 2: Dose Expansion|Death|1|||
154843412|NCT03215030|558859247|FG006|Part 2: Dose Expansion|Death|5|||
154843413|NCT03215030|558859248|FG007|Part 2: Dose Expansion|Death|4|||
154843414|NCT03215030|558859249|FG008|Part 2: Dose Expansion|Death|0|||
154843415|NCT03215030|558859250|FG009|Part 2: Dose Expansion|Death|0|||
154843416|NCT03215030|558859251|FG010|Part 2: Dose Expansion|Death|0|||
154843417|NCT03215030|558859252|FG011|Part 2: Dose Expansion|Death|0|||
154843418|NCT03215030|558859241|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
154843419|NCT03215030|558859242|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
154843420|NCT03215030|558859243|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
154843421|NCT03215030|558859244|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
154843422|NCT03215030|558859245|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
154843423|NCT03215030|558859246|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
154843424|NCT03215030|558859247|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
154843425|NCT03215030|558859248|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
154843426|NCT03215030|558859249|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
154843427|NCT03215030|558859250|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
154843428|NCT03215030|558859251|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
154843429|NCT03215030|558859252|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
154843430|NCT03215030|558859241|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
154843431|NCT03215030|558859242|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
154843432|NCT03215030|558859243|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
154843433|NCT03215030|558859244|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
154843434|NCT03215030|558859245|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
154843435|NCT03215030|558859246|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
154843436|NCT03215030|558859247|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
154843437|NCT03215030|558859248|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
154843438|NCT03215030|558859249|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
154843439|NCT03215030|558859250|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
154843440|NCT03215030|558859251|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
154843441|NCT03215030|558859252|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
154843442|NCT03215030|558859241|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843443|NCT03215030|558859242|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843444|NCT03215030|558859243|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843445|NCT03215030|558859244|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843446|NCT03215030|558859245|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843447|NCT03215030|558859246|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843448|NCT03215030|558859247|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843449|NCT03215030|558859248|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843450|NCT03215030|558859249|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
154843451|NCT03215030|558859250|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
154843452|NCT03215030|558859251|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843453|NCT03215030|558859252|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
154843454|NCT03215030|558859241|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843455|NCT03215030|558859242|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843456|NCT03215030|558859243|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843457|NCT03215030|558859244|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843458|NCT03215030|558859245|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843459|NCT03215030|558859246|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843460|NCT03215030|558859247|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843461|NCT03215030|558859248|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843462|NCT03215030|558859249|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
154843463|NCT03215030|558859250|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
154843464|NCT03215030|558859251|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843465|NCT03215030|558859252|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
154843466|NCT03215030|558859241|FG000|Part 3: Dose Extension|Death|0|||
154843467|NCT03215030|558859242|FG001|Part 3: Dose Extension|Death|0|||
154843468|NCT03215030|558859243|FG002|Part 3: Dose Extension|Death|0|||
154843469|NCT03215030|558859244|FG003|Part 3: Dose Extension|Death|0|||
154843470|NCT03215030|558859245|FG004|Part 3: Dose Extension|Death|0|||
154843471|NCT03215030|558859246|FG005|Part 3: Dose Extension|Death|0|||
154843472|NCT03215030|558859247|FG006|Part 3: Dose Extension|Death|0|||
154843473|NCT03215030|558859248|FG007|Part 3: Dose Extension|Death|0|||
154843474|NCT03215030|558859249|FG008|Part 3: Dose Extension|Death|19|||
154843475|NCT03215030|558859250|FG009|Part 3: Dose Extension|Death|20|||
154843476|NCT03215030|558859251|FG010|Part 3: Dose Extension|Death|0|||
154843477|NCT03215030|558859252|FG011|Part 3: Dose Extension|Death|0|||
154843478|NCT03215030|558859241|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
154843479|NCT03215030|558859242|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
154843480|NCT03215030|558859243|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
154843481|NCT03215030|558859244|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
154843482|NCT03215030|558859245|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
154843483|NCT03215030|558859246|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
154843484|NCT03215030|558859247|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
154843485|NCT03215030|558859248|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
154843486|NCT03215030|558859249|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
154843487|NCT03215030|558859250|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
154843488|NCT03215030|558859251|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
154843489|NCT03215030|558859252|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
154843490|NCT03215030|558859241|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843491|NCT03215030|558859242|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843492|NCT03215030|558859243|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843493|NCT03215030|558859244|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843494|NCT03215030|558859245|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843495|NCT03215030|558859246|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843496|NCT03215030|558859247|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843497|NCT03215030|558859248|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843498|NCT03215030|558859249|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843499|NCT03215030|558859250|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
154843500|NCT03215030|558859251|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
154843501|NCT03215030|558859252|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
154843502|NCT05416138|558859253|FG000|Overall Study|Withdrawal by Subject|2|||
154843503|NCT05416138|558859254|FG001|Overall Study|Withdrawal by Subject|1|||
154843504|NCT01284114|558859255|FG000|Overall Study|viral infection|1|||
154843505|NCT01284114|558859255|FG000|Overall Study|From the results of ALLTITUDE study|1|||
154843506|NCT01284114|558859255|FG000|Overall Study|Symptomatic hypotension|1|||
154843507|NCT01284114|558859255|FG000|Overall Study|dizziness|1|||
154843508|NCT00598975|558859256|FG000|Overall Study|Adverse Event|1|||
154843509|NCT00598975|558859257|FG001|Overall Study|Adverse Event|1|||
154843510|NCT00598975|558859256|FG000|Overall Study|Brain metastases|1|||
154843511|NCT00598975|558859257|FG001|Overall Study|Brain metastases|0|||
154843512|NCT00598975|558859256|FG000|Overall Study|Withdrawal by Subject|1|||
154843513|NCT00598975|558859257|FG001|Overall Study|Withdrawal by Subject|1|||
154843514|NCT00598975|558859256|FG000|Overall Study|Withdrawal of consent|0|||
154843515|NCT00598975|558859257|FG001|Overall Study|Withdrawal of consent|1|||
154843516|NCT00598975|558859256|FG000|Overall Study|Disease progression|8|||
154843517|NCT00598975|558859257|FG001|Overall Study|Disease progression|3|||
154843518|NCT00598975|558859256|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
154843519|NCT00598975|558859257|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
154843520|NCT03409744|558859266|FG000|Overall Study|Death|2|||
154843521|NCT03409744|558859266|FG000|Overall Study|Physician Decision|5|||
154843522|NCT03409744|558859266|FG000|Overall Study|Pregnancy|1|||
154843523|NCT03409744|558859266|FG000|Overall Study|Lost to Follow-up|1|||
154843524|NCT03409744|558859266|FG000|Overall Study|Protocol Violation|1|||
155104877|NCT00289289|559813895|FG001|Overall Study|Withdrawal by Subject|3|||
155104878|NCT00289289|559813896|FG002|Overall Study|Withdrawal by Subject|15|||
155104879|NCT00289289|559813894|FG000|Overall Study|Lost to Follow-up|1|||
155104880|NCT00289289|559813895|FG001|Overall Study|Lost to Follow-up|0|||
155104881|NCT00289289|559813896|FG002|Overall Study|Lost to Follow-up|1|||
155104882|NCT00289289|559813894|FG000|Overall Study|Death|4|||
155104883|NCT00289289|559813895|FG001|Overall Study|Death|2|||
155104884|NCT00289289|559813896|FG002|Overall Study|Death|5|||
155104885|NCT00289289|559813894|FG000|Overall Study|No implant attempted|0|||
155104886|NCT00289289|559813895|FG001|Overall Study|No implant attempted|0|||
155104887|NCT00289289|559813896|FG002|Overall Study|No implant attempted|1|||
155104888|NCT00289289|559813894|FG000|Overall Study|Physician Decision|1|||
155104889|NCT00289289|559813895|FG001|Overall Study|Physician Decision|0|||
155104890|NCT00289289|559813896|FG002|Overall Study|Physician Decision|6|||
155104891|NCT00289289|559813894|FG000|Overall Study|Non-study device implanted|2|||
155104892|NCT00289289|559813895|FG001|Overall Study|Non-study device implanted|1|||
155104893|NCT00289289|559813896|FG002|Overall Study|Non-study device implanted|3|||
155104894|NCT00289289|559813894|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
154843525|NCT00494091|558859267|FG000|Overall Study|Death|5|||
154843526|NCT00494091|558859268|FG001|Overall Study|Death|54|||
154843527|NCT00494091|558859267|FG000|Overall Study|Lost to Follow-up|0|||
154843528|NCT00494091|558859268|FG001|Overall Study|Lost to Follow-up|4|||
154843529|NCT00494091|558859267|FG000|Overall Study|Other|1|||
154843530|NCT00494091|558859268|FG001|Overall Study|Other|11|||
154843531|NCT00494091|558859267|FG000|Overall Study|Withdrawal by Subject|0|||
154843532|NCT00494091|558859268|FG001|Overall Study|Withdrawal by Subject|7|||
154843533|NCT00984204|558859269|FG000|Overall Study|Death|1|||
155104895|NCT00289289|559813895|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
155104896|NCT00289289|559813896|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
155104897|NCT00289289|559813894|FG000|Overall Study|Other Exit Reason|6|||
154843534|NCT00984204|558859269|FG000|Overall Study|Lost to Follow-up|4|||
154843535|NCT00984204|558859269|FG000|Overall Study|Lack of Efficacy|10|||
154843536|NCT00122135|558859271|FG000|Overall Study|Withdrawal by Subject|3|||
154843537|NCT00122135|558859272|FG001|Overall Study|Withdrawal by Subject|0|||
154843538|NCT02770326|558859276|FG000|Overall Study|Death|3|||
154843539|NCT02770326|558859276|FG000|Overall Study|Lost to Follow-up|1|||
154843540|NCT02814565|558859280|FG000|Overall Study|Lack of Efficacy|0|||
154843541|NCT02814565|558859281|FG001|Overall Study|Lack of Efficacy|1|||
154843542|NCT02814565|558859280|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
154843543|NCT02814565|558859281|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
154843544|NCT02792842|558859284|FG000|Overall Study|Adverse Event|4|||
154843545|NCT02792842|558859285|FG001|Overall Study|Adverse Event|2|||
154843546|NCT02792842|558859286|FG002|Overall Study|Adverse Event|3|||
154843547|NCT02792842|558859284|FG000|Overall Study|Withdrawal by Subject|0|||
154843548|NCT02792842|558859285|FG001|Overall Study|Withdrawal by Subject|1|||
154843549|NCT02792842|558859286|FG002|Overall Study|Withdrawal by Subject|2|||
154843550|NCT02792842|558859284|FG000|Overall Study|Lost to Follow-up|0|||
154843551|NCT02792842|558859285|FG001|Overall Study|Lost to Follow-up|0|||
154843552|NCT02792842|558859286|FG002|Overall Study|Lost to Follow-up|1|||
154843553|NCT02792842|558859284|FG000|Overall Study|Schedule delay|0|||
154843554|NCT02792842|558859285|FG001|Overall Study|Schedule delay|1|||
154843555|NCT02792842|558859286|FG002|Overall Study|Schedule delay|1|||
154843556|NCT01046825|558859291|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
154843557|NCT01046825|558859292|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
154843558|NCT01046825|558859293|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
154843559|NCT01046825|558859294|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
154843560|NCT01046825|558859295|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
154843561|NCT01046825|558859291|FG000|Overall Study|Physician Decision|0|||
154843562|NCT01046825|558859292|FG001|Overall Study|Physician Decision|1|||
154843563|NCT01046825|558859293|FG002|Overall Study|Physician Decision|2|||
154843564|NCT01046825|558859294|FG003|Overall Study|Physician Decision|0|||
154843565|NCT01046825|558859295|FG004|Overall Study|Physician Decision|0|||
154843566|NCT01046825|558859291|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
154843567|NCT01046825|558859292|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
154843568|NCT01046825|558859293|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
154843569|NCT01046825|558859294|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
154843570|NCT01046825|558859295|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
154843571|NCT01046825|558859291|FG000|Overall Study|Found to be ineligible|0|||
154843572|NCT01046825|558859292|FG001|Overall Study|Found to be ineligible|1|||
154843573|NCT01046825|558859293|FG002|Overall Study|Found to be ineligible|0|||
154843574|NCT01046825|558859294|FG003|Overall Study|Found to be ineligible|0|||
154843575|NCT01046825|558859295|FG004|Overall Study|Found to be ineligible|0|||
154843576|NCT01046825|558859291|FG000|Overall Study|Death|0|||
154843577|NCT01046825|558859292|FG001|Overall Study|Death|0|||
154843578|NCT01046825|558859293|FG002|Overall Study|Death|0|||
154843579|NCT01046825|558859294|FG003|Overall Study|Death|1|||
154843580|NCT01046825|558859295|FG004|Overall Study|Death|0|||
154843581|NCT01046825|558859291|FG000|Overall Study|Did not submit biology samples|0|||
154843582|NCT01046825|558859292|FG001|Overall Study|Did not submit biology samples|0|||
154843583|NCT01046825|558859293|FG002|Overall Study|Did not submit biology samples|0|||
154843584|NCT01046825|558859294|FG003|Overall Study|Did not submit biology samples|0|||
154843585|NCT01046825|558859295|FG004|Overall Study|Did not submit biology samples|13|||
154843586|NCT04735653|558859296|FG000|Overall Study|Lost to Follow-up|17|||
154843587|NCT04735653|558859297|FG001|Overall Study|Lost to Follow-up|7|||
154843588|NCT04735653|558859296|FG000|Overall Study|Withdrawal by Subject|8|||
154843589|NCT04735653|558859297|FG001|Overall Study|Withdrawal by Subject|2|||
154843590|NCT04735653|558859296|FG000|Overall Study|Death|0|||
154843591|NCT04735653|558859297|FG001|Overall Study|Death|2|||
154843592|NCT04735653|558859296|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
154843593|NCT04735653|558859297|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
154843594|NCT03975647|558859298|FG000|Overall Study|Death|71|||
154843595|NCT03975647|558859299|FG001|Overall Study|Death|63|||
154843596|NCT03975647|558859298|FG000|Overall Study|Lost to Follow-up|2|||
154843597|NCT03975647|558859299|FG001|Overall Study|Lost to Follow-up|2|||
154843598|NCT03975647|558859298|FG000|Overall Study|Subject withdrawal of consent|7|||
154843599|NCT03975647|558859299|FG001|Overall Study|Subject withdrawal of consent|11|||
154843600|NCT03735667|558859300|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
154843601|NCT03735667|558859301|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
154843602|NCT03735667|558859302|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
154843603|NCT03735667|558859300|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
154843604|NCT03735667|558859301|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
154843605|NCT03735667|558859302|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
154843606|NCT03735667|558859300|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
154843607|NCT03735667|558859301|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
154843608|NCT03735667|558859302|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
154843609|NCT03735667|558859300|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
154843610|NCT03735667|558859301|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
154843611|NCT03735667|558859302|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
154843612|NCT03735667|558859300|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
154843613|NCT03735667|558859301|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
154843614|NCT03735667|558859302|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
154843615|NCT03735667|558859300|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
154843616|NCT03735667|558859301|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
154843617|NCT03735667|558859302|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
154843618|NCT03735667|558859300|FG000|4D-CT Substudy (subset of Main RCT)|Death|8|||
154843619|NCT03735667|558859301|FG001|4D-CT Substudy (subset of Main RCT)|Death|5|||
154843620|NCT03735667|558859302|FG002|4D-CT Substudy (subset of Main RCT)|Death|0|||
154843621|NCT03735667|558859300|FG000|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
154843622|NCT03735667|558859301|FG001|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|4|||
154843623|NCT03735667|558859302|FG002|4D-CT Substudy (subset of Main RCT)|Withdrawal by Subject|0|||
154843624|NCT03735667|558859300|FG000|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|1|||
155104898|NCT00289289|559813895|FG001|Overall Study|Other Exit Reason|4|||
155104899|NCT00289289|559813896|FG002|Overall Study|Other Exit Reason|12|||
155104900|NCT00407602|559813897|FG000|Overall Study|Death - unrelated to device|1|||
155104901|NCT00407602|559813897|FG000|Overall Study|Device explanted|5|||
155104902|NCT00407602|559813897|FG000|Overall Study|Withdrawal by Subject|1|||
155104903|NCT00577707|559813898|FG000|Overall Study|Withdrawal by Subject|3|||
155104904|NCT03706430|559813899|FG000|Overall Study|No A-Line placed|5|||
154843625|NCT03735667|558859301|FG001|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
154843626|NCT03735667|558859302|FG002|4D-CT Substudy (subset of Main RCT)|Lost to Follow-up|0|||
155104905|NCT03706430|559813899|FG000|Overall Study|Subject had gel nail polish|1|||
155104906|NCT03706430|559813899|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
154843627|NCT03735667|558859300|FG000|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
154843628|NCT03735667|558859301|FG001|4D-CT Substudy (subset of Main RCT)|Physician Decision|1|||
154843629|NCT03735667|558859302|FG002|4D-CT Substudy (subset of Main RCT)|Physician Decision|0|||
154843630|NCT03735667|558859300|FG000|4D-CT Substudy (subset of Main RCT)|Other|0|||
154843631|NCT03735667|558859301|FG001|4D-CT Substudy (subset of Main RCT)|Other|1|||
154843632|NCT03735667|558859302|FG002|4D-CT Substudy (subset of Main RCT)|Other|0|||
154843633|NCT03735667|558859300|FG000|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
154843634|NCT03735667|558859301|FG001|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|3|||
154843635|NCT03735667|558859302|FG002|4D-CT Substudy (subset of Main RCT)|1-Year Visit Not Done|0|||
154843636|NCT00999908|558859303|FG000|Treatment Period 1|Subject withdrew consent|2|||
154843637|NCT00999908|558859304|FG001|Treatment Period 1|Subject withdrew consent|0|||
154843638|NCT00999908|558859305|FG002|Treatment Period 1|Subject withdrew consent|0|||
154843639|NCT00999908|558859303|FG000|Treatment Period 2|Protocol Violation|1|||
154843640|NCT00999908|558859304|FG001|Treatment Period 2|Protocol Violation|0|||
154843641|NCT00999908|558859305|FG002|Treatment Period 2|Protocol Violation|0|||
154843642|NCT02780648|558859306|FG000|Overall Study|Disease Progression|1|||
154843643|NCT02780648|558859307|FG001|Overall Study|Disease Progression|0|||
154843644|NCT00293579|558859308|FG000|Overall Study|Withdrawal by Subject|1|||
154843645|NCT00262873|558859309|FG000|Overall Study|Adverse Event|3|||
154971156|NCT04556734|559318533|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154971157|NCT04556734|559318534|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154971158|NCT04556734|559318535|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154971159|NCT04556734|559318536|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154843646|NCT00262873|558859309|FG000|Overall Study|Withdrawal by Subject|5|||
154843647|NCT03440814|558859312|FG000|Overall Study|Adverse Event|2|||
154843648|NCT03440814|558859313|FG001|Overall Study|Adverse Event|1|||
154843649|NCT03440814|558859312|FG000|Overall Study|Lost to Follow-up|2|||
154843650|NCT03440814|558859313|FG001|Overall Study|Lost to Follow-up|0|||
154843651|NCT03440814|558859312|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
154843652|NCT03440814|558859313|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
154843653|NCT00088374|558859314|FG000|Overall Study|patient did not receive any 17AAG|1|||
154843654|NCT00088374|558859314|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
154843655|NCT03205995|558859324|FG000|Overall Study|Adverse Event|1|||
154843656|NCT03205995|558859324|FG000|Overall Study|Death|1|||
154843657|NCT03205995|558859324|FG000|Overall Study|Physician Decision|2|||
154843658|NCT03205995|558859324|FG000|Overall Study|Protocol Violation|2|||
154843659|NCT05913232|558859326|FG000|Overall Study|Adverse Event|0|||
154843660|NCT05913232|558859327|FG001|Overall Study|Adverse Event|2|||
154843661|NCT05913232|558859328|FG002|Overall Study|Adverse Event|1|||
154843662|NCT05913232|558859329|FG003|Overall Study|Adverse Event|1|||
154843663|NCT05103332|558859332|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843664|NCT05103332|558859333|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
154843665|NCT05103332|558859334|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
154843666|NCT05103332|558859335|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843667|NCT05103332|558859336|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843668|NCT05103332|558859337|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
154843669|NCT05103332|558859338|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843670|NCT05103332|558859339|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843671|NCT05103332|558859340|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843672|NCT05103332|558859341|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843673|NCT05103332|558859342|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843674|NCT05103332|558859343|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843675|NCT05103332|558859344|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843676|NCT05103332|558859345|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843677|NCT05103332|558859346|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843678|NCT05103332|558859347|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154971160|NCT04556734|559318537|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
154971161|NCT04556734|559318538|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
154971162|NCT04556734|559318531|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
154971163|NCT04556734|559318532|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
154971164|NCT04556734|559318533|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
154971165|NCT04556734|559318534|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
154971166|NCT04556734|559318535|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
154843679|NCT05103332|558859348|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843680|NCT05103332|558859349|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843681|NCT05103332|558859332|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843682|NCT05103332|558859333|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
154843683|NCT05103332|558859334|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
154971167|NCT04556734|559318536|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
154971168|NCT04556734|559318537|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
154971169|NCT04556734|559318538|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
154971170|NCT04556734|559318531|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154971171|NCT04556734|559318532|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154843684|NCT05103332|558859335|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
154843685|NCT05103332|558859336|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843686|NCT05103332|558859337|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843687|NCT05103332|558859338|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843688|NCT05103332|558859339|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843689|NCT05103332|558859340|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843690|NCT05103332|558859341|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843691|NCT05103332|558859342|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843692|NCT05103332|558859343|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843693|NCT05103332|558859344|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843694|NCT05103332|558859345|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843695|NCT05103332|558859346|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843696|NCT05103332|558859347|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843697|NCT05103332|558859348|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843698|NCT05103332|558859349|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
154843699|NCT05103332|558859332|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
154843700|NCT05103332|558859333|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
154843701|NCT05103332|558859334|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
154843702|NCT05103332|558859335|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
154843703|NCT05103332|558859336|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
154843704|NCT05103332|558859337|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
154843705|NCT05103332|558859338|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843706|NCT05103332|558859339|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843707|NCT05103332|558859340|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843708|NCT05103332|558859341|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843709|NCT05103332|558859342|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843710|NCT05103332|558859343|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843711|NCT05103332|558859344|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843712|NCT05103332|558859345|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843713|NCT05103332|558859346|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843714|NCT05103332|558859347|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843715|NCT05103332|558859348|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843716|NCT05103332|558859349|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843717|NCT05103332|558859332|FG000|DB Period (6 Months=168 Days)|Other|0|||
154843718|NCT05103332|558859333|FG001|DB Period (6 Months=168 Days)|Other|0|||
154843719|NCT05103332|558859334|FG002|DB Period (6 Months=168 Days)|Other|0|||
154843720|NCT05103332|558859335|FG003|DB Period (6 Months=168 Days)|Other|1|||
154843721|NCT05103332|558859336|FG004|DB Period (6 Months=168 Days)|Other|0|||
154843722|NCT05103332|558859337|FG005|DB Period (6 Months=168 Days)|Other|0|||
154843723|NCT05103332|558859338|FG006|DB Period (6 Months=168 Days)|Other|0|||
154843724|NCT05103332|558859339|FG007|DB Period (6 Months=168 Days)|Other|0|||
154843725|NCT05103332|558859340|FG008|DB Period (6 Months=168 Days)|Other|0|||
154843726|NCT05103332|558859341|FG009|DB Period (6 Months=168 Days)|Other|0|||
154843727|NCT05103332|558859342|FG010|DB Period (6 Months=168 Days)|Other|0|||
154843728|NCT05103332|558859343|FG011|DB Period (6 Months=168 Days)|Other|0|||
154843729|NCT05103332|558859344|FG012|DB Period (6 Months=168 Days)|Other|0|||
154843730|NCT05103332|558859345|FG013|DB Period (6 Months=168 Days)|Other|0|||
154843731|NCT05103332|558859346|FG014|DB Period (6 Months=168 Days)|Other|0|||
154843732|NCT05103332|558859347|FG015|DB Period (6 Months=168 Days)|Other|0|||
154843733|NCT05103332|558859348|FG016|DB Period (6 Months=168 Days)|Other|0|||
154843734|NCT05103332|558859349|FG017|DB Period (6 Months=168 Days)|Other|0|||
154843735|NCT05103332|558859332|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843736|NCT05103332|558859333|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843737|NCT05103332|558859334|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843738|NCT05103332|558859335|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843739|NCT05103332|558859336|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843740|NCT05103332|558859337|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843741|NCT05103332|558859338|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843742|NCT05103332|558859339|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843743|NCT05103332|558859340|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843744|NCT05103332|558859341|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843745|NCT05103332|558859342|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
154843746|NCT05103332|558859343|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843747|NCT05103332|558859344|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843748|NCT05103332|558859345|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843749|NCT05103332|558859346|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843750|NCT05103332|558859347|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843751|NCT05103332|558859348|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843752|NCT05103332|558859349|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
154843753|NCT05103332|558859332|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843754|NCT05103332|558859333|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843755|NCT05103332|558859334|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843756|NCT05103332|558859335|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843757|NCT05103332|558859336|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843758|NCT05103332|558859337|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843759|NCT05103332|558859338|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843760|NCT05103332|558859339|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843761|NCT05103332|558859340|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
154843762|NCT05103332|558859341|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843763|NCT05103332|558859342|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843764|NCT05103332|558859343|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843765|NCT05103332|558859344|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843766|NCT05103332|558859345|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843767|NCT05103332|558859346|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843768|NCT05103332|558859347|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843769|NCT05103332|558859348|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843770|NCT05103332|558859349|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
154843771|NCT05103332|558859332|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843772|NCT05103332|558859333|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843773|NCT05103332|558859334|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843774|NCT05103332|558859335|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843775|NCT05103332|558859336|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843776|NCT05103332|558859337|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843777|NCT05103332|558859338|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843778|NCT05103332|558859339|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843779|NCT05103332|558859340|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843780|NCT05103332|558859341|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843781|NCT05103332|558859342|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843782|NCT05103332|558859343|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
154843783|NCT05103332|558859344|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843784|NCT05103332|558859345|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843785|NCT05103332|558859346|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843786|NCT05103332|558859347|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843787|NCT05103332|558859348|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843788|NCT05103332|558859349|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
154843789|NCT05103332|558859332|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843790|NCT05103332|558859333|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843791|NCT05103332|558859334|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843792|NCT05103332|558859335|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843793|NCT05103332|558859336|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843794|NCT05103332|558859337|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843795|NCT05103332|558859338|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
154843796|NCT05103332|558859339|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
154843797|NCT05103332|558859340|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843798|NCT05103332|558859341|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
154843799|NCT05103332|558859342|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
154843800|NCT05103332|558859343|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
154843801|NCT05103332|558859344|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843802|NCT05103332|558859345|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843803|NCT05103332|558859346|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843804|NCT05103332|558859347|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843805|NCT05103332|558859348|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843806|NCT05103332|558859349|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
154843807|NCT05103332|558859332|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843808|NCT05103332|558859333|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843809|NCT05103332|558859334|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843810|NCT05103332|558859335|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843811|NCT05103332|558859336|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843812|NCT05103332|558859337|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843813|NCT05103332|558859338|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843814|NCT05103332|558859339|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843815|NCT05103332|558859340|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155104907|NCT03706430|559813899|FG000|Overall Study|Cancelled Case|6|||
154843816|NCT05103332|558859341|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
155173530|NCT02043899|560074803|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
155104908|NCT03706430|559813899|FG000|Overall Study|Physician Decision|2|||
154843817|NCT05103332|558859342|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843818|NCT05103332|558859343|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
154843819|NCT05103332|558859344|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
154843820|NCT05103332|558859345|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
154843821|NCT05103332|558859346|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
154843822|NCT05103332|558859347|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
154843823|NCT05103332|558859348|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
154843824|NCT05103332|558859349|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
154843825|NCT05103332|558859332|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843826|NCT05103332|558859333|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843827|NCT05103332|558859334|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843828|NCT05103332|558859335|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843829|NCT05103332|558859336|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843830|NCT05103332|558859337|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843831|NCT05103332|558859338|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843832|NCT05103332|558859339|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843833|NCT05103332|558859340|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843834|NCT05103332|558859341|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843835|NCT05103332|558859342|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843836|NCT05103332|558859343|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843837|NCT05103332|558859344|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843838|NCT05103332|558859345|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843839|NCT05103332|558859346|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843840|NCT05103332|558859347|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843841|NCT05103332|558859348|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
154843842|NCT05103332|558859349|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
155104909|NCT00145626|559813900|FG000|Overall Study|Did not have NK infusions|2|||
155104910|NCT00145626|559813900|FG000|Overall Study|Turned 2 years old before treatment|1|||
155104911|NCT00145626|559813900|FG000|Overall Study|Death|1|||
155104912|NCT00145626|559813900|FG000|Overall Study|Withdrawal by Subject|1|||
155104913|NCT01392573|559813901|FG000|Overall Study|Adverse Event|1|||
155104914|NCT01392573|559813902|FG001|Overall Study|Adverse Event|3|||
155104915|NCT01392573|559813901|FG000|Overall Study|Lack of Efficacy|1|||
155104916|NCT01392573|559813902|FG001|Overall Study|Lack of Efficacy|2|||
155104917|NCT01392573|559813901|FG000|Overall Study|Protocol Violation|0|||
154843843|NCT05103332|558859332|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843844|NCT05103332|558859333|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843845|NCT05103332|558859334|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843846|NCT05103332|558859335|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
155104918|NCT01392573|559813902|FG001|Overall Study|Protocol Violation|2|||
155104919|NCT01392573|559813901|FG000|Overall Study|Withdrawal Criteria|13|||
155104920|NCT01392573|559813902|FG001|Overall Study|Withdrawal Criteria|15|||
155104921|NCT01392573|559813901|FG000|Overall Study|Site closure|8|||
155104922|NCT01392573|559813902|FG001|Overall Study|Site closure|7|||
155104923|NCT01392573|559813901|FG000|Overall Study|Unclassified|9|||
155104924|NCT01392573|559813902|FG001|Overall Study|Unclassified|6|||
154843847|NCT05103332|558859336|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843848|NCT05103332|558859337|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843849|NCT05103332|558859338|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843850|NCT05103332|558859339|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843851|NCT05103332|558859340|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843852|NCT05103332|558859341|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843853|NCT05103332|558859342|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843854|NCT05103332|558859343|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
154843855|NCT05103332|558859344|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
154843856|NCT05103332|558859345|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
154843857|NCT05103332|558859346|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
154843858|NCT05103332|558859347|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
155104925|NCT00200967|559813903|FG000|First Treatment Period|Withdrawal by Subject|5|||
154843859|NCT05103332|558859348|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
154843860|NCT05103332|558859349|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
155104926|NCT00200967|559813904|FG001|First Treatment Period|Withdrawal by Subject|1|||
155104927|NCT00200967|559813903|FG000|First Treatment Period|Pregnancy|1|||
155104928|NCT00200967|559813904|FG001|First Treatment Period|Pregnancy|0|||
155104929|NCT00200967|559813903|FG000|Wash-out Period|Lost to Follow-up|0|||
155104930|NCT00200967|559813904|FG001|Wash-out Period|Lost to Follow-up|1|||
155104931|NCT00200967|559813903|FG000|Second Treatment Period|Withdrawal by Subject|1|||
154843861|NCT05103332|558859332|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843862|NCT05103332|558859333|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843863|NCT05103332|558859334|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843864|NCT05103332|558859335|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843865|NCT05103332|558859336|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843866|NCT05103332|558859337|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843867|NCT05103332|558859338|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843868|NCT05103332|558859339|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843869|NCT05103332|558859340|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843870|NCT05103332|558859341|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843871|NCT05103332|558859342|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843872|NCT05103332|558859343|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843873|NCT05103332|558859344|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843874|NCT05103332|558859345|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843875|NCT05103332|558859346|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
154843876|NCT05103332|558859347|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
154843877|NCT05103332|558859348|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
154843878|NCT05103332|558859349|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
154843879|NCT05103332|558859332|FG000|SFU Period (6 Months=168 Days)|Death|0|||
154843880|NCT05103332|558859333|FG001|SFU Period (6 Months=168 Days)|Death|0|||
154843881|NCT05103332|558859334|FG002|SFU Period (6 Months=168 Days)|Death|0|||
154843882|NCT05103332|558859335|FG003|SFU Period (6 Months=168 Days)|Death|0|||
154843883|NCT05103332|558859336|FG004|SFU Period (6 Months=168 Days)|Death|0|||
154843884|NCT05103332|558859337|FG005|SFU Period (6 Months=168 Days)|Death|0|||
154843885|NCT05103332|558859338|FG006|SFU Period (6 Months=168 Days)|Death|0|||
154843886|NCT05103332|558859339|FG007|SFU Period (6 Months=168 Days)|Death|0|||
154843887|NCT05103332|558859340|FG008|SFU Period (6 Months=168 Days)|Death|0|||
154843888|NCT05103332|558859341|FG009|SFU Period (6 Months=168 Days)|Death|0|||
154843889|NCT05103332|558859342|FG010|SFU Period (6 Months=168 Days)|Death|0|||
154843890|NCT05103332|558859343|FG011|SFU Period (6 Months=168 Days)|Death|0|||
154843891|NCT05103332|558859344|FG012|SFU Period (6 Months=168 Days)|Death|0|||
154843892|NCT05103332|558859345|FG013|SFU Period (6 Months=168 Days)|Death|0|||
154843893|NCT05103332|558859346|FG014|SFU Period (6 Months=168 Days)|Death|1|||
154843894|NCT05103332|558859347|FG015|SFU Period (6 Months=168 Days)|Death|0|||
154843895|NCT05103332|558859348|FG016|SFU Period (6 Months=168 Days)|Death|0|||
154843896|NCT05103332|558859349|FG017|SFU Period (6 Months=168 Days)|Death|1|||
154843897|NCT04428476|558859350|FG000|Overall Study|Withdrawal by Subject|1|||
154843898|NCT04428476|558859350|FG000|Overall Study|Still on treatment|12|||
154843899|NCT01358864|558859357|FG000|Overall Study|Adverse Event|0|||
154843900|NCT01358864|558859358|FG001|Overall Study|Adverse Event|6|||
154843901|NCT01358864|558859359|FG002|Overall Study|Adverse Event|9|||
154843902|NCT01358864|558859360|FG003|Overall Study|Adverse Event|0|||
154843903|NCT01358864|558859361|FG004|Overall Study|Adverse Event|4|||
154843904|NCT01358864|558859362|FG005|Overall Study|Adverse Event|8|||
154843905|NCT01358864|558859363|FG006|Overall Study|Adverse Event|12|||
154843906|NCT01358864|558859364|FG007|Overall Study|Adverse Event|7|||
154843907|NCT01358864|558859357|FG000|Overall Study|Lack of Efficacy|26|||
154843908|NCT01358864|558859358|FG001|Overall Study|Lack of Efficacy|3|||
154843909|NCT01358864|558859359|FG002|Overall Study|Lack of Efficacy|4|||
154843910|NCT01358864|558859360|FG003|Overall Study|Lack of Efficacy|19|||
154843911|NCT01358864|558859361|FG004|Overall Study|Lack of Efficacy|7|||
154843912|NCT01358864|558859362|FG005|Overall Study|Lack of Efficacy|4|||
154843913|NCT01358864|558859363|FG006|Overall Study|Lack of Efficacy|49|||
154843914|NCT01358864|558859364|FG007|Overall Study|Lack of Efficacy|44|||
154843915|NCT01358864|558859357|FG000|Overall Study|Lost to Follow-up|0|||
154843916|NCT01358864|558859358|FG001|Overall Study|Lost to Follow-up|0|||
154843917|NCT01358864|558859359|FG002|Overall Study|Lost to Follow-up|1|||
154843918|NCT01358864|558859360|FG003|Overall Study|Lost to Follow-up|0|||
154843919|NCT01358864|558859361|FG004|Overall Study|Lost to Follow-up|0|||
154843920|NCT01358864|558859362|FG005|Overall Study|Lost to Follow-up|0|||
154843921|NCT01358864|558859363|FG006|Overall Study|Lost to Follow-up|0|||
154843922|NCT01358864|558859364|FG007|Overall Study|Lost to Follow-up|1|||
154843923|NCT01358864|558859357|FG000|Overall Study|Withdrawal by Subject|3|||
154843924|NCT01358864|558859358|FG001|Overall Study|Withdrawal by Subject|4|||
154843925|NCT01358864|558859359|FG002|Overall Study|Withdrawal by Subject|2|||
154843926|NCT01358864|558859360|FG003|Overall Study|Withdrawal by Subject|0|||
154843927|NCT01358864|558859361|FG004|Overall Study|Withdrawal by Subject|0|||
154843928|NCT01358864|558859362|FG005|Overall Study|Withdrawal by Subject|1|||
154843929|NCT01358864|558859363|FG006|Overall Study|Withdrawal by Subject|1|||
154843930|NCT01358864|558859364|FG007|Overall Study|Withdrawal by Subject|3|||
154843931|NCT01358864|558859357|FG000|Overall Study|Other reason not defined above|2|||
154843932|NCT01358864|558859358|FG001|Overall Study|Other reason not defined above|0|||
154843933|NCT01358864|558859359|FG002|Overall Study|Other reason not defined above|0|||
154843934|NCT01358864|558859360|FG003|Overall Study|Other reason not defined above|0|||
154843935|NCT01358864|558859361|FG004|Overall Study|Other reason not defined above|0|||
154843936|NCT01358864|558859362|FG005|Overall Study|Other reason not defined above|0|||
154843937|NCT01358864|558859363|FG006|Overall Study|Other reason not defined above|2|||
154843938|NCT01358864|558859364|FG007|Overall Study|Other reason not defined above|0|||
154843939|NCT01358864|558859357|FG000|Overall Study|Not treated|0|||
154843940|NCT01358864|558859358|FG001|Overall Study|Not treated|0|||
154843941|NCT01358864|558859359|FG002|Overall Study|Not treated|0|||
154843942|NCT01358864|558859360|FG003|Overall Study|Not treated|0|||
154843943|NCT01358864|558859361|FG004|Overall Study|Not treated|0|||
154843944|NCT01358864|558859362|FG005|Overall Study|Not treated|0|||
154843945|NCT01358864|558859363|FG006|Overall Study|Not treated|1|||
154843946|NCT01358864|558859364|FG007|Overall Study|Not treated|0|||
154843947|NCT04042103|558859369|FG000|Overall Study|Lost to Follow-up|1|||
154971172|NCT04556734|559318533|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154971173|NCT04556734|559318534|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
154971174|NCT04556734|559318535|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
154971175|NCT04556734|559318536|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
154971176|NCT04556734|559318537|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
154843948|NCT04042103|558859369|FG000|Overall Study|Withdrawal by Subject|1|||
154843949|NCT04209855|558859370|FG000|Overall Study|Death|161|||
154843950|NCT04209855|558859371|FG001|Overall Study|Death|177|||
154843951|NCT04209855|558859370|FG000|Overall Study|PI Discretion|1|||
154971177|NCT04556734|559318538|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
154971178|NCT01680016|559318544|FG000|Overall Study|Adverse Event|0|||
154971179|NCT01680016|559318545|FG001|Overall Study|Adverse Event|0|||
154971180|NCT01680016|559318546|FG002|Overall Study|Adverse Event|1|||
154971181|NCT01680016|559318547|FG003|Overall Study|Adverse Event|4|||
154971182|NCT01680016|559318544|FG000|Overall Study|The Subject went out of The Trial|1|||
154971183|NCT01680016|559318545|FG001|Overall Study|The Subject went out of The Trial|0|||
154971184|NCT01680016|559318546|FG002|Overall Study|The Subject went out of The Trial|3|||
154971185|NCT01680016|559318547|FG003|Overall Study|The Subject went out of The Trial|0|||
154971186|NCT01680016|559318544|FG000|Overall Study|Protocol Violation|0|||
154971187|NCT01680016|559318545|FG001|Overall Study|Protocol Violation|1|||
154971188|NCT01680016|559318546|FG002|Overall Study|Protocol Violation|0|||
154971189|NCT01680016|559318547|FG003|Overall Study|Protocol Violation|0|||
154971190|NCT01680016|559318544|FG000|Overall Study|Withdrawal by Subject|5|||
154971191|NCT01680016|559318545|FG001|Overall Study|Withdrawal by Subject|7|||
154971192|NCT01680016|559318546|FG002|Overall Study|Withdrawal by Subject|1|||
154971193|NCT01680016|559318547|FG003|Overall Study|Withdrawal by Subject|1|||
154971194|NCT01958060|559318549|FG000|Overall Study|Not treated|2|||
154971195|NCT01958060|559318550|FG001|Overall Study|Not treated|0|||
154971196|NCT01958060|559318551|FG002|Overall Study|Not treated|0|||
154971197|NCT01958060|559318552|FG003|Overall Study|Not treated|0|||
154971198|NCT01958060|559318553|FG004|Overall Study|Not treated|1|||
154971199|NCT01958060|559318554|FG005|Overall Study|Not treated|0|||
154971200|NCT04980456|559318560|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
154971201|NCT04980456|559318561|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
154971202|NCT04980456|559318560|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
154971203|NCT04980456|559318561|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
154843952|NCT04209855|558859371|FG001|Overall Study|PI Discretion|1|||
154843953|NCT04209855|558859370|FG000|Overall Study|Lost to Follow-up|5|||
154843954|NCT04209855|558859371|FG001|Overall Study|Lost to Follow-up|2|||
154843955|NCT04209855|558859370|FG000|Overall Study|Withdrew consent|10|||
154843956|NCT04209855|558859371|FG001|Overall Study|Withdrew consent|24|||
154843957|NCT04209855|558859370|FG000|Overall Study|Sponsor decision|44|||
154843958|NCT04209855|558859371|FG001|Overall Study|Sponsor decision|18|||
154843959|NCT04209855|558859370|FG000|Overall Study|Other than specified|6|||
154843960|NCT04209855|558859371|FG001|Overall Study|Other than specified|4|||
154843961|NCT00271817|558859372|FG000|Part 1|Adverse Event|68|||
154843962|NCT00271817|558859373|FG001|Part 1|Adverse Event|25|||
154971204|NCT04980456|559318560|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
154971205|NCT04980456|559318561|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
154971206|NCT04980456|559318560|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
154971207|NCT04980456|559318561|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
154971208|NCT02846883|559318564|FG000|Overall Study|Death|0|||
154971209|NCT02846883|559318565|FG001|Overall Study|Death|1|||
154971210|NCT02846883|559318566|FG002|Overall Study|Death|1|||
155104932|NCT00200967|559813904|FG001|Second Treatment Period|Withdrawal by Subject|2|||
154843963|NCT00271817|558859374|FG002|Part 1|Adverse Event|156|||
154843964|NCT00271817|558859372|FG000|Part 1|Lost to Follow-up|6|||
154843965|NCT00271817|558859373|FG001|Part 1|Lost to Follow-up|8|||
154843966|NCT00271817|558859374|FG002|Part 1|Lost to Follow-up|24|||
154843967|NCT00271817|558859372|FG000|Part 1|Protocol Violation|5|||
154843968|NCT00271817|558859373|FG001|Part 1|Protocol Violation|4|||
154843969|NCT00271817|558859374|FG002|Part 1|Protocol Violation|7|||
154843970|NCT00271817|558859372|FG000|Part 1|Patient Moved|3|||
154971211|NCT02846883|559318564|FG000|Overall Study|Lost to Follow-up|0|||
154971212|NCT02846883|559318565|FG001|Overall Study|Lost to Follow-up|0|||
154971213|NCT02846883|559318566|FG002|Overall Study|Lost to Follow-up|1|||
154843971|NCT00271817|558859373|FG001|Part 1|Patient Moved|1|||
154843972|NCT00271817|558859374|FG002|Part 1|Patient Moved|5|||
154843973|NCT00271817|558859372|FG000|Part 1|Withdrawal by Subject|23|||
154843974|NCT00271817|558859373|FG001|Part 1|Withdrawal by Subject|17|||
154843975|NCT00271817|558859374|FG002|Part 1|Withdrawal by Subject|45|||
154843976|NCT00271817|558859372|FG000|Part 1|LDL < 50 mg/dL|1|||
154843977|NCT00271817|558859373|FG001|Part 1|LDL < 50 mg/dL|4|||
154843978|NCT00271817|558859374|FG002|Part 1|LDL < 50 mg/dL|48|||
154843979|NCT00271817|558859372|FG000|Part 2|Adverse Event|0|||
154843980|NCT00271817|558859373|FG001|Part 2|Adverse Event|17|||
154843981|NCT00271817|558859374|FG002|Part 2|Adverse Event|33|||
154843982|NCT00271817|558859372|FG000|Part 2|Lack of Efficacy|0|||
154843983|NCT00271817|558859373|FG001|Part 2|Lack of Efficacy|1|||
154843984|NCT00271817|558859374|FG002|Part 2|Lack of Efficacy|6|||
154843985|NCT00271817|558859372|FG000|Part 2|Lost to Follow-up|0|||
154843986|NCT00271817|558859373|FG001|Part 2|Lost to Follow-up|6|||
154843987|NCT00271817|558859374|FG002|Part 2|Lost to Follow-up|18|||
154843988|NCT00271817|558859372|FG000|Part 2|Protocol Violation|0|||
154843989|NCT00271817|558859373|FG001|Part 2|Protocol Violation|3|||
154843990|NCT00271817|558859374|FG002|Part 2|Protocol Violation|5|||
154843991|NCT00271817|558859372|FG000|Part 2|Patient Moved|0|||
154843992|NCT00271817|558859373|FG001|Part 2|Patient Moved|0|||
154843993|NCT00271817|558859374|FG002|Part 2|Patient Moved|5|||
154843994|NCT00271817|558859372|FG000|Part 2|Withdrawal by Subject|0|||
154843995|NCT00271817|558859373|FG001|Part 2|Withdrawal by Subject|2|||
154843996|NCT00271817|558859374|FG002|Part 2|Withdrawal by Subject|13|||
154843997|NCT00271817|558859372|FG000|Part 2|LDL < 50 mg/dL|0|||
154843998|NCT00271817|558859373|FG001|Part 2|LDL < 50 mg/dL|3|||
154843999|NCT00271817|558859374|FG002|Part 2|LDL < 50 mg/dL|4|||
154844000|NCT01471782|558859376|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
154844001|NCT01471782|558859377|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
154844002|NCT01471782|558859378|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
154844003|NCT01471782|558859379|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
154844004|NCT01471782|558859380|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
154844005|NCT01471782|558859381|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
154844006|NCT01471782|558859376|FG000|Overall Study|Lack of Efficacy|1|||
154844007|NCT01471782|558859377|FG001|Overall Study|Lack of Efficacy|2|||
154844008|NCT01471782|558859378|FG002|Overall Study|Lack of Efficacy|1|||
154844009|NCT01471782|558859379|FG003|Overall Study|Lack of Efficacy|1|||
154844010|NCT01471782|558859380|FG004|Overall Study|Lack of Efficacy|5|||
154844011|NCT01471782|558859381|FG005|Overall Study|Lack of Efficacy|18|||
154844012|NCT01471782|558859376|FG000|Overall Study|Adverse Event|1|||
154844013|NCT01471782|558859377|FG001|Overall Study|Adverse Event|1|||
154844014|NCT01471782|558859378|FG002|Overall Study|Adverse Event|2|||
154844015|NCT01471782|558859379|FG003|Overall Study|Adverse Event|2|||
154844016|NCT01471782|558859380|FG004|Overall Study|Adverse Event|3|||
154844017|NCT01471782|558859381|FG005|Overall Study|Adverse Event|1|||
154844018|NCT01471782|558859376|FG000|Overall Study|Other|0|||
154844019|NCT01471782|558859377|FG001|Overall Study|Other|0|||
154844020|NCT01471782|558859378|FG002|Overall Study|Other|1|||
154844021|NCT01471782|558859379|FG003|Overall Study|Other|1|||
154844022|NCT01471782|558859380|FG004|Overall Study|Other|6|||
154844023|NCT01471782|558859381|FG005|Overall Study|Other|5|||
154844024|NCT01471782|558859376|FG000|Overall Study|Change of Chemotherapy|1|||
154844025|NCT01471782|558859377|FG001|Overall Study|Change of Chemotherapy|1|||
154844026|NCT01471782|558859378|FG002|Overall Study|Change of Chemotherapy|0|||
154844027|NCT01471782|558859379|FG003|Overall Study|Change of Chemotherapy|0|||
154844028|NCT01471782|558859380|FG004|Overall Study|Change of Chemotherapy|1|||
154844029|NCT01471782|558859381|FG005|Overall Study|Change of Chemotherapy|4|||
154844030|NCT01471782|558859376|FG000|Overall Study|Disease Relapse|0|||
154844031|NCT01471782|558859377|FG001|Overall Study|Disease Relapse|0|||
154844032|NCT01471782|558859378|FG002|Overall Study|Disease Relapse|0|||
155173531|NCT02043899|560074803|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
155173532|NCT02043899|560074803|FG000|Overall Study|Treatment delayed|1|||
154844033|NCT01471782|558859379|FG003|Overall Study|Disease Relapse|1|||
154844034|NCT01471782|558859380|FG004|Overall Study|Disease Relapse|2|||
154844035|NCT01471782|558859381|FG005|Overall Study|Disease Relapse|1|||
154844036|NCT01471782|558859376|FG000|Overall Study|Physician Decision|0|||
154844037|NCT01471782|558859377|FG001|Overall Study|Physician Decision|0|||
154844038|NCT01471782|558859378|FG002|Overall Study|Physician Decision|0|||
154844039|NCT01471782|558859379|FG003|Overall Study|Physician Decision|0|||
154844040|NCT01471782|558859380|FG004|Overall Study|Physician Decision|3|||
154844041|NCT01471782|558859381|FG005|Overall Study|Physician Decision|8|||
154844042|NCT01471782|558859376|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154844043|NCT01471782|558859377|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154844044|NCT01471782|558859378|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
154844045|NCT01471782|558859379|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
154844046|NCT01471782|558859380|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
155173533|NCT01106092|560074805|FG000|Overall Study|Withdrawal by Subject|0|||
154844047|NCT01471782|558859381|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
154844048|NCT01471782|558859376|FG000|Overall Study|Death|0|||
154844049|NCT01471782|558859377|FG001|Overall Study|Death|0|||
154844050|NCT01471782|558859378|FG002|Overall Study|Death|0|||
154844051|NCT01471782|558859379|FG003|Overall Study|Death|0|||
154844052|NCT01471782|558859380|FG004|Overall Study|Death|0|||
154844053|NCT01471782|558859381|FG005|Overall Study|Death|1|||
154844054|NCT00936208|558859382|FG000|Overall Study|Protocol Violation|37|||
154844055|NCT00936208|558859383|FG001|Overall Study|Protocol Violation|22|||
154844056|NCT04428424|558859384|FG000|Overall Study|Does not meet entrance criteria|132|||
154844057|NCT04428424|558859384|FG000|Overall Study|Lost to Follow-up|115|||
154844058|NCT01564862|558859385|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
154844059|NCT01564862|558859386|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
154844060|NCT01564862|558859387|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
154844061|NCT01564862|558859385|FG000|Overall Study|Major Protocol Deviation|3|||
154844062|NCT01564862|558859386|FG001|Overall Study|Major Protocol Deviation|3|||
154844063|NCT01564862|558859387|FG002|Overall Study|Major Protocol Deviation|4|||
154844064|NCT01564862|558859385|FG000|Overall Study|Lost to Follow-up|10|||
154844065|NCT01564862|558859386|FG001|Overall Study|Lost to Follow-up|8|||
154844066|NCT01564862|558859387|FG002|Overall Study|Lost to Follow-up|6|||
154844067|NCT01564862|558859385|FG000|Overall Study|Voluntary Withdrawal|9|||
154844068|NCT01564862|558859386|FG001|Overall Study|Voluntary Withdrawal|6|||
154844069|NCT01564862|558859387|FG002|Overall Study|Voluntary Withdrawal|8|||
154844070|NCT01564862|558859385|FG000|Overall Study|Lack of Efficacy|1|||
154844071|NCT01564862|558859386|FG001|Overall Study|Lack of Efficacy|5|||
154844072|NCT01564862|558859387|FG002|Overall Study|Lack of Efficacy|6|||
154844073|NCT01564862|558859385|FG000|Overall Study|Other reason(s)|1|||
154844074|NCT01564862|558859386|FG001|Overall Study|Other reason(s)|0|||
154844075|NCT01564862|558859387|FG002|Overall Study|Other reason(s)|0|||
154844076|NCT02193074|558859390|FG000|Overall Study|Withdrawal by Subject|1|||
154844077|NCT02193074|558859391|FG001|Overall Study|Withdrawal by Subject|2|||
154844078|NCT02193074|558859390|FG000|Overall Study|Adverse Event|16|||
154844079|NCT02193074|558859391|FG001|Overall Study|Adverse Event|13|||
154844080|NCT02872311|558861417|FG000|Overall Study|Death|2|||
154844081|NCT02872311|558861418|FG001|Overall Study|Death|0|||
154844082|NCT02872311|558861419|FG002|Overall Study|Death|0|||
154844083|NCT02872311|558861420|FG003|Overall Study|Death|0|||
154844084|NCT02872311|558861421|FG004|Overall Study|Death|0|||
154844085|NCT02872311|558861417|FG000|Overall Study|Lost to Follow-up|2|||
154844086|NCT02872311|558861418|FG001|Overall Study|Lost to Follow-up|0|||
154844087|NCT02872311|558861419|FG002|Overall Study|Lost to Follow-up|0|||
154844088|NCT02872311|558861420|FG003|Overall Study|Lost to Follow-up|0|||
154844089|NCT02872311|558861421|FG004|Overall Study|Lost to Follow-up|0|||
154844090|NCT02872311|558861417|FG000|Overall Study|Protocol Violation|0|||
154844091|NCT02872311|558861418|FG001|Overall Study|Protocol Violation|2|||
154844092|NCT02872311|558861419|FG002|Overall Study|Protocol Violation|1|||
154844093|NCT02872311|558861420|FG003|Overall Study|Protocol Violation|0|||
154844094|NCT02872311|558861421|FG004|Overall Study|Protocol Violation|0|||
154844095|NCT01121393|558861428|FG000|Overall Study|Progressive disease|201|||
154844096|NCT01121393|558861429|FG001|Overall Study|Progressive disease|20|||
154844097|NCT01121393|558861428|FG000|Overall Study|Other Adverse events|24|||
154844098|NCT01121393|558861429|FG001|Overall Study|Other Adverse events|45|||
154844099|NCT01121393|558861428|FG000|Overall Study|Non-compliant with protocol|0|||
154844100|NCT01121393|558861429|FG001|Overall Study|Non-compliant with protocol|3|||
154844101|NCT01121393|558861428|FG000|Overall Study|Lost to Follow-up|1|||
155104933|NCT00200967|559813903|FG000|Run-out Period|Lost to Follow-up|1|||
155104934|NCT00200967|559813904|FG001|Run-out Period|Lost to Follow-up|0|||
155104935|NCT00980460|559813905|FG000|Overall Study|Death|0|||
154844102|NCT01121393|558861429|FG001|Overall Study|Lost to Follow-up|0|||
154844103|NCT01121393|558861428|FG000|Overall Study|Refused cont. medication|7|||
154844104|NCT01121393|558861429|FG001|Overall Study|Refused cont. medication|7|||
154844105|NCT01121393|558861428|FG000|Overall Study|Not treated|3|||
154844106|NCT01121393|558861429|FG001|Overall Study|Not treated|9|||
154844107|NCT01121393|558861428|FG000|Overall Study|Other than listed|6|||
155104936|NCT00980460|559813906|FG001|Overall Study|Death|0|||
154844108|NCT01121393|558861429|FG001|Overall Study|Other than listed|0|||
154844109|NCT04372927|558861430|FG000|Overall Study|Death|1|||
154844110|NCT00577993|558861431|FG000|Overall Study|Adverse Event|1|||
154844111|NCT00577993|558861432|FG001|Overall Study|Adverse Event|0|||
154844112|NCT00577993|558861433|FG002|Overall Study|Adverse Event|0|||
154844113|NCT00577993|558861431|FG000|Overall Study|Death|0|||
154844114|NCT00577993|558861432|FG001|Overall Study|Death|1|||
154844115|NCT00577993|558861433|FG002|Overall Study|Death|1|||
154844116|NCT00577993|558861431|FG000|Overall Study|Lack of Efficacy|0|||
154844117|NCT00577993|558861432|FG001|Overall Study|Lack of Efficacy|1|||
154844118|NCT00577993|558861433|FG002|Overall Study|Lack of Efficacy|0|||
155104937|NCT00980460|559813907|FG002|Overall Study|Death|1|||
155104938|NCT00980460|559813908|FG003|Overall Study|Death|2|||
154844119|NCT00577993|558861431|FG000|Overall Study|Protocol Violation|2|||
154844120|NCT00577993|558861432|FG001|Overall Study|Protocol Violation|3|||
154844121|NCT00577993|558861433|FG002|Overall Study|Protocol Violation|0|||
154844122|NCT00577993|558861431|FG000|Overall Study|Withdrawal by Subject|1|||
154844123|NCT00577993|558861432|FG001|Overall Study|Withdrawal by Subject|0|||
154844124|NCT00577993|558861433|FG002|Overall Study|Withdrawal by Subject|2|||
154844125|NCT00577993|558861431|FG000|Overall Study|Conversion|2|||
154844126|NCT00577993|558861432|FG001|Overall Study|Conversion|5|||
154844127|NCT00577993|558861433|FG002|Overall Study|Conversion|0|||
154844128|NCT00577993|558861431|FG000|Overall Study|Uninsured|1|||
154844129|NCT00577993|558861432|FG001|Overall Study|Uninsured|0|||
154844130|NCT00577993|558861433|FG002|Overall Study|Uninsured|0|||
154844131|NCT03033745|558861440|FG000|Overall Study|Protocol Violation|0|||
154844132|NCT03033745|558861441|FG001|Overall Study|Protocol Violation|0|||
154844133|NCT03033745|558861442|FG002|Overall Study|Protocol Violation|1|||
154844134|NCT03033745|558861440|FG000|Overall Study|Adverse Event|1|||
154844135|NCT03033745|558861441|FG001|Overall Study|Adverse Event|0|||
154844136|NCT03033745|558861442|FG002|Overall Study|Adverse Event|1|||
155104939|NCT00980460|559813909|FG004|Overall Study|Death|1|||
155104940|NCT00980460|559813905|FG000|Overall Study|Lack of Efficacy|0|||
155104941|NCT00980460|559813906|FG001|Overall Study|Lack of Efficacy|0|||
155104942|NCT00980460|559813907|FG002|Overall Study|Lack of Efficacy|10|||
155104943|NCT00980460|559813908|FG003|Overall Study|Lack of Efficacy|6|||
155104944|NCT00980460|559813909|FG004|Overall Study|Lack of Efficacy|8|||
155104945|NCT00980460|559813905|FG000|Overall Study|Lost to Follow-up|0|||
155104946|NCT00980460|559813906|FG001|Overall Study|Lost to Follow-up|0|||
155104947|NCT00980460|559813907|FG002|Overall Study|Lost to Follow-up|0|||
155104948|NCT00980460|559813908|FG003|Overall Study|Lost to Follow-up|1|||
155104949|NCT00980460|559813909|FG004|Overall Study|Lost to Follow-up|0|||
155104950|NCT00980460|559813905|FG000|Overall Study|Physician Decision|0|||
155104951|NCT00980460|559813906|FG001|Overall Study|Physician Decision|0|||
155104952|NCT00980460|559813907|FG002|Overall Study|Physician Decision|11|||
155104953|NCT00980460|559813908|FG003|Overall Study|Physician Decision|5|||
155104954|NCT00980460|559813909|FG004|Overall Study|Physician Decision|3|||
154844137|NCT03033745|558861440|FG000|Overall Study|Withdrawal by Subject|0|||
154844138|NCT03033745|558861441|FG001|Overall Study|Withdrawal by Subject|1|||
154844139|NCT03033745|558861442|FG002|Overall Study|Withdrawal by Subject|0|||
154844140|NCT00608985|558861443|FG000|Overall Study|Adverse Event|2|||
154844141|NCT00608985|558861444|FG001|Overall Study|Adverse Event|7|||
154844142|NCT00608985|558861445|FG002|Overall Study|Adverse Event|4|||
154844143|NCT00608985|558861446|FG003|Overall Study|Adverse Event|6|||
154844144|NCT00608985|558861443|FG000|Overall Study|Administrative/Other|7|||
154844145|NCT00608985|558861444|FG001|Overall Study|Administrative/Other|4|||
154844146|NCT00608985|558861445|FG002|Overall Study|Administrative/Other|1|||
154844147|NCT00608985|558861446|FG003|Overall Study|Administrative/Other|2|||
154844148|NCT00608985|558861443|FG000|Overall Study|Withdrawal of Consent|5|||
154844149|NCT00608985|558861444|FG001|Overall Study|Withdrawal of Consent|1|||
154844150|NCT00608985|558861445|FG002|Overall Study|Withdrawal of Consent|1|||
154844151|NCT00608985|558861446|FG003|Overall Study|Withdrawal of Consent|1|||
154844152|NCT00608985|558861443|FG000|Overall Study|Lost to Follow-up|2|||
154844153|NCT00608985|558861444|FG001|Overall Study|Lost to Follow-up|1|||
154844154|NCT00608985|558861445|FG002|Overall Study|Lost to Follow-up|0|||
154844155|NCT00608985|558861446|FG003|Overall Study|Lost to Follow-up|0|||
154844156|NCT01999582|558861447|FG000|Overall Study|Withdrawal by Subject|0|||
154844157|NCT01999582|558861448|FG001|Overall Study|Withdrawal by Subject|0|||
154844158|NCT01999582|558861449|FG002|Overall Study|Withdrawal by Subject|0|||
154844159|NCT01999582|558861450|FG003|Overall Study|Withdrawal by Subject|1|||
154844160|NCT01999582|558861451|FG004|Overall Study|Withdrawal by Subject|0|||
155104955|NCT00980460|559813905|FG000|Overall Study|Withdrawal by Subject|0|||
155104956|NCT00980460|559813906|FG001|Overall Study|Withdrawal by Subject|0|||
155104957|NCT00980460|559813907|FG002|Overall Study|Withdrawal by Subject|1|||
155104958|NCT00980460|559813908|FG003|Overall Study|Withdrawal by Subject|0|||
155104959|NCT00980460|559813909|FG004|Overall Study|Withdrawal by Subject|0|||
155104960|NCT00980460|559813905|FG000|Overall Study|Ineligible|0|||
155104961|NCT00980460|559813906|FG001|Overall Study|Ineligible|2|||
155104962|NCT00980460|559813907|FG002|Overall Study|Ineligible|3|||
155104963|NCT00980460|559813908|FG003|Overall Study|Ineligible|1|||
155173534|NCT01106092|560074806|FG001|Overall Study|Withdrawal by Subject|0|||
154844161|NCT01999582|558861452|FG005|Overall Study|Withdrawal by Subject|0|||
154844162|NCT01999582|558861447|FG000|Overall Study|Adverse Event|0|||
154844163|NCT01999582|558861448|FG001|Overall Study|Adverse Event|0|||
154844164|NCT01999582|558861449|FG002|Overall Study|Adverse Event|3|||
154844165|NCT01999582|558861450|FG003|Overall Study|Adverse Event|0|||
154844166|NCT01999582|558861451|FG004|Overall Study|Adverse Event|1|||
154844167|NCT01999582|558861452|FG005|Overall Study|Adverse Event|0|||
154844168|NCT01999582|558861447|FG000|Overall Study|Other Reasons|1|||
154844169|NCT01999582|558861448|FG001|Overall Study|Other Reasons|0|||
154844170|NCT01999582|558861449|FG002|Overall Study|Other Reasons|3|||
154844171|NCT01999582|558861450|FG003|Overall Study|Other Reasons|1|||
154844172|NCT01999582|558861451|FG004|Overall Study|Other Reasons|1|||
154844173|NCT01999582|558861452|FG005|Overall Study|Other Reasons|2|||
155104964|NCT00980460|559813909|FG004|Overall Study|Ineligible|4|||
155104965|NCT00980460|559813905|FG000|Overall Study|Refusal of further therapy|0|||
155104966|NCT00980460|559813906|FG001|Overall Study|Refusal of further therapy|2|||
154844174|NCT01999582|558861447|FG000|Overall Study|Protocol Violation|1|||
154844175|NCT01999582|558861448|FG001|Overall Study|Protocol Violation|0|||
154844176|NCT01999582|558861449|FG002|Overall Study|Protocol Violation|0|||
154844177|NCT01999582|558861450|FG003|Overall Study|Protocol Violation|0|||
154844178|NCT01999582|558861451|FG004|Overall Study|Protocol Violation|0|||
154844179|NCT01999582|558861452|FG005|Overall Study|Protocol Violation|1|||
154844180|NCT01999582|558861447|FG000|Overall Study|Lack of Efficacy|1|||
154844181|NCT01999582|558861448|FG001|Overall Study|Lack of Efficacy|3|||
154844182|NCT01999582|558861449|FG002|Overall Study|Lack of Efficacy|0|||
154844183|NCT01999582|558861450|FG003|Overall Study|Lack of Efficacy|1|||
154844184|NCT01999582|558861451|FG004|Overall Study|Lack of Efficacy|0|||
154844185|NCT01999582|558861452|FG005|Overall Study|Lack of Efficacy|0|||
154844186|NCT00661271|558861453|FG000|Overall Study|Lost to Follow-up|28|||
154844187|NCT00661271|558861454|FG001|Overall Study|Lost to Follow-up|25|||
154844188|NCT03728309|558861458|FG000|Overall Study|Randomized but not Treated|0|||
154844189|NCT03728309|558861459|FG001|Overall Study|Randomized but not Treated|1|||
154844190|NCT03728309|558861458|FG000|Overall Study|Adverse Event|0|||
154844191|NCT03728309|558861459|FG001|Overall Study|Adverse Event|1|||
154844192|NCT03728309|558861458|FG000|Overall Study|Withdrawal by Subject|2|||
154844193|NCT03728309|558861459|FG001|Overall Study|Withdrawal by Subject|8|||
154844194|NCT03728309|558861458|FG000|Overall Study|Lost to Follow-up|9|||
154844195|NCT03728309|558861459|FG001|Overall Study|Lost to Follow-up|10|||
154844196|NCT03728309|558861458|FG000|Overall Study|Protocol Deviation|0|||
154844197|NCT03728309|558861459|FG001|Overall Study|Protocol Deviation|1|||
154844198|NCT03728309|558861458|FG000|Overall Study|Due to COVID|1|||
154844199|NCT03728309|558861459|FG001|Overall Study|Due to COVID|3|||
154844200|NCT00953758|558861460|FG000|Overall Study|Death|2|||
154844201|NCT00953758|558861461|FG001|Overall Study|Death|0|||
154844202|NCT00953758|558861462|FG002|Overall Study|Death|1|||
154844203|NCT00953758|558861463|FG003|Overall Study|Death|1|||
154844204|NCT00953758|558861464|FG004|Overall Study|Death|1|||
154844205|NCT00953758|558861465|FG005|Overall Study|Death|1|||
154844206|NCT00953758|558861466|FG006|Overall Study|Death|1|||
154844207|NCT00953758|558861467|FG007|Overall Study|Death|3|||
154844208|NCT00953758|558861468|FG008|Overall Study|Death|1|||
154844209|NCT00953758|558861469|FG009|Overall Study|Death|0|||
154844210|NCT00953758|558861460|FG000|Overall Study|Participant refused further follow-up|0|||
154844211|NCT00953758|558861461|FG001|Overall Study|Participant refused further follow-up|0|||
154844212|NCT00953758|558861462|FG002|Overall Study|Participant refused further follow-up|1|||
154844213|NCT00953758|558861463|FG003|Overall Study|Participant refused further follow-up|0|||
154844214|NCT00953758|558861464|FG004|Overall Study|Participant refused further follow-up|3|||
154844215|NCT00953758|558861465|FG005|Overall Study|Participant refused further follow-up|0|||
154844216|NCT00953758|558861466|FG006|Overall Study|Participant refused further follow-up|0|||
154844217|NCT00953758|558861467|FG007|Overall Study|Participant refused further follow-up|0|||
154844218|NCT00953758|558861468|FG008|Overall Study|Participant refused further follow-up|1|||
154844219|NCT00953758|558861469|FG009|Overall Study|Participant refused further follow-up|0|||
154844220|NCT00953758|558861460|FG000|Overall Study|Lost to Follow-up|0|||
154844221|NCT00953758|558861461|FG001|Overall Study|Lost to Follow-up|0|||
154844222|NCT00953758|558861462|FG002|Overall Study|Lost to Follow-up|0|||
154844223|NCT00953758|558861463|FG003|Overall Study|Lost to Follow-up|1|||
154844224|NCT00953758|558861464|FG004|Overall Study|Lost to Follow-up|0|||
154844225|NCT00953758|558861465|FG005|Overall Study|Lost to Follow-up|0|||
154844226|NCT00953758|558861466|FG006|Overall Study|Lost to Follow-up|0|||
154844227|NCT00953758|558861467|FG007|Overall Study|Lost to Follow-up|1|||
154844228|NCT00953758|558861468|FG008|Overall Study|Lost to Follow-up|0|||
154844229|NCT00953758|558861469|FG009|Overall Study|Lost to Follow-up|1|||
154844230|NCT00953758|558861460|FG000|Overall Study|Physician Decision|0|||
154844231|NCT00953758|558861461|FG001|Overall Study|Physician Decision|0|||
154844232|NCT00953758|558861462|FG002|Overall Study|Physician Decision|0|||
154844233|NCT00953758|558861463|FG003|Overall Study|Physician Decision|0|||
154844234|NCT00953758|558861464|FG004|Overall Study|Physician Decision|1|||
154844235|NCT00953758|558861465|FG005|Overall Study|Physician Decision|0|||
154844236|NCT00953758|558861466|FG006|Overall Study|Physician Decision|0|||
154844237|NCT00953758|558861467|FG007|Overall Study|Physician Decision|0|||
154844238|NCT00953758|558861468|FG008|Overall Study|Physician Decision|0|||
154844239|NCT00953758|558861469|FG009|Overall Study|Physician Decision|0|||
154844240|NCT00953758|558861460|FG000|Overall Study|Disease progression|0|||
154844241|NCT00953758|558861461|FG001|Overall Study|Disease progression|0|||
154844242|NCT00953758|558861462|FG002|Overall Study|Disease progression|0|||
154844243|NCT00953758|558861463|FG003|Overall Study|Disease progression|0|||
154844244|NCT00953758|558861464|FG004|Overall Study|Disease progression|1|||
154971214|NCT02846883|559318564|FG000|Overall Study|Withdrawal by Subject|1|||
154844245|NCT00953758|558861465|FG005|Overall Study|Disease progression|0|||
154844246|NCT00953758|558861466|FG006|Overall Study|Disease progression|0|||
154844247|NCT00953758|558861467|FG007|Overall Study|Disease progression|0|||
154844248|NCT00953758|558861468|FG008|Overall Study|Disease progression|0|||
154844249|NCT00953758|558861469|FG009|Overall Study|Disease progression|0|||
154844250|NCT00953758|558861460|FG000|Overall Study|Participant went for transplant|0|||
154844251|NCT00953758|558861461|FG001|Overall Study|Participant went for transplant|0|||
154844252|NCT00953758|558861462|FG002|Overall Study|Participant went for transplant|0|||
154844253|NCT00953758|558861463|FG003|Overall Study|Participant went for transplant|0|||
154844254|NCT00953758|558861464|FG004|Overall Study|Participant went for transplant|0|||
154844255|NCT00953758|558861465|FG005|Overall Study|Participant went for transplant|0|||
154844256|NCT00953758|558861466|FG006|Overall Study|Participant went for transplant|0|||
155104967|NCT00980460|559813907|FG002|Overall Study|Refusal of further therapy|3|||
155104968|NCT00980460|559813908|FG003|Overall Study|Refusal of further therapy|2|||
155104969|NCT00980460|559813909|FG004|Overall Study|Refusal of further therapy|0|||
155104970|NCT00980460|559813905|FG000|Overall Study|No therapy within 42 days of resection|0|||
155104971|NCT00980460|559813906|FG001|Overall Study|No therapy within 42 days of resection|0|||
155104972|NCT00980460|559813907|FG002|Overall Study|No therapy within 42 days of resection|3|||
155104973|NCT00980460|559813908|FG003|Overall Study|No therapy within 42 days of resection|1|||
154844257|NCT00953758|558861467|FG007|Overall Study|Participant went for transplant|0|||
154844258|NCT00953758|558861468|FG008|Overall Study|Participant went for transplant|1|||
154844259|NCT00953758|558861469|FG009|Overall Study|Participant went for transplant|0|||
155104974|NCT00980460|559813909|FG004|Overall Study|No therapy within 42 days of resection|0|||
154844260|NCT00927095|558861472|FG000|Overall Study|Adverse Event|3|||
154844261|NCT00927095|558861473|FG001|Overall Study|Adverse Event|1|||
154844262|NCT00927095|558861474|FG002|Overall Study|Adverse Event|0|||
154844263|NCT00927095|558861472|FG000|Overall Study|Withdrawal by Subject|2|||
154844264|NCT00927095|558861473|FG001|Overall Study|Withdrawal by Subject|1|||
154844265|NCT00927095|558861474|FG002|Overall Study|Withdrawal by Subject|1|||
154844266|NCT00927095|558861472|FG000|Overall Study|Physician Decision|1|||
154844267|NCT00927095|558861473|FG001|Overall Study|Physician Decision|2|||
154844268|NCT00927095|558861474|FG002|Overall Study|Physician Decision|1|||
154844269|NCT00044512|558861481|FG000|Follow Up|Lost to Follow-up|2|||
154844270|NCT05130463|558861484|FG000|Overall Study|Unspecified reasons|2|||
154844271|NCT05130463|558861484|FG000|Overall Study|off-label indication dose|435|||
154844272|NCT03652662|558861485|FG000|Overall Study|Withdrawal by Subject|2|||
154844273|NCT03652662|558861486|FG001|Overall Study|Withdrawal by Subject|1|||
154844274|NCT03652662|558861485|FG000|Overall Study|Lost to Follow-up|1|||
154844275|NCT03652662|558861486|FG001|Overall Study|Lost to Follow-up|0|||
154971215|NCT02846883|559318565|FG001|Overall Study|Withdrawal by Subject|0|||
155104975|NCT00980460|559813905|FG000|Overall Study|No transplant by protocol timepoints|0|||
155104976|NCT00980460|559813906|FG001|Overall Study|No transplant by protocol timepoints|0|||
155104977|NCT00980460|559813907|FG002|Overall Study|No transplant by protocol timepoints|3|||
155104978|NCT00980460|559813908|FG003|Overall Study|No transplant by protocol timepoints|0|||
155104979|NCT00980460|559813909|FG004|Overall Study|No transplant by protocol timepoints|0|||
155104980|NCT05696444|559813910|FG000|Treatment|Physician Decision|0|||
155104981|NCT05696444|559813911|FG001|Treatment|Physician Decision|1|||
155173535|NCT01106092|560074807|FG002|Overall Study|Withdrawal by Subject|0|||
155173536|NCT01106092|560074808|FG003|Overall Study|Withdrawal by Subject|1|||
155173537|NCT02434471|560074811|FG000|Overall Study|Physician Decision|9|||
155173538|NCT01604278|560074816|FG000|Overall Study|Lack of Efficacy|0|||
155173539|NCT01604278|560074817|FG001|Overall Study|Lack of Efficacy|1|||
155173540|NCT01604278|560074816|FG000|Overall Study|Lost to Follow-up|1|||
155173541|NCT01604278|560074817|FG001|Overall Study|Lost to Follow-up|0|||
154844276|NCT00487539|558861487|FG000|Overall Study|Adverse Event|3|||
154844277|NCT00487539|558861488|FG001|Overall Study|Adverse Event|2|||
154844278|NCT00487539|558861489|FG002|Overall Study|Adverse Event|1|||
154844279|NCT00487539|558861490|FG003|Overall Study|Adverse Event|1|||
154844280|NCT00487539|558861487|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154844281|NCT00487539|558861488|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154844282|NCT00487539|558861489|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
154844283|NCT00487539|558861490|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
154844284|NCT00487539|558861487|FG000|Overall Study|Other|3|||
154844285|NCT00487539|558861488|FG001|Overall Study|Other|1|||
154844286|NCT00487539|558861489|FG002|Overall Study|Other|2|||
154844287|NCT00487539|558861490|FG003|Overall Study|Other|2|||
154844288|NCT02751502|558861491|FG000|Overall Study|Lack of funding|4|||
154844289|NCT00852995|558861492|FG000|Overall Study|Adverse Event|1|||
154844290|NCT00852995|558861493|FG001|Overall Study|Adverse Event|0|||
154844291|NCT00852995|558861494|FG002|Overall Study|Adverse Event|4|||
154844292|NCT00852995|558861495|FG003|Overall Study|Adverse Event|0|||
154844293|NCT00852995|558861496|FG004|Overall Study|Adverse Event|0|||
154844294|NCT00852995|558861492|FG000|Overall Study|Lost to Follow-up|0|||
154844295|NCT00852995|558861493|FG001|Overall Study|Lost to Follow-up|1|||
154844296|NCT00852995|558861494|FG002|Overall Study|Lost to Follow-up|1|||
154844297|NCT00852995|558861495|FG003|Overall Study|Lost to Follow-up|0|||
154844298|NCT00852995|558861496|FG004|Overall Study|Lost to Follow-up|0|||
154844299|NCT00852995|558861492|FG000|Overall Study|Withdrawal by Subject|4|||
154844300|NCT00852995|558861493|FG001|Overall Study|Withdrawal by Subject|0|||
154844301|NCT00852995|558861494|FG002|Overall Study|Withdrawal by Subject|0|||
154844302|NCT00852995|558861495|FG003|Overall Study|Withdrawal by Subject|1|||
154844303|NCT00852995|558861496|FG004|Overall Study|Withdrawal by Subject|2|||
154844304|NCT00852995|558861492|FG000|Overall Study|Non-Compliance|0|||
154844305|NCT00852995|558861493|FG001|Overall Study|Non-Compliance|0|||
154844306|NCT00852995|558861494|FG002|Overall Study|Non-Compliance|0|||
154844307|NCT00852995|558861495|FG003|Overall Study|Non-Compliance|2|||
154844308|NCT00852995|558861496|FG004|Overall Study|Non-Compliance|0|||
154844309|NCT00852995|558861492|FG000|Overall Study|Progressive Disease|1|||
154844310|NCT00852995|558861493|FG001|Overall Study|Progressive Disease|0|||
154844311|NCT00852995|558861494|FG002|Overall Study|Progressive Disease|0|||
154844312|NCT00852995|558861495|FG003|Overall Study|Progressive Disease|2|||
154844313|NCT00852995|558861496|FG004|Overall Study|Progressive Disease|1|||
154844314|NCT00852995|558861492|FG000|Overall Study|Physician Decision|1|||
154844315|NCT00852995|558861493|FG001|Overall Study|Physician Decision|0|||
154844316|NCT00852995|558861494|FG002|Overall Study|Physician Decision|0|||
154844317|NCT00852995|558861495|FG003|Overall Study|Physician Decision|0|||
154844318|NCT00852995|558861496|FG004|Overall Study|Physician Decision|0|||
154844319|NCT00852995|558861492|FG000|Overall Study|Protocol Violation|0|||
154844320|NCT00852995|558861493|FG001|Overall Study|Protocol Violation|0|||
154844321|NCT00852995|558861494|FG002|Overall Study|Protocol Violation|0|||
154844322|NCT00852995|558861495|FG003|Overall Study|Protocol Violation|0|||
154844323|NCT00852995|558861496|FG004|Overall Study|Protocol Violation|1|||
154844324|NCT00852995|558861492|FG000|Overall Study|Moved Out of Area|1|||
154844325|NCT00852995|558861493|FG001|Overall Study|Moved Out of Area|0|||
154844326|NCT00852995|558861494|FG002|Overall Study|Moved Out of Area|0|||
154844327|NCT00852995|558861495|FG003|Overall Study|Moved Out of Area|0|||
154844328|NCT00852995|558861496|FG004|Overall Study|Moved Out of Area|0|||
154844329|NCT03499028|558861497|FG000|Overall Study|Lost to Follow-up|12|||
154844330|NCT03499028|558861498|FG001|Overall Study|Lost to Follow-up|9|||
154844331|NCT03499028|558861497|FG000|Overall Study|Withdrawal by Subject|5|||
154844332|NCT03499028|558861498|FG001|Overall Study|Withdrawal by Subject|8|||
154844333|NCT03499028|558861497|FG000|Overall Study|Unplanned SNF discharge|5|||
154844334|NCT03499028|558861498|FG001|Overall Study|Unplanned SNF discharge|8|||
154844335|NCT01110200|558861499|FG000|Overall Study|Adverse Event|28|||
154844336|NCT01110200|558861500|FG001|Overall Study|Adverse Event|28|||
154844337|NCT01110200|558861499|FG000|Overall Study|Withdrawal by Subject|25|||
155104982|NCT05696444|559813912|FG002|Treatment|Physician Decision|0|||
155104983|NCT05696444|559813910|FG000|30 Days|Death|1|||
155104984|NCT05696444|559813911|FG001|30 Days|Death|1|||
155104985|NCT05696444|559813912|FG002|30 Days|Death|0|||
155104986|NCT05696444|559813910|FG000|30 Days|Missed Visit|1|||
154844338|NCT01110200|558861500|FG001|Overall Study|Withdrawal by Subject|32|||
154844339|NCT01110200|558861499|FG000|Overall Study|Lack of Efficacy|16|||
154844340|NCT01110200|558861500|FG001|Overall Study|Lack of Efficacy|25|||
154844341|NCT01110200|558861499|FG000|Overall Study|Protocol Violation|14|||
154844342|NCT01110200|558861500|FG001|Overall Study|Protocol Violation|12|||
154844343|NCT01110200|558861499|FG000|Overall Study|Physician Decision|13|||
155104987|NCT05696444|559813911|FG001|30 Days|Missed Visit|1|||
154844344|NCT01110200|558861500|FG001|Overall Study|Physician Decision|17|||
154844345|NCT01110200|558861499|FG000|Overall Study|Lost to Follow-up|10|||
154844346|NCT01110200|558861500|FG001|Overall Study|Lost to Follow-up|7|||
154844347|NCT01437397|558861501|FG000|Overall Study|Lost to Follow-up|9|||
154844348|NCT01437397|558861502|FG001|Overall Study|Lost to Follow-up|4|||
154844349|NCT01437397|558861503|FG002|Overall Study|Lost to Follow-up|2|||
155104988|NCT05696444|559813912|FG002|30 Days|Missed Visit|1|||
154844350|NCT01437397|558861504|FG003|Overall Study|Lost to Follow-up|4|||
154844351|NCT01437397|558861505|FG004|Overall Study|Lost to Follow-up|5|||
154844352|NCT01437397|558861501|FG000|Overall Study|Withdrawal by Subject|11|||
155104989|NCT05200572|559813913|FG000|Overall Study|Withdrawal by Subject|14|||
155104990|NCT02013778|559815470|FG000|Overall Study|Death|4|||
155104991|NCT02013778|559815470|FG000|Overall Study|Withdrawal by Subject|1|||
155104992|NCT02013778|559815470|FG000|Overall Study|Physician Decision|1|||
154844353|NCT01437397|558861502|FG001|Overall Study|Withdrawal by Subject|12|||
154844354|NCT01437397|558861503|FG002|Overall Study|Withdrawal by Subject|24|||
154844355|NCT01437397|558861504|FG003|Overall Study|Withdrawal by Subject|11|||
154844356|NCT01437397|558861505|FG004|Overall Study|Withdrawal by Subject|22|||
154844357|NCT01437397|558861501|FG000|Overall Study|Protocol Violation|10|||
154844358|NCT01437397|558861502|FG001|Overall Study|Protocol Violation|12|||
154844359|NCT01437397|558861503|FG002|Overall Study|Protocol Violation|13|||
154844360|NCT01437397|558861504|FG003|Overall Study|Protocol Violation|21|||
154844361|NCT01437397|558861505|FG004|Overall Study|Protocol Violation|19|||
154844362|NCT01437397|558861501|FG000|Overall Study|Lack of Efficacy|5|||
154844363|NCT01437397|558861502|FG001|Overall Study|Lack of Efficacy|4|||
154844364|NCT01437397|558861503|FG002|Overall Study|Lack of Efficacy|8|||
154844365|NCT01437397|558861504|FG003|Overall Study|Lack of Efficacy|10|||
154844366|NCT01437397|558861505|FG004|Overall Study|Lack of Efficacy|20|||
154844367|NCT01437397|558861501|FG000|Overall Study|Adverse Event|21|||
154844368|NCT01437397|558861502|FG001|Overall Study|Adverse Event|22|||
154844369|NCT01437397|558861503|FG002|Overall Study|Adverse Event|16|||
154844370|NCT01437397|558861504|FG003|Overall Study|Adverse Event|14|||
154844371|NCT01437397|558861505|FG004|Overall Study|Adverse Event|21|||
154844372|NCT01437397|558861501|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
154844373|NCT01437397|558861502|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
154844374|NCT01437397|558861503|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
154844375|NCT01437397|558861504|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
154844376|NCT01437397|558861505|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
154844377|NCT00866307|558861507|FG000|Induction|Adverse Event|5|||
154844378|NCT00866307|558861508|FG001|Induction|Adverse Event|0|||
154844379|NCT00866307|558861509|FG002|Induction|Adverse Event|0|||
154844380|NCT00866307|558861507|FG000|Induction|Death|2|||
154844381|NCT00866307|558861508|FG001|Induction|Death|0|||
154844382|NCT00866307|558861509|FG002|Induction|Death|0|||
154844383|NCT00866307|558861507|FG000|Induction|Physician Decision|5|||
154844384|NCT00866307|558861508|FG001|Induction|Physician Decision|0|||
154844385|NCT00866307|558861509|FG002|Induction|Physician Decision|0|||
154844386|NCT00866307|558861507|FG000|Induction|Progressive Disease|1|||
154844387|NCT00866307|558861508|FG001|Induction|Progressive Disease|0|||
154844388|NCT00866307|558861509|FG002|Induction|Progressive Disease|0|||
154844389|NCT00866307|558861507|FG000|Induction|Identification of Patients with Day 29 M|3|||
154844390|NCT00866307|558861508|FG001|Induction|Identification of Patients with Day 29 M|0|||
154844391|NCT00866307|558861509|FG002|Induction|Identification of Patients with Day 29 M|0|||
154844392|NCT00866307|558861507|FG000|Induction|Inadequate cytognetic samples th|1|||
154844393|NCT00866307|558861508|FG001|Induction|Inadequate cytognetic samples th|0|||
154844394|NCT00866307|558861509|FG002|Induction|Inadequate cytognetic samples th|0|||
154844395|NCT00866307|558861507|FG000|Induction|Improper post-induction consent|2|||
154844396|NCT00866307|558861508|FG001|Induction|Improper post-induction consent|0|||
154844397|NCT00866307|558861509|FG002|Induction|Improper post-induction consent|0|||
154844398|NCT00866307|558861507|FG000|Induction|Study was closed at the time|1|||
154844399|NCT00866307|558861508|FG001|Induction|Study was closed at the time|0|||
154844400|NCT00866307|558861509|FG002|Induction|Study was closed at the time|0|||
154844401|NCT00866307|558861507|FG000|Consolidation/Maintenance|Adverse Event|0|||
154844402|NCT00866307|558861508|FG001|Consolidation/Maintenance|Adverse Event|0|||
154844403|NCT00866307|558861509|FG002|Consolidation/Maintenance|Adverse Event|8|||
154844404|NCT00866307|558861507|FG000|Consolidation/Maintenance|Death|0|||
154844405|NCT00866307|558861508|FG001|Consolidation/Maintenance|Death|0|||
155104993|NCT02013778|559815470|FG000|Overall Study|Adverse Event|1|||
155104994|NCT00861757|559815471|FG000|Overall Study|Adverse Event|1|||
155104995|NCT00861757|559815472|FG001|Overall Study|Adverse Event|5|||
155104996|NCT00861757|559815473|FG002|Overall Study|Adverse Event|7|||
155104997|NCT00861757|559815474|FG003|Overall Study|Adverse Event|2|||
155104998|NCT00861757|559815471|FG000|Overall Study|Entry Criteria Not Met|1|||
154844406|NCT00866307|558861509|FG002|Consolidation/Maintenance|Death|1|||
154844407|NCT00866307|558861507|FG000|Consolidation/Maintenance|Physician Decision|0|||
154844408|NCT00866307|558861508|FG001|Consolidation/Maintenance|Physician Decision|3|||
154844409|NCT00866307|558861509|FG002|Consolidation/Maintenance|Physician Decision|2|||
155104999|NCT00861757|559815472|FG001|Overall Study|Entry Criteria Not Met|2|||
155105000|NCT00861757|559815473|FG002|Overall Study|Entry Criteria Not Met|1|||
154844410|NCT00866307|558861507|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
154844411|NCT00866307|558861508|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
154844412|NCT00866307|558861509|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
154844413|NCT00866307|558861507|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
154844414|NCT00866307|558861508|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
154844415|NCT00866307|558861509|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
154844416|NCT00866307|558861507|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
154844417|NCT00866307|558861508|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
154844418|NCT00866307|558861509|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
154844419|NCT00866307|558861507|FG000|Consolidation/Maintenance|Therapy error|0|||
154844420|NCT00866307|558861508|FG001|Consolidation/Maintenance|Therapy error|1|||
154844421|NCT00866307|558861509|FG002|Consolidation/Maintenance|Therapy error|0|||
154844422|NCT00866307|558861507|FG000|Consolidation/Maintenance|Non-compliance|0|||
154844423|NCT00866307|558861508|FG001|Consolidation/Maintenance|Non-compliance|0|||
154844424|NCT00866307|558861509|FG002|Consolidation/Maintenance|Non-compliance|1|||
154844425|NCT00866307|558861507|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
154844426|NCT00866307|558861508|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
154844427|NCT00866307|558861509|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
154844428|NCT02573155|558861510|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
154844429|NCT02573155|558861511|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
154844430|NCT02573155|558861510|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
154844431|NCT02573155|558861511|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
154844432|NCT02573155|558861510|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
154844433|NCT02573155|558861511|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
154844434|NCT02573155|558861510|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
154844435|NCT02573155|558861511|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
154844436|NCT02573155|558861510|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
154844437|NCT02573155|558861511|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
154844438|NCT02573155|558861510|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
154844439|NCT02573155|558861511|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
154844440|NCT02573155|558861510|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
154844441|NCT02573155|558861511|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
154844442|NCT02573155|558861510|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
154844443|NCT02573155|558861511|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
154844444|NCT02508194|558861516|FG000|Overall Study|Death|5|||
154844445|NCT02508194|558861517|FG001|Overall Study|Death|3|||
154844446|NCT02508194|558861516|FG000|Overall Study|Lost to Follow-up|25|||
154844447|NCT02508194|558861517|FG001|Overall Study|Lost to Follow-up|18|||
154844448|NCT02508194|558861516|FG000|Overall Study|Withdrawal by Subject|20|||
154844449|NCT02508194|558861517|FG001|Overall Study|Withdrawal by Subject|18|||
154844450|NCT02508194|558861516|FG000|Overall Study|Error in Randomization|1|||
155105001|NCT00861757|559815474|FG003|Overall Study|Entry Criteria Not Met|1|||
154844451|NCT02508194|558861517|FG001|Overall Study|Error in Randomization|3|||
154844452|NCT02508194|558861516|FG000|Overall Study|Principal Investigator Decision|1|||
154844453|NCT02508194|558861517|FG001|Overall Study|Principal Investigator Decision|2|||
154844454|NCT00511355|558861518|FG000|Overall Study|Adverse Event|4|||
154844455|NCT00511355|558861519|FG001|Overall Study|Adverse Event|4|||
154844456|NCT00511355|558861518|FG000|Overall Study|Pregnancy Wish|1|||
154844457|NCT00511355|558861519|FG001|Overall Study|Pregnancy Wish|0|||
154844458|NCT00511355|558861518|FG000|Overall Study|Lost to Follow-up|2|||
154844459|NCT00511355|558861519|FG001|Overall Study|Lost to Follow-up|1|||
154844460|NCT00511355|558861518|FG000|Overall Study|Other Reason|0|||
154844461|NCT00511355|558861519|FG001|Overall Study|Other Reason|1|||
154844462|NCT00511355|558861518|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
154844463|NCT00511355|558861519|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
154844464|NCT00511355|558861518|FG000|Overall Study|Withdrawal of informed consent|0|||
154844465|NCT00511355|558861519|FG001|Overall Study|Withdrawal of informed consent|1|||
154844466|NCT00511355|558861518|FG000|Overall Study|Other reason pre-treatment|0|||
154844467|NCT00511355|558861519|FG001|Overall Study|Other reason pre-treatment|1|||
154844468|NCT00454805|558861521|FG000|Overall Study|Withdrawal by Subject|9|||
154844469|NCT00454805|558861522|FG001|Overall Study|Withdrawal by Subject|2|||
154844470|NCT00454805|558861521|FG000|Overall Study|Death|0|||
154844471|NCT00454805|558861522|FG001|Overall Study|Death|2|||
154844472|NCT00454805|558861521|FG000|Overall Study|Disease progression|16|||
154844473|NCT00454805|558861522|FG001|Overall Study|Disease progression|19|||
154844474|NCT00454805|558861521|FG000|Overall Study|In order to begin radiotherapy|1|||
154844475|NCT00454805|558861522|FG001|Overall Study|In order to begin radiotherapy|0|||
154844476|NCT00217087|558861523|FG000|Overall Study|decided to have esophagectomy|1|||
154844477|NCT00217087|558861524|FG001|Overall Study|decided to have esophagectomy|2|||
154844478|NCT00217087|558861523|FG000|Overall Study|completed less than 12 months return|10|||
154844479|NCT00217087|558861524|FG001|Overall Study|completed less than 12 months return|18|||
154844480|NCT04947800|558861531|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
154844481|NCT04947800|558861532|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
154844482|NCT04947800|558861533|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
154844483|NCT03892746|558861534|FG000|Overall Study|Withdrawal by Subject|2|||
155105002|NCT00861757|559815471|FG000|Overall Study|Lack of Efficacy|3|||
155105003|NCT00861757|559815472|FG001|Overall Study|Lack of Efficacy|1|||
155105004|NCT00861757|559815473|FG002|Overall Study|Lack of Efficacy|0|||
154844484|NCT03892746|558861535|FG001|Overall Study|Withdrawal by Subject|1|||
154844485|NCT03892746|558861534|FG000|Overall Study|Lost to Follow-up|2|||
154844486|NCT03892746|558861535|FG001|Overall Study|Lost to Follow-up|0|||
154844487|NCT02158091|558861536|FG000|Overall Study|DLT|2|||
154844488|NCT02158091|558861537|FG001|Overall Study|DLT|1|||
154844489|NCT02158091|558861538|FG002|Overall Study|DLT|0|||
154844490|NCT03977467|558861539|FG000|Overall Study|Disease Progression|1|||
154844491|NCT03977467|558861540|FG001|Overall Study|Disease Progression|1|||
154844492|NCT03977467|558861541|FG002|Overall Study|Disease Progression|30|||
154844493|NCT03977467|558861542|FG003|Overall Study|Disease Progression|0|||
154844494|NCT03977467|558861539|FG000|Overall Study|Adverse Event|0|||
154844495|NCT03977467|558861540|FG001|Overall Study|Adverse Event|1|||
154844496|NCT03977467|558861541|FG002|Overall Study|Adverse Event|0|||
154844497|NCT03977467|558861542|FG003|Overall Study|Adverse Event|0|||
154844498|NCT03977467|558861539|FG000|Overall Study|Death|0|||
154844499|NCT03977467|558861540|FG001|Overall Study|Death|0|||
154844500|NCT03977467|558861541|FG002|Overall Study|Death|3|||
154844501|NCT03977467|558861542|FG003|Overall Study|Death|0|||
154844502|NCT03977467|558861539|FG000|Overall Study|Lack of Efficacy|0|||
154844503|NCT03977467|558861540|FG001|Overall Study|Lack of Efficacy|0|||
154844504|NCT03977467|558861541|FG002|Overall Study|Lack of Efficacy|1|||
154844505|NCT03977467|558861542|FG003|Overall Study|Lack of Efficacy|0|||
154844506|NCT03977467|558861539|FG000|Overall Study|Withdrawal by Subject|2|||
154844507|NCT03977467|558861540|FG001|Overall Study|Withdrawal by Subject|1|||
154844508|NCT03977467|558861541|FG002|Overall Study|Withdrawal by Subject|4|||
154844509|NCT03977467|558861542|FG003|Overall Study|Withdrawal by Subject|0|||
155173542|NCT01604278|560074816|FG000|Overall Study|Administrative problems|2|||
155173543|NCT01604278|560074817|FG001|Overall Study|Administrative problems|1|||
154844510|NCT03977467|558861539|FG000|Overall Study|Study Terminated|1|||
154844511|NCT03977467|558861540|FG001|Overall Study|Study Terminated|0|||
154844512|NCT03977467|558861541|FG002|Overall Study|Study Terminated|0|||
154844513|NCT03977467|558861542|FG003|Overall Study|Study Terminated|1|||
154844514|NCT01318109|558861543|FG000|Overall Study|Adverse Event|0|||
154844515|NCT01318109|558861544|FG001|Overall Study|Adverse Event|2|||
154844516|NCT01318109|558861545|FG002|Overall Study|Adverse Event|0|||
154844517|NCT01318109|558861543|FG000|Overall Study|Withdrawal by Subject|1|||
154844518|NCT01318109|558861544|FG001|Overall Study|Withdrawal by Subject|0|||
154844519|NCT01318109|558861545|FG002|Overall Study|Withdrawal by Subject|0|||
154844520|NCT01318109|558861543|FG000|Overall Study|Schedule Conflict|0|||
154844521|NCT01318109|558861544|FG001|Overall Study|Schedule Conflict|1|||
154844522|NCT01318109|558861545|FG002|Overall Study|Schedule Conflict|0|||
154844523|NCT01328951|558861546|FG000|Overall Study|Disease Progression|17|||
154844524|NCT01328951|558861547|FG001|Overall Study|Disease Progression|14|||
154844525|NCT01328951|558861546|FG000|Overall Study|Adverse Event|2|||
154844526|NCT01328951|558861547|FG001|Overall Study|Adverse Event|0|||
154844527|NCT01328951|558861546|FG000|Overall Study|Death|243|||
154844528|NCT01328951|558861547|FG001|Overall Study|Death|258|||
154844529|NCT01328951|558861546|FG000|Overall Study|Lost to Follow-up|6|||
154844530|NCT01328951|558861547|FG001|Overall Study|Lost to Follow-up|7|||
154844531|NCT01328951|558861546|FG000|Overall Study|Withdrawal by Subject|6|||
154844532|NCT01328951|558861547|FG001|Overall Study|Withdrawal by Subject|6|||
154844533|NCT01328951|558861546|FG000|Overall Study|Study Closed by the Sponsor|36|||
154844534|NCT01328951|558861547|FG001|Overall Study|Study Closed by the Sponsor|31|||
154844535|NCT01328951|558861546|FG000|Overall Study|Other|11|||
154844536|NCT01328951|558861547|FG001|Overall Study|Other|6|||
154844537|NCT00861744|558861563|FG000|Overall Study|Adverse Event|0|||
154844538|NCT00861744|558861564|FG001|Overall Study|Adverse Event|0|||
154844539|NCT00861744|558861565|FG002|Overall Study|Adverse Event|0|||
154844540|NCT00861744|558861566|FG003|Overall Study|Adverse Event|1|||
154844541|NCT00861744|558861563|FG000|Overall Study|Lost to Follow-up|7|||
154844542|NCT00861744|558861564|FG001|Overall Study|Lost to Follow-up|19|||
154844543|NCT00861744|558861565|FG002|Overall Study|Lost to Follow-up|17|||
154844544|NCT00861744|558861566|FG003|Overall Study|Lost to Follow-up|12|||
154844545|NCT00861744|558861563|FG000|Overall Study|Withdrawal by Subject|10|||
154844546|NCT00861744|558861564|FG001|Overall Study|Withdrawal by Subject|6|||
154844547|NCT00861744|558861565|FG002|Overall Study|Withdrawal by Subject|6|||
154844548|NCT00861744|558861566|FG003|Overall Study|Withdrawal by Subject|19|||
154844549|NCT00861744|558861563|FG000|Overall Study|Protocol Violation|0|||
154844550|NCT00861744|558861564|FG001|Overall Study|Protocol Violation|1|||
154844551|NCT00861744|558861565|FG002|Overall Study|Protocol Violation|0|||
154844552|NCT00861744|558861566|FG003|Overall Study|Protocol Violation|0|||
154844553|NCT00861744|558861563|FG000|Overall Study|Migration from study area|0|||
154844554|NCT00861744|558861564|FG001|Overall Study|Migration from study area|3|||
154844555|NCT00861744|558861565|FG002|Overall Study|Migration from study area|1|||
154844556|NCT00861744|558861566|FG003|Overall Study|Migration from study area|0|||
154844557|NCT00861744|558861563|FG000|Overall Study|Blood draws|0|||
154844558|NCT00861744|558861564|FG001|Overall Study|Blood draws|0|||
154844559|NCT00861744|558861565|FG002|Overall Study|Blood draws|0|||
154844560|NCT00861744|558861566|FG003|Overall Study|Blood draws|1|||
154844561|NCT03359759|558861567|FG000|Overall Study|Death|3|||
154844562|NCT03359759|558861567|FG000|Overall Study|Lost to Follow-up|2|||
154844563|NCT05568888|558861568|FG000|Overall Study|Physician Decision|1|||
154844564|NCT05568888|558861569|FG001|Overall Study|Physician Decision|0|||
154844565|NCT05568888|558861568|FG000|Overall Study|Protocol Deviation|2|||
154844566|NCT05568888|558861569|FG001|Overall Study|Protocol Deviation|1|||
154844567|NCT05568888|558861568|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
154844568|NCT05568888|558861569|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
154844569|NCT05568888|558861568|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
154844570|NCT05568888|558861569|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
154844571|NCT05568888|558861568|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
154844572|NCT05568888|558861569|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
154844573|NCT02396589|558861571|FG000|Intervention|Lost to Follow-up|1|||
154844574|NCT02396589|558861572|FG001|Intervention|Lost to Follow-up|0|||
154844575|NCT02396589|558861571|FG000|6 Month Follow-up|change in health status|0|||
154844576|NCT02396589|558861572|FG001|6 Month Follow-up|change in health status|1|||
155105005|NCT00861757|559815474|FG003|Overall Study|Lack of Efficacy|1|||
154844577|NCT02396589|558861571|FG000|9 Month Follow-up|Death|0|||
154844578|NCT02396589|558861572|FG001|9 Month Follow-up|Death|1|||
154844579|NCT02396589|558861571|FG000|12 Month Follow up|Lost to Follow-up|0|||
154844580|NCT02396589|558861572|FG001|12 Month Follow up|Lost to Follow-up|2|||
154844581|NCT04381650|558861573|FG000|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844582|NCT04381650|558861574|FG001|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844583|NCT04381650|558861575|FG002|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844584|NCT04381650|558861576|FG003|Phase 1b (Dose Escalation)|New anti-cancer therapy|1|||
154844585|NCT04381650|558861577|FG004|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844586|NCT04381650|558861578|FG005|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844587|NCT04381650|558861579|FG006|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844588|NCT04381650|558861580|FG007|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844589|NCT04381650|558861581|FG008|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844590|NCT04381650|558861582|FG009|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844591|NCT04381650|558861583|FG010|Phase 1b (Dose Escalation)|New anti-cancer therapy|0|||
154844592|NCT04381650|558861573|FG000|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844593|NCT04381650|558861574|FG001|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844594|NCT04381650|558861575|FG002|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844595|NCT04381650|558861576|FG003|Phase 1b (Dose Escalation)|Lost to Follow-up|1|||
154844596|NCT04381650|558861577|FG004|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844597|NCT04381650|558861578|FG005|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844598|NCT04381650|558861579|FG006|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844599|NCT04381650|558861580|FG007|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844600|NCT04381650|558861581|FG008|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844601|NCT04381650|558861582|FG009|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844602|NCT04381650|558861583|FG010|Phase 1b (Dose Escalation)|Lost to Follow-up|0|||
154844603|NCT04381650|558861573|FG000|Phase 1b (Dose Escalation)|Progressive Disease|1|||
154844604|NCT04381650|558861574|FG001|Phase 1b (Dose Escalation)|Progressive Disease|3|||
154844605|NCT04381650|558861575|FG002|Phase 1b (Dose Escalation)|Progressive Disease|12|||
154844606|NCT04381650|558861576|FG003|Phase 1b (Dose Escalation)|Progressive Disease|8|||
154844607|NCT04381650|558861577|FG004|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844608|NCT04381650|558861578|FG005|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844609|NCT04381650|558861579|FG006|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844610|NCT04381650|558861580|FG007|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844611|NCT04381650|558861581|FG008|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844612|NCT04381650|558861582|FG009|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844613|NCT04381650|558861583|FG010|Phase 1b (Dose Escalation)|Progressive Disease|0|||
154844614|NCT04381650|558861573|FG000|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844615|NCT04381650|558861574|FG001|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844616|NCT04381650|558861575|FG002|Phase 1b (Dose Escalation)|Withdrawal by Subject|11|||
154844617|NCT04381650|558861576|FG003|Phase 1b (Dose Escalation)|Withdrawal by Subject|4|||
154844618|NCT04381650|558861577|FG004|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844619|NCT04381650|558861578|FG005|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844620|NCT04381650|558861579|FG006|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844621|NCT04381650|558861580|FG007|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844622|NCT04381650|558861581|FG008|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844623|NCT04381650|558861582|FG009|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844624|NCT04381650|558861583|FG010|Phase 1b (Dose Escalation)|Withdrawal by Subject|0|||
154844625|NCT04381650|558861573|FG000|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844626|NCT04381650|558861574|FG001|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
154844627|NCT04381650|558861575|FG002|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
154844628|NCT04381650|558861576|FG003|Phase 1b (Dose Escalation)|Reason Not Specified|1|||
154844629|NCT04381650|558861577|FG004|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844630|NCT04381650|558861578|FG005|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844631|NCT04381650|558861579|FG006|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844632|NCT04381650|558861580|FG007|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844633|NCT04381650|558861581|FG008|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844634|NCT04381650|558861582|FG009|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844635|NCT04381650|558861583|FG010|Phase 1b (Dose Escalation)|Reason Not Specified|0|||
154844636|NCT04381650|558861573|FG000|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844637|NCT04381650|558861574|FG001|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844638|NCT04381650|558861575|FG002|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844639|NCT04381650|558861576|FG003|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844640|NCT04381650|558861577|FG004|Phase 2 (Dose Expansion)|New anti-cancer therapy|3|||
154844641|NCT04381650|558861578|FG005|Phase 2 (Dose Expansion)|New anti-cancer therapy|1|||
154844642|NCT04381650|558861579|FG006|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844643|NCT04381650|558861580|FG007|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844644|NCT04381650|558861581|FG008|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844645|NCT04381650|558861582|FG009|Phase 2 (Dose Expansion)|New anti-cancer therapy|2|||
155105006|NCT00861757|559815471|FG000|Overall Study|Lost to Follow-up|1|||
155105007|NCT00861757|559815472|FG001|Overall Study|Lost to Follow-up|0|||
154844646|NCT04381650|558861583|FG010|Phase 2 (Dose Expansion)|New anti-cancer therapy|0|||
154844647|NCT04381650|558861573|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844648|NCT04381650|558861574|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844649|NCT04381650|558861575|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844650|NCT04381650|558861576|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844651|NCT04381650|558861577|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844652|NCT04381650|558861578|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844653|NCT04381650|558861579|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844654|NCT04381650|558861580|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
154844655|NCT04381650|558861581|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
154844656|NCT04381650|558861582|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
154844657|NCT04381650|558861583|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
154844658|NCT04381650|558861573|FG000|Phase 2 (Dose Expansion)|Progressive Disease|0|||
154844659|NCT04381650|558861574|FG001|Phase 2 (Dose Expansion)|Progressive Disease|0|||
154844660|NCT04381650|558861575|FG002|Phase 2 (Dose Expansion)|Progressive Disease|0|||
154844661|NCT04381650|558861576|FG003|Phase 2 (Dose Expansion)|Progressive Disease|0|||
154844662|NCT04381650|558861577|FG004|Phase 2 (Dose Expansion)|Progressive Disease|2|||
154844663|NCT04381650|558861578|FG005|Phase 2 (Dose Expansion)|Progressive Disease|1|||
154844664|NCT04381650|558861579|FG006|Phase 2 (Dose Expansion)|Progressive Disease|0|||
154844665|NCT04381650|558861580|FG007|Phase 2 (Dose Expansion)|Progressive Disease|3|||
154844666|NCT04381650|558861581|FG008|Phase 2 (Dose Expansion)|Progressive Disease|3|||
154844667|NCT04381650|558861582|FG009|Phase 2 (Dose Expansion)|Progressive Disease|4|||
154844668|NCT04381650|558861583|FG010|Phase 2 (Dose Expansion)|Progressive Disease|2|||
154844669|NCT04381650|558861573|FG000|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
154844670|NCT04381650|558861574|FG001|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
154844671|NCT04381650|558861575|FG002|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
154844672|NCT04381650|558861576|FG003|Phase 2 (Dose Expansion)|Withdrawal by Subject|0|||
154844673|NCT04381650|558861577|FG004|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
154844674|NCT04381650|558861578|FG005|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
154844675|NCT04381650|558861579|FG006|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
154844676|NCT04381650|558861580|FG007|Phase 2 (Dose Expansion)|Withdrawal by Subject|2|||
154844677|NCT04381650|558861581|FG008|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
154844678|NCT04381650|558861582|FG009|Phase 2 (Dose Expansion)|Withdrawal by Subject|4|||
154844679|NCT04381650|558861583|FG010|Phase 2 (Dose Expansion)|Withdrawal by Subject|1|||
154844680|NCT04381650|558861573|FG000|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844681|NCT04381650|558861574|FG001|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844682|NCT04381650|558861575|FG002|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844683|NCT04381650|558861576|FG003|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844684|NCT04381650|558861577|FG004|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844685|NCT04381650|558861578|FG005|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844686|NCT04381650|558861579|FG006|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844687|NCT04381650|558861580|FG007|Phase 2 (Dose Expansion)|Reason Not Specified|1|||
154844688|NCT04381650|558861581|FG008|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844689|NCT04381650|558861582|FG009|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844690|NCT04381650|558861583|FG010|Phase 2 (Dose Expansion)|Reason Not Specified|0|||
154844691|NCT05593016|558862970|FG000|Overall Study|Death|1|||
154844692|NCT05593016|558862971|FG001|Overall Study|Death|1|||
154844693|NCT05593016|558862972|FG002|Overall Study|Death|1|||
154844694|NCT05593016|558862973|FG003|Overall Study|Death|0|||
154844695|NCT05593016|558862974|FG004|Overall Study|Death|0|||
154844696|NCT05593016|558862970|FG000|Overall Study|Lost to Follow-up|1|||
154844697|NCT05593016|558862971|FG001|Overall Study|Lost to Follow-up|1|||
154844698|NCT05593016|558862972|FG002|Overall Study|Lost to Follow-up|1|||
154844699|NCT05593016|558862973|FG003|Overall Study|Lost to Follow-up|2|||
154844700|NCT05593016|558862974|FG004|Overall Study|Lost to Follow-up|0|||
154844701|NCT04705051|558862975|FG000|Overall Study|Enrolled but not treated|1|||
154844702|NCT04705051|558862975|FG000|Overall Study|Study terminated by sponsor|23|||
154844703|NCT00482014|558862976|FG000|Overall Study|Withdrawal by Subject|1|||
154844704|NCT00482014|558862977|FG001|Overall Study|Withdrawal by Subject|2|||
154844705|NCT00482014|558862978|FG002|Overall Study|Withdrawal by Subject|3|||
154844706|NCT00482014|558862979|FG003|Overall Study|Withdrawal by Subject|4|||
154844707|NCT00482014|558862976|FG000|Overall Study|Adverse Event|3|||
154844708|NCT00482014|558862977|FG001|Overall Study|Adverse Event|0|||
154844709|NCT00482014|558862978|FG002|Overall Study|Adverse Event|2|||
154844710|NCT00482014|558862979|FG003|Overall Study|Adverse Event|8|||
154844711|NCT00482014|558862976|FG000|Overall Study|Death|1|||
154844712|NCT00482014|558862977|FG001|Overall Study|Death|2|||
154844713|NCT00482014|558862978|FG002|Overall Study|Death|1|||
154844714|NCT00482014|558862979|FG003|Overall Study|Death|4|||
154844715|NCT00482014|558862976|FG000|Overall Study|Lack of Efficacy|1|||
154844716|NCT00482014|558862977|FG001|Overall Study|Lack of Efficacy|0|||
154844717|NCT00482014|558862978|FG002|Overall Study|Lack of Efficacy|4|||
154844718|NCT00482014|558862979|FG003|Overall Study|Lack of Efficacy|6|||
154844719|NCT00482014|558862976|FG000|Overall Study|Sponsor Decision|1|||
154844720|NCT00482014|558862977|FG001|Overall Study|Sponsor Decision|2|||
154844721|NCT00482014|558862978|FG002|Overall Study|Sponsor Decision|1|||
154844722|NCT00482014|558862979|FG003|Overall Study|Sponsor Decision|1|||
154844723|NCT03686397|558862980|FG000|Overall Study|Lack of Efficacy|3|||
154844724|NCT03686397|558862981|FG001|Overall Study|Lack of Efficacy|5|||
154844725|NCT03686397|558862980|FG000|Overall Study|Adverse Event|0|||
154844726|NCT03686397|558862981|FG001|Overall Study|Adverse Event|1|||
154844727|NCT03686397|558862980|FG000|Overall Study|Protocol Violation|0|||
154844728|NCT03686397|558862981|FG001|Overall Study|Protocol Violation|1|||
154844729|NCT03686397|558862980|FG000|Overall Study|Withdrawal by Subject|0|||
154844730|NCT03686397|558862981|FG001|Overall Study|Withdrawal by Subject|1|||
154844731|NCT03686397|558862980|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
154844732|NCT03686397|558862981|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
154844733|NCT01790503|558862984|FG000|Overall Study|Adverse Event|1|||
154971216|NCT02846883|559318566|FG002|Overall Study|Withdrawal by Subject|0|||
155105008|NCT00861757|559815473|FG002|Overall Study|Lost to Follow-up|1|||
154844734|NCT01790503|558862985|FG001|Overall Study|Adverse Event|0|||
154844735|NCT01790503|558862986|FG002|Overall Study|Adverse Event|0|||
154844736|NCT01790503|558862987|FG003|Overall Study|Adverse Event|0|||
154844737|NCT01790503|558862988|FG004|Overall Study|Adverse Event|0|||
154844738|NCT01790503|558862989|FG005|Overall Study|Adverse Event|2|||
154844739|NCT01790503|558862990|FG006|Overall Study|Adverse Event|0|||
154844740|NCT01790503|558862991|FG007|Overall Study|Adverse Event|0|||
154844741|NCT01790503|558862992|FG008|Overall Study|Adverse Event|2|||
154844742|NCT01790503|558862993|FG009|Overall Study|Adverse Event|4|||
154844743|NCT01790503|558862994|FG010|Overall Study|Adverse Event|7|||
154844744|NCT01790503|558862984|FG000|Overall Study|Withdrawal by Subject|0|||
154844745|NCT01790503|558862985|FG001|Overall Study|Withdrawal by Subject|0|||
154844746|NCT01790503|558862986|FG002|Overall Study|Withdrawal by Subject|1|||
154844747|NCT01790503|558862987|FG003|Overall Study|Withdrawal by Subject|1|||
154844748|NCT01790503|558862988|FG004|Overall Study|Withdrawal by Subject|1|||
154844749|NCT01790503|558862989|FG005|Overall Study|Withdrawal by Subject|2|||
154844750|NCT01790503|558862990|FG006|Overall Study|Withdrawal by Subject|1|||
154844751|NCT01790503|558862991|FG007|Overall Study|Withdrawal by Subject|0|||
154844752|NCT01790503|558862992|FG008|Overall Study|Withdrawal by Subject|0|||
154844753|NCT01790503|558862993|FG009|Overall Study|Withdrawal by Subject|0|||
154844754|NCT01790503|558862994|FG010|Overall Study|Withdrawal by Subject|1|||
154844755|NCT01790503|558862984|FG000|Overall Study|Disease progression|2|||
154844756|NCT01790503|558862985|FG001|Overall Study|Disease progression|1|||
154844757|NCT01790503|558862986|FG002|Overall Study|Disease progression|0|||
154844758|NCT01790503|558862987|FG003|Overall Study|Disease progression|1|||
154844759|NCT01790503|558862988|FG004|Overall Study|Disease progression|2|||
154844760|NCT01790503|558862989|FG005|Overall Study|Disease progression|1|||
154844761|NCT01790503|558862990|FG006|Overall Study|Disease progression|0|||
154844762|NCT01790503|558862991|FG007|Overall Study|Disease progression|1|||
154844763|NCT01790503|558862992|FG008|Overall Study|Disease progression|0|||
154844764|NCT01790503|558862993|FG009|Overall Study|Disease progression|17|||
154844765|NCT01790503|558862994|FG010|Overall Study|Disease progression|7|||
154844766|NCT01790503|558862984|FG000|Overall Study|Protocol Violation|0|||
154844767|NCT01790503|558862985|FG001|Overall Study|Protocol Violation|0|||
154844768|NCT01790503|558862986|FG002|Overall Study|Protocol Violation|0|||
154844769|NCT01790503|558862987|FG003|Overall Study|Protocol Violation|0|||
154844770|NCT01790503|558862988|FG004|Overall Study|Protocol Violation|0|||
154844771|NCT01790503|558862989|FG005|Overall Study|Protocol Violation|0|||
154844772|NCT01790503|558862990|FG006|Overall Study|Protocol Violation|0|||
154844773|NCT01790503|558862991|FG007|Overall Study|Protocol Violation|0|||
154844774|NCT01790503|558862992|FG008|Overall Study|Protocol Violation|0|||
154844775|NCT01790503|558862993|FG009|Overall Study|Protocol Violation|1|||
154844776|NCT01790503|558862994|FG010|Overall Study|Protocol Violation|0|||
154844777|NCT01790503|558862984|FG000|Overall Study|Physician Decision|0|||
154844778|NCT01790503|558862985|FG001|Overall Study|Physician Decision|0|||
154844779|NCT01790503|558862986|FG002|Overall Study|Physician Decision|0|||
154844780|NCT01790503|558862987|FG003|Overall Study|Physician Decision|0|||
154844781|NCT01790503|558862988|FG004|Overall Study|Physician Decision|0|||
154844782|NCT01790503|558862989|FG005|Overall Study|Physician Decision|0|||
154844783|NCT01790503|558862990|FG006|Overall Study|Physician Decision|0|||
154844784|NCT01790503|558862991|FG007|Overall Study|Physician Decision|0|||
154844785|NCT01790503|558862992|FG008|Overall Study|Physician Decision|0|||
154844786|NCT01790503|558862993|FG009|Overall Study|Physician Decision|1|||
154844787|NCT01790503|558862994|FG010|Overall Study|Physician Decision|1|||
154844788|NCT01790503|558862984|FG000|Overall Study|Death|0|||
154844789|NCT01790503|558862985|FG001|Overall Study|Death|0|||
154844790|NCT01790503|558862986|FG002|Overall Study|Death|0|||
154844791|NCT01790503|558862987|FG003|Overall Study|Death|0|||
154844792|NCT01790503|558862988|FG004|Overall Study|Death|0|||
154844793|NCT01790503|558862989|FG005|Overall Study|Death|0|||
154844794|NCT01790503|558862990|FG006|Overall Study|Death|0|||
154844795|NCT01790503|558862991|FG007|Overall Study|Death|0|||
154844796|NCT01790503|558862992|FG008|Overall Study|Death|0|||
154844797|NCT01790503|558862993|FG009|Overall Study|Death|1|||
154844798|NCT01790503|558862994|FG010|Overall Study|Death|0|||
154844799|NCT01790503|558862984|FG000|Overall Study|Non Compliance|0|||
154971217|NCT02846883|559318564|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
155173544|NCT01604278|560074816|FG000|Overall Study|Withdrawal by Subject|3|||
154844800|NCT01790503|558862985|FG001|Overall Study|Non Compliance|0|||
154844801|NCT01790503|558862986|FG002|Overall Study|Non Compliance|0|||
154844802|NCT01790503|558862987|FG003|Overall Study|Non Compliance|0|||
154844803|NCT01790503|558862988|FG004|Overall Study|Non Compliance|1|||
154844804|NCT01790503|558862989|FG005|Overall Study|Non Compliance|0|||
154844805|NCT01790503|558862990|FG006|Overall Study|Non Compliance|0|||
154844806|NCT01790503|558862991|FG007|Overall Study|Non Compliance|0|||
154844807|NCT01790503|558862992|FG008|Overall Study|Non Compliance|0|||
154844808|NCT01790503|558862993|FG009|Overall Study|Non Compliance|0|||
154844809|NCT01790503|558862994|FG010|Overall Study|Non Compliance|0|||
154844810|NCT01790503|558862984|FG000|Overall Study|Other|0|||
154844811|NCT01790503|558862985|FG001|Overall Study|Other|0|||
154844812|NCT01790503|558862986|FG002|Overall Study|Other|0|||
154844813|NCT01790503|558862987|FG003|Overall Study|Other|0|||
154844814|NCT01790503|558862988|FG004|Overall Study|Other|1|||
154844815|NCT01790503|558862989|FG005|Overall Study|Other|0|||
154844816|NCT01790503|558862990|FG006|Overall Study|Other|0|||
154844817|NCT01790503|558862991|FG007|Overall Study|Other|0|||
154844818|NCT01790503|558862992|FG008|Overall Study|Other|1|||
154844819|NCT01790503|558862993|FG009|Overall Study|Other|2|||
154844820|NCT01790503|558862994|FG010|Overall Study|Other|0|||
154844821|NCT04161131|558862999|FG000|Overall Study|Ineligible|2|||
154844822|NCT04161131|558862999|FG000|Overall Study|Lost to Follow-up|4|||
154844823|NCT03733392|558863000|FG000|Overall Study|Withdrawal by Subject|11|||
154844824|NCT03733392|558863001|FG001|Overall Study|Withdrawal by Subject|1|||
154844825|NCT03733392|558863000|FG000|Overall Study|Death|1|||
154844826|NCT03733392|558863001|FG001|Overall Study|Death|0|||
154844827|NCT03733392|558863000|FG000|Overall Study|Lost to Follow-up|5|||
154844828|NCT03733392|558863001|FG001|Overall Study|Lost to Follow-up|0|||
154844829|NCT03733392|558863000|FG000|Overall Study|Protocol Violation|0|||
154844830|NCT03733392|558863001|FG001|Overall Study|Protocol Violation|1|||
154844831|NCT03733392|558863000|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
154844832|NCT03733392|558863001|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
154844833|NCT03733392|558863000|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
154844834|NCT03733392|558863001|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
154844835|NCT03733392|558863000|FG000|Overall Study|Patient Non-Compliance|2|||
154844836|NCT03733392|558863001|FG001|Overall Study|Patient Non-Compliance|1|||
154844837|NCT03733392|558863000|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
154844838|NCT03733392|558863001|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
154844839|NCT03733392|558863000|FG000|Overall Study|Withdrawal prior to procedure|5|||
154844840|NCT03733392|558863001|FG001|Overall Study|Withdrawal prior to procedure|2|||
154844841|NCT02740478|558863002|FG000|Overall Study|Withdrawal by Subject|1|||
154844842|NCT04316585|558863003|FG000|Overall Study|Adverse Event|2|||
154844843|NCT04316585|558863004|FG001|Overall Study|Adverse Event|1|||
154844844|NCT04316585|558863003|FG000|Overall Study|Lost to Follow-up|1|||
154844845|NCT04316585|558863004|FG001|Overall Study|Lost to Follow-up|0|||
154844846|NCT04316585|558863003|FG000|Overall Study|Withdrawal by Subject|2|||
154844847|NCT04316585|558863004|FG001|Overall Study|Withdrawal by Subject|3|||
154844848|NCT04316585|558863003|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
154844849|NCT04316585|558863004|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
154844850|NCT04316585|558863003|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
154844851|NCT04316585|558863004|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
154844852|NCT00618748|558863006|FG000|Overall Study|Adverse Event|4|||
154844853|NCT00618748|558863007|FG001|Overall Study|Adverse Event|3|||
154844854|NCT00618748|558863008|FG002|Overall Study|Adverse Event|8|||
154844855|NCT00618748|558863006|FG000|Overall Study|Physician Decision|3|||
154844856|NCT00618748|558863007|FG001|Overall Study|Physician Decision|1|||
154844857|NCT00618748|558863008|FG002|Overall Study|Physician Decision|1|||
154844858|NCT00618748|558863006|FG000|Overall Study|Withdrawal by Subject|4|||
154844859|NCT00618748|558863007|FG001|Overall Study|Withdrawal by Subject|1|||
154844860|NCT00618748|558863008|FG002|Overall Study|Withdrawal by Subject|5|||
154844861|NCT03269344|558863009|FG000|Overall Study|Protocol Violation|4|||
154844862|NCT03269344|558863010|FG001|Overall Study|Protocol Violation|3|||
154844863|NCT02479802|558863015|FG000|Overall Study|Lost to Follow-up|1|||
154844864|NCT02479802|558863015|FG000|Overall Study|Adverse Event|1|||
154844865|NCT03124784|558863020|FG000|Overall Study|Adverse Event|1|||
154844866|NCT03124784|558863020|FG000|Overall Study|Computer/Equip Malfunction|1|||
154844867|NCT05702515|558863021|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
154844868|NCT02162732|558863022|FG000|Overall Study|Biopsy not performed.|18|||
154844869|NCT01784965|558863023|FG000|Overall Study|Withdrawal by Subject|6|||
154844870|NCT01784965|558863024|FG001|Overall Study|Withdrawal by Subject|3|||
154844871|NCT01784965|558863023|FG000|Overall Study|Adverse Event|0|||
154844872|NCT01784965|558863024|FG001|Overall Study|Adverse Event|8|||
154844873|NCT03757988|558863027|FG000|Overall Study|Withdrawal by Subject|1|||
155105009|NCT00861757|559815474|FG003|Overall Study|Lost to Follow-up|1|||
155105010|NCT00861757|559815471|FG000|Overall Study|Physician Decision|0|||
155105011|NCT00861757|559815472|FG001|Overall Study|Physician Decision|0|||
155105012|NCT00861757|559815473|FG002|Overall Study|Physician Decision|0|||
154844874|NCT05289830|558863028|FG000|Overall Study|Lost to Follow-up|1|||
154844875|NCT05289830|558863029|FG001|Overall Study|Lost to Follow-up|1|||
154844876|NCT05289830|558863028|FG000|Overall Study|Physician Decision|0|||
154844877|NCT05289830|558863029|FG001|Overall Study|Physician Decision|1|||
154844878|NCT02847624|558863030|FG000|Overall Study|Lost to Follow-up|28|||
154844879|NCT02847624|558863030|FG000|Overall Study|Protocol Violation|98|||
154844880|NCT02847624|558863030|FG000|Overall Study|Case report failures|4|||
154844881|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
154844882|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
154844883|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
154844884|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
154844885|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154844886|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154844887|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
154844888|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154844889|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
154844890|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154844891|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154844892|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154844893|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
154844894|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
154844895|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
154844896|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
154844897|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
154844898|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
154844899|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
154844900|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
154844901|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
154844902|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
154844903|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
154844904|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
154844905|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
154844906|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
154844907|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
154844908|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
154844909|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
154844910|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
154844911|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
154844912|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
154844913|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
154844914|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
154844915|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
154844916|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
154844917|NCT03403205|558863039|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
154844918|NCT03403205|558863040|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
154844919|NCT03403205|558863041|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
154844920|NCT03403205|558863042|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
154844921|NCT03403205|558863043|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
154844922|NCT03403205|558863044|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
154844923|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
154844924|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
154844925|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
154844926|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
154844927|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
154844928|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
154844929|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
154844930|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
154844931|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
154844932|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
154844933|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
154844934|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
154844935|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Death|1|||
154844936|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Death|0|||
154844937|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Death|0|||
154844938|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Death|0|||
154844939|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Death|0|||
154844940|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Death|0|||
154844941|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
154844942|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
154844943|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
154844944|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
154844945|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
154844946|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
154844947|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
154971218|NCT02846883|559318565|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
155105013|NCT00861757|559815474|FG003|Overall Study|Physician Decision|1|||
155105014|NCT00861757|559815471|FG000|Overall Study|Protocol Violation|2|||
154844948|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
154844949|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
154844950|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
154844951|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
154844952|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
154844953|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
154844954|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
154844955|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
154844956|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
154844957|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
154844958|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
154844959|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
154844960|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
154844961|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
154844962|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
154844963|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
154844964|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
154844965|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
154844966|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
154844967|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
154844968|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
154844969|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
154844970|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
154844971|NCT03403205|558863039|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
154844972|NCT03403205|558863040|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
154844973|NCT03403205|558863041|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
154844974|NCT03403205|558863042|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
154844975|NCT03403205|558863043|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
154844976|NCT03403205|558863044|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
154844977|NCT00706030|558863045|FG000|Overall Study|Disease Progression|4|||
154844978|NCT00706030|558863046|FG001|Overall Study|Disease Progression|6|||
154844979|NCT00706030|558863047|FG002|Overall Study|Disease Progression|46|||
154844980|NCT00706030|558863048|FG003|Overall Study|Disease Progression|12|||
154844981|NCT00706030|558863045|FG000|Overall Study|Adverse Event|1|||
154844982|NCT00706030|558863046|FG001|Overall Study|Adverse Event|0|||
154844983|NCT00706030|558863047|FG002|Overall Study|Adverse Event|4|||
154844984|NCT00706030|558863048|FG003|Overall Study|Adverse Event|2|||
154844985|NCT00706030|558863045|FG000|Overall Study|Withdrawal by Subject|1|||
154844986|NCT00706030|558863046|FG001|Overall Study|Withdrawal by Subject|0|||
154844987|NCT00706030|558863047|FG002|Overall Study|Withdrawal by Subject|2|||
154844988|NCT00706030|558863048|FG003|Overall Study|Withdrawal by Subject|0|||
154844989|NCT00706030|558863045|FG000|Overall Study|Physician Decision|0|||
154844990|NCT00706030|558863046|FG001|Overall Study|Physician Decision|0|||
154844991|NCT00706030|558863047|FG002|Overall Study|Physician Decision|2|||
154844992|NCT00706030|558863048|FG003|Overall Study|Physician Decision|0|||
154844993|NCT00706030|558863045|FG000|Overall Study|Not recorded|0|||
154844994|NCT00706030|558863046|FG001|Overall Study|Not recorded|0|||
154844995|NCT00706030|558863047|FG002|Overall Study|Not recorded|2|||
154844996|NCT00706030|558863048|FG003|Overall Study|Not recorded|0|||
154844997|NCT00706030|558863045|FG000|Overall Study|Protocol Violation|0|||
154844998|NCT00706030|558863046|FG001|Overall Study|Protocol Violation|0|||
154844999|NCT00706030|558863047|FG002|Overall Study|Protocol Violation|1|||
154845000|NCT00706030|558863048|FG003|Overall Study|Protocol Violation|1|||
154845001|NCT00706030|558863045|FG000|Overall Study|Failed to return|0|||
154845002|NCT00706030|558863046|FG001|Overall Study|Failed to return|0|||
154845003|NCT00706030|558863047|FG002|Overall Study|Failed to return|1|||
154845004|NCT00706030|558863048|FG003|Overall Study|Failed to return|0|||
154845005|NCT00706030|558863045|FG000|Overall Study|Symptomatic Deterioration|0|||
154845006|NCT00706030|558863046|FG001|Overall Study|Symptomatic Deterioration|0|||
154845007|NCT00706030|558863047|FG002|Overall Study|Symptomatic Deterioration|1|||
154845008|NCT00706030|558863048|FG003|Overall Study|Symptomatic Deterioration|0|||
154845009|NCT00706030|558863045|FG000|Overall Study|No treatment received|0|||
154845010|NCT00706030|558863046|FG001|Overall Study|No treatment received|0|||
154845011|NCT00706030|558863047|FG002|Overall Study|No treatment received|0|||
154845012|NCT00706030|558863048|FG003|Overall Study|No treatment received|1|||
154845013|NCT00706030|558863045|FG000|Overall Study|Death|0|||
154845014|NCT00706030|558863046|FG001|Overall Study|Death|0|||
154845015|NCT00706030|558863047|FG002|Overall Study|Death|1|||
154845016|NCT00706030|558863048|FG003|Overall Study|Death|0|||
154845017|NCT05779072|558863049|FG000|Overall Study|Lost to Follow-up|0|||
155105015|NCT00861757|559815472|FG001|Overall Study|Protocol Violation|2|||
154845018|NCT05779072|558863050|FG001|Overall Study|Lost to Follow-up|1|||
154845019|NCT05779072|558863049|FG000|Overall Study|Withdrawal by Subject|1|||
154845020|NCT05779072|558863050|FG001|Overall Study|Withdrawal by Subject|5|||
154845021|NCT03847610|558863051|FG000|Overall Study|Withdrawal by Subject|1|||
154845022|NCT02004873|558863052|FG000|Overall Study|Implant unsuccessful|6|||
154845023|NCT02004873|558863052|FG000|Overall Study|Awaiting 6-month visit|390|||
154845024|NCT02004873|558863052|FG000|Overall Study|Missed 6-month visit|4|||
154845025|NCT02004873|558863052|FG000|Overall Study|Death|23|||
154845026|NCT02004873|558863052|FG000|Overall Study|Withdrawal by Subject|1|||
154845027|NCT01445769|558863053|FG000|Overall Study|Consent Withdrawn|2|||
154845028|NCT01445769|558863053|FG000|Overall Study|Disease Progression|1|||
154845029|NCT01445769|558863053|FG000|Overall Study|Lost to Follow-up|5|||
154845030|NCT02799069|558863056|FG000|Overall Study|Adverse Event|0|||
154845031|NCT02799069|558863057|FG001|Overall Study|Adverse Event|2|||
154845032|NCT02799069|558863058|FG002|Overall Study|Adverse Event|2|||
154845033|NCT02799069|558863056|FG000|Overall Study|Lack of Efficacy|2|||
154845034|NCT02799069|558863057|FG001|Overall Study|Lack of Efficacy|0|||
154845035|NCT02799069|558863058|FG002|Overall Study|Lack of Efficacy|0|||
154845036|NCT02799069|558863056|FG000|Overall Study|Lost to Follow-up|1|||
154845037|NCT02799069|558863057|FG001|Overall Study|Lost to Follow-up|1|||
154845038|NCT02799069|558863058|FG002|Overall Study|Lost to Follow-up|0|||
154845039|NCT02799069|558863056|FG000|Overall Study|Withdrawal by Subject|4|||
154845040|NCT02799069|558863057|FG001|Overall Study|Withdrawal by Subject|4|||
154845041|NCT02799069|558863058|FG002|Overall Study|Withdrawal by Subject|3|||
154845042|NCT02799069|558863056|FG000|Overall Study|Protocol Violation|1|||
154845043|NCT02799069|558863057|FG001|Overall Study|Protocol Violation|0|||
154845044|NCT02799069|558863058|FG002|Overall Study|Protocol Violation|2|||
154845045|NCT03212170|558863067|FG000|Overall Study|Withdrawal by Subject|1|||
154845046|NCT02678390|558863069|FG000|AE (1 Day)|Withdrawal by Subject|0|||
154845047|NCT02678390|558863070|FG001|AE (1 Day)|Withdrawal by Subject|1|||
154845048|NCT02925156|558863071|FG000|Overall Study|Lost to Follow-up|27|||
154845049|NCT02925156|558863072|FG001|Overall Study|Lost to Follow-up|53|||
154845050|NCT02925156|558863073|FG002|Overall Study|Lost to Follow-up|51|||
154845051|NCT02925156|558863074|FG003|Overall Study|Lost to Follow-up|59|||
154845052|NCT02925156|558863075|FG004|Overall Study|Lost to Follow-up|89|||
154845053|NCT02925156|558863076|FG005|Overall Study|Lost to Follow-up|107|||
154845054|NCT02925156|558863077|FG006|Overall Study|Lost to Follow-up|34|||
154845055|NCT02925156|558863078|FG007|Overall Study|Lost to Follow-up|36|||
154845056|NCT02925156|558863079|FG008|Overall Study|Lost to Follow-up|73|||
154845057|NCT02925156|558863080|FG009|Overall Study|Lost to Follow-up|34|||
154845058|NCT01681433|558863083|FG000|Overall Study|Lack of Efficacy|23|||
154845059|NCT01681433|558863084|FG001|Overall Study|Lack of Efficacy|23|||
154845060|NCT01681433|558863083|FG000|Overall Study|Withdrawal by Subject|5|||
154845061|NCT01681433|558863084|FG001|Overall Study|Withdrawal by Subject|5|||
154845062|NCT01681433|558863083|FG000|Overall Study|Protocol Violation|2|||
154845063|NCT01681433|558863084|FG001|Overall Study|Protocol Violation|0|||
154845064|NCT01681433|558863083|FG000|Overall Study|Adverse Event|2|||
154845065|NCT01681433|558863084|FG001|Overall Study|Adverse Event|4|||
154845066|NCT01681433|558863083|FG000|Overall Study|Lost to Follow-up|0|||
154845067|NCT01681433|558863084|FG001|Overall Study|Lost to Follow-up|1|||
154845068|NCT00730639|558863085|FG000|Overall Study|Adverse Event|3|||
154845069|NCT00730639|558863086|FG001|Overall Study|Adverse Event|0|||
154845070|NCT00730639|558863087|FG002|Overall Study|Adverse Event|9|||
154845071|NCT00730639|558863088|FG003|Overall Study|Adverse Event|8|||
154845072|NCT00730639|558863089|FG004|Overall Study|Adverse Event|23|||
154845073|NCT00730639|558863085|FG000|Overall Study|Complete Response|0|||
154845074|NCT00730639|558863086|FG001|Overall Study|Complete Response|0|||
154845075|NCT00730639|558863087|FG002|Overall Study|Complete Response|2|||
154845076|NCT00730639|558863088|FG003|Overall Study|Complete Response|2|||
154845077|NCT00730639|558863089|FG004|Overall Study|Complete Response|1|||
154845078|NCT00730639|558863085|FG000|Overall Study|Completed Maximum Cycles|0|||
154845079|NCT00730639|558863086|FG001|Overall Study|Completed Maximum Cycles|0|||
154845080|NCT00730639|558863087|FG002|Overall Study|Completed Maximum Cycles|11|||
154845081|NCT00730639|558863088|FG003|Overall Study|Completed Maximum Cycles|3|||
154845082|NCT00730639|558863089|FG004|Overall Study|Completed Maximum Cycles|6|||
154845083|NCT00730639|558863085|FG000|Overall Study|Death|0|||
154845084|NCT00730639|558863086|FG001|Overall Study|Death|0|||
154845085|NCT00730639|558863087|FG002|Overall Study|Death|0|||
154845086|NCT00730639|558863088|FG003|Overall Study|Death|0|||
154845087|NCT00730639|558863089|FG004|Overall Study|Death|2|||
154845088|NCT00730639|558863085|FG000|Overall Study|Disease Progression|12|||
154845089|NCT00730639|558863086|FG001|Overall Study|Disease Progression|13|||
154845090|NCT00730639|558863087|FG002|Overall Study|Disease Progression|48|||
154845091|NCT00730639|558863088|FG003|Overall Study|Disease Progression|32|||
154845092|NCT00730639|558863089|FG004|Overall Study|Disease Progression|88|||
154845093|NCT00730639|558863085|FG000|Overall Study|non-specified|0|||
154845094|NCT00730639|558863086|FG001|Overall Study|non-specified|0|||
154845095|NCT00730639|558863087|FG002|Overall Study|non-specified|4|||
154845096|NCT00730639|558863088|FG003|Overall Study|non-specified|2|||
154845097|NCT00730639|558863089|FG004|Overall Study|non-specified|3|||
154845098|NCT00730639|558863085|FG000|Overall Study|Protocol Violation|0|||
154845099|NCT00730639|558863086|FG001|Overall Study|Protocol Violation|0|||
154845100|NCT00730639|558863087|FG002|Overall Study|Protocol Violation|1|||
154845101|NCT00730639|558863088|FG003|Overall Study|Protocol Violation|0|||
154845102|NCT00730639|558863089|FG004|Overall Study|Protocol Violation|0|||
154845103|NCT00730639|558863085|FG000|Overall Study|Withdrawal by Subject|0|||
154845104|NCT00730639|558863086|FG001|Overall Study|Withdrawal by Subject|0|||
154845105|NCT00730639|558863087|FG002|Overall Study|Withdrawal by Subject|6|||
154845106|NCT00730639|558863088|FG003|Overall Study|Withdrawal by Subject|3|||
154845107|NCT00730639|558863089|FG004|Overall Study|Withdrawal by Subject|4|||
154845108|NCT00730639|558863085|FG000|Overall Study|Treatment on-going|2|||
154845109|NCT00730639|558863086|FG001|Overall Study|Treatment on-going|5|||
154845110|NCT00730639|558863087|FG002|Overall Study|Treatment on-going|5|||
154845111|NCT00730639|558863088|FG003|Overall Study|Treatment on-going|4|||
154845112|NCT00730639|558863089|FG004|Overall Study|Treatment on-going|4|||
154845113|NCT01632566|558863090|FG000|Overall Study|Withdrawal by Subject|0|||
154845114|NCT01632566|558863091|FG001|Overall Study|Withdrawal by Subject|1|||
154845115|NCT01632566|558863092|FG002|Overall Study|Withdrawal by Subject|0|||
154845116|NCT01632566|558863093|FG003|Overall Study|Withdrawal by Subject|0|||
154845117|NCT01632566|558863094|FG004|Overall Study|Withdrawal by Subject|0|||
154845118|NCT01632566|558863090|FG000|Overall Study|Sponsor Decision|0|||
154845119|NCT01632566|558863091|FG001|Overall Study|Sponsor Decision|2|||
154845120|NCT01632566|558863092|FG002|Overall Study|Sponsor Decision|9|||
154845121|NCT01632566|558863093|FG003|Overall Study|Sponsor Decision|2|||
154845122|NCT01632566|558863094|FG004|Overall Study|Sponsor Decision|2|||
154845123|NCT03208231|558863095|FG000|Overall Study|Death|1|||
154845124|NCT03208231|558863096|FG001|Overall Study|Death|2|||
154845125|NCT03208231|558863095|FG000|Overall Study|Moved and unable to get to clinic|1|||
154845126|NCT03208231|558863096|FG001|Overall Study|Moved and unable to get to clinic|0|||
154845127|NCT03208231|558863095|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
154845128|NCT03208231|558863096|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
154845129|NCT04982250|558863102|FG000|Overall Study|Lost to Follow-up|0|||
154845130|NCT04982250|558863103|FG001|Overall Study|Lost to Follow-up|26|||
154845131|NCT04982250|558863104|FG002|Overall Study|Lost to Follow-up|0|||
154845132|NCT04982250|558863105|FG003|Overall Study|Lost to Follow-up|0|||
154845133|NCT04982250|558863106|FG004|Overall Study|Lost to Follow-up|72|||
154845134|NCT04982250|558863107|FG005|Overall Study|Lost to Follow-up|69|||
154845135|NCT04982250|558863102|FG000|Overall Study|Not Eligible to Enroll|0|||
154845136|NCT04982250|558863103|FG001|Overall Study|Not Eligible to Enroll|0|||
154845137|NCT04982250|558863104|FG002|Overall Study|Not Eligible to Enroll|0|||
154845138|NCT04982250|558863105|FG003|Overall Study|Not Eligible to Enroll|0|||
154845139|NCT04982250|558863106|FG004|Overall Study|Not Eligible to Enroll|10|||
154845140|NCT04982250|558863107|FG005|Overall Study|Not Eligible to Enroll|7|||
154845141|NCT02289950|558863110|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
155105016|NCT00861757|559815473|FG002|Overall Study|Protocol Violation|4|||
154845142|NCT02289950|558863111|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
154845143|NCT02289950|558863110|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
154845144|NCT02289950|558863111|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
154845145|NCT02289950|558863110|FG000|Overall Study|Lost to Follow-up|1|||
154845146|NCT02289950|558863111|FG001|Overall Study|Lost to Follow-up|0|||
154845147|NCT02289950|558863110|FG000|Overall Study|Physician Decision|9|||
154845148|NCT02289950|558863111|FG001|Overall Study|Physician Decision|3|||
154845149|NCT02289950|558863110|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
154845150|NCT02289950|558863111|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
154845151|NCT02289950|558863110|FG000|Overall Study|Withdrawal by Subject|1|||
154845152|NCT02289950|558863111|FG001|Overall Study|Withdrawal by Subject|3|||
154845153|NCT02289950|558863110|FG000|Overall Study|Test article held for greater than 28 days|0|||
154845154|NCT02289950|558863111|FG001|Overall Study|Test article held for greater than 28 days|1|||
154845155|NCT02289950|558863110|FG000|Overall Study|Adverse Event|11|||
154845156|NCT02289950|558863111|FG001|Overall Study|Adverse Event|3|||
154845157|NCT02289950|558863110|FG000|Overall Study|Death|1|||
154845158|NCT02289950|558863111|FG001|Overall Study|Death|1|||
154845159|NCT02289950|558863110|FG000|Overall Study|Other|5|||
155105017|NCT00861757|559815474|FG003|Overall Study|Protocol Violation|1|||
155105018|NCT00861757|559815471|FG000|Overall Study|Withdrawal by Subject|1|||
155105019|NCT00861757|559815472|FG001|Overall Study|Withdrawal by Subject|5|||
154845160|NCT02289950|558863111|FG001|Overall Study|Other|2|||
154845161|NCT02289950|558863110|FG000|Overall Study|Not Treated|2|||
155105020|NCT00861757|559815473|FG002|Overall Study|Withdrawal by Subject|5|||
154845162|NCT02289950|558863111|FG001|Overall Study|Not Treated|1|||
155105021|NCT00861757|559815474|FG003|Overall Study|Withdrawal by Subject|2|||
154845163|NCT04518462|558863112|FG000|Overall Study|Withdrawal by Subject|0|||
155105022|NCT00391053|559815483|FG000|Overall Study|Serious Adverse Events|1|||
154845164|NCT04518462|558863113|FG001|Overall Study|Withdrawal by Subject|0|||
154845165|NCT04518462|558863114|FG002|Overall Study|Withdrawal by Subject|1|||
154845166|NCT04518462|558863112|FG000|Overall Study|Physician Decision|1|||
154845167|NCT04518462|558863113|FG001|Overall Study|Physician Decision|1|||
155105023|NCT00391053|559815484|FG001|Overall Study|Serious Adverse Events|0|||
154845168|NCT04518462|558863114|FG002|Overall Study|Physician Decision|0|||
154845169|NCT01003210|558863115|FG000|Overall Study|Lost to Follow-up|1|||
154845170|NCT01003210|558863116|FG001|Overall Study|Lost to Follow-up|3|||
154845171|NCT01411085|558863117|FG000|Overall Study|Physician Decision|1|||
154845172|NCT01411085|558863117|FG000|Overall Study|Protocol Violation|1|||
154845173|NCT01411085|558863117|FG000|Overall Study|Adverse Event|1|||
154845174|NCT05036083|558863118|FG000|Overall Study|Physician Decision|1|||
154845175|NCT05036083|558863118|FG000|Overall Study|Withdrawal by Subject|1|||
154845176|NCT05036083|558863118|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
154845177|NCT05036083|558863118|FG000|Overall Study|IV not sustainable|1|||
154845178|NCT04745689|558863119|FG000|Overall Study|Death|9|||
154845179|NCT04745689|558863120|FG001|Overall Study|Death|6|||
154845180|NCT04745689|558863119|FG000|Overall Study|Lost to Follow-up|1|||
154845181|NCT04745689|558863120|FG001|Overall Study|Lost to Follow-up|0|||
154845182|NCT04745689|558863119|FG000|Overall Study|Withdrawal by Subject|2|||
154845183|NCT04745689|558863120|FG001|Overall Study|Withdrawal by Subject|0|||
154845184|NCT04745689|558863119|FG000|Overall Study|Study terminated by sponsor|10|||
154845185|NCT04745689|558863120|FG001|Overall Study|Study terminated by sponsor|3|||
154845186|NCT02553460|558863121|FG000|Overall Study|Death|3|||
154845187|NCT02553460|558863121|FG000|Overall Study|Withdrawal by Subject|1|||
154845188|NCT02553460|558863121|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
154845189|NCT02553460|558863121|FG000|Overall Study|Relapse or Transplant|14|||
154845190|NCT02553460|558863121|FG000|Overall Study|No response to treatment|2|||
154845191|NCT02553460|558863121|FG000|Overall Study|CAR T cells|2|||
154845192|NCT07099521|558863124|FG000|Overall Study|Incompeleted stimulus program|1|||
154845193|NCT07099521|558863125|FG001|Overall Study|Incompeleted stimulus program|0|||
154845194|NCT07099521|558863124|FG000|Overall Study|Non-social anxiety symtpoms|0|||
154845195|NCT07099521|558863125|FG001|Overall Study|Non-social anxiety symtpoms|1|||
154845196|NCT07099521|558863124|FG000|Overall Study|Extreme values|2|||
154845197|NCT07099521|558863125|FG001|Overall Study|Extreme values|4|||
154845198|NCT01178138|558864909|FG000|Overall Study|Lost to Follow-up|8|||
154845199|NCT01178138|558864909|FG000|Overall Study|Withdrawal by Subject|7|||
154845200|NCT01178138|558864909|FG000|Overall Study|Physician Decision|8|||
154845201|NCT02322710|558864911|FG000|Overall Study|No efficacy assessment post-baseline|0|||
154845202|NCT02322710|558864912|FG001|Overall Study|No efficacy assessment post-baseline|1|||
154845203|NCT02322710|558864911|FG000|Overall Study|Protocol Violation|20|||
154845204|NCT02322710|558864912|FG001|Overall Study|Protocol Violation|25|||
154845205|NCT02615990|558864913|FG000|Overall Study|study terminated|1|||
154845206|NCT02615990|558864914|FG001|Overall Study|study terminated|1|||
154845207|NCT00808444|558864921|FG000|Overall Study|Withdrawal by Subject|1|||
154845208|NCT00808444|558864922|FG001|Overall Study|Withdrawal by Subject|0|||
154845209|NCT00808444|558864921|FG000|Overall Study|Lost to Follow-up|0|||
154845210|NCT00808444|558864922|FG001|Overall Study|Lost to Follow-up|1|||
154845211|NCT01461044|558864923|FG000|Overall Study|Death|58|||
154845212|NCT01461044|558864924|FG001|Overall Study|Death|35|||
154845213|NCT01461044|558864923|FG000|Overall Study|Lost to Follow-up|12|||
154845214|NCT01461044|558864924|FG001|Overall Study|Lost to Follow-up|5|||
154845215|NCT04401267|558864925|FG000|Overall Study|Death|0|||
154845216|NCT04401267|558864926|FG001|Overall Study|Death|1|||
154845217|NCT04401267|558864925|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
154845218|NCT04401267|558864926|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
154845219|NCT04401267|558864925|FG000|Overall Study|Found to be Ineligible|1|||
154845220|NCT04401267|558864926|FG001|Overall Study|Found to be Ineligible|0|||
154845221|NCT04294459|558864932|FG000|Overall Study|Adverse Event|0|||
154845222|NCT04294459|558864933|FG001|Overall Study|Adverse Event|1|||
154845223|NCT02787863|558864934|FG000|Overall Study|Death|1|||
154845224|NCT02787863|558864935|FG001|Overall Study|Death|0|||
154845225|NCT02787863|558864936|FG002|Overall Study|Death|1|||
154845226|NCT02787863|558864937|FG003|Overall Study|Death|0|||
154845227|NCT02787863|558864938|FG004|Overall Study|Death|0|||
154845228|NCT02787863|558864939|FG005|Overall Study|Death|0|||
154845229|NCT02787863|558864940|FG006|Overall Study|Death|0|||
154845230|NCT02787863|558864941|FG007|Overall Study|Death|0|||
154845231|NCT02787863|558864934|FG000|Overall Study|Withdrawal by Subject|0|||
155173545|NCT01604278|560074817|FG001|Overall Study|Withdrawal by Subject|3|||
155173546|NCT01604278|560074816|FG000|Overall Study|Adverse Event|3|||
154845232|NCT02787863|558864935|FG001|Overall Study|Withdrawal by Subject|1|||
154845233|NCT02787863|558864936|FG002|Overall Study|Withdrawal by Subject|1|||
154845234|NCT02787863|558864937|FG003|Overall Study|Withdrawal by Subject|0|||
154845235|NCT02787863|558864938|FG004|Overall Study|Withdrawal by Subject|0|||
154845236|NCT02787863|558864939|FG005|Overall Study|Withdrawal by Subject|0|||
154845237|NCT02787863|558864940|FG006|Overall Study|Withdrawal by Subject|0|||
154845238|NCT02787863|558864941|FG007|Overall Study|Withdrawal by Subject|0|||
154845239|NCT02450487|558864942|FG000|Overall Study|Lost to Follow-up|3|||
154845240|NCT04142983|558864944|FG000|Overall Study|Lost to Follow-up|73|||
154845241|NCT04142983|558864944|FG000|Overall Study|Withdrawal by Subject|10|||
154845242|NCT04142983|558864944|FG000|Overall Study|Physician Decision|1|||
155173547|NCT01604278|560074817|FG001|Overall Study|Adverse Event|5|||
154845243|NCT04142983|558864944|FG000|Overall Study|Adverse Event|1|||
155105024|NCT00391053|559815485|FG002|Overall Study|Serious Adverse Events|1|||
155105025|NCT00391053|559815486|FG003|Overall Study|Serious Adverse Events|4|||
155105026|NCT00391053|559815483|FG000|Overall Study|Protocol Violation|2|||
155105027|NCT00391053|559815484|FG001|Overall Study|Protocol Violation|0|||
155105028|NCT00391053|559815485|FG002|Overall Study|Protocol Violation|0|||
154845244|NCT04142983|558864944|FG000|Overall Study|No longer eligible|4|||
154845245|NCT04142983|558864944|FG000|Overall Study|Screen Failure|10|||
154845246|NCT01789970|558864945|FG000|Open-label Titration Period|Adverse Event|68|||
154845247|NCT01789970|558864946|FG001|Open-label Titration Period|Adverse Event|0|||
154845248|NCT01789970|558864947|FG002|Open-label Titration Period|Adverse Event|0|||
154845249|NCT01789970|558864945|FG000|Open-label Titration Period|Lack of Efficacy|31|||
154845250|NCT01789970|558864946|FG001|Open-label Titration Period|Lack of Efficacy|0|||
154845251|NCT01789970|558864947|FG002|Open-label Titration Period|Lack of Efficacy|0|||
154845252|NCT01789970|558864945|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
154845253|NCT01789970|558864946|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
154845254|NCT01789970|558864947|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
154845255|NCT01789970|558864945|FG000|Open-label Titration Period|Protocol Violation|18|||
154845256|NCT01789970|558864946|FG001|Open-label Titration Period|Protocol Violation|0|||
154845257|NCT01789970|558864947|FG002|Open-label Titration Period|Protocol Violation|0|||
154845258|NCT01789970|558864945|FG000|Open-label Titration Period|Lost to Follow-up|5|||
154845259|NCT01789970|558864946|FG001|Open-label Titration Period|Lost to Follow-up|0|||
154845260|NCT01789970|558864947|FG002|Open-label Titration Period|Lost to Follow-up|0|||
154845261|NCT01789970|558864945|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
154845262|NCT01789970|558864946|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
154845263|NCT01789970|558864947|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
154845264|NCT01789970|558864945|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
154845265|NCT01789970|558864946|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
154845266|NCT01789970|558864947|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
154845267|NCT01789970|558864945|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
154845268|NCT01789970|558864946|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
154845269|NCT01789970|558864947|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
154845270|NCT01789970|558864945|FG000|Open-label Titration Period|Pregnancy|2|||
154845271|NCT01789970|558864946|FG001|Open-label Titration Period|Pregnancy|0|||
154845272|NCT01789970|558864947|FG002|Open-label Titration Period|Pregnancy|0|||
154845273|NCT01789970|558864945|FG000|Open-label Titration Period|Other|76|||
154845274|NCT01789970|558864946|FG001|Open-label Titration Period|Other|0|||
154845275|NCT01789970|558864947|FG002|Open-label Titration Period|Other|0|||
154845276|NCT01789970|558864945|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
154845277|NCT01789970|558864946|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
154845278|NCT01789970|558864947|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
154845279|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
154845280|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
154845281|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
154845282|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
154845283|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
154845284|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
154845285|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
154845286|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
154845287|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
154845288|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
154845289|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
154845290|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
154845291|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
154845292|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
155105029|NCT00391053|559815486|FG003|Overall Study|Protocol Violation|0|||
155105030|NCT00391053|559815483|FG000|Overall Study|Lost to Follow-up|1|||
155105031|NCT00391053|559815484|FG001|Overall Study|Lost to Follow-up|0|||
155105032|NCT00391053|559815485|FG002|Overall Study|Lost to Follow-up|0|||
155105033|NCT00391053|559815486|FG003|Overall Study|Lost to Follow-up|5|||
155105034|NCT00391053|559815483|FG000|Overall Study|Withdrawal by Subject|5|||
155105035|NCT00391053|559815484|FG001|Overall Study|Withdrawal by Subject|1|||
155105036|NCT00391053|559815485|FG002|Overall Study|Withdrawal by Subject|1|||
155105037|NCT00391053|559815486|FG003|Overall Study|Withdrawal by Subject|1|||
155105038|NCT02140970|559815487|FG000|Overall Study|Lost to Follow-up|1|||
155105039|NCT02140970|559815488|FG001|Overall Study|Lost to Follow-up|2|||
154845293|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
154845294|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
154845295|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
155105040|NCT02140970|559815487|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
154845296|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
154845297|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
154845298|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
154845299|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
154845300|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
154845301|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
154845302|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
154845303|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
154845304|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
154845305|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
154845306|NCT01789970|558864945|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
154845307|NCT01789970|558864946|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
154845308|NCT01789970|558864947|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
154845309|NCT01847885|558864951|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
154845310|NCT01847885|558864952|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
154845311|NCT01847885|558864953|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
154845312|NCT01847885|558864951|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
154845313|NCT01847885|558864952|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
154845314|NCT01847885|558864953|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
154845315|NCT01847885|558864951|FG000|Initial Enrollment (Consented)|Screen failure|39|||
154845316|NCT01847885|558864952|FG001|Initial Enrollment (Consented)|Screen failure|0|||
154845317|NCT01847885|558864953|FG002|Initial Enrollment (Consented)|Screen failure|0|||
154845318|NCT01847885|558864951|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
154845319|NCT01847885|558864952|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
154845320|NCT01847885|558864953|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
154845321|NCT01847885|558864951|FG000|Randomization|Protocol Violation|0|||
154845322|NCT01847885|558864952|FG001|Randomization|Protocol Violation|1|||
154845323|NCT01847885|558864953|FG002|Randomization|Protocol Violation|0|||
154845324|NCT01847885|558864951|FG000|Randomization|Withdrawal by Subject|0|||
154845325|NCT01847885|558864952|FG001|Randomization|Withdrawal by Subject|0|||
154845326|NCT01847885|558864953|FG002|Randomization|Withdrawal by Subject|2|||
154845327|NCT01847885|558864951|FG000|Randomization|Screen Failure|0|||
154845328|NCT01847885|558864952|FG001|Randomization|Screen Failure|3|||
154845329|NCT01847885|558864953|FG002|Randomization|Screen Failure|0|||
154845330|NCT02574637|558864954|FG000|Double-blind Period|Adverse Event|1|||
154845331|NCT02574637|558864955|FG001|Double-blind Period|Adverse Event|0|||
154845332|NCT02574637|558864956|FG002|Double-blind Period|Adverse Event|0|||
154845333|NCT02574637|558864957|FG003|Double-blind Period|Adverse Event|0|||
154845334|NCT02574637|558864958|FG004|Double-blind Period|Adverse Event|0|||
154845335|NCT02574637|558864959|FG005|Double-blind Period|Adverse Event|0|||
154845336|NCT02574637|558864960|FG006|Double-blind Period|Adverse Event|0|||
154845337|NCT02574637|558864961|FG007|Double-blind Period|Adverse Event|0|||
154845338|NCT02574637|558864962|FG008|Double-blind Period|Adverse Event|0|||
154845339|NCT02574637|558864963|FG009|Double-blind Period|Adverse Event|0|||
154845340|NCT02574637|558864954|FG000|Double-blind Period|Lack of Efficacy|0|||
154845341|NCT02574637|558864955|FG001|Double-blind Period|Lack of Efficacy|0|||
154845342|NCT02574637|558864956|FG002|Double-blind Period|Lack of Efficacy|2|||
154845343|NCT02574637|558864957|FG003|Double-blind Period|Lack of Efficacy|0|||
154845344|NCT02574637|558864958|FG004|Double-blind Period|Lack of Efficacy|0|||
154845345|NCT02574637|558864959|FG005|Double-blind Period|Lack of Efficacy|0|||
154845346|NCT02574637|558864960|FG006|Double-blind Period|Lack of Efficacy|0|||
154845347|NCT02574637|558864961|FG007|Double-blind Period|Lack of Efficacy|0|||
154845348|NCT02574637|558864962|FG008|Double-blind Period|Lack of Efficacy|0|||
154845349|NCT02574637|558864963|FG009|Double-blind Period|Lack of Efficacy|0|||
154845350|NCT02574637|558864954|FG000|Double-blind Period|Protocol Deviation|1|||
154845351|NCT02574637|558864955|FG001|Double-blind Period|Protocol Deviation|0|||
154845352|NCT02574637|558864956|FG002|Double-blind Period|Protocol Deviation|0|||
154845353|NCT02574637|558864957|FG003|Double-blind Period|Protocol Deviation|0|||
154845354|NCT02574637|558864958|FG004|Double-blind Period|Protocol Deviation|0|||
154845355|NCT02574637|558864959|FG005|Double-blind Period|Protocol Deviation|0|||
154845356|NCT02574637|558864960|FG006|Double-blind Period|Protocol Deviation|0|||
154845357|NCT02574637|558864961|FG007|Double-blind Period|Protocol Deviation|0|||
154845358|NCT02574637|558864962|FG008|Double-blind Period|Protocol Deviation|0|||
154845359|NCT02574637|558864963|FG009|Double-blind Period|Protocol Deviation|0|||
154845360|NCT02574637|558864954|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
154845361|NCT02574637|558864955|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
154845362|NCT02574637|558864956|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
154845363|NCT02574637|558864957|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
154845364|NCT02574637|558864958|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
154845365|NCT02574637|558864959|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
154845366|NCT02574637|558864960|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
154845367|NCT02574637|558864961|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
154845368|NCT02574637|558864962|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
154845369|NCT02574637|558864963|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
154845370|NCT02574637|558864954|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
154845371|NCT02574637|558864955|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
154845372|NCT02574637|558864956|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
154845373|NCT02574637|558864957|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
154845374|NCT02574637|558864958|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
154845375|NCT02574637|558864959|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
154845376|NCT02574637|558864960|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
154845377|NCT02574637|558864961|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
154845378|NCT02574637|558864962|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
154845379|NCT02574637|558864963|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
154845380|NCT02574637|558864954|FG000|Double-blind Period|Reason Not Specified|0|||
154845381|NCT02574637|558864955|FG001|Double-blind Period|Reason Not Specified|0|||
154845382|NCT02574637|558864956|FG002|Double-blind Period|Reason Not Specified|0|||
154845383|NCT02574637|558864957|FG003|Double-blind Period|Reason Not Specified|1|||
154845384|NCT02574637|558864958|FG004|Double-blind Period|Reason Not Specified|0|||
154845385|NCT02574637|558864959|FG005|Double-blind Period|Reason Not Specified|0|||
154845386|NCT02574637|558864960|FG006|Double-blind Period|Reason Not Specified|0|||
154845387|NCT02574637|558864961|FG007|Double-blind Period|Reason Not Specified|0|||
154845388|NCT02574637|558864962|FG008|Double-blind Period|Reason Not Specified|0|||
154845389|NCT02574637|558864963|FG009|Double-blind Period|Reason Not Specified|0|||
154845390|NCT02574637|558864954|FG000|Open-label (OL) Period|Adverse Event|0|||
154845391|NCT02574637|558864955|FG001|Open-label (OL) Period|Adverse Event|0|||
154845392|NCT02574637|558864956|FG002|Open-label (OL) Period|Adverse Event|0|||
154845393|NCT02574637|558864957|FG003|Open-label (OL) Period|Adverse Event|0|||
154845394|NCT02574637|558864958|FG004|Open-label (OL) Period|Adverse Event|0|||
154845395|NCT02574637|558864959|FG005|Open-label (OL) Period|Adverse Event|0|||
154845396|NCT02574637|558864960|FG006|Open-label (OL) Period|Adverse Event|0|||
154845397|NCT02574637|558864961|FG007|Open-label (OL) Period|Adverse Event|0|||
154845398|NCT02574637|558864962|FG008|Open-label (OL) Period|Adverse Event|1|||
154845399|NCT02574637|558864963|FG009|Open-label (OL) Period|Adverse Event|0|||
154845400|NCT02574637|558864954|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
154845401|NCT02574637|558864955|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
154845402|NCT02574637|558864956|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
154845403|NCT02574637|558864957|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
154845404|NCT02574637|558864958|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
154845405|NCT02574637|558864959|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
154845406|NCT02574637|558864960|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
154845407|NCT02574637|558864961|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
154845408|NCT02574637|558864962|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
154845409|NCT02574637|558864963|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
154845410|NCT02574637|558864954|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
154845411|NCT02574637|558864955|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
154845412|NCT02574637|558864956|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
154845413|NCT02574637|558864957|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
154845414|NCT02574637|558864958|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
154845415|NCT02574637|558864959|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
154845416|NCT02574637|558864960|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
154845417|NCT02574637|558864961|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
154845418|NCT02574637|558864962|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
154845419|NCT02574637|558864963|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
154845420|NCT02499029|558864967|FG000|Overall Study|Lost to Follow-up|2|||
154845421|NCT02499029|558864968|FG001|Overall Study|Lost to Follow-up|2|||
154845422|NCT02499029|558864967|FG000|Overall Study|Physician Decision|2|||
154845423|NCT02499029|558864968|FG001|Overall Study|Physician Decision|1|||
154845424|NCT02499029|558864967|FG000|Overall Study|Death|1|||
154845425|NCT02499029|558864968|FG001|Overall Study|Death|0|||
154845426|NCT04823949|558864969|FG000|Overall Study|Withdrawal by Subject|0|||
154845427|NCT04823949|558864970|FG001|Overall Study|Withdrawal by Subject|4|||
154845428|NCT04823949|558864969|FG000|Overall Study|Physician Decision|0|||
154845429|NCT04823949|558864970|FG001|Overall Study|Physician Decision|1|||
154845430|NCT00756938|558864971|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
154845431|NCT00756938|558864972|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
154845432|NCT00756938|558864973|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
154845433|NCT00756938|558864974|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
154845434|NCT00756938|558864971|FG000|12-week Base Study|Protocol Violation|0|||
154845435|NCT00756938|558864972|FG001|12-week Base Study|Protocol Violation|0|||
154845436|NCT00756938|558864973|FG002|12-week Base Study|Protocol Violation|1|||
154845437|NCT00756938|558864974|FG003|12-week Base Study|Protocol Violation|0|||
155173548|NCT01604278|560074816|FG000|Overall Study|Protocol Deviation|5|||
154845438|NCT00756938|558864971|FG000|12-week Base Study|Lost to Follow-up|1|||
154845439|NCT00756938|558864972|FG001|12-week Base Study|Lost to Follow-up|0|||
154845440|NCT00756938|558864973|FG002|12-week Base Study|Lost to Follow-up|0|||
154845441|NCT00756938|558864974|FG003|12-week Base Study|Lost to Follow-up|0|||
154845442|NCT00756938|558864971|FG000|Optional Extension|Lack of Efficacy|0|||
154845443|NCT00756938|558864972|FG001|Optional Extension|Lack of Efficacy|0|||
154845444|NCT00756938|558864973|FG002|Optional Extension|Lack of Efficacy|0|||
154845445|NCT00756938|558864974|FG003|Optional Extension|Lack of Efficacy|1|||
154845446|NCT00756938|558864971|FG000|Optional Extension|End of Study|0|||
154845447|NCT00756938|558864972|FG001|Optional Extension|End of Study|0|||
154845448|NCT00756938|558864973|FG002|Optional Extension|End of Study|0|||
154845449|NCT00756938|558864974|FG003|Optional Extension|End of Study|11|||
154845450|NCT00756938|558864971|FG000|Optional Extension|Protocol-specific criteria met|0|||
154845451|NCT00756938|558864972|FG001|Optional Extension|Protocol-specific criteria met|0|||
154845452|NCT00756938|558864973|FG002|Optional Extension|Protocol-specific criteria met|0|||
154845453|NCT00756938|558864974|FG003|Optional Extension|Protocol-specific criteria met|9|||
154845454|NCT00756938|558864971|FG000|Optional Extension|Physician Decision|0|||
154845455|NCT00756938|558864972|FG001|Optional Extension|Physician Decision|0|||
154845456|NCT00756938|558864973|FG002|Optional Extension|Physician Decision|0|||
154845457|NCT00756938|558864974|FG003|Optional Extension|Physician Decision|3|||
154845458|NCT00756938|558864971|FG000|Optional Extension|Lost to Follow-up|0|||
154845459|NCT00756938|558864972|FG001|Optional Extension|Lost to Follow-up|0|||
154845460|NCT00756938|558864973|FG002|Optional Extension|Lost to Follow-up|0|||
154845461|NCT00756938|558864974|FG003|Optional Extension|Lost to Follow-up|1|||
154845462|NCT00756938|558864971|FG000|Optional Extension|Protocol Violation|0|||
154845463|NCT00756938|558864972|FG001|Optional Extension|Protocol Violation|0|||
154845464|NCT00756938|558864973|FG002|Optional Extension|Protocol Violation|0|||
154845465|NCT00756938|558864974|FG003|Optional Extension|Protocol Violation|1|||
154845466|NCT00756938|558864971|FG000|Optional Extension|Withdrawal by Subject|0|||
154845467|NCT00756938|558864972|FG001|Optional Extension|Withdrawal by Subject|0|||
154845468|NCT00756938|558864973|FG002|Optional Extension|Withdrawal by Subject|0|||
154845469|NCT00756938|558864974|FG003|Optional Extension|Withdrawal by Subject|10|||
154845470|NCT00756938|558864971|FG000|Optional Extension|Adverse Event|0|||
154845471|NCT00756938|558864972|FG001|Optional Extension|Adverse Event|0|||
154845472|NCT00756938|558864973|FG002|Optional Extension|Adverse Event|0|||
154845473|NCT00756938|558864974|FG003|Optional Extension|Adverse Event|1|||
154845474|NCT00094055|558864975|FG000|Overall Study|Adverse Event|11|||
154845475|NCT00094055|558864975|FG000|Overall Study|Death|4|||
154845476|NCT00094055|558864975|FG000|Overall Study|Lack of Efficacy|17|||
154845477|NCT00094055|558864975|FG000|Overall Study|Lost to Follow-up|2|||
154845478|NCT00094055|558864975|FG000|Overall Study|progressive disease|2|||
154845479|NCT00094055|558864975|FG000|Overall Study|clinical progression|1|||
154845480|NCT00094055|558864975|FG000|Overall Study|roll-over to another study|14|||
154845481|NCT00094055|558864975|FG000|Overall Study|Withdrawal by Subject|9|||
154845482|NCT00441545|558864976|FG000|First Intervention|Adverse Event|6|||
154845483|NCT00441545|558864977|FG001|First Intervention|Adverse Event|5|||
154845484|NCT00441545|558864976|FG000|First Intervention|Protocol Violation|2|||
154845485|NCT00441545|558864977|FG001|First Intervention|Protocol Violation|2|||
154845486|NCT00441545|558864976|FG000|First Intervention|Withdrawal by Subject|3|||
154845487|NCT00441545|558864977|FG001|First Intervention|Withdrawal by Subject|3|||
154845488|NCT00441545|558864976|FG000|First Intervention|Kidney transplant|1|||
154845489|NCT00441545|558864977|FG001|First Intervention|Kidney transplant|1|||
154845490|NCT00441545|558864976|FG000|First Intervention|Lack of Efficacy|2|||
154845491|NCT00441545|558864977|FG001|First Intervention|Lack of Efficacy|0|||
154845492|NCT00441545|558864976|FG000|First Intervention|Subject exceeded safety criteria|0|||
154845493|NCT00441545|558864977|FG001|First Intervention|Subject exceeded safety criteria|1|||
154845494|NCT00441545|558864976|FG000|First Intervention|Subject met an exclusionary criteria|1|||
154845495|NCT00441545|558864977|FG001|First Intervention|Subject met an exclusionary criteria|0|||
154845496|NCT00441545|558864976|FG000|First Intervention|Extended hospitalization|1|||
154845497|NCT00441545|558864977|FG001|First Intervention|Extended hospitalization|0|||
154845498|NCT00441545|558864976|FG000|First Intervention|Site error|1|||
154845499|NCT00441545|558864977|FG001|First Intervention|Site error|0|||
154845500|NCT00441545|558864976|FG000|First Intervention|Sponsor's request|1|||
154845501|NCT00441545|558864977|FG001|First Intervention|Sponsor's request|0|||
154845502|NCT00441545|558864976|FG000|Second Intervention|Adverse Event|5|||
154845503|NCT00441545|558864977|FG001|Second Intervention|Adverse Event|2|||
154845504|NCT00441545|558864976|FG000|Second Intervention|Protocol Violation|4|||
154845505|NCT00441545|558864977|FG001|Second Intervention|Protocol Violation|1|||
154845506|NCT00441545|558864976|FG000|Second Intervention|Withdrawal by Subject|1|||
154845507|NCT00441545|558864977|FG001|Second Intervention|Withdrawal by Subject|1|||
154845508|NCT00441545|558864976|FG000|Second Intervention|Kidney Transplant|1|||
154845509|NCT00441545|558864977|FG001|Second Intervention|Kidney Transplant|1|||
154845510|NCT00441545|558864976|FG000|Second Intervention|Lack of Efficacy|0|||
154845511|NCT00441545|558864977|FG001|Second Intervention|Lack of Efficacy|1|||
154971219|NCT02846883|559318566|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
154845512|NCT00441545|558864976|FG000|Second Intervention|Subject exceeded safety criteria|1|||
154845513|NCT00441545|558864977|FG001|Second Intervention|Subject exceeded safety criteria|0|||
154845514|NCT00441545|558864976|FG000|Second Intervention|Subject moved|0|||
154845515|NCT00441545|558864977|FG001|Second Intervention|Subject moved|1|||
154845516|NCT01707693|558864978|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
154845517|NCT01707693|558864979|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
154845518|NCT01707693|558864978|FG000|Overall Study Allocation|Protocol Violation|4|||
154845519|NCT01707693|558864979|FG001|Overall Study Allocation|Protocol Violation|3|||
154845520|NCT01707693|558864978|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
154845521|NCT01707693|558864979|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
154845522|NCT01707693|558864978|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
154845523|NCT01707693|558864979|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
154845524|NCT02556255|558864981|FG000|Overall Study|Lost to Follow-up|4|||
154845525|NCT03115151|558864982|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
154845526|NCT03115151|558864983|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
154845527|NCT03115151|558864982|FG000|Overall Study|Epidural catheter removal|1|||
154845528|NCT03115151|558864983|FG001|Overall Study|Epidural catheter removal|0|||
154845529|NCT03115151|558864982|FG000|Overall Study|Withdrawal by Subject|0|||
154845530|NCT03115151|558864983|FG001|Overall Study|Withdrawal by Subject|1|||
154845531|NCT03115151|558864982|FG000|Overall Study|Intervention not received according to the protocol.|1|||
154845532|NCT03115151|558864983|FG001|Overall Study|Intervention not received according to the protocol.|1|||
154845533|NCT03115151|558864982|FG000|Overall Study|Physician Decision|1|||
154845534|NCT03115151|558864983|FG001|Overall Study|Physician Decision|0|||
154845535|NCT03115151|558864982|FG000|Overall Study|Randomization not applied|1|||
154845536|NCT03115151|558864983|FG001|Overall Study|Randomization not applied|1|||
154845537|NCT01325428|558864984|FG000|Part A|Progressive disease according to RECIST|9|||
154845538|NCT01325428|558864984|FG000|Part A|Clinical signs, symptoms of progression|2|||
154845539|NCT01325428|558864984|FG000|Part A|Other adverse event|1|||
154845540|NCT01325428|558864984|FG000|Part A|Refused continue taking trial medication|2|||
154845541|NCT01325428|558864984|FG000|Part A|Other reason not defined above|2|||
154845542|NCT01325428|558864984|FG000|Part B|Refused continue taking trial medication|2|||
154845543|NCT01325428|558864984|FG000|Part B|Other reason not defined above|1|||
154845544|NCT02682901|558864985|FG000|Overall Study|Adverse Event|10|||
154845545|NCT02682901|558864986|FG001|Overall Study|Adverse Event|3|||
154845546|NCT02682901|558864985|FG000|Overall Study|Lack of Efficacy|0|||
154845547|NCT02682901|558864986|FG001|Overall Study|Lack of Efficacy|1|||
154845548|NCT03870555|558864987|FG000|Period 3 (2 Days)|Adverse Event|1|||
154845549|NCT03870555|558864988|FG001|Period 3 (2 Days)|Adverse Event|0|||
154845550|NCT03870555|558864989|FG002|Period 3 (2 Days)|Adverse Event|0|||
154845551|NCT03713944|558864990|FG000|Study Treatment|Patient non-compliance|1|||
154845552|NCT03713944|558864990|FG000|Study Treatment|Alternative Cancer Therapy|3|||
154845553|NCT03713944|558864990|FG000|Study Treatment|Disease Progression|18|||
154845554|NCT03713944|558864990|FG000|Study Treatment|AE/Side Effects/Complications|2|||
154845555|NCT03713944|558864990|FG000|Study Treatment|Death|2|||
154845556|NCT03713944|558864990|FG000|Study Treatment|Withdrawal by Subject|1|||
154845557|NCT03713944|558864990|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
154845558|NCT03713944|558864990|FG000|Study Treatment|Symptomatic Deterioration|2|||
154845559|NCT03713944|558864990|FG000|Follow up|Withdrawal by Subject|2|||
154845560|NCT03713944|558864990|FG000|Follow up|Death|11|||
154845561|NCT03713944|558864990|FG000|Follow up|Study Terminated|3|||
154845562|NCT02695628|558865008|FG000|Overall Study|Withdrawal by Subject|1|||
154845563|NCT00720109|558865009|FG000|Induction Period|Did not meet eligibility criteria|3|||
154845564|NCT00720109|558865010|FG001|Induction Period|Did not meet eligibility criteria|0|||
154845565|NCT00720109|558865011|FG002|Induction Period|Did not meet eligibility criteria|0|||
154845566|NCT00720109|558865009|FG000|Induction Period|Bone Marrow Transplant|2|||
154845567|NCT00720109|558865010|FG001|Induction Period|Bone Marrow Transplant|0|||
154845568|NCT00720109|558865011|FG002|Induction Period|Bone Marrow Transplant|0|||
154845569|NCT00720109|558865009|FG000|Induction Period|Physician Decision|1|||
154845570|NCT00720109|558865010|FG001|Induction Period|Physician Decision|0|||
154845571|NCT00720109|558865011|FG002|Induction Period|Physician Decision|0|||
154845572|NCT00720109|558865009|FG000|Risk Stratification Period|Adverse Event|0|||
154845573|NCT00720109|558865010|FG001|Risk Stratification Period|Adverse Event|1|||
154845574|NCT00720109|558865011|FG002|Risk Stratification Period|Adverse Event|0|||
154845575|NCT00720109|558865009|FG000|Risk Stratification Period|Physician Decision|0|||
154845576|NCT00720109|558865010|FG001|Risk Stratification Period|Physician Decision|2|||
154845577|NCT00720109|558865011|FG002|Risk Stratification Period|Physician Decision|1|||
154845578|NCT00720109|558865009|FG000|Risk Stratification Period|Bone marrow transplant|0|||
154845579|NCT00720109|558865010|FG001|Risk Stratification Period|Bone marrow transplant|9|||
154845580|NCT00720109|558865011|FG002|Risk Stratification Period|Bone marrow transplant|7|||
154845581|NCT00720109|558865009|FG000|Risk Stratification Period|Disease progression or relapse|0|||
154845582|NCT00720109|558865010|FG001|Risk Stratification Period|Disease progression or relapse|2|||
154845583|NCT00720109|558865011|FG002|Risk Stratification Period|Disease progression or relapse|0|||
154924170|NCT01015118|559146403|FG001|Overall Study|Withdrawal by Subject|27|||
154845584|NCT00720109|558865009|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
154845585|NCT00720109|558865010|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
154845586|NCT00720109|558865011|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
154845587|NCT03595553|558865012|FG000|Overall Study|Withdrawal by Subject|20|||
154845588|NCT03595553|558865013|FG001|Overall Study|Withdrawal by Subject|8|||
154845589|NCT03595553|558865012|FG000|Overall Study|Physician Decision|3|||
154845590|NCT03595553|558865013|FG001|Overall Study|Physician Decision|2|||
154845591|NCT03595553|558865012|FG000|Overall Study|Adverse Event|2|||
154845592|NCT03595553|558865013|FG001|Overall Study|Adverse Event|5|||
154845593|NCT03595553|558865012|FG000|Overall Study|Death|24|||
154845594|NCT03595553|558865013|FG001|Overall Study|Death|22|||
154845595|NCT03595553|558865012|FG000|Overall Study|Lost to Follow-up|6|||
154845596|NCT03595553|558865013|FG001|Overall Study|Lost to Follow-up|7|||
154845597|NCT03595553|558865012|FG000|Overall Study|Other as indicated in CSR|3|||
154845598|NCT03595553|558865013|FG001|Overall Study|Other as indicated in CSR|3|||
154845599|NCT03595553|558865012|FG000|Overall Study|Sponsor Decision|0|||
154845600|NCT03595553|558865013|FG001|Overall Study|Sponsor Decision|1|||
154845601|NCT00903929|558865014|FG000|Overall Study|Withdrawal by Subject|0|||
154845602|NCT00903929|558865015|FG001|Overall Study|Withdrawal by Subject|0|||
154845603|NCT00903929|558865016|FG002|Overall Study|Withdrawal by Subject|1|||
154845604|NCT00903929|558865017|FG003|Overall Study|Withdrawal by Subject|2|||
154845605|NCT00903929|558865014|FG000|Overall Study|Adverse Event|0|||
154845606|NCT00903929|558865015|FG001|Overall Study|Adverse Event|0|||
154845607|NCT00903929|558865016|FG002|Overall Study|Adverse Event|0|||
154845608|NCT00903929|558865017|FG003|Overall Study|Adverse Event|1|||
154845609|NCT02665286|558865018|FG000|Overall Study|Lost to Follow-up|3|||
154845610|NCT02665286|558865019|FG001|Overall Study|Lost to Follow-up|2|||
154845611|NCT02665286|558865020|FG002|Overall Study|Lost to Follow-up|1|||
154845612|NCT00626093|558865022|FG000|Overall Study|Lost to Follow-up|5|||
154845613|NCT00626093|558865022|FG000|Overall Study|Death|1|||
154845614|NCT00626093|558865022|FG000|Overall Study|Physician Decision|4|||
154845615|NCT00626093|558865022|FG000|Overall Study|Withdrawal by Subject|6|||
154845616|NCT00626093|558865022|FG000|Overall Study|Protocol Violation|1|||
154845617|NCT00626093|558865022|FG000|Overall Study|One of the required devices not implante|6|||
154845618|NCT04153188|558865031|FG000|Overall Study|Lost to Follow-up|1|||
154845619|NCT04153188|558865032|FG001|Overall Study|Lost to Follow-up|1|||
154845620|NCT04153188|558865031|FG000|Overall Study|Withdrawal by Subject|2|||
154845621|NCT04153188|558865032|FG001|Overall Study|Withdrawal by Subject|0|||
154845622|NCT04153188|558865031|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
154845623|NCT04153188|558865032|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
154845624|NCT01489527|558865033|FG000|Overall Study|Pregnancy|9|||
154845625|NCT01489527|558865034|FG001|Overall Study|Pregnancy|14|||
154845626|NCT01489527|558865033|FG000|Overall Study|Participant moved|6|||
154845627|NCT01489527|558865034|FG001|Overall Study|Participant moved|7|||
154845628|NCT01489527|558865033|FG000|Overall Study|Withdrawal by Subject|0|||
154845629|NCT01489527|558865034|FG001|Overall Study|Withdrawal by Subject|4|||
154845630|NCT01489527|558865033|FG000|Overall Study|Lost to Follow-up|5|||
154845631|NCT01489527|558865034|FG001|Overall Study|Lost to Follow-up|1|||
154845632|NCT01489527|558865033|FG000|Overall Study|Procedures|1|||
154845633|NCT01489527|558865034|FG001|Overall Study|Procedures|0|||
154971220|NCT02846883|559318564|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
154845634|NCT01489527|558865033|FG000|Overall Study|Not compliant|1|||
154845635|NCT01489527|558865034|FG001|Overall Study|Not compliant|0|||
154845636|NCT04899232|558865035|FG000|Screening Period|Physician Decision|1|||
154845637|NCT04899232|558865036|FG001|Screening Period|Physician Decision|0|||
154845638|NCT04899232|558865037|FG002|Screening Period|Physician Decision|0|||
154845639|NCT04899232|558865035|FG000|Screening Period|Withdrawal by Subject|1|||
154845640|NCT04899232|558865036|FG001|Screening Period|Withdrawal by Subject|0|||
154845641|NCT04899232|558865037|FG002|Screening Period|Withdrawal by Subject|0|||
154845642|NCT04899232|558865035|FG000|Screening Period|Participant discharged before receiving intervention|3|||
154845643|NCT04899232|558865036|FG001|Screening Period|Participant discharged before receiving intervention|0|||
154845644|NCT04899232|558865037|FG002|Screening Period|Participant discharged before receiving intervention|0|||
154845645|NCT00700271|558865038|FG000|Overall Study|Adverse Event|4|||
154845646|NCT00700271|558865039|FG001|Overall Study|Adverse Event|6|||
155173549|NCT01604278|560074817|FG001|Overall Study|Protocol Deviation|3|||
154845647|NCT00700271|558865038|FG000|Overall Study|Protocol Violation|1|||
154845648|NCT00700271|558865039|FG001|Overall Study|Protocol Violation|0|||
154845649|NCT00700271|558865038|FG000|Overall Study|Administrative Reasons|1|||
154845650|NCT00700271|558865039|FG001|Overall Study|Administrative Reasons|0|||
154845651|NCT00700271|558865038|FG000|Overall Study|Withdrawal by Subject|6|||
154845652|NCT00700271|558865039|FG001|Overall Study|Withdrawal by Subject|4|||
154845653|NCT00700271|558865038|FG000|Overall Study|Lost to Follow-up|2|||
154845654|NCT00700271|558865039|FG001|Overall Study|Lost to Follow-up|2|||
154845655|NCT02406781|558865040|FG000|Overall Study|Protocol Violation|2|||
154845656|NCT02406781|558865041|FG001|Overall Study|Protocol Violation|2|||
154845657|NCT02406781|558865042|FG002|Overall Study|Protocol Violation|2|||
154845658|NCT02406781|558865043|FG003|Overall Study|Protocol Violation|2|||
154845659|NCT02406781|558865044|FG004|Overall Study|Protocol Violation|1|||
154845660|NCT02406781|558865045|FG005|Overall Study|Protocol Violation|5|||
154845661|NCT02406781|558865046|FG006|Overall Study|Protocol Violation|3|||
154845662|NCT02926950|558865047|FG000|Overall Study|Adverse Event|4|||
154845663|NCT02926950|558865048|FG001|Overall Study|Adverse Event|6|||
154845664|NCT02926950|558865047|FG000|Overall Study|At the participant's own request|21|||
154845665|NCT02926950|558865048|FG001|Overall Study|At the participant's own request|25|||
154845666|NCT02926950|558865047|FG000|Overall Study|Reason not Specified|17|||
154845667|NCT02926950|558865048|FG001|Overall Study|Reason not Specified|9|||
154845668|NCT02926950|558865047|FG000|Overall Study|Lost to Follow-up|7|||
154845669|NCT02926950|558865048|FG001|Overall Study|Lost to Follow-up|8|||
154845670|NCT04622046|558865056|FG000|Intervention Period|Adverse Event|1|||
154845671|NCT04622046|558865056|FG000|Intervention Period|Withdrawal by Subject|2|||
154845672|NCT04622046|558865056|FG000|Extension Period|Ongoing in the Extension Period|21|||
154845673|NCT03505021|558865057|FG000|Overall Study|Protocol Violation|1|||
154845674|NCT03505021|558865058|FG001|Overall Study|Protocol Violation|0|||
154845675|NCT03505021|558865057|FG000|Overall Study|Death|9|||
154845676|NCT03505021|558865058|FG001|Overall Study|Death|8|||
154845677|NCT03505021|558865057|FG000|Overall Study|Consent withdrawn by subject|6|||
154845678|NCT03505021|558865058|FG001|Overall Study|Consent withdrawn by subject|1|||
154845679|NCT03505021|558865057|FG000|Overall Study|Lost to Follow-up|5|||
154845680|NCT03505021|558865058|FG001|Overall Study|Lost to Follow-up|3|||
154845681|NCT03505021|558865057|FG000|Overall Study|Adverse Event|26|||
154845682|NCT03505021|558865058|FG001|Overall Study|Adverse Event|9|||
154845683|NCT03505021|558865057|FG000|Overall Study|Disease progression|33|||
154845684|NCT03505021|558865058|FG001|Overall Study|Disease progression|17|||
154845685|NCT03505021|558865057|FG000|Overall Study|Other|11|||
154845686|NCT03505021|558865058|FG001|Overall Study|Other|5|||
154845687|NCT03505021|558865057|FG000|Overall Study|Personal reason|21|||
154845688|NCT03505021|558865058|FG001|Overall Study|Personal reason|12|||
154845689|NCT01844986|558865059|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
154845690|NCT01844986|558865060|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
154845691|NCT01844986|558865059|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
154845692|NCT01844986|558865060|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
154845693|NCT01844986|558865059|FG000|Overall Study (Global Cohort)|Death|55|||
154845694|NCT01844986|558865060|FG001|Overall Study (Global Cohort)|Death|26|||
154845695|NCT01844986|558865059|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
154845696|NCT01844986|558865060|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
154845697|NCT01844986|558865059|FG000|Overall Study (China Cohort)|Death|10|||
154845698|NCT01844986|558865060|FG001|Overall Study (China Cohort)|Death|6|||
154845699|NCT04440592|558865061|FG000|Overall Study|Adverse Event|8|||
154845700|NCT04440592|558865062|FG001|Overall Study|Adverse Event|0|||
154845701|NCT04440592|558865061|FG000|Overall Study|Lost to Follow-up|1|||
154845702|NCT04440592|558865062|FG001|Overall Study|Lost to Follow-up|0|||
154845703|NCT04440592|558865061|FG000|Overall Study|Withdrawal by Subject|1|||
154845704|NCT04440592|558865062|FG001|Overall Study|Withdrawal by Subject|1|||
154845705|NCT04440592|558865061|FG000|Overall Study|Other therapy needed|0|||
154845706|NCT04440592|558865062|FG001|Overall Study|Other therapy needed|1|||
154845707|NCT02028455|558865063|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
154845708|NCT02028455|558865064|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
154845709|NCT02028455|558865065|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
154845710|NCT02028455|558865066|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
154845711|NCT02028455|558865067|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
154845712|NCT02028455|558865068|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
154845713|NCT02028455|558865069|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
154845714|NCT02028455|558865070|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
154845715|NCT02028455|558865063|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
154845716|NCT02028455|558865064|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
154845717|NCT02028455|558865065|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
154845718|NCT02028455|558865066|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
154845719|NCT02028455|558865067|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
154845720|NCT02028455|558865068|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
154845721|NCT02028455|558865069|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
154845722|NCT02028455|558865070|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
154845723|NCT02028455|558865063|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
154845724|NCT02028455|558865064|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
154845725|NCT02028455|558865065|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
154845726|NCT02028455|558865066|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
154845727|NCT02028455|558865067|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
154845728|NCT02028455|558865068|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
154845729|NCT02028455|558865069|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
154845730|NCT02028455|558865070|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
154845731|NCT02028455|558865063|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
154845732|NCT02028455|558865064|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
154845733|NCT02028455|558865065|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
154845734|NCT02028455|558865066|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
154845735|NCT02028455|558865067|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
154845736|NCT02028455|558865068|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
154845737|NCT02028455|558865069|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
154845738|NCT02028455|558865070|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
154845739|NCT02392429|558867310|FG000|Screening|Screen failure|15|||
154845740|NCT02392429|558867310|FG000|Enrolled Participants|Ineligible due to disease|3|||
154845741|NCT02392429|558867310|FG000|Enrolled Participants|Withdrawal by Subject|4|||
154845742|NCT02392429|558867310|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
154845743|NCT02392429|558867310|FG000|Evaluable|Death|5|||
154845744|NCT02392429|558867310|FG000|Evaluable|Withdrawal by Subject|1|||
154845745|NCT02392429|558867310|FG000|Evaluable|Adverse Event|1|||
154845746|NCT02392429|558867310|FG000|Evaluable|remission bone marrow biopsy|3|||
154845747|NCT01241708|558867311|FG000|Overall Study|Withdrawal by Subject|6|||
154845748|NCT01241708|558867311|FG000|Overall Study|Screen Failure|6|||
154845749|NCT01241708|558867311|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
154845750|NCT01241708|558867311|FG000|Overall Study|Lost to Follow-up|5|||
154845751|NCT04137887|558867312|FG000|Overall Study|Death|102|||
154845752|NCT04137887|558867313|FG001|Overall Study|Death|92|||
154845753|NCT04137887|558867312|FG000|Overall Study|Withdrawal by Subject|2|||
154845754|NCT04137887|558867313|FG001|Overall Study|Withdrawal by Subject|3|||
154845755|NCT04137887|558867312|FG000|Overall Study|Randomized but not treated|0|||
154845756|NCT04137887|558867313|FG001|Overall Study|Randomized but not treated|1|||
154845757|NCT04183335|558867316|FG000|Overall Study|Adverse Event|1|||
154845758|NCT04183335|558867317|FG001|Overall Study|Adverse Event|0|||
154845759|NCT04183335|558867316|FG000|Overall Study|Withdrawal by Subject|12|||
154845760|NCT04183335|558867317|FG001|Overall Study|Withdrawal by Subject|3|||
154845761|NCT00049673|558867318|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
154845762|NCT00049673|558867319|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
154845763|NCT05064059|558867322|FG000|Overall Study|Death|199|||
154845764|NCT05064059|558867323|FG001|Overall Study|Death|196|||
154845765|NCT05064059|558867322|FG000|Overall Study|Physician Decision|4|||
154845766|NCT05064059|558867323|FG001|Overall Study|Physician Decision|2|||
154845767|NCT05064059|558867322|FG000|Overall Study|Sponsor Decision|14|||
154845768|NCT05064059|558867323|FG001|Overall Study|Sponsor Decision|11|||
154845769|NCT05064059|558867322|FG000|Overall Study|Withdrawal by Subject|4|||
154845770|NCT05064059|558867323|FG001|Overall Study|Withdrawal by Subject|11|||
154845771|NCT01934140|558867324|FG000|Persistence Phase (Year 6-10)|Other|24|||
154845772|NCT01934140|558867325|FG001|Persistence Phase (Year 6-10)|Other|6|||
154845773|NCT01934140|558867324|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
155105041|NCT02140970|559815488|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
154845774|NCT01934140|558867325|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
154845775|NCT01934140|558867324|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
154845776|NCT01934140|558867325|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
154845777|NCT01934140|558867324|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
154845778|NCT01934140|558867325|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
154845779|NCT01934140|558867324|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
154845780|NCT01934140|558867325|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
154845781|NCT01934140|558867324|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
154845782|NCT01934140|558867325|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
154845783|NCT01934140|558867324|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
154845784|NCT01934140|558867325|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
154845785|NCT01934140|558867324|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
154845786|NCT01934140|558867325|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
154845787|NCT00200850|558867331|FG000|Overall Study|relocation|1|||
154845788|NCT00200850|558867332|FG001|Overall Study|relocation|0|||
154845789|NCT00200850|558867333|FG002|Overall Study|relocation|1|||
154845790|NCT00200850|558867331|FG000|Overall Study|too busy|1|||
154845791|NCT00200850|558867332|FG001|Overall Study|too busy|0|||
154845792|NCT00200850|558867333|FG002|Overall Study|too busy|0|||
154845793|NCT00200850|558867331|FG000|Overall Study|Pregnancy|0|||
154845794|NCT00200850|558867332|FG001|Overall Study|Pregnancy|0|||
154845795|NCT00200850|558867333|FG002|Overall Study|Pregnancy|1|||
154845796|NCT00200850|558867331|FG000|Overall Study|Poor adherence|0|||
154845797|NCT00200850|558867332|FG001|Overall Study|Poor adherence|0|||
155105042|NCT02140970|559815487|FG000|Overall Study|Did not meet inclusion criteria|0|||
155105043|NCT02140970|559815488|FG001|Overall Study|Did not meet inclusion criteria|1|||
155105044|NCT00603941|559815492|FG000|Overall Study|Disease progression|6|||
155105045|NCT00603941|559815493|FG001|Overall Study|Disease progression|7|||
155105046|NCT00603941|559815494|FG002|Overall Study|Disease progression|1|||
155105047|NCT00603941|559815492|FG000|Overall Study|Adverse Event|1|||
155105048|NCT00603941|559815493|FG001|Overall Study|Adverse Event|0|||
155105049|NCT00603941|559815494|FG002|Overall Study|Adverse Event|1|||
155105050|NCT00603941|559815492|FG000|Overall Study|Physician Decision|0|||
155105051|NCT00603941|559815493|FG001|Overall Study|Physician Decision|1|||
155105052|NCT00603941|559815494|FG002|Overall Study|Physician Decision|0|||
155105053|NCT00603941|559815492|FG000|Overall Study|Withdrawal by Subject|0|||
155105054|NCT00603941|559815493|FG001|Overall Study|Withdrawal by Subject|2|||
154845798|NCT00200850|558867333|FG002|Overall Study|Poor adherence|1|||
154845799|NCT00200850|558867331|FG000|Overall Study|optic neuritis|0|||
154845800|NCT00200850|558867332|FG001|Overall Study|optic neuritis|0|||
154845801|NCT00200850|558867333|FG002|Overall Study|optic neuritis|1|||
154845802|NCT00200850|558867331|FG000|Overall Study|Adverse Event|1|||
154845803|NCT00200850|558867332|FG001|Overall Study|Adverse Event|1|||
154845804|NCT00200850|558867333|FG002|Overall Study|Adverse Event|2|||
154845805|NCT01449708|558867334|FG000|Overall Study|Protocol Violation|0|||
154845806|NCT01449708|558867335|FG001|Overall Study|Protocol Violation|1|||
154845807|NCT01449708|558867334|FG000|Overall Study|surgical complication|1|||
154845808|NCT01449708|558867335|FG001|Overall Study|surgical complication|2|||
154845809|NCT01449708|558867334|FG000|Overall Study|respiratory failure|1|||
154845810|NCT01449708|558867335|FG001|Overall Study|respiratory failure|0|||
154845811|NCT02889796|558867336|FG000|Overall Study|Withdrew Consent|18|||
154845812|NCT02889796|558867337|FG001|Overall Study|Withdrew Consent|29|||
154845813|NCT02889796|558867338|FG002|Overall Study|Withdrew Consent|20|||
154845814|NCT02889796|558867339|FG003|Overall Study|Withdrew Consent|1|||
154845815|NCT02889796|558867340|FG004|Overall Study|Withdrew Consent|2|||
154845816|NCT02889796|558867341|FG005|Overall Study|Withdrew Consent|35|||
154845817|NCT02889796|558867336|FG000|Overall Study|Investigator's Discretion|10|||
154845818|NCT02889796|558867337|FG001|Overall Study|Investigator's Discretion|9|||
154845819|NCT02889796|558867338|FG002|Overall Study|Investigator's Discretion|10|||
154845820|NCT02889796|558867339|FG003|Overall Study|Investigator's Discretion|3|||
154845821|NCT02889796|558867340|FG004|Overall Study|Investigator's Discretion|0|||
154845822|NCT02889796|558867341|FG005|Overall Study|Investigator's Discretion|15|||
154845823|NCT02889796|558867336|FG000|Overall Study|Adverse Event|17|||
154845824|NCT02889796|558867337|FG001|Overall Study|Adverse Event|8|||
154845825|NCT02889796|558867338|FG002|Overall Study|Adverse Event|8|||
154845826|NCT02889796|558867339|FG003|Overall Study|Adverse Event|4|||
154845827|NCT02889796|558867340|FG004|Overall Study|Adverse Event|1|||
154845828|NCT02889796|558867341|FG005|Overall Study|Adverse Event|7|||
154845829|NCT02889796|558867336|FG000|Overall Study|Lost to Follow-up|5|||
154845830|NCT02889796|558867337|FG001|Overall Study|Lost to Follow-up|7|||
154845831|NCT02889796|558867338|FG002|Overall Study|Lost to Follow-up|2|||
154845832|NCT02889796|558867339|FG003|Overall Study|Lost to Follow-up|0|||
154845833|NCT02889796|558867340|FG004|Overall Study|Lost to Follow-up|2|||
154845834|NCT02889796|558867341|FG005|Overall Study|Lost to Follow-up|6|||
154845835|NCT02889796|558867336|FG000|Overall Study|Protocol Violation|0|||
154845836|NCT02889796|558867337|FG001|Overall Study|Protocol Violation|1|||
154845837|NCT02889796|558867338|FG002|Overall Study|Protocol Violation|3|||
154845838|NCT02889796|558867339|FG003|Overall Study|Protocol Violation|0|||
154845839|NCT02889796|558867340|FG004|Overall Study|Protocol Violation|0|||
154845840|NCT02889796|558867341|FG005|Overall Study|Protocol Violation|4|||
154845841|NCT02889796|558867336|FG000|Overall Study|Non-compliance With Study Drug|0|||
154845842|NCT02889796|558867337|FG001|Overall Study|Non-compliance With Study Drug|2|||
154845843|NCT02889796|558867338|FG002|Overall Study|Non-compliance With Study Drug|0|||
154845844|NCT02889796|558867339|FG003|Overall Study|Non-compliance With Study Drug|0|||
154845845|NCT02889796|558867340|FG004|Overall Study|Non-compliance With Study Drug|1|||
154845846|NCT02889796|558867341|FG005|Overall Study|Non-compliance With Study Drug|2|||
155105055|NCT00603941|559815494|FG002|Overall Study|Withdrawal by Subject|0|||
155105056|NCT03592771|559815495|FG000|Overall Study|Adverse Event|2|||
155105057|NCT03592771|559815496|FG001|Overall Study|Adverse Event|0|||
154845847|NCT02889796|558867336|FG000|Overall Study|Death|1|||
154845848|NCT02889796|558867337|FG001|Overall Study|Death|1|||
154845849|NCT02889796|558867338|FG002|Overall Study|Death|0|||
154845850|NCT02889796|558867339|FG003|Overall Study|Death|1|||
154845851|NCT02889796|558867340|FG004|Overall Study|Death|0|||
154845852|NCT02889796|558867341|FG005|Overall Study|Death|1|||
154845853|NCT02889796|558867336|FG000|Overall Study|Pregnancy|0|||
154845854|NCT02889796|558867337|FG001|Overall Study|Pregnancy|1|||
154845855|NCT02889796|558867338|FG002|Overall Study|Pregnancy|1|||
154845856|NCT02889796|558867339|FG003|Overall Study|Pregnancy|0|||
154845857|NCT02889796|558867340|FG004|Overall Study|Pregnancy|0|||
154845858|NCT02889796|558867341|FG005|Overall Study|Pregnancy|0|||
154845859|NCT02889796|558867336|FG000|Overall Study|Randomized but not Dosed|2|||
154845860|NCT02889796|558867337|FG001|Overall Study|Randomized but not Dosed|0|||
155105058|NCT03592771|559815497|FG002|Overall Study|Adverse Event|1|||
155105059|NCT03592771|559815495|FG000|Overall Study|Death|0|||
154845861|NCT02889796|558867338|FG002|Overall Study|Randomized but not Dosed|0|||
154845862|NCT02889796|558867339|FG003|Overall Study|Randomized but not Dosed|0|||
154845863|NCT02889796|558867340|FG004|Overall Study|Randomized but not Dosed|0|||
154845864|NCT02889796|558867341|FG005|Overall Study|Randomized but not Dosed|2|||
154845865|NCT01414257|558867342|FG000|Overall Study|No Visit After First Day of Treatment|12|||
154845866|NCT01414257|558867342|FG000|Overall Study|Protocol Violation|10|||
154845867|NCT02421887|558867343|FG000|Overall Study|Lost to Follow-up|5|||
154845868|NCT02421887|558867344|FG001|Overall Study|Lost to Follow-up|0|||
154845869|NCT02421887|558867343|FG000|Overall Study|Withdrawal by Subject|8|||
154845870|NCT02421887|558867344|FG001|Overall Study|Withdrawal by Subject|5|||
154845871|NCT02421887|558867343|FG000|Overall Study|Physician Decision|2|||
154845872|NCT02421887|558867344|FG001|Overall Study|Physician Decision|4|||
154845873|NCT02421887|558867343|FG000|Overall Study|Adverse Event|2|||
154845874|NCT02421887|558867344|FG001|Overall Study|Adverse Event|0|||
154845875|NCT01882907|558867345|FG000|Overall Study|Adverse Event|3|||
154845876|NCT01882907|558867346|FG001|Overall Study|Adverse Event|1|||
154845877|NCT01882907|558867345|FG000|Overall Study|Lack of Efficacy|0|||
154845878|NCT01882907|558867346|FG001|Overall Study|Lack of Efficacy|3|||
154845879|NCT01882907|558867345|FG000|Overall Study|Lost to Follow-up|1|||
154845880|NCT01882907|558867346|FG001|Overall Study|Lost to Follow-up|4|||
154845881|NCT01882907|558867345|FG000|Overall Study|Protocol Violation|10|||
154845882|NCT01882907|558867346|FG001|Overall Study|Protocol Violation|14|||
154845883|NCT01882907|558867345|FG000|Overall Study|Withdrawal by Subject|0|||
154845884|NCT01882907|558867346|FG001|Overall Study|Withdrawal by Subject|6|||
154845885|NCT01978093|558867347|FG000|Overall Study|Death|1|||
154845886|NCT01978093|558867348|FG001|Overall Study|Death|0|||
154845887|NCT01978093|558867347|FG000|Overall Study|Adverse Event|0|||
154845888|NCT01978093|558867348|FG001|Overall Study|Adverse Event|5|||
154845889|NCT01978093|558867347|FG000|Overall Study|Protocol Violation|8|||
154845890|NCT01978093|558867348|FG001|Overall Study|Protocol Violation|2|||
154845891|NCT01978093|558867347|FG000|Overall Study|Withdrawal by Subject|29|||
154845892|NCT01978093|558867348|FG001|Overall Study|Withdrawal by Subject|25|||
154845893|NCT01978093|558867347|FG000|Overall Study|Lost to Follow-up|11|||
154845894|NCT01978093|558867348|FG001|Overall Study|Lost to Follow-up|15|||
154845895|NCT01978093|558867347|FG000|Overall Study|Migrated/moved from study area|11|||
154845896|NCT01978093|558867348|FG001|Overall Study|Migrated/moved from study area|13|||
154845897|NCT01978093|558867347|FG000|Overall Study|Loss of kaiser coverage|4|||
154845898|NCT01978093|558867348|FG001|Overall Study|Loss of kaiser coverage|10|||
154845899|NCT01978093|558867347|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
154845900|NCT01978093|558867348|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
154845901|NCT01978093|558867347|FG000|Overall Study|Mother lost custody of child|0|||
154845902|NCT01978093|558867348|FG001|Overall Study|Mother lost custody of child|1|||
154845903|NCT01978093|558867347|FG000|Overall Study|Child was in care of grandmother|0|||
154845904|NCT01978093|558867348|FG001|Overall Study|Child was in care of grandmother|1|||
154845905|NCT01978093|558867347|FG000|Overall Study|N/A for vaccine administration|0|||
154845906|NCT01978093|558867348|FG001|Overall Study|N/A for vaccine administration|1|||
154845907|NCT01467492|558867349|FG000|Overall Study|Withdrawal by Subject|6|||
154845908|NCT01467492|558867350|FG001|Overall Study|Withdrawal by Subject|4|||
154845909|NCT01467492|558867349|FG000|Overall Study|Study Terminated by Sponsor|6|||
154845910|NCT01467492|558867350|FG001|Overall Study|Study Terminated by Sponsor|4|||
154845911|NCT01467492|558867349|FG000|Overall Study|Adverse Event|4|||
154845912|NCT01467492|558867350|FG001|Overall Study|Adverse Event|3|||
154845913|NCT01467492|558867349|FG000|Overall Study|Lost to Follow-up|3|||
154845914|NCT01467492|558867350|FG001|Overall Study|Lost to Follow-up|2|||
154845915|NCT01467492|558867349|FG000|Overall Study|Undefined|2|||
154845916|NCT01467492|558867350|FG001|Overall Study|Undefined|0|||
154845917|NCT01467492|558867349|FG000|Overall Study|Enrolled But Not Treated|1|||
154845918|NCT01467492|558867350|FG001|Overall Study|Enrolled But Not Treated|0|||
154845919|NCT04269395|558867351|FG000|Overall Study|Lost to Follow-up|1|||
154845920|NCT04269395|558867352|FG001|Overall Study|Lost to Follow-up|0|||
154845921|NCT04269395|558867351|FG000|Overall Study|Study terminated by Sponsor|13|||
154845922|NCT04269395|558867352|FG001|Overall Study|Study terminated by Sponsor|10|||
154845923|NCT01491178|558867353|FG000|Overall Study|Adverse Event|1016|||
154845924|NCT01491178|558867353|FG000|Overall Study|Improvement of NVAF|210|||
154845925|NCT01491178|558867353|FG000|Overall Study|To conduct invasive treatment|59|||
154845926|NCT01491178|558867353|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
154845927|NCT01491178|558867353|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
154845928|NCT01491178|558867353|FG000|Overall Study|To take a contraindication|20|||
154845929|NCT01491178|558867353|FG000|Overall Study|Other than specified above|657|||
154845930|NCT05689047|558867356|FG000|Overall Study|Lost to Follow-up|0|||
154845931|NCT05689047|558867357|FG001|Overall Study|Lost to Follow-up|1|||
154845932|NCT05689047|558867356|FG000|Overall Study|Protocol Deviation|1|||
154845933|NCT05689047|558867357|FG001|Overall Study|Protocol Deviation|0|||
154845934|NCT01604512|558867358|FG000|Overall Study|Withdrawal by Subject|3|||
154845935|NCT01604512|558867358|FG000|Overall Study|Not treated|4|||
154845936|NCT01415752|558867359|FG000|Induction (Step 1)|Ineligible|4|||
154845937|NCT01415752|558867360|FG001|Induction (Step 1)|Ineligible|3|||
154845938|NCT01415752|558867361|FG002|Induction (Step 1)|Ineligible|4|||
154845939|NCT01415752|558867362|FG003|Induction (Step 1)|Ineligible|4|||
154845940|NCT01415752|558867359|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
154845941|NCT01415752|558867360|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
154845942|NCT01415752|558867361|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
154845943|NCT01415752|558867362|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
154845944|NCT01415752|558867359|FG000|Maintenance (Step 2)|Adverse Event|3|||
154845945|NCT01415752|558867360|FG001|Maintenance (Step 2)|Adverse Event|4|||
154845946|NCT01415752|558867361|FG002|Maintenance (Step 2)|Adverse Event|9|||
154845947|NCT01415752|558867362|FG003|Maintenance (Step 2)|Adverse Event|6|||
154845948|NCT01415752|558867359|FG000|Maintenance (Step 2)|Death|1|||
154845949|NCT01415752|558867360|FG001|Maintenance (Step 2)|Death|1|||
154845950|NCT01415752|558867361|FG002|Maintenance (Step 2)|Death|2|||
154845951|NCT01415752|558867362|FG003|Maintenance (Step 2)|Death|0|||
154845952|NCT01415752|558867359|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
154845953|NCT01415752|558867360|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
154845954|NCT01415752|558867361|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
154845955|NCT01415752|558867362|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
154845956|NCT01415752|558867359|FG000|Maintenance (Step 2)|Alternative therapy|0|||
154845957|NCT01415752|558867360|FG001|Maintenance (Step 2)|Alternative therapy|1|||
154845958|NCT01415752|558867361|FG002|Maintenance (Step 2)|Alternative therapy|0|||
154845959|NCT01415752|558867362|FG003|Maintenance (Step 2)|Alternative therapy|0|||
154845960|NCT01415752|558867359|FG000|Maintenance (Step 2)|Other reasons|3|||
154845961|NCT01415752|558867360|FG001|Maintenance (Step 2)|Other reasons|6|||
154845962|NCT01415752|558867361|FG002|Maintenance (Step 2)|Other reasons|4|||
154845963|NCT01415752|558867362|FG003|Maintenance (Step 2)|Other reasons|6|||
154845964|NCT01415752|558867359|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
154845965|NCT01415752|558867360|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
154845966|NCT01415752|558867361|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
154845967|NCT01415752|558867362|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
154845968|NCT01415752|558867359|FG000|Maintenance (Step 2)|ineligible|1|||
154845969|NCT01415752|558867360|FG001|Maintenance (Step 2)|ineligible|1|||
154845970|NCT01415752|558867361|FG002|Maintenance (Step 2)|ineligible|1|||
154845971|NCT01415752|558867362|FG003|Maintenance (Step 2)|ineligible|0|||
154845972|NCT01415752|558867359|FG000|Maintenance (Step 2)|Missing|4|||
154845973|NCT01415752|558867360|FG001|Maintenance (Step 2)|Missing|1|||
154845974|NCT01415752|558867361|FG002|Maintenance (Step 2)|Missing|4|||
154845975|NCT01415752|558867362|FG003|Maintenance (Step 2)|Missing|3|||
154845976|NCT03286842|558867363|FG000|Overall Study|Patients rolled over to another study|80|||
154845977|NCT00252057|558867364|FG000|Overall Study|Withdrawal by Subject|2|||
154845978|NCT00252057|558867365|FG001|Overall Study|Withdrawal by Subject|5|||
154845979|NCT00252057|558867364|FG000|Overall Study|Death|1|||
154845980|NCT00252057|558867365|FG001|Overall Study|Death|2|||
154845981|NCT00252057|558867364|FG000|Overall Study|Participant previously enrolled|0|||
154845982|NCT00252057|558867365|FG001|Overall Study|Participant previously enrolled|1|||
154845983|NCT01496066|558867367|FG000|Overall Study|Lost to Follow-up|8|||
154845984|NCT01496066|558867368|FG001|Overall Study|Lost to Follow-up|5|||
154845985|NCT01496066|558867367|FG000|Overall Study|Explant|3|||
154845986|NCT01496066|558867368|FG001|Overall Study|Explant|0|||
154845987|NCT01496066|558867367|FG000|Overall Study|Death|1|||
154845988|NCT01496066|558867368|FG001|Overall Study|Death|4|||
154845989|NCT02926209|558867369|FG000|Study Cohort|Poor Bowel Preparation|1|||
154845990|NCT02926209|558867370|FG001|Study Cohort|Poor Bowel Preparation|0|||
154845991|NCT01587079|558867371|FG000|Overall Study|Protocol-specified criteria|9|||
154845992|NCT01587079|558867371|FG000|Overall Study|Protocol Violation|5|||
154845993|NCT01587079|558867371|FG000|Overall Study|Lost to Follow-up|2|||
154845994|NCT01587079|558867371|FG000|Overall Study|Physician Decision|2|||
154845995|NCT01587079|558867371|FG000|Overall Study|Withdrawal by Subject|7|||
154845996|NCT01587079|558867371|FG000|Overall Study|Adverse Event|14|||
154845997|NCT01764633|558867372|FG000|Overall Study|Withdrawal by Subject|105|||
154845998|NCT01764633|558867373|FG001|Overall Study|Withdrawal by Subject|88|||
154845999|NCT01764633|558867372|FG000|Overall Study|Lost to Follow-up|13|||
154846000|NCT01764633|558867373|FG001|Overall Study|Lost to Follow-up|5|||
154846001|NCT02268058|558867374|FG000|Overall Study|Protocol Violation|1|||
154846002|NCT02268058|558867375|FG001|Overall Study|Protocol Violation|0|||
154846003|NCT02268058|558867376|FG002|Overall Study|Protocol Violation|0|||
154846004|NCT02268058|558867377|FG003|Overall Study|Protocol Violation|0|||
154846005|NCT04781816|558867383|FG000|Overall Study|Adverse Event|0|||
154846006|NCT04781816|558867384|FG001|Overall Study|Adverse Event|1|||
154846007|NCT04781816|558867383|FG000|Overall Study|Withdrawal by Subject|1|||
154846008|NCT04781816|558867384|FG001|Overall Study|Withdrawal by Subject|1|||
154846009|NCT04781816|558867383|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
154846010|NCT04781816|558867384|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
154846011|NCT00643994|558867385|FG000|Overall Study|Death|24|||
154846012|NCT00643994|558867385|FG000|Overall Study|Lost to Follow-up|72|||
154846013|NCT02706730|558867388|FG000|Overall Study|Adverse Event|3|||
154846014|NCT02706730|558867388|FG000|Overall Study|Lack of Efficacy|5|||
154846015|NCT02706730|558867388|FG000|Overall Study|Withdrawal by Subject|11|||
154846016|NCT02706730|558867388|FG000|Overall Study|Study Terminated by Sponsor|11|||
154846017|NCT02706730|558867388|FG000|Overall Study|Subject chose not to receive injection|3|||
154846018|NCT02347176|558867393|FG000|Overall Study|Lost to Follow-up|2|||
154846019|NCT02347176|558867394|FG001|Overall Study|Lost to Follow-up|3|||
154846020|NCT02347176|558867395|FG002|Overall Study|Lost to Follow-up|1|||
154846021|NCT02347176|558867396|FG003|Overall Study|Lost to Follow-up|1|||
154846022|NCT02347176|558867393|FG000|Overall Study|Withdrawal by Subject|9|||
154846023|NCT02347176|558867394|FG001|Overall Study|Withdrawal by Subject|5|||
154846024|NCT02347176|558867395|FG002|Overall Study|Withdrawal by Subject|5|||
154846025|NCT02347176|558867396|FG003|Overall Study|Withdrawal by Subject|3|||
154846026|NCT02347176|558867393|FG000|Overall Study|Other|1|||
154846027|NCT02347176|558867394|FG001|Overall Study|Other|2|||
154846028|NCT02347176|558867395|FG002|Overall Study|Other|2|||
154846029|NCT02347176|558867396|FG003|Overall Study|Other|0|||
154846030|NCT00411554|558867399|FG000|Overall Study|Adverse Event|2|||
154846031|NCT00411554|558867400|FG001|Overall Study|Adverse Event|4|||
154846032|NCT00411554|558867399|FG000|Overall Study|Lack of Efficacy|2|||
154846033|NCT00411554|558867400|FG001|Overall Study|Lack of Efficacy|5|||
154846034|NCT00411554|558867399|FG000|Overall Study|Withdrawal by Subject|3|||
154846035|NCT00411554|558867400|FG001|Overall Study|Withdrawal by Subject|0|||
154846036|NCT00411554|558867399|FG000|Overall Study|Patient Moved|1|||
154846037|NCT00411554|558867400|FG001|Overall Study|Patient Moved|0|||
154846038|NCT01081795|558867405|FG000|Overall Study|Adverse Event|18|||
154846039|NCT01081795|558867406|FG001|Overall Study|Adverse Event|23|||
154846040|NCT01081795|558867407|FG002|Overall Study|Adverse Event|6|||
154846041|NCT01081795|558867405|FG000|Overall Study|Lack of Efficacy|7|||
154846042|NCT01081795|558867406|FG001|Overall Study|Lack of Efficacy|5|||
154846043|NCT01081795|558867407|FG002|Overall Study|Lack of Efficacy|19|||
154846044|NCT01081795|558867405|FG000|Overall Study|Subject's schedule|1|||
154846045|NCT01081795|558867406|FG001|Overall Study|Subject's schedule|1|||
154846046|NCT01081795|558867407|FG002|Overall Study|Subject's schedule|2|||
154846047|NCT01081795|558867405|FG000|Overall Study|Revocation of informed consent|2|||
154846048|NCT01081795|558867406|FG001|Overall Study|Revocation of informed consent|0|||
154846049|NCT01081795|558867407|FG002|Overall Study|Revocation of informed consent|0|||
154846050|NCT01081795|558867405|FG000|Overall Study|Ineligible for participation|1|||
154846051|NCT01081795|558867406|FG001|Overall Study|Ineligible for participation|0|||
154846052|NCT01081795|558867407|FG002|Overall Study|Ineligible for participation|0|||
154846053|NCT01081795|558867405|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
154846054|NCT01081795|558867406|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
154846055|NCT01081795|558867407|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
154846056|NCT01081795|558867405|FG000|Overall Study|Using drug with restricted days of use|2|||
154846057|NCT01081795|558867406|FG001|Overall Study|Using drug with restricted days of use|3|||
154846058|NCT01081795|558867407|FG002|Overall Study|Using drug with restricted days of use|2|||
154846059|NCT01081795|558867405|FG000|Overall Study|Other|1|||
154846060|NCT01081795|558867406|FG001|Overall Study|Other|2|||
154846061|NCT01081795|558867407|FG002|Overall Study|Other|0|||
154846062|NCT02462473|558867408|FG000|Overall Study|Death|1|||
154846063|NCT02462473|558867408|FG000|Overall Study|Other|3|||
154846064|NCT01536860|558867409|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
154846065|NCT01536860|558867410|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
154846066|NCT01536860|558867411|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
154846067|NCT01543087|558867416|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
154846068|NCT01543087|558867417|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
154846069|NCT01543087|558867418|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
154846070|NCT01543087|558867419|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
154846071|NCT01543087|558867420|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
154846072|NCT01543087|558867421|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
154846073|NCT01543087|558867416|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
154846074|NCT01543087|558867417|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
154846075|NCT01543087|558867418|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
154846076|NCT01543087|558867419|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
154846077|NCT01543087|558867420|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
154846078|NCT01543087|558867421|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
154846079|NCT01543087|558867416|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
154846080|NCT01543087|558867417|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
154846081|NCT01543087|558867418|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
154846082|NCT01543087|558867419|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
154846083|NCT01543087|558867420|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
154971221|NCT02846883|559318565|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
154846084|NCT01543087|558867421|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
154846085|NCT01543087|558867416|FG000|Stage 1 (48 Months)|Other than specified|5|||
154846086|NCT01543087|558867417|FG001|Stage 1 (48 Months)|Other than specified|0|||
154846087|NCT01543087|558867418|FG002|Stage 1 (48 Months)|Other than specified|9|||
154846088|NCT01543087|558867419|FG003|Stage 1 (48 Months)|Other than specified|0|||
154846089|NCT01543087|558867420|FG004|Stage 1 (48 Months)|Other than specified|0|||
154846090|NCT01543087|558867421|FG005|Stage 1 (48 Months)|Other than specified|0|||
154846091|NCT01543087|558867416|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
154971222|NCT02846883|559318566|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
154971223|NCT00927251|559318567|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
154971224|NCT00442351|559318571|FG000|Overall Study|Administrative|6|||
154971225|NCT00442351|559318572|FG001|Overall Study|Administrative|5|||
154971226|NCT00442351|559318571|FG000|Overall Study|Did not meet protocol eligibility|1|||
154846092|NCT01543087|558867417|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
154846093|NCT01543087|558867418|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
154846094|NCT01543087|558867419|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
154846095|NCT01543087|558867420|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
154846096|NCT01543087|558867421|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
154846097|NCT01543087|558867416|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
154846098|NCT01543087|558867417|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
154846099|NCT01543087|558867418|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
154846100|NCT01543087|558867419|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
154846101|NCT01543087|558867420|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
154846102|NCT01543087|558867421|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
154846103|NCT01543087|558867416|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
154846104|NCT01543087|558867417|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
154846105|NCT01543087|558867418|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
154846106|NCT01543087|558867419|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
154846107|NCT01543087|558867420|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
154846108|NCT01543087|558867421|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
154846109|NCT04673786|558867423|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
154846110|NCT04673786|558867424|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
154846111|NCT04673786|558867425|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
154846112|NCT04673786|558867423|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
154846113|NCT04673786|558867424|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
154846114|NCT04673786|558867425|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
154846115|NCT04673786|558867423|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
154846116|NCT04673786|558867424|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
154846117|NCT04673786|558867425|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
154846118|NCT04673786|558867423|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
154846119|NCT04673786|558867424|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
154846120|NCT04673786|558867425|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
154846121|NCT04673786|558867423|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
154846122|NCT04673786|558867424|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
154846123|NCT04673786|558867425|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
154846124|NCT04673786|558867423|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
154846125|NCT04673786|558867424|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
154846126|NCT04673786|558867425|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
154846127|NCT00143455|558867428|FG000|Cohort 1|Adverse Event|8|||
154846128|NCT00143455|558867429|FG001|Cohort 1|Adverse Event|4|||
154846129|NCT00143455|558867430|FG002|Cohort 1|Adverse Event|0|||
154846130|NCT00143455|558867431|FG003|Cohort 1|Adverse Event|0|||
154846131|NCT00143455|558867428|FG000|Cohort 1|Death|5|||
154846132|NCT00143455|558867429|FG001|Cohort 1|Death|2|||
154846133|NCT00143455|558867430|FG002|Cohort 1|Death|0|||
154846134|NCT00143455|558867431|FG003|Cohort 1|Death|0|||
154846135|NCT00143455|558867428|FG000|Cohort 1|Progressive Disease|0|||
154846136|NCT00143455|558867429|FG001|Cohort 1|Progressive Disease|6|||
154846137|NCT00143455|558867430|FG002|Cohort 1|Progressive Disease|0|||
154846138|NCT00143455|558867431|FG003|Cohort 1|Progressive Disease|0|||
154846139|NCT00143455|558867428|FG000|Cohort 1|Withdrawal by Subject|1|||
154846140|NCT00143455|558867429|FG001|Cohort 1|Withdrawal by Subject|4|||
154846141|NCT00143455|558867430|FG002|Cohort 1|Withdrawal by Subject|0|||
154846142|NCT00143455|558867431|FG003|Cohort 1|Withdrawal by Subject|0|||
154846143|NCT00143455|558867428|FG000|Cohort 1|Randomized But Not Treated|0|||
154846144|NCT00143455|558867429|FG001|Cohort 1|Randomized But Not Treated|1|||
154846145|NCT00143455|558867430|FG002|Cohort 1|Randomized But Not Treated|0|||
154846146|NCT00143455|558867431|FG003|Cohort 1|Randomized But Not Treated|0|||
154846147|NCT00143455|558867428|FG000|Cohort 2|Adverse Event|0|||
154846148|NCT00143455|558867429|FG001|Cohort 2|Adverse Event|0|||
154846149|NCT00143455|558867430|FG002|Cohort 2|Adverse Event|42|||
154846150|NCT00143455|558867431|FG003|Cohort 2|Adverse Event|30|||
154846151|NCT00143455|558867428|FG000|Cohort 2|No Longer Required Study Treatment|0|||
154846152|NCT00143455|558867429|FG001|Cohort 2|No Longer Required Study Treatment|0|||
154846153|NCT00143455|558867430|FG002|Cohort 2|No Longer Required Study Treatment|1|||
154971227|NCT00442351|559318572|FG001|Overall Study|Did not meet protocol eligibility|0|||
154971228|NCT00442351|559318571|FG000|Overall Study|Other|0|||
154846154|NCT00143455|558867431|FG003|Cohort 2|No Longer Required Study Treatment|0|||
155105060|NCT03592771|559815496|FG001|Overall Study|Death|1|||
155105061|NCT03592771|559815497|FG002|Overall Study|Death|1|||
155105062|NCT03592771|559815495|FG000|Overall Study|Lost to Follow-up|5|||
155105063|NCT03592771|559815496|FG001|Overall Study|Lost to Follow-up|11|||
154846155|NCT00143455|558867428|FG000|Cohort 2|Protocol Violation|0|||
154846156|NCT00143455|558867429|FG001|Cohort 2|Protocol Violation|0|||
154846157|NCT00143455|558867430|FG002|Cohort 2|Protocol Violation|1|||
154846158|NCT00143455|558867431|FG003|Cohort 2|Protocol Violation|1|||
154846159|NCT00143455|558867428|FG000|Cohort 2|Lost to Follow-up|0|||
154846160|NCT00143455|558867429|FG001|Cohort 2|Lost to Follow-up|0|||
154846161|NCT00143455|558867430|FG002|Cohort 2|Lost to Follow-up|1|||
154846162|NCT00143455|558867431|FG003|Cohort 2|Lost to Follow-up|4|||
154846163|NCT00143455|558867428|FG000|Cohort 2|Death|0|||
154846164|NCT00143455|558867429|FG001|Cohort 2|Death|0|||
154846165|NCT00143455|558867430|FG002|Cohort 2|Death|20|||
154846166|NCT00143455|558867431|FG003|Cohort 2|Death|12|||
154846167|NCT00143455|558867428|FG000|Cohort 2|Progressive Disease|0|||
154846168|NCT00143455|558867429|FG001|Cohort 2|Progressive Disease|0|||
154846169|NCT00143455|558867430|FG002|Cohort 2|Progressive Disease|20|||
154846170|NCT00143455|558867431|FG003|Cohort 2|Progressive Disease|27|||
154846171|NCT00143455|558867428|FG000|Cohort 2|Withdrawal by Subject|0|||
154846172|NCT00143455|558867429|FG001|Cohort 2|Withdrawal by Subject|0|||
154846173|NCT00143455|558867430|FG002|Cohort 2|Withdrawal by Subject|13|||
154846174|NCT00143455|558867431|FG003|Cohort 2|Withdrawal by Subject|12|||
154846175|NCT00143455|558867428|FG000|Cohort 2|Other|0|||
154846176|NCT00143455|558867429|FG001|Cohort 2|Other|0|||
154846177|NCT00143455|558867430|FG002|Cohort 2|Other|7|||
154846178|NCT00143455|558867431|FG003|Cohort 2|Other|6|||
154846179|NCT00143455|558867428|FG000|Cohort 2|Randomized But Not Treated|0|||
154846180|NCT00143455|558867429|FG001|Cohort 2|Randomized But Not Treated|0|||
154846181|NCT00143455|558867430|FG002|Cohort 2|Randomized But Not Treated|1|||
154846182|NCT00143455|558867431|FG003|Cohort 2|Randomized But Not Treated|1|||
154846183|NCT01298492|558867432|FG000|Overall Study|Death|2|||
154846184|NCT01298492|558867432|FG000|Overall Study|Insufficient Clinical Response|22|||
154846185|NCT01298492|558867432|FG000|Overall Study|Lost to Follow-up|12|||
154846186|NCT01298492|558867432|FG000|Overall Study|Withdrawal by Subject|47|||
154846187|NCT01298492|558867432|FG000|Overall Study|Other (Unspecified)|7|||
154846188|NCT01298492|558867432|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
154846189|NCT01298492|558867432|FG000|Overall Study|Protocol Violation|2|||
154846190|NCT01298492|558867432|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
154846191|NCT01298492|558867432|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
154846192|NCT02902120|558867433|FG000|Overall Study|Lack of Efficacy|1|||
154846193|NCT03298022|558867435|FG000|Overall Study|Lack of Efficacy|4|||
154846194|NCT03298022|558867435|FG000|Overall Study|Withdrawal by Subject|7|||
154846195|NCT03298022|558867435|FG000|Overall Study|Adverse Event|1|||
154846196|NCT03298022|558867435|FG000|Overall Study|disease relapse|1|||
154846197|NCT03694925|558867436|FG000|Overall Study|Inadequate laboratory testing|0|||
154846198|NCT03694925|558867437|FG001|Overall Study|Inadequate laboratory testing|3|||
154846199|NCT03694925|558867438|FG002|Overall Study|Inadequate laboratory testing|0|||
154846200|NCT01422239|558867439|FG000|Overall Study|Lost to Follow-up|4|||
154846201|NCT01422239|558867440|FG001|Overall Study|Lost to Follow-up|3|||
154846202|NCT03467958|558867441|FG000|Overall Study|Adverse Event|20|||
154846203|NCT03467958|558867442|FG001|Overall Study|Adverse Event|32|||
154846204|NCT03467958|558867443|FG002|Overall Study|Adverse Event|5|||
154846205|NCT03467958|558867444|FG003|Overall Study|Adverse Event|3|||
154846206|NCT03467958|558867445|FG004|Overall Study|Adverse Event|3|||
154846207|NCT03467958|558867446|FG005|Overall Study|Adverse Event|3|||
154846208|NCT03467958|558867447|FG006|Overall Study|Adverse Event|6|||
154846209|NCT03467958|558867448|FG007|Overall Study|Adverse Event|5|||
154846210|NCT03467958|558867449|FG008|Overall Study|Adverse Event|0|||
154846211|NCT03467958|558867441|FG000|Overall Study|Lack of Efficacy|59|||
154846212|NCT03467958|558867442|FG001|Overall Study|Lack of Efficacy|120|||
154846213|NCT03467958|558867443|FG002|Overall Study|Lack of Efficacy|6|||
154846214|NCT03467958|558867444|FG003|Overall Study|Lack of Efficacy|9|||
154846215|NCT03467958|558867445|FG004|Overall Study|Lack of Efficacy|8|||
154846216|NCT03467958|558867446|FG005|Overall Study|Lack of Efficacy|9|||
154846217|NCT03467958|558867447|FG006|Overall Study|Lack of Efficacy|11|||
154846218|NCT03467958|558867448|FG007|Overall Study|Lack of Efficacy|9|||
154846219|NCT03467958|558867449|FG008|Overall Study|Lack of Efficacy|3|||
154846220|NCT03467958|558867441|FG000|Overall Study|Lost to Follow-up|1|||
154846221|NCT03467958|558867442|FG001|Overall Study|Lost to Follow-up|2|||
155105064|NCT03592771|559815497|FG002|Overall Study|Lost to Follow-up|15|||
155105065|NCT03592771|559815495|FG000|Overall Study|Withdrawal by Subject|0|||
154846222|NCT03467958|558867443|FG002|Overall Study|Lost to Follow-up|1|||
154846223|NCT03467958|558867444|FG003|Overall Study|Lost to Follow-up|0|||
154846224|NCT03467958|558867445|FG004|Overall Study|Lost to Follow-up|4|||
154846225|NCT03467958|558867446|FG005|Overall Study|Lost to Follow-up|0|||
154846226|NCT03467958|558867447|FG006|Overall Study|Lost to Follow-up|0|||
154846227|NCT03467958|558867448|FG007|Overall Study|Lost to Follow-up|0|||
155105066|NCT03592771|559815496|FG001|Overall Study|Withdrawal by Subject|2|||
154846228|NCT03467958|558867449|FG008|Overall Study|Lost to Follow-up|0|||
154846229|NCT03467958|558867441|FG000|Overall Study|Other reasons|8|||
154846230|NCT03467958|558867442|FG001|Overall Study|Other reasons|14|||
154846231|NCT03467958|558867443|FG002|Overall Study|Other reasons|2|||
154846232|NCT03467958|558867444|FG003|Overall Study|Other reasons|1|||
154846233|NCT03467958|558867445|FG004|Overall Study|Other reasons|4|||
154846234|NCT03467958|558867446|FG005|Overall Study|Other reasons|0|||
154846235|NCT03467958|558867447|FG006|Overall Study|Other reasons|1|||
154846236|NCT03467958|558867448|FG007|Overall Study|Other reasons|0|||
154846237|NCT03467958|558867449|FG008|Overall Study|Other reasons|1|||
154846238|NCT03467958|558867441|FG000|Overall Study|Pregnancy|1|||
154846239|NCT03467958|558867442|FG001|Overall Study|Pregnancy|0|||
154846240|NCT03467958|558867443|FG002|Overall Study|Pregnancy|0|||
154846241|NCT03467958|558867444|FG003|Overall Study|Pregnancy|0|||
154846242|NCT03467958|558867445|FG004|Overall Study|Pregnancy|0|||
154846243|NCT03467958|558867446|FG005|Overall Study|Pregnancy|1|||
154846244|NCT03467958|558867447|FG006|Overall Study|Pregnancy|0|||
154846245|NCT03467958|558867448|FG007|Overall Study|Pregnancy|0|||
154846246|NCT03467958|558867449|FG008|Overall Study|Pregnancy|0|||
154846247|NCT03467958|558867441|FG000|Overall Study|Study terminated by sponsor|65|||
154846248|NCT03467958|558867442|FG001|Overall Study|Study terminated by sponsor|117|||
154846249|NCT03467958|558867443|FG002|Overall Study|Study terminated by sponsor|45|||
154846250|NCT03467958|558867444|FG003|Overall Study|Study terminated by sponsor|64|||
154846251|NCT03467958|558867445|FG004|Overall Study|Study terminated by sponsor|66|||
154846252|NCT03467958|558867446|FG005|Overall Study|Study terminated by sponsor|17|||
154846253|NCT03467958|558867447|FG006|Overall Study|Study terminated by sponsor|11|||
154846254|NCT03467958|558867448|FG007|Overall Study|Study terminated by sponsor|5|||
154846255|NCT03467958|558867449|FG008|Overall Study|Study terminated by sponsor|5|||
154846256|NCT03467958|558867441|FG000|Overall Study|Withdrawal by Subject|25|||
154846257|NCT03467958|558867442|FG001|Overall Study|Withdrawal by Subject|44|||
154846258|NCT03467958|558867443|FG002|Overall Study|Withdrawal by Subject|7|||
154846259|NCT03467958|558867444|FG003|Overall Study|Withdrawal by Subject|8|||
154846260|NCT03467958|558867445|FG004|Overall Study|Withdrawal by Subject|6|||
154846261|NCT03467958|558867446|FG005|Overall Study|Withdrawal by Subject|8|||
154846262|NCT03467958|558867447|FG006|Overall Study|Withdrawal by Subject|4|||
154846263|NCT03467958|558867448|FG007|Overall Study|Withdrawal by Subject|1|||
154846264|NCT03467958|558867449|FG008|Overall Study|Withdrawal by Subject|4|||
154846265|NCT01687712|558867450|FG000|Cycle 1|Not Biochemically Pregnant|386|||
154846266|NCT01687712|558867451|FG001|Cycle 1|Not Biochemically Pregnant|348|||
154846267|NCT01687712|558867450|FG000|Cycle 1|Early Pregnancy Loss|43|||
154846268|NCT01687712|558867451|FG001|Cycle 1|Early Pregnancy Loss|60|||
154846269|NCT01687712|558867450|FG000|Cycle 1|Ectopic Pregnancy|5|||
154846270|NCT01687712|558867451|FG001|Cycle 1|Ectopic Pregnancy|5|||
154846271|NCT01687712|558867450|FG000|Cycle 1|Heterotropic Pregnancy|1|||
154846272|NCT01687712|558867451|FG001|Cycle 1|Heterotropic Pregnancy|0|||
154846273|NCT01687712|558867450|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
154846274|NCT01687712|558867451|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
154846275|NCT01687712|558867450|FG000|Cycle 1|Abortion|3|||
154846276|NCT01687712|558867451|FG001|Cycle 1|Abortion|0|||
154846277|NCT01687712|558867450|FG000|Cycle 1|Intrauterine Fetal Death|0|||
154846278|NCT01687712|558867451|FG001|Cycle 1|Intrauterine Fetal Death|1|||
154846279|NCT01687712|558867450|FG000|Cycle 1|Lost to Follow-up|1|||
154846280|NCT01687712|558867451|FG001|Cycle 1|Lost to Follow-up|1|||
154846281|NCT01687712|558867450|FG000|Cycle 2|Not Biochemically Pregnant|74|||
154846282|NCT01687712|558867451|FG001|Cycle 2|Not Biochemically Pregnant|77|||
154846283|NCT01687712|558867450|FG000|Cycle 2|Early Pregnancy Loss|18|||
154846284|NCT01687712|558867451|FG001|Cycle 2|Early Pregnancy Loss|16|||
154971229|NCT00442351|559318572|FG001|Overall Study|Other|1|||
154971230|NCT01074008|559318580|FG000|Overall Study|Adverse Event|0|||
154971231|NCT01074008|559318581|FG001|Overall Study|Adverse Event|1|||
154971232|NCT01074008|559318582|FG002|Overall Study|Adverse Event|0|||
154846285|NCT01687712|558867450|FG000|Cycle 2|Ectopic Pregnancy|0|||
154846286|NCT01687712|558867451|FG001|Cycle 2|Ectopic Pregnancy|1|||
154846287|NCT01687712|558867450|FG000|Cycle 2|Still Birth|1|||
154846288|NCT01687712|558867451|FG001|Cycle 2|Still Birth|0|||
154846289|NCT01687712|558867450|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
154846290|NCT01687712|558867451|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
154846291|NCT01687712|558867450|FG000|Cycle 3|Not Biochemically Pregnant|21|||
154971233|NCT01074008|559318583|FG003|Overall Study|Adverse Event|0|||
154971234|NCT01074008|559318584|FG004|Overall Study|Adverse Event|0|||
155173550|NCT02870933|560074818|FG000|Overall Study|Death|2|||
154846292|NCT01687712|558867451|FG001|Cycle 3|Not Biochemically Pregnant|22|||
154846293|NCT01687712|558867450|FG000|Cycle 3|Early Pregnancy Loss|1|||
154846294|NCT01687712|558867451|FG001|Cycle 3|Early Pregnancy Loss|2|||
154846295|NCT01687712|558867450|FG000|Cycle 3|Ectopic Pregnancy|1|||
154846296|NCT01687712|558867451|FG001|Cycle 3|Ectopic Pregnancy|0|||
154846297|NCT01687712|558867450|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
154846298|NCT01687712|558867451|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
154846299|NCT00516737|558867456|FG000|Overall Study|Lost to Follow-up|2|||
154846300|NCT00516737|558867457|FG001|Overall Study|Lost to Follow-up|0|||
154971235|NCT01074008|559318585|FG005|Overall Study|Adverse Event|0|||
154846301|NCT00516737|558867456|FG000|Overall Study|Physician Decision|0|||
154846302|NCT00516737|558867457|FG001|Overall Study|Physician Decision|1|||
154846303|NCT00516737|558867456|FG000|Overall Study|Withdrawal by Subject|0|||
154846304|NCT00516737|558867457|FG001|Overall Study|Withdrawal by Subject|1|||
154846305|NCT00516737|558867456|FG000|Overall Study|Lack of Qualifying Event|9|||
154846306|NCT00516737|558867457|FG001|Overall Study|Lack of Qualifying Event|6|||
154846307|NCT01844895|558867458|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
154846308|NCT01844895|558867458|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
154846309|NCT01844895|558867458|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
154846310|NCT01844895|558867458|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
154846311|NCT01844895|558867458|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
154846312|NCT01844895|558867458|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
154846313|NCT01844895|558867458|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
154846314|NCT00848354|558867459|FG000|Phase 1|Adverse Event|5|||
154846315|NCT00848354|558867460|FG001|Phase 1|Adverse Event|4|||
154846316|NCT00848354|558867459|FG000|Phase 1|Discontinuation of study by sponsor|2|||
154846317|NCT00848354|558867460|FG001|Phase 1|Discontinuation of study by sponsor|1|||
154846318|NCT00848354|558867459|FG000|Phase 1|Failed to return|0|||
154846319|NCT00848354|558867460|FG001|Phase 1|Failed to return|1|||
154846320|NCT00848354|558867459|FG000|Phase 1|Lost to Follow-up|1|||
154846321|NCT00848354|558867460|FG001|Phase 1|Lost to Follow-up|1|||
154846322|NCT00848354|558867459|FG000|Phase 1|Unspecified Reason|1|||
154846323|NCT00848354|558867460|FG001|Phase 1|Unspecified Reason|1|||
154846324|NCT00848354|558867459|FG000|Phase 1|Protocol Violation|1|||
154846325|NCT00848354|558867460|FG001|Phase 1|Protocol Violation|1|||
154846326|NCT00848354|558867459|FG000|Phase 1|Withdrawal by Subject|2|||
154846327|NCT00848354|558867460|FG001|Phase 1|Withdrawal by Subject|4|||
154846328|NCT00848354|558867459|FG000|Phase 1|Lack of Efficacy|0|||
154846329|NCT00848354|558867460|FG001|Phase 1|Lack of Efficacy|1|||
154846330|NCT00848354|558867459|FG000|Phase 2 Year 1|Adverse Event|7|||
154846331|NCT00848354|558867460|FG001|Phase 2 Year 1|Adverse Event|2|||
154846332|NCT00848354|558867459|FG000|Phase 2 Year 1|Death|1|||
154846333|NCT00848354|558867460|FG001|Phase 2 Year 1|Death|0|||
154846334|NCT00848354|558867459|FG000|Phase 2 Year 1|Failed to Return|1|||
154846335|NCT00848354|558867460|FG001|Phase 2 Year 1|Failed to Return|1|||
154846336|NCT00848354|558867459|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
154846337|NCT00848354|558867460|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
154846338|NCT00848354|558867459|FG000|Phase 2 Year 1|Unspecified Reason|3|||
154846339|NCT00848354|558867460|FG001|Phase 2 Year 1|Unspecified Reason|0|||
154846340|NCT00848354|558867459|FG000|Phase 2 Year 1|Protocol Violation|4|||
154846341|NCT00848354|558867460|FG001|Phase 2 Year 1|Protocol Violation|1|||
154846342|NCT00848354|558867459|FG000|Phase 2 Year 1|Subject Request|1|||
154846343|NCT00848354|558867460|FG001|Phase 2 Year 1|Subject Request|2|||
154846344|NCT00848354|558867459|FG000|Phase 2 Year 2|Adverse Event|12|||
154846345|NCT00848354|558867460|FG001|Phase 2 Year 2|Adverse Event|2|||
154846346|NCT00848354|558867459|FG000|Phase 2 Year 2|Death|2|||
154846347|NCT00848354|558867460|FG001|Phase 2 Year 2|Death|0|||
154846348|NCT00848354|558867459|FG000|Phase 2 Year 2|Failed to return|3|||
154846349|NCT00848354|558867460|FG001|Phase 2 Year 2|Failed to return|0|||
154846350|NCT00848354|558867459|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
154846351|NCT00848354|558867460|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
154846352|NCT00848354|558867459|FG000|Phase 2 Year 2|Unspecified Reason|1|||
154846353|NCT00848354|558867460|FG001|Phase 2 Year 2|Unspecified Reason|0|||
154846354|NCT00848354|558867459|FG000|Phase 2 Year 2|Protocol Violation|1|||
154846355|NCT00848354|558867460|FG001|Phase 2 Year 2|Protocol Violation|1|||
154846356|NCT00848354|558867459|FG000|Phase 2 Year 2|Subject Request|1|||
154846357|NCT00848354|558867460|FG001|Phase 2 Year 2|Subject Request|1|||
154846358|NCT00848354|558867459|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
154846359|NCT00848354|558867460|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
154846360|NCT00512798|558867463|FG000|Overall Study|Death|0|||
154846361|NCT00512798|558867464|FG001|Overall Study|Death|3|||
154846362|NCT00512798|558867463|FG000|Overall Study|Adverse Event|2|||
154846363|NCT00512798|558867464|FG001|Overall Study|Adverse Event|4|||
154846364|NCT00512798|558867463|FG000|Overall Study|Progression of disease|14|||
154846365|NCT00512798|558867464|FG001|Overall Study|Progression of disease|20|||
154846366|NCT00512798|558867463|FG000|Overall Study|Withdrawal by Subject|3|||
154846367|NCT00512798|558867464|FG001|Overall Study|Withdrawal by Subject|0|||
154846368|NCT00915343|558867465|FG000|Part B - Open Label Period|Treatment switch|0|||
154846369|NCT00915343|558867466|FG001|Part B - Open Label Period|Treatment switch|0|||
154846370|NCT00915343|558867467|FG002|Part B - Open Label Period|Treatment switch|1|||
154846371|NCT00915343|558867465|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
154846372|NCT00915343|558867466|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
154846373|NCT00915343|558867467|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
154846374|NCT00911989|558867468|FG000|Overall Study|Adverse Event|1|||
154846375|NCT03064841|558867469|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
154846376|NCT03064841|558867469|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
154846377|NCT03064841|558867469|FG000|Overall Study|Screen failure|2|||
154846378|NCT03434977|558867470|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
154846379|NCT03434977|558867471|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
154846380|NCT01250379|558867472|FG000|Overall Study|Death|141|||
154846381|NCT01250379|558867473|FG001|Overall Study|Death|148|||
154846382|NCT01250379|558867472|FG000|Overall Study|Withdrawal by Subject|32|||
154846383|NCT01250379|558867473|FG001|Overall Study|Withdrawal by Subject|20|||
154846384|NCT01250379|558867472|FG000|Overall Study|Physician Decision|11|||
154846385|NCT01250379|558867473|FG001|Overall Study|Physician Decision|3|||
154846386|NCT01250379|558867472|FG000|Overall Study|Protocol Violation|2|||
154846387|NCT01250379|558867473|FG001|Overall Study|Protocol Violation|8|||
154846388|NCT01250379|558867472|FG000|Overall Study|Lost to Follow-up|9|||
154846389|NCT01250379|558867473|FG001|Overall Study|Lost to Follow-up|6|||
154846390|NCT01250379|558867472|FG000|Overall Study|Adverse Event|5|||
154846391|NCT01250379|558867473|FG001|Overall Study|Adverse Event|4|||
154846392|NCT01250379|558867472|FG000|Overall Study|Other|0|||
154846393|NCT01250379|558867473|FG001|Overall Study|Other|4|||
154846394|NCT01250379|558867472|FG000|Overall Study|Participant noncompliance|2|||
154846395|NCT01250379|558867473|FG001|Overall Study|Participant noncompliance|0|||
154846396|NCT01314716|558867474|FG000|Double-Blind Phase|Randomized but not treated|1|||
154846397|NCT01314716|558867475|FG001|Double-Blind Phase|Randomized but not treated|1|||
154846398|NCT01314716|558867474|FG000|Double-Blind Phase|Adverse Event|10|||
154846399|NCT01314716|558867475|FG001|Double-Blind Phase|Adverse Event|4|||
154846400|NCT01314716|558867474|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
154846401|NCT01314716|558867475|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
154846402|NCT01314716|558867474|FG000|Double-Blind Phase|Lost to Follow-up|0|||
154846403|NCT01314716|558867475|FG001|Double-Blind Phase|Lost to Follow-up|1|||
154846404|NCT01314716|558867474|FG000|Double-Blind Phase|Sponsor request|1|||
154846405|NCT01314716|558867475|FG001|Double-Blind Phase|Sponsor request|2|||
154846406|NCT01314716|558867474|FG000|Double-Blind Phase|Physician Decision|0|||
154846407|NCT01314716|558867475|FG001|Double-Blind Phase|Physician Decision|1|||
154846408|NCT01314716|558867474|FG000|Open-Label Phase|Adverse Event|4|||
154846409|NCT01314716|558867475|FG001|Open-Label Phase|Adverse Event|6|||
154846410|NCT01314716|558867474|FG000|Open-Label Phase|Withdrawal by Subject|1|||
154846411|NCT01314716|558867475|FG001|Open-Label Phase|Withdrawal by Subject|2|||
154846412|NCT01314716|558867474|FG000|Open-Label Phase|Physician Decision|5|||
154846413|NCT01314716|558867475|FG001|Open-Label Phase|Physician Decision|4|||
154846414|NCT03087955|558868986|FG000|Overall Study|Death|4|||
154846415|NCT03087955|558868987|FG001|Overall Study|Death|0|||
154846416|NCT03087955|558868986|FG000|Overall Study|Lack of Efficacy|2|||
154846417|NCT03087955|558868987|FG001|Overall Study|Lack of Efficacy|0|||
154846418|NCT03087955|558868986|FG000|Overall Study|Lost to Follow-up|1|||
154846419|NCT03087955|558868987|FG001|Overall Study|Lost to Follow-up|0|||
154846420|NCT03266016|558868994|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
154846421|NCT03266016|558868995|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
154846422|NCT03266016|558868996|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
154846423|NCT03266016|558868997|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
154846424|NCT03266016|558868994|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
154846425|NCT03266016|558868995|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
154846426|NCT03266016|558868996|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
154846427|NCT03266016|558868997|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
154846428|NCT00403260|558869000|FG000|Overall Study|Adverse Event|5|||
154846429|NCT00403260|558869001|FG001|Overall Study|Adverse Event|4|||
154846430|NCT00403260|558869000|FG000|Overall Study|Withdrawal by Subject|5|||
154846431|NCT00403260|558869001|FG001|Overall Study|Withdrawal by Subject|6|||
154846432|NCT00403260|558869000|FG000|Overall Study|Lost to Follow-up|49|||
154846433|NCT00403260|558869001|FG001|Overall Study|Lost to Follow-up|25|||
154846434|NCT00403260|558869000|FG000|Overall Study|Re-appearance of P. falciparum|34|||
154846435|NCT00403260|558869001|FG001|Overall Study|Re-appearance of P. falciparum|25|||
154846436|NCT00403260|558869000|FG000|Overall Study|P. vivax infection|26|||
154846437|NCT00403260|558869001|FG001|Overall Study|P. vivax infection|4|||
154846438|NCT00403260|558869000|FG000|Overall Study|Mixed infection with P. vivax|2|||
154846439|NCT00403260|558869001|FG001|Overall Study|Mixed infection with P. vivax|0|||
154846440|NCT00403260|558869000|FG000|Overall Study|Mixed infection with P. falciparum|1|||
154971236|NCT01074008|559318586|FG006|Overall Study|Adverse Event|0|||
154846441|NCT00403260|558869001|FG001|Overall Study|Mixed infection with P. falciparum|0|||
154846442|NCT00403260|558869000|FG000|Overall Study|P. vivax infection at screening|1|||
154846443|NCT00403260|558869001|FG001|Overall Study|P. vivax infection at screening|0|||
155105067|NCT03592771|559815497|FG002|Overall Study|Withdrawal by Subject|0|||
154846444|NCT00403260|558869000|FG000|Overall Study|P. ovale infection|1|||
154846445|NCT00403260|558869001|FG001|Overall Study|P. ovale infection|0|||
154846446|NCT00403260|558869000|FG000|Overall Study|Gametocyte re-appearance|1|||
154846447|NCT00403260|558869001|FG001|Overall Study|Gametocyte re-appearance|1|||
154846448|NCT00403260|558869000|FG000|Overall Study|Withdrawn from study accidentally|0|||
154846449|NCT00403260|558869001|FG001|Overall Study|Withdrawn from study accidentally|1|||
154846450|NCT02968810|558869002|FG000|Overall Study|Lost to Follow-up|1|||
154846451|NCT02968810|558869003|FG001|Overall Study|Lost to Follow-up|0|||
154846452|NCT02968810|558869002|FG000|Overall Study|Physician Decision|1|||
154846453|NCT02968810|558869003|FG001|Overall Study|Physician Decision|0|||
154846454|NCT02968810|558869002|FG000|Overall Study|Withdrawal by Subject|1|||
154846455|NCT02968810|558869003|FG001|Overall Study|Withdrawal by Subject|3|||
154846456|NCT02968810|558869002|FG000|Overall Study|Disease Progression|0|||
154846457|NCT02968810|558869003|FG001|Overall Study|Disease Progression|1|||
154846458|NCT01535729|558869004|FG000|Overall Study|Withdrawal by Subject|2|||
154846459|NCT01535729|558869004|FG000|Overall Study|Disease progression|230|||
154846460|NCT01535729|558869004|FG000|Overall Study|Discontinued treatment|25|||
154846461|NCT01535729|558869004|FG000|Overall Study|Lost to Follow-up|8|||
154846462|NCT01535729|558869004|FG000|Overall Study|Death|52|||
154846463|NCT01535729|558869004|FG000|Overall Study|Other|19|||
154846464|NCT01535729|558869004|FG000|Overall Study|Did not sign informed consent|1|||
154846465|NCT01535729|558869004|FG000|Overall Study|No previous chemotherapy|33|||
154846466|NCT01535729|558869004|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
154846467|NCT01535729|558869004|FG000|Overall Study|Protocol Violation|11|||
154846468|NCT01535729|558869004|FG000|Overall Study|Screening failure|1|||
154846469|NCT01535729|558869004|FG000|Overall Study|Not treated|9|||
154846470|NCT01535729|558869004|FG000|Overall Study|No participant record available|5|||
154846471|NCT02944448|558869005|FG000|Overall Study|Adverse Event|37|||
154846472|NCT02944448|558869006|FG001|Overall Study|Adverse Event|6|||
154846473|NCT02944448|558869005|FG000|Overall Study|Lack of Efficacy|8|||
154846474|NCT02944448|558869006|FG001|Overall Study|Lack of Efficacy|5|||
154846475|NCT02944448|558869005|FG000|Overall Study|Lost to Follow-up|3|||
154846476|NCT02944448|558869006|FG001|Overall Study|Lost to Follow-up|1|||
154846477|NCT02944448|558869005|FG000|Overall Study|Protocol Violation|25|||
154846478|NCT02944448|558869006|FG001|Overall Study|Protocol Violation|7|||
154846479|NCT02944448|558869005|FG000|Overall Study|Withdrawal by Subject|14|||
154846480|NCT02944448|558869006|FG001|Overall Study|Withdrawal by Subject|4|||
154846481|NCT02944448|558869005|FG000|Overall Study|Sponsor did not supply drug in time|0|||
154846482|NCT02944448|558869006|FG001|Overall Study|Sponsor did not supply drug in time|1|||
154846483|NCT02944448|558869005|FG000|Overall Study|Noncompliant with dosing|1|||
154846484|NCT02944448|558869006|FG001|Overall Study|Noncompliant with dosing|0|||
154846485|NCT02944448|558869005|FG000|Overall Study|Abnormal laboratory values|1|||
154846486|NCT02944448|558869006|FG001|Overall Study|Abnormal laboratory values|0|||
154846487|NCT00716976|558869012|FG000|Overall Study|Adverse Event|2|||
154846488|NCT00716976|558869013|FG001|Overall Study|Adverse Event|0|||
154846489|NCT00716976|558869012|FG000|Overall Study|Death|1|||
154846490|NCT00716976|558869013|FG001|Overall Study|Death|0|||
154846491|NCT00716976|558869012|FG000|Overall Study|Physician Decision|2|||
154846492|NCT00716976|558869013|FG001|Overall Study|Physician Decision|2|||
154846493|NCT00716976|558869012|FG000|Overall Study|Withdrawal by Subject|5|||
154846494|NCT00716976|558869013|FG001|Overall Study|Withdrawal by Subject|1|||
154846495|NCT00716976|558869012|FG000|Overall Study|Premature discontinuation cisplatin|5|||
154846496|NCT00716976|558869013|FG001|Overall Study|Premature discontinuation cisplatin|4|||
154846497|NCT00716976|558869012|FG000|Overall Study|Radiation during protocol|1|||
154846498|NCT00716976|558869013|FG001|Overall Study|Radiation during protocol|0|||
154846499|NCT00716976|558869012|FG000|Overall Study|Ineligibles|4|||
154846500|NCT00716976|558869013|FG001|Overall Study|Ineligibles|2|||
154846501|NCT00805740|558869018|FG000|Overall Study|Death|7|||
154846502|NCT00805740|558869019|FG001|Overall Study|Death|4|||
154846503|NCT00805740|558869018|FG000|Overall Study|Withdrawal by Subject|1|||
154846504|NCT00805740|558869019|FG001|Overall Study|Withdrawal by Subject|0|||
154846505|NCT00805740|558869018|FG000|Overall Study|Lost to Follow-up|1|||
154846506|NCT00805740|558869019|FG001|Overall Study|Lost to Follow-up|0|||
154846507|NCT00805740|558869018|FG000|Overall Study|Randomized, but not treated|2|||
154846508|NCT00805740|558869019|FG001|Overall Study|Randomized, but not treated|0|||
154846509|NCT05227690|558869027|FG000|Overall Study|Adverse Event|5|||
154846510|NCT05227690|558869028|FG001|Overall Study|Adverse Event|6|||
154846511|NCT05227690|558869029|FG002|Overall Study|Adverse Event|10|||
154846512|NCT05227690|558869027|FG000|Overall Study|Lack of Efficacy|2|||
154846513|NCT05227690|558869028|FG001|Overall Study|Lack of Efficacy|4|||
154846514|NCT05227690|558869029|FG002|Overall Study|Lack of Efficacy|1|||
154846515|NCT05227690|558869027|FG000|Overall Study|Physician Decision|6|||
155105068|NCT05069597|559815498|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
155173551|NCT02870933|560074819|FG001|Overall Study|Death|1|||
154846516|NCT05227690|558869028|FG001|Overall Study|Physician Decision|0|||
154846517|NCT05227690|558869029|FG002|Overall Study|Physician Decision|4|||
154846518|NCT05227690|558869027|FG000|Overall Study|Withdrawal of consent|28|||
154846519|NCT05227690|558869028|FG001|Overall Study|Withdrawal of consent|27|||
154846520|NCT05227690|558869029|FG002|Overall Study|Withdrawal of consent|21|||
154846521|NCT05227690|558869027|FG000|Overall Study|Other, not specified|2|||
154846522|NCT05227690|558869028|FG001|Overall Study|Other, not specified|2|||
154846523|NCT05227690|558869029|FG002|Overall Study|Other, not specified|1|||
154846524|NCT04033367|558869030|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
154846525|NCT04033367|558869031|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
154846526|NCT04033367|558869030|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
154846527|NCT04033367|558869031|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
154846528|NCT04033367|558869030|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
155105069|NCT05069597|559815499|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
155105070|NCT00735553|559815500|FG000|Overall Study|Study prematurely terminated|77|||
155105071|NCT02707965|559815502|FG000|Overall Study|Withdrawal by Subject|0|||
155105072|NCT02707965|559815503|FG001|Overall Study|Withdrawal by Subject|0|||
155105073|NCT02707965|559815504|FG002|Overall Study|Withdrawal by Subject|1|||
155105074|NCT02707965|559815505|FG003|Overall Study|Withdrawal by Subject|0|||
155105075|NCT02707965|559815506|FG004|Overall Study|Withdrawal by Subject|0|||
155105076|NCT02707965|559815507|FG005|Overall Study|Withdrawal by Subject|0|||
155105077|NCT02707965|559815508|FG006|Overall Study|Withdrawal by Subject|0|||
155105078|NCT02707965|559815509|FG007|Overall Study|Withdrawal by Subject|2|||
155105079|NCT02707965|559815510|FG008|Overall Study|Withdrawal by Subject|0|||
155105080|NCT02707965|559815511|FG009|Overall Study|Withdrawal by Subject|0|||
155105081|NCT02707965|559815512|FG010|Overall Study|Withdrawal by Subject|0|||
155105082|NCT02707965|559815513|FG011|Overall Study|Withdrawal by Subject|0|||
155105083|NCT02707965|559815514|FG012|Overall Study|Withdrawal by Subject|0|||
155105084|NCT02707965|559815515|FG013|Overall Study|Withdrawal by Subject|0|||
154846529|NCT04033367|558869031|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
154846530|NCT04033367|558869030|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
154846531|NCT04033367|558869031|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
154846532|NCT01191697|558869032|FG000|Overall Study|Death|1|||
154846533|NCT01191697|558869032|FG000|Overall Study|Physician Decision|2|||
154846534|NCT01191697|558869032|FG000|Overall Study|Pursue chemoradiation|2|||
154846535|NCT01191697|558869032|FG000|Overall Study|Break from chemotherapy|2|||
154846536|NCT01191697|558869032|FG000|Overall Study|Withdrawal by Subject|1|||
154846537|NCT01191697|558869032|FG000|Overall Study|Surveillance|1|||
154846538|NCT01191697|558869032|FG000|Overall Study|Adverse Event|2|||
154846539|NCT01191697|558869032|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
154846540|NCT01191697|558869032|FG000|Overall Study|Not completed but analyzed|25|||
154846541|NCT01534676|558869033|FG000|Overall Study|Study closed due to poor enrollment|2|||
154846542|NCT01534676|558869034|FG001|Overall Study|Study closed due to poor enrollment|1|||
154846543|NCT02634580|558869035|FG000|Double-blind Treatment Period|Subject Request|1|||
154846544|NCT02634580|558869036|FG001|Double-blind Treatment Period|Subject Request|0|||
154846545|NCT02634580|558869037|FG002|Double-blind Treatment Period|Subject Request|1|||
154846546|NCT02634580|558869038|FG003|Double-blind Treatment Period|Subject Request|1|||
154846547|NCT02634580|558869035|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
154846548|NCT02634580|558869036|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
154846549|NCT02634580|558869037|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
154846550|NCT02634580|558869038|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
154846551|NCT01396005|558869039|FG000|Overall Study|Withdrawal by Subject|0|||
154846552|NCT01396005|558869040|FG001|Overall Study|Withdrawal by Subject|1|||
154846553|NCT01396005|558869039|FG000|Overall Study|Non-compliance with protocol|0|||
154846554|NCT01396005|558869040|FG001|Overall Study|Non-compliance with protocol|1|||
154846555|NCT03132636|558869043|FG000|Overall Study|Adverse Event|1|||
154846556|NCT03132636|558869044|FG001|Overall Study|Adverse Event|2|||
154846557|NCT03132636|558869043|FG000|Overall Study|Death|4|||
154846558|NCT03132636|558869044|FG001|Overall Study|Death|7|||
154846559|NCT03132636|558869043|FG000|Overall Study|Lost to Follow-up|3|||
154846560|NCT03132636|558869044|FG001|Overall Study|Lost to Follow-up|2|||
154846561|NCT03132636|558869043|FG000|Overall Study|Non compliance with protocol by participant|1|||
154846562|NCT03132636|558869044|FG001|Overall Study|Non compliance with protocol by participant|1|||
154846563|NCT03132636|558869043|FG000|Overall Study|Subject decision|1|||
154846564|NCT03132636|558869044|FG001|Overall Study|Subject decision|9|||
154846565|NCT03132636|558869043|FG000|Overall Study|Sponsor decision|0|||
154846566|NCT03132636|558869044|FG001|Overall Study|Sponsor decision|1|||
154846567|NCT03132636|558869043|FG000|Overall Study|Physician Decision|1|||
154846568|NCT03132636|558869044|FG001|Overall Study|Physician Decision|0|||
154846569|NCT03132636|558869043|FG000|Overall Study|Progressive disease|33|||
154846570|NCT03132636|558869044|FG001|Overall Study|Progressive disease|36|||
154846571|NCT03132636|558869043|FG000|Overall Study|Withdrawal of consent|2|||
154846572|NCT03132636|558869044|FG001|Overall Study|Withdrawal of consent|5|||
154846573|NCT03132636|558869043|FG000|Overall Study|Did not re-consent|1|||
154846574|NCT03132636|558869044|FG001|Overall Study|Did not re-consent|0|||
155105085|NCT02707965|559815516|FG014|Overall Study|Withdrawal by Subject|0|||
154846575|NCT03132636|558869043|FG000|Overall Study|Lost insurance coverage|1|||
154846576|NCT03132636|558869044|FG001|Overall Study|Lost insurance coverage|0|||
154846577|NCT03132636|558869043|FG000|Overall Study|Related to radiological outcomes|0|||
155105086|NCT02707965|559815517|FG015|Overall Study|Withdrawal by Subject|0|||
155105087|NCT02707965|559815502|FG000|Overall Study|PI decisions|0|||
155105088|NCT02707965|559815503|FG001|Overall Study|PI decisions|0|||
154846578|NCT03132636|558869044|FG001|Overall Study|Related to radiological outcomes|1|||
154846579|NCT03132636|558869043|FG000|Overall Study|Unable to come to site for continued visits|0|||
154846580|NCT03132636|558869044|FG001|Overall Study|Unable to come to site for continued visits|1|||
154846581|NCT03083886|558869045|FG000|Overall Study|Withdrawal by Subject|51|||
154846582|NCT03083886|558869046|FG001|Overall Study|Withdrawal by Subject|73|||
155105089|NCT02707965|559815504|FG002|Overall Study|PI decisions|0|||
154846583|NCT03083886|558869047|FG002|Overall Study|Withdrawal by Subject|104|||
154846584|NCT03083886|558869045|FG000|Overall Study|Missing Baseline data|43|||
154846585|NCT03083886|558869046|FG001|Overall Study|Missing Baseline data|42|||
154846586|NCT03083886|558869047|FG002|Overall Study|Missing Baseline data|31|||
154846587|NCT03083886|558869045|FG000|Overall Study|Investigator terminated|1|||
154846588|NCT03083886|558869046|FG001|Overall Study|Investigator terminated|6|||
154846589|NCT03083886|558869047|FG002|Overall Study|Investigator terminated|3|||
154846590|NCT01391507|558869048|FG000|Overall Study|Death|0|||
154846591|NCT01391507|558869049|FG001|Overall Study|Death|0|||
154846592|NCT01391507|558869050|FG002|Overall Study|Death|0|||
154846593|NCT01391507|558869051|FG003|Overall Study|Death|1|||
154846594|NCT01391507|558869048|FG000|Overall Study|Adverse Event|1|||
154846595|NCT01391507|558869049|FG001|Overall Study|Adverse Event|1|||
154846596|NCT01391507|558869050|FG002|Overall Study|Adverse Event|2|||
154846597|NCT01391507|558869051|FG003|Overall Study|Adverse Event|2|||
154846598|NCT01391507|558869048|FG000|Overall Study|Withdrawal by Subject|1|||
154846599|NCT01391507|558869049|FG001|Overall Study|Withdrawal by Subject|2|||
154846600|NCT01391507|558869050|FG002|Overall Study|Withdrawal by Subject|1|||
154846601|NCT01391507|558869051|FG003|Overall Study|Withdrawal by Subject|1|||
154846602|NCT01391507|558869048|FG000|Overall Study|Lack of Efficacy|0|||
154846603|NCT01391507|558869049|FG001|Overall Study|Lack of Efficacy|0|||
154846604|NCT01391507|558869050|FG002|Overall Study|Lack of Efficacy|0|||
154846605|NCT01391507|558869051|FG003|Overall Study|Lack of Efficacy|1|||
154846606|NCT01391507|558869048|FG000|Overall Study|Protocol Violation|2|||
154846607|NCT01391507|558869049|FG001|Overall Study|Protocol Violation|1|||
154846608|NCT01391507|558869050|FG002|Overall Study|Protocol Violation|1|||
154846609|NCT01391507|558869051|FG003|Overall Study|Protocol Violation|2|||
154846610|NCT01453855|558869052|FG000|Overall Study|Adverse Event|3|||
154846611|NCT01453855|558869053|FG001|Overall Study|Adverse Event|4|||
154846612|NCT01453855|558869052|FG000|Overall Study|Lost to Follow-up|2|||
154846613|NCT01453855|558869053|FG001|Overall Study|Lost to Follow-up|1|||
154846614|NCT01453855|558869052|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
154846615|NCT01453855|558869053|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
154846616|NCT01453855|558869052|FG000|Overall Study|Noncompliance|1|||
154846617|NCT01453855|558869053|FG001|Overall Study|Noncompliance|0|||
154846618|NCT01453855|558869052|FG000|Overall Study|Inadequate Control of IOP|1|||
154846619|NCT01453855|558869053|FG001|Overall Study|Inadequate Control of IOP|5|||
154846620|NCT01453855|558869052|FG000|Overall Study|Other|0|||
154846621|NCT01453855|558869053|FG001|Overall Study|Other|1|||
154846622|NCT04161495|558869054|FG000|Overall Study|Withdrawal by Subject|3|||
154846623|NCT04161495|558869055|FG001|Overall Study|Withdrawal by Subject|0|||
154846624|NCT04161495|558869054|FG000|Overall Study|Protocol Violation|1|||
154846625|NCT04161495|558869055|FG001|Overall Study|Protocol Violation|0|||
154846626|NCT04161495|558869054|FG000|Overall Study|Prohibited concomitant medication|3|||
154846627|NCT04161495|558869055|FG001|Overall Study|Prohibited concomitant medication|0|||
154846628|NCT04161495|558869054|FG000|Overall Study|Adverse Event|1|||
154846629|NCT04161495|558869055|FG001|Overall Study|Adverse Event|0|||
154846630|NCT04161495|558869054|FG000|Overall Study|Other - Unspecified|1|||
154846631|NCT04161495|558869055|FG001|Overall Study|Other - Unspecified|0|||
154846632|NCT04161495|558869054|FG000|Overall Study|Death|0|||
154846633|NCT04161495|558869055|FG001|Overall Study|Death|1|||
154846634|NCT01562548|558869056|FG000|Overall Study|Lost to Follow-up|0|||
154846635|NCT01562548|558869057|FG001|Overall Study|Lost to Follow-up|0|||
154846636|NCT01562548|558869058|FG002|Overall Study|Lost to Follow-up|1|||
154846637|NCT01562548|558869059|FG003|Overall Study|Lost to Follow-up|0|||
154846638|NCT03655756|558869060|FG000|Overall Study|Death|1|||
154846639|NCT01340209|558869061|FG000|Overall Study|Adverse Event|1|||
154846640|NCT01340209|558869062|FG001|Overall Study|Adverse Event|1|||
154846641|NCT01340209|558869063|FG002|Overall Study|Adverse Event|2|||
154846642|NCT01340209|558869061|FG000|Overall Study|Protocol Violation|1|||
154846643|NCT01340209|558869062|FG001|Overall Study|Protocol Violation|2|||
154846644|NCT01340209|558869063|FG002|Overall Study|Protocol Violation|1|||
154846645|NCT01340209|558869061|FG000|Overall Study|Withdrawal by Subject|0|||
154846646|NCT01340209|558869062|FG001|Overall Study|Withdrawal by Subject|0|||
154846647|NCT01340209|558869063|FG002|Overall Study|Withdrawal by Subject|1|||
154846648|NCT01340209|558869061|FG000|Overall Study|Other reason not defined above|3|||
154846649|NCT01340209|558869062|FG001|Overall Study|Other reason not defined above|5|||
154846650|NCT01340209|558869063|FG002|Overall Study|Other reason not defined above|4|||
154846651|NCT00253630|558869064|FG000|Overall Study|ineligible|2|||
154846652|NCT00209339|558869065|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
154846653|NCT00209339|558869065|FG000|At 12 Months Follow-up|Death|1|||
154846654|NCT00209339|558869065|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
154846655|NCT00209339|558869065|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
154846656|NCT00209339|558869065|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
154846657|NCT00209339|558869065|FG000|At 24 Months Follow-up|Death|1|||
154846658|NCT00209339|558869065|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
154846659|NCT00209339|558869065|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
154846660|NCT00209339|558869065|FG000|At 4 Years Follow-up|Death|1|||
154846661|NCT00209339|558869065|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
154846662|NCT00209339|558869065|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
154846663|NCT00209339|558869065|FG000|At 5 Years Follow-up|Death|1|||
154846664|NCT01239160|558869066|FG000|Overall Study|Lost to Follow-up|3|||
154846665|NCT01239160|558869067|FG001|Overall Study|Lost to Follow-up|5|||
154846666|NCT01239160|558869068|FG002|Overall Study|Lost to Follow-up|0|||
154846667|NCT01239160|558869066|FG000|Overall Study|Withdrawal by Subject|17|||
154846668|NCT01239160|558869067|FG001|Overall Study|Withdrawal by Subject|6|||
154846669|NCT01239160|558869068|FG002|Overall Study|Withdrawal by Subject|2|||
154846670|NCT01239160|558869066|FG000|Overall Study|Physician Decision|5|||
154846671|NCT01239160|558869067|FG001|Overall Study|Physician Decision|7|||
154846672|NCT01239160|558869068|FG002|Overall Study|Physician Decision|2|||
154846673|NCT01239160|558869066|FG000|Overall Study|Early Termination Due to Study Closure|0|||
154846674|NCT01239160|558869067|FG001|Overall Study|Early Termination Due to Study Closure|1|||
154846675|NCT01239160|558869068|FG002|Overall Study|Early Termination Due to Study Closure|6|||
154846676|NCT02062658|558869069|FG000|Overall Study|Withdrawal by Subject|1|||
154846677|NCT02062658|558869069|FG000|Overall Study|Lack of Efficacy|1|||
154846678|NCT04016311|558869078|FG000|Overall Study|Withdrawal by Subject|1|||
154846679|NCT04016311|558869079|FG001|Overall Study|Withdrawal by Subject|0|||
154846680|NCT04029519|558869080|FG000|Overall Study|Protocol Violation|1|||
154846681|NCT04029519|558869080|FG000|Overall Study|Withdrawal by Subject|3|||
154846682|NCT04029519|558869080|FG000|Overall Study|Lost to Follow-up|1|||
154846683|NCT00939692|558869089|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
154846684|NCT00939692|558869090|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
154846685|NCT00939692|558869089|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
154846686|NCT00939692|558869090|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
154846687|NCT02161211|558869091|FG000|Overall Study|Lost to Follow-up|21|||
154846688|NCT02161211|558869092|FG001|Overall Study|Lost to Follow-up|27|||
154846689|NCT02161211|558869093|FG002|Overall Study|Lost to Follow-up|21|||
154846690|NCT02161211|558869091|FG000|Overall Study|Dropped|12|||
154846691|NCT02161211|558869092|FG001|Overall Study|Dropped|5|||
154846692|NCT02161211|558869093|FG002|Overall Study|Dropped|9|||
154846693|NCT00430508|558869095|FG000|Overall Study|Adverse Event|2|||
154846694|NCT00430508|558869096|FG001|Overall Study|Adverse Event|3|||
154846695|NCT00430508|558869097|FG002|Overall Study|Adverse Event|5|||
154846696|NCT00430508|558869098|FG003|Overall Study|Adverse Event|3|||
154846697|NCT00430508|558869095|FG000|Overall Study|Withdrawal by Subject|0|||
154846698|NCT00430508|558869096|FG001|Overall Study|Withdrawal by Subject|1|||
154846699|NCT00430508|558869097|FG002|Overall Study|Withdrawal by Subject|1|||
154846700|NCT00430508|558869098|FG003|Overall Study|Withdrawal by Subject|1|||
154846701|NCT00430508|558869095|FG000|Overall Study|responder at visit 4|0|||
154846702|NCT00430508|558869096|FG001|Overall Study|responder at visit 4|0|||
154846703|NCT00430508|558869097|FG002|Overall Study|responder at visit 4|2|||
154846704|NCT00430508|558869098|FG003|Overall Study|responder at visit 4|0|||
154846705|NCT00430508|558869095|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
154846706|NCT00430508|558869096|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
154846707|NCT00430508|558869097|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
154846708|NCT00430508|558869098|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
154846709|NCT00430508|558869095|FG000|Overall Study|Other|1|||
154846710|NCT00430508|558869096|FG001|Overall Study|Other|1|||
154846711|NCT00430508|558869097|FG002|Overall Study|Other|3|||
154846712|NCT00430508|558869098|FG003|Overall Study|Other|0|||
154846713|NCT01164722|558869099|FG000|Overall Study|Adverse Event|0|||
154846714|NCT01164722|558869100|FG001|Overall Study|Adverse Event|1|||
154846715|NCT01164722|558869099|FG000|Overall Study|Withdrawal by Subject|3|||
154846716|NCT01164722|558869100|FG001|Overall Study|Withdrawal by Subject|4|||
154846717|NCT01164722|558869099|FG000|Overall Study|Lost to Follow-up|3|||
154846718|NCT01164722|558869100|FG001|Overall Study|Lost to Follow-up|6|||
154846719|NCT01164722|558869099|FG000|Overall Study|met protocol criteria for non-treatment|11|||
154846720|NCT01164722|558869100|FG001|Overall Study|met protocol criteria for non-treatment|1|||
154846721|NCT01164722|558869099|FG000|Overall Study|enrolled on other study, concomitant med|1|||
154846722|NCT01164722|558869100|FG001|Overall Study|enrolled on other study, concomitant med|3|||
154846723|NCT03889639|558869101|FG000|Overall Study|Withdrawal by Subject|0|||
154846724|NCT03889639|558869102|FG001|Overall Study|Withdrawal by Subject|0|||
154846725|NCT03889639|558869103|FG002|Overall Study|Withdrawal by Subject|0|||
154846726|NCT03889639|558869104|FG003|Overall Study|Withdrawal by Subject|0|||
154846727|NCT03889639|558869105|FG004|Overall Study|Withdrawal by Subject|0|||
154846728|NCT03889639|558869106|FG005|Overall Study|Withdrawal by Subject|0|||
154846729|NCT03889639|558869107|FG006|Overall Study|Withdrawal by Subject|0|||
154846730|NCT03889639|558869108|FG007|Overall Study|Withdrawal by Subject|1|||
154846731|NCT01703858|558869109|FG000|Overall Study|Withdrawal by Subject|0|||
154846732|NCT01703858|558869110|FG001|Overall Study|Withdrawal by Subject|1|||
154846733|NCT01703858|558869111|FG002|Overall Study|Withdrawal by Subject|0|||
154846734|NCT00993031|558869112|FG000|Overall Study|Death|0|||
154846735|NCT00993031|558869113|FG001|Overall Study|Death|1|||
154846736|NCT00993031|558869112|FG000|Overall Study|Physician Decision|0|||
154846737|NCT00993031|558869113|FG001|Overall Study|Physician Decision|2|||
154846738|NCT00993031|558869112|FG000|Overall Study|Withdrawal by Subject|3|||
154846739|NCT00993031|558869113|FG001|Overall Study|Withdrawal by Subject|3|||
154846740|NCT00993031|558869112|FG000|Overall Study|Lost to Follow-up|19|||
154846741|NCT00993031|558869113|FG001|Overall Study|Lost to Follow-up|13|||
154846742|NCT01834729|558869116|FG000|Overall Study|Did not return bowel diaries|0|||
154846743|NCT01834729|558869117|FG001|Overall Study|Did not return bowel diaries|0|||
154846744|NCT01834729|558869118|FG002|Overall Study|Did not return bowel diaries|3|||
154846745|NCT01834729|558869119|FG003|Overall Study|Did not return bowel diaries|0|||
154846746|NCT01834729|558869116|FG000|Overall Study|Withdrawal by Subject|1|||
154846747|NCT01834729|558869117|FG001|Overall Study|Withdrawal by Subject|1|||
154846748|NCT01834729|558869118|FG002|Overall Study|Withdrawal by Subject|0|||
154846749|NCT01834729|558869119|FG003|Overall Study|Withdrawal by Subject|0|||
154846750|NCT01834729|558869116|FG000|Overall Study|Adverse Event|0|||
154846751|NCT01834729|558869117|FG001|Overall Study|Adverse Event|0|||
154846752|NCT01834729|558869118|FG002|Overall Study|Adverse Event|0|||
154846753|NCT01834729|558869119|FG003|Overall Study|Adverse Event|2|||
154846754|NCT03403192|558869120|FG000|Overall Study|Lost to Follow-up|1|||
154846755|NCT03403192|558869121|FG001|Overall Study|Lost to Follow-up|2|||
154846756|NCT03403192|558869122|FG002|Overall Study|Lost to Follow-up|0|||
154846757|NCT03403192|558869123|FG003|Overall Study|Lost to Follow-up|0|||
154846758|NCT03403192|558869120|FG000|Overall Study|Unable to respond|0|||
154846759|NCT03403192|558869121|FG001|Overall Study|Unable to respond|1|||
154846760|NCT03403192|558869122|FG002|Overall Study|Unable to respond|0|||
154846761|NCT03403192|558869123|FG003|Overall Study|Unable to respond|0|||
154846762|NCT03403192|558869120|FG000|Overall Study|Incomplete|3|||
154846763|NCT03403192|558869121|FG001|Overall Study|Incomplete|1|||
154846764|NCT03403192|558869122|FG002|Overall Study|Incomplete|3|||
154846765|NCT03403192|558869123|FG003|Overall Study|Incomplete|6|||
154846766|NCT02340663|558869125|FG000|Overall Study|Lost to Follow-up|1|||
154846767|NCT02340663|558869126|FG001|Overall Study|Lost to Follow-up|0|||
154846768|NCT02340663|558869125|FG000|Overall Study|Protocol Violation|1|||
154846769|NCT02340663|558869126|FG001|Overall Study|Protocol Violation|0|||
154846770|NCT02340663|558869125|FG000|Overall Study|Withdrawal by Subject|3|||
154846771|NCT02340663|558869126|FG001|Overall Study|Withdrawal by Subject|1|||
154846772|NCT01353703|558869127|FG000|Overall Study|Migrated/moved from study area|1|||
154846773|NCT01353703|558869128|FG001|Overall Study|Migrated/moved from study area|0|||
154846774|NCT03033875|558869129|FG000|Overall Study|Withdrawal by Subject|5|||
154846775|NCT03033875|558869130|FG001|Overall Study|Withdrawal by Subject|9|||
154846776|NCT03033875|558869131|FG002|Overall Study|Withdrawal by Subject|4|||
154846777|NCT03033875|558869129|FG000|Overall Study|Other|14|||
154846778|NCT03033875|558869130|FG001|Overall Study|Other|15|||
154846779|NCT03033875|558869131|FG002|Overall Study|Other|8|||
154846780|NCT01928381|558869141|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
154846781|NCT01928381|558869142|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
154846782|NCT01928381|558869143|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
154846783|NCT01928381|558869144|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
154846784|NCT01928381|558869145|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
154846785|NCT01928381|558869146|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
154846786|NCT01928381|558869147|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
154846787|NCT01928381|558869141|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
154846788|NCT01928381|558869142|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
154846789|NCT01928381|558869143|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
154846790|NCT01928381|558869144|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
154846791|NCT01928381|558869145|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
154846792|NCT01928381|558869146|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
154846793|NCT01928381|558869147|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
154846794|NCT01928381|558869141|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
154846795|NCT01928381|558869142|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
154846796|NCT01928381|558869143|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
154846797|NCT01928381|558869144|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
155105090|NCT02707965|559815505|FG003|Overall Study|PI decisions|0|||
154846798|NCT01928381|558869145|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
154846799|NCT01928381|558869146|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
154846800|NCT01928381|558869147|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
154846801|NCT01928381|558869141|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
154846802|NCT01928381|558869142|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
154846803|NCT01928381|558869143|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
154846804|NCT01928381|558869144|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
154846805|NCT01928381|558869145|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
154846806|NCT01928381|558869146|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
154846807|NCT01928381|558869147|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
154846808|NCT01928381|558869141|FG000|Part 1 - Pain Training|Protocol Violation|1|||
155105091|NCT02707965|559815506|FG004|Overall Study|PI decisions|0|||
154846809|NCT01928381|558869142|FG001|Part 1 - Pain Training|Protocol Violation|0|||
154846810|NCT01928381|558869143|FG002|Part 1 - Pain Training|Protocol Violation|0|||
154846811|NCT01928381|558869144|FG003|Part 1 - Pain Training|Protocol Violation|0|||
154846812|NCT01928381|558869145|FG004|Part 1 - Pain Training|Protocol Violation|0|||
154846813|NCT01928381|558869146|FG005|Part 1 - Pain Training|Protocol Violation|0|||
154846814|NCT01928381|558869147|FG006|Part 1 - Pain Training|Protocol Violation|0|||
154846815|NCT01928381|558869141|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
154846816|NCT01928381|558869142|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
154846817|NCT01928381|558869143|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
154846818|NCT01928381|558869144|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
154846819|NCT01928381|558869145|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
154846820|NCT01928381|558869146|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
154846821|NCT01928381|558869147|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
154846822|NCT01928381|558869141|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
154846823|NCT01928381|558869142|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
154846824|NCT01928381|558869143|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
154846825|NCT01928381|558869144|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
154846826|NCT01928381|558869145|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
154846827|NCT01928381|558869146|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
154846828|NCT01928381|558869147|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
154846829|NCT01928381|558869141|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
154846830|NCT01928381|558869142|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
154846831|NCT01928381|558869143|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
154846832|NCT01928381|558869144|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
154846833|NCT01928381|558869145|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
154846834|NCT01928381|558869146|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
154846835|NCT01928381|558869147|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
154846836|NCT01928381|558869141|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
154846837|NCT01928381|558869142|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
154846838|NCT01928381|558869143|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
154846839|NCT01928381|558869144|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
154846840|NCT01928381|558869145|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
154846841|NCT01928381|558869146|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
154846842|NCT01928381|558869147|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
154846843|NCT01928381|558869141|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
154846844|NCT01928381|558869142|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
154846845|NCT01928381|558869143|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
154846846|NCT01928381|558869144|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
154846847|NCT01928381|558869145|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
154846848|NCT01928381|558869146|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
154846849|NCT01928381|558869147|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
154846850|NCT01928381|558869141|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
154846851|NCT01928381|558869142|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
154846852|NCT01928381|558869143|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
154846853|NCT01928381|558869144|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
154846854|NCT01928381|558869145|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
154846855|NCT01928381|558869146|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
154846856|NCT01928381|558869147|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
154846857|NCT01928381|558869141|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
154846858|NCT01928381|558869142|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
155105092|NCT02707965|559815507|FG005|Overall Study|PI decisions|0|||
155105093|NCT02707965|559815508|FG006|Overall Study|PI decisions|0|||
155105094|NCT02707965|559815509|FG007|Overall Study|PI decisions|0|||
155105095|NCT02707965|559815510|FG008|Overall Study|PI decisions|0|||
155105096|NCT02707965|559815511|FG009|Overall Study|PI decisions|0|||
155105097|NCT02707965|559815512|FG010|Overall Study|PI decisions|0|||
155105098|NCT02707965|559815513|FG011|Overall Study|PI decisions|0|||
155105099|NCT02707965|559815514|FG012|Overall Study|PI decisions|0|||
154846859|NCT01928381|558869143|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
154846860|NCT01928381|558869144|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
154846861|NCT01928381|558869145|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
154846862|NCT01928381|558869146|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
154846863|NCT01928381|558869147|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
154846864|NCT01928381|558869141|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
154846865|NCT01928381|558869142|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
154846866|NCT01928381|558869143|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
154846867|NCT01928381|558869144|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
155105100|NCT02707965|559815515|FG013|Overall Study|PI decisions|0|||
154846868|NCT01928381|558869145|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
154846869|NCT01928381|558869146|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
154846870|NCT01928381|558869147|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
154846871|NCT01928381|558869141|FG000|Washout First Intervention|Protocol Violation|0|||
154846872|NCT01928381|558869142|FG001|Washout First Intervention|Protocol Violation|0|||
154846873|NCT01928381|558869143|FG002|Washout First Intervention|Protocol Violation|0|||
154846874|NCT01928381|558869144|FG003|Washout First Intervention|Protocol Violation|0|||
154846875|NCT01928381|558869145|FG004|Washout First Intervention|Protocol Violation|1|||
154846876|NCT01928381|558869146|FG005|Washout First Intervention|Protocol Violation|0|||
154846877|NCT01928381|558869147|FG006|Washout First Intervention|Protocol Violation|0|||
154846878|NCT01928381|558869141|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
154846879|NCT01928381|558869142|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
154846880|NCT01928381|558869143|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
154846881|NCT01928381|558869144|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
154846882|NCT01928381|558869145|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
154846883|NCT01928381|558869146|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
154846884|NCT01928381|558869147|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
154846885|NCT01928381|558869141|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
154846886|NCT01928381|558869142|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
154846887|NCT01928381|558869143|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
154846888|NCT01928381|558869144|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
154846889|NCT01928381|558869145|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
154846890|NCT01928381|558869146|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
154846891|NCT01928381|558869147|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
154846892|NCT04484285|558871379|FG000|Overall Study|Unable to operate stimulator|3|||
154846893|NCT04484285|558871380|FG001|Overall Study|Unable to operate stimulator|0|||
154846894|NCT01227902|558871382|FG000|Overall Study|Adverse Event|12|||
154846895|NCT01227902|558871383|FG001|Overall Study|Adverse Event|8|||
154846896|NCT01227902|558871384|FG002|Overall Study|Adverse Event|11|||
154846897|NCT01227902|558871385|FG003|Overall Study|Adverse Event|4|||
154846898|NCT01227902|558871382|FG000|Overall Study|Lack of Efficacy|1|||
154846899|NCT01227902|558871383|FG001|Overall Study|Lack of Efficacy|2|||
154846900|NCT01227902|558871384|FG002|Overall Study|Lack of Efficacy|2|||
154846901|NCT01227902|558871385|FG003|Overall Study|Lack of Efficacy|1|||
154846902|NCT01227902|558871382|FG000|Overall Study|Protocol Violation|1|||
154846903|NCT01227902|558871383|FG001|Overall Study|Protocol Violation|0|||
154846904|NCT01227902|558871384|FG002|Overall Study|Protocol Violation|0|||
154846905|NCT01227902|558871385|FG003|Overall Study|Protocol Violation|0|||
154846906|NCT01227902|558871382|FG000|Overall Study|Lost to Follow-up|0|||
154846907|NCT01227902|558871383|FG001|Overall Study|Lost to Follow-up|0|||
154846908|NCT01227902|558871384|FG002|Overall Study|Lost to Follow-up|1|||
154846909|NCT01227902|558871385|FG003|Overall Study|Lost to Follow-up|2|||
154846910|NCT01227902|558871382|FG000|Overall Study|Physician Decision|0|||
154846911|NCT01227902|558871383|FG001|Overall Study|Physician Decision|1|||
154846912|NCT01227902|558871384|FG002|Overall Study|Physician Decision|1|||
154846913|NCT01227902|558871385|FG003|Overall Study|Physician Decision|0|||
154846914|NCT01227902|558871382|FG000|Overall Study|Withdrawal by Subject|4|||
154846915|NCT01227902|558871383|FG001|Overall Study|Withdrawal by Subject|2|||
154846916|NCT01227902|558871384|FG002|Overall Study|Withdrawal by Subject|4|||
154846917|NCT01227902|558871385|FG003|Overall Study|Withdrawal by Subject|3|||
154846918|NCT05280756|558871386|FG000|Overall Study|Lost to Follow-up|1|||
154846919|NCT05280756|558871387|FG001|Overall Study|Lost to Follow-up|1|||
154971237|NCT01074008|559318587|FG007|Overall Study|Adverse Event|0|||
155105101|NCT02707965|559815516|FG014|Overall Study|PI decisions|2|||
155105102|NCT02707965|559815517|FG015|Overall Study|PI decisions|0|||
155105103|NCT02707965|559815502|FG000|Overall Study|Protocol deviation|1|||
155105104|NCT02707965|559815503|FG001|Overall Study|Protocol deviation|1|||
155105105|NCT02707965|559815504|FG002|Overall Study|Protocol deviation|0|||
155105106|NCT02707965|559815505|FG003|Overall Study|Protocol deviation|0|||
155105107|NCT02707965|559815506|FG004|Overall Study|Protocol deviation|0|||
155105108|NCT02707965|559815507|FG005|Overall Study|Protocol deviation|0|||
155105109|NCT02707965|559815508|FG006|Overall Study|Protocol deviation|0|||
155105110|NCT02707965|559815509|FG007|Overall Study|Protocol deviation|1|||
155105111|NCT02707965|559815510|FG008|Overall Study|Protocol deviation|0|||
154846920|NCT00768898|558871388|FG000|Overall Study|Unrelated injury|1|||
154846921|NCT00768898|558871388|FG000|Overall Study|Headache|1|||
154846922|NCT00542997|558871391|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
154846923|NCT00542997|558871391|FG000|Wash in / Wash Out Period|Adverse Event|3|||
154846924|NCT00542997|558871391|FG000|Efficacy Period|Adverse Event|3|||
155105112|NCT02707965|559815511|FG009|Overall Study|Protocol deviation|0|||
154846925|NCT03160560|558871394|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
154971238|NCT01074008|559318588|FG008|Overall Study|Adverse Event|0|||
155105113|NCT02707965|559815512|FG010|Overall Study|Protocol deviation|0|||
155105114|NCT02707965|559815513|FG011|Overall Study|Protocol deviation|0|||
155105115|NCT02707965|559815514|FG012|Overall Study|Protocol deviation|0|||
154846926|NCT03160560|558871395|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
154846927|NCT03160560|558871396|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
154846928|NCT03160560|558871397|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
154846929|NCT03160560|558871394|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
154846930|NCT03160560|558871395|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
154846931|NCT03160560|558871396|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
154846932|NCT03160560|558871397|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
154846933|NCT01777763|558871408|FG000|Overall Study|Adverse Event|2|||
154846934|NCT01777763|558871409|FG001|Overall Study|Adverse Event|32|||
154846935|NCT01777763|558871408|FG000|Overall Study|Protocol Violation|1|||
154846936|NCT01777763|558871409|FG001|Overall Study|Protocol Violation|7|||
154846937|NCT01777763|558871408|FG000|Overall Study|Withdrawal by Subject|0|||
154846938|NCT01777763|558871409|FG001|Overall Study|Withdrawal by Subject|2|||
154846939|NCT01777763|558871408|FG000|Overall Study|Treatment Failure|1|||
154846940|NCT01777763|558871409|FG001|Overall Study|Treatment Failure|6|||
154846941|NCT02787850|558871414|FG000|Overall Study|Withdrawal by Subject|0|||
154846942|NCT02787850|558871415|FG001|Overall Study|Withdrawal by Subject|1|||
154846943|NCT03718143|558871416|FG000|Overall Study|Death|1|||
154846944|NCT03718143|558871417|FG001|Overall Study|Death|0|||
154846945|NCT03718143|558871418|FG002|Overall Study|Death|0|||
154846946|NCT03718143|558871416|FG000|Overall Study|Progression of Disease|1|||
154846947|NCT03718143|558871417|FG001|Overall Study|Progression of Disease|0|||
154846948|NCT03718143|558871418|FG002|Overall Study|Progression of Disease|0|||
154846949|NCT03718143|558871416|FG000|Overall Study|Withdrawal of Informed Consent|1|||
154846950|NCT03718143|558871417|FG001|Overall Study|Withdrawal of Informed Consent|2|||
154846951|NCT03718143|558871418|FG002|Overall Study|Withdrawal of Informed Consent|1|||
154846952|NCT03905863|558871419|FG000|Overall Study|Adverse Event|2|||
154846953|NCT03905863|558871420|FG001|Overall Study|Adverse Event|4|||
154846954|NCT03905863|558871419|FG000|Overall Study|Withdrawal by Subject|2|||
154846955|NCT03905863|558871420|FG001|Overall Study|Withdrawal by Subject|2|||
154846956|NCT03905863|558871419|FG000|Overall Study|Physician Decision|0|||
154846957|NCT03905863|558871420|FG001|Overall Study|Physician Decision|3|||
154846958|NCT03905863|558871419|FG000|Overall Study|Lost to Follow-up|1|||
154846959|NCT03905863|558871420|FG001|Overall Study|Lost to Follow-up|0|||
154846960|NCT03905863|558871419|FG000|Overall Study|Protocol Violation|0|||
154846961|NCT03905863|558871420|FG001|Overall Study|Protocol Violation|2|||
154846962|NCT03905863|558871419|FG000|Overall Study|Death|0|||
154846963|NCT03905863|558871420|FG001|Overall Study|Death|1|||
154846964|NCT01072344|558871421|FG000|Overall Study|Relasped-reached end point|7|||
154846965|NCT01072344|558871422|FG001|Overall Study|Relasped-reached end point|12|||
154846966|NCT01072344|558871421|FG000|Overall Study|Protocol Violation|1|||
154846967|NCT01072344|558871422|FG001|Overall Study|Protocol Violation|2|||
154846968|NCT01072344|558871421|FG000|Overall Study|Lost to Follow-up|3|||
154846969|NCT01072344|558871422|FG001|Overall Study|Lost to Follow-up|4|||
154846970|NCT02723201|558871425|FG000|Second Intervention Period|Protocol Violation|1|||
154846971|NCT02723201|558871426|FG001|Second Intervention Period|Protocol Violation|0|||
154846972|NCT02723201|558871427|FG002|Second Intervention Period|Protocol Violation|0|||
154846973|NCT02723201|558871425|FG000|Second Intervention Period|Adverse Event|1|||
154846974|NCT02723201|558871426|FG001|Second Intervention Period|Adverse Event|0|||
154846975|NCT02723201|558871427|FG002|Second Intervention Period|Adverse Event|0|||
154846976|NCT03472560|558871428|FG000|Overall Study|Subject transfer to continuation protocol|0|||
154846977|NCT03472560|558871429|FG001|Overall Study|Subject transfer to continuation protocol|1|||
154846978|NCT03472560|558871428|FG000|Overall Study|Withdrawal by Subject|4|||
154846979|NCT03472560|558871429|FG001|Overall Study|Withdrawal by Subject|0|||
154846980|NCT03472560|558871428|FG000|Overall Study|Progressive disease|24|||
154846981|NCT03472560|558871429|FG001|Overall Study|Progressive disease|8|||
154846982|NCT03472560|558871428|FG000|Overall Study|Physician Decision|1|||
154846983|NCT03472560|558871429|FG001|Overall Study|Physician Decision|0|||
154846984|NCT03472560|558871428|FG000|Overall Study|Death|7|||
154846985|NCT03472560|558871429|FG001|Overall Study|Death|4|||
154846986|NCT03472560|558871428|FG000|Overall Study|Adverse Event|5|||
154846987|NCT03472560|558871429|FG001|Overall Study|Adverse Event|3|||
154846988|NCT03472560|558871428|FG000|Overall Study|Global deterioration of health status|0|||
154846989|NCT03472560|558871429|FG001|Overall Study|Global deterioration of health status|4|||
154846990|NCT01946178|558871430|FG000|Overall Study|Pregnancy|1|||
154846991|NCT01946178|558871430|FG000|Overall Study|Lost to Follow-up|1|||
154846992|NCT02908880|558871437|FG000|Overall Study|Lost to Follow-up|4|||
154846993|NCT02908880|558871437|FG000|Overall Study|Explantation of the device|1|||
154846994|NCT02908880|558871437|FG000|Overall Study|Withdrawal by Subject|17|||
154846995|NCT02908880|558871437|FG000|Overall Study|Death|5|||
154846996|NCT00424827|558871438|FG000|Overall Study|Adverse Event|1|||
154846997|NCT02397473|558871441|FG000|Treatment Phase|Adverse Event|1|||
154846998|NCT02397473|558871442|FG001|Treatment Phase|Adverse Event|2|||
154846999|NCT02397473|558871441|FG000|Treatment Phase|Lack of Efficacy|8|||
154847000|NCT02397473|558871442|FG001|Treatment Phase|Lack of Efficacy|1|||
154847001|NCT02397473|558871441|FG000|Treatment Phase|Lost to Follow-up|1|||
154847002|NCT02397473|558871442|FG001|Treatment Phase|Lost to Follow-up|0|||
154847003|NCT02397473|558871441|FG000|Treatment Phase|Withdrawal by Subject|2|||
154847004|NCT02397473|558871442|FG001|Treatment Phase|Withdrawal by Subject|1|||
154847005|NCT02397473|558871441|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
154847006|NCT02397473|558871442|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
154847007|NCT02397473|558871441|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
154847008|NCT02397473|558871442|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
154847009|NCT02397473|558871441|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
154847010|NCT02397473|558871442|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
154847011|NCT02397473|558871441|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
154847012|NCT02397473|558871442|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
154847013|NCT02397473|558871441|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
154847014|NCT02397473|558871442|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
154847015|NCT00491179|558871443|FG000|Overall Study|Adverse Event|5|||
154847016|NCT00491179|558871444|FG001|Overall Study|Adverse Event|1|||
154847017|NCT00491179|558871443|FG000|Overall Study|Withdrawal by Subject|2|||
154847018|NCT00491179|558871444|FG001|Overall Study|Withdrawal by Subject|1|||
154847019|NCT02009878|558871448|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
154847020|NCT02009878|558871449|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
154847021|NCT02009878|558871450|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
154847022|NCT01790048|558871452|FG000|Overall Study|Incorrect Age|9|||
154847023|NCT01790048|558871453|FG001|Overall Study|Incorrect Age|14|||
154847024|NCT01790048|558871452|FG000|Overall Study|data entry error|0|||
154847025|NCT01790048|558871453|FG001|Overall Study|data entry error|1|||
154847026|NCT01790048|558871452|FG000|Overall Study|Other|0|||
154847027|NCT01790048|558871453|FG001|Overall Study|Other|2|||
154847028|NCT01790048|558871452|FG000|Overall Study|SAM at Enrollment|2|||
154847029|NCT01790048|558871453|FG001|Overall Study|SAM at Enrollment|0|||
154847030|NCT01790048|558871452|FG000|Overall Study|Measurement error|1|||
154847031|NCT01790048|558871453|FG001|Overall Study|Measurement error|0|||
154847032|NCT00584233|558871454|FG000|Overall Study|Withdrawal by Subject|5|||
154847033|NCT00584233|558871454|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
154847034|NCT03178487|558871458|FG000|Period 1|Adverse Event|1|||
154847035|NCT03178487|558871459|FG001|Period 1|Adverse Event|2|||
154847036|NCT03178487|558871458|FG000|Period 1|Withdrawal by Subject|2|||
154847037|NCT03178487|558871459|FG001|Period 1|Withdrawal by Subject|1|||
154847038|NCT03178487|558871458|FG000|Period 1|Lost to Follow-up|1|||
154847039|NCT03178487|558871459|FG001|Period 1|Lost to Follow-up|0|||
154847040|NCT03178487|558871458|FG000|Period 1|Other|0|||
154847041|NCT03178487|558871459|FG001|Period 1|Other|1|||
154847042|NCT03178487|558871458|FG000|Period 2|Adverse Event|4|||
154847043|NCT03178487|558871459|FG001|Period 2|Adverse Event|4|||
154847044|NCT03178487|558871458|FG000|Period 2|Withdrawal by Subject|6|||
154847045|NCT03178487|558871459|FG001|Period 2|Withdrawal by Subject|6|||
154847046|NCT03178487|558871458|FG000|Period 2|Lost to Follow-up|2|||
154847047|NCT03178487|558871459|FG001|Period 2|Lost to Follow-up|2|||
154847048|NCT03178487|558871458|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
154847049|NCT03178487|558871459|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
154847050|NCT03178487|558871458|FG000|Period 2|Other|8|||
154847051|NCT03178487|558871459|FG001|Period 2|Other|7|||
154847052|NCT01285908|558871466|FG000|Baseline Measurement|unable to insert catheter|1|||
154847053|NCT01285908|558871467|FG001|Baseline Measurement|unable to insert catheter|0|||
154847054|NCT01285908|558871468|FG002|Baseline Measurement|unable to insert catheter|0|||
154847055|NCT01285908|558871466|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
154847056|NCT01285908|558871467|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
154847057|NCT01285908|558871468|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
154847058|NCT01285908|558871466|FG000|Baseline Measurement|unable to tolerate procedure|1|||
154847059|NCT01285908|558871467|FG001|Baseline Measurement|unable to tolerate procedure|0|||
154847060|NCT01285908|558871468|FG002|Baseline Measurement|unable to tolerate procedure|0|||
154847061|NCT03529773|558871469|FG000|Overall Study|Adverse Event|0|||
154847062|NCT03529773|558871470|FG001|Overall Study|Adverse Event|0|||
154847063|NCT03529773|558871471|FG002|Overall Study|Adverse Event|0|||
154847064|NCT03529773|558871472|FG003|Overall Study|Adverse Event|0|||
154847065|NCT03529773|558871473|FG004|Overall Study|Adverse Event|0|||
154847066|NCT03529773|558871474|FG005|Overall Study|Adverse Event|0|||
154847067|NCT03529773|558871475|FG006|Overall Study|Adverse Event|0|||
154847068|NCT03529773|558871476|FG007|Overall Study|Adverse Event|0|||
154847069|NCT03529773|558871477|FG008|Overall Study|Adverse Event|0|||
154847070|NCT03529773|558871478|FG009|Overall Study|Adverse Event|0|||
154847071|NCT03529773|558871479|FG010|Overall Study|Adverse Event|0|||
154971239|NCT01074008|559318580|FG000|Overall Study|Withdrawal by Subject|1|||
154847072|NCT03529773|558871480|FG011|Overall Study|Adverse Event|0|||
154847073|NCT03529773|558871481|FG012|Overall Study|Adverse Event|0|||
154847074|NCT03529773|558871482|FG013|Overall Study|Adverse Event|0|||
154847075|NCT03529773|558871483|FG014|Overall Study|Adverse Event|0|||
154847076|NCT03529773|558871484|FG015|Overall Study|Adverse Event|0|||
154847077|NCT03529773|558871485|FG016|Overall Study|Adverse Event|0|||
154847078|NCT03529773|558871486|FG017|Overall Study|Adverse Event|0|||
154847079|NCT03529773|558871487|FG018|Overall Study|Adverse Event|0|||
154847080|NCT03529773|558871488|FG019|Overall Study|Adverse Event|0|||
154847081|NCT03529773|558871489|FG020|Overall Study|Adverse Event|0|||
154847082|NCT03529773|558871490|FG021|Overall Study|Adverse Event|0|||
154847083|NCT03529773|558871491|FG022|Overall Study|Adverse Event|0|||
154847084|NCT03529773|558871492|FG023|Overall Study|Adverse Event|0|||
154847085|NCT03529773|558871493|FG024|Overall Study|Adverse Event|0|||
154847086|NCT03529773|558871494|FG025|Overall Study|Adverse Event|0|||
154847087|NCT03529773|558871495|FG026|Overall Study|Adverse Event|0|||
154847088|NCT03529773|558871496|FG027|Overall Study|Adverse Event|0|||
154847089|NCT03529773|558871497|FG028|Overall Study|Adverse Event|0|||
154847090|NCT03529773|558871498|FG029|Overall Study|Adverse Event|0|||
154847091|NCT03529773|558871499|FG030|Overall Study|Adverse Event|1|||
154847092|NCT03529773|558871500|FG031|Overall Study|Adverse Event|0|||
154847093|NCT03529773|558871501|FG032|Overall Study|Adverse Event|0|||
154847094|NCT03529773|558871502|FG033|Overall Study|Adverse Event|0|||
154847095|NCT03529773|558871503|FG034|Overall Study|Adverse Event|0|||
154847096|NCT03529773|558871504|FG035|Overall Study|Adverse Event|1|||
154847097|NCT03529773|558871505|FG036|Overall Study|Adverse Event|0|||
154847098|NCT03529773|558871506|FG037|Overall Study|Adverse Event|0|||
154847099|NCT03529773|558871507|FG038|Overall Study|Adverse Event|1|||
154847100|NCT03529773|558871508|FG039|Overall Study|Adverse Event|1|||
154847101|NCT03529773|558871469|FG000|Overall Study|Death|0|||
154847102|NCT03529773|558871470|FG001|Overall Study|Death|0|||
154847103|NCT03529773|558871471|FG002|Overall Study|Death|0|||
154847104|NCT03529773|558871472|FG003|Overall Study|Death|0|||
154847105|NCT03529773|558871473|FG004|Overall Study|Death|0|||
154847106|NCT03529773|558871474|FG005|Overall Study|Death|0|||
154847107|NCT03529773|558871475|FG006|Overall Study|Death|0|||
154847108|NCT03529773|558871476|FG007|Overall Study|Death|0|||
154847109|NCT03529773|558871477|FG008|Overall Study|Death|0|||
154847110|NCT03529773|558871478|FG009|Overall Study|Death|0|||
154847111|NCT03529773|558871479|FG010|Overall Study|Death|0|||
154847112|NCT03529773|558871480|FG011|Overall Study|Death|0|||
154847113|NCT03529773|558871481|FG012|Overall Study|Death|1|||
154847114|NCT03529773|558871482|FG013|Overall Study|Death|0|||
154847115|NCT03529773|558871483|FG014|Overall Study|Death|0|||
154847116|NCT03529773|558871484|FG015|Overall Study|Death|0|||
154847117|NCT03529773|558871485|FG016|Overall Study|Death|0|||
154847118|NCT03529773|558871486|FG017|Overall Study|Death|0|||
154847119|NCT03529773|558871487|FG018|Overall Study|Death|0|||
154847120|NCT03529773|558871488|FG019|Overall Study|Death|1|||
154847121|NCT03529773|558871489|FG020|Overall Study|Death|0|||
154847122|NCT03529773|558871490|FG021|Overall Study|Death|0|||
154847123|NCT03529773|558871491|FG022|Overall Study|Death|1|||
154847124|NCT03529773|558871492|FG023|Overall Study|Death|0|||
154847125|NCT03529773|558871493|FG024|Overall Study|Death|0|||
154847126|NCT03529773|558871494|FG025|Overall Study|Death|0|||
154847127|NCT03529773|558871495|FG026|Overall Study|Death|0|||
154847128|NCT03529773|558871496|FG027|Overall Study|Death|0|||
154847129|NCT03529773|558871497|FG028|Overall Study|Death|0|||
154847130|NCT03529773|558871498|FG029|Overall Study|Death|0|||
154847131|NCT03529773|558871499|FG030|Overall Study|Death|0|||
154847132|NCT03529773|558871500|FG031|Overall Study|Death|0|||
154847133|NCT03529773|558871501|FG032|Overall Study|Death|0|||
154847134|NCT03529773|558871502|FG033|Overall Study|Death|1|||
154847135|NCT03529773|558871503|FG034|Overall Study|Death|1|||
154847136|NCT03529773|558871504|FG035|Overall Study|Death|0|||
154847137|NCT03529773|558871505|FG036|Overall Study|Death|1|||
154847138|NCT03529773|558871506|FG037|Overall Study|Death|0|||
154847139|NCT03529773|558871507|FG038|Overall Study|Death|0|||
155105116|NCT02707965|559815515|FG013|Overall Study|Protocol deviation|0|||
154847140|NCT03529773|558871508|FG039|Overall Study|Death|0|||
154847141|NCT03529773|558871469|FG000|Overall Study|Lost to Follow-up|0|||
154847142|NCT03529773|558871470|FG001|Overall Study|Lost to Follow-up|0|||
154847143|NCT03529773|558871471|FG002|Overall Study|Lost to Follow-up|1|||
154847144|NCT03529773|558871472|FG003|Overall Study|Lost to Follow-up|0|||
154847145|NCT03529773|558871473|FG004|Overall Study|Lost to Follow-up|1|||
154847146|NCT03529773|558871474|FG005|Overall Study|Lost to Follow-up|1|||
154847147|NCT03529773|558871475|FG006|Overall Study|Lost to Follow-up|0|||
154847148|NCT03529773|558871476|FG007|Overall Study|Lost to Follow-up|0|||
154847149|NCT03529773|558871477|FG008|Overall Study|Lost to Follow-up|0|||
154847150|NCT03529773|558871478|FG009|Overall Study|Lost to Follow-up|0|||
154847151|NCT03529773|558871479|FG010|Overall Study|Lost to Follow-up|0|||
154847152|NCT03529773|558871480|FG011|Overall Study|Lost to Follow-up|0|||
154847153|NCT03529773|558871481|FG012|Overall Study|Lost to Follow-up|0|||
154847154|NCT03529773|558871482|FG013|Overall Study|Lost to Follow-up|1|||
154847155|NCT03529773|558871483|FG014|Overall Study|Lost to Follow-up|4|||
154847156|NCT03529773|558871484|FG015|Overall Study|Lost to Follow-up|1|||
154847157|NCT03529773|558871485|FG016|Overall Study|Lost to Follow-up|1|||
154847158|NCT03529773|558871486|FG017|Overall Study|Lost to Follow-up|0|||
154847159|NCT03529773|558871487|FG018|Overall Study|Lost to Follow-up|1|||
154847160|NCT03529773|558871488|FG019|Overall Study|Lost to Follow-up|1|||
154847161|NCT03529773|558871489|FG020|Overall Study|Lost to Follow-up|2|||
154847162|NCT03529773|558871490|FG021|Overall Study|Lost to Follow-up|4|||
154847163|NCT03529773|558871491|FG022|Overall Study|Lost to Follow-up|3|||
154847164|NCT03529773|558871492|FG023|Overall Study|Lost to Follow-up|4|||
154847165|NCT03529773|558871493|FG024|Overall Study|Lost to Follow-up|3|||
154847166|NCT03529773|558871494|FG025|Overall Study|Lost to Follow-up|5|||
154847167|NCT03529773|558871495|FG026|Overall Study|Lost to Follow-up|5|||
154847168|NCT03529773|558871496|FG027|Overall Study|Lost to Follow-up|0|||
154847169|NCT03529773|558871497|FG028|Overall Study|Lost to Follow-up|0|||
154847170|NCT03529773|558871498|FG029|Overall Study|Lost to Follow-up|0|||
154847171|NCT03529773|558871499|FG030|Overall Study|Lost to Follow-up|1|||
154847172|NCT03529773|558871500|FG031|Overall Study|Lost to Follow-up|0|||
154847173|NCT03529773|558871501|FG032|Overall Study|Lost to Follow-up|0|||
154847174|NCT03529773|558871502|FG033|Overall Study|Lost to Follow-up|1|||
154847175|NCT03529773|558871503|FG034|Overall Study|Lost to Follow-up|1|||
154847176|NCT03529773|558871504|FG035|Overall Study|Lost to Follow-up|0|||
154847177|NCT03529773|558871505|FG036|Overall Study|Lost to Follow-up|0|||
154847178|NCT03529773|558871506|FG037|Overall Study|Lost to Follow-up|3|||
154847179|NCT03529773|558871507|FG038|Overall Study|Lost to Follow-up|1|||
154847180|NCT03529773|558871508|FG039|Overall Study|Lost to Follow-up|1|||
154847181|NCT03529773|558871469|FG000|Overall Study|No longer meets eligibility criteria|0|||
154847182|NCT03529773|558871470|FG001|Overall Study|No longer meets eligibility criteria|0|||
154847183|NCT03529773|558871471|FG002|Overall Study|No longer meets eligibility criteria|0|||
154847184|NCT03529773|558871472|FG003|Overall Study|No longer meets eligibility criteria|0|||
154847185|NCT03529773|558871473|FG004|Overall Study|No longer meets eligibility criteria|0|||
154847186|NCT03529773|558871474|FG005|Overall Study|No longer meets eligibility criteria|0|||
154847187|NCT03529773|558871475|FG006|Overall Study|No longer meets eligibility criteria|0|||
154847188|NCT03529773|558871476|FG007|Overall Study|No longer meets eligibility criteria|0|||
154847189|NCT03529773|558871477|FG008|Overall Study|No longer meets eligibility criteria|0|||
154847190|NCT03529773|558871478|FG009|Overall Study|No longer meets eligibility criteria|0|||
154847191|NCT03529773|558871479|FG010|Overall Study|No longer meets eligibility criteria|0|||
154847192|NCT03529773|558871480|FG011|Overall Study|No longer meets eligibility criteria|0|||
154847193|NCT03529773|558871481|FG012|Overall Study|No longer meets eligibility criteria|0|||
154847194|NCT03529773|558871482|FG013|Overall Study|No longer meets eligibility criteria|0|||
154847195|NCT03529773|558871483|FG014|Overall Study|No longer meets eligibility criteria|0|||
154847196|NCT03529773|558871484|FG015|Overall Study|No longer meets eligibility criteria|0|||
154847197|NCT03529773|558871485|FG016|Overall Study|No longer meets eligibility criteria|0|||
154847198|NCT03529773|558871486|FG017|Overall Study|No longer meets eligibility criteria|0|||
154847199|NCT03529773|558871487|FG018|Overall Study|No longer meets eligibility criteria|0|||
154847200|NCT03529773|558871488|FG019|Overall Study|No longer meets eligibility criteria|0|||
154847201|NCT03529773|558871489|FG020|Overall Study|No longer meets eligibility criteria|0|||
154847202|NCT03529773|558871490|FG021|Overall Study|No longer meets eligibility criteria|0|||
154847203|NCT03529773|558871491|FG022|Overall Study|No longer meets eligibility criteria|1|||
154847204|NCT03529773|558871492|FG023|Overall Study|No longer meets eligibility criteria|0|||
154847205|NCT03529773|558871493|FG024|Overall Study|No longer meets eligibility criteria|0|||
154847206|NCT03529773|558871494|FG025|Overall Study|No longer meets eligibility criteria|0|||
154847207|NCT03529773|558871495|FG026|Overall Study|No longer meets eligibility criteria|0|||
154847208|NCT03529773|558871496|FG027|Overall Study|No longer meets eligibility criteria|0|||
154847209|NCT03529773|558871497|FG028|Overall Study|No longer meets eligibility criteria|0|||
154847210|NCT03529773|558871498|FG029|Overall Study|No longer meets eligibility criteria|0|||
154847211|NCT03529773|558871499|FG030|Overall Study|No longer meets eligibility criteria|0|||
154847212|NCT03529773|558871500|FG031|Overall Study|No longer meets eligibility criteria|0|||
154847213|NCT03529773|558871501|FG032|Overall Study|No longer meets eligibility criteria|0|||
154847214|NCT03529773|558871502|FG033|Overall Study|No longer meets eligibility criteria|0|||
154847215|NCT03529773|558871503|FG034|Overall Study|No longer meets eligibility criteria|0|||
154847216|NCT03529773|558871504|FG035|Overall Study|No longer meets eligibility criteria|0|||
154847217|NCT03529773|558871505|FG036|Overall Study|No longer meets eligibility criteria|0|||
154971240|NCT01074008|559318581|FG001|Overall Study|Withdrawal by Subject|1|||
154971241|NCT01074008|559318582|FG002|Overall Study|Withdrawal by Subject|1|||
154971242|NCT01074008|559318583|FG003|Overall Study|Withdrawal by Subject|0|||
154971243|NCT01074008|559318584|FG004|Overall Study|Withdrawal by Subject|1|||
154971244|NCT01074008|559318585|FG005|Overall Study|Withdrawal by Subject|0|||
154971245|NCT01074008|559318586|FG006|Overall Study|Withdrawal by Subject|0|||
154971246|NCT01074008|559318587|FG007|Overall Study|Withdrawal by Subject|0|||
154971247|NCT01074008|559318588|FG008|Overall Study|Withdrawal by Subject|0|||
154971248|NCT01074008|559318580|FG000|Overall Study|Lost to Follow-up|0|||
154971249|NCT01074008|559318581|FG001|Overall Study|Lost to Follow-up|1|||
154971250|NCT01074008|559318582|FG002|Overall Study|Lost to Follow-up|1|||
154971251|NCT01074008|559318583|FG003|Overall Study|Lost to Follow-up|1|||
154971252|NCT01074008|559318584|FG004|Overall Study|Lost to Follow-up|1|||
154971253|NCT01074008|559318585|FG005|Overall Study|Lost to Follow-up|0|||
154971254|NCT01074008|559318586|FG006|Overall Study|Lost to Follow-up|1|||
154847218|NCT03529773|558871506|FG037|Overall Study|No longer meets eligibility criteria|0|||
154847219|NCT03529773|558871507|FG038|Overall Study|No longer meets eligibility criteria|1|||
154847220|NCT03529773|558871508|FG039|Overall Study|No longer meets eligibility criteria|0|||
154847221|NCT03529773|558871469|FG000|Overall Study|Other|0|||
154847222|NCT03529773|558871470|FG001|Overall Study|Other|0|||
154847223|NCT03529773|558871471|FG002|Overall Study|Other|0|||
154847224|NCT03529773|558871472|FG003|Overall Study|Other|0|||
154847225|NCT03529773|558871473|FG004|Overall Study|Other|0|||
154847226|NCT03529773|558871474|FG005|Overall Study|Other|0|||
154847227|NCT03529773|558871475|FG006|Overall Study|Other|0|||
154847228|NCT03529773|558871476|FG007|Overall Study|Other|0|||
154847229|NCT03529773|558871477|FG008|Overall Study|Other|0|||
154847230|NCT03529773|558871478|FG009|Overall Study|Other|0|||
154847231|NCT03529773|558871479|FG010|Overall Study|Other|0|||
154847232|NCT03529773|558871480|FG011|Overall Study|Other|0|||
154847233|NCT03529773|558871481|FG012|Overall Study|Other|1|||
154847234|NCT03529773|558871482|FG013|Overall Study|Other|0|||
154847235|NCT03529773|558871483|FG014|Overall Study|Other|2|||
154847236|NCT03529773|558871484|FG015|Overall Study|Other|0|||
154847237|NCT03529773|558871485|FG016|Overall Study|Other|0|||
154847238|NCT03529773|558871486|FG017|Overall Study|Other|3|||
154847239|NCT03529773|558871487|FG018|Overall Study|Other|0|||
154847240|NCT03529773|558871488|FG019|Overall Study|Other|0|||
154847241|NCT03529773|558871489|FG020|Overall Study|Other|1|||
154847242|NCT03529773|558871490|FG021|Overall Study|Other|0|||
154847243|NCT03529773|558871491|FG022|Overall Study|Other|1|||
154847244|NCT03529773|558871492|FG023|Overall Study|Other|0|||
154847245|NCT03529773|558871493|FG024|Overall Study|Other|3|||
154847246|NCT03529773|558871494|FG025|Overall Study|Other|2|||
154847247|NCT03529773|558871495|FG026|Overall Study|Other|2|||
154847248|NCT03529773|558871496|FG027|Overall Study|Other|0|||
154847249|NCT03529773|558871497|FG028|Overall Study|Other|0|||
154847250|NCT03529773|558871498|FG029|Overall Study|Other|0|||
154847251|NCT03529773|558871499|FG030|Overall Study|Other|0|||
154847252|NCT03529773|558871500|FG031|Overall Study|Other|0|||
154847253|NCT03529773|558871501|FG032|Overall Study|Other|0|||
154847254|NCT03529773|558871502|FG033|Overall Study|Other|0|||
154847255|NCT03529773|558871503|FG034|Overall Study|Other|1|||
154847256|NCT03529773|558871504|FG035|Overall Study|Other|1|||
154847257|NCT03529773|558871505|FG036|Overall Study|Other|0|||
154847258|NCT03529773|558871506|FG037|Overall Study|Other|0|||
154847259|NCT03529773|558871507|FG038|Overall Study|Other|0|||
154847260|NCT03529773|558871508|FG039|Overall Study|Other|0|||
154847261|NCT03529773|558871469|FG000|Overall Study|Physician Decision|0|||
154847262|NCT03529773|558871470|FG001|Overall Study|Physician Decision|0|||
154847263|NCT03529773|558871471|FG002|Overall Study|Physician Decision|0|||
154847264|NCT03529773|558871472|FG003|Overall Study|Physician Decision|0|||
154847265|NCT03529773|558871473|FG004|Overall Study|Physician Decision|0|||
154847266|NCT03529773|558871474|FG005|Overall Study|Physician Decision|0|||
154847267|NCT03529773|558871475|FG006|Overall Study|Physician Decision|0|||
154847268|NCT03529773|558871476|FG007|Overall Study|Physician Decision|0|||
154847269|NCT03529773|558871477|FG008|Overall Study|Physician Decision|0|||
154847270|NCT03529773|558871478|FG009|Overall Study|Physician Decision|0|||
154847271|NCT03529773|558871479|FG010|Overall Study|Physician Decision|0|||
154847272|NCT03529773|558871480|FG011|Overall Study|Physician Decision|0|||
154847273|NCT03529773|558871481|FG012|Overall Study|Physician Decision|0|||
154847274|NCT03529773|558871482|FG013|Overall Study|Physician Decision|0|||
154847275|NCT03529773|558871483|FG014|Overall Study|Physician Decision|0|||
154847276|NCT03529773|558871484|FG015|Overall Study|Physician Decision|0|||
154847277|NCT03529773|558871485|FG016|Overall Study|Physician Decision|0|||
154847278|NCT03529773|558871486|FG017|Overall Study|Physician Decision|0|||
154847279|NCT03529773|558871487|FG018|Overall Study|Physician Decision|0|||
154847280|NCT03529773|558871488|FG019|Overall Study|Physician Decision|1|||
154847281|NCT03529773|558871489|FG020|Overall Study|Physician Decision|1|||
154847282|NCT03529773|558871490|FG021|Overall Study|Physician Decision|0|||
155105117|NCT02707965|559815516|FG014|Overall Study|Protocol deviation|0|||
154847283|NCT03529773|558871491|FG022|Overall Study|Physician Decision|0|||
154847284|NCT03529773|558871492|FG023|Overall Study|Physician Decision|0|||
154847285|NCT03529773|558871493|FG024|Overall Study|Physician Decision|0|||
155105118|NCT02707965|559815517|FG015|Overall Study|Protocol deviation|0|||
154847286|NCT03529773|558871494|FG025|Overall Study|Physician Decision|0|||
154847287|NCT03529773|558871495|FG026|Overall Study|Physician Decision|0|||
154847288|NCT03529773|558871496|FG027|Overall Study|Physician Decision|0|||
154847289|NCT03529773|558871497|FG028|Overall Study|Physician Decision|0|||
154847290|NCT03529773|558871498|FG029|Overall Study|Physician Decision|0|||
154847291|NCT03529773|558871499|FG030|Overall Study|Physician Decision|0|||
154847292|NCT03529773|558871500|FG031|Overall Study|Physician Decision|0|||
154847293|NCT03529773|558871501|FG032|Overall Study|Physician Decision|0|||
154847294|NCT03529773|558871502|FG033|Overall Study|Physician Decision|0|||
154847295|NCT03529773|558871503|FG034|Overall Study|Physician Decision|0|||
154847296|NCT03529773|558871504|FG035|Overall Study|Physician Decision|0|||
154847297|NCT03529773|558871505|FG036|Overall Study|Physician Decision|0|||
154847298|NCT03529773|558871506|FG037|Overall Study|Physician Decision|0|||
154847299|NCT03529773|558871507|FG038|Overall Study|Physician Decision|0|||
154847300|NCT03529773|558871508|FG039|Overall Study|Physician Decision|0|||
154847301|NCT03529773|558871469|FG000|Overall Study|Protocol Violation|0|||
154847302|NCT03529773|558871470|FG001|Overall Study|Protocol Violation|0|||
154847303|NCT03529773|558871471|FG002|Overall Study|Protocol Violation|0|||
154847304|NCT03529773|558871472|FG003|Overall Study|Protocol Violation|0|||
154847305|NCT03529773|558871473|FG004|Overall Study|Protocol Violation|0|||
154847306|NCT03529773|558871474|FG005|Overall Study|Protocol Violation|0|||
154847307|NCT03529773|558871475|FG006|Overall Study|Protocol Violation|0|||
154847308|NCT03529773|558871476|FG007|Overall Study|Protocol Violation|0|||
154847309|NCT03529773|558871477|FG008|Overall Study|Protocol Violation|0|||
154847310|NCT03529773|558871478|FG009|Overall Study|Protocol Violation|0|||
154847311|NCT03529773|558871479|FG010|Overall Study|Protocol Violation|0|||
154847312|NCT03529773|558871480|FG011|Overall Study|Protocol Violation|0|||
154847313|NCT03529773|558871481|FG012|Overall Study|Protocol Violation|0|||
154847314|NCT03529773|558871482|FG013|Overall Study|Protocol Violation|0|||
154847315|NCT03529773|558871483|FG014|Overall Study|Protocol Violation|0|||
154847316|NCT03529773|558871484|FG015|Overall Study|Protocol Violation|0|||
154847317|NCT03529773|558871485|FG016|Overall Study|Protocol Violation|0|||
154847318|NCT03529773|558871486|FG017|Overall Study|Protocol Violation|0|||
154847319|NCT03529773|558871487|FG018|Overall Study|Protocol Violation|0|||
154847320|NCT03529773|558871488|FG019|Overall Study|Protocol Violation|0|||
154847321|NCT03529773|558871489|FG020|Overall Study|Protocol Violation|0|||
154847322|NCT03529773|558871490|FG021|Overall Study|Protocol Violation|0|||
154847323|NCT03529773|558871491|FG022|Overall Study|Protocol Violation|0|||
154847324|NCT03529773|558871492|FG023|Overall Study|Protocol Violation|0|||
154847325|NCT03529773|558871493|FG024|Overall Study|Protocol Violation|0|||
154847326|NCT03529773|558871494|FG025|Overall Study|Protocol Violation|0|||
154847327|NCT03529773|558871495|FG026|Overall Study|Protocol Violation|0|||
154847328|NCT03529773|558871496|FG027|Overall Study|Protocol Violation|0|||
154847329|NCT03529773|558871497|FG028|Overall Study|Protocol Violation|0|||
154847330|NCT03529773|558871498|FG029|Overall Study|Protocol Violation|0|||
154847331|NCT03529773|558871499|FG030|Overall Study|Protocol Violation|1|||
154847332|NCT03529773|558871500|FG031|Overall Study|Protocol Violation|0|||
154847333|NCT03529773|558871501|FG032|Overall Study|Protocol Violation|0|||
154847334|NCT03529773|558871502|FG033|Overall Study|Protocol Violation|0|||
154847335|NCT03529773|558871503|FG034|Overall Study|Protocol Violation|0|||
154847336|NCT03529773|558871504|FG035|Overall Study|Protocol Violation|0|||
154847337|NCT03529773|558871505|FG036|Overall Study|Protocol Violation|0|||
154847338|NCT03529773|558871506|FG037|Overall Study|Protocol Violation|0|||
154847339|NCT03529773|558871507|FG038|Overall Study|Protocol Violation|0|||
154847340|NCT03529773|558871508|FG039|Overall Study|Protocol Violation|0|||
154847341|NCT03529773|558871469|FG000|Overall Study|Withdrawal by Subject|0|||
154847342|NCT03529773|558871470|FG001|Overall Study|Withdrawal by Subject|0|||
154847343|NCT03529773|558871471|FG002|Overall Study|Withdrawal by Subject|0|||
154847344|NCT03529773|558871472|FG003|Overall Study|Withdrawal by Subject|0|||
154847345|NCT03529773|558871473|FG004|Overall Study|Withdrawal by Subject|0|||
154847346|NCT03529773|558871474|FG005|Overall Study|Withdrawal by Subject|0|||
154847347|NCT03529773|558871475|FG006|Overall Study|Withdrawal by Subject|0|||
154847348|NCT03529773|558871476|FG007|Overall Study|Withdrawal by Subject|1|||
154847349|NCT03529773|558871477|FG008|Overall Study|Withdrawal by Subject|0|||
154847350|NCT03529773|558871478|FG009|Overall Study|Withdrawal by Subject|1|||
154847351|NCT03529773|558871479|FG010|Overall Study|Withdrawal by Subject|1|||
154847352|NCT03529773|558871480|FG011|Overall Study|Withdrawal by Subject|0|||
154847353|NCT03529773|558871481|FG012|Overall Study|Withdrawal by Subject|0|||
154847354|NCT03529773|558871482|FG013|Overall Study|Withdrawal by Subject|0|||
154847355|NCT03529773|558871483|FG014|Overall Study|Withdrawal by Subject|0|||
154847356|NCT03529773|558871484|FG015|Overall Study|Withdrawal by Subject|3|||
154847357|NCT03529773|558871485|FG016|Overall Study|Withdrawal by Subject|0|||
154847358|NCT03529773|558871486|FG017|Overall Study|Withdrawal by Subject|2|||
154847359|NCT03529773|558871487|FG018|Overall Study|Withdrawal by Subject|3|||
154847360|NCT03529773|558871488|FG019|Overall Study|Withdrawal by Subject|1|||
154847361|NCT03529773|558871489|FG020|Overall Study|Withdrawal by Subject|3|||
154847362|NCT03529773|558871490|FG021|Overall Study|Withdrawal by Subject|1|||
154847363|NCT03529773|558871491|FG022|Overall Study|Withdrawal by Subject|1|||
154847364|NCT03529773|558871492|FG023|Overall Study|Withdrawal by Subject|2|||
154847365|NCT03529773|558871493|FG024|Overall Study|Withdrawal by Subject|2|||
154847366|NCT03529773|558871494|FG025|Overall Study|Withdrawal by Subject|4|||
154847367|NCT03529773|558871495|FG026|Overall Study|Withdrawal by Subject|2|||
154847368|NCT03529773|558871496|FG027|Overall Study|Withdrawal by Subject|1|||
154847369|NCT03529773|558871497|FG028|Overall Study|Withdrawal by Subject|1|||
154847370|NCT03529773|558871498|FG029|Overall Study|Withdrawal by Subject|0|||
154847371|NCT03529773|558871499|FG030|Overall Study|Withdrawal by Subject|0|||
154847372|NCT03529773|558871500|FG031|Overall Study|Withdrawal by Subject|0|||
154847373|NCT03529773|558871501|FG032|Overall Study|Withdrawal by Subject|0|||
154847374|NCT03529773|558871502|FG033|Overall Study|Withdrawal by Subject|0|||
154847375|NCT03529773|558871503|FG034|Overall Study|Withdrawal by Subject|1|||
154847376|NCT03529773|558871504|FG035|Overall Study|Withdrawal by Subject|2|||
154847377|NCT03529773|558871505|FG036|Overall Study|Withdrawal by Subject|0|||
155173552|NCT02870933|560074818|FG000|Overall Study|Withdrawal by Subject|0|||
155173553|NCT02870933|560074819|FG001|Overall Study|Withdrawal by Subject|1|||
154847378|NCT03529773|558871506|FG037|Overall Study|Withdrawal by Subject|2|||
154847379|NCT03529773|558871507|FG038|Overall Study|Withdrawal by Subject|1|||
154847380|NCT03529773|558871508|FG039|Overall Study|Withdrawal by Subject|1|||
154847381|NCT03529773|558871469|FG000|Overall Study|Screen Failure|0|||
154847382|NCT03529773|558871470|FG001|Overall Study|Screen Failure|0|||
154847383|NCT03529773|558871471|FG002|Overall Study|Screen Failure|0|||
154847384|NCT03529773|558871472|FG003|Overall Study|Screen Failure|0|||
154847385|NCT03529773|558871473|FG004|Overall Study|Screen Failure|0|||
154847386|NCT03529773|558871474|FG005|Overall Study|Screen Failure|0|||
154847387|NCT03529773|558871475|FG006|Overall Study|Screen Failure|0|||
154847388|NCT03529773|558871476|FG007|Overall Study|Screen Failure|0|||
154847389|NCT03529773|558871477|FG008|Overall Study|Screen Failure|0|||
154847390|NCT03529773|558871478|FG009|Overall Study|Screen Failure|0|||
154847391|NCT03529773|558871479|FG010|Overall Study|Screen Failure|0|||
154847392|NCT03529773|558871480|FG011|Overall Study|Screen Failure|0|||
154847393|NCT03529773|558871481|FG012|Overall Study|Screen Failure|0|||
154847394|NCT03529773|558871482|FG013|Overall Study|Screen Failure|0|||
154847395|NCT03529773|558871483|FG014|Overall Study|Screen Failure|0|||
154847396|NCT03529773|558871484|FG015|Overall Study|Screen Failure|0|||
154847397|NCT03529773|558871485|FG016|Overall Study|Screen Failure|0|||
154847398|NCT03529773|558871486|FG017|Overall Study|Screen Failure|0|||
154847399|NCT03529773|558871487|FG018|Overall Study|Screen Failure|0|||
154847400|NCT03529773|558871488|FG019|Overall Study|Screen Failure|0|||
154847401|NCT03529773|558871489|FG020|Overall Study|Screen Failure|0|||
154847402|NCT03529773|558871490|FG021|Overall Study|Screen Failure|0|||
154847403|NCT03529773|558871491|FG022|Overall Study|Screen Failure|0|||
154847404|NCT03529773|558871492|FG023|Overall Study|Screen Failure|0|||
154847405|NCT03529773|558871493|FG024|Overall Study|Screen Failure|0|||
154847406|NCT03529773|558871494|FG025|Overall Study|Screen Failure|0|||
154847407|NCT03529773|558871495|FG026|Overall Study|Screen Failure|0|||
154847408|NCT03529773|558871496|FG027|Overall Study|Screen Failure|0|||
154847409|NCT03529773|558871497|FG028|Overall Study|Screen Failure|0|||
154847410|NCT03529773|558871498|FG029|Overall Study|Screen Failure|0|||
154847411|NCT03529773|558871499|FG030|Overall Study|Screen Failure|0|||
154847412|NCT03529773|558871500|FG031|Overall Study|Screen Failure|0|||
154847413|NCT03529773|558871501|FG032|Overall Study|Screen Failure|0|||
154847414|NCT03529773|558871502|FG033|Overall Study|Screen Failure|0|||
154847415|NCT03529773|558871503|FG034|Overall Study|Screen Failure|0|||
154847416|NCT03529773|558871504|FG035|Overall Study|Screen Failure|0|||
154847417|NCT03529773|558871505|FG036|Overall Study|Screen Failure|1|||
154847418|NCT03529773|558871506|FG037|Overall Study|Screen Failure|1|||
154847419|NCT03529773|558871507|FG038|Overall Study|Screen Failure|0|||
154847420|NCT03529773|558871508|FG039|Overall Study|Screen Failure|1|||
154847421|NCT03529773|558871469|FG000|Overall Study|Randomized but not vaccinated|0|||
154847422|NCT03529773|558871470|FG001|Overall Study|Randomized but not vaccinated|0|||
154847423|NCT03529773|558871471|FG002|Overall Study|Randomized but not vaccinated|0|||
154847424|NCT03529773|558871472|FG003|Overall Study|Randomized but not vaccinated|0|||
154847425|NCT03529773|558871473|FG004|Overall Study|Randomized but not vaccinated|0|||
154847426|NCT03529773|558871474|FG005|Overall Study|Randomized but not vaccinated|0|||
154847427|NCT03529773|558871475|FG006|Overall Study|Randomized but not vaccinated|0|||
154847428|NCT03529773|558871476|FG007|Overall Study|Randomized but not vaccinated|0|||
154847429|NCT03529773|558871477|FG008|Overall Study|Randomized but not vaccinated|0|||
154847430|NCT03529773|558871478|FG009|Overall Study|Randomized but not vaccinated|0|||
154847431|NCT03529773|558871479|FG010|Overall Study|Randomized but not vaccinated|0|||
154847432|NCT03529773|558871480|FG011|Overall Study|Randomized but not vaccinated|0|||
154847433|NCT03529773|558871481|FG012|Overall Study|Randomized but not vaccinated|0|||
154847434|NCT03529773|558871482|FG013|Overall Study|Randomized but not vaccinated|0|||
155105119|NCT00131352|559815518|FG000|Initial Treatment Period|Adverse Event|1|||
155105120|NCT00131352|559815519|FG001|Initial Treatment Period|Adverse Event|3|||
155105121|NCT00131352|559815518|FG000|Initial Treatment Period|Non-compliant|1|||
155105122|NCT00131352|559815519|FG001|Initial Treatment Period|Non-compliant|2|||
155105123|NCT00131352|559815518|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
155105124|NCT00131352|559815519|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
155105125|NCT00131352|559815518|FG000|Initial Treatment Period|Lack of Efficacy|6|||
155105126|NCT00131352|559815519|FG001|Initial Treatment Period|Lack of Efficacy|4|||
154847435|NCT03529773|558871483|FG014|Overall Study|Randomized but not vaccinated|0|||
155105127|NCT00131352|559815518|FG000|Initial Treatment Period|Other|0|||
154847436|NCT03529773|558871484|FG015|Overall Study|Randomized but not vaccinated|0|||
154847437|NCT03529773|558871485|FG016|Overall Study|Randomized but not vaccinated|0|||
154847438|NCT03529773|558871486|FG017|Overall Study|Randomized but not vaccinated|1|||
154847439|NCT03529773|558871487|FG018|Overall Study|Randomized but not vaccinated|0|||
154847440|NCT03529773|558871488|FG019|Overall Study|Randomized but not vaccinated|0|||
154847441|NCT03529773|558871489|FG020|Overall Study|Randomized but not vaccinated|0|||
154847442|NCT03529773|558871490|FG021|Overall Study|Randomized but not vaccinated|0|||
154847443|NCT03529773|558871491|FG022|Overall Study|Randomized but not vaccinated|0|||
154971255|NCT01074008|559318587|FG007|Overall Study|Lost to Follow-up|0|||
154847444|NCT03529773|558871492|FG023|Overall Study|Randomized but not vaccinated|0|||
154847445|NCT03529773|558871493|FG024|Overall Study|Randomized but not vaccinated|0|||
154847446|NCT03529773|558871494|FG025|Overall Study|Randomized but not vaccinated|0|||
154847447|NCT03529773|558871495|FG026|Overall Study|Randomized but not vaccinated|0|||
154847448|NCT03529773|558871496|FG027|Overall Study|Randomized but not vaccinated|1|||
154847449|NCT03529773|558871497|FG028|Overall Study|Randomized but not vaccinated|0|||
154847450|NCT03529773|558871498|FG029|Overall Study|Randomized but not vaccinated|0|||
154847451|NCT03529773|558871499|FG030|Overall Study|Randomized but not vaccinated|0|||
154847452|NCT03529773|558871500|FG031|Overall Study|Randomized but not vaccinated|0|||
154847453|NCT03529773|558871501|FG032|Overall Study|Randomized but not vaccinated|0|||
154847454|NCT03529773|558871502|FG033|Overall Study|Randomized but not vaccinated|0|||
154847455|NCT03529773|558871503|FG034|Overall Study|Randomized but not vaccinated|0|||
154847456|NCT03529773|558871504|FG035|Overall Study|Randomized but not vaccinated|0|||
154847457|NCT03529773|558871505|FG036|Overall Study|Randomized but not vaccinated|0|||
154847458|NCT03529773|558871506|FG037|Overall Study|Randomized but not vaccinated|0|||
154847459|NCT03529773|558871507|FG038|Overall Study|Randomized but not vaccinated|0|||
154847460|NCT03529773|558871508|FG039|Overall Study|Randomized but not vaccinated|0|||
154847461|NCT03237065|558871511|FG000|Overall Study|Adverse Event|0|||
154847462|NCT03237065|558871512|FG001|Overall Study|Adverse Event|2|||
154847463|NCT03237065|558871511|FG000|Overall Study|Protocol Violation|0|||
154847464|NCT03237065|558871512|FG001|Overall Study|Protocol Violation|1|||
154847465|NCT03237065|558871511|FG000|Overall Study|Withdrawal by Subject|3|||
154847466|NCT03237065|558871512|FG001|Overall Study|Withdrawal by Subject|0|||
154847467|NCT03237065|558871511|FG000|Overall Study|Lost to Follow-up|1|||
154847468|NCT03237065|558871512|FG001|Overall Study|Lost to Follow-up|0|||
154847469|NCT03237065|558871511|FG000|Overall Study|Unable to obtain venous access|0|||
154847470|NCT03237065|558871512|FG001|Overall Study|Unable to obtain venous access|1|||
154847471|NCT00429858|558871513|FG000|Overall Study|Withdrawal by Subject|1|||
154847472|NCT00429858|558871513|FG000|Overall Study|Study Termination|1|||
154847473|NCT01537211|558871515|FG000|Overall Study|Lost to Follow-up|0|||
154847474|NCT01537211|558871516|FG001|Overall Study|Lost to Follow-up|1|||
154847475|NCT02475655|558871517|FG000|Overall Study|Lost to Follow-up|0|||
154847476|NCT02475655|558871518|FG001|Overall Study|Lost to Follow-up|1|||
154847477|NCT00257010|558871523|FG000|Overall Study|Lack of Efficacy|11|||
154847478|NCT00257010|558871523|FG000|Overall Study|Lost to Follow-up|53|||
154847479|NCT00257010|558871523|FG000|Overall Study|Withdrawal by Subject|34|||
154847480|NCT00257010|558871523|FG000|Overall Study|Adverse Event|10|||
154847481|NCT00257010|558871523|FG000|Overall Study|various|11|||
154847482|NCT00257010|558871523|FG000|Overall Study|no headache reported|9|||
154847483|NCT00662792|558871524|FG000|Period 1|Personal Reasons|0|||
154847484|NCT00662792|558871525|FG001|Period 1|Personal Reasons|0|||
154847485|NCT00662792|558871526|FG002|Period 1|Personal Reasons|1|||
154847486|NCT00662792|558871527|FG003|Period 1|Personal Reasons|0|||
154847487|NCT00662792|558871524|FG000|Period 1|Refused continuing medication|0|||
154847488|NCT00662792|558871525|FG001|Period 1|Refused continuing medication|1|||
154847489|NCT00662792|558871526|FG002|Period 1|Refused continuing medication|1|||
154847490|NCT00662792|558871527|FG003|Period 1|Refused continuing medication|0|||
154847491|NCT00662792|558871524|FG000|Period 1|Lost to Follow-up|1|||
154847492|NCT00662792|558871525|FG001|Period 1|Lost to Follow-up|0|||
154847493|NCT00662792|558871526|FG002|Period 1|Lost to Follow-up|0|||
154847494|NCT00662792|558871527|FG003|Period 1|Lost to Follow-up|0|||
154847495|NCT00662792|558871524|FG000|Period 1|Other adverse event (AE)|0|||
154847496|NCT00662792|558871525|FG001|Period 1|Other adverse event (AE)|2|||
154847497|NCT00662792|558871526|FG002|Period 1|Other adverse event (AE)|0|||
154847498|NCT00662792|558871527|FG003|Period 1|Other adverse event (AE)|0|||
154847499|NCT00662792|558871524|FG000|Period 1|Worsening of disease under study (AE)|1|||
154847500|NCT00662792|558871525|FG001|Period 1|Worsening of disease under study (AE)|3|||
154847501|NCT00662792|558871526|FG002|Period 1|Worsening of disease under study (AE)|2|||
154847502|NCT00662792|558871527|FG003|Period 1|Worsening of disease under study (AE)|0|||
154847503|NCT00662792|558871524|FG000|Period 1|Not treated|0|||
154847504|NCT00662792|558871525|FG001|Period 1|Not treated|1|||
154847505|NCT00662792|558871526|FG002|Period 1|Not treated|0|||
154847506|NCT00662792|558871527|FG003|Period 1|Not treated|0|||
154847507|NCT00662792|558871524|FG000|Period 2|Worsening of disease under study|1|||
154847508|NCT00662792|558871525|FG001|Period 2|Worsening of disease under study|0|||
154847509|NCT00662792|558871526|FG002|Period 2|Worsening of disease under study|0|||
154847510|NCT00662792|558871527|FG003|Period 2|Worsening of disease under study|3|||
154847511|NCT00662792|558871524|FG000|Period 3|Refused continuing medication|1|||
155105128|NCT00131352|559815519|FG001|Initial Treatment Period|Other|2|||
155105129|NCT00131352|559815518|FG000|Repeat Treatment Period|Adverse Event|1|||
155105130|NCT00131352|559815519|FG001|Repeat Treatment Period|Adverse Event|0|||
154847512|NCT00662792|558871525|FG001|Period 3|Refused continuing medication|0|||
154847513|NCT00662792|558871526|FG002|Period 3|Refused continuing medication|1|||
154847514|NCT00662792|558871527|FG003|Period 3|Refused continuing medication|0|||
154847515|NCT00662792|558871524|FG000|Period 3|Other adverse event (AE)|0|||
154847516|NCT00662792|558871525|FG001|Period 3|Other adverse event (AE)|0|||
154847517|NCT00662792|558871526|FG002|Period 3|Other adverse event (AE)|1|||
155105131|NCT00131352|559815518|FG000|Repeat Treatment Period|Other|1|||
155105132|NCT00131352|559815519|FG001|Repeat Treatment Period|Other|0|||
155105133|NCT00135330|559815520|FG000|Overall Study|Adverse Event|2|||
155105134|NCT00135330|559815521|FG001|Overall Study|Adverse Event|5|||
155105135|NCT00135330|559815522|FG002|Overall Study|Adverse Event|1|||
155105136|NCT00135330|559815520|FG000|Overall Study|Lost to Follow-up|0|||
155105137|NCT00135330|559815521|FG001|Overall Study|Lost to Follow-up|2|||
155105138|NCT00135330|559815522|FG002|Overall Study|Lost to Follow-up|3|||
154847518|NCT00662792|558871527|FG003|Period 3|Other adverse event (AE)|1|||
154847519|NCT00662792|558871524|FG000|Period 4|Refused continuing medication|0|||
154847520|NCT00662792|558871525|FG001|Period 4|Refused continuing medication|1|||
154847521|NCT00662792|558871526|FG002|Period 4|Refused continuing medication|0|||
154847522|NCT00662792|558871527|FG003|Period 4|Refused continuing medication|0|||
154847523|NCT00662792|558871524|FG000|Period 4|Other adverse event (AE)|1|||
154847524|NCT00662792|558871525|FG001|Period 4|Other adverse event (AE)|0|||
154847525|NCT00662792|558871526|FG002|Period 4|Other adverse event (AE)|0|||
154847526|NCT00662792|558871527|FG003|Period 4|Other adverse event (AE)|0|||
154847527|NCT00662792|558871524|FG000|Period 4|Worsening of disease under study (AE)|0|||
154847528|NCT00662792|558871525|FG001|Period 4|Worsening of disease under study (AE)|0|||
154847529|NCT00662792|558871526|FG002|Period 4|Worsening of disease under study (AE)|0|||
154847530|NCT00662792|558871527|FG003|Period 4|Worsening of disease under study (AE)|1|||
154847531|NCT02474082|558871530|FG000|Overall Study|Adverse Event|2|||
154847532|NCT02474082|558871531|FG001|Overall Study|Adverse Event|32|||
154847533|NCT02474082|558871530|FG000|Overall Study|Withdrawal of informed consent|1|||
154847534|NCT02474082|558871531|FG001|Overall Study|Withdrawal of informed consent|11|||
154847535|NCT02474082|558871530|FG000|Overall Study|Lost to Follow-up|2|||
154847536|NCT02474082|558871531|FG001|Overall Study|Lost to Follow-up|2|||
154847537|NCT02474082|558871530|FG000|Overall Study|Dose tapering not achieved|0|||
154847538|NCT02474082|558871531|FG001|Overall Study|Dose tapering not achieved|4|||
154847539|NCT02474082|558871530|FG000|Overall Study|Participant/guardian decision|1|||
154847540|NCT02474082|558871531|FG001|Overall Study|Participant/guardian decision|2|||
154847541|NCT02474082|558871530|FG000|Overall Study|Non-compliance with study treatment|0|||
154847542|NCT02474082|558871531|FG001|Overall Study|Non-compliance with study treatment|2|||
154847543|NCT02474082|558871530|FG000|Overall Study|Protocol deviation|0|||
154847544|NCT02474082|558871531|FG001|Overall Study|Protocol deviation|1|||
154847545|NCT01463098|558871534|FG000|Part A (11 Days)|Participant Choice|2|||
154847546|NCT01463098|558871535|FG001|Part A (11 Days)|Participant Choice|0|||
154847547|NCT01463098|558871536|FG002|Part A (11 Days)|Participant Choice|0|||
154847548|NCT01463098|558871537|FG003|Part A (11 Days)|Participant Choice|0|||
154847549|NCT01463098|558871538|FG004|Part A (11 Days)|Participant Choice|0|||
154847550|NCT01463098|558871539|FG005|Part A (11 Days)|Participant Choice|0|||
154847551|NCT01463098|558871540|FG006|Part A (11 Days)|Participant Choice|0|||
154847552|NCT01463098|558871541|FG007|Part A (11 Days)|Participant Choice|0|||
154847553|NCT01463098|558871542|FG008|Part A (11 Days)|Participant Choice|1|||
154847554|NCT01463098|558871543|FG009|Part A (11 Days)|Participant Choice|0|||
154847555|NCT01463098|558871544|FG010|Part A (11 Days)|Participant Choice|0|||
154847556|NCT01463098|558871545|FG011|Part A (11 Days)|Participant Choice|0|||
154847557|NCT01463098|558871546|FG012|Part A (11 Days)|Participant Choice|0|||
154847558|NCT01463098|558871547|FG013|Part A (11 Days)|Participant Choice|0|||
154847559|NCT01463098|558871534|FG000|Part A (11 Days)|Lost to Follow-up|0|||
154847560|NCT01463098|558871535|FG001|Part A (11 Days)|Lost to Follow-up|0|||
154847561|NCT01463098|558871536|FG002|Part A (11 Days)|Lost to Follow-up|0|||
154847562|NCT01463098|558871537|FG003|Part A (11 Days)|Lost to Follow-up|0|||
155105139|NCT00135330|559815520|FG000|Overall Study|Physician Decision|1|||
154847563|NCT01463098|558871538|FG004|Part A (11 Days)|Lost to Follow-up|1|||
154847564|NCT01463098|558871539|FG005|Part A (11 Days)|Lost to Follow-up|0|||
154847565|NCT01463098|558871540|FG006|Part A (11 Days)|Lost to Follow-up|0|||
154847566|NCT01463098|558871541|FG007|Part A (11 Days)|Lost to Follow-up|0|||
154847567|NCT01463098|558871542|FG008|Part A (11 Days)|Lost to Follow-up|0|||
154847568|NCT01463098|558871543|FG009|Part A (11 Days)|Lost to Follow-up|0|||
154847569|NCT01463098|558871544|FG010|Part A (11 Days)|Lost to Follow-up|0|||
154847570|NCT01463098|558871545|FG011|Part A (11 Days)|Lost to Follow-up|0|||
154847571|NCT01463098|558871546|FG012|Part A (11 Days)|Lost to Follow-up|0|||
154847572|NCT01463098|558871547|FG013|Part A (11 Days)|Lost to Follow-up|0|||
154847573|NCT01463098|558871534|FG000|Part B (11 Days)|Participant Choice|0|||
154847574|NCT01463098|558871535|FG001|Part B (11 Days)|Participant Choice|0|||
154847575|NCT01463098|558871536|FG002|Part B (11 Days)|Participant Choice|0|||
154847576|NCT01463098|558871537|FG003|Part B (11 Days)|Participant Choice|0|||
154847577|NCT01463098|558871538|FG004|Part B (11 Days)|Participant Choice|0|||
154847578|NCT01463098|558871539|FG005|Part B (11 Days)|Participant Choice|0|||
154847579|NCT01463098|558871540|FG006|Part B (11 Days)|Participant Choice|0|||
154971256|NCT01074008|559318588|FG008|Overall Study|Lost to Follow-up|4|||
155105140|NCT00135330|559815521|FG001|Overall Study|Physician Decision|1|||
155105141|NCT00135330|559815522|FG002|Overall Study|Physician Decision|0|||
154847580|NCT01463098|558871541|FG007|Part B (11 Days)|Participant Choice|0|||
154847581|NCT01463098|558871542|FG008|Part B (11 Days)|Participant Choice|0|||
154847582|NCT01463098|558871543|FG009|Part B (11 Days)|Participant Choice|0|||
154847583|NCT01463098|558871544|FG010|Part B (11 Days)|Participant Choice|0|||
154847584|NCT01463098|558871545|FG011|Part B (11 Days)|Participant Choice|1|||
154847585|NCT01463098|558871546|FG012|Part B (11 Days)|Participant Choice|0|||
154847586|NCT01463098|558871547|FG013|Part B (11 Days)|Participant Choice|0|||
154847587|NCT04317274|558871548|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
154847588|NCT04317274|558871549|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
154847589|NCT04317274|558871550|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
154847590|NCT04317274|558871551|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
154847591|NCT00699907|558871552|FG000|Overall Study|Withdrawal by Subject|2|||
154847592|NCT00699907|558871553|FG001|Overall Study|Withdrawal by Subject|1|||
154847593|NCT00699907|558871554|FG002|Overall Study|Withdrawal by Subject|0|||
154847594|NCT00699907|558871552|FG000|Overall Study|No usable sample|0|||
154847595|NCT00699907|558871553|FG001|Overall Study|No usable sample|9|||
154847596|NCT00699907|558871554|FG002|Overall Study|No usable sample|8|||
154847597|NCT02286947|558871577|FG000|Overall Study|Withdrawal by Subject|2|||
154847598|NCT01145066|558871578|FG000|Overall Study|To resume NSAIDs|2|||
154847599|NCT01145066|558871579|FG001|Overall Study|To resume NSAIDs|2|||
154847600|NCT01145066|558871580|FG002|Overall Study|To resume NSAIDs|1|||
154847601|NCT01145066|558871578|FG000|Overall Study|Non-related surgery|0|||
154847602|NCT01145066|558871579|FG001|Overall Study|Non-related surgery|0|||
154847603|NCT01145066|558871580|FG002|Overall Study|Non-related surgery|1|||
154847604|NCT01145066|558871578|FG000|Overall Study|Withdrawal by Subject|0|||
154847605|NCT01145066|558871579|FG001|Overall Study|Withdrawal by Subject|0|||
154847606|NCT01145066|558871580|FG002|Overall Study|Withdrawal by Subject|2|||
154847607|NCT01145066|558871578|FG000|Overall Study|To start new med|1|||
154847608|NCT01145066|558871579|FG001|Overall Study|To start new med|0|||
154847609|NCT01145066|558871580|FG002|Overall Study|To start new med|0|||
154847610|NCT01145066|558871578|FG000|Overall Study|problems swallowing capsule|1|||
154847611|NCT01145066|558871579|FG001|Overall Study|problems swallowing capsule|0|||
154847612|NCT01145066|558871580|FG002|Overall Study|problems swallowing capsule|0|||
154847613|NCT01145066|558871578|FG000|Overall Study|Abdominal discomfort|0|||
154847614|NCT01145066|558871579|FG001|Overall Study|Abdominal discomfort|1|||
154847615|NCT01145066|558871580|FG002|Overall Study|Abdominal discomfort|0|||
154847616|NCT01145066|558871578|FG000|Overall Study|Low platelet count|0|||
154847617|NCT01145066|558871579|FG001|Overall Study|Low platelet count|1|||
154847618|NCT01145066|558871580|FG002|Overall Study|Low platelet count|0|||
154847619|NCT03920670|558871581|FG000|Overall Study|Protocol Violation|2|||
154847620|NCT03920670|558871582|FG001|Overall Study|Protocol Violation|2|||
154847621|NCT03920670|558871581|FG000|Overall Study|Adverse Event|1|||
154847622|NCT03920670|558871582|FG001|Overall Study|Adverse Event|0|||
154847623|NCT00573794|558871588|FG000|Overall Study|Adverse Event|81|||
154847624|NCT00573794|558871588|FG000|Overall Study|Withdrew Consent|90|||
154847625|NCT00573794|558871588|FG000|Overall Study|Lost to Follow-up|13|||
154847626|NCT00573794|558871588|FG000|Overall Study|Protocol Violation|6|||
154847627|NCT00573794|558871588|FG000|Overall Study|Lack of Efficacy|94|||
154847628|NCT00573794|558871588|FG000|Overall Study|Other|46|||
154847629|NCT02270242|558871589|FG000|Overall Study|Withdrawal by Subject|18|||
154847630|NCT02270242|558871590|FG001|Overall Study|Withdrawal by Subject|25|||
154847631|NCT02270242|558871589|FG000|Overall Study|Lost to Follow-up|41|||
154847632|NCT02270242|558871590|FG001|Overall Study|Lost to Follow-up|27|||
154847633|NCT02270242|558871589|FG000|Overall Study|Physician Decision|0|||
154847634|NCT02270242|558871590|FG001|Overall Study|Physician Decision|1|||
154847635|NCT01984268|558871591|FG000|Overall Study|Study Terminated|15|||
154971257|NCT01453153|559318598|FG000|Overall Study|Physician Decision|0|||
154971258|NCT01453153|559318599|FG001|Overall Study|Physician Decision|0|||
154971259|NCT01453153|559318600|FG002|Overall Study|Physician Decision|1|||
154971260|NCT01453153|559318598|FG000|Overall Study|Progressive Disease|3|||
154971261|NCT01453153|559318599|FG001|Overall Study|Progressive Disease|2|||
154971262|NCT01453153|559318600|FG002|Overall Study|Progressive Disease|16|||
154971263|NCT01453153|559318598|FG000|Overall Study|Withdrawal by Subject|0|||
154971264|NCT01453153|559318599|FG001|Overall Study|Withdrawal by Subject|1|||
154971265|NCT01453153|559318600|FG002|Overall Study|Withdrawal by Subject|2|||
154971266|NCT01453153|559318598|FG000|Overall Study|Adverse Event|1|||
154847636|NCT02527707|558873554|FG000|Overall Study|Adverse Event|1|||
154847637|NCT02527707|558873554|FG000|Overall Study|Adverse Event|1|||
154847638|NCT01641939|558873555|FG000|Overall Study|Death|90|||
154847639|NCT01641939|558873556|FG001|Overall Study|Death|187|||
154847640|NCT01641939|558873557|FG002|Overall Study|Death|61|||
154847641|NCT01641939|558873555|FG000|Overall Study|Lost to Follow-up|3|||
154847642|NCT01641939|558873556|FG001|Overall Study|Lost to Follow-up|2|||
154847643|NCT01641939|558873557|FG002|Overall Study|Lost to Follow-up|1|||
154847644|NCT01641939|558873555|FG000|Overall Study|Withdrawal by Subject|14|||
154847645|NCT01641939|558873556|FG001|Overall Study|Withdrawal by Subject|11|||
154847646|NCT01641939|558873557|FG002|Overall Study|Withdrawal by Subject|5|||
154971267|NCT01453153|559318599|FG001|Overall Study|Adverse Event|1|||
155105142|NCT00135330|559815520|FG000|Overall Study|Protocol Violation|4|||
155105143|NCT00135330|559815521|FG001|Overall Study|Protocol Violation|3|||
155105144|NCT00135330|559815522|FG002|Overall Study|Protocol Violation|3|||
155105145|NCT00135330|559815520|FG000|Overall Study|Patient Decision|5|||
155105146|NCT00135330|559815521|FG001|Overall Study|Patient Decision|1|||
155105147|NCT00135330|559815522|FG002|Overall Study|Patient Decision|4|||
155105148|NCT00135330|559815520|FG000|Overall Study|Sponsor Decision|0|||
155105149|NCT00135330|559815521|FG001|Overall Study|Sponsor Decision|1|||
155105150|NCT00135330|559815522|FG002|Overall Study|Sponsor Decision|0|||
155105151|NCT02253433|559815526|FG000|Overall Study|Unable to Contact|9|||
154971268|NCT01453153|559318600|FG002|Overall Study|Adverse Event|1|||
155105152|NCT02253433|559815527|FG001|Overall Study|Unable to Contact|16|||
154971269|NCT01350934|559318601|FG000|Base Study|Adverse Event|6|||
154971270|NCT01350934|559318602|FG001|Base Study|Adverse Event|0|||
154971271|NCT01350934|559318601|FG000|Base Study|Lost to Follow-up|1|||
154971272|NCT01350934|559318602|FG001|Base Study|Lost to Follow-up|0|||
154847647|NCT01641939|558873555|FG000|Overall Study|Study Terminated by Sponsor|10|||
154847648|NCT01641939|558873556|FG001|Overall Study|Study Terminated by Sponsor|28|||
154847649|NCT01641939|558873557|FG002|Overall Study|Study Terminated by Sponsor|3|||
154847650|NCT00975156|558873565|FG000|Overall Study|Protocol Violation|0|||
154847651|NCT00975156|558873566|FG001|Overall Study|Protocol Violation|1|||
154847652|NCT05499559|558873567|FG000|Overall Study|Lost to Follow-up|467|||
154847653|NCT02971202|558873572|FG000|Overall Study|Pregnancy|1|||
154847654|NCT02971202|558873573|FG001|Overall Study|Pregnancy|0|||
154847655|NCT02971202|558873574|FG002|Overall Study|Pregnancy|0|||
154847656|NCT02971202|558873572|FG000|Overall Study|screen fail after consent|1|||
154847657|NCT02971202|558873573|FG001|Overall Study|screen fail after consent|0|||
154847658|NCT02971202|558873574|FG002|Overall Study|screen fail after consent|1|||
154847659|NCT01001702|558873579|FG000|Overall Study|Lost to Follow-up|7|||
154847660|NCT01001702|558873579|FG000|Overall Study|Adverse Event|7|||
154847661|NCT01001702|558873579|FG000|Overall Study|Sponsor Discontinued Study|4|||
154847662|NCT01001702|558873579|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
154847663|NCT01001702|558873579|FG000|Overall Study|Investigator withdrew Subject|10|||
154847664|NCT01001702|558873579|FG000|Overall Study|Withdrawal by Subject|19|||
154847665|NCT01001702|558873579|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
154847666|NCT02494596|558873580|FG000|Overall Study|Insufficient Therapeutic Response|3|||
154847667|NCT02494596|558873581|FG001|Overall Study|Insufficient Therapeutic Response|3|||
154847668|NCT02494596|558873582|FG002|Overall Study|Insufficient Therapeutic Response|1|||
154847669|NCT02494596|558873580|FG000|Overall Study|Adverse Event|0|||
154847670|NCT02494596|558873581|FG001|Overall Study|Adverse Event|1|||
154847671|NCT02494596|558873582|FG002|Overall Study|Adverse Event|0|||
154847672|NCT02494596|558873580|FG000|Overall Study|Refused Treatment|0|||
154847673|NCT02494596|558873581|FG001|Overall Study|Refused Treatment|1|||
154847674|NCT02494596|558873582|FG002|Overall Study|Refused Treatment|0|||
154847675|NCT02222714|558873583|FG000|Overall Study|Death|0|||
154847676|NCT02222714|558873584|FG001|Overall Study|Death|2|||
154847677|NCT02222714|558873585|FG002|Overall Study|Death|3|||
154847678|NCT02222714|558873586|FG003|Overall Study|Death|4|||
154847679|NCT02222714|558873587|FG004|Overall Study|Death|6|||
154847680|NCT02222714|558873583|FG000|Overall Study|Withdrawal by Subject|0|||
154847681|NCT02222714|558873584|FG001|Overall Study|Withdrawal by Subject|0|||
154847682|NCT02222714|558873585|FG002|Overall Study|Withdrawal by Subject|1|||
154847683|NCT02222714|558873586|FG003|Overall Study|Withdrawal by Subject|0|||
154847684|NCT02222714|558873587|FG004|Overall Study|Withdrawal by Subject|1|||
154847685|NCT00159432|558873588|FG000|Overall Study|Adverse Event|1|||
154847686|NCT00159432|558873588|FG000|Overall Study|Death|1|||
154847687|NCT00159432|558873588|FG000|Overall Study|Lack of Efficacy|8|||
154847688|NCT04537208|558873593|FG000|Overall Study|Adverse Event|0|||
154847689|NCT04537208|558873594|FG001|Overall Study|Adverse Event|0|||
154847690|NCT04537208|558873595|FG002|Overall Study|Adverse Event|0|||
154847691|NCT04537208|558873596|FG003|Overall Study|Adverse Event|0|||
154847692|NCT04537208|558873597|FG004|Overall Study|Adverse Event|0|||
154847693|NCT04537208|558873598|FG005|Overall Study|Adverse Event|0|||
154847694|NCT04537208|558873599|FG006|Overall Study|Adverse Event|0|||
154847695|NCT04537208|558873600|FG007|Overall Study|Adverse Event|0|||
154847696|NCT04537208|558873601|FG008|Overall Study|Adverse Event|1|||
154847697|NCT04537208|558873602|FG009|Overall Study|Adverse Event|0|||
154847698|NCT04537208|558873603|FG010|Overall Study|Adverse Event|0|||
154847699|NCT04537208|558873593|FG000|Overall Study|Protocol deviation|0|||
154847700|NCT04537208|558873594|FG001|Overall Study|Protocol deviation|0|||
154847701|NCT04537208|558873595|FG002|Overall Study|Protocol deviation|2|||
154847702|NCT04537208|558873596|FG003|Overall Study|Protocol deviation|0|||
154847703|NCT04537208|558873597|FG004|Overall Study|Protocol deviation|0|||
154847704|NCT04537208|558873598|FG005|Overall Study|Protocol deviation|2|||
154847705|NCT04537208|558873599|FG006|Overall Study|Protocol deviation|4|||
154847706|NCT04537208|558873600|FG007|Overall Study|Protocol deviation|0|||
154847707|NCT04537208|558873601|FG008|Overall Study|Protocol deviation|1|||
154847708|NCT04537208|558873602|FG009|Overall Study|Protocol deviation|0|||
154847709|NCT04537208|558873603|FG010|Overall Study|Protocol deviation|2|||
154847710|NCT04537208|558873593|FG000|Overall Study|Withdrawal by Subject|4|||
154847711|NCT04537208|558873594|FG001|Overall Study|Withdrawal by Subject|2|||
154847712|NCT04537208|558873595|FG002|Overall Study|Withdrawal by Subject|1|||
154847713|NCT04537208|558873596|FG003|Overall Study|Withdrawal by Subject|3|||
154847714|NCT04537208|558873597|FG004|Overall Study|Withdrawal by Subject|5|||
154847715|NCT04537208|558873598|FG005|Overall Study|Withdrawal by Subject|1|||
154847716|NCT04537208|558873599|FG006|Overall Study|Withdrawal by Subject|6|||
154847717|NCT04537208|558873600|FG007|Overall Study|Withdrawal by Subject|1|||
154847718|NCT04537208|558873601|FG008|Overall Study|Withdrawal by Subject|7|||
154847719|NCT04537208|558873602|FG009|Overall Study|Withdrawal by Subject|2|||
154847720|NCT04537208|558873603|FG010|Overall Study|Withdrawal by Subject|4|||
154847721|NCT04537208|558873593|FG000|Overall Study|Lost to Follow-up|4|||
154847722|NCT04537208|558873594|FG001|Overall Study|Lost to Follow-up|1|||
154847723|NCT04537208|558873595|FG002|Overall Study|Lost to Follow-up|3|||
154847724|NCT04537208|558873596|FG003|Overall Study|Lost to Follow-up|4|||
154847725|NCT04537208|558873597|FG004|Overall Study|Lost to Follow-up|3|||
154847726|NCT04537208|558873598|FG005|Overall Study|Lost to Follow-up|2|||
154847727|NCT04537208|558873599|FG006|Overall Study|Lost to Follow-up|3|||
154847728|NCT04537208|558873600|FG007|Overall Study|Lost to Follow-up|2|||
154847729|NCT04537208|558873601|FG008|Overall Study|Lost to Follow-up|7|||
154847730|NCT04537208|558873602|FG009|Overall Study|Lost to Follow-up|2|||
154847731|NCT04537208|558873603|FG010|Overall Study|Lost to Follow-up|2|||
154847732|NCT00704964|558873605|FG000|Overall Study|Not completed on time|328|||
154847733|NCT02161562|558873607|FG000|Overall Study|Withdrawal by Subject|5|||
154847734|NCT02161562|558873608|FG001|Overall Study|Withdrawal by Subject|8|||
154847735|NCT02161562|558873607|FG000|Overall Study|Protocol Violation|9|||
154847736|NCT02161562|558873608|FG001|Overall Study|Protocol Violation|4|||
154847737|NCT02161562|558873607|FG000|Overall Study|Pregnancy|1|||
154847738|NCT02161562|558873608|FG001|Overall Study|Pregnancy|2|||
154847739|NCT02161562|558873607|FG000|Overall Study|Lost to Follow-up|3|||
154847740|NCT02161562|558873608|FG001|Overall Study|Lost to Follow-up|1|||
154847741|NCT02161562|558873607|FG000|Overall Study|Lack of Efficacy|4|||
154847742|NCT02161562|558873608|FG001|Overall Study|Lack of Efficacy|1|||
154847743|NCT02161562|558873607|FG000|Overall Study|Adverse Event|1|||
154847744|NCT02161562|558873608|FG001|Overall Study|Adverse Event|1|||
154847745|NCT02161562|558873607|FG000|Overall Study|Participant moved back to home country|1|||
154847746|NCT02161562|558873608|FG001|Overall Study|Participant moved back to home country|0|||
154847747|NCT02161562|558873607|FG000|Overall Study|Withdrew due to being out of the country|1|||
154847748|NCT02161562|558873608|FG001|Overall Study|Withdrew due to being out of the country|0|||
154847749|NCT02161562|558873607|FG000|Overall Study|Participant moved out of province|1|||
154847750|NCT02161562|558873608|FG001|Overall Study|Participant moved out of province|0|||
154847751|NCT02450578|558873611|FG000|Overall Study|ECG abnormality so not treated|1|||
154847752|NCT02450578|558873612|FG001|Overall Study|ECG abnormality so not treated|0|||
154847753|NCT02450578|558873613|FG002|Overall Study|ECG abnormality so not treated|0|||
154847754|NCT02450578|558873614|FG003|Overall Study|ECG abnormality so not treated|0|||
154847755|NCT00090545|558873616|FG000|Overall Study|Disease progression on study|21|||
154847756|NCT00090545|558873617|FG001|Overall Study|Disease progression on study|17|||
154847757|NCT00090545|558873616|FG000|Overall Study|Refused further treatment|1|||
154847758|NCT00090545|558873617|FG001|Overall Study|Refused further treatment|4|||
154847759|NCT00090545|558873616|FG000|Overall Study|Death|0|||
154847760|NCT00090545|558873617|FG001|Overall Study|Death|1|||
154847761|NCT00090545|558873616|FG000|Overall Study|Adverse Event|0|||
154847762|NCT00090545|558873617|FG001|Overall Study|Adverse Event|2|||
154847763|NCT00523991|558873619|FG000|Overall Study|Adverse Event|6|||
154847764|NCT00523991|558873620|FG001|Overall Study|Adverse Event|5|||
154847765|NCT00523991|558873619|FG000|Overall Study|Protocol Violation|1|||
154847766|NCT00523991|558873620|FG001|Overall Study|Protocol Violation|4|||
154847767|NCT00523991|558873619|FG000|Overall Study|Lost to Follow-up|4|||
154847768|NCT00523991|558873620|FG001|Overall Study|Lost to Follow-up|1|||
154847769|NCT00523991|558873619|FG000|Overall Study|Withdrawal by Subject|7|||
154847770|NCT00523991|558873620|FG001|Overall Study|Withdrawal by Subject|17|||
154847771|NCT00523991|558873619|FG000|Overall Study|Other reason (not specified)|3|||
154847772|NCT00523991|558873620|FG001|Overall Study|Other reason (not specified)|0|||
154847773|NCT02971670|558873626|FG000|Overall Study|Withdrawal by Subject|4|||
154847774|NCT02971670|558873627|FG001|Overall Study|Withdrawal by Subject|1|||
154847775|NCT02971670|558873628|FG002|Overall Study|Withdrawal by Subject|1|||
154847776|NCT02971670|558873629|FG003|Overall Study|Withdrawal by Subject|2|||
154847777|NCT00288080|558873630|FG000|Overall Study|Withdrawal by Subject|1|||
154847778|NCT00288080|558873631|FG001|Overall Study|Withdrawal by Subject|3|||
154847779|NCT00288080|558873630|FG000|Overall Study|Protocol Violation|25|||
154847780|NCT00288080|558873631|FG001|Overall Study|Protocol Violation|20|||
154847781|NCT00379795|558873632|FG000|Overall Study|Death|31|||
154847782|NCT00379795|558873633|FG001|Overall Study|Death|8|||
154847783|NCT00379795|558873634|FG002|Overall Study|Death|6|||
154847784|NCT00379795|558873635|FG003|Overall Study|Death|4|||
154847785|NCT00379795|558873636|FG004|Overall Study|Death|7|||
154847786|NCT00379795|558873632|FG000|Overall Study|Adverse Event|17|||
154847787|NCT00379795|558873633|FG001|Overall Study|Adverse Event|3|||
154847788|NCT00379795|558873634|FG002|Overall Study|Adverse Event|3|||
154847789|NCT00379795|558873635|FG003|Overall Study|Adverse Event|1|||
154847790|NCT00379795|558873636|FG004|Overall Study|Adverse Event|4|||
154847791|NCT00379795|558873632|FG000|Overall Study|Lost to Follow-up|8|||
154847792|NCT00379795|558873633|FG001|Overall Study|Lost to Follow-up|1|||
154847793|NCT00379795|558873634|FG002|Overall Study|Lost to Follow-up|2|||
154847794|NCT00379795|558873635|FG003|Overall Study|Lost to Follow-up|1|||
154847795|NCT00379795|558873636|FG004|Overall Study|Lost to Follow-up|4|||
154847796|NCT00379795|558873632|FG000|Overall Study|Physician Decision|25|||
154847797|NCT00379795|558873633|FG001|Overall Study|Physician Decision|0|||
154847798|NCT00379795|558873634|FG002|Overall Study|Physician Decision|2|||
154847799|NCT00379795|558873635|FG003|Overall Study|Physician Decision|2|||
154847800|NCT00379795|558873636|FG004|Overall Study|Physician Decision|2|||
154847801|NCT00379795|558873632|FG000|Overall Study|Withdrawal by Subject|94|||
154847802|NCT00379795|558873633|FG001|Overall Study|Withdrawal by Subject|11|||
154847803|NCT00379795|558873634|FG002|Overall Study|Withdrawal by Subject|19|||
155105153|NCT02253433|559815526|FG000|Overall Study|Death|1|||
155105154|NCT02253433|559815527|FG001|Overall Study|Death|1|||
155105155|NCT02253433|559815526|FG000|Overall Study|No Longer Interested|3|||
155105156|NCT02253433|559815527|FG001|Overall Study|No Longer Interested|15|||
155105157|NCT02253433|559815526|FG000|Overall Study|Out of Study Area|2|||
155105158|NCT02253433|559815527|FG001|Overall Study|Out of Study Area|7|||
155105159|NCT02253433|559815526|FG000|Overall Study|Uncomfortable with home visitors|0|||
155105160|NCT02253433|559815527|FG001|Overall Study|Uncomfortable with home visitors|3|||
155105161|NCT02253433|559815526|FG000|Overall Study|Unstable Housing/Homeless|0|||
155105162|NCT02253433|559815527|FG001|Overall Study|Unstable Housing/Homeless|7|||
154847804|NCT00379795|558873635|FG003|Overall Study|Withdrawal by Subject|7|||
154847805|NCT00379795|558873636|FG004|Overall Study|Withdrawal by Subject|14|||
155105163|NCT02253433|559815526|FG000|Overall Study|Too Busy|0|||
155105164|NCT02253433|559815527|FG001|Overall Study|Too Busy|4|||
155105165|NCT02253433|559815526|FG000|Overall Study|Medical or Other Concerns|1|||
154847806|NCT00379795|558873632|FG000|Overall Study|Subject non-compliance|7|||
154847807|NCT00379795|558873633|FG001|Overall Study|Subject non-compliance|2|||
154847808|NCT00379795|558873634|FG002|Overall Study|Subject non-compliance|0|||
154847809|NCT00379795|558873635|FG003|Overall Study|Subject non-compliance|0|||
154847810|NCT00379795|558873636|FG004|Overall Study|Subject non-compliance|1|||
154847811|NCT00379795|558873632|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
154847812|NCT00379795|558873633|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
154847813|NCT00379795|558873634|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
154847814|NCT00379795|558873635|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
154847815|NCT00379795|558873636|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
154847816|NCT00379795|558873632|FG000|Overall Study|Subjects condition mandated intervention|34|||
154847817|NCT00379795|558873633|FG001|Overall Study|Subjects condition mandated intervention|9|||
154847818|NCT00379795|558873634|FG002|Overall Study|Subjects condition mandated intervention|7|||
154847819|NCT00379795|558873635|FG003|Overall Study|Subjects condition mandated intervention|5|||
154847820|NCT00379795|558873636|FG004|Overall Study|Subjects condition mandated intervention|7|||
154847821|NCT00379795|558873632|FG000|Overall Study|Sponsor's decision|257|||
154847822|NCT00379795|558873633|FG001|Overall Study|Sponsor's decision|17|||
154847823|NCT00379795|558873634|FG002|Overall Study|Sponsor's decision|54|||
154847824|NCT00379795|558873635|FG003|Overall Study|Sponsor's decision|47|||
154847825|NCT00379795|558873636|FG004|Overall Study|Sponsor's decision|10|||
154847826|NCT00763321|558873637|FG000|Open-label Period|Adverse Event|24|||
154847827|NCT00763321|558873638|FG001|Open-label Period|Adverse Event|0|||
154847828|NCT00763321|558873639|FG002|Open-label Period|Adverse Event|0|||
154847829|NCT00763321|558873637|FG000|Open-label Period|Lost to Follow-up|14|||
154847830|NCT00763321|558873638|FG001|Open-label Period|Lost to Follow-up|0|||
154847831|NCT00763321|558873639|FG002|Open-label Period|Lost to Follow-up|0|||
154847832|NCT00763321|558873637|FG000|Open-label Period|Withdrawal by Subject|7|||
154847833|NCT00763321|558873638|FG001|Open-label Period|Withdrawal by Subject|0|||
154847834|NCT00763321|558873639|FG002|Open-label Period|Withdrawal by Subject|0|||
154847835|NCT00763321|558873637|FG000|Open-label Period|Subject noncompliant|7|||
154847836|NCT00763321|558873638|FG001|Open-label Period|Subject noncompliant|0|||
154847837|NCT00763321|558873639|FG002|Open-label Period|Subject noncompliant|0|||
154847838|NCT00763321|558873637|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
154847839|NCT00763321|558873638|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
154847840|NCT00763321|558873639|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
154847841|NCT00763321|558873637|FG000|Open-label Period|Lack of Efficacy|2|||
154847842|NCT00763321|558873638|FG001|Open-label Period|Lack of Efficacy|0|||
154847843|NCT00763321|558873639|FG002|Open-label Period|Lack of Efficacy|0|||
154847844|NCT00763321|558873637|FG000|Open-label Period|Other|4|||
154847845|NCT00763321|558873638|FG001|Open-label Period|Other|0|||
154847846|NCT00763321|558873639|FG002|Open-label Period|Other|0|||
154847847|NCT00763321|558873637|FG000|Double-blind Period|Lack of Efficacy|0|||
154847848|NCT00763321|558873638|FG001|Double-blind Period|Lack of Efficacy|9|||
154847849|NCT00763321|558873639|FG002|Double-blind Period|Lack of Efficacy|17|||
154847850|NCT00763321|558873637|FG000|Double-blind Period|Adverse Event|0|||
154847851|NCT00763321|558873638|FG001|Double-blind Period|Adverse Event|4|||
154847852|NCT00763321|558873639|FG002|Double-blind Period|Adverse Event|4|||
154847853|NCT00763321|558873637|FG000|Double-blind Period|Lost to Follow-up|0|||
154847854|NCT00763321|558873638|FG001|Double-blind Period|Lost to Follow-up|4|||
154847855|NCT00763321|558873639|FG002|Double-blind Period|Lost to Follow-up|2|||
154847856|NCT00763321|558873637|FG000|Double-blind Period|Withdrawal by Subject|0|||
154847857|NCT00763321|558873638|FG001|Double-blind Period|Withdrawal by Subject|2|||
154847858|NCT00763321|558873639|FG002|Double-blind Period|Withdrawal by Subject|3|||
154847859|NCT00763321|558873637|FG000|Double-blind Period|Other|0|||
154847860|NCT00763321|558873638|FG001|Double-blind Period|Other|2|||
155105166|NCT02253433|559815527|FG001|Overall Study|Medical or Other Concerns|2|||
155105167|NCT02229825|559815530|FG000|Overall Study|Personal Reasons|0|||
155105168|NCT02229825|559815531|FG001|Overall Study|Personal Reasons|1|||
154847861|NCT00763321|558873639|FG002|Double-blind Period|Other|3|||
154847862|NCT03175549|558873640|FG000|Overall Study|Lost to Follow-up|2|||
154847863|NCT03175549|558873641|FG001|Overall Study|Lost to Follow-up|2|||
154847864|NCT03175549|558873640|FG000|Overall Study|Medication non-compliance|2|||
154847865|NCT03175549|558873641|FG001|Overall Study|Medication non-compliance|2|||
154847866|NCT02486757|558873642|FG000|Overall Study|Lost to Follow-up|1|||
155105169|NCT02229825|559815530|FG000|Overall Study|Refused continuing medication|7|||
155105170|NCT02229825|559815531|FG001|Overall Study|Refused continuing medication|6|||
155105171|NCT02229825|559815530|FG000|Overall Study|Lost to Follow-up|1|||
155105172|NCT02229825|559815531|FG001|Overall Study|Lost to Follow-up|2|||
155105173|NCT02229825|559815530|FG000|Overall Study|Protocol Violation|1|||
155105174|NCT02229825|559815531|FG001|Overall Study|Protocol Violation|1|||
155105175|NCT02229825|559815530|FG000|Overall Study|Lack of Efficacy|4|||
155105176|NCT02229825|559815531|FG001|Overall Study|Lack of Efficacy|10|||
155105177|NCT02229825|559815530|FG000|Overall Study|Adverse Event|11|||
155105178|NCT02229825|559815531|FG001|Overall Study|Adverse Event|9|||
155105179|NCT02229825|559815530|FG000|Overall Study|Not treated|0|||
155105180|NCT02229825|559815531|FG001|Overall Study|Not treated|1|||
155105181|NCT01532921|559815532|FG000|Overall Study|Death|3|||
155105182|NCT01532921|559815532|FG000|Overall Study|Withdrawal by Subject|2|||
155105183|NCT01532921|559815532|FG000|Overall Study|Lost to Follow-up|3|||
155105184|NCT01532921|559815532|FG000|Overall Study|Physician Decision|7|||
155105185|NCT01532921|559815532|FG000|Overall Study|Device was explanted during procedure|1|||
154847867|NCT02793232|558873643|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847868|NCT02793232|558873644|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847869|NCT02793232|558873645|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847870|NCT02793232|558873646|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847871|NCT02793232|558873647|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
154847872|NCT02793232|558873648|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847873|NCT02793232|558873649|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
154847874|NCT02793232|558873650|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847875|NCT02793232|558873651|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
154847876|NCT02387580|558873652|FG000|Overall Study|Withdrawal by Subject|0|||
154847877|NCT02387580|558873653|FG001|Overall Study|Withdrawal by Subject|0|||
154847878|NCT02387580|558873654|FG002|Overall Study|Withdrawal by Subject|0|||
154847879|NCT02387580|558873655|FG003|Overall Study|Withdrawal by Subject|1|||
154847880|NCT02387580|558873656|FG004|Overall Study|Withdrawal by Subject|0|||
154847881|NCT02387580|558873657|FG005|Overall Study|Withdrawal by Subject|0|||
154847882|NCT04849780|558873658|FG000|Period 1|Covid-19 Related|1|||
154847883|NCT04849780|558873659|FG001|Period 1|Covid-19 Related|0|||
154847884|NCT04849780|558873658|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
154847885|NCT04849780|558873659|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
154847886|NCT04849780|558873658|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
154847887|NCT04849780|558873659|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
154847888|NCT00725075|558873660|FG000|Overall Study|Use of Excluded Medication|0|||
154847889|NCT00725075|558873661|FG001|Overall Study|Use of Excluded Medication|1|||
154847890|NCT00725075|558873662|FG002|Overall Study|Use of Excluded Medication|0|||
154847891|NCT00725075|558873660|FG000|Overall Study|Protocol Violation|0|||
154847892|NCT00725075|558873661|FG001|Overall Study|Protocol Violation|0|||
154847893|NCT00725075|558873662|FG002|Overall Study|Protocol Violation|1|||
154847894|NCT00725075|558873660|FG000|Overall Study|Lost to Follow-up|1|||
154847895|NCT00725075|558873661|FG001|Overall Study|Lost to Follow-up|0|||
154847896|NCT00725075|558873662|FG002|Overall Study|Lost to Follow-up|0|||
154847897|NCT00725075|558873660|FG000|Overall Study|Withdrawal by Subject|4|||
154847898|NCT00725075|558873661|FG001|Overall Study|Withdrawal by Subject|5|||
154847899|NCT00725075|558873662|FG002|Overall Study|Withdrawal by Subject|4|||
154847900|NCT00725075|558873660|FG000|Overall Study|Adverse Event|2|||
154847901|NCT00725075|558873661|FG001|Overall Study|Adverse Event|1|||
154847902|NCT00725075|558873662|FG002|Overall Study|Adverse Event|1|||
154847903|NCT00725075|558873660|FG000|Overall Study|Worsening of Disease|2|||
154847904|NCT00725075|558873661|FG001|Overall Study|Worsening of Disease|1|||
154847905|NCT00725075|558873662|FG002|Overall Study|Worsening of Disease|2|||
154847906|NCT00725075|558873660|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
154847907|NCT00725075|558873661|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
154847908|NCT00725075|558873662|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
154847909|NCT00725075|558873660|FG000|Overall Study|Other|1|||
154847910|NCT00725075|558873661|FG001|Overall Study|Other|0|||
154847911|NCT00725075|558873662|FG002|Overall Study|Other|0|||
154847912|NCT00087646|558873663|FG000|Overall Study|Adverse Event|37|||
155105186|NCT01390298|559815533|FG000|Overall Study|Death|1|||
155105187|NCT01390298|559815533|FG000|Overall Study|long term ICU admission|1|||
155105188|NCT01390298|559815533|FG000|Overall Study|Withdrawal by Subject|14|||
155105189|NCT01390298|559815533|FG000|Overall Study|Lost to Follow-up|7|||
155105190|NCT01390298|559815533|FG000|Overall Study|Surgery cancelled|1|||
154847913|NCT00087646|558873664|FG001|Overall Study|Adverse Event|6|||
155105191|NCT02443337|559815534|FG000|Overall Study|Adverse Event|0|||
155105192|NCT02443337|559815535|FG001|Overall Study|Adverse Event|1|||
154847914|NCT00087646|558873665|FG002|Overall Study|Adverse Event|18|||
154847915|NCT00087646|558873666|FG003|Overall Study|Adverse Event|20|||
154847916|NCT00087646|558873663|FG000|Overall Study|Death|0|||
154847917|NCT00087646|558873664|FG001|Overall Study|Death|1|||
154847918|NCT00087646|558873665|FG002|Overall Study|Death|0|||
154847919|NCT00087646|558873666|FG003|Overall Study|Death|0|||
154847920|NCT00087646|558873663|FG000|Overall Study|Withdrawal by Subject|6|||
154847921|NCT00087646|558873664|FG001|Overall Study|Withdrawal by Subject|1|||
154847922|NCT00087646|558873665|FG002|Overall Study|Withdrawal by Subject|2|||
154847923|NCT00087646|558873666|FG003|Overall Study|Withdrawal by Subject|2|||
154847924|NCT00087646|558873663|FG000|Overall Study|Insufficient therapeutic response|64|||
154847925|NCT00087646|558873664|FG001|Overall Study|Insufficient therapeutic response|24|||
154847926|NCT00087646|558873665|FG002|Overall Study|Insufficient therapeutic response|38|||
154847927|NCT00087646|558873666|FG003|Overall Study|Insufficient therapeutic response|51|||
154847928|NCT00087646|558873663|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
154847929|NCT00087646|558873664|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
154847930|NCT00087646|558873665|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
154847931|NCT00087646|558873666|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
154847932|NCT00087646|558873663|FG000|Overall Study|Failure to Return|5|||
154847933|NCT00087646|558873664|FG001|Overall Study|Failure to Return|2|||
154847934|NCT00087646|558873665|FG002|Overall Study|Failure to Return|2|||
154847935|NCT00087646|558873666|FG003|Overall Study|Failure to Return|3|||
154847936|NCT00087646|558873663|FG000|Overall Study|Administrative/Other|6|||
154847937|NCT00087646|558873664|FG001|Overall Study|Administrative/Other|1|||
154847938|NCT00087646|558873665|FG002|Overall Study|Administrative/Other|1|||
154847939|NCT00087646|558873666|FG003|Overall Study|Administrative/Other|2|||
154847940|NCT00087646|558873663|FG000|Overall Study|Other Protocol Violation|3|||
154847941|NCT00087646|558873664|FG001|Overall Study|Other Protocol Violation|1|||
154847942|NCT00087646|558873665|FG002|Overall Study|Other Protocol Violation|0|||
154847943|NCT00087646|558873666|FG003|Overall Study|Other Protocol Violation|0|||
154847944|NCT00087646|558873663|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
154847945|NCT00087646|558873664|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
154847946|NCT00087646|558873665|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
154847947|NCT00087646|558873666|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
154847948|NCT03979274|558873669|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154847949|NCT03979274|558873670|FG001|Treatment Period 2|Withdrawal by Subject|1|||
154847950|NCT01060059|558873671|FG000|Overall Study|Adverse Event|1|||
154847951|NCT01060059|558873672|FG001|Overall Study|Adverse Event|1|||
154847952|NCT01060059|558873671|FG000|Overall Study|Death|2|||
154847953|NCT01060059|558873672|FG001|Overall Study|Death|3|||
154847954|NCT01060059|558873671|FG000|Overall Study|Lost to Follow-up|18|||
154847955|NCT01060059|558873672|FG001|Overall Study|Lost to Follow-up|34|||
154847956|NCT01060059|558873671|FG000|Overall Study|entry criteria not met|4|||
154847957|NCT01060059|558873672|FG001|Overall Study|entry criteria not met|3|||
154847958|NCT01060059|558873671|FG000|Overall Study|Withdrawal by Subject|35|||
154847959|NCT01060059|558873672|FG001|Overall Study|Withdrawal by Subject|23|||
154847960|NCT01060059|558873671|FG000|Overall Study|lack of glycemic control|2|||
154847961|NCT01060059|558873672|FG001|Overall Study|lack of glycemic control|1|||
154847962|NCT01060059|558873671|FG000|Overall Study|lack of compliance|5|||
154847963|NCT01060059|558873672|FG001|Overall Study|lack of compliance|2|||
154847964|NCT02302963|558873675|FG000|Overall Study|Withdrawal by Subject|2|||
154847965|NCT02302963|558873676|FG001|Overall Study|Withdrawal by Subject|1|||
154847966|NCT02302963|558873675|FG000|Overall Study|Steroid injection|0|||
154847967|NCT02302963|558873676|FG001|Overall Study|Steroid injection|1|||
154847968|NCT02302963|558873675|FG000|Overall Study|Physician Decision|1|||
154847969|NCT02302963|558873676|FG001|Overall Study|Physician Decision|0|||
154847970|NCT01614093|558873677|FG000|Overall Study|Withdrawal by Subject|1|||
154847971|NCT04820309|558873681|FG000|Overall Study|Adverse Event|96|||
154847972|NCT04820309|558873681|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
154847973|NCT04820309|558873681|FG000|Overall Study|Consent Withdrawn|93|||
154847974|NCT04820309|558873681|FG000|Overall Study|failure to adhere to protocol|32|||
154971273|NCT01350934|559318601|FG000|Base Study|Protocol Violation|1|||
154971274|NCT01350934|559318602|FG001|Base Study|Protocol Violation|1|||
154971275|NCT01350934|559318601|FG000|Base Study|Withdrawal by Subject|1|||
154971276|NCT01350934|559318602|FG001|Base Study|Withdrawal by Subject|2|||
154971277|NCT01350934|559318601|FG000|Base Study|Non-Compliance With Study Drug|2|||
154971278|NCT01350934|559318602|FG001|Base Study|Non-Compliance With Study Drug|0|||
155173554|NCT01252667|560074821|FG000|Overall Study|Transplant aborted post-conditioning|0|||
154847975|NCT04820309|558873681|FG000|Overall Study|alcohol or drug use|6|||
154847976|NCT04820309|558873681|FG000|Overall Study|Lost to Follow-up|46|||
154847977|NCT04820309|558873681|FG000|Overall Study|Death|2|||
154847978|NCT04820309|558873681|FG000|Overall Study|Pregnancy|1|||
154847979|NCT04820309|558873681|FG000|Overall Study|Other reasons|12|||
154847980|NCT04202679|558873684|FG000|Overall Study|Adverse Event|2|||
154847981|NCT04202679|558873685|FG001|Overall Study|Adverse Event|0|||
154847982|NCT04202679|558873684|FG000|Overall Study|Poor compliance to protocol|1|||
154847983|NCT04202679|558873685|FG001|Overall Study|Poor compliance to protocol|0|||
154847984|NCT04202679|558873684|FG000|Overall Study|Withdrawal by Subject|23|||
154847985|NCT04202679|558873685|FG001|Overall Study|Withdrawal by Subject|6|||
154847986|NCT05902364|558873686|FG000|Overall Study|Adverse Event|1|||
154971279|NCT01350934|559318601|FG000|Extension Study|Adverse Event|2|||
154847987|NCT05902364|558873687|FG001|Overall Study|Adverse Event|0|||
154847988|NCT03864653|558873688|FG000|Overall Study|Withdrawal by Subject|1|||
154847989|NCT02482129|558873689|FG000|Overall Study|Adverse Event-prior to treatment|0|||
154847990|NCT02482129|558873690|FG001|Overall Study|Adverse Event-prior to treatment|1|||
154847991|NCT02482129|558873689|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
154847992|NCT02482129|558873690|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
154847993|NCT02482129|558873689|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
154847994|NCT02482129|558873690|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
154847995|NCT02482129|558873689|FG000|Overall Study|Criteria not met-prior to treatment|1|||
154847996|NCT02482129|558873690|FG001|Overall Study|Criteria not met-prior to treatment|0|||
154847997|NCT02482129|558873689|FG000|Overall Study|Adverse Event|1|||
154847998|NCT02482129|558873690|FG001|Overall Study|Adverse Event|0|||
154847999|NCT02482129|558873689|FG000|Overall Study|Withdrawal by Subject|2|||
154848000|NCT02482129|558873690|FG001|Overall Study|Withdrawal by Subject|0|||
154848001|NCT02482129|558873689|FG000|Overall Study|Criteria not met|1|||
154848002|NCT02482129|558873690|FG001|Overall Study|Criteria not met|0|||
154848003|NCT01877083|558873691|FG000|Treatment Phase|Disease Progression|10|||
154848004|NCT01877083|558873691|FG000|Treatment Phase|Clinical Progression|1|||
154848005|NCT01877083|558873691|FG000|Treatment Phase|Adverse Event|6|||
154848006|NCT01877083|558873691|FG000|Treatment Phase|Withdrawal by Subject|2|||
154848007|NCT01877083|558873691|FG000|Treatment Phase|Lost to Follow-up|1|||
154848008|NCT01877083|558873691|FG000|Extension Phase|Disease Progression|3|||
154848009|NCT01877083|558873691|FG000|Extension Phase|Adverse Event|2|||
154848010|NCT00429585|558873694|FG000|Overall Study|Death|1|||
154848011|NCT00429585|558873695|FG001|Overall Study|Death|0|||
154848012|NCT00429585|558873694|FG000|Overall Study|Lost to Follow-up|27|||
154848013|NCT00429585|558873695|FG001|Overall Study|Lost to Follow-up|20|||
154848014|NCT00429585|558873694|FG000|Overall Study|Physician Decision|2|||
154848015|NCT00429585|558873695|FG001|Overall Study|Physician Decision|0|||
154848016|NCT01582308|558873696|FG000|Period 1|Withdrawal by Subject|0|||
154848017|NCT01582308|558873697|FG001|Period 1|Withdrawal by Subject|0|||
154848018|NCT01582308|558873698|FG002|Period 1|Withdrawal by Subject|0|||
154848019|NCT01582308|558873699|FG003|Period 1|Withdrawal by Subject|0|||
154848020|NCT01582308|558873700|FG004|Period 1|Withdrawal by Subject|0|||
154848021|NCT01582308|558873701|FG005|Period 1|Withdrawal by Subject|0|||
154848022|NCT01582308|558873702|FG006|Period 1|Withdrawal by Subject|1|||
154848023|NCT01582308|558873703|FG007|Period 1|Withdrawal by Subject|0|||
154848024|NCT01582308|558873704|FG008|Period 1|Withdrawal by Subject|0|||
154848025|NCT01582308|558873705|FG009|Period 1|Withdrawal by Subject|0|||
154848026|NCT01582308|558873696|FG000|10-day Washout Following Period 1|Physician Decision|0|||
154848027|NCT01582308|558873697|FG001|10-day Washout Following Period 1|Physician Decision|0|||
154848028|NCT01582308|558873698|FG002|10-day Washout Following Period 1|Physician Decision|0|||
154848029|NCT01582308|558873699|FG003|10-day Washout Following Period 1|Physician Decision|0|||
154848030|NCT01582308|558873700|FG004|10-day Washout Following Period 1|Physician Decision|1|||
154848031|NCT01582308|558873701|FG005|10-day Washout Following Period 1|Physician Decision|0|||
154848032|NCT01582308|558873702|FG006|10-day Washout Following Period 1|Physician Decision|0|||
154848033|NCT01582308|558873703|FG007|10-day Washout Following Period 1|Physician Decision|0|||
154848034|NCT01582308|558873704|FG008|10-day Washout Following Period 1|Physician Decision|0|||
154848035|NCT01582308|558873705|FG009|10-day Washout Following Period 1|Physician Decision|0|||
154848036|NCT01582308|558873696|FG000|Period 4|Physician Decision|1|||
154848037|NCT01582308|558873697|FG001|Period 4|Physician Decision|0|||
154848038|NCT01582308|558873698|FG002|Period 4|Physician Decision|0|||
154848039|NCT01582308|558873699|FG003|Period 4|Physician Decision|0|||
154848040|NCT01582308|558873700|FG004|Period 4|Physician Decision|0|||
155105193|NCT02443337|559815534|FG000|Overall Study|Clinical Progressive Disease|3|||
155105194|NCT02443337|559815535|FG001|Overall Study|Clinical Progressive Disease|0|||
154848041|NCT01582308|558873701|FG005|Period 4|Physician Decision|1|||
154848042|NCT01582308|558873702|FG006|Period 4|Physician Decision|0|||
154848043|NCT01582308|558873703|FG007|Period 4|Physician Decision|0|||
154848044|NCT01582308|558873704|FG008|Period 4|Physician Decision|0|||
154848045|NCT01582308|558873705|FG009|Period 4|Physician Decision|1|||
154848046|NCT00684957|558873709|FG000|Overall Study|Withdrawal by Subject|1|||
155105195|NCT02443337|559815534|FG000|Overall Study|Withdrawal by Subject|2|||
155105196|NCT02443337|559815535|FG001|Overall Study|Withdrawal by Subject|1|||
154848047|NCT00684957|558873710|FG001|Overall Study|Withdrawal by Subject|1|||
154848048|NCT00684957|558873709|FG000|Overall Study|Lost to Follow-up|1|||
154848049|NCT00684957|558873710|FG001|Overall Study|Lost to Follow-up|0|||
154848050|NCT04341948|558873711|FG000|Overall Study|Adverse Event|0|||
154848051|NCT04341948|558873712|FG001|Overall Study|Adverse Event|1|||
154848052|NCT04341948|558873711|FG000|Overall Study|Lost to Follow-up|6|||
154848053|NCT04341948|558873712|FG001|Overall Study|Lost to Follow-up|1|||
155105197|NCT00040742|559815536|FG000|Overall Study|Death|0|||
154848054|NCT04341948|558873711|FG000|Overall Study|Physician Decision|1|||
154848055|NCT04341948|558873712|FG001|Overall Study|Physician Decision|2|||
154848056|NCT04341948|558873711|FG000|Overall Study|Withdrawal by Participant|6|||
154971280|NCT01350934|559318602|FG001|Extension Study|Adverse Event|1|||
155105198|NCT00040742|559815537|FG001|Overall Study|Death|0|||
155105199|NCT00040742|559815538|FG002|Overall Study|Death|1|||
155105200|NCT00040742|559815539|FG003|Overall Study|Death|0|||
155105201|NCT00040742|559815536|FG000|Overall Study|Adverse Event|15|||
155105202|NCT00040742|559815537|FG001|Overall Study|Adverse Event|16|||
155105203|NCT00040742|559815538|FG002|Overall Study|Adverse Event|21|||
155105204|NCT00040742|559815539|FG003|Overall Study|Adverse Event|9|||
155105205|NCT00040742|559815536|FG000|Overall Study|Withdrawal by Subject|7|||
155105206|NCT00040742|559815537|FG001|Overall Study|Withdrawal by Subject|15|||
155105207|NCT00040742|559815538|FG002|Overall Study|Withdrawal by Subject|10|||
155105208|NCT00040742|559815539|FG003|Overall Study|Withdrawal by Subject|13|||
155105209|NCT00040742|559815536|FG000|Overall Study|Chemotoxicity|4|||
155105210|NCT00040742|559815537|FG001|Overall Study|Chemotoxicity|3|||
155105211|NCT00040742|559815538|FG002|Overall Study|Chemotoxicity|5|||
155105212|NCT00040742|559815539|FG003|Overall Study|Chemotoxicity|2|||
155105213|NCT00040742|559815536|FG000|Overall Study|Incomplete Forms|6|||
155105214|NCT00040742|559815537|FG001|Overall Study|Incomplete Forms|10|||
155105215|NCT00040742|559815538|FG002|Overall Study|Incomplete Forms|4|||
155105216|NCT00040742|559815539|FG003|Overall Study|Incomplete Forms|5|||
155105217|NCT00040742|559815536|FG000|Overall Study|Other medical|7|||
155105218|NCT00040742|559815537|FG001|Overall Study|Other medical|5|||
155105219|NCT00040742|559815538|FG002|Overall Study|Other medical|5|||
155105220|NCT00040742|559815539|FG003|Overall Study|Other medical|5|||
155105221|NCT02997865|559815541|FG000|Overall Study|Death|2|||
155105222|NCT02997865|559815542|FG001|Overall Study|Death|1|||
155105223|NCT02997865|559815541|FG000|Overall Study|Lost to Follow-up|6|||
155105224|NCT02997865|559815542|FG001|Overall Study|Lost to Follow-up|3|||
155105225|NCT02997865|559815541|FG000|Overall Study|Withdrawal by Subject|5|||
155105226|NCT02997865|559815542|FG001|Overall Study|Withdrawal by Subject|0|||
155105227|NCT01119066|559815543|FG000|Overall Study|Withdrawal by Subject|4|||
155105228|NCT01119066|559815544|FG001|Overall Study|Withdrawal by Subject|6|||
155105229|NCT01119066|559815545|FG002|Overall Study|Withdrawal by Subject|0|||
155105230|NCT01119066|559815546|FG003|Overall Study|Withdrawal by Subject|0|||
154848057|NCT04341948|558873712|FG001|Overall Study|Withdrawal by Participant|3|||
154848058|NCT04341948|558873711|FG000|Overall Study|Lack of compliance by Participant|1|||
154848059|NCT04341948|558873712|FG001|Overall Study|Lack of compliance by Participant|0|||
154848060|NCT03406897|558873713|FG000|Overall Study|Lost to Follow-up|1|||
154848061|NCT03406897|558873714|FG001|Overall Study|Lost to Follow-up|2|||
154848062|NCT03406897|558873713|FG000|Overall Study|Withdrawal by Subject|4|||
154848063|NCT03406897|558873714|FG001|Overall Study|Withdrawal by Subject|4|||
154848064|NCT03406897|558873713|FG000|Overall Study|Physician Decision|0|||
154848065|NCT03406897|558873714|FG001|Overall Study|Physician Decision|1|||
154848066|NCT06272370|558875371|FG000|Overall Study|Lost to Follow-up|0|||
154848067|NCT06272370|558875372|FG001|Overall Study|Lost to Follow-up|3|||
154848068|NCT06272370|558875373|FG002|Overall Study|Lost to Follow-up|1|||
154848069|NCT06272370|558875374|FG003|Overall Study|Lost to Follow-up|1|||
154848070|NCT02363478|558875379|FG000|Overall Study|Lost to Follow-up|4|||
154848071|NCT02363478|558875379|FG000|Overall Study|Adverse Event|4|||
154848072|NCT00930059|558875380|FG000|Overall Study|Death|1|||
154848073|NCT00930059|558875381|FG001|Overall Study|Death|0|||
154848074|NCT00930059|558875380|FG000|Overall Study|Did not meet entrance criteria|1|||
154848075|NCT00930059|558875381|FG001|Overall Study|Did not meet entrance criteria|1|||
154848076|NCT00930059|558875380|FG000|Overall Study|Withdrawal by Subject|3|||
154848077|NCT00930059|558875381|FG001|Overall Study|Withdrawal by Subject|4|||
154848078|NCT00930059|558875380|FG000|Overall Study|Other|1|||
154848079|NCT00930059|558875381|FG001|Overall Study|Other|0|||
154848080|NCT00930059|558875380|FG000|Overall Study|1 site terminated by sponsor|1|||
154848081|NCT00930059|558875381|FG001|Overall Study|1 site terminated by sponsor|1|||
154848082|NCT00930059|558875380|FG000|Overall Study|Adverse Event|1|||
154848083|NCT00930059|558875381|FG001|Overall Study|Adverse Event|6|||
154848084|NCT01299766|558875383|FG000|Overall Study|Death|5|||
154848085|NCT01299766|558875384|FG001|Overall Study|Death|4|||
154848086|NCT01299766|558875383|FG000|Overall Study|Withdrawal by Subject|29|||
154848087|NCT01299766|558875384|FG001|Overall Study|Withdrawal by Subject|19|||
154848088|NCT04002310|558875385|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
155105231|NCT01119066|559815543|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
155105232|NCT01119066|559815544|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
155105233|NCT01119066|559815545|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
155105234|NCT01119066|559815546|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
155105235|NCT01119066|559815543|FG000|Overall Study|Relapse identified before transplant|1|||
155105236|NCT01119066|559815544|FG001|Overall Study|Relapse identified before transplant|0|||
154848089|NCT04002310|558875386|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
154848090|NCT04002310|558875387|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
154848091|NCT04002310|558875388|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
154848092|NCT04002310|558875389|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
154848093|NCT00352534|558875390|FG000|Initial Staging|Ineligible|8|||
154848094|NCT00352534|558875391|FG001|Initial Staging|Ineligible|9|||
155105237|NCT01119066|559815545|FG002|Overall Study|Relapse identified before transplant|0|||
155105238|NCT01119066|559815546|FG003|Overall Study|Relapse identified before transplant|0|||
155105239|NCT01119066|559815543|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
155105240|NCT01119066|559815544|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
155105241|NCT01119066|559815545|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
154848095|NCT00352534|558875392|FG002|Initial Staging|Ineligible|0|||
154848096|NCT00352534|558875393|FG003|Initial Staging|Ineligible|0|||
154848097|NCT00352534|558875394|FG004|Initial Staging|Ineligible|0|||
154848098|NCT00352534|558875395|FG005|Initial Staging|Ineligible|0|||
154848099|NCT00352534|558875396|FG006|Initial Staging|Ineligible|0|||
154848100|NCT00352534|558875390|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
154848101|NCT00352534|558875391|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
154848102|NCT00352534|558875392|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
154848103|NCT00352534|558875393|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
154848104|NCT00352534|558875394|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
154848105|NCT00352534|558875395|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
154848106|NCT00352534|558875396|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
154848107|NCT00352534|558875390|FG000|Final Risk Group Assignment|Physician Decision|0|||
154848108|NCT00352534|558875391|FG001|Final Risk Group Assignment|Physician Decision|0|||
154848109|NCT00352534|558875392|FG002|Final Risk Group Assignment|Physician Decision|0|||
154848110|NCT00352534|558875393|FG003|Final Risk Group Assignment|Physician Decision|0|||
154848111|NCT00352534|558875394|FG004|Final Risk Group Assignment|Physician Decision|0|||
154848112|NCT00352534|558875395|FG005|Final Risk Group Assignment|Physician Decision|8|||
154848113|NCT00352534|558875396|FG006|Final Risk Group Assignment|Physician Decision|0|||
154848114|NCT00352534|558875390|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
154848115|NCT00352534|558875391|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
154848116|NCT00352534|558875392|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
154848117|NCT00352534|558875393|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
154848118|NCT00352534|558875394|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
154848119|NCT00352534|558875395|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
154848120|NCT00352534|558875396|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
154848121|NCT00352534|558875390|FG000|Final Risk Group Assignment|Ineligible|0|||
154848122|NCT00352534|558875391|FG001|Final Risk Group Assignment|Ineligible|0|||
154848123|NCT00352534|558875392|FG002|Final Risk Group Assignment|Ineligible|3|||
154848124|NCT00352534|558875393|FG003|Final Risk Group Assignment|Ineligible|1|||
154848125|NCT00352534|558875394|FG004|Final Risk Group Assignment|Ineligible|0|||
154848126|NCT00352534|558875395|FG005|Final Risk Group Assignment|Ineligible|13|||
154848127|NCT00352534|558875396|FG006|Final Risk Group Assignment|Ineligible|0|||
154848128|NCT00352534|558875390|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
154848129|NCT00352534|558875391|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
154848130|NCT00352534|558875392|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
154848131|NCT00352534|558875393|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
154848132|NCT00352534|558875394|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
154848133|NCT00352534|558875395|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
154848134|NCT00352534|558875396|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
154848135|NCT00352534|558875390|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
154848136|NCT00352534|558875391|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
154848137|NCT00352534|558875392|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
154848138|NCT00352534|558875393|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
155105242|NCT01119066|559815546|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
155105243|NCT01119066|559815543|FG000|Overall Study|Relapse identified before transplant|0|||
154848139|NCT00352534|558875394|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
154848140|NCT00352534|558875395|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
154848141|NCT00352534|558875396|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
154848142|NCT00352534|558875390|FG000|Final Risk Group Assignment|Death|0|||
154848143|NCT00352534|558875391|FG001|Final Risk Group Assignment|Death|0|||
154848144|NCT00352534|558875392|FG002|Final Risk Group Assignment|Death|0|||
154848145|NCT00352534|558875393|FG003|Final Risk Group Assignment|Death|0|||
154971281|NCT01350934|559318601|FG000|Extension Study|Lost to Follow-up|2|||
154971282|NCT01350934|559318602|FG001|Extension Study|Lost to Follow-up|0|||
154971283|NCT01350934|559318601|FG000|Extension Study|Protocol Violation|1|||
154848146|NCT00352534|558875394|FG004|Final Risk Group Assignment|Death|0|||
154848147|NCT00352534|558875395|FG005|Final Risk Group Assignment|Death|2|||
154848148|NCT00352534|558875396|FG006|Final Risk Group Assignment|Death|0|||
154848149|NCT02090855|558875397|FG000|Overall Study|no evaluable Standard of Truth results|2|||
154848150|NCT00544869|558875398|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
154848151|NCT00544869|558875399|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
154971284|NCT01350934|559318602|FG001|Extension Study|Protocol Violation|1|||
154848152|NCT00544869|558875400|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
154848153|NCT00544869|558875398|FG000|Overall Study|Adverse Event|6|||
154848154|NCT00544869|558875399|FG001|Overall Study|Adverse Event|1|||
154848155|NCT00544869|558875400|FG002|Overall Study|Adverse Event|0|||
154848156|NCT00544869|558875398|FG000|Overall Study|Lack of Efficacy|1|||
154848157|NCT00544869|558875399|FG001|Overall Study|Lack of Efficacy|1|||
154848158|NCT00544869|558875400|FG002|Overall Study|Lack of Efficacy|0|||
154848159|NCT00544869|558875398|FG000|Overall Study|Physician Decision|2|||
154848160|NCT00544869|558875399|FG001|Overall Study|Physician Decision|0|||
154848161|NCT00544869|558875400|FG002|Overall Study|Physician Decision|0|||
154848162|NCT01354028|558875401|FG000|Overall Study|Physician Decision|0|||
154848163|NCT01354028|558875402|FG001|Overall Study|Physician Decision|2|||
154848164|NCT01354028|558875401|FG000|Overall Study|Discharged before study start|2|||
154848165|NCT01354028|558875402|FG001|Overall Study|Discharged before study start|2|||
154848166|NCT01354028|558875401|FG000|Overall Study|No quiet alert state|0|||
154848167|NCT01354028|558875402|FG001|Overall Study|No quiet alert state|1|||
154848168|NCT03968419|558875405|FG000|Treatment Period|Adverse Event|0|||
154848169|NCT03968419|558875406|FG001|Treatment Period|Adverse Event|0|||
154848170|NCT03968419|558875407|FG002|Treatment Period|Adverse Event|1|||
154848171|NCT03968419|558875405|FG000|Safety Follow-up Period|Death|3|||
154848172|NCT03968419|558875406|FG001|Safety Follow-up Period|Death|2|||
154848173|NCT03968419|558875407|FG002|Safety Follow-up Period|Death|1|||
154848174|NCT03968419|558875405|FG000|Safety Follow-up Period|Subject Decision|2|||
154848175|NCT03968419|558875406|FG001|Safety Follow-up Period|Subject Decision|1|||
154848176|NCT03968419|558875407|FG002|Safety Follow-up Period|Subject Decision|0|||
154848177|NCT00935883|558875408|FG000|Treatment Period|Physician Decision|1|||
154848178|NCT00935883|558875409|FG001|Treatment Period|Physician Decision|0|||
154848179|NCT00935883|558875408|FG000|Treatment Period|Withdrawal by Subject|0|||
154848180|NCT00935883|558875409|FG001|Treatment Period|Withdrawal by Subject|2|||
154848181|NCT02894840|558875412|FG000|Overall Study|Lost to Follow-up|1|||
154848182|NCT02894840|558875413|FG001|Overall Study|Lost to Follow-up|0|||
154848183|NCT02894840|558875414|FG002|Overall Study|Lost to Follow-up|3|||
154848184|NCT02894840|558875415|FG003|Overall Study|Lost to Follow-up|0|||
154848185|NCT00804687|558875416|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
154848186|NCT00804687|558875417|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
154848187|NCT00804687|558875418|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
154848188|NCT00804687|558875419|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
154848189|NCT00804687|558875420|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
154848190|NCT00804687|558875421|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
154848191|NCT00804687|558875416|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
154848192|NCT00804687|558875417|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
154848193|NCT00804687|558875418|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
154848194|NCT00804687|558875419|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
154848195|NCT00804687|558875420|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
154848196|NCT00804687|558875421|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
154848197|NCT00804687|558875416|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
154848198|NCT00804687|558875417|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
154848199|NCT00804687|558875418|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
154848200|NCT00804687|558875419|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
154848201|NCT00804687|558875420|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
154848202|NCT00804687|558875421|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
154848203|NCT00804687|558875416|FG000|Period 5: Treatment Period|Positive drug test|1|||
154848204|NCT00804687|558875417|FG001|Period 5: Treatment Period|Positive drug test|0|||
154848205|NCT00804687|558875418|FG002|Period 5: Treatment Period|Positive drug test|0|||
154848206|NCT00804687|558875419|FG003|Period 5: Treatment Period|Positive drug test|0|||
154848207|NCT00804687|558875420|FG004|Period 5: Treatment Period|Positive drug test|0|||
154848208|NCT00804687|558875421|FG005|Period 5: Treatment Period|Positive drug test|0|||
154848209|NCT00323557|558875435|FG000|Overall Study|Physician Decision|1|||
154848210|NCT00323557|558875436|FG001|Overall Study|Physician Decision|0|||
154848211|NCT00197054|558875437|FG000|Overall Study|Withdrawal by Subject|9|||
154848212|NCT00197054|558875438|FG001|Overall Study|Withdrawal by Subject|3|||
154848213|NCT00197054|558875439|FG002|Overall Study|Withdrawal by Subject|3|||
154848214|NCT00197054|558875437|FG000|Overall Study|Moved from area|7|||
154848215|NCT00197054|558875438|FG001|Overall Study|Moved from area|14|||
154848216|NCT00197054|558875439|FG002|Overall Study|Moved from area|9|||
154848217|NCT00197054|558875437|FG000|Overall Study|Lost to Follow-up|1|||
154848218|NCT00197054|558875438|FG001|Overall Study|Lost to Follow-up|4|||
154848219|NCT00197054|558875439|FG002|Overall Study|Lost to Follow-up|0|||
154848220|NCT00684515|558875440|FG000|Overall Study|Adverse Event|3|||
154848221|NCT00684515|558875441|FG001|Overall Study|Adverse Event|3|||
154848222|NCT00684515|558875442|FG002|Overall Study|Adverse Event|1|||
154848223|NCT00684515|558875440|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
154848224|NCT00684515|558875441|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
154848225|NCT00684515|558875442|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
154848226|NCT04428411|558875445|FG000|Overall Study|Lost to Follow-up|114|||
155105244|NCT01119066|559815544|FG001|Overall Study|Relapse identified before transplant|4|||
155105245|NCT01119066|559815545|FG002|Overall Study|Relapse identified before transplant|0|||
154848227|NCT00634569|558875446|FG000|Overall Study|Withdrawal by Subject|0|||
154848228|NCT00634569|558875447|FG001|Overall Study|Withdrawal by Subject|4|||
154848229|NCT00634569|558875446|FG000|Overall Study|Physician Decision|0|||
154848230|NCT00634569|558875447|FG001|Overall Study|Physician Decision|1|||
154848231|NCT01163786|558875448|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
154848232|NCT01163786|558875448|FG000|Treatment With Bortezomib|Adverse Event|2|||
154848233|NCT01163786|558875448|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
154848234|NCT02918019|558875449|FG000|Overall Study|Death|0|||
154848235|NCT02918019|558875450|FG001|Overall Study|Death|0|||
154848236|NCT02918019|558875451|FG002|Overall Study|Death|1|||
154848237|NCT02918019|558875452|FG003|Overall Study|Death|0|||
154848238|NCT02918019|558875449|FG000|Overall Study|Lost to Follow-up|1|||
154848239|NCT02918019|558875450|FG001|Overall Study|Lost to Follow-up|1|||
154848240|NCT02918019|558875451|FG002|Overall Study|Lost to Follow-up|0|||
154848241|NCT02918019|558875452|FG003|Overall Study|Lost to Follow-up|1|||
154848242|NCT02918019|558875449|FG000|Overall Study|Principal investigator request|0|||
154848243|NCT02918019|558875450|FG001|Overall Study|Principal investigator request|0|||
154848244|NCT02918019|558875451|FG002|Overall Study|Principal investigator request|0|||
154848245|NCT02918019|558875452|FG003|Overall Study|Principal investigator request|1|||
154848246|NCT02918019|558875449|FG000|Overall Study|Physician Decision|1|||
154848247|NCT02918019|558875450|FG001|Overall Study|Physician Decision|3|||
154848248|NCT02918019|558875451|FG002|Overall Study|Physician Decision|2|||
154848249|NCT02918019|558875452|FG003|Overall Study|Physician Decision|0|||
154848250|NCT02918019|558875449|FG000|Overall Study|Protocol deviation|1|||
154848251|NCT02918019|558875450|FG001|Overall Study|Protocol deviation|1|||
154848252|NCT02918019|558875451|FG002|Overall Study|Protocol deviation|0|||
154848253|NCT02918019|558875452|FG003|Overall Study|Protocol deviation|2|||
154848254|NCT02918019|558875449|FG000|Overall Study|Withdrawal by Subject|3|||
154848255|NCT02918019|558875450|FG001|Overall Study|Withdrawal by Subject|4|||
154848256|NCT02918019|558875451|FG002|Overall Study|Withdrawal by Subject|6|||
154848257|NCT02918019|558875452|FG003|Overall Study|Withdrawal by Subject|4|||
154848258|NCT02918019|558875449|FG000|Overall Study|Adverse Event|0|||
154848259|NCT02918019|558875450|FG001|Overall Study|Adverse Event|1|||
154848260|NCT02918019|558875451|FG002|Overall Study|Adverse Event|0|||
154848261|NCT02918019|558875452|FG003|Overall Study|Adverse Event|1|||
154848262|NCT01212185|558875453|FG000|Overall Study|Protocol Violation|2|||
154848263|NCT01212185|558875454|FG001|Overall Study|Protocol Violation|1|||
154848264|NCT03555266|558875455|FG000|Overall Study|Protocol Violation|6|||
154848265|NCT03555266|558875456|FG001|Overall Study|Protocol Violation|4|||
154848266|NCT01699087|558875460|FG000|Overall Study|Lost to Follow-up|7|||
154848267|NCT01699087|558875460|FG000|Overall Study|Screen failure (prior to treatment)|15|||
154848268|NCT01699087|558875460|FG000|Overall Study|Unable to make future visits|2|||
154848269|NCT03370770|558875461|FG000|Overall Study|Patient was followed in another hospital center|1|||
154848270|NCT03370770|558875461|FG000|Overall Study|Progressive Disease|98|||
154848271|NCT03370770|558875461|FG000|Overall Study|Adverse Event|2|||
154848272|NCT03370770|558875461|FG000|Overall Study|Death|5|||
154848273|NCT02167945|558875462|FG000|Overall Study|Adverse Event|16|||
154848274|NCT02167945|558875462|FG000|Overall Study|Withdrew Consent|42|||
154848275|NCT02167945|558875462|FG000|Overall Study|Lost to Follow-up|122|||
154848276|NCT02167945|558875462|FG000|Overall Study|COVID-19 logistical restrictions|6|||
154848277|NCT02167945|558875462|FG000|Overall Study|Other, not specified|63|||
154848278|NCT00132730|558875463|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
154848279|NCT00132730|558875464|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
154848280|NCT00132730|558875465|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
154848281|NCT00132730|558875466|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
154848282|NCT00132730|558875467|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
154848283|NCT00132730|558875468|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
154848284|NCT00132730|558875463|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
154848285|NCT00132730|558875464|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
154848286|NCT00132730|558875465|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
154848287|NCT00132730|558875466|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
154848288|NCT00132730|558875467|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
154848289|NCT00132730|558875468|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
154848290|NCT00132730|558875463|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
154848291|NCT00132730|558875464|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
154848292|NCT00132730|558875465|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
154848293|NCT00132730|558875466|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
154848294|NCT00132730|558875467|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
154848295|NCT00132730|558875468|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
154971285|NCT01350934|559318601|FG000|Extension Study|Lack of Efficacy|0|||
155105246|NCT01119066|559815546|FG003|Overall Study|Relapse identified before transplant|0|||
154848296|NCT00132730|558875463|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
154848297|NCT00132730|558875464|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
154848298|NCT00132730|558875465|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
154848299|NCT00132730|558875466|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
154848300|NCT00132730|558875467|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
154848301|NCT00132730|558875468|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
154848302|NCT00132730|558875463|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
154848303|NCT00132730|558875464|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
154848304|NCT00132730|558875465|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
154848305|NCT00132730|558875466|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
154848306|NCT00132730|558875467|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
154848307|NCT00132730|558875468|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
154848308|NCT00132730|558875463|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
154848309|NCT00132730|558875464|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
154848310|NCT00132730|558875465|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
154848311|NCT00132730|558875466|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
154848312|NCT00132730|558875467|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
154848313|NCT00132730|558875468|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
154848314|NCT00132730|558875463|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
154848315|NCT00132730|558875464|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
154848316|NCT00132730|558875465|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
154848317|NCT00132730|558875466|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
154848318|NCT00132730|558875467|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
154848319|NCT00132730|558875468|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
154848320|NCT00132730|558875463|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
154848321|NCT00132730|558875464|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
154848322|NCT00132730|558875465|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
154848323|NCT00132730|558875466|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
154848324|NCT00132730|558875467|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
154848325|NCT00132730|558875468|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
154848326|NCT00132730|558875463|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
154848327|NCT00132730|558875464|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
154848328|NCT00132730|558875465|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
154848329|NCT00132730|558875466|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
154971286|NCT01350934|559318602|FG001|Extension Study|Lack of Efficacy|1|||
154971287|NCT01350934|559318601|FG000|Extension Study|Withdrawal by Subject|0|||
154971288|NCT01350934|559318602|FG001|Extension Study|Withdrawal by Subject|1|||
155105247|NCT02243371|559815553|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
155105248|NCT02243371|559815554|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
155105249|NCT02243371|559815553|FG000|Overall Study|Death (unrelated)|2|||
155105250|NCT02243371|559815554|FG001|Overall Study|Death (unrelated)|4|||
155105251|NCT02243371|559815553|FG000|Overall Study|Adverse Event (unrelated)|0|||
155105252|NCT02243371|559815554|FG001|Overall Study|Adverse Event (unrelated)|1|||
155105253|NCT02243371|559815553|FG000|Overall Study|Lack of Clinical Benefit|0|||
155105254|NCT02243371|559815554|FG001|Overall Study|Lack of Clinical Benefit|1|||
155105255|NCT02243371|559815553|FG000|Overall Study|Withdrawal by Subject|0|||
155105256|NCT02243371|559815554|FG001|Overall Study|Withdrawal by Subject|2|||
154848330|NCT00132730|558875467|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
154848331|NCT00132730|558875468|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
154848332|NCT00132730|558875463|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
154848333|NCT00132730|558875464|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
154848334|NCT00132730|558875465|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
154848335|NCT00132730|558875466|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
154848336|NCT00132730|558875467|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
154848337|NCT00132730|558875468|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
154848338|NCT00132730|558875463|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
154848339|NCT00132730|558875464|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
154848340|NCT00132730|558875465|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
154848341|NCT00132730|558875466|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
154848342|NCT00132730|558875467|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
154848343|NCT00132730|558875468|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
154971289|NCT03547635|559318603|FG000|Overall Study|Adverse Event|5|||
155105257|NCT02441101|559815555|FG000|Overall Study|Withdrawal by Subject|1|||
155105258|NCT02441101|559815556|FG001|Overall Study|Withdrawal by Subject|0|||
155105259|NCT02441101|559815555|FG000|Overall Study|Lost to Follow-up|1|||
154848344|NCT00132730|558875463|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
154848345|NCT00132730|558875464|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
154848346|NCT00132730|558875465|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
154848347|NCT00132730|558875466|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
154848348|NCT00132730|558875467|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
154848349|NCT00132730|558875468|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
154848350|NCT03021642|558875469|FG000|Washout Period (21 Days)|Adverse Event|1|||
154848351|NCT03021642|558875470|FG001|Washout Period (21 Days)|Adverse Event|1|||
154848352|NCT00094757|558875471|FG000|Overall Study|Adverse Event|11|||
154848353|NCT00094757|558875472|FG001|Overall Study|Adverse Event|9|||
154848354|NCT00094757|558875473|FG002|Overall Study|Adverse Event|6|||
154848355|NCT00094757|558875471|FG000|Overall Study|Lack of Efficacy|11|||
154848356|NCT00094757|558875472|FG001|Overall Study|Lack of Efficacy|15|||
154848357|NCT00094757|558875473|FG002|Overall Study|Lack of Efficacy|8|||
154848358|NCT00094757|558875471|FG000|Overall Study|Lost to Follow-up|3|||
154848359|NCT00094757|558875472|FG001|Overall Study|Lost to Follow-up|5|||
154848360|NCT00094757|558875473|FG002|Overall Study|Lost to Follow-up|6|||
154848361|NCT00094757|558875471|FG000|Overall Study|Patient Moved|2|||
154848362|NCT00094757|558875472|FG001|Overall Study|Patient Moved|1|||
154848363|NCT00094757|558875473|FG002|Overall Study|Patient Moved|1|||
154848364|NCT00094757|558875471|FG000|Overall Study|Protocol Violation|8|||
154971290|NCT03547635|559318604|FG001|Overall Study|Adverse Event|2|||
154971291|NCT03547635|559318605|FG002|Overall Study|Adverse Event|3|||
154971292|NCT03547635|559318603|FG000|Overall Study|Lost to Follow-up|1|||
154971293|NCT03547635|559318604|FG001|Overall Study|Lost to Follow-up|3|||
154971294|NCT03547635|559318605|FG002|Overall Study|Lost to Follow-up|4|||
154971295|NCT03547635|559318603|FG000|Overall Study|Withdrawal by Subject|1|||
154971296|NCT03547635|559318604|FG001|Overall Study|Withdrawal by Subject|0|||
154971297|NCT03547635|559318605|FG002|Overall Study|Withdrawal by Subject|0|||
154971298|NCT03547635|559318603|FG000|Overall Study|Withdrawal By PI|0|||
154971299|NCT03547635|559318604|FG001|Overall Study|Withdrawal By PI|1|||
154971300|NCT03547635|559318605|FG002|Overall Study|Withdrawal By PI|0|||
154971301|NCT03547635|559318603|FG000|Overall Study|Withdrawal by Sponsor|0|||
154971302|NCT03547635|559318604|FG001|Overall Study|Withdrawal by Sponsor|0|||
154971303|NCT03547635|559318605|FG002|Overall Study|Withdrawal by Sponsor|1|||
154971304|NCT03547635|559318603|FG000|Overall Study|Errant Randomization before Treatment|0|||
154971305|NCT03547635|559318604|FG001|Overall Study|Errant Randomization before Treatment|1|||
154971306|NCT03547635|559318605|FG002|Overall Study|Errant Randomization before Treatment|0|||
154971307|NCT03547635|559318603|FG000|Overall Study|Withdrawal by Subject|1|||
154971308|NCT03547635|559318604|FG001|Overall Study|Withdrawal by Subject|0|||
154971309|NCT03547635|559318605|FG002|Overall Study|Withdrawal by Subject|0|||
154971310|NCT01011335|559318606|FG000|Overall Study|Lost to Follow-up|0|||
154971311|NCT01011335|559318607|FG001|Overall Study|Lost to Follow-up|0|||
154971312|NCT01011335|559318608|FG002|Overall Study|Lost to Follow-up|1|||
154971313|NCT01011335|559318609|FG003|Overall Study|Lost to Follow-up|1|||
154971314|NCT01011335|559318610|FG004|Overall Study|Lost to Follow-up|1|||
154971315|NCT01011335|559318611|FG005|Overall Study|Lost to Follow-up|1|||
154971316|NCT01011335|559318612|FG006|Overall Study|Lost to Follow-up|2|||
154971317|NCT01011335|559318613|FG007|Overall Study|Lost to Follow-up|2|||
154971318|NCT01011335|559318614|FG008|Overall Study|Lost to Follow-up|1|||
154971319|NCT01011335|559318615|FG009|Overall Study|Lost to Follow-up|0|||
154971320|NCT01011335|559318616|FG010|Overall Study|Lost to Follow-up|0|||
154971321|NCT01011335|559318617|FG011|Overall Study|Lost to Follow-up|1|||
154971322|NCT01011335|559318618|FG012|Overall Study|Lost to Follow-up|2|||
154971323|NCT01011335|559318606|FG000|Overall Study|Protocol Violation|0|||
154971324|NCT01011335|559318607|FG001|Overall Study|Protocol Violation|1|||
154971325|NCT01011335|559318608|FG002|Overall Study|Protocol Violation|0|||
154971326|NCT01011335|559318609|FG003|Overall Study|Protocol Violation|0|||
154971327|NCT01011335|559318610|FG004|Overall Study|Protocol Violation|0|||
154971328|NCT01011335|559318611|FG005|Overall Study|Protocol Violation|0|||
154971329|NCT01011335|559318612|FG006|Overall Study|Protocol Violation|0|||
154971330|NCT01011335|559318613|FG007|Overall Study|Protocol Violation|0|||
154971331|NCT01011335|559318614|FG008|Overall Study|Protocol Violation|0|||
154848365|NCT00094757|558875472|FG001|Overall Study|Protocol Violation|5|||
154848366|NCT00094757|558875473|FG002|Overall Study|Protocol Violation|3|||
154971332|NCT01011335|559318615|FG009|Overall Study|Protocol Violation|0|||
154971333|NCT01011335|559318616|FG010|Overall Study|Protocol Violation|0|||
154971334|NCT01011335|559318617|FG011|Overall Study|Protocol Violation|0|||
154848367|NCT00094757|558875471|FG000|Overall Study|Withdrawal by Subject|14|||
154848368|NCT00094757|558875472|FG001|Overall Study|Withdrawal by Subject|21|||
154848369|NCT00094757|558875473|FG002|Overall Study|Withdrawal by Subject|5|||
154971335|NCT01011335|559318618|FG012|Overall Study|Protocol Violation|0|||
154971336|NCT01011335|559318606|FG000|Overall Study|Moved/deployed or no booster|1|||
154971337|NCT01011335|559318607|FG001|Overall Study|Moved/deployed or no booster|0|||
154971338|NCT01011335|559318608|FG002|Overall Study|Moved/deployed or no booster|0|||
154971339|NCT01011335|559318609|FG003|Overall Study|Moved/deployed or no booster|1|||
154971340|NCT01011335|559318610|FG004|Overall Study|Moved/deployed or no booster|0|||
154848370|NCT00094757|558875471|FG000|Overall Study|Other|3|||
154848371|NCT00094757|558875472|FG001|Overall Study|Other|3|||
154848372|NCT00094757|558875473|FG002|Overall Study|Other|1|||
154848373|NCT00094757|558875471|FG000|Overall Study|Protocol specified discontinuation|1|||
154848374|NCT00094757|558875472|FG001|Overall Study|Protocol specified discontinuation|3|||
154848375|NCT00094757|558875473|FG002|Overall Study|Protocol specified discontinuation|0|||
154848376|NCT01192347|558875477|FG000|Overall Study|Death|3|||
154848377|NCT01192347|558875477|FG000|Overall Study|Lost to Follow-up|3|||
154848378|NCT01192347|558875477|FG000|Overall Study|Withdrawal by Subject|1|||
154848379|NCT01192347|558875477|FG000|Overall Study|Adverse Event|1|||
154848380|NCT01192347|558875477|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
154848381|NCT01192347|558875477|FG000|Overall Study|Patient seen in different hospital|1|||
154848382|NCT01192347|558875477|FG000|Overall Study|Patient not visiting hospital regularly|1|||
154848383|NCT01192347|558875477|FG000|Overall Study|Patient did not show up for visits|1|||
154848384|NCT02623335|558875478|FG000|Overall Study|Death|8|||
154848385|NCT02623335|558875479|FG001|Overall Study|Death|7|||
154848386|NCT02623335|558875478|FG000|Overall Study|Lost to Follow-up|15|||
154848387|NCT02623335|558875479|FG001|Overall Study|Lost to Follow-up|23|||
154848388|NCT02623335|558875478|FG000|Overall Study|Withdrawal by Subject|2|||
154848389|NCT02623335|558875479|FG001|Overall Study|Withdrawal by Subject|5|||
154848390|NCT02623335|558875478|FG000|Overall Study|Protocol Violation|2|||
154848391|NCT02623335|558875479|FG001|Overall Study|Protocol Violation|1|||
154848392|NCT00395967|558875480|FG000|Treatment Period|Failed Mobilization|1|||
154848393|NCT00395967|558875480|FG000|Follow-up Period|Death|1|||
154848394|NCT00395967|558875480|FG000|Follow-up Period|Lost to Follow-up|1|||
154848395|NCT01262976|558875481|FG000|Up to Month 2|Serious Adverse Event|0|||
154848396|NCT01262976|558875482|FG001|Up to Month 2|Serious Adverse Event|0|||
154848397|NCT01262976|558875483|FG002|Up to Month 2|Serious Adverse Event|1|||
154848398|NCT01262976|558875484|FG003|Up to Month 2|Serious Adverse Event|0|||
154848399|NCT01262976|558875485|FG004|Up to Month 2|Serious Adverse Event|0|||
154848400|NCT01262976|558875486|FG005|Up to Month 2|Serious Adverse Event|0|||
154848401|NCT01262976|558875481|FG000|Up to Month 2|Withdrawal by Subject|1|||
154848402|NCT01262976|558875482|FG001|Up to Month 2|Withdrawal by Subject|0|||
154848403|NCT01262976|558875483|FG002|Up to Month 2|Withdrawal by Subject|0|||
154848404|NCT01262976|558875484|FG003|Up to Month 2|Withdrawal by Subject|0|||
154848405|NCT01262976|558875485|FG004|Up to Month 2|Withdrawal by Subject|0|||
154848406|NCT01262976|558875486|FG005|Up to Month 2|Withdrawal by Subject|0|||
154848407|NCT01262976|558875481|FG000|Up to Month 2|Migrated/moved from study area|0|||
154848408|NCT01262976|558875482|FG001|Up to Month 2|Migrated/moved from study area|1|||
154848409|NCT01262976|558875483|FG002|Up to Month 2|Migrated/moved from study area|0|||
154848410|NCT01262976|558875484|FG003|Up to Month 2|Migrated/moved from study area|0|||
154848411|NCT01262976|558875485|FG004|Up to Month 2|Migrated/moved from study area|1|||
154848412|NCT01262976|558875486|FG005|Up to Month 2|Migrated/moved from study area|1|||
154848413|NCT01262976|558875481|FG000|Up to Month 2|Lost to Follow-up|1|||
154848414|NCT01262976|558875482|FG001|Up to Month 2|Lost to Follow-up|0|||
154848415|NCT01262976|558875483|FG002|Up to Month 2|Lost to Follow-up|0|||
154848416|NCT01262976|558875484|FG003|Up to Month 2|Lost to Follow-up|1|||
154848417|NCT01262976|558875485|FG004|Up to Month 2|Lost to Follow-up|1|||
154848418|NCT01262976|558875486|FG005|Up to Month 2|Lost to Follow-up|1|||
154848419|NCT01262976|558875481|FG000|Up to Month 2|Other|1|||
154848420|NCT01262976|558875482|FG001|Up to Month 2|Other|0|||
154848421|NCT01262976|558875483|FG002|Up to Month 2|Other|0|||
154848422|NCT01262976|558875484|FG003|Up to Month 2|Other|1|||
154848423|NCT01262976|558875485|FG004|Up to Month 2|Other|0|||
154848424|NCT01262976|558875486|FG005|Up to Month 2|Other|2|||
154848425|NCT01262976|558875481|FG000|Up to Month 7|Serious Adverse Event|0|||
154848426|NCT01262976|558875482|FG001|Up to Month 7|Serious Adverse Event|0|||
154848427|NCT01262976|558875483|FG002|Up to Month 7|Serious Adverse Event|2|||
154848428|NCT01262976|558875484|FG003|Up to Month 7|Serious Adverse Event|0|||
154848429|NCT01262976|558875485|FG004|Up to Month 7|Serious Adverse Event|0|||
154848430|NCT01262976|558875486|FG005|Up to Month 7|Serious Adverse Event|0|||
155173555|NCT01252667|560074822|FG001|Overall Study|Transplant aborted post-conditioning|0|||
154848431|NCT01262976|558875481|FG000|Up to Month 7|Withdrawal by Subject|1|||
154848432|NCT01262976|558875482|FG001|Up to Month 7|Withdrawal by Subject|0|||
154848433|NCT01262976|558875483|FG002|Up to Month 7|Withdrawal by Subject|0|||
155173556|NCT01252667|560074823|FG002|Overall Study|Transplant aborted post-conditioning|0|||
154848434|NCT01262976|558875484|FG003|Up to Month 7|Withdrawal by Subject|0|||
154848435|NCT01262976|558875485|FG004|Up to Month 7|Withdrawal by Subject|0|||
154848436|NCT01262976|558875486|FG005|Up to Month 7|Withdrawal by Subject|0|||
154848437|NCT01262976|558875481|FG000|Up to Month 7|Migrated/moved from study area|0|||
154848438|NCT01262976|558875482|FG001|Up to Month 7|Migrated/moved from study area|0|||
154848439|NCT01262976|558875483|FG002|Up to Month 7|Migrated/moved from study area|1|||
154848440|NCT01262976|558875484|FG003|Up to Month 7|Migrated/moved from study area|3|||
154848441|NCT01262976|558875485|FG004|Up to Month 7|Migrated/moved from study area|1|||
154848442|NCT01262976|558875486|FG005|Up to Month 7|Migrated/moved from study area|1|||
154848443|NCT01262976|558875481|FG000|Up to Month 7|Lost to Follow-up|1|||
154848444|NCT01262976|558875482|FG001|Up to Month 7|Lost to Follow-up|0|||
154848445|NCT01262976|558875483|FG002|Up to Month 7|Lost to Follow-up|1|||
155105260|NCT02441101|559815556|FG001|Overall Study|Lost to Follow-up|0|||
155105261|NCT02441101|559815555|FG000|Overall Study|PI relocated and study terminated|1|||
155105262|NCT02441101|559815556|FG001|Overall Study|PI relocated and study terminated|0|||
155105263|NCT00271856|559815559|FG000|Overall Study|Withdrawal by Subject|1|||
155105264|NCT00271856|559815560|FG001|Overall Study|Withdrawal by Subject|7|||
155105265|NCT00271856|559815559|FG000|Overall Study|Lost to Follow-up|10|||
154848446|NCT01262976|558875484|FG003|Up to Month 7|Lost to Follow-up|3|||
154848447|NCT01262976|558875485|FG004|Up to Month 7|Lost to Follow-up|1|||
154848448|NCT01262976|558875486|FG005|Up to Month 7|Lost to Follow-up|3|||
154848449|NCT01262976|558875481|FG000|Up to Month 7|Other|3|||
154848450|NCT01262976|558875482|FG001|Up to Month 7|Other|0|||
154848451|NCT01262976|558875483|FG002|Up to Month 7|Other|2|||
154848452|NCT01262976|558875484|FG003|Up to Month 7|Other|0|||
154848453|NCT01262976|558875485|FG004|Up to Month 7|Other|0|||
154848454|NCT01262976|558875486|FG005|Up to Month 7|Other|0|||
154848455|NCT01262976|558875481|FG000|Up to Year 1|Serious Adverse Event|0|||
154848456|NCT01262976|558875482|FG001|Up to Year 1|Serious Adverse Event|0|||
154848457|NCT01262976|558875483|FG002|Up to Year 1|Serious Adverse Event|2|||
154848458|NCT01262976|558875484|FG003|Up to Year 1|Serious Adverse Event|0|||
154848459|NCT01262976|558875485|FG004|Up to Year 1|Serious Adverse Event|0|||
154848460|NCT01262976|558875486|FG005|Up to Year 1|Serious Adverse Event|0|||
154848461|NCT01262976|558875481|FG000|Up to Year 1|Withdrawal by Subject|1|||
154848462|NCT01262976|558875482|FG001|Up to Year 1|Withdrawal by Subject|0|||
154848463|NCT01262976|558875483|FG002|Up to Year 1|Withdrawal by Subject|0|||
154848464|NCT01262976|558875484|FG003|Up to Year 1|Withdrawal by Subject|0|||
154848465|NCT01262976|558875485|FG004|Up to Year 1|Withdrawal by Subject|0|||
154848466|NCT01262976|558875486|FG005|Up to Year 1|Withdrawal by Subject|0|||
154848467|NCT01262976|558875481|FG000|Up to Year 1|Migrated/moved from study area|1|||
154848468|NCT01262976|558875482|FG001|Up to Year 1|Migrated/moved from study area|0|||
154848469|NCT01262976|558875483|FG002|Up to Year 1|Migrated/moved from study area|0|||
154848470|NCT01262976|558875484|FG003|Up to Year 1|Migrated/moved from study area|3|||
154848471|NCT01262976|558875485|FG004|Up to Year 1|Migrated/moved from study area|3|||
154971341|NCT01011335|559318611|FG005|Overall Study|Moved/deployed or no booster|0|||
154971342|NCT01011335|559318612|FG006|Overall Study|Moved/deployed or no booster|1|||
154971343|NCT01011335|559318613|FG007|Overall Study|Moved/deployed or no booster|0|||
154971344|NCT01011335|559318614|FG008|Overall Study|Moved/deployed or no booster|1|||
154971345|NCT01011335|559318615|FG009|Overall Study|Moved/deployed or no booster|0|||
154971346|NCT01011335|559318616|FG010|Overall Study|Moved/deployed or no booster|2|||
154971347|NCT01011335|559318617|FG011|Overall Study|Moved/deployed or no booster|0|||
154971348|NCT01011335|559318618|FG012|Overall Study|Moved/deployed or no booster|0|||
154971349|NCT01011335|559318606|FG000|Overall Study|Adverse Event|0|||
154971350|NCT01011335|559318607|FG001|Overall Study|Adverse Event|0|||
154971351|NCT01011335|559318608|FG002|Overall Study|Adverse Event|0|||
154971352|NCT01011335|559318609|FG003|Overall Study|Adverse Event|0|||
154971353|NCT01011335|559318610|FG004|Overall Study|Adverse Event|0|||
154971354|NCT01011335|559318611|FG005|Overall Study|Adverse Event|0|||
154971355|NCT01011335|559318612|FG006|Overall Study|Adverse Event|0|||
154971356|NCT01011335|559318613|FG007|Overall Study|Adverse Event|0|||
154971357|NCT01011335|559318614|FG008|Overall Study|Adverse Event|0|||
154971358|NCT01011335|559318615|FG009|Overall Study|Adverse Event|0|||
154971359|NCT01011335|559318616|FG010|Overall Study|Adverse Event|4|||
154971360|NCT01011335|559318617|FG011|Overall Study|Adverse Event|0|||
154971361|NCT01011335|559318618|FG012|Overall Study|Adverse Event|1|||
154971362|NCT01813435|559318621|FG000|Overall Study|did not finish experimental regimen|1902|||
154971363|NCT01813435|559318622|FG001|Overall Study|did not finish experimental regimen|770|||
154971364|NCT01813435|559318621|FG000|Overall Study|Lost to Follow-up|268|||
154971365|NCT01813435|559318622|FG001|Overall Study|Lost to Follow-up|237|||
154971366|NCT02415387|559318630|FG000|Overall Study|Withdrawal by Subject|6|||
154971367|NCT02415387|559318631|FG001|Overall Study|Withdrawal by Subject|1|||
154971368|NCT02415387|559318630|FG000|Overall Study|blood draw problem|0|||
154971369|NCT02415387|559318631|FG001|Overall Study|blood draw problem|1|||
154971370|NCT02415387|559318630|FG000|Overall Study|Protocol Violation|1|||
155105266|NCT00271856|559815560|FG001|Overall Study|Lost to Follow-up|11|||
155105267|NCT03012828|559815561|FG000|Overall Study|Lost to Follow-up|1|||
155105268|NCT03012828|559815562|FG001|Overall Study|Lost to Follow-up|0|||
154848472|NCT01262976|558875486|FG005|Up to Year 1|Migrated/moved from study area|2|||
154848473|NCT01262976|558875481|FG000|Up to Year 1|Lost to Follow-up|4|||
154848474|NCT01262976|558875482|FG001|Up to Year 1|Lost to Follow-up|0|||
154848475|NCT01262976|558875483|FG002|Up to Year 1|Lost to Follow-up|0|||
154848476|NCT01262976|558875484|FG003|Up to Year 1|Lost to Follow-up|1|||
154848477|NCT01262976|558875485|FG004|Up to Year 1|Lost to Follow-up|6|||
154971371|NCT02415387|559318631|FG001|Overall Study|Protocol Violation|0|||
154971372|NCT01765751|559318632|FG000|Overall Study|Lost to Follow-up|0|||
154971373|NCT01765751|559318633|FG001|Overall Study|Lost to Follow-up|2|||
155105269|NCT03012828|559815563|FG002|Overall Study|Lost to Follow-up|1|||
155105270|NCT03012828|559815564|FG003|Overall Study|Lost to Follow-up|0|||
154848478|NCT01262976|558875486|FG005|Up to Year 1|Lost to Follow-up|5|||
154848479|NCT01262976|558875481|FG000|Up to Year 1|Other|3|||
154848480|NCT01262976|558875482|FG001|Up to Year 1|Other|1|||
154848481|NCT01262976|558875483|FG002|Up to Year 1|Other|0|||
154848482|NCT01262976|558875484|FG003|Up to Year 1|Other|0|||
154848483|NCT01262976|558875485|FG004|Up to Year 1|Other|2|||
154848484|NCT01262976|558875486|FG005|Up to Year 1|Other|1|||
154848485|NCT01262976|558875481|FG000|Up to Year 1|Subjects with unknown completion status|0|||
154848486|NCT01262976|558875482|FG001|Up to Year 1|Subjects with unknown completion status|0|||
154848487|NCT01262976|558875483|FG002|Up to Year 1|Subjects with unknown completion status|1|||
154848488|NCT01262976|558875484|FG003|Up to Year 1|Subjects with unknown completion status|0|||
154848489|NCT01262976|558875485|FG004|Up to Year 1|Subjects with unknown completion status|0|||
154848490|NCT01262976|558875486|FG005|Up to Year 1|Subjects with unknown completion status|1|||
154848491|NCT01262976|558875481|FG000|Up to Year 2|Serious Adverse Event|0|||
154848492|NCT01262976|558875482|FG001|Up to Year 2|Serious Adverse Event|0|||
154848493|NCT01262976|558875483|FG002|Up to Year 2|Serious Adverse Event|2|||
154848494|NCT01262976|558875484|FG003|Up to Year 2|Serious Adverse Event|0|||
154848495|NCT01262976|558875485|FG004|Up to Year 2|Serious Adverse Event|0|||
154848496|NCT01262976|558875486|FG005|Up to Year 2|Serious Adverse Event|0|||
154848497|NCT01262976|558875481|FG000|Up to Year 2|Withdrawal by Subject|1|||
154848498|NCT01262976|558875482|FG001|Up to Year 2|Withdrawal by Subject|0|||
154848499|NCT01262976|558875483|FG002|Up to Year 2|Withdrawal by Subject|0|||
154848500|NCT01262976|558875484|FG003|Up to Year 2|Withdrawal by Subject|0|||
154848501|NCT01262976|558875485|FG004|Up to Year 2|Withdrawal by Subject|0|||
154848502|NCT01262976|558875486|FG005|Up to Year 2|Withdrawal by Subject|0|||
154848503|NCT01262976|558875481|FG000|Up to Year 2|Migrated/moved from study area|0|||
154848504|NCT01262976|558875482|FG001|Up to Year 2|Migrated/moved from study area|0|||
154848505|NCT01262976|558875483|FG002|Up to Year 2|Migrated/moved from study area|0|||
154848506|NCT01262976|558875484|FG003|Up to Year 2|Migrated/moved from study area|2|||
154848507|NCT01262976|558875485|FG004|Up to Year 2|Migrated/moved from study area|1|||
154848508|NCT01262976|558875486|FG005|Up to Year 2|Migrated/moved from study area|2|||
154848509|NCT01262976|558875481|FG000|Up to Year 2|Lost to Follow-up|1|||
154848510|NCT01262976|558875482|FG001|Up to Year 2|Lost to Follow-up|1|||
154848511|NCT01262976|558875483|FG002|Up to Year 2|Lost to Follow-up|2|||
154848512|NCT01262976|558875484|FG003|Up to Year 2|Lost to Follow-up|2|||
154848513|NCT01262976|558875485|FG004|Up to Year 2|Lost to Follow-up|3|||
154848514|NCT01262976|558875486|FG005|Up to Year 2|Lost to Follow-up|3|||
154848515|NCT01262976|558875481|FG000|Up to Year 2|Subjects with unknown completion status|0|||
154848516|NCT01262976|558875482|FG001|Up to Year 2|Subjects with unknown completion status|0|||
154848517|NCT01262976|558875483|FG002|Up to Year 2|Subjects with unknown completion status|1|||
154848518|NCT01262976|558875484|FG003|Up to Year 2|Subjects with unknown completion status|0|||
154848519|NCT01262976|558875485|FG004|Up to Year 2|Subjects with unknown completion status|0|||
154848520|NCT01262976|558875486|FG005|Up to Year 2|Subjects with unknown completion status|0|||
154848521|NCT01262976|558875481|FG000|Up to Year 2|Other|3|||
154848522|NCT01262976|558875482|FG001|Up to Year 2|Other|0|||
154848523|NCT01262976|558875483|FG002|Up to Year 2|Other|0|||
154848524|NCT01262976|558875484|FG003|Up to Year 2|Other|0|||
154848525|NCT01262976|558875485|FG004|Up to Year 2|Other|0|||
154848526|NCT01262976|558875486|FG005|Up to Year 2|Other|0|||
154848527|NCT01262976|558875481|FG000|Up to Year 3|Serious Adverse Event|0|||
154848528|NCT01262976|558875482|FG001|Up to Year 3|Serious Adverse Event|0|||
154848529|NCT01262976|558875483|FG002|Up to Year 3|Serious Adverse Event|2|||
154848530|NCT01262976|558875484|FG003|Up to Year 3|Serious Adverse Event|0|||
154848531|NCT01262976|558875485|FG004|Up to Year 3|Serious Adverse Event|0|||
154848532|NCT01262976|558875486|FG005|Up to Year 3|Serious Adverse Event|0|||
154848533|NCT01262976|558875481|FG000|Up to Year 3|Withdrawal by Subject|1|||
154848534|NCT01262976|558875482|FG001|Up to Year 3|Withdrawal by Subject|0|||
154848535|NCT01262976|558875483|FG002|Up to Year 3|Withdrawal by Subject|0|||
154848536|NCT01262976|558875484|FG003|Up to Year 3|Withdrawal by Subject|0|||
154848537|NCT01262976|558875485|FG004|Up to Year 3|Withdrawal by Subject|0|||
154848538|NCT01262976|558875486|FG005|Up to Year 3|Withdrawal by Subject|0|||
154848539|NCT01262976|558875481|FG000|Up to Year 3|Migrated/moved from study area|0|||
154848540|NCT01262976|558875482|FG001|Up to Year 3|Migrated/moved from study area|0|||
154848541|NCT01262976|558875483|FG002|Up to Year 3|Migrated/moved from study area|0|||
154848542|NCT01262976|558875484|FG003|Up to Year 3|Migrated/moved from study area|2|||
154848543|NCT01262976|558875485|FG004|Up to Year 3|Migrated/moved from study area|1|||
154848544|NCT01262976|558875486|FG005|Up to Year 3|Migrated/moved from study area|1|||
154848545|NCT01262976|558875481|FG000|Up to Year 3|Lost to Follow-up|2|||
154848546|NCT01262976|558875482|FG001|Up to Year 3|Lost to Follow-up|2|||
154848547|NCT01262976|558875483|FG002|Up to Year 3|Lost to Follow-up|4|||
154848548|NCT01262976|558875484|FG003|Up to Year 3|Lost to Follow-up|3|||
154848549|NCT01262976|558875485|FG004|Up to Year 3|Lost to Follow-up|1|||
155173557|NCT01252667|560074824|FG003|Overall Study|Transplant aborted post-conditioning|0|||
154848550|NCT01262976|558875486|FG005|Up to Year 3|Lost to Follow-up|3|||
154848551|NCT01262976|558875481|FG000|Up to Year 3|Subjects with unknown completion status|0|||
154848552|NCT01262976|558875482|FG001|Up to Year 3|Subjects with unknown completion status|0|||
154848553|NCT01262976|558875483|FG002|Up to Year 3|Subjects with unknown completion status|1|||
154848554|NCT01262976|558875484|FG003|Up to Year 3|Subjects with unknown completion status|0|||
154848555|NCT01262976|558875485|FG004|Up to Year 3|Subjects with unknown completion status|0|||
154848556|NCT01262976|558875486|FG005|Up to Year 3|Subjects with unknown completion status|0|||
154848557|NCT01262976|558875481|FG000|Up to Year 3|Other|3|||
154848558|NCT01262976|558875482|FG001|Up to Year 3|Other|0|||
154848559|NCT01262976|558875483|FG002|Up to Year 3|Other|0|||
154848560|NCT01262976|558875484|FG003|Up to Year 3|Other|0|||
154848561|NCT01262976|558875485|FG004|Up to Year 3|Other|0|||
154848562|NCT01262976|558875486|FG005|Up to Year 3|Other|0|||
154848563|NCT01528787|558875487|FG000|Overall Study|Withdrawal by Subject|0|||
154848564|NCT01528787|558875488|FG001|Overall Study|Withdrawal by Subject|0|||
154848565|NCT01528787|558875489|FG002|Overall Study|Withdrawal by Subject|0|||
154848566|NCT01528787|558875490|FG003|Overall Study|Withdrawal by Subject|1|||
154848567|NCT01528787|558875487|FG000|Overall Study|Family Emergency|0|||
154848568|NCT01528787|558875488|FG001|Overall Study|Family Emergency|0|||
154848569|NCT01528787|558875489|FG002|Overall Study|Family Emergency|1|||
154848570|NCT01528787|558875490|FG003|Overall Study|Family Emergency|0|||
154848571|NCT03433781|558875493|FG000|Overall Study|Progression of Disease|1|||
154848572|NCT03433781|558875494|FG001|Overall Study|Progression of Disease|0|||
154848573|NCT03433781|558875495|FG002|Overall Study|Progression of Disease|0|||
154848574|NCT03433781|558875493|FG000|Overall Study|Physician Decision|0|||
154848575|NCT03433781|558875494|FG001|Overall Study|Physician Decision|1|||
154848576|NCT03433781|558875495|FG002|Overall Study|Physician Decision|0|||
154848577|NCT00797823|558875496|FG000|First Period (Initial Randomization)|Physician Decision|1|||
154848578|NCT00797823|558875497|FG001|First Period (Initial Randomization)|Physician Decision|0|||
154848579|NCT00797823|558875498|FG002|First Period (Initial Randomization)|Physician Decision|0|||
154848580|NCT02809833|558875499|FG000|Overall Study|Death|3|||
154848581|NCT02809833|558875499|FG000|Overall Study|Intolerance|54|||
154848582|NCT02809833|558875499|FG000|Overall Study|Lack of Efficacy|89|||
154848583|NCT02809833|558875499|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
154848584|NCT02809833|558875499|FG000|Overall Study|Noncompliance|1|||
154848585|NCT02809833|558875499|FG000|Overall Study|Withdrawal by Subject|34|||
155105271|NCT03012828|559815565|FG004|Overall Study|Lost to Follow-up|1|||
154848586|NCT02809833|558875499|FG000|Overall Study|Lost to Follow-up|35|||
154848587|NCT02809833|558875499|FG000|Overall Study|Adverse Event (AE)|24|||
154848588|NCT02809833|558875499|FG000|Overall Study|Other|5|||
154848589|NCT02809833|558875499|FG000|Overall Study|Missing Information|52|||
154848590|NCT00408694|558875500|FG000|Overall Study|Ineligible|1|||
154848591|NCT00408694|558875500|FG000|Overall Study|No protocol treatment|1|||
154848592|NCT03261531|558875504|FG000|Overall Study|Withdrawal by Subject|4|||
154848593|NCT01700192|558875505|FG000|Overall Study|Adverse Event|73|||
154848594|NCT01700192|558875506|FG001|Overall Study|Adverse Event|18|||
154848595|NCT01700192|558875505|FG000|Overall Study|Lack of Efficacy|1|||
154848596|NCT01700192|558875506|FG001|Overall Study|Lack of Efficacy|0|||
154848597|NCT01700192|558875505|FG000|Overall Study|Lost to Follow-up|42|||
154848598|NCT01700192|558875506|FG001|Overall Study|Lost to Follow-up|29|||
154848599|NCT01700192|558875505|FG000|Overall Study|Noncompliance with study drug|0|||
154848600|NCT01700192|558875506|FG001|Overall Study|Noncompliance with study drug|5|||
154848601|NCT01700192|558875505|FG000|Overall Study|Physician Decision|2|||
154848602|NCT01700192|558875506|FG001|Overall Study|Physician Decision|3|||
154848603|NCT01700192|558875505|FG000|Overall Study|Pregnancy|1|||
154848604|NCT01700192|558875506|FG001|Overall Study|Pregnancy|4|||
154848605|NCT01700192|558875505|FG000|Overall Study|Progressive disease|1|||
154848606|NCT01700192|558875506|FG001|Overall Study|Progressive disease|0|||
154848607|NCT01700192|558875505|FG000|Overall Study|Protocol Violation|3|||
154848608|NCT01700192|558875506|FG001|Overall Study|Protocol Violation|4|||
154848609|NCT01700192|558875505|FG000|Overall Study|Technical problems|0|||
154848610|NCT01700192|558875506|FG001|Overall Study|Technical problems|1|||
154971374|NCT01765751|559318634|FG002|Overall Study|Lost to Follow-up|1|||
155105272|NCT03012828|559815566|FG005|Overall Study|Lost to Follow-up|0|||
154848611|NCT01700192|558875505|FG000|Overall Study|Withdrawal by Subject|56|||
154848612|NCT01700192|558875506|FG001|Overall Study|Withdrawal by Subject|64|||
154848613|NCT01700192|558875505|FG000|Overall Study|Never received study drug|1|||
154848614|NCT01700192|558875506|FG001|Overall Study|Never received study drug|0|||
154848615|NCT00744874|558875508|FG000|Overall Study|Lost to Follow-up|1|||
154848616|NCT00744874|558875508|FG000|Overall Study|Withdrawal by Subject|1|||
154848617|NCT00744874|558875508|FG000|Overall Study|Study Device not available at procedure|1|||
154848618|NCT00744874|558875508|FG000|Overall Study|Unable to accomodate schedule|1|||
154848619|NCT00357500|558875514|FG000|Overall Study|Adverse Event|3|||
154848620|NCT00357500|558875514|FG000|Overall Study|Withdrawal by Subject|5|||
154848621|NCT00357500|558875514|FG000|Overall Study|Progressive Disease|65|||
154848622|NCT00357500|558875514|FG000|Overall Study|Not Started Protocol Therapy|4|||
154848623|NCT02301403|558875515|FG000|Overall Study|Withdrawal by Subject|28|||
154848624|NCT02301403|558875516|FG001|Overall Study|Withdrawal by Subject|41|||
154848625|NCT01816243|558875519|FG000|Overall Study|Adverse Event|6|||
155105273|NCT03012828|559815561|FG000|Overall Study|Withdrawal by Subject|0|||
154848626|NCT01816243|558875519|FG000|Overall Study|Lost to Follow-up|1|||
154848627|NCT01816243|558875519|FG000|Overall Study|Lack of Efficacy|1|||
154848628|NCT01816243|558875519|FG000|Overall Study|Not eligible for the study|1|||
154848629|NCT01816243|558875519|FG000|Overall Study|Amputation|3|||
154848630|NCT03551743|558875520|FG000|Overall Study|Adverse Event|1|||
154848631|NCT03551743|558875521|FG001|Overall Study|Adverse Event|0|||
155105274|NCT03012828|559815562|FG001|Overall Study|Withdrawal by Subject|0|||
155105275|NCT03012828|559815563|FG002|Overall Study|Withdrawal by Subject|1|||
155105276|NCT03012828|559815564|FG003|Overall Study|Withdrawal by Subject|0|||
155105277|NCT03012828|559815565|FG004|Overall Study|Withdrawal by Subject|0|||
155105278|NCT03012828|559815566|FG005|Overall Study|Withdrawal by Subject|1|||
155105279|NCT03012828|559815561|FG000|Overall Study|Non-compliance with protocol|0|||
154848632|NCT03551743|558875522|FG002|Overall Study|Adverse Event|0|||
154848633|NCT03551743|558875523|FG003|Overall Study|Adverse Event|0|||
154848634|NCT03551743|558875520|FG000|Overall Study|Withdrawal by Subject|1|||
154848635|NCT03551743|558875521|FG001|Overall Study|Withdrawal by Subject|0|||
154848636|NCT03551743|558875522|FG002|Overall Study|Withdrawal by Subject|0|||
154848637|NCT03551743|558875523|FG003|Overall Study|Withdrawal by Subject|0|||
154848638|NCT02317562|558875524|FG000|Overall Study|Physician Decision|1|||
154848639|NCT02317562|558875524|FG000|Overall Study|early termination of the study|8|||
154848640|NCT02317562|558875524|FG000|Overall Study|Lack of Efficacy|4|||
154848641|NCT02317562|558875524|FG000|Overall Study|Withdrawal by Subject|1|||
154848642|NCT00603915|558875525|FG000|Overall Study|Physician Decision|1|||
154848643|NCT03891901|558875526|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
154848644|NCT03891901|558875527|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848645|NCT03891901|558875528|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848646|NCT03891901|558875529|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848647|NCT03891901|558875530|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848648|NCT03891901|558875531|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848649|NCT03891901|558875532|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848650|NCT03891901|558875533|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848651|NCT03891901|558875534|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
154848652|NCT03891901|558875526|FG000|Overall Study|Adverse Event|2|||
154848653|NCT03891901|558875527|FG001|Overall Study|Adverse Event|2|||
154848654|NCT03891901|558875528|FG002|Overall Study|Adverse Event|0|||
154848655|NCT03891901|558875529|FG003|Overall Study|Adverse Event|0|||
154971375|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
154971376|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
154971377|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
154971378|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
154971379|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
154971380|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
154971381|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
154971382|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
154971383|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
154971384|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
154971385|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
154971386|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
154971387|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
154971388|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
154971389|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
154971390|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
154971391|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
155105280|NCT03012828|559815562|FG001|Overall Study|Non-compliance with protocol|0|||
155105281|NCT03012828|559815563|FG002|Overall Study|Non-compliance with protocol|0|||
155105282|NCT03012828|559815564|FG003|Overall Study|Non-compliance with protocol|0|||
155173558|NCT01252667|560074825|FG004|Overall Study|Transplant aborted post-conditioning|0|||
154848656|NCT03891901|558875530|FG004|Overall Study|Adverse Event|0|||
154848657|NCT03891901|558875531|FG005|Overall Study|Adverse Event|0|||
154848658|NCT03891901|558875532|FG006|Overall Study|Adverse Event|0|||
154848659|NCT03891901|558875533|FG007|Overall Study|Adverse Event|0|||
154848660|NCT03891901|558875534|FG008|Overall Study|Adverse Event|0|||
154848661|NCT03891901|558875526|FG000|Overall Study|Poor venous access|1|||
154848662|NCT03891901|558875527|FG001|Overall Study|Poor venous access|0|||
154848663|NCT03891901|558875528|FG002|Overall Study|Poor venous access|0|||
154848664|NCT03891901|558875529|FG003|Overall Study|Poor venous access|0|||
154848665|NCT03891901|558875530|FG004|Overall Study|Poor venous access|0|||
154848666|NCT03891901|558875531|FG005|Overall Study|Poor venous access|0|||
154848667|NCT03891901|558875532|FG006|Overall Study|Poor venous access|0|||
154848668|NCT03891901|558875533|FG007|Overall Study|Poor venous access|0|||
154848669|NCT03891901|558875534|FG008|Overall Study|Poor venous access|0|||
154848670|NCT03891901|558875526|FG000|Overall Study|Withdrawal by Subject|0|||
154848671|NCT03891901|558875527|FG001|Overall Study|Withdrawal by Subject|2|||
154848672|NCT03891901|558875528|FG002|Overall Study|Withdrawal by Subject|0|||
154848673|NCT03891901|558875529|FG003|Overall Study|Withdrawal by Subject|0|||
154848674|NCT03891901|558875530|FG004|Overall Study|Withdrawal by Subject|0|||
154848675|NCT03891901|558875531|FG005|Overall Study|Withdrawal by Subject|0|||
154848676|NCT03891901|558875532|FG006|Overall Study|Withdrawal by Subject|0|||
154848677|NCT03891901|558875533|FG007|Overall Study|Withdrawal by Subject|0|||
154848678|NCT03891901|558875534|FG008|Overall Study|Withdrawal by Subject|0|||
154848679|NCT01724528|558875535|FG000|Overall Study|Death|3|||
154848680|NCT01724528|558875536|FG001|Overall Study|Death|0|||
154848681|NCT01724528|558875535|FG000|Overall Study|Withdrawal by Subject|0|||
154848682|NCT01724528|558875536|FG001|Overall Study|Withdrawal by Subject|2|||
154848683|NCT01724528|558875535|FG000|Overall Study|Protocol Violation|0|||
154848684|NCT01724528|558875536|FG001|Overall Study|Protocol Violation|1|||
154848685|NCT01724528|558875535|FG000|Overall Study|Patient refused to attend last visit|1|||
154848686|NCT01724528|558875536|FG001|Overall Study|Patient refused to attend last visit|0|||
154848687|NCT05574062|558875537|FG000|Pre Run-In|Screening failure|3|||
154848688|NCT05574062|558875538|FG001|Pre Run-In|Screening failure|0|||
154848689|NCT05574062|558875539|FG002|Pre Run-In|Screening failure|0|||
154848690|NCT05574062|558875540|FG003|Pre Run-In|Screening failure|0|||
154848691|NCT05574062|558875541|FG004|Pre Run-In|Screening failure|0|||
154848692|NCT05574062|558875537|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
154848693|NCT05574062|558875538|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
154848694|NCT05574062|558875539|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
154848695|NCT05574062|558875540|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
154848696|NCT05574062|558875541|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
154848697|NCT05574062|558875537|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
154848698|NCT05574062|558875538|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
154848699|NCT05574062|558875539|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
154848700|NCT05574062|558875540|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
154848701|NCT05574062|558875541|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
154848702|NCT05574062|558875537|FG000|Continuation Phase Period 1|Physician Decision|1|||
154848703|NCT05574062|558875538|FG001|Continuation Phase Period 1|Physician Decision|0|||
154848704|NCT05574062|558875539|FG002|Continuation Phase Period 1|Physician Decision|0|||
154848705|NCT05574062|558875540|FG003|Continuation Phase Period 1|Physician Decision|0|||
154848706|NCT05574062|558875541|FG004|Continuation Phase Period 1|Physician Decision|0|||
154848707|NCT05574062|558875537|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
154848708|NCT05574062|558875538|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
154848709|NCT05574062|558875539|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
154848710|NCT05574062|558875540|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
154848711|NCT05574062|558875541|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
154848712|NCT05574062|558875537|FG000|Continuation Phase Period 1|Adverse Event|1|||
154848713|NCT05574062|558875538|FG001|Continuation Phase Period 1|Adverse Event|0|||
154848714|NCT05574062|558875539|FG002|Continuation Phase Period 1|Adverse Event|0|||
154848715|NCT05574062|558875540|FG003|Continuation Phase Period 1|Adverse Event|0|||
154848716|NCT05574062|558875541|FG004|Continuation Phase Period 1|Adverse Event|0|||
154848717|NCT05574062|558875537|FG000|Continuation Phase Period 1|Death|1|||
154848718|NCT05574062|558875538|FG001|Continuation Phase Period 1|Death|0|||
154848719|NCT05574062|558875539|FG002|Continuation Phase Period 1|Death|0|||
154848720|NCT05574062|558875540|FG003|Continuation Phase Period 1|Death|0|||
154848721|NCT05574062|558875541|FG004|Continuation Phase Period 1|Death|0|||
154848722|NCT05574062|558875537|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
154848723|NCT05574062|558875538|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
154848724|NCT05574062|558875539|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
154848725|NCT05574062|558875540|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
154848726|NCT05574062|558875541|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
154971392|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
154848727|NCT01031446|558875548|FG000|Overall Study|Disease Progression|38|||
154848728|NCT01031446|558875548|FG000|Overall Study|Adverse Event|9|||
154848729|NCT01031446|558875548|FG000|Overall Study|Physician Decision|4|||
154848730|NCT01031446|558875548|FG000|Overall Study|Withdrawal by Subject|3|||
154848731|NCT01031446|558875548|FG000|Overall Study|Still on treatment|1|||
154848732|NCT03631706|558875550|FG000|Overall Study|Randomized, not treated|1|||
154848733|NCT03631706|558875551|FG001|Overall Study|Randomized, not treated|0|||
154971393|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
154971394|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
154971395|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
154971396|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
154971397|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
154971398|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
154971399|NCT01710358|559318636|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
154971400|NCT01710358|559318637|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
154971401|NCT01710358|559318638|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
154971402|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
154971403|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
154971404|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
154971405|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
154971406|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
154971407|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
154971408|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
154971409|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
154971410|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
154971411|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
154971412|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
154971413|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
154971414|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
154971415|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
154971416|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
154971417|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
154971418|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
154971419|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
154971420|NCT01710358|559318636|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
154971421|NCT01710358|559318637|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
154971422|NCT01710358|559318638|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
155173559|NCT01252667|560074826|FG005|Overall Study|Transplant aborted post-conditioning|1|||
155173560|NCT01738646|560074827|FG000|Overall Study|Still Receiving Treatment|2|||
154848734|NCT00865020|558875554|FG000|Overall Study|Withdrawal by Subject|22|||
154848735|NCT00865020|558875555|FG001|Overall Study|Withdrawal by Subject|16|||
154848736|NCT00865020|558875554|FG000|Overall Study|Adverse Event|9|||
154848737|NCT00865020|558875555|FG001|Overall Study|Adverse Event|14|||
154848738|NCT00865020|558875554|FG000|Overall Study|Abnormal test procedure result(s)|6|||
154848739|NCT00865020|558875555|FG001|Overall Study|Abnormal test procedure result(s)|8|||
154848740|NCT00865020|558875554|FG000|Overall Study|Lost to Follow-up|6|||
154848741|NCT00865020|558875555|FG001|Overall Study|Lost to Follow-up|4|||
154848742|NCT00865020|558875554|FG000|Overall Study|Protocol deviation|4|||
154848743|NCT00865020|558875555|FG001|Overall Study|Protocol deviation|1|||
154848744|NCT00865020|558875554|FG000|Overall Study|Administrative problems|0|||
154848745|NCT00865020|558875555|FG001|Overall Study|Administrative problems|2|||
154848746|NCT00865020|558875554|FG000|Overall Study|Abnormal laboratory value(s)|0|||
154848747|NCT00865020|558875555|FG001|Overall Study|Abnormal laboratory value(s)|1|||
154848748|NCT00865020|558875554|FG000|Overall Study|Death|0|||
154848749|NCT00865020|558875555|FG001|Overall Study|Death|1|||
154848750|NCT00865020|558875554|FG000|Overall Study|Randomized but discontinued|2|||
154848751|NCT00865020|558875555|FG001|Overall Study|Randomized but discontinued|4|||
154848752|NCT00546364|558877101|FG000|Overall Study|Disease progression|5|||
154848753|NCT00546364|558877102|FG001|Overall Study|Disease progression|11|||
154848754|NCT00546364|558877103|FG002|Overall Study|Disease progression|8|||
154848755|NCT00546364|558877101|FG000|Overall Study|Completed and off treatment|1|||
154848756|NCT00546364|558877102|FG001|Overall Study|Completed and off treatment|0|||
154848757|NCT00546364|558877103|FG002|Overall Study|Completed and off treatment|2|||
154848758|NCT00546364|558877101|FG000|Overall Study|Administrative reason by sponsor|1|||
154848759|NCT00546364|558877102|FG001|Overall Study|Administrative reason by sponsor|0|||
154848760|NCT00546364|558877103|FG002|Overall Study|Administrative reason by sponsor|0|||
154848761|NCT00546364|558877101|FG000|Overall Study|Poor compliance/noncompliance|0|||
154848762|NCT00546364|558877102|FG001|Overall Study|Poor compliance/noncompliance|0|||
154848763|NCT00546364|558877103|FG002|Overall Study|Poor compliance/noncompliance|1|||
154848764|NCT00546364|558877101|FG000|Overall Study|No longer meets study criteria|1|||
154848765|NCT00546364|558877102|FG001|Overall Study|No longer meets study criteria|1|||
154848766|NCT00546364|558877103|FG002|Overall Study|No longer meets study criteria|0|||
154848767|NCT00546364|558877101|FG000|Overall Study|Withdrawal by Subject|5|||
154848768|NCT00546364|558877102|FG001|Overall Study|Withdrawal by Subject|6|||
154848769|NCT00546364|558877103|FG002|Overall Study|Withdrawal by Subject|3|||
154848770|NCT00546364|558877101|FG000|Overall Study|Prior taxotere|1|||
154848771|NCT00546364|558877102|FG001|Overall Study|Prior taxotere|0|||
154848772|NCT00546364|558877103|FG002|Overall Study|Prior taxotere|0|||
154848773|NCT00546364|558877101|FG000|Overall Study|Mixed response|1|||
154848774|NCT00546364|558877102|FG001|Overall Study|Mixed response|0|||
154848775|NCT00546364|558877103|FG002|Overall Study|Mixed response|0|||
154848776|NCT00546364|558877101|FG000|Overall Study|Palliative treatment|1|||
154848777|NCT00546364|558877102|FG001|Overall Study|Palliative treatment|0|||
154848778|NCT00546364|558877103|FG002|Overall Study|Palliative treatment|1|||
154848779|NCT00546364|558877101|FG000|Overall Study|Target lesions resected|1|||
154848780|NCT00546364|558877102|FG001|Overall Study|Target lesions resected|0|||
154848781|NCT00546364|558877103|FG002|Overall Study|Target lesions resected|0|||
154848782|NCT00546364|558877101|FG000|Overall Study|Physician Decision|0|||
154848783|NCT00546364|558877102|FG001|Overall Study|Physician Decision|0|||
154848784|NCT00546364|558877103|FG002|Overall Study|Physician Decision|1|||
154848785|NCT00546364|558877101|FG000|Overall Study|Sponsor decision|0|||
154848786|NCT00546364|558877102|FG001|Overall Study|Sponsor decision|0|||
154848787|NCT00546364|558877103|FG002|Overall Study|Sponsor decision|1|||
154848788|NCT03064763|558877104|FG000|Overall Study|Lost to Follow-up|1|||
154848789|NCT03064763|558877104|FG000|Overall Study|Death|8|||
154848790|NCT00619502|558877108|FG000|Overall Study|Lost to Follow-up|8|||
154848791|NCT00619502|558877109|FG001|Overall Study|Lost to Follow-up|10|||
154848792|NCT00223496|558877112|FG000|Overall Study|screen failure|9|||
154848793|NCT00223496|558877112|FG000|Overall Study|Lost to Follow-up|4|||
154848794|NCT00223496|558877112|FG000|Overall Study|Lack of Efficacy|6|||
154848795|NCT00223496|558877112|FG000|Overall Study|Withdrawal by Subject|1|||
154848796|NCT00223496|558877112|FG000|Overall Study|Physician Decision|2|||
154848797|NCT05425563|558877117|FG000|Overall Study|Withdrawal by Subject|17|||
154848798|NCT02624492|558877122|FG000|Overall Study|Adverse Event|2|||
154848799|NCT02624492|558877123|FG001|Overall Study|Adverse Event|2|||
154848800|NCT02624492|558877124|FG002|Overall Study|Adverse Event|2|||
154848801|NCT02624492|558877122|FG000|Overall Study|Progressive disease|0|||
154971423|NCT01710358|559318636|FG000|Rescue Period|Adverse Event|0|||
154848802|NCT02624492|558877123|FG001|Overall Study|Progressive disease|2|||
154848803|NCT02624492|558877124|FG002|Overall Study|Progressive disease|3|||
154848804|NCT00343512|558877130|FG000|Overall Study|Withdrawal by Subject|2|||
154848805|NCT02400255|558877131|FG000|Overall Study|Relapse|4|||
154848806|NCT02400255|558877132|FG001|Overall Study|Relapse|1|||
154848807|NCT02400255|558877133|FG002|Overall Study|Relapse|1|||
154848808|NCT02400255|558877134|FG003|Overall Study|Relapse|2|||
154848809|NCT02400255|558877131|FG000|Overall Study|Adverse Event|6|||
154848810|NCT02400255|558877132|FG001|Overall Study|Adverse Event|3|||
155105283|NCT03012828|559815565|FG004|Overall Study|Non-compliance with protocol|1|||
155105284|NCT03012828|559815566|FG005|Overall Study|Non-compliance with protocol|0|||
155105285|NCT03012828|559815561|FG000|Overall Study|Delay to last visit would delay DBL|0|||
155105286|NCT03012828|559815562|FG001|Overall Study|Delay to last visit would delay DBL|0|||
155105287|NCT03012828|559815563|FG002|Overall Study|Delay to last visit would delay DBL|0|||
154848811|NCT02400255|558877133|FG002|Overall Study|Adverse Event|0|||
154848812|NCT02400255|558877134|FG003|Overall Study|Adverse Event|0|||
154848813|NCT02400255|558877131|FG000|Overall Study|Physician Decision|6|||
154848814|NCT02400255|558877132|FG001|Overall Study|Physician Decision|0|||
154848815|NCT02400255|558877133|FG002|Overall Study|Physician Decision|0|||
154848816|NCT02400255|558877134|FG003|Overall Study|Physician Decision|0|||
154848817|NCT02400255|558877131|FG000|Overall Study|Loss of insurance|1|||
154848818|NCT02400255|558877132|FG001|Overall Study|Loss of insurance|0|||
154848819|NCT02400255|558877133|FG002|Overall Study|Loss of insurance|0|||
154848820|NCT02400255|558877134|FG003|Overall Study|Loss of insurance|0|||
154848821|NCT02568046|558877135|FG000|Overall Study|Adverse Event|0|||
154848822|NCT02568046|558877136|FG001|Overall Study|Adverse Event|1|||
154848823|NCT02568046|558877135|FG000|Overall Study|Death|2|||
154848824|NCT02568046|558877136|FG001|Overall Study|Death|0|||
154848825|NCT02568046|558877135|FG000|Overall Study|Progressive Disease|1|||
154848826|NCT02568046|558877136|FG001|Overall Study|Progressive Disease|0|||
154848827|NCT02568046|558877135|FG000|Overall Study|Withdrawal by Subject|2|||
154848828|NCT02568046|558877136|FG001|Overall Study|Withdrawal by Subject|1|||
154848829|NCT02568046|558877135|FG000|Overall Study|Other Events|0|||
154848830|NCT02568046|558877136|FG001|Overall Study|Other Events|1|||
154848831|NCT00193063|558877137|FG000|Overall Study|Lack of Efficacy|3|||
154848832|NCT00193063|558877137|FG000|Overall Study|Adverse Event|1|||
154848833|NCT01127165|558877138|FG000|Overall Study|Adverse Event|2|||
154848834|NCT01127165|558877139|FG001|Overall Study|Adverse Event|2|||
154848835|NCT01127165|558877138|FG000|Overall Study|Lack of Efficacy|10|||
154848836|NCT01127165|558877139|FG001|Overall Study|Lack of Efficacy|8|||
154848837|NCT01127165|558877138|FG000|Overall Study|Lost to Follow-up|3|||
154848838|NCT01127165|558877139|FG001|Overall Study|Lost to Follow-up|5|||
154848839|NCT01127165|558877138|FG000|Overall Study|Withdrawal by Subject|1|||
154848840|NCT01127165|558877139|FG001|Overall Study|Withdrawal by Subject|3|||
154848841|NCT01127165|558877138|FG000|Overall Study|Protocol Violation|0|||
154848842|NCT01127165|558877139|FG001|Overall Study|Protocol Violation|1|||
154848843|NCT02435849|558877140|FG000|Overall Study|Death|23|||
154848844|NCT02435849|558877141|FG001|Overall Study|Death|0|||
154848845|NCT02435849|558877140|FG000|Overall Study|Lack of Efficacy|10|||
154848846|NCT02435849|558877141|FG001|Overall Study|Lack of Efficacy|0|||
154848847|NCT02435849|558877140|FG000|Overall Study|New therapy for study indication|8|||
154848848|NCT02435849|558877141|FG001|Overall Study|New therapy for study indication|0|||
154848849|NCT02435849|558877140|FG000|Overall Study|Subject/guardian decision|5|||
154848850|NCT02435849|558877141|FG001|Overall Study|Subject/guardian decision|1|||
154848851|NCT02435849|558877140|FG000|Overall Study|Lost to Follow-up|1|||
154848852|NCT02435849|558877141|FG001|Overall Study|Lost to Follow-up|0|||
154848853|NCT02435849|558877140|FG000|Overall Study|Physician Decision|1|||
154848854|NCT02435849|558877141|FG001|Overall Study|Physician Decision|0|||
154848855|NCT01017952|558877142|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
154848856|NCT01017952|558877143|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154848857|NCT01017952|558877144|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154848858|NCT01017952|558877145|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154848859|NCT01017952|558877146|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154848860|NCT01017952|558877142|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
154848861|NCT01017952|558877143|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
154848862|NCT01017952|558877144|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
154848863|NCT01017952|558877145|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
154848864|NCT01017952|558877146|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
154848865|NCT01017952|558877142|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
154848866|NCT01017952|558877143|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
154848867|NCT01017952|558877144|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
154848868|NCT01017952|558877145|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
154848869|NCT01017952|558877146|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
154848870|NCT01017952|558877142|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
154848871|NCT01017952|558877143|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154848872|NCT01017952|558877144|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154848873|NCT01017952|558877145|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154848874|NCT01017952|558877146|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154848875|NCT01017952|558877142|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
154848876|NCT01017952|558877143|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
154848877|NCT01017952|558877144|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
155105288|NCT03012828|559815564|FG003|Overall Study|Delay to last visit would delay DBL|0|||
155105289|NCT03012828|559815565|FG004|Overall Study|Delay to last visit would delay DBL|0|||
154848878|NCT01017952|558877145|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
154848879|NCT01017952|558877146|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
154848880|NCT01017952|558877142|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
154848881|NCT01017952|558877143|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154848882|NCT01017952|558877144|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154848883|NCT01017952|558877145|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154848884|NCT01017952|558877146|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154848885|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
154848886|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
154848887|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
154848888|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
154848889|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
154848890|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
154848891|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
154848892|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
154848893|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
154848894|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
154848895|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
154848896|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
154848897|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
154848898|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
154848899|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
154848900|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
154848901|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
154848902|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
154848903|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
154848904|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
154848905|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
154848906|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
154848907|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
154848908|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
154848909|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
154848910|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
154848911|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
154848912|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
154848913|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
154848914|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
154848915|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154848916|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
154848917|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
154848918|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
154848919|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
154848920|NCT01017952|558877142|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
154848921|NCT01017952|558877143|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
154848922|NCT01017952|558877144|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
154848923|NCT01017952|558877145|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
154848924|NCT01017952|558877146|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
154848925|NCT01064167|558877147|FG000|Overall Study|Protocol Violation|14|||
154848926|NCT01064167|558877148|FG001|Overall Study|Protocol Violation|15|||
154848927|NCT03984305|558877151|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
154848928|NCT03984305|558877152|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
154848929|NCT03984305|558877151|FG000|Overall Study|Withdrawal by Subject|3|||
154848930|NCT03984305|558877152|FG001|Overall Study|Withdrawal by Subject|3|||
154848931|NCT03984305|558877151|FG000|Overall Study|Lost to Follow-up|1|||
154848932|NCT03984305|558877152|FG001|Overall Study|Lost to Follow-up|0|||
154848933|NCT00352105|558877153|FG000|Overall Study|Death|5|||
154848934|NCT00352105|558877153|FG000|Overall Study|Withdrawal by Subject|5|||
154848935|NCT00352105|558877153|FG000|Overall Study|Lack of Efficacy|9|||
154848936|NCT00352105|558877153|FG000|Overall Study|Adverse Event|19|||
154848937|NCT00352105|558877153|FG000|Overall Study|Protocol Violation|2|||
154848938|NCT02979431|558877156|FG000|Overall Study|Parent/guardian withdrew consent|2|||
154848939|NCT02979431|558877157|FG001|Overall Study|Parent/guardian withdrew consent|1|||
154848940|NCT02979431|558877158|FG002|Overall Study|Parent/guardian withdrew consent|1|||
154848941|NCT02979431|558877159|FG003|Overall Study|Parent/guardian withdrew consent|1|||
154848942|NCT02979431|558877156|FG000|Overall Study|Randomized but received no study drug|1|||
154848943|NCT02979431|558877157|FG001|Overall Study|Randomized but received no study drug|1|||
154848944|NCT02979431|558877158|FG002|Overall Study|Randomized but received no study drug|0|||
154848945|NCT02979431|558877159|FG003|Overall Study|Randomized but received no study drug|0|||
154848946|NCT02979431|558877156|FG000|Overall Study|Adverse Event|0|||
154848947|NCT02979431|558877157|FG001|Overall Study|Adverse Event|0|||
154848948|NCT02979431|558877158|FG002|Overall Study|Adverse Event|1|||
154848949|NCT02979431|558877159|FG003|Overall Study|Adverse Event|0|||
154848950|NCT02979431|558877156|FG000|Overall Study|Subject left country after Day14|1|||
154848951|NCT02979431|558877157|FG001|Overall Study|Subject left country after Day14|0|||
154848952|NCT02979431|558877158|FG002|Overall Study|Subject left country after Day14|0|||
154848953|NCT02979431|558877159|FG003|Overall Study|Subject left country after Day14|0|||
154848954|NCT01656434|558877160|FG000|Overall Study|Adverse Event|199|||
154848955|NCT01656434|558877161|FG001|Overall Study|Adverse Event|63|||
154848956|NCT01656434|558877160|FG000|Overall Study|Enrollment terminated at trial site|2|||
154848957|NCT01656434|558877161|FG001|Overall Study|Enrollment terminated at trial site|0|||
154848958|NCT01656434|558877160|FG000|Overall Study|Lost to Follow-up|309|||
154848959|NCT01656434|558877161|FG001|Overall Study|Lost to Follow-up|76|||
154848960|NCT01656434|558877160|FG000|Overall Study|Site discontinued study participation|24|||
154848961|NCT01656434|558877161|FG001|Overall Study|Site discontinued study participation|9|||
154848962|NCT01656434|558877160|FG000|Overall Study|Screen failure|2|||
154848963|NCT01656434|558877161|FG001|Overall Study|Screen failure|0|||
154848964|NCT01656434|558877160|FG000|Overall Study|Protocol Violation|7|||
154848965|NCT01656434|558877161|FG001|Overall Study|Protocol Violation|0|||
154848966|NCT01656434|558877160|FG000|Overall Study|Pregnancy wish|18|||
154848967|NCT01656434|558877161|FG001|Overall Study|Pregnancy wish|6|||
154848968|NCT01656434|558877160|FG000|Overall Study|Pregnancy|45|||
154848969|NCT01656434|558877161|FG001|Overall Study|Pregnancy|10|||
154848970|NCT01656434|558877160|FG000|Overall Study|Physician Decision|7|||
154848971|NCT01656434|558877161|FG001|Overall Study|Physician Decision|2|||
154848972|NCT01656434|558877160|FG000|Overall Study|Non-compliance with study drug|48|||
154848973|NCT01656434|558877161|FG001|Overall Study|Non-compliance with study drug|9|||
154848974|NCT01656434|558877160|FG000|Overall Study|Study terminated by sponsor|1501|||
154848975|NCT01656434|558877161|FG001|Overall Study|Study terminated by sponsor|348|||
154848976|NCT01656434|558877160|FG000|Overall Study|Participant discontinued; drug related|13|||
154848977|NCT01656434|558877161|FG001|Overall Study|Participant discontinued; drug related|4|||
154848978|NCT01656434|558877160|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
154848979|NCT01656434|558877161|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
154848980|NCT01656434|558877160|FG000|Overall Study|Non-compliance with protocol|39|||
154848981|NCT01656434|558877161|FG001|Overall Study|Non-compliance with protocol|15|||
154848982|NCT01656434|558877160|FG000|Overall Study|Participant moved|40|||
154848983|NCT01656434|558877161|FG001|Overall Study|Participant moved|12|||
154848984|NCT01656434|558877160|FG000|Overall Study|Participant withdrew consent|28|||
154848985|NCT01656434|558877161|FG001|Overall Study|Participant withdrew consent|9|||
154848986|NCT01656434|558877160|FG000|Overall Study|Withdrawal by Subject|64|||
154848987|NCT01656434|558877161|FG001|Overall Study|Withdrawal by Subject|7|||
154848988|NCT01727258|558877162|FG000|Overall Study|Adverse Event|0|||
154848989|NCT01727258|558877163|FG001|Overall Study|Adverse Event|2|||
154848990|NCT01727258|558877164|FG002|Overall Study|Adverse Event|0|||
154848991|NCT01727258|558877162|FG000|Overall Study|Noncompliance with Study Drug|0|||
154848992|NCT01727258|558877163|FG001|Overall Study|Noncompliance with Study Drug|0|||
154848993|NCT01727258|558877164|FG002|Overall Study|Noncompliance with Study Drug|1|||
154848994|NCT01727258|558877162|FG000|Overall Study|Withdrawal by Subject|1|||
154848995|NCT01727258|558877163|FG001|Overall Study|Withdrawal by Subject|1|||
154848996|NCT01727258|558877164|FG002|Overall Study|Withdrawal by Subject|0|||
154848997|NCT01727258|558877162|FG000|Overall Study|Lost to Follow-up|1|||
154848998|NCT01727258|558877163|FG001|Overall Study|Lost to Follow-up|0|||
154848999|NCT01727258|558877164|FG002|Overall Study|Lost to Follow-up|0|||
154849000|NCT01818726|558877175|FG000|Overall Study|Administrative reasons|5|||
154849001|NCT01818726|558877176|FG001|Overall Study|Administrative reasons|1|||
155105290|NCT03012828|559815566|FG005|Overall Study|Delay to last visit would delay DBL|1|||
155105291|NCT04599803|559815567|FG000|Overall Study|Withdrawal by Subject|5|||
155105292|NCT04599803|559815567|FG000|Overall Study|Lost to Follow-up|26|||
155105293|NCT02544750|559815568|FG000|Overall Study|Physician Decision|3|||
155105294|NCT02544750|559815569|FG001|Overall Study|Physician Decision|1|||
155105295|NCT02544750|559815568|FG000|Overall Study|Other reasons|69|||
155105296|NCT02544750|559815569|FG001|Overall Study|Other reasons|39|||
155105297|NCT02544750|559815568|FG000|Overall Study|Met withdrawal criteria|2|||
154849002|NCT01818726|558877175|FG000|Overall Study|Withdrawal by Subject|0|||
154849003|NCT01818726|558877176|FG001|Overall Study|Withdrawal by Subject|1|||
154849004|NCT01818726|558877175|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
154849005|NCT01818726|558877176|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
154849006|NCT00993928|558877182|FG000|Overall Study|Withdrawal by Subject|4|||
154849007|NCT00993928|558877183|FG001|Overall Study|Withdrawal by Subject|7|||
154849008|NCT00993928|558877182|FG000|Overall Study|ineligible|1|||
154849009|NCT00993928|558877183|FG001|Overall Study|ineligible|0|||
154849010|NCT04871711|558877184|FG000|Overall Study|Withdrawal by Subject|11|||
154849011|NCT04871711|558877185|FG001|Overall Study|Withdrawal by Subject|5|||
154849012|NCT04871711|558877184|FG000|Overall Study|Lack of Efficacy|5|||
154849013|NCT04871711|558877185|FG001|Overall Study|Lack of Efficacy|7|||
154849014|NCT04871711|558877184|FG000|Overall Study|Adverse Event|2|||
154849015|NCT04871711|558877185|FG001|Overall Study|Adverse Event|6|||
154849016|NCT04871711|558877184|FG000|Overall Study|Various reasons|2|||
154849017|NCT04871711|558877185|FG001|Overall Study|Various reasons|1|||
154849018|NCT04871711|558877184|FG000|Overall Study|Lost to Follow-up|0|||
154849019|NCT04871711|558877185|FG001|Overall Study|Lost to Follow-up|2|||
154849020|NCT01920711|558877186|FG000|Overall Study|Death|347|||
154849021|NCT01920711|558877187|FG001|Overall Study|Death|356|||
154849022|NCT01920711|558877186|FG000|Overall Study|Lost to Follow-up|13|||
154849023|NCT01920711|558877187|FG001|Overall Study|Lost to Follow-up|14|||
154849024|NCT01920711|558877186|FG000|Overall Study|Withdrawal by Subject|4|||
154849025|NCT01920711|558877187|FG001|Overall Study|Withdrawal by Subject|3|||
154849026|NCT02319044|558877189|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
154849027|NCT02319044|558877190|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
154849028|NCT02319044|558877191|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
154849029|NCT02319044|558877189|FG000|Overall Study|Withdrawal by Subject|3|||
154849030|NCT02319044|558877190|FG001|Overall Study|Withdrawal by Subject|3|||
154849031|NCT02319044|558877191|FG002|Overall Study|Withdrawal by Subject|6|||
154849032|NCT02319044|558877189|FG000|Overall Study|Condition under investigation worsened|100|||
154849033|NCT02319044|558877190|FG001|Overall Study|Condition under investigation worsened|50|||
154849034|NCT02319044|558877191|FG002|Overall Study|Condition under investigation worsened|46|||
154849035|NCT02319044|558877189|FG000|Overall Study|Adverse Event|17|||
154849036|NCT02319044|558877190|FG001|Overall Study|Adverse Event|2|||
154849037|NCT02319044|558877191|FG002|Overall Study|Adverse Event|8|||
154849038|NCT02319044|558877189|FG000|Overall Study|Study specific discontinuation criteria|2|||
154849039|NCT02319044|558877190|FG001|Overall Study|Study specific discontinuation criteria|2|||
154849040|NCT02319044|558877191|FG002|Overall Study|Study specific discontinuation criteria|1|||
154849041|NCT02319044|558877189|FG000|Overall Study|Not treated|0|||
154849042|NCT02319044|558877190|FG001|Overall Study|Not treated|2|||
154971424|NCT01710358|559318637|FG001|Rescue Period|Adverse Event|15|||
154971425|NCT01710358|559318638|FG002|Rescue Period|Adverse Event|0|||
154971426|NCT01710358|559318636|FG000|Rescue Period|Death|0|||
155105298|NCT02544750|559815569|FG001|Overall Study|Met withdrawal criteria|2|||
155105299|NCT02544750|559815568|FG000|Overall Study|Transition To Commercial Product|1|||
155105300|NCT02544750|559815569|FG001|Overall Study|Transition To Commercial Product|0|||
155105301|NCT02544750|559815568|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
155105302|NCT02544750|559815569|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
155105303|NCT02544750|559815568|FG000|Overall Study|Adverse Event|8|||
155105304|NCT02544750|559815569|FG001|Overall Study|Adverse Event|10|||
155105305|NCT02544750|559815568|FG000|Overall Study|Withdrawal by Subject|10|||
155105306|NCT02544750|559815569|FG001|Overall Study|Withdrawal by Subject|4|||
155105307|NCT02544750|559815568|FG000|Overall Study|Lost to Follow-up|1|||
155105308|NCT02544750|559815569|FG001|Overall Study|Lost to Follow-up|0|||
155105309|NCT02366923|559815570|FG000|Overall Study|Withdrawal by Subject|1|||
155105310|NCT02366923|559815570|FG000|Overall Study|Positive Slit Lamp Findings|2|||
155105311|NCT02366923|559815570|FG000|Overall Study|High Astigmatism|3|||
155105312|NCT04677543|559815571|FG000|Overall Study|Withdrawal by Subject|4|||
155105313|NCT04677543|559815572|FG001|Overall Study|Withdrawal by Subject|1|||
155105314|NCT04677543|559815571|FG000|Overall Study|Physician Decision|0|||
155105315|NCT04677543|559815572|FG001|Overall Study|Physician Decision|1|||
155105316|NCT04677543|559815571|FG000|Overall Study|Adverse Event|0|||
155105317|NCT04677543|559815572|FG001|Overall Study|Adverse Event|1|||
155105318|NCT02520388|559815575|FG000|Overall Study|Physician Decision|1|||
155105319|NCT02520388|559815576|FG001|Overall Study|Physician Decision|0|||
155105320|NCT02520388|559815575|FG000|Overall Study|Subject or parent/guardian request|0|||
155105321|NCT02520388|559815576|FG001|Overall Study|Subject or parent/guardian request|6|||
155105322|NCT02520388|559815575|FG000|Overall Study|Adverse Event|1|||
155105323|NCT02520388|559815576|FG001|Overall Study|Adverse Event|4|||
155105324|NCT02520388|559815575|FG000|Overall Study|Lost to Follow-up|3|||
155105325|NCT02520388|559815576|FG001|Overall Study|Lost to Follow-up|2|||
155105326|NCT02520388|559815575|FG000|Overall Study|Other (reason not defined)|4|||
155105327|NCT02520388|559815576|FG001|Overall Study|Other (reason not defined)|4|||
155105328|NCT01437111|559815577|FG000|Overall Study|Adverse Event|2|||
155105329|NCT01437111|559815577|FG000|Overall Study|Withdrawal by Subject|4|||
155105330|NCT01437111|559815577|FG000|Overall Study|Not reported|5|||
154849043|NCT02319044|558877191|FG002|Overall Study|Not treated|2|||
154849044|NCT02026063|558877194|FG000|Overall Study|Physician Decision|0|||
154849045|NCT02026063|558877195|FG001|Overall Study|Physician Decision|10|||
154849046|NCT02026063|558877194|FG000|Overall Study|Noncompliance with Study Drug|1|||
154849047|NCT02026063|558877195|FG001|Overall Study|Noncompliance with Study Drug|1|||
155105331|NCT01437111|559815577|FG000|Overall Study|Physician Decision|1|||
154849048|NCT02026063|558877194|FG000|Overall Study|Withdrawal of Consent|1|||
154849049|NCT02026063|558877195|FG001|Overall Study|Withdrawal of Consent|6|||
154971427|NCT01710358|559318637|FG001|Rescue Period|Death|1|||
154849050|NCT02026063|558877194|FG000|Overall Study|Adverse Event|5|||
154849051|NCT02026063|558877195|FG001|Overall Study|Adverse Event|20|||
154849052|NCT02026063|558877194|FG000|Overall Study|Lack of Efficacy|0|||
154849053|NCT02026063|558877195|FG001|Overall Study|Lack of Efficacy|4|||
154849054|NCT02026063|558877194|FG000|Overall Study|Lost to Follow-up|0|||
154849055|NCT02026063|558877195|FG001|Overall Study|Lost to Follow-up|1|||
154849056|NCT02026063|558877194|FG000|Overall Study|Reason not Specified|2|||
154849057|NCT02026063|558877195|FG001|Overall Study|Reason not Specified|7|||
154849058|NCT02154087|558877197|FG000|Overall Study|Study Termination|1|||
154849059|NCT04556617|558877205|FG000|Overall Study|progressive disease|0|||
154849060|NCT04556617|558877206|FG001|Overall Study|progressive disease|2|||
154849061|NCT04556617|558877207|FG002|Overall Study|progressive disease|2|||
154849062|NCT04556617|558877208|FG003|Overall Study|progressive disease|1|||
154849063|NCT04556617|558877209|FG004|Overall Study|progressive disease|1|||
154849064|NCT04556617|558877205|FG000|Overall Study|Physician Decision|0|||
154849065|NCT04556617|558877206|FG001|Overall Study|Physician Decision|0|||
154849066|NCT04556617|558877207|FG002|Overall Study|Physician Decision|2|||
154849067|NCT04556617|558877208|FG003|Overall Study|Physician Decision|0|||
154849068|NCT04556617|558877209|FG004|Overall Study|Physician Decision|0|||
154849069|NCT04556617|558877205|FG000|Overall Study|Adverse Event|0|||
154849070|NCT04556617|558877206|FG001|Overall Study|Adverse Event|0|||
154849071|NCT04556617|558877207|FG002|Overall Study|Adverse Event|2|||
154849072|NCT04556617|558877208|FG003|Overall Study|Adverse Event|3|||
154849073|NCT04556617|558877209|FG004|Overall Study|Adverse Event|0|||
155105332|NCT01437111|559815577|FG000|Overall Study|Lost to Follow-up|5|||
155105333|NCT01437111|559815577|FG000|Overall Study|Protocol Violation|1|||
155105334|NCT02623205|559815578|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
155105335|NCT02623205|559815579|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
155105336|NCT02342288|559815580|FG000|Overall Study|no protocol anesthesiologist available|3|||
155105337|NCT02342288|559815581|FG001|Overall Study|no protocol anesthesiologist available|2|||
154849074|NCT04556617|558877205|FG000|Overall Study|Withdrawal by Subject|0|||
154849075|NCT04556617|558877206|FG001|Overall Study|Withdrawal by Subject|2|||
154849076|NCT04556617|558877207|FG002|Overall Study|Withdrawal by Subject|1|||
154849077|NCT04556617|558877208|FG003|Overall Study|Withdrawal by Subject|1|||
154849078|NCT04556617|558877209|FG004|Overall Study|Withdrawal by Subject|0|||
154849079|NCT04556617|558877205|FG000|Overall Study|PSA increase|0|||
154849080|NCT04556617|558877206|FG001|Overall Study|PSA increase|1|||
154849081|NCT04556617|558877207|FG002|Overall Study|PSA increase|0|||
154849082|NCT04556617|558877208|FG003|Overall Study|PSA increase|0|||
154849083|NCT04556617|558877209|FG004|Overall Study|PSA increase|0|||
154849084|NCT04556617|558877205|FG000|Overall Study|Sponsor study termination|1|||
154849085|NCT04556617|558877206|FG001|Overall Study|Sponsor study termination|0|||
154849086|NCT04556617|558877207|FG002|Overall Study|Sponsor study termination|0|||
154849087|NCT04556617|558877208|FG003|Overall Study|Sponsor study termination|0|||
154849088|NCT04556617|558877209|FG004|Overall Study|Sponsor study termination|0|||
154849089|NCT04949841|558877210|FG000|Overall Study|Adverse Event|7|||
154849090|NCT04949841|558877210|FG000|Overall Study|Death|1|||
154849091|NCT04949841|558877210|FG000|Overall Study|Withdrawal by Subject|52|||
154849092|NCT04949841|558877210|FG000|Overall Study|Pregnancy|4|||
154849093|NCT04949841|558877210|FG000|Overall Study|Lost to Follow-up|9|||
154849094|NCT04949841|558877210|FG000|Overall Study|Lack of Efficacy|55|||
154849095|NCT04949841|558877210|FG000|Overall Study|Various reasons|9|||
154849096|NCT05702736|558877213|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
154849097|NCT05702736|558877214|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
154849098|NCT05702736|558877213|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
154849099|NCT05702736|558877214|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
154849100|NCT04811716|558877217|FG000|Overall Study|Withdrawal by Subject|2|||
154849101|NCT04811716|558877218|FG001|Overall Study|Withdrawal by Subject|0|||
154849102|NCT00644787|558877219|FG000|Period 1: Titration Phase|Adverse Event|11|||
154849103|NCT00644787|558877220|FG001|Period 1: Titration Phase|Adverse Event|0|||
154971428|NCT01710358|559318638|FG002|Rescue Period|Death|0|||
154971429|NCT01710358|559318636|FG000|Rescue Period|Lack of Efficacy|0|||
154971430|NCT01710358|559318637|FG001|Rescue Period|Lack of Efficacy|7|||
155105338|NCT02342288|559815580|FG000|Overall Study|anesthesia leak in system|1|||
155105339|NCT02342288|559815581|FG001|Overall Study|anesthesia leak in system|0|||
154849104|NCT00644787|558877221|FG002|Period 1: Titration Phase|Adverse Event|0|||
154849105|NCT00644787|558877219|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
154849106|NCT00644787|558877220|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
154849107|NCT00644787|558877221|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
154849108|NCT00644787|558877219|FG000|Period 1: Titration Phase|Physician Decision|1|||
154849109|NCT00644787|558877220|FG001|Period 1: Titration Phase|Physician Decision|0|||
154849110|NCT00644787|558877221|FG002|Period 1: Titration Phase|Physician Decision|0|||
154849111|NCT00644787|558877219|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
154849112|NCT00644787|558877220|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
154849113|NCT00644787|558877221|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
154971431|NCT01710358|559318638|FG002|Rescue Period|Lack of Efficacy|0|||
154849114|NCT00644787|558877219|FG000|Period 1: Titration Phase|Worsening of complications|1|||
154849115|NCT00644787|558877220|FG001|Period 1: Titration Phase|Worsening of complications|0|||
154849116|NCT00644787|558877221|FG002|Period 1: Titration Phase|Worsening of complications|0|||
154849117|NCT00644787|558877219|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
154849118|NCT00644787|558877220|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
154849119|NCT00644787|558877221|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
154849120|NCT00644787|558877219|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
154849121|NCT00644787|558877220|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
154849122|NCT00644787|558877221|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
154849123|NCT00644787|558877219|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
155105340|NCT02342288|559815580|FG000|Overall Study|Withdrawal by Subject|1|||
154849124|NCT00644787|558877220|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
154849125|NCT00644787|558877221|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
154849126|NCT00644787|558877219|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
154849127|NCT00644787|558877220|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
154849128|NCT00644787|558877221|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
154849129|NCT00644787|558877219|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
154849130|NCT00644787|558877220|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
154849131|NCT00644787|558877221|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
154849132|NCT00644787|558877219|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
154849133|NCT00644787|558877220|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
154849134|NCT00644787|558877221|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
154849135|NCT00644787|558877219|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
154849136|NCT00644787|558877220|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
154849137|NCT00644787|558877221|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
154849138|NCT00546052|558877222|FG000|Overall Study|Adverse Event|47|||
154849139|NCT00546052|558877222|FG000|Overall Study|Lost to Follow-up|144|||
154849140|NCT00546052|558877222|FG000|Overall Study|Protocol Violation|9|||
154849141|NCT00546052|558877222|FG000|Overall Study|Withdrawal by Subject|20|||
154849142|NCT00546052|558877222|FG000|Overall Study|Non Compliance|7|||
154849143|NCT03048422|558877223|FG000|Overall Study|Death|1|||
154849144|NCT03048422|558877224|FG001|Overall Study|Death|0|||
154849145|NCT03048422|558877225|FG002|Overall Study|Death|0|||
154849146|NCT03048422|558877223|FG000|Overall Study|Lost to Follow-up|5|||
154849147|NCT03048422|558877224|FG001|Overall Study|Lost to Follow-up|0|||
154849148|NCT03048422|558877225|FG002|Overall Study|Lost to Follow-up|1|||
154849149|NCT03048422|558877223|FG000|Overall Study|Withdrawal by Subject|5|||
154849150|NCT03048422|558877224|FG001|Overall Study|Withdrawal by Subject|7|||
154849151|NCT03048422|558877225|FG002|Overall Study|Withdrawal by Subject|4|||
154849152|NCT03048422|558877223|FG000|Overall Study|Moved|3|||
154849153|NCT03048422|558877224|FG001|Overall Study|Moved|2|||
154849154|NCT03048422|558877225|FG002|Overall Study|Moved|2|||
154849155|NCT03048422|558877223|FG000|Overall Study|Noncompliant with Study Requirements|2|||
154849156|NCT03048422|558877224|FG001|Overall Study|Noncompliant with Study Requirements|1|||
154849157|NCT03048422|558877225|FG002|Overall Study|Noncompliant with Study Requirements|2|||
154849158|NCT03048422|558877223|FG000|Overall Study|Not Able to Get to Clinic|1|||
154849159|NCT03048422|558877224|FG001|Overall Study|Not Able to Get to Clinic|0|||
154849160|NCT03048422|558877225|FG002|Overall Study|Not Able to Get to Clinic|0|||
154849161|NCT00500682|558877226|FG000|Overall Study|Adverse Event|37|||
154849162|NCT00500682|558877227|FG001|Overall Study|Adverse Event|29|||
154849163|NCT00500682|558877226|FG000|Overall Study|Death|25|||
154849164|NCT00500682|558877227|FG001|Overall Study|Death|16|||
155105341|NCT02342288|559815581|FG001|Overall Study|Withdrawal by Subject|0|||
155105342|NCT02342288|559815580|FG000|Overall Study|coordinator contaminated with blood|0|||
155105343|NCT02342288|559815581|FG001|Overall Study|coordinator contaminated with blood|1|||
155105344|NCT02342288|559815580|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
155105345|NCT02342288|559815581|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
155105346|NCT02342288|559815580|FG000|Overall Study|coordinator not available|0|||
155105347|NCT02342288|559815581|FG001|Overall Study|coordinator not available|2|||
155105348|NCT02375373|559815583|FG000|Overall Study|Withdrawal by Subject|11|||
154849165|NCT00500682|558877226|FG000|Overall Study|Lost to Follow-up|11|||
154849166|NCT00500682|558877227|FG001|Overall Study|Lost to Follow-up|11|||
154849167|NCT00500682|558877226|FG000|Overall Study|Physician Decision|6|||
154849168|NCT00500682|558877227|FG001|Overall Study|Physician Decision|10|||
154849169|NCT00500682|558877226|FG000|Overall Study|Pregnancy|2|||
154849170|NCT00500682|558877227|FG001|Overall Study|Pregnancy|0|||
154849171|NCT00500682|558877226|FG000|Overall Study|Protocol Violation|1|||
155105349|NCT01445613|559815585|FG000|30-day Follow-up|Withdrawal by Subject|6|||
154849172|NCT00500682|558877227|FG001|Overall Study|Protocol Violation|3|||
154849173|NCT00500682|558877226|FG000|Overall Study|Withdrawal by Subject|80|||
154849174|NCT00500682|558877227|FG001|Overall Study|Withdrawal by Subject|74|||
154849175|NCT00500682|558877226|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
155105350|NCT01445613|559815585|FG000|30-day Follow-up|Physician Decision|3|||
155105351|NCT01445613|559815585|FG000|30-day Follow-up|Missed visit|23|||
155105352|NCT01445613|559815585|FG000|30-day Follow-up|Death|3|||
155105353|NCT01445613|559815585|FG000|1-year Follow-up|Withdrawal by Subject|12|||
155105354|NCT01445613|559815585|FG000|1-year Follow-up|Missed visit|29|||
155105355|NCT01445613|559815585|FG000|1-year Follow-up|Lost to Follow-up|2|||
155105356|NCT01445613|559815585|FG000|1-year Follow-up|Death|30|||
155105357|NCT01445613|559815585|FG000|1-year Follow-up|Physician Decision|2|||
155105358|NCT01445613|559815585|FG000|1-year Follow-up|Received a non-study stent|2|||
155105359|NCT03711370|559815586|FG000|Overall Study|Lost to Follow-up|16|||
155105360|NCT03711370|559815587|FG001|Overall Study|Lost to Follow-up|10|||
155105361|NCT03711370|559815586|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
155105362|NCT03711370|559815587|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
155105363|NCT01169701|559815588|FG000|Overall Study|Lost to Follow-up|1|||
155105364|NCT01169701|559815589|FG001|Overall Study|Lost to Follow-up|1|||
155105365|NCT01169701|559815588|FG000|Overall Study|Withdrawal by Subject|1|||
155105366|NCT01169701|559815589|FG001|Overall Study|Withdrawal by Subject|3|||
155105367|NCT01169701|559815588|FG000|Overall Study|Adverse Event|1|||
155105368|NCT01169701|559815589|FG001|Overall Study|Adverse Event|2|||
154849176|NCT00500682|558877227|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
154849177|NCT00772668|558877233|FG000|Overall Study|Physician Decision|3|||
154849178|NCT02002975|558878681|FG000|Overall Study|Case Report Forms Uncollected|135|||
154849179|NCT02002975|558878681|FG000|Overall Study|Protocol Deviation|437|||
154849180|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
154849181|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
154849182|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
154849183|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
154849184|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
154849185|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
154849186|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
154849187|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
154849188|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
154849189|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
154849190|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
154849191|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
154849192|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
154849193|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
154849194|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
154849195|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
154849196|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
154849197|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
154849198|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
154849199|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
154849200|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
154849201|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
154849202|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
154849203|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
154849204|NCT04660643|558878682|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
154849205|NCT04660643|558878683|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
155105369|NCT01169701|559815588|FG000|Overall Study|Exclusion criteria|2|||
155105370|NCT01169701|559815589|FG001|Overall Study|Exclusion criteria|0|||
155105371|NCT01169701|559815588|FG000|Overall Study|Death|0|||
155105372|NCT01169701|559815589|FG001|Overall Study|Death|1|||
155105373|NCT01169701|559815588|FG000|Overall Study|Administrative problems|0|||
155105374|NCT01169701|559815589|FG001|Overall Study|Administrative problems|1|||
155105375|NCT01169701|559815588|FG000|Overall Study|Serious adverse event|0|||
155105376|NCT01169701|559815589|FG001|Overall Study|Serious adverse event|1|||
155105377|NCT01169701|559815588|FG000|Overall Study|Sponsor decision|0|||
155105378|NCT01169701|559815589|FG001|Overall Study|Sponsor decision|1|||
155105379|NCT04188834|559815590|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
155105380|NCT00553436|559815591|FG000|Overall Study|Conversion to another procedure|1|||
154849206|NCT04660643|558878684|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
154849207|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
154849208|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
154849209|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
154849210|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
155105381|NCT02455336|559815594|FG000|Overall Study|Withdrawal by Subject|0|||
155105382|NCT02455336|559815595|FG001|Overall Study|Withdrawal by Subject|2|||
155105383|NCT02455336|559815594|FG000|Overall Study|Adverse Event|3|||
155105384|NCT02455336|559815595|FG001|Overall Study|Adverse Event|0|||
155105385|NCT02455336|559815594|FG000|Overall Study|Non-responder to treatment|2|||
155105386|NCT02455336|559815595|FG001|Overall Study|Non-responder to treatment|0|||
155105387|NCT00391430|559815596|FG000|Overall Study|Withdrawal by Subject|3|||
155105388|NCT00391430|559815597|FG001|Overall Study|Withdrawal by Subject|0|||
155105389|NCT00391430|559815598|FG002|Overall Study|Withdrawal by Subject|12|||
155105390|NCT03299244|559815599|FG000|Overall Study|Withdrawal by Subject|34|||
155105391|NCT03299244|559815600|FG001|Overall Study|Withdrawal by Subject|29|||
155105392|NCT03299244|559815599|FG000|Overall Study|Decision by Sponsor|4|||
155105393|NCT03299244|559815600|FG001|Overall Study|Decision by Sponsor|5|||
155105394|NCT03299244|559815599|FG000|Overall Study|Death|9|||
155105395|NCT03299244|559815600|FG001|Overall Study|Death|4|||
155105396|NCT02517398|559815604|FG000|Overall Study|Death|2|||
155105397|NCT02517398|559815605|FG001|Overall Study|Death|3|||
155105398|NCT02517398|559815606|FG002|Overall Study|Death|4|||
155105399|NCT02517398|559815607|FG003|Overall Study|Death|2|||
155105400|NCT02517398|559815608|FG004|Overall Study|Death|3|||
154849211|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
154849212|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
154849213|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
154849214|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
154849215|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
154849216|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
154849217|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
154849218|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
154849219|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
154849220|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
154849221|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
154849222|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
154849223|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
154849224|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
154849225|NCT04660643|558878682|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
154849226|NCT04660643|558878683|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
154849227|NCT04660643|558878684|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
154849228|NCT03988907|558878685|FG000|Overall Study|Unable to complete visit|0|||
154849229|NCT03988907|558878686|FG001|Overall Study|Unable to complete visit|1|||
154849230|NCT03609619|558878690|FG000|Overall Study|Adverse Event|1|||
154849231|NCT03609619|558878691|FG001|Overall Study|Adverse Event|0|||
154849232|NCT03609619|558878690|FG000|Overall Study|Lack of Efficacy|1|||
154849233|NCT03609619|558878691|FG001|Overall Study|Lack of Efficacy|2|||
154849234|NCT03609619|558878690|FG000|Overall Study|Protocol Violation|5|||
154849235|NCT03609619|558878691|FG001|Overall Study|Protocol Violation|0|||
154849236|NCT03609619|558878690|FG000|Overall Study|Withdrawal by Subject|2|||
154849237|NCT03609619|558878691|FG001|Overall Study|Withdrawal by Subject|3|||
154849238|NCT03609619|558878690|FG000|Overall Study|Lost to Follow-up|1|||
154849239|NCT03609619|558878691|FG001|Overall Study|Lost to Follow-up|1|||
154849240|NCT05162066|558878692|FG000|Overall Study|Adverse Event|1|||
154849241|NCT05162066|558878693|FG001|Overall Study|Adverse Event|0|||
154849242|NCT05162066|558878694|FG002|Overall Study|Adverse Event|0|||
154849243|NCT05162066|558878692|FG000|Overall Study|Perceived lack of efficacy|1|||
154849244|NCT05162066|558878693|FG001|Overall Study|Perceived lack of efficacy|0|||
154849245|NCT05162066|558878694|FG002|Overall Study|Perceived lack of efficacy|0|||
154849246|NCT00568555|558878695|FG000|Overall Study|Withdrawal by Subject|1|||
154849247|NCT00568555|558878696|FG001|Overall Study|Withdrawal by Subject|1|||
154849248|NCT01220414|558878697|FG000|Overall Study|Withdrawal by Subject|1|||
154849249|NCT01220414|558878698|FG001|Overall Study|Withdrawal by Subject|0|||
154849250|NCT01220414|558878699|FG002|Overall Study|Withdrawal by Subject|0|||
154849251|NCT01220414|558878700|FG003|Overall Study|Withdrawal by Subject|1|||
154849252|NCT00623831|558878703|FG000|Overall Study|Withdrawal by Subject|1|||
154849253|NCT00623831|558878704|FG001|Overall Study|Withdrawal by Subject|0|||
154849254|NCT00623831|558878703|FG000|Overall Study|Progressive Disease|0|||
154849255|NCT00623831|558878704|FG001|Overall Study|Progressive Disease|1|||
154849256|NCT01276821|558878705|FG000|Overall Study|Protocol Violation|0|||
154849257|NCT01276821|558878706|FG001|Overall Study|Protocol Violation|1|||
154849258|NCT03068325|558878707|FG000|Overall Study|Lost to Follow-up|5|||
155105401|NCT02517398|559815609|FG005|Overall Study|Death|8|||
155105402|NCT02517398|559815610|FG006|Overall Study|Death|3|||
154849259|NCT00066690|558878708|FG000|Overall Study|Adverse Event|145|||
154849260|NCT00066690|558878709|FG001|Overall Study|Adverse Event|58|||
154849261|NCT00066690|558878710|FG002|Overall Study|Adverse Event|126|||
154849262|NCT00066690|558878708|FG000|Overall Study|Death|3|||
154849263|NCT00066690|558878709|FG001|Overall Study|Death|0|||
154849264|NCT00066690|558878710|FG002|Overall Study|Death|2|||
154849265|NCT00066690|558878708|FG000|Overall Study|Lack of Efficacy|114|||
155105403|NCT02517398|559815611|FG007|Overall Study|Death|2|||
155105404|NCT02517398|559815612|FG008|Overall Study|Death|6|||
155105405|NCT02517398|559815613|FG009|Overall Study|Death|24|||
154849266|NCT00066690|558878709|FG001|Overall Study|Lack of Efficacy|110|||
154849267|NCT00066690|558878710|FG002|Overall Study|Lack of Efficacy|76|||
154849268|NCT00066690|558878708|FG000|Overall Study|Lost to Follow-up|40|||
154849269|NCT00066690|558878709|FG001|Overall Study|Lost to Follow-up|21|||
154849270|NCT00066690|558878710|FG002|Overall Study|Lost to Follow-up|29|||
154849271|NCT00066690|558878708|FG000|Overall Study|Withdrawal by Subject|50|||
154849272|NCT00066690|558878709|FG001|Overall Study|Withdrawal by Subject|55|||
154849273|NCT00066690|558878710|FG002|Overall Study|Withdrawal by Subject|49|||
154849274|NCT00066690|558878708|FG000|Overall Study|Treatment Ongoing|246|||
154849275|NCT00066690|558878709|FG001|Overall Study|Treatment Ongoing|278|||
154849276|NCT00066690|558878710|FG002|Overall Study|Treatment Ongoing|282|||
154849277|NCT02939131|558878711|FG000|Overall Study|Unable to get to clinic|6|||
154849278|NCT02939131|558878712|FG001|Overall Study|Unable to get to clinic|4|||
154849279|NCT02939131|558878711|FG000|Overall Study|Lost to Follow-up|2|||
154849280|NCT02939131|558878712|FG001|Overall Study|Lost to Follow-up|4|||
154849281|NCT02939131|558878711|FG000|Overall Study|severe debilitation|1|||
154849282|NCT02939131|558878712|FG001|Overall Study|severe debilitation|0|||
154849283|NCT02939131|558878711|FG000|Overall Study|Other|0|||
154849284|NCT02939131|558878712|FG001|Overall Study|Other|1|||
154849285|NCT02939131|558878711|FG000|Overall Study|not willing to adhere to protocol|2|||
154849286|NCT02939131|558878712|FG001|Overall Study|not willing to adhere to protocol|0|||
154849287|NCT03569202|558878716|FG000|Part 3|Physician Decision|1|||
154849288|NCT03569202|558878717|FG001|Part 3|Physician Decision|0|||
154849289|NCT03569202|558878716|FG000|Part 3|Other|1|||
154849290|NCT03569202|558878717|FG001|Part 3|Other|1|||
154849291|NCT01668654|558878718|FG000|Overall Study|Study Closed/Terminated|3|||
154849292|NCT01668654|558878718|FG000|Overall Study|Withdrawal by Subject|1|||
154849293|NCT02658448|558878719|FG000|Overall Study|Lost to Follow-up|1|||
154849294|NCT03634800|558878720|FG000|Overall Study|Adverse Event|1|||
154849295|NCT03634800|558878720|FG000|Overall Study|Disease Progression|4|||
154849296|NCT03634800|558878720|FG000|Overall Study|Withdrawal by Subject|1|||
154849297|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
154849298|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
154849299|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
154849300|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
154849301|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
154849302|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
154849303|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
154849304|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
154849305|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
154849306|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
154849307|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
154849308|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
154849309|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
154849310|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
154849311|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
154849312|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
154849313|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
154849314|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
154849315|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
154849316|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
154849317|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
154849318|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
154971432|NCT01710358|559318636|FG000|Rescue Period|Withdrawal by Subject|0|||
154971433|NCT01710358|559318637|FG001|Rescue Period|Withdrawal by Subject|8|||
154971434|NCT01710358|559318638|FG002|Rescue Period|Withdrawal by Subject|0|||
154971435|NCT03167606|559318644|FG000|Overall Study|Lost to Follow-up|73|||
154971436|NCT03167606|559318645|FG001|Overall Study|Lost to Follow-up|64|||
155105406|NCT02517398|559815614|FG010|Overall Study|Death|53|||
154971437|NCT03167606|559318644|FG000|Overall Study|Withdrawal by Subject|6|||
155105407|NCT02517398|559815615|FG011|Overall Study|Death|25|||
154849319|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
154849320|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
154849321|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Death|2|||
154849322|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Death|1|||
154849323|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Death|2|||
154849324|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Graft loss|0|||
154849325|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Graft loss|2|||
154849326|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Graft loss|0|||
154849327|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
154971438|NCT03167606|559318645|FG001|Overall Study|Withdrawal by Subject|5|||
155105408|NCT02517398|559815616|FG012|Overall Study|Death|73|||
155105409|NCT02517398|559815617|FG013|Overall Study|Death|29|||
155105410|NCT02517398|559815618|FG014|Overall Study|Death|26|||
155105411|NCT02517398|559815619|FG015|Overall Study|Death|23|||
155105412|NCT02517398|559815620|FG016|Overall Study|Death|26|||
155105413|NCT02517398|559815621|FG017|Overall Study|Death|25|||
155105414|NCT02517398|559815622|FG018|Overall Study|Death|22|||
155105415|NCT02517398|559815623|FG019|Overall Study|Death|7|||
155105416|NCT02517398|559815624|FG020|Overall Study|Death|26|||
155105417|NCT02517398|559815625|FG021|Overall Study|Death|30|||
155105418|NCT02517398|559815626|FG022|Overall Study|Death|20|||
155105419|NCT02517398|559815604|FG000|Overall Study|Other|0|||
155105420|NCT02517398|559815605|FG001|Overall Study|Other|0|||
155105421|NCT02517398|559815606|FG002|Overall Study|Other|0|||
155105422|NCT02517398|559815607|FG003|Overall Study|Other|1|||
155105423|NCT02517398|559815608|FG004|Overall Study|Other|0|||
155105424|NCT02517398|559815609|FG005|Overall Study|Other|0|||
155105425|NCT02517398|559815610|FG006|Overall Study|Other|0|||
155105426|NCT02517398|559815611|FG007|Overall Study|Other|0|||
154971439|NCT03167606|559318644|FG000|Overall Study|Withdrawal by Investigator|0|||
154971440|NCT03167606|559318645|FG001|Overall Study|Withdrawal by Investigator|2|||
155105427|NCT02517398|559815612|FG008|Overall Study|Other|0|||
155105428|NCT02517398|559815613|FG009|Overall Study|Other|1|||
155105429|NCT02517398|559815614|FG010|Overall Study|Other|0|||
154849328|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
154849329|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
154849330|NCT01114529|558878721|FG000|Completed Study Medication at Month 24|Missing|2|||
154849331|NCT01114529|558878722|FG001|Completed Study Medication at Month 24|Missing|0|||
154849332|NCT01114529|558878723|FG002|Completed Study Medication at Month 24|Missing|0|||
154849333|NCT01114529|558878721|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
154849334|NCT01114529|558878722|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
154849335|NCT01114529|558878723|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
154849336|NCT01114529|558878721|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
154849337|NCT01114529|558878722|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
154849338|NCT01114529|558878723|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
154849339|NCT01114529|558878721|FG000|Completed Study Phase at Month 24|Death|8|||
154849340|NCT01114529|558878722|FG001|Completed Study Phase at Month 24|Death|5|||
154849341|NCT01114529|558878723|FG002|Completed Study Phase at Month 24|Death|4|||
154849342|NCT01114529|558878721|FG000|Completed Study Phase at Month 24|Other|2|||
154849343|NCT01114529|558878722|FG001|Completed Study Phase at Month 24|Other|0|||
154849344|NCT01114529|558878723|FG002|Completed Study Phase at Month 24|Other|0|||
154849345|NCT01114529|558878721|FG000|Completed Study Phase at Month 24|Missing|2|||
154849346|NCT01114529|558878722|FG001|Completed Study Phase at Month 24|Missing|0|||
154849347|NCT01114529|558878723|FG002|Completed Study Phase at Month 24|Missing|0|||
154849348|NCT01235962|558878725|FG000|Overall Study|Withdrawal by Subject|20|||
154849349|NCT01235962|558878726|FG001|Overall Study|Withdrawal by Subject|19|||
154849350|NCT01235962|558878727|FG002|Overall Study|Withdrawal by Subject|62|||
154849351|NCT01235962|558878728|FG003|Overall Study|Withdrawal by Subject|49|||
154849352|NCT01235962|558878725|FG000|Overall Study|Lost to Follow-up|21|||
154849353|NCT01235962|558878726|FG001|Overall Study|Lost to Follow-up|16|||
154849354|NCT01235962|558878727|FG002|Overall Study|Lost to Follow-up|47|||
154849355|NCT01235962|558878728|FG003|Overall Study|Lost to Follow-up|32|||
154849356|NCT01235962|558878725|FG000|Overall Study|Physician Decision|5|||
154849357|NCT01235962|558878726|FG001|Overall Study|Physician Decision|0|||
154849358|NCT01235962|558878727|FG002|Overall Study|Physician Decision|9|||
154849359|NCT01235962|558878728|FG003|Overall Study|Physician Decision|5|||
154849360|NCT01580397|558878729|FG000|Overall Study|Lack of Efficacy|14|||
154849361|NCT02883244|558878730|FG000|Overall Study|Lost to Follow-up|0|||
154849362|NCT02883244|558878731|FG001|Overall Study|Lost to Follow-up|1|||
154849363|NCT02435914|558878732|FG000|Overall Study|Ocular Adverse Event|1|||
154849364|NCT02435914|558878733|FG001|Overall Study|Ocular Adverse Event|0|||
154849365|NCT02435914|558878734|FG002|Overall Study|Ocular Adverse Event|0|||
154849366|NCT02435914|558878735|FG003|Overall Study|Ocular Adverse Event|0|||
154849367|NCT02435914|558878732|FG000|Overall Study|Withdrawal by Subject|0|||
154849368|NCT02435914|558878733|FG001|Overall Study|Withdrawal by Subject|1|||
154849369|NCT02435914|558878734|FG002|Overall Study|Withdrawal by Subject|0|||
155105430|NCT02517398|559815615|FG011|Overall Study|Other|0|||
154849370|NCT02435914|558878735|FG003|Overall Study|Withdrawal by Subject|0|||
155105431|NCT02517398|559815616|FG012|Overall Study|Other|0|||
154849371|NCT02435914|558878732|FG000|Overall Study|Other Miscellaneous Reason|0|||
154849372|NCT02435914|558878733|FG001|Overall Study|Other Miscellaneous Reason|0|||
154971441|NCT03314857|559318646|FG000|Overall Study|Death|4|||
155105432|NCT02517398|559815617|FG013|Overall Study|Other|1|||
155105433|NCT02517398|559815618|FG014|Overall Study|Other|0|||
155105434|NCT02517398|559815619|FG015|Overall Study|Other|1|||
155105435|NCT02517398|559815620|FG016|Overall Study|Other|1|||
155105436|NCT02517398|559815621|FG017|Overall Study|Other|0|||
155105437|NCT02517398|559815622|FG018|Overall Study|Other|0|||
155105438|NCT02517398|559815623|FG019|Overall Study|Other|1|||
155105439|NCT02517398|559815624|FG020|Overall Study|Other|0|||
155105440|NCT02517398|559815625|FG021|Overall Study|Other|0|||
155105441|NCT02517398|559815626|FG022|Overall Study|Other|0|||
155105442|NCT02517398|559815604|FG000|Overall Study|Lost to Follow-up|0|||
155105443|NCT02517398|559815605|FG001|Overall Study|Lost to Follow-up|0|||
155105444|NCT02517398|559815606|FG002|Overall Study|Lost to Follow-up|0|||
155105445|NCT02517398|559815607|FG003|Overall Study|Lost to Follow-up|0|||
155105446|NCT02517398|559815608|FG004|Overall Study|Lost to Follow-up|0|||
155105447|NCT02517398|559815609|FG005|Overall Study|Lost to Follow-up|0|||
155105448|NCT02517398|559815610|FG006|Overall Study|Lost to Follow-up|0|||
155105449|NCT02517398|559815611|FG007|Overall Study|Lost to Follow-up|0|||
155105450|NCT02517398|559815612|FG008|Overall Study|Lost to Follow-up|0|||
155105451|NCT02517398|559815613|FG009|Overall Study|Lost to Follow-up|1|||
155105452|NCT02517398|559815614|FG010|Overall Study|Lost to Follow-up|0|||
155105453|NCT02517398|559815615|FG011|Overall Study|Lost to Follow-up|2|||
155105454|NCT02517398|559815616|FG012|Overall Study|Lost to Follow-up|2|||
155105455|NCT02517398|559815617|FG013|Overall Study|Lost to Follow-up|0|||
155105456|NCT02517398|559815618|FG014|Overall Study|Lost to Follow-up|1|||
155105457|NCT02517398|559815619|FG015|Overall Study|Lost to Follow-up|1|||
155105458|NCT02517398|559815620|FG016|Overall Study|Lost to Follow-up|0|||
155105459|NCT02517398|559815621|FG017|Overall Study|Lost to Follow-up|3|||
155105460|NCT02517398|559815622|FG018|Overall Study|Lost to Follow-up|1|||
155105461|NCT02517398|559815623|FG019|Overall Study|Lost to Follow-up|0|||
155105462|NCT02517398|559815624|FG020|Overall Study|Lost to Follow-up|1|||
155105463|NCT02517398|559815625|FG021|Overall Study|Lost to Follow-up|0|||
155105464|NCT02517398|559815626|FG022|Overall Study|Lost to Follow-up|2|||
155105465|NCT02517398|559815604|FG000|Overall Study|Withdrew Consent|0|||
155105466|NCT02517398|559815605|FG001|Overall Study|Withdrew Consent|0|||
155105467|NCT02517398|559815606|FG002|Overall Study|Withdrew Consent|0|||
155105468|NCT02517398|559815607|FG003|Overall Study|Withdrew Consent|0|||
155105469|NCT02517398|559815608|FG004|Overall Study|Withdrew Consent|0|||
155105470|NCT02517398|559815609|FG005|Overall Study|Withdrew Consent|0|||
155105471|NCT02517398|559815610|FG006|Overall Study|Withdrew Consent|1|||
155105472|NCT02517398|559815611|FG007|Overall Study|Withdrew Consent|0|||
155105473|NCT02517398|559815612|FG008|Overall Study|Withdrew Consent|0|||
155105474|NCT02517398|559815613|FG009|Overall Study|Withdrew Consent|2|||
155105475|NCT02517398|559815614|FG010|Overall Study|Withdrew Consent|7|||
155105476|NCT02517398|559815615|FG011|Overall Study|Withdrew Consent|1|||
155105477|NCT02517398|559815616|FG012|Overall Study|Withdrew Consent|5|||
155105478|NCT02517398|559815617|FG013|Overall Study|Withdrew Consent|4|||
155105479|NCT02517398|559815618|FG014|Overall Study|Withdrew Consent|2|||
155105480|NCT02517398|559815619|FG015|Overall Study|Withdrew Consent|5|||
155105481|NCT02517398|559815620|FG016|Overall Study|Withdrew Consent|4|||
154849373|NCT02435914|558878734|FG002|Overall Study|Other Miscellaneous Reason|1|||
154849374|NCT02435914|558878735|FG003|Overall Study|Other Miscellaneous Reason|0|||
154849375|NCT01405053|558878736|FG000|Overall Study|Adverse Event|3|||
154849376|NCT01405053|558878737|FG001|Overall Study|Adverse Event|0|||
154849377|NCT01405053|558878736|FG000|Overall Study|Lost to Follow-up|0|||
154849378|NCT01405053|558878737|FG001|Overall Study|Lost to Follow-up|1|||
154849379|NCT01405053|558878736|FG000|Overall Study|Participant choice|2|||
154849380|NCT01405053|558878737|FG001|Overall Study|Participant choice|1|||
154849381|NCT01405053|558878736|FG000|Overall Study|Inadequate therapeutic effect|2|||
154849382|NCT01405053|558878737|FG001|Overall Study|Inadequate therapeutic effect|1|||
154849383|NCT01405053|558878736|FG000|Overall Study|Withdrawal by Subject|3|||
154849384|NCT01405053|558878737|FG001|Overall Study|Withdrawal by Subject|4|||
154849385|NCT01405053|558878736|FG000|Overall Study|Other|0|||
154849386|NCT01405053|558878737|FG001|Overall Study|Other|1|||
154849387|NCT00464178|558878745|FG000|Overall Study|Protocol Violation|1|||
154849388|NCT00464178|558878745|FG000|Overall Study|Withdrawal by Subject|1|||
154849389|NCT01972074|558878752|FG000|Overall Study|Adverse Event|4|||
154849390|NCT01972074|558878753|FG001|Overall Study|Adverse Event|1|||
154849391|NCT01972074|558878754|FG002|Overall Study|Adverse Event|0|||
154849392|NCT01972074|558878752|FG000|Overall Study|Lack of Efficacy|1|||
154849393|NCT01972074|558878753|FG001|Overall Study|Lack of Efficacy|1|||
154849394|NCT01972074|558878754|FG002|Overall Study|Lack of Efficacy|0|||
154849395|NCT01972074|558878752|FG000|Overall Study|Lost to Follow-up|0|||
154849396|NCT01972074|558878753|FG001|Overall Study|Lost to Follow-up|1|||
154849397|NCT01972074|558878754|FG002|Overall Study|Lost to Follow-up|1|||
154849398|NCT01972074|558878752|FG000|Overall Study|Withdrawal by Subject|1|||
154849399|NCT01972074|558878753|FG001|Overall Study|Withdrawal by Subject|1|||
154849400|NCT01972074|558878754|FG002|Overall Study|Withdrawal by Subject|1|||
154849401|NCT01972074|558878752|FG000|Overall Study|Scanner Unavailable|0|||
154849402|NCT01972074|558878753|FG001|Overall Study|Scanner Unavailable|0|||
154849403|NCT01972074|558878754|FG002|Overall Study|Scanner Unavailable|1|||
154849404|NCT03687502|558878760|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
154849405|NCT03687502|558878760|FG000|Overall Study|Lumason not available|1|||
154849406|NCT00486278|558878762|FG000|Overall Study|Adverse Event|5|||
154849407|NCT00486278|558878762|FG000|Overall Study|Withdrawal by Subject|2|||
154849408|NCT00486278|558878762|FG000|Overall Study|Physician Decision|2|||
154849409|NCT02183519|558878768|FG000|Overall Study|computer error|3|||
154849410|NCT02183519|558878769|FG001|Overall Study|computer error|0|||
154849411|NCT02183519|558878768|FG000|Overall Study|Did not respond to cough inducter|0|||
154849412|NCT02183519|558878769|FG001|Overall Study|Did not respond to cough inducter|3|||
154849413|NCT01777581|558878771|FG000|Overall Study|Lost to Follow-up|1|||
154849414|NCT01777581|558878772|FG001|Overall Study|Lost to Follow-up|1|||
154849415|NCT01777581|558878771|FG000|Overall Study|Adverse Event|2|||
154849416|NCT01777581|558878772|FG001|Overall Study|Adverse Event|0|||
154849417|NCT01777581|558878771|FG000|Overall Study|Lack of Efficacy|0|||
154849418|NCT01777581|558878772|FG001|Overall Study|Lack of Efficacy|1|||
154849419|NCT05168267|558878773|FG000|Overall Study|Withdrawal by Subject|2|||
154849420|NCT05168267|558878774|FG001|Overall Study|Withdrawal by Subject|1|||
154849421|NCT05168267|558878773|FG000|Overall Study|Withdrawn by Therapist|1|||
154849422|NCT05168267|558878774|FG001|Overall Study|Withdrawn by Therapist|1|||
154849423|NCT05168267|558878773|FG000|Overall Study|Left Facility|1|||
154849424|NCT05168267|558878774|FG001|Overall Study|Left Facility|0|||
155105482|NCT02517398|559815621|FG017|Overall Study|Withdrew Consent|2|||
155105483|NCT02517398|559815622|FG018|Overall Study|Withdrew Consent|3|||
155105484|NCT02517398|559815623|FG019|Overall Study|Withdrew Consent|2|||
155105485|NCT02517398|559815624|FG020|Overall Study|Withdrew Consent|9|||
155105486|NCT02517398|559815625|FG021|Overall Study|Withdrew Consent|3|||
155105487|NCT02517398|559815626|FG022|Overall Study|Withdrew Consent|1|||
155105488|NCT01154452|559815633|FG000|Phase Ib|Not Treated|1|||
155105489|NCT01154452|559815634|FG001|Phase Ib|Not Treated|0|||
155173561|NCT03642132|560074828|FG000|Chemotherapy Period|Adverse Event|1|||
154849425|NCT02887521|558878775|FG000|Overall Study|Withdrawal by Subject|0|||
155105490|NCT01154452|559815635|FG002|Phase Ib|Not Treated|0|||
155105491|NCT01154452|559815636|FG003|Phase Ib|Not Treated|0|||
155105492|NCT01154452|559815633|FG000|Phase Ib|Adverse Event|2|||
154849426|NCT02887521|558878776|FG001|Overall Study|Withdrawal by Subject|3|||
154849427|NCT02937350|558878777|FG000|Overall Study|Withdrawal by Subject|0|||
154849428|NCT02937350|558878778|FG001|Overall Study|Withdrawal by Subject|1|||
154849429|NCT02937350|558878779|FG002|Overall Study|Withdrawal by Subject|0|||
154849430|NCT00695565|558878780|FG000|Overall Study|Lost to Follow-up|4|||
155105493|NCT01154452|559815634|FG001|Phase Ib|Adverse Event|1|||
155105494|NCT01154452|559815635|FG002|Phase Ib|Adverse Event|0|||
155105495|NCT01154452|559815636|FG003|Phase Ib|Adverse Event|0|||
154849431|NCT00695565|558878781|FG001|Overall Study|Lost to Follow-up|4|||
154849432|NCT00695565|558878780|FG000|Overall Study|Adverse Event|3|||
154849433|NCT00695565|558878781|FG001|Overall Study|Adverse Event|1|||
154849434|NCT00695565|558878780|FG000|Overall Study|Protocol Violation|3|||
154849435|NCT00695565|558878781|FG001|Overall Study|Protocol Violation|1|||
154849436|NCT00695565|558878780|FG000|Overall Study|Withdrawal by Subject|1|||
154849437|NCT00695565|558878781|FG001|Overall Study|Withdrawal by Subject|1|||
154849438|NCT00695565|558878780|FG000|Overall Study|Lack of Efficacy|1|||
154849439|NCT00695565|558878781|FG001|Overall Study|Lack of Efficacy|1|||
154849440|NCT00695565|558878780|FG000|Overall Study|Subject did not follow instructions|1|||
154849441|NCT00695565|558878781|FG001|Overall Study|Subject did not follow instructions|1|||
154849442|NCT01462266|558878782|FG000|Overall Study|Adverse Event|7|||
154849443|NCT01462266|558878783|FG001|Overall Study|Adverse Event|6|||
154849444|NCT01462266|558878782|FG000|Overall Study|Death|2|||
154849445|NCT01462266|558878783|FG001|Overall Study|Death|1|||
154849446|NCT01462266|558878782|FG000|Overall Study|Lack of Efficacy|0|||
154849447|NCT01462266|558878783|FG001|Overall Study|Lack of Efficacy|2|||
154849448|NCT01462266|558878782|FG000|Overall Study|Lost to Follow-up|4|||
154849449|NCT01462266|558878783|FG001|Overall Study|Lost to Follow-up|3|||
154849450|NCT01462266|558878782|FG000|Overall Study|Non-compliance with study drug|3|||
154849451|NCT01462266|558878783|FG001|Overall Study|Non-compliance with study drug|0|||
154849452|NCT01462266|558878782|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
154849453|NCT01462266|558878783|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
154849454|NCT01462266|558878782|FG000|Overall Study|Physician Decision|2|||
154849455|NCT01462266|558878783|FG001|Overall Study|Physician Decision|5|||
154849456|NCT01462266|558878782|FG000|Overall Study|Protocol Violation|1|||
154849457|NCT01462266|558878783|FG001|Overall Study|Protocol Violation|3|||
154849458|NCT01462266|558878782|FG000|Overall Study|Withdrawal by Subject|7|||
154849459|NCT01462266|558878783|FG001|Overall Study|Withdrawal by Subject|2|||
154849460|NCT01462266|558878782|FG000|Overall Study|Screen failure|1|||
154849461|NCT01462266|558878783|FG001|Overall Study|Screen failure|1|||
154849462|NCT01106846|558878784|FG000|Overall Study|Change in surgical procedure|0|||
154849463|NCT01106846|558878785|FG001|Overall Study|Change in surgical procedure|1|||
154849464|NCT03110900|558878799|FG000|Overall Study|Sponsor withdrew|1|||
154849465|NCT03110900|558878800|FG001|Overall Study|Sponsor withdrew|1|||
154849466|NCT02321436|558878801|FG000|Overall Study|Withdrawal by Subject|1|||
154849467|NCT02321436|558878802|FG001|Overall Study|Withdrawal by Subject|0|||
154849468|NCT02321436|558878801|FG000|Overall Study|Lost to Follow-up|0|||
154849469|NCT02321436|558878802|FG001|Overall Study|Lost to Follow-up|1|||
154849470|NCT03355300|558878803|FG000|Overall Study|Physician Decision|0|||
154849471|NCT03355300|558878804|FG001|Overall Study|Physician Decision|1|||
154849472|NCT03355300|558878803|FG000|Overall Study|Lack of Efficacy|2|||
154849473|NCT03355300|558878804|FG001|Overall Study|Lack of Efficacy|1|||
154849474|NCT03355300|558878803|FG000|Overall Study|Other reason|1|||
154849475|NCT03355300|558878804|FG001|Overall Study|Other reason|0|||
154849476|NCT02531646|558878819|FG000|Overall Study|equip. image processing issue|5|||
154849477|NCT02531646|558878820|FG001|Overall Study|equip. image processing issue|1|||
154849478|NCT02531646|558878821|FG002|Overall Study|equip. image processing issue|0|||
154849479|NCT03344003|558878822|FG000|Overall Study|Switched to alternative treatment|1|||
154849480|NCT03344003|558878823|FG001|Overall Study|Switched to alternative treatment|0|||
154849481|NCT03344003|558878822|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
154849482|NCT03344003|558878823|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
154849483|NCT01182428|558878824|FG000|Overall Study|Physician Decision|1|||
154849484|NCT01182428|558878825|FG001|Overall Study|Physician Decision|0|||
154849485|NCT01182428|558878824|FG000|Overall Study|Lost to Follow-up|9|||
154849486|NCT01182428|558878825|FG001|Overall Study|Lost to Follow-up|1|||
154849487|NCT01182428|558878824|FG000|Overall Study|Withdrawal by Subject|1|||
154849488|NCT01182428|558878825|FG001|Overall Study|Withdrawal by Subject|0|||
154849489|NCT05888103|558880166|FG000|Overall Study|Participant decision|3|||
154849490|NCT05888103|558880167|FG001|Overall Study|Participant decision|3|||
154849491|NCT05900115|558880168|FG000|Overall Study|Lost to Follow-up|129|||
154849492|NCT05900115|558880169|FG001|Overall Study|Lost to Follow-up|98|||
154849493|NCT02554929|558880170|FG000|Overall Study|Lost to Follow-up|4|||
154849494|NCT02554929|558880171|FG001|Overall Study|Lost to Follow-up|4|||
154849495|NCT02554929|558880170|FG000|Overall Study|Withdrawal by Subject|2|||
154849496|NCT02554929|558880171|FG001|Overall Study|Withdrawal by Subject|8|||
154849497|NCT01916980|558880172|FG000|Overall Study|Adverse Event|4|||
154971442|NCT03314857|559318646|FG000|Overall Study|Physician Decision|1|||
154971443|NCT00397254|559318649|FG000|Overall Study|Lost to Follow-up|2|||
154971444|NCT00397254|559318650|FG001|Overall Study|Lost to Follow-up|2|||
154849498|NCT01916980|558880173|FG001|Overall Study|Adverse Event|2|||
154849499|NCT01916980|558880172|FG000|Overall Study|Lack of Efficacy|2|||
154849500|NCT01916980|558880173|FG001|Overall Study|Lack of Efficacy|2|||
154849501|NCT01916980|558880172|FG000|Overall Study|Withdrawal by Subject|1|||
154849502|NCT01916980|558880173|FG001|Overall Study|Withdrawal by Subject|0|||
154849503|NCT02324270|558880174|FG000|Overall Study|Withdrawal by Subject|0|||
154849504|NCT02324270|558880175|FG001|Overall Study|Withdrawal by Subject|1|||
154849505|NCT02324270|558880176|FG002|Overall Study|Withdrawal by Subject|0|||
154849506|NCT02324270|558880174|FG000|Overall Study|Lost to Follow-up|4|||
154849507|NCT02324270|558880175|FG001|Overall Study|Lost to Follow-up|3|||
154849508|NCT02324270|558880176|FG002|Overall Study|Lost to Follow-up|4|||
154849509|NCT02324270|558880174|FG000|Overall Study|Protocol Violation|0|||
154849510|NCT02324270|558880175|FG001|Overall Study|Protocol Violation|1|||
154849511|NCT02324270|558880176|FG002|Overall Study|Protocol Violation|1|||
154849512|NCT02324270|558880174|FG000|Overall Study|Non Compliance with Study Drug|1|||
154849513|NCT02324270|558880175|FG001|Overall Study|Non Compliance with Study Drug|2|||
154849514|NCT02324270|558880176|FG002|Overall Study|Non Compliance with Study Drug|0|||
154849515|NCT03521791|558880177|FG000|Overall Study|Protocol Violation|7|||
154849516|NCT03521791|558880178|FG001|Overall Study|Protocol Violation|17|||
154849517|NCT00680836|558880180|FG000|Overall Study|Withdrawal by Subject|3|||
154849518|NCT00680836|558880181|FG001|Overall Study|Withdrawal by Subject|0|||
154849519|NCT00680836|558880180|FG000|Overall Study|Lost to Follow-up|3|||
154849520|NCT00680836|558880181|FG001|Overall Study|Lost to Follow-up|1|||
154849521|NCT00680836|558880180|FG000|Overall Study|Physician Decision|2|||
154849522|NCT00680836|558880181|FG001|Overall Study|Physician Decision|1|||
154849523|NCT03786432|558880182|FG000|Overall Study|Screen Failure after consent|1|||
154849524|NCT03786432|558880182|FG000|Overall Study|Lost to Follow-up|4|||
154849525|NCT03786432|558880182|FG000|Overall Study|did not complete 12 month CT scan|1|||
154849526|NCT00388947|558880183|FG000|Overall Study|Protocol Violation|47|||
154849527|NCT03038308|558880184|FG000|Overall Study|Surgical resection|1|||
154849528|NCT03038308|558880184|FG000|Overall Study|Withdrawal by Subject|2|||
154849529|NCT03038308|558880184|FG000|Overall Study|Lost to Follow-up|1|||
154849530|NCT04187092|558880185|FG000|Overall Study|Lost to Follow-up|1|||
154849531|NCT04187092|558880186|FG001|Overall Study|Lost to Follow-up|1|||
154849532|NCT04187092|558880185|FG000|Overall Study|Withdrawal by Subject|1|||
155105496|NCT01154452|559815633|FG000|Phase II|Withdrawal by Subject|0|||
155105497|NCT01154452|559815634|FG001|Phase II|Withdrawal by Subject|0|||
155105498|NCT01154452|559815635|FG002|Phase II|Withdrawal by Subject|1|||
154849533|NCT04187092|558880186|FG001|Overall Study|Withdrawal by Subject|1|||
154849534|NCT04187092|558880185|FG000|Overall Study|Adverse Event|0|||
154849535|NCT04187092|558880186|FG001|Overall Study|Adverse Event|1|||
154849536|NCT00771472|558880188|FG000|Overall Study|Physician Decision|2|||
154849537|NCT00771472|558880189|FG001|Overall Study|Physician Decision|3|||
154849538|NCT00771472|558880188|FG000|Overall Study|Progressive Disease|3|||
154849539|NCT00771472|558880189|FG001|Overall Study|Progressive Disease|1|||
154849540|NCT00771472|558880188|FG000|Overall Study|Protocol Violation|1|||
154849541|NCT00771472|558880189|FG001|Overall Study|Protocol Violation|0|||
154849542|NCT00880750|558880193|FG000|First Intervention|Adverse Event|1|||
154849543|NCT00880750|558880194|FG001|First Intervention|Adverse Event|0|||
154849544|NCT00880750|558880193|FG000|First Intervention|Unable to collect urine|4|||
154849545|NCT00880750|558880194|FG001|First Intervention|Unable to collect urine|0|||
154849546|NCT00880750|558880193|FG000|First Intervention|Non-compliance with meals|0|||
154849547|NCT00880750|558880194|FG001|First Intervention|Non-compliance with meals|1|||
154849548|NCT00880750|558880193|FG000|First Intervention|Withdrawal by Subject|2|||
154849549|NCT00880750|558880194|FG001|First Intervention|Withdrawal by Subject|0|||
154849550|NCT00880750|558880193|FG000|First Intervention|Lost to Follow-up|2|||
154849551|NCT00880750|558880194|FG001|First Intervention|Lost to Follow-up|0|||
154849552|NCT00880750|558880193|FG000|Second Intervention|Withdrawal by Subject|2|||
154849553|NCT00880750|558880194|FG001|Second Intervention|Withdrawal by Subject|2|||
154849554|NCT00880750|558880193|FG000|Second Intervention|Protocol Violation|1|||
154849555|NCT00880750|558880194|FG001|Second Intervention|Protocol Violation|0|||
154849556|NCT00880750|558880193|FG000|Second Intervention|Unable to collect urine|1|||
154849557|NCT00880750|558880194|FG001|Second Intervention|Unable to collect urine|0|||
154849558|NCT01246206|558880195|FG000|Overall Study|Patient did not receive study regiments.|1|||
154849559|NCT01231555|558880198|FG000|Overall Study|Study terminated|8|||
154849560|NCT01231555|558880199|FG001|Overall Study|Study terminated|5|||
154849561|NCT01231555|558880200|FG002|Overall Study|Study terminated|8|||
155105499|NCT01154452|559815636|FG003|Phase II|Withdrawal by Subject|2|||
155105500|NCT01154452|559815633|FG000|Phase II|Adverse Event|0|||
155105501|NCT01154452|559815634|FG001|Phase II|Adverse Event|0|||
154849562|NCT01231555|558880198|FG000|Overall Study|Withdrawal by Subject|0|||
154849563|NCT01231555|558880199|FG001|Overall Study|Withdrawal by Subject|2|||
154849564|NCT01231555|558880200|FG002|Overall Study|Withdrawal by Subject|0|||
154849565|NCT00688909|558880201|FG000|Overall Study|Adverse Event|28|||
154849566|NCT00688909|558880201|FG000|Overall Study|Patient withdrew consent|2|||
154849567|NCT00688909|558880201|FG000|Overall Study|Administrative problems|1|||
154849568|NCT00688909|558880201|FG000|Overall Study|Protocol Violation|2|||
154849569|NCT00669617|558880203|FG000|Period 1|Withdrawal by Subject|0|||
154849570|NCT00669617|558880204|FG001|Period 1|Withdrawal by Subject|0|||
154849571|NCT00669617|558880205|FG002|Period 1|Withdrawal by Subject|1|||
154849572|NCT00669617|558880206|FG003|Period 1|Withdrawal by Subject|0|||
154849573|NCT00669617|558880207|FG004|Period 1|Withdrawal by Subject|0|||
154849574|NCT00669617|558880203|FG000|Period 1|Protocol Deviation|0|||
155105502|NCT01154452|559815635|FG002|Phase II|Adverse Event|4|||
155105503|NCT01154452|559815636|FG003|Phase II|Adverse Event|4|||
154849575|NCT00669617|558880204|FG001|Period 1|Protocol Deviation|0|||
154849576|NCT00669617|558880205|FG002|Period 1|Protocol Deviation|0|||
154849577|NCT00669617|558880206|FG003|Period 1|Protocol Deviation|0|||
154849578|NCT00669617|558880207|FG004|Period 1|Protocol Deviation|1|||
154849579|NCT00669617|558880203|FG000|Period 3|Lost to Follow-up|1|||
154849580|NCT00669617|558880204|FG001|Period 3|Lost to Follow-up|0|||
154849581|NCT00669617|558880205|FG002|Period 3|Lost to Follow-up|0|||
154849582|NCT00669617|558880206|FG003|Period 3|Lost to Follow-up|0|||
154849583|NCT00669617|558880207|FG004|Period 3|Lost to Follow-up|0|||
154849584|NCT01748071|558880208|FG000|Overall Study|Adverse Event|2|||
154849585|NCT01748071|558880209|FG001|Overall Study|Adverse Event|2|||
154849586|NCT01748071|558880210|FG002|Overall Study|Adverse Event|0|||
154849587|NCT00700180|558880211|FG000|Overall Study|Death|99|||
154849588|NCT00700180|558880212|FG001|Overall Study|Death|114|||
154849589|NCT00700180|558880211|FG000|Overall Study|Alive on treatment|5|||
154849590|NCT00700180|558880212|FG001|Overall Study|Alive on treatment|3|||
154849591|NCT00700180|558880211|FG000|Overall Study|Alive in follow-up|46|||
154849592|NCT00700180|558880212|FG001|Overall Study|Alive in follow-up|27|||
154849593|NCT00700180|558880211|FG000|Overall Study|Lost to Follow-up|4|||
154849594|NCT00700180|558880212|FG001|Overall Study|Lost to Follow-up|5|||
154849595|NCT01613326|558880213|FG000|Overall Study|Adverse Event|7|||
154849596|NCT01613326|558880214|FG001|Overall Study|Adverse Event|5|||
154849597|NCT01613326|558880213|FG000|Overall Study|Withdrawal by Subject|3|||
154849598|NCT01613326|558880214|FG001|Overall Study|Withdrawal by Subject|4|||
154849599|NCT01613326|558880213|FG000|Overall Study|Abnormal test procedure result(s)|2|||
154849600|NCT01613326|558880214|FG001|Overall Study|Abnormal test procedure result(s)|0|||
154849601|NCT01613326|558880213|FG000|Overall Study|inability to use device|1|||
154849602|NCT01613326|558880214|FG001|Overall Study|inability to use device|0|||
154849603|NCT01613326|558880213|FG000|Overall Study|Lack of Efficacy|0|||
154849604|NCT01613326|558880214|FG001|Overall Study|Lack of Efficacy|1|||
154849605|NCT01613326|558880213|FG000|Overall Study|Lost to Follow-up|0|||
154849606|NCT01613326|558880214|FG001|Overall Study|Lost to Follow-up|1|||
154849607|NCT01613326|558880213|FG000|Overall Study|Administrative|0|||
154849608|NCT01613326|558880214|FG001|Overall Study|Administrative|2|||
154849609|NCT01613326|558880213|FG000|Overall Study|Protocol Violation|0|||
154849610|NCT01613326|558880214|FG001|Overall Study|Protocol Violation|1|||
154849611|NCT00420511|558880217|FG000|Overall Study|Adverse Event|1|||
154849612|NCT00420511|558880218|FG001|Overall Study|Adverse Event|1|||
154849613|NCT00420511|558880217|FG000|Overall Study|Lost to Follow-up|1|||
154849614|NCT00420511|558880218|FG001|Overall Study|Lost to Follow-up|0|||
154849615|NCT02415712|558880219|FG000|Overall Study|Protocol Violation|16|||
154849616|NCT04557384|558880220|FG000|Overall Study|Study Terminated by Sponsor|1|||
154849617|NCT04557384|558880220|FG000|Overall Study|Death|1|||
154849618|NCT00454779|558880221|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
154849619|NCT00454779|558880222|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
154849620|NCT00454779|558880221|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
154849621|NCT00454779|558880222|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
154849622|NCT00454779|558880221|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
154849623|NCT00454779|558880222|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
154849624|NCT00454779|558880221|FG000|First-line Treatment Phase|Protocol Violation|0|||
154849625|NCT00454779|558880222|FG001|First-line Treatment Phase|Protocol Violation|1|||
154849626|NCT00454779|558880221|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
154849627|NCT00454779|558880222|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
154849628|NCT00454779|558880221|FG000|First-line Treatment Phase|Ongoing|1|||
154849629|NCT00454779|558880222|FG001|First-line Treatment Phase|Ongoing|0|||
154849630|NCT00454779|558880221|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
154849631|NCT00454779|558880222|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
154849632|NCT00454779|558880221|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
154849633|NCT00454779|558880222|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
154849634|NCT00454779|558880221|FG000|Second-line Treatment Phase|Ongoing|0|||
154849635|NCT00454779|558880222|FG001|Second-line Treatment Phase|Ongoing|1|||
154849636|NCT01337973|558880224|FG000|Overall Study|Lost to Follow-up|2|||
154849637|NCT01337973|558880225|FG001|Overall Study|Lost to Follow-up|4|||
154849638|NCT01337973|558880226|FG002|Overall Study|Lost to Follow-up|3|||
154849639|NCT01337973|558880224|FG000|Overall Study|Death|1|||
154849640|NCT01337973|558880225|FG001|Overall Study|Death|2|||
154849641|NCT01337973|558880226|FG002|Overall Study|Death|1|||
154849642|NCT01337973|558880224|FG000|Overall Study|Withdrawal by Subject|10|||
154849643|NCT01337973|558880225|FG001|Overall Study|Withdrawal by Subject|8|||
154849644|NCT01337973|558880226|FG002|Overall Study|Withdrawal by Subject|4|||
154849645|NCT01337973|558880224|FG000|Overall Study|missing data on primary outcome|3|||
154849646|NCT01337973|558880225|FG001|Overall Study|missing data on primary outcome|1|||
154849647|NCT01337973|558880226|FG002|Overall Study|missing data on primary outcome|3|||
154849648|NCT02522767|558880229|FG000|Double-blind|Withdrawal by Subject|8|||
154849649|NCT02522767|558880230|FG001|Double-blind|Withdrawal by Subject|11|||
154849650|NCT02522767|558880229|FG000|Double-blind|Lost to Follow-up|1|||
154971445|NCT00152451|559318654|FG000|Overall Study|Adverse Event|4|||
154849651|NCT02522767|558880230|FG001|Double-blind|Lost to Follow-up|0|||
154849652|NCT02522767|558880229|FG000|Double-blind|Adverse Event|1|||
154849653|NCT02522767|558880230|FG001|Double-blind|Adverse Event|10|||
154849654|NCT02522767|558880229|FG000|Double-blind|Protocol Violation|0|||
154849655|NCT02522767|558880230|FG001|Double-blind|Protocol Violation|1|||
154849656|NCT02522767|558880229|FG000|Double-blind|Lack of Efficacy|0|||
154849657|NCT02522767|558880230|FG001|Double-blind|Lack of Efficacy|2|||
154849658|NCT02522767|558880229|FG000|Double-blind|Protocol Deviation|1|||
154849659|NCT02522767|558880230|FG001|Double-blind|Protocol Deviation|0|||
154849660|NCT02522767|558880229|FG000|Open-label|Withdrawal by Subject|2|||
154849661|NCT02522767|558880230|FG001|Open-label|Withdrawal by Subject|3|||
154849662|NCT02522767|558880229|FG000|Open-label|Lost to Follow-up|0|||
154849663|NCT02522767|558880230|FG001|Open-label|Lost to Follow-up|1|||
154849664|NCT02522767|558880229|FG000|Open-label|Adverse Event|2|||
154849665|NCT02522767|558880230|FG001|Open-label|Adverse Event|1|||
154849666|NCT02522767|558880229|FG000|Open-label|Lack of Efficacy|1|||
154849667|NCT02522767|558880230|FG001|Open-label|Lack of Efficacy|1|||
154849668|NCT02522767|558880229|FG000|Open-label|Protocol Violation|0|||
154849669|NCT02522767|558880230|FG001|Open-label|Protocol Violation|1|||
154849670|NCT00254566|558880231|FG000|Overall Study|Death|1|||
154849671|NCT00254566|558880232|FG001|Overall Study|Death|0|||
154849672|NCT00254566|558880231|FG000|Overall Study|Adverse Event|5|||
154849673|NCT00254566|558880232|FG001|Overall Study|Adverse Event|4|||
154849674|NCT00254566|558880231|FG000|Overall Study|Lack of Efficacy|12|||
154849675|NCT00254566|558880232|FG001|Overall Study|Lack of Efficacy|9|||
154849676|NCT00254566|558880231|FG000|Overall Study|Other|1|||
154849677|NCT00254566|558880232|FG001|Overall Study|Other|5|||
154849678|NCT00254566|558880231|FG000|Overall Study|Withdrawal by Subject|5|||
154849679|NCT00254566|558880232|FG001|Overall Study|Withdrawal by Subject|6|||
154849680|NCT00254566|558880231|FG000|Overall Study|Lost to Follow-up|7|||
154849681|NCT00254566|558880232|FG001|Overall Study|Lost to Follow-up|2|||
154849682|NCT00548548|558880234|FG000|Overall Study|Death|345|||
154849683|NCT00548548|558880235|FG001|Overall Study|Death|348|||
154849684|NCT00548548|558880234|FG000|Overall Study|Lost to Follow-up|17|||
154849685|NCT00548548|558880235|FG001|Overall Study|Lost to Follow-up|18|||
154849686|NCT01705691|558880238|FG000|Overall Study|Death|1|||
154849687|NCT01705691|558880239|FG001|Overall Study|Death|2|||
154849688|NCT01705691|558880238|FG000|Overall Study|Withdrawal by Subject|1|||
154849689|NCT01705691|558880239|FG001|Overall Study|Withdrawal by Subject|2|||
154849690|NCT01705691|558880238|FG000|Overall Study|Lost to Follow-up|1|||
154849691|NCT01705691|558880239|FG001|Overall Study|Lost to Follow-up|1|||
154849692|NCT01705691|558880238|FG000|Overall Study|Other|0|||
154849693|NCT01705691|558880239|FG001|Overall Study|Other|1|||
154849694|NCT00191451|558880240|FG000|Overall Study|Withdrawal by Subject|2|||
154849695|NCT00191451|558880241|FG001|Overall Study|Withdrawal by Subject|3|||
154849696|NCT00191451|558880242|FG002|Overall Study|Withdrawal by Subject|5|||
154849697|NCT00191451|558880240|FG000|Overall Study|Physician Decision|2|||
154849698|NCT00191451|558880241|FG001|Overall Study|Physician Decision|9|||
154849699|NCT00191451|558880242|FG002|Overall Study|Physician Decision|6|||
154849700|NCT00191451|558880240|FG000|Overall Study|Sponsor Decision|1|||
154849701|NCT00191451|558880241|FG001|Overall Study|Sponsor Decision|0|||
154849702|NCT00191451|558880242|FG002|Overall Study|Sponsor Decision|0|||
154849703|NCT00191451|558880240|FG000|Overall Study|Ineligible|0|||
154849704|NCT00191451|558880241|FG001|Overall Study|Ineligible|1|||
154849705|NCT00191451|558880242|FG002|Overall Study|Ineligible|0|||
154849706|NCT00191451|558880240|FG000|Overall Study|Reason Not Specified|2|||
154849707|NCT00191451|558880241|FG001|Overall Study|Reason Not Specified|1|||
154849708|NCT00191451|558880242|FG002|Overall Study|Reason Not Specified|3|||
154849709|NCT00272987|558880247|FG000|Overall Study|Adverse Event|1|||
154849710|NCT00272987|558880248|FG001|Overall Study|Adverse Event|0|||
154849711|NCT00272987|558880249|FG002|Overall Study|Adverse Event|0|||
154849712|NCT00272987|558880247|FG000|Overall Study|Lost to Follow-up|3|||
154849713|NCT00272987|558880248|FG001|Overall Study|Lost to Follow-up|1|||
154849714|NCT00272987|558880249|FG002|Overall Study|Lost to Follow-up|1|||
154849715|NCT00272987|558880247|FG000|Overall Study|Withdrawal by Subject|1|||
154849716|NCT00272987|558880248|FG001|Overall Study|Withdrawal by Subject|0|||
154849717|NCT00272987|558880249|FG002|Overall Study|Withdrawal by Subject|3|||
154849718|NCT00272987|558880247|FG000|Overall Study|Sponsor Terminated study|0|||
154849719|NCT00272987|558880248|FG001|Overall Study|Sponsor Terminated study|1|||
154849720|NCT00272987|558880249|FG002|Overall Study|Sponsor Terminated study|1|||
154849721|NCT00272987|558880247|FG000|Overall Study|Disease progression|1|||
154849722|NCT00272987|558880248|FG001|Overall Study|Disease progression|1|||
154849723|NCT00272987|558880249|FG002|Overall Study|Disease progression|2|||
154849724|NCT00272987|558880247|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
154849725|NCT00272987|558880248|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
154849726|NCT00272987|558880249|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
154849727|NCT00272987|558880247|FG000|Overall Study|Death|1|||
154849728|NCT00272987|558880248|FG001|Overall Study|Death|0|||
154849729|NCT00272987|558880249|FG002|Overall Study|Death|0|||
154849730|NCT02614079|558880250|FG000|Overall Study|Withdrawal by Subject|1|||
154849731|NCT03543410|558880254|FG000|Overall Study|Adverse Event|10|||
154849732|NCT03543410|558880255|FG001|Overall Study|Adverse Event|8|||
154849733|NCT03543410|558880256|FG002|Overall Study|Adverse Event|2|||
154849734|NCT03543410|558880254|FG000|Overall Study|Lack of Efficacy|0|||
154849735|NCT03543410|558880255|FG001|Overall Study|Lack of Efficacy|1|||
154849736|NCT03543410|558880256|FG002|Overall Study|Lack of Efficacy|0|||
154849737|NCT03543410|558880254|FG000|Overall Study|Lost to Follow-up|0|||
154971446|NCT00323258|559318657|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
154849738|NCT03543410|558880255|FG001|Overall Study|Lost to Follow-up|1|||
154849739|NCT03543410|558880256|FG002|Overall Study|Lost to Follow-up|0|||
154849740|NCT03543410|558880254|FG000|Overall Study|Withdrawal by Subject|5|||
154849741|NCT03543410|558880255|FG001|Overall Study|Withdrawal by Subject|2|||
154849742|NCT03543410|558880256|FG002|Overall Study|Withdrawal by Subject|8|||
154849743|NCT03543410|558880254|FG000|Overall Study|Protocol Violation|0|||
154849744|NCT03543410|558880255|FG001|Overall Study|Protocol Violation|1|||
154849745|NCT03543410|558880256|FG002|Overall Study|Protocol Violation|0|||
154849746|NCT03543410|558880254|FG000|Overall Study|Due to COVID-19|4|||
154849747|NCT03543410|558880255|FG001|Overall Study|Due to COVID-19|0|||
154849748|NCT03543410|558880256|FG002|Overall Study|Due to COVID-19|2|||
154849749|NCT03543410|558880254|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
154849750|NCT03543410|558880255|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
154849751|NCT03543410|558880256|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
154849752|NCT03543410|558880254|FG000|Overall Study|Not Due to COVID-19|2|||
154849753|NCT03543410|558880255|FG001|Overall Study|Not Due to COVID-19|0|||
154849754|NCT03543410|558880256|FG002|Overall Study|Not Due to COVID-19|1|||
154849755|NCT00130286|558880258|FG000|Overall Study|Withdrawal by Subject|0|||
154849756|NCT00130286|558880259|FG001|Overall Study|Withdrawal by Subject|1|||
154849757|NCT00130286|558880260|FG002|Overall Study|Withdrawal by Subject|2|||
154849758|NCT00130286|558880261|FG003|Overall Study|Withdrawal by Subject|2|||
154849759|NCT00130286|558880258|FG000|Overall Study|Adverse Event|0|||
154849760|NCT00130286|558880259|FG001|Overall Study|Adverse Event|0|||
154849761|NCT00130286|558880260|FG002|Overall Study|Adverse Event|2|||
154849762|NCT00130286|558880261|FG003|Overall Study|Adverse Event|0|||
154849763|NCT00130286|558880258|FG000|Overall Study|Missing lab specimens|0|||
154849764|NCT00130286|558880259|FG001|Overall Study|Missing lab specimens|2|||
154849765|NCT00130286|558880260|FG002|Overall Study|Missing lab specimens|0|||
154849766|NCT00130286|558880261|FG003|Overall Study|Missing lab specimens|0|||
154849767|NCT03604445|558880262|FG000|Overall Study|Death|0|||
154849768|NCT03604445|558880263|FG001|Overall Study|Death|0|||
154849769|NCT03604445|558880264|FG002|Overall Study|Death|0|||
154849770|NCT03604445|558880265|FG003|Overall Study|Death|0|||
154849771|NCT03604445|558880266|FG004|Overall Study|Death|0|||
154849772|NCT03604445|558880267|FG005|Overall Study|Death|0|||
154849773|NCT03604445|558880268|FG006|Overall Study|Death|0|||
154849774|NCT03604445|558880269|FG007|Overall Study|Death|0|||
154849775|NCT03604445|558880270|FG008|Overall Study|Death|1|||
154849776|NCT03604445|558880262|FG000|Overall Study|Withdrawal by Subject|0|||
154849777|NCT03604445|558880263|FG001|Overall Study|Withdrawal by Subject|0|||
154849778|NCT03604445|558880264|FG002|Overall Study|Withdrawal by Subject|0|||
154849779|NCT03604445|558880265|FG003|Overall Study|Withdrawal by Subject|0|||
154849780|NCT03604445|558880266|FG004|Overall Study|Withdrawal by Subject|0|||
154849781|NCT03604445|558880267|FG005|Overall Study|Withdrawal by Subject|0|||
154849782|NCT03604445|558880268|FG006|Overall Study|Withdrawal by Subject|1|||
154849783|NCT03604445|558880269|FG007|Overall Study|Withdrawal by Subject|0|||
154849784|NCT03604445|558880270|FG008|Overall Study|Withdrawal by Subject|0|||
154849785|NCT03604445|558880262|FG000|Overall Study|Missing visit|0|||
154849786|NCT03604445|558880263|FG001|Overall Study|Missing visit|0|||
154849787|NCT03604445|558880264|FG002|Overall Study|Missing visit|0|||
154849788|NCT03604445|558880265|FG003|Overall Study|Missing visit|0|||
154849789|NCT03604445|558880266|FG004|Overall Study|Missing visit|0|||
154849790|NCT03604445|558880267|FG005|Overall Study|Missing visit|1|||
154849791|NCT03604445|558880268|FG006|Overall Study|Missing visit|0|||
154849792|NCT03604445|558880269|FG007|Overall Study|Missing visit|1|||
154971447|NCT00323258|559318658|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
154971448|NCT00323258|559318657|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
154849793|NCT03604445|558880270|FG008|Overall Study|Missing visit|0|||
154849794|NCT03604445|558880262|FG000|Overall Study|Adverse Event|0|||
154849795|NCT03604445|558880263|FG001|Overall Study|Adverse Event|0|||
154849796|NCT03604445|558880264|FG002|Overall Study|Adverse Event|0|||
154849797|NCT03604445|558880265|FG003|Overall Study|Adverse Event|1|||
155105504|NCT00130039|559815637|FG000|Overall Study|Withdrawal by Subject|15|||
154849798|NCT03604445|558880266|FG004|Overall Study|Adverse Event|0|||
154849799|NCT03604445|558880267|FG005|Overall Study|Adverse Event|0|||
154849800|NCT03604445|558880268|FG006|Overall Study|Adverse Event|0|||
154849801|NCT03604445|558880269|FG007|Overall Study|Adverse Event|0|||
154849802|NCT03604445|558880270|FG008|Overall Study|Adverse Event|1|||
154849803|NCT00611247|558880273|FG000|Overall Study|Death|1|||
154849804|NCT00611247|558880274|FG001|Overall Study|Death|5|||
154849805|NCT00611247|558880273|FG000|Overall Study|Lack of Efficacy|1|||
154849806|NCT00611247|558880274|FG001|Overall Study|Lack of Efficacy|16|||
154849807|NCT00243659|558880275|FG000|Overall Study|Withdrawal by Subject|1|||
154849808|NCT00243659|558880276|FG001|Overall Study|Withdrawal by Subject|1|||
154849809|NCT00243659|558880275|FG000|Overall Study|Protocol Violation|1|||
154849810|NCT00243659|558880276|FG001|Overall Study|Protocol Violation|2|||
154849811|NCT01890421|558880277|FG000|Overall Study|Adverse Event|1|||
154849812|NCT01890421|558880277|FG000|Overall Study|Other reason|10|||
154849813|NCT00268242|558880278|FG000|Overall Study|Death|1|||
154849814|NCT01665144|558880279|FG000|Core Part|Withdrawal by Subject|96|||
154849815|NCT01665144|558880280|FG001|Core Part|Withdrawal by Subject|77|||
154849816|NCT01665144|558880281|FG002|Core Part|Withdrawal by Subject|0|||
154849817|NCT01665144|558880279|FG000|Core Part|Adverse Event|45|||
154849818|NCT01665144|558880280|FG001|Core Part|Adverse Event|18|||
154849819|NCT01665144|558880281|FG002|Core Part|Adverse Event|0|||
154849820|NCT01665144|558880279|FG000|Core Part|Lack of Efficacy|16|||
154849821|NCT01665144|558880280|FG001|Core Part|Lack of Efficacy|11|||
154849822|NCT01665144|558880281|FG002|Core Part|Lack of Efficacy|0|||
154849823|NCT01665144|558880279|FG000|Core Part|Lost to Follow-up|9|||
154849824|NCT01665144|558880280|FG001|Core Part|Lost to Follow-up|8|||
154849825|NCT01665144|558880281|FG002|Core Part|Lost to Follow-up|0|||
154849826|NCT01665144|558880279|FG000|Core Part|Physician Decision|13|||
154849827|NCT01665144|558880280|FG001|Core Part|Physician Decision|1|||
154849828|NCT01665144|558880281|FG002|Core Part|Physician Decision|0|||
154849829|NCT01665144|558880279|FG000|Core Part|Progressive disease|8|||
154849830|NCT01665144|558880280|FG001|Core Part|Progressive disease|4|||
154849831|NCT01665144|558880281|FG002|Core Part|Progressive disease|0|||
154849832|NCT01665144|558880279|FG000|Core Part|Non-compliance with study treatment|5|||
154849833|NCT01665144|558880280|FG001|Core Part|Non-compliance with study treatment|0|||
154849834|NCT01665144|558880281|FG002|Core Part|Non-compliance with study treatment|0|||
154849835|NCT01665144|558880279|FG000|Core Part|Death|3|||
154849836|NCT01665144|558880280|FG001|Core Part|Death|1|||
154849837|NCT01665144|558880281|FG002|Core Part|Death|0|||
154849838|NCT01665144|558880279|FG000|Core Part|Protocol deviation|3|||
154849839|NCT01665144|558880280|FG001|Core Part|Protocol deviation|1|||
154849840|NCT01665144|558880281|FG002|Core Part|Protocol deviation|0|||
154849841|NCT01665144|558880279|FG000|Core Part|New therapy for study indication|2|||
154849842|NCT01665144|558880280|FG001|Core Part|New therapy for study indication|1|||
154849843|NCT01665144|558880281|FG002|Core Part|New therapy for study indication|0|||
154849844|NCT01665144|558880279|FG000|Core Part|Technical problems|2|||
154849845|NCT01665144|558880280|FG001|Core Part|Technical problems|0|||
154849846|NCT01665144|558880281|FG002|Core Part|Technical problems|0|||
154849847|NCT01665144|558880279|FG000|Extension Part|Patient/guardian decision|180|||
154849848|NCT01665144|558880280|FG001|Extension Part|Patient/guardian decision|0|||
154849849|NCT01665144|558880281|FG002|Extension Part|Patient/guardian decision|98|||
154849850|NCT01665144|558880279|FG000|Extension Part|Adverse Event|104|||
154849851|NCT01665144|558880280|FG001|Extension Part|Adverse Event|0|||
154849852|NCT01665144|558880281|FG002|Extension Part|Adverse Event|59|||
154849853|NCT01665144|558880279|FG000|Extension Part|Study closed early|42|||
154849854|NCT01665144|558880280|FG001|Extension Part|Study closed early|0|||
154849855|NCT01665144|558880281|FG002|Extension Part|Study closed early|19|||
154849856|NCT01665144|558880279|FG000|Extension Part|Progressive disease|36|||
154849857|NCT01665144|558880280|FG001|Extension Part|Progressive disease|0|||
154849858|NCT01665144|558880281|FG002|Extension Part|Progressive disease|14|||
154849859|NCT01665144|558880279|FG000|Extension Part|Lack of Efficacy|37|||
154849860|NCT01665144|558880280|FG001|Extension Part|Lack of Efficacy|0|||
154849861|NCT01665144|558880281|FG002|Extension Part|Lack of Efficacy|12|||
154849862|NCT01665144|558880279|FG000|Extension Part|Physician Decision|29|||
154849863|NCT01665144|558880280|FG001|Extension Part|Physician Decision|0|||
154849864|NCT01665144|558880281|FG002|Extension Part|Physician Decision|13|||
154849865|NCT01665144|558880279|FG000|Extension Part|Technical problems|20|||
154849866|NCT01665144|558880280|FG001|Extension Part|Technical problems|0|||
154849867|NCT01665144|558880281|FG002|Extension Part|Technical problems|8|||
154849868|NCT01665144|558880279|FG000|Extension Part|Death|20|||
154849869|NCT01665144|558880280|FG001|Extension Part|Death|0|||
154849870|NCT01665144|558880281|FG002|Extension Part|Death|4|||
154971449|NCT00323258|559318658|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
154971450|NCT00323258|559318657|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
154849871|NCT01665144|558880279|FG000|Extension Part|Missing|12|||
154849872|NCT01665144|558880280|FG001|Extension Part|Missing|0|||
154849873|NCT01665144|558880281|FG002|Extension Part|Missing|6|||
154849874|NCT01665144|558880279|FG000|Extension Part|Lost to Follow-up|9|||
154849875|NCT01665144|558880280|FG001|Extension Part|Lost to Follow-up|0|||
154849876|NCT01665144|558880281|FG002|Extension Part|Lost to Follow-up|5|||
154849877|NCT01665144|558880279|FG000|Extension Part|New therapy for study indication|3|||
154849878|NCT01665144|558880280|FG001|Extension Part|New therapy for study indication|0|||
154849879|NCT01665144|558880281|FG002|Extension Part|New therapy for study indication|2|||
154849880|NCT01665144|558880279|FG000|Extension Part|Protocol deviation|3|||
154849881|NCT01665144|558880280|FG001|Extension Part|Protocol deviation|0|||
154849882|NCT01665144|558880281|FG002|Extension Part|Protocol deviation|0|||
154849883|NCT01913483|558880282|FG000|Overall Study|Withdrawal by Subject|1|||
154849884|NCT01913483|558880283|FG001|Overall Study|Withdrawal by Subject|2|||
154849885|NCT01913483|558880282|FG000|Overall Study|Lost to Follow-up|6|||
154849886|NCT01913483|558880283|FG001|Overall Study|Lost to Follow-up|3|||
154849887|NCT01913483|558880282|FG000|Overall Study|Death|14|||
154849888|NCT01913483|558880283|FG001|Overall Study|Death|17|||
154849889|NCT03969888|558880284|FG000|Overall Study|Never Received Study Drug|0|||
154849890|NCT03969888|558880285|FG001|Overall Study|Never Received Study Drug|0|||
155105505|NCT00130039|559815638|FG001|Overall Study|Withdrawal by Subject|11|||
155105506|NCT00130039|559815637|FG000|Overall Study|Lost to Follow-up|3|||
155105507|NCT00130039|559815638|FG001|Overall Study|Lost to Follow-up|1|||
154849891|NCT03969888|558880286|FG002|Overall Study|Never Received Study Drug|1|||
154849892|NCT03969888|558880287|FG003|Overall Study|Never Received Study Drug|0|||
154849893|NCT03969888|558880288|FG004|Overall Study|Never Received Study Drug|0|||
154849894|NCT03969888|558880289|FG005|Overall Study|Never Received Study Drug|0|||
154849895|NCT03969888|558880290|FG006|Overall Study|Never Received Study Drug|1|||
154849896|NCT03969888|558880291|FG007|Overall Study|Never Received Study Drug|0|||
154849897|NCT03969888|558880284|FG000|Overall Study|Reason Not Specified|0|||
154849898|NCT03969888|558880285|FG001|Overall Study|Reason Not Specified|0|||
154849899|NCT03969888|558880286|FG002|Overall Study|Reason Not Specified|0|||
154849900|NCT03969888|558880287|FG003|Overall Study|Reason Not Specified|0|||
154849901|NCT03969888|558880288|FG004|Overall Study|Reason Not Specified|0|||
154849902|NCT03969888|558880289|FG005|Overall Study|Reason Not Specified|0|||
154849903|NCT03969888|558880290|FG006|Overall Study|Reason Not Specified|0|||
154849904|NCT03969888|558880291|FG007|Overall Study|Reason Not Specified|1|||
154849905|NCT04506294|558880292|FG000|Overall Study|Lost to Follow-up|70|||
154849906|NCT04506294|558880293|FG001|Overall Study|Lost to Follow-up|20|||
154849907|NCT04506294|558880292|FG000|Overall Study|Withdrawal by Subject|16|||
154849908|NCT04506294|558880293|FG001|Overall Study|Withdrawal by Subject|2|||
154849909|NCT01469000|558880296|FG000|Overall Study|Withdrawal by Subject|16|||
154849910|NCT01469000|558880297|FG001|Overall Study|Withdrawal by Subject|3|||
154849911|NCT01469000|558880296|FG000|Overall Study|Sponsor Decision|4|||
154849912|NCT01469000|558880297|FG001|Overall Study|Sponsor Decision|1|||
154849913|NCT00769119|558880301|FG000|Overall Study|Voluntary discontinuation|0|||
154849914|NCT00769119|558880302|FG001|Overall Study|Voluntary discontinuation|2|||
154849915|NCT00769119|558880301|FG000|Overall Study|Adverse Event|1|||
154849916|NCT00769119|558880302|FG001|Overall Study|Adverse Event|1|||
154849917|NCT00769119|558880301|FG000|Overall Study|Disallowed medication|1|||
154849918|NCT00769119|558880302|FG001|Overall Study|Disallowed medication|0|||
154849919|NCT06228586|558880310|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
154849920|NCT06228586|558880311|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
154849921|NCT02949128|558882223|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
154849922|NCT02949128|558882223|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
154849923|NCT02949128|558882223|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
154849924|NCT02949128|558882223|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
154849925|NCT02949128|558882223|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
154849926|NCT02949128|558882223|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
154849927|NCT02949128|558882223|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
154849928|NCT02949128|558882223|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
154849929|NCT02949128|558882223|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
154849930|NCT02949128|558882223|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
154849931|NCT01602341|558882224|FG000|Overall Study|Adverse Event|0|||
154849932|NCT01602341|558882225|FG001|Overall Study|Adverse Event|1|||
154849933|NCT02152345|558882226|FG000|Overall Study|Case Cancellations|2|||
154849934|NCT02152345|558882227|FG001|Overall Study|Case Cancellations|4|||
154849935|NCT02152345|558882226|FG000|Overall Study|Withdrawal by Subject|2|||
154849936|NCT02152345|558882227|FG001|Overall Study|Withdrawal by Subject|1|||
154849937|NCT00483327|558882229|FG000|Overall Study|Adverse Event|1|||
154849938|NCT00483327|558882229|FG000|Overall Study|Withdrawal by Subject|3|||
154849939|NCT00483327|558882229|FG000|Overall Study|Lost to Follow-up|4|||
154849940|NCT00483327|558882229|FG000|Overall Study|Patient Non Compliance|2|||
154849941|NCT01390389|558882230|FG000|Overall Study|Withdrawal by Subject|2|||
154849942|NCT01390389|558882231|FG001|Overall Study|Withdrawal by Subject|0|||
154849943|NCT01390389|558882230|FG000|Overall Study|Screen Fail|2|||
154849944|NCT01390389|558882231|FG001|Overall Study|Screen Fail|1|||
155105508|NCT00130039|559815637|FG000|Overall Study|Adverse Event|4|||
154849945|NCT03593915|558882232|FG000|Overall Study|Adverse Event|0|||
154849946|NCT03593915|558882233|FG001|Overall Study|Adverse Event|0|||
154849947|NCT03593915|558882234|FG002|Overall Study|Adverse Event|0|||
155105509|NCT00130039|559815638|FG001|Overall Study|Adverse Event|2|||
155105510|NCT00130039|559815637|FG000|Overall Study|Physician Decision|3|||
155105511|NCT00130039|559815638|FG001|Overall Study|Physician Decision|0|||
154849948|NCT03593915|558882235|FG003|Overall Study|Adverse Event|1|||
154849949|NCT03593915|558882236|FG004|Overall Study|Adverse Event|0|||
154849950|NCT03593915|558882237|FG005|Overall Study|Adverse Event|0|||
154849951|NCT03593915|558882232|FG000|Overall Study|Physician Decision|0|||
154849952|NCT03593915|558882233|FG001|Overall Study|Physician Decision|0|||
154849953|NCT03593915|558882234|FG002|Overall Study|Physician Decision|0|||
154849954|NCT03593915|558882235|FG003|Overall Study|Physician Decision|0|||
154849955|NCT03593915|558882236|FG004|Overall Study|Physician Decision|0|||
154849956|NCT03593915|558882237|FG005|Overall Study|Physician Decision|1|||
154849957|NCT01583179|558882238|FG000|Overall Study|Screen failure|1|||
154849958|NCT01583179|558882239|FG001|Overall Study|Screen failure|2|||
154849959|NCT00772629|558882241|FG000|Overall Study|Subject was not vaccinated|1|||
154849960|NCT00772629|558882242|FG001|Overall Study|Subject was not vaccinated|0|||
154849961|NCT01171820|558882248|FG000|Overall Study|Death|3|||
154849962|NCT01171820|558882249|FG001|Overall Study|Death|3|||
154849963|NCT01171820|558882248|FG000|Overall Study|Lost to Follow-up|0|||
154849964|NCT01171820|558882249|FG001|Overall Study|Lost to Follow-up|1|||
154849965|NCT01171820|558882248|FG000|Overall Study|Withdrawal by Subject|2|||
154849966|NCT01171820|558882249|FG001|Overall Study|Withdrawal by Subject|0|||
154849967|NCT01171820|558882248|FG000|Overall Study|Physician Decision|0|||
154849968|NCT01171820|558882249|FG001|Overall Study|Physician Decision|1|||
154849969|NCT01171820|558882248|FG000|Overall Study|1-Year Missed Visit|1|||
154849970|NCT01171820|558882249|FG001|Overall Study|1-Year Missed Visit|1|||
154849971|NCT01871090|558882250|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
154849972|NCT01871090|558882251|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
154849973|NCT01871090|558882250|FG000|Overall Study|Interrogation not completed correctly|1|||
154849974|NCT01871090|558882251|FG001|Overall Study|Interrogation not completed correctly|0|||
154849975|NCT01871090|558882250|FG000|Overall Study|Subject Non-Compliance|0|||
154849976|NCT01871090|558882251|FG001|Overall Study|Subject Non-Compliance|1|||
154849977|NCT01307033|558882252|FG000|8-week Double-blind Period|Adverse Event|2|||
154849978|NCT01307033|558882253|FG001|8-week Double-blind Period|Adverse Event|0|||
154849979|NCT01307033|558882254|FG002|8-week Double-blind Period|Adverse Event|0|||
154849980|NCT01307033|558882255|FG003|8-week Double-blind Period|Adverse Event|0|||
154849981|NCT01307033|558882252|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
154849982|NCT01307033|558882253|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
154849983|NCT01307033|558882254|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
154849984|NCT01307033|558882255|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
154849985|NCT01307033|558882252|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
154849986|NCT01307033|558882253|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
154849987|NCT01307033|558882254|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
154849988|NCT01307033|558882255|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
154849989|NCT01307033|558882252|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
154849990|NCT01307033|558882253|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
154849991|NCT01307033|558882254|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
154849992|NCT01307033|558882255|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
154849993|NCT01307033|558882252|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
154849994|NCT01307033|558882253|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
154849995|NCT01307033|558882254|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
154849996|NCT01307033|558882255|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
154849997|NCT01307033|558882252|FG000|44-week Open-label Extension|Adverse Event|0|||
154849998|NCT01307033|558882253|FG001|44-week Open-label Extension|Adverse Event|0|||
154849999|NCT01307033|558882254|FG002|44-week Open-label Extension|Adverse Event|2|||
154850000|NCT01307033|558882255|FG003|44-week Open-label Extension|Adverse Event|1|||
154850001|NCT01307033|558882252|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
154850002|NCT01307033|558882253|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
154850003|NCT01307033|558882254|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
154850004|NCT01307033|558882255|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
154850005|NCT01307033|558882252|FG000|44-week Open-label Extension|Physician Decision|0|||
154850006|NCT01307033|558882253|FG001|44-week Open-label Extension|Physician Decision|0|||
154850007|NCT01307033|558882254|FG002|44-week Open-label Extension|Physician Decision|1|||
154850008|NCT01307033|558882255|FG003|44-week Open-label Extension|Physician Decision|0|||
154850009|NCT01307033|558882252|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
154850010|NCT01307033|558882253|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
154850011|NCT01307033|558882254|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
154850012|NCT01307033|558882255|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
154850013|NCT01307033|558882252|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
154850014|NCT01307033|558882253|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
154850015|NCT01307033|558882254|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
154850016|NCT01307033|558882255|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
154850017|NCT01307033|558882252|FG000|44-week Open-label Extension|Death|0|||
154850018|NCT01307033|558882253|FG001|44-week Open-label Extension|Death|0|||
154850019|NCT01307033|558882254|FG002|44-week Open-label Extension|Death|0|||
154971451|NCT00323258|559318658|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
154850020|NCT01307033|558882255|FG003|44-week Open-label Extension|Death|1|||
154850021|NCT03588741|558882260|FG000|Overall Study|Withdrawal by Subject|1|||
154850022|NCT00605267|558882261|FG000|Overall Study|Adverse Event|0|||
154850023|NCT00605267|558882262|FG001|Overall Study|Adverse Event|1|||
154850024|NCT00605267|558882261|FG000|Overall Study|Lack of Efficacy|1|||
154850025|NCT00605267|558882262|FG001|Overall Study|Lack of Efficacy|5|||
154850026|NCT00605267|558882261|FG000|Overall Study|Withdrawal by Subject|2|||
154850027|NCT00605267|558882262|FG001|Overall Study|Withdrawal by Subject|3|||
154850028|NCT00793793|558882263|FG000|Overall Study|Adverse Event|0|||
154850029|NCT00793793|558882264|FG001|Overall Study|Adverse Event|0|||
154850030|NCT00793793|558882265|FG002|Overall Study|Adverse Event|1|||
154850031|NCT00793793|558882266|FG003|Overall Study|Adverse Event|1|||
154850032|NCT00793793|558882267|FG004|Overall Study|Adverse Event|0|||
154850033|NCT00793793|558882268|FG005|Overall Study|Adverse Event|1|||
154850034|NCT00793793|558882269|FG006|Overall Study|Adverse Event|2|||
154850035|NCT00793793|558882270|FG007|Overall Study|Adverse Event|0|||
154850036|NCT00793793|558882271|FG008|Overall Study|Adverse Event|0|||
154850037|NCT00793793|558882272|FG009|Overall Study|Adverse Event|0|||
154850038|NCT00793793|558882273|FG010|Overall Study|Adverse Event|0|||
154850039|NCT00793793|558882274|FG011|Overall Study|Adverse Event|2|||
154850040|NCT00793793|558882263|FG000|Overall Study|Protocol Violation|0|||
154850041|NCT00793793|558882264|FG001|Overall Study|Protocol Violation|0|||
154850042|NCT00793793|558882265|FG002|Overall Study|Protocol Violation|0|||
154850043|NCT00793793|558882266|FG003|Overall Study|Protocol Violation|1|||
154850044|NCT00793793|558882267|FG004|Overall Study|Protocol Violation|0|||
154850045|NCT00793793|558882268|FG005|Overall Study|Protocol Violation|0|||
154850046|NCT00793793|558882269|FG006|Overall Study|Protocol Violation|0|||
154850047|NCT00793793|558882270|FG007|Overall Study|Protocol Violation|0|||
154850048|NCT00793793|558882271|FG008|Overall Study|Protocol Violation|0|||
154850049|NCT00793793|558882272|FG009|Overall Study|Protocol Violation|0|||
154850050|NCT00793793|558882273|FG010|Overall Study|Protocol Violation|0|||
154850051|NCT00793793|558882274|FG011|Overall Study|Protocol Violation|0|||
154850052|NCT00793793|558882263|FG000|Overall Study|Lost to Follow-up|0|||
154850053|NCT00793793|558882264|FG001|Overall Study|Lost to Follow-up|0|||
154850054|NCT00793793|558882265|FG002|Overall Study|Lost to Follow-up|1|||
154850055|NCT00793793|558882266|FG003|Overall Study|Lost to Follow-up|0|||
154850056|NCT00793793|558882267|FG004|Overall Study|Lost to Follow-up|0|||
154850057|NCT00793793|558882268|FG005|Overall Study|Lost to Follow-up|0|||
154850058|NCT00793793|558882269|FG006|Overall Study|Lost to Follow-up|0|||
154850059|NCT00793793|558882270|FG007|Overall Study|Lost to Follow-up|0|||
154850060|NCT00793793|558882271|FG008|Overall Study|Lost to Follow-up|1|||
154850061|NCT00793793|558882272|FG009|Overall Study|Lost to Follow-up|3|||
154850062|NCT00793793|558882273|FG010|Overall Study|Lost to Follow-up|1|||
154850063|NCT00793793|558882274|FG011|Overall Study|Lost to Follow-up|0|||
154850064|NCT00793793|558882263|FG000|Overall Study|Withdrawal by Subject|0|||
154850065|NCT00793793|558882264|FG001|Overall Study|Withdrawal by Subject|0|||
154850066|NCT00793793|558882265|FG002|Overall Study|Withdrawal by Subject|0|||
154850067|NCT00793793|558882266|FG003|Overall Study|Withdrawal by Subject|0|||
154850068|NCT00793793|558882267|FG004|Overall Study|Withdrawal by Subject|1|||
154850069|NCT00793793|558882268|FG005|Overall Study|Withdrawal by Subject|0|||
154850070|NCT00793793|558882269|FG006|Overall Study|Withdrawal by Subject|0|||
154850071|NCT00793793|558882270|FG007|Overall Study|Withdrawal by Subject|0|||
154850072|NCT00793793|558882271|FG008|Overall Study|Withdrawal by Subject|1|||
154850073|NCT00793793|558882272|FG009|Overall Study|Withdrawal by Subject|0|||
154850074|NCT00793793|558882273|FG010|Overall Study|Withdrawal by Subject|0|||
154850075|NCT00793793|558882274|FG011|Overall Study|Withdrawal by Subject|0|||
154850076|NCT00793793|558882263|FG000|Overall Study|reason not specified|0|||
154850077|NCT00793793|558882264|FG001|Overall Study|reason not specified|1|||
154850078|NCT00793793|558882265|FG002|Overall Study|reason not specified|0|||
154850079|NCT00793793|558882266|FG003|Overall Study|reason not specified|1|||
154971452|NCT00323258|559318657|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
154971453|NCT00323258|559318658|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
154971454|NCT00323258|559318657|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
154971455|NCT00323258|559318658|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
154971456|NCT00323258|559318657|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
154971457|NCT00323258|559318658|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
154971458|NCT00323258|559318657|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
154971459|NCT00323258|559318658|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
154850080|NCT00793793|558882267|FG004|Overall Study|reason not specified|1|||
154850081|NCT00793793|558882268|FG005|Overall Study|reason not specified|1|||
154850082|NCT00793793|558882269|FG006|Overall Study|reason not specified|2|||
154850083|NCT00793793|558882270|FG007|Overall Study|reason not specified|0|||
154850084|NCT00793793|558882271|FG008|Overall Study|reason not specified|7|||
154850085|NCT00793793|558882272|FG009|Overall Study|reason not specified|6|||
154850086|NCT00793793|558882273|FG010|Overall Study|reason not specified|2|||
154850087|NCT00793793|558882274|FG011|Overall Study|reason not specified|4|||
154850088|NCT01445535|558882275|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
154850089|NCT01445535|558882276|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
155105512|NCT00130039|559815637|FG000|Overall Study|clinical events without follow up MRI|5|||
155105513|NCT00130039|559815638|FG001|Overall Study|clinical events without follow up MRI|4|||
155105514|NCT01198574|559815641|FG000|Overall Study|Resigned from schools|4|||
155105515|NCT01198574|559815642|FG001|Overall Study|Resigned from schools|1|||
155105516|NCT01198574|559815643|FG002|Overall Study|Resigned from schools|1|||
155105517|NCT01198574|559815644|FG003|Overall Study|Resigned from schools|4|||
155105518|NCT03744910|559817512|FG000|Overall Study|Withdrew Consent|1|||
155105519|NCT03744910|559817513|FG001|Overall Study|Withdrew Consent|8|||
155105520|NCT03744910|559817512|FG000|Overall Study|Physician Decision|5|||
155105521|NCT03744910|559817513|FG001|Overall Study|Physician Decision|4|||
155105522|NCT03744910|559817512|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
155105523|NCT03744910|559817513|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
155105524|NCT03744910|559817512|FG000|Overall Study|Lost to Follow-up|0|||
155105525|NCT03744910|559817513|FG001|Overall Study|Lost to Follow-up|1|||
155105526|NCT03744910|559817512|FG000|Overall Study|Other-unspecified|4|||
155105527|NCT03744910|559817513|FG001|Overall Study|Other-unspecified|1|||
155105528|NCT03280303|559817514|FG000|Overall Study|Death|505|||
155105529|NCT03280303|559817514|FG000|Overall Study|Study terminated by sponsor|383|||
155105530|NCT03280303|559817514|FG000|Overall Study|Other|148|||
155105531|NCT03280303|559817514|FG000|Overall Study|No longer willing to participate in study|101|||
155105532|NCT03280303|559817514|FG000|Overall Study|Lost to follow up|39|||
155105533|NCT03280303|559817514|FG000|Overall Study|Adverse Event|20|||
155105534|NCT00948857|559817515|FG000|Overall Study|Lost to Follow-up|1|||
155105535|NCT00948857|559817516|FG001|Overall Study|Lost to Follow-up|0|||
155105536|NCT03430843|559817517|FG000|Overall Study|Death|233|||
155105537|NCT03430843|559817518|FG001|Overall Study|Death|233|||
155105538|NCT03430843|559817517|FG000|Overall Study|Sponsor Decision|17|||
155105539|NCT03430843|559817518|FG001|Overall Study|Sponsor Decision|6|||
155105540|NCT03430843|559817517|FG000|Overall Study|Withdrawal by Subject|5|||
155105541|NCT03430843|559817518|FG001|Overall Study|Withdrawal by Subject|14|||
155105542|NCT03430843|559817517|FG000|Overall Study|Lost to Follow-up|1|||
155105543|NCT03430843|559817518|FG001|Overall Study|Lost to Follow-up|3|||
155105544|NCT05360966|559817523|FG000|Overall Study|Adverse Event|5|||
155105545|NCT05360966|559817524|FG001|Overall Study|Adverse Event|5|||
155105546|NCT05360966|559817523|FG000|Overall Study|Withdrawal of Consent|5|||
155105547|NCT05360966|559817524|FG001|Overall Study|Withdrawal of Consent|3|||
154850090|NCT01445535|558882277|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
154850091|NCT01445535|558882278|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
154850092|NCT01445535|558882275|FG000|Overall Study|Disease progression|1|||
154850093|NCT01445535|558882276|FG001|Overall Study|Disease progression|0|||
154850094|NCT01445535|558882277|FG002|Overall Study|Disease progression|1|||
154850095|NCT01445535|558882278|FG003|Overall Study|Disease progression|0|||
154850096|NCT01445535|558882275|FG000|Overall Study|PI discretion|0|||
154850097|NCT01445535|558882276|FG001|Overall Study|PI discretion|0|||
154850098|NCT01445535|558882277|FG002|Overall Study|PI discretion|0|||
154850099|NCT01445535|558882278|FG003|Overall Study|PI discretion|1|||
154850100|NCT00883493|558882283|FG000|Overall Study|Adverse Event|11|||
154850101|NCT00883493|558882284|FG001|Overall Study|Adverse Event|12|||
154850102|NCT00883493|558882283|FG000|Overall Study|Lack of Efficacy|4|||
154850103|NCT00883493|558882284|FG001|Overall Study|Lack of Efficacy|3|||
154850104|NCT00883493|558882283|FG000|Overall Study|Lost to Follow-up|7|||
154850105|NCT00883493|558882284|FG001|Overall Study|Lost to Follow-up|6|||
154850106|NCT00883493|558882283|FG000|Overall Study|Withdrawal by Subject|11|||
154850107|NCT00883493|558882284|FG001|Overall Study|Withdrawal by Subject|20|||
154850108|NCT00883493|558882283|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
154850109|NCT00883493|558882284|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
154850110|NCT00883493|558882283|FG000|Overall Study|Study specific disc. criteria|2|||
154850111|NCT00883493|558882284|FG001|Overall Study|Study specific disc. criteria|0|||
154850112|NCT00883493|558882283|FG000|Overall Study|Other|5|||
154850113|NCT00883493|558882284|FG001|Overall Study|Other|3|||
154850114|NCT01622569|558882285|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
154850115|NCT01622569|558882286|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
154850116|NCT01622569|558882287|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
155105548|NCT05360966|559817523|FG000|Overall Study|Noncompliance|2|||
155105549|NCT05360966|559817524|FG001|Overall Study|Noncompliance|1|||
155105550|NCT05360966|559817523|FG000|Overall Study|Lost to Follow-up|2|||
155105551|NCT05360966|559817524|FG001|Overall Study|Lost to Follow-up|3|||
154850117|NCT01622569|558882288|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
154850118|NCT01622569|558882285|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
154850119|NCT01622569|558882286|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
155105552|NCT05360966|559817523|FG000|Overall Study|Protocol Deviation|2|||
155105553|NCT05360966|559817524|FG001|Overall Study|Protocol Deviation|1|||
155105554|NCT05360966|559817523|FG000|Overall Study|As specified in the Clinical Study Report|1|||
154850120|NCT01622569|558882287|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
154850121|NCT01622569|558882288|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
155105555|NCT05360966|559817524|FG001|Overall Study|As specified in the Clinical Study Report|3|||
154850122|NCT01622569|558882285|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
154850123|NCT01622569|558882286|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
154850124|NCT01622569|558882287|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
154850125|NCT01622569|558882288|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
154850126|NCT01622569|558882285|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
154850127|NCT01622569|558882286|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
154850128|NCT01622569|558882287|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
154850129|NCT01622569|558882288|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
154850130|NCT01622569|558882285|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
154850131|NCT01622569|558882286|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
154850132|NCT01622569|558882287|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
154850133|NCT01622569|558882288|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
154850134|NCT01622569|558882285|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
154850135|NCT01622569|558882286|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
154850136|NCT01622569|558882287|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
154850137|NCT01622569|558882288|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
154850138|NCT01622569|558882285|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
154850139|NCT01622569|558882286|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
154850140|NCT01622569|558882287|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
154850141|NCT01622569|558882288|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
154850142|NCT01622569|558882285|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
154850143|NCT01622569|558882286|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
154850144|NCT01622569|558882287|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
154850145|NCT01622569|558882288|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
154850146|NCT01505894|558882289|FG000|Overall Study|Adverse Event|1|||
154850147|NCT01505894|558882290|FG001|Overall Study|Adverse Event|0|||
154850148|NCT01505894|558882291|FG002|Overall Study|Adverse Event|0|||
154850149|NCT01505894|558882292|FG003|Overall Study|Adverse Event|0|||
154850150|NCT01505894|558882293|FG004|Overall Study|Adverse Event|0|||
154850151|NCT01505894|558882294|FG005|Overall Study|Adverse Event|0|||
154850152|NCT01505894|558882295|FG006|Overall Study|Adverse Event|0|||
154850153|NCT01505894|558882296|FG007|Overall Study|Adverse Event|0|||
154850154|NCT01505894|558882297|FG008|Overall Study|Adverse Event|0|||
154850155|NCT01505894|558882289|FG000|Overall Study|Other than specified|0|||
154850156|NCT01505894|558882290|FG001|Overall Study|Other than specified|0|||
154850157|NCT01505894|558882291|FG002|Overall Study|Other than specified|0|||
154850158|NCT01505894|558882292|FG003|Overall Study|Other than specified|0|||
154850159|NCT01505894|558882293|FG004|Overall Study|Other than specified|1|||
154850160|NCT01505894|558882294|FG005|Overall Study|Other than specified|0|||
154850161|NCT01505894|558882295|FG006|Overall Study|Other than specified|0|||
154850162|NCT01505894|558882296|FG007|Overall Study|Other than specified|0|||
154850163|NCT01505894|558882297|FG008|Overall Study|Other than specified|0|||
154850164|NCT04173741|558882298|FG000|Overall Study|IVC measurement cannot be done|1|||
154850165|NCT04173741|558882299|FG001|Overall Study|IVC measurement cannot be done|1|||
154850166|NCT00059202|558882300|FG000|Overall Study|Withdrawal by Subject|5|||
154850167|NCT00059202|558882301|FG001|Overall Study|Withdrawal by Subject|9|||
154850168|NCT00059202|558882300|FG000|Overall Study|Protocol Violation|1|||
154850169|NCT00059202|558882301|FG001|Overall Study|Protocol Violation|3|||
154850170|NCT00059202|558882300|FG000|Overall Study|drug toxicity|0|||
154850171|NCT00059202|558882301|FG001|Overall Study|drug toxicity|3|||
154850172|NCT01940484|558882304|FG000|Overall Study|Withdrawal by Subject|3|||
154850173|NCT01940484|558882304|FG000|Overall Study|Underwent transplantation|4|||
154850174|NCT01940484|558882304|FG000|Overall Study|Death|2|||
154850175|NCT01940484|558882304|FG000|Overall Study|Adverse Event|1|||
154850176|NCT03106779|558882305|FG000|Overall Study|Lack of Efficacy|33|||
154850177|NCT03106779|558882306|FG001|Overall Study|Lack of Efficacy|24|||
154850178|NCT03106779|558882305|FG000|Overall Study|Adverse Event|8|||
154850179|NCT03106779|558882306|FG001|Overall Study|Adverse Event|16|||
154850180|NCT03106779|558882305|FG000|Overall Study|Physician Decision|10|||
154850181|NCT03106779|558882306|FG001|Overall Study|Physician Decision|6|||
154850182|NCT03106779|558882305|FG000|Overall Study|Patient/guardian decision|4|||
154850183|NCT03106779|558882306|FG001|Overall Study|Patient/guardian decision|3|||
154850184|NCT03106779|558882305|FG000|Overall Study|Progressive disease|1|||
154850185|NCT03106779|558882306|FG001|Overall Study|Progressive disease|3|||
154850186|NCT03106779|558882305|FG000|Overall Study|Lost to Follow-up|1|||
154850187|NCT03106779|558882306|FG001|Overall Study|Lost to Follow-up|2|||
154850188|NCT03106779|558882305|FG000|Overall Study|Death|1|||
154850189|NCT03106779|558882306|FG001|Overall Study|Death|0|||
154850190|NCT03106779|558882305|FG000|Overall Study|Protocol Violation|1|||
154971460|NCT04473326|559318659|FG000|Overall Study|Death|0|||
154971461|NCT04473326|559318660|FG001|Overall Study|Death|1|||
154971462|NCT04473326|559318659|FG000|Overall Study|Withdrawal by Subject|1|||
154850191|NCT03106779|558882306|FG001|Overall Study|Protocol Violation|0|||
154850192|NCT03106779|558882305|FG000|Overall Study|Not treated|1|||
154850193|NCT03106779|558882306|FG001|Overall Study|Not treated|0|||
154850194|NCT04233229|558882307|FG000|Overall Study|Withdrawal by Subject|0|||
154850195|NCT04233229|558882308|FG001|Overall Study|Withdrawal by Subject|1|||
154850196|NCT04233229|558882307|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
154850197|NCT04233229|558882308|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
154850198|NCT04233229|558882307|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
154850199|NCT04233229|558882308|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
154850200|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
154850201|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
154850202|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
154850203|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
154850204|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
154850205|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
154850206|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
154850207|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
154850208|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
154850209|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
154850210|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
154850211|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
154850212|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
154850213|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
154850214|NCT02288247|558882309|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
154850215|NCT02288247|558882310|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
154850216|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
154850217|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
154850218|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
154850219|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
154850220|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
154850221|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
154850222|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
154850223|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
154850224|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
154850225|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
154850226|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
154850227|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
154850228|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
154850229|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
154850230|NCT02288247|558882309|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
154850231|NCT02288247|558882310|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
154850232|NCT04652804|558882311|FG000|Overall Study|Ineligible post randomization|1|||
154850233|NCT04652804|558882312|FG001|Overall Study|Ineligible post randomization|0|||
154850234|NCT04652804|558882313|FG002|Overall Study|Ineligible post randomization|1|||
154850235|NCT04652804|558882314|FG003|Overall Study|Ineligible post randomization|0|||
154850236|NCT04652804|558882315|FG004|Overall Study|Ineligible post randomization|1|||
154850237|NCT04652804|558882316|FG005|Overall Study|Ineligible post randomization|1|||
154850238|NCT04652804|558882311|FG000|Overall Study|Missing SVR lab results|2|||
154850239|NCT04652804|558882312|FG001|Overall Study|Missing SVR lab results|0|||
154850240|NCT04652804|558882313|FG002|Overall Study|Missing SVR lab results|0|||
154850241|NCT04652804|558882314|FG003|Overall Study|Missing SVR lab results|0|||
154850242|NCT04652804|558882315|FG004|Overall Study|Missing SVR lab results|0|||
154850243|NCT04652804|558882316|FG005|Overall Study|Missing SVR lab results|0|||
154850244|NCT00584194|558882317|FG000|Overall Study|Other|135|||
154850245|NCT04093531|558882318|FG000|Overall Study|failed screening|4|||
154850246|NCT00841763|558882319|FG000|Overall Study|Withdrawal by Subject|60|||
154850247|NCT00841763|558882320|FG001|Overall Study|Withdrawal by Subject|17|||
154850248|NCT00841763|558882321|FG002|Overall Study|Withdrawal by Subject|4|||
154850249|NCT00841763|558882322|FG003|Overall Study|Withdrawal by Subject|1|||
154850250|NCT00841763|558882319|FG000|Overall Study|Adverse Event|9|||
154850251|NCT00841763|558882320|FG001|Overall Study|Adverse Event|10|||
154850252|NCT00841763|558882321|FG002|Overall Study|Adverse Event|3|||
154850253|NCT00841763|558882322|FG003|Overall Study|Adverse Event|2|||
154850254|NCT00841763|558882319|FG000|Overall Study|Lost to Follow-up|63|||
154850255|NCT00841763|558882320|FG001|Overall Study|Lost to Follow-up|25|||
154850256|NCT00841763|558882321|FG002|Overall Study|Lost to Follow-up|0|||
154850257|NCT00841763|558882322|FG003|Overall Study|Lost to Follow-up|0|||
154850258|NCT00841763|558882319|FG000|Overall Study|Protocol Violation|20|||
154850259|NCT00841763|558882320|FG001|Overall Study|Protocol Violation|3|||
154850260|NCT00841763|558882321|FG002|Overall Study|Protocol Violation|1|||
155105556|NCT05396014|559817525|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
155105557|NCT05396014|559817526|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105558|NCT05396014|559817527|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105559|NCT05396014|559817528|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105560|NCT05396014|559817529|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105561|NCT05396014|559817530|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105562|NCT05396014|559817531|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105563|NCT05396014|559817532|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105564|NCT05396014|559817533|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105565|NCT05396014|559817534|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105566|NCT05396014|559817535|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105567|NCT05396014|559817536|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105568|NCT05396014|559817537|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105569|NCT05396014|559817538|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
154850261|NCT00841763|558882322|FG003|Overall Study|Protocol Violation|0|||
154850262|NCT00841763|558882319|FG000|Overall Study|Administrative Reasons|3|||
154850263|NCT00841763|558882320|FG001|Overall Study|Administrative Reasons|1|||
154850264|NCT00841763|558882321|FG002|Overall Study|Administrative Reasons|0|||
154850265|NCT00841763|558882322|FG003|Overall Study|Administrative Reasons|0|||
154850266|NCT00841763|558882319|FG000|Overall Study|Unable to Classify|7|||
154850267|NCT00841763|558882320|FG001|Overall Study|Unable to Classify|1|||
154850268|NCT00841763|558882321|FG002|Overall Study|Unable to Classify|0|||
154850269|NCT00841763|558882322|FG003|Overall Study|Unable to Classify|0|||
154850270|NCT01109940|558882331|FG000|Overall Study|Administrative problems|2|||
154850271|NCT01109940|558882332|FG001|Overall Study|Administrative problems|0|||
154850272|NCT01109940|558882333|FG002|Overall Study|Administrative problems|0|||
154850273|NCT01109940|558882334|FG003|Overall Study|Administrative problems|0|||
154850274|NCT01109940|558882331|FG000|Overall Study|Serious Adverse Event|2|||
154850275|NCT01109940|558882332|FG001|Overall Study|Serious Adverse Event|1|||
154850276|NCT01109940|558882333|FG002|Overall Study|Serious Adverse Event|0|||
154850277|NCT01109940|558882334|FG003|Overall Study|Serious Adverse Event|0|||
154850278|NCT01109940|558882331|FG000|Overall Study|Lost to Follow-up|1|||
154850279|NCT01109940|558882332|FG001|Overall Study|Lost to Follow-up|0|||
154850280|NCT01109940|558882333|FG002|Overall Study|Lost to Follow-up|0|||
154850281|NCT01109940|558882334|FG003|Overall Study|Lost to Follow-up|0|||
154850282|NCT01109940|558882331|FG000|Overall Study|Patient withdrew consent|1|||
154850283|NCT01109940|558882332|FG001|Overall Study|Patient withdrew consent|1|||
154850284|NCT01109940|558882333|FG002|Overall Study|Patient withdrew consent|0|||
154850285|NCT01109940|558882334|FG003|Overall Study|Patient withdrew consent|0|||
154850286|NCT01109940|558882331|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
154850287|NCT01109940|558882332|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154850288|NCT01109940|558882333|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
154850289|NCT01109940|558882334|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
154850290|NCT02769624|558882335|FG000|Overall Study|Lost to Follow-up|0|||
154850291|NCT02769624|558882336|FG001|Overall Study|Lost to Follow-up|1|||
154850292|NCT00179959|558882337|FG000|Overall Study|Lost to Follow-up|3|||
154850293|NCT00179959|558882338|FG001|Overall Study|Lost to Follow-up|1|||
154850294|NCT00179959|558882337|FG000|Overall Study|Withdrawal by Subject|3|||
155173562|NCT03642132|560074829|FG001|Chemotherapy Period|Adverse Event|1|||
154850295|NCT00179959|558882338|FG001|Overall Study|Withdrawal by Subject|2|||
154850296|NCT00236080|558882339|FG000|Overall Study|Adverse Event|0|||
154850297|NCT00236080|558882340|FG001|Overall Study|Adverse Event|0|||
154850298|NCT00236080|558882341|FG002|Overall Study|Adverse Event|3|||
154850299|NCT00236080|558882342|FG003|Overall Study|Adverse Event|1|||
154850300|NCT00236080|558882343|FG004|Overall Study|Adverse Event|0|||
154850301|NCT00236080|558882339|FG000|Overall Study|Lost to Follow-up|0|||
154850302|NCT00236080|558882340|FG001|Overall Study|Lost to Follow-up|1|||
154850303|NCT00236080|558882341|FG002|Overall Study|Lost to Follow-up|0|||
154850304|NCT00236080|558882342|FG003|Overall Study|Lost to Follow-up|0|||
154850305|NCT00236080|558882343|FG004|Overall Study|Lost to Follow-up|0|||
154850306|NCT00236080|558882339|FG000|Overall Study|Physician Decision|1|||
154850307|NCT00236080|558882340|FG001|Overall Study|Physician Decision|0|||
154850308|NCT00236080|558882341|FG002|Overall Study|Physician Decision|1|||
154850309|NCT00236080|558882342|FG003|Overall Study|Physician Decision|1|||
154850310|NCT00236080|558882343|FG004|Overall Study|Physician Decision|1|||
154850311|NCT00236080|558882339|FG000|Overall Study|Withdrawal by Subject|1|||
154850312|NCT00236080|558882340|FG001|Overall Study|Withdrawal by Subject|0|||
154850313|NCT00236080|558882341|FG002|Overall Study|Withdrawal by Subject|0|||
154850314|NCT00236080|558882342|FG003|Overall Study|Withdrawal by Subject|0|||
154850315|NCT00236080|558882343|FG004|Overall Study|Withdrawal by Subject|0|||
154850316|NCT00236080|558882339|FG000|Overall Study|Miscellaneous|0|||
154850317|NCT00236080|558882340|FG001|Overall Study|Miscellaneous|0|||
154850318|NCT00236080|558882341|FG002|Overall Study|Miscellaneous|1|||
154850319|NCT00236080|558882342|FG003|Overall Study|Miscellaneous|0|||
154850320|NCT00236080|558882343|FG004|Overall Study|Miscellaneous|0|||
155105570|NCT05396014|559817539|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105571|NCT05396014|559817540|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105572|NCT05396014|559817541|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105573|NCT05396014|559817542|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
154850321|NCT01214044|558882344|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
154850322|NCT01214044|558882344|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
154850323|NCT01214044|558882344|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
154850324|NCT01214044|558882344|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
154850325|NCT01214044|558882344|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
154850326|NCT01214044|558882344|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
154850327|NCT04698525|558882345|FG000|Overall Study|Lost to Follow-up|1|||
154850328|NCT04698525|558882346|FG001|Overall Study|Lost to Follow-up|2|||
154850329|NCT04698525|558882345|FG000|Overall Study|Three suffered of Covid-19|2|||
154850330|NCT04698525|558882346|FG001|Overall Study|Three suffered of Covid-19|1|||
154850331|NCT01961544|558882347|FG000|Overall Study|Protocol Violation|1|||
154850332|NCT01961544|558882347|FG000|Overall Study|Withdrawal by Subject|7|||
154850333|NCT01961544|558882347|FG000|Overall Study|Adverse Event|1|||
154850334|NCT01961544|558882347|FG000|Overall Study|Physician Decision|2|||
154850335|NCT01961544|558882347|FG000|Overall Study|Poor Tolerance|1|||
154850336|NCT01961544|558882347|FG000|Overall Study|Aggravation of Steral Pain|1|||
154850337|NCT02211261|558882348|FG000|Overall Study|Withdrawal by Subject|0|||
154850338|NCT02211261|558882349|FG001|Overall Study|Withdrawal by Subject|0|||
154850339|NCT02211261|558882350|FG002|Overall Study|Withdrawal by Subject|1|||
154850340|NCT02211261|558882351|FG003|Overall Study|Withdrawal by Subject|0|||
154850341|NCT02211261|558882352|FG004|Overall Study|Withdrawal by Subject|2|||
154850342|NCT02211261|558882353|FG005|Overall Study|Withdrawal by Subject|0|||
154850343|NCT02211261|558882354|FG006|Overall Study|Withdrawal by Subject|0|||
154850344|NCT02211261|558882355|FG007|Overall Study|Withdrawal by Subject|0|||
154850345|NCT02211261|558882356|FG008|Overall Study|Withdrawal by Subject|0|||
154850346|NCT02211261|558882357|FG009|Overall Study|Withdrawal by Subject|0|||
154850347|NCT02211261|558882358|FG010|Overall Study|Withdrawal by Subject|0|||
154850348|NCT02211261|558882348|FG000|Overall Study|Other|0|||
154850349|NCT02211261|558882349|FG001|Overall Study|Other|0|||
154850350|NCT02211261|558882350|FG002|Overall Study|Other|0|||
154850351|NCT02211261|558882351|FG003|Overall Study|Other|0|||
154850352|NCT02211261|558882352|FG004|Overall Study|Other|0|||
154850353|NCT02211261|558882353|FG005|Overall Study|Other|1|||
154850354|NCT02211261|558882354|FG006|Overall Study|Other|0|||
154850355|NCT02211261|558882355|FG007|Overall Study|Other|0|||
154850356|NCT02211261|558882356|FG008|Overall Study|Other|0|||
154850357|NCT02211261|558882357|FG009|Overall Study|Other|2|||
154850358|NCT02211261|558882358|FG010|Overall Study|Other|0|||
154850359|NCT02211261|558882348|FG000|Overall Study|Lost to Follow-up|0|||
154850360|NCT02211261|558882349|FG001|Overall Study|Lost to Follow-up|0|||
154850361|NCT02211261|558882350|FG002|Overall Study|Lost to Follow-up|0|||
154850362|NCT02211261|558882351|FG003|Overall Study|Lost to Follow-up|0|||
154850363|NCT02211261|558882352|FG004|Overall Study|Lost to Follow-up|0|||
154850364|NCT02211261|558882353|FG005|Overall Study|Lost to Follow-up|0|||
154850365|NCT02211261|558882354|FG006|Overall Study|Lost to Follow-up|0|||
154850366|NCT02211261|558882355|FG007|Overall Study|Lost to Follow-up|1|||
154850367|NCT02211261|558882356|FG008|Overall Study|Lost to Follow-up|0|||
154850368|NCT02211261|558882357|FG009|Overall Study|Lost to Follow-up|0|||
154850369|NCT02211261|558882358|FG010|Overall Study|Lost to Follow-up|0|||
154850370|NCT02817087|558882359|FG000|Overall Study|Withdrawal by Subject|2|||
154850371|NCT02817087|558882360|FG001|Overall Study|Withdrawal by Subject|0|||
154850372|NCT00480857|558882361|FG000|Overall Study|Lack of Efficacy|2|||
154850373|NCT02551159|558882366|FG000|Overall Study|Death|352|||
154850374|NCT02551159|558882367|FG001|Overall Study|Death|174|||
154850375|NCT02551159|558882368|FG002|Overall Study|Death|161|||
154971463|NCT04473326|559318660|FG001|Overall Study|Withdrawal by Subject|2|||
154971464|NCT00252564|559318663|FG000|Overall Study|Adverse Event|17|||
155105574|NCT05396014|559817543|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105575|NCT05396014|559817544|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105576|NCT05396014|559817545|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105577|NCT05396014|559817546|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105578|NCT05396014|559817547|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105579|NCT05396014|559817548|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155173563|NCT03642132|560074830|FG002|Chemotherapy Period|Adverse Event|0|||
154850376|NCT02551159|558882366|FG000|Overall Study|Withdrawal by Subject|8|||
154850377|NCT02551159|558882367|FG001|Overall Study|Withdrawal by Subject|5|||
154850378|NCT02551159|558882368|FG002|Overall Study|Withdrawal by Subject|16|||
154850379|NCT02551159|558882366|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
154850380|NCT02551159|558882367|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
154850381|NCT02551159|558882368|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
154850382|NCT06098729|558882369|FG000|Overall Study|Withdrawal by Subject|1|||
154850383|NCT02175680|558882376|FG000|Overall Study|non-compliance|1|||
154850384|NCT02175680|558882376|FG000|Overall Study|other non-medical reason|1|||
154850385|NCT01116544|558882380|FG000|Overall Study|Protocol Violation|1|||
154850386|NCT01116544|558882381|FG001|Overall Study|Protocol Violation|0|||
154850387|NCT01116544|558882380|FG000|Overall Study|Withdrawal by Subject|1|||
154850388|NCT01116544|558882381|FG001|Overall Study|Withdrawal by Subject|1|||
154850389|NCT02419508|558882382|FG000|Overall Study|Adverse Event|9|||
154850390|NCT02419508|558882383|FG001|Overall Study|Adverse Event|3|||
154850391|NCT02419508|558882382|FG000|Overall Study|Withdrawal by Subject|1|||
154850392|NCT02419508|558882383|FG001|Overall Study|Withdrawal by Subject|0|||
154850393|NCT02419508|558882382|FG000|Overall Study|Other - Reason not specified|0|||
154850394|NCT02419508|558882383|FG001|Overall Study|Other - Reason not specified|1|||
154850395|NCT01738971|558882386|FG000|Overall Study|Lost to Follow-up|19|||
154850396|NCT01738971|558882387|FG001|Overall Study|Lost to Follow-up|30|||
154850397|NCT01738971|558882388|FG002|Overall Study|Lost to Follow-up|17|||
154850398|NCT04698629|558882397|FG000|Overall Study|Adverse Event|1|||
154850399|NCT02320487|558882398|FG000|Overall Study|Reason not Specified|1|||
154850400|NCT02320487|558882398|FG000|Overall Study|Physician Decision|5|||
154850401|NCT02320487|558882398|FG000|Overall Study|Withdrawal by Subject|1|||
154850402|NCT02320487|558882398|FG000|Overall Study|Death|3|||
154850403|NCT02320487|558882398|FG000|Overall Study|Adverse Event|11|||
154850404|NCT01475734|558884793|FG000|Overall Study|Withdrawal by Subject|1|||
154850405|NCT01475734|558884794|FG001|Overall Study|Withdrawal by Subject|0|||
154850406|NCT01475734|558884793|FG000|Overall Study|Protocol Violation|1|||
154850407|NCT01475734|558884794|FG001|Overall Study|Protocol Violation|0|||
154850408|NCT01475734|558884793|FG000|Overall Study|Physician Decision|0|||
154850409|NCT01475734|558884794|FG001|Overall Study|Physician Decision|1|||
154850410|NCT00667576|558884803|FG000|Overall Study|Withdrawal by Subject|1|||
154850411|NCT00667576|558884804|FG001|Overall Study|Withdrawal by Subject|0|||
154850412|NCT00667576|558884805|FG002|Overall Study|Withdrawal by Subject|1|||
154850413|NCT00667576|558884806|FG003|Overall Study|Withdrawal by Subject|1|||
154850414|NCT00667576|558884807|FG004|Overall Study|Withdrawal by Subject|1|||
154850415|NCT00667576|558884803|FG000|Overall Study|Adverse Event|1|||
154850416|NCT00667576|558884804|FG001|Overall Study|Adverse Event|1|||
154850417|NCT00667576|558884805|FG002|Overall Study|Adverse Event|0|||
154850418|NCT00667576|558884806|FG003|Overall Study|Adverse Event|0|||
154850419|NCT00667576|558884807|FG004|Overall Study|Adverse Event|0|||
154850420|NCT00667576|558884803|FG000|Overall Study|Lost to Follow-up|0|||
154850421|NCT00667576|558884804|FG001|Overall Study|Lost to Follow-up|0|||
154850422|NCT00667576|558884805|FG002|Overall Study|Lost to Follow-up|1|||
154850423|NCT00667576|558884806|FG003|Overall Study|Lost to Follow-up|0|||
154850424|NCT00667576|558884807|FG004|Overall Study|Lost to Follow-up|0|||
154850425|NCT00667576|558884803|FG000|Overall Study|Protocol Violation|0|||
154850426|NCT00667576|558884804|FG001|Overall Study|Protocol Violation|0|||
154850427|NCT00667576|558884805|FG002|Overall Study|Protocol Violation|0|||
154850428|NCT00667576|558884806|FG003|Overall Study|Protocol Violation|1|||
154850429|NCT00667576|558884807|FG004|Overall Study|Protocol Violation|0|||
154850430|NCT00667576|558884803|FG000|Overall Study|Physician Decision|0|||
154850431|NCT00667576|558884804|FG001|Overall Study|Physician Decision|0|||
154850432|NCT00667576|558884805|FG002|Overall Study|Physician Decision|0|||
154850433|NCT00667576|558884806|FG003|Overall Study|Physician Decision|1|||
154850434|NCT00667576|558884807|FG004|Overall Study|Physician Decision|0|||
154850435|NCT00667576|558884803|FG000|Overall Study|Missed Visit|0|||
154850436|NCT00667576|558884804|FG001|Overall Study|Missed Visit|0|||
154850437|NCT00667576|558884805|FG002|Overall Study|Missed Visit|0|||
154850438|NCT00667576|558884806|FG003|Overall Study|Missed Visit|1|||
154850439|NCT00667576|558884807|FG004|Overall Study|Missed Visit|0|||
154850440|NCT00670007|558884811|FG000|Overall Study|Drug abuse|1|||
154850441|NCT00670007|558884811|FG000|Overall Study|Lung transplant|1|||
154850442|NCT00670007|558884811|FG000|Overall Study|Travel/Vacation|1|||
154850443|NCT00670007|558884811|FG000|Overall Study|Adverse event, serious fatal|1|||
154850444|NCT00670007|558884811|FG000|Overall Study|Adverse Event|1|||
154850445|NCT00670007|558884811|FG000|Overall Study|Withdrawal by Subject|4|||
154850446|NCT00618722|558884812|FG000|Overall Study|Refusal of Treatment|0|||
154850447|NCT00618722|558884813|FG001|Overall Study|Refusal of Treatment|0|||
154850448|NCT00618722|558884814|FG002|Overall Study|Refusal of Treatment|1|||
154850449|NCT00618722|558884815|FG003|Overall Study|Refusal of Treatment|0|||
154850450|NCT00618722|558884812|FG000|Overall Study|Patient Request|1|||
154850451|NCT00618722|558884813|FG001|Overall Study|Patient Request|1|||
154850452|NCT00618722|558884814|FG002|Overall Study|Patient Request|1|||
154850453|NCT00618722|558884815|FG003|Overall Study|Patient Request|1|||
154850454|NCT00618722|558884812|FG000|Overall Study|Inability to Complete Study Procedure|0|||
154850455|NCT00618722|558884813|FG001|Overall Study|Inability to Complete Study Procedure|1|||
154850456|NCT00618722|558884814|FG002|Overall Study|Inability to Complete Study Procedure|0|||
154850457|NCT00618722|558884815|FG003|Overall Study|Inability to Complete Study Procedure|0|||
154850458|NCT00618722|558884812|FG000|Overall Study|Lost to Follow-up|2|||
154850459|NCT00618722|558884813|FG001|Overall Study|Lost to Follow-up|0|||
154850460|NCT00618722|558884814|FG002|Overall Study|Lost to Follow-up|0|||
154850461|NCT00618722|558884815|FG003|Overall Study|Lost to Follow-up|2|||
154850462|NCT00618722|558884812|FG000|Overall Study|Miscellaneous Reasons|0|||
154850463|NCT00618722|558884813|FG001|Overall Study|Miscellaneous Reasons|0|||
154850464|NCT00618722|558884814|FG002|Overall Study|Miscellaneous Reasons|1|||
154850465|NCT00618722|558884815|FG003|Overall Study|Miscellaneous Reasons|1|||
154850466|NCT00925600|558884816|FG000|Overall Study|Withdrawal by Subject|16|||
154850467|NCT00925600|558884817|FG001|Overall Study|Withdrawal by Subject|14|||
154850468|NCT00925600|558884816|FG000|Overall Study|Death|4|||
154850469|NCT00925600|558884817|FG001|Overall Study|Death|3|||
154850470|NCT00925600|558884816|FG000|Overall Study|Lost to Follow-up|2|||
154850471|NCT00925600|558884817|FG001|Overall Study|Lost to Follow-up|2|||
154850472|NCT00925600|558884816|FG000|Overall Study|Disease Progression|1|||
154850473|NCT00925600|558884817|FG001|Overall Study|Disease Progression|3|||
154850474|NCT00925600|558884816|FG000|Overall Study|Administrative Decision|1|||
154850475|NCT00925600|558884817|FG001|Overall Study|Administrative Decision|1|||
154850476|NCT00925600|558884816|FG000|Overall Study|Noncompliance|2|||
154850477|NCT00925600|558884817|FG001|Overall Study|Noncompliance|0|||
154850478|NCT00925600|558884816|FG000|Overall Study|Ineligibility Determined|2|||
154850479|NCT00925600|558884817|FG001|Overall Study|Ineligibility Determined|0|||
154850480|NCT00925600|558884816|FG000|Overall Study|Protocol Deviation|0|||
154850481|NCT00925600|558884817|FG001|Overall Study|Protocol Deviation|1|||
154850482|NCT00925600|558884816|FG000|Overall Study|Requirement for Alternative Therapy|0|||
154850483|NCT00925600|558884817|FG001|Overall Study|Requirement for Alternative Therapy|1|||
154850484|NCT00925600|558884816|FG000|Overall Study|Other|3|||
154850485|NCT00925600|558884817|FG001|Overall Study|Other|1|||
154850486|NCT00925600|558884816|FG000|Overall Study|Adverse Event|1|||
154850487|NCT00925600|558884817|FG001|Overall Study|Adverse Event|2|||
154850488|NCT00127127|558884822|FG000|Overall Study|Adverse Event|0|||
154850489|NCT00127127|558884823|FG001|Overall Study|Adverse Event|2|||
154850490|NCT00127127|558884824|FG002|Overall Study|Adverse Event|0|||
154850491|NCT00127127|558884825|FG003|Overall Study|Adverse Event|1|||
154850492|NCT00127127|558884822|FG000|Overall Study|Lack of Efficacy|1|||
154850493|NCT00127127|558884823|FG001|Overall Study|Lack of Efficacy|3|||
154850494|NCT00127127|558884824|FG002|Overall Study|Lack of Efficacy|0|||
154850495|NCT00127127|558884825|FG003|Overall Study|Lack of Efficacy|2|||
154850496|NCT00200057|558884826|FG000|Overall Study|Lack of Efficacy|3|||
154850497|NCT00200057|558884826|FG000|Overall Study|Exited due to terminal illness of PI|2|||
154850498|NCT00200057|558884826|FG000|Overall Study|Withdrawal by Subject|1|||
154850499|NCT00200057|558884826|FG000|Overall Study|Change in medical condition|1|||
154850500|NCT00200057|558884826|FG000|Overall Study|Infection|1|||
154850501|NCT00200057|558884826|FG000|Overall Study|Death|1|||
154850502|NCT01059448|558884828|FG000|Overall Study|Adverse Event|1|||
154850503|NCT01059448|558884829|FG001|Overall Study|Adverse Event|3|||
154850504|NCT01059448|558884830|FG002|Overall Study|Adverse Event|0|||
154850505|NCT01059448|558884831|FG003|Overall Study|Adverse Event|1|||
154850506|NCT01059448|558884828|FG000|Overall Study|Withdrawal by Subject|2|||
154850507|NCT01059448|558884829|FG001|Overall Study|Withdrawal by Subject|0|||
154850508|NCT01059448|558884830|FG002|Overall Study|Withdrawal by Subject|2|||
154850509|NCT01059448|558884831|FG003|Overall Study|Withdrawal by Subject|4|||
154850510|NCT01059448|558884828|FG000|Overall Study|Disease Progression|2|||
154850511|NCT01059448|558884829|FG001|Overall Study|Disease Progression|1|||
154850512|NCT01059448|558884830|FG002|Overall Study|Disease Progression|4|||
154850513|NCT01059448|558884831|FG003|Overall Study|Disease Progression|2|||
154850514|NCT01059448|558884828|FG000|Overall Study|Administrative Decision|43|||
154850515|NCT01059448|558884829|FG001|Overall Study|Administrative Decision|49|||
154850516|NCT01059448|558884830|FG002|Overall Study|Administrative Decision|45|||
154850517|NCT01059448|558884831|FG003|Overall Study|Administrative Decision|46|||
154850518|NCT01059448|558884828|FG000|Overall Study|Lost to Follow-up|0|||
154850519|NCT01059448|558884829|FG001|Overall Study|Lost to Follow-up|0|||
154850520|NCT01059448|558884830|FG002|Overall Study|Lost to Follow-up|2|||
154850521|NCT01059448|558884831|FG003|Overall Study|Lost to Follow-up|0|||
154850522|NCT01059448|558884828|FG000|Overall Study|Death|0|||
154850523|NCT01059448|558884829|FG001|Overall Study|Death|1|||
154850524|NCT01059448|558884830|FG002|Overall Study|Death|0|||
154850525|NCT01059448|558884831|FG003|Overall Study|Death|0|||
154850526|NCT01059448|558884828|FG000|Overall Study|Other|1|||
154850527|NCT01059448|558884829|FG001|Overall Study|Other|1|||
154850528|NCT01059448|558884830|FG002|Overall Study|Other|0|||
154850529|NCT01059448|558884831|FG003|Overall Study|Other|1|||
154850530|NCT00778830|558884832|FG000|Overall Study|Ongoing at data cut-off|0|||
154850531|NCT00778830|558884833|FG001|Overall Study|Ongoing at data cut-off|1|||
154971465|NCT00252564|559318664|FG001|Overall Study|Adverse Event|13|||
154971466|NCT00252564|559318663|FG000|Overall Study|Unrelated Complication|2|||
154850532|NCT05512949|558884834|FG000|Overall Study|Lost to Follow-up|4|||
154850533|NCT05512949|558884835|FG001|Overall Study|Lost to Follow-up|6|||
154850534|NCT05512949|558884836|FG002|Overall Study|Lost to Follow-up|2|||
154850535|NCT05512949|558884834|FG000|Overall Study|Protocol Violation|0|||
154850536|NCT05512949|558884835|FG001|Overall Study|Protocol Violation|0|||
154850537|NCT05512949|558884836|FG002|Overall Study|Protocol Violation|1|||
154850538|NCT05512949|558884834|FG000|Overall Study|Withdrawal by Subject|1|||
154850539|NCT05512949|558884835|FG001|Overall Study|Withdrawal by Subject|1|||
154850540|NCT05512949|558884836|FG002|Overall Study|Withdrawal by Subject|2|||
154850541|NCT05512949|558884834|FG000|Overall Study|Completion status unknown|1|||
154850542|NCT05512949|558884835|FG001|Overall Study|Completion status unknown|3|||
154850543|NCT05512949|558884836|FG002|Overall Study|Completion status unknown|0|||
154850544|NCT01891643|558884837|FG000|Overall Study|Adverse event unrelated to study drug|2|||
154850545|NCT01891643|558884838|FG001|Overall Study|Adverse event unrelated to study drug|5|||
154850546|NCT01891643|558884837|FG000|Overall Study|Disease Progression|4|||
154850547|NCT01891643|558884838|FG001|Overall Study|Disease Progression|3|||
154850548|NCT01891643|558884837|FG000|Overall Study|Study Drug Toxicity|3|||
154850549|NCT01891643|558884838|FG001|Overall Study|Study Drug Toxicity|0|||
154850550|NCT01891643|558884837|FG000|Overall Study|Maximum Clinical Benefit|0|||
154850551|NCT01891643|558884838|FG001|Overall Study|Maximum Clinical Benefit|1|||
154850552|NCT01891643|558884837|FG000|Overall Study|Poor/Non-compliance|0|||
154850553|NCT01891643|558884838|FG001|Overall Study|Poor/Non-compliance|1|||
154850554|NCT01891643|558884837|FG000|Overall Study|Participant request to discontinue|1|||
154850555|NCT01891643|558884838|FG001|Overall Study|Participant request to discontinue|0|||
154850556|NCT02810964|558884841|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
154850557|NCT02810964|558884842|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
154850558|NCT02810964|558884841|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
154850559|NCT02810964|558884842|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
154850560|NCT02810964|558884841|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
154850561|NCT02810964|558884842|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
154850562|NCT02810964|558884841|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
154850563|NCT02810964|558884842|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
154850564|NCT03523351|558884843|FG000|Overall Study|Death|13|||
154850565|NCT03523351|558884844|FG001|Overall Study|Death|11|||
154850566|NCT03523351|558884843|FG000|Overall Study|Lost to Follow-up|2|||
154850567|NCT03523351|558884844|FG001|Overall Study|Lost to Follow-up|3|||
154850568|NCT03523351|558884843|FG000|Overall Study|Withdrawal by Subject|4|||
154850569|NCT03523351|558884844|FG001|Overall Study|Withdrawal by Subject|0|||
154850570|NCT03523351|558884843|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
154850571|NCT03523351|558884844|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
154850572|NCT01430442|558884846|FG000|Overall Study|Subject Withdrew Consent|3|||
154850573|NCT01430442|558884847|FG001|Overall Study|Subject Withdrew Consent|0|||
154850574|NCT01430442|558884848|FG002|Overall Study|Subject Withdrew Consent|1|||
154850575|NCT01430442|558884849|FG003|Overall Study|Subject Withdrew Consent|0|||
154850576|NCT01430442|558884850|FG004|Overall Study|Subject Withdrew Consent|2|||
154850577|NCT01430442|558884851|FG005|Overall Study|Subject Withdrew Consent|1|||
154850578|NCT01430442|558884852|FG006|Overall Study|Subject Withdrew Consent|5|||
154850579|NCT01430442|558884853|FG007|Overall Study|Subject Withdrew Consent|2|||
154850580|NCT01430442|558884846|FG000|Overall Study|Lost to Follow-up|2|||
154850581|NCT01430442|558884847|FG001|Overall Study|Lost to Follow-up|0|||
154850582|NCT01430442|558884848|FG002|Overall Study|Lost to Follow-up|1|||
154850583|NCT01430442|558884849|FG003|Overall Study|Lost to Follow-up|2|||
154850584|NCT01430442|558884850|FG004|Overall Study|Lost to Follow-up|2|||
154850585|NCT01430442|558884851|FG005|Overall Study|Lost to Follow-up|1|||
154850586|NCT01430442|558884852|FG006|Overall Study|Lost to Follow-up|5|||
154850587|NCT01430442|558884853|FG007|Overall Study|Lost to Follow-up|1|||
154850588|NCT01430442|558884846|FG000|Overall Study|Pregnancy|1|||
154850589|NCT01430442|558884847|FG001|Overall Study|Pregnancy|0|||
154850590|NCT01430442|558884848|FG002|Overall Study|Pregnancy|0|||
154850591|NCT01430442|558884849|FG003|Overall Study|Pregnancy|0|||
154850592|NCT01430442|558884850|FG004|Overall Study|Pregnancy|0|||
154850593|NCT01430442|558884851|FG005|Overall Study|Pregnancy|1|||
154850594|NCT01430442|558884852|FG006|Overall Study|Pregnancy|0|||
154850595|NCT01430442|558884853|FG007|Overall Study|Pregnancy|0|||
154850596|NCT01430442|558884846|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
154850597|NCT01430442|558884847|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
154971467|NCT00252564|559318664|FG001|Overall Study|Unrelated Complication|1|||
154971468|NCT00252564|559318663|FG000|Overall Study|Disease Progression|14|||
154971469|NCT00252564|559318664|FG001|Overall Study|Disease Progression|20|||
154971470|NCT00252564|559318663|FG000|Overall Study|Death|0|||
154971471|NCT00252564|559318664|FG001|Overall Study|Death|3|||
154971472|NCT00252564|559318663|FG000|Overall Study|Physician Decision|1|||
154971473|NCT00252564|559318664|FG001|Overall Study|Physician Decision|0|||
154971474|NCT00252564|559318663|FG000|Overall Study|Lost to Follow-up|1|||
154971475|NCT00252564|559318664|FG001|Overall Study|Lost to Follow-up|0|||
154971476|NCT00252564|559318663|FG000|Overall Study|Patient Request|4|||
154971477|NCT00252564|559318664|FG001|Overall Study|Patient Request|5|||
154971478|NCT00252564|559318663|FG000|Overall Study|Withdrawal by Subject|0|||
154850598|NCT01430442|558884848|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
154850599|NCT01430442|558884849|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
154971479|NCT00252564|559318664|FG001|Overall Study|Withdrawal by Subject|2|||
154971480|NCT01097694|559318665|FG000|Overall Study|Adverse Event|5|||
154971481|NCT01097694|559318666|FG001|Overall Study|Adverse Event|0|||
154850600|NCT01430442|558884850|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
154850601|NCT01430442|558884851|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
154850602|NCT01430442|558884852|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
154850603|NCT01430442|558884853|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
154850604|NCT00132041|558884858|FG000|Baseline|Ineligible|6|||
154850605|NCT00132041|558884858|FG000|3 Months Post Ablation|Transplant|1|||
154850606|NCT00132041|558884858|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
154850607|NCT00132041|558884858|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
154850608|NCT00132041|558884858|FG000|6 Months Post Ablation|Death|2|||
154850609|NCT00132041|558884858|FG000|6 Months Post Ablation|Transplant|6|||
154850610|NCT00132041|558884858|FG000|9 Months Post Ablation|Death|1|||
154850611|NCT00132041|558884858|FG000|9 Months Post Ablation|Transplant|1|||
154850612|NCT00132041|558884858|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
154850613|NCT00132041|558884858|FG000|12 Months Post Ablation|Death|1|||
154850614|NCT00132041|558884858|FG000|12 Months Post Ablation|Transplant|1|||
154850615|NCT00132041|558884858|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
154850616|NCT00132041|558884858|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
154850617|NCT00132041|558884858|FG000|15 Months Post Ablation|Death|1|||
154850618|NCT00132041|558884858|FG000|15 Months Post Ablation|Transplant|5|||
154850619|NCT00132041|558884858|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
154850620|NCT00132041|558884858|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
154850621|NCT00132041|558884858|FG000|18 Months Post Ablation|Transplant|1|||
154850622|NCT00132041|558884858|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
154850623|NCT00132041|558884858|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
154850624|NCT03969875|558884859|FG000|Overall Study|did not receive allocated intervention|3|||
154850625|NCT03969875|558884860|FG001|Overall Study|did not receive allocated intervention|3|||
154850626|NCT03969875|558884861|FG002|Overall Study|did not receive allocated intervention|4|||
154850627|NCT03969875|558884859|FG000|Overall Study|Protocol Violation|4|||
154850628|NCT03969875|558884860|FG001|Overall Study|Protocol Violation|2|||
154850629|NCT03969875|558884861|FG002|Overall Study|Protocol Violation|2|||
154850630|NCT00167245|558884862|FG000|Overall Study|Lost to Follow-up|20|||
154850631|NCT00167245|558884863|FG001|Overall Study|Lost to Follow-up|31|||
154850632|NCT00167245|558884862|FG000|Overall Study|Withdrawal by Subject|5|||
154850633|NCT00167245|558884863|FG001|Overall Study|Withdrawal by Subject|8|||
154850634|NCT00167245|558884862|FG000|Overall Study|Incarcerated|3|||
154850635|NCT00167245|558884863|FG001|Overall Study|Incarcerated|2|||
154850636|NCT00167245|558884862|FG000|Overall Study|Drowsy|1|||
154850637|NCT00167245|558884863|FG001|Overall Study|Drowsy|0|||
154850638|NCT02911688|558884867|FG000|Washout|Lost to Follow-up|1|||
154850639|NCT02911688|558884868|FG001|Washout|Lost to Follow-up|1|||
154850640|NCT02911688|558884867|FG000|Washout|Withdrawal by Subject|0|||
154850641|NCT02911688|558884868|FG001|Washout|Withdrawal by Subject|1|||
154850642|NCT00947531|558884875|FG000|Overall Study|Withdrawal by Subject|10|||
154850643|NCT00947531|558884876|FG001|Overall Study|Withdrawal by Subject|7|||
154850644|NCT00947531|558884875|FG000|Overall Study|Administrative Reason|0|||
154850645|NCT00947531|558884876|FG001|Overall Study|Administrative Reason|1|||
154850646|NCT00947531|558884875|FG000|Overall Study|Adverse Event|2|||
154850647|NCT00947531|558884876|FG001|Overall Study|Adverse Event|2|||
154850648|NCT00947531|558884875|FG000|Overall Study|Lack of Efficacy|1|||
154850649|NCT00947531|558884876|FG001|Overall Study|Lack of Efficacy|0|||
154850650|NCT00947531|558884875|FG000|Overall Study|Other|1|||
154850651|NCT00947531|558884876|FG001|Overall Study|Other|1|||
154850652|NCT01773421|558884878|FG000|Treatment Phase|Other|0|||
154850653|NCT01773421|558884879|FG001|Treatment Phase|Other|0|||
154850654|NCT01773421|558884880|FG002|Treatment Phase|Other|2|||
154850655|NCT01773421|558884881|FG003|Treatment Phase|Other|0|||
154850656|NCT01773421|558884882|FG004|Treatment Phase|Other|0|||
154850657|NCT01773421|558884883|FG005|Treatment Phase|Other|0|||
154850658|NCT01773421|558884884|FG006|Treatment Phase|Other|0|||
154850659|NCT01773421|558884878|FG000|Treatment Phase|Adverse Event|0|||
154850660|NCT01773421|558884879|FG001|Treatment Phase|Adverse Event|0|||
154971482|NCT01097694|559318665|FG000|Overall Study|Lost to Follow-up|0|||
154971483|NCT01097694|559318666|FG001|Overall Study|Lost to Follow-up|3|||
154971484|NCT01097694|559318665|FG000|Overall Study|Withdrawal by Subject|3|||
154971485|NCT01097694|559318666|FG001|Overall Study|Withdrawal by Subject|1|||
154971486|NCT02179190|559318667|FG000|Enrollment|Exit Prior to Device Attempt|11|||
154971487|NCT02179190|559318667|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
154971488|NCT02179190|559318667|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
154971489|NCT02179190|559318667|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
155173564|NCT03642132|560074828|FG000|Chemotherapy Period|Physician's decision|4|||
155173565|NCT03642132|560074829|FG001|Chemotherapy Period|Physician's decision|1|||
154850661|NCT01773421|558884880|FG002|Treatment Phase|Adverse Event|3|||
154850662|NCT01773421|558884881|FG003|Treatment Phase|Adverse Event|1|||
154850663|NCT01773421|558884882|FG004|Treatment Phase|Adverse Event|0|||
154850664|NCT01773421|558884883|FG005|Treatment Phase|Adverse Event|0|||
154850665|NCT01773421|558884884|FG006|Treatment Phase|Adverse Event|0|||
154850666|NCT01773421|558884878|FG000|Treatment Phase|Withdrawal by Subject|0|||
154850667|NCT01773421|558884879|FG001|Treatment Phase|Withdrawal by Subject|0|||
154850668|NCT01773421|558884880|FG002|Treatment Phase|Withdrawal by Subject|1|||
154850669|NCT01773421|558884881|FG003|Treatment Phase|Withdrawal by Subject|1|||
154850670|NCT01773421|558884882|FG004|Treatment Phase|Withdrawal by Subject|0|||
154850671|NCT01773421|558884883|FG005|Treatment Phase|Withdrawal by Subject|0|||
154850672|NCT01773421|558884884|FG006|Treatment Phase|Withdrawal by Subject|0|||
154850673|NCT01773421|558884878|FG000|Extension Phase|Other|0|||
154850674|NCT01773421|558884879|FG001|Extension Phase|Other|0|||
154850675|NCT01773421|558884880|FG002|Extension Phase|Other|0|||
154850676|NCT01773421|558884881|FG003|Extension Phase|Other|0|||
154850677|NCT01773421|558884882|FG004|Extension Phase|Other|1|||
154850678|NCT01773421|558884883|FG005|Extension Phase|Other|2|||
154850679|NCT01773421|558884884|FG006|Extension Phase|Other|0|||
154850680|NCT01773421|558884878|FG000|Extension Phase|Adverse Event|0|||
154850681|NCT01773421|558884879|FG001|Extension Phase|Adverse Event|0|||
154850682|NCT01773421|558884880|FG002|Extension Phase|Adverse Event|0|||
154850683|NCT01773421|558884881|FG003|Extension Phase|Adverse Event|0|||
154850684|NCT01773421|558884882|FG004|Extension Phase|Adverse Event|2|||
154850685|NCT01773421|558884883|FG005|Extension Phase|Adverse Event|0|||
154850686|NCT01773421|558884884|FG006|Extension Phase|Adverse Event|0|||
154850687|NCT02327260|558884885|FG000|Overall Study|Lost to Follow-up|2|||
154850688|NCT02327260|558884886|FG001|Overall Study|Lost to Follow-up|3|||
154850689|NCT02327260|558884887|FG002|Overall Study|Lost to Follow-up|2|||
154850690|NCT02327260|558884885|FG000|Overall Study|invalid phone number|1|||
154850691|NCT02327260|558884886|FG001|Overall Study|invalid phone number|1|||
154850692|NCT02327260|558884887|FG002|Overall Study|invalid phone number|0|||
154850693|NCT02327260|558884885|FG000|Overall Study|non-adherence to protocol|2|||
154850694|NCT02327260|558884886|FG001|Overall Study|non-adherence to protocol|0|||
154850695|NCT02327260|558884887|FG002|Overall Study|non-adherence to protocol|0|||
154850696|NCT02327260|558884885|FG000|Overall Study|cognitive concerns|1|||
154850697|NCT02327260|558884886|FG001|Overall Study|cognitive concerns|0|||
154850698|NCT02327260|558884887|FG002|Overall Study|cognitive concerns|0|||
154850699|NCT03502330|558884888|FG000|Overall Study|Adverse Event|2|||
154850700|NCT03502330|558884889|FG001|Overall Study|Adverse Event|1|||
154850701|NCT03502330|558884890|FG002|Overall Study|Adverse Event|0|||
154850702|NCT03502330|558884891|FG003|Overall Study|Adverse Event|0|||
154850703|NCT03502330|558884892|FG004|Overall Study|Adverse Event|1|||
154850704|NCT03502330|558884893|FG005|Overall Study|Adverse Event|0|||
154850705|NCT03502330|558884894|FG006|Overall Study|Adverse Event|1|||
154850706|NCT03502330|558884895|FG007|Overall Study|Adverse Event|1|||
154850707|NCT03502330|558884896|FG008|Overall Study|Adverse Event|0|||
154850708|NCT03502330|558884888|FG000|Overall Study|Lack of Efficacy|1|||
154850709|NCT03502330|558884889|FG001|Overall Study|Lack of Efficacy|5|||
154850710|NCT03502330|558884890|FG002|Overall Study|Lack of Efficacy|3|||
154850711|NCT03502330|558884891|FG003|Overall Study|Lack of Efficacy|5|||
154850712|NCT03502330|558884892|FG004|Overall Study|Lack of Efficacy|1|||
154850713|NCT03502330|558884893|FG005|Overall Study|Lack of Efficacy|5|||
154850714|NCT03502330|558884894|FG006|Overall Study|Lack of Efficacy|5|||
154850715|NCT03502330|558884895|FG007|Overall Study|Lack of Efficacy|6|||
154850716|NCT03502330|558884896|FG008|Overall Study|Lack of Efficacy|0|||
154850717|NCT03502330|558884888|FG000|Overall Study|Physician Decision|0|||
154850718|NCT03502330|558884889|FG001|Overall Study|Physician Decision|0|||
154850719|NCT03502330|558884890|FG002|Overall Study|Physician Decision|0|||
154850720|NCT03502330|558884891|FG003|Overall Study|Physician Decision|0|||
154850721|NCT03502330|558884892|FG004|Overall Study|Physician Decision|1|||
154850722|NCT03502330|558884893|FG005|Overall Study|Physician Decision|0|||
154850723|NCT03502330|558884894|FG006|Overall Study|Physician Decision|0|||
154850724|NCT03502330|558884895|FG007|Overall Study|Physician Decision|0|||
154850725|NCT03502330|558884896|FG008|Overall Study|Physician Decision|0|||
154850726|NCT03502330|558884888|FG000|Overall Study|Withdrawal by Subject|0|||
154850727|NCT03502330|558884889|FG001|Overall Study|Withdrawal by Subject|0|||
154850728|NCT03502330|558884890|FG002|Overall Study|Withdrawal by Subject|0|||
154850729|NCT03502330|558884891|FG003|Overall Study|Withdrawal by Subject|0|||
154850730|NCT03502330|558884892|FG004|Overall Study|Withdrawal by Subject|0|||
154850731|NCT03502330|558884893|FG005|Overall Study|Withdrawal by Subject|1|||
154850732|NCT03502330|558884894|FG006|Overall Study|Withdrawal by Subject|0|||
154850733|NCT03502330|558884895|FG007|Overall Study|Withdrawal by Subject|1|||
154850734|NCT03502330|558884896|FG008|Overall Study|Withdrawal by Subject|0|||
154850735|NCT03502330|558884888|FG000|Overall Study|Death|0|||
154850736|NCT03502330|558884889|FG001|Overall Study|Death|0|||
154850737|NCT03502330|558884890|FG002|Overall Study|Death|0|||
154850738|NCT03502330|558884891|FG003|Overall Study|Death|0|||
154850739|NCT03502330|558884892|FG004|Overall Study|Death|0|||
154850740|NCT03502330|558884893|FG005|Overall Study|Death|0|||
154850741|NCT03502330|558884894|FG006|Overall Study|Death|2|||
154850742|NCT03502330|558884895|FG007|Overall Study|Death|0|||
154850743|NCT03502330|558884896|FG008|Overall Study|Death|0|||
154850744|NCT02804763|558884900|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
154850745|NCT02804763|558884901|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
154850746|NCT02804763|558884902|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
154850747|NCT02804763|558884903|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
154850748|NCT02804763|558884900|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
154850749|NCT02804763|558884901|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
154850750|NCT02804763|558884902|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
154850751|NCT02804763|558884903|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
154850752|NCT02804763|558884900|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
154850753|NCT02804763|558884901|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
154850754|NCT02804763|558884902|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
154850755|NCT02804763|558884903|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
154850756|NCT02804763|558884900|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
154850757|NCT02804763|558884901|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
154971490|NCT02179190|559318667|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
154971491|NCT02179190|559318667|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
154971492|NCT00697827|559318669|FG000|Overall Study|enrolled but not treated|2|||
154971493|NCT00697827|559318670|FG001|Overall Study|enrolled but not treated|1|||
154971494|NCT04049097|559318673|FG000|Overall Study|Adverse Event|18|||
154971495|NCT04049097|559318673|FG000|Overall Study|Death|2|||
154971496|NCT04049097|559318673|FG000|Overall Study|Lost to Follow-up|1|||
154971497|NCT04049097|559318673|FG000|Overall Study|Physician Decision|2|||
154971498|NCT04049097|559318673|FG000|Overall Study|Withdrawal by Subject|9|||
154971499|NCT04049097|559318673|FG000|Overall Study|Protocol Violation|2|||
154971500|NCT04049097|559318673|FG000|Overall Study|Other|1|||
154971501|NCT04049097|559318673|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
154971502|NCT04194151|559318674|FG000|Overall Study|Physician Decision|1|||
154971503|NCT04194151|559318675|FG001|Overall Study|Physician Decision|1|||
154971504|NCT04194151|559318676|FG002|Overall Study|Physician Decision|1|||
154971505|NCT04194151|559318677|FG003|Overall Study|Physician Decision|1|||
154971506|NCT04194151|559318678|FG004|Overall Study|Physician Decision|0|||
154971507|NCT04194151|559318679|FG005|Overall Study|Physician Decision|1|||
154971508|NCT04194151|559318674|FG000|Overall Study|Monitorization problem|0|||
154971509|NCT04194151|559318675|FG001|Overall Study|Monitorization problem|1|||
154971510|NCT04194151|559318676|FG002|Overall Study|Monitorization problem|0|||
154971511|NCT04194151|559318677|FG003|Overall Study|Monitorization problem|0|||
154971512|NCT04194151|559318678|FG004|Overall Study|Monitorization problem|0|||
154971513|NCT04194151|559318679|FG005|Overall Study|Monitorization problem|0|||
154971514|NCT05135273|559320544|FG000|Overall Study|Recruited into the army|0|||
154971515|NCT05135273|559320545|FG001|Overall Study|Recruited into the army|0|||
154971516|NCT05135273|559320546|FG002|Overall Study|Recruited into the army|0|||
154971517|NCT05135273|559320547|FG003|Overall Study|Recruited into the army|0|||
154971518|NCT05135273|559320548|FG004|Overall Study|Recruited into the army|1|||
154971519|NCT05135273|559320549|FG005|Overall Study|Recruited into the army|0|||
154971520|NCT05135273|559320550|FG006|Overall Study|Recruited into the army|0|||
154971521|NCT05135273|559320551|FG007|Overall Study|Recruited into the army|0|||
154971522|NCT05135273|559320544|FG000|Overall Study|Moved away from study site|0|||
154971523|NCT05135273|559320545|FG001|Overall Study|Moved away from study site|0|||
154971524|NCT05135273|559320546|FG002|Overall Study|Moved away from study site|0|||
154971525|NCT05135273|559320547|FG003|Overall Study|Moved away from study site|0|||
154971526|NCT05135273|559320548|FG004|Overall Study|Moved away from study site|0|||
154971527|NCT05135273|559320549|FG005|Overall Study|Moved away from study site|1|||
154971528|NCT05135273|559320550|FG006|Overall Study|Moved away from study site|1|||
154971529|NCT05135273|559320551|FG007|Overall Study|Moved away from study site|0|||
154971530|NCT05135273|559320544|FG000|Overall Study|Travel|0|||
154971531|NCT05135273|559320545|FG001|Overall Study|Travel|0|||
154971532|NCT05135273|559320546|FG002|Overall Study|Travel|0|||
154971533|NCT05135273|559320547|FG003|Overall Study|Travel|0|||
154971534|NCT05135273|559320548|FG004|Overall Study|Travel|0|||
154971535|NCT05135273|559320549|FG005|Overall Study|Travel|0|||
154971536|NCT05135273|559320550|FG006|Overall Study|Travel|0|||
154971537|NCT05135273|559320551|FG007|Overall Study|Travel|1|||
154971538|NCT03035890|559320557|FG000|Overall Study|Death|1|||
154971539|NCT03243396|559320558|FG000|Overall Study|Lost to Follow-up|2|||
154971540|NCT03243396|559320559|FG001|Overall Study|Lost to Follow-up|3|||
154971541|NCT03243396|559320560|FG002|Overall Study|Lost to Follow-up|15|||
154971542|NCT03243396|559320561|FG003|Overall Study|Lost to Follow-up|8|||
154850758|NCT02804763|558884902|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
154850759|NCT02804763|558884903|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
154971543|NCT03243396|559320562|FG004|Overall Study|Lost to Follow-up|1|||
154971544|NCT03243396|559320563|FG005|Overall Study|Lost to Follow-up|4|||
154971545|NCT03243396|559320564|FG006|Overall Study|Lost to Follow-up|9|||
154971546|NCT03687242|559320565|FG000|Overall Study|Adverse Event|1|||
154971547|NCT01243151|559320569|FG000|Overall Study|Adverse Event|0|||
154971548|NCT01243151|559320570|FG001|Overall Study|Adverse Event|1|||
154971549|NCT01243151|559320571|FG002|Overall Study|Adverse Event|0|||
154971550|NCT01243151|559320572|FG003|Overall Study|Adverse Event|0|||
154971551|NCT01243151|559320573|FG004|Overall Study|Adverse Event|0|||
154850760|NCT02804763|558884900|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
154850761|NCT02804763|558884901|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
154850762|NCT02804763|558884902|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
154850763|NCT02804763|558884903|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
154850764|NCT02804763|558884900|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
154850765|NCT02804763|558884901|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
154850766|NCT02804763|558884902|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
154850767|NCT02804763|558884903|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
154850768|NCT01400932|558884908|FG000|Overall Study|Adverse Event|10|||
154850769|NCT01400932|558884909|FG001|Overall Study|Adverse Event|5|||
154850770|NCT01400932|558884908|FG000|Overall Study|Lack of Efficacy|0|||
154850771|NCT01400932|558884909|FG001|Overall Study|Lack of Efficacy|3|||
154850772|NCT01400932|558884908|FG000|Overall Study|Withdrawal by Subject|2|||
154850773|NCT01400932|558884909|FG001|Overall Study|Withdrawal by Subject|6|||
154850774|NCT01400932|558884908|FG000|Overall Study|Lost to Follow-up|1|||
154850775|NCT01400932|558884909|FG001|Overall Study|Lost to Follow-up|0|||
154850776|NCT01400932|558884908|FG000|Overall Study|Protocol Deviation|0|||
154850777|NCT01400932|558884909|FG001|Overall Study|Protocol Deviation|1|||
154850778|NCT01400932|558884908|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
154850779|NCT01400932|558884909|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
154850780|NCT00860158|558884910|FG000|Overall Study|Study Terminated|1|||
154850781|NCT02472847|558884911|FG000|Overall Study|Withdrawal by Subject|1|||
154850782|NCT02472847|558884912|FG001|Overall Study|Withdrawal by Subject|5|||
154850783|NCT04656990|558884913|FG000|Baseline|pandemic|20|||
154850784|NCT04656990|558884914|FG001|Baseline|pandemic|24|||
154850785|NCT04656990|558884913|FG000|Follow Up Period|Lost to Follow-up|61|||
154850786|NCT04656990|558884914|FG001|Follow Up Period|Lost to Follow-up|73|||
154850787|NCT03244059|558884915|FG000|Specific Aim 1|Physician Decision|1|||
154850788|NCT03244059|558884916|FG001|Specific Aim 1|Physician Decision|0|||
154850789|NCT03244059|558884915|FG000|Specific Aim 2|Physician Decision|1|||
154850790|NCT03244059|558884916|FG001|Specific Aim 2|Physician Decision|0|||
154850791|NCT05499520|558884917|FG000|Overall Study|Lost to Follow-up|0|||
154850792|NCT05499520|558884918|FG001|Overall Study|Lost to Follow-up|0|||
154850793|NCT05499520|558884919|FG002|Overall Study|Lost to Follow-up|38|||
154850794|NCT05499520|558884920|FG003|Overall Study|Lost to Follow-up|41|||
154850795|NCT05499520|558884921|FG004|Overall Study|Lost to Follow-up|46|||
154850796|NCT05499520|558884922|FG005|Overall Study|Lost to Follow-up|0|||
154850797|NCT05499520|558884923|FG006|Overall Study|Lost to Follow-up|31|||
154850798|NCT05499520|558884924|FG007|Overall Study|Lost to Follow-up|45|||
154850799|NCT05499520|558884925|FG008|Overall Study|Lost to Follow-up|42|||
154850800|NCT05499520|558884926|FG009|Overall Study|Lost to Follow-up|0|||
154850801|NCT05499520|558884927|FG010|Overall Study|Lost to Follow-up|0|||
154850802|NCT05499520|558884928|FG011|Overall Study|Lost to Follow-up|37|||
154850803|NCT05499520|558884929|FG012|Overall Study|Lost to Follow-up|53|||
154850804|NCT05499520|558884930|FG013|Overall Study|Lost to Follow-up|49|||
154850805|NCT05499520|558884931|FG014|Overall Study|Lost to Follow-up|0|||
154971552|NCT01243151|559320569|FG000|Overall Study|Protocol Violation|0|||
154971553|NCT01243151|559320570|FG001|Overall Study|Protocol Violation|0|||
154971554|NCT01243151|559320571|FG002|Overall Study|Protocol Violation|1|||
154971555|NCT01243151|559320572|FG003|Overall Study|Protocol Violation|0|||
154971556|NCT01243151|559320573|FG004|Overall Study|Protocol Violation|0|||
154971557|NCT01243151|559320569|FG000|Overall Study|Other|0|||
154850806|NCT05499520|558884932|FG015|Overall Study|Lost to Follow-up|36|||
154850807|NCT05499520|558884933|FG016|Overall Study|Lost to Follow-up|58|||
154850808|NCT05499520|558884934|FG017|Overall Study|Lost to Follow-up|53|||
154850809|NCT00840827|558884936|FG000|Overall Study|Adverse Event|1|||
154850810|NCT00840827|558884936|FG000|Overall Study|Lack of Efficacy|4|||
154850811|NCT00840827|558884936|FG000|Overall Study|Physician Decision|1|||
154850812|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
154850813|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
154850814|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
154850815|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
154850816|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
154850817|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
154850818|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
154850819|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
154850820|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
154850821|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
154850822|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154850823|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
154971558|NCT01243151|559320570|FG001|Overall Study|Other|0|||
154971559|NCT01243151|559320571|FG002|Overall Study|Other|0|||
155105580|NCT05396014|559817549|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105581|NCT05396014|559817550|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
154850824|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
154850825|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154850826|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154850827|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
154850828|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
154850829|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
154850830|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
154850831|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
154850832|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
154850833|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
154850834|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
154850835|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
154850836|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
154850837|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
154850838|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
154850839|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
154850840|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
154850841|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
154850842|NCT05195528|558884938|FG000|Placebo-controlled Treatment Period|Other|0|||
154850843|NCT05195528|558884939|FG001|Placebo-controlled Treatment Period|Other|0|||
154850844|NCT05195528|558884940|FG002|Placebo-controlled Treatment Period|Other|1|||
154850845|NCT05195528|558884941|FG003|Placebo-controlled Treatment Period|Other|0|||
154850846|NCT05195528|558884942|FG004|Placebo-controlled Treatment Period|Other|0|||
154850847|NCT05195528|558884938|FG000|Extension Period|PTE or AE or SAE|0|||
154850848|NCT05195528|558884939|FG001|Extension Period|PTE or AE or SAE|4|||
154850849|NCT05195528|558884940|FG002|Extension Period|PTE or AE or SAE|5|||
154850850|NCT05195528|558884941|FG003|Extension Period|PTE or AE or SAE|4|||
154850851|NCT05195528|558884942|FG004|Extension Period|PTE or AE or SAE|4|||
154850852|NCT05195528|558884938|FG000|Extension Period|Protocol Violation|0|||
154850853|NCT05195528|558884939|FG001|Extension Period|Protocol Violation|2|||
154850854|NCT05195528|558884940|FG002|Extension Period|Protocol Violation|1|||
154850855|NCT05195528|558884941|FG003|Extension Period|Protocol Violation|0|||
154850856|NCT05195528|558884942|FG004|Extension Period|Protocol Violation|1|||
154850857|NCT05195528|558884938|FG000|Extension Period|Lost to Follow-up|0|||
154850858|NCT05195528|558884939|FG001|Extension Period|Lost to Follow-up|6|||
154850859|NCT05195528|558884940|FG002|Extension Period|Lost to Follow-up|13|||
154850860|NCT05195528|558884941|FG003|Extension Period|Lost to Follow-up|3|||
154850861|NCT05195528|558884942|FG004|Extension Period|Lost to Follow-up|7|||
154850862|NCT05195528|558884938|FG000|Extension Period|Withdrawal by Subject|0|||
154850863|NCT05195528|558884939|FG001|Extension Period|Withdrawal by Subject|12|||
154850864|NCT05195528|558884940|FG002|Extension Period|Withdrawal by Subject|9|||
154850865|NCT05195528|558884941|FG003|Extension Period|Withdrawal by Subject|6|||
154850866|NCT05195528|558884942|FG004|Extension Period|Withdrawal by Subject|5|||
154850867|NCT05195528|558884938|FG000|Extension Period|Lack of Efficacy|0|||
154850868|NCT05195528|558884939|FG001|Extension Period|Lack of Efficacy|3|||
154850869|NCT05195528|558884940|FG002|Extension Period|Lack of Efficacy|0|||
154850870|NCT05195528|558884941|FG003|Extension Period|Lack of Efficacy|0|||
154850871|NCT05195528|558884942|FG004|Extension Period|Lack of Efficacy|2|||
154850872|NCT05195528|558884938|FG000|Extension Period|Not Treated|0|||
154850873|NCT05195528|558884939|FG001|Extension Period|Not Treated|0|||
154850874|NCT05195528|558884940|FG002|Extension Period|Not Treated|2|||
154850875|NCT05195528|558884941|FG003|Extension Period|Not Treated|3|||
154850876|NCT05195528|558884942|FG004|Extension Period|Not Treated|0|||
154850877|NCT05195528|558884938|FG000|Extension Period|Other|0|||
154850878|NCT05195528|558884939|FG001|Extension Period|Other|1|||
154850879|NCT05195528|558884940|FG002|Extension Period|Other|1|||
154850880|NCT05195528|558884941|FG003|Extension Period|Other|0|||
154850881|NCT05195528|558884942|FG004|Extension Period|Other|0|||
154850882|NCT02487108|558884943|FG000|Overall Study|Adverse Event|1|||
154850883|NCT02487108|558884944|FG001|Overall Study|Adverse Event|6|||
154850884|NCT02487108|558884945|FG002|Overall Study|Adverse Event|12|||
154850885|NCT02487108|558884946|FG003|Overall Study|Adverse Event|6|||
154850886|NCT02487108|558884943|FG000|Overall Study|Withdrawal by Subject|8|||
154850887|NCT02487108|558884944|FG001|Overall Study|Withdrawal by Subject|5|||
154850888|NCT02487108|558884945|FG002|Overall Study|Withdrawal by Subject|5|||
154850889|NCT02487108|558884946|FG003|Overall Study|Withdrawal by Subject|0|||
155105582|NCT05396014|559817551|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
154850890|NCT02487108|558884943|FG000|Overall Study|Non-compliance to study medication|3|||
154850891|NCT02487108|558884944|FG001|Overall Study|Non-compliance to study medication|2|||
154850892|NCT02487108|558884945|FG002|Overall Study|Non-compliance to study medication|5|||
154850893|NCT02487108|558884946|FG003|Overall Study|Non-compliance to study medication|4|||
154850894|NCT02487108|558884943|FG000|Overall Study|Protocol Violation|1|||
154971560|NCT01243151|559320572|FG003|Overall Study|Other|1|||
154971561|NCT01243151|559320573|FG004|Overall Study|Other|0|||
154971562|NCT01243151|559320569|FG000|Overall Study|Randomized but not treated|0|||
154971563|NCT01243151|559320570|FG001|Overall Study|Randomized but not treated|0|||
155105583|NCT05396014|559817552|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
154850895|NCT02487108|558884944|FG001|Overall Study|Protocol Violation|1|||
154850896|NCT02487108|558884945|FG002|Overall Study|Protocol Violation|2|||
154850897|NCT02487108|558884946|FG003|Overall Study|Protocol Violation|0|||
154850898|NCT02487108|558884943|FG000|Overall Study|Non-compliance to study procedures|0|||
154850899|NCT02487108|558884944|FG001|Overall Study|Non-compliance to study procedures|0|||
154850900|NCT02487108|558884945|FG002|Overall Study|Non-compliance to study procedures|0|||
154850901|NCT02487108|558884946|FG003|Overall Study|Non-compliance to study procedures|1|||
154850902|NCT02487108|558884943|FG000|Overall Study|Other than specified|3|||
154850903|NCT02487108|558884944|FG001|Overall Study|Other than specified|2|||
154850904|NCT02487108|558884945|FG002|Overall Study|Other than specified|2|||
154850905|NCT02487108|558884946|FG003|Overall Study|Other than specified|0|||
154850906|NCT02720757|558884947|FG000|Overall Study|Other reason|5|||
154850907|NCT02720757|558884947|FG000|Overall Study|Loss of contact|4|||
154850908|NCT02720757|558884947|FG000|Overall Study|Informed consent withdrawal|1|||
154850909|NCT02720757|558884947|FG000|Overall Study|Patients wish to withdraw|2|||
154850910|NCT02720757|558884947|FG000|Overall Study|Missing|3|||
154850911|NCT02720757|558884947|FG000|Overall Study|General exclusion|3|||
154850912|NCT00168831|558884949|FG000|Overall Study|Adverse Event|36|||
154850913|NCT00168831|558884950|FG001|Overall Study|Adverse Event|47|||
154850914|NCT00168831|558884951|FG002|Overall Study|Adverse Event|74|||
154850915|NCT00168831|558884949|FG000|Overall Study|Lost to Follow-up|5|||
154850916|NCT00168831|558884950|FG001|Overall Study|Lost to Follow-up|6|||
154850917|NCT00168831|558884951|FG002|Overall Study|Lost to Follow-up|4|||
154850918|NCT00168831|558884949|FG000|Overall Study|Withdrawal by Subject|7|||
154850919|NCT00168831|558884950|FG001|Overall Study|Withdrawal by Subject|14|||
154850920|NCT00168831|558884951|FG002|Overall Study|Withdrawal by Subject|19|||
154850921|NCT00168831|558884949|FG000|Overall Study|Protocol Violation|6|||
154850922|NCT00168831|558884950|FG001|Overall Study|Protocol Violation|11|||
154850923|NCT00168831|558884951|FG002|Overall Study|Protocol Violation|11|||
154850924|NCT00168831|558884949|FG000|Overall Study|Other|6|||
154850925|NCT00168831|558884950|FG001|Overall Study|Other|3|||
154850926|NCT00168831|558884951|FG002|Overall Study|Other|6|||
154850927|NCT00648167|558884952|FG000|Overall Study|Adverse Event|6|||
154850928|NCT00648167|558884952|FG000|Overall Study|unable to swallow tablets|1|||
154850929|NCT00927368|558884953|FG000|Overall Study|enrollment in another study|1|||
154850930|NCT00927368|558884954|FG001|Overall Study|enrollment in another study|1|||
154850931|NCT00927368|558884955|FG002|Overall Study|enrollment in another study|2|||
154850932|NCT00927368|558884953|FG000|Overall Study|Lost to Follow-up|4|||
154850933|NCT00927368|558884954|FG001|Overall Study|Lost to Follow-up|0|||
154850934|NCT00927368|558884955|FG002|Overall Study|Lost to Follow-up|0|||
154850935|NCT00927368|558884953|FG000|Overall Study|equipment failure|1|||
154850936|NCT00927368|558884954|FG001|Overall Study|equipment failure|0|||
154850937|NCT00927368|558884955|FG002|Overall Study|equipment failure|0|||
154850938|NCT00927368|558884953|FG000|Overall Study|ineligible post randomization|0|||
154850939|NCT00927368|558884954|FG001|Overall Study|ineligible post randomization|3|||
154850940|NCT00927368|558884955|FG002|Overall Study|ineligible post randomization|1|||
154850941|NCT00927368|558884953|FG000|Overall Study|cancellation of surgery|0|||
154850942|NCT00927368|558884954|FG001|Overall Study|cancellation of surgery|1|||
154850943|NCT00927368|558884955|FG002|Overall Study|cancellation of surgery|2|||
154850944|NCT00331409|558884959|FG000|Overall Study|Lack of Efficacy|4|||
154850945|NCT01482910|558884960|FG000|Overall Study|Adverse Event|6|||
154850946|NCT01482910|558884961|FG001|Overall Study|Adverse Event|5|||
154850947|NCT01482910|558884960|FG000|Overall Study|Lost to Follow-up|0|||
154850948|NCT01482910|558884961|FG001|Overall Study|Lost to Follow-up|1|||
154850949|NCT01482910|558884960|FG000|Overall Study|Protocol Violation|1|||
154850950|NCT01482910|558884961|FG001|Overall Study|Protocol Violation|1|||
154850951|NCT01482910|558884960|FG000|Overall Study|Withdrawal by Subject|7|||
154850952|NCT01482910|558884961|FG001|Overall Study|Withdrawal by Subject|2|||
154850953|NCT01482910|558884960|FG000|Overall Study|Death|1|||
154850954|NCT01482910|558884961|FG001|Overall Study|Death|0|||
154971564|NCT01243151|559320571|FG002|Overall Study|Randomized but not treated|0|||
155105584|NCT05396014|559817553|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105585|NCT05396014|559817554|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
154850955|NCT03222349|558884962|FG000|Overall Study|Treatment B not done|5|||
154850956|NCT03222349|558884963|FG001|Overall Study|Treatment B not done|0|||
154850957|NCT03222349|558884962|FG000|Overall Study|Lost to Follow-up|1|||
154850958|NCT03222349|558884963|FG001|Overall Study|Lost to Follow-up|2|||
154850959|NCT03222349|558884962|FG000|Overall Study|Withdrawal by Subject|1|||
154850960|NCT03222349|558884963|FG001|Overall Study|Withdrawal by Subject|0|||
154850961|NCT03222349|558884962|FG000|Overall Study|Treatment A not done|0|||
154850962|NCT03222349|558884963|FG001|Overall Study|Treatment A not done|5|||
154850963|NCT03222349|558884962|FG000|Overall Study|Study terminated by sponsor|1|||
154850964|NCT03222349|558884963|FG001|Overall Study|Study terminated by sponsor|0|||
154850965|NCT03739528|558884964|FG000|Overall Study|Not treated|8|||
154850966|NCT03739528|558884965|FG001|Overall Study|Not treated|12|||
154850967|NCT03739528|558884964|FG000|Overall Study|Treatment and study discontinued|6|||
154850968|NCT03739528|558884965|FG001|Overall Study|Treatment and study discontinued|2|||
154850969|NCT03739528|558884964|FG000|Overall Study|Treatment discontinued + study completed|1|||
154850970|NCT03739528|558884965|FG001|Overall Study|Treatment discontinued + study completed|3|||
154850971|NCT05099640|558884968|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
154850972|NCT05099640|558884969|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
154850973|NCT05099640|558884970|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
154850974|NCT05099640|558884968|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
154850975|NCT05099640|558884969|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
154850976|NCT05099640|558884970|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
154850977|NCT05099640|558884968|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
154850978|NCT05099640|558884969|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
154850979|NCT05099640|558884970|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
154850980|NCT05099640|558884968|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
154850981|NCT05099640|558884969|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
154850982|NCT05099640|558884970|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
154850983|NCT05099640|558884968|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
154850984|NCT05099640|558884969|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
154850985|NCT05099640|558884970|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
154850986|NCT05099640|558884968|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
154850987|NCT05099640|558884969|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
154850988|NCT05099640|558884970|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
154850989|NCT01552681|558884971|FG000|Overall Study|Withdrawal by Subject|4|||
154850990|NCT01552681|558884972|FG001|Overall Study|Withdrawal by Subject|0|||
154850991|NCT01552681|558884971|FG000|Overall Study|Physician Decision|1|||
154850992|NCT01552681|558884972|FG001|Overall Study|Physician Decision|0|||
154850993|NCT01552681|558884971|FG000|Overall Study|Subject moved away|0|||
154850994|NCT01552681|558884972|FG001|Overall Study|Subject moved away|1|||
154850995|NCT03075163|558884973|FG000|Overall Study|not eligible for treatment limb|138|||
154850996|NCT03075163|558884974|FG001|Overall Study|not eligible for treatment limb|138|||
154850997|NCT01731678|558884977|FG000|Overall Study|Withdrawal by Subject|3|||
154850998|NCT01731678|558884977|FG000|Overall Study|Did not meet inclusion criteria|1|||
154850999|NCT01731678|558884977|FG000|Overall Study|RMT too high, making TMS difficult|3|||
154851000|NCT03665285|558884978|FG000|Overall Study|Started New Anticancer Treatment|1|||
154851001|NCT03665285|558884979|FG001|Overall Study|Started New Anticancer Treatment|1|||
154851002|NCT03665285|558884980|FG002|Overall Study|Started New Anticancer Treatment|2|||
154851003|NCT03665285|558884981|FG003|Overall Study|Started New Anticancer Treatment|4|||
154851004|NCT03665285|558884982|FG004|Overall Study|Started New Anticancer Treatment|1|||
154851005|NCT03665285|558884983|FG005|Overall Study|Started New Anticancer Treatment|1|||
154851006|NCT03665285|558884984|FG006|Overall Study|Started New Anticancer Treatment|2|||
154851007|NCT03665285|558884985|FG007|Overall Study|Started New Anticancer Treatment|15|||
154851008|NCT03665285|558884986|FG008|Overall Study|Started New Anticancer Treatment|1|||
154851009|NCT03665285|558884978|FG000|Overall Study|Disease Progression|0|||
154851010|NCT03665285|558884979|FG001|Overall Study|Disease Progression|0|||
154851011|NCT03665285|558884980|FG002|Overall Study|Disease Progression|3|||
154851012|NCT03665285|558884981|FG003|Overall Study|Disease Progression|1|||
154851013|NCT03665285|558884982|FG004|Overall Study|Disease Progression|0|||
154851014|NCT03665285|558884983|FG005|Overall Study|Disease Progression|0|||
154851015|NCT03665285|558884984|FG006|Overall Study|Disease Progression|0|||
154851016|NCT03665285|558884985|FG007|Overall Study|Disease Progression|7|||
154851017|NCT03665285|558884986|FG008|Overall Study|Disease Progression|1|||
154851018|NCT03665285|558884978|FG000|Overall Study|Hospice|0|||
154851019|NCT03665285|558884979|FG001|Overall Study|Hospice|0|||
154851020|NCT03665285|558884980|FG002|Overall Study|Hospice|0|||
154851021|NCT03665285|558884981|FG003|Overall Study|Hospice|0|||
154851022|NCT03665285|558884982|FG004|Overall Study|Hospice|0|||
154851023|NCT03665285|558884983|FG005|Overall Study|Hospice|0|||
154851024|NCT03665285|558884984|FG006|Overall Study|Hospice|0|||
154851025|NCT03665285|558884985|FG007|Overall Study|Hospice|2|||
154851026|NCT03665285|558884986|FG008|Overall Study|Hospice|0|||
154851027|NCT03665285|558884978|FG000|Overall Study|Withdrawal by Subject|0|||
154851028|NCT03665285|558884979|FG001|Overall Study|Withdrawal by Subject|0|||
154851029|NCT03665285|558884980|FG002|Overall Study|Withdrawal by Subject|0|||
154851030|NCT03665285|558884981|FG003|Overall Study|Withdrawal by Subject|0|||
154851031|NCT03665285|558884982|FG004|Overall Study|Withdrawal by Subject|1|||
154851032|NCT03665285|558884983|FG005|Overall Study|Withdrawal by Subject|0|||
154851033|NCT03665285|558884984|FG006|Overall Study|Withdrawal by Subject|0|||
154851034|NCT03665285|558884985|FG007|Overall Study|Withdrawal by Subject|2|||
154851035|NCT03665285|558884986|FG008|Overall Study|Withdrawal by Subject|0|||
154851036|NCT03665285|558884978|FG000|Overall Study|Physician Decision|0|||
154851037|NCT03665285|558884979|FG001|Overall Study|Physician Decision|0|||
154851038|NCT03665285|558884980|FG002|Overall Study|Physician Decision|0|||
154851039|NCT03665285|558884981|FG003|Overall Study|Physician Decision|0|||
154851040|NCT03665285|558884982|FG004|Overall Study|Physician Decision|0|||
154851041|NCT03665285|558884983|FG005|Overall Study|Physician Decision|0|||
154851042|NCT03665285|558884984|FG006|Overall Study|Physician Decision|0|||
154851043|NCT03665285|558884985|FG007|Overall Study|Physician Decision|2|||
154851044|NCT03665285|558884986|FG008|Overall Study|Physician Decision|0|||
154851045|NCT00354601|558884987|FG000|Overall Study|Protocol Violation|1|||
154851046|NCT00354601|558884987|FG000|Overall Study|progression|1|||
154851047|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
154851048|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
154851049|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
154851050|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Death|28|||
154851051|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Death|0|||
154851052|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Death|0|||
154851053|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
154851054|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
154851055|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
154851056|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
154851057|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
154851058|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
154851059|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
154851060|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
154851061|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
154851062|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
154851063|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
154851064|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
154851065|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
154851066|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
154851067|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
154851068|NCT00820755|558884990|FG000|Period 1: Combination Therapy Phase|Other|11|||
154851069|NCT00820755|558884991|FG001|Period 1: Combination Therapy Phase|Other|0|||
154851070|NCT00820755|558884992|FG002|Period 1: Combination Therapy Phase|Other|0|||
154851071|NCT00820755|558884990|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
154851072|NCT00820755|558884991|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
154851073|NCT00820755|558884992|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
154851074|NCT02251912|558884993|FG000|Overall Study|Withdrawal by Subject|2|||
154851075|NCT02251912|558884994|FG001|Overall Study|Withdrawal by Subject|3|||
154851076|NCT02251912|558884993|FG000|Overall Study|Adverse Event|0|||
154851077|NCT02251912|558884994|FG001|Overall Study|Adverse Event|2|||
154851078|NCT03434379|558884996|FG000|Global Period|Lost to Follow-up|3|||
154851079|NCT03434379|558884997|FG001|Global Period|Lost to Follow-up|6|||
154851080|NCT03434379|558884998|FG002|Global Period|Lost to Follow-up|0|||
154851081|NCT03434379|558884999|FG003|Global Period|Lost to Follow-up|0|||
154851082|NCT03434379|558884996|FG000|Global Period|Death|115|||
154851083|NCT03434379|558884997|FG001|Global Period|Death|228|||
154851084|NCT03434379|558884998|FG002|Global Period|Death|0|||
154851085|NCT03434379|558884999|FG003|Global Period|Death|0|||
154851086|NCT03434379|558884996|FG000|Global Period|Withdrawal by Subject|20|||
154851087|NCT03434379|558884997|FG001|Global Period|Withdrawal by Subject|21|||
154851088|NCT03434379|558884998|FG002|Global Period|Withdrawal by Subject|0|||
154851089|NCT03434379|558884999|FG003|Global Period|Withdrawal by Subject|0|||
154851090|NCT03434379|558884996|FG000|Global Period|Reason Unspecified|0|||
154851091|NCT03434379|558884997|FG001|Global Period|Reason Unspecified|1|||
154851092|NCT03434379|558884998|FG002|Global Period|Reason Unspecified|0|||
154851093|NCT03434379|558884999|FG003|Global Period|Reason Unspecified|0|||
154851094|NCT03434379|558884996|FG000|Global Period|Study Ended by Sponsor|26|||
154851095|NCT03434379|558884997|FG001|Global Period|Study Ended by Sponsor|80|||
154851096|NCT03434379|558884998|FG002|Global Period|Study Ended by Sponsor|0|||
154851097|NCT03434379|558884999|FG003|Global Period|Study Ended by Sponsor|0|||
154851098|NCT03434379|558884996|FG000|Global Period|Physician Decision|1|||
154851099|NCT03434379|558884997|FG001|Global Period|Physician Decision|0|||
154851100|NCT03434379|558884998|FG002|Global Period|Physician Decision|0|||
154851101|NCT03434379|558884999|FG003|Global Period|Physician Decision|0|||
154851102|NCT03434379|558884996|FG000|China Extension Period|Lost to Follow-up|0|||
154851103|NCT03434379|558884997|FG001|China Extension Period|Lost to Follow-up|0|||
154851104|NCT03434379|558884998|FG002|China Extension Period|Lost to Follow-up|2|||
154851105|NCT03434379|558884999|FG003|China Extension Period|Lost to Follow-up|3|||
154971565|NCT01243151|559320572|FG003|Overall Study|Randomized but not treated|1|||
154971566|NCT01243151|559320573|FG004|Overall Study|Randomized but not treated|0|||
154851106|NCT03434379|558884996|FG000|China Extension Period|Death|0|||
154851107|NCT03434379|558884997|FG001|China Extension Period|Death|0|||
154851108|NCT03434379|558884998|FG002|China Extension Period|Death|46|||
154851109|NCT03434379|558884999|FG003|China Extension Period|Death|88|||
154851110|NCT03434379|558884996|FG000|China Extension Period|Withdrawal by Subject|0|||
154851111|NCT03434379|558884997|FG001|China Extension Period|Withdrawal by Subject|0|||
154851112|NCT03434379|558884998|FG002|China Extension Period|Withdrawal by Subject|8|||
154851113|NCT03434379|558884999|FG003|China Extension Period|Withdrawal by Subject|6|||
154851114|NCT03434379|558884996|FG000|China Extension Period|Study Ended by Sponsor|0|||
155105586|NCT05396014|559817555|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105587|NCT05396014|559817556|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105588|NCT05396014|559817557|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105589|NCT05396014|559817558|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105590|NCT05396014|559817559|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105591|NCT05396014|559817560|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105592|NCT05396014|559817561|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105593|NCT05396014|559817562|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105594|NCT05396014|559817563|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105595|NCT05396014|559817564|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
155105596|NCT05396014|559817565|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105597|NCT05396014|559817566|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105598|NCT05396014|559817567|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
155105599|NCT05396014|559817525|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
155105600|NCT05396014|559817526|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105601|NCT05396014|559817527|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105602|NCT05396014|559817528|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105603|NCT05396014|559817529|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105604|NCT05396014|559817530|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105605|NCT05396014|559817531|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105606|NCT05396014|559817532|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105607|NCT05396014|559817533|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105608|NCT05396014|559817534|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105609|NCT05396014|559817535|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105610|NCT05396014|559817536|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105611|NCT05396014|559817537|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105612|NCT05396014|559817538|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
154851115|NCT03434379|558884997|FG001|China Extension Period|Study Ended by Sponsor|0|||
154851116|NCT03434379|558884998|FG002|China Extension Period|Study Ended by Sponsor|5|||
154851117|NCT03434379|558884999|FG003|China Extension Period|Study Ended by Sponsor|36|||
154851118|NCT00686647|558885005|FG000|Overall Study|Lost to Follow-up|1|||
154851119|NCT00686647|558885005|FG000|Overall Study|Death|1|||
154851120|NCT03179436|558885007|FG000|Overall Study|Withdrawal by Subject|1|||
154851121|NCT03179436|558885008|FG001|Overall Study|Withdrawal by Subject|0|||
154851122|NCT03179436|558885009|FG002|Overall Study|Withdrawal by Subject|0|||
154851123|NCT03179436|558885010|FG003|Overall Study|Withdrawal by Subject|4|||
154851124|NCT03179436|558885011|FG004|Overall Study|Withdrawal by Subject|2|||
154851125|NCT03179436|558885012|FG005|Overall Study|Withdrawal by Subject|2|||
154851126|NCT03179436|558885013|FG006|Overall Study|Withdrawal by Subject|5|||
154851127|NCT03179436|558885014|FG007|Overall Study|Withdrawal by Subject|0|||
154851128|NCT03179436|558885015|FG008|Overall Study|Withdrawal by Subject|3|||
154851129|NCT03179436|558885016|FG009|Overall Study|Withdrawal by Subject|0|||
154851130|NCT03179436|558885017|FG010|Overall Study|Withdrawal by Subject|0|||
154851131|NCT03179436|558885018|FG011|Overall Study|Withdrawal by Subject|0|||
154851132|NCT03179436|558885007|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154851133|NCT03179436|558885008|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154851134|NCT03179436|558885009|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
154851135|NCT03179436|558885010|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
154851136|NCT03179436|558885011|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
154851137|NCT03179436|558885012|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155105613|NCT05396014|559817539|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105614|NCT05396014|559817540|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105615|NCT05396014|559817541|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105616|NCT05396014|559817542|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
154851138|NCT03179436|558885013|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
154851139|NCT03179436|558885014|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
154851140|NCT03179436|558885015|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
154851141|NCT03179436|558885016|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
154851142|NCT03179436|558885017|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
154851143|NCT03179436|558885018|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
154851144|NCT03179436|558885007|FG000|Overall Study|Sponsor Decision|0|||
154851145|NCT03179436|558885008|FG001|Overall Study|Sponsor Decision|0|||
154851146|NCT03179436|558885009|FG002|Overall Study|Sponsor Decision|1|||
154851147|NCT03179436|558885010|FG003|Overall Study|Sponsor Decision|3|||
154851148|NCT03179436|558885011|FG004|Overall Study|Sponsor Decision|9|||
154851149|NCT03179436|558885012|FG005|Overall Study|Sponsor Decision|7|||
154851150|NCT03179436|558885013|FG006|Overall Study|Sponsor Decision|2|||
154851151|NCT03179436|558885014|FG007|Overall Study|Sponsor Decision|4|||
154851152|NCT03179436|558885015|FG008|Overall Study|Sponsor Decision|23|||
154851153|NCT03179436|558885016|FG009|Overall Study|Sponsor Decision|6|||
154851154|NCT03179436|558885017|FG010|Overall Study|Sponsor Decision|7|||
154851155|NCT03179436|558885018|FG011|Overall Study|Sponsor Decision|5|||
154851156|NCT03179436|558885007|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851157|NCT03179436|558885008|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
154851158|NCT03179436|558885009|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851159|NCT03179436|558885010|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851160|NCT03179436|558885011|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851161|NCT03179436|558885012|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
154851162|NCT03179436|558885013|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851163|NCT03179436|558885014|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851164|NCT03179436|558885015|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851165|NCT03179436|558885016|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851166|NCT03179436|558885017|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851167|NCT03179436|558885018|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
154851168|NCT03179436|558885007|FG000|Overall Study|Lost to Follow-up|1|||
154851169|NCT03179436|558885008|FG001|Overall Study|Lost to Follow-up|0|||
154851170|NCT03179436|558885009|FG002|Overall Study|Lost to Follow-up|0|||
154851171|NCT03179436|558885010|FG003|Overall Study|Lost to Follow-up|1|||
154851172|NCT03179436|558885011|FG004|Overall Study|Lost to Follow-up|0|||
154851173|NCT03179436|558885012|FG005|Overall Study|Lost to Follow-up|1|||
154851174|NCT03179436|558885013|FG006|Overall Study|Lost to Follow-up|0|||
154851175|NCT03179436|558885014|FG007|Overall Study|Lost to Follow-up|0|||
154851176|NCT03179436|558885015|FG008|Overall Study|Lost to Follow-up|1|||
154851177|NCT03179436|558885016|FG009|Overall Study|Lost to Follow-up|1|||
154851178|NCT03179436|558885017|FG010|Overall Study|Lost to Follow-up|0|||
154851179|NCT03179436|558885018|FG011|Overall Study|Lost to Follow-up|0|||
154851180|NCT03179436|558885007|FG000|Overall Study|Death|12|||
154851181|NCT03179436|558885008|FG001|Overall Study|Death|17|||
154851182|NCT03179436|558885009|FG002|Overall Study|Death|7|||
154851183|NCT03179436|558885010|FG003|Overall Study|Death|32|||
154851184|NCT03179436|558885011|FG004|Overall Study|Death|29|||
154851185|NCT03179436|558885012|FG005|Overall Study|Death|30|||
154851186|NCT03179436|558885013|FG006|Overall Study|Death|33|||
154851187|NCT03179436|558885014|FG007|Overall Study|Death|9|||
154851188|NCT03179436|558885015|FG008|Overall Study|Death|84|||
154851189|NCT03179436|558885016|FG009|Overall Study|Death|33|||
154851190|NCT03179436|558885017|FG010|Overall Study|Death|22|||
154851191|NCT03179436|558885018|FG011|Overall Study|Death|15|||
154851192|NCT01634555|558885019|FG000|Overall Study|Adverse Event|3|||
154851193|NCT01634555|558885019|FG000|Overall Study|Physician Decision|1|||
154851194|NCT00809328|558887161|FG000|Overall Study|Lack of Efficacy|18|||
154851195|NCT00809328|558887161|FG000|Overall Study|Adverse Event|6|||
154851196|NCT00809328|558887161|FG000|Overall Study|Protocol Violation|3|||
154851197|NCT00809328|558887161|FG000|Overall Study|Withdrawal by Subject|2|||
154851198|NCT00282243|558887164|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
154851199|NCT00282243|558887164|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
154851200|NCT00282243|558887164|FG000|Extension Treatment Period|Adverse Event|15|||
154851201|NCT00282243|558887164|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
154851202|NCT00282243|558887164|FG000|Extension Treatment Period|Non-compliance|2|||
155173566|NCT03642132|560074830|FG002|Chemotherapy Period|Physician's decision|0|||
154851203|NCT00282243|558887164|FG000|Extension Treatment Period|Physician Decision|1|||
154851204|NCT00270894|558887165|FG000|Overall Study|Adverse Event|1|||
154851205|NCT00270894|558887165|FG000|Overall Study|Withdrawal by Subject|1|||
154851206|NCT00686127|558887166|FG000|Overall Study|Withdrawal by Subject|14|||
154851207|NCT00686127|558887167|FG001|Overall Study|Withdrawal by Subject|6|||
154851208|NCT01552902|558887174|FG000|Overall Study|Adverse Event|1|||
154851209|NCT01552902|558887175|FG001|Overall Study|Adverse Event|15|||
154971567|NCT00288704|559320574|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
154851210|NCT01552902|558887176|FG002|Overall Study|Adverse Event|14|||
154851211|NCT01552902|558887174|FG000|Overall Study|Protocol Violation|3|||
154851212|NCT01552902|558887175|FG001|Overall Study|Protocol Violation|3|||
154971568|NCT00288704|559320575|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
154971569|NCT00288704|559320576|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
154851213|NCT01552902|558887176|FG002|Overall Study|Protocol Violation|3|||
154851214|NCT01552902|558887174|FG000|Overall Study|Lack of Efficacy|4|||
154851215|NCT01552902|558887175|FG001|Overall Study|Lack of Efficacy|3|||
154851216|NCT01552902|558887176|FG002|Overall Study|Lack of Efficacy|1|||
154851217|NCT01552902|558887174|FG000|Overall Study|Withdrawal by Subject|1|||
154851218|NCT01552902|558887175|FG001|Overall Study|Withdrawal by Subject|9|||
155173567|NCT03642132|560074828|FG000|Chemotherapy Period|Progressive disease|0|||
155173568|NCT03642132|560074829|FG001|Chemotherapy Period|Progressive disease|0|||
154851219|NCT01552902|558887176|FG002|Overall Study|Withdrawal by Subject|6|||
154851220|NCT01552902|558887174|FG000|Overall Study|Lost to Follow-up|1|||
154851221|NCT01552902|558887175|FG001|Overall Study|Lost to Follow-up|3|||
154851222|NCT01552902|558887176|FG002|Overall Study|Lost to Follow-up|6|||
154851223|NCT01552902|558887174|FG000|Overall Study|Other|3|||
154851224|NCT01552902|558887175|FG001|Overall Study|Other|4|||
154851225|NCT01552902|558887176|FG002|Overall Study|Other|3|||
154851226|NCT04088409|558887177|FG000|Part A|Withdrawal by Subject|2|||
154851227|NCT04088409|558887178|FG001|Part A|Withdrawal by Subject|1|||
154851228|NCT04088409|558887177|FG000|Part A|Did Not Meet Randomization Criteria|2|||
154851229|NCT04088409|558887178|FG001|Part A|Did Not Meet Randomization Criteria|0|||
154851230|NCT04088409|558887177|FG000|Part A|Lack of Efficacy|9|||
154851231|NCT04088409|558887178|FG001|Part A|Lack of Efficacy|0|||
154851232|NCT04088409|558887177|FG000|Part A|Lost to Follow-up|1|||
154851233|NCT04088409|558887178|FG001|Part A|Lost to Follow-up|0|||
154851234|NCT04088409|558887177|FG000|Part A|Adverse Event|1|||
154851235|NCT04088409|558887178|FG001|Part A|Adverse Event|0|||
154851236|NCT04088409|558887177|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
154851237|NCT04088409|558887178|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
154851238|NCT04088409|558887177|FG000|Part B|Ongoing Treatment|10|||
154851239|NCT04088409|558887178|FG001|Part B|Ongoing Treatment|0|||
154851240|NCT00400400|558887179|FG000|Overall Study|Adverse Event|9|||
154851241|NCT00400400|558887180|FG001|Overall Study|Adverse Event|8|||
154851242|NCT00400400|558887179|FG000|Overall Study|Protocol Violation|2|||
154851243|NCT00400400|558887180|FG001|Overall Study|Protocol Violation|0|||
154851244|NCT00400400|558887179|FG000|Overall Study|Withdrawal by Subject|1|||
154851245|NCT00400400|558887180|FG001|Overall Study|Withdrawal by Subject|3|||
154851246|NCT00400400|558887179|FG000|Overall Study|Administrative Problem|1|||
154971570|NCT00288704|559320574|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
154851247|NCT00400400|558887180|FG001|Overall Study|Administrative Problem|0|||
154851248|NCT00400400|558887179|FG000|Overall Study|Lost to Follow-up|0|||
154851249|NCT00400400|558887180|FG001|Overall Study|Lost to Follow-up|1|||
154851250|NCT00400400|558887179|FG000|Overall Study|Did not receive study drug|1|||
154851251|NCT00400400|558887180|FG001|Overall Study|Did not receive study drug|3|||
154851252|NCT00364689|558887181|FG000|Overall Study|Lost to Follow-up|1|||
154851253|NCT03653390|558887191|FG000|Overall Study|Lost to Follow-up|12|||
154851254|NCT03653390|558887192|FG001|Overall Study|Lost to Follow-up|8|||
154851255|NCT03653390|558887193|FG002|Overall Study|Lost to Follow-up|7|||
154851256|NCT03653390|558887191|FG000|Overall Study|Withdrawal by Subject|6|||
154851257|NCT03653390|558887192|FG001|Overall Study|Withdrawal by Subject|1|||
154851258|NCT03653390|558887193|FG002|Overall Study|Withdrawal by Subject|1|||
154851259|NCT03653390|558887191|FG000|Overall Study|Death|1|||
154851260|NCT03653390|558887192|FG001|Overall Study|Death|0|||
154851261|NCT03653390|558887193|FG002|Overall Study|Death|0|||
154851262|NCT03653390|558887191|FG000|Overall Study|Paper Survey Lost|1|||
154851263|NCT03653390|558887192|FG001|Overall Study|Paper Survey Lost|0|||
154851264|NCT03653390|558887193|FG002|Overall Study|Paper Survey Lost|0|||
154851265|NCT03118947|558887194|FG000|Overall Study|Adverse Event|7|||
154851266|NCT03118947|558887194|FG000|Overall Study|Death|3|||
154851267|NCT03118947|558887194|FG000|Overall Study|Lack of Efficacy|4|||
154851268|NCT03118947|558887194|FG000|Overall Study|Non-compliance with study drug|1|||
154851269|NCT03118947|558887194|FG000|Overall Study|Protocol Violation|2|||
154851270|NCT03118947|558887194|FG000|Overall Study|Withdrawal by Subject|3|||
154851271|NCT03118947|558887194|FG000|Overall Study|Withdrawal by caregiver|3|||
154851272|NCT03118947|558887194|FG000|Overall Study|Change in patient's living situation|4|||
154851273|NCT03118947|558887194|FG000|Overall Study|Lost to Follow-up|2|||
154851274|NCT04451330|558887197|FG000|Overall Study|Adverse Event|1|||
154851275|NCT04451330|558887198|FG001|Overall Study|Adverse Event|2|||
154851276|NCT04451330|558887197|FG000|Overall Study|Lost to Follow-up|5|||
154851277|NCT04451330|558887198|FG001|Overall Study|Lost to Follow-up|0|||
154851278|NCT04451330|558887197|FG000|Overall Study|Withdrawal by Subject|3|||
154851279|NCT04451330|558887198|FG001|Overall Study|Withdrawal by Subject|1|||
154851280|NCT04451330|558887197|FG000|Overall Study|Withdrawal by parent/guardian|1|||
154851281|NCT04451330|558887198|FG001|Overall Study|Withdrawal by parent/guardian|0|||
154851282|NCT04451330|558887197|FG000|Overall Study|Other than specified|0|||
154851283|NCT04451330|558887198|FG001|Overall Study|Other than specified|1|||
154851284|NCT01987908|558887209|FG000|Placebo Lead-in Period|Adverse Event|2|||
154851285|NCT01987908|558887210|FG001|Placebo Lead-in Period|Adverse Event|0|||
154851286|NCT01987908|558887211|FG002|Placebo Lead-in Period|Adverse Event|0|||
154851287|NCT01987908|558887209|FG000|Placebo Lead-in Period|Physician Decision|2|||
154851288|NCT01987908|558887210|FG001|Placebo Lead-in Period|Physician Decision|0|||
154851289|NCT01987908|558887211|FG002|Placebo Lead-in Period|Physician Decision|0|||
154851290|NCT01987908|558887209|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
154851291|NCT01987908|558887210|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
154851292|NCT01987908|558887211|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
154851293|NCT01987908|558887209|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
154851294|NCT01987908|558887210|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
154851295|NCT01987908|558887211|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
154851296|NCT01987908|558887209|FG000|Treatment Period|Adverse Event|0|||
154851297|NCT01987908|558887210|FG001|Treatment Period|Adverse Event|1|||
154851298|NCT01987908|558887211|FG002|Treatment Period|Adverse Event|1|||
154851299|NCT01987908|558887209|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
154851300|NCT01987908|558887210|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
154851301|NCT01987908|558887211|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
154851302|NCT01987908|558887209|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
154851303|NCT01987908|558887210|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
154851304|NCT01987908|558887211|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
154851305|NCT00849667|558887212|FG000|Overall Study|Withdrawal by Subject|16|||
154851306|NCT00849667|558887213|FG001|Overall Study|Withdrawal by Subject|33|||
154851307|NCT00849667|558887214|FG002|Overall Study|Withdrawal by Subject|35|||
154851308|NCT00849667|558887212|FG000|Overall Study|Lost to Follow-up|8|||
154851309|NCT00849667|558887213|FG001|Overall Study|Lost to Follow-up|8|||
154851310|NCT00849667|558887214|FG002|Overall Study|Lost to Follow-up|8|||
154851311|NCT00849667|558887212|FG000|Overall Study|Adverse Event|1|||
154851312|NCT00849667|558887213|FG001|Overall Study|Adverse Event|2|||
154851313|NCT00849667|558887214|FG002|Overall Study|Adverse Event|0|||
154851314|NCT00849667|558887212|FG000|Overall Study|Other|18|||
154851315|NCT00849667|558887213|FG001|Overall Study|Other|19|||
155105617|NCT05396014|559817543|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105618|NCT05396014|559817544|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
154851316|NCT00849667|558887214|FG002|Overall Study|Other|18|||
154851317|NCT00849667|558887212|FG000|Overall Study|Progressive disease|119|||
154851318|NCT00849667|558887213|FG001|Overall Study|Progressive disease|100|||
154851319|NCT00849667|558887214|FG002|Overall Study|Progressive disease|112|||
154851320|NCT00849667|558887212|FG000|Overall Study|Sponsor decision|208|||
154851321|NCT00849667|558887213|FG001|Overall Study|Sponsor decision|204|||
154851322|NCT00849667|558887214|FG002|Overall Study|Sponsor decision|190|||
154851323|NCT00849667|558887212|FG000|Overall Study|Investigator discretion|0|||
154851324|NCT00849667|558887213|FG001|Overall Study|Investigator discretion|0|||
154851325|NCT00849667|558887214|FG002|Overall Study|Investigator discretion|1|||
154851326|NCT00189462|558887215|FG000|Overall Study|Lack of Efficacy|5|||
154851327|NCT00189462|558887216|FG001|Overall Study|Lack of Efficacy|1|||
154851328|NCT00189462|558887215|FG000|Overall Study|Lost to Follow-up|18|||
154851329|NCT00189462|558887216|FG001|Overall Study|Lost to Follow-up|20|||
154851330|NCT01869348|558887217|FG000|Overall Study|Withdrawal by Subject|1|||
154851331|NCT01869348|558887218|FG001|Overall Study|Withdrawal by Subject|1|||
154851332|NCT02789657|558887219|FG000|Overall Study|Withdrawal by Subject|2|||
154851333|NCT02789657|558887220|FG001|Overall Study|Withdrawal by Subject|0|||
154851334|NCT02789657|558887221|FG002|Overall Study|Withdrawal by Subject|0|||
154851335|NCT02789657|558887222|FG003|Overall Study|Withdrawal by Subject|0|||
154851336|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Adverse Event|21|||
154851337|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Adverse Event|6|||
155105619|NCT05396014|559817545|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105620|NCT05396014|559817546|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105621|NCT05396014|559817547|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105622|NCT05396014|559817548|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105623|NCT05396014|559817549|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105624|NCT05396014|559817550|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105625|NCT05396014|559817551|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
155105626|NCT05396014|559817552|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105627|NCT05396014|559817553|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105628|NCT05396014|559817554|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105629|NCT05396014|559817555|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105630|NCT05396014|559817556|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105631|NCT05396014|559817557|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105632|NCT05396014|559817558|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105633|NCT05396014|559817559|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105634|NCT05396014|559817560|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105635|NCT05396014|559817561|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105636|NCT05396014|559817562|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105637|NCT05396014|559817563|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105638|NCT05396014|559817564|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
155105639|NCT05396014|559817565|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105640|NCT05396014|559817566|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105641|NCT05396014|559817567|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
155105642|NCT05396014|559817525|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
155105643|NCT05396014|559817526|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105644|NCT05396014|559817527|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105645|NCT05396014|559817528|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105646|NCT05396014|559817529|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105647|NCT05396014|559817530|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105648|NCT05396014|559817531|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105649|NCT05396014|559817532|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105650|NCT05396014|559817533|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105651|NCT05396014|559817534|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105652|NCT05396014|559817535|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105653|NCT05396014|559817536|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105654|NCT05396014|559817537|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105655|NCT05396014|559817538|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
155105656|NCT05396014|559817539|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105657|NCT05396014|559817540|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105658|NCT05396014|559817541|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105659|NCT05396014|559817542|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105660|NCT05396014|559817543|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105661|NCT05396014|559817544|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105662|NCT05396014|559817545|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105663|NCT05396014|559817546|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105664|NCT05396014|559817547|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105665|NCT05396014|559817548|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105666|NCT05396014|559817549|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105667|NCT05396014|559817550|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105668|NCT05396014|559817551|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
155105669|NCT05396014|559817552|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
154851338|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
154851339|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
154851340|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
154851341|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
154851342|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
154851343|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
154851344|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Physician Decision|0|||
154851345|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Physician Decision|3|||
154851346|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
154851347|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
154851348|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
154851349|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
154851350|NCT00510276|558887233|FG000|Acute Double-Blind Phase|Subject Decision|26|||
154851351|NCT00510276|558887234|FG001|Acute Double-Blind Phase|Subject Decision|28|||
154851352|NCT00510276|558887233|FG000|Extension Open-Label Phase|Adverse Event|9|||
154851353|NCT00510276|558887234|FG001|Extension Open-Label Phase|Adverse Event|18|||
154851354|NCT00510276|558887233|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
154851355|NCT00510276|558887234|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
154851356|NCT00510276|558887233|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
154851357|NCT00510276|558887234|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
154851358|NCT00510276|558887233|FG000|Extension Open-Label Phase|Physician Decision|2|||
154851359|NCT00510276|558887234|FG001|Extension Open-Label Phase|Physician Decision|3|||
154851360|NCT00510276|558887233|FG000|Extension Open-Label Phase|Protocol Violation|0|||
154851361|NCT00510276|558887234|FG001|Extension Open-Label Phase|Protocol Violation|1|||
154851362|NCT00510276|558887233|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
154851363|NCT00510276|558887234|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
154851364|NCT00510276|558887233|FG000|Extension Open-Label Phase|Subject Decision|7|||
154851365|NCT00510276|558887234|FG001|Extension Open-Label Phase|Subject Decision|9|||
154851366|NCT01500057|558887235|FG000|Overall Study|Lost to Follow-up|6|||
154851367|NCT01500057|558887236|FG001|Overall Study|Lost to Follow-up|4|||
154851368|NCT00888355|558887241|FG000|Overall Study|Adverse Event|10|||
154851369|NCT00888355|558887242|FG001|Overall Study|Adverse Event|0|||
154851370|NCT00888355|558887243|FG002|Overall Study|Adverse Event|3|||
154851371|NCT00888355|558887244|FG003|Overall Study|Adverse Event|3|||
154851372|NCT00888355|558887241|FG000|Overall Study|Lack of Efficacy|9|||
154851373|NCT00888355|558887242|FG001|Overall Study|Lack of Efficacy|2|||
154851374|NCT00888355|558887243|FG002|Overall Study|Lack of Efficacy|5|||
154851375|NCT00888355|558887244|FG003|Overall Study|Lack of Efficacy|2|||
154851376|NCT00888355|558887241|FG000|Overall Study|Lost to Follow-up|0|||
154851377|NCT00888355|558887242|FG001|Overall Study|Lost to Follow-up|2|||
154851378|NCT00888355|558887243|FG002|Overall Study|Lost to Follow-up|2|||
154851379|NCT00888355|558887244|FG003|Overall Study|Lost to Follow-up|0|||
154851380|NCT00888355|558887241|FG000|Overall Study|Protocol Violation|3|||
154851381|NCT00888355|558887242|FG001|Overall Study|Protocol Violation|2|||
154851382|NCT00888355|558887243|FG002|Overall Study|Protocol Violation|1|||
154851383|NCT00888355|558887244|FG003|Overall Study|Protocol Violation|2|||
154851384|NCT00888355|558887241|FG000|Overall Study|Withdrawal by Subject|0|||
154851385|NCT00888355|558887242|FG001|Overall Study|Withdrawal by Subject|3|||
154851386|NCT00888355|558887243|FG002|Overall Study|Withdrawal by Subject|1|||
154851387|NCT00888355|558887244|FG003|Overall Study|Withdrawal by Subject|3|||
154851388|NCT03157531|558887250|FG000|Overall Study|Death|2|||
154851389|NCT03157531|558887250|FG000|Overall Study|Lost to Follow-up|4|||
154851390|NCT03603652|558887251|FG000|Overall Study|Death|2|||
154851391|NCT03213366|558887252|FG000|Overall Study|Lost to Follow-up|9|||
154851392|NCT03213366|558887253|FG001|Overall Study|Lost to Follow-up|4|||
154851393|NCT00666926|558887254|FG000|Overall Study|Adverse Event|0|||
154851394|NCT00666926|558887255|FG001|Overall Study|Adverse Event|0|||
154851395|NCT00666926|558887256|FG002|Overall Study|Adverse Event|0|||
154851396|NCT00666926|558887257|FG003|Overall Study|Adverse Event|0|||
154851397|NCT00666926|558887258|FG004|Overall Study|Adverse Event|0|||
154851398|NCT00666926|558887259|FG005|Overall Study|Adverse Event|0|||
154851399|NCT00666926|558887260|FG006|Overall Study|Adverse Event|0|||
154851400|NCT00666926|558887261|FG007|Overall Study|Adverse Event|0|||
154851401|NCT00666926|558887262|FG008|Overall Study|Adverse Event|0|||
154851402|NCT00666926|558887263|FG009|Overall Study|Adverse Event|2|||
154851403|NCT00666926|558887264|FG010|Overall Study|Adverse Event|2|||
154851404|NCT00666926|558887265|FG011|Overall Study|Adverse Event|2|||
154851405|NCT00666926|558887266|FG012|Overall Study|Adverse Event|0|||
154851406|NCT00666926|558887267|FG013|Overall Study|Adverse Event|1|||
154851407|NCT00666926|558887268|FG014|Overall Study|Adverse Event|0|||
154851408|NCT00666926|558887269|FG015|Overall Study|Adverse Event|0|||
154851409|NCT00666926|558887254|FG000|Overall Study|Laboratory abnormality|0|||
154851410|NCT00666926|558887255|FG001|Overall Study|Laboratory abnormality|0|||
154851411|NCT00666926|558887256|FG002|Overall Study|Laboratory abnormality|0|||
154851412|NCT00666926|558887257|FG003|Overall Study|Laboratory abnormality|0|||
154851413|NCT00666926|558887258|FG004|Overall Study|Laboratory abnormality|0|||
154851414|NCT00666926|558887259|FG005|Overall Study|Laboratory abnormality|0|||
154971571|NCT00288704|559320575|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
154851415|NCT00666926|558887260|FG006|Overall Study|Laboratory abnormality|0|||
154851416|NCT00666926|558887261|FG007|Overall Study|Laboratory abnormality|0|||
154851417|NCT00666926|558887262|FG008|Overall Study|Laboratory abnormality|0|||
154851418|NCT00666926|558887263|FG009|Overall Study|Laboratory abnormality|0|||
154851419|NCT00666926|558887264|FG010|Overall Study|Laboratory abnormality|1|||
154851420|NCT00666926|558887265|FG011|Overall Study|Laboratory abnormality|0|||
154851421|NCT00666926|558887266|FG012|Overall Study|Laboratory abnormality|0|||
154851422|NCT00666926|558887267|FG013|Overall Study|Laboratory abnormality|0|||
154851423|NCT00666926|558887268|FG014|Overall Study|Laboratory abnormality|0|||
154851424|NCT00666926|558887269|FG015|Overall Study|Laboratory abnormality|1|||
154851425|NCT00666926|558887254|FG000|Overall Study|Lack of Efficacy|0|||
154851426|NCT00666926|558887255|FG001|Overall Study|Lack of Efficacy|0|||
154851427|NCT00666926|558887256|FG002|Overall Study|Lack of Efficacy|0|||
154851428|NCT00666926|558887257|FG003|Overall Study|Lack of Efficacy|0|||
154851429|NCT00666926|558887258|FG004|Overall Study|Lack of Efficacy|0|||
154851430|NCT00666926|558887259|FG005|Overall Study|Lack of Efficacy|1|||
154851431|NCT00666926|558887260|FG006|Overall Study|Lack of Efficacy|0|||
154851432|NCT00666926|558887261|FG007|Overall Study|Lack of Efficacy|0|||
154851433|NCT00666926|558887262|FG008|Overall Study|Lack of Efficacy|0|||
154851434|NCT00666926|558887263|FG009|Overall Study|Lack of Efficacy|0|||
154851435|NCT00666926|558887264|FG010|Overall Study|Lack of Efficacy|0|||
154851436|NCT00666926|558887265|FG011|Overall Study|Lack of Efficacy|1|||
154851437|NCT00666926|558887266|FG012|Overall Study|Lack of Efficacy|0|||
154851438|NCT00666926|558887267|FG013|Overall Study|Lack of Efficacy|0|||
154851439|NCT00666926|558887268|FG014|Overall Study|Lack of Efficacy|0|||
154851440|NCT00666926|558887269|FG015|Overall Study|Lack of Efficacy|0|||
154851441|NCT00666926|558887254|FG000|Overall Study|Lost to Follow-up|0|||
154851442|NCT00666926|558887255|FG001|Overall Study|Lost to Follow-up|0|||
154851443|NCT00666926|558887256|FG002|Overall Study|Lost to Follow-up|0|||
154851444|NCT00666926|558887257|FG003|Overall Study|Lost to Follow-up|1|||
154851445|NCT00666926|558887258|FG004|Overall Study|Lost to Follow-up|0|||
154851446|NCT00666926|558887259|FG005|Overall Study|Lost to Follow-up|0|||
154851447|NCT00666926|558887260|FG006|Overall Study|Lost to Follow-up|0|||
154851448|NCT00666926|558887261|FG007|Overall Study|Lost to Follow-up|0|||
154851449|NCT00666926|558887262|FG008|Overall Study|Lost to Follow-up|0|||
154851450|NCT00666926|558887263|FG009|Overall Study|Lost to Follow-up|0|||
154851451|NCT00666926|558887264|FG010|Overall Study|Lost to Follow-up|0|||
154851452|NCT00666926|558887265|FG011|Overall Study|Lost to Follow-up|0|||
154851453|NCT00666926|558887266|FG012|Overall Study|Lost to Follow-up|0|||
154851454|NCT00666926|558887267|FG013|Overall Study|Lost to Follow-up|0|||
154851455|NCT00666926|558887268|FG014|Overall Study|Lost to Follow-up|0|||
154851456|NCT00666926|558887269|FG015|Overall Study|Lost to Follow-up|0|||
154851457|NCT00666926|558887254|FG000|Overall Study|Other|2|||
154851458|NCT00666926|558887255|FG001|Overall Study|Other|4|||
154851459|NCT00666926|558887256|FG002|Overall Study|Other|3|||
154851460|NCT00666926|558887257|FG003|Overall Study|Other|3|||
154851461|NCT00666926|558887258|FG004|Overall Study|Other|3|||
154851462|NCT00666926|558887259|FG005|Overall Study|Other|3|||
154851463|NCT00666926|558887260|FG006|Overall Study|Other|4|||
155105670|NCT05396014|559817553|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105671|NCT05396014|559817554|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105672|NCT05396014|559817555|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105673|NCT05396014|559817556|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105674|NCT05396014|559817557|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105675|NCT05396014|559817558|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105676|NCT05396014|559817559|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105677|NCT05396014|559817560|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105678|NCT05396014|559817561|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105679|NCT05396014|559817562|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105680|NCT05396014|559817563|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105681|NCT05396014|559817564|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
155105682|NCT05396014|559817565|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105683|NCT05396014|559817566|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105684|NCT05396014|559817567|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
155105685|NCT05396014|559817525|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154851464|NCT00666926|558887261|FG007|Overall Study|Other|0|||
154851465|NCT00666926|558887262|FG008|Overall Study|Other|3|||
154851466|NCT00666926|558887263|FG009|Overall Study|Other|5|||
154851467|NCT00666926|558887264|FG010|Overall Study|Other|3|||
154851468|NCT00666926|558887265|FG011|Overall Study|Other|26|||
154851469|NCT00666926|558887266|FG012|Overall Study|Other|3|||
154851470|NCT00666926|558887267|FG013|Overall Study|Other|2|||
154851471|NCT00666926|558887268|FG014|Overall Study|Other|4|||
154851472|NCT00666926|558887269|FG015|Overall Study|Other|4|||
154851473|NCT00666926|558887254|FG000|Overall Study|Withdrawal by Subject|0|||
154851474|NCT00666926|558887255|FG001|Overall Study|Withdrawal by Subject|0|||
154851475|NCT00666926|558887256|FG002|Overall Study|Withdrawal by Subject|0|||
154851476|NCT00666926|558887257|FG003|Overall Study|Withdrawal by Subject|0|||
155105686|NCT05396014|559817526|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105687|NCT05396014|559817527|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154851477|NCT00666926|558887258|FG004|Overall Study|Withdrawal by Subject|0|||
154851478|NCT00666926|558887259|FG005|Overall Study|Withdrawal by Subject|0|||
154851479|NCT00666926|558887260|FG006|Overall Study|Withdrawal by Subject|0|||
154851480|NCT00666926|558887261|FG007|Overall Study|Withdrawal by Subject|1|||
154851481|NCT00666926|558887262|FG008|Overall Study|Withdrawal by Subject|0|||
154851482|NCT00666926|558887263|FG009|Overall Study|Withdrawal by Subject|3|||
154851483|NCT00666926|558887264|FG010|Overall Study|Withdrawal by Subject|0|||
154851484|NCT00666926|558887265|FG011|Overall Study|Withdrawal by Subject|3|||
154851485|NCT00666926|558887266|FG012|Overall Study|Withdrawal by Subject|0|||
154851486|NCT00666926|558887267|FG013|Overall Study|Withdrawal by Subject|1|||
154851487|NCT00666926|558887268|FG014|Overall Study|Withdrawal by Subject|3|||
154851488|NCT00666926|558887269|FG015|Overall Study|Withdrawal by Subject|3|||
154851489|NCT00666926|558887254|FG000|Overall Study|Death|0|||
154851490|NCT00666926|558887255|FG001|Overall Study|Death|0|||
154851491|NCT00666926|558887256|FG002|Overall Study|Death|0|||
154851492|NCT00666926|558887257|FG003|Overall Study|Death|0|||
154851493|NCT00666926|558887258|FG004|Overall Study|Death|0|||
154851494|NCT00666926|558887259|FG005|Overall Study|Death|0|||
154851495|NCT00666926|558887260|FG006|Overall Study|Death|0|||
154851496|NCT00666926|558887261|FG007|Overall Study|Death|0|||
154851497|NCT00666926|558887262|FG008|Overall Study|Death|0|||
154851498|NCT00666926|558887263|FG009|Overall Study|Death|0|||
154851499|NCT00666926|558887264|FG010|Overall Study|Death|0|||
154851500|NCT00666926|558887265|FG011|Overall Study|Death|1|||
154851501|NCT00666926|558887266|FG012|Overall Study|Death|0|||
154851502|NCT00666926|558887267|FG013|Overall Study|Death|0|||
154851503|NCT00666926|558887268|FG014|Overall Study|Death|0|||
154851504|NCT00666926|558887269|FG015|Overall Study|Death|0|||
154851505|NCT01960855|558887270|FG000|Overall Study|Subject noncompliant|1|||
154851506|NCT01960855|558887271|FG001|Overall Study|Subject noncompliant|0|||
154851507|NCT01960855|558887272|FG002|Overall Study|Subject noncompliant|0|||
154851508|NCT01960855|558887273|FG003|Overall Study|Subject noncompliant|0|||
154851509|NCT01960855|558887274|FG004|Overall Study|Subject noncompliant|0|||
154851510|NCT01960855|558887270|FG000|Overall Study|Adverse Event|2|||
154851511|NCT01960855|558887271|FG001|Overall Study|Adverse Event|0|||
154851512|NCT01960855|558887272|FG002|Overall Study|Adverse Event|6|||
154851513|NCT01960855|558887273|FG003|Overall Study|Adverse Event|2|||
154851514|NCT01960855|558887274|FG004|Overall Study|Adverse Event|2|||
154851515|NCT01960855|558887270|FG000|Overall Study|Lack of Efficacy|1|||
154851516|NCT01960855|558887271|FG001|Overall Study|Lack of Efficacy|1|||
154851517|NCT01960855|558887272|FG002|Overall Study|Lack of Efficacy|0|||
154851518|NCT01960855|558887273|FG003|Overall Study|Lack of Efficacy|0|||
154851519|NCT01960855|558887274|FG004|Overall Study|Lack of Efficacy|0|||
154851520|NCT01960855|558887270|FG000|Overall Study|Other|2|||
154851521|NCT01960855|558887271|FG001|Overall Study|Other|1|||
154851522|NCT01960855|558887272|FG002|Overall Study|Other|1|||
154851523|NCT01960855|558887273|FG003|Overall Study|Other|1|||
154851524|NCT01960855|558887274|FG004|Overall Study|Other|0|||
154851525|NCT01960855|558887270|FG000|Overall Study|Consent withdrawn by subject|3|||
154851526|NCT01960855|558887271|FG001|Overall Study|Consent withdrawn by subject|1|||
154851527|NCT01960855|558887272|FG002|Overall Study|Consent withdrawn by subject|2|||
154851528|NCT01960855|558887273|FG003|Overall Study|Consent withdrawn by subject|1|||
154851529|NCT01960855|558887274|FG004|Overall Study|Consent withdrawn by subject|1|||
154851530|NCT01960855|558887270|FG000|Overall Study|Lost to Follow-up|2|||
154851531|NCT01960855|558887271|FG001|Overall Study|Lost to Follow-up|1|||
154851532|NCT01960855|558887272|FG002|Overall Study|Lost to Follow-up|0|||
154851533|NCT01960855|558887273|FG003|Overall Study|Lost to Follow-up|0|||
154851534|NCT01960855|558887274|FG004|Overall Study|Lost to Follow-up|2|||
154851535|NCT02058147|558887275|FG000|Overall Study|Randomized but not treated|0|||
154851536|NCT02058147|558887276|FG001|Overall Study|Randomized but not treated|0|||
154851537|NCT02058147|558887277|FG002|Overall Study|Randomized but not treated|1|||
154851538|NCT02058147|558887275|FG000|Overall Study|Adverse Event|12|||
154851539|NCT02058147|558887276|FG001|Overall Study|Adverse Event|9|||
154851540|NCT02058147|558887277|FG002|Overall Study|Adverse Event|21|||
154851541|NCT02058147|558887275|FG000|Overall Study|Lack of Efficacy|1|||
154851542|NCT02058147|558887276|FG001|Overall Study|Lack of Efficacy|0|||
154851543|NCT02058147|558887277|FG002|Overall Study|Lack of Efficacy|3|||
154851544|NCT02058147|558887275|FG000|Overall Study|Poor compliance to protocol|8|||
154851545|NCT02058147|558887276|FG001|Overall Study|Poor compliance to protocol|9|||
154851546|NCT02058147|558887277|FG002|Overall Study|Poor compliance to protocol|4|||
154851547|NCT02058147|558887275|FG000|Overall Study|Other than specified|8|||
154851548|NCT02058147|558887276|FG001|Overall Study|Other than specified|9|||
154851549|NCT02058147|558887277|FG002|Overall Study|Other than specified|0|||
154851550|NCT01318122|558887278|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
154851551|NCT01318122|558887279|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
154851552|NCT01318122|558887280|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
154971572|NCT00288704|559320576|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
154851553|NCT01318122|558887281|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
154851554|NCT01318122|558887278|FG000|Enrolled - Long-Term Extension Study|Other|1|||
154851555|NCT01318122|558887279|FG001|Enrolled - Long-Term Extension Study|Other|0|||
154851556|NCT01318122|558887280|FG002|Enrolled - Long-Term Extension Study|Other|0|||
154851557|NCT01318122|558887281|FG003|Enrolled - Long-Term Extension Study|Other|0|||
154851558|NCT01318122|558887278|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
154851559|NCT01318122|558887279|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
154851560|NCT01318122|558887280|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
154851561|NCT01318122|558887281|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
154851562|NCT01318122|558887278|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
154851563|NCT01318122|558887279|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
154851564|NCT01318122|558887280|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
154851565|NCT01318122|558887281|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
154851566|NCT01318122|558887278|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
154851567|NCT01318122|558887279|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
154851568|NCT01318122|558887280|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
154851569|NCT01318122|558887281|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
154851570|NCT01318122|558887278|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
154851571|NCT01318122|558887279|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
154851572|NCT01318122|558887280|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
154851573|NCT01318122|558887281|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
154851574|NCT01486199|558887282|FG000|Two Year Period Between Study Days|Physician Decision|1|||
154851575|NCT01486199|558887283|FG001|Two Year Period Between Study Days|Physician Decision|0|||
154851576|NCT02154425|558887289|FG000|Screening Period|Adverse Event|1|||
154851577|NCT00773279|558887290|FG000|Period 1|Adverse Event|2|||
154851578|NCT00773279|558887291|FG001|Period 1|Adverse Event|1|||
154851579|NCT00773279|558887290|FG000|Period 1|Lack of Efficacy|0|||
154851580|NCT00773279|558887291|FG001|Period 1|Lack of Efficacy|2|||
154851581|NCT00773279|558887290|FG000|Period 1|Unclassified|5|||
154851582|NCT00773279|558887291|FG001|Period 1|Unclassified|1|||
154851583|NCT00773279|558887290|FG000|Period 2|Adverse Event|0|||
154851584|NCT00773279|558887291|FG001|Period 2|Adverse Event|1|||
154851585|NCT00773279|558887290|FG000|Period 2|Lack of Efficacy|1|||
154851586|NCT00773279|558887291|FG001|Period 2|Lack of Efficacy|0|||
154851587|NCT00773279|558887290|FG000|Period 2|Protocol Violation|0|||
154851588|NCT00773279|558887291|FG001|Period 2|Protocol Violation|3|||
154851589|NCT00773279|558887290|FG000|Period 2|Unclassified|2|||
154851590|NCT00773279|558887291|FG001|Period 2|Unclassified|2|||
154851591|NCT01133171|558887298|FG000|Overall Study|Withdrawal by Subject|1|||
154851592|NCT01133171|558887299|FG001|Overall Study|Withdrawal by Subject|2|||
154851593|NCT01133171|558887300|FG002|Overall Study|Withdrawal by Subject|0|||
154851594|NCT02526550|558887301|FG000|Overall Study|Lost to Follow-up|1|||
154851595|NCT04062214|558887305|FG000|Week 12|Death|1|||
154851596|NCT04062214|558887306|FG001|Week 12|Death|1|||
154851597|NCT04062214|558887305|FG000|Week 12|Withdrawal by Subject|14|||
154851598|NCT04062214|558887306|FG001|Week 12|Withdrawal by Subject|13|||
154851599|NCT04062214|558887305|FG000|Week 12|Lost to Follow-up|55|||
154851600|NCT04062214|558887306|FG001|Week 12|Lost to Follow-up|68|||
154851601|NCT04062214|558887305|FG000|Week 12|Intermittent missing|31|||
154851602|NCT04062214|558887306|FG001|Week 12|Intermittent missing|29|||
154851603|NCT04062214|558887305|FG000|Week 36|Withdrawal by Subject|4|||
154851604|NCT04062214|558887306|FG001|Week 36|Withdrawal by Subject|5|||
154851605|NCT04062214|558887305|FG000|Week 36|Lost to Follow-up|50|||
154851606|NCT04062214|558887306|FG001|Week 36|Lost to Follow-up|46|||
154851607|NCT04062214|558887305|FG000|Week 36|Death|0|||
154851608|NCT04062214|558887306|FG001|Week 36|Death|1|||
154851609|NCT00091832|558887307|FG000|Overall Study|Physician Decision|1|||
154851610|NCT00091832|558887308|FG001|Overall Study|Physician Decision|0|||
154851611|NCT00091832|558887309|FG002|Overall Study|Physician Decision|0|||
154851612|NCT00091832|558887310|FG003|Overall Study|Physician Decision|0|||
154851613|NCT00091832|558887311|FG004|Overall Study|Physician Decision|0|||
154851614|NCT00091832|558887312|FG005|Overall Study|Physician Decision|0|||
154851615|NCT00091832|558887307|FG000|Overall Study|Adverse Event|0|||
154971573|NCT00288704|559320574|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
154851616|NCT00091832|558887308|FG001|Overall Study|Adverse Event|0|||
154851617|NCT00091832|558887309|FG002|Overall Study|Adverse Event|0|||
155105688|NCT05396014|559817528|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154851618|NCT00091832|558887310|FG003|Overall Study|Adverse Event|1|||
154851619|NCT00091832|558887311|FG004|Overall Study|Adverse Event|3|||
154851620|NCT00091832|558887312|FG005|Overall Study|Adverse Event|0|||
154851621|NCT00091832|558887307|FG000|Overall Study|Withdrawal by Subject|4|||
154851622|NCT00091832|558887308|FG001|Overall Study|Withdrawal by Subject|5|||
155105689|NCT05396014|559817529|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154851623|NCT00091832|558887309|FG002|Overall Study|Withdrawal by Subject|0|||
154851624|NCT00091832|558887310|FG003|Overall Study|Withdrawal by Subject|1|||
154851625|NCT00091832|558887311|FG004|Overall Study|Withdrawal by Subject|3|||
154851626|NCT00091832|558887312|FG005|Overall Study|Withdrawal by Subject|1|||
154971574|NCT00288704|559320575|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
154851627|NCT00091832|558887307|FG000|Overall Study|Death|6|||
154851628|NCT00091832|558887308|FG001|Overall Study|Death|4|||
154851629|NCT00091832|558887309|FG002|Overall Study|Death|5|||
154851630|NCT00091832|558887310|FG003|Overall Study|Death|8|||
154851631|NCT00091832|558887311|FG004|Overall Study|Death|5|||
154851632|NCT00091832|558887312|FG005|Overall Study|Death|6|||
154851633|NCT00091832|558887307|FG000|Overall Study|Disease Progression|2|||
154851634|NCT00091832|558887308|FG001|Overall Study|Disease Progression|0|||
154851635|NCT00091832|558887309|FG002|Overall Study|Disease Progression|0|||
154851636|NCT00091832|558887310|FG003|Overall Study|Disease Progression|1|||
154851637|NCT00091832|558887311|FG004|Overall Study|Disease Progression|1|||
154851638|NCT00091832|558887312|FG005|Overall Study|Disease Progression|2|||
154851639|NCT00091832|558887307|FG000|Overall Study|Ineligibility Determined|0|||
154851640|NCT00091832|558887308|FG001|Overall Study|Ineligibility Determined|0|||
154851641|NCT00091832|558887309|FG002|Overall Study|Ineligibility Determined|1|||
154851642|NCT00091832|558887310|FG003|Overall Study|Ineligibility Determined|0|||
154851643|NCT00091832|558887311|FG004|Overall Study|Ineligibility Determined|1|||
154851644|NCT00091832|558887312|FG005|Overall Study|Ineligibility Determined|0|||
154851645|NCT00091832|558887307|FG000|Overall Study|Lost to Follow-up|1|||
154851646|NCT00091832|558887308|FG001|Overall Study|Lost to Follow-up|0|||
154851647|NCT00091832|558887309|FG002|Overall Study|Lost to Follow-up|3|||
154851648|NCT00091832|558887310|FG003|Overall Study|Lost to Follow-up|3|||
154851649|NCT00091832|558887311|FG004|Overall Study|Lost to Follow-up|2|||
154851650|NCT00091832|558887312|FG005|Overall Study|Lost to Follow-up|1|||
154851651|NCT00091832|558887307|FG000|Overall Study|Noncompliance|0|||
154851652|NCT00091832|558887308|FG001|Overall Study|Noncompliance|1|||
154851653|NCT00091832|558887309|FG002|Overall Study|Noncompliance|0|||
154851654|NCT00091832|558887310|FG003|Overall Study|Noncompliance|0|||
154851655|NCT00091832|558887311|FG004|Overall Study|Noncompliance|0|||
154851656|NCT00091832|558887312|FG005|Overall Study|Noncompliance|0|||
154851657|NCT00091832|558887307|FG000|Overall Study|Other|0|||
154851658|NCT00091832|558887308|FG001|Overall Study|Other|1|||
154851659|NCT00091832|558887309|FG002|Overall Study|Other|2|||
154851660|NCT00091832|558887310|FG003|Overall Study|Other|0|||
154851661|NCT00091832|558887311|FG004|Overall Study|Other|0|||
154851662|NCT00091832|558887312|FG005|Overall Study|Other|0|||
154851663|NCT00091832|558887307|FG000|Overall Study|Protocol Violation|0|||
154851664|NCT00091832|558887308|FG001|Overall Study|Protocol Violation|0|||
154851665|NCT00091832|558887309|FG002|Overall Study|Protocol Violation|1|||
154851666|NCT00091832|558887310|FG003|Overall Study|Protocol Violation|0|||
154851667|NCT00091832|558887311|FG004|Overall Study|Protocol Violation|0|||
154851668|NCT00091832|558887312|FG005|Overall Study|Protocol Violation|1|||
154851669|NCT01557166|558887316|FG000|Overall Study|Adverse Event|20|||
154851670|NCT01557166|558887317|FG001|Overall Study|Adverse Event|6|||
154851671|NCT01557166|558887316|FG000|Overall Study|Lack of Efficacy|2|||
154851672|NCT01557166|558887317|FG001|Overall Study|Lack of Efficacy|1|||
154851673|NCT01557166|558887316|FG000|Overall Study|Protocol Violation|8|||
154851674|NCT01557166|558887317|FG001|Overall Study|Protocol Violation|5|||
154851675|NCT01557166|558887316|FG000|Overall Study|Withdrawn consent|12|||
154851676|NCT01557166|558887317|FG001|Overall Study|Withdrawn consent|20|||
154851677|NCT01557166|558887316|FG000|Overall Study|Target dose not tolerated|1|||
154851678|NCT01557166|558887317|FG001|Overall Study|Target dose not tolerated|0|||
154851679|NCT01557166|558887316|FG000|Overall Study|Psychiatric disorder|1|||
154851680|NCT01557166|558887317|FG001|Overall Study|Psychiatric disorder|0|||
154851681|NCT01557166|558887316|FG000|Overall Study|Unclassified|2|||
154851682|NCT01557166|558887317|FG001|Overall Study|Unclassified|5|||
154851683|NCT00946309|558887318|FG000|Overall Study|Protocol Violation|1|||
154851684|NCT00946309|558887319|FG001|Overall Study|Protocol Violation|0|||
154851685|NCT00946309|558887318|FG000|Overall Study|Lost to Follow-up|0|||
154851686|NCT00946309|558887319|FG001|Overall Study|Lost to Follow-up|1|||
154851687|NCT00946309|558887318|FG000|Overall Study|Procedure cancelled/discontinued|0|||
154851688|NCT00946309|558887319|FG001|Overall Study|Procedure cancelled/discontinued|3|||
154851689|NCT01465659|558887323|FG000|Completed 1 Cycle of Treatment|Death|0|||
154851690|NCT01465659|558887324|FG001|Completed 1 Cycle of Treatment|Death|1|||
154851691|NCT01465659|558887325|FG002|Completed 1 Cycle of Treatment|Death|0|||
154851692|NCT01465659|558887326|FG003|Completed 1 Cycle of Treatment|Death|0|||
154851693|NCT01465659|558887323|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
154851694|NCT01465659|558887324|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
154851695|NCT01465659|558887325|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
154851696|NCT01465659|558887326|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
154851697|NCT01465659|558887323|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
154851698|NCT01465659|558887324|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
154851699|NCT01465659|558887325|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
154851700|NCT01465659|558887326|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
154851701|NCT01465659|558887323|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
154851702|NCT01465659|558887324|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
154851703|NCT01465659|558887325|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
154851704|NCT01465659|558887326|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
154851705|NCT01465659|558887323|FG000|Completed Follow for 1 Year|Death|6|||
155173569|NCT03642132|560074830|FG002|Chemotherapy Period|Progressive disease|1|||
155173570|NCT03642132|560074828|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
155173571|NCT03642132|560074829|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
155173572|NCT03642132|560074830|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
155173573|NCT03642132|560074828|FG000|Chemotherapy Period|Other|1|||
155173574|NCT03642132|560074829|FG001|Chemotherapy Period|Other|0|||
155173575|NCT03642132|560074830|FG002|Chemotherapy Period|Other|2|||
155173576|NCT03642132|560074828|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
155173577|NCT03642132|560074829|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
155173578|NCT03642132|560074830|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
155173579|NCT03642132|560074828|FG000|Maintenance Period|Adverse Event|1|||
155173580|NCT03642132|560074829|FG001|Maintenance Period|Adverse Event|2|||
155173581|NCT03642132|560074830|FG002|Maintenance Period|Adverse Event|0|||
155173582|NCT03642132|560074828|FG000|Maintenance Period|Non-compliance with study drug|0|||
155173583|NCT03642132|560074829|FG001|Maintenance Period|Non-compliance with study drug|0|||
155173584|NCT03642132|560074830|FG002|Maintenance Period|Non-compliance with study drug|1|||
155173585|NCT03642132|560074828|FG000|Maintenance Period|Physician's decision|2|||
155173586|NCT03642132|560074829|FG001|Maintenance Period|Physician's decision|2|||
155173587|NCT03642132|560074830|FG002|Maintenance Period|Physician's decision|2|||
155173588|NCT03642132|560074828|FG000|Maintenance Period|Progressive disease|9|||
155173589|NCT03642132|560074829|FG001|Maintenance Period|Progressive disease|3|||
155173590|NCT03642132|560074830|FG002|Maintenance Period|Progressive disease|6|||
155173591|NCT03642132|560074828|FG000|Maintenance Period|Other|0|||
155173592|NCT03642132|560074829|FG001|Maintenance Period|Other|0|||
155173593|NCT03642132|560074830|FG002|Maintenance Period|Other|3|||
155173594|NCT03642132|560074828|FG000|Maintenance Period|Withdrawal by Subject|1|||
155173595|NCT03642132|560074829|FG001|Maintenance Period|Withdrawal by Subject|1|||
155173596|NCT03642132|560074830|FG002|Maintenance Period|Withdrawal by Subject|2|||
155173597|NCT03642132|560074828|FG000|Follow-up Period|Other|0|||
155173598|NCT03642132|560074829|FG001|Follow-up Period|Other|0|||
155173599|NCT03642132|560074830|FG002|Follow-up Period|Other|1|||
155173600|NCT03642132|560074828|FG000|Follow-up Period|Withdrawal by Subject|1|||
155173601|NCT03642132|560074829|FG001|Follow-up Period|Withdrawal by Subject|2|||
155173602|NCT03642132|560074830|FG002|Follow-up Period|Withdrawal by Subject|0|||
155173603|NCT03642132|560074828|FG000|Follow-up Period|Study terminated by sponsor|1|||
155173604|NCT03642132|560074829|FG001|Follow-up Period|Study terminated by sponsor|0|||
155173605|NCT03642132|560074830|FG002|Follow-up Period|Study terminated by sponsor|1|||
155173606|NCT03642132|560074828|FG000|Follow-up Period|Lack of Efficacy|1|||
155173607|NCT03642132|560074829|FG001|Follow-up Period|Lack of Efficacy|0|||
155173608|NCT03642132|560074830|FG002|Follow-up Period|Lack of Efficacy|0|||
155173609|NCT03642132|560074828|FG000|Follow-up Period|Death|1|||
154851706|NCT01465659|558887324|FG001|Completed Follow for 1 Year|Death|3|||
154851707|NCT01465659|558887325|FG002|Completed Follow for 1 Year|Death|2|||
154851708|NCT01465659|558887326|FG003|Completed Follow for 1 Year|Death|4|||
154851709|NCT02445586|558887332|FG000|Overall Study|Death|14|||
154851710|NCT02445586|558887332|FG000|Overall Study|Withdrawal by Subject|13|||
154851711|NCT02445586|558887332|FG000|Overall Study|Disease Progression|10|||
154851712|NCT02445586|558887332|FG000|Overall Study|Protocol Violation|1|||
154851713|NCT02445586|558887332|FG000|Overall Study|Medical Condition|1|||
154851714|NCT00428597|558887333|FG000|Overall Study|Randomized but not treated|3|||
154851715|NCT00428597|558887334|FG001|Overall Study|Randomized but not treated|3|||
154851716|NCT00428597|558887333|FG000|Overall Study|Objective Progression or Relapse|19|||
154851717|NCT00428597|558887334|FG001|Overall Study|Objective Progression or Relapse|47|||
154851718|NCT00428597|558887333|FG000|Overall Study|Study Terminated by Sponsor|41|||
154851719|NCT00428597|558887334|FG001|Overall Study|Study Terminated by Sponsor|16|||
154851720|NCT00428597|558887333|FG000|Overall Study|Adverse Event|15|||
154851721|NCT00428597|558887334|FG001|Overall Study|Adverse Event|7|||
154851722|NCT00428597|558887333|FG000|Overall Study|Global Deterioration of Health Status|1|||
154851723|NCT00428597|558887334|FG001|Overall Study|Global Deterioration of Health Status|5|||
154851724|NCT00428597|558887333|FG000|Overall Study|Protocol Violation|2|||
154851725|NCT00428597|558887334|FG001|Overall Study|Protocol Violation|1|||
154851726|NCT00428597|558887333|FG000|Overall Study|Withdrawal by Subject|2|||
154851727|NCT00428597|558887334|FG001|Overall Study|Withdrawal by Subject|1|||
154851728|NCT00428597|558887333|FG000|Overall Study|Other|1|||
154851729|NCT00428597|558887334|FG001|Overall Study|Other|1|||
154851730|NCT00428597|558887333|FG000|Overall Study|Lost to Follow-up|0|||
154851731|NCT00428597|558887334|FG001|Overall Study|Lost to Follow-up|1|||
155173610|NCT03642132|560074829|FG001|Follow-up Period|Death|0|||
154851732|NCT00428597|558887333|FG000|Overall Study|Pregnancy|1|||
154851733|NCT00428597|558887334|FG001|Overall Study|Pregnancy|0|||
154851734|NCT00428597|558887333|FG000|Overall Study|Death|1|||
154851735|NCT00428597|558887334|FG001|Overall Study|Death|3|||
154851736|NCT00578643|558887335|FG000|Overall Study|Death|1|||
154851737|NCT00578643|558887335|FG000|Overall Study|Lost to Follow-up|1|||
154851738|NCT01725750|558887336|FG000|Overall Study|Adverse Event|1|||
155173611|NCT03642132|560074830|FG002|Follow-up Period|Death|2|||
154851739|NCT01725750|558887337|FG001|Overall Study|Adverse Event|0|||
155173612|NCT03642132|560074828|FG000|Follow-up Period|Adverse Event|1|||
155173613|NCT03642132|560074829|FG001|Follow-up Period|Adverse Event|0|||
154851740|NCT01725750|558887336|FG000|Overall Study|Lost to Follow-up|1|||
154851741|NCT01725750|558887337|FG001|Overall Study|Lost to Follow-up|1|||
154851742|NCT01725750|558887336|FG000|Overall Study|Withdrawal by Subject|0|||
154851743|NCT01725750|558887337|FG001|Overall Study|Withdrawal by Subject|9|||
154851744|NCT03828487|558887340|FG000|Overall Study|Physician Decision|1|||
154851745|NCT02447848|558887341|FG000|Overall Study|Patient discharged|3|||
154851746|NCT02447848|558887341|FG000|Overall Study|Lack of Efficacy|4|||
154851747|NCT02447848|558887341|FG000|Overall Study|Withdrawal by Subject|4|||
154851748|NCT02307370|558887342|FG000|Overall Study|Death|5|||
154851749|NCT02307370|558887342|FG000|Overall Study|Lost to Follow-up|1|||
154851750|NCT02307370|558887342|FG000|Overall Study|Withdrawal by Subject|1|||
154851751|NCT02307370|558887342|FG000|Overall Study|Declined Addendum ICF|6|||
154851752|NCT02307370|558887342|FG000|Overall Study|No response during telephone contact|5|||
154851753|NCT02307370|558887342|FG000|Overall Study|Protocol Violation|1|||
154851754|NCT01506882|558887343|FG000|Overall Study|Lack of Efficacy|4|||
154851755|NCT01506882|558887344|FG001|Overall Study|Lack of Efficacy|3|||
154851756|NCT01506882|558887343|FG000|Overall Study|Lost to Follow-up|1|||
154851757|NCT01506882|558887344|FG001|Overall Study|Lost to Follow-up|0|||
154851758|NCT01506882|558887343|FG000|Overall Study|Withdrawal by Subject|9|||
154851759|NCT01506882|558887344|FG001|Overall Study|Withdrawal by Subject|3|||
154851760|NCT01506882|558887343|FG000|Overall Study|SAE, non-fatal|2|||
154851761|NCT01506882|558887344|FG001|Overall Study|SAE, non-fatal|0|||
154971575|NCT00288704|559320576|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
154971576|NCT00288704|559320574|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
154971577|NCT00288704|559320575|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
154851762|NCT01506882|558887343|FG000|Overall Study|AE, non-serious non-fatal|3|||
154851763|NCT01506882|558887344|FG001|Overall Study|AE, non-serious non-fatal|1|||
154851764|NCT01506882|558887343|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
154851765|NCT01506882|558887344|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
154851766|NCT01506882|558887343|FG000|Overall Study|Other Reason|2|||
154851767|NCT01506882|558887344|FG001|Overall Study|Other Reason|0|||
154851768|NCT02591615|558889161|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
154971578|NCT00288704|559320576|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
154971579|NCT00288704|559320574|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
154971580|NCT00288704|559320575|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
154971581|NCT00288704|559320576|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
154971582|NCT00288704|559320574|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
154971583|NCT00288704|559320575|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
154971584|NCT00288704|559320576|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
154971585|NCT00288704|559320574|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
154971586|NCT00288704|559320575|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
154971587|NCT00288704|559320576|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
154971588|NCT01579006|559320577|FG000|Overall Study|Lack of Efficacy|10|||
154971589|NCT01579006|559320577|FG000|Overall Study|Adverse Event|13|||
154971590|NCT01579006|559320577|FG000|Overall Study|Withdrawal by Subject|5|||
154971591|NCT01579006|559320577|FG000|Overall Study|Non-compliance|3|||
154971592|NCT01579006|559320577|FG000|Overall Study|Due to participant's health fund|1|||
154971593|NCT01579006|559320577|FG000|Overall Study|Scheduled surgery|1|||
154971594|NCT00799708|559320579|FG000|Overall Study|non-compliance|1|||
154971595|NCT00799708|559320580|FG001|Overall Study|non-compliance|0|||
154971596|NCT00799708|559320581|FG002|Overall Study|non-compliance|0|||
154971597|NCT00880334|559320582|FG000|Randomized Phase|Physician Decision|1|||
154971598|NCT00880334|559320583|FG001|Randomized Phase|Physician Decision|0|||
154971599|NCT00880334|559320582|FG000|Randomized Phase|Withdrawal by Subject|2|||
154971600|NCT00880334|559320583|FG001|Randomized Phase|Withdrawal by Subject|1|||
154971601|NCT00880334|559320582|FG000|Randomized Phase|Inadequate Labs|1|||
154971602|NCT00880334|559320583|FG001|Randomized Phase|Inadequate Labs|1|||
154971603|NCT00880334|559320582|FG000|Randomized Phase|Brain Metastasis|0|||
154971604|NCT00880334|559320583|FG001|Randomized Phase|Brain Metastasis|1|||
154971605|NCT00880334|559320582|FG000|Randomized Phase|Crossover Participants|0|||
154971606|NCT00880334|559320583|FG001|Randomized Phase|Crossover Participants|37|||
154971607|NCT02473393|559320584|FG000|Overall Study|Adverse Event|0|||
154971608|NCT02473393|559320585|FG001|Overall Study|Adverse Event|0|||
154971609|NCT02473393|559320586|FG002|Overall Study|Adverse Event|1|||
154971610|NCT02473393|559320587|FG003|Overall Study|Adverse Event|0|||
154971611|NCT02473393|559320584|FG000|Overall Study|Withdrawal by Subject|0|||
154971612|NCT02473393|559320585|FG001|Overall Study|Withdrawal by Subject|0|||
154971613|NCT02473393|559320586|FG002|Overall Study|Withdrawal by Subject|1|||
154971614|NCT02473393|559320587|FG003|Overall Study|Withdrawal by Subject|1|||
154971615|NCT02274558|559320591|FG000|Overall Study|Adverse Event|2|||
154851769|NCT02591615|558889162|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
154851770|NCT02591615|558889163|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
154971616|NCT02274558|559320592|FG001|Overall Study|Adverse Event|4|||
154971617|NCT02274558|559320593|FG002|Overall Study|Adverse Event|2|||
154971618|NCT02274558|559320591|FG000|Overall Study|Non-compliance|2|||
155105690|NCT05396014|559817530|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105691|NCT05396014|559817531|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105692|NCT05396014|559817532|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105693|NCT05396014|559817533|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105694|NCT05396014|559817534|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105695|NCT05396014|559817535|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105696|NCT05396014|559817536|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105697|NCT05396014|559817537|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105698|NCT05396014|559817538|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105699|NCT05396014|559817539|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105700|NCT05396014|559817540|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105701|NCT05396014|559817541|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105702|NCT05396014|559817542|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105703|NCT05396014|559817543|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105704|NCT05396014|559817544|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105705|NCT05396014|559817545|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105706|NCT05396014|559817546|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105707|NCT05396014|559817547|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154971619|NCT02274558|559320592|FG001|Overall Study|Non-compliance|1|||
154971620|NCT02274558|559320593|FG002|Overall Study|Non-compliance|0|||
154971621|NCT02274558|559320591|FG000|Overall Study|Withdrawal by Subject|1|||
154971622|NCT02274558|559320592|FG001|Overall Study|Withdrawal by Subject|5|||
154971623|NCT02274558|559320593|FG002|Overall Study|Withdrawal by Subject|4|||
154971624|NCT02274558|559320591|FG000|Overall Study|Death|0|||
154971625|NCT02274558|559320592|FG001|Overall Study|Death|0|||
154971626|NCT02274558|559320593|FG002|Overall Study|Death|1|||
154971627|NCT02274558|559320591|FG000|Overall Study|Lost to Follow-up|2|||
154971628|NCT02274558|559320592|FG001|Overall Study|Lost to Follow-up|1|||
154971629|NCT02274558|559320593|FG002|Overall Study|Lost to Follow-up|1|||
154971630|NCT02274558|559320591|FG000|Overall Study|Physician Decision|0|||
154971631|NCT02274558|559320592|FG001|Overall Study|Physician Decision|2|||
154971632|NCT02274558|559320593|FG002|Overall Study|Physician Decision|1|||
154971633|NCT01257581|559320594|FG000|Overall Study|Early Termination|3|||
154971634|NCT01257581|559320595|FG001|Overall Study|Early Termination|1|||
154971635|NCT01257581|559320596|FG002|Overall Study|Early Termination|2|||
154971636|NCT01257581|559320594|FG000|Overall Study|Death|2|||
154971637|NCT01257581|559320595|FG001|Overall Study|Death|2|||
154971638|NCT01257581|559320596|FG002|Overall Study|Death|4|||
154971639|NCT01157234|559320599|FG000|Overall Study|Withdrawal by Subject|1|||
154971640|NCT01157234|559320600|FG001|Overall Study|Withdrawal by Subject|0|||
154971641|NCT02733627|559320609|FG000|Overall Study|Adverse Event|0|||
154971642|NCT02733627|559320610|FG001|Overall Study|Adverse Event|1|||
154971643|NCT02733627|559320611|FG002|Overall Study|Adverse Event|1|||
154971644|NCT02733627|559320612|FG003|Overall Study|Adverse Event|0|||
154971645|NCT02733627|559320609|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
154971646|NCT02733627|559320610|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
154971647|NCT02733627|559320611|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
154971648|NCT02733627|559320612|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
154971649|NCT00059332|559320613|FG000|Overall Study|Withdrawal by Subject|2|||
154971650|NCT00059332|559320614|FG001|Overall Study|Withdrawal by Subject|1|||
154971651|NCT00059332|559320613|FG000|Overall Study|Lost to Follow-up|1|||
154971652|NCT00059332|559320614|FG001|Overall Study|Lost to Follow-up|1|||
154971653|NCT01408888|559320617|FG000|First Intervention|Adverse Event|0|||
154971654|NCT01408888|559320618|FG001|First Intervention|Adverse Event|1|||
154971655|NCT01408888|559320617|FG000|First Intervention|Withdrawal by Subject|0|||
154971656|NCT01408888|559320618|FG001|First Intervention|Withdrawal by Subject|2|||
154971657|NCT01408888|559320617|FG000|Second Intervention|Withdrawal by Subject|1|||
154971658|NCT01408888|559320618|FG001|Second Intervention|Withdrawal by Subject|0|||
154971659|NCT01408888|559320617|FG000|Second Intervention|Adverse Event|1|||
154971660|NCT01408888|559320618|FG001|Second Intervention|Adverse Event|0|||
154971661|NCT01698554|559320633|FG000|Overall Study|Adverse Event|2|||
154971662|NCT01698554|559320634|FG001|Overall Study|Adverse Event|5|||
154971663|NCT01698554|559320635|FG002|Overall Study|Adverse Event|0|||
154971664|NCT01698554|559320636|FG003|Overall Study|Adverse Event|1|||
154971665|NCT01698554|559320633|FG000|Overall Study|Lost to Follow-up|1|||
154971666|NCT01698554|559320634|FG001|Overall Study|Lost to Follow-up|0|||
154971667|NCT01698554|559320635|FG002|Overall Study|Lost to Follow-up|0|||
154971668|NCT01698554|559320636|FG003|Overall Study|Lost to Follow-up|0|||
154971669|NCT01698554|559320633|FG000|Overall Study|Personal Reasons|0|||
154971670|NCT01698554|559320634|FG001|Overall Study|Personal Reasons|5|||
154971671|NCT01698554|559320635|FG002|Overall Study|Personal Reasons|1|||
154971672|NCT01698554|559320636|FG003|Overall Study|Personal Reasons|1|||
155105708|NCT05396014|559817548|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154851771|NCT02591615|558889164|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
154851772|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
154851773|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
154851774|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
154851775|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
154851776|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
154851777|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
154851778|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
154851779|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
154851780|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
154851781|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
154851782|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
154851783|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
154851784|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
154851785|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
154851786|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
154851787|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
154851788|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
154851789|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
154851790|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
154851791|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
154851792|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
154851793|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
154851794|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
154851795|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
154851796|NCT02591615|558889161|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
154851797|NCT02591615|558889162|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
154851798|NCT02591615|558889163|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
154851799|NCT02591615|558889164|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
154851800|NCT02591615|558889161|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
154851801|NCT02591615|558889162|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
154851802|NCT02591615|558889163|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
154851803|NCT02591615|558889164|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
154851804|NCT02591615|558889161|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
154851805|NCT02591615|558889162|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
154851806|NCT02591615|558889163|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
154851807|NCT02591615|558889164|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
154851808|NCT02591615|558889161|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
154851809|NCT02591615|558889162|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
154851810|NCT02591615|558889163|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
154851811|NCT02591615|558889164|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
154851812|NCT02591615|558889161|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
154851813|NCT02591615|558889162|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
154851814|NCT02591615|558889163|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
154851815|NCT02591615|558889164|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
154851816|NCT02591615|558889161|FG000|Maintenance MK-3475|Adverse Event|0|||
154851817|NCT02591615|558889162|FG001|Maintenance MK-3475|Adverse Event|3|||
154851818|NCT02591615|558889163|FG002|Maintenance MK-3475|Adverse Event|1|||
154851819|NCT02591615|558889164|FG003|Maintenance MK-3475|Adverse Event|2|||
154851820|NCT02591615|558889161|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
154851821|NCT02591615|558889162|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
154851822|NCT02591615|558889163|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
154851823|NCT02591615|558889164|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
154851824|NCT02591615|558889161|FG000|Maintenance MK-3475|Death|0|||
154851825|NCT02591615|558889162|FG001|Maintenance MK-3475|Death|1|||
154851826|NCT02591615|558889163|FG002|Maintenance MK-3475|Death|1|||
154851827|NCT02591615|558889164|FG003|Maintenance MK-3475|Death|0|||
154851828|NCT02591615|558889161|FG000|Maintenance MK-3475|Physician discretion|0|||
154851829|NCT02591615|558889162|FG001|Maintenance MK-3475|Physician discretion|0|||
154851830|NCT02591615|558889163|FG002|Maintenance MK-3475|Physician discretion|1|||
154851831|NCT02591615|558889164|FG003|Maintenance MK-3475|Physician discretion|0|||
154851832|NCT02591615|558889161|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
154851833|NCT02591615|558889162|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
154851834|NCT02591615|558889163|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
154851835|NCT02591615|558889164|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
154851836|NCT02591615|558889161|FG000|Maintenance MK-3475|In active treatment|2|||
154851837|NCT02591615|558889162|FG001|Maintenance MK-3475|In active treatment|0|||
154851838|NCT02591615|558889163|FG002|Maintenance MK-3475|In active treatment|0|||
154851839|NCT02591615|558889164|FG003|Maintenance MK-3475|In active treatment|1|||
154851840|NCT04047797|558889167|FG000|Overall Study|Progressive Disease|1|||
154851841|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
154851842|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
154851843|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
154851844|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154851845|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154851846|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154851847|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154851848|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154851849|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
154851850|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
154851851|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
154851852|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154851853|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154851854|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154851855|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154851856|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154851857|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
154851858|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
154851859|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
154851860|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154851861|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154851862|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154851863|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154851864|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154851865|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
154851866|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
154851867|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
154851868|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154851869|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154851870|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154851871|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154851872|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154851873|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
154851874|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
154851875|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
154851876|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154851877|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154851878|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154851879|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154851880|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154851881|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
154851882|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
154851883|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154851884|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154851885|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154851886|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154851887|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154851888|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154851889|NCT01097629|558889173|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
154851890|NCT01097629|558889174|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
154851891|NCT01097629|558889175|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
154851892|NCT01097629|558889176|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154851893|NCT01097629|558889177|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154851894|NCT01097629|558889178|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154851895|NCT01097629|558889179|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154851896|NCT01097629|558889180|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154851897|NCT01097629|558889173|FG000|DB RO Phase|Withdrawal by Subject|0|||
154851898|NCT01097629|558889174|FG001|DB RO Phase|Withdrawal by Subject|0|||
154851899|NCT01097629|558889175|FG002|DB RO Phase|Withdrawal by Subject|0|||
154851900|NCT01097629|558889176|FG003|DB RO Phase|Withdrawal by Subject|0|||
154851901|NCT01097629|558889177|FG004|DB RO Phase|Withdrawal by Subject|0|||
154851902|NCT01097629|558889178|FG005|DB RO Phase|Withdrawal by Subject|0|||
154851903|NCT01097629|558889179|FG006|DB RO Phase|Withdrawal by Subject|0|||
154851904|NCT01097629|558889180|FG007|DB RO Phase|Withdrawal by Subject|1|||
154851905|NCT01097629|558889173|FG000|DB RO Phase|Protocol Violation|0|||
154851906|NCT01097629|558889174|FG001|DB RO Phase|Protocol Violation|0|||
155105709|NCT05396014|559817549|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105710|NCT05396014|559817550|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105711|NCT05396014|559817551|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
155105712|NCT05396014|559817552|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
154851907|NCT01097629|558889175|FG002|DB RO Phase|Protocol Violation|0|||
154851908|NCT01097629|558889176|FG003|DB RO Phase|Protocol Violation|1|||
154851909|NCT01097629|558889177|FG004|DB RO Phase|Protocol Violation|0|||
154851910|NCT01097629|558889178|FG005|DB RO Phase|Protocol Violation|1|||
154851911|NCT01097629|558889179|FG006|DB RO Phase|Protocol Violation|1|||
154851912|NCT01097629|558889180|FG007|DB RO Phase|Protocol Violation|0|||
154851913|NCT01097629|558889173|FG000|DB RO Phase|Lost to Follow-up|0|||
154851914|NCT01097629|558889174|FG001|DB RO Phase|Lost to Follow-up|0|||
154851915|NCT01097629|558889175|FG002|DB RO Phase|Lost to Follow-up|0|||
154851916|NCT01097629|558889176|FG003|DB RO Phase|Lost to Follow-up|0|||
154851917|NCT01097629|558889177|FG004|DB RO Phase|Lost to Follow-up|0|||
154851918|NCT01097629|558889178|FG005|DB RO Phase|Lost to Follow-up|0|||
154851919|NCT01097629|558889179|FG006|DB RO Phase|Lost to Follow-up|2|||
154851920|NCT01097629|558889180|FG007|DB RO Phase|Lost to Follow-up|0|||
154851921|NCT00956943|558889181|FG000|Overall Study|Lost to Follow-up|9|||
154851922|NCT00956943|558889182|FG001|Overall Study|Lost to Follow-up|10|||
154851923|NCT02663895|558889183|FG000|Overall Study|Adverse Event|3|||
154851924|NCT02663895|558889183|FG000|Overall Study|Physician Decision|2|||
154851925|NCT02663895|558889183|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
154851926|NCT02663895|558889183|FG000|Overall Study|Withdrawal by Subject|1|||
154851927|NCT01793792|558889184|FG000|Overall Study|Death|5|||
154851928|NCT01793792|558889184|FG000|Overall Study|Lost to Follow-up|5|||
154851929|NCT01793792|558889184|FG000|Overall Study|Withdrawal by Subject|1|||
154851930|NCT01793792|558889184|FG000|Overall Study|Device Not Implanted|1|||
154851931|NCT00851903|558889187|FG000|Overall Study|Withdrawal by Subject|2|||
154851932|NCT01070329|558889188|FG000|Overall Study|Adverse Event|13|||
154851933|NCT01070329|558889189|FG001|Overall Study|Adverse Event|10|||
154851934|NCT01070329|558889188|FG000|Overall Study|Lost to Follow-up|22|||
154851935|NCT01070329|558889189|FG001|Overall Study|Lost to Follow-up|12|||
154851936|NCT01070329|558889188|FG000|Overall Study|Withdrawal by Subject|9|||
154851937|NCT01070329|558889189|FG001|Overall Study|Withdrawal by Subject|11|||
154851938|NCT01070329|558889188|FG000|Overall Study|Protocol Violation|3|||
154851939|NCT01070329|558889189|FG001|Overall Study|Protocol Violation|8|||
154851940|NCT01070329|558889188|FG000|Overall Study|Lack of Efficacy|2|||
154851941|NCT01070329|558889189|FG001|Overall Study|Lack of Efficacy|6|||
154851942|NCT01070329|558889188|FG000|Overall Study|Physician Decision|2|||
154851943|NCT01070329|558889189|FG001|Overall Study|Physician Decision|1|||
154851944|NCT01070329|558889188|FG000|Overall Study|Entry Criteria Not Met|1|||
154851945|NCT01070329|558889189|FG001|Overall Study|Entry Criteria Not Met|0|||
154851946|NCT01070329|558889188|FG000|Overall Study|Sponsor Decision|0|||
154851947|NCT01070329|558889189|FG001|Overall Study|Sponsor Decision|1|||
154851948|NCT02863848|558889190|FG000|Overall Study|Lost to Follow-up|1|||
154851949|NCT02863848|558889191|FG001|Overall Study|Lost to Follow-up|1|||
154851950|NCT02863848|558889190|FG000|Overall Study|Protocol Violation|1|||
154851951|NCT02863848|558889191|FG001|Overall Study|Protocol Violation|2|||
154851952|NCT06441877|558889192|FG000|Overall Study|Withdrawal by Subject|0|||
154851953|NCT06441877|558889193|FG001|Overall Study|Withdrawal by Subject|2|||
154851954|NCT06441877|558889194|FG002|Overall Study|Withdrawal by Subject|0|||
154851955|NCT06441877|558889195|FG003|Overall Study|Withdrawal by Subject|0|||
154851956|NCT03980938|558889196|FG000|Treatment Period 1|Study Terminated|1|||
154851957|NCT03980938|558889197|FG001|Treatment Period 1|Study Terminated|1|||
154851958|NCT03980938|558889196|FG000|Treatment Period 2|Study Terminated|2|||
154851959|NCT03980938|558889197|FG001|Treatment Period 2|Study Terminated|2|||
154851960|NCT03706365|558889198|FG000|Overall Study|Lost to Follow-up|7|||
154851961|NCT03706365|558889199|FG001|Overall Study|Lost to Follow-up|0|||
154851962|NCT03706365|558889198|FG000|Overall Study|Withdrawal by Subject|17|||
154851963|NCT03706365|558889199|FG001|Overall Study|Withdrawal by Subject|15|||
154851964|NCT03706365|558889198|FG000|Overall Study|On Study Treatment|51|||
155173614|NCT03642132|560074830|FG002|Follow-up Period|Adverse Event|0|||
154851965|NCT03706365|558889199|FG001|Overall Study|On Study Treatment|51|||
154851966|NCT03116113|558889200|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851967|NCT03116113|558889201|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851968|NCT03116113|558889202|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851969|NCT03116113|558889203|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851970|NCT03116113|558889204|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851971|NCT03116113|558889205|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851972|NCT03116113|558889206|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
154851973|NCT03116113|558889207|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
154851974|NCT03116113|558889208|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
154851975|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154851976|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
154851977|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154851978|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154851979|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154851980|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
154851981|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
155105713|NCT05396014|559817553|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105714|NCT05396014|559817554|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105715|NCT05396014|559817555|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105716|NCT05396014|559817556|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105717|NCT05396014|559817557|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105718|NCT05396014|559817558|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105719|NCT05396014|559817559|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105720|NCT05396014|559817560|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105721|NCT05396014|559817561|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105722|NCT05396014|559817562|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105723|NCT05396014|559817563|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105724|NCT05396014|559817564|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
155105725|NCT05396014|559817565|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105726|NCT05396014|559817566|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105727|NCT05396014|559817567|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
155105728|NCT05396014|559817525|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105729|NCT05396014|559817526|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105730|NCT05396014|559817527|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105731|NCT05396014|559817528|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105732|NCT05396014|559817529|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105733|NCT05396014|559817530|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105734|NCT05396014|559817531|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105735|NCT05396014|559817532|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105736|NCT05396014|559817533|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105737|NCT05396014|559817534|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105738|NCT05396014|559817535|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105739|NCT05396014|559817536|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105740|NCT05396014|559817537|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105741|NCT05396014|559817538|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105742|NCT05396014|559817539|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105743|NCT05396014|559817540|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105744|NCT05396014|559817541|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105745|NCT05396014|559817542|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105746|NCT05396014|559817543|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105747|NCT05396014|559817544|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105748|NCT05396014|559817545|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105749|NCT05396014|559817546|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105750|NCT05396014|559817547|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105751|NCT05396014|559817548|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105752|NCT05396014|559817549|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105753|NCT05396014|559817550|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105754|NCT05396014|559817551|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
155105755|NCT05396014|559817552|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105756|NCT05396014|559817553|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105757|NCT05396014|559817554|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105758|NCT05396014|559817555|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105759|NCT05396014|559817556|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105760|NCT05396014|559817557|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105761|NCT05396014|559817558|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105762|NCT05396014|559817559|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105763|NCT05396014|559817560|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105764|NCT05396014|559817561|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105765|NCT05396014|559817562|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105766|NCT05396014|559817563|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105767|NCT05396014|559817564|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105768|NCT05396014|559817565|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105769|NCT05396014|559817566|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105770|NCT05396014|559817567|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
155105771|NCT05396014|559817525|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105772|NCT05396014|559817526|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105773|NCT05396014|559817527|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
154851982|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
155105774|NCT05396014|559817528|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
154851983|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
154851984|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
154851985|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
154851986|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
154851987|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154851988|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
154851989|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
154851990|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
154851991|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
154851992|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
154851993|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
154851994|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
154851995|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154851996|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154851997|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154851998|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
154851999|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852000|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
154852001|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
154852002|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
154852003|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
154852004|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
154852005|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
154852006|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
154852007|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
154852008|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
154852009|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
154852010|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
154852011|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
154852012|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
154852013|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
154852014|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
154852015|NCT00289913|558889211|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
154852016|NCT00289913|558889212|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852017|NCT00289913|558889213|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
154852018|NCT00289913|558889214|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852019|NCT00289913|558889215|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852020|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852021|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852022|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
154852023|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852024|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852025|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
154852026|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
154852027|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
154852028|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
154852029|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
154852030|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
154852031|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
154852032|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
154852033|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
154852034|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
154852035|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
154852036|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
154852037|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
154852038|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154852039|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154852040|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
154971673|NCT01698554|559320633|FG000|Overall Study|Protocol Violation|2|||
154971674|NCT01698554|559320634|FG001|Overall Study|Protocol Violation|0|||
154971675|NCT01698554|559320635|FG002|Overall Study|Protocol Violation|1|||
154971676|NCT01698554|559320636|FG003|Overall Study|Protocol Violation|0|||
154971677|NCT01698554|559320633|FG000|Overall Study|Other Miscellaneous Reasons|1|||
154852041|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852042|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
154852043|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852044|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852045|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
154852046|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
154852047|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
154852048|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
154852049|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
154852050|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
154852051|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
154852052|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
154852053|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
154852054|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
154852055|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
154852056|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
154852057|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
154852058|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
154852059|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
154852060|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
154852061|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
154852062|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
154852063|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
154852064|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
154852065|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
154852066|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
154852067|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
154852068|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
154852069|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
154852070|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
154852071|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
154852072|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
154852073|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
154852074|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
154852075|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
154852076|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
154852077|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
154852078|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
154852079|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
154852080|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
154852081|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
154852082|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
154852083|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
154852084|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
154852085|NCT00289913|558889211|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
154852086|NCT00289913|558889212|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
154852087|NCT00289913|558889213|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
154852088|NCT00289913|558889214|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
154852089|NCT00289913|558889215|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
154852090|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852091|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
154852092|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852093|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852094|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
154852095|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
154852096|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
155173615|NCT02577887|560074832|FG000|Overall Study|Death|93|||
154852097|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
154971678|NCT01698554|559320634|FG001|Overall Study|Other Miscellaneous Reasons|0|||
154971679|NCT01698554|559320635|FG002|Overall Study|Other Miscellaneous Reasons|0|||
154971680|NCT01698554|559320636|FG003|Overall Study|Other Miscellaneous Reasons|0|||
154971681|NCT01943435|559320637|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
154971682|NCT01943435|559320638|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
155173616|NCT02577887|560074832|FG000|Overall Study|Protocol Violation|125|||
154852098|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
154852099|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
154852100|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154852101|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154852102|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154852103|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
154852104|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
154852105|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852106|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852107|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852108|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
154852109|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
154852110|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
154852111|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
154852112|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
154852113|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
154852114|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
154852115|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
154852116|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
154852117|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
154852118|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
154852119|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
154852120|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
154852121|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
154852122|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
154852123|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
154852124|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
154852125|NCT00289913|558889211|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852126|NCT00289913|558889212|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
154852127|NCT00289913|558889213|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852128|NCT00289913|558889214|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852129|NCT00289913|558889215|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
154852130|NCT03822884|558889216|FG000|Overall Study|Withdrawal by Subject|0|||
154852131|NCT03822884|558889217|FG001|Overall Study|Withdrawal by Subject|0|||
154852132|NCT03822884|558889218|FG002|Overall Study|Withdrawal by Subject|0|||
154852133|NCT03822884|558889219|FG003|Overall Study|Withdrawal by Subject|0|||
154852134|NCT03822884|558889220|FG004|Overall Study|Withdrawal by Subject|1|||
154852135|NCT03822884|558889221|FG005|Overall Study|Withdrawal by Subject|0|||
154852136|NCT02411448|558889226|FG000|Overall Study|Withdrawal by Subject|1|||
154852137|NCT02411448|558889227|FG001|Overall Study|Withdrawal by Subject|14|||
154852138|NCT02411448|558889228|FG002|Overall Study|Withdrawal by Subject|9|||
154852139|NCT02411448|558889226|FG000|Overall Study|Other|0|||
154852140|NCT02411448|558889227|FG001|Overall Study|Other|2|||
154852141|NCT02411448|558889228|FG002|Overall Study|Other|0|||
154852142|NCT02411448|558889226|FG000|Overall Study|Did not receive study treatment|0|||
154852143|NCT02411448|558889227|FG001|Overall Study|Did not receive study treatment|3|||
154852144|NCT02411448|558889228|FG002|Overall Study|Did not receive study treatment|0|||
154852145|NCT02411448|558889226|FG000|Overall Study|Alive on study treatment|3|||
154852146|NCT02411448|558889227|FG001|Overall Study|Alive on study treatment|64|||
154852147|NCT02411448|558889228|FG002|Overall Study|Alive on study treatment|43|||
154852148|NCT02631538|558889229|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
154852149|NCT02631538|558889230|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
154852150|NCT02631538|558889231|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
154852151|NCT02631538|558889232|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
154852152|NCT02631538|558889229|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
154852153|NCT02631538|558889230|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
154852154|NCT02631538|558889231|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
154852155|NCT02631538|558889232|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
154852156|NCT02631538|558889229|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
154971683|NCT01943435|559320639|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
154971684|NCT01943435|559320637|FG000|Intervention Period|Withdrawal by Subject|3|||
155173617|NCT02577887|560074832|FG000|Overall Study|Withdrawal by Subject|80|||
154852157|NCT02631538|558889230|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
154852158|NCT02631538|558889231|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
154852159|NCT02631538|558889232|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
154852160|NCT02631538|558889229|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
154852161|NCT02631538|558889230|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
155173618|NCT00864916|560074833|FG000|Overall Study|Lost to Follow-up|4|||
154852162|NCT02631538|558889231|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
154852163|NCT02631538|558889232|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
154852164|NCT02631538|558889229|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
154852165|NCT02631538|558889230|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
154852166|NCT02631538|558889231|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
154852167|NCT02631538|558889232|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
154852168|NCT02631538|558889229|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
154852169|NCT02631538|558889230|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
154852170|NCT02631538|558889231|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
154852171|NCT02631538|558889232|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
154852172|NCT01688050|558889233|FG000|Overall Study|Death|7|||
154852173|NCT01688050|558889233|FG000|Overall Study|Conversion to open repair|1|||
154852174|NCT01688050|558889233|FG000|Overall Study|Lost to Follow-up|13|||
154852175|NCT01688050|558889233|FG000|Overall Study|Withdrawal by Subject|10|||
154852176|NCT01848145|558889234|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
154852177|NCT01848145|558889234|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
154852178|NCT01848145|558889234|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
154852179|NCT01848145|558889234|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
154852180|NCT01848145|558889234|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
154852181|NCT01848145|558889234|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
154852182|NCT01848145|558889234|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
154852183|NCT01554579|558889235|FG000|Overall Study|Adverse Event|6|||
154852184|NCT01554579|558889236|FG001|Overall Study|Adverse Event|25|||
154852185|NCT01554579|558889235|FG000|Overall Study|Lack of Efficacy|2|||
154852186|NCT01554579|558889236|FG001|Overall Study|Lack of Efficacy|1|||
154852187|NCT01554579|558889235|FG000|Overall Study|Withdrawal by Subject|2|||
154852188|NCT01554579|558889236|FG001|Overall Study|Withdrawal by Subject|1|||
154852189|NCT00234039|558889237|FG000|Overall Study|Adverse Event|2|||
155105775|NCT05396014|559817529|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105776|NCT05396014|559817530|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105777|NCT05396014|559817531|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105778|NCT05396014|559817532|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105779|NCT05396014|559817533|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105780|NCT05396014|559817534|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105781|NCT05396014|559817535|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105782|NCT05396014|559817536|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105783|NCT05396014|559817537|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105784|NCT05396014|559817538|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
155105785|NCT05396014|559817539|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105786|NCT05396014|559817540|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105787|NCT05396014|559817541|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105788|NCT05396014|559817542|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105789|NCT05396014|559817543|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105790|NCT05396014|559817544|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105791|NCT05396014|559817545|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105792|NCT05396014|559817546|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105793|NCT05396014|559817547|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105794|NCT05396014|559817548|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105795|NCT05396014|559817549|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105796|NCT05396014|559817550|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105797|NCT05396014|559817551|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105798|NCT05396014|559817552|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105799|NCT05396014|559817553|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105800|NCT05396014|559817554|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105801|NCT05396014|559817555|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105802|NCT05396014|559817556|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105803|NCT05396014|559817557|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105804|NCT05396014|559817558|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105805|NCT05396014|559817559|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105806|NCT05396014|559817560|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105807|NCT05396014|559817561|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105808|NCT05396014|559817562|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155173619|NCT00864916|560074834|FG001|Overall Study|Lost to Follow-up|4|||
154852190|NCT00234039|558889237|FG000|Overall Study|Progression/relapse|34|||
154852191|NCT00234039|558889237|FG000|Overall Study|Other - Not Protocol Specified|3|||
154852192|NCT00234039|558889237|FG000|Overall Study|Ineligible|9|||
154852193|NCT00234039|558889237|FG000|Overall Study|No Protocol Treatment Received|2|||
154852194|NCT03683394|558889238|FG000|Overall Study|Withdrawal by Subject|4|||
154852195|NCT03683394|558889239|FG001|Overall Study|Withdrawal by Subject|8|||
154852196|NCT03683394|558889238|FG000|Overall Study|Lost to Follow-up|7|||
154852197|NCT03683394|558889239|FG001|Overall Study|Lost to Follow-up|0|||
154852198|NCT03683394|558889238|FG000|Overall Study|Death|3|||
154852199|NCT03683394|558889239|FG001|Overall Study|Death|1|||
154852200|NCT03072160|558889242|FG000|Overall Study|Adverse Event|3|||
154852201|NCT03072160|558889243|FG001|Overall Study|Adverse Event|1|||
154852202|NCT03072160|558889242|FG000|Overall Study|Refused further treatment|6|||
154852203|NCT03072160|558889243|FG001|Overall Study|Refused further treatment|1|||
154852204|NCT03072160|558889242|FG000|Overall Study|Physician Decision|1|||
154852205|NCT03072160|558889243|FG001|Overall Study|Physician Decision|0|||
154852206|NCT03072160|558889242|FG000|Overall Study|Disease progression on study|1|||
154852207|NCT03072160|558889243|FG001|Overall Study|Disease progression on study|1|||
154852208|NCT03072160|558889242|FG000|Overall Study|No contact|0|||
154852209|NCT03072160|558889243|FG001|Overall Study|No contact|1|||
154852210|NCT04426695|558889244|FG000|Overall Study|Death|2|||
154852211|NCT04426695|558889245|FG001|Overall Study|Death|0|||
154852212|NCT04426695|558889246|FG002|Overall Study|Death|1|||
154852213|NCT04426695|558889247|FG003|Overall Study|Death|27|||
154852214|NCT04426695|558889248|FG004|Overall Study|Death|25|||
154852215|NCT04426695|558889249|FG005|Overall Study|Death|21|||
154852216|NCT04426695|558889250|FG006|Overall Study|Death|42|||
154852217|NCT04426695|558889251|FG007|Overall Study|Death|23|||
154852218|NCT04426695|558889252|FG008|Overall Study|Death|37|||
154852219|NCT04426695|558889253|FG009|Overall Study|Death|14|||
154852220|NCT04426695|558889254|FG010|Overall Study|Death|8|||
154852221|NCT04426695|558889255|FG011|Overall Study|Death|7|||
154852222|NCT04426695|558889256|FG012|Overall Study|Death|13|||
154852223|NCT04426695|558889257|FG013|Overall Study|Death|25|||
154852224|NCT04426695|558889258|FG014|Overall Study|Death|19|||
154852225|NCT04426695|558889259|FG015|Overall Study|Death|7|||
154852226|NCT04426695|558889260|FG016|Overall Study|Death|8|||
154852227|NCT04426695|558889261|FG017|Overall Study|Death|4|||
154852228|NCT04426695|558889244|FG000|Overall Study|Lost to Follow-up|2|||
154852229|NCT04426695|558889245|FG001|Overall Study|Lost to Follow-up|4|||
154852230|NCT04426695|558889246|FG002|Overall Study|Lost to Follow-up|1|||
154852231|NCT04426695|558889247|FG003|Overall Study|Lost to Follow-up|19|||
154852232|NCT04426695|558889248|FG004|Overall Study|Lost to Follow-up|10|||
154852233|NCT04426695|558889249|FG005|Overall Study|Lost to Follow-up|14|||
154852234|NCT04426695|558889250|FG006|Overall Study|Lost to Follow-up|5|||
154852235|NCT04426695|558889251|FG007|Overall Study|Lost to Follow-up|14|||
154852236|NCT04426695|558889252|FG008|Overall Study|Lost to Follow-up|10|||
154852237|NCT04426695|558889253|FG009|Overall Study|Lost to Follow-up|11|||
154852238|NCT04426695|558889254|FG010|Overall Study|Lost to Follow-up|12|||
154852239|NCT04426695|558889255|FG011|Overall Study|Lost to Follow-up|6|||
154852240|NCT04426695|558889256|FG012|Overall Study|Lost to Follow-up|2|||
154852241|NCT04426695|558889257|FG013|Overall Study|Lost to Follow-up|2|||
154852242|NCT04426695|558889258|FG014|Overall Study|Lost to Follow-up|2|||
154852243|NCT04426695|558889259|FG015|Overall Study|Lost to Follow-up|0|||
154852244|NCT04426695|558889260|FG016|Overall Study|Lost to Follow-up|0|||
154852245|NCT04426695|558889261|FG017|Overall Study|Lost to Follow-up|0|||
154852246|NCT04426695|558889244|FG000|Overall Study|Participant Decision|1|||
154852247|NCT04426695|558889245|FG001|Overall Study|Participant Decision|2|||
154852248|NCT04426695|558889246|FG002|Overall Study|Participant Decision|2|||
154852249|NCT04426695|558889247|FG003|Overall Study|Participant Decision|12|||
154852250|NCT04426695|558889248|FG004|Overall Study|Participant Decision|18|||
154852251|NCT04426695|558889249|FG005|Overall Study|Participant Decision|22|||
154852252|NCT04426695|558889250|FG006|Overall Study|Participant Decision|13|||
154852253|NCT04426695|558889251|FG007|Overall Study|Participant Decision|13|||
155105809|NCT05396014|559817563|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105810|NCT05396014|559817564|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105811|NCT05396014|559817565|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
154852254|NCT04426695|558889252|FG008|Overall Study|Participant Decision|10|||
154852255|NCT04426695|558889253|FG009|Overall Study|Participant Decision|15|||
154852256|NCT04426695|558889254|FG010|Overall Study|Participant Decision|16|||
154852257|NCT04426695|558889255|FG011|Overall Study|Participant Decision|17|||
154852258|NCT04426695|558889256|FG012|Overall Study|Participant Decision|2|||
154852259|NCT04426695|558889257|FG013|Overall Study|Participant Decision|1|||
154852260|NCT04426695|558889258|FG014|Overall Study|Participant Decision|2|||
154852261|NCT04426695|558889259|FG015|Overall Study|Participant Decision|0|||
154852262|NCT04426695|558889260|FG016|Overall Study|Participant Decision|0|||
154852263|NCT04426695|558889261|FG017|Overall Study|Participant Decision|0|||
154852264|NCT04426695|558889244|FG000|Overall Study|Adverse Event|0|||
154852265|NCT04426695|558889245|FG001|Overall Study|Adverse Event|0|||
154852266|NCT04426695|558889246|FG002|Overall Study|Adverse Event|0|||
154852267|NCT04426695|558889247|FG003|Overall Study|Adverse Event|0|||
154852268|NCT04426695|558889248|FG004|Overall Study|Adverse Event|0|||
154852269|NCT04426695|558889249|FG005|Overall Study|Adverse Event|0|||
154852270|NCT04426695|558889250|FG006|Overall Study|Adverse Event|0|||
154852271|NCT04426695|558889251|FG007|Overall Study|Adverse Event|1|||
154852272|NCT04426695|558889252|FG008|Overall Study|Adverse Event|0|||
154852273|NCT04426695|558889253|FG009|Overall Study|Adverse Event|0|||
154852274|NCT04426695|558889254|FG010|Overall Study|Adverse Event|1|||
154852275|NCT04426695|558889255|FG011|Overall Study|Adverse Event|1|||
154852276|NCT04426695|558889256|FG012|Overall Study|Adverse Event|0|||
154852277|NCT04426695|558889257|FG013|Overall Study|Adverse Event|0|||
154852278|NCT04426695|558889258|FG014|Overall Study|Adverse Event|0|||
154852279|NCT04426695|558889259|FG015|Overall Study|Adverse Event|0|||
154852280|NCT04426695|558889260|FG016|Overall Study|Adverse Event|0|||
154852281|NCT04426695|558889261|FG017|Overall Study|Adverse Event|0|||
154852282|NCT04426695|558889244|FG000|Overall Study|Sponsor Request|0|||
154852283|NCT04426695|558889245|FG001|Overall Study|Sponsor Request|0|||
154852284|NCT04426695|558889246|FG002|Overall Study|Sponsor Request|0|||
154852285|NCT04426695|558889247|FG003|Overall Study|Sponsor Request|0|||
154852286|NCT04426695|558889248|FG004|Overall Study|Sponsor Request|0|||
154852287|NCT04426695|558889249|FG005|Overall Study|Sponsor Request|0|||
154852288|NCT04426695|558889250|FG006|Overall Study|Sponsor Request|1|||
154852289|NCT04426695|558889251|FG007|Overall Study|Sponsor Request|0|||
154852290|NCT04426695|558889252|FG008|Overall Study|Sponsor Request|0|||
154852291|NCT04426695|558889253|FG009|Overall Study|Sponsor Request|0|||
154852292|NCT04426695|558889254|FG010|Overall Study|Sponsor Request|0|||
154852293|NCT04426695|558889255|FG011|Overall Study|Sponsor Request|0|||
154852294|NCT04426695|558889256|FG012|Overall Study|Sponsor Request|0|||
154852295|NCT04426695|558889257|FG013|Overall Study|Sponsor Request|0|||
154852296|NCT04426695|558889258|FG014|Overall Study|Sponsor Request|0|||
154852297|NCT04426695|558889259|FG015|Overall Study|Sponsor Request|0|||
154852298|NCT04426695|558889260|FG016|Overall Study|Sponsor Request|0|||
154852299|NCT04426695|558889261|FG017|Overall Study|Sponsor Request|0|||
154852300|NCT04426695|558889244|FG000|Overall Study|Physician Decision|0|||
154852301|NCT04426695|558889245|FG001|Overall Study|Physician Decision|0|||
154852302|NCT04426695|558889246|FG002|Overall Study|Physician Decision|0|||
154852303|NCT04426695|558889247|FG003|Overall Study|Physician Decision|0|||
154852304|NCT04426695|558889248|FG004|Overall Study|Physician Decision|0|||
154852305|NCT04426695|558889249|FG005|Overall Study|Physician Decision|0|||
154852306|NCT04426695|558889250|FG006|Overall Study|Physician Decision|0|||
154852307|NCT04426695|558889251|FG007|Overall Study|Physician Decision|0|||
154852308|NCT04426695|558889252|FG008|Overall Study|Physician Decision|0|||
154852309|NCT04426695|558889253|FG009|Overall Study|Physician Decision|1|||
154852310|NCT04426695|558889254|FG010|Overall Study|Physician Decision|0|||
154852311|NCT04426695|558889255|FG011|Overall Study|Physician Decision|0|||
154852312|NCT04426695|558889256|FG012|Overall Study|Physician Decision|1|||
154852313|NCT04426695|558889257|FG013|Overall Study|Physician Decision|0|||
154852314|NCT04426695|558889258|FG014|Overall Study|Physician Decision|0|||
154852315|NCT04426695|558889259|FG015|Overall Study|Physician Decision|0|||
154852316|NCT04426695|558889260|FG016|Overall Study|Physician Decision|0|||
154852317|NCT04426695|558889261|FG017|Overall Study|Physician Decision|0|||
154852318|NCT04426695|558889244|FG000|Overall Study|Randomized but Never Treated|3|||
155105812|NCT05396014|559817566|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105813|NCT05396014|559817567|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
155105814|NCT05396014|559817525|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
155105815|NCT05396014|559817526|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105816|NCT05396014|559817527|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105817|NCT05396014|559817528|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105818|NCT05396014|559817529|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105819|NCT05396014|559817530|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105820|NCT05396014|559817531|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105821|NCT05396014|559817532|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105822|NCT05396014|559817533|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155173620|NCT00864916|560074833|FG000|Overall Study|Protocol Violation|1|||
155173621|NCT00864916|560074834|FG001|Overall Study|Protocol Violation|0|||
154852319|NCT04426695|558889245|FG001|Overall Study|Randomized but Never Treated|1|||
154852320|NCT04426695|558889246|FG002|Overall Study|Randomized but Never Treated|0|||
154852321|NCT04426695|558889247|FG003|Overall Study|Randomized but Never Treated|4|||
154852322|NCT04426695|558889248|FG004|Overall Study|Randomized but Never Treated|5|||
154852323|NCT04426695|558889249|FG005|Overall Study|Randomized but Never Treated|5|||
154852324|NCT04426695|558889250|FG006|Overall Study|Randomized but Never Treated|4|||
154852325|NCT04426695|558889251|FG007|Overall Study|Randomized but Never Treated|6|||
154852326|NCT04426695|558889252|FG008|Overall Study|Randomized but Never Treated|6|||
154852327|NCT04426695|558889253|FG009|Overall Study|Randomized but Never Treated|3|||
154852328|NCT04426695|558889254|FG010|Overall Study|Randomized but Never Treated|3|||
154852329|NCT04426695|558889255|FG011|Overall Study|Randomized but Never Treated|6|||
154852330|NCT04426695|558889256|FG012|Overall Study|Randomized but Never Treated|1|||
154852331|NCT04426695|558889257|FG013|Overall Study|Randomized but Never Treated|2|||
154852332|NCT04426695|558889258|FG014|Overall Study|Randomized but Never Treated|0|||
154852333|NCT04426695|558889259|FG015|Overall Study|Randomized but Never Treated|0|||
154852334|NCT04426695|558889260|FG016|Overall Study|Randomized but Never Treated|0|||
154852335|NCT04426695|558889261|FG017|Overall Study|Randomized but Never Treated|0|||
154852336|NCT04303000|558889262|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
154852337|NCT04303000|558889263|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
154852338|NCT04303000|558889264|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
154852339|NCT01058096|558889265|FG000|Double-blind Treatment Phase|Adverse Event|11|||
154852340|NCT01058096|558889266|FG001|Double-blind Treatment Phase|Adverse Event|15|||
154852341|NCT01058096|558889265|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
154852342|NCT01058096|558889266|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
154852343|NCT01058096|558889265|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
154852344|NCT01058096|558889266|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
154852345|NCT01058096|558889265|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
154852346|NCT01058096|558889266|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
154852347|NCT01058096|558889265|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
154852348|NCT01058096|558889266|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
154852349|NCT01058096|558889265|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
154852350|NCT01058096|558889266|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
154852351|NCT05655377|558889267|FG000|Overall Study|Withdrawal by Subject|2|||
154852352|NCT00553462|558889271|FG000|Overall Study|Adverse Event|4|||
154852353|NCT00553462|558889271|FG000|Overall Study|Progression|4|||
155105823|NCT05396014|559817534|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105824|NCT05396014|559817535|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105825|NCT05396014|559817536|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105826|NCT05396014|559817537|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105827|NCT05396014|559817538|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
155105828|NCT05396014|559817539|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105829|NCT05396014|559817540|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105830|NCT05396014|559817541|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105831|NCT05396014|559817542|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105832|NCT05396014|559817543|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
154852354|NCT00553462|558889271|FG000|Overall Study|Withdrawal by Subject|5|||
154852355|NCT00553462|558889271|FG000|Overall Study|Physician Decision|1|||
154852356|NCT01262625|558889274|FG000|Overall Study|Administrative Error|1|||
154852357|NCT01262625|558889275|FG001|Overall Study|Administrative Error|1|||
154852358|NCT01262625|558889274|FG000|Overall Study|Site Closed|1|||
154852359|NCT01262625|558889275|FG001|Overall Study|Site Closed|0|||
154852360|NCT00110994|558889277|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
154852361|NCT00110994|558889278|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
154852362|NCT00110994|558889277|FG000|Double-blind (DB) Treatment|Death|1|||
154852363|NCT00110994|558889278|FG001|Double-blind (DB) Treatment|Death|0|||
154852364|NCT00110994|558889277|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
154852365|NCT00110994|558889278|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
154852366|NCT00110994|558889277|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
154852367|NCT00110994|558889278|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
154852368|NCT00110994|558889277|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
154852369|NCT00110994|558889278|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
154852370|NCT00110994|558889277|FG000|Double-blind (DB) Treatment|other reasons|2|||
154852371|NCT00110994|558889278|FG001|Double-blind (DB) Treatment|other reasons|3|||
154852372|NCT00110994|558889277|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
154852373|NCT00110994|558889278|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
154852374|NCT00110994|558889277|FG000|Active Follow-up|Other reasons|0|||
154852375|NCT00110994|558889278|FG001|Active Follow-up|Other reasons|2|||
154852376|NCT00110994|558889277|FG000|Long Term Follow-up|Death|19|||
154852377|NCT00110994|558889278|FG001|Long Term Follow-up|Death|17|||
154852378|NCT02772757|558889280|FG000|Overall Study|Withdrawal by Subject|1|||
154852379|NCT02772757|558889281|FG001|Overall Study|Withdrawal by Subject|0|||
154852380|NCT02772757|558889282|FG002|Overall Study|Withdrawal by Subject|1|||
154852381|NCT02772757|558889280|FG000|Overall Study|Protocol Violation|0|||
154852382|NCT02772757|558889281|FG001|Overall Study|Protocol Violation|0|||
154852383|NCT02772757|558889282|FG002|Overall Study|Protocol Violation|1|||
154852384|NCT02772757|558889280|FG000|Overall Study|Physician Decision|0|||
154852385|NCT02772757|558889281|FG001|Overall Study|Physician Decision|3|||
154852386|NCT02772757|558889282|FG002|Overall Study|Physician Decision|3|||
154852387|NCT00531960|558889283|FG000|Overall Study|Adverse Event|5|||
154852388|NCT00531960|558889284|FG001|Overall Study|Adverse Event|4|||
154852389|NCT00531960|558889283|FG000|Overall Study|Death|3|||
154852390|NCT00531960|558889284|FG001|Overall Study|Death|2|||
154852391|NCT00531960|558889283|FG000|Overall Study|Lack of Efficacy|42|||
154852392|NCT00531960|558889284|FG001|Overall Study|Lack of Efficacy|41|||
154852393|NCT00531960|558889283|FG000|Overall Study|Violation of Selection Criteria|2|||
154852394|NCT00531960|558889284|FG001|Overall Study|Violation of Selection Criteria|0|||
154852395|NCT00531960|558889283|FG000|Overall Study|Refused Treatment|5|||
155105833|NCT05396014|559817544|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105834|NCT05396014|559817545|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
154852396|NCT00531960|558889284|FG001|Overall Study|Refused Treatment|6|||
154852397|NCT00531960|558889283|FG000|Overall Study|Other|4|||
154852398|NCT00531960|558889284|FG001|Overall Study|Other|10|||
154852399|NCT02471716|558889290|FG000|Overall Study|Withdrawal by Subject|0|||
154852400|NCT02471716|558889291|FG001|Overall Study|Withdrawal by Subject|1|||
154852401|NCT02471716|558889292|FG002|Overall Study|Withdrawal by Subject|0|||
155105835|NCT05396014|559817546|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
154852402|NCT02471716|558889293|FG003|Overall Study|Withdrawal by Subject|2|||
154852403|NCT02471716|558889294|FG004|Overall Study|Withdrawal by Subject|5|||
154852404|NCT02471716|558889290|FG000|Overall Study|Study Terminiated by sponsor|0|||
154852405|NCT02471716|558889291|FG001|Overall Study|Study Terminiated by sponsor|0|||
154852406|NCT02471716|558889292|FG002|Overall Study|Study Terminiated by sponsor|0|||
154852407|NCT02471716|558889293|FG003|Overall Study|Study Terminiated by sponsor|1|||
154852408|NCT02471716|558889294|FG004|Overall Study|Study Terminiated by sponsor|0|||
154852409|NCT02471716|558889290|FG000|Overall Study|Lost to Follow-up|0|||
154852410|NCT02471716|558889291|FG001|Overall Study|Lost to Follow-up|0|||
154852411|NCT02471716|558889292|FG002|Overall Study|Lost to Follow-up|0|||
154852412|NCT02471716|558889293|FG003|Overall Study|Lost to Follow-up|3|||
154852413|NCT02471716|558889294|FG004|Overall Study|Lost to Follow-up|2|||
154852414|NCT02471716|558889290|FG000|Overall Study|Death|0|||
154852415|NCT02471716|558889291|FG001|Overall Study|Death|0|||
154852416|NCT02471716|558889292|FG002|Overall Study|Death|0|||
154852417|NCT02471716|558889293|FG003|Overall Study|Death|1|||
154852418|NCT02471716|558889294|FG004|Overall Study|Death|0|||
154852419|NCT02471716|558889290|FG000|Overall Study|Other|0|||
154852420|NCT02471716|558889291|FG001|Overall Study|Other|0|||
154852421|NCT02471716|558889292|FG002|Overall Study|Other|0|||
154852422|NCT02471716|558889293|FG003|Overall Study|Other|8|||
154852423|NCT02471716|558889294|FG004|Overall Study|Other|9|||
154852424|NCT04178772|558889309|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
154852425|NCT04178772|558889309|FG000|Overall Study|study terminated early due to COVID-19|7|||
154852426|NCT01481896|558889312|FG000|Overall Study|Lost to Follow-up|12|||
154852427|NCT01162421|558889317|FG000|Overall Study|Did not receive study drug|2|||
154852428|NCT01162421|558889318|FG001|Overall Study|Did not receive study drug|1|||
154852429|NCT01162421|558889317|FG000|Overall Study|Adverse Event|2|||
154852430|NCT01162421|558889318|FG001|Overall Study|Adverse Event|5|||
154852431|NCT01162421|558889317|FG000|Overall Study|Lost to Follow-up|0|||
154852432|NCT01162421|558889318|FG001|Overall Study|Lost to Follow-up|2|||
154852433|NCT01162421|558889317|FG000|Overall Study|Lack of Efficacy|2|||
154852434|NCT01162421|558889318|FG001|Overall Study|Lack of Efficacy|2|||
154852435|NCT01162421|558889317|FG000|Overall Study|Other|2|||
154852436|NCT01162421|558889318|FG001|Overall Study|Other|3|||
154852437|NCT03336502|558889319|FG000|Overall Study|Physician Decision|0|||
154852438|NCT03336502|558889320|FG001|Overall Study|Physician Decision|1|||
154852439|NCT03336502|558889319|FG000|Overall Study|Prohibited Drugs|1|||
154852440|NCT03336502|558889320|FG001|Overall Study|Prohibited Drugs|1|||
154852441|NCT03336502|558889319|FG000|Overall Study|Death|1|||
154852442|NCT03336502|558889320|FG001|Overall Study|Death|2|||
154852443|NCT03336502|558889319|FG000|Overall Study|Adverse Event|2|||
154852444|NCT03336502|558889320|FG001|Overall Study|Adverse Event|5|||
154852445|NCT01107444|558889325|FG000|Overall Study|Withdrawal by Subject|8|||
154852446|NCT01107444|558889326|FG001|Overall Study|Withdrawal by Subject|12|||
154852447|NCT01107444|558889325|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
154852448|NCT01107444|558889326|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
154852449|NCT03310970|558889330|FG000|Overall Study|Withdrawal by Subject|0|||
154852450|NCT03310970|558889331|FG001|Overall Study|Withdrawal by Subject|1|||
154852451|NCT01446419|558889332|FG000|Overall Study|Death|1|||
154852452|NCT01446419|558889333|FG001|Overall Study|Death|0|||
154971685|NCT01943435|559320638|FG001|Intervention Period|Withdrawal by Subject|3|||
154971686|NCT01943435|559320639|FG002|Intervention Period|Withdrawal by Subject|4|||
154971687|NCT01943435|559320637|FG000|2 Month Follow up|Lost to Follow-up|2|||
154971688|NCT01943435|559320638|FG001|2 Month Follow up|Lost to Follow-up|3|||
154971689|NCT01943435|559320639|FG002|2 Month Follow up|Lost to Follow-up|0|||
154971690|NCT01943435|559320637|FG000|6 Month Follow up|Lost to Follow-up|12|||
155105836|NCT05396014|559817547|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105837|NCT05396014|559817548|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
154852453|NCT01446419|558889332|FG000|Overall Study|Withdrawal by Subject|1|||
154852454|NCT01446419|558889333|FG001|Overall Study|Withdrawal by Subject|1|||
154852455|NCT01446419|558889332|FG000|Overall Study|Terminated per protocol|3|||
154852456|NCT01446419|558889333|FG001|Overall Study|Terminated per protocol|0|||
154852457|NCT04025632|558890988|FG000|Overall Study|Adverse Event|1|||
154852458|NCT04025632|558890989|FG001|Overall Study|Adverse Event|1|||
154852459|NCT04025632|558890988|FG000|Overall Study|Withdrawal by Subject|1|||
154852460|NCT04025632|558890989|FG001|Overall Study|Withdrawal by Subject|1|||
154852461|NCT04025632|558890988|FG000|Overall Study|Study Terminated by Sponsor|10|||
154852462|NCT04025632|558890989|FG001|Overall Study|Study Terminated by Sponsor|9|||
154971691|NCT01943435|559320638|FG001|6 Month Follow up|Lost to Follow-up|7|||
154971692|NCT01943435|559320639|FG002|6 Month Follow up|Lost to Follow-up|15|||
155105838|NCT05396014|559817549|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
154852463|NCT04025632|558890988|FG000|Overall Study|Physician Decision|3|||
154852464|NCT04025632|558890989|FG001|Overall Study|Physician Decision|1|||
154852465|NCT02159807|558890992|FG000|Overall Study|Adverse Event|0|||
154852466|NCT02159807|558890993|FG001|Overall Study|Adverse Event|0|||
154852467|NCT02159807|558890994|FG002|Overall Study|Adverse Event|1|||
154852468|NCT02159807|558890992|FG000|Overall Study|No CSF|1|||
154852469|NCT02159807|558890993|FG001|Overall Study|No CSF|1|||
154852470|NCT02159807|558890994|FG002|Overall Study|No CSF|1|||
154852471|NCT02159807|558890992|FG000|Overall Study|elevated blood pressure|0|||
154852472|NCT02159807|558890993|FG001|Overall Study|elevated blood pressure|0|||
154852473|NCT02159807|558890994|FG002|Overall Study|elevated blood pressure|1|||
154852474|NCT00950170|558890995|FG000|Overall Study|Parent/Legal Guardian Request|1|||
154852475|NCT00950170|558890995|FG000|Overall Study|Adverse Event|2|||
154852476|NCT00950170|558890995|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
154852477|NCT02367521|558890998|FG000|Overall Study|severe headache after intervention|2|||
154852478|NCT02367521|558890999|FG001|Overall Study|severe headache after intervention|0|||
154852479|NCT02367521|558890998|FG000|Overall Study|unable to find transportation|2|||
154852480|NCT02367521|558890999|FG001|Overall Study|unable to find transportation|0|||
154852481|NCT00600171|558891000|FG000|Overall Study|Adverse Event|0|||
154852482|NCT00600171|558891001|FG001|Overall Study|Adverse Event|1|||
154852483|NCT00600171|558891002|FG002|Overall Study|Adverse Event|0|||
154852484|NCT00600171|558891003|FG003|Overall Study|Adverse Event|0|||
154852485|NCT00600171|558891004|FG004|Overall Study|Adverse Event|1|||
154852486|NCT00600171|558891005|FG005|Overall Study|Adverse Event|0|||
154852487|NCT00600171|558891000|FG000|Overall Study|Lack of Efficacy|9|||
154852488|NCT00600171|558891001|FG001|Overall Study|Lack of Efficacy|12|||
154852489|NCT00600171|558891002|FG002|Overall Study|Lack of Efficacy|3|||
154852490|NCT00600171|558891003|FG003|Overall Study|Lack of Efficacy|5|||
154852491|NCT00600171|558891004|FG004|Overall Study|Lack of Efficacy|4|||
154852492|NCT00600171|558891005|FG005|Overall Study|Lack of Efficacy|0|||
154852493|NCT00600171|558891000|FG000|Overall Study|Protocol Violation|1|||
154852494|NCT00600171|558891001|FG001|Overall Study|Protocol Violation|2|||
154852495|NCT00600171|558891002|FG002|Overall Study|Protocol Violation|0|||
154852496|NCT00600171|558891003|FG003|Overall Study|Protocol Violation|1|||
154852497|NCT00600171|558891004|FG004|Overall Study|Protocol Violation|0|||
154852498|NCT00600171|558891005|FG005|Overall Study|Protocol Violation|0|||
154852499|NCT00600171|558891000|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
154852500|NCT00600171|558891001|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
154852501|NCT00600171|558891002|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
154852502|NCT00600171|558891003|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
154852503|NCT00600171|558891004|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
154852504|NCT00600171|558891005|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
154852505|NCT00600171|558891000|FG000|Overall Study|Withdrawal by Subject|3|||
154852506|NCT00600171|558891001|FG001|Overall Study|Withdrawal by Subject|0|||
154852507|NCT00600171|558891002|FG002|Overall Study|Withdrawal by Subject|0|||
154852508|NCT00600171|558891003|FG003|Overall Study|Withdrawal by Subject|1|||
154852509|NCT00600171|558891004|FG004|Overall Study|Withdrawal by Subject|1|||
154852510|NCT00600171|558891005|FG005|Overall Study|Withdrawal by Subject|1|||
154852511|NCT00600171|558891000|FG000|Overall Study|Physician Decision|0|||
154852512|NCT00600171|558891001|FG001|Overall Study|Physician Decision|1|||
154852513|NCT00600171|558891002|FG002|Overall Study|Physician Decision|0|||
154852514|NCT00600171|558891003|FG003|Overall Study|Physician Decision|1|||
154852515|NCT00600171|558891004|FG004|Overall Study|Physician Decision|0|||
154852516|NCT00600171|558891005|FG005|Overall Study|Physician Decision|2|||
154852517|NCT00600171|558891000|FG000|Overall Study|Lost to Follow-up|0|||
154852518|NCT00600171|558891001|FG001|Overall Study|Lost to Follow-up|0|||
154852519|NCT00600171|558891002|FG002|Overall Study|Lost to Follow-up|0|||
154852520|NCT00600171|558891003|FG003|Overall Study|Lost to Follow-up|1|||
154852521|NCT00600171|558891004|FG004|Overall Study|Lost to Follow-up|0|||
154852522|NCT00600171|558891005|FG005|Overall Study|Lost to Follow-up|0|||
154852523|NCT00542191|558891006|FG000|Overall Study|Death|3|||
154852524|NCT00469612|558891007|FG000|Overall Study|Study terminated before data collected|2|||
154852525|NCT00469612|558891008|FG001|Overall Study|Study terminated before data collected|0|||
154852526|NCT02357420|558891011|FG000|Overall Study|Adverse Event|3|||
154852527|NCT02357420|558891012|FG001|Overall Study|Adverse Event|3|||
154852528|NCT02357420|558891013|FG002|Overall Study|Adverse Event|8|||
154852529|NCT02357420|558891014|FG003|Overall Study|Adverse Event|9|||
154852530|NCT02357420|558891011|FG000|Overall Study|Investigator Decision|1|||
154852531|NCT02357420|558891012|FG001|Overall Study|Investigator Decision|0|||
154852532|NCT02357420|558891013|FG002|Overall Study|Investigator Decision|0|||
154852533|NCT02357420|558891014|FG003|Overall Study|Investigator Decision|0|||
154852534|NCT02357420|558891011|FG000|Overall Study|Prohibited Medication|1|||
154852535|NCT02357420|558891012|FG001|Overall Study|Prohibited Medication|1|||
154852536|NCT02357420|558891013|FG002|Overall Study|Prohibited Medication|0|||
154852537|NCT02357420|558891014|FG003|Overall Study|Prohibited Medication|0|||
154852538|NCT02357420|558891011|FG000|Overall Study|Protocol Non-compliance|0|||
154852539|NCT02357420|558891012|FG001|Overall Study|Protocol Non-compliance|0|||
154852540|NCT02357420|558891013|FG002|Overall Study|Protocol Non-compliance|0|||
154852541|NCT02357420|558891014|FG003|Overall Study|Protocol Non-compliance|1|||
154852542|NCT02357420|558891011|FG000|Overall Study|Withdrawn Consent|4|||
154852543|NCT02357420|558891012|FG001|Overall Study|Withdrawn Consent|8|||
154852544|NCT02357420|558891013|FG002|Overall Study|Withdrawn Consent|6|||
154852545|NCT02357420|558891014|FG003|Overall Study|Withdrawn Consent|6|||
154852546|NCT02357420|558891011|FG000|Overall Study|Lost to Follow-up|3|||
154852547|NCT02357420|558891012|FG001|Overall Study|Lost to Follow-up|0|||
154852548|NCT02357420|558891013|FG002|Overall Study|Lost to Follow-up|2|||
154852549|NCT02357420|558891014|FG003|Overall Study|Lost to Follow-up|3|||
154852550|NCT00440726|558891018|FG000|Phase 1|Dose-Limiting Toxicity|0|||
154852551|NCT00440726|558891019|FG001|Phase 1|Dose-Limiting Toxicity|1|||
154852552|NCT00440726|558891020|FG002|Phase 1|Dose-Limiting Toxicity|0|||
154852553|NCT00440726|558891018|FG000|Phase 1|Physician Decision|1|||
154852554|NCT00440726|558891019|FG001|Phase 1|Physician Decision|0|||
154852555|NCT00440726|558891020|FG002|Phase 1|Physician Decision|0|||
154852556|NCT00440726|558891018|FG000|Phase 2|Death|0|||
154852557|NCT00440726|558891019|FG001|Phase 2|Death|0|||
154852558|NCT00440726|558891020|FG002|Phase 2|Death|1|||
154852559|NCT00440726|558891018|FG000|Phase 2|Adverse Event|0|||
154852560|NCT00440726|558891019|FG001|Phase 2|Adverse Event|0|||
154852561|NCT00440726|558891020|FG002|Phase 2|Adverse Event|1|||
154852562|NCT01808612|558891021|FG000|Treatment Period|Adverse Event|8|||
154852563|NCT01808612|558891022|FG001|Treatment Period|Adverse Event|4|||
154852564|NCT01808612|558891023|FG002|Treatment Period|Adverse Event|3|||
155105839|NCT05396014|559817550|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105840|NCT05396014|559817551|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105841|NCT05396014|559817552|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105842|NCT05396014|559817553|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105843|NCT05396014|559817554|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105844|NCT05396014|559817555|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105845|NCT05396014|559817556|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105846|NCT05396014|559817557|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105847|NCT05396014|559817558|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105848|NCT05396014|559817559|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105849|NCT05396014|559817560|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105850|NCT05396014|559817561|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105851|NCT05396014|559817562|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105852|NCT05396014|559817563|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105853|NCT05396014|559817564|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
155105854|NCT05396014|559817565|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105855|NCT05396014|559817566|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105856|NCT05396014|559817567|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
155105857|NCT05396014|559817525|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
155105858|NCT05396014|559817526|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105859|NCT05396014|559817527|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105860|NCT05396014|559817528|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105861|NCT05396014|559817529|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
154852565|NCT01808612|558891021|FG000|Treatment Period|Lost to Follow-up|2|||
154852566|NCT01808612|558891022|FG001|Treatment Period|Lost to Follow-up|2|||
154852567|NCT01808612|558891023|FG002|Treatment Period|Lost to Follow-up|1|||
154852568|NCT01808612|558891021|FG000|Treatment Period|Protocol Violation|1|||
154852569|NCT01808612|558891022|FG001|Treatment Period|Protocol Violation|0|||
154852570|NCT01808612|558891023|FG002|Treatment Period|Protocol Violation|0|||
154852571|NCT01808612|558891021|FG000|Treatment Period|Withdrawal by Subject|1|||
154852572|NCT01808612|558891022|FG001|Treatment Period|Withdrawal by Subject|0|||
154852573|NCT01808612|558891023|FG002|Treatment Period|Withdrawal by Subject|4|||
154852574|NCT01808612|558891021|FG000|Treatment Period|Physician Decision|1|||
154852575|NCT01808612|558891022|FG001|Treatment Period|Physician Decision|0|||
154852576|NCT01808612|558891023|FG002|Treatment Period|Physician Decision|4|||
154852577|NCT01808612|558891021|FG000|Treatment Period|Sponsor Decision|1|||
154852578|NCT01808612|558891022|FG001|Treatment Period|Sponsor Decision|0|||
154852579|NCT01808612|558891023|FG002|Treatment Period|Sponsor Decision|0|||
154852580|NCT01808612|558891021|FG000|Treatment Period|Lack of Efficacy|1|||
154852581|NCT01808612|558891022|FG001|Treatment Period|Lack of Efficacy|1|||
154852582|NCT01808612|558891023|FG002|Treatment Period|Lack of Efficacy|2|||
155105862|NCT05396014|559817530|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155173622|NCT00864916|560074833|FG000|Overall Study|Withdrawal by Subject|1|||
154852583|NCT01808612|558891021|FG000|Discontinuation Period|Adverse Event|1|||
154852584|NCT01808612|558891022|FG001|Discontinuation Period|Adverse Event|0|||
154852585|NCT01808612|558891023|FG002|Discontinuation Period|Adverse Event|0|||
154852586|NCT01808612|558891021|FG000|Discontinuation Period|Physician Decision|1|||
154852587|NCT01808612|558891022|FG001|Discontinuation Period|Physician Decision|0|||
154852588|NCT01808612|558891023|FG002|Discontinuation Period|Physician Decision|0|||
154852589|NCT01808612|558891021|FG000|Discontinuation Period|Lost to Follow-up|0|||
154852590|NCT01808612|558891022|FG001|Discontinuation Period|Lost to Follow-up|1|||
154852591|NCT01808612|558891023|FG002|Discontinuation Period|Lost to Follow-up|0|||
154852592|NCT00110019|558891024|FG000|Overall Study|Lack of Efficacy|253|||
154852593|NCT00110019|558891025|FG001|Overall Study|Lack of Efficacy|285|||
154852594|NCT00110019|558891024|FG000|Overall Study|Adverse Event|61|||
154852595|NCT00110019|558891025|FG001|Overall Study|Adverse Event|40|||
154852596|NCT00110019|558891024|FG000|Overall Study|Death|13|||
154852597|NCT00110019|558891025|FG001|Overall Study|Death|15|||
154852598|NCT00110019|558891024|FG000|Overall Study|Withdrawal by Subject|21|||
154852599|NCT00110019|558891025|FG001|Overall Study|Withdrawal by Subject|9|||
154852600|NCT00110019|558891024|FG000|Overall Study|alternative therapy|5|||
154852601|NCT00110019|558891025|FG001|Overall Study|alternative therapy|1|||
154852602|NCT00110019|558891024|FG000|Overall Study|complicating disease|1|||
154852603|NCT00110019|558891025|FG001|Overall Study|complicating disease|1|||
154852604|NCT00110019|558891024|FG000|Overall Study|symptom deterioration|13|||
154852605|NCT00110019|558891025|FG001|Overall Study|symptom deterioration|16|||
154852606|NCT00110019|558891024|FG000|Overall Study|Not start protocol therapy|17|||
154852607|NCT00110019|558891025|FG001|Overall Study|Not start protocol therapy|16|||
154852608|NCT00110019|558891024|FG000|Overall Study|other reasons|22|||
154852609|NCT00110019|558891025|FG001|Overall Study|other reasons|30|||
154852610|NCT02239263|558891026|FG000|Overall Study|Protocol Violation|6|||
154852611|NCT01046695|558891027|FG000|Overall Study|Subject had a pacemaker|0|||
154852612|NCT01046695|558891028|FG001|Overall Study|Subject had a pacemaker|1|||
154852613|NCT01046695|558891027|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
154852614|NCT01046695|558891028|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
154852615|NCT00559273|558891032|FG000|Correction Period (20 Weeks)|Death|3|||
154852616|NCT00559273|558891033|FG001|Correction Period (20 Weeks)|Death|4|||
154852617|NCT00559273|558891032|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
154852618|NCT00559273|558891033|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
154852619|NCT00559273|558891032|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
154852620|NCT00559273|558891033|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
154852621|NCT00559273|558891032|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
154852622|NCT00559273|558891033|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
154852623|NCT00559273|558891032|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
154852624|NCT00559273|558891033|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
154852625|NCT00559273|558891032|FG000|Evaluation Period (8 Weeks)|Death|1|||
154852626|NCT00559273|558891033|FG001|Evaluation Period (8 Weeks)|Death|3|||
154852627|NCT00559273|558891032|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
154852628|NCT00559273|558891033|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
154852629|NCT00559273|558891032|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
154852630|NCT00559273|558891033|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
154852631|NCT00559273|558891032|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
154852632|NCT00559273|558891033|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
154852633|NCT01256177|558891034|FG000|Overall Study|Withdrawal by Subject|23|||
154852634|NCT01256177|558891035|FG001|Overall Study|Withdrawal by Subject|22|||
154852635|NCT01256177|558891034|FG000|Overall Study|Lost to Follow-up|2|||
154852636|NCT01256177|558891035|FG001|Overall Study|Lost to Follow-up|2|||
154852637|NCT01256177|558891034|FG000|Overall Study|Adverse Event|8|||
154852638|NCT01256177|558891035|FG001|Overall Study|Adverse Event|9|||
154852639|NCT01256177|558891034|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
154852640|NCT01256177|558891035|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
154852641|NCT01256177|558891034|FG000|Overall Study|Condition under Investigation Worsened|1|||
154852642|NCT01256177|558891035|FG001|Overall Study|Condition under Investigation Worsened|0|||
154852643|NCT01256177|558891034|FG000|Overall Study|Lack of Efficacy|11|||
154852644|NCT01256177|558891035|FG001|Overall Study|Lack of Efficacy|2|||
154852645|NCT01256177|558891034|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
154852646|NCT01256177|558891035|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
154852647|NCT01728779|558891039|FG000|Overall Study|Withdrawal by Subject|1|||
154852648|NCT01925209|558891040|FG000|Treatment Epoch|Physician Decision|1|||
154852649|NCT01925209|558891041|FG001|Treatment Epoch|Physician Decision|0|||
154852650|NCT01925209|558891042|FG002|Treatment Epoch|Physician Decision|0|||
154852651|NCT01925209|558891043|FG003|Treatment Epoch|Physician Decision|0|||
154852652|NCT01925209|558891040|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
154852653|NCT01925209|558891041|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
154852654|NCT01925209|558891042|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
154852655|NCT01925209|558891043|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
154852656|NCT01925209|558891040|FG000|Treatment Epoch|Death|1|||
154852657|NCT01925209|558891041|FG001|Treatment Epoch|Death|0|||
154852658|NCT01925209|558891042|FG002|Treatment Epoch|Death|0|||
154852659|NCT01925209|558891043|FG003|Treatment Epoch|Death|0|||
155105863|NCT05396014|559817531|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
154852660|NCT01925209|558891040|FG000|Treatment Epoch|Protocol deviation|0|||
154852661|NCT01925209|558891041|FG001|Treatment Epoch|Protocol deviation|0|||
154852662|NCT01925209|558891042|FG002|Treatment Epoch|Protocol deviation|1|||
154852663|NCT01925209|558891043|FG003|Treatment Epoch|Protocol deviation|1|||
154852664|NCT01925209|558891040|FG000|Treatment Epoch|Withdrawal by Subject|4|||
154852665|NCT01925209|558891041|FG001|Treatment Epoch|Withdrawal by Subject|3|||
154852666|NCT01925209|558891042|FG002|Treatment Epoch|Withdrawal by Subject|3|||
154852667|NCT01925209|558891043|FG003|Treatment Epoch|Withdrawal by Subject|2|||
154852668|NCT01925209|558891040|FG000|Treatment Epoch|Adverse Event|3|||
155105864|NCT05396014|559817532|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105865|NCT05396014|559817533|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105866|NCT05396014|559817534|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105867|NCT05396014|559817535|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105868|NCT05396014|559817536|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105869|NCT05396014|559817537|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105870|NCT05396014|559817538|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105871|NCT05396014|559817539|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105872|NCT05396014|559817540|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105873|NCT05396014|559817541|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105874|NCT05396014|559817542|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105875|NCT05396014|559817543|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105876|NCT05396014|559817544|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105877|NCT05396014|559817545|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105878|NCT05396014|559817546|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105879|NCT05396014|559817547|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105880|NCT05396014|559817548|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105881|NCT05396014|559817549|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105882|NCT05396014|559817550|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105883|NCT05396014|559817551|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
155105884|NCT05396014|559817552|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105885|NCT05396014|559817553|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105886|NCT05396014|559817554|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105887|NCT05396014|559817555|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105888|NCT05396014|559817556|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
154852669|NCT01925209|558891041|FG001|Treatment Epoch|Adverse Event|5|||
154852670|NCT01925209|558891042|FG002|Treatment Epoch|Adverse Event|3|||
154852671|NCT01925209|558891043|FG003|Treatment Epoch|Adverse Event|1|||
154852672|NCT01925209|558891040|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
154852673|NCT01925209|558891041|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
154852674|NCT01925209|558891042|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
154852675|NCT01925209|558891043|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
154852676|NCT01925209|558891040|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
154852677|NCT01925209|558891041|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
154852678|NCT01925209|558891042|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
154852679|NCT01925209|558891043|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
154852680|NCT01925209|558891040|FG000|Follow-up|Adverse Event|1|||
154852681|NCT01925209|558891041|FG001|Follow-up|Adverse Event|4|||
154852682|NCT01925209|558891042|FG002|Follow-up|Adverse Event|0|||
154852683|NCT01925209|558891043|FG003|Follow-up|Adverse Event|1|||
154852684|NCT01925209|558891040|FG000|Follow-up|Physician Decision|0|||
154852685|NCT01925209|558891041|FG001|Follow-up|Physician Decision|0|||
154852686|NCT01925209|558891042|FG002|Follow-up|Physician Decision|1|||
154852687|NCT01925209|558891043|FG003|Follow-up|Physician Decision|0|||
154852688|NCT01925209|558891040|FG000|Follow-up|Non-compliance with study treatment|0|||
154852689|NCT01925209|558891041|FG001|Follow-up|Non-compliance with study treatment|0|||
154852690|NCT01925209|558891042|FG002|Follow-up|Non-compliance with study treatment|0|||
155105889|NCT05396014|559817557|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105890|NCT05396014|559817558|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105891|NCT05396014|559817559|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105892|NCT05396014|559817560|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105893|NCT05396014|559817561|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
154852691|NCT01925209|558891043|FG003|Follow-up|Non-compliance with study treatment|1|||
154852692|NCT01925209|558891040|FG000|Follow-up|Withdrawal by Subject|0|||
154852693|NCT01925209|558891041|FG001|Follow-up|Withdrawal by Subject|2|||
154852694|NCT01925209|558891042|FG002|Follow-up|Withdrawal by Subject|0|||
154852695|NCT01925209|558891043|FG003|Follow-up|Withdrawal by Subject|2|||
154852696|NCT00448708|558891044|FG000|Overall Study|Death|21|||
154852697|NCT00448708|558891045|FG001|Overall Study|Death|17|||
154852698|NCT00448708|558891044|FG000|Overall Study|Withdrawal by Subject|8|||
154852699|NCT00448708|558891045|FG001|Overall Study|Withdrawal by Subject|4|||
154852700|NCT00448708|558891044|FG000|Overall Study|Lost to Follow-up|6|||
154852701|NCT00448708|558891045|FG001|Overall Study|Lost to Follow-up|8|||
154852702|NCT00448708|558891044|FG000|Overall Study|not listed|0|||
155105894|NCT05396014|559817562|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105895|NCT05396014|559817563|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105896|NCT05396014|559817564|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105897|NCT05396014|559817565|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105898|NCT05396014|559817566|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
154852703|NCT00448708|558891045|FG001|Overall Study|not listed|2|||
154852704|NCT04398732|558891046|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
154852705|NCT01299727|558891048|FG000|Overall Study|Withdrawal by Subject|1|||
155105899|NCT05396014|559817567|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
155105900|NCT05396014|559817525|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
154852706|NCT01299727|558891049|FG001|Overall Study|Withdrawal by Subject|0|||
154852707|NCT01299727|558891050|FG002|Overall Study|Withdrawal by Subject|0|||
154852708|NCT01299727|558891048|FG000|Overall Study|Adverse Event|0|||
154852709|NCT01299727|558891049|FG001|Overall Study|Adverse Event|0|||
154852710|NCT01299727|558891050|FG002|Overall Study|Adverse Event|1|||
154852711|NCT01299727|558891048|FG000|Overall Study|Completed the Treatment Period|3|||
154852712|NCT01299727|558891049|FG001|Overall Study|Completed the Treatment Period|4|||
154852713|NCT01299727|558891050|FG002|Overall Study|Completed the Treatment Period|3|||
154852714|NCT03882424|558891051|FG000|Overall Study|Lost to Follow-up|3|||
154852715|NCT03882424|558891052|FG001|Overall Study|Lost to Follow-up|0|||
154852716|NCT03882424|558891053|FG002|Overall Study|Lost to Follow-up|0|||
154852717|NCT03882424|558891051|FG000|Overall Study|schedule conflict|1|||
154852718|NCT03882424|558891052|FG001|Overall Study|schedule conflict|0|||
154852719|NCT03882424|558891053|FG002|Overall Study|schedule conflict|0|||
154852720|NCT01596257|558891058|FG000|Overall Study|Inadequate Collection|23|||
154852721|NCT01596257|558891059|FG001|Overall Study|Inadequate Collection|19|||
154852722|NCT01570244|558891063|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
154852723|NCT03486392|558891066|FG000|Overall Study|Lost to Follow-up|0|||
154852724|NCT03486392|558891067|FG001|Overall Study|Lost to Follow-up|0|||
154852725|NCT03486392|558891068|FG002|Overall Study|Lost to Follow-up|8|||
154852726|NCT03486392|558891069|FG003|Overall Study|Lost to Follow-up|5|||
154852727|NCT03486392|558891070|FG004|Overall Study|Lost to Follow-up|2|||
154852728|NCT03486392|558891066|FG000|Overall Study|Withdrawal by Subject|3|||
154852729|NCT03486392|558891067|FG001|Overall Study|Withdrawal by Subject|0|||
154852730|NCT03486392|558891068|FG002|Overall Study|Withdrawal by Subject|6|||
154852731|NCT03486392|558891069|FG003|Overall Study|Withdrawal by Subject|4|||
154852732|NCT03486392|558891070|FG004|Overall Study|Withdrawal by Subject|1|||
154852733|NCT03486392|558891066|FG000|Overall Study|Death|0|||
154852734|NCT03486392|558891067|FG001|Overall Study|Death|0|||
154852735|NCT03486392|558891068|FG002|Overall Study|Death|0|||
154852736|NCT03486392|558891069|FG003|Overall Study|Death|0|||
154852737|NCT03486392|558891070|FG004|Overall Study|Death|1|||
154852738|NCT00441792|558891071|FG000|Overall Study|Lost to Follow-up|0|||
154852739|NCT00441792|558891072|FG001|Overall Study|Lost to Follow-up|2|||
154852740|NCT02532855|558891076|FG000|Overall Study|Lost to Follow-up|4|||
154852741|NCT02532855|558891077|FG001|Overall Study|Lost to Follow-up|3|||
154852742|NCT02532855|558891076|FG000|Overall Study|Withdrawal by Subject|4|||
154852743|NCT02532855|558891077|FG001|Overall Study|Withdrawal by Subject|8|||
154852744|NCT01879410|558891080|FG000|Overall Study|Adverse Event|9|||
154852745|NCT01879410|558891081|FG001|Overall Study|Adverse Event|14|||
154852746|NCT01879410|558891080|FG000|Overall Study|Lack of Efficacy|4|||
154852747|NCT01879410|558891081|FG001|Overall Study|Lack of Efficacy|6|||
154852748|NCT01879410|558891080|FG000|Overall Study|Protocol Violation|1|||
154852749|NCT01879410|558891081|FG001|Overall Study|Protocol Violation|7|||
154852750|NCT01879410|558891080|FG000|Overall Study|Lost to Follow-up|2|||
154852751|NCT01879410|558891081|FG001|Overall Study|Lost to Follow-up|1|||
154852752|NCT01879410|558891080|FG000|Overall Study|Withdrawal by Subject|7|||
154852753|NCT01879410|558891081|FG001|Overall Study|Withdrawal by Subject|8|||
154852754|NCT01879410|558891080|FG000|Overall Study|Randomised in Error|1|||
154852755|NCT01879410|558891081|FG001|Overall Study|Randomised in Error|2|||
154852756|NCT01360645|558891083|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
154852757|NCT01360645|558891084|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
154852758|NCT01360645|558891085|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
154852759|NCT01360645|558891086|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
154852760|NCT01360645|558891083|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
154852761|NCT01360645|558891084|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
154852762|NCT01360645|558891085|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
154852763|NCT01360645|558891086|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
154852764|NCT01360645|558891083|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
154852765|NCT01360645|558891084|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
154852766|NCT01360645|558891085|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
154852767|NCT01360645|558891086|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
154852768|NCT01360645|558891083|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
154852769|NCT01360645|558891084|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
154852770|NCT01360645|558891085|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
155105901|NCT05396014|559817526|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105902|NCT05396014|559817527|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105903|NCT05396014|559817528|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105904|NCT05396014|559817529|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105905|NCT05396014|559817530|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
154852771|NCT01360645|558891086|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
155105906|NCT05396014|559817531|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105907|NCT05396014|559817532|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105908|NCT05396014|559817533|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105909|NCT05396014|559817534|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105910|NCT05396014|559817535|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105911|NCT05396014|559817536|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105912|NCT05396014|559817537|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105913|NCT05396014|559817538|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
155105914|NCT05396014|559817539|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105915|NCT05396014|559817540|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105916|NCT05396014|559817541|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105917|NCT05396014|559817542|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105918|NCT05396014|559817543|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105919|NCT05396014|559817544|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105920|NCT05396014|559817545|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105921|NCT05396014|559817546|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105922|NCT05396014|559817547|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105923|NCT05396014|559817548|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105924|NCT05396014|559817549|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105925|NCT05396014|559817550|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105926|NCT05396014|559817551|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105927|NCT05396014|559817552|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105928|NCT05396014|559817553|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105929|NCT05396014|559817554|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155173623|NCT00864916|560074834|FG001|Overall Study|Withdrawal by Subject|0|||
155173624|NCT03890666|560074835|FG000|Overall Study|Withdrawal by Subject|0|||
154852772|NCT01360645|558891083|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
154852773|NCT01360645|558891084|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
154852774|NCT01360645|558891085|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
154852775|NCT01360645|558891086|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
154852776|NCT01360645|558891083|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
154852777|NCT01360645|558891084|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
154852778|NCT01360645|558891085|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
154852779|NCT01360645|558891086|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
154852780|NCT01360645|558891083|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
154852781|NCT01360645|558891084|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
154852782|NCT01360645|558891085|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
154852783|NCT01360645|558891086|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
154852784|NCT01360645|558891083|FG000|Phase B (6 Weeks)|Adverse Event|0|||
154852785|NCT01360645|558891084|FG001|Phase B (6 Weeks)|Adverse Event|6|||
154852786|NCT01360645|558891085|FG002|Phase B (6 Weeks)|Adverse Event|0|||
154852787|NCT01360645|558891086|FG003|Phase B (6 Weeks)|Adverse Event|0|||
154852788|NCT01360645|558891083|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
154852789|NCT01360645|558891084|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
154852790|NCT01360645|558891085|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
154852791|NCT01360645|558891086|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
154852792|NCT01360645|558891083|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
154852793|NCT01360645|558891084|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
154852794|NCT01360645|558891085|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
154852795|NCT01360645|558891086|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
154852796|NCT01360645|558891083|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
154852797|NCT01360645|558891084|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
154852798|NCT01360645|558891085|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
155173625|NCT03890666|560074836|FG001|Overall Study|Withdrawal by Subject|1|||
154852799|NCT01360645|558891086|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
154852800|NCT01360645|558891083|FG000|Phase A+|Lost to Follow-up|0|||
154852801|NCT01360645|558891084|FG001|Phase A+|Lost to Follow-up|0|||
154852802|NCT01360645|558891085|FG002|Phase A+|Lost to Follow-up|0|||
154852803|NCT01360645|558891086|FG003|Phase A+|Lost to Follow-up|7|||
154852804|NCT01360645|558891083|FG000|Phase A+|Adverse Event|0|||
154852805|NCT01360645|558891084|FG001|Phase A+|Adverse Event|0|||
154852806|NCT01360645|558891085|FG002|Phase A+|Adverse Event|0|||
154852807|NCT01360645|558891086|FG003|Phase A+|Adverse Event|2|||
154852808|NCT01360645|558891083|FG000|Phase A+|Met Withdrawal Criteria|0|||
154852809|NCT01360645|558891084|FG001|Phase A+|Met Withdrawal Criteria|0|||
154852810|NCT01360645|558891085|FG002|Phase A+|Met Withdrawal Criteria|0|||
154852811|NCT01360645|558891086|FG003|Phase A+|Met Withdrawal Criteria|4|||
154852812|NCT01360645|558891083|FG000|Phase A+|Physician Decision|0|||
154852813|NCT01360645|558891084|FG001|Phase A+|Physician Decision|0|||
154852814|NCT01360645|558891085|FG002|Phase A+|Physician Decision|0|||
154852815|NCT01360645|558891086|FG003|Phase A+|Physician Decision|2|||
154971693|NCT01617096|559320646|FG000|Overall Study|Withdrawal by Subject|96|||
154971694|NCT01617096|559320647|FG001|Overall Study|Withdrawal by Subject|81|||
155173626|NCT03890666|560074835|FG000|Overall Study|Protocol deviation|1|||
155173627|NCT03890666|560074836|FG001|Overall Study|Protocol deviation|4|||
154852816|NCT01360645|558891083|FG000|Phase A+|Withdrawal by Subject|0|||
154852817|NCT01360645|558891084|FG001|Phase A+|Withdrawal by Subject|0|||
154852818|NCT01360645|558891085|FG002|Phase A+|Withdrawal by Subject|0|||
154852819|NCT01360645|558891086|FG003|Phase A+|Withdrawal by Subject|5|||
154852820|NCT01360645|558891083|FG000|Phase A+|Protocol Deviation|0|||
154852821|NCT01360645|558891084|FG001|Phase A+|Protocol Deviation|0|||
154852822|NCT01360645|558891085|FG002|Phase A+|Protocol Deviation|0|||
154852823|NCT01360645|558891086|FG003|Phase A+|Protocol Deviation|4|||
154852824|NCT01737931|558891093|FG000|Overall Study|Withdrawal by Subject|0|||
154852825|NCT01737931|558891094|FG001|Overall Study|Withdrawal by Subject|1|||
154852826|NCT01737931|558891095|FG002|Overall Study|Withdrawal by Subject|1|||
154852827|NCT01737931|558891093|FG000|Overall Study|Physician Decision|0|||
154852828|NCT01737931|558891094|FG001|Overall Study|Physician Decision|1|||
154852829|NCT01737931|558891095|FG002|Overall Study|Physician Decision|0|||
154852830|NCT02041962|558891096|FG000|Overall Study|Lost Aetna Coverage|43|||
154852831|NCT02041962|558891097|FG001|Overall Study|Lost Aetna Coverage|40|||
154852832|NCT02041962|558891096|FG000|Overall Study|Death|1|||
154852833|NCT02041962|558891097|FG001|Overall Study|Death|1|||
154852834|NCT02041962|558891096|FG000|Overall Study|Lost to Follow-up|37|||
154852835|NCT02041962|558891097|FG001|Overall Study|Lost to Follow-up|32|||
154852836|NCT02041962|558891096|FG000|Overall Study|Withdrawal by Subject|0|||
154852837|NCT02041962|558891097|FG001|Overall Study|Withdrawal by Subject|11|||
154852838|NCT00330187|558891098|FG000|Overall Study|Lost to Follow-up|12|||
154852839|NCT00330187|558891099|FG001|Overall Study|Lost to Follow-up|13|||
154852840|NCT00330187|558891100|FG002|Overall Study|Lost to Follow-up|14|||
154852841|NCT00330187|558891101|FG003|Overall Study|Lost to Follow-up|10|||
154852842|NCT00330187|558891098|FG000|Overall Study|Withdrawal by Subject|8|||
154852843|NCT00330187|558891099|FG001|Overall Study|Withdrawal by Subject|5|||
154852844|NCT00330187|558891100|FG002|Overall Study|Withdrawal by Subject|4|||
154852845|NCT00330187|558891101|FG003|Overall Study|Withdrawal by Subject|4|||
154852846|NCT01573910|558891102|FG000|Overall Study|Adverse Event|4|||
154852847|NCT01573910|558891103|FG001|Overall Study|Adverse Event|4|||
154852848|NCT01573910|558891102|FG000|Overall Study|Lost to Follow-up|2|||
154852849|NCT01573910|558891103|FG001|Overall Study|Lost to Follow-up|1|||
154852850|NCT01573910|558891102|FG000|Overall Study|Withdrawal by Subject|0|||
154852851|NCT01573910|558891103|FG001|Overall Study|Withdrawal by Subject|1|||
154852852|NCT01573910|558891102|FG000|Overall Study|Protocol Violation|3|||
154852853|NCT01573910|558891103|FG001|Overall Study|Protocol Violation|0|||
154852854|NCT01573910|558891102|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
154852855|NCT01573910|558891103|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
154852856|NCT00364182|558891104|FG000|First Intervention|Secondary prophylaxis|1|||
154852857|NCT00364182|558891105|FG001|First Intervention|Secondary prophylaxis|0|||
154852858|NCT00364182|558891106|FG002|First Intervention|Secondary prophylaxis|0|||
154852859|NCT00364182|558891104|FG000|First Intervention|Withdrawal by Subject|2|||
154852860|NCT00364182|558891105|FG001|First Intervention|Withdrawal by Subject|0|||
154852861|NCT00364182|558891106|FG002|First Intervention|Withdrawal by Subject|0|||
154852862|NCT00364182|558891104|FG000|Second Intervention|non-compliance|0|||
154852863|NCT00364182|558891105|FG001|Second Intervention|non-compliance|1|||
154852864|NCT00364182|558891106|FG002|Second Intervention|non-compliance|1|||
154852865|NCT00364182|558891104|FG000|Second Intervention|Protocol Violation|0|||
154852866|NCT00364182|558891105|FG001|Second Intervention|Protocol Violation|1|||
154852867|NCT00364182|558891106|FG002|Second Intervention|Protocol Violation|0|||
154852868|NCT00364182|558891104|FG000|Second Intervention|Adverse Event|0|||
154852869|NCT00364182|558891105|FG001|Second Intervention|Adverse Event|0|||
154852870|NCT00364182|558891106|FG002|Second Intervention|Adverse Event|1|||
154852871|NCT00364182|558891104|FG000|Third Intervention|non-compliance|0|||
154852872|NCT00364182|558891105|FG001|Third Intervention|non-compliance|1|||
154852873|NCT00364182|558891106|FG002|Third Intervention|non-compliance|0|||
154852874|NCT00364182|558891104|FG000|Third Intervention|Lost to Follow-up|0|||
154971695|NCT01617096|559320646|FG000|Overall Study|Lost to Follow-up|37|||
154971696|NCT01617096|559320647|FG001|Overall Study|Lost to Follow-up|32|||
154971697|NCT01617096|559320646|FG000|Overall Study|Physician Decision|10|||
154971698|NCT01617096|559320647|FG001|Overall Study|Physician Decision|18|||
154971699|NCT01617096|559320646|FG000|Overall Study|Death|4|||
154971700|NCT01617096|559320647|FG001|Overall Study|Death|3|||
154852875|NCT00364182|558891105|FG001|Third Intervention|Lost to Follow-up|0|||
154852876|NCT00364182|558891106|FG002|Third Intervention|Lost to Follow-up|1|||
154852877|NCT02601573|558891107|FG000|Overall Study|Lost to Follow-up|0|||
154852878|NCT02601573|558891108|FG001|Overall Study|Lost to Follow-up|3|||
154852879|NCT02601573|558891109|FG002|Overall Study|Lost to Follow-up|1|||
154852880|NCT02601573|558891110|FG003|Overall Study|Lost to Follow-up|0|||
154852881|NCT02601573|558891111|FG004|Overall Study|Lost to Follow-up|2|||
154852882|NCT02601573|558891107|FG000|Overall Study|Withdrawal by Subject|0|||
154971701|NCT01617096|559320646|FG000|Overall Study|Other|1|||
155173628|NCT03890666|560074835|FG000|Overall Study|Lost to Follow-up|2|||
154852883|NCT02601573|558891108|FG001|Overall Study|Withdrawal by Subject|1|||
154852884|NCT02601573|558891109|FG002|Overall Study|Withdrawal by Subject|0|||
154852885|NCT02601573|558891110|FG003|Overall Study|Withdrawal by Subject|1|||
154852886|NCT02601573|558891111|FG004|Overall Study|Withdrawal by Subject|0|||
154852887|NCT00974220|558891112|FG000|Treatment Period 1|Adverse Event|2|||
154852888|NCT00974220|558891113|FG001|Treatment Period 1|Adverse Event|1|||
154852889|NCT00974220|558891112|FG000|Treatment Period 1|noncompliant subjects|0|||
154852890|NCT00974220|558891113|FG001|Treatment Period 1|noncompliant subjects|1|||
154852891|NCT01850615|558891114|FG000|Overall Study|Protocol Violation|4|||
154852892|NCT01850615|558891115|FG001|Overall Study|Protocol Violation|1|||
154852893|NCT01850615|558891114|FG000|Overall Study|Adverse Event|2|||
154852894|NCT01850615|558891115|FG001|Overall Study|Adverse Event|1|||
154852895|NCT01850615|558891114|FG000|Overall Study|Withdrawal by Subject|3|||
154852896|NCT01850615|558891115|FG001|Overall Study|Withdrawal by Subject|1|||
154852897|NCT01850615|558891114|FG000|Overall Study|Lost to Follow-up|0|||
154852898|NCT01850615|558891115|FG001|Overall Study|Lost to Follow-up|1|||
154852899|NCT01850615|558891114|FG000|Overall Study|Unclassified|0|||
154852900|NCT01850615|558891115|FG001|Overall Study|Unclassified|1|||
154852901|NCT00706628|558891116|FG000|Overall Study|Other Adverse Event|16|||
154852902|NCT00706628|558891117|FG001|Overall Study|Other Adverse Event|5|||
154852903|NCT00706628|558891118|FG002|Overall Study|Other Adverse Event|5|||
154852904|NCT00706628|558891119|FG003|Overall Study|Other Adverse Event|2|||
154852905|NCT00706628|558891116|FG000|Overall Study|Non compliant with protocol|0|||
154852906|NCT00706628|558891117|FG001|Overall Study|Non compliant with protocol|1|||
154852907|NCT00706628|558891118|FG002|Overall Study|Non compliant with protocol|0|||
154852908|NCT00706628|558891119|FG003|Overall Study|Non compliant with protocol|0|||
154852909|NCT00706628|558891116|FG000|Overall Study|Consent withdrawn|6|||
154852910|NCT00706628|558891117|FG001|Overall Study|Consent withdrawn|1|||
154852911|NCT00706628|558891118|FG002|Overall Study|Consent withdrawn|3|||
154852912|NCT00706628|558891119|FG003|Overall Study|Consent withdrawn|0|||
154852913|NCT00706628|558891116|FG000|Overall Study|Progressive disease|20|||
154852914|NCT00706628|558891117|FG001|Overall Study|Progressive disease|13|||
154852915|NCT00706628|558891118|FG002|Overall Study|Progressive disease|8|||
154852916|NCT00706628|558891119|FG003|Overall Study|Progressive disease|1|||
154852917|NCT00706628|558891116|FG000|Overall Study|Other than those stated above|4|||
154852918|NCT00706628|558891117|FG001|Overall Study|Other than those stated above|0|||
154852919|NCT00706628|558891118|FG002|Overall Study|Other than those stated above|0|||
154852920|NCT00706628|558891119|FG003|Overall Study|Other than those stated above|0|||
154852921|NCT00706628|558891116|FG000|Overall Study|Not treated|1|||
154852922|NCT00706628|558891117|FG001|Overall Study|Not treated|1|||
154852923|NCT00706628|558891118|FG002|Overall Study|Not treated|0|||
154852924|NCT00706628|558891119|FG003|Overall Study|Not treated|0|||
154852925|NCT02921425|558891120|FG000|Overall Study|Protocol Violation|9|||
154852926|NCT01227967|558891121|FG000|Overall Study|Protocol Violation|3|||
154852927|NCT01227967|558891122|FG001|Overall Study|Protocol Violation|1|||
154852928|NCT01227967|558891121|FG000|Overall Study|Death|0|||
154852929|NCT01227967|558891122|FG001|Overall Study|Death|1|||
154852930|NCT01227967|558891121|FG000|Overall Study|Lost to Follow-up|8|||
154852931|NCT01227967|558891122|FG001|Overall Study|Lost to Follow-up|3|||
154852932|NCT01227967|558891121|FG000|Overall Study|Withdrawal by Subject|4|||
154852933|NCT01227967|558891122|FG001|Overall Study|Withdrawal by Subject|3|||
154852934|NCT01227967|558891121|FG000|Overall Study|Physician Decision|0|||
154852935|NCT01227967|558891122|FG001|Overall Study|Physician Decision|1|||
154852936|NCT01227967|558891121|FG000|Overall Study|Never Started Treatment|0|||
154852937|NCT01227967|558891122|FG001|Overall Study|Never Started Treatment|4|||
154852938|NCT01227967|558891121|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
154852939|NCT01227967|558891122|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
154852940|NCT01948830|558891123|FG000|Overall Study|Physician Decision|1|||
154852941|NCT01948830|558891124|FG001|Overall Study|Physician Decision|3|||
154852942|NCT01948830|558891123|FG000|Overall Study|Protocol deviation|1|||
154852943|NCT01948830|558891124|FG001|Overall Study|Protocol deviation|2|||
154852944|NCT01948830|558891123|FG000|Overall Study|Lost to Follow-up|5|||
154852945|NCT01948830|558891124|FG001|Overall Study|Lost to Follow-up|4|||
154852946|NCT01948830|558891123|FG000|Overall Study|Withdrawal by Subject|14|||
155173629|NCT03890666|560074836|FG001|Overall Study|Lost to Follow-up|5|||
154971702|NCT01617096|559320647|FG001|Overall Study|Other|3|||
155173630|NCT03890666|560074835|FG000|Overall Study|Other than specified|1|||
154852947|NCT01948830|558891124|FG001|Overall Study|Withdrawal by Subject|17|||
154852948|NCT01948830|558891123|FG000|Overall Study|Adverse Event|9|||
154852949|NCT01948830|558891124|FG001|Overall Study|Adverse Event|2|||
154852950|NCT01948830|558891123|FG000|Overall Study|Death|3|||
154852951|NCT01948830|558891124|FG001|Overall Study|Death|4|||
154852952|NCT01145560|558891125|FG000|Overall Study|Withdrawal by Subject|2|||
154852953|NCT01145560|558891126|FG001|Overall Study|Withdrawal by Subject|1|||
154852954|NCT01145560|558891127|FG002|Overall Study|Withdrawal by Subject|0|||
154852955|NCT01145560|558891125|FG000|Overall Study|Lost to Follow-up|1|||
154852956|NCT01145560|558891126|FG001|Overall Study|Lost to Follow-up|1|||
154852957|NCT01145560|558891127|FG002|Overall Study|Lost to Follow-up|1|||
154971703|NCT02046122|559320652|FG000|Overall Study|Physician Decision|8|||
154852958|NCT01145560|558891125|FG000|Overall Study|No study drug by 24h after organ failure|1|||
154852959|NCT01145560|558891126|FG001|Overall Study|No study drug by 24h after organ failure|0|||
154852960|NCT01145560|558891127|FG002|Overall Study|No study drug by 24h after organ failure|0|||
154852961|NCT01145560|558891125|FG000|Overall Study|Accidental unblinding of study treatment|0|||
154852962|NCT01145560|558891126|FG001|Overall Study|Accidental unblinding of study treatment|1|||
154852963|NCT01145560|558891127|FG002|Overall Study|Accidental unblinding of study treatment|0|||
154852964|NCT01145560|558891125|FG000|Overall Study|False insurance information|0|||
154852965|NCT01145560|558891126|FG001|Overall Study|False insurance information|1|||
154852966|NCT01145560|558891127|FG002|Overall Study|False insurance information|0|||
154852967|NCT01145560|558891125|FG000|Overall Study|Withdrawal of therapy|0|||
154852968|NCT01145560|558891126|FG001|Overall Study|Withdrawal of therapy|0|||
154852969|NCT01145560|558891127|FG002|Overall Study|Withdrawal of therapy|1|||
154852970|NCT02149810|558891129|FG000|Overall Study|Physician Decision|1|||
154852971|NCT02149810|558891130|FG001|Overall Study|Physician Decision|2|||
154852972|NCT02149810|558891129|FG000|Overall Study|Lost to Follow-up|2|||
154852973|NCT02149810|558891130|FG001|Overall Study|Lost to Follow-up|1|||
154852974|NCT02149810|558891129|FG000|Overall Study|Withdrawal by Subject|5|||
154852975|NCT02149810|558891130|FG001|Overall Study|Withdrawal by Subject|1|||
154852976|NCT04082663|558891148|FG000|Overall Study|Adverse Event|6|||
154852977|NCT04082663|558891148|FG000|Overall Study|Lost to Follow-up|1|||
154852978|NCT02542072|558891149|FG000|First Intervention (1 Month)|Adverse Event|1|||
154852979|NCT02542072|558891150|FG001|First Intervention (1 Month)|Adverse Event|1|||
154852980|NCT02542072|558891149|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
154852981|NCT02542072|558891150|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
154852982|NCT02542072|558891149|FG000|First Intervention (1 Month)|Lens discomfort|1|||
154852983|NCT02542072|558891150|FG001|First Intervention (1 Month)|Lens discomfort|2|||
154852984|NCT02542072|558891149|FG000|First Intervention (1 Month)|Protocol Violation|1|||
154852985|NCT02542072|558891150|FG001|First Intervention (1 Month)|Protocol Violation|0|||
154852986|NCT02542072|558891149|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
154852987|NCT02542072|558891150|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
154852988|NCT02542072|558891149|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
154852989|NCT02542072|558891150|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
154852990|NCT05032950|558891152|FG000|Overall Study|Adverse Event|0|||
154852991|NCT05032950|558891153|FG001|Overall Study|Adverse Event|0|||
154852992|NCT05032950|558891154|FG002|Overall Study|Adverse Event|1|||
154852993|NCT05032950|558891155|FG003|Overall Study|Adverse Event|1|||
154852994|NCT05032950|558891156|FG004|Overall Study|Adverse Event|0|||
154852995|NCT05032950|558891157|FG005|Overall Study|Adverse Event|0|||
154852996|NCT01990261|558891158|FG000|Overall Study|Death Before Treatment Start|2|||
154852997|NCT01990261|558891158|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
154852998|NCT01990261|558891158|FG000|Overall Study|Death From other Causes|1|||
154852999|NCT01990261|558891158|FG000|Overall Study|Disease Progression (PD)|8|||
154853000|NCT01990261|558891158|FG000|Overall Study|PD Before Treatment Start|1|||
154853001|NCT01990261|558891158|FG000|Overall Study|Dossier not Approved|1|||
154853002|NCT01990261|558891158|FG000|Overall Study|Lost to Follow-up|2|||
154853003|NCT02474329|558891162|FG000|Overall Study|Withdraw or did not contribute data.|13|||
154853004|NCT01356589|558891163|FG000|Overall Study|Enrolled, but not treated|3|||
154853005|NCT01356589|558891163|FG000|Overall Study|Dose data not recorded|2|||
154853006|NCT04343651|558891164|FG000|Overall Study|Physician Decision|2|||
154853007|NCT04343651|558891165|FG001|Overall Study|Physician Decision|1|||
154853008|NCT04343651|558891164|FG000|Overall Study|Lost to Follow-up|2|||
154853009|NCT04343651|558891165|FG001|Overall Study|Lost to Follow-up|1|||
154853010|NCT04343651|558891164|FG000|Overall Study|Protocol Violation|4|||
154853011|NCT04343651|558891165|FG001|Overall Study|Protocol Violation|6|||
154853012|NCT04343651|558891164|FG000|Overall Study|Missing|3|||
154853013|NCT04343651|558891165|FG001|Overall Study|Missing|9|||
154853014|NCT04343651|558891164|FG000|Overall Study|Withdrawal by Subject|0|||
154853015|NCT04343651|558891165|FG001|Overall Study|Withdrawal by Subject|4|||
154853016|NCT04343651|558891164|FG000|Overall Study|Death|0|||
154853017|NCT04343651|558891165|FG001|Overall Study|Death|1|||
154853018|NCT04343651|558891164|FG000|Overall Study|Did not start treatment|1|||
154853019|NCT04343651|558891165|FG001|Overall Study|Did not start treatment|1|||
154853020|NCT04343651|558891164|FG000|Overall Study|Patient did not complete visits 3-6|0|||
154853021|NCT04343651|558891165|FG001|Overall Study|Patient did not complete visits 3-6|1|||
154853022|NCT04188197|558892895|FG000|Overall Study|Lost to Follow-up|4|||
154853023|NCT04188197|558892896|FG001|Overall Study|Lost to Follow-up|1|||
154853024|NCT04188197|558892895|FG000|Overall Study|Withdrawal by Subject|1|||
154853025|NCT04188197|558892896|FG001|Overall Study|Withdrawal by Subject|1|||
154853026|NCT04188197|558892895|FG000|Overall Study|Pregnancy|0|||
154853027|NCT04188197|558892896|FG001|Overall Study|Pregnancy|1|||
154853028|NCT02613208|558892897|FG000|Overall Study|Withdrawal by Subject|1|||
154853029|NCT02613208|558892897|FG000|Overall Study|Change of address|2|||
154853030|NCT02613208|558892897|FG000|Overall Study|Physician Decision|2|||
154853031|NCT02613208|558892897|FG000|Overall Study|Lost to Follow-up|5|||
154853032|NCT02613208|558892897|FG000|Overall Study|Death|37|||
155105930|NCT05396014|559817555|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105931|NCT05396014|559817556|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105932|NCT05396014|559817557|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105933|NCT05396014|559817558|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105934|NCT05396014|559817559|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
154853033|NCT05742984|558892900|FG000|Overall Study|Adverse Event|0|||
154853034|NCT05742984|558892901|FG001|Overall Study|Adverse Event|0|||
154853035|NCT05742984|558892902|FG002|Overall Study|Adverse Event|1|||
154853036|NCT05742984|558892903|FG003|Overall Study|Adverse Event|0|||
154853037|NCT05742984|558892904|FG004|Overall Study|Adverse Event|1|||
154853038|NCT05742984|558892905|FG005|Overall Study|Adverse Event|1|||
154853039|NCT05742984|558892900|FG000|Overall Study|Withdrawal by Subject|0|||
154853040|NCT05742984|558892901|FG001|Overall Study|Withdrawal by Subject|1|||
154853041|NCT05742984|558892902|FG002|Overall Study|Withdrawal by Subject|0|||
154853042|NCT05742984|558892903|FG003|Overall Study|Withdrawal by Subject|0|||
154853043|NCT05742984|558892904|FG004|Overall Study|Withdrawal by Subject|0|||
154853044|NCT05742984|558892905|FG005|Overall Study|Withdrawal by Subject|2|||
154853045|NCT02162862|558892906|FG000|Overall Study|Lost to Follow-up|0|||
154853046|NCT02162862|558892907|FG001|Overall Study|Lost to Follow-up|11|||
154853047|NCT02162862|558892908|FG002|Overall Study|Lost to Follow-up|0|||
154853048|NCT02162862|558892906|FG000|Overall Study|Subject did not feel the med was needed|0|||
154853049|NCT02162862|558892907|FG001|Overall Study|Subject did not feel the med was needed|0|||
154853050|NCT02162862|558892908|FG002|Overall Study|Subject did not feel the med was needed|4|||
154853051|NCT01279057|558892912|FG000|Overall Study|Adverse Event|1|||
154853052|NCT01279057|558892913|FG001|Overall Study|Adverse Event|0|||
154853053|NCT01279057|558892914|FG002|Overall Study|Adverse Event|1|||
154853054|NCT01279057|558892912|FG000|Overall Study|Insufficient therapeutic response|0|||
154853055|NCT01279057|558892913|FG001|Overall Study|Insufficient therapeutic response|0|||
154853056|NCT01279057|558892914|FG002|Overall Study|Insufficient therapeutic response|1|||
154853057|NCT01279057|558892912|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
154853058|NCT01279057|558892913|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
154853059|NCT01279057|558892914|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
154853060|NCT01279057|558892912|FG000|Overall Study|Withdrew consent|2|||
154853061|NCT01279057|558892913|FG001|Overall Study|Withdrew consent|0|||
154853062|NCT01279057|558892914|FG002|Overall Study|Withdrew consent|1|||
154853063|NCT01279057|558892912|FG000|Overall Study|Pregnancy|0|||
154853064|NCT01279057|558892913|FG001|Overall Study|Pregnancy|1|||
154853065|NCT01279057|558892914|FG002|Overall Study|Pregnancy|0|||
154853066|NCT01279057|558892912|FG000|Overall Study|Other|3|||
154853067|NCT01279057|558892913|FG001|Overall Study|Other|3|||
154853068|NCT01279057|558892914|FG002|Overall Study|Other|0|||
154853069|NCT01427309|558892916|FG000|Overall Study|Lost to Follow-up|130|||
154853070|NCT01427309|558892917|FG001|Overall Study|Lost to Follow-up|145|||
154853071|NCT01427309|558892918|FG002|Overall Study|Lost to Follow-up|122|||
154853072|NCT01427309|558892919|FG003|Overall Study|Lost to Follow-up|135|||
154853073|NCT01427309|558892916|FG000|Overall Study|Protocol Violation|42|||
154853074|NCT01427309|558892917|FG001|Overall Study|Protocol Violation|69|||
154853075|NCT01427309|558892918|FG002|Overall Study|Protocol Violation|125|||
154853076|NCT01427309|558892919|FG003|Overall Study|Protocol Violation|124|||
154853077|NCT01427309|558892916|FG000|Overall Study|Adverse Event|0|||
154853078|NCT01427309|558892917|FG001|Overall Study|Adverse Event|0|||
154853079|NCT01427309|558892918|FG002|Overall Study|Adverse Event|3|||
154853080|NCT01427309|558892919|FG003|Overall Study|Adverse Event|1|||
154853081|NCT01427309|558892916|FG000|Overall Study|Serious adverse event|52|||
154853082|NCT01427309|558892917|FG001|Overall Study|Serious adverse event|45|||
154853083|NCT01427309|558892918|FG002|Overall Study|Serious adverse event|50|||
154853084|NCT01427309|558892919|FG003|Overall Study|Serious adverse event|61|||
154853085|NCT01427309|558892916|FG000|Overall Study|Withdrawal by Subject|148|||
154853086|NCT01427309|558892917|FG001|Overall Study|Withdrawal by Subject|148|||
154853087|NCT01427309|558892918|FG002|Overall Study|Withdrawal by Subject|61|||
154853088|NCT01427309|558892919|FG003|Overall Study|Withdrawal by Subject|55|||
155105935|NCT05396014|559817560|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
154853089|NCT03617705|558892922|FG000|Overall Study|Withdrawal by Subject|2|||
154853090|NCT03617705|558892922|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
155105936|NCT05396014|559817561|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
154853091|NCT03617705|558892922|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
154853092|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
154853093|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
154853094|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
154853095|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
154853096|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
154971704|NCT02046122|559320652|FG000|Overall Study|Withdrawal by Subject|1|||
154853097|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
154853098|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
155105937|NCT05396014|559817562|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105938|NCT05396014|559817563|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105939|NCT05396014|559817564|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105940|NCT05396014|559817565|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105941|NCT05396014|559817566|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105942|NCT05396014|559817567|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
155105943|NCT05396014|559817525|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105944|NCT05396014|559817526|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105945|NCT05396014|559817527|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105946|NCT05396014|559817528|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
154853099|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
154853100|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
154853101|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
154853102|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
154853103|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
154853104|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
154853105|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
154853106|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
154853107|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
154853108|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
154853109|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
154853110|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
154853111|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
154853112|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
154853113|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
154853114|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
154853115|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
154853116|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
154853117|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
154853118|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
154853119|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
154853120|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
154853121|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
154853122|NCT00849017|558892923|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
154853123|NCT00849017|558892924|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
154853124|NCT00849017|558892925|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
154853125|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
154853126|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
154853127|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
154853128|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
154853129|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
154853130|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
154853131|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
154853132|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
154853133|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
154853134|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
154853135|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
154853136|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
154853137|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
154853138|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
154853139|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
154853140|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
154853141|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
154853142|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
154853143|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
154853144|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
154853145|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
154853146|NCT00849017|558892923|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
154853147|NCT00849017|558892924|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
154853148|NCT00849017|558892925|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
154853149|NCT00214461|558892926|FG000|Overall Study|Adverse Event|0|||
154853150|NCT00214461|558892927|FG001|Overall Study|Adverse Event|0|||
154853151|NCT00214461|558892928|FG002|Overall Study|Adverse Event|1|||
154853152|NCT00214461|558892929|FG003|Overall Study|Adverse Event|1|||
154853153|NCT00214461|558892926|FG000|Overall Study|Withdrawal by Subject|0|||
154853154|NCT00214461|558892927|FG001|Overall Study|Withdrawal by Subject|0|||
154853155|NCT00214461|558892928|FG002|Overall Study|Withdrawal by Subject|1|||
154853156|NCT00214461|558892929|FG003|Overall Study|Withdrawal by Subject|0|||
154853157|NCT02024971|558892931|FG000|Overall Study|Data Not Available|30|||
154853158|NCT02024971|558892931|FG000|Overall Study|Lost to Follow-up|6|||
154971705|NCT04535986|559320655|FG000|Overall Study|Death|4|||
155173631|NCT03890666|560074836|FG001|Overall Study|Other than specified|8|||
154853159|NCT02908100|558892932|FG000|Overall Study|Adverse Event|7|||
154853160|NCT02908100|558892933|FG001|Overall Study|Adverse Event|6|||
154853161|NCT02908100|558892934|FG002|Overall Study|Adverse Event|9|||
154853162|NCT02908100|558892932|FG000|Overall Study|Death|2|||
154853163|NCT02908100|558892933|FG001|Overall Study|Death|0|||
154853164|NCT02908100|558892934|FG002|Overall Study|Death|0|||
154853165|NCT02908100|558892932|FG000|Overall Study|Lack of Efficacy|2|||
154853166|NCT02908100|558892933|FG001|Overall Study|Lack of Efficacy|3|||
155105947|NCT05396014|559817529|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105948|NCT05396014|559817530|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105949|NCT05396014|559817531|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105950|NCT05396014|559817532|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105951|NCT05396014|559817533|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
155105952|NCT05396014|559817534|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105953|NCT05396014|559817535|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105954|NCT05396014|559817536|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105955|NCT05396014|559817537|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105956|NCT05396014|559817538|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105957|NCT05396014|559817539|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105958|NCT05396014|559817540|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105959|NCT05396014|559817541|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105960|NCT05396014|559817542|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105961|NCT05396014|559817543|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
154853167|NCT02908100|558892934|FG002|Overall Study|Lack of Efficacy|3|||
154853168|NCT02908100|558892932|FG000|Overall Study|Lost to Follow-up|0|||
154853169|NCT02908100|558892933|FG001|Overall Study|Lost to Follow-up|1|||
154853170|NCT02908100|558892934|FG002|Overall Study|Lost to Follow-up|2|||
154853171|NCT02908100|558892932|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154853172|NCT02908100|558892933|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154853173|NCT02908100|558892934|FG002|Overall Study|Non-Compliance With Study Drug|2|||
154853174|NCT02908100|558892932|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
154853175|NCT02908100|558892933|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
154853176|NCT02908100|558892934|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
154853177|NCT02908100|558892932|FG000|Overall Study|Physician Decision|0|||
154853178|NCT02908100|558892933|FG001|Overall Study|Physician Decision|1|||
154853179|NCT02908100|558892934|FG002|Overall Study|Physician Decision|0|||
154853180|NCT02908100|558892932|FG000|Overall Study|Pregnancy|1|||
154853181|NCT02908100|558892933|FG001|Overall Study|Pregnancy|2|||
154853182|NCT02908100|558892934|FG002|Overall Study|Pregnancy|0|||
154853183|NCT02908100|558892932|FG000|Overall Study|Withdrawal by Subject|8|||
154853184|NCT02908100|558892933|FG001|Overall Study|Withdrawal by Subject|7|||
154853185|NCT02908100|558892934|FG002|Overall Study|Withdrawal by Subject|5|||
154853186|NCT02908100|558892932|FG000|Overall Study|Randomised in Error|1|||
154853187|NCT02908100|558892933|FG001|Overall Study|Randomised in Error|0|||
154853188|NCT02908100|558892934|FG002|Overall Study|Randomised in Error|0|||
154853189|NCT05254418|558892935|FG000|Overall Study|Adverse Event|2|||
154853190|NCT06118385|558892937|FG000|Overall Study|Protocol Violation|0|||
154853191|NCT06118385|558892938|FG001|Overall Study|Protocol Violation|0|||
154853192|NCT06118385|558892939|FG002|Overall Study|Protocol Violation|0|||
154853193|NCT06118385|558892940|FG003|Overall Study|Protocol Violation|0|||
154853194|NCT06118385|558892941|FG004|Overall Study|Protocol Violation|0|||
154853195|NCT06118385|558892942|FG005|Overall Study|Protocol Violation|0|||
154853196|NCT06118385|558892943|FG006|Overall Study|Protocol Violation|0|||
154853197|NCT06118385|558892944|FG007|Overall Study|Protocol Violation|0|||
154853198|NCT06118385|558892945|FG008|Overall Study|Protocol Violation|1|||
154853199|NCT06118385|558892946|FG009|Overall Study|Protocol Violation|0|||
154853200|NCT06118385|558892947|FG010|Overall Study|Protocol Violation|0|||
154853201|NCT06118385|558892948|FG011|Overall Study|Protocol Violation|0|||
154853202|NCT06118385|558892937|FG000|Overall Study|Out-of-range blood tests|0|||
154853203|NCT06118385|558892938|FG001|Overall Study|Out-of-range blood tests|0|||
154853204|NCT06118385|558892939|FG002|Overall Study|Out-of-range blood tests|0|||
154853205|NCT06118385|558892940|FG003|Overall Study|Out-of-range blood tests|0|||
154853206|NCT06118385|558892941|FG004|Overall Study|Out-of-range blood tests|0|||
154853207|NCT06118385|558892942|FG005|Overall Study|Out-of-range blood tests|0|||
154853208|NCT06118385|558892943|FG006|Overall Study|Out-of-range blood tests|0|||
154853209|NCT06118385|558892944|FG007|Overall Study|Out-of-range blood tests|0|||
154853210|NCT06118385|558892945|FG008|Overall Study|Out-of-range blood tests|1|||
154853211|NCT06118385|558892946|FG009|Overall Study|Out-of-range blood tests|0|||
154853212|NCT06118385|558892947|FG010|Overall Study|Out-of-range blood tests|0|||
155105962|NCT05396014|559817544|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
154853213|NCT06118385|558892948|FG011|Overall Study|Out-of-range blood tests|0|||
154853214|NCT02318784|558892949|FG000|Overall Study|Adverse Event|13|||
154853215|NCT02318784|558892949|FG000|Overall Study|Death|2|||
154853216|NCT02318784|558892949|FG000|Overall Study|Progressive Disease|37|||
154853217|NCT02318784|558892949|FG000|Overall Study|Withdrawal by Subject|10|||
154853218|NCT00331006|558892950|FG000|Screening Phase|Withdrawal by Subject|1|||
154853219|NCT00331006|558892950|FG000|Screening Phase|enrollment halted|1|||
154853220|NCT00331006|558892950|FG000|Screening Phase|Lost to Follow-up|1|||
154853221|NCT00331006|558892950|FG000|Screening Phase|Ineligible for treatment phase|4|||
154853222|NCT00331006|558892950|FG000|Treatment Phase|Withdrawal by Subject|1|||
154853223|NCT00331006|558892950|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
154853224|NCT00331006|558892950|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
154853225|NCT01950819|558892953|FG000|Overall Study|Graft Loss|35|||
154853226|NCT01950819|558892954|FG001|Overall Study|Graft Loss|30|||
154853227|NCT01950819|558892953|FG000|Overall Study|Death|29|||
154853228|NCT01950819|558892954|FG001|Overall Study|Death|34|||
154853229|NCT01950819|558892953|FG000|Overall Study|Subject / Gardian decision|54|||
154853230|NCT01950819|558892954|FG001|Overall Study|Subject / Gardian decision|51|||
154853231|NCT01950819|558892953|FG000|Overall Study|technical problems|2|||
154853232|NCT01950819|558892954|FG001|Overall Study|technical problems|0|||
154853233|NCT01950819|558892953|FG000|Overall Study|Pregnancy|0|||
154853234|NCT01950819|558892954|FG001|Overall Study|Pregnancy|2|||
154853235|NCT01950819|558892953|FG000|Overall Study|Lost to Follow-up|9|||
154853236|NCT01950819|558892954|FG001|Overall Study|Lost to Follow-up|17|||
154853237|NCT01014585|558892959|FG000|Overall Study|Adverse Event|0|||
154853238|NCT01014585|558892960|FG001|Overall Study|Adverse Event|2|||
154853239|NCT01014585|558892961|FG002|Overall Study|Adverse Event|0|||
154853240|NCT01014585|558892962|FG003|Overall Study|Adverse Event|3|||
154853241|NCT01014585|558892959|FG000|Overall Study|Withdrawal by Subject|2|||
154853242|NCT01014585|558892960|FG001|Overall Study|Withdrawal by Subject|0|||
154853243|NCT01014585|558892961|FG002|Overall Study|Withdrawal by Subject|1|||
154853244|NCT01014585|558892962|FG003|Overall Study|Withdrawal by Subject|3|||
154853245|NCT01014585|558892959|FG000|Overall Study|Lost to Follow-up|0|||
154853246|NCT01014585|558892960|FG001|Overall Study|Lost to Follow-up|0|||
154853247|NCT01014585|558892961|FG002|Overall Study|Lost to Follow-up|0|||
154853248|NCT01014585|558892962|FG003|Overall Study|Lost to Follow-up|2|||
154853249|NCT01014585|558892959|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
154853250|NCT01014585|558892960|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
154853251|NCT01014585|558892961|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
154853252|NCT01014585|558892962|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
154853253|NCT04897867|558892963|FG000|Overall Study|Withdrawal of Consent|1|||
154853254|NCT04897867|558892963|FG000|Overall Study|Pregnancy|1|||
154853255|NCT04897867|558892963|FG000|Overall Study|Lost to Follow-up|7|||
154853256|NCT04897867|558892963|FG000|Overall Study|Reason not Specified|2|||
154853257|NCT00508391|558892964|FG000|First Treatment|Withdrawal by Subject|6|||
154853258|NCT00508391|558892965|FG001|First Treatment|Withdrawal by Subject|3|||
154853259|NCT00508391|558892964|FG000|Second Treatment|Withdrawal by Subject|2|||
154853260|NCT00508391|558892965|FG001|Second Treatment|Withdrawal by Subject|0|||
154853261|NCT00880256|558892969|FG000|Overall Study|Lost to Follow-up|28|||
154853262|NCT01686568|558892970|FG000|Main Study|Withdrawal by Subject|1|||
154853263|NCT01686568|558892971|FG001|Main Study|Withdrawal by Subject|3|||
154853264|NCT01686568|558892970|FG000|Main Study|Noncompliance with protocol|0|||
154853265|NCT01686568|558892971|FG001|Main Study|Noncompliance with protocol|1|||
154853266|NCT01686568|558892970|FG000|Main Study|Liver enzymes above range of exclusion|1|||
154853267|NCT01686568|558892971|FG001|Main Study|Liver enzymes above range of exclusion|0|||
154853268|NCT01686568|558892970|FG000|Sub-Study|Not consented for sub-study|2|||
154853269|NCT01686568|558892971|FG001|Sub-Study|Not consented for sub-study|2|||
154853270|NCT01838044|558892972|FG000|Overall Study|Adverse Event|4|||
154853271|NCT01838044|558892973|FG001|Overall Study|Adverse Event|6|||
154853272|NCT01838044|558892972|FG000|Overall Study|Protocol Violation|3|||
154853273|NCT01838044|558892973|FG001|Overall Study|Protocol Violation|3|||
154853274|NCT01838044|558892972|FG000|Overall Study|Withdrawal by Subject|0|||
154853275|NCT01838044|558892973|FG001|Overall Study|Withdrawal by Subject|2|||
154853276|NCT01838044|558892972|FG000|Overall Study|Insufficient clinical response|1|||
154853277|NCT01838044|558892973|FG001|Overall Study|Insufficient clinical response|2|||
154853278|NCT01838044|558892972|FG000|Overall Study|Medication error without associated AE|0|||
154853279|NCT01838044|558892973|FG001|Overall Study|Medication error without associated AE|1|||
154853280|NCT01838044|558892972|FG000|Overall Study|Lost to Follow-up|0|||
154853281|NCT01838044|558892973|FG001|Overall Study|Lost to Follow-up|2|||
154853282|NCT01413958|558892974|FG000|Overall Study|Lost to Follow-up|0|||
154853283|NCT01413958|558892975|FG001|Overall Study|Lost to Follow-up|1|||
154853284|NCT02908516|558892976|FG000|Overall Study|Study Terminated|3|||
154853285|NCT02908516|558892977|FG001|Overall Study|Study Terminated|3|||
154853286|NCT01225562|558892978|FG000|Overall Study|Withdrawal by Subject|52|||
155105963|NCT05396014|559817545|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105964|NCT05396014|559817546|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
154853287|NCT01225562|558892979|FG001|Overall Study|Withdrawal by Subject|50|||
154853288|NCT01225562|558892980|FG002|Overall Study|Withdrawal by Subject|52|||
154853289|NCT01225562|558892978|FG000|Overall Study|Lost to Follow-up|3|||
154853290|NCT01225562|558892979|FG001|Overall Study|Lost to Follow-up|6|||
154853291|NCT01225562|558892980|FG002|Overall Study|Lost to Follow-up|1|||
154853292|NCT03403400|558892982|FG000|Overall Study|Lost to Follow-up|1|||
154853293|NCT03403400|558892983|FG001|Overall Study|Lost to Follow-up|0|||
154853294|NCT03403400|558892984|FG002|Overall Study|Lost to Follow-up|1|||
154853295|NCT03403400|558892982|FG000|Overall Study|Hospitalization|1|||
154853296|NCT03403400|558892983|FG001|Overall Study|Hospitalization|0|||
154853297|NCT03403400|558892984|FG002|Overall Study|Hospitalization|0|||
154853298|NCT03403400|558892982|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
154853299|NCT03403400|558892983|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
154971706|NCT04535986|559320656|FG001|Overall Study|Death|5|||
154853300|NCT03403400|558892984|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
154853301|NCT00712348|558892988|FG000|Overall Study|Withdrawal by Subject|1|||
154853302|NCT01273064|558892991|FG000|Overall Study|Adverse Event|5|||
154853303|NCT01273064|558892992|FG001|Overall Study|Adverse Event|1|||
154853304|NCT01273064|558892993|FG002|Overall Study|Adverse Event|3|||
154853305|NCT01273064|558892994|FG003|Overall Study|Adverse Event|2|||
154853306|NCT01273064|558892995|FG004|Overall Study|Adverse Event|1|||
154853307|NCT01273064|558892991|FG000|Overall Study|Withdrawal by Subject|4|||
154853308|NCT01273064|558892992|FG001|Overall Study|Withdrawal by Subject|2|||
154853309|NCT01273064|558892993|FG002|Overall Study|Withdrawal by Subject|2|||
154853310|NCT01273064|558892994|FG003|Overall Study|Withdrawal by Subject|2|||
154853311|NCT01273064|558892995|FG004|Overall Study|Withdrawal by Subject|0|||
154853312|NCT01273064|558892991|FG000|Overall Study|Study Termination|13|||
154853313|NCT01273064|558892992|FG001|Overall Study|Study Termination|27|||
154853314|NCT01273064|558892993|FG002|Overall Study|Study Termination|26|||
154853315|NCT01273064|558892994|FG003|Overall Study|Study Termination|16|||
154853316|NCT01273064|558892995|FG004|Overall Study|Study Termination|8|||
154853317|NCT01273064|558892991|FG000|Overall Study|Lost to Follow-up|1|||
154853318|NCT01273064|558892992|FG001|Overall Study|Lost to Follow-up|0|||
154853319|NCT01273064|558892993|FG002|Overall Study|Lost to Follow-up|0|||
154853320|NCT01273064|558892994|FG003|Overall Study|Lost to Follow-up|0|||
154853321|NCT01273064|558892995|FG004|Overall Study|Lost to Follow-up|0|||
154853322|NCT01273064|558892991|FG000|Overall Study|Physician Decision|0|||
154853323|NCT01273064|558892992|FG001|Overall Study|Physician Decision|0|||
154853324|NCT01273064|558892993|FG002|Overall Study|Physician Decision|0|||
154853325|NCT01273064|558892994|FG003|Overall Study|Physician Decision|0|||
154853326|NCT01273064|558892995|FG004|Overall Study|Physician Decision|1|||
154853327|NCT04666038|558892996|FG000|Overall Study|Progressive Disease|2|||
154853328|NCT04666038|558892997|FG001|Overall Study|Progressive Disease|0|||
154853329|NCT04666038|558892996|FG000|Overall Study|Death|38|||
154853330|NCT04666038|558892997|FG001|Overall Study|Death|32|||
154853331|NCT04666038|558892996|FG000|Overall Study|Withdrawal by Subject|10|||
154853332|NCT04666038|558892997|FG001|Overall Study|Withdrawal by Subject|19|||
154853333|NCT04666038|558892996|FG000|Overall Study|Lost to Follow-up|0|||
154853334|NCT04666038|558892997|FG001|Overall Study|Lost to Follow-up|2|||
154853335|NCT04666038|558892996|FG000|Overall Study|On Study Treatment|46|||
154853336|NCT04666038|558892997|FG001|Overall Study|On Study Treatment|5|||
154853337|NCT04666038|558892996|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
154853338|NCT04666038|558892997|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
154853339|NCT01375764|558893004|FG000|Overall Study|Lost to Follow-up|0|||
154853340|NCT01375764|558893005|FG001|Overall Study|Lost to Follow-up|1|||
154853341|NCT01375764|558893006|FG002|Overall Study|Lost to Follow-up|0|||
154853342|NCT01375764|558893007|FG003|Overall Study|Lost to Follow-up|0|||
154853343|NCT01375764|558893008|FG004|Overall Study|Lost to Follow-up|0|||
154853344|NCT01375764|558893004|FG000|Overall Study|Withdrawal by Subject|2|||
154853345|NCT01375764|558893005|FG001|Overall Study|Withdrawal by Subject|0|||
154853346|NCT01375764|558893006|FG002|Overall Study|Withdrawal by Subject|0|||
154853347|NCT01375764|558893007|FG003|Overall Study|Withdrawal by Subject|0|||
154853348|NCT01375764|558893008|FG004|Overall Study|Withdrawal by Subject|1|||
154853349|NCT01375764|558893004|FG000|Overall Study|Other|0|||
154853350|NCT01375764|558893005|FG001|Overall Study|Other|0|||
154853351|NCT01375764|558893006|FG002|Overall Study|Other|0|||
154853352|NCT01375764|558893007|FG003|Overall Study|Other|1|||
154853353|NCT01375764|558893008|FG004|Overall Study|Other|0|||
154971707|NCT04535986|559320655|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
154971708|NCT04535986|559320656|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
154971709|NCT04535986|559320655|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
154971710|NCT04535986|559320656|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
154971711|NCT04535986|559320655|FG000|Overall Study|Adverse Event|10|||
154971712|NCT04535986|559320656|FG001|Overall Study|Adverse Event|1|||
154971713|NCT04535986|559320655|FG000|Overall Study|Lack of Efficacy|3|||
154971714|NCT04535986|559320656|FG001|Overall Study|Lack of Efficacy|2|||
154971715|NCT04535986|559320655|FG000|Overall Study|Investigator discretion|3|||
154971716|NCT04535986|559320656|FG001|Overall Study|Investigator discretion|0|||
154853354|NCT02867761|558893009|FG000|Overall Study|Participant withdrawn by investigator|0|||
154853355|NCT02867761|558893010|FG001|Overall Study|Participant withdrawn by investigator|1|||
154853356|NCT02867761|558893009|FG000|Overall Study|Lost to Follow-up|25|||
154853357|NCT02867761|558893010|FG001|Overall Study|Lost to Follow-up|18|||
154853358|NCT02867761|558893009|FG000|Overall Study|Unable to complete protocol|3|||
154853359|NCT02867761|558893010|FG001|Overall Study|Unable to complete protocol|7|||
154853360|NCT03595280|558893011|FG000|Overall Study|Lost to Follow-up|6|||
154853361|NCT03595280|558893012|FG001|Overall Study|Lost to Follow-up|9|||
154853362|NCT03595280|558893013|FG002|Overall Study|Lost to Follow-up|15|||
154853363|NCT02411747|558893014|FG000|Overall Study|Withdrawal by Subject|1|||
154971717|NCT04535986|559320655|FG000|Overall Study|Withdrawal by Subject|32|||
154853364|NCT02411747|558893015|FG001|Overall Study|Withdrawal by Subject|0|||
154853365|NCT02411747|558893014|FG000|Overall Study|Protocol Violation|2|||
154971718|NCT04535986|559320656|FG001|Overall Study|Withdrawal by Subject|14|||
154853366|NCT02411747|558893015|FG001|Overall Study|Protocol Violation|4|||
154853367|NCT00675597|558893016|FG000|Overall Study|Withdrawal by Subject|3|||
154853368|NCT01176916|558893017|FG000|Overall Study|Adverse Event|61|||
154853369|NCT01176916|558893017|FG000|Overall Study|Death|1|||
154853370|NCT01176916|558893017|FG000|Overall Study|Lost to Follow-up|15|||
154853371|NCT01176916|558893017|FG000|Overall Study|Objective progression or relapse|17|||
154853372|NCT01176916|558893017|FG000|Overall Study|Protocol Violation|24|||
154853373|NCT01176916|558893017|FG000|Overall Study|Withdrawal by Subject|37|||
154853374|NCT01176916|558893017|FG000|Overall Study|Other|6|||
154853375|NCT01176916|558893017|FG000|Overall Study|Withdrawal prior to Treatment|6|||
154853376|NCT03158220|558893020|FG000|Overall Study|Screen Failure|0|||
154853377|NCT03158220|558893021|FG001|Overall Study|Screen Failure|1|||
154853378|NCT03158220|558893020|FG000|Overall Study|Withdrawal by Subject|8|||
154853379|NCT03158220|558893021|FG001|Overall Study|Withdrawal by Subject|9|||
154853380|NCT03158220|558893020|FG000|Overall Study|Status unknown|0|||
154853381|NCT03158220|558893021|FG001|Overall Study|Status unknown|1|||
154853382|NCT03158220|558893020|FG000|Overall Study|Lost to Follow-up|8|||
154853383|NCT03158220|558893021|FG001|Overall Study|Lost to Follow-up|5|||
154853384|NCT03158220|558893020|FG000|Overall Study|Physician Decision|1|||
154853385|NCT03158220|558893021|FG001|Overall Study|Physician Decision|0|||
154853386|NCT00560755|558893022|FG000|Overall Study|Protocol Violation|15|||
154853387|NCT00560755|558893022|FG000|Overall Study|Withdrawal by Subject|26|||
154853388|NCT00560755|558893022|FG000|Overall Study|Lost to Follow-up|9|||
154853389|NCT00560755|558893022|FG000|Overall Study|Adverse Event|8|||
154853390|NCT00560755|558893022|FG000|Overall Study|Physician Decision|2|||
154853391|NCT01439945|558893023|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
154853392|NCT01439945|558893024|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
154853393|NCT01439945|558893025|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
154853394|NCT01439945|558893026|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
154853395|NCT01439945|558893023|FG000|Double-Blind Treatment Phase|Ineligible|1|||
154853396|NCT01439945|558893024|FG001|Double-Blind Treatment Phase|Ineligible|2|||
154853397|NCT01439945|558893025|FG002|Double-Blind Treatment Phase|Ineligible|0|||
154853398|NCT01439945|558893026|FG003|Double-Blind Treatment Phase|Ineligible|1|||
154853399|NCT02959814|558893029|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
154853400|NCT02959814|558893029|FG000|Overall Study|Excluded based on anatomical criteria|2|||
154853401|NCT02959814|558893029|FG000|Overall Study|Protocol Violation|7|||
154853402|NCT02959814|558893029|FG000|Overall Study|FFR not measured|2|||
154853403|NCT02959814|558893029|FG000|Overall Study|In-procedure QFR not computed|6|||
154853404|NCT02959814|558893029|FG000|Overall Study|Excluded by FFR core-lab|24|||
154853405|NCT01609842|558893033|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
154853406|NCT01609842|558893034|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
154853407|NCT03186989|558893035|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853408|NCT03186989|558893036|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853409|NCT03186989|558893037|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
154853410|NCT03186989|558893038|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
154853411|NCT03186989|558893039|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
154853412|NCT03186989|558893040|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853413|NCT03186989|558893041|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853414|NCT03186989|558893042|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853415|NCT03186989|558893043|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853416|NCT03186989|558893044|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853417|NCT03186989|558893045|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
154853418|NCT03186989|558893035|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853419|NCT03186989|558893036|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853420|NCT03186989|558893037|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853421|NCT03186989|558893038|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853422|NCT03186989|558893039|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853423|NCT03186989|558893040|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
154853424|NCT03186989|558893041|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853425|NCT03186989|558893042|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853426|NCT03186989|558893043|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853427|NCT03186989|558893044|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853428|NCT03186989|558893045|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
154853429|NCT03186989|558893035|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853430|NCT03186989|558893036|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853431|NCT03186989|558893037|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853432|NCT03186989|558893038|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853433|NCT03186989|558893039|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853434|NCT03186989|558893040|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853435|NCT03186989|558893041|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
155105965|NCT05396014|559817547|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
154853436|NCT03186989|558893042|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853437|NCT03186989|558893043|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853438|NCT03186989|558893044|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853439|NCT03186989|558893045|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
154853440|NCT03186989|558893035|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853441|NCT03186989|558893036|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853442|NCT03186989|558893037|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853443|NCT03186989|558893038|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853444|NCT03186989|558893039|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853445|NCT03186989|558893040|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
154853446|NCT03186989|558893041|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
154853447|NCT03186989|558893042|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853448|NCT03186989|558893043|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
154853449|NCT03186989|558893044|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853450|NCT03186989|558893045|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
154853451|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
154853452|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
154853453|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
154853454|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
154853455|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
154853456|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
154853457|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
154853458|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
154853459|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
154853460|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
154853461|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
154853462|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
154853463|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
154853464|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
154853465|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
154853466|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
154853467|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
154853468|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
154853469|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
154853470|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
154853471|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853472|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853473|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853474|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853475|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853476|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853477|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
154853478|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
154853479|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
154853480|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
154853481|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
154853482|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
154853483|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
154853484|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
154853485|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
154853486|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
154853487|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
154853488|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
154853489|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
154853490|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
154853491|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
154853492|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
154853493|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
154853494|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
155105966|NCT05396014|559817548|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105967|NCT05396014|559817549|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105968|NCT05396014|559817550|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
154853495|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
154853496|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853497|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853498|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
154853499|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853500|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853501|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853502|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853503|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853504|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
154853505|NCT01583374|558893046|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853506|NCT01583374|558893047|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
154853507|NCT01583374|558893048|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853508|NCT01583374|558893049|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853509|NCT01583374|558893050|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853510|NCT01583374|558893051|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853511|NCT01583374|558893052|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853512|NCT01583374|558893053|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853513|NCT01583374|558893054|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
154853514|NCT01583374|558893046|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853515|NCT01583374|558893047|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853516|NCT01583374|558893048|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853517|NCT01583374|558893049|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853518|NCT01583374|558893050|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853519|NCT01583374|558893051|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853520|NCT01583374|558893052|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853521|NCT01583374|558893053|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
155105969|NCT05396014|559817551|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105970|NCT05396014|559817552|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105971|NCT05396014|559817553|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105972|NCT05396014|559817554|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105973|NCT05396014|559817555|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105974|NCT05396014|559817556|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105975|NCT05396014|559817557|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105976|NCT05396014|559817558|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105977|NCT05396014|559817559|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105978|NCT05396014|559817560|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105979|NCT05396014|559817561|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
154853522|NCT01583374|558893054|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
154853523|NCT01583374|558893046|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
154853524|NCT01583374|558893047|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
154853525|NCT01583374|558893048|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
154853526|NCT01583374|558893049|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
154853527|NCT01583374|558893050|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
154853528|NCT01583374|558893051|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
154853529|NCT01583374|558893052|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
154853530|NCT01583374|558893053|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
154853531|NCT01583374|558893054|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
154853532|NCT01583374|558893046|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
154853533|NCT01583374|558893047|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
154853534|NCT01583374|558893048|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
154853535|NCT01583374|558893049|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
154971719|NCT04535986|559320655|FG000|Overall Study|Lost to Follow-up|5|||
154971720|NCT04535986|559320656|FG001|Overall Study|Lost to Follow-up|3|||
154971721|NCT04535986|559320655|FG000|Overall Study|Other|7|||
154971722|NCT04535986|559320656|FG001|Overall Study|Other|3|||
154971723|NCT01196390|559320657|FG000|Overall Study|Protocol Violation|4|||
154971724|NCT01196390|559320658|FG001|Overall Study|Protocol Violation|5|||
154971725|NCT03141151|559320661|FG000|Overall Study|Lost to Follow-up|3|||
154971726|NCT03141151|559320662|FG001|Overall Study|Lost to Follow-up|2|||
154971727|NCT03141151|559320661|FG000|Overall Study|Withdrawal by Subject|3|||
154971728|NCT03141151|559320662|FG001|Overall Study|Withdrawal by Subject|2|||
154971729|NCT04561115|559320669|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
154971730|NCT04561115|559320670|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
154971731|NCT04561115|559320669|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
154971732|NCT04561115|559320670|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
154971733|NCT04561115|559320669|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
154853536|NCT01583374|558893050|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
154853537|NCT01583374|558893051|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
154853538|NCT01583374|558893052|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
154853539|NCT01583374|558893053|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
154853540|NCT01583374|558893054|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
154853541|NCT01583374|558893046|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
154853542|NCT01583374|558893047|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
154853543|NCT01583374|558893048|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
154853544|NCT01583374|558893049|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
154853545|NCT01583374|558893050|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
154853546|NCT01583374|558893051|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
154853547|NCT01583374|558893052|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
154853548|NCT01583374|558893053|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
154853549|NCT01583374|558893054|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
154853550|NCT01583374|558893046|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
154853551|NCT01583374|558893047|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
154853552|NCT01583374|558893048|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
154853553|NCT01583374|558893049|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
154853554|NCT01583374|558893050|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
154853555|NCT01583374|558893051|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
154853556|NCT01583374|558893052|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
154853557|NCT01583374|558893053|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
154853558|NCT01583374|558893054|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
154853559|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
154853560|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
154853561|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
154853562|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
154853563|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
154853564|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
154853565|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
154853566|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
154853567|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
154853568|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
154853569|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
154853570|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
154853571|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
154853572|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
154853573|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
154853574|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
154853575|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
154853576|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
154853577|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
154853578|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
154853579|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
154853580|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
154853581|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
154853582|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
154853583|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
154853584|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
154853585|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
154853586|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
154853587|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
154853588|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
154853589|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
154853590|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
154853591|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
154853592|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
154853593|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
154853594|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
154853595|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853596|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853597|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853598|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853599|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
154853600|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853601|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
154853602|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853603|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
154853604|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
154853605|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
154853606|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
154853607|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
154853608|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
154853609|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
154853610|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
154853611|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
154853612|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
154853613|NCT01583374|558893046|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
154853614|NCT01583374|558893047|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
154853615|NCT01583374|558893048|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
154853616|NCT01583374|558893049|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
154853617|NCT01583374|558893050|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
154853618|NCT01583374|558893051|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
154853619|NCT01583374|558893052|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
154853620|NCT01583374|558893053|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
154853621|NCT01583374|558893054|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
154853622|NCT00821678|558893057|FG000|Overall Study|Withdrawal by Subject|8|||
154853623|NCT00821678|558893058|FG001|Overall Study|Withdrawal by Subject|0|||
154853624|NCT00821678|558893057|FG000|Overall Study|Lost to Follow-up|13|||
154853625|NCT00821678|558893058|FG001|Overall Study|Lost to Follow-up|12|||
154853626|NCT00821678|558893057|FG000|Overall Study|Death|0|||
154853627|NCT00821678|558893058|FG001|Overall Study|Death|2|||
154853628|NCT03219164|558895267|FG000|Overall Study|Study Terminated by Sponsor|16|||
154853629|NCT03219164|558895268|FG001|Overall Study|Study Terminated by Sponsor|12|||
154853630|NCT03219164|558895267|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
154853631|NCT03219164|558895268|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
154853632|NCT03219164|558895267|FG000|Overall Study|Lost to Follow-up|1|||
154853633|NCT03219164|558895268|FG001|Overall Study|Lost to Follow-up|1|||
154853634|NCT03219164|558895267|FG000|Overall Study|Adverse Event|1|||
154853635|NCT03219164|558895268|FG001|Overall Study|Adverse Event|0|||
154853636|NCT03219164|558895267|FG000|Overall Study|Non-Compliance with Study Drug|1|||
154853637|NCT03219164|558895268|FG001|Overall Study|Non-Compliance with Study Drug|0|||
154853638|NCT03219164|558895267|FG000|Overall Study|Protocol Violation|0|||
154853639|NCT03219164|558895268|FG001|Overall Study|Protocol Violation|1|||
154853640|NCT03219164|558895267|FG000|Overall Study|Withdrew Assent|1|||
154853641|NCT03219164|558895268|FG001|Overall Study|Withdrew Assent|0|||
154853642|NCT00376961|558895269|FG000|Initial Registration|Adverse Event|1|||
154853643|NCT00376961|558895270|FG001|Initial Registration|Adverse Event|0|||
154853644|NCT00376961|558895269|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
154853645|NCT00376961|558895270|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
154853646|NCT00376961|558895269|FG000|Initial Registration|Progression/relapse|1|||
154853647|NCT00376961|558895270|FG001|Initial Registration|Progression/relapse|0|||
154853648|NCT00376961|558895269|FG000|Initial Registration|Ineligible|3|||
154853649|NCT00376961|558895270|FG001|Initial Registration|Ineligible|0|||
154853650|NCT00376961|558895269|FG000|Maintenance|Adverse Event|0|||
154853651|NCT00376961|558895270|FG001|Maintenance|Adverse Event|1|||
154853652|NCT00376961|558895269|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
154853653|NCT00376961|558895270|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
154853654|NCT00376961|558895269|FG000|Maintenance|Progression/relapse|0|||
154853655|NCT00376961|558895270|FG001|Maintenance|Progression/relapse|18|||
154853656|NCT00376961|558895269|FG000|Maintenance|Ineligible|0|||
154853657|NCT00376961|558895270|FG001|Maintenance|Ineligible|3|||
154853658|NCT04574999|558895272|FG000|Overall Study|Adverse Event|1|||
154853659|NCT04574999|558895273|FG001|Overall Study|Adverse Event|0|||
154853660|NCT04574999|558895272|FG000|Overall Study|Lack of Efficacy|2|||
154853661|NCT04574999|558895273|FG001|Overall Study|Lack of Efficacy|3|||
154853662|NCT04574999|558895272|FG000|Overall Study|Protocol Violation|1|||
154853663|NCT04574999|558895273|FG001|Overall Study|Protocol Violation|0|||
154853664|NCT04574999|558895272|FG000|Overall Study|Withdrawal by Subject|2|||
154853665|NCT04574999|558895273|FG001|Overall Study|Withdrawal by Subject|2|||
154853666|NCT04574999|558895272|FG000|Overall Study|Lost to Follow-up|1|||
154853667|NCT04574999|558895273|FG001|Overall Study|Lost to Follow-up|0|||
154853668|NCT04574999|558895272|FG000|Overall Study|Personal problems|1|||
154853669|NCT04574999|558895273|FG001|Overall Study|Personal problems|0|||
154853670|NCT04574999|558895272|FG000|Overall Study|Previous planned surgery|1|||
154853671|NCT04574999|558895273|FG001|Overall Study|Previous planned surgery|0|||
154853672|NCT00008385|558895275|FG000|Overall Study|Off treatment reasons not reported|79|||
155105980|NCT05396014|559817562|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
154853673|NCT00008385|558895276|FG001|Overall Study|Off treatment reasons not reported|70|||
154853674|NCT00008385|558895275|FG000|Overall Study|Progressive disease|52|||
154853675|NCT00008385|558895276|FG001|Overall Study|Progressive disease|117|||
154853676|NCT00008385|558895275|FG000|Overall Study|Adverse Event|8|||
154853677|NCT00008385|558895276|FG001|Overall Study|Adverse Event|20|||
154853678|NCT00008385|558895275|FG000|Overall Study|Death|12|||
154853679|NCT00008385|558895276|FG001|Overall Study|Death|18|||
154853680|NCT00008385|558895275|FG000|Overall Study|Withdrawal by Subject|67|||
154853681|NCT00008385|558895276|FG001|Overall Study|Withdrawal by Subject|157|||
154853682|NCT00008385|558895275|FG000|Overall Study|Start non-protocol therapy|3|||
154853683|NCT00008385|558895276|FG001|Overall Study|Start non-protocol therapy|1|||
154853684|NCT00008385|558895275|FG000|Overall Study|Other complicating disease|17|||
154853685|NCT00008385|558895276|FG001|Overall Study|Other complicating disease|30|||
154853686|NCT00008385|558895275|FG000|Overall Study|Maximum dose reached|0|||
154853687|NCT00008385|558895276|FG001|Overall Study|Maximum dose reached|2|||
154853688|NCT00008385|558895275|FG000|Overall Study|Other|105|||
154853689|NCT00008385|558895276|FG001|Overall Study|Other|212|||
154853690|NCT00008385|558895275|FG000|Overall Study|Not start protocol therapy|44|||
154853691|NCT00008385|558895276|FG001|Overall Study|Not start protocol therapy|175|||
154853692|NCT05148884|558895277|FG000|Overall Study|Withdrawal by Subject|3|||
154853693|NCT05148884|558895278|FG001|Overall Study|Withdrawal by Subject|0|||
154853694|NCT05148884|558895277|FG000|Overall Study|Deep brain stimulation operation|0|||
154853695|NCT05148884|558895278|FG001|Overall Study|Deep brain stimulation operation|1|||
154853696|NCT00317044|558895281|FG000|Overall Study|Protocol Violation|28|||
154853697|NCT00317044|558895282|FG001|Overall Study|Protocol Violation|22|||
154853698|NCT00317044|558895283|FG002|Overall Study|Protocol Violation|20|||
154853699|NCT00317044|558895281|FG000|Overall Study|Adverse Event|4|||
154853700|NCT00317044|558895282|FG001|Overall Study|Adverse Event|7|||
154853701|NCT00317044|558895283|FG002|Overall Study|Adverse Event|4|||
154853702|NCT00317044|558895281|FG000|Overall Study|Withdrawal by Subject|10|||
154853703|NCT00317044|558895282|FG001|Overall Study|Withdrawal by Subject|7|||
154853704|NCT00317044|558895283|FG002|Overall Study|Withdrawal by Subject|12|||
154853705|NCT00317044|558895281|FG000|Overall Study|Lost to Follow-up|0|||
154853706|NCT00317044|558895282|FG001|Overall Study|Lost to Follow-up|2|||
154853707|NCT00317044|558895283|FG002|Overall Study|Lost to Follow-up|3|||
154853708|NCT00317044|558895281|FG000|Overall Study|Multiple Reasons|6|||
154853709|NCT00317044|558895282|FG001|Overall Study|Multiple Reasons|2|||
154853710|NCT00317044|558895283|FG002|Overall Study|Multiple Reasons|6|||
154853711|NCT04317690|558895286|FG000|Overall Study|did not have complete information for primary outcome|0|||
154853712|NCT04317690|558895287|FG001|Overall Study|did not have complete information for primary outcome|4|||
154853713|NCT04317690|558895288|FG002|Overall Study|did not have complete information for primary outcome|0|||
154853714|NCT04317690|558895289|FG003|Overall Study|did not have complete information for primary outcome|2|||
154853715|NCT04317690|558895290|FG004|Overall Study|did not have complete information for primary outcome|0|||
154853716|NCT01719757|558895291|FG000|Overall Study|Adverse Event|38|||
154853717|NCT01719757|558895291|FG000|Overall Study|Withdrawal by Subject|15|||
154853718|NCT01719757|558895291|FG000|Overall Study|Lost to Follow-up|20|||
154853719|NCT01719757|558895291|FG000|Overall Study|Protocol Violation|1|||
154853720|NCT01719757|558895291|FG000|Overall Study|well controlled pain|27|||
154853721|NCT02626338|558895292|FG000|Overall Study|Lack of Efficacy|3|||
154853722|NCT02626338|558895293|FG001|Overall Study|Lack of Efficacy|2|||
154853723|NCT02626338|558895294|FG002|Overall Study|Lack of Efficacy|0|||
154853724|NCT03312218|558895300|FG000|Overall Study|Never signed in to access the app|54|||
154853725|NCT03312218|558895301|FG001|Overall Study|Never signed in to access the app|58|||
154853726|NCT01901224|558895302|FG000|Overall Study|study was not funded and terminated|2|||
154853727|NCT01254669|558895306|FG000|Overall Study|Withdrawal by Subject|0|||
154853728|NCT01254669|558895307|FG001|Overall Study|Withdrawal by Subject|1|||
154853729|NCT01254669|558895306|FG000|Overall Study|time constraint|2|||
154853730|NCT01254669|558895307|FG001|Overall Study|time constraint|2|||
154853731|NCT01254669|558895306|FG000|Overall Study|called to clinic during intervention|1|||
154853732|NCT01254669|558895307|FG001|Overall Study|called to clinic during intervention|1|||
154853733|NCT00103012|558895308|FG000|Overall Study|Withdrawal by Subject|2|||
154853734|NCT00103012|558895309|FG001|Overall Study|Withdrawal by Subject|1|||
154853735|NCT00103012|558895310|FG002|Overall Study|Withdrawal by Subject|2|||
154853736|NCT00103012|558895308|FG000|Overall Study|Pregnancy|1|||
154853737|NCT00103012|558895309|FG001|Overall Study|Pregnancy|0|||
154853738|NCT00103012|558895310|FG002|Overall Study|Pregnancy|0|||
154853739|NCT00103012|558895308|FG000|Overall Study|Adverse Event|0|||
154853740|NCT00103012|558895309|FG001|Overall Study|Adverse Event|0|||
154853741|NCT00103012|558895310|FG002|Overall Study|Adverse Event|1|||
154853742|NCT00103012|558895308|FG000|Overall Study|Subject non-compliant with medications|0|||
154853743|NCT00103012|558895309|FG001|Overall Study|Subject non-compliant with medications|0|||
154853744|NCT00103012|558895310|FG002|Overall Study|Subject non-compliant with medications|1|||
154853745|NCT05211336|558895313|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
154853746|NCT05211336|558895314|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
154853747|NCT05211336|558895313|FG000|Overall Study|Progressive disease|0|||
154853748|NCT05211336|558895314|FG001|Overall Study|Progressive disease|4|||
154853749|NCT05211336|558895313|FG000|Overall Study|Death due to myocardial infarction|0|||
154853750|NCT05211336|558895314|FG001|Overall Study|Death due to myocardial infarction|1|||
154853751|NCT05211336|558895313|FG000|Overall Study|Death due to unknown cause|0|||
154853752|NCT05211336|558895314|FG001|Overall Study|Death due to unknown cause|1|||
154853753|NCT05211336|558895313|FG000|Overall Study|Worsening kidney function and quality of response|0|||
154853754|NCT05211336|558895314|FG001|Overall Study|Worsening kidney function and quality of response|1|||
154853755|NCT00393718|558895319|FG000|Overall Study|Adverse Event|20|||
154853756|NCT00393718|558895320|FG001|Overall Study|Adverse Event|8|||
154853757|NCT00393718|558895319|FG000|Overall Study|Protocol Violation|1|||
154853758|NCT00393718|558895320|FG001|Overall Study|Protocol Violation|2|||
154853759|NCT00393718|558895319|FG000|Overall Study|Lack of Efficacy|10|||
154853760|NCT00393718|558895320|FG001|Overall Study|Lack of Efficacy|9|||
154853761|NCT00393718|558895319|FG000|Overall Study|Hypoglycaemia|3|||
154853762|NCT00393718|558895320|FG001|Overall Study|Hypoglycaemia|2|||
154853763|NCT00393718|558895319|FG000|Overall Study|Subject decision|5|||
154853764|NCT00393718|558895320|FG001|Overall Study|Subject decision|0|||
154853765|NCT00393718|558895319|FG000|Overall Study|Withdrawal of consent|2|||
154853766|NCT00393718|558895320|FG001|Overall Study|Withdrawal of consent|1|||
154853767|NCT00393718|558895319|FG000|Overall Study|Missed measurement|1|||
154853768|NCT00393718|558895320|FG001|Overall Study|Missed measurement|0|||
154853769|NCT00393718|558895319|FG000|Overall Study|Move|1|||
154853770|NCT00393718|558895320|FG001|Overall Study|Move|0|||
154853771|NCT01084551|558895325|FG000|Overall Study|Adverse Event|2|||
154853772|NCT01084551|558895326|FG001|Overall Study|Adverse Event|9|||
154853773|NCT01084551|558895327|FG002|Overall Study|Adverse Event|4|||
154853774|NCT01084551|558895325|FG000|Overall Study|Lack of Efficacy|2|||
154853775|NCT01084551|558895326|FG001|Overall Study|Lack of Efficacy|0|||
154853776|NCT01084551|558895327|FG002|Overall Study|Lack of Efficacy|1|||
154853777|NCT01084551|558895325|FG000|Overall Study|Withdrawal by Subject|2|||
154853778|NCT01084551|558895326|FG001|Overall Study|Withdrawal by Subject|1|||
154853779|NCT01084551|558895327|FG002|Overall Study|Withdrawal by Subject|0|||
154853780|NCT01084551|558895325|FG000|Overall Study|Protocol Violation|2|||
154853781|NCT01084551|558895326|FG001|Overall Study|Protocol Violation|4|||
154853782|NCT01084551|558895327|FG002|Overall Study|Protocol Violation|0|||
154853783|NCT01084551|558895325|FG000|Overall Study|Lost to Follow-up|0|||
154853784|NCT01084551|558895326|FG001|Overall Study|Lost to Follow-up|0|||
154853785|NCT01084551|558895327|FG002|Overall Study|Lost to Follow-up|3|||
154853786|NCT01084551|558895325|FG000|Overall Study|Physician Decision|1|||
154853787|NCT01084551|558895326|FG001|Overall Study|Physician Decision|0|||
154853788|NCT01084551|558895327|FG002|Overall Study|Physician Decision|0|||
154853789|NCT03902080|558895328|FG000|Overall Study|Adverse Event|17|||
154853790|NCT03902080|558895329|FG001|Overall Study|Adverse Event|15|||
154853791|NCT03902080|558895328|FG000|Overall Study|Withdrawal by Subject|28|||
154853792|NCT03902080|558895329|FG001|Overall Study|Withdrawal by Subject|35|||
154853793|NCT03902080|558895328|FG000|Overall Study|Lost to Follow-up|6|||
154853794|NCT03902080|558895329|FG001|Overall Study|Lost to Follow-up|7|||
154853795|NCT03902080|558895328|FG000|Overall Study|Other|3|||
154853796|NCT03902080|558895329|FG001|Overall Study|Other|5|||
154853797|NCT03902080|558895328|FG000|Overall Study|Non compliance|4|||
154853798|NCT03902080|558895329|FG001|Overall Study|Non compliance|3|||
154853799|NCT03902080|558895328|FG000|Overall Study|Physician Decision|5|||
154853800|NCT03902080|558895329|FG001|Overall Study|Physician Decision|1|||
154853801|NCT03902080|558895328|FG000|Overall Study|Protocol Violation|3|||
154853802|NCT03902080|558895329|FG001|Overall Study|Protocol Violation|3|||
154853803|NCT03902080|558895328|FG000|Overall Study|Lack of Efficacy|1|||
154853804|NCT03902080|558895329|FG001|Overall Study|Lack of Efficacy|3|||
154853805|NCT03902080|558895328|FG000|Overall Study|Withdrawn prior to dosing|0|||
154853806|NCT03902080|558895329|FG001|Overall Study|Withdrawn prior to dosing|1|||
154853807|NCT04684420|558895330|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154853808|NCT04684420|558895331|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
154853809|NCT04684420|558895332|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
154853810|NCT04684420|558895333|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
154853811|NCT04684420|558895330|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
154853812|NCT04684420|558895331|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
154853813|NCT04684420|558895332|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
154853814|NCT04684420|558895333|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
154853815|NCT00463476|558895334|FG000|Overall Study|Withdrawal by Subject|1|||
154853816|NCT00463476|558895335|FG001|Overall Study|Withdrawal by Subject|2|||
154853817|NCT00463476|558895334|FG000|Overall Study|Lost to Follow-up|1|||
154853818|NCT00463476|558895335|FG001|Overall Study|Lost to Follow-up|1|||
154853819|NCT01703000|558895337|FG000|Overall Study|Death|1|||
154853820|NCT00434967|558895338|FG000|Overall Study|Adverse Event|2|||
154853821|NCT00434967|558895339|FG001|Overall Study|Adverse Event|4|||
154853822|NCT00434967|558895340|FG002|Overall Study|Adverse Event|3|||
154853823|NCT00434967|558895341|FG003|Overall Study|Adverse Event|3|||
154853824|NCT00434967|558895338|FG000|Overall Study|Lost to Follow-up|0|||
154853825|NCT00434967|558895339|FG001|Overall Study|Lost to Follow-up|0|||
154853826|NCT00434967|558895340|FG002|Overall Study|Lost to Follow-up|1|||
154853827|NCT00434967|558895341|FG003|Overall Study|Lost to Follow-up|0|||
154853828|NCT00434967|558895338|FG000|Overall Study|Withdrawal by Subject|2|||
154853829|NCT00434967|558895339|FG001|Overall Study|Withdrawal by Subject|2|||
154853830|NCT00434967|558895340|FG002|Overall Study|Withdrawal by Subject|4|||
154853831|NCT00434967|558895341|FG003|Overall Study|Withdrawal by Subject|6|||
154853832|NCT00434967|558895338|FG000|Overall Study|Randomized in error|0|||
154853833|NCT00434967|558895339|FG001|Overall Study|Randomized in error|0|||
154853834|NCT00434967|558895340|FG002|Overall Study|Randomized in error|0|||
154853835|NCT00434967|558895341|FG003|Overall Study|Randomized in error|1|||
154853836|NCT00434967|558895338|FG000|Overall Study|Protocol Violation|0|||
154853837|NCT00434967|558895339|FG001|Overall Study|Protocol Violation|1|||
154853838|NCT00434967|558895340|FG002|Overall Study|Protocol Violation|0|||
154853839|NCT00434967|558895341|FG003|Overall Study|Protocol Violation|1|||
154853840|NCT00434967|558895338|FG000|Overall Study|Physician Decision|1|||
154853841|NCT00434967|558895339|FG001|Overall Study|Physician Decision|1|||
154853842|NCT00434967|558895340|FG002|Overall Study|Physician Decision|1|||
154853843|NCT00434967|558895341|FG003|Overall Study|Physician Decision|0|||
154853844|NCT00434967|558895338|FG000|Overall Study|Patient Disposition Challenges|2|||
154853845|NCT00434967|558895339|FG001|Overall Study|Patient Disposition Challenges|0|||
154853846|NCT00434967|558895340|FG002|Overall Study|Patient Disposition Challenges|0|||
154853847|NCT00434967|558895341|FG003|Overall Study|Patient Disposition Challenges|3|||
154853848|NCT03502187|558895342|FG000|Overall Study|Withdrawal by Subject|4|||
154853849|NCT03502187|558895343|FG001|Overall Study|Withdrawal by Subject|3|||
154853850|NCT03502187|558895344|FG002|Overall Study|Withdrawal by Subject|3|||
154853851|NCT03502187|558895342|FG000|Overall Study|Lost to Follow-up|5|||
154853852|NCT03502187|558895343|FG001|Overall Study|Lost to Follow-up|4|||
154853853|NCT03502187|558895344|FG002|Overall Study|Lost to Follow-up|5|||
154853854|NCT02913313|558895345|FG000|Overall Study|DISEASE PROGRESSION|1|||
154853855|NCT02913313|558895346|FG001|Overall Study|DISEASE PROGRESSION|2|||
154853856|NCT02913313|558895347|FG002|Overall Study|DISEASE PROGRESSION|2|||
154853857|NCT02913313|558895348|FG003|Overall Study|DISEASE PROGRESSION|4|||
154853858|NCT02913313|558895349|FG004|Overall Study|DISEASE PROGRESSION|6|||
154853859|NCT02913313|558895350|FG005|Overall Study|DISEASE PROGRESSION|4|||
154853860|NCT02913313|558895351|FG006|Overall Study|DISEASE PROGRESSION|19|||
154853861|NCT02913313|558895352|FG007|Overall Study|DISEASE PROGRESSION|3|||
154853862|NCT02913313|558895353|FG008|Overall Study|DISEASE PROGRESSION|4|||
154853863|NCT02913313|558895354|FG009|Overall Study|DISEASE PROGRESSION|4|||
154853864|NCT02913313|558895355|FG010|Overall Study|DISEASE PROGRESSION|11|||
154853865|NCT02913313|558895356|FG011|Overall Study|DISEASE PROGRESSION|5|||
154853866|NCT02913313|558895357|FG012|Overall Study|DISEASE PROGRESSION|14|||
154853867|NCT02913313|558895358|FG013|Overall Study|DISEASE PROGRESSION|3|||
154853868|NCT02913313|558895345|FG000|Overall Study|Not Reported|0|||
154853869|NCT02913313|558895346|FG001|Overall Study|Not Reported|0|||
154853870|NCT02913313|558895347|FG002|Overall Study|Not Reported|0|||
154853871|NCT02913313|558895348|FG003|Overall Study|Not Reported|0|||
154853872|NCT02913313|558895349|FG004|Overall Study|Not Reported|1|||
154853873|NCT02913313|558895350|FG005|Overall Study|Not Reported|0|||
154853874|NCT02913313|558895351|FG006|Overall Study|Not Reported|0|||
154853875|NCT02913313|558895352|FG007|Overall Study|Not Reported|0|||
154853876|NCT02913313|558895353|FG008|Overall Study|Not Reported|0|||
154853877|NCT02913313|558895354|FG009|Overall Study|Not Reported|0|||
154853878|NCT02913313|558895355|FG010|Overall Study|Not Reported|4|||
154853879|NCT02913313|558895356|FG011|Overall Study|Not Reported|0|||
154853880|NCT02913313|558895357|FG012|Overall Study|Not Reported|0|||
154853881|NCT02913313|558895358|FG013|Overall Study|Not Reported|0|||
154853882|NCT02913313|558895345|FG000|Overall Study|Other reasons|0|||
154853883|NCT02913313|558895346|FG001|Overall Study|Other reasons|0|||
154853884|NCT02913313|558895347|FG002|Overall Study|Other reasons|0|||
154853885|NCT02913313|558895348|FG003|Overall Study|Other reasons|0|||
154853886|NCT02913313|558895349|FG004|Overall Study|Other reasons|1|||
154853887|NCT02913313|558895350|FG005|Overall Study|Other reasons|0|||
154853888|NCT02913313|558895351|FG006|Overall Study|Other reasons|0|||
154853889|NCT02913313|558895352|FG007|Overall Study|Other reasons|0|||
154853890|NCT02913313|558895353|FG008|Overall Study|Other reasons|0|||
154853891|NCT02913313|558895354|FG009|Overall Study|Other reasons|0|||
154853892|NCT02913313|558895355|FG010|Overall Study|Other reasons|1|||
154853893|NCT02913313|558895356|FG011|Overall Study|Other reasons|0|||
154853894|NCT02913313|558895357|FG012|Overall Study|Other reasons|0|||
154853895|NCT02913313|558895358|FG013|Overall Study|Other reasons|0|||
154853896|NCT02913313|558895345|FG000|Overall Study|Withdrawal by Subject|0|||
154853897|NCT02913313|558895346|FG001|Overall Study|Withdrawal by Subject|0|||
154853898|NCT02913313|558895347|FG002|Overall Study|Withdrawal by Subject|1|||
154853899|NCT02913313|558895348|FG003|Overall Study|Withdrawal by Subject|0|||
154853900|NCT02913313|558895349|FG004|Overall Study|Withdrawal by Subject|0|||
154853901|NCT02913313|558895350|FG005|Overall Study|Withdrawal by Subject|0|||
154853902|NCT02913313|558895351|FG006|Overall Study|Withdrawal by Subject|1|||
154853903|NCT02913313|558895352|FG007|Overall Study|Withdrawal by Subject|1|||
154853904|NCT02913313|558895353|FG008|Overall Study|Withdrawal by Subject|0|||
154853905|NCT02913313|558895354|FG009|Overall Study|Withdrawal by Subject|0|||
154853906|NCT02913313|558895355|FG010|Overall Study|Withdrawal by Subject|1|||
154853907|NCT02913313|558895356|FG011|Overall Study|Withdrawal by Subject|0|||
154853908|NCT02913313|558895357|FG012|Overall Study|Withdrawal by Subject|0|||
154853909|NCT02913313|558895358|FG013|Overall Study|Withdrawal by Subject|0|||
154853910|NCT02913313|558895345|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853911|NCT02913313|558895346|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853912|NCT02913313|558895347|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853913|NCT02913313|558895348|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853914|NCT02913313|558895349|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853915|NCT02913313|558895350|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853916|NCT02913313|558895351|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853917|NCT02913313|558895352|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853918|NCT02913313|558895353|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853919|NCT02913313|558895354|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853920|NCT02913313|558895355|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
154853921|NCT02913313|558895356|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
154853922|NCT02913313|558895357|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
154853923|NCT02913313|558895358|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
154853924|NCT02913313|558895345|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
154853925|NCT02913313|558895346|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
154853926|NCT02913313|558895347|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
154853927|NCT02913313|558895348|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
154853928|NCT02913313|558895349|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
154853929|NCT02913313|558895350|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
154853930|NCT02913313|558895351|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
154853931|NCT02913313|558895352|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
154853932|NCT02913313|558895353|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
154853933|NCT02913313|558895354|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
154853934|NCT02913313|558895355|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
154853935|NCT02913313|558895356|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
154853936|NCT02913313|558895357|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
154853937|NCT02913313|558895358|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
154853938|NCT04276207|558895360|FG000|Period 1|Withdrawal by Subject|0|||
154853939|NCT04276207|558895361|FG001|Period 1|Withdrawal by Subject|1|||
154853940|NCT02690194|558895362|FG000|Overall Study|Withdrawal by Subject|1|||
154853941|NCT02690194|558895363|FG001|Overall Study|Withdrawal by Subject|4|||
154853942|NCT02690194|558895364|FG002|Overall Study|Withdrawal by Subject|0|||
154853943|NCT03624946|558895365|FG000|Overall Study|Lost to Follow-up|0|||
154853944|NCT03624946|558895366|FG001|Overall Study|Lost to Follow-up|1|||
154853945|NCT00624520|558895367|FG000|Overall Study|Withdrawal by Subject|12|||
154853946|NCT00624520|558895368|FG001|Overall Study|Withdrawal by Subject|7|||
154853947|NCT00624520|558895367|FG000|Overall Study|Death|0|||
154853948|NCT00624520|558895368|FG001|Overall Study|Death|1|||
154853949|NCT00675025|558895369|FG000|Overall Study|Study Terminated by Sponsor|38|||
154853950|NCT00675025|558895370|FG001|Overall Study|Study Terminated by Sponsor|42|||
154853951|NCT00675025|558895369|FG000|Overall Study|Adverse Event|6|||
154853952|NCT00675025|558895370|FG001|Overall Study|Adverse Event|11|||
154853953|NCT00675025|558895369|FG000|Overall Study|Lost to Follow-up|6|||
154853954|NCT00675025|558895370|FG001|Overall Study|Lost to Follow-up|4|||
154853955|NCT00675025|558895369|FG000|Overall Study|Withdrawal by Subject|4|||
154853956|NCT00675025|558895370|FG001|Overall Study|Withdrawal by Subject|6|||
154853957|NCT00556426|558895374|FG000|Overall Study|Withdrawal by Subject|3|||
154853958|NCT00556426|558895374|FG000|Overall Study|Death|6|||
154853959|NCT00944034|558895376|FG000|Overall Study|Inappropriate enrollment|0|||
154853960|NCT00944034|558895377|FG001|Overall Study|Inappropriate enrollment|1|||
154853961|NCT00944034|558895378|FG002|Overall Study|Inappropriate enrollment|0|||
154853962|NCT00944034|558895379|FG003|Overall Study|Inappropriate enrollment|1|||
154853963|NCT00944034|558895380|FG004|Overall Study|Inappropriate enrollment|2|||
154853964|NCT00944034|558895381|FG005|Overall Study|Inappropriate enrollment|1|||
154853965|NCT00944034|558895382|FG006|Overall Study|Inappropriate enrollment|0|||
154853966|NCT00944034|558895383|FG007|Overall Study|Inappropriate enrollment|0|||
154853967|NCT00944034|558895384|FG008|Overall Study|Inappropriate enrollment|1|||
154853968|NCT00944034|558895385|FG009|Overall Study|Inappropriate enrollment|1|||
154853969|NCT00944034|558895386|FG010|Overall Study|Inappropriate enrollment|0|||
154853970|NCT00944034|558895387|FG011|Overall Study|Inappropriate enrollment|0|||
154853971|NCT00944034|558895376|FG000|Overall Study|Withdrawal by Subject|3|||
154853972|NCT00944034|558895377|FG001|Overall Study|Withdrawal by Subject|2|||
154853973|NCT00944034|558895378|FG002|Overall Study|Withdrawal by Subject|6|||
154853974|NCT00944034|558895379|FG003|Overall Study|Withdrawal by Subject|2|||
154853975|NCT00944034|558895380|FG004|Overall Study|Withdrawal by Subject|5|||
154853976|NCT00944034|558895381|FG005|Overall Study|Withdrawal by Subject|8|||
154853977|NCT00944034|558895382|FG006|Overall Study|Withdrawal by Subject|2|||
154853978|NCT00944034|558895383|FG007|Overall Study|Withdrawal by Subject|2|||
154853979|NCT00944034|558895384|FG008|Overall Study|Withdrawal by Subject|3|||
154853980|NCT00944034|558895385|FG009|Overall Study|Withdrawal by Subject|4|||
154853981|NCT00944034|558895386|FG010|Overall Study|Withdrawal by Subject|0|||
154853982|NCT00944034|558895387|FG011|Overall Study|Withdrawal by Subject|4|||
154853983|NCT00944034|558895376|FG000|Overall Study|Lost to Follow-up|0|||
154853984|NCT00944034|558895377|FG001|Overall Study|Lost to Follow-up|4|||
154853985|NCT00944034|558895378|FG002|Overall Study|Lost to Follow-up|2|||
155173632|NCT01155011|560074842|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
155173633|NCT01155011|560074843|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
154853986|NCT00944034|558895379|FG003|Overall Study|Lost to Follow-up|0|||
154853987|NCT00944034|558895380|FG004|Overall Study|Lost to Follow-up|5|||
154853988|NCT00944034|558895381|FG005|Overall Study|Lost to Follow-up|7|||
154853989|NCT00944034|558895382|FG006|Overall Study|Lost to Follow-up|0|||
154853990|NCT00944034|558895383|FG007|Overall Study|Lost to Follow-up|1|||
154853991|NCT00944034|558895384|FG008|Overall Study|Lost to Follow-up|5|||
154853992|NCT00944034|558895385|FG009|Overall Study|Lost to Follow-up|1|||
154853993|NCT00944034|558895386|FG010|Overall Study|Lost to Follow-up|1|||
154853994|NCT00944034|558895387|FG011|Overall Study|Lost to Follow-up|0|||
154853995|NCT00944034|558895376|FG000|Overall Study|Death|0|||
154853996|NCT00944034|558895377|FG001|Overall Study|Death|0|||
154853997|NCT00944034|558895378|FG002|Overall Study|Death|1|||
154853998|NCT00944034|558895379|FG003|Overall Study|Death|0|||
154853999|NCT00944034|558895380|FG004|Overall Study|Death|0|||
154854000|NCT00944034|558895381|FG005|Overall Study|Death|0|||
154854001|NCT00944034|558895382|FG006|Overall Study|Death|0|||
154854002|NCT00944034|558895383|FG007|Overall Study|Death|0|||
154854003|NCT00944034|558895384|FG008|Overall Study|Death|0|||
154854004|NCT00944034|558895385|FG009|Overall Study|Death|0|||
154854005|NCT00944034|558895386|FG010|Overall Study|Death|0|||
154854006|NCT00944034|558895387|FG011|Overall Study|Death|0|||
154854007|NCT00944034|558895376|FG000|Overall Study|Protocol Violation|2|||
154854008|NCT00944034|558895377|FG001|Overall Study|Protocol Violation|0|||
154854009|NCT00944034|558895378|FG002|Overall Study|Protocol Violation|0|||
154854010|NCT00944034|558895379|FG003|Overall Study|Protocol Violation|1|||
154854011|NCT00944034|558895380|FG004|Overall Study|Protocol Violation|2|||
154854012|NCT00944034|558895381|FG005|Overall Study|Protocol Violation|3|||
154854013|NCT00944034|558895382|FG006|Overall Study|Protocol Violation|0|||
154854014|NCT00944034|558895383|FG007|Overall Study|Protocol Violation|1|||
154854015|NCT00944034|558895384|FG008|Overall Study|Protocol Violation|1|||
154854016|NCT00944034|558895385|FG009|Overall Study|Protocol Violation|4|||
154854017|NCT00944034|558895386|FG010|Overall Study|Protocol Violation|0|||
154854018|NCT00944034|558895387|FG011|Overall Study|Protocol Violation|0|||
154854019|NCT00944034|558895376|FG000|Overall Study|Unable to classify|0|||
154854020|NCT00944034|558895377|FG001|Overall Study|Unable to classify|0|||
154854021|NCT00944034|558895378|FG002|Overall Study|Unable to classify|0|||
154854022|NCT00944034|558895379|FG003|Overall Study|Unable to classify|0|||
154854023|NCT00944034|558895380|FG004|Overall Study|Unable to classify|0|||
154854024|NCT00944034|558895381|FG005|Overall Study|Unable to classify|1|||
154854025|NCT00944034|558895382|FG006|Overall Study|Unable to classify|1|||
154854026|NCT00944034|558895383|FG007|Overall Study|Unable to classify|1|||
154854027|NCT00944034|558895384|FG008|Overall Study|Unable to classify|0|||
154854028|NCT00944034|558895385|FG009|Overall Study|Unable to classify|0|||
154854029|NCT00944034|558895386|FG010|Overall Study|Unable to classify|0|||
154854030|NCT00944034|558895387|FG011|Overall Study|Unable to classify|0|||
154854031|NCT00944034|558895376|FG000|Overall Study|Administrative reason|0|||
154854032|NCT00944034|558895377|FG001|Overall Study|Administrative reason|0|||
154854033|NCT00944034|558895378|FG002|Overall Study|Administrative reason|0|||
154854034|NCT00944034|558895379|FG003|Overall Study|Administrative reason|0|||
154854035|NCT00944034|558895380|FG004|Overall Study|Administrative reason|0|||
154854036|NCT00944034|558895381|FG005|Overall Study|Administrative reason|0|||
154854037|NCT00944034|558895382|FG006|Overall Study|Administrative reason|1|||
154854038|NCT00944034|558895383|FG007|Overall Study|Administrative reason|0|||
154854039|NCT00944034|558895384|FG008|Overall Study|Administrative reason|0|||
154854040|NCT00944034|558895385|FG009|Overall Study|Administrative reason|0|||
154854041|NCT00944034|558895386|FG010|Overall Study|Administrative reason|0|||
154854042|NCT00944034|558895387|FG011|Overall Study|Administrative reason|0|||
154854043|NCT02347631|558895396|FG000|First Intervention (2 Months)|Adverse Event|1|||
154854044|NCT02347631|558895397|FG001|First Intervention (2 Months)|Adverse Event|1|||
154854045|NCT02347631|558895396|FG000|First Intervention (2 Months)|Pregnancy|1|||
154854046|NCT02347631|558895397|FG001|First Intervention (2 Months)|Pregnancy|0|||
154854047|NCT02347631|558895396|FG000|First Intervention (2 Months)|Moved out of area|0|||
154854048|NCT02347631|558895397|FG001|First Intervention (2 Months)|Moved out of area|2|||
154854049|NCT02347631|558895396|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
154854050|NCT02347631|558895397|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
154854051|NCT02347631|558895396|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
154854052|NCT02347631|558895397|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
154854053|NCT02347631|558895396|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
154854054|NCT02347631|558895397|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
154854055|NCT02347631|558895396|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
154854056|NCT02347631|558895397|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
154854057|NCT02347631|558895396|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
154854058|NCT02347631|558895397|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
154854059|NCT00238264|558895399|FG000|Overall Study|Death|7|||
154854060|NCT00238264|558895399|FG000|Overall Study|Lost to Follow-up|18|||
154854061|NCT00238264|558895399|FG000|Overall Study|Withdrawal by Subject|4|||
154854062|NCT00238264|558895399|FG000|Overall Study|Ineligible|7|||
154854063|NCT00713219|558895400|FG000|Overall Study|Death|1|||
154854064|NCT00713219|558895400|FG000|Overall Study|Protocol Violation|1|||
154854065|NCT00802360|558895403|FG000|Overall Study|Stimulation failure|4|||
154854066|NCT00802360|558895404|FG001|Overall Study|Stimulation failure|0|||
154854067|NCT00802360|558895405|FG002|Overall Study|Stimulation failure|3|||
154854068|NCT00802360|558895406|FG003|Overall Study|Stimulation failure|3|||
154854069|NCT00802360|558895403|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
154854070|NCT00802360|558895404|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
154854071|NCT00802360|558895405|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
154854072|NCT00802360|558895406|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
154854073|NCT00802360|558895403|FG000|Overall Study|Cycle cancelled|0|||
154854074|NCT00802360|558895404|FG001|Overall Study|Cycle cancelled|1|||
154854075|NCT00802360|558895405|FG002|Overall Study|Cycle cancelled|1|||
154854076|NCT00802360|558895406|FG003|Overall Study|Cycle cancelled|1|||
154854077|NCT00802360|558895403|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
154854078|NCT00802360|558895404|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
154854079|NCT00802360|558895405|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
154854080|NCT00802360|558895406|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
154854081|NCT00802360|558895403|FG000|Overall Study|No positive serum pregnancy|17|||
154854082|NCT00802360|558895404|FG001|Overall Study|No positive serum pregnancy|20|||
154854083|NCT00802360|558895405|FG002|Overall Study|No positive serum pregnancy|14|||
154854084|NCT00802360|558895406|FG003|Overall Study|No positive serum pregnancy|10|||
154854085|NCT00802360|558895403|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
154854086|NCT00802360|558895404|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
154854087|NCT00802360|558895405|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
154854088|NCT00802360|558895406|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
154854089|NCT00802360|558895403|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
154854090|NCT00802360|558895404|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
154854091|NCT00802360|558895405|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
154854092|NCT00802360|558895406|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
154854093|NCT00802360|558895403|FG000|Overall Study|Other|2|||
154854094|NCT00802360|558895404|FG001|Overall Study|Other|3|||
154854095|NCT00802360|558895405|FG002|Overall Study|Other|6|||
154854096|NCT00802360|558895406|FG003|Overall Study|Other|3|||
154854097|NCT02978222|558895409|FG000|Overall Study|Withdrawal by Subject|2|||
154854098|NCT02978222|558895410|FG001|Overall Study|Withdrawal by Subject|2|||
154854099|NCT02978222|558895409|FG000|Overall Study|Physician Decision|2|||
154854100|NCT02978222|558895410|FG001|Overall Study|Physician Decision|0|||
154854101|NCT02978222|558895409|FG000|Overall Study|Adverse Event|0|||
154854102|NCT02978222|558895410|FG001|Overall Study|Adverse Event|1|||
154854103|NCT02978222|558895409|FG000|Overall Study|Death|1|||
154854104|NCT02978222|558895410|FG001|Overall Study|Death|0|||
154854105|NCT02978222|558895409|FG000|Overall Study|Disease Progression|32|||
154854106|NCT02978222|558895410|FG001|Overall Study|Disease Progression|32|||
154854107|NCT02978222|558895409|FG000|Overall Study|Early Study Termination|24|||
154854108|NCT02978222|558895410|FG001|Overall Study|Early Study Termination|21|||
154854109|NCT03258814|558895413|FG000|Overall Study|Early Termination|4|||
154854110|NCT03258814|558895414|FG001|Overall Study|Early Termination|3|||
154854111|NCT03258814|558895415|FG002|Overall Study|Early Termination|10|||
154854112|NCT01900002|558895416|FG000|Overall Study|Withdrawal by Subject|2|||
154854113|NCT01900002|558895416|FG000|Overall Study|ineligible for Y-90|4|||
154854114|NCT01662648|558895421|FG000|Overall Study|Death|1|||
154854115|NCT01662648|558895422|FG001|Overall Study|Death|3|||
154854116|NCT01662648|558895421|FG000|Overall Study|Adverse Event|40|||
154854117|NCT01662648|558895422|FG001|Overall Study|Adverse Event|37|||
154854118|NCT01662648|558895421|FG000|Overall Study|Lack of Efficacy|17|||
154854119|NCT01662648|558895422|FG001|Overall Study|Lack of Efficacy|16|||
154854120|NCT01662648|558895421|FG000|Overall Study|Participant ineligible to continue trial|1|||
154854121|NCT01662648|558895422|FG001|Overall Study|Participant ineligible to continue trial|1|||
155105981|NCT05396014|559817563|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105982|NCT05396014|559817564|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
155105983|NCT05396014|559817565|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
155105984|NCT05396014|559817566|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
155105985|NCT05396014|559817567|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
155105986|NCT05396014|559817525|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
154854122|NCT01662648|558895421|FG000|Overall Study|Lost to Follow-up|24|||
154854123|NCT01662648|558895422|FG001|Overall Study|Lost to Follow-up|36|||
154854124|NCT01662648|558895421|FG000|Overall Study|Withdrawal by Subject|36|||
154854125|NCT01662648|558895422|FG001|Overall Study|Withdrawal by Subject|53|||
154854126|NCT01662648|558895421|FG000|Overall Study|Participant non-compliant|16|||
154854127|NCT01662648|558895422|FG001|Overall Study|Participant non-compliant|20|||
154854128|NCT01662648|558895421|FG000|Overall Study|Other|8|||
154854129|NCT01662648|558895422|FG001|Overall Study|Other|11|||
154854130|NCT01662648|558895421|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
154854131|NCT01662648|558895422|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
154854132|NCT01662648|558895421|FG000|Overall Study|LOE and other reason unspecified|1|||
154854133|NCT01662648|558895422|FG001|Overall Study|LOE and other reason unspecified|0|||
154854134|NCT01662648|558895421|FG000|Overall Study|LOE and Participant non-compliant|0|||
154854135|NCT01662648|558895422|FG001|Overall Study|LOE and Participant non-compliant|1|||
154854136|NCT02928952|558895425|FG000|Overall Study|Lost to Follow-up|5|||
154854137|NCT02928952|558895426|FG001|Overall Study|Lost to Follow-up|5|||
154854138|NCT02928952|558895425|FG000|Overall Study|Withdrawal by Subject|5|||
154854139|NCT02928952|558895426|FG001|Overall Study|Withdrawal by Subject|1|||
154854140|NCT02928952|558895425|FG000|Overall Study|Physician Decision|0|||
154854141|NCT02928952|558895426|FG001|Overall Study|Physician Decision|1|||
154854142|NCT02292212|558895427|FG000|ViE Phase|Withdrawal by Subject|1|||
154854143|NCT02292212|558895427|FG000|ViE Phase|Protocol Violation|2|||
154854144|NCT04957290|558895428|FG000|Overall Study|Progressive disease|3|||
154854145|NCT04957290|558895429|FG001|Overall Study|Progressive disease|3|||
154854146|NCT04957290|558895430|FG002|Overall Study|Progressive disease|2|||
154854147|NCT04957290|558895431|FG003|Overall Study|Progressive disease|0|||
154854148|NCT04957290|558895432|FG004|Overall Study|Progressive disease|0|||
154854149|NCT04957290|558895433|FG005|Overall Study|Progressive disease|0|||
154854150|NCT04957290|558895428|FG000|Overall Study|Withdrawal by Subject|1|||
154854151|NCT04957290|558895429|FG001|Overall Study|Withdrawal by Subject|0|||
154854152|NCT04957290|558895430|FG002|Overall Study|Withdrawal by Subject|1|||
154854153|NCT04957290|558895431|FG003|Overall Study|Withdrawal by Subject|0|||
154854154|NCT04957290|558895432|FG004|Overall Study|Withdrawal by Subject|0|||
154854155|NCT04957290|558895433|FG005|Overall Study|Withdrawal by Subject|0|||
154854156|NCT04957290|558895428|FG000|Overall Study|Death|0|||
154854157|NCT04957290|558895429|FG001|Overall Study|Death|2|||
154854158|NCT04957290|558895430|FG002|Overall Study|Death|1|||
154854159|NCT04957290|558895431|FG003|Overall Study|Death|0|||
154854160|NCT04957290|558895432|FG004|Overall Study|Death|0|||
154854161|NCT04957290|558895433|FG005|Overall Study|Death|0|||
154854162|NCT04957290|558895428|FG000|Overall Study|non compliance with study drug|0|||
154854163|NCT04957290|558895429|FG001|Overall Study|non compliance with study drug|1|||
154854164|NCT04957290|558895430|FG002|Overall Study|non compliance with study drug|0|||
154854165|NCT04957290|558895431|FG003|Overall Study|non compliance with study drug|0|||
154854166|NCT04957290|558895432|FG004|Overall Study|non compliance with study drug|0|||
154854167|NCT04957290|558895433|FG005|Overall Study|non compliance with study drug|0|||
154854168|NCT04957290|558895428|FG000|Overall Study|none specified.|0|||
154854169|NCT04957290|558895429|FG001|Overall Study|none specified.|1|||
154854170|NCT04957290|558895430|FG002|Overall Study|none specified.|2|||
154854171|NCT04957290|558895431|FG003|Overall Study|none specified.|0|||
154854172|NCT04957290|558895432|FG004|Overall Study|none specified.|0|||
154854173|NCT04957290|558895433|FG005|Overall Study|none specified.|0|||
154854174|NCT04957290|558895428|FG000|Overall Study|unacceptable toxicity|0|||
154854175|NCT04957290|558895429|FG001|Overall Study|unacceptable toxicity|0|||
154854176|NCT04957290|558895430|FG002|Overall Study|unacceptable toxicity|1|||
154854177|NCT04957290|558895431|FG003|Overall Study|unacceptable toxicity|0|||
154854178|NCT04957290|558895432|FG004|Overall Study|unacceptable toxicity|0|||
154854179|NCT04957290|558895433|FG005|Overall Study|unacceptable toxicity|0|||
154854180|NCT04957290|558895428|FG000|Overall Study|Adverse Event|0|||
154854181|NCT04957290|558895429|FG001|Overall Study|Adverse Event|0|||
154854182|NCT04957290|558895430|FG002|Overall Study|Adverse Event|1|||
154854183|NCT04957290|558895431|FG003|Overall Study|Adverse Event|0|||
154854184|NCT04957290|558895432|FG004|Overall Study|Adverse Event|0|||
154854185|NCT04957290|558895433|FG005|Overall Study|Adverse Event|0|||
154854186|NCT04957290|558895428|FG000|Overall Study|study terminated by sponsor|0|||
154854187|NCT04957290|558895429|FG001|Overall Study|study terminated by sponsor|0|||
154854188|NCT04957290|558895430|FG002|Overall Study|study terminated by sponsor|2|||
154854189|NCT04957290|558895431|FG003|Overall Study|study terminated by sponsor|0|||
154854190|NCT04957290|558895432|FG004|Overall Study|study terminated by sponsor|0|||
154854191|NCT04957290|558895433|FG005|Overall Study|study terminated by sponsor|0|||
154854192|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854193|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854194|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854195|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
154854196|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854197|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
154854198|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854199|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854200|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854201|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854202|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854203|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854204|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854205|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854206|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854207|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854208|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854209|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854210|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854211|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854212|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854213|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854214|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
154854215|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
154854216|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
154854217|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
154854218|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
154854219|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
154854220|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
154854221|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
154854222|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854223|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854224|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854225|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854226|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854227|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854228|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854229|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854230|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854231|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154971734|NCT04561115|559320670|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
154971735|NCT03259165|559320671|FG000|Overall Study|COVID 19 pandemic|1|||
154971736|NCT03259165|559320672|FG001|Overall Study|COVID 19 pandemic|1|||
154971737|NCT03732833|559320679|FG000|Overall Study|Adverse Event|0|||
154971738|NCT03732833|559320680|FG001|Overall Study|Adverse Event|3|||
154971739|NCT03732833|559320681|FG002|Overall Study|Adverse Event|1|||
154971740|NCT03732833|559320679|FG000|Overall Study|Withdrawal by Subject|11|||
154971741|NCT03732833|559320680|FG001|Overall Study|Withdrawal by Subject|13|||
154971742|NCT03732833|559320681|FG002|Overall Study|Withdrawal by Subject|8|||
154971743|NCT03732833|559320679|FG000|Overall Study|Lost to Follow-up|3|||
154971744|NCT03732833|559320680|FG001|Overall Study|Lost to Follow-up|5|||
154971745|NCT03732833|559320681|FG002|Overall Study|Lost to Follow-up|4|||
154971746|NCT03732833|559320679|FG000|Overall Study|Pregnancy|0|||
154971747|NCT03732833|559320680|FG001|Overall Study|Pregnancy|2|||
154971748|NCT03732833|559320681|FG002|Overall Study|Pregnancy|0|||
154971749|NCT03732833|559320679|FG000|Overall Study|Physician Decision|2|||
154971750|NCT03732833|559320680|FG001|Overall Study|Physician Decision|3|||
154971751|NCT03732833|559320681|FG002|Overall Study|Physician Decision|1|||
154854232|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854233|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854234|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854235|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854236|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854237|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
154854238|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
154854239|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
154854240|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
154854241|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
154854242|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
154854243|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
154854244|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
154854245|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
154854246|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154971752|NCT03732833|559320679|FG000|Overall Study|Covid-19 related and other reasons|2|||
154971753|NCT03732833|559320680|FG001|Overall Study|Covid-19 related and other reasons|7|||
154971754|NCT03732833|559320681|FG002|Overall Study|Covid-19 related and other reasons|3|||
154971755|NCT02004691|559320682|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
154971756|NCT02004691|559320683|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
154854247|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854248|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854249|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854250|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854251|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854252|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854253|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854254|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854255|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854256|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854257|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854258|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854259|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854260|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
154854261|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854262|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854263|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
154854264|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854265|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
154854266|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854267|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854268|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854269|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854270|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854271|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854272|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854273|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854274|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854275|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854276|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854277|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854278|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854279|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854280|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854281|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854282|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854283|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
154854284|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
154854285|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854286|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854287|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
154854288|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854289|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854290|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854291|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154971757|NCT02004691|559320682|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
154971758|NCT02004691|559320683|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
154971759|NCT02004691|559320682|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
154971760|NCT02004691|559320683|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
154971761|NCT02004691|559320682|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
154971762|NCT02004691|559320683|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
154971763|NCT02004691|559320682|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
154971764|NCT02004691|559320683|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
154971765|NCT02004691|559320682|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
154971766|NCT02004691|559320683|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
154971767|NCT02623218|559320684|FG000|Overall Study|Lost to Follow-up|0|||
154971768|NCT02623218|559320685|FG001|Overall Study|Lost to Follow-up|1|||
154971769|NCT02623218|559320686|FG002|Overall Study|Lost to Follow-up|0|||
154971770|NCT02623218|559320687|FG003|Overall Study|Lost to Follow-up|0|||
154971771|NCT02623218|559320688|FG004|Overall Study|Lost to Follow-up|0|||
154971772|NCT01726803|559320689|FG000|Overall Study|Lost to Follow-up|6|||
154854292|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154971773|NCT01726803|559320690|FG001|Overall Study|Lost to Follow-up|1|||
154971774|NCT01726803|559320689|FG000|Overall Study|Withdrawal by Subject|1|||
154971775|NCT01726803|559320690|FG001|Overall Study|Withdrawal by Subject|0|||
154854293|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854294|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854295|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854296|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854297|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854298|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854299|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854300|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854301|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854302|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854303|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854304|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854305|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854306|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
154854307|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854308|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854309|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
154854310|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854311|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854312|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854313|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854314|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854315|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854316|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854317|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854318|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854319|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854320|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854321|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854322|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854323|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854324|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854325|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854326|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854327|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854328|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854329|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
154854330|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854331|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854332|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
154854333|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854334|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854335|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854336|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854337|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854338|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854339|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854340|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854341|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854342|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854343|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854344|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854345|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854346|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854347|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854348|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854349|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854350|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854351|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854352|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
154854353|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854354|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854355|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854356|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
154854357|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854358|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854359|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854360|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854361|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854362|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854363|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854364|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854365|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854366|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854367|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854368|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854369|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854370|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854371|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854372|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854373|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854374|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854375|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
154854376|NCT00896532|558895434|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854377|NCT00896532|558895435|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
154854378|NCT00896532|558895436|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854379|NCT00896532|558895437|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
154854380|NCT00896532|558895438|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
154854381|NCT00896532|558895439|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854382|NCT00896532|558895440|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854383|NCT00896532|558895441|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854384|NCT00896532|558895442|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854385|NCT00896532|558895443|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854386|NCT00896532|558895444|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854387|NCT00896532|558895445|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854388|NCT00896532|558895446|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854389|NCT00896532|558895447|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854390|NCT00896532|558895448|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854391|NCT00896532|558895449|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854392|NCT00896532|558895450|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854393|NCT00896532|558895451|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854394|NCT00896532|558895452|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854395|NCT00896532|558895453|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854396|NCT00896532|558895454|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854397|NCT00896532|558895455|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854398|NCT00896532|558895456|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
154854399|NCT00896532|558895434|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854400|NCT00896532|558895435|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854401|NCT00896532|558895436|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854402|NCT00896532|558895437|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854403|NCT00896532|558895438|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854404|NCT00896532|558895439|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854405|NCT00896532|558895440|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854406|NCT00896532|558895441|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854407|NCT00896532|558895442|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
154854408|NCT00896532|558895443|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854409|NCT00896532|558895444|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854410|NCT00896532|558895445|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854411|NCT00896532|558895446|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854412|NCT00896532|558895447|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154971776|NCT01970592|559320693|FG000|Overall Study|Withdrawal by Subject|4|||
154971777|NCT01970592|559320693|FG000|Overall Study|Physician Decision|1|||
154971778|NCT01970592|559320693|FG000|Overall Study|Adverse Event|1|||
154971779|NCT01320722|559320696|FG000|Overall Study|Did not Receive Intervention|3|||
154854413|NCT00896532|558895448|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854414|NCT00896532|558895449|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854415|NCT00896532|558895450|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154971780|NCT01320722|559320697|FG001|Overall Study|Did not Receive Intervention|2|||
154854416|NCT00896532|558895451|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854417|NCT00896532|558895452|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854418|NCT00896532|558895453|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854419|NCT00896532|558895454|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854420|NCT00896532|558895455|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854421|NCT00896532|558895456|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
154854422|NCT00896532|558895434|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854423|NCT00896532|558895435|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854424|NCT00896532|558895436|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854425|NCT00896532|558895437|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854426|NCT00896532|558895438|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854427|NCT00896532|558895439|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854428|NCT00896532|558895440|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854429|NCT00896532|558895441|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854430|NCT00896532|558895442|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854431|NCT00896532|558895443|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854432|NCT00896532|558895444|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854433|NCT00896532|558895445|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854434|NCT00896532|558895446|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
154854435|NCT00896532|558895447|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854436|NCT00896532|558895448|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854437|NCT00896532|558895449|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854438|NCT00896532|558895450|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854439|NCT00896532|558895451|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854440|NCT00896532|558895452|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854441|NCT00896532|558895453|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854442|NCT00896532|558895454|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854443|NCT00896532|558895455|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854444|NCT00896532|558895456|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
154854445|NCT00896532|558895434|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854446|NCT00896532|558895435|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854447|NCT00896532|558895436|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854448|NCT00896532|558895437|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854449|NCT00896532|558895438|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854450|NCT00896532|558895439|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854451|NCT00896532|558895440|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854452|NCT00896532|558895441|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854453|NCT00896532|558895442|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854454|NCT00896532|558895443|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854455|NCT00896532|558895444|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
154854456|NCT00896532|558895445|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854457|NCT00896532|558895446|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
154854458|NCT00896532|558895447|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854459|NCT00896532|558895448|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854460|NCT00896532|558895449|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854461|NCT00896532|558895450|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854462|NCT00896532|558895451|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854463|NCT00896532|558895452|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854464|NCT00896532|558895453|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854465|NCT00896532|558895454|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854466|NCT00896532|558895455|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854467|NCT00896532|558895456|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
154854468|NCT00896532|558895434|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854469|NCT00896532|558895435|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854470|NCT00896532|558895436|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854471|NCT00896532|558895437|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854472|NCT00896532|558895438|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854473|NCT00896532|558895439|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854474|NCT00896532|558895440|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854475|NCT00896532|558895441|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154971781|NCT01320722|559320698|FG002|Overall Study|Did not Receive Intervention|1|||
154971782|NCT01320722|559320699|FG003|Overall Study|Did not Receive Intervention|1|||
155105987|NCT05396014|559817526|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105988|NCT05396014|559817527|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105989|NCT05396014|559817528|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
154854476|NCT00896532|558895442|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854477|NCT00896532|558895443|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854478|NCT00896532|558895444|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854479|NCT00896532|558895445|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854480|NCT00896532|558895446|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
154854481|NCT00896532|558895447|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
154854482|NCT00896532|558895448|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854483|NCT00896532|558895449|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854484|NCT00896532|558895450|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854485|NCT00896532|558895451|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854486|NCT00896532|558895452|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854487|NCT00896532|558895453|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854488|NCT00896532|558895454|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854489|NCT00896532|558895455|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854490|NCT00896532|558895456|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
154854491|NCT00896532|558895434|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
154854492|NCT00896532|558895435|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
154854493|NCT00896532|558895436|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
154854494|NCT00896532|558895437|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
154854495|NCT00896532|558895438|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
154854496|NCT00896532|558895439|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
154854497|NCT00896532|558895440|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
154854498|NCT00896532|558895441|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
154854499|NCT00896532|558895442|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
154854500|NCT00896532|558895443|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
154854501|NCT00896532|558895444|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
154854502|NCT00896532|558895445|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
154854503|NCT00896532|558895446|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
154854504|NCT00896532|558895447|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
154854505|NCT00896532|558895448|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
154854506|NCT00896532|558895449|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
154854507|NCT00896532|558895450|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
154854508|NCT00896532|558895451|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
154854509|NCT00896532|558895452|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
154854510|NCT00896532|558895453|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
154854511|NCT00896532|558895454|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
154854512|NCT00896532|558895455|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
154854513|NCT00896532|558895456|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
154854514|NCT00896532|558895434|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854515|NCT00896532|558895435|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854516|NCT00896532|558895436|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854517|NCT00896532|558895437|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854518|NCT00896532|558895438|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854519|NCT00896532|558895439|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854520|NCT00896532|558895440|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854521|NCT00896532|558895441|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854522|NCT00896532|558895442|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854523|NCT00896532|558895443|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854524|NCT00896532|558895444|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854525|NCT00896532|558895445|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854526|NCT00896532|558895446|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854527|NCT00896532|558895447|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854528|NCT00896532|558895448|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854529|NCT00896532|558895449|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
154854530|NCT00896532|558895450|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
154854531|NCT00896532|558895451|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854532|NCT00896532|558895452|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854533|NCT00896532|558895453|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854534|NCT00896532|558895454|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854535|NCT00896532|558895455|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854536|NCT00896532|558895456|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
154854537|NCT00896532|558895434|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854538|NCT00896532|558895435|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854539|NCT00896532|558895436|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854540|NCT00896532|558895437|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854541|NCT00896532|558895438|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155105990|NCT05396014|559817529|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105991|NCT05396014|559817530|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105992|NCT05396014|559817531|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155105993|NCT05396014|559817532|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105994|NCT05396014|559817533|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
155105995|NCT05396014|559817534|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
154854542|NCT00896532|558895439|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
155105996|NCT05396014|559817535|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105997|NCT05396014|559817536|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105998|NCT05396014|559817537|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155105999|NCT05396014|559817538|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106000|NCT05396014|559817539|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106001|NCT05396014|559817540|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106002|NCT05396014|559817541|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106003|NCT05396014|559817542|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106004|NCT05396014|559817543|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106005|NCT05396014|559817544|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106006|NCT05396014|559817545|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106007|NCT05396014|559817546|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106008|NCT05396014|559817547|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
155106009|NCT05396014|559817548|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106010|NCT05396014|559817549|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106011|NCT05396014|559817550|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106012|NCT05396014|559817551|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106013|NCT05396014|559817552|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106014|NCT05396014|559817553|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106015|NCT05396014|559817554|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106016|NCT05396014|559817555|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
154854543|NCT00896532|558895440|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854544|NCT00896532|558895441|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854545|NCT00896532|558895442|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854546|NCT00896532|558895443|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854547|NCT00896532|558895444|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854548|NCT00896532|558895445|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854549|NCT00896532|558895446|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854550|NCT00896532|558895447|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854551|NCT00896532|558895448|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854552|NCT00896532|558895449|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
154854553|NCT00896532|558895450|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
154854554|NCT00896532|558895451|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
154854555|NCT00896532|558895452|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854556|NCT00896532|558895453|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854557|NCT00896532|558895454|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854558|NCT00896532|558895455|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854559|NCT00896532|558895456|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
154854560|NCT00896532|558895434|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854561|NCT00896532|558895435|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854562|NCT00896532|558895436|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854563|NCT00896532|558895437|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854564|NCT00896532|558895438|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854565|NCT00896532|558895439|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854566|NCT00896532|558895440|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854567|NCT00896532|558895441|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854568|NCT00896532|558895442|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854569|NCT00896532|558895443|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854570|NCT00896532|558895444|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854571|NCT00896532|558895445|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854572|NCT00896532|558895446|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854573|NCT00896532|558895447|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854574|NCT00896532|558895448|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854575|NCT00896532|558895449|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854576|NCT00896532|558895450|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
154854577|NCT00896532|558895451|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854578|NCT00896532|558895452|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854579|NCT00896532|558895453|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854580|NCT00896532|558895454|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854581|NCT00896532|558895455|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854582|NCT00896532|558895456|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
154854583|NCT00896532|558895434|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
154854584|NCT00896532|558895435|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
154854585|NCT00896532|558895436|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
154854586|NCT00896532|558895437|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
154854587|NCT00896532|558895438|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
154854588|NCT00896532|558895439|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
154854589|NCT00896532|558895440|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
154854590|NCT00896532|558895441|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
154854591|NCT00896532|558895442|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
154854592|NCT00896532|558895443|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
154854593|NCT00896532|558895444|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
154854594|NCT00896532|558895445|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
154854595|NCT00896532|558895446|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
154854596|NCT00896532|558895447|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
154854597|NCT00896532|558895448|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
154854598|NCT00896532|558895449|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
154854599|NCT00896532|558895450|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
154854600|NCT00896532|558895451|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
154854601|NCT00896532|558895452|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
154854602|NCT00896532|558895453|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
154854603|NCT00896532|558895454|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
154854604|NCT00896532|558895455|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
154854605|NCT00896532|558895456|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
154854606|NCT00896532|558895434|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854607|NCT00896532|558895435|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854608|NCT00896532|558895436|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854609|NCT00896532|558895437|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854610|NCT00896532|558895438|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854611|NCT00896532|558895439|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854612|NCT00896532|558895440|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854613|NCT00896532|558895441|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854614|NCT00896532|558895442|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854615|NCT00896532|558895443|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854616|NCT00896532|558895444|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854617|NCT00896532|558895445|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854618|NCT00896532|558895446|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854619|NCT00896532|558895447|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854620|NCT00896532|558895448|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854621|NCT00896532|558895449|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854622|NCT00896532|558895450|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
154854623|NCT00896532|558895451|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854624|NCT00896532|558895452|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854625|NCT00896532|558895453|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854626|NCT00896532|558895454|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854627|NCT00896532|558895455|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854628|NCT00896532|558895456|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
154854629|NCT00896532|558895434|FG000|Months 48-72: Follow-on Phase|Death|0|||
154854630|NCT00896532|558895435|FG001|Months 48-72: Follow-on Phase|Death|0|||
154854631|NCT00896532|558895436|FG002|Months 48-72: Follow-on Phase|Death|0|||
154854632|NCT00896532|558895437|FG003|Months 48-72: Follow-on Phase|Death|0|||
154854633|NCT00896532|558895438|FG004|Months 48-72: Follow-on Phase|Death|0|||
154854634|NCT00896532|558895439|FG005|Months 48-72: Follow-on Phase|Death|0|||
154854635|NCT00896532|558895440|FG006|Months 48-72: Follow-on Phase|Death|0|||
154854636|NCT00896532|558895441|FG007|Months 48-72: Follow-on Phase|Death|0|||
154854637|NCT00896532|558895442|FG008|Months 48-72: Follow-on Phase|Death|0|||
154854638|NCT00896532|558895443|FG009|Months 48-72: Follow-on Phase|Death|0|||
154854639|NCT00896532|558895444|FG010|Months 48-72: Follow-on Phase|Death|0|||
155106017|NCT05396014|559817556|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106018|NCT05396014|559817557|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106019|NCT05396014|559817558|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106020|NCT05396014|559817559|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106021|NCT05396014|559817560|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
155106022|NCT05396014|559817561|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106023|NCT05396014|559817562|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106024|NCT05396014|559817563|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
154854640|NCT00896532|558895445|FG011|Months 48-72: Follow-on Phase|Death|0|||
154854641|NCT00896532|558895446|FG012|Months 48-72: Follow-on Phase|Death|0|||
154854642|NCT00896532|558895447|FG013|Months 48-72: Follow-on Phase|Death|0|||
154854643|NCT00896532|558895448|FG014|Months 48-72: Follow-on Phase|Death|0|||
154854644|NCT00896532|558895449|FG015|Months 48-72: Follow-on Phase|Death|0|||
154854645|NCT00896532|558895450|FG016|Months 48-72: Follow-on Phase|Death|0|||
154854646|NCT00896532|558895451|FG017|Months 48-72: Follow-on Phase|Death|0|||
154854647|NCT00896532|558895452|FG018|Months 48-72: Follow-on Phase|Death|1|||
154854648|NCT00896532|558895453|FG019|Months 48-72: Follow-on Phase|Death|0|||
154854649|NCT00896532|558895454|FG020|Months 48-72: Follow-on Phase|Death|0|||
154854650|NCT00896532|558895455|FG021|Months 48-72: Follow-on Phase|Death|0|||
154854651|NCT00896532|558895456|FG022|Months 48-72: Follow-on Phase|Death|0|||
154854652|NCT00896532|558895434|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854653|NCT00896532|558895435|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854654|NCT00896532|558895436|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854655|NCT00896532|558895437|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854656|NCT00896532|558895438|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854657|NCT00896532|558895439|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854658|NCT00896532|558895440|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854659|NCT00896532|558895441|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854660|NCT00896532|558895442|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854661|NCT00896532|558895443|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854662|NCT00896532|558895444|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854663|NCT00896532|558895445|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854664|NCT00896532|558895446|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854665|NCT00896532|558895447|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854666|NCT00896532|558895448|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854667|NCT00896532|558895449|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854668|NCT00896532|558895450|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854669|NCT00896532|558895451|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854670|NCT00896532|558895452|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854671|NCT00896532|558895453|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854672|NCT00896532|558895454|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854673|NCT00896532|558895455|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
154854674|NCT00896532|558895456|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
154854675|NCT00896532|558895434|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854676|NCT00896532|558895435|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854677|NCT00896532|558895436|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854678|NCT00896532|558895437|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854679|NCT00896532|558895438|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854680|NCT00896532|558895439|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854681|NCT00896532|558895440|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854682|NCT00896532|558895441|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854683|NCT00896532|558895442|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854684|NCT00896532|558895443|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854685|NCT00896532|558895444|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854686|NCT00896532|558895445|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854687|NCT00896532|558895446|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854688|NCT00896532|558895447|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854689|NCT00896532|558895448|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854690|NCT00896532|558895449|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854691|NCT00896532|558895450|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854692|NCT00896532|558895451|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854693|NCT00896532|558895452|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854694|NCT00896532|558895453|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854695|NCT00896532|558895454|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854696|NCT00896532|558895455|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
154854697|NCT00896532|558895456|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
154854698|NCT00848120|558895457|FG000|Overall Study|Adverse Event|1|||
154854699|NCT01961115|558895466|FG000|Overall Study|Disease Progression|1|||
154854700|NCT01961115|558895467|FG001|Overall Study|Disease Progression|0|||
154854701|NCT01961115|558895468|FG002|Overall Study|Disease Progression|3|||
154854702|NCT01961115|558895466|FG000|Overall Study|Adverse Event|1|||
154854703|NCT01961115|558895467|FG001|Overall Study|Adverse Event|0|||
154854704|NCT01961115|558895468|FG002|Overall Study|Adverse Event|1|||
154854705|NCT00705263|558895473|FG000|Overall Study|Withdrawal by Subject|2|||
154854706|NCT05501119|558895474|FG000|Overall Study|Withdrawal by Subject|2|||
154854707|NCT05501119|558895474|FG000|Overall Study|Lost to Follow-up|5|||
154854708|NCT01752023|558895475|FG000|Overall Study|Physician Decision|2|||
154854709|NCT01752023|558895476|FG001|Overall Study|Physician Decision|1|||
154854710|NCT02899156|558895477|FG000|Overall Study|Death|1|||
154854711|NCT02899156|558895478|FG001|Overall Study|Death|0|||
154854712|NCT02899156|558895477|FG000|Overall Study|Physician Decision|0|||
154854713|NCT02899156|558895478|FG001|Overall Study|Physician Decision|1|||
154854714|NCT02440581|558895479|FG000|Overall Study|Death|0|||
154854715|NCT02440581|558895480|FG001|Overall Study|Death|0|||
154854716|NCT02440581|558895481|FG002|Overall Study|Death|7|||
154854717|NCT02440581|558895482|FG003|Overall Study|Death|5|||
154854718|NCT02440581|558895479|FG000|Overall Study|Transplanted|1|||
154854719|NCT02440581|558895480|FG001|Overall Study|Transplanted|0|||
154854720|NCT02440581|558895481|FG002|Overall Study|Transplanted|3|||
154854721|NCT02440581|558895482|FG003|Overall Study|Transplanted|2|||
154854722|NCT02440581|558895479|FG000|Overall Study|Withdrawal by Subject|4|||
154854723|NCT02440581|558895480|FG001|Overall Study|Withdrawal by Subject|11|||
154854724|NCT02440581|558895481|FG002|Overall Study|Withdrawal by Subject|3|||
154854725|NCT02440581|558895482|FG003|Overall Study|Withdrawal by Subject|7|||
154854726|NCT00787787|558895483|FG000|Overall Study|Lack of Efficacy|4|||
154854727|NCT00787787|558895483|FG000|Overall Study|Adverse Event|3|||
154854728|NCT01468987|558895484|FG000|Overall Study|Adverse Event|12|||
154854729|NCT01468987|558895485|FG001|Overall Study|Adverse Event|9|||
154854730|NCT01468987|558895484|FG000|Overall Study|Death|4|||
154854731|NCT01468987|558895485|FG001|Overall Study|Death|1|||
154854732|NCT01468987|558895484|FG000|Overall Study|Lost to Follow-up|10|||
154854733|NCT01468987|558895485|FG001|Overall Study|Lost to Follow-up|5|||
154854734|NCT01468987|558895484|FG000|Overall Study|Protocol Violation|8|||
154854735|NCT01468987|558895485|FG001|Overall Study|Protocol Violation|2|||
154854736|NCT01468987|558895484|FG000|Overall Study|Withdrawal by Subject|28|||
154854737|NCT01468987|558895485|FG001|Overall Study|Withdrawal by Subject|28|||
154854738|NCT01468987|558895484|FG000|Overall Study|Physician Decision|8|||
154854739|NCT01468987|558895485|FG001|Overall Study|Physician Decision|15|||
154854740|NCT01468987|558895484|FG000|Overall Study|Sponsor Decision|1|||
154854741|NCT01468987|558895485|FG001|Overall Study|Sponsor Decision|0|||
154854742|NCT01889602|558895488|FG000|First Intervention|Adverse Event|1|||
154854743|NCT01889602|558895489|FG001|First Intervention|Adverse Event|1|||
154854744|NCT01889602|558895490|FG002|First Intervention|Adverse Event|1|||
154854745|NCT01889602|558895488|FG000|First Intervention|Protocol Violation|0|||
154854746|NCT01889602|558895489|FG001|First Intervention|Protocol Violation|1|||
154854747|NCT01889602|558895490|FG002|First Intervention|Protocol Violation|1|||
154854748|NCT01889602|558895488|FG000|First Intervention|Study ending|0|||
154854749|NCT01889602|558895489|FG001|First Intervention|Study ending|1|||
154854750|NCT01889602|558895490|FG002|First Intervention|Study ending|0|||
154854751|NCT01889602|558895488|FG000|Second Intervention|Adverse Event|0|||
154854752|NCT01889602|558895489|FG001|Second Intervention|Adverse Event|0|||
154854753|NCT01889602|558895490|FG002|Second Intervention|Adverse Event|1|||
154854754|NCT01889602|558895488|FG000|Second Intervention|Study ending|1|||
154854755|NCT01889602|558895489|FG001|Second Intervention|Study ending|0|||
154854756|NCT01889602|558895490|FG002|Second Intervention|Study ending|0|||
154854757|NCT01889602|558895488|FG000|Second Intervention|Withdrawal by Subject|0|||
154854758|NCT01889602|558895489|FG001|Second Intervention|Withdrawal by Subject|0|||
154854759|NCT01889602|558895490|FG002|Second Intervention|Withdrawal by Subject|1|||
154854760|NCT01889602|558895488|FG000|Third Intervention|Protocol Violation|1|||
154971783|NCT01320722|559320700|FG004|Overall Study|Did not Receive Intervention|2|||
154971784|NCT01320722|559320696|FG000|Overall Study|Lost to Follow-up|0|||
154854761|NCT01889602|558895489|FG001|Third Intervention|Protocol Violation|0|||
154854762|NCT01889602|558895490|FG002|Third Intervention|Protocol Violation|0|||
154854763|NCT01889602|558895488|FG000|Third Intervention|Withdrawal by Subject|2|||
154854764|NCT01889602|558895489|FG001|Third Intervention|Withdrawal by Subject|2|||
154854765|NCT01889602|558895490|FG002|Third Intervention|Withdrawal by Subject|0|||
154854766|NCT01078805|558895494|FG000|Overall Study|Clinically significant abnormal lab|5|||
154854767|NCT01078805|558895494|FG000|Overall Study|Death|134|||
154854768|NCT01078805|558895494|FG000|Overall Study|Lost to Follow-up|676|||
154854769|NCT01078805|558895494|FG000|Overall Study|Physician Decision|169|||
154854770|NCT01078805|558895494|FG000|Overall Study|Serious adverse event|26|||
154854771|NCT01078805|558895494|FG000|Overall Study|Sponsor decision|46|||
154854772|NCT01078805|558895494|FG000|Overall Study|Withdrawal by Subject|739|||
154854773|NCT01078805|558895494|FG000|Overall Study|Other|173|||
154854774|NCT01078805|558895494|FG000|Overall Study|Didn't take study drug|82|||
154854775|NCT02246621|558895495|FG000|Overall Study|Withdrawal by Subject|28|||
154854776|NCT02246621|558895496|FG001|Overall Study|Withdrawal by Subject|16|||
154854777|NCT02246621|558895495|FG000|Overall Study|Lost to Follow-up|1|||
154854778|NCT02246621|558895496|FG001|Overall Study|Lost to Follow-up|0|||
154854779|NCT02246621|558895495|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
154854780|NCT02246621|558895496|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
154854781|NCT01292057|558895500|FG000|Overall Study|Protocol Violation|1|||
154854782|NCT01292057|558895501|FG001|Overall Study|Protocol Violation|1|||
154854783|NCT01292057|558895500|FG000|Overall Study|Lost to Follow-up|1|||
154854784|NCT01292057|558895501|FG001|Overall Study|Lost to Follow-up|1|||
154854785|NCT01974817|558897215|FG000|Overall Study|Death|4|||
154854786|NCT01974817|558897215|FG000|Overall Study|Lost to Follow-up|2|||
154854787|NCT01974817|558897215|FG000|Overall Study|Protocol Violation|2|||
154854788|NCT03658889|558897216|FG000|Overall Study|Protocol Violation|2|||
154854789|NCT03658889|558897217|FG001|Overall Study|Protocol Violation|0|||
154854790|NCT01524991|558897222|FG000|Overall Study|Adverse Event|12|||
154854791|NCT01524991|558897222|FG000|Overall Study|Death|1|||
154854792|NCT01524991|558897222|FG000|Overall Study|Disease ProgressionDu|17|||
154854793|NCT01524991|558897222|FG000|Overall Study|Other complicating disease|1|||
154854794|NCT01524991|558897222|FG000|Overall Study|Withdrawal by Subject|2|||
154854795|NCT01524991|558897222|FG000|Overall Study|Symptomatic Deterioration|1|||
154854796|NCT01805180|558897223|FG000|Lead-in Donor Phase|screen failure|1|||
154854797|NCT01805180|558897224|FG001|Lead-in Donor Phase|screen failure|0|||
154854798|NCT01805180|558897225|FG002|Lead-in Donor Phase|screen failure|0|||
154854799|NCT00206726|558897228|FG000|Overall Study|Delayed recovery of blood counts|1|||
154854800|NCT00206726|558897228|FG000|Overall Study|Progressive disease or relapsed disease|18|||
154854801|NCT00206726|558897228|FG000|Overall Study|Placed on new protocol|1|||
154854802|NCT00206726|558897228|FG000|Overall Study|Bone marrow transplant|1|||
154854803|NCT00206726|558897228|FG000|Overall Study|Adverse Event|17|||
154854804|NCT00206726|558897228|FG000|Overall Study|Death|4|||
154854805|NCT00206726|558897228|FG000|Overall Study|Protocol Violation|1|||
154854806|NCT00206726|558897228|FG000|Overall Study|Withdrawal by Subject|8|||
154854807|NCT01341457|558897231|FG000|Overall Study|Adverse Event|2|||
154854808|NCT01341457|558897232|FG001|Overall Study|Adverse Event|0|||
154854809|NCT00365989|558897233|FG000|Overall Study|Withdrawal by Subject|1|||
154854810|NCT00365989|558897233|FG000|Overall Study|Non-compliance|1|||
154854811|NCT00832819|558897234|FG000|Overall Study|Adverse Event|0|||
154854812|NCT00832819|558897235|FG001|Overall Study|Adverse Event|1|||
154854813|NCT00832819|558897236|FG002|Overall Study|Adverse Event|0|||
154854814|NCT00832819|558897234|FG000|Overall Study|Protocol Violation|0|||
154854815|NCT00832819|558897235|FG001|Overall Study|Protocol Violation|0|||
154854816|NCT00832819|558897236|FG002|Overall Study|Protocol Violation|1|||
154854817|NCT02318095|558897237|FG000|Overall Study|Adverse Event|1|||
154854818|NCT01717638|558897238|FG000|Overall Study|Lost to Follow-up|0|||
154854819|NCT01717638|558897239|FG001|Overall Study|Lost to Follow-up|0|||
154854820|NCT01717638|558897240|FG002|Overall Study|Lost to Follow-up|0|||
154854821|NCT01717638|558897241|FG003|Overall Study|Lost to Follow-up|0|||
154854822|NCT01717638|558897242|FG004|Overall Study|Lost to Follow-up|0|||
154854823|NCT01717638|558897243|FG005|Overall Study|Lost to Follow-up|1|||
154854824|NCT01717638|558897244|FG006|Overall Study|Lost to Follow-up|0|||
154854825|NCT01717638|558897245|FG007|Overall Study|Lost to Follow-up|0|||
154854826|NCT01717638|558897246|FG008|Overall Study|Lost to Follow-up|0|||
154854827|NCT01717638|558897247|FG009|Overall Study|Lost to Follow-up|0|||
154854828|NCT01717638|558897248|FG010|Overall Study|Lost to Follow-up|0|||
154854829|NCT01717638|558897249|FG011|Overall Study|Lost to Follow-up|0|||
154854830|NCT01717638|558897250|FG012|Overall Study|Lost to Follow-up|0|||
154854831|NCT01717638|558897238|FG000|Overall Study|Father in hospital|0|||
154854832|NCT01717638|558897239|FG001|Overall Study|Father in hospital|0|||
154854833|NCT01717638|558897240|FG002|Overall Study|Father in hospital|0|||
154854834|NCT01717638|558897241|FG003|Overall Study|Father in hospital|0|||
154854835|NCT01717638|558897242|FG004|Overall Study|Father in hospital|0|||
154854836|NCT01717638|558897243|FG005|Overall Study|Father in hospital|0|||
154854837|NCT01717638|558897244|FG006|Overall Study|Father in hospital|0|||
154854838|NCT01717638|558897245|FG007|Overall Study|Father in hospital|0|||
154854839|NCT01717638|558897246|FG008|Overall Study|Father in hospital|0|||
154854840|NCT01717638|558897247|FG009|Overall Study|Father in hospital|0|||
154854841|NCT01717638|558897248|FG010|Overall Study|Father in hospital|0|||
154854842|NCT01717638|558897249|FG011|Overall Study|Father in hospital|0|||
154854843|NCT01717638|558897250|FG012|Overall Study|Father in hospital|1|||
154854844|NCT01717638|558897238|FG000|Overall Study|Withdrawal by Subject|0|||
154854845|NCT01717638|558897239|FG001|Overall Study|Withdrawal by Subject|1|||
154854846|NCT01717638|558897240|FG002|Overall Study|Withdrawal by Subject|1|||
154854847|NCT01717638|558897241|FG003|Overall Study|Withdrawal by Subject|0|||
154854848|NCT01717638|558897242|FG004|Overall Study|Withdrawal by Subject|1|||
154854849|NCT01717638|558897243|FG005|Overall Study|Withdrawal by Subject|0|||
154854850|NCT01717638|558897244|FG006|Overall Study|Withdrawal by Subject|2|||
154854851|NCT01717638|558897245|FG007|Overall Study|Withdrawal by Subject|1|||
154854852|NCT01717638|558897246|FG008|Overall Study|Withdrawal by Subject|2|||
154854853|NCT01717638|558897247|FG009|Overall Study|Withdrawal by Subject|1|||
154854854|NCT01717638|558897248|FG010|Overall Study|Withdrawal by Subject|0|||
154854855|NCT01717638|558897249|FG011|Overall Study|Withdrawal by Subject|0|||
154854856|NCT01717638|558897250|FG012|Overall Study|Withdrawal by Subject|18|||
154854857|NCT01061008|558897252|FG000|Overall Study|Badiocephalic fistula failed|3|||
154854858|NCT01061008|558897253|FG001|Overall Study|Badiocephalic fistula failed|2|||
154854859|NCT01061008|558897252|FG000|Overall Study|Death|1|||
154854860|NCT01061008|558897253|FG001|Overall Study|Death|0|||
154854861|NCT01061008|558897252|FG000|Overall Study|Withdrawal by Subject|1|||
154854862|NCT01061008|558897253|FG001|Overall Study|Withdrawal by Subject|3|||
154854863|NCT01061008|558897252|FG000|Overall Study|Unable to exercise following surgery|1|||
154854864|NCT01061008|558897253|FG001|Overall Study|Unable to exercise following surgery|0|||
154854865|NCT01061008|558897252|FG000|Overall Study|Adverse Event|0|||
154854866|NCT01061008|558897253|FG001|Overall Study|Adverse Event|1|||
154854867|NCT04067518|558897255|FG000|Overall Study|Adverse Event|1|||
154854868|NCT04067518|558897256|FG001|Overall Study|Adverse Event|3|||
154854869|NCT04067518|558897255|FG000|Overall Study|Screen failures|0|||
154854870|NCT04067518|558897256|FG001|Overall Study|Screen failures|1|||
154854871|NCT04067518|558897255|FG000|Overall Study|Enrolled but not treated|0|||
154854872|NCT04067518|558897256|FG001|Overall Study|Enrolled but not treated|1|||
154854873|NCT00862251|558897257|FG000|Overall Study|Adverse Event|8|||
154854874|NCT00862251|558897258|FG001|Overall Study|Adverse Event|3|||
154854875|NCT00862251|558897259|FG002|Overall Study|Adverse Event|1|||
154854876|NCT00862251|558897257|FG000|Overall Study|Lost to Follow-up|0|||
154854877|NCT00862251|558897258|FG001|Overall Study|Lost to Follow-up|0|||
154854878|NCT00862251|558897259|FG002|Overall Study|Lost to Follow-up|1|||
154854879|NCT00862251|558897257|FG000|Overall Study|Protocol Violation|2|||
154854880|NCT00862251|558897258|FG001|Overall Study|Protocol Violation|0|||
154854881|NCT00862251|558897259|FG002|Overall Study|Protocol Violation|1|||
154854882|NCT00862251|558897257|FG000|Overall Study|Withdrawal by Subject|9|||
154854883|NCT00862251|558897258|FG001|Overall Study|Withdrawal by Subject|2|||
154854884|NCT00862251|558897259|FG002|Overall Study|Withdrawal by Subject|6|||
154854885|NCT02796755|558897260|FG000|Overall Study|Adverse Event|2|||
154854886|NCT02796755|558897261|FG001|Overall Study|Adverse Event|0|||
154854887|NCT02304926|558897263|FG000|Overall Study|Lost to Follow-up|2|||
154854888|NCT02304926|558897264|FG001|Overall Study|Lost to Follow-up|1|||
154854889|NCT04258579|558897266|FG000|Overall Study|Withdrawal by Subject|7|||
154854890|NCT04258579|558897266|FG000|Overall Study|Lost to Follow-up|3|||
154854891|NCT04258579|558897266|FG000|Overall Study|Protocol Violation|2|||
154854892|NCT04258579|558897266|FG000|Overall Study|Adverse Event|1|||
154854893|NCT04007159|558897267|FG000|Induction Phase|(missed study visits)|16|||
154854894|NCT04007159|558897267|FG000|Induction Phase|Withdrawal by Subject|4|||
154854895|NCT04007159|558897267|FG000|Induction Phase|Adverse Event|2|||
154854896|NCT04007159|558897267|FG000|Challenge Phase|missed study visits|3|||
154854897|NCT02076165|558897269|FG000|Overall Study|Lost to Follow-up|7|||
154854898|NCT02076165|558897270|FG001|Overall Study|Lost to Follow-up|5|||
154854899|NCT02076165|558897269|FG000|Overall Study|Refused follow-up assessment|1|||
154854900|NCT02076165|558897270|FG001|Overall Study|Refused follow-up assessment|1|||
154854901|NCT03804684|558897271|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
154854902|NCT03804684|558897272|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
154854903|NCT03183128|558897274|FG000|Overall Study|Adverse Event|1|||
154854904|NCT03183128|558897275|FG001|Overall Study|Adverse Event|2|||
154854905|NCT03183128|558897274|FG000|Overall Study|Withdrawal by Subject|1|||
154854906|NCT03183128|558897275|FG001|Overall Study|Withdrawal by Subject|8|||
154854907|NCT03183128|558897274|FG000|Overall Study|Protocol Violation|2|||
154854908|NCT03183128|558897275|FG001|Overall Study|Protocol Violation|0|||
154854909|NCT03183128|558897274|FG000|Overall Study|Lack of Efficacy|4|||
154854910|NCT03183128|558897275|FG001|Overall Study|Lack of Efficacy|27|||
154854911|NCT03183128|558897274|FG000|Overall Study|Lost to Follow-up|1|||
154854912|NCT03183128|558897275|FG001|Overall Study|Lost to Follow-up|0|||
154854913|NCT03183128|558897274|FG000|Overall Study|Death|2|||
154854914|NCT03183128|558897275|FG001|Overall Study|Death|0|||
154854915|NCT03183128|558897274|FG000|Overall Study|Physician Decision|1|||
154854916|NCT03183128|558897275|FG001|Overall Study|Physician Decision|0|||
154854917|NCT02266433|558897277|FG000|Overall Study|Lost to Follow-up|54|||
154854918|NCT02266433|558897278|FG001|Overall Study|Lost to Follow-up|46|||
154854919|NCT02266433|558897277|FG000|Overall Study|Withdrawal by Subject|5|||
154854920|NCT02266433|558897278|FG001|Overall Study|Withdrawal by Subject|7|||
154854921|NCT02658812|558897279|FG000|Overall Study|Disease Progression|7|||
154854922|NCT02658812|558897279|FG000|Overall Study|Unrelated to study treatment|1|||
154854923|NCT02658812|558897279|FG000|Overall Study|Adverse Event|1|||
154854924|NCT01512264|558897282|FG000|Overall Study|Lost to Follow-up|0|||
154854925|NCT01512264|558897283|FG001|Overall Study|Lost to Follow-up|0|||
154971785|NCT01320722|559320697|FG001|Overall Study|Lost to Follow-up|1|||
154854926|NCT01512264|558897284|FG002|Overall Study|Lost to Follow-up|0|||
154854927|NCT01512264|558897285|FG003|Overall Study|Lost to Follow-up|1|||
154854928|NCT01194440|558897286|FG000|Baseline (First Dose)|Reason not specified|4|||
154854929|NCT01194440|558897286|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
154854930|NCT01194440|558897286|FG000|Baseline (First Dose)|Change in therapy|1|||
154854931|NCT01194440|558897286|FG000|Baseline (First Dose)|Adverse Event|1|||
154854932|NCT01194440|558897286|FG000|6-months (2nd Dose)|Change in therapy|4|||
154854933|NCT01931059|558897287|FG000|Day 1|Pregnancy|0|||
154854934|NCT01931059|558897288|FG001|Day 1|Pregnancy|1|||
154854935|NCT01931059|558897287|FG000|Day3|Lost to Follow-up|1|||
154971786|NCT01320722|559320698|FG002|Overall Study|Lost to Follow-up|0|||
154971787|NCT01320722|559320699|FG003|Overall Study|Lost to Follow-up|1|||
154971788|NCT01320722|559320700|FG004|Overall Study|Lost to Follow-up|3|||
154971789|NCT01320722|559320696|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
154971790|NCT01320722|559320697|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
154971791|NCT01320722|559320698|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
154971792|NCT01320722|559320699|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
154971793|NCT01320722|559320700|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
154971794|NCT01320722|559320696|FG000|Overall Study|Participant Developed a Rash|0|||
154971795|NCT01320722|559320697|FG001|Overall Study|Participant Developed a Rash|0|||
154971796|NCT01320722|559320698|FG002|Overall Study|Participant Developed a Rash|2|||
154971797|NCT01320722|559320699|FG003|Overall Study|Participant Developed a Rash|1|||
155106025|NCT05396014|559817564|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
155106026|NCT05396014|559817565|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106027|NCT05396014|559817566|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
155106028|NCT05396014|559817567|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
155106029|NCT05396014|559817525|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
154854936|NCT01931059|558897288|FG001|Day3|Lost to Follow-up|0|||
154854937|NCT02675075|558897290|FG000|Overall Study|Lost to Follow-up|3|||
154854938|NCT02675075|558897291|FG001|Overall Study|Lost to Follow-up|0|||
154854939|NCT03686969|558897300|FG000|Overall Study|Study terminated|1|||
154854940|NCT03686969|558897301|FG001|Overall Study|Study terminated|0|||
154854941|NCT01988090|558897306|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
154854942|NCT01988090|558897307|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
154854943|NCT01988090|558897306|FG000|Start Treament After Randomization|Protocol Violation|0|||
154854944|NCT01988090|558897307|FG001|Start Treament After Randomization|Protocol Violation|1|||
154854945|NCT01988090|558897306|FG000|Complete Study After Start|Withdrawal by Subject|2|||
154854946|NCT01988090|558897307|FG001|Complete Study After Start|Withdrawal by Subject|0|||
154854947|NCT01988090|558897306|FG000|Complete Study After Start|Protocol Violation|1|||
154854948|NCT01988090|558897307|FG001|Complete Study After Start|Protocol Violation|1|||
154854949|NCT03887130|558897310|FG000|Overall Study|Progressive disease|23|||
154854950|NCT03887130|558897311|FG001|Overall Study|Progressive disease|14|||
154854951|NCT03887130|558897312|FG002|Overall Study|Progressive disease|7|||
154854952|NCT03887130|558897310|FG000|Overall Study|Protocol Violation|3|||
154854953|NCT03887130|558897311|FG001|Overall Study|Protocol Violation|1|||
154854954|NCT03887130|558897312|FG002|Overall Study|Protocol Violation|2|||
154854955|NCT03887130|558897310|FG000|Overall Study|Drug related toxicity|7|||
154854956|NCT03887130|558897311|FG001|Overall Study|Drug related toxicity|7|||
154854957|NCT03887130|558897312|FG002|Overall Study|Drug related toxicity|13|||
154854958|NCT03887130|558897310|FG000|Overall Study|Non drug related toxicity|3|||
154854959|NCT03887130|558897311|FG001|Overall Study|Non drug related toxicity|0|||
154854960|NCT03887130|558897312|FG002|Overall Study|Non drug related toxicity|0|||
154854961|NCT03887130|558897310|FG000|Overall Study|Death|2|||
154854962|NCT03887130|558897311|FG001|Overall Study|Death|2|||
154854963|NCT03887130|558897312|FG002|Overall Study|Death|1|||
154854964|NCT03887130|558897310|FG000|Overall Study|Withdrawal by Subject|7|||
154854965|NCT03887130|558897311|FG001|Overall Study|Withdrawal by Subject|6|||
154854966|NCT03887130|558897312|FG002|Overall Study|Withdrawal by Subject|11|||
154854967|NCT03887130|558897310|FG000|Overall Study|other reason|6|||
154854968|NCT03887130|558897311|FG001|Overall Study|other reason|20|||
154854969|NCT03887130|558897312|FG002|Overall Study|other reason|17|||
154854970|NCT00927563|558897313|FG000|Overall Study|Lost to Follow-up|1|||
154854971|NCT00927563|558897313|FG000|Overall Study|Withdrawal by Subject|1|||
154854972|NCT02497001|558897316|FG000|Overall Study|Lost to Follow-up|10|||
154854973|NCT02497001|558897317|FG001|Overall Study|Lost to Follow-up|2|||
154854974|NCT02497001|558897318|FG002|Overall Study|Lost to Follow-up|0|||
154854975|NCT02497001|558897319|FG003|Overall Study|Lost to Follow-up|2|||
154854976|NCT02497001|558897316|FG000|Overall Study|Adverse Event|28|||
154854977|NCT02497001|558897317|FG001|Overall Study|Adverse Event|30|||
154854978|NCT02497001|558897318|FG002|Overall Study|Adverse Event|11|||
154854979|NCT02497001|558897319|FG003|Overall Study|Adverse Event|11|||
154971798|NCT01320722|559320700|FG004|Overall Study|Participant Developed a Rash|1|||
154971799|NCT01320722|559320696|FG000|Overall Study|Non-compliant with Medication|0|||
154971800|NCT01320722|559320697|FG001|Overall Study|Non-compliant with Medication|0|||
154971801|NCT01320722|559320698|FG002|Overall Study|Non-compliant with Medication|1|||
154971802|NCT01320722|559320699|FG003|Overall Study|Non-compliant with Medication|0|||
154854980|NCT02497001|558897316|FG000|Overall Study|Withdrawal by Subject|14|||
154854981|NCT02497001|558897317|FG001|Overall Study|Withdrawal by Subject|37|||
154854982|NCT02497001|558897318|FG002|Overall Study|Withdrawal by Subject|19|||
154854983|NCT02497001|558897319|FG003|Overall Study|Withdrawal by Subject|15|||
154854984|NCT02497001|558897316|FG000|Overall Study|Physician Decision|5|||
154854985|NCT02497001|558897317|FG001|Overall Study|Physician Decision|11|||
154854986|NCT02497001|558897318|FG002|Overall Study|Physician Decision|5|||
154854987|NCT02497001|558897319|FG003|Overall Study|Physician Decision|1|||
154854988|NCT02497001|558897316|FG000|Overall Study|subjects that were not treated|1|||
154854989|NCT02497001|558897317|FG001|Overall Study|subjects that were not treated|2|||
154854990|NCT02497001|558897318|FG002|Overall Study|subjects that were not treated|2|||
154854991|NCT02497001|558897319|FG003|Overall Study|subjects that were not treated|1|||
154854992|NCT02497001|558897316|FG000|Overall Study|Major Protocol Deviation|3|||
154854993|NCT02497001|558897317|FG001|Overall Study|Major Protocol Deviation|4|||
154854994|NCT02497001|558897318|FG002|Overall Study|Major Protocol Deviation|4|||
154854995|NCT02497001|558897319|FG003|Overall Study|Major Protocol Deviation|4|||
154854996|NCT02497001|558897316|FG000|Overall Study|Lack of Efficacy|10|||
154854997|NCT02497001|558897317|FG001|Overall Study|Lack of Efficacy|16|||
154854998|NCT02497001|558897318|FG002|Overall Study|Lack of Efficacy|6|||
154854999|NCT02497001|558897319|FG003|Overall Study|Lack of Efficacy|6|||
154855000|NCT02497001|558897316|FG000|Overall Study|Protocol Violation|3|||
154855001|NCT02497001|558897317|FG001|Overall Study|Protocol Violation|1|||
155106030|NCT05396014|559817526|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106031|NCT05396014|559817527|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106032|NCT05396014|559817528|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106033|NCT05396014|559817529|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106034|NCT05396014|559817530|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106035|NCT05396014|559817531|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
154855002|NCT02497001|558897318|FG002|Overall Study|Protocol Violation|3|||
154855003|NCT02497001|558897319|FG003|Overall Study|Protocol Violation|1|||
154855004|NCT00654498|558897322|FG000|Overall Study|Not Treated|1|||
154855005|NCT00654498|558897323|FG001|Overall Study|Not Treated|0|||
154855006|NCT00654498|558897322|FG000|Overall Study|Adverse Event|6|||
154855007|NCT00654498|558897323|FG001|Overall Study|Adverse Event|1|||
154855008|NCT00654498|558897322|FG000|Overall Study|Protocol Violation|1|||
154855009|NCT00654498|558897323|FG001|Overall Study|Protocol Violation|1|||
154855010|NCT00654498|558897322|FG000|Overall Study|Lost to Follow-up|1|||
154855011|NCT00654498|558897323|FG001|Overall Study|Lost to Follow-up|5|||
154855012|NCT00654498|558897322|FG000|Overall Study|Withdrawal by Subject|1|||
154855013|NCT00654498|558897323|FG001|Overall Study|Withdrawal by Subject|0|||
154855014|NCT00654498|558897322|FG000|Overall Study|Other reason not defined above|4|||
154855015|NCT00654498|558897323|FG001|Overall Study|Other reason not defined above|5|||
154855016|NCT03430986|558897325|FG000|24-week Control Period|Adverse Event|1|||
154855017|NCT03430986|558897326|FG001|24-week Control Period|Adverse Event|0|||
154855018|NCT03430986|558897325|FG000|24-week Control Period|Lost to Follow-up|2|||
154855019|NCT03430986|558897326|FG001|24-week Control Period|Lost to Follow-up|2|||
154855020|NCT03430986|558897325|FG000|24-week Control Period|Withdrawal by Participant|5|||
154855021|NCT03430986|558897326|FG001|24-week Control Period|Withdrawal by Participant|0|||
154855022|NCT03430986|558897325|FG000|24-week Control Period|Protocol Deviation|0|||
154855023|NCT03430986|558897326|FG001|24-week Control Period|Protocol Deviation|2|||
154855024|NCT03430986|558897325|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
154855025|NCT03430986|558897326|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
154855026|NCT03430986|558897325|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
154855027|NCT03430986|558897326|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
154855028|NCT01412957|558897328|FG000|Overall Study|Withdrawal by Subject|6|||
154855029|NCT01412957|558897329|FG001|Overall Study|Withdrawal by Subject|22|||
154855030|NCT01412957|558897328|FG000|Overall Study|Lost to Follow-up|7|||
154855031|NCT01412957|558897329|FG001|Overall Study|Lost to Follow-up|2|||
154855032|NCT01412957|558897328|FG000|Overall Study|Death|136|||
154855033|NCT01412957|558897329|FG001|Overall Study|Death|133|||
154855034|NCT01245673|558897330|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
154855035|NCT04722991|558897339|FG000|Overall Study|Adverse Event|12|||
154855036|NCT04722991|558897340|FG001|Overall Study|Adverse Event|4|||
154855037|NCT04722991|558897339|FG000|Overall Study|Death|2|||
154855038|NCT04722991|558897340|FG001|Overall Study|Death|0|||
154855039|NCT04722991|558897339|FG000|Overall Study|Lost to Follow-up|1|||
154855040|NCT04722991|558897340|FG001|Overall Study|Lost to Follow-up|1|||
154855041|NCT04722991|558897339|FG000|Overall Study|Withdrawal cirterion met|2|||
154855042|NCT04722991|558897340|FG001|Overall Study|Withdrawal cirterion met|2|||
154855043|NCT04722991|558897339|FG000|Overall Study|Other|1|||
154855044|NCT04722991|558897340|FG001|Overall Study|Other|0|||
154855045|NCT04722991|558897339|FG000|Overall Study|Non-compliance|0|||
154855046|NCT04722991|558897340|FG001|Overall Study|Non-compliance|1|||
154855047|NCT04722991|558897339|FG000|Overall Study|Withdrawal by Subject|0|||
154855048|NCT04722991|558897340|FG001|Overall Study|Withdrawal by Subject|1|||
154855049|NCT01445678|558897344|FG000|Overall Study|Adverse Event|12|||
154855050|NCT01445678|558897345|FG001|Overall Study|Adverse Event|8|||
154855051|NCT01445678|558897344|FG000|Overall Study|Lack of Efficacy|0|||
154855052|NCT01445678|558897345|FG001|Overall Study|Lack of Efficacy|2|||
154855053|NCT01445678|558897344|FG000|Overall Study|Lost to Follow-up|8|||
154855054|NCT01445678|558897345|FG001|Overall Study|Lost to Follow-up|5|||
154855055|NCT01445678|558897344|FG000|Overall Study|Protocol Violation|1|||
154855056|NCT01445678|558897345|FG001|Overall Study|Protocol Violation|1|||
154855057|NCT01445678|558897344|FG000|Overall Study|Withdrawal by Subject|9|||
154855058|NCT01445678|558897345|FG001|Overall Study|Withdrawal by Subject|5|||
154855059|NCT01459614|558897348|FG000|Overall Study|Adverse Event|1|||
154855060|NCT01459614|558897349|FG001|Overall Study|Adverse Event|0|||
154855061|NCT00630331|558897353|FG000|Overall Study|Death|2|||
154855062|NCT00630331|558897354|FG001|Overall Study|Death|1|||
154855063|NCT00630331|558897355|FG002|Overall Study|Death|1|||
154855064|NCT00630331|558897353|FG000|Overall Study|Adverse Event|1|||
154855065|NCT00630331|558897354|FG001|Overall Study|Adverse Event|0|||
154855066|NCT00630331|558897355|FG002|Overall Study|Adverse Event|0|||
154855067|NCT00630331|558897353|FG000|Overall Study|Withdrawal by Subject|12|||
154855068|NCT00630331|558897354|FG001|Overall Study|Withdrawal by Subject|7|||
154855069|NCT00630331|558897355|FG002|Overall Study|Withdrawal by Subject|5|||
154855070|NCT00630331|558897353|FG000|Overall Study|Lost to Follow-up|175|||
154855071|NCT00630331|558897354|FG001|Overall Study|Lost to Follow-up|143|||
154855072|NCT00630331|558897355|FG002|Overall Study|Lost to Follow-up|170|||
154855073|NCT00630331|558897353|FG000|Overall Study|Inappropriate enrollment|3|||
154855074|NCT00630331|558897354|FG001|Overall Study|Inappropriate enrollment|6|||
154855075|NCT00630331|558897355|FG002|Overall Study|Inappropriate enrollment|3|||
154855076|NCT00630331|558897353|FG000|Overall Study|Unable to classify|9|||
154855077|NCT00630331|558897354|FG001|Overall Study|Unable to classify|4|||
154855078|NCT00630331|558897355|FG002|Overall Study|Unable to classify|3|||
154855079|NCT00630331|558897353|FG000|Overall Study|Protocol Violation|4|||
154855080|NCT00630331|558897354|FG001|Overall Study|Protocol Violation|5|||
154855081|NCT00630331|558897355|FG002|Overall Study|Protocol Violation|6|||
154855082|NCT01929135|558897362|FG000|Overall Study|Lost to Follow-up|1|||
154855083|NCT01929135|558897363|FG001|Overall Study|Lost to Follow-up|1|||
154855084|NCT02425098|558897364|FG000|Overall Study|Lost to Follow-up|7|||
154855085|NCT02425098|558897365|FG001|Overall Study|Lost to Follow-up|7|||
154855086|NCT02425098|558897364|FG000|Overall Study|Withdrawal by Subject|4|||
154855087|NCT02425098|558897365|FG001|Overall Study|Withdrawal by Subject|8|||
154855088|NCT02425098|558897364|FG000|Overall Study|Pregnancy|2|||
154855089|NCT02425098|558897365|FG001|Overall Study|Pregnancy|0|||
154855090|NCT02425098|558897364|FG000|Overall Study|Reason not Specified|0|||
154855091|NCT02425098|558897365|FG001|Overall Study|Reason not Specified|1|||
154855092|NCT02078219|558897366|FG000|Overall Study|Other|2|||
154855093|NCT02078219|558897367|FG001|Overall Study|Other|2|||
154855094|NCT02078219|558897368|FG002|Overall Study|Other|3|||
154855095|NCT02078219|558897369|FG003|Overall Study|Other|0|||
154855096|NCT02078219|558897370|FG004|Overall Study|Other|1|||
154855097|NCT02078219|558897366|FG000|Overall Study|Withdrawal by Subject|0|||
154855098|NCT02078219|558897367|FG001|Overall Study|Withdrawal by Subject|1|||
154855099|NCT02078219|558897368|FG002|Overall Study|Withdrawal by Subject|0|||
154855100|NCT02078219|558897369|FG003|Overall Study|Withdrawal by Subject|1|||
154855101|NCT02078219|558897370|FG004|Overall Study|Withdrawal by Subject|1|||
154855102|NCT02078219|558897366|FG000|Overall Study|Protocol Violation|0|||
154855103|NCT02078219|558897367|FG001|Overall Study|Protocol Violation|0|||
154855104|NCT02078219|558897368|FG002|Overall Study|Protocol Violation|0|||
154855105|NCT02078219|558897369|FG003|Overall Study|Protocol Violation|1|||
154855106|NCT02078219|558897370|FG004|Overall Study|Protocol Violation|0|||
154855107|NCT02078219|558897366|FG000|Overall Study|Death|0|||
154855108|NCT02078219|558897367|FG001|Overall Study|Death|0|||
154855109|NCT02078219|558897368|FG002|Overall Study|Death|0|||
154855110|NCT02078219|558897369|FG003|Overall Study|Death|1|||
154855111|NCT02078219|558897370|FG004|Overall Study|Death|0|||
154855112|NCT02078219|558897366|FG000|Overall Study|Adverse Event|1|||
154855113|NCT02078219|558897367|FG001|Overall Study|Adverse Event|1|||
154855114|NCT02078219|558897368|FG002|Overall Study|Adverse Event|3|||
154855115|NCT02078219|558897369|FG003|Overall Study|Adverse Event|1|||
154855116|NCT02078219|558897370|FG004|Overall Study|Adverse Event|0|||
154855117|NCT03641560|558897371|FG000|Overall Study|Withdrawal by Subject|6|||
154855118|NCT03641560|558897371|FG000|Overall Study|Progressive disease|40|||
154855119|NCT03641560|558897371|FG000|Overall Study|Death|6|||
154855120|NCT04439279|558899030|FG000|Overall Study|Adverse Event|7|||
154855121|NCT04439279|558899030|FG000|Overall Study|Death|4|||
154855122|NCT04439279|558899030|FG000|Overall Study|Disease progression|17|||
154855123|NCT04439279|558899030|FG000|Overall Study|Complicating disease|3|||
154855124|NCT04439279|558899030|FG000|Overall Study|Withdrawal by Subject|2|||
154855125|NCT04439279|558899030|FG000|Overall Study|Ineligible|1|||
154855126|NCT04439279|558899030|FG000|Overall Study|Treatment still ongoing|1|||
154855127|NCT02689492|558899031|FG000|Overall Study|Lost to Follow-up|61|||
154855128|NCT02689492|558899031|FG000|Overall Study|Withdrawal by Subject|11|||
154855129|NCT02689492|558899031|FG000|Overall Study|Death|9|||
154855130|NCT02689492|558899031|FG000|Overall Study|Physician Decision|2|||
154855131|NCT02689492|558899031|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
154855132|NCT02689492|558899031|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
154855133|NCT02689492|558899031|FG000|Overall Study|Other than listed|1|||
154855134|NCT02732951|558899032|FG000|Overall Study|Other than listed|1|||
154855135|NCT02732951|558899033|FG001|Overall Study|Other than listed|0|||
154855136|NCT02732951|558899032|FG000|Overall Study|Lost to Follow-up|0|||
154855137|NCT02732951|558899033|FG001|Overall Study|Lost to Follow-up|1|||
154855138|NCT02732951|558899032|FG000|Overall Study|Adverse Event|4|||
154855139|NCT02732951|558899033|FG001|Overall Study|Adverse Event|4|||
154855140|NCT02732951|558899032|FG000|Overall Study|Protocol Violation|0|||
154855141|NCT02732951|558899033|FG001|Overall Study|Protocol Violation|1|||
154855142|NCT01750918|558899034|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
154855143|NCT01750918|558899035|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
154855144|NCT01750918|558899036|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
154855145|NCT01750918|558899037|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
154855146|NCT01750918|558899038|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
154855147|NCT01750918|558899039|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
154855148|NCT01750918|558899040|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
154855149|NCT01750918|558899041|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
154855150|NCT01750918|558899034|FG000|Overall Study|Lost to Follow-up|0|||
154855151|NCT01750918|558899035|FG001|Overall Study|Lost to Follow-up|0|||
154855152|NCT01750918|558899036|FG002|Overall Study|Lost to Follow-up|2|||
154855153|NCT01750918|558899037|FG003|Overall Study|Lost to Follow-up|2|||
154855154|NCT01750918|558899038|FG004|Overall Study|Lost to Follow-up|0|||
154855155|NCT01750918|558899039|FG005|Overall Study|Lost to Follow-up|0|||
154855156|NCT01750918|558899040|FG006|Overall Study|Lost to Follow-up|0|||
154855157|NCT01750918|558899041|FG007|Overall Study|Lost to Follow-up|1|||
154855158|NCT01750918|558899034|FG000|Overall Study|Withdrawal by Subject|0|||
154855159|NCT01750918|558899035|FG001|Overall Study|Withdrawal by Subject|0|||
154855160|NCT01750918|558899036|FG002|Overall Study|Withdrawal by Subject|1|||
154855161|NCT01750918|558899037|FG003|Overall Study|Withdrawal by Subject|2|||
154855162|NCT01750918|558899038|FG004|Overall Study|Withdrawal by Subject|1|||
154855163|NCT01750918|558899039|FG005|Overall Study|Withdrawal by Subject|1|||
154855164|NCT01750918|558899040|FG006|Overall Study|Withdrawal by Subject|2|||
154855165|NCT01750918|558899041|FG007|Overall Study|Withdrawal by Subject|2|||
154855166|NCT02031679|558899044|FG000|Overall Study|Protocol Violation|0|||
154855167|NCT02031679|558899045|FG001|Overall Study|Protocol Violation|1|||
154855168|NCT02031679|558899044|FG000|Overall Study|Lack of Efficacy|0|||
154855169|NCT02031679|558899045|FG001|Overall Study|Lack of Efficacy|1|||
154855170|NCT02338843|558899047|FG000|Overall Study|Adverse Event|2|||
154855171|NCT02338843|558899048|FG001|Overall Study|Adverse Event|1|||
154855172|NCT02338843|558899047|FG000|Overall Study|Death|40|||
154855173|NCT02338843|558899048|FG001|Overall Study|Death|53|||
154855174|NCT02338843|558899047|FG000|Overall Study|Physician Decision|1|||
154855175|NCT02338843|558899048|FG001|Overall Study|Physician Decision|0|||
154855176|NCT02338843|558899047|FG000|Overall Study|Withdrawal by Subject|0|||
154855177|NCT02338843|558899048|FG001|Overall Study|Withdrawal by Subject|2|||
154855178|NCT02338843|558899047|FG000|Overall Study|Subject Recovered|0|||
154855179|NCT02338843|558899048|FG001|Overall Study|Subject Recovered|2|||
154855180|NCT02338843|558899047|FG000|Overall Study|Discontinued prior to randomizat|1|||
154855181|NCT02338843|558899048|FG001|Overall Study|Discontinued prior to randomizat|0|||
154855182|NCT00110305|558899053|FG000|Overall Study|Adverse Event|46|||
154855183|NCT00110305|558899054|FG001|Overall Study|Adverse Event|13|||
154855184|NCT00110305|558899053|FG000|Overall Study|Sponsors Decision|1|||
154855185|NCT00110305|558899054|FG001|Overall Study|Sponsors Decision|0|||
154855186|NCT00110305|558899053|FG000|Overall Study|Subject Non-Compliant|9|||
154855187|NCT00110305|558899054|FG001|Overall Study|Subject Non-Compliant|2|||
154855188|NCT00110305|558899053|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
154855189|NCT00110305|558899054|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
154855190|NCT00110305|558899053|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
154855191|NCT00110305|558899054|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
154855192|NCT00110305|558899053|FG000|Overall Study|Protocol Violation|0|||
154855193|NCT00110305|558899054|FG001|Overall Study|Protocol Violation|1|||
154855194|NCT00110305|558899053|FG000|Overall Study|Withdrawal by Subject|7|||
154855195|NCT00110305|558899054|FG001|Overall Study|Withdrawal by Subject|7|||
154855196|NCT00110305|558899053|FG000|Overall Study|Lost to Follow-up|20|||
154855197|NCT00110305|558899054|FG001|Overall Study|Lost to Follow-up|3|||
154855198|NCT00110305|558899053|FG000|Overall Study|Other|8|||
154971803|NCT01320722|559320700|FG004|Overall Study|Non-compliant with Medication|0|||
155106036|NCT05396014|559817532|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106037|NCT05396014|559817533|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106038|NCT05396014|559817534|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106039|NCT05396014|559817535|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106040|NCT05396014|559817536|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
154855199|NCT00110305|558899054|FG001|Overall Study|Other|2|||
154855200|NCT05047523|558899062|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
154855201|NCT05047523|558899063|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
154855202|NCT05047523|558899064|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
154855203|NCT05047523|558899065|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
154855204|NCT05047523|558899066|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
154855205|NCT05047523|558899067|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
154971804|NCT01320722|559320696|FG000|Overall Study|Adverse Event|0|||
155106041|NCT05396014|559817537|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
154855206|NCT05047523|558899062|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154855207|NCT05047523|558899063|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
154855208|NCT05047523|558899064|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154855209|NCT05047523|558899065|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154855210|NCT05047523|558899066|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154855211|NCT05047523|558899067|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
154855212|NCT05047523|558899062|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
154855213|NCT05047523|558899063|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
154855214|NCT05047523|558899064|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
154855215|NCT05047523|558899065|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
154855216|NCT05047523|558899066|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
154855217|NCT05047523|558899067|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
154855218|NCT05047523|558899062|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
154855219|NCT05047523|558899063|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154855220|NCT05047523|558899064|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154855221|NCT05047523|558899065|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154855222|NCT05047523|558899066|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154855223|NCT05047523|558899067|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
154855224|NCT05047523|558899062|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
154855225|NCT05047523|558899063|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
154855226|NCT05047523|558899064|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
154855227|NCT05047523|558899065|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
154855228|NCT05047523|558899066|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
154855229|NCT05047523|558899067|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
154855230|NCT05047523|558899062|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
154855231|NCT05047523|558899063|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
154855232|NCT05047523|558899064|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
154855233|NCT05047523|558899065|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
154855234|NCT05047523|558899066|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
154855235|NCT05047523|558899067|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
154855236|NCT00224016|558899068|FG000|Titration Period|Withdrawal by Subject|0|||
154855237|NCT00224016|558899069|FG001|Titration Period|Withdrawal by Subject|1|||
154855238|NCT00224016|558899068|FG000|Titration Period|Lost to Follow-up|1|||
154855239|NCT00224016|558899069|FG001|Titration Period|Lost to Follow-up|0|||
154855240|NCT00224016|558899068|FG000|Maintenance Period|Withdrawal by Subject|2|||
154855241|NCT00224016|558899069|FG001|Maintenance Period|Withdrawal by Subject|0|||
154971805|NCT01320722|559320697|FG001|Overall Study|Adverse Event|0|||
154971806|NCT01320722|559320698|FG002|Overall Study|Adverse Event|3|||
154971807|NCT01320722|559320699|FG003|Overall Study|Adverse Event|6|||
154971808|NCT01320722|559320700|FG004|Overall Study|Adverse Event|0|||
154971809|NCT01320722|559320696|FG000|Overall Study|Not Compliant with Study Procedures|0|||
154971810|NCT01320722|559320697|FG001|Overall Study|Not Compliant with Study Procedures|0|||
154971811|NCT01320722|559320698|FG002|Overall Study|Not Compliant with Study Procedures|0|||
154971812|NCT01320722|559320699|FG003|Overall Study|Not Compliant with Study Procedures|4|||
154971813|NCT01320722|559320700|FG004|Overall Study|Not Compliant with Study Procedures|0|||
154971814|NCT01320722|559320696|FG000|Overall Study|Pregnancy|0|||
154971815|NCT01320722|559320697|FG001|Overall Study|Pregnancy|0|||
154971816|NCT01320722|559320698|FG002|Overall Study|Pregnancy|0|||
154971817|NCT01320722|559320699|FG003|Overall Study|Pregnancy|1|||
154971818|NCT01320722|559320700|FG004|Overall Study|Pregnancy|0|||
154971819|NCT01320722|559320696|FG000|Overall Study|Started an Exclusionary Medication|0|||
154971820|NCT01320722|559320697|FG001|Overall Study|Started an Exclusionary Medication|0|||
154971821|NCT01320722|559320698|FG002|Overall Study|Started an Exclusionary Medication|0|||
154971822|NCT01320722|559320699|FG003|Overall Study|Started an Exclusionary Medication|0|||
154971823|NCT01320722|559320700|FG004|Overall Study|Started an Exclusionary Medication|1|||
154971824|NCT01320722|559320696|FG000|Overall Study|Withdrew due to Health Condition|0|||
154971825|NCT01320722|559320697|FG001|Overall Study|Withdrew due to Health Condition|0|||
154971826|NCT01320722|559320698|FG002|Overall Study|Withdrew due to Health Condition|0|||
154971827|NCT01320722|559320699|FG003|Overall Study|Withdrew due to Health Condition|0|||
154971828|NCT01320722|559320700|FG004|Overall Study|Withdrew due to Health Condition|1|||
154971829|NCT03980522|559320701|FG000|Treatment Period|Adverse Event|1|||
154971830|NCT03980522|559320702|FG001|Treatment Period|Adverse Event|0|||
154971831|NCT03980522|559320703|FG002|Treatment Period|Adverse Event|0|||
154855242|NCT00224016|558899068|FG000|Maintenance Period|Lost to Follow-up|0|||
154855243|NCT00224016|558899069|FG001|Maintenance Period|Lost to Follow-up|1|||
154855244|NCT00582556|558899072|FG000|Overall Study|Withdrawal by Subject|0|||
154855245|NCT00582556|558899073|FG001|Overall Study|Withdrawal by Subject|1|||
154971832|NCT03980522|559320704|FG003|Treatment Period|Adverse Event|0|||
154971833|NCT03980522|559320705|FG004|Treatment Period|Adverse Event|0|||
154971834|NCT01091363|559320706|FG000|Overall Study|Withdrawal by Subject|11|||
154971835|NCT01091363|559320707|FG001|Overall Study|Withdrawal by Subject|15|||
155106042|NCT05396014|559817538|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155106043|NCT05396014|559817539|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106044|NCT05396014|559817540|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106045|NCT05396014|559817541|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106046|NCT05396014|559817542|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106047|NCT05396014|559817543|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106048|NCT05396014|559817544|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106049|NCT05396014|559817545|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106050|NCT05396014|559817546|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106051|NCT05396014|559817547|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106052|NCT05396014|559817548|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106053|NCT05396014|559817549|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106054|NCT05396014|559817550|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106055|NCT05396014|559817551|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155106056|NCT05396014|559817552|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106057|NCT05396014|559817553|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106058|NCT05396014|559817554|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106059|NCT05396014|559817555|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106060|NCT05396014|559817556|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106061|NCT05396014|559817557|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106062|NCT05396014|559817558|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106063|NCT05396014|559817559|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155106064|NCT05396014|559817560|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106065|NCT05396014|559817561|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106066|NCT05396014|559817562|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106067|NCT05396014|559817563|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106068|NCT05396014|559817564|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106069|NCT05396014|559817565|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106070|NCT05396014|559817566|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
155106071|NCT05396014|559817567|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
155106072|NCT05396014|559817525|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106073|NCT05396014|559817526|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106074|NCT05396014|559817527|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106075|NCT05396014|559817528|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106076|NCT05396014|559817529|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106077|NCT05396014|559817530|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106078|NCT05396014|559817531|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106079|NCT05396014|559817532|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106080|NCT05396014|559817533|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106081|NCT05396014|559817534|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106082|NCT05396014|559817535|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106083|NCT05396014|559817536|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106084|NCT05396014|559817537|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106085|NCT05396014|559817538|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106086|NCT05396014|559817539|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106087|NCT05396014|559817540|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106088|NCT05396014|559817541|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106089|NCT05396014|559817542|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106090|NCT05396014|559817543|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106091|NCT05396014|559817544|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106092|NCT05396014|559817545|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106093|NCT05396014|559817546|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106094|NCT05396014|559817547|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106095|NCT05396014|559817548|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106096|NCT05396014|559817549|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106097|NCT05396014|559817550|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106098|NCT05396014|559817551|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
155106099|NCT05396014|559817552|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106100|NCT05396014|559817553|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106101|NCT05396014|559817554|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106102|NCT05396014|559817555|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106103|NCT05396014|559817556|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106104|NCT05396014|559817557|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106105|NCT05396014|559817558|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106106|NCT05396014|559817559|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106107|NCT05396014|559817560|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106108|NCT05396014|559817561|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106109|NCT05396014|559817562|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106110|NCT05396014|559817563|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106111|NCT05396014|559817564|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106112|NCT05396014|559817565|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106113|NCT05396014|559817566|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106114|NCT05396014|559817567|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
155106115|NCT04439539|559817568|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
155106116|NCT04439539|559817569|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
155106117|NCT04439539|559817570|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
155106118|NCT04439539|559817568|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
155106119|NCT04439539|559817569|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
154855246|NCT00582556|558899074|FG002|Overall Study|Withdrawal by Subject|1|||
154855247|NCT00582556|558899072|FG000|Overall Study|Physician Decision|0|||
154855248|NCT00582556|558899073|FG001|Overall Study|Physician Decision|0|||
154855249|NCT00582556|558899074|FG002|Overall Study|Physician Decision|1|||
154855250|NCT01993888|558899075|FG000|Overall Study|Death|1|||
154855251|NCT01993888|558899076|FG001|Overall Study|Death|1|||
154855252|NCT01993888|558899075|FG000|Overall Study|Lost to Follow-up|1|||
154855253|NCT01993888|558899076|FG001|Overall Study|Lost to Follow-up|1|||
154855254|NCT01993888|558899075|FG000|Overall Study|Withdrawal by Subject|0|||
154855255|NCT01993888|558899076|FG001|Overall Study|Withdrawal by Subject|1|||
154855256|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
154855257|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
154855258|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
154855259|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
154855260|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
154855261|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
154855262|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
154855263|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
154855264|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
154855265|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
154855266|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
154855267|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
154855268|NCT02747927|558899080|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
154855269|NCT02747927|558899081|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
154855270|NCT02747927|558899080|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
154855271|NCT02747927|558899081|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
154855272|NCT02747927|558899080|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
154855273|NCT02747927|558899081|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
154855274|NCT02747927|558899080|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
154855275|NCT02747927|558899081|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
154855276|NCT02747927|558899080|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
154855277|NCT02747927|558899081|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
154855278|NCT02747927|558899080|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
154855279|NCT02747927|558899081|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
154855280|NCT02747927|558899080|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
154855281|NCT02747927|558899081|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
154855282|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
154855283|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
154855284|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
154855285|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
154855286|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
154855287|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
154855288|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
154855289|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
154855290|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
154855291|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
154855292|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
154855293|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
154855294|NCT02747927|558899080|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
154855295|NCT02747927|558899081|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
154855296|NCT02747927|558899080|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
154855297|NCT02747927|558899081|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
154855298|NCT02747927|558899080|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
154855299|NCT02747927|558899081|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
154855300|NCT02747927|558899080|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
155106120|NCT04439539|559817570|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
155106121|NCT04439539|559817568|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
155106122|NCT04439539|559817569|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
155106123|NCT04439539|559817570|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
155106124|NCT05258890|559817572|FG000|Overall Study|Patient withdrawal|6|||
155106125|NCT05258890|559817573|FG001|Overall Study|Patient withdrawal|7|||
155106126|NCT05258890|559817572|FG000|Overall Study|Patient lost to follow-up|10|||
155106127|NCT05258890|559817573|FG001|Overall Study|Patient lost to follow-up|3|||
155106128|NCT05258890|559817572|FG000|Overall Study|Social network member withdrawal|1|||
154855301|NCT02747927|558899081|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
154855302|NCT02747927|558899080|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
154855303|NCT02747927|558899081|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
154855304|NCT02747927|558899080|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
154855305|NCT02747927|558899081|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
154855306|NCT02747927|558899080|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
154855307|NCT02747927|558899081|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
154855308|NCT02747927|558899080|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
154855309|NCT02747927|558899081|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
154855310|NCT02747927|558899080|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
154855311|NCT02747927|558899081|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
154855312|NCT02747927|558899080|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
154855313|NCT02747927|558899081|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
154855314|NCT02747927|558899080|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
154855315|NCT02747927|558899081|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
154855316|NCT02747927|558899080|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
154855317|NCT02747927|558899081|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
154855318|NCT02747927|558899080|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
154855319|NCT02747927|558899081|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
154855320|NCT00522392|558899085|FG000|Overall Study|Disease progression|0|||
154855321|NCT00522392|558899086|FG001|Overall Study|Disease progression|3|||
154855322|NCT00522392|558899085|FG000|Overall Study|Adverse Event|7|||
154855323|NCT00522392|558899086|FG001|Overall Study|Adverse Event|7|||
154855324|NCT00522392|558899085|FG000|Overall Study|Withdrawal by Subject|1|||
154855325|NCT00522392|558899086|FG001|Overall Study|Withdrawal by Subject|1|||
154855326|NCT00522392|558899085|FG000|Overall Study|Physician Decision|0|||
154855327|NCT00522392|558899086|FG001|Overall Study|Physician Decision|1|||
154855328|NCT00522392|558899085|FG000|Overall Study|Non-compliance|0|||
154855329|NCT00522392|558899086|FG001|Overall Study|Non-compliance|1|||
154855330|NCT00430755|558899089|FG000|Overall Study|Withdrawal by Subject|53|||
154855331|NCT01409928|558899090|FG000|Overall Study|Physician Decision|12|||
154855332|NCT00988247|558899091|FG000|Overall Study|Adverse Event|17|||
154855333|NCT00988247|558899092|FG001|Overall Study|Adverse Event|3|||
154855334|NCT00988247|558899091|FG000|Overall Study|Withdrawal by Subject|44|||
154855335|NCT00988247|558899092|FG001|Overall Study|Withdrawal by Subject|13|||
154855336|NCT00988247|558899091|FG000|Overall Study|Pregnancy|1|||
154855337|NCT00988247|558899092|FG001|Overall Study|Pregnancy|2|||
154855338|NCT00988247|558899091|FG000|Overall Study|Lost to Follow-up|11|||
154855339|NCT00988247|558899092|FG001|Overall Study|Lost to Follow-up|2|||
154855340|NCT00988247|558899091|FG000|Overall Study|Protocol Violation|4|||
154855341|NCT00988247|558899092|FG001|Overall Study|Protocol Violation|5|||
154855342|NCT00988247|558899091|FG000|Overall Study|Sponsor requested withdrawal|3|||
154855343|NCT00988247|558899092|FG001|Overall Study|Sponsor requested withdrawal|1|||
154855344|NCT00988247|558899091|FG000|Overall Study|Other|3|||
154855345|NCT00988247|558899092|FG001|Overall Study|Other|0|||
154855346|NCT01354132|558899093|FG000|Randomization|Physician Decision|1|||
154855347|NCT01354132|558899094|FG001|Randomization|Physician Decision|0|||
154855348|NCT01354132|558899093|FG000|Randomization|Withdrawal by Subject|0|||
154855349|NCT01354132|558899094|FG001|Randomization|Withdrawal by Subject|1|||
154855350|NCT01354132|558899093|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
154855351|NCT01354132|558899094|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
154855352|NCT01354132|558899093|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
154855353|NCT01354132|558899094|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
154855354|NCT01354132|558899093|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
154855355|NCT01354132|558899094|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
154855356|NCT00928070|558899097|FG000|Overall Study|Lost to Follow-up|1|||
154855357|NCT00928070|558899098|FG001|Overall Study|Lost to Follow-up|2|||
154855358|NCT00928070|558899097|FG000|Overall Study|Withdrawal by Subject|10|||
154855359|NCT00928070|558899098|FG001|Overall Study|Withdrawal by Subject|3|||
154855360|NCT00928070|558899097|FG000|Overall Study|Adverse Event|14|||
154855361|NCT00928070|558899098|FG001|Overall Study|Adverse Event|26|||
154855362|NCT00928070|558899097|FG000|Overall Study|Lack of Efficacy|9|||
155106129|NCT05258890|559817573|FG001|Overall Study|Social network member withdrawal|0|||
154855363|NCT00928070|558899098|FG001|Overall Study|Lack of Efficacy|5|||
154855364|NCT00928070|558899097|FG000|Overall Study|Did not meet entrance criteria|16|||
154855365|NCT00928070|558899098|FG001|Overall Study|Did not meet entrance criteria|9|||
154855366|NCT00928070|558899097|FG000|Overall Study|Protocol Violation|6|||
154855367|NCT00928070|558899098|FG001|Overall Study|Protocol Violation|5|||
154855368|NCT00928070|558899097|FG000|Overall Study|Randomized but not treated|2|||
154855369|NCT00928070|558899098|FG001|Overall Study|Randomized but not treated|2|||
154855370|NCT00928070|558899097|FG000|Overall Study|Other|5|||
154855371|NCT00928070|558899098|FG001|Overall Study|Other|5|||
155106130|NCT05258890|559817572|FG000|Overall Study|Social network member lost to follow-up|5|||
154855372|NCT02360098|558899099|FG000|Overall Study|Physician Decision|7|||
154855373|NCT01919307|558899105|FG000|Overall Study|Withdrawal by Subject|9|||
154855374|NCT02771522|558899108|FG000|Overall Study|Lost to Follow-up|3|||
154855375|NCT02771522|558899108|FG000|Overall Study|Withdrawal by Subject|2|||
154855376|NCT02771522|558899108|FG000|Overall Study|No white spot lesions|3|||
154855377|NCT02388295|558899109|FG000|Dose Escalation Week 1|Adverse Event|1|||
154855378|NCT02388295|558899110|FG001|Dose Escalation Week 1|Adverse Event|2|||
154855379|NCT02388295|558899111|FG002|Dose Escalation Week 1|Adverse Event|1|||
154855380|NCT02388295|558899109|FG000|Dose Escalation Week 1|Determined not eligible|1|||
154855381|NCT02388295|558899110|FG001|Dose Escalation Week 1|Determined not eligible|1|||
154855382|NCT02388295|558899111|FG002|Dose Escalation Week 1|Determined not eligible|1|||
154855383|NCT02388295|558899109|FG000|Dose Escalation Week 2|Protocol Violation|0|||
154855384|NCT02388295|558899110|FG001|Dose Escalation Week 2|Protocol Violation|1|||
154855385|NCT02388295|558899111|FG002|Dose Escalation Week 2|Protocol Violation|0|||
154855386|NCT02388295|558899109|FG000|Dose Escalation Week 2|Determined not eligible|1|||
154855387|NCT02388295|558899110|FG001|Dose Escalation Week 2|Determined not eligible|1|||
154855388|NCT02388295|558899111|FG002|Dose Escalation Week 2|Determined not eligible|1|||
154855389|NCT02388295|558899109|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
154855390|NCT02388295|558899110|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
154855391|NCT02388295|558899111|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
154855392|NCT01551693|558899112|FG000|Overall Study|Disease Progression|1|||
154855393|NCT01551693|558899113|FG001|Overall Study|Disease Progression|0|||
154855394|NCT01551693|558899112|FG000|Overall Study|Adverse Event|0|||
154855395|NCT01551693|558899113|FG001|Overall Study|Adverse Event|1|||
154855396|NCT01551693|558899112|FG000|Overall Study|Withdrawal by Subject|0|||
154855397|NCT01551693|558899113|FG001|Overall Study|Withdrawal by Subject|1|||
154855398|NCT02429856|558899114|FG000|Overall Study|Death|12|||
154855399|NCT02429856|558899115|FG001|Overall Study|Death|13|||
154855400|NCT02429856|558899114|FG000|Overall Study|Lost to Follow-up|6|||
154855401|NCT02429856|558899115|FG001|Overall Study|Lost to Follow-up|5|||
154855402|NCT02429856|558899114|FG000|Overall Study|Withdrawal by Subject|1|||
154855403|NCT02429856|558899115|FG001|Overall Study|Withdrawal by Subject|1|||
154855404|NCT04134494|558899119|FG000|Overall Study|Lost to Follow-up|2|||
154855405|NCT00781365|558899120|FG000|Overall Study|Withdrawal by Subject|13|||
154855406|NCT00781365|558899121|FG001|Overall Study|Withdrawal by Subject|8|||
154855407|NCT00781365|558899120|FG000|Overall Study|Did Not Attend Visit|20|||
154855408|NCT00781365|558899121|FG001|Overall Study|Did Not Attend Visit|28|||
154855409|NCT00781365|558899120|FG000|Overall Study|Language barrier|1|||
154855410|NCT00781365|558899121|FG001|Overall Study|Language barrier|0|||
154855411|NCT00348140|558899131|FG000|Overall Study|Adverse Event|46|||
154855412|NCT00348140|558899132|FG001|Overall Study|Adverse Event|49|||
154855413|NCT00348140|558899133|FG002|Overall Study|Adverse Event|78|||
154855414|NCT00348140|558899131|FG000|Overall Study|Lost to Follow-up|4|||
154855415|NCT00348140|558899132|FG001|Overall Study|Lost to Follow-up|4|||
154855416|NCT00348140|558899133|FG002|Overall Study|Lost to Follow-up|4|||
154855417|NCT00348140|558899131|FG000|Overall Study|Protocol Violation|12|||
154855418|NCT00348140|558899132|FG001|Overall Study|Protocol Violation|13|||
154855419|NCT00348140|558899133|FG002|Overall Study|Protocol Violation|14|||
154855420|NCT00348140|558899131|FG000|Overall Study|Withdrawal by Subject|32|||
154855421|NCT00348140|558899132|FG001|Overall Study|Withdrawal by Subject|40|||
154855422|NCT00348140|558899133|FG002|Overall Study|Withdrawal by Subject|40|||
154855423|NCT00348140|558899131|FG000|Overall Study|Non-compliance|8|||
154855424|NCT00348140|558899132|FG001|Overall Study|Non-compliance|13|||
154855425|NCT00348140|558899133|FG002|Overall Study|Non-compliance|5|||
154855426|NCT00348140|558899131|FG000|Overall Study|Participant at risk due to study drug|2|||
154855427|NCT00348140|558899132|FG001|Overall Study|Participant at risk due to study drug|0|||
154855428|NCT00348140|558899133|FG002|Overall Study|Participant at risk due to study drug|0|||
154855429|NCT00348140|558899131|FG000|Overall Study|Conditional medication increased dose|1|||
154855430|NCT00348140|558899132|FG001|Overall Study|Conditional medication increased dose|0|||
154855431|NCT00348140|558899133|FG002|Overall Study|Conditional medication increased dose|0|||
154855432|NCT00348140|558899131|FG000|Overall Study|Caregiver related|4|||
154855433|NCT00348140|558899132|FG001|Overall Study|Caregiver related|7|||
154855434|NCT00348140|558899133|FG002|Overall Study|Caregiver related|3|||
154855435|NCT00348140|558899131|FG000|Overall Study|Participant hospitalised|3|||
154855436|NCT00348140|558899132|FG001|Overall Study|Participant hospitalised|0|||
154855437|NCT00348140|558899133|FG002|Overall Study|Participant hospitalised|0|||
154855438|NCT00348140|558899131|FG000|Overall Study|Efficacy related|1|||
154855439|NCT00348140|558899132|FG001|Overall Study|Efficacy related|1|||
154855440|NCT00348140|558899133|FG002|Overall Study|Efficacy related|0|||
154855441|NCT00348140|558899131|FG000|Overall Study|Administration related|3|||
154855442|NCT00348140|558899132|FG001|Overall Study|Administration related|1|||
154855443|NCT00348140|558899133|FG002|Overall Study|Administration related|1|||
155106131|NCT05258890|559817573|FG001|Overall Study|Social network member lost to follow-up|0|||
154855444|NCT00348140|558899131|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
154855445|NCT00348140|558899132|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
154855446|NCT00348140|558899133|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
155106132|NCT05959447|559817580|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
155106133|NCT05959447|559817581|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
155106134|NCT05959447|559817580|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
155106135|NCT05959447|559817581|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
155106136|NCT05959447|559817580|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
155106137|NCT05959447|559817581|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
155106138|NCT05959447|559817580|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
155106139|NCT05959447|559817581|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
155106140|NCT03015363|559817588|FG000|Overall Study|Physician Decision|14|||
155106141|NCT03015363|559817588|FG000|Overall Study|Withdrawal by Subject|3|||
155106142|NCT00958360|559817589|FG000|Overall Study|Withdrawal by Subject|3|||
155106143|NCT00958360|559817590|FG001|Overall Study|Withdrawal by Subject|1|||
155106144|NCT00958360|559817589|FG000|Overall Study|Death|6|||
155106145|NCT00958360|559817590|FG001|Overall Study|Death|7|||
155106146|NCT00958360|559817589|FG000|Overall Study|Physician Decision|2|||
155106147|NCT00958360|559817590|FG001|Overall Study|Physician Decision|1|||
155106148|NCT00958360|559817589|FG000|Overall Study|Lost to Follow-up|0|||
155106149|NCT00958360|559817590|FG001|Overall Study|Lost to Follow-up|1|||
155106150|NCT03107052|559817591|FG000|Overall Study|Adverse Event|6|||
155106151|NCT03107052|559817592|FG001|Overall Study|Adverse Event|1|||
155106152|NCT03107052|559817593|FG002|Overall Study|Adverse Event|2|||
155106153|NCT03107052|559817591|FG000|Overall Study|Withdrawal by Subject|9|||
155106154|NCT03107052|559817592|FG001|Overall Study|Withdrawal by Subject|5|||
155106155|NCT03107052|559817593|FG002|Overall Study|Withdrawal by Subject|8|||
155106156|NCT03107052|559817591|FG000|Overall Study|Protocol Violation|6|||
155106157|NCT03107052|559817592|FG001|Overall Study|Protocol Violation|0|||
155106158|NCT03107052|559817593|FG002|Overall Study|Protocol Violation|3|||
155106159|NCT03107052|559817591|FG000|Overall Study|Lost to Follow-up|4|||
155106160|NCT03107052|559817592|FG001|Overall Study|Lost to Follow-up|0|||
155106161|NCT03107052|559817593|FG002|Overall Study|Lost to Follow-up|1|||
155106162|NCT03107052|559817591|FG000|Overall Study|Lack of Efficacy|23|||
155106163|NCT03107052|559817592|FG001|Overall Study|Lack of Efficacy|7|||
155106164|NCT03107052|559817593|FG002|Overall Study|Lack of Efficacy|4|||
155106165|NCT03107052|559817591|FG000|Overall Study|Other than specified|4|||
155106166|NCT03107052|559817592|FG001|Overall Study|Other than specified|2|||
155106167|NCT03107052|559817593|FG002|Overall Study|Other than specified|0|||
154855447|NCT00348140|558899131|FG000|Overall Study|Participant unwell|1|||
154855448|NCT00348140|558899132|FG001|Overall Study|Participant unwell|0|||
154855449|NCT00348140|558899133|FG002|Overall Study|Participant unwell|0|||
154855450|NCT00348140|558899131|FG000|Overall Study|Screen failure|1|||
154855451|NCT00348140|558899132|FG001|Overall Study|Screen failure|0|||
154855452|NCT00348140|558899133|FG002|Overall Study|Screen failure|0|||
154855453|NCT00348140|558899131|FG000|Overall Study|Investigator decided to discontinue|4|||
154855454|NCT00348140|558899132|FG001|Overall Study|Investigator decided to discontinue|1|||
154855455|NCT00348140|558899133|FG002|Overall Study|Investigator decided to discontinue|4|||
154855456|NCT00348140|558899131|FG000|Overall Study|Decided to discontinue on their own|1|||
154855457|NCT00348140|558899132|FG001|Overall Study|Decided to discontinue on their own|4|||
154855458|NCT00348140|558899133|FG002|Overall Study|Decided to discontinue on their own|1|||
154855459|NCT00348140|558899131|FG000|Overall Study|Use of prohibited drug|1|||
154855460|NCT00348140|558899132|FG001|Overall Study|Use of prohibited drug|0|||
154855461|NCT00348140|558899133|FG002|Overall Study|Use of prohibited drug|2|||
154855462|NCT00348140|558899131|FG000|Overall Study|Disease progression|1|||
154855463|NCT00348140|558899132|FG001|Overall Study|Disease progression|2|||
154855464|NCT00348140|558899133|FG002|Overall Study|Disease progression|5|||
154855465|NCT00348140|558899131|FG000|Overall Study|Increased risk of cardiac infarction|0|||
154855466|NCT00348140|558899132|FG001|Overall Study|Increased risk of cardiac infarction|1|||
154855467|NCT00348140|558899133|FG002|Overall Study|Increased risk of cardiac infarction|0|||
154855468|NCT00348140|558899131|FG000|Overall Study|Serious adverse event|0|||
154855469|NCT00348140|558899132|FG001|Overall Study|Serious adverse event|1|||
154855470|NCT00348140|558899133|FG002|Overall Study|Serious adverse event|0|||
154855471|NCT00348140|558899131|FG000|Overall Study|Abnormal ECG|0|||
154855472|NCT00348140|558899132|FG001|Overall Study|Abnormal ECG|1|||
154855473|NCT00348140|558899133|FG002|Overall Study|Abnormal ECG|3|||
154855474|NCT00348140|558899131|FG000|Overall Study|Participant died|0|||
154855475|NCT00348140|558899132|FG001|Overall Study|Participant died|1|||
154855476|NCT00348140|558899133|FG002|Overall Study|Participant died|0|||
154855477|NCT00348140|558899131|FG000|Overall Study|Exclusion criteria met|0|||
154855478|NCT00348140|558899132|FG001|Overall Study|Exclusion criteria met|0|||
154855479|NCT00348140|558899133|FG002|Overall Study|Exclusion criteria met|1|||
154855480|NCT00348140|558899131|FG000|Overall Study|Memory declined|0|||
154855481|NCT00348140|558899132|FG001|Overall Study|Memory declined|0|||
154855482|NCT00348140|558899133|FG002|Overall Study|Memory declined|1|||
154855483|NCT00868790|558899136|FG000|Period 1|Adverse Event|1|||
154855484|NCT00868790|558899137|FG001|Period 1|Adverse Event|0|||
154855485|NCT00868790|558899138|FG002|Period 1|Adverse Event|0|||
154855486|NCT00868790|558899139|FG003|Period 1|Adverse Event|0|||
154855487|NCT00868790|558899140|FG004|Period 1|Adverse Event|0|||
154855488|NCT00868790|558899141|FG005|Period 1|Adverse Event|0|||
154855489|NCT00868790|558899142|FG006|Period 1|Adverse Event|0|||
154855490|NCT00868790|558899143|FG007|Period 1|Adverse Event|3|||
154855491|NCT00868790|558899144|FG008|Period 1|Adverse Event|1|||
154855492|NCT00868790|558899145|FG009|Period 1|Adverse Event|0|||
154855493|NCT00868790|558899146|FG010|Period 1|Adverse Event|0|||
154855494|NCT00868790|558899147|FG011|Period 1|Adverse Event|0|||
154855495|NCT00868790|558899148|FG012|Period 1|Adverse Event|0|||
154855496|NCT00868790|558899149|FG013|Period 1|Adverse Event|1|||
154855497|NCT00868790|558899136|FG000|Period 1|Protocol Violation|1|||
154855498|NCT00868790|558899137|FG001|Period 1|Protocol Violation|0|||
154855499|NCT00868790|558899138|FG002|Period 1|Protocol Violation|0|||
154855500|NCT00868790|558899139|FG003|Period 1|Protocol Violation|0|||
155106168|NCT03107052|559817591|FG000|Overall Study|Study terminated due to futility|67|||
155106169|NCT03107052|559817592|FG001|Overall Study|Study terminated due to futility|31|||
155106170|NCT03107052|559817593|FG002|Overall Study|Study terminated due to futility|23|||
155106171|NCT02263326|559817594|FG000|Overall Study|Lost to Follow-up|1|||
154855501|NCT00868790|558899140|FG004|Period 1|Protocol Violation|0|||
154855502|NCT00868790|558899141|FG005|Period 1|Protocol Violation|0|||
154855503|NCT00868790|558899142|FG006|Period 1|Protocol Violation|0|||
154855504|NCT00868790|558899143|FG007|Period 1|Protocol Violation|0|||
154855505|NCT00868790|558899144|FG008|Period 1|Protocol Violation|0|||
154855506|NCT00868790|558899145|FG009|Period 1|Protocol Violation|0|||
155106172|NCT02263326|559817595|FG001|Overall Study|Lost to Follow-up|1|||
154855507|NCT00868790|558899146|FG010|Period 1|Protocol Violation|0|||
154855508|NCT00868790|558899147|FG011|Period 1|Protocol Violation|0|||
154855509|NCT00868790|558899148|FG012|Period 1|Protocol Violation|0|||
154855510|NCT00868790|558899149|FG013|Period 1|Protocol Violation|0|||
154855511|NCT00868790|558899136|FG000|Period 1|Withdrawal by Subject|0|||
154855512|NCT00868790|558899137|FG001|Period 1|Withdrawal by Subject|1|||
154855513|NCT00868790|558899138|FG002|Period 1|Withdrawal by Subject|0|||
154855514|NCT00868790|558899139|FG003|Period 1|Withdrawal by Subject|0|||
154855515|NCT00868790|558899140|FG004|Period 1|Withdrawal by Subject|0|||
154855516|NCT00868790|558899141|FG005|Period 1|Withdrawal by Subject|0|||
154855517|NCT00868790|558899142|FG006|Period 1|Withdrawal by Subject|0|||
154855518|NCT00868790|558899143|FG007|Period 1|Withdrawal by Subject|0|||
154855519|NCT00868790|558899144|FG008|Period 1|Withdrawal by Subject|0|||
154855520|NCT00868790|558899145|FG009|Period 1|Withdrawal by Subject|0|||
154855521|NCT00868790|558899146|FG010|Period 1|Withdrawal by Subject|0|||
154855522|NCT00868790|558899147|FG011|Period 1|Withdrawal by Subject|0|||
154855523|NCT00868790|558899148|FG012|Period 1|Withdrawal by Subject|0|||
154855524|NCT00868790|558899149|FG013|Period 1|Withdrawal by Subject|1|||
154855525|NCT00868790|558899136|FG000|Period 1|Abnormal Triglycerides|0|||
154855526|NCT00868790|558899137|FG001|Period 1|Abnormal Triglycerides|0|||
154855527|NCT00868790|558899138|FG002|Period 1|Abnormal Triglycerides|0|||
154855528|NCT00868790|558899139|FG003|Period 1|Abnormal Triglycerides|0|||
154855529|NCT00868790|558899140|FG004|Period 1|Abnormal Triglycerides|1|||
154855530|NCT00868790|558899141|FG005|Period 1|Abnormal Triglycerides|0|||
154855531|NCT00868790|558899142|FG006|Period 1|Abnormal Triglycerides|0|||
154855532|NCT00868790|558899143|FG007|Period 1|Abnormal Triglycerides|0|||
154855533|NCT00868790|558899144|FG008|Period 1|Abnormal Triglycerides|0|||
154855534|NCT00868790|558899145|FG009|Period 1|Abnormal Triglycerides|0|||
154855535|NCT00868790|558899146|FG010|Period 1|Abnormal Triglycerides|0|||
154855536|NCT00868790|558899147|FG011|Period 1|Abnormal Triglycerides|0|||
154855537|NCT00868790|558899148|FG012|Period 1|Abnormal Triglycerides|0|||
154855538|NCT00868790|558899149|FG013|Period 1|Abnormal Triglycerides|0|||
154855539|NCT00868790|558899136|FG000|Period 1|Lost to Follow-up|0|||
154855540|NCT00868790|558899137|FG001|Period 1|Lost to Follow-up|0|||
154855541|NCT00868790|558899138|FG002|Period 1|Lost to Follow-up|0|||
154855542|NCT00868790|558899139|FG003|Period 1|Lost to Follow-up|0|||
154855543|NCT00868790|558899140|FG004|Period 1|Lost to Follow-up|0|||
154855544|NCT00868790|558899141|FG005|Period 1|Lost to Follow-up|1|||
154855545|NCT00868790|558899142|FG006|Period 1|Lost to Follow-up|0|||
154855546|NCT00868790|558899143|FG007|Period 1|Lost to Follow-up|0|||
154855547|NCT00868790|558899144|FG008|Period 1|Lost to Follow-up|0|||
154855548|NCT00868790|558899145|FG009|Period 1|Lost to Follow-up|0|||
154855549|NCT00868790|558899146|FG010|Period 1|Lost to Follow-up|0|||
154855550|NCT00868790|558899147|FG011|Period 1|Lost to Follow-up|0|||
154855551|NCT00868790|558899148|FG012|Period 1|Lost to Follow-up|0|||
154855552|NCT00868790|558899149|FG013|Period 1|Lost to Follow-up|0|||
154855553|NCT00868790|558899136|FG000|Period 2|Adverse Event|0|||
154855554|NCT00868790|558899137|FG001|Period 2|Adverse Event|0|||
154855555|NCT00868790|558899138|FG002|Period 2|Adverse Event|0|||
154855556|NCT00868790|558899139|FG003|Period 2|Adverse Event|0|||
154855557|NCT00868790|558899140|FG004|Period 2|Adverse Event|0|||
154855558|NCT00868790|558899141|FG005|Period 2|Adverse Event|0|||
154855559|NCT00868790|558899142|FG006|Period 2|Adverse Event|0|||
154855560|NCT00868790|558899143|FG007|Period 2|Adverse Event|0|||
154855561|NCT00868790|558899144|FG008|Period 2|Adverse Event|1|||
154855562|NCT00868790|558899145|FG009|Period 2|Adverse Event|0|||
154855563|NCT00868790|558899146|FG010|Period 2|Adverse Event|0|||
154855564|NCT00868790|558899147|FG011|Period 2|Adverse Event|0|||
154855565|NCT00868790|558899148|FG012|Period 2|Adverse Event|0|||
154855566|NCT00868790|558899149|FG013|Period 2|Adverse Event|0|||
154855567|NCT00868790|558899136|FG000|Period 2|Lost to Follow-up|0|||
154855568|NCT00868790|558899137|FG001|Period 2|Lost to Follow-up|1|||
154855569|NCT00868790|558899138|FG002|Period 2|Lost to Follow-up|0|||
154855570|NCT00868790|558899139|FG003|Period 2|Lost to Follow-up|0|||
154855571|NCT00868790|558899140|FG004|Period 2|Lost to Follow-up|0|||
154855572|NCT00868790|558899141|FG005|Period 2|Lost to Follow-up|1|||
154855573|NCT00868790|558899142|FG006|Period 2|Lost to Follow-up|0|||
154855574|NCT00868790|558899143|FG007|Period 2|Lost to Follow-up|0|||
154855575|NCT00868790|558899144|FG008|Period 2|Lost to Follow-up|0|||
154855576|NCT00868790|558899145|FG009|Period 2|Lost to Follow-up|0|||
154855577|NCT00868790|558899146|FG010|Period 2|Lost to Follow-up|0|||
154855578|NCT00868790|558899147|FG011|Period 2|Lost to Follow-up|0|||
154971836|NCT01091363|559320706|FG000|Overall Study|Lost to Follow-up|2|||
154971837|NCT01091363|559320707|FG001|Overall Study|Lost to Follow-up|2|||
155106173|NCT00500357|559817596|FG000|Overall Study|Death|1|||
155106174|NCT00078806|559817597|FG000|Part 1A|Adverse Event|2|||
155106175|NCT00078806|559817598|FG001|Part 1A|Adverse Event|0|||
155106176|NCT00078806|559817599|FG002|Part 1A|Adverse Event|0|||
154971838|NCT01215721|559320712|FG000|Overall Study|Adverse Event|2|||
155106177|NCT00078806|559817600|FG003|Part 1A|Adverse Event|0|||
154855579|NCT00868790|558899148|FG012|Period 2|Lost to Follow-up|0|||
154855580|NCT00868790|558899149|FG013|Period 2|Lost to Follow-up|0|||
154855581|NCT00868790|558899136|FG000|Period 2|Withdrawal by Subject|0|||
155106178|NCT00078806|559817597|FG000|Part 1A|Lack of Efficacy|7|||
155106179|NCT00078806|559817598|FG001|Part 1A|Lack of Efficacy|0|||
154855582|NCT00868790|558899137|FG001|Period 2|Withdrawal by Subject|0|||
154855583|NCT00868790|558899138|FG002|Period 2|Withdrawal by Subject|0|||
154855584|NCT00868790|558899139|FG003|Period 2|Withdrawal by Subject|0|||
154855585|NCT00868790|558899140|FG004|Period 2|Withdrawal by Subject|0|||
154855586|NCT00868790|558899141|FG005|Period 2|Withdrawal by Subject|0|||
154855587|NCT00868790|558899142|FG006|Period 2|Withdrawal by Subject|0|||
154855588|NCT00868790|558899143|FG007|Period 2|Withdrawal by Subject|0|||
154855589|NCT00868790|558899144|FG008|Period 2|Withdrawal by Subject|1|||
154855590|NCT00868790|558899145|FG009|Period 2|Withdrawal by Subject|0|||
154855591|NCT00868790|558899146|FG010|Period 2|Withdrawal by Subject|0|||
154855592|NCT00868790|558899147|FG011|Period 2|Withdrawal by Subject|0|||
154855593|NCT00868790|558899148|FG012|Period 2|Withdrawal by Subject|0|||
154855594|NCT00868790|558899149|FG013|Period 2|Withdrawal by Subject|1|||
154855595|NCT00868790|558899136|FG000|Period 3|Adverse Event|0|||
154855596|NCT00868790|558899137|FG001|Period 3|Adverse Event|0|||
154855597|NCT00868790|558899138|FG002|Period 3|Adverse Event|0|||
154855598|NCT00868790|558899139|FG003|Period 3|Adverse Event|0|||
154855599|NCT00868790|558899140|FG004|Period 3|Adverse Event|0|||
154855600|NCT00868790|558899141|FG005|Period 3|Adverse Event|0|||
154855601|NCT00868790|558899142|FG006|Period 3|Adverse Event|0|||
154855602|NCT00868790|558899143|FG007|Period 3|Adverse Event|0|||
154855603|NCT00868790|558899144|FG008|Period 3|Adverse Event|0|||
154855604|NCT00868790|558899145|FG009|Period 3|Adverse Event|1|||
154855605|NCT00868790|558899146|FG010|Period 3|Adverse Event|0|||
154855606|NCT00868790|558899147|FG011|Period 3|Adverse Event|0|||
154855607|NCT00868790|558899148|FG012|Period 3|Adverse Event|0|||
154855608|NCT00868790|558899149|FG013|Period 3|Adverse Event|0|||
154855609|NCT00868790|558899136|FG000|Period 3|Protocol Violation|0|||
154855610|NCT00868790|558899137|FG001|Period 3|Protocol Violation|0|||
154855611|NCT00868790|558899138|FG002|Period 3|Protocol Violation|0|||
154855612|NCT00868790|558899139|FG003|Period 3|Protocol Violation|0|||
154855613|NCT00868790|558899140|FG004|Period 3|Protocol Violation|0|||
154855614|NCT00868790|558899141|FG005|Period 3|Protocol Violation|0|||
154855615|NCT00868790|558899142|FG006|Period 3|Protocol Violation|0|||
154855616|NCT00868790|558899143|FG007|Period 3|Protocol Violation|0|||
154855617|NCT00868790|558899144|FG008|Period 3|Protocol Violation|0|||
154855618|NCT00868790|558899145|FG009|Period 3|Protocol Violation|0|||
154855619|NCT00868790|558899146|FG010|Period 3|Protocol Violation|1|||
154855620|NCT00868790|558899147|FG011|Period 3|Protocol Violation|0|||
154855621|NCT00868790|558899148|FG012|Period 3|Protocol Violation|0|||
154855622|NCT00868790|558899149|FG013|Period 3|Protocol Violation|0|||
154855623|NCT00868790|558899136|FG000|Period 3|Study Terminated by Sponsor|0|||
154855624|NCT00868790|558899137|FG001|Period 3|Study Terminated by Sponsor|0|||
154855625|NCT00868790|558899138|FG002|Period 3|Study Terminated by Sponsor|0|||
154855626|NCT00868790|558899139|FG003|Period 3|Study Terminated by Sponsor|1|||
154855627|NCT00868790|558899140|FG004|Period 3|Study Terminated by Sponsor|0|||
154855628|NCT00868790|558899141|FG005|Period 3|Study Terminated by Sponsor|0|||
154855629|NCT00868790|558899142|FG006|Period 3|Study Terminated by Sponsor|0|||
154855630|NCT00868790|558899143|FG007|Period 3|Study Terminated by Sponsor|0|||
154855631|NCT00868790|558899144|FG008|Period 3|Study Terminated by Sponsor|0|||
154855632|NCT00868790|558899145|FG009|Period 3|Study Terminated by Sponsor|0|||
154855633|NCT00868790|558899146|FG010|Period 3|Study Terminated by Sponsor|0|||
154855634|NCT00868790|558899147|FG011|Period 3|Study Terminated by Sponsor|0|||
154855635|NCT00868790|558899148|FG012|Period 3|Study Terminated by Sponsor|0|||
154855636|NCT00868790|558899149|FG013|Period 3|Study Terminated by Sponsor|0|||
154855637|NCT00868790|558899136|FG000|Period 4|Adverse Event|0|||
154855638|NCT00868790|558899137|FG001|Period 4|Adverse Event|0|||
154855639|NCT00868790|558899138|FG002|Period 4|Adverse Event|0|||
154855640|NCT00868790|558899139|FG003|Period 4|Adverse Event|0|||
154855641|NCT00868790|558899140|FG004|Period 4|Adverse Event|0|||
154855642|NCT00868790|558899141|FG005|Period 4|Adverse Event|0|||
154855643|NCT00868790|558899142|FG006|Period 4|Adverse Event|0|||
154855644|NCT00868790|558899143|FG007|Period 4|Adverse Event|1|||
154855645|NCT00868790|558899144|FG008|Period 4|Adverse Event|0|||
154855646|NCT00868790|558899145|FG009|Period 4|Adverse Event|0|||
154855647|NCT00868790|558899146|FG010|Period 4|Adverse Event|1|||
154855648|NCT00868790|558899147|FG011|Period 4|Adverse Event|0|||
154855649|NCT00868790|558899148|FG012|Period 4|Adverse Event|1|||
154855650|NCT00868790|558899149|FG013|Period 4|Adverse Event|0|||
154855651|NCT00868790|558899136|FG000|Period 4|Lost to Follow-up|0|||
154855652|NCT00868790|558899137|FG001|Period 4|Lost to Follow-up|0|||
154855653|NCT00868790|558899138|FG002|Period 4|Lost to Follow-up|0|||
155106180|NCT00078806|559817599|FG002|Part 1A|Lack of Efficacy|0|||
155106181|NCT00078806|559817600|FG003|Part 1A|Lack of Efficacy|0|||
155106182|NCT00078806|559817597|FG000|Part 1A|Other|1|||
155106183|NCT00078806|559817598|FG001|Part 1A|Other|0|||
155106184|NCT00078806|559817599|FG002|Part 1A|Other|0|||
155106185|NCT00078806|559817600|FG003|Part 1A|Other|0|||
155106186|NCT00078806|559817597|FG000|Part 1B|Adverse Event|1|||
154855654|NCT00868790|558899139|FG003|Period 4|Lost to Follow-up|0|||
155106187|NCT00078806|559817598|FG001|Part 1B|Adverse Event|0|||
155106188|NCT00078806|559817599|FG002|Part 1B|Adverse Event|0|||
155173634|NCT01155011|560074842|FG000|Baseline to 6 Months|investigator decision, moved|4|||
154855655|NCT00868790|558899140|FG004|Period 4|Lost to Follow-up|0|||
154855656|NCT00868790|558899141|FG005|Period 4|Lost to Follow-up|0|||
154855657|NCT00868790|558899142|FG006|Period 4|Lost to Follow-up|0|||
154855658|NCT00868790|558899143|FG007|Period 4|Lost to Follow-up|1|||
154855659|NCT00868790|558899144|FG008|Period 4|Lost to Follow-up|0|||
154855660|NCT00868790|558899145|FG009|Period 4|Lost to Follow-up|0|||
154855661|NCT00868790|558899146|FG010|Period 4|Lost to Follow-up|0|||
155106189|NCT00078806|559817600|FG003|Part 1B|Adverse Event|0|||
155106190|NCT00078806|559817597|FG000|Part 1B|Lack of Efficacy|7|||
155106191|NCT00078806|559817598|FG001|Part 1B|Lack of Efficacy|0|||
155106192|NCT00078806|559817599|FG002|Part 1B|Lack of Efficacy|0|||
155106193|NCT00078806|559817600|FG003|Part 1B|Lack of Efficacy|0|||
155106194|NCT00078806|559817597|FG000|Part 2|Adverse Event|0|||
155106195|NCT00078806|559817598|FG001|Part 2|Adverse Event|1|||
154855662|NCT00868790|558899147|FG011|Period 4|Lost to Follow-up|0|||
154855663|NCT00868790|558899148|FG012|Period 4|Lost to Follow-up|0|||
154855664|NCT00868790|558899149|FG013|Period 4|Lost to Follow-up|0|||
154855665|NCT00868790|558899136|FG000|Period 4|Study Terminated by Sponsor|2|||
154855666|NCT00868790|558899137|FG001|Period 4|Study Terminated by Sponsor|0|||
154855667|NCT00868790|558899138|FG002|Period 4|Study Terminated by Sponsor|0|||
154855668|NCT00868790|558899139|FG003|Period 4|Study Terminated by Sponsor|0|||
154855669|NCT00868790|558899140|FG004|Period 4|Study Terminated by Sponsor|0|||
154855670|NCT00868790|558899141|FG005|Period 4|Study Terminated by Sponsor|0|||
154855671|NCT00868790|558899142|FG006|Period 4|Study Terminated by Sponsor|0|||
154855672|NCT00868790|558899143|FG007|Period 4|Study Terminated by Sponsor|1|||
154855673|NCT00868790|558899144|FG008|Period 4|Study Terminated by Sponsor|2|||
154855674|NCT00868790|558899145|FG009|Period 4|Study Terminated by Sponsor|0|||
154855675|NCT00868790|558899146|FG010|Period 4|Study Terminated by Sponsor|2|||
154855676|NCT00868790|558899147|FG011|Period 4|Study Terminated by Sponsor|1|||
154855677|NCT00868790|558899148|FG012|Period 4|Study Terminated by Sponsor|0|||
154855678|NCT00868790|558899149|FG013|Period 4|Study Terminated by Sponsor|1|||
154855679|NCT00868790|558899136|FG000|Period 4|Abnormal ALT/AST|0|||
154855680|NCT00868790|558899137|FG001|Period 4|Abnormal ALT/AST|0|||
154855681|NCT00868790|558899138|FG002|Period 4|Abnormal ALT/AST|1|||
154855682|NCT00868790|558899139|FG003|Period 4|Abnormal ALT/AST|0|||
154855683|NCT00868790|558899140|FG004|Period 4|Abnormal ALT/AST|0|||
154855684|NCT00868790|558899141|FG005|Period 4|Abnormal ALT/AST|0|||
154855685|NCT00868790|558899142|FG006|Period 4|Abnormal ALT/AST|0|||
154855686|NCT00868790|558899143|FG007|Period 4|Abnormal ALT/AST|0|||
154855687|NCT00868790|558899144|FG008|Period 4|Abnormal ALT/AST|0|||
154855688|NCT00868790|558899145|FG009|Period 4|Abnormal ALT/AST|0|||
154855689|NCT00868790|558899146|FG010|Period 4|Abnormal ALT/AST|0|||
154855690|NCT00868790|558899147|FG011|Period 4|Abnormal ALT/AST|0|||
154855691|NCT00868790|558899148|FG012|Period 4|Abnormal ALT/AST|0|||
154855692|NCT00868790|558899149|FG013|Period 4|Abnormal ALT/AST|0|||
154855693|NCT00868790|558899136|FG000|Post-study|Withdrawal by Subject|0|||
154855694|NCT00868790|558899137|FG001|Post-study|Withdrawal by Subject|0|||
154855695|NCT00868790|558899138|FG002|Post-study|Withdrawal by Subject|0|||
154855696|NCT00868790|558899139|FG003|Post-study|Withdrawal by Subject|0|||
154855697|NCT00868790|558899140|FG004|Post-study|Withdrawal by Subject|1|||
154855698|NCT00868790|558899141|FG005|Post-study|Withdrawal by Subject|0|||
154855699|NCT00868790|558899142|FG006|Post-study|Withdrawal by Subject|0|||
154855700|NCT00868790|558899143|FG007|Post-study|Withdrawal by Subject|0|||
154971839|NCT00045162|559320713|FG000|Overall Study|Ineligible|12|||
154971840|NCT00045162|559320714|FG001|Overall Study|Ineligible|8|||
154971841|NCT00045162|559320713|FG000|Overall Study|Not treated|7|||
154971842|NCT00045162|559320714|FG001|Overall Study|Not treated|2|||
154971843|NCT00045162|559320713|FG000|Overall Study|Adverse Event|55|||
154971844|NCT00045162|559320714|FG001|Overall Study|Adverse Event|50|||
154971845|NCT00045162|559320713|FG000|Overall Study|Lack of Efficacy|32|||
154971846|NCT00045162|559320714|FG001|Overall Study|Lack of Efficacy|29|||
154971847|NCT00045162|559320713|FG000|Overall Study|Death|10|||
154971848|NCT00045162|559320714|FG001|Overall Study|Death|10|||
154971849|NCT00045162|559320713|FG000|Overall Study|Withdrawal by Subject|5|||
154971850|NCT00045162|559320714|FG001|Overall Study|Withdrawal by Subject|3|||
154971851|NCT00045162|559320713|FG000|Overall Study|Other|21|||
154971852|NCT00045162|559320714|FG001|Overall Study|Other|16|||
154971853|NCT01044433|559320715|FG000|Overall Study|Lost to Follow-up|3|||
154971854|NCT01044433|559320715|FG000|Overall Study|Withdrawal by Subject|3|||
154971855|NCT00826241|559320716|FG000|Overall Study|Withdrawal from Follow-up|1|||
154971856|NCT00826241|559320716|FG000|Overall Study|Withdrew consent|2|||
155106196|NCT00078806|559817599|FG002|Part 2|Adverse Event|0|||
154971857|NCT00826241|559320716|FG000|Overall Study|Death|4|||
155106197|NCT00078806|559817600|FG003|Part 2|Adverse Event|0|||
155106198|NCT01893411|559817603|FG000|Overall Study|Protocol Violation|1|||
154855701|NCT00868790|558899144|FG008|Post-study|Withdrawal by Subject|0|||
154855702|NCT00868790|558899145|FG009|Post-study|Withdrawal by Subject|0|||
154971858|NCT00826241|559320716|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
154971859|NCT00826241|559320716|FG000|Overall Study|Non-compliance|1|||
155106199|NCT01893411|559817604|FG001|Overall Study|Protocol Violation|0|||
154855703|NCT00868790|558899146|FG010|Post-study|Withdrawal by Subject|0|||
154855704|NCT00868790|558899147|FG011|Post-study|Withdrawal by Subject|0|||
154855705|NCT00868790|558899148|FG012|Post-study|Withdrawal by Subject|0|||
154855706|NCT00868790|558899149|FG013|Post-study|Withdrawal by Subject|0|||
154855707|NCT00868790|558899136|FG000|Post-study|Excluded Medication|0|||
154855708|NCT00868790|558899137|FG001|Post-study|Excluded Medication|0|||
154855709|NCT00868790|558899138|FG002|Post-study|Excluded Medication|0|||
154855710|NCT00868790|558899139|FG003|Post-study|Excluded Medication|0|||
154855711|NCT00868790|558899140|FG004|Post-study|Excluded Medication|0|||
154855712|NCT00868790|558899141|FG005|Post-study|Excluded Medication|0|||
155106200|NCT01893411|559817605|FG002|Overall Study|Protocol Violation|0|||
154855713|NCT00868790|558899142|FG006|Post-study|Excluded Medication|0|||
154855714|NCT00868790|558899143|FG007|Post-study|Excluded Medication|2|||
154855715|NCT00868790|558899144|FG008|Post-study|Excluded Medication|0|||
154855716|NCT00868790|558899145|FG009|Post-study|Excluded Medication|1|||
154855717|NCT00868790|558899146|FG010|Post-study|Excluded Medication|0|||
154855718|NCT00868790|558899147|FG011|Post-study|Excluded Medication|0|||
154855719|NCT00868790|558899148|FG012|Post-study|Excluded Medication|0|||
154855720|NCT00868790|558899149|FG013|Post-study|Excluded Medication|0|||
154855721|NCT01264939|558899150|FG000|Overall Study|Adverse Event|1|||
154855722|NCT01264939|558899151|FG001|Overall Study|Adverse Event|3|||
154855723|NCT01264939|558899150|FG000|Overall Study|Lost to Follow-up|0|||
154855724|NCT01264939|558899151|FG001|Overall Study|Lost to Follow-up|3|||
154855725|NCT01264939|558899150|FG000|Overall Study|Physician Decision|1|||
154855726|NCT01264939|558899151|FG001|Overall Study|Physician Decision|1|||
154855727|NCT01264939|558899150|FG000|Overall Study|Patient/Guardian Decision|8|||
154855728|NCT01264939|558899151|FG001|Overall Study|Patient/Guardian Decision|10|||
154855729|NCT01264939|558899150|FG000|Overall Study|Disease Progression|8|||
154855730|NCT01264939|558899151|FG001|Overall Study|Disease Progression|11|||
154855731|NCT00737529|558899157|FG000|Overall Study|Disease Progression|95|||
154855732|NCT00737529|558899157|FG000|Overall Study|Adverse Event|24|||
154855733|NCT00737529|558899157|FG000|Overall Study|Withdrawal by Subject|5|||
154855734|NCT00737529|558899157|FG000|Overall Study|Death|4|||
154855735|NCT00737529|558899157|FG000|Overall Study|Protocol Violation|1|||
154855736|NCT00737529|558899157|FG000|Overall Study|Other|4|||
154855737|NCT00854828|558899160|FG000|Overall Study|Death|1|||
154855738|NCT00854828|558899161|FG001|Overall Study|Death|0|||
154855739|NCT00854828|558899162|FG002|Overall Study|Death|0|||
154855740|NCT00854828|558899163|FG003|Overall Study|Death|0|||
154855741|NCT00854828|558899160|FG000|Overall Study|Withdrawal by Subject|1|||
154855742|NCT00854828|558899161|FG001|Overall Study|Withdrawal by Subject|1|||
154855743|NCT00854828|558899162|FG002|Overall Study|Withdrawal by Subject|0|||
154855744|NCT00854828|558899163|FG003|Overall Study|Withdrawal by Subject|9|||
154855745|NCT00854828|558899160|FG000|Overall Study|Missed 24mo visit|1|||
154855746|NCT00854828|558899161|FG001|Overall Study|Missed 24mo visit|1|||
154855747|NCT00854828|558899162|FG002|Overall Study|Missed 24mo visit|8|||
154855748|NCT00854828|558899163|FG003|Overall Study|Missed 24mo visit|8|||
154855749|NCT01282229|558899164|FG000|Overall Study|Protocol Violation|2|||
154855750|NCT00996203|558899165|FG000|Overall Study|Adverse Event|3|||
154855751|NCT00996203|558899165|FG000|Overall Study|Lost to Follow-up|1|||
154855752|NCT00996203|558899165|FG000|Overall Study|Lack of Efficacy|1|||
154855753|NCT00996203|558899165|FG000|Overall Study|Protocol Violation|2|||
154855754|NCT01671280|558899166|FG000|Overall Study|Withdrawal by Subject|2|||
155106201|NCT01893411|559817603|FG000|Overall Study|Physician Decision|1|||
155106202|NCT01893411|559817604|FG001|Overall Study|Physician Decision|1|||
154855755|NCT01959165|558899167|FG000|Overall Study|Adverse Event|0|||
154855756|NCT01959165|558899168|FG001|Overall Study|Adverse Event|0|||
154855757|NCT01959165|558899169|FG002|Overall Study|Adverse Event|0|||
154855758|NCT01959165|558899170|FG003|Overall Study|Adverse Event|1|||
154855759|NCT01959165|558899167|FG000|Overall Study|Lack of Efficacy|1|||
155106203|NCT01893411|559817605|FG002|Overall Study|Physician Decision|2|||
155106204|NCT01893411|559817603|FG000|Overall Study|Lack of Efficacy|2|||
155106205|NCT01893411|559817604|FG001|Overall Study|Lack of Efficacy|1|||
154855760|NCT01959165|558899168|FG001|Overall Study|Lack of Efficacy|0|||
154855761|NCT01959165|558899169|FG002|Overall Study|Lack of Efficacy|0|||
154855762|NCT01959165|558899170|FG003|Overall Study|Lack of Efficacy|0|||
154855763|NCT01959165|558899167|FG000|Overall Study|overdose|0|||
155106206|NCT01893411|559817605|FG002|Overall Study|Lack of Efficacy|0|||
155106207|NCT01893411|559817603|FG000|Overall Study|Other|3|||
154855764|NCT01959165|558899168|FG001|Overall Study|overdose|0|||
154855765|NCT01959165|558899169|FG002|Overall Study|overdose|0|||
154855766|NCT01959165|558899170|FG003|Overall Study|overdose|1|||
154855767|NCT01959165|558899167|FG000|Overall Study|Welfare recipient|0|||
154855768|NCT01959165|558899168|FG001|Overall Study|Welfare recipient|1|||
154855769|NCT01959165|558899169|FG002|Overall Study|Welfare recipient|0|||
154855770|NCT01959165|558899170|FG003|Overall Study|Welfare recipient|0|||
154855771|NCT00961961|558899171|FG000|Phase I|Withdrawal by Subject|7|||
154855772|NCT00961961|558899172|FG001|Phase I|Withdrawal by Subject|0|||
154855773|NCT00961961|558899173|FG002|Phase I|Withdrawal by Subject|0|||
154855774|NCT00961961|558899174|FG003|Phase I|Withdrawal by Subject|0|||
155106208|NCT01893411|559817604|FG001|Overall Study|Other|1|||
155106209|NCT01893411|559817605|FG002|Overall Study|Other|3|||
155106210|NCT01893411|559817603|FG000|Overall Study|Adverse Event|1|||
155106211|NCT01893411|559817604|FG001|Overall Study|Adverse Event|0|||
155106212|NCT01893411|559817605|FG002|Overall Study|Adverse Event|0|||
155106213|NCT01893411|559817603|FG000|Overall Study|Withdrawal by Subject|7|||
155106214|NCT01893411|559817604|FG001|Overall Study|Withdrawal by Subject|4|||
155106215|NCT01893411|559817605|FG002|Overall Study|Withdrawal by Subject|3|||
155106216|NCT01893411|559817603|FG000|Overall Study|Lost to Follow-up|2|||
155106217|NCT01893411|559817604|FG001|Overall Study|Lost to Follow-up|0|||
155106218|NCT01893411|559817605|FG002|Overall Study|Lost to Follow-up|1|||
155106219|NCT00566982|559817606|FG000|Overall Study|Adverse Event|6|||
155106220|NCT00566982|559817607|FG001|Overall Study|Adverse Event|48|||
155106221|NCT00566982|559817606|FG000|Overall Study|Withdrawal by Subject|1|||
155106222|NCT00566982|559817607|FG001|Overall Study|Withdrawal by Subject|14|||
155106223|NCT00566982|559817606|FG000|Overall Study|Protocol Violation|1|||
155106224|NCT00566982|559817607|FG001|Overall Study|Protocol Violation|4|||
155106225|NCT00566982|559817606|FG000|Overall Study|Lost to Follow-up|0|||
155106226|NCT00566982|559817607|FG001|Overall Study|Lost to Follow-up|1|||
155106227|NCT00566982|559817606|FG000|Overall Study|Other-family problems & doctor's request|0|||
155106228|NCT00566982|559817607|FG001|Overall Study|Other-family problems & doctor's request|2|||
155106229|NCT00161616|559817608|FG000|Overall Study|Withdrawal by Subject|6|||
155106230|NCT00161616|559817609|FG001|Overall Study|Withdrawal by Subject|5|||
155106231|NCT00161616|559817608|FG000|Overall Study|Physician Decision|1|||
155106232|NCT00161616|559817609|FG001|Overall Study|Physician Decision|0|||
155106233|NCT00161616|559817608|FG000|Overall Study|Death|1|||
155106234|NCT00161616|559817609|FG001|Overall Study|Death|1|||
154855775|NCT00961961|558899171|FG000|Phase I|Lost to Follow-up|10|||
154855776|NCT00961961|558899172|FG001|Phase I|Lost to Follow-up|0|||
154855777|NCT00961961|558899173|FG002|Phase I|Lost to Follow-up|0|||
154855778|NCT00961961|558899174|FG003|Phase I|Lost to Follow-up|0|||
154855779|NCT00961961|558899171|FG000|Phase I|Lack of Efficacy|94|||
154855780|NCT00961961|558899172|FG001|Phase I|Lack of Efficacy|0|||
154855781|NCT00961961|558899173|FG002|Phase I|Lack of Efficacy|0|||
154855782|NCT00961961|558899174|FG003|Phase I|Lack of Efficacy|0|||
154855783|NCT00961961|558899171|FG000|Phase I|Adverse Event|7|||
154855784|NCT00961961|558899172|FG001|Phase I|Adverse Event|0|||
154855785|NCT00961961|558899173|FG002|Phase I|Adverse Event|0|||
154855786|NCT00961961|558899174|FG003|Phase I|Adverse Event|0|||
154855787|NCT00961961|558899171|FG000|Phase I|Physician Decision|8|||
154855788|NCT00961961|558899172|FG001|Phase I|Physician Decision|0|||
154855789|NCT00961961|558899173|FG002|Phase I|Physician Decision|0|||
154855790|NCT00961961|558899174|FG003|Phase I|Physician Decision|0|||
154855791|NCT00961961|558899171|FG000|Phase II|Lost to Follow-up|0|||
154855792|NCT00961961|558899172|FG001|Phase II|Lost to Follow-up|0|||
154855793|NCT00961961|558899173|FG002|Phase II|Lost to Follow-up|10|||
154855794|NCT00961961|558899174|FG003|Phase II|Lost to Follow-up|7|||
154855795|NCT00961961|558899171|FG000|Phase II|Adverse Event|0|||
154855796|NCT00961961|558899172|FG001|Phase II|Adverse Event|0|||
154855797|NCT00961961|558899173|FG002|Phase II|Adverse Event|0|||
154855798|NCT00961961|558899174|FG003|Phase II|Adverse Event|1|||
154855799|NCT00961961|558899171|FG000|Phase II|Physician Decision|0|||
154855800|NCT00961961|558899172|FG001|Phase II|Physician Decision|0|||
154855801|NCT00961961|558899173|FG002|Phase II|Physician Decision|1|||
154855802|NCT00961961|558899174|FG003|Phase II|Physician Decision|0|||
154855803|NCT00961961|558899171|FG000|Phase II|Withdrawal by Subject|0|||
154855804|NCT00961961|558899172|FG001|Phase II|Withdrawal by Subject|0|||
154855805|NCT00961961|558899173|FG002|Phase II|Withdrawal by Subject|1|||
154971860|NCT00826241|559320716|FG000|Overall Study|Progression of disease|1|||
155106235|NCT00161616|559817608|FG000|Overall Study|Lost to Follow-up|17|||
154855806|NCT00961961|558899174|FG003|Phase II|Withdrawal by Subject|0|||
154855807|NCT01870739|558899182|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
154855808|NCT01870739|558899183|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
154855809|NCT01870739|558899182|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
154855810|NCT01870739|558899183|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
155106236|NCT00161616|559817609|FG001|Overall Study|Lost to Follow-up|13|||
155106237|NCT00161616|559817608|FG000|Overall Study|Protocol deviation|1|||
155106238|NCT00161616|559817609|FG001|Overall Study|Protocol deviation|0|||
155106239|NCT02719691|559817610|FG000|Overall Study|Physician Decision|0|||
155106240|NCT02719691|559817611|FG001|Overall Study|Physician Decision|0|||
155106241|NCT02719691|559817612|FG002|Overall Study|Physician Decision|1|||
155106242|NCT02719691|559817613|FG003|Overall Study|Physician Decision|0|||
154855811|NCT01870739|558899182|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
154855812|NCT01870739|558899183|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
154855813|NCT01870739|558899182|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
154855814|NCT01870739|558899183|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
154855815|NCT01870739|558899182|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
154855816|NCT01870739|558899183|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
155106243|NCT02719691|559817614|FG004|Overall Study|Physician Decision|0|||
155106244|NCT02719691|559817615|FG005|Overall Study|Physician Decision|0|||
155106245|NCT02719691|559817616|FG006|Overall Study|Physician Decision|0|||
154855817|NCT01870739|558899182|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
154855818|NCT01870739|558899183|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
154855819|NCT01870739|558899182|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
154855820|NCT01870739|558899183|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
154855821|NCT01926626|558899185|FG000|Overall Study|Withdrawal by Subject|15|||
154855822|NCT01926626|558899185|FG000|Overall Study|Lost to Follow-up|7|||
154855823|NCT03136107|558899188|FG000|Overall Study|Other (Not specified)|1|||
154855824|NCT03283085|558899189|FG000|Overall Study|Adverse Event|18|||
154855825|NCT03283085|558899190|FG001|Overall Study|Adverse Event|3|||
154855826|NCT03283085|558899191|FG002|Overall Study|Adverse Event|13|||
154855827|NCT03283085|558899192|FG003|Overall Study|Adverse Event|0|||
154855828|NCT03283085|558899193|FG004|Overall Study|Adverse Event|0|||
154855829|NCT03283085|558899194|FG005|Overall Study|Adverse Event|5|||
154855830|NCT03283085|558899189|FG000|Overall Study|Death|0|||
154855831|NCT03283085|558899190|FG001|Overall Study|Death|0|||
154855832|NCT03283085|558899191|FG002|Overall Study|Death|3|||
154855833|NCT03283085|558899192|FG003|Overall Study|Death|1|||
154855834|NCT03283085|558899193|FG004|Overall Study|Death|0|||
154855835|NCT03283085|558899194|FG005|Overall Study|Death|0|||
154855836|NCT03283085|558899189|FG000|Overall Study|Withdrawal by Subject|42|||
154855837|NCT03283085|558899190|FG001|Overall Study|Withdrawal by Subject|21|||
154855838|NCT03283085|558899191|FG002|Overall Study|Withdrawal by Subject|66|||
154855839|NCT03283085|558899192|FG003|Overall Study|Withdrawal by Subject|3|||
154855840|NCT03283085|558899193|FG004|Overall Study|Withdrawal by Subject|3|||
154855841|NCT03283085|558899194|FG005|Overall Study|Withdrawal by Subject|5|||
154855842|NCT03283085|558899189|FG000|Overall Study|Physician Decision|14|||
154855843|NCT03283085|558899190|FG001|Overall Study|Physician Decision|8|||
154855844|NCT03283085|558899191|FG002|Overall Study|Physician Decision|19|||
154855845|NCT03283085|558899192|FG003|Overall Study|Physician Decision|0|||
154855846|NCT03283085|558899193|FG004|Overall Study|Physician Decision|0|||
154855847|NCT03283085|558899194|FG005|Overall Study|Physician Decision|2|||
154855848|NCT03283085|558899189|FG000|Overall Study|Site Terminated by Sponsor|1|||
154855849|NCT03283085|558899190|FG001|Overall Study|Site Terminated by Sponsor|0|||
154855850|NCT03283085|558899191|FG002|Overall Study|Site Terminated by Sponsor|3|||
154855851|NCT03283085|558899192|FG003|Overall Study|Site Terminated by Sponsor|0|||
154855852|NCT03283085|558899193|FG004|Overall Study|Site Terminated by Sponsor|0|||
154855853|NCT03283085|558899194|FG005|Overall Study|Site Terminated by Sponsor|0|||
154855854|NCT03283085|558899189|FG000|Overall Study|Lost to Follow-up|2|||
154855855|NCT03283085|558899190|FG001|Overall Study|Lost to Follow-up|0|||
154855856|NCT03283085|558899191|FG002|Overall Study|Lost to Follow-up|2|||
154855857|NCT03283085|558899192|FG003|Overall Study|Lost to Follow-up|0|||
154855858|NCT03283085|558899193|FG004|Overall Study|Lost to Follow-up|0|||
154855859|NCT03283085|558899194|FG005|Overall Study|Lost to Follow-up|1|||
154855860|NCT03283085|558899189|FG000|Overall Study|Pregnancy|0|||
154855861|NCT03283085|558899190|FG001|Overall Study|Pregnancy|0|||
154855862|NCT03283085|558899191|FG002|Overall Study|Pregnancy|1|||
154855863|NCT03283085|558899192|FG003|Overall Study|Pregnancy|0|||
154855864|NCT03283085|558899193|FG004|Overall Study|Pregnancy|0|||
154855865|NCT03283085|558899194|FG005|Overall Study|Pregnancy|0|||
154855866|NCT03283085|558899189|FG000|Overall Study|Lack of Efficacy|12|||
154855867|NCT03283085|558899190|FG001|Overall Study|Lack of Efficacy|6|||
154855868|NCT03283085|558899191|FG002|Overall Study|Lack of Efficacy|24|||
154855869|NCT03283085|558899192|FG003|Overall Study|Lack of Efficacy|1|||
154855870|NCT03283085|558899193|FG004|Overall Study|Lack of Efficacy|1|||
154855871|NCT03283085|558899194|FG005|Overall Study|Lack of Efficacy|0|||
154855872|NCT03283085|558899189|FG000|Overall Study|Reason not Specified|0|||
154855873|NCT03283085|558899190|FG001|Overall Study|Reason not Specified|4|||
154855874|NCT03283085|558899191|FG002|Overall Study|Reason not Specified|8|||
154855875|NCT03283085|558899192|FG003|Overall Study|Reason not Specified|0|||
155106246|NCT02719691|559817610|FG000|Overall Study|Withdrawal by Subject|0|||
155106247|NCT02719691|559817611|FG001|Overall Study|Withdrawal by Subject|0|||
155106248|NCT02719691|559817612|FG002|Overall Study|Withdrawal by Subject|0|||
155106249|NCT02719691|559817613|FG003|Overall Study|Withdrawal by Subject|0|||
155106250|NCT02719691|559817614|FG004|Overall Study|Withdrawal by Subject|0|||
155106251|NCT02719691|559817615|FG005|Overall Study|Withdrawal by Subject|1|||
155106252|NCT02719691|559817616|FG006|Overall Study|Withdrawal by Subject|0|||
155106253|NCT02141633|559817619|FG000|Overall Study|Physician Decision|1|||
155106254|NCT02141633|559817620|FG001|Overall Study|Physician Decision|0|||
155106255|NCT02403817|559817621|FG000|Overall Study|Withdrawal by Subject|5|||
154855876|NCT03283085|558899193|FG004|Overall Study|Reason not Specified|0|||
154855877|NCT03283085|558899194|FG005|Overall Study|Reason not Specified|1|||
154855878|NCT00891202|558899195|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
154855879|NCT00891202|558899196|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
154855880|NCT00891202|558899197|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
154855881|NCT00891202|558899198|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
154855882|NCT00891202|558899195|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
154855883|NCT00891202|558899196|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
154855884|NCT00891202|558899197|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
154855885|NCT00891202|558899198|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
154855886|NCT00891202|558899195|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
154855887|NCT00891202|558899196|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
154855888|NCT00891202|558899197|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
154855889|NCT00891202|558899198|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
154855890|NCT00891202|558899195|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
154855891|NCT00891202|558899196|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
154855892|NCT00891202|558899197|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
154855893|NCT00891202|558899198|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
154855894|NCT02292771|558899202|FG000|Overall Study|Withdrawal by Subject|2|||
154855895|NCT02292771|558899203|FG001|Overall Study|Withdrawal by Subject|1|||
154855896|NCT02292771|558899202|FG000|Overall Study|Lost to Follow-up|2|||
154855897|NCT02292771|558899203|FG001|Overall Study|Lost to Follow-up|1|||
154855898|NCT01468311|558899204|FG000|Overall Study|mobilization failure|1|||
154855899|NCT01468311|558899204|FG000|Overall Study|Withdrawal by Subject|1|||
154855900|NCT04840667|558901260|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
154855901|NCT04854499|558901263|FG000|Overall Study|Study Terminated by Sponsor|5|||
154855902|NCT04854499|558901264|FG001|Overall Study|Study Terminated by Sponsor|27|||
154855903|NCT04854499|558901265|FG002|Overall Study|Study Terminated by Sponsor|28|||
154855904|NCT04854499|558901266|FG003|Overall Study|Study Terminated by Sponsor|19|||
154855905|NCT04854499|558901267|FG004|Overall Study|Study Terminated by Sponsor|1|||
154855906|NCT04854499|558901268|FG005|Overall Study|Study Terminated by Sponsor|10|||
154855907|NCT04854499|558901263|FG000|Overall Study|Death|1|||
154855908|NCT04854499|558901264|FG001|Overall Study|Death|23|||
154855909|NCT04854499|558901265|FG002|Overall Study|Death|21|||
154855910|NCT04854499|558901266|FG003|Overall Study|Death|7|||
154855911|NCT04854499|558901267|FG004|Overall Study|Death|6|||
154855912|NCT04854499|558901268|FG005|Overall Study|Death|24|||
154855913|NCT04854499|558901263|FG000|Overall Study|Investigator's Discretion|0|||
154855914|NCT04854499|558901264|FG001|Overall Study|Investigator's Discretion|1|||
154855915|NCT04854499|558901265|FG002|Overall Study|Investigator's Discretion|3|||
154855916|NCT04854499|558901266|FG003|Overall Study|Investigator's Discretion|4|||
154855917|NCT04854499|558901267|FG004|Overall Study|Investigator's Discretion|1|||
154855918|NCT04854499|558901268|FG005|Overall Study|Investigator's Discretion|5|||
154855919|NCT04854499|558901263|FG000|Overall Study|Withdrew Consent|0|||
154855920|NCT04854499|558901264|FG001|Overall Study|Withdrew Consent|1|||
154855921|NCT04854499|558901265|FG002|Overall Study|Withdrew Consent|2|||
154855922|NCT04854499|558901266|FG003|Overall Study|Withdrew Consent|2|||
154855923|NCT04854499|558901267|FG004|Overall Study|Withdrew Consent|0|||
154855924|NCT04854499|558901268|FG005|Overall Study|Withdrew Consent|1|||
154855925|NCT04854499|558901263|FG000|Overall Study|Lost to Follow-up|0|||
154855926|NCT04854499|558901264|FG001|Overall Study|Lost to Follow-up|0|||
154855927|NCT04854499|558901265|FG002|Overall Study|Lost to Follow-up|0|||
154855928|NCT04854499|558901266|FG003|Overall Study|Lost to Follow-up|0|||
154855929|NCT04854499|558901267|FG004|Overall Study|Lost to Follow-up|0|||
154855930|NCT04854499|558901268|FG005|Overall Study|Lost to Follow-up|1|||
154855931|NCT00398112|558901285|FG000|Overall Study|Adverse Event|4|||
154855932|NCT00398112|558901285|FG000|Overall Study|Disease progression|9|||
154855933|NCT00398112|558901285|FG000|Overall Study|Alternative treatment|1|||
154855934|NCT00398112|558901285|FG000|Overall Study|Withdrawal by Subject|3|||
154855935|NCT00398112|558901285|FG000|Overall Study|Death|1|||
154855936|NCT02300129|558901287|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
154855937|NCT02300129|558901288|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
154855938|NCT02300129|558901289|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
154855939|NCT02300129|558901290|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
154855940|NCT02300129|558901287|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
154855941|NCT02300129|558901288|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
154855942|NCT02300129|558901289|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
154855943|NCT02300129|558901290|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
154855944|NCT02300129|558901287|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
154855945|NCT02300129|558901288|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
154855946|NCT02300129|558901289|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
154855947|NCT02300129|558901290|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
154855948|NCT03932812|558901292|FG000|Overall Study|Lost to Follow-up|12|||
154855949|NCT03932812|558901293|FG001|Overall Study|Lost to Follow-up|14|||
154855950|NCT03932812|558901292|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
154855951|NCT03932812|558901293|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
154855952|NCT01154101|558901298|FG000|Overall Study|Adverse Event|0|||
154855953|NCT01154101|558901299|FG001|Overall Study|Adverse Event|2|||
154855954|NCT01154101|558901300|FG002|Overall Study|Adverse Event|1|||
154855955|NCT01154101|558901301|FG003|Overall Study|Adverse Event|1|||
154855956|NCT01154101|558901302|FG004|Overall Study|Adverse Event|0|||
154855957|NCT01154101|558901298|FG000|Overall Study|Lost to Follow-up|0|||
154855958|NCT01154101|558901299|FG001|Overall Study|Lost to Follow-up|1|||
154855959|NCT01154101|558901300|FG002|Overall Study|Lost to Follow-up|0|||
154855960|NCT01154101|558901301|FG003|Overall Study|Lost to Follow-up|1|||
154855961|NCT01154101|558901302|FG004|Overall Study|Lost to Follow-up|0|||
154855962|NCT01154101|558901298|FG000|Overall Study|Withdrawal by Subject|0|||
154855963|NCT01154101|558901299|FG001|Overall Study|Withdrawal by Subject|1|||
154855964|NCT01154101|558901300|FG002|Overall Study|Withdrawal by Subject|2|||
154855965|NCT01154101|558901301|FG003|Overall Study|Withdrawal by Subject|0|||
154855966|NCT01154101|558901302|FG004|Overall Study|Withdrawal by Subject|1|||
154855967|NCT05019131|558901303|FG000|Overall Study|Lost to Follow-up|0|||
154855968|NCT05019131|558901304|FG001|Overall Study|Lost to Follow-up|3|||
154855969|NCT03575104|558901305|FG000|Overall Study|Adverse Event|4|||
154855970|NCT03575104|558901306|FG001|Overall Study|Adverse Event|3|||
154855971|NCT03575104|558901307|FG002|Overall Study|Adverse Event|4|||
154855972|NCT03575104|558901305|FG000|Overall Study|Withdrawal by Subject|13|||
154855973|NCT03575104|558901306|FG001|Overall Study|Withdrawal by Subject|16|||
154855974|NCT03575104|558901307|FG002|Overall Study|Withdrawal by Subject|11|||
154855975|NCT03575104|558901305|FG000|Overall Study|Other reasons|6|||
154855976|NCT03575104|558901306|FG001|Overall Study|Other reasons|8|||
154855977|NCT03575104|558901307|FG002|Overall Study|Other reasons|6|||
154855978|NCT03575104|558901305|FG000|Overall Study|Lost to Follow-up|1|||
154855979|NCT03575104|558901306|FG001|Overall Study|Lost to Follow-up|2|||
154855980|NCT03575104|558901307|FG002|Overall Study|Lost to Follow-up|1|||
154855981|NCT02661594|558901308|FG000|Overall Study|Protocol Violation|1|||
154855982|NCT02661594|558901309|FG001|Overall Study|Protocol Violation|0|||
154855983|NCT02661594|558901310|FG002|Overall Study|Protocol Violation|1|||
154855984|NCT02661594|558901311|FG003|Overall Study|Protocol Violation|0|||
154855985|NCT00432237|558901312|FG000|Overall Study|Adverse Event|0|||
154855986|NCT00432237|558901313|FG001|Overall Study|Adverse Event|0|||
154855987|NCT00432237|558901314|FG002|Overall Study|Adverse Event|0|||
154855988|NCT00432237|558901315|FG003|Overall Study|Adverse Event|1|||
154855989|NCT00432237|558901312|FG000|Overall Study|Lack of Efficacy|0|||
154855990|NCT00432237|558901313|FG001|Overall Study|Lack of Efficacy|0|||
154855991|NCT00432237|558901314|FG002|Overall Study|Lack of Efficacy|0|||
154855992|NCT00432237|558901315|FG003|Overall Study|Lack of Efficacy|1|||
154855993|NCT00432237|558901312|FG000|Overall Study|Lost to Follow-up|10|||
154855994|NCT00432237|558901313|FG001|Overall Study|Lost to Follow-up|10|||
154855995|NCT00432237|558901314|FG002|Overall Study|Lost to Follow-up|18|||
154855996|NCT00432237|558901315|FG003|Overall Study|Lost to Follow-up|18|||
154855997|NCT00432237|558901312|FG000|Overall Study|Physician Decision|1|||
154855998|NCT00432237|558901313|FG001|Overall Study|Physician Decision|3|||
154855999|NCT00432237|558901314|FG002|Overall Study|Physician Decision|2|||
154856000|NCT00432237|558901315|FG003|Overall Study|Physician Decision|1|||
154856001|NCT00432237|558901312|FG000|Overall Study|Pregnancy|0|||
154856002|NCT00432237|558901313|FG001|Overall Study|Pregnancy|1|||
154856003|NCT00432237|558901314|FG002|Overall Study|Pregnancy|0|||
154856004|NCT00432237|558901315|FG003|Overall Study|Pregnancy|0|||
154856005|NCT00432237|558901312|FG000|Overall Study|Protocol Violation|13|||
154856006|NCT00432237|558901313|FG001|Overall Study|Protocol Violation|10|||
154856007|NCT00432237|558901314|FG002|Overall Study|Protocol Violation|11|||
154856008|NCT00432237|558901315|FG003|Overall Study|Protocol Violation|8|||
154856009|NCT00432237|558901312|FG000|Overall Study|Withdrawal by Subject|5|||
154856010|NCT00432237|558901313|FG001|Overall Study|Withdrawal by Subject|6|||
154856011|NCT00432237|558901314|FG002|Overall Study|Withdrawal by Subject|9|||
154856012|NCT00432237|558901315|FG003|Overall Study|Withdrawal by Subject|11|||
154856013|NCT00432237|558901312|FG000|Overall Study|Lack of Qualifying Event|38|||
154856014|NCT00432237|558901313|FG001|Overall Study|Lack of Qualifying Event|71|||
155106256|NCT02403817|559817622|FG001|Overall Study|Withdrawal by Subject|0|||
155106257|NCT00473889|559817625|FG000|Overall Study|Did not receive study medication|1|||
155106258|NCT00473889|559817626|FG001|Overall Study|Did not receive study medication|4|||
155106259|NCT00473889|559817625|FG000|Overall Study|Adverse Event|30|||
155106260|NCT00473889|559817626|FG001|Overall Study|Adverse Event|17|||
155106261|NCT00473889|559817625|FG000|Overall Study|Protocol Violation|4|||
155106262|NCT00473889|559817626|FG001|Overall Study|Protocol Violation|2|||
154856015|NCT00432237|558901314|FG002|Overall Study|Lack of Qualifying Event|69|||
154856016|NCT00432237|558901315|FG003|Overall Study|Lack of Qualifying Event|84|||
154856017|NCT03049449|558901319|FG000|Overall Study|Did not receive treatment.|0|||
154856018|NCT03049449|558901320|FG001|Overall Study|Did not receive treatment.|0|||
154856019|NCT03049449|558901321|FG002|Overall Study|Did not receive treatment.|0|||
154856020|NCT03049449|558901322|FG003|Overall Study|Did not receive treatment.|0|||
154856021|NCT03049449|558901323|FG004|Overall Study|Did not receive treatment.|0|||
154856022|NCT03049449|558901324|FG005|Overall Study|Did not receive treatment.|0|||
154856023|NCT03049449|558901325|FG006|Overall Study|Did not receive treatment.|0|||
154856024|NCT03049449|558901326|FG007|Overall Study|Did not receive treatment.|0|||
154856025|NCT03049449|558901327|FG008|Overall Study|Did not receive treatment.|1|||
154856026|NCT03049449|558901328|FG009|Overall Study|Did not receive treatment.|0|||
154856027|NCT03049449|558901319|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
154856028|NCT03049449|558901320|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
155106263|NCT00473889|559817625|FG000|Overall Study|Lack of Efficacy|28|||
154856029|NCT03049449|558901321|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
154856030|NCT03049449|558901322|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
154856031|NCT03049449|558901323|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
154856032|NCT03049449|558901324|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
154856033|NCT03049449|558901325|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
154856034|NCT03049449|558901326|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
154856035|NCT03049449|558901327|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
154856036|NCT03049449|558901328|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
154856037|NCT03049449|558901319|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856038|NCT03049449|558901320|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856039|NCT03049449|558901321|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856040|NCT03049449|558901322|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856041|NCT03049449|558901323|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856042|NCT03049449|558901324|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856043|NCT03049449|558901325|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856044|NCT03049449|558901326|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
154856045|NCT03049449|558901327|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
154856046|NCT03049449|558901328|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
154856047|NCT03304522|558901334|FG000|Overall Study|Adverse Event|0|||
154856048|NCT03304522|558901335|FG001|Overall Study|Adverse Event|4|||
154856049|NCT03304522|558901334|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
154856050|NCT03304522|558901335|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
154856051|NCT03304522|558901334|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
154856052|NCT03304522|558901335|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
154856053|NCT03304522|558901334|FG000|Overall Study|Other|0|||
154856054|NCT03304522|558901335|FG001|Overall Study|Other|1|||
154856055|NCT02649634|558901339|FG000|Overall Study|Withdrawal by Subject|3|||
154856056|NCT02649634|558901340|FG001|Overall Study|Withdrawal by Subject|5|||
154856057|NCT02649634|558901339|FG000|Overall Study|Lost to Follow-up|0|||
154856058|NCT02649634|558901340|FG001|Overall Study|Lost to Follow-up|1|||
154856059|NCT00763009|558901342|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
154856060|NCT01111604|558901343|FG000|Overall Study|Lost to Follow-up|0|||
154856061|NCT01111604|558901344|FG001|Overall Study|Lost to Follow-up|0|||
154856062|NCT01111604|558901345|FG002|Overall Study|Lost to Follow-up|1|||
154856063|NCT01111604|558901343|FG000|Overall Study|Withdrew Consent|3|||
154856064|NCT01111604|558901344|FG001|Overall Study|Withdrew Consent|0|||
154856065|NCT01111604|558901345|FG002|Overall Study|Withdrew Consent|2|||
154856066|NCT01111604|558901343|FG000|Overall Study|Withdrawal by Subject|2|||
154856067|NCT01111604|558901344|FG001|Overall Study|Withdrawal by Subject|0|||
154856068|NCT01111604|558901345|FG002|Overall Study|Withdrawal by Subject|0|||
154856069|NCT01111604|558901343|FG000|Overall Study|Death|1|||
154856070|NCT01111604|558901344|FG001|Overall Study|Death|0|||
154856071|NCT01111604|558901345|FG002|Overall Study|Death|0|||
154856072|NCT01111604|558901343|FG000|Overall Study|Met Exclusion Criteria|2|||
154856073|NCT01111604|558901344|FG001|Overall Study|Met Exclusion Criteria|0|||
154856074|NCT01111604|558901345|FG002|Overall Study|Met Exclusion Criteria|0|||
154856075|NCT01295125|558901347|FG000|Overall Study|Study stopped prematurely|9|||
154856076|NCT01355289|558901348|FG000|Core Study|Adverse Event, Non-Fatal|1|||
154856077|NCT01355289|558901349|FG001|Core Study|Adverse Event, Non-Fatal|0|||
154856078|NCT01355289|558901350|FG002|Core Study|Adverse Event, Non-Fatal|0|||
154856079|NCT01355289|558901351|FG003|Core Study|Adverse Event, Non-Fatal|0|||
154856080|NCT01355289|558901352|FG004|Core Study|Adverse Event, Non-Fatal|0|||
154856081|NCT01355289|558901348|FG000|Core Study|Inadequate Therapeutic Effect|0|||
154856082|NCT01355289|558901349|FG001|Core Study|Inadequate Therapeutic Effect|0|||
154856083|NCT01355289|558901350|FG002|Core Study|Inadequate Therapeutic Effect|0|||
154856084|NCT01355289|558901351|FG003|Core Study|Inadequate Therapeutic Effect|1|||
154856085|NCT01355289|558901352|FG004|Core Study|Inadequate Therapeutic Effect|0|||
154856086|NCT01355289|558901348|FG000|Core Study|Other|0|||
154856087|NCT01355289|558901349|FG001|Core Study|Other|0|||
154856088|NCT01355289|558901350|FG002|Core Study|Other|0|||
154856089|NCT01355289|558901351|FG003|Core Study|Other|1|||
155106264|NCT00473889|559817626|FG001|Overall Study|Lack of Efficacy|29|||
154856090|NCT01355289|558901352|FG004|Core Study|Other|0|||
154856091|NCT01355289|558901348|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
154856092|NCT01355289|558901349|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
154856093|NCT01355289|558901350|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
154856094|NCT01355289|558901351|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
154856095|NCT01355289|558901352|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
154856096|NCT01355289|558901348|FG000|Open Label Extension|Lost to Follow-up|0|||
154856097|NCT01355289|558901349|FG001|Open Label Extension|Lost to Follow-up|0|||
154856098|NCT01355289|558901350|FG002|Open Label Extension|Lost to Follow-up|0|||
154856099|NCT01355289|558901351|FG003|Open Label Extension|Lost to Follow-up|0|||
154856100|NCT01355289|558901352|FG004|Open Label Extension|Lost to Follow-up|1|||
154856101|NCT01355289|558901348|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
154856102|NCT01355289|558901349|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
154856103|NCT01355289|558901350|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
154856104|NCT01355289|558901351|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
154856105|NCT01355289|558901352|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
154856106|NCT01355289|558901348|FG000|Open Label Extension|Other|0|||
154856107|NCT01355289|558901349|FG001|Open Label Extension|Other|0|||
154856108|NCT01355289|558901350|FG002|Open Label Extension|Other|0|||
154856109|NCT01355289|558901351|FG003|Open Label Extension|Other|0|||
154856110|NCT01355289|558901352|FG004|Open Label Extension|Other|3|||
154856111|NCT01756456|558901359|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
154856112|NCT01756456|558901360|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
154856113|NCT01756456|558901361|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
154856114|NCT01756456|558901362|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
154856115|NCT01756456|558901363|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
154856116|NCT01756456|558901364|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
154856117|NCT01756456|558901359|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
154856118|NCT01756456|558901360|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
154856119|NCT01756456|558901361|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
154856120|NCT01756456|558901362|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
154856121|NCT01756456|558901363|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
154856122|NCT01756456|558901364|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
154856123|NCT01756456|558901359|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
154856124|NCT01756456|558901360|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
154856125|NCT01756456|558901361|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
154856126|NCT01756456|558901362|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
154856127|NCT01756456|558901363|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
154856128|NCT01756456|558901364|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
154856129|NCT01756456|558901359|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
154856130|NCT01756456|558901360|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
154856131|NCT01756456|558901361|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
154856132|NCT01756456|558901362|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
154856133|NCT01756456|558901363|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
154856134|NCT01756456|558901364|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
154856135|NCT01756456|558901359|FG000|Treatment Period: Phase I/II|Other causes|0|||
154856136|NCT01756456|558901360|FG001|Treatment Period: Phase I/II|Other causes|0|||
154856137|NCT01756456|558901361|FG002|Treatment Period: Phase I/II|Other causes|0|||
154856138|NCT01756456|558901362|FG003|Treatment Period: Phase I/II|Other causes|1|||
154856139|NCT01756456|558901363|FG004|Treatment Period: Phase I/II|Other causes|2|||
154856140|NCT01756456|558901364|FG005|Treatment Period: Phase I/II|Other causes|2|||
154856141|NCT01756456|558901359|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
154856142|NCT01756456|558901360|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
154856143|NCT01756456|558901361|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
154856144|NCT01756456|558901362|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
154856145|NCT01756456|558901363|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
154856146|NCT01756456|558901364|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
154856147|NCT01756456|558901359|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
154856148|NCT01756456|558901360|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
154856149|NCT01756456|558901361|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
154856150|NCT01756456|558901362|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
154856151|NCT01756456|558901363|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
154856152|NCT01756456|558901364|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
154856153|NCT01756456|558901359|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
154856154|NCT01756456|558901360|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
154856155|NCT01756456|558901361|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
155106265|NCT00473889|559817625|FG000|Overall Study|Lost to Follow-up|2|||
155106266|NCT00473889|559817626|FG001|Overall Study|Lost to Follow-up|1|||
155106267|NCT00473889|559817625|FG000|Overall Study|Physician Decision|10|||
154971861|NCT00826241|559320716|FG000|Overall Study|Patient refused follow-up|3|||
155106268|NCT00473889|559817626|FG001|Overall Study|Physician Decision|5|||
154856156|NCT01756456|558901362|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
154856157|NCT01756456|558901363|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
154856158|NCT01756456|558901364|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
155106269|NCT00473889|559817625|FG000|Overall Study|Trial Terminated|3|||
154856159|NCT01756456|558901359|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
154856160|NCT01756456|558901360|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
154856161|NCT01756456|558901361|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
154856162|NCT01756456|558901362|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
154856163|NCT01756456|558901363|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
154856164|NCT01756456|558901364|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
154856165|NCT01756456|558901359|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
154856166|NCT01756456|558901360|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
154856167|NCT01756456|558901361|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
154856168|NCT01756456|558901362|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
154856169|NCT01756456|558901363|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
154856170|NCT01756456|558901364|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
154856171|NCT01756456|558901359|FG000|Follow Up Period Phase I/II|Other causes|0|||
154856172|NCT01756456|558901360|FG001|Follow Up Period Phase I/II|Other causes|0|||
154856173|NCT01756456|558901361|FG002|Follow Up Period Phase I/II|Other causes|0|||
154856174|NCT01756456|558901362|FG003|Follow Up Period Phase I/II|Other causes|1|||
154856175|NCT01756456|558901363|FG004|Follow Up Period Phase I/II|Other causes|3|||
154856176|NCT01756456|558901364|FG005|Follow Up Period Phase I/II|Other causes|5|||
154856177|NCT03838484|558901367|FG000|Overall Study|Lost to Follow-up|0|||
154856178|NCT03838484|558901368|FG001|Overall Study|Lost to Follow-up|1|||
154856179|NCT03838484|558901369|FG002|Overall Study|Lost to Follow-up|0|||
154856180|NCT03838484|558901370|FG003|Overall Study|Lost to Follow-up|0|||
154856181|NCT00813995|558901371|FG000|Overall Study|Clinical adverse event|9|||
154856182|NCT00813995|558901372|FG001|Overall Study|Clinical adverse event|3|||
154856183|NCT00813995|558901371|FG000|Overall Study|Laboratory adverse event|0|||
154856184|NCT00813995|558901372|FG001|Overall Study|Laboratory adverse event|2|||
154856185|NCT00813995|558901371|FG000|Overall Study|Lack of Efficacy|1|||
154856186|NCT00813995|558901372|FG001|Overall Study|Lack of Efficacy|0|||
154856187|NCT00813995|558901371|FG000|Overall Study|Lost to Follow-up|4|||
154856188|NCT00813995|558901372|FG001|Overall Study|Lost to Follow-up|2|||
154856189|NCT00813995|558901371|FG000|Overall Study|Other reason|2|||
154856190|NCT00813995|558901372|FG001|Overall Study|Other reason|2|||
154856191|NCT00813995|558901371|FG000|Overall Study|Protocol Violation|3|||
154856192|NCT00813995|558901372|FG001|Overall Study|Protocol Violation|2|||
154856193|NCT00813995|558901371|FG000|Overall Study|Subject moved|4|||
154856194|NCT00813995|558901372|FG001|Overall Study|Subject moved|0|||
154856195|NCT00813995|558901371|FG000|Overall Study|Withdrawal by Subject|0|||
154856196|NCT00813995|558901372|FG001|Overall Study|Withdrawal by Subject|5|||
154856197|NCT02507349|558901373|FG000|Overall Study|Death|12|||
154856198|NCT02507349|558901374|FG001|Overall Study|Death|16|||
154856199|NCT02507349|558901373|FG000|Overall Study|Withdrawal by Subject|1|||
154856200|NCT02507349|558901374|FG001|Overall Study|Withdrawal by Subject|1|||
154856201|NCT02507349|558901373|FG000|Overall Study|Lost to Follow-up|174|||
154856202|NCT02507349|558901374|FG001|Overall Study|Lost to Follow-up|144|||
154856203|NCT01614964|558901375|FG000|Overall Study|Withdrawal by Subject|2|||
154856204|NCT01614964|558901376|FG001|Overall Study|Withdrawal by Subject|0|||
154856205|NCT01614964|558901375|FG000|Overall Study|Lost to Follow-up|3|||
154856206|NCT01614964|558901376|FG001|Overall Study|Lost to Follow-up|0|||
154856207|NCT00860470|558901385|FG000|Overall Study|Death|6|||
154856208|NCT00860470|558901386|FG001|Overall Study|Death|10|||
154856209|NCT00860470|558901385|FG000|Overall Study|Moved away|8|||
154856210|NCT00860470|558901386|FG001|Overall Study|Moved away|10|||
154856211|NCT00860470|558901385|FG000|Overall Study|Lost to Follow-up|34|||
154856212|NCT00860470|558901386|FG001|Overall Study|Lost to Follow-up|39|||
154856213|NCT02700984|558901388|FG000|Overall Study|Death|2|||
154856214|NCT02700984|558901389|FG001|Overall Study|Death|1|||
154856215|NCT02700984|558901388|FG000|Overall Study|Lost to Follow-up|2|||
154856216|NCT02700984|558901389|FG001|Overall Study|Lost to Follow-up|1|||
154856217|NCT02700984|558901388|FG000|Overall Study|Physician Decision|0|||
154856218|NCT02700984|558901389|FG001|Overall Study|Physician Decision|1|||
154856219|NCT02700984|558901388|FG000|Overall Study|Withdrawal by Subject|8|||
154856220|NCT02700984|558901389|FG001|Overall Study|Withdrawal by Subject|9|||
154856221|NCT02700984|558901388|FG000|Overall Study|Reason not specified|3|||
154856222|NCT02700984|558901389|FG001|Overall Study|Reason not specified|2|||
154856223|NCT01032629|558901390|FG000|Overall Study|Closed Site|21|||
154856224|NCT01032629|558901391|FG001|Overall Study|Closed Site|18|||
154856225|NCT01032629|558901392|FG002|Overall Study|Closed Site|16|||
154856226|NCT01032629|558901390|FG000|Overall Study|Withdrawal by Subject|50|||
154856227|NCT01032629|558901391|FG001|Overall Study|Withdrawal by Subject|36|||
154856228|NCT01032629|558901392|FG002|Overall Study|Withdrawal by Subject|35|||
154856229|NCT01032629|558901390|FG000|Overall Study|Lost to Follow-up|74|||
154856230|NCT01032629|558901391|FG001|Overall Study|Lost to Follow-up|47|||
154856231|NCT01032629|558901392|FG002|Overall Study|Lost to Follow-up|37|||
154856232|NCT03371355|558901393|FG000|Overall Study|Investigator judgment|0|||
154856233|NCT03371355|558901394|FG001|Overall Study|Investigator judgment|0|||
154856234|NCT03371355|558901395|FG002|Overall Study|Investigator judgment|1|||
154856235|NCT03371355|558901396|FG003|Overall Study|Investigator judgment|1|||
154856236|NCT03371355|558901393|FG000|Overall Study|Voluntary withdrawal|1|||
155106270|NCT00473889|559817626|FG001|Overall Study|Trial Terminated|6|||
155106271|NCT00473889|559817625|FG000|Overall Study|Withdrawal by Subject|5|||
155106272|NCT00473889|559817626|FG001|Overall Study|Withdrawal by Subject|0|||
155106273|NCT01498692|559817630|FG000|Overall Study|Death|4|||
154856237|NCT03371355|558901394|FG001|Overall Study|Voluntary withdrawal|0|||
154856238|NCT03371355|558901395|FG002|Overall Study|Voluntary withdrawal|1|||
154856239|NCT03371355|558901396|FG003|Overall Study|Voluntary withdrawal|2|||
154856240|NCT03371355|558901393|FG000|Overall Study|Adverse Event|0|||
155106274|NCT01498692|559817630|FG000|Overall Study|Withdrawal by Subject|1|||
155106275|NCT01498692|559817630|FG000|Overall Study|Missed 12-month visit|3|||
155106276|NCT01947283|559817631|FG000|Overall Study|Death|1|||
155106277|NCT01947283|559817632|FG001|Overall Study|Death|1|||
155106278|NCT01947283|559817633|FG002|Overall Study|Death|1|||
155106279|NCT01947283|559817634|FG003|Overall Study|Death|0|||
155106280|NCT01947283|559817635|FG004|Overall Study|Death|0|||
155106281|NCT01947283|559817636|FG005|Overall Study|Death|0|||
155106282|NCT01947283|559817637|FG006|Overall Study|Death|0|||
155106283|NCT01947283|559817631|FG000|Overall Study|Lost to Follow-up|4|||
155106284|NCT01947283|559817632|FG001|Overall Study|Lost to Follow-up|6|||
155106285|NCT01947283|559817633|FG002|Overall Study|Lost to Follow-up|5|||
155106286|NCT01947283|559817634|FG003|Overall Study|Lost to Follow-up|5|||
155106287|NCT01947283|559817635|FG004|Overall Study|Lost to Follow-up|0|||
155106288|NCT01947283|559817636|FG005|Overall Study|Lost to Follow-up|2|||
155106289|NCT01947283|559817637|FG006|Overall Study|Lost to Follow-up|5|||
155106290|NCT01947283|559817631|FG000|Overall Study|Withdrawal by Subject|10|||
155106291|NCT01947283|559817632|FG001|Overall Study|Withdrawal by Subject|8|||
155106292|NCT01947283|559817633|FG002|Overall Study|Withdrawal by Subject|4|||
155106293|NCT01947283|559817634|FG003|Overall Study|Withdrawal by Subject|1|||
155106294|NCT01947283|559817635|FG004|Overall Study|Withdrawal by Subject|0|||
155106295|NCT01947283|559817636|FG005|Overall Study|Withdrawal by Subject|0|||
155106296|NCT01947283|559817637|FG006|Overall Study|Withdrawal by Subject|2|||
155106297|NCT01947283|559817631|FG000|Overall Study|No Clinical Recording|12|||
155106298|NCT01947283|559817632|FG001|Overall Study|No Clinical Recording|6|||
155106299|NCT01947283|559817633|FG002|Overall Study|No Clinical Recording|8|||
155106300|NCT01947283|559817634|FG003|Overall Study|No Clinical Recording|10|||
155106301|NCT01947283|559817635|FG004|Overall Study|No Clinical Recording|0|||
155106302|NCT01947283|559817636|FG005|Overall Study|No Clinical Recording|0|||
155106303|NCT01947283|559817637|FG006|Overall Study|No Clinical Recording|0|||
155106304|NCT01947283|559817631|FG000|Overall Study|Non-coding Clinical Recording language|0|||
155106305|NCT01947283|559817632|FG001|Overall Study|Non-coding Clinical Recording language|0|||
155106306|NCT01947283|559817633|FG002|Overall Study|Non-coding Clinical Recording language|0|||
155106307|NCT01947283|559817634|FG003|Overall Study|Non-coding Clinical Recording language|1|||
155106308|NCT01947283|559817635|FG004|Overall Study|Non-coding Clinical Recording language|0|||
155106309|NCT01947283|559817636|FG005|Overall Study|Non-coding Clinical Recording language|0|||
155106310|NCT01947283|559817637|FG006|Overall Study|Non-coding Clinical Recording language|0|||
155106311|NCT01947283|559817631|FG000|Overall Study|Missing Follow-up Assessment|2|||
155106312|NCT01947283|559817632|FG001|Overall Study|Missing Follow-up Assessment|2|||
155106313|NCT01947283|559817633|FG002|Overall Study|Missing Follow-up Assessment|3|||
155106314|NCT01947283|559817634|FG003|Overall Study|Missing Follow-up Assessment|0|||
155106315|NCT01947283|559817635|FG004|Overall Study|Missing Follow-up Assessment|0|||
155106316|NCT01947283|559817636|FG005|Overall Study|Missing Follow-up Assessment|2|||
155106317|NCT01947283|559817637|FG006|Overall Study|Missing Follow-up Assessment|0|||
155106318|NCT01947283|559817631|FG000|Overall Study|No patients were enrolled in study|0|||
155106319|NCT01947283|559817632|FG001|Overall Study|No patients were enrolled in study|0|||
155106320|NCT01947283|559817633|FG002|Overall Study|No patients were enrolled in study|0|||
154856241|NCT03371355|558901394|FG001|Overall Study|Adverse Event|1|||
154856242|NCT03371355|558901395|FG002|Overall Study|Adverse Event|2|||
154856243|NCT03371355|558901396|FG003|Overall Study|Adverse Event|3|||
154856244|NCT03371355|558901393|FG000|Overall Study|Reason not Specified|0|||
154856245|NCT03371355|558901394|FG001|Overall Study|Reason not Specified|1|||
154856246|NCT03371355|558901395|FG002|Overall Study|Reason not Specified|0|||
154856247|NCT03371355|558901396|FG003|Overall Study|Reason not Specified|1|||
154856248|NCT00619957|558901401|FG000|Month 24 Double-Blind|Adverse Event|9|||
154856249|NCT00619957|558901402|FG001|Month 24 Double-Blind|Adverse Event|7|||
154856250|NCT00619957|558901401|FG000|Month 24 Double-Blind|Protocol Violation|1|||
154856251|NCT00619957|558901402|FG001|Month 24 Double-Blind|Protocol Violation|0|||
154856252|NCT00619957|558901401|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
154856253|NCT00619957|558901402|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
154856254|NCT00619957|558901401|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
154856255|NCT00619957|558901402|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
154856256|NCT00619957|558901401|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
154856257|NCT00619957|558901402|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
154856258|NCT00619957|558901401|FG000|Month 48 Open-Label|Adverse Event|4|||
154856259|NCT00619957|558901402|FG001|Month 48 Open-Label|Adverse Event|4|||
154856260|NCT00619957|558901401|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
154856261|NCT00619957|558901402|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
154856262|NCT00619957|558901401|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
154856263|NCT00619957|558901402|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
154856264|NCT00723957|558901403|FG000|Overall Study|Adverse event unrelated to study drug|1|||
154856265|NCT00723957|558901404|FG001|Overall Study|Adverse event unrelated to study drug|4|||
154856266|NCT00723957|558901403|FG000|Overall Study|Death|3|||
154856267|NCT00723957|558901404|FG001|Overall Study|Death|4|||
154856268|NCT00723957|558901403|FG000|Overall Study|Disease progression|27|||
154856269|NCT00723957|558901404|FG001|Overall Study|Disease progression|25|||
154856270|NCT00723957|558901403|FG000|Overall Study|Maximum clinical benefit|4|||
154856271|NCT00723957|558901404|FG001|Overall Study|Maximum clinical benefit|5|||
154856272|NCT00723957|558901403|FG000|Overall Study|Investigator decision|1|||
154856273|NCT00723957|558901404|FG001|Overall Study|Investigator decision|1|||
154856274|NCT00723957|558901403|FG000|Overall Study|Study drug toxicity|4|||
154856275|NCT00723957|558901404|FG001|Overall Study|Study drug toxicity|6|||
154856276|NCT00723957|558901403|FG000|Overall Study|Withdrawal by Subject|7|||
154856277|NCT00723957|558901404|FG001|Overall Study|Withdrawal by Subject|5|||
154856278|NCT00723957|558901403|FG000|Overall Study|Reason not analyzed|1|||
154856279|NCT00723957|558901404|FG001|Overall Study|Reason not analyzed|0|||
154856280|NCT00723957|558901403|FG000|Overall Study|Never received treatment|3|||
154856281|NCT00723957|558901404|FG001|Overall Study|Never received treatment|3|||
154856282|NCT01763164|558901409|FG000|Treatment Phase|Participant/Guardian decision|26|||
154856283|NCT01763164|558901410|FG001|Treatment Phase|Participant/Guardian decision|14|||
154856284|NCT01763164|558901409|FG000|Treatment Phase|Protocol Violation|1|||
154856285|NCT01763164|558901410|FG001|Treatment Phase|Protocol Violation|1|||
154856286|NCT01763164|558901409|FG000|Treatment Phase|Progressive Disease|142|||
154856287|NCT01763164|558901410|FG001|Treatment Phase|Progressive Disease|76|||
154856288|NCT01763164|558901409|FG000|Treatment Phase|Physician Decision|24|||
154856289|NCT01763164|558901410|FG001|Treatment Phase|Physician Decision|13|||
154856290|NCT01763164|558901409|FG000|Treatment Phase|Death|10|||
155106321|NCT01947283|559817634|FG003|Overall Study|No patients were enrolled in study|0|||
155106322|NCT01947283|559817635|FG004|Overall Study|No patients were enrolled in study|0|||
154856291|NCT01763164|558901410|FG001|Treatment Phase|Death|1|||
154856292|NCT01763164|558901409|FG000|Treatment Phase|Adverse Event|66|||
154856293|NCT01763164|558901410|FG001|Treatment Phase|Adverse Event|8|||
154856294|NCT01763164|558901409|FG000|Treatment Phase|Randomized but not Treated|0|||
155106323|NCT01947283|559817636|FG005|Overall Study|No patients were enrolled in study|3|||
155106324|NCT01947283|559817637|FG006|Overall Study|No patients were enrolled in study|1|||
154856295|NCT01763164|558901410|FG001|Treatment Phase|Randomized but not Treated|19|||
154856296|NCT01763164|558901409|FG000|Treatment Phase|Other|0|||
154856297|NCT01763164|558901410|FG001|Treatment Phase|Other|1|||
154856298|NCT01763164|558901409|FG000|Follow up Phase|New therapy for study indication|12|||
154856299|NCT01763164|558901410|FG001|Follow up Phase|New therapy for study indication|3|||
154856300|NCT01763164|558901409|FG000|Follow up Phase|Death|21|||
154856301|NCT01763164|558901410|FG001|Follow up Phase|Death|4|||
154856302|NCT01763164|558901409|FG000|Follow up Phase|Subject/guardian decision|9|||
154856303|NCT01763164|558901410|FG001|Follow up Phase|Subject/guardian decision|2|||
154856304|NCT01763164|558901409|FG000|Follow up Phase|Progressive disease|127|||
154856305|NCT01763164|558901410|FG001|Follow up Phase|Progressive disease|62|||
154856306|NCT01763164|558901409|FG000|Follow up Phase|Physician Decision|10|||
155106325|NCT04729972|559817638|FG000|Overall Study|Adverse Event|1|||
155106326|NCT00430989|559817639|FG000|Overall Study|Lost to Follow-up|2|||
154856307|NCT01763164|558901410|FG001|Follow up Phase|Physician Decision|3|||
154856308|NCT01763164|558901409|FG000|Follow up Phase|Lost to Follow-up|1|||
154856309|NCT01763164|558901410|FG001|Follow up Phase|Lost to Follow-up|0|||
154856310|NCT01763164|558901409|FG000|Follow up Phase|Adverse Event|17|||
154856311|NCT01763164|558901410|FG001|Follow up Phase|Adverse Event|1|||
154856312|NCT01360996|558901411|FG000|Overall Study|Withdrawal by Subject|4|||
154856313|NCT01360996|558901412|FG001|Overall Study|Withdrawal by Subject|3|||
154856314|NCT01360996|558901413|FG002|Overall Study|Withdrawal by Subject|2|||
154856315|NCT01360996|558901411|FG000|Overall Study|Noncompliant|2|||
154856316|NCT01360996|558901412|FG001|Overall Study|Noncompliant|0|||
154856317|NCT01360996|558901413|FG002|Overall Study|Noncompliant|0|||
154856318|NCT03377634|558901414|FG000|Study Period|Adverse Event|1|||
154856319|NCT03377634|558901415|FG001|Study Period|Adverse Event|0|||
154856320|NCT03377634|558901414|FG000|Study Period|Withdrawal by Subject|1|||
154856321|NCT03377634|558901415|FG001|Study Period|Withdrawal by Subject|0|||
154856322|NCT04964258|558901416|FG000|Overall Study|Lost to Follow-up|1|||
154856323|NCT04964258|558901417|FG001|Overall Study|Lost to Follow-up|0|||
154856324|NCT04964258|558901418|FG002|Overall Study|Lost to Follow-up|0|||
154856325|NCT04964258|558901419|FG003|Overall Study|Lost to Follow-up|0|||
154856326|NCT04964258|558901420|FG004|Overall Study|Lost to Follow-up|0|||
154856327|NCT04964258|558901421|FG005|Overall Study|Lost to Follow-up|1|||
154856328|NCT04964258|558901422|FG006|Overall Study|Lost to Follow-up|0|||
154856329|NCT04964258|558901423|FG007|Overall Study|Lost to Follow-up|0|||
154856330|NCT04964258|558901424|FG008|Overall Study|Lost to Follow-up|0|||
154856331|NCT04964258|558901425|FG009|Overall Study|Lost to Follow-up|0|||
154856332|NCT04964258|558901426|FG010|Overall Study|Lost to Follow-up|0|||
154856333|NCT02965378|558901427|FG000|Overall Study|Progression|16|||
154856334|NCT02965378|558901428|FG001|Overall Study|Progression|4|||
155106327|NCT00430989|559817640|FG001|Overall Study|Lost to Follow-up|3|||
155106328|NCT00430989|559817639|FG000|Overall Study|Withdrawal by Subject|15|||
155106329|NCT00430989|559817640|FG001|Overall Study|Withdrawal by Subject|14|||
155106330|NCT00430989|559817639|FG000|Overall Study|Protocol Violation|30|||
154856335|NCT02965378|558901427|FG000|Overall Study|Adverse Event|5|||
154856336|NCT02965378|558901428|FG001|Overall Study|Adverse Event|2|||
154856337|NCT02965378|558901427|FG000|Overall Study|Death|2|||
154856338|NCT02965378|558901428|FG001|Overall Study|Death|0|||
154856339|NCT02965378|558901427|FG000|Overall Study|Refusal|2|||
154856340|NCT02965378|558901428|FG001|Overall Study|Refusal|1|||
154856341|NCT02965378|558901427|FG000|Overall Study|Not protocol specified|0|||
154856342|NCT02965378|558901428|FG001|Overall Study|Not protocol specified|2|||
154856343|NCT01384292|558901431|FG000|Part B|Severe non-compliance to protocol|1|||
154856344|NCT01384292|558901432|FG001|Part B|Severe non-compliance to protocol|0|||
154856345|NCT01384292|558901433|FG002|Part B|Severe non-compliance to protocol|0|||
154856346|NCT01171612|558901434|FG000|Overall Study|Lost to Follow-up|51|||
154856347|NCT04525703|558901435|FG000|Overall Study|Lost to Follow-up|6|||
154856348|NCT04525703|558901436|FG001|Overall Study|Lost to Follow-up|15|||
154856349|NCT04525703|558901437|FG002|Overall Study|Lost to Follow-up|8|||
154856350|NCT01285349|558901438|FG000|Overall Study|Lost to Follow-up|27|||
154856351|NCT01285349|558901439|FG001|Overall Study|Lost to Follow-up|20|||
154856352|NCT01285349|558901440|FG002|Overall Study|Lost to Follow-up|27|||
154856353|NCT02909153|558901441|FG000|Overall Study|Withdrawal by Subject|0|||
154856354|NCT02909153|558901442|FG001|Overall Study|Withdrawal by Subject|1|||
154856355|NCT02909153|558901443|FG002|Overall Study|Withdrawal by Subject|0|||
154856356|NCT02909153|558901444|FG003|Overall Study|Withdrawal by Subject|0|||
154856357|NCT02909153|558901445|FG004|Overall Study|Withdrawal by Subject|0|||
154856358|NCT00565617|558901446|FG000|Overall Study|Withdrawal by Subject|1|||
154856359|NCT03040024|558901447|FG000|Overall Study|Adverse Event|0|||
154856360|NCT03040024|558901448|FG001|Overall Study|Adverse Event|1|||
154856361|NCT03040024|558901449|FG002|Overall Study|Adverse Event|0|||
154856362|NCT03040024|558901447|FG000|Overall Study|Death|0|||
154856363|NCT03040024|558901448|FG001|Overall Study|Death|1|||
154856364|NCT03040024|558901449|FG002|Overall Study|Death|0|||
154856365|NCT03040024|558901447|FG000|Overall Study|Physician Decision|0|||
154856366|NCT03040024|558901448|FG001|Overall Study|Physician Decision|0|||
154856367|NCT03040024|558901449|FG002|Overall Study|Physician Decision|1|||
154856368|NCT00484315|558901453|FG000|12-Month Clinical Follow-up|Death|6|||
154856369|NCT00484315|558901454|FG001|12-Month Clinical Follow-up|Death|2|||
155106331|NCT00430989|559817640|FG001|Overall Study|Protocol Violation|37|||
154856370|NCT00484315|558901453|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
154856371|NCT00484315|558901454|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
154856372|NCT00484315|558901453|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
154856373|NCT00484315|558901454|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
154856374|NCT00484315|558901453|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
154856375|NCT00484315|558901454|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
154856376|NCT00484315|558901453|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
154856377|NCT00484315|558901454|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
154856378|NCT00484315|558901453|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
154856379|NCT00484315|558901454|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
154971862|NCT00826241|559320716|FG000|Overall Study|Lost to Follow-up|9|||
155106332|NCT00430989|559817639|FG000|Overall Study|Not eligible|13|||
155106333|NCT00430989|559817640|FG001|Overall Study|Not eligible|6|||
155106334|NCT03782259|559817641|FG000|Overall Study|Lost to Follow-up|1|||
155106335|NCT03782259|559817642|FG001|Overall Study|Lost to Follow-up|1|||
155106336|NCT03782259|559817641|FG000|Overall Study|Moved out of state|0|||
155106337|NCT03782259|559817642|FG001|Overall Study|Moved out of state|2|||
155106338|NCT03782259|559817641|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
154856380|NCT00484315|558901453|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
155106339|NCT03782259|559817642|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
155106340|NCT03782259|559817641|FG000|Overall Study|Subject discontinued intervention|1|||
155106341|NCT03782259|559817642|FG001|Overall Study|Subject discontinued intervention|0|||
155106342|NCT00590122|559817643|FG000|Overall Study|swallowed oral dissolving dose|1|||
155106343|NCT00590122|559817644|FG001|Overall Study|swallowed oral dissolving dose|0|||
155106344|NCT03050450|559817645|FG000|Overall Study|Physician Decision|1|||
155106345|NCT03050450|559817646|FG001|Overall Study|Physician Decision|0|||
155106346|NCT03050450|559817647|FG002|Overall Study|Physician Decision|0|||
154856381|NCT00484315|558901454|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
154856382|NCT00943683|558901455|FG000|Overall Study|Adverse Event|3|||
154856383|NCT00943683|558901456|FG001|Overall Study|Adverse Event|3|||
154856384|NCT00943683|558901455|FG000|Overall Study|Lost to Follow-up|1|||
154856385|NCT00943683|558901456|FG001|Overall Study|Lost to Follow-up|1|||
154856386|NCT00943683|558901455|FG000|Overall Study|Protocol Violation|1|||
154856387|NCT00943683|558901456|FG001|Overall Study|Protocol Violation|2|||
154856388|NCT00943683|558901455|FG000|Overall Study|Withdrawal by Subject|1|||
154856389|NCT00943683|558901456|FG001|Overall Study|Withdrawal by Subject|0|||
154856390|NCT00943683|558901455|FG000|Overall Study|Patient Moved|1|||
154856391|NCT00943683|558901456|FG001|Overall Study|Patient Moved|0|||
154856392|NCT01565980|558901458|FG000|Overall Study|Death|1|||
154856393|NCT01565980|558901459|FG001|Overall Study|Death|0|||
154856394|NCT01565980|558901458|FG000|Overall Study|Lost to Follow-up|1|||
154856395|NCT01565980|558901459|FG001|Overall Study|Lost to Follow-up|0|||
154856396|NCT01565980|558901458|FG000|Overall Study|health complications|1|||
154856397|NCT01565980|558901459|FG001|Overall Study|health complications|1|||
154856398|NCT01565980|558901458|FG000|Overall Study|stopped medical treatment|1|||
154856399|NCT01565980|558901459|FG001|Overall Study|stopped medical treatment|0|||
154856400|NCT01565980|558901458|FG000|Overall Study|Withdrawal by Subject|0|||
154856401|NCT01565980|558901459|FG001|Overall Study|Withdrawal by Subject|3|||
154856402|NCT01817790|558901470|FG000|Overall Study|Adverse Event|0|||
154856403|NCT01817790|558901471|FG001|Overall Study|Adverse Event|2|||
154856404|NCT01817790|558901470|FG000|Overall Study|Lost to Follow-up|0|||
154856405|NCT01817790|558901471|FG001|Overall Study|Lost to Follow-up|1|||
154856406|NCT01817790|558901470|FG000|Overall Study|Protocol Violation|2|||
154856407|NCT01817790|558901471|FG001|Overall Study|Protocol Violation|1|||
154856408|NCT01817790|558901470|FG000|Overall Study|Withdrawal by Subject|1|||
154856409|NCT01817790|558901471|FG001|Overall Study|Withdrawal by Subject|3|||
154856410|NCT01817790|558901470|FG000|Overall Study|Other: Could not attend appointment|1|||
154856411|NCT01817790|558901471|FG001|Overall Study|Other: Could not attend appointment|1|||
154856412|NCT01671345|558901472|FG000|Overall Study|Lost to Follow-up|10|||
154856413|NCT01671345|558901473|FG001|Overall Study|Lost to Follow-up|6|||
154856414|NCT01671345|558901472|FG000|Overall Study|visit with non-participating physician|3|||
154856415|NCT01671345|558901473|FG001|Overall Study|visit with non-participating physician|3|||
154856416|NCT03636906|558901474|FG000|Overall Study|Adverse Event|0|||
154856417|NCT03636906|558901475|FG001|Overall Study|Adverse Event|0|||
154856418|NCT03636906|558901476|FG002|Overall Study|Adverse Event|1|||
154856419|NCT03636906|558901474|FG000|Overall Study|Lost to Follow-up|1|||
154856420|NCT03636906|558901475|FG001|Overall Study|Lost to Follow-up|0|||
154856421|NCT03636906|558901476|FG002|Overall Study|Lost to Follow-up|0|||
154856422|NCT03636906|558901474|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
154856423|NCT03636906|558901475|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
154856424|NCT03636906|558901476|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
154856425|NCT03636906|558901474|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
155106347|NCT03050450|559817648|FG003|Overall Study|Physician Decision|0|||
154856426|NCT03636906|558901475|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
154856427|NCT03636906|558901476|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
154856428|NCT03636906|558901474|FG000|Overall Study|Other|0|||
154856429|NCT03636906|558901475|FG001|Overall Study|Other|0|||
154856430|NCT03636906|558901476|FG002|Overall Study|Other|1|||
155106348|NCT03050450|559817649|FG004|Overall Study|Physician Decision|0|||
155106349|NCT01642901|559817650|FG000|12-month Follow-up|Withdrawal by Subject|1|||
155106350|NCT01642901|559817651|FG001|12-month Follow-up|Withdrawal by Subject|0|||
154856431|NCT03690869|558901478|FG000|Overall Study|Adverse Event|0|||
154856432|NCT03690869|558901479|FG001|Overall Study|Adverse Event|0|||
154856433|NCT03690869|558901480|FG002|Overall Study|Adverse Event|0|||
154856434|NCT03690869|558901481|FG003|Overall Study|Adverse Event|1|||
155106351|NCT03520920|559817652|FG000|Overall Study|Death|13|||
155106352|NCT03520920|559817653|FG001|Overall Study|Death|1|||
155106353|NCT03520920|559817654|FG002|Overall Study|Death|0|||
155106354|NCT03520920|559817652|FG000|Overall Study|Withdrawal by Subject|2|||
155106355|NCT03520920|559817653|FG001|Overall Study|Withdrawal by Subject|1|||
155106356|NCT03520920|559817654|FG002|Overall Study|Withdrawal by Subject|0|||
155106357|NCT03520920|559817652|FG000|Overall Study|Study Terminated by the Sponsor|5|||
155106358|NCT03520920|559817653|FG001|Overall Study|Study Terminated by the Sponsor|14|||
154856435|NCT03690869|558901482|FG004|Overall Study|Adverse Event|0|||
154856436|NCT03690869|558901483|FG005|Overall Study|Adverse Event|0|||
154856437|NCT03690869|558901484|FG006|Overall Study|Adverse Event|0|||
154856438|NCT03690869|558901485|FG007|Overall Study|Adverse Event|1|||
155106359|NCT03520920|559817654|FG002|Overall Study|Study Terminated by the Sponsor|5|||
154856439|NCT03690869|558901486|FG008|Overall Study|Adverse Event|0|||
154856440|NCT03690869|558901487|FG009|Overall Study|Adverse Event|1|||
154856441|NCT03690869|558901478|FG000|Overall Study|Death|1|||
154856442|NCT03690869|558901479|FG001|Overall Study|Death|1|||
154856443|NCT03690869|558901480|FG002|Overall Study|Death|1|||
154856444|NCT03690869|558901481|FG003|Overall Study|Death|4|||
154856445|NCT03690869|558901482|FG004|Overall Study|Death|2|||
154856446|NCT03690869|558901483|FG005|Overall Study|Death|5|||
154856447|NCT03690869|558901484|FG006|Overall Study|Death|3|||
154856448|NCT03690869|558901485|FG007|Overall Study|Death|2|||
154856449|NCT03690869|558901486|FG008|Overall Study|Death|0|||
154856450|NCT03690869|558901487|FG009|Overall Study|Death|3|||
154856451|NCT03690869|558901478|FG000|Overall Study|Lost to Follow-up|0|||
154856452|NCT03690869|558901479|FG001|Overall Study|Lost to Follow-up|0|||
154856453|NCT03690869|558901480|FG002|Overall Study|Lost to Follow-up|1|||
154856454|NCT03690869|558901481|FG003|Overall Study|Lost to Follow-up|0|||
154856455|NCT03690869|558901482|FG004|Overall Study|Lost to Follow-up|0|||
154856456|NCT03690869|558901483|FG005|Overall Study|Lost to Follow-up|0|||
154856457|NCT03690869|558901484|FG006|Overall Study|Lost to Follow-up|0|||
154856458|NCT03690869|558901485|FG007|Overall Study|Lost to Follow-up|0|||
154856459|NCT03690869|558901486|FG008|Overall Study|Lost to Follow-up|0|||
154856460|NCT03690869|558901487|FG009|Overall Study|Lost to Follow-up|0|||
154856461|NCT03690869|558901478|FG000|Overall Study|Other Treatment|1|||
154856462|NCT03690869|558901479|FG001|Overall Study|Other Treatment|1|||
154856463|NCT03690869|558901480|FG002|Overall Study|Other Treatment|1|||
154856464|NCT03690869|558901481|FG003|Overall Study|Other Treatment|2|||
154856465|NCT03690869|558901482|FG004|Overall Study|Other Treatment|3|||
154856466|NCT03690869|558901483|FG005|Overall Study|Other Treatment|1|||
154856467|NCT03690869|558901484|FG006|Overall Study|Other Treatment|2|||
154856468|NCT03690869|558901485|FG007|Overall Study|Other Treatment|7|||
154856469|NCT03690869|558901486|FG008|Overall Study|Other Treatment|0|||
154856470|NCT03690869|558901487|FG009|Overall Study|Other Treatment|3|||
154856471|NCT03690869|558901478|FG000|Overall Study|Physician Decision|0|||
154856472|NCT03690869|558901479|FG001|Overall Study|Physician Decision|1|||
154856473|NCT03690869|558901480|FG002|Overall Study|Physician Decision|0|||
154856474|NCT03690869|558901481|FG003|Overall Study|Physician Decision|0|||
154856475|NCT03690869|558901482|FG004|Overall Study|Physician Decision|0|||
154856476|NCT03690869|558901483|FG005|Overall Study|Physician Decision|0|||
154856477|NCT03690869|558901484|FG006|Overall Study|Physician Decision|0|||
154856478|NCT03690869|558901485|FG007|Overall Study|Physician Decision|0|||
154856479|NCT03690869|558901486|FG008|Overall Study|Physician Decision|0|||
154856480|NCT03690869|558901487|FG009|Overall Study|Physician Decision|0|||
154856481|NCT03690869|558901478|FG000|Overall Study|Progressive Disease|1|||
154856482|NCT03690869|558901479|FG001|Overall Study|Progressive Disease|2|||
154856483|NCT03690869|558901480|FG002|Overall Study|Progressive Disease|0|||
155106360|NCT00372619|559817655|FG000|Overall Study|Ineligible|0|||
155106361|NCT00372619|559817656|FG001|Overall Study|Ineligible|0|||
155106362|NCT00372619|559817657|FG002|Overall Study|Ineligible|0|||
155106363|NCT00372619|559817658|FG003|Overall Study|Ineligible|0|||
155106364|NCT00372619|559817659|FG004|Overall Study|Ineligible|0|||
155106365|NCT00372619|559817660|FG005|Overall Study|Ineligible|2|||
154856484|NCT03690869|558901481|FG003|Overall Study|Progressive Disease|1|||
154856485|NCT03690869|558901482|FG004|Overall Study|Progressive Disease|0|||
154856486|NCT03690869|558901483|FG005|Overall Study|Progressive Disease|0|||
154856487|NCT03690869|558901484|FG006|Overall Study|Progressive Disease|0|||
154856488|NCT03690869|558901485|FG007|Overall Study|Progressive Disease|0|||
154856489|NCT03690869|558901486|FG008|Overall Study|Progressive Disease|1|||
154856490|NCT03690869|558901487|FG009|Overall Study|Progressive Disease|1|||
154856491|NCT03690869|558901478|FG000|Overall Study|Subject Decision|0|||
154856492|NCT03690869|558901479|FG001|Overall Study|Subject Decision|0|||
155106366|NCT00372619|559817661|FG006|Overall Study|Ineligible|0|||
154856493|NCT03690869|558901480|FG002|Overall Study|Subject Decision|0|||
154856494|NCT03690869|558901481|FG003|Overall Study|Subject Decision|1|||
155106367|NCT00372619|559817655|FG000|Overall Study|Inevaluable|0|||
154856495|NCT03690869|558901482|FG004|Overall Study|Subject Decision|0|||
155106368|NCT00372619|559817656|FG001|Overall Study|Inevaluable|0|||
155106369|NCT00372619|559817657|FG002|Overall Study|Inevaluable|0|||
154856496|NCT03690869|558901483|FG005|Overall Study|Subject Decision|0|||
154856497|NCT03690869|558901484|FG006|Overall Study|Subject Decision|0|||
154856498|NCT03690869|558901485|FG007|Overall Study|Subject Decision|1|||
154856499|NCT03690869|558901486|FG008|Overall Study|Subject Decision|0|||
154856500|NCT03690869|558901487|FG009|Overall Study|Subject Decision|0|||
154856501|NCT04280081|558901488|FG000|Overall Study|Adverse Event|4|||
154856502|NCT04280081|558901488|FG000|Overall Study|Death|2|||
154856503|NCT04280081|558901488|FG000|Overall Study|Progressive Disease|6|||
154856504|NCT03263806|558903313|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
154856505|NCT03263806|558903314|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
154856506|NCT03263806|558903313|FG000|Overall Study|Withdrawal by Subject|0|||
154856507|NCT03263806|558903314|FG001|Overall Study|Withdrawal by Subject|1|||
154856508|NCT03263806|558903313|FG000|Overall Study|Study Termination|5|||
154856509|NCT03263806|558903314|FG001|Overall Study|Study Termination|6|||
154856510|NCT00023322|558903321|FG000|Overall Study|Lost to Follow-up|1|||
154856511|NCT01609933|558903327|FG000|Overall Study|Adverse Event|1|||
154856512|NCT01609933|558903327|FG000|Overall Study|Withdrawal by Subject|3|||
154856513|NCT01252966|558903328|FG000|Overall Study|Lost to Follow-up|16|||
154856514|NCT01252966|558903329|FG001|Overall Study|Lost to Follow-up|10|||
154856515|NCT01252966|558903328|FG000|Overall Study|Withdrawal by Subject|7|||
154856516|NCT01252966|558903329|FG001|Overall Study|Withdrawal by Subject|3|||
154856517|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
154856518|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
154856519|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
154856520|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
154856521|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
154856522|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
154856523|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
154971863|NCT00826241|559320716|FG000|Overall Study|Could not obtain records|1|||
154971864|NCT00826241|559320716|FG000|Overall Study|Screen failure|2|||
154971865|NCT00826241|559320716|FG000|Overall Study|Pt unable to proceed to registration|1|||
154971866|NCT00826241|559320716|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
154971867|NCT03407729|559320717|FG000|Overall Study|Lost to Follow-up|2|||
154971868|NCT03407729|559320718|FG001|Overall Study|Lost to Follow-up|0|||
154971869|NCT03407729|559320717|FG000|Overall Study|Unable to schedule|0|||
154971870|NCT03407729|559320718|FG001|Overall Study|Unable to schedule|3|||
154971871|NCT00830167|559320721|FG000|Overall Study|Lack of Efficacy|26|||
154971872|NCT00830167|559320722|FG001|Overall Study|Lack of Efficacy|10|||
154971873|NCT00830167|559320721|FG000|Overall Study|Adverse Event|8|||
154971874|NCT00830167|559320722|FG001|Overall Study|Adverse Event|24|||
154971875|NCT00830167|559320721|FG000|Overall Study|Not meeting entrance criteria|2|||
154971876|NCT00830167|559320722|FG001|Overall Study|Not meeting entrance criteria|5|||
154971877|NCT00830167|559320721|FG000|Overall Study|Withdrawal by Subject|2|||
154971878|NCT00830167|559320722|FG001|Overall Study|Withdrawal by Subject|0|||
154971879|NCT00830167|559320721|FG000|Overall Study|Lost to Follow-up|0|||
154971880|NCT00830167|559320722|FG001|Overall Study|Lost to Follow-up|1|||
154971881|NCT00830167|559320721|FG000|Overall Study|Protocol Violation|0|||
154971882|NCT00830167|559320722|FG001|Overall Study|Protocol Violation|1|||
154971883|NCT00830167|559320721|FG000|Overall Study|Other|2|||
154971884|NCT00830167|559320722|FG001|Overall Study|Other|2|||
154971885|NCT00494013|559320723|FG000|Overall Study|Adverse Event|0|||
154971886|NCT00494013|559320724|FG001|Overall Study|Adverse Event|1|||
154971887|NCT00494013|559320723|FG000|Overall Study|Entry Criteria Not Met|1|||
154971888|NCT00494013|559320724|FG001|Overall Study|Entry Criteria Not Met|4|||
154971889|NCT00494013|559320723|FG000|Overall Study|Lost to Follow-up|5|||
154971890|NCT00494013|559320724|FG001|Overall Study|Lost to Follow-up|6|||
154971891|NCT00494013|559320723|FG000|Overall Study|Physician Decision|3|||
154971892|NCT00494013|559320724|FG001|Overall Study|Physician Decision|5|||
154971893|NCT00494013|559320723|FG000|Overall Study|Protocol Violation|8|||
154971894|NCT00494013|559320724|FG001|Overall Study|Protocol Violation|5|||
154971895|NCT00494013|559320723|FG000|Overall Study|Withdrawal by Subject|13|||
154971896|NCT00494013|559320724|FG001|Overall Study|Withdrawal by Subject|14|||
154971897|NCT00494013|559320723|FG000|Overall Study|Sponsor Decision|0|||
154971898|NCT00494013|559320724|FG001|Overall Study|Sponsor Decision|1|||
154971899|NCT01539239|559320725|FG000|Overall Study|Death|5|||
154971900|NCT01539239|559320726|FG001|Overall Study|Death|5|||
154971901|NCT01539239|559320725|FG000|Overall Study|Lost to Follow-up|7|||
154971902|NCT01539239|559320726|FG001|Overall Study|Lost to Follow-up|12|||
154856524|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
154971903|NCT00633022|559320729|FG000|Overall Study|Adverse Event|1|||
154971904|NCT00633022|559320730|FG001|Overall Study|Adverse Event|0|||
154971905|NCT00633022|559320731|FG002|Overall Study|Adverse Event|5|||
154856525|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
154856526|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
154971906|NCT00633022|559320729|FG000|Overall Study|Physician Decision|0|||
154971907|NCT00633022|559320730|FG001|Overall Study|Physician Decision|1|||
154971908|NCT00633022|559320731|FG002|Overall Study|Physician Decision|0|||
154971909|NCT01751087|559320735|FG000|Overall Study|Withdrawal by Subject|1|||
154971910|NCT01751087|559320736|FG001|Overall Study|Withdrawal by Subject|0|||
154971911|NCT01751087|559320737|FG002|Overall Study|Withdrawal by Subject|0|||
154856527|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
154856528|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
154856529|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
154856530|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
154856531|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
154856532|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
154856533|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
154856534|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
154856535|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
154856536|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
154856537|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
154856538|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
154856539|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
154856540|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
154856541|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
154856542|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
154856543|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
154856544|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
154856545|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
154856546|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
154856547|NCT02660580|558903333|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
154856548|NCT02660580|558903334|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
154856549|NCT02660580|558903335|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
154856550|NCT02660580|558903336|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
154856551|NCT02660580|558903337|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
154856552|NCT02660580|558903333|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
154856553|NCT02660580|558903334|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
154856554|NCT02660580|558903335|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
154856555|NCT02660580|558903336|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
154856556|NCT02660580|558903337|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
154856557|NCT02660580|558903333|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
154856558|NCT02660580|558903334|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
154856559|NCT02660580|558903335|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
154856560|NCT02660580|558903336|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
154856561|NCT02660580|558903337|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
154856562|NCT02660580|558903333|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
154856563|NCT02660580|558903334|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
154856564|NCT02660580|558903335|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
154856565|NCT02660580|558903336|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
154971912|NCT01751087|559320735|FG000|Overall Study|Physician Decision|0|||
154971913|NCT01751087|559320736|FG001|Overall Study|Physician Decision|0|||
154971914|NCT01751087|559320737|FG002|Overall Study|Physician Decision|1|||
154856566|NCT02660580|558903337|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
154856567|NCT02660580|558903333|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
154856568|NCT02660580|558903334|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
154856569|NCT02660580|558903335|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
154856570|NCT02660580|558903336|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
154856571|NCT02660580|558903337|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
154856572|NCT02660580|558903333|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
154856573|NCT02660580|558903334|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
154856574|NCT02660580|558903335|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
154856575|NCT02660580|558903336|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
154856576|NCT02660580|558903337|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
154856577|NCT02660580|558903333|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
154856578|NCT02660580|558903334|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
154856579|NCT02660580|558903335|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
154971915|NCT01188226|559322217|FG000|Overall Study|Withdrawal by Subject|4|||
154971916|NCT02293460|559322218|FG000|Overall Study|Protocol Violation|1|||
154971917|NCT02293460|559322218|FG000|Overall Study|Lack of Efficacy|2|||
154971918|NCT02293460|559322218|FG000|Overall Study|Adverse Event|2|||
154971919|NCT02293460|559322218|FG000|Overall Study|Withdrawal by Subject|1|||
154971920|NCT00500318|559322220|FG000|Overall Study|Adverse Event|3|||
154971921|NCT00500318|559322221|FG001|Overall Study|Adverse Event|8|||
155106370|NCT00372619|559817658|FG003|Overall Study|Inevaluable|0|||
154971922|NCT00500318|559322220|FG000|Overall Study|Protocol Violation|1|||
154971923|NCT00500318|559322221|FG001|Overall Study|Protocol Violation|3|||
155106371|NCT00372619|559817659|FG004|Overall Study|Inevaluable|0|||
154856580|NCT02660580|558903336|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
154856581|NCT02660580|558903337|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
154856582|NCT05415449|558903338|FG000|Overall Study|Lost to Follow-up|2|||
154856583|NCT05415449|558903338|FG000|Overall Study|Withdrawal by Subject|4|||
154856584|NCT02185521|558903342|FG000|Overall Study|Withdrawal by Subject|1|||
154856585|NCT02185521|558903342|FG000|Overall Study|Protocol Violation|1|||
154856586|NCT01169779|558903343|FG000|Overall Study|Adverse Event|3|||
154856587|NCT01169779|558903344|FG001|Overall Study|Adverse Event|11|||
154856588|NCT01169779|558903343|FG000|Overall Study|Lack of Efficacy|1|||
154856589|NCT01169779|558903344|FG001|Overall Study|Lack of Efficacy|0|||
154856590|NCT01169779|558903343|FG000|Overall Study|Protocol Violation|1|||
154856591|NCT01169779|558903344|FG001|Overall Study|Protocol Violation|1|||
154856592|NCT01169779|558903343|FG000|Overall Study|Withdrawal by Subject|3|||
154856593|NCT01169779|558903344|FG001|Overall Study|Withdrawal by Subject|2|||
154856594|NCT01169779|558903343|FG000|Overall Study|Familial and personal reasons|3|||
154856595|NCT01169779|558903344|FG001|Overall Study|Familial and personal reasons|3|||
154856596|NCT03293654|558903345|FG000|Overall Study|Lost to Follow-up|0|||
154856597|NCT03293654|558903346|FG001|Overall Study|Lost to Follow-up|1|||
154856598|NCT03293654|558903347|FG002|Overall Study|Lost to Follow-up|0|||
154856599|NCT05052723|558903349|FG000|Overall Study|Death|19|||
154856600|NCT01933932|558903350|FG000|Overall Study|Death|173|||
154856601|NCT01933932|558903351|FG001|Overall Study|Death|163|||
154856602|NCT01933932|558903350|FG000|Overall Study|Withdrawal by Subject|11|||
154856603|NCT01933932|558903351|FG001|Overall Study|Withdrawal by Subject|14|||
154856604|NCT01933932|558903350|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
154971924|NCT00500318|559322220|FG000|Overall Study|Withdrawal by Subject|1|||
154971925|NCT00500318|559322221|FG001|Overall Study|Withdrawal by Subject|2|||
154971926|NCT00500318|559322220|FG000|Overall Study|Lack of Efficacy|0|||
154971927|NCT00500318|559322221|FG001|Overall Study|Lack of Efficacy|3|||
154971928|NCT00500318|559322220|FG000|Overall Study|Other Reason|0|||
154971929|NCT00500318|559322221|FG001|Overall Study|Other Reason|1|||
154971930|NCT00224484|559322239|FG000|Overall Study|Serious Adverse Event|1|||
154971931|NCT00224484|559322240|FG001|Overall Study|Serious Adverse Event|1|||
154971932|NCT00224484|559322241|FG002|Overall Study|Serious Adverse Event|0|||
154971933|NCT00224484|559322239|FG000|Overall Study|Non-Serious Adverse Event|5|||
154971934|NCT00224484|559322240|FG001|Overall Study|Non-Serious Adverse Event|7|||
154971935|NCT00224484|559322241|FG002|Overall Study|Non-Serious Adverse Event|3|||
154971936|NCT00224484|559322239|FG000|Overall Study|Protocol Violation|2|||
154971937|NCT00224484|559322240|FG001|Overall Study|Protocol Violation|2|||
154971938|NCT00224484|559322241|FG002|Overall Study|Protocol Violation|0|||
154971939|NCT00224484|559322239|FG000|Overall Study|Withdrawal by Subject|49|||
154971940|NCT00224484|559322240|FG001|Overall Study|Withdrawal by Subject|18|||
154971941|NCT00224484|559322241|FG002|Overall Study|Withdrawal by Subject|16|||
154971942|NCT00224484|559322239|FG000|Overall Study|Migrated/moved from study area|18|||
154971943|NCT00224484|559322240|FG001|Overall Study|Migrated/moved from study area|5|||
154971944|NCT00224484|559322241|FG002|Overall Study|Migrated/moved from study area|5|||
154971945|NCT00224484|559322239|FG000|Overall Study|Lost to Follow-up|66|||
154971946|NCT00224484|559322240|FG001|Overall Study|Lost to Follow-up|28|||
154971947|NCT00224484|559322241|FG002|Overall Study|Lost to Follow-up|36|||
154971948|NCT00224484|559322239|FG000|Overall Study|Reason not specified|5|||
154971949|NCT00224484|559322240|FG001|Overall Study|Reason not specified|4|||
154971950|NCT00224484|559322241|FG002|Overall Study|Reason not specified|2|||
154971951|NCT02805309|559322242|FG000|Overall Study|Lost to Follow-up|2|||
154971952|NCT02805309|559322243|FG001|Overall Study|Lost to Follow-up|2|||
154971953|NCT02805309|559322244|FG002|Overall Study|Lost to Follow-up|2|||
154971954|NCT02805309|559322242|FG000|Overall Study|Post-Randomization Exclusion|0|||
154971955|NCT02805309|559322243|FG001|Overall Study|Post-Randomization Exclusion|2|||
154971956|NCT02805309|559322244|FG002|Overall Study|Post-Randomization Exclusion|1|||
154971957|NCT01636934|559322247|FG000|Overall Study|Withdrawal by Subject|3|||
154971958|NCT01636934|559322248|FG001|Overall Study|Withdrawal by Subject|2|||
154971959|NCT01636934|559322247|FG000|Overall Study|Chemo cancel|1|||
154971960|NCT01636934|559322248|FG001|Overall Study|Chemo cancel|0|||
154971961|NCT01636934|559322247|FG000|Overall Study|Too ill to continue|1|||
154971962|NCT01636934|559322248|FG001|Overall Study|Too ill to continue|0|||
154971963|NCT01636934|559322247|FG000|Overall Study|Never started study medication|1|||
154971964|NCT01636934|559322248|FG001|Overall Study|Never started study medication|1|||
154971965|NCT05393271|559322256|FG000|Overall Study|Physician Decision|0|||
154971966|NCT05393271|559322257|FG001|Overall Study|Physician Decision|0|||
154971967|NCT05393271|559322258|FG002|Overall Study|Physician Decision|0|||
154971968|NCT05393271|559322259|FG003|Overall Study|Physician Decision|0|||
154971969|NCT05393271|559322260|FG004|Overall Study|Physician Decision|0|||
154971970|NCT05393271|559322261|FG005|Overall Study|Physician Decision|0|||
154856605|NCT01933932|558903351|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
154856606|NCT03155997|558903353|FG000|Overall Study|Withdrawal by Subject|119|||
154971971|NCT05393271|559322262|FG006|Overall Study|Physician Decision|1|||
154856607|NCT03155997|558903354|FG001|Overall Study|Withdrawal by Subject|134|||
154856608|NCT03155997|558903353|FG000|Overall Study|Lost to Follow-up|12|||
154856609|NCT03155997|558903354|FG001|Overall Study|Lost to Follow-up|13|||
154856610|NCT03155997|558903353|FG000|Overall Study|Missing disposition data|0|||
154856611|NCT03155997|558903354|FG001|Overall Study|Missing disposition data|1|||
154856612|NCT03155997|558903353|FG000|Overall Study|On study treatment|2027|||
154856613|NCT03155997|558903354|FG001|Overall Study|On study treatment|2074|||
154856614|NCT02054702|558903362|FG000|Overall Study|Lost to Follow-up|3|||
154856615|NCT02054702|558903363|FG001|Overall Study|Lost to Follow-up|5|||
154856616|NCT02054702|558903362|FG000|Overall Study|Adverse Event|3|||
154856617|NCT02054702|558903363|FG001|Overall Study|Adverse Event|1|||
154856618|NCT02054702|558903362|FG000|Overall Study|Met Withdrawal Criteria|4|||
154856619|NCT02054702|558903363|FG001|Overall Study|Met Withdrawal Criteria|1|||
154856620|NCT02054702|558903362|FG000|Overall Study|Physician Decision|0|||
154856621|NCT02054702|558903363|FG001|Overall Study|Physician Decision|1|||
154856622|NCT02054702|558903362|FG000|Overall Study|Withdrawal by Subject|14|||
154856623|NCT02054702|558903363|FG001|Overall Study|Withdrawal by Subject|4|||
154856624|NCT00934102|558903364|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
154856625|NCT00934102|558903365|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
154856626|NCT00934102|558903366|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
154856627|NCT01262898|558903367|FG000|Overall Study|Protocol Violation|1|||
154856628|NCT01262898|558903368|FG001|Overall Study|Protocol Violation|1|||
154856629|NCT01262898|558903369|FG002|Overall Study|Protocol Violation|0|||
154856630|NCT01262898|558903370|FG003|Overall Study|Protocol Violation|0|||
154856631|NCT01262898|558903367|FG000|Overall Study|Lost to Follow-up|1|||
154856632|NCT01262898|558903368|FG001|Overall Study|Lost to Follow-up|0|||
154856633|NCT01262898|558903369|FG002|Overall Study|Lost to Follow-up|0|||
154856634|NCT01262898|558903370|FG003|Overall Study|Lost to Follow-up|0|||
154856635|NCT01262898|558903367|FG000|Overall Study|Withdrawal by Subject|1|||
154856636|NCT01262898|558903368|FG001|Overall Study|Withdrawal by Subject|1|||
154856637|NCT01262898|558903369|FG002|Overall Study|Withdrawal by Subject|0|||
154856638|NCT01262898|558903370|FG003|Overall Study|Withdrawal by Subject|0|||
154856639|NCT00792298|558903371|FG000|Treatment Period 1|Adverse Event|0|||
154856640|NCT00792298|558903372|FG001|Treatment Period 1|Adverse Event|1|||
154856641|NCT00792298|558903373|FG002|Treatment Period 1|Adverse Event|0|||
154856642|NCT00792298|558903374|FG003|Treatment Period 1|Adverse Event|1|||
154856643|NCT00792298|558903375|FG004|Treatment Period 1|Adverse Event|0|||
154856644|NCT00792298|558903376|FG005|Treatment Period 1|Adverse Event|1|||
154856645|NCT00792298|558903377|FG006|Treatment Period 1|Adverse Event|1|||
154856646|NCT00792298|558903378|FG007|Treatment Period 1|Adverse Event|0|||
154856647|NCT00792298|558903371|FG000|Treatment Period 1|Lack of Efficacy|0|||
154856648|NCT00792298|558903372|FG001|Treatment Period 1|Lack of Efficacy|0|||
154856649|NCT00792298|558903373|FG002|Treatment Period 1|Lack of Efficacy|1|||
154856650|NCT00792298|558903374|FG003|Treatment Period 1|Lack of Efficacy|0|||
154856651|NCT00792298|558903375|FG004|Treatment Period 1|Lack of Efficacy|0|||
154856652|NCT00792298|558903376|FG005|Treatment Period 1|Lack of Efficacy|0|||
154856653|NCT00792298|558903377|FG006|Treatment Period 1|Lack of Efficacy|0|||
154856654|NCT00792298|558903378|FG007|Treatment Period 1|Lack of Efficacy|0|||
154971972|NCT05393271|559322263|FG007|Overall Study|Physician Decision|0|||
154971973|NCT05393271|559322264|FG008|Overall Study|Physician Decision|0|||
154971974|NCT05393271|559322265|FG009|Overall Study|Physician Decision|0|||
154971975|NCT05393271|559322266|FG010|Overall Study|Physician Decision|0|||
154971976|NCT02048813|559322267|FG000|Overall Study|Still on treatment|279|||
154971977|NCT02048813|559322268|FG001|Overall Study|Still on treatment|0|||
154971978|NCT02048813|559322267|FG000|Overall Study|Adverse Event|40|||
154971979|NCT02048813|559322268|FG001|Overall Study|Adverse Event|38|||
154971980|NCT02048813|559322267|FG000|Overall Study|Disease progression|13|||
154971981|NCT02048813|559322268|FG001|Overall Study|Disease progression|3|||
154971982|NCT02048813|559322267|FG000|Overall Study|Withdrawal by Subject|7|||
154971983|NCT02048813|559322268|FG001|Overall Study|Withdrawal by Subject|8|||
154971984|NCT02048813|559322267|FG000|Overall Study|Death|2|||
154971985|NCT02048813|559322268|FG001|Overall Study|Death|1|||
154971986|NCT02048813|559322267|FG000|Overall Study|Complication|2|||
154971987|NCT02048813|559322268|FG001|Overall Study|Complication|2|||
154971988|NCT02048813|559322267|FG000|Overall Study|Non-protocol therapy|0|||
154971989|NCT02048813|559322268|FG001|Overall Study|Non-protocol therapy|1|||
154856655|NCT00792298|558903371|FG000|Treatment Period 1|Withdrawal by Subject|1|||
154856656|NCT00792298|558903372|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154856657|NCT00792298|558903373|FG002|Treatment Period 1|Withdrawal by Subject|1|||
154856658|NCT00792298|558903374|FG003|Treatment Period 1|Withdrawal by Subject|2|||
154856659|NCT00792298|558903375|FG004|Treatment Period 1|Withdrawal by Subject|0|||
154856660|NCT00792298|558903376|FG005|Treatment Period 1|Withdrawal by Subject|2|||
154856661|NCT00792298|558903377|FG006|Treatment Period 1|Withdrawal by Subject|1|||
154971990|NCT02048813|559322267|FG000|Overall Study|Second primary cancer|2|||
154971991|NCT02048813|559322268|FG001|Overall Study|Second primary cancer|0|||
154971992|NCT02048813|559322267|FG000|Overall Study|Insurance|2|||
154971993|NCT02048813|559322268|FG001|Overall Study|Insurance|0|||
155173635|NCT01155011|560074843|FG001|Baseline to 6 Months|investigator decision, moved|5|||
154856662|NCT00792298|558903378|FG007|Treatment Period 1|Withdrawal by Subject|0|||
154856663|NCT00792298|558903371|FG000|Treatment Period 1|Lost to Follow-up|0|||
154856664|NCT00792298|558903372|FG001|Treatment Period 1|Lost to Follow-up|0|||
154856665|NCT00792298|558903373|FG002|Treatment Period 1|Lost to Follow-up|0|||
154856666|NCT00792298|558903374|FG003|Treatment Period 1|Lost to Follow-up|0|||
154856667|NCT00792298|558903375|FG004|Treatment Period 1|Lost to Follow-up|0|||
154856668|NCT00792298|558903376|FG005|Treatment Period 1|Lost to Follow-up|0|||
154856669|NCT00792298|558903377|FG006|Treatment Period 1|Lost to Follow-up|1|||
154856670|NCT00792298|558903378|FG007|Treatment Period 1|Lost to Follow-up|0|||
154856671|NCT00792298|558903371|FG000|Treatment Period 1|Physician Decision|0|||
154856672|NCT00792298|558903372|FG001|Treatment Period 1|Physician Decision|0|||
154856673|NCT00792298|558903373|FG002|Treatment Period 1|Physician Decision|0|||
154856674|NCT00792298|558903374|FG003|Treatment Period 1|Physician Decision|1|||
154856675|NCT00792298|558903375|FG004|Treatment Period 1|Physician Decision|0|||
154856676|NCT00792298|558903376|FG005|Treatment Period 1|Physician Decision|0|||
154856677|NCT00792298|558903377|FG006|Treatment Period 1|Physician Decision|1|||
154856678|NCT00792298|558903378|FG007|Treatment Period 1|Physician Decision|0|||
154856679|NCT00792298|558903371|FG000|Treatment Period 1|Protocol Violation|0|||
154856680|NCT00792298|558903372|FG001|Treatment Period 1|Protocol Violation|0|||
154856681|NCT00792298|558903373|FG002|Treatment Period 1|Protocol Violation|0|||
154856682|NCT00792298|558903374|FG003|Treatment Period 1|Protocol Violation|0|||
154856683|NCT00792298|558903375|FG004|Treatment Period 1|Protocol Violation|0|||
154856684|NCT00792298|558903376|FG005|Treatment Period 1|Protocol Violation|0|||
154856685|NCT00792298|558903377|FG006|Treatment Period 1|Protocol Violation|0|||
154856686|NCT00792298|558903378|FG007|Treatment Period 1|Protocol Violation|1|||
154856687|NCT00792298|558903371|FG000|Washout|Adverse Event|0|||
154856688|NCT00792298|558903372|FG001|Washout|Adverse Event|0|||
154856689|NCT00792298|558903373|FG002|Washout|Adverse Event|0|||
154856690|NCT00792298|558903374|FG003|Washout|Adverse Event|0|||
154856691|NCT00792298|558903375|FG004|Washout|Adverse Event|0|||
154856692|NCT00792298|558903376|FG005|Washout|Adverse Event|1|||
154856693|NCT00792298|558903377|FG006|Washout|Adverse Event|0|||
154856694|NCT00792298|558903378|FG007|Washout|Adverse Event|0|||
154856695|NCT00792298|558903371|FG000|Washout|Withdrawal by Subject|0|||
154856696|NCT00792298|558903372|FG001|Washout|Withdrawal by Subject|0|||
154856697|NCT00792298|558903373|FG002|Washout|Withdrawal by Subject|1|||
154856698|NCT00792298|558903374|FG003|Washout|Withdrawal by Subject|0|||
154856699|NCT00792298|558903375|FG004|Washout|Withdrawal by Subject|0|||
154856700|NCT00792298|558903376|FG005|Washout|Withdrawal by Subject|1|||
154856701|NCT00792298|558903377|FG006|Washout|Withdrawal by Subject|0|||
154856702|NCT00792298|558903378|FG007|Washout|Withdrawal by Subject|0|||
154856703|NCT00792298|558903371|FG000|Treatment Period 2|Lack of Efficacy|0|||
154856704|NCT00792298|558903372|FG001|Treatment Period 2|Lack of Efficacy|0|||
154856705|NCT00792298|558903373|FG002|Treatment Period 2|Lack of Efficacy|0|||
154856706|NCT00792298|558903374|FG003|Treatment Period 2|Lack of Efficacy|0|||
154856707|NCT00792298|558903375|FG004|Treatment Period 2|Lack of Efficacy|1|||
154856708|NCT00792298|558903376|FG005|Treatment Period 2|Lack of Efficacy|0|||
154856709|NCT00792298|558903377|FG006|Treatment Period 2|Lack of Efficacy|0|||
154856710|NCT00792298|558903378|FG007|Treatment Period 2|Lack of Efficacy|0|||
154856711|NCT00792298|558903371|FG000|Treatment Period 2|Physician Decision|0|||
154856712|NCT00792298|558903372|FG001|Treatment Period 2|Physician Decision|0|||
154856713|NCT00792298|558903373|FG002|Treatment Period 2|Physician Decision|0|||
154856714|NCT00792298|558903374|FG003|Treatment Period 2|Physician Decision|0|||
154856715|NCT00792298|558903375|FG004|Treatment Period 2|Physician Decision|0|||
154856716|NCT00792298|558903376|FG005|Treatment Period 2|Physician Decision|0|||
154856717|NCT00792298|558903377|FG006|Treatment Period 2|Physician Decision|1|||
154856718|NCT00792298|558903378|FG007|Treatment Period 2|Physician Decision|0|||
154856719|NCT00792298|558903371|FG000|Treatment Period 2|Pregnancy|0|||
154856720|NCT00792298|558903372|FG001|Treatment Period 2|Pregnancy|0|||
154856721|NCT00792298|558903373|FG002|Treatment Period 2|Pregnancy|1|||
154856722|NCT00792298|558903374|FG003|Treatment Period 2|Pregnancy|0|||
154856723|NCT00792298|558903375|FG004|Treatment Period 2|Pregnancy|0|||
154856724|NCT00792298|558903376|FG005|Treatment Period 2|Pregnancy|0|||
154856725|NCT00792298|558903377|FG006|Treatment Period 2|Pregnancy|0|||
154856726|NCT00792298|558903378|FG007|Treatment Period 2|Pregnancy|0|||
154856727|NCT00792298|558903371|FG000|Treatment Period 2|Withdrawal by Subject|1|||
154856728|NCT00792298|558903372|FG001|Treatment Period 2|Withdrawal by Subject|1|||
154856729|NCT00792298|558903373|FG002|Treatment Period 2|Withdrawal by Subject|0|||
154856730|NCT00792298|558903374|FG003|Treatment Period 2|Withdrawal by Subject|2|||
154856731|NCT00792298|558903375|FG004|Treatment Period 2|Withdrawal by Subject|1|||
154856732|NCT00792298|558903376|FG005|Treatment Period 2|Withdrawal by Subject|0|||
154856733|NCT00792298|558903377|FG006|Treatment Period 2|Withdrawal by Subject|0|||
154856734|NCT00792298|558903378|FG007|Treatment Period 2|Withdrawal by Subject|2|||
154856735|NCT00486603|558903381|FG000|Overall Study|Withdrawal by Subject|1|||
154856736|NCT00486603|558903382|FG001|Overall Study|Withdrawal by Subject|0|||
154856737|NCT00486603|558903383|FG002|Overall Study|Withdrawal by Subject|0|||
154856738|NCT00486603|558903384|FG003|Overall Study|Withdrawal by Subject|0|||
154856739|NCT00486603|558903385|FG004|Overall Study|Withdrawal by Subject|0|||
154856740|NCT00486603|558903381|FG000|Overall Study|Physician Decision|0|||
154856741|NCT00486603|558903382|FG001|Overall Study|Physician Decision|1|||
154856742|NCT00486603|558903383|FG002|Overall Study|Physician Decision|0|||
154856743|NCT00486603|558903384|FG003|Overall Study|Physician Decision|0|||
154856744|NCT00486603|558903385|FG004|Overall Study|Physician Decision|0|||
154856745|NCT02706938|558903387|FG000|First Period, 6 Weeks|Adverse Event|8|||
154856746|NCT02706938|558903388|FG001|First Period, 6 Weeks|Adverse Event|0|||
154856747|NCT02706938|558903387|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
154856748|NCT02706938|558903388|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
154856749|NCT02706938|558903387|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
154856750|NCT02706938|558903388|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
154856751|NCT02706938|558903387|FG000|Second Period, 6 Weeks|Adverse Event|0|||
154856752|NCT02706938|558903388|FG001|Second Period, 6 Weeks|Adverse Event|7|||
154856753|NCT02706938|558903387|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
154856754|NCT02706938|558903388|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
154856755|NCT00888238|558903389|FG000|Washout Period After Period 2|Adverse Event|0|||
154856756|NCT00888238|558903390|FG001|Washout Period After Period 2|Adverse Event|0|||
154856757|NCT00888238|558903391|FG002|Washout Period After Period 2|Adverse Event|1|||
154856758|NCT02868892|558903392|FG000|Overall Study|Investigator left site and no follow-up|6|||
154856759|NCT01454076|558903394|FG000|Overall Study|Other|2|||
154856760|NCT01454076|558903395|FG001|Overall Study|Other|0|||
154856761|NCT01454076|558903396|FG002|Overall Study|Other|0|||
154856762|NCT01454076|558903397|FG003|Overall Study|Other|1|||
154856763|NCT01454076|558903398|FG004|Overall Study|Other|2|||
154856764|NCT01454076|558903394|FG000|Overall Study|Withdrawal by Subject|3|||
154856765|NCT01454076|558903395|FG001|Overall Study|Withdrawal by Subject|4|||
154856766|NCT01454076|558903396|FG002|Overall Study|Withdrawal by Subject|2|||
154856767|NCT01454076|558903397|FG003|Overall Study|Withdrawal by Subject|1|||
154856768|NCT01454076|558903398|FG004|Overall Study|Withdrawal by Subject|2|||
154856769|NCT01454076|558903394|FG000|Overall Study|Adverse Event|8|||
154856770|NCT01454076|558903395|FG001|Overall Study|Adverse Event|2|||
154856771|NCT01454076|558903396|FG002|Overall Study|Adverse Event|7|||
154856772|NCT01454076|558903397|FG003|Overall Study|Adverse Event|0|||
154856773|NCT01454076|558903398|FG004|Overall Study|Adverse Event|2|||
154856774|NCT01526148|558903405|FG000|Overall Study|Adverse Event|6|||
154856775|NCT01526148|558903406|FG001|Overall Study|Adverse Event|5|||
154856776|NCT01526148|558903405|FG000|Overall Study|Lost to Follow-up|3|||
154856777|NCT01526148|558903406|FG001|Overall Study|Lost to Follow-up|6|||
154856778|NCT01526148|558903405|FG000|Overall Study|Withdrawal by Subject|2|||
154856779|NCT01526148|558903406|FG001|Overall Study|Withdrawal by Subject|0|||
154856780|NCT01526148|558903405|FG000|Overall Study|Unstable Medical Condition|1|||
154856781|NCT01526148|558903406|FG001|Overall Study|Unstable Medical Condition|0|||
154856782|NCT01526148|558903405|FG000|Overall Study|Unable to discontinue concomitant med|1|||
154856783|NCT01526148|558903406|FG001|Overall Study|Unable to discontinue concomitant med|0|||
154856784|NCT01526148|558903405|FG000|Overall Study|Moved out of state|1|||
154856785|NCT01526148|558903406|FG001|Overall Study|Moved out of state|0|||
154856786|NCT01526148|558903405|FG000|Overall Study|Incarcerated|0|||
154856787|NCT01526148|558903406|FG001|Overall Study|Incarcerated|2|||
154856788|NCT01173653|558903407|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
154856789|NCT01173653|558903408|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
154856790|NCT00291551|558903409|FG000|Overall Study|Death|7|||
154856791|NCT00291551|558903409|FG000|Overall Study|Withdrawal by Subject|6|||
154856792|NCT02452762|558903410|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
154856793|NCT02452762|558903411|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
154856794|NCT02452762|558903410|FG000|Overall Study|Withdrawal by Subject|1|||
154856795|NCT02452762|558903411|FG001|Overall Study|Withdrawal by Subject|0|||
154856796|NCT00584870|558903412|FG000|Overall Study|Adverse Event|4|||
154856797|NCT00584870|558903413|FG001|Overall Study|Adverse Event|3|||
154856798|NCT00584870|558903414|FG002|Overall Study|Adverse Event|2|||
155106372|NCT00372619|559817660|FG005|Overall Study|Inevaluable|1|||
155106373|NCT00372619|559817661|FG006|Overall Study|Inevaluable|0|||
154856799|NCT00584870|558903412|FG000|Overall Study|Lost to Follow-up|4|||
154856800|NCT00584870|558903413|FG001|Overall Study|Lost to Follow-up|1|||
154856801|NCT00584870|558903414|FG002|Overall Study|Lost to Follow-up|1|||
154856802|NCT00584870|558903412|FG000|Overall Study|Lack of Efficacy|7|||
154856803|NCT00584870|558903413|FG001|Overall Study|Lack of Efficacy|14|||
154856804|NCT00584870|558903414|FG002|Overall Study|Lack of Efficacy|8|||
154856805|NCT00584870|558903412|FG000|Overall Study|Withdrawal by Subject|10|||
154856806|NCT00584870|558903413|FG001|Overall Study|Withdrawal by Subject|5|||
154856807|NCT00584870|558903414|FG002|Overall Study|Withdrawal by Subject|3|||
154856808|NCT00584870|558903412|FG000|Overall Study|Protocol Violation|1|||
154856809|NCT00584870|558903413|FG001|Overall Study|Protocol Violation|1|||
154856810|NCT00584870|558903414|FG002|Overall Study|Protocol Violation|2|||
154856811|NCT00584870|558903412|FG000|Overall Study|Did not met entrance criteria|1|||
154856812|NCT00584870|558903413|FG001|Overall Study|Did not met entrance criteria|0|||
154856813|NCT00584870|558903414|FG002|Overall Study|Did not met entrance criteria|0|||
154856814|NCT00584870|558903412|FG000|Overall Study|Other|2|||
155106374|NCT00066222|559817662|FG000|Overall Study|No protocol treatment received|1|||
155106375|NCT00988052|559817671|FG000|Overall Study|Missing|1|||
154856815|NCT00584870|558903413|FG001|Overall Study|Other|0|||
154856816|NCT00584870|558903414|FG002|Overall Study|Other|0|||
154856817|NCT00584870|558903412|FG000|Overall Study|Randomized but not treated|0|||
154856818|NCT00584870|558903413|FG001|Overall Study|Randomized but not treated|1|||
154856819|NCT00584870|558903414|FG002|Overall Study|Randomized but not treated|2|||
154856820|NCT00631137|558903415|FG000|Overall Study|Withdrawal by Subject|1|||
154856821|NCT00631137|558903416|FG001|Overall Study|Withdrawal by Subject|0|||
154856822|NCT03682120|558903417|FG000|Overall Study|Lost to Follow-up|11|||
154856823|NCT03682120|558903418|FG001|Overall Study|Lost to Follow-up|4|||
154856824|NCT03682120|558903419|FG002|Overall Study|Lost to Follow-up|5|||
154856825|NCT03682120|558903420|FG003|Overall Study|Lost to Follow-up|2|||
154856826|NCT03682120|558903417|FG000|Overall Study|Physician Decision|1|||
154856827|NCT03682120|558903418|FG001|Overall Study|Physician Decision|0|||
154856828|NCT03682120|558903419|FG002|Overall Study|Physician Decision|0|||
154856829|NCT03682120|558903420|FG003|Overall Study|Physician Decision|0|||
154856830|NCT03682120|558903417|FG000|Overall Study|Withdrawal by Subject|1|||
154856831|NCT03682120|558903418|FG001|Overall Study|Withdrawal by Subject|2|||
154856832|NCT03682120|558903419|FG002|Overall Study|Withdrawal by Subject|3|||
154856833|NCT03682120|558903420|FG003|Overall Study|Withdrawal by Subject|0|||
154856834|NCT03682120|558903417|FG000|Overall Study|Death|0|||
154856835|NCT03682120|558903418|FG001|Overall Study|Death|1|||
154856836|NCT03682120|558903419|FG002|Overall Study|Death|0|||
154856837|NCT03682120|558903420|FG003|Overall Study|Death|0|||
154856838|NCT03682120|558903417|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
154856839|NCT03682120|558903418|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
154971994|NCT02048813|559322267|FG000|Overall Study|Wound infection/healing|2|||
154971995|NCT02048813|559322268|FG001|Overall Study|Wound infection/healing|0|||
154971996|NCT02048813|559322267|FG000|Overall Study|Missed appointment|3|||
154971997|NCT02048813|559322268|FG001|Overall Study|Missed appointment|0|||
154971998|NCT02048813|559322267|FG000|Overall Study|Never started treatment|2|||
154971999|NCT02048813|559322268|FG001|Overall Study|Never started treatment|17|||
154972000|NCT01708954|559322269|FG000|Step 1|Disease progression|26|||
154972001|NCT01708954|559322270|FG001|Step 1|Disease progression|17|||
154972002|NCT01708954|559322271|FG002|Step 1|Disease progression|14|||
154972003|NCT01708954|559322269|FG000|Step 1|Adverse Event|3|||
154972004|NCT01708954|559322270|FG001|Step 1|Adverse Event|11|||
154972005|NCT01708954|559322271|FG002|Step 1|Adverse Event|13|||
154972006|NCT01708954|559322269|FG000|Step 1|Death|3|||
154972007|NCT01708954|559322270|FG001|Step 1|Death|2|||
154972008|NCT01708954|559322271|FG002|Step 1|Death|3|||
154972009|NCT01708954|559322269|FG000|Step 1|Withdrawal by Subject|2|||
154972010|NCT01708954|559322270|FG001|Step 1|Withdrawal by Subject|5|||
154972011|NCT01708954|559322271|FG002|Step 1|Withdrawal by Subject|3|||
154856840|NCT03682120|558903419|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
154856841|NCT03682120|558903420|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
154856842|NCT01015833|558903421|FG000|Overall Study|Death|1|||
154856843|NCT01015833|558903422|FG001|Overall Study|Death|0|||
154856844|NCT01015833|558903421|FG000|Overall Study|Withdrawal by Subject|3|||
154856845|NCT01015833|558903422|FG001|Overall Study|Withdrawal by Subject|2|||
154856846|NCT01015833|558903421|FG000|Overall Study|Adverse Event|0|||
154856847|NCT01015833|558903422|FG001|Overall Study|Adverse Event|1|||
154856848|NCT01015833|558903421|FG000|Overall Study|Physician Decision|2|||
154856849|NCT01015833|558903422|FG001|Overall Study|Physician Decision|0|||
154856850|NCT01015833|558903421|FG000|Overall Study|Symptomatic deterioration|0|||
154856851|NCT01015833|558903422|FG001|Overall Study|Symptomatic deterioration|1|||
154856852|NCT01015833|558903421|FG000|Overall Study|Other|5|||
154856853|NCT01015833|558903422|FG001|Overall Study|Other|1|||
154856854|NCT01015833|558903421|FG000|Overall Study|Motor Vehicle Accidents|1|||
154856855|NCT01015833|558903422|FG001|Overall Study|Motor Vehicle Accidents|0|||
154856856|NCT01015833|558903421|FG000|Overall Study|Did not start treatment|1|||
154856857|NCT01015833|558903422|FG001|Overall Study|Did not start treatment|0|||
154856858|NCT03529409|558903431|FG000|Randomized|Lost to Follow-up|0|||
154856859|NCT03529409|558903432|FG001|Randomized|Lost to Follow-up|0|||
154856860|NCT03529409|558903433|FG002|Randomized|Lost to Follow-up|4|||
154856861|NCT03529409|558903431|FG000|Randomized|Excluded|0|||
154856862|NCT03529409|558903432|FG001|Randomized|Excluded|0|||
154972012|NCT01708954|559322269|FG000|Step 1|Other complicating disease|0|||
154972013|NCT01708954|559322270|FG001|Step 1|Other complicating disease|2|||
154972014|NCT01708954|559322271|FG002|Step 1|Other complicating disease|0|||
154972015|NCT01708954|559322269|FG000|Step 1|Crossed over to Step 2|2|||
154856863|NCT03529409|558903433|FG002|Randomized|Excluded|1|||
154856864|NCT03529409|558903431|FG000|Post-treatment Assessment|Death|1|||
154972016|NCT01708954|559322270|FG001|Step 1|Crossed over to Step 2|0|||
154972017|NCT01708954|559322271|FG002|Step 1|Crossed over to Step 2|0|||
154972018|NCT01708954|559322269|FG000|Step 1|Symptomatic deterioration|1|||
154972019|NCT01708954|559322270|FG001|Step 1|Symptomatic deterioration|0|||
154972020|NCT01708954|559322271|FG002|Step 1|Symptomatic deterioration|1|||
154856865|NCT03529409|558903432|FG001|Post-treatment Assessment|Death|0|||
154856866|NCT03529409|558903433|FG002|Post-treatment Assessment|Death|0|||
154972021|NCT01708954|559322269|FG000|Step 1|Off-treatment reason not submitted|1|||
154856867|NCT03529409|558903431|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
154856868|NCT03529409|558903432|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
154856869|NCT03529409|558903433|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
154856870|NCT03529409|558903431|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
154856871|NCT03529409|558903432|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
154856872|NCT03529409|558903433|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
154856873|NCT03529409|558903431|FG000|Follow-up Assessment|Death|1|||
154856874|NCT03529409|558903432|FG001|Follow-up Assessment|Death|0|||
154856875|NCT03529409|558903433|FG002|Follow-up Assessment|Death|0|||
154856876|NCT03529409|558903431|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
154856877|NCT03529409|558903432|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
154856878|NCT03529409|558903433|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
154856879|NCT01497262|558903434|FG000|Overall Study|Abnormal Lab Values|4|||
154856880|NCT01497262|558903434|FG000|Overall Study|Abnormal Test Procedure Result|1|||
154856881|NCT01497262|558903434|FG000|Overall Study|Physician Decision|1|||
154856882|NCT01497262|558903434|FG000|Overall Study|Withdrawal by Subject|2|||
154856883|NCT01497262|558903434|FG000|Overall Study|Adverse Event|2|||
154972022|NCT01708954|559322270|FG001|Step 1|Off-treatment reason not submitted|1|||
154972023|NCT01708954|559322271|FG002|Step 1|Off-treatment reason not submitted|1|||
154972024|NCT01708954|559322269|FG000|Step 1|Ineligible or never received treatment|4|||
154972025|NCT01708954|559322270|FG001|Step 1|Ineligible or never received treatment|2|||
154972026|NCT01708954|559322271|FG002|Step 1|Ineligible or never received treatment|8|||
154972027|NCT01708954|559322269|FG000|Step 2|Disease progression|9|||
154972028|NCT01708954|559322270|FG001|Step 2|Disease progression|4|||
154972029|NCT01708954|559322271|FG002|Step 2|Disease progression|0|||
154972030|NCT01708954|559322269|FG000|Step 2|Adverse Event|3|||
154972031|NCT01708954|559322270|FG001|Step 2|Adverse Event|2|||
154972032|NCT01708954|559322271|FG002|Step 2|Adverse Event|0|||
154972033|NCT01708954|559322269|FG000|Step 2|Withdrawal by Subject|1|||
154972034|NCT01708954|559322270|FG001|Step 2|Withdrawal by Subject|1|||
154972035|NCT01708954|559322271|FG002|Step 2|Withdrawal by Subject|0|||
154972036|NCT05996198|559322272|FG000|Overall Study|Withdrawal by Subject|1|||
154972037|NCT05996198|559322273|FG001|Overall Study|Withdrawal by Subject|0|||
154972038|NCT01192776|559322274|FG000|Overall Study|Death|8|||
154972039|NCT01192776|559322275|FG001|Overall Study|Death|15|||
154972040|NCT01192776|559322276|FG002|Overall Study|Death|18|||
154972041|NCT01192776|559322277|FG003|Overall Study|Death|15|||
154972042|NCT01192776|559322274|FG000|Overall Study|Lost to Follow-up|3|||
154972043|NCT01192776|559322275|FG001|Overall Study|Lost to Follow-up|6|||
154972044|NCT01192776|559322276|FG002|Overall Study|Lost to Follow-up|3|||
154972045|NCT01192776|559322277|FG003|Overall Study|Lost to Follow-up|5|||
154972046|NCT00413049|559322281|FG000|Overall Study|Adverse Event|10|||
154972047|NCT00413049|559322282|FG001|Overall Study|Adverse Event|8|||
154972048|NCT00413049|559322281|FG000|Overall Study|Withdrawal by Subject|7|||
154972049|NCT00413049|559322282|FG001|Overall Study|Withdrawal by Subject|5|||
154972050|NCT00413049|559322281|FG000|Overall Study|Lost to Follow-up|2|||
154972051|NCT00413049|559322282|FG001|Overall Study|Lost to Follow-up|3|||
154972052|NCT00413049|559322281|FG000|Overall Study|Protocol Violation|3|||
154972053|NCT00413049|559322282|FG001|Overall Study|Protocol Violation|1|||
154972054|NCT00413049|559322281|FG000|Overall Study|Subject no longer requires study drug|0|||
154972055|NCT00413049|559322282|FG001|Overall Study|Subject no longer requires study drug|1|||
154972056|NCT00413049|559322281|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154972057|NCT00413049|559322282|FG001|Overall Study|Abnormal laboratory value(s)|0|||
154972058|NCT00413049|559322281|FG000|Overall Study|Lack of Efficacy|1|||
154972059|NCT00413049|559322282|FG001|Overall Study|Lack of Efficacy|0|||
154972060|NCT00487695|559322287|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
154972061|NCT00487695|559322288|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
154972062|NCT00487695|559322287|FG000|First Procedure|active wheezing (did not have procedure)|1|||
154972063|NCT00487695|559322288|FG001|First Procedure|active wheezing (did not have procedure)|0|||
154972064|NCT00487695|559322287|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
154856884|NCT01497262|558903434|FG000|Overall Study|Protocol Violation|1|||
154856885|NCT01651780|558903437|FG000|Overall Study|Physician decision: No 30-day visit|2|||
154856886|NCT01651780|558903438|FG001|Overall Study|Physician decision: No 30-day visit|1|||
154856887|NCT01651780|558903437|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
154972065|NCT00487695|559322288|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
154972066|NCT00487695|559322287|FG000|Second Procedure|active wheezing|0|||
154972067|NCT00487695|559322288|FG001|Second Procedure|active wheezing|1|||
154972068|NCT00487695|559322287|FG000|Second Procedure|Withdrawal by Subject|1|||
154972069|NCT00487695|559322288|FG001|Second Procedure|Withdrawal by Subject|2|||
154972070|NCT02104817|559322289|FG000|Overall Study|Death|363|||
154972071|NCT02104817|559322290|FG001|Overall Study|Death|330|||
154972072|NCT02104817|559322289|FG000|Overall Study|Lost to Follow-up|3|||
154972073|NCT02104817|559322290|FG001|Overall Study|Lost to Follow-up|2|||
154972074|NCT02104817|559322289|FG000|Overall Study|Protocol Violation|0|||
154972075|NCT02104817|559322290|FG001|Overall Study|Protocol Violation|1|||
154972076|NCT02104817|559322289|FG000|Overall Study|Study terminated by sponsor|5854|||
154972077|NCT02104817|559322290|FG001|Overall Study|Study terminated by sponsor|5901|||
154972078|NCT02104817|559322289|FG000|Overall Study|Withdrawal by Subject|111|||
154972079|NCT02104817|559322290|FG001|Overall Study|Withdrawal by Subject|78|||
154972080|NCT02104817|559322289|FG000|Overall Study|Other reasons|128|||
154972081|NCT02104817|559322290|FG001|Overall Study|Other reasons|135|||
154972082|NCT04633642|559322291|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
154972083|NCT04633642|559322292|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
154972084|NCT00611884|559322293|FG000|Overall Study|Adverse Event|1|||
154972085|NCT00611884|559322294|FG001|Overall Study|Adverse Event|0|||
154972086|NCT00611884|559322295|FG002|Overall Study|Adverse Event|0|||
154972087|NCT00611884|559322296|FG003|Overall Study|Adverse Event|1|||
154972088|NCT00611884|559322293|FG000|Overall Study|Non-Compliance|1|||
154972089|NCT00611884|559322294|FG001|Overall Study|Non-Compliance|4|||
154972090|NCT00611884|559322295|FG002|Overall Study|Non-Compliance|2|||
154972091|NCT00611884|559322296|FG003|Overall Study|Non-Compliance|2|||
154972092|NCT00611884|559322293|FG000|Overall Study|Lack of Efficacy|0|||
154972093|NCT00611884|559322294|FG001|Overall Study|Lack of Efficacy|1|||
154972094|NCT00611884|559322295|FG002|Overall Study|Lack of Efficacy|0|||
154972095|NCT00611884|559322296|FG003|Overall Study|Lack of Efficacy|0|||
154972096|NCT00611884|559322293|FG000|Overall Study|Unclassified|7|||
154972097|NCT00611884|559322294|FG001|Overall Study|Unclassified|4|||
154972098|NCT00611884|559322295|FG002|Overall Study|Unclassified|2|||
154972099|NCT00611884|559322296|FG003|Overall Study|Unclassified|3|||
154972100|NCT00981799|559322297|FG000|Overall Study|Adverse Event|1|||
154972101|NCT00981799|559322298|FG001|Overall Study|Adverse Event|1|||
154972102|NCT00981799|559322299|FG002|Overall Study|Adverse Event|0|||
154972103|NCT00981799|559322300|FG003|Overall Study|Adverse Event|0|||
154972104|NCT00160524|559322301|FG000|Overall Study|Adverse Event|119|||
154972105|NCT00160524|559322301|FG000|Overall Study|Adverse Event and Other|94|||
154972106|NCT00160524|559322301|FG000|Overall Study|Protocol Violation|16|||
154972107|NCT00160524|559322301|FG000|Overall Study|Protocol Violation and Other|2|||
154972108|NCT00160524|559322301|FG000|Overall Study|Withdrawal by Subject|141|||
154972109|NCT00160524|559322301|FG000|Overall Study|Withdrawal by Subject and Other|17|||
154972110|NCT00160524|559322301|FG000|Overall Study|Physician Decision|27|||
154972111|NCT00160524|559322301|FG000|Overall Study|Physician Decision and Other|6|||
154972112|NCT00160524|559322301|FG000|Overall Study|Lost to Follow-up|13|||
154972113|NCT00160524|559322301|FG000|Overall Study|Lost to Follow-up and Other|1|||
154972114|NCT00160524|559322301|FG000|Overall Study|Lack of Efficacy|21|||
154972115|NCT00160524|559322301|FG000|Overall Study|Lack of Efficacy and Other|1|||
154856888|NCT01651780|558903438|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
154856889|NCT01651780|558903437|FG000|Overall Study|Withdrawal by Subject|2|||
154856890|NCT01651780|558903438|FG001|Overall Study|Withdrawal by Subject|0|||
154856891|NCT01651780|558903437|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
154856892|NCT01651780|558903438|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
154856893|NCT01651780|558903437|FG000|Overall Study|Lost to Follow-up|1|||
154856894|NCT01651780|558903438|FG001|Overall Study|Lost to Follow-up|2|||
154856895|NCT01651780|558903437|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
154856896|NCT01651780|558903438|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
154856897|NCT03898063|558903439|FG000|Overall Study|Withdrawal by Subject|10|||
154856898|NCT03898063|558903440|FG001|Overall Study|Withdrawal by Subject|8|||
154856899|NCT02949830|558903441|FG000|Overall Study|Adverse Event|1|||
154856900|NCT02949830|558903441|FG000|Overall Study|Withdrawal by Subject|1|||
154856901|NCT01290887|558903442|FG000|Overall Study|Adverse Event|6|||
154856902|NCT01290887|558903443|FG001|Overall Study|Adverse Event|11|||
154856903|NCT01290887|558903442|FG000|Overall Study|Lack of Efficacy|4|||
154856904|NCT01290887|558903443|FG001|Overall Study|Lack of Efficacy|5|||
154856905|NCT01290887|558903442|FG000|Overall Study|Withdrawal by Subject|26|||
154856906|NCT01290887|558903443|FG001|Overall Study|Withdrawal by Subject|32|||
154856907|NCT01290887|558903442|FG000|Overall Study|Protocol Violation|2|||
154972116|NCT00160524|559322301|FG000|Overall Study|Other|20|||
154972117|NCT04892147|559322302|FG000|Overall Study|Withdrawal by Subject|2|||
154972118|NCT04892147|559322303|FG001|Overall Study|Withdrawal by Subject|0|||
154972119|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
154972120|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
154972121|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
154972122|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
154856908|NCT01290887|558903443|FG001|Overall Study|Protocol Violation|1|||
154856909|NCT01290887|558903442|FG000|Overall Study|Lost to Follow-up|4|||
154856910|NCT01290887|558903443|FG001|Overall Study|Lost to Follow-up|4|||
154856911|NCT01290887|558903442|FG000|Overall Study|Non-compliance to study procedures|0|||
154856912|NCT01290887|558903443|FG001|Overall Study|Non-compliance to study procedures|1|||
154856913|NCT01290887|558903442|FG000|Overall Study|Non-compliance to study medications|1|||
154856914|NCT01290887|558903443|FG001|Overall Study|Non-compliance to study medications|0|||
154856915|NCT01290887|558903442|FG000|Overall Study|Sponsor closure of study|420|||
155106376|NCT00988052|559817672|FG001|Overall Study|Missing|0|||
154856916|NCT01290887|558903443|FG001|Overall Study|Sponsor closure of study|476|||
154856917|NCT01290887|558903442|FG000|Overall Study|Other|3|||
154856918|NCT01290887|558903443|FG001|Overall Study|Other|6|||
154856919|NCT01628926|558903444|FG000|Overall Study|Adverse Event|13|||
154856920|NCT01628926|558903445|FG001|Overall Study|Adverse Event|11|||
154856921|NCT01628926|558903446|FG002|Overall Study|Adverse Event|9|||
154856922|NCT01628926|558903444|FG000|Overall Study|Lack of Efficacy|2|||
154856923|NCT01628926|558903445|FG001|Overall Study|Lack of Efficacy|1|||
154856924|NCT01628926|558903446|FG002|Overall Study|Lack of Efficacy|5|||
154856925|NCT01628926|558903444|FG000|Overall Study|Withdrawal by Subject|6|||
154856926|NCT01628926|558903445|FG001|Overall Study|Withdrawal by Subject|4|||
154856927|NCT01628926|558903446|FG002|Overall Study|Withdrawal by Subject|2|||
154856928|NCT01628926|558903444|FG000|Overall Study|Protocol Violation|0|||
154856929|NCT01628926|558903445|FG001|Overall Study|Protocol Violation|1|||
154856930|NCT01628926|558903446|FG002|Overall Study|Protocol Violation|0|||
154972123|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
154972124|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
154972125|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
154972126|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
154972127|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
154972128|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
154972129|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
154972130|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
154972131|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
154972132|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
154972133|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
154972134|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
154972135|NCT01067521|559322305|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
154972136|NCT01067521|559322306|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
154972137|NCT01067521|559322305|FG000|Open-Label Period|Death|3|||
154972138|NCT01067521|559322306|FG001|Open-Label Period|Death|1|||
154972139|NCT01067521|559322305|FG000|Open-Label Period|Adverse Event|30|||
154972140|NCT01067521|559322306|FG001|Open-Label Period|Adverse Event|28|||
154972141|NCT01067521|559322305|FG000|Open-Label Period|Withdrawal by Subject|160|||
155106377|NCT00988052|559817671|FG000|Overall Study|Teva requested subject withdrawal|3|||
155106378|NCT00988052|559817672|FG001|Overall Study|Teva requested subject withdrawal|1|||
155106379|NCT00988052|559817671|FG000|Overall Study|Death|1|||
155106380|NCT00988052|559817672|FG001|Overall Study|Death|3|||
155106381|NCT00988052|559817671|FG000|Overall Study|Protocol Violation|6|||
155106382|NCT00988052|559817672|FG001|Overall Study|Protocol Violation|5|||
155106383|NCT00988052|559817671|FG000|Overall Study|Pregnancy|6|||
155106384|NCT00988052|559817672|FG001|Overall Study|Pregnancy|6|||
155106385|NCT00988052|559817671|FG000|Overall Study|Lack of Efficacy|8|||
155106386|NCT00988052|559817672|FG001|Overall Study|Lack of Efficacy|7|||
155106387|NCT00988052|559817671|FG000|Overall Study|Lost to Follow-up|6|||
154856931|NCT01628926|558903444|FG000|Overall Study|Discontinuation criteria|3|||
154856932|NCT01628926|558903445|FG001|Overall Study|Discontinuation criteria|4|||
154972142|NCT01067521|559322306|FG001|Open-Label Period|Withdrawal by Subject|88|||
154972143|NCT01067521|559322305|FG000|Open-Label Period|Physician Decision|13|||
154972144|NCT01067521|559322306|FG001|Open-Label Period|Physician Decision|11|||
154972145|NCT01067521|559322305|FG000|Open-Label Period|Non-compliance with study drug|5|||
154972146|NCT01067521|559322306|FG001|Open-Label Period|Non-compliance with study drug|0|||
154972147|NCT01067521|559322305|FG000|Open-Label Period|Protocol Violation|3|||
154972148|NCT01067521|559322306|FG001|Open-Label Period|Protocol Violation|0|||
154972149|NCT01067521|559322305|FG000|Open-Label Period|Pregnancy|14|||
154972150|NCT01067521|559322306|FG001|Open-Label Period|Pregnancy|8|||
154972151|NCT01067521|559322305|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
154972152|NCT01067521|559322306|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
154972153|NCT01067521|559322305|FG000|Open-Label Period|Lost to Follow-up|21|||
154972154|NCT01067521|559322306|FG001|Open-Label Period|Lost to Follow-up|20|||
154972155|NCT01547728|559322310|FG000|Overall Study|Change in procedure and equipment|1|||
154972156|NCT01547728|559322310|FG000|Overall Study|Drug not ready for subject|1|||
154972157|NCT01547728|559322310|FG000|Overall Study|Screen failure|39|||
154972158|NCT03828539|559322311|FG000|Overall Study|Adverse Event|3|||
154972159|NCT03828539|559322312|FG001|Overall Study|Adverse Event|12|||
154972160|NCT03828539|559322311|FG000|Overall Study|Patient's/guardian's decision|3|||
154972161|NCT03828539|559322312|FG001|Overall Study|Patient's/guardian's decision|5|||
154972162|NCT03828539|559322311|FG000|Overall Study|Lost to Follow-up|4|||
154972163|NCT03828539|559322312|FG001|Overall Study|Lost to Follow-up|2|||
154972164|NCT03828539|559322311|FG000|Overall Study|Protocol Violation|3|||
154972165|NCT03828539|559322312|FG001|Overall Study|Protocol Violation|2|||
154972166|NCT03828539|559322311|FG000|Overall Study|Withdrawal of informed consent|2|||
154972167|NCT03828539|559322312|FG001|Overall Study|Withdrawal of informed consent|1|||
154972168|NCT03828539|559322311|FG000|Overall Study|New therapy for study indication|1|||
154972169|NCT03828539|559322312|FG001|Overall Study|New therapy for study indication|0|||
154972170|NCT00766493|559322313|FG000|30 Days Post-Procedure|Discontinued|7|||
154972171|NCT00766493|559322313|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
154972172|NCT00766493|559322313|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
154972173|NCT01849458|559322315|FG000|Overall Study|Lost to Follow-up|4|||
154972174|NCT00024258|559322318|FG000|Overall Study|Withdrawal by Subject|1|||
154972175|NCT00024258|559322318|FG000|Overall Study|Disease Progression|8|||
154972176|NCT03950674|559322319|FG000|Overall Study|Death|16|||
154972177|NCT03950674|559322320|FG001|Overall Study|Death|15|||
154972178|NCT03950674|559322319|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
154972179|NCT03950674|559322320|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
154856933|NCT01628926|558903446|FG002|Overall Study|Discontinuation criteria|0|||
154856934|NCT01628926|558903444|FG000|Overall Study|Physician Decision|2|||
154856935|NCT01628926|558903445|FG001|Overall Study|Physician Decision|2|||
154856936|NCT01628926|558903446|FG002|Overall Study|Physician Decision|1|||
154856937|NCT02116621|558903447|FG000|Baseline|Withdrawal by Subject|0|||
154856938|NCT02116621|558903448|FG001|Baseline|Withdrawal by Subject|4|||
154856939|NCT02116621|558903447|FG000|Three Month Follow-up|Death|1|||
154856940|NCT02116621|558903448|FG001|Three Month Follow-up|Death|1|||
154856941|NCT02116621|558903447|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
154856942|NCT02116621|558903448|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
154856943|NCT02116621|558903447|FG000|Three Month Follow-up|Lost to Follow-up|0|||
154856944|NCT02116621|558903448|FG001|Three Month Follow-up|Lost to Follow-up|1|||
154856945|NCT02116621|558903447|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
154856946|NCT02116621|558903448|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
154856947|NCT02116621|558903447|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
154856948|NCT02116621|558903448|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
154856949|NCT02116621|558903447|FG000|Six Month Follow-up|Lost to Follow-up|2|||
154856950|NCT02116621|558903448|FG001|Six Month Follow-up|Lost to Follow-up|1|||
154856951|NCT02116621|558903447|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
154856952|NCT02116621|558903448|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
154856953|NCT02116621|558903447|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
154856954|NCT02116621|558903448|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
154856955|NCT02116621|558903447|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
154972180|NCT01898598|559322321|FG000|Overall Study|Adverse Event|1|||
154856956|NCT02116621|558903448|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
154856957|NCT02116621|558903447|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
154972181|NCT01898598|559322322|FG001|Overall Study|Adverse Event|0|||
154856958|NCT02116621|558903448|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
154972182|NCT01898598|559322321|FG000|Overall Study|Withdrawal by Subject|3|||
154972183|NCT01898598|559322322|FG001|Overall Study|Withdrawal by Subject|0|||
154972184|NCT01898598|559322321|FG000|Overall Study|Lost to Follow-up|0|||
154972185|NCT01898598|559322322|FG001|Overall Study|Lost to Follow-up|1|||
154972186|NCT01898598|559322321|FG000|Overall Study|Other|0|||
154972187|NCT01898598|559322322|FG001|Overall Study|Other|1|||
154972188|NCT03833427|559322323|FG000|Overall Study|Death|4|||
154856959|NCT02116621|558903447|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
155106388|NCT00988052|559817672|FG001|Overall Study|Lost to Follow-up|11|||
155106389|NCT00988052|559817671|FG000|Overall Study|Physician Decision|27|||
155106390|NCT00988052|559817672|FG001|Overall Study|Physician Decision|28|||
155106391|NCT00988052|559817671|FG000|Overall Study|Adverse Event|35|||
155106392|NCT00988052|559817672|FG001|Overall Study|Adverse Event|28|||
155106393|NCT00988052|559817671|FG000|Overall Study|Withdrawal by Subject|90|||
155106394|NCT00988052|559817672|FG001|Overall Study|Withdrawal by Subject|91|||
155106395|NCT00988052|559817671|FG000|Overall Study|Study terminated by sponsor|240|||
155106396|NCT00988052|559817672|FG001|Overall Study|Study terminated by sponsor|236|||
155106397|NCT00295646|559817673|FG000|Overall Study|Protocol Violation|18|||
154856960|NCT02116621|558903448|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
155106398|NCT00295646|559817674|FG001|Overall Study|Protocol Violation|20|||
155106399|NCT00295646|559817675|FG002|Overall Study|Protocol Violation|20|||
155106400|NCT00295646|559817676|FG003|Overall Study|Protocol Violation|18|||
155106401|NCT00295646|559817673|FG000|Overall Study|Withdrawal by Subject|8|||
155106402|NCT00295646|559817674|FG001|Overall Study|Withdrawal by Subject|9|||
155106403|NCT00295646|559817675|FG002|Overall Study|Withdrawal by Subject|11|||
155106404|NCT00295646|559817676|FG003|Overall Study|Withdrawal by Subject|14|||
155106405|NCT00295646|559817673|FG000|Overall Study|Lost to Follow-up|0|||
155106406|NCT00295646|559817674|FG001|Overall Study|Lost to Follow-up|5|||
155106407|NCT00295646|559817675|FG002|Overall Study|Lost to Follow-up|1|||
155106408|NCT00295646|559817676|FG003|Overall Study|Lost to Follow-up|5|||
155106409|NCT00295646|559817673|FG000|Overall Study|Death|9|||
155106410|NCT00295646|559817674|FG001|Overall Study|Death|7|||
155106411|NCT00295646|559817675|FG002|Overall Study|Death|18|||
155106412|NCT00295646|559817676|FG003|Overall Study|Death|8|||
155106413|NCT01509846|559817678|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
155106414|NCT01509846|559817679|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
155106415|NCT01509846|559817680|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
155106416|NCT01509846|559817681|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
155106417|NCT01509846|559817682|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
155106418|NCT01509846|559817678|FG000|Received Vaccination 2|Illness|0|||
155106419|NCT01509846|559817679|FG001|Received Vaccination 2|Illness|0|||
155106420|NCT01509846|559817680|FG002|Received Vaccination 2|Illness|0|||
155106421|NCT01509846|559817681|FG003|Received Vaccination 2|Illness|0|||
155106422|NCT01509846|559817682|FG004|Received Vaccination 2|Illness|1|||
155106423|NCT01509846|559817678|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
155106424|NCT01509846|559817679|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
155106425|NCT01509846|559817680|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
155106426|NCT01509846|559817681|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
155106427|NCT01509846|559817682|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
155106428|NCT01509846|559817678|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
155106429|NCT01509846|559817679|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
155106430|NCT01509846|559817680|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
155106431|NCT01509846|559817681|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
155106432|NCT01509846|559817682|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
155106433|NCT01509846|559817678|FG000|Received Vaccination 3|Pregnancy|0|||
155106434|NCT01509846|559817679|FG001|Received Vaccination 3|Pregnancy|0|||
155106435|NCT01509846|559817680|FG002|Received Vaccination 3|Pregnancy|0|||
155106436|NCT01509846|559817681|FG003|Received Vaccination 3|Pregnancy|1|||
155106437|NCT01509846|559817682|FG004|Received Vaccination 3|Pregnancy|0|||
155106438|NCT01509846|559817678|FG000|Received Vaccination 3|Lost to Follow-up|0|||
155106439|NCT01509846|559817679|FG001|Received Vaccination 3|Lost to Follow-up|0|||
155106440|NCT01509846|559817680|FG002|Received Vaccination 3|Lost to Follow-up|1|||
155106441|NCT01509846|559817681|FG003|Received Vaccination 3|Lost to Follow-up|0|||
155106442|NCT01509846|559817682|FG004|Received Vaccination 3|Lost to Follow-up|0|||
155106443|NCT01637584|559817684|FG000|Overall Study|Withdrawal by Subject|1|||
154856961|NCT03437447|558903449|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154856962|NCT03437447|558903450|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154856963|NCT03437447|558903451|FG002|Treatment Period 1|Withdrawal by Subject|1|||
154856964|NCT04752384|558903453|FG000|Overall Study|Withdrawal by Subject|1|||
154856965|NCT04752384|558903453|FG000|Overall Study|Death|1|||
155106444|NCT01637584|559817685|FG001|Overall Study|Withdrawal by Subject|3|||
155106445|NCT04396795|559817686|FG000|Month 1|Lost to Follow-up|2|||
155106446|NCT04396795|559817687|FG001|Month 1|Lost to Follow-up|3|||
155106447|NCT04396795|559817686|FG000|Month 3|Lost to Follow-up|1|||
155106448|NCT04396795|559817687|FG001|Month 3|Lost to Follow-up|3|||
155106449|NCT04396795|559817686|FG000|Month 6|Lost to Follow-up|3|||
155106450|NCT04396795|559817687|FG001|Month 6|Lost to Follow-up|3|||
155106451|NCT02484443|559817688|FG000|Overall Study|Lack of Efficacy|28|||
155106452|NCT02484443|559817688|FG000|Overall Study|Physician Decision|2|||
155106453|NCT02484443|559817688|FG000|Overall Study|Ineligible|2|||
155106454|NCT02595866|559817689|FG000|Overall Study|Adverse Event|2|||
155106455|NCT02595866|559817690|FG001|Overall Study|Adverse Event|5|||
154856966|NCT03726268|558903454|FG000|Overall Study|Physician Decision|2|||
154856967|NCT03726268|558903455|FG001|Overall Study|Physician Decision|8|||
155106456|NCT02595866|559817689|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
154856968|NCT03726268|558903456|FG002|Overall Study|Physician Decision|6|||
154856969|NCT03726268|558903457|FG003|Overall Study|Physician Decision|3|||
154856970|NCT03726268|558903454|FG000|Overall Study|Withdrawal by Subject|11|||
154856971|NCT03726268|558903455|FG001|Overall Study|Withdrawal by Subject|5|||
154856972|NCT03726268|558903456|FG002|Overall Study|Withdrawal by Subject|9|||
154856973|NCT03726268|558903457|FG003|Overall Study|Withdrawal by Subject|8|||
154856974|NCT01986062|558903458|FG000|Overall Study|Lost to Follow-up|1|||
154856975|NCT01986062|558903459|FG001|Overall Study|Lost to Follow-up|0|||
154856976|NCT01986062|558903458|FG000|Overall Study|Withdrawal by Subject|0|||
154856977|NCT01986062|558903459|FG001|Overall Study|Withdrawal by Subject|1|||
154856978|NCT03538743|558903460|FG000|Overall Study|Adverse Event|0|||
154856979|NCT03538743|558903461|FG001|Overall Study|Adverse Event|0|||
154856980|NCT03538743|558903462|FG002|Overall Study|Adverse Event|1|||
154856981|NCT03538743|558903463|FG003|Overall Study|Adverse Event|1|||
154856982|NCT03538743|558903464|FG004|Overall Study|Adverse Event|0|||
154856983|NCT03538743|558903465|FG005|Overall Study|Adverse Event|0|||
154856984|NCT03538743|558903466|FG006|Overall Study|Adverse Event|0|||
154856985|NCT03538743|558903467|FG007|Overall Study|Adverse Event|0|||
154856986|NCT03538743|558903468|FG008|Overall Study|Adverse Event|0|||
154856987|NCT03538743|558903460|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
154856988|NCT03538743|558903461|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
154856989|NCT03538743|558903462|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
154856990|NCT03538743|558903463|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
154856991|NCT03538743|558903464|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
154856992|NCT03538743|558903465|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
154856993|NCT03538743|558903466|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
154856994|NCT03538743|558903467|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
154856995|NCT03538743|558903468|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
154856996|NCT03538743|558903460|FG000|Overall Study|Withdrawal by Subject|0|||
154856997|NCT03538743|558903461|FG001|Overall Study|Withdrawal by Subject|0|||
154856998|NCT03538743|558903462|FG002|Overall Study|Withdrawal by Subject|0|||
154856999|NCT03538743|558903463|FG003|Overall Study|Withdrawal by Subject|1|||
154857000|NCT03538743|558903464|FG004|Overall Study|Withdrawal by Subject|0|||
154857001|NCT03538743|558903465|FG005|Overall Study|Withdrawal by Subject|0|||
154857002|NCT03538743|558903466|FG006|Overall Study|Withdrawal by Subject|0|||
154857003|NCT03538743|558903467|FG007|Overall Study|Withdrawal by Subject|0|||
154857004|NCT03538743|558903468|FG008|Overall Study|Withdrawal by Subject|0|||
154857005|NCT01955707|558903470|FG000|Overall Study|Adverse Event|1|||
154857006|NCT01955707|558903471|FG001|Overall Study|Adverse Event|2|||
154857007|NCT01955707|558903470|FG000|Overall Study|Lost to Follow-up|2|||
154857008|NCT01955707|558903471|FG001|Overall Study|Lost to Follow-up|1|||
154857009|NCT01955707|558903470|FG000|Overall Study|Withdrawal by Subject|0|||
154857010|NCT01955707|558903471|FG001|Overall Study|Withdrawal by Subject|3|||
154857011|NCT01955707|558903470|FG000|Overall Study|Death|13|||
154857012|NCT01955707|558903471|FG001|Overall Study|Death|14|||
154857013|NCT01955707|558903470|FG000|Overall Study|Other|4|||
154857014|NCT01955707|558903471|FG001|Overall Study|Other|2|||
154857015|NCT06001307|558904729|FG000|Overall Study|Lost to Follow-up|1|||
154857016|NCT06001307|558904730|FG001|Overall Study|Lost to Follow-up|2|||
154857017|NCT03532100|558904731|FG000|Overall Study|Intervention malfunction|1|||
154857018|NCT03896581|558904732|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
154857019|NCT03896581|558904733|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
154857020|NCT03896581|558904732|FG000|Overall Study|Withdrawal by Subject|4|||
154857021|NCT03896581|558904733|FG001|Overall Study|Withdrawal by Subject|1|||
154857022|NCT03896581|558904732|FG000|Overall Study|Lost to Follow-up|1|||
154857023|NCT03896581|558904733|FG001|Overall Study|Lost to Follow-up|0|||
154857024|NCT03896581|558904732|FG000|Overall Study|Lack of Efficacy|2|||
154857025|NCT03896581|558904733|FG001|Overall Study|Lack of Efficacy|1|||
154857026|NCT03896581|558904732|FG000|Overall Study|Adverse event, non-fatal|0|||
154857027|NCT03896581|558904733|FG001|Overall Study|Adverse event, non-fatal|2|||
154857028|NCT00960076|558904734|FG000|Overall Study|Adverse Event|1|||
154857029|NCT00960076|558904735|FG001|Overall Study|Adverse Event|7|||
154857030|NCT00960076|558904734|FG000|Overall Study|No longer met study criteria|1|||
154857031|NCT00960076|558904735|FG001|Overall Study|No longer met study criteria|5|||
154857032|NCT00960076|558904734|FG000|Overall Study|Withdrawal by Subject|1|||
154857033|NCT00960076|558904735|FG001|Overall Study|Withdrawal by Subject|2|||
154857034|NCT00960076|558904734|FG000|Overall Study|Lost to Follow-up|3|||
154857035|NCT00960076|558904735|FG001|Overall Study|Lost to Follow-up|3|||
154857036|NCT00960076|558904734|FG000|Overall Study|Severe non-compliance to protocol|1|||
154857037|NCT00960076|558904735|FG001|Overall Study|Severe non-compliance to protocol|2|||
154857038|NCT00960076|558904734|FG000|Overall Study|Hyperglycemia|1|||
154857039|NCT00960076|558904735|FG001|Overall Study|Hyperglycemia|5|||
154857040|NCT00960076|558904734|FG000|Overall Study|Did not attend the termination visit|0|||
154857041|NCT00960076|558904735|FG001|Overall Study|Did not attend the termination visit|1|||
154857042|NCT02029976|558904736|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
155173636|NCT01155011|560074842|FG000|Baseline to 6 Months|Death|0|||
155106457|NCT02595866|559817690|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
154857043|NCT02029976|558904737|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
154857044|NCT02029976|558904736|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
154857045|NCT02029976|558904737|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
154857046|NCT02029976|558904736|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
154857047|NCT02029976|558904737|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
154857048|NCT02029976|558904736|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
154857049|NCT02029976|558904737|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
154857050|NCT01445171|558904738|FG000|Overall Study|Lost to Follow-up|11|||
154857051|NCT01445171|558904738|FG000|Overall Study|Withdrawal by Subject|16|||
154857052|NCT01445171|558904738|FG000|Overall Study|Death|51|||
154857053|NCT01445171|558904738|FG000|Overall Study|Subjects declined to return for followup|9|||
154857054|NCT01445171|558904738|FG000|Overall Study|Consented but did not receive device|8|||
154857055|NCT00162773|558904739|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
154857056|NCT05194345|558904742|FG000|Overall Study|Withdrawal by Subject|6|||
154857057|NCT05194345|558904743|FG001|Overall Study|Withdrawal by Subject|4|||
154857058|NCT05194345|558904744|FG002|Overall Study|Withdrawal by Subject|0|||
154857059|NCT05194345|558904742|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
154857060|NCT05194345|558904743|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
154857061|NCT05194345|558904744|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
154857062|NCT03124459|558904748|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
154857063|NCT03124459|558904749|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
154857064|NCT03124459|558904750|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
154857065|NCT03124459|558904751|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
154857066|NCT03124459|558904752|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
154857067|NCT03124459|558904753|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
154857068|NCT03124459|558904748|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
154857069|NCT03124459|558904749|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
154857070|NCT03124459|558904750|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
154857071|NCT03124459|558904751|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
154857072|NCT03124459|558904752|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
154857073|NCT03124459|558904753|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
154857074|NCT03124459|558904748|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
154857075|NCT03124459|558904749|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
154857076|NCT03124459|558904750|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
154857077|NCT03124459|558904751|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
154857078|NCT03124459|558904752|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
154857079|NCT03124459|558904753|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
154857080|NCT03124459|558904748|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
154857081|NCT03124459|558904749|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
154857082|NCT03124459|558904750|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
154857083|NCT03124459|558904751|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
154857084|NCT03124459|558904752|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
154857085|NCT03124459|558904753|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
154857086|NCT03124459|558904748|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
154857087|NCT03124459|558904749|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
154857088|NCT03124459|558904750|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
154857089|NCT03124459|558904751|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
154857090|NCT03124459|558904752|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
154857091|NCT03124459|558904753|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
154857092|NCT03124459|558904748|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
154857093|NCT03124459|558904749|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
154857094|NCT03124459|558904750|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
154857095|NCT03124459|558904751|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
154857096|NCT03124459|558904752|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
154857097|NCT03124459|558904753|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
154972189|NCT03833427|559322324|FG001|Overall Study|Death|2|||
155106458|NCT02595866|559817689|FG000|Overall Study|Death|0|||
155106459|NCT02595866|559817690|FG001|Overall Study|Death|1|||
155106460|NCT02595866|559817689|FG000|Overall Study|Incarceration|1|||
155106461|NCT02595866|559817690|FG001|Overall Study|Incarceration|0|||
155106462|NCT02595866|559817689|FG000|Overall Study|Lack of Efficacy|17|||
155106463|NCT02595866|559817690|FG001|Overall Study|Lack of Efficacy|7|||
155106464|NCT02595866|559817689|FG000|Overall Study|Physician Decision|4|||
155106465|NCT02595866|559817690|FG001|Overall Study|Physician Decision|3|||
155106466|NCT02595866|559817689|FG000|Overall Study|Switched to Alternative Treatment|1|||
155106467|NCT02595866|559817690|FG001|Overall Study|Switched to Alternative Treatment|0|||
155173637|NCT01155011|560074843|FG001|Baseline to 6 Months|Death|1|||
154857098|NCT01028352|558904754|FG000|Overall Study|Ineligible due to baseline average pain|5|||
154857099|NCT01028352|558904754|FG000|Overall Study|Withdrawal by Subject|1|||
154857100|NCT01903876|558904755|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
154857101|NCT01903876|558904756|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
154857102|NCT01903876|558904755|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
154857103|NCT01903876|558904756|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
154857104|NCT00826748|558904766|FG000|Overall Study|Withdrawal by Subject|0|||
154857105|NCT00826748|558904767|FG001|Overall Study|Withdrawal by Subject|0|||
154857106|NCT00826748|558904768|FG002|Overall Study|Withdrawal by Subject|2|||
154857107|NCT00826748|558904766|FG000|Overall Study|Physician Decision|0|||
154857108|NCT00826748|558904767|FG001|Overall Study|Physician Decision|0|||
154857109|NCT00826748|558904768|FG002|Overall Study|Physician Decision|1|||
154857110|NCT00826748|558904766|FG000|Overall Study|Samples Did Not pass QC|0|||
154857111|NCT00826748|558904767|FG001|Overall Study|Samples Did Not pass QC|0|||
154857112|NCT00826748|558904768|FG002|Overall Study|Samples Did Not pass QC|1|||
154857113|NCT01887912|558904769|FG000|Overall Study|Serious adverse event|400|||
154857114|NCT01887912|558904770|FG001|Overall Study|Serious adverse event|198|||
154857115|NCT01887912|558904769|FG000|Overall Study|Other Adverse Event|34|||
154857116|NCT01887912|558904770|FG001|Overall Study|Other Adverse Event|15|||
154857117|NCT01887912|558904769|FG000|Overall Study|Protocol Violation|67|||
154857118|NCT01887912|558904770|FG001|Overall Study|Protocol Violation|37|||
154857119|NCT01887912|558904769|FG000|Overall Study|Lost to Follow-up|163|||
154857120|NCT01887912|558904770|FG001|Overall Study|Lost to Follow-up|74|||
154857121|NCT01887912|558904769|FG000|Overall Study|Withdrawal by Subject|606|||
154857122|NCT01887912|558904770|FG001|Overall Study|Withdrawal by Subject|349|||
154857123|NCT01887912|558904769|FG000|Overall Study|Other|122|||
154857124|NCT01887912|558904770|FG001|Overall Study|Other|58|||
154857125|NCT04462536|558904771|FG000|Overall Study|Withdrawal by Subject|3|||
154857126|NCT04462536|558904772|FG001|Overall Study|Withdrawal by Subject|9|||
154857127|NCT04462536|558904771|FG000|Overall Study|Lost to Follow-up|2|||
154857128|NCT04462536|558904772|FG001|Overall Study|Lost to Follow-up|4|||
154857129|NCT00450580|558904775|FG000|Overall Study|Adverse Event|5|||
154972190|NCT03833427|559322325|FG002|Overall Study|Death|9|||
154972191|NCT03833427|559322326|FG003|Overall Study|Death|11|||
154972192|NCT03833427|559322327|FG004|Overall Study|Death|0|||
154972193|NCT03833427|559322328|FG005|Overall Study|Death|0|||
154972194|NCT03833427|559322329|FG006|Overall Study|Death|0|||
154972195|NCT03833427|559322323|FG000|Overall Study|Withdrawal by Subject|0|||
154972196|NCT03833427|559322324|FG001|Overall Study|Withdrawal by Subject|1|||
154972197|NCT03833427|559322325|FG002|Overall Study|Withdrawal by Subject|1|||
154972198|NCT03833427|559322326|FG003|Overall Study|Withdrawal by Subject|0|||
154972199|NCT03833427|559322327|FG004|Overall Study|Withdrawal by Subject|0|||
154857130|NCT00450580|558904776|FG001|Overall Study|Adverse Event|7|||
154857131|NCT00450580|558904775|FG000|Overall Study|Lost to Follow-up|4|||
154857132|NCT00450580|558904776|FG001|Overall Study|Lost to Follow-up|5|||
154857133|NCT00450580|558904775|FG000|Overall Study|Withdrawal by Subject|2|||
154857134|NCT00450580|558904776|FG001|Overall Study|Withdrawal by Subject|2|||
154857135|NCT00450580|558904775|FG000|Overall Study|Protocol Violation|1|||
154857136|NCT00450580|558904776|FG001|Overall Study|Protocol Violation|1|||
154857137|NCT00450580|558904775|FG000|Overall Study|Protocol-defined virologic failure|1|||
154857138|NCT00450580|558904776|FG001|Overall Study|Protocol-defined virologic failure|0|||
154857139|NCT00450580|558904775|FG000|Overall Study|Could not comply with scheduled visits|1|||
154857140|NCT00450580|558904776|FG001|Overall Study|Could not comply with scheduled visits|0|||
154857141|NCT00450580|558904775|FG000|Overall Study|Patient went to Brazil|1|||
154857142|NCT00450580|558904776|FG001|Overall Study|Patient went to Brazil|0|||
154857143|NCT00450580|558904775|FG000|Overall Study|Patient could not swallow Norvir|1|||
154857144|NCT00450580|558904776|FG001|Overall Study|Patient could not swallow Norvir|0|||
154857145|NCT00450580|558904775|FG000|Overall Study|Withdrawal due to pregnancy|0|||
154857146|NCT00450580|558904776|FG001|Overall Study|Withdrawal due to pregnancy|1|||
154857147|NCT00332709|558904781|FG000|Overall Study|Adverse Event|11|||
154857148|NCT00332709|558904782|FG001|Overall Study|Adverse Event|14|||
154857149|NCT00332709|558904781|FG000|Overall Study|Withdrawal by Subject|2|||
154857150|NCT00332709|558904782|FG001|Overall Study|Withdrawal by Subject|3|||
154857151|NCT00332709|558904781|FG000|Overall Study|Lost to Follow-up|2|||
154857152|NCT00332709|558904782|FG001|Overall Study|Lost to Follow-up|0|||
154857153|NCT00332709|558904781|FG000|Overall Study|Administrative Problems|0|||
154857154|NCT00332709|558904782|FG001|Overall Study|Administrative Problems|3|||
154972200|NCT03833427|559322328|FG005|Overall Study|Withdrawal by Subject|0|||
154972201|NCT03833427|559322329|FG006|Overall Study|Withdrawal by Subject|0|||
154857155|NCT00332709|558904781|FG000|Overall Study|Abnormal test procedure result|1|||
154857156|NCT00332709|558904782|FG001|Overall Study|Abnormal test procedure result|0|||
154857157|NCT00191854|558904787|FG000|Overall Study|Death|26|||
154857158|NCT00191854|558904788|FG001|Overall Study|Death|23|||
154857159|NCT00191854|558904789|FG002|Overall Study|Death|29|||
154857160|NCT00191854|558904787|FG000|Overall Study|Lost to Follow-up|7|||
154857161|NCT00191854|558904788|FG001|Overall Study|Lost to Follow-up|5|||
154972202|NCT03833427|559322323|FG000|Overall Study|Sponsor Decision|0|||
154972203|NCT03833427|559322324|FG001|Overall Study|Sponsor Decision|0|||
154857162|NCT00191854|558904789|FG002|Overall Study|Lost to Follow-up|5|||
154857163|NCT00191854|558904787|FG000|Overall Study|Withdrawal by Subject|4|||
154857164|NCT00191854|558904788|FG001|Overall Study|Withdrawal by Subject|2|||
154857165|NCT00191854|558904789|FG002|Overall Study|Withdrawal by Subject|3|||
154857166|NCT00191854|558904787|FG000|Overall Study|Sponsor Decision|0|||
154857167|NCT00191854|558904788|FG001|Overall Study|Sponsor Decision|0|||
154857168|NCT00191854|558904789|FG002|Overall Study|Sponsor Decision|1|||
154857169|NCT00191854|558904787|FG000|Overall Study|Screen Failure|0|||
154857170|NCT00191854|558904788|FG001|Overall Study|Screen Failure|0|||
154857171|NCT00191854|558904789|FG002|Overall Study|Screen Failure|1|||
154857172|NCT02601950|558904790|FG000|Overall Study|Participant enrolled in rollover study|0|||
154857173|NCT02601950|558904791|FG001|Overall Study|Participant enrolled in rollover study|0|||
154857174|NCT02601950|558904792|FG002|Overall Study|Participant enrolled in rollover study|1|||
154857175|NCT02601950|558904793|FG003|Overall Study|Participant enrolled in rollover study|0|||
154857176|NCT02601950|558904794|FG004|Overall Study|Participant enrolled in rollover study|1|||
154857177|NCT02601950|558904795|FG005|Overall Study|Participant enrolled in rollover study|1|||
154857178|NCT02601950|558904796|FG006|Overall Study|Participant enrolled in rollover study|1|||
154857179|NCT02601950|558904797|FG007|Overall Study|Participant enrolled in rollover study|0|||
154857180|NCT02601950|558904790|FG000|Overall Study|Disease progression - radiological|21|||
154857181|NCT02601950|558904791|FG001|Overall Study|Disease progression - radiological|26|||
154857182|NCT02601950|558904792|FG002|Overall Study|Disease progression - radiological|22|||
154857183|NCT02601950|558904793|FG003|Overall Study|Disease progression - radiological|11|||
154857184|NCT02601950|558904794|FG004|Overall Study|Disease progression - radiological|46|||
154857185|NCT02601950|558904795|FG005|Overall Study|Disease progression - radiological|52|||
154857186|NCT02601950|558904796|FG006|Overall Study|Disease progression - radiological|7|||
154857187|NCT02601950|558904797|FG007|Overall Study|Disease progression - radiological|5|||
154857188|NCT02601950|558904790|FG000|Overall Study|Disease progression - clinical|3|||
154857189|NCT02601950|558904791|FG001|Overall Study|Disease progression - clinical|5|||
154857190|NCT02601950|558904792|FG002|Overall Study|Disease progression - clinical|4|||
154857191|NCT02601950|558904793|FG003|Overall Study|Disease progression - clinical|2|||
154857192|NCT02601950|558904794|FG004|Overall Study|Disease progression - clinical|6|||
154857193|NCT02601950|558904795|FG005|Overall Study|Disease progression - clinical|6|||
154857194|NCT02601950|558904796|FG006|Overall Study|Disease progression - clinical|5|||
154857195|NCT02601950|558904797|FG007|Overall Study|Disease progression - clinical|1|||
154857196|NCT02601950|558904790|FG000|Overall Study|Death|6|||
154857197|NCT02601950|558904791|FG001|Overall Study|Death|0|||
154857198|NCT02601950|558904792|FG002|Overall Study|Death|3|||
154857199|NCT02601950|558904793|FG003|Overall Study|Death|1|||
154857200|NCT02601950|558904794|FG004|Overall Study|Death|4|||
154857201|NCT02601950|558904795|FG005|Overall Study|Death|1|||
154857202|NCT02601950|558904796|FG006|Overall Study|Death|0|||
154857203|NCT02601950|558904797|FG007|Overall Study|Death|0|||
154857204|NCT02601950|558904790|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857205|NCT02601950|558904791|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857206|NCT02601950|558904792|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857207|NCT02601950|558904793|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857208|NCT02601950|558904794|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857209|NCT02601950|558904795|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
154857210|NCT02601950|558904796|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857211|NCT02601950|558904797|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
154857212|NCT02601950|558904790|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
154857213|NCT02601950|558904791|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
154857214|NCT02601950|558904792|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
154857215|NCT02601950|558904793|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
154857216|NCT02601950|558904794|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
154857217|NCT02601950|558904795|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
154857218|NCT02601950|558904796|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
154857219|NCT02601950|558904797|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
154857220|NCT02601950|558904790|FG000|Overall Study|Non-compliance|0|||
154857221|NCT02601950|558904791|FG001|Overall Study|Non-compliance|1|||
154857222|NCT02601950|558904792|FG002|Overall Study|Non-compliance|0|||
154857223|NCT02601950|558904793|FG003|Overall Study|Non-compliance|0|||
154857224|NCT02601950|558904794|FG004|Overall Study|Non-compliance|0|||
154857225|NCT02601950|558904795|FG005|Overall Study|Non-compliance|1|||
154857226|NCT02601950|558904796|FG006|Overall Study|Non-compliance|1|||
154857227|NCT02601950|558904797|FG007|Overall Study|Non-compliance|0|||
154857228|NCT02601950|558904790|FG000|Overall Study|Participant refused further study treatment|0|||
154857229|NCT02601950|558904791|FG001|Overall Study|Participant refused further study treatment|1|||
154857230|NCT02601950|558904792|FG002|Overall Study|Participant refused further study treatment|1|||
154857231|NCT02601950|558904793|FG003|Overall Study|Participant refused further study treatment|0|||
154857232|NCT02601950|558904794|FG004|Overall Study|Participant refused further study treatment|2|||
154857233|NCT02601950|558904795|FG005|Overall Study|Participant refused further study treatment|2|||
154857234|NCT02601950|558904796|FG006|Overall Study|Participant refused further study treatment|2|||
154857235|NCT02601950|558904797|FG007|Overall Study|Participant refused further study treatment|1|||
154857236|NCT02601950|558904790|FG000|Overall Study|Investigator discretion|1|||
154857237|NCT02601950|558904791|FG001|Overall Study|Investigator discretion|0|||
154857238|NCT02601950|558904792|FG002|Overall Study|Investigator discretion|1|||
154857239|NCT02601950|558904793|FG003|Overall Study|Investigator discretion|0|||
154857240|NCT02601950|558904794|FG004|Overall Study|Investigator discretion|1|||
154857241|NCT02601950|558904795|FG005|Overall Study|Investigator discretion|1|||
154857242|NCT02601950|558904796|FG006|Overall Study|Investigator discretion|1|||
154857243|NCT02601950|558904797|FG007|Overall Study|Investigator discretion|0|||
154857244|NCT02601950|558904790|FG000|Overall Study|Other|0|||
154857245|NCT02601950|558904791|FG001|Overall Study|Other|0|||
154857246|NCT02601950|558904792|FG002|Overall Study|Other|0|||
154857247|NCT02601950|558904793|FG003|Overall Study|Other|0|||
154857248|NCT02601950|558904794|FG004|Overall Study|Other|2|||
154857249|NCT02601950|558904795|FG005|Overall Study|Other|2|||
154857250|NCT02601950|558904796|FG006|Overall Study|Other|1|||
154857251|NCT02601950|558904797|FG007|Overall Study|Other|0|||
154857252|NCT02157883|558904800|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
154857253|NCT02157883|558904800|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
154857254|NCT02157883|558904800|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
154857255|NCT02157883|558904800|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
154857256|NCT02157883|558904800|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
154857257|NCT01323478|558904801|FG000|Overall Study|Adverse Event|7|||
154857258|NCT01323478|558904801|FG000|Overall Study|Lack of Efficacy|4|||
154857259|NCT01323478|558904801|FG000|Overall Study|Non-compliance With Study Product|3|||
154857260|NCT01323478|558904801|FG000|Overall Study|Protocol Violation|1|||
154857261|NCT01323478|558904801|FG000|Overall Study|Withdrawal of Consent|1|||
154857262|NCT01323478|558904801|FG000|Overall Study|Administrative or Other Reasons|8|||
154857263|NCT01756274|558904805|FG000|Overall Study|Protocol Violation|2|||
154857264|NCT01756274|558904805|FG000|Overall Study|Laboratory error|1|||
154857265|NCT03367871|558904808|FG000|Overall Study|Lost to Follow-up|1|||
154857266|NCT01670994|558904810|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
154857267|NCT01670994|558904811|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
154857268|NCT01670994|558904810|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
154857269|NCT01670994|558904811|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
154857270|NCT01670994|558904810|FG000|Overall Study|Patient experienced DLT|0|||
154857271|NCT01670994|558904811|FG001|Overall Study|Patient experienced DLT|1|||
154857272|NCT02013544|558904812|FG000|Overall Study|Adverse Event|5|||
154857273|NCT02013544|558904813|FG001|Overall Study|Adverse Event|5|||
154857274|NCT02013544|558904812|FG000|Overall Study|Lost to Follow-up|2|||
154857275|NCT02013544|558904813|FG001|Overall Study|Lost to Follow-up|3|||
154857276|NCT02013544|558904812|FG000|Overall Study|Withdrawal by Subject|2|||
154857277|NCT02013544|558904813|FG001|Overall Study|Withdrawal by Subject|8|||
154857278|NCT02013544|558904812|FG000|Overall Study|Physician Decision|0|||
154857279|NCT02013544|558904813|FG001|Overall Study|Physician Decision|1|||
154857280|NCT02013544|558904812|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
154857281|NCT02013544|558904813|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
154857282|NCT00891735|558904814|FG000|Overall Study|Adverse Event|2|||
154857283|NCT00891735|558904815|FG001|Overall Study|Adverse Event|0|||
154857284|NCT00891735|558904816|FG002|Overall Study|Adverse Event|2|||
154857285|NCT00891735|558904817|FG003|Overall Study|Adverse Event|0|||
154857286|NCT00891735|558904814|FG000|Overall Study|Death|8|||
154857287|NCT00891735|558904815|FG001|Overall Study|Death|5|||
154857288|NCT00891735|558904816|FG002|Overall Study|Death|4|||
154857289|NCT00891735|558904817|FG003|Overall Study|Death|5|||
154857290|NCT00891735|558904814|FG000|Overall Study|Lost to Follow-up|2|||
154857291|NCT00891735|558904815|FG001|Overall Study|Lost to Follow-up|2|||
154857292|NCT00891735|558904816|FG002|Overall Study|Lost to Follow-up|2|||
154857293|NCT00891735|558904817|FG003|Overall Study|Lost to Follow-up|2|||
154857294|NCT00891735|558904814|FG000|Overall Study|Physician's decision to withdraw patient|1|||
154857295|NCT00891735|558904815|FG001|Overall Study|Physician's decision to withdraw patient|0|||
154857296|NCT00891735|558904816|FG002|Overall Study|Physician's decision to withdraw patient|0|||
154857297|NCT00891735|558904817|FG003|Overall Study|Physician's decision to withdraw patient|0|||
154857298|NCT00891735|558904814|FG000|Overall Study|Patient's decision to withdraw|4|||
154857299|NCT00891735|558904815|FG001|Overall Study|Patient's decision to withdraw|9|||
154857300|NCT00891735|558904816|FG002|Overall Study|Patient's decision to withdraw|4|||
154857301|NCT00891735|558904817|FG003|Overall Study|Patient's decision to withdraw|8|||
154857302|NCT00481065|558904820|FG000|Overall Study|Adverse event or death|1|||
154857303|NCT00481065|558904821|FG001|Overall Study|Adverse event or death|1|||
154857304|NCT00481065|558904822|FG002|Overall Study|Adverse event or death|3|||
154857305|NCT00481065|558904823|FG003|Overall Study|Adverse event or death|0|||
154857306|NCT00481065|558904824|FG004|Overall Study|Adverse event or death|2|||
154857307|NCT00481065|558904825|FG005|Overall Study|Adverse event or death|0|||
154857308|NCT00481065|558904826|FG006|Overall Study|Adverse event or death|1|||
154857309|NCT00481065|558904827|FG007|Overall Study|Adverse event or death|1|||
154857310|NCT00481065|558904820|FG000|Overall Study|Withdrawal by Subject|11|||
155106468|NCT02595866|559817689|FG000|Overall Study|Study Terminated|0|||
155106469|NCT02595866|559817690|FG001|Overall Study|Study Terminated|4|||
154857311|NCT00481065|558904821|FG001|Overall Study|Withdrawal by Subject|12|||
154857312|NCT00481065|558904822|FG002|Overall Study|Withdrawal by Subject|7|||
154857313|NCT00481065|558904823|FG003|Overall Study|Withdrawal by Subject|11|||
154857314|NCT00481065|558904824|FG004|Overall Study|Withdrawal by Subject|13|||
154857315|NCT00481065|558904825|FG005|Overall Study|Withdrawal by Subject|12|||
154857316|NCT00481065|558904826|FG006|Overall Study|Withdrawal by Subject|9|||
154857317|NCT00481065|558904827|FG007|Overall Study|Withdrawal by Subject|10|||
154857318|NCT00481065|558904820|FG000|Overall Study|Lost to Follow-up|4|||
154857319|NCT00481065|558904821|FG001|Overall Study|Lost to Follow-up|2|||
154857320|NCT00481065|558904822|FG002|Overall Study|Lost to Follow-up|4|||
154857321|NCT00481065|558904823|FG003|Overall Study|Lost to Follow-up|3|||
154857322|NCT00481065|558904824|FG004|Overall Study|Lost to Follow-up|3|||
154857323|NCT00481065|558904825|FG005|Overall Study|Lost to Follow-up|3|||
154857324|NCT00481065|558904826|FG006|Overall Study|Lost to Follow-up|2|||
154857325|NCT00481065|558904827|FG007|Overall Study|Lost to Follow-up|5|||
154857326|NCT00481065|558904820|FG000|Overall Study|Inappropriate enrollment|4|||
154857327|NCT00481065|558904821|FG001|Overall Study|Inappropriate enrollment|0|||
154857328|NCT00481065|558904822|FG002|Overall Study|Inappropriate enrollment|2|||
154857329|NCT00481065|558904823|FG003|Overall Study|Inappropriate enrollment|0|||
154857330|NCT00481065|558904824|FG004|Overall Study|Inappropriate enrollment|2|||
154857331|NCT00481065|558904825|FG005|Overall Study|Inappropriate enrollment|1|||
154857332|NCT00481065|558904826|FG006|Overall Study|Inappropriate enrollment|0|||
154857333|NCT00481065|558904827|FG007|Overall Study|Inappropriate enrollment|1|||
154857334|NCT00481065|558904820|FG000|Overall Study|Administrative reason|0|||
154857335|NCT00481065|558904821|FG001|Overall Study|Administrative reason|0|||
154857336|NCT00481065|558904822|FG002|Overall Study|Administrative reason|0|||
154857337|NCT00481065|558904823|FG003|Overall Study|Administrative reason|0|||
154857338|NCT00481065|558904824|FG004|Overall Study|Administrative reason|0|||
154857339|NCT00481065|558904825|FG005|Overall Study|Administrative reason|2|||
154857340|NCT00481065|558904826|FG006|Overall Study|Administrative reason|1|||
154857341|NCT00481065|558904827|FG007|Overall Study|Administrative reason|0|||
154857342|NCT00481065|558904820|FG000|Overall Study|Protocol Violation|2|||
154857343|NCT00481065|558904821|FG001|Overall Study|Protocol Violation|1|||
154857344|NCT00481065|558904822|FG002|Overall Study|Protocol Violation|1|||
154857345|NCT00481065|558904823|FG003|Overall Study|Protocol Violation|1|||
154857346|NCT00481065|558904824|FG004|Overall Study|Protocol Violation|2|||
154857347|NCT00481065|558904825|FG005|Overall Study|Protocol Violation|6|||
154857348|NCT00481065|558904826|FG006|Overall Study|Protocol Violation|3|||
154857349|NCT00481065|558904827|FG007|Overall Study|Protocol Violation|2|||
154857350|NCT00481065|558904820|FG000|Overall Study|Unable to classify|0|||
154857351|NCT00481065|558904821|FG001|Overall Study|Unable to classify|1|||
154857352|NCT00481065|558904822|FG002|Overall Study|Unable to classify|2|||
154857353|NCT00481065|558904823|FG003|Overall Study|Unable to classify|0|||
154972204|NCT03833427|559322325|FG002|Overall Study|Sponsor Decision|1|||
154972205|NCT03833427|559322326|FG003|Overall Study|Sponsor Decision|3|||
154972206|NCT03833427|559322327|FG004|Overall Study|Sponsor Decision|0|||
154972207|NCT03833427|559322328|FG005|Overall Study|Sponsor Decision|0|||
155106470|NCT02595866|559817689|FG000|Overall Study|Withdrawal by Subject|6|||
155106471|NCT02595866|559817690|FG001|Overall Study|Withdrawal by Subject|1|||
155106472|NCT02689206|559817692|FG000|Overall Study|Adverse Event|0|||
155106473|NCT02689206|559817693|FG001|Overall Study|Adverse Event|0|||
155106474|NCT02689206|559817694|FG002|Overall Study|Adverse Event|1|||
155106475|NCT02689206|559817695|FG003|Overall Study|Adverse Event|0|||
155106476|NCT02689206|559817696|FG004|Overall Study|Adverse Event|2|||
155106477|NCT02689206|559817692|FG000|Overall Study|Protocol Violation|1|||
155106478|NCT02689206|559817693|FG001|Overall Study|Protocol Violation|0|||
154972208|NCT03833427|559322329|FG006|Overall Study|Sponsor Decision|0|||
154972209|NCT03448692|559322330|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
154972210|NCT03448692|559322331|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
154972211|NCT03448692|559322330|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
155106479|NCT02689206|559817694|FG002|Overall Study|Protocol Violation|0|||
155106480|NCT02689206|559817695|FG003|Overall Study|Protocol Violation|1|||
155106481|NCT02689206|559817696|FG004|Overall Study|Protocol Violation|2|||
155106482|NCT02689206|559817692|FG000|Overall Study|Other: Reached stopping criteria|0|||
154857354|NCT00481065|558904824|FG004|Overall Study|Unable to classify|1|||
154857355|NCT00481065|558904825|FG005|Overall Study|Unable to classify|0|||
154857356|NCT00481065|558904826|FG006|Overall Study|Unable to classify|0|||
154857357|NCT00481065|558904827|FG007|Overall Study|Unable to classify|0|||
154857358|NCT03094195|558904833|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
154857359|NCT03094195|558904834|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
154972212|NCT03448692|559322331|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
154857360|NCT03094195|558904835|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
154857361|NCT03094195|558904836|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154857362|NCT03094195|558904837|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154857363|NCT03094195|558904838|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154857364|NCT03094195|558904839|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154857365|NCT03094195|558904840|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154857366|NCT03094195|558904833|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
154857367|NCT03094195|558904834|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
154857368|NCT03094195|558904835|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
154857369|NCT03094195|558904836|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154857370|NCT03094195|558904837|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154857371|NCT03094195|558904838|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154857372|NCT03094195|558904839|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154857373|NCT03094195|558904840|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154857374|NCT03094195|558904833|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857375|NCT03094195|558904834|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857376|NCT03094195|558904835|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
154857377|NCT03094195|558904836|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857378|NCT03094195|558904837|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857379|NCT03094195|558904838|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857380|NCT03094195|558904839|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857381|NCT03094195|558904840|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154857382|NCT03094195|558904833|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154857383|NCT03094195|558904834|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
154857384|NCT03094195|558904835|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
154857385|NCT03094195|558904836|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154857386|NCT03094195|558904837|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154857387|NCT03094195|558904838|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154857388|NCT03094195|558904839|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154857389|NCT03094195|558904840|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154857390|NCT01957137|558904841|FG000|Randomized Portion|Adverse Event|1|||
154857391|NCT01957137|558904841|FG000|Randomized Portion|Withdrawal by Subject|1|||
154857392|NCT00054132|558904842|FG000|Overall Study|Not Treated|1|||
154857393|NCT01795547|558904847|FG000|Overall Study|Adverse Event|16|||
154857394|NCT01795547|558904848|FG001|Overall Study|Adverse Event|27|||
154857395|NCT01795547|558904847|FG000|Overall Study|Lack of Efficacy|8|||
154857396|NCT01795547|558904848|FG001|Overall Study|Lack of Efficacy|3|||
154857397|NCT01795547|558904847|FG000|Overall Study|Protocol Violation|6|||
154857398|NCT01795547|558904848|FG001|Overall Study|Protocol Violation|4|||
154857399|NCT01795547|558904847|FG000|Overall Study|Lost to Follow-up|2|||
154857400|NCT01795547|558904848|FG001|Overall Study|Lost to Follow-up|5|||
154857401|NCT01795547|558904847|FG000|Overall Study|Withdrawal of consent|7|||
154857402|NCT01795547|558904848|FG001|Overall Study|Withdrawal of consent|12|||
154857403|NCT01795547|558904847|FG000|Overall Study|Not Treated|4|||
154857404|NCT01795547|558904848|FG001|Overall Study|Not Treated|10|||
154857405|NCT01795547|558904847|FG000|Overall Study|Non-compliance with IMP|1|||
154857406|NCT01795547|558904848|FG001|Overall Study|Non-compliance with IMP|1|||
154857407|NCT01795547|558904847|FG000|Overall Study|Others|4|||
154857408|NCT01795547|558904848|FG001|Overall Study|Others|1|||
154857409|NCT01795547|558904847|FG000|Overall Study|Not stated|0|||
154857410|NCT01795547|558904848|FG001|Overall Study|Not stated|1|||
154857411|NCT00591734|558904853|FG000|Overall Study|Lack of Efficacy|35|||
154857412|NCT00591734|558904853|FG000|Overall Study|Adverse Event|5|||
154857413|NCT00591734|558904853|FG000|Overall Study|Physician Decision|5|||
154857414|NCT00591734|558904853|FG000|Overall Study|Intercurrent Illness|8|||
154857415|NCT00784758|558904856|FG000|Overall Study|Withdrawal by Subject|3|||
154857416|NCT00784758|558904857|FG001|Overall Study|Withdrawal by Subject|0|||
154857417|NCT00784758|558904856|FG000|Overall Study|Adverse Event|1|||
154857418|NCT00784758|558904857|FG001|Overall Study|Adverse Event|0|||
154972213|NCT03448692|559322330|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
154972214|NCT03448692|559322331|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
154972215|NCT03448692|559322330|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
154972216|NCT03448692|559322331|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
154972217|NCT03448692|559322330|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
154972218|NCT03448692|559322331|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
154972219|NCT03428945|559322334|FG000|Overall Study|Lost to Follow-up|5|||
154972220|NCT03428945|559322335|FG001|Overall Study|Lost to Follow-up|3|||
154857419|NCT02040142|558904858|FG000|Overall Study|Lost to Follow-up|5|||
154857420|NCT02040142|558904858|FG000|Overall Study|Death|17|||
154857421|NCT02040142|558904858|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
154972221|NCT03428945|559322334|FG000|Overall Study|Withdrawal by Subject|10|||
155106483|NCT02689206|559817693|FG001|Overall Study|Other: Reached stopping criteria|1|||
155106484|NCT02689206|559817694|FG002|Overall Study|Other: Reached stopping criteria|2|||
154857422|NCT04439331|558904865|FG000|Overall Study|Never Start Protocol Therapy|2|||
154857423|NCT04439331|558904865|FG000|Overall Study|Ineligible|2|||
154857424|NCT04439331|558904865|FG000|Overall Study|Mutation Status Not Confirmed|1|||
154857425|NCT04439331|558904865|FG000|Overall Study|Adverse Event|1|||
154857426|NCT04439331|558904865|FG000|Overall Study|Death|1|||
154857427|NCT04439331|558904865|FG000|Overall Study|Disease Progression|20|||
154857428|NCT04439331|558904865|FG000|Overall Study|Withdrawal by Subject|6|||
154857429|NCT04439331|558904865|FG000|Overall Study|Physician Decision|1|||
154857430|NCT04439331|558904865|FG000|Overall Study|Other Complicating Disease|1|||
154857431|NCT00413959|558904868|FG000|Overall Study|Pt had only one cycle.|1|||
154857432|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
154857433|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
154857434|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
154857435|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
154857436|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
154857437|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
154857438|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
154857439|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
154857440|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
154857441|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
154857442|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
154857443|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
154857444|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
154857445|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
154857446|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
154857447|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
154857448|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
154857449|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
154857450|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
154857451|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
154857452|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
154857453|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
154857454|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
154857455|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
154857456|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
154857457|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
154857458|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
154857459|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
154857460|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
154857461|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
154857462|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
154857463|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
154857464|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
154857465|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
154857466|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
154857467|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
154857468|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
154857469|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
154857470|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
154857471|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
154857472|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
154857473|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
154857474|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
154857475|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
154857476|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
154857477|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
154857478|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
154857479|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
154857480|NCT01707992|558904871|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
154857481|NCT01707992|558904872|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
154857482|NCT01707992|558904873|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
154857483|NCT01707992|558904874|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
154857484|NCT01707992|558904875|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
154972222|NCT03428945|559322335|FG001|Overall Study|Withdrawal by Subject|10|||
154972223|NCT00982228|559322336|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
154857485|NCT01707992|558904876|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
154857486|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
154857487|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
154857488|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
154857489|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
154857490|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
154857491|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
154857492|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
154857493|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
154857494|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
154857495|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
154857496|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
154857497|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
154857498|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
154857499|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
154857500|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
154857501|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
154857502|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
154857503|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
154857504|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
154857505|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
154857506|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
154857507|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
154857508|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
154857509|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
154857510|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
154857511|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
154857512|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
154857513|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
154857514|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
154857515|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
154857516|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Death|0|||
154857517|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Death|0|||
154857518|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Death|0|||
154857519|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Death|2|||
154857520|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Death|0|||
154857521|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Death|0|||
154857522|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
154857523|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
154857524|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
154857525|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
154857526|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
154857527|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
154857528|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
154857529|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
154857530|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
154857531|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
154857532|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
154972224|NCT00982228|559322337|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
154972225|NCT00982228|559322336|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
154972226|NCT00982228|559322337|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
154972227|NCT00982228|559322336|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
154972228|NCT00982228|559322337|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
154972229|NCT00982228|559322336|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
154972230|NCT00982228|559322337|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
154972231|NCT00982228|559322336|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
154972232|NCT00982228|559322337|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
154972233|NCT00982228|559322336|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
154972234|NCT00982228|559322337|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
154972235|NCT00982228|559322336|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
154972236|NCT00982228|559322337|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
154972237|NCT00982228|559322336|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
154972238|NCT00982228|559322337|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
154972239|NCT00982228|559322336|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
154972240|NCT00982228|559322337|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
154857533|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
154857534|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
155106485|NCT02689206|559817695|FG003|Overall Study|Other: Reached stopping criteria|3|||
154857535|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
154857536|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
154857537|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
154857538|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
154857539|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
154857540|NCT01707992|558904871|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
154857541|NCT01707992|558904872|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
154857542|NCT01707992|558904873|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
154857543|NCT01707992|558904874|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
154857544|NCT01707992|558904875|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
154857545|NCT01707992|558904876|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
154857546|NCT03498521|558904877|FG000|Overall Study|Death|227|||
154857547|NCT03498521|558904878|FG001|Overall Study|Death|79|||
154857548|NCT03498521|558904879|FG002|Overall Study|Death|84|||
154857549|NCT03498521|558904877|FG000|Overall Study|Exclusion criteria|1|||
154857550|NCT03498521|558904878|FG001|Overall Study|Exclusion criteria|0|||
154857551|NCT03498521|558904879|FG002|Overall Study|Exclusion criteria|0|||
154857552|NCT03498521|558904877|FG000|Overall Study|Lost to Follow-up|4|||
154857553|NCT03498521|558904878|FG001|Overall Study|Lost to Follow-up|3|||
154857554|NCT03498521|558904879|FG002|Overall Study|Lost to Follow-up|3|||
154857555|NCT03498521|558904877|FG000|Overall Study|No profile due to technical failure|1|||
154857556|NCT03498521|558904878|FG001|Overall Study|No profile due to technical failure|0|||
154857557|NCT03498521|558904879|FG002|Overall Study|No profile due to technical failure|0|||
154857558|NCT03498521|558904877|FG000|Overall Study|Physician Decision|3|||
154857559|NCT03498521|558904878|FG001|Overall Study|Physician Decision|1|||
154857560|NCT03498521|558904879|FG002|Overall Study|Physician Decision|0|||
154857561|NCT03498521|558904877|FG000|Overall Study|Withdrawal by Subject|11|||
155106486|NCT02689206|559817696|FG004|Overall Study|Other: Reached stopping criteria|4|||
155106487|NCT02689206|559817692|FG000|Overall Study|Physician Decision|1|||
155106488|NCT02689206|559817693|FG001|Overall Study|Physician Decision|0|||
155106489|NCT02689206|559817694|FG002|Overall Study|Physician Decision|0|||
155106490|NCT02689206|559817695|FG003|Overall Study|Physician Decision|0|||
155106491|NCT02689206|559817696|FG004|Overall Study|Physician Decision|0|||
155106492|NCT02689206|559817692|FG000|Overall Study|Withdrawal by Subject|1|||
155106493|NCT02689206|559817693|FG001|Overall Study|Withdrawal by Subject|0|||
155106494|NCT02689206|559817694|FG002|Overall Study|Withdrawal by Subject|1|||
155106495|NCT02689206|559817695|FG003|Overall Study|Withdrawal by Subject|0|||
155106496|NCT02689206|559817696|FG004|Overall Study|Withdrawal by Subject|0|||
155106497|NCT02131311|559817698|FG000|Overall Study|Adverse Event|2|||
155106498|NCT02131311|559817698|FG000|Overall Study|Protocol Violation|1|||
155106499|NCT02131311|559817698|FG000|Overall Study|Lost to Follow-up|1|||
155106500|NCT00255723|559817699|FG000|Overall Study|Adverse Event|1|||
155106501|NCT00255723|559817700|FG001|Overall Study|Adverse Event|1|||
155106502|NCT00255723|559817699|FG000|Overall Study|Death|0|||
155106503|NCT00255723|559817700|FG001|Overall Study|Death|1|||
155106504|NCT00255723|559817699|FG000|Overall Study|Response Data Not Available|1|||
155106505|NCT00255723|559817700|FG001|Overall Study|Response Data Not Available|0|||
155106506|NCT00431444|559817701|FG000|Overall Study|Protocol Violation|1|||
155106507|NCT00431444|559817702|FG001|Overall Study|Protocol Violation|4|||
155106508|NCT00431444|559817701|FG000|Overall Study|Adverse Event|2|||
155106509|NCT00431444|559817702|FG001|Overall Study|Adverse Event|1|||
155106510|NCT00431444|559817701|FG000|Overall Study|Withdrawal by Subject|1|||
155106511|NCT00431444|559817702|FG001|Overall Study|Withdrawal by Subject|1|||
155106512|NCT00431444|559817701|FG000|Overall Study|Lost to Follow-up|1|||
154857562|NCT03498521|558904878|FG001|Overall Study|Withdrawal by Subject|6|||
154857563|NCT03498521|558904879|FG002|Overall Study|Withdrawal by Subject|2|||
154857564|NCT03498521|558904877|FG000|Overall Study|Study terminated by sponsor|79|||
154857565|NCT03498521|558904878|FG001|Overall Study|Study terminated by sponsor|21|||
154857566|NCT03498521|558904879|FG002|Overall Study|Study terminated by sponsor|4|||
154857567|NCT02612909|558906548|FG000|Phase 2|Withdrawal by Subject|2|||
154857568|NCT02612909|558906549|FG001|Phase 2|Withdrawal by Subject|5|||
154857569|NCT02612909|558906550|FG002|Phase 2|Withdrawal by Subject|0|||
154857570|NCT02612909|558906551|FG003|Phase 2|Withdrawal by Subject|0|||
154857571|NCT02612909|558906552|FG004|Phase 2|Withdrawal by Subject|0|||
154857572|NCT02612909|558906548|FG000|Phase 2|Pregnancy|0|||
154857573|NCT02612909|558906549|FG001|Phase 2|Pregnancy|0|||
155106513|NCT00431444|559817702|FG001|Overall Study|Lost to Follow-up|0|||
155106514|NCT00431444|559817701|FG000|Overall Study|Administrative Problems|0|||
155106515|NCT00431444|559817702|FG001|Overall Study|Administrative Problems|1|||
155106516|NCT03497039|559817706|FG000|Overall Study|Withdrawal by Subject|1|||
154857574|NCT02612909|558906550|FG002|Phase 2|Pregnancy|1|||
155106517|NCT03497039|559817707|FG001|Overall Study|Withdrawal by Subject|0|||
155106518|NCT03497039|559817706|FG000|Overall Study|Protocol Violation|0|||
155106519|NCT03497039|559817707|FG001|Overall Study|Protocol Violation|1|||
154857575|NCT02612909|558906551|FG003|Phase 2|Pregnancy|0|||
154857576|NCT02612909|558906552|FG004|Phase 2|Pregnancy|0|||
154857577|NCT02612909|558906548|FG000|Phase 3|Withdrawal by Subject|0|||
154857578|NCT02612909|558906549|FG001|Phase 3|Withdrawal by Subject|0|||
154857579|NCT02612909|558906550|FG002|Phase 3|Withdrawal by Subject|0|||
154857580|NCT02612909|558906551|FG003|Phase 3|Withdrawal by Subject|1|||
154857581|NCT02612909|558906552|FG004|Phase 3|Withdrawal by Subject|0|||
154857582|NCT05067127|558906555|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
154857583|NCT05067127|558906556|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
155106520|NCT02131662|559817709|FG000|Overall Study|Protocol Violation|1|||
155106521|NCT02131662|559817710|FG001|Overall Study|Protocol Violation|0|||
155106522|NCT02131662|559817711|FG002|Overall Study|Protocol Violation|0|||
155106523|NCT02131662|559817712|FG003|Overall Study|Protocol Violation|0|||
155106524|NCT02131662|559817713|FG004|Overall Study|Protocol Violation|0|||
155106525|NCT02131662|559817709|FG000|Overall Study|Other|2|||
155106526|NCT02131662|559817710|FG001|Overall Study|Other|4|||
155106527|NCT02131662|559817711|FG002|Overall Study|Other|3|||
155106528|NCT02131662|559817712|FG003|Overall Study|Other|3|||
155106529|NCT02131662|559817713|FG004|Overall Study|Other|4|||
155106530|NCT02131662|559817709|FG000|Overall Study|Adverse Event|0|||
155106531|NCT02131662|559817710|FG001|Overall Study|Adverse Event|1|||
155106532|NCT02131662|559817711|FG002|Overall Study|Adverse Event|1|||
155106533|NCT02131662|559817712|FG003|Overall Study|Adverse Event|1|||
155106534|NCT02131662|559817713|FG004|Overall Study|Adverse Event|3|||
154857584|NCT05067127|558906557|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
154857585|NCT05067127|558906558|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
154857586|NCT05067127|558906555|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
154857587|NCT05067127|558906556|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
154857588|NCT05067127|558906557|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
154857589|NCT05067127|558906558|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
154857590|NCT05067127|558906555|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
154857591|NCT05067127|558906556|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
154857592|NCT05067127|558906557|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
154857593|NCT05067127|558906558|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
154857594|NCT05067127|558906555|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
154857595|NCT05067127|558906556|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
154857596|NCT05067127|558906557|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
154857597|NCT05067127|558906558|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
154857598|NCT05067127|558906555|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
154857599|NCT05067127|558906556|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
154857600|NCT05067127|558906557|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
154857601|NCT05067127|558906558|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
154857602|NCT05067127|558906555|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
154857603|NCT05067127|558906556|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
154857604|NCT05067127|558906557|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
154857605|NCT05067127|558906558|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
154857606|NCT05067127|558906555|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
154857607|NCT05067127|558906556|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
154857608|NCT05067127|558906557|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
154857609|NCT05067127|558906558|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
154857610|NCT05540652|558906563|FG000|Overall Study|Withdrawal by Subject|1|||
154857611|NCT05113940|558906564|FG000|Part A (18 Days)|Adverse Event|0|||
154857612|NCT05113940|558906565|FG001|Part A (18 Days)|Adverse Event|0|||
154857613|NCT05113940|558906566|FG002|Part A (18 Days)|Adverse Event|1|||
154857614|NCT05113940|558906567|FG003|Part A (18 Days)|Adverse Event|1|||
154857615|NCT05113940|558906568|FG004|Part A (18 Days)|Adverse Event|1|||
154857616|NCT05113940|558906569|FG005|Part A (18 Days)|Adverse Event|0|||
154857617|NCT05113940|558906570|FG006|Part A (18 Days)|Adverse Event|0|||
154857618|NCT05113940|558906571|FG007|Part A (18 Days)|Adverse Event|0|||
154857619|NCT05113940|558906572|FG008|Part A (18 Days)|Adverse Event|0|||
155106535|NCT02131662|559817709|FG000|Overall Study|Pregnancy|0|||
155106536|NCT02131662|559817710|FG001|Overall Study|Pregnancy|1|||
155106537|NCT02131662|559817711|FG002|Overall Study|Pregnancy|0|||
155106538|NCT02131662|559817712|FG003|Overall Study|Pregnancy|1|||
155106539|NCT02131662|559817713|FG004|Overall Study|Pregnancy|0|||
155106540|NCT02131662|559817709|FG000|Overall Study|Wish for pregnancy|0|||
155106541|NCT02131662|559817710|FG001|Overall Study|Wish for pregnancy|0|||
154857620|NCT05113940|558906573|FG009|Part A (18 Days)|Adverse Event|0|||
154857621|NCT05113940|558906574|FG010|Part A (18 Days)|Adverse Event|0|||
154857622|NCT05113940|558906575|FG011|Part A (18 Days)|Adverse Event|2|||
154857623|NCT05113940|558906576|FG012|Part A (18 Days)|Adverse Event|0|||
154857624|NCT05113940|558906577|FG013|Part A (18 Days)|Adverse Event|0|||
154857625|NCT05113940|558906578|FG014|Part A (18 Days)|Adverse Event|0|||
155106542|NCT02131662|559817711|FG002|Overall Study|Wish for pregnancy|0|||
155106543|NCT02131662|559817712|FG003|Overall Study|Wish for pregnancy|0|||
155106544|NCT02131662|559817713|FG004|Overall Study|Wish for pregnancy|1|||
155106545|NCT02131662|559817709|FG000|Overall Study|Lack of Efficacy|1|||
154857626|NCT05113940|558906564|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857627|NCT05113940|558906565|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857628|NCT05113940|558906566|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857629|NCT05113940|558906567|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857630|NCT05113940|558906568|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857631|NCT05113940|558906569|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857632|NCT05113940|558906570|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857633|NCT05113940|558906571|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
155106546|NCT02131662|559817710|FG001|Overall Study|Lack of Efficacy|0|||
155106547|NCT02131662|559817711|FG002|Overall Study|Lack of Efficacy|0|||
155106548|NCT02131662|559817712|FG003|Overall Study|Lack of Efficacy|0|||
155106549|NCT02131662|559817713|FG004|Overall Study|Lack of Efficacy|1|||
155106550|NCT02131662|559817709|FG000|Overall Study|Withdrawal by Subject|1|||
155106551|NCT02131662|559817710|FG001|Overall Study|Withdrawal by Subject|5|||
155106552|NCT02131662|559817711|FG002|Overall Study|Withdrawal by Subject|1|||
155106553|NCT02131662|559817712|FG003|Overall Study|Withdrawal by Subject|5|||
155106554|NCT02131662|559817713|FG004|Overall Study|Withdrawal by Subject|6|||
155106555|NCT02131662|559817709|FG000|Overall Study|Lost to Follow-up|1|||
155106556|NCT02131662|559817710|FG001|Overall Study|Lost to Follow-up|3|||
154857634|NCT05113940|558906572|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857635|NCT05113940|558906573|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857636|NCT05113940|558906574|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857637|NCT05113940|558906575|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857638|NCT05113940|558906576|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857639|NCT05113940|558906577|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
154857640|NCT05113940|558906578|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
154857641|NCT01701258|558906579|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
155106557|NCT02131662|559817711|FG002|Overall Study|Lost to Follow-up|0|||
155106558|NCT02131662|559817712|FG003|Overall Study|Lost to Follow-up|9|||
155106559|NCT02131662|559817713|FG004|Overall Study|Lost to Follow-up|0|||
155106560|NCT02131662|559817709|FG000|Overall Study|Not treated|2|||
155106561|NCT02131662|559817710|FG001|Overall Study|Not treated|0|||
155106562|NCT02131662|559817711|FG002|Overall Study|Not treated|2|||
155106563|NCT02131662|559817712|FG003|Overall Study|Not treated|2|||
155106564|NCT02131662|559817713|FG004|Overall Study|Not treated|3|||
155106565|NCT03554018|559817714|FG000|Overall Study|Lost to Follow-up|3|||
155106566|NCT03554018|559817715|FG001|Overall Study|Lost to Follow-up|7|||
155106567|NCT01928433|559817717|FG000|Overall Study|Adverse Event|5|||
155106568|NCT01928433|559817718|FG001|Overall Study|Adverse Event|2|||
155106569|NCT01928433|559817719|FG002|Overall Study|Adverse Event|5|||
155106570|NCT01928433|559817717|FG000|Overall Study|Protocol Violation|0|||
155106571|NCT01928433|559817718|FG001|Overall Study|Protocol Violation|0|||
155106572|NCT01928433|559817719|FG002|Overall Study|Protocol Violation|2|||
155106573|NCT01928433|559817717|FG000|Overall Study|Lack of Efficacy|5|||
155106574|NCT01928433|559817718|FG001|Overall Study|Lack of Efficacy|4|||
155106575|NCT01928433|559817719|FG002|Overall Study|Lack of Efficacy|4|||
155106576|NCT01928433|559817717|FG000|Overall Study|Withdrawal by Subject|0|||
155106577|NCT01928433|559817718|FG001|Overall Study|Withdrawal by Subject|4|||
155106578|NCT01928433|559817719|FG002|Overall Study|Withdrawal by Subject|0|||
155106579|NCT01928433|559817717|FG000|Overall Study|Negative screening urine culture|7|||
155106580|NCT01928433|559817718|FG001|Overall Study|Negative screening urine culture|6|||
155106581|NCT01928433|559817719|FG002|Overall Study|Negative screening urine culture|10|||
155106582|NCT01928433|559817717|FG000|Overall Study|Lost to Follow-up|0|||
154857642|NCT01701258|558906580|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
154857643|NCT01701258|558906581|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
155106583|NCT01928433|559817718|FG001|Overall Study|Lost to Follow-up|2|||
155106584|NCT01928433|559817719|FG002|Overall Study|Lost to Follow-up|3|||
155106585|NCT01928433|559817717|FG000|Overall Study|Other reasons|3|||
155106586|NCT01928433|559817718|FG001|Overall Study|Other reasons|3|||
155106587|NCT01928433|559817719|FG002|Overall Study|Other reasons|4|||
155106588|NCT01740687|559817720|FG000|Overall Study|Lost to Follow-up|11|||
155106589|NCT01740687|559817720|FG000|Overall Study|Withdrawal by Subject|2|||
155106590|NCT01740687|559817720|FG000|Overall Study|other reason|22|||
155106591|NCT01740687|559817720|FG000|Overall Study|treatment not received|2|||
155106592|NCT00854724|559818997|FG000|First Intervention|Withdrawal by Subject|1|||
155106593|NCT00854724|559818998|FG001|First Intervention|Withdrawal by Subject|1|||
154857644|NCT01701258|558906582|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
154857645|NCT01701258|558906583|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
154857646|NCT01701258|558906584|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
155106594|NCT00854724|559818997|FG000|Washout|Protocol Violation|1|||
155106595|NCT00854724|559818998|FG001|Washout|Protocol Violation|0|||
155106596|NCT00854724|559818997|FG000|Washout|Withdrawal by Subject|0|||
155106597|NCT00854724|559818998|FG001|Washout|Withdrawal by Subject|1|||
155106598|NCT00854724|559818997|FG000|Second Intervention|Protocol Violation|1|||
155106599|NCT00854724|559818998|FG001|Second Intervention|Protocol Violation|0|||
154857647|NCT01701258|558906585|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
154857648|NCT01701258|558906586|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
154857649|NCT01701258|558906587|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
154857650|NCT01701258|558906588|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
154857651|NCT01701258|558906589|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
154857652|NCT01701258|558906590|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
154857653|NCT01701258|558906591|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
154857654|NCT01701258|558906579|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
154857655|NCT01701258|558906580|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
154857656|NCT01701258|558906581|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
154857657|NCT01701258|558906582|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
154857658|NCT01701258|558906583|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
154857659|NCT01701258|558906584|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
154857660|NCT01701258|558906585|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
154857661|NCT01701258|558906586|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
154857662|NCT01701258|558906587|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
154857663|NCT01701258|558906588|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
154857664|NCT01701258|558906589|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
154857665|NCT01701258|558906590|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
154857666|NCT01701258|558906591|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
154857667|NCT01701258|558906579|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
154857668|NCT01701258|558906580|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
154857669|NCT01701258|558906581|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
154857670|NCT01701258|558906582|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
154857671|NCT01701258|558906583|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
154857672|NCT01701258|558906584|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
154857673|NCT01701258|558906585|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
154857674|NCT01701258|558906586|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
154857675|NCT01701258|558906587|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
154857676|NCT01701258|558906588|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
154857677|NCT01701258|558906589|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
154857678|NCT01701258|558906590|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
154857679|NCT01701258|558906591|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
154857680|NCT01701258|558906579|FG000|Assessment and Scheduling|Investigator Terminated|2|||
154857681|NCT01701258|558906580|FG001|Assessment and Scheduling|Investigator Terminated|0|||
154857682|NCT01701258|558906581|FG002|Assessment and Scheduling|Investigator Terminated|0|||
154857683|NCT01701258|558906582|FG003|Assessment and Scheduling|Investigator Terminated|0|||
154857684|NCT01701258|558906583|FG004|Assessment and Scheduling|Investigator Terminated|0|||
154857685|NCT01701258|558906584|FG005|Assessment and Scheduling|Investigator Terminated|0|||
154857686|NCT01701258|558906585|FG006|Assessment and Scheduling|Investigator Terminated|0|||
154857687|NCT01701258|558906586|FG007|Assessment and Scheduling|Investigator Terminated|0|||
154857688|NCT01701258|558906587|FG008|Assessment and Scheduling|Investigator Terminated|0|||
154857689|NCT01701258|558906588|FG009|Assessment and Scheduling|Investigator Terminated|0|||
154857690|NCT01701258|558906589|FG010|Assessment and Scheduling|Investigator Terminated|0|||
154857691|NCT01701258|558906590|FG011|Assessment and Scheduling|Investigator Terminated|0|||
154857692|NCT01701258|558906591|FG012|Assessment and Scheduling|Investigator Terminated|0|||
154857693|NCT00885365|558906593|FG000|4 Weeks ON Treatment|Adverse Event|2|||
154857694|NCT00885365|558906594|FG001|4 Weeks ON Treatment|Adverse Event|4|||
154857695|NCT00885365|558906593|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
154857696|NCT00885365|558906594|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
154857697|NCT00885365|558906593|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
154857698|NCT00885365|558906594|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
154857699|NCT01824979|558906595|FG000|Overall Study|Withdrawal by Subject|5|||
154857700|NCT01824979|558906596|FG001|Overall Study|Withdrawal by Subject|0|||
154857701|NCT01824979|558906595|FG000|Overall Study|Physician Decision|2|||
154857702|NCT01824979|558906596|FG001|Overall Study|Physician Decision|0|||
154857703|NCT01824979|558906595|FG000|Overall Study|Protocol Violation|6|||
154857704|NCT01824979|558906596|FG001|Overall Study|Protocol Violation|13|||
154857705|NCT01193686|558906608|FG000|Overall Study|Withdrawal by Subject|4|||
154857706|NCT01193686|558906609|FG001|Overall Study|Withdrawal by Subject|1|||
154857707|NCT01193686|558906608|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
154857708|NCT01193686|558906609|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
154857709|NCT04373460|558906614|FG000|Overall Study|Did not receive tranfusion|18|||
154857710|NCT04373460|558906615|FG001|Overall Study|Did not receive tranfusion|26|||
154857711|NCT00454207|558906616|FG000|Overall Study|Adverse Event|3|||
154857712|NCT00454207|558906617|FG001|Overall Study|Adverse Event|1|||
154857713|NCT00454207|558906616|FG000|Overall Study|Lack of Efficacy|1|||
154857714|NCT00454207|558906617|FG001|Overall Study|Lack of Efficacy|0|||
154857715|NCT00454207|558906616|FG000|Overall Study|Protocol Violation|0|||
154857716|NCT00454207|558906617|FG001|Overall Study|Protocol Violation|1|||
154857717|NCT01672957|558906618|FG000|Overall Study|Protocol Violation|48|||
154857718|NCT01672957|558906618|FG000|Overall Study|Death|2|||
154857719|NCT01672957|558906618|FG000|Overall Study|ICF Signed After Transplantation|5|||
154857720|NCT00151892|558906619|FG000|Overall Study|Lack of Efficacy|50|||
154857721|NCT00151892|558906620|FG001|Overall Study|Lack of Efficacy|57|||
154857722|NCT00151892|558906619|FG000|Overall Study|Patient request|10|||
154857723|NCT00151892|558906620|FG001|Overall Study|Patient request|7|||
154857724|NCT00151892|558906619|FG000|Overall Study|Lost to Follow-up|5|||
154857725|NCT00151892|558906620|FG001|Overall Study|Lost to Follow-up|10|||
154857726|NCT00151892|558906619|FG000|Overall Study|Adverse Event|6|||
154857727|NCT00151892|558906620|FG001|Overall Study|Adverse Event|3|||
154857728|NCT00151892|558906619|FG000|Overall Study|Protocol Violation|3|||
154857729|NCT00151892|558906620|FG001|Overall Study|Protocol Violation|3|||
154857730|NCT00151892|558906619|FG000|Overall Study|Non-compliance|0|||
154857731|NCT00151892|558906620|FG001|Overall Study|Non-compliance|1|||
154857732|NCT00151892|558906619|FG000|Overall Study|Pregnancy|0|||
154857733|NCT00151892|558906620|FG001|Overall Study|Pregnancy|1|||
154857734|NCT00151892|558906619|FG000|Overall Study|Did not return for a visit|1|||
154857735|NCT00151892|558906620|FG001|Overall Study|Did not return for a visit|0|||
154857736|NCT00151892|558906619|FG000|Overall Study|Used prohibited corticosteroids|1|||
154857737|NCT00151892|558906620|FG001|Overall Study|Used prohibited corticosteroids|0|||
154857738|NCT00151892|558906619|FG000|Overall Study|Lack of study medication at center|0|||
154857739|NCT00151892|558906620|FG001|Overall Study|Lack of study medication at center|1|||
154857740|NCT02901431|558906621|FG000|PK Part|Adverse Event|0|||
154857741|NCT02901431|558906622|FG001|PK Part|Adverse Event|1|||
154857742|NCT02901431|558906623|FG002|PK Part|Adverse Event|0|||
154857743|NCT02901431|558906624|FG003|PK Part|Adverse Event|0|||
154857744|NCT02901431|558906625|FG004|PK Part|Adverse Event|0|||
154857745|NCT02901431|558906626|FG005|PK Part|Adverse Event|0|||
154857746|NCT02901431|558906627|FG006|PK Part|Adverse Event|0|||
154857747|NCT02901431|558906628|FG007|PK Part|Adverse Event|0|||
154857748|NCT02901431|558906629|FG008|PK Part|Adverse Event|0|||
154857749|NCT02901431|558906630|FG009|PK Part|Adverse Event|0|||
154857750|NCT02901431|558906631|FG010|PK Part|Adverse Event|0|||
154857751|NCT02901431|558906632|FG011|PK Part|Adverse Event|0|||
154857752|NCT02901431|558906633|FG012|PK Part|Adverse Event|0|||
154857753|NCT02901431|558906621|FG000|PK Part|Lost to Follow-up|0|||
154857754|NCT02901431|558906622|FG001|PK Part|Lost to Follow-up|0|||
154857755|NCT02901431|558906623|FG002|PK Part|Lost to Follow-up|1|||
154857756|NCT02901431|558906624|FG003|PK Part|Lost to Follow-up|0|||
154857757|NCT02901431|558906625|FG004|PK Part|Lost to Follow-up|0|||
154857758|NCT02901431|558906626|FG005|PK Part|Lost to Follow-up|0|||
154857759|NCT02901431|558906627|FG006|PK Part|Lost to Follow-up|0|||
154857760|NCT02901431|558906628|FG007|PK Part|Lost to Follow-up|0|||
154857761|NCT02901431|558906629|FG008|PK Part|Lost to Follow-up|0|||
154857762|NCT02901431|558906630|FG009|PK Part|Lost to Follow-up|0|||
154857763|NCT02901431|558906631|FG010|PK Part|Lost to Follow-up|0|||
154857764|NCT02901431|558906632|FG011|PK Part|Lost to Follow-up|0|||
154857765|NCT02901431|558906633|FG012|PK Part|Lost to Follow-up|0|||
154857766|NCT02901431|558906621|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
154857767|NCT02901431|558906622|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857768|NCT02901431|558906623|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857769|NCT02901431|558906624|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857770|NCT02901431|558906625|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857771|NCT02901431|558906626|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857772|NCT02901431|558906627|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857773|NCT02901431|558906628|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857774|NCT02901431|558906629|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857775|NCT02901431|558906630|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857776|NCT02901431|558906631|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857777|NCT02901431|558906632|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857778|NCT02901431|558906633|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
154857779|NCT02901431|558906621|FG000|PK Part|Pending dose confirmation|0|||
154857780|NCT02901431|558906622|FG001|PK Part|Pending dose confirmation|1|||
154857781|NCT02901431|558906623|FG002|PK Part|Pending dose confirmation|0|||
154857782|NCT02901431|558906624|FG003|PK Part|Pending dose confirmation|0|||
154857783|NCT02901431|558906625|FG004|PK Part|Pending dose confirmation|0|||
154857784|NCT02901431|558906626|FG005|PK Part|Pending dose confirmation|0|||
154857785|NCT02901431|558906627|FG006|PK Part|Pending dose confirmation|0|||
154857786|NCT02901431|558906628|FG007|PK Part|Pending dose confirmation|0|||
154857787|NCT02901431|558906629|FG008|PK Part|Pending dose confirmation|0|||
154857788|NCT02901431|558906630|FG009|PK Part|Pending dose confirmation|0|||
154857789|NCT02901431|558906631|FG010|PK Part|Pending dose confirmation|0|||
154857790|NCT02901431|558906632|FG011|PK Part|Pending dose confirmation|0|||
154857791|NCT02901431|558906633|FG012|PK Part|Pending dose confirmation|0|||
154857792|NCT02901431|558906621|FG000|PK Part|8 weeks of treatment ran out|2|||
154857793|NCT02901431|558906622|FG001|PK Part|8 weeks of treatment ran out|0|||
154857794|NCT02901431|558906623|FG002|PK Part|8 weeks of treatment ran out|0|||
154857795|NCT02901431|558906624|FG003|PK Part|8 weeks of treatment ran out|0|||
154857796|NCT02901431|558906625|FG004|PK Part|8 weeks of treatment ran out|0|||
154857797|NCT02901431|558906626|FG005|PK Part|8 weeks of treatment ran out|0|||
154857798|NCT02901431|558906627|FG006|PK Part|8 weeks of treatment ran out|0|||
154857799|NCT02901431|558906628|FG007|PK Part|8 weeks of treatment ran out|0|||
154857800|NCT02901431|558906629|FG008|PK Part|8 weeks of treatment ran out|0|||
154857801|NCT02901431|558906630|FG009|PK Part|8 weeks of treatment ran out|0|||
154857802|NCT02901431|558906631|FG010|PK Part|8 weeks of treatment ran out|0|||
154857803|NCT02901431|558906632|FG011|PK Part|8 weeks of treatment ran out|0|||
154857804|NCT02901431|558906633|FG012|PK Part|8 weeks of treatment ran out|0|||
154857805|NCT02901431|558906621|FG000|PK Part|Stopped treatment after 8 weeks|1|||
154857806|NCT02901431|558906622|FG001|PK Part|Stopped treatment after 8 weeks|0|||
154857807|NCT02901431|558906623|FG002|PK Part|Stopped treatment after 8 weeks|1|||
154857808|NCT02901431|558906624|FG003|PK Part|Stopped treatment after 8 weeks|0|||
154857809|NCT02901431|558906625|FG004|PK Part|Stopped treatment after 8 weeks|0|||
154857810|NCT02901431|558906626|FG005|PK Part|Stopped treatment after 8 weeks|0|||
154857811|NCT02901431|558906627|FG006|PK Part|Stopped treatment after 8 weeks|0|||
154857812|NCT02901431|558906628|FG007|PK Part|Stopped treatment after 8 weeks|0|||
154857813|NCT02901431|558906629|FG008|PK Part|Stopped treatment after 8 weeks|0|||
154857814|NCT02901431|558906630|FG009|PK Part|Stopped treatment after 8 weeks|0|||
154857815|NCT02901431|558906631|FG010|PK Part|Stopped treatment after 8 weeks|0|||
154857816|NCT02901431|558906632|FG011|PK Part|Stopped treatment after 8 weeks|0|||
154857817|NCT02901431|558906633|FG012|PK Part|Stopped treatment after 8 weeks|0|||
154857818|NCT02901431|558906621|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
154857819|NCT02901431|558906622|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857820|NCT02901431|558906623|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
154857821|NCT02901431|558906624|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857822|NCT02901431|558906625|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857823|NCT02901431|558906626|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857824|NCT02901431|558906627|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857825|NCT02901431|558906628|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857826|NCT02901431|558906629|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857827|NCT02901431|558906630|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857828|NCT02901431|558906631|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857829|NCT02901431|558906632|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857830|NCT02901431|558906633|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
154857831|NCT02901431|558906621|FG000|PK Part|Discontinued per Sponsor|0|||
154857832|NCT02901431|558906622|FG001|PK Part|Discontinued per Sponsor|3|||
154857833|NCT02901431|558906623|FG002|PK Part|Discontinued per Sponsor|0|||
154857834|NCT02901431|558906624|FG003|PK Part|Discontinued per Sponsor|0|||
154857835|NCT02901431|558906625|FG004|PK Part|Discontinued per Sponsor|0|||
154857836|NCT02901431|558906626|FG005|PK Part|Discontinued per Sponsor|0|||
154857837|NCT02901431|558906627|FG006|PK Part|Discontinued per Sponsor|0|||
154857838|NCT02901431|558906628|FG007|PK Part|Discontinued per Sponsor|0|||
154857839|NCT02901431|558906629|FG008|PK Part|Discontinued per Sponsor|0|||
154857840|NCT02901431|558906630|FG009|PK Part|Discontinued per Sponsor|0|||
154857841|NCT02901431|558906631|FG010|PK Part|Discontinued per Sponsor|0|||
154857842|NCT02901431|558906632|FG011|PK Part|Discontinued per Sponsor|0|||
154857843|NCT02901431|558906633|FG012|PK Part|Discontinued per Sponsor|0|||
154857844|NCT02901431|558906621|FG000|PK Part|Withdrawal by Subject|1|||
154857845|NCT02901431|558906622|FG001|PK Part|Withdrawal by Subject|1|||
154857846|NCT02901431|558906623|FG002|PK Part|Withdrawal by Subject|3|||
154857847|NCT02901431|558906624|FG003|PK Part|Withdrawal by Subject|0|||
154857848|NCT02901431|558906625|FG004|PK Part|Withdrawal by Subject|0|||
154857849|NCT02901431|558906626|FG005|PK Part|Withdrawal by Subject|0|||
154857850|NCT02901431|558906627|FG006|PK Part|Withdrawal by Subject|0|||
154857851|NCT02901431|558906628|FG007|PK Part|Withdrawal by Subject|0|||
154857852|NCT02901431|558906629|FG008|PK Part|Withdrawal by Subject|0|||
154857853|NCT02901431|558906630|FG009|PK Part|Withdrawal by Subject|0|||
154857854|NCT02901431|558906631|FG010|PK Part|Withdrawal by Subject|0|||
154857855|NCT02901431|558906632|FG011|PK Part|Withdrawal by Subject|0|||
154857856|NCT02901431|558906633|FG012|PK Part|Withdrawal by Subject|0|||
154857857|NCT02901431|558906621|FG000|Main Treatment Part|Adverse Event|0|||
154857858|NCT02901431|558906622|FG001|Main Treatment Part|Adverse Event|0|||
154857859|NCT02901431|558906623|FG002|Main Treatment Part|Adverse Event|0|||
154857860|NCT02901431|558906624|FG003|Main Treatment Part|Adverse Event|3|||
154857861|NCT02901431|558906625|FG004|Main Treatment Part|Adverse Event|3|||
154857862|NCT02901431|558906626|FG005|Main Treatment Part|Adverse Event|4|||
154857863|NCT02901431|558906627|FG006|Main Treatment Part|Adverse Event|1|||
154857864|NCT02901431|558906628|FG007|Main Treatment Part|Adverse Event|0|||
154857865|NCT02901431|558906629|FG008|Main Treatment Part|Adverse Event|0|||
154857866|NCT02901431|558906630|FG009|Main Treatment Part|Adverse Event|0|||
154857867|NCT02901431|558906631|FG010|Main Treatment Part|Adverse Event|0|||
154857868|NCT02901431|558906632|FG011|Main Treatment Part|Adverse Event|0|||
154857869|NCT02901431|558906633|FG012|Main Treatment Part|Adverse Event|0|||
154857870|NCT02901431|558906621|FG000|Main Treatment Part|Lack of Efficacy|0|||
154857871|NCT02901431|558906622|FG001|Main Treatment Part|Lack of Efficacy|0|||
154857872|NCT02901431|558906623|FG002|Main Treatment Part|Lack of Efficacy|0|||
154857873|NCT02901431|558906624|FG003|Main Treatment Part|Lack of Efficacy|1|||
154857874|NCT02901431|558906625|FG004|Main Treatment Part|Lack of Efficacy|0|||
154857875|NCT02901431|558906626|FG005|Main Treatment Part|Lack of Efficacy|0|||
154857876|NCT02901431|558906627|FG006|Main Treatment Part|Lack of Efficacy|0|||
154857877|NCT02901431|558906628|FG007|Main Treatment Part|Lack of Efficacy|0|||
154857878|NCT02901431|558906629|FG008|Main Treatment Part|Lack of Efficacy|0|||
154857879|NCT02901431|558906630|FG009|Main Treatment Part|Lack of Efficacy|0|||
154857880|NCT02901431|558906631|FG010|Main Treatment Part|Lack of Efficacy|0|||
154857881|NCT02901431|558906632|FG011|Main Treatment Part|Lack of Efficacy|0|||
154857882|NCT02901431|558906633|FG012|Main Treatment Part|Lack of Efficacy|0|||
154857883|NCT02901431|558906621|FG000|Main Treatment Part|Lost to Follow-up|0|||
154857884|NCT02901431|558906622|FG001|Main Treatment Part|Lost to Follow-up|0|||
154857885|NCT02901431|558906623|FG002|Main Treatment Part|Lost to Follow-up|0|||
154857886|NCT02901431|558906624|FG003|Main Treatment Part|Lost to Follow-up|3|||
154857887|NCT02901431|558906625|FG004|Main Treatment Part|Lost to Follow-up|1|||
154857888|NCT02901431|558906626|FG005|Main Treatment Part|Lost to Follow-up|2|||
154857889|NCT02901431|558906627|FG006|Main Treatment Part|Lost to Follow-up|3|||
154857890|NCT02901431|558906628|FG007|Main Treatment Part|Lost to Follow-up|0|||
154857891|NCT02901431|558906629|FG008|Main Treatment Part|Lost to Follow-up|0|||
154857892|NCT02901431|558906630|FG009|Main Treatment Part|Lost to Follow-up|0|||
154857893|NCT02901431|558906631|FG010|Main Treatment Part|Lost to Follow-up|0|||
154857894|NCT02901431|558906632|FG011|Main Treatment Part|Lost to Follow-up|0|||
154857895|NCT02901431|558906633|FG012|Main Treatment Part|Lost to Follow-up|0|||
154857896|NCT02901431|558906621|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
154857897|NCT02901431|558906622|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
154857898|NCT02901431|558906623|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
154857899|NCT02901431|558906624|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
154857900|NCT02901431|558906625|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
154857901|NCT02901431|558906626|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
154857902|NCT02901431|558906627|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
154857903|NCT02901431|558906628|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
154857904|NCT02901431|558906629|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
154857905|NCT02901431|558906630|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
154857906|NCT02901431|558906631|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
154857907|NCT02901431|558906632|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
154857908|NCT02901431|558906633|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
154857909|NCT02901431|558906621|FG000|Main Treatment Part|Physician Decision|0|||
154857910|NCT02901431|558906622|FG001|Main Treatment Part|Physician Decision|0|||
154857911|NCT02901431|558906623|FG002|Main Treatment Part|Physician Decision|0|||
154857912|NCT02901431|558906624|FG003|Main Treatment Part|Physician Decision|1|||
154857913|NCT02901431|558906625|FG004|Main Treatment Part|Physician Decision|0|||
154857914|NCT02901431|558906626|FG005|Main Treatment Part|Physician Decision|0|||
154857915|NCT02901431|558906627|FG006|Main Treatment Part|Physician Decision|1|||
154857916|NCT02901431|558906628|FG007|Main Treatment Part|Physician Decision|0|||
154857917|NCT02901431|558906629|FG008|Main Treatment Part|Physician Decision|0|||
154857918|NCT02901431|558906630|FG009|Main Treatment Part|Physician Decision|0|||
154857919|NCT02901431|558906631|FG010|Main Treatment Part|Physician Decision|0|||
154857920|NCT02901431|558906632|FG011|Main Treatment Part|Physician Decision|0|||
154857921|NCT02901431|558906633|FG012|Main Treatment Part|Physician Decision|0|||
154857922|NCT02901431|558906621|FG000|Main Treatment Part|Withdrawal by Subject|0|||
154857923|NCT02901431|558906622|FG001|Main Treatment Part|Withdrawal by Subject|0|||
154857924|NCT02901431|558906623|FG002|Main Treatment Part|Withdrawal by Subject|0|||
154857925|NCT02901431|558906624|FG003|Main Treatment Part|Withdrawal by Subject|18|||
154857926|NCT02901431|558906625|FG004|Main Treatment Part|Withdrawal by Subject|3|||
154857927|NCT02901431|558906626|FG005|Main Treatment Part|Withdrawal by Subject|5|||
154857928|NCT02901431|558906627|FG006|Main Treatment Part|Withdrawal by Subject|6|||
154857929|NCT02901431|558906628|FG007|Main Treatment Part|Withdrawal by Subject|0|||
154857930|NCT02901431|558906629|FG008|Main Treatment Part|Withdrawal by Subject|0|||
154857931|NCT02901431|558906630|FG009|Main Treatment Part|Withdrawal by Subject|0|||
154857932|NCT02901431|558906631|FG010|Main Treatment Part|Withdrawal by Subject|0|||
154857933|NCT02901431|558906632|FG011|Main Treatment Part|Withdrawal by Subject|0|||
154857934|NCT02901431|558906633|FG012|Main Treatment Part|Withdrawal by Subject|0|||
154857935|NCT02901431|558906621|FG000|Open Label Part|Adverse Event|0|||
154857936|NCT02901431|558906622|FG001|Open Label Part|Adverse Event|0|||
154857937|NCT02901431|558906623|FG002|Open Label Part|Adverse Event|0|||
154857938|NCT02901431|558906624|FG003|Open Label Part|Adverse Event|0|||
154857939|NCT02901431|558906625|FG004|Open Label Part|Adverse Event|0|||
154857940|NCT02901431|558906626|FG005|Open Label Part|Adverse Event|0|||
154857941|NCT02901431|558906627|FG006|Open Label Part|Adverse Event|0|||
154857942|NCT02901431|558906628|FG007|Open Label Part|Adverse Event|0|||
154857943|NCT02901431|558906629|FG008|Open Label Part|Adverse Event|4|||
154857944|NCT02901431|558906630|FG009|Open Label Part|Adverse Event|4|||
154857945|NCT02901431|558906631|FG010|Open Label Part|Adverse Event|0|||
154857946|NCT02901431|558906632|FG011|Open Label Part|Adverse Event|4|||
154857947|NCT02901431|558906633|FG012|Open Label Part|Adverse Event|1|||
154857948|NCT02901431|558906621|FG000|Open Label Part|Lost to Follow-up|0|||
154857949|NCT02901431|558906622|FG001|Open Label Part|Lost to Follow-up|0|||
154857950|NCT02901431|558906623|FG002|Open Label Part|Lost to Follow-up|0|||
154857951|NCT02901431|558906624|FG003|Open Label Part|Lost to Follow-up|0|||
154857952|NCT02901431|558906625|FG004|Open Label Part|Lost to Follow-up|0|||
154857953|NCT02901431|558906626|FG005|Open Label Part|Lost to Follow-up|0|||
154857954|NCT02901431|558906627|FG006|Open Label Part|Lost to Follow-up|0|||
154857955|NCT02901431|558906628|FG007|Open Label Part|Lost to Follow-up|0|||
154857956|NCT02901431|558906629|FG008|Open Label Part|Lost to Follow-up|2|||
154857957|NCT02901431|558906630|FG009|Open Label Part|Lost to Follow-up|2|||
154857958|NCT02901431|558906631|FG010|Open Label Part|Lost to Follow-up|1|||
154857959|NCT02901431|558906632|FG011|Open Label Part|Lost to Follow-up|1|||
154857960|NCT02901431|558906633|FG012|Open Label Part|Lost to Follow-up|1|||
154857961|NCT02901431|558906621|FG000|Open Label Part|Physician Decision|0|||
154857962|NCT02901431|558906622|FG001|Open Label Part|Physician Decision|0|||
154857963|NCT02901431|558906623|FG002|Open Label Part|Physician Decision|0|||
154857964|NCT02901431|558906624|FG003|Open Label Part|Physician Decision|0|||
154857965|NCT02901431|558906625|FG004|Open Label Part|Physician Decision|0|||
154857966|NCT02901431|558906626|FG005|Open Label Part|Physician Decision|0|||
154857967|NCT02901431|558906627|FG006|Open Label Part|Physician Decision|0|||
154857968|NCT02901431|558906628|FG007|Open Label Part|Physician Decision|0|||
154857969|NCT02901431|558906629|FG008|Open Label Part|Physician Decision|1|||
154857970|NCT02901431|558906630|FG009|Open Label Part|Physician Decision|1|||
154857971|NCT02901431|558906631|FG010|Open Label Part|Physician Decision|0|||
154857972|NCT02901431|558906632|FG011|Open Label Part|Physician Decision|0|||
154857973|NCT02901431|558906633|FG012|Open Label Part|Physician Decision|0|||
154857974|NCT02901431|558906621|FG000|Open Label Part|Study Terminated By Sponsor|0|||
154857975|NCT02901431|558906622|FG001|Open Label Part|Study Terminated By Sponsor|0|||
154857976|NCT02901431|558906623|FG002|Open Label Part|Study Terminated By Sponsor|0|||
154857977|NCT02901431|558906624|FG003|Open Label Part|Study Terminated By Sponsor|0|||
154857978|NCT02901431|558906625|FG004|Open Label Part|Study Terminated By Sponsor|0|||
154857979|NCT02901431|558906626|FG005|Open Label Part|Study Terminated By Sponsor|0|||
154857980|NCT02901431|558906627|FG006|Open Label Part|Study Terminated By Sponsor|0|||
154857981|NCT02901431|558906628|FG007|Open Label Part|Study Terminated By Sponsor|0|||
154857982|NCT02901431|558906629|FG008|Open Label Part|Study Terminated By Sponsor|35|||
154857983|NCT02901431|558906630|FG009|Open Label Part|Study Terminated By Sponsor|12|||
154857984|NCT02901431|558906631|FG010|Open Label Part|Study Terminated By Sponsor|21|||
154857985|NCT02901431|558906632|FG011|Open Label Part|Study Terminated By Sponsor|31|||
154857986|NCT02901431|558906633|FG012|Open Label Part|Study Terminated By Sponsor|0|||
154857987|NCT02901431|558906621|FG000|Open Label Part|Withdrawal by Subject|0|||
154857988|NCT02901431|558906622|FG001|Open Label Part|Withdrawal by Subject|0|||
154857989|NCT02901431|558906623|FG002|Open Label Part|Withdrawal by Subject|0|||
154857990|NCT02901431|558906624|FG003|Open Label Part|Withdrawal by Subject|0|||
154857991|NCT02901431|558906625|FG004|Open Label Part|Withdrawal by Subject|0|||
154857992|NCT02901431|558906626|FG005|Open Label Part|Withdrawal by Subject|0|||
154857993|NCT02901431|558906627|FG006|Open Label Part|Withdrawal by Subject|0|||
154857994|NCT02901431|558906628|FG007|Open Label Part|Withdrawal by Subject|0|||
154857995|NCT02901431|558906629|FG008|Open Label Part|Withdrawal by Subject|6|||
154857996|NCT02901431|558906630|FG009|Open Label Part|Withdrawal by Subject|5|||
154857997|NCT02901431|558906631|FG010|Open Label Part|Withdrawal by Subject|7|||
154857998|NCT02901431|558906632|FG011|Open Label Part|Withdrawal by Subject|3|||
154857999|NCT02901431|558906633|FG012|Open Label Part|Withdrawal by Subject|1|||
154858000|NCT03440944|558906634|FG000|Overall Study|Physician Decision|1|||
154858001|NCT03440944|558906635|FG001|Overall Study|Physician Decision|0|||
154858002|NCT03440944|558906634|FG000|Overall Study|No Acceptable Vasculature|0|||
154858003|NCT03440944|558906635|FG001|Overall Study|No Acceptable Vasculature|1|||
154858004|NCT04672083|558906636|FG000|Overall Study|Lost to Follow-up|1|||
154858005|NCT04672083|558906637|FG001|Overall Study|Lost to Follow-up|0|||
154858006|NCT04672083|558906638|FG002|Overall Study|Lost to Follow-up|0|||
154858007|NCT04672083|558906639|FG003|Overall Study|Lost to Follow-up|0|||
155106600|NCT00854724|559818997|FG000|Second Intervention|Physician Decision|0|||
155106601|NCT00854724|559818998|FG001|Second Intervention|Physician Decision|1|||
155106602|NCT00933608|559819000|FG000|Overall Study|Adverse Event|4|||
155106603|NCT00933608|559819001|FG001|Overall Study|Adverse Event|2|||
154858008|NCT04672083|558906640|FG004|Overall Study|Lost to Follow-up|0|||
154858009|NCT01551745|558906641|FG000|Overall Study|Withdrawal by Subject|1|||
154858010|NCT01551745|558906641|FG000|Overall Study|Disease Progression|2|||
154858011|NCT01661790|558906642|FG000|Overall Study|Lost to Follow-up|0|||
154858012|NCT01661790|558906643|FG001|Overall Study|Lost to Follow-up|2|||
154858013|NCT02764541|558906644|FG000|Overall Study|Withdrawal by Subject|0|||
154858014|NCT02764541|558906645|FG001|Overall Study|Withdrawal by Subject|0|||
154858015|NCT02764541|558906646|FG002|Overall Study|Withdrawal by Subject|0|||
154858016|NCT02764541|558906647|FG003|Overall Study|Withdrawal by Subject|0|||
154858017|NCT02764541|558906648|FG004|Overall Study|Withdrawal by Subject|1|||
154858018|NCT02764541|558906649|FG005|Overall Study|Withdrawal by Subject|1|||
154858019|NCT02764541|558906650|FG006|Overall Study|Withdrawal by Subject|0|||
154858020|NCT02764541|558906651|FG007|Overall Study|Withdrawal by Subject|1|||
155106604|NCT00933608|559819000|FG000|Overall Study|Physician Decision|1|||
154858021|NCT02764541|558906644|FG000|Overall Study|Adverse Event|1|||
154858022|NCT02764541|558906645|FG001|Overall Study|Adverse Event|0|||
154858023|NCT02764541|558906646|FG002|Overall Study|Adverse Event|0|||
154858024|NCT02764541|558906647|FG003|Overall Study|Adverse Event|0|||
154858025|NCT02764541|558906648|FG004|Overall Study|Adverse Event|0|||
154858026|NCT02764541|558906649|FG005|Overall Study|Adverse Event|0|||
154858027|NCT02764541|558906650|FG006|Overall Study|Adverse Event|1|||
154858028|NCT02764541|558906651|FG007|Overall Study|Adverse Event|0|||
154858029|NCT02764541|558906644|FG000|Overall Study|Metastasis|1|||
154858030|NCT02764541|558906645|FG001|Overall Study|Metastasis|0|||
154858031|NCT02764541|558906646|FG002|Overall Study|Metastasis|0|||
154858032|NCT02764541|558906647|FG003|Overall Study|Metastasis|0|||
154858033|NCT02764541|558906648|FG004|Overall Study|Metastasis|0|||
154858034|NCT02764541|558906649|FG005|Overall Study|Metastasis|0|||
154858035|NCT02764541|558906650|FG006|Overall Study|Metastasis|0|||
154858036|NCT02764541|558906651|FG007|Overall Study|Metastasis|0|||
154858037|NCT02764541|558906644|FG000|Overall Study|Disease progression|1|||
154858038|NCT02764541|558906645|FG001|Overall Study|Disease progression|1|||
154858039|NCT02764541|558906646|FG002|Overall Study|Disease progression|0|||
154858040|NCT02764541|558906647|FG003|Overall Study|Disease progression|0|||
154858041|NCT02764541|558906648|FG004|Overall Study|Disease progression|0|||
154858042|NCT02764541|558906649|FG005|Overall Study|Disease progression|0|||
154858043|NCT02764541|558906650|FG006|Overall Study|Disease progression|0|||
154858044|NCT02764541|558906651|FG007|Overall Study|Disease progression|1|||
154858045|NCT02764541|558906644|FG000|Overall Study|Protocol Violation|0|||
154858046|NCT02764541|558906645|FG001|Overall Study|Protocol Violation|0|||
154858047|NCT02764541|558906646|FG002|Overall Study|Protocol Violation|0|||
154858048|NCT02764541|558906647|FG003|Overall Study|Protocol Violation|1|||
154858049|NCT02764541|558906648|FG004|Overall Study|Protocol Violation|0|||
154858050|NCT02764541|558906649|FG005|Overall Study|Protocol Violation|1|||
154858051|NCT02764541|558906650|FG006|Overall Study|Protocol Violation|0|||
154858052|NCT02764541|558906651|FG007|Overall Study|Protocol Violation|0|||
154858053|NCT02764541|558906644|FG000|Overall Study|Physician Decision|0|||
154858054|NCT02764541|558906645|FG001|Overall Study|Physician Decision|0|||
154858055|NCT02764541|558906646|FG002|Overall Study|Physician Decision|0|||
154858056|NCT02764541|558906647|FG003|Overall Study|Physician Decision|1|||
154858057|NCT02764541|558906648|FG004|Overall Study|Physician Decision|0|||
154858058|NCT02764541|558906649|FG005|Overall Study|Physician Decision|0|||
154858059|NCT02764541|558906650|FG006|Overall Study|Physician Decision|0|||
154858060|NCT02764541|558906651|FG007|Overall Study|Physician Decision|1|||
154858061|NCT02764541|558906644|FG000|Overall Study|Three Cycles completed before surgery|0|||
154858062|NCT02764541|558906645|FG001|Overall Study|Three Cycles completed before surgery|0|||
154858063|NCT02764541|558906646|FG002|Overall Study|Three Cycles completed before surgery|0|||
154858064|NCT02764541|558906647|FG003|Overall Study|Three Cycles completed before surgery|1|||
154858065|NCT02764541|558906648|FG004|Overall Study|Three Cycles completed before surgery|0|||
154858066|NCT02764541|558906649|FG005|Overall Study|Three Cycles completed before surgery|0|||
154858067|NCT02764541|558906650|FG006|Overall Study|Three Cycles completed before surgery|0|||
154858068|NCT02764541|558906651|FG007|Overall Study|Three Cycles completed before surgery|0|||
154858069|NCT02764541|558906644|FG000|Overall Study|Patient Compliance|0|||
154858070|NCT02764541|558906645|FG001|Overall Study|Patient Compliance|0|||
154858071|NCT02764541|558906646|FG002|Overall Study|Patient Compliance|1|||
154858072|NCT02764541|558906647|FG003|Overall Study|Patient Compliance|0|||
154858073|NCT02764541|558906648|FG004|Overall Study|Patient Compliance|0|||
154858074|NCT02764541|558906649|FG005|Overall Study|Patient Compliance|0|||
154858075|NCT02764541|558906650|FG006|Overall Study|Patient Compliance|0|||
154858076|NCT02764541|558906651|FG007|Overall Study|Patient Compliance|0|||
154858077|NCT02764541|558906644|FG000|Overall Study|Death|0|||
154858078|NCT02764541|558906645|FG001|Overall Study|Death|0|||
154858079|NCT02764541|558906646|FG002|Overall Study|Death|0|||
154858080|NCT02764541|558906647|FG003|Overall Study|Death|0|||
154858081|NCT02764541|558906648|FG004|Overall Study|Death|0|||
154858082|NCT02764541|558906649|FG005|Overall Study|Death|0|||
154858083|NCT02764541|558906650|FG006|Overall Study|Death|1|||
154858084|NCT02764541|558906651|FG007|Overall Study|Death|0|||
154858085|NCT02764541|558906644|FG000|Overall Study|Insurance reasons|0|||
154858086|NCT02764541|558906645|FG001|Overall Study|Insurance reasons|0|||
154858087|NCT02764541|558906646|FG002|Overall Study|Insurance reasons|0|||
154858088|NCT02764541|558906647|FG003|Overall Study|Insurance reasons|0|||
154858089|NCT02764541|558906648|FG004|Overall Study|Insurance reasons|0|||
154858090|NCT02764541|558906649|FG005|Overall Study|Insurance reasons|0|||
154858091|NCT02764541|558906650|FG006|Overall Study|Insurance reasons|1|||
154858092|NCT02764541|558906651|FG007|Overall Study|Insurance reasons|0|||
154858093|NCT02048904|558906652|FG000|Overall Study|Withdrawal by Subject|7|||
154858094|NCT02048904|558906652|FG000|Overall Study|Physician Decision|70|||
154858095|NCT00749190|558906655|FG000|Overall Study|Adverse Event|0|||
154858096|NCT00749190|558906656|FG001|Overall Study|Adverse Event|2|||
154858097|NCT00749190|558906657|FG002|Overall Study|Adverse Event|0|||
154858098|NCT00749190|558906658|FG003|Overall Study|Adverse Event|4|||
154858099|NCT00749190|558906659|FG004|Overall Study|Adverse Event|0|||
154858100|NCT00749190|558906660|FG005|Overall Study|Adverse Event|3|||
154858101|NCT00749190|558906661|FG006|Overall Study|Adverse Event|0|||
154858102|NCT00749190|558906655|FG000|Overall Study|Lack of Efficacy|3|||
154858103|NCT00749190|558906656|FG001|Overall Study|Lack of Efficacy|1|||
154858104|NCT00749190|558906657|FG002|Overall Study|Lack of Efficacy|1|||
154858105|NCT00749190|558906658|FG003|Overall Study|Lack of Efficacy|0|||
154858106|NCT00749190|558906659|FG004|Overall Study|Lack of Efficacy|0|||
154858107|NCT00749190|558906660|FG005|Overall Study|Lack of Efficacy|1|||
154858108|NCT00749190|558906661|FG006|Overall Study|Lack of Efficacy|0|||
154858109|NCT00749190|558906655|FG000|Overall Study|Withdrawal by Subject|2|||
154858110|NCT00749190|558906656|FG001|Overall Study|Withdrawal by Subject|1|||
154858111|NCT00749190|558906657|FG002|Overall Study|Withdrawal by Subject|0|||
154858112|NCT00749190|558906658|FG003|Overall Study|Withdrawal by Subject|0|||
154858113|NCT00749190|558906659|FG004|Overall Study|Withdrawal by Subject|0|||
154858114|NCT00749190|558906660|FG005|Overall Study|Withdrawal by Subject|1|||
154858115|NCT00749190|558906661|FG006|Overall Study|Withdrawal by Subject|0|||
154858116|NCT00749190|558906655|FG000|Overall Study|Protocol Violation|0|||
154858117|NCT00749190|558906656|FG001|Overall Study|Protocol Violation|1|||
154858118|NCT00749190|558906657|FG002|Overall Study|Protocol Violation|0|||
154858119|NCT00749190|558906658|FG003|Overall Study|Protocol Violation|0|||
154858120|NCT00749190|558906659|FG004|Overall Study|Protocol Violation|0|||
154858121|NCT00749190|558906660|FG005|Overall Study|Protocol Violation|0|||
154858122|NCT00749190|558906661|FG006|Overall Study|Protocol Violation|1|||
154858123|NCT00749190|558906655|FG000|Overall Study|Other reason not defined above|0|||
154858124|NCT00749190|558906656|FG001|Overall Study|Other reason not defined above|0|||
154858125|NCT00749190|558906657|FG002|Overall Study|Other reason not defined above|0|||
154858126|NCT00749190|558906658|FG003|Overall Study|Other reason not defined above|1|||
154858127|NCT00749190|558906659|FG004|Overall Study|Other reason not defined above|0|||
154858128|NCT00749190|558906660|FG005|Overall Study|Other reason not defined above|0|||
154858129|NCT00749190|558906661|FG006|Overall Study|Other reason not defined above|0|||
154858130|NCT02330419|558906665|FG000|Overall Study|Lost to Follow-up|3|||
154858131|NCT02330419|558906666|FG001|Overall Study|Lost to Follow-up|7|||
154858132|NCT04370509|558906667|FG000|Overall Study|Adverse Event|1|||
154858133|NCT04370509|558906668|FG001|Overall Study|Adverse Event|0|||
154858134|NCT04370509|558906667|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
154858135|NCT04370509|558906668|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
154858136|NCT04743856|558906669|FG000|Overall Study|Lost to Follow-up|6|||
154972241|NCT00982228|559322336|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
154972242|NCT00982228|559322337|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
154972243|NCT02289820|559322339|FG000|Overall Study|Withdrawal by Subject|2|||
154972244|NCT02289820|559322340|FG001|Overall Study|Withdrawal by Subject|1|||
154972245|NCT02289820|559322341|FG002|Overall Study|Withdrawal by Subject|2|||
154972246|NCT02289820|559322342|FG003|Overall Study|Withdrawal by Subject|1|||
154972247|NCT02289820|559322343|FG004|Overall Study|Withdrawal by Subject|0|||
154972248|NCT02289820|559322344|FG005|Overall Study|Withdrawal by Subject|0|||
155106605|NCT00933608|559819001|FG001|Overall Study|Physician Decision|0|||
155106606|NCT00336284|559819006|FG000|Overall Study|Death|52|||
155106607|NCT00336284|559819007|FG001|Overall Study|Death|26|||
155106608|NCT00336284|559819006|FG000|Overall Study|Lost to Follow-up|82|||
155106609|NCT00336284|559819007|FG001|Overall Study|Lost to Follow-up|61|||
155106610|NCT00336284|559819006|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
154972249|NCT02289820|559322345|FG006|Overall Study|Withdrawal by Subject|1|||
155106611|NCT00336284|559819007|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
155106612|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
155106613|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
155106614|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
155106615|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
155106616|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
154858137|NCT04743856|558906670|FG001|Overall Study|Lost to Follow-up|7|||
154858138|NCT04743856|558906669|FG000|Overall Study|Withdrawal by Subject|1|||
154858139|NCT04743856|558906670|FG001|Overall Study|Withdrawal by Subject|0|||
154858140|NCT04696861|558906671|FG000|Overall Study|Death|1|||
154858141|NCT04696861|558906672|FG001|Overall Study|Death|0|||
154858142|NCT04696861|558906671|FG000|Overall Study|Lost to Follow-up|3|||
154858143|NCT04696861|558906672|FG001|Overall Study|Lost to Follow-up|0|||
155106617|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
154858144|NCT04439188|558906673|FG000|Overall Study|Ineligible|3|||
154858145|NCT04439188|558906673|FG000|Overall Study|Adverse Event|4|||
154858146|NCT04439188|558906673|FG000|Overall Study|Death|1|||
154858147|NCT04439188|558906673|FG000|Overall Study|Disease Progression|25|||
154858148|NCT04439188|558906673|FG000|Overall Study|Withdrawal by Subject|2|||
154858149|NCT01813890|558906676|FG000|Overall Study|Adverse Event|0|||
154858150|NCT01813890|558906677|FG001|Overall Study|Adverse Event|3|||
154858151|NCT01813890|558906678|FG002|Overall Study|Adverse Event|4|||
154858152|NCT01813890|558906676|FG000|Overall Study|Lack of Efficacy|9|||
154858153|NCT01813890|558906677|FG001|Overall Study|Lack of Efficacy|1|||
154858154|NCT01813890|558906678|FG002|Overall Study|Lack of Efficacy|2|||
155106618|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
154858155|NCT04482647|558906679|FG000|Overall Study|Time constraints|2|||
154858156|NCT04482647|558906679|FG000|Overall Study|Health issues|1|||
154858157|NCT04482647|558906679|FG000|Overall Study|Death in the family|1|||
154858158|NCT04482647|558906679|FG000|Overall Study|Disliked the intervention|1|||
154858159|NCT04482647|558906679|FG000|Overall Study|No reasons specified|7|||
154858160|NCT03952559|558906680|FG000|Double Blind Treatment Period|Adverse Event|0|||
154858161|NCT03952559|558906681|FG001|Double Blind Treatment Period|Adverse Event|2|||
154858162|NCT03952559|558906682|FG002|Double Blind Treatment Period|Adverse Event|1|||
154858163|NCT03952559|558906683|FG003|Double Blind Treatment Period|Adverse Event|0|||
154858164|NCT03952559|558906684|FG004|Double Blind Treatment Period|Adverse Event|1|||
154858165|NCT03952559|558906680|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
154858166|NCT03952559|558906681|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
154858167|NCT03952559|558906682|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
154858168|NCT03952559|558906683|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
154858169|NCT03952559|558906684|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
154858170|NCT03952559|558906680|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
154858171|NCT03952559|558906681|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
154858172|NCT03952559|558906682|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
154858173|NCT03952559|558906683|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
154858174|NCT03952559|558906684|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
154858175|NCT03952559|558906680|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
154858176|NCT03952559|558906681|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
154858177|NCT03952559|558906682|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
154858178|NCT03952559|558906683|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
154858179|NCT03952559|558906684|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
154858180|NCT02875223|558906685|FG000|Overall Study|Other reasons|0|||
154858181|NCT02875223|558906686|FG001|Overall Study|Other reasons|0|||
154858182|NCT02875223|558906687|FG002|Overall Study|Other reasons|1|||
154858183|NCT02875223|558906688|FG003|Overall Study|Other reasons|0|||
154858184|NCT02875223|558906689|FG004|Overall Study|Other reasons|1|||
154858185|NCT02875223|558906690|FG005|Overall Study|Other reasons|2|||
154858186|NCT02875223|558906691|FG006|Overall Study|Other reasons|0|||
154858187|NCT02875223|558906692|FG007|Overall Study|Other reasons|2|||
154858188|NCT02875223|558906693|FG008|Overall Study|Other reasons|0|||
154858189|NCT02875223|558906694|FG009|Overall Study|Other reasons|0|||
154858190|NCT02875223|558906695|FG010|Overall Study|Other reasons|0|||
154858191|NCT02875223|558906696|FG011|Overall Study|Other reasons|0|||
154858192|NCT02875223|558906697|FG012|Overall Study|Other reasons|0|||
154858193|NCT02875223|558906685|FG000|Overall Study|Withdrawal by Subject|0|||
154858194|NCT02875223|558906686|FG001|Overall Study|Withdrawal by Subject|0|||
154858195|NCT02875223|558906687|FG002|Overall Study|Withdrawal by Subject|0|||
154858196|NCT02875223|558906688|FG003|Overall Study|Withdrawal by Subject|0|||
154858197|NCT02875223|558906689|FG004|Overall Study|Withdrawal by Subject|1|||
154858198|NCT02875223|558906690|FG005|Overall Study|Withdrawal by Subject|1|||
154858199|NCT02875223|558906691|FG006|Overall Study|Withdrawal by Subject|0|||
154858200|NCT02875223|558906692|FG007|Overall Study|Withdrawal by Subject|0|||
154858201|NCT02875223|558906693|FG008|Overall Study|Withdrawal by Subject|1|||
154858202|NCT02875223|558906694|FG009|Overall Study|Withdrawal by Subject|0|||
154858203|NCT02875223|558906695|FG010|Overall Study|Withdrawal by Subject|0|||
154858204|NCT02875223|558906696|FG011|Overall Study|Withdrawal by Subject|0|||
154858205|NCT02875223|558906697|FG012|Overall Study|Withdrawal by Subject|0|||
154858206|NCT02875223|558906685|FG000|Overall Study|Progressive disease|0|||
154858207|NCT02875223|558906686|FG001|Overall Study|Progressive disease|0|||
154858208|NCT02875223|558906687|FG002|Overall Study|Progressive disease|1|||
154858209|NCT02875223|558906688|FG003|Overall Study|Progressive disease|0|||
154858210|NCT02875223|558906689|FG004|Overall Study|Progressive disease|0|||
154858211|NCT02875223|558906690|FG005|Overall Study|Progressive disease|0|||
154858212|NCT02875223|558906691|FG006|Overall Study|Progressive disease|0|||
154858213|NCT02875223|558906692|FG007|Overall Study|Progressive disease|0|||
154858214|NCT02875223|558906693|FG008|Overall Study|Progressive disease|0|||
154858215|NCT02875223|558906694|FG009|Overall Study|Progressive disease|12|||
154858216|NCT02875223|558906695|FG010|Overall Study|Progressive disease|2|||
154858217|NCT02875223|558906696|FG011|Overall Study|Progressive disease|3|||
154858218|NCT02875223|558906697|FG012|Overall Study|Progressive disease|6|||
154858219|NCT02875223|558906685|FG000|Overall Study|Death|4|||
154858220|NCT02875223|558906686|FG001|Overall Study|Death|4|||
154858221|NCT02875223|558906687|FG002|Overall Study|Death|3|||
154858222|NCT02875223|558906688|FG003|Overall Study|Death|4|||
154858223|NCT02875223|558906689|FG004|Overall Study|Death|2|||
154858224|NCT02875223|558906690|FG005|Overall Study|Death|3|||
154858225|NCT02875223|558906691|FG006|Overall Study|Death|5|||
154858226|NCT02875223|558906692|FG007|Overall Study|Death|7|||
154858227|NCT02875223|558906693|FG008|Overall Study|Death|3|||
154858228|NCT02875223|558906694|FG009|Overall Study|Death|2|||
154858229|NCT02875223|558906695|FG010|Overall Study|Death|0|||
154858230|NCT02875223|558906696|FG011|Overall Study|Death|0|||
154858231|NCT02875223|558906697|FG012|Overall Study|Death|0|||
154858232|NCT02875223|558906685|FG000|Overall Study|Lost to Follow-up|0|||
154858233|NCT02875223|558906686|FG001|Overall Study|Lost to Follow-up|1|||
154858234|NCT02875223|558906687|FG002|Overall Study|Lost to Follow-up|1|||
154858235|NCT02875223|558906688|FG003|Overall Study|Lost to Follow-up|0|||
154858236|NCT02875223|558906689|FG004|Overall Study|Lost to Follow-up|1|||
154972250|NCT02289820|559322339|FG000|Overall Study|Death|0|||
154972251|NCT02289820|559322340|FG001|Overall Study|Death|0|||
154972252|NCT02289820|559322341|FG002|Overall Study|Death|1|||
154972253|NCT02289820|559322342|FG003|Overall Study|Death|0|||
154972254|NCT02289820|559322343|FG004|Overall Study|Death|0|||
154972255|NCT02289820|559322344|FG005|Overall Study|Death|0|||
154972256|NCT02289820|559322345|FG006|Overall Study|Death|0|||
154972257|NCT02289820|559322339|FG000|Overall Study|Lost to Follow-up|0|||
154858237|NCT02875223|558906690|FG005|Overall Study|Lost to Follow-up|0|||
154858238|NCT02875223|558906691|FG006|Overall Study|Lost to Follow-up|1|||
154858239|NCT02875223|558906692|FG007|Overall Study|Lost to Follow-up|1|||
154858240|NCT02875223|558906693|FG008|Overall Study|Lost to Follow-up|0|||
154858241|NCT02875223|558906694|FG009|Overall Study|Lost to Follow-up|0|||
154858242|NCT02875223|558906695|FG010|Overall Study|Lost to Follow-up|0|||
154858243|NCT02875223|558906696|FG011|Overall Study|Lost to Follow-up|0|||
154858244|NCT02875223|558906697|FG012|Overall Study|Lost to Follow-up|0|||
155173638|NCT01155011|560074842|FG000|6 to 12 Months|Withdrawal by Subject|8|||
154858245|NCT01827384|558906700|FG000|Overall Study|Switched to alternative treatment|0|||
154858246|NCT01827384|558906701|FG001|Overall Study|Switched to alternative treatment|0|||
154858247|NCT01827384|558906702|FG002|Overall Study|Switched to alternative treatment|0|||
154858248|NCT01827384|558906703|FG003|Overall Study|Switched to alternative treatment|0|||
154858249|NCT01827384|558906704|FG004|Overall Study|Switched to alternative treatment|0|||
154858250|NCT01827384|558906705|FG005|Overall Study|Switched to alternative treatment|0|||
154858251|NCT01827384|558906706|FG006|Overall Study|Switched to alternative treatment|0|||
154858252|NCT01827384|558906707|FG007|Overall Study|Switched to alternative treatment|0|||
154858253|NCT01827384|558906708|FG008|Overall Study|Switched to alternative treatment|0|||
154858254|NCT01827384|558906709|FG009|Overall Study|Switched to alternative treatment|0|||
154858255|NCT01827384|558906710|FG010|Overall Study|Switched to alternative treatment|0|||
154858256|NCT01827384|558906711|FG011|Overall Study|Switched to alternative treatment|0|||
154858257|NCT01827384|558906712|FG012|Overall Study|Switched to alternative treatment|0|||
154858258|NCT01827384|558906713|FG013|Overall Study|Switched to alternative treatment|2|||
154858259|NCT01827384|558906700|FG000|Overall Study|Disease progression before treatment|0|||
154858260|NCT01827384|558906701|FG001|Overall Study|Disease progression before treatment|0|||
154858261|NCT01827384|558906702|FG002|Overall Study|Disease progression before treatment|0|||
154858262|NCT01827384|558906703|FG003|Overall Study|Disease progression before treatment|0|||
154858263|NCT01827384|558906704|FG004|Overall Study|Disease progression before treatment|0|||
154858264|NCT01827384|558906705|FG005|Overall Study|Disease progression before treatment|0|||
154858265|NCT01827384|558906706|FG006|Overall Study|Disease progression before treatment|0|||
154858266|NCT01827384|558906707|FG007|Overall Study|Disease progression before treatment|0|||
154858267|NCT01827384|558906708|FG008|Overall Study|Disease progression before treatment|0|||
154858268|NCT01827384|558906709|FG009|Overall Study|Disease progression before treatment|0|||
154858269|NCT01827384|558906710|FG010|Overall Study|Disease progression before treatment|0|||
154858270|NCT01827384|558906711|FG011|Overall Study|Disease progression before treatment|0|||
154858271|NCT01827384|558906712|FG012|Overall Study|Disease progression before treatment|0|||
154858272|NCT01827384|558906713|FG013|Overall Study|Disease progression before treatment|4|||
154858273|NCT01827384|558906700|FG000|Overall Study|Ineligible|0|||
154858274|NCT01827384|558906701|FG001|Overall Study|Ineligible|0|||
154858275|NCT01827384|558906702|FG002|Overall Study|Ineligible|0|||
154858276|NCT01827384|558906703|FG003|Overall Study|Ineligible|0|||
154858277|NCT01827384|558906704|FG004|Overall Study|Ineligible|0|||
154858278|NCT01827384|558906705|FG005|Overall Study|Ineligible|0|||
154858279|NCT01827384|558906706|FG006|Overall Study|Ineligible|0|||
154858280|NCT01827384|558906707|FG007|Overall Study|Ineligible|0|||
154858281|NCT01827384|558906708|FG008|Overall Study|Ineligible|0|||
154858282|NCT01827384|558906709|FG009|Overall Study|Ineligible|0|||
154858283|NCT01827384|558906710|FG010|Overall Study|Ineligible|0|||
154858284|NCT01827384|558906711|FG011|Overall Study|Ineligible|0|||
154858285|NCT01827384|558906712|FG012|Overall Study|Ineligible|0|||
154972258|NCT02289820|559322340|FG001|Overall Study|Lost to Follow-up|0|||
154972259|NCT02289820|559322341|FG002|Overall Study|Lost to Follow-up|3|||
154858286|NCT01827384|558906713|FG013|Overall Study|Ineligible|19|||
154858287|NCT01827384|558906700|FG000|Overall Study|Participant died before treatment|0|||
154858288|NCT01827384|558906701|FG001|Overall Study|Participant died before treatment|0|||
154858289|NCT01827384|558906702|FG002|Overall Study|Participant died before treatment|0|||
154972260|NCT02289820|559322342|FG003|Overall Study|Lost to Follow-up|1|||
154972261|NCT02289820|559322343|FG004|Overall Study|Lost to Follow-up|0|||
154858290|NCT01827384|558906703|FG003|Overall Study|Participant died before treatment|0|||
154858291|NCT01827384|558906704|FG004|Overall Study|Participant died before treatment|0|||
154858292|NCT01827384|558906705|FG005|Overall Study|Participant died before treatment|0|||
154858293|NCT01827384|558906706|FG006|Overall Study|Participant died before treatment|0|||
154972262|NCT02289820|559322344|FG005|Overall Study|Lost to Follow-up|1|||
154858294|NCT01827384|558906707|FG007|Overall Study|Participant died before treatment|0|||
154858295|NCT01827384|558906708|FG008|Overall Study|Participant died before treatment|0|||
154858296|NCT01827384|558906709|FG009|Overall Study|Participant died before treatment|0|||
154858297|NCT01827384|558906710|FG010|Overall Study|Participant died before treatment|0|||
154858298|NCT01827384|558906711|FG011|Overall Study|Participant died before treatment|0|||
154858299|NCT01827384|558906712|FG012|Overall Study|Participant died before treatment|0|||
154858300|NCT01827384|558906713|FG013|Overall Study|Participant died before treatment|5|||
154858301|NCT01827384|558906700|FG000|Overall Study|Insufficient tumor cells|0|||
154858302|NCT01827384|558906701|FG001|Overall Study|Insufficient tumor cells|0|||
154858303|NCT01827384|558906702|FG002|Overall Study|Insufficient tumor cells|0|||
154858304|NCT01827384|558906703|FG003|Overall Study|Insufficient tumor cells|0|||
154858305|NCT01827384|558906704|FG004|Overall Study|Insufficient tumor cells|0|||
154858306|NCT01827384|558906705|FG005|Overall Study|Insufficient tumor cells|0|||
154858307|NCT01827384|558906706|FG006|Overall Study|Insufficient tumor cells|0|||
154858308|NCT01827384|558906707|FG007|Overall Study|Insufficient tumor cells|0|||
154858309|NCT01827384|558906708|FG008|Overall Study|Insufficient tumor cells|0|||
154858310|NCT01827384|558906709|FG009|Overall Study|Insufficient tumor cells|0|||
154858311|NCT01827384|558906710|FG010|Overall Study|Insufficient tumor cells|0|||
154858312|NCT01827384|558906711|FG011|Overall Study|Insufficient tumor cells|0|||
154858313|NCT01827384|558906712|FG012|Overall Study|Insufficient tumor cells|0|||
154858314|NCT01827384|558906713|FG013|Overall Study|Insufficient tumor cells|13|||
154858315|NCT01827384|558906700|FG000|Overall Study|No actionable mutation|0|||
154858316|NCT01827384|558906701|FG001|Overall Study|No actionable mutation|0|||
154858317|NCT01827384|558906702|FG002|Overall Study|No actionable mutation|0|||
154858318|NCT01827384|558906703|FG003|Overall Study|No actionable mutation|0|||
154858319|NCT01827384|558906704|FG004|Overall Study|No actionable mutation|0|||
154858320|NCT01827384|558906705|FG005|Overall Study|No actionable mutation|0|||
154858321|NCT01827384|558906706|FG006|Overall Study|No actionable mutation|0|||
154858322|NCT01827384|558906707|FG007|Overall Study|No actionable mutation|0|||
154858323|NCT01827384|558906708|FG008|Overall Study|No actionable mutation|0|||
154858324|NCT01827384|558906709|FG009|Overall Study|No actionable mutation|0|||
154858325|NCT01827384|558906710|FG010|Overall Study|No actionable mutation|0|||
154858326|NCT01827384|558906711|FG011|Overall Study|No actionable mutation|0|||
154858327|NCT01827384|558906712|FG012|Overall Study|No actionable mutation|0|||
154858328|NCT01827384|558906713|FG013|Overall Study|No actionable mutation|73|||
154858329|NCT01827384|558906700|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
154858330|NCT01827384|558906701|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
154858331|NCT01827384|558906702|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
154858332|NCT01827384|558906703|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
154858333|NCT01827384|558906704|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
154858334|NCT01827384|558906705|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
154858335|NCT01827384|558906706|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
154858336|NCT01827384|558906707|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
154858337|NCT01827384|558906708|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
154858338|NCT01827384|558906709|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
154858339|NCT01827384|558906710|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
154858340|NCT01827384|558906711|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
154858341|NCT01827384|558906712|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
154858342|NCT01827384|558906713|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
154858343|NCT04167345|558906718|FG000|Overall Study|Other|1|||
154858344|NCT04167345|558906719|FG001|Overall Study|Other|1|||
154858345|NCT04167345|558906720|FG002|Overall Study|Other|0|||
154858346|NCT04167345|558906721|FG003|Overall Study|Other|0|||
154858347|NCT04167345|558906722|FG004|Overall Study|Other|0|||
154858348|NCT04375761|558908519|FG000|Overall Study|Death|1|||
154858349|NCT04375761|558908520|FG001|Overall Study|Death|2|||
154858350|NCT04375761|558908519|FG000|Overall Study|Lost to Follow-up|203|||
154858351|NCT04375761|558908520|FG001|Overall Study|Lost to Follow-up|380|||
154858352|NCT04375761|558908519|FG000|Overall Study|Withdrawal by Subject|47|||
154858353|NCT04375761|558908520|FG001|Overall Study|Withdrawal by Subject|98|||
154858354|NCT04375761|558908519|FG000|Overall Study|Noncompliance with study procedure|121|||
154858355|NCT04375761|558908520|FG001|Overall Study|Noncompliance with study procedure|251|||
154858356|NCT04375761|558908519|FG000|Overall Study|Reimbursement not enough|1|||
154858357|NCT04375761|558908520|FG001|Overall Study|Reimbursement not enough|2|||
154972263|NCT02289820|559322345|FG006|Overall Study|Lost to Follow-up|1|||
154858358|NCT04375761|558908519|FG000|Overall Study|Unforeseen family circumstances|1|||
154858359|NCT04375761|558908520|FG001|Overall Study|Unforeseen family circumstances|3|||
154858360|NCT04375761|558908519|FG000|Overall Study|Test too painful|1|||
154972264|NCT02289820|559322339|FG000|Overall Study|withdrawal of consent|0|||
154972265|NCT02289820|559322340|FG001|Overall Study|withdrawal of consent|1|||
154858361|NCT04375761|558908520|FG001|Overall Study|Test too painful|1|||
154858362|NCT04375761|558908519|FG000|Overall Study|Moved|0|||
154858363|NCT04375761|558908520|FG001|Overall Study|Moved|2|||
154858364|NCT04375761|558908519|FG000|Overall Study|Nonresponsive|0|||
154858365|NCT04375761|558908520|FG001|Overall Study|Nonresponsive|5|||
154858366|NCT03797001|558908521|FG000|Overall Study|Withdrawn due to COVID19|4|||
154858367|NCT03797001|558908522|FG001|Overall Study|Withdrawn due to COVID19|0|||
154858368|NCT03797001|558908521|FG000|Overall Study|Withdrawal by Subject|7|||
154858369|NCT03797001|558908522|FG001|Overall Study|Withdrawal by Subject|6|||
154858370|NCT03797001|558908521|FG000|Overall Study|Adverse Event|0|||
154858371|NCT03797001|558908522|FG001|Overall Study|Adverse Event|1|||
154858372|NCT00500266|558908537|FG000|Overall Study|Death|3|||
154858373|NCT00500266|558908537|FG000|Overall Study|Lost to Follow-up|3|||
154858374|NCT00500266|558908537|FG000|Overall Study|Withdrawal by Subject|3|||
154858375|NCT00500266|558908537|FG000|Overall Study|Assigned, not treated|4|||
154858376|NCT01431287|558908538|FG000|Overall Study|not treated|0|||
154858377|NCT01431287|558908539|FG001|Overall Study|not treated|0|||
154858378|NCT01431287|558908540|FG002|Overall Study|not treated|1|||
154858379|NCT01431287|558908541|FG003|Overall Study|not treated|0|||
154858380|NCT01431287|558908542|FG004|Overall Study|not treated|0|||
154858381|NCT01431287|558908538|FG000|Overall Study|Adverse Event|59|||
154858382|NCT01431287|558908539|FG001|Overall Study|Adverse Event|57|||
154858383|NCT01431287|558908540|FG002|Overall Study|Adverse Event|53|||
154858384|NCT01431287|558908541|FG003|Overall Study|Adverse Event|33|||
154858385|NCT01431287|558908542|FG004|Overall Study|Adverse Event|41|||
154858386|NCT01431287|558908538|FG000|Overall Study|Non compliant with protocol|6|||
154858387|NCT01431287|558908539|FG001|Overall Study|Non compliant with protocol|6|||
154858388|NCT01431287|558908540|FG002|Overall Study|Non compliant with protocol|5|||
154858389|NCT01431287|558908541|FG003|Overall Study|Non compliant with protocol|6|||
154858390|NCT01431287|558908542|FG004|Overall Study|Non compliant with protocol|5|||
154858391|NCT01431287|558908538|FG000|Overall Study|Lost to Follow-up|0|||
154858392|NCT01431287|558908539|FG001|Overall Study|Lost to Follow-up|3|||
154858393|NCT01431287|558908540|FG002|Overall Study|Lost to Follow-up|2|||
154858394|NCT01431287|558908541|FG003|Overall Study|Lost to Follow-up|3|||
154858395|NCT01431287|558908542|FG004|Overall Study|Lost to Follow-up|1|||
154858396|NCT01431287|558908538|FG000|Overall Study|Consent withdrawn not due to AE|29|||
154858397|NCT01431287|558908539|FG001|Overall Study|Consent withdrawn not due to AE|30|||
154858398|NCT01431287|558908540|FG002|Overall Study|Consent withdrawn not due to AE|34|||
154858399|NCT01431287|558908541|FG003|Overall Study|Consent withdrawn not due to AE|19|||
154858400|NCT01431287|558908542|FG004|Overall Study|Consent withdrawn not due to AE|29|||
154858401|NCT01431287|558908538|FG000|Overall Study|not stated above|4|||
154858402|NCT01431287|558908539|FG001|Overall Study|not stated above|2|||
154858403|NCT01431287|558908540|FG002|Overall Study|not stated above|2|||
154858404|NCT01431287|558908541|FG003|Overall Study|not stated above|2|||
154858405|NCT01431287|558908542|FG004|Overall Study|not stated above|1|||
154858406|NCT00278629|558908545|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
154858407|NCT05224258|558908548|FG000|Overall Study|Withdrawal by Subject|1|||
154858408|NCT05224258|558908549|FG001|Overall Study|Withdrawal by Subject|1|||
154972266|NCT02289820|559322341|FG002|Overall Study|withdrawal of consent|0|||
154972267|NCT02289820|559322342|FG003|Overall Study|withdrawal of consent|0|||
154972268|NCT02289820|559322343|FG004|Overall Study|withdrawal of consent|0|||
154972269|NCT02289820|559322344|FG005|Overall Study|withdrawal of consent|0|||
154972270|NCT02289820|559322345|FG006|Overall Study|withdrawal of consent|0|||
154972271|NCT02786927|559322352|FG000|Overall Study|Adverse Event|1|||
154972272|NCT02786927|559322352|FG000|Overall Study|Protocol Violation|4|||
154972273|NCT01801917|559322353|FG000|Period 1 - Randomized|Adverse Event|1|||
154972274|NCT01801917|559322354|FG001|Period 1 - Randomized|Adverse Event|0|||
154972275|NCT01801917|559322355|FG002|Period 1 - Randomized|Adverse Event|1|||
154972276|NCT01801917|559322356|FG003|Period 1 - Randomized|Adverse Event|0|||
154972277|NCT01924364|559322357|FG000|Overall Study|Physician Decision|3|||
154972278|NCT02416934|559322359|FG000|Overall Study|given steroids|1|||
154972279|NCT02416934|559322360|FG001|Overall Study|given steroids|2|||
154858409|NCT05224258|558908548|FG000|Overall Study|Physician Decision|1|||
154858410|NCT05224258|558908549|FG001|Overall Study|Physician Decision|1|||
154858411|NCT05224258|558908548|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
154858412|NCT05224258|558908549|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154972280|NCT02416934|559322359|FG000|Overall Study|Lost to Follow-up|0|||
154858413|NCT05224258|558908548|FG000|Overall Study|Study Product No Longer in Use|1|||
154858414|NCT05224258|558908549|FG001|Overall Study|Study Product No Longer in Use|0|||
154858415|NCT05224258|558908548|FG000|Overall Study|Adverse Event|0|||
154858416|NCT05224258|558908549|FG001|Overall Study|Adverse Event|1|||
154858417|NCT05224258|558908548|FG000|Overall Study|Protocol Deviation|0|||
154858418|NCT05224258|558908549|FG001|Overall Study|Protocol Deviation|1|||
154858419|NCT03615222|558908558|FG000|Overall Study|Ineligible|26|||
154858420|NCT03615222|558908558|FG000|Overall Study|Withdrawal by Subject|7|||
154858421|NCT03615222|558908558|FG000|Overall Study|Death|1|||
154858422|NCT01552057|558908559|FG000|Overall Study|Adverse Event|14|||
154858423|NCT01552057|558908560|FG001|Overall Study|Adverse Event|15|||
154858424|NCT01552057|558908559|FG000|Overall Study|Lack of Efficacy|8|||
154858425|NCT01552057|558908560|FG001|Overall Study|Lack of Efficacy|23|||
154858426|NCT01552057|558908559|FG000|Overall Study|Withdrawal by Subject|5|||
154858427|NCT01552057|558908560|FG001|Overall Study|Withdrawal by Subject|8|||
154858428|NCT01552057|558908559|FG000|Overall Study|Entry Criteria Not Met|2|||
154858429|NCT01552057|558908560|FG001|Overall Study|Entry Criteria Not Met|2|||
154858430|NCT01552057|558908559|FG000|Overall Study|Physician Decision|1|||
154858431|NCT01552057|558908560|FG001|Overall Study|Physician Decision|0|||
154858432|NCT04572633|558908561|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
154858433|NCT03480802|558908562|FG000|Overall Study|Lost to Follow-up|5|||
154858434|NCT03480802|558908563|FG001|Overall Study|Lost to Follow-up|1|||
154858435|NCT03480802|558908562|FG000|Overall Study|Withdrawal by Subject|2|||
154858436|NCT03480802|558908563|FG001|Overall Study|Withdrawal by Subject|1|||
154858437|NCT03480802|558908562|FG000|Overall Study|Relocated|0|||
154858438|NCT03480802|558908563|FG001|Overall Study|Relocated|1|||
154858439|NCT04439266|558908566|FG000|Overall Study|Ineligible|1|||
154858440|NCT04439266|558908566|FG000|Overall Study|Adverse Event|1|||
154858441|NCT04439266|558908566|FG000|Overall Study|Death|1|||
154858442|NCT04439266|558908566|FG000|Overall Study|Disease progression|1|||
154858443|NCT04439266|558908566|FG000|Overall Study|Still on treatment|1|||
154858444|NCT06161012|558908568|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
154858445|NCT06161012|558908569|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
154858446|NCT00408005|558908570|FG000|Induction|Adverse Event|19|||
154858447|NCT00408005|558908571|FG001|Induction|Adverse Event|3|||
154858448|NCT00408005|558908572|FG002|Induction|Adverse Event|0|||
154858449|NCT00408005|558908573|FG003|Induction|Adverse Event|0|||
154858450|NCT00408005|558908574|FG004|Induction|Adverse Event|0|||
154858451|NCT00408005|558908575|FG005|Induction|Adverse Event|0|||
154858452|NCT00408005|558908576|FG006|Induction|Adverse Event|0|||
154858453|NCT00408005|558908577|FG007|Induction|Adverse Event|0|||
154858454|NCT00408005|558908570|FG000|Induction|Death|6|||
154858455|NCT00408005|558908571|FG001|Induction|Death|0|||
154858456|NCT00408005|558908572|FG002|Induction|Death|0|||
154858457|NCT00408005|558908573|FG003|Induction|Death|0|||
154858458|NCT00408005|558908574|FG004|Induction|Death|0|||
154858459|NCT00408005|558908575|FG005|Induction|Death|0|||
154858460|NCT00408005|558908576|FG006|Induction|Death|0|||
154858461|NCT00408005|558908577|FG007|Induction|Death|0|||
154858462|NCT00408005|558908570|FG000|Induction|Physician Decision|83|||
154858463|NCT00408005|558908571|FG001|Induction|Physician Decision|9|||
154858464|NCT00408005|558908572|FG002|Induction|Physician Decision|0|||
154858465|NCT00408005|558908573|FG003|Induction|Physician Decision|0|||
154858466|NCT00408005|558908574|FG004|Induction|Physician Decision|0|||
154858467|NCT00408005|558908575|FG005|Induction|Physician Decision|0|||
154858468|NCT00408005|558908576|FG006|Induction|Physician Decision|0|||
154858469|NCT00408005|558908577|FG007|Induction|Physician Decision|0|||
154858470|NCT00408005|558908570|FG000|Induction|Withdrawal by Subject|2|||
154858471|NCT00408005|558908571|FG001|Induction|Withdrawal by Subject|4|||
154858472|NCT00408005|558908572|FG002|Induction|Withdrawal by Subject|0|||
154858473|NCT00408005|558908573|FG003|Induction|Withdrawal by Subject|0|||
154858474|NCT00408005|558908574|FG004|Induction|Withdrawal by Subject|0|||
154858475|NCT00408005|558908575|FG005|Induction|Withdrawal by Subject|0|||
154858476|NCT00408005|558908576|FG006|Induction|Withdrawal by Subject|0|||
154858477|NCT00408005|558908577|FG007|Induction|Withdrawal by Subject|0|||
154858478|NCT00408005|558908570|FG000|Induction|Ineligible|33|||
154858479|NCT00408005|558908571|FG001|Induction|Ineligible|14|||
154858480|NCT00408005|558908572|FG002|Induction|Ineligible|0|||
154858481|NCT00408005|558908573|FG003|Induction|Ineligible|0|||
154858482|NCT00408005|558908574|FG004|Induction|Ineligible|0|||
154858483|NCT00408005|558908575|FG005|Induction|Ineligible|0|||
154858484|NCT00408005|558908576|FG006|Induction|Ineligible|0|||
154858485|NCT00408005|558908577|FG007|Induction|Ineligible|0|||
154858486|NCT00408005|558908570|FG000|Induction|Refusal of Further Protocol Therapy|225|||
154858487|NCT00408005|558908571|FG001|Induction|Refusal of Further Protocol Therapy|44|||
154858488|NCT00408005|558908572|FG002|Induction|Refusal of Further Protocol Therapy|0|||
154858489|NCT00408005|558908573|FG003|Induction|Refusal of Further Protocol Therapy|0|||
154858490|NCT00408005|558908574|FG004|Induction|Refusal of Further Protocol Therapy|0|||
154858491|NCT00408005|558908575|FG005|Induction|Refusal of Further Protocol Therapy|0|||
154858492|NCT00408005|558908576|FG006|Induction|Refusal of Further Protocol Therapy|0|||
154858493|NCT00408005|558908577|FG007|Induction|Refusal of Further Protocol Therapy|0|||
154858494|NCT00408005|558908570|FG000|Induction|Entered another COG therapeutic protocol|4|||
154858495|NCT00408005|558908571|FG001|Induction|Entered another COG therapeutic protocol|0|||
154858496|NCT00408005|558908572|FG002|Induction|Entered another COG therapeutic protocol|0|||
154858497|NCT00408005|558908573|FG003|Induction|Entered another COG therapeutic protocol|0|||
154858498|NCT00408005|558908574|FG004|Induction|Entered another COG therapeutic protocol|0|||
154858499|NCT00408005|558908575|FG005|Induction|Entered another COG therapeutic protocol|0|||
154858500|NCT00408005|558908576|FG006|Induction|Entered another COG therapeutic protocol|0|||
154858501|NCT00408005|558908577|FG007|Induction|Entered another COG therapeutic protocol|0|||
154858502|NCT00408005|558908570|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
154972281|NCT02416934|559322360|FG001|Overall Study|Lost to Follow-up|2|||
155106619|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
155106620|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
155106621|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
155106622|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
155106623|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
155106624|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
155106625|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
155106626|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
154858503|NCT00408005|558908571|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
154858504|NCT00408005|558908572|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
154858505|NCT00408005|558908573|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
154858506|NCT00408005|558908574|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
154858507|NCT00408005|558908575|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
154858508|NCT00408005|558908576|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
154858509|NCT00408005|558908577|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
154858510|NCT00408005|558908570|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
154858511|NCT00408005|558908571|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
154858512|NCT00408005|558908572|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
154858513|NCT00408005|558908573|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
154858514|NCT00408005|558908574|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
154858515|NCT00408005|558908575|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
154858516|NCT00408005|558908576|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
154858517|NCT00408005|558908577|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
154858518|NCT00408005|558908570|FG000|Induction|Progressive Disease|0|||
154858519|NCT00408005|558908571|FG001|Induction|Progressive Disease|1|||
154858520|NCT00408005|558908572|FG002|Induction|Progressive Disease|0|||
154858521|NCT00408005|558908573|FG003|Induction|Progressive Disease|0|||
154858522|NCT00408005|558908574|FG004|Induction|Progressive Disease|0|||
154858523|NCT00408005|558908575|FG005|Induction|Progressive Disease|0|||
154858524|NCT00408005|558908576|FG006|Induction|Progressive Disease|0|||
154858525|NCT00408005|558908577|FG007|Induction|Progressive Disease|0|||
154858526|NCT00408005|558908570|FG000|Induction|Inevaluable|18|||
154858527|NCT00408005|558908571|FG001|Induction|Inevaluable|14|||
154858528|NCT00408005|558908572|FG002|Induction|Inevaluable|0|||
154858529|NCT00408005|558908573|FG003|Induction|Inevaluable|0|||
154858530|NCT00408005|558908574|FG004|Induction|Inevaluable|0|||
154858531|NCT00408005|558908575|FG005|Induction|Inevaluable|0|||
154858532|NCT00408005|558908576|FG006|Induction|Inevaluable|0|||
154858533|NCT00408005|558908577|FG007|Induction|Inevaluable|0|||
154858534|NCT00408005|558908570|FG000|Induction|Failed to Complete Randomization|3|||
154858535|NCT00408005|558908571|FG001|Induction|Failed to Complete Randomization|2|||
154858536|NCT00408005|558908572|FG002|Induction|Failed to Complete Randomization|0|||
154858537|NCT00408005|558908573|FG003|Induction|Failed to Complete Randomization|0|||
154858538|NCT00408005|558908574|FG004|Induction|Failed to Complete Randomization|0|||
154858539|NCT00408005|558908575|FG005|Induction|Failed to Complete Randomization|0|||
154858540|NCT00408005|558908576|FG006|Induction|Failed to Complete Randomization|0|||
154858541|NCT00408005|558908577|FG007|Induction|Failed to Complete Randomization|0|||
154858542|NCT00408005|558908570|FG000|Induction|Protocol Deviation|3|||
154858543|NCT00408005|558908571|FG001|Induction|Protocol Deviation|1|||
154858544|NCT00408005|558908572|FG002|Induction|Protocol Deviation|0|||
154858545|NCT00408005|558908573|FG003|Induction|Protocol Deviation|0|||
154858546|NCT00408005|558908574|FG004|Induction|Protocol Deviation|0|||
154858547|NCT00408005|558908575|FG005|Induction|Protocol Deviation|0|||
154858548|NCT00408005|558908576|FG006|Induction|Protocol Deviation|0|||
154858549|NCT00408005|558908577|FG007|Induction|Protocol Deviation|0|||
154858550|NCT00408005|558908570|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
154858551|NCT00408005|558908571|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
154858552|NCT00408005|558908572|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
154858553|NCT00408005|558908573|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
154972282|NCT02416934|559322359|FG000|Overall Study|Withdrawal by Subject|1|||
154972283|NCT02416934|559322360|FG001|Overall Study|Withdrawal by Subject|0|||
154972284|NCT02416934|559322359|FG000|Overall Study|recruited during continuing renewal proc|0|||
154972285|NCT02416934|559322360|FG001|Overall Study|recruited during continuing renewal proc|1|||
154972286|NCT02416934|559322359|FG000|Overall Study|Protocol Violation|0|||
154858554|NCT00408005|558908574|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
154858555|NCT00408005|558908575|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
154858556|NCT00408005|558908576|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
154858557|NCT00408005|558908577|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
154858558|NCT00408005|558908570|FG000|Induction|Recurrent leukemia|1|||
154858559|NCT00408005|558908571|FG001|Induction|Recurrent leukemia|0|||
154858560|NCT00408005|558908572|FG002|Induction|Recurrent leukemia|0|||
154972287|NCT02416934|559322360|FG001|Overall Study|Protocol Violation|1|||
154972288|NCT02416934|559322359|FG000|Overall Study|surgery started late|0|||
154858561|NCT00408005|558908573|FG003|Induction|Recurrent leukemia|0|||
154858562|NCT00408005|558908574|FG004|Induction|Recurrent leukemia|0|||
154858563|NCT00408005|558908575|FG005|Induction|Recurrent leukemia|0|||
154858564|NCT00408005|558908576|FG006|Induction|Recurrent leukemia|0|||
154858565|NCT00408005|558908577|FG007|Induction|Recurrent leukemia|0|||
154858566|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
154858567|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
154858568|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
154858569|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
154858570|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
154858571|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
154858572|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
154858573|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
154858574|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
154858575|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
154858576|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
154858577|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
154858578|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
154858579|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
154858580|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
154858581|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
154858582|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
154858583|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
154858584|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
154858585|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
154858586|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
154858587|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
154858588|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
154858589|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
154858590|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
154858591|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
154858592|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
154858593|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
154858594|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
154858595|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
154858596|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
154858597|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
154858598|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
154858599|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
154858600|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
154858601|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
154858602|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
154858603|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
154858604|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
154858605|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
154858606|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
154858607|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
154858608|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
154858609|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
154858610|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
154858611|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
154858612|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
154858613|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
154858614|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858615|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858616|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858617|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858618|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
154858619|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858620|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858621|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
154858622|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
155106627|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
155106628|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
155106629|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
155106630|NCT03308968|559819010|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
154858623|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
154858624|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
154858625|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
154858626|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
154858627|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
154858628|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
154858629|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
154858630|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
154858631|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
154858632|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
154858633|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
154858634|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
154858635|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
154858636|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
154858637|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
154858638|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858639|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858640|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858641|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858642|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858643|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
154858644|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858645|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
154858646|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
154858647|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
154858648|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
154858649|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
154858650|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
154858651|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
154858652|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
154858653|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
154858654|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
154858655|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
154858656|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
154858657|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
154858658|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
154858659|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
154858660|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
154858661|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
154858662|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
154858663|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
154858664|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
154858665|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
154858666|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
154858667|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
154858668|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
154858669|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
154858670|NCT00408005|558908570|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
154858671|NCT00408005|558908571|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
154858672|NCT00408005|558908572|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
154858673|NCT00408005|558908573|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
154858674|NCT00408005|558908574|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
155106631|NCT03308968|559819011|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
155106632|NCT03308968|559819012|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
155106633|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
155106634|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
154858675|NCT00408005|558908575|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
154858676|NCT00408005|558908576|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
154858677|NCT00408005|558908577|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
154858678|NCT05424276|558908578|FG000|Overall Study|Adverse Event|1|||
154858679|NCT05424276|558908579|FG001|Overall Study|Adverse Event|0|||
154858680|NCT05424276|558908580|FG002|Overall Study|Adverse Event|0|||
154858681|NCT05424276|558908581|FG003|Overall Study|Adverse Event|2|||
154858682|NCT05424276|558908578|FG000|Overall Study|Withdrawal by Subject|0|||
154858683|NCT05424276|558908579|FG001|Overall Study|Withdrawal by Subject|0|||
154858684|NCT05424276|558908580|FG002|Overall Study|Withdrawal by Subject|2|||
154858685|NCT05424276|558908581|FG003|Overall Study|Withdrawal by Subject|0|||
154858686|NCT05424276|558908578|FG000|Overall Study|Protocol Violation|0|||
154858687|NCT05424276|558908579|FG001|Overall Study|Protocol Violation|1|||
154858688|NCT05424276|558908580|FG002|Overall Study|Protocol Violation|0|||
154858689|NCT05424276|558908581|FG003|Overall Study|Protocol Violation|0|||
154858690|NCT05424276|558908578|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
154858691|NCT05424276|558908579|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
154858692|NCT05424276|558908580|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
154858693|NCT05424276|558908581|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
154858694|NCT04454489|558908583|FG000|Overall Study|Disease progression|12|||
154858695|NCT04454489|558908583|FG000|Overall Study|Death|4|||
154858696|NCT04454489|558908583|FG000|Overall Study|Adverse Event|1|||
154858697|NCT04454489|558908583|FG000|Overall Study|Physician Decision|1|||
154858698|NCT00501228|558908584|FG000|Overall Study|Withdrawal by Subject|1|||
154858699|NCT01147926|558908585|FG000|Overall Study|Subject Withdrew Consent|9|||
154858700|NCT01147926|558908586|FG001|Overall Study|Subject Withdrew Consent|10|||
154858701|NCT01147926|558908585|FG000|Overall Study|Adverse Event|7|||
154858702|NCT01147926|558908586|FG001|Overall Study|Adverse Event|6|||
154858703|NCT01147926|558908585|FG000|Overall Study|Subject Non-Compliant|5|||
154858704|NCT01147926|558908586|FG001|Overall Study|Subject Non-Compliant|4|||
154858705|NCT01147926|558908585|FG000|Overall Study|Principal investigator left hospital|1|||
154858706|NCT01147926|558908586|FG001|Overall Study|Principal investigator left hospital|3|||
154858707|NCT01147926|558908585|FG000|Overall Study|Selection criteria not met|3|||
154858708|NCT01147926|558908586|FG001|Overall Study|Selection criteria not met|1|||
154858709|NCT01147926|558908585|FG000|Overall Study|Lost to Follow-up|0|||
154858710|NCT01147926|558908586|FG001|Overall Study|Lost to Follow-up|2|||
154858711|NCT01147926|558908585|FG000|Overall Study|Sponsor's Decision|0|||
154858712|NCT01147926|558908586|FG001|Overall Study|Sponsor's Decision|1|||
154858713|NCT01147926|558908585|FG000|Overall Study|Lack of Efficacy|1|||
154858714|NCT01147926|558908586|FG001|Overall Study|Lack of Efficacy|0|||
154858715|NCT01147926|558908585|FG000|Overall Study|Too busy, no time for study|1|||
154858716|NCT01147926|558908586|FG001|Overall Study|Too busy, no time for study|0|||
155106635|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
154858717|NCT01147926|558908585|FG000|Overall Study|Went on holiday|0|||
154858718|NCT01147926|558908586|FG001|Overall Study|Went on holiday|1|||
154858719|NCT01147926|558908585|FG000|Overall Study|Colonoscopy result|0|||
154858720|NCT01147926|558908586|FG001|Overall Study|Colonoscopy result|1|||
154858721|NCT03514914|558908587|FG000|Overall Study|Death|3|||
154858722|NCT03514914|558908588|FG001|Overall Study|Death|3|||
154858723|NCT03514914|558908587|FG000|Overall Study|Lost to Follow-up|117|||
154858724|NCT03514914|558908588|FG001|Overall Study|Lost to Follow-up|89|||
154858725|NCT03926143|558908589|FG000|Overall Study|Physician Decision|3|||
154858726|NCT03926143|558908589|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
154858727|NCT03926143|558908589|FG000|Overall Study|Adverse Event|2|||
154858728|NCT03926143|558908589|FG000|Overall Study|Progressive disease|3|||
154858729|NCT00473876|558908595|FG000|Overall Study|Lost to Follow-up|3|||
154858730|NCT00473876|558908596|FG001|Overall Study|Lost to Follow-up|1|||
154858731|NCT01276288|558908597|FG000|Overall Study|Adverse Event|1|||
155106636|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
154858732|NCT01276288|558908598|FG001|Overall Study|Adverse Event|1|||
154858733|NCT01276288|558908599|FG002|Overall Study|Adverse Event|0|||
154858734|NCT01276288|558908600|FG003|Overall Study|Adverse Event|0|||
154858735|NCT01276288|558908597|FG000|Overall Study|not treated|1|||
155106637|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
154858736|NCT01276288|558908598|FG001|Overall Study|not treated|0|||
154858737|NCT01276288|558908599|FG002|Overall Study|not treated|0|||
154858738|NCT01276288|558908600|FG003|Overall Study|not treated|0|||
154858739|NCT03401749|558908601|FG000|Overall Study|Lost to Follow-up|20|||
154858740|NCT03401749|558908602|FG001|Overall Study|Lost to Follow-up|16|||
154858741|NCT03401749|558908603|FG002|Overall Study|Lost to Follow-up|26|||
154858742|NCT03406962|558908604|FG000|Overall Study|Death|2|||
154858743|NCT03406962|558908604|FG000|Overall Study|Adverse Event|1|||
154858744|NCT03853694|558908605|FG000|Overall Study|Protocol Violation|3|||
154858745|NCT03853694|558908606|FG001|Overall Study|Protocol Violation|5|||
154858746|NCT03853694|558908607|FG002|Overall Study|Protocol Violation|3|||
154858747|NCT03853694|558908605|FG000|Overall Study|Delivered early|0|||
154858748|NCT03853694|558908606|FG001|Overall Study|Delivered early|1|||
154858749|NCT03853694|558908607|FG002|Overall Study|Delivered early|0|||
154858750|NCT03853694|558908605|FG000|Overall Study|not suitable to proceed|0|||
154858751|NCT03853694|558908606|FG001|Overall Study|not suitable to proceed|1|||
154858752|NCT03853694|558908607|FG002|Overall Study|not suitable to proceed|0|||
154858753|NCT03853694|558908605|FG000|Overall Study|difficult surgery|0|||
154858754|NCT03853694|558908606|FG001|Overall Study|difficult surgery|0|||
154858755|NCT03853694|558908607|FG002|Overall Study|difficult surgery|1|||
154858756|NCT03853694|558908605|FG000|Overall Study|Lost to Follow-up|0|||
154858757|NCT03853694|558908606|FG001|Overall Study|Lost to Follow-up|1|||
154858758|NCT03853694|558908607|FG002|Overall Study|Lost to Follow-up|0|||
154858759|NCT03853694|558908605|FG000|Overall Study|Withdrawal by Subject|0|||
154858760|NCT03853694|558908606|FG001|Overall Study|Withdrawal by Subject|1|||
154858761|NCT03853694|558908607|FG002|Overall Study|Withdrawal by Subject|0|||
154858762|NCT01818297|558908608|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
154858763|NCT01818297|558908609|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
154858764|NCT01818297|558908608|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
154858765|NCT01818297|558908609|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
154858766|NCT01818297|558908608|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
154858767|NCT01818297|558908609|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
154858768|NCT03896295|558908610|FG000|Overall Study|Adverse Event|0|||
154858769|NCT03896295|558908611|FG001|Overall Study|Adverse Event|1|||
154858770|NCT03896295|558908610|FG000|Overall Study|COVID-19|7|||
154858771|NCT03896295|558908611|FG001|Overall Study|COVID-19|29|||
154858772|NCT03029832|558908612|FG000|Overall Study|Safety Follow-Up Completed|2|||
154858773|NCT03029832|558908613|FG001|Overall Study|Safety Follow-Up Completed|0|||
154858774|NCT03029832|558908612|FG000|Overall Study|Death due to Disease Progression|1|||
154858775|NCT03029832|558908613|FG001|Overall Study|Death due to Disease Progression|0|||
154858776|NCT03029832|558908612|FG000|Overall Study|Study Terminated By Sponsor|1|||
154858777|NCT03029832|558908613|FG001|Overall Study|Study Terminated By Sponsor|1|||
154858778|NCT01412229|558908614|FG000|Overall Study|Physician Decision|1|||
154858779|NCT00700804|558908616|FG000|Overall Study|Withdrawal by Subject|1|||
154858780|NCT00700804|558908617|FG001|Overall Study|Withdrawal by Subject|2|||
154858781|NCT00700804|558908616|FG000|Overall Study|Protocol Violation|1|||
154858782|NCT00700804|558908617|FG001|Overall Study|Protocol Violation|1|||
154858783|NCT00700804|558908616|FG000|Overall Study|Loose Stools|1|||
154858784|NCT00700804|558908617|FG001|Overall Study|Loose Stools|1|||
154858785|NCT04223609|558908618|FG000|Overall Study|Adverse Event|0|||
154858786|NCT04223609|558908619|FG001|Overall Study|Adverse Event|1|||
154858787|NCT04223609|558908618|FG000|Overall Study|Missed last visit|0|||
154858788|NCT04223609|558908619|FG001|Overall Study|Missed last visit|1|||
154858789|NCT03832387|558908622|FG000|Overall Study|Protocol Violation|2|||
154858790|NCT03832387|558908623|FG001|Overall Study|Protocol Violation|6|||
154858791|NCT03832387|558908622|FG000|Overall Study|EXCLUSION CRITERIA|3|||
154858792|NCT03832387|558908623|FG001|Overall Study|EXCLUSION CRITERIA|1|||
154858793|NCT05775289|558908624|FG000|Overall Study|Study Ongoing|20|||
154858794|NCT05775289|558908625|FG001|Overall Study|Study Ongoing|53|||
154858795|NCT05775289|558908626|FG002|Overall Study|Study Ongoing|15|||
154858796|NCT05775289|558908627|FG003|Overall Study|Study Ongoing|55|||
154858797|NCT05775289|558908624|FG000|Overall Study|Death|4|||
154858798|NCT05775289|558908625|FG001|Overall Study|Death|11|||
154858799|NCT05775289|558908626|FG002|Overall Study|Death|8|||
154858800|NCT05775289|558908627|FG003|Overall Study|Death|12|||
154858801|NCT05775289|558908624|FG000|Overall Study|Lost to Follow-up|0|||
154858802|NCT05775289|558908625|FG001|Overall Study|Lost to Follow-up|1|||
154858803|NCT05775289|558908626|FG002|Overall Study|Lost to Follow-up|0|||
154858804|NCT05775289|558908627|FG003|Overall Study|Lost to Follow-up|0|||
154858805|NCT05775289|558908624|FG000|Overall Study|Progressive Disease|0|||
154858806|NCT05775289|558908625|FG001|Overall Study|Progressive Disease|0|||
154858807|NCT05775289|558908626|FG002|Overall Study|Progressive Disease|1|||
154858808|NCT05775289|558908627|FG003|Overall Study|Progressive Disease|0|||
154858809|NCT05775289|558908624|FG000|Overall Study|Withdrawal by Subject|1|||
154858810|NCT05775289|558908625|FG001|Overall Study|Withdrawal by Subject|1|||
154858811|NCT05775289|558908626|FG002|Overall Study|Withdrawal by Subject|0|||
154858812|NCT05775289|558908627|FG003|Overall Study|Withdrawal by Subject|0|||
154972289|NCT02416934|559322360|FG001|Overall Study|surgery started late|1|||
154858813|NCT00490542|558908629|FG000|Overall Study|Lost to Follow-up|3|||
154858814|NCT00490542|558908630|FG001|Overall Study|Lost to Follow-up|0|||
154858815|NCT00490542|558908629|FG000|Overall Study|Adverse Event|3|||
154858816|NCT00490542|558908630|FG001|Overall Study|Adverse Event|3|||
154858817|NCT00490542|558908629|FG000|Overall Study|Lack of Efficacy|1|||
154858818|NCT00490542|558908630|FG001|Overall Study|Lack of Efficacy|1|||
154858819|NCT02848833|558908633|FG000|Overall Study|subject who are duplicated|1|||
154858820|NCT02848833|558908633|FG000|Overall Study|have not taken the study drug|11|||
154858821|NCT02848833|558908633|FG000|Overall Study|follow-up failure|6|||
154858822|NCT02848833|558908633|FG000|Overall Study|Protocol Violation|119|||
154858823|NCT02847598|558908634|FG000|Overall Study|Adverse Event|0|||
154858824|NCT02847598|558908635|FG001|Overall Study|Adverse Event|0|||
154858825|NCT02847598|558908636|FG002|Overall Study|Adverse Event|0|||
154858826|NCT02847598|558908637|FG003|Overall Study|Adverse Event|0|||
154858827|NCT02847598|558908638|FG004|Overall Study|Adverse Event|0|||
154858828|NCT02847598|558908639|FG005|Overall Study|Adverse Event|0|||
154858829|NCT02847598|558908640|FG006|Overall Study|Adverse Event|0|||
154858830|NCT02847598|558908641|FG007|Overall Study|Adverse Event|1|||
154858831|NCT02847598|558908634|FG000|Overall Study|Consent withdrawn|2|||
154858832|NCT02847598|558908635|FG001|Overall Study|Consent withdrawn|0|||
154858833|NCT02847598|558908636|FG002|Overall Study|Consent withdrawn|0|||
154858834|NCT02847598|558908637|FG003|Overall Study|Consent withdrawn|4|||
154858835|NCT02847598|558908638|FG004|Overall Study|Consent withdrawn|3|||
154858836|NCT02847598|558908639|FG005|Overall Study|Consent withdrawn|2|||
154858837|NCT02847598|558908640|FG006|Overall Study|Consent withdrawn|1|||
154858838|NCT02847598|558908641|FG007|Overall Study|Consent withdrawn|3|||
154858839|NCT02847598|558908634|FG000|Overall Study|Death|3|||
154858840|NCT02847598|558908635|FG001|Overall Study|Death|0|||
154858841|NCT02847598|558908636|FG002|Overall Study|Death|0|||
154858842|NCT02847598|558908637|FG003|Overall Study|Death|0|||
154858843|NCT02847598|558908638|FG004|Overall Study|Death|0|||
154858844|NCT02847598|558908639|FG005|Overall Study|Death|0|||
154858845|NCT02847598|558908640|FG006|Overall Study|Death|0|||
154858846|NCT02847598|558908641|FG007|Overall Study|Death|0|||
154858847|NCT02847598|558908634|FG000|Overall Study|Lost to Follow-up|0|||
154858848|NCT02847598|558908635|FG001|Overall Study|Lost to Follow-up|0|||
154858849|NCT02847598|558908636|FG002|Overall Study|Lost to Follow-up|0|||
154858850|NCT02847598|558908637|FG003|Overall Study|Lost to Follow-up|0|||
154858851|NCT02847598|558908638|FG004|Overall Study|Lost to Follow-up|0|||
154858852|NCT02847598|558908639|FG005|Overall Study|Lost to Follow-up|1|||
154858853|NCT02847598|558908640|FG006|Overall Study|Lost to Follow-up|1|||
154858854|NCT02847598|558908641|FG007|Overall Study|Lost to Follow-up|0|||
154858855|NCT00215150|558910040|FG000|Open Label Phase|Lost to Follow-up|7|||
154858856|NCT00215150|558910040|FG000|Open Label Phase|Withdrawal by Subject|1|||
154858857|NCT00215150|558910040|FG000|Open Label Phase|Did not complete a post base visit|13|||
154858858|NCT00215150|558910040|FG000|Open Label Phase|Did not meet randomization criteria|9|||
154858859|NCT00215150|558910040|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
154858860|NCT00215150|558910040|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
154858861|NCT00215150|558910040|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
154858862|NCT02251743|558910041|FG000|Overall Study|Withdrawal by Subject|1|||
154858863|NCT02251743|558910042|FG001|Overall Study|Withdrawal by Subject|1|||
154858864|NCT00476086|558910046|FG000|Overall Study|Alternative therapy|1|||
154858865|NCT00476086|558910046|FG000|Overall Study|Progressive Disease|4|||
154858866|NCT02900092|558910047|FG000|Overall Study|Adverse Event|1|||
154858867|NCT03895203|558910048|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
154858868|NCT03895203|558910049|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
154858869|NCT03895203|558910050|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
154858870|NCT03895203|558910051|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
154858871|NCT03895203|558910052|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
154858872|NCT03895203|558910053|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
154858873|NCT03895203|558910048|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
154858874|NCT03895203|558910049|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
154858875|NCT03895203|558910050|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
154858876|NCT03895203|558910051|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
154858877|NCT03895203|558910052|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
154858878|NCT03895203|558910053|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
154858879|NCT03895203|558910048|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
154858880|NCT03895203|558910049|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
154858881|NCT03895203|558910050|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
154858882|NCT03895203|558910051|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
154858883|NCT03895203|558910052|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
154858884|NCT03895203|558910053|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
154858885|NCT03895203|558910048|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
154858886|NCT03895203|558910049|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
154858887|NCT03895203|558910050|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
154858888|NCT03895203|558910051|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
154858889|NCT03895203|558910052|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
155106638|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
155106639|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
155106640|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
154858890|NCT03895203|558910053|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
154858891|NCT03895203|558910048|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
154858892|NCT03895203|558910049|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
154858893|NCT03895203|558910050|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
154858894|NCT03895203|558910051|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
154972290|NCT02416934|559322359|FG000|Overall Study|re-operation|1|||
154858895|NCT03895203|558910052|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
154858896|NCT03895203|558910053|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
154858897|NCT03895203|558910048|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
154858898|NCT03895203|558910049|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
154858899|NCT03895203|558910050|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
154858900|NCT03895203|558910051|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
154858901|NCT03895203|558910052|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
154858902|NCT03895203|558910053|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
154858903|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
154858904|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
154858905|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
154858906|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
154858907|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
154858908|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
154858909|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
154858910|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
154858911|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
154858912|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
154858913|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
154858914|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
154858915|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
154858916|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
154858917|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
154858918|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
154858919|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
154858920|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
154858921|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
154858922|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
154858923|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
154858924|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
154858925|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
154858926|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
154858927|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
154858928|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
154858929|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
154858930|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
154858931|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
154858932|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
154858933|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
154858934|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
154858935|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
154858936|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
154858937|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
154858938|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
154858939|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
154858940|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
154858941|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
154858942|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
154858943|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
154858944|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
154858945|NCT03895203|558910048|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
154858946|NCT03895203|558910049|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
154858947|NCT03895203|558910050|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
154858948|NCT03895203|558910051|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
154858949|NCT03895203|558910052|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
154858950|NCT03895203|558910053|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
154858951|NCT01389245|558910054|FG000|Overall Study|Protocol Violation|10|||
154858952|NCT01389245|558910054|FG000|Overall Study|Lost to Follow-up|3|||
154858953|NCT01389245|558910054|FG000|Overall Study|Withdrawal by Subject|2|||
154858954|NCT02542267|558910060|FG000|Overall Study|Withdrawal by Subject|10|||
154858955|NCT02542267|558910060|FG000|Overall Study|Physician Decision|6|||
154858956|NCT02542267|558910060|FG000|Overall Study|Lost to Follow-up|4|||
154858957|NCT02542267|558910060|FG000|Overall Study|Death|13|||
154858958|NCT02542267|558910060|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
155106641|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
155106642|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
155106643|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
155106644|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
155106645|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
155106646|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
155106647|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
155106648|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
155106649|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
155106650|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
155106651|NCT03308968|559819010|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
155106652|NCT03308968|559819011|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
155106653|NCT03308968|559819012|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
155106654|NCT01521923|559819016|FG000|Overall Study|AE, serious fatal|1|||
155106655|NCT01521923|559819017|FG001|Overall Study|AE, serious fatal|0|||
155106656|NCT01521923|559819018|FG002|Overall Study|AE, serious fatal|0|||
155106657|NCT01521923|559819019|FG003|Overall Study|AE, serious fatal|0|||
155106658|NCT01521923|559819016|FG000|Overall Study|SAE, non-fatal|0|||
155106659|NCT01521923|559819017|FG001|Overall Study|SAE, non-fatal|2|||
155106660|NCT01521923|559819018|FG002|Overall Study|SAE, non-fatal|2|||
155106661|NCT01521923|559819019|FG003|Overall Study|SAE, non-fatal|0|||
155106662|NCT01521923|559819016|FG000|Overall Study|AE, non-serious, non-fatal|1|||
155106663|NCT01521923|559819017|FG001|Overall Study|AE, non-serious, non-fatal|3|||
155106664|NCT01521923|559819018|FG002|Overall Study|AE, non-serious, non-fatal|6|||
155106665|NCT01521923|559819019|FG003|Overall Study|AE, non-serious, non-fatal|2|||
155106666|NCT01521923|559819016|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
155106667|NCT01521923|559819017|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
155106668|NCT01521923|559819018|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
155106669|NCT01521923|559819019|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
155106670|NCT01521923|559819016|FG000|Overall Study|Lack of Efficacy|1|||
155106671|NCT01521923|559819017|FG001|Overall Study|Lack of Efficacy|1|||
155106672|NCT01521923|559819018|FG002|Overall Study|Lack of Efficacy|0|||
155106673|NCT01521923|559819019|FG003|Overall Study|Lack of Efficacy|0|||
155106674|NCT01521923|559819016|FG000|Overall Study|Protocol Violation|0|||
155106675|NCT01521923|559819017|FG001|Overall Study|Protocol Violation|0|||
155106676|NCT01521923|559819018|FG002|Overall Study|Protocol Violation|1|||
155106677|NCT01521923|559819019|FG003|Overall Study|Protocol Violation|0|||
155106678|NCT01521923|559819016|FG000|Overall Study|Lost to Follow-up|1|||
155106679|NCT01521923|559819017|FG001|Overall Study|Lost to Follow-up|0|||
155106680|NCT01521923|559819018|FG002|Overall Study|Lost to Follow-up|2|||
155106681|NCT01521923|559819019|FG003|Overall Study|Lost to Follow-up|1|||
154858959|NCT02542267|558910060|FG000|Overall Study|Other|9|||
154858960|NCT00442598|558910061|FG000|Overall Study|Adverse Event|1|||
154858961|NCT00442598|558910062|FG001|Overall Study|Adverse Event|0|||
154858962|NCT00442598|558910063|FG002|Overall Study|Adverse Event|0|||
154858963|NCT00442598|558910061|FG000|Overall Study|Tumor progression|3|||
154858964|NCT00442598|558910062|FG001|Overall Study|Tumor progression|4|||
154858965|NCT00442598|558910063|FG002|Overall Study|Tumor progression|0|||
154858966|NCT00442598|558910061|FG000|Overall Study|Clinical deterioration|1|||
154858967|NCT00442598|558910062|FG001|Overall Study|Clinical deterioration|2|||
154858968|NCT00442598|558910063|FG002|Overall Study|Clinical deterioration|0|||
154858969|NCT00442598|558910061|FG000|Overall Study|CA125 progression|0|||
154858970|NCT00442598|558910062|FG001|Overall Study|CA125 progression|1|||
154858971|NCT00442598|558910063|FG002|Overall Study|CA125 progression|0|||
154858972|NCT00442598|558910061|FG000|Overall Study|Reduced creatinine clearance|1|||
154858973|NCT00442598|558910062|FG001|Overall Study|Reduced creatinine clearance|0|||
154858974|NCT00442598|558910063|FG002|Overall Study|Reduced creatinine clearance|0|||
154858975|NCT00442598|558910061|FG000|Overall Study|Death|0|||
154858976|NCT00442598|558910062|FG001|Overall Study|Death|1|||
154858977|NCT00442598|558910063|FG002|Overall Study|Death|0|||
154858978|NCT03093402|558910064|FG000|Overall Study|Lost to Follow-up|1|||
154858979|NCT03093402|558910065|FG001|Overall Study|Lost to Follow-up|0|||
155106682|NCT01521923|559819016|FG000|Overall Study|Withdrawal by Subject|1|||
154858980|NCT03093402|558910066|FG002|Overall Study|Lost to Follow-up|0|||
154858981|NCT03093402|558910067|FG003|Overall Study|Lost to Follow-up|0|||
154858982|NCT03093402|558910064|FG000|Overall Study|Withdrawal by Subject|3|||
154858983|NCT03093402|558910065|FG001|Overall Study|Withdrawal by Subject|3|||
154858984|NCT03093402|558910066|FG002|Overall Study|Withdrawal by Subject|0|||
155106683|NCT01521923|559819017|FG001|Overall Study|Withdrawal by Subject|1|||
155106684|NCT01521923|559819018|FG002|Overall Study|Withdrawal by Subject|1|||
155106685|NCT01521923|559819019|FG003|Overall Study|Withdrawal by Subject|2|||
155106686|NCT01521923|559819016|FG000|Overall Study|Other|2|||
155106687|NCT01521923|559819017|FG001|Overall Study|Other|1|||
155106688|NCT01521923|559819018|FG002|Overall Study|Other|3|||
154858985|NCT03093402|558910067|FG003|Overall Study|Withdrawal by Subject|1|||
154972291|NCT02416934|559322360|FG001|Overall Study|re-operation|0|||
155106689|NCT01521923|559819019|FG003|Overall Study|Other|6|||
155106690|NCT01521923|559819016|FG000|Overall Study|AE, captured in Period 1|0|||
155106691|NCT01521923|559819017|FG001|Overall Study|AE, captured in Period 1|1|||
155106692|NCT01521923|559819018|FG002|Overall Study|AE, captured in Period 1|0|||
155106693|NCT01521923|559819019|FG003|Overall Study|AE, captured in Period 1|1|||
155106694|NCT03037476|559819020|FG000|Overall Study|Lost to Follow-up|63|||
155106695|NCT03037476|559819021|FG001|Overall Study|Lost to Follow-up|46|||
155106696|NCT04908384|559819027|FG000|Overall Study|Lost to Follow-up|4|||
155106697|NCT04908384|559819028|FG001|Overall Study|Lost to Follow-up|4|||
155106698|NCT04908384|559819029|FG002|Overall Study|Lost to Follow-up|0|||
155106699|NCT04908384|559819030|FG003|Overall Study|Lost to Follow-up|0|||
155106700|NCT00833469|559819031|FG000|Overall Study|Withdrawal by Subject|1|||
155106701|NCT00833469|559819031|FG000|Overall Study|Lost to Follow-up|1|||
155106702|NCT01208324|559819032|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
155106703|NCT01208324|559819033|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
155106704|NCT01208324|559819034|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
155106705|NCT01208324|559819035|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
155106706|NCT02943070|559819036|FG000|Overall Study|Physician Decision|1|||
155106707|NCT02943070|559819036|FG000|Overall Study|Adverse Event|2|||
155106708|NCT02943070|559819036|FG000|Overall Study|Death|2|||
155106709|NCT02943070|559819036|FG000|Overall Study|Withdrawal by Subject|3|||
155106710|NCT02943070|559819036|FG000|Overall Study|Lost to Follow-up|4|||
155106711|NCT02943070|559819036|FG000|Overall Study|Retreatment or TURP|13|||
155106712|NCT02943070|559819036|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
155106713|NCT01701362|559819037|FG000|Overall Study|Adverse events not related to study drug|1|||
155106714|NCT01701362|559819038|FG001|Overall Study|Adverse events not related to study drug|6|||
155106715|NCT01701362|559819037|FG000|Overall Study|Adverse events related to study drug|12|||
155106716|NCT01701362|559819038|FG001|Overall Study|Adverse events related to study drug|10|||
155106717|NCT01701362|559819037|FG000|Overall Study|Protocol Violation|5|||
155106718|NCT01701362|559819038|FG001|Overall Study|Protocol Violation|3|||
155106719|NCT01701362|559819037|FG000|Overall Study|No longer willing to participate|8|||
155106720|NCT01701362|559819038|FG001|Overall Study|No longer willing to participate|14|||
155106721|NCT01701362|559819037|FG000|Overall Study|Lost to Follow-up|6|||
155106722|NCT01701362|559819038|FG001|Overall Study|Lost to Follow-up|9|||
155106723|NCT01701362|559819037|FG000|Overall Study|Insufficient clinical response|6|||
154858986|NCT03093402|558910064|FG000|Overall Study|Withdrew prior to dosing|2|||
154858987|NCT03093402|558910065|FG001|Overall Study|Withdrew prior to dosing|1|||
154858988|NCT03093402|558910066|FG002|Overall Study|Withdrew prior to dosing|2|||
154858989|NCT03093402|558910067|FG003|Overall Study|Withdrew prior to dosing|3|||
154858990|NCT03093402|558910064|FG000|Overall Study|Ineligible for study|1|||
154858991|NCT03093402|558910065|FG001|Overall Study|Ineligible for study|0|||
154858992|NCT03093402|558910066|FG002|Overall Study|Ineligible for study|0|||
154858993|NCT03093402|558910067|FG003|Overall Study|Ineligible for study|0|||
154858994|NCT03093402|558910064|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
154858995|NCT03093402|558910065|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
154858996|NCT03093402|558910066|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
154858997|NCT03093402|558910067|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
154858998|NCT02886702|558910070|FG000|Overall Study|Other|4|||
154858999|NCT02886702|558910071|FG001|Overall Study|Other|3|||
154859000|NCT02886702|558910072|FG002|Overall Study|Other|9|||
154859001|NCT02886702|558910070|FG000|Overall Study|Withdrawal by Subject|24|||
154859002|NCT02886702|558910071|FG001|Overall Study|Withdrawal by Subject|18|||
154859003|NCT02886702|558910072|FG002|Overall Study|Withdrawal by Subject|22|||
154859004|NCT02886702|558910070|FG000|Overall Study|Significant Worsening of Condition|0|||
154859005|NCT02886702|558910071|FG001|Overall Study|Significant Worsening of Condition|1|||
154859006|NCT02886702|558910072|FG002|Overall Study|Significant Worsening of Condition|0|||
154859007|NCT02886702|558910070|FG000|Overall Study|Protocol Violation|2|||
154859008|NCT02886702|558910071|FG001|Overall Study|Protocol Violation|2|||
154859009|NCT02886702|558910072|FG002|Overall Study|Protocol Violation|1|||
154859010|NCT02886702|558910070|FG000|Overall Study|Non-Compliance With Study Drug|0|||
154859011|NCT02886702|558910071|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155106724|NCT01701362|559819038|FG001|Overall Study|Insufficient clinical response|6|||
155106725|NCT01701362|559819037|FG000|Overall Study|Death|0|||
155106726|NCT01701362|559819038|FG001|Overall Study|Death|1|||
154859012|NCT02886702|558910072|FG002|Overall Study|Non-Compliance With Study Drug|4|||
154859013|NCT02886702|558910070|FG000|Overall Study|Lost to Follow-up|11|||
155106727|NCT01701362|559819037|FG000|Overall Study|Randomized but not treated|1|||
155106728|NCT01701362|559819038|FG001|Overall Study|Randomized but not treated|2|||
154859014|NCT02886702|558910071|FG001|Overall Study|Lost to Follow-up|13|||
154859015|NCT02886702|558910072|FG002|Overall Study|Lost to Follow-up|8|||
154859016|NCT02886702|558910070|FG000|Overall Study|Lack of Efficacy|3|||
155106729|NCT01701362|559819037|FG000|Overall Study|Reasons other than those mentioned above|3|||
155106730|NCT01701362|559819038|FG001|Overall Study|Reasons other than those mentioned above|5|||
154859017|NCT02886702|558910071|FG001|Overall Study|Lack of Efficacy|4|||
155106731|NCT00570778|559819039|FG000|Overall Study|Protocol deviation|2|||
154859018|NCT02886702|558910072|FG002|Overall Study|Lack of Efficacy|5|||
154859019|NCT02886702|558910070|FG000|Overall Study|Adverse Event|4|||
154859020|NCT02886702|558910071|FG001|Overall Study|Adverse Event|9|||
154859021|NCT02886702|558910072|FG002|Overall Study|Adverse Event|3|||
154859022|NCT02886702|558910070|FG000|Overall Study|Administrative Reasons|0|||
154859023|NCT02886702|558910071|FG001|Overall Study|Administrative Reasons|0|||
154859024|NCT02886702|558910072|FG002|Overall Study|Administrative Reasons|1|||
154859025|NCT01147497|558910080|FG000|Overall Study|failed insertion|2|||
154859026|NCT01147497|558910081|FG001|Overall Study|failed insertion|0|||
154859027|NCT02731742|558910084|FG000|Overall Study|Death|1|||
154859028|NCT02731742|558910085|FG001|Overall Study|Death|2|||
154859029|NCT02731742|558910086|FG002|Overall Study|Death|5|||
154859030|NCT02731742|558910087|FG003|Overall Study|Death|0|||
154859031|NCT02731742|558910084|FG000|Overall Study|Physician Decision|0|||
154859032|NCT02731742|558910085|FG001|Overall Study|Physician Decision|0|||
154859033|NCT02731742|558910086|FG002|Overall Study|Physician Decision|0|||
154859034|NCT02731742|558910087|FG003|Overall Study|Physician Decision|1|||
154859035|NCT02731742|558910084|FG000|Overall Study|Study Terminated by Sponsor|2|||
154859036|NCT02731742|558910085|FG001|Overall Study|Study Terminated by Sponsor|1|||
154859037|NCT02731742|558910086|FG002|Overall Study|Study Terminated by Sponsor|1|||
154859038|NCT02731742|558910087|FG003|Overall Study|Study Terminated by Sponsor|1|||
154859039|NCT02561156|558910097|FG000|Part 2|Adverse Event|0|||
154859040|NCT02561156|558910098|FG001|Part 2|Adverse Event|0|||
154859041|NCT02561156|558910099|FG002|Part 2|Adverse Event|0|||
154859042|NCT02561156|558910100|FG003|Part 2|Adverse Event|0|||
154859043|NCT02561156|558910101|FG004|Part 2|Adverse Event|0|||
154859044|NCT02561156|558910102|FG005|Part 2|Adverse Event|0|||
154859045|NCT02561156|558910103|FG006|Part 2|Adverse Event|0|||
154859046|NCT02561156|558910104|FG007|Part 2|Adverse Event|0|||
154859047|NCT02561156|558910105|FG008|Part 2|Adverse Event|0|||
154859048|NCT02561156|558910106|FG009|Part 2|Adverse Event|0|||
154859049|NCT02561156|558910107|FG010|Part 2|Adverse Event|0|||
154859050|NCT02561156|558910108|FG011|Part 2|Adverse Event|1|||
154859051|NCT02561156|558910109|FG012|Part 2|Adverse Event|0|||
154859052|NCT01071070|558910110|FG000|Overall Study|Adverse Event|0|||
154859053|NCT01071070|558910111|FG001|Overall Study|Adverse Event|3|||
154859054|NCT01071070|558910110|FG000|Overall Study|Withdrawal by Subject|1|||
154859055|NCT01071070|558910111|FG001|Overall Study|Withdrawal by Subject|0|||
154859056|NCT01071070|558910110|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
154859057|NCT01071070|558910111|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
154859058|NCT01071070|558910110|FG000|Overall Study|Hypercalcemia|1|||
154859059|NCT01071070|558910111|FG001|Overall Study|Hypercalcemia|0|||
154859060|NCT02207907|558910115|FG000|Overall Study|Lost to Follow-up|3|||
154859061|NCT02207907|558910116|FG001|Overall Study|Lost to Follow-up|1|||
154859062|NCT02207907|558910115|FG000|Overall Study|Withdrawal by Subject|5|||
154859063|NCT02207907|558910116|FG001|Overall Study|Withdrawal by Subject|6|||
154859064|NCT02207907|558910115|FG000|Overall Study|Did not meet study criteria|3|||
154859065|NCT02207907|558910116|FG001|Overall Study|Did not meet study criteria|0|||
155106732|NCT00570778|559819040|FG001|Overall Study|Protocol deviation|1|||
154859066|NCT02207907|558910115|FG000|Overall Study|Pregnancy|0|||
154859067|NCT02207907|558910116|FG001|Overall Study|Pregnancy|1|||
154859068|NCT03545282|558910121|FG000|Overall Study|Lost to Follow-up|15|||
154859069|NCT03545282|558910122|FG001|Overall Study|Lost to Follow-up|10|||
154859070|NCT03545282|558910121|FG000|Overall Study|Withdrawal by Subject|2|||
154859071|NCT03545282|558910122|FG001|Overall Study|Withdrawal by Subject|2|||
154859072|NCT00755079|558910123|FG000|Overall Study|Lost to Follow-up|1|||
154859073|NCT00755079|558910124|FG001|Overall Study|Lost to Follow-up|3|||
155106733|NCT00570778|559819041|FG002|Overall Study|Protocol deviation|2|||
155106734|NCT00570778|559819042|FG003|Overall Study|Protocol deviation|2|||
154859074|NCT00755079|558910123|FG000|Overall Study|Adverse Event|0|||
154859075|NCT00755079|558910124|FG001|Overall Study|Adverse Event|1|||
154859076|NCT00755079|558910123|FG000|Overall Study|Withdrawal by Subject|0|||
154859077|NCT00755079|558910124|FG001|Overall Study|Withdrawal by Subject|2|||
154859078|NCT02209506|558910125|FG000|Overall Study|Withdrawal by Subject|0|||
154859079|NCT02209506|558910126|FG001|Overall Study|Withdrawal by Subject|0|||
154859080|NCT02209506|558910127|FG002|Overall Study|Withdrawal by Subject|0|||
154859081|NCT02209506|558910128|FG003|Overall Study|Withdrawal by Subject|0|||
154859082|NCT02209506|558910129|FG004|Overall Study|Withdrawal by Subject|1|||
154859083|NCT00629083|558910132|FG000|Overall Study|Adverse Event|0|||
154859084|NCT00629083|558910133|FG001|Overall Study|Adverse Event|2|||
154859085|NCT00629083|558910132|FG000|Overall Study|Lack of Efficacy|3|||
154859086|NCT00629083|558910133|FG001|Overall Study|Lack of Efficacy|1|||
154859087|NCT00629083|558910132|FG000|Overall Study|Withdrawal by Subject|10|||
154859088|NCT00629083|558910133|FG001|Overall Study|Withdrawal by Subject|2|||
154859089|NCT00629083|558910132|FG000|Overall Study|Lost to Follow-up|12|||
154859090|NCT00629083|558910133|FG001|Overall Study|Lost to Follow-up|8|||
154859091|NCT00629083|558910132|FG000|Overall Study|Moved out of country/state|2|||
154859092|NCT00629083|558910133|FG001|Overall Study|Moved out of country/state|1|||
154859093|NCT00629083|558910132|FG000|Overall Study|Refused to return for 12 month visit|1|||
155106735|NCT00570778|559819039|FG000|Overall Study|Adverse Event|0|||
155106736|NCT00570778|559819040|FG001|Overall Study|Adverse Event|1|||
155106737|NCT00570778|559819041|FG002|Overall Study|Adverse Event|4|||
155106738|NCT00570778|559819042|FG003|Overall Study|Adverse Event|1|||
155106739|NCT00570778|559819039|FG000|Overall Study|Subject withdrew consent|0|||
155106740|NCT00570778|559819040|FG001|Overall Study|Subject withdrew consent|1|||
155106741|NCT00570778|559819041|FG002|Overall Study|Subject withdrew consent|0|||
155106742|NCT00570778|559819042|FG003|Overall Study|Subject withdrew consent|1|||
155106743|NCT00570778|559819039|FG000|Overall Study|Abnormal test procedure|1|||
155106744|NCT00570778|559819040|FG001|Overall Study|Abnormal test procedure|0|||
155106745|NCT00570778|559819041|FG002|Overall Study|Abnormal test procedure|0|||
155106746|NCT00570778|559819042|FG003|Overall Study|Abnormal test procedure|0|||
155106747|NCT00570778|559819039|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155106748|NCT00570778|559819040|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155106749|NCT00570778|559819041|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
154859094|NCT00629083|558910133|FG001|Overall Study|Refused to return for 12 month visit|0|||
154859095|NCT00805207|558910134|FG000|Overall Study|Protocol Violation|0|||
154859096|NCT00805207|558910135|FG001|Overall Study|Protocol Violation|0|||
154859097|NCT00805207|558910136|FG002|Overall Study|Protocol Violation|1|||
154859098|NCT00805207|558910137|FG003|Overall Study|Protocol Violation|0|||
154859099|NCT00805207|558910138|FG004|Overall Study|Protocol Violation|0|||
154859100|NCT00805207|558910139|FG005|Overall Study|Protocol Violation|0|||
154859101|NCT00805207|558910140|FG006|Overall Study|Protocol Violation|0|||
154859102|NCT00805207|558910141|FG007|Overall Study|Protocol Violation|0|||
154859103|NCT00805207|558910142|FG008|Overall Study|Protocol Violation|0|||
154859104|NCT00805207|558910134|FG000|Overall Study|Physician Decision|0|||
154859105|NCT00805207|558910135|FG001|Overall Study|Physician Decision|1|||
154859106|NCT00805207|558910136|FG002|Overall Study|Physician Decision|0|||
154859107|NCT00805207|558910137|FG003|Overall Study|Physician Decision|0|||
154859108|NCT00805207|558910138|FG004|Overall Study|Physician Decision|0|||
154859109|NCT00805207|558910139|FG005|Overall Study|Physician Decision|1|||
154859110|NCT00805207|558910140|FG006|Overall Study|Physician Decision|0|||
154859111|NCT00805207|558910141|FG007|Overall Study|Physician Decision|0|||
154859112|NCT00805207|558910142|FG008|Overall Study|Physician Decision|0|||
154859113|NCT00805207|558910134|FG000|Overall Study|Withdrawal by Subject|0|||
154859114|NCT00805207|558910135|FG001|Overall Study|Withdrawal by Subject|1|||
154859115|NCT00805207|558910136|FG002|Overall Study|Withdrawal by Subject|0|||
154859116|NCT00805207|558910137|FG003|Overall Study|Withdrawal by Subject|0|||
154859117|NCT00805207|558910138|FG004|Overall Study|Withdrawal by Subject|1|||
154859118|NCT00805207|558910139|FG005|Overall Study|Withdrawal by Subject|2|||
154859119|NCT00805207|558910140|FG006|Overall Study|Withdrawal by Subject|0|||
154859120|NCT00805207|558910141|FG007|Overall Study|Withdrawal by Subject|0|||
154859121|NCT00805207|558910142|FG008|Overall Study|Withdrawal by Subject|0|||
154859122|NCT00064701|558910143|FG000|One Year Post-transplant|Did not receive study drug|7|||
154859123|NCT00064701|558910144|FG001|One Year Post-transplant|Did not receive study drug|12|||
154859124|NCT00064701|558910145|FG002|One Year Post-transplant|Did not receive study drug|11|||
154859125|NCT00064701|558910143|FG000|One Year Post-transplant|Adverse Event|23|||
154859126|NCT00064701|558910144|FG001|One Year Post-transplant|Adverse Event|19|||
154859127|NCT00064701|558910145|FG002|One Year Post-transplant|Adverse Event|37|||
154859128|NCT00064701|558910143|FG000|One Year Post-transplant|Rejection|0|||
154859129|NCT00064701|558910144|FG001|One Year Post-transplant|Rejection|1|||
154859130|NCT00064701|558910145|FG002|One Year Post-transplant|Rejection|16|||
154859131|NCT00064701|558910143|FG000|One Year Post-transplant|Non-compliance|4|||
154859132|NCT00064701|558910144|FG001|One Year Post-transplant|Non-compliance|2|||
154859133|NCT00064701|558910145|FG002|One Year Post-transplant|Non-compliance|5|||
154859134|NCT00064701|558910143|FG000|One Year Post-transplant|Graft Failure|3|||
154859135|NCT00064701|558910144|FG001|One Year Post-transplant|Graft Failure|2|||
154859136|NCT00064701|558910145|FG002|One Year Post-transplant|Graft Failure|1|||
154859137|NCT00064701|558910143|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
154859138|NCT00064701|558910144|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
154859139|NCT00064701|558910145|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
154859140|NCT00064701|558910143|FG000|One Year Post-transplant|Lost to Follow-up|1|||
154859141|NCT00064701|558910144|FG001|One Year Post-transplant|Lost to Follow-up|0|||
154859142|NCT00064701|558910145|FG002|One Year Post-transplant|Lost to Follow-up|0|||
155106750|NCT00570778|559819042|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
154859143|NCT00064701|558910143|FG000|One Year Post-transplant|Converted to rapamycin|1|||
154859144|NCT00064701|558910144|FG001|One Year Post-transplant|Converted to rapamycin|0|||
154859145|NCT00064701|558910145|FG002|One Year Post-transplant|Converted to rapamycin|0|||
154859146|NCT00064701|558910143|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
154859147|NCT00064701|558910144|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
154859148|NCT00064701|558910145|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
154859149|NCT00064701|558910143|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
155106751|NCT00570778|559819039|FG000|Overall Study|Lost to Follow-up|0|||
155106752|NCT00570778|559819040|FG001|Overall Study|Lost to Follow-up|0|||
155106753|NCT00570778|559819041|FG002|Overall Study|Lost to Follow-up|1|||
155106754|NCT00570778|559819042|FG003|Overall Study|Lost to Follow-up|0|||
154859150|NCT00064701|558910144|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
154859151|NCT00064701|558910145|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
154859152|NCT00064701|558910143|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
154859153|NCT00064701|558910144|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
154859154|NCT00064701|558910145|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
154859155|NCT00064701|558910143|FG000|One Year Post-transplant|Poor absorption|0|||
154859156|NCT00064701|558910144|FG001|One Year Post-transplant|Poor absorption|1|||
154859157|NCT00064701|558910145|FG002|One Year Post-transplant|Poor absorption|0|||
154859158|NCT00064701|558910143|FG000|One Year Post-transplant|Pancreas transplant|0|||
154859159|NCT00064701|558910144|FG001|One Year Post-transplant|Pancreas transplant|0|||
154859160|NCT00064701|558910145|FG002|One Year Post-transplant|Pancreas transplant|1|||
154859161|NCT00064701|558910143|FG000|Clinical Continuation Phase|Adverse Event|12|||
154859162|NCT00064701|558910144|FG001|Clinical Continuation Phase|Adverse Event|21|||
154859163|NCT00064701|558910145|FG002|Clinical Continuation Phase|Adverse Event|14|||
154859164|NCT00064701|558910143|FG000|Clinical Continuation Phase|Non-compliance|8|||
154859165|NCT00064701|558910144|FG001|Clinical Continuation Phase|Non-compliance|6|||
154859166|NCT00064701|558910145|FG002|Clinical Continuation Phase|Non-compliance|7|||
154859167|NCT00064701|558910143|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
154859168|NCT00064701|558910144|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
154859169|NCT00064701|558910145|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
154859170|NCT00064701|558910143|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
154859171|NCT00064701|558910144|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
154859172|NCT00064701|558910145|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
154859173|NCT00064701|558910143|FG000|Clinical Continuation Phase|Graft Failure|5|||
154859174|NCT00064701|558910144|FG001|Clinical Continuation Phase|Graft Failure|5|||
154859175|NCT00064701|558910145|FG002|Clinical Continuation Phase|Graft Failure|2|||
154859176|NCT00064701|558910143|FG000|Clinical Continuation Phase|Rejection|1|||
154859177|NCT00064701|558910144|FG001|Clinical Continuation Phase|Rejection|2|||
154859178|NCT00064701|558910145|FG002|Clinical Continuation Phase|Rejection|2|||
154859179|NCT00064701|558910143|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
154859180|NCT00064701|558910144|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
154859181|NCT00064701|558910145|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
154859182|NCT00064701|558910143|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
154859183|NCT00064701|558910144|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
154859184|NCT00064701|558910145|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
154859185|NCT00064701|558910143|FG000|Clinical Continuation Phase|Physician Decision|1|||
154859186|NCT00064701|558910144|FG001|Clinical Continuation Phase|Physician Decision|3|||
154859187|NCT00064701|558910145|FG002|Clinical Continuation Phase|Physician Decision|0|||
154859188|NCT00064701|558910143|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
154859189|NCT00064701|558910144|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
154859190|NCT00064701|558910145|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
154859191|NCT00064701|558910143|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
154859192|NCT00064701|558910144|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
154859193|NCT00064701|558910145|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
154859194|NCT00064701|558910143|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
154859195|NCT00064701|558910144|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
154859196|NCT00064701|558910145|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
154859197|NCT00064701|558910143|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
155106755|NCT00570778|559819039|FG000|Overall Study|Subject no longer requires study drug|0|||
155106756|NCT00570778|559819040|FG001|Overall Study|Subject no longer requires study drug|1|||
155106757|NCT00570778|559819041|FG002|Overall Study|Subject no longer requires study drug|0|||
155106758|NCT00570778|559819042|FG003|Overall Study|Subject no longer requires study drug|0|||
155106759|NCT00249808|559819045|FG000|Overall Study|Other|27|||
155106760|NCT00249808|559819045|FG000|Overall Study|Protocol Violation|3|||
155106761|NCT00249808|559819045|FG000|Overall Study|Lost to Follow-up|8|||
155106762|NCT00249808|559819045|FG000|Overall Study|Adverse Event|81|||
154859198|NCT00064701|558910144|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
154859199|NCT00064701|558910145|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
154859200|NCT00064701|558910143|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
154859201|NCT00064701|558910144|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
155106763|NCT00249808|559819045|FG000|Overall Study|Lack of Efficacy|52|||
154859202|NCT00064701|558910145|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
154859203|NCT00064701|558910143|FG000|Clinical Continuation Phase|Patient opted out|0|||
154859204|NCT00064701|558910144|FG001|Clinical Continuation Phase|Patient opted out|0|||
154859205|NCT00064701|558910145|FG002|Clinical Continuation Phase|Patient opted out|1|||
154859206|NCT03308188|558910146|FG000|Overall Study|Withdrawal by Subject|0|||
154859207|NCT03308188|558910147|FG001|Overall Study|Withdrawal by Subject|3|||
155106764|NCT00249808|559819045|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
154859208|NCT03308188|558910146|FG000|Overall Study|Death|0|||
154859209|NCT03308188|558910147|FG001|Overall Study|Death|1|||
154859210|NCT00772447|558910148|FG000|Overall Study|Withdrawal by Subject|9|||
154859211|NCT00772447|558910149|FG001|Overall Study|Withdrawal by Subject|5|||
154859212|NCT00772447|558910148|FG000|Overall Study|Physician Decision|4|||
154859213|NCT00772447|558910149|FG001|Overall Study|Physician Decision|8|||
154859214|NCT00772447|558910148|FG000|Overall Study|Lost to Follow-up|2|||
154859215|NCT00772447|558910149|FG001|Overall Study|Lost to Follow-up|4|||
154859216|NCT00772447|558910148|FG000|Overall Study|incorrect enrolment|3|||
154859217|NCT00772447|558910149|FG001|Overall Study|incorrect enrolment|4|||
154859218|NCT00772447|558910148|FG000|Overall Study|Protocol Violation|0|||
154859219|NCT00772447|558910149|FG001|Overall Study|Protocol Violation|1|||
154859220|NCT00772447|558910148|FG000|Overall Study|all others|2|||
154859221|NCT00772447|558910149|FG001|Overall Study|all others|2|||
154859222|NCT00552110|558910150|FG000|Overall Study|Serious or Life-Threatening AE|0|||
154859223|NCT00552110|558910151|FG001|Overall Study|Serious or Life-Threatening AE|0|||
154859224|NCT00552110|558910152|FG002|Overall Study|Serious or Life-Threatening AE|1|||
154859225|NCT00552110|558910153|FG003|Overall Study|Serious or Life-Threatening AE|0|||
154859226|NCT00552110|558910154|FG004|Overall Study|Serious or Life-Threatening AE|0|||
154859227|NCT00552110|558910150|FG000|Overall Study|Lack of Efficacy|1|||
154859228|NCT00552110|558910151|FG001|Overall Study|Lack of Efficacy|0|||
154859229|NCT00552110|558910152|FG002|Overall Study|Lack of Efficacy|0|||
154859230|NCT00552110|558910153|FG003|Overall Study|Lack of Efficacy|1|||
154859231|NCT00552110|558910154|FG004|Overall Study|Lack of Efficacy|4|||
154859232|NCT00552110|558910150|FG000|Overall Study|Withdrawal by Subject|0|||
154859233|NCT00552110|558910151|FG001|Overall Study|Withdrawal by Subject|2|||
154859234|NCT00552110|558910152|FG002|Overall Study|Withdrawal by Subject|0|||
154859235|NCT00552110|558910153|FG003|Overall Study|Withdrawal by Subject|3|||
154859236|NCT00552110|558910154|FG004|Overall Study|Withdrawal by Subject|2|||
154859237|NCT00552110|558910150|FG000|Overall Study|Lost to Follow-up|0|||
154859238|NCT00552110|558910151|FG001|Overall Study|Lost to Follow-up|0|||
154859239|NCT00552110|558910152|FG002|Overall Study|Lost to Follow-up|0|||
154859240|NCT00552110|558910153|FG003|Overall Study|Lost to Follow-up|1|||
154859241|NCT00552110|558910154|FG004|Overall Study|Lost to Follow-up|1|||
154859242|NCT00552110|558910150|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
154859243|NCT00552110|558910151|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
154859244|NCT00552110|558910152|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
154859245|NCT00552110|558910153|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
154859246|NCT00552110|558910154|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
154859247|NCT00552110|558910150|FG000|Overall Study|Withdrawn per Sponsor|0|||
154859248|NCT00552110|558910151|FG001|Overall Study|Withdrawn per Sponsor|1|||
154859249|NCT00552110|558910152|FG002|Overall Study|Withdrawn per Sponsor|0|||
154859250|NCT00552110|558910153|FG003|Overall Study|Withdrawn per Sponsor|0|||
154859251|NCT00552110|558910154|FG004|Overall Study|Withdrawn per Sponsor|1|||
154859252|NCT00552110|558910150|FG000|Overall Study|Use of Prohibited Medication|1|||
154859253|NCT00552110|558910151|FG001|Overall Study|Use of Prohibited Medication|1|||
154859254|NCT00552110|558910152|FG002|Overall Study|Use of Prohibited Medication|0|||
154859255|NCT00552110|558910153|FG003|Overall Study|Use of Prohibited Medication|0|||
154859256|NCT00552110|558910154|FG004|Overall Study|Use of Prohibited Medication|0|||
154859257|NCT00552110|558910150|FG000|Overall Study|Delay of Study due to Relabeling|0|||
154859258|NCT00552110|558910151|FG001|Overall Study|Delay of Study due to Relabeling|0|||
154859259|NCT00552110|558910152|FG002|Overall Study|Delay of Study due to Relabeling|0|||
154859260|NCT00552110|558910153|FG003|Overall Study|Delay of Study due to Relabeling|1|||
154859261|NCT00552110|558910154|FG004|Overall Study|Delay of Study due to Relabeling|0|||
154859262|NCT00552110|558910150|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
154859263|NCT00552110|558910151|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
154859264|NCT00552110|558910152|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
154859265|NCT00552110|558910153|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
154859266|NCT00552110|558910154|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
154859267|NCT00552110|558910150|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
154859268|NCT00552110|558910151|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
154859269|NCT00552110|558910152|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
154859270|NCT00552110|558910153|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
154859271|NCT00552110|558910154|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
154859272|NCT00655928|558910160|FG000|Overall Study|Withdrawal by Subject|2|||
154859273|NCT00655928|558910161|FG001|Overall Study|Withdrawal by Subject|1|||
154859274|NCT00655928|558910160|FG000|Overall Study|Physician Decision|1|||
154859275|NCT00655928|558910161|FG001|Overall Study|Physician Decision|1|||
154859276|NCT00998738|558910163|FG000|Overall Study|Uknown|1|||
154859277|NCT01291017|558910170|FG000|Overall Study|Lost to Follow-up|2|||
154859278|NCT01291017|558910170|FG000|Overall Study|Withdrawal by Subject|3|||
154859279|NCT04980391|558910171|FG000|Overall Study|Death|0|||
154859280|NCT04980391|558910172|FG001|Overall Study|Death|0|||
154859281|NCT04980391|558910173|FG002|Overall Study|Death|1|||
154859282|NCT04980391|558910174|FG003|Overall Study|Death|1|||
154859283|NCT04980391|558910171|FG000|Overall Study|Lost to Follow-up|3|||
154859284|NCT04980391|558910172|FG001|Overall Study|Lost to Follow-up|3|||
154859285|NCT04980391|558910173|FG002|Overall Study|Lost to Follow-up|2|||
154859286|NCT04980391|558910174|FG003|Overall Study|Lost to Follow-up|3|||
154859287|NCT04980391|558910171|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
154859288|NCT04980391|558910172|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
154859289|NCT04980391|558910173|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
154859290|NCT04980391|558910174|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
154859291|NCT04980391|558910171|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154859292|NCT04980391|558910172|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154859293|NCT04980391|558910173|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
154859294|NCT04980391|558910174|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154859295|NCT04980391|558910171|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
154859296|NCT04980391|558910172|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
154859297|NCT04980391|558910173|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
154859298|NCT04980391|558910174|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
154859299|NCT02091440|558912710|FG000|Overall Study|Death|2|||
154859300|NCT00783289|558912711|FG000|Overall Study|Protocol Violation|0|||
154859301|NCT00783289|558912712|FG001|Overall Study|Protocol Violation|1|||
154859302|NCT00783289|558912713|FG002|Overall Study|Protocol Violation|0|||
154859303|NCT00783289|558912714|FG003|Overall Study|Protocol Violation|0|||
154859304|NCT03095703|558912717|FG000|Overall Study|Withdrawal by Subject|1|||
154859305|NCT02443402|558912720|FG000|Overall Study|Withdrawal by Subject|3|||
154859306|NCT02443402|558912721|FG001|Overall Study|Withdrawal by Subject|1|||
154859307|NCT02443402|558912720|FG000|Overall Study|Screen Failure|1|||
154859308|NCT02443402|558912721|FG001|Overall Study|Screen Failure|2|||
154859309|NCT01562028|558912724|FG000|Overall Study|Withdrawal by Subject|1|||
154859310|NCT01562028|558912725|FG001|Overall Study|Withdrawal by Subject|1|||
154859311|NCT01562028|558912724|FG000|Overall Study|Lost to Follow-up|2|||
154859312|NCT01562028|558912725|FG001|Overall Study|Lost to Follow-up|1|||
154859313|NCT00364793|558912726|FG000|Overall Study|Adverse Event|2|||
154859314|NCT00364793|558912727|FG001|Overall Study|Adverse Event|0|||
154859315|NCT00364793|558912728|FG002|Overall Study|Adverse Event|0|||
154859316|NCT00364793|558912729|FG003|Overall Study|Adverse Event|0|||
154859317|NCT00364793|558912726|FG000|Overall Study|Death|1|||
154859318|NCT00364793|558912727|FG001|Overall Study|Death|0|||
154859319|NCT00364793|558912728|FG002|Overall Study|Death|1|||
154859320|NCT00364793|558912729|FG003|Overall Study|Death|0|||
154859321|NCT00364793|558912726|FG000|Overall Study|Lack of Efficacy|3|||
154859322|NCT00364793|558912727|FG001|Overall Study|Lack of Efficacy|3|||
154859323|NCT00364793|558912728|FG002|Overall Study|Lack of Efficacy|1|||
154859324|NCT00364793|558912729|FG003|Overall Study|Lack of Efficacy|1|||
154859325|NCT00364793|558912726|FG000|Overall Study|Lost to Follow-up|1|||
154859326|NCT00364793|558912727|FG001|Overall Study|Lost to Follow-up|0|||
154859327|NCT00364793|558912728|FG002|Overall Study|Lost to Follow-up|2|||
154859328|NCT00364793|558912729|FG003|Overall Study|Lost to Follow-up|0|||
154859329|NCT00364793|558912726|FG000|Overall Study|Poor or non-compliance|1|||
154859330|NCT00364793|558912727|FG001|Overall Study|Poor or non-compliance|1|||
154859331|NCT00364793|558912728|FG002|Overall Study|Poor or non-compliance|0|||
154859332|NCT00364793|558912729|FG003|Overall Study|Poor or non-compliance|1|||
154859333|NCT00364793|558912726|FG000|Overall Study|No longer meets criteria|0|||
154859334|NCT00364793|558912727|FG001|Overall Study|No longer meets criteria|0|||
154859335|NCT00364793|558912728|FG002|Overall Study|No longer meets criteria|0|||
154859336|NCT00364793|558912729|FG003|Overall Study|No longer meets criteria|1|||
154859337|NCT00364793|558912726|FG000|Overall Study|Withdrawal by Subject|0|||
154859338|NCT00364793|558912727|FG001|Overall Study|Withdrawal by Subject|1|||
154859339|NCT00364793|558912728|FG002|Overall Study|Withdrawal by Subject|0|||
154859340|NCT00364793|558912729|FG003|Overall Study|Withdrawal by Subject|0|||
154859341|NCT00391976|558912730|FG000|Overall Study|Adverse Event|0|||
154859342|NCT00391976|558912731|FG001|Overall Study|Adverse Event|0|||
154859343|NCT00391976|558912732|FG002|Overall Study|Adverse Event|1|||
154859344|NCT00391976|558912730|FG000|Overall Study|Withdrawal of consent|0|||
154859345|NCT00391976|558912731|FG001|Overall Study|Withdrawal of consent|1|||
154859346|NCT00391976|558912732|FG002|Overall Study|Withdrawal of consent|1|||
154859347|NCT00391976|558912730|FG000|Overall Study|Lost to Follow-up|1|||
154859348|NCT00391976|558912731|FG001|Overall Study|Lost to Follow-up|2|||
154859349|NCT00391976|558912732|FG002|Overall Study|Lost to Follow-up|0|||
154859350|NCT00391976|558912730|FG000|Overall Study|Inappropriate enrollment|1|||
154859351|NCT00391976|558912731|FG001|Overall Study|Inappropriate enrollment|1|||
154859352|NCT00391976|558912732|FG002|Overall Study|Inappropriate enrollment|0|||
154859353|NCT00391976|558912730|FG000|Overall Study|Protocol deviation/violation|4|||
154859354|NCT00391976|558912731|FG001|Overall Study|Protocol deviation/violation|2|||
154859355|NCT00391976|558912732|FG002|Overall Study|Protocol deviation/violation|1|||
154859356|NCT00391976|558912730|FG000|Overall Study|Recurrence/no eradication of infection|21|||
154859357|NCT00391976|558912731|FG001|Overall Study|Recurrence/no eradication of infection|19|||
154859358|NCT00391976|558912732|FG002|Overall Study|Recurrence/no eradication of infection|0|||
154859359|NCT00391976|558912730|FG000|Overall Study|Unable to classify|0|||
154859360|NCT00391976|558912731|FG001|Overall Study|Unable to classify|0|||
154859361|NCT00391976|558912732|FG002|Overall Study|Unable to classify|1|||
154859362|NCT00391976|558912730|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
154859363|NCT00391976|558912731|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
154859364|NCT00391976|558912732|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
154859365|NCT00775021|558912736|FG000|First Intervention|Lost to Follow-up|1|||
154859366|NCT00775021|558912737|FG001|First Intervention|Lost to Follow-up|0|||
154859367|NCT00775021|558912736|FG000|Second Intervention|Adverse Event|0|||
154859368|NCT00775021|558912737|FG001|Second Intervention|Adverse Event|1|||
154859369|NCT05817045|558912758|FG000|Overall Study|Protocol Violation|0|||
154859370|NCT05817045|558912759|FG001|Overall Study|Protocol Violation|3|||
154859371|NCT05817045|558912758|FG000|Overall Study|Withdrawal by Subject|10|||
154859372|NCT05817045|558912759|FG001|Overall Study|Withdrawal by Subject|7|||
154859373|NCT05817045|558912758|FG000|Overall Study|Physician Decision|3|||
154859374|NCT05817045|558912759|FG001|Overall Study|Physician Decision|0|||
154859375|NCT05817045|558912758|FG000|Overall Study|Lost to Follow-up|0|||
154859376|NCT05817045|558912759|FG001|Overall Study|Lost to Follow-up|1|||
154859377|NCT05817045|558912758|FG000|Overall Study|Device Deficiency|1|||
154859378|NCT05817045|558912759|FG001|Overall Study|Device Deficiency|0|||
154859379|NCT05817045|558912758|FG000|Overall Study|System Error|1|||
154859380|NCT05817045|558912759|FG001|Overall Study|System Error|0|||
154859381|NCT01506141|558912760|FG000|Overall Study|Adverse Event|0|||
154859382|NCT01506141|558912761|FG001|Overall Study|Adverse Event|2|||
154859383|NCT01506141|558912760|FG000|Overall Study|Participation Terminated by Investigator|1|||
154859384|NCT01506141|558912761|FG001|Overall Study|Participation Terminated by Investigator|1|||
154859385|NCT01506141|558912760|FG000|Overall Study|Site Terminated by Sponsor|2|||
154859386|NCT01506141|558912761|FG001|Overall Study|Site Terminated by Sponsor|0|||
154859387|NCT01506141|558912760|FG000|Overall Study|Reason Not Specified|4|||
154972292|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
154972293|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
155106765|NCT00711594|559819046|FG000|Overall Study|Progressive disease|2|||
155106766|NCT00711594|559819047|FG001|Overall Study|Progressive disease|2|||
155106767|NCT00711594|559819048|FG002|Overall Study|Progressive disease|6|||
155106768|NCT00711594|559819049|FG003|Overall Study|Progressive disease|44|||
155106769|NCT00711594|559819046|FG000|Overall Study|Other Adverse Event|1|||
155106770|NCT00711594|559819047|FG001|Overall Study|Other Adverse Event|0|||
155106771|NCT00711594|559819048|FG002|Overall Study|Other Adverse Event|0|||
155106772|NCT00711594|559819049|FG003|Overall Study|Other Adverse Event|16|||
155106773|NCT00711594|559819046|FG000|Overall Study|Withdrawal by Subject|0|||
155106774|NCT00711594|559819047|FG001|Overall Study|Withdrawal by Subject|1|||
155106775|NCT00711594|559819048|FG002|Overall Study|Withdrawal by Subject|0|||
155106776|NCT00711594|559819049|FG003|Overall Study|Withdrawal by Subject|2|||
155106777|NCT00984165|559819062|FG000|Overall Study|Death on study|2|||
155106778|NCT00984165|559819063|FG001|Overall Study|Death on study|0|||
155106779|NCT00984165|559819064|FG002|Overall Study|Death on study|0|||
155106780|NCT00984165|559819065|FG003|Overall Study|Death on study|0|||
155106781|NCT00984165|559819062|FG000|Overall Study|Disease progression on study|5|||
155106782|NCT00984165|559819063|FG001|Overall Study|Disease progression on study|1|||
155106783|NCT00984165|559819064|FG002|Overall Study|Disease progression on study|0|||
155106784|NCT00984165|559819065|FG003|Overall Study|Disease progression on study|0|||
155106785|NCT00984165|559819062|FG000|Overall Study|Death of recipient|0|||
155106786|NCT00984165|559819063|FG001|Overall Study|Death of recipient|0|||
155106787|NCT00984165|559819064|FG002|Overall Study|Death of recipient|0|||
155106788|NCT00984165|559819065|FG003|Overall Study|Death of recipient|1|||
155106789|NCT00984165|559819062|FG000|Overall Study|New protocol|0|||
155106790|NCT00984165|559819063|FG001|Overall Study|New protocol|0|||
155106791|NCT00984165|559819064|FG002|Overall Study|New protocol|0|||
155106792|NCT00984165|559819065|FG003|Overall Study|New protocol|1|||
155106793|NCT00984165|559819062|FG000|Overall Study|P+/donor pair removed from protocol|0|||
154859388|NCT01506141|558912761|FG001|Overall Study|Reason Not Specified|2|||
154859389|NCT04889209|558912762|FG000|All Cohorts Except 15E|Adverse Event|0|||
154859390|NCT04889209|558912763|FG001|All Cohorts Except 15E|Adverse Event|0|||
154859391|NCT04889209|558912764|FG002|All Cohorts Except 15E|Adverse Event|0|||
154859392|NCT04889209|558912765|FG003|All Cohorts Except 15E|Adverse Event|0|||
155106794|NCT00984165|559819063|FG001|Overall Study|P+/donor pair removed from protocol|0|||
154972294|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
154859393|NCT04889209|558912766|FG004|All Cohorts Except 15E|Adverse Event|0|||
154859394|NCT04889209|558912767|FG005|All Cohorts Except 15E|Adverse Event|0|||
155106795|NCT00984165|559819064|FG002|Overall Study|P+/donor pair removed from protocol|0|||
155106796|NCT00984165|559819065|FG003|Overall Study|P+/donor pair removed from protocol|1|||
155106797|NCT00984165|559819062|FG000|Overall Study|removed with a pair recipient|0|||
155106798|NCT00984165|559819063|FG001|Overall Study|removed with a pair recipient|0|||
155106799|NCT00984165|559819064|FG002|Overall Study|removed with a pair recipient|0|||
155106800|NCT00984165|559819065|FG003|Overall Study|removed with a pair recipient|1|||
155106801|NCT00700622|559819067|FG000|Overall Study|Adverse Event|4|||
155106802|NCT00700622|559819068|FG001|Overall Study|Adverse Event|0|||
155106803|NCT00700622|559819067|FG000|Overall Study|Lost to Follow-up|0|||
154859395|NCT04889209|558912768|FG006|All Cohorts Except 15E|Adverse Event|1|||
154859396|NCT04889209|558912769|FG007|All Cohorts Except 15E|Adverse Event|0|||
154859397|NCT04889209|558912770|FG008|All Cohorts Except 15E|Adverse Event|0|||
154859398|NCT04889209|558912771|FG009|All Cohorts Except 15E|Adverse Event|0|||
154859399|NCT04889209|558912772|FG010|All Cohorts Except 15E|Adverse Event|0|||
154859400|NCT04889209|558912773|FG011|All Cohorts Except 15E|Adverse Event|0|||
154859401|NCT04889209|558912774|FG012|All Cohorts Except 15E|Adverse Event|0|||
154859402|NCT04889209|558912775|FG013|All Cohorts Except 15E|Adverse Event|0|||
154859403|NCT04889209|558912776|FG014|All Cohorts Except 15E|Adverse Event|0|||
154859404|NCT04889209|558912777|FG015|All Cohorts Except 15E|Adverse Event|0|||
154859405|NCT04889209|558912778|FG016|All Cohorts Except 15E|Adverse Event|0|||
154859406|NCT04889209|558912779|FG017|All Cohorts Except 15E|Adverse Event|0|||
154859407|NCT04889209|558912762|FG000|All Cohorts Except 15E|Death|0|||
154859408|NCT04889209|558912763|FG001|All Cohorts Except 15E|Death|1|||
154859409|NCT04889209|558912764|FG002|All Cohorts Except 15E|Death|0|||
154859410|NCT04889209|558912765|FG003|All Cohorts Except 15E|Death|0|||
154859411|NCT04889209|558912766|FG004|All Cohorts Except 15E|Death|0|||
154859412|NCT04889209|558912767|FG005|All Cohorts Except 15E|Death|0|||
154859413|NCT04889209|558912768|FG006|All Cohorts Except 15E|Death|0|||
154859414|NCT04889209|558912769|FG007|All Cohorts Except 15E|Death|0|||
154859415|NCT04889209|558912770|FG008|All Cohorts Except 15E|Death|0|||
154859416|NCT04889209|558912771|FG009|All Cohorts Except 15E|Death|0|||
154859417|NCT04889209|558912772|FG010|All Cohorts Except 15E|Death|0|||
154859418|NCT04889209|558912773|FG011|All Cohorts Except 15E|Death|0|||
154859419|NCT04889209|558912774|FG012|All Cohorts Except 15E|Death|0|||
154859420|NCT04889209|558912775|FG013|All Cohorts Except 15E|Death|0|||
154859421|NCT04889209|558912776|FG014|All Cohorts Except 15E|Death|0|||
154859422|NCT04889209|558912777|FG015|All Cohorts Except 15E|Death|0|||
154859423|NCT04889209|558912778|FG016|All Cohorts Except 15E|Death|0|||
154859424|NCT04889209|558912779|FG017|All Cohorts Except 15E|Death|0|||
154859425|NCT04889209|558912762|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
154859426|NCT04889209|558912763|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
154859427|NCT04889209|558912764|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
154859428|NCT04889209|558912765|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
154859429|NCT04889209|558912766|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
154859430|NCT04889209|558912767|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
154859431|NCT04889209|558912768|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
154859432|NCT04889209|558912769|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
154859433|NCT04889209|558912770|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
154859434|NCT04889209|558912771|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
154859435|NCT04889209|558912772|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
154859436|NCT04889209|558912773|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
154859437|NCT04889209|558912774|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
154859438|NCT04889209|558912775|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
154859439|NCT04889209|558912776|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
154859440|NCT04889209|558912777|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
154859441|NCT04889209|558912778|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
154859442|NCT04889209|558912779|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
154859443|NCT04889209|558912762|FG000|All Cohorts Except 15E|Physician Decision|0|||
154859444|NCT04889209|558912763|FG001|All Cohorts Except 15E|Physician Decision|0|||
154859445|NCT04889209|558912764|FG002|All Cohorts Except 15E|Physician Decision|0|||
154859446|NCT04889209|558912765|FG003|All Cohorts Except 15E|Physician Decision|0|||
154859447|NCT04889209|558912766|FG004|All Cohorts Except 15E|Physician Decision|1|||
154859448|NCT04889209|558912767|FG005|All Cohorts Except 15E|Physician Decision|0|||
154859449|NCT04889209|558912768|FG006|All Cohorts Except 15E|Physician Decision|0|||
154859450|NCT04889209|558912769|FG007|All Cohorts Except 15E|Physician Decision|1|||
154859451|NCT04889209|558912770|FG008|All Cohorts Except 15E|Physician Decision|0|||
154859452|NCT04889209|558912771|FG009|All Cohorts Except 15E|Physician Decision|1|||
154859453|NCT04889209|558912772|FG010|All Cohorts Except 15E|Physician Decision|0|||
154859454|NCT04889209|558912773|FG011|All Cohorts Except 15E|Physician Decision|1|||
154859455|NCT04889209|558912774|FG012|All Cohorts Except 15E|Physician Decision|1|||
155106804|NCT00700622|559819068|FG001|Overall Study|Lost to Follow-up|1|||
155106805|NCT00700622|559819067|FG000|Overall Study|Physician Decision|2|||
155106806|NCT00700622|559819068|FG001|Overall Study|Physician Decision|1|||
155106807|NCT00700622|559819067|FG000|Overall Study|Protocol Violation|0|||
154859456|NCT04889209|558912775|FG013|All Cohorts Except 15E|Physician Decision|0|||
154859457|NCT04889209|558912776|FG014|All Cohorts Except 15E|Physician Decision|0|||
154859458|NCT04889209|558912777|FG015|All Cohorts Except 15E|Physician Decision|0|||
154859459|NCT04889209|558912778|FG016|All Cohorts Except 15E|Physician Decision|0|||
154859460|NCT04889209|558912779|FG017|All Cohorts Except 15E|Physician Decision|0|||
154859461|NCT04889209|558912762|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
154859462|NCT04889209|558912763|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
154859463|NCT04889209|558912764|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
155106808|NCT00700622|559819068|FG001|Overall Study|Protocol Violation|1|||
155106809|NCT00700622|559819067|FG000|Overall Study|Withdrawal by Subject|4|||
154859464|NCT04889209|558912765|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
154859465|NCT04889209|558912766|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
154859466|NCT04889209|558912767|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859467|NCT04889209|558912768|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859468|NCT04889209|558912769|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
154859469|NCT04889209|558912770|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859470|NCT04889209|558912771|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859471|NCT04889209|558912772|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859472|NCT04889209|558912773|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859473|NCT04889209|558912774|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859474|NCT04889209|558912775|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
154859475|NCT04889209|558912776|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
154859476|NCT04889209|558912777|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
154859477|NCT04889209|558912778|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
154859478|NCT04889209|558912779|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
154859479|NCT04889209|558912762|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
154859480|NCT04889209|558912763|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
154859481|NCT04889209|558912764|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859482|NCT04889209|558912765|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859483|NCT04889209|558912766|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859484|NCT04889209|558912767|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
154859485|NCT04889209|558912768|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859486|NCT04889209|558912769|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
154859487|NCT04889209|558912770|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859488|NCT04889209|558912771|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
154859489|NCT04889209|558912772|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859490|NCT04889209|558912773|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859491|NCT04889209|558912774|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859492|NCT04889209|558912775|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859493|NCT04889209|558912776|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859494|NCT04889209|558912777|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859495|NCT04889209|558912778|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
154859496|NCT04889209|558912779|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
154859497|NCT04889209|558912762|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859498|NCT04889209|558912763|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859499|NCT04889209|558912764|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859500|NCT04889209|558912765|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
154859501|NCT04889209|558912766|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859502|NCT04889209|558912767|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859503|NCT04889209|558912768|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859504|NCT04889209|558912769|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859505|NCT04889209|558912770|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859506|NCT04889209|558912771|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859507|NCT04889209|558912772|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859508|NCT04889209|558912773|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859509|NCT04889209|558912774|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859510|NCT04889209|558912775|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859511|NCT04889209|558912776|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859512|NCT04889209|558912777|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859513|NCT04889209|558912778|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859514|NCT04889209|558912779|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
154859515|NCT04889209|558912762|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859516|NCT04889209|558912763|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859517|NCT04889209|558912764|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
155106810|NCT00700622|559819068|FG001|Overall Study|Withdrawal by Subject|1|||
155106811|NCT00700622|559819067|FG000|Overall Study|Other|3|||
155106812|NCT00700622|559819068|FG001|Overall Study|Other|1|||
155106813|NCT00383331|559819069|FG000|Overall Study|Protocol Violation|0|||
155106814|NCT00383331|559819070|FG001|Overall Study|Protocol Violation|1|||
155106815|NCT02836717|559819076|FG000|Test Phase|Lack of Efficacy|14|||
155106816|NCT02836717|559819077|FG001|Test Phase|Lack of Efficacy|8|||
154859518|NCT04889209|558912765|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859519|NCT04889209|558912766|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859520|NCT04889209|558912767|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859521|NCT04889209|558912768|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859522|NCT04889209|558912769|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859523|NCT04889209|558912770|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859524|NCT04889209|558912771|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859525|NCT04889209|558912772|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859526|NCT04889209|558912773|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859527|NCT04889209|558912774|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859528|NCT04889209|558912775|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859529|NCT04889209|558912776|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859530|NCT04889209|558912777|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859531|NCT04889209|558912778|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
154859532|NCT04889209|558912779|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
154859533|NCT04889209|558912762|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859534|NCT04889209|558912763|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859535|NCT04889209|558912764|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859536|NCT04889209|558912765|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859537|NCT04889209|558912766|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859538|NCT04889209|558912767|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859539|NCT04889209|558912768|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859540|NCT04889209|558912769|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859541|NCT04889209|558912770|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859542|NCT04889209|558912771|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859543|NCT04889209|558912772|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859544|NCT04889209|558912773|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859545|NCT04889209|558912774|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859546|NCT04889209|558912775|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859547|NCT04889209|558912776|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859548|NCT04889209|558912777|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859549|NCT04889209|558912778|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
154859550|NCT04889209|558912779|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
154859551|NCT04889209|558912762|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859552|NCT04889209|558912763|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859553|NCT04889209|558912764|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859554|NCT04889209|558912765|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859555|NCT04889209|558912766|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859556|NCT04889209|558912767|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859557|NCT04889209|558912768|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859558|NCT04889209|558912769|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859559|NCT04889209|558912770|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859560|NCT04889209|558912771|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859561|NCT04889209|558912772|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859562|NCT04889209|558912773|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859563|NCT04889209|558912774|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859564|NCT04889209|558912775|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859565|NCT04889209|558912776|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859566|NCT04889209|558912777|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859567|NCT04889209|558912778|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
154859568|NCT04889209|558912779|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
154859569|NCT04889209|558912762|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859570|NCT04889209|558912763|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859571|NCT04889209|558912764|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859572|NCT04889209|558912765|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859573|NCT04889209|558912766|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859574|NCT04889209|558912767|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859575|NCT04889209|558912768|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859576|NCT04889209|558912769|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859577|NCT04889209|558912770|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859578|NCT04889209|558912771|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
155106817|NCT02836717|559819078|FG002|Test Phase|Lack of Efficacy|0|||
155106818|NCT02836717|559819076|FG000|Study Phase|Adverse Event|2|||
154859579|NCT04889209|558912772|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859580|NCT04889209|558912773|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859581|NCT04889209|558912774|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859582|NCT04889209|558912775|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859583|NCT04889209|558912776|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
154859584|NCT04889209|558912777|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859585|NCT04889209|558912778|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859586|NCT04889209|558912779|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
154859587|NCT04607408|558912780|FG000|Overall Study|Lost to Follow-up|0|||
154859588|NCT04607408|558912781|FG001|Overall Study|Lost to Follow-up|0|||
154859589|NCT04607408|558912782|FG002|Overall Study|Lost to Follow-up|0|||
154859590|NCT04607408|558912783|FG003|Overall Study|Lost to Follow-up|1|||
154859591|NCT04607408|558912784|FG004|Overall Study|Lost to Follow-up|0|||
154859592|NCT04607408|558912780|FG000|Overall Study|Withdrawal by Subject|0|||
154859593|NCT04607408|558912781|FG001|Overall Study|Withdrawal by Subject|1|||
154859594|NCT04607408|558912782|FG002|Overall Study|Withdrawal by Subject|0|||
154859595|NCT04607408|558912783|FG003|Overall Study|Withdrawal by Subject|1|||
154859596|NCT04607408|558912784|FG004|Overall Study|Withdrawal by Subject|0|||
154859597|NCT01725165|558912787|FG000|Overall Study|Death|11|||
154859598|NCT01725165|558912788|FG001|Overall Study|Death|18|||
154859599|NCT02688647|558912791|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
154859600|NCT02688647|558912792|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
154859601|NCT02688647|558912791|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
154859602|NCT02688647|558912792|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
154859603|NCT02688647|558912791|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
154859604|NCT02688647|558912792|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
154859605|NCT02688647|558912791|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
154859606|NCT02688647|558912792|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
154859607|NCT02688647|558912791|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
154859608|NCT02688647|558912792|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
154859609|NCT02688647|558912791|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
154859610|NCT02688647|558912792|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
154859611|NCT02688647|558912791|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
154859612|NCT02688647|558912792|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
154859613|NCT03619213|558912793|FG000|Overall Study|Lost to Follow-up|2|||
154859614|NCT03619213|558912794|FG001|Overall Study|Lost to Follow-up|1|||
154859615|NCT03619213|558912793|FG000|Overall Study|Withdrawal by Subject|8|||
154859616|NCT03619213|558912794|FG001|Overall Study|Withdrawal by Subject|10|||
154859617|NCT00382967|558912795|FG000|Overall Study|Protocol Violation|1|||
154859618|NCT00382967|558912796|FG001|Overall Study|Protocol Violation|1|||
154859619|NCT04026568|558912797|FG000|Overall Study|study terminated|0|||
154859620|NCT04026568|558912798|FG001|Overall Study|study terminated|1|||
154859621|NCT00331760|558912799|FG000|Overall Study|Ineligible / no protocol treatment|15|||
154859622|NCT00331760|558912800|FG001|Overall Study|Ineligible / no protocol treatment|8|||
154859623|NCT00461175|558912801|FG000|Overall Study|Protocol Violation|522|||
154859624|NCT00461175|558912802|FG001|Overall Study|Protocol Violation|365|||
154859625|NCT03093155|558912804|FG000|Overall Study|Not Eligible|1|||
154859626|NCT03093155|558912805|FG001|Overall Study|Not Eligible|0|||
154859627|NCT03093155|558912804|FG000|Overall Study|Withdrawal by Subject|0|||
154859628|NCT03093155|558912805|FG001|Overall Study|Withdrawal by Subject|1|||
154859629|NCT00826514|558912806|FG000|Overall Study|Adverse Event|1|||
154859630|NCT00826514|558912807|FG001|Overall Study|Adverse Event|1|||
154859631|NCT00826514|558912806|FG000|Overall Study|Lack of Efficacy|0|||
154859632|NCT00826514|558912807|FG001|Overall Study|Lack of Efficacy|1|||
154859633|NCT00826514|558912806|FG000|Overall Study|Withdrawal by Subject|2|||
154859634|NCT00826514|558912807|FG001|Overall Study|Withdrawal by Subject|3|||
154859635|NCT01773473|558912808|FG000|Overall Study|Adverse Event|3|||
154859636|NCT01773473|558912809|FG001|Overall Study|Adverse Event|2|||
154859637|NCT01773473|558912808|FG000|Overall Study|Protocol Violation|0|||
154859638|NCT01773473|558912809|FG001|Overall Study|Protocol Violation|4|||
154859639|NCT01773473|558912808|FG000|Overall Study|Physician Decision|3|||
154859640|NCT01773473|558912809|FG001|Overall Study|Physician Decision|5|||
154859641|NCT01773473|558912808|FG000|Overall Study|Sponsor Decision|2|||
154859642|NCT01773473|558912809|FG001|Overall Study|Sponsor Decision|0|||
154859643|NCT01773473|558912808|FG000|Overall Study|Lack of Efficacy|0|||
154859644|NCT01773473|558912809|FG001|Overall Study|Lack of Efficacy|1|||
154859645|NCT01773473|558912808|FG000|Overall Study|Non-Compliance with study drug|1|||
154859646|NCT01773473|558912809|FG001|Overall Study|Non-Compliance with study drug|4|||
154859647|NCT01773473|558912808|FG000|Overall Study|Withdrawal by Subject|5|||
154859648|NCT01773473|558912809|FG001|Overall Study|Withdrawal by Subject|3|||
154859649|NCT01773473|558912808|FG000|Overall Study|Lost to Follow-up|2|||
155106819|NCT02836717|559819077|FG001|Study Phase|Adverse Event|0|||
154859650|NCT01773473|558912809|FG001|Overall Study|Lost to Follow-up|0|||
154859651|NCT01085682|558912810|FG000|Overall Study|Withdrawal by Subject|25|||
154859652|NCT01085682|558912811|FG001|Overall Study|Withdrawal by Subject|25|||
154859653|NCT00158184|558912815|FG000|Overall Study|personal issues|3|||
154859654|NCT00158184|558912816|FG001|Overall Study|personal issues|1|||
154859655|NCT00158184|558912815|FG000|Overall Study|failed for follow unit/study rules|2|||
154859656|NCT00158184|558912816|FG001|Overall Study|failed for follow unit/study rules|0|||
154859657|NCT00158184|558912815|FG000|Overall Study|Adverse Event|1|||
154859658|NCT00158184|558912816|FG001|Overall Study|Adverse Event|1|||
154859659|NCT02620020|558912817|FG000|Overall Study|Adverse Event|8|||
154859660|NCT02620020|558912818|FG001|Overall Study|Adverse Event|4|||
154859661|NCT02620020|558912819|FG002|Overall Study|Adverse Event|3|||
154859662|NCT02620020|558912820|FG003|Overall Study|Adverse Event|5|||
154859663|NCT02620020|558912817|FG000|Overall Study|Lost to Follow-up|4|||
154859664|NCT02620020|558912818|FG001|Overall Study|Lost to Follow-up|8|||
154859665|NCT02620020|558912819|FG002|Overall Study|Lost to Follow-up|1|||
154859666|NCT02620020|558912820|FG003|Overall Study|Lost to Follow-up|4|||
154859667|NCT02620020|558912817|FG000|Overall Study|Physician Decision|7|||
154859668|NCT02620020|558912818|FG001|Overall Study|Physician Decision|4|||
154859669|NCT02620020|558912819|FG002|Overall Study|Physician Decision|3|||
154859670|NCT02620020|558912820|FG003|Overall Study|Physician Decision|4|||
154859671|NCT02620020|558912817|FG000|Overall Study|Protocol Violation|5|||
154859672|NCT02620020|558912818|FG001|Overall Study|Protocol Violation|2|||
154859673|NCT02620020|558912819|FG002|Overall Study|Protocol Violation|1|||
154859674|NCT02620020|558912820|FG003|Overall Study|Protocol Violation|1|||
154859675|NCT02620020|558912817|FG000|Overall Study|Withdrawal by Subject|20|||
154859676|NCT02620020|558912818|FG001|Overall Study|Withdrawal by Subject|16|||
154859677|NCT02620020|558912819|FG002|Overall Study|Withdrawal by Subject|17|||
154859678|NCT02620020|558912820|FG003|Overall Study|Withdrawal by Subject|12|||
154859679|NCT02620020|558912817|FG000|Overall Study|Death|0|||
154859680|NCT02620020|558912818|FG001|Overall Study|Death|1|||
154859681|NCT02620020|558912819|FG002|Overall Study|Death|0|||
154859682|NCT02620020|558912820|FG003|Overall Study|Death|0|||
154859683|NCT01025635|558912824|FG000|Overall Study|Withdrawal by Subject|6|||
154859684|NCT01025635|558912825|FG001|Overall Study|Withdrawal by Subject|7|||
154859685|NCT01025635|558912824|FG000|Overall Study|Protocol Violation|4|||
154859686|NCT01025635|558912825|FG001|Overall Study|Protocol Violation|2|||
154859687|NCT01025635|558912824|FG000|Overall Study|Lack of Efficacy|0|||
154859688|NCT01025635|558912825|FG001|Overall Study|Lack of Efficacy|1|||
154859689|NCT01025635|558912824|FG000|Overall Study|Lost to Follow-up|9|||
154859690|NCT01025635|558912825|FG001|Overall Study|Lost to Follow-up|13|||
154859691|NCT01025635|558912824|FG000|Overall Study|Reason not known|4|||
154859692|NCT01025635|558912825|FG001|Overall Study|Reason not known|2|||
154859693|NCT02393209|558912826|FG000|Overall Study|Study Terminated by Sponsor|1|||
154859694|NCT02393209|558912827|FG001|Overall Study|Study Terminated by Sponsor|1|||
154859695|NCT02393209|558912828|FG002|Overall Study|Study Terminated by Sponsor|0|||
154859696|NCT02393209|558912829|FG003|Overall Study|Study Terminated by Sponsor|0|||
154859697|NCT02393209|558912826|FG000|Overall Study|Withdrawal by Patient|1|||
154859698|NCT02393209|558912827|FG001|Overall Study|Withdrawal by Patient|0|||
154859699|NCT02393209|558912828|FG002|Overall Study|Withdrawal by Patient|0|||
154859700|NCT02393209|558912829|FG003|Overall Study|Withdrawal by Patient|0|||
154859701|NCT02393209|558912826|FG000|Overall Study|Death|2|||
154859702|NCT02393209|558912827|FG001|Overall Study|Death|2|||
154972295|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
154972296|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
154972297|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
154972298|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
154972299|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
154972300|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
154972301|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
154972302|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
154972303|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
154859703|NCT02393209|558912828|FG002|Overall Study|Death|0|||
154859704|NCT02393209|558912829|FG003|Overall Study|Death|0|||
154859705|NCT02393209|558912826|FG000|Overall Study|Death due to Disease Progression|2|||
154859706|NCT02393209|558912827|FG001|Overall Study|Death due to Disease Progression|2|||
154859707|NCT02393209|558912828|FG002|Overall Study|Death due to Disease Progression|0|||
154859708|NCT02393209|558912829|FG003|Overall Study|Death due to Disease Progression|0|||
154859709|NCT02393209|558912826|FG000|Overall Study|Death from Legionella Infection|0|||
154859710|NCT02393209|558912827|FG001|Overall Study|Death from Legionella Infection|1|||
154859711|NCT02393209|558912828|FG002|Overall Study|Death from Legionella Infection|0|||
154859712|NCT02393209|558912829|FG003|Overall Study|Death from Legionella Infection|0|||
154859713|NCT02393209|558912826|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
154859714|NCT02393209|558912827|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
154859715|NCT02393209|558912828|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
154859716|NCT02393209|558912829|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
154859717|NCT02393209|558912826|FG000|Overall Study|Lost to Follow-up|0|||
154859718|NCT02393209|558912827|FG001|Overall Study|Lost to Follow-up|1|||
154859719|NCT02393209|558912828|FG002|Overall Study|Lost to Follow-up|0|||
154859720|NCT02393209|558912829|FG003|Overall Study|Lost to Follow-up|0|||
154859721|NCT00727402|558912830|FG000|Overall Study|Physician Decision|116|||
154859722|NCT03751111|558912831|FG000|Overall Study|Lack of Efficacy|9|||
154859723|NCT03751111|558912832|FG001|Overall Study|Lack of Efficacy|30|||
154859724|NCT03751111|558912831|FG000|Overall Study|Adverse Event|3|||
154859725|NCT03751111|558912832|FG001|Overall Study|Adverse Event|2|||
154859726|NCT02582671|558912833|FG000|Overall Study|Failure to return|1|||
154859727|NCT02582671|558912833|FG000|Overall Study|Other, not specified|1|||
154859728|NCT01287104|558912838|FG000|Overall Study|Patient developed progressive disease|1|||
154859729|NCT01287104|558912839|FG001|Overall Study|Patient developed progressive disease|1|||
154859730|NCT01287104|558912840|FG002|Overall Study|Patient developed progressive disease|3|||
154859731|NCT01287104|558912841|FG003|Overall Study|Patient developed progressive disease|2|||
154859732|NCT01287104|558912838|FG000|Overall Study|Donor anaphylaxis|0|||
154859733|NCT01287104|558912839|FG001|Overall Study|Donor anaphylaxis|1|||
154859734|NCT01287104|558912840|FG002|Overall Study|Donor anaphylaxis|0|||
154859735|NCT01287104|558912841|FG003|Overall Study|Donor anaphylaxis|1|||
154859736|NCT01287104|558912838|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
154859737|NCT01287104|558912839|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
154859738|NCT01287104|558912840|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
154859739|NCT01287104|558912841|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
154859740|NCT01287104|558912838|FG000|Overall Study|Low donor chimerism|0|||
154859741|NCT01287104|558912839|FG001|Overall Study|Low donor chimerism|1|||
154859742|NCT01287104|558912840|FG002|Overall Study|Low donor chimerism|0|||
154859743|NCT01287104|558912841|FG003|Overall Study|Low donor chimerism|0|||
154859744|NCT01287104|558912838|FG000|Overall Study|NK cells did not meet release criteria|0|||
154859745|NCT01287104|558912839|FG001|Overall Study|NK cells did not meet release criteria|1|||
154859746|NCT01287104|558912840|FG002|Overall Study|NK cells did not meet release criteria|0|||
154859747|NCT01287104|558912841|FG003|Overall Study|NK cells did not meet release criteria|0|||
154859748|NCT00098787|558912842|FG000|Overall Study|Never started treatment|3|||
154859749|NCT00098787|558912843|FG001|Overall Study|Never started treatment|2|||
154859750|NCT00098787|558912844|FG002|Overall Study|Never started treatment|1|||
154972304|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
154972305|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
154972306|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
154972307|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
154972308|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
154972309|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
154972310|NCT00950300|559322363|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
154972311|NCT00950300|559322364|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
154972312|NCT00950300|559322363|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
154972313|NCT00950300|559322364|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
154972314|NCT00950300|559322363|FG000|TFFU Period|Death|4|||
154972315|NCT00950300|559322364|FG001|TFFU Period|Death|1|||
154972316|NCT00950300|559322363|FG000|TFFU Period|Refused Treatment|10|||
154972317|NCT00950300|559322364|FG001|TFFU Period|Refused Treatment|11|||
154972318|NCT00950300|559322363|FG000|TFFU Period|Failure to Return|16|||
154972319|NCT00950300|559322364|FG001|TFFU Period|Failure to Return|16|||
154972320|NCT00950300|559322363|FG000|TFFU Period|Recurrence of Disease|63|||
154972321|NCT00950300|559322364|FG001|TFFU Period|Recurrence of Disease|72|||
154972322|NCT00950300|559322363|FG000|TFFU Period|Other|4|||
154972323|NCT00950300|559322364|FG001|TFFU Period|Other|3|||
154972324|NCT00950300|559322363|FG000|SFU Period|Death|44|||
154972325|NCT00950300|559322364|FG001|SFU Period|Death|42|||
154972326|NCT00950300|559322363|FG000|SFU Period|Lost to Follow-up|30|||
154972327|NCT00950300|559322364|FG001|SFU Period|Lost to Follow-up|28|||
154972328|NCT00950300|559322363|FG000|SFU Period|Withdrawal by Subject|4|||
154972329|NCT00950300|559322364|FG001|SFU Period|Withdrawal by Subject|8|||
154972330|NCT03201003|559322369|FG000|Overall Study|Adverse Event|14|||
154972331|NCT03201003|559322370|FG001|Overall Study|Adverse Event|1|||
154972332|NCT03201003|559322369|FG000|Overall Study|Other reasons|5|||
154972333|NCT03201003|559322370|FG001|Overall Study|Other reasons|1|||
154972334|NCT03201003|559322369|FG000|Overall Study|Withdrawal by Subject|4|||
154972335|NCT03201003|559322370|FG001|Overall Study|Withdrawal by Subject|1|||
154972336|NCT03201003|559322369|FG000|Overall Study|Lost to Follow-up|2|||
154972337|NCT03201003|559322370|FG001|Overall Study|Lost to Follow-up|0|||
154972338|NCT03201003|559322369|FG000|Overall Study|Protocol Violation|1|||
154859751|NCT00098787|558912842|FG000|Overall Study|Ineligible|9|||
154859752|NCT00098787|558912843|FG001|Overall Study|Ineligible|7|||
154859753|NCT00098787|558912844|FG002|Overall Study|Ineligible|3|||
154972339|NCT03201003|559322370|FG001|Overall Study|Protocol Violation|0|||
154859754|NCT00098787|558912842|FG000|Overall Study|Disease progression|28|||
154972340|NCT00834613|559322371|FG000|First Intervention|Protocol Violation|1|||
154859755|NCT00098787|558912843|FG001|Overall Study|Disease progression|17|||
154859756|NCT00098787|558912844|FG002|Overall Study|Disease progression|23|||
154859757|NCT00098787|558912842|FG000|Overall Study|Adverse Event|8|||
154859758|NCT00098787|558912843|FG001|Overall Study|Adverse Event|17|||
154859759|NCT00098787|558912844|FG002|Overall Study|Adverse Event|8|||
154859760|NCT00098787|558912842|FG000|Overall Study|Death|6|||
154859761|NCT00098787|558912843|FG001|Overall Study|Death|1|||
154859762|NCT00098787|558912844|FG002|Overall Study|Death|0|||
154859763|NCT00098787|558912842|FG000|Overall Study|Withdrawal by Subject|4|||
154859764|NCT00098787|558912843|FG001|Overall Study|Withdrawal by Subject|12|||
154859765|NCT00098787|558912844|FG002|Overall Study|Withdrawal by Subject|6|||
154859766|NCT00098787|558912842|FG000|Overall Study|Alternative therapy|8|||
154859767|NCT00098787|558912843|FG001|Overall Study|Alternative therapy|13|||
154859768|NCT00098787|558912844|FG002|Overall Study|Alternative therapy|13|||
154859769|NCT00098787|558912842|FG000|Overall Study|Other|7|||
154859770|NCT00098787|558912843|FG001|Overall Study|Other|6|||
154859771|NCT00098787|558912844|FG002|Overall Study|Other|9|||
154859772|NCT00195650|558912850|FG000|Overall Study|Adverse Event|194|||
154859773|NCT00195650|558912850|FG000|Overall Study|Lack of Efficacy|99|||
154859774|NCT00195650|558912850|FG000|Overall Study|Withdrawal by Subject|67|||
154859775|NCT00195650|558912850|FG000|Overall Study|Lost to Follow-up|44|||
154859776|NCT00195650|558912850|FG000|Overall Study|Death|23|||
154859777|NCT00195650|558912850|FG000|Overall Study|Protocol Violation|15|||
154859778|NCT00195650|558912850|FG000|Overall Study|Administrative reasons|83|||
154859779|NCT01478958|558912851|FG000|Overall Study|Withdrawal by Subject|1|||
154859780|NCT01478958|558912852|FG001|Overall Study|Withdrawal by Subject|1|||
154859781|NCT01478958|558912853|FG002|Overall Study|Withdrawal by Subject|1|||
154859782|NCT01478958|558912851|FG000|Overall Study|Weight loss|1|||
154859783|NCT01478958|558912852|FG001|Overall Study|Weight loss|0|||
154859784|NCT01478958|558912853|FG002|Overall Study|Weight loss|0|||
154859785|NCT01478958|558912851|FG000|Overall Study|Re-located|0|||
154859786|NCT01478958|558912852|FG001|Overall Study|Re-located|1|||
154859787|NCT01478958|558912853|FG002|Overall Study|Re-located|0|||
154859788|NCT01478958|558912851|FG000|Overall Study|Unable to comply|0|||
154859789|NCT01478958|558912852|FG001|Overall Study|Unable to comply|0|||
154859790|NCT01478958|558912853|FG002|Overall Study|Unable to comply|2|||
154859791|NCT01147809|558912854|FG000|Phase I (168 Days)|Adverse Event|0|||
154859792|NCT01147809|558912855|FG001|Phase I (168 Days)|Adverse Event|0|||
154859793|NCT01147809|558912856|FG002|Phase I (168 Days)|Adverse Event|0|||
154859794|NCT01147809|558912857|FG003|Phase I (168 Days)|Adverse Event|1|||
154859795|NCT01147809|558912858|FG004|Phase I (168 Days)|Adverse Event|0|||
154859796|NCT01147809|558912859|FG005|Phase I (168 Days)|Adverse Event|0|||
154859797|NCT01147809|558912854|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
154859798|NCT01147809|558912855|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
154859799|NCT01147809|558912856|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
154859800|NCT01147809|558912857|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
154859801|NCT01147809|558912858|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
154859802|NCT01147809|558912859|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
154859803|NCT01147809|558912854|FG000|Phase I (168 Days)|Physician Decision|0|||
154859804|NCT01147809|558912855|FG001|Phase I (168 Days)|Physician Decision|1|||
154859805|NCT01147809|558912856|FG002|Phase I (168 Days)|Physician Decision|2|||
154859806|NCT01147809|558912857|FG003|Phase I (168 Days)|Physician Decision|0|||
154859807|NCT01147809|558912858|FG004|Phase I (168 Days)|Physician Decision|0|||
154859808|NCT01147809|558912859|FG005|Phase I (168 Days)|Physician Decision|0|||
154859809|NCT01147809|558912854|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
154859810|NCT01147809|558912855|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
154859811|NCT01147809|558912856|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
154859812|NCT01147809|558912857|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
155106820|NCT02836717|559819078|FG002|Study Phase|Adverse Event|0|||
154859813|NCT01147809|558912858|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
154859814|NCT01147809|558912859|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
154859815|NCT01147809|558912854|FG000|Phase II (168 Days)|Adverse Event|0|||
154859816|NCT01147809|558912855|FG001|Phase II (168 Days)|Adverse Event|0|||
154859817|NCT01147809|558912856|FG002|Phase II (168 Days)|Adverse Event|0|||
154859818|NCT01147809|558912857|FG003|Phase II (168 Days)|Adverse Event|0|||
154859819|NCT01147809|558912858|FG004|Phase II (168 Days)|Adverse Event|3|||
154859820|NCT01147809|558912859|FG005|Phase II (168 Days)|Adverse Event|6|||
154859821|NCT01147809|558912854|FG000|Phase II (168 Days)|Protocol Violation|0|||
154859822|NCT01147809|558912855|FG001|Phase II (168 Days)|Protocol Violation|0|||
154859823|NCT01147809|558912856|FG002|Phase II (168 Days)|Protocol Violation|0|||
154859824|NCT01147809|558912857|FG003|Phase II (168 Days)|Protocol Violation|0|||
154859825|NCT01147809|558912858|FG004|Phase II (168 Days)|Protocol Violation|0|||
154859826|NCT01147809|558912859|FG005|Phase II (168 Days)|Protocol Violation|1|||
154859827|NCT01147809|558912854|FG000|Phase II (168 Days)|Physician Decision|0|||
154859828|NCT01147809|558912855|FG001|Phase II (168 Days)|Physician Decision|0|||
154859829|NCT01147809|558912856|FG002|Phase II (168 Days)|Physician Decision|0|||
154859830|NCT01147809|558912857|FG003|Phase II (168 Days)|Physician Decision|0|||
154859831|NCT01147809|558912858|FG004|Phase II (168 Days)|Physician Decision|5|||
154859832|NCT01147809|558912859|FG005|Phase II (168 Days)|Physician Decision|11|||
154859833|NCT01147809|558912854|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
154859834|NCT01147809|558912855|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
154859835|NCT01147809|558912856|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
154859836|NCT01147809|558912857|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
154859837|NCT01147809|558912858|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
154859838|NCT01147809|558912859|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
154859839|NCT01147809|558912854|FG000|Phase II (168 Days)|Ongoing|0|||
154859840|NCT01147809|558912855|FG001|Phase II (168 Days)|Ongoing|0|||
155106821|NCT02836717|559819076|FG000|Study Phase|Lack of Efficacy|8|||
155106822|NCT02836717|559819077|FG001|Study Phase|Lack of Efficacy|6|||
154859841|NCT01147809|558912856|FG002|Phase II (168 Days)|Ongoing|0|||
154859842|NCT01147809|558912857|FG003|Phase II (168 Days)|Ongoing|0|||
154859843|NCT01147809|558912858|FG004|Phase II (168 Days)|Ongoing|1|||
154859844|NCT01147809|558912859|FG005|Phase II (168 Days)|Ongoing|0|||
154859845|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
154859846|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
154859847|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
154859848|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
154859849|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
154859850|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
154859851|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
154859852|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
154859853|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
154859854|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
154859855|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
154859856|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
154859857|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
154859858|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
154859859|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
154859860|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
154859861|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
154859862|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
154859863|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
154859864|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
154859865|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
154859866|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
154859867|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
154859868|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
154859869|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
154859870|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
154859871|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
154859872|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859873|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859874|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
154859875|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859876|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859877|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859878|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859879|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859880|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
154859881|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
154859882|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
154859883|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
154859884|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
154859885|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
154859886|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
154859887|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
154859888|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
154859889|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
154859890|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
154859891|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859892|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859893|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859894|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859895|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859896|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155106823|NCT02836717|559819078|FG002|Study Phase|Lack of Efficacy|1|||
154859897|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859898|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
154859899|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
154859900|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
154859901|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859902|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859903|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859904|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859905|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859906|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859907|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
154859908|NCT01307423|558912860|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859909|NCT01307423|558912861|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
154859910|NCT01307423|558912862|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
154859911|NCT01307423|558912863|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859912|NCT01307423|558912864|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859913|NCT01307423|558912865|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859914|NCT01307423|558912866|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859915|NCT01307423|558912867|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859916|NCT01307423|558912868|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
154859917|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
154859918|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
154859919|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
154859920|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
154859921|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
154859922|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
154859923|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
154859924|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
154859925|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
154859926|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
154859927|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
154859928|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
154859929|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
154859930|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
154859931|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
154859932|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
154859933|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
154859934|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
154859935|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859936|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859937|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859938|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859939|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859940|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
154859941|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859942|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859943|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
154859944|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
154859945|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
154859946|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
154859947|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
154859948|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
154859949|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
154859950|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
154859951|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
154859952|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
155106824|NCT02836717|559819076|FG000|Study Phase|Withdrawal by Subject|1|||
155106825|NCT02836717|559819077|FG001|Study Phase|Withdrawal by Subject|0|||
155106826|NCT02836717|559819078|FG002|Study Phase|Withdrawal by Subject|0|||
154859953|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859954|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859955|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859956|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
154859957|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
155106827|NCT02836717|559819076|FG000|Study Phase|Death|1|||
154859958|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859959|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859960|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859961|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
154859962|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
154859963|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
154859964|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
154859965|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
154859966|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
154859967|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
154859968|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
154859969|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
154859970|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
154859971|NCT01307423|558912860|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859972|NCT01307423|558912861|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859973|NCT01307423|558912862|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859974|NCT01307423|558912863|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859975|NCT01307423|558912864|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859976|NCT01307423|558912865|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
154859977|NCT01307423|558912866|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859978|NCT01307423|558912867|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859979|NCT01307423|558912868|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
154859980|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
154859981|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
154859982|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
154859983|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
154859984|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
154859985|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
154859986|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
154859987|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
154859988|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
154859989|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
154859990|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
154859991|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
154859992|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
154859993|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
154859994|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
154859995|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
154859996|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
154859997|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
154859998|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154859999|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860000|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
154860001|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860002|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860003|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860004|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860005|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860006|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
154860007|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
154860008|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
154860009|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
154860010|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
154860011|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
154860012|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
154860013|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
154860014|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
154860015|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
154860016|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
154860017|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
154860018|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
154860019|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
154860020|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155106828|NCT02836717|559819077|FG001|Study Phase|Death|0|||
154860021|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
154860022|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155106829|NCT02836717|559819078|FG002|Study Phase|Death|0|||
155106830|NCT02836717|559819076|FG000|Study Phase|abdominal surgeries|2|||
155106831|NCT02836717|559819077|FG001|Study Phase|abdominal surgeries|1|||
155106832|NCT02836717|559819078|FG002|Study Phase|abdominal surgeries|0|||
155106833|NCT01309997|559819079|FG000|Overall Study|Adverse Event|1|||
154860023|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
154860024|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
154860025|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
154860026|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
154860027|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
154860028|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
154860029|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
154860030|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
154860031|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
154860032|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
154860033|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
154860034|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
154860035|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
154860036|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
154860037|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
154860038|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
154860039|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
154860040|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
154860041|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
154860042|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
154860043|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860044|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
154860045|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
154860046|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860047|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860048|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860049|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860050|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860051|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
154860052|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
154860053|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
154860054|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
154860055|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
154860056|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
154860057|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
154860058|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
154860059|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
154860060|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
154860061|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
154860062|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
154860063|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
154860064|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
154860065|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
154860066|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
154860067|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
154860068|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
154860069|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
154860070|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860071|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
154860072|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860073|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860074|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860075|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860076|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860077|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
154860078|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
154860079|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860080|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
155106834|NCT01309997|559819080|FG001|Overall Study|Adverse Event|0|||
155106835|NCT01309997|559819079|FG000|Overall Study|Death|1|||
154860081|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860082|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860083|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860084|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860085|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155106836|NCT01309997|559819080|FG001|Overall Study|Death|3|||
154860086|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860087|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
154860088|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860089|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
154860090|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860091|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860092|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860093|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860094|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860095|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
154860096|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
154860097|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
154860098|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
154860099|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
154860100|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
154860101|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
154860102|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
154860103|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
154860104|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
154860105|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
154860106|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860107|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860108|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
154860109|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860110|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860111|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860112|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860113|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860114|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
154860115|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860116|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860117|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860118|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860119|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860120|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860121|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860122|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
154860123|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
154860124|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
154860125|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
154860126|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
154860127|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
154860128|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
154860129|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
154860130|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
154860131|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
154860132|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
154860133|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860134|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
154860135|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
154860136|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860137|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860138|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860139|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860140|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860141|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
154860142|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
154860143|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
154860144|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
154860145|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
154860146|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
154860147|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
154860148|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
154860149|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
154860150|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
154860151|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860152|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
154860153|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860154|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860155|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860156|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860157|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860158|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860159|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
154860160|NCT01307423|558912860|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
154860161|NCT01307423|558912861|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
154860162|NCT01307423|558912862|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
154860163|NCT01307423|558912863|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
154860164|NCT01307423|558912864|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
154860165|NCT01307423|558912865|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
154860166|NCT01307423|558912866|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
154860167|NCT01307423|558912867|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
154860168|NCT01307423|558912868|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
154860169|NCT01499290|558912869|FG000|Overall Study|Withdrawal by Subject|22|||
154860170|NCT01499290|558912870|FG001|Overall Study|Withdrawal by Subject|15|||
154860171|NCT01499290|558912869|FG000|Overall Study|Not specified in study report|11|||
154860172|NCT01499290|558912870|FG001|Overall Study|Not specified in study report|5|||
154860173|NCT01499290|558912869|FG000|Overall Study|Condition improved/subject recovered|1|||
154860174|NCT01499290|558912870|FG001|Overall Study|Condition improved/subject recovered|0|||
154860175|NCT01499290|558912869|FG000|Overall Study|Lack of Efficacy|7|||
154860176|NCT01499290|558912870|FG001|Overall Study|Lack of Efficacy|8|||
154860177|NCT01499290|558912869|FG000|Overall Study|Adverse Event|14|||
154860178|NCT01499290|558912870|FG001|Overall Study|Adverse Event|7|||
154860179|NCT00707577|558912871|FG000|Overall Study|Withdrawal by Subject|3|||
154860180|NCT00707577|558912872|FG001|Overall Study|Withdrawal by Subject|2|||
154860181|NCT00707577|558912871|FG000|Overall Study|Lost to Follow-up|34|||
154860182|NCT00707577|558912872|FG001|Overall Study|Lost to Follow-up|25|||
154860183|NCT00707577|558912871|FG000|Overall Study|Left employment|13|||
154860184|NCT00707577|558912872|FG001|Overall Study|Left employment|10|||
154860185|NCT00707577|558912871|FG000|Overall Study|Pregnancy|4|||
154860186|NCT00707577|558912872|FG001|Overall Study|Pregnancy|1|||
154860187|NCT00190775|558912873|FG000|Overall Study|Adverse Event|57|||
154860188|NCT00190775|558912874|FG001|Overall Study|Adverse Event|22|||
154860189|NCT00190775|558912873|FG000|Overall Study|Satisfactory Response|1|||
154860190|NCT00190775|558912874|FG001|Overall Study|Satisfactory Response|0|||
154860191|NCT00190775|558912873|FG000|Overall Study|Lack of Efficacy|28|||
154860192|NCT00190775|558912874|FG001|Overall Study|Lack of Efficacy|32|||
154860193|NCT00190775|558912873|FG000|Overall Study|Lost to Follow-up|31|||
154860194|NCT00190775|558912874|FG001|Overall Study|Lost to Follow-up|23|||
154860195|NCT00190775|558912873|FG000|Overall Study|Participant Moved|0|||
154860196|NCT00190775|558912874|FG001|Overall Study|Participant Moved|1|||
154860197|NCT00190775|558912873|FG000|Overall Study|Withdrawal by Subject|24|||
154860198|NCT00190775|558912874|FG001|Overall Study|Withdrawal by Subject|13|||
154860199|NCT00190775|558912873|FG000|Overall Study|Sponsor Decision|1|||
154860200|NCT00190775|558912874|FG001|Overall Study|Sponsor Decision|0|||
154860201|NCT00190775|558912873|FG000|Overall Study|Physician Decision|3|||
154860202|NCT00190775|558912874|FG001|Overall Study|Physician Decision|0|||
154860203|NCT00190775|558912873|FG000|Overall Study|Noncompliance|3|||
154860204|NCT00190775|558912874|FG001|Overall Study|Noncompliance|5|||
154860205|NCT00190775|558912873|FG000|Overall Study|Protocol Violation|0|||
154860206|NCT00190775|558912874|FG001|Overall Study|Protocol Violation|1|||
154860207|NCT00190775|558912873|FG000|Overall Study|Exclusion Criteria Met|1|||
154860208|NCT00190775|558912874|FG001|Overall Study|Exclusion Criteria Met|3|||
154860209|NCT01794780|558912875|FG000|Overall Study|Adverse Event|0|||
154860210|NCT01794780|558912876|FG001|Overall Study|Adverse Event|1|||
154860211|NCT01794780|558912877|FG002|Overall Study|Adverse Event|2|||
154860212|NCT01794780|558912878|FG003|Overall Study|Adverse Event|0|||
154860213|NCT01794780|558912879|FG004|Overall Study|Adverse Event|0|||
154860214|NCT01794780|558912880|FG005|Overall Study|Adverse Event|0|||
154860215|NCT01794780|558912881|FG006|Overall Study|Adverse Event|0|||
154860216|NCT01794780|558912882|FG007|Overall Study|Adverse Event|0|||
154860217|NCT01794780|558912875|FG000|Overall Study|Death|0|||
154860218|NCT01794780|558912876|FG001|Overall Study|Death|2|||
154860219|NCT01794780|558912877|FG002|Overall Study|Death|14|||
154860220|NCT01794780|558912878|FG003|Overall Study|Death|1|||
155106837|NCT01309997|559819079|FG000|Overall Study|Lack of Efficacy|2|||
154860221|NCT01794780|558912879|FG004|Overall Study|Death|0|||
154860222|NCT01794780|558912880|FG005|Overall Study|Death|9|||
154860223|NCT01794780|558912881|FG006|Overall Study|Death|4|||
154860224|NCT01794780|558912882|FG007|Overall Study|Death|0|||
154860225|NCT01794780|558912875|FG000|Overall Study|Lost to Follow-up|10|||
154860226|NCT01794780|558912876|FG001|Overall Study|Lost to Follow-up|64|||
154860227|NCT01794780|558912877|FG002|Overall Study|Lost to Follow-up|165|||
154860228|NCT01794780|558912878|FG003|Overall Study|Lost to Follow-up|53|||
154860229|NCT01794780|558912879|FG004|Overall Study|Lost to Follow-up|2|||
154860230|NCT01794780|558912880|FG005|Overall Study|Lost to Follow-up|99|||
154860231|NCT01794780|558912881|FG006|Overall Study|Lost to Follow-up|30|||
154860232|NCT01794780|558912882|FG007|Overall Study|Lost to Follow-up|5|||
154972341|NCT00834613|559322372|FG001|First Intervention|Protocol Violation|0|||
154972342|NCT01709903|559322373|FG000|Overall Study|administrative problems|2|||
154860233|NCT01794780|558912875|FG000|Overall Study|Withdrew informed consent|7|||
154860234|NCT01794780|558912876|FG001|Overall Study|Withdrew informed consent|17|||
154860235|NCT01794780|558912877|FG002|Overall Study|Withdrew informed consent|36|||
154860236|NCT01794780|558912878|FG003|Overall Study|Withdrew informed consent|9|||
154860237|NCT01794780|558912879|FG004|Overall Study|Withdrew informed consent|0|||
154860238|NCT01794780|558912880|FG005|Overall Study|Withdrew informed consent|48|||
154860239|NCT01794780|558912881|FG006|Overall Study|Withdrew informed consent|4|||
154860240|NCT01794780|558912882|FG007|Overall Study|Withdrew informed consent|3|||
154860241|NCT01794780|558912875|FG000|Overall Study|Other|0|||
154860242|NCT01794780|558912876|FG001|Overall Study|Other|12|||
154860243|NCT01794780|558912877|FG002|Overall Study|Other|25|||
154860244|NCT01794780|558912878|FG003|Overall Study|Other|20|||
154860245|NCT01794780|558912879|FG004|Overall Study|Other|1|||
154860246|NCT01794780|558912880|FG005|Overall Study|Other|24|||
154860247|NCT01794780|558912881|FG006|Overall Study|Other|4|||
154860248|NCT01794780|558912882|FG007|Overall Study|Other|1|||
154860249|NCT02209766|558912884|FG000|Overall Study|Withdrawal by Subject|0|||
154860250|NCT02209766|558912885|FG001|Overall Study|Withdrawal by Subject|0|||
154860251|NCT02209766|558912886|FG002|Overall Study|Withdrawal by Subject|0|||
154860252|NCT02209766|558912887|FG003|Overall Study|Withdrawal by Subject|1|||
154860253|NCT02209766|558912888|FG004|Overall Study|Withdrawal by Subject|0|||
154860254|NCT00327444|558912889|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
154860255|NCT00327444|558912890|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
154860256|NCT00327444|558912889|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
154860257|NCT00327444|558912890|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
154860258|NCT00327444|558912889|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
154860259|NCT00327444|558912890|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
154860260|NCT00327444|558912889|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
154860261|NCT00327444|558912890|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
154860262|NCT00327444|558912889|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
154860263|NCT00327444|558912890|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
154860264|NCT00327444|558912889|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
154860265|NCT00327444|558912890|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
154860266|NCT00327444|558912889|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
154860267|NCT00327444|558912890|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
154860268|NCT00327444|558912889|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
154860269|NCT00327444|558912890|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
154860270|NCT01791855|558912892|FG000|Overall Study|Adverse Event|0|||
154860271|NCT01791855|558912893|FG001|Overall Study|Adverse Event|0|||
154860272|NCT01791855|558912894|FG002|Overall Study|Adverse Event|0|||
154860273|NCT01791855|558912895|FG003|Overall Study|Adverse Event|1|||
154860274|NCT01791855|558912892|FG000|Overall Study|Randomized, not treated|0|||
154860275|NCT01791855|558912893|FG001|Overall Study|Randomized, not treated|1|||
154860276|NCT01791855|558912894|FG002|Overall Study|Randomized, not treated|0|||
154860277|NCT01791855|558912895|FG003|Overall Study|Randomized, not treated|0|||
154860278|NCT01709331|558912896|FG000|Overall Study|Adverse Event|1|||
154860279|NCT04439344|558912897|FG000|Overall Study|Never started threapy|3|||
154860280|NCT04439344|558912897|FG000|Overall Study|Ineligible|3|||
154860281|NCT04439344|558912897|FG000|Overall Study|Adverse Event|13|||
154860282|NCT04439344|558912897|FG000|Overall Study|Death|2|||
154860283|NCT04439344|558912897|FG000|Overall Study|Disease progression|29|||
154860284|NCT04439344|558912897|FG000|Overall Study|Withdrawal by Subject|2|||
154860285|NCT04439344|558912897|FG000|Overall Study|Alternative therapy|1|||
154860286|NCT03770403|558912898|FG000|Overall Study|Adverse Event|8|||
154860287|NCT03770403|558912898|FG000|Overall Study|Death|5|||
154860288|NCT03770403|558912898|FG000|Overall Study|Physician Decision|1|||
154860289|NCT03770403|558912898|FG000|Overall Study|Sponsor decision|1|||
154860290|NCT03770403|558912898|FG000|Overall Study|Study terminated by Sponsor|1|||
154860291|NCT03770403|558912898|FG000|Overall Study|Withdrawal by Subject|13|||
154860292|NCT03770403|558912898|FG000|Overall Study|Other|88|||
154860293|NCT00642642|558912909|FG000|Treatment & Follow Up|Adverse Event|2|||
154860294|NCT00642642|558912909|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
154860295|NCT00642642|558912909|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
154972343|NCT01709903|559322374|FG001|Overall Study|administrative problems|6|||
154860296|NCT02500537|558912910|FG000|Overall Study|Death|2|||
154860297|NCT02500537|558912911|FG001|Overall Study|Death|0|||
154972344|NCT01709903|559322373|FG000|Overall Study|Abnormal test procedure results|1|||
154972345|NCT01709903|559322374|FG001|Overall Study|Abnormal test procedure results|0|||
154860298|NCT02500537|558912910|FG000|Overall Study|Lost to Follow-up|0|||
154860299|NCT02500537|558912911|FG001|Overall Study|Lost to Follow-up|1|||
154972346|NCT01709903|559322373|FG000|Overall Study|In ability to use device|1|||
154860300|NCT02500537|558912910|FG000|Overall Study|Withdrawal by Subject|1|||
154972347|NCT01709903|559322374|FG001|Overall Study|In ability to use device|1|||
154972348|NCT01709903|559322373|FG000|Overall Study|no longer needed study drug|0|||
155106838|NCT01309997|559819080|FG001|Overall Study|Lack of Efficacy|2|||
155106839|NCT01309997|559819079|FG000|Overall Study|Withdrawal by Subject|1|||
155106840|NCT01309997|559819080|FG001|Overall Study|Withdrawal by Subject|1|||
155106841|NCT00282087|559819081|FG000|Overall Study|Death|1|||
155106842|NCT00405392|559819082|FG000|Overall Study|Adverse Event|15|||
154860301|NCT02500537|558912911|FG001|Overall Study|Withdrawal by Subject|0|||
154860302|NCT00355121|558912912|FG000|Overall Study|Did not receive study vaccine|1|||
154860303|NCT00355121|558912913|FG001|Overall Study|Did not receive study vaccine|0|||
154860304|NCT00355121|558912914|FG002|Overall Study|Did not receive study vaccine|1|||
154860305|NCT00355121|558912912|FG000|Overall Study|Adverse Event|0|||
154860306|NCT00355121|558912913|FG001|Overall Study|Adverse Event|1|||
154860307|NCT00355121|558912914|FG002|Overall Study|Adverse Event|0|||
154860308|NCT00355121|558912912|FG000|Overall Study|Protocol Violation|7|||
154860309|NCT00355121|558912913|FG001|Overall Study|Protocol Violation|9|||
154860310|NCT00355121|558912914|FG002|Overall Study|Protocol Violation|1|||
154860311|NCT00355121|558912912|FG000|Overall Study|Lost to Follow-up|4|||
154860312|NCT00355121|558912913|FG001|Overall Study|Lost to Follow-up|7|||
154860313|NCT00355121|558912914|FG002|Overall Study|Lost to Follow-up|1|||
154860314|NCT00355121|558912912|FG000|Overall Study|Withdrawal by Subject|9|||
154860315|NCT00355121|558912913|FG001|Overall Study|Withdrawal by Subject|10|||
154860316|NCT00355121|558912914|FG002|Overall Study|Withdrawal by Subject|2|||
154860317|NCT00355121|558912912|FG000|Overall Study|Serious adverse events|0|||
154860318|NCT00355121|558912913|FG001|Overall Study|Serious adverse events|2|||
154860319|NCT00355121|558912914|FG002|Overall Study|Serious adverse events|0|||
154860320|NCT01587989|558912915|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
154860321|NCT01587989|558912916|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
154860322|NCT01587989|558912917|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
154860323|NCT01587989|558912915|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
154860324|NCT01587989|558912916|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
154860325|NCT01587989|558912917|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
154860326|NCT01587989|558912915|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
154860327|NCT01587989|558912916|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
154860328|NCT01587989|558912917|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
154860329|NCT01587989|558912915|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
154860330|NCT01587989|558912916|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
154860331|NCT01587989|558912917|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
154860332|NCT01587989|558912915|FG000|Randomized Study Treatment|Screening failure|0|||
154860333|NCT01587989|558912916|FG001|Randomized Study Treatment|Screening failure|1|||
154860334|NCT01587989|558912917|FG002|Randomized Study Treatment|Screening failure|0|||
154860335|NCT01587989|558912915|FG000|Randomized Study Treatment|Physician Decision|0|||
154860336|NCT01587989|558912916|FG001|Randomized Study Treatment|Physician Decision|0|||
154860337|NCT01587989|558912917|FG002|Randomized Study Treatment|Physician Decision|1|||
154860338|NCT03313050|558912918|FG000|Stage 2: 12 Months|Adverse Event|0|||
154860339|NCT03313050|558912919|FG001|Stage 2: 12 Months|Adverse Event|0|||
154860340|NCT03313050|558912920|FG002|Stage 2: 12 Months|Adverse Event|0|||
154860341|NCT03313050|558912921|FG003|Stage 2: 12 Months|Adverse Event|1|||
154860342|NCT03313050|558912918|FG000|Stage 2: 12 Months|Death|0|||
154860343|NCT03313050|558912919|FG001|Stage 2: 12 Months|Death|0|||
154860344|NCT03313050|558912920|FG002|Stage 2: 12 Months|Death|3|||
154860345|NCT03313050|558912921|FG003|Stage 2: 12 Months|Death|0|||
154860346|NCT03313050|558912918|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
154860347|NCT03313050|558912919|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
154860348|NCT03313050|558912920|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
154860349|NCT03313050|558912921|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
154860350|NCT03313050|558912918|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
154860351|NCT03313050|558912919|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
155106843|NCT00405392|559819083|FG001|Overall Study|Adverse Event|14|||
155106844|NCT00405392|559819082|FG000|Overall Study|Did not meet Eligibility criteria|7|||
154860352|NCT03313050|558912920|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
154860353|NCT03313050|558912921|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
154860354|NCT03313050|558912918|FG000|Stage 2: 12 Months|Protocol deviation|0|||
154860355|NCT03313050|558912919|FG001|Stage 2: 12 Months|Protocol deviation|0|||
154860356|NCT03313050|558912920|FG002|Stage 2: 12 Months|Protocol deviation|7|||
154860357|NCT03313050|558912921|FG003|Stage 2: 12 Months|Protocol deviation|7|||
154860358|NCT03313050|558912918|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
155106845|NCT00405392|559819083|FG001|Overall Study|Did not meet Eligibility criteria|2|||
155106846|NCT00405392|559819082|FG000|Overall Study|Withdrawal by Subject|4|||
155106847|NCT00405392|559819083|FG001|Overall Study|Withdrawal by Subject|3|||
154860359|NCT03313050|558912919|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
154860360|NCT03313050|558912920|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
154860361|NCT03313050|558912921|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
154860362|NCT03313050|558912918|FG000|Stage 2: 12 Months|Other|0|||
154860363|NCT03313050|558912919|FG001|Stage 2: 12 Months|Other|0|||
154860364|NCT03313050|558912920|FG002|Stage 2: 12 Months|Other|0|||
154860365|NCT03313050|558912921|FG003|Stage 2: 12 Months|Other|1|||
154860366|NCT04211337|558912922|FG000|Overall Study|On Treatment|175|||
154860367|NCT04211337|558912923|FG001|Overall Study|On Treatment|40|||
154860368|NCT04211337|558912922|FG000|Overall Study|Withdrawal by Subject|0|||
154860369|NCT04211337|558912923|FG001|Overall Study|Withdrawal by Subject|2|||
154860370|NCT05630846|558915657|FG000|Overall Study|Death|1|||
154860371|NCT05630846|558915658|FG001|Overall Study|Death|0|||
154860372|NCT05630846|558915659|FG002|Overall Study|Death|0|||
154860373|NCT05630846|558915660|FG003|Overall Study|Death|0|||
154860374|NCT05630846|558915657|FG000|Overall Study|Withdrawal by Subject|3|||
154860375|NCT05630846|558915658|FG001|Overall Study|Withdrawal by Subject|3|||
154860376|NCT05630846|558915659|FG002|Overall Study|Withdrawal by Subject|4|||
154860377|NCT05630846|558915660|FG003|Overall Study|Withdrawal by Subject|1|||
154860378|NCT05630846|558915657|FG000|Overall Study|Lost to Follow-up|6|||
154860379|NCT05630846|558915658|FG001|Overall Study|Lost to Follow-up|5|||
154860380|NCT05630846|558915659|FG002|Overall Study|Lost to Follow-up|2|||
154860381|NCT05630846|558915660|FG003|Overall Study|Lost to Follow-up|5|||
154860382|NCT05630846|558915657|FG000|Overall Study|Other|1|||
154860383|NCT05630846|558915658|FG001|Overall Study|Other|0|||
154860384|NCT05630846|558915659|FG002|Overall Study|Other|0|||
154860385|NCT05630846|558915660|FG003|Overall Study|Other|0|||
154860386|NCT03019549|558915661|FG000|Washout|DId not meet genotype criteria|11|||
154860387|NCT03019549|558915661|FG000|Period 2|Adverse Event|2|||
154860388|NCT03019549|558915661|FG000|Period 2|Physician Decision|2|||
154860389|NCT03019549|558915661|FG000|Period 2|Withdrawal by Subject|1|||
154860390|NCT01412879|558915662|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
154860391|NCT01412879|558915663|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
154860392|NCT01412879|558915664|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
154860393|NCT01412879|558915662|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
154860394|NCT01412879|558915663|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
154860395|NCT01412879|558915664|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
154860396|NCT01412879|558915662|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
154860397|NCT01412879|558915663|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
154860398|NCT01412879|558915664|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
154860399|NCT01412879|558915662|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
154860400|NCT01412879|558915663|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
154860401|NCT01412879|558915664|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
154860402|NCT01412879|558915662|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
154860403|NCT01412879|558915663|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
154860404|NCT01412879|558915664|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
154860405|NCT04030195|558915665|FG000|Overall Study|Withdrawal by Subject|2|||
154860406|NCT04030195|558915666|FG001|Overall Study|Withdrawal by Subject|0|||
154860407|NCT04030195|558915667|FG002|Overall Study|Withdrawal by Subject|0|||
154860408|NCT01056107|558915669|FG000|Overall Study|Withdrawal by Subject|0|||
154860409|NCT01056107|558915670|FG001|Overall Study|Withdrawal by Subject|1|||
154860410|NCT01056107|558915671|FG002|Overall Study|Withdrawal by Subject|3|||
154860411|NCT01056107|558915672|FG003|Overall Study|Withdrawal by Subject|0|||
154860412|NCT00377962|558915673|FG000|Core Study: 0-12 Months|Adverse Event|18|||
154860413|NCT00377962|558915674|FG001|Core Study: 0-12 Months|Adverse Event|2|||
154860414|NCT00377962|558915673|FG000|Core Study: 0-12 Months|Death|3|||
154860415|NCT00377962|558915674|FG001|Core Study: 0-12 Months|Death|0|||
154860416|NCT00377962|558915673|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
154860417|NCT00377962|558915674|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
154860418|NCT00377962|558915673|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
154860419|NCT00377962|558915674|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
154860420|NCT00377962|558915673|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
154860421|NCT00377962|558915674|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
154860422|NCT00377962|558915673|FG000|Extension Study: 12-24 Months|Death|1|||
154860423|NCT00377962|558915674|FG001|Extension Study: 12-24 Months|Death|1|||
154860424|NCT00377962|558915673|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
154860425|NCT00377962|558915674|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
154860426|NCT00377962|558915673|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
154860427|NCT00377962|558915674|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
154860428|NCT00377962|558915673|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
154860429|NCT00377962|558915674|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
154972349|NCT01709903|559322374|FG001|Overall Study|no longer needed study drug|1|||
155106848|NCT00405392|559819082|FG000|Overall Study|Lost to Follow-up|1|||
154860430|NCT00260208|558915682|FG000|Overall Study|Subject withdrew consent|11|||
154860431|NCT00260208|558915683|FG001|Overall Study|Subject withdrew consent|7|||
154860432|NCT00260208|558915682|FG000|Overall Study|Lost to Follow-up|6|||
154860433|NCT00260208|558915683|FG001|Overall Study|Lost to Follow-up|1|||
155106849|NCT00405392|559819083|FG001|Overall Study|Lost to Follow-up|2|||
154860434|NCT00260208|558915682|FG000|Overall Study|Death|12|||
154860435|NCT00260208|558915683|FG001|Overall Study|Death|10|||
154860436|NCT00260208|558915682|FG000|Overall Study|Missing|18|||
154860437|NCT00260208|558915683|FG001|Overall Study|Missing|16|||
154860438|NCT03323749|558915684|FG000|Double-blind Period|Lost to Follow-up|4|||
154860439|NCT03323749|558915685|FG001|Double-blind Period|Lost to Follow-up|5|||
154860440|NCT03323749|558915684|FG000|Double-blind Period|Adverse Event|3|||
154860441|NCT03323749|558915685|FG001|Double-blind Period|Adverse Event|1|||
154860442|NCT03323749|558915684|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
154860443|NCT03323749|558915685|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
154860444|NCT03323749|558915684|FG000|Open-Label Period|Adverse Event|3|||
154860445|NCT03323749|558915685|FG001|Open-Label Period|Adverse Event|10|||
154860446|NCT03323749|558915684|FG000|Open-Label Period|Withdrawal by Subject|7|||
154860447|NCT03323749|558915685|FG001|Open-Label Period|Withdrawal by Subject|5|||
154860448|NCT03263091|558915686|FG000|OL Component|Withdrawal by Subject|1|||
154860449|NCT03263091|558915687|FG001|OL Component|Withdrawal by Subject|1|||
154860450|NCT03263091|558915688|FG002|OL Component|Withdrawal by Subject|0|||
154860451|NCT03263091|558915689|FG003|OL Component|Withdrawal by Subject|0|||
154860452|NCT03263091|558915690|FG004|OL Component|Withdrawal by Subject|0|||
154860453|NCT03263091|558915691|FG005|OL Component|Withdrawal by Subject|0|||
154860454|NCT03263091|558915686|FG000|OL Component|Physician Decision|0|||
154860455|NCT03263091|558915687|FG001|OL Component|Physician Decision|1|||
154860456|NCT03263091|558915688|FG002|OL Component|Physician Decision|2|||
154860457|NCT03263091|558915689|FG003|OL Component|Physician Decision|0|||
154860458|NCT03263091|558915690|FG004|OL Component|Physician Decision|0|||
154860459|NCT03263091|558915691|FG005|OL Component|Physician Decision|0|||
154860460|NCT03263091|558915686|FG000|OL Component|Death|1|||
154860461|NCT03263091|558915687|FG001|OL Component|Death|0|||
154860462|NCT03263091|558915688|FG002|OL Component|Death|0|||
154860463|NCT03263091|558915689|FG003|OL Component|Death|0|||
154860464|NCT03263091|558915690|FG004|OL Component|Death|0|||
154860465|NCT03263091|558915691|FG005|OL Component|Death|0|||
154860466|NCT03263091|558915686|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
154860467|NCT03263091|558915687|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
154860468|NCT03263091|558915688|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
154860469|NCT03263091|558915689|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
154860470|NCT03263091|558915690|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
154860471|NCT03263091|558915691|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
154860472|NCT03263091|558915686|FG000|OL High-EPO Component|Physician Decision|0|||
154860473|NCT03263091|558915687|FG001|OL High-EPO Component|Physician Decision|0|||
154860474|NCT03263091|558915688|FG002|OL High-EPO Component|Physician Decision|0|||
154860475|NCT03263091|558915689|FG003|OL High-EPO Component|Physician Decision|1|||
154860476|NCT03263091|558915690|FG004|OL High-EPO Component|Physician Decision|0|||
154860477|NCT03263091|558915691|FG005|OL High-EPO Component|Physician Decision|0|||
154860478|NCT03263091|558915686|FG000|OL High-EPO Component|Death|0|||
154860479|NCT03263091|558915687|FG001|OL High-EPO Component|Death|0|||
154860480|NCT03263091|558915688|FG002|OL High-EPO Component|Death|0|||
154860481|NCT03263091|558915689|FG003|OL High-EPO Component|Death|3|||
154860482|NCT03263091|558915690|FG004|OL High-EPO Component|Death|0|||
154860483|NCT03263091|558915691|FG005|OL High-EPO Component|Death|0|||
154860484|NCT03263091|558915686|FG000|DB Component|Withdrawal by Subject|0|||
154860485|NCT03263091|558915687|FG001|DB Component|Withdrawal by Subject|0|||
154860486|NCT03263091|558915688|FG002|DB Component|Withdrawal by Subject|0|||
154860487|NCT03263091|558915689|FG003|DB Component|Withdrawal by Subject|0|||
154860488|NCT03263091|558915690|FG004|DB Component|Withdrawal by Subject|22|||
154860489|NCT03263091|558915691|FG005|DB Component|Withdrawal by Subject|8|||
154860490|NCT03263091|558915686|FG000|DB Component|Physician Decision|0|||
154860491|NCT03263091|558915687|FG001|DB Component|Physician Decision|0|||
154860492|NCT03263091|558915688|FG002|DB Component|Physician Decision|0|||
154860493|NCT03263091|558915689|FG003|DB Component|Physician Decision|0|||
154860494|NCT03263091|558915690|FG004|DB Component|Physician Decision|3|||
154860495|NCT03263091|558915691|FG005|DB Component|Physician Decision|1|||
154860496|NCT03263091|558915686|FG000|DB Component|Adverse Event|0|||
154860497|NCT03263091|558915687|FG001|DB Component|Adverse Event|0|||
154860498|NCT03263091|558915688|FG002|DB Component|Adverse Event|0|||
154860499|NCT03263091|558915689|FG003|DB Component|Adverse Event|0|||
154860500|NCT03263091|558915690|FG004|DB Component|Adverse Event|2|||
154860501|NCT03263091|558915691|FG005|DB Component|Adverse Event|1|||
154860502|NCT03263091|558915686|FG000|DB Component|Lost to Follow-up|0|||
154860503|NCT03263091|558915687|FG001|DB Component|Lost to Follow-up|0|||
154860504|NCT03263091|558915688|FG002|DB Component|Lost to Follow-up|0|||
154860505|NCT03263091|558915689|FG003|DB Component|Lost to Follow-up|0|||
154860506|NCT03263091|558915690|FG004|DB Component|Lost to Follow-up|2|||
154860507|NCT03263091|558915691|FG005|DB Component|Lost to Follow-up|1|||
154860508|NCT03263091|558915686|FG000|DB Component|Death|0|||
154860509|NCT03263091|558915687|FG001|DB Component|Death|0|||
154860510|NCT03263091|558915688|FG002|DB Component|Death|0|||
154860511|NCT03263091|558915689|FG003|DB Component|Death|0|||
154860512|NCT03263091|558915690|FG004|DB Component|Death|7|||
154860513|NCT03263091|558915691|FG005|DB Component|Death|4|||
154860514|NCT03263091|558915686|FG000|DB Component|Other than specified|0|||
154860515|NCT03263091|558915687|FG001|DB Component|Other than specified|0|||
154860516|NCT03263091|558915688|FG002|DB Component|Other than specified|0|||
154860517|NCT03263091|558915689|FG003|DB Component|Other than specified|0|||
154860518|NCT03263091|558915690|FG004|DB Component|Other than specified|8|||
154860519|NCT03263091|558915691|FG005|DB Component|Other than specified|6|||
154860520|NCT01821963|558915692|FG000|Overall Study|Adverse Event|1|||
154860521|NCT00506389|558915693|FG000|In-treatment Period|Other|3|||
154860522|NCT00506389|558915694|FG001|In-treatment Period|Other|3|||
154860523|NCT00506389|558915695|FG002|In-treatment Period|Other|4|||
154860524|NCT00506389|558915693|FG000|In-treatment Period|Lost to Follow-up|0|||
154860525|NCT00506389|558915694|FG001|In-treatment Period|Lost to Follow-up|0|||
154860526|NCT00506389|558915695|FG002|In-treatment Period|Lost to Follow-up|1|||
154860527|NCT00506389|558915693|FG000|In-treatment Period|Lack of compliance|1|||
154860528|NCT00506389|558915694|FG001|In-treatment Period|Lack of compliance|0|||
154860529|NCT00506389|558915695|FG002|In-treatment Period|Lack of compliance|0|||
154860530|NCT00506389|558915693|FG000|In-treatment Period|Reasons not related to trial|4|||
154860531|NCT00506389|558915694|FG001|In-treatment Period|Reasons not related to trial|1|||
154860532|NCT00506389|558915695|FG002|In-treatment Period|Reasons not related to trial|0|||
154860533|NCT00506389|558915693|FG000|In-treatment Period|Withdrawal by Subject|3|||
154860534|NCT00506389|558915694|FG001|In-treatment Period|Withdrawal by Subject|3|||
154860535|NCT00506389|558915695|FG002|In-treatment Period|Withdrawal by Subject|4|||
154860536|NCT00506389|558915693|FG000|In-treatment Period|Lack of Efficacy|0|||
154860537|NCT00506389|558915694|FG001|In-treatment Period|Lack of Efficacy|2|||
154860538|NCT00506389|558915695|FG002|In-treatment Period|Lack of Efficacy|0|||
154860539|NCT00506389|558915693|FG000|In-treatment Period|Adverse Event|11|||
154860540|NCT00506389|558915694|FG001|In-treatment Period|Adverse Event|5|||
154860541|NCT00506389|558915695|FG002|In-treatment Period|Adverse Event|2|||
154860542|NCT00506389|558915693|FG000|In-treatment Period|Randomized but not treated|4|||
154860543|NCT00506389|558915694|FG001|In-treatment Period|Randomized but not treated|1|||
154860544|NCT00506389|558915695|FG002|In-treatment Period|Randomized but not treated|1|||
154860545|NCT03539432|558915696|FG000|Overall Study|Lost to Follow-up|0|||
154860546|NCT03539432|558915697|FG001|Overall Study|Lost to Follow-up|1|||
154860547|NCT01381094|558915698|FG000|Overall Study|Adverse Event|1|||
154860548|NCT01381094|558915699|FG001|Overall Study|Adverse Event|2|||
154860549|NCT01381094|558915700|FG002|Overall Study|Adverse Event|0|||
154860550|NCT01381094|558915701|FG003|Overall Study|Adverse Event|1|||
154860551|NCT01381094|558915702|FG004|Overall Study|Adverse Event|0|||
154860552|NCT01381094|558915698|FG000|Overall Study|Lost to Follow-up|0|||
154860553|NCT01381094|558915699|FG001|Overall Study|Lost to Follow-up|0|||
154860554|NCT01381094|558915700|FG002|Overall Study|Lost to Follow-up|0|||
154860555|NCT01381094|558915701|FG003|Overall Study|Lost to Follow-up|0|||
154860556|NCT01381094|558915702|FG004|Overall Study|Lost to Follow-up|1|||
154860557|NCT01381094|558915698|FG000|Overall Study|Withdrawal of informed consent|0|||
154860558|NCT01381094|558915699|FG001|Overall Study|Withdrawal of informed consent|1|||
154860559|NCT01381094|558915700|FG002|Overall Study|Withdrawal of informed consent|0|||
154860560|NCT01381094|558915701|FG003|Overall Study|Withdrawal of informed consent|0|||
154860561|NCT01381094|558915702|FG004|Overall Study|Withdrawal of informed consent|0|||
154860562|NCT01381094|558915698|FG000|Overall Study|Participant given Aranesp injection|1|||
154860563|NCT01381094|558915699|FG001|Overall Study|Participant given Aranesp injection|0|||
154860564|NCT01381094|558915700|FG002|Overall Study|Participant given Aranesp injection|0|||
154860565|NCT01381094|558915701|FG003|Overall Study|Participant given Aranesp injection|0|||
154860566|NCT01381094|558915702|FG004|Overall Study|Participant given Aranesp injection|0|||
154860567|NCT01934504|558915712|FG000|Overall Study|Protocol Deviation|0|||
154860568|NCT01934504|558915713|FG001|Overall Study|Protocol Deviation|0|||
154860569|NCT01934504|558915714|FG002|Overall Study|Protocol Deviation|0|||
154860570|NCT01934504|558915715|FG003|Overall Study|Protocol Deviation|2|||
154860571|NCT01934504|558915712|FG000|Overall Study|Study Terminated by Sponsor|1|||
154860572|NCT01934504|558915713|FG001|Overall Study|Study Terminated by Sponsor|0|||
154860573|NCT01934504|558915714|FG002|Overall Study|Study Terminated by Sponsor|5|||
154860574|NCT01934504|558915715|FG003|Overall Study|Study Terminated by Sponsor|5|||
154860575|NCT02665689|558915716|FG000|Overall Study|Adverse Event|1|||
154860576|NCT02665689|558915717|FG001|Overall Study|Adverse Event|0|||
154860577|NCT02665689|558915716|FG000|Overall Study|Trial termination|1|||
154860578|NCT02665689|558915717|FG001|Overall Study|Trial termination|1|||
154860579|NCT02665689|558915716|FG000|Overall Study|Lost to Follow-up|0|||
154860580|NCT02665689|558915717|FG001|Overall Study|Lost to Follow-up|1|||
154860581|NCT00824564|558915718|FG000|Overall Study|Lost to Follow-up|5|||
154860582|NCT00824564|558915719|FG001|Overall Study|Lost to Follow-up|7|||
154860583|NCT00824564|558915718|FG000|Overall Study|Withdrawal by Subject|1|||
154860584|NCT00824564|558915719|FG001|Overall Study|Withdrawal by Subject|1|||
154860585|NCT00824564|558915718|FG000|Overall Study|Other|1|||
154860586|NCT00824564|558915719|FG001|Overall Study|Other|2|||
154860587|NCT00824564|558915718|FG000|Overall Study|Randomized, but not treated|1|||
154860588|NCT00824564|558915719|FG001|Overall Study|Randomized, but not treated|0|||
154860589|NCT00996840|558915728|FG000|Overall Study|Adverse Event|0|||
154860590|NCT00996840|558915729|FG001|Overall Study|Adverse Event|1|||
154860591|NCT00996840|558915730|FG002|Overall Study|Adverse Event|0|||
154860592|NCT00996840|558915731|FG003|Overall Study|Adverse Event|0|||
154860593|NCT00996840|558915732|FG004|Overall Study|Adverse Event|0|||
154860594|NCT00996840|558915728|FG000|Overall Study|Physician Decision|0|||
154860595|NCT00996840|558915729|FG001|Overall Study|Physician Decision|0|||
154860596|NCT00996840|558915730|FG002|Overall Study|Physician Decision|1|||
154860597|NCT00996840|558915731|FG003|Overall Study|Physician Decision|1|||
154860598|NCT00996840|558915732|FG004|Overall Study|Physician Decision|2|||
154860599|NCT00996840|558915728|FG000|Overall Study|Withdrawal by Subject|1|||
154860600|NCT00996840|558915729|FG001|Overall Study|Withdrawal by Subject|1|||
154860601|NCT00996840|558915730|FG002|Overall Study|Withdrawal by Subject|0|||
154860602|NCT00996840|558915731|FG003|Overall Study|Withdrawal by Subject|0|||
154860603|NCT00996840|558915732|FG004|Overall Study|Withdrawal by Subject|0|||
154860604|NCT00603239|558915733|FG000|Overall Study|Adverse Event|4|||
154860605|NCT00603239|558915734|FG001|Overall Study|Adverse Event|1|||
154860606|NCT00603239|558915733|FG000|Overall Study|Entry criteria not met|0|||
154860607|NCT00603239|558915734|FG001|Overall Study|Entry criteria not met|1|||
154860608|NCT00603239|558915733|FG000|Overall Study|Loss of glucose control|3|||
154860609|NCT00603239|558915734|FG001|Overall Study|Loss of glucose control|0|||
154860610|NCT00603239|558915733|FG000|Overall Study|Lost to Follow-up|2|||
154860611|NCT00603239|558915734|FG001|Overall Study|Lost to Follow-up|1|||
154860612|NCT00603239|558915733|FG000|Overall Study|Physician Decision|2|||
154860613|NCT00603239|558915734|FG001|Overall Study|Physician Decision|0|||
154860614|NCT00603239|558915733|FG000|Overall Study|Protocol Violation|2|||
154860615|NCT00603239|558915734|FG001|Overall Study|Protocol Violation|0|||
154860616|NCT00603239|558915733|FG000|Overall Study|Subject decision|2|||
154860617|NCT00603239|558915734|FG001|Overall Study|Subject decision|1|||
154860618|NCT02292849|558915735|FG000|Overall Study|Lost to Follow-up|0|||
154860619|NCT02292849|558915736|FG001|Overall Study|Lost to Follow-up|2|||
154860620|NCT02292849|558915737|FG002|Overall Study|Lost to Follow-up|2|||
154860621|NCT02292849|558915735|FG000|Overall Study|Physician Decision|4|||
154860622|NCT02292849|558915736|FG001|Overall Study|Physician Decision|0|||
154860623|NCT02292849|558915737|FG002|Overall Study|Physician Decision|0|||
154860624|NCT04125680|558915739|FG000|Overall Study|Lost to Follow-up|15|||
154860625|NCT00097539|558915740|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
154860626|NCT00097539|558915741|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
154860627|NCT00097539|558915742|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
154860628|NCT00097539|558915743|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
154860629|NCT00097539|558915744|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
154860630|NCT00097539|558915745|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
154860631|NCT00097539|558915746|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
154860632|NCT00097539|558915740|FG000|Overall Study|Withdrawal by Subject|925|||
154860633|NCT00097539|558915741|FG001|Overall Study|Withdrawal by Subject|323|||
154860634|NCT00097539|558915742|FG002|Overall Study|Withdrawal by Subject|346|||
154860635|NCT00097539|558915743|FG003|Overall Study|Withdrawal by Subject|217|||
154860636|NCT00097539|558915744|FG004|Overall Study|Withdrawal by Subject|68|||
154860637|NCT00097539|558915745|FG005|Overall Study|Withdrawal by Subject|229|||
154860638|NCT00097539|558915746|FG006|Overall Study|Withdrawal by Subject|3|||
154860639|NCT00097539|558915740|FG000|Overall Study|Participant Non-compliant|2140|||
154860640|NCT00097539|558915741|FG001|Overall Study|Participant Non-compliant|567|||
154860641|NCT00097539|558915742|FG002|Overall Study|Participant Non-compliant|1067|||
154860642|NCT00097539|558915743|FG003|Overall Study|Participant Non-compliant|353|||
154860643|NCT00097539|558915744|FG004|Overall Study|Participant Non-compliant|136|||
154860644|NCT00097539|558915745|FG005|Overall Study|Participant Non-compliant|543|||
154860645|NCT00097539|558915746|FG006|Overall Study|Participant Non-compliant|18|||
154860646|NCT00097539|558915740|FG000|Overall Study|Lack of Efficacy|249|||
154860647|NCT00097539|558915741|FG001|Overall Study|Lack of Efficacy|122|||
154860648|NCT00097539|558915742|FG002|Overall Study|Lack of Efficacy|202|||
155106850|NCT00405392|559819082|FG000|Overall Study|Data missing|2|||
155106851|NCT00405392|559819083|FG001|Overall Study|Data missing|0|||
155106852|NCT00405392|559819082|FG000|Overall Study|Non-compliance|0|||
155106853|NCT00405392|559819083|FG001|Overall Study|Non-compliance|1|||
154860649|NCT00097539|558915743|FG003|Overall Study|Lack of Efficacy|105|||
154860650|NCT00097539|558915744|FG004|Overall Study|Lack of Efficacy|45|||
154860651|NCT00097539|558915745|FG005|Overall Study|Lack of Efficacy|228|||
154860652|NCT00097539|558915746|FG006|Overall Study|Lack of Efficacy|5|||
154860653|NCT00097539|558915740|FG000|Overall Study|Adverse Event|78|||
154860654|NCT00097539|558915741|FG001|Overall Study|Adverse Event|133|||
154860655|NCT00097539|558915742|FG002|Overall Study|Adverse Event|37|||
154860656|NCT00097539|558915743|FG003|Overall Study|Adverse Event|27|||
154860657|NCT00097539|558915744|FG004|Overall Study|Adverse Event|30|||
154860658|NCT00097539|558915745|FG005|Overall Study|Adverse Event|59|||
154860659|NCT00097539|558915746|FG006|Overall Study|Adverse Event|1|||
154860660|NCT00097539|558915740|FG000|Overall Study|Death|2|||
154860661|NCT00097539|558915741|FG001|Overall Study|Death|7|||
154860662|NCT00097539|558915742|FG002|Overall Study|Death|0|||
154860663|NCT00097539|558915743|FG003|Overall Study|Death|0|||
155106854|NCT00405392|559819082|FG000|Overall Study|Other|1|||
154860664|NCT00097539|558915744|FG004|Overall Study|Death|1|||
154860665|NCT00097539|558915745|FG005|Overall Study|Death|3|||
154860666|NCT00097539|558915746|FG006|Overall Study|Death|0|||
154860667|NCT00097539|558915740|FG000|Overall Study|Reasons Other Than Above|3602|||
154860668|NCT00097539|558915741|FG001|Overall Study|Reasons Other Than Above|1382|||
154860669|NCT00097539|558915742|FG002|Overall Study|Reasons Other Than Above|1757|||
154860670|NCT00097539|558915743|FG003|Overall Study|Reasons Other Than Above|692|||
154860671|NCT00097539|558915744|FG004|Overall Study|Reasons Other Than Above|361|||
154860672|NCT00097539|558915745|FG005|Overall Study|Reasons Other Than Above|1244|||
154860673|NCT00097539|558915746|FG006|Overall Study|Reasons Other Than Above|34|||
154860674|NCT00097539|558915740|FG000|Overall Study|Reason not Specified|111|||
154860675|NCT00097539|558915741|FG001|Overall Study|Reason not Specified|49|||
154860676|NCT00097539|558915742|FG002|Overall Study|Reason not Specified|53|||
154860677|NCT00097539|558915743|FG003|Overall Study|Reason not Specified|21|||
154860678|NCT00097539|558915744|FG004|Overall Study|Reason not Specified|11|||
154860679|NCT00097539|558915745|FG005|Overall Study|Reason not Specified|40|||
154860680|NCT00097539|558915746|FG006|Overall Study|Reason not Specified|2|||
154860681|NCT05127486|558915747|FG000|Overall Study|Adverse Event|2|||
154860682|NCT05127486|558915748|FG001|Overall Study|Adverse Event|4|||
154860683|NCT05127486|558915747|FG000|Overall Study|Lack of Efficacy|1|||
154860684|NCT05127486|558915748|FG001|Overall Study|Lack of Efficacy|0|||
154860685|NCT05127486|558915747|FG000|Overall Study|Pregnancy|0|||
154860686|NCT05127486|558915748|FG001|Overall Study|Pregnancy|1|||
154860687|NCT05127486|558915747|FG000|Overall Study|Physician Decision|4|||
154860688|NCT05127486|558915748|FG001|Overall Study|Physician Decision|1|||
154860689|NCT05127486|558915747|FG000|Overall Study|Withdrawal by Subject|14|||
154860690|NCT05127486|558915748|FG001|Overall Study|Withdrawal by Subject|13|||
154860691|NCT05127486|558915747|FG000|Overall Study|Lost to Follow-up|5|||
154860692|NCT05127486|558915748|FG001|Overall Study|Lost to Follow-up|8|||
154860693|NCT00049127|558915749|FG000|Overall Study|Withdrawal by Subject|0|||
154860694|NCT00049127|558915750|FG001|Overall Study|Withdrawal by Subject|0|||
154860695|NCT00049127|558915751|FG002|Overall Study|Withdrawal by Subject|1|||
154860696|NCT00049127|558915752|FG003|Overall Study|Withdrawal by Subject|0|||
154860697|NCT00049127|558915753|FG004|Overall Study|Withdrawal by Subject|0|||
154860698|NCT02582515|558915754|FG000|Overall Study|Withdrawal by Subject|0|||
154860699|NCT02582515|558915755|FG001|Overall Study|Withdrawal by Subject|1|||
154860700|NCT00363415|558915756|FG000|Overall Study|Progressive Disease|196|||
154860701|NCT00363415|558915757|FG001|Overall Study|Progressive Disease|107|||
154860702|NCT00363415|558915756|FG000|Overall Study|Sponsor Decision|67|||
154860703|NCT00363415|558915757|FG001|Overall Study|Sponsor Decision|31|||
154860704|NCT00363415|558915756|FG000|Overall Study|Death|32|||
154860705|NCT00363415|558915757|FG001|Overall Study|Death|29|||
154860706|NCT00363415|558915756|FG000|Overall Study|Adverse Event|24|||
154860707|NCT00363415|558915757|FG001|Overall Study|Adverse Event|15|||
154860708|NCT00363415|558915756|FG000|Overall Study|Physician Decision|18|||
154860709|NCT00363415|558915757|FG001|Overall Study|Physician Decision|35|||
154860710|NCT00363415|558915756|FG000|Overall Study|Entry Criteria Not Met|11|||
154860711|NCT00363415|558915757|FG001|Overall Study|Entry Criteria Not Met|10|||
154860712|NCT00363415|558915756|FG000|Overall Study|Withdrawal by Subject|9|||
154860713|NCT00363415|558915757|FG001|Overall Study|Withdrawal by Subject|15|||
154860714|NCT00363415|558915756|FG000|Overall Study|Lost to Follow-up|3|||
154860715|NCT00363415|558915757|FG001|Overall Study|Lost to Follow-up|3|||
154860716|NCT00363415|558915756|FG000|Overall Study|Protocol Violation|1|||
154860717|NCT00363415|558915757|FG001|Overall Study|Protocol Violation|4|||
154860718|NCT01287754|558915760|FG000|Overall Study|Death|2|||
154860719|NCT01287754|558915761|FG001|Overall Study|Death|12|||
154860720|NCT01287754|558915760|FG000|Overall Study|Lost to Follow-up|1|||
154860721|NCT01287754|558915761|FG001|Overall Study|Lost to Follow-up|6|||
154860722|NCT01287754|558915760|FG000|Overall Study|Protocol Violation|0|||
154860723|NCT01287754|558915761|FG001|Overall Study|Protocol Violation|3|||
154860724|NCT00001337|558915762|FG000|Overall Study|Switched to alternate treatment|2|||
154860725|NCT00001337|558915763|FG001|Overall Study|Switched to alternate treatment|2|||
154860726|NCT00001337|558915764|FG002|Overall Study|Switched to alternate treatment|0|||
154860727|NCT00001337|558915762|FG000|Overall Study|Refused further treatment|2|||
154860728|NCT00001337|558915763|FG001|Overall Study|Refused further treatment|1|||
154860729|NCT00001337|558915764|FG002|Overall Study|Refused further treatment|0|||
154860730|NCT00001337|558915762|FG000|Overall Study|Began other Tx|1|||
154860731|NCT00001337|558915763|FG001|Overall Study|Began other Tx|0|||
154860732|NCT00001337|558915764|FG002|Overall Study|Began other Tx|0|||
154860733|NCT00001337|558915762|FG000|Overall Study|Physician Decision|3|||
154860734|NCT00001337|558915763|FG001|Overall Study|Physician Decision|1|||
154860735|NCT00001337|558915764|FG002|Overall Study|Physician Decision|0|||
154860736|NCT00001337|558915762|FG000|Overall Study|Doesn't have NHL|0|||
154860737|NCT00001337|558915763|FG001|Overall Study|Doesn't have NHL|1|||
154860738|NCT00001337|558915764|FG002|Overall Study|Doesn't have NHL|0|||
154860739|NCT00001337|558915762|FG000|Overall Study|Non protocol tx needed|3|||
154860740|NCT00001337|558915763|FG001|Overall Study|Non protocol tx needed|1|||
154860741|NCT00001337|558915764|FG002|Overall Study|Non protocol tx needed|0|||
154860742|NCT00001337|558915762|FG000|Overall Study|Protocol change|1|||
154860743|NCT00001337|558915763|FG001|Overall Study|Protocol change|0|||
154860744|NCT00001337|558915764|FG002|Overall Study|Protocol change|0|||
154860745|NCT00001337|558915762|FG000|Overall Study|2nd primary disease|0|||
154860746|NCT00001337|558915763|FG001|Overall Study|2nd primary disease|0|||
154860747|NCT00001337|558915764|FG002|Overall Study|2nd primary disease|1|||
154860748|NCT00001337|558915762|FG000|Overall Study|Death during follow up period|9|||
154860749|NCT00001337|558915763|FG001|Overall Study|Death during follow up period|4|||
154860750|NCT00001337|558915764|FG002|Overall Study|Death during follow up period|0|||
154860751|NCT00001337|558915762|FG000|Overall Study|Death on study|19|||
154860752|NCT00001337|558915763|FG001|Overall Study|Death on study|9|||
154860753|NCT00001337|558915764|FG002|Overall Study|Death on study|0|||
154860754|NCT00001337|558915762|FG000|Overall Study|Disease progression during follow-up period|3|||
154860755|NCT00001337|558915763|FG001|Overall Study|Disease progression during follow-up period|1|||
154860756|NCT00001337|558915764|FG002|Overall Study|Disease progression during follow-up period|0|||
154972350|NCT01709903|559322373|FG000|Overall Study|Lost to Follow-up|0|||
154972351|NCT01709903|559322374|FG001|Overall Study|Lost to Follow-up|2|||
154972352|NCT01709903|559322373|FG000|Overall Study|Death|2|||
154972353|NCT01709903|559322374|FG001|Overall Study|Death|0|||
154972354|NCT01709903|559322373|FG000|Overall Study|Protocol Violation|3|||
154972355|NCT01709903|559322374|FG001|Overall Study|Protocol Violation|2|||
154972356|NCT01709903|559322373|FG000|Overall Study|Lack of Efficacy|3|||
154972357|NCT01709903|559322374|FG001|Overall Study|Lack of Efficacy|3|||
154972358|NCT01709903|559322373|FG000|Overall Study|Withdrawal by Subject|6|||
154972359|NCT01709903|559322374|FG001|Overall Study|Withdrawal by Subject|6|||
154972360|NCT01709903|559322373|FG000|Overall Study|Adverse Event|11|||
154972361|NCT01709903|559322374|FG001|Overall Study|Adverse Event|18|||
154972362|NCT00697619|559322375|FG000|Overall Study|Lack of Efficacy|2|||
154972363|NCT00697619|559322376|FG001|Overall Study|Lack of Efficacy|2|||
154972364|NCT00697619|559322375|FG000|Overall Study|Adverse Event|4|||
154972365|NCT00697619|559322376|FG001|Overall Study|Adverse Event|6|||
154972366|NCT04662710|559323540|FG000|Overall Study|Death|14|||
154972367|NCT04662710|559323541|FG001|Overall Study|Death|331|||
154972368|NCT04662710|559323542|FG002|Overall Study|Death|367|||
154972369|NCT04662710|559323540|FG000|Overall Study|Ongoing|1|||
154972370|NCT04662710|559323541|FG001|Overall Study|Ongoing|109|||
154972371|NCT04662710|559323542|FG002|Overall Study|Ongoing|56|||
154972372|NCT04662710|559323540|FG000|Overall Study|Withdrawal by Subject|0|||
154972373|NCT04662710|559323541|FG001|Overall Study|Withdrawal by Subject|3|||
154972374|NCT04662710|559323542|FG002|Overall Study|Withdrawal by Subject|14|||
154972375|NCT02722616|559323543|FG000|Overall Study|Sponsor closed study after one month|2|||
154972376|NCT02722616|559323544|FG001|Overall Study|Sponsor closed study after one month|0|||
154972377|NCT02722616|559323545|FG002|Overall Study|Sponsor closed study after one month|0|||
154972378|NCT01705717|559323546|FG000|Overall Study|Adverse Event|2|||
154972379|NCT01705717|559323547|FG001|Overall Study|Adverse Event|2|||
154972380|NCT01705717|559323546|FG000|Overall Study|Lack of Efficacy|0|||
154972381|NCT01705717|559323547|FG001|Overall Study|Lack of Efficacy|1|||
154972382|NCT01705717|559323546|FG000|Overall Study|Other|0|||
154972383|NCT01705717|559323547|FG001|Overall Study|Other|2|||
154972384|NCT00517192|559323552|FG000|Overall Study|Adverse Event|1|||
154972385|NCT00517192|559323553|FG001|Overall Study|Adverse Event|1|||
154972386|NCT00517192|559323552|FG000|Overall Study|Lost to Follow-up|1|||
154972387|NCT00517192|559323553|FG001|Overall Study|Lost to Follow-up|1|||
154972388|NCT00517192|559323552|FG000|Overall Study|Withdrawal by Subject|1|||
154972389|NCT00517192|559323553|FG001|Overall Study|Withdrawal by Subject|0|||
154972390|NCT00517192|559323552|FG000|Overall Study|Early termination of the trial|16|||
154972391|NCT00517192|559323553|FG001|Overall Study|Early termination of the trial|18|||
154972392|NCT02246764|559323555|FG000|Overall Study|Adverse Event|15|||
154972393|NCT02246764|559323556|FG001|Overall Study|Adverse Event|29|||
154972394|NCT02246764|559323557|FG002|Overall Study|Adverse Event|1|||
154972395|NCT02246764|559323555|FG000|Overall Study|Withdrawal by Subject|0|||
154972396|NCT02246764|559323556|FG001|Overall Study|Withdrawal by Subject|0|||
154972397|NCT02246764|559323557|FG002|Overall Study|Withdrawal by Subject|1|||
154972398|NCT02246764|559323555|FG000|Overall Study|Disallowed Concomitant Medication|1|||
154972399|NCT02246764|559323556|FG001|Overall Study|Disallowed Concomitant Medication|0|||
154972400|NCT02246764|559323557|FG002|Overall Study|Disallowed Concomitant Medication|0|||
154972401|NCT02246764|559323555|FG000|Overall Study|Physician Decision|0|||
154972402|NCT02246764|559323556|FG001|Overall Study|Physician Decision|2|||
154972403|NCT02246764|559323557|FG002|Overall Study|Physician Decision|1|||
154860757|NCT00001337|558915762|FG000|Overall Study|Disease progression on study|33|||
154860758|NCT00001337|558915763|FG001|Overall Study|Disease progression on study|41|||
154860759|NCT00001337|558915764|FG002|Overall Study|Disease progression on study|0|||
154972404|NCT02246764|559323555|FG000|Overall Study|Protocol Violation|2|||
154972405|NCT02246764|559323556|FG001|Overall Study|Protocol Violation|1|||
154972406|NCT02246764|559323557|FG002|Overall Study|Protocol Violation|1|||
154972407|NCT03433703|559323558|FG000|Overall Study|Study terminated by Sponsor|2|||
154972408|NCT03223909|559323559|FG000|Overall Study|Protocol Violation|48|||
154972409|NCT03223909|559323560|FG001|Overall Study|Protocol Violation|45|||
154972410|NCT03223909|559323561|FG002|Overall Study|Protocol Violation|16|||
154860760|NCT00001337|558915762|FG000|Overall Study|Lost to further follow-up|10|||
154860761|NCT00001337|558915763|FG001|Overall Study|Lost to further follow-up|6|||
154860762|NCT00001337|558915764|FG002|Overall Study|Lost to further follow-up|0|||
154860763|NCT00001337|558915762|FG000|Overall Study|2nd malignancy|1|||
154860764|NCT00001337|558915763|FG001|Overall Study|2nd malignancy|0|||
154860765|NCT00001337|558915764|FG002|Overall Study|2nd malignancy|0|||
154860766|NCT00001337|558915762|FG000|Overall Study|Treatment for second lymphoma|0|||
154860767|NCT00001337|558915763|FG001|Overall Study|Treatment for second lymphoma|1|||
154860768|NCT00001337|558915764|FG002|Overall Study|Treatment for second lymphoma|0|||
154860769|NCT00001337|558915762|FG000|Overall Study|Transfer to transplant|0|||
154860770|NCT00001337|558915763|FG001|Overall Study|Transfer to transplant|1|||
155106855|NCT00405392|559819083|FG001|Overall Study|Other|5|||
154860771|NCT00001337|558915764|FG002|Overall Study|Transfer to transplant|0|||
154860772|NCT00809133|558915771|FG000|Overall Study|Progressive disease|2|||
154860773|NCT00809133|558915772|FG001|Overall Study|Progressive disease|5|||
154860774|NCT00809133|558915773|FG002|Overall Study|Progressive disease|5|||
154860775|NCT00809133|558915774|FG003|Overall Study|Progressive disease|3|||
154860776|NCT00809133|558915775|FG004|Overall Study|Progressive disease|4|||
154860777|NCT00809133|558915776|FG005|Overall Study|Progressive disease|1|||
154860778|NCT00809133|558915777|FG006|Overall Study|Progressive disease|3|||
154860779|NCT00809133|558915778|FG007|Overall Study|Progressive disease|3|||
154860780|NCT00809133|558915779|FG008|Overall Study|Progressive disease|3|||
154860781|NCT00809133|558915780|FG009|Overall Study|Progressive disease|9|||
154860782|NCT00809133|558915781|FG010|Overall Study|Progressive disease|5|||
154860783|NCT00809133|558915782|FG011|Overall Study|Progressive disease|7|||
154860784|NCT00809133|558915783|FG012|Overall Study|Progressive disease|5|||
154860785|NCT00809133|558915784|FG013|Overall Study|Progressive disease|4|||
154860786|NCT00809133|558915771|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860787|NCT00809133|558915772|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860788|NCT00809133|558915773|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860789|NCT00809133|558915774|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860790|NCT00809133|558915775|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860791|NCT00809133|558915776|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
154860792|NCT00809133|558915777|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
154860793|NCT00809133|558915778|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
154860794|NCT00809133|558915779|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860795|NCT00809133|558915780|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860796|NCT00809133|558915781|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860797|NCT00809133|558915782|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860798|NCT00809133|558915783|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
154860799|NCT00809133|558915784|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
154860800|NCT00809133|558915771|FG000|Overall Study|Other adverse event|1|||
155106856|NCT00470262|559819091|FG000|Overall Study|Withdrawal by Subject|2|||
155106857|NCT00470262|559819092|FG001|Overall Study|Withdrawal by Subject|0|||
155106858|NCT01970241|559819093|FG000|Overall Study|Withdrawal by Subject|2|||
155106859|NCT01970241|559819094|FG001|Overall Study|Withdrawal by Subject|0|||
155106860|NCT01970241|559819093|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
155106861|NCT01970241|559819094|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
155106862|NCT03472495|559819095|FG000|Overall Study|Treatment no longer indicated|1|||
155106863|NCT03472495|559819096|FG001|Overall Study|Treatment no longer indicated|2|||
155106864|NCT03472495|559819095|FG000|Overall Study|Physician Decision|0|||
155106865|NCT03472495|559819096|FG001|Overall Study|Physician Decision|2|||
155106866|NCT01479764|559819097|FG000|Randomized|Adverse Event|1|||
155106867|NCT01479764|559819098|FG001|Randomized|Adverse Event|1|||
155106868|NCT01479764|559819097|FG000|Randomized|Withdrawal by Subject|1|||
155106869|NCT01479764|559819098|FG001|Randomized|Withdrawal by Subject|0|||
155106870|NCT01479764|559819097|FG000|Treated|Lost to Follow-up|0|||
155106871|NCT01479764|559819098|FG001|Treated|Lost to Follow-up|2|||
155106872|NCT03082677|559819099|FG000|Overall Study|Not Treated|2|||
155106873|NCT00191945|559819104|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
155106874|NCT00191945|559819105|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
155106875|NCT00191945|559819104|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
155106876|NCT00191945|559819105|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
154860801|NCT00809133|558915772|FG001|Overall Study|Other adverse event|1|||
154860802|NCT00809133|558915773|FG002|Overall Study|Other adverse event|1|||
154860803|NCT00809133|558915774|FG003|Overall Study|Other adverse event|0|||
154860804|NCT00809133|558915775|FG004|Overall Study|Other adverse event|0|||
154860805|NCT00809133|558915776|FG005|Overall Study|Other adverse event|3|||
154860806|NCT00809133|558915777|FG006|Overall Study|Other adverse event|2|||
154860807|NCT00809133|558915778|FG007|Overall Study|Other adverse event|4|||
155106877|NCT00191945|559819104|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
155106878|NCT00191945|559819105|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
155106879|NCT00191945|559819104|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
154860808|NCT00809133|558915779|FG008|Overall Study|Other adverse event|0|||
154860809|NCT00809133|558915780|FG009|Overall Study|Other adverse event|0|||
154860810|NCT00809133|558915781|FG010|Overall Study|Other adverse event|1|||
154860811|NCT00809133|558915782|FG011|Overall Study|Other adverse event|1|||
154860812|NCT00809133|558915783|FG012|Overall Study|Other adverse event|0|||
154860813|NCT00809133|558915784|FG013|Overall Study|Other adverse event|1|||
154860814|NCT00809133|558915771|FG000|Overall Study|Lost to Follow-up|0|||
154860815|NCT00809133|558915772|FG001|Overall Study|Lost to Follow-up|0|||
154860816|NCT00809133|558915773|FG002|Overall Study|Lost to Follow-up|0|||
154860817|NCT00809133|558915774|FG003|Overall Study|Lost to Follow-up|0|||
154860818|NCT00809133|558915775|FG004|Overall Study|Lost to Follow-up|0|||
154860819|NCT00809133|558915776|FG005|Overall Study|Lost to Follow-up|1|||
154860820|NCT00809133|558915777|FG006|Overall Study|Lost to Follow-up|0|||
154860821|NCT00809133|558915778|FG007|Overall Study|Lost to Follow-up|0|||
154860822|NCT00809133|558915779|FG008|Overall Study|Lost to Follow-up|0|||
154860823|NCT00809133|558915780|FG009|Overall Study|Lost to Follow-up|0|||
154860824|NCT00809133|558915781|FG010|Overall Study|Lost to Follow-up|0|||
154860825|NCT00809133|558915782|FG011|Overall Study|Lost to Follow-up|0|||
154860826|NCT00809133|558915783|FG012|Overall Study|Lost to Follow-up|0|||
154860827|NCT00809133|558915784|FG013|Overall Study|Lost to Follow-up|0|||
154860828|NCT00809133|558915771|FG000|Overall Study|Consent withdrawn|0|||
154860829|NCT00809133|558915772|FG001|Overall Study|Consent withdrawn|0|||
154860830|NCT00809133|558915773|FG002|Overall Study|Consent withdrawn|0|||
154860831|NCT00809133|558915774|FG003|Overall Study|Consent withdrawn|0|||
154860832|NCT00809133|558915775|FG004|Overall Study|Consent withdrawn|1|||
154860833|NCT00809133|558915776|FG005|Overall Study|Consent withdrawn|0|||
154860834|NCT00809133|558915777|FG006|Overall Study|Consent withdrawn|0|||
154860835|NCT00809133|558915778|FG007|Overall Study|Consent withdrawn|0|||
154860836|NCT00809133|558915779|FG008|Overall Study|Consent withdrawn|0|||
154860837|NCT00809133|558915780|FG009|Overall Study|Consent withdrawn|0|||
154860838|NCT00809133|558915781|FG010|Overall Study|Consent withdrawn|0|||
154860839|NCT00809133|558915782|FG011|Overall Study|Consent withdrawn|0|||
154860840|NCT00809133|558915783|FG012|Overall Study|Consent withdrawn|0|||
154860841|NCT00809133|558915784|FG013|Overall Study|Consent withdrawn|0|||
154860842|NCT00809133|558915771|FG000|Overall Study|Other not mentioned above|0|||
154860843|NCT00809133|558915772|FG001|Overall Study|Other not mentioned above|1|||
154860844|NCT00809133|558915773|FG002|Overall Study|Other not mentioned above|0|||
154860845|NCT00809133|558915774|FG003|Overall Study|Other not mentioned above|0|||
154860846|NCT00809133|558915775|FG004|Overall Study|Other not mentioned above|0|||
154860847|NCT00809133|558915776|FG005|Overall Study|Other not mentioned above|1|||
154860848|NCT00809133|558915777|FG006|Overall Study|Other not mentioned above|0|||
154860849|NCT00809133|558915778|FG007|Overall Study|Other not mentioned above|0|||
154860850|NCT00809133|558915779|FG008|Overall Study|Other not mentioned above|0|||
154860851|NCT00809133|558915780|FG009|Overall Study|Other not mentioned above|0|||
154860852|NCT00809133|558915781|FG010|Overall Study|Other not mentioned above|0|||
154860853|NCT00809133|558915782|FG011|Overall Study|Other not mentioned above|0|||
154860854|NCT00809133|558915783|FG012|Overall Study|Other not mentioned above|0|||
154860855|NCT00809133|558915784|FG013|Overall Study|Other not mentioned above|0|||
154860856|NCT00619229|558915785|FG000|Overall Study|Withdrawal by Subject|1|||
154860857|NCT00619229|558915786|FG001|Overall Study|Withdrawal by Subject|1|||
154860858|NCT00619229|558915785|FG000|Overall Study|Lost to Follow-up|1|||
154860859|NCT00619229|558915786|FG001|Overall Study|Lost to Follow-up|0|||
154860860|NCT00619229|558915785|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
154860861|NCT00619229|558915786|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
154860862|NCT00619229|558915785|FG000|Overall Study|Investigator planned Cataract Operation|1|||
154860863|NCT00619229|558915786|FG001|Overall Study|Investigator planned Cataract Operation|0|||
154860864|NCT03417440|558915787|FG000|Overall Study|Lost to Follow-up|0|||
154860865|NCT03417440|558915788|FG001|Overall Study|Lost to Follow-up|1|||
154860866|NCT03417440|558915789|FG002|Overall Study|Lost to Follow-up|0|||
154860867|NCT03417440|558915790|FG003|Overall Study|Lost to Follow-up|0|||
154860868|NCT03417440|558915791|FG004|Overall Study|Lost to Follow-up|1|||
154860869|NCT03417440|558915792|FG005|Overall Study|Lost to Follow-up|0|||
155106880|NCT00191945|559819105|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
155106881|NCT00429182|559819106|FG000|Overall Study|Not evaluable, Disease Progression|2|||
155106882|NCT00429182|559819106|FG000|Overall Study|Not eligible|5|||
155106883|NCT01451749|559819108|FG000|Overall Study|Protocol Violation|14|||
155106884|NCT01451749|559819109|FG001|Overall Study|Protocol Violation|7|||
155106885|NCT01451749|559819108|FG000|Overall Study|Lost to Follow-up|15|||
154860870|NCT03417440|558915793|FG006|Overall Study|Lost to Follow-up|0|||
154860871|NCT03417440|558915794|FG007|Overall Study|Lost to Follow-up|0|||
154860872|NCT03417440|558915787|FG000|Overall Study|Withdrawal by Subject|2|||
154972411|NCT00098475|559323564|FG000|Step 1|Progressive disease|33|||
154860873|NCT03417440|558915788|FG001|Overall Study|Withdrawal by Subject|0|||
154860874|NCT03417440|558915789|FG002|Overall Study|Withdrawal by Subject|2|||
154860875|NCT03417440|558915790|FG003|Overall Study|Withdrawal by Subject|1|||
154860876|NCT03417440|558915791|FG004|Overall Study|Withdrawal by Subject|1|||
154860877|NCT03417440|558915792|FG005|Overall Study|Withdrawal by Subject|0|||
154860878|NCT03417440|558915793|FG006|Overall Study|Withdrawal by Subject|0|||
154860879|NCT03417440|558915794|FG007|Overall Study|Withdrawal by Subject|1|||
154860880|NCT02786901|558915795|FG000|Overall Study|Adverse Event|1|||
155106886|NCT01451749|559819109|FG001|Overall Study|Lost to Follow-up|5|||
154860881|NCT02786901|558915796|FG001|Overall Study|Adverse Event|1|||
154860882|NCT02786901|558915797|FG002|Overall Study|Adverse Event|2|||
154860883|NCT02786901|558915795|FG000|Overall Study|Physician Decision|1|||
154860884|NCT02786901|558915796|FG001|Overall Study|Physician Decision|0|||
154860885|NCT02786901|558915797|FG002|Overall Study|Physician Decision|0|||
154860886|NCT02786901|558915795|FG000|Overall Study|Rescue Therapy Use|71|||
154860887|NCT02786901|558915796|FG001|Overall Study|Rescue Therapy Use|49|||
154860888|NCT02786901|558915797|FG002|Overall Study|Rescue Therapy Use|33|||
154860889|NCT02786901|558915795|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
154860890|NCT02786901|558915796|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
154860891|NCT02786901|558915797|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
154860892|NCT02786901|558915795|FG000|Overall Study|Disallowed medication|1|||
154860893|NCT02786901|558915796|FG001|Overall Study|Disallowed medication|1|||
154860894|NCT02786901|558915797|FG002|Overall Study|Disallowed medication|0|||
154860895|NCT02786901|558915795|FG000|Overall Study|Randomized in error|2|||
154860896|NCT02786901|558915796|FG001|Overall Study|Randomized in error|0|||
154860897|NCT02786901|558915797|FG002|Overall Study|Randomized in error|1|||
154860898|NCT00607048|558915799|FG000|Overall Study|Adverse Event|0|||
154860899|NCT00607048|558915800|FG001|Overall Study|Adverse Event|1|||
154860900|NCT00607048|558915801|FG002|Overall Study|Adverse Event|0|||
154860901|NCT00607048|558915802|FG003|Overall Study|Adverse Event|0|||
154860902|NCT00607048|558915803|FG004|Overall Study|Adverse Event|4|||
154860903|NCT00607048|558915804|FG005|Overall Study|Adverse Event|0|||
154860904|NCT00607048|558915799|FG000|Overall Study|Global deterioration of health|1|||
154860905|NCT00607048|558915800|FG001|Overall Study|Global deterioration of health|0|||
154860906|NCT00607048|558915801|FG002|Overall Study|Global deterioration of health|0|||
154860907|NCT00607048|558915802|FG003|Overall Study|Global deterioration of health|0|||
154860908|NCT00607048|558915803|FG004|Overall Study|Global deterioration of health|0|||
154860909|NCT00607048|558915804|FG005|Overall Study|Global deterioration of health|0|||
154860910|NCT00607048|558915799|FG000|Overall Study|Objective disease progression - relapse|1|||
154860911|NCT00607048|558915800|FG001|Overall Study|Objective disease progression - relapse|2|||
154860912|NCT00607048|558915801|FG002|Overall Study|Objective disease progression - relapse|4|||
154860913|NCT00607048|558915802|FG003|Overall Study|Objective disease progression - relapse|2|||
154860914|NCT00607048|558915803|FG004|Overall Study|Objective disease progression - relapse|2|||
154860915|NCT00607048|558915804|FG005|Overall Study|Objective disease progression - relapse|2|||
154860916|NCT00607048|558915799|FG000|Overall Study|Withdrawal by Subject|0|||
154860917|NCT00607048|558915800|FG001|Overall Study|Withdrawal by Subject|0|||
154860918|NCT00607048|558915801|FG002|Overall Study|Withdrawal by Subject|0|||
154860919|NCT00607048|558915802|FG003|Overall Study|Withdrawal by Subject|1|||
154860920|NCT00607048|558915803|FG004|Overall Study|Withdrawal by Subject|0|||
154860921|NCT00607048|558915804|FG005|Overall Study|Withdrawal by Subject|2|||
154860922|NCT00607048|558915799|FG000|Overall Study|Other|1|||
154860923|NCT00607048|558915800|FG001|Overall Study|Other|1|||
154860924|NCT00607048|558915801|FG002|Overall Study|Other|0|||
154860925|NCT00607048|558915802|FG003|Overall Study|Other|0|||
154860926|NCT00607048|558915803|FG004|Overall Study|Other|0|||
154860927|NCT00607048|558915804|FG005|Overall Study|Other|1|||
154860928|NCT00699192|558915805|FG000|Overall Study|Missing|1|||
154860929|NCT00699192|558915806|FG001|Overall Study|Missing|1|||
154860930|NCT00699192|558915807|FG002|Overall Study|Missing|1|||
154860931|NCT00699192|558915805|FG000|Overall Study|Adverse Event|9|||
154860932|NCT00699192|558915806|FG001|Overall Study|Adverse Event|4|||
154860933|NCT00699192|558915807|FG002|Overall Study|Adverse Event|3|||
154860934|NCT00699192|558915805|FG000|Overall Study|Abnormal test procedure result(s)|0|||
154860935|NCT00699192|558915806|FG001|Overall Study|Abnormal test procedure result(s)|0|||
154860936|NCT00699192|558915807|FG002|Overall Study|Abnormal test procedure result(s)|1|||
154860937|NCT00699192|558915805|FG000|Overall Study|Lack of Efficacy|0|||
154860938|NCT00699192|558915806|FG001|Overall Study|Lack of Efficacy|0|||
154860939|NCT00699192|558915807|FG002|Overall Study|Lack of Efficacy|1|||
154860940|NCT00699192|558915805|FG000|Overall Study|Withdrawal by Subject|3|||
154860941|NCT00699192|558915806|FG001|Overall Study|Withdrawal by Subject|2|||
154860942|NCT00699192|558915807|FG002|Overall Study|Withdrawal by Subject|4|||
154860943|NCT00699192|558915805|FG000|Overall Study|Administrative problems|1|||
154860944|NCT00699192|558915806|FG001|Overall Study|Administrative problems|3|||
154860945|NCT00699192|558915807|FG002|Overall Study|Administrative problems|1|||
154860946|NCT00699192|558915805|FG000|Overall Study|Protocol Violation|2|||
154860947|NCT00699192|558915806|FG001|Overall Study|Protocol Violation|2|||
154860948|NCT00699192|558915807|FG002|Overall Study|Protocol Violation|0|||
154860949|NCT04336163|558915808|FG000|Overall Study|Lost to Follow-up|55|||
154860950|NCT04336163|558915809|FG001|Overall Study|Lost to Follow-up|0|||
154860951|NCT03663166|558915812|FG000|Overall Study|Withdrawal by Subject|1|||
154860952|NCT00929240|558915814|FG000|Initial Treatment Phase|Adverse Event|31|||
154860953|NCT00929240|558915815|FG001|Initial Treatment Phase|Adverse Event|0|||
154860954|NCT00929240|558915816|FG002|Initial Treatment Phase|Adverse Event|0|||
154860955|NCT00929240|558915814|FG000|Initial Treatment Phase|Disease progression|41|||
154860956|NCT00929240|558915815|FG001|Initial Treatment Phase|Disease progression|0|||
154860957|NCT00929240|558915816|FG002|Initial Treatment Phase|Disease progression|0|||
154860958|NCT00929240|558915814|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
154860959|NCT00929240|558915815|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
154860960|NCT00929240|558915816|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
155106887|NCT01451749|559819108|FG000|Overall Study|Meet the exclusion criteria,and|1|||
155106888|NCT01451749|559819109|FG001|Overall Study|Meet the exclusion criteria,and|1|||
155106889|NCT01451749|559819108|FG000|Overall Study|Adverse Event|2|||
155106890|NCT01451749|559819109|FG001|Overall Study|Adverse Event|0|||
154860961|NCT00929240|558915814|FG000|Initial Treatment Phase|Protocol Violation|5|||
154860962|NCT00929240|558915815|FG001|Initial Treatment Phase|Protocol Violation|0|||
154860963|NCT00929240|558915816|FG002|Initial Treatment Phase|Protocol Violation|0|||
154860964|NCT00929240|558915814|FG000|Initial Treatment Phase|Death|2|||
154860965|NCT00929240|558915815|FG001|Initial Treatment Phase|Death|0|||
154860966|NCT00929240|558915816|FG002|Initial Treatment Phase|Death|0|||
154860967|NCT00929240|558915814|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
154860968|NCT00929240|558915815|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
154860969|NCT00929240|558915816|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
154860970|NCT00929240|558915814|FG000|Initial Treatment Phase|Physician Decision|4|||
154860971|NCT00929240|558915815|FG001|Initial Treatment Phase|Physician Decision|0|||
154860972|NCT00929240|558915816|FG002|Initial Treatment Phase|Physician Decision|0|||
154860973|NCT00929240|558915814|FG000|Maintenance Phase|Disease progression|0|||
154860974|NCT00929240|558915815|FG001|Maintenance Phase|Disease progression|73|||
154860975|NCT00929240|558915816|FG002|Maintenance Phase|Disease progression|60|||
154860976|NCT00929240|558915814|FG000|Maintenance Phase|Adverse Event|0|||
154860977|NCT00929240|558915815|FG001|Maintenance Phase|Adverse Event|9|||
154860978|NCT00929240|558915816|FG002|Maintenance Phase|Adverse Event|12|||
154860979|NCT00929240|558915814|FG000|Maintenance Phase|Withdrawal by Subject|0|||
154860980|NCT00929240|558915815|FG001|Maintenance Phase|Withdrawal by Subject|2|||
154860981|NCT00929240|558915816|FG002|Maintenance Phase|Withdrawal by Subject|6|||
154860982|NCT00929240|558915814|FG000|Maintenance Phase|Protocol Violation|0|||
154860983|NCT00929240|558915815|FG001|Maintenance Phase|Protocol Violation|1|||
154860984|NCT00929240|558915816|FG002|Maintenance Phase|Protocol Violation|0|||
154860985|NCT00929240|558915814|FG000|Maintenance Phase|Health authority/Study termination|0|||
154860986|NCT00929240|558915815|FG001|Maintenance Phase|Health authority/Study termination|1|||
154860987|NCT00929240|558915816|FG002|Maintenance Phase|Health authority/Study termination|2|||
154860988|NCT00929240|558915814|FG000|Maintenance Phase|Physician Decision|0|||
154860989|NCT00929240|558915815|FG001|Maintenance Phase|Physician Decision|2|||
154860990|NCT00929240|558915816|FG002|Maintenance Phase|Physician Decision|1|||
154860991|NCT00929240|558915814|FG000|Maintenance Phase|Change of treatment|0|||
154860992|NCT00929240|558915815|FG001|Maintenance Phase|Change of treatment|4|||
154860993|NCT00929240|558915816|FG002|Maintenance Phase|Change of treatment|0|||
154860994|NCT00929240|558915814|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
154860995|NCT00929240|558915815|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
154860996|NCT00929240|558915816|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
154860997|NCT00929240|558915814|FG000|Maintenance Phase|Participant not treated|0|||
154860998|NCT00929240|558915815|FG001|Maintenance Phase|Participant not treated|2|||
154860999|NCT00929240|558915816|FG002|Maintenance Phase|Participant not treated|0|||
154861000|NCT00684814|558915817|FG000|Washout Period of 7 Days|Adverse Event|1|||
154861001|NCT00684814|558915818|FG001|Washout Period of 7 Days|Adverse Event|2|||
154861002|NCT00684814|558915817|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
154861003|NCT00684814|558915818|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
154861004|NCT00684814|558915817|FG000|Second Intervention|Adverse Event|1|||
154861005|NCT00684814|558915818|FG001|Second Intervention|Adverse Event|0|||
154861006|NCT02203149|558915819|FG000|Part 1|Adverse Event|0|||
154861007|NCT02203149|558915820|FG001|Part 1|Adverse Event|1|||
154861008|NCT02203149|558915821|FG002|Part 1|Adverse Event|0|||
154861009|NCT02203149|558915822|FG003|Part 1|Adverse Event|0|||
154861010|NCT02203149|558915823|FG004|Part 1|Adverse Event|0|||
154861011|NCT02203149|558915819|FG000|Part 2|Death|0|||
154861012|NCT02203149|558915820|FG001|Part 2|Death|0|||
154861013|NCT02203149|558915821|FG002|Part 2|Death|1|||
154861014|NCT02203149|558915822|FG003|Part 2|Death|1|||
154861015|NCT02203149|558915823|FG004|Part 2|Death|0|||
154861016|NCT02203149|558915819|FG000|Part 2|Withdrawal by Subject|0|||
154861017|NCT02203149|558915820|FG001|Part 2|Withdrawal by Subject|0|||
154861018|NCT02203149|558915821|FG002|Part 2|Withdrawal by Subject|0|||
154861019|NCT02203149|558915822|FG003|Part 2|Withdrawal by Subject|1|||
154861020|NCT02203149|558915823|FG004|Part 2|Withdrawal by Subject|0|||
154861021|NCT02203149|558915819|FG000|Part 2|Adverse Event|0|||
154861022|NCT02203149|558915820|FG001|Part 2|Adverse Event|0|||
154861023|NCT02203149|558915821|FG002|Part 2|Adverse Event|0|||
154861024|NCT02203149|558915822|FG003|Part 2|Adverse Event|1|||
154861025|NCT02203149|558915823|FG004|Part 2|Adverse Event|1|||
154861026|NCT02537678|558915824|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
154861027|NCT02537678|558915825|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
154972412|NCT00098475|559323565|FG001|Step 1|Progressive disease|35|||
154861028|NCT02537678|558915824|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
154861029|NCT02537678|558915825|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
154861030|NCT02537678|558915824|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
154861031|NCT02537678|558915825|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
154861032|NCT02537678|558915824|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
154861033|NCT02537678|558915825|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
154861034|NCT02537678|558915824|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
154861035|NCT02537678|558915825|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
154861036|NCT02537678|558915824|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
154861037|NCT02537678|558915825|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
154861038|NCT02537678|558915824|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
154861039|NCT02537678|558915825|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
154861040|NCT04348851|558915826|FG000|Post-Test 1|Withdrawal by Subject|0|||
154861041|NCT04348851|558915827|FG001|Post-Test 1|Withdrawal by Subject|1|||
154861042|NCT04348851|558915828|FG002|Post-Test 1|Withdrawal by Subject|0|||
154861043|NCT04348851|558915829|FG003|Post-Test 1|Withdrawal by Subject|0|||
154861044|NCT04348851|558915826|FG000|Post-Test 1|Lost to Follow-up|0|||
154861045|NCT04348851|558915827|FG001|Post-Test 1|Lost to Follow-up|1|||
154861046|NCT04348851|558915828|FG002|Post-Test 1|Lost to Follow-up|0|||
154861047|NCT04348851|558915829|FG003|Post-Test 1|Lost to Follow-up|0|||
154861048|NCT04348851|558915826|FG000|Post-Test 2|Stroke survivor death|0|||
154861049|NCT04348851|558915827|FG001|Post-Test 2|Stroke survivor death|1|||
154861050|NCT04348851|558915828|FG002|Post-Test 2|Stroke survivor death|0|||
154861051|NCT04348851|558915829|FG003|Post-Test 2|Stroke survivor death|1|||
154861052|NCT00432809|558915830|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
154861053|NCT00432809|558915831|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
154861054|NCT00432809|558915832|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
154861055|NCT00432809|558915830|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
154861056|NCT00432809|558915831|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
154861057|NCT00432809|558915832|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
154861058|NCT04052139|558915833|FG000|Overall Study|Lost to Follow-up|2|||
154861059|NCT04052139|558915834|FG001|Overall Study|Lost to Follow-up|0|||
154861060|NCT04052139|558915835|FG002|Overall Study|Lost to Follow-up|0|||
154861061|NCT04052139|558915833|FG000|Overall Study|Withdrawal by Subject|1|||
154861062|NCT04052139|558915834|FG001|Overall Study|Withdrawal by Subject|0|||
154861063|NCT04052139|558915835|FG002|Overall Study|Withdrawal by Subject|0|||
154861064|NCT01658514|558915836|FG000|Overall Study|Protocol Violation|1|||
154861065|NCT01658514|558915837|FG001|Overall Study|Protocol Violation|0|||
154861066|NCT01658514|558915838|FG002|Overall Study|Protocol Violation|2|||
154861067|NCT00144170|558915839|FG000|Overall Study|Adverse Event|84|||
154861068|NCT00144170|558915840|FG001|Overall Study|Adverse Event|41|||
154861069|NCT00144170|558915839|FG000|Overall Study|Protocol Violation|23|||
154861070|NCT00144170|558915840|FG001|Overall Study|Protocol Violation|16|||
154861071|NCT00144170|558915839|FG000|Overall Study|Lost to Follow-up|5|||
154861072|NCT00144170|558915840|FG001|Overall Study|Lost to Follow-up|10|||
154861073|NCT00144170|558915839|FG000|Overall Study|Withdrawal by Subject|29|||
154861074|NCT00144170|558915840|FG001|Overall Study|Withdrawal by Subject|13|||
154861075|NCT00144170|558915839|FG000|Overall Study|Other reason not defined above|211|||
154861076|NCT00144170|558915840|FG001|Overall Study|Other reason not defined above|316|||
154861077|NCT00981526|558915841|FG000|Overall Study|Withdrawal by Subject|0|||
154861078|NCT00981526|558915842|FG001|Overall Study|Withdrawal by Subject|2|||
154861079|NCT00981526|558915841|FG000|Overall Study|Physician Decision|4|||
154861080|NCT00981526|558915842|FG001|Overall Study|Physician Decision|4|||
154861081|NCT00332202|558915843|FG000|Overall Study|Adverse Event|72|||
154861082|NCT00332202|558915844|FG001|Overall Study|Adverse Event|28|||
154972413|NCT00098475|559323566|FG002|Step 1|Progressive disease|2|||
154861083|NCT00332202|558915843|FG000|Overall Study|Lost to Follow-up|2|||
154861084|NCT00332202|558915844|FG001|Overall Study|Lost to Follow-up|1|||
154861085|NCT00332202|558915843|FG000|Overall Study|Physician Decision|6|||
154861086|NCT00332202|558915844|FG001|Overall Study|Physician Decision|8|||
154861087|NCT00332202|558915843|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
154861088|NCT00332202|558915844|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
154861089|NCT00332202|558915843|FG000|Overall Study|Protocol Violation|7|||
154861090|NCT00332202|558915844|FG001|Overall Study|Protocol Violation|2|||
154861091|NCT00332202|558915843|FG000|Overall Study|Sponsor Decision|1|||
154861092|NCT00332202|558915844|FG001|Overall Study|Sponsor Decision|2|||
154861093|NCT00332202|558915843|FG000|Overall Study|Withdrawal by Subject|36|||
154861094|NCT00332202|558915844|FG001|Overall Study|Withdrawal by Subject|17|||
154861095|NCT00332202|558915843|FG000|Overall Study|Progressive Disease|106|||
154861096|NCT00332202|558915844|FG001|Overall Study|Progressive Disease|60|||
154861097|NCT00332202|558915843|FG000|Overall Study|Death|5|||
154861098|NCT00332202|558915844|FG001|Overall Study|Death|2|||
154861099|NCT00957853|558915845|FG000|Overall Study|Withdrawal by Subject|1|||
154972414|NCT00098475|559323567|FG003|Step 1|Progressive disease|1|||
154861100|NCT00957853|558915846|FG001|Overall Study|Withdrawal by Subject|0|||
154861101|NCT00957853|558915847|FG002|Overall Study|Withdrawal by Subject|0|||
154861102|NCT02495948|558915850|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
154861103|NCT02495948|558915851|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
154861104|NCT02495948|558915850|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
154861105|NCT02495948|558915851|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
154861106|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
154861107|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
154861108|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
154861109|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
154861110|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
154861111|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
154861112|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
154861113|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
154861114|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
154861115|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
154861116|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
154861117|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
154861118|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
154861119|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
154861120|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
154861121|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
154861122|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
154861123|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
154861124|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
154861125|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
154861126|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
154861127|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
154861128|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
154861129|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
154861130|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
154861131|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
154861132|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
154861133|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
154861134|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
154861135|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
154861136|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
154861137|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
154861138|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
154861139|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
154861140|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
154861141|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
154861142|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
154861143|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
154861144|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
154861145|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
154861146|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
154861147|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
154861148|NCT00100048|558915852|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
154861149|NCT00100048|558915853|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
154861150|NCT00100048|558915854|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
154861151|NCT00100048|558915855|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
154861152|NCT00100048|558915856|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
154861153|NCT00100048|558915857|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
154861154|NCT00496366|558917335|FG000|Overall Study|Death|1|||
154861155|NCT00768222|558917336|FG000|Overall Study|Lost to Follow-up|1|||
154861156|NCT00768222|558917337|FG001|Overall Study|Lost to Follow-up|1|||
154861157|NCT00768222|558917336|FG000|Overall Study|Withdrawal by Subject|3|||
154861158|NCT00768222|558917337|FG001|Overall Study|Withdrawal by Subject|1|||
154861159|NCT00768222|558917336|FG000|Overall Study|Protocol Violation|0|||
154861160|NCT00768222|558917337|FG001|Overall Study|Protocol Violation|2|||
154861161|NCT04938648|558917345|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
154861162|NCT04938648|558917346|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
154861163|NCT04938648|558917345|FG000|Overall Study|Patient too ill|0|||
154861164|NCT04938648|558917346|FG001|Overall Study|Patient too ill|1|||
154861165|NCT04938648|558917345|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
154861166|NCT04938648|558917346|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
154861167|NCT04938648|558917345|FG000|Overall Study|Patient did not have memory problems|1|||
154861168|NCT04938648|558917346|FG001|Overall Study|Patient did not have memory problems|1|||
154861169|NCT04938648|558917345|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
154861170|NCT04938648|558917346|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
154861171|NCT04938648|558917345|FG000|Overall Study|Care partner could not be reached|0|||
154861172|NCT04938648|558917346|FG001|Overall Study|Care partner could not be reached|1|||
154861173|NCT04938648|558917345|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
154861174|NCT04938648|558917346|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
154861175|NCT04938648|558917345|FG000|Overall Study|Withdrawal by Subject|2|||
154861176|NCT04938648|558917346|FG001|Overall Study|Withdrawal by Subject|1|||
154861177|NCT05027802|558917347|FG000|Overall Study|Adverse Event|2|||
154861178|NCT05027802|558917347|FG000|Overall Study|Withdrawal by Subject|18|||
154861179|NCT05027802|558917347|FG000|Overall Study|Death|2|||
154861180|NCT05027802|558917347|FG000|Overall Study|Other|1|||
154861181|NCT00502840|558917348|FG000|Overall Study|Adverse Event|5|||
154861182|NCT00502840|558917348|FG000|Overall Study|Additional or changed therapy|48|||
154861183|NCT00502840|558917348|FG000|Overall Study|Lack of Efficacy|11|||
154861184|NCT00502840|558917348|FG000|Overall Study|Protocol Violation|4|||
154861185|NCT00502840|558917348|FG000|Overall Study|Withdrawal by Subject|5|||
154861186|NCT00502840|558917348|FG000|Overall Study|Lost to Follow-up|6|||
154861187|NCT00502840|558917348|FG000|Overall Study|Administrative problems|1|||
154861188|NCT00502840|558917348|FG000|Overall Study|Other|20|||
154861189|NCT01974323|558917349|FG000|Overall Study|Other Reasons|25|||
154861190|NCT01974323|558917350|FG001|Overall Study|Other Reasons|28|||
154861191|NCT01974323|558917349|FG000|Overall Study|Protocol Violation|2|||
154861192|NCT01974323|558917350|FG001|Overall Study|Protocol Violation|2|||
154861193|NCT01974323|558917349|FG000|Overall Study|Personal Reasons|15|||
154861194|NCT01974323|558917350|FG001|Overall Study|Personal Reasons|19|||
154861195|NCT01974323|558917349|FG000|Overall Study|Lost to Follow-up|45|||
154861196|NCT01974323|558917350|FG001|Overall Study|Lost to Follow-up|40|||
154861197|NCT01974323|558917349|FG000|Overall Study|Pregnancy|2|||
154861198|NCT01974323|558917350|FG001|Overall Study|Pregnancy|1|||
154861199|NCT01974323|558917349|FG000|Overall Study|Lack of Efficacy|1|||
154861200|NCT01974323|558917350|FG001|Overall Study|Lack of Efficacy|1|||
154861201|NCT01974323|558917349|FG000|Overall Study|Adverse Event|2|||
154861202|NCT01974323|558917350|FG001|Overall Study|Adverse Event|2|||
154861203|NCT01700829|558917351|FG000|Overall Study|Withdrawal by Subject|1|||
154861204|NCT01700829|558917352|FG001|Overall Study|Withdrawal by Subject|1|||
154861205|NCT01075178|558917353|FG000|Subject Matching|eligible but not matched|130|||
154861206|NCT01075178|558917354|FG001|Subject Matching|eligible but not matched|403|||
154861207|NCT01075178|558917353|FG000|Subject Chart Review|died before chart review period|0|||
154861208|NCT01075178|558917354|FG001|Subject Chart Review|died before chart review period|2|||
154861209|NCT01075178|558917353|FG000|Subject Chart Review|no data collected due to site closure|3|||
154861210|NCT01075178|558917354|FG001|Subject Chart Review|no data collected due to site closure|4|||
154861211|NCT01075178|558917353|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
154861212|NCT01075178|558917354|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
154861213|NCT00316264|558917355|FG000|Overall Study|Lost to Follow-up|0|||
154861214|NCT00316264|558917356|FG001|Overall Study|Lost to Follow-up|1|||
154861215|NCT00316264|558917357|FG002|Overall Study|Lost to Follow-up|0|||
154861216|NCT00316264|558917355|FG000|Overall Study|Withdrawal of Consent|3|||
154861217|NCT00316264|558917356|FG001|Overall Study|Withdrawal of Consent|5|||
154861218|NCT00316264|558917357|FG002|Overall Study|Withdrawal of Consent|6|||
154861219|NCT00316264|558917355|FG000|Overall Study|Death|2|||
154861220|NCT00316264|558917356|FG001|Overall Study|Death|0|||
154861221|NCT00316264|558917357|FG002|Overall Study|Death|0|||
154861222|NCT00316264|558917355|FG000|Overall Study|Other|1|||
154861223|NCT00316264|558917356|FG001|Overall Study|Other|1|||
154861224|NCT00316264|558917357|FG002|Overall Study|Other|0|||
154861225|NCT00355264|558917358|FG000|Extension (Variable Duration)|Adverse Event|1|||
154861226|NCT00355264|558917358|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
154861227|NCT01451645|558917359|FG000|Overall Study|Protocol Violation|1|||
154861228|NCT01451645|558917360|FG001|Overall Study|Protocol Violation|0|||
154861229|NCT01451645|558917359|FG000|Overall Study|Adverse Event|0|||
154861230|NCT01451645|558917360|FG001|Overall Study|Adverse Event|3|||
154861231|NCT01451645|558917359|FG000|Overall Study|Withdrawal by Subject|4|||
154861232|NCT01451645|558917360|FG001|Overall Study|Withdrawal by Subject|2|||
154861233|NCT01451645|558917359|FG000|Overall Study|Lost to Follow-up|4|||
154861234|NCT01451645|558917360|FG001|Overall Study|Lost to Follow-up|3|||
154861235|NCT04927312|558917361|FG000|Overall Study|Adverse Event|1|||
154861236|NCT04927312|558917361|FG000|Overall Study|Death|1|||
154861237|NCT04927312|558917361|FG000|Overall Study|Withdrawal by Subject|1|||
154861238|NCT04927312|558917361|FG000|Overall Study|Other|1|||
154861239|NCT04919564|558917363|FG000|Overall Study|Lost to Follow-up|1|||
154861240|NCT04919564|558917364|FG001|Overall Study|Lost to Follow-up|0|||
154861241|NCT04919564|558917363|FG000|Overall Study|Physician Decision|1|||
154861242|NCT04919564|558917364|FG001|Overall Study|Physician Decision|1|||
154861243|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
154861244|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
154861245|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
154861246|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
154861247|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
154861248|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
154861249|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
154861250|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
154861251|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
154861252|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
154861253|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
154861254|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
154861255|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
154861256|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
154861257|NCT00446030|558917375|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
154861258|NCT00446030|558917376|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
154861259|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
154861260|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
154861261|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
154861262|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
154861263|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
154861264|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
154861265|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
154861266|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
154861267|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
154861268|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
154861269|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
154861270|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
154861271|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
154861272|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
154861273|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
154861274|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
154861275|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
154861276|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
154861277|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
154861278|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
154861279|NCT00446030|558917375|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
154861280|NCT00446030|558917376|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
154861281|NCT00858832|558917377|FG000|Overall Study|became ineligible: delivered vaginally|1|||
154861282|NCT00858832|558917378|FG001|Overall Study|became ineligible: delivered vaginally|0|||
154861283|NCT00858832|558917377|FG000|Overall Study|Adverse Event|0|||
154861284|NCT00858832|558917378|FG001|Overall Study|Adverse Event|1|||
154861285|NCT05292755|558917379|FG000|Overall Study|Lost to Follow-up|5|||
154861286|NCT05292755|558917380|FG001|Overall Study|Lost to Follow-up|9|||
154861287|NCT00519077|558917382|FG000|Overall Study|Death|6|||
154861288|NCT00519077|558917382|FG000|Overall Study|Other|2|||
154861289|NCT01967225|558917383|FG000|Overall Study|Adverse Event|3|||
154861290|NCT01967225|558917384|FG001|Overall Study|Adverse Event|1|||
154861291|NCT01967225|558917383|FG000|Overall Study|Withdrawal by Subject|2|||
154861292|NCT01967225|558917384|FG001|Overall Study|Withdrawal by Subject|1|||
154861293|NCT01967225|558917383|FG000|Overall Study|Lack of Efficacy|1|||
154861294|NCT01967225|558917384|FG001|Overall Study|Lack of Efficacy|1|||
154861295|NCT01967225|558917383|FG000|Overall Study|Switching to other therapy|2|||
154861296|NCT01967225|558917384|FG001|Overall Study|Switching to other therapy|0|||
154861297|NCT01967225|558917383|FG000|Overall Study|Protocol driven decision point|1|||
154861298|NCT01967225|558917384|FG001|Overall Study|Protocol driven decision point|0|||
154861299|NCT01967225|558917383|FG000|Overall Study|Logistical difficulties|1|||
154861300|NCT01967225|558917384|FG001|Overall Study|Logistical difficulties|0|||
154861301|NCT01967225|558917383|FG000|Overall Study|Protocol Violation|2|||
154861302|NCT01967225|558917384|FG001|Overall Study|Protocol Violation|0|||
154861303|NCT02305563|558917385|FG000|Treatment Period|Disease progression|0|||
154861304|NCT02305563|558917386|FG001|Treatment Period|Disease progression|0|||
154861305|NCT02305563|558917387|FG002|Treatment Period|Disease progression|15|||
154861306|NCT02305563|558917388|FG003|Treatment Period|Disease progression|6|||
154861307|NCT02305563|558917389|FG004|Treatment Period|Disease progression|6|||
154861308|NCT02305563|558917385|FG000|Treatment Period|Study drug toxicity|0|||
154861309|NCT02305563|558917386|FG001|Treatment Period|Study drug toxicity|0|||
154861310|NCT02305563|558917387|FG002|Treatment Period|Study drug toxicity|0|||
154861311|NCT02305563|558917388|FG003|Treatment Period|Study drug toxicity|1|||
154861312|NCT02305563|558917389|FG004|Treatment Period|Study drug toxicity|2|||
154861313|NCT02305563|558917385|FG000|Treatment Period|Death|0|||
154861314|NCT02305563|558917386|FG001|Treatment Period|Death|0|||
154861315|NCT02305563|558917387|FG002|Treatment Period|Death|1|||
155106891|NCT01451749|559819108|FG000|Overall Study|Withdrawal by Subject|0|||
155106892|NCT01451749|559819109|FG001|Overall Study|Withdrawal by Subject|1|||
155106893|NCT00972517|559819110|FG000|Overall Study|Adverse Event|0|||
155106894|NCT00972517|559819111|FG001|Overall Study|Adverse Event|0|||
155106895|NCT00972517|559819112|FG002|Overall Study|Adverse Event|0|||
155106896|NCT00972517|559819113|FG003|Overall Study|Adverse Event|1|||
155106897|NCT00972517|559819114|FG004|Overall Study|Adverse Event|0|||
155106898|NCT00972517|559819115|FG005|Overall Study|Adverse Event|0|||
155106899|NCT00972517|559819110|FG000|Overall Study|Withdrawal by Subject|0|||
155106900|NCT00972517|559819111|FG001|Overall Study|Withdrawal by Subject|1|||
155106901|NCT00972517|559819112|FG002|Overall Study|Withdrawal by Subject|0|||
155106902|NCT00972517|559819113|FG003|Overall Study|Withdrawal by Subject|2|||
155106903|NCT00972517|559819114|FG004|Overall Study|Withdrawal by Subject|1|||
155106904|NCT00972517|559819115|FG005|Overall Study|Withdrawal by Subject|0|||
155106905|NCT02311881|559819116|FG000|Overall Study|Did not meet the study criteria|2|||
155106906|NCT02311881|559819117|FG001|Overall Study|Did not meet the study criteria|2|||
155106907|NCT02311881|559819118|FG002|Overall Study|Did not meet the study criteria|0|||
155106908|NCT02311881|559819116|FG000|Overall Study|Adverse Event|7|||
155106909|NCT02311881|559819117|FG001|Overall Study|Adverse Event|15|||
155106910|NCT02311881|559819118|FG002|Overall Study|Adverse Event|8|||
155106911|NCT02311881|559819116|FG000|Overall Study|Lost to Follow-up|3|||
155106912|NCT02311881|559819117|FG001|Overall Study|Lost to Follow-up|3|||
155106913|NCT02311881|559819118|FG002|Overall Study|Lost to Follow-up|2|||
155106914|NCT02311881|559819116|FG000|Overall Study|Protocol Violation|1|||
155106915|NCT02311881|559819117|FG001|Overall Study|Protocol Violation|2|||
155106916|NCT02311881|559819118|FG002|Overall Study|Protocol Violation|3|||
155106917|NCT02311881|559819116|FG000|Overall Study|Withdrawal of consent|14|||
155106918|NCT02311881|559819117|FG001|Overall Study|Withdrawal of consent|16|||
155106919|NCT02311881|559819118|FG002|Overall Study|Withdrawal of consent|17|||
155106920|NCT02311881|559819116|FG000|Overall Study|Other|0|||
155106921|NCT02311881|559819117|FG001|Overall Study|Other|0|||
155106922|NCT02311881|559819118|FG002|Overall Study|Other|1|||
154861316|NCT02305563|558917388|FG003|Treatment Period|Death|2|||
154861317|NCT02305563|558917389|FG004|Treatment Period|Death|1|||
154861318|NCT02305563|558917385|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
154861319|NCT02305563|558917386|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
154861320|NCT02305563|558917387|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
154861321|NCT02305563|558917388|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
154861322|NCT02305563|558917389|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
154861323|NCT02305563|558917385|FG000|Treatment Period|Participant request to stop therapy|0|||
154861324|NCT02305563|558917386|FG001|Treatment Period|Participant request to stop therapy|2|||
154861325|NCT02305563|558917387|FG002|Treatment Period|Participant request to stop therapy|0|||
154861326|NCT02305563|558917388|FG003|Treatment Period|Participant request to stop therapy|1|||
154861327|NCT02305563|558917389|FG004|Treatment Period|Participant request to stop therapy|0|||
154861328|NCT02305563|558917385|FG000|Treatment Period|Participant withdrew consent|0|||
154861329|NCT02305563|558917386|FG001|Treatment Period|Participant withdrew consent|0|||
154861330|NCT02305563|558917387|FG002|Treatment Period|Participant withdrew consent|1|||
154861331|NCT02305563|558917388|FG003|Treatment Period|Participant withdrew consent|1|||
154861332|NCT02305563|558917389|FG004|Treatment Period|Participant withdrew consent|1|||
154861333|NCT02305563|558917385|FG000|Treatment Period|Maximum clinical benefit|0|||
154861334|NCT02305563|558917386|FG001|Treatment Period|Maximum clinical benefit|0|||
154861335|NCT02305563|558917387|FG002|Treatment Period|Maximum clinical benefit|0|||
154861336|NCT02305563|558917388|FG003|Treatment Period|Maximum clinical benefit|0|||
154861337|NCT02305563|558917389|FG004|Treatment Period|Maximum clinical benefit|1|||
155106923|NCT02311881|559819116|FG000|Overall Study|Lack of Efficacy|1|||
155106924|NCT02311881|559819117|FG001|Overall Study|Lack of Efficacy|2|||
154861338|NCT02305563|558917385|FG000|Treatment Period|Poor/non-compliance|0|||
154861339|NCT02305563|558917386|FG001|Treatment Period|Poor/non-compliance|0|||
154861340|NCT02305563|558917387|FG002|Treatment Period|Poor/non-compliance|0|||
154861341|NCT02305563|558917388|FG003|Treatment Period|Poor/non-compliance|0|||
154861342|NCT02305563|558917389|FG004|Treatment Period|Poor/non-compliance|1|||
154861343|NCT02305563|558917385|FG000|Treatment Period|Administrative reason by Sponsor|0|||
154861344|NCT02305563|558917386|FG001|Treatment Period|Administrative reason by Sponsor|0|||
154861345|NCT02305563|558917387|FG002|Treatment Period|Administrative reason by Sponsor|0|||
154861346|NCT02305563|558917388|FG003|Treatment Period|Administrative reason by Sponsor|0|||
155106925|NCT02311881|559819118|FG002|Overall Study|Lack of Efficacy|0|||
155106926|NCT02311881|559819116|FG000|Overall Study|Subject has border line pregnancy test|1|||
155106927|NCT02311881|559819117|FG001|Overall Study|Subject has border line pregnancy test|0|||
155106928|NCT02311881|559819118|FG002|Overall Study|Subject has border line pregnancy test|0|||
155106929|NCT02311881|559819116|FG000|Overall Study|Withdrawal by Subject|3|||
155106930|NCT02311881|559819117|FG001|Overall Study|Withdrawal by Subject|1|||
155106931|NCT02311881|559819118|FG002|Overall Study|Withdrawal by Subject|4|||
154861347|NCT02305563|558917389|FG004|Treatment Period|Administrative reason by Sponsor|1|||
154861348|NCT02305563|558917385|FG000|Treatment Period|other reason|2|||
154861349|NCT02305563|558917386|FG001|Treatment Period|other reason|0|||
154861350|NCT02305563|558917387|FG002|Treatment Period|other reason|2|||
154861351|NCT02305563|558917388|FG003|Treatment Period|other reason|2|||
154861352|NCT02305563|558917389|FG004|Treatment Period|other reason|1|||
154861353|NCT02305563|558917385|FG000|Treatment Period|Randomized but not treated|0|||
154861354|NCT02305563|558917386|FG001|Treatment Period|Randomized but not treated|0|||
154861355|NCT02305563|558917387|FG002|Treatment Period|Randomized but not treated|0|||
154861356|NCT02305563|558917388|FG003|Treatment Period|Randomized but not treated|0|||
154861357|NCT02305563|558917389|FG004|Treatment Period|Randomized but not treated|2|||
154861358|NCT02305563|558917385|FG000|Treatment Period|added ULO, then disease progression|0|||
154861359|NCT02305563|558917386|FG001|Treatment Period|added ULO, then disease progression|0|||
154861360|NCT02305563|558917387|FG002|Treatment Period|added ULO, then disease progression|0|||
154861361|NCT02305563|558917388|FG003|Treatment Period|added ULO, then disease progression|0|||
154861362|NCT02305563|558917389|FG004|Treatment Period|added ULO, then disease progression|4|||
154861363|NCT02305563|558917385|FG000|Treatment Period|added ULO; then other reason|0|||
154861364|NCT02305563|558917386|FG001|Treatment Period|added ULO; then other reason|0|||
154861365|NCT02305563|558917387|FG002|Treatment Period|added ULO; then other reason|0|||
154861366|NCT02305563|558917388|FG003|Treatment Period|added ULO; then other reason|0|||
154861367|NCT02305563|558917389|FG004|Treatment Period|added ULO; then other reason|1|||
154861368|NCT02305563|558917385|FG000|Treatment Period|added ULO, then request to stop|0|||
154861369|NCT02305563|558917386|FG001|Treatment Period|added ULO, then request to stop|0|||
154861370|NCT02305563|558917387|FG002|Treatment Period|added ULO, then request to stop|0|||
154861371|NCT02305563|558917388|FG003|Treatment Period|added ULO, then request to stop|0|||
154861372|NCT02305563|558917389|FG004|Treatment Period|added ULO, then request to stop|1|||
154861373|NCT02305563|558917385|FG000|Follow-up Period|Death|0|||
154861374|NCT02305563|558917386|FG001|Follow-up Period|Death|0|||
154861375|NCT02305563|558917387|FG002|Follow-up Period|Death|5|||
154861376|NCT02305563|558917388|FG003|Follow-up Period|Death|4|||
154861377|NCT02305563|558917389|FG004|Follow-up Period|Death|7|||
154861378|NCT02305563|558917385|FG000|Follow-up Period|Participant withdrew consent|0|||
154861379|NCT02305563|558917386|FG001|Follow-up Period|Participant withdrew consent|0|||
154861380|NCT02305563|558917387|FG002|Follow-up Period|Participant withdrew consent|2|||
154861381|NCT02305563|558917388|FG003|Follow-up Period|Participant withdrew consent|1|||
154861382|NCT02305563|558917389|FG004|Follow-up Period|Participant withdrew consent|0|||
154861383|NCT02305563|558917385|FG000|Follow-up Period|other reason|0|||
154861384|NCT02305563|558917386|FG001|Follow-up Period|other reason|0|||
154861385|NCT02305563|558917387|FG002|Follow-up Period|other reason|0|||
154861386|NCT02305563|558917388|FG003|Follow-up Period|other reason|0|||
154861387|NCT02305563|558917389|FG004|Follow-up Period|other reason|1|||
154861388|NCT02305563|558917385|FG000|Follow-up Period|Followup no longer required per protocol|3|||
154861389|NCT02305563|558917386|FG001|Follow-up Period|Followup no longer required per protocol|3|||
154861390|NCT02305563|558917387|FG002|Follow-up Period|Followup no longer required per protocol|4|||
154861391|NCT02305563|558917388|FG003|Follow-up Period|Followup no longer required per protocol|1|||
154861392|NCT02305563|558917389|FG004|Follow-up Period|Followup no longer required per protocol|4|||
154861393|NCT01275222|558917395|FG000|Phase l by Treatment|Adverse Event|1|||
154861394|NCT01275222|558917396|FG001|Phase l by Treatment|Adverse Event|4|||
154861395|NCT01275222|558917397|FG002|Phase l by Treatment|Adverse Event|2|||
154861396|NCT01275222|558917398|FG003|Phase l by Treatment|Adverse Event|3|||
154861397|NCT01275222|558917399|FG004|Phase l by Treatment|Adverse Event|0|||
154861398|NCT01275222|558917400|FG005|Phase l by Treatment|Adverse Event|0|||
154861399|NCT01275222|558917395|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
154861400|NCT01275222|558917396|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
154861401|NCT01275222|558917397|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
154861402|NCT01275222|558917398|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
154861403|NCT01275222|558917399|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
154861404|NCT01275222|558917400|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
154861405|NCT01275222|558917395|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
154861406|NCT01275222|558917396|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
154861407|NCT01275222|558917397|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
154861408|NCT01275222|558917398|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
154861409|NCT01275222|558917399|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
154861410|NCT01275222|558917400|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
154861411|NCT01275222|558917395|FG000|Phase l by Treatment|Disease progression|12|||
154861412|NCT01275222|558917396|FG001|Phase l by Treatment|Disease progression|8|||
154861413|NCT01275222|558917397|FG002|Phase l by Treatment|Disease progression|2|||
154861414|NCT01275222|558917398|FG003|Phase l by Treatment|Disease progression|5|||
154861415|NCT01275222|558917399|FG004|Phase l by Treatment|Disease progression|0|||
154861416|NCT01275222|558917400|FG005|Phase l by Treatment|Disease progression|0|||
154861417|NCT01275222|558917395|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
155106932|NCT02311881|559819116|FG000|Overall Study|Sponsor Decision|1|||
154861418|NCT01275222|558917396|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
154861419|NCT01275222|558917397|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
154861420|NCT01275222|558917398|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
154861421|NCT01275222|558917399|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
154861422|NCT01275222|558917400|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
154861423|NCT01275222|558917395|FG000|Phase l by Treatment|Death|0|||
154861424|NCT01275222|558917396|FG001|Phase l by Treatment|Death|1|||
154861425|NCT01275222|558917397|FG002|Phase l by Treatment|Death|0|||
154861426|NCT01275222|558917398|FG003|Phase l by Treatment|Death|1|||
154861427|NCT01275222|558917399|FG004|Phase l by Treatment|Death|0|||
154861428|NCT01275222|558917400|FG005|Phase l by Treatment|Death|0|||
154861429|NCT01275222|558917395|FG000|Phase ll by Stratum|Adverse Event|0|||
154861430|NCT01275222|558917396|FG001|Phase ll by Stratum|Adverse Event|0|||
154861431|NCT01275222|558917397|FG002|Phase ll by Stratum|Adverse Event|0|||
154861432|NCT01275222|558917398|FG003|Phase ll by Stratum|Adverse Event|0|||
154861433|NCT01275222|558917399|FG004|Phase ll by Stratum|Adverse Event|2|||
154861434|NCT01275222|558917400|FG005|Phase ll by Stratum|Adverse Event|10|||
154861435|NCT01275222|558917395|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
154861436|NCT01275222|558917396|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
154861437|NCT01275222|558917397|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
154861438|NCT01275222|558917398|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
154861439|NCT01275222|558917399|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
154861440|NCT01275222|558917400|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
154861441|NCT01275222|558917395|FG000|Phase ll by Stratum|Disease progression|0|||
154861442|NCT01275222|558917396|FG001|Phase ll by Stratum|Disease progression|0|||
154861443|NCT01275222|558917397|FG002|Phase ll by Stratum|Disease progression|0|||
154861444|NCT01275222|558917398|FG003|Phase ll by Stratum|Disease progression|0|||
154861445|NCT01275222|558917399|FG004|Phase ll by Stratum|Disease progression|23|||
154861446|NCT01275222|558917400|FG005|Phase ll by Stratum|Disease progression|31|||
154861447|NCT01275222|558917395|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
154861448|NCT01275222|558917396|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
154861449|NCT01275222|558917397|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
154861450|NCT01275222|558917398|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
154861451|NCT01275222|558917399|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
154861452|NCT01275222|558917400|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
154861453|NCT01275222|558917395|FG000|Phase ll by Stratum|Death|0|||
154861454|NCT01275222|558917396|FG001|Phase ll by Stratum|Death|0|||
154861455|NCT01275222|558917397|FG002|Phase ll by Stratum|Death|0|||
154861456|NCT01275222|558917398|FG003|Phase ll by Stratum|Death|0|||
154861457|NCT01275222|558917399|FG004|Phase ll by Stratum|Death|1|||
154861458|NCT01275222|558917400|FG005|Phase ll by Stratum|Death|1|||
154861459|NCT01243268|558917402|FG000|Overall Study|Lost to Follow-up|4|||
154861460|NCT01243268|558917402|FG000|Overall Study|Protocol Violation|51|||
154861461|NCT01243268|558917402|FG000|Overall Study|Deviation with contract date|7|||
154861462|NCT01243268|558917402|FG000|Overall Study|Duplicate subject|2|||
154861463|NCT01822561|558917407|FG000|Overall Study|Withdrawal by Subject|2|||
154861464|NCT01444300|558917408|FG000|Overall Study|Adverse Event|4|||
154861465|NCT01444300|558917409|FG001|Overall Study|Adverse Event|0|||
154861466|NCT02722044|558917410|FG000|Overall Study|Adverse Event|2|||
154861467|NCT02722044|558917410|FG000|Overall Study|Physician Decision|1|||
154861468|NCT02722044|558917410|FG000|Overall Study|Withdrawal by Subject|1|||
154861469|NCT02722044|558917410|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
154861470|NCT00818259|558917414|FG000|Part I|Withdrawal by Subject|1|||
154861471|NCT00818259|558917415|FG001|Part I|Withdrawal by Subject|0|||
154861472|NCT00818259|558917416|FG002|Part I|Withdrawal by Subject|0|||
154861473|NCT00818259|558917417|FG003|Part I|Withdrawal by Subject|0|||
154861474|NCT00818259|558917418|FG004|Part I|Withdrawal by Subject|0|||
154972415|NCT00098475|559323564|FG000|Step 1|Adverse Event|56|||
154972416|NCT00098475|559323565|FG001|Step 1|Adverse Event|37|||
154972417|NCT00098475|559323566|FG002|Step 1|Adverse Event|0|||
154972418|NCT00098475|559323567|FG003|Step 1|Adverse Event|1|||
154861475|NCT00818259|558917419|FG005|Part I|Withdrawal by Subject|0|||
154861476|NCT00818259|558917420|FG006|Part I|Withdrawal by Subject|0|||
154861477|NCT00818259|558917421|FG007|Part I|Withdrawal by Subject|0|||
154861478|NCT00818259|558917422|FG008|Part I|Withdrawal by Subject|0|||
154861479|NCT00818259|558917414|FG000|Part II|Physician Decision|0|||
154861480|NCT00818259|558917415|FG001|Part II|Physician Decision|0|||
154972419|NCT00098475|559323564|FG000|Step 1|Death|8|||
154972420|NCT00098475|559323565|FG001|Step 1|Death|5|||
154861481|NCT00818259|558917416|FG002|Part II|Physician Decision|1|||
154861482|NCT00818259|558917417|FG003|Part II|Physician Decision|0|||
154972421|NCT00098475|559323566|FG002|Step 1|Death|0|||
154972422|NCT00098475|559323567|FG003|Step 1|Death|1|||
154861483|NCT00818259|558917418|FG004|Part II|Physician Decision|0|||
154861484|NCT00818259|558917419|FG005|Part II|Physician Decision|0|||
154861485|NCT00818259|558917420|FG006|Part II|Physician Decision|0|||
154861486|NCT00818259|558917421|FG007|Part II|Physician Decision|0|||
154972423|NCT00098475|559323564|FG000|Step 1|Withdrawal by Subject|14|||
154972424|NCT00098475|559323565|FG001|Step 1|Withdrawal by Subject|11|||
154861487|NCT00818259|558917422|FG008|Part II|Physician Decision|0|||
154861488|NCT00818259|558917414|FG000|Part II|Lack of Efficacy|0|||
154861489|NCT00818259|558917415|FG001|Part II|Lack of Efficacy|0|||
154861490|NCT00818259|558917416|FG002|Part II|Lack of Efficacy|0|||
154861491|NCT00818259|558917417|FG003|Part II|Lack of Efficacy|1|||
154861492|NCT00818259|558917418|FG004|Part II|Lack of Efficacy|0|||
154861493|NCT00818259|558917419|FG005|Part II|Lack of Efficacy|0|||
154861494|NCT00818259|558917420|FG006|Part II|Lack of Efficacy|0|||
154861495|NCT00818259|558917421|FG007|Part II|Lack of Efficacy|0|||
154861496|NCT00818259|558917422|FG008|Part II|Lack of Efficacy|0|||
154861497|NCT00818259|558917414|FG000|Part II|Not Treated|0|||
154861498|NCT00818259|558917415|FG001|Part II|Not Treated|0|||
154861499|NCT00818259|558917416|FG002|Part II|Not Treated|0|||
155106933|NCT02311881|559819117|FG001|Overall Study|Sponsor Decision|1|||
155106934|NCT02311881|559819118|FG002|Overall Study|Sponsor Decision|1|||
155106935|NCT02311881|559819116|FG000|Overall Study|Protocol Deviation|1|||
155106936|NCT02311881|559819117|FG001|Overall Study|Protocol Deviation|0|||
155106937|NCT02311881|559819118|FG002|Overall Study|Protocol Deviation|0|||
155106938|NCT02311881|559819116|FG000|Overall Study|Non-Compliance|1|||
155106939|NCT02311881|559819117|FG001|Overall Study|Non-Compliance|0|||
155106940|NCT02311881|559819118|FG002|Overall Study|Non-Compliance|2|||
155106941|NCT02311881|559819116|FG000|Overall Study|Physician Decision|0|||
155106942|NCT02311881|559819117|FG001|Overall Study|Physician Decision|0|||
155106943|NCT02311881|559819118|FG002|Overall Study|Physician Decision|1|||
155106944|NCT02311881|559819116|FG000|Overall Study|Medical Monitor Discretion|0|||
155106945|NCT02311881|559819117|FG001|Overall Study|Medical Monitor Discretion|0|||
155106946|NCT02311881|559819118|FG002|Overall Study|Medical Monitor Discretion|1|||
155106947|NCT02311881|559819116|FG000|Overall Study|Participant taking another medication|0|||
155106948|NCT02311881|559819117|FG001|Overall Study|Participant taking another medication|0|||
155106949|NCT02311881|559819118|FG002|Overall Study|Participant taking another medication|1|||
155106950|NCT02311881|559819116|FG000|Overall Study|Serious Adverse Event|0|||
155106951|NCT02311881|559819117|FG001|Overall Study|Serious Adverse Event|1|||
155106952|NCT02311881|559819118|FG002|Overall Study|Serious Adverse Event|0|||
155106953|NCT00556439|559819123|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
155106954|NCT00556439|559819124|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
155106955|NCT00556439|559819125|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
155106956|NCT00556439|559819126|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
155106957|NCT00556439|559819123|FG000|Study Entry to Week 12|Physician Decision|1|||
155106958|NCT00556439|559819124|FG001|Study Entry to Week 12|Physician Decision|0|||
155106959|NCT00556439|559819125|FG002|Study Entry to Week 12|Physician Decision|0|||
155106960|NCT00556439|559819126|FG003|Study Entry to Week 12|Physician Decision|0|||
155106961|NCT00556439|559819123|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
155106962|NCT00556439|559819124|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
155106963|NCT00556439|559819125|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
155106964|NCT00556439|559819126|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
155106965|NCT00556439|559819123|FG000|Study Entry to Week 12|Recurrent infection|1|||
155106966|NCT00556439|559819124|FG001|Study Entry to Week 12|Recurrent infection|0|||
155106967|NCT00556439|559819125|FG002|Study Entry to Week 12|Recurrent infection|0|||
155106968|NCT00556439|559819126|FG003|Study Entry to Week 12|Recurrent infection|0|||
154861500|NCT00818259|558917417|FG003|Part II|Not Treated|1|||
154861501|NCT00818259|558917418|FG004|Part II|Not Treated|0|||
154861502|NCT00818259|558917419|FG005|Part II|Not Treated|0|||
154861503|NCT00818259|558917420|FG006|Part II|Not Treated|0|||
154861504|NCT00818259|558917421|FG007|Part II|Not Treated|0|||
154861505|NCT00818259|558917422|FG008|Part II|Not Treated|0|||
154861506|NCT00818259|558917414|FG000|Part IV|Physician Decision|0|||
154861507|NCT00818259|558917415|FG001|Part IV|Physician Decision|0|||
155106969|NCT00556439|559819123|FG000|Study Entry to Week 12|Malignancy|0|||
155106970|NCT00556439|559819124|FG001|Study Entry to Week 12|Malignancy|0|||
155106971|NCT00556439|559819125|FG002|Study Entry to Week 12|Malignancy|1|||
155106972|NCT00556439|559819126|FG003|Study Entry to Week 12|Malignancy|0|||
155106973|NCT00556439|559819123|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
155106974|NCT00556439|559819124|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
155106975|NCT00556439|559819125|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
155106976|NCT00556439|559819126|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
154861508|NCT00818259|558917416|FG002|Part IV|Physician Decision|0|||
154861509|NCT00818259|558917417|FG003|Part IV|Physician Decision|0|||
154861510|NCT00818259|558917418|FG004|Part IV|Physician Decision|0|||
154861511|NCT00818259|558917419|FG005|Part IV|Physician Decision|1|||
154861512|NCT00818259|558917420|FG006|Part IV|Physician Decision|0|||
154861513|NCT00818259|558917421|FG007|Part IV|Physician Decision|0|||
154861514|NCT00818259|558917422|FG008|Part IV|Physician Decision|0|||
155106977|NCT00556439|559819123|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
155106978|NCT00556439|559819124|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
154861515|NCT00818259|558917414|FG000|Part V|Adverse Event|0|||
154861516|NCT00818259|558917415|FG001|Part V|Adverse Event|0|||
154861517|NCT00818259|558917416|FG002|Part V|Adverse Event|0|||
154861518|NCT00818259|558917417|FG003|Part V|Adverse Event|0|||
154861519|NCT00818259|558917418|FG004|Part V|Adverse Event|0|||
154861520|NCT00818259|558917419|FG005|Part V|Adverse Event|0|||
154861521|NCT00818259|558917420|FG006|Part V|Adverse Event|0|||
154861522|NCT00818259|558917421|FG007|Part V|Adverse Event|1|||
154861523|NCT00818259|558917422|FG008|Part V|Adverse Event|0|||
154861524|NCT02970929|558917430|FG000|Overall Study|Adverse Event|18|||
154861525|NCT02970929|558917430|FG000|Overall Study|Lack of Efficacy|8|||
154861526|NCT02970929|558917430|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
154861527|NCT02970929|558917430|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
154861528|NCT02970929|558917430|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
154861529|NCT02970929|558917430|FG000|Overall Study|LOST TO FOLLOWUP|6|||
154861530|NCT02970929|558917430|FG000|Overall Study|MOVED OUT OF STATE|1|||
154861531|NCT02970929|558917430|FG000|Overall Study|Withdrawal by Subject|16|||
154861532|NCT02370121|558917439|FG000|Overall Study|Lost to Follow-up|1|||
154861533|NCT02370121|558917440|FG001|Overall Study|Lost to Follow-up|1|||
154861534|NCT02654002|558917443|FG000|Overall Study|Adverse Event|0|||
154861535|NCT02654002|558917444|FG001|Overall Study|Adverse Event|0|||
154861536|NCT02654002|558917445|FG002|Overall Study|Adverse Event|0|||
154861537|NCT02654002|558917446|FG003|Overall Study|Adverse Event|0|||
154861538|NCT02654002|558917447|FG004|Overall Study|Adverse Event|0|||
154861539|NCT02654002|558917448|FG005|Overall Study|Adverse Event|0|||
154861540|NCT02654002|558917449|FG006|Overall Study|Adverse Event|1|||
154861541|NCT02654002|558917450|FG007|Overall Study|Adverse Event|0|||
154861542|NCT02654002|558917451|FG008|Overall Study|Adverse Event|0|||
154861543|NCT02654002|558917443|FG000|Overall Study|Withdrew Consent|0|||
154861544|NCT02654002|558917444|FG001|Overall Study|Withdrew Consent|0|||
154861545|NCT02654002|558917445|FG002|Overall Study|Withdrew Consent|0|||
154861546|NCT02654002|558917446|FG003|Overall Study|Withdrew Consent|0|||
154861547|NCT02654002|558917447|FG004|Overall Study|Withdrew Consent|0|||
154861548|NCT02654002|558917448|FG005|Overall Study|Withdrew Consent|1|||
154861549|NCT02654002|558917449|FG006|Overall Study|Withdrew Consent|0|||
154861550|NCT02654002|558917450|FG007|Overall Study|Withdrew Consent|1|||
154861551|NCT02654002|558917451|FG008|Overall Study|Withdrew Consent|0|||
154861552|NCT01523873|558917452|FG000|Overall Study|Protocol Violation|422|||
154861553|NCT00275561|558917455|FG000|Overall Study|Withdrawal by Subject|0|||
154861554|NCT00275561|558917456|FG001|Overall Study|Withdrawal by Subject|1|||
154861555|NCT00275561|558917455|FG000|Overall Study|Travel|1|||
154861556|NCT00275561|558917456|FG001|Overall Study|Travel|1|||
154861557|NCT00275561|558917455|FG000|Overall Study|Scheduling|1|||
154861558|NCT00275561|558917456|FG001|Overall Study|Scheduling|2|||
154861559|NCT00275561|558917455|FG000|Overall Study|Family Issues|0|||
154861560|NCT00275561|558917456|FG001|Overall Study|Family Issues|2|||
154861561|NCT01769105|558917457|FG000|First Intervention|Protocol Violation|2|||
154861562|NCT01769105|558917458|FG001|First Intervention|Protocol Violation|2|||
154861563|NCT01769105|558917457|FG000|Cross-over|Lost to Follow-up|5|||
154861564|NCT01769105|558917458|FG001|Cross-over|Lost to Follow-up|0|||
154861565|NCT01392183|558917463|FG000|First Drug Administration|Adverse Event|3|||
154861566|NCT01392183|558917464|FG001|First Drug Administration|Adverse Event|2|||
154861567|NCT01392183|558917463|FG000|First Drug Administration|Death|1|||
154861568|NCT01392183|558917464|FG001|First Drug Administration|Death|0|||
154861569|NCT01392183|558917463|FG000|First Drug Administration|Withdrawal by Subject|10|||
154861570|NCT01392183|558917464|FG001|First Drug Administration|Withdrawal by Subject|17|||
154861571|NCT00963807|558917467|FG000|Overall Study|Physician Decision|2|||
154861572|NCT00963807|558917467|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
154861573|NCT00963807|558917467|FG000|Overall Study|Disease progression|15|||
154861574|NCT00684177|558917470|FG000|Overall Study|Adverse Event|4|||
154861575|NCT00684177|558917471|FG001|Overall Study|Adverse Event|3|||
154861576|NCT00684177|558917470|FG000|Overall Study|Lack of Efficacy|10|||
154861577|NCT00684177|558917471|FG001|Overall Study|Lack of Efficacy|15|||
154861578|NCT00684177|558917470|FG000|Overall Study|Protocol Violation|1|||
154861579|NCT00684177|558917471|FG001|Overall Study|Protocol Violation|0|||
154861580|NCT00684177|558917470|FG000|Overall Study|Lost to Follow-up|2|||
154861581|NCT00684177|558917471|FG001|Overall Study|Lost to Follow-up|1|||
154861582|NCT00684177|558917470|FG000|Overall Study|Physician Decision|2|||
154861583|NCT00684177|558917471|FG001|Overall Study|Physician Decision|0|||
154861584|NCT00684177|558917470|FG000|Overall Study|Withdrawal by Subject|1|||
154861585|NCT00684177|558917471|FG001|Overall Study|Withdrawal by Subject|2|||
154861586|NCT00684177|558917470|FG000|Overall Study|Other|1|||
154861587|NCT00684177|558917471|FG001|Overall Study|Other|2|||
154861588|NCT02224664|558919018|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
154861589|NCT02224664|558919019|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
154861590|NCT02224664|558919020|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
154861591|NCT02224664|558919021|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
154861592|NCT02224664|558919022|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
154861593|NCT02224664|558919018|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
154861594|NCT02224664|558919019|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
154861595|NCT02224664|558919020|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
154861596|NCT02224664|558919021|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
154861597|NCT02224664|558919022|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
154861598|NCT02224664|558919018|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
154861599|NCT02224664|558919019|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
154861600|NCT02224664|558919020|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
154861601|NCT02224664|558919021|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
154861602|NCT02224664|558919022|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
154861603|NCT01024244|558919026|FG000|Overall Study|Adverse Event|1|||
154861604|NCT01024244|558919027|FG001|Overall Study|Adverse Event|2|||
154861605|NCT01024244|558919028|FG002|Overall Study|Adverse Event|0|||
154861606|NCT01024244|558919029|FG003|Overall Study|Adverse Event|1|||
154861607|NCT01024244|558919030|FG004|Overall Study|Adverse Event|2|||
154861608|NCT01024244|558919026|FG000|Overall Study|Entry Criteria Not Met|0|||
154861609|NCT01024244|558919027|FG001|Overall Study|Entry Criteria Not Met|1|||
154861610|NCT01024244|558919028|FG002|Overall Study|Entry Criteria Not Met|0|||
154861611|NCT01024244|558919029|FG003|Overall Study|Entry Criteria Not Met|0|||
154861612|NCT01024244|558919030|FG004|Overall Study|Entry Criteria Not Met|0|||
154861613|NCT01024244|558919026|FG000|Overall Study|Lack of Efficacy|1|||
154861614|NCT01024244|558919027|FG001|Overall Study|Lack of Efficacy|0|||
154861615|NCT01024244|558919028|FG002|Overall Study|Lack of Efficacy|0|||
154861616|NCT01024244|558919029|FG003|Overall Study|Lack of Efficacy|0|||
154861617|NCT01024244|558919030|FG004|Overall Study|Lack of Efficacy|0|||
154861618|NCT01024244|558919026|FG000|Overall Study|Protocol Violation|1|||
154861619|NCT01024244|558919027|FG001|Overall Study|Protocol Violation|0|||
154861620|NCT01024244|558919028|FG002|Overall Study|Protocol Violation|0|||
154861621|NCT01024244|558919029|FG003|Overall Study|Protocol Violation|0|||
154861622|NCT01024244|558919030|FG004|Overall Study|Protocol Violation|2|||
154861623|NCT01024244|558919026|FG000|Overall Study|Sponsor Decision|14|||
154861624|NCT01024244|558919027|FG001|Overall Study|Sponsor Decision|7|||
154861625|NCT01024244|558919028|FG002|Overall Study|Sponsor Decision|14|||
154861626|NCT01024244|558919029|FG003|Overall Study|Sponsor Decision|12|||
154861627|NCT01024244|558919030|FG004|Overall Study|Sponsor Decision|10|||
154861628|NCT01024244|558919026|FG000|Overall Study|Withdrawal by Subject|0|||
154861629|NCT01024244|558919027|FG001|Overall Study|Withdrawal by Subject|1|||
154861630|NCT01024244|558919028|FG002|Overall Study|Withdrawal by Subject|0|||
154861631|NCT01024244|558919029|FG003|Overall Study|Withdrawal by Subject|0|||
154861632|NCT01024244|558919030|FG004|Overall Study|Withdrawal by Subject|0|||
154861633|NCT00265941|558919034|FG000|Overall Study|Protocol Violation|22|||
154861634|NCT00265941|558919035|FG001|Overall Study|Protocol Violation|25|||
154861635|NCT00265941|558919034|FG000|Overall Study|Lost to Follow-up|1|||
154861636|NCT00265941|558919035|FG001|Overall Study|Lost to Follow-up|1|||
154861637|NCT03976401|558919040|FG000|Overall Study|Adverse Event|2|||
154861638|NCT03976401|558919041|FG001|Overall Study|Adverse Event|0|||
154861639|NCT03976401|558919042|FG002|Overall Study|Adverse Event|4|||
154861640|NCT03976401|558919043|FG003|Overall Study|Adverse Event|1|||
154861641|NCT03976401|558919044|FG004|Overall Study|Adverse Event|1|||
154861642|NCT03976401|558919045|FG005|Overall Study|Adverse Event|0|||
154861643|NCT03976401|558919040|FG000|Overall Study|Withdrawal by Subject|0|||
154861644|NCT03976401|558919041|FG001|Overall Study|Withdrawal by Subject|1|||
154861645|NCT03976401|558919042|FG002|Overall Study|Withdrawal by Subject|0|||
154861646|NCT03976401|558919043|FG003|Overall Study|Withdrawal by Subject|0|||
154861647|NCT03976401|558919044|FG004|Overall Study|Withdrawal by Subject|0|||
154861648|NCT03976401|558919045|FG005|Overall Study|Withdrawal by Subject|1|||
154861649|NCT03976401|558919040|FG000|Overall Study|Physician Decision|0|||
154861650|NCT03976401|558919041|FG001|Overall Study|Physician Decision|0|||
154861651|NCT03976401|558919042|FG002|Overall Study|Physician Decision|1|||
154861652|NCT03976401|558919043|FG003|Overall Study|Physician Decision|0|||
154861653|NCT03976401|558919044|FG004|Overall Study|Physician Decision|0|||
155106979|NCT00556439|559819125|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
155106980|NCT00556439|559819126|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
154861654|NCT03976401|558919045|FG005|Overall Study|Physician Decision|0|||
154861655|NCT03976401|558919040|FG000|Overall Study|Lost to Follow-up|1|||
154861656|NCT03976401|558919041|FG001|Overall Study|Lost to Follow-up|2|||
154972425|NCT00098475|559323566|FG002|Step 1|Withdrawal by Subject|0|||
154972426|NCT00098475|559323567|FG003|Step 1|Withdrawal by Subject|0|||
154972427|NCT00098475|559323564|FG000|Step 1|Physician Decision|5|||
154972428|NCT00098475|559323565|FG001|Step 1|Physician Decision|2|||
154861657|NCT03976401|558919042|FG002|Overall Study|Lost to Follow-up|0|||
154861658|NCT03976401|558919043|FG003|Overall Study|Lost to Follow-up|0|||
154972429|NCT00098475|559323566|FG002|Step 1|Physician Decision|0|||
154861659|NCT03976401|558919044|FG004|Overall Study|Lost to Follow-up|0|||
154861660|NCT03976401|558919045|FG005|Overall Study|Lost to Follow-up|0|||
154861661|NCT03976401|558919040|FG000|Overall Study|Protocol Violation|0|||
154861662|NCT03976401|558919041|FG001|Overall Study|Protocol Violation|1|||
154861663|NCT03976401|558919042|FG002|Overall Study|Protocol Violation|0|||
154861664|NCT03976401|558919043|FG003|Overall Study|Protocol Violation|0|||
154861665|NCT03976401|558919044|FG004|Overall Study|Protocol Violation|0|||
154972430|NCT00098475|559323567|FG003|Step 1|Physician Decision|0|||
154861666|NCT03976401|558919045|FG005|Overall Study|Protocol Violation|0|||
154861667|NCT03976401|558919040|FG000|Overall Study|Withdrew Consent|0|||
154861668|NCT03976401|558919041|FG001|Overall Study|Withdrew Consent|0|||
154861669|NCT03976401|558919042|FG002|Overall Study|Withdrew Consent|0|||
154861670|NCT03976401|558919043|FG003|Overall Study|Withdrew Consent|1|||
154861671|NCT03976401|558919044|FG004|Overall Study|Withdrew Consent|0|||
154861672|NCT03976401|558919045|FG005|Overall Study|Withdrew Consent|0|||
154861673|NCT02197377|558919050|FG000|Overall Study|Insertion Failure|0|||
154861674|NCT02197377|558919051|FG001|Overall Study|Insertion Failure|3|||
154861675|NCT00833092|558919053|FG000|Overall Study|Withdrawal by Subject|2|||
154861676|NCT00833092|558919054|FG001|Overall Study|Withdrawal by Subject|3|||
154861677|NCT00833092|558919053|FG000|Overall Study|Protocol Violation|2|||
154861678|NCT00833092|558919054|FG001|Overall Study|Protocol Violation|1|||
154861679|NCT00833092|558919053|FG000|Overall Study|Diarrhea|0|||
154861680|NCT00833092|558919054|FG001|Overall Study|Diarrhea|2|||
154861681|NCT00833092|558919053|FG000|Overall Study|constipation|0|||
154861682|NCT00833092|558919054|FG001|Overall Study|constipation|1|||
154861683|NCT02983604|558919055|FG000|Overall Study|Enrolled but not Treated|0|||
154861684|NCT02983604|558919056|FG001|Overall Study|Enrolled but not Treated|0|||
154861685|NCT02983604|558919057|FG002|Overall Study|Enrolled but not Treated|1|||
154861686|NCT02983604|558919058|FG003|Overall Study|Enrolled but not Treated|0|||
154861687|NCT00466505|558919059|FG000|Overall Study|disease progression|13|||
154861688|NCT00466505|558919059|FG000|Overall Study|Adverse Event|4|||
154861689|NCT01241786|558919067|FG000|Overall Study|Lack of Efficacy|5|||
154861690|NCT03182738|558919068|FG000|Overall Study|Lost to Follow-up|9|||
154861691|NCT03182738|558919069|FG001|Overall Study|Lost to Follow-up|3|||
154861692|NCT03182738|558919068|FG000|Overall Study|Pregnancy|0|||
154861693|NCT03182738|558919069|FG001|Overall Study|Pregnancy|1|||
154861694|NCT03182738|558919068|FG000|Overall Study|Withdrawal by Subject|0|||
154861695|NCT03182738|558919069|FG001|Overall Study|Withdrawal by Subject|1|||
154972431|NCT00098475|559323564|FG000|Step 1|Alternative therapy|31|||
154972432|NCT00098475|559323565|FG001|Step 1|Alternative therapy|43|||
154861696|NCT02886715|558919070|FG000|Overall Study|Non-Compliance With Study Drug|0|||
154861697|NCT02886715|558919071|FG001|Overall Study|Non-Compliance With Study Drug|2|||
154861698|NCT02886715|558919072|FG002|Overall Study|Non-Compliance With Study Drug|0|||
154861699|NCT02886715|558919070|FG000|Overall Study|Adverse Event|4|||
154861700|NCT02886715|558919071|FG001|Overall Study|Adverse Event|2|||
154861701|NCT02886715|558919072|FG002|Overall Study|Adverse Event|0|||
154861702|NCT02886715|558919070|FG000|Overall Study|Lack of Efficacy|0|||
154861703|NCT02886715|558919071|FG001|Overall Study|Lack of Efficacy|2|||
154861704|NCT02886715|558919072|FG002|Overall Study|Lack of Efficacy|1|||
154861705|NCT02886715|558919070|FG000|Overall Study|Lost to Follow-up|29|||
154861706|NCT02886715|558919071|FG001|Overall Study|Lost to Follow-up|26|||
154861707|NCT02886715|558919072|FG002|Overall Study|Lost to Follow-up|10|||
154861708|NCT02886715|558919070|FG000|Overall Study|Pregnancy|1|||
154861709|NCT02886715|558919071|FG001|Overall Study|Pregnancy|1|||
154861710|NCT02886715|558919072|FG002|Overall Study|Pregnancy|1|||
154861711|NCT02886715|558919070|FG000|Overall Study|Protocol Violation|3|||
155106981|NCT00556439|559819123|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
155106982|NCT00556439|559819124|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
155106983|NCT00556439|559819125|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
155106984|NCT00556439|559819126|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
155106985|NCT00556439|559819123|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
155106986|NCT00556439|559819124|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
154861712|NCT02886715|558919071|FG001|Overall Study|Protocol Violation|2|||
154972433|NCT00098475|559323566|FG002|Step 1|Alternative therapy|1|||
154972434|NCT00098475|559323567|FG003|Step 1|Alternative therapy|0|||
154972435|NCT00098475|559323564|FG000|Step 1|Other disease|2|||
155106987|NCT00556439|559819125|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
155106988|NCT00556439|559819126|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
154861713|NCT02886715|558919072|FG002|Overall Study|Protocol Violation|1|||
154861714|NCT02886715|558919070|FG000|Overall Study|Withdrawal by Subject|20|||
154861715|NCT02886715|558919071|FG001|Overall Study|Withdrawal by Subject|18|||
154972436|NCT00098475|559323565|FG001|Step 1|Other disease|1|||
154972437|NCT00098475|559323566|FG002|Step 1|Other disease|1|||
154861716|NCT02886715|558919072|FG002|Overall Study|Withdrawal by Subject|5|||
154972438|NCT00098475|559323567|FG003|Step 1|Other disease|0|||
154861717|NCT02886715|558919070|FG000|Overall Study|missing|7|||
155106989|NCT02100423|559819127|FG000|Overall Study|Death|1|||
154861718|NCT02886715|558919071|FG001|Overall Study|missing|2|||
154861719|NCT02886715|558919072|FG002|Overall Study|missing|2|||
154861720|NCT00503399|558919073|FG000|Overall Study|Death|2|||
154861721|NCT00503399|558919074|FG001|Overall Study|Death|1|||
154861722|NCT00503399|558919073|FG000|Overall Study|Protocol Violation|1|||
154861723|NCT00503399|558919074|FG001|Overall Study|Protocol Violation|0|||
154861724|NCT00503399|558919073|FG000|Overall Study|Withdrawal by Subject|4|||
154861725|NCT00503399|558919074|FG001|Overall Study|Withdrawal by Subject|2|||
154972439|NCT00098475|559323564|FG000|Step 1|Never started treatment|0|||
154972440|NCT00098475|559323565|FG001|Step 1|Never started treatment|2|||
154861726|NCT00503399|558919073|FG000|Overall Study|Adverse Event|0|||
154861727|NCT00503399|558919074|FG001|Overall Study|Adverse Event|3|||
154861728|NCT00503399|558919073|FG000|Overall Study|Lost to Follow-up|0|||
154861729|NCT00503399|558919074|FG001|Overall Study|Lost to Follow-up|2|||
154861730|NCT01676961|558919075|FG000|Overall Study|Death|3|||
154861731|NCT01676961|558919075|FG000|Overall Study|Lost to Follow-up|1|||
154861732|NCT01676961|558919075|FG000|Overall Study|Withdrawal by Subject|1|||
154861733|NCT03168867|558919076|FG000|Overall Study|Withdrawal by Subject|1|||
154861734|NCT03168867|558919077|FG001|Overall Study|Withdrawal by Subject|5|||
154861735|NCT01128387|558919080|FG000|Overall Study|Physician Decision|0|||
154861736|NCT01128387|558919081|FG001|Overall Study|Physician Decision|1|||
154861737|NCT04433117|558919088|FG000|Overall Study|Withdrawal by Subject|1|||
154861738|NCT04433117|558919089|FG001|Overall Study|Withdrawal by Subject|0|||
154861739|NCT00824421|558919090|FG000|Overall Study|Adverse Event|6|||
154861740|NCT00824421|558919091|FG001|Overall Study|Adverse Event|6|||
154861741|NCT00824421|558919092|FG002|Overall Study|Adverse Event|6|||
154861742|NCT00824421|558919090|FG000|Overall Study|Death|0|||
154861743|NCT00824421|558919091|FG001|Overall Study|Death|1|||
154861744|NCT00824421|558919092|FG002|Overall Study|Death|0|||
154861745|NCT00824421|558919090|FG000|Overall Study|Lack of Efficacy|5|||
154861746|NCT00824421|558919091|FG001|Overall Study|Lack of Efficacy|7|||
154861747|NCT00824421|558919092|FG002|Overall Study|Lack of Efficacy|4|||
154861748|NCT00824421|558919090|FG000|Overall Study|Lost to Follow-up|2|||
154861749|NCT00824421|558919091|FG001|Overall Study|Lost to Follow-up|3|||
154861750|NCT00824421|558919092|FG002|Overall Study|Lost to Follow-up|0|||
154861751|NCT00824421|558919090|FG000|Overall Study|Pregnancy|1|||
154861752|NCT00824421|558919091|FG001|Overall Study|Pregnancy|0|||
154861753|NCT00824421|558919092|FG002|Overall Study|Pregnancy|1|||
154861754|NCT00824421|558919090|FG000|Overall Study|Withdrawal by Subject|2|||
154861755|NCT00824421|558919091|FG001|Overall Study|Withdrawal by Subject|3|||
154861756|NCT00824421|558919092|FG002|Overall Study|Withdrawal by Subject|3|||
154861757|NCT00824421|558919090|FG000|Overall Study|Randomized but not Treated|1|||
154861758|NCT00824421|558919091|FG001|Overall Study|Randomized but not Treated|1|||
154861759|NCT00824421|558919092|FG002|Overall Study|Randomized but not Treated|0|||
154861760|NCT00824421|558919090|FG000|Overall Study|Other|0|||
154861761|NCT00824421|558919091|FG001|Overall Study|Other|1|||
154861762|NCT00824421|558919092|FG002|Overall Study|Other|0|||
154861763|NCT02499952|558919094|FG000|Overall Study|Lost to Follow-up|1|||
154861764|NCT02499952|558919094|FG000|Overall Study|Death|9|||
154861765|NCT05089708|558919095|FG000|Overall Study|Lost to Follow-up|9|||
154861766|NCT05089708|558919096|FG001|Overall Study|Lost to Follow-up|7|||
154861767|NCT05089708|558919095|FG000|Overall Study|Withdrawal by Subject|3|||
154861768|NCT05089708|558919096|FG001|Overall Study|Withdrawal by Subject|1|||
154861769|NCT05089708|558919095|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
154861770|NCT05089708|558919096|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
154861771|NCT05089708|558919095|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
154861772|NCT05089708|558919096|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
154861773|NCT02286102|558919097|FG000|Overall Study|Screen Failure|1|||
154861774|NCT02286102|558919098|FG001|Overall Study|Screen Failure|1|||
154861775|NCT02120417|558919099|FG000|Overall Study|Death|5|||
154861776|NCT02120417|558919100|FG001|Overall Study|Death|1|||
154861777|NCT02120417|558919099|FG000|Overall Study|Adverse Event|3|||
154861778|NCT02120417|558919100|FG001|Overall Study|Adverse Event|9|||
154861779|NCT02120417|558919099|FG000|Overall Study|Participant decision|4|||
154861780|NCT02120417|558919100|FG001|Overall Study|Participant decision|4|||
154861781|NCT02120417|558919099|FG000|Overall Study|Disease progression|41|||
154861782|NCT02120417|558919100|FG001|Overall Study|Disease progression|45|||
154861783|NCT02120417|558919099|FG000|Overall Study|Noncompliance with study treatment|0|||
154861784|NCT02120417|558919100|FG001|Overall Study|Noncompliance with study treatment|2|||
154861785|NCT02120417|558919099|FG000|Overall Study|Physician Decision|2|||
154861786|NCT02120417|558919100|FG001|Overall Study|Physician Decision|3|||
154861787|NCT02120417|558919099|FG000|Overall Study|Other unspecified|5|||
154861788|NCT02120417|558919100|FG001|Overall Study|Other unspecified|4|||
154861789|NCT00927485|558919101|FG000|Overall Study|Adverse Event|4|||
154861790|NCT00927485|558919102|FG001|Overall Study|Adverse Event|2|||
154861791|NCT00927485|558919101|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
154861792|NCT00927485|558919102|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
154861793|NCT01440101|558919103|FG000|Overall Study|Adverse Event|2|||
154861794|NCT01440101|558919104|FG001|Overall Study|Adverse Event|0|||
154861795|NCT01440101|558919105|FG002|Overall Study|Adverse Event|0|||
154861796|NCT01440101|558919103|FG000|Overall Study|Withdrawal by Subject|0|||
154861797|NCT01440101|558919104|FG001|Overall Study|Withdrawal by Subject|3|||
154861798|NCT01440101|558919105|FG002|Overall Study|Withdrawal by Subject|1|||
154861799|NCT01440101|558919103|FG000|Overall Study|Other|0|||
154861800|NCT01440101|558919104|FG001|Overall Study|Other|1|||
154861801|NCT01440101|558919105|FG002|Overall Study|Other|0|||
154861802|NCT04325503|558919111|FG000|Overall Study|Withdrawal by Subject|1|||
154924171|NCT01015118|559146402|FG000|Overall Study|Other Adverse Event (AE)|141|||
154924172|NCT01015118|559146403|FG001|Overall Study|Other Adverse Event (AE)|33|||
154861803|NCT04325503|558919111|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
154861804|NCT00702143|558919112|FG000|Overall Study|Lost to Follow-up|0|||
154861805|NCT00702143|558919113|FG001|Overall Study|Lost to Follow-up|0|||
154861806|NCT00702143|558919114|FG002|Overall Study|Lost to Follow-up|1|||
154861807|NCT03871491|558919115|FG000|Overall Study|Withdrawal by Subject|14|||
154861808|NCT03871491|558919116|FG001|Overall Study|Withdrawal by Subject|14|||
154861809|NCT03871491|558919117|FG002|Overall Study|Withdrawal by Subject|14|||
154861810|NCT03871491|558919118|FG003|Overall Study|Withdrawal by Subject|14|||
154861811|NCT03871491|558919115|FG000|Overall Study|Physician Decision|0|||
154861812|NCT03871491|558919116|FG001|Overall Study|Physician Decision|0|||
154861813|NCT03871491|558919117|FG002|Overall Study|Physician Decision|1|||
154861814|NCT03871491|558919118|FG003|Overall Study|Physician Decision|1|||
154861815|NCT03871491|558919115|FG000|Overall Study|Lost to Follow-up|50|||
154861816|NCT03871491|558919116|FG001|Overall Study|Lost to Follow-up|15|||
154861817|NCT03871491|558919117|FG002|Overall Study|Lost to Follow-up|36|||
154861818|NCT03871491|558919118|FG003|Overall Study|Lost to Follow-up|11|||
154861819|NCT05202808|558919119|FG000|Overall Study|Lost to Follow-up|3|||
154861820|NCT05202808|558919120|FG001|Overall Study|Lost to Follow-up|1|||
154861821|NCT04996797|558919121|FG000|Overall Study|Adverse Event|0|||
154861822|NCT04996797|558919122|FG001|Overall Study|Adverse Event|2|||
154861823|NCT04996797|558919123|FG002|Overall Study|Adverse Event|0|||
154861824|NCT04996797|558919124|FG003|Overall Study|Adverse Event|1|||
154861825|NCT04996797|558919121|FG000|Overall Study|Lack of Efficacy|0|||
154861826|NCT04996797|558919122|FG001|Overall Study|Lack of Efficacy|2|||
154861827|NCT04996797|558919123|FG002|Overall Study|Lack of Efficacy|0|||
154861828|NCT04996797|558919124|FG003|Overall Study|Lack of Efficacy|0|||
154861829|NCT04996797|558919121|FG000|Overall Study|Prohibited Medication|0|||
154861830|NCT04996797|558919122|FG001|Overall Study|Prohibited Medication|1|||
154861831|NCT04996797|558919123|FG002|Overall Study|Prohibited Medication|0|||
154861832|NCT04996797|558919124|FG003|Overall Study|Prohibited Medication|0|||
154861833|NCT04996797|558919121|FG000|Overall Study|Ongoing|68|||
154861834|NCT04996797|558919122|FG001|Overall Study|Ongoing|60|||
154861835|NCT04996797|558919123|FG002|Overall Study|Ongoing|22|||
154861836|NCT04996797|558919124|FG003|Overall Study|Ongoing|20|||
154861837|NCT04996797|558919121|FG000|Overall Study|Withdrawal by Subject|0|||
154861838|NCT04996797|558919122|FG001|Overall Study|Withdrawal by Subject|2|||
154861839|NCT04996797|558919123|FG002|Overall Study|Withdrawal by Subject|0|||
154861840|NCT04996797|558919124|FG003|Overall Study|Withdrawal by Subject|0|||
154861841|NCT02793544|558919125|FG000|Overall Study|Death|10|||
154861842|NCT02793544|558919126|FG001|Overall Study|Death|8|||
154861843|NCT02793544|558919125|FG000|Overall Study|Lost to Follow-up|2|||
154861844|NCT02793544|558919126|FG001|Overall Study|Lost to Follow-up|0|||
154861845|NCT02793544|558919125|FG000|Overall Study|Withdrawal by Subject|1|||
154861846|NCT02793544|558919126|FG001|Overall Study|Withdrawal by Subject|0|||
154861847|NCT04091217|558919127|FG000|Overall Study|Lost to Follow-up|2|||
154861848|NCT02747004|558919128|FG000|Overall Study|Withdrawal by Subject|8|||
154861849|NCT02747004|558919129|FG001|Overall Study|Withdrawal by Subject|5|||
154861850|NCT02747004|558919130|FG002|Overall Study|Withdrawal by Subject|4|||
154861851|NCT02747004|558919128|FG000|Overall Study|Lost to Follow-up|1|||
154861852|NCT02747004|558919129|FG001|Overall Study|Lost to Follow-up|2|||
154861853|NCT02747004|558919130|FG002|Overall Study|Lost to Follow-up|2|||
154861854|NCT02747004|558919128|FG000|Overall Study|on study treatment/follow-up|48|||
154861855|NCT02747004|558919129|FG001|Overall Study|on study treatment/follow-up|42|||
154861856|NCT02747004|558919130|FG002|Overall Study|on study treatment/follow-up|41|||
154861857|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
154861858|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
154861859|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
154861860|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
154861861|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
154861862|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
154861863|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
154861864|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
154861865|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
154861866|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
154861867|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
154861868|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
154861869|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
154861870|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
154861871|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
154861872|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
154861873|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
154861874|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
154861875|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
154861876|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
154861877|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Death|0|||
155106990|NCT02100423|559819127|FG000|Overall Study|Withdrawal by Subject|3|||
155106991|NCT02100423|559819127|FG000|Overall Study|Adverse Event|1|||
155106992|NCT02100423|559819127|FG000|Overall Study|Physician Decision|1|||
155106993|NCT02949024|559819128|FG000|Overall Study|Withdrawal by Subject|0|||
155106994|NCT02949024|559819129|FG001|Overall Study|Withdrawal by Subject|1|||
155106995|NCT00443872|559821092|FG000|Overall Study|Protocol Violation|7|||
155106996|NCT00443872|559821092|FG000|Overall Study|Lost to Follow-up|2|||
155106997|NCT00443872|559821092|FG000|Overall Study|Adverse Event|8|||
155106998|NCT01014767|559821093|FG000|Overall Study|PI left institution, data unavailable|12|||
155106999|NCT01014767|559821094|FG001|Overall Study|PI left institution, data unavailable|1|||
155107000|NCT01014767|559821095|FG002|Overall Study|PI left institution, data unavailable|4|||
155107001|NCT01014767|559821096|FG003|Overall Study|PI left institution, data unavailable|1|||
155107002|NCT01709110|559821097|FG000|Overall Study|Adverse Event|56|||
155107003|NCT01709110|559821098|FG001|Overall Study|Adverse Event|48|||
155107004|NCT01709110|559821097|FG000|Overall Study|Death|14|||
155107005|NCT01709110|559821098|FG001|Overall Study|Death|6|||
155107006|NCT01709110|559821097|FG000|Overall Study|Lost to Follow-up|7|||
155107007|NCT01709110|559821098|FG001|Overall Study|Lost to Follow-up|5|||
155107008|NCT01709110|559821097|FG000|Overall Study|Protocol Violation|4|||
155107009|NCT01709110|559821098|FG001|Overall Study|Protocol Violation|6|||
155107010|NCT01709110|559821097|FG000|Overall Study|Withdrawal by Subject|96|||
155107011|NCT01709110|559821098|FG001|Overall Study|Withdrawal by Subject|89|||
155107012|NCT01709110|559821097|FG000|Overall Study|Physician Decision|4|||
155107013|NCT01709110|559821098|FG001|Overall Study|Physician Decision|10|||
155107014|NCT01709110|559821097|FG000|Overall Study|Sponsor Decision|2|||
155107015|NCT01709110|559821098|FG001|Overall Study|Sponsor Decision|2|||
155107016|NCT01709110|559821097|FG000|Overall Study|Lack of Efficacy|1|||
155107017|NCT01709110|559821098|FG001|Overall Study|Lack of Efficacy|1|||
155107018|NCT01709110|559821097|FG000|Overall Study|Caregiver Decision|1|||
155107019|NCT01709110|559821098|FG001|Overall Study|Caregiver Decision|1|||
155107020|NCT02789345|559821099|FG000|Overall Study|Adverse Event|0|||
155107021|NCT02789345|559821100|FG001|Overall Study|Adverse Event|0|||
155107022|NCT02789345|559821101|FG002|Overall Study|Adverse Event|1|||
155107023|NCT02789345|559821099|FG000|Overall Study|Death|0|||
155107024|NCT02789345|559821100|FG001|Overall Study|Death|0|||
154861878|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Death|1|||
154861879|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Death|0|||
154861880|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Death|0|||
154861881|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Death|0|||
154861882|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
154861883|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
154861884|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
154861885|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
154861886|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
154861887|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
154861888|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
154861889|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
154861890|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
154861891|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
154861892|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
154861893|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
154861894|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
154861895|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
154861896|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
154861897|NCT05087030|558919131|FG000|Main Period (Week 0 to Week 52)|Other|1|||
154861898|NCT05087030|558919132|FG001|Main Period (Week 0 to Week 52)|Other|2|||
154861899|NCT05087030|558919133|FG002|Main Period (Week 0 to Week 52)|Other|0|||
154861900|NCT05087030|558919134|FG003|Main Period (Week 0 to Week 52)|Other|0|||
154861901|NCT05087030|558919135|FG004|Main Period (Week 0 to Week 52)|Other|0|||
154861902|NCT05087030|558919131|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155107025|NCT02789345|559821101|FG002|Overall Study|Death|1|||
155107026|NCT02789345|559821099|FG000|Overall Study|Physician Decision|2|||
155107027|NCT02789345|559821100|FG001|Overall Study|Physician Decision|0|||
154861903|NCT05087030|558919132|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155107028|NCT02789345|559821101|FG002|Overall Study|Physician Decision|1|||
155107029|NCT02789345|559821099|FG000|Overall Study|Progressive Disease|1|||
155107030|NCT02789345|559821100|FG001|Overall Study|Progressive Disease|3|||
155107031|NCT02789345|559821101|FG002|Overall Study|Progressive Disease|14|||
155107032|NCT04123093|559821107|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
155107033|NCT04123093|559821108|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
155107034|NCT04123093|559821107|FG000|Phase 2|Physician Decision|0|||
155107035|NCT04123093|559821108|FG001|Phase 2|Physician Decision|1|||
155107036|NCT04123093|559821107|FG000|Phase 2|Withdrawal by Subject|0|||
155107037|NCT04123093|559821108|FG001|Phase 2|Withdrawal by Subject|1|||
155107038|NCT03226249|559821109|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
155107039|NCT03226249|559821109|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
155107040|NCT03226249|559821109|FG000|Survival Follow-up|Patients still in follow-up.|30|||
155107041|NCT00588237|559821112|FG000|Overall Study|Evaluable for toxicity only|3|||
155107042|NCT00588237|559821112|FG000|Overall Study|Patien not treated|1|||
155107043|NCT01164891|559821126|FG000|Overall Study|Disease Progression|5|||
155107044|NCT01164891|559821126|FG000|Overall Study|Adverse Event|1|||
155107045|NCT00441142|559821127|FG000|Overall Study|Adverse Event|2|||
155107046|NCT00441142|559821128|FG001|Overall Study|Adverse Event|3|||
155107047|NCT00441142|559821129|FG002|Overall Study|Adverse Event|3|||
155107048|NCT00441142|559821130|FG003|Overall Study|Adverse Event|22|||
155107049|NCT00441142|559821127|FG000|Overall Study|Lack of Efficacy|3|||
155107050|NCT00441142|559821128|FG001|Overall Study|Lack of Efficacy|3|||
155107051|NCT00441142|559821129|FG002|Overall Study|Lack of Efficacy|17|||
155107052|NCT00441142|559821130|FG003|Overall Study|Lack of Efficacy|32|||
155107053|NCT00441142|559821127|FG000|Overall Study|Withdrawal by Subject|0|||
155107054|NCT00441142|559821128|FG001|Overall Study|Withdrawal by Subject|0|||
155107055|NCT00441142|559821129|FG002|Overall Study|Withdrawal by Subject|2|||
155107056|NCT00441142|559821130|FG003|Overall Study|Withdrawal by Subject|10|||
155107057|NCT00441142|559821127|FG000|Overall Study|Patient still receiving active study tx|1|||
155107058|NCT00441142|559821128|FG001|Overall Study|Patient still receiving active study tx|0|||
154861904|NCT05087030|558919133|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
154861905|NCT05087030|558919134|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
154861906|NCT05087030|558919135|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
154861907|NCT04885257|558919136|FG000|Overall Study|Withdrawal by Subject|1|||
154861908|NCT04885257|558919137|FG001|Overall Study|Withdrawal by Subject|0|||
154861909|NCT04640766|558919138|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
154861910|NCT02597062|558919139|FG000|Overall Study|Ineligible|1|||
154861911|NCT00741819|558919140|FG000|Overall Study|Adverse Event|3|||
154861912|NCT00741819|558919140|FG000|Overall Study|Withdrawal by Subject|3|||
154861913|NCT00741819|558919140|FG000|Overall Study|Death|1|||
154861914|NCT00741819|558919140|FG000|Overall Study|Disease progression|1|||
154861915|NCT00686543|558919143|FG000|Overall Study|Adverse Event|9|||
154861916|NCT00686543|558919144|FG001|Overall Study|Adverse Event|1|||
154861917|NCT00686543|558919145|FG002|Overall Study|Adverse Event|3|||
154861918|NCT00686543|558919146|FG003|Overall Study|Adverse Event|2|||
154861919|NCT00686543|558919143|FG000|Overall Study|Withdrawal by Subject|2|||
154861920|NCT00686543|558919144|FG001|Overall Study|Withdrawal by Subject|0|||
154861921|NCT00686543|558919145|FG002|Overall Study|Withdrawal by Subject|0|||
154861922|NCT00686543|558919146|FG003|Overall Study|Withdrawal by Subject|0|||
154861923|NCT00686543|558919143|FG000|Overall Study|Protocol Violation|3|||
154861924|NCT00686543|558919144|FG001|Overall Study|Protocol Violation|0|||
154861925|NCT00686543|558919145|FG002|Overall Study|Protocol Violation|2|||
154861926|NCT00686543|558919146|FG003|Overall Study|Protocol Violation|1|||
154861927|NCT00609622|558919147|FG000|Overall Study|Adverse Event|14|||
154861928|NCT00609622|558919148|FG001|Overall Study|Adverse Event|10|||
154861929|NCT00609622|558919147|FG000|Overall Study|Withdrawal by Subject|4|||
154861930|NCT00609622|558919148|FG001|Overall Study|Withdrawal by Subject|20|||
154861931|NCT00609622|558919147|FG000|Overall Study|Death|1|||
154861932|NCT00609622|558919148|FG001|Overall Study|Death|4|||
154861933|NCT00609622|558919147|FG000|Overall Study|Protocol Violation|1|||
154861934|NCT00609622|558919148|FG001|Overall Study|Protocol Violation|1|||
154861935|NCT00609622|558919147|FG000|Overall Study|Objective progression or relapse|47|||
154861936|NCT00609622|558919148|FG001|Overall Study|Objective progression or relapse|41|||
154861937|NCT00609622|558919147|FG000|Overall Study|Study terminated by sponsor|16|||
154861938|NCT00609622|558919148|FG001|Overall Study|Study terminated by sponsor|3|||
154861939|NCT00609622|558919147|FG000|Overall Study|Other|7|||
155107059|NCT00441142|559821129|FG002|Overall Study|Patient still receiving active study tx|0|||
155107060|NCT00441142|559821130|FG003|Overall Study|Patient still receiving active study tx|2|||
155107061|NCT00441142|559821127|FG000|Overall Study|Physician Decision|0|||
155107062|NCT00441142|559821128|FG001|Overall Study|Physician Decision|1|||
154861940|NCT00609622|558919148|FG001|Overall Study|Other|14|||
154861941|NCT00609622|558919147|FG000|Overall Study|Global deterioration of health status|6|||
154861942|NCT00609622|558919148|FG001|Overall Study|Global deterioration of health status|2|||
154861943|NCT01237951|558919149|FG000|Overall Study|Death|1|||
154861944|NCT01708057|558919150|FG000|Overall Study|Withdrawal due to study termination.|1|||
154861945|NCT01708057|558919151|FG001|Overall Study|Withdrawal due to study termination.|1|||
154861946|NCT01708057|558919152|FG002|Overall Study|Withdrawal due to study termination.|1|||
154972441|NCT00098475|559323566|FG002|Step 1|Never started treatment|0|||
155107063|NCT00441142|559821129|FG002|Overall Study|Physician Decision|0|||
155107064|NCT00441142|559821130|FG003|Overall Study|Physician Decision|1|||
155107065|NCT00441142|559821127|FG000|Overall Study|Death|0|||
155107066|NCT00441142|559821128|FG001|Overall Study|Death|0|||
155107067|NCT00441142|559821129|FG002|Overall Study|Death|0|||
155107068|NCT00441142|559821130|FG003|Overall Study|Death|1|||
155107069|NCT01703091|559821131|FG000|Overall Study|Adverse Event|5|||
155107070|NCT01703091|559821132|FG001|Overall Study|Adverse Event|3|||
155107071|NCT01703091|559821131|FG000|Overall Study|Physician Decision|2|||
155107072|NCT01703091|559821132|FG001|Overall Study|Physician Decision|1|||
155107073|NCT01703091|559821131|FG000|Overall Study|Withdrawal by Subject|1|||
155107074|NCT01703091|559821132|FG001|Overall Study|Withdrawal by Subject|0|||
155107075|NCT01703091|559821131|FG000|Overall Study|Sponsor Decision|1|||
155107076|NCT01703091|559821132|FG001|Overall Study|Sponsor Decision|0|||
155107077|NCT02550288|559821133|FG000|Overall Study|Adverse Event|0|||
155107078|NCT02550288|559821134|FG001|Overall Study|Adverse Event|1|||
155107079|NCT02550288|559821135|FG002|Overall Study|Adverse Event|0|||
155107080|NCT02550288|559821136|FG003|Overall Study|Adverse Event|0|||
154861947|NCT00924703|558919153|FG000|Overall Study|Withdrawal by Subject|11|||
154861948|NCT00924703|558919153|FG000|Overall Study|Physician Decision|5|||
154861949|NCT00924703|558919153|FG000|Overall Study|Lost to Follow-up|3|||
154861950|NCT00924703|558919153|FG000|Overall Study|Adverse Event|2|||
155107081|NCT02550288|559821137|FG004|Overall Study|Adverse Event|0|||
154861951|NCT00924703|558919153|FG000|Overall Study|Withdrawal by Sponsor|1|||
154861952|NCT00666562|558919156|FG000|Overall Study|Withdrawal by Subject|0|||
154861953|NCT00666562|558919157|FG001|Overall Study|Withdrawal by Subject|1|||
154861954|NCT00666562|558919158|FG002|Overall Study|Withdrawal by Subject|0|||
154861955|NCT00666562|558919156|FG000|Overall Study|Concomitant Medication|0|||
155173639|NCT01155011|560074843|FG001|6 to 12 Months|Withdrawal by Subject|5|||
155173640|NCT01155011|560074842|FG000|6 to 12 Months|Death|1|||
155173641|NCT01155011|560074843|FG001|6 to 12 Months|Death|5|||
155173642|NCT02122783|560074844|FG000|Overall Study|Adverse Event|0|||
155173643|NCT02122783|560074845|FG001|Overall Study|Adverse Event|1|||
155173644|NCT00322621|560074848|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
155173645|NCT00322621|560074849|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
155173646|NCT00322621|560074850|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
155173647|NCT00322621|560074848|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
155173648|NCT00322621|560074849|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
155173649|NCT00322621|560074850|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
154861956|NCT00666562|558919157|FG001|Overall Study|Concomitant Medication|1|||
154861957|NCT00666562|558919158|FG002|Overall Study|Concomitant Medication|0|||
154861958|NCT04906707|558919159|FG000|Overall Study|Withdrawal by Subject|2|||
154861959|NCT04906707|558919160|FG001|Overall Study|Withdrawal by Subject|0|||
154861960|NCT04906707|558919159|FG000|Overall Study|Withdrawal due to PI decision|1|||
154861961|NCT04906707|558919160|FG001|Overall Study|Withdrawal due to PI decision|0|||
154861962|NCT04906707|558919159|FG000|Overall Study|Lost to Follow-up|0|||
154861963|NCT04906707|558919160|FG001|Overall Study|Lost to Follow-up|1|||
154861964|NCT01976806|558919161|FG000|Overall Study|Lost to Follow-up|1|||
154861965|NCT01976806|558919162|FG001|Overall Study|Lost to Follow-up|4|||
154861966|NCT01976806|558919161|FG000|Overall Study|Adverse Event|1|||
154861967|NCT01976806|558919162|FG001|Overall Study|Adverse Event|1|||
154861968|NCT01976806|558919161|FG000|Overall Study|Withdrawal by Subject|1|||
154861969|NCT01976806|558919162|FG001|Overall Study|Withdrawal by Subject|1|||
154861970|NCT03929250|558919164|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
154861971|NCT03929250|558919165|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
154861972|NCT05262764|558919168|FG000|Overall Study|Case report form not collected|9|||
154861973|NCT05262764|558919168|FG000|Overall Study|No patient visits after entry|23|||
154861974|NCT05262764|558919168|FG000|Overall Study|Registration rule not followed|2|||
154861975|NCT05262764|558919168|FG000|Overall Study|Patient of non-chronic heart failure|1|||
154861976|NCT04429022|558919169|FG000|Overall Study|Protocol Violation|18|||
154861977|NCT04429022|558919170|FG001|Overall Study|Protocol Violation|1|||
154861978|NCT00075881|558920230|FG000|Overall Study|Lack of Efficacy|18|||
154861979|NCT00075881|558920230|FG000|Overall Study|Adverse Event|7|||
154861980|NCT00075881|558920230|FG000|Overall Study|Death|1|||
154861981|NCT00075881|558920230|FG000|Overall Study|Withdrawal by Subject|2|||
154861982|NCT00075881|558920230|FG000|Overall Study|Protocol Violation|4|||
154861983|NCT00075881|558920230|FG000|Overall Study|other complicating disease|3|||
154861984|NCT00075881|558920230|FG000|Overall Study|other|4|||
154861985|NCT00075881|558920230|FG000|Overall Study|missing data|2|||
154861986|NCT00075881|558920230|FG000|Overall Study|Ineligible|1|||
154861987|NCT00075881|558920230|FG000|Overall Study|never start protocol therapy|1|||
154861988|NCT02109029|558920233|FG000|Part B|Adverse Event|0|||
154861989|NCT02109029|558920234|FG001|Part B|Adverse Event|0|||
154861990|NCT02109029|558920235|FG002|Part B|Adverse Event|0|||
154861991|NCT02109029|558920236|FG003|Part B|Adverse Event|0|||
154861992|NCT02109029|558920237|FG004|Part B|Adverse Event|1|||
154861993|NCT02109029|558920238|FG005|Part B|Adverse Event|1|||
154861994|NCT03195894|558920239|FG000|Overall Study|"An example is Started other treatment."|4|||
154861995|NCT03195894|558920240|FG001|Overall Study|"An example is Started other treatment."|5|||
154861996|NCT03195894|558920239|FG000|Overall Study|Withdrawal by Subject|15|||
155107082|NCT02550288|559821133|FG000|Overall Study|Physician Decision|0|||
155107083|NCT02550288|559821134|FG001|Overall Study|Physician Decision|0|||
154861997|NCT03195894|558920240|FG001|Overall Study|Withdrawal by Subject|4|||
154861998|NCT03195894|558920239|FG000|Overall Study|Lost to Follow-up|14|||
154861999|NCT03195894|558920240|FG001|Overall Study|Lost to Follow-up|19|||
154862000|NCT00686205|558920244|FG000|Overall Study|Protocol Violation|127|||
154862001|NCT00686205|558920245|FG001|Overall Study|Protocol Violation|0|||
154862002|NCT00686205|558920244|FG000|Overall Study|Withdrawal by Subject|2|||
154862003|NCT00686205|558920245|FG001|Overall Study|Withdrawal by Subject|0|||
154862004|NCT00686205|558920244|FG000|Overall Study|Specimen handling procedure altered|5878|||
154862005|NCT00686205|558920245|FG001|Overall Study|Specimen handling procedure altered|0|||
154862006|NCT00686205|558920244|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
154862007|NCT00686205|558920245|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
154862008|NCT01217606|558920246|FG000|Initial Treatment Phase|Other Reasons|0|||
154862009|NCT01217606|558920247|FG001|Initial Treatment Phase|Other Reasons|2|||
154862010|NCT01217606|558920246|FG000|Initial Treatment Phase|Protocol Violation|3|||
154862011|NCT01217606|558920247|FG001|Initial Treatment Phase|Protocol Violation|2|||
154862012|NCT01217606|558920246|FG000|Initial Treatment Phase|Personal Reasons|0|||
154862013|NCT01217606|558920247|FG001|Initial Treatment Phase|Personal Reasons|2|||
154862014|NCT01217606|558920246|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
154862015|NCT01217606|558920247|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
154862016|NCT01217606|558920246|FG000|Initial Treatment Phase|Adverse Event|10|||
154862017|NCT01217606|558920247|FG001|Initial Treatment Phase|Adverse Event|6|||
154862018|NCT01217606|558920246|FG000|9-Month Masked Extension|Adverse Event|3|||
154862019|NCT01217606|558920247|FG001|9-Month Masked Extension|Adverse Event|6|||
154862020|NCT01217606|558920246|FG000|9-Month Masked Extension|Other Reasons|4|||
154862021|NCT01217606|558920247|FG001|9-Month Masked Extension|Other Reasons|4|||
154862022|NCT01217606|558920246|FG000|9-Month Masked Extension|Personal Reasons|2|||
154862023|NCT01217606|558920247|FG001|9-Month Masked Extension|Personal Reasons|1|||
154862024|NCT01217606|558920246|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
154862025|NCT01217606|558920247|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
154862026|NCT01217606|558920246|FG000|9-Month Masked Extension|Pregnancy|1|||
154862027|NCT01217606|558920247|FG001|9-Month Masked Extension|Pregnancy|0|||
154862028|NCT01217606|558920246|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
154862029|NCT01217606|558920247|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
154862030|NCT02966314|558920249|FG000|Overall Study|Lost to Follow-up|1|||
154862031|NCT02966314|558920250|FG001|Overall Study|Lost to Follow-up|0|||
154862032|NCT02725788|558920251|FG000|Overall Study|Lost to Follow-up|1|||
154862033|NCT02725788|558920252|FG001|Overall Study|Lost to Follow-up|1|||
154862034|NCT02725788|558920251|FG000|Overall Study|Protocol Violation|0|||
154862035|NCT02725788|558920252|FG001|Overall Study|Protocol Violation|1|||
154862036|NCT00828464|558920253|FG000|Overall Study|Withdrawal by Subject|1|||
154862037|NCT00474240|558920254|FG000|Overall Study|Withdrawal by Subject|1|||
154862038|NCT00474240|558920255|FG001|Overall Study|Withdrawal by Subject|1|||
154862039|NCT00474240|558920256|FG002|Overall Study|Withdrawal by Subject|0|||
154862040|NCT00474240|558920257|FG003|Overall Study|Withdrawal by Subject|2|||
154862041|NCT00474240|558920258|FG004|Overall Study|Withdrawal by Subject|3|||
154862042|NCT00474240|558920259|FG005|Overall Study|Withdrawal by Subject|1|||
154862043|NCT00474240|558920254|FG000|Overall Study|Adverse Event|0|||
154862044|NCT00474240|558920255|FG001|Overall Study|Adverse Event|0|||
154862045|NCT00474240|558920256|FG002|Overall Study|Adverse Event|9|||
154862046|NCT00474240|558920257|FG003|Overall Study|Adverse Event|14|||
154862047|NCT00474240|558920258|FG004|Overall Study|Adverse Event|5|||
154862048|NCT00474240|558920259|FG005|Overall Study|Adverse Event|16|||
154862049|NCT00474240|558920254|FG000|Overall Study|Removed due to lab value|0|||
154862050|NCT00474240|558920255|FG001|Overall Study|Removed due to lab value|0|||
154862051|NCT00474240|558920256|FG002|Overall Study|Removed due to lab value|0|||
154862052|NCT00474240|558920257|FG003|Overall Study|Removed due to lab value|0|||
154862053|NCT00474240|558920258|FG004|Overall Study|Removed due to lab value|0|||
154862054|NCT00474240|558920259|FG005|Overall Study|Removed due to lab value|1|||
154862055|NCT03812510|558920262|FG000|Overall Study|Lost to Follow-up|39|||
154862056|NCT03812510|558920262|FG000|Overall Study|Withdrawal by Subject|42|||
154862057|NCT03812510|558920262|FG000|Overall Study|Physician Decision|2|||
154862058|NCT03812510|558920262|FG000|Overall Study|Study Terminated by Sponsor|9|||
154862059|NCT03812510|558920262|FG000|Overall Study|Did Not Start Study Medication|55|||
154862060|NCT03812510|558920262|FG000|Overall Study|Adverse Event|5|||
154862061|NCT03075839|558920263|FG000|Overall Study|Lost to Follow-up|4|||
154862062|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
154862063|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
154862064|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
154862065|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
154862066|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
154862067|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
154862068|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Personal issues|2|||
154862069|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Personal issues|0|||
154862070|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Personal issues|0|||
154862071|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Too busy|7|||
154862072|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Too busy|1|||
154862073|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Too busy|0|||
155107084|NCT02550288|559821135|FG002|Overall Study|Physician Decision|0|||
154862074|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Pain|2|||
155107085|NCT02550288|559821136|FG003|Overall Study|Physician Decision|1|||
155107086|NCT02550288|559821137|FG004|Overall Study|Physician Decision|0|||
155107087|NCT02550288|559821133|FG000|Overall Study|Protocol Violation|2|||
155107088|NCT02550288|559821134|FG001|Overall Study|Protocol Violation|2|||
154862075|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Pain|0|||
154862076|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Pain|0|||
154862077|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Moved|1|||
154862078|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Moved|0|||
154862079|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Moved|0|||
154862080|NCT00594399|558920264|FG000|Initial 3 Month Counseling|Family illness|1|||
154862081|NCT00594399|558920265|FG001|Initial 3 Month Counseling|Family illness|0|||
154862082|NCT00594399|558920266|FG002|Initial 3 Month Counseling|Family illness|0|||
154862083|NCT00594399|558920264|FG000|Rerandomization Arm 1 Only|Death|2|||
154862084|NCT00594399|558920265|FG001|Rerandomization Arm 1 Only|Death|1|||
154862085|NCT00594399|558920266|FG002|Rerandomization Arm 1 Only|Death|0|||
154862086|NCT00594399|558920264|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
154862087|NCT00594399|558920265|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
154862088|NCT00594399|558920266|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
154862089|NCT00659438|558920267|FG000|Overall Study|Withdrawal by Subject|2|||
154862090|NCT00659438|558920268|FG001|Overall Study|Withdrawal by Subject|2|||
154862091|NCT00659438|558920267|FG000|Overall Study|Death|11|||
154862092|NCT00659438|558920268|FG001|Overall Study|Death|6|||
154862093|NCT00659438|558920267|FG000|Overall Study|Lost to Follow-up|1|||
154862094|NCT00659438|558920268|FG001|Overall Study|Lost to Follow-up|0|||
154862095|NCT02469246|558920270|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
154972442|NCT00098475|559323567|FG003|Step 1|Never started treatment|0|||
154972443|NCT00098475|559323564|FG000|Step 1|Still on treatment as of this analysis|14|||
154862096|NCT02469246|558920271|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
154862097|NCT02469246|558920270|FG000|Double-Blind Phase|Adverse Event|12|||
155107089|NCT02550288|559821135|FG002|Overall Study|Protocol Violation|1|||
155107090|NCT02550288|559821136|FG003|Overall Study|Protocol Violation|0|||
155107091|NCT02550288|559821137|FG004|Overall Study|Protocol Violation|3|||
155107092|NCT02550288|559821133|FG000|Overall Study|Participant moved|0|||
155107093|NCT02550288|559821134|FG001|Overall Study|Participant moved|0|||
155107094|NCT02550288|559821135|FG002|Overall Study|Participant moved|0|||
155107095|NCT02550288|559821136|FG003|Overall Study|Participant moved|1|||
155107096|NCT02550288|559821137|FG004|Overall Study|Participant moved|0|||
155107097|NCT02550288|559821133|FG000|Overall Study|Withdrawal by Subject|0|||
155107098|NCT02550288|559821134|FG001|Overall Study|Withdrawal by Subject|0|||
155107099|NCT02550288|559821135|FG002|Overall Study|Withdrawal by Subject|0|||
155107100|NCT02550288|559821136|FG003|Overall Study|Withdrawal by Subject|1|||
155107101|NCT02550288|559821137|FG004|Overall Study|Withdrawal by Subject|0|||
155107102|NCT01524224|559821140|FG000|Overall Study|Progressive Disease|1|||
155107103|NCT01524224|559821141|FG001|Overall Study|Progressive Disease|0|||
155107104|NCT01524224|559821142|FG002|Overall Study|Progressive Disease|2|||
155107105|NCT01524224|559821143|FG003|Overall Study|Progressive Disease|1|||
155107106|NCT01524224|559821144|FG004|Overall Study|Progressive Disease|2|||
155107107|NCT01524224|559821145|FG005|Overall Study|Progressive Disease|1|||
154972444|NCT00098475|559323565|FG001|Step 1|Still on treatment as of this analysis|27|||
154972445|NCT00098475|559323566|FG002|Step 1|Still on treatment as of this analysis|0|||
155107108|NCT01524224|559821146|FG006|Overall Study|Progressive Disease|1|||
155107109|NCT01524224|559821147|FG007|Overall Study|Progressive Disease|5|||
155107110|NCT01524224|559821140|FG000|Overall Study|Withdrawal by Subject|2|||
155107111|NCT01524224|559821141|FG001|Overall Study|Withdrawal by Subject|0|||
155107112|NCT01524224|559821142|FG002|Overall Study|Withdrawal by Subject|0|||
155107113|NCT01524224|559821143|FG003|Overall Study|Withdrawal by Subject|0|||
155107114|NCT01524224|559821144|FG004|Overall Study|Withdrawal by Subject|0|||
155107115|NCT01524224|559821145|FG005|Overall Study|Withdrawal by Subject|0|||
155107116|NCT01524224|559821146|FG006|Overall Study|Withdrawal by Subject|2|||
155107117|NCT01524224|559821147|FG007|Overall Study|Withdrawal by Subject|0|||
155107118|NCT01524224|559821140|FG000|Overall Study|Adverse Event|0|||
155107119|NCT01524224|559821141|FG001|Overall Study|Adverse Event|1|||
154972446|NCT00098475|559323567|FG003|Step 1|Still on treatment as of this analysis|0|||
155107120|NCT01524224|559821142|FG002|Overall Study|Adverse Event|0|||
155107121|NCT01524224|559821143|FG003|Overall Study|Adverse Event|0|||
155107122|NCT01524224|559821144|FG004|Overall Study|Adverse Event|0|||
155107123|NCT01524224|559821145|FG005|Overall Study|Adverse Event|1|||
155107124|NCT01524224|559821146|FG006|Overall Study|Adverse Event|0|||
155107125|NCT01524224|559821147|FG007|Overall Study|Adverse Event|0|||
155107126|NCT01524224|559821140|FG000|Overall Study|Physician Decision|0|||
155107127|NCT01524224|559821141|FG001|Overall Study|Physician Decision|0|||
155107128|NCT01524224|559821142|FG002|Overall Study|Physician Decision|0|||
155107129|NCT01524224|559821143|FG003|Overall Study|Physician Decision|1|||
155107130|NCT01524224|559821144|FG004|Overall Study|Physician Decision|1|||
155107131|NCT01524224|559821145|FG005|Overall Study|Physician Decision|0|||
154862098|NCT02469246|558920271|FG001|Double-Blind Phase|Adverse Event|9|||
155107132|NCT01524224|559821146|FG006|Overall Study|Physician Decision|0|||
154862099|NCT02469246|558920270|FG000|Double-Blind Phase|Death|2|||
154862100|NCT02469246|558920271|FG001|Double-Blind Phase|Death|0|||
155107133|NCT01524224|559821147|FG007|Overall Study|Physician Decision|1|||
155107134|NCT01524224|559821140|FG000|Overall Study|Sponsor Decision|0|||
155107135|NCT01524224|559821141|FG001|Overall Study|Sponsor Decision|0|||
155107136|NCT01524224|559821142|FG002|Overall Study|Sponsor Decision|0|||
154862101|NCT02469246|558920270|FG000|Double-Blind Phase|Lack of Efficacy|2|||
155107137|NCT01524224|559821143|FG003|Overall Study|Sponsor Decision|0|||
154972447|NCT00098475|559323564|FG000|Step 1|Knee surgery|1|||
154972448|NCT00098475|559323565|FG001|Step 1|Knee surgery|0|||
154972449|NCT00098475|559323566|FG002|Step 1|Knee surgery|0|||
154972450|NCT00098475|559323567|FG003|Step 1|Knee surgery|0|||
154972451|NCT00098475|559323564|FG000|Step 1|Complications|1|||
154972452|NCT00098475|559323565|FG001|Step 1|Complications|0|||
154972453|NCT00098475|559323566|FG002|Step 1|Complications|0|||
154972454|NCT00098475|559323567|FG003|Step 1|Complications|0|||
154972455|NCT00098475|559323564|FG000|Step 1|Cannot comply due to other tx|0|||
154972456|NCT00098475|559323565|FG001|Step 1|Cannot comply due to other tx|1|||
154972457|NCT00098475|559323566|FG002|Step 1|Cannot comply due to other tx|0|||
154972458|NCT00098475|559323567|FG003|Step 1|Cannot comply due to other tx|0|||
154972459|NCT00098475|559323564|FG000|Step 1|Both patient and physician's decision|2|||
154972460|NCT00098475|559323565|FG001|Step 1|Both patient and physician's decision|1|||
154972461|NCT00098475|559323566|FG002|Step 1|Both patient and physician's decision|0|||
154972462|NCT00098475|559323567|FG003|Step 1|Both patient and physician's decision|0|||
154972463|NCT00098475|559323564|FG000|Step 1|Incorrect disease assessment|2|||
154972464|NCT00098475|559323565|FG001|Step 1|Incorrect disease assessment|0|||
154972465|NCT00098475|559323566|FG002|Step 1|Incorrect disease assessment|0|||
154972466|NCT00098475|559323567|FG003|Step 1|Incorrect disease assessment|0|||
154972467|NCT00098475|559323564|FG000|Step 1|Off treatment for > specified timeframe|1|||
154972468|NCT00098475|559323565|FG001|Step 1|Off treatment for > specified timeframe|1|||
154972469|NCT00098475|559323566|FG002|Step 1|Off treatment for > specified timeframe|0|||
154972470|NCT00098475|559323567|FG003|Step 1|Off treatment for > specified timeframe|0|||
154972471|NCT00098475|559323564|FG000|Step 1|Declining performance status|0|||
155107138|NCT01524224|559821144|FG004|Overall Study|Sponsor Decision|1|||
155107139|NCT01524224|559821145|FG005|Overall Study|Sponsor Decision|0|||
155107140|NCT01524224|559821146|FG006|Overall Study|Sponsor Decision|0|||
155107141|NCT01524224|559821147|FG007|Overall Study|Sponsor Decision|0|||
155107142|NCT05420961|559821150|FG000|Overall Study|Withdrawal by Subject|2|||
155107143|NCT05420961|559821151|FG001|Overall Study|Withdrawal by Subject|1|||
155107144|NCT05420961|559821152|FG002|Overall Study|Withdrawal by Subject|1|||
155107145|NCT05420961|559821153|FG003|Overall Study|Withdrawal by Subject|0|||
155107146|NCT05420961|559821154|FG004|Overall Study|Withdrawal by Subject|0|||
155107147|NCT05420961|559821150|FG000|Overall Study|Lost to Follow-up|0|||
154862102|NCT02469246|558920271|FG001|Double-Blind Phase|Lack of Efficacy|1|||
155107148|NCT05420961|559821151|FG001|Overall Study|Lost to Follow-up|0|||
155107149|NCT05420961|559821152|FG002|Overall Study|Lost to Follow-up|1|||
155107150|NCT05420961|559821153|FG003|Overall Study|Lost to Follow-up|0|||
155107151|NCT05420961|559821154|FG004|Overall Study|Lost to Follow-up|0|||
155107152|NCT05420961|559821150|FG000|Overall Study|Randomized by mistake without study treatment|0|||
155107153|NCT05420961|559821151|FG001|Overall Study|Randomized by mistake without study treatment|0|||
155107154|NCT05420961|559821152|FG002|Overall Study|Randomized by mistake without study treatment|1|||
155107155|NCT05420961|559821153|FG003|Overall Study|Randomized by mistake without study treatment|0|||
155107156|NCT05420961|559821154|FG004|Overall Study|Randomized by mistake without study treatment|1|||
155107157|NCT04283656|559821155|FG000|Overall Study|Adverse Event|1|||
155107158|NCT04283656|559821156|FG001|Overall Study|Adverse Event|0|||
155107159|NCT04283656|559821155|FG000|Overall Study|Lost to Follow-up|0|||
155107160|NCT04283656|559821156|FG001|Overall Study|Lost to Follow-up|1|||
155107161|NCT00803361|559821157|FG000|Overall Study|Adverse Event|13|||
155107162|NCT00803361|559821158|FG001|Overall Study|Adverse Event|3|||
155107163|NCT00803361|559821157|FG000|Overall Study|Lack of Efficacy|4|||
155107164|NCT00803361|559821158|FG001|Overall Study|Lack of Efficacy|13|||
155107165|NCT00803361|559821157|FG000|Overall Study|Lost to Follow-up|1|||
155107166|NCT00803361|559821158|FG001|Overall Study|Lost to Follow-up|2|||
155107167|NCT00803361|559821157|FG000|Overall Study|Physician Decision|1|||
155107168|NCT00803361|559821158|FG001|Overall Study|Physician Decision|0|||
155107169|NCT00803361|559821157|FG000|Overall Study|Protocol Violation|2|||
155107170|NCT00803361|559821158|FG001|Overall Study|Protocol Violation|4|||
155107171|NCT00803361|559821157|FG000|Overall Study|Withdrawal by Subject|5|||
155107172|NCT00803361|559821158|FG001|Overall Study|Withdrawal by Subject|6|||
155107173|NCT04445519|559821159|FG000|Overall Study|Due to adaptive design|3|||
155107174|NCT04445519|559821160|FG001|Overall Study|Due to adaptive design|0|||
155107175|NCT04445519|559821161|FG002|Overall Study|Due to adaptive design|0|||
155107176|NCT04445519|559821159|FG000|Overall Study|Lost to Follow-up|0|||
155107177|NCT04445519|559821160|FG001|Overall Study|Lost to Follow-up|1|||
155107178|NCT04445519|559821161|FG002|Overall Study|Lost to Follow-up|4|||
155107179|NCT04445519|559821159|FG000|Overall Study|Sponsor or IRB Decision|0|||
155107180|NCT04445519|559821160|FG001|Overall Study|Sponsor or IRB Decision|1|||
155107181|NCT04445519|559821161|FG002|Overall Study|Sponsor or IRB Decision|2|||
155107182|NCT04445519|559821159|FG000|Overall Study|Withdrawal by Subject|0|||
155107183|NCT04445519|559821160|FG001|Overall Study|Withdrawal by Subject|3|||
155107184|NCT04445519|559821161|FG002|Overall Study|Withdrawal by Subject|3|||
155107185|NCT04445519|559821159|FG000|Overall Study|Adverse Event|0|||
155107186|NCT04445519|559821160|FG001|Overall Study|Adverse Event|8|||
155107187|NCT04445519|559821161|FG002|Overall Study|Adverse Event|6|||
154862103|NCT02469246|558920270|FG000|Double-Blind Phase|Investigator's Discretion|8|||
154862104|NCT02469246|558920271|FG001|Double-Blind Phase|Investigator's Discretion|8|||
154862105|NCT02469246|558920270|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
154862106|NCT02469246|558920271|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
154862107|NCT02469246|558920270|FG000|Double-Blind Phase|Protocol Violation|1|||
154862108|NCT02469246|558920271|FG001|Double-Blind Phase|Protocol Violation|1|||
154862109|NCT02469246|558920270|FG000|Double-Blind Phase|Withdrew Consent|25|||
154862110|NCT02469246|558920271|FG001|Double-Blind Phase|Withdrew Consent|25|||
154862111|NCT02469246|558920270|FG000|Double-Blind Phase|Lost to Follow-up|9|||
154862112|NCT02469246|558920271|FG001|Double-Blind Phase|Lost to Follow-up|5|||
154862113|NCT00922935|558920275|FG000|Overall Study|Protocol Violation|0|||
154862114|NCT00922935|558920276|FG001|Overall Study|Protocol Violation|3|||
154862115|NCT00922935|558920277|FG002|Overall Study|Protocol Violation|0|||
154862116|NCT00922935|558920275|FG000|Overall Study|Physician Decision|1|||
154862117|NCT00922935|558920276|FG001|Overall Study|Physician Decision|1|||
154862118|NCT00922935|558920277|FG002|Overall Study|Physician Decision|0|||
154862119|NCT00922935|558920275|FG000|Overall Study|Lost to Follow-up|0|||
154862120|NCT00922935|558920276|FG001|Overall Study|Lost to Follow-up|1|||
154862121|NCT00922935|558920277|FG002|Overall Study|Lost to Follow-up|0|||
154862122|NCT01491945|558920278|FG000|Overall Study|Death|30|||
154862123|NCT01491945|558920278|FG000|Overall Study|Withdrwan/LTF|16|||
154862124|NCT01491945|558920278|FG000|Overall Study|Conversion|4|||
154862125|NCT01491945|558920278|FG000|Overall Study|Missed Visit|1|||
154862126|NCT02201940|558920279|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
154862127|NCT02201940|558920280|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
154862128|NCT02201940|558920279|FG000|Overall Study|Lack of Efficacy|2|||
154862129|NCT02201940|558920280|FG001|Overall Study|Lack of Efficacy|113|||
154862130|NCT02201940|558920279|FG000|Overall Study|Lost to Follow-up|5|||
154862131|NCT02201940|558920280|FG001|Overall Study|Lost to Follow-up|0|||
154862132|NCT02201940|558920279|FG000|Overall Study|Withdrew Consent|2|||
154862133|NCT02201940|558920280|FG001|Overall Study|Withdrew Consent|1|||
154862134|NCT02201940|558920279|FG000|Overall Study|Investigator's Discretion|1|||
154862135|NCT02201940|558920280|FG001|Overall Study|Investigator's Discretion|1|||
154862136|NCT02201940|558920279|FG000|Overall Study|Death|1|||
154862137|NCT02201940|558920280|FG001|Overall Study|Death|0|||
154862138|NCT02201940|558920279|FG000|Overall Study|Adverse Event|0|||
154862139|NCT02201940|558920280|FG001|Overall Study|Adverse Event|1|||
154862140|NCT02700451|558920281|FG000|Overall Study|Protocol Violation|2|||
154862141|NCT02700451|558920282|FG001|Overall Study|Protocol Violation|2|||
154862142|NCT02700451|558920283|FG002|Overall Study|Protocol Violation|3|||
154862143|NCT02700451|558920281|FG000|Overall Study|Discontinued intervention|14|||
154862144|NCT02700451|558920282|FG001|Overall Study|Discontinued intervention|15|||
154862145|NCT02700451|558920283|FG002|Overall Study|Discontinued intervention|14|||
154862146|NCT00404092|558920285|FG000|Overall Study|Death|1|||
154862147|NCT00404092|558920286|FG001|Overall Study|Death|0|||
154862148|NCT00404092|558920287|FG002|Overall Study|Death|0|||
154862149|NCT00404092|558920288|FG003|Overall Study|Death|0|||
154862150|NCT00404092|558920285|FG000|Overall Study|Adverse Event|0|||
154862151|NCT00404092|558920286|FG001|Overall Study|Adverse Event|0|||
154862152|NCT00404092|558920287|FG002|Overall Study|Adverse Event|1|||
154862153|NCT00404092|558920288|FG003|Overall Study|Adverse Event|0|||
154862154|NCT01511445|558920289|FG000|Overall Study|Lost to Follow-up|3|||
154862155|NCT01511445|558920290|FG001|Overall Study|Lost to Follow-up|1|||
154862156|NCT01511445|558920289|FG000|Overall Study|Protocol Violation|1|||
154862157|NCT01511445|558920290|FG001|Overall Study|Protocol Violation|3|||
154862158|NCT01511445|558920289|FG000|Overall Study|Protocol Violation|1|||
154862159|NCT01511445|558920290|FG001|Overall Study|Protocol Violation|0|||
154862160|NCT02344576|558920294|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
154862161|NCT02344576|558920295|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
155107188|NCT04445519|559821159|FG000|Overall Study|Other Reason|0|||
155107189|NCT04445519|559821160|FG001|Overall Study|Other Reason|1|||
155107190|NCT04445519|559821161|FG002|Overall Study|Other Reason|1|||
155107191|NCT04445519|559821159|FG000|Overall Study|Protocol Violation|0|||
155107192|NCT04445519|559821160|FG001|Overall Study|Protocol Violation|0|||
155107193|NCT04445519|559821161|FG002|Overall Study|Protocol Violation|1|||
155107194|NCT02858440|559821166|FG000|Overall Study|Lost to Follow-up|3|||
155107195|NCT02858440|559821166|FG000|Overall Study|Protocol Violation|2|||
154862162|NCT02344576|558920296|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
154862163|NCT02344576|558920297|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
154862164|NCT02344576|558920294|FG000|1-Month Follow-Up|Death|13|||
154862165|NCT02344576|558920295|FG001|1-Month Follow-Up|Death|8|||
154862166|NCT02344576|558920296|FG002|1-Month Follow-Up|Death|0|||
155173650|NCT00322621|560074848|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
155173651|NCT00322621|560074849|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
155107196|NCT02858440|559821166|FG000|Overall Study|Consent withdrawal|3|||
155107197|NCT02858440|559821166|FG000|Overall Study|Migrated/moved from study area|4|||
155107198|NCT00783835|559821167|FG000|Overall Study|Adverse Event|3|||
155107199|NCT00783835|559821167|FG000|Overall Study|Medical Criteria|1|||
155107200|NCT00783835|559821167|FG000|Overall Study|Withdrawal by Subject|2|||
155107201|NCT00783835|559821167|FG000|Overall Study|Lost to Follow-up|1|||
155107202|NCT00783835|559821167|FG000|Overall Study|Participant not Adherent|3|||
155107203|NCT01945996|559821168|FG000|Overall Study|Lost to Follow-up|3|||
155107204|NCT01945996|559821169|FG001|Overall Study|Lost to Follow-up|5|||
155107205|NCT04660552|559821170|FG000|Overall Study|Withdrawal by Subject|3|||
154862167|NCT02344576|558920297|FG003|1-Month Follow-Up|Death|0|||
154862168|NCT02344576|558920294|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
154862169|NCT02344576|558920295|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
154862170|NCT02344576|558920296|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
154862171|NCT02344576|558920297|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
155107206|NCT04660552|559821171|FG001|Overall Study|Withdrawal by Subject|1|||
155107207|NCT03248167|559821172|FG000|Overall Study|Withdrawal by Subject|2|||
155107208|NCT03248167|559821173|FG001|Overall Study|Withdrawal by Subject|2|||
155107209|NCT03248167|559821172|FG000|Overall Study|Physician Decision|0|||
155107210|NCT03248167|559821173|FG001|Overall Study|Physician Decision|1|||
155107211|NCT03248167|559821172|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
155107212|NCT03248167|559821173|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
155107213|NCT03248167|559821172|FG000|Overall Study|Lost to Follow-up|1|||
154862172|NCT02344576|558920294|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
155173652|NCT00322621|560074850|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
155173653|NCT00322621|560074848|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
155173654|NCT00322621|560074849|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
155107214|NCT03248167|559821173|FG001|Overall Study|Lost to Follow-up|0|||
155107215|NCT02122146|559821174|FG000|Part 1: Dose Escalation|Death|0|||
154862173|NCT02344576|558920295|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
155107216|NCT02122146|559821175|FG001|Part 1: Dose Escalation|Death|1|||
155107217|NCT02122146|559821176|FG002|Part 1: Dose Escalation|Death|1|||
155107218|NCT02122146|559821177|FG003|Part 1: Dose Escalation|Death|0|||
155107219|NCT02122146|559821178|FG004|Part 1: Dose Escalation|Death|0|||
155107220|NCT02122146|559821179|FG005|Part 1: Dose Escalation|Death|0|||
155107221|NCT02122146|559821180|FG006|Part 1: Dose Escalation|Death|0|||
155107222|NCT02122146|559821181|FG007|Part 1: Dose Escalation|Death|0|||
155107223|NCT02122146|559821174|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
155107224|NCT02122146|559821175|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
155107225|NCT02122146|559821176|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
155107226|NCT02122146|559821177|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
155107227|NCT02122146|559821178|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
155107228|NCT02122146|559821179|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
155107229|NCT02122146|559821180|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
155107230|NCT02122146|559821181|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
155107231|NCT02122146|559821174|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155107232|NCT02122146|559821175|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155107233|NCT02122146|559821176|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155107234|NCT02122146|559821177|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
155173655|NCT00322621|560074850|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
155173656|NCT00322621|560074848|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
155173657|NCT00322621|560074849|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
155173658|NCT00322621|560074850|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
155173659|NCT00322621|560074848|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
155173660|NCT00322621|560074849|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
155173661|NCT00322621|560074850|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
155173662|NCT00322621|560074848|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
155173663|NCT00322621|560074849|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
155173664|NCT00322621|560074850|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
155173665|NCT00322621|560074848|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
155173666|NCT00322621|560074849|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
155173667|NCT00322621|560074850|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
155173668|NCT00322621|560074848|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
155173669|NCT00322621|560074849|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
155173670|NCT00322621|560074850|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
155173671|NCT00322621|560074848|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
155173672|NCT00322621|560074849|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
155173673|NCT00322621|560074850|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
155173674|NCT00322621|560074848|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
155173675|NCT00322621|560074849|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
155173676|NCT00322621|560074850|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
155173677|NCT01038869|560074853|FG000|Overall Study|Withdrawal by Subject|1|||
155173678|NCT01038869|560074853|FG000|Overall Study|Lost to Follow-up|6|||
155173679|NCT02213133|560074855|FG000|Overall Study|Participant discontinued study therapy|2|||
155173680|NCT02213133|560074856|FG001|Overall Study|Participant discontinued study therapy|0|||
155107235|NCT02122146|559821178|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155107236|NCT02122146|559821179|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155173681|NCT02213133|560074857|FG002|Overall Study|Participant discontinued study therapy|0|||
155173682|NCT02213133|560074855|FG000|Overall Study|Participant withdrew informed consent|2|||
155107237|NCT02122146|559821180|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155107238|NCT02122146|559821181|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
155107239|NCT02122146|559821174|FG000|Part 1: Dose Escalation|Other|1|||
155107240|NCT02122146|559821175|FG001|Part 1: Dose Escalation|Other|0|||
155107241|NCT02122146|559821176|FG002|Part 1: Dose Escalation|Other|0|||
155107242|NCT02122146|559821177|FG003|Part 1: Dose Escalation|Other|0|||
155107243|NCT02122146|559821178|FG004|Part 1: Dose Escalation|Other|0|||
155107244|NCT02122146|559821179|FG005|Part 1: Dose Escalation|Other|1|||
155107245|NCT02122146|559821180|FG006|Part 1: Dose Escalation|Other|1|||
155107246|NCT02122146|559821181|FG007|Part 1: Dose Escalation|Other|2|||
155107247|NCT00992056|559821186|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
155107248|NCT00992056|559821187|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
155107249|NCT00992056|559821186|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
155107250|NCT00992056|559821187|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
155107251|NCT01001767|559821190|FG000|Overall Study|no baseline study performed|1|||
155107252|NCT01001767|559821191|FG001|Overall Study|no baseline study performed|0|||
155107253|NCT01001767|559821190|FG000|Overall Study|Protocol Violation|1|||
155107254|NCT01001767|559821191|FG001|Overall Study|Protocol Violation|0|||
155107255|NCT01001767|559821190|FG000|Overall Study|Lost to Follow-up|1|||
155107256|NCT01001767|559821191|FG001|Overall Study|Lost to Follow-up|0|||
155107257|NCT01001767|559821190|FG000|Overall Study|Physician Decision|1|||
155107258|NCT01001767|559821191|FG001|Overall Study|Physician Decision|0|||
155107259|NCT02584452|559821192|FG000|Overall Study|Physician Decision|1|||
155107260|NCT02584452|559821193|FG001|Overall Study|Physician Decision|1|||
155107261|NCT02584452|559821192|FG000|Overall Study|Lost to Follow-up|1|||
155107262|NCT02584452|559821193|FG001|Overall Study|Lost to Follow-up|1|||
155107263|NCT01107392|559821194|FG000|Overall Study|Adverse Event|2|||
155107264|NCT01107392|559821195|FG001|Overall Study|Adverse Event|0|||
155107265|NCT01107392|559821194|FG000|Overall Study|Personal Reasons|2|||
155107266|NCT01107392|559821195|FG001|Overall Study|Personal Reasons|3|||
155107267|NCT01107392|559821194|FG000|Overall Study|Administrative decision|1|||
155107268|NCT01107392|559821195|FG001|Overall Study|Administrative decision|0|||
155107269|NCT00851552|559821196|FG000|Overall Study|Death|2|||
155107270|NCT00851552|559821196|FG000|Overall Study|Adverse Event|1|||
155107271|NCT00851552|559821196|FG000|Overall Study|Disease Progression|4|||
155107272|NCT00177294|559821197|FG000|Overall Study|Withdrawal by Subject|7|||
155107273|NCT00177294|559821198|FG001|Overall Study|Withdrawal by Subject|5|||
155107274|NCT02998671|559821199|FG000|Period 1|Study Terminated By Sponsor|2|||
155107275|NCT02998671|559821200|FG001|Period 1|Study Terminated By Sponsor|1|||
154972472|NCT00098475|559323565|FG001|Step 1|Declining performance status|1|||
154972473|NCT00098475|559323566|FG002|Step 1|Declining performance status|0|||
155107276|NCT02998671|559821201|FG002|Period 1|Study Terminated By Sponsor|0|||
155107277|NCT02998671|559821202|FG003|Period 1|Study Terminated By Sponsor|0|||
155107278|NCT02998671|559821203|FG004|Period 1|Study Terminated By Sponsor|1|||
155107279|NCT02998671|559821199|FG000|Period 1|Withdrawal by Subject|1|||
155107280|NCT02998671|559821200|FG001|Period 1|Withdrawal by Subject|2|||
155107281|NCT02998671|559821201|FG002|Period 1|Withdrawal by Subject|0|||
155107282|NCT02998671|559821202|FG003|Period 1|Withdrawal by Subject|0|||
155107283|NCT02998671|559821203|FG004|Period 1|Withdrawal by Subject|2|||
155107284|NCT02998671|559821199|FG000|Period 1|Pregnancy|1|||
155107285|NCT02998671|559821200|FG001|Period 1|Pregnancy|0|||
154862174|NCT02344576|558920296|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
154862175|NCT02344576|558920297|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
154862176|NCT02344576|558920294|FG000|6-Month Follow-Up|Death|14|||
155107286|NCT02998671|559821201|FG002|Period 1|Pregnancy|0|||
155107287|NCT02998671|559821202|FG003|Period 1|Pregnancy|0|||
155107288|NCT02998671|559821203|FG004|Period 1|Pregnancy|0|||
155107289|NCT02998671|559821199|FG000|Period 1|Adverse Event|0|||
155107290|NCT02998671|559821200|FG001|Period 1|Adverse Event|0|||
155107291|NCT02998671|559821201|FG002|Period 1|Adverse Event|0|||
154862177|NCT02344576|558920295|FG001|6-Month Follow-Up|Death|14|||
154862178|NCT02344576|558920296|FG002|6-Month Follow-Up|Death|0|||
154862179|NCT02344576|558920297|FG003|6-Month Follow-Up|Death|0|||
154862180|NCT02344576|558920294|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
154862181|NCT02344576|558920295|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
154862182|NCT02344576|558920296|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
154862183|NCT02344576|558920297|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
155107292|NCT02998671|559821202|FG003|Period 1|Adverse Event|0|||
155107293|NCT02998671|559821203|FG004|Period 1|Adverse Event|1|||
155107294|NCT02998671|559821199|FG000|Period 2|Adverse Event|0|||
155107295|NCT02998671|559821200|FG001|Period 2|Adverse Event|1|||
155107296|NCT02998671|559821201|FG002|Period 2|Adverse Event|0|||
155107297|NCT02998671|559821202|FG003|Period 2|Adverse Event|0|||
155107298|NCT02998671|559821203|FG004|Period 2|Adverse Event|0|||
155107299|NCT02998671|559821199|FG000|Period 2|Study Terminated By Sponsor|3|||
155107300|NCT02998671|559821200|FG001|Period 2|Study Terminated By Sponsor|5|||
155107301|NCT02998671|559821201|FG002|Period 2|Study Terminated By Sponsor|1|||
155107302|NCT02998671|559821202|FG003|Period 2|Study Terminated By Sponsor|3|||
155107303|NCT02998671|559821203|FG004|Period 2|Study Terminated By Sponsor|0|||
155107304|NCT02998671|559821199|FG000|Period 2|Withdrawal by Subject|0|||
155107305|NCT02998671|559821200|FG001|Period 2|Withdrawal by Subject|1|||
155107306|NCT02998671|559821201|FG002|Period 2|Withdrawal by Subject|0|||
155107307|NCT02998671|559821202|FG003|Period 2|Withdrawal by Subject|0|||
155107308|NCT02998671|559821203|FG004|Period 2|Withdrawal by Subject|0|||
155107309|NCT02998671|559821199|FG000|Period 2|Lost to Follow-up|0|||
155107310|NCT02998671|559821200|FG001|Period 2|Lost to Follow-up|0|||
155107311|NCT02998671|559821201|FG002|Period 2|Lost to Follow-up|0|||
155107312|NCT02998671|559821202|FG003|Period 2|Lost to Follow-up|1|||
155107313|NCT02998671|559821203|FG004|Period 2|Lost to Follow-up|0|||
155107314|NCT01558596|559821205|FG000|Overall Study|Withdrawal by Subject|1|||
155107315|NCT01558596|559821206|FG001|Overall Study|Withdrawal by Subject|0|||
155107316|NCT01558596|559821205|FG000|Overall Study|surgery elsewhere or cancelled|1|||
155107317|NCT01558596|559821206|FG001|Overall Study|surgery elsewhere or cancelled|1|||
155107318|NCT01558596|559821205|FG000|Overall Study|Protocol Violation|1|||
155107319|NCT01558596|559821206|FG001|Overall Study|Protocol Violation|0|||
155107320|NCT02038946|559821209|FG000|Overall Study|Death|5|||
155107321|NCT02038946|559821209|FG000|Overall Study|Withdrawal by Subject|3|||
155107322|NCT02038946|559821209|FG000|Overall Study|Lost to Follow-up|2|||
155107323|NCT02038946|559821209|FG000|Overall Study|Other reasons|2|||
155107324|NCT02473471|559821210|FG000|Overall Study|poor oral hygiene|2|||
155107325|NCT02473471|559821210|FG000|Overall Study|Lost to Follow-up|1|||
155107326|NCT02063984|559821215|FG000|Overall Study|Lost to Follow-up|6|||
155107327|NCT02063984|559821216|FG001|Overall Study|Lost to Follow-up|5|||
155107328|NCT01536561|559821221|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
155107329|NCT01536561|559821221|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
155107330|NCT01536561|559821221|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
155107331|NCT01536561|559821221|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
155107332|NCT01536561|559821221|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
155107333|NCT01536561|559821221|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
155107334|NCT01030952|559821222|FG000|Overall Study|Protocol Violation|0|||
155107335|NCT01030952|559821223|FG001|Overall Study|Protocol Violation|1|||
155107336|NCT01030952|559821222|FG000|Overall Study|Informed consent withdrawal|1|||
155107337|NCT01030952|559821223|FG001|Overall Study|Informed consent withdrawal|0|||
155107338|NCT01030952|559821222|FG000|Overall Study|Lost to Follow-up|0|||
154862184|NCT02344576|558920294|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
154862185|NCT02344576|558920295|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
154862186|NCT02344576|558920296|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
154862187|NCT02344576|558920297|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
154862188|NCT02337387|558920299|FG000|Overall Study|Adverse Event|0|||
154862189|NCT02337387|558920300|FG001|Overall Study|Adverse Event|1|||
154862190|NCT02337387|558920301|FG002|Overall Study|Adverse Event|0|||
154862191|NCT02337387|558920302|FG003|Overall Study|Adverse Event|0|||
154862192|NCT02337387|558920299|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
154862193|NCT02337387|558920300|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
154862194|NCT02337387|558920301|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
154862195|NCT02337387|558920302|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
154862196|NCT02853760|558920303|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
154972474|NCT00098475|559323567|FG003|Step 1|Declining performance status|0|||
155107339|NCT01030952|559821223|FG001|Overall Study|Lost to Follow-up|1|||
155107340|NCT01030952|559821222|FG000|Overall Study|Unexplained|1|||
155107341|NCT01030952|559821223|FG001|Overall Study|Unexplained|1|||
155107342|NCT02467192|559821224|FG000|Overall Study|Death|1|||
155107343|NCT02467192|559821224|FG000|Overall Study|revealed to have pneumonia before|2|||
155107344|NCT00958347|559821225|FG000|Overall Study|Death|43|||
155107345|NCT00958347|559821225|FG000|Overall Study|Withdrawal by Subject|23|||
155107346|NCT00958347|559821225|FG000|Overall Study|Lost to Follow-up|15|||
154972475|NCT00098475|559323564|FG000|Step 1|Insurance issue|0|||
155107347|NCT00958347|559821225|FG000|Overall Study|revision/removal|10|||
155107348|NCT00958347|559821225|FG000|Overall Study|study termination|135|||
155107349|NCT01603043|559821226|FG000|Overall Study|Study Futility|7|||
155107350|NCT01603043|559821227|FG001|Overall Study|Study Futility|3|||
155107351|NCT02146131|559821247|FG000|Overall Study|Physician Decision|61|||
155107352|NCT02146131|559821248|FG001|Overall Study|Physician Decision|56|||
155107353|NCT02567799|559821249|FG000|Concurrent Chemoradiotherapy|Death|1|||
155173683|NCT02213133|560074856|FG001|Overall Study|Participant withdrew informed consent|1|||
155107354|NCT02567799|559821250|FG001|Concurrent Chemoradiotherapy|Death|0|||
155107355|NCT02567799|559821251|FG002|Concurrent Chemoradiotherapy|Death|0|||
155107356|NCT02567799|559821249|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
155107357|NCT02567799|559821250|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
155107358|NCT02567799|559821251|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
155107359|NCT02567799|559821249|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
155107360|NCT02567799|559821250|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
155107361|NCT02567799|559821251|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
155107362|NCT02567799|559821249|FG000|Follow-up|Death|1|||
155107363|NCT02567799|559821250|FG001|Follow-up|Death|0|||
155107364|NCT02567799|559821251|FG002|Follow-up|Death|1|||
155107365|NCT02567799|559821249|FG000|Follow-up|Progressive Disease|1|||
155107366|NCT02567799|559821250|FG001|Follow-up|Progressive Disease|1|||
155107367|NCT02567799|559821251|FG002|Follow-up|Progressive Disease|3|||
155107368|NCT00861692|559821256|FG000|Overall Study|Death|6|||
155107369|NCT02218697|559821259|FG000|Overall Study|Adverse Event|0|||
155107370|NCT02218697|559821260|FG001|Overall Study|Adverse Event|2|||
155107371|NCT02218697|559821259|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
154972476|NCT00098475|559323565|FG001|Step 1|Insurance issue|1|||
155107372|NCT02218697|559821260|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
155107373|NCT02218697|559821259|FG000|Overall Study|Withdrawal by Subject|2|||
155107374|NCT02218697|559821260|FG001|Overall Study|Withdrawal by Subject|3|||
155107375|NCT02142803|559821261|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
155107376|NCT02142803|559821262|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
155107377|NCT02142803|559821263|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
155107378|NCT02142803|559821264|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
154862197|NCT02853760|558920304|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
154862198|NCT02853760|558920305|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
154862199|NCT02853760|558920306|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
154862200|NCT02853760|558920307|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
154862201|NCT02853760|558920308|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
154862202|NCT01624142|558920309|FG000|Overall Study|Withdrawal by Subject|14|||
154862203|NCT01624142|558920310|FG001|Overall Study|Withdrawal by Subject|4|||
154862204|NCT01624142|558920309|FG000|Overall Study|Death|3|||
154862205|NCT01624142|558920310|FG001|Overall Study|Death|6|||
155107379|NCT05111002|559821265|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
154862206|NCT01624142|558920309|FG000|Overall Study|Study Closure|12|||
154862207|NCT01624142|558920310|FG001|Overall Study|Study Closure|6|||
154862208|NCT01624142|558920309|FG000|Overall Study|Lost to Follow-up|2|||
154862209|NCT01624142|558920310|FG001|Overall Study|Lost to Follow-up|0|||
154862210|NCT01624142|558920309|FG000|Overall Study|Other|1|||
154862211|NCT01624142|558920310|FG001|Overall Study|Other|0|||
154862212|NCT04826900|558920311|FG000|Overall Study|Family factor|1|||
154862213|NCT04826900|558920312|FG001|Overall Study|Family factor|1|||
154862214|NCT03372941|558920313|FG000|Overall Study|Lost to Follow-up|2|||
154862215|NCT03372941|558920314|FG001|Overall Study|Lost to Follow-up|4|||
155173684|NCT02213133|560074857|FG002|Overall Study|Participant withdrew informed consent|2|||
154862216|NCT01053429|558920315|FG000|Overall Study|Adverse Event|64|||
154862217|NCT01053429|558920315|FG000|Overall Study|Other|309|||
154862218|NCT00752986|558920316|FG000|Overall Study|Withdrawal by Subject|2|||
154862219|NCT00752986|558920317|FG001|Overall Study|Withdrawal by Subject|1|||
154862220|NCT00752986|558920318|FG002|Overall Study|Withdrawal by Subject|2|||
154862221|NCT00752986|558920316|FG000|Overall Study|Protocol Violation|3|||
154862222|NCT00752986|558920317|FG001|Overall Study|Protocol Violation|0|||
154862223|NCT00752986|558920318|FG002|Overall Study|Protocol Violation|0|||
154862224|NCT01697345|558920319|FG000|Overall Study|Withdrawal by Subject|1|||
154862225|NCT02382133|558920320|FG000|Overall Study|Death|22|||
154862226|NCT02382133|558920320|FG000|Overall Study|transfer out of ICU|4|||
154862227|NCT02382133|558920320|FG000|Overall Study|Physician Decision|2|||
154862228|NCT02382133|558920320|FG000|Overall Study|arterial catheter loss|4|||
154862229|NCT02382133|558920320|FG000|Overall Study|pressure injury both sites|1|||
154862230|NCT03972488|558920324|FG000|Overall Study|Progressive disease|42|||
154862231|NCT03972488|558920325|FG001|Overall Study|Progressive disease|44|||
154862232|NCT03972488|558920324|FG000|Overall Study|Physician Decision|13|||
154862233|NCT03972488|558920325|FG001|Overall Study|Physician Decision|7|||
154862234|NCT03972488|558920324|FG000|Overall Study|Adverse Event|8|||
154862235|NCT03972488|558920325|FG001|Overall Study|Adverse Event|1|||
154862236|NCT03972488|558920324|FG000|Overall Study|Death|4|||
154862237|NCT03972488|558920325|FG001|Overall Study|Death|4|||
155173685|NCT02213133|560074855|FG000|Overall Study|Disease progression|11|||
154862238|NCT03972488|558920324|FG000|Overall Study|Withdrawal by Subject|3|||
154862239|NCT03972488|558920325|FG001|Overall Study|Withdrawal by Subject|4|||
154972477|NCT00098475|559323566|FG002|Step 1|Insurance issue|0|||
155107380|NCT05111002|559821266|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
155107381|NCT05111002|559821265|FG000|Secondary Outcome|Lost to Follow-up|1|||
155107382|NCT05111002|559821266|FG001|Secondary Outcome|Lost to Follow-up|0|||
155107383|NCT02712996|559821267|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
155107384|NCT02712996|559821268|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
155107385|NCT01016132|559821272|FG000|Overall Study|Discomfort|1|||
155107386|NCT00338286|559823062|FG000|Overall Study|Withdrawal by Subject|50|||
155107387|NCT00338286|559823063|FG001|Overall Study|Withdrawal by Subject|54|||
155107388|NCT00338286|559823062|FG000|Overall Study|Lost to Follow-up|80|||
155107389|NCT00338286|559823063|FG001|Overall Study|Lost to Follow-up|66|||
155107390|NCT00338286|559823062|FG000|Overall Study|Other|103|||
155107391|NCT00338286|559823063|FG001|Overall Study|Other|93|||
155107392|NCT01265563|559823064|FG000|Overall Study|Withdrawal by Subject|0|||
155107393|NCT01265563|559823065|FG001|Overall Study|Withdrawal by Subject|1|||
155107394|NCT01265563|559823066|FG002|Overall Study|Withdrawal by Subject|1|||
155107395|NCT01265563|559823067|FG003|Overall Study|Withdrawal by Subject|0|||
155107396|NCT01265563|559823068|FG004|Overall Study|Withdrawal by Subject|2|||
155107397|NCT00022763|559823079|FG000|Overall Study|Adverse Event|1|||
155107398|NCT00022763|559823080|FG001|Overall Study|Adverse Event|2|||
155107399|NCT00022763|559823079|FG000|Overall Study|Injection Site Reactions|0|||
155107400|NCT00022763|559823080|FG001|Overall Study|Injection Site Reactions|2|||
155107401|NCT00022763|559823079|FG000|Overall Study|Death|0|||
155107402|NCT00022763|559823080|FG001|Overall Study|Death|1|||
155107403|NCT00022763|559823079|FG000|Overall Study|Lost to Follow-up|0|||
155107404|NCT00022763|559823080|FG001|Overall Study|Lost to Follow-up|3|||
155107405|NCT00022763|559823079|FG000|Overall Study|Withdrawal by Subject|4|||
155107406|NCT00022763|559823080|FG001|Overall Study|Withdrawal by Subject|7|||
155107407|NCT00022763|559823079|FG000|Overall Study|Insufficient Therapy|1|||
155107408|NCT00022763|559823080|FG001|Overall Study|Insufficient Therapy|0|||
155107409|NCT00022763|559823079|FG000|Overall Study|Admin|3|||
155107410|NCT00022763|559823080|FG001|Overall Study|Admin|2|||
155107411|NCT04908865|559823081|FG000|Overall Study|Adverse Event|2|||
155107412|NCT04908865|559823081|FG000|Overall Study|Lack of Efficacy|5|||
155107413|NCT04908865|559823081|FG000|Overall Study|Lost to Follow-up|1|||
155107414|NCT05312697|559823082|FG000|Overall Study|Sponsor Terminated Trial|2|||
155107415|NCT02201329|559823083|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
155107416|NCT02201329|559823083|FG000|Overall Study|Withdrawal by Subject|2|||
155107417|NCT01534351|559823084|FG000|Overall Study|Study Terminated Early|1|||
155107418|NCT01534351|559823085|FG001|Overall Study|Study Terminated Early|0|||
155107419|NCT01534351|559823086|FG002|Overall Study|Study Terminated Early|0|||
155107420|NCT02702609|559823087|FG000|Overall Study|Lost to Follow-up|8|||
155107421|NCT02702609|559823088|FG001|Overall Study|Lost to Follow-up|4|||
155107422|NCT02702609|559823087|FG000|Overall Study|Physician Decision|1|||
155107423|NCT02702609|559823088|FG001|Overall Study|Physician Decision|0|||
155107424|NCT02674464|559823089|FG000|Overall Study|Death|10|||
155173686|NCT02213133|560074856|FG001|Overall Study|Disease progression|2|||
155173687|NCT02213133|560074857|FG002|Overall Study|Disease progression|0|||
155173688|NCT02213133|560074855|FG000|Overall Study|Adverse Event (AE)|1|||
155107425|NCT02674464|559823090|FG001|Overall Study|Death|21|||
155107426|NCT02674464|559823089|FG000|Overall Study|Withdrawal by Subject|24|||
155107427|NCT02674464|559823090|FG001|Overall Study|Withdrawal by Subject|44|||
155107428|NCT02674464|559823089|FG000|Overall Study|Lost to Follow-up|97|||
155107429|NCT02674464|559823090|FG001|Overall Study|Lost to Follow-up|92|||
155107430|NCT02674464|559823089|FG000|Overall Study|Outside survey window|6|||
155107431|NCT02674464|559823090|FG001|Overall Study|Outside survey window|3|||
155107432|NCT04153981|559823091|FG000|Overall Study|Death|1|||
155107433|NCT04153981|559823091|FG000|Overall Study|Withdrawal by Subject|24|||
154862240|NCT03972488|558920324|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
154862241|NCT03972488|558920325|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
154862242|NCT00045032|558920334|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
154862243|NCT00045032|558920335|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
154862244|NCT00045032|558920336|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
154862245|NCT00045032|558920334|FG000|Overall Study|Death|22|||
154862246|NCT00045032|558920335|FG001|Overall Study|Death|24|||
154862247|NCT00045032|558920336|FG002|Overall Study|Death|17|||
154862248|NCT00045032|558920334|FG000|Overall Study|Insufficient Therapeutic Response|542|||
154862249|NCT00045032|558920335|FG001|Overall Study|Insufficient Therapeutic Response|437|||
154862250|NCT00045032|558920336|FG002|Overall Study|Insufficient Therapeutic Response|445|||
154862251|NCT00045032|558920334|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
154862252|NCT00045032|558920335|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
154862253|NCT00045032|558920336|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
154862254|NCT00045032|558920334|FG000|Overall Study|Other Protocol Violation|2|||
154862255|NCT00045032|558920335|FG001|Overall Study|Other Protocol Violation|0|||
154862256|NCT00045032|558920336|FG002|Overall Study|Other Protocol Violation|1|||
154862257|NCT00045032|558920334|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
154862258|NCT00045032|558920335|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
154862259|NCT00045032|558920336|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
154862260|NCT00045032|558920334|FG000|Overall Study|Failure to Return|57|||
154862261|NCT00045032|558920335|FG001|Overall Study|Failure to Return|62|||
154862262|NCT00045032|558920336|FG002|Overall Study|Failure to Return|61|||
154862263|NCT00045032|558920334|FG000|Overall Study|Other|93|||
154862264|NCT00045032|558920335|FG001|Overall Study|Other|84|||
154862265|NCT00045032|558920336|FG002|Overall Study|Other|105|||
154862266|NCT02582658|558920337|FG000|Overall Study|Failure to Return|10|||
154862267|NCT02582658|558920337|FG000|Overall Study|Insufficient Virological Response|2|||
154862268|NCT02582658|558920337|FG000|Overall Study|Withdrawn Consent|1|||
155107434|NCT04153981|559823091|FG000|Overall Study|Lost to Follow-up|1|||
155107435|NCT04153981|559823091|FG000|Overall Study|Physician Decision|1|||
155107436|NCT04153981|559823091|FG000|Overall Study|Due to Unavailable Glucometer|1|||
155107437|NCT04153981|559823091|FG000|Overall Study|Covid 19|52|||
155107438|NCT04153981|559823091|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
155107439|NCT04153981|559823091|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
155107440|NCT01262638|559823092|FG000|Overall Study|Adverse Event|3|||
155107441|NCT01262638|559823093|FG001|Overall Study|Adverse Event|4|||
155107442|NCT01262638|559823094|FG002|Overall Study|Adverse Event|3|||
155107443|NCT01262638|559823095|FG003|Overall Study|Adverse Event|4|||
155107444|NCT01262638|559823092|FG000|Overall Study|Protocol Violation|1|||
155107445|NCT01262638|559823093|FG001|Overall Study|Protocol Violation|0|||
155107446|NCT01262638|559823094|FG002|Overall Study|Protocol Violation|0|||
155107447|NCT01262638|559823095|FG003|Overall Study|Protocol Violation|1|||
155107448|NCT01262638|559823092|FG000|Overall Study|Withdrawal by Subject|2|||
155107449|NCT01262638|559823093|FG001|Overall Study|Withdrawal by Subject|1|||
155107450|NCT01262638|559823094|FG002|Overall Study|Withdrawal by Subject|0|||
155107451|NCT01262638|559823095|FG003|Overall Study|Withdrawal by Subject|1|||
155107452|NCT01262638|559823092|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155107453|NCT01262638|559823093|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155107454|NCT01262638|559823094|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
155107455|NCT01262638|559823095|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155107456|NCT01262638|559823092|FG000|Overall Study|Lost to Follow-up|1|||
155107457|NCT01262638|559823093|FG001|Overall Study|Lost to Follow-up|1|||
155107458|NCT01262638|559823094|FG002|Overall Study|Lost to Follow-up|1|||
155107459|NCT01262638|559823095|FG003|Overall Study|Lost to Follow-up|1|||
155107460|NCT01262638|559823092|FG000|Overall Study|Participant Went Out of Town|0|||
155107461|NCT01262638|559823093|FG001|Overall Study|Participant Went Out of Town|0|||
155107462|NCT01262638|559823094|FG002|Overall Study|Participant Went Out of Town|1|||
155107463|NCT01262638|559823095|FG003|Overall Study|Participant Went Out of Town|0|||
155107464|NCT01369199|559823098|FG000|Overall Study|Withdrawal by Subject|1|||
155107465|NCT01369199|559823098|FG000|Overall Study|Lost to Follow-up|2|||
155107466|NCT01066104|559823099|FG000|Overall Study|Adverse Event|1|||
155107467|NCT01066104|559823100|FG001|Overall Study|Adverse Event|1|||
154862269|NCT02582658|558920337|FG000|Overall Study|Death|1|||
154862270|NCT02582658|558920337|FG000|Overall Study|Not further specified|11|||
155107468|NCT01066104|559823099|FG000|Overall Study|Protocol Violation|1|||
155107469|NCT01066104|559823100|FG001|Overall Study|Protocol Violation|0|||
155107470|NCT01667133|559823101|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
155107471|NCT01667133|559823102|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
155107472|NCT01667133|559823103|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
155107473|NCT01667133|559823104|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
155107474|NCT01667133|559823105|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
155173689|NCT02213133|560074856|FG001|Overall Study|Adverse Event (AE)|0|||
154862271|NCT02581995|558920338|FG000|Overall Study|Unspecified other|3|||
154862272|NCT02581995|558920338|FG000|Overall Study|Adverse Event|6|||
154862273|NCT02581995|558920338|FG000|Overall Study|Lost to Follow-up|5|||
154862274|NCT02581995|558920338|FG000|Overall Study|Withdrawal by participant|12|||
154862275|NCT02581995|558920338|FG000|Overall Study|Physician Decision|1|||
154862276|NCT02581995|558920338|FG000|Overall Study|Death|4|||
154862277|NCT03277196|558920340|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
154862278|NCT03277196|558920340|FG000|Overall Study|Lost to Follow-up|3|||
154862279|NCT03277196|558920340|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
154862280|NCT03277196|558920340|FG000|Overall Study|Other|2|||
155173690|NCT02213133|560074857|FG002|Overall Study|Adverse Event (AE)|0|||
154862281|NCT06119191|558920341|FG000|Overall Study|Adverse Event|0|||
154862282|NCT06119191|558920342|FG001|Overall Study|Adverse Event|1|||
154862283|NCT06119191|558920341|FG000|Overall Study|Protocol Violation|1|||
154862284|NCT06119191|558920342|FG001|Overall Study|Protocol Violation|0|||
154972478|NCT00098475|559323567|FG003|Step 1|Insurance issue|0|||
154972479|NCT00098475|559323564|FG000|Step 1|Rising paraprotein|0|||
154972480|NCT00098475|559323565|FG001|Step 1|Rising paraprotein|1|||
154972481|NCT00098475|559323566|FG002|Step 1|Rising paraprotein|0|||
154972482|NCT00098475|559323567|FG003|Step 1|Rising paraprotein|0|||
154972483|NCT00098475|559323564|FG000|Step 1|Referred to other physicians|0|||
154972484|NCT00098475|559323565|FG001|Step 1|Referred to other physicians|1|||
154972485|NCT00098475|559323566|FG002|Step 1|Referred to other physicians|0|||
154972486|NCT00098475|559323567|FG003|Step 1|Referred to other physicians|0|||
154972487|NCT00098475|559323564|FG000|Step 1|Criteria to continue treatment not met|0|||
154972488|NCT00098475|559323565|FG001|Step 1|Criteria to continue treatment not met|1|||
154972489|NCT00098475|559323566|FG002|Step 1|Criteria to continue treatment not met|0|||
155107475|NCT01667133|559823106|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
155107476|NCT01667133|559823107|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
155107477|NCT01667133|559823108|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
155107478|NCT01667133|559823109|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
155107479|NCT01667133|559823110|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
155107480|NCT01667133|559823111|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
155107481|NCT01667133|559823112|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
155107482|NCT01667133|559823101|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107483|NCT01667133|559823102|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
154972490|NCT00098475|559323567|FG003|Step 1|Criteria to continue treatment not met|0|||
154972491|NCT00098475|559323564|FG000|Step 1|Misinterpretation of lab data|0|||
155107484|NCT01667133|559823103|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
154972492|NCT00098475|559323565|FG001|Step 1|Misinterpretation of lab data|1|||
154862285|NCT00374556|558921772|FG000|Overall Study|Lost to Follow-up|1|||
154862286|NCT00374556|558921773|FG001|Overall Study|Lost to Follow-up|0|||
154862287|NCT00374556|558921772|FG000|Overall Study|Removed at baseline due to medical cond|0|||
154862288|NCT00374556|558921773|FG001|Overall Study|Removed at baseline due to medical cond|1|||
154862289|NCT00473694|558921774|FG000|Overall Study|Adverse Event|0|||
154862290|NCT00473694|558921775|FG001|Overall Study|Adverse Event|1|||
154862291|NCT00473694|558921776|FG002|Overall Study|Adverse Event|0|||
154862292|NCT00473694|558921777|FG003|Overall Study|Adverse Event|0|||
155173691|NCT02213133|560074855|FG000|Overall Study|Death|16|||
155173692|NCT02213133|560074856|FG001|Overall Study|Death|2|||
155173693|NCT02213133|560074857|FG002|Overall Study|Death|1|||
155107485|NCT01667133|559823104|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107486|NCT01667133|559823105|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107487|NCT01667133|559823106|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107488|NCT01667133|559823107|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107489|NCT01667133|559823108|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107490|NCT01667133|559823109|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107491|NCT01667133|559823110|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107492|NCT01667133|559823111|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155107493|NCT01667133|559823112|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
155173694|NCT02213133|560074855|FG000|Overall Study|Other|5|||
155107494|NCT01667133|559823101|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
155173695|NCT02213133|560074856|FG001|Overall Study|Other|0|||
154972493|NCT00098475|559323566|FG002|Step 1|Misinterpretation of lab data|0|||
155107495|NCT01667133|559823102|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
154972494|NCT00098475|559323567|FG003|Step 1|Misinterpretation of lab data|0|||
155107496|NCT01667133|559823103|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
155107497|NCT01667133|559823104|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
155107498|NCT01667133|559823105|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
155107499|NCT01667133|559823106|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
155107500|NCT01667133|559823107|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
155107501|NCT01667133|559823108|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
155107502|NCT01667133|559823109|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
155107503|NCT01667133|559823110|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
155107504|NCT01667133|559823111|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
155107505|NCT01667133|559823112|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
155107506|NCT01667133|559823101|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
154972495|NCT00098475|559323564|FG000|Step 1|Patient fell with fracture|1|||
154972496|NCT00098475|559323565|FG001|Step 1|Patient fell with fracture|0|||
154972497|NCT00098475|559323566|FG002|Step 1|Patient fell with fracture|0|||
154972498|NCT00098475|559323567|FG003|Step 1|Patient fell with fracture|0|||
154972499|NCT00098475|559323564|FG000|Step 1|Not documented|0|||
154972500|NCT00098475|559323565|FG001|Step 1|Not documented|1|||
154972501|NCT00098475|559323566|FG002|Step 1|Not documented|0|||
154972502|NCT00098475|559323567|FG003|Step 1|Not documented|0|||
154972503|NCT00098475|559323564|FG000|Step 2|Disease progression|1|||
154972504|NCT00098475|559323565|FG001|Step 2|Disease progression|4|||
154972505|NCT00098475|559323566|FG002|Step 2|Disease progression|0|||
154972506|NCT00098475|559323567|FG003|Step 2|Disease progression|0|||
154972507|NCT00098475|559323564|FG000|Step 2|Adverse Event|2|||
154972508|NCT00098475|559323565|FG001|Step 2|Adverse Event|0|||
154972509|NCT00098475|559323566|FG002|Step 2|Adverse Event|0|||
155107507|NCT01667133|559823102|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107508|NCT01667133|559823103|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107509|NCT01667133|559823104|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
155107510|NCT01667133|559823105|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
154972510|NCT00098475|559323567|FG003|Step 2|Adverse Event|0|||
154972511|NCT00098475|559323564|FG000|Step 2|Withdrawal by Subject|0|||
154972512|NCT00098475|559323565|FG001|Step 2|Withdrawal by Subject|2|||
154972513|NCT00098475|559323566|FG002|Step 2|Withdrawal by Subject|0|||
154972514|NCT00098475|559323567|FG003|Step 2|Withdrawal by Subject|0|||
154972515|NCT00098475|559323564|FG000|Step 2|Physician Decision|0|||
155107511|NCT01667133|559823106|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107512|NCT01667133|559823107|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107513|NCT01667133|559823108|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107514|NCT01667133|559823109|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107515|NCT01667133|559823110|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107516|NCT01667133|559823111|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107517|NCT01667133|559823112|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
155107518|NCT01667133|559823101|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
155107519|NCT01667133|559823102|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
155107520|NCT01667133|559823103|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
155107521|NCT01667133|559823104|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
155107522|NCT01667133|559823105|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
155107523|NCT01667133|559823106|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
155107524|NCT01667133|559823107|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
155107525|NCT01667133|559823108|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
155107526|NCT01667133|559823109|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
155107527|NCT01667133|559823110|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
155107528|NCT01667133|559823111|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
155107529|NCT01667133|559823112|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
155107530|NCT01667133|559823101|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107531|NCT01667133|559823102|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107532|NCT01667133|559823103|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107533|NCT01667133|559823104|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107534|NCT01667133|559823105|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107535|NCT01667133|559823106|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107536|NCT01667133|559823107|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107537|NCT01667133|559823108|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107538|NCT01667133|559823109|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107539|NCT01667133|559823110|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
155107540|NCT01667133|559823111|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107541|NCT01667133|559823112|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
155107542|NCT01667133|559823101|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
154972516|NCT00098475|559323565|FG001|Step 2|Physician Decision|1|||
155107543|NCT01667133|559823102|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
155107544|NCT01667133|559823103|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
155107545|NCT01667133|559823104|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
155107546|NCT01667133|559823105|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
154972517|NCT00098475|559323566|FG002|Step 2|Physician Decision|0|||
154972518|NCT00098475|559323567|FG003|Step 2|Physician Decision|0|||
154972519|NCT00098475|559323564|FG000|Step 2|Alternative therapy|1|||
154972520|NCT00098475|559323565|FG001|Step 2|Alternative therapy|2|||
154972521|NCT00098475|559323566|FG002|Step 2|Alternative therapy|0|||
154972522|NCT00098475|559323567|FG003|Step 2|Alternative therapy|0|||
154972523|NCT00098475|559323564|FG000|Step 2|Never started treatment|1|||
154972524|NCT00098475|559323565|FG001|Step 2|Never started treatment|1|||
154972525|NCT00098475|559323566|FG002|Step 2|Never started treatment|0|||
154972526|NCT00098475|559323567|FG003|Step 2|Never started treatment|0|||
154972527|NCT03422068|559323568|FG000|Overall Study|Adverse Event|0|||
154972528|NCT03422068|559323569|FG001|Overall Study|Adverse Event|1|||
154972529|NCT03422068|559323568|FG000|Overall Study|Inconvenience to frequent study visits|0|||
154972530|NCT03422068|559323569|FG001|Overall Study|Inconvenience to frequent study visits|1|||
155107547|NCT01667133|559823106|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
155173696|NCT02213133|560074857|FG002|Overall Study|Other|0|||
154972531|NCT01583530|559323570|FG000|Overall Study|Adverse Event|0|||
154972532|NCT01583530|559323571|FG001|Overall Study|Adverse Event|0|||
154972533|NCT01583530|559323572|FG002|Overall Study|Adverse Event|0|||
155173697|NCT02350764|560074858|FG000|Overall Study|Adverse Event|4|||
155173698|NCT02350764|560074858|FG000|Overall Study|Death|3|||
155173699|NCT02350764|560074858|FG000|Overall Study|Physician Decision|2|||
155173700|NCT02350764|560074858|FG000|Overall Study|Withdrawal by Subject|2|||
155173701|NCT00977080|560074859|FG000|Overall Study|Adverse Event|2|||
155173702|NCT00977080|560074860|FG001|Overall Study|Adverse Event|7|||
155173703|NCT00977080|560074861|FG002|Overall Study|Adverse Event|7|||
155173704|NCT00977080|560074862|FG003|Overall Study|Adverse Event|7|||
155173705|NCT00977080|560074859|FG000|Overall Study|Withdrawal by Subject|1|||
155173706|NCT00977080|560074860|FG001|Overall Study|Withdrawal by Subject|5|||
155173707|NCT00977080|560074861|FG002|Overall Study|Withdrawal by Subject|1|||
155173708|NCT00977080|560074862|FG003|Overall Study|Withdrawal by Subject|5|||
155173709|NCT00977080|560074859|FG000|Overall Study|Protocol Violation|7|||
155173710|NCT00977080|560074860|FG001|Overall Study|Protocol Violation|3|||
155173711|NCT00977080|560074861|FG002|Overall Study|Protocol Violation|4|||
155173712|NCT00977080|560074862|FG003|Overall Study|Protocol Violation|3|||
154862293|NCT00473694|558921774|FG000|Overall Study|Participants did not receive treatment|11|||
154862294|NCT00473694|558921775|FG001|Overall Study|Participants did not receive treatment|3|||
155107548|NCT01667133|559823107|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
155107549|NCT01667133|559823108|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
155107550|NCT01667133|559823109|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
155107551|NCT01667133|559823110|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
155107552|NCT01667133|559823111|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
155107553|NCT01667133|559823112|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
155107554|NCT01667133|559823101|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107555|NCT01667133|559823102|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107556|NCT01667133|559823103|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107557|NCT01667133|559823104|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107558|NCT01667133|559823105|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107559|NCT01667133|559823106|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107560|NCT01667133|559823107|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107561|NCT01667133|559823108|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107562|NCT01667133|559823109|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107563|NCT01667133|559823110|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
155107564|NCT01667133|559823111|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107565|NCT01667133|559823112|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
155107566|NCT01667133|559823101|FG000|Phase 2: Dose-expansion|Death|0|||
155107567|NCT01667133|559823102|FG001|Phase 2: Dose-expansion|Death|0|||
155107568|NCT01667133|559823103|FG002|Phase 2: Dose-expansion|Death|0|||
155107569|NCT01667133|559823104|FG003|Phase 2: Dose-expansion|Death|0|||
155107570|NCT01667133|559823105|FG004|Phase 2: Dose-expansion|Death|0|||
155107571|NCT01667133|559823106|FG005|Phase 2: Dose-expansion|Death|0|||
155107572|NCT01667133|559823107|FG006|Phase 2: Dose-expansion|Death|0|||
155173713|NCT00977080|560074859|FG000|Overall Study|Noncompliance|0|||
155173714|NCT00977080|560074860|FG001|Overall Study|Noncompliance|2|||
155173715|NCT00977080|560074861|FG002|Overall Study|Noncompliance|1|||
155173716|NCT00977080|560074862|FG003|Overall Study|Noncompliance|0|||
155173717|NCT00977080|560074859|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
154862295|NCT00473694|558921776|FG002|Overall Study|Participants did not receive treatment|5|||
154862296|NCT00473694|558921777|FG003|Overall Study|Participants did not receive treatment|6|||
155107573|NCT01667133|559823108|FG007|Phase 2: Dose-expansion|Death|0|||
155107574|NCT01667133|559823109|FG008|Phase 2: Dose-expansion|Death|0|||
155107575|NCT01667133|559823110|FG009|Phase 2: Dose-expansion|Death|1|||
155173718|NCT00977080|560074860|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
155173719|NCT00977080|560074861|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
155173720|NCT00977080|560074862|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
155173721|NCT00977080|560074859|FG000|Overall Study|Required kidney transplantation|1|||
155173722|NCT00977080|560074860|FG001|Overall Study|Required kidney transplantation|3|||
155173723|NCT00977080|560074861|FG002|Overall Study|Required kidney transplantation|3|||
155173724|NCT00977080|560074862|FG003|Overall Study|Required kidney transplantation|1|||
155173725|NCT00977080|560074859|FG000|Overall Study|Travel for family reasons|1|||
155173726|NCT00977080|560074860|FG001|Overall Study|Travel for family reasons|0|||
155173727|NCT00977080|560074861|FG002|Overall Study|Travel for family reasons|0|||
155173728|NCT00977080|560074862|FG003|Overall Study|Travel for family reasons|0|||
155173729|NCT00313781|560074863|FG000|Before Crossover|Death|22|||
155173730|NCT00313781|560074864|FG001|Before Crossover|Death|8|||
155173731|NCT00313781|560074865|FG002|Before Crossover|Death|0|||
155173732|NCT00313781|560074863|FG000|Before Crossover|Lost to Follow-up|0|||
155173733|NCT00313781|560074864|FG001|Before Crossover|Lost to Follow-up|3|||
155173734|NCT00313781|560074865|FG002|Before Crossover|Lost to Follow-up|0|||
155173735|NCT00313781|560074863|FG000|Before Crossover|Withdrawal by Subject|3|||
155173736|NCT00313781|560074864|FG001|Before Crossover|Withdrawal by Subject|1|||
155173737|NCT00313781|560074865|FG002|Before Crossover|Withdrawal by Subject|0|||
155173738|NCT00313781|560074863|FG000|Before Crossover|Other|45|||
155173739|NCT00313781|560074864|FG001|Before Crossover|Other|30|||
155173740|NCT00313781|560074865|FG002|Before Crossover|Other|0|||
155173741|NCT00313781|560074863|FG000|Before Crossover|Crossover|0|||
155173742|NCT00313781|560074864|FG001|Before Crossover|Crossover|37|||
155173743|NCT00313781|560074865|FG002|Before Crossover|Crossover|0|||
155173744|NCT00313781|560074863|FG000|Before Crossover|Randomized, not treated|5|||
155173745|NCT00313781|560074864|FG001|Before Crossover|Randomized, not treated|0|||
155173746|NCT00313781|560074865|FG002|Before Crossover|Randomized, not treated|0|||
155173747|NCT00313781|560074863|FG000|After Crossover|Death|0|||
155173748|NCT00313781|560074864|FG001|After Crossover|Death|0|||
155173749|NCT00313781|560074865|FG002|After Crossover|Death|6|||
155173750|NCT00313781|560074863|FG000|After Crossover|Withdrawal by Subject|0|||
155173751|NCT00313781|560074864|FG001|After Crossover|Withdrawal by Subject|0|||
155173752|NCT00313781|560074865|FG002|After Crossover|Withdrawal by Subject|3|||
155173753|NCT00313781|560074863|FG000|After Crossover|Other|0|||
155173754|NCT00313781|560074864|FG001|After Crossover|Other|0|||
155173755|NCT00313781|560074865|FG002|After Crossover|Other|18|||
155173756|NCT01546623|560074866|FG000|Overall Study|Adverse Event|2|||
155173757|NCT01546623|560074867|FG001|Overall Study|Adverse Event|3|||
155173758|NCT01546623|560074866|FG000|Overall Study|Major Protocol Deviation|1|||
155173759|NCT01546623|560074867|FG001|Overall Study|Major Protocol Deviation|1|||
155173760|NCT01546623|560074866|FG000|Overall Study|High Prostate specific antigen|2|||
155173761|NCT01546623|560074867|FG001|Overall Study|High Prostate specific antigen|1|||
155173762|NCT01546623|560074866|FG000|Overall Study|Did Not Receive Study Drug|1|||
155173763|NCT01546623|560074867|FG001|Overall Study|Did Not Receive Study Drug|1|||
155173764|NCT03567343|560074868|FG000|Overall Study|Lost to Follow-up|2|||
155173765|NCT03567343|560074869|FG001|Overall Study|Lost to Follow-up|1|||
155173766|NCT03567343|560074868|FG000|Overall Study|No longer eligible|2|||
155173767|NCT03567343|560074869|FG001|Overall Study|No longer eligible|1|||
155173768|NCT03567343|560074868|FG000|Overall Study|Adverse Event|1|||
155173769|NCT03567343|560074869|FG001|Overall Study|Adverse Event|0|||
154862297|NCT00473694|558921774|FG000|Overall Study|Lost to Follow-up|0|||
155173770|NCT03567343|560074868|FG000|Overall Study|Protocol Violation|1|||
155173771|NCT03567343|560074869|FG001|Overall Study|Protocol Violation|1|||
155173772|NCT02466659|560074870|FG000|Overall Study|Lost to Follow-up|5|||
154862298|NCT00473694|558921775|FG001|Overall Study|Lost to Follow-up|0|||
154862299|NCT00473694|558921776|FG002|Overall Study|Lost to Follow-up|0|||
155173773|NCT02466659|560074871|FG001|Overall Study|Lost to Follow-up|2|||
154862300|NCT00473694|558921777|FG003|Overall Study|Lost to Follow-up|1|||
155173774|NCT00486811|560074874|FG000|Overall Study|Adverse Event|28|||
155173775|NCT00486811|560074875|FG001|Overall Study|Adverse Event|60|||
155173776|NCT00486811|560074876|FG002|Overall Study|Adverse Event|135|||
155173777|NCT00486811|560074874|FG000|Overall Study|Lack of Efficacy|34|||
154862301|NCT03874234|558921780|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862302|NCT03874234|558921781|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862303|NCT03874234|558921782|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862304|NCT03874234|558921783|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
154862305|NCT03874234|558921784|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862306|NCT03874234|558921785|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862307|NCT03874234|558921786|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862308|NCT03874234|558921787|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862309|NCT03874234|558921788|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862310|NCT03874234|558921789|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862311|NCT03874234|558921790|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862312|NCT03874234|558921791|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862313|NCT03874234|558921792|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
154862314|NCT03874234|558921780|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
154862315|NCT03874234|558921781|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862316|NCT03874234|558921782|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862317|NCT03874234|558921783|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862318|NCT03874234|558921784|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862319|NCT03874234|558921785|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862320|NCT03874234|558921786|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862321|NCT03874234|558921787|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862322|NCT03874234|558921788|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862323|NCT03874234|558921789|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862324|NCT03874234|558921790|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862325|NCT03874234|558921791|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862326|NCT03874234|558921792|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
154862327|NCT03874234|558921780|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862328|NCT03874234|558921781|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862329|NCT03874234|558921782|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862330|NCT03874234|558921783|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
154862331|NCT03874234|558921784|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862332|NCT03874234|558921785|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862333|NCT03874234|558921786|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862334|NCT03874234|558921787|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862335|NCT03874234|558921788|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862336|NCT03874234|558921789|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862337|NCT03874234|558921790|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862338|NCT03874234|558921791|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862339|NCT03874234|558921792|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
154862340|NCT03874234|558921780|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862341|NCT03874234|558921781|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862342|NCT03874234|558921782|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862343|NCT03874234|558921783|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862344|NCT03874234|558921784|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
154862345|NCT03874234|558921785|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862346|NCT03874234|558921786|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862347|NCT03874234|558921787|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862348|NCT03874234|558921788|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862349|NCT03874234|558921789|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862350|NCT03874234|558921790|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862351|NCT03874234|558921791|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862352|NCT03874234|558921792|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
154862353|NCT03874234|558921780|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862354|NCT03874234|558921781|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862355|NCT03874234|558921782|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862356|NCT03874234|558921783|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862357|NCT03874234|558921784|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862358|NCT03874234|558921785|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862359|NCT03874234|558921786|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862360|NCT03874234|558921787|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
154862361|NCT03874234|558921788|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862362|NCT03874234|558921789|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862363|NCT03874234|558921790|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862364|NCT03874234|558921791|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862365|NCT03874234|558921792|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
154862366|NCT03874234|558921780|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154972534|NCT01583530|559323573|FG003|Overall Study|Adverse Event|0|||
154972535|NCT01583530|559323574|FG004|Overall Study|Adverse Event|0|||
154972536|NCT01583530|559323575|FG005|Overall Study|Adverse Event|1|||
154972537|NCT01583530|559323570|FG000|Overall Study|Withdrawal by Subject|0|||
154972538|NCT01583530|559323571|FG001|Overall Study|Withdrawal by Subject|3|||
154972539|NCT01583530|559323572|FG002|Overall Study|Withdrawal by Subject|0|||
154972540|NCT01583530|559323573|FG003|Overall Study|Withdrawal by Subject|1|||
154972541|NCT01583530|559323574|FG004|Overall Study|Withdrawal by Subject|1|||
154972542|NCT01583530|559323575|FG005|Overall Study|Withdrawal by Subject|2|||
154972543|NCT01583530|559323570|FG000|Overall Study|Lost to Follow-up|0|||
154972544|NCT01583530|559323571|FG001|Overall Study|Lost to Follow-up|0|||
154972545|NCT01583530|559323572|FG002|Overall Study|Lost to Follow-up|0|||
154972546|NCT01583530|559323573|FG003|Overall Study|Lost to Follow-up|0|||
154972547|NCT01583530|559323574|FG004|Overall Study|Lost to Follow-up|3|||
154972548|NCT01583530|559323575|FG005|Overall Study|Lost to Follow-up|0|||
154972549|NCT01583530|559323570|FG000|Overall Study|Lack of compliance|0|||
154972550|NCT01583530|559323571|FG001|Overall Study|Lack of compliance|0|||
154972551|NCT01583530|559323572|FG002|Overall Study|Lack of compliance|0|||
154972552|NCT01583530|559323573|FG003|Overall Study|Lack of compliance|0|||
154972553|NCT01583530|559323574|FG004|Overall Study|Lack of compliance|1|||
154972554|NCT01583530|559323575|FG005|Overall Study|Lack of compliance|0|||
154972555|NCT02416180|559323576|FG000|Overall Study|Withdrawal by Subject|1|||
154972556|NCT02985398|559323577|FG000|Overall Study|Adverse Event|1|||
154972557|NCT02985398|559323577|FG000|Overall Study|Lost to Follow-up|4|||
154972558|NCT02985398|559323577|FG000|Overall Study|Withdrawal by Subject|8|||
154972559|NCT02985398|559323577|FG000|Overall Study|Study Burden|9|||
154972560|NCT02472639|559323583|FG000|Overall Study|Physician Decision|4|||
154972561|NCT02472639|559323584|FG001|Overall Study|Physician Decision|3|||
154972562|NCT00046839|559323585|FG000|Overall Study|Ineligible / No protocol treatment|0|||
154972563|NCT00046839|559323586|FG001|Overall Study|Ineligible / No protocol treatment|2|||
154972564|NCT00046839|559323585|FG000|Overall Study|Withdrawal of consent|1|||
154972565|NCT00046839|559323586|FG001|Overall Study|Withdrawal of consent|0|||
154972566|NCT00751023|559323588|FG000|Overall Study|Lost to Follow-up|11|||
154972567|NCT00751023|559323589|FG001|Overall Study|Lost to Follow-up|7|||
155107576|NCT01667133|559823111|FG010|Phase 2: Dose-expansion|Death|0|||
155107577|NCT01667133|559823112|FG011|Phase 2: Dose-expansion|Death|0|||
155107578|NCT01667133|559823101|FG000|Phase 2: Dose-expansion|Other|0|||
155107579|NCT01667133|559823102|FG001|Phase 2: Dose-expansion|Other|0|||
155107580|NCT01667133|559823103|FG002|Phase 2: Dose-expansion|Other|0|||
154862367|NCT03874234|558921781|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862368|NCT03874234|558921782|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862369|NCT03874234|558921783|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862370|NCT03874234|558921784|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
154862371|NCT03874234|558921785|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
154862372|NCT03874234|558921786|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862373|NCT03874234|558921787|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862374|NCT03874234|558921788|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862375|NCT03874234|558921789|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862376|NCT03874234|558921790|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862377|NCT03874234|558921791|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862378|NCT03874234|558921792|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
154862379|NCT03874234|558921780|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862380|NCT03874234|558921781|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862381|NCT03874234|558921782|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155107581|NCT01667133|559823104|FG003|Phase 2: Dose-expansion|Other|0|||
155107582|NCT01667133|559823105|FG004|Phase 2: Dose-expansion|Other|0|||
155107583|NCT01667133|559823106|FG005|Phase 2: Dose-expansion|Other|0|||
155107584|NCT01667133|559823107|FG006|Phase 2: Dose-expansion|Other|0|||
155107585|NCT01667133|559823108|FG007|Phase 2: Dose-expansion|Other|0|||
155107586|NCT01667133|559823109|FG008|Phase 2: Dose-expansion|Other|0|||
155107587|NCT01667133|559823110|FG009|Phase 2: Dose-expansion|Other|0|||
155107588|NCT01667133|559823111|FG010|Phase 2: Dose-expansion|Other|0|||
155107589|NCT01667133|559823112|FG011|Phase 2: Dose-expansion|Other|1|||
154862382|NCT03874234|558921783|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154972568|NCT02050321|559323590|FG000|Overall Study|Withdrawal by Subject|1|||
155107590|NCT01916824|559823115|FG000|Overall Study|Lost to Follow-up|3|||
155107591|NCT01916824|559823116|FG001|Overall Study|Lost to Follow-up|6|||
154972569|NCT02050321|559323590|FG000|Overall Study|Adverse Event|1|||
154972570|NCT04768114|559323592|FG000|Overall Study|Lost to Follow-up|5|||
154972571|NCT04768114|559323593|FG001|Overall Study|Lost to Follow-up|10|||
154972572|NCT04768114|559323592|FG000|Overall Study|Withdrawal by Subject|0|||
154972573|NCT04768114|559323593|FG001|Overall Study|Withdrawal by Subject|1|||
154972574|NCT00715676|559323601|FG000|Overall Study|Adverse Event|3|||
154972575|NCT00715676|559323602|FG001|Overall Study|Adverse Event|5|||
155107592|NCT01916824|559823115|FG000|Overall Study|Physician Decision|2|||
155107593|NCT01916824|559823116|FG001|Overall Study|Physician Decision|0|||
155107594|NCT01916824|559823115|FG000|Overall Study|Withdrawal by Subject|2|||
155107595|NCT01916824|559823116|FG001|Overall Study|Withdrawal by Subject|3|||
155107596|NCT00771927|559823119|FG000|Overall Study|Adverse Event|100|||
155107597|NCT00771927|559823120|FG001|Overall Study|Adverse Event|105|||
155107598|NCT00771927|559823119|FG000|Overall Study|Lack of Efficacy|70|||
155107599|NCT00771927|559823120|FG001|Overall Study|Lack of Efficacy|42|||
155107600|NCT00771927|559823119|FG000|Overall Study|Lost to Follow-up|46|||
155107601|NCT00771927|559823120|FG001|Overall Study|Lost to Follow-up|46|||
155107602|NCT00771927|559823119|FG000|Overall Study|Withdrawal by Subject|16|||
155107603|NCT00771927|559823120|FG001|Overall Study|Withdrawal by Subject|17|||
155107604|NCT00771927|559823119|FG000|Overall Study|Other reason|23|||
155107605|NCT00771927|559823120|FG001|Overall Study|Other reason|27|||
155107606|NCT03835481|559823121|FG000|Double-blind Period|Other not stated below|0|||
155107607|NCT03835481|559823122|FG001|Double-blind Period|Other not stated below|0|||
155107608|NCT03835481|559823123|FG002|Double-blind Period|Other not stated below|0|||
155107609|NCT03835481|559823124|FG003|Double-blind Period|Other not stated below|1|||
155107610|NCT03835481|559823125|FG004|Double-blind Period|Other not stated below|1|||
155107611|NCT03835481|559823121|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
155107612|NCT03835481|559823122|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
155107613|NCT03835481|559823123|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
155107614|NCT03835481|559823124|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
155107615|NCT03835481|559823125|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
155107616|NCT03835481|559823121|FG000|Double-blind Period|Withdrawal by Subject|0|||
155107617|NCT03835481|559823122|FG001|Double-blind Period|Withdrawal by Subject|0|||
155107618|NCT03835481|559823123|FG002|Double-blind Period|Withdrawal by Subject|1|||
155107619|NCT03835481|559823124|FG003|Double-blind Period|Withdrawal by Subject|0|||
155107620|NCT03835481|559823125|FG004|Double-blind Period|Withdrawal by Subject|5|||
155107621|NCT03835481|559823121|FG000|Double-blind Period|Lost to Follow-up|0|||
155107622|NCT03835481|559823122|FG001|Double-blind Period|Lost to Follow-up|0|||
155107623|NCT03835481|559823123|FG002|Double-blind Period|Lost to Follow-up|0|||
155107624|NCT03835481|559823124|FG003|Double-blind Period|Lost to Follow-up|1|||
155107625|NCT03835481|559823125|FG004|Double-blind Period|Lost to Follow-up|0|||
155107626|NCT03835481|559823121|FG000|Double-blind Period|Protocol Violation|0|||
155107627|NCT03835481|559823122|FG001|Double-blind Period|Protocol Violation|2|||
155107628|NCT03835481|559823123|FG002|Double-blind Period|Protocol Violation|0|||
155107629|NCT03835481|559823124|FG003|Double-blind Period|Protocol Violation|1|||
155107630|NCT03835481|559823125|FG004|Double-blind Period|Protocol Violation|0|||
155107631|NCT03835481|559823121|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
155107632|NCT03835481|559823122|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
155107633|NCT03835481|559823123|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
155107634|NCT03835481|559823124|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
155107635|NCT03835481|559823125|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
155107636|NCT03835481|559823121|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
155107637|NCT03835481|559823122|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
155107638|NCT03835481|559823123|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
155107639|NCT03835481|559823124|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
155107640|NCT03835481|559823125|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
155107641|NCT03835481|559823121|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
155107642|NCT03835481|559823122|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
155107643|NCT03835481|559823123|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
155107644|NCT03835481|559823124|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
155107645|NCT03835481|559823125|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
155107646|NCT03835481|559823121|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
155107647|NCT03835481|559823122|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
154862383|NCT03874234|558921784|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862384|NCT03874234|558921785|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155107648|NCT03835481|559823123|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
155107649|NCT03835481|559823124|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
155107650|NCT03835481|559823125|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
155107651|NCT03835481|559823121|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155107652|NCT03835481|559823122|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155173778|NCT00486811|560074875|FG001|Overall Study|Lack of Efficacy|14|||
155173779|NCT00486811|560074876|FG002|Overall Study|Lack of Efficacy|7|||
154862385|NCT03874234|558921786|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
154862386|NCT03874234|558921787|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155107653|NCT03835481|559823123|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155107654|NCT03835481|559823124|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
155107655|NCT03835481|559823125|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
155107656|NCT03835481|559823121|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
154862387|NCT03874234|558921788|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862388|NCT03874234|558921789|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862389|NCT03874234|558921790|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
155173780|NCT00486811|560074874|FG000|Overall Study|Lost to Follow-up|4|||
155173781|NCT00486811|560074875|FG001|Overall Study|Lost to Follow-up|6|||
155173782|NCT00486811|560074876|FG002|Overall Study|Lost to Follow-up|4|||
155173783|NCT00486811|560074874|FG000|Overall Study|Withdrawal by Subject|33|||
155173784|NCT00486811|560074875|FG001|Overall Study|Withdrawal by Subject|44|||
155173785|NCT00486811|560074876|FG002|Overall Study|Withdrawal by Subject|58|||
155173786|NCT00486811|560074874|FG000|Overall Study|Study drug non-compliant|5|||
155173787|NCT00486811|560074875|FG001|Overall Study|Study drug non-compliant|6|||
155173788|NCT00486811|560074876|FG002|Overall Study|Study drug non-compliant|3|||
155173789|NCT00486811|560074874|FG000|Overall Study|All other|18|||
155173790|NCT00486811|560074875|FG001|Overall Study|All other|11|||
155173791|NCT00486811|560074876|FG002|Overall Study|All other|7|||
155173792|NCT01590758|560074877|FG000|Overall Study|Withdrawal by Subject|0|||
155173793|NCT01590758|560074878|FG001|Overall Study|Withdrawal by Subject|3|||
155173794|NCT01590758|560074877|FG000|Overall Study|Physician Decision|1|||
155173795|NCT01590758|560074878|FG001|Overall Study|Physician Decision|2|||
155173796|NCT01590758|560074877|FG000|Overall Study|Lost to Follow-up|4|||
155173797|NCT01590758|560074878|FG001|Overall Study|Lost to Follow-up|2|||
155173798|NCT02756806|560074879|FG000|Overall Study|Study terminated early|5|||
155173799|NCT02228980|560074880|FG000|Overall Study|Adverse Event|14|||
154862390|NCT03874234|558921791|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862391|NCT03874234|558921792|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
154862392|NCT03874234|558921780|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862393|NCT03874234|558921781|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862394|NCT03874234|558921782|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862395|NCT03874234|558921783|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862396|NCT03874234|558921784|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
155107657|NCT03835481|559823122|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
155107658|NCT03835481|559823123|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
155107659|NCT03835481|559823124|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
155107660|NCT03835481|559823125|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
155107661|NCT00976716|559823132|FG000|Overall Study|Adverse Event|1|||
155107662|NCT04222699|559823133|FG000|Overall Study|Lost to Follow-up|2|||
155107663|NCT01814046|559823142|FG000|Drug Administration|Death due to complications of RSV|1|||
155107664|NCT01814046|559823143|FG001|Drug Administration|Death due to complications of RSV|0|||
155107665|NCT01814046|559823144|FG002|Drug Administration|Death due to complications of RSV|0|||
155107666|NCT00564902|559823145|FG000|Overall Study|Withdrawal by Subject|0|||
155107667|NCT00564902|559823146|FG001|Overall Study|Withdrawal by Subject|3|||
155107668|NCT00564902|559823147|FG002|Overall Study|Withdrawal by Subject|4|||
155107669|NCT00564902|559823145|FG000|Overall Study|Death|1|||
155107670|NCT00564902|559823146|FG001|Overall Study|Death|1|||
155107671|NCT00564902|559823147|FG002|Overall Study|Death|0|||
155107672|NCT04552288|559823150|FG000|Overall Study|Death|3|||
155107673|NCT04552288|559823150|FG000|Overall Study|Lost to Follow-up|6|||
155107674|NCT04552288|559823150|FG000|Overall Study|Physician Decision|3|||
155107675|NCT04552288|559823150|FG000|Overall Study|Protocol Violation|9|||
155107676|NCT04552288|559823150|FG000|Overall Study|Withdrawal by Subject|6|||
155107677|NCT04552288|559823150|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
155107678|NCT03089047|559823151|FG000|Overall Study|Lost to Follow-up|1|||
155107679|NCT03089047|559823152|FG001|Overall Study|Lost to Follow-up|0|||
155107680|NCT03599518|559823153|FG000|Overall Study|Clinical progression|0|||
155107681|NCT03599518|559823154|FG001|Overall Study|Clinical progression|0|||
155107682|NCT03599518|559823155|FG002|Overall Study|Clinical progression|0|||
155107683|NCT03599518|559823156|FG003|Overall Study|Clinical progression|0|||
155107684|NCT03599518|559823157|FG004|Overall Study|Clinical progression|1|||
155107685|NCT03599518|559823153|FG000|Overall Study|Adverse Event|0|||
155107686|NCT03599518|559823154|FG001|Overall Study|Adverse Event|0|||
155107687|NCT03599518|559823155|FG002|Overall Study|Adverse Event|0|||
154862397|NCT03874234|558921785|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862398|NCT03874234|558921786|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155107688|NCT03599518|559823156|FG003|Overall Study|Adverse Event|0|||
155107689|NCT03599518|559823157|FG004|Overall Study|Adverse Event|1|||
155173800|NCT02228980|560074881|FG001|Overall Study|Adverse Event|0|||
155173801|NCT02228980|560074882|FG002|Overall Study|Adverse Event|0|||
154862399|NCT03874234|558921787|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154972576|NCT00715676|559323603|FG002|Overall Study|Adverse Event|21|||
155107690|NCT03599518|559823153|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
155107691|NCT03599518|559823154|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
155107692|NCT03599518|559823155|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
155173802|NCT02228980|560074883|FG003|Overall Study|Adverse Event|0|||
155173803|NCT02228980|560074880|FG000|Overall Study|Protocol Violation|7|||
155173804|NCT02228980|560074881|FG001|Overall Study|Protocol Violation|0|||
155173805|NCT02228980|560074882|FG002|Overall Study|Protocol Violation|0|||
155173806|NCT02228980|560074883|FG003|Overall Study|Protocol Violation|0|||
155173807|NCT02228980|560074880|FG000|Overall Study|Withdrawal by Subject|3|||
155173808|NCT02228980|560074881|FG001|Overall Study|Withdrawal by Subject|3|||
155173809|NCT02228980|560074882|FG002|Overall Study|Withdrawal by Subject|2|||
155173810|NCT02228980|560074883|FG003|Overall Study|Withdrawal by Subject|3|||
155173811|NCT02929498|560074884|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
155173812|NCT02929498|560074885|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
155173813|NCT02929498|560074886|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
155173814|NCT02929498|560074884|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
155173815|NCT02929498|560074885|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
155173816|NCT02929498|560074886|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
154862400|NCT03874234|558921788|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155173817|NCT00096356|560074889|FG000|Overall Study|Adverse Event|11|||
155173818|NCT00096356|560074890|FG001|Overall Study|Adverse Event|9|||
155173819|NCT00096356|560074889|FG000|Overall Study|Physician Decision|5|||
155173820|NCT00096356|560074890|FG001|Overall Study|Physician Decision|3|||
155173821|NCT00096356|560074889|FG000|Overall Study|Withdrawal by Subject|17|||
155173822|NCT00096356|560074890|FG001|Overall Study|Withdrawal by Subject|23|||
155173823|NCT00096356|560074889|FG000|Overall Study|Lack of Efficacy|1|||
155173824|NCT00096356|560074890|FG001|Overall Study|Lack of Efficacy|0|||
155173825|NCT00096356|560074889|FG000|Overall Study|multiple reasons|10|||
155173826|NCT00096356|560074890|FG001|Overall Study|multiple reasons|18|||
155173827|NCT03288142|560074892|FG000|Overall Study|Lost to Follow-up|22|||
155173828|NCT03288142|560074893|FG001|Overall Study|Lost to Follow-up|15|||
155173829|NCT02034409|560074894|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
155173830|NCT02034409|560074895|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
155173831|NCT02034409|560074894|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
155173832|NCT02034409|560074895|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
155173833|NCT02034409|560074894|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
155173834|NCT02034409|560074895|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
155173835|NCT02034409|560074894|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
155173836|NCT02034409|560074895|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
155173837|NCT02034409|560074894|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
155173838|NCT02034409|560074895|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
155173839|NCT02034409|560074894|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
155173840|NCT02034409|560074895|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
155173841|NCT02270944|560074899|FG000|Overall Study|Lost to Follow-up|9|||
155173842|NCT02270944|560074900|FG001|Overall Study|Lost to Follow-up|4|||
155173843|NCT02270944|560074899|FG000|Overall Study|Withdrawal by Subject|2|||
155173844|NCT02270944|560074900|FG001|Overall Study|Withdrawal by Subject|1|||
155173845|NCT01699867|560074901|FG000|Overall Study|Screening Failure|3|||
155173846|NCT04002908|560074914|FG000|Overall Study|Death|41|||
155173847|NCT04002908|560074915|FG001|Overall Study|Death|0|||
155173848|NCT04002908|560074916|FG002|Overall Study|Death|0|||
155173849|NCT04002908|560074917|FG003|Overall Study|Death|0|||
155173850|NCT04002908|560074914|FG000|Overall Study|Withdrawal by Subject|112|||
155173851|NCT04002908|560074915|FG001|Overall Study|Withdrawal by Subject|0|||
155173852|NCT04002908|560074916|FG002|Overall Study|Withdrawal by Subject|0|||
155173853|NCT04002908|560074917|FG003|Overall Study|Withdrawal by Subject|0|||
155173854|NCT04002908|560074914|FG000|Overall Study|Lost to Follow-up|72|||
155173855|NCT04002908|560074915|FG001|Overall Study|Lost to Follow-up|0|||
155173856|NCT04002908|560074916|FG002|Overall Study|Lost to Follow-up|0|||
155173857|NCT04002908|560074917|FG003|Overall Study|Lost to Follow-up|0|||
155173858|NCT04002908|560074914|FG000|Overall Study|Infant died, so mother withdrawn|34|||
155173859|NCT04002908|560074915|FG001|Overall Study|Infant died, so mother withdrawn|0|||
155173860|NCT04002908|560074916|FG002|Overall Study|Infant died, so mother withdrawn|0|||
155173861|NCT04002908|560074917|FG003|Overall Study|Infant died, so mother withdrawn|0|||
155173862|NCT00530504|560074918|FG000|Overall Study|Death|54|||
154862401|NCT03874234|558921789|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862402|NCT03874234|558921790|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862403|NCT03874234|558921791|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
154862404|NCT03874234|558921792|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
155173863|NCT00530504|560074918|FG000|Overall Study|Lost to Follow-up|26|||
155173864|NCT00530504|560074918|FG000|Overall Study|Withdrawal by Subject|39|||
154862405|NCT01896232|558921798|FG000|Overall Study|Death|6|||
154862406|NCT01896232|558921799|FG001|Overall Study|Death|10|||
154862407|NCT01896232|558921798|FG000|Overall Study|Withdrawal by Subject|32|||
155173865|NCT00530504|560074918|FG000|Overall Study|Exited study due to other reasons|33|||
155173866|NCT00006289|560074919|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
155173867|NCT00006289|560074920|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
155173868|NCT00006289|560074919|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
154972577|NCT00715676|559323601|FG000|Overall Study|Withdrawal by Subject|1|||
154972578|NCT00715676|559323602|FG001|Overall Study|Withdrawal by Subject|3|||
154972579|NCT00715676|559323603|FG002|Overall Study|Withdrawal by Subject|8|||
154972580|NCT00715676|559323601|FG000|Overall Study|Lost to Follow-up|1|||
154972581|NCT00715676|559323602|FG001|Overall Study|Lost to Follow-up|2|||
154972582|NCT00715676|559323603|FG002|Overall Study|Lost to Follow-up|1|||
154972583|NCT00715676|559323601|FG000|Overall Study|Terminated by Sponsor|1|||
154972584|NCT00715676|559323602|FG001|Overall Study|Terminated by Sponsor|0|||
154972585|NCT00715676|559323603|FG002|Overall Study|Terminated by Sponsor|0|||
154972586|NCT00715676|559323601|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
154972587|NCT00715676|559323602|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
154972588|NCT00715676|559323603|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
154972589|NCT00715676|559323601|FG000|Overall Study|Use of Exclusionary Medication|0|||
154972590|NCT00715676|559323602|FG001|Overall Study|Use of Exclusionary Medication|0|||
154972591|NCT00715676|559323603|FG002|Overall Study|Use of Exclusionary Medication|1|||
154972592|NCT00715676|559323601|FG000|Overall Study|Elevated Blood Glucose|0|||
154972593|NCT00715676|559323602|FG001|Overall Study|Elevated Blood Glucose|1|||
154972594|NCT00715676|559323603|FG002|Overall Study|Elevated Blood Glucose|0|||
154972595|NCT01963260|559323604|FG000|Overall Study|Withdrawal by Subject|2|||
154972596|NCT01963260|559323605|FG001|Overall Study|Withdrawal by Subject|0|||
154972597|NCT01963260|559323606|FG002|Overall Study|Withdrawal by Subject|0|||
154972598|NCT01963260|559323607|FG003|Overall Study|Withdrawal by Subject|1|||
154972599|NCT01963260|559323608|FG004|Overall Study|Withdrawal by Subject|2|||
154972600|NCT01963260|559323609|FG005|Overall Study|Withdrawal by Subject|0|||
154972601|NCT01963260|559323610|FG006|Overall Study|Withdrawal by Subject|0|||
154972602|NCT01963260|559323611|FG007|Overall Study|Withdrawal by Subject|0|||
154972603|NCT01963260|559323612|FG008|Overall Study|Withdrawal by Subject|0|||
154972604|NCT01963260|559323613|FG009|Overall Study|Withdrawal by Subject|0|||
154972605|NCT01341405|559323614|FG000|Overall Study|Adverse Event|0|||
154972606|NCT01341405|559323615|FG001|Overall Study|Adverse Event|1|||
154972607|NCT01341405|559323616|FG002|Overall Study|Adverse Event|1|||
154972608|NCT01341405|559323614|FG000|Overall Study|Withdrawal by Subject|3|||
154972609|NCT01341405|559323615|FG001|Overall Study|Withdrawal by Subject|2|||
154972610|NCT01341405|559323616|FG002|Overall Study|Withdrawal by Subject|1|||
154972611|NCT00057941|559323617|FG000|Overall Study|Death|1|||
154972612|NCT00057941|559323618|FG001|Overall Study|Death|2|||
154972613|NCT00057941|559323617|FG000|Overall Study|Adverse Event|7|||
154972614|NCT00057941|559323618|FG001|Overall Study|Adverse Event|9|||
154972615|NCT00057941|559323617|FG000|Overall Study|Lack of Efficacy|54|||
154972616|NCT00057941|559323618|FG001|Overall Study|Lack of Efficacy|53|||
154972617|NCT00057941|559323617|FG000|Overall Study|Withdrawal by Subject|6|||
154972618|NCT00057941|559323618|FG001|Overall Study|Withdrawal by Subject|1|||
154972619|NCT00057941|559323617|FG000|Overall Study|still on treatment|3|||
154972620|NCT00057941|559323618|FG001|Overall Study|still on treatment|1|||
154972621|NCT00057941|559323617|FG000|Overall Study|insurance, symptomatic deterioration|1|||
154972622|NCT00057941|559323618|FG001|Overall Study|insurance, symptomatic deterioration|3|||
154972623|NCT00057941|559323617|FG000|Overall Study|Ineligible|2|||
154862408|NCT01896232|558921799|FG001|Overall Study|Withdrawal by Subject|31|||
154862409|NCT01896232|558921798|FG000|Overall Study|Sponsor Decision|2|||
154862410|NCT01896232|558921799|FG001|Overall Study|Sponsor Decision|0|||
154862411|NCT01896232|558921798|FG000|Overall Study|Lost to Follow-up|9|||
154862412|NCT01896232|558921799|FG001|Overall Study|Lost to Follow-up|12|||
154862413|NCT00486902|558921809|FG000|Overall Study|Withdrawal by Subject|1|||
154862414|NCT00486902|558921810|FG001|Overall Study|Withdrawal by Subject|2|||
154862415|NCT00486902|558921809|FG000|Overall Study|decision for postpartum tubal ligation|3|||
154862416|NCT00486902|558921810|FG001|Overall Study|decision for postpartum tubal ligation|1|||
154862417|NCT00486902|558921809|FG000|Overall Study|spinal anesthetic protocal violation|1|||
154862418|NCT00486902|558921810|FG001|Overall Study|spinal anesthetic protocal violation|1|||
154862419|NCT00486902|558921809|FG000|Overall Study|Did not meet inclusion criteria|1|||
154862420|NCT00486902|558921810|FG001|Overall Study|Did not meet inclusion criteria|0|||
154862421|NCT00486902|558921809|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
154862422|NCT00486902|558921810|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
154862423|NCT04178590|558921813|FG000|Overall Study|Pregnancy|1|||
154862424|NCT04178590|558921813|FG000|Overall Study|Lost to Follow-up|1|||
154862425|NCT04723537|558921814|FG000|Overall Study|Withdrawal by Subject|3|||
154862426|NCT04723537|558921815|FG001|Overall Study|Withdrawal by Subject|0|||
154862427|NCT04723537|558921816|FG002|Overall Study|Withdrawal by Subject|0|||
154862428|NCT04723537|558921814|FG000|Overall Study|Physician Decision|0|||
154862429|NCT04723537|558921815|FG001|Overall Study|Physician Decision|0|||
154862430|NCT04723537|558921816|FG002|Overall Study|Physician Decision|1|||
154972624|NCT00057941|559323618|FG001|Overall Study|Ineligible|5|||
154972625|NCT02760433|559323619|FG000|Overall Study|Lost to Follow-up|1|||
154972626|NCT02760433|559323620|FG001|Overall Study|Lost to Follow-up|0|||
154972627|NCT02760433|559323621|FG002|Overall Study|Lost to Follow-up|1|||
154972628|NCT02760433|559323622|FG003|Overall Study|Lost to Follow-up|0|||
154972629|NCT02760433|559323623|FG004|Overall Study|Lost to Follow-up|0|||
155107693|NCT03599518|559823156|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
155107694|NCT03599518|559823157|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
155107695|NCT03599518|559823153|FG000|Overall Study|Participant withdrawal from study treatment|0|||
155107696|NCT03599518|559823154|FG001|Overall Study|Participant withdrawal from study treatment|0|||
155107697|NCT03599518|559823155|FG002|Overall Study|Participant withdrawal from study treatment|1|||
155107698|NCT03599518|559823156|FG003|Overall Study|Participant withdrawal from study treatment|0|||
155107699|NCT03599518|559823157|FG004|Overall Study|Participant withdrawal from study treatment|0|||
155107700|NCT03583359|559823158|FG000|Overall Study|Withdrawal by Subject|15|||
155107701|NCT03583359|559823159|FG001|Overall Study|Withdrawal by Subject|6|||
155107702|NCT03583359|559823158|FG000|Overall Study|Lost to Follow-up|12|||
155107703|NCT03583359|559823159|FG001|Overall Study|Lost to Follow-up|3|||
155107704|NCT03583359|559823158|FG000|Overall Study|Adverse Event|0|||
155107705|NCT03583359|559823159|FG001|Overall Study|Adverse Event|1|||
155107706|NCT03583359|559823158|FG000|Overall Study|Protocol Violation|0|||
155107707|NCT03583359|559823159|FG001|Overall Study|Protocol Violation|1|||
155107708|NCT03583359|559823158|FG000|Overall Study|Other|2|||
155107709|NCT03583359|559823159|FG001|Overall Study|Other|1|||
155107710|NCT01831466|559823167|FG000|Overall Study|Protocol Violation|1|||
155107711|NCT01831466|559823168|FG001|Overall Study|Protocol Violation|1|||
155107712|NCT01831466|559823169|FG002|Overall Study|Protocol Violation|2|||
155107713|NCT01831466|559823170|FG003|Overall Study|Protocol Violation|0|||
155107714|NCT01831466|559823171|FG004|Overall Study|Protocol Violation|0|||
155107715|NCT01831466|559823172|FG005|Overall Study|Protocol Violation|1|||
155107716|NCT01831466|559823173|FG006|Overall Study|Protocol Violation|0|||
155107717|NCT01831466|559823174|FG007|Overall Study|Protocol Violation|0|||
155107718|NCT01831466|559823175|FG008|Overall Study|Protocol Violation|0|||
155107719|NCT01831466|559823176|FG009|Overall Study|Protocol Violation|0|||
155107720|NCT01831466|559823177|FG010|Overall Study|Protocol Violation|0|||
155107721|NCT01831466|559823178|FG011|Overall Study|Protocol Violation|0|||
155107722|NCT01831466|559823167|FG000|Overall Study|Other|2|||
155107723|NCT01831466|559823168|FG001|Overall Study|Other|3|||
155107724|NCT01831466|559823169|FG002|Overall Study|Other|2|||
155107725|NCT01831466|559823170|FG003|Overall Study|Other|2|||
155107726|NCT01831466|559823171|FG004|Overall Study|Other|2|||
155107727|NCT01831466|559823172|FG005|Overall Study|Other|1|||
155107728|NCT01831466|559823173|FG006|Overall Study|Other|0|||
155107729|NCT01831466|559823174|FG007|Overall Study|Other|0|||
155107730|NCT01831466|559823175|FG008|Overall Study|Other|0|||
155107731|NCT01831466|559823176|FG009|Overall Study|Other|0|||
155107732|NCT01831466|559823177|FG010|Overall Study|Other|0|||
155107733|NCT01831466|559823178|FG011|Overall Study|Other|0|||
155107734|NCT01831466|559823167|FG000|Overall Study|Non-compliance with study treatment|2|||
155107735|NCT01831466|559823168|FG001|Overall Study|Non-compliance with study treatment|1|||
155107736|NCT01831466|559823169|FG002|Overall Study|Non-compliance with study treatment|1|||
155107737|NCT01831466|559823170|FG003|Overall Study|Non-compliance with study treatment|0|||
155107738|NCT01831466|559823171|FG004|Overall Study|Non-compliance with study treatment|0|||
155107739|NCT01831466|559823172|FG005|Overall Study|Non-compliance with study treatment|1|||
155173869|NCT00006289|560074920|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
155173870|NCT04359901|560074929|FG000|Overall Study|Withdrawal by Subject|0|||
155173871|NCT04359901|560074930|FG001|Overall Study|Withdrawal by Subject|1|||
155173872|NCT04359901|560074929|FG000|Overall Study|Death|6|||
155173873|NCT04359901|560074930|FG001|Overall Study|Death|2|||
155173874|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155173875|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
154862431|NCT04723537|558921814|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
154862432|NCT04723537|558921815|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
155107740|NCT01831466|559823173|FG006|Overall Study|Non-compliance with study treatment|0|||
155107741|NCT01831466|559823174|FG007|Overall Study|Non-compliance with study treatment|0|||
155107742|NCT01831466|559823175|FG008|Overall Study|Non-compliance with study treatment|0|||
155107743|NCT01831466|559823176|FG009|Overall Study|Non-compliance with study treatment|0|||
155107744|NCT01831466|559823177|FG010|Overall Study|Non-compliance with study treatment|0|||
155107745|NCT01831466|559823178|FG011|Overall Study|Non-compliance with study treatment|0|||
155107746|NCT01831466|559823167|FG000|Overall Study|Death|0|||
155107747|NCT01831466|559823168|FG001|Overall Study|Death|1|||
155107748|NCT01831466|559823169|FG002|Overall Study|Death|0|||
155107749|NCT01831466|559823170|FG003|Overall Study|Death|0|||
155107750|NCT01831466|559823171|FG004|Overall Study|Death|0|||
155107751|NCT01831466|559823172|FG005|Overall Study|Death|0|||
155107752|NCT01831466|559823173|FG006|Overall Study|Death|0|||
155107753|NCT01831466|559823174|FG007|Overall Study|Death|0|||
155107754|NCT01831466|559823175|FG008|Overall Study|Death|0|||
155107755|NCT01831466|559823176|FG009|Overall Study|Death|0|||
155107756|NCT01831466|559823177|FG010|Overall Study|Death|0|||
155107757|NCT01831466|559823178|FG011|Overall Study|Death|0|||
155107758|NCT01831466|559823167|FG000|Overall Study|Withdrawal by Subject|6|||
155107759|NCT01831466|559823168|FG001|Overall Study|Withdrawal by Subject|3|||
155107760|NCT01831466|559823169|FG002|Overall Study|Withdrawal by Subject|3|||
155107761|NCT01831466|559823170|FG003|Overall Study|Withdrawal by Subject|3|||
155107762|NCT01831466|559823171|FG004|Overall Study|Withdrawal by Subject|3|||
155107763|NCT01831466|559823172|FG005|Overall Study|Withdrawal by Subject|5|||
155107764|NCT01831466|559823173|FG006|Overall Study|Withdrawal by Subject|0|||
155107765|NCT01831466|559823174|FG007|Overall Study|Withdrawal by Subject|0|||
155107766|NCT01831466|559823175|FG008|Overall Study|Withdrawal by Subject|0|||
155107767|NCT01831466|559823176|FG009|Overall Study|Withdrawal by Subject|1|||
155107768|NCT01831466|559823177|FG010|Overall Study|Withdrawal by Subject|0|||
155107769|NCT01831466|559823178|FG011|Overall Study|Withdrawal by Subject|1|||
155107770|NCT01831466|559823167|FG000|Overall Study|Lost to Follow-up|0|||
155107771|NCT01831466|559823168|FG001|Overall Study|Lost to Follow-up|1|||
155107772|NCT01831466|559823169|FG002|Overall Study|Lost to Follow-up|4|||
155107773|NCT01831466|559823170|FG003|Overall Study|Lost to Follow-up|2|||
155107774|NCT01831466|559823171|FG004|Overall Study|Lost to Follow-up|0|||
155107775|NCT01831466|559823172|FG005|Overall Study|Lost to Follow-up|3|||
155107776|NCT01831466|559823173|FG006|Overall Study|Lost to Follow-up|0|||
155107777|NCT01831466|559823174|FG007|Overall Study|Lost to Follow-up|0|||
155107778|NCT01831466|559823175|FG008|Overall Study|Lost to Follow-up|0|||
155107779|NCT01831466|559823176|FG009|Overall Study|Lost to Follow-up|1|||
155107780|NCT01831466|559823177|FG010|Overall Study|Lost to Follow-up|0|||
155107781|NCT01831466|559823178|FG011|Overall Study|Lost to Follow-up|1|||
155107782|NCT01831466|559823167|FG000|Overall Study|Lack of Efficacy|5|||
155107783|NCT01831466|559823168|FG001|Overall Study|Lack of Efficacy|8|||
155107784|NCT01831466|559823169|FG002|Overall Study|Lack of Efficacy|7|||
155107785|NCT01831466|559823170|FG003|Overall Study|Lack of Efficacy|6|||
155107786|NCT01831466|559823171|FG004|Overall Study|Lack of Efficacy|9|||
155107787|NCT01831466|559823172|FG005|Overall Study|Lack of Efficacy|8|||
155107788|NCT01831466|559823173|FG006|Overall Study|Lack of Efficacy|1|||
155107789|NCT01831466|559823174|FG007|Overall Study|Lack of Efficacy|1|||
155107790|NCT01831466|559823175|FG008|Overall Study|Lack of Efficacy|2|||
155107791|NCT01831466|559823176|FG009|Overall Study|Lack of Efficacy|2|||
155107792|NCT01831466|559823177|FG010|Overall Study|Lack of Efficacy|2|||
155107793|NCT01831466|559823178|FG011|Overall Study|Lack of Efficacy|0|||
155107794|NCT01831466|559823167|FG000|Overall Study|Adverse Event|0|||
155107795|NCT01831466|559823168|FG001|Overall Study|Adverse Event|0|||
155107796|NCT01831466|559823169|FG002|Overall Study|Adverse Event|4|||
155107797|NCT01831466|559823170|FG003|Overall Study|Adverse Event|6|||
155107798|NCT01831466|559823171|FG004|Overall Study|Adverse Event|3|||
155107799|NCT01831466|559823172|FG005|Overall Study|Adverse Event|7|||
155107800|NCT01831466|559823173|FG006|Overall Study|Adverse Event|0|||
155107801|NCT01831466|559823174|FG007|Overall Study|Adverse Event|1|||
155107802|NCT01831466|559823175|FG008|Overall Study|Adverse Event|1|||
155107803|NCT01831466|559823176|FG009|Overall Study|Adverse Event|1|||
155107804|NCT01831466|559823177|FG010|Overall Study|Adverse Event|0|||
155107805|NCT01831466|559823178|FG011|Overall Study|Adverse Event|2|||
155107806|NCT04380753|559823186|FG000|Overall Study|Participants continuing study|4|||
155107807|NCT04380753|559823186|FG000|Overall Study|Death|2|||
155107808|NCT00809926|559823187|FG000|Overall Study|Adverse Event|18|||
155107809|NCT00809926|559823188|FG001|Overall Study|Adverse Event|10|||
155107810|NCT00809926|559823187|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155107811|NCT00809926|559823188|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
154862433|NCT04723537|558921816|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
154862434|NCT02432807|558921817|FG000|Overall Study|Adverse Event|0|||
154862435|NCT02432807|558921818|FG001|Overall Study|Adverse Event|2|||
154862436|NCT02432807|558921817|FG000|Overall Study|Lost to Follow-up|1|||
154862437|NCT02432807|558921818|FG001|Overall Study|Lost to Follow-up|0|||
154862438|NCT02432807|558921817|FG000|Overall Study|Withdrawal by Subject|1|||
154862439|NCT02432807|558921818|FG001|Overall Study|Withdrawal by Subject|1|||
154862440|NCT02432807|558921817|FG000|Overall Study|Other|1|||
154862441|NCT02432807|558921818|FG001|Overall Study|Other|1|||
154862442|NCT02210780|558921820|FG000|Overall Study|Adverse Event|0|||
154862443|NCT02210780|558921821|FG001|Overall Study|Adverse Event|5|||
154862444|NCT02210780|558921820|FG000|Overall Study|Lost to Follow-up|2|||
154862445|NCT02210780|558921821|FG001|Overall Study|Lost to Follow-up|1|||
154862446|NCT02210780|558921820|FG000|Overall Study|Withdrawal by Subject|1|||
154862447|NCT02210780|558921821|FG001|Overall Study|Withdrawal by Subject|1|||
154862448|NCT02210780|558921820|FG000|Overall Study|Physician Decision|1|||
154862449|NCT02210780|558921821|FG001|Overall Study|Physician Decision|0|||
154862450|NCT02210780|558921820|FG000|Overall Study|Protocol Violation|1|||
154862451|NCT02210780|558921821|FG001|Overall Study|Protocol Violation|0|||
154862452|NCT02210780|558921820|FG000|Overall Study|Other than specified above|0|||
154862453|NCT02210780|558921821|FG001|Overall Study|Other than specified above|1|||
154862454|NCT00942409|558921822|FG000|Overall Study|Lack of Efficacy|1|||
154862455|NCT00942409|558921822|FG000|Overall Study|study drug unavailable|2|||
154862456|NCT01697215|558921825|FG000|Overall Study|Physician Decision|5|||
154972630|NCT02760433|559323619|FG000|Overall Study|Withdrawal by Subject|23|||
154862457|NCT01697215|558921825|FG000|Overall Study|Malfunction|9|||
154862458|NCT01697215|558921825|FG000|Overall Study|CXR not available|9|||
154862459|NCT01929083|558921826|FG000|Intervention 1|Lost to Follow-up|2|||
154862460|NCT01929083|558921827|FG001|Intervention 1|Lost to Follow-up|0|||
154972631|NCT02760433|559323620|FG001|Overall Study|Withdrawal by Subject|9|||
154972632|NCT02760433|559323621|FG002|Overall Study|Withdrawal by Subject|0|||
155107812|NCT00809926|559823187|FG000|Overall Study|Patient withdrew consent|8|||
154862461|NCT01929083|558921826|FG000|Intervention 1|Nonadherent to study medications|1|||
154972633|NCT02760433|559323622|FG003|Overall Study|Withdrawal by Subject|2|||
155107813|NCT00809926|559823188|FG001|Overall Study|Patient withdrew consent|6|||
154972634|NCT02760433|559323623|FG004|Overall Study|Withdrawal by Subject|9|||
154972635|NCT02760433|559323619|FG000|Overall Study|Lack of Response At Week 14|0|||
155173876|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155107814|NCT00809926|559823187|FG000|Overall Study|Lost to Follow-up|2|||
155107815|NCT00809926|559823188|FG001|Overall Study|Lost to Follow-up|1|||
155107816|NCT00809926|559823187|FG000|Overall Study|Administrative Problems|0|||
155107817|NCT00809926|559823188|FG001|Overall Study|Administrative Problems|1|||
155107818|NCT00809926|559823187|FG000|Overall Study|Protocol deviation|0|||
155107819|NCT00809926|559823188|FG001|Overall Study|Protocol deviation|2|||
155107820|NCT04776720|559823206|FG000|Overall Study|COVID Related|4|||
155107821|NCT04776720|559823207|FG001|Overall Study|COVID Related|2|||
155107822|NCT04776720|559823206|FG000|Overall Study|Adverse Event|2|||
155107823|NCT04776720|559823207|FG001|Overall Study|Adverse Event|0|||
155107824|NCT04776720|559823206|FG000|Overall Study|Serious Adverse Event|0|||
155107825|NCT04776720|559823207|FG001|Overall Study|Serious Adverse Event|1|||
155107826|NCT04776720|559823206|FG000|Overall Study|Too Busy|3|||
155107827|NCT04776720|559823207|FG001|Overall Study|Too Busy|1|||
155107828|NCT04776720|559823206|FG000|Overall Study|Lost to Follow-up|1|||
155107829|NCT04776720|559823207|FG001|Overall Study|Lost to Follow-up|2|||
155107830|NCT04776720|559823206|FG000|Overall Study|Family|2|||
155107831|NCT04776720|559823207|FG001|Overall Study|Family|2|||
155107832|NCT04776720|559823206|FG000|Overall Study|No remote technology access|0|||
155107833|NCT04776720|559823207|FG001|Overall Study|No remote technology access|1|||
155107834|NCT04776720|559823206|FG000|Overall Study|Withdrawal by Subject|1|||
155107835|NCT04776720|559823207|FG001|Overall Study|Withdrawal by Subject|0|||
155107836|NCT04776720|559823206|FG000|Overall Study|Cannot tolerate intervention|1|||
155107837|NCT04776720|559823207|FG001|Overall Study|Cannot tolerate intervention|0|||
155107838|NCT04776720|559823206|FG000|Overall Study|Incomplete outcome data|6|||
155107839|NCT04776720|559823207|FG001|Overall Study|Incomplete outcome data|1|||
155107840|NCT05356910|559823210|FG000|Overall Study|Lost to Follow-up|10|||
155107841|NCT05356910|559823211|FG001|Overall Study|Lost to Follow-up|19|||
155107842|NCT05356910|559823212|FG002|Overall Study|Lost to Follow-up|0|||
155107843|NCT05356910|559823213|FG003|Overall Study|Lost to Follow-up|0|||
155107844|NCT05356910|559823210|FG000|Overall Study|Withdrawal by Subject|4|||
154972636|NCT02760433|559323620|FG001|Overall Study|Lack of Response At Week 14|0|||
154972637|NCT02760433|559323621|FG002|Overall Study|Lack of Response At Week 14|0|||
154972638|NCT02760433|559323622|FG003|Overall Study|Lack of Response At Week 14|0|||
155107845|NCT05356910|559823211|FG001|Overall Study|Withdrawal by Subject|2|||
155173877|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
155107846|NCT05356910|559823212|FG002|Overall Study|Withdrawal by Subject|0|||
154972639|NCT02760433|559323623|FG004|Overall Study|Lack of Response At Week 14|1|||
155107847|NCT05356910|559823213|FG003|Overall Study|Withdrawal by Subject|0|||
155173878|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155107848|NCT03306433|559823217|FG000|Overall Study|Lost to Follow-up|3|||
155107849|NCT03306433|559823217|FG000|Overall Study|Patient did not have teeth extracted|1|||
155150936|NCT00633477|559988126|FG000|Overall Study|Randomized but not treated|1|||
155173879|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
155173880|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
155173881|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
155173882|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
155173883|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
155173884|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173885|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
155107850|NCT03306433|559823217|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
155107851|NCT00819156|559823218|FG000|Overall Study|Adverse Event|1|||
155107852|NCT00819156|559823219|FG001|Overall Study|Adverse Event|4|||
155107853|NCT00819156|559823220|FG002|Overall Study|Adverse Event|2|||
155107854|NCT00819156|559823221|FG003|Overall Study|Adverse Event|1|||
155107855|NCT00819156|559823222|FG004|Overall Study|Adverse Event|2|||
155107856|NCT00819156|559823223|FG005|Overall Study|Adverse Event|3|||
155107857|NCT00819156|559823218|FG000|Overall Study|Withdrawal by Subject|0|||
155107858|NCT00819156|559823219|FG001|Overall Study|Withdrawal by Subject|3|||
155107859|NCT00819156|559823220|FG002|Overall Study|Withdrawal by Subject|2|||
155107860|NCT00819156|559823221|FG003|Overall Study|Withdrawal by Subject|0|||
155107861|NCT00819156|559823222|FG004|Overall Study|Withdrawal by Subject|1|||
155107862|NCT00819156|559823223|FG005|Overall Study|Withdrawal by Subject|0|||
155107863|NCT00819156|559823218|FG000|Overall Study|Protocol Violation|1|||
155107864|NCT00819156|559823219|FG001|Overall Study|Protocol Violation|0|||
155107865|NCT00819156|559823220|FG002|Overall Study|Protocol Violation|1|||
155107866|NCT00819156|559823221|FG003|Overall Study|Protocol Violation|0|||
155107867|NCT00819156|559823222|FG004|Overall Study|Protocol Violation|0|||
155107868|NCT00819156|559823223|FG005|Overall Study|Protocol Violation|1|||
155107869|NCT00819156|559823218|FG000|Overall Study|Lost to Follow-up|0|||
155107870|NCT00819156|559823219|FG001|Overall Study|Lost to Follow-up|1|||
155107871|NCT00819156|559823220|FG002|Overall Study|Lost to Follow-up|0|||
155107872|NCT00819156|559823221|FG003|Overall Study|Lost to Follow-up|0|||
155107873|NCT00819156|559823222|FG004|Overall Study|Lost to Follow-up|0|||
155107874|NCT00819156|559823223|FG005|Overall Study|Lost to Follow-up|2|||
155107875|NCT00819156|559823218|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
155107876|NCT00819156|559823219|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
155107877|NCT00819156|559823220|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
155107878|NCT00819156|559823221|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
155107879|NCT00819156|559823222|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
155107880|NCT00819156|559823223|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
155107881|NCT00819156|559823218|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
155107882|NCT00819156|559823219|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155107883|NCT00819156|559823220|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155107884|NCT00819156|559823221|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155107885|NCT00819156|559823222|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
155107886|NCT00819156|559823223|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
155107887|NCT00819156|559823218|FG000|Overall Study|Prostate-specific antigen progression|0|||
155107888|NCT00819156|559823219|FG001|Overall Study|Prostate-specific antigen progression|0|||
155107889|NCT00819156|559823220|FG002|Overall Study|Prostate-specific antigen progression|0|||
155107890|NCT00819156|559823221|FG003|Overall Study|Prostate-specific antigen progression|0|||
155107891|NCT00819156|559823222|FG004|Overall Study|Prostate-specific antigen progression|1|||
155107892|NCT00819156|559823223|FG005|Overall Study|Prostate-specific antigen progression|0|||
155107893|NCT00790582|559823224|FG000|Overall Study|Death|14|||
155107894|NCT00790582|559823225|FG001|Overall Study|Death|32|||
155107895|NCT00790582|559823224|FG000|Overall Study|Physician Decision|7|||
155107896|NCT00790582|559823225|FG001|Overall Study|Physician Decision|1|||
155107897|NCT00790582|559823224|FG000|Overall Study|Lost to Follow-up|3|||
155107898|NCT00790582|559823225|FG001|Overall Study|Lost to Follow-up|3|||
155107899|NCT00790582|559823224|FG000|Overall Study|Withdrawal by Subject|7|||
155107900|NCT00790582|559823225|FG001|Overall Study|Withdrawal by Subject|51|||
155107901|NCT00803595|559823226|FG000|Overall Study|Adverse Event|3|||
155107902|NCT00803595|559823227|FG001|Overall Study|Adverse Event|4|||
155107903|NCT00803595|559823228|FG002|Overall Study|Adverse Event|1|||
155107904|NCT00803595|559823226|FG000|Overall Study|Protocol Violation|7|||
155173886|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173887|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173888|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173889|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173890|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173891|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
155173892|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
155173893|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
155173894|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
155173895|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
155173896|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
155173897|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
155173898|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
155173899|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
155173900|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
155173901|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|Other|0|||
155173902|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|Other|0|||
155173903|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|Other|1|||
155173904|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|Other|1|||
155173905|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|Other|0|||
155173906|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|Other|0|||
155173907|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|Other|0|||
155173908|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|Other|1|||
155173909|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|Other|0|||
155173910|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|Death|0|||
155173911|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|Death|0|||
155173912|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|Death|0|||
155173913|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|Death|0|||
155173914|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|Death|0|||
155173915|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|Death|1|||
155173916|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|Death|0|||
155173917|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|Death|0|||
154972640|NCT02760433|559323619|FG000|Overall Study|Subject refused to continue the study|1|||
155107905|NCT00803595|559823227|FG001|Overall Study|Protocol Violation|2|||
155107906|NCT00803595|559823228|FG002|Overall Study|Protocol Violation|12|||
155107907|NCT00803595|559823226|FG000|Overall Study|Withdrawal by Subject|5|||
155107908|NCT00803595|559823227|FG001|Overall Study|Withdrawal by Subject|2|||
155107909|NCT00803595|559823228|FG002|Overall Study|Withdrawal by Subject|3|||
155107910|NCT00703846|559823230|FG000|Overall Study|Adverse Event|8|||
155107911|NCT00703846|559823230|FG000|Overall Study|Lost to Follow-up|55|||
155107912|NCT00703846|559823230|FG000|Overall Study|Lack of Efficacy|15|||
155107913|NCT00703846|559823230|FG000|Overall Study|Noncompliance with Study Treatment|2|||
155107914|NCT00703846|559823230|FG000|Overall Study|Withdrawal by Subject|40|||
155107915|NCT00703846|559823230|FG000|Overall Study|Death|1|||
155107916|NCT00703846|559823230|FG000|Overall Study|Other|14|||
155107917|NCT00703846|559823230|FG000|Overall Study|Did Not Receive Study Drug|2|||
155107918|NCT04601532|559823231|FG000|Overall Study|Lost to Follow-up|1|||
155107919|NCT04601532|559823232|FG001|Overall Study|Lost to Follow-up|2|||
155107920|NCT04601532|559823231|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
155107921|NCT04601532|559823232|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
155107922|NCT02195700|559823233|FG000|Overall Study|Protocol Violation|0|||
155107923|NCT02195700|559823234|FG001|Overall Study|Protocol Violation|2|||
155107924|NCT02195700|559823233|FG000|Overall Study|Noncompliance|1|||
155107925|NCT02195700|559823234|FG001|Overall Study|Noncompliance|0|||
155107926|NCT02195700|559823233|FG000|Overall Study|Adverse Event|1|||
155107927|NCT02195700|559823234|FG001|Overall Study|Adverse Event|2|||
155107928|NCT02195700|559823233|FG000|Overall Study|Withdrawal by Subject|3|||
155107929|NCT02195700|559823234|FG001|Overall Study|Withdrawal by Subject|2|||
155107930|NCT02195700|559823233|FG000|Overall Study|Lost to Follow-up|1|||
155107931|NCT02195700|559823234|FG001|Overall Study|Lost to Follow-up|1|||
155107932|NCT00451958|559823235|FG000|CS21A (NCT00451958)|Adverse Event|21|||
155107933|NCT00451958|559823236|FG001|CS21A (NCT00451958)|Adverse Event|34|||
155173918|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|Death|0|||
155173919|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155173920|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155173921|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155107934|NCT00451958|559823237|FG002|CS21A (NCT00451958)|Adverse Event|14|||
155107935|NCT00451958|559823238|FG003|CS21A (NCT00451958)|Adverse Event|17|||
155107936|NCT00451958|559823239|FG004|CS21A (NCT00451958)|Adverse Event|0|||
155107937|NCT00451958|559823235|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
155107938|NCT00451958|559823236|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
154972641|NCT02760433|559323620|FG001|Overall Study|Subject refused to continue the study|0|||
154972642|NCT02760433|559323621|FG002|Overall Study|Subject refused to continue the study|0|||
154972643|NCT02760433|559323622|FG003|Overall Study|Subject refused to continue the study|0|||
154972644|NCT02760433|559323623|FG004|Overall Study|Subject refused to continue the study|0|||
154972645|NCT02760433|559323619|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
154972646|NCT02760433|559323620|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
154972647|NCT02760433|559323621|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
154972648|NCT02760433|559323622|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
154972649|NCT02760433|559323623|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
154972650|NCT02760433|559323619|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
154972651|NCT02760433|559323620|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
154972652|NCT02760433|559323621|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
154972653|NCT02760433|559323622|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
154972654|NCT02760433|559323623|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
154972655|NCT01863433|559323626|FG000|Overall Study|Protocol Violation|1|||
154972656|NCT02224053|559323627|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
154972657|NCT02224053|559323627|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
154972658|NCT02224053|559323627|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
154972659|NCT02224053|559323627|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
154972660|NCT02224053|559323627|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
154972661|NCT00360490|559323635|FG000|Overall Study|Adverse Event|4|||
154972662|NCT00360490|559323636|FG001|Overall Study|Adverse Event|2|||
154972663|NCT00360490|559323635|FG000|Overall Study|Lost to Follow-up|2|||
154972664|NCT00360490|559323636|FG001|Overall Study|Lost to Follow-up|1|||
154972665|NCT00360490|559323635|FG000|Overall Study|Physician Decision|2|||
154972666|NCT00360490|559323636|FG001|Overall Study|Physician Decision|1|||
154972667|NCT00360490|559323635|FG000|Overall Study|Protocol Violation|0|||
154972668|NCT00360490|559323636|FG001|Overall Study|Protocol Violation|4|||
154972669|NCT00360490|559323635|FG000|Overall Study|Withdrawal by Subject|1|||
154972670|NCT00360490|559323636|FG001|Overall Study|Withdrawal by Subject|3|||
155107939|NCT00451958|559823237|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
155107940|NCT00451958|559823238|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
154972671|NCT02005276|559323637|FG000|Overall Study|No longer interested|5|||
155107941|NCT00451958|559823239|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
155107942|NCT00451958|559823235|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
155107943|NCT00451958|559823236|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
155107944|NCT00451958|559823237|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
155107945|NCT00451958|559823238|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
155107946|NCT00451958|559823239|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
154972672|NCT02005276|559323638|FG001|Overall Study|No longer interested|2|||
154972673|NCT02005276|559323639|FG002|Overall Study|No longer interested|3|||
154972674|NCT02005276|559323640|FG003|Overall Study|No longer interested|3|||
154972675|NCT00265785|559323641|FG000|Overall Study|Adverse Event|4|||
154972676|NCT00265785|559323641|FG000|Overall Study|Withdrawal by Subject|3|||
154972677|NCT00265785|559323641|FG000|Overall Study|Progression/Relapse|15|||
154972678|NCT00265785|559323641|FG000|Overall Study|Not protocol specified|2|||
154972679|NCT00265785|559323641|FG000|Overall Study|Ineligible|1|||
154972680|NCT00265785|559323641|FG000|Overall Study|Did not receive protocol treatment|2|||
154972681|NCT03919695|559323642|FG000|3-month Follow-up|Death|1|||
154972682|NCT03919695|559323643|FG001|3-month Follow-up|Death|1|||
154972683|NCT03919695|559323642|FG000|3-month Follow-up|unable to contact|0|||
154972684|NCT03919695|559323643|FG001|3-month Follow-up|unable to contact|3|||
154972685|NCT03919695|559323642|FG000|3-month Follow-up|in prison|0|||
154972686|NCT03919695|559323643|FG001|3-month Follow-up|in prison|1|||
154972687|NCT03919695|559323642|FG000|6-month Follow-up|Death|0|||
154972688|NCT03919695|559323643|FG001|6-month Follow-up|Death|1|||
154972689|NCT03919695|559323642|FG000|6-month Follow-up|Lost to Follow-up|1|||
154972690|NCT03919695|559323643|FG001|6-month Follow-up|Lost to Follow-up|2|||
154972691|NCT03919695|559323642|FG000|6-month Follow-up|in prison|0|||
154972692|NCT03919695|559323643|FG001|6-month Follow-up|in prison|2|||
154972693|NCT03919695|559323642|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
154972694|NCT03919695|559323643|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
154972695|NCT03919695|559323642|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
154972696|NCT03919695|559323643|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
154972697|NCT01688882|559323644|FG000|Overall Study|Adverse Event|1|||
154972698|NCT01688882|559323645|FG001|Overall Study|Adverse Event|0|||
154972699|NCT01688882|559323644|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154972700|NCT01688882|559323645|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
154972701|NCT01688882|559323644|FG000|Overall Study|Administrative problems|1|||
154972702|NCT01688882|559323645|FG001|Overall Study|Administrative problems|0|||
154972703|NCT00124618|559323646|FG000|Overall Study|Ineligible|1|||
154972704|NCT05467540|559323647|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
154972705|NCT05467540|559323647|FG000|3-Month Follow-up|Lost to Follow-up|4|||
154972706|NCT05467540|559323647|FG000|3-Month Follow-up|Death|5|||
154972707|NCT05467540|559323647|FG000|12-Month Follow-up|Lost to Follow-up|6|||
154972708|NCT05467540|559323647|FG000|12-Month Follow-up|Death|8|||
154972709|NCT05467540|559323647|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
154972710|NCT03382041|559323650|FG000|Overall Study|Consent Form Lost|2|||
154972711|NCT03382041|559323651|FG001|Overall Study|Consent Form Lost|1|||
154972712|NCT03382041|559323650|FG000|Overall Study|Withdrawal by Subject|1|||
154972713|NCT03382041|559323651|FG001|Overall Study|Withdrawal by Subject|4|||
154972714|NCT03382041|559323650|FG000|Overall Study|Lost to Follow-up|1|||
154972715|NCT03382041|559323651|FG001|Overall Study|Lost to Follow-up|4|||
154972716|NCT03493919|559323657|FG000|Overall Study|Other|2|||
154972717|NCT03493919|559323658|FG001|Overall Study|Other|0|||
154972718|NCT03493919|559323659|FG002|Overall Study|Other|1|||
154972719|NCT03493919|559323660|FG003|Overall Study|Other|0|||
154972720|NCT03493919|559323657|FG000|Overall Study|Withdrawal by Subject|9|||
154972721|NCT03493919|559323658|FG001|Overall Study|Withdrawal by Subject|3|||
155107947|NCT00451958|559823235|FG000|CS21A (NCT00451958)|Physician Decision|2|||
155107948|NCT00451958|559823236|FG001|CS21A (NCT00451958)|Physician Decision|4|||
155107949|NCT00451958|559823237|FG002|CS21A (NCT00451958)|Physician Decision|4|||
155107950|NCT00451958|559823238|FG003|CS21A (NCT00451958)|Physician Decision|4|||
155107951|NCT00451958|559823239|FG004|CS21A (NCT00451958)|Physician Decision|0|||
155107952|NCT00451958|559823235|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
155107953|NCT00451958|559823236|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
155107954|NCT00451958|559823237|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
155107955|NCT00451958|559823238|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
155107956|NCT00451958|559823239|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
154862462|NCT01929083|558921827|FG001|Intervention 1|Nonadherent to study medications|0|||
154862463|NCT01929083|558921826|FG000|Intervention 2|Adverse Event|0|||
154862464|NCT01929083|558921827|FG001|Intervention 2|Adverse Event|1|||
154862465|NCT02599402|558921828|FG000|Overall Study|Disease progression|153|||
154862466|NCT02599402|558921828|FG000|Overall Study|Study drug toxicity|201|||
154862467|NCT02599402|558921828|FG000|Overall Study|Death|26|||
154862468|NCT02599402|558921828|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
154862469|NCT02599402|558921828|FG000|Overall Study|Participant request to discontinue study treatment|13|||
155173922|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155173923|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155173924|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
155173925|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
155173926|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155173927|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
155173928|NCT00557856|560074931|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
155173929|NCT00557856|560074932|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173930|NCT00557856|560074933|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173931|NCT00557856|560074934|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173932|NCT00557856|560074935|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173933|NCT00557856|560074936|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173934|NCT00557856|560074937|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173935|NCT00557856|560074938|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173936|NCT00557856|560074939|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
155173937|NCT00557856|560074931|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
155173938|NCT00557856|560074932|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
155107957|NCT00451958|559823235|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
155107958|NCT00451958|559823236|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
155107959|NCT00451958|559823237|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
155107960|NCT00451958|559823238|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
155107961|NCT00451958|559823239|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
155107962|NCT01027650|559823242|FG000|Overall Study|Personal Reasons|0|||
155107963|NCT01027650|559823243|FG001|Overall Study|Personal Reasons|0|||
155107964|NCT01027650|559823244|FG002|Overall Study|Personal Reasons|0|||
155107965|NCT01027650|559823245|FG003|Overall Study|Personal Reasons|0|||
155107966|NCT01027650|559823246|FG004|Overall Study|Personal Reasons|2|||
155107967|NCT01027650|559823247|FG005|Overall Study|Personal Reasons|1|||
155107968|NCT01027650|559823248|FG006|Overall Study|Personal Reasons|0|||
155107969|NCT01027650|559823249|FG007|Overall Study|Personal Reasons|0|||
155107970|NCT01027650|559823242|FG000|Overall Study|Lost to Follow-up|0|||
155107971|NCT01027650|559823243|FG001|Overall Study|Lost to Follow-up|0|||
155107972|NCT01027650|559823244|FG002|Overall Study|Lost to Follow-up|0|||
155107973|NCT01027650|559823245|FG003|Overall Study|Lost to Follow-up|0|||
155107974|NCT01027650|559823246|FG004|Overall Study|Lost to Follow-up|0|||
155107975|NCT01027650|559823247|FG005|Overall Study|Lost to Follow-up|0|||
155107976|NCT01027650|559823248|FG006|Overall Study|Lost to Follow-up|1|||
155107977|NCT01027650|559823249|FG007|Overall Study|Lost to Follow-up|0|||
155107978|NCT01027650|559823242|FG000|Overall Study|Lack of Efficacy|0|||
155107979|NCT01027650|559823243|FG001|Overall Study|Lack of Efficacy|0|||
155107980|NCT01027650|559823244|FG002|Overall Study|Lack of Efficacy|0|||
155107981|NCT01027650|559823245|FG003|Overall Study|Lack of Efficacy|0|||
155107982|NCT01027650|559823246|FG004|Overall Study|Lack of Efficacy|0|||
155107983|NCT01027650|559823247|FG005|Overall Study|Lack of Efficacy|1|||
155107984|NCT01027650|559823248|FG006|Overall Study|Lack of Efficacy|0|||
155107985|NCT01027650|559823249|FG007|Overall Study|Lack of Efficacy|0|||
155107986|NCT01082081|559823250|FG000|Overall Study|Lost to Follow-up|0|||
155107987|NCT01082081|559823251|FG001|Overall Study|Lost to Follow-up|0|||
155107988|NCT01082081|559823252|FG002|Overall Study|Lost to Follow-up|1|||
155107989|NCT01082081|559823250|FG000|Overall Study|Withdrawal by Subject|0|||
155107990|NCT01082081|559823251|FG001|Overall Study|Withdrawal by Subject|0|||
155107991|NCT01082081|559823252|FG002|Overall Study|Withdrawal by Subject|1|||
155107992|NCT01082081|559823250|FG000|Overall Study|Other Reason|0|||
155107993|NCT01082081|559823251|FG001|Overall Study|Other Reason|1|||
155107994|NCT01082081|559823252|FG002|Overall Study|Other Reason|0|||
155107995|NCT02175277|559823253|FG000|Overall Study|Protocol-specified Criteria|1|||
155107996|NCT00670930|559823254|FG000|Overall Study|Adminstrative Problem|0|||
155107997|NCT00670930|559823255|FG001|Overall Study|Adminstrative Problem|1|||
155107998|NCT00670930|559823254|FG000|Overall Study|Lost to Follow-up|1|||
155107999|NCT00670930|559823255|FG001|Overall Study|Lost to Follow-up|0|||
155108000|NCT01042158|559823256|FG000|Overall Study|Physician Decision|1|||
155108001|NCT02712983|559825117|FG000|Treatment Phase|Adverse Event|3|||
155108002|NCT02712983|559825118|FG001|Treatment Phase|Adverse Event|1|||
155108003|NCT02712983|559825119|FG002|Treatment Phase|Adverse Event|1|||
155108004|NCT02712983|559825120|FG003|Treatment Phase|Adverse Event|4|||
155108005|NCT02712983|559825121|FG004|Treatment Phase|Adverse Event|3|||
155108006|NCT02712983|559825122|FG005|Treatment Phase|Adverse Event|0|||
155108007|NCT02712983|559825123|FG006|Treatment Phase|Adverse Event|6|||
155108008|NCT02712983|559825124|FG007|Treatment Phase|Adverse Event|6|||
155108009|NCT02712983|559825125|FG008|Treatment Phase|Adverse Event|1|||
155108010|NCT02712983|559825117|FG000|Treatment Phase|Protocol Deviation|0|||
155108011|NCT02712983|559825118|FG001|Treatment Phase|Protocol Deviation|0|||
155108012|NCT02712983|559825119|FG002|Treatment Phase|Protocol Deviation|0|||
155108013|NCT02712983|559825120|FG003|Treatment Phase|Protocol Deviation|2|||
154862470|NCT02599402|558921828|FG000|Overall Study|Participant withdrew consent|5|||
154862471|NCT02599402|558921828|FG000|Overall Study|Lost to Follow-up|1|||
154862472|NCT02599402|558921828|FG000|Overall Study|Maximum Clinical Benefit|7|||
154862473|NCT02599402|558921828|FG000|Overall Study|Poor/non-compliance|1|||
154862474|NCT02599402|558921828|FG000|Overall Study|Pregnancy|1|||
154862475|NCT02599402|558921828|FG000|Overall Study|Participant no longer met study criteria|7|||
154862476|NCT02599402|558921828|FG000|Overall Study|Other Reasons|95|||
154862477|NCT02945657|558921829|FG000|Overall Study|Adverse Event|1|||
154862478|NCT02945657|558921829|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
154862479|NCT00087438|558921836|FG000|Overall Study|Ineligible / No protocol treatment|4|||
154862480|NCT01486264|558921837|FG000|Overall Study|Death|1|||
154862481|NCT01486264|558921838|FG001|Overall Study|Death|1|||
154862482|NCT01486264|558921837|FG000|Overall Study|Adverse Event|3|||
154862483|NCT01486264|558921838|FG001|Overall Study|Adverse Event|3|||
154862484|NCT01486264|558921837|FG000|Overall Study|Lack of Efficacy|6|||
154862485|NCT01486264|558921838|FG001|Overall Study|Lack of Efficacy|10|||
154862486|NCT01486264|558921837|FG000|Overall Study|Withdrawal by Subject|7|||
154862487|NCT01486264|558921838|FG001|Overall Study|Withdrawal by Subject|18|||
155108014|NCT02712983|559825121|FG004|Treatment Phase|Protocol Deviation|0|||
155108015|NCT02712983|559825122|FG005|Treatment Phase|Protocol Deviation|0|||
155108016|NCT02712983|559825123|FG006|Treatment Phase|Protocol Deviation|1|||
155108017|NCT02712983|559825124|FG007|Treatment Phase|Protocol Deviation|0|||
155108018|NCT02712983|559825125|FG008|Treatment Phase|Protocol Deviation|0|||
155108019|NCT02712983|559825117|FG000|Treatment Phase|Technical Problems|0|||
155108020|NCT02712983|559825118|FG001|Treatment Phase|Technical Problems|0|||
155108021|NCT02712983|559825119|FG002|Treatment Phase|Technical Problems|0|||
155108022|NCT02712983|559825120|FG003|Treatment Phase|Technical Problems|0|||
155108023|NCT02712983|559825121|FG004|Treatment Phase|Technical Problems|0|||
155108024|NCT02712983|559825122|FG005|Treatment Phase|Technical Problems|0|||
155108025|NCT02712983|559825123|FG006|Treatment Phase|Technical Problems|1|||
155108026|NCT02712983|559825124|FG007|Treatment Phase|Technical Problems|0|||
155108027|NCT02712983|559825125|FG008|Treatment Phase|Technical Problems|0|||
155108028|NCT02712983|559825117|FG000|Treatment Phase|Physician Decision|0|||
155108029|NCT02712983|559825118|FG001|Treatment Phase|Physician Decision|0|||
154862488|NCT01486264|558921837|FG000|Overall Study|Physician Decision|1|||
154862489|NCT01486264|558921838|FG001|Overall Study|Physician Decision|1|||
154862490|NCT01486264|558921837|FG000|Overall Study|Protocol Violation|3|||
154862491|NCT01486264|558921838|FG001|Overall Study|Protocol Violation|0|||
154862492|NCT01486264|558921837|FG000|Overall Study|Lost to Follow-up|3|||
154862493|NCT01486264|558921838|FG001|Overall Study|Lost to Follow-up|2|||
154862494|NCT01486264|558921837|FG000|Overall Study|Other|5|||
154862495|NCT01486264|558921838|FG001|Overall Study|Other|11|||
154862496|NCT01486264|558921837|FG000|Overall Study|Not treated|0|||
154862497|NCT01486264|558921838|FG001|Overall Study|Not treated|1|||
154862498|NCT00283387|558921839|FG000|First Intervention|Subject non-compliant|1|||
154862499|NCT00283387|558921840|FG001|First Intervention|Subject non-compliant|1|||
154862500|NCT00283387|558921839|FG000|First Intervention|Withdrawal by Subject|0|||
154862501|NCT00283387|558921840|FG001|First Intervention|Withdrawal by Subject|1|||
154862502|NCT05340504|558921845|FG000|Overall Study|Withdrawal by Subject|1|||
154862503|NCT05340504|558921846|FG001|Overall Study|Withdrawal by Subject|0|||
154862504|NCT03068715|558921847|FG000|Overall Study|No longer met inclusion criteria|1|||
154862505|NCT03068715|558921848|FG001|Overall Study|No longer met inclusion criteria|0|||
154862506|NCT03584009|558921849|FG000|Overall Study|Death|25|||
154862507|NCT03584009|558921850|FG001|Overall Study|Death|18|||
154862508|NCT03584009|558921849|FG000|Overall Study|Lost to Follow-up|0|||
154862509|NCT03584009|558921850|FG001|Overall Study|Lost to Follow-up|1|||
154862510|NCT03584009|558921849|FG000|Overall Study|Physician Decision|1|||
154862511|NCT03584009|558921850|FG001|Overall Study|Physician Decision|1|||
154862512|NCT03584009|558921849|FG000|Overall Study|Study Terminated by Sponsor|22|||
154862513|NCT03584009|558921850|FG001|Overall Study|Study Terminated by Sponsor|30|||
154972722|NCT03493919|559323659|FG002|Overall Study|Withdrawal by Subject|1|||
155108030|NCT02712983|559825119|FG002|Treatment Phase|Physician Decision|0|||
155108031|NCT02712983|559825120|FG003|Treatment Phase|Physician Decision|0|||
155108032|NCT02712983|559825121|FG004|Treatment Phase|Physician Decision|0|||
154862514|NCT03584009|558921849|FG000|Overall Study|Withdrawal by Subject|3|||
154862515|NCT03584009|558921850|FG001|Overall Study|Withdrawal by Subject|2|||
154972723|NCT03493919|559323660|FG003|Overall Study|Withdrawal by Subject|1|||
154972724|NCT03493919|559323657|FG000|Overall Study|Lost to Follow-up|5|||
155108033|NCT02712983|559825122|FG005|Treatment Phase|Physician Decision|0|||
155108034|NCT02712983|559825123|FG006|Treatment Phase|Physician Decision|0|||
155108035|NCT02712983|559825124|FG007|Treatment Phase|Physician Decision|1|||
155108036|NCT02712983|559825125|FG008|Treatment Phase|Physician Decision|1|||
155108037|NCT02712983|559825117|FG000|Treatment Phase|Subject Decision|2|||
155108038|NCT02712983|559825118|FG001|Treatment Phase|Subject Decision|0|||
155108039|NCT02712983|559825119|FG002|Treatment Phase|Subject Decision|0|||
155108040|NCT02712983|559825120|FG003|Treatment Phase|Subject Decision|2|||
155108041|NCT02712983|559825121|FG004|Treatment Phase|Subject Decision|1|||
155108042|NCT02712983|559825122|FG005|Treatment Phase|Subject Decision|0|||
155108043|NCT02712983|559825123|FG006|Treatment Phase|Subject Decision|1|||
155108044|NCT02712983|559825124|FG007|Treatment Phase|Subject Decision|2|||
155108045|NCT02712983|559825125|FG008|Treatment Phase|Subject Decision|0|||
155108046|NCT02712983|559825117|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155108047|NCT02712983|559825118|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
155108048|NCT02712983|559825119|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155108049|NCT02712983|559825120|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155108050|NCT02712983|559825121|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155108051|NCT02712983|559825122|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155108052|NCT02712983|559825123|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
155108053|NCT02712983|559825124|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
155108054|NCT02712983|559825125|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
155108055|NCT02712983|559825117|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108056|NCT02712983|559825118|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108057|NCT02712983|559825119|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108058|NCT02712983|559825120|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
155108059|NCT02712983|559825121|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108060|NCT02712983|559825122|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108061|NCT02712983|559825123|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108062|NCT02712983|559825124|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108063|NCT02712983|559825125|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
155108064|NCT02712983|559825117|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155108065|NCT02712983|559825118|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155108066|NCT02712983|559825119|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155108067|NCT02712983|559825120|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155108068|NCT02712983|559825121|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
155108069|NCT02712983|559825122|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
155108070|NCT02712983|559825123|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
155108071|NCT02712983|559825124|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
155108072|NCT02712983|559825125|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
155108073|NCT00064259|559825126|FG000|Overall Study|Adverse Event|1|||
155108074|NCT00064259|559825127|FG001|Overall Study|Adverse Event|0|||
155108075|NCT00064259|559825128|FG002|Overall Study|Adverse Event|0|||
155108076|NCT00064259|559825129|FG003|Overall Study|Adverse Event|1|||
155108077|NCT01132651|559825132|FG000|Overall Study|Lost to Follow-up|1|||
155108078|NCT01132651|559825133|FG001|Overall Study|Lost to Follow-up|1|||
155108079|NCT02547038|559825139|FG000|Overall Study|Lost to Follow-up|3|||
155108080|NCT02547038|559825140|FG001|Overall Study|Lost to Follow-up|2|||
155108081|NCT00516893|559825141|FG000|Overall Study|Lost to Follow-up|4|||
155108082|NCT00516893|559825141|FG000|Overall Study|Adverse Event|3|||
154862516|NCT00768560|558921851|FG000|Intervention Set 1|Adverse Event|0|||
154862517|NCT00768560|558921852|FG001|Intervention Set 1|Adverse Event|1|||
154862518|NCT00768560|558921853|FG002|Intervention Set 1|Adverse Event|0|||
154862519|NCT00768560|558921854|FG003|Intervention Set 1|Adverse Event|0|||
154862520|NCT00768560|558921855|FG004|Intervention Set 1|Adverse Event|0|||
154862521|NCT00768560|558921856|FG005|Intervention Set 1|Adverse Event|0|||
154862522|NCT00117312|558921857|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
154862523|NCT00117312|558921858|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
154862524|NCT00117312|558921859|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
154862525|NCT00117312|558921860|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
154862526|NCT00117312|558921857|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
154862527|NCT00117312|558921858|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
154862528|NCT00117312|558921859|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
154862529|NCT00117312|558921860|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
154862530|NCT00117312|558921857|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
154862531|NCT00117312|558921858|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
154862532|NCT00117312|558921859|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
154862533|NCT00117312|558921860|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
154862534|NCT00117312|558921857|FG000|Overall Study|Other|0|||
154862535|NCT00117312|558921858|FG001|Overall Study|Other|1|||
154862536|NCT00117312|558921859|FG002|Overall Study|Other|3|||
154862537|NCT00117312|558921860|FG003|Overall Study|Other|1|||
154862538|NCT00117312|558921857|FG000|Overall Study|Patient choice|0|||
154862539|NCT00117312|558921858|FG001|Overall Study|Patient choice|0|||
154862540|NCT00117312|558921859|FG002|Overall Study|Patient choice|2|||
154862541|NCT00117312|558921860|FG003|Overall Study|Patient choice|1|||
154862542|NCT00117312|558921857|FG000|Overall Study|Adverse Event|0|||
154862543|NCT00117312|558921858|FG001|Overall Study|Adverse Event|2|||
154862544|NCT00117312|558921859|FG002|Overall Study|Adverse Event|0|||
154862545|NCT00117312|558921860|FG003|Overall Study|Adverse Event|0|||
155108083|NCT00516893|559825141|FG000|Overall Study|Withdrawal by Subject|2|||
155108084|NCT00516893|559825141|FG000|Overall Study|Noncompliance|2|||
155108085|NCT00516893|559825141|FG000|Overall Study|Death|1|||
155108086|NCT00516893|559825141|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
155108087|NCT00516893|559825141|FG000|Overall Study|Relocated|1|||
155108088|NCT00516893|559825141|FG000|Overall Study|Pregnancy|1|||
155108089|NCT00516893|559825141|FG000|Overall Study|Received Medication From Another Study|1|||
155108090|NCT01340625|559825144|FG000|First Intervention|Adverse Event|1|||
155108091|NCT01340625|559825145|FG001|First Intervention|Adverse Event|0|||
155108092|NCT01340625|559825144|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
155108093|NCT01340625|559825145|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
155108094|NCT00559845|559825146|FG000|Overall Study|Withdrew Consent|1|||
155108095|NCT00559845|559825146|FG000|Overall Study|Disease Progression|1|||
155108096|NCT00559845|559825146|FG000|Overall Study|Adverse Event|3|||
155108097|NCT00559845|559825146|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
155108098|NCT00559845|559825146|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
155108099|NCT03654040|559825149|FG000|Overall Study|Death|1|||
155108100|NCT03654040|559825150|FG001|Overall Study|Death|0|||
155108101|NCT03654040|559825149|FG000|Overall Study|Withdrawal by Subject|1|||
155108102|NCT03654040|559825150|FG001|Overall Study|Withdrawal by Subject|0|||
155108103|NCT03654040|559825149|FG000|Overall Study|Study terminated by sponsor|8|||
155108104|NCT03654040|559825150|FG001|Overall Study|Study terminated by sponsor|2|||
155108105|NCT03654040|559825149|FG000|Overall Study|Failure to initiate study therapy|2|||
155108106|NCT03654040|559825150|FG001|Overall Study|Failure to initiate study therapy|0|||
155108107|NCT03654040|559825149|FG000|Overall Study|Transplanted at another center|2|||
155108108|NCT03654040|559825150|FG001|Overall Study|Transplanted at another center|0|||
155108109|NCT03654040|559825149|FG000|Overall Study|Failure to meet eligibility criteria|14|||
155108110|NCT03654040|559825150|FG001|Overall Study|Failure to meet eligibility criteria|2|||
155108111|NCT03654040|559825149|FG000|Overall Study|No longer transplant candidate|1|||
155108112|NCT03654040|559825150|FG001|Overall Study|No longer transplant candidate|0|||
155108113|NCT03654040|559825149|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
155108114|NCT03654040|559825150|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
155108115|NCT03654040|559825149|FG000|Overall Study|Recipient ineligible|0|||
155108116|NCT03654040|559825150|FG001|Overall Study|Recipient ineligible|2|||
155108117|NCT03654040|559825149|FG000|Overall Study|Received deceased liver|0|||
155108118|NCT03654040|559825150|FG001|Overall Study|Received deceased liver|1|||
155108119|NCT03645421|559825151|FG000|Overall Study|Adverse Event|0|||
155108120|NCT03645421|559825152|FG001|Overall Study|Adverse Event|0|||
155108121|NCT03645421|559825153|FG002|Overall Study|Adverse Event|4|||
155108122|NCT03645421|559825154|FG003|Overall Study|Adverse Event|1|||
155108123|NCT03645421|559825151|FG000|Overall Study|Withdrawal by patient|0|||
155108124|NCT03645421|559825152|FG001|Overall Study|Withdrawal by patient|0|||
155108125|NCT03645421|559825153|FG002|Overall Study|Withdrawal by patient|0|||
155108126|NCT03645421|559825154|FG003|Overall Study|Withdrawal by patient|3|||
155108127|NCT03645421|559825151|FG000|Overall Study|Study specific withdrawal criteria|0|||
155108128|NCT03645421|559825152|FG001|Overall Study|Study specific withdrawal criteria|0|||
155108129|NCT03645421|559825153|FG002|Overall Study|Study specific withdrawal criteria|1|||
155108130|NCT03645421|559825154|FG003|Overall Study|Study specific withdrawal criteria|0|||
155108131|NCT03850093|559825156|FG000|Overall Study|Withdrawal by Subject|1|||
155108132|NCT03850093|559825157|FG001|Overall Study|Withdrawal by Subject|0|||
155108133|NCT03850093|559825158|FG002|Overall Study|Withdrawal by Subject|2|||
155108134|NCT00224120|559825160|FG000|Overall Study|Adverse Event|10|||
155108135|NCT00224120|559825161|FG001|Overall Study|Adverse Event|4|||
155108136|NCT00224120|559825160|FG000|Overall Study|Protocol Violation|1|||
155108137|NCT00224120|559825161|FG001|Overall Study|Protocol Violation|0|||
155173939|NCT00557856|560074933|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
155173940|NCT00557856|560074934|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
155108138|NCT00224120|559825160|FG000|Overall Study|Withdrawal by Subject|5|||
155108139|NCT00224120|559825161|FG001|Overall Study|Withdrawal by Subject|10|||
155108140|NCT00224120|559825160|FG000|Overall Study|Lack of Efficacy|0|||
155108141|NCT00224120|559825161|FG001|Overall Study|Lack of Efficacy|2|||
155108142|NCT00224120|559825160|FG000|Overall Study|Lost to Follow-up|2|||
155108143|NCT00224120|559825161|FG001|Overall Study|Lost to Follow-up|3|||
155108144|NCT00224120|559825160|FG000|Overall Study|Other|4|||
155108145|NCT00224120|559825161|FG001|Overall Study|Other|5|||
155108146|NCT00104416|559825164|FG000|Double-Blind Phase|Adverse Event|2|||
155173941|NCT00557856|560074935|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
155173942|NCT00557856|560074936|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
155108147|NCT00104416|559825165|FG001|Double-Blind Phase|Adverse Event|1|||
155108148|NCT00104416|559825166|FG002|Double-Blind Phase|Adverse Event|0|||
155108149|NCT00104416|559825167|FG003|Double-Blind Phase|Adverse Event|0|||
155108150|NCT00104416|559825168|FG004|Double-Blind Phase|Adverse Event|0|||
155108151|NCT00104416|559825164|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155108152|NCT00104416|559825165|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155108153|NCT00104416|559825166|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155108154|NCT00104416|559825167|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155108155|NCT00104416|559825168|FG004|Double-Blind Phase|Lost to Follow-up|0|||
154862546|NCT00117312|558921857|FG000|Overall Study|Protocol Violation|0|||
154862547|NCT00117312|558921858|FG001|Overall Study|Protocol Violation|1|||
154862548|NCT00117312|558921859|FG002|Overall Study|Protocol Violation|3|||
154862549|NCT00117312|558921860|FG003|Overall Study|Protocol Violation|0|||
154862550|NCT00117312|558921857|FG000|Overall Study|PSA decrease <=50%|0|||
154862551|NCT00117312|558921858|FG001|Overall Study|PSA decrease <=50%|2|||
154862552|NCT00117312|558921859|FG002|Overall Study|PSA decrease <=50%|2|||
154862553|NCT00117312|558921860|FG003|Overall Study|PSA decrease <=50%|4|||
154862554|NCT00117312|558921857|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
154862555|NCT00117312|558921858|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
154862556|NCT00117312|558921859|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
154862557|NCT00117312|558921860|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
154862558|NCT00117312|558921857|FG000|Overall Study|Hepatic abnormality|0|||
154862559|NCT00117312|558921858|FG001|Overall Study|Hepatic abnormality|1|||
154862560|NCT00117312|558921859|FG002|Overall Study|Hepatic abnormality|0|||
154862561|NCT00117312|558921860|FG003|Overall Study|Hepatic abnormality|1|||
154862562|NCT00117312|558921857|FG000|Overall Study|Withdrawal by Subject|0|||
154862563|NCT00117312|558921858|FG001|Overall Study|Withdrawal by Subject|2|||
154862564|NCT00117312|558921859|FG002|Overall Study|Withdrawal by Subject|0|||
154862565|NCT00117312|558921860|FG003|Overall Study|Withdrawal by Subject|0|||
154862566|NCT01535235|558921861|FG000|Overall Study|Adverse Event|1|||
154862567|NCT01535235|558921862|FG001|Overall Study|Adverse Event|0|||
154862568|NCT00509106|558921865|FG000|Overall Study|Adverse Event|3|||
154862569|NCT00509106|558921866|FG001|Overall Study|Adverse Event|2|||
154862570|NCT00509106|558921865|FG000|Overall Study|Noncompliance|0|||
154862571|NCT00509106|558921866|FG001|Overall Study|Noncompliance|1|||
154862572|NCT00509106|558921865|FG000|Overall Study|At the request of sponsor/investigator|1|||
154862573|NCT00509106|558921866|FG001|Overall Study|At the request of sponsor/investigator|2|||
154862574|NCT00509106|558921865|FG000|Overall Study|Withdrew consent|4|||
154862575|NCT00509106|558921866|FG001|Overall Study|Withdrew consent|8|||
154862576|NCT00509106|558921865|FG000|Overall Study|Lost to Follow-up|16|||
154862577|NCT00509106|558921866|FG001|Overall Study|Lost to Follow-up|10|||
154862578|NCT00509106|558921865|FG000|Overall Study|Other|1|||
154862579|NCT00509106|558921866|FG001|Overall Study|Other|0|||
154862580|NCT00509106|558921865|FG000|Overall Study|Death|6|||
154862581|NCT00509106|558921866|FG001|Overall Study|Death|6|||
154862582|NCT01051739|558921869|FG000|Overall Study|Death|3|||
154862583|NCT01051739|558921870|FG001|Overall Study|Death|3|||
154862584|NCT01051739|558921869|FG000|Overall Study|Withdrawal by Subject|25|||
154862585|NCT01051739|558921870|FG001|Overall Study|Withdrawal by Subject|10|||
154862586|NCT03830281|558921871|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
154862587|NCT03830281|558921872|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
154862588|NCT03830281|558921871|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
154862589|NCT03830281|558921872|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
154862590|NCT03830281|558921871|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
154862591|NCT03830281|558921872|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
154862592|NCT03830281|558921871|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
154862593|NCT03830281|558921872|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
154862594|NCT03830281|558921871|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
154862595|NCT03830281|558921872|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
154862596|NCT03830281|558921871|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
154862597|NCT03830281|558921872|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
154862598|NCT03830281|558921871|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
154862599|NCT03830281|558921872|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
154862600|NCT03830281|558921871|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
154862601|NCT03830281|558921872|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
154862602|NCT03830281|558921871|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
154862603|NCT03830281|558921872|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
155108156|NCT00104416|559825164|FG000|Double-Blind Phase|Protocol Violation|0|||
155108157|NCT00104416|559825165|FG001|Double-Blind Phase|Protocol Violation|1|||
155108158|NCT00104416|559825166|FG002|Double-Blind Phase|Protocol Violation|0|||
155108159|NCT00104416|559825167|FG003|Double-Blind Phase|Protocol Violation|0|||
155108160|NCT00104416|559825168|FG004|Double-Blind Phase|Protocol Violation|0|||
155108161|NCT00104416|559825164|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
155108162|NCT00104416|559825165|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
155173943|NCT00557856|560074937|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
155173944|NCT00557856|560074938|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
155173945|NCT00557856|560074939|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
155173946|NCT00557856|560074931|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173947|NCT00557856|560074932|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173948|NCT00557856|560074933|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173949|NCT00557856|560074934|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173950|NCT00557856|560074935|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173951|NCT00557856|560074936|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173952|NCT00557856|560074937|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173953|NCT00557856|560074938|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
155173954|NCT00557856|560074939|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
155173955|NCT00557856|560074931|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
155173956|NCT00557856|560074932|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
155173957|NCT00557856|560074933|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
155173958|NCT00557856|560074934|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
155173959|NCT00557856|560074935|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
155173960|NCT00557856|560074936|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
155173961|NCT00557856|560074937|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
155173962|NCT00557856|560074938|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
155173963|NCT00557856|560074939|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
155173964|NCT00557856|560074931|FG000|Part 2: Exploratory Phase|Other|0|||
155173965|NCT00557856|560074932|FG001|Part 2: Exploratory Phase|Other|0|||
155173966|NCT00557856|560074933|FG002|Part 2: Exploratory Phase|Other|0|||
155173967|NCT00557856|560074934|FG003|Part 2: Exploratory Phase|Other|0|||
155173968|NCT00557856|560074935|FG004|Part 2: Exploratory Phase|Other|0|||
155173969|NCT00557856|560074936|FG005|Part 2: Exploratory Phase|Other|0|||
155173970|NCT00557856|560074937|FG006|Part 2: Exploratory Phase|Other|0|||
154862604|NCT00201851|558921873|FG000|Overall Study|Lost to Follow-up|2|||
154862605|NCT00201851|558921874|FG001|Overall Study|Lost to Follow-up|1|||
154862606|NCT00201851|558921875|FG002|Overall Study|Lost to Follow-up|0|||
154862607|NCT00201851|558921873|FG000|Overall Study|Ineligible post enrollment|6|||
154862608|NCT00201851|558921874|FG001|Overall Study|Ineligible post enrollment|1|||
154862609|NCT00201851|558921875|FG002|Overall Study|Ineligible post enrollment|1|||
154862610|NCT00074958|558921877|FG000|Overall Study|Adverse Event|1|||
154862611|NCT02690701|558921881|FG000|Treatment Period 1|Adverse Event|2|||
154862612|NCT02690701|558921882|FG001|Treatment Period 1|Adverse Event|2|||
154862613|NCT02690701|558921881|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154862614|NCT02690701|558921882|FG001|Treatment Period 1|Withdrawal by Subject|1|||
154862615|NCT02690701|558921881|FG000|Treatment Period 2|Adverse Event|2|||
154862616|NCT02690701|558921882|FG001|Treatment Period 2|Adverse Event|0|||
154862617|NCT02690701|558921881|FG000|Treatment Period 2|Lack of Efficacy|1|||
154862618|NCT02690701|558921882|FG001|Treatment Period 2|Lack of Efficacy|0|||
154862619|NCT02690701|558921881|FG000|Treatment Period 2|Lost to Follow-up|0|||
154862620|NCT02690701|558921882|FG001|Treatment Period 2|Lost to Follow-up|2|||
154862621|NCT02690701|558921881|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154862622|NCT02690701|558921882|FG001|Treatment Period 2|Withdrawal by Subject|2|||
154862623|NCT02690701|558921881|FG000|Treatment Period 2|Protocol Violation|0|||
154862624|NCT02690701|558921882|FG001|Treatment Period 2|Protocol Violation|1|||
154862625|NCT01856114|558921883|FG000|Overall Study|Withdrawal by Subject|1|||
154862626|NCT01856114|558921884|FG001|Overall Study|Withdrawal by Subject|0|||
154862627|NCT01856114|558921883|FG000|Overall Study|Adverse Event|1|||
154862628|NCT01856114|558921884|FG001|Overall Study|Adverse Event|0|||
154862629|NCT01642212|558921885|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
154862630|NCT01642212|558921886|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
154862631|NCT01642212|558921887|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
154862632|NCT01642212|558921888|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
154862633|NCT01642212|558921889|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
154862634|NCT01642212|558921885|FG000|Double-blind Treatment|Other|0|||
154862635|NCT01642212|558921886|FG001|Double-blind Treatment|Other|2|||
154862636|NCT01642212|558921887|FG002|Double-blind Treatment|Other|1|||
154862637|NCT01642212|558921888|FG003|Double-blind Treatment|Other|0|||
155173971|NCT00557856|560074938|FG007|Part 2: Exploratory Phase|Other|0|||
155173972|NCT00557856|560074939|FG008|Part 2: Exploratory Phase|Other|1|||
155173973|NCT00557856|560074931|FG000|Part 2: Exploratory Phase|Death|0|||
155173974|NCT00557856|560074932|FG001|Part 2: Exploratory Phase|Death|0|||
155173975|NCT00557856|560074933|FG002|Part 2: Exploratory Phase|Death|0|||
155173976|NCT00557856|560074934|FG003|Part 2: Exploratory Phase|Death|0|||
154862638|NCT01642212|558921889|FG004|Double-blind Treatment|Other|0|||
154862639|NCT01642212|558921885|FG000|Double-blind Treatment|Non-compliance|0|||
154862640|NCT01642212|558921886|FG001|Double-blind Treatment|Non-compliance|1|||
154862641|NCT01642212|558921887|FG002|Double-blind Treatment|Non-compliance|0|||
154862642|NCT01642212|558921888|FG003|Double-blind Treatment|Non-compliance|0|||
154862643|NCT01642212|558921889|FG004|Double-blind Treatment|Non-compliance|0|||
155173977|NCT00557856|560074935|FG004|Part 2: Exploratory Phase|Death|0|||
154972725|NCT03493919|559323658|FG001|Overall Study|Lost to Follow-up|0|||
155108163|NCT00104416|559825166|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155108164|NCT00104416|559825167|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155108165|NCT00104416|559825168|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155108166|NCT00104416|559825164|FG000|Double-Blind Phase|Pregnancy|1|||
155108167|NCT00104416|559825165|FG001|Double-Blind Phase|Pregnancy|0|||
155108168|NCT00104416|559825166|FG002|Double-Blind Phase|Pregnancy|0|||
155108169|NCT00104416|559825167|FG003|Double-Blind Phase|Pregnancy|0|||
155108170|NCT00104416|559825168|FG004|Double-Blind Phase|Pregnancy|0|||
155108171|NCT00104416|559825164|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
155108172|NCT00104416|559825165|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
155108173|NCT00104416|559825166|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
155108174|NCT00104416|559825167|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
155108175|NCT00104416|559825168|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
154972726|NCT03493919|559323659|FG002|Overall Study|Lost to Follow-up|0|||
154972727|NCT03493919|559323660|FG003|Overall Study|Lost to Follow-up|3|||
155108176|NCT00104416|559825164|FG000|Continuation Phase|Adverse Event|0|||
155108177|NCT00104416|559825165|FG001|Continuation Phase|Adverse Event|0|||
155108178|NCT00104416|559825166|FG002|Continuation Phase|Adverse Event|2|||
155108179|NCT00104416|559825167|FG003|Continuation Phase|Adverse Event|0|||
154862644|NCT01642212|558921885|FG000|Double-blind Treatment|Adverse Event|0|||
154862645|NCT01642212|558921886|FG001|Double-blind Treatment|Adverse Event|0|||
154862646|NCT01642212|558921887|FG002|Double-blind Treatment|Adverse Event|1|||
154862647|NCT01642212|558921888|FG003|Double-blind Treatment|Adverse Event|0|||
154862648|NCT01642212|558921889|FG004|Double-blind Treatment|Adverse Event|0|||
154862649|NCT01642212|558921885|FG000|Open-label Extension|Adverse Event|0|||
154862650|NCT01642212|558921886|FG001|Open-label Extension|Adverse Event|0|||
154862651|NCT01642212|558921887|FG002|Open-label Extension|Adverse Event|0|||
154862652|NCT01642212|558921888|FG003|Open-label Extension|Adverse Event|3|||
154862653|NCT01642212|558921889|FG004|Open-label Extension|Adverse Event|0|||
154862654|NCT01642212|558921885|FG000|Open-label Extension|Sponsor Decision|0|||
154862655|NCT01642212|558921886|FG001|Open-label Extension|Sponsor Decision|0|||
154862656|NCT01642212|558921887|FG002|Open-label Extension|Sponsor Decision|0|||
154862657|NCT01642212|558921888|FG003|Open-label Extension|Sponsor Decision|7|||
154862658|NCT01642212|558921889|FG004|Open-label Extension|Sponsor Decision|4|||
154862659|NCT01642212|558921885|FG000|Open-label Extension|Consent Withdrawn|0|||
154862660|NCT01642212|558921886|FG001|Open-label Extension|Consent Withdrawn|0|||
154862661|NCT01642212|558921887|FG002|Open-label Extension|Consent Withdrawn|0|||
154862662|NCT01642212|558921888|FG003|Open-label Extension|Consent Withdrawn|0|||
154862663|NCT01642212|558921889|FG004|Open-label Extension|Consent Withdrawn|2|||
154862664|NCT01642212|558921885|FG000|Open-label Extension|Lost to Follow-up|0|||
154862665|NCT01642212|558921886|FG001|Open-label Extension|Lost to Follow-up|0|||
154862666|NCT01642212|558921887|FG002|Open-label Extension|Lost to Follow-up|0|||
154862667|NCT01642212|558921888|FG003|Open-label Extension|Lost to Follow-up|0|||
154862668|NCT01642212|558921889|FG004|Open-label Extension|Lost to Follow-up|1|||
154862669|NCT01642212|558921885|FG000|Open-label Extension|Other|0|||
154862670|NCT01642212|558921886|FG001|Open-label Extension|Other|0|||
154862671|NCT01642212|558921887|FG002|Open-label Extension|Other|0|||
154862672|NCT01642212|558921888|FG003|Open-label Extension|Other|0|||
154862673|NCT01642212|558921889|FG004|Open-label Extension|Other|1|||
154862674|NCT03430310|558921890|FG000|Overall Study|Protocol Violation|2|||
154862675|NCT03430310|558921891|FG001|Overall Study|Protocol Violation|0|||
154862676|NCT03430310|558921890|FG000|Overall Study|Withdrawal by Subject|3|||
154862677|NCT03430310|558921891|FG001|Overall Study|Withdrawal by Subject|2|||
154862678|NCT03430310|558921890|FG000|Overall Study|COVID shutdown March 2020|0|||
154862679|NCT03430310|558921891|FG001|Overall Study|COVID shutdown March 2020|1|||
154862680|NCT01446809|558921892|FG000|Overall Study|Adverse Event|0|||
154862681|NCT01446809|558921893|FG001|Overall Study|Adverse Event|0|||
154862682|NCT01446809|558921894|FG002|Overall Study|Adverse Event|1|||
154862683|NCT01446809|558921892|FG000|Overall Study|Failure to complete study procedures|0|||
154862684|NCT01446809|558921893|FG001|Overall Study|Failure to complete study procedures|0|||
154862685|NCT01446809|558921894|FG002|Overall Study|Failure to complete study procedures|1|||
154862686|NCT01331161|558921895|FG000|Overall Study|Physician Decision|1|||
154862687|NCT01331161|558921896|FG001|Overall Study|Physician Decision|0|||
154972728|NCT03493919|559323657|FG000|Overall Study|Adverse Event|0|||
154862688|NCT01331161|558921895|FG000|Overall Study|Lost to Follow-up|0|||
154862689|NCT01331161|558921896|FG001|Overall Study|Lost to Follow-up|1|||
154972729|NCT03493919|559323658|FG001|Overall Study|Adverse Event|1|||
155108180|NCT00104416|559825168|FG004|Continuation Phase|Adverse Event|2|||
154862690|NCT01331161|558921895|FG000|Overall Study|Pregnancy|0|||
154862691|NCT01331161|558921896|FG001|Overall Study|Pregnancy|1|||
154862692|NCT04909463|558924415|FG000|Overall Study|Withdrawal by Subject|0|||
154862693|NCT04909463|558924416|FG001|Overall Study|Withdrawal by Subject|1|||
154862694|NCT04909463|558924417|FG002|Overall Study|Withdrawal by Subject|0|||
154862695|NCT04909463|558924418|FG003|Overall Study|Withdrawal by Subject|0|||
154862696|NCT04909463|558924415|FG000|Overall Study|Lost to Follow-up|2|||
154862697|NCT04909463|558924416|FG001|Overall Study|Lost to Follow-up|1|||
154862698|NCT04909463|558924417|FG002|Overall Study|Lost to Follow-up|1|||
154862699|NCT04909463|558924418|FG003|Overall Study|Lost to Follow-up|0|||
154862700|NCT01614457|558924427|FG000|Overall Study|Non-Compliance|1|||
154862701|NCT01614457|558924428|FG001|Overall Study|Non-Compliance|0|||
154862702|NCT01614457|558924427|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
154862703|NCT01614457|558924428|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
154862704|NCT03518840|558924429|FG000|Overall Study|Lost to Follow-up|6|||
154862705|NCT02468193|558924432|FG000|Overall Study|Adverse Event|4|||
154862706|NCT02468193|558924432|FG000|Overall Study|Subject/ Guardian decision|2|||
154862707|NCT00742781|558924433|FG000|Overall Study|Withdrawal by Subject|3|||
154862708|NCT01416181|558924434|FG000|Part 1|Other|10|||
154862709|NCT01416181|558924435|FG001|Part 1|Other|24|||
154862710|NCT01416181|558924434|FG000|Part 1|Death|0|||
154862711|NCT01416181|558924435|FG001|Part 1|Death|1|||
154862712|NCT01416181|558924434|FG000|Part 1|Investigator Decision|7|||
154862713|NCT01416181|558924435|FG001|Part 1|Investigator Decision|6|||
154862714|NCT01416181|558924434|FG000|Part 1|Withdrawal by Subject|74|||
154862715|NCT01416181|558924435|FG001|Part 1|Withdrawal by Subject|48|||
154862716|NCT01416181|558924434|FG000|Part 1|Lack of Efficacy|16|||
154862717|NCT01416181|558924435|FG001|Part 1|Lack of Efficacy|8|||
154862718|NCT01416181|558924434|FG000|Part 1|Lost to Follow-up|1|||
154862719|NCT01416181|558924435|FG001|Part 1|Lost to Follow-up|1|||
154862720|NCT01416181|558924434|FG000|Part 1|Adverse Event|15|||
154862721|NCT01416181|558924435|FG001|Part 1|Adverse Event|18|||
154862722|NCT01416181|558924434|FG000|Part 1|Ongoing in Follow-Up|14|||
154862723|NCT01416181|558924435|FG001|Part 1|Ongoing in Follow-Up|8|||
154862724|NCT01416181|558924434|FG000|Part 2|Adverse Event|11|||
154862725|NCT01416181|558924435|FG001|Part 2|Adverse Event|4|||
154862726|NCT01416181|558924434|FG000|Part 2|Other|234|||
154862727|NCT01416181|558924435|FG001|Part 2|Other|267|||
154862728|NCT01416181|558924434|FG000|Part 2|Investigator Decision|6|||
154862729|NCT01416181|558924435|FG001|Part 2|Investigator Decision|7|||
154862730|NCT01416181|558924434|FG000|Part 2|Withdrawal by Subject|14|||
154862731|NCT01416181|558924435|FG001|Part 2|Withdrawal by Subject|5|||
154862732|NCT01416181|558924434|FG000|Part 2|Lack of Efficacy|4|||
154862733|NCT01416181|558924435|FG001|Part 2|Lack of Efficacy|1|||
154862734|NCT01416181|558924434|FG000|Part 2|Lost to Follow-up|2|||
154862735|NCT01416181|558924435|FG001|Part 2|Lost to Follow-up|2|||
154862736|NCT03816995|558924438|FG000|Overall Study|Withdrawal by Subject|3|||
154862737|NCT03816995|558924439|FG001|Overall Study|Withdrawal by Subject|1|||
154862738|NCT03816995|558924438|FG000|Overall Study|Cancelled Surgery|8|||
154862739|NCT03816995|558924439|FG001|Overall Study|Cancelled Surgery|12|||
154862740|NCT03816995|558924438|FG000|Overall Study|No wound protector used|11|||
154862741|NCT03816995|558924439|FG001|Overall Study|No wound protector used|17|||
154862742|NCT03816995|558924438|FG000|Overall Study|Protocol Violation|2|||
154862743|NCT03816995|558924439|FG001|Overall Study|Protocol Violation|3|||
154862744|NCT00541307|558924440|FG000|Overall Study|Death|5|||
154862745|NCT00541307|558924440|FG000|Overall Study|Physician Decision|3|||
154862746|NCT00541307|558924440|FG000|Overall Study|Withdrawal by Subject|6|||
154862747|NCT00541307|558924440|FG000|Overall Study|Lost to Follow-up|4|||
154862748|NCT00541307|558924440|FG000|Overall Study|Subject returned early (outside window)|1|||
154862749|NCT00541307|558924440|FG000|Overall Study|Surgical Bypass|5|||
154862750|NCT01485614|558924447|FG000|Randomization|Not Treated|1|||
154862751|NCT01485614|558924448|FG001|Randomization|Not Treated|0|||
154862752|NCT01485614|558924449|FG002|Randomization|Not Treated|0|||
154862753|NCT01485614|558924450|FG003|Randomization|Not Treated|0|||
154862754|NCT01485614|558924447|FG000|Weeks 0-20|Lost to Follow-up|2|||
154862755|NCT01485614|558924448|FG001|Weeks 0-20|Lost to Follow-up|0|||
154862756|NCT01485614|558924449|FG002|Weeks 0-20|Lost to Follow-up|0|||
154862757|NCT01485614|558924450|FG003|Weeks 0-20|Lost to Follow-up|0|||
154862758|NCT01485614|558924447|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
154862759|NCT01485614|558924448|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
154862760|NCT01485614|558924449|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
154862761|NCT01485614|558924450|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
154862762|NCT01485614|558924447|FG000|Weeks 0-20|Withdrawal by Subject|3|||
154862763|NCT01485614|558924448|FG001|Weeks 0-20|Withdrawal by Subject|2|||
154862764|NCT01485614|558924449|FG002|Weeks 0-20|Withdrawal by Subject|1|||
154862765|NCT01485614|558924450|FG003|Weeks 0-20|Withdrawal by Subject|0|||
154862766|NCT01485614|558924447|FG000|Weeks 20-54|Lost to Follow-up|4|||
154862767|NCT01485614|558924448|FG001|Weeks 20-54|Lost to Follow-up|3|||
154862768|NCT01485614|558924449|FG002|Weeks 20-54|Lost to Follow-up|1|||
154862769|NCT01485614|558924450|FG003|Weeks 20-54|Lost to Follow-up|0|||
154862770|NCT01485614|558924447|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
154862771|NCT01485614|558924448|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
155173978|NCT00557856|560074936|FG005|Part 2: Exploratory Phase|Death|0|||
154862772|NCT01485614|558924449|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
154862773|NCT01485614|558924450|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
154862774|NCT01485614|558924447|FG000|Weeks 20-54|Withdrawal by Subject|5|||
154862775|NCT01485614|558924448|FG001|Weeks 20-54|Withdrawal by Subject|3|||
154862776|NCT01485614|558924449|FG002|Weeks 20-54|Withdrawal by Subject|0|||
154862777|NCT01485614|558924450|FG003|Weeks 20-54|Withdrawal by Subject|0|||
154862778|NCT00733902|558924451|FG000|Overall Study|Death|0|||
154862779|NCT00733902|558924452|FG001|Overall Study|Death|0|||
154862780|NCT00733902|558924453|FG002|Overall Study|Death|0|||
154862781|NCT00733902|558924454|FG003|Overall Study|Death|1|||
154862782|NCT00733902|558924451|FG000|Overall Study|Adverse Event|3|||
154862783|NCT00733902|558924452|FG001|Overall Study|Adverse Event|4|||
155108181|NCT00104416|559825164|FG000|Continuation Phase|Lost to Follow-up|0|||
155108182|NCT00104416|559825165|FG001|Continuation Phase|Lost to Follow-up|0|||
155108183|NCT00104416|559825166|FG002|Continuation Phase|Lost to Follow-up|1|||
155108184|NCT00104416|559825167|FG003|Continuation Phase|Lost to Follow-up|0|||
155108185|NCT00104416|559825168|FG004|Continuation Phase|Lost to Follow-up|1|||
155108186|NCT00104416|559825164|FG000|Continuation Phase|Withdrawal by Subject|0|||
155108187|NCT00104416|559825165|FG001|Continuation Phase|Withdrawal by Subject|0|||
155108188|NCT00104416|559825166|FG002|Continuation Phase|Withdrawal by Subject|2|||
155108189|NCT00104416|559825167|FG003|Continuation Phase|Withdrawal by Subject|1|||
155108190|NCT00104416|559825168|FG004|Continuation Phase|Withdrawal by Subject|1|||
155108191|NCT00104416|559825164|FG000|Continuation Phase|Pregnancy|0|||
155108192|NCT00104416|559825165|FG001|Continuation Phase|Pregnancy|0|||
155108193|NCT00104416|559825166|FG002|Continuation Phase|Pregnancy|1|||
155108194|NCT00104416|559825167|FG003|Continuation Phase|Pregnancy|1|||
155108195|NCT00104416|559825168|FG004|Continuation Phase|Pregnancy|0|||
155108196|NCT00104416|559825164|FG000|Continuation Phase|Non-compliance|0|||
155108197|NCT00104416|559825165|FG001|Continuation Phase|Non-compliance|0|||
155108198|NCT00104416|559825166|FG002|Continuation Phase|Non-compliance|0|||
155108199|NCT00104416|559825167|FG003|Continuation Phase|Non-compliance|0|||
155108200|NCT00104416|559825168|FG004|Continuation Phase|Non-compliance|1|||
155108201|NCT03462641|559825173|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
155108202|NCT03462641|559825174|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
155108203|NCT03462641|559825173|FG000|Visit 2|Withdrawal by Subject|0|||
155108204|NCT03462641|559825174|FG001|Visit 2|Withdrawal by Subject|1|||
155108205|NCT01804049|559825175|FG000|Overall Study|Adverse Event|2|||
155108206|NCT01804049|559825176|FG001|Overall Study|Adverse Event|10|||
155108207|NCT01804049|559825175|FG000|Overall Study|Lost to Follow-up|2|||
155108208|NCT01804049|559825176|FG001|Overall Study|Lost to Follow-up|1|||
155108209|NCT01804049|559825175|FG000|Overall Study|Decreased interest/personal|4|||
155108210|NCT01804049|559825176|FG001|Overall Study|Decreased interest/personal|5|||
155108211|NCT01804049|559825175|FG000|Overall Study|Other health concerns|2|||
155108212|NCT01804049|559825176|FG001|Overall Study|Other health concerns|7|||
155108213|NCT01804049|559825175|FG000|Overall Study|Moved out of area|0|||
155108214|NCT01804049|559825176|FG001|Overall Study|Moved out of area|7|||
155108215|NCT01804049|559825175|FG000|Overall Study|other MD recommended|1|||
155108216|NCT01804049|559825176|FG001|Overall Study|other MD recommended|1|||
155108217|NCT01804049|559825175|FG000|Overall Study|Enrollment in dual studies|0|||
155108218|NCT01804049|559825176|FG001|Overall Study|Enrollment in dual studies|1|||
155108219|NCT00070109|559825177|FG000|Overall Study|Death|1|||
155108220|NCT00070109|559825178|FG001|Overall Study|Death|1|||
155108221|NCT00070109|559825179|FG002|Overall Study|Death|0|||
155108222|NCT00070109|559825180|FG003|Overall Study|Death|0|||
155108223|NCT00070109|559825181|FG004|Overall Study|Death|1|||
155108224|NCT00070109|559825177|FG000|Overall Study|Lack of Efficacy|6|||
155108225|NCT00070109|559825178|FG001|Overall Study|Lack of Efficacy|4|||
155108226|NCT00070109|559825179|FG002|Overall Study|Lack of Efficacy|5|||
155108227|NCT00070109|559825180|FG003|Overall Study|Lack of Efficacy|15|||
155108228|NCT00070109|559825181|FG004|Overall Study|Lack of Efficacy|5|||
155108229|NCT00070109|559825177|FG000|Overall Study|Physician Decision|1|||
155108230|NCT00070109|559825178|FG001|Overall Study|Physician Decision|0|||
155108231|NCT00070109|559825179|FG002|Overall Study|Physician Decision|0|||
155108232|NCT00070109|559825180|FG003|Overall Study|Physician Decision|0|||
155108233|NCT00070109|559825181|FG004|Overall Study|Physician Decision|0|||
155108234|NCT00070109|559825177|FG000|Overall Study|Withdrawal by Subject|0|||
155108235|NCT00070109|559825178|FG001|Overall Study|Withdrawal by Subject|1|||
155108236|NCT00070109|559825179|FG002|Overall Study|Withdrawal by Subject|1|||
155108237|NCT00070109|559825180|FG003|Overall Study|Withdrawal by Subject|0|||
155173979|NCT00557856|560074937|FG006|Part 2: Exploratory Phase|Death|0|||
154862784|NCT00733902|558924453|FG002|Overall Study|Adverse Event|7|||
155108238|NCT00070109|559825181|FG004|Overall Study|Withdrawal by Subject|0|||
155108239|NCT00070109|559825177|FG000|Overall Study|Adverse Event|0|||
155108240|NCT00070109|559825178|FG001|Overall Study|Adverse Event|0|||
155108241|NCT00070109|559825179|FG002|Overall Study|Adverse Event|2|||
155108242|NCT00070109|559825180|FG003|Overall Study|Adverse Event|4|||
155108243|NCT00070109|559825181|FG004|Overall Study|Adverse Event|2|||
155108244|NCT00070109|559825177|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
154862785|NCT00733902|558924454|FG003|Overall Study|Adverse Event|11|||
154862786|NCT00733902|558924451|FG000|Overall Study|Lack of Efficacy|56|||
154862787|NCT00733902|558924452|FG001|Overall Study|Lack of Efficacy|21|||
154862788|NCT00733902|558924453|FG002|Overall Study|Lack of Efficacy|34|||
154862789|NCT00733902|558924454|FG003|Overall Study|Lack of Efficacy|23|||
154862790|NCT00733902|558924451|FG000|Overall Study|Protocol Violation|4|||
154862791|NCT00733902|558924452|FG001|Overall Study|Protocol Violation|6|||
154862792|NCT00733902|558924453|FG002|Overall Study|Protocol Violation|3|||
154862793|NCT00733902|558924454|FG003|Overall Study|Protocol Violation|3|||
154862794|NCT00733902|558924451|FG000|Overall Study|Withdrawal by Subject|10|||
154862795|NCT00733902|558924452|FG001|Overall Study|Withdrawal by Subject|5|||
154862796|NCT00733902|558924453|FG002|Overall Study|Withdrawal by Subject|4|||
154862797|NCT00733902|558924454|FG003|Overall Study|Withdrawal by Subject|16|||
154862798|NCT00733902|558924451|FG000|Overall Study|Entered extension study|89|||
154862799|NCT00733902|558924452|FG001|Overall Study|Entered extension study|124|||
154862800|NCT00733902|558924453|FG002|Overall Study|Entered extension study|111|||
154862801|NCT00733902|558924454|FG003|Overall Study|Entered extension study|109|||
154862802|NCT00733902|558924451|FG000|Overall Study|Randomized but not treated|2|||
154862803|NCT00733902|558924452|FG001|Overall Study|Randomized but not treated|2|||
154862804|NCT00733902|558924453|FG002|Overall Study|Randomized but not treated|2|||
154862805|NCT00733902|558924454|FG003|Overall Study|Randomized but not treated|1|||
154862806|NCT01503021|558924459|FG000|Overall Study|Adverse Event|7|||
154862807|NCT01503021|558924460|FG001|Overall Study|Adverse Event|6|||
154862808|NCT01503021|558924459|FG000|Overall Study|Death|0|||
154862809|NCT01503021|558924460|FG001|Overall Study|Death|2|||
154862810|NCT01503021|558924459|FG000|Overall Study|Lost to Follow-up|2|||
154862811|NCT01503021|558924460|FG001|Overall Study|Lost to Follow-up|0|||
154862812|NCT01503021|558924459|FG000|Overall Study|Physician Decision|3|||
154862813|NCT01503021|558924460|FG001|Overall Study|Physician Decision|0|||
154862814|NCT01503021|558924459|FG000|Overall Study|Protocol Violation|1|||
154862815|NCT01503021|558924460|FG001|Overall Study|Protocol Violation|3|||
154862816|NCT01503021|558924459|FG000|Overall Study|Withdrawal by Subject|9|||
154862817|NCT01503021|558924460|FG001|Overall Study|Withdrawal by Subject|8|||
154862818|NCT01503021|558924459|FG000|Overall Study|Moved, received transplant, etc.|5|||
154862819|NCT01503021|558924460|FG001|Overall Study|Moved, received transplant, etc.|7|||
154862820|NCT03941548|558924461|FG000|Overall Study|Adverse Event|0|||
154862821|NCT03941548|558924462|FG001|Overall Study|Adverse Event|1|||
154862822|NCT03941548|558924461|FG000|Overall Study|Lost to Follow-up|0|||
154862823|NCT03941548|558924462|FG001|Overall Study|Lost to Follow-up|1|||
155108245|NCT00070109|559825178|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
155108246|NCT00070109|559825179|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
155108247|NCT00070109|559825180|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
155108248|NCT00070109|559825181|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
155108249|NCT01147250|559825184|FG000|Overall Study|Lost to Follow-up|14|||
155108250|NCT01147250|559825185|FG001|Overall Study|Lost to Follow-up|11|||
155108251|NCT01147250|559825184|FG000|Overall Study|Withdrawal by Subject|83|||
155108252|NCT01147250|559825185|FG001|Overall Study|Withdrawal by Subject|88|||
155108253|NCT01147250|559825184|FG000|Overall Study|Site termination by sponsor|13|||
155108254|NCT01147250|559825185|FG001|Overall Study|Site termination by sponsor|5|||
155108255|NCT01147250|559825184|FG000|Overall Study|Other than specified|0|||
155108256|NCT01147250|559825185|FG001|Overall Study|Other than specified|1|||
155108257|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155108258|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
155108259|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155108260|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155108261|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155108262|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
155108263|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
154862824|NCT03941548|558924461|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
154862825|NCT03941548|558924462|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
155108264|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
155108265|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155173980|NCT00557856|560074938|FG007|Part 2: Exploratory Phase|Death|0|||
155173981|NCT00557856|560074939|FG008|Part 2: Exploratory Phase|Death|2|||
155173982|NCT00557856|560074931|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
154862826|NCT01242111|558924464|FG000|Overall Study|Adverse Event|1|||
154862827|NCT01242111|558924464|FG000|Overall Study|Withdrawal by Subject|1|||
154862828|NCT01242111|558924464|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
154862829|NCT00870688|558924465|FG000|Overall Study|Lost to Follow-up|2|||
154862830|NCT00870688|558924465|FG000|Overall Study|Death, Unrelated|1|||
154862831|NCT00870688|558924465|FG000|Overall Study|Granules in the Stools|1|||
154862832|NCT02015819|558924466|FG000|Overall Study|Rickham catheter was misaligned|0|||
154862833|NCT02015819|558924467|FG001|Overall Study|Rickham catheter was misaligned|0|||
154862834|NCT02015819|558924468|FG002|Overall Study|Rickham catheter was misaligned|0|||
155108266|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155108267|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155108268|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155108269|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
155108270|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
155108271|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155108272|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155108273|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155108274|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155108275|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
155108276|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
155108277|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155108278|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155108279|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155108280|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
155108281|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155108282|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
155108283|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155108284|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155108285|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155108286|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155108287|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
155108288|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
155108289|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155108290|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155108291|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155108292|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
155108293|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155108294|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
155108295|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155108296|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155108297|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155108298|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
155108299|NCT03985943|559825190|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155108300|NCT03985943|559825191|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
155108301|NCT03985943|559825192|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155108302|NCT03985943|559825193|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155108303|NCT03985943|559825194|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155108304|NCT03985943|559825195|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
155108305|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155108306|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155108307|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
155108308|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
155108309|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
155108310|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
155108311|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155108312|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155108313|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
154862835|NCT02015819|558924469|FG003|Overall Study|Rickham catheter was misaligned|1|||
154862836|NCT00728416|558924482|FG000|Overall Study|Adverse Event|1|||
154862837|NCT00728416|558924483|FG001|Overall Study|Adverse Event|1|||
155108314|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
155108315|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
155108316|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
155108317|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
155108318|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
155108319|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
155108320|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
155108321|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
155108322|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
155108323|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154862838|NCT00728416|558924482|FG000|Overall Study|Treatment Failure|0|||
155173983|NCT00557856|560074932|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173984|NCT00557856|560074933|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173985|NCT00557856|560074934|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173986|NCT00557856|560074935|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173987|NCT00557856|560074936|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173988|NCT00557856|560074937|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173989|NCT00557856|560074938|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
155173990|NCT00557856|560074939|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
155173991|NCT01379508|560074940|FG000|Treatment to Week 104|Adverse Event|2|||
155173992|NCT01379508|560074941|FG001|Treatment to Week 104|Adverse Event|0|||
155173993|NCT01379508|560074942|FG002|Treatment to Week 104|Adverse Event|5|||
155173994|NCT01379508|560074943|FG003|Treatment to Week 104|Adverse Event|0|||
155173995|NCT01379508|560074940|FG000|Treatment to Week 104|Abnormal lab value|1|||
155173996|NCT01379508|560074941|FG001|Treatment to Week 104|Abnormal lab value|0|||
155173997|NCT01379508|560074942|FG002|Treatment to Week 104|Abnormal lab value|0|||
155173998|NCT01379508|560074943|FG003|Treatment to Week 104|Abnormal lab value|0|||
155173999|NCT01379508|560074940|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
155174000|NCT01379508|560074941|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
155174001|NCT01379508|560074942|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
155174002|NCT01379508|560074943|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
155174003|NCT01379508|560074940|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
155174004|NCT01379508|560074941|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
155174005|NCT01379508|560074942|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
155174006|NCT01379508|560074943|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
155174007|NCT01379508|560074940|FG000|Treatment to Week 104|Lost to Follow-up|5|||
155174008|NCT01379508|560074941|FG001|Treatment to Week 104|Lost to Follow-up|0|||
155174009|NCT01379508|560074942|FG002|Treatment to Week 104|Lost to Follow-up|3|||
155174010|NCT01379508|560074943|FG003|Treatment to Week 104|Lost to Follow-up|0|||
155174011|NCT01379508|560074940|FG000|Treatment to Week 104|Administrative problems|3|||
155174012|NCT01379508|560074941|FG001|Treatment to Week 104|Administrative problems|1|||
155174013|NCT01379508|560074942|FG002|Treatment to Week 104|Administrative problems|0|||
155174014|NCT01379508|560074943|FG003|Treatment to Week 104|Administrative problems|0|||
155174015|NCT01379508|560074940|FG000|Treatment to Week 104|Protocol Violation|1|||
155174016|NCT01379508|560074941|FG001|Treatment to Week 104|Protocol Violation|1|||
155174017|NCT01379508|560074942|FG002|Treatment to Week 104|Protocol Violation|1|||
155174018|NCT01379508|560074943|FG003|Treatment to Week 104|Protocol Violation|0|||
155174019|NCT01379508|560074940|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
155174020|NCT01379508|560074941|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
155174021|NCT01379508|560074942|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
155174022|NCT01379508|560074943|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
155174023|NCT01379508|560074940|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
155174024|NCT01379508|560074941|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
155174025|NCT01379508|560074942|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
155174026|NCT01379508|560074943|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
155174027|NCT01379508|560074940|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
155174028|NCT01379508|560074941|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
155174029|NCT01379508|560074942|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
155174030|NCT01379508|560074943|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
155174031|NCT01379508|560074940|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
155174032|NCT01379508|560074941|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
155174033|NCT01379508|560074942|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
155174034|NCT01379508|560074943|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
155174035|NCT03865316|560076581|FG000|Overall Study|Procedure Cancelled|4|||
155174036|NCT03865316|560076581|FG000|Overall Study|Equipment failure|4|||
155174037|NCT03137069|560076586|FG000|Overall Study|Withdrawal by Subject|1|||
155174038|NCT03137069|560076587|FG001|Overall Study|Withdrawal by Subject|2|||
155174039|NCT03137069|560076588|FG002|Overall Study|Withdrawal by Subject|2|||
155174040|NCT03137069|560076589|FG003|Overall Study|Withdrawal by Subject|2|||
155174041|NCT03137069|560076590|FG004|Overall Study|Withdrawal by Subject|0|||
155174042|NCT03137069|560076591|FG005|Overall Study|Withdrawal by Subject|0|||
155174043|NCT03137069|560076586|FG000|Overall Study|Adverse Event|0|||
155174044|NCT03137069|560076587|FG001|Overall Study|Adverse Event|3|||
155174045|NCT03137069|560076588|FG002|Overall Study|Adverse Event|1|||
155174046|NCT03137069|560076589|FG003|Overall Study|Adverse Event|1|||
155174047|NCT03137069|560076590|FG004|Overall Study|Adverse Event|0|||
155174048|NCT03137069|560076591|FG005|Overall Study|Adverse Event|1|||
154862839|NCT00728416|558924483|FG001|Overall Study|Treatment Failure|1|||
154862840|NCT00728416|558924482|FG000|Overall Study|Withdrawal by Subject|1|||
154862841|NCT00728416|558924483|FG001|Overall Study|Withdrawal by Subject|0|||
154862842|NCT04112914|558924484|FG000|Overall Study|Lost to Follow-up|13|||
154862843|NCT04112914|558924485|FG001|Overall Study|Lost to Follow-up|9|||
154972730|NCT03493919|559323659|FG002|Overall Study|Adverse Event|0|||
154972731|NCT03493919|559323660|FG003|Overall Study|Adverse Event|0|||
154972732|NCT01337596|559323661|FG000|Overall Study|Withdrawal by Subject|0|||
154972733|NCT01337596|559323662|FG001|Overall Study|Withdrawal by Subject|0|||
154972734|NCT01337596|559323663|FG002|Overall Study|Withdrawal by Subject|0|||
154972735|NCT01337596|559323664|FG003|Overall Study|Withdrawal by Subject|0|||
154972736|NCT01337596|559323665|FG004|Overall Study|Withdrawal by Subject|2|||
154972737|NCT01337596|559323666|FG005|Overall Study|Withdrawal by Subject|0|||
154972738|NCT01337596|559323667|FG006|Overall Study|Withdrawal by Subject|0|||
154972739|NCT01337596|559323668|FG007|Overall Study|Withdrawal by Subject|0|||
154972740|NCT01337596|559323669|FG008|Overall Study|Withdrawal by Subject|0|||
154972741|NCT04490057|559323678|FG000|Stage 1|Death|1|||
154972742|NCT04490057|559323679|FG001|Stage 1|Death|2|||
154972743|NCT04490057|559323680|FG002|Stage 1|Death|0|||
154972744|NCT04490057|559323681|FG003|Stage 1|Death|0|||
154972745|NCT04490057|559323682|FG004|Stage 1|Death|0|||
154972746|NCT04490057|559323683|FG005|Stage 1|Death|0|||
154972747|NCT04490057|559323684|FG006|Stage 1|Death|0|||
154972748|NCT04490057|559323685|FG007|Stage 1|Death|0|||
154972749|NCT04490057|559323678|FG000|Stage 1|Withdrawal by Subject|2|||
154972750|NCT04490057|559323679|FG001|Stage 1|Withdrawal by Subject|0|||
154972751|NCT04490057|559323680|FG002|Stage 1|Withdrawal by Subject|0|||
154972752|NCT04490057|559323681|FG003|Stage 1|Withdrawal by Subject|0|||
154972753|NCT04490057|559323682|FG004|Stage 1|Withdrawal by Subject|0|||
154972754|NCT04490057|559323683|FG005|Stage 1|Withdrawal by Subject|0|||
154972755|NCT04490057|559323684|FG006|Stage 1|Withdrawal by Subject|0|||
154972756|NCT04490057|559323685|FG007|Stage 1|Withdrawal by Subject|0|||
154972757|NCT04490057|559323678|FG000|Stage 2|Death|0|||
154972758|NCT04490057|559323679|FG001|Stage 2|Death|0|||
154972759|NCT04490057|559323680|FG002|Stage 2|Death|0|||
154972760|NCT04490057|559323681|FG003|Stage 2|Death|0|||
154972761|NCT04490057|559323682|FG004|Stage 2|Death|1|||
154972762|NCT04490057|559323683|FG005|Stage 2|Death|0|||
154972763|NCT04490057|559323684|FG006|Stage 2|Death|0|||
154972764|NCT04490057|559323685|FG007|Stage 2|Death|0|||
154972765|NCT04490057|559323678|FG000|Stage 2|Lost to Follow-up|0|||
154972766|NCT04490057|559323679|FG001|Stage 2|Lost to Follow-up|0|||
154972767|NCT04490057|559323680|FG002|Stage 2|Lost to Follow-up|0|||
154972768|NCT04490057|559323681|FG003|Stage 2|Lost to Follow-up|11|||
154972769|NCT04490057|559323682|FG004|Stage 2|Lost to Follow-up|17|||
154972770|NCT04490057|559323683|FG005|Stage 2|Lost to Follow-up|4|||
154972771|NCT04490057|559323684|FG006|Stage 2|Lost to Follow-up|21|||
154972772|NCT04490057|559323685|FG007|Stage 2|Lost to Follow-up|14|||
154972773|NCT05480800|559325198|FG000|Overall Study|Withdrawal by Subject|0|||
154972774|NCT05480800|559325199|FG001|Overall Study|Withdrawal by Subject|0|||
154972775|NCT05480800|559325200|FG002|Overall Study|Withdrawal by Subject|2|||
154972776|NCT05480800|559325201|FG003|Overall Study|Withdrawal by Subject|1|||
154972777|NCT05480800|559325202|FG004|Overall Study|Withdrawal by Subject|0|||
154972778|NCT05480800|559325203|FG005|Overall Study|Withdrawal by Subject|0|||
154972779|NCT05480800|559325204|FG006|Overall Study|Withdrawal by Subject|1|||
154972780|NCT05480800|559325205|FG007|Overall Study|Withdrawal by Subject|0|||
154972781|NCT05480800|559325198|FG000|Overall Study|Other|0|||
154972782|NCT05480800|559325199|FG001|Overall Study|Other|0|||
155108324|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154972783|NCT05480800|559325200|FG002|Overall Study|Other|0|||
154972784|NCT05480800|559325201|FG003|Overall Study|Other|0|||
154972785|NCT05480800|559325202|FG004|Overall Study|Other|0|||
154972786|NCT05480800|559325203|FG005|Overall Study|Other|0|||
154972787|NCT05480800|559325204|FG006|Overall Study|Other|1|||
154972788|NCT05480800|559325205|FG007|Overall Study|Other|0|||
154972789|NCT00676650|559325210|FG000|Overall Study|Death|45|||
154972790|NCT00676650|559325211|FG001|Overall Study|Death|14|||
154972791|NCT00676650|559325210|FG000|Overall Study|Adverse Event|159|||
154972792|NCT00676650|559325211|FG001|Overall Study|Adverse Event|21|||
154972793|NCT00676650|559325210|FG000|Overall Study|Global deterioration of health status|66|||
154972794|NCT00676650|559325211|FG001|Overall Study|Global deterioration of health status|31|||
154972795|NCT00676650|559325210|FG000|Overall Study|Lost to Follow-up|0|||
154972796|NCT00676650|559325211|FG001|Overall Study|Lost to Follow-up|1|||
154972797|NCT00676650|559325210|FG000|Overall Study|Objective progression or relapse|189|||
154972798|NCT00676650|559325211|FG001|Overall Study|Objective progression or relapse|140|||
155108325|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154972799|NCT00676650|559325210|FG000|Overall Study|Other|14|||
154972800|NCT00676650|559325211|FG001|Overall Study|Other|10|||
154972801|NCT00676650|559325210|FG000|Overall Study|Protocol Violation|3|||
154972802|NCT00676650|559325211|FG001|Overall Study|Protocol Violation|1|||
154972803|NCT00676650|559325210|FG000|Overall Study|Study terminated by sponsor|57|||
154972804|NCT00676650|559325211|FG001|Overall Study|Study terminated by sponsor|43|||
154972805|NCT00676650|559325210|FG000|Overall Study|Withdrawal by Subject|48|||
154972806|NCT00676650|559325211|FG001|Overall Study|Withdrawal by Subject|24|||
154972807|NCT00676650|559325210|FG000|Overall Study|Randomized but not treated|3|||
154972808|NCT00676650|559325211|FG001|Overall Study|Randomized but not treated|4|||
154972809|NCT02297841|559325215|FG000|Overall Study|Withdrawal by Subject|1|||
155108326|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155108327|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155108328|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155108329|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155108330|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
154862844|NCT04112914|558924484|FG000|Overall Study|Withdrawal by Subject|1|||
154862845|NCT04112914|558924485|FG001|Overall Study|Withdrawal by Subject|0|||
154862846|NCT01120626|558924486|FG000|Overall Study|Withdrawal by Subject|1|||
154862847|NCT01120626|558924487|FG001|Overall Study|Withdrawal by Subject|0|||
154862848|NCT02635204|558924488|FG000|Overall Study|Adverse Event|1|||
154862849|NCT02635204|558924489|FG001|Overall Study|Adverse Event|0|||
154862850|NCT02635204|558924488|FG000|Overall Study|Lost to Follow-up|1|||
154862851|NCT02635204|558924489|FG001|Overall Study|Lost to Follow-up|1|||
154862852|NCT05421754|558924494|FG000|Overall Study|Technical issue with sensor|1|||
154862853|NCT03527043|558924495|FG000|Overall Study|Withdrawal by Subject|1|||
154862854|NCT03527043|558924496|FG001|Overall Study|Withdrawal by Subject|0|||
154862855|NCT01772134|558924502|FG000|Overall Study|Adverse Event|6|||
154862856|NCT01772134|558924503|FG001|Overall Study|Adverse Event|5|||
154862857|NCT01772134|558924504|FG002|Overall Study|Adverse Event|10|||
154862858|NCT01772134|558924502|FG000|Overall Study|Withdrew Consent|3|||
154862859|NCT01772134|558924503|FG001|Overall Study|Withdrew Consent|1|||
154862860|NCT01772134|558924504|FG002|Overall Study|Withdrew Consent|5|||
154862861|NCT01772134|558924502|FG000|Overall Study|Lost to Follow-up|2|||
154862862|NCT01772134|558924503|FG001|Overall Study|Lost to Follow-up|0|||
154862863|NCT01772134|558924504|FG002|Overall Study|Lost to Follow-up|0|||
154862864|NCT01772134|558924502|FG000|Overall Study|Protocol Deviation|4|||
154862865|NCT01772134|558924503|FG001|Overall Study|Protocol Deviation|3|||
154862866|NCT01772134|558924504|FG002|Overall Study|Protocol Deviation|3|||
154862867|NCT01772134|558924502|FG000|Overall Study|Lack of Efficacy|11|||
154862868|NCT01772134|558924503|FG001|Overall Study|Lack of Efficacy|5|||
154862869|NCT01772134|558924504|FG002|Overall Study|Lack of Efficacy|3|||
154862870|NCT01772134|558924502|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
154862871|NCT01772134|558924503|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
154862872|NCT01772134|558924504|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
154862873|NCT01772134|558924502|FG000|Overall Study|Randomized Study Medication Not Received|2|||
154862874|NCT01772134|558924503|FG001|Overall Study|Randomized Study Medication Not Received|0|||
154862875|NCT01772134|558924504|FG002|Overall Study|Randomized Study Medication Not Received|1|||
154862876|NCT00636818|558924505|FG000|Overall Study|Adverse Event|1|||
154862877|NCT00636818|558924505|FG000|Overall Study|Lost to Follow-up|2|||
154862878|NCT00636818|558924505|FG000|Overall Study|Entry Criteria Exclusion|3|||
154862879|NCT00636818|558924505|FG000|Overall Study|Protocol Violation|1|||
154862880|NCT00636818|558924505|FG000|Overall Study|Withdrawal by Subject|4|||
154862881|NCT01023789|558924508|FG000|3 - Year Visit|Death|29|||
154862882|NCT01023789|558924508|FG000|3 - Year Visit|Withdrawal of consent|1|||
154862883|NCT01023789|558924508|FG000|3 - Year Visit|Lost to Follow-up|13|||
154862884|NCT02115308|558924516|FG000|Overall Study|Safety Screening|2|||
154862885|NCT02115308|558924517|FG001|Overall Study|Safety Screening|2|||
154862886|NCT01442181|558924525|FG000|Overall Study|patient refused surgery|1|||
154862887|NCT01442181|558924526|FG001|Overall Study|patient refused surgery|0|||
154862888|NCT01442181|558924525|FG000|Overall Study|no insurance for surgery|1|||
154862889|NCT01442181|558924526|FG001|Overall Study|no insurance for surgery|0|||
154862890|NCT01442181|558924525|FG000|Overall Study|low ejection factor|0|||
154862891|NCT01442181|558924526|FG001|Overall Study|low ejection factor|1|||
154862892|NCT01442181|558924525|FG000|Overall Study|Lost to Follow-up|1|||
154862893|NCT01442181|558924526|FG001|Overall Study|Lost to Follow-up|1|||
154862894|NCT01442181|558924525|FG000|Overall Study|patient in an additional study|1|||
154862895|NCT01442181|558924526|FG001|Overall Study|patient in an additional study|0|||
154862896|NCT01442181|558924525|FG000|Overall Study|atrial fibrillation not noted|0|||
154862897|NCT01442181|558924526|FG001|Overall Study|atrial fibrillation not noted|1|||
154862898|NCT00749203|558924527|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
154862899|NCT00749203|558924528|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
154862900|NCT00749203|558924527|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
154862901|NCT00749203|558924528|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
154862902|NCT00749203|558924527|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
154862903|NCT00749203|558924528|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
154862904|NCT00749203|558924527|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
154862905|NCT00749203|558924528|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
154862906|NCT00749203|558924527|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
154862907|NCT00749203|558924528|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
154862908|NCT00749203|558924527|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
154862909|NCT00749203|558924528|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
154862910|NCT02034123|558924529|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862911|NCT02034123|558924530|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862912|NCT02034123|558924531|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862913|NCT02034123|558924532|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862914|NCT02034123|558924533|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
155108331|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
155108332|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155108333|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
155108334|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
155108335|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
155108336|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
155108337|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
155108338|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
155108339|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
155108340|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
155108341|NCT03985943|559825190|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
155108342|NCT03985943|559825191|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
155108343|NCT03985943|559825192|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
155108344|NCT03985943|559825193|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
155108345|NCT03985943|559825194|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
155108346|NCT03985943|559825195|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
155108347|NCT00716482|559825196|FG000|Overall Study|Lost to Follow-up|6|||
155108348|NCT00716482|559825196|FG000|Overall Study|Inadequate acquisition or analysis|50|||
155108349|NCT00716482|559825196|FG000|Overall Study|no pathology obtained|10|||
155108350|NCT00716482|559825196|FG000|Overall Study|technical/machine error|28|||
155108351|NCT00716482|559825196|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
155108352|NCT03248531|559825197|FG000|Overall Study|Adverse Event|0|||
155108353|NCT03248531|559825198|FG001|Overall Study|Adverse Event|0|||
155108354|NCT03248531|559825199|FG002|Overall Study|Adverse Event|1|||
155108355|NCT03248531|559825197|FG000|Overall Study|Lost to Follow-up|1|||
155108356|NCT03248531|559825198|FG001|Overall Study|Lost to Follow-up|0|||
155108357|NCT03248531|559825199|FG002|Overall Study|Lost to Follow-up|5|||
155108358|NCT03248531|559825197|FG000|Overall Study|Withdrawal by Subject|3|||
155108359|NCT03248531|559825198|FG001|Overall Study|Withdrawal by Subject|3|||
155108360|NCT03248531|559825199|FG002|Overall Study|Withdrawal by Subject|2|||
155108361|NCT03248531|559825197|FG000|Overall Study|Sponsor Request|0|||
155108362|NCT03248531|559825198|FG001|Overall Study|Sponsor Request|2|||
155108363|NCT03248531|559825199|FG002|Overall Study|Sponsor Request|0|||
155108364|NCT04075513|559825200|FG000|Overall Study|Withdrawal by Subject|2|||
155108365|NCT04075513|559825201|FG001|Overall Study|Withdrawal by Subject|2|||
155108366|NCT04075513|559825200|FG000|Overall Study|Lack of Efficacy|1|||
155108367|NCT04075513|559825201|FG001|Overall Study|Lack of Efficacy|0|||
155108368|NCT04075513|559825200|FG000|Overall Study|Lost to Follow-up|4|||
155108369|NCT04075513|559825201|FG001|Overall Study|Lost to Follow-up|2|||
155108370|NCT04075513|559825200|FG000|Overall Study|Switch to insulin pump|1|||
155108371|NCT04075513|559825201|FG001|Overall Study|Switch to insulin pump|0|||
155108372|NCT05411822|559825204|FG000|Overall Study|Withdrawal by Subject|2|||
155108373|NCT05411822|559825205|FG001|Overall Study|Withdrawal by Subject|1|||
155108374|NCT01071252|559825206|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
155108375|NCT01071252|559825207|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
155108376|NCT01071252|559825208|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
155108377|NCT01071252|559825209|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
155108378|NCT01071252|559825210|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
155108379|NCT01071252|559825206|FG000|Overall Study|Withdrawal by Subject|8|||
155108380|NCT01071252|559825207|FG001|Overall Study|Withdrawal by Subject|2|||
155108381|NCT01071252|559825208|FG002|Overall Study|Withdrawal by Subject|1|||
154862915|NCT02034123|558924534|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155108382|NCT01071252|559825209|FG003|Overall Study|Withdrawal by Subject|2|||
155108383|NCT01071252|559825210|FG004|Overall Study|Withdrawal by Subject|3|||
155108384|NCT01071252|559825206|FG000|Overall Study|administrative problems|1|||
155108385|NCT01071252|559825207|FG001|Overall Study|administrative problems|1|||
155108386|NCT01071252|559825208|FG002|Overall Study|administrative problems|0|||
155108387|NCT01071252|559825209|FG003|Overall Study|administrative problems|2|||
155108388|NCT01071252|559825210|FG004|Overall Study|administrative problems|1|||
155108389|NCT01071252|559825206|FG000|Overall Study|Lost to Follow-up|1|||
155108390|NCT01071252|559825207|FG001|Overall Study|Lost to Follow-up|0|||
155108391|NCT01071252|559825208|FG002|Overall Study|Lost to Follow-up|1|||
155174049|NCT03137069|560076586|FG000|Overall Study|Protocol Violation|0|||
154862916|NCT02034123|558924535|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155108392|NCT01071252|559825209|FG003|Overall Study|Lost to Follow-up|2|||
155108393|NCT01071252|559825210|FG004|Overall Study|Lost to Follow-up|0|||
155108394|NCT01071252|559825206|FG000|Overall Study|Adverse Event|1|||
155108395|NCT01071252|559825207|FG001|Overall Study|Adverse Event|1|||
155108396|NCT01071252|559825208|FG002|Overall Study|Adverse Event|0|||
155108397|NCT01071252|559825209|FG003|Overall Study|Adverse Event|1|||
155174050|NCT03137069|560076587|FG001|Overall Study|Protocol Violation|1|||
155174051|NCT03137069|560076588|FG002|Overall Study|Protocol Violation|0|||
154862917|NCT02034123|558924536|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
154862918|NCT02034123|558924537|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
154862919|NCT02034123|558924538|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862920|NCT02034123|558924539|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862921|NCT02034123|558924540|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862922|NCT02034123|558924541|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862923|NCT02034123|558924542|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862924|NCT02034123|558924543|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
155108398|NCT01071252|559825210|FG004|Overall Study|Adverse Event|0|||
155108399|NCT01071252|559825206|FG000|Overall Study|Death|0|||
155108400|NCT01071252|559825207|FG001|Overall Study|Death|0|||
155108401|NCT01071252|559825208|FG002|Overall Study|Death|0|||
155108402|NCT01071252|559825209|FG003|Overall Study|Death|0|||
155108403|NCT01071252|559825210|FG004|Overall Study|Death|1|||
155108404|NCT02125838|559825211|FG000|Overall Study|Lost to Follow-up|4|||
155108405|NCT02125838|559825212|FG001|Overall Study|Lost to Follow-up|4|||
155108406|NCT00787839|559825213|FG000|Overall Study|Failure to have the OGTT was most common|404|||
155108407|NCT03902392|559825214|FG000|Overall Study|Lost to Follow-up|7|||
155108408|NCT03902392|559825215|FG001|Overall Study|Lost to Follow-up|7|||
155108409|NCT00244725|559825220|FG000|Overall Study|Lost to Follow-up|3|||
155108410|NCT00244725|559825221|FG001|Overall Study|Lost to Follow-up|4|||
155108411|NCT00244725|559825222|FG002|Overall Study|Lost to Follow-up|9|||
155108412|NCT00244725|559825223|FG003|Overall Study|Lost to Follow-up|2|||
155108413|NCT00244725|559825220|FG000|Overall Study|Withdrawal by Subject|9|||
155108414|NCT00244725|559825221|FG001|Overall Study|Withdrawal by Subject|7|||
155108415|NCT00244725|559825222|FG002|Overall Study|Withdrawal by Subject|7|||
155108416|NCT00244725|559825223|FG003|Overall Study|Withdrawal by Subject|8|||
155108417|NCT00244725|559825220|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
155108418|NCT00244725|559825221|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
155108419|NCT00244725|559825222|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
155108420|NCT00244725|559825223|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
155108421|NCT00244725|559825220|FG000|Overall Study|Physician Decision|3|||
155108422|NCT00244725|559825221|FG001|Overall Study|Physician Decision|0|||
155108423|NCT00244725|559825222|FG002|Overall Study|Physician Decision|1|||
155108424|NCT00244725|559825223|FG003|Overall Study|Physician Decision|2|||
155108425|NCT00244725|559825220|FG000|Overall Study|Adverse Events|3|||
155108426|NCT00244725|559825221|FG001|Overall Study|Adverse Events|1|||
155108427|NCT00244725|559825222|FG002|Overall Study|Adverse Events|4|||
154862925|NCT02034123|558924544|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862926|NCT02034123|558924545|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862927|NCT02034123|558924546|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
154862928|NCT02034123|558924529|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862929|NCT02034123|558924530|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862930|NCT02034123|558924531|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862931|NCT02034123|558924532|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
154862932|NCT02034123|558924533|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862933|NCT02034123|558924534|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862934|NCT02034123|558924535|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862935|NCT02034123|558924536|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862936|NCT02034123|558924537|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862937|NCT02034123|558924538|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862938|NCT02034123|558924539|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862939|NCT02034123|558924540|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862940|NCT02034123|558924541|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862941|NCT02034123|558924542|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
155108428|NCT00244725|559825223|FG003|Overall Study|Adverse Events|4|||
155108429|NCT00244725|559825220|FG000|Overall Study|Withdrwal by participant|1|||
155108430|NCT00244725|559825221|FG001|Overall Study|Withdrwal by participant|0|||
155108431|NCT00244725|559825222|FG002|Overall Study|Withdrwal by participant|0|||
155108432|NCT00244725|559825223|FG003|Overall Study|Withdrwal by participant|1|||
155108433|NCT00244725|559825220|FG000|Overall Study|Liver function test abnormality|2|||
155108434|NCT00244725|559825221|FG001|Overall Study|Liver function test abnormality|0|||
154862942|NCT02034123|558924543|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154972810|NCT02297841|559325215|FG000|Overall Study|Protocol Violation|7|||
155108435|NCT00244725|559825222|FG002|Overall Study|Liver function test abnormality|0|||
155108436|NCT00244725|559825223|FG003|Overall Study|Liver function test abnormality|1|||
155108437|NCT00244725|559825220|FG000|Overall Study|Sponsor withdrew the participant|1|||
155108438|NCT00244725|559825221|FG001|Overall Study|Sponsor withdrew the participant|0|||
155108439|NCT00244725|559825222|FG002|Overall Study|Sponsor withdrew the participant|0|||
155108440|NCT00244725|559825223|FG003|Overall Study|Sponsor withdrew the participant|1|||
155108441|NCT00244725|559825220|FG000|Overall Study|Mediciation Error|0|||
155108442|NCT00244725|559825221|FG001|Overall Study|Mediciation Error|1|||
154862943|NCT02034123|558924544|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862944|NCT02034123|558924545|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862945|NCT02034123|558924546|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
154862946|NCT02034123|558924529|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862947|NCT02034123|558924530|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862948|NCT02034123|558924531|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862949|NCT02034123|558924532|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862950|NCT02034123|558924533|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862951|NCT02034123|558924534|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862952|NCT02034123|558924535|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862953|NCT02034123|558924536|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862954|NCT02034123|558924537|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
154862955|NCT02034123|558924538|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862956|NCT02034123|558924539|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862957|NCT02034123|558924540|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862958|NCT02034123|558924541|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862959|NCT02034123|558924542|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862960|NCT02034123|558924543|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154924173|NCT01015118|559146402|FG000|Overall Study|Worsening or AE of underlying disease|5|||
154924174|NCT01015118|559146403|FG001|Overall Study|Worsening or AE of underlying disease|4|||
155108443|NCT00244725|559825222|FG002|Overall Study|Mediciation Error|0|||
155108444|NCT00244725|559825223|FG003|Overall Study|Mediciation Error|0|||
155108445|NCT00244725|559825220|FG000|Overall Study|Rehab Refused to allow participantion|0|||
154924175|NCT01015118|559146402|FG000|Overall Study|Progressive disease|364|||
154924176|NCT01015118|559146403|FG001|Overall Study|Progressive disease|229|||
154924177|NCT01015118|559146402|FG000|Overall Study|Not treated|9|||
154924178|NCT01015118|559146403|FG001|Overall Study|Not treated|5|||
154924179|NCT01015118|559146402|FG000|Overall Study|Other than stated above|42|||
154924180|NCT01015118|559146403|FG001|Overall Study|Other than stated above|23|||
154924181|NCT00071006|559146406|FG000|Overall Study|Lack of Efficacy|7|||
154924182|NCT00071006|559146406|FG000|Overall Study|Adverse Event|1|||
154924183|NCT00071006|559146406|FG000|Overall Study|Withdrawal by Subject|1|||
154924184|NCT00071006|559146406|FG000|Overall Study|Other|3|||
154924185|NCT05261126|559146407|FG000|Overall Study|Death|0|||
154924186|NCT05261126|559146408|FG001|Overall Study|Death|0|||
154924187|NCT05261126|559146409|FG002|Overall Study|Death|1|||
154924188|NCT05261126|559146410|FG003|Overall Study|Death|0|||
154924189|NCT05261126|559146411|FG004|Overall Study|Death|0|||
154924190|NCT05261126|559146407|FG000|Overall Study|Lost to Follow-up|0|||
154924191|NCT05261126|559146408|FG001|Overall Study|Lost to Follow-up|0|||
154924192|NCT05261126|559146409|FG002|Overall Study|Lost to Follow-up|0|||
154924193|NCT05261126|559146410|FG003|Overall Study|Lost to Follow-up|0|||
154924194|NCT05261126|559146411|FG004|Overall Study|Lost to Follow-up|1|||
154924195|NCT05261126|559146407|FG000|Overall Study|Physician Decision|1|||
154924196|NCT05261126|559146408|FG001|Overall Study|Physician Decision|0|||
154924197|NCT05261126|559146409|FG002|Overall Study|Physician Decision|0|||
154924198|NCT05261126|559146410|FG003|Overall Study|Physician Decision|0|||
154924199|NCT05261126|559146411|FG004|Overall Study|Physician Decision|0|||
154924200|NCT05261126|559146407|FG000|Overall Study|Screen Failure|0|||
154924201|NCT05261126|559146408|FG001|Overall Study|Screen Failure|0|||
154924202|NCT05261126|559146409|FG002|Overall Study|Screen Failure|0|||
154924203|NCT05261126|559146410|FG003|Overall Study|Screen Failure|0|||
154924204|NCT05261126|559146411|FG004|Overall Study|Screen Failure|1|||
154924205|NCT05261126|559146407|FG000|Overall Study|Withdrawal by Subject|1|||
154924206|NCT05261126|559146408|FG001|Overall Study|Withdrawal by Subject|0|||
154924207|NCT05261126|559146409|FG002|Overall Study|Withdrawal by Subject|1|||
154924208|NCT05261126|559146410|FG003|Overall Study|Withdrawal by Subject|1|||
154924209|NCT05261126|559146411|FG004|Overall Study|Withdrawal by Subject|0|||
154924210|NCT05261126|559146407|FG000|Overall Study|Not Recorded|0|||
154924211|NCT05261126|559146408|FG001|Overall Study|Not Recorded|0|||
154924212|NCT05261126|559146409|FG002|Overall Study|Not Recorded|0|||
154924213|NCT05261126|559146410|FG003|Overall Study|Not Recorded|1|||
154924214|NCT05261126|559146411|FG004|Overall Study|Not Recorded|0|||
154924215|NCT05939388|559146412|FG000|Overall Study|Lost to Follow-up|1|||
154924216|NCT03901274|559146413|FG000|Overall Study|Lost to Follow-up|120|||
154924217|NCT03901274|559146414|FG001|Overall Study|Lost to Follow-up|124|||
154924218|NCT03901274|559146413|FG000|Overall Study|Withdrawal by Subject|0|||
154924219|NCT03901274|559146414|FG001|Overall Study|Withdrawal by Subject|6|||
154924220|NCT05570604|559146415|FG000|Overall Study|Lost to Follow-up|1|||
154924221|NCT05570604|559146416|FG001|Overall Study|Lost to Follow-up|5|||
154924222|NCT05570604|559146415|FG000|Overall Study|Illness|2|||
154924223|NCT05570604|559146416|FG001|Overall Study|Illness|2|||
155108446|NCT00244725|559825221|FG001|Overall Study|Rehab Refused to allow participantion|1|||
155108447|NCT00244725|559825222|FG002|Overall Study|Rehab Refused to allow participantion|0|||
155108448|NCT00244725|559825223|FG003|Overall Study|Rehab Refused to allow participantion|0|||
155108449|NCT00244725|559825220|FG000|Overall Study|Headache|0|||
155108450|NCT00244725|559825221|FG001|Overall Study|Headache|1|||
155108451|NCT00244725|559825222|FG002|Overall Study|Headache|0|||
155108452|NCT00244725|559825223|FG003|Overall Study|Headache|0|||
155108453|NCT00244725|559825220|FG000|Overall Study|Received prohibited medication|0|||
155108454|NCT00244725|559825221|FG001|Overall Study|Received prohibited medication|1|||
155108455|NCT00244725|559825222|FG002|Overall Study|Received prohibited medication|0|||
155108456|NCT00244725|559825223|FG003|Overall Study|Received prohibited medication|1|||
155108457|NCT00244725|559825220|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
155108458|NCT00244725|559825221|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
155108459|NCT00244725|559825222|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
155108460|NCT00244725|559825223|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
155108461|NCT00244725|559825220|FG000|Overall Study|Administrative reason|0|||
155108462|NCT00244725|559825221|FG001|Overall Study|Administrative reason|0|||
155108463|NCT00244725|559825222|FG002|Overall Study|Administrative reason|1|||
155108464|NCT00244725|559825223|FG003|Overall Study|Administrative reason|0|||
155108465|NCT00244725|559825220|FG000|Overall Study|Vomit|0|||
155108466|NCT00244725|559825221|FG001|Overall Study|Vomit|0|||
155108467|NCT00244725|559825222|FG002|Overall Study|Vomit|1|||
155108468|NCT00244725|559825223|FG003|Overall Study|Vomit|0|||
155108469|NCT00244725|559825220|FG000|Overall Study|Failed to follow-up|0|||
155108470|NCT00244725|559825221|FG001|Overall Study|Failed to follow-up|0|||
155108471|NCT00244725|559825222|FG002|Overall Study|Failed to follow-up|1|||
155108472|NCT00244725|559825223|FG003|Overall Study|Failed to follow-up|1|||
155108473|NCT00335738|559825224|FG000|Overall Study|Physician Decision|6|||
155108474|NCT00335738|559825225|FG001|Overall Study|Physician Decision|0|||
155108475|NCT00335738|559825224|FG000|Overall Study|Withdrawal by Subject|2|||
155108476|NCT00335738|559825225|FG001|Overall Study|Withdrawal by Subject|0|||
155108477|NCT00335738|559825224|FG000|Overall Study|Ineligible|3|||
155108478|NCT00335738|559825225|FG001|Overall Study|Ineligible|4|||
155108479|NCT01104545|559825226|FG000|Overall Study|Adverse Event|0|||
155108480|NCT01104545|559825227|FG001|Overall Study|Adverse Event|1|||
155108481|NCT01104545|559825228|FG002|Overall Study|Adverse Event|2|||
155108482|NCT04532294|559825229|FG000|Overall Study|Withdrawal by Subject|0|||
155108483|NCT04532294|559825230|FG001|Overall Study|Withdrawal by Subject|0|||
155108484|NCT04532294|559825231|FG002|Overall Study|Withdrawal by Subject|1|||
155108485|NCT04532294|559825229|FG000|Overall Study|Participants Not Dosed|0|||
155108486|NCT04532294|559825230|FG001|Overall Study|Participants Not Dosed|0|||
155108487|NCT04532294|559825231|FG002|Overall Study|Participants Not Dosed|2|||
155108488|NCT00375505|559825232|FG000|Overall Study|Adverse Event|1|||
155108489|NCT00375505|559825233|FG001|Overall Study|Adverse Event|2|||
155108490|NCT02798315|559825234|FG000|Overall Study|Failure to return|1|||
155108491|NCT00005947|559825235|FG000|Overall Study|Death|54|||
155108492|NCT00005947|559825236|FG001|Overall Study|Death|40|||
155108493|NCT00005947|559825235|FG000|Overall Study|Patient Refused to Continue|2|||
155108494|NCT00005947|559825236|FG001|Overall Study|Patient Refused to Continue|1|||
155108495|NCT00005947|559825235|FG000|Overall Study|Site Closure|1|||
155108496|NCT00005947|559825236|FG001|Overall Study|Site Closure|0|||
155108497|NCT03335150|559825239|FG000|Overall Study|Withdrawal by Subject|10|||
155108498|NCT03335150|559825240|FG001|Overall Study|Withdrawal by Subject|4|||
155108499|NCT03335150|559825239|FG000|Overall Study|Adverse Event|0|||
155108500|NCT03335150|559825240|FG001|Overall Study|Adverse Event|1|||
155108501|NCT01352221|559825241|FG000|Double-blind Phase|Adverse Event|6|||
155108502|NCT01352221|559825242|FG001|Double-blind Phase|Adverse Event|4|||
155108503|NCT01352221|559825243|FG002|Double-blind Phase|Adverse Event|0|||
155108504|NCT01352221|559825244|FG003|Double-blind Phase|Adverse Event|0|||
155108505|NCT01352221|559825241|FG000|Double-blind Phase|Withdrawal by Subject|3|||
155108506|NCT01352221|559825242|FG001|Double-blind Phase|Withdrawal by Subject|5|||
154862961|NCT02034123|558924544|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862962|NCT02034123|558924545|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
155108507|NCT01352221|559825243|FG002|Double-blind Phase|Withdrawal by Subject|0|||
155108508|NCT01352221|559825244|FG003|Double-blind Phase|Withdrawal by Subject|0|||
155108509|NCT01352221|559825241|FG000|Double-blind Phase|Lost to Follow-up|0|||
155108510|NCT01352221|559825242|FG001|Double-blind Phase|Lost to Follow-up|1|||
155108511|NCT01352221|559825243|FG002|Double-blind Phase|Lost to Follow-up|0|||
155108512|NCT01352221|559825244|FG003|Double-blind Phase|Lost to Follow-up|0|||
155108513|NCT01352221|559825241|FG000|Double-blind Phase|Protocol Violation|0|||
155108514|NCT01352221|559825242|FG001|Double-blind Phase|Protocol Violation|1|||
155108515|NCT01352221|559825243|FG002|Double-blind Phase|Protocol Violation|0|||
155108516|NCT01352221|559825244|FG003|Double-blind Phase|Protocol Violation|0|||
155108517|NCT01352221|559825241|FG000|Open-label Phase|Physician Decision|0|||
155108518|NCT01352221|559825242|FG001|Open-label Phase|Physician Decision|0|||
155108519|NCT01352221|559825243|FG002|Open-label Phase|Physician Decision|2|||
155174052|NCT03137069|560076589|FG003|Overall Study|Protocol Violation|1|||
155108520|NCT01352221|559825244|FG003|Open-label Phase|Physician Decision|1|||
155108521|NCT01352221|559825241|FG000|Open-label Phase|Pregnancy|0|||
155108522|NCT01352221|559825242|FG001|Open-label Phase|Pregnancy|0|||
155108523|NCT01352221|559825243|FG002|Open-label Phase|Pregnancy|1|||
155108524|NCT01352221|559825244|FG003|Open-label Phase|Pregnancy|0|||
155108525|NCT01352221|559825241|FG000|Open-label Phase|Adverse Event|0|||
155108526|NCT01352221|559825242|FG001|Open-label Phase|Adverse Event|0|||
155108527|NCT01352221|559825243|FG002|Open-label Phase|Adverse Event|8|||
155108528|NCT01352221|559825244|FG003|Open-label Phase|Adverse Event|4|||
155108529|NCT01352221|559825241|FG000|Open-label Phase|Withdrawal by Subject|0|||
155108530|NCT01352221|559825242|FG001|Open-label Phase|Withdrawal by Subject|0|||
155108531|NCT01352221|559825243|FG002|Open-label Phase|Withdrawal by Subject|1|||
155108532|NCT01352221|559825244|FG003|Open-label Phase|Withdrawal by Subject|6|||
155108533|NCT01352221|559825241|FG000|Open-label Phase|Worsening of IBD|0|||
155108534|NCT01352221|559825242|FG001|Open-label Phase|Worsening of IBD|0|||
155108535|NCT01352221|559825243|FG002|Open-label Phase|Worsening of IBD|1|||
155108536|NCT01352221|559825244|FG003|Open-label Phase|Worsening of IBD|0|||
155108537|NCT02566785|559825245|FG000|Overall Study|Lost to Follow-up|0|||
155108538|NCT02566785|559825246|FG001|Overall Study|Lost to Follow-up|2|||
155108539|NCT02566785|559825245|FG000|Overall Study|Worsening condition|1|||
155108540|NCT02566785|559825246|FG001|Overall Study|Worsening condition|1|||
155108541|NCT01597908|559825247|FG000|Randomized Phase|Death|217|||
155108542|NCT01597908|559825248|FG001|Randomized Phase|Death|238|||
155108543|NCT01597908|559825249|FG002|Randomized Phase|Death|0|||
155108544|NCT01597908|559825247|FG000|Randomized Phase|Sponsor Decision|93|||
155108545|NCT01597908|559825248|FG001|Randomized Phase|Sponsor Decision|39|||
155108546|NCT01597908|559825249|FG002|Randomized Phase|Sponsor Decision|0|||
155108547|NCT01597908|559825247|FG000|Randomized Phase|Lost to Follow-up|9|||
155108548|NCT01597908|559825248|FG001|Randomized Phase|Lost to Follow-up|16|||
155108549|NCT01597908|559825249|FG002|Randomized Phase|Lost to Follow-up|0|||
155108550|NCT01597908|559825247|FG000|Randomized Phase|Physician Decision|6|||
155108551|NCT01597908|559825248|FG001|Randomized Phase|Physician Decision|3|||
155108552|NCT01597908|559825249|FG002|Randomized Phase|Physician Decision|0|||
155174053|NCT03137069|560076590|FG004|Overall Study|Protocol Violation|1|||
155174054|NCT03137069|560076591|FG005|Overall Study|Protocol Violation|1|||
155174055|NCT03137069|560076586|FG000|Overall Study|Physician Decision|0|||
155174056|NCT03137069|560076587|FG001|Overall Study|Physician Decision|0|||
154862963|NCT02034123|558924546|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
154862964|NCT02034123|558924529|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862965|NCT02034123|558924530|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862966|NCT02034123|558924531|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862967|NCT02034123|558924532|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
154862968|NCT02034123|558924533|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
154862969|NCT02034123|558924534|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862970|NCT02034123|558924535|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862971|NCT02034123|558924536|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862972|NCT02034123|558924537|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862973|NCT02034123|558924538|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862974|NCT02034123|558924539|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862975|NCT02034123|558924540|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862976|NCT02034123|558924541|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862977|NCT02034123|558924542|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862978|NCT02034123|558924543|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862979|NCT02034123|558924544|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862980|NCT02034123|558924545|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862981|NCT02034123|558924546|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
154862982|NCT00246259|558924547|FG000|Overall Study|Other|3|||
154862983|NCT00246259|558924548|FG001|Overall Study|Other|3|||
154862984|NCT00246259|558924547|FG000|Overall Study|Not stable by Week 18|2|||
154862985|NCT00246259|558924548|FG001|Overall Study|Not stable by Week 18|1|||
155108553|NCT01597908|559825247|FG000|Randomized Phase|Withdrawal by Subject|26|||
155174057|NCT03137069|560076588|FG002|Overall Study|Physician Decision|0|||
155174058|NCT03137069|560076589|FG003|Overall Study|Physician Decision|1|||
155174059|NCT03137069|560076590|FG004|Overall Study|Physician Decision|0|||
154862986|NCT00246259|558924547|FG000|Overall Study|Participant non-compliant|4|||
154862987|NCT00246259|558924548|FG001|Overall Study|Participant non-compliant|9|||
154862988|NCT00246259|558924547|FG000|Overall Study|Lack of Efficacy|2|||
154862989|NCT00246259|558924548|FG001|Overall Study|Lack of Efficacy|2|||
155108554|NCT01597908|559825248|FG001|Randomized Phase|Withdrawal by Subject|22|||
155108555|NCT01597908|559825249|FG002|Randomized Phase|Withdrawal by Subject|0|||
155108556|NCT01597908|559825247|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
155108557|NCT01597908|559825248|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
155108558|NCT01597908|559825249|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
154862990|NCT00246259|558924547|FG000|Overall Study|Investigator withdrew participant|2|||
154862991|NCT00246259|558924548|FG001|Overall Study|Investigator withdrew participant|0|||
154862992|NCT00246259|558924547|FG000|Overall Study|Adverse Event|5|||
154862993|NCT00246259|558924548|FG001|Overall Study|Adverse Event|0|||
154862994|NCT00246259|558924547|FG000|Overall Study|Lost to Follow-up|3|||
154862995|NCT00246259|558924548|FG001|Overall Study|Lost to Follow-up|4|||
155108559|NCT01597908|559825247|FG000|Crossover Phase|Death|0|||
155108560|NCT01597908|559825248|FG001|Crossover Phase|Death|0|||
155108561|NCT01597908|559825249|FG002|Crossover Phase|Death|11|||
155108562|NCT01597908|559825247|FG000|Crossover Phase|Withdrawal by Subject|0|||
155108563|NCT01597908|559825248|FG001|Crossover Phase|Withdrawal by Subject|0|||
155108564|NCT01597908|559825249|FG002|Crossover Phase|Withdrawal by Subject|3|||
155108565|NCT01597908|559825247|FG000|Crossover Phase|Sponsor Decision|0|||
154972811|NCT05061992|559325216|FG000|Overall Study|Excess bowel movements|1|||
155108566|NCT01597908|559825248|FG001|Crossover Phase|Sponsor Decision|0|||
155108567|NCT01597908|559825249|FG002|Crossover Phase|Sponsor Decision|20|||
155108568|NCT00281099|559825252|FG000|Overall Study|Death|46|||
155108569|NCT00281099|559825253|FG001|Overall Study|Death|57|||
155108570|NCT00281099|559825252|FG000|Overall Study|Lost to Follow-up|10|||
155108571|NCT00281099|559825253|FG001|Overall Study|Lost to Follow-up|19|||
155108572|NCT00281099|559825252|FG000|Overall Study|Withdrawal by Subject|65|||
155108573|NCT00281099|559825253|FG001|Overall Study|Withdrawal by Subject|70|||
155108574|NCT00281099|559825252|FG000|Overall Study|Physician Decision|79|||
155108575|NCT00281099|559825253|FG001|Overall Study|Physician Decision|72|||
155108576|NCT00281099|559825252|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
155108577|NCT00281099|559825253|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
155108578|NCT00837161|559825254|FG000|Overall Study|refused hysterectomy|2|||
155108579|NCT02931838|559825255|FG000|Overall Study|Reason not provided by investigator|1|||
155108580|NCT02931838|559825256|FG001|Overall Study|Reason not provided by investigator|0|||
155108581|NCT02931838|559825257|FG002|Overall Study|Reason not provided by investigator|1|||
155108582|NCT02931838|559825258|FG003|Overall Study|Reason not provided by investigator|0|||
155108583|NCT02931838|559825259|FG004|Overall Study|Reason not provided by investigator|0|||
155108584|NCT02931838|559825260|FG005|Overall Study|Reason not provided by investigator|0|||
155108585|NCT02931838|559825255|FG000|Overall Study|Poor/non-compliance|0|||
155108586|NCT02931838|559825256|FG001|Overall Study|Poor/non-compliance|0|||
155108587|NCT02931838|559825257|FG002|Overall Study|Poor/non-compliance|1|||
155108588|NCT02931838|559825258|FG003|Overall Study|Poor/non-compliance|0|||
155108589|NCT02931838|559825259|FG004|Overall Study|Poor/non-compliance|0|||
155108590|NCT02931838|559825260|FG005|Overall Study|Poor/non-compliance|0|||
155108591|NCT02931838|559825255|FG000|Overall Study|Lack of Efficacy|5|||
155108592|NCT02931838|559825256|FG001|Overall Study|Lack of Efficacy|4|||
155108593|NCT02931838|559825257|FG002|Overall Study|Lack of Efficacy|0|||
155108594|NCT02931838|559825258|FG003|Overall Study|Lack of Efficacy|0|||
155108595|NCT02931838|559825259|FG004|Overall Study|Lack of Efficacy|0|||
155108596|NCT02931838|559825260|FG005|Overall Study|Lack of Efficacy|1|||
155108597|NCT02931838|559825255|FG000|Overall Study|Lost to Follow-up|1|||
155108598|NCT02931838|559825256|FG001|Overall Study|Lost to Follow-up|0|||
155108599|NCT02931838|559825257|FG002|Overall Study|Lost to Follow-up|1|||
155108600|NCT02931838|559825258|FG003|Overall Study|Lost to Follow-up|1|||
155108601|NCT02931838|559825259|FG004|Overall Study|Lost to Follow-up|2|||
155108602|NCT02931838|559825260|FG005|Overall Study|Lost to Follow-up|0|||
155108603|NCT02931838|559825255|FG000|Overall Study|Subject request to discontinue treatment|4|||
155108604|NCT02931838|559825256|FG001|Overall Study|Subject request to discontinue treatment|3|||
155108605|NCT02931838|559825257|FG002|Overall Study|Subject request to discontinue treatment|3|||
155108606|NCT02931838|559825258|FG003|Overall Study|Subject request to discontinue treatment|0|||
155108607|NCT02931838|559825259|FG004|Overall Study|Subject request to discontinue treatment|1|||
155108608|NCT02931838|559825260|FG005|Overall Study|Subject request to discontinue treatment|0|||
155108609|NCT02931838|559825255|FG000|Overall Study|Withdrawal by Subject|1|||
155108610|NCT02931838|559825256|FG001|Overall Study|Withdrawal by Subject|2|||
154972812|NCT05061992|559325217|FG001|Overall Study|Excess bowel movements|0|||
155108611|NCT02931838|559825257|FG002|Overall Study|Withdrawal by Subject|0|||
155108612|NCT02931838|559825258|FG003|Overall Study|Withdrawal by Subject|1|||
155108613|NCT02931838|559825259|FG004|Overall Study|Withdrawal by Subject|0|||
155174060|NCT03137069|560076591|FG005|Overall Study|Physician Decision|0|||
155108614|NCT02931838|559825260|FG005|Overall Study|Withdrawal by Subject|0|||
155108615|NCT02931838|559825255|FG000|Overall Study|Adverse Event|2|||
155108616|NCT02931838|559825256|FG001|Overall Study|Adverse Event|1|||
155108617|NCT02931838|559825257|FG002|Overall Study|Adverse Event|2|||
155108618|NCT02931838|559825258|FG003|Overall Study|Adverse Event|1|||
155108619|NCT02931838|559825259|FG004|Overall Study|Adverse Event|3|||
155108620|NCT02931838|559825260|FG005|Overall Study|Adverse Event|1|||
155108621|NCT00104728|559825261|FG000|Overall Study|screen failures|19|||
155108622|NCT01963767|559825262|FG000|Overall Study|Withdrawal by Subject|4|||
154862996|NCT00246259|558924547|FG000|Overall Study|Withdrawal by Subject|5|||
154862997|NCT00246259|558924548|FG001|Overall Study|Withdrawal by Subject|1|||
154862998|NCT00246259|558924547|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
155108623|NCT01963767|559825263|FG001|Overall Study|Withdrawal by Subject|2|||
155108624|NCT01963767|559825262|FG000|Overall Study|Adverse Event|2|||
155108625|NCT01963767|559825263|FG001|Overall Study|Adverse Event|0|||
155108626|NCT02709577|559825264|FG000|Overall Study|non-accommodating anatomy|0|||
155108627|NCT02709577|559825265|FG001|Overall Study|non-accommodating anatomy|1|||
155108628|NCT02709577|559825266|FG002|Overall Study|non-accommodating anatomy|0|||
155108629|NCT02709577|559825267|FG003|Overall Study|non-accommodating anatomy|0|||
155108630|NCT02709577|559825264|FG000|Overall Study|procedural complication|0|||
155108631|NCT02709577|559825265|FG001|Overall Study|procedural complication|1|||
155108632|NCT02709577|559825266|FG002|Overall Study|procedural complication|0|||
155108633|NCT02709577|559825267|FG003|Overall Study|procedural complication|0|||
155108634|NCT02709577|559825264|FG000|Overall Study|Withdrawal by Subject|2|||
155108635|NCT02709577|559825265|FG001|Overall Study|Withdrawal by Subject|3|||
155108636|NCT02709577|559825266|FG002|Overall Study|Withdrawal by Subject|2|||
155108637|NCT02709577|559825267|FG003|Overall Study|Withdrawal by Subject|0|||
155108638|NCT03823287|559825268|FG000|Overall Study|Withdrawal by Subject|25|||
155108639|NCT03823287|559825269|FG001|Overall Study|Withdrawal by Subject|17|||
155108640|NCT03823287|559825268|FG000|Overall Study|Death|13|||
155108641|NCT03823287|559825269|FG001|Overall Study|Death|7|||
155108642|NCT03823287|559825268|FG000|Overall Study|Lost to Follow-up|7|||
155108643|NCT03823287|559825269|FG001|Overall Study|Lost to Follow-up|8|||
155108644|NCT03823287|559825268|FG000|Overall Study|Adverse Event|6|||
155108645|NCT03823287|559825269|FG001|Overall Study|Adverse Event|8|||
155108646|NCT03823287|559825268|FG000|Overall Study|Physician Decision|5|||
155108647|NCT03823287|559825269|FG001|Overall Study|Physician Decision|2|||
155108648|NCT03823287|559825268|FG000|Overall Study|Lack of Efficacy|2|||
155108649|NCT03823287|559825269|FG001|Overall Study|Lack of Efficacy|0|||
155108650|NCT03823287|559825268|FG000|Overall Study|Other|2|||
155108651|NCT03823287|559825269|FG001|Overall Study|Other|4|||
155108652|NCT01059864|559825270|FG000|Open-Label Run-In Phase|Adverse Event|7|||
155108653|NCT01059864|559825271|FG001|Open-Label Run-In Phase|Adverse Event|0|||
155108654|NCT01059864|559825272|FG002|Open-Label Run-In Phase|Adverse Event|0|||
155108655|NCT01059864|559825270|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
155108656|NCT01059864|559825271|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
155108657|NCT01059864|559825272|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
155108658|NCT01059864|559825270|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
155108659|NCT01059864|559825271|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
155108660|NCT01059864|559825272|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
155108661|NCT01059864|559825270|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
155108662|NCT01059864|559825271|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
155108663|NCT01059864|559825272|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
155108664|NCT01059864|559825270|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
155108665|NCT01059864|559825271|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
155108666|NCT01059864|559825272|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
155108667|NCT01059864|559825270|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155108668|NCT01059864|559825271|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
155108669|NCT01059864|559825272|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
155108670|NCT01575808|559825274|FG000|Overall Study|Death|2|||
155108671|NCT01575808|559825275|FG001|Overall Study|Death|0|||
155108672|NCT01575808|559825274|FG000|Overall Study|Withdrawal by Subject|1|||
155108673|NCT01575808|559825275|FG001|Overall Study|Withdrawal by Subject|0|||
155108674|NCT03159468|559825276|FG000|Overall Study|Withdrawal by Subject|0|||
155108675|NCT03159468|559825277|FG001|Overall Study|Withdrawal by Subject|0|||
155108676|NCT03159468|559825278|FG002|Overall Study|Withdrawal by Subject|3|||
155108677|NCT03159468|559825279|FG003|Overall Study|Withdrawal by Subject|0|||
155108678|NCT03159468|559825280|FG004|Overall Study|Withdrawal by Subject|0|||
155108679|NCT03159468|559825281|FG005|Overall Study|Withdrawal by Subject|0|||
155108680|NCT00912782|559825282|FG000|Overall Study|Death|2|||
155108681|NCT00912782|559825283|FG001|Overall Study|Death|1|||
155108682|NCT00912782|559825282|FG000|Overall Study|Lost to Follow-up|0|||
155108683|NCT00912782|559825283|FG001|Overall Study|Lost to Follow-up|1|||
155108684|NCT00912782|559825282|FG000|Overall Study|Did not receive vascular access type|1|||
155108685|NCT00912782|559825283|FG001|Overall Study|Did not receive vascular access type|2|||
155108686|NCT00912782|559825282|FG000|Overall Study|Relocated before study completion|0|||
155108687|NCT00912782|559825283|FG001|Overall Study|Relocated before study completion|1|||
154862999|NCT00246259|558924548|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
154863000|NCT04233424|558924549|FG000|Overall Study|Death|15|||
154863001|NCT04233424|558924550|FG001|Overall Study|Death|16|||
154863002|NCT04233424|558924549|FG000|Overall Study|Withdrawal by Subject|2|||
154863003|NCT04233424|558924550|FG001|Overall Study|Withdrawal by Subject|8|||
155108688|NCT03062280|559826899|FG000|Overall Study|Adverse Event|1|||
155108689|NCT03062280|559826899|FG000|Overall Study|Death|1|||
155108690|NCT03062280|559826899|FG000|Overall Study|Fertility Treatment|2|||
155108691|NCT03062280|559826899|FG000|Overall Study|Physician Decision|2|||
155108692|NCT03062280|559826899|FG000|Overall Study|Pregnancy|5|||
155108693|NCT03062280|559826899|FG000|Overall Study|Withdrawal by Subject|11|||
155108694|NCT00814580|559826900|FG000|Overall Study|Adverse Event|6|||
155108695|NCT00814580|559826901|FG001|Overall Study|Adverse Event|15|||
155108696|NCT00814580|559826900|FG000|Overall Study|Lack of Efficacy|18|||
155108697|NCT00814580|559826901|FG001|Overall Study|Lack of Efficacy|25|||
155108698|NCT00814580|559826900|FG000|Overall Study|Protocol Violation|2|||
155108699|NCT00814580|559826901|FG001|Overall Study|Protocol Violation|0|||
155108700|NCT00814580|559826900|FG000|Overall Study|Withdrawal by Subject|2|||
155108701|NCT00814580|559826901|FG001|Overall Study|Withdrawal by Subject|2|||
155108702|NCT00814580|559826900|FG000|Overall Study|Other|1|||
155108703|NCT00814580|559826901|FG001|Overall Study|Other|3|||
155108704|NCT00814580|559826900|FG000|Overall Study|Did Not Take Drug|2|||
155108705|NCT00814580|559826901|FG001|Overall Study|Did Not Take Drug|2|||
155108706|NCT01519791|559826902|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
155108707|NCT01519791|559826903|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
155108708|NCT01519791|559826902|FG000|Overall Study|Protocol Violation|6|||
155108709|NCT01519791|559826903|FG001|Overall Study|Protocol Violation|19|||
155108710|NCT01519791|559826902|FG000|Overall Study|Other Reason|87|||
155108711|NCT01519791|559826903|FG001|Overall Study|Other Reason|222|||
155108712|NCT01519791|559826902|FG000|Overall Study|subjects randomized in error|2|||
155108713|NCT01519791|559826903|FG001|Overall Study|subjects randomized in error|0|||
155108714|NCT01519791|559826902|FG000|Overall Study|Lack of Efficacy|16|||
155108715|NCT01519791|559826903|FG001|Overall Study|Lack of Efficacy|20|||
155108716|NCT01519791|559826902|FG000|Overall Study|SAE, non-fatal|6|||
155108717|NCT01519791|559826903|FG001|Overall Study|SAE, non-fatal|22|||
155108718|NCT01519791|559826902|FG000|Overall Study|AE, serious fatal|0|||
155108719|NCT01519791|559826903|FG001|Overall Study|AE, serious fatal|1|||
155108720|NCT01519791|559826902|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
155108721|NCT01519791|559826903|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
155108722|NCT01519791|559826902|FG000|Overall Study|AE, non-serious non-fatal|12|||
155108723|NCT01519791|559826903|FG001|Overall Study|AE, non-serious non-fatal|31|||
154863004|NCT04233424|558924549|FG000|Overall Study|Physician Decision|1|||
154863005|NCT04233424|558924550|FG001|Overall Study|Physician Decision|3|||
154863006|NCT04233424|558924549|FG000|Overall Study|Protocol Violation|3|||
154863007|NCT04233424|558924550|FG001|Overall Study|Protocol Violation|1|||
154863008|NCT04233424|558924549|FG000|Overall Study|Lost to Follow-up|1|||
154863009|NCT04233424|558924550|FG001|Overall Study|Lost to Follow-up|3|||
154863010|NCT04233424|558924549|FG000|Overall Study|subject refuse to visit site|2|||
154863011|NCT04233424|558924550|FG001|Overall Study|subject refuse to visit site|0|||
154863012|NCT03133767|558924551|FG000|Overall Study|Lost to Follow-up|38|||
154863013|NCT03133767|558924552|FG001|Overall Study|Lost to Follow-up|24|||
154863014|NCT03133767|558924551|FG000|Overall Study|Protocol Violation|0|||
154863015|NCT03133767|558924552|FG001|Overall Study|Protocol Violation|1|||
154863016|NCT02698189|558924553|FG000|Overall Study|Physician Decision|3|||
154863017|NCT02698189|558924554|FG001|Overall Study|Physician Decision|0|||
154863018|NCT02698189|558924553|FG000|Overall Study|Progressive disease|0|||
154863019|NCT02698189|558924554|FG001|Overall Study|Progressive disease|5|||
154863020|NCT02698189|558924553|FG000|Overall Study|Study terminated by sponsor|0|||
154863021|NCT02698189|558924554|FG001|Overall Study|Study terminated by sponsor|1|||
154863022|NCT02240706|558924555|FG000|Overall Study|Lack of Efficacy|2|||
154863023|NCT02240706|558924556|FG001|Overall Study|Lack of Efficacy|2|||
154863024|NCT02240706|558924557|FG002|Overall Study|Lack of Efficacy|2|||
155108724|NCT01519791|559826902|FG000|Overall Study|Withdrawal by Subject|15|||
155108725|NCT01519791|559826903|FG001|Overall Study|Withdrawal by Subject|37|||
155108726|NCT01519791|559826902|FG000|Overall Study|Lost to Follow-up|6|||
155108727|NCT01519791|559826903|FG001|Overall Study|Lost to Follow-up|14|||
155108728|NCT00623233|559826904|FG000|Overall Study|Adverse Event|10|||
155108729|NCT00623233|559826904|FG000|Overall Study|Physician Decision|10|||
155108730|NCT00623233|559826904|FG000|Overall Study|Lost to Follow-up|1|||
155108731|NCT00623233|559826904|FG000|Overall Study|Withdrawal by Subject|3|||
154863025|NCT02240706|558924558|FG003|Overall Study|Lack of Efficacy|2|||
154863026|NCT02240706|558924559|FG004|Overall Study|Lack of Efficacy|5|||
154863027|NCT02240706|558924560|FG005|Overall Study|Lack of Efficacy|0|||
154863028|NCT02240706|558924561|FG006|Overall Study|Lack of Efficacy|0|||
154863029|NCT02240706|558924555|FG000|Overall Study|Adverse Event|1|||
155108732|NCT00459875|559826905|FG000|Overall Study|Ineligible participant|1|||
155108733|NCT00459875|559826905|FG000|Overall Study|Adverse Event|2|||
155108734|NCT03206970|559826906|FG000|Overall Study|Death|21|||
155108735|NCT03206970|559826906|FG000|Overall Study|Withdrawal by Subject|13|||
155108736|NCT03206970|559826906|FG000|Overall Study|Lost to Follow-up|3|||
155108737|NCT03206970|559826906|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
155108738|NCT03379259|559826907|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
155108739|NCT03379259|559826908|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
155108740|NCT03379259|559826909|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
155108741|NCT03379259|559826910|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
155108742|NCT03379259|559826911|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
155108743|NCT03379259|559826912|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
155108744|NCT03379259|559826907|FG000|Overall Study|Death|0|||
155108745|NCT03379259|559826908|FG001|Overall Study|Death|1|||
155108746|NCT03379259|559826909|FG002|Overall Study|Death|2|||
155108747|NCT03379259|559826910|FG003|Overall Study|Death|1|||
155108748|NCT03379259|559826911|FG004|Overall Study|Death|4|||
155108749|NCT03379259|559826912|FG005|Overall Study|Death|2|||
155108750|NCT03379259|559826907|FG000|Overall Study|Withdrawal by Subject|0|||
155108751|NCT03379259|559826908|FG001|Overall Study|Withdrawal by Subject|0|||
155108752|NCT03379259|559826909|FG002|Overall Study|Withdrawal by Subject|1|||
155108753|NCT03379259|559826910|FG003|Overall Study|Withdrawal by Subject|0|||
155108754|NCT03379259|559826911|FG004|Overall Study|Withdrawal by Subject|2|||
155108755|NCT03379259|559826912|FG005|Overall Study|Withdrawal by Subject|0|||
155108756|NCT03379259|559826907|FG000|Overall Study|Study terminated by sponsor|0|||
155108757|NCT03379259|559826908|FG001|Overall Study|Study terminated by sponsor|0|||
155108758|NCT03379259|559826909|FG002|Overall Study|Study terminated by sponsor|0|||
155108759|NCT03379259|559826910|FG003|Overall Study|Study terminated by sponsor|1|||
155108760|NCT03379259|559826911|FG004|Overall Study|Study terminated by sponsor|1|||
155108761|NCT03379259|559826912|FG005|Overall Study|Study terminated by sponsor|4|||
155108762|NCT03379259|559826907|FG000|Overall Study|Disease progression|0|||
155108763|NCT03379259|559826908|FG001|Overall Study|Disease progression|0|||
155108764|NCT03379259|559826909|FG002|Overall Study|Disease progression|0|||
155174061|NCT03137069|560076586|FG000|Overall Study|Study Terminated by Sponsor|0|||
155174062|NCT03137069|560076587|FG001|Overall Study|Study Terminated by Sponsor|0|||
155174063|NCT03137069|560076588|FG002|Overall Study|Study Terminated by Sponsor|0|||
155174064|NCT03137069|560076589|FG003|Overall Study|Study Terminated by Sponsor|0|||
154863030|NCT02240706|558924556|FG001|Overall Study|Adverse Event|0|||
154863031|NCT02240706|558924557|FG002|Overall Study|Adverse Event|1|||
154863032|NCT02240706|558924558|FG003|Overall Study|Adverse Event|0|||
154863033|NCT02240706|558924559|FG004|Overall Study|Adverse Event|2|||
154863034|NCT02240706|558924560|FG005|Overall Study|Adverse Event|0|||
154863035|NCT02240706|558924561|FG006|Overall Study|Adverse Event|0|||
154863036|NCT02240706|558924555|FG000|Overall Study|Progressive disease|0|||
154863037|NCT02240706|558924556|FG001|Overall Study|Progressive disease|0|||
154863038|NCT02240706|558924557|FG002|Overall Study|Progressive disease|0|||
154863039|NCT02240706|558924558|FG003|Overall Study|Progressive disease|0|||
154863040|NCT02240706|558924559|FG004|Overall Study|Progressive disease|1|||
154863041|NCT02240706|558924560|FG005|Overall Study|Progressive disease|0|||
154863042|NCT02240706|558924561|FG006|Overall Study|Progressive disease|0|||
154863043|NCT02240706|558924555|FG000|Overall Study|Dose limiting toxicity|0|||
154863044|NCT02240706|558924556|FG001|Overall Study|Dose limiting toxicity|0|||
154863045|NCT02240706|558924557|FG002|Overall Study|Dose limiting toxicity|0|||
154863046|NCT02240706|558924558|FG003|Overall Study|Dose limiting toxicity|0|||
154863047|NCT02240706|558924559|FG004|Overall Study|Dose limiting toxicity|1|||
154863048|NCT02240706|558924560|FG005|Overall Study|Dose limiting toxicity|0|||
154863049|NCT02240706|558924561|FG006|Overall Study|Dose limiting toxicity|0|||
154863050|NCT02240706|558924555|FG000|Overall Study|Refused to continue taking medication|0|||
154863051|NCT02240706|558924556|FG001|Overall Study|Refused to continue taking medication|1|||
154863052|NCT02240706|558924557|FG002|Overall Study|Refused to continue taking medication|3|||
154863053|NCT02240706|558924558|FG003|Overall Study|Refused to continue taking medication|1|||
154863054|NCT02240706|558924559|FG004|Overall Study|Refused to continue taking medication|2|||
154863055|NCT02240706|558924560|FG005|Overall Study|Refused to continue taking medication|0|||
154863056|NCT02240706|558924561|FG006|Overall Study|Refused to continue taking medication|0|||
154863057|NCT02240706|558924555|FG000|Overall Study|Insurance billing concerns|0|||
154863058|NCT02240706|558924556|FG001|Overall Study|Insurance billing concerns|0|||
154863059|NCT02240706|558924557|FG002|Overall Study|Insurance billing concerns|0|||
154863060|NCT02240706|558924558|FG003|Overall Study|Insurance billing concerns|1|||
154863061|NCT02240706|558924559|FG004|Overall Study|Insurance billing concerns|0|||
155108765|NCT03379259|559826910|FG003|Overall Study|Disease progression|1|||
155108766|NCT03379259|559826911|FG004|Overall Study|Disease progression|0|||
155108767|NCT03379259|559826912|FG005|Overall Study|Disease progression|1|||
155108768|NCT03379259|559826907|FG000|Overall Study|Lost to Follow-up|0|||
155108769|NCT03379259|559826908|FG001|Overall Study|Lost to Follow-up|0|||
155174065|NCT03137069|560076590|FG004|Overall Study|Study Terminated by Sponsor|1|||
155174066|NCT03137069|560076591|FG005|Overall Study|Study Terminated by Sponsor|0|||
154863062|NCT02240706|558924560|FG005|Overall Study|Insurance billing concerns|0|||
154863063|NCT02240706|558924561|FG006|Overall Study|Insurance billing concerns|0|||
154863064|NCT03301857|558924562|FG000|Overall Study|Death|0|||
154863065|NCT03301857|558924563|FG001|Overall Study|Death|2|||
154972813|NCT05061992|559325216|FG000|Overall Study|Complications of Medical Care|1|||
154972814|NCT05061992|559325217|FG001|Overall Study|Complications of Medical Care|0|||
154972815|NCT05061992|559325216|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
154972816|NCT05061992|559325217|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
154972817|NCT05061992|559325216|FG000|Overall Study|Withdrawal by Subject|0|||
154972818|NCT05061992|559325217|FG001|Overall Study|Withdrawal by Subject|1|||
154972819|NCT05212948|559325230|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
154972820|NCT05212948|559325231|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
154972821|NCT05212948|559325230|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
154972822|NCT05212948|559325231|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
154972823|NCT05212948|559325230|FG000|Initial Vaccination Period|Pregnancy|20|||
154972824|NCT05212948|559325231|FG001|Initial Vaccination Period|Pregnancy|14|||
154972825|NCT05212948|559325230|FG000|Initial Vaccination Period|Physician Decision|686|||
154972826|NCT05212948|559325231|FG001|Initial Vaccination Period|Physician Decision|401|||
154972827|NCT05212948|559325230|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
154972828|NCT05212948|559325231|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
154972829|NCT05212948|559325230|FG000|Initial Vaccination Period|Death|23|||
154972830|NCT05212948|559325231|FG001|Initial Vaccination Period|Death|18|||
154972831|NCT05212948|559325230|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
154972832|NCT05212948|559325231|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
154972833|NCT05212948|559325230|FG000|Initial Vaccination Period|Adverse Event|36|||
154972834|NCT05212948|559325231|FG001|Initial Vaccination Period|Adverse Event|23|||
154972835|NCT05212948|559325230|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
154972836|NCT05212948|559325231|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
154972837|NCT05212948|559325230|FG000|Crossover Vaccination Period|Pregnancy|6|||
154972838|NCT05212948|559325231|FG001|Crossover Vaccination Period|Pregnancy|1|||
154972839|NCT05212948|559325230|FG000|Crossover Vaccination Period|Physician Decision|49|||
154972840|NCT05212948|559325231|FG001|Crossover Vaccination Period|Physician Decision|24|||
154972841|NCT05212948|559325230|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
154972842|NCT05212948|559325231|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
154972843|NCT05212948|559325230|FG000|Crossover Vaccination Period|Death|10|||
154972844|NCT05212948|559325231|FG001|Crossover Vaccination Period|Death|5|||
154972845|NCT05212948|559325230|FG000|Crossover Vaccination Period|Adverse Event|9|||
154972846|NCT05212948|559325231|FG001|Crossover Vaccination Period|Adverse Event|4|||
154972847|NCT05347693|559325232|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
154972848|NCT05347693|559325233|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
154972849|NCT05347693|559325234|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
154972850|NCT05347693|559325232|FG000|Inpatient Period|Withdrawal of consent|10|||
154972851|NCT05347693|559325233|FG001|Inpatient Period|Withdrawal of consent|0|||
154972852|NCT05347693|559325234|FG002|Inpatient Period|Withdrawal of consent|0|||
154972853|NCT05347693|559325232|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
154972854|NCT05347693|559325233|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
154972855|NCT05347693|559325234|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
154972856|NCT05347693|559325232|FG000|Inpatient Period|Screening Failure|8|||
154972857|NCT05347693|559325233|FG001|Inpatient Period|Screening Failure|0|||
154972858|NCT05347693|559325234|FG002|Inpatient Period|Screening Failure|0|||
154972859|NCT05347693|559325232|FG000|Inpatient Period|Death|2|||
155108770|NCT03379259|559826909|FG002|Overall Study|Lost to Follow-up|0|||
155108771|NCT03379259|559826910|FG003|Overall Study|Lost to Follow-up|0|||
155108772|NCT03379259|559826911|FG004|Overall Study|Lost to Follow-up|1|||
155108773|NCT03379259|559826912|FG005|Overall Study|Lost to Follow-up|0|||
155108774|NCT03379259|559826907|FG000|Overall Study|Deteriorating condition|0|||
155108775|NCT03379259|559826908|FG001|Overall Study|Deteriorating condition|0|||
155108776|NCT03379259|559826909|FG002|Overall Study|Deteriorating condition|0|||
155108777|NCT03379259|559826910|FG003|Overall Study|Deteriorating condition|0|||
155108778|NCT03379259|559826911|FG004|Overall Study|Deteriorating condition|1|||
155108779|NCT03379259|559826912|FG005|Overall Study|Deteriorating condition|0|||
155108780|NCT00438360|559826913|FG000|Overall Study|Adverse Event|6|||
155108781|NCT00438360|559826914|FG001|Overall Study|Adverse Event|1|||
155108782|NCT00438360|559826913|FG000|Overall Study|Lack of Efficacy|42|||
155108783|NCT00438360|559826914|FG001|Overall Study|Lack of Efficacy|27|||
155174067|NCT03137069|560076586|FG000|Overall Study|Data Entry Error|0|||
154972860|NCT05347693|559325233|FG001|Inpatient Period|Death|0|||
154972861|NCT05347693|559325234|FG002|Inpatient Period|Death|0|||
154972862|NCT05347693|559325232|FG000|Inpatient Period|Physician Decision|5|||
154972863|NCT05347693|559325233|FG001|Inpatient Period|Physician Decision|0|||
154972864|NCT05347693|559325234|FG002|Inpatient Period|Physician Decision|0|||
154972865|NCT05347693|559325232|FG000|Inpatient Period|Adverse Event|3|||
154972866|NCT05347693|559325233|FG001|Inpatient Period|Adverse Event|0|||
154972867|NCT05347693|559325234|FG002|Inpatient Period|Adverse Event|0|||
154972868|NCT05347693|559325232|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
154972869|NCT05347693|559325233|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
154863066|NCT03301857|558924562|FG000|Overall Study|Lost to Follow-up|4|||
154863067|NCT03301857|558924563|FG001|Overall Study|Lost to Follow-up|2|||
154863068|NCT03301857|558924562|FG000|Overall Study|Decision by Sponsor|6|||
154863069|NCT03301857|558924563|FG001|Overall Study|Decision by Sponsor|0|||
154863070|NCT03301857|558924562|FG000|Overall Study|Withdrawal by Subject|12|||
154863071|NCT03301857|558924563|FG001|Overall Study|Withdrawal by Subject|4|||
154863072|NCT05502289|558924581|FG000|Period 1|Out Of Window|1|||
154863073|NCT05502289|558924582|FG001|Period 1|Out Of Window|0|||
154863074|NCT01564784|558924590|FG000|Overall Study|Other|1|||
154863075|NCT01564784|558924591|FG001|Overall Study|Other|0|||
154863076|NCT01564784|558924590|FG000|Overall Study|Subject refused further follow-up|1|||
154863077|NCT01564784|558924591|FG001|Overall Study|Subject refused further follow-up|6|||
154863078|NCT01564784|558924590|FG000|Overall Study|Lost to Follow-up|1|||
154863079|NCT01564784|558924591|FG001|Overall Study|Lost to Follow-up|1|||
154863080|NCT01564784|558924590|FG000|Overall Study|Death|131|||
154863081|NCT01564784|558924591|FG001|Overall Study|Death|126|||
154863082|NCT05300087|558924592|FG000|Overall Study|Withdrawal by Subject|0|||
154863083|NCT05300087|558924593|FG001|Overall Study|Withdrawal by Subject|1|||
154863084|NCT01126580|558924594|FG000|Overall Study|Adverse Event|14|||
154863085|NCT01126580|558924595|FG001|Overall Study|Adverse Event|8|||
154863086|NCT01126580|558924596|FG002|Overall Study|Adverse Event|12|||
154863087|NCT01126580|558924594|FG000|Overall Study|Withdrawal by Subject|11|||
154863088|NCT01126580|558924595|FG001|Overall Study|Withdrawal by Subject|19|||
154863089|NCT01126580|558924596|FG002|Overall Study|Withdrawal by Subject|14|||
154863090|NCT01126580|558924594|FG000|Overall Study|Sponsor Decision|5|||
154863091|NCT01126580|558924595|FG001|Overall Study|Sponsor Decision|4|||
154863092|NCT01126580|558924596|FG002|Overall Study|Sponsor Decision|7|||
154863093|NCT01126580|558924594|FG000|Overall Study|Physician Decision|1|||
154863094|NCT01126580|558924595|FG001|Overall Study|Physician Decision|1|||
154863095|NCT01126580|558924596|FG002|Overall Study|Physician Decision|2|||
154863096|NCT01126580|558924594|FG000|Overall Study|Entry Criteria Not Met|1|||
154863097|NCT01126580|558924595|FG001|Overall Study|Entry Criteria Not Met|1|||
154863098|NCT01126580|558924596|FG002|Overall Study|Entry Criteria Not Met|2|||
154863099|NCT01126580|558924594|FG000|Overall Study|Lack of Efficacy|2|||
154863100|NCT01126580|558924595|FG001|Overall Study|Lack of Efficacy|3|||
154863101|NCT01126580|558924596|FG002|Overall Study|Lack of Efficacy|4|||
154863102|NCT01126580|558924594|FG000|Overall Study|Protocol Violation|0|||
154863103|NCT01126580|558924595|FG001|Overall Study|Protocol Violation|1|||
154863104|NCT01126580|558924596|FG002|Overall Study|Protocol Violation|2|||
154863105|NCT01126580|558924594|FG000|Overall Study|Lost to Follow-up|15|||
154863106|NCT01126580|558924595|FG001|Overall Study|Lost to Follow-up|13|||
154863107|NCT01126580|558924596|FG002|Overall Study|Lost to Follow-up|9|||
154863108|NCT01126580|558924594|FG000|Overall Study|Treatment Non-compliance|0|||
154863109|NCT01126580|558924595|FG001|Overall Study|Treatment Non-compliance|2|||
154863110|NCT01126580|558924596|FG002|Overall Study|Treatment Non-compliance|3|||
154863111|NCT01731002|558924606|FG000|Overall Study|Adverse Event|0|||
154863112|NCT01731002|558924607|FG001|Overall Study|Adverse Event|2|||
154863113|NCT01731002|558924608|FG002|Overall Study|Adverse Event|2|||
154863114|NCT01731002|558924606|FG000|Overall Study|Non-Compliant|0|||
154863115|NCT01731002|558924607|FG001|Overall Study|Non-Compliant|1|||
154863116|NCT01731002|558924608|FG002|Overall Study|Non-Compliant|0|||
154863117|NCT01731002|558924606|FG000|Overall Study|Lost to Follow-up|1|||
154863118|NCT01731002|558924607|FG001|Overall Study|Lost to Follow-up|0|||
154863119|NCT01731002|558924608|FG002|Overall Study|Lost to Follow-up|0|||
154863120|NCT01731002|558924606|FG000|Overall Study|Test Agent Discontinuation|0|||
154863121|NCT01731002|558924607|FG001|Overall Study|Test Agent Discontinuation|1|||
154863122|NCT01731002|558924608|FG002|Overall Study|Test Agent Discontinuation|0|||
155108784|NCT00438360|559826913|FG000|Overall Study|Other|24|||
155108785|NCT00438360|559826914|FG001|Overall Study|Other|15|||
155108786|NCT03249909|559826917|FG000|Overall Study|Withdrawal by Subject|3|||
155108787|NCT03249909|559826918|FG001|Overall Study|Withdrawal by Subject|0|||
155108788|NCT03249909|559826919|FG002|Overall Study|Withdrawal by Subject|0|||
155108789|NCT03249909|559826917|FG000|Overall Study|Adverse Event|3|||
155108790|NCT03249909|559826918|FG001|Overall Study|Adverse Event|0|||
155108791|NCT03249909|559826919|FG002|Overall Study|Adverse Event|0|||
154863123|NCT01731002|558924606|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
154863124|NCT01731002|558924607|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
154863125|NCT01731002|558924608|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
154863126|NCT01731002|558924606|FG000|Overall Study|Elevated IOP|1|||
154863127|NCT01731002|558924607|FG001|Overall Study|Elevated IOP|0|||
154863128|NCT01731002|558924608|FG002|Overall Study|Elevated IOP|0|||
154863129|NCT01731002|558924606|FG000|Overall Study|Inappropriate use of study medications|0|||
154863130|NCT01731002|558924607|FG001|Overall Study|Inappropriate use of study medications|0|||
154863131|NCT01731002|558924608|FG002|Overall Study|Inappropriate use of study medications|1|||
154863132|NCT00947349|558924611|FG000|Triple Treatment Combination Period|Adverse Event|0|||
154863133|NCT00947349|558924612|FG001|Triple Treatment Combination Period|Adverse Event|1|||
154924224|NCT04527380|559146419|FG000|Overall Study|Lack of Efficacy|0|||
154924225|NCT04527380|559146420|FG001|Overall Study|Lack of Efficacy|1|||
154863134|NCT00947349|558924613|FG002|Triple Treatment Combination Period|Adverse Event|0|||
155108792|NCT03249909|559826917|FG000|Overall Study|Lost to Follow-up|0|||
155108793|NCT03249909|559826918|FG001|Overall Study|Lost to Follow-up|1|||
155108794|NCT03249909|559826919|FG002|Overall Study|Lost to Follow-up|0|||
155108795|NCT05286658|559826920|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
155108796|NCT05286658|559826920|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
155108797|NCT00842153|559826921|FG000|Overall Study|Adverse Event|0|||
155108798|NCT00842153|559826922|FG001|Overall Study|Adverse Event|1|||
155108799|NCT00842153|559826921|FG000|Overall Study|Lost to Follow-up|1|||
155108800|NCT00842153|559826922|FG001|Overall Study|Lost to Follow-up|2|||
155108801|NCT03517371|559826923|FG000|Overall Study|Adverse Event|8|||
155108802|NCT03517371|559826924|FG001|Overall Study|Adverse Event|9|||
155108803|NCT03517371|559826923|FG000|Overall Study|Lost to Follow-up|1|||
155108804|NCT03517371|559826924|FG001|Overall Study|Lost to Follow-up|2|||
155108805|NCT03517371|559826923|FG000|Overall Study|Withdrawal by Subject|4|||
155108806|NCT03517371|559826924|FG001|Overall Study|Withdrawal by Subject|4|||
155108807|NCT03517371|559826923|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
155108808|NCT03517371|559826924|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
155108809|NCT03517371|559826923|FG000|Overall Study|COVID restrictions|2|||
155108810|NCT03517371|559826924|FG001|Overall Study|COVID restrictions|0|||
155108811|NCT03517371|559826923|FG000|Overall Study|Receiving DBS Surgery|0|||
155108812|NCT03517371|559826924|FG001|Overall Study|Receiving DBS Surgery|1|||
155108813|NCT01345929|559826926|FG000|Overall Study|Withdrawal by Subject|9|||
155108814|NCT01345929|559826927|FG001|Overall Study|Withdrawal by Subject|8|||
155108815|NCT01345929|559826926|FG000|Overall Study|Lost to Follow-up|9|||
155108816|NCT01345929|559826927|FG001|Overall Study|Lost to Follow-up|9|||
155108817|NCT01345929|559826926|FG000|Overall Study|Adverse Event|0|||
155108818|NCT01345929|559826927|FG001|Overall Study|Adverse Event|1|||
155108819|NCT01345929|559826926|FG000|Overall Study|Didn't meet eligibility criteria|2|||
155108820|NCT01345929|559826927|FG001|Overall Study|Didn't meet eligibility criteria|0|||
155108821|NCT01345929|559826926|FG000|Overall Study|40,000 CFU/ML|1|||
155108822|NCT01345929|559826927|FG001|Overall Study|40,000 CFU/ML|0|||
155108823|NCT01345929|559826926|FG000|Overall Study|Patient withdrawal|0|||
155108824|NCT01345929|559826927|FG001|Overall Study|Patient withdrawal|1|||
155108825|NCT02819297|559826928|FG000|Overall Study|Withdrawal by Subject|25|||
155108826|NCT02819297|559826929|FG001|Overall Study|Withdrawal by Subject|13|||
155108827|NCT02819297|559826928|FG000|Overall Study|Lost to Follow-up|12|||
155108828|NCT02819297|559826929|FG001|Overall Study|Lost to Follow-up|14|||
155108829|NCT02819297|559826928|FG000|Overall Study|Adverse Event|12|||
155108830|NCT02819297|559826929|FG001|Overall Study|Adverse Event|10|||
155108831|NCT02819297|559826928|FG000|Overall Study|Physician Decision|5|||
155108832|NCT02819297|559826929|FG001|Overall Study|Physician Decision|5|||
155108833|NCT02819297|559826928|FG000|Overall Study|Lack of Efficacy|5|||
155108834|NCT02819297|559826929|FG001|Overall Study|Lack of Efficacy|8|||
155108835|NCT02819297|559826928|FG000|Overall Study|Protocol Violation|1|||
155108836|NCT02819297|559826929|FG001|Overall Study|Protocol Violation|2|||
155108837|NCT01670279|559826930|FG000|Overall Study|Adverse Event|0|||
155108838|NCT01670279|559826931|FG001|Overall Study|Adverse Event|1|||
155108839|NCT01670279|559826932|FG002|Overall Study|Adverse Event|0|||
155108840|NCT01670279|559826933|FG003|Overall Study|Adverse Event|0|||
155108841|NCT01670279|559826930|FG000|Overall Study|Physician Decision|0|||
155108842|NCT01670279|559826931|FG001|Overall Study|Physician Decision|1|||
155108843|NCT01670279|559826932|FG002|Overall Study|Physician Decision|0|||
155108844|NCT01670279|559826933|FG003|Overall Study|Physician Decision|0|||
155108845|NCT01670279|559826930|FG000|Overall Study|Participant met withdrawal criteria|0|||
155108846|NCT01670279|559826931|FG001|Overall Study|Participant met withdrawal criteria|0|||
155108847|NCT01670279|559826932|FG002|Overall Study|Participant met withdrawal criteria|0|||
155108848|NCT01670279|559826933|FG003|Overall Study|Participant met withdrawal criteria|1|||
155108849|NCT01901614|559826936|FG000|Overall Study|Adverse Event|0|||
155108850|NCT01901614|559826937|FG001|Overall Study|Adverse Event|1|||
155108851|NCT01901614|559826936|FG000|Overall Study|Lost to Follow-up|1|||
155108852|NCT01901614|559826937|FG001|Overall Study|Lost to Follow-up|0|||
155108853|NCT01901614|559826936|FG000|Overall Study|Screen Fail|1|||
155108854|NCT01901614|559826937|FG001|Overall Study|Screen Fail|0|||
155108855|NCT03629223|559826938|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
154863135|NCT00947349|558924614|FG003|Triple Treatment Combination Period|Adverse Event|0|||
155108856|NCT03629223|559826939|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
155108857|NCT03629223|559826940|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
155108858|NCT03629223|559826941|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
155108859|NCT03629223|559826942|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
155108860|NCT03629223|559826943|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
155108861|NCT03629223|559826938|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155108862|NCT03629223|559826939|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155108863|NCT03629223|559826940|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155108864|NCT03629223|559826941|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
155108865|NCT03629223|559826942|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155108866|NCT03629223|559826943|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
155108867|NCT03629223|559826938|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155108868|NCT03629223|559826939|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
154863136|NCT00947349|558924611|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
154863137|NCT00947349|558924612|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
154863138|NCT00947349|558924613|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
154863139|NCT00947349|558924614|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
154863140|NCT00947349|558924611|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
154863141|NCT00947349|558924612|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
154863142|NCT00947349|558924613|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
154863143|NCT00947349|558924614|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
154863144|NCT00947349|558924611|FG000|Overall Study Standard of Care|Other|0|||
154863145|NCT00947349|558924612|FG001|Overall Study Standard of Care|Other|0|||
154863146|NCT00947349|558924613|FG002|Overall Study Standard of Care|Other|0|||
154863147|NCT00947349|558924614|FG003|Overall Study Standard of Care|Other|1|||
154863148|NCT00538681|558924615|FG000|Overall Study|Progressive Disease|7|||
154863149|NCT00538681|558924616|FG001|Overall Study|Progressive Disease|0|||
154863150|NCT00538681|558924617|FG002|Overall Study|Progressive Disease|1|||
154863151|NCT00538681|558924618|FG003|Overall Study|Progressive Disease|0|||
154863152|NCT00538681|558924615|FG000|Overall Study|Sponsor Decision|1|||
154863153|NCT00538681|558924616|FG001|Overall Study|Sponsor Decision|3|||
154863154|NCT00538681|558924617|FG002|Overall Study|Sponsor Decision|8|||
154863155|NCT00538681|558924618|FG003|Overall Study|Sponsor Decision|9|||
154863156|NCT00538681|558924615|FG000|Overall Study|Adverse Event|1|||
154863157|NCT00538681|558924616|FG001|Overall Study|Adverse Event|1|||
154863158|NCT00538681|558924617|FG002|Overall Study|Adverse Event|1|||
154863159|NCT00538681|558924618|FG003|Overall Study|Adverse Event|0|||
154863160|NCT00538681|558924615|FG000|Overall Study|Death|0|||
154863161|NCT00538681|558924616|FG001|Overall Study|Death|0|||
154863162|NCT00538681|558924617|FG002|Overall Study|Death|1|||
154863163|NCT00538681|558924618|FG003|Overall Study|Death|1|||
154863164|NCT00538681|558924615|FG000|Overall Study|Investigator Decision|0|||
154863165|NCT00538681|558924616|FG001|Overall Study|Investigator Decision|0|||
154863166|NCT00538681|558924617|FG002|Overall Study|Investigator Decision|0|||
154863167|NCT00538681|558924618|FG003|Overall Study|Investigator Decision|1|||
154863168|NCT02770807|558924620|FG000|Overall Study|Adverse Event|3|||
154863169|NCT02770807|558924621|FG001|Overall Study|Adverse Event|3|||
154863170|NCT02770807|558924622|FG002|Overall Study|Adverse Event|1|||
154863171|NCT02770807|558924620|FG000|Overall Study|Withdrawal by Subject|7|||
154863172|NCT02770807|558924621|FG001|Overall Study|Withdrawal by Subject|3|||
154863173|NCT02770807|558924622|FG002|Overall Study|Withdrawal by Subject|4|||
154863174|NCT02770807|558924620|FG000|Overall Study|Other|0|||
155108869|NCT03629223|559826940|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155108870|NCT03629223|559826941|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155108871|NCT03629223|559826942|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155108872|NCT03629223|559826943|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
155108873|NCT03629223|559826938|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155108874|NCT03629223|559826939|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
155108875|NCT03629223|559826940|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155108876|NCT03629223|559826941|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155108877|NCT03629223|559826942|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
155108878|NCT03629223|559826943|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
154863175|NCT02770807|558924621|FG001|Overall Study|Other|1|||
154863176|NCT02770807|558924622|FG002|Overall Study|Other|0|||
154863177|NCT02770807|558924620|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
154863178|NCT02770807|558924621|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
154863179|NCT02770807|558924622|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
154863180|NCT02770807|558924620|FG000|Overall Study|Physician Decision|0|||
155108879|NCT03629223|559826938|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
155108880|NCT03629223|559826939|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155108881|NCT03629223|559826940|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155108882|NCT03629223|559826941|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
154863181|NCT02770807|558924621|FG001|Overall Study|Physician Decision|0|||
154863182|NCT02770807|558924622|FG002|Overall Study|Physician Decision|1|||
154863183|NCT00222105|558924625|FG000|Overall Study|Removed due to wrong diagnosis|1|||
154863184|NCT00222105|558924625|FG000|Overall Study|Withdrawal by Subject|1|||
154863185|NCT00222105|558924625|FG000|Overall Study|Adverse Event|8|||
154863186|NCT00222105|558924625|FG000|Overall Study|Treatment delays|2|||
154863187|NCT00222105|558924625|FG000|Overall Study|Death|2|||
154863188|NCT00853632|558926556|FG000|Overall Study|Death|88|||
155174068|NCT03137069|560076587|FG001|Overall Study|Data Entry Error|0|||
154863189|NCT00853632|558926556|FG000|Overall Study|Withdrawal by Subject|45|||
154863190|NCT00853632|558926556|FG000|Overall Study|Lost to Follow-up|30|||
154863191|NCT00853632|558926556|FG000|Overall Study|Reoperation/Explant|17|||
154863192|NCT00853632|558926556|FG000|Overall Study|Exit with other reason|22|||
154972870|NCT05347693|559325234|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
154972871|NCT05347693|559325232|FG000|Outpatient Period|Adverse Event|0|||
154972872|NCT05347693|559325233|FG001|Outpatient Period|Adverse Event|9|||
154972873|NCT05347693|559325234|FG002|Outpatient Period|Adverse Event|0|||
154972874|NCT05347693|559325232|FG000|Outpatient Period|Death|0|||
154972875|NCT05347693|559325233|FG001|Outpatient Period|Death|6|||
154972876|NCT05347693|559325234|FG002|Outpatient Period|Death|2|||
154972877|NCT05347693|559325232|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
154972878|NCT05347693|559325233|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
154972879|NCT05347693|559325234|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
154972880|NCT05347693|559325232|FG000|Outpatient Period|Lost to Follow-up|0|||
154972881|NCT05347693|559325233|FG001|Outpatient Period|Lost to Follow-up|0|||
154972882|NCT05347693|559325234|FG002|Outpatient Period|Lost to Follow-up|1|||
154972883|NCT05347693|559325232|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
154972884|NCT05347693|559325233|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
154972885|NCT05347693|559325234|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
154972886|NCT05347693|559325232|FG000|Outpatient Period|Scheduled hemodialysis|0|||
154972887|NCT05347693|559325233|FG001|Outpatient Period|Scheduled hemodialysis|1|||
154972888|NCT05347693|559325234|FG002|Outpatient Period|Scheduled hemodialysis|0|||
154972889|NCT05347693|559325232|FG000|Outpatient Period|Severe HK|0|||
154972890|NCT05347693|559325233|FG001|Outpatient Period|Severe HK|0|||
154972891|NCT05347693|559325234|FG002|Outpatient Period|Severe HK|1|||
154972892|NCT05347693|559325232|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
154972893|NCT05347693|559325233|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
154972894|NCT05347693|559325234|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
154972895|NCT05347693|559325232|FG000|Outpatient Period|Start of dialysis|0|||
154972896|NCT05347693|559325233|FG001|Outpatient Period|Start of dialysis|0|||
154972897|NCT05347693|559325234|FG002|Outpatient Period|Start of dialysis|1|||
154972898|NCT05347693|559325232|FG000|Outpatient Period|The participant entered hemodialysis|0|||
154972899|NCT05347693|559325233|FG001|Outpatient Period|The participant entered hemodialysis|0|||
154972900|NCT05347693|559325234|FG002|Outpatient Period|The participant entered hemodialysis|1|||
154972901|NCT05347693|559325232|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
154972902|NCT05347693|559325233|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
154972903|NCT05347693|559325234|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
154972904|NCT05347693|559325232|FG000|Outpatient Period|Withdrawal by Subject|0|||
154972905|NCT05347693|559325233|FG001|Outpatient Period|Withdrawal by Subject|8|||
154972906|NCT05347693|559325234|FG002|Outpatient Period|Withdrawal by Subject|5|||
154972907|NCT00695110|559325237|FG000|Treatment Period 1|Adverse Event|1|||
154972908|NCT00695110|559325237|FG000|Treatment Period 1|Withdrawal by Subject|2|||
154972909|NCT00695110|559325237|FG000|Treatment Period 3|Withdrawal by Subject|1|||
154972910|NCT00695110|559325237|FG000|Treatment Period 4|Adverse Event|1|||
154972911|NCT04675775|559325241|FG000|Overall Study|Withdrawal by Subject|7|||
154972912|NCT04941768|559325245|FG000|Overall Study|Lost to Follow-up|10|||
154972913|NCT04941768|559325245|FG000|Overall Study|Death|24|||
154972914|NCT04941768|559325245|FG000|Overall Study|Progressive Disease|4|||
154972915|NCT04941768|559325245|FG000|Overall Study|Withdrawal by Subject|4|||
154972916|NCT04941768|559325245|FG000|Overall Study|Other|3|||
154972917|NCT04941768|559325245|FG000|Overall Study|Treatment ongoing|21|||
154972918|NCT04941768|559325245|FG000|Overall Study|Off treatment and in follow-up|21|||
154972919|NCT03302078|559325246|FG000|Washout Period|Adverse Event|0|||
154972920|NCT03302078|559325247|FG001|Washout Period|Adverse Event|1|||
154972921|NCT05148299|559325248|FG000|Treatment Period|Adverse Event|1|||
154972922|NCT05148299|559325248|FG000|Treatment Period|Physician Decision|1|||
154972923|NCT05148299|559325248|FG000|Treatment Period|Death|1|||
154972924|NCT05148299|559325248|FG000|Follow-up Period|Death|3|||
154972925|NCT02161549|559325249|FG000|Overall Study|Physician Decision|6|||
154972926|NCT02161549|559325250|FG001|Overall Study|Physician Decision|2|||
154972927|NCT02340780|559325251|FG000|Overall Study|Ineligible|1|||
154972928|NCT01957150|559325252|FG000|Overall Study|Adverse Event|23|||
154972929|NCT01957150|559325253|FG001|Overall Study|Adverse Event|20|||
154972930|NCT01957150|559325252|FG000|Overall Study|Withdrawal by Subject|13|||
154972931|NCT01957150|559325253|FG001|Overall Study|Withdrawal by Subject|17|||
154972932|NCT01957150|559325252|FG000|Overall Study|Physician Decision|3|||
154972933|NCT01957150|559325253|FG001|Overall Study|Physician Decision|6|||
154972934|NCT01957150|559325252|FG000|Overall Study|Lost to Follow-up|4|||
154972935|NCT01957150|559325253|FG001|Overall Study|Lost to Follow-up|4|||
154972936|NCT01957150|559325252|FG000|Overall Study|Protocol Violation|1|||
154972937|NCT01957150|559325253|FG001|Overall Study|Protocol Violation|0|||
154972938|NCT01957150|559325252|FG000|Overall Study|Lack of Efficacy|11|||
154972939|NCT01957150|559325253|FG001|Overall Study|Lack of Efficacy|11|||
154972940|NCT01856192|559325254|FG000|Overall Study|Adverse Event|12|||
154972941|NCT01856192|559325255|FG001|Overall Study|Adverse Event|4|||
155108883|NCT03629223|559826942|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155108884|NCT03629223|559826943|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
155108885|NCT01555073|559826944|FG000|Overall Study|Lost to Follow-up|1|||
155108886|NCT01555073|559826945|FG001|Overall Study|Lost to Follow-up|2|||
155108887|NCT01555073|559826946|FG002|Overall Study|Lost to Follow-up|0|||
155108888|NCT01555073|559826947|FG003|Overall Study|Lost to Follow-up|5|||
155108889|NCT02027311|559826948|FG000|Overall Study|Protocol Violation|3|||
155108890|NCT02027311|559826949|FG001|Overall Study|Protocol Violation|2|||
155108891|NCT03928418|559826950|FG000|Overall Study|Lost to Follow-up|5|||
155108892|NCT03928418|559826951|FG001|Overall Study|Lost to Follow-up|3|||
155108893|NCT03928418|559826952|FG002|Overall Study|Lost to Follow-up|5|||
155108894|NCT03928418|559826950|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
155108895|NCT03928418|559826951|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
155108896|NCT03928418|559826952|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
155108897|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
155108898|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
155108899|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
155108900|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
155108901|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Death|58|||
155108902|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Death|65|||
155108903|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Adverse Event|28|||
155108904|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Adverse Event|40|||
155108905|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Disease Progression|22|||
155108906|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Disease Progression|35|||
155108907|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Other|25|||
155108908|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Other|33|||
155108909|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
155108910|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
155108911|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Noncompliance|8|||
155108912|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Noncompliance|8|||
155108913|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
155108914|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
155108915|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
155108916|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
155108917|NCT00286091|559826962|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
155108918|NCT00286091|559826963|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
155108919|NCT00286091|559826962|FG000|Open-label Treatment Phase|Physician Decision|24|||
155108920|NCT00286091|559826963|FG001|Open-label Treatment Phase|Physician Decision|21|||
155108921|NCT00286091|559826962|FG000|Open-label Treatment Phase|Adverse Event|5|||
155108922|NCT00286091|559826963|FG001|Open-label Treatment Phase|Adverse Event|16|||
155108923|NCT00286091|559826962|FG000|Open-label Treatment Phase|Other|11|||
155108924|NCT00286091|559826963|FG001|Open-label Treatment Phase|Other|11|||
155108925|NCT00286091|559826962|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
155108926|NCT00286091|559826963|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
155108927|NCT00286091|559826962|FG000|Open-label Treatment Phase|Death|10|||
155108928|NCT00286091|559826963|FG001|Open-label Treatment Phase|Death|7|||
155108929|NCT00286091|559826962|FG000|Open-label Treatment Phase|Disease Progression|9|||
155108930|NCT00286091|559826963|FG001|Open-label Treatment Phase|Disease Progression|3|||
155108931|NCT00286091|559826962|FG000|Open-label Treatment Phase|Noncompliance|3|||
155108932|NCT00286091|559826963|FG001|Open-label Treatment Phase|Noncompliance|1|||
155108933|NCT00286091|559826962|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
155108934|NCT00286091|559826963|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
155174069|NCT03137069|560076588|FG002|Overall Study|Data Entry Error|0|||
155174070|NCT03137069|560076589|FG003|Overall Study|Data Entry Error|1|||
155174071|NCT03137069|560076590|FG004|Overall Study|Data Entry Error|0|||
155174072|NCT03137069|560076591|FG005|Overall Study|Data Entry Error|0|||
155174073|NCT02522624|560076593|FG000|Overall Study|Technical failure|1|||
155108935|NCT00286091|559826962|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
155108936|NCT00286091|559826963|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
155108937|NCT00286091|559826962|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
155108938|NCT00286091|559826963|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
155108939|NCT03799952|559826964|FG000|Overall Study|Program was too easy, discontinued|1|||
155108940|NCT03799952|559826965|FG001|Overall Study|Program was too easy, discontinued|0|||
155108941|NCT03799952|559826964|FG000|Overall Study|Lost to Follow-up|0|||
155108942|NCT03799952|559826965|FG001|Overall Study|Lost to Follow-up|2|||
155108943|NCT02936869|559826966|FG000|Overall Study|Lost to Follow-up|1|||
155108944|NCT02936869|559826967|FG001|Overall Study|Lost to Follow-up|3|||
155108945|NCT02936869|559826966|FG000|Overall Study|Death|0|||
155108946|NCT02936869|559826967|FG001|Overall Study|Death|1|||
155108947|NCT02936869|559826966|FG000|Overall Study|Legal Case|0|||
155108948|NCT02936869|559826967|FG001|Overall Study|Legal Case|1|||
155108949|NCT02936869|559826966|FG000|Overall Study|Protocol Violation|1|||
155174074|NCT02522624|560076594|FG001|Overall Study|Technical failure|0|||
155108950|NCT02936869|559826967|FG001|Overall Study|Protocol Violation|0|||
155108951|NCT04004221|559826972|FG000|Overall Study|Death|89|||
155108952|NCT04004221|559826972|FG000|Overall Study|Withdrawal by Subject|5|||
155108953|NCT04004221|559826972|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
155108954|NCT04004221|559826972|FG000|Overall Study|Sponsor Decision|9|||
155108955|NCT04004221|559826972|FG000|Overall Study|Participant refused to enter LTE|1|||
155108956|NCT03423238|559826975|FG000|Overall Study|Lost to Follow-up|1|||
155108957|NCT03423238|559826976|FG001|Overall Study|Lost to Follow-up|0|||
155108958|NCT03423238|559826975|FG000|Overall Study|Withdrawal by Subject|1|||
155108959|NCT03423238|559826976|FG001|Overall Study|Withdrawal by Subject|0|||
155108960|NCT02036580|559826980|FG000|Overall Study|Withdrawal by Subject|0|||
155108961|NCT02036580|559826981|FG001|Overall Study|Withdrawal by Subject|1|||
155108962|NCT02036580|559826982|FG002|Overall Study|Withdrawal by Subject|0|||
155108963|NCT02036580|559826980|FG000|Overall Study|Adverse Event|1|||
155108964|NCT02036580|559826981|FG001|Overall Study|Adverse Event|0|||
155108965|NCT02036580|559826982|FG002|Overall Study|Adverse Event|0|||
155108966|NCT00506454|559826983|FG000|Overall Study|Withdrawal by Subject|1|||
155108967|NCT00506454|559826984|FG001|Overall Study|Withdrawal by Subject|1|||
155108968|NCT00902850|559826985|FG000|Overall Study|Physician Decision|2|||
155108969|NCT00902850|559826986|FG001|Overall Study|Physician Decision|2|||
155108970|NCT00260832|559826987|FG000|Overall Study|Adverse Event|26|||
155108971|NCT00260832|559826988|FG001|Overall Study|Adverse Event|19|||
155108972|NCT00260832|559826987|FG000|Overall Study|Progression|116|||
155108973|NCT00260832|559826988|FG001|Overall Study|Progression|96|||
155108974|NCT00260832|559826987|FG000|Overall Study|Withdrawal by Subject|15|||
155108975|NCT00260832|559826988|FG001|Overall Study|Withdrawal by Subject|17|||
155108976|NCT00260832|559826987|FG000|Overall Study|Physician Decision|15|||
155108977|NCT00260832|559826988|FG001|Overall Study|Physician Decision|9|||
155108978|NCT00260832|559826987|FG000|Overall Study|Death|43|||
155108979|NCT00260832|559826988|FG001|Overall Study|Death|62|||
155108980|NCT00260832|559826987|FG000|Overall Study|Other|10|||
155108981|NCT00260832|559826988|FG001|Overall Study|Other|7|||
155108982|NCT00260832|559826987|FG000|Overall Study|Protocol Violation|3|||
155108983|NCT00260832|559826988|FG001|Overall Study|Protocol Violation|1|||
155108984|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
155108985|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
155108986|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
155108987|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155108988|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155108989|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155108990|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
155108991|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
155108992|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155108993|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155108994|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155108995|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155108996|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155108997|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
155108998|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
155108999|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
155109000|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
155109001|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155109002|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155109003|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155109004|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
155109005|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
155109006|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
155109007|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155109008|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155109009|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155109010|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155109011|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
155109012|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
155109013|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155109014|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155109015|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155109016|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155109017|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155109018|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
155174075|NCT00369629|560076595|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
155174076|NCT00369629|560076596|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
155174077|NCT00369629|560076597|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
155174078|NCT00369629|560076598|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
155174079|NCT00369629|560076595|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
155174080|NCT00369629|560076596|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
155174081|NCT00369629|560076597|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
155174082|NCT00369629|560076598|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
155174083|NCT00369629|560076595|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
155174084|NCT00369629|560076596|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
155174085|NCT00369629|560076597|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
155174086|NCT00369629|560076598|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
155174087|NCT00369629|560076595|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
155174088|NCT00369629|560076596|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
155174089|NCT00369629|560076597|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
155174090|NCT00369629|560076598|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
155174091|NCT00369629|560076595|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
155174092|NCT00369629|560076596|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
155174093|NCT00369629|560076597|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
155174094|NCT00369629|560076598|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
155174095|NCT00369629|560076595|FG000|Completed 4 More Cycles|Progressive disease|2|||
155174096|NCT00369629|560076596|FG001|Completed 4 More Cycles|Progressive disease|1|||
155174097|NCT00369629|560076597|FG002|Completed 4 More Cycles|Progressive disease|2|||
155174098|NCT00369629|560076598|FG003|Completed 4 More Cycles|Progressive disease|0|||
155174099|NCT00369629|560076595|FG000|Follow up for 1 Year|Death|2|||
155174100|NCT00369629|560076596|FG001|Follow up for 1 Year|Death|1|||
155174101|NCT00369629|560076597|FG002|Follow up for 1 Year|Death|1|||
155174102|NCT00369629|560076598|FG003|Follow up for 1 Year|Death|0|||
155174103|NCT00369629|560076595|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
154863193|NCT03528681|558926559|FG000|Open-Label Phase|Physician Decision|2|||
154863194|NCT03528681|558926560|FG001|Open-Label Phase|Physician Decision|0|||
154863195|NCT03528681|558926561|FG002|Open-Label Phase|Physician Decision|0|||
154863196|NCT03528681|558926562|FG003|Open-Label Phase|Physician Decision|0|||
154863197|NCT03528681|558926559|FG000|Open-Label Phase|Withdrawal by Subject|8|||
154863198|NCT03528681|558926560|FG001|Open-Label Phase|Withdrawal by Subject|0|||
154863199|NCT03528681|558926561|FG002|Open-Label Phase|Withdrawal by Subject|0|||
154863200|NCT03528681|558926562|FG003|Open-Label Phase|Withdrawal by Subject|0|||
154863201|NCT03528681|558926559|FG000|Open-Label Phase|(Not collected)|4|||
154863202|NCT03528681|558926560|FG001|Open-Label Phase|(Not collected)|0|||
154863203|NCT03528681|558926561|FG002|Open-Label Phase|(Not collected)|0|||
154863204|NCT03528681|558926562|FG003|Open-Label Phase|(Not collected)|0|||
154863205|NCT03528681|558926559|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
154863206|NCT03528681|558926560|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
154863207|NCT03528681|558926561|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
154863208|NCT03528681|558926562|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
154863209|NCT03528681|558926559|FG000|Randomized Treatment Phase|Physician Decision|0|||
154863210|NCT03528681|558926560|FG001|Randomized Treatment Phase|Physician Decision|5|||
154863211|NCT03528681|558926561|FG002|Randomized Treatment Phase|Physician Decision|1|||
154863212|NCT03528681|558926562|FG003|Randomized Treatment Phase|Physician Decision|2|||
154863213|NCT03528681|558926559|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
154863214|NCT03528681|558926560|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
154863215|NCT03528681|558926561|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
154863216|NCT03528681|558926562|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
154863217|NCT03528681|558926559|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
154863218|NCT03528681|558926560|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
154863219|NCT03528681|558926561|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
155174104|NCT00369629|560076596|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
154863220|NCT03528681|558926562|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
154863221|NCT03528681|558926559|FG000|Randomized Treatment Phase|(Not collected)|0|||
154863222|NCT03528681|558926560|FG001|Randomized Treatment Phase|(Not collected)|4|||
154863223|NCT03528681|558926561|FG002|Randomized Treatment Phase|(Not collected)|6|||
154863224|NCT03528681|558926562|FG003|Randomized Treatment Phase|(Not collected)|5|||
154863225|NCT02017444|558926567|FG000|Overall Study|Physician Decision|1|||
154863226|NCT02017444|558926568|FG001|Overall Study|Physician Decision|0|||
154863227|NCT02017444|558926567|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
154863228|NCT02017444|558926568|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
155174105|NCT00369629|560076597|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
155174106|NCT00369629|560076598|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
155174107|NCT00369629|560076595|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
154863229|NCT02342171|558926571|FG000|Overall Study|Death|4|||
154972942|NCT01856192|559325254|FG000|Overall Study|Alternative therapy|0|||
154972943|NCT01856192|559325255|FG001|Overall Study|Alternative therapy|3|||
154972944|NCT01856192|559325254|FG000|Overall Study|Death|3|||
154972945|NCT01856192|559325255|FG001|Overall Study|Death|5|||
154972946|NCT01856192|559325254|FG000|Overall Study|Lack of Efficacy|0|||
154972947|NCT01856192|559325255|FG001|Overall Study|Lack of Efficacy|5|||
154972948|NCT01856192|559325254|FG000|Overall Study|Withdrawal by Subject|1|||
154972949|NCT01856192|559325255|FG001|Overall Study|Withdrawal by Subject|1|||
154972950|NCT01856192|559325254|FG000|Overall Study|Other diseases|1|||
154972951|NCT01856192|559325255|FG001|Overall Study|Other diseases|0|||
154972952|NCT01856192|559325254|FG000|Overall Study|Never started treatment|7|||
154972953|NCT01856192|559325255|FG001|Overall Study|Never started treatment|5|||
154972954|NCT01856192|559325254|FG000|Overall Study|Path ineligible|20|||
154972955|NCT01856192|559325255|FG001|Overall Study|Path ineligible|34|||
154972956|NCT01856192|559325254|FG000|Overall Study|Non-path ineligible|2|||
154972957|NCT01856192|559325255|FG001|Overall Study|Non-path ineligible|2|||
154972958|NCT01856192|559325254|FG000|Overall Study|Physician Decision|1|||
154972959|NCT01856192|559325255|FG001|Overall Study|Physician Decision|1|||
154972960|NCT01856192|559325254|FG000|Overall Study|Suspicion of progressive disease|1|||
154972961|NCT01856192|559325255|FG001|Overall Study|Suspicion of progressive disease|0|||
154972962|NCT01856192|559325254|FG000|Overall Study|Non-compliance|1|||
154972963|NCT01856192|559325255|FG001|Overall Study|Non-compliance|0|||
154972964|NCT00640926|559325259|FG000|Overall Study|Adverse Event|2|||
154972965|NCT00640926|559325260|FG001|Overall Study|Adverse Event|3|||
154972966|NCT00640926|559325261|FG002|Overall Study|Adverse Event|2|||
154972967|NCT00640926|559325259|FG000|Overall Study|Lack of Efficacy|0|||
154972968|NCT00640926|559325260|FG001|Overall Study|Lack of Efficacy|2|||
154972969|NCT00640926|559325261|FG002|Overall Study|Lack of Efficacy|1|||
154972970|NCT00640926|559325259|FG000|Overall Study|Protocol Violation|2|||
154972971|NCT00640926|559325260|FG001|Overall Study|Protocol Violation|0|||
154972972|NCT00640926|559325261|FG002|Overall Study|Protocol Violation|2|||
154972973|NCT00640926|559325259|FG000|Overall Study|Lost to Follow-up|3|||
154972974|NCT00640926|559325260|FG001|Overall Study|Lost to Follow-up|1|||
154972975|NCT00640926|559325261|FG002|Overall Study|Lost to Follow-up|2|||
154972976|NCT00640926|559325259|FG000|Overall Study|Withdrawal by Subject|1|||
154972977|NCT00640926|559325260|FG001|Overall Study|Withdrawal by Subject|0|||
154972978|NCT00640926|559325261|FG002|Overall Study|Withdrawal by Subject|1|||
154972979|NCT01841073|559325264|FG000|Overall Study|Adverse Event|1|||
154972980|NCT01841073|559325265|FG001|Overall Study|Adverse Event|1|||
154972981|NCT01841073|559325264|FG000|Overall Study|Physician Decision|1|||
154972982|NCT01841073|559325265|FG001|Overall Study|Physician Decision|0|||
154972983|NCT01841073|559325264|FG000|Overall Study|Lost to Follow-up|0|||
154972984|NCT01841073|559325265|FG001|Overall Study|Lost to Follow-up|2|||
154972985|NCT02858037|559325266|FG000|Overall Study|Death|1|||
154972986|NCT02858037|559325266|FG000|Overall Study|Withdrawal by Subject|18|||
154972987|NCT02858037|559325266|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
154972988|NCT02858037|559325266|FG000|Overall Study|Lost to Follow-up|3|||
154972989|NCT02858037|559325266|FG000|Overall Study|Other|4|||
154972990|NCT00283842|559325267|FG000|Overall Study|Adverse Event|8|||
154972991|NCT00283842|559325268|FG001|Overall Study|Adverse Event|7|||
154972992|NCT00283842|559325269|FG002|Overall Study|Adverse Event|21|||
154972993|NCT00283842|559325270|FG003|Overall Study|Adverse Event|21|||
155109019|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155109020|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
155109021|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155109022|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155109023|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155109024|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155109025|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
155109026|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
155109027|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
154972994|NCT00283842|559325271|FG004|Overall Study|Adverse Event|5|||
154972995|NCT00283842|559325267|FG000|Overall Study|Protocol Violation|1|||
154972996|NCT00283842|559325268|FG001|Overall Study|Protocol Violation|5|||
154972997|NCT00283842|559325269|FG002|Overall Study|Protocol Violation|4|||
154972998|NCT00283842|559325270|FG003|Overall Study|Protocol Violation|0|||
154972999|NCT00283842|559325271|FG004|Overall Study|Protocol Violation|0|||
154973000|NCT00283842|559325267|FG000|Overall Study|Protocol deviation|0|||
154973001|NCT00283842|559325268|FG001|Overall Study|Protocol deviation|0|||
154973002|NCT00283842|559325269|FG002|Overall Study|Protocol deviation|0|||
154973003|NCT00283842|559325270|FG003|Overall Study|Protocol deviation|0|||
154973004|NCT00283842|559325271|FG004|Overall Study|Protocol deviation|2|||
154973005|NCT00283842|559325267|FG000|Overall Study|Withdrawal by Subject|2|||
154973006|NCT00283842|559325268|FG001|Overall Study|Withdrawal by Subject|1|||
154973007|NCT00283842|559325269|FG002|Overall Study|Withdrawal by Subject|1|||
154973008|NCT00283842|559325270|FG003|Overall Study|Withdrawal by Subject|5|||
154973009|NCT00283842|559325271|FG004|Overall Study|Withdrawal by Subject|4|||
155109028|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
155109029|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155109030|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155109031|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155109032|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
155109033|NCT03745638|559826989|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
155109034|NCT03745638|559826990|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
154863230|NCT02342171|558926572|FG001|Overall Study|Death|87|||
154863231|NCT02342171|558926571|FG000|Overall Study|Received favipiravir|10|||
154863232|NCT02342171|558926572|FG001|Overall Study|Received favipiravir|0|||
154863233|NCT02342171|558926571|FG000|Overall Study|Missing cycle treshold value|1|||
154863234|NCT02342171|558926572|FG001|Overall Study|Missing cycle treshold value|0|||
154863235|NCT02342171|558926571|FG000|Overall Study|Unknown outcome|0|||
155109035|NCT03745638|559826991|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
154863236|NCT02342171|558926572|FG001|Overall Study|Unknown outcome|1|||
154863237|NCT02342171|558926571|FG000|Overall Study|Missing age data|0|||
154863238|NCT02342171|558926572|FG001|Overall Study|Missing age data|1|||
154863239|NCT00886821|558926577|FG000|Stage 2|Adverse Event|0|||
154863240|NCT00886821|558926578|FG001|Stage 2|Adverse Event|0|||
154863241|NCT00886821|558926579|FG002|Stage 2|Adverse Event|0|||
154863242|NCT00886821|558926580|FG003|Stage 2|Adverse Event|0|||
154863243|NCT00886821|558926581|FG004|Stage 2|Adverse Event|0|||
154863244|NCT00886821|558926582|FG005|Stage 2|Adverse Event|0|||
154863245|NCT00886821|558926583|FG006|Stage 2|Adverse Event|0|||
154863246|NCT00886821|558926584|FG007|Stage 2|Adverse Event|0|||
154863247|NCT00886821|558926585|FG008|Stage 2|Adverse Event|0|||
154863248|NCT00886821|558926586|FG009|Stage 2|Adverse Event|0|||
154863249|NCT00886821|558926587|FG010|Stage 2|Adverse Event|0|||
154863250|NCT00886821|558926588|FG011|Stage 2|Adverse Event|1|||
154863251|NCT00886821|558926589|FG012|Stage 2|Adverse Event|3|||
154863252|NCT00886821|558926590|FG013|Stage 2|Adverse Event|0|||
154863253|NCT00886821|558926577|FG000|Stage 2|Lost to Follow-up|0|||
154863254|NCT00886821|558926578|FG001|Stage 2|Lost to Follow-up|0|||
154863255|NCT00886821|558926579|FG002|Stage 2|Lost to Follow-up|0|||
154863256|NCT00886821|558926580|FG003|Stage 2|Lost to Follow-up|0|||
154863257|NCT00886821|558926581|FG004|Stage 2|Lost to Follow-up|0|||
154863258|NCT00886821|558926582|FG005|Stage 2|Lost to Follow-up|0|||
154863259|NCT00886821|558926583|FG006|Stage 2|Lost to Follow-up|0|||
154863260|NCT00886821|558926584|FG007|Stage 2|Lost to Follow-up|0|||
154863261|NCT00886821|558926585|FG008|Stage 2|Lost to Follow-up|0|||
154863262|NCT00886821|558926586|FG009|Stage 2|Lost to Follow-up|0|||
154863263|NCT00886821|558926587|FG010|Stage 2|Lost to Follow-up|0|||
154863264|NCT00886821|558926588|FG011|Stage 2|Lost to Follow-up|0|||
154863265|NCT00886821|558926589|FG012|Stage 2|Lost to Follow-up|2|||
154863266|NCT00886821|558926590|FG013|Stage 2|Lost to Follow-up|1|||
154863267|NCT04645797|558926591|FG000|Overall Study|Disease Progression|3|||
154863268|NCT04645797|558926592|FG001|Overall Study|Disease Progression|3|||
154863269|NCT04645797|558926593|FG002|Overall Study|Disease Progression|1|||
154863270|NCT04645797|558926594|FG003|Overall Study|Disease Progression|0|||
154863271|NCT04645797|558926595|FG004|Overall Study|Disease Progression|0|||
154863272|NCT04645797|558926596|FG005|Overall Study|Disease Progression|0|||
154863273|NCT04645797|558926597|FG006|Overall Study|Disease Progression|0|||
154863274|NCT04645797|558926591|FG000|Overall Study|Death|3|||
154863275|NCT04645797|558926592|FG001|Overall Study|Death|1|||
154863276|NCT04645797|558926593|FG002|Overall Study|Death|0|||
154863277|NCT04645797|558926594|FG003|Overall Study|Death|0|||
154863278|NCT04645797|558926595|FG004|Overall Study|Death|0|||
154863279|NCT04645797|558926596|FG005|Overall Study|Death|0|||
154863280|NCT04645797|558926597|FG006|Overall Study|Death|0|||
154863281|NCT03596164|558926598|FG000|Overall Study|Adverse Event|0|||
154863282|NCT03596164|558926599|FG001|Overall Study|Adverse Event|1|||
154863283|NCT03596164|558926598|FG000|Overall Study|Death|1|||
154863284|NCT03596164|558926599|FG001|Overall Study|Death|0|||
154863285|NCT00389207|558926600|FG000|Overall Study|Adverse Event|26|||
155109036|NCT03745638|559826992|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155109037|NCT03745638|559826993|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
154863286|NCT00389207|558926601|FG001|Overall Study|Adverse Event|32|||
154863287|NCT00389207|558926602|FG002|Overall Study|Adverse Event|10|||
154863288|NCT00389207|558926600|FG000|Overall Study|Protocol Violation|3|||
154863289|NCT00389207|558926601|FG001|Overall Study|Protocol Violation|1|||
154863290|NCT00389207|558926602|FG002|Overall Study|Protocol Violation|4|||
154863291|NCT00389207|558926600|FG000|Overall Study|Lost to Follow-up|12|||
154863292|NCT00389207|558926601|FG001|Overall Study|Lost to Follow-up|9|||
154863293|NCT00389207|558926602|FG002|Overall Study|Lost to Follow-up|7|||
154863294|NCT00389207|558926600|FG000|Overall Study|Withdrawal by Subject|5|||
154863295|NCT00389207|558926601|FG001|Overall Study|Withdrawal by Subject|7|||
154863296|NCT00389207|558926602|FG002|Overall Study|Withdrawal by Subject|11|||
154863297|NCT00389207|558926600|FG000|Overall Study|Other|17|||
154863298|NCT00389207|558926601|FG001|Overall Study|Other|23|||
154863299|NCT00389207|558926602|FG002|Overall Study|Other|9|||
155109038|NCT03745638|559826994|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155109039|NCT03745638|559826995|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
155109040|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155109041|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155109042|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155109043|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155109044|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
155109045|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
154863300|NCT02500550|558926604|FG000|Overall Study|Death|7|||
154863301|NCT03293680|558926609|FG000|Overall Study|Death|1|||
154863302|NCT03293680|558926609|FG000|Overall Study|Did not meet inclusion criteria|8|||
154863303|NCT02604264|558926611|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
154863304|NCT02604264|558926612|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
154863305|NCT03192904|558926613|FG000|Overall Study|Physician Decision|3|||
154863306|NCT03192904|558926614|FG001|Overall Study|Physician Decision|1|||
154863307|NCT03192904|558926613|FG000|Overall Study|Lost to Follow-up|0|||
155174108|NCT00369629|560076596|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
155174109|NCT00369629|560076597|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
154863308|NCT03192904|558926614|FG001|Overall Study|Lost to Follow-up|1|||
154863309|NCT00424398|558926615|FG000|Overall Study|Withdrawal by Subject|2|||
154863310|NCT00424398|558926616|FG001|Overall Study|Withdrawal by Subject|1|||
154863311|NCT00424398|558926617|FG002|Overall Study|Withdrawal by Subject|0|||
154863312|NCT00424398|558926615|FG000|Overall Study|Subject met exclusion criteria|1|||
154863313|NCT00424398|558926616|FG001|Overall Study|Subject met exclusion criteria|0|||
154863314|NCT00424398|558926617|FG002|Overall Study|Subject met exclusion criteria|0|||
154863315|NCT01309737|558926621|FG000|Week 0 to 16|Death|1|||
154863316|NCT01309737|558926622|FG001|Week 0 to 16|Death|0|||
154863317|NCT01309737|558926623|FG002|Week 0 to 16|Death|1|||
154863318|NCT01309737|558926624|FG003|Week 0 to 16|Death|0|||
154863319|NCT01309737|558926625|FG004|Week 0 to 16|Death|0|||
154863320|NCT01309737|558926621|FG000|Week 0 to 16|Adverse Event|11|||
154863321|NCT01309737|558926622|FG001|Week 0 to 16|Adverse Event|10|||
154863322|NCT01309737|558926623|FG002|Week 0 to 16|Adverse Event|5|||
154863323|NCT01309737|558926624|FG003|Week 0 to 16|Adverse Event|0|||
154863324|NCT01309737|558926625|FG004|Week 0 to 16|Adverse Event|0|||
154863325|NCT01309737|558926621|FG000|Week 0 to 16|Lack of Efficacy|15|||
154863326|NCT01309737|558926622|FG001|Week 0 to 16|Lack of Efficacy|2|||
154863327|NCT01309737|558926623|FG002|Week 0 to 16|Lack of Efficacy|24|||
154863328|NCT01309737|558926624|FG003|Week 0 to 16|Lack of Efficacy|0|||
154863329|NCT01309737|558926625|FG004|Week 0 to 16|Lack of Efficacy|0|||
154863330|NCT01309737|558926621|FG000|Week 0 to 16|Lost to Follow-up|7|||
154863331|NCT01309737|558926622|FG001|Week 0 to 16|Lost to Follow-up|8|||
154863332|NCT01309737|558926623|FG002|Week 0 to 16|Lost to Follow-up|3|||
154863333|NCT01309737|558926624|FG003|Week 0 to 16|Lost to Follow-up|0|||
154863334|NCT01309737|558926625|FG004|Week 0 to 16|Lost to Follow-up|0|||
154863335|NCT01309737|558926621|FG000|Week 0 to 16|Withdrawal by Subject|7|||
154863336|NCT01309737|558926622|FG001|Week 0 to 16|Withdrawal by Subject|6|||
154863337|NCT01309737|558926623|FG002|Week 0 to 16|Withdrawal by Subject|7|||
154863338|NCT01309737|558926624|FG003|Week 0 to 16|Withdrawal by Subject|0|||
154863339|NCT01309737|558926625|FG004|Week 0 to 16|Withdrawal by Subject|0|||
154863340|NCT01309737|558926621|FG000|Week 0 to 16|Other|10|||
154863341|NCT01309737|558926622|FG001|Week 0 to 16|Other|14|||
154863342|NCT01309737|558926623|FG002|Week 0 to 16|Other|4|||
154863343|NCT01309737|558926624|FG003|Week 0 to 16|Other|0|||
154863344|NCT01309737|558926625|FG004|Week 0 to 16|Other|0|||
154863345|NCT01309737|558926621|FG000|Week 0 to 16|Randomized, but not treated|1|||
154863346|NCT01309737|558926622|FG001|Week 0 to 16|Randomized, but not treated|0|||
154863347|NCT01309737|558926623|FG002|Week 0 to 16|Randomized, but not treated|0|||
154863348|NCT01309737|558926624|FG003|Week 0 to 16|Randomized, but not treated|0|||
154863349|NCT01309737|558926625|FG004|Week 0 to 16|Randomized, but not treated|0|||
154863350|NCT01309737|558926621|FG000|Week 16 to 52|Death|0|||
154863351|NCT01309737|558926622|FG001|Week 16 to 52|Death|0|||
154863352|NCT01309737|558926623|FG002|Week 16 to 52|Death|0|||
154863353|NCT01309737|558926624|FG003|Week 16 to 52|Death|0|||
154863354|NCT01309737|558926625|FG004|Week 16 to 52|Death|1|||
154863355|NCT01309737|558926621|FG000|Week 16 to 52|Adverse Event|7|||
154863356|NCT01309737|558926622|FG001|Week 16 to 52|Adverse Event|7|||
155109046|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
155109047|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
154863357|NCT01309737|558926623|FG002|Week 16 to 52|Adverse Event|0|||
154863358|NCT01309737|558926624|FG003|Week 16 to 52|Adverse Event|6|||
154863359|NCT01309737|558926625|FG004|Week 16 to 52|Adverse Event|5|||
154863360|NCT01309737|558926621|FG000|Week 16 to 52|Lack of Efficacy|107|||
154863361|NCT01309737|558926622|FG001|Week 16 to 52|Lack of Efficacy|76|||
154863362|NCT01309737|558926623|FG002|Week 16 to 52|Lack of Efficacy|0|||
154863363|NCT01309737|558926624|FG003|Week 16 to 52|Lack of Efficacy|25|||
155109048|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
154973010|NCT00283842|559325267|FG000|Overall Study|Lack of Efficacy|1|||
154973011|NCT00283842|559325268|FG001|Overall Study|Lack of Efficacy|3|||
154973012|NCT00283842|559325269|FG002|Overall Study|Lack of Efficacy|1|||
154973013|NCT00283842|559325270|FG003|Overall Study|Lack of Efficacy|0|||
154973014|NCT00283842|559325271|FG004|Overall Study|Lack of Efficacy|3|||
154973015|NCT00283842|559325267|FG000|Overall Study|Lost to Follow-up|0|||
154973016|NCT00283842|559325268|FG001|Overall Study|Lost to Follow-up|2|||
154973017|NCT00283842|559325269|FG002|Overall Study|Lost to Follow-up|4|||
154973018|NCT00283842|559325270|FG003|Overall Study|Lost to Follow-up|1|||
154973019|NCT00283842|559325271|FG004|Overall Study|Lost to Follow-up|1|||
154973020|NCT00550147|559325272|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
154973021|NCT00550147|559325272|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
154973022|NCT00550147|559325272|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
154973023|NCT00550147|559325272|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
154973024|NCT00550147|559325272|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
154973025|NCT04320745|559325273|FG000|Overall Study|Adverse Event|26|||
154973026|NCT04320745|559325273|FG000|Overall Study|Withdrawal by Subject|4|||
154973027|NCT04320745|559325273|FG000|Overall Study|Lost to Follow-up|12|||
154973028|NCT04320745|559325273|FG000|Overall Study|Protocol Deviation|2|||
154973029|NCT04320745|559325273|FG000|Overall Study|Non-compliance With Study Drug|2|||
154973030|NCT04320745|559325273|FG000|Overall Study|Reason Not Specified|1|||
154973031|NCT01685008|559325274|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
154973032|NCT01685008|559325275|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
154973033|NCT01685008|559325276|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
154973034|NCT01685008|559325277|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
154973035|NCT01685008|559325274|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
154973036|NCT01685008|559325275|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
154973037|NCT01685008|559325276|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
154973038|NCT01685008|559325277|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
154973039|NCT01685008|559325274|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
154973040|NCT01685008|559325275|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
154973041|NCT01685008|559325276|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
154973042|NCT01685008|559325277|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
154973043|NCT01685008|559325274|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
154973044|NCT01685008|559325275|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
154973045|NCT01685008|559325276|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
154973046|NCT01685008|559325277|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
154973047|NCT01685008|559325274|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
154973048|NCT01685008|559325275|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
154973049|NCT01685008|559325276|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
154973050|NCT01685008|559325277|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
154973051|NCT04994431|559325279|FG000|Overall Study|Adverse Event|1|||
155109049|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155109050|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
155109051|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
155109052|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
155109053|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
155109054|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155109055|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155109056|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
155109057|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
155109058|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
155109059|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
155109060|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
155109061|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155109062|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155109063|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155109064|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155109065|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
155109066|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
155109067|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
155109068|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155109069|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
154973052|NCT04994431|559325280|FG001|Overall Study|Adverse Event|0|||
155109070|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
154973053|NCT02151149|559325284|FG000|Treatment Period|Death|2|||
154973054|NCT02151149|559325285|FG001|Treatment Period|Death|3|||
154973055|NCT02151149|559325284|FG000|Treatment Period|Adverse Event|17|||
154973056|NCT02151149|559325285|FG001|Treatment Period|Adverse Event|14|||
155174110|NCT00369629|560076598|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
155174111|NCT04839562|560076599|FG000|Overall Study|Withdrawal by Subject|0|||
155174112|NCT04839562|560076600|FG001|Overall Study|Withdrawal by Subject|1|||
155174113|NCT04839562|560076599|FG000|Overall Study|Physician Decision|0|||
155174114|NCT04839562|560076600|FG001|Overall Study|Physician Decision|1|||
155174115|NCT00877773|560076601|FG000|Overall Study|Disease Progression|44|||
155174116|NCT01347580|560076602|FG000|Overall Study|Withdrawal by Subject|13|||
155174117|NCT01347580|560076603|FG001|Overall Study|Withdrawal by Subject|23|||
155174118|NCT01347580|560076602|FG000|Overall Study|Death|30|||
155174119|NCT01347580|560076603|FG001|Overall Study|Death|19|||
155174120|NCT01347580|560076602|FG000|Overall Study|Protocol Violation|10|||
155174121|NCT01347580|560076603|FG001|Overall Study|Protocol Violation|7|||
155174122|NCT01347580|560076602|FG000|Overall Study|Lost to Follow-up|3|||
155174123|NCT01347580|560076603|FG001|Overall Study|Lost to Follow-up|1|||
155174124|NCT01347580|560076602|FG000|Overall Study|Had other reason|9|||
155174125|NCT01347580|560076603|FG001|Overall Study|Had other reason|6|||
155174126|NCT01964755|560076604|FG000|Overall Study|Death|2|||
155174127|NCT01659554|560076606|FG000|Overall Study|Study Termination|4|||
155174128|NCT00097981|560076618|FG000|Overall Study|Adverse Event|31|||
155174129|NCT00097981|560076619|FG001|Overall Study|Adverse Event|44|||
155174130|NCT00097981|560076618|FG000|Overall Study|Withdrawal by Subject|10|||
155174131|NCT00097981|560076619|FG001|Overall Study|Withdrawal by Subject|8|||
155174132|NCT00097981|560076618|FG000|Overall Study|Protocol Violation|1|||
155174133|NCT00097981|560076619|FG001|Overall Study|Protocol Violation|1|||
155174134|NCT00097981|560076618|FG000|Overall Study|Death|2|||
155174135|NCT00097981|560076619|FG001|Overall Study|Death|4|||
155174136|NCT00097981|560076618|FG000|Overall Study|Physician Decision|7|||
155174137|NCT00097981|560076619|FG001|Overall Study|Physician Decision|1|||
155174138|NCT00097981|560076618|FG000|Overall Study|Disease Progression|8|||
155174139|NCT00097981|560076619|FG001|Overall Study|Disease Progression|2|||
155174140|NCT00097981|560076618|FG000|Overall Study|Transplant planned|28|||
155174141|NCT00097981|560076619|FG001|Overall Study|Transplant planned|27|||
155174142|NCT00097981|560076618|FG000|Overall Study|Other|19|||
155174143|NCT00097981|560076619|FG001|Overall Study|Other|13|||
155174144|NCT00412373|560076620|FG000|Overall Study|Adverse Event|8|||
155174145|NCT00412373|560076621|FG001|Overall Study|Adverse Event|13|||
155174146|NCT00412373|560076620|FG000|Overall Study|Lack of Efficacy|16|||
155174147|NCT00412373|560076621|FG001|Overall Study|Lack of Efficacy|22|||
155174148|NCT00412373|560076620|FG000|Overall Study|Lost to Follow-up|7|||
155174149|NCT00412373|560076621|FG001|Overall Study|Lost to Follow-up|13|||
155174150|NCT00412373|560076620|FG000|Overall Study|Withdrawal by Subject|8|||
155174151|NCT00412373|560076621|FG001|Overall Study|Withdrawal by Subject|27|||
155174152|NCT00412373|560076620|FG000|Overall Study|Other|2|||
155174153|NCT00412373|560076621|FG001|Overall Study|Other|2|||
155174154|NCT03032380|560076627|FG000|Overall Study|Adverse Event|0|||
155174155|NCT03032380|560076628|FG001|Overall Study|Adverse Event|1|||
155174156|NCT03032380|560076627|FG000|Overall Study|Lack of Efficacy|1|||
155174157|NCT03032380|560076628|FG001|Overall Study|Lack of Efficacy|0|||
155174158|NCT03032380|560076627|FG000|Overall Study|Withdrawal by Subject|2|||
155174159|NCT03032380|560076628|FG001|Overall Study|Withdrawal by Subject|3|||
155174160|NCT03032380|560076627|FG000|Overall Study|Recovery|0|||
155174161|NCT03032380|560076628|FG001|Overall Study|Recovery|1|||
155174162|NCT03032380|560076627|FG000|Overall Study|Death|39|||
155174163|NCT03032380|560076628|FG001|Overall Study|Death|34|||
155174164|NCT03032380|560076627|FG000|Overall Study|Other - Miscellaneous|0|||
155174165|NCT03032380|560076628|FG001|Overall Study|Other - Miscellaneous|1|||
155174166|NCT04493892|560076629|FG000|Overall Study|Withdrawal by Subject|15|||
155174167|NCT02267317|560076632|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
154863364|NCT01309737|558926625|FG004|Week 16 to 52|Lack of Efficacy|21|||
154863365|NCT01309737|558926621|FG000|Week 16 to 52|Lost to Follow-up|4|||
154863366|NCT01309737|558926622|FG001|Week 16 to 52|Lost to Follow-up|2|||
154863367|NCT01309737|558926623|FG002|Week 16 to 52|Lost to Follow-up|0|||
154863368|NCT01309737|558926624|FG003|Week 16 to 52|Lost to Follow-up|1|||
154863369|NCT01309737|558926625|FG004|Week 16 to 52|Lost to Follow-up|4|||
155174168|NCT02267317|560076633|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155174169|NCT02267317|560076634|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155174170|NCT02267317|560076635|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155174171|NCT02267317|560076636|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
155174172|NCT02267317|560076637|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
154863370|NCT01309737|558926621|FG000|Week 16 to 52|Withdrawal by Subject|5|||
155174173|NCT02267317|560076632|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
155174174|NCT02267317|560076633|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155174175|NCT02267317|560076634|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155174176|NCT02267317|560076635|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
155174177|NCT02267317|560076636|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
154863371|NCT01309737|558926622|FG001|Week 16 to 52|Withdrawal by Subject|6|||
155174178|NCT02267317|560076637|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
154863372|NCT01309737|558926623|FG002|Week 16 to 52|Withdrawal by Subject|0|||
154863373|NCT01309737|558926624|FG003|Week 16 to 52|Withdrawal by Subject|0|||
154863374|NCT01309737|558926625|FG004|Week 16 to 52|Withdrawal by Subject|2|||
154863375|NCT01309737|558926621|FG000|Week 16 to 52|Other|10|||
154863376|NCT01309737|558926622|FG001|Week 16 to 52|Other|12|||
154863377|NCT01309737|558926623|FG002|Week 16 to 52|Other|0|||
154863378|NCT01309737|558926624|FG003|Week 16 to 52|Other|2|||
154973057|NCT02151149|559325284|FG000|Treatment Period|Progressive Disease|25|||
154973058|NCT02151149|559325285|FG001|Treatment Period|Progressive Disease|24|||
154973059|NCT02151149|559325284|FG000|Treatment Period|Symptomatic Deterioration|2|||
154973060|NCT02151149|559325285|FG001|Treatment Period|Symptomatic Deterioration|10|||
154973061|NCT02151149|559325284|FG000|Treatment Period|Withdrawal by Subject|13|||
154973062|NCT02151149|559325285|FG001|Treatment Period|Withdrawal by Subject|11|||
154973063|NCT02151149|559325284|FG000|Treatment Period|Miscellaneous|8|||
154973064|NCT02151149|559325285|FG001|Treatment Period|Miscellaneous|7|||
154973065|NCT02151149|559325284|FG000|Treatment Period|Participants randomized but not treated|3|||
154973066|NCT02151149|559325285|FG001|Treatment Period|Participants randomized but not treated|2|||
154973067|NCT02151149|559325284|FG000|Follow-Up Period|Lost to Follow-up|2|||
154973068|NCT02151149|559325285|FG001|Follow-Up Period|Lost to Follow-up|3|||
154973069|NCT02151149|559325284|FG000|Follow-Up Period|Death|37|||
154973070|NCT02151149|559325285|FG001|Follow-Up Period|Death|34|||
154973071|NCT03419962|559325288|FG000|Overall Study|Change to other medication|1|||
154973072|NCT03419962|559325288|FG000|Overall Study|Refusal of continuing with trial drug|1|||
154973073|NCT03419962|559325288|FG000|Overall Study|Lost to Follow-up|3|||
154973074|NCT03419962|559325288|FG000|Overall Study|Difficulty in inhaling the doses|1|||
154973075|NCT03419962|559325288|FG000|Overall Study|Missing completion data|31|||
154973076|NCT04142658|559325289|FG000|Overall Study|Death|2|||
154973077|NCT04142658|559325290|FG001|Overall Study|Death|1|||
154973078|NCT04142658|559325289|FG000|Overall Study|Lost to Follow-up|4|||
154973079|NCT04142658|559325290|FG001|Overall Study|Lost to Follow-up|13|||
154973080|NCT04142658|559325289|FG000|Overall Study|Withdrawal by Subject|9|||
154973081|NCT04142658|559325290|FG001|Overall Study|Withdrawal by Subject|16|||
154973082|NCT01781234|559325291|FG000|Overall Study|Adverse Event|2|||
154973083|NCT01781234|559325292|FG001|Overall Study|Adverse Event|0|||
154973084|NCT01781234|559325291|FG000|Overall Study|Protocol Violation|3|||
154973085|NCT01781234|559325292|FG001|Overall Study|Protocol Violation|0|||
154973086|NCT01781234|559325291|FG000|Overall Study|Withdrawal by Subject|4|||
154973087|NCT01781234|559325292|FG001|Overall Study|Withdrawal by Subject|3|||
154973088|NCT03439085|559325293|FG000|Overall Study|Death|2|||
154973089|NCT03439085|559325293|FG000|Overall Study|Screen Failure|20|||
154973090|NCT01499160|559325297|FG000|Overall Study|Adverse Event|1|||
154973091|NCT01499160|559325297|FG000|Overall Study|Withdrawal by Subject|1|||
154973092|NCT01438476|559325301|FG000|Overall Study|Protocol Violation|1|||
154973093|NCT01438476|559325302|FG001|Overall Study|Protocol Violation|0|||
154973094|NCT01438476|559325301|FG000|Overall Study|Withdrawal by Subject|1|||
154973095|NCT01438476|559325302|FG001|Overall Study|Withdrawal by Subject|0|||
154973096|NCT01438476|559325301|FG000|Overall Study|No Surgery- Disease|8|||
154973097|NCT01438476|559325302|FG001|Overall Study|No Surgery- Disease|10|||
154973098|NCT01438476|559325301|FG000|Overall Study|Communication barrier|0|||
154973099|NCT01438476|559325302|FG001|Overall Study|Communication barrier|1|||
154973100|NCT03566238|559325304|FG000|Overall Study|Adverse Event|0|||
154973101|NCT03566238|559325305|FG001|Overall Study|Adverse Event|0|||
154973102|NCT03566238|559325306|FG002|Overall Study|Adverse Event|1|||
154973103|NCT03566238|559325304|FG000|Overall Study|Lack of Efficacy|5|||
154973104|NCT03566238|559325305|FG001|Overall Study|Lack of Efficacy|4|||
154973105|NCT03566238|559325306|FG002|Overall Study|Lack of Efficacy|2|||
154973106|NCT03566238|559325304|FG000|Overall Study|Other|0|||
154973107|NCT03566238|559325305|FG001|Overall Study|Other|1|||
154973108|NCT03566238|559325306|FG002|Overall Study|Other|0|||
154973109|NCT00860262|559325310|FG000|Overall Study|Adverse Event|9|||
154973110|NCT00860262|559325311|FG001|Overall Study|Adverse Event|6|||
155109071|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
154863379|NCT01309737|558926625|FG004|Week 16 to 52|Other|0|||
154863380|NCT00709202|558926626|FG000|Overall Study|Withdrawal by Subject|6|||
154973111|NCT00860262|559325312|FG002|Overall Study|Adverse Event|7|||
154973112|NCT00860262|559325310|FG000|Overall Study|Protocol Violation|0|||
154973113|NCT00860262|559325311|FG001|Overall Study|Protocol Violation|1|||
154973114|NCT00860262|559325312|FG002|Overall Study|Protocol Violation|0|||
154973115|NCT00860262|559325310|FG000|Overall Study|Lost to Follow-up|2|||
154973116|NCT00860262|559325311|FG001|Overall Study|Lost to Follow-up|0|||
154973117|NCT00860262|559325312|FG002|Overall Study|Lost to Follow-up|1|||
154973118|NCT00860262|559325310|FG000|Overall Study|Withdrawal by Subject|4|||
154973119|NCT00860262|559325311|FG001|Overall Study|Withdrawal by Subject|8|||
154973120|NCT00860262|559325312|FG002|Overall Study|Withdrawal by Subject|6|||
154973121|NCT00860262|559325310|FG000|Overall Study|Lack of Efficacy|0|||
154973122|NCT00860262|559325311|FG001|Overall Study|Lack of Efficacy|4|||
154973123|NCT00860262|559325312|FG002|Overall Study|Lack of Efficacy|3|||
154973124|NCT00860262|559325310|FG000|Overall Study|Other|5|||
154973125|NCT00860262|559325311|FG001|Overall Study|Other|3|||
154863381|NCT00709202|558926627|FG001|Overall Study|Withdrawal by Subject|6|||
154863382|NCT00855439|558926628|FG000|Overall Study|Withdrawal by Subject|2|||
154863383|NCT00855439|558926629|FG001|Overall Study|Withdrawal by Subject|0|||
154863384|NCT00855439|558926628|FG000|Overall Study|Pregnancy|1|||
154863385|NCT00855439|558926629|FG001|Overall Study|Pregnancy|0|||
154863386|NCT02272790|558926633|FG000|Overall Study|Physician Decision|0|||
154863387|NCT02272790|558926634|FG001|Overall Study|Physician Decision|1|||
154863388|NCT02272790|558926635|FG002|Overall Study|Physician Decision|0|||
154863389|NCT02272790|558926636|FG003|Overall Study|Physician Decision|0|||
154863390|NCT02272790|558926637|FG004|Overall Study|Physician Decision|0|||
154863391|NCT02272790|558926638|FG005|Overall Study|Physician Decision|0|||
154863392|NCT01076179|558926639|FG000|Overall Study|Withdrawal by Subject|1|||
154863393|NCT03459040|558926640|FG000|Overall Study|Death|8|||
154863394|NCT03459040|558926640|FG000|Overall Study|Withdrawal by Subject|1|||
154863395|NCT00986349|558926641|FG000|Overall Study|Unsuccessful implant procedure|3|||
154863396|NCT00986349|558926641|FG000|Overall Study|Adverse Event|2|||
154863397|NCT00986349|558926641|FG000|Overall Study|Physician Decision|1|||
154863398|NCT00986349|558926641|FG000|Overall Study|device migration|1|||
154863399|NCT02299934|558926642|FG000|Overall Study|Termination of study|13|||
154863400|NCT01273818|558926643|FG000|Overall Study|Physician Decision|13|||
154863401|NCT01273818|558926644|FG001|Overall Study|Physician Decision|2|||
154863402|NCT01273818|558926645|FG002|Overall Study|Physician Decision|9|||
154863403|NCT03815175|558926646|FG000|Overall Study|Subject Lost to Follow-up|6|||
154863404|NCT03815175|558926646|FG000|Overall Study|Subject Withdrew Consent|48|||
154863405|NCT03815175|558926646|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
154863406|NCT03815175|558926646|FG000|Overall Study|Death|86|||
154863407|NCT03815175|558926646|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
154863408|NCT03815175|558926646|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
154863409|NCT03815175|558926646|FG000|Overall Study|Other Status Change Reason|1|||
154863410|NCT03815175|558926646|FG000|Overall Study|Missed Visit|12|||
154863411|NCT03577990|558926647|FG000|Overall Study|Lost to Follow-up|4|||
154863412|NCT03577990|558926648|FG001|Overall Study|Lost to Follow-up|6|||
154863413|NCT03577990|558926647|FG000|Overall Study|Withdrawal by Subject|4|||
154863414|NCT03577990|558926648|FG001|Overall Study|Withdrawal by Subject|7|||
154863415|NCT03934684|558926653|FG000|Overall Study|Participants continuing in study|11|||
154863416|NCT03934684|558926654|FG001|Overall Study|Participants continuing in study|4|||
154863417|NCT03934684|558926653|FG000|Overall Study|Discontinuation of carfilzomib|20|||
154863418|NCT03934684|558926654|FG001|Overall Study|Discontinuation of carfilzomib|30|||
154863419|NCT03934684|558926653|FG000|Overall Study|Death|2|||
154863420|NCT03934684|558926654|FG001|Overall Study|Death|2|||
154863421|NCT03934684|558926653|FG000|Overall Study|Lost to Follow-up|2|||
154863422|NCT03934684|558926654|FG001|Overall Study|Lost to Follow-up|5|||
154863423|NCT03934684|558926653|FG000|Overall Study|Withdrawal by Subject|7|||
154863424|NCT03934684|558926654|FG001|Overall Study|Withdrawal by Subject|8|||
154863425|NCT01073943|558926655|FG000|Overall Study|Withdrawal by Subject|8|||
154863426|NCT01073943|558926656|FG001|Overall Study|Withdrawal by Subject|2|||
154863427|NCT01073943|558926655|FG000|Overall Study|Protocol Violation|2|||
154863428|NCT01073943|558926656|FG001|Overall Study|Protocol Violation|1|||
154863429|NCT01073943|558926655|FG000|Overall Study|Adverse Event|1|||
154863430|NCT01073943|558926656|FG001|Overall Study|Adverse Event|1|||
154863431|NCT01073943|558926655|FG000|Overall Study|Lost to Follow-up|0|||
154863432|NCT01073943|558926656|FG001|Overall Study|Lost to Follow-up|2|||
154863433|NCT01073943|558926655|FG000|Overall Study|Power outage; colonoscopy not done|1|||
154863434|NCT01073943|558926656|FG001|Overall Study|Power outage; colonoscopy not done|0|||
154863435|NCT01073943|558926655|FG000|Overall Study|Subject forgot|0|||
154863436|NCT01073943|558926656|FG001|Overall Study|Subject forgot|1|||
154863437|NCT01073943|558926655|FG000|Overall Study|Unable to return for follow-up|0|||
154863438|NCT01073943|558926656|FG001|Overall Study|Unable to return for follow-up|1|||
154863439|NCT01073943|558926655|FG000|Overall Study|Could not tolerate prep|1|||
154863440|NCT01073943|558926656|FG001|Overall Study|Could not tolerate prep|0|||
154863441|NCT00488631|558926657|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
154863442|NCT00488631|558926658|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
154863443|NCT00488631|558926659|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
154863444|NCT00488631|558926660|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
154863445|NCT00488631|558926661|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
154863446|NCT00488631|558926662|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
154863447|NCT00488631|558926663|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
154863448|NCT00488631|558926664|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
154863449|NCT00488631|558926665|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
154863450|NCT00488631|558926666|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
154863451|NCT00488631|558926657|FG000|Double Blind Period (Week 0-54)|Death|0|||
154863452|NCT00488631|558926658|FG001|Double Blind Period (Week 0-54)|Death|0|||
154863453|NCT00488631|558926659|FG002|Double Blind Period (Week 0-54)|Death|0|||
154863454|NCT00488631|558926660|FG003|Double Blind Period (Week 0-54)|Death|0|||
154863455|NCT00488631|558926661|FG004|Double Blind Period (Week 0-54)|Death|0|||
155109072|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155174179|NCT02208063|560076640|FG000|Overall Study|Death|3|||
155174180|NCT02208063|560076641|FG001|Overall Study|Death|5|||
155174181|NCT02208063|560076640|FG000|Overall Study|Not Specified in report|3|||
155174182|NCT02208063|560076641|FG001|Overall Study|Not Specified in report|4|||
155174183|NCT02208063|560076640|FG000|Overall Study|Withdrawal by Subject|5|||
155174184|NCT02208063|560076641|FG001|Overall Study|Withdrawal by Subject|2|||
155174185|NCT02208063|560076640|FG000|Overall Study|Lost to Follow-up|1|||
155174186|NCT02208063|560076641|FG001|Overall Study|Lost to Follow-up|0|||
155174187|NCT00913458|560076642|FG000|Phase 1|Non-Responder|54|||
155174188|NCT00913458|560076643|FG001|Phase 1|Non-Responder|0|||
155174189|NCT00913458|560076644|FG002|Phase 1|Non-Responder|0|||
155174190|NCT00913458|560076645|FG003|Phase 1|Non-Responder|0|||
155174191|NCT00913458|560076646|FG004|Phase 1|Non-Responder|0|||
155174192|NCT00913458|560076647|FG005|Phase 1|Non-Responder|0|||
155174193|NCT00913458|560076648|FG006|Phase 1|Non-Responder|0|||
155174194|NCT00913458|560076642|FG000|Phase 1|Subject Request|17|||
155174195|NCT00913458|560076643|FG001|Phase 1|Subject Request|0|||
155174196|NCT00913458|560076644|FG002|Phase 1|Subject Request|0|||
155174197|NCT00913458|560076645|FG003|Phase 1|Subject Request|0|||
155174198|NCT00913458|560076646|FG004|Phase 1|Subject Request|0|||
155174199|NCT00913458|560076647|FG005|Phase 1|Subject Request|0|||
155174200|NCT00913458|560076648|FG006|Phase 1|Subject Request|0|||
155174201|NCT00913458|560076642|FG000|Phase 1|Adverse Event|20|||
155174202|NCT00913458|560076643|FG001|Phase 1|Adverse Event|0|||
155174203|NCT00913458|560076644|FG002|Phase 1|Adverse Event|0|||
155174204|NCT00913458|560076645|FG003|Phase 1|Adverse Event|0|||
155174205|NCT00913458|560076646|FG004|Phase 1|Adverse Event|0|||
155174206|NCT00913458|560076647|FG005|Phase 1|Adverse Event|0|||
155174207|NCT00913458|560076648|FG006|Phase 1|Adverse Event|0|||
155174208|NCT00913458|560076642|FG000|Phase 1|Lost to Follow-up|2|||
155174209|NCT00913458|560076643|FG001|Phase 1|Lost to Follow-up|0|||
155174210|NCT00913458|560076644|FG002|Phase 1|Lost to Follow-up|0|||
155174211|NCT00913458|560076645|FG003|Phase 1|Lost to Follow-up|0|||
155174212|NCT00913458|560076646|FG004|Phase 1|Lost to Follow-up|0|||
155174213|NCT00913458|560076647|FG005|Phase 1|Lost to Follow-up|0|||
155174214|NCT00913458|560076648|FG006|Phase 1|Lost to Follow-up|0|||
155174215|NCT00913458|560076642|FG000|Phase 1|Protocol Violation|10|||
155174216|NCT00913458|560076643|FG001|Phase 1|Protocol Violation|0|||
155174217|NCT00913458|560076644|FG002|Phase 1|Protocol Violation|0|||
155174218|NCT00913458|560076645|FG003|Phase 1|Protocol Violation|0|||
155174219|NCT00913458|560076646|FG004|Phase 1|Protocol Violation|0|||
155174220|NCT00913458|560076647|FG005|Phase 1|Protocol Violation|0|||
155174221|NCT00913458|560076648|FG006|Phase 1|Protocol Violation|0|||
155174222|NCT00913458|560076642|FG000|Phase 1|Sponsor|2|||
155174223|NCT00913458|560076643|FG001|Phase 1|Sponsor|0|||
155174224|NCT00913458|560076644|FG002|Phase 1|Sponsor|0|||
155174225|NCT00913458|560076645|FG003|Phase 1|Sponsor|0|||
155174226|NCT00913458|560076646|FG004|Phase 1|Sponsor|0|||
155174227|NCT00913458|560076647|FG005|Phase 1|Sponsor|0|||
155174228|NCT00913458|560076648|FG006|Phase 1|Sponsor|0|||
155174229|NCT00913458|560076642|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
155174230|NCT00913458|560076643|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
155174231|NCT00913458|560076644|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
155174232|NCT00913458|560076645|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
155174233|NCT00913458|560076646|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
155174234|NCT00913458|560076647|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
155174235|NCT00913458|560076648|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
155174236|NCT00913458|560076642|FG000|Phase 2|Non-Responder|0|||
154863456|NCT00488631|558926662|FG005|Double Blind Period (Week 0-54)|Death|1|||
154863457|NCT00488631|558926663|FG006|Double Blind Period (Week 0-54)|Death|0|||
154863458|NCT00488631|558926664|FG007|Double Blind Period (Week 0-54)|Death|0|||
154863459|NCT00488631|558926665|FG008|Double Blind Period (Week 0-54)|Death|0|||
154863460|NCT00488631|558926666|FG009|Double Blind Period (Week 0-54)|Death|0|||
155174237|NCT00913458|560076643|FG001|Phase 2|Non-Responder|5|||
154863461|NCT00488631|558926657|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
154863462|NCT00488631|558926658|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
155174238|NCT00913458|560076644|FG002|Phase 2|Non-Responder|7|||
155174239|NCT00913458|560076645|FG003|Phase 2|Non-Responder|12|||
154863463|NCT00488631|558926659|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
154863464|NCT00488631|558926660|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
155174240|NCT00913458|560076646|FG004|Phase 2|Non-Responder|0|||
155174241|NCT00913458|560076647|FG005|Phase 2|Non-Responder|0|||
155174242|NCT00913458|560076648|FG006|Phase 2|Non-Responder|0|||
155174243|NCT00913458|560076642|FG000|Phase 2|Subject Request|0|||
155174244|NCT00913458|560076643|FG001|Phase 2|Subject Request|0|||
155174245|NCT00913458|560076644|FG002|Phase 2|Subject Request|1|||
155174246|NCT00913458|560076645|FG003|Phase 2|Subject Request|2|||
155174247|NCT00913458|560076646|FG004|Phase 2|Subject Request|0|||
155174248|NCT00913458|560076647|FG005|Phase 2|Subject Request|0|||
155174249|NCT00913458|560076648|FG006|Phase 2|Subject Request|0|||
155174250|NCT00913458|560076642|FG000|Phase 2|Adverse Event|0|||
155174251|NCT00913458|560076643|FG001|Phase 2|Adverse Event|3|||
155174252|NCT00913458|560076644|FG002|Phase 2|Adverse Event|0|||
154863465|NCT00488631|558926661|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
154863466|NCT00488631|558926662|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
154863467|NCT00488631|558926663|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
154863468|NCT00488631|558926664|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
154863469|NCT00488631|558926665|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
154863470|NCT00488631|558926666|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
154863471|NCT00488631|558926657|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
154863472|NCT00488631|558926658|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
154863473|NCT00488631|558926659|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
154863474|NCT00488631|558926660|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
154863475|NCT00488631|558926661|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
154863476|NCT00488631|558926662|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
154863477|NCT00488631|558926663|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
154863478|NCT00488631|558926664|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
154863479|NCT00488631|558926665|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
154863480|NCT00488631|558926666|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
154863481|NCT00488631|558926657|FG000|Double Blind Period (Week 0-54)|Other|6|||
154863482|NCT00488631|558926658|FG001|Double Blind Period (Week 0-54)|Other|12|||
154863483|NCT00488631|558926659|FG002|Double Blind Period (Week 0-54)|Other|10|||
154863484|NCT00488631|558926660|FG003|Double Blind Period (Week 0-54)|Other|11|||
154863485|NCT00488631|558926661|FG004|Double Blind Period (Week 0-54)|Other|14|||
154863486|NCT00488631|558926662|FG005|Double Blind Period (Week 0-54)|Other|34|||
154863487|NCT00488631|558926663|FG006|Double Blind Period (Week 0-54)|Other|0|||
154863488|NCT00488631|558926664|FG007|Double Blind Period (Week 0-54)|Other|0|||
154863489|NCT00488631|558926665|FG008|Double Blind Period (Week 0-54)|Other|0|||
154863490|NCT00488631|558926666|FG009|Double Blind Period (Week 0-54)|Other|0|||
154863491|NCT00488631|558926657|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863492|NCT00488631|558926658|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863493|NCT00488631|558926659|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863494|NCT00488631|558926660|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863495|NCT00488631|558926661|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863496|NCT00488631|558926662|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863497|NCT00488631|558926663|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
154863498|NCT00488631|558926664|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
154863499|NCT00488631|558926665|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
154863500|NCT00488631|558926666|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
154863501|NCT00488631|558926657|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
154863502|NCT00488631|558926658|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
154863503|NCT00488631|558926659|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
154863504|NCT00488631|558926660|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
154863505|NCT00488631|558926661|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
154863506|NCT00488631|558926662|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
154863507|NCT00488631|558926663|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
154863508|NCT00488631|558926664|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
154863509|NCT00488631|558926665|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
154863510|NCT00488631|558926666|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
154863511|NCT00488631|558926657|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
154863512|NCT00488631|558926658|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
154863513|NCT00488631|558926659|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
154863514|NCT00488631|558926660|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
154863515|NCT00488631|558926661|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
154863516|NCT00488631|558926662|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
154863517|NCT00488631|558926663|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
154863518|NCT00488631|558926664|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
154863519|NCT00488631|558926665|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
154863520|NCT00488631|558926666|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
154863521|NCT00488631|558926657|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863522|NCT00488631|558926658|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863523|NCT00488631|558926659|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863524|NCT00488631|558926660|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863525|NCT00488631|558926661|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863526|NCT00488631|558926662|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863527|NCT00488631|558926663|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
154973126|NCT00860262|559325312|FG002|Overall Study|Other|1|||
154973127|NCT01374451|559325334|FG000|Overall Study|Administrative problems|1|||
155109073|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
154863528|NCT00488631|558926664|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863529|NCT00488631|558926665|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
154863530|NCT00488631|558926666|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
154863531|NCT00488631|558926657|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863532|NCT00488631|558926658|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863533|NCT00488631|558926659|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863534|NCT00488631|558926660|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863535|NCT00488631|558926661|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863536|NCT00488631|558926662|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863537|NCT00488631|558926663|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
154863538|NCT00488631|558926664|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
154863539|NCT00488631|558926665|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
154863540|NCT00488631|558926666|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
154863541|NCT00761215|558926672|FG000|Overall Study|Randomized but didn't receive drug|1|||
154863542|NCT00761215|558926673|FG001|Overall Study|Randomized but didn't receive drug|1|||
154863543|NCT00761215|558926674|FG002|Overall Study|Randomized but didn't receive drug|2|||
154863544|NCT00761215|558926672|FG000|Overall Study|Lost to Follow-up|6|||
154863545|NCT00761215|558926673|FG001|Overall Study|Lost to Follow-up|3|||
154863546|NCT00761215|558926674|FG002|Overall Study|Lost to Follow-up|6|||
154863547|NCT00761215|558926672|FG000|Overall Study|Withdrawal by Subject|1|||
154863548|NCT00761215|558926673|FG001|Overall Study|Withdrawal by Subject|0|||
154863549|NCT00761215|558926674|FG002|Overall Study|Withdrawal by Subject|0|||
154863550|NCT00761215|558926672|FG000|Overall Study|Bacteremia|1|||
154863551|NCT00761215|558926673|FG001|Overall Study|Bacteremia|0|||
154863552|NCT00761215|558926674|FG002|Overall Study|Bacteremia|0|||
154863553|NCT05662332|558926675|FG000|Overall Study|Death|3|||
154863554|NCT05662332|558926676|FG001|Overall Study|Death|3|||
154863555|NCT05662332|558926675|FG000|Overall Study|Lost to Follow-up|3|||
154863556|NCT05662332|558926676|FG001|Overall Study|Lost to Follow-up|8|||
154863557|NCT05662332|558926675|FG000|Overall Study|Physician Decision|1|||
154863558|NCT05662332|558926676|FG001|Overall Study|Physician Decision|2|||
154863559|NCT05662332|558926675|FG000|Overall Study|Protocol Deviation|2|||
154863560|NCT05662332|558926676|FG001|Overall Study|Protocol Deviation|1|||
154863561|NCT05662332|558926675|FG000|Overall Study|Withdrawal by Subject|14|||
154863562|NCT05662332|558926676|FG001|Overall Study|Withdrawal by Subject|14|||
154863563|NCT05662332|558926675|FG000|Overall Study|Assigned Treatment by Mistake|5|||
154863564|NCT05662332|558926676|FG001|Overall Study|Assigned Treatment by Mistake|7|||
154863565|NCT05662332|558926675|FG000|Overall Study|Non-compliance with study drug|4|||
154863566|NCT05662332|558926676|FG001|Overall Study|Non-compliance with study drug|1|||
154863567|NCT05662332|558926675|FG000|Overall Study|Due to Bariatric surgery|1|||
154863568|NCT05662332|558926676|FG001|Overall Study|Due to Bariatric surgery|0|||
154863569|NCT05662332|558926675|FG000|Overall Study|Subject Moving out of State|0|||
154863570|NCT05662332|558926676|FG001|Overall Study|Subject Moving out of State|1|||
154863571|NCT05662332|558926675|FG000|Overall Study|Subject Missed the Schedule|1|||
154863572|NCT05662332|558926676|FG001|Overall Study|Subject Missed the Schedule|0|||
154863573|NCT05662332|558926675|FG000|Overall Study|The Patient Moved to Another City|1|||
154863574|NCT05662332|558926676|FG001|Overall Study|The Patient Moved to Another City|0|||
154863575|NCT00667277|558926677|FG000|Overall Study|Withdrawal by Subject|2|||
154863576|NCT03248128|558926678|FG000|Overall Study|Lost to Follow-up|1|||
155109074|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
155109075|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155109076|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155109077|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
155109078|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
155109079|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
155109080|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
155109081|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
155109082|NCT03745638|559826989|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155109083|NCT03745638|559826990|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155109084|NCT03745638|559826991|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
154863577|NCT03248128|558926679|FG001|Overall Study|Lost to Follow-up|0|||
154863578|NCT03248128|558926678|FG000|Overall Study|Withdrawal by Subject|16|||
154863579|NCT03248128|558926679|FG001|Overall Study|Withdrawal by Subject|14|||
154863580|NCT03248128|558926678|FG000|Overall Study|Site Closed|4|||
154863581|NCT03248128|558926679|FG001|Overall Study|Site Closed|3|||
154863582|NCT03248128|558926678|FG000|Overall Study|Randomized, but did not receive treatment|1|||
154863583|NCT03248128|558926679|FG001|Overall Study|Randomized, but did not receive treatment|3|||
154863584|NCT01914679|558926680|FG000|Overall Study|Lack of Efficacy|1|||
154863585|NCT01914679|558926680|FG000|Overall Study|Sponsor terminated study|4|||
154863586|NCT04321343|558926689|FG000|Overall Study|Adverse Event|0|||
154863587|NCT04321343|558926690|FG001|Overall Study|Adverse Event|0|||
154863588|NCT04321343|558926691|FG002|Overall Study|Adverse Event|1|||
154863589|NCT04321343|558926692|FG003|Overall Study|Adverse Event|0|||
154863590|NCT04321343|558926689|FG000|Overall Study|Death|0|||
154863591|NCT04321343|558926690|FG001|Overall Study|Death|0|||
154863592|NCT04321343|558926691|FG002|Overall Study|Death|0|||
154863593|NCT04321343|558926692|FG003|Overall Study|Death|1|||
154863594|NCT04321343|558926689|FG000|Overall Study|Pregnancy|1|||
154863595|NCT04321343|558926690|FG001|Overall Study|Pregnancy|0|||
154863596|NCT04321343|558926691|FG002|Overall Study|Pregnancy|0|||
154863597|NCT04321343|558926692|FG003|Overall Study|Pregnancy|0|||
154863598|NCT04321343|558926689|FG000|Overall Study|Protocol Violation|1|||
154863599|NCT04321343|558926690|FG001|Overall Study|Protocol Violation|1|||
154863600|NCT04321343|558926691|FG002|Overall Study|Protocol Violation|1|||
154863601|NCT04321343|558926692|FG003|Overall Study|Protocol Violation|1|||
154863602|NCT04321343|558926689|FG000|Overall Study|Withdrawal by Subject|0|||
154863603|NCT04321343|558926690|FG001|Overall Study|Withdrawal by Subject|6|||
154863604|NCT04321343|558926691|FG002|Overall Study|Withdrawal by Subject|0|||
154863605|NCT04321343|558926692|FG003|Overall Study|Withdrawal by Subject|2|||
154863606|NCT04321343|558926689|FG000|Overall Study|Lost to Follow-up|2|||
154863607|NCT04321343|558926690|FG001|Overall Study|Lost to Follow-up|2|||
154863608|NCT04321343|558926691|FG002|Overall Study|Lost to Follow-up|1|||
154863609|NCT04321343|558926692|FG003|Overall Study|Lost to Follow-up|3|||
154863610|NCT01682044|558926693|FG000|Overall Study|Death|1|||
154863611|NCT01682044|558926693|FG000|Overall Study|Progression|3|||
154863612|NCT01084252|558928706|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863613|NCT01084252|558928707|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863614|NCT01084252|558928708|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863615|NCT01084252|558928709|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863616|NCT01084252|558928710|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863617|NCT01084252|558928711|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863618|NCT01084252|558928712|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863619|NCT01084252|558928713|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863620|NCT01084252|558928714|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863621|NCT01084252|558928715|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863622|NCT01084252|558928716|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863623|NCT01084252|558928717|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863624|NCT01084252|558928718|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
154863625|NCT01084252|558928719|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
154863626|NCT04364854|558928720|FG000|Overall Study|Withdrawal by Subject|1|||
154863627|NCT04364854|558928721|FG001|Overall Study|Withdrawal by Subject|0|||
154863628|NCT04364854|558928722|FG002|Overall Study|Withdrawal by Subject|1|||
154863629|NCT04364854|558928723|FG003|Overall Study|Withdrawal by Subject|3|||
154863630|NCT04364854|558928720|FG000|Overall Study|Death|1|||
154863631|NCT04364854|558928721|FG001|Overall Study|Death|0|||
154863632|NCT04364854|558928722|FG002|Overall Study|Death|0|||
154863633|NCT04364854|558928723|FG003|Overall Study|Death|0|||
154863634|NCT04364854|558928720|FG000|Overall Study|Lost to Follow-up|0|||
154863635|NCT04364854|558928721|FG001|Overall Study|Lost to Follow-up|0|||
154863636|NCT04364854|558928722|FG002|Overall Study|Lost to Follow-up|0|||
154863637|NCT04364854|558928723|FG003|Overall Study|Lost to Follow-up|1|||
154863638|NCT04493619|558928725|FG000|Overall Study|Death|4|||
154863639|NCT04493619|558928726|FG001|Overall Study|Death|3|||
154863640|NCT04493619|558928727|FG002|Overall Study|Death|3|||
154863641|NCT04493619|558928728|FG003|Overall Study|Death|4|||
154863642|NCT04493619|558928725|FG000|Overall Study|Study discontinued early|10|||
154863643|NCT04493619|558928726|FG001|Overall Study|Study discontinued early|0|||
154973128|NCT01374451|559325335|FG001|Overall Study|Administrative problems|0|||
154973129|NCT00089973|559325336|FG000|Overall Study|Adverse Event|3|||
154973130|NCT00089973|559325336|FG000|Overall Study|Withdrawal by Subject|1|||
154863644|NCT04493619|558928727|FG002|Overall Study|Study discontinued early|4|||
154863645|NCT04493619|558928728|FG003|Overall Study|Study discontinued early|8|||
154863646|NCT04493619|558928725|FG000|Overall Study|Lost to Follow-up|0|||
154863647|NCT04493619|558928726|FG001|Overall Study|Lost to Follow-up|0|||
154863648|NCT04493619|558928727|FG002|Overall Study|Lost to Follow-up|0|||
154863649|NCT04493619|558928728|FG003|Overall Study|Lost to Follow-up|1|||
154863650|NCT03368859|558928730|FG000|Overall Study|Withdrew Consent|5|||
154863651|NCT03368859|558928731|FG001|Overall Study|Withdrew Consent|4|||
154863652|NCT03368859|558928730|FG000|Overall Study|Death|12|||
154863653|NCT03368859|558928731|FG001|Overall Study|Death|6|||
154863654|NCT03368859|558928730|FG000|Overall Study|Study terminated by Sponsor|18|||
154863655|NCT03368859|558928731|FG001|Overall Study|Study terminated by Sponsor|23|||
154863656|NCT03368859|558928730|FG000|Overall Study|Other|1|||
154973131|NCT00089973|559325336|FG000|Overall Study|Disease progression|45|||
154863657|NCT03368859|558928731|FG001|Overall Study|Other|1|||
154863658|NCT02559505|558928732|FG000|Overall Study|Lost to Follow-up|23|||
154863659|NCT02559505|558928733|FG001|Overall Study|Lost to Follow-up|20|||
154863660|NCT02559505|558928732|FG000|Overall Study|Withdrawal by Subject|4|||
154863661|NCT02559505|558928733|FG001|Overall Study|Withdrawal by Subject|2|||
154863662|NCT03523585|558928734|FG000|Overall Study|Progressive Disease|174|||
154863663|NCT03523585|558928735|FG001|Overall Study|Progressive Disease|64|||
154863664|NCT03523585|558928736|FG002|Overall Study|Progressive Disease|77|||
154863665|NCT03523585|558928734|FG000|Overall Study|Adverse Event|74|||
154863666|NCT03523585|558928735|FG001|Overall Study|Adverse Event|5|||
154863667|NCT03523585|558928736|FG002|Overall Study|Adverse Event|9|||
154863668|NCT03523585|558928734|FG000|Overall Study|Withdrawal by Subject|30|||
154863669|NCT03523585|558928735|FG001|Overall Study|Withdrawal by Subject|11|||
154863670|NCT03523585|558928736|FG002|Overall Study|Withdrawal by Subject|6|||
154863671|NCT03523585|558928734|FG000|Overall Study|Clinical Progression|23|||
154863672|NCT03523585|558928735|FG001|Overall Study|Clinical Progression|5|||
154863673|NCT03523585|558928736|FG002|Overall Study|Clinical Progression|10|||
154863674|NCT03523585|558928734|FG000|Overall Study|Death|4|||
154863675|NCT03523585|558928735|FG001|Overall Study|Death|0|||
154863676|NCT03523585|558928736|FG002|Overall Study|Death|1|||
154863677|NCT03523585|558928734|FG000|Overall Study|Physician Decision|2|||
154863678|NCT03523585|558928735|FG001|Overall Study|Physician Decision|1|||
154863679|NCT03523585|558928736|FG002|Overall Study|Physician Decision|0|||
154863680|NCT03523585|558928734|FG000|Overall Study|Lost to Follow-up|1|||
154863681|NCT03523585|558928735|FG001|Overall Study|Lost to Follow-up|0|||
154863682|NCT03523585|558928736|FG002|Overall Study|Lost to Follow-up|0|||
154863683|NCT03523585|558928734|FG000|Overall Study|Miscellaneous|1|||
154863684|NCT03523585|558928735|FG001|Overall Study|Miscellaneous|0|||
154863685|NCT03523585|558928736|FG002|Overall Study|Miscellaneous|0|||
154863686|NCT03523585|558928734|FG000|Overall Study|Protocol Deviation|1|||
154863687|NCT03523585|558928735|FG001|Overall Study|Protocol Deviation|0|||
154863688|NCT03523585|558928736|FG002|Overall Study|Protocol Deviation|1|||
154863689|NCT03523585|558928734|FG000|Overall Study|Randomized But Not Treated|2|||
154863690|NCT03523585|558928735|FG001|Overall Study|Randomized But Not Treated|4|||
154863691|NCT03523585|558928736|FG002|Overall Study|Randomized But Not Treated|3|||
154863692|NCT00698516|558928737|FG000|Overall Study|Study Termination|2|||
154863693|NCT00698516|558928737|FG000|Overall Study|Withdrawal by Subject|3|||
154863694|NCT05882890|558928738|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
154863695|NCT04331899|558928749|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
154863696|NCT04331899|558928750|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
154863697|NCT01062399|558928753|FG000|Overall Study|Protocol Violation|0|||
154863698|NCT01062399|558928754|FG001|Overall Study|Protocol Violation|1|||
154863699|NCT01062399|558928755|FG002|Overall Study|Protocol Violation|0|||
154863700|NCT01062399|558928756|FG003|Overall Study|Protocol Violation|6|||
154863701|NCT01062399|558928757|FG004|Overall Study|Protocol Violation|4|||
154863702|NCT02424539|558928758|FG000|Overall Study|Adverse Event|0|||
154863703|NCT02424539|558928759|FG001|Overall Study|Adverse Event|0|||
154863704|NCT02424539|558928760|FG002|Overall Study|Adverse Event|1|||
154863705|NCT02424539|558928758|FG000|Overall Study|Physician Decision|0|||
154863706|NCT02424539|558928759|FG001|Overall Study|Physician Decision|0|||
154863707|NCT02424539|558928760|FG002|Overall Study|Physician Decision|1|||
154863708|NCT02424539|558928758|FG000|Overall Study|Withdrawal by Subject|3|||
154863709|NCT02424539|558928759|FG001|Overall Study|Withdrawal by Subject|1|||
154863710|NCT02424539|558928760|FG002|Overall Study|Withdrawal by Subject|0|||
154863711|NCT02424539|558928758|FG000|Overall Study|Other: Reached stopping criteria|11|||
155109085|NCT03745638|559826992|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155109086|NCT03745638|559826993|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
155109087|NCT03745638|559826994|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
155109088|NCT03745638|559826995|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
155109089|NCT02993822|559827003|FG000|Overall Study|Lack of Efficacy|1|||
155109090|NCT02993822|559827004|FG001|Overall Study|Lack of Efficacy|1|||
155109091|NCT02993822|559827005|FG002|Overall Study|Lack of Efficacy|0|||
155109092|NCT02993822|559827006|FG003|Overall Study|Lack of Efficacy|0|||
154863712|NCT02424539|558928759|FG001|Overall Study|Other: Reached stopping criteria|7|||
154863713|NCT02424539|558928760|FG002|Overall Study|Other: Reached stopping criteria|6|||
154863714|NCT00719810|558928761|FG000|Overall Study|Adverse Event|0|||
154863715|NCT00719810|558928762|FG001|Overall Study|Adverse Event|2|||
154863716|NCT00719810|558928763|FG002|Overall Study|Adverse Event|3|||
155109093|NCT02993822|559827003|FG000|Overall Study|Protocol Violation|1|||
155109094|NCT02993822|559827004|FG001|Overall Study|Protocol Violation|0|||
155109095|NCT02993822|559827005|FG002|Overall Study|Protocol Violation|0|||
155109096|NCT02993822|559827006|FG003|Overall Study|Protocol Violation|0|||
154863717|NCT00719810|558928761|FG000|Overall Study|Lost to Follow-up|2|||
154863718|NCT00719810|558928762|FG001|Overall Study|Lost to Follow-up|0|||
154863719|NCT00719810|558928763|FG002|Overall Study|Lost to Follow-up|3|||
154973132|NCT00089973|559325336|FG000|Overall Study|Death|1|||
155109097|NCT02993822|559827003|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
155109098|NCT02993822|559827004|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
155109099|NCT02993822|559827005|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
155109100|NCT02993822|559827006|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
155109101|NCT02993822|559827003|FG000|Overall Study|Adverse Event|3|||
155109102|NCT02993822|559827004|FG001|Overall Study|Adverse Event|1|||
154863720|NCT00719810|558928761|FG000|Overall Study|Physician Decision|0|||
154863721|NCT00719810|558928762|FG001|Overall Study|Physician Decision|1|||
154863722|NCT00719810|558928763|FG002|Overall Study|Physician Decision|0|||
154863723|NCT00719810|558928761|FG000|Overall Study|Withdrawal by Subject|1|||
154863724|NCT00719810|558928762|FG001|Overall Study|Withdrawal by Subject|1|||
154863725|NCT00719810|558928763|FG002|Overall Study|Withdrawal by Subject|2|||
154863726|NCT04893265|558928786|FG000|Overall Study|Withdrawal by Subject|2|||
154863727|NCT04893265|558928787|FG001|Overall Study|Withdrawal by Subject|5|||
154863728|NCT04893265|558928786|FG000|Overall Study|Lost to Follow-up|0|||
154863729|NCT04893265|558928787|FG001|Overall Study|Lost to Follow-up|4|||
154973133|NCT04640194|559325337|FG000|Overall Study|Adverse Event|3|||
154863730|NCT02465034|558928788|FG000|Overall Study|Withdrawal by Subject|1|||
154973134|NCT04640194|559325338|FG001|Overall Study|Adverse Event|7|||
154973135|NCT04640194|559325339|FG002|Overall Study|Adverse Event|0|||
154973136|NCT04640194|559325340|FG003|Overall Study|Adverse Event|5|||
154973137|NCT04640194|559325341|FG004|Overall Study|Adverse Event|0|||
154973138|NCT04640194|559325342|FG005|Overall Study|Adverse Event|4|||
154973139|NCT04640194|559325343|FG006|Overall Study|Adverse Event|0|||
154973140|NCT04640194|559325337|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
154973141|NCT04640194|559325338|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
154973142|NCT04640194|559325339|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
154973143|NCT04640194|559325340|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
154973144|NCT04640194|559325341|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
154973145|NCT04640194|559325342|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
154973146|NCT04640194|559325343|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
154973147|NCT04640194|559325337|FG000|Overall Study|fibrinogen level too low|0|||
154973148|NCT04640194|559325338|FG001|Overall Study|fibrinogen level too low|0|||
154973149|NCT04640194|559325339|FG002|Overall Study|fibrinogen level too low|0|||
154973150|NCT04640194|559325340|FG003|Overall Study|fibrinogen level too low|1|||
154973151|NCT04640194|559325341|FG004|Overall Study|fibrinogen level too low|0|||
154973152|NCT04640194|559325342|FG005|Overall Study|fibrinogen level too low|0|||
154973153|NCT04640194|559325343|FG006|Overall Study|fibrinogen level too low|0|||
154973154|NCT04640194|559325337|FG000|Overall Study|mild bleeding|0|||
154973155|NCT04640194|559325338|FG001|Overall Study|mild bleeding|0|||
154973156|NCT04640194|559325339|FG002|Overall Study|mild bleeding|0|||
154973157|NCT04640194|559325340|FG003|Overall Study|mild bleeding|1|||
154973158|NCT04640194|559325341|FG004|Overall Study|mild bleeding|0|||
154973159|NCT04640194|559325342|FG005|Overall Study|mild bleeding|0|||
154973160|NCT04640194|559325343|FG006|Overall Study|mild bleeding|0|||
154973161|NCT04640194|559325337|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
154973162|NCT04640194|559325338|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
154973163|NCT04640194|559325339|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
154973164|NCT04640194|559325340|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
154973165|NCT04640194|559325341|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
154973166|NCT04640194|559325342|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
154973167|NCT04640194|559325343|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
154973168|NCT04584983|559325344|FG000|Overall Study|Parental request for withdraw|2|||
154973169|NCT04584983|559325345|FG001|Overall Study|Parental request for withdraw|0|||
154973170|NCT05377489|559325346|FG000|Overall Study|Withdrawal by Subject|122|||
154973171|NCT05377489|559325346|FG000|Overall Study|Lost to Follow-up|21|||
154973172|NCT05377489|559325346|FG000|Overall Study|Lack of Efficacy|10|||
154973173|NCT05377489|559325346|FG000|Overall Study|Adverse Event|5|||
154973174|NCT05377489|559325346|FG000|Overall Study|Death|4|||
154973175|NCT05377489|559325346|FG000|Overall Study|Physician Decision|3|||
154973176|NCT05377489|559325346|FG000|Overall Study|Protocol Violation|1|||
154973177|NCT05377489|559325346|FG000|Overall Study|Other|9|||
154973178|NCT00724958|559325347|FG000|Overall Study|Adverse Event|28|||
154973179|NCT00724958|559325347|FG000|Overall Study|Loss of Response|40|||
154973180|NCT00724958|559325347|FG000|Overall Study|No Response|18|||
154973181|NCT00724958|559325347|FG000|Overall Study|Remission|7|||
154973182|NCT00724958|559325347|FG000|Overall Study|Other Reason|76|||
154973183|NCT00724958|559325347|FG000|Overall Study|No documentation for end of therapy|13|||
154973184|NCT02129062|559326817|FG000|Overall Study|Death|1|||
154973185|NCT02129062|559326817|FG000|Overall Study|Disease Progression|2|||
154973186|NCT02031237|559326818|FG000|Overall Study|Death|1|||
154973187|NCT02031237|559326819|FG001|Overall Study|Death|5|||
154973188|NCT02031237|559326820|FG002|Overall Study|Death|0|||
154973189|NCT02031237|559326818|FG000|Overall Study|Physician Decision|0|||
154973190|NCT02031237|559326819|FG001|Overall Study|Physician Decision|1|||
155109103|NCT02993822|559827005|FG002|Overall Study|Adverse Event|7|||
154863731|NCT02465034|558928789|FG001|Overall Study|Withdrawal by Subject|1|||
154863732|NCT02465034|558928788|FG000|Overall Study|Screen fail|2|||
154863733|NCT02465034|558928789|FG001|Overall Study|Screen fail|0|||
154863734|NCT02465034|558928788|FG000|Overall Study|Could not be scheduled for study visit|0|||
154863735|NCT02465034|558928789|FG001|Overall Study|Could not be scheduled for study visit|5|||
154863736|NCT00573131|558928790|FG000|Overall Study|Withdrawal by Subject|10|||
154863737|NCT00573131|558928791|FG001|Overall Study|Withdrawal by Subject|8|||
154863738|NCT02401256|558928796|FG000|Overall Study|Adverse Event|5|||
154863739|NCT02401256|558928796|FG000|Overall Study|Withdrawal by Subject|12|||
154863740|NCT03090191|558928797|FG000|Overall Study|Adverse Event|90|||
154863741|NCT03090191|558928798|FG001|Overall Study|Adverse Event|72|||
154863742|NCT03090191|558928797|FG000|Overall Study|Death|365|||
154863743|NCT03090191|558928798|FG001|Overall Study|Death|358|||
154863744|NCT03090191|558928797|FG000|Overall Study|Lost to Follow-up|382|||
154863745|NCT03090191|558928798|FG001|Overall Study|Lost to Follow-up|394|||
154863746|NCT03090191|558928797|FG000|Overall Study|Physician Decision|77|||
154863747|NCT03090191|558928798|FG001|Overall Study|Physician Decision|66|||
154863748|NCT03090191|558928797|FG000|Overall Study|Protocol Violation|43|||
154863749|NCT03090191|558928798|FG001|Overall Study|Protocol Violation|52|||
154863750|NCT03090191|558928797|FG000|Overall Study|Withdrawal by Subject|2160|||
154863751|NCT03090191|558928798|FG001|Overall Study|Withdrawal by Subject|2133|||
154863752|NCT03090191|558928797|FG000|Overall Study|Site terminated|7|||
154863753|NCT03090191|558928798|FG001|Overall Study|Site terminated|8|||
154863754|NCT03090191|558928797|FG000|Overall Study|Other|66|||
154863755|NCT03090191|558928798|FG001|Overall Study|Other|60|||
154863756|NCT03090191|558928797|FG000|Overall Study|Withdrawn before any study vaccination|43|||
154863757|NCT03090191|558928798|FG001|Overall Study|Withdrawn before any study vaccination|52|||
154863758|NCT00893789|558928800|FG000|Overall Study|Withdrawal by Subject|3|||
154863759|NCT00893789|558928801|FG001|Overall Study|Withdrawal by Subject|1|||
154863760|NCT00893789|558928802|FG002|Overall Study|Withdrawal by Subject|3|||
154863761|NCT00893789|558928803|FG003|Overall Study|Withdrawal by Subject|1|||
154863762|NCT00893789|558928800|FG000|Overall Study|Noncompliance With Study Drug|1|||
154863763|NCT00893789|558928801|FG001|Overall Study|Noncompliance With Study Drug|0|||
154863764|NCT00893789|558928802|FG002|Overall Study|Noncompliance With Study Drug|1|||
154863765|NCT00893789|558928803|FG003|Overall Study|Noncompliance With Study Drug|2|||
154863766|NCT00893789|558928800|FG000|Overall Study|Noncompliance With Study Procedures|1|||
154863767|NCT00893789|558928801|FG001|Overall Study|Noncompliance With Study Procedures|0|||
154863768|NCT00893789|558928802|FG002|Overall Study|Noncompliance With Study Procedures|0|||
154863769|NCT00893789|558928803|FG003|Overall Study|Noncompliance With Study Procedures|0|||
154863770|NCT00893789|558928800|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
154863771|NCT00893789|558928801|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
154863772|NCT00893789|558928802|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
154863773|NCT00893789|558928803|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
154863774|NCT00893789|558928800|FG000|Overall Study|Adverse Event|0|||
154863775|NCT00893789|558928801|FG001|Overall Study|Adverse Event|2|||
154863776|NCT00893789|558928802|FG002|Overall Study|Adverse Event|1|||
154863777|NCT00893789|558928803|FG003|Overall Study|Adverse Event|5|||
154863778|NCT00893789|558928800|FG000|Overall Study|Protocol Violation|0|||
154863779|NCT00893789|558928801|FG001|Overall Study|Protocol Violation|1|||
154863780|NCT00893789|558928802|FG002|Overall Study|Protocol Violation|1|||
155109104|NCT02993822|559827006|FG003|Overall Study|Adverse Event|0|||
155109105|NCT02993822|559827003|FG000|Overall Study|Withdrawal by Subject|4|||
155109106|NCT02993822|559827004|FG001|Overall Study|Withdrawal by Subject|2|||
155109107|NCT02993822|559827005|FG002|Overall Study|Withdrawal by Subject|2|||
155109108|NCT02993822|559827006|FG003|Overall Study|Withdrawal by Subject|3|||
155109109|NCT02993822|559827003|FG000|Overall Study|Lost to Follow-up|1|||
155109110|NCT02993822|559827004|FG001|Overall Study|Lost to Follow-up|0|||
155109111|NCT02993822|559827005|FG002|Overall Study|Lost to Follow-up|1|||
155109112|NCT02993822|559827006|FG003|Overall Study|Lost to Follow-up|0|||
155109113|NCT01221753|559827010|FG000|Overall Study|Adverse Event|1|||
155109114|NCT01854775|559827011|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
155109115|NCT01854775|559827012|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
155109116|NCT01854775|559827013|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
155109117|NCT01854775|559827011|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
155109118|NCT01854775|559827012|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
155109119|NCT01854775|559827013|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
155109120|NCT01854775|559827011|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
155174253|NCT00913458|560076645|FG003|Phase 2|Adverse Event|1|||
155174254|NCT00913458|560076646|FG004|Phase 2|Adverse Event|0|||
154863781|NCT00893789|558928803|FG003|Overall Study|Protocol Violation|4|||
154863782|NCT00893789|558928800|FG000|Overall Study|Lost to Follow-up|0|||
155109121|NCT01854775|559827012|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
155109122|NCT01854775|559827013|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
155109123|NCT01854775|559827011|FG000|Extension Phase|Pregnancy|3|||
155109124|NCT01854775|559827012|FG001|Extension Phase|Pregnancy|0|||
154863783|NCT00893789|558928801|FG001|Overall Study|Lost to Follow-up|0|||
154863784|NCT00893789|558928802|FG002|Overall Study|Lost to Follow-up|0|||
154863785|NCT00893789|558928803|FG003|Overall Study|Lost to Follow-up|1|||
154863786|NCT02024464|558928804|FG000|Overall Study|Discontinued|5|||
154863787|NCT02024464|558928805|FG001|Overall Study|Discontinued|4|||
154863788|NCT02024464|558928804|FG000|Overall Study|Missed Visits|1|||
154863789|NCT02024464|558928805|FG001|Overall Study|Missed Visits|0|||
154863790|NCT02024464|558928804|FG000|Overall Study|Lost to Follow-up|4|||
154863791|NCT02024464|558928805|FG001|Overall Study|Lost to Follow-up|7|||
154863792|NCT01931865|558928818|FG000|Overall Study|Lost to Follow-up|2|||
154863793|NCT01931865|558928818|FG000|Overall Study|Withdrawal by Subject|2|||
154863794|NCT01121406|558928819|FG000|Overall Study|Progressive disease RECIST|44|||
154863795|NCT01121406|558928820|FG001|Overall Study|Progressive disease RECIST|28|||
154863796|NCT01121406|558928819|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
154863797|NCT01121406|558928820|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
154863798|NCT01121406|558928819|FG000|Overall Study|Other AE|3|||
154863799|NCT01121406|558928820|FG001|Overall Study|Other AE|10|||
154863800|NCT01121406|558928819|FG000|Overall Study|Non-compliant with protocol|0|||
154863801|NCT01121406|558928820|FG001|Overall Study|Non-compliant with protocol|2|||
154863802|NCT01121406|558928819|FG000|Overall Study|Lost to Follow-up|0|||
154863803|NCT01121406|558928820|FG001|Overall Study|Lost to Follow-up|1|||
154863804|NCT01121406|558928819|FG000|Overall Study|Refused continuation of study med.|1|||
154863805|NCT01121406|558928820|FG001|Overall Study|Refused continuation of study med.|2|||
154863806|NCT01121406|558928819|FG000|Overall Study|Reason other than specified above|2|||
154863807|NCT01121406|558928820|FG001|Overall Study|Reason other than specified above|6|||
154863808|NCT01121406|558928819|FG000|Overall Study|Not treated|1|||
154863809|NCT01121406|558928820|FG001|Overall Study|Not treated|0|||
154863810|NCT00504257|558928821|FG000|Overall Study|Withdrawal by Subject|2|||
154863811|NCT00504257|558928821|FG000|Overall Study|ineligible histology|2|||
154863812|NCT02750410|558928822|FG000|Double-Blind Treatment Period|Adverse Event|2|||
154863813|NCT02750410|558928823|FG001|Double-Blind Treatment Period|Adverse Event|2|||
154863814|NCT02750410|558928822|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154863815|NCT02750410|558928823|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
154863816|NCT02750410|558928822|FG000|Open-Label Extension Period|Adverse Event|5|||
154863817|NCT02750410|558928823|FG001|Open-Label Extension Period|Adverse Event|3|||
154863818|NCT02750410|558928822|FG000|Open-Label Extension Period|Protocol Violation|0|||
154863819|NCT02750410|558928823|FG001|Open-Label Extension Period|Protocol Violation|1|||
154863820|NCT02750410|558928822|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
154863821|NCT02750410|558928823|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
154863822|NCT01531725|558928828|FG000|Overall Study|Protocol Violation|5|||
154863823|NCT03215277|558928829|FG000|Overall Study|Adverse Event|2|||
154863824|NCT03215277|558928830|FG001|Overall Study|Adverse Event|3|||
154863825|NCT03215277|558928829|FG000|Overall Study|Death|1|||
154863826|NCT03215277|558928830|FG001|Overall Study|Death|0|||
154863827|NCT03215277|558928829|FG000|Overall Study|Lost to Follow-up|0|||
154863828|NCT03215277|558928830|FG001|Overall Study|Lost to Follow-up|1|||
154863829|NCT03215277|558928829|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
154863830|NCT03215277|558928830|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
154863831|NCT00500071|558928832|FG000|Screening and Washout Phase|Protocol Violation|1|||
154863832|NCT00500071|558928832|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
154863833|NCT00500071|558928832|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
154863834|NCT00500071|558928832|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
154863835|NCT00500071|558928832|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
154863836|NCT00500071|558928832|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
154863837|NCT00500071|558928832|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
154863838|NCT00356915|558928836|FG000|Overall Study|Non compliance|1|||
154863839|NCT00356915|558928837|FG001|Overall Study|Non compliance|2|||
154863840|NCT00356915|558928838|FG002|Overall Study|Non compliance|1|||
154863841|NCT00356915|558928836|FG000|Overall Study|Protocol Violation|2|||
154863842|NCT00356915|558928837|FG001|Overall Study|Protocol Violation|3|||
154863843|NCT00356915|558928838|FG002|Overall Study|Protocol Violation|2|||
154863844|NCT00356915|558928836|FG000|Overall Study|Withdrawal by Subject|14|||
154863845|NCT00356915|558928837|FG001|Overall Study|Withdrawal by Subject|14|||
154863846|NCT00356915|558928838|FG002|Overall Study|Withdrawal by Subject|10|||
155109125|NCT01854775|559827013|FG002|Extension Phase|Pregnancy|0|||
155109126|NCT01854775|559827011|FG000|Extension Phase|Investigator's Discretion|1|||
155109127|NCT01854775|559827012|FG001|Extension Phase|Investigator's Discretion|0|||
155109128|NCT01854775|559827013|FG002|Extension Phase|Investigator's Discretion|0|||
155109129|NCT01854775|559827011|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
155109130|NCT01854775|559827012|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
155109131|NCT01854775|559827013|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
154863847|NCT00356915|558928836|FG000|Overall Study|Lack of Efficacy|0|||
154863848|NCT00356915|558928837|FG001|Overall Study|Lack of Efficacy|0|||
154863849|NCT00356915|558928838|FG002|Overall Study|Lack of Efficacy|3|||
154863850|NCT00356915|558928836|FG000|Overall Study|Lost to Follow-up|27|||
154863851|NCT00356915|558928837|FG001|Overall Study|Lost to Follow-up|34|||
154863852|NCT00356915|558928838|FG002|Overall Study|Lost to Follow-up|14|||
154863853|NCT00356915|558928836|FG000|Overall Study|Administrative Decision|0|||
154863854|NCT00356915|558928837|FG001|Overall Study|Administrative Decision|0|||
154863855|NCT00356915|558928838|FG002|Overall Study|Administrative Decision|1|||
154863856|NCT00356915|558928836|FG000|Overall Study|Physician Decision|0|||
154863857|NCT00356915|558928837|FG001|Overall Study|Physician Decision|2|||
154863858|NCT00356915|558928838|FG002|Overall Study|Physician Decision|0|||
154863859|NCT00356915|558928836|FG000|Overall Study|Adverse Event|21|||
154863860|NCT00356915|558928837|FG001|Overall Study|Adverse Event|31|||
154863861|NCT00356915|558928838|FG002|Overall Study|Adverse Event|8|||
154863862|NCT00356915|558928836|FG000|Overall Study|Miscellaneous reasons|11|||
154863863|NCT00356915|558928837|FG001|Overall Study|Miscellaneous reasons|8|||
154863864|NCT00356915|558928838|FG002|Overall Study|Miscellaneous reasons|3|||
154863865|NCT02580058|558928847|FG000|Overall Study|Adverse Event|16|||
154863866|NCT02580058|558928848|FG001|Overall Study|Adverse Event|30|||
154863867|NCT02580058|558928849|FG002|Overall Study|Adverse Event|20|||
154863868|NCT02580058|558928847|FG000|Overall Study|Death|4|||
154863869|NCT02580058|558928848|FG001|Overall Study|Death|4|||
154863870|NCT02580058|558928849|FG002|Overall Study|Death|5|||
154863871|NCT02580058|558928847|FG000|Overall Study|Physician Decision|1|||
154863872|NCT02580058|558928848|FG001|Overall Study|Physician Decision|3|||
154863873|NCT02580058|558928849|FG002|Overall Study|Physician Decision|11|||
154863874|NCT02580058|558928847|FG000|Overall Study|Other|5|||
154863875|NCT02580058|558928848|FG001|Overall Study|Other|1|||
154863876|NCT02580058|558928849|FG002|Overall Study|Other|3|||
154863877|NCT02580058|558928847|FG000|Overall Study|Withdrawal by Subject|4|||
154863878|NCT02580058|558928848|FG001|Overall Study|Withdrawal by Subject|7|||
154863879|NCT02580058|558928849|FG002|Overall Study|Withdrawal by Subject|31|||
154863880|NCT02580058|558928847|FG000|Overall Study|Global Deterioration of Health Status|19|||
154863881|NCT02580058|558928848|FG001|Overall Study|Global Deterioration of Health Status|18|||
154863882|NCT02580058|558928849|FG002|Overall Study|Global Deterioration of Health Status|24|||
154863883|NCT02580058|558928847|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
154863884|NCT02580058|558928848|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
154863885|NCT02580058|558928849|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
154863886|NCT02580058|558928847|FG000|Overall Study|Progressive Disease|137|||
154863887|NCT02580058|558928848|FG001|Overall Study|Progressive Disease|125|||
154863888|NCT02580058|558928849|FG002|Overall Study|Progressive Disease|94|||
154863889|NCT02580058|558928847|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154863890|NCT02580058|558928848|FG001|Overall Study|Non-Compliance With Study Drug|0|||
154863891|NCT02580058|558928849|FG002|Overall Study|Non-Compliance With Study Drug|0|||
154863892|NCT02333227|558928850|FG000|Overall Study|Lost to Follow-up|137|||
154863893|NCT02333227|558928851|FG001|Overall Study|Lost to Follow-up|106|||
154863894|NCT02333227|558928850|FG000|Overall Study|Pregnancy Interrupted|42|||
154863895|NCT02333227|558928851|FG001|Overall Study|Pregnancy Interrupted|89|||
154863896|NCT02333227|558928850|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
154863897|NCT02333227|558928851|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
154863898|NCT04375878|558928854|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
154863899|NCT04375878|558928855|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
154863900|NCT04375878|558928856|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
155109132|NCT01854775|559827011|FG000|Extension Phase|Lost to Follow-up|2|||
155109133|NCT01854775|559827012|FG001|Extension Phase|Lost to Follow-up|0|||
155109134|NCT01854775|559827013|FG002|Extension Phase|Lost to Follow-up|0|||
155109135|NCT01854775|559827011|FG000|Extension Phase|Still on Study|32|||
155109136|NCT01854775|559827012|FG001|Extension Phase|Still on Study|47|||
155109137|NCT01854775|559827013|FG002|Extension Phase|Still on Study|18|||
155109138|NCT03135431|559827020|FG000|Overall Study|Study Surgeon not available|2|||
155109139|NCT03135431|559827021|FG001|Overall Study|Study Surgeon not available|0|||
155109140|NCT02597452|559827022|FG000|Overall Study|testing incomplete|30|||
155109141|NCT01659996|559827023|FG000|Overall Study|Protocol Violation|3|||
155109142|NCT01659996|559827024|FG001|Overall Study|Protocol Violation|3|||
155109143|NCT01659996|559827025|FG002|Overall Study|Protocol Violation|3|||
155109144|NCT01659996|559827023|FG000|Overall Study|Lost to Follow-up|1|||
155109145|NCT01659996|559827024|FG001|Overall Study|Lost to Follow-up|3|||
155109146|NCT01659996|559827025|FG002|Overall Study|Lost to Follow-up|2|||
155109147|NCT01659996|559827023|FG000|Overall Study|Adverse Event|0|||
155109148|NCT01659996|559827024|FG001|Overall Study|Adverse Event|0|||
155109149|NCT01659996|559827025|FG002|Overall Study|Adverse Event|1|||
154863901|NCT04375878|558928857|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
154863902|NCT04375878|558928858|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
154863903|NCT04375878|558928859|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
154863904|NCT04375878|558928854|FG000|Crossover First and Second Interventions|Adverse Event|0|||
154863905|NCT04375878|558928855|FG001|Crossover First and Second Interventions|Adverse Event|0|||
154863906|NCT04375878|558928856|FG002|Crossover First and Second Interventions|Adverse Event|1|||
154863907|NCT04375878|558928857|FG003|Crossover First and Second Interventions|Adverse Event|0|||
154863908|NCT04375878|558928858|FG004|Crossover First and Second Interventions|Adverse Event|0|||
154863909|NCT04375878|558928859|FG005|Crossover First and Second Interventions|Adverse Event|0|||
154863910|NCT04375878|558928854|FG000|Extension Phase|Withdrawal by Subject|0|||
155109150|NCT01659996|559827023|FG000|Overall Study|Withdrawal by Subject|4|||
155109151|NCT01659996|559827024|FG001|Overall Study|Withdrawal by Subject|1|||
155174255|NCT00913458|560076647|FG005|Phase 2|Adverse Event|0|||
155174256|NCT00913458|560076648|FG006|Phase 2|Adverse Event|0|||
154973191|NCT02031237|559326820|FG002|Overall Study|Physician Decision|0|||
154973192|NCT02031237|559326818|FG000|Overall Study|Withdrawal by Subject|2|||
154973193|NCT02031237|559326819|FG001|Overall Study|Withdrawal by Subject|2|||
154973194|NCT02031237|559326820|FG002|Overall Study|Withdrawal by Subject|0|||
154973195|NCT02031237|559326818|FG000|Overall Study|Protocol Violation|2|||
154973196|NCT02031237|559326819|FG001|Overall Study|Protocol Violation|6|||
154973197|NCT02031237|559326820|FG002|Overall Study|Protocol Violation|0|||
154973198|NCT02031237|559326818|FG000|Overall Study|Alternate Treatment Given|0|||
154973199|NCT02031237|559326819|FG001|Overall Study|Alternate Treatment Given|0|||
154973200|NCT02031237|559326820|FG002|Overall Study|Alternate Treatment Given|3|||
154973201|NCT00377156|559326825|FG000|Overall Study|Death|23|||
154973202|NCT00377156|559326826|FG001|Overall Study|Death|19|||
154973203|NCT00377156|559326825|FG000|Overall Study|Withdrawal by Subject|16|||
154973204|NCT00377156|559326826|FG001|Overall Study|Withdrawal by Subject|24|||
154973205|NCT00377156|559326825|FG000|Overall Study|Had follow-up <90 d|3|||
154973206|NCT00377156|559326826|FG001|Overall Study|Had follow-up <90 d|6|||
154973207|NCT00377156|559326825|FG000|Overall Study|Cancellation|1|||
154973208|NCT00377156|559326826|FG001|Overall Study|Cancellation|0|||
154973209|NCT00377156|559326825|FG000|Overall Study|Refused testing|0|||
154973210|NCT00377156|559326826|FG001|Overall Study|Refused testing|1|||
154973211|NCT00377156|559326825|FG000|Overall Study|Ineligible|0|||
154973212|NCT00377156|559326826|FG001|Overall Study|Ineligible|1|||
154973213|NCT00377156|559326825|FG000|Overall Study|Disability or language problem|0|||
155109152|NCT01659996|559827025|FG002|Overall Study|Withdrawal by Subject|5|||
155109153|NCT02701764|559827026|FG000|Overall Study|Lost to Follow-up|0|||
155109154|NCT02701764|559827027|FG001|Overall Study|Lost to Follow-up|1|||
154863911|NCT04375878|558928855|FG001|Extension Phase|Withdrawal by Subject|0|||
154863912|NCT04375878|558928856|FG002|Extension Phase|Withdrawal by Subject|0|||
154863913|NCT04375878|558928857|FG003|Extension Phase|Withdrawal by Subject|0|||
154863914|NCT04375878|558928858|FG004|Extension Phase|Withdrawal by Subject|1|||
154863915|NCT04375878|558928859|FG005|Extension Phase|Withdrawal by Subject|0|||
154863916|NCT03022461|558928860|FG000|Overall Study|Death|3|||
154863917|NCT01982630|558928861|FG000|Overall Study|Adverse Event|2|||
154863918|NCT01982630|558928862|FG001|Overall Study|Adverse Event|0|||
154863919|NCT01982630|558928863|FG002|Overall Study|Adverse Event|1|||
154863920|NCT01982630|558928864|FG003|Overall Study|Adverse Event|0|||
154863921|NCT01982630|558928865|FG004|Overall Study|Adverse Event|1|||
154863922|NCT01982630|558928866|FG005|Overall Study|Adverse Event|2|||
154863923|NCT01982630|558928867|FG006|Overall Study|Adverse Event|1|||
154863924|NCT01982630|558928868|FG007|Overall Study|Adverse Event|0|||
154863925|NCT01982630|558928861|FG000|Overall Study|Physician Decision|1|||
154863926|NCT01982630|558928862|FG001|Overall Study|Physician Decision|0|||
154863927|NCT01982630|558928863|FG002|Overall Study|Physician Decision|2|||
154863928|NCT01982630|558928864|FG003|Overall Study|Physician Decision|1|||
154863929|NCT01982630|558928865|FG004|Overall Study|Physician Decision|2|||
154863930|NCT01982630|558928866|FG005|Overall Study|Physician Decision|0|||
154863931|NCT01982630|558928867|FG006|Overall Study|Physician Decision|0|||
154863932|NCT01982630|558928868|FG007|Overall Study|Physician Decision|0|||
154863933|NCT01982630|558928861|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863934|NCT01982630|558928862|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863935|NCT01982630|558928863|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
154863936|NCT01982630|558928864|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863937|NCT01982630|558928865|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863938|NCT01982630|558928866|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863939|NCT01982630|558928867|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863940|NCT01982630|558928868|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
154863941|NCT01982630|558928861|FG000|Overall Study|Withdrawal by Subject|0|||
154863942|NCT01982630|558928862|FG001|Overall Study|Withdrawal by Subject|0|||
154863943|NCT01982630|558928863|FG002|Overall Study|Withdrawal by Subject|0|||
154863944|NCT01982630|558928864|FG003|Overall Study|Withdrawal by Subject|0|||
155109155|NCT01170273|559827032|FG000|Overall Study|Lost to Follow-up|6|||
155109156|NCT01170273|559827033|FG001|Overall Study|Lost to Follow-up|8|||
154863945|NCT01982630|558928865|FG004|Overall Study|Withdrawal by Subject|0|||
154863946|NCT01982630|558928866|FG005|Overall Study|Withdrawal by Subject|1|||
154973214|NCT00377156|559326826|FG001|Overall Study|Disability or language problem|1|||
154973215|NCT00377156|559326825|FG000|Overall Study|Other|5|||
154973216|NCT00377156|559326826|FG001|Overall Study|Other|2|||
154973217|NCT01802216|559326827|FG000|4 Month Visit|Participant did not show to visit|3|||
154973218|NCT01802216|559326828|FG001|4 Month Visit|Participant did not show to visit|4|||
154863947|NCT01982630|558928867|FG006|Overall Study|Withdrawal by Subject|0|||
155109157|NCT01170273|559827032|FG000|Overall Study|Protocol Violation|1|||
154863948|NCT01982630|558928868|FG007|Overall Study|Withdrawal by Subject|0|||
154863949|NCT00561353|558928869|FG000|Overall Study|Subject reached a virologic endpoint|2|||
154863950|NCT00561353|558928870|FG001|Overall Study|Subject reached a virologic endpoint|1|||
154863951|NCT00561353|558928871|FG002|Overall Study|Subject reached a virologic endpoint|1|||
154973219|NCT01802216|559326827|FG000|8 Month Visit|Participant did not show to visit|3|||
155109158|NCT01170273|559827033|FG001|Overall Study|Protocol Violation|0|||
154863952|NCT00561353|558928872|FG003|Overall Study|Subject reached a virologic endpoint|4|||
154863953|NCT00561353|558928873|FG004|Overall Study|Subject reached a virologic endpoint|1|||
154863954|NCT00561353|558928874|FG005|Overall Study|Subject reached a virologic endpoint|3|||
154863955|NCT00561353|558928875|FG006|Overall Study|Subject reached a virologic endpoint|4|||
154863956|NCT00561353|558928876|FG007|Overall Study|Subject reached a virologic endpoint|4|||
154863957|NCT00561353|558928877|FG008|Overall Study|Subject reached a virologic endpoint|5|||
154863958|NCT00561353|558928878|FG009|Overall Study|Subject reached a virologic endpoint|0|||
154863959|NCT00561353|558928869|FG000|Overall Study|Subject ineligible to continue the trial|0|||
154863960|NCT00561353|558928870|FG001|Overall Study|Subject ineligible to continue the trial|0|||
154863961|NCT00561353|558928871|FG002|Overall Study|Subject ineligible to continue the trial|0|||
154863962|NCT00561353|558928872|FG003|Overall Study|Subject ineligible to continue the trial|0|||
154863963|NCT00561353|558928873|FG004|Overall Study|Subject ineligible to continue the trial|0|||
154863964|NCT00561353|558928874|FG005|Overall Study|Subject ineligible to continue the trial|1|||
154863965|NCT00561353|558928875|FG006|Overall Study|Subject ineligible to continue the trial|1|||
154863966|NCT00561353|558928876|FG007|Overall Study|Subject ineligible to continue the trial|0|||
154863967|NCT00561353|558928877|FG008|Overall Study|Subject ineligible to continue the trial|2|||
154863968|NCT00561353|558928878|FG009|Overall Study|Subject ineligible to continue the trial|1|||
154863969|NCT00561353|558928869|FG000|Overall Study|Other|1|||
154863970|NCT00561353|558928870|FG001|Overall Study|Other|0|||
154863971|NCT00561353|558928871|FG002|Overall Study|Other|1|||
154863972|NCT00561353|558928872|FG003|Overall Study|Other|0|||
154863973|NCT00561353|558928873|FG004|Overall Study|Other|0|||
154863974|NCT00561353|558928874|FG005|Overall Study|Other|2|||
154863975|NCT00561353|558928875|FG006|Overall Study|Other|0|||
154863976|NCT00561353|558928876|FG007|Overall Study|Other|0|||
154863977|NCT00561353|558928877|FG008|Overall Study|Other|0|||
154863978|NCT00561353|558928878|FG009|Overall Study|Other|0|||
154863979|NCT00561353|558928869|FG000|Overall Study|Adverse Event|0|||
154863980|NCT00561353|558928870|FG001|Overall Study|Adverse Event|0|||
154863981|NCT00561353|558928871|FG002|Overall Study|Adverse Event|0|||
155109159|NCT01170273|559827032|FG000|Overall Study|Death|1|||
154863982|NCT00561353|558928872|FG003|Overall Study|Adverse Event|2|||
154863983|NCT00561353|558928873|FG004|Overall Study|Adverse Event|0|||
154863984|NCT00561353|558928874|FG005|Overall Study|Adverse Event|0|||
154863985|NCT00561353|558928875|FG006|Overall Study|Adverse Event|1|||
154863986|NCT00561353|558928876|FG007|Overall Study|Adverse Event|0|||
154863987|NCT00561353|558928877|FG008|Overall Study|Adverse Event|0|||
154863988|NCT00561353|558928878|FG009|Overall Study|Adverse Event|1|||
154863989|NCT00561353|558928869|FG000|Overall Study|Lost to Follow-up|2|||
154863990|NCT00561353|558928870|FG001|Overall Study|Lost to Follow-up|0|||
154863991|NCT00561353|558928871|FG002|Overall Study|Lost to Follow-up|1|||
154863992|NCT00561353|558928872|FG003|Overall Study|Lost to Follow-up|0|||
155109160|NCT01170273|559827033|FG001|Overall Study|Death|0|||
154863993|NCT00561353|558928873|FG004|Overall Study|Lost to Follow-up|0|||
154863994|NCT00561353|558928874|FG005|Overall Study|Lost to Follow-up|0|||
154863995|NCT00561353|558928875|FG006|Overall Study|Lost to Follow-up|0|||
154863996|NCT00561353|558928876|FG007|Overall Study|Lost to Follow-up|0|||
154863997|NCT00561353|558928877|FG008|Overall Study|Lost to Follow-up|0|||
154863998|NCT00561353|558928878|FG009|Overall Study|Lost to Follow-up|0|||
154863999|NCT00561353|558928869|FG000|Overall Study|Withdrawal by Subject|0|||
154864000|NCT00561353|558928870|FG001|Overall Study|Withdrawal by Subject|2|||
154864001|NCT00561353|558928871|FG002|Overall Study|Withdrawal by Subject|0|||
154864002|NCT00561353|558928872|FG003|Overall Study|Withdrawal by Subject|0|||
154864003|NCT00561353|558928873|FG004|Overall Study|Withdrawal by Subject|0|||
154864004|NCT00561353|558928874|FG005|Overall Study|Withdrawal by Subject|0|||
154864005|NCT00561353|558928875|FG006|Overall Study|Withdrawal by Subject|0|||
154864006|NCT00561353|558928876|FG007|Overall Study|Withdrawal by Subject|0|||
154864007|NCT00561353|558928877|FG008|Overall Study|Withdrawal by Subject|0|||
154973220|NCT01802216|559326828|FG001|8 Month Visit|Participant did not show to visit|5|||
155109161|NCT01170273|559827032|FG000|Overall Study|Adverse Event|0|||
155109162|NCT01170273|559827033|FG001|Overall Study|Adverse Event|1|||
155109163|NCT02482428|559828402|FG000|Overall Study|Lost to Follow-up|4|||
155109164|NCT02482428|559828403|FG001|Overall Study|Lost to Follow-up|9|||
154864008|NCT00561353|558928878|FG009|Overall Study|Withdrawal by Subject|0|||
154864009|NCT00256295|558928879|FG000|Overall Study|Withdrawal by Subject|3|||
154864010|NCT00256295|558928879|FG000|Overall Study|Death|1|||
154864011|NCT05369806|558928883|FG000|Overall Study|Lost to Follow-up|1|||
154864012|NCT00628355|558928884|FG000|Overall Study|Withdrawal by Subject|1|||
154864013|NCT00628355|558928885|FG001|Overall Study|Withdrawal by Subject|1|||
154864014|NCT00140855|558928886|FG000|Overall Study|Progressive disease|2|||
154864015|NCT03542682|558928888|FG000|Overall Study|COVID-19 Protocol|0|||
154864016|NCT03542682|558928889|FG001|Overall Study|COVID-19 Protocol|1|||
154864017|NCT01097044|558928895|FG000|Overall Study|Withdrawal by Subject|4|||
154864018|NCT01097044|558928896|FG001|Overall Study|Withdrawal by Subject|4|||
154864019|NCT01097044|558928895|FG000|Overall Study|Lost to Follow-up|1|||
154864020|NCT01097044|558928896|FG001|Overall Study|Lost to Follow-up|0|||
155109165|NCT02482428|559828404|FG002|Overall Study|Lost to Follow-up|1|||
155109166|NCT02482428|559828405|FG003|Overall Study|Lost to Follow-up|2|||
155109167|NCT02482428|559828406|FG004|Overall Study|Lost to Follow-up|4|||
154864021|NCT01097044|558928895|FG000|Overall Study|Withdrawal by Sponsor|0|||
154864022|NCT01097044|558928896|FG001|Overall Study|Withdrawal by Sponsor|1|||
154864023|NCT04865731|558928900|FG000|Overall Study|Physician Decision|2|||
154864024|NCT04865731|558928901|FG001|Overall Study|Physician Decision|1|||
154864025|NCT04865731|558928900|FG000|Overall Study|Adverse Event|1|||
154864026|NCT04865731|558928901|FG001|Overall Study|Adverse Event|0|||
154864027|NCT04865731|558928900|FG000|Overall Study|Withdrawal by Subject|0|||
154864028|NCT04865731|558928901|FG001|Overall Study|Withdrawal by Subject|1|||
154864029|NCT00875420|558930826|FG000|Overall Study|Adverse Event|0|||
154864030|NCT00875420|558930827|FG001|Overall Study|Adverse Event|1|||
154864031|NCT00875420|558930828|FG002|Overall Study|Adverse Event|1|||
154864032|NCT00875420|558930829|FG003|Overall Study|Adverse Event|0|||
154864033|NCT00875420|558930830|FG004|Overall Study|Adverse Event|0|||
154864034|NCT00875420|558930826|FG000|Overall Study|Inability to complete study procedures|1|||
154864035|NCT00875420|558930827|FG001|Overall Study|Inability to complete study procedures|0|||
154864036|NCT00875420|558930828|FG002|Overall Study|Inability to complete study procedures|1|||
154864037|NCT00875420|558930829|FG003|Overall Study|Inability to complete study procedures|1|||
154864038|NCT00875420|558930830|FG004|Overall Study|Inability to complete study procedures|1|||
154864039|NCT00875420|558930826|FG000|Overall Study|Lost to Follow-up|1|||
154864040|NCT00875420|558930827|FG001|Overall Study|Lost to Follow-up|0|||
154864041|NCT00875420|558930828|FG002|Overall Study|Lost to Follow-up|0|||
154864042|NCT00875420|558930829|FG003|Overall Study|Lost to Follow-up|0|||
154864043|NCT00875420|558930830|FG004|Overall Study|Lost to Follow-up|0|||
154864044|NCT00875420|558930826|FG000|Overall Study|Personal reason|0|||
154864045|NCT00875420|558930827|FG001|Overall Study|Personal reason|0|||
154864046|NCT00875420|558930828|FG002|Overall Study|Personal reason|0|||
154864047|NCT00875420|558930829|FG003|Overall Study|Personal reason|0|||
154864048|NCT00875420|558930830|FG004|Overall Study|Personal reason|1|||
154864049|NCT00875420|558930826|FG000|Overall Study|Prohibited medication|0|||
154864050|NCT00875420|558930827|FG001|Overall Study|Prohibited medication|0|||
154864051|NCT00875420|558930828|FG002|Overall Study|Prohibited medication|0|||
154864052|NCT00875420|558930829|FG003|Overall Study|Prohibited medication|1|||
154864053|NCT00875420|558930830|FG004|Overall Study|Prohibited medication|0|||
154864054|NCT00875420|558930826|FG000|Overall Study|Sponsor decision|0|||
154864055|NCT00875420|558930827|FG001|Overall Study|Sponsor decision|1|||
154864056|NCT00875420|558930828|FG002|Overall Study|Sponsor decision|0|||
154864057|NCT00875420|558930829|FG003|Overall Study|Sponsor decision|0|||
154864058|NCT00875420|558930830|FG004|Overall Study|Sponsor decision|0|||
154864059|NCT00875420|558930826|FG000|Overall Study|Withdrawal by Subject|0|||
154864060|NCT00875420|558930827|FG001|Overall Study|Withdrawal by Subject|0|||
154864061|NCT00875420|558930828|FG002|Overall Study|Withdrawal by Subject|1|||
154864062|NCT00875420|558930829|FG003|Overall Study|Withdrawal by Subject|0|||
154864063|NCT00875420|558930830|FG004|Overall Study|Withdrawal by Subject|0|||
154864064|NCT00914628|558930831|FG000|Overall Study|Death|35|||
154864065|NCT00914628|558930832|FG001|Overall Study|Death|17|||
154864066|NCT00914628|558930831|FG000|Overall Study|Medical decision|4|||
154864067|NCT00914628|558930832|FG001|Overall Study|Medical decision|0|||
154864068|NCT00914628|558930831|FG000|Overall Study|Protocol Violation|1|||
154864069|NCT00914628|558930832|FG001|Overall Study|Protocol Violation|0|||
154864070|NCT00914628|558930831|FG000|Overall Study|Lack of Efficacy|1|||
154864071|NCT00914628|558930832|FG001|Overall Study|Lack of Efficacy|0|||
154864072|NCT00914628|558930831|FG000|Overall Study|non-randomized|1|||
154864073|NCT00914628|558930832|FG001|Overall Study|non-randomized|0|||
154864074|NCT00914628|558930831|FG000|Overall Study|Relapse|1|||
154864075|NCT00914628|558930832|FG001|Overall Study|Relapse|2|||
154864076|NCT00914628|558930831|FG000|Overall Study|Study terminated by Sponsor|14|||
154864077|NCT00914628|558930832|FG001|Overall Study|Study terminated by Sponsor|8|||
154864078|NCT00914628|558930831|FG000|Overall Study|Patients who did not receive a single dose|7|||
154864079|NCT00914628|558930832|FG001|Overall Study|Patients who did not receive a single dose|1|||
154864080|NCT03716726|558930833|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
154864081|NCT03716726|558930834|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
154864082|NCT03716726|558930833|FG000|12 Months Followup|Lost to Follow-up|10|||
154864083|NCT03716726|558930834|FG001|12 Months Followup|Lost to Follow-up|17|||
155109168|NCT02482428|559828402|FG000|Overall Study|Physician Decision|0|||
155109169|NCT02482428|559828403|FG001|Overall Study|Physician Decision|0|||
154864084|NCT02579603|558930835|FG000|Overall Study|Not treated|1|||
154864085|NCT02579603|558930836|FG001|Overall Study|Not treated|0|||
155109170|NCT02482428|559828404|FG002|Overall Study|Physician Decision|0|||
154864086|NCT02579603|558930835|FG000|Overall Study|Adverse Event|2|||
154864087|NCT02579603|558930836|FG001|Overall Study|Adverse Event|2|||
154864088|NCT02579603|558930835|FG000|Overall Study|Other than stated|1|||
154973221|NCT01802216|559326827|FG000|12 Month Visit|Participant did not show to visit|3|||
155109171|NCT02482428|559828405|FG003|Overall Study|Physician Decision|0|||
155109172|NCT02482428|559828406|FG004|Overall Study|Physician Decision|1|||
154864089|NCT02579603|558930836|FG001|Overall Study|Other than stated|0|||
155109173|NCT02482428|559828402|FG000|Overall Study|protocol deviation|1|||
154864090|NCT00942162|558930837|FG000|Overall Study|Death|45|||
154864091|NCT00942162|558930838|FG001|Overall Study|Death|35|||
154864092|NCT00942162|558930839|FG002|Overall Study|Death|0|||
154864093|NCT00942162|558930837|FG000|Overall Study|Withdrawal by Subject|7|||
154864094|NCT00942162|558930838|FG001|Overall Study|Withdrawal by Subject|2|||
154864095|NCT00942162|558930839|FG002|Overall Study|Withdrawal by Subject|0|||
154864096|NCT00942162|558930837|FG000|Overall Study|Lost to Follow-up|4|||
154864097|NCT00942162|558930838|FG001|Overall Study|Lost to Follow-up|0|||
154864098|NCT00942162|558930839|FG002|Overall Study|Lost to Follow-up|0|||
154864099|NCT00942162|558930837|FG000|Overall Study|Other|14|||
154864100|NCT00942162|558930838|FG001|Overall Study|Other|13|||
154864101|NCT00942162|558930839|FG002|Overall Study|Other|2|||
154864102|NCT01006356|558930843|FG000|Overall Study|Adverse Event|6|||
154864103|NCT01006356|558930843|FG000|Overall Study|Physician Decision|1|||
154864104|NCT01006356|558930843|FG000|Overall Study|Paticipants did not cooperate|6|||
154864105|NCT01006356|558930843|FG000|Overall Study|Withdrawal by Subject|1|||
154864106|NCT01006356|558930843|FG000|Overall Study|Choice by participants|2|||
154864107|NCT01006356|558930843|FG000|Overall Study|Protocol Violation|3|||
154864108|NCT01006356|558930843|FG000|Overall Study|Other|23|||
154864109|NCT01756157|558930847|FG000|First Intervention Period|Withdrawal by Subject|1|||
154864110|NCT01756157|558930848|FG001|First Intervention Period|Withdrawal by Subject|0|||
154864111|NCT01756157|558930847|FG000|First Intervention Period|Lost to Follow-up|0|||
154864112|NCT01756157|558930848|FG001|First Intervention Period|Lost to Follow-up|2|||
154864113|NCT02799381|558930851|FG000|Overall Study|Withdrew consent|3|||
154864114|NCT02799381|558930852|FG001|Overall Study|Withdrew consent|2|||
154864115|NCT02799381|558930851|FG000|Overall Study|Adverse Event|0|||
154864116|NCT02799381|558930852|FG001|Overall Study|Adverse Event|1|||
154864117|NCT02799381|558930851|FG000|Overall Study|Participant did not take any study drug|1|||
154864118|NCT02799381|558930852|FG001|Overall Study|Participant did not take any study drug|0|||
154864119|NCT02698410|558930853|FG000|Overall Study|Adverse Event|2|||
154864120|NCT02698410|558930853|FG000|Overall Study|Withdrawal by Subject|1|||
154864121|NCT02698410|558930853|FG000|Overall Study|Other|1|||
154864122|NCT03952130|558930854|FG000|Overall Study|Adverse Event|0|||
154864123|NCT03952130|558930855|FG001|Overall Study|Adverse Event|1|||
154864124|NCT03952130|558930854|FG000|Overall Study|Lost to Follow-up|1|||
154864125|NCT03952130|558930855|FG001|Overall Study|Lost to Follow-up|0|||
154864126|NCT03952130|558930854|FG000|Overall Study|Withdrawal by Subject|1|||
154864127|NCT03952130|558930855|FG001|Overall Study|Withdrawal by Subject|5|||
154864128|NCT01713348|558930856|FG000|Overall Study|Withdrawal by Subject|3|||
154864129|NCT01713348|558930857|FG001|Overall Study|Withdrawal by Subject|2|||
154864130|NCT01713348|558930858|FG002|Overall Study|Withdrawal by Subject|2|||
154864131|NCT01713348|558930859|FG003|Overall Study|Withdrawal by Subject|0|||
154864132|NCT01713348|558930856|FG000|Overall Study|Lost to Follow-up|1|||
154864133|NCT01713348|558930857|FG001|Overall Study|Lost to Follow-up|0|||
154864134|NCT01713348|558930858|FG002|Overall Study|Lost to Follow-up|0|||
154864135|NCT01713348|558930859|FG003|Overall Study|Lost to Follow-up|0|||
154864136|NCT02638012|558930860|FG000|Overall Study|Lost to Follow-up|1|||
154864137|NCT00621023|558930862|FG000|Overall Study|Death|5|||
154864138|NCT00621023|558930862|FG000|Overall Study|Follow up discontinued|1|||
154864139|NCT03199911|558930869|FG000|Overall Study|Lost to Follow-up|5|||
154864140|NCT03199911|558930870|FG001|Overall Study|Lost to Follow-up|5|||
154864141|NCT03199911|558930869|FG000|Overall Study|Did not proceed with surgery|2|||
154864142|NCT03199911|558930870|FG001|Overall Study|Did not proceed with surgery|1|||
154864143|NCT01845025|558930874|FG000|Overall Study|Adverse Event|6|||
154864144|NCT01845025|558930875|FG001|Overall Study|Adverse Event|3|||
154864145|NCT01845025|558930874|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154864146|NCT01845025|558930875|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
154864147|NCT01845025|558930874|FG000|Overall Study|Withdrawal by Subject|48|||
154864148|NCT01845025|558930875|FG001|Overall Study|Withdrawal by Subject|44|||
154864149|NCT01845025|558930874|FG000|Overall Study|Lost to Follow-up|13|||
154864150|NCT01845025|558930875|FG001|Overall Study|Lost to Follow-up|13|||
154864151|NCT01845025|558930874|FG000|Overall Study|Administrative problems|8|||
154864152|NCT01845025|558930875|FG001|Overall Study|Administrative problems|8|||
154864153|NCT01845025|558930874|FG000|Overall Study|Death|2|||
154864154|NCT01845025|558930875|FG001|Overall Study|Death|0|||
154864155|NCT01845025|558930874|FG000|Overall Study|Protocol deviation|3|||
154864156|NCT01845025|558930875|FG001|Overall Study|Protocol deviation|6|||
154864157|NCT01845025|558930874|FG000|Overall Study|Missing|1|||
154864158|NCT01845025|558930875|FG001|Overall Study|Missing|1|||
154864159|NCT01324830|558930878|FG000|Overall Study|Progressive Disease|3|||
154864160|NCT01324830|558930879|FG001|Overall Study|Progressive Disease|2|||
154864161|NCT01324830|558930880|FG002|Overall Study|Progressive Disease|3|||
154864162|NCT01324830|558930881|FG003|Overall Study|Progressive Disease|3|||
154973222|NCT01802216|559326828|FG001|12 Month Visit|Participant did not show to visit|4|||
154864163|NCT01324830|558930882|FG004|Overall Study|Progressive Disease|6|||
154864164|NCT01324830|558930883|FG005|Overall Study|Progressive Disease|6|||
154864165|NCT01324830|558930884|FG006|Overall Study|Progressive Disease|3|||
154864166|NCT01324830|558930885|FG007|Overall Study|Progressive Disease|3|||
154864167|NCT01324830|558930886|FG008|Overall Study|Progressive Disease|3|||
155109174|NCT02482428|559828403|FG001|Overall Study|protocol deviation|1|||
155109175|NCT02482428|559828404|FG002|Overall Study|protocol deviation|0|||
155109176|NCT02482428|559828405|FG003|Overall Study|protocol deviation|0|||
155109177|NCT02482428|559828406|FG004|Overall Study|protocol deviation|0|||
155109178|NCT02482428|559828402|FG000|Overall Study|subject/guardian decision|4|||
155109179|NCT02482428|559828403|FG001|Overall Study|subject/guardian decision|2|||
155109180|NCT02482428|559828404|FG002|Overall Study|subject/guardian decision|0|||
155109181|NCT02482428|559828405|FG003|Overall Study|subject/guardian decision|0|||
155109182|NCT02482428|559828406|FG004|Overall Study|subject/guardian decision|2|||
155109183|NCT00809835|559828409|FG000|Overall Study|Lost to Follow-up|7|||
155109184|NCT00809835|559828410|FG001|Overall Study|Lost to Follow-up|6|||
155109185|NCT00809835|559828411|FG002|Overall Study|Lost to Follow-up|10|||
155109186|NCT00809835|559828412|FG003|Overall Study|Lost to Follow-up|2|||
155109187|NCT00809835|559828409|FG000|Overall Study|Withdrawal by Subject|1|||
155109188|NCT00809835|559828410|FG001|Overall Study|Withdrawal by Subject|1|||
155109189|NCT00809835|559828411|FG002|Overall Study|Withdrawal by Subject|1|||
155109190|NCT00809835|559828412|FG003|Overall Study|Withdrawal by Subject|0|||
155109191|NCT05160415|559828413|FG000|Overall Study|Withdrawal by Subject|3|||
155109192|NCT00576628|559828414|FG000|Overall Study|Adverse Event|11|||
155109193|NCT00576628|559828414|FG000|Overall Study|Death|2|||
155109194|NCT00576628|559828414|FG000|Overall Study|Failure to return|1|||
155109195|NCT00576628|559828414|FG000|Overall Study|Refused Treatment|8|||
155109196|NCT00576628|559828414|FG000|Overall Study|Pregnancy|1|||
155109197|NCT00576628|559828414|FG000|Overall Study|RBC transfusion|1|||
154864168|NCT01324830|558930887|FG009|Overall Study|Progressive Disease|6|||
154864169|NCT01324830|558930888|FG010|Overall Study|Progressive Disease|2|||
154864170|NCT01324830|558930889|FG011|Overall Study|Progressive Disease|1|||
154864171|NCT01324830|558930890|FG012|Overall Study|Progressive Disease|1|||
154864172|NCT01324830|558930891|FG013|Overall Study|Progressive Disease|1|||
154864173|NCT01324830|558930892|FG014|Overall Study|Progressive Disease|1|||
154864174|NCT01324830|558930893|FG015|Overall Study|Progressive Disease|3|||
154864175|NCT01324830|558930894|FG016|Overall Study|Progressive Disease|2|||
154864176|NCT01324830|558930895|FG017|Overall Study|Progressive Disease|3|||
154864177|NCT01324830|558930896|FG018|Overall Study|Progressive Disease|4|||
154864178|NCT01324830|558930878|FG000|Overall Study|Dose limiting toxicity|0|||
154864179|NCT01324830|558930879|FG001|Overall Study|Dose limiting toxicity|0|||
154864180|NCT01324830|558930880|FG002|Overall Study|Dose limiting toxicity|0|||
154864181|NCT01324830|558930881|FG003|Overall Study|Dose limiting toxicity|0|||
154864182|NCT01324830|558930882|FG004|Overall Study|Dose limiting toxicity|1|||
154864183|NCT01324830|558930883|FG005|Overall Study|Dose limiting toxicity|0|||
154864184|NCT01324830|558930884|FG006|Overall Study|Dose limiting toxicity|0|||
154864185|NCT01324830|558930885|FG007|Overall Study|Dose limiting toxicity|0|||
154864186|NCT01324830|558930886|FG008|Overall Study|Dose limiting toxicity|0|||
154864187|NCT01324830|558930887|FG009|Overall Study|Dose limiting toxicity|0|||
154864188|NCT01324830|558930888|FG010|Overall Study|Dose limiting toxicity|0|||
154864189|NCT01324830|558930889|FG011|Overall Study|Dose limiting toxicity|0|||
154864190|NCT01324830|558930890|FG012|Overall Study|Dose limiting toxicity|0|||
154864191|NCT01324830|558930891|FG013|Overall Study|Dose limiting toxicity|0|||
154864192|NCT01324830|558930892|FG014|Overall Study|Dose limiting toxicity|0|||
154864193|NCT01324830|558930893|FG015|Overall Study|Dose limiting toxicity|0|||
154864194|NCT01324830|558930894|FG016|Overall Study|Dose limiting toxicity|1|||
154864195|NCT01324830|558930895|FG017|Overall Study|Dose limiting toxicity|1|||
154864196|NCT01324830|558930896|FG018|Overall Study|Dose limiting toxicity|1|||
154864197|NCT01324830|558930878|FG000|Overall Study|Reason not mentioned above|0|||
154864198|NCT01324830|558930879|FG001|Overall Study|Reason not mentioned above|0|||
154864199|NCT01324830|558930880|FG002|Overall Study|Reason not mentioned above|0|||
154864200|NCT01324830|558930881|FG003|Overall Study|Reason not mentioned above|0|||
154864201|NCT01324830|558930882|FG004|Overall Study|Reason not mentioned above|0|||
154864202|NCT01324830|558930883|FG005|Overall Study|Reason not mentioned above|0|||
154864203|NCT01324830|558930884|FG006|Overall Study|Reason not mentioned above|0|||
154864204|NCT01324830|558930885|FG007|Overall Study|Reason not mentioned above|0|||
154864205|NCT01324830|558930886|FG008|Overall Study|Reason not mentioned above|0|||
154864206|NCT01324830|558930887|FG009|Overall Study|Reason not mentioned above|0|||
154864207|NCT01324830|558930888|FG010|Overall Study|Reason not mentioned above|0|||
154864208|NCT01324830|558930889|FG011|Overall Study|Reason not mentioned above|0|||
154864209|NCT01324830|558930890|FG012|Overall Study|Reason not mentioned above|0|||
154864210|NCT01324830|558930891|FG013|Overall Study|Reason not mentioned above|0|||
154864211|NCT01324830|558930892|FG014|Overall Study|Reason not mentioned above|0|||
154864212|NCT01324830|558930893|FG015|Overall Study|Reason not mentioned above|0|||
154864213|NCT01324830|558930894|FG016|Overall Study|Reason not mentioned above|0|||
154864214|NCT01324830|558930895|FG017|Overall Study|Reason not mentioned above|1|||
155109198|NCT00576628|559828414|FG000|Overall Study|Progression of Kidney Disease|1|||
155109199|NCT00576628|559828414|FG000|Overall Study|Progression of Renal Failure|1|||
155109200|NCT00576628|559828414|FG000|Overall Study|The patient move into other town|1|||
154864215|NCT01324830|558930896|FG018|Overall Study|Reason not mentioned above|0|||
154864216|NCT01324830|558930878|FG000|Overall Study|Adverse Event, serious fatal|0|||
154973223|NCT02459418|559326829|FG000|Overall Study|Exclusion Criteria|4|||
154864217|NCT01324830|558930879|FG001|Overall Study|Adverse Event, serious fatal|1|||
154864218|NCT01324830|558930880|FG002|Overall Study|Adverse Event, serious fatal|0|||
154864219|NCT01324830|558930881|FG003|Overall Study|Adverse Event, serious fatal|0|||
154864220|NCT01324830|558930882|FG004|Overall Study|Adverse Event, serious fatal|0|||
154864221|NCT01324830|558930883|FG005|Overall Study|Adverse Event, serious fatal|0|||
154864222|NCT01324830|558930884|FG006|Overall Study|Adverse Event, serious fatal|0|||
154864223|NCT01324830|558930885|FG007|Overall Study|Adverse Event, serious fatal|0|||
154864224|NCT01324830|558930886|FG008|Overall Study|Adverse Event, serious fatal|0|||
154864225|NCT01324830|558930887|FG009|Overall Study|Adverse Event, serious fatal|0|||
154864226|NCT01324830|558930888|FG010|Overall Study|Adverse Event, serious fatal|0|||
154864227|NCT01324830|558930889|FG011|Overall Study|Adverse Event, serious fatal|0|||
154864228|NCT01324830|558930890|FG012|Overall Study|Adverse Event, serious fatal|0|||
154864229|NCT01324830|558930891|FG013|Overall Study|Adverse Event, serious fatal|0|||
154864230|NCT01324830|558930892|FG014|Overall Study|Adverse Event, serious fatal|0|||
154864231|NCT01324830|558930893|FG015|Overall Study|Adverse Event, serious fatal|0|||
154864232|NCT01324830|558930894|FG016|Overall Study|Adverse Event, serious fatal|0|||
154864233|NCT01324830|558930895|FG017|Overall Study|Adverse Event, serious fatal|0|||
154864234|NCT01324830|558930896|FG018|Overall Study|Adverse Event, serious fatal|0|||
154864235|NCT01324830|558930878|FG000|Overall Study|Adverse Event, non-fatal|0|||
154864236|NCT01324830|558930879|FG001|Overall Study|Adverse Event, non-fatal|0|||
154864237|NCT01324830|558930880|FG002|Overall Study|Adverse Event, non-fatal|0|||
154864238|NCT01324830|558930881|FG003|Overall Study|Adverse Event, non-fatal|0|||
154864239|NCT01324830|558930882|FG004|Overall Study|Adverse Event, non-fatal|0|||
154864240|NCT01324830|558930883|FG005|Overall Study|Adverse Event, non-fatal|0|||
154864241|NCT01324830|558930884|FG006|Overall Study|Adverse Event, non-fatal|0|||
154864242|NCT01324830|558930885|FG007|Overall Study|Adverse Event, non-fatal|0|||
154864243|NCT01324830|558930886|FG008|Overall Study|Adverse Event, non-fatal|2|||
154864244|NCT01324830|558930887|FG009|Overall Study|Adverse Event, non-fatal|0|||
154864245|NCT01324830|558930888|FG010|Overall Study|Adverse Event, non-fatal|1|||
154864246|NCT01324830|558930889|FG011|Overall Study|Adverse Event, non-fatal|0|||
154864247|NCT01324830|558930890|FG012|Overall Study|Adverse Event, non-fatal|0|||
154864248|NCT01324830|558930891|FG013|Overall Study|Adverse Event, non-fatal|0|||
154864249|NCT01324830|558930892|FG014|Overall Study|Adverse Event, non-fatal|0|||
154864250|NCT01324830|558930893|FG015|Overall Study|Adverse Event, non-fatal|0|||
154864251|NCT01324830|558930894|FG016|Overall Study|Adverse Event, non-fatal|0|||
154864252|NCT01324830|558930895|FG017|Overall Study|Adverse Event, non-fatal|1|||
154864253|NCT01324830|558930896|FG018|Overall Study|Adverse Event, non-fatal|0|||
154864254|NCT01324830|558930878|FG000|Overall Study|Withdrawal by Subject|0|||
154864255|NCT01324830|558930879|FG001|Overall Study|Withdrawal by Subject|0|||
154864256|NCT01324830|558930880|FG002|Overall Study|Withdrawal by Subject|0|||
154864257|NCT01324830|558930881|FG003|Overall Study|Withdrawal by Subject|0|||
154864258|NCT01324830|558930882|FG004|Overall Study|Withdrawal by Subject|0|||
154864259|NCT01324830|558930883|FG005|Overall Study|Withdrawal by Subject|1|||
154864260|NCT01324830|558930884|FG006|Overall Study|Withdrawal by Subject|0|||
154864261|NCT01324830|558930885|FG007|Overall Study|Withdrawal by Subject|0|||
154864262|NCT01324830|558930886|FG008|Overall Study|Withdrawal by Subject|0|||
154864263|NCT01324830|558930887|FG009|Overall Study|Withdrawal by Subject|0|||
154864264|NCT01324830|558930888|FG010|Overall Study|Withdrawal by Subject|1|||
154864265|NCT01324830|558930889|FG011|Overall Study|Withdrawal by Subject|0|||
154864266|NCT01324830|558930890|FG012|Overall Study|Withdrawal by Subject|0|||
155109201|NCT00576628|559828414|FG000|Overall Study|Transplantation|1|||
154864267|NCT01324830|558930891|FG013|Overall Study|Withdrawal by Subject|0|||
154864268|NCT01324830|558930892|FG014|Overall Study|Withdrawal by Subject|0|||
154864269|NCT01324830|558930893|FG015|Overall Study|Withdrawal by Subject|0|||
154864270|NCT01324830|558930894|FG016|Overall Study|Withdrawal by Subject|0|||
154864271|NCT01324830|558930895|FG017|Overall Study|Withdrawal by Subject|0|||
154864272|NCT01324830|558930896|FG018|Overall Study|Withdrawal by Subject|1|||
154864273|NCT01973283|558930897|FG000|Overall Study|Lost to Follow-up|4|||
154864274|NCT00817414|558930898|FG000|Overall Study|Adverse Event|1|||
154864275|NCT00817414|558930899|FG001|Overall Study|Adverse Event|1|||
154864276|NCT00817414|558930900|FG002|Overall Study|Adverse Event|1|||
154864277|NCT00817414|558930901|FG003|Overall Study|Adverse Event|0|||
155109202|NCT00576628|559828414|FG000|Overall Study|Dialysis|15|||
154864278|NCT00817414|558930902|FG004|Overall Study|Adverse Event|0|||
154864279|NCT00817414|558930898|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
154864280|NCT00817414|558930899|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
154864281|NCT00817414|558930900|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
154864282|NCT00817414|558930901|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
154864283|NCT00817414|558930902|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
154864284|NCT00817414|558930898|FG000|Overall Study|Withdrawal by Subject|1|||
154864285|NCT00817414|558930899|FG001|Overall Study|Withdrawal by Subject|1|||
154864286|NCT00817414|558930900|FG002|Overall Study|Withdrawal by Subject|0|||
154864287|NCT00817414|558930901|FG003|Overall Study|Withdrawal by Subject|0|||
154864288|NCT00817414|558930902|FG004|Overall Study|Withdrawal by Subject|0|||
154864289|NCT00817414|558930898|FG000|Overall Study|Lost to Follow-up|0|||
154864290|NCT00817414|558930899|FG001|Overall Study|Lost to Follow-up|0|||
154864291|NCT00817414|558930900|FG002|Overall Study|Lost to Follow-up|1|||
154864292|NCT00817414|558930901|FG003|Overall Study|Lost to Follow-up|1|||
154864293|NCT00817414|558930902|FG004|Overall Study|Lost to Follow-up|1|||
154864294|NCT00817414|558930898|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
154864295|NCT00817414|558930899|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
154864296|NCT00817414|558930900|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
154864297|NCT00817414|558930901|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
154864298|NCT00817414|558930902|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
154864299|NCT00817414|558930898|FG000|Overall Study|Protocol Violation|0|||
154864300|NCT00817414|558930899|FG001|Overall Study|Protocol Violation|0|||
154864301|NCT00817414|558930900|FG002|Overall Study|Protocol Violation|0|||
154864302|NCT00817414|558930901|FG003|Overall Study|Protocol Violation|0|||
154864303|NCT00817414|558930902|FG004|Overall Study|Protocol Violation|1|||
154864304|NCT00886938|558930903|FG000|Overall Study|Adverse Event|1|||
154864305|NCT00886938|558930903|FG000|Overall Study|Withdrawal by Subject|1|||
154864306|NCT03872180|558930908|FG000|Overall Study|Adverse Event|4|||
154864307|NCT03872180|558930908|FG000|Overall Study|Lack of Efficacy|2|||
154864308|NCT00947154|558930909|FG000|Overall Study|Lost to Follow-up|1|||
154864309|NCT00900796|558930912|FG000|Phase 1|Lacked sufficient information|4|||
154864310|NCT00900796|558930912|FG000|Phase 1|Missing information at Week 16|7|||
154864311|NCT00900796|558930912|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
154864312|NCT00900796|558930912|FG000|Phase 2|Lost to Follow-up|5|||
154864313|NCT02586805|558930917|FG000|Overall Study|Withdrawal by Subject|3|||
154864314|NCT02586805|558930918|FG001|Overall Study|Withdrawal by Subject|1|||
154864315|NCT02586805|558930919|FG002|Overall Study|Withdrawal by Subject|1|||
154864316|NCT02586805|558930920|FG003|Overall Study|Withdrawal by Subject|2|||
154864317|NCT02586805|558930917|FG000|Overall Study|Adverse Event|2|||
154864318|NCT02586805|558930918|FG001|Overall Study|Adverse Event|0|||
154864319|NCT02586805|558930919|FG002|Overall Study|Adverse Event|1|||
154864320|NCT02586805|558930920|FG003|Overall Study|Adverse Event|0|||
154864321|NCT02586805|558930917|FG000|Overall Study|Lost to Follow-up|0|||
154864322|NCT02586805|558930918|FG001|Overall Study|Lost to Follow-up|0|||
154864323|NCT02586805|558930919|FG002|Overall Study|Lost to Follow-up|1|||
154864324|NCT02586805|558930920|FG003|Overall Study|Lost to Follow-up|0|||
154864325|NCT02586805|558930917|FG000|Overall Study|Physician Decision|1|||
154864326|NCT02586805|558930918|FG001|Overall Study|Physician Decision|0|||
154864327|NCT02586805|558930919|FG002|Overall Study|Physician Decision|0|||
154864328|NCT02586805|558930920|FG003|Overall Study|Physician Decision|0|||
154864329|NCT01859403|558930921|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
154864330|NCT01859403|558930922|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
154864331|NCT01859403|558930921|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
154864332|NCT01859403|558930922|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
154864333|NCT01859403|558930921|FG000|Primary Endpoint Measure|Physician Decision|0|||
154864334|NCT01859403|558930922|FG001|Primary Endpoint Measure|Physician Decision|1|||
154864335|NCT01859403|558930921|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
154864336|NCT01859403|558930922|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
154864337|NCT00811252|558930923|FG000|Overall Study|Adverse Event|6|||
154864338|NCT00811252|558930924|FG001|Overall Study|Adverse Event|10|||
154864339|NCT00811252|558930925|FG002|Overall Study|Adverse Event|15|||
154864340|NCT00811252|558930923|FG000|Overall Study|Lack of Efficacy|7|||
154864341|NCT00811252|558930924|FG001|Overall Study|Lack of Efficacy|2|||
154864342|NCT00811252|558930925|FG002|Overall Study|Lack of Efficacy|0|||
154864343|NCT00811252|558930923|FG000|Overall Study|Protocol Violation|3|||
154864344|NCT00811252|558930924|FG001|Overall Study|Protocol Violation|3|||
154864345|NCT00811252|558930925|FG002|Overall Study|Protocol Violation|2|||
154864346|NCT00811252|558930923|FG000|Overall Study|Withdrawal of Consent|1|||
154864347|NCT00811252|558930924|FG001|Overall Study|Withdrawal of Consent|2|||
154864348|NCT00811252|558930925|FG002|Overall Study|Withdrawal of Consent|2|||
154864349|NCT00811252|558930923|FG000|Overall Study|Lost to Follow-up|0|||
154864350|NCT00811252|558930924|FG001|Overall Study|Lost to Follow-up|0|||
154864351|NCT00811252|558930925|FG002|Overall Study|Lost to Follow-up|2|||
154864352|NCT00811252|558930923|FG000|Overall Study|Administrative or Other Reasons|0|||
154864353|NCT00811252|558930924|FG001|Overall Study|Administrative or Other Reasons|3|||
154864354|NCT00811252|558930925|FG002|Overall Study|Administrative or Other Reasons|2|||
154864355|NCT01157117|558930926|FG000|Overall Study|Dosing Symptoms|0|||
154864356|NCT01157117|558930927|FG001|Overall Study|Dosing Symptoms|4|||
154864357|NCT01157117|558930928|FG002|Overall Study|Dosing Symptoms|0|||
154864358|NCT01157117|558930926|FG000|Overall Study|Withdrawal by Subject|4|||
154864359|NCT01157117|558930927|FG001|Overall Study|Withdrawal by Subject|1|||
154864360|NCT01157117|558930928|FG002|Overall Study|Withdrawal by Subject|1|||
154864361|NCT01157117|558930926|FG000|Overall Study|Lack of Efficacy|1|||
154864362|NCT01157117|558930927|FG001|Overall Study|Lack of Efficacy|1|||
154864363|NCT01157117|558930928|FG002|Overall Study|Lack of Efficacy|0|||
154864364|NCT01157117|558930926|FG000|Overall Study|Lost to Follow-up|0|||
154864365|NCT01157117|558930927|FG001|Overall Study|Lost to Follow-up|0|||
154864366|NCT01157117|558930928|FG002|Overall Study|Lost to Follow-up|1|||
154864367|NCT01157117|558930926|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
154864368|NCT01157117|558930927|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
154864369|NCT01157117|558930928|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
154864370|NCT00813748|558930930|FG000|Skin Test Substudy|Physician Decision|0|||
154864371|NCT00813748|558930931|FG001|Skin Test Substudy|Physician Decision|1|||
154864372|NCT01829048|558930934|FG000|Overall Study|Withdrawal by Subject|0|||
154864373|NCT01829048|558930935|FG001|Overall Study|Withdrawal by Subject|0|||
154864374|NCT01829048|558930936|FG002|Overall Study|Withdrawal by Subject|0|||
154864375|NCT01829048|558930937|FG003|Overall Study|Withdrawal by Subject|2|||
154864376|NCT01829048|558930938|FG004|Overall Study|Withdrawal by Subject|0|||
154864377|NCT00892437|558930939|FG000|Randomized Phase|Randomized but not treated|6|||
154864378|NCT00892437|558930940|FG001|Randomized Phase|Randomized but not treated|0|||
154864379|NCT00892437|558930939|FG000|Randomized Phase|Adverse Event|2|||
154864380|NCT00892437|558930940|FG001|Randomized Phase|Adverse Event|2|||
154864381|NCT00892437|558930939|FG000|Randomized Phase|Lost to Follow-up|1|||
154864382|NCT00892437|558930940|FG001|Randomized Phase|Lost to Follow-up|3|||
154864383|NCT00892437|558930939|FG000|Randomized Phase|Investigator's Discretion|1|||
154864384|NCT00892437|558930940|FG001|Randomized Phase|Investigator's Discretion|0|||
154864385|NCT00892437|558930939|FG000|Randomized Phase|Withdrew Consent|1|||
154864386|NCT00892437|558930940|FG001|Randomized Phase|Withdrew Consent|0|||
154864387|NCT00892437|558930939|FG000|Open-Label Extension Phase|Adverse Event|4|||
154864388|NCT00892437|558930940|FG001|Open-Label Extension Phase|Adverse Event|2|||
154864389|NCT00892437|558930939|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
154864390|NCT00892437|558930940|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
154864391|NCT00892437|558930939|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
154864392|NCT00892437|558930940|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
154864393|NCT00892437|558930939|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
154864394|NCT00892437|558930940|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
154864395|NCT00892437|558930939|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
154864396|NCT00892437|558930940|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
154864397|NCT03185130|558930942|FG000|Overall Study|Withdrawal by Subject|0|||
154864398|NCT03185130|558930943|FG001|Overall Study|Withdrawal by Subject|2|||
154864399|NCT02286960|558930944|FG000|Overall Study|Lost to Follow-up|3|||
154864400|NCT02286960|558930945|FG001|Overall Study|Lost to Follow-up|3|||
154864401|NCT02504541|558930947|FG000|Overall Study|Adverse Event|4|||
154864402|NCT02504541|558930947|FG000|Overall Study|Withdrawal by Subject|4|||
154864403|NCT02504541|558930947|FG000|Overall Study|Lost to Follow-up|1|||
154864404|NCT02504541|558930947|FG000|Overall Study|Met Stopping Criteria|1|||
154864405|NCT02504541|558930947|FG000|Overall Study|Protocol Violation|2|||
154864406|NCT02504541|558930947|FG000|Overall Study|Termination by Sponsor|1|||
154864407|NCT02504541|558930947|FG000|Overall Study|Other|2|||
154864408|NCT02504541|558930947|FG000|Overall Study|Multiple|5|||
154864409|NCT02317510|558930961|FG000|Overall Study|Adverse Event|0|||
154864410|NCT02317510|558930962|FG001|Overall Study|Adverse Event|1|||
154864411|NCT00472303|558930963|FG000|Titration Phase|Adverse Event|22|||
154864412|NCT00472303|558930964|FG001|Titration Phase|Adverse Event|12|||
154864413|NCT00472303|558930965|FG002|Titration Phase|Adverse Event|0|||
154864414|NCT00472303|558930963|FG000|Titration Phase|Death|4|||
154864415|NCT00472303|558930964|FG001|Titration Phase|Death|2|||
154864416|NCT00472303|558930965|FG002|Titration Phase|Death|0|||
154864417|NCT00472303|558930963|FG000|Titration Phase|Lack of Efficacy|10|||
154864418|NCT00472303|558930964|FG001|Titration Phase|Lack of Efficacy|0|||
154864419|NCT00472303|558930965|FG002|Titration Phase|Lack of Efficacy|0|||
154864420|NCT00472303|558930963|FG000|Titration Phase|Withdrawal by Subject|16|||
154864421|NCT00472303|558930964|FG001|Titration Phase|Withdrawal by Subject|13|||
154864422|NCT00472303|558930965|FG002|Titration Phase|Withdrawal by Subject|0|||
154864423|NCT00472303|558930963|FG000|Titration Phase|Trial Medication non-compliant|4|||
154864424|NCT00472303|558930964|FG001|Titration Phase|Trial Medication non-compliant|1|||
154864425|NCT00472303|558930965|FG002|Titration Phase|Trial Medication non-compliant|0|||
154864426|NCT00472303|558930963|FG000|Titration Phase|Other|3|||
155109203|NCT02516982|559828421|FG000|Overall Study|Called in to antenatal appointment|32|||
155109204|NCT02516982|559828422|FG001|Overall Study|Called in to antenatal appointment|35|||
155109205|NCT02516982|559828423|FG002|Overall Study|Called in to antenatal appointment|0|||
155109206|NCT02516982|559828424|FG003|Overall Study|Called in to antenatal appointment|0|||
155109207|NCT02516982|559828421|FG000|Overall Study|Withdrawal by Subject|0|||
154864427|NCT00472303|558930964|FG001|Titration Phase|Other|1|||
154864428|NCT00472303|558930965|FG002|Titration Phase|Other|0|||
154864429|NCT00472303|558930963|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
154864430|NCT00472303|558930964|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
154864431|NCT00472303|558930965|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
154864432|NCT00472303|558930963|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
154864433|NCT00472303|558930964|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
154864434|NCT00472303|558930965|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
154864435|NCT00472303|558930963|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
154864436|NCT00472303|558930964|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
154864437|NCT00472303|558930965|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
154864438|NCT00472303|558930963|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
154864439|NCT00472303|558930964|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
154864440|NCT00472303|558930965|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
154864441|NCT00472303|558930963|FG000|Discontinuations After Titration Phase|Other|5|||
154864442|NCT00472303|558930964|FG001|Discontinuations After Titration Phase|Other|0|||
154864443|NCT00472303|558930965|FG002|Discontinuations After Titration Phase|Other|0|||
154864444|NCT00472303|558930963|FG000|Maintenance Phase|Adverse Event|5|||
154864445|NCT00472303|558930964|FG001|Maintenance Phase|Adverse Event|6|||
154864446|NCT00472303|558930965|FG002|Maintenance Phase|Adverse Event|6|||
154864447|NCT00472303|558930963|FG000|Maintenance Phase|Death|3|||
154864448|NCT00472303|558930964|FG001|Maintenance Phase|Death|0|||
154864449|NCT00472303|558930965|FG002|Maintenance Phase|Death|2|||
154864450|NCT00472303|558930963|FG000|Maintenance Phase|Lack of Efficacy|2|||
154864451|NCT00472303|558930964|FG001|Maintenance Phase|Lack of Efficacy|2|||
154864452|NCT00472303|558930965|FG002|Maintenance Phase|Lack of Efficacy|4|||
154864453|NCT00472303|558930963|FG000|Maintenance Phase|Withdrawal by Subject|6|||
154864454|NCT00472303|558930964|FG001|Maintenance Phase|Withdrawal by Subject|7|||
154864455|NCT00472303|558930965|FG002|Maintenance Phase|Withdrawal by Subject|3|||
154864456|NCT00472303|558930963|FG000|Maintenance Phase|Trial medication non-compliant|0|||
154864457|NCT00472303|558930964|FG001|Maintenance Phase|Trial medication non-compliant|0|||
154864458|NCT00472303|558930965|FG002|Maintenance Phase|Trial medication non-compliant|1|||
154864459|NCT00472303|558930963|FG000|Maintenance Phase|Resolution of pain|0|||
154864460|NCT00472303|558930964|FG001|Maintenance Phase|Resolution of pain|0|||
154864461|NCT00472303|558930965|FG002|Maintenance Phase|Resolution of pain|1|||
154864462|NCT00472303|558930963|FG000|Maintenance Phase|Other|1|||
154864463|NCT00472303|558930964|FG001|Maintenance Phase|Other|1|||
154864464|NCT00472303|558930965|FG002|Maintenance Phase|Other|0|||
154864465|NCT01122927|558930966|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
154864466|NCT01122927|558930967|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
154864467|NCT01122927|558930966|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
154864468|NCT01122927|558930967|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
154864469|NCT01122927|558930966|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
154864470|NCT01122927|558930967|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
154864471|NCT01122927|558930966|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
154864472|NCT01122927|558930967|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
154864473|NCT01122927|558930966|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
154864474|NCT01122927|558930967|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
154864475|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
154864476|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
154864477|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
154864478|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
154864479|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
154864480|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
154864481|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
154864482|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
154864483|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
154864484|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
154864485|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
154864486|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
154864487|NCT01122927|558930966|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
154864488|NCT01122927|558930967|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
154864489|NCT03427073|558930975|FG000|Overall Study|Disease Progression|1|||
154864490|NCT03427073|558930976|FG001|Overall Study|Disease Progression|1|||
154864491|NCT03427073|558930977|FG002|Overall Study|Disease Progression|1|||
154864492|NCT03427073|558930978|FG003|Overall Study|Disease Progression|3|||
154864493|NCT03427073|558930979|FG004|Overall Study|Disease Progression|3|||
154864494|NCT03427073|558930980|FG005|Overall Study|Disease Progression|4|||
154864495|NCT03427073|558930981|FG006|Overall Study|Disease Progression|2|||
154864496|NCT03427073|558930982|FG007|Overall Study|Disease Progression|3|||
154864497|NCT03427073|558930975|FG000|Overall Study|Physician Decision|0|||
154864498|NCT03427073|558930976|FG001|Overall Study|Physician Decision|0|||
154864499|NCT03427073|558930977|FG002|Overall Study|Physician Decision|0|||
154864500|NCT03427073|558930978|FG003|Overall Study|Physician Decision|0|||
154864501|NCT03427073|558930979|FG004|Overall Study|Physician Decision|0|||
154864502|NCT03427073|558930980|FG005|Overall Study|Physician Decision|0|||
155174257|NCT00913458|560076642|FG000|Phase 2|Lost to Follow-up|0|||
154864503|NCT03427073|558930981|FG006|Overall Study|Physician Decision|1|||
154864504|NCT03427073|558930982|FG007|Overall Study|Physician Decision|1|||
155174258|NCT00913458|560076643|FG001|Phase 2|Lost to Follow-up|0|||
155174259|NCT00913458|560076644|FG002|Phase 2|Lost to Follow-up|0|||
155174260|NCT00913458|560076645|FG003|Phase 2|Lost to Follow-up|1|||
155174261|NCT00913458|560076646|FG004|Phase 2|Lost to Follow-up|0|||
155174262|NCT00913458|560076647|FG005|Phase 2|Lost to Follow-up|0|||
155174263|NCT00913458|560076648|FG006|Phase 2|Lost to Follow-up|0|||
155174264|NCT00913458|560076642|FG000|Phase 2|Protocol Violation|0|||
155174265|NCT00913458|560076643|FG001|Phase 2|Protocol Violation|2|||
155174266|NCT00913458|560076644|FG002|Phase 2|Protocol Violation|0|||
155174267|NCT00913458|560076645|FG003|Phase 2|Protocol Violation|0|||
155174268|NCT00913458|560076646|FG004|Phase 2|Protocol Violation|0|||
155174269|NCT00913458|560076647|FG005|Phase 2|Protocol Violation|0|||
155174270|NCT00913458|560076648|FG006|Phase 2|Protocol Violation|0|||
155174271|NCT00913458|560076642|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
155174272|NCT00913458|560076643|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
155174273|NCT00913458|560076644|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
155174274|NCT00913458|560076645|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
154864505|NCT01244737|558930983|FG000|Overall Study|Physician Decision|2|||
154864506|NCT01244737|558930984|FG001|Overall Study|Physician Decision|18|||
154864507|NCT01244737|558930985|FG002|Overall Study|Physician Decision|5|||
154864508|NCT01244737|558930983|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
154864509|NCT01244737|558930984|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
154864510|NCT01244737|558930985|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
154864511|NCT01244737|558930983|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
154864512|NCT01244737|558930984|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
154864513|NCT01244737|558930985|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
154864514|NCT01244737|558930983|FG000|Overall Study|MIB immunopathology results not available|3|||
154864515|NCT01244737|558930984|FG001|Overall Study|MIB immunopathology results not available|2|||
154864516|NCT01244737|558930985|FG002|Overall Study|MIB immunopathology results not available|0|||
154864517|NCT01244737|558930983|FG000|Overall Study|PET data failure|0|||
154864518|NCT01244737|558930984|FG001|Overall Study|PET data failure|1|||
154864519|NCT01244737|558930985|FG002|Overall Study|PET data failure|0|||
154864520|NCT01244737|558930983|FG000|Overall Study|Withdrawal by Subject|0|||
154864521|NCT01244737|558930984|FG001|Overall Study|Withdrawal by Subject|0|||
154864522|NCT01244737|558930985|FG002|Overall Study|Withdrawal by Subject|1|||
154864523|NCT02835495|558930988|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
154864524|NCT02835495|558930989|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
154864525|NCT02835495|558930988|FG000|Overall Study|Declined in-person follow-up visit|4|||
154864526|NCT02835495|558930989|FG001|Overall Study|Declined in-person follow-up visit|2|||
154864527|NCT02371629|558930991|FG000|Overall Study|Patient decision|14|||
154864528|NCT02371629|558930992|FG001|Overall Study|Patient decision|10|||
154864529|NCT02371629|558930991|FG000|Overall Study|Adverse Event|8|||
154864530|NCT02371629|558930992|FG001|Overall Study|Adverse Event|8|||
154864531|NCT02371629|558930991|FG000|Overall Study|Physician Decision|2|||
154864532|NCT02371629|558930992|FG001|Overall Study|Physician Decision|3|||
154864533|NCT02371629|558930991|FG000|Overall Study|Death|1|||
154864534|NCT02371629|558930992|FG001|Overall Study|Death|1|||
154864535|NCT02371629|558930991|FG000|Overall Study|Noncompliance with study treatment|1|||
154864536|NCT02371629|558930992|FG001|Overall Study|Noncompliance with study treatment|0|||
154864537|NCT02371629|558930991|FG000|Overall Study|Lack of Efficacy|0|||
154864538|NCT02371629|558930992|FG001|Overall Study|Lack of Efficacy|2|||
154864539|NCT02371629|558930991|FG000|Overall Study|Protocol deviation|0|||
154864540|NCT02371629|558930992|FG001|Overall Study|Protocol deviation|1|||
154864541|NCT03486314|558930993|FG000|Part A|Adverse Event|1|||
154864542|NCT03486314|558930994|FG001|Part A|Adverse Event|0|||
154864543|NCT03486314|558930995|FG002|Part A|Adverse Event|0|||
154864544|NCT03486314|558930993|FG000|Part A|Symptomatic Deterioration|2|||
154864545|NCT03486314|558930994|FG001|Part A|Symptomatic Deterioration|0|||
154864546|NCT03486314|558930995|FG002|Part A|Symptomatic Deterioration|0|||
155174275|NCT00913458|560076646|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
155174276|NCT00913458|560076647|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
155174277|NCT00913458|560076648|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
155174278|NCT00913458|560076642|FG000|Phase 3|Adverse Event|0|||
155174279|NCT00913458|560076643|FG001|Phase 3|Adverse Event|0|||
155174280|NCT00913458|560076644|FG002|Phase 3|Adverse Event|0|||
155174281|NCT00913458|560076645|FG003|Phase 3|Adverse Event|0|||
155174282|NCT00913458|560076646|FG004|Phase 3|Adverse Event|5|||
154864547|NCT00542828|558931000|FG000|Overall Study|Physician Decision|1|||
154864548|NCT00542828|558931000|FG000|Overall Study|Need for Prohibited Treatment|3|||
154864549|NCT00542828|558931000|FG000|Overall Study|Study Prematurely Discontinued|7|||
154864550|NCT00542828|558931000|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
155174283|NCT00913458|560076647|FG005|Phase 3|Adverse Event|4|||
155174284|NCT00913458|560076648|FG006|Phase 3|Adverse Event|1|||
154864551|NCT01364467|558931001|FG000|Overall Study|Lost to Follow-up|1|||
154864552|NCT01364467|558931002|FG001|Overall Study|Lost to Follow-up|2|||
155174285|NCT00913458|560076642|FG000|Phase 3|Lost to Follow-up|0|||
154864553|NCT01634243|558931003|FG000|Overall Study|Adverse Event|5|||
154864554|NCT01634243|558931004|FG001|Overall Study|Adverse Event|5|||
154864555|NCT01634243|558931003|FG000|Overall Study|Lack of Efficacy|1|||
154864556|NCT01634243|558931004|FG001|Overall Study|Lack of Efficacy|0|||
154864557|NCT04283461|558931005|FG000|Overall Study|Enrolled in separate trial|0|||
154864558|NCT04283461|558931006|FG001|Overall Study|Enrolled in separate trial|0|||
154864559|NCT04283461|558931007|FG002|Overall Study|Enrolled in separate trial|8|||
154864560|NCT04283461|558931008|FG003|Overall Study|Enrolled in separate trial|13|||
154864561|NCT04283461|558931009|FG004|Overall Study|Enrolled in separate trial|12|||
154864562|NCT04283461|558931010|FG005|Overall Study|Enrolled in separate trial|0|||
154864563|NCT04283461|558931011|FG006|Overall Study|Enrolled in separate trial|0|||
154864564|NCT04283461|558931012|FG007|Overall Study|Enrolled in separate trial|8|||
154864565|NCT04283461|558931013|FG008|Overall Study|Enrolled in separate trial|0|||
154864566|NCT04283461|558931014|FG009|Overall Study|Enrolled in separate trial|0|||
154864567|NCT04283461|558931015|FG010|Overall Study|Enrolled in separate trial|0|||
154864568|NCT04283461|558931016|FG011|Overall Study|Enrolled in separate trial|7|||
154864569|NCT04283461|558931017|FG012|Overall Study|Enrolled in separate trial|0|||
154864570|NCT05490771|558931018|FG000|Overall Study|Disease progression|18|||
154864571|NCT05490771|558931018|FG000|Overall Study|Adverse Event|3|||
154864572|NCT05490771|558931018|FG000|Overall Study|Other complicating disease|1|||
154864573|NCT05490771|558931018|FG000|Overall Study|Withdrawal by Subject|3|||
154864574|NCT05490771|558931018|FG000|Overall Study|Physician Decision|1|||
154864575|NCT05490771|558931018|FG000|Overall Study|Still on treatment|2|||
154864576|NCT05490771|558931018|FG000|Overall Study|Never start protocol therapy|5|||
154864577|NCT05490771|558931018|FG000|Overall Study|Ineligible|2|||
154864578|NCT00816036|558931021|FG000|Overall Study|Death|47|||
154864579|NCT00816036|558931022|FG001|Overall Study|Death|28|||
154864580|NCT00816036|558931021|FG000|Overall Study|Lost to Follow-up|75|||
154864581|NCT00816036|558931022|FG001|Overall Study|Lost to Follow-up|57|||
154864582|NCT00816036|558931021|FG000|Overall Study|Withdrawal by Subject|54|||
154864583|NCT00816036|558931022|FG001|Overall Study|Withdrawal by Subject|23|||
154864584|NCT00004980|558931023|FG000|Overall Study|Withdrawal by Subject|1|||
154864585|NCT00004980|558931024|FG001|Overall Study|Withdrawal by Subject|0|||
154864586|NCT00004980|558931023|FG000|Overall Study|memory difficulties|1|||
154864587|NCT00004980|558931024|FG001|Overall Study|memory difficulties|1|||
154864588|NCT00004980|558931023|FG000|Overall Study|Physician Decision|0|||
154864589|NCT00004980|558931024|FG001|Overall Study|Physician Decision|1|||
154864590|NCT01299025|558931025|FG000|Overall Study|Withdrawal by Subject|2|||
154864591|NCT01299025|558931026|FG001|Overall Study|Withdrawal by Subject|1|||
154864592|NCT01299025|558931025|FG000|Overall Study|Lost to Follow-up|1|||
154864593|NCT01299025|558931026|FG001|Overall Study|Lost to Follow-up|0|||
154864594|NCT01624194|558931027|FG000|Overall Study|Lost to Follow-up|1|||
154864595|NCT01624194|558931028|FG001|Overall Study|Lost to Follow-up|0|||
154864596|NCT01624194|558931027|FG000|Overall Study|Withdrawal by Subject|1|||
154864597|NCT01624194|558931028|FG001|Overall Study|Withdrawal by Subject|0|||
154864598|NCT03212261|558931029|FG000|Overall Study|Became ineligible d/t tech|2|||
154864599|NCT03212261|558931029|FG000|Overall Study|Tech Trouble- No first study visit|1|||
154864600|NCT03212261|558931029|FG000|Overall Study|Lost to Follow-up|7|||
154864601|NCT03212261|558931029|FG000|Overall Study|Family Emergency|1|||
154864602|NCT03212261|558931029|FG000|Overall Study|Too busy/ No time|5|||
154864603|NCT05480514|558931030|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
154864604|NCT05480514|558931031|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
154864605|NCT05480514|558931030|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
154864606|NCT05480514|558931031|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
154864607|NCT05480514|558931030|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
154864608|NCT05480514|558931031|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
154864609|NCT05480514|558931030|FG000|Period 1|Covid-19 Related|1|||
154864610|NCT05480514|558931031|FG001|Period 1|Covid-19 Related|0|||
154864611|NCT05480514|558931030|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
154864612|NCT05480514|558931031|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
154973224|NCT02459418|559326830|FG001|Overall Study|Exclusion Criteria|0|||
154864613|NCT05738486|558932576|FG000|Overall Study|Continuing Study|194|||
154864614|NCT05738486|558932577|FG001|Overall Study|Continuing Study|196|||
154864615|NCT05738486|558932578|FG002|Overall Study|Continuing Study|193|||
154973225|NCT02459418|559326829|FG000|Overall Study|Protocol Violation|0|||
154973226|NCT02459418|559326830|FG001|Overall Study|Protocol Violation|2|||
154973227|NCT02459418|559326829|FG000|Overall Study|Physician Decision|0|||
155109208|NCT02516982|559828422|FG001|Overall Study|Withdrawal by Subject|0|||
154864616|NCT05738486|558932579|FG003|Overall Study|Continuing Study|191|||
154864617|NCT05738486|558932576|FG000|Overall Study|Withdrawal by Subject|8|||
154864618|NCT05738486|558932577|FG001|Overall Study|Withdrawal by Subject|5|||
154864619|NCT05738486|558932578|FG002|Overall Study|Withdrawal by Subject|7|||
154864620|NCT05738486|558932579|FG003|Overall Study|Withdrawal by Subject|13|||
154864621|NCT05738486|558932576|FG000|Overall Study|Adverse Event|4|||
154864622|NCT05738486|558932577|FG001|Overall Study|Adverse Event|6|||
154864623|NCT05738486|558932578|FG002|Overall Study|Adverse Event|4|||
154864624|NCT05738486|558932579|FG003|Overall Study|Adverse Event|5|||
154864625|NCT05738486|558932576|FG000|Overall Study|Physician Decision|0|||
154864626|NCT05738486|558932577|FG001|Overall Study|Physician Decision|2|||
154864627|NCT05738486|558932578|FG002|Overall Study|Physician Decision|4|||
154864628|NCT05738486|558932579|FG003|Overall Study|Physician Decision|1|||
154864629|NCT05738486|558932576|FG000|Overall Study|Lost to Follow-up|1|||
154864630|NCT05738486|558932577|FG001|Overall Study|Lost to Follow-up|1|||
154864631|NCT05738486|558932578|FG002|Overall Study|Lost to Follow-up|2|||
154864632|NCT05738486|558932579|FG003|Overall Study|Lost to Follow-up|1|||
154864633|NCT05738486|558932576|FG000|Overall Study|Participant was Non-ambulatory|0|||
154864634|NCT05738486|558932577|FG001|Overall Study|Participant was Non-ambulatory|0|||
154864635|NCT05738486|558932578|FG002|Overall Study|Participant was Non-ambulatory|1|||
154864636|NCT05738486|558932579|FG003|Overall Study|Participant was Non-ambulatory|0|||
154864637|NCT05738486|558932576|FG000|Overall Study|Participant had Poor Venous Access|0|||
154864638|NCT05738486|558932577|FG001|Overall Study|Participant had Poor Venous Access|0|||
154864639|NCT05738486|558932578|FG002|Overall Study|Participant had Poor Venous Access|0|||
154864640|NCT05738486|558932579|FG003|Overall Study|Participant had Poor Venous Access|1|||
154864641|NCT05738486|558932576|FG000|Overall Study|Assigned Treatment by Mistake|0|||
154864642|NCT05738486|558932577|FG001|Overall Study|Assigned Treatment by Mistake|0|||
154864643|NCT05738486|558932578|FG002|Overall Study|Assigned Treatment by Mistake|0|||
154864644|NCT05738486|558932579|FG003|Overall Study|Assigned Treatment by Mistake|1|||
154864645|NCT05738486|558932576|FG000|Overall Study|Death|0|||
154864646|NCT05738486|558932577|FG001|Overall Study|Death|0|||
154864647|NCT05738486|558932578|FG002|Overall Study|Death|1|||
154864648|NCT05738486|558932579|FG003|Overall Study|Death|0|||
154864649|NCT05738486|558932576|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
154864650|NCT05738486|558932577|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
154864651|NCT05738486|558932578|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
154864652|NCT05738486|558932579|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
154864653|NCT03395210|558932580|FG000|Overall Study|Other|0|||
154864654|NCT03395210|558932581|FG001|Overall Study|Other|0|||
154864655|NCT03395210|558932582|FG002|Overall Study|Other|0|||
154864656|NCT03395210|558932583|FG003|Overall Study|Other|0|||
154864657|NCT03395210|558932584|FG004|Overall Study|Other|1|||
154864658|NCT03395210|558932580|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
154864659|NCT03395210|558932581|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
154864660|NCT03395210|558932582|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
154864661|NCT03395210|558932583|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
154864662|NCT03395210|558932584|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
154864663|NCT03395210|558932580|FG000|Overall Study|Adverse Event|1|||
154864664|NCT03395210|558932581|FG001|Overall Study|Adverse Event|0|||
154864665|NCT03395210|558932582|FG002|Overall Study|Adverse Event|2|||
154864666|NCT03395210|558932583|FG003|Overall Study|Adverse Event|4|||
154864667|NCT03395210|558932584|FG004|Overall Study|Adverse Event|3|||
154864668|NCT03395210|558932580|FG000|Overall Study|Need of Rescue Medication|1|||
154864669|NCT03395210|558932581|FG001|Overall Study|Need of Rescue Medication|0|||
154864670|NCT03395210|558932582|FG002|Overall Study|Need of Rescue Medication|1|||
154864671|NCT03395210|558932583|FG003|Overall Study|Need of Rescue Medication|4|||
154864672|NCT03395210|558932584|FG004|Overall Study|Need of Rescue Medication|0|||
154864673|NCT03395210|558932580|FG000|Overall Study|Lack of Response|0|||
154864674|NCT03395210|558932581|FG001|Overall Study|Lack of Response|0|||
154864675|NCT03395210|558932582|FG002|Overall Study|Lack of Response|0|||
154864676|NCT03395210|558932583|FG003|Overall Study|Lack of Response|5|||
154864677|NCT03395210|558932584|FG004|Overall Study|Lack of Response|5|||
154864678|NCT03395210|558932580|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
154864679|NCT03395210|558932581|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
154864680|NCT03395210|558932582|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
154864681|NCT03395210|558932583|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
154864682|NCT03395210|558932584|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
154864683|NCT03395210|558932580|FG000|Overall Study|Participant Decision|1|||
154864684|NCT03395210|558932581|FG001|Overall Study|Participant Decision|1|||
154864685|NCT03395210|558932582|FG002|Overall Study|Participant Decision|0|||
154864686|NCT03395210|558932583|FG003|Overall Study|Participant Decision|4|||
154864687|NCT03395210|558932584|FG004|Overall Study|Participant Decision|0|||
154864688|NCT03395210|558932580|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
154864689|NCT03395210|558932581|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
154864690|NCT03395210|558932582|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
154864691|NCT03395210|558932583|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
154864692|NCT03395210|558932584|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
154864693|NCT01672892|558932585|FG000|Overall Study|Protocol Violation|7|||
154864694|NCT01672892|558932586|FG001|Overall Study|Protocol Violation|3|||
154864695|NCT02128490|558932595|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
154864696|NCT02128490|558932596|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
154973228|NCT02459418|559326830|FG001|Overall Study|Physician Decision|2|||
154864697|NCT02128490|558932597|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
154864698|NCT02128490|558932598|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
154864699|NCT02128490|558932599|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
154864700|NCT02128490|558932595|FG000|Overall Study|Major Protocol Deviation|1|||
154864701|NCT02128490|558932596|FG001|Overall Study|Major Protocol Deviation|2|||
154864702|NCT02128490|558932597|FG002|Overall Study|Major Protocol Deviation|0|||
154864703|NCT02128490|558932598|FG003|Overall Study|Major Protocol Deviation|2|||
154864704|NCT02128490|558932599|FG004|Overall Study|Major Protocol Deviation|2|||
154864705|NCT02128490|558932595|FG000|Overall Study|Lost to Follow-up|0|||
154864706|NCT02128490|558932596|FG001|Overall Study|Lost to Follow-up|0|||
154864707|NCT02128490|558932597|FG002|Overall Study|Lost to Follow-up|1|||
154864708|NCT02128490|558932598|FG003|Overall Study|Lost to Follow-up|1|||
154864709|NCT02128490|558932599|FG004|Overall Study|Lost to Follow-up|1|||
154864710|NCT02128490|558932595|FG000|Overall Study|Voluntary Withdrawal|3|||
154864711|NCT02128490|558932596|FG001|Overall Study|Voluntary Withdrawal|3|||
154864712|NCT02128490|558932597|FG002|Overall Study|Voluntary Withdrawal|1|||
154864713|NCT02128490|558932598|FG003|Overall Study|Voluntary Withdrawal|1|||
154864714|NCT02128490|558932599|FG004|Overall Study|Voluntary Withdrawal|2|||
154864715|NCT02128490|558932595|FG000|Overall Study|Lack of Efficacy|0|||
154864716|NCT02128490|558932596|FG001|Overall Study|Lack of Efficacy|1|||
154864717|NCT02128490|558932597|FG002|Overall Study|Lack of Efficacy|0|||
154864718|NCT02128490|558932598|FG003|Overall Study|Lack of Efficacy|0|||
154864719|NCT02128490|558932599|FG004|Overall Study|Lack of Efficacy|0|||
154864720|NCT02128490|558932595|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
154864721|NCT02128490|558932596|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
154864722|NCT02128490|558932597|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
154864723|NCT02128490|558932598|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
154864724|NCT02128490|558932599|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
154864725|NCT02128490|558932595|FG000|Overall Study|Other Miscellaneous Reasons|0|||
154864726|NCT02128490|558932596|FG001|Overall Study|Other Miscellaneous Reasons|0|||
154864727|NCT02128490|558932597|FG002|Overall Study|Other Miscellaneous Reasons|2|||
154864728|NCT02128490|558932598|FG003|Overall Study|Other Miscellaneous Reasons|1|||
154864729|NCT02128490|558932599|FG004|Overall Study|Other Miscellaneous Reasons|1|||
154864730|NCT02243176|558932600|FG000|Overall Study|Other reason|1|||
154864731|NCT02243176|558932601|FG001|Overall Study|Other reason|2|||
154864732|NCT02243176|558932600|FG000|Overall Study|protocol specified withdrawal critera|1|||
154864733|NCT02243176|558932601|FG001|Overall Study|protocol specified withdrawal critera|3|||
154864734|NCT02243176|558932600|FG000|Overall Study|Protocol Violation|2|||
154864735|NCT02243176|558932601|FG001|Overall Study|Protocol Violation|1|||
154864736|NCT02243176|558932600|FG000|Overall Study|Withdrawal by Subject|8|||
154864737|NCT02243176|558932601|FG001|Overall Study|Withdrawal by Subject|7|||
154864738|NCT02243176|558932600|FG000|Overall Study|Adverse Event|2|||
154864739|NCT02243176|558932601|FG001|Overall Study|Adverse Event|2|||
154864740|NCT03311126|558932603|FG000|Induction|Death|1|||
154864741|NCT03311126|558932603|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
154864742|NCT03113500|558932604|FG000|Overall Study|Withdrawal by Subject|1|||
154864743|NCT02517515|558932607|FG000|Overall Study|Adverse Event|0|||
154864744|NCT02517515|558932608|FG001|Overall Study|Adverse Event|1|||
154864745|NCT02517515|558932607|FG000|Overall Study|Withdrew Consent|0|||
154864746|NCT02517515|558932608|FG001|Overall Study|Withdrew Consent|1|||
154864747|NCT02517515|558932607|FG000|Overall Study|Lost to Follow-up|1|||
155109209|NCT02516982|559828423|FG002|Overall Study|Withdrawal by Subject|1|||
155109210|NCT02516982|559828424|FG003|Overall Study|Withdrawal by Subject|2|||
155109211|NCT02516982|559828421|FG000|Overall Study|Protocol Violation|0|||
155109212|NCT02516982|559828422|FG001|Overall Study|Protocol Violation|0|||
155109213|NCT02516982|559828423|FG002|Overall Study|Protocol Violation|1|||
155109214|NCT02516982|559828424|FG003|Overall Study|Protocol Violation|1|||
155109215|NCT02516982|559828421|FG000|Overall Study|Did not install the app|0|||
155109216|NCT02516982|559828422|FG001|Overall Study|Did not install the app|0|||
155109217|NCT02516982|559828423|FG002|Overall Study|Did not install the app|46|||
155109218|NCT02516982|559828424|FG003|Overall Study|Did not install the app|47|||
155109219|NCT01951586|559828429|FG000|Overall Study|Death|61|||
155109220|NCT01951586|559828430|FG001|Overall Study|Death|120|||
155109221|NCT01951586|559828429|FG000|Overall Study|Withdrawal by Subject|8|||
154864748|NCT02517515|558932608|FG001|Overall Study|Lost to Follow-up|0|||
154864749|NCT02517515|558932607|FG000|Overall Study|Other|1|||
154864750|NCT02517515|558932608|FG001|Overall Study|Other|0|||
154864751|NCT00469079|558932609|FG000|Overall Study|Lack of Efficacy|3|||
154864752|NCT00469079|558932610|FG001|Overall Study|Lack of Efficacy|8|||
154864753|NCT00469079|558932611|FG002|Overall Study|Lack of Efficacy|5|||
154864754|NCT00469079|558932609|FG000|Overall Study|Adverse Event|1|||
154864755|NCT00469079|558932610|FG001|Overall Study|Adverse Event|3|||
154864756|NCT00469079|558932611|FG002|Overall Study|Adverse Event|2|||
154864757|NCT00469079|558932609|FG000|Overall Study|Lost to Follow-up|4|||
155109222|NCT01951586|559828430|FG001|Overall Study|Withdrawal by Subject|17|||
154864758|NCT00469079|558932610|FG001|Overall Study|Lost to Follow-up|8|||
154864759|NCT00469079|558932611|FG002|Overall Study|Lost to Follow-up|10|||
154864760|NCT00469079|558932609|FG000|Overall Study|Withdrawal by Subject|1|||
154864761|NCT00469079|558932610|FG001|Overall Study|Withdrawal by Subject|2|||
154864762|NCT00469079|558932611|FG002|Overall Study|Withdrawal by Subject|2|||
154864763|NCT00469079|558932609|FG000|Overall Study|Ineligible|0|||
154864764|NCT00469079|558932610|FG001|Overall Study|Ineligible|1|||
154864765|NCT00469079|558932611|FG002|Overall Study|Ineligible|0|||
154864766|NCT02981472|558932612|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
154864767|NCT02981472|558932613|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
154864768|NCT02981472|558932612|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
154864769|NCT02981472|558932613|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154864770|NCT02981472|558932612|FG000|Treatment Period|Adverse Event|6|||
154864771|NCT02981472|558932613|FG001|Treatment Period|Adverse Event|1|||
154864772|NCT02981472|558932612|FG000|Treatment Period|Participant withdrew consent|1|||
154864773|NCT02981472|558932613|FG001|Treatment Period|Participant withdrew consent|0|||
154864774|NCT02981472|558932612|FG000|Treatment Period|Lost to Follow-up|0|||
154864775|NCT02981472|558932613|FG001|Treatment Period|Lost to Follow-up|1|||
154864776|NCT02874794|558932618|FG000|Overall Study|Physician Decision|3|||
154864777|NCT02874794|558932619|FG001|Overall Study|Physician Decision|2|||
154864778|NCT02874794|558932618|FG000|Overall Study|Withdrawal by Subject|2|||
154864779|NCT02874794|558932619|FG001|Overall Study|Withdrawal by Subject|8|||
154864780|NCT02874794|558932618|FG000|Overall Study|Death|2|||
154864781|NCT02874794|558932619|FG001|Overall Study|Death|1|||
154864782|NCT01473004|558932620|FG000|Overall Study|Incomplete Lobar Treatment|1|||
154864783|NCT01473004|558932621|FG001|Overall Study|Incomplete Lobar Treatment|0|||
154864784|NCT00613314|558932625|FG000|Overall Study|Adverse Event|5|||
154864785|NCT00613314|558932625|FG000|Overall Study|Protocol Violation|14|||
154864786|NCT00613314|558932625|FG000|Overall Study|Lost to Follow-up|46|||
154864787|NCT00613314|558932625|FG000|Overall Study|Other reason not defined above|90|||
154864788|NCT01584024|558932626|FG000|Overall Study|Lost to Follow-up|10|||
154864789|NCT01584024|558932626|FG000|Overall Study|Withdrawal by Subject|3|||
154864790|NCT04419506|558932629|FG000|Overall Study|Adverse Event|0|||
154864791|NCT04419506|558932630|FG001|Overall Study|Adverse Event|10|||
154864792|NCT04419506|558932631|FG002|Overall Study|Adverse Event|0|||
154864793|NCT04419506|558932632|FG003|Overall Study|Adverse Event|3|||
154864794|NCT04419506|558932629|FG000|Overall Study|Withdrawal by Subject|0|||
154864795|NCT04419506|558932630|FG001|Overall Study|Withdrawal by Subject|0|||
154864796|NCT04419506|558932631|FG002|Overall Study|Withdrawal by Subject|0|||
154864797|NCT04419506|558932632|FG003|Overall Study|Withdrawal by Subject|1|||
154864798|NCT04419506|558932629|FG000|Overall Study|poor-compliance|0|||
154864799|NCT04419506|558932630|FG001|Overall Study|poor-compliance|0|||
154864800|NCT04419506|558932631|FG002|Overall Study|poor-compliance|0|||
154864801|NCT04419506|558932632|FG003|Overall Study|poor-compliance|1|||
154864802|NCT00345605|558932633|FG000|Arm 1|Adverse Event|0|||
154864803|NCT00345605|558932634|FG001|Arm 1|Adverse Event|1|||
154864804|NCT00345605|558932633|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
154864805|NCT00345605|558932634|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
154864806|NCT01126619|558932639|FG000|Overall Study|Not eligible for the study|2|||
154864807|NCT01126619|558932639|FG000|Overall Study|Investigator decision|4|||
154864808|NCT01126619|558932639|FG000|Overall Study|Serious adverse event|1|||
154864809|NCT01126619|558932639|FG000|Overall Study|Withdrawal by Subject|9|||
154864810|NCT01126619|558932639|FG000|Overall Study|Non-compliance|1|||
154864811|NCT04876391|558932640|FG000|Overall Study|Withdrawal by Subject|1|||
154864812|NCT04876391|558932641|FG001|Overall Study|Withdrawal by Subject|10|||
154864813|NCT04876391|558932640|FG000|Overall Study|Lost to Follow-up|2|||
154864814|NCT04876391|558932641|FG001|Overall Study|Lost to Follow-up|4|||
154864815|NCT04876391|558932640|FG000|Overall Study|Lack of Efficacy|0|||
154864816|NCT04876391|558932641|FG001|Overall Study|Lack of Efficacy|2|||
154864817|NCT04876391|558932640|FG000|Overall Study|Adverse Event|3|||
154864818|NCT04876391|558932641|FG001|Overall Study|Adverse Event|1|||
154864819|NCT04876391|558932640|FG000|Overall Study|Patient non-compliance|0|||
154864820|NCT04876391|558932641|FG001|Overall Study|Patient non-compliance|1|||
154864821|NCT04876391|558932640|FG000|Overall Study|Personal reasons|0|||
154864822|NCT04876391|558932641|FG001|Overall Study|Personal reasons|1|||
154864823|NCT04876391|558932640|FG000|Overall Study|Withdrawn as per protocol|2|||
154864824|NCT04876391|558932641|FG001|Overall Study|Withdrawn as per protocol|2|||
154864825|NCT03293030|558932642|FG000|Overall Study|Withdrawal by Subject|3|||
154864826|NCT04899271|558932643|FG000|Overall Study|Lost to Follow-up|1|||
154864827|NCT04899271|558932644|FG001|Overall Study|Lost to Follow-up|0|||
154864828|NCT04899271|558932643|FG000|Overall Study|Subject request/consent withdrawal|2|||
154864829|NCT04899271|558932644|FG001|Overall Study|Subject request/consent withdrawal|0|||
154864830|NCT02318602|558932646|FG000|Overall Study|Adverse Event|0|||
154864831|NCT02318602|558932647|FG001|Overall Study|Adverse Event|1|||
154864832|NCT02318602|558932648|FG002|Overall Study|Adverse Event|1|||
154864833|NCT02318602|558932646|FG000|Overall Study|Withdrawal by Subject|0|||
154864834|NCT02318602|558932647|FG001|Overall Study|Withdrawal by Subject|3|||
154864835|NCT02318602|558932648|FG002|Overall Study|Withdrawal by Subject|0|||
154864836|NCT02318602|558932646|FG000|Overall Study|Death|1|||
154864837|NCT02318602|558932647|FG001|Overall Study|Death|0|||
155174286|NCT00913458|560076643|FG001|Phase 3|Lost to Follow-up|0|||
155174287|NCT00913458|560076644|FG002|Phase 3|Lost to Follow-up|0|||
155174288|NCT00913458|560076645|FG003|Phase 3|Lost to Follow-up|0|||
155174289|NCT00913458|560076646|FG004|Phase 3|Lost to Follow-up|2|||
155174290|NCT00913458|560076647|FG005|Phase 3|Lost to Follow-up|0|||
155174291|NCT00913458|560076648|FG006|Phase 3|Lost to Follow-up|0|||
155174292|NCT00913458|560076642|FG000|Phase 3|Non-Responder|0|||
155174293|NCT00913458|560076643|FG001|Phase 3|Non-Responder|0|||
155174294|NCT00913458|560076644|FG002|Phase 3|Non-Responder|0|||
155174295|NCT00913458|560076645|FG003|Phase 3|Non-Responder|0|||
155174296|NCT00913458|560076646|FG004|Phase 3|Non-Responder|0|||
155174297|NCT00913458|560076647|FG005|Phase 3|Non-Responder|1|||
155174298|NCT00913458|560076648|FG006|Phase 3|Non-Responder|3|||
155174299|NCT00913458|560076642|FG000|Phase 3|Withdrawal by Subject|0|||
155174300|NCT00913458|560076643|FG001|Phase 3|Withdrawal by Subject|0|||
155174301|NCT00913458|560076644|FG002|Phase 3|Withdrawal by Subject|0|||
155174302|NCT00913458|560076645|FG003|Phase 3|Withdrawal by Subject|0|||
155174303|NCT00913458|560076646|FG004|Phase 3|Withdrawal by Subject|1|||
155174304|NCT00913458|560076647|FG005|Phase 3|Withdrawal by Subject|2|||
155174305|NCT00913458|560076648|FG006|Phase 3|Withdrawal by Subject|0|||
155174306|NCT00913458|560076642|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
154864838|NCT02318602|558932648|FG002|Overall Study|Death|0|||
154864839|NCT02318602|558932646|FG000|Overall Study|Guardian decision to withdraw|0|||
154864840|NCT02318602|558932647|FG001|Overall Study|Guardian decision to withdraw|0|||
154864841|NCT02318602|558932648|FG002|Overall Study|Guardian decision to withdraw|1|||
154864842|NCT00095303|558932649|FG000|Main Study|Lost to Follow-up|91|||
154864843|NCT00095303|558932650|FG001|Main Study|Lost to Follow-up|87|||
154864844|NCT00095303|558932649|FG000|Follow Up Study|Lost to Follow-up|59|||
154864845|NCT00095303|558932650|FG001|Follow Up Study|Lost to Follow-up|58|||
154864846|NCT03228186|558932653|FG000|Overall Study|Patient never started treatment|1|||
154864847|NCT03953118|558932656|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
154864848|NCT03953118|558932657|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
154864849|NCT00258154|558932658|FG000|Overall Study|Adverse Event|1|||
154864850|NCT00258154|558932659|FG001|Overall Study|Adverse Event|0|||
154864851|NCT00258154|558932658|FG000|Overall Study|Lost to Follow-up|0|||
154864852|NCT00258154|558932659|FG001|Overall Study|Lost to Follow-up|1|||
154864853|NCT00258154|558932658|FG000|Overall Study|Protocol Violation|2|||
154864854|NCT00258154|558932659|FG001|Overall Study|Protocol Violation|1|||
154864855|NCT00258154|558932658|FG000|Overall Study|Withdrawal by Subject|3|||
154864856|NCT00258154|558932659|FG001|Overall Study|Withdrawal by Subject|4|||
154864857|NCT00258154|558932658|FG000|Overall Study|Patient Moved|3|||
154864858|NCT00258154|558932659|FG001|Overall Study|Patient Moved|1|||
154864859|NCT05139030|558932665|FG000|Overall Study|Withdrawal by Subject|1|||
154864860|NCT05139030|558932666|FG001|Overall Study|Withdrawal by Subject|3|||
154864861|NCT05139030|558932665|FG000|Overall Study|Adverse Event|0|||
154864862|NCT05139030|558932666|FG001|Overall Study|Adverse Event|1|||
154864863|NCT05139030|558932665|FG000|Overall Study|Failure to meet continuation criteria|0|||
154864864|NCT05139030|558932666|FG001|Overall Study|Failure to meet continuation criteria|1|||
154864865|NCT02502864|558932671|FG000|Overall Study|Withdrawal by Subject|1|||
154864866|NCT03772327|558932672|FG000|Overall Study|Lost to Follow-up|3|||
154864867|NCT03772327|558932673|FG001|Overall Study|Lost to Follow-up|4|||
154864868|NCT03772327|558932672|FG000|Overall Study|Withdrawal by Subject|2|||
154864869|NCT03772327|558932673|FG001|Overall Study|Withdrawal by Subject|3|||
154864870|NCT00613626|558932677|FG000|Overall Study|Ineligible|0|||
154864871|NCT00613626|558932678|FG001|Overall Study|Ineligible|1|||
154864872|NCT00613626|558932679|FG002|Overall Study|Ineligible|0|||
154864873|NCT00820040|558932685|FG000|Overall Study|Death|1|||
154864874|NCT00820040|558932685|FG000|Overall Study|Sponsor terminated study|1|||
154864875|NCT00820040|558932685|FG000|Overall Study|Screen failure|1|||
154864876|NCT01259466|558932690|FG000|Overall Study|Withdrawal by Subject|1|||
154864877|NCT01259466|558932691|FG001|Overall Study|Withdrawal by Subject|9|||
154864878|NCT01824602|558932696|FG000|Overall Study|Withdrawal by Subject|0|||
155174307|NCT00913458|560076643|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
155174308|NCT00913458|560076644|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
154864879|NCT01824602|558932697|FG001|Overall Study|Withdrawal by Subject|0|||
154864880|NCT01824602|558932698|FG002|Overall Study|Withdrawal by Subject|1|||
154864881|NCT01824602|558932699|FG003|Overall Study|Withdrawal by Subject|2|||
154864882|NCT01824602|558932696|FG000|Overall Study|Patient non-compliance|0|||
154864883|NCT01824602|558932697|FG001|Overall Study|Patient non-compliance|0|||
154864884|NCT01824602|558932698|FG002|Overall Study|Patient non-compliance|1|||
154864885|NCT01824602|558932699|FG003|Overall Study|Patient non-compliance|0|||
154864886|NCT01824602|558932696|FG000|Overall Study|Adverse Event|1|||
154864887|NCT01824602|558932697|FG001|Overall Study|Adverse Event|0|||
155174309|NCT00913458|560076645|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
155174310|NCT00913458|560076646|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
155174311|NCT00913458|560076647|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
155174312|NCT00913458|560076648|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
154864888|NCT01824602|558932698|FG002|Overall Study|Adverse Event|2|||
154864889|NCT01824602|558932699|FG003|Overall Study|Adverse Event|2|||
154864890|NCT01824602|558932696|FG000|Overall Study|Treatment failure|0|||
154864891|NCT01824602|558932697|FG001|Overall Study|Treatment failure|0|||
154864892|NCT01824602|558932698|FG002|Overall Study|Treatment failure|0|||
154864893|NCT01824602|558932699|FG003|Overall Study|Treatment failure|1|||
154864894|NCT00184054|558932700|FG000|Overall Study|Adverse Event|1|||
154864895|NCT02296840|558932701|FG000|Overall Study|Adverse Event|1|||
154864896|NCT02296840|558932702|FG001|Overall Study|Adverse Event|1|||
154864897|NCT02296840|558932701|FG000|Overall Study|Protocol Violation|2|||
154864898|NCT02296840|558932702|FG001|Overall Study|Protocol Violation|1|||
154864899|NCT02296840|558932701|FG000|Overall Study|Lost to Follow-up|6|||
154864900|NCT02296840|558932702|FG001|Overall Study|Lost to Follow-up|17|||
154864901|NCT02485717|558932703|FG000|Overall Study|Lost to Follow-up|6|||
154864902|NCT02485717|558932704|FG001|Overall Study|Lost to Follow-up|0|||
154864903|NCT02485717|558932705|FG002|Overall Study|Lost to Follow-up|0|||
154864904|NCT02485717|558932703|FG000|Overall Study|Withdrawal by Subject|0|||
154864905|NCT02485717|558932704|FG001|Overall Study|Withdrawal by Subject|0|||
154864906|NCT02485717|558932705|FG002|Overall Study|Withdrawal by Subject|1|||
154864907|NCT02485717|558932703|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
154864908|NCT02485717|558932704|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
154864909|NCT02485717|558932705|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
154973229|NCT02459418|559326829|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
154864910|NCT02485717|558932703|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
154864911|NCT02485717|558932704|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
154864912|NCT02485717|558932705|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
154864913|NCT02827877|558932706|FG000|Overall Study|Withdrawal by Subject|1|||
154864914|NCT00814710|558932709|FG000|Overall Study|Adverse Event|1|||
154864915|NCT00814710|558932710|FG001|Overall Study|Adverse Event|0|||
154864916|NCT00814710|558932709|FG000|Overall Study|Lost to Follow-up|7|||
154864917|NCT00814710|558932710|FG001|Overall Study|Lost to Follow-up|3|||
154864918|NCT03885284|558932711|FG000|Overall Study|Disease Progression|1|||
154864919|NCT03885284|558932712|FG001|Overall Study|Disease Progression|3|||
154864920|NCT03885284|558932711|FG000|Overall Study|Physician Decision|0|||
154864921|NCT03885284|558932712|FG001|Overall Study|Physician Decision|1|||
154864922|NCT00002850|558932715|FG000|Overall Study|Death|4|||
154864923|NCT00002850|558932716|FG001|Overall Study|Death|1|||
154864924|NCT00002850|558932717|FG002|Overall Study|Death|3|||
154864925|NCT00002850|558932715|FG000|Overall Study|Protocol Violation|1|||
154864926|NCT00002850|558932716|FG001|Overall Study|Protocol Violation|0|||
154864927|NCT00002850|558932717|FG002|Overall Study|Protocol Violation|1|||
154864928|NCT00002850|558932715|FG000|Overall Study|Withdrawal by Subject|0|||
154864929|NCT00002850|558932716|FG001|Overall Study|Withdrawal by Subject|1|||
154864930|NCT00002850|558932717|FG002|Overall Study|Withdrawal by Subject|0|||
155109223|NCT01951586|559828429|FG000|Overall Study|Lost to Follow-up|0|||
155109224|NCT01951586|559828430|FG001|Overall Study|Lost to Follow-up|1|||
155109225|NCT01951586|559828429|FG000|Overall Study|Sponsor Decision|9|||
155109226|NCT01951586|559828430|FG001|Overall Study|Sponsor Decision|10|||
155109227|NCT02120781|559828433|FG000|Overall Study|Physician Decision|2|||
155109228|NCT02120781|559828434|FG001|Overall Study|Physician Decision|0|||
155109229|NCT02120781|559828433|FG000|Overall Study|Completion not documented|2|||
155109230|NCT02120781|559828434|FG001|Overall Study|Completion not documented|1|||
155109231|NCT03195660|559828435|FG000|Overall Study|The study was terminated|2|||
155109232|NCT00375427|559828436|FG000|Overall Study|Adverse Event|21|||
155109233|NCT00375427|559828437|FG001|Overall Study|Adverse Event|27|||
155109234|NCT00375427|559828436|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155109235|NCT00375427|559828437|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155109236|NCT00375427|559828436|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155109237|NCT00375427|559828437|FG001|Overall Study|Abnormal laboratory value(s)|2|||
155109238|NCT00375427|559828436|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
155109239|NCT00375427|559828437|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155109240|NCT00375427|559828436|FG000|Overall Study|Patient no longer requires study drug|3|||
155109241|NCT00375427|559828437|FG001|Overall Study|Patient no longer requires study drug|7|||
155109242|NCT00375427|559828436|FG000|Overall Study|Protocol Violation|10|||
155109243|NCT00375427|559828437|FG001|Overall Study|Protocol Violation|8|||
155109244|NCT00375427|559828436|FG000|Overall Study|Withdrawal by Subject|9|||
155109245|NCT00375427|559828437|FG001|Overall Study|Withdrawal by Subject|13|||
155109246|NCT00375427|559828436|FG000|Overall Study|Lost to Follow-up|1|||
155109247|NCT00375427|559828437|FG001|Overall Study|Lost to Follow-up|1|||
155109248|NCT00375427|559828436|FG000|Overall Study|Administrative reasons|0|||
155109249|NCT00375427|559828437|FG001|Overall Study|Administrative reasons|1|||
155109250|NCT00375427|559828436|FG000|Overall Study|Death|11|||
155109251|NCT00375427|559828437|FG001|Overall Study|Death|10|||
155109252|NCT03286543|559828442|FG000|Consented|Screen failure before randomization|2|||
155109253|NCT03286543|559828443|FG001|Consented|Screen failure before randomization|0|||
155109254|NCT03286543|559828444|FG002|Consented|Screen failure before randomization|0|||
155109255|NCT03286543|559828442|FG000|Consented|Screen failure before enrollment|4|||
154973230|NCT02459418|559326830|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
154973231|NCT02459418|559326829|FG000|Overall Study|Adverse Event|0|||
154973232|NCT02459418|559326830|FG001|Overall Study|Adverse Event|1|||
154973233|NCT02459418|559326829|FG000|Overall Study|Withdrawal by Subject|1|||
154973234|NCT02459418|559326830|FG001|Overall Study|Withdrawal by Subject|1|||
154973235|NCT02459418|559326829|FG000|Overall Study|Elevated Creatine Kinase|1|||
154973236|NCT02459418|559326830|FG001|Overall Study|Elevated Creatine Kinase|0|||
154973237|NCT02459418|559326829|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
154973238|NCT02459418|559326830|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
154973239|NCT00653159|559326831|FG000|Overall Study|Adverse Event|4|||
154973240|NCT00653159|559326832|FG001|Overall Study|Adverse Event|1|||
154973241|NCT00653159|559326831|FG000|Overall Study|Lost to Follow-up|1|||
154973242|NCT00653159|559326832|FG001|Overall Study|Lost to Follow-up|2|||
154973243|NCT01872715|559326833|FG000|Overall Study|Adverse Event|1|||
154973244|NCT01872715|559326833|FG000|Overall Study|Protocol Violation|1|||
154973245|NCT01872715|559326833|FG000|Overall Study|Withdrawal by Subject|2|||
154973246|NCT05693805|559326835|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
154973247|NCT05693805|559326836|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
154973248|NCT02152982|559326837|FG000|Overall Study|Withdrawal by Subject|17|||
154973249|NCT02152982|559326838|FG001|Overall Study|Withdrawal by Subject|16|||
154973250|NCT02152982|559326837|FG000|Overall Study|Did not start treatment|11|||
154973251|NCT02152982|559326838|FG001|Overall Study|Did not start treatment|5|||
154973252|NCT02152982|559326837|FG000|Overall Study|Disease progression|41|||
154973253|NCT02152982|559326838|FG001|Overall Study|Disease progression|52|||
154973254|NCT02152982|559326837|FG000|Overall Study|Adverse Event|7|||
154973255|NCT02152982|559326838|FG001|Overall Study|Adverse Event|12|||
154973256|NCT02152982|559326837|FG000|Overall Study|Complicating disease|1|||
154973257|NCT02152982|559326838|FG001|Overall Study|Complicating disease|1|||
154973258|NCT02152982|559326837|FG000|Overall Study|Death|0|||
154973259|NCT02152982|559326838|FG001|Overall Study|Death|3|||
154973260|NCT02152982|559326837|FG000|Overall Study|Physician Decision|3|||
154973261|NCT02152982|559326838|FG001|Overall Study|Physician Decision|0|||
154973262|NCT03230487|559326841|FG000|Overall Study|Adverse Event|0|||
154973263|NCT03230487|559326842|FG001|Overall Study|Adverse Event|0|||
154973264|NCT03230487|559326843|FG002|Overall Study|Adverse Event|0|||
154973265|NCT03230487|559326844|FG003|Overall Study|Adverse Event|1|||
154973266|NCT03230487|559326845|FG004|Overall Study|Adverse Event|0|||
154973267|NCT03230487|559326846|FG005|Overall Study|Adverse Event|0|||
154973268|NCT01755975|559326851|FG000|Overall Study|Adverse Event|0|||
154973269|NCT01755975|559326852|FG001|Overall Study|Adverse Event|0|||
154864931|NCT01450540|558932718|FG000|Overall Study|Withdrawal by Subject|19|||
154864932|NCT01450540|558932719|FG001|Overall Study|Withdrawal by Subject|13|||
154864933|NCT01450540|558932718|FG000|Overall Study|protocol deviation|3|||
154864934|NCT01450540|558932719|FG001|Overall Study|protocol deviation|23|||
154864935|NCT00840463|558932720|FG000|Overall Study|Adverse Event|1|||
154864936|NCT00840463|558932721|FG001|Overall Study|Adverse Event|0|||
154864937|NCT01887210|558932725|FG000|Overall Study|Withdrawal by Subject|1|||
154864938|NCT01887210|558932726|FG001|Overall Study|Withdrawal by Subject|3|||
154864939|NCT01887210|558932725|FG000|Overall Study|Lost to Follow-up|0|||
154864940|NCT01887210|558932726|FG001|Overall Study|Lost to Follow-up|1|||
154864941|NCT02452359|558932727|FG000|Overall Study|Adverse Event|1|||
154864942|NCT02452359|558932727|FG000|Overall Study|Lost to Follow-up|15|||
154864943|NCT02452359|558932727|FG000|Overall Study|Pregnancy|1|||
154864944|NCT02452359|558932727|FG000|Overall Study|Withdrawal by Subject|4|||
154864945|NCT03414359|558932728|FG000|Overall Study|Lack of Efficacy|1|||
154864946|NCT03414359|558932729|FG001|Overall Study|Lack of Efficacy|1|||
154973270|NCT01755975|559326853|FG002|Overall Study|Adverse Event|1|||
154973271|NCT01755975|559326854|FG003|Overall Study|Adverse Event|0|||
154864947|NCT03414359|558932728|FG000|Overall Study|Protocol Violation|0|||
154864948|NCT03414359|558932729|FG001|Overall Study|Protocol Violation|1|||
154864949|NCT03439345|558933960|FG000|Overall Study|Lost to Follow-up|0|||
154864950|NCT03439345|558933961|FG001|Overall Study|Lost to Follow-up|1|||
154864951|NCT03439345|558933960|FG000|Overall Study|Consent withdrawn|0|||
154973272|NCT01755975|559326855|FG004|Overall Study|Adverse Event|2|||
154973273|NCT03653026|559326856|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
154973274|NCT03653026|559326857|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
154973275|NCT03653026|559326858|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
154973276|NCT03653026|559326859|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
154973277|NCT03653026|559326856|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
154864952|NCT03439345|558933961|FG001|Overall Study|Consent withdrawn|1|||
154864953|NCT05405166|558933962|FG000|Overall Study|Death|49|||
154864954|NCT05405166|558933963|FG001|Overall Study|Death|50|||
154864955|NCT05405166|558933962|FG000|Overall Study|Withdrawal by Subject|10|||
154864956|NCT05405166|558933963|FG001|Overall Study|Withdrawal by Subject|3|||
154973278|NCT03653026|559326857|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
154973279|NCT03653026|559326858|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
154973280|NCT03653026|559326859|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
154864957|NCT05405166|558933962|FG000|Overall Study|Ongoing at the time of PCD|209|||
154864958|NCT05405166|558933963|FG001|Overall Study|Ongoing at the time of PCD|210|||
154864959|NCT01386385|558933964|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
154864960|NCT01386385|558933965|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864961|NCT01386385|558933966|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864962|NCT01386385|558933967|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864963|NCT01386385|558933968|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864964|NCT01386385|558933969|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864965|NCT01386385|558933970|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864966|NCT01386385|558933971|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
154864967|NCT01386385|558933964|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
154864968|NCT01386385|558933965|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864969|NCT01386385|558933966|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864970|NCT01386385|558933967|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864971|NCT01386385|558933968|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864972|NCT01386385|558933969|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864973|NCT01386385|558933970|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864974|NCT01386385|558933971|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
154864975|NCT01386385|558933964|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864976|NCT01386385|558933965|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864977|NCT01386385|558933966|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
154864978|NCT01386385|558933967|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864979|NCT01386385|558933968|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864980|NCT01386385|558933969|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864981|NCT01386385|558933970|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864982|NCT01386385|558933971|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
154864983|NCT01386385|558933964|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864984|NCT01386385|558933965|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864985|NCT01386385|558933966|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864986|NCT01386385|558933967|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864987|NCT01386385|558933968|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
154864988|NCT01386385|558933969|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864989|NCT01386385|558933970|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864990|NCT01386385|558933971|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
154864991|NCT01386385|558933964|FG000|Phase II Concurrent CRT|Adverse Event|0|||
154864992|NCT01386385|558933965|FG001|Phase II Concurrent CRT|Adverse Event|0|||
154864993|NCT01386385|558933966|FG002|Phase II Concurrent CRT|Adverse Event|0|||
154864994|NCT01386385|558933967|FG003|Phase II Concurrent CRT|Adverse Event|0|||
154864995|NCT01386385|558933968|FG004|Phase II Concurrent CRT|Adverse Event|0|||
154864996|NCT01386385|558933969|FG005|Phase II Concurrent CRT|Adverse Event|0|||
154864997|NCT01386385|558933970|FG006|Phase II Concurrent CRT|Adverse Event|3|||
154864998|NCT01386385|558933971|FG007|Phase II Concurrent CRT|Adverse Event|3|||
154864999|NCT01386385|558933964|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865000|NCT01386385|558933965|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865001|NCT01386385|558933966|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865002|NCT01386385|558933967|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865003|NCT01386385|558933968|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865004|NCT01386385|558933969|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865005|NCT01386385|558933970|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
154865006|NCT01386385|558933971|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
154865007|NCT01386385|558933964|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
154865008|NCT01386385|558933965|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
154865009|NCT01386385|558933966|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
154865010|NCT01386385|558933967|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
154865011|NCT01386385|558933968|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
154865012|NCT01386385|558933969|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
154865013|NCT01386385|558933970|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
154865014|NCT01386385|558933971|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
154865015|NCT01386385|558933964|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
154865016|NCT01386385|558933965|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
154865017|NCT01386385|558933966|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
155109256|NCT03286543|559828443|FG001|Consented|Screen failure before enrollment|0|||
155109257|NCT03286543|559828444|FG002|Consented|Screen failure before enrollment|0|||
154865018|NCT01386385|558933967|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
154865019|NCT01386385|558933968|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
154865020|NCT01386385|558933969|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
154865021|NCT01386385|558933970|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
154865022|NCT01386385|558933971|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
154865023|NCT01386385|558933964|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
154865024|NCT01386385|558933965|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
154865025|NCT01386385|558933966|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
154865026|NCT01386385|558933967|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
154865027|NCT01386385|558933968|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
154865028|NCT01386385|558933969|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
154865029|NCT01386385|558933970|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
154865030|NCT01386385|558933971|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
154865031|NCT03746080|558933973|FG000|Overall Study|In follow up|2|||
154865032|NCT03746080|558933973|FG000|Overall Study|Death|15|||
154865033|NCT01348919|558933977|FG000|Overall Study|Adverse Event|3|||
154865034|NCT01348919|558933978|FG001|Overall Study|Adverse Event|1|||
154865035|NCT01348919|558933979|FG002|Overall Study|Adverse Event|0|||
154865036|NCT01348919|558933977|FG000|Overall Study|Withdrawal by Subject|0|||
154865037|NCT01348919|558933978|FG001|Overall Study|Withdrawal by Subject|1|||
154865038|NCT01348919|558933979|FG002|Overall Study|Withdrawal by Subject|0|||
154865039|NCT01348919|558933977|FG000|Overall Study|Disease progression|0|||
154865040|NCT01348919|558933978|FG001|Overall Study|Disease progression|1|||
154865041|NCT01348919|558933979|FG002|Overall Study|Disease progression|1|||
154865042|NCT06400238|558933982|FG000|Overall Study|Started Protocol Therapy|2|||
154865043|NCT06400238|558933982|FG000|Overall Study|Adverse Event|1|||
154865044|NCT06400238|558933982|FG000|Overall Study|Death|1|||
154865045|NCT06400238|558933982|FG000|Overall Study|Disease Progression|27|||
154865046|NCT06400238|558933982|FG000|Overall Study|Withdrawal by Subject|2|||
154865047|NCT06400238|558933982|FG000|Overall Study|Physician Decision|2|||
154865048|NCT01009463|558933987|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
154865049|NCT01009463|558933988|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154865050|NCT01009463|558933989|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154865051|NCT01009463|558933990|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154865052|NCT01009463|558933991|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
154865053|NCT01009463|558933987|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
154865054|NCT01009463|558933988|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
154865055|NCT01009463|558933989|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
154865056|NCT01009463|558933990|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
154865057|NCT01009463|558933991|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
154865058|NCT01009463|558933987|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
154865059|NCT01009463|558933988|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154865060|NCT01009463|558933989|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154865061|NCT01009463|558933990|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154865062|NCT01009463|558933991|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
154865063|NCT01009463|558933987|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
154865064|NCT01009463|558933988|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
154865065|NCT01009463|558933989|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
154865066|NCT01009463|558933990|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
154865067|NCT01009463|558933991|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
154865068|NCT01009463|558933987|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
154865069|NCT01009463|558933988|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154865070|NCT01009463|558933989|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154865071|NCT01009463|558933990|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154865072|NCT01009463|558933991|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
154865073|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
154865074|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
154865075|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
154865076|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
154865077|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
154865078|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
154865079|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
154865080|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
154865081|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
154865082|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
154865083|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
154865084|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
154865085|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
154865086|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
154865087|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
154865088|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
154865089|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
154865090|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
154865091|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
154865092|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
154865093|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
154865094|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
154865095|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
154865096|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
154865097|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
154865098|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
154865099|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
154865100|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
154865101|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
154865102|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
154865103|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154865104|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
154865105|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
154865106|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
154865107|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
154865108|NCT01009463|558933987|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
154865109|NCT01009463|558933988|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
154865110|NCT01009463|558933989|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
154865111|NCT01009463|558933990|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
154865112|NCT01009463|558933991|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
154865113|NCT04430348|558933994|FG000|Overall Study|Death|3|||
154865114|NCT04430348|558933995|FG001|Overall Study|Death|2|||
154865115|NCT04430348|558933996|FG002|Overall Study|Death|2|||
154865116|NCT04430348|558933997|FG003|Overall Study|Death|2|||
154865117|NCT04430348|558933998|FG004|Overall Study|Death|2|||
154865118|NCT04430348|558933999|FG005|Overall Study|Death|3|||
154865119|NCT04430348|558933994|FG000|Overall Study|Lost to Follow-up|0|||
154865120|NCT04430348|558933995|FG001|Overall Study|Lost to Follow-up|0|||
154865121|NCT04430348|558933996|FG002|Overall Study|Lost to Follow-up|0|||
154865122|NCT04430348|558933997|FG003|Overall Study|Lost to Follow-up|1|||
154865123|NCT04430348|558933998|FG004|Overall Study|Lost to Follow-up|0|||
154865124|NCT04430348|558933999|FG005|Overall Study|Lost to Follow-up|0|||
154865125|NCT04430348|558933994|FG000|Overall Study|Adverse Event|0|||
154865126|NCT04430348|558933995|FG001|Overall Study|Adverse Event|0|||
154865127|NCT04430348|558933996|FG002|Overall Study|Adverse Event|0|||
154865128|NCT04430348|558933997|FG003|Overall Study|Adverse Event|0|||
154865129|NCT04430348|558933998|FG004|Overall Study|Adverse Event|0|||
154865130|NCT04430348|558933999|FG005|Overall Study|Adverse Event|1|||
154865131|NCT04430348|558933994|FG000|Overall Study|Withdrawal by Subject|0|||
154865132|NCT04430348|558933995|FG001|Overall Study|Withdrawal by Subject|1|||
154865133|NCT04430348|558933996|FG002|Overall Study|Withdrawal by Subject|0|||
154865134|NCT04430348|558933997|FG003|Overall Study|Withdrawal by Subject|0|||
154865135|NCT04430348|558933998|FG004|Overall Study|Withdrawal by Subject|0|||
154865136|NCT04430348|558933999|FG005|Overall Study|Withdrawal by Subject|1|||
154865137|NCT04430348|558933994|FG000|Overall Study|Study Terminated by Sponsor|0|||
154865138|NCT04430348|558933995|FG001|Overall Study|Study Terminated by Sponsor|0|||
154865139|NCT04430348|558933996|FG002|Overall Study|Study Terminated by Sponsor|2|||
154865140|NCT04430348|558933997|FG003|Overall Study|Study Terminated by Sponsor|0|||
154865141|NCT04430348|558933998|FG004|Overall Study|Study Terminated by Sponsor|1|||
154865142|NCT04430348|558933999|FG005|Overall Study|Study Terminated by Sponsor|1|||
154865143|NCT03839524|558934004|FG000|Overall Study|Adverse Event|1|||
154865144|NCT04329949|558934009|FG000|Overall Study|Death|36|||
154865145|NCT04329949|558934009|FG000|Overall Study|Withdrawal by Subject|4|||
154865146|NCT04329949|558934009|FG000|Overall Study|Termination of study by sponsor|3|||
154865147|NCT02037919|558934010|FG000|Overall Study|Lost to Follow-up|30|||
154865148|NCT02037919|558934011|FG001|Overall Study|Lost to Follow-up|45|||
154865149|NCT00917384|558934014|FG000|Overall Study|Lost to Follow-up|4|||
154865150|NCT00917384|558934015|FG001|Overall Study|Lost to Follow-up|2|||
154865151|NCT00917384|558934014|FG000|Overall Study|Withdrawal by Subject|10|||
154865152|NCT00917384|558934015|FG001|Overall Study|Withdrawal by Subject|2|||
154865153|NCT03717922|558934018|FG000|Overall Study|Lost to Follow-up|2|||
154865154|NCT03717922|558934019|FG001|Overall Study|Lost to Follow-up|2|||
154865155|NCT01458340|558934020|FG000|Overall Study|Adverse Event|5|||
154865156|NCT01458340|558934021|FG001|Overall Study|Adverse Event|4|||
154865157|NCT01458340|558934022|FG002|Overall Study|Adverse Event|2|||
154865158|NCT01458340|558934020|FG000|Overall Study|Lost to Follow-up|3|||
154865159|NCT01458340|558934021|FG001|Overall Study|Lost to Follow-up|3|||
154865160|NCT01458340|558934022|FG002|Overall Study|Lost to Follow-up|10|||
154865161|NCT01458340|558934020|FG000|Overall Study|Miscellaneous|0|||
154865162|NCT01458340|558934021|FG001|Overall Study|Miscellaneous|1|||
154865163|NCT01458340|558934022|FG002|Overall Study|Miscellaneous|0|||
154865164|NCT01458340|558934020|FG000|Overall Study|Physician Decision|1|||
154865165|NCT01458340|558934021|FG001|Overall Study|Physician Decision|1|||
154865166|NCT01458340|558934022|FG002|Overall Study|Physician Decision|2|||
154865167|NCT01458340|558934020|FG000|Overall Study|Protocol Violation|6|||
154865168|NCT01458340|558934021|FG001|Overall Study|Protocol Violation|6|||
154865169|NCT01458340|558934022|FG002|Overall Study|Protocol Violation|5|||
154865170|NCT01458340|558934020|FG000|Overall Study|Withdrawal by Subject|12|||
154865171|NCT01458340|558934021|FG001|Overall Study|Withdrawal by Subject|6|||
154865172|NCT01458340|558934022|FG002|Overall Study|Withdrawal by Subject|4|||
154865173|NCT03126227|558934023|FG000|Overall Study|Adverse Event|43|||
154865174|NCT03126227|558934024|FG001|Overall Study|Adverse Event|4|||
154865175|NCT03126227|558934023|FG000|Overall Study|Death|0|||
154865176|NCT03126227|558934024|FG001|Overall Study|Death|1|||
154865177|NCT03126227|558934023|FG000|Overall Study|Lost to Follow-up|0|||
154865178|NCT03126227|558934024|FG001|Overall Study|Lost to Follow-up|1|||
154865179|NCT03126227|558934023|FG000|Overall Study|Physician Decision|2|||
154865180|NCT03126227|558934024|FG001|Overall Study|Physician Decision|0|||
154865181|NCT03126227|558934023|FG000|Overall Study|Protocol Violation|1|||
154865182|NCT03126227|558934024|FG001|Overall Study|Protocol Violation|0|||
154865183|NCT03126227|558934023|FG000|Overall Study|Withdrawal by Subject|19|||
154865184|NCT03126227|558934024|FG001|Overall Study|Withdrawal by Subject|3|||
154865185|NCT03126227|558934023|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
154865186|NCT03126227|558934024|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
154865187|NCT03126227|558934023|FG000|Overall Study|Lack of dosing compliance|2|||
154865188|NCT03126227|558934024|FG001|Overall Study|Lack of dosing compliance|0|||
154865189|NCT03126227|558934023|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
154865190|NCT03126227|558934024|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
154865191|NCT03126227|558934023|FG000|Overall Study|Scheduling conflict|1|||
154865192|NCT03126227|558934024|FG001|Overall Study|Scheduling conflict|0|||
154865193|NCT01021007|558934027|FG000|Overall Study|Lost to Follow-up|1|||
154865194|NCT01021007|558934028|FG001|Overall Study|Lost to Follow-up|1|||
154865195|NCT01021007|558934027|FG000|Overall Study|Adverse Event|1|||
154865196|NCT01021007|558934028|FG001|Overall Study|Adverse Event|3|||
154865197|NCT01575548|558934029|FG000|Overall Study|Adverse Event|15|||
154865198|NCT01575548|558934030|FG001|Overall Study|Adverse Event|2|||
154865199|NCT01575548|558934029|FG000|Overall Study|Disease progression|12|||
154865200|NCT01575548|558934030|FG001|Overall Study|Disease progression|25|||
154865201|NCT01575548|558934029|FG000|Overall Study|Death|1|||
154865202|NCT01575548|558934030|FG001|Overall Study|Death|0|||
154865203|NCT01575548|558934029|FG000|Overall Study|Other complicating disease|1|||
154865204|NCT01575548|558934030|FG001|Overall Study|Other complicating disease|0|||
154865205|NCT01575548|558934029|FG000|Overall Study|Withdrawal by Subject|7|||
154865206|NCT01575548|558934030|FG001|Overall Study|Withdrawal by Subject|3|||
154865207|NCT01575548|558934029|FG000|Overall Study|Noncompliance|1|||
154865208|NCT01575548|558934030|FG001|Overall Study|Noncompliance|0|||
154865209|NCT01575548|558934029|FG000|Overall Study|Anticipated surgery|0|||
154865210|NCT01575548|558934030|FG001|Overall Study|Anticipated surgery|1|||
154865211|NCT01575548|558934029|FG000|Overall Study|Never started protocol therapy|3|||
154865212|NCT01575548|558934030|FG001|Overall Study|Never started protocol therapy|2|||
154865213|NCT00693706|558934034|FG000|Overall Study|Protocol Violation|0|||
154865214|NCT00693706|558934035|FG001|Overall Study|Protocol Violation|1|||
154865215|NCT00730236|558934039|FG000|Overall Study|Adverse Event|4|||
154865216|NCT00730236|558934039|FG000|Overall Study|Withdrawal by Subject|1|||
154865217|NCT00730236|558934039|FG000|Overall Study|Non-compliance|1|||
154865218|NCT00465569|558934041|FG000|Overall Study|persistent eczema during dose escalation|1|||
154865219|NCT00465569|558934042|FG001|Overall Study|persistent eczema during dose escalation|0|||
154865220|NCT02388776|558934043|FG000|Overall Study|Death|1|||
154865221|NCT02388776|558934043|FG000|Overall Study|Lost to Follow-up|1|||
154865222|NCT03826914|558934044|FG000|Overall Study|Withdrawal by Subject|1|||
155109258|NCT03286543|559828442|FG000|Consented|TKA cancelled after enrollment|1|||
155109259|NCT03286543|559828443|FG001|Consented|TKA cancelled after enrollment|0|||
155109260|NCT03286543|559828444|FG002|Consented|TKA cancelled after enrollment|0|||
155109261|NCT03286543|559828442|FG000|Consented|Withdrawn from study|12|||
155109262|NCT03286543|559828443|FG001|Consented|Withdrawn from study|0|||
155109263|NCT03286543|559828444|FG002|Consented|Withdrawn from study|0|||
155109264|NCT03286543|559828442|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
155109265|NCT03286543|559828443|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
154865223|NCT03826914|558934045|FG001|Overall Study|Withdrawal by Subject|1|||
154865224|NCT00104871|558934048|FG000|Overall Study|Not evaluable|1|||
154865225|NCT00519532|558934051|FG000|Overall Study|Adverse Event|11|||
154865226|NCT00519532|558934051|FG000|Overall Study|Withdrawal by Subject|5|||
154865227|NCT00519532|558934051|FG000|Overall Study|Lost to Follow-up|2|||
154865228|NCT02932267|558934056|FG000|Overall Study|Withdrawal by Subject|3|||
154865229|NCT02932267|558934056|FG000|Overall Study|Lost to Follow-up|4|||
154865230|NCT02932267|558934056|FG000|Overall Study|Pregnancy|1|||
154865231|NCT04090164|558934057|FG000|Overall Study|incomplete data on file|245|||
154865232|NCT04090164|558934058|FG001|Overall Study|incomplete data on file|0|||
154865233|NCT00957372|558934069|FG000|PART I|Lost to Follow-up|0|||
154865234|NCT00957372|558934070|FG001|PART I|Lost to Follow-up|0|||
154865235|NCT00957372|558934071|FG002|PART I|Lost to Follow-up|1|||
154865236|NCT00957372|558934072|FG003|PART I|Lost to Follow-up|0|||
154865237|NCT00957372|558934069|FG000|PART II|Withdrawal by Subject|0|||
154865238|NCT00957372|558934070|FG001|PART II|Withdrawal by Subject|0|||
154865239|NCT00957372|558934071|FG002|PART II|Withdrawal by Subject|0|||
154865240|NCT00957372|558934072|FG003|PART II|Withdrawal by Subject|8|||
154865241|NCT00957372|558934069|FG000|PART II|Physician Decision|0|||
154865242|NCT00957372|558934070|FG001|PART II|Physician Decision|0|||
154865243|NCT00957372|558934071|FG002|PART II|Physician Decision|0|||
154865244|NCT00957372|558934072|FG003|PART II|Physician Decision|1|||
154865245|NCT00957372|558934069|FG000|PART II|Pregnancy|0|||
154865246|NCT00957372|558934070|FG001|PART II|Pregnancy|0|||
154865247|NCT00957372|558934071|FG002|PART II|Pregnancy|0|||
154865248|NCT00957372|558934072|FG003|PART II|Pregnancy|1|||
154865249|NCT00957372|558934069|FG000|PART II|Not Know|0|||
154865250|NCT00957372|558934070|FG001|PART II|Not Know|0|||
154865251|NCT00957372|558934071|FG002|PART II|Not Know|0|||
154865252|NCT00957372|558934072|FG003|PART II|Not Know|20|||
154865253|NCT00957372|558934069|FG000|PART II|Adverse Event|0|||
154865254|NCT00957372|558934070|FG001|PART II|Adverse Event|0|||
154865255|NCT00957372|558934071|FG002|PART II|Adverse Event|0|||
154865256|NCT00957372|558934072|FG003|PART II|Adverse Event|10|||
154865257|NCT00957372|558934069|FG000|PART II|Patient non-compliance|0|||
154865258|NCT00957372|558934070|FG001|PART II|Patient non-compliance|0|||
154865259|NCT00957372|558934071|FG002|PART II|Patient non-compliance|0|||
154865260|NCT00957372|558934072|FG003|PART II|Patient non-compliance|4|||
154865261|NCT01444391|558934075|FG000|Overall Study|Death|1|||
154865262|NCT00630032|558934076|FG000|Overall Study|Death|55|||
154865263|NCT00630032|558934077|FG001|Overall Study|Death|49|||
154865264|NCT00630032|558934076|FG000|Overall Study|Withdrawal by Subject|3|||
154865265|NCT00630032|558934077|FG001|Overall Study|Withdrawal by Subject|2|||
154865266|NCT00630032|558934076|FG000|Overall Study|Lost to Follow-up|18|||
154865267|NCT00630032|558934077|FG001|Overall Study|Lost to Follow-up|31|||
154865268|NCT00630032|558934076|FG000|Overall Study|Protocol Violation|1|||
154865269|NCT00630032|558934077|FG001|Overall Study|Protocol Violation|0|||
154865270|NCT00630032|558934076|FG000|Overall Study|Patient has moved|1|||
154865271|NCT00630032|558934077|FG001|Overall Study|Patient has moved|1|||
154865272|NCT00630032|558934076|FG000|Overall Study|Disease progression|1|||
154865273|NCT00630032|558934077|FG001|Overall Study|Disease progression|1|||
154865274|NCT00630032|558934076|FG000|Overall Study|End of monitoring in US centers|11|||
154865275|NCT00630032|558934077|FG001|Overall Study|End of monitoring in US centers|11|||
154865276|NCT02332915|558934078|FG000|Overall Study|Moved out of region|3|||
154865277|NCT02332915|558934079|FG001|Overall Study|Moved out of region|0|||
154865278|NCT02332915|558934078|FG000|Overall Study|Unrelated illness|1|||
154865279|NCT02332915|558934079|FG001|Overall Study|Unrelated illness|1|||
154865280|NCT02332915|558934078|FG000|Overall Study|Travel distance prohibitive|0|||
154865281|NCT02332915|558934079|FG001|Overall Study|Travel distance prohibitive|1|||
154865282|NCT02332915|558934078|FG000|Overall Study|did not meet inclusion criteria|2|||
154865283|NCT02332915|558934079|FG001|Overall Study|did not meet inclusion criteria|4|||
154865284|NCT01901328|558934080|FG000|Overall Study|Lost to Follow-up|1|||
154865285|NCT01901328|558934081|FG001|Overall Study|Lost to Follow-up|0|||
154865286|NCT01901328|558934080|FG000|Overall Study|Physician Decision|0|||
154865287|NCT01901328|558934081|FG001|Overall Study|Physician Decision|1|||
154865288|NCT01901328|558934080|FG000|Overall Study|Protocol Violation|1|||
154865289|NCT01901328|558934081|FG001|Overall Study|Protocol Violation|1|||
154865290|NCT01901328|558934080|FG000|Overall Study|Study Terminated by Sponsor|19|||
154865291|NCT01901328|558934081|FG001|Overall Study|Study Terminated by Sponsor|16|||
154865292|NCT01901328|558934080|FG000|Overall Study|Withdrawal by Subject|1|||
154865293|NCT01901328|558934081|FG001|Overall Study|Withdrawal by Subject|2|||
154865294|NCT01901328|558934080|FG000|Overall Study|Lack of Efficacy|0|||
154865295|NCT01901328|558934081|FG001|Overall Study|Lack of Efficacy|1|||
154865296|NCT02462889|558934082|FG000|Overall Study|Withdrawal by Subject|2|||
154865297|NCT02462889|558934083|FG001|Overall Study|Withdrawal by Subject|6|||
154865298|NCT02462889|558934082|FG000|Overall Study|Death|1|||
154865299|NCT02462889|558934083|FG001|Overall Study|Death|5|||
154865300|NCT03232073|558934086|FG000|Overall Study|Death|1|||
154865301|NCT03232073|558934087|FG001|Overall Study|Death|0|||
154865302|NCT03232073|558934086|FG000|Overall Study|Adverse Event|7|||
154865303|NCT03232073|558934087|FG001|Overall Study|Adverse Event|12|||
154865304|NCT03232073|558934086|FG000|Overall Study|Lost to Follow-up|6|||
154865305|NCT03232073|558934087|FG001|Overall Study|Lost to Follow-up|6|||
154865306|NCT03232073|558934086|FG000|Overall Study|Lack of Efficacy|10|||
154865307|NCT03232073|558934087|FG001|Overall Study|Lack of Efficacy|8|||
154865308|NCT03232073|558934086|FG000|Overall Study|Physician Decision|9|||
154865309|NCT03232073|558934087|FG001|Overall Study|Physician Decision|2|||
154865310|NCT03232073|558934086|FG000|Overall Study|Withdrawal by Subject|54|||
154865311|NCT03232073|558934087|FG001|Overall Study|Withdrawal by Subject|39|||
154865312|NCT02032875|558934088|FG000|Treatment Period|Adverse Event|1|||
154865313|NCT02032875|558934089|FG001|Treatment Period|Adverse Event|0|||
154865314|NCT02032875|558934088|FG000|Treatment Period|Liver transplant, No extension needed|0|||
155174313|NCT02366091|560076649|FG000|Overall Study|Withdrawal by Subject|3|||
155174314|NCT02366091|560076650|FG001|Overall Study|Withdrawal by Subject|7|||
155174315|NCT02366091|560076651|FG002|Overall Study|Withdrawal by Subject|3|||
155174316|NCT02366091|560076652|FG003|Overall Study|Withdrawal by Subject|1|||
155174317|NCT03595618|560076653|FG000|Overall Study|Adverse Event|16|||
155174318|NCT03595618|560076654|FG001|Overall Study|Adverse Event|17|||
155174319|NCT03595618|560076655|FG002|Overall Study|Adverse Event|20|||
155174320|NCT03595618|560076656|FG003|Overall Study|Adverse Event|8|||
155174321|NCT03595618|560076653|FG000|Overall Study|Withdrawal by Subject|12|||
155174322|NCT03595618|560076654|FG001|Overall Study|Withdrawal by Subject|14|||
155174323|NCT03595618|560076655|FG002|Overall Study|Withdrawal by Subject|14|||
155174324|NCT03595618|560076656|FG003|Overall Study|Withdrawal by Subject|10|||
155174325|NCT03595618|560076653|FG000|Overall Study|Lost to Follow-up|6|||
155174326|NCT03595618|560076654|FG001|Overall Study|Lost to Follow-up|4|||
155174327|NCT03595618|560076655|FG002|Overall Study|Lost to Follow-up|5|||
155174328|NCT03595618|560076656|FG003|Overall Study|Lost to Follow-up|6|||
155174329|NCT03595618|560076653|FG000|Overall Study|Protocol Violation|2|||
155174330|NCT03595618|560076654|FG001|Overall Study|Protocol Violation|0|||
155174331|NCT03595618|560076655|FG002|Overall Study|Protocol Violation|6|||
155174332|NCT03595618|560076656|FG003|Overall Study|Protocol Violation|2|||
155174333|NCT03595618|560076653|FG000|Overall Study|Physician Decision|0|||
155174334|NCT03595618|560076654|FG001|Overall Study|Physician Decision|0|||
155174335|NCT03595618|560076655|FG002|Overall Study|Physician Decision|1|||
155174336|NCT03595618|560076656|FG003|Overall Study|Physician Decision|2|||
155174337|NCT03595618|560076653|FG000|Overall Study|Miscellaneous|7|||
155174338|NCT03595618|560076654|FG001|Overall Study|Miscellaneous|5|||
155174339|NCT03595618|560076655|FG002|Overall Study|Miscellaneous|10|||
155174340|NCT03595618|560076656|FG003|Overall Study|Miscellaneous|6|||
155174341|NCT02338232|560076657|FG000|Overall Study|Screen Failure|3|||
155174342|NCT02338232|560076657|FG000|Overall Study|Withdrawal by Subject|6|||
155174343|NCT02338232|560076657|FG000|Overall Study|Adverse Event|2|||
155174344|NCT02279407|560076660|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
155174345|NCT02279407|560076661|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
155174346|NCT02279407|560076662|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
155174347|NCT02279407|560076663|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
155174348|NCT02279407|560076660|FG000|Overall Study|Withdrawal by Subject|1|||
155174349|NCT02279407|560076661|FG001|Overall Study|Withdrawal by Subject|0|||
155174350|NCT02279407|560076662|FG002|Overall Study|Withdrawal by Subject|1|||
155174351|NCT02279407|560076663|FG003|Overall Study|Withdrawal by Subject|1|||
155174352|NCT02279407|560076660|FG000|Overall Study|Adverse Event|1|||
155174353|NCT02279407|560076661|FG001|Overall Study|Adverse Event|1|||
155174354|NCT02279407|560076662|FG002|Overall Study|Adverse Event|2|||
155174355|NCT02279407|560076663|FG003|Overall Study|Adverse Event|0|||
155174356|NCT01105065|560076664|FG000|Overall Study|Adverse Event|5|||
155174357|NCT01105065|560076664|FG000|Overall Study|Technical Problems|1|||
155174358|NCT00422084|560076665|FG000|Overall Study|Adverse Event|21|||
155174359|NCT00422084|560076666|FG001|Overall Study|Adverse Event|7|||
155174360|NCT00422084|560076665|FG000|Overall Study|Withdrawal by Subject|12|||
155174361|NCT00422084|560076666|FG001|Overall Study|Withdrawal by Subject|9|||
155174362|NCT00422084|560076665|FG000|Overall Study|Lost to Follow-up|14|||
155174363|NCT00422084|560076666|FG001|Overall Study|Lost to Follow-up|9|||
155174364|NCT00422084|560076665|FG000|Overall Study|Protocol Violation|4|||
155174365|NCT00422084|560076666|FG001|Overall Study|Protocol Violation|1|||
155174366|NCT00422084|560076665|FG000|Overall Study|Lack of Efficacy|40|||
155174367|NCT00422084|560076666|FG001|Overall Study|Lack of Efficacy|42|||
155174368|NCT00422084|560076665|FG000|Overall Study|P. vivax infection|3|||
155174369|NCT00422084|560076666|FG001|Overall Study|P. vivax infection|6|||
155174370|NCT00422084|560076665|FG000|Overall Study|Cyesis|1|||
154865315|NCT02032875|558934089|FG001|Treatment Period|Liver transplant, No extension needed|1|||
154865316|NCT02032875|558934088|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
154865317|NCT02032875|558934089|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
154865318|NCT02032875|558934088|FG000|Follow-up Period|Death|0|||
154865319|NCT02032875|558934089|FG001|Follow-up Period|Death|1|||
154865320|NCT02032875|558934088|FG000|Follow-up Period|Virologic Relapse|3|||
154865321|NCT02032875|558934089|FG001|Follow-up Period|Virologic Relapse|10|||
155174371|NCT00422084|560076666|FG001|Overall Study|Cyesis|0|||
155174372|NCT00422084|560076665|FG000|Overall Study|Withdrawn from study accidentally|1|||
155174373|NCT00422084|560076666|FG001|Overall Study|Withdrawn from study accidentally|0|||
155174374|NCT00422084|560076665|FG000|Overall Study|Non-compliance|1|||
155174375|NCT00422084|560076666|FG001|Overall Study|Non-compliance|0|||
155174376|NCT00422084|560076665|FG000|Overall Study|Re-location|0|||
155174377|NCT00422084|560076666|FG001|Overall Study|Re-location|1|||
155174378|NCT00422084|560076665|FG000|Overall Study|Not defined|1|||
155174379|NCT00422084|560076666|FG001|Overall Study|Not defined|1|||
155174380|NCT03774823|560076667|FG000|Overall Study|Withdrawal by Subject|1|||
155174381|NCT03774823|560076668|FG001|Overall Study|Withdrawal by Subject|1|||
155174382|NCT00329849|560076674|FG000|Overall Study|Withdrawal by Subject|6|||
155174383|NCT00329849|560076675|FG001|Overall Study|Withdrawal by Subject|4|||
154865322|NCT03191786|558934094|FG000|Overall Study|Death|236|||
154865323|NCT03191786|558934095|FG001|Overall Study|Death|127|||
154865324|NCT03191786|558934094|FG000|Overall Study|Lost to Follow-up|9|||
154865325|NCT03191786|558934095|FG001|Overall Study|Lost to Follow-up|3|||
154865326|NCT03191786|558934094|FG000|Overall Study|Physician Decision|1|||
154865327|NCT03191786|558934095|FG001|Overall Study|Physician Decision|0|||
154865328|NCT03191786|558934094|FG000|Overall Study|Moved to Post Trial Access Program|30|||
154865329|NCT03191786|558934095|FG001|Overall Study|Moved to Post Trial Access Program|5|||
154865330|NCT03191786|558934094|FG000|Overall Study|Withdrawal by Subject|26|||
154865331|NCT03191786|558934095|FG001|Overall Study|Withdrawal by Subject|16|||
154865332|NCT05847881|558934096|FG000|Overall Study|Principal Investigator Decision|8|||
154865333|NCT05847881|558934096|FG000|Overall Study|Withdrawal by Subject|2|||
154865334|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
154865335|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
154865336|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
154865337|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
154865338|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
154865339|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
154865340|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
154865341|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
154865342|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
154865343|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
154865344|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
154865345|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
154865346|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
154865347|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
154865348|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
154865349|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
154865350|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
154865351|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
154865352|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Death|0|||
154865353|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Death|1|||
154865354|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Death|0|||
154865355|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
154865356|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
154865357|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
154865358|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
154865359|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
154865360|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
154865361|NCT00430781|558935944|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
154865362|NCT00430781|558935945|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
154865363|NCT00430781|558935946|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
154865364|NCT00430781|558935944|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
154865365|NCT00430781|558935945|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
154865366|NCT00430781|558935946|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
154865367|NCT00430781|558935944|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
154865368|NCT00430781|558935945|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
154865369|NCT00430781|558935946|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
154865370|NCT00430781|558935944|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
154865371|NCT00430781|558935945|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
154865372|NCT00430781|558935946|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
154865373|NCT00430781|558935944|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
154865374|NCT00430781|558935945|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
154865375|NCT00430781|558935946|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
154865376|NCT00430781|558935944|FG000|Final Analysis; 31 July 2008|Other|0|||
154865377|NCT00430781|558935945|FG001|Final Analysis; 31 July 2008|Other|1|||
154865378|NCT00430781|558935946|FG002|Final Analysis; 31 July 2008|Other|0|||
154865379|NCT00430781|558935944|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
154865380|NCT00430781|558935945|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
154865381|NCT00430781|558935946|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
154865382|NCT00430781|558935944|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
154865383|NCT00430781|558935945|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
154865384|NCT00430781|558935946|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
154865385|NCT00430781|558935944|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
154865386|NCT00430781|558935945|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
154865387|NCT00430781|558935946|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
154865388|NCT00430781|558935944|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
154865389|NCT00430781|558935945|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
154865390|NCT00430781|558935946|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
154865391|NCT00430781|558935944|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
154865392|NCT00430781|558935945|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
154865393|NCT00430781|558935946|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
154865394|NCT00430781|558935944|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
154865395|NCT00430781|558935945|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
154865396|NCT00430781|558935946|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
154865397|NCT00430781|558935944|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
154865398|NCT00430781|558935945|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
154865399|NCT00430781|558935946|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
154865400|NCT05408858|558935947|FG000|Overall Study|no longer met eligibility criteria|1|||
154865401|NCT01451515|558935955|FG000|Overall Study|Death|0|||
154865402|NCT01451515|558935956|FG001|Overall Study|Death|1|||
154865403|NCT01451515|558935957|FG002|Overall Study|Death|0|||
154865404|NCT01451515|558935955|FG000|Overall Study|Withdrawal by Subject|0|||
154865405|NCT01451515|558935956|FG001|Overall Study|Withdrawal by Subject|1|||
154865406|NCT01451515|558935957|FG002|Overall Study|Withdrawal by Subject|0|||
154865407|NCT01451515|558935955|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
154865408|NCT01451515|558935956|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
154865409|NCT01451515|558935957|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
154865410|NCT01451515|558935955|FG000|Overall Study|Relapse (except CNS)|1|||
154865411|NCT01451515|558935956|FG001|Overall Study|Relapse (except CNS)|1|||
154865412|NCT01451515|558935957|FG002|Overall Study|Relapse (except CNS)|0|||
154865413|NCT03230097|558935963|FG000|Overall Study|Adverse Event|2|||
154865414|NCT03230097|558935964|FG001|Overall Study|Adverse Event|1|||
154865415|NCT03230097|558935963|FG000|Overall Study|non-compliance|0|||
154865416|NCT03230097|558935964|FG001|Overall Study|non-compliance|1|||
154865417|NCT03230097|558935963|FG000|Overall Study|Lost to Follow-up|2|||
154865418|NCT03230097|558935964|FG001|Overall Study|Lost to Follow-up|4|||
154865419|NCT03230097|558935963|FG000|Overall Study|Withdrawal by Subject|7|||
154865420|NCT03230097|558935964|FG001|Overall Study|Withdrawal by Subject|3|||
154865421|NCT03230097|558935963|FG000|Overall Study|Trial termination|4|||
154865422|NCT03230097|558935964|FG001|Overall Study|Trial termination|5|||
154865423|NCT03230097|558935963|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
154865424|NCT03230097|558935964|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
154865425|NCT03230097|558935963|FG000|Overall Study|outcome event|0|||
154865426|NCT03230097|558935964|FG001|Overall Study|outcome event|1|||
154865427|NCT01702805|558935971|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
154865428|NCT01702805|558935972|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
154865429|NCT01702805|558935971|FG000|Overall Study|Incomplete Follow-up|18|||
154865430|NCT01702805|558935972|FG001|Overall Study|Incomplete Follow-up|15|||
154865431|NCT01702805|558935971|FG000|Overall Study|Vital Status Assessment Only|40|||
154865432|NCT01702805|558935972|FG001|Overall Study|Vital Status Assessment Only|39|||
154865433|NCT01702805|558935971|FG000|Overall Study|Lost to Follow-up|5|||
154865434|NCT01702805|558935972|FG001|Overall Study|Lost to Follow-up|5|||
154865435|NCT00635102|558935973|FG000|Overall Study|Withdrawal by Subject|7|||
154865436|NCT00635102|558935974|FG001|Overall Study|Withdrawal by Subject|8|||
154865437|NCT00440401|558935976|FG000|Overall Study|Adverse Event|2|||
154865438|NCT00440401|558935977|FG001|Overall Study|Adverse Event|1|||
154865439|NCT00440401|558935976|FG000|Overall Study|Other|2|||
154865440|NCT00440401|558935977|FG001|Overall Study|Other|5|||
154865441|NCT01925703|558935978|FG000|Overall Study|Physician Decision|1|||
154865442|NCT01925703|558935978|FG000|Overall Study|Lost to Follow-up|2|||
154865443|NCT01925703|558935978|FG000|Overall Study|Discharge prior to full iron repletion|1|||
154865444|NCT01238120|558935980|FG000|Overall Study|Withdrawal by Subject|4|||
154865445|NCT01238120|558935981|FG001|Overall Study|Withdrawal by Subject|1|||
154865446|NCT01238120|558935982|FG002|Overall Study|Withdrawal by Subject|2|||
154865447|NCT01238120|558935983|FG003|Overall Study|Withdrawal by Subject|5|||
154865448|NCT01238120|558935980|FG000|Overall Study|Lost to Follow-up|2|||
154865449|NCT01238120|558935981|FG001|Overall Study|Lost to Follow-up|0|||
154865450|NCT01238120|558935982|FG002|Overall Study|Lost to Follow-up|1|||
154865451|NCT01238120|558935983|FG003|Overall Study|Lost to Follow-up|1|||
154865452|NCT01238120|558935980|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
154865453|NCT01238120|558935981|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
154865454|NCT01238120|558935982|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
154865455|NCT01238120|558935983|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
154865456|NCT00881205|558935984|FG000|Overall Study|Adverse Event|8|||
154865457|NCT00881205|558935985|FG001|Overall Study|Adverse Event|3|||
154865458|NCT00881205|558935984|FG000|Overall Study|Withdrawal by Subject|1|||
154865459|NCT00881205|558935985|FG001|Overall Study|Withdrawal by Subject|2|||
154865460|NCT00881205|558935984|FG000|Overall Study|Lost to Follow-up|0|||
154865461|NCT00881205|558935985|FG001|Overall Study|Lost to Follow-up|1|||
154865462|NCT00881205|558935984|FG000|Overall Study|Administrative problems|1|||
154865463|NCT00881205|558935985|FG001|Overall Study|Administrative problems|1|||
154865464|NCT00881205|558935984|FG000|Overall Study|Condition no longer requires drug|1|||
154865465|NCT00881205|558935985|FG001|Overall Study|Condition no longer requires drug|0|||
154865466|NCT02498652|558935988|FG000|Overall Study|Protocol Violation|0|||
154865467|NCT02498652|558935989|FG001|Overall Study|Protocol Violation|1|||
154865468|NCT01193335|558935990|FG000|After Infant Series|Lost to Follow-up|1|||
154865469|NCT01193335|558935991|FG001|After Infant Series|Lost to Follow-up|2|||
154865470|NCT01193335|558935990|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
154865471|NCT01193335|558935991|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
155174384|NCT03996369|560076676|FG000|Overall Study|Protocol deviation|1|||
155174385|NCT03996369|560076677|FG001|Overall Study|Protocol deviation|1|||
155174386|NCT03996369|560076676|FG000|Overall Study|Physician Decision|4|||
155174387|NCT03996369|560076677|FG001|Overall Study|Physician Decision|2|||
155174388|NCT03996369|560076676|FG000|Overall Study|Participant decision|0|||
154865472|NCT01193335|558935990|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
154865473|NCT01193335|558935991|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
154865474|NCT01193335|558935990|FG000|1-Year Follow-up|Lost to Follow-up|4|||
154865475|NCT01193335|558935991|FG001|1-Year Follow-up|Lost to Follow-up|0|||
154865476|NCT01193335|558935990|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
154865477|NCT01193335|558935991|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
154865478|NCT01193335|558935990|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
154865479|NCT01193335|558935991|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
154865480|NCT01733329|558935992|FG000|Overall Study|Protocol Violation|1|||
154865481|NCT01733329|558935993|FG001|Overall Study|Protocol Violation|1|||
154865482|NCT01733329|558935992|FG000|Overall Study|Uterine artery injury|1|||
154865483|NCT01733329|558935993|FG001|Overall Study|Uterine artery injury|0|||
154865484|NCT01985321|558935999|FG000|Overall Study|Protocol Violation|4|||
154865485|NCT01985321|558936000|FG001|Overall Study|Protocol Violation|3|||
154865486|NCT01985321|558935999|FG000|Overall Study|Withdrawal by Subject|1|||
154865487|NCT01985321|558936000|FG001|Overall Study|Withdrawal by Subject|0|||
154865488|NCT01985321|558935999|FG000|Overall Study|Lost to Follow-up|5|||
154865489|NCT01985321|558936000|FG001|Overall Study|Lost to Follow-up|2|||
154865490|NCT01985321|558935999|FG000|Overall Study|Subject treated wrong type of sore|1|||
154865491|NCT01985321|558936000|FG001|Overall Study|Subject treated wrong type of sore|0|||
154865492|NCT00482001|558936001|FG000|Overall Study|Protocol Violation|1|||
154865493|NCT00482001|558936002|FG001|Overall Study|Protocol Violation|1|||
154865494|NCT04786210|558936003|FG000|Overall Study|Lost to Follow-up|2|||
154865495|NCT04786210|558936003|FG000|Overall Study|Withdrawal by Subject|4|||
154865496|NCT04334148|558936006|FG000|Overall Study|positive nasal swab at baseline|0|||
154865497|NCT04334148|558936007|FG001|Overall Study|positive nasal swab at baseline|1|||
154865498|NCT00498173|558936008|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
154865499|NCT00498173|558936009|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
154865500|NCT00498173|558936010|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
154865501|NCT04246047|558936011|FG000|Overall Study|Death|50|||
154865502|NCT04246047|558936012|FG001|Overall Study|Death|77|||
154865503|NCT04246047|558936011|FG000|Overall Study|Lost to Follow-up|1|||
154865504|NCT04246047|558936012|FG001|Overall Study|Lost to Follow-up|3|||
154865505|NCT04246047|558936011|FG000|Overall Study|Physician Decision|4|||
154865506|NCT04246047|558936012|FG001|Overall Study|Physician Decision|10|||
154865507|NCT04246047|558936011|FG000|Overall Study|Withdrawal by Subject|19|||
154865508|NCT04246047|558936012|FG001|Overall Study|Withdrawal by Subject|26|||
154865509|NCT04246047|558936011|FG000|Overall Study|Ongoing|169|||
154865510|NCT04246047|558936012|FG001|Overall Study|Ongoing|135|||
154865511|NCT04689828|558936013|FG000|Overall Study|Subject decision|5|||
154865512|NCT04689828|558936014|FG001|Overall Study|Subject decision|5|||
154865513|NCT04689828|558936013|FG000|Overall Study|Adverse Event|12|||
154865514|NCT04689828|558936014|FG001|Overall Study|Adverse Event|12|||
154865515|NCT04689828|558936013|FG000|Overall Study|Physician Decision|24|||
154865516|NCT04689828|558936014|FG001|Overall Study|Physician Decision|32|||
154865517|NCT04689828|558936013|FG000|Overall Study|Progressive disease|54|||
154865518|NCT04689828|558936014|FG001|Overall Study|Progressive disease|173|||
154865519|NCT04689828|558936013|FG000|Overall Study|Death|0|||
154865520|NCT04689828|558936014|FG001|Overall Study|Death|1|||
154865521|NCT04689828|558936013|FG000|Overall Study|Lost to Follow-up|1|||
154865522|NCT04689828|558936014|FG001|Overall Study|Lost to Follow-up|0|||
154865523|NCT04689828|558936013|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
154865524|NCT04689828|558936014|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
154865525|NCT04689828|558936013|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
154865526|NCT04689828|558936014|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
154865527|NCT04689828|558936013|FG000|Overall Study|Participants not treated|7|||
154865528|NCT04689828|558936014|FG001|Overall Study|Participants not treated|2|||
154865529|NCT04332419|558936021|FG000|Overall Study|Withdrawal by Subject|1|||
155174389|NCT03996369|560076677|FG001|Overall Study|Participant decision|1|||
154865530|NCT02493751|558936022|FG000|Overall Study|Withdrawal by Subject|2|||
154865531|NCT02493751|558936023|FG001|Overall Study|Withdrawal by Subject|8|||
154865532|NCT02493751|558936022|FG000|Overall Study|Death|6|||
154865533|NCT02493751|558936023|FG001|Overall Study|Death|13|||
154865534|NCT02493751|558936022|FG000|Overall Study|Lost to Follow-up|2|||
155174390|NCT03996369|560076676|FG000|Overall Study|Lack of Efficacy|4|||
154865535|NCT02493751|558936023|FG001|Overall Study|Lost to Follow-up|3|||
154865536|NCT02493751|558936022|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
154865537|NCT02493751|558936023|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
154865538|NCT00519623|558936024|FG000|Overall Study|Adverse Event|1|||
154865539|NCT03819140|558936027|FG000|Overall Study|Lost to Follow-up|1|||
154865540|NCT03819140|558936028|FG001|Overall Study|Lost to Follow-up|2|||
154865541|NCT03819140|558936027|FG000|Overall Study|Withdrawal by Subject|3|||
154865542|NCT03819140|558936028|FG001|Overall Study|Withdrawal by Subject|2|||
154865543|NCT03819140|558936027|FG000|Overall Study|Adverse Event|0|||
154865544|NCT03819140|558936028|FG001|Overall Study|Adverse Event|1|||
154865545|NCT03819140|558936027|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
154865546|NCT03819140|558936028|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
154865547|NCT03819140|558936027|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
154865548|NCT03819140|558936028|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
154865549|NCT02192359|558936029|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
154865550|NCT02192359|558936030|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
154865551|NCT02192359|558936031|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
154865552|NCT02192359|558936032|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
154865553|NCT02192359|558936029|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
154865554|NCT02192359|558936030|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
154865555|NCT02192359|558936031|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
154865556|NCT02192359|558936032|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
154865557|NCT02192359|558936029|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
154865558|NCT02192359|558936030|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
154865559|NCT02192359|558936031|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
154865560|NCT02192359|558936032|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
154865561|NCT00457639|558936033|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
154865562|NCT00457639|558936034|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
154865563|NCT00457639|558936033|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
154865564|NCT00457639|558936034|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
154865565|NCT00457639|558936033|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
154865566|NCT00457639|558936034|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
154865567|NCT02117687|558936035|FG000|Overall Study|Lost to Follow-up|0|||
154865568|NCT02117687|558936036|FG001|Overall Study|Lost to Follow-up|1|||
154865569|NCT02117687|558936035|FG000|Overall Study|Adverse Event|0|||
154865570|NCT02117687|558936036|FG001|Overall Study|Adverse Event|2|||
154865571|NCT02117687|558936035|FG000|Overall Study|Other Reasons|1|||
154865572|NCT02117687|558936036|FG001|Overall Study|Other Reasons|1|||
154865573|NCT01687673|558936048|FG000|Overall Study|Physician Decision|1|||
154865574|NCT02234622|558936049|FG000|Overall Study|Withdrawal by Subject|16|||
154865575|NCT02234622|558936050|FG001|Overall Study|Withdrawal by Subject|22|||
154865576|NCT02234622|558936049|FG000|Overall Study|Lost to Follow-up|27|||
154865577|NCT02234622|558936050|FG001|Overall Study|Lost to Follow-up|14|||
154865578|NCT03476239|558936051|FG000|Overall Study|Withdrawal by Subject|10|||
154865579|NCT03476239|558936051|FG000|Overall Study|Death|80|||
154865580|NCT03476239|558936051|FG000|Overall Study|Lost to Follow-up|8|||
154865581|NCT00618956|558936052|FG000|Overall Study|Adverse Event|10|||
154865582|NCT00618956|558936053|FG001|Overall Study|Adverse Event|34|||
154865583|NCT00618956|558936052|FG000|Overall Study|Lack of Efficacy|2|||
154865584|NCT00618956|558936053|FG001|Overall Study|Lack of Efficacy|1|||
154865585|NCT00618956|558936052|FG000|Overall Study|Withdrawal by Subject|5|||
154865586|NCT00618956|558936053|FG001|Overall Study|Withdrawal by Subject|7|||
154865587|NCT00618956|558936052|FG000|Overall Study|Lost to Follow-up|4|||
154865588|NCT00618956|558936053|FG001|Overall Study|Lost to Follow-up|5|||
154865589|NCT00618956|558936052|FG000|Overall Study|Protocol Violation|2|||
154865590|NCT00618956|558936053|FG001|Overall Study|Protocol Violation|2|||
154865591|NCT00618956|558936052|FG000|Overall Study|did not meet criteria, non-compliance|2|||
154865592|NCT00618956|558936053|FG001|Overall Study|did not meet criteria, non-compliance|1|||
154865593|NCT03598777|558936054|FG000|Overall Study|Study Terminated by Sponsor|3|||
154865594|NCT03598777|558936055|FG001|Overall Study|Study Terminated by Sponsor|0|||
154865595|NCT03598777|558936056|FG002|Overall Study|Study Terminated by Sponsor|0|||
154865596|NCT03598777|558936057|FG003|Overall Study|Study Terminated by Sponsor|0|||
154865597|NCT03598777|558936058|FG004|Overall Study|Study Terminated by Sponsor|15|||
154865598|NCT03598777|558936054|FG000|Overall Study|Withdrawal by Subject|1|||
154865599|NCT03598777|558936055|FG001|Overall Study|Withdrawal by Subject|1|||
154865600|NCT03598777|558936056|FG002|Overall Study|Withdrawal by Subject|0|||
154865601|NCT03598777|558936057|FG003|Overall Study|Withdrawal by Subject|0|||
154865602|NCT03598777|558936058|FG004|Overall Study|Withdrawal by Subject|0|||
154865603|NCT03598777|558936054|FG000|Overall Study|Adverse Event|1|||
154865604|NCT03598777|558936055|FG001|Overall Study|Adverse Event|0|||
154865605|NCT03598777|558936056|FG002|Overall Study|Adverse Event|0|||
154865606|NCT03598777|558936057|FG003|Overall Study|Adverse Event|0|||
154865607|NCT03598777|558936058|FG004|Overall Study|Adverse Event|0|||
154865608|NCT03598777|558936054|FG000|Overall Study|Lost to Follow-up|1|||
154865609|NCT03598777|558936055|FG001|Overall Study|Lost to Follow-up|0|||
154865610|NCT03598777|558936056|FG002|Overall Study|Lost to Follow-up|0|||
154865611|NCT03598777|558936057|FG003|Overall Study|Lost to Follow-up|0|||
154865612|NCT03598777|558936058|FG004|Overall Study|Lost to Follow-up|0|||
154865613|NCT02006576|558936059|FG000|Overall Study|Withdrawal by Subject|4|||
154865614|NCT02006576|558936060|FG001|Overall Study|Withdrawal by Subject|6|||
154865615|NCT02006576|558936061|FG002|Overall Study|Withdrawal by Subject|2|||
154865616|NCT02006576|558936059|FG000|Overall Study|Death|0|||
154865617|NCT02006576|558936060|FG001|Overall Study|Death|0|||
154865618|NCT02006576|558936061|FG002|Overall Study|Death|1|||
154865619|NCT02006576|558936059|FG000|Overall Study|Lost to Follow-up|1|||
154865620|NCT02006576|558936060|FG001|Overall Study|Lost to Follow-up|0|||
154865621|NCT02006576|558936061|FG002|Overall Study|Lost to Follow-up|1|||
154865622|NCT02006576|558936059|FG000|Overall Study|Screen Failure, too sick, other|13|||
154865623|NCT02006576|558936060|FG001|Overall Study|Screen Failure, too sick, other|1|||
154865624|NCT02006576|558936061|FG002|Overall Study|Screen Failure, too sick, other|13|||
154865625|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
154865626|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
154865627|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
154865628|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
154865629|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
154865630|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
154865631|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
154865632|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
154865633|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
154865634|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
154865635|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
154865636|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
154865637|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
154865638|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
154865639|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
154865640|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
154865641|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
154865642|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
154865643|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
154865644|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
154865645|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
154865646|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
154865647|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
154865648|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
154865649|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
154865650|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
154865651|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
154865652|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
154865653|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
154865654|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
154865655|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
154865656|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
154865657|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
154865658|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
154865659|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
154865660|NCT00785577|558936062|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
154865661|NCT00785577|558936063|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
154865662|NCT00785577|558936064|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
154865663|NCT00785577|558936065|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
154973281|NCT03653026|559326856|FG000|Part 1: Placebo-controlled Period|Other|0|||
154973282|NCT03653026|559326857|FG001|Part 1: Placebo-controlled Period|Other|3|||
154865664|NCT00785577|558936066|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
154865665|NCT00785577|558936062|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
154865666|NCT00785577|558936063|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
154865667|NCT00785577|558936064|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
155109266|NCT03286543|559828444|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
154865668|NCT00785577|558936065|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
154865669|NCT00785577|558936066|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
154973283|NCT03653026|559326858|FG002|Part 1: Placebo-controlled Period|Other|0|||
154973284|NCT03653026|559326859|FG003|Part 1: Placebo-controlled Period|Other|0|||
154865670|NCT00785577|558936062|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
154865671|NCT00785577|558936063|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
154865672|NCT00785577|558936064|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
154865673|NCT00785577|558936065|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
154865674|NCT00785577|558936066|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
154865675|NCT01650805|558936071|FG000|Overall Study|Withdrawal by Subject|1|||
154865676|NCT01650805|558936072|FG001|Overall Study|Withdrawal by Subject|0|||
154865677|NCT02515669|558936073|FG000|228 Week Open-Label Phase|Other|0|||
154865678|NCT02515669|558936074|FG001|228 Week Open-Label Phase|Other|0|||
154865679|NCT02515669|558936075|FG002|228 Week Open-Label Phase|Other|1|||
154865680|NCT02515669|558936076|FG003|228 Week Open-Label Phase|Other|4|||
154865681|NCT02515669|558936073|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
154865682|NCT02515669|558936074|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
154865683|NCT02515669|558936075|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
154865684|NCT02515669|558936076|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
154865685|NCT02515669|558936073|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
154865686|NCT02515669|558936074|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
154865687|NCT02515669|558936075|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
154865688|NCT02515669|558936076|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
154865689|NCT02515669|558936073|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
154865690|NCT02515669|558936074|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
154865691|NCT02515669|558936075|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
154865692|NCT02515669|558936076|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
154865693|NCT02515669|558936073|FG000|228 Week Open-Label Phase|Missing|0|||
154865694|NCT02515669|558936074|FG001|228 Week Open-Label Phase|Missing|2|||
154865695|NCT02515669|558936075|FG002|228 Week Open-Label Phase|Missing|2|||
154865696|NCT02515669|558936076|FG003|228 Week Open-Label Phase|Missing|2|||
154865697|NCT03750838|558936077|FG000|Overall Study|Lost to Follow-up|10|||
154865698|NCT03750838|558936078|FG001|Overall Study|Lost to Follow-up|6|||
154865699|NCT04070378|558936084|FG000|Overall Study|Withdrawal by Subject|2|||
154865700|NCT04070378|558936084|FG000|Overall Study|Screen Failure|6|||
154865701|NCT04070378|558936084|FG000|Overall Study|Physician Decision|1|||
154865702|NCT04070378|558936084|FG000|Overall Study|Adverse Event|1|||
154865703|NCT05781542|558937431|FG000|Overall Study|Lost to Follow-up|1|||
154865704|NCT05781542|558937432|FG001|Overall Study|Lost to Follow-up|0|||
154865705|NCT05781542|558937433|FG002|Overall Study|Lost to Follow-up|1|||
154865706|NCT01843374|558937438|FG000|Overall Study|Death|155|||
154865707|NCT01843374|558937439|FG001|Overall Study|Death|313|||
154865708|NCT01843374|558937438|FG000|Overall Study|Withdrawal by Subject|14|||
154865709|NCT01843374|558937439|FG001|Overall Study|Withdrawal by Subject|20|||
154865710|NCT01843374|558937438|FG000|Overall Study|Withdrawing due to Other reason|20|||
154865711|NCT01843374|558937439|FG001|Overall Study|Withdrawing due to Other reason|46|||
154865712|NCT01826214|558937440|FG000|Overall Study|Adverse Event|7|||
154865713|NCT01826214|558937441|FG001|Overall Study|Adverse Event|6|||
154865714|NCT01826214|558937440|FG000|Overall Study|Death|3|||
154865715|NCT01826214|558937441|FG001|Overall Study|Death|1|||
154865716|NCT01826214|558937440|FG000|Overall Study|Lost to Follow-up|1|||
154865717|NCT01826214|558937441|FG001|Overall Study|Lost to Follow-up|0|||
154865718|NCT01826214|558937440|FG000|Overall Study|Physician Decision|0|||
154865719|NCT01826214|558937441|FG001|Overall Study|Physician Decision|2|||
154865720|NCT01826214|558937440|FG000|Overall Study|Progressive disease|22|||
154865721|NCT01826214|558937441|FG001|Overall Study|Progressive disease|21|||
154865722|NCT01826214|558937440|FG000|Overall Study|Study terminated by Sponsor|0|||
154865723|NCT01826214|558937441|FG001|Overall Study|Study terminated by Sponsor|1|||
154865724|NCT01826214|558937440|FG000|Overall Study|Subject/guardian decision|2|||
154865725|NCT01826214|558937441|FG001|Overall Study|Subject/guardian decision|3|||
154865726|NCT00955110|558937442|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
154865727|NCT00955110|558937442|FG000|Treatment Phase|Adverse Event|2|||
154865728|NCT00955110|558937442|FG000|Treatment Phase|Administrative reasons|2|||
154865729|NCT00955110|558937442|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
154865730|NCT00955110|558937442|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
154865731|NCT03704051|558937447|FG000|Overall Study|Withdrawal by Subject|4|||
154865732|NCT03704051|558937448|FG001|Overall Study|Withdrawal by Subject|0|||
154865733|NCT01981187|558937457|FG000|Overall Study|Participant/guardian decision|2|||
154865734|NCT01981187|558937457|FG000|Overall Study|Physician Decision|1|||
155174391|NCT03996369|560076677|FG001|Overall Study|Lack of Efficacy|0|||
154865735|NCT01981187|558937457|FG000|Overall Study|Disease progression|2|||
154865736|NCT01981187|558937457|FG000|Overall Study|Adverse Event|7|||
154865737|NCT01943539|558937458|FG000|Overall Study|Non-compliance with at-home intervention|4|||
154865738|NCT01943539|558937459|FG001|Overall Study|Non-compliance with at-home intervention|0|||
154865739|NCT01362322|558937460|FG000|Overall Study|Withdrawal by Subject|3|||
154865740|NCT01362322|558937461|FG001|Overall Study|Withdrawal by Subject|1|||
154865741|NCT01362322|558937460|FG000|Overall Study|Lost to Follow-up|2|||
154865742|NCT01362322|558937461|FG001|Overall Study|Lost to Follow-up|6|||
155174392|NCT03996369|560076676|FG000|Overall Study|Adverse Event|9|||
155174393|NCT03996369|560076677|FG001|Overall Study|Adverse Event|0|||
155174394|NCT03996369|560076676|FG000|Overall Study|Withdrawal by Subject|6|||
155174395|NCT03996369|560076677|FG001|Overall Study|Withdrawal by Subject|8|||
155174396|NCT03996369|560076676|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
155174397|NCT03996369|560076677|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
155174398|NCT03996369|560076676|FG000|Overall Study|Lost to Follow-up|0|||
155174399|NCT03996369|560076677|FG001|Overall Study|Lost to Follow-up|1|||
155174400|NCT01579812|560076683|FG000|Overall Study|Ineligible after treatment start|40|||
155174401|NCT01579812|560076683|FG000|Overall Study|Patient choice|3|||
155174402|NCT01579812|560076683|FG000|Overall Study|Noncompliance|3|||
155174403|NCT01579812|560076683|FG000|Overall Study|Withdrawal by Subject|6|||
155174404|NCT00653432|560076685|FG000|Overall Study|Adverse Event|4|||
155174405|NCT00653432|560076686|FG001|Overall Study|Adverse Event|1|||
155174406|NCT00653432|560076685|FG000|Overall Study|Withdrawal by Subject|4|||
155174407|NCT00653432|560076686|FG001|Overall Study|Withdrawal by Subject|5|||
155174408|NCT00653432|560076685|FG000|Overall Study|Lost to Follow-up|7|||
155174409|NCT00653432|560076686|FG001|Overall Study|Lost to Follow-up|6|||
155174410|NCT00653432|560076685|FG000|Overall Study|Use/Need of Con Therapy|2|||
155174411|NCT00653432|560076686|FG001|Overall Study|Use/Need of Con Therapy|1|||
155174412|NCT00653432|560076685|FG000|Overall Study|Other - Reason Not Provided|5|||
155174413|NCT00653432|560076686|FG001|Overall Study|Other - Reason Not Provided|3|||
155174414|NCT05277337|560076687|FG000|Overall Study|Lost to Follow-up|2|||
155174415|NCT05277337|560076688|FG001|Overall Study|Lost to Follow-up|0|||
155174416|NCT05277337|560076687|FG000|Overall Study|Withdrawal by Subject|1|||
155174417|NCT05277337|560076688|FG001|Overall Study|Withdrawal by Subject|0|||
155174418|NCT03726996|560076689|FG000|Overall Study|Parent's decision|2|||
155174419|NCT03726996|560076689|FG000|Overall Study|Study early termination|2|||
155174420|NCT03531632|560076694|FG000|Overall Study|Adverse Event|0|||
155174421|NCT03531632|560076695|FG001|Overall Study|Adverse Event|0|||
155174422|NCT03531632|560076696|FG002|Overall Study|Adverse Event|1|||
155174423|NCT03531632|560076694|FG000|Overall Study|Death|4|||
155174424|NCT03531632|560076695|FG001|Overall Study|Death|0|||
155174425|NCT03531632|560076696|FG002|Overall Study|Death|14|||
155174426|NCT03531632|560076694|FG000|Overall Study|Study Terminated|1|||
155174427|NCT03531632|560076695|FG001|Overall Study|Study Terminated|3|||
155174428|NCT03531632|560076696|FG002|Overall Study|Study Terminated|11|||
155174429|NCT01224782|560076699|FG000|Overall Study|Lost to Follow-up|177|||
155174430|NCT01224782|560076699|FG000|Overall Study|Withdrawal by Subject|16|||
155174431|NCT01224782|560076699|FG000|Overall Study|Death|14|||
155174432|NCT01224782|560076699|FG000|Overall Study|Improvement|13|||
155174433|NCT01224782|560076699|FG000|Overall Study|Adverse Event|12|||
154865743|NCT02158533|558937466|FG000|Stage 1|Adverse Event|6|||
154865744|NCT02158533|558937467|FG001|Stage 1|Adverse Event|4|||
154865745|NCT02158533|558937468|FG002|Stage 1|Adverse Event|7|||
154865746|NCT02158533|558937469|FG003|Stage 1|Adverse Event|0|||
154865747|NCT02158533|558937470|FG004|Stage 1|Adverse Event|0|||
154865748|NCT02158533|558937471|FG005|Stage 1|Adverse Event|0|||
154865749|NCT02158533|558937466|FG000|Stage 1|Withdrawal by Subject|3|||
154865750|NCT02158533|558937467|FG001|Stage 1|Withdrawal by Subject|2|||
154865751|NCT02158533|558937468|FG002|Stage 1|Withdrawal by Subject|1|||
154865752|NCT02158533|558937469|FG003|Stage 1|Withdrawal by Subject|0|||
154865753|NCT02158533|558937470|FG004|Stage 1|Withdrawal by Subject|0|||
154865754|NCT02158533|558937471|FG005|Stage 1|Withdrawal by Subject|0|||
154865755|NCT02158533|558937466|FG000|Stage 1|Lack of Efficacy|1|||
154865756|NCT02158533|558937467|FG001|Stage 1|Lack of Efficacy|0|||
154865757|NCT02158533|558937468|FG002|Stage 1|Lack of Efficacy|0|||
154865758|NCT02158533|558937469|FG003|Stage 1|Lack of Efficacy|0|||
154865759|NCT02158533|558937470|FG004|Stage 1|Lack of Efficacy|0|||
154865760|NCT02158533|558937471|FG005|Stage 1|Lack of Efficacy|0|||
154865761|NCT02158533|558937466|FG000|Stage 1|Lost to Follow-up|3|||
155174434|NCT01224782|560076699|FG000|Overall Study|Adverse Reaction|11|||
154865762|NCT02158533|558937467|FG001|Stage 1|Lost to Follow-up|1|||
154865763|NCT02158533|558937468|FG002|Stage 1|Lost to Follow-up|0|||
154865764|NCT02158533|558937469|FG003|Stage 1|Lost to Follow-up|0|||
154973285|NCT03653026|559326856|FG000|Part 2: Open-label Extension|Adverse Event|0|||
154865765|NCT02158533|558937470|FG004|Stage 1|Lost to Follow-up|0|||
154865766|NCT02158533|558937471|FG005|Stage 1|Lost to Follow-up|0|||
154865767|NCT02158533|558937466|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
154865768|NCT02158533|558937467|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
154865769|NCT02158533|558937468|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
155174435|NCT01224782|560076699|FG000|Overall Study|Noncompliance|10|||
155174436|NCT01224782|560076699|FG000|Overall Study|Other|4|||
155174437|NCT01224782|560076699|FG000|Overall Study|Start of Dialysis|3|||
155174438|NCT01224782|560076699|FG000|Overall Study|Change of Treatment|1|||
155174439|NCT01224782|560076699|FG000|Overall Study|Financial Reasons|1|||
155174440|NCT01224782|560076699|FG000|Overall Study|Deterioration|1|||
155174441|NCT01224782|560076699|FG000|Overall Study|Transplantation|1|||
155174442|NCT03554486|560076700|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
155174443|NCT03554486|560076701|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
154865770|NCT02158533|558937469|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
154865771|NCT02158533|558937470|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
154865772|NCT02158533|558937471|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
154865773|NCT02158533|558937466|FG000|Stage 1|Non-compliance with study visits|1|||
154865774|NCT02158533|558937467|FG001|Stage 1|Non-compliance with study visits|0|||
154865775|NCT02158533|558937468|FG002|Stage 1|Non-compliance with study visits|0|||
154865776|NCT02158533|558937469|FG003|Stage 1|Non-compliance with study visits|0|||
154865777|NCT02158533|558937470|FG004|Stage 1|Non-compliance with study visits|0|||
154865778|NCT02158533|558937471|FG005|Stage 1|Non-compliance with study visits|0|||
154865779|NCT02158533|558937466|FG000|Stage 2|Adverse Event|0|||
154865780|NCT02158533|558937467|FG001|Stage 2|Adverse Event|0|||
154865781|NCT02158533|558937468|FG002|Stage 2|Adverse Event|0|||
154865782|NCT02158533|558937469|FG003|Stage 2|Adverse Event|0|||
154865783|NCT02158533|558937470|FG004|Stage 2|Adverse Event|0|||
154865784|NCT02158533|558937471|FG005|Stage 2|Adverse Event|1|||
154865785|NCT02158533|558937466|FG000|Stage 2|Lack of Efficacy|0|||
154865786|NCT02158533|558937467|FG001|Stage 2|Lack of Efficacy|0|||
154973286|NCT03653026|559326857|FG001|Part 2: Open-label Extension|Adverse Event|0|||
154973287|NCT03653026|559326858|FG002|Part 2: Open-label Extension|Adverse Event|1|||
154973288|NCT03653026|559326859|FG003|Part 2: Open-label Extension|Adverse Event|1|||
154973289|NCT03653026|559326856|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
154973290|NCT03653026|559326857|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
154973291|NCT03653026|559326858|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
154973292|NCT03653026|559326859|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
154973293|NCT03653026|559326856|FG000|Part 2: Open-label Extension|Other|0|||
154973294|NCT03653026|559326857|FG001|Part 2: Open-label Extension|Other|0|||
154973295|NCT03653026|559326858|FG002|Part 2: Open-label Extension|Other|1|||
154865787|NCT02158533|558937468|FG002|Stage 2|Lack of Efficacy|0|||
154865788|NCT02158533|558937469|FG003|Stage 2|Lack of Efficacy|0|||
154865789|NCT02158533|558937470|FG004|Stage 2|Lack of Efficacy|1|||
154865790|NCT02158533|558937471|FG005|Stage 2|Lack of Efficacy|0|||
154973296|NCT03653026|559326859|FG003|Part 2: Open-label Extension|Other|2|||
154973297|NCT01933919|559326862|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
154865791|NCT02158533|558937466|FG000|Stage 2|Lost to Follow-up|0|||
154865792|NCT02158533|558937467|FG001|Stage 2|Lost to Follow-up|0|||
154865793|NCT02158533|558937468|FG002|Stage 2|Lost to Follow-up|0|||
154865794|NCT02158533|558937469|FG003|Stage 2|Lost to Follow-up|1|||
154865795|NCT02158533|558937470|FG004|Stage 2|Lost to Follow-up|1|||
154865796|NCT02158533|558937471|FG005|Stage 2|Lost to Follow-up|2|||
154865797|NCT02158533|558937466|FG000|Stage 2|Withdrawal by Subject|0|||
154865798|NCT02158533|558937467|FG001|Stage 2|Withdrawal by Subject|0|||
154865799|NCT02158533|558937468|FG002|Stage 2|Withdrawal by Subject|0|||
154865800|NCT02158533|558937469|FG003|Stage 2|Withdrawal by Subject|0|||
154865801|NCT02158533|558937470|FG004|Stage 2|Withdrawal by Subject|1|||
154865802|NCT02158533|558937471|FG005|Stage 2|Withdrawal by Subject|2|||
154865803|NCT02158533|558937466|FG000|Stage 2|Physician Decision|0|||
154865804|NCT02158533|558937467|FG001|Stage 2|Physician Decision|0|||
154865805|NCT02158533|558937468|FG002|Stage 2|Physician Decision|0|||
154865806|NCT02158533|558937469|FG003|Stage 2|Physician Decision|0|||
154865807|NCT02158533|558937470|FG004|Stage 2|Physician Decision|1|||
154865808|NCT02158533|558937471|FG005|Stage 2|Physician Decision|0|||
154865809|NCT02158533|558937466|FG000|Stage 2|Pregnancy|0|||
154865810|NCT02158533|558937467|FG001|Stage 2|Pregnancy|0|||
154973298|NCT01933919|559326863|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
154973299|NCT01933919|559326862|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
154973300|NCT01933919|559326863|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
154973301|NCT01933919|559326862|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
154973302|NCT01933919|559326863|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
154973303|NCT01933919|559326862|FG000|Open-label Long-term Phase|Adverse Event|2|||
154973304|NCT01933919|559326863|FG001|Open-label Long-term Phase|Adverse Event|0|||
154973305|NCT01933919|559326862|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
154973306|NCT01933919|559326863|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
154865811|NCT02158533|558937468|FG002|Stage 2|Pregnancy|0|||
154865812|NCT02158533|558937469|FG003|Stage 2|Pregnancy|1|||
154973307|NCT01933919|559326862|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
154973308|NCT01933919|559326863|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
154973309|NCT01933919|559326862|FG000|Open-label Long-term Phase|Other|1|||
154973310|NCT01933919|559326863|FG001|Open-label Long-term Phase|Other|2|||
154973311|NCT00852917|559326864|FG000|Overall Study|Adverse Event|13|||
154865813|NCT02158533|558937470|FG004|Stage 2|Pregnancy|0|||
154865814|NCT02158533|558937471|FG005|Stage 2|Pregnancy|0|||
154865815|NCT02158533|558937466|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
154865816|NCT02158533|558937467|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
154865817|NCT02158533|558937468|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
154865818|NCT02158533|558937469|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
154865819|NCT02158533|558937470|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
154865820|NCT02158533|558937471|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
155109267|NCT03286543|559828442|FG000|Study Enrollment|Withdrawn from study|0|||
155174444|NCT03554486|560076702|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
155174445|NCT03554486|560076700|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
154865821|NCT02158533|558937466|FG000|Stage 2|Non-adherence with study visits|0|||
154865822|NCT02158533|558937467|FG001|Stage 2|Non-adherence with study visits|0|||
154865823|NCT02158533|558937468|FG002|Stage 2|Non-adherence with study visits|0|||
154865824|NCT02158533|558937469|FG003|Stage 2|Non-adherence with study visits|0|||
154865825|NCT02158533|558937470|FG004|Stage 2|Non-adherence with study visits|0|||
154865826|NCT02158533|558937471|FG005|Stage 2|Non-adherence with study visits|1|||
154865827|NCT00384956|558937472|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
154865828|NCT00174941|558937476|FG000|Overall Study|Adverse Event|1|||
154865829|NCT00174941|558937477|FG001|Overall Study|Adverse Event|10|||
155109268|NCT03286543|559828443|FG001|Study Enrollment|Withdrawn from study|6|||
155109269|NCT03286543|559828444|FG002|Study Enrollment|Withdrawn from study|6|||
155109270|NCT05332392|559828445|FG000|Overall Study|Did not meet inclusion criteria|25|||
155109271|NCT05332392|559828445|FG000|Overall Study|Principal Investigator's decision|17|||
155109272|NCT05332392|559828445|FG000|Overall Study|Adverse Event|1|||
155109273|NCT05332392|559828445|FG000|Overall Study|Subject's decision|1|||
155109274|NCT01268046|559828446|FG000|Overall Study|Withdrawal by Subject|1|||
155109275|NCT01268046|559828447|FG001|Overall Study|Withdrawal by Subject|0|||
155109276|NCT01268046|559828448|FG002|Overall Study|Withdrawal by Subject|0|||
155109277|NCT01268046|559828449|FG003|Overall Study|Withdrawal by Subject|1|||
155109278|NCT01268046|559828446|FG000|Overall Study|Lost to Follow-up|0|||
155109279|NCT01268046|559828447|FG001|Overall Study|Lost to Follow-up|0|||
155109280|NCT01268046|559828448|FG002|Overall Study|Lost to Follow-up|1|||
155109281|NCT01268046|559828449|FG003|Overall Study|Lost to Follow-up|0|||
155109282|NCT03636893|559828450|FG000|Overall Study|Death|0|||
155109283|NCT03636893|559828451|FG001|Overall Study|Death|1|||
155109284|NCT03636893|559828450|FG000|Overall Study|Protocol Violation|0|||
155109285|NCT03636893|559828451|FG001|Overall Study|Protocol Violation|3|||
155109286|NCT03636893|559828450|FG000|Overall Study|Withdrawal by Subject|1|||
155109287|NCT03636893|559828451|FG001|Overall Study|Withdrawal by Subject|2|||
155109288|NCT03636893|559828450|FG000|Overall Study|Refusal to surgery|4|||
155109289|NCT03636893|559828451|FG001|Overall Study|Refusal to surgery|3|||
155109290|NCT03636893|559828450|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
155109291|NCT03636893|559828451|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
155109292|NCT03636893|559828450|FG000|Overall Study|Adverse Event|1|||
155109293|NCT03636893|559828451|FG001|Overall Study|Adverse Event|1|||
155109294|NCT02314156|559828452|FG000|Overall Study|Adverse Event|1|||
155109295|NCT02314156|559828453|FG001|Overall Study|Adverse Event|0|||
155109296|NCT02314156|559828452|FG000|Overall Study|Withdrawal by Subject|1|||
155109297|NCT02314156|559828453|FG001|Overall Study|Withdrawal by Subject|0|||
155109298|NCT00758069|559828454|FG000|Overall Study|Lack of Efficacy|0|||
155109299|NCT00758069|559828455|FG001|Overall Study|Lack of Efficacy|0|||
155109300|NCT00758069|559828456|FG002|Overall Study|Lack of Efficacy|1|||
155109301|NCT00758069|559828454|FG000|Overall Study|Incorrect Study Drug|1|||
155109302|NCT00758069|559828455|FG001|Overall Study|Incorrect Study Drug|0|||
155109303|NCT00758069|559828456|FG002|Overall Study|Incorrect Study Drug|0|||
155109304|NCT04560816|559828457|FG000|Overall Study|Withdrawal by Subject|1|||
155109305|NCT04560816|559828458|FG001|Overall Study|Withdrawal by Subject|1|||
155109306|NCT04560816|559828459|FG002|Overall Study|Withdrawal by Subject|1|||
155109307|NCT04560816|559828460|FG003|Overall Study|Withdrawal by Subject|0|||
155109308|NCT04560816|559828461|FG004|Overall Study|Withdrawal by Subject|3|||
155109309|NCT04560816|559828462|FG005|Overall Study|Withdrawal by Subject|0|||
155109310|NCT04560816|559828457|FG000|Overall Study|Lost to Follow-up|1|||
155109311|NCT04560816|559828458|FG001|Overall Study|Lost to Follow-up|0|||
155109312|NCT04560816|559828459|FG002|Overall Study|Lost to Follow-up|0|||
155109313|NCT04560816|559828460|FG003|Overall Study|Lost to Follow-up|0|||
155109314|NCT04560816|559828461|FG004|Overall Study|Lost to Follow-up|0|||
155174446|NCT03554486|560076701|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
154865830|NCT00174941|558937478|FG002|Overall Study|Adverse Event|2|||
155174447|NCT03554486|560076702|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
154865831|NCT00174941|558937479|FG003|Overall Study|Adverse Event|13|||
154865832|NCT00174941|558937476|FG000|Overall Study|Protocol Violation|0|||
154865833|NCT00174941|558937477|FG001|Overall Study|Protocol Violation|1|||
155109315|NCT04560816|559828462|FG005|Overall Study|Lost to Follow-up|0|||
155109316|NCT04560816|559828457|FG000|Overall Study|Protocol Violation|1|||
155109317|NCT04560816|559828458|FG001|Overall Study|Protocol Violation|0|||
155109318|NCT04560816|559828459|FG002|Overall Study|Protocol Violation|0|||
155109319|NCT04560816|559828460|FG003|Overall Study|Protocol Violation|0|||
155109320|NCT04560816|559828461|FG004|Overall Study|Protocol Violation|0|||
155109321|NCT04560816|559828462|FG005|Overall Study|Protocol Violation|0|||
155109322|NCT02277691|559828463|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
155109323|NCT02277691|559828463|FG000|Overall Study|Voluntary Withdrawal|7|||
154865834|NCT00174941|558937478|FG002|Overall Study|Protocol Violation|0|||
155109324|NCT02277691|559828463|FG000|Overall Study|Lack of Efficacy|5|||
155109325|NCT02277691|559828463|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
154865835|NCT00174941|558937479|FG003|Overall Study|Protocol Violation|1|||
154865836|NCT00174941|558937476|FG000|Overall Study|Lost to Follow-up|0|||
154865837|NCT00174941|558937477|FG001|Overall Study|Lost to Follow-up|3|||
154865838|NCT00174941|558937478|FG002|Overall Study|Lost to Follow-up|2|||
154865839|NCT00174941|558937479|FG003|Overall Study|Lost to Follow-up|5|||
154865840|NCT00174941|558937476|FG000|Overall Study|Personal Reason(s)|0|||
154865841|NCT00174941|558937477|FG001|Overall Study|Personal Reason(s)|14|||
154865842|NCT00174941|558937478|FG002|Overall Study|Personal Reason(s)|8|||
154865843|NCT00174941|558937479|FG003|Overall Study|Personal Reason(s)|22|||
154865844|NCT00174941|558937476|FG000|Overall Study|Gout Flare|0|||
154865845|NCT00174941|558937477|FG001|Overall Study|Gout Flare|4|||
154865846|NCT00174941|558937478|FG002|Overall Study|Gout Flare|4|||
154865847|NCT00174941|558937479|FG003|Overall Study|Gout Flare|8|||
154865848|NCT00174941|558937476|FG000|Overall Study|Reason Not Specified|1|||
154865849|NCT00174941|558937477|FG001|Overall Study|Reason Not Specified|6|||
154865850|NCT00174941|558937478|FG002|Overall Study|Reason Not Specified|2|||
154865851|NCT00174941|558937479|FG003|Overall Study|Reason Not Specified|9|||
154865852|NCT01588197|558937492|FG000|Overall Study|Lack of Efficacy|0|||
154865853|NCT01588197|558937493|FG001|Overall Study|Lack of Efficacy|1|||
154865854|NCT01588197|558937492|FG000|Overall Study|No MRI|1|||
154865855|NCT01588197|558937493|FG001|Overall Study|No MRI|0|||
154865856|NCT01938625|558937500|FG000|Overall Study|Withdrawal by Subject|0|||
154865857|NCT01938625|558937501|FG001|Overall Study|Withdrawal by Subject|1|||
154865858|NCT01938625|558937500|FG000|Overall Study|Adverse Event|0|||
154865859|NCT01938625|558937501|FG001|Overall Study|Adverse Event|1|||
154865860|NCT01937312|558937502|FG000|Overall Study|Adverse Event|10|||
154865861|NCT01937312|558937503|FG001|Overall Study|Adverse Event|1|||
154865862|NCT01937312|558937502|FG000|Overall Study|Lack of Efficacy|0|||
154865863|NCT01937312|558937503|FG001|Overall Study|Lack of Efficacy|1|||
154865864|NCT01937312|558937502|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
154865865|NCT01937312|558937503|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
154865866|NCT00091793|558937504|FG000|Overall Study|Adverse Event|1|||
154865867|NCT00091793|558937505|FG001|Overall Study|Adverse Event|2|||
154865868|NCT00091793|558937504|FG000|Overall Study|Withdrawal by Subject|10|||
154865869|NCT00091793|558937505|FG001|Overall Study|Withdrawal by Subject|15|||
154865870|NCT00091793|558937504|FG000|Overall Study|Ineligibility determined|2|||
154865871|NCT00091793|558937505|FG001|Overall Study|Ineligibility determined|0|||
154865872|NCT00091793|558937504|FG000|Overall Study|Lost to Follow-up|7|||
154973312|NCT00852917|559326865|FG001|Overall Study|Adverse Event|20|||
154973313|NCT00852917|559326866|FG002|Overall Study|Adverse Event|35|||
154973314|NCT00852917|559326867|FG003|Overall Study|Adverse Event|17|||
154973315|NCT00852917|559326864|FG000|Overall Study|Lack of Efficacy|21|||
154973316|NCT00852917|559326865|FG001|Overall Study|Lack of Efficacy|11|||
154973317|NCT00852917|559326866|FG002|Overall Study|Lack of Efficacy|11|||
154973318|NCT00852917|559326867|FG003|Overall Study|Lack of Efficacy|47|||
154973319|NCT00852917|559326864|FG000|Overall Study|Withdrawal by Subject|4|||
154973320|NCT00852917|559326865|FG001|Overall Study|Withdrawal by Subject|8|||
154973321|NCT00852917|559326866|FG002|Overall Study|Withdrawal by Subject|10|||
154973322|NCT00852917|559326867|FG003|Overall Study|Withdrawal by Subject|9|||
154973323|NCT00852917|559326864|FG000|Overall Study|Physician Decision|6|||
154973324|NCT00852917|559326865|FG001|Overall Study|Physician Decision|7|||
154973325|NCT00852917|559326866|FG002|Overall Study|Physician Decision|2|||
154973326|NCT00852917|559326867|FG003|Overall Study|Physician Decision|19|||
154973327|NCT00852917|559326864|FG000|Overall Study|Death|0|||
154973328|NCT00852917|559326865|FG001|Overall Study|Death|0|||
154973329|NCT00852917|559326866|FG002|Overall Study|Death|0|||
154973330|NCT00852917|559326867|FG003|Overall Study|Death|1|||
154973331|NCT02575339|559326868|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
154973332|NCT02575339|559326869|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
154973333|NCT02575339|559326870|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
154973334|NCT02575339|559326868|FG000|Study Treatment|Disease Progression|5|||
154973335|NCT02575339|559326869|FG001|Study Treatment|Disease Progression|2|||
154973336|NCT02575339|559326870|FG002|Study Treatment|Disease Progression|0|||
154973337|NCT02575339|559326868|FG000|Study Treatment|Adverse Event|1|||
154973338|NCT02575339|559326869|FG001|Study Treatment|Adverse Event|2|||
154973339|NCT02575339|559326870|FG002|Study Treatment|Adverse Event|0|||
154973340|NCT02575339|559326868|FG000|Follow up|Death|6|||
154973341|NCT02575339|559326869|FG001|Follow up|Death|2|||
154865873|NCT00091793|558937505|FG001|Overall Study|Lost to Follow-up|5|||
154865874|NCT00091793|558937504|FG000|Overall Study|Noncompliance|2|||
154865875|NCT00091793|558937505|FG001|Overall Study|Noncompliance|0|||
154865876|NCT00091793|558937504|FG000|Overall Study|Other|2|||
154865877|NCT00091793|558937505|FG001|Overall Study|Other|0|||
154865878|NCT05309083|558937506|FG000|Overall Study|Withdrawal by Subject|2|||
154865879|NCT01184989|558937508|FG000|Overall Study|Adverse Event|11|||
154865880|NCT01184989|558937508|FG000|Overall Study|Withdrawal by Subject|1|||
154865881|NCT05370157|558937511|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
154973342|NCT02575339|559326870|FG002|Follow up|Death|0|||
154973343|NCT02575339|559326868|FG000|Follow up|Study Terminated|0|||
154865882|NCT05370157|558937512|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
154865883|NCT05370157|558937511|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
154865884|NCT05370157|558937512|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
154865885|NCT01508676|558937513|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
154865886|NCT01508676|558937514|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
154865887|NCT01508676|558937513|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
154865888|NCT01508676|558937514|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
154865889|NCT01508676|558937513|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
154865890|NCT01508676|558937514|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
154865891|NCT01508676|558937513|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
154865892|NCT01508676|558937514|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
154865893|NCT01508676|558937513|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
154865894|NCT01508676|558937514|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
154865895|NCT06129487|558937516|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
154865896|NCT06129487|558937517|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
154865897|NCT00587223|558937527|FG000|Overall Study|Adverse Event|1|||
154865898|NCT00195351|558937528|FG000|Overall Study|Lost to Follow-up|9|||
154865899|NCT00195351|558937529|FG001|Overall Study|Lost to Follow-up|9|||
154865900|NCT00195351|558937528|FG000|Overall Study|Withdrawal by Subject|6|||
154865901|NCT00195351|558937529|FG001|Overall Study|Withdrawal by Subject|3|||
154865902|NCT00195351|558937528|FG000|Overall Study|Protocol Deviation|3|||
154865903|NCT00195351|558937529|FG001|Overall Study|Protocol Deviation|2|||
154865904|NCT00195351|558937528|FG000|Overall Study|Death|3|||
154865905|NCT00195351|558937529|FG001|Overall Study|Death|1|||
154865906|NCT00195351|558937528|FG000|Overall Study|Lack of Efficacy|0|||
154865907|NCT00195351|558937529|FG001|Overall Study|Lack of Efficacy|1|||
154865908|NCT02111369|558937530|FG000|Overall Study|Lost to Follow-up|2|||
154865909|NCT02111369|558937530|FG000|Overall Study|Withdrawal by Subject|1|||
154865910|NCT00828451|558937535|FG000|Overall Study|Death|2|||
154865911|NCT00828451|558937535|FG000|Overall Study|Lack of intravenous line|7|||
154865912|NCT00828451|558937535|FG000|Overall Study|Withdrawal by Subject|1|||
154865913|NCT00828451|558937535|FG000|Overall Study|Deterioration in clinical status|1|||
154865914|NCT00095121|558937541|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
154865915|NCT00095121|558937542|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
154865916|NCT00095121|558937541|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
154865917|NCT00095121|558937542|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
154865918|NCT04358458|558937548|FG000|Overall Study|Death|1|||
154865919|NCT04358458|558937549|FG001|Overall Study|Death|1|||
154865920|NCT04358458|558937550|FG002|Overall Study|Death|3|||
154865921|NCT04358458|558937551|FG003|Overall Study|Death|8|||
154865922|NCT04358458|558937552|FG004|Overall Study|Death|1|||
154865923|NCT04358458|558937553|FG005|Overall Study|Death|6|||
154865924|NCT04358458|558937554|FG006|Overall Study|Death|2|||
154865925|NCT04358458|558937555|FG007|Overall Study|Death|3|||
154865926|NCT04358458|558937548|FG000|Overall Study|Lost to Follow-up|0|||
154865927|NCT04358458|558937549|FG001|Overall Study|Lost to Follow-up|0|||
154865928|NCT04358458|558937550|FG002|Overall Study|Lost to Follow-up|0|||
154865929|NCT04358458|558937551|FG003|Overall Study|Lost to Follow-up|0|||
154865930|NCT04358458|558937552|FG004|Overall Study|Lost to Follow-up|0|||
154865931|NCT04358458|558937553|FG005|Overall Study|Lost to Follow-up|0|||
154865932|NCT04358458|558937554|FG006|Overall Study|Lost to Follow-up|0|||
154865933|NCT04358458|558937555|FG007|Overall Study|Lost to Follow-up|1|||
154865934|NCT04358458|558937548|FG000|Overall Study|Site is closing study participation|0|||
154865935|NCT04358458|558937549|FG001|Overall Study|Site is closing study participation|0|||
154865936|NCT04358458|558937550|FG002|Overall Study|Site is closing study participation|0|||
154865937|NCT04358458|558937551|FG003|Overall Study|Site is closing study participation|1|||
154865938|NCT04358458|558937552|FG004|Overall Study|Site is closing study participation|0|||
154865939|NCT04358458|558937553|FG005|Overall Study|Site is closing study participation|0|||
154865940|NCT04358458|558937554|FG006|Overall Study|Site is closing study participation|0|||
154865941|NCT04358458|558937555|FG007|Overall Study|Site is closing study participation|0|||
154865942|NCT04358458|558937548|FG000|Overall Study|Sponsor request|2|||
154865943|NCT04358458|558937549|FG001|Overall Study|Sponsor request|3|||
154865944|NCT04358458|558937550|FG002|Overall Study|Sponsor request|3|||
154973344|NCT02575339|559326869|FG001|Follow up|Study Terminated|2|||
154865945|NCT04358458|558937551|FG003|Overall Study|Sponsor request|0|||
154865946|NCT04358458|558937552|FG004|Overall Study|Sponsor request|2|||
154865947|NCT04358458|558937553|FG005|Overall Study|Sponsor request|3|||
154865948|NCT04358458|558937554|FG006|Overall Study|Sponsor request|1|||
154865949|NCT04358458|558937555|FG007|Overall Study|Sponsor request|1|||
154865950|NCT04358458|558937548|FG000|Overall Study|Withdrawal by Subject|0|||
154865951|NCT04358458|558937549|FG001|Overall Study|Withdrawal by Subject|0|||
154865952|NCT04358458|558937550|FG002|Overall Study|Withdrawal by Subject|1|||
154865953|NCT04358458|558937551|FG003|Overall Study|Withdrawal by Subject|1|||
154865954|NCT04358458|558937552|FG004|Overall Study|Withdrawal by Subject|0|||
154865955|NCT04358458|558937553|FG005|Overall Study|Withdrawal by Subject|1|||
154865956|NCT04358458|558937554|FG006|Overall Study|Withdrawal by Subject|0|||
155174448|NCT03554486|560076700|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
155174449|NCT03554486|560076701|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
155174450|NCT03554486|560076702|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
155174451|NCT01616693|560076704|FG000|Evaluated for Safety|Physician Decision|1|||
155174452|NCT01616693|560076705|FG001|Evaluated for Safety|Physician Decision|0|||
155174453|NCT01616693|560076706|FG002|Evaluated for Safety|Physician Decision|1|||
155174454|NCT01616693|560076707|FG003|Evaluated for Safety|Physician Decision|0|||
155174455|NCT01616693|560076704|FG000|Received Both Vaccines|Adverse Event|2|||
155174456|NCT01616693|560076705|FG001|Received Both Vaccines|Adverse Event|0|||
155174457|NCT01616693|560076706|FG002|Received Both Vaccines|Adverse Event|0|||
155174458|NCT01616693|560076707|FG003|Received Both Vaccines|Adverse Event|0|||
155174459|NCT01616693|560076704|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
155174460|NCT01616693|560076705|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
155174461|NCT01616693|560076706|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
155174462|NCT01616693|560076707|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
155174463|NCT01616693|560076704|FG000|Received Both Vaccines|Lost to Follow-up|4|||
155174464|NCT01616693|560076705|FG001|Received Both Vaccines|Lost to Follow-up|3|||
155174465|NCT01616693|560076706|FG002|Received Both Vaccines|Lost to Follow-up|4|||
155174466|NCT01616693|560076707|FG003|Received Both Vaccines|Lost to Follow-up|4|||
155174467|NCT01616693|560076704|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
155174468|NCT01616693|560076705|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
155174469|NCT01616693|560076706|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
155174470|NCT01616693|560076707|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
155174471|NCT02925338|560076711|FG000|Overall Study|Death|0|||
155174472|NCT02925338|560076712|FG001|Overall Study|Death|2|||
155174473|NCT02925338|560076713|FG002|Overall Study|Death|1|||
155174474|NCT02925338|560076714|FG003|Overall Study|Death|0|||
155174475|NCT02925338|560076715|FG004|Overall Study|Death|0|||
155174476|NCT02925338|560076711|FG000|Overall Study|Lost to Follow-up|30|||
155174477|NCT02925338|560076712|FG001|Overall Study|Lost to Follow-up|10|||
155174478|NCT02925338|560076713|FG002|Overall Study|Lost to Follow-up|1|||
155174479|NCT02925338|560076714|FG003|Overall Study|Lost to Follow-up|16|||
155174480|NCT02925338|560076715|FG004|Overall Study|Lost to Follow-up|3|||
154865957|NCT04358458|558937555|FG007|Overall Study|Withdrawal by Subject|1|||
154865958|NCT04636177|558937556|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
154865959|NCT04636177|558937557|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
154865960|NCT04636177|558937556|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
154865961|NCT04636177|558937557|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
154865962|NCT04636177|558937556|FG000|Single-arm portion|Withdrawal by Subject|1|||
154865963|NCT04636177|558937557|FG001|Single-arm portion|Withdrawal by Subject|0|||
154865964|NCT04636177|558937556|FG000|Single-arm portion|Adverse Event|1|||
154865965|NCT04636177|558937557|FG001|Single-arm portion|Adverse Event|0|||
154865966|NCT02495077|558939570|FG000|Overall Study|Adverse Event|0|||
154865967|NCT02495077|558939571|FG001|Overall Study|Adverse Event|1|||
154865968|NCT02495077|558939572|FG002|Overall Study|Adverse Event|1|||
154865969|NCT02495077|558939573|FG003|Overall Study|Adverse Event|0|||
154865970|NCT02495077|558939570|FG000|Overall Study|Death|3|||
154865971|NCT02495077|558939571|FG001|Overall Study|Death|5|||
154865972|NCT02495077|558939572|FG002|Overall Study|Death|0|||
154865973|NCT02495077|558939573|FG003|Overall Study|Death|0|||
154865974|NCT02495077|558939570|FG000|Overall Study|Lost to Follow-up|6|||
154865975|NCT02495077|558939571|FG001|Overall Study|Lost to Follow-up|4|||
154865976|NCT02495077|558939572|FG002|Overall Study|Lost to Follow-up|0|||
154865977|NCT02495077|558939573|FG003|Overall Study|Lost to Follow-up|0|||
154865978|NCT02495077|558939570|FG000|Overall Study|Physician Decision|2|||
154865979|NCT02495077|558939571|FG001|Overall Study|Physician Decision|1|||
154865980|NCT02495077|558939572|FG002|Overall Study|Physician Decision|4|||
154865981|NCT02495077|558939573|FG003|Overall Study|Physician Decision|0|||
154865982|NCT02495077|558939570|FG000|Overall Study|Protocol Violation|0|||
154865983|NCT02495077|558939571|FG001|Overall Study|Protocol Violation|1|||
154865984|NCT02495077|558939572|FG002|Overall Study|Protocol Violation|0|||
154865985|NCT02495077|558939573|FG003|Overall Study|Protocol Violation|0|||
154865986|NCT02495077|558939570|FG000|Overall Study|Screen Failure|0|||
154865987|NCT02495077|558939571|FG001|Overall Study|Screen Failure|0|||
154865988|NCT02495077|558939572|FG002|Overall Study|Screen Failure|0|||
154865989|NCT02495077|558939573|FG003|Overall Study|Screen Failure|48|||
154865990|NCT02495077|558939570|FG000|Overall Study|Withdrawal by Subject|7|||
154865991|NCT02495077|558939571|FG001|Overall Study|Withdrawal by Subject|7|||
154865992|NCT02495077|558939572|FG002|Overall Study|Withdrawal by Subject|7|||
154865993|NCT02495077|558939573|FG003|Overall Study|Withdrawal by Subject|0|||
154865994|NCT02495077|558939570|FG000|Overall Study|Covid-19 research restrictions|1|||
155174481|NCT02925338|560076711|FG000|Overall Study|Withdrawal by Subject|3|||
155174482|NCT02925338|560076712|FG001|Overall Study|Withdrawal by Subject|0|||
155174483|NCT02925338|560076713|FG002|Overall Study|Withdrawal by Subject|3|||
155174484|NCT02925338|560076714|FG003|Overall Study|Withdrawal by Subject|2|||
155174485|NCT02925338|560076715|FG004|Overall Study|Withdrawal by Subject|2|||
155174486|NCT02925338|560076711|FG000|Overall Study|Missing|38|||
154865995|NCT02495077|558939571|FG001|Overall Study|Covid-19 research restrictions|0|||
154865996|NCT02495077|558939572|FG002|Overall Study|Covid-19 research restrictions|0|||
154865997|NCT02495077|558939573|FG003|Overall Study|Covid-19 research restrictions|0|||
154865998|NCT02495077|558939570|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
154865999|NCT02495077|558939571|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
154866000|NCT02495077|558939572|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
154866001|NCT02495077|558939573|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
154866002|NCT02495077|558939570|FG000|Overall Study|Incarcerated|0|||
154866003|NCT02495077|558939571|FG001|Overall Study|Incarcerated|1|||
154866004|NCT02495077|558939572|FG002|Overall Study|Incarcerated|0|||
154866005|NCT02495077|558939573|FG003|Overall Study|Incarcerated|0|||
154866006|NCT02495077|558939570|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
154866007|NCT02495077|558939571|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
154866008|NCT02495077|558939572|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
154866009|NCT02495077|558939573|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
154866010|NCT02495077|558939570|FG000|Overall Study|Timing of transplant and randomization|0|||
154866011|NCT02495077|558939571|FG001|Overall Study|Timing of transplant and randomization|0|||
154866012|NCT02495077|558939572|FG002|Overall Study|Timing of transplant and randomization|5|||
154866013|NCT02495077|558939573|FG003|Overall Study|Timing of transplant and randomization|0|||
154866014|NCT02742649|558939574|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
154866015|NCT02742649|558939575|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
154866016|NCT02742649|558939576|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
154866017|NCT02742649|558939577|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
154866018|NCT02742649|558939578|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
154866019|NCT02742649|558939574|FG000|Double-Blind Treatment Period|Adverse Event|0|||
154866020|NCT02742649|558939575|FG001|Double-Blind Treatment Period|Adverse Event|1|||
154866021|NCT02742649|558939576|FG002|Double-Blind Treatment Period|Adverse Event|0|||
154866022|NCT02742649|558939577|FG003|Double-Blind Treatment Period|Adverse Event|0|||
154866023|NCT02742649|558939578|FG004|Double-Blind Treatment Period|Adverse Event|0|||
154866024|NCT02742649|558939574|FG000|Open-Label Period|Lost to Follow-up|0|||
154866025|NCT02742649|558939575|FG001|Open-Label Period|Lost to Follow-up|0|||
154866026|NCT02742649|558939576|FG002|Open-Label Period|Lost to Follow-up|0|||
154866027|NCT02742649|558939577|FG003|Open-Label Period|Lost to Follow-up|0|||
154866028|NCT02742649|558939578|FG004|Open-Label Period|Lost to Follow-up|1|||
154866029|NCT03167619|558939582|FG000|Overall Study|Death|11|||
154866030|NCT03167619|558939583|FG001|Overall Study|Death|8|||
154866031|NCT03167619|558939582|FG000|Overall Study|Withdrawal by Subject|1|||
154866032|NCT03167619|558939583|FG001|Overall Study|Withdrawal by Subject|2|||
154866033|NCT03167619|558939582|FG000|Overall Study|Physician Decision|0|||
154866034|NCT03167619|558939583|FG001|Overall Study|Physician Decision|1|||
154866035|NCT02082184|558939585|FG000|Overall Study|Adverse Event|1|||
154866036|NCT02082184|558939586|FG001|Overall Study|Adverse Event|0|||
154866037|NCT02082184|558939585|FG000|Overall Study|Medical diagnosis|1|||
154866038|NCT02082184|558939586|FG001|Overall Study|Medical diagnosis|2|||
154866039|NCT02082184|558939585|FG000|Overall Study|Device associated symptoms|5|||
154866040|NCT02082184|558939586|FG001|Overall Study|Device associated symptoms|0|||
154866041|NCT02082184|558939585|FG000|Overall Study|Withdrawal by Subject|3|||
154866042|NCT02082184|558939586|FG001|Overall Study|Withdrawal by Subject|2|||
154866043|NCT02082184|558939585|FG000|Overall Study|Protocol Violation|0|||
154866044|NCT02082184|558939586|FG001|Overall Study|Protocol Violation|6|||
154866045|NCT02082184|558939585|FG000|Overall Study|Lost to Follow-up|0|||
154866046|NCT02082184|558939586|FG001|Overall Study|Lost to Follow-up|2|||
154866047|NCT02082184|558939585|FG000|Overall Study|Subject non-compliance|0|||
154866048|NCT02082184|558939586|FG001|Overall Study|Subject non-compliance|1|||
154866049|NCT02413398|558939589|FG000|Overall Study|Lost to Follow-up|2|||
154866050|NCT02413398|558939590|FG001|Overall Study|Lost to Follow-up|4|||
154866051|NCT02413398|558939589|FG000|Overall Study|Withdrawal by Subject|1|||
154866052|NCT02413398|558939590|FG001|Overall Study|Withdrawal by Subject|1|||
154866053|NCT02413398|558939589|FG000|Overall Study|Other Eligibility criteria|1|||
154866054|NCT02413398|558939590|FG001|Overall Study|Other Eligibility criteria|2|||
154866055|NCT00537940|558939593|FG000|Overall Study|Adverse Event|20|||
155109326|NCT02846389|559828466|FG000|Overall Study|Withdrawal by Subject|1|||
155109327|NCT02846389|559828467|FG001|Overall Study|Withdrawal by Subject|1|||
155109328|NCT03818607|559828468|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
155109329|NCT03818607|559828469|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
154866056|NCT00537940|558939594|FG001|Overall Study|Adverse Event|19|||
155109330|NCT03818607|559828468|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
154866057|NCT00537940|558939593|FG000|Overall Study|Lack of Efficacy|8|||
154866058|NCT00537940|558939594|FG001|Overall Study|Lack of Efficacy|16|||
154866059|NCT00537940|558939593|FG000|Overall Study|Lost to Follow-up|23|||
154866060|NCT00537940|558939594|FG001|Overall Study|Lost to Follow-up|29|||
154866061|NCT00537940|558939593|FG000|Overall Study|Withdrawal by Subject|113|||
155109331|NCT03818607|559828469|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
154866062|NCT00537940|558939594|FG001|Overall Study|Withdrawal by Subject|95|||
154866063|NCT00537940|558939593|FG000|Overall Study|Protocol Violation|6|||
154866064|NCT00537940|558939594|FG001|Overall Study|Protocol Violation|4|||
154866065|NCT00537940|558939593|FG000|Overall Study|Pregnancy|1|||
154866066|NCT00537940|558939594|FG001|Overall Study|Pregnancy|1|||
154866067|NCT00537940|558939593|FG000|Overall Study|Study terminated by sponsor|2|||
154866068|NCT00537940|558939594|FG001|Overall Study|Study terminated by sponsor|3|||
154866069|NCT00537940|558939593|FG000|Overall Study|Other|10|||
154866070|NCT00537940|558939594|FG001|Overall Study|Other|12|||
154866071|NCT03715465|558939596|FG000|Overall Study|Withdrawal by Subject|1|||
154866072|NCT03715465|558939597|FG001|Overall Study|Withdrawal by Subject|2|||
154866073|NCT01389128|558939601|FG000|Overall Study|Fetal distress|1|||
154866074|NCT01389128|558939602|FG001|Overall Study|Fetal distress|0|||
154866075|NCT01389128|558939601|FG000|Overall Study|Cervix dilation stop|1|||
154866076|NCT01389128|558939602|FG001|Overall Study|Cervix dilation stop|2|||
154866077|NCT01389128|558939601|FG000|Overall Study|Rapid labor evolution|3|||
154866078|NCT01389128|558939602|FG001|Overall Study|Rapid labor evolution|2|||
154866079|NCT01389128|558939601|FG000|Overall Study|Intolerance to procedure|0|||
154866080|NCT01389128|558939602|FG001|Overall Study|Intolerance to procedure|2|||
154866081|NCT00756002|558939604|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
154866082|NCT00756002|558939605|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
154866083|NCT00756002|558939604|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
154866084|NCT00756002|558939605|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
154866085|NCT00756002|558939604|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
154866086|NCT00756002|558939605|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
154866087|NCT00756002|558939604|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
154866088|NCT00756002|558939605|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
154866089|NCT00756002|558939604|FG000|Double-Blind Treatment Period|Other|2|||
154866090|NCT00756002|558939605|FG001|Double-Blind Treatment Period|Other|2|||
154866091|NCT04329923|558939606|FG000|Overall Study|Withdrawal by Subject|1|||
154866092|NCT04329923|558939607|FG001|Overall Study|Withdrawal by Subject|4|||
154866093|NCT04329923|558939608|FG002|Overall Study|Withdrawal by Subject|1|||
154866094|NCT04329923|558939609|FG003|Overall Study|Withdrawal by Subject|1|||
154866095|NCT04329923|558939610|FG004|Overall Study|Withdrawal by Subject|1|||
154866096|NCT04329923|558939611|FG005|Overall Study|Withdrawal by Subject|1|||
154866097|NCT04329923|558939606|FG000|Overall Study|early termination of study|0|||
154866098|NCT04329923|558939607|FG001|Overall Study|early termination of study|0|||
154866099|NCT04329923|558939608|FG002|Overall Study|early termination of study|0|||
154866100|NCT04329923|558939609|FG003|Overall Study|early termination of study|0|||
154866101|NCT04329923|558939610|FG004|Overall Study|early termination of study|1|||
154866102|NCT04329923|558939611|FG005|Overall Study|early termination of study|2|||
154866103|NCT04329923|558939606|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
154866104|NCT04329923|558939607|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
154866105|NCT04329923|558939608|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
154866106|NCT04329923|558939609|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
154866107|NCT04329923|558939610|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
154866108|NCT04329923|558939611|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
154866109|NCT03334214|558939612|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
154866110|NCT03334214|558939613|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
154866111|NCT03334214|558939612|FG000|Overall Study|Withdrawal by Subject|0|||
154866112|NCT03334214|558939613|FG001|Overall Study|Withdrawal by Subject|1|||
154866113|NCT03334214|558939612|FG000|Overall Study|Other|1|||
154866114|NCT03334214|558939613|FG001|Overall Study|Other|0|||
154866115|NCT00550238|558939621|FG000|Overall Study|Adverse Event|88|||
154866116|NCT00550238|558939621|FG000|Overall Study|Death|34|||
154866117|NCT00550238|558939621|FG000|Overall Study|Disease progression|46|||
154866118|NCT00550238|558939621|FG000|Overall Study|Withdrawal by Subject|167|||
154866119|NCT00550238|558939621|FG000|Overall Study|Physician Decision|31|||
154866120|NCT00550238|558939621|FG000|Overall Study|Patient noncompliance|25|||
154866121|NCT00550238|558939621|FG000|Overall Study|Lost to Follow-up|13|||
154866122|NCT00550238|558939621|FG000|Overall Study|Sponsor decision|55|||
154866123|NCT01486238|558939623|FG000|Overall Study|Death|0|||
154866124|NCT01486238|558939624|FG001|Overall Study|Death|2|||
154866125|NCT01486238|558939623|FG000|Overall Study|Withdrawal by Subject|2|||
154866126|NCT01486238|558939624|FG001|Overall Study|Withdrawal by Subject|1|||
154866127|NCT01486238|558939623|FG000|Overall Study|Lost to Follow-up|0|||
154866128|NCT01486238|558939624|FG001|Overall Study|Lost to Follow-up|3|||
154866129|NCT01050062|558939625|FG000|Overall Study|Adverse Event|75|||
154866130|NCT01050062|558939626|FG001|Overall Study|Adverse Event|22|||
154866131|NCT01050062|558939625|FG000|Overall Study|Lost to Follow-up|83|||
154866132|NCT01050062|558939626|FG001|Overall Study|Lost to Follow-up|35|||
154866133|NCT01050062|558939625|FG000|Overall Study|Lack of Efficacy|22|||
154866134|NCT01050062|558939626|FG001|Overall Study|Lack of Efficacy|35|||
154866135|NCT01050062|558939625|FG000|Overall Study|Physician Decision|74|||
154866136|NCT01050062|558939626|FG001|Overall Study|Physician Decision|9|||
154866137|NCT01050062|558939625|FG000|Overall Study|Others|17|||
154866138|NCT01050062|558939626|FG001|Overall Study|Others|11|||
154866139|NCT01570491|558939628|FG000|Overall Study|Lost to Follow-up|3|||
154866140|NCT01570491|558939629|FG001|Overall Study|Lost to Follow-up|1|||
154866141|NCT01570491|558939628|FG000|Overall Study|treatment: not given or discontinued|2|||
154866142|NCT01570491|558939629|FG001|Overall Study|treatment: not given or discontinued|0|||
154866143|NCT00754390|558939633|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
154866144|NCT00754390|558939633|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
154866145|NCT00754390|558939633|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
154866146|NCT00754390|558939633|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
154866147|NCT00847613|558939634|FG000|Overall Study|Ongoing at cut-off date|250|||
154866148|NCT00847613|558939635|FG001|Overall Study|Ongoing at cut-off date|265|||
154866149|NCT00847613|558939636|FG002|Overall Study|Ongoing at cut-off date|64|||
154866150|NCT00847613|558939637|FG003|Overall Study|Ongoing at cut-off date|64|||
154866151|NCT00847613|558939634|FG000|Overall Study|Death|1|||
154866152|NCT00847613|558939635|FG001|Overall Study|Death|1|||
154866153|NCT00847613|558939636|FG002|Overall Study|Death|0|||
154866154|NCT00847613|558939637|FG003|Overall Study|Death|0|||
154866155|NCT00847613|558939634|FG000|Overall Study|Adverse Event|36|||
154866156|NCT00847613|558939635|FG001|Overall Study|Adverse Event|26|||
154866157|NCT00847613|558939636|FG002|Overall Study|Adverse Event|5|||
154866158|NCT00847613|558939637|FG003|Overall Study|Adverse Event|6|||
154866159|NCT00847613|558939634|FG000|Overall Study|Lack of Efficacy|7|||
154866160|NCT00847613|558939635|FG001|Overall Study|Lack of Efficacy|3|||
154866161|NCT00847613|558939636|FG002|Overall Study|Lack of Efficacy|3|||
154866162|NCT00847613|558939637|FG003|Overall Study|Lack of Efficacy|1|||
154866163|NCT00847613|558939634|FG000|Overall Study|Study terminated by Sponsor|1|||
154866164|NCT00847613|558939635|FG001|Overall Study|Study terminated by Sponsor|0|||
154866165|NCT00847613|558939636|FG002|Overall Study|Study terminated by Sponsor|2|||
154866166|NCT00847613|558939637|FG003|Overall Study|Study terminated by Sponsor|1|||
154866167|NCT00847613|558939634|FG000|Overall Study|Lost to Follow-up|5|||
154866168|NCT00847613|558939635|FG001|Overall Study|Lost to Follow-up|0|||
154866169|NCT00847613|558939636|FG002|Overall Study|Lost to Follow-up|0|||
154866170|NCT00847613|558939637|FG003|Overall Study|Lost to Follow-up|3|||
154866171|NCT00847613|558939634|FG000|Overall Study|Protocol Violation|6|||
154866172|NCT00847613|558939635|FG001|Overall Study|Protocol Violation|6|||
154866173|NCT00847613|558939636|FG002|Overall Study|Protocol Violation|3|||
154866174|NCT00847613|558939637|FG003|Overall Study|Protocol Violation|1|||
154866175|NCT00847613|558939634|FG000|Overall Study|Pregnancy|1|||
154866176|NCT00847613|558939635|FG001|Overall Study|Pregnancy|1|||
154866177|NCT00847613|558939636|FG002|Overall Study|Pregnancy|0|||
154866178|NCT00847613|558939637|FG003|Overall Study|Pregnancy|0|||
154866179|NCT00847613|558939634|FG000|Overall Study|Site closure|1|||
154866180|NCT00847613|558939635|FG001|Overall Study|Site closure|0|||
154866181|NCT00847613|558939636|FG002|Overall Study|Site closure|0|||
154866182|NCT00847613|558939637|FG003|Overall Study|Site closure|1|||
154866183|NCT00847613|558939634|FG000|Overall Study|Withdrawal by Subject|8|||
154866184|NCT00847613|558939635|FG001|Overall Study|Withdrawal by Subject|11|||
154866185|NCT00847613|558939636|FG002|Overall Study|Withdrawal by Subject|2|||
154866186|NCT00847613|558939637|FG003|Overall Study|Withdrawal by Subject|2|||
154866187|NCT00847613|558939634|FG000|Overall Study|Participant moved|4|||
154866188|NCT00847613|558939635|FG001|Overall Study|Participant moved|1|||
154866189|NCT00847613|558939636|FG002|Overall Study|Participant moved|0|||
154866190|NCT00847613|558939637|FG003|Overall Study|Participant moved|0|||
154866191|NCT00847613|558939634|FG000|Overall Study|Sponsor request|0|||
154866192|NCT00847613|558939635|FG001|Overall Study|Sponsor request|1|||
154866193|NCT00847613|558939636|FG002|Overall Study|Sponsor request|0|||
154866194|NCT00847613|558939637|FG003|Overall Study|Sponsor request|0|||
154866195|NCT00847613|558939634|FG000|Overall Study|Randomized, but not treated|0|||
154866196|NCT00847613|558939635|FG001|Overall Study|Randomized, but not treated|3|||
154866197|NCT00847613|558939636|FG002|Overall Study|Randomized, but not treated|0|||
154866198|NCT00847613|558939637|FG003|Overall Study|Randomized, but not treated|0|||
154866199|NCT00847613|558939634|FG000|Overall Study|Other|1|||
154866200|NCT00847613|558939635|FG001|Overall Study|Other|1|||
154866201|NCT00847613|558939636|FG002|Overall Study|Other|2|||
154866202|NCT00847613|558939637|FG003|Overall Study|Other|0|||
154866203|NCT00845429|558939638|FG000|Overall Study|Protocol Violation|5|||
154866204|NCT00845429|558939639|FG001|Overall Study|Protocol Violation|4|||
154866205|NCT00845429|558939640|FG002|Overall Study|Protocol Violation|7|||
154866206|NCT00845429|558939638|FG000|Overall Study|Lost to Follow-up|7|||
154866207|NCT00845429|558939639|FG001|Overall Study|Lost to Follow-up|9|||
154866208|NCT00845429|558939640|FG002|Overall Study|Lost to Follow-up|10|||
154866209|NCT00845429|558939638|FG000|Overall Study|Withdrawal by Subject|2|||
154866210|NCT00845429|558939639|FG001|Overall Study|Withdrawal by Subject|2|||
154866211|NCT00845429|558939640|FG002|Overall Study|Withdrawal by Subject|2|||
154866212|NCT00845429|558939638|FG000|Overall Study|Serious adverse event|0|||
154866213|NCT00845429|558939639|FG001|Overall Study|Serious adverse event|0|||
154866214|NCT00845429|558939640|FG002|Overall Study|Serious adverse event|1|||
154866215|NCT01480180|558939643|FG000|Main Phase|Withdrawal criteria|12|||
154866216|NCT01480180|558939644|FG001|Main Phase|Withdrawal criteria|1|||
154866217|NCT01480180|558939645|FG002|Main Phase|Withdrawal criteria|0|||
154866218|NCT01480180|558939646|FG003|Main Phase|Withdrawal criteria|0|||
154866219|NCT01480180|558939647|FG004|Main Phase|Withdrawal criteria|0|||
154866220|NCT01480180|558939648|FG005|Main Phase|Withdrawal criteria|0|||
154866221|NCT01480180|558939643|FG000|Main Phase|Lack of Efficacy|1|||
154866222|NCT01480180|558939644|FG001|Main Phase|Lack of Efficacy|0|||
154866223|NCT01480180|558939645|FG002|Main Phase|Lack of Efficacy|0|||
154866224|NCT01480180|558939646|FG003|Main Phase|Lack of Efficacy|0|||
154866225|NCT01480180|558939647|FG004|Main Phase|Lack of Efficacy|0|||
154866226|NCT01480180|558939648|FG005|Main Phase|Lack of Efficacy|0|||
154866227|NCT01480180|558939643|FG000|Main Phase|Non-compliance|3|||
154866228|NCT01480180|558939644|FG001|Main Phase|Non-compliance|0|||
154866229|NCT01480180|558939645|FG002|Main Phase|Non-compliance|0|||
154866230|NCT01480180|558939646|FG003|Main Phase|Non-compliance|0|||
154866231|NCT01480180|558939647|FG004|Main Phase|Non-compliance|0|||
154866232|NCT01480180|558939648|FG005|Main Phase|Non-compliance|0|||
154866233|NCT01480180|558939643|FG000|Main Phase|Unclassified|3|||
154866234|NCT01480180|558939644|FG001|Main Phase|Unclassified|0|||
154866235|NCT01480180|558939645|FG002|Main Phase|Unclassified|0|||
154866236|NCT01480180|558939646|FG003|Main Phase|Unclassified|0|||
154866237|NCT01480180|558939647|FG004|Main Phase|Unclassified|0|||
154866238|NCT01480180|558939648|FG005|Main Phase|Unclassified|0|||
154866239|NCT01480180|558939643|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
154866240|NCT01480180|558939644|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
154866241|NCT01480180|558939645|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
154866242|NCT01480180|558939646|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
154866243|NCT01480180|558939647|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
154866244|NCT01480180|558939648|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
154866245|NCT01480180|558939643|FG000|Extension Phase, Part 1|Unclassified|0|||
154866246|NCT01480180|558939644|FG001|Extension Phase, Part 1|Unclassified|0|||
154866247|NCT01480180|558939645|FG002|Extension Phase, Part 1|Unclassified|1|||
154866248|NCT01480180|558939646|FG003|Extension Phase, Part 1|Unclassified|0|||
154866249|NCT01480180|558939647|FG004|Extension Phase, Part 1|Unclassified|0|||
154866250|NCT01480180|558939648|FG005|Extension Phase, Part 1|Unclassified|0|||
154866251|NCT01480180|558939643|FG000|Extension Phase, Part 1|Adverse Event|0|||
154866252|NCT01480180|558939644|FG001|Extension Phase, Part 1|Adverse Event|0|||
154866253|NCT01480180|558939645|FG002|Extension Phase, Part 1|Adverse Event|4|||
154866254|NCT01480180|558939646|FG003|Extension Phase, Part 1|Adverse Event|1|||
154866255|NCT01480180|558939647|FG004|Extension Phase, Part 1|Adverse Event|0|||
154866256|NCT01480180|558939648|FG005|Extension Phase, Part 1|Adverse Event|0|||
154866257|NCT01480180|558939643|FG000|Extension Phase, Part 1|Change of treatment|0|||
154866258|NCT01480180|558939644|FG001|Extension Phase, Part 1|Change of treatment|0|||
154866259|NCT01480180|558939645|FG002|Extension Phase, Part 1|Change of treatment|0|||
154866260|NCT01480180|558939646|FG003|Extension Phase, Part 1|Change of treatment|9|||
154866261|NCT01480180|558939647|FG004|Extension Phase, Part 1|Change of treatment|0|||
154866262|NCT01480180|558939648|FG005|Extension Phase, Part 1|Change of treatment|0|||
154866263|NCT01480180|558939643|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
154866264|NCT01480180|558939644|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
154866265|NCT01480180|558939645|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
154866266|NCT01480180|558939646|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
154866267|NCT01480180|558939647|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
154866268|NCT01480180|558939648|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
154866269|NCT01480180|558939643|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
154866270|NCT01480180|558939644|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
154866271|NCT01480180|558939645|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
154866272|NCT01480180|558939646|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
154866273|NCT01480180|558939647|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
154866274|NCT01480180|558939648|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
154866275|NCT01480180|558939643|FG000|Extension Phase, Part 2|Unclassified|0|||
154866276|NCT01480180|558939644|FG001|Extension Phase, Part 2|Unclassified|0|||
154866277|NCT01480180|558939645|FG002|Extension Phase, Part 2|Unclassified|3|||
154866278|NCT01480180|558939646|FG003|Extension Phase, Part 2|Unclassified|1|||
154866279|NCT01480180|558939647|FG004|Extension Phase, Part 2|Unclassified|1|||
154866280|NCT01480180|558939648|FG005|Extension Phase, Part 2|Unclassified|0|||
154866281|NCT04222725|558939649|FG000|Overall Study|Adverse Event|0|||
154866282|NCT04222725|558939650|FG001|Overall Study|Adverse Event|1|||
154866283|NCT04222725|558939651|FG002|Overall Study|Adverse Event|0|||
154866284|NCT04222725|558939652|FG003|Overall Study|Adverse Event|0|||
154866285|NCT00658333|558939653|FG000|Overall Study|Adverse Event|2|||
154866286|NCT00658333|558939654|FG001|Overall Study|Adverse Event|1|||
154866287|NCT03519178|558939655|FG000|PF-06873600 Treatment|Adverse Event|0|||
154866288|NCT03519178|558939656|FG001|PF-06873600 Treatment|Adverse Event|0|||
154866289|NCT03519178|558939657|FG002|PF-06873600 Treatment|Adverse Event|0|||
154866290|NCT03519178|558939658|FG003|PF-06873600 Treatment|Adverse Event|0|||
154866291|NCT03519178|558939659|FG004|PF-06873600 Treatment|Adverse Event|0|||
154866292|NCT03519178|558939660|FG005|PF-06873600 Treatment|Adverse Event|0|||
154866293|NCT03519178|558939661|FG006|PF-06873600 Treatment|Adverse Event|0|||
154866294|NCT03519178|558939662|FG007|PF-06873600 Treatment|Adverse Event|2|||
155174487|NCT02925338|560076712|FG001|Overall Study|Missing|27|||
155174488|NCT02925338|560076713|FG002|Overall Study|Missing|0|||
155174489|NCT02925338|560076714|FG003|Overall Study|Missing|3|||
155174490|NCT02925338|560076715|FG004|Overall Study|Missing|2|||
155174491|NCT02925338|560076711|FG000|Overall Study|Participant's Decision|11|||
155174492|NCT02925338|560076712|FG001|Overall Study|Participant's Decision|7|||
155174493|NCT02925338|560076713|FG002|Overall Study|Participant's Decision|3|||
155174494|NCT02925338|560076714|FG003|Overall Study|Participant's Decision|8|||
155174495|NCT02925338|560076715|FG004|Overall Study|Participant's Decision|1|||
155174496|NCT02925338|560076711|FG000|Overall Study|Treatment Discontinuation|144|||
155174497|NCT02925338|560076712|FG001|Overall Study|Treatment Discontinuation|65|||
155174498|NCT02925338|560076713|FG002|Overall Study|Treatment Discontinuation|56|||
155174499|NCT02925338|560076714|FG003|Overall Study|Treatment Discontinuation|131|||
155174500|NCT02925338|560076715|FG004|Overall Study|Treatment Discontinuation|22|||
155174501|NCT00029146|560076720|FG000|Overall Study|Lost to Follow-up|2|||
155174502|NCT00029146|560076721|FG001|Overall Study|Lost to Follow-up|1|||
155174503|NCT01765218|560076722|FG000|Overall Study|Protocol Violation|1|||
155174504|NCT01765218|560076723|FG001|Overall Study|Protocol Violation|2|||
154866295|NCT03519178|558939663|FG008|PF-06873600 Treatment|Adverse Event|1|||
154866296|NCT03519178|558939664|FG009|PF-06873600 Treatment|Adverse Event|0|||
154866297|NCT03519178|558939665|FG010|PF-06873600 Treatment|Adverse Event|0|||
154866298|NCT03519178|558939666|FG011|PF-06873600 Treatment|Adverse Event|0|||
154866299|NCT03519178|558939667|FG012|PF-06873600 Treatment|Adverse Event|1|||
154866300|NCT03519178|558939668|FG013|PF-06873600 Treatment|Adverse Event|3|||
154866301|NCT03519178|558939669|FG014|PF-06873600 Treatment|Adverse Event|2|||
154866302|NCT03519178|558939655|FG000|PF-06873600 Treatment|Death|0|||
154866303|NCT03519178|558939656|FG001|PF-06873600 Treatment|Death|0|||
154866304|NCT03519178|558939657|FG002|PF-06873600 Treatment|Death|0|||
154866305|NCT03519178|558939658|FG003|PF-06873600 Treatment|Death|0|||
154866306|NCT03519178|558939659|FG004|PF-06873600 Treatment|Death|0|||
154866307|NCT03519178|558939660|FG005|PF-06873600 Treatment|Death|0|||
154866308|NCT03519178|558939661|FG006|PF-06873600 Treatment|Death|0|||
154866309|NCT03519178|558939662|FG007|PF-06873600 Treatment|Death|0|||
154866310|NCT03519178|558939663|FG008|PF-06873600 Treatment|Death|1|||
154866311|NCT03519178|558939664|FG009|PF-06873600 Treatment|Death|1|||
154866312|NCT03519178|558939665|FG010|PF-06873600 Treatment|Death|0|||
154866313|NCT03519178|558939666|FG011|PF-06873600 Treatment|Death|0|||
154866314|NCT03519178|558939667|FG012|PF-06873600 Treatment|Death|0|||
154866315|NCT03519178|558939668|FG013|PF-06873600 Treatment|Death|0|||
154866316|NCT03519178|558939669|FG014|PF-06873600 Treatment|Death|1|||
154866317|NCT03519178|558939655|FG000|PF-06873600 Treatment|Physician Decision|0|||
154866318|NCT03519178|558939656|FG001|PF-06873600 Treatment|Physician Decision|0|||
154866319|NCT03519178|558939657|FG002|PF-06873600 Treatment|Physician Decision|0|||
154866320|NCT03519178|558939658|FG003|PF-06873600 Treatment|Physician Decision|0|||
154866321|NCT03519178|558939659|FG004|PF-06873600 Treatment|Physician Decision|0|||
154866322|NCT03519178|558939660|FG005|PF-06873600 Treatment|Physician Decision|0|||
154866323|NCT03519178|558939661|FG006|PF-06873600 Treatment|Physician Decision|0|||
154866324|NCT03519178|558939662|FG007|PF-06873600 Treatment|Physician Decision|1|||
154866325|NCT03519178|558939663|FG008|PF-06873600 Treatment|Physician Decision|0|||
154866326|NCT03519178|558939664|FG009|PF-06873600 Treatment|Physician Decision|0|||
154866327|NCT03519178|558939665|FG010|PF-06873600 Treatment|Physician Decision|1|||
154866328|NCT03519178|558939666|FG011|PF-06873600 Treatment|Physician Decision|0|||
154866329|NCT03519178|558939667|FG012|PF-06873600 Treatment|Physician Decision|0|||
154866330|NCT03519178|558939668|FG013|PF-06873600 Treatment|Physician Decision|4|||
154866331|NCT03519178|558939669|FG014|PF-06873600 Treatment|Physician Decision|1|||
154866332|NCT03519178|558939655|FG000|PF-06873600 Treatment|Progressive disease|1|||
154973345|NCT02575339|559326870|FG002|Follow up|Study Terminated|0|||
155174505|NCT01011309|560076724|FG000|Overall Study|Adverse Event|2|||
155174506|NCT01011309|560076725|FG001|Overall Study|Adverse Event|1|||
155174507|NCT01011309|560076726|FG002|Overall Study|Adverse Event|2|||
155174508|NCT01011309|560076724|FG000|Overall Study|Lack of Efficacy|0|||
155174509|NCT01011309|560076725|FG001|Overall Study|Lack of Efficacy|1|||
155174510|NCT01011309|560076726|FG002|Overall Study|Lack of Efficacy|0|||
154866333|NCT03519178|558939656|FG001|PF-06873600 Treatment|Progressive disease|1|||
154866334|NCT03519178|558939657|FG002|PF-06873600 Treatment|Progressive disease|1|||
154866335|NCT03519178|558939658|FG003|PF-06873600 Treatment|Progressive disease|1|||
154866336|NCT03519178|558939659|FG004|PF-06873600 Treatment|Progressive disease|6|||
154866337|NCT03519178|558939660|FG005|PF-06873600 Treatment|Progressive disease|7|||
155174511|NCT01011309|560076724|FG000|Overall Study|Protocol Violation|0|||
154866338|NCT03519178|558939661|FG006|PF-06873600 Treatment|Progressive disease|3|||
154866339|NCT03519178|558939662|FG007|PF-06873600 Treatment|Progressive disease|7|||
154866340|NCT03519178|558939663|FG008|PF-06873600 Treatment|Progressive disease|3|||
154866341|NCT03519178|558939664|FG009|PF-06873600 Treatment|Progressive disease|5|||
155174512|NCT01011309|560076725|FG001|Overall Study|Protocol Violation|1|||
155174513|NCT01011309|560076726|FG002|Overall Study|Protocol Violation|3|||
155174514|NCT05092360|560076736|FG000|Overall Study|Withdrawal by Subject|21|||
155174515|NCT05092360|560076737|FG001|Overall Study|Withdrawal by Subject|4|||
155174516|NCT05092360|560076738|FG002|Overall Study|Withdrawal by Subject|9|||
154866342|NCT03519178|558939665|FG010|PF-06873600 Treatment|Progressive disease|4|||
154866343|NCT03519178|558939666|FG011|PF-06873600 Treatment|Progressive disease|3|||
154866344|NCT03519178|558939667|FG012|PF-06873600 Treatment|Progressive disease|4|||
154866345|NCT03519178|558939668|FG013|PF-06873600 Treatment|Progressive disease|28|||
154866346|NCT03519178|558939669|FG014|PF-06873600 Treatment|Progressive disease|8|||
154866347|NCT03519178|558939655|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
154866348|NCT03519178|558939656|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
154866349|NCT03519178|558939657|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
154866350|NCT03519178|558939658|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
154866351|NCT03519178|558939659|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
154866352|NCT03519178|558939660|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
154866353|NCT03519178|558939661|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
154866354|NCT03519178|558939662|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
154866355|NCT03519178|558939663|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
154866356|NCT03519178|558939664|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
154866357|NCT03519178|558939665|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
154866358|NCT03519178|558939666|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
154866359|NCT03519178|558939667|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
154866360|NCT03519178|558939668|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
154866361|NCT03519178|558939669|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
154866362|NCT03519178|558939655|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
154866363|NCT03519178|558939656|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
154866364|NCT03519178|558939657|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
154866365|NCT03519178|558939658|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
154866366|NCT03519178|558939659|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
154866367|NCT03519178|558939660|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
154866368|NCT03519178|558939661|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
154866369|NCT03519178|558939662|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
154866370|NCT03519178|558939663|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
154866371|NCT03519178|558939664|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
154866372|NCT03519178|558939665|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
154866373|NCT03519178|558939666|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
154866374|NCT03519178|558939667|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
154866375|NCT03519178|558939668|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
154866376|NCT03519178|558939669|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
154866377|NCT03519178|558939655|FG000|PF-06873600 Treatment|Refused further treatment|0|||
154866378|NCT03519178|558939656|FG001|PF-06873600 Treatment|Refused further treatment|1|||
154866379|NCT03519178|558939657|FG002|PF-06873600 Treatment|Refused further treatment|0|||
154866380|NCT03519178|558939658|FG003|PF-06873600 Treatment|Refused further treatment|0|||
154866381|NCT03519178|558939659|FG004|PF-06873600 Treatment|Refused further treatment|1|||
154866382|NCT03519178|558939660|FG005|PF-06873600 Treatment|Refused further treatment|0|||
154866383|NCT03519178|558939661|FG006|PF-06873600 Treatment|Refused further treatment|0|||
154866384|NCT03519178|558939662|FG007|PF-06873600 Treatment|Refused further treatment|0|||
154866385|NCT03519178|558939663|FG008|PF-06873600 Treatment|Refused further treatment|0|||
154866386|NCT03519178|558939664|FG009|PF-06873600 Treatment|Refused further treatment|0|||
154866387|NCT03519178|558939665|FG010|PF-06873600 Treatment|Refused further treatment|0|||
154866388|NCT03519178|558939666|FG011|PF-06873600 Treatment|Refused further treatment|0|||
154866389|NCT03519178|558939667|FG012|PF-06873600 Treatment|Refused further treatment|0|||
154866390|NCT03519178|558939668|FG013|PF-06873600 Treatment|Refused further treatment|0|||
154866391|NCT03519178|558939669|FG014|PF-06873600 Treatment|Refused further treatment|1|||
154866392|NCT03519178|558939655|FG000|PF-06873600 Treatment|Other|0|||
154866393|NCT03519178|558939656|FG001|PF-06873600 Treatment|Other|0|||
154866394|NCT03519178|558939657|FG002|PF-06873600 Treatment|Other|0|||
154866395|NCT03519178|558939658|FG003|PF-06873600 Treatment|Other|0|||
154866396|NCT03519178|558939659|FG004|PF-06873600 Treatment|Other|0|||
154866397|NCT03519178|558939660|FG005|PF-06873600 Treatment|Other|0|||
154866398|NCT03519178|558939661|FG006|PF-06873600 Treatment|Other|0|||
154866399|NCT03519178|558939662|FG007|PF-06873600 Treatment|Other|0|||
154866400|NCT03519178|558939663|FG008|PF-06873600 Treatment|Other|1|||
154866401|NCT03519178|558939664|FG009|PF-06873600 Treatment|Other|0|||
154866402|NCT03519178|558939665|FG010|PF-06873600 Treatment|Other|0|||
154866403|NCT03519178|558939666|FG011|PF-06873600 Treatment|Other|0|||
154866404|NCT03519178|558939667|FG012|PF-06873600 Treatment|Other|0|||
154866405|NCT03519178|558939668|FG013|PF-06873600 Treatment|Other|1|||
154866406|NCT03519178|558939669|FG014|PF-06873600 Treatment|Other|3|||
154866407|NCT03519178|558939655|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
154866408|NCT03519178|558939656|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
154866409|NCT03519178|558939657|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
154866410|NCT03519178|558939658|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
154866411|NCT03519178|558939659|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
154866412|NCT03519178|558939660|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
154866413|NCT03519178|558939661|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
154866414|NCT03519178|558939662|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
154866415|NCT03519178|558939663|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
154866416|NCT03519178|558939664|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
154866417|NCT03519178|558939665|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
154866418|NCT03519178|558939666|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
154866419|NCT03519178|558939667|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
154866420|NCT03519178|558939668|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
154866421|NCT03519178|558939669|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
154866422|NCT03519178|558939655|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866423|NCT03519178|558939656|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866424|NCT03519178|558939657|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866425|NCT03519178|558939658|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866426|NCT03519178|558939659|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866427|NCT03519178|558939660|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866428|NCT03519178|558939661|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866429|NCT03519178|558939662|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866430|NCT03519178|558939663|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866431|NCT03519178|558939664|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866432|NCT03519178|558939665|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866433|NCT03519178|558939666|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866434|NCT03519178|558939667|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
154866435|NCT03519178|558939668|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
154866436|NCT03519178|558939669|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
154866437|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Adverse Event|0|||
154866438|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Adverse Event|0|||
154866439|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Adverse Event|0|||
154866440|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Adverse Event|0|||
154866441|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Adverse Event|0|||
154866442|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Adverse Event|0|||
154866443|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Adverse Event|0|||
154866444|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Adverse Event|0|||
154866445|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Adverse Event|0|||
154866446|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Adverse Event|0|||
154866447|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Adverse Event|0|||
154866448|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Adverse Event|0|||
154866449|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Adverse Event|0|||
154866450|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Adverse Event|1|||
154866451|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Adverse Event|0|||
154866452|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Death|0|||
154866453|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Death|0|||
154866454|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Death|0|||
154866455|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Death|0|||
154866456|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Death|0|||
154866457|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Death|0|||
154866458|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Death|0|||
154866459|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Death|0|||
154866460|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Death|0|||
154866461|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Death|1|||
154866462|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Death|0|||
154866463|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Death|0|||
154866464|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Death|0|||
154866465|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Death|0|||
154866466|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Death|1|||
155109332|NCT03818607|559828468|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
155109333|NCT03818607|559828469|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
155109334|NCT02249091|559828471|FG000|Overall Study|Lack of Efficacy|8|||
155109335|NCT02249091|559828472|FG001|Overall Study|Lack of Efficacy|3|||
155109336|NCT02249091|559828471|FG000|Overall Study|Physician Decision|4|||
154866467|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866468|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866469|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866470|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866471|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866472|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866473|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866474|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866475|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866476|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
155109337|NCT02249091|559828472|FG001|Overall Study|Physician Decision|1|||
155109338|NCT02249091|559828471|FG000|Overall Study|Withdrawal by Subject|2|||
154866477|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866478|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866479|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866480|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
154866481|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
154866482|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Physician Decision|0|||
154866483|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Physician Decision|0|||
154866484|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Physician Decision|0|||
154866485|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Physician Decision|0|||
154866486|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Physician Decision|0|||
154866487|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Physician Decision|0|||
154866488|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Physician Decision|0|||
154866489|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Physician Decision|0|||
154866490|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Physician Decision|0|||
154866491|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Physician Decision|0|||
154866492|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Physician Decision|0|||
154866493|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Physician Decision|0|||
154866494|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Physician Decision|0|||
154866495|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Physician Decision|4|||
154866496|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Physician Decision|2|||
154866497|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Progressive disease|0|||
154866498|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Progressive disease|0|||
154866499|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Progressive disease|0|||
154866500|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Progressive disease|0|||
154866501|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Progressive disease|0|||
154866502|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Progressive disease|0|||
154866503|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Progressive disease|0|||
154866504|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Progressive disease|0|||
154866505|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Progressive disease|0|||
154866506|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Progressive disease|5|||
154866507|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Progressive disease|0|||
154866508|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Progressive disease|0|||
154866509|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Progressive disease|0|||
154866510|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Progressive disease|30|||
154866511|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Progressive disease|8|||
154866512|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866513|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866514|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866515|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866516|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866517|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866518|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866519|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866520|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866521|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866522|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866523|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866524|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
154866525|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
154866526|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
154866527|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866528|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866529|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866530|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866531|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866532|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866533|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866534|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866535|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866536|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
154866537|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866538|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866539|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
154866540|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
154866541|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
154866542|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866543|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866544|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866545|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866546|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866547|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866548|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
154973346|NCT02575339|559326868|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
154866549|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866550|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866551|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
154866552|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866553|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866554|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866555|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
154866556|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
154866557|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
154866558|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
154866559|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
154866560|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
154866561|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
154866562|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
154866563|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
154866564|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
154866565|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
154866566|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
154866567|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
154866568|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
154866569|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
154866570|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
154866571|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
154866572|NCT03519178|558939655|FG000|Fulvestrant. Treatment|Other|0|||
154866573|NCT03519178|558939656|FG001|Fulvestrant. Treatment|Other|0|||
154866574|NCT03519178|558939657|FG002|Fulvestrant. Treatment|Other|0|||
154866575|NCT03519178|558939658|FG003|Fulvestrant. Treatment|Other|0|||
154866576|NCT03519178|558939659|FG004|Fulvestrant. Treatment|Other|0|||
154866577|NCT03519178|558939660|FG005|Fulvestrant. Treatment|Other|0|||
154866578|NCT03519178|558939661|FG006|Fulvestrant. Treatment|Other|0|||
154866579|NCT03519178|558939662|FG007|Fulvestrant. Treatment|Other|0|||
154866580|NCT03519178|558939663|FG008|Fulvestrant. Treatment|Other|0|||
154866581|NCT03519178|558939664|FG009|Fulvestrant. Treatment|Other|0|||
154866582|NCT03519178|558939665|FG010|Fulvestrant. Treatment|Other|0|||
154866583|NCT03519178|558939666|FG011|Fulvestrant. Treatment|Other|0|||
154866584|NCT03519178|558939667|FG012|Fulvestrant. Treatment|Other|0|||
154866585|NCT03519178|558939668|FG013|Fulvestrant. Treatment|Other|1|||
154866586|NCT03519178|558939669|FG014|Fulvestrant. Treatment|Other|3|||
154866587|NCT03519178|558939655|FG000|Letrozole Treatment|Physician Decision|0|||
154866588|NCT03519178|558939656|FG001|Letrozole Treatment|Physician Decision|0|||
154866589|NCT03519178|558939657|FG002|Letrozole Treatment|Physician Decision|0|||
154866590|NCT03519178|558939658|FG003|Letrozole Treatment|Physician Decision|0|||
154866591|NCT03519178|558939659|FG004|Letrozole Treatment|Physician Decision|0|||
154866592|NCT03519178|558939660|FG005|Letrozole Treatment|Physician Decision|0|||
154866593|NCT03519178|558939661|FG006|Letrozole Treatment|Physician Decision|0|||
154866594|NCT03519178|558939662|FG007|Letrozole Treatment|Physician Decision|0|||
154866595|NCT03519178|558939663|FG008|Letrozole Treatment|Physician Decision|0|||
154866596|NCT03519178|558939664|FG009|Letrozole Treatment|Physician Decision|0|||
154866597|NCT03519178|558939665|FG010|Letrozole Treatment|Physician Decision|1|||
154866598|NCT03519178|558939666|FG011|Letrozole Treatment|Physician Decision|0|||
154866599|NCT03519178|558939667|FG012|Letrozole Treatment|Physician Decision|0|||
154866600|NCT03519178|558939668|FG013|Letrozole Treatment|Physician Decision|0|||
154866601|NCT03519178|558939669|FG014|Letrozole Treatment|Physician Decision|0|||
154866602|NCT03519178|558939655|FG000|Letrozole Treatment|Progressive disease|0|||
154866603|NCT03519178|558939656|FG001|Letrozole Treatment|Progressive disease|0|||
154866604|NCT03519178|558939657|FG002|Letrozole Treatment|Progressive disease|0|||
154866605|NCT03519178|558939658|FG003|Letrozole Treatment|Progressive disease|0|||
154866606|NCT03519178|558939659|FG004|Letrozole Treatment|Progressive disease|0|||
154866607|NCT03519178|558939660|FG005|Letrozole Treatment|Progressive disease|0|||
154973347|NCT02575339|559326869|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
154973348|NCT02575339|559326870|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
154866608|NCT03519178|558939661|FG006|Letrozole Treatment|Progressive disease|0|||
154866609|NCT03519178|558939662|FG007|Letrozole Treatment|Progressive disease|0|||
154866610|NCT03519178|558939663|FG008|Letrozole Treatment|Progressive disease|0|||
154866611|NCT03519178|558939664|FG009|Letrozole Treatment|Progressive disease|0|||
154866612|NCT03519178|558939665|FG010|Letrozole Treatment|Progressive disease|4|||
154866613|NCT03519178|558939666|FG011|Letrozole Treatment|Progressive disease|0|||
154973349|NCT01358877|559326871|FG000|Overall Study|Withdrawal by Subject|475|||
154973350|NCT01358877|559326872|FG001|Overall Study|Withdrawal by Subject|466|||
154866614|NCT03519178|558939667|FG012|Letrozole Treatment|Progressive disease|0|||
154866615|NCT03519178|558939668|FG013|Letrozole Treatment|Progressive disease|0|||
155109339|NCT02249091|559828472|FG001|Overall Study|Withdrawal by Subject|2|||
154866616|NCT03519178|558939669|FG014|Letrozole Treatment|Progressive disease|0|||
154866617|NCT03519178|558939655|FG000|Letrozole Treatment|Global deterioration of health status|0|||
154866618|NCT03519178|558939656|FG001|Letrozole Treatment|Global deterioration of health status|0|||
154866619|NCT03519178|558939657|FG002|Letrozole Treatment|Global deterioration of health status|0|||
154866620|NCT03519178|558939658|FG003|Letrozole Treatment|Global deterioration of health status|0|||
154866621|NCT03519178|558939659|FG004|Letrozole Treatment|Global deterioration of health status|0|||
154866622|NCT03519178|558939660|FG005|Letrozole Treatment|Global deterioration of health status|0|||
154866623|NCT03519178|558939661|FG006|Letrozole Treatment|Global deterioration of health status|0|||
154866624|NCT03519178|558939662|FG007|Letrozole Treatment|Global deterioration of health status|0|||
154866625|NCT03519178|558939663|FG008|Letrozole Treatment|Global deterioration of health status|0|||
154866626|NCT03519178|558939664|FG009|Letrozole Treatment|Global deterioration of health status|0|||
154866627|NCT03519178|558939665|FG010|Letrozole Treatment|Global deterioration of health status|2|||
154866628|NCT03519178|558939666|FG011|Letrozole Treatment|Global deterioration of health status|0|||
154866629|NCT03519178|558939667|FG012|Letrozole Treatment|Global deterioration of health status|0|||
154866630|NCT03519178|558939668|FG013|Letrozole Treatment|Global deterioration of health status|0|||
154866631|NCT03519178|558939669|FG014|Letrozole Treatment|Global deterioration of health status|0|||
154866632|NCT03519178|558939655|FG000|Follow-Up|Death|0|||
154866633|NCT03519178|558939656|FG001|Follow-Up|Death|0|||
154866634|NCT03519178|558939657|FG002|Follow-Up|Death|0|||
154866635|NCT03519178|558939658|FG003|Follow-Up|Death|0|||
154866636|NCT03519178|558939659|FG004|Follow-Up|Death|0|||
154866637|NCT03519178|558939660|FG005|Follow-Up|Death|0|||
154866638|NCT03519178|558939661|FG006|Follow-Up|Death|0|||
154866639|NCT03519178|558939662|FG007|Follow-Up|Death|0|||
154866640|NCT03519178|558939663|FG008|Follow-Up|Death|3|||
154866641|NCT03519178|558939664|FG009|Follow-Up|Death|1|||
154866642|NCT03519178|558939665|FG010|Follow-Up|Death|0|||
154866643|NCT03519178|558939666|FG011|Follow-Up|Death|0|||
154866644|NCT03519178|558939667|FG012|Follow-Up|Death|2|||
154866645|NCT03519178|558939668|FG013|Follow-Up|Death|0|||
154866646|NCT03519178|558939669|FG014|Follow-Up|Death|0|||
154866647|NCT03519178|558939655|FG000|Follow-Up|Lost to Follow-up|0|||
154866648|NCT03519178|558939656|FG001|Follow-Up|Lost to Follow-up|0|||
154866649|NCT03519178|558939657|FG002|Follow-Up|Lost to Follow-up|0|||
154866650|NCT03519178|558939658|FG003|Follow-Up|Lost to Follow-up|0|||
154866651|NCT03519178|558939659|FG004|Follow-Up|Lost to Follow-up|0|||
154866652|NCT03519178|558939660|FG005|Follow-Up|Lost to Follow-up|3|||
154866653|NCT03519178|558939661|FG006|Follow-Up|Lost to Follow-up|1|||
154866654|NCT03519178|558939662|FG007|Follow-Up|Lost to Follow-up|4|||
154866655|NCT03519178|558939663|FG008|Follow-Up|Lost to Follow-up|1|||
154866656|NCT03519178|558939664|FG009|Follow-Up|Lost to Follow-up|0|||
154866657|NCT03519178|558939665|FG010|Follow-Up|Lost to Follow-up|0|||
154866658|NCT03519178|558939666|FG011|Follow-Up|Lost to Follow-up|0|||
154866659|NCT03519178|558939667|FG012|Follow-Up|Lost to Follow-up|0|||
154866660|NCT03519178|558939668|FG013|Follow-Up|Lost to Follow-up|0|||
154866661|NCT03519178|558939669|FG014|Follow-Up|Lost to Follow-up|0|||
154866662|NCT03519178|558939655|FG000|Follow-Up|Withdrawal by Subject|1|||
154866663|NCT03519178|558939656|FG001|Follow-Up|Withdrawal by Subject|2|||
154866664|NCT03519178|558939657|FG002|Follow-Up|Withdrawal by Subject|2|||
154866665|NCT03519178|558939658|FG003|Follow-Up|Withdrawal by Subject|3|||
154866666|NCT03519178|558939659|FG004|Follow-Up|Withdrawal by Subject|5|||
154866667|NCT03519178|558939660|FG005|Follow-Up|Withdrawal by Subject|1|||
154866668|NCT03519178|558939661|FG006|Follow-Up|Withdrawal by Subject|2|||
154866669|NCT03519178|558939662|FG007|Follow-Up|Withdrawal by Subject|6|||
154866670|NCT03519178|558939663|FG008|Follow-Up|Withdrawal by Subject|5|||
154866671|NCT03519178|558939664|FG009|Follow-Up|Withdrawal by Subject|2|||
154866672|NCT03519178|558939665|FG010|Follow-Up|Withdrawal by Subject|3|||
154866673|NCT03519178|558939666|FG011|Follow-Up|Withdrawal by Subject|5|||
154866674|NCT03519178|558939667|FG012|Follow-Up|Withdrawal by Subject|2|||
154866675|NCT03519178|558939668|FG013|Follow-Up|Withdrawal by Subject|0|||
154866676|NCT03519178|558939669|FG014|Follow-Up|Withdrawal by Subject|0|||
154866677|NCT03519178|558939655|FG000|Follow-Up|Other|0|||
154866678|NCT03519178|558939656|FG001|Follow-Up|Other|0|||
154866679|NCT03519178|558939657|FG002|Follow-Up|Other|0|||
154866680|NCT03519178|558939658|FG003|Follow-Up|Other|0|||
154866681|NCT03519178|558939659|FG004|Follow-Up|Other|0|||
154866682|NCT03519178|558939660|FG005|Follow-Up|Other|0|||
154866683|NCT03519178|558939661|FG006|Follow-Up|Other|0|||
154866684|NCT03519178|558939662|FG007|Follow-Up|Other|1|||
154866685|NCT03519178|558939663|FG008|Follow-Up|Other|0|||
154866686|NCT03519178|558939664|FG009|Follow-Up|Other|0|||
154866687|NCT03519178|558939665|FG010|Follow-Up|Other|0|||
154866688|NCT03519178|558939666|FG011|Follow-Up|Other|0|||
154866689|NCT03519178|558939667|FG012|Follow-Up|Other|0|||
154866690|NCT03519178|558939668|FG013|Follow-Up|Other|0|||
155109340|NCT02249091|559828471|FG000|Overall Study|Death|3|||
154866691|NCT03519178|558939669|FG014|Follow-Up|Other|0|||
154866692|NCT03519178|558939655|FG000|Long-term Follow-up|Death|0|||
154866693|NCT03519178|558939656|FG001|Long-term Follow-up|Death|0|||
154866694|NCT03519178|558939657|FG002|Long-term Follow-up|Death|0|||
154866695|NCT03519178|558939658|FG003|Long-term Follow-up|Death|0|||
154866696|NCT03519178|558939659|FG004|Long-term Follow-up|Death|0|||
154866697|NCT03519178|558939660|FG005|Long-term Follow-up|Death|0|||
154866698|NCT03519178|558939661|FG006|Long-term Follow-up|Death|0|||
154866699|NCT03519178|558939662|FG007|Long-term Follow-up|Death|0|||
154866700|NCT03519178|558939663|FG008|Long-term Follow-up|Death|0|||
154866701|NCT03519178|558939664|FG009|Long-term Follow-up|Death|0|||
154866702|NCT03519178|558939665|FG010|Long-term Follow-up|Death|0|||
154866703|NCT03519178|558939666|FG011|Long-term Follow-up|Death|0|||
154866704|NCT03519178|558939667|FG012|Long-term Follow-up|Death|0|||
154866705|NCT03519178|558939668|FG013|Long-term Follow-up|Death|4|||
154866706|NCT03519178|558939669|FG014|Long-term Follow-up|Death|4|||
154866707|NCT03519178|558939655|FG000|Long-term Follow-up|Lost to Follow-up|0|||
154866708|NCT03519178|558939656|FG001|Long-term Follow-up|Lost to Follow-up|0|||
154866709|NCT03519178|558939657|FG002|Long-term Follow-up|Lost to Follow-up|0|||
154866710|NCT03519178|558939658|FG003|Long-term Follow-up|Lost to Follow-up|0|||
154866711|NCT03519178|558939659|FG004|Long-term Follow-up|Lost to Follow-up|0|||
154866712|NCT03519178|558939660|FG005|Long-term Follow-up|Lost to Follow-up|0|||
154866713|NCT03519178|558939661|FG006|Long-term Follow-up|Lost to Follow-up|0|||
154866714|NCT03519178|558939662|FG007|Long-term Follow-up|Lost to Follow-up|0|||
154866715|NCT03519178|558939663|FG008|Long-term Follow-up|Lost to Follow-up|0|||
154866716|NCT03519178|558939664|FG009|Long-term Follow-up|Lost to Follow-up|0|||
154866717|NCT03519178|558939665|FG010|Long-term Follow-up|Lost to Follow-up|0|||
154866718|NCT03519178|558939666|FG011|Long-term Follow-up|Lost to Follow-up|0|||
154866719|NCT03519178|558939667|FG012|Long-term Follow-up|Lost to Follow-up|0|||
154866720|NCT03519178|558939668|FG013|Long-term Follow-up|Lost to Follow-up|1|||
154866721|NCT03519178|558939669|FG014|Long-term Follow-up|Lost to Follow-up|1|||
154866722|NCT03519178|558939655|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
154866723|NCT03519178|558939656|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
154866724|NCT03519178|558939657|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
154866725|NCT03519178|558939658|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
154866726|NCT03519178|558939659|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
154866727|NCT03519178|558939660|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
154866728|NCT03519178|558939661|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
154866729|NCT03519178|558939662|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
154866730|NCT03519178|558939663|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
154866731|NCT03519178|558939664|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
154866732|NCT03519178|558939665|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
154866733|NCT03519178|558939666|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
154866734|NCT03519178|558939667|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
154866735|NCT03519178|558939668|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
154866736|NCT03519178|558939669|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
154866737|NCT03519178|558939655|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
154866738|NCT03519178|558939656|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
154866739|NCT03519178|558939657|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
154866740|NCT03519178|558939658|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
154866741|NCT03519178|558939659|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
154866742|NCT03519178|558939660|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
154866743|NCT03519178|558939661|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
154866744|NCT03519178|558939662|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
154866745|NCT03519178|558939663|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
154866746|NCT03519178|558939664|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
154866747|NCT03519178|558939665|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
154866748|NCT03519178|558939666|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
154866749|NCT03519178|558939667|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
154866750|NCT03519178|558939668|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
154866751|NCT03519178|558939669|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
154866752|NCT03519178|558939655|FG000|Long-term Follow-up|Other|0|||
154866753|NCT03519178|558939656|FG001|Long-term Follow-up|Other|0|||
154866754|NCT03519178|558939657|FG002|Long-term Follow-up|Other|0|||
154866755|NCT03519178|558939658|FG003|Long-term Follow-up|Other|0|||
154866756|NCT03519178|558939659|FG004|Long-term Follow-up|Other|0|||
154866757|NCT03519178|558939660|FG005|Long-term Follow-up|Other|0|||
155109341|NCT02249091|559828472|FG001|Overall Study|Death|4|||
154866758|NCT03519178|558939661|FG006|Long-term Follow-up|Other|0|||
154866759|NCT03519178|558939662|FG007|Long-term Follow-up|Other|0|||
154866760|NCT03519178|558939663|FG008|Long-term Follow-up|Other|0|||
154866761|NCT03519178|558939664|FG009|Long-term Follow-up|Other|0|||
154866762|NCT03519178|558939665|FG010|Long-term Follow-up|Other|0|||
154866763|NCT03519178|558939666|FG011|Long-term Follow-up|Other|0|||
154866764|NCT03519178|558939667|FG012|Long-term Follow-up|Other|0|||
154866765|NCT03519178|558939668|FG013|Long-term Follow-up|Other|0|||
154866766|NCT03519178|558939669|FG014|Long-term Follow-up|Other|1|||
154866767|NCT03519178|558939655|FG000|Long-term Follow-up|Global deterioration of health status|0|||
154866768|NCT03519178|558939656|FG001|Long-term Follow-up|Global deterioration of health status|0|||
154866769|NCT03519178|558939657|FG002|Long-term Follow-up|Global deterioration of health status|0|||
154866770|NCT03519178|558939658|FG003|Long-term Follow-up|Global deterioration of health status|0|||
155109342|NCT02249091|559828471|FG000|Overall Study|Adverse Event|1|||
155109343|NCT02249091|559828472|FG001|Overall Study|Adverse Event|0|||
155109344|NCT02249091|559828471|FG000|Overall Study|Stable disease with following SCT|0|||
155109345|NCT02249091|559828472|FG001|Overall Study|Stable disease with following SCT|1|||
154866771|NCT03519178|558939659|FG004|Long-term Follow-up|Global deterioration of health status|0|||
154866772|NCT03519178|558939660|FG005|Long-term Follow-up|Global deterioration of health status|0|||
154866773|NCT03519178|558939661|FG006|Long-term Follow-up|Global deterioration of health status|0|||
154866774|NCT03519178|558939662|FG007|Long-term Follow-up|Global deterioration of health status|0|||
154866775|NCT03519178|558939663|FG008|Long-term Follow-up|Global deterioration of health status|0|||
154866776|NCT03519178|558939664|FG009|Long-term Follow-up|Global deterioration of health status|0|||
154866777|NCT03519178|558939665|FG010|Long-term Follow-up|Global deterioration of health status|0|||
154866778|NCT03519178|558939666|FG011|Long-term Follow-up|Global deterioration of health status|0|||
154866779|NCT03519178|558939667|FG012|Long-term Follow-up|Global deterioration of health status|0|||
154866780|NCT03519178|558939668|FG013|Long-term Follow-up|Global deterioration of health status|1|||
154866781|NCT03519178|558939669|FG014|Long-term Follow-up|Global deterioration of health status|0|||
154866782|NCT03256539|558939672|FG000|Overall Study|Withdrawal by Subject|0|||
154866783|NCT03256539|558939673|FG001|Overall Study|Withdrawal by Subject|3|||
154866784|NCT03256539|558939672|FG000|Overall Study|Unexpected closure of study components|8|||
154866785|NCT03256539|558939673|FG001|Overall Study|Unexpected closure of study components|4|||
154866786|NCT05755438|558939676|FG000|12-week DBVC Period|Adverse Event|4|||
154866787|NCT05755438|558939677|FG001|12-week DBVC Period|Adverse Event|1|||
154866788|NCT05755438|558939676|FG000|12-week DBVC Period|Physician Decision|1|||
154866789|NCT05755438|558939677|FG001|12-week DBVC Period|Physician Decision|1|||
154866790|NCT05755438|558939676|FG000|12-week DBVC Period|Protocol Violation|4|||
154866791|NCT05755438|558939677|FG001|12-week DBVC Period|Protocol Violation|2|||
154866792|NCT05755438|558939676|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
154866793|NCT05755438|558939677|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
154866794|NCT05755438|558939676|FG000|12-week DBVC Period|Sponsor Decision|1|||
154866795|NCT05755438|558939677|FG001|12-week DBVC Period|Sponsor Decision|0|||
154866796|NCT05755438|558939676|FG000|40-week OLE Period|Adverse Event|0|||
154866797|NCT05755438|558939677|FG001|40-week OLE Period|Adverse Event|2|||
154866798|NCT05755438|558939676|FG000|40-week OLE Period|Lack of Efficacy|1|||
154866799|NCT05755438|558939677|FG001|40-week OLE Period|Lack of Efficacy|1|||
154866800|NCT05755438|558939676|FG000|40-week OLE Period|Lost to Follow-up|1|||
154866801|NCT05755438|558939677|FG001|40-week OLE Period|Lost to Follow-up|0|||
154866802|NCT05755438|558939676|FG000|40-week OLE Period|Physician Decision|1|||
154866803|NCT05755438|558939677|FG001|40-week OLE Period|Physician Decision|1|||
154866804|NCT05755438|558939676|FG000|40-week OLE Period|Protocol Violation|1|||
154866805|NCT05755438|558939677|FG001|40-week OLE Period|Protocol Violation|1|||
154866806|NCT05755438|558939676|FG000|40-week OLE Period|Withdrawal by Subject|6|||
154866807|NCT05755438|558939677|FG001|40-week OLE Period|Withdrawal by Subject|6|||
154866808|NCT05755438|558939676|FG000|40-week OLE Period|Sponsor Decision|3|||
154866809|NCT05755438|558939677|FG001|40-week OLE Period|Sponsor Decision|0|||
154866810|NCT05755438|558939676|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
154866811|NCT05755438|558939677|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
154866812|NCT05755438|558939676|FG000|40-week OLE Period|Ongoing|46|||
154866813|NCT05755438|558939677|FG001|40-week OLE Period|Ongoing|58|||
154866814|NCT03914300|558939679|FG000|Overall Study|Adverse Event|1|||
154866815|NCT00624338|558939688|FG000|Overall Study|Adverse Event|14|||
154866816|NCT00624338|558939689|FG001|Overall Study|Adverse Event|14|||
154866817|NCT00624338|558939690|FG002|Overall Study|Adverse Event|18|||
154866818|NCT00624338|558939688|FG000|Overall Study|Lost to Follow-up|1|||
154866819|NCT00624338|558939689|FG001|Overall Study|Lost to Follow-up|0|||
154866820|NCT00624338|558939690|FG002|Overall Study|Lost to Follow-up|0|||
154866821|NCT00624338|558939688|FG000|Overall Study|Lack of Efficacy|11|||
154866822|NCT00624338|558939689|FG001|Overall Study|Lack of Efficacy|3|||
154866823|NCT00624338|558939690|FG002|Overall Study|Lack of Efficacy|14|||
154866824|NCT00624338|558939688|FG000|Overall Study|Protocol Violation|3|||
154866825|NCT00624338|558939689|FG001|Overall Study|Protocol Violation|3|||
154866826|NCT00624338|558939690|FG002|Overall Study|Protocol Violation|2|||
154866827|NCT00624338|558939688|FG000|Overall Study|Death|0|||
154866828|NCT00624338|558939689|FG001|Overall Study|Death|2|||
154866829|NCT00624338|558939690|FG002|Overall Study|Death|0|||
154866830|NCT00624338|558939688|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
154866831|NCT00624338|558939689|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
154866832|NCT00624338|558939690|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
154866833|NCT00624338|558939688|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
154866834|NCT00624338|558939689|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
154866835|NCT00624338|558939690|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
154866836|NCT00624338|558939688|FG000|Overall Study|Other|15|||
154866837|NCT00624338|558939689|FG001|Overall Study|Other|5|||
154866838|NCT00624338|558939690|FG002|Overall Study|Other|9|||
154866839|NCT00624338|558939688|FG000|Overall Study|Randomized but not treated|2|||
154866840|NCT00624338|558939689|FG001|Overall Study|Randomized but not treated|1|||
154866841|NCT00624338|558939690|FG002|Overall Study|Randomized but not treated|3|||
154866842|NCT01548638|558939691|FG000|Overall Study|Protocol Violation|3|||
154866843|NCT01548638|558939691|FG000|Overall Study|Withdrawal by Subject|1|||
154866844|NCT01476787|558939695|FG000|Treatment|Progression|64|||
154866845|NCT01476787|558939696|FG001|Treatment|Progression|71|||
154866846|NCT01476787|558939695|FG000|Treatment|Toxicity|44|||
154866847|NCT01476787|558939696|FG001|Treatment|Toxicity|16|||
154866848|NCT01476787|558939695|FG000|Treatment|Death|0|||
154866849|NCT01476787|558939696|FG001|Treatment|Death|1|||
154866850|NCT01476787|558939695|FG000|Treatment|Withdrawal by Subject|3|||
154866851|NCT01476787|558939696|FG001|Treatment|Withdrawal by Subject|14|||
154866852|NCT01476787|558939695|FG000|Treatment|Major protocol violation|1|||
154866853|NCT01476787|558939696|FG001|Treatment|Major protocol violation|6|||
154866854|NCT01476787|558939695|FG000|Treatment|Other reasons|10|||
154866855|NCT01476787|558939696|FG001|Treatment|Other reasons|22|||
154866856|NCT01476787|558939695|FG000|Treatment|Concurrent illness|12|||
154866857|NCT01476787|558939696|FG001|Treatment|Concurrent illness|9|||
154866858|NCT01476787|558939695|FG000|Treatment|Insufficient response|15|||
154866859|NCT01476787|558939696|FG001|Treatment|Insufficient response|3|||
154866860|NCT01476787|558939695|FG000|Treatment|Voluntary treatment discontinuation|8|||
154866861|NCT01476787|558939696|FG001|Treatment|Voluntary treatment discontinuation|4|||
155109346|NCT02249091|559828471|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
155109347|NCT02249091|559828472|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
155109348|NCT02249091|559828471|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
155109349|NCT02249091|559828472|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
155109350|NCT02249091|559828471|FG000|Overall Study|Refractory AML|1|||
155109351|NCT02249091|559828472|FG001|Overall Study|Refractory AML|1|||
155109352|NCT02684617|559828473|FG000|Overall Study|Adverse Event|1|||
155109353|NCT02684617|559828474|FG001|Overall Study|Adverse Event|0|||
155109354|NCT02684617|559828475|FG002|Overall Study|Adverse Event|1|||
155109355|NCT02684617|559828473|FG000|Overall Study|Death|8|||
155109356|NCT02684617|559828474|FG001|Overall Study|Death|16|||
155109357|NCT02684617|559828475|FG002|Overall Study|Death|28|||
155109358|NCT02684617|559828473|FG000|Overall Study|Withdrawal by Subject|2|||
155109359|NCT02684617|559828474|FG001|Overall Study|Withdrawal by Subject|0|||
155109360|NCT02684617|559828475|FG002|Overall Study|Withdrawal by Subject|4|||
155109361|NCT02684617|559828473|FG000|Overall Study|Screen Failure|1|||
155109362|NCT02684617|559828474|FG001|Overall Study|Screen Failure|0|||
155109363|NCT02684617|559828475|FG002|Overall Study|Screen Failure|2|||
155109364|NCT02684617|559828473|FG000|Overall Study|Study Terminated by Sponsor|6|||
155109365|NCT02684617|559828474|FG001|Overall Study|Study Terminated by Sponsor|1|||
155109366|NCT02684617|559828475|FG002|Overall Study|Study Terminated by Sponsor|5|||
155109367|NCT02141399|559828476|FG000|Overall Study|Adverse Event|158|||
155109368|NCT02141399|559828476|FG000|Overall Study|Lack of Efficacy|62|||
155109369|NCT02141399|559828476|FG000|Overall Study|Lost to Follow-up|151|||
155109370|NCT02141399|559828476|FG000|Overall Study|Non-compliance with study drug|18|||
155109371|NCT02141399|559828476|FG000|Overall Study|Other|45|||
155109372|NCT02141399|559828476|FG000|Overall Study|Physician Decision|17|||
155109373|NCT02141399|559828476|FG000|Overall Study|Pregnancy|3|||
155109374|NCT02141399|559828476|FG000|Overall Study|Protocol Violation|38|||
155109375|NCT02141399|559828476|FG000|Overall Study|Withdrawal by Subject|238|||
155109376|NCT02141399|559828476|FG000|Overall Study|Failure to meet eligibility criteria|14|||
155109377|NCT00615719|559828477|FG000|Overall Study|Physician Decision|5|||
155109378|NCT02318368|559828478|FG000|Overall Study|Withdrawal by Subject|2|||
155109379|NCT02318368|559828479|FG001|Overall Study|Withdrawal by Subject|0|||
155109380|NCT02318368|559828478|FG000|Overall Study|Study terminated by the sponsor|5|||
155109381|NCT02318368|559828479|FG001|Overall Study|Study terminated by the sponsor|2|||
155109382|NCT02318368|559828478|FG000|Overall Study|Death|0|||
155109383|NCT02318368|559828479|FG001|Overall Study|Death|1|||
155109384|NCT00935493|559828480|FG000|Overall Study|Lost to Follow-up|1|||
155109385|NCT00935493|559828481|FG001|Overall Study|Lost to Follow-up|1|||
155109386|NCT00935493|559828482|FG002|Overall Study|Lost to Follow-up|1|||
155109387|NCT00935493|559828480|FG000|Overall Study|Treatment Discontinued|0|||
155109388|NCT00935493|559828481|FG001|Overall Study|Treatment Discontinued|1|||
155109389|NCT00935493|559828482|FG002|Overall Study|Treatment Discontinued|0|||
155109390|NCT02091362|559828489|FG000|Period 1|Protocol Violation|1|||
155109391|NCT02091362|559828490|FG001|Period 1|Protocol Violation|0|||
155109392|NCT02091362|559828489|FG000|Period 1|Withdrawal by Subject|2|||
155109393|NCT02091362|559828490|FG001|Period 1|Withdrawal by Subject|3|||
155109394|NCT02091362|559828489|FG000|Period 1|Lost to Follow-up|0|||
155109395|NCT02091362|559828490|FG001|Period 1|Lost to Follow-up|1|||
155109396|NCT02091362|559828489|FG000|Period 1|Adverse Event|2|||
155109397|NCT02091362|559828490|FG001|Period 1|Adverse Event|0|||
155109398|NCT02091362|559828489|FG000|Wash-out|Lost to Follow-up|1|||
155109399|NCT02091362|559828490|FG001|Wash-out|Lost to Follow-up|1|||
154866862|NCT01591330|558939697|FG000|Period 1|Adverse Event|1|||
154866863|NCT01591330|558939698|FG001|Period 1|Adverse Event|0|||
154866864|NCT01591330|558939699|FG002|Period 1|Adverse Event|0|||
155109400|NCT02091362|559828489|FG000|Wash-out|Withdrawal by Subject|0|||
155109401|NCT02091362|559828490|FG001|Wash-out|Withdrawal by Subject|2|||
155109402|NCT02091362|559828489|FG000|Period 2|Adverse Event|1|||
155109403|NCT02091362|559828490|FG001|Period 2|Adverse Event|0|||
154866865|NCT01591330|558939700|FG003|Period 1|Adverse Event|0|||
154866866|NCT01591330|558939697|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
154866867|NCT01591330|558939698|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
154866868|NCT01591330|558939699|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
154866869|NCT01591330|558939700|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
154866870|NCT01591330|558939697|FG000|Period 2|Adverse Event|1|||
154866871|NCT01591330|558939698|FG001|Period 2|Adverse Event|0|||
154866872|NCT01591330|558939699|FG002|Period 2|Adverse Event|0|||
154973351|NCT01358877|559326871|FG000|Overall Study|Recurrence of disease|181|||
154973352|NCT01358877|559326872|FG001|Overall Study|Recurrence of disease|269|||
154973353|NCT01358877|559326871|FG000|Overall Study|Lost to Follow-up|181|||
154973354|NCT01358877|559326872|FG001|Overall Study|Lost to Follow-up|176|||
154973355|NCT01358877|559326871|FG000|Overall Study|Death|41|||
154973356|NCT01358877|559326872|FG001|Overall Study|Death|46|||
154973357|NCT01358877|559326871|FG000|Overall Study|Adverse Event|39|||
154973358|NCT01358877|559326872|FG001|Overall Study|Adverse Event|42|||
154973359|NCT01358877|559326871|FG000|Overall Study|Physician Decision|43|||
154973360|NCT01358877|559326872|FG001|Overall Study|Physician Decision|32|||
154973361|NCT01358877|559326871|FG000|Overall Study|Contralateral breast cancer|42|||
154973362|NCT01358877|559326872|FG001|Overall Study|Contralateral breast cancer|28|||
154973363|NCT01358877|559326871|FG000|Overall Study|Reason not specified|37|||
154973364|NCT01358877|559326872|FG001|Overall Study|Reason not specified|29|||
154973365|NCT02510261|559326873|FG000|Overall Study|Adverse Event|5|||
154973366|NCT02510261|559326874|FG001|Overall Study|Adverse Event|8|||
154973367|NCT02510261|559326875|FG002|Overall Study|Adverse Event|0|||
154973368|NCT02510261|559326873|FG000|Overall Study|Physician Decision|1|||
154973369|NCT02510261|559326874|FG001|Overall Study|Physician Decision|5|||
154973370|NCT02510261|559326875|FG002|Overall Study|Physician Decision|0|||
154973371|NCT02510261|559326873|FG000|Overall Study|Death|19|||
154973372|NCT02510261|559326874|FG001|Overall Study|Death|19|||
154973373|NCT02510261|559326875|FG002|Overall Study|Death|0|||
154973374|NCT02510261|559326873|FG000|Overall Study|Withdrawal by Subject|3|||
154973375|NCT02510261|559326874|FG001|Overall Study|Withdrawal by Subject|10|||
154973376|NCT02510261|559326875|FG002|Overall Study|Withdrawal by Subject|3|||
154973377|NCT02003222|559326879|FG000|Induction|Never started treatment|0|||
154973378|NCT02003222|559326880|FG001|Induction|Never started treatment|0|||
154973379|NCT02003222|559326881|FG002|Induction|Never started treatment|0|||
154973380|NCT02003222|559326882|FG003|Induction|Never started treatment|0|||
154973381|NCT02003222|559326883|FG004|Induction|Never started treatment|8|||
154973382|NCT02003222|559326879|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
154973383|NCT02003222|559326880|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
154973384|NCT02003222|559326881|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
154973385|NCT02003222|559326882|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
154973386|NCT02003222|559326883|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
154973387|NCT02003222|559326879|FG000|Induction|Adverse Event|0|||
154973388|NCT02003222|559326880|FG001|Induction|Adverse Event|0|||
154973389|NCT02003222|559326881|FG002|Induction|Adverse Event|0|||
154973390|NCT02003222|559326882|FG003|Induction|Adverse Event|0|||
154973391|NCT02003222|559326883|FG004|Induction|Adverse Event|13|||
154973392|NCT02003222|559326879|FG000|Induction|Alternative therapy|0|||
154973393|NCT02003222|559326880|FG001|Induction|Alternative therapy|0|||
154973394|NCT02003222|559326881|FG002|Induction|Alternative therapy|0|||
154973395|NCT02003222|559326882|FG003|Induction|Alternative therapy|0|||
154973396|NCT02003222|559326883|FG004|Induction|Alternative therapy|12|||
154973397|NCT02003222|559326879|FG000|Induction|Disease progression|0|||
154973398|NCT02003222|559326880|FG001|Induction|Disease progression|0|||
154973399|NCT02003222|559326881|FG002|Induction|Disease progression|0|||
154973400|NCT02003222|559326882|FG003|Induction|Disease progression|0|||
154973401|NCT02003222|559326883|FG004|Induction|Disease progression|22|||
154973402|NCT02003222|559326879|FG000|Induction|Death|0|||
154866873|NCT01591330|558939700|FG003|Period 2|Adverse Event|0|||
154866874|NCT01919411|558939709|FG000|Overall Study|Lost to Follow-up|2|||
154866875|NCT01919411|558939710|FG001|Overall Study|Lost to Follow-up|4|||
154866876|NCT01919411|558939709|FG000|Overall Study|Physician Decision|1|||
154973403|NCT02003222|559326880|FG001|Induction|Death|0|||
154973404|NCT02003222|559326881|FG002|Induction|Death|0|||
154973405|NCT02003222|559326882|FG003|Induction|Death|0|||
154973406|NCT02003222|559326883|FG004|Induction|Death|3|||
154973407|NCT02003222|559326879|FG000|Induction|Withdrawal by Subject|0|||
154973408|NCT02003222|559326880|FG001|Induction|Withdrawal by Subject|0|||
154866877|NCT01919411|558939710|FG001|Overall Study|Physician Decision|0|||
154866878|NCT01919411|558939709|FG000|Overall Study|Protocol Violation|2|||
154973409|NCT02003222|559326881|FG002|Induction|Withdrawal by Subject|0|||
154973410|NCT02003222|559326882|FG003|Induction|Withdrawal by Subject|0|||
154866879|NCT01919411|558939710|FG001|Overall Study|Protocol Violation|1|||
154973411|NCT02003222|559326883|FG004|Induction|Withdrawal by Subject|8|||
154973412|NCT02003222|559326879|FG000|Induction|Other reasons|0|||
154973413|NCT02003222|559326880|FG001|Induction|Other reasons|0|||
154973414|NCT02003222|559326881|FG002|Induction|Other reasons|0|||
154973415|NCT02003222|559326882|FG003|Induction|Other reasons|0|||
154866880|NCT00144300|558939711|FG000|Overall Study|Adverse Event|18|||
155109404|NCT02091362|559828489|FG000|Period 2|Lost to Follow-up|0|||
155109405|NCT02091362|559828490|FG001|Period 2|Lost to Follow-up|1|||
155109406|NCT02091362|559828489|FG000|Period 2|Withdrawal by Subject|1|||
155109407|NCT02091362|559828490|FG001|Period 2|Withdrawal by Subject|1|||
155109408|NCT00690430|559828491|FG000|Core Phase|Abnormal Laboratory value|0|||
155109409|NCT00690430|559828492|FG001|Core Phase|Abnormal Laboratory value|1|||
155109410|NCT00690430|559828493|FG002|Core Phase|Abnormal Laboratory value|0|||
155109411|NCT00690430|559828491|FG000|Core Phase|Adverse Event|5|||
154866881|NCT00144300|558939712|FG001|Overall Study|Adverse Event|16|||
154866882|NCT00144300|558939711|FG000|Overall Study|Protocol Violation|1|||
154866883|NCT00144300|558939712|FG001|Overall Study|Protocol Violation|3|||
154866884|NCT00144300|558939711|FG000|Overall Study|Lost to Follow-up|3|||
154866885|NCT00144300|558939712|FG001|Overall Study|Lost to Follow-up|0|||
154866886|NCT00144300|558939711|FG000|Overall Study|Withdrawal by Subject|6|||
154866887|NCT00144300|558939712|FG001|Overall Study|Withdrawal by Subject|6|||
154866888|NCT00144300|558939711|FG000|Overall Study|Other reason (not specified)|1|||
154866889|NCT00144300|558939712|FG001|Overall Study|Other reason (not specified)|3|||
154866890|NCT02403206|558939714|FG000|Overall Study|Lost to Follow-up|4|||
154866891|NCT02403206|558939715|FG001|Overall Study|Lost to Follow-up|3|||
154866892|NCT02403206|558939714|FG000|Overall Study|Physician Decision|2|||
154866893|NCT02403206|558939715|FG001|Overall Study|Physician Decision|0|||
155109412|NCT00690430|559828492|FG001|Core Phase|Adverse Event|1|||
155109413|NCT00690430|559828493|FG002|Core Phase|Adverse Event|0|||
155109414|NCT00690430|559828491|FG000|Core Phase|Death|0|||
155109415|NCT00690430|559828492|FG001|Core Phase|Death|2|||
155109416|NCT00690430|559828493|FG002|Core Phase|Death|0|||
155109417|NCT00690430|559828491|FG000|Core Phase|Protocol Violation|1|||
155109418|NCT00690430|559828492|FG001|Core Phase|Protocol Violation|0|||
155109419|NCT00690430|559828493|FG002|Core Phase|Protocol Violation|0|||
155109420|NCT00690430|559828491|FG000|Core Phase|Withdrawal by Subject|3|||
155109421|NCT00690430|559828492|FG001|Core Phase|Withdrawal by Subject|3|||
155109422|NCT00690430|559828493|FG002|Core Phase|Withdrawal by Subject|0|||
155109423|NCT00690430|559828491|FG000|Core Phase|Subject no longer requires study drug|1|||
155109424|NCT00690430|559828492|FG001|Core Phase|Subject no longer requires study drug|0|||
155109425|NCT00690430|559828493|FG002|Core Phase|Subject no longer requires study drug|0|||
155109426|NCT00690430|559828491|FG000|Core Phase|Lack of Efficacy|8|||
155109427|NCT00690430|559828492|FG001|Core Phase|Lack of Efficacy|10|||
155109428|NCT00690430|559828493|FG002|Core Phase|Lack of Efficacy|0|||
155109429|NCT00690430|559828491|FG000|Core Phase|Administrative Problems|0|||
155109430|NCT00690430|559828492|FG001|Core Phase|Administrative Problems|1|||
155109431|NCT00690430|559828493|FG002|Core Phase|Administrative Problems|0|||
155109432|NCT00690430|559828491|FG000|Core Phase|Early Termination|0|||
155109433|NCT00690430|559828492|FG001|Core Phase|Early Termination|5|||
155109434|NCT00690430|559828493|FG002|Core Phase|Early Termination|0|||
155109435|NCT00690430|559828491|FG000|Extension Phase|Lack of Efficacy|3|||
155109436|NCT00690430|559828492|FG001|Extension Phase|Lack of Efficacy|1|||
155109437|NCT00690430|559828493|FG002|Extension Phase|Lack of Efficacy|4|||
155109438|NCT00690430|559828491|FG000|Extension Phase|Abnormal Lab Values|1|||
155109439|NCT00690430|559828492|FG001|Extension Phase|Abnormal Lab Values|0|||
155109440|NCT00690430|559828493|FG002|Extension Phase|Abnormal Lab Values|0|||
154866894|NCT02403206|558939714|FG000|Overall Study|Withdrawal by Subject|3|||
154866895|NCT02403206|558939715|FG001|Overall Study|Withdrawal by Subject|3|||
154866896|NCT02403206|558939714|FG000|Overall Study|Reason not given|2|||
154866897|NCT02403206|558939715|FG001|Overall Study|Reason not given|4|||
154866898|NCT01676116|558939716|FG000|Overall Study|Withdrawal criteria|2|||
154866899|NCT01676116|558939717|FG001|Overall Study|Withdrawal criteria|14|||
154866900|NCT01676116|558939716|FG000|Overall Study|Adverse Event|1|||
154866901|NCT01676116|558939717|FG001|Overall Study|Adverse Event|2|||
154866902|NCT01676116|558939716|FG000|Overall Study|Unclassified|4|||
154866903|NCT01676116|558939717|FG001|Overall Study|Unclassified|10|||
154866904|NCT01676116|558939716|FG000|Overall Study|Protocol Violation|9|||
154866905|NCT01676116|558939717|FG001|Overall Study|Protocol Violation|3|||
154866906|NCT01877655|558939718|FG000|Overall Study|Death|57|||
154866907|NCT01877655|558939719|FG001|Overall Study|Death|52|||
154866908|NCT01877655|558939718|FG000|Overall Study|Withdrawal by Subject|18|||
154866909|NCT01877655|558939719|FG001|Overall Study|Withdrawal by Subject|26|||
154866910|NCT01877655|558939718|FG000|Overall Study|Physician Decision|11|||
154866911|NCT01877655|558939719|FG001|Overall Study|Physician Decision|10|||
154866912|NCT01877655|558939718|FG000|Overall Study|Miscellaneous|4|||
154866913|NCT01877655|558939719|FG001|Overall Study|Miscellaneous|4|||
154866914|NCT01877655|558939718|FG000|Overall Study|Randomized but Never Received Drug|8|||
155109441|NCT00690430|559828491|FG000|Extension Phase|Abnormal test procedure results|1|||
155109442|NCT00690430|559828492|FG001|Extension Phase|Abnormal test procedure results|0|||
154866915|NCT01877655|558939719|FG001|Overall Study|Randomized but Never Received Drug|5|||
154866916|NCT01821677|558939722|FG000|Overall Study|Adverse Event|4|||
154866917|NCT01821677|558939723|FG001|Overall Study|Adverse Event|6|||
155109443|NCT00690430|559828493|FG002|Extension Phase|Abnormal test procedure results|0|||
155109444|NCT00690430|559828491|FG000|Extension Phase|Administrative Problems|0|||
155109445|NCT00690430|559828492|FG001|Extension Phase|Administrative Problems|1|||
155109446|NCT00690430|559828493|FG002|Extension Phase|Administrative Problems|1|||
155109447|NCT00690430|559828491|FG000|Extension Phase|Adverse Event|2|||
155109448|NCT00690430|559828492|FG001|Extension Phase|Adverse Event|1|||
155109449|NCT00690430|559828493|FG002|Extension Phase|Adverse Event|2|||
155109450|NCT00690430|559828491|FG000|Extension Phase|Death|1|||
155109451|NCT00690430|559828492|FG001|Extension Phase|Death|1|||
155109452|NCT00690430|559828493|FG002|Extension Phase|Death|1|||
155109453|NCT00690430|559828491|FG000|Extension Phase|Withdrawal by Subject|0|||
155109454|NCT00690430|559828492|FG001|Extension Phase|Withdrawal by Subject|0|||
155109455|NCT00690430|559828493|FG002|Extension Phase|Withdrawal by Subject|2|||
155109456|NCT00690430|559828491|FG000|Extension Phase|Early Termination|10|||
155109457|NCT00690430|559828492|FG001|Extension Phase|Early Termination|1|||
155109458|NCT00690430|559828493|FG002|Extension Phase|Early Termination|3|||
155109459|NCT02565147|559828494|FG000|Overall Study|Withdrawal by Subject|5|||
155109460|NCT02565147|559828495|FG001|Overall Study|Withdrawal by Subject|1|||
155109461|NCT02565147|559828494|FG000|Overall Study|Lost to Follow-up|0|||
155109462|NCT02565147|559828495|FG001|Overall Study|Lost to Follow-up|1|||
155109463|NCT02565147|559828494|FG000|Overall Study|Death|1|||
155109464|NCT02565147|559828495|FG001|Overall Study|Death|1|||
155109465|NCT04470050|559828499|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155109466|NCT04470050|559828500|FG001|Double-blind Treatment Phase|Adverse Event|0|||
155109467|NCT04470050|559828501|FG002|Double-blind Treatment Phase|Adverse Event|0|||
155109468|NCT04470050|559828502|FG003|Double-blind Treatment Phase|Adverse Event|1|||
155109469|NCT04470050|559828503|FG004|Double-blind Treatment Phase|Adverse Event|0|||
155109470|NCT04470050|559828504|FG005|Double-blind Treatment Phase|Adverse Event|0|||
155109471|NCT04470050|559828505|FG006|Double-blind Treatment Phase|Adverse Event|0|||
155109472|NCT04470050|559828499|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155109473|NCT04470050|559828500|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
155109474|NCT04470050|559828501|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
155109475|NCT04470050|559828502|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
155109476|NCT04470050|559828503|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
155109477|NCT04470050|559828504|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
155109478|NCT04470050|559828505|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
155109479|NCT04470050|559828499|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
155109480|NCT04470050|559828500|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
155109481|NCT04470050|559828501|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
155109482|NCT04470050|559828502|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
155109483|NCT04470050|559828503|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
155109484|NCT04470050|559828504|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
155109485|NCT04470050|559828505|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
155109486|NCT03098433|559828506|FG000|Overall Study|Withdrawal by Subject|10|||
155109487|NCT03640507|559828507|FG000|Overall Study|Withdrawal by Subject|0|||
155109488|NCT03640507|559828508|FG001|Overall Study|Withdrawal by Subject|0|||
155109489|NCT03640507|559828509|FG002|Overall Study|Withdrawal by Subject|1|||
155109490|NCT01270880|559828510|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
155109491|NCT00395486|559828511|FG000|Overall Study|Adverse Event|1|||
155109492|NCT00395486|559828512|FG001|Overall Study|Adverse Event|2|||
155109493|NCT00395486|559828511|FG000|Overall Study|Withdrawal by Subject|5|||
154866918|NCT01821677|558939724|FG002|Overall Study|Adverse Event|5|||
154866919|NCT01821677|558939722|FG000|Overall Study|Physician Decision|1|||
154866920|NCT01821677|558939723|FG001|Overall Study|Physician Decision|4|||
154866921|NCT01821677|558939724|FG002|Overall Study|Physician Decision|1|||
154866922|NCT01821677|558939722|FG000|Overall Study|Non-compliance|0|||
154866923|NCT01821677|558939723|FG001|Overall Study|Non-compliance|1|||
154866924|NCT01821677|558939724|FG002|Overall Study|Non-compliance|2|||
154866925|NCT01821677|558939722|FG000|Overall Study|Lost to Follow-up|2|||
154866926|NCT01821677|558939723|FG001|Overall Study|Lost to Follow-up|1|||
154866927|NCT01821677|558939724|FG002|Overall Study|Lost to Follow-up|3|||
155109494|NCT00395486|559828512|FG001|Overall Study|Withdrawal by Subject|2|||
155109495|NCT00395486|559828511|FG000|Overall Study|Lost to Follow-up|0|||
155109496|NCT00395486|559828512|FG001|Overall Study|Lost to Follow-up|1|||
155109497|NCT01939977|559828514|FG000|Overall Study|Adverse Event|4|||
155109498|NCT01939977|559828515|FG001|Overall Study|Adverse Event|3|||
155109499|NCT01939977|559828514|FG000|Overall Study|Lack of Efficacy|3|||
155109500|NCT01939977|559828515|FG001|Overall Study|Lack of Efficacy|0|||
155109501|NCT01939977|559828514|FG000|Overall Study|Physician Decision|1|||
154866928|NCT01821677|558939722|FG000|Overall Study|Protocol Violation|0|||
154866929|NCT01821677|558939723|FG001|Overall Study|Protocol Violation|0|||
154866930|NCT01821677|558939724|FG002|Overall Study|Protocol Violation|2|||
154973416|NCT02003222|559326883|FG004|Induction|Other reasons|22|||
155109502|NCT01939977|559828515|FG001|Overall Study|Physician Decision|1|||
155109503|NCT01939977|559828514|FG000|Overall Study|Withdrawal by Subject|0|||
155109504|NCT01939977|559828515|FG001|Overall Study|Withdrawal by Subject|2|||
155109505|NCT01939977|559828514|FG000|Overall Study|Did not meet inclusion criteria|1|||
155109506|NCT01939977|559828515|FG001|Overall Study|Did not meet inclusion criteria|0|||
155174517|NCT05092360|560076739|FG003|Overall Study|Withdrawal by Subject|26|||
155174518|NCT05092360|560076736|FG000|Overall Study|Death|97|||
155174519|NCT05092360|560076737|FG001|Overall Study|Death|14|||
155174520|NCT05092360|560076738|FG002|Overall Study|Death|31|||
155174521|NCT05092360|560076739|FG003|Overall Study|Death|101|||
155174522|NCT05092360|560076736|FG000|Overall Study|Lost to Follow-up|1|||
155174523|NCT05092360|560076737|FG001|Overall Study|Lost to Follow-up|2|||
155174524|NCT05092360|560076738|FG002|Overall Study|Lost to Follow-up|2|||
155174525|NCT05092360|560076739|FG003|Overall Study|Lost to Follow-up|2|||
155174526|NCT05092360|560076736|FG000|Overall Study|Study terminated by sponsor|65|||
155174527|NCT05092360|560076737|FG001|Overall Study|Study terminated by sponsor|7|||
155174528|NCT05092360|560076738|FG002|Overall Study|Study terminated by sponsor|13|||
155174529|NCT05092360|560076739|FG003|Overall Study|Study terminated by sponsor|61|||
155174530|NCT01675167|560076740|FG000|Open-label Titration Phase|Adverse Event|81|||
155174531|NCT01675167|560076741|FG001|Open-label Titration Phase|Adverse Event|0|||
155174532|NCT01675167|560076742|FG002|Open-label Titration Phase|Adverse Event|0|||
155174533|NCT01675167|560076740|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
155174534|NCT01675167|560076741|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
155174535|NCT01675167|560076742|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
155174536|NCT01675167|560076740|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
155174537|NCT01675167|560076741|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
155174538|NCT01675167|560076742|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
155174539|NCT01675167|560076740|FG000|Open-label Titration Phase|Protocol Violation|43|||
155174540|NCT01675167|560076741|FG001|Open-label Titration Phase|Protocol Violation|0|||
155174541|NCT01675167|560076742|FG002|Open-label Titration Phase|Protocol Violation|0|||
155174542|NCT01675167|560076740|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
155174543|NCT01675167|560076741|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
155174544|NCT01675167|560076742|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
155174545|NCT01675167|560076740|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
155174546|NCT01675167|560076741|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
155174547|NCT01675167|560076742|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
155174548|NCT01675167|560076740|FG000|Open-label Titration Phase|Other|55|||
155174549|NCT01675167|560076741|FG001|Open-label Titration Phase|Other|0|||
155174550|NCT01675167|560076742|FG002|Open-label Titration Phase|Other|0|||
155174551|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
155174552|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
155174553|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
155174554|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155174555|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
155174556|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
155174557|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155174558|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Adverse Event|5|||
155174559|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Adverse Event|13|||
155174560|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
155174561|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
155174562|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
155174563|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155174564|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
155174565|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
155174566|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
155174567|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
155174568|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
155174569|NCT01675167|560076740|FG000|Double-blind Treatment Phase|Other|0|||
154866931|NCT01821677|558939722|FG000|Overall Study|Withdrawal by Subject|7|||
154866932|NCT01821677|558939723|FG001|Overall Study|Withdrawal by Subject|3|||
154866933|NCT01821677|558939724|FG002|Overall Study|Withdrawal by Subject|2|||
155174570|NCT01675167|560076741|FG001|Double-blind Treatment Phase|Other|7|||
155174571|NCT01675167|560076742|FG002|Double-blind Treatment Phase|Other|5|||
155174572|NCT01525225|560076743|FG000|Enrollment|No longer met study criteria|1|||
155174573|NCT01525225|560076743|FG000|Enrollment|Other|1|||
155174574|NCT00363545|560076744|FG000|Overall Study|Serious Adverse Event|0|||
155174575|NCT00363545|560076745|FG001|Overall Study|Serious Adverse Event|1|||
154866934|NCT01821677|558939722|FG000|Overall Study|Other|9|||
154866935|NCT01821677|558939723|FG001|Overall Study|Other|0|||
154866936|NCT01821677|558939724|FG002|Overall Study|Other|0|||
154866937|NCT00538733|558939725|FG000|Overall Study|Adverse Event|8|||
154866938|NCT00538733|558939725|FG000|Overall Study|Death|1|||
154866939|NCT00538733|558939725|FG000|Overall Study|declined to participate|2|||
154866940|NCT00538733|558939725|FG000|Overall Study|still on therapy|1|||
154866941|NCT03567187|558939728|FG000|Overall Study|Lost to Follow-up|18|||
154866942|NCT03497689|558939729|FG000|Overall Study|Adverse Event|2|||
154866943|NCT03497689|558939729|FG000|Overall Study|Death|1|||
154866944|NCT03497689|558939729|FG000|Overall Study|Physician Decision|1|||
154866945|NCT03497689|558939729|FG000|Overall Study|Withdrawal by Subject|1|||
155174576|NCT00363545|560076744|FG000|Overall Study|Withdrawal by Subject|12|||
155174577|NCT00363545|560076745|FG001|Overall Study|Withdrawal by Subject|15|||
155174578|NCT00363545|560076744|FG000|Overall Study|Migrated/moved from study area|3|||
155174579|NCT00363545|560076745|FG001|Overall Study|Migrated/moved from study area|6|||
155174580|NCT00363545|560076744|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
155174581|NCT00363545|560076745|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
155174582|NCT00363545|560076744|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
155174583|NCT00363545|560076745|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
155174584|NCT00363545|560076744|FG000|Overall Study|Others|1|||
155174585|NCT00363545|560076745|FG001|Overall Study|Others|0|||
155174586|NCT01182844|560076746|FG000|Overall Study|Withdrawal by Subject|0|||
155174587|NCT01182844|560076747|FG001|Overall Study|Withdrawal by Subject|2|||
155174588|NCT05009979|560076751|FG000|Overall Study|Withdrawal by Subject|1|||
155174589|NCT01330017|560078229|FG000|Overall Study|Adverse Event|0|||
155174590|NCT01330017|560078230|FG001|Overall Study|Adverse Event|1|||
155174591|NCT01330017|560078231|FG002|Overall Study|Adverse Event|1|||
155174592|NCT01330017|560078232|FG003|Overall Study|Adverse Event|4|||
155174593|NCT01330017|560078233|FG004|Overall Study|Adverse Event|0|||
155174594|NCT01330017|560078229|FG000|Overall Study|Withdrawal by Subject|0|||
155174595|NCT01330017|560078230|FG001|Overall Study|Withdrawal by Subject|0|||
155174596|NCT01330017|560078231|FG002|Overall Study|Withdrawal by Subject|1|||
155174597|NCT01330017|560078232|FG003|Overall Study|Withdrawal by Subject|0|||
155174598|NCT01330017|560078233|FG004|Overall Study|Withdrawal by Subject|1|||
154866946|NCT03497689|558939729|FG000|Overall Study|Protocol Violation|2|||
154866947|NCT03596645|558939732|FG000|Overall Study|Adverse Event|17|||
154866948|NCT03596645|558939733|FG001|Overall Study|Adverse Event|0|||
154866949|NCT03596645|558939732|FG000|Overall Study|Lack of Efficacy|8|||
154866950|NCT03596645|558939733|FG001|Overall Study|Lack of Efficacy|0|||
154866951|NCT03596645|558939732|FG000|Overall Study|Lost to Follow-up|1|||
154866952|NCT03596645|558939733|FG001|Overall Study|Lost to Follow-up|1|||
154866953|NCT03596645|558939732|FG000|Overall Study|Physician Decision|1|||
154866954|NCT03596645|558939733|FG001|Overall Study|Physician Decision|1|||
154866955|NCT03596645|558939732|FG000|Overall Study|Protocol Violation|1|||
154866956|NCT03596645|558939733|FG001|Overall Study|Protocol Violation|0|||
154866957|NCT03596645|558939732|FG000|Overall Study|Initiated Prohibited Medication|1|||
154866958|NCT03596645|558939733|FG001|Overall Study|Initiated Prohibited Medication|0|||
154866959|NCT03596645|558939732|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
154866960|NCT03596645|558939733|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154866961|NCT03596645|558939732|FG000|Overall Study|No mucosal healing achieved|1|||
154866962|NCT03596645|558939733|FG001|Overall Study|No mucosal healing achieved|0|||
154866963|NCT03596645|558939732|FG000|Overall Study|Disease progression|1|||
154866964|NCT03596645|558939733|FG001|Overall Study|Disease progression|0|||
154866965|NCT03596645|558939732|FG000|Overall Study|Ongoing|37|||
154866966|NCT03596645|558939733|FG001|Overall Study|Ongoing|12|||
154866967|NCT03596645|558939732|FG000|Overall Study|Randomized but not treated|0|||
154866968|NCT03596645|558939733|FG001|Overall Study|Randomized but not treated|1|||
154866969|NCT01123889|558941181|FG000|Overall Study|Lost to Follow-up|3|||
154866970|NCT01123889|558941182|FG001|Overall Study|Lost to Follow-up|1|||
154866971|NCT00443560|558941183|FG000|Overall Study|No intrathecal dose|58|||
154866972|NCT00443560|558941184|FG001|Overall Study|No intrathecal dose|26|||
154866973|NCT00443560|558941183|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
154866974|NCT00443560|558941184|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
154866975|NCT02333331|558941185|FG000|Overall Study|Adverse Event|1|||
154866976|NCT02333331|558941186|FG001|Overall Study|Adverse Event|0|||
154866977|NCT02333331|558941187|FG002|Overall Study|Adverse Event|4|||
154866978|NCT02333331|558941188|FG003|Overall Study|Adverse Event|1|||
154866979|NCT02333331|558941185|FG000|Overall Study|Death|0|||
154866980|NCT02333331|558941186|FG001|Overall Study|Death|0|||
154866981|NCT02333331|558941187|FG002|Overall Study|Death|2|||
154866982|NCT02333331|558941188|FG003|Overall Study|Death|0|||
154866983|NCT02333331|558941185|FG000|Overall Study|Lost to Follow-up|0|||
154866984|NCT02333331|558941186|FG001|Overall Study|Lost to Follow-up|0|||
155174599|NCT01330017|560078229|FG000|Overall Study|Lost to Follow-up|0|||
155174600|NCT01330017|560078230|FG001|Overall Study|Lost to Follow-up|0|||
155174601|NCT01330017|560078231|FG002|Overall Study|Lost to Follow-up|1|||
155174602|NCT01330017|560078232|FG003|Overall Study|Lost to Follow-up|0|||
154866985|NCT02333331|558941187|FG002|Overall Study|Lost to Follow-up|1|||
154866986|NCT02333331|558941188|FG003|Overall Study|Lost to Follow-up|0|||
154866987|NCT02333331|558941185|FG000|Overall Study|Physician Decision|0|||
154866988|NCT02333331|558941186|FG001|Overall Study|Physician Decision|1|||
154866989|NCT02333331|558941187|FG002|Overall Study|Physician Decision|0|||
154866990|NCT02333331|558941188|FG003|Overall Study|Physician Decision|0|||
154866991|NCT02333331|558941185|FG000|Overall Study|Protocol Deviation|0|||
154866992|NCT02333331|558941186|FG001|Overall Study|Protocol Deviation|3|||
154866993|NCT02333331|558941187|FG002|Overall Study|Protocol Deviation|2|||
154866994|NCT02333331|558941188|FG003|Overall Study|Protocol Deviation|1|||
154866995|NCT02333331|558941185|FG000|Overall Study|Patient/Guardian Decision|1|||
155174603|NCT01330017|560078233|FG004|Overall Study|Lost to Follow-up|0|||
154866996|NCT02333331|558941186|FG001|Overall Study|Patient/Guardian Decision|2|||
154866997|NCT02333331|558941187|FG002|Overall Study|Patient/Guardian Decision|9|||
154866998|NCT02333331|558941188|FG003|Overall Study|Patient/Guardian Decision|1|||
154866999|NCT01494038|558941189|FG000|Overall Study|Protocol Violation|1|||
154867000|NCT01494038|558941190|FG001|Overall Study|Protocol Violation|1|||
154867001|NCT01494038|558941189|FG000|Overall Study|Lost to Follow-up|18|||
154867002|NCT01494038|558941190|FG001|Overall Study|Lost to Follow-up|20|||
154867003|NCT01494038|558941189|FG000|Overall Study|Withdrawal by Subject|44|||
154867004|NCT01494038|558941190|FG001|Overall Study|Withdrawal by Subject|34|||
154867005|NCT01494038|558941189|FG000|Overall Study|Not able to get to clinic|21|||
154867006|NCT01494038|558941190|FG001|Overall Study|Not able to get to clinic|15|||
154867007|NCT01494038|558941189|FG000|Overall Study|Not willing to adhere to reqs|2|||
154867008|NCT01494038|558941190|FG001|Overall Study|Not willing to adhere to reqs|9|||
154867009|NCT01494038|558941189|FG000|Overall Study|Death|2|||
154867010|NCT01494038|558941190|FG001|Overall Study|Death|4|||
154867011|NCT00685178|558941195|FG000|Overall Study|Adverse Event|1|||
154867012|NCT00685178|558941196|FG001|Overall Study|Adverse Event|5|||
154867013|NCT00685178|558941197|FG002|Overall Study|Adverse Event|2|||
154867014|NCT00685178|558941198|FG003|Overall Study|Adverse Event|4|||
154867015|NCT00685178|558941195|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
154867016|NCT00685178|558941196|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
154867017|NCT00685178|558941197|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
154867018|NCT00685178|558941198|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
154867019|NCT00685178|558941195|FG000|Overall Study|voluntary study discharge|4|||
154867020|NCT00685178|558941196|FG001|Overall Study|voluntary study discharge|5|||
154867021|NCT00685178|558941197|FG002|Overall Study|voluntary study discharge|1|||
154867022|NCT00685178|558941198|FG003|Overall Study|voluntary study discharge|1|||
154867023|NCT00685178|558941195|FG000|Overall Study|incarcerated|1|||
154867024|NCT00685178|558941196|FG001|Overall Study|incarcerated|3|||
154867025|NCT00685178|558941197|FG002|Overall Study|incarcerated|7|||
154867026|NCT00685178|558941198|FG003|Overall Study|incarcerated|0|||
154867027|NCT00685178|558941195|FG000|Overall Study|administrative (disciplinary) discharge|0|||
154867028|NCT00685178|558941196|FG001|Overall Study|administrative (disciplinary) discharge|1|||
154867029|NCT00685178|558941197|FG002|Overall Study|administrative (disciplinary) discharge|0|||
154867030|NCT00685178|558941198|FG003|Overall Study|administrative (disciplinary) discharge|2|||
154867031|NCT00685178|558941195|FG000|Overall Study|Pregnancy|0|||
154867032|NCT00685178|558941196|FG001|Overall Study|Pregnancy|0|||
154867033|NCT00685178|558941197|FG002|Overall Study|Pregnancy|0|||
154867034|NCT00685178|558941198|FG003|Overall Study|Pregnancy|1|||
154867035|NCT00077623|558941206|FG000|Overall Study|Adverse Event|1|||
154867036|NCT00077623|558941207|FG001|Overall Study|Adverse Event|0|||
154867037|NCT00077623|558941208|FG002|Overall Study|Adverse Event|1|||
154867038|NCT00077623|558941206|FG000|Overall Study|Withdrawal by Subject|2|||
154867039|NCT00077623|558941207|FG001|Overall Study|Withdrawal by Subject|10|||
154867040|NCT00077623|558941208|FG002|Overall Study|Withdrawal by Subject|1|||
154867041|NCT00077623|558941206|FG000|Overall Study|Other-Non safety reason|18|||
154867042|NCT00077623|558941207|FG001|Overall Study|Other-Non safety reason|15|||
154867043|NCT00077623|558941208|FG002|Overall Study|Other-Non safety reason|19|||
154867044|NCT00077623|558941206|FG000|Overall Study|Insufficient therapeutic response|2|||
154867045|NCT00077623|558941207|FG001|Overall Study|Insufficient therapeutic response|0|||
154867046|NCT00077623|558941208|FG002|Overall Study|Insufficient therapeutic response|0|||
154867047|NCT00077623|558941206|FG000|Overall Study|Death|12|||
154867048|NCT00077623|558941207|FG001|Overall Study|Death|18|||
154867049|NCT00077623|558941208|FG002|Overall Study|Death|11|||
154867050|NCT00077623|558941206|FG000|Overall Study|Failure to return|1|||
154867051|NCT00077623|558941207|FG001|Overall Study|Failure to return|0|||
154867052|NCT00077623|558941208|FG002|Overall Study|Failure to return|0|||
154867053|NCT01334125|558941209|FG000|Overall Study|Lost to Follow-up|3|||
154867054|NCT01334125|558941210|FG001|Overall Study|Lost to Follow-up|3|||
154867055|NCT02138110|558941214|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
154867056|NCT02138110|558941214|FG000|Overall Scaffold Implantation|Death|3|||
154867057|NCT00882713|558941216|FG000|Overall Study|Adverse Event|2|||
154867058|NCT00882713|558941216|FG000|Overall Study|Death|3|||
154867059|NCT00882713|558941216|FG000|Overall Study|Administrative reasons|4|||
154867060|NCT00882713|558941216|FG000|Overall Study|refused treatment/withdrew consent|4|||
154867061|NCT00882713|558941216|FG000|Overall Study|Blood transfusion|2|||
154867062|NCT00882713|558941216|FG000|Overall Study|Insufficient therapeutic response|3|||
154867063|NCT00882713|558941216|FG000|Overall Study|Failure to return|2|||
154867064|NCT00882713|558941216|FG000|Overall Study|Other - Reasons|2|||
154867065|NCT00401973|558941219|FG000|Overall Study|Adverse Event|2|||
154867066|NCT00401973|558941220|FG001|Overall Study|Adverse Event|8|||
154867067|NCT00401973|558941221|FG002|Overall Study|Adverse Event|4|||
154867068|NCT00401973|558941219|FG000|Overall Study|Clinical Relapse|0|||
154867069|NCT00401973|558941220|FG001|Overall Study|Clinical Relapse|1|||
154867070|NCT00401973|558941221|FG002|Overall Study|Clinical Relapse|1|||
154867071|NCT00401973|558941219|FG000|Overall Study|Lack of Efficacy|0|||
154867072|NCT00401973|558941220|FG001|Overall Study|Lack of Efficacy|0|||
154867073|NCT00401973|558941221|FG002|Overall Study|Lack of Efficacy|3|||
154867074|NCT00401973|558941219|FG000|Overall Study|Lost to Follow-up|2|||
154867075|NCT00401973|558941220|FG001|Overall Study|Lost to Follow-up|2|||
154867076|NCT00401973|558941221|FG002|Overall Study|Lost to Follow-up|2|||
154867077|NCT00401973|558941219|FG000|Overall Study|Physician Decision|2|||
154867078|NCT00401973|558941220|FG001|Overall Study|Physician Decision|0|||
154867079|NCT00401973|558941221|FG002|Overall Study|Physician Decision|1|||
154867080|NCT00401973|558941219|FG000|Overall Study|Protocol Violation|1|||
154867081|NCT00401973|558941220|FG001|Overall Study|Protocol Violation|2|||
154867082|NCT00401973|558941221|FG002|Overall Study|Protocol Violation|3|||
154867083|NCT00401973|558941219|FG000|Overall Study|Sponsor Decision|0|||
154867084|NCT00401973|558941220|FG001|Overall Study|Sponsor Decision|1|||
154867085|NCT00401973|558941221|FG002|Overall Study|Sponsor Decision|0|||
154867086|NCT00401973|558941219|FG000|Overall Study|Withdrawal by Subject|4|||
154867087|NCT00401973|558941220|FG001|Overall Study|Withdrawal by Subject|12|||
154867088|NCT00401973|558941221|FG002|Overall Study|Withdrawal by Subject|9|||
154867089|NCT01335971|558941234|FG000|Overall Study|Withdrawal by Subject|1|||
154867090|NCT01335971|558941235|FG001|Overall Study|Withdrawal by Subject|0|||
154867091|NCT01335971|558941236|FG002|Overall Study|Withdrawal by Subject|0|||
154867092|NCT01335971|558941234|FG000|Overall Study|Did not complete bronchoscopy|1|||
154867093|NCT01335971|558941235|FG001|Overall Study|Did not complete bronchoscopy|1|||
154867094|NCT01335971|558941236|FG002|Overall Study|Did not complete bronchoscopy|1|||
154867095|NCT05299892|558941237|FG000|Overall Study|Withdrawal by Subject|2|||
154867096|NCT01059812|558941238|FG000|Overall Study|Adverse Event|9|||
154867097|NCT01059812|558941239|FG001|Overall Study|Adverse Event|5|||
154867098|NCT01059812|558941238|FG000|Overall Study|Lack of Efficacy|2|||
154867099|NCT01059812|558941239|FG001|Overall Study|Lack of Efficacy|2|||
154867100|NCT01059812|558941238|FG000|Overall Study|Protocol Violation|3|||
154867101|NCT01059812|558941239|FG001|Overall Study|Protocol Violation|1|||
154867102|NCT01059812|558941238|FG000|Overall Study|Withdrawal Criteria|9|||
154867103|NCT01059812|558941239|FG001|Overall Study|Withdrawal Criteria|4|||
154867104|NCT01059812|558941238|FG000|Overall Study|Unclassified|14|||
154867105|NCT01059812|558941239|FG001|Overall Study|Unclassified|4|||
154867106|NCT00149214|558941240|FG000|Overall Study|Adverse Event|12|||
154867107|NCT00149214|558941241|FG001|Overall Study|Adverse Event|9|||
154867108|NCT00149214|558941240|FG000|Overall Study|Withdrawal by Subject|4|||
154867109|NCT00149214|558941241|FG001|Overall Study|Withdrawal by Subject|1|||
154867110|NCT00149214|558941240|FG000|Overall Study|Physician Decision|3|||
154867111|NCT00149214|558941241|FG001|Overall Study|Physician Decision|3|||
154867112|NCT00149214|558941240|FG000|Overall Study|Sponsor Decision|0|||
154867113|NCT00149214|558941241|FG001|Overall Study|Sponsor Decision|1|||
154867114|NCT00149214|558941240|FG000|Overall Study|Progressive Disease|7|||
154867115|NCT00149214|558941241|FG001|Overall Study|Progressive Disease|3|||
154867116|NCT01260181|558941247|FG000|Overall Study|Decision of Investigator|1|||
154867117|NCT02088034|558941250|FG000|Overall Study|Lost to Follow-up|1|||
154867118|NCT02088034|558941251|FG001|Overall Study|Lost to Follow-up|1|||
154867119|NCT02088034|558941252|FG002|Overall Study|Lost to Follow-up|0|||
154867120|NCT02088034|558941250|FG000|Overall Study|Pregnancy|2|||
154867121|NCT02088034|558941251|FG001|Overall Study|Pregnancy|1|||
154867122|NCT02088034|558941252|FG002|Overall Study|Pregnancy|2|||
154867123|NCT03794986|558941253|FG000|Overall Study|0 Sessions Attended|34|||
154867124|NCT03794986|558941254|FG001|Overall Study|0 Sessions Attended|37|||
154867125|NCT03794986|558941253|FG000|Overall Study|Withdrawal by Subject|4|||
154867126|NCT03794986|558941254|FG001|Overall Study|Withdrawal by Subject|6|||
154867127|NCT03794986|558941253|FG000|Overall Study|Protocol Violation|1|||
154867128|NCT03794986|558941254|FG001|Overall Study|Protocol Violation|0|||
154867129|NCT03133481|558941255|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
154867130|NCT03133481|558941256|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
154867131|NCT00637728|558941261|FG000|Double-blind Phase|Adverse Event|1|||
154867132|NCT00637728|558941262|FG001|Double-blind Phase|Adverse Event|0|||
154867133|NCT00637728|558941263|FG002|Double-blind Phase|Adverse Event|0|||
154867134|NCT00637728|558941261|FG000|Double-blind Phase|Non-compliance|2|||
154867135|NCT00637728|558941262|FG001|Double-blind Phase|Non-compliance|0|||
154867136|NCT00637728|558941263|FG002|Double-blind Phase|Non-compliance|0|||
154867137|NCT00637728|558941261|FG000|Double-blind Phase|Study Discontinued|1|||
154867138|NCT00637728|558941262|FG001|Double-blind Phase|Study Discontinued|1|||
154867139|NCT00637728|558941263|FG002|Double-blind Phase|Study Discontinued|0|||
155174604|NCT01330017|560078229|FG000|Overall Study|Protocol Violation|0|||
154867140|NCT01873950|558941264|FG000|Period 5|Withdrawal by Subject|0|||
154867141|NCT01873950|558941265|FG001|Period 5|Withdrawal by Subject|0|||
154867142|NCT01873950|558941266|FG002|Period 5|Withdrawal by Subject|0|||
154867143|NCT01873950|558941267|FG003|Period 5|Withdrawal by Subject|1|||
154867144|NCT01873950|558941268|FG004|Period 5|Withdrawal by Subject|0|||
154867145|NCT03894540|558941269|FG000|Overall Study|Adverse Event|0|||
154867146|NCT03894540|558941270|FG001|Overall Study|Adverse Event|0|||
154867147|NCT03894540|558941271|FG002|Overall Study|Adverse Event|0|||
154867148|NCT03894540|558941272|FG003|Overall Study|Adverse Event|0|||
154973417|NCT02003222|559326879|FG000|Intensification|Never started treatment|0|||
154867149|NCT03894540|558941273|FG004|Overall Study|Adverse Event|1|||
154867150|NCT03894540|558941274|FG005|Overall Study|Adverse Event|0|||
154867151|NCT03894540|558941269|FG000|Overall Study|Withdrawal by Subject|0|||
154867152|NCT03894540|558941270|FG001|Overall Study|Withdrawal by Subject|0|||
154867153|NCT03894540|558941271|FG002|Overall Study|Withdrawal by Subject|0|||
154867154|NCT03894540|558941272|FG003|Overall Study|Withdrawal by Subject|0|||
154867155|NCT03894540|558941273|FG004|Overall Study|Withdrawal by Subject|1|||
154867156|NCT03894540|558941274|FG005|Overall Study|Withdrawal by Subject|0|||
154867157|NCT03894540|558941269|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
154867158|NCT03894540|558941270|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
154867159|NCT03894540|558941271|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
154867160|NCT03894540|558941272|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
154867161|NCT03894540|558941273|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
154867162|NCT03894540|558941274|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
154867163|NCT03894540|558941269|FG000|Overall Study|Progressive Disease Clinical|1|||
154867164|NCT03894540|558941270|FG001|Overall Study|Progressive Disease Clinical|1|||
154867165|NCT03894540|558941271|FG002|Overall Study|Progressive Disease Clinical|0|||
154867166|NCT03894540|558941272|FG003|Overall Study|Progressive Disease Clinical|1|||
154867167|NCT03894540|558941273|FG004|Overall Study|Progressive Disease Clinical|5|||
154867168|NCT03894540|558941274|FG005|Overall Study|Progressive Disease Clinical|1|||
154867169|NCT03894540|558941269|FG000|Overall Study|Study termination by sponsor|0|||
154867170|NCT03894540|558941270|FG001|Overall Study|Study termination by sponsor|0|||
154867171|NCT03894540|558941271|FG002|Overall Study|Study termination by sponsor|0|||
154867172|NCT03894540|558941272|FG003|Overall Study|Study termination by sponsor|0|||
154867173|NCT03894540|558941273|FG004|Overall Study|Study termination by sponsor|2|||
154867174|NCT03894540|558941274|FG005|Overall Study|Study termination by sponsor|0|||
154973418|NCT02003222|559326880|FG001|Intensification|Never started treatment|0|||
155109507|NCT01939977|559828514|FG000|Overall Study|Did not receive study medication|0|||
155109508|NCT01939977|559828515|FG001|Overall Study|Did not receive study medication|1|||
155109509|NCT00465972|559828518|FG000|Overall Study|Withdrawal by Subject|2|||
155109510|NCT00465972|559828519|FG001|Overall Study|Withdrawal by Subject|1|||
155109511|NCT02097719|559828520|FG000|Overall Study|Subject Withdrew Consent|1|||
155109512|NCT02097719|559828521|FG001|Overall Study|Subject Withdrew Consent|0|||
155109513|NCT02097719|559828520|FG000|Overall Study|Lost to Follow-up|0|||
155109514|NCT02097719|559828521|FG001|Overall Study|Lost to Follow-up|1|||
155109515|NCT02097719|559828520|FG000|Overall Study|Adverse Event|2|||
155109516|NCT02097719|559828521|FG001|Overall Study|Adverse Event|0|||
155109517|NCT03292640|559828522|FG000|Overall Study|Withdrawal by Subject|17|||
155109518|NCT03292640|559828523|FG001|Overall Study|Withdrawal by Subject|16|||
155109519|NCT03292640|559828522|FG000|Overall Study|Adverse Event|20|||
155109520|NCT03292640|559828523|FG001|Overall Study|Adverse Event|2|||
155109521|NCT03292640|559828522|FG000|Overall Study|Lost to Follow-up|24|||
155109522|NCT03292640|559828523|FG001|Overall Study|Lost to Follow-up|24|||
155109523|NCT00984594|559828526|FG000|Overall Study|Lost to Follow-up|1|||
155109524|NCT00984594|559828527|FG001|Overall Study|Lost to Follow-up|0|||
155109525|NCT00984594|559828526|FG000|Overall Study|Withdrawal by Subject|0|||
155109526|NCT00984594|559828527|FG001|Overall Study|Withdrawal by Subject|1|||
155109527|NCT00851890|559828528|FG000|Overall Study|Lost to Follow-up|0|||
155109528|NCT00851890|559828529|FG001|Overall Study|Lost to Follow-up|1|||
155109529|NCT00851890|559828530|FG002|Overall Study|Lost to Follow-up|0|||
155109530|NCT00851890|559828531|FG003|Overall Study|Lost to Follow-up|1|||
155109531|NCT02015481|559828532|FG000|Overall Study|Death|1|||
155109532|NCT03122145|559828533|FG000|Overall Study|Concurrent respiratory disease|3|||
155109533|NCT03122145|559828534|FG001|Overall Study|Concurrent respiratory disease|0|||
155109534|NCT02016716|559828535|FG000|Overall Study|Withdrawal by Subject|5|||
155109535|NCT02016716|559828536|FG001|Overall Study|Withdrawal by Subject|5|||
155109536|NCT02016716|559828537|FG002|Overall Study|Withdrawal by Subject|5|||
155109537|NCT02016716|559828535|FG000|Overall Study|Protocol-specified Criteria|0|||
155109538|NCT02016716|559828536|FG001|Overall Study|Protocol-specified Criteria|1|||
155109539|NCT02016716|559828537|FG002|Overall Study|Protocol-specified Criteria|0|||
155109540|NCT02016716|559828535|FG000|Overall Study|Lost to Follow-up|1|||
155109541|NCT02016716|559828536|FG001|Overall Study|Lost to Follow-up|2|||
155109542|NCT02016716|559828537|FG002|Overall Study|Lost to Follow-up|1|||
155109543|NCT00079391|559828538|FG000|Overall Study|Withdrawal by Subject|1|||
155109544|NCT03206918|559828539|FG000|Overall Study|Death|11|||
155109545|NCT03206918|559828539|FG000|Overall Study|Withdrawal by Subject|5|||
155109546|NCT03206918|559828539|FG000|Overall Study|Study terminated by sponsor|12|||
155109547|NCT03206918|559828539|FG000|Overall Study|Lost to Follow-up|3|||
155109548|NCT03206918|559828539|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
155109549|NCT03108521|559828542|FG000|Overall Study|Lost to Follow-up|3|||
155109550|NCT03108521|559828543|FG001|Overall Study|Lost to Follow-up|0|||
155109551|NCT03108521|559828542|FG000|Overall Study|Lack of Efficacy|2|||
155109552|NCT03108521|559828543|FG001|Overall Study|Lack of Efficacy|0|||
155109553|NCT03108521|559828542|FG000|Overall Study|Physician Decision|4|||
154867175|NCT03000452|558941275|FG000|Treatment Period|Death|1|||
154867176|NCT03000452|558941275|FG000|Treatment Period|Progressive Disease (PD)|14|||
154867177|NCT03000452|558941275|FG000|Treatment Period|Physician Decision|1|||
154867178|NCT03000452|558941275|FG000|Treatment Period|Miscellaneous|2|||
154867179|NCT03000452|558941275|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
154867180|NCT03000452|558941275|FG000|Follow-Up Period|Death|3|||
154867181|NCT03000452|558941275|FG000|Follow-Up Period|Withdrawal by Subject|3|||
154867182|NCT03043365|558941276|FG000|Weeks 0 to Week 8|Adverse Event|1|||
154867183|NCT03043365|558941277|FG001|Weeks 0 to Week 8|Adverse Event|3|||
154867184|NCT03043365|558941276|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
154867185|NCT03043365|558941277|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
154867186|NCT03043365|558941276|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
154867187|NCT03043365|558941277|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
154867188|NCT00593112|558941278|FG000|Overall Study|Scan Anxiety|3|||
154867189|NCT00593112|558941279|FG001|Overall Study|Scan Anxiety|0|||
154867190|NCT00593112|558941278|FG000|Overall Study|Abnormal Scan|1|||
154867191|NCT00593112|558941279|FG001|Overall Study|Abnormal Scan|0|||
154867192|NCT00593112|558941278|FG000|Overall Study|Unreadable Scan|1|||
154867193|NCT00593112|558941279|FG001|Overall Study|Unreadable Scan|0|||
154867194|NCT00593112|558941278|FG000|Overall Study|Withdrawal by Subject|5|||
154867195|NCT00593112|558941279|FG001|Overall Study|Withdrawal by Subject|0|||
154867196|NCT02723630|558941280|FG000|Intervention Period 1|Adverse Event|1|||
154867197|NCT02723630|558941281|FG001|Intervention Period 1|Adverse Event|0|||
154867198|NCT02723630|558941282|FG002|Intervention Period 1|Adverse Event|0|||
154867199|NCT02723630|558941283|FG003|Intervention Period 1|Adverse Event|0|||
154867200|NCT02723630|558941284|FG004|Intervention Period 1|Adverse Event|0|||
154867201|NCT02723630|558941285|FG005|Intervention Period 1|Adverse Event|0|||
154867202|NCT02723630|558941280|FG000|Intervention Period 3|consumption of restricted item|0|||
154867203|NCT02723630|558941281|FG001|Intervention Period 3|consumption of restricted item|1|||
154867204|NCT02723630|558941282|FG002|Intervention Period 3|consumption of restricted item|0|||
154867205|NCT02723630|558941283|FG003|Intervention Period 3|consumption of restricted item|0|||
154867206|NCT02723630|558941284|FG004|Intervention Period 3|consumption of restricted item|0|||
154867207|NCT02723630|558941285|FG005|Intervention Period 3|consumption of restricted item|0|||
154867208|NCT00537745|558941286|FG000|Overall Study|Did not meet eligibility criteria|2|||
154867209|NCT00537745|558941286|FG000|Overall Study|Withdrawal by Subject|2|||
154867210|NCT00537745|558941286|FG000|Overall Study|Subject unable to provide Interlock info|1|||
154867211|NCT03700892|558941290|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
154867212|NCT03700892|558941291|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
154867213|NCT03700892|558941292|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
154867214|NCT00849212|558941293|FG000|Overall Study|Lack of Efficacy|1|||
154867215|NCT00849212|558941293|FG000|Overall Study|Withdrawal by Subject|3|||
154867216|NCT00849212|558941293|FG000|Overall Study|Adverse Event|2|||
154867217|NCT00849212|558941293|FG000|Overall Study|Miscellaneous|1|||
154867218|NCT04407507|558941294|FG000|Overall Study|Withdrawal by Subject|0|||
154867219|NCT04407507|558941295|FG001|Overall Study|Withdrawal by Subject|1|||
154867220|NCT01499576|558941296|FG000|Overall Study|Physician Decision|12|||
154867221|NCT01499576|558941296|FG000|Overall Study|Withdrawal by Subject|9|||
154867222|NCT03396471|558941299|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
154867223|NCT03396471|558941299|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
154867224|NCT03396471|558941299|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
154867225|NCT03396471|558941299|FG000|Study Treatment - Up to 22 Months|Death|2|||
154867226|NCT03396471|558941299|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
154867227|NCT03396471|558941299|FG000|Follow up - Up to 2 Years|Death|9|||
154867228|NCT03396471|558941299|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
154867229|NCT03396471|558941299|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
154867230|NCT03396471|558941299|FG000|Follow up - Up to 2 Years|study terminated|1|||
154867231|NCT03396471|558941299|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
154867232|NCT03396471|558941299|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
154867233|NCT00923091|558941300|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
154867234|NCT00923091|558941301|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
155174605|NCT01330017|560078230|FG001|Overall Study|Protocol Violation|0|||
154867235|NCT00923091|558941302|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
155174606|NCT01330017|560078231|FG002|Overall Study|Protocol Violation|0|||
155174607|NCT01330017|560078232|FG003|Overall Study|Protocol Violation|1|||
155174608|NCT01330017|560078233|FG004|Overall Study|Protocol Violation|0|||
155174609|NCT01330017|560078229|FG000|Overall Study|Unknown Reason|5|||
154867236|NCT00923091|558941303|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
154867237|NCT00923091|558941304|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
154867238|NCT00923091|558941305|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
154867239|NCT00923091|558941306|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
155174610|NCT01330017|560078230|FG001|Overall Study|Unknown Reason|3|||
155174611|NCT01330017|560078231|FG002|Overall Study|Unknown Reason|5|||
154867240|NCT00923091|558941307|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
154867241|NCT00923091|558941308|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
154867242|NCT00923091|558941309|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
154867243|NCT00923091|558941310|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
154867244|NCT00923091|558941311|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
154867245|NCT00923091|558941312|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
154867246|NCT00923091|558941300|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
154867247|NCT00923091|558941301|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
154867248|NCT00923091|558941302|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
154867249|NCT00923091|558941303|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
154867250|NCT00923091|558941304|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
154867251|NCT00923091|558941305|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
154867252|NCT00923091|558941306|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
154867253|NCT00923091|558941307|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
154867254|NCT00923091|558941308|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
154867255|NCT00923091|558941309|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
154867256|NCT00923091|558941310|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
154867257|NCT00923091|558941311|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
154867258|NCT00923091|558941312|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
154867259|NCT00923091|558941300|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
154867260|NCT00923091|558941301|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
154867261|NCT00923091|558941302|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
154867262|NCT00923091|558941303|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
154867263|NCT00923091|558941304|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
154867264|NCT00923091|558941305|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
154867265|NCT00923091|558941306|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
154867266|NCT00923091|558941307|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
154867267|NCT00923091|558941308|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
154867268|NCT00923091|558941309|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
154867269|NCT00923091|558941310|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
154867270|NCT00923091|558941311|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
154867271|NCT00923091|558941312|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
154867272|NCT00923091|558941300|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867273|NCT00923091|558941301|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867274|NCT00923091|558941302|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867275|NCT00923091|558941303|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867276|NCT00923091|558941304|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867277|NCT00923091|558941305|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
154867278|NCT00923091|558941306|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867279|NCT00923091|558941307|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867280|NCT00923091|558941308|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867281|NCT00923091|558941309|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867282|NCT00923091|558941310|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867283|NCT00923091|558941311|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867284|NCT00923091|558941312|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
154867285|NCT00923091|558941300|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867286|NCT00923091|558941301|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
154867287|NCT00923091|558941302|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867288|NCT00923091|558941303|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
154867289|NCT00923091|558941304|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867290|NCT00923091|558941305|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
154867291|NCT00923091|558941306|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867292|NCT00923091|558941307|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867293|NCT00923091|558941308|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867294|NCT00923091|558941309|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867295|NCT00923091|558941310|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867296|NCT00923091|558941311|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867297|NCT00923091|558941312|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
154867298|NCT00923091|558941300|FG000|Period III (Single-Blind)|Adverse Event|5|||
154867299|NCT00923091|558941301|FG001|Period III (Single-Blind)|Adverse Event|0|||
154867300|NCT00923091|558941302|FG002|Period III (Single-Blind)|Adverse Event|0|||
154867301|NCT00923091|558941303|FG003|Period III (Single-Blind)|Adverse Event|0|||
154867302|NCT00923091|558941304|FG004|Period III (Single-Blind)|Adverse Event|0|||
154867303|NCT00923091|558941305|FG005|Period III (Single-Blind)|Adverse Event|0|||
154867304|NCT00923091|558941306|FG006|Period III (Single-Blind)|Adverse Event|0|||
154867305|NCT00923091|558941307|FG007|Period III (Single-Blind)|Adverse Event|0|||
154867306|NCT00923091|558941308|FG008|Period III (Single-Blind)|Adverse Event|0|||
154867307|NCT00923091|558941309|FG009|Period III (Single-Blind)|Adverse Event|0|||
154867308|NCT00923091|558941310|FG010|Period III (Single-Blind)|Adverse Event|0|||
154867309|NCT00923091|558941311|FG011|Period III (Single-Blind)|Adverse Event|0|||
154867310|NCT00923091|558941312|FG012|Period III (Single-Blind)|Adverse Event|0|||
154867311|NCT00923091|558941300|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
154867312|NCT00923091|558941301|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867313|NCT00923091|558941302|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867314|NCT00923091|558941303|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867315|NCT00923091|558941304|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867316|NCT00923091|558941305|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867317|NCT00923091|558941306|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867318|NCT00923091|558941307|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867319|NCT00923091|558941308|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867320|NCT00923091|558941309|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867321|NCT00923091|558941310|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867322|NCT00923091|558941311|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867323|NCT00923091|558941312|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
154867324|NCT00923091|558941300|FG000|Period III (Single-Blind)|Protocol Violation|3|||
154867325|NCT00923091|558941301|FG001|Period III (Single-Blind)|Protocol Violation|0|||
154867326|NCT00923091|558941302|FG002|Period III (Single-Blind)|Protocol Violation|0|||
154867327|NCT00923091|558941303|FG003|Period III (Single-Blind)|Protocol Violation|0|||
154867328|NCT00923091|558941304|FG004|Period III (Single-Blind)|Protocol Violation|0|||
154867329|NCT00923091|558941305|FG005|Period III (Single-Blind)|Protocol Violation|0|||
154867330|NCT00923091|558941306|FG006|Period III (Single-Blind)|Protocol Violation|0|||
154867331|NCT00923091|558941307|FG007|Period III (Single-Blind)|Protocol Violation|0|||
154867332|NCT00923091|558941308|FG008|Period III (Single-Blind)|Protocol Violation|0|||
154867333|NCT00923091|558941309|FG009|Period III (Single-Blind)|Protocol Violation|0|||
154867334|NCT00923091|558941310|FG010|Period III (Single-Blind)|Protocol Violation|0|||
154867335|NCT00923091|558941311|FG011|Period III (Single-Blind)|Protocol Violation|0|||
154867336|NCT00923091|558941312|FG012|Period III (Single-Blind)|Protocol Violation|0|||
154867337|NCT00923091|558941300|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
154867338|NCT00923091|558941301|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
154867339|NCT00923091|558941302|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
154867340|NCT00923091|558941303|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
154867341|NCT00923091|558941304|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
154867342|NCT00923091|558941305|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
154867343|NCT00923091|558941306|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
154867344|NCT00923091|558941307|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
154867345|NCT00923091|558941308|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
154867346|NCT00923091|558941309|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
154867347|NCT00923091|558941310|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
154867348|NCT00923091|558941311|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
154867349|NCT00923091|558941312|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
154867350|NCT00923091|558941300|FG000|Period IV (Double-Blind)|Adverse Event|2|||
154867351|NCT00923091|558941301|FG001|Period IV (Double-Blind)|Adverse Event|0|||
154867352|NCT00923091|558941302|FG002|Period IV (Double-Blind)|Adverse Event|0|||
154867353|NCT00923091|558941303|FG003|Period IV (Double-Blind)|Adverse Event|0|||
154867354|NCT00923091|558941304|FG004|Period IV (Double-Blind)|Adverse Event|0|||
154867355|NCT00923091|558941305|FG005|Period IV (Double-Blind)|Adverse Event|0|||
154867356|NCT00923091|558941306|FG006|Period IV (Double-Blind)|Adverse Event|0|||
154867357|NCT00923091|558941307|FG007|Period IV (Double-Blind)|Adverse Event|0|||
154867358|NCT00923091|558941308|FG008|Period IV (Double-Blind)|Adverse Event|0|||
154867359|NCT00923091|558941309|FG009|Period IV (Double-Blind)|Adverse Event|0|||
154867360|NCT00923091|558941310|FG010|Period IV (Double-Blind)|Adverse Event|0|||
154867361|NCT00923091|558941311|FG011|Period IV (Double-Blind)|Adverse Event|0|||
154867362|NCT00923091|558941312|FG012|Period IV (Double-Blind)|Adverse Event|0|||
154867363|NCT00923091|558941300|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867364|NCT00923091|558941301|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
154867365|NCT00923091|558941302|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867366|NCT00923091|558941303|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867367|NCT00923091|558941304|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867368|NCT00923091|558941305|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867369|NCT00923091|558941306|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867370|NCT00923091|558941307|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867371|NCT00923091|558941308|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867372|NCT00923091|558941309|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867373|NCT00923091|558941310|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867374|NCT00923091|558941311|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867375|NCT00923091|558941312|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
154867376|NCT00923091|558941300|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
154867377|NCT00923091|558941301|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
154867378|NCT00923091|558941302|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
154867379|NCT00923091|558941303|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
154867380|NCT00923091|558941304|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
154867381|NCT00923091|558941305|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
154867382|NCT00923091|558941306|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
154867383|NCT00923091|558941307|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
154867384|NCT00923091|558941308|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
154867385|NCT00923091|558941309|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
154867386|NCT00923091|558941310|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
154867387|NCT00923091|558941311|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
154867388|NCT00923091|558941312|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
154867389|NCT00923091|558941300|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867390|NCT00923091|558941301|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867391|NCT00923091|558941302|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867392|NCT00923091|558941303|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867393|NCT00923091|558941304|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867394|NCT00923091|558941305|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867395|NCT00923091|558941306|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867396|NCT00923091|558941307|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867397|NCT00923091|558941308|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
154867398|NCT00923091|558941309|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867399|NCT00923091|558941310|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867400|NCT00923091|558941311|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
154867401|NCT00923091|558941312|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
154867402|NCT00923091|558941300|FG000|Period V (Double -Blind)|Protocol Violation|0|||
154867403|NCT00923091|558941301|FG001|Period V (Double -Blind)|Protocol Violation|0|||
154867404|NCT00923091|558941302|FG002|Period V (Double -Blind)|Protocol Violation|0|||
154867405|NCT00923091|558941303|FG003|Period V (Double -Blind)|Protocol Violation|0|||
154867406|NCT00923091|558941304|FG004|Period V (Double -Blind)|Protocol Violation|0|||
154867407|NCT00923091|558941305|FG005|Period V (Double -Blind)|Protocol Violation|0|||
154867408|NCT00923091|558941306|FG006|Period V (Double -Blind)|Protocol Violation|0|||
154867409|NCT00923091|558941307|FG007|Period V (Double -Blind)|Protocol Violation|0|||
154867410|NCT00923091|558941308|FG008|Period V (Double -Blind)|Protocol Violation|0|||
154867411|NCT00923091|558941309|FG009|Period V (Double -Blind)|Protocol Violation|0|||
154867412|NCT00923091|558941310|FG010|Period V (Double -Blind)|Protocol Violation|0|||
154867413|NCT00923091|558941311|FG011|Period V (Double -Blind)|Protocol Violation|0|||
154867414|NCT00923091|558941312|FG012|Period V (Double -Blind)|Protocol Violation|1|||
154867415|NCT00923091|558941300|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
154867416|NCT00923091|558941301|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
154867417|NCT00923091|558941302|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
154867418|NCT00923091|558941303|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
154867419|NCT00923091|558941304|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
154867420|NCT00923091|558941305|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
154867421|NCT00923091|558941306|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
154867422|NCT00923091|558941307|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
154867423|NCT00923091|558941308|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
154867424|NCT00923091|558941309|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
154867425|NCT00923091|558941310|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
154867426|NCT00923091|558941311|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
154867427|NCT00923091|558941312|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
154867428|NCT00923091|558941300|FG000|Period VI (Open-Label)|Adverse Event|17|||
154867429|NCT00923091|558941301|FG001|Period VI (Open-Label)|Adverse Event|0|||
154867430|NCT00923091|558941302|FG002|Period VI (Open-Label)|Adverse Event|4|||
154867431|NCT00923091|558941303|FG003|Period VI (Open-Label)|Adverse Event|1|||
154867432|NCT00923091|558941304|FG004|Period VI (Open-Label)|Adverse Event|1|||
154867433|NCT00923091|558941305|FG005|Period VI (Open-Label)|Adverse Event|0|||
154867434|NCT00923091|558941306|FG006|Period VI (Open-Label)|Adverse Event|0|||
154867435|NCT00923091|558941307|FG007|Period VI (Open-Label)|Adverse Event|0|||
154867436|NCT00923091|558941308|FG008|Period VI (Open-Label)|Adverse Event|0|||
154867437|NCT00923091|558941309|FG009|Period VI (Open-Label)|Adverse Event|0|||
154867438|NCT00923091|558941310|FG010|Period VI (Open-Label)|Adverse Event|0|||
154867439|NCT00923091|558941311|FG011|Period VI (Open-Label)|Adverse Event|0|||
154867440|NCT00923091|558941312|FG012|Period VI (Open-Label)|Adverse Event|0|||
155109554|NCT03108521|559828543|FG001|Overall Study|Physician Decision|0|||
154867441|NCT00923091|558941300|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
154867442|NCT00923091|558941301|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
155109555|NCT03108521|559828542|FG000|Overall Study|Adverse Event|3|||
155109556|NCT03108521|559828543|FG001|Overall Study|Adverse Event|0|||
155109557|NCT06899737|559828549|FG000|Overall Study|Lost to Follow-up|19|||
154867443|NCT00923091|558941302|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
155109558|NCT06899737|559828550|FG001|Overall Study|Lost to Follow-up|7|||
155174612|NCT01330017|560078232|FG003|Overall Study|Unknown Reason|7|||
155174613|NCT01330017|560078233|FG004|Overall Study|Unknown Reason|2|||
154867444|NCT00923091|558941303|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867445|NCT00923091|558941304|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
154867446|NCT00923091|558941305|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867447|NCT00923091|558941306|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867448|NCT00923091|558941307|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867449|NCT00923091|558941308|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867450|NCT00923091|558941309|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867451|NCT00923091|558941310|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867452|NCT00923091|558941311|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867453|NCT00923091|558941312|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
154867454|NCT00923091|558941300|FG000|Period VI (Open-Label)|Protocol Violation|6|||
154867455|NCT00923091|558941301|FG001|Period VI (Open-Label)|Protocol Violation|1|||
154867456|NCT00923091|558941302|FG002|Period VI (Open-Label)|Protocol Violation|3|||
154867457|NCT00923091|558941303|FG003|Period VI (Open-Label)|Protocol Violation|1|||
154867458|NCT00923091|558941304|FG004|Period VI (Open-Label)|Protocol Violation|4|||
154867459|NCT00923091|558941305|FG005|Period VI (Open-Label)|Protocol Violation|0|||
154867460|NCT00923091|558941306|FG006|Period VI (Open-Label)|Protocol Violation|0|||
154867461|NCT00923091|558941307|FG007|Period VI (Open-Label)|Protocol Violation|0|||
154867462|NCT00923091|558941308|FG008|Period VI (Open-Label)|Protocol Violation|0|||
154867463|NCT00923091|558941309|FG009|Period VI (Open-Label)|Protocol Violation|0|||
154867464|NCT00923091|558941310|FG010|Period VI (Open-Label)|Protocol Violation|0|||
154867465|NCT00923091|558941311|FG011|Period VI (Open-Label)|Protocol Violation|0|||
154867466|NCT00923091|558941312|FG012|Period VI (Open-Label)|Protocol Violation|0|||
154867467|NCT00923091|558941300|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
154867468|NCT00923091|558941301|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
154867469|NCT00923091|558941302|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
154867470|NCT00923091|558941303|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
154867471|NCT00923091|558941304|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
154867472|NCT00923091|558941305|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
154867473|NCT00923091|558941306|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
154867474|NCT00923091|558941307|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
154867475|NCT00923091|558941308|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
154867476|NCT00923091|558941309|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
154867477|NCT00923091|558941310|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
154867478|NCT00923091|558941311|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
154867479|NCT00923091|558941312|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
154867480|NCT00923091|558941300|FG000|Period VI (Open-Label)|Other Reason|0|||
154867481|NCT00923091|558941301|FG001|Period VI (Open-Label)|Other Reason|0|||
154867482|NCT00923091|558941302|FG002|Period VI (Open-Label)|Other Reason|0|||
154867483|NCT00923091|558941303|FG003|Period VI (Open-Label)|Other Reason|1|||
154867484|NCT00923091|558941304|FG004|Period VI (Open-Label)|Other Reason|1|||
154867485|NCT00923091|558941305|FG005|Period VI (Open-Label)|Other Reason|0|||
154867486|NCT00923091|558941306|FG006|Period VI (Open-Label)|Other Reason|0|||
154867487|NCT00923091|558941307|FG007|Period VI (Open-Label)|Other Reason|0|||
154867488|NCT00923091|558941308|FG008|Period VI (Open-Label)|Other Reason|0|||
154867489|NCT00923091|558941309|FG009|Period VI (Open-Label)|Other Reason|0|||
154867490|NCT00923091|558941310|FG010|Period VI (Open-Label)|Other Reason|0|||
154867491|NCT00923091|558941311|FG011|Period VI (Open-Label)|Other Reason|0|||
154867492|NCT00923091|558941312|FG012|Period VI (Open-Label)|Other Reason|0|||
154867493|NCT03237845|558941316|FG000|Overall Study|Adverse Event|0|||
154867494|NCT03237845|558941317|FG001|Overall Study|Adverse Event|1|||
154867495|NCT03237845|558941316|FG000|Overall Study|Lost to Follow-up|13|||
154867496|NCT03237845|558941317|FG001|Overall Study|Lost to Follow-up|10|||
154867497|NCT03237845|558941316|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
154867498|NCT03237845|558941317|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
154867499|NCT03237845|558941316|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
154867500|NCT03237845|558941317|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
154867501|NCT03237845|558941316|FG000|Overall Study|Physician Decision|1|||
154867502|NCT03237845|558941317|FG001|Overall Study|Physician Decision|2|||
154867503|NCT03237845|558941316|FG000|Overall Study|Pregnancy|1|||
154867504|NCT03237845|558941317|FG001|Overall Study|Pregnancy|0|||
154867505|NCT03237845|558941316|FG000|Overall Study|Protocol Deviation|0|||
154867506|NCT03237845|558941317|FG001|Overall Study|Protocol Deviation|1|||
154867507|NCT03237845|558941316|FG000|Overall Study|Technical Problems|8|||
154867508|NCT03237845|558941317|FG001|Overall Study|Technical Problems|1|||
154867509|NCT03237845|558941316|FG000|Overall Study|Withdrawal by Subject|3|||
154867510|NCT03237845|558941317|FG001|Overall Study|Withdrawal by Subject|3|||
154867511|NCT03237845|558941316|FG000|Overall Study|Other Reasons|4|||
154867512|NCT03237845|558941317|FG001|Overall Study|Other Reasons|0|||
154867513|NCT01221233|558941318|FG000|Overall Study|Withdrawal by Subject|3|||
154867514|NCT01221233|558941319|FG001|Overall Study|Withdrawal by Subject|1|||
154867515|NCT02460822|558941324|FG000|Overall Study|Withdrawal by Subject|1|||
154973419|NCT02003222|559326881|FG002|Intensification|Never started treatment|0|||
155109559|NCT03110029|559828552|FG000|Overall Study|Withdrawal by Subject|1|||
154867516|NCT00971321|558941325|FG000|Up to Month 7|Withdrawal by Subject|1|||
154867517|NCT00971321|558941326|FG001|Up to Month 7|Withdrawal by Subject|0|||
154867518|NCT00971321|558941325|FG000|Up to Month 7|Migrated/moved from study area|3|||
154867519|NCT00971321|558941326|FG001|Up to Month 7|Migrated/moved from study area|2|||
154867520|NCT00971321|558941325|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
154867521|NCT00971321|558941326|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
154867522|NCT00971321|558941325|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
154867523|NCT00971321|558941326|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
154867524|NCT00971321|558941325|FG000|Up to Month 11-12|Lost to Follow-up|1|||
154867525|NCT00971321|558941326|FG001|Up to Month 11-12|Lost to Follow-up|0|||
154867526|NCT02782715|558941327|FG000|Overall Study|Withdrawal by Subject|1|||
154867527|NCT01662999|558941331|FG000|Period 3|Withdrawal by Subject|0|||
154867528|NCT01662999|558941332|FG001|Period 3|Withdrawal by Subject|1|||
154867529|NCT01662999|558941333|FG002|Period 3|Withdrawal by Subject|0|||
154867530|NCT01662999|558941334|FG003|Period 3|Withdrawal by Subject|0|||
154867531|NCT01662999|558941335|FG004|Period 3|Withdrawal by Subject|0|||
154867532|NCT01662999|558941336|FG005|Period 3|Withdrawal by Subject|0|||
154867533|NCT01933672|558941340|FG000|Metformin Run-in Period|Adverse Event|1|||
154867534|NCT01933672|558941341|FG001|Metformin Run-in Period|Adverse Event|0|||
154867535|NCT01933672|558941342|FG002|Metformin Run-in Period|Adverse Event|0|||
154867536|NCT01933672|558941343|FG003|Metformin Run-in Period|Adverse Event|0|||
154867537|NCT01933672|558941344|FG004|Metformin Run-in Period|Adverse Event|0|||
154867538|NCT01933672|558941345|FG005|Metformin Run-in Period|Adverse Event|0|||
154867539|NCT01933672|558941346|FG006|Metformin Run-in Period|Adverse Event|0|||
154867540|NCT01933672|558941340|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
154867541|NCT01933672|558941341|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
154867542|NCT01933672|558941342|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
154867543|NCT01933672|558941343|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
154867544|NCT01933672|558941344|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
154867545|NCT01933672|558941345|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
154867546|NCT01933672|558941346|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
154867547|NCT01933672|558941340|FG000|Metformin Run-in Period|Other|5|||
154867548|NCT01933672|558941341|FG001|Metformin Run-in Period|Other|0|||
154867549|NCT01933672|558941342|FG002|Metformin Run-in Period|Other|0|||
154867550|NCT01933672|558941343|FG003|Metformin Run-in Period|Other|0|||
154867551|NCT01933672|558941344|FG004|Metformin Run-in Period|Other|0|||
154867552|NCT01933672|558941345|FG005|Metformin Run-in Period|Other|0|||
154867553|NCT01933672|558941346|FG006|Metformin Run-in Period|Other|0|||
154867554|NCT01933672|558941340|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867555|NCT01933672|558941341|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
155109560|NCT03110029|559828553|FG001|Overall Study|Withdrawal by Subject|1|||
155109561|NCT03281629|559828554|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
155109562|NCT03281629|559828555|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
155109563|NCT03281629|559828554|FG000|Overall Study|Death|0|||
155109564|NCT03281629|559828555|FG001|Overall Study|Death|1|||
155109565|NCT03281629|559828554|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
155109566|NCT03281629|559828555|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
155109567|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
155109568|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
155109569|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
155109570|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
155109571|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
155109572|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
155109573|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
155109574|NCT01673854|559828561|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
155109575|NCT01673854|559828561|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
155109576|NCT01673854|559828561|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
155109577|NCT01673854|559828561|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
154867556|NCT01933672|558941342|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867557|NCT01933672|558941343|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867558|NCT01933672|558941344|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
154867559|NCT01933672|558941345|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867560|NCT01933672|558941346|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867561|NCT01933672|558941340|FG000|First Intervention Period (12-16 Days)|Other|0|||
154867562|NCT01933672|558941341|FG001|First Intervention Period (12-16 Days)|Other|0|||
154867563|NCT01933672|558941342|FG002|First Intervention Period (12-16 Days)|Other|1|||
154867564|NCT01933672|558941343|FG003|First Intervention Period (12-16 Days)|Other|0|||
154867565|NCT01933672|558941344|FG004|First Intervention Period (12-16 Days)|Other|0|||
155174614|NCT01122264|560078235|FG000|Overall Study|Adverse Event|6|||
155174615|NCT01122264|560078236|FG001|Overall Study|Adverse Event|5|||
155174616|NCT01122264|560078237|FG002|Overall Study|Adverse Event|7|||
155174617|NCT01122264|560078235|FG000|Overall Study|Death|1|||
155174618|NCT01122264|560078236|FG001|Overall Study|Death|0|||
155174619|NCT01122264|560078237|FG002|Overall Study|Death|0|||
155174620|NCT01122264|560078235|FG000|Overall Study|Lost to Follow-up|5|||
155174621|NCT01122264|560078236|FG001|Overall Study|Lost to Follow-up|9|||
155174622|NCT01122264|560078237|FG002|Overall Study|Lost to Follow-up|13|||
155174623|NCT01122264|560078235|FG000|Overall Study|Entry Criteria Not Met|1|||
155174624|NCT01122264|560078236|FG001|Overall Study|Entry Criteria Not Met|0|||
155174625|NCT01122264|560078237|FG002|Overall Study|Entry Criteria Not Met|0|||
155174626|NCT01122264|560078235|FG000|Overall Study|Protocol Violation|7|||
155174627|NCT01122264|560078236|FG001|Overall Study|Protocol Violation|7|||
155174628|NCT01122264|560078237|FG002|Overall Study|Protocol Violation|9|||
155174629|NCT01122264|560078235|FG000|Overall Study|Withdrawal by Subject|6|||
155174630|NCT01122264|560078236|FG001|Overall Study|Withdrawal by Subject|6|||
155174631|NCT01122264|560078237|FG002|Overall Study|Withdrawal by Subject|16|||
155174632|NCT01122264|560078235|FG000|Overall Study|Physician Decision|3|||
155174633|NCT01122264|560078236|FG001|Overall Study|Physician Decision|1|||
155174634|NCT01122264|560078237|FG002|Overall Study|Physician Decision|1|||
155174635|NCT01122264|560078235|FG000|Overall Study|Lack of Efficacy|3|||
155174636|NCT01122264|560078236|FG001|Overall Study|Lack of Efficacy|1|||
155174637|NCT01122264|560078237|FG002|Overall Study|Lack of Efficacy|1|||
155174638|NCT00640224|560078238|FG000|Overall Study|Lost to Follow-up|5|||
155174639|NCT00640224|560078239|FG001|Overall Study|Lost to Follow-up|2|||
155174640|NCT00640224|560078240|FG002|Overall Study|Lost to Follow-up|0|||
155174641|NCT00640224|560078241|FG003|Overall Study|Lost to Follow-up|0|||
155174642|NCT00640224|560078238|FG000|Overall Study|Withdrawal by Subject|1|||
155174643|NCT00640224|560078239|FG001|Overall Study|Withdrawal by Subject|0|||
155174644|NCT00640224|560078240|FG002|Overall Study|Withdrawal by Subject|0|||
155174645|NCT00640224|560078241|FG003|Overall Study|Withdrawal by Subject|0|||
154867566|NCT01933672|558941345|FG005|First Intervention Period (12-16 Days)|Other|1|||
154867567|NCT01933672|558941346|FG006|First Intervention Period (12-16 Days)|Other|0|||
154867568|NCT01933672|558941340|FG000|Second Intervention Period (12-16 Days)|Other|0|||
154867569|NCT01933672|558941341|FG001|Second Intervention Period (12-16 Days)|Other|1|||
154867570|NCT01933672|558941342|FG002|Second Intervention Period (12-16 Days)|Other|1|||
155174646|NCT00640224|560078238|FG000|Overall Study|Headaches|0|||
155174647|NCT00640224|560078239|FG001|Overall Study|Headaches|1|||
155174648|NCT00640224|560078240|FG002|Overall Study|Headaches|0|||
155174649|NCT00640224|560078241|FG003|Overall Study|Headaches|0|||
155174650|NCT00422513|560078242|FG000|Overall Study|Lack of Efficacy|4|||
154867571|NCT01933672|558941343|FG003|Second Intervention Period (12-16 Days)|Other|0|||
154867572|NCT01933672|558941344|FG004|Second Intervention Period (12-16 Days)|Other|0|||
154867573|NCT01933672|558941345|FG005|Second Intervention Period (12-16 Days)|Other|0|||
154867574|NCT01933672|558941346|FG006|Second Intervention Period (12-16 Days)|Other|0|||
154867575|NCT01933672|558941340|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867576|NCT01933672|558941341|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867577|NCT01933672|558941342|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867578|NCT01933672|558941343|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
154867579|NCT01933672|558941344|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867580|NCT01933672|558941345|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867581|NCT01933672|558941346|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
154867582|NCT01933672|558941340|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
154867583|NCT01933672|558941341|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
154867584|NCT01933672|558941342|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
154867585|NCT01933672|558941343|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
154867586|NCT01933672|558941344|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
154867587|NCT01933672|558941345|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
155174651|NCT00422513|560078243|FG001|Overall Study|Lack of Efficacy|5|||
155174652|NCT00422513|560078242|FG000|Overall Study|Protocol Violation|23|||
155174653|NCT00422513|560078243|FG001|Overall Study|Protocol Violation|7|||
155174654|NCT00422513|560078242|FG000|Overall Study|Refused Treatment|4|||
154867588|NCT01933672|558941346|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
154867589|NCT05165394|558942984|FG000|Overall Study|Withdrawal by Subject|5|||
155174655|NCT00422513|560078243|FG001|Overall Study|Refused Treatment|2|||
155174656|NCT00422513|560078242|FG000|Overall Study|Withdrawal by Subject|2|||
155174657|NCT00422513|560078243|FG001|Overall Study|Withdrawal by Subject|1|||
155174658|NCT00422513|560078242|FG000|Overall Study|early termination of the study|67|||
155174659|NCT00422513|560078243|FG001|Overall Study|early termination of the study|80|||
155174660|NCT00422513|560078242|FG000|Overall Study|Adverse Event|4|||
155174661|NCT00422513|560078243|FG001|Overall Study|Adverse Event|4|||
155174662|NCT00422513|560078242|FG000|Overall Study|Death|3|||
155174663|NCT00422513|560078243|FG001|Overall Study|Death|7|||
155174664|NCT03135119|560078244|FG000|Overall Study|Lost to Follow-up|2|||
155174665|NCT03135119|560078245|FG001|Overall Study|Lost to Follow-up|0|||
155174666|NCT03135119|560078244|FG000|Overall Study|Physician Decision|1|||
155174667|NCT03135119|560078245|FG001|Overall Study|Physician Decision|1|||
155174668|NCT03135119|560078244|FG000|Overall Study|COVID-19 Shutdown|2|||
155174669|NCT03135119|560078245|FG001|Overall Study|COVID-19 Shutdown|2|||
155174670|NCT01478048|560078246|FG000|Overall Study|Disease Progression|52|||
155174671|NCT01478048|560078247|FG001|Overall Study|Disease Progression|35|||
155174672|NCT01478048|560078246|FG000|Overall Study|study drug toxicity|11|||
155174673|NCT01478048|560078247|FG001|Overall Study|study drug toxicity|14|||
155174674|NCT01478048|560078246|FG000|Overall Study|Adverse Event|2|||
155174675|NCT01478048|560078247|FG001|Overall Study|Adverse Event|11|||
155174676|NCT01478048|560078246|FG000|Overall Study|subject request to discontinue treatment|3|||
155174677|NCT01478048|560078247|FG001|Overall Study|subject request to discontinue treatment|5|||
155174678|NCT01478048|560078246|FG000|Overall Study|Withdrawal by Subject|2|||
155174679|NCT01478048|560078247|FG001|Overall Study|Withdrawal by Subject|5|||
155174680|NCT01478048|560078246|FG000|Overall Study|non-specified|6|||
155174681|NCT01478048|560078247|FG001|Overall Study|non-specified|4|||
155174682|NCT01478048|560078246|FG000|Overall Study|poor/non-compliance|0|||
155174683|NCT01478048|560078247|FG001|Overall Study|poor/non-compliance|1|||
155174684|NCT01478048|560078246|FG000|Overall Study|no longer meets study criteria|1|||
155174685|NCT01478048|560078247|FG001|Overall Study|no longer meets study criteria|0|||
155174686|NCT01369329|560078249|FG000|Overall Study|Withdrawal by Subject|8|||
154867590|NCT05165394|558942985|FG001|Overall Study|Withdrawal by Subject|1|||
154867591|NCT05165394|558942984|FG000|Overall Study|Lost to Follow-up|1|||
154867592|NCT05165394|558942985|FG001|Overall Study|Lost to Follow-up|2|||
154867593|NCT05165394|558942984|FG000|Overall Study|Other Than Specified|0|||
154867594|NCT05165394|558942985|FG001|Overall Study|Other Than Specified|1|||
154867595|NCT00001259|558942988|FG000|Study 2|Adverse Event|0|||
154867596|NCT00001259|558942989|FG001|Study 2|Adverse Event|0|||
154867597|NCT00001259|558942990|FG002|Study 2|Adverse Event|0|||
154867598|NCT00001259|558942991|FG003|Study 2|Adverse Event|0|||
154867599|NCT00001259|558942992|FG004|Study 2|Adverse Event|2|||
154867600|NCT00001259|558942993|FG005|Study 2|Adverse Event|0|||
154867601|NCT00001259|558942994|FG006|Study 2|Adverse Event|0|||
154867602|NCT03705494|558942995|FG000|Overall Study|Lost to Follow-up|2|||
154867603|NCT03705494|558942996|FG001|Overall Study|Lost to Follow-up|1|||
154867604|NCT03705494|558942995|FG000|Overall Study|Withdrawal by Subject|5|||
154867605|NCT03705494|558942996|FG001|Overall Study|Withdrawal by Subject|2|||
154867606|NCT01582282|558942997|FG000|Overall Study|Adverse Event|1|||
154867607|NCT01582282|558942998|FG001|Overall Study|Adverse Event|1|||
154867608|NCT01582282|558942999|FG002|Overall Study|Adverse Event|0|||
154867609|NCT01582282|558942997|FG000|Overall Study|Lost to Follow-up|1|||
154867610|NCT01582282|558942998|FG001|Overall Study|Lost to Follow-up|0|||
154867611|NCT01582282|558942999|FG002|Overall Study|Lost to Follow-up|0|||
154867612|NCT01582282|558942997|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
154867613|NCT01582282|558942998|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
154867614|NCT01582282|558942999|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
154867615|NCT03937986|558943001|FG000|Overall Study|COVID-19 Pandemic|1|||
154867616|NCT02839746|558943003|FG000|Overall Study|Not met selection criteria|12|||
154867617|NCT02089737|558943004|FG000|Overall Study|Survey form not completed|5|||
154867618|NCT02089737|558943004|FG000|Overall Study|Not treated|1|||
154867619|NCT01330381|558943005|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
154867620|NCT01330381|558943006|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
154973420|NCT02003222|559326882|FG003|Intensification|Never started treatment|0|||
154973421|NCT02003222|559326883|FG004|Intensification|Never started treatment|2|||
154973422|NCT02003222|559326879|FG000|Intensification|Adverse Event|0|||
154973423|NCT02003222|559326880|FG001|Intensification|Adverse Event|0|||
154973424|NCT02003222|559326881|FG002|Intensification|Adverse Event|0|||
154973425|NCT02003222|559326882|FG003|Intensification|Adverse Event|0|||
154973426|NCT02003222|559326883|FG004|Intensification|Adverse Event|6|||
154973427|NCT02003222|559326879|FG000|Intensification|Alternative therapy|0|||
154973428|NCT02003222|559326880|FG001|Intensification|Alternative therapy|0|||
154973429|NCT02003222|559326881|FG002|Intensification|Alternative therapy|0|||
155174687|NCT01369329|560078250|FG001|Overall Study|Withdrawal by Subject|6|||
155174688|NCT01369329|560078251|FG002|Overall Study|Withdrawal by Subject|10|||
155174689|NCT01369329|560078249|FG000|Overall Study|Lost to Follow-up|2|||
155174690|NCT01369329|560078250|FG001|Overall Study|Lost to Follow-up|2|||
155174691|NCT01369329|560078251|FG002|Overall Study|Lost to Follow-up|2|||
155174692|NCT01369329|560078249|FG000|Overall Study|Other|2|||
155174693|NCT01369329|560078250|FG001|Overall Study|Other|3|||
154867621|NCT01330381|558943007|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
154867622|NCT01330381|558943005|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
154867623|NCT01330381|558943006|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
155174694|NCT01369329|560078251|FG002|Overall Study|Other|2|||
155174695|NCT04644315|560078252|FG000|Overall Study|Subject withdrawal of consent|1|||
155174696|NCT01836276|560078253|FG000|Overall Study|Lost to Follow-up|28|||
155174697|NCT01836276|560078254|FG001|Overall Study|Lost to Follow-up|51|||
155174698|NCT01561898|560078257|FG000|Overall Study|Withdrawal by Subject|0|||
154867624|NCT01330381|558943007|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
154867625|NCT01330381|558943005|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
154867626|NCT01330381|558943006|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
154867627|NCT01330381|558943007|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
154867628|NCT01330381|558943005|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
154867629|NCT01330381|558943006|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
154867630|NCT01330381|558943007|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
154867631|NCT01330381|558943005|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
154867632|NCT01330381|558943006|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
154867633|NCT01330381|558943007|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
154867634|NCT01330381|558943005|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
154973430|NCT02003222|559326882|FG003|Intensification|Alternative therapy|0|||
154973431|NCT02003222|559326883|FG004|Intensification|Alternative therapy|8|||
154867635|NCT01330381|558943006|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
154867636|NCT01330381|558943007|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
154867637|NCT01330381|558943005|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
154867638|NCT01330381|558943006|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
154867639|NCT01330381|558943007|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
154867640|NCT01330381|558943005|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
154867641|NCT01330381|558943006|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
154867642|NCT01330381|558943007|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
154867643|NCT01330381|558943005|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
154867644|NCT01330381|558943006|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
154867645|NCT01330381|558943007|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
154867646|NCT01330381|558943005|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
154867647|NCT01330381|558943006|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
154867648|NCT01330381|558943007|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
154867649|NCT01272180|558943013|FG000|Overall Study|Adverse Event|0|||
154867650|NCT01272180|558943014|FG001|Overall Study|Adverse Event|0|||
154867651|NCT01272180|558943015|FG002|Overall Study|Adverse Event|1|||
154867652|NCT01272180|558943016|FG003|Overall Study|Adverse Event|0|||
154867653|NCT01272180|558943013|FG000|Overall Study|Withdrawal by Subject|2|||
154867654|NCT01272180|558943014|FG001|Overall Study|Withdrawal by Subject|6|||
154867655|NCT01272180|558943015|FG002|Overall Study|Withdrawal by Subject|3|||
154867656|NCT01272180|558943016|FG003|Overall Study|Withdrawal by Subject|2|||
154867657|NCT01272180|558943013|FG000|Overall Study|Lost to Follow-up|15|||
154867658|NCT01272180|558943014|FG001|Overall Study|Lost to Follow-up|14|||
154867659|NCT01272180|558943015|FG002|Overall Study|Lost to Follow-up|8|||
154867660|NCT01272180|558943016|FG003|Overall Study|Lost to Follow-up|10|||
154867661|NCT01272180|558943013|FG000|Overall Study|Inappropriate enrollment|0|||
154867662|NCT01272180|558943014|FG001|Overall Study|Inappropriate enrollment|0|||
154867663|NCT01272180|558943015|FG002|Overall Study|Inappropriate enrollment|1|||
154867664|NCT01272180|558943016|FG003|Overall Study|Inappropriate enrollment|1|||
154867665|NCT01272180|558943013|FG000|Overall Study|Protocol Violation|0|||
154867666|NCT01272180|558943014|FG001|Overall Study|Protocol Violation|1|||
154867667|NCT01272180|558943015|FG002|Overall Study|Protocol Violation|0|||
154867668|NCT01272180|558943016|FG003|Overall Study|Protocol Violation|1|||
154867669|NCT03351244|558943017|FG000|Overall Study|Adverse Event|7|||
154867670|NCT03351244|558943018|FG001|Overall Study|Adverse Event|11|||
154867671|NCT03351244|558943019|FG002|Overall Study|Adverse Event|12|||
154867672|NCT03351244|558943017|FG000|Overall Study|Investigator's decision|0|||
154867673|NCT03351244|558943018|FG001|Overall Study|Investigator's decision|0|||
154867674|NCT03351244|558943019|FG002|Overall Study|Investigator's decision|2|||
154867675|NCT03351244|558943017|FG000|Overall Study|System error|0|||
154867676|NCT03351244|558943018|FG001|Overall Study|System error|0|||
154867677|NCT03351244|558943019|FG002|Overall Study|System error|2|||
154867678|NCT03351244|558943017|FG000|Overall Study|COVID-19 restrictions|3|||
154867679|NCT03351244|558943018|FG001|Overall Study|COVID-19 restrictions|0|||
154867680|NCT03351244|558943019|FG002|Overall Study|COVID-19 restrictions|1|||
154867681|NCT03351244|558943017|FG000|Overall Study|Non-compliance|2|||
154867682|NCT03351244|558943018|FG001|Overall Study|Non-compliance|5|||
154867683|NCT03351244|558943019|FG002|Overall Study|Non-compliance|0|||
154867684|NCT03351244|558943017|FG000|Overall Study|Withdrawal by Subject|11|||
154867685|NCT03351244|558943018|FG001|Overall Study|Withdrawal by Subject|16|||
154867686|NCT03351244|558943019|FG002|Overall Study|Withdrawal by Subject|13|||
154867687|NCT03351244|558943017|FG000|Overall Study|Lost to Follow-up|2|||
154973432|NCT02003222|559326879|FG000|Intensification|Disease progression|0|||
154973433|NCT02003222|559326880|FG001|Intensification|Disease progression|0|||
154973434|NCT02003222|559326881|FG002|Intensification|Disease progression|0|||
154973435|NCT02003222|559326882|FG003|Intensification|Disease progression|0|||
154973436|NCT02003222|559326883|FG004|Intensification|Disease progression|18|||
154867688|NCT03351244|558943018|FG001|Overall Study|Lost to Follow-up|6|||
154867689|NCT03351244|558943019|FG002|Overall Study|Lost to Follow-up|4|||
154867690|NCT03351244|558943017|FG000|Overall Study|Protocol Violation|2|||
154867691|NCT03351244|558943018|FG001|Overall Study|Protocol Violation|2|||
154867692|NCT03351244|558943019|FG002|Overall Study|Protocol Violation|0|||
154867693|NCT01844076|558943024|FG000|Overall Study|Adverse Event|1|||
154867694|NCT01844076|558943025|FG001|Overall Study|Adverse Event|0|||
154867695|NCT01844076|558943026|FG002|Overall Study|Adverse Event|0|||
154867696|NCT01844076|558943027|FG003|Overall Study|Adverse Event|0|||
154867697|NCT01844076|558943024|FG000|Overall Study|Withdrawal by Subject|1|||
154867698|NCT01844076|558943025|FG001|Overall Study|Withdrawal by Subject|0|||
154867699|NCT01844076|558943026|FG002|Overall Study|Withdrawal by Subject|0|||
154867700|NCT01844076|558943027|FG003|Overall Study|Withdrawal by Subject|0|||
154867701|NCT00308620|558943035|FG000|Overall Study|Death|1|||
154867702|NCT00308620|558943036|FG001|Overall Study|Death|1|||
154867703|NCT00308620|558943037|FG002|Overall Study|Death|0|||
154867704|NCT00308620|558943035|FG000|Overall Study|Lost to Follow-up|0|||
154867705|NCT00308620|558943036|FG001|Overall Study|Lost to Follow-up|0|||
154867706|NCT00308620|558943037|FG002|Overall Study|Lost to Follow-up|1|||
154867707|NCT01025336|558943041|FG000|Overall Study|Protocol Violation|0|||
154867708|NCT01025336|558943042|FG001|Overall Study|Protocol Violation|0|||
154867709|NCT01025336|558943043|FG002|Overall Study|Protocol Violation|0|||
154867710|NCT01025336|558943044|FG003|Overall Study|Protocol Violation|2|||
154867711|NCT01025336|558943045|FG004|Overall Study|Protocol Violation|0|||
154867712|NCT00474253|558943046|FG000|Overall Study|Withdrew consent|2|||
154867713|NCT00474253|558943047|FG001|Overall Study|Withdrew consent|0|||
154867714|NCT00474253|558943046|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
154867715|NCT00474253|558943047|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
154867716|NCT00474253|558943046|FG000|Overall Study|Lost to Follow-up|1|||
154867717|NCT00474253|558943047|FG001|Overall Study|Lost to Follow-up|0|||
154867718|NCT00474253|558943046|FG000|Overall Study|Discharged prior to study completion|0|||
154867719|NCT00474253|558943047|FG001|Overall Study|Discharged prior to study completion|1|||
154867720|NCT01165229|558943048|FG000|Overall Study|Serious Adverse Event|456|||
154867721|NCT01165229|558943049|FG001|Overall Study|Serious Adverse Event|487|||
154867722|NCT01165229|558943048|FG000|Overall Study|Non-Serious Adverse Event|47|||
154867723|NCT01165229|558943049|FG001|Overall Study|Non-Serious Adverse Event|15|||
154867724|NCT01165229|558943048|FG000|Overall Study|Protocol Violation|6|||
154867725|NCT01165229|558943049|FG001|Overall Study|Protocol Violation|8|||
154867726|NCT01165229|558943048|FG000|Overall Study|Withdrawal by Subject|387|||
154867727|NCT01165229|558943049|FG001|Overall Study|Withdrawal by Subject|396|||
154867728|NCT01165229|558943048|FG000|Overall Study|Migrated/moved from study area|51|||
154867729|NCT01165229|558943049|FG001|Overall Study|Migrated/moved from study area|46|||
154867730|NCT01165229|558943048|FG000|Overall Study|Lost to Follow-up|123|||
154867731|NCT01165229|558943049|FG001|Overall Study|Lost to Follow-up|133|||
154867732|NCT01165229|558943048|FG000|Overall Study|Suspected HZ Episode|2|||
154867733|NCT01165229|558943049|FG001|Overall Study|Suspected HZ Episode|2|||
154867734|NCT01165229|558943048|FG000|Overall Study|No reason from the subject|108|||
154867735|NCT01165229|558943049|FG001|Overall Study|No reason from the subject|102|||
154867736|NCT01165229|558943048|FG000|Overall Study|Unknown completion status|0|||
154867737|NCT01165229|558943049|FG001|Overall Study|Unknown completion status|1|||
154867738|NCT01512368|558943052|FG000|Overall Study|Protocol Violation|3|||
154867739|NCT02532543|558943053|FG000|Overall Study|Lost to Follow-up|0|||
154867740|NCT02532543|558943054|FG001|Overall Study|Lost to Follow-up|0|||
154867741|NCT02532543|558943055|FG002|Overall Study|Lost to Follow-up|1|||
154867742|NCT02532543|558943056|FG003|Overall Study|Lost to Follow-up|0|||
154867743|NCT01319929|558943059|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
154867744|NCT01319929|558943060|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
154867745|NCT01319929|558943059|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
154867746|NCT01319929|558943060|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
154867747|NCT01319929|558943059|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
154867748|NCT01319929|558943060|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
155109578|NCT01673854|559828561|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
155109579|NCT00334737|559828562|FG000|Hospital Phase|Death|1|||
155109580|NCT00334737|559828563|FG001|Hospital Phase|Death|2|||
155109581|NCT00334737|559828564|FG002|Hospital Phase|Death|3|||
154867749|NCT01319929|558943059|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
154867750|NCT01319929|558943060|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
154867751|NCT01319929|558943059|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
154867752|NCT01319929|558943060|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
154867753|NCT01645280|558943062|FG000|Overall Study|Death|0|||
154867754|NCT01645280|558943063|FG001|Overall Study|Death|1|||
155109582|NCT00334737|559828562|FG000|Hospital Phase|Withdrawal by Subject|0|||
154867755|NCT01645280|558943064|FG002|Overall Study|Death|0|||
154867756|NCT01645280|558943065|FG003|Overall Study|Death|0|||
154867757|NCT01645280|558943066|FG004|Overall Study|Death|0|||
154867758|NCT01645280|558943062|FG000|Overall Study|Withdrawal by Subject|4|||
154867759|NCT01645280|558943063|FG001|Overall Study|Withdrawal by Subject|0|||
154867760|NCT01645280|558943064|FG002|Overall Study|Withdrawal by Subject|2|||
155174699|NCT01561898|560078258|FG001|Overall Study|Withdrawal by Subject|8|||
155174700|NCT01561898|560078259|FG002|Overall Study|Withdrawal by Subject|12|||
155174701|NCT01561898|560078260|FG003|Overall Study|Withdrawal by Subject|5|||
155174702|NCT01561898|560078257|FG000|Overall Study|Lack of Efficacy|0|||
155174703|NCT01561898|560078258|FG001|Overall Study|Lack of Efficacy|8|||
155174704|NCT01561898|560078259|FG002|Overall Study|Lack of Efficacy|10|||
155174705|NCT01561898|560078260|FG003|Overall Study|Lack of Efficacy|5|||
154867761|NCT01645280|558943065|FG003|Overall Study|Withdrawal by Subject|4|||
154867762|NCT01645280|558943066|FG004|Overall Study|Withdrawal by Subject|5|||
154867763|NCT01645280|558943062|FG000|Overall Study|Lost to Follow-up|0|||
154867764|NCT01645280|558943063|FG001|Overall Study|Lost to Follow-up|0|||
154867765|NCT01645280|558943064|FG002|Overall Study|Lost to Follow-up|0|||
154867766|NCT01645280|558943065|FG003|Overall Study|Lost to Follow-up|2|||
154867767|NCT01645280|558943066|FG004|Overall Study|Lost to Follow-up|1|||
154867768|NCT01645280|558943062|FG000|Overall Study|Other|1|||
154867769|NCT01645280|558943063|FG001|Overall Study|Other|1|||
154867770|NCT01645280|558943064|FG002|Overall Study|Other|2|||
154867771|NCT01645280|558943065|FG003|Overall Study|Other|0|||
154867772|NCT01645280|558943066|FG004|Overall Study|Other|0|||
154867773|NCT01645280|558943062|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
154867774|NCT01645280|558943063|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
154867775|NCT01645280|558943064|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
154867776|NCT01645280|558943065|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
154867777|NCT01645280|558943066|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
154867778|NCT03368404|558943080|FG000|Overall Study|Adverse Event|2|||
154867779|NCT03368404|558943081|FG001|Overall Study|Adverse Event|1|||
154867780|NCT03368404|558943080|FG000|Overall Study|Withdrawal by Subject|1|||
154867781|NCT03368404|558943081|FG001|Overall Study|Withdrawal by Subject|1|||
154867782|NCT01751646|558943087|FG000|Overall Study|Lost to Follow-up|5|||
154867783|NCT01751646|558943088|FG001|Overall Study|Lost to Follow-up|1|||
154867784|NCT01751646|558943087|FG000|Overall Study|Withdrawal by Subject|0|||
154867785|NCT01751646|558943088|FG001|Overall Study|Withdrawal by Subject|4|||
154867786|NCT01751646|558943087|FG000|Overall Study|Starting hormone therapy|1|||
154867787|NCT01751646|558943088|FG001|Overall Study|Starting hormone therapy|0|||
154867788|NCT01751646|558943087|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
154867789|NCT01751646|558943088|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
154867790|NCT01751646|558943087|FG000|Overall Study|Inadvertent enrollment|1|||
154867791|NCT01751646|558943088|FG001|Overall Study|Inadvertent enrollment|1|||
154867792|NCT01751646|558943087|FG000|Overall Study|Moved out of the area|1|||
154867793|NCT01751646|558943088|FG001|Overall Study|Moved out of the area|5|||
154867794|NCT01751646|558943087|FG000|Overall Study|Inability to attend required visits|0|||
154867795|NCT01751646|558943088|FG001|Overall Study|Inability to attend required visits|1|||
154867796|NCT01751646|558943087|FG000|Overall Study|Off study due to multiple obligations|0|||
154867797|NCT01751646|558943088|FG001|Overall Study|Off study due to multiple obligations|1|||
154867798|NCT01751646|558943087|FG000|Overall Study|Fails to comply with study requirements|0|||
154867799|NCT01751646|558943088|FG001|Overall Study|Fails to comply with study requirements|1|||
154867800|NCT01751646|558943087|FG000|Overall Study|Childcare issues|1|||
154867801|NCT01751646|558943088|FG001|Overall Study|Childcare issues|1|||
154867802|NCT02190591|558943089|FG000|Overall Study|Withdrawal by Subject|1|||
154867803|NCT02190591|558943090|FG001|Overall Study|Withdrawal by Subject|8|||
154867804|NCT02190591|558943089|FG000|Overall Study|Protocol Violation|1|||
154867805|NCT02190591|558943090|FG001|Overall Study|Protocol Violation|0|||
154867806|NCT02190591|558943089|FG000|Overall Study|did not use peanut ball as instructed|0|||
154867807|NCT02190591|558943090|FG001|Overall Study|did not use peanut ball as instructed|2|||
154867808|NCT02190591|558943089|FG000|Overall Study|face presentation so she was ineligible|0|||
154867809|NCT02190591|558943090|FG001|Overall Study|face presentation so she was ineligible|1|||
154867810|NCT00857246|558943091|FG000|Induction Regimen|Adverse Event|1|||
154867811|NCT00857246|558943091|FG000|Induction Regimen|disease-related complications|1|||
154867812|NCT00857246|558943091|FG000|Induction Regimen|Withdrawal by Subject|1|||
154867813|NCT00857246|558943091|FG000|Surgery (Curative)|disease progression|6|||
154867814|NCT00857246|558943091|FG000|ChemoRT|Withdrawal by Subject|1|||
154867815|NCT00857246|558943091|FG000|ChemoRT|Adverse Event|2|||
154867816|NCT02426086|558943092|FG000|Overall Study|Death|33|||
154867817|NCT02426086|558943093|FG001|Overall Study|Death|36|||
154867818|NCT02426086|558943092|FG000|Overall Study|Lost to Follow-up|2|||
155174706|NCT01561898|560078257|FG000|Overall Study|Worsening of complications|0|||
155174707|NCT01561898|560078258|FG001|Overall Study|Worsening of complications|1|||
155174708|NCT01561898|560078259|FG002|Overall Study|Worsening of complications|0|||
155174709|NCT01561898|560078260|FG003|Overall Study|Worsening of complications|0|||
154867819|NCT02426086|558943093|FG001|Overall Study|Lost to Follow-up|0|||
154867820|NCT02426086|558943092|FG000|Overall Study|Study Terminated by Sponsor|5|||
154867821|NCT02426086|558943093|FG001|Overall Study|Study Terminated by Sponsor|14|||
154867822|NCT02426086|558943092|FG000|Overall Study|Withdrawal by Subject|8|||
154867823|NCT02426086|558943093|FG001|Overall Study|Withdrawal by Subject|9|||
154867824|NCT04542291|558943094|FG000|Overall Study|Adverse Event|1|||
154867825|NCT04542291|558943094|FG000|Overall Study|Physician Decision|2|||
154867826|NCT00524303|558943095|FG000|Overall Study|Lost to Follow-up|6|||
154867827|NCT00524303|558943096|FG001|Overall Study|Lost to Follow-up|0|||
154867828|NCT00524303|558943097|FG002|Overall Study|Lost to Follow-up|3|||
154867829|NCT00524303|558943095|FG000|Overall Study|Protocol Violation|0|||
154867830|NCT00524303|558943096|FG001|Overall Study|Protocol Violation|1|||
154867831|NCT00524303|558943097|FG002|Overall Study|Protocol Violation|1|||
155109583|NCT00334737|559828563|FG001|Hospital Phase|Withdrawal by Subject|0|||
155109584|NCT00334737|559828564|FG002|Hospital Phase|Withdrawal by Subject|1|||
155109585|NCT00334737|559828562|FG000|Hospital Phase|Did not receive study drug|1|||
155109586|NCT00334737|559828563|FG001|Hospital Phase|Did not receive study drug|0|||
155109587|NCT00334737|559828564|FG002|Hospital Phase|Did not receive study drug|0|||
155109588|NCT00334737|559828562|FG000|Follow up Phase|Lost to Follow-up|5|||
155109589|NCT00334737|559828563|FG001|Follow up Phase|Lost to Follow-up|3|||
155109590|NCT00334737|559828564|FG002|Follow up Phase|Lost to Follow-up|6|||
155109591|NCT02316353|559828565|FG000|Overall Study|Pregnancy|1|||
155109592|NCT02316353|559828566|FG001|Overall Study|Pregnancy|3|||
155109593|NCT02316353|559828565|FG000|Overall Study|Adverse Event|1|||
155109594|NCT02316353|559828566|FG001|Overall Study|Adverse Event|3|||
155109595|NCT02316353|559828565|FG000|Overall Study|Withdrawal by Subject|6|||
155109596|NCT02316353|559828566|FG001|Overall Study|Withdrawal by Subject|2|||
155109597|NCT00375674|559828567|FG000|Overall Study|Other|26|||
155109598|NCT00375674|559828568|FG001|Overall Study|Other|18|||
155109599|NCT00375674|559828567|FG000|Overall Study|Death|67|||
155109600|NCT00375674|559828568|FG001|Overall Study|Death|76|||
155109601|NCT00375674|559828567|FG000|Overall Study|Participants refused further follow-up|31|||
155109602|NCT00375674|559828568|FG001|Overall Study|Participants refused further follow-up|30|||
155109603|NCT00375674|559828567|FG000|Overall Study|Lost to Follow-up|17|||
155109604|NCT00375674|559828568|FG001|Overall Study|Lost to Follow-up|15|||
155109605|NCT00375674|559828567|FG000|Overall Study|Enrolled but not treated|3|||
155109606|NCT00375674|559828568|FG001|Overall Study|Enrolled but not treated|2|||
155109607|NCT00875485|559831006|FG000|Challenge Dose Epoch|Pregnancy|1|||
155109608|NCT00875485|559831007|FG001|Challenge Dose Epoch|Pregnancy|0|||
155109609|NCT02908685|559831008|FG000|Part 1 OLE|Withdrawal by Subject|0|||
155109610|NCT02908685|559831009|FG001|Part 1 OLE|Withdrawal by Subject|0|||
155109611|NCT02908685|559831010|FG002|Part 1 OLE|Withdrawal by Subject|0|||
154867832|NCT00524303|558943095|FG000|Overall Study|Withdrawal by Subject|3|||
154867833|NCT00524303|558943096|FG001|Overall Study|Withdrawal by Subject|0|||
154867834|NCT00524303|558943097|FG002|Overall Study|Withdrawal by Subject|4|||
154867835|NCT00524303|558943095|FG000|Overall Study|Death|0|||
154867836|NCT00524303|558943096|FG001|Overall Study|Death|2|||
154867837|NCT00524303|558943097|FG002|Overall Study|Death|3|||
154867838|NCT00524303|558943095|FG000|Overall Study|Adverse Event|1|||
154867839|NCT00524303|558943096|FG001|Overall Study|Adverse Event|2|||
154867840|NCT00524303|558943097|FG002|Overall Study|Adverse Event|3|||
154867841|NCT00524303|558943095|FG000|Overall Study|Did not Complete Study Dosing|1|||
154867842|NCT00524303|558943096|FG001|Overall Study|Did not Complete Study Dosing|0|||
154867843|NCT00524303|558943097|FG002|Overall Study|Did not Complete Study Dosing|0|||
154867844|NCT00524303|558943095|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
154867845|NCT00524303|558943096|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
154867846|NCT00524303|558943097|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
154867847|NCT00524303|558943095|FG000|Overall Study|Disease Progression|0|||
154867848|NCT00524303|558943096|FG001|Overall Study|Disease Progression|4|||
154867849|NCT00524303|558943097|FG002|Overall Study|Disease Progression|1|||
154867850|NCT00524303|558943095|FG000|Overall Study|Disease Recurrence|0|||
154867851|NCT00524303|558943096|FG001|Overall Study|Disease Recurrence|1|||
154867852|NCT00524303|558943097|FG002|Overall Study|Disease Recurrence|0|||
154867853|NCT00524303|558943095|FG000|Overall Study|Sponsor Request|0|||
154867854|NCT00524303|558943096|FG001|Overall Study|Sponsor Request|0|||
154867855|NCT00524303|558943097|FG002|Overall Study|Sponsor Request|1|||
154867856|NCT00524303|558943095|FG000|Overall Study|Physician Decision|0|||
154867857|NCT00524303|558943096|FG001|Overall Study|Physician Decision|0|||
154867858|NCT00524303|558943097|FG002|Overall Study|Physician Decision|1|||
154867859|NCT00524303|558943095|FG000|Overall Study|Completed 5 years|0|||
154867860|NCT00524303|558943096|FG001|Overall Study|Completed 5 years|0|||
154867861|NCT00524303|558943097|FG002|Overall Study|Completed 5 years|1|||
154867862|NCT03478683|558943098|FG000|Overall Study|Adverse Event|5|||
154867863|NCT03478683|558943099|FG001|Overall Study|Adverse Event|3|||
154867864|NCT03478683|558943098|FG000|Overall Study|Lost to Follow-up|0|||
154867865|NCT03478683|558943099|FG001|Overall Study|Lost to Follow-up|5|||
154867866|NCT03478683|558943098|FG000|Overall Study|Physician Decision|1|||
154867867|NCT03478683|558943099|FG001|Overall Study|Physician Decision|3|||
154867868|NCT03478683|558943098|FG000|Overall Study|Withdrawal by Subject|7|||
154867869|NCT03478683|558943099|FG001|Overall Study|Withdrawal by Subject|7|||
155109612|NCT02908685|559831011|FG003|Part 1 OLE|Withdrawal by Subject|0|||
155109613|NCT02908685|559831012|FG004|Part 1 OLE|Withdrawal by Subject|0|||
154867870|NCT01607892|558943104|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
154867871|NCT01607892|558943105|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
155109614|NCT02908685|559831013|FG005|Part 1 OLE|Withdrawal by Subject|0|||
155109615|NCT02908685|559831014|FG006|Part 1 OLE|Withdrawal by Subject|0|||
154973437|NCT02003222|559326879|FG000|Intensification|Withdrawal by Subject|0|||
154973438|NCT02003222|559326880|FG001|Intensification|Withdrawal by Subject|0|||
154973439|NCT02003222|559326881|FG002|Intensification|Withdrawal by Subject|0|||
154973440|NCT02003222|559326882|FG003|Intensification|Withdrawal by Subject|0|||
154973441|NCT02003222|559326883|FG004|Intensification|Withdrawal by Subject|5|||
154973442|NCT02003222|559326879|FG000|Intensification|Other reasons|0|||
154973443|NCT02003222|559326880|FG001|Intensification|Other reasons|0|||
154973444|NCT02003222|559326881|FG002|Intensification|Other reasons|0|||
154973445|NCT02003222|559326882|FG003|Intensification|Other reasons|0|||
154973446|NCT02003222|559326883|FG004|Intensification|Other reasons|8|||
154973447|NCT01886872|559326889|FG000|Overall Study|Ineligible|7|||
154973448|NCT01886872|559326890|FG001|Overall Study|Ineligible|4|||
154973449|NCT01886872|559326891|FG002|Overall Study|Ineligible|12|||
154973450|NCT02167594|559326892|FG000|Overall Study|Withdrawal by Subject|2|||
154973451|NCT02167594|559326893|FG001|Overall Study|Withdrawal by Subject|0|||
154973452|NCT02167594|559326894|FG002|Overall Study|Withdrawal by Subject|0|||
154973453|NCT02167594|559326892|FG000|Overall Study|Death|0|||
154973454|NCT02167594|559326893|FG001|Overall Study|Death|1|||
154973455|NCT02167594|559326894|FG002|Overall Study|Death|0|||
154973456|NCT03294317|559326896|FG000|Overall Study|Physician Decision|1|||
155109616|NCT02908685|559831015|FG007|Part 1 OLE|Withdrawal by Subject|0|||
155109617|NCT02908685|559831016|FG008|Part 1 OLE|Withdrawal by Subject|0|||
155109618|NCT02908685|559831017|FG009|Part 1 OLE|Withdrawal by Subject|0|||
154867872|NCT01607892|558943106|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
154867873|NCT01607892|558943107|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
154867874|NCT01607892|558943108|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
154867875|NCT01607892|558943104|FG000|Overall Study|Death|4|||
154867876|NCT01607892|558943105|FG001|Overall Study|Death|2|||
154867877|NCT01607892|558943106|FG002|Overall Study|Death|8|||
154867878|NCT01607892|558943107|FG003|Overall Study|Death|10|||
154867879|NCT01607892|558943108|FG004|Overall Study|Death|3|||
154867880|NCT01607892|558943104|FG000|Overall Study|Investigator discretion|2|||
154867881|NCT01607892|558943105|FG001|Overall Study|Investigator discretion|4|||
154867882|NCT01607892|558943106|FG002|Overall Study|Investigator discretion|4|||
154867883|NCT01607892|558943107|FG003|Overall Study|Investigator discretion|8|||
154867884|NCT01607892|558943108|FG004|Overall Study|Investigator discretion|0|||
154867885|NCT01607892|558943104|FG000|Overall Study|Other treatments became available|1|||
154867886|NCT01607892|558943105|FG001|Overall Study|Other treatments became available|1|||
154867887|NCT01607892|558943106|FG002|Overall Study|Other treatments became available|0|||
154867888|NCT01607892|558943107|FG003|Overall Study|Other treatments became available|0|||
154867889|NCT01607892|558943108|FG004|Overall Study|Other treatments became available|2|||
154867890|NCT01607892|558943104|FG000|Overall Study|Intercurrent illness|1|||
154867891|NCT01607892|558943105|FG001|Overall Study|Intercurrent illness|0|||
154867892|NCT01607892|558943106|FG002|Overall Study|Intercurrent illness|0|||
154973457|NCT03294317|559326896|FG000|Overall Study|Withdrawal by Subject|6|||
154973458|NCT03294317|559326896|FG000|Overall Study|Lost to Follow-up|1|||
154973459|NCT03294317|559326896|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
154973460|NCT03294317|559326896|FG000|Overall Study|Failed HB lead implant|8|||
155109619|NCT02908685|559831018|FG010|Part 1 OLE|Withdrawal by Subject|2|||
155109620|NCT02908685|559831019|FG011|Part 1 OLE|Withdrawal by Subject|1|||
155109621|NCT02908685|559831020|FG012|Part 1 OLE|Withdrawal by Subject|0|||
155109622|NCT02908685|559831021|FG013|Part 1 OLE|Withdrawal by Subject|0|||
155109623|NCT02908685|559831008|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109624|NCT02908685|559831009|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109625|NCT02908685|559831010|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109626|NCT02908685|559831011|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109627|NCT02908685|559831012|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109628|NCT02908685|559831013|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109629|NCT02908685|559831014|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109630|NCT02908685|559831015|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109631|NCT02908685|559831016|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
154867893|NCT01607892|558943107|FG003|Overall Study|Intercurrent illness|3|||
154973461|NCT03294317|559326896|FG000|Overall Study|Received CRT instead|1|||
154973462|NCT03294317|559326896|FG000|Overall Study|Exited after lead revision|2|||
154973463|NCT02911935|559326897|FG000|Overall Study|Lost to Follow-up|5|||
154973464|NCT02911935|559326898|FG001|Overall Study|Lost to Follow-up|7|||
155109632|NCT02908685|559831017|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109633|NCT02908685|559831018|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
154973465|NCT00603512|559326899|FG000|Overall Study|Adverse Event|0|||
154973466|NCT00603512|559326900|FG001|Overall Study|Adverse Event|2|||
154973467|NCT00603512|559326901|FG002|Overall Study|Adverse Event|4|||
154973468|NCT00603512|559326902|FG003|Overall Study|Adverse Event|4|||
154973469|NCT00603512|559326903|FG004|Overall Study|Adverse Event|2|||
154973470|NCT00603512|559326899|FG000|Overall Study|Lack of Efficacy|0|||
154973471|NCT00603512|559326900|FG001|Overall Study|Lack of Efficacy|1|||
154973472|NCT00603512|559326901|FG002|Overall Study|Lack of Efficacy|0|||
155109634|NCT02908685|559831019|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
155109635|NCT02908685|559831020|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
155109636|NCT02908685|559831021|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
154867894|NCT01607892|558943108|FG004|Overall Study|Intercurrent illness|0|||
154867895|NCT01607892|558943104|FG000|Overall Study|Non-Compliance with study procedures|0|||
154867896|NCT01607892|558943105|FG001|Overall Study|Non-Compliance with study procedures|0|||
154867897|NCT01607892|558943106|FG002|Overall Study|Non-Compliance with study procedures|1|||
154867898|NCT01607892|558943107|FG003|Overall Study|Non-Compliance with study procedures|0|||
154867899|NCT01607892|558943108|FG004|Overall Study|Non-Compliance with study procedures|0|||
154867900|NCT01607892|558943104|FG000|Overall Study|Consent withdrawn by participant|9|||
154867901|NCT01607892|558943105|FG001|Overall Study|Consent withdrawn by participant|4|||
154867902|NCT01607892|558943106|FG002|Overall Study|Consent withdrawn by participant|24|||
154867903|NCT01607892|558943107|FG003|Overall Study|Consent withdrawn by participant|14|||
154867904|NCT01607892|558943108|FG004|Overall Study|Consent withdrawn by participant|4|||
154867905|NCT01607892|558943104|FG000|Overall Study|Disease progression|38|||
154867906|NCT01607892|558943105|FG001|Overall Study|Disease progression|13|||
154867907|NCT01607892|558943106|FG002|Overall Study|Disease progression|37|||
154867908|NCT01607892|558943107|FG003|Overall Study|Disease progression|57|||
154867909|NCT01607892|558943108|FG004|Overall Study|Disease progression|9|||
154867910|NCT01607892|558943104|FG000|Overall Study|Incidence or severity of Adverse events|3|||
154867911|NCT01607892|558943105|FG001|Overall Study|Incidence or severity of Adverse events|3|||
154867912|NCT01607892|558943106|FG002|Overall Study|Incidence or severity of Adverse events|7|||
154867913|NCT01607892|558943107|FG003|Overall Study|Incidence or severity of Adverse events|2|||
154867914|NCT01607892|558943108|FG004|Overall Study|Incidence or severity of Adverse events|6|||
154867915|NCT03022422|558943111|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
154867916|NCT03022422|558943112|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
154867917|NCT03022422|558943113|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
154867918|NCT03022422|558943114|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
154867919|NCT03022422|558943115|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
154867920|NCT03022422|558943116|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
154867921|NCT01287117|558943117|FG000|Overall Study|Adverse Event|2|||
154867922|NCT01287117|558943118|FG001|Overall Study|Adverse Event|1|||
154867923|NCT01287117|558943119|FG002|Overall Study|Adverse Event|1|||
154867924|NCT01287117|558943120|FG003|Overall Study|Adverse Event|1|||
154867925|NCT01287117|558943117|FG000|Overall Study|Lost to Follow-up|1|||
154867926|NCT01287117|558943118|FG001|Overall Study|Lost to Follow-up|1|||
154867927|NCT01287117|558943119|FG002|Overall Study|Lost to Follow-up|0|||
154867928|NCT01287117|558943120|FG003|Overall Study|Lost to Follow-up|0|||
154867929|NCT01287117|558943117|FG000|Overall Study|Physician Decision|0|||
154867930|NCT01287117|558943118|FG001|Overall Study|Physician Decision|1|||
154867931|NCT01287117|558943119|FG002|Overall Study|Physician Decision|1|||
154867932|NCT01287117|558943120|FG003|Overall Study|Physician Decision|1|||
154867933|NCT01287117|558943117|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
154867934|NCT01287117|558943118|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
154867935|NCT01287117|558943119|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
154867936|NCT01287117|558943120|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
154867937|NCT01287117|558943117|FG000|Overall Study|Disease Progression|10|||
154867938|NCT01287117|558943118|FG001|Overall Study|Disease Progression|5|||
154867939|NCT01287117|558943119|FG002|Overall Study|Disease Progression|6|||
154867940|NCT01287117|558943120|FG003|Overall Study|Disease Progression|5|||
154867941|NCT01769404|558943126|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
154867942|NCT01769404|558943127|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
154867943|NCT01769404|558943126|FG000|Treatment Period 1|Withdrawal by Subject|3|||
154867944|NCT01769404|558943127|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154867945|NCT01769404|558943126|FG000|Treatment Period 1|Sponsor decision|1|||
154867946|NCT01769404|558943127|FG001|Treatment Period 1|Sponsor decision|0|||
154867947|NCT01769404|558943126|FG000|Treatment Period 2|Sponsor decision|7|||
154867948|NCT01769404|558943127|FG001|Treatment Period 2|Sponsor decision|0|||
154867949|NCT02277444|558943139|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
154867950|NCT02277444|558943139|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
154867951|NCT02277444|558943139|FG000|Treatment Period (Week 0-52)|Other|1|||
154867952|NCT02277444|558943139|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
154867953|NCT02277444|558943139|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
154867954|NCT02277444|558943139|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
154867955|NCT02277444|558943139|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
154867956|NCT02277444|558943139|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
154867957|NCT02277444|558943139|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
154867958|NCT05278104|558943140|FG000|Overall Study|Not treated|1|||
154867959|NCT05278104|558943141|FG001|Overall Study|Not treated|0|||
154867960|NCT05278104|558943140|FG000|Overall Study|Adverse Event|2|||
154867961|NCT05278104|558943141|FG001|Overall Study|Adverse Event|1|||
154867962|NCT05278104|558943140|FG000|Overall Study|Exclusion criteria not met|1|||
154867963|NCT05278104|558943141|FG001|Overall Study|Exclusion criteria not met|0|||
154867964|NCT05635838|558945362|FG000|16-Week DBVC Period|Adverse Event|2|||
154867965|NCT05635838|558945363|FG001|16-Week DBVC Period|Adverse Event|0|||
154867966|NCT05635838|558945364|FG002|16-Week DBVC Period|Adverse Event|0|||
154867967|NCT05635838|558945365|FG003|16-Week DBVC Period|Adverse Event|0|||
154867968|NCT05635838|558945362|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
154867969|NCT05635838|558945363|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
154867970|NCT05635838|558945364|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
154867971|NCT05635838|558945365|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
155109637|NCT02908685|559831008|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
154867972|NCT05635838|558945362|FG000|16-Week DBVC Period|Physician Decision|0|||
154867973|NCT05635838|558945363|FG001|16-Week DBVC Period|Physician Decision|1|||
154867974|NCT05635838|558945364|FG002|16-Week DBVC Period|Physician Decision|0|||
154867975|NCT05635838|558945365|FG003|16-Week DBVC Period|Physician Decision|0|||
154867976|NCT05635838|558945362|FG000|16-Week DBVC Period|Protocol Violation|1|||
154867977|NCT05635838|558945363|FG001|16-Week DBVC Period|Protocol Violation|0|||
154867978|NCT05635838|558945364|FG002|16-Week DBVC Period|Protocol Violation|0|||
154867979|NCT05635838|558945365|FG003|16-Week DBVC Period|Protocol Violation|0|||
154867980|NCT05635838|558945362|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
154867981|NCT05635838|558945363|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
154867982|NCT05635838|558945364|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
154867983|NCT05635838|558945365|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
154867984|NCT05635838|558945362|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
154867985|NCT05635838|558945363|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
154867986|NCT05635838|558945364|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
154867987|NCT05635838|558945365|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
154867988|NCT05635838|558945362|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
154867989|NCT05635838|558945363|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
154867990|NCT05635838|558945364|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
154867991|NCT05635838|558945365|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
154867992|NCT05635838|558945362|FG000|16-Week OLE Period|Adverse Event|0|||
154867993|NCT05635838|558945363|FG001|16-Week OLE Period|Adverse Event|0|||
154867994|NCT05635838|558945364|FG002|16-Week OLE Period|Adverse Event|0|||
154867995|NCT05635838|558945365|FG003|16-Week OLE Period|Adverse Event|2|||
154867996|NCT05635838|558945362|FG000|16-Week OLE Period|Lost to Follow-up|0|||
154867997|NCT05635838|558945363|FG001|16-Week OLE Period|Lost to Follow-up|0|||
154867998|NCT05635838|558945364|FG002|16-Week OLE Period|Lost to Follow-up|1|||
154867999|NCT05635838|558945365|FG003|16-Week OLE Period|Lost to Follow-up|3|||
154868000|NCT05635838|558945362|FG000|16-Week OLE Period|Physician Decision|0|||
154868001|NCT05635838|558945363|FG001|16-Week OLE Period|Physician Decision|0|||
154868002|NCT05635838|558945364|FG002|16-Week OLE Period|Physician Decision|0|||
154868003|NCT05635838|558945365|FG003|16-Week OLE Period|Physician Decision|1|||
154868004|NCT05635838|558945362|FG000|16-Week OLE Period|Protocol Violation|0|||
154868005|NCT05635838|558945363|FG001|16-Week OLE Period|Protocol Violation|0|||
154868006|NCT05635838|558945364|FG002|16-Week OLE Period|Protocol Violation|1|||
154868007|NCT05635838|558945365|FG003|16-Week OLE Period|Protocol Violation|1|||
154868008|NCT05635838|558945362|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
154868009|NCT05635838|558945363|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
154868010|NCT05635838|558945364|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
154868011|NCT05635838|558945365|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
154868012|NCT05635838|558945362|FG000|16-Week OLE Period|Pregnancy|0|||
154868013|NCT05635838|558945363|FG001|16-Week OLE Period|Pregnancy|0|||
154868014|NCT05635838|558945364|FG002|16-Week OLE Period|Pregnancy|1|||
154868015|NCT05635838|558945365|FG003|16-Week OLE Period|Pregnancy|0|||
154868016|NCT02031146|558945367|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
154868017|NCT02031146|558945368|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
154868018|NCT02031146|558945369|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
154868019|NCT02031146|558945370|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
154868020|NCT02031146|558945371|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
154868021|NCT02031146|558945372|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
154868022|NCT02031146|558945373|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
154868023|NCT02629393|558945374|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
154868024|NCT02629393|558945374|FG000|Overall Study|Physician Decision|1|||
154868025|NCT00744055|558945375|FG000|Overall Study|Withdrawal by Subject|6|||
154868026|NCT00744055|558945376|FG001|Overall Study|Withdrawal by Subject|9|||
154868027|NCT00744055|558945375|FG000|Overall Study|Lack of Efficacy|0|||
154868028|NCT00744055|558945376|FG001|Overall Study|Lack of Efficacy|1|||
154868029|NCT00744055|558945375|FG000|Overall Study|Physician Decision|0|||
154868030|NCT00744055|558945376|FG001|Overall Study|Physician Decision|2|||
154868031|NCT00744055|558945375|FG000|Overall Study|Protocol Violation|1|||
155174710|NCT01561898|560078257|FG000|Overall Study|Lost to Follow-up|0|||
154868032|NCT00744055|558945376|FG001|Overall Study|Protocol Violation|1|||
154868033|NCT00744055|558945375|FG000|Overall Study|Lost to Follow-up|0|||
154868034|NCT00744055|558945376|FG001|Overall Study|Lost to Follow-up|1|||
154868035|NCT02413255|558945379|FG000|Overall Study|Voluntary Withdrawal|0|||
154868036|NCT02413255|558945380|FG001|Overall Study|Voluntary Withdrawal|0|||
155109638|NCT02908685|559831009|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109639|NCT02908685|559831010|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109640|NCT02908685|559831011|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109641|NCT02908685|559831012|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109642|NCT02908685|559831013|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109643|NCT02908685|559831014|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109644|NCT02908685|559831015|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109645|NCT02908685|559831016|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109646|NCT02908685|559831017|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109647|NCT02908685|559831018|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109648|NCT02908685|559831019|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109649|NCT02908685|559831020|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
155109650|NCT02908685|559831021|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
155109651|NCT02908685|559831008|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109652|NCT02908685|559831009|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109653|NCT02908685|559831010|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109654|NCT02908685|559831011|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109655|NCT02908685|559831012|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109656|NCT02908685|559831013|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109657|NCT02908685|559831014|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109658|NCT02908685|559831015|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
154868037|NCT02413255|558945381|FG002|Overall Study|Voluntary Withdrawal|0|||
154868038|NCT02413255|558945382|FG003|Overall Study|Voluntary Withdrawal|0|||
154868039|NCT02413255|558945383|FG004|Overall Study|Voluntary Withdrawal|0|||
154868040|NCT02413255|558945384|FG005|Overall Study|Voluntary Withdrawal|0|||
154868041|NCT02413255|558945385|FG006|Overall Study|Voluntary Withdrawal|0|||
154868042|NCT02413255|558945386|FG007|Overall Study|Voluntary Withdrawal|0|||
154868043|NCT02413255|558945387|FG008|Overall Study|Voluntary Withdrawal|0|||
154868044|NCT02413255|558945388|FG009|Overall Study|Voluntary Withdrawal|0|||
154868045|NCT02413255|558945389|FG010|Overall Study|Voluntary Withdrawal|0|||
154868046|NCT02413255|558945390|FG011|Overall Study|Voluntary Withdrawal|0|||
154868047|NCT02413255|558945391|FG012|Overall Study|Voluntary Withdrawal|0|||
154868048|NCT02413255|558945392|FG013|Overall Study|Voluntary Withdrawal|0|||
154868049|NCT02413255|558945393|FG014|Overall Study|Voluntary Withdrawal|1|||
154868050|NCT02413255|558945394|FG015|Overall Study|Voluntary Withdrawal|0|||
154868051|NCT02413255|558945395|FG016|Overall Study|Voluntary Withdrawal|0|||
154868052|NCT02760602|558945398|FG000|Overall Study|Withdrawal by Subject|1|||
154868053|NCT02760602|558945399|FG001|Overall Study|Withdrawal by Subject|0|||
154868054|NCT02760602|558945398|FG000|Overall Study|Terminated by sponsor|12|||
154868055|NCT02760602|558945399|FG001|Overall Study|Terminated by sponsor|13|||
154868056|NCT03056287|558945400|FG000|Overall Study|Withdrawal by Subject|0|||
154868057|NCT03056287|558945401|FG001|Overall Study|Withdrawal by Subject|1|||
154868058|NCT03056287|558945402|FG002|Overall Study|Withdrawal by Subject|0|||
154868059|NCT03056287|558945403|FG003|Overall Study|Withdrawal by Subject|0|||
154868060|NCT03056287|558945400|FG000|Overall Study|move out of area|0|||
154868061|NCT03056287|558945401|FG001|Overall Study|move out of area|0|||
154868062|NCT03056287|558945402|FG002|Overall Study|move out of area|1|||
154868063|NCT03056287|558945403|FG003|Overall Study|move out of area|1|||
154868064|NCT02424149|558945405|FG000|Overall Study|surgery cancelled|2|||
154868065|NCT02424149|558945406|FG001|Overall Study|surgery cancelled|0|||
154868066|NCT02424149|558945405|FG000|Overall Study|Withdrawal by Subject|0|||
154868067|NCT02424149|558945406|FG001|Overall Study|Withdrawal by Subject|1|||
154868068|NCT01357239|558945411|FG000|Stratum: All Patients|Adverse Event|0|||
154868069|NCT01357239|558945412|FG001|Stratum: All Patients|Adverse Event|0|||
154868070|NCT01357239|558945413|FG002|Stratum: All Patients|Adverse Event|1|||
154868071|NCT01357239|558945414|FG003|Stratum: All Patients|Adverse Event|1|||
154868072|NCT01357239|558945411|FG000|Stratum: All Patients|Subject withdrew consent|0|||
154868073|NCT01357239|558945412|FG001|Stratum: All Patients|Subject withdrew consent|0|||
154868074|NCT01357239|558945413|FG002|Stratum: All Patients|Subject withdrew consent|1|||
154868075|NCT01357239|558945414|FG003|Stratum: All Patients|Subject withdrew consent|1|||
154868076|NCT01357239|558945411|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
154868077|NCT01357239|558945412|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
154868078|NCT01357239|558945413|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
154868079|NCT01357239|558945414|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
154868080|NCT01357239|558945411|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
154868081|NCT01357239|558945412|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
154868082|NCT01357239|558945413|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
154868083|NCT01357239|558945414|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
154868084|NCT01357239|558945411|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
154868085|NCT01357239|558945412|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
154868086|NCT01357239|558945413|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
154868087|NCT01357239|558945414|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
154868088|NCT00852930|558945422|FG000|Overall Study|Withdrawal by Subject|1|||
154973473|NCT00603512|559326902|FG003|Overall Study|Lack of Efficacy|0|||
154973474|NCT00603512|559326903|FG004|Overall Study|Lack of Efficacy|1|||
154973475|NCT00603512|559326899|FG000|Overall Study|Other|2|||
154868089|NCT00852930|558945423|FG001|Overall Study|Withdrawal by Subject|1|||
154868090|NCT00852930|558945424|FG002|Overall Study|Withdrawal by Subject|1|||
154868091|NCT00852930|558945422|FG000|Overall Study|Physician Decision|0|||
154868092|NCT00852930|558945423|FG001|Overall Study|Physician Decision|0|||
154868093|NCT00852930|558945424|FG002|Overall Study|Physician Decision|1|||
154973476|NCT00603512|559326900|FG001|Overall Study|Other|1|||
154973477|NCT00603512|559326901|FG002|Overall Study|Other|0|||
154973478|NCT00603512|559326902|FG003|Overall Study|Other|1|||
154973479|NCT00603512|559326903|FG004|Overall Study|Other|1|||
154973480|NCT00603512|559326899|FG000|Overall Study|Withdrawal by Subject|0|||
154973481|NCT00603512|559326900|FG001|Overall Study|Withdrawal by Subject|0|||
154973482|NCT00603512|559326901|FG002|Overall Study|Withdrawal by Subject|0|||
154973483|NCT00603512|559326902|FG003|Overall Study|Withdrawal by Subject|0|||
154973484|NCT00603512|559326903|FG004|Overall Study|Withdrawal by Subject|1|||
154973485|NCT00603512|559326899|FG000|Overall Study|Randomized but not treated|0|||
154973486|NCT00603512|559326900|FG001|Overall Study|Randomized but not treated|1|||
154973487|NCT00603512|559326901|FG002|Overall Study|Randomized but not treated|1|||
154973488|NCT00603512|559326902|FG003|Overall Study|Randomized but not treated|2|||
154973489|NCT00603512|559326903|FG004|Overall Study|Randomized but not treated|0|||
154973490|NCT04979858|559326904|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
154973491|NCT04979858|559326905|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
154973492|NCT04253236|559326906|FG000|Overall Study|Adverse Event|1|||
154973493|NCT04253236|559326907|FG001|Overall Study|Adverse Event|0|||
154973494|NCT04253236|559326906|FG000|Overall Study|Safety Concerns|1|||
154973495|NCT04253236|559326907|FG001|Overall Study|Safety Concerns|0|||
154973496|NCT04253236|559326906|FG000|Overall Study|Study Terminated by Sponsor|1|||
154973497|NCT04253236|559326907|FG001|Overall Study|Study Terminated by Sponsor|0|||
154973498|NCT02169336|559326912|FG000|Overall Study|Lack of Efficacy|1|||
154973499|NCT02169336|559326913|FG001|Overall Study|Lack of Efficacy|1|||
154973500|NCT02169336|559326914|FG002|Overall Study|Lack of Efficacy|0|||
154973501|NCT02169336|559326912|FG000|Overall Study|Adverse Event|2|||
154973502|NCT02169336|559326913|FG001|Overall Study|Adverse Event|3|||
154973503|NCT02169336|559326914|FG002|Overall Study|Adverse Event|1|||
154973504|NCT02169336|559326912|FG000|Overall Study|Withdrawal by Subject|1|||
154973505|NCT02169336|559326913|FG001|Overall Study|Withdrawal by Subject|0|||
154973506|NCT02169336|559326914|FG002|Overall Study|Withdrawal by Subject|0|||
154973507|NCT02169336|559326912|FG000|Overall Study|Physician Decision|0|||
154973508|NCT02169336|559326913|FG001|Overall Study|Physician Decision|0|||
154973509|NCT02169336|559326914|FG002|Overall Study|Physician Decision|1|||
154973510|NCT02169336|559326912|FG000|Overall Study|Subject declined to continue dosing|0|||
154973511|NCT02169336|559326913|FG001|Overall Study|Subject declined to continue dosing|0|||
154973512|NCT02169336|559326914|FG002|Overall Study|Subject declined to continue dosing|1|||
154973513|NCT04718129|559326915|FG000|Overall Study|Lost to Follow-up|6|||
154973514|NCT04718129|559326916|FG001|Overall Study|Lost to Follow-up|7|||
154973515|NCT01598896|559326917|FG000|Overall Study|Withdrawal by Subject|0|||
154973516|NCT01598896|559326918|FG001|Overall Study|Withdrawal by Subject|1|||
154973517|NCT01598896|559326917|FG000|Overall Study|Lack of Efficacy|0|||
154973518|NCT01598896|559326918|FG001|Overall Study|Lack of Efficacy|1|||
154973519|NCT00420095|559326919|FG000|Overall Study|Adverse Event|1|||
154973520|NCT00420095|559326920|FG001|Overall Study|Adverse Event|0|||
154973521|NCT00420095|559326919|FG000|Overall Study|Protocol Violation|1|||
154973522|NCT00420095|559326920|FG001|Overall Study|Protocol Violation|1|||
154973523|NCT00420095|559326919|FG000|Overall Study|Lost to Follow-up|1|||
154973524|NCT00420095|559326920|FG001|Overall Study|Lost to Follow-up|0|||
154973525|NCT00393705|559326921|FG000|Overall Study|Adverse Event|0|||
154973526|NCT00393705|559326922|FG001|Overall Study|Adverse Event|2|||
154973527|NCT00393705|559326921|FG000|Overall Study|Death|0|||
155109659|NCT02908685|559831016|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
154973528|NCT00393705|559326922|FG001|Overall Study|Death|1|||
154973529|NCT00393705|559326921|FG000|Overall Study|Lost to Follow-up|2|||
154973530|NCT00393705|559326922|FG001|Overall Study|Lost to Follow-up|2|||
154973531|NCT00393705|559326921|FG000|Overall Study|Entry Criteria Not Met|10|||
154973532|NCT00393705|559326922|FG001|Overall Study|Entry Criteria Not Met|10|||
154973533|NCT00393705|559326921|FG000|Overall Study|Protocol Violation|4|||
154973534|NCT00393705|559326922|FG001|Overall Study|Protocol Violation|3|||
154973535|NCT00393705|559326921|FG000|Overall Study|Withdrawal by Subject|5|||
154973536|NCT00393705|559326922|FG001|Overall Study|Withdrawal by Subject|3|||
154973537|NCT00393705|559326921|FG000|Overall Study|Physician Decision|2|||
154973538|NCT00393705|559326922|FG001|Overall Study|Physician Decision|2|||
154973539|NCT01120691|559326925|FG000|Overall Study|Adverse Event|59|||
154973540|NCT01120691|559326926|FG001|Overall Study|Adverse Event|67|||
154868094|NCT00779038|558945425|FG000|Overall Study|Study Prematurely Terminated|13|||
154868095|NCT05372315|558945426|FG000|Overall Study|Withdrawal by Subject|1|||
154868096|NCT05372315|558945427|FG001|Overall Study|Withdrawal by Subject|0|||
154868097|NCT00328198|558945428|FG000|Treatment|Adverse Event|21|||
154868098|NCT00328198|558945428|FG000|Treatment|Death|1|||
154868099|NCT00328198|558945428|FG000|Treatment|Physician Decision|5|||
154868100|NCT00328198|558945428|FG000|Treatment|Withdrawal by Subject|5|||
154868101|NCT00328198|558945428|FG000|Treatment|Evidence of disease progression|2|||
155109660|NCT02908685|559831017|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
154868102|NCT00328198|558945428|FG000|Treatment|Non-compliance|1|||
154868103|NCT00328198|558945428|FG000|Treatment|Confirmed complete response, MRD -|3|||
154868104|NCT00328198|558945428|FG000|Follow-up|Lost to Follow-up|4|||
154868105|NCT00328198|558945428|FG000|Follow-up|Death|31|||
154868106|NCT00650585|558945429|FG000|Overall Study|Lost to Follow-up|505|||
154868107|NCT00650585|558945430|FG001|Overall Study|Lost to Follow-up|482|||
154868108|NCT00650585|558945429|FG000|Overall Study|No parental consent|935|||
154868109|NCT00650585|558945430|FG001|Overall Study|No parental consent|866|||
154868110|NCT00650585|558945429|FG000|Overall Study|Excluded/ruled ineligible|357|||
154868111|NCT00650585|558945430|FG001|Overall Study|Excluded/ruled ineligible|129|||
154868112|NCT02640612|558945433|FG000|Overall Study|Adverse Event|6|||
154868113|NCT02640612|558945434|FG001|Overall Study|Adverse Event|7|||
154868114|NCT02640612|558945435|FG002|Overall Study|Adverse Event|2|||
154868115|NCT02640612|558945433|FG000|Overall Study|Death|1|||
155109661|NCT02908685|559831018|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109662|NCT02908685|559831019|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109663|NCT02908685|559831020|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
155109664|NCT02908685|559831021|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
155109665|NCT02908685|559831008|FG000|Part 2 OLE: > Month 24|Death|0|||
155109666|NCT02908685|559831009|FG001|Part 2 OLE: > Month 24|Death|0|||
155109667|NCT02908685|559831010|FG002|Part 2 OLE: > Month 24|Death|0|||
155109668|NCT02908685|559831011|FG003|Part 2 OLE: > Month 24|Death|0|||
155109669|NCT02908685|559831012|FG004|Part 2 OLE: > Month 24|Death|0|||
155109670|NCT02908685|559831013|FG005|Part 2 OLE: > Month 24|Death|0|||
155109671|NCT02908685|559831014|FG006|Part 2 OLE: > Month 24|Death|0|||
155109672|NCT02908685|559831015|FG007|Part 2 OLE: > Month 24|Death|0|||
155109673|NCT02908685|559831016|FG008|Part 2 OLE: > Month 24|Death|0|||
155109674|NCT02908685|559831017|FG009|Part 2 OLE: > Month 24|Death|0|||
155109675|NCT02908685|559831018|FG010|Part 2 OLE: > Month 24|Death|0|||
155109676|NCT02908685|559831019|FG011|Part 2 OLE: > Month 24|Death|0|||
155109677|NCT02908685|559831020|FG012|Part 2 OLE: > Month 24|Death|1|||
155109678|NCT02908685|559831021|FG013|Part 2 OLE: > Month 24|Death|0|||
155109679|NCT02908685|559831008|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
155109680|NCT02908685|559831009|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
155109681|NCT02908685|559831010|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
155109682|NCT02908685|559831011|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
155109683|NCT02908685|559831012|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
155109684|NCT02908685|559831013|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
155109685|NCT02908685|559831014|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
155109686|NCT02908685|559831015|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
155109687|NCT02908685|559831016|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
155109688|NCT02908685|559831017|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
155109689|NCT02908685|559831018|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
155109690|NCT02908685|559831019|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
155109691|NCT02908685|559831020|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
155109692|NCT02908685|559831021|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
155109693|NCT02908685|559831008|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109694|NCT02908685|559831009|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109695|NCT02908685|559831010|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109696|NCT02908685|559831011|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109697|NCT02908685|559831012|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109698|NCT02908685|559831013|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109699|NCT02908685|559831014|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109700|NCT02908685|559831015|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109701|NCT02908685|559831016|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
154868116|NCT02640612|558945434|FG001|Overall Study|Death|0|||
154868117|NCT02640612|558945435|FG002|Overall Study|Death|0|||
154868118|NCT02640612|558945433|FG000|Overall Study|Withdrawal by Subject|10|||
154868119|NCT02640612|558945434|FG001|Overall Study|Withdrawal by Subject|3|||
155109702|NCT02908685|559831017|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109703|NCT02908685|559831018|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109704|NCT02908685|559831019|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
155109705|NCT02908685|559831020|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
155109706|NCT02908685|559831021|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
154868120|NCT02640612|558945435|FG002|Overall Study|Withdrawal by Subject|3|||
154868121|NCT02640612|558945433|FG000|Overall Study|Lost to Follow-up|4|||
154868122|NCT02640612|558945434|FG001|Overall Study|Lost to Follow-up|1|||
154868123|NCT02640612|558945435|FG002|Overall Study|Lost to Follow-up|1|||
154868124|NCT02640612|558945433|FG000|Overall Study|Protocol Violation|0|||
154868125|NCT02640612|558945434|FG001|Overall Study|Protocol Violation|2|||
154868126|NCT02640612|558945435|FG002|Overall Study|Protocol Violation|0|||
154868127|NCT02640612|558945433|FG000|Overall Study|Lack of Efficacy|1|||
154868128|NCT02640612|558945434|FG001|Overall Study|Lack of Efficacy|1|||
154868129|NCT02640612|558945435|FG002|Overall Study|Lack of Efficacy|0|||
154868130|NCT03865407|558945451|FG000|Overall Study|Adverse Event|1|||
154868131|NCT03865407|558945452|FG001|Overall Study|Adverse Event|0|||
154868132|NCT03865407|558945451|FG000|Overall Study|Withdrawal by Subject|1|||
154868133|NCT03865407|558945452|FG001|Overall Study|Withdrawal by Subject|0|||
154868134|NCT03865407|558945451|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
154868135|NCT03865407|558945452|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
154868136|NCT02117050|558945454|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
154868137|NCT00546819|558945459|FG000|Overall Study|Adverse Event|2|||
154868138|NCT00546819|558945460|FG001|Overall Study|Adverse Event|3|||
154868139|NCT00546819|558945459|FG000|Overall Study|Lost to Follow-up|2|||
154868140|NCT00546819|558945460|FG001|Overall Study|Lost to Follow-up|1|||
154868141|NCT00546819|558945459|FG000|Overall Study|Withdrawal by Subject|4|||
154868142|NCT00546819|558945460|FG001|Overall Study|Withdrawal by Subject|2|||
154868143|NCT03849560|558945461|FG000|Overall Study|Withdrawal by Subject|1|||
154868144|NCT03849560|558945462|FG001|Overall Study|Withdrawal by Subject|0|||
154868145|NCT03849560|558945463|FG002|Overall Study|Withdrawal by Subject|0|||
154868146|NCT01254344|558945468|FG000|Overall Study|Adverse Event|2|||
154868147|NCT01254344|558945469|FG001|Overall Study|Adverse Event|5|||
154868148|NCT01254344|558945468|FG000|Overall Study|Physician Decision|7|||
154868149|NCT01254344|558945469|FG001|Overall Study|Physician Decision|4|||
154868150|NCT01254344|558945468|FG000|Overall Study|Protocol Violation|1|||
154868151|NCT01254344|558945469|FG001|Overall Study|Protocol Violation|4|||
154868152|NCT01254344|558945468|FG000|Overall Study|Withdrawal by Subject|3|||
154868153|NCT01254344|558945469|FG001|Overall Study|Withdrawal by Subject|6|||
154868154|NCT00467649|558945470|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
154868155|NCT00467649|558945471|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
154868156|NCT00467649|558945472|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
154868157|NCT00467649|558945473|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
154868158|NCT00467649|558945474|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
154868159|NCT00467649|558945475|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
154868160|NCT00467649|558945470|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
154868161|NCT00467649|558945471|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
154868162|NCT00467649|558945472|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
154868163|NCT00467649|558945473|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
154868164|NCT00467649|558945474|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
154868165|NCT00467649|558945475|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
154868166|NCT00467649|558945470|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
154868167|NCT00467649|558945471|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
154868168|NCT00467649|558945472|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
154868169|NCT00467649|558945473|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
154868170|NCT00467649|558945474|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
154868171|NCT00467649|558945475|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
154868172|NCT00467649|558945470|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
154868173|NCT00467649|558945471|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
154868174|NCT00467649|558945472|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
154868175|NCT00467649|558945473|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
154868176|NCT00467649|558945474|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
154868177|NCT00467649|558945475|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
154868178|NCT00467649|558945470|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
154868179|NCT00467649|558945471|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
154868180|NCT00467649|558945472|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
154868181|NCT00467649|558945473|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
155174711|NCT01561898|560078258|FG001|Overall Study|Lost to Follow-up|0|||
154868182|NCT00467649|558945474|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
154868183|NCT00467649|558945475|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
154868184|NCT00467649|558945470|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
154868185|NCT00467649|558945471|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
155174712|NCT01561898|560078259|FG002|Overall Study|Lost to Follow-up|1|||
154868186|NCT00467649|558945472|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
154868187|NCT00467649|558945473|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
154868188|NCT00467649|558945474|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
154868189|NCT00467649|558945475|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
154868190|NCT00467649|558945470|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
155174713|NCT01561898|560078260|FG003|Overall Study|Lost to Follow-up|0|||
155174714|NCT01561898|560078257|FG000|Overall Study|Adverse Event|1|||
155174715|NCT01561898|560078258|FG001|Overall Study|Adverse Event|19|||
155174716|NCT01561898|560078259|FG002|Overall Study|Adverse Event|14|||
155174717|NCT01561898|560078260|FG003|Overall Study|Adverse Event|9|||
155174718|NCT01561898|560078257|FG000|Overall Study|Physician Decision|1|||
155174719|NCT01561898|560078258|FG001|Overall Study|Physician Decision|5|||
155174720|NCT01561898|560078259|FG002|Overall Study|Physician Decision|7|||
155174721|NCT01561898|560078260|FG003|Overall Study|Physician Decision|1|||
155174722|NCT00331552|560078261|FG000|Period 3: Phase II|Neurological Symptoms|1|||
155174723|NCT00331552|560078262|FG001|Period 3: Phase II|Neurological Symptoms|0|||
155174724|NCT00331552|560078261|FG000|Period 3: Phase II|Severe Nausea|1|||
155174725|NCT00331552|560078262|FG001|Period 3: Phase II|Severe Nausea|0|||
155174726|NCT01883453|560078263|FG000|Overall Study|No episode of common cold|25|||
155174727|NCT01883453|560078264|FG001|Overall Study|No episode of common cold|23|||
155174728|NCT03560518|560078273|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
155174729|NCT03560518|560078274|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
155174730|NCT03560518|560078275|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
155174731|NCT03560518|560078273|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
155174732|NCT03560518|560078274|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
155174733|NCT03560518|560078275|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
155174734|NCT03560518|560078273|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155174735|NCT03560518|560078274|FG001|Double Blind Treatment Period|Protocol Violation|2|||
155174736|NCT03560518|560078275|FG002|Double Blind Treatment Period|Protocol Violation|0|||
155174737|NCT03560518|560078273|FG000|Double Blind Treatment Period|Pregnancy|0|||
155174738|NCT03560518|560078274|FG001|Double Blind Treatment Period|Pregnancy|2|||
155174739|NCT03560518|560078275|FG002|Double Blind Treatment Period|Pregnancy|0|||
155174740|NCT03560518|560078273|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
155174741|NCT03560518|560078274|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
155174742|NCT03560518|560078275|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
155174743|NCT03560518|560078273|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
155174744|NCT03560518|560078274|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
155174745|NCT03560518|560078275|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
155174746|NCT03560518|560078273|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
155174747|NCT03560518|560078274|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
155174748|NCT03560518|560078275|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
155174749|NCT03560518|560078273|FG000|Double Blind Treatment Period|Adverse Event|0|||
155174750|NCT03560518|560078274|FG001|Double Blind Treatment Period|Adverse Event|3|||
155174751|NCT03560518|560078275|FG002|Double Blind Treatment Period|Adverse Event|1|||
155174752|NCT00159822|560078276|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
155174753|NCT00159822|560078276|FG000|Voriconazole Treatment Period|Adverse Event|9|||
155174754|NCT00159822|560078276|FG000|Voriconazole Treatment Period|Death|4|||
155174755|NCT00159822|560078276|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
155174756|NCT00159822|560078276|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
155174757|NCT00159822|560078276|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
155174758|NCT00159822|560078276|FG000|Post-treatment Follow-up Period|Death|1|||
155174759|NCT00159822|560078276|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
155174760|NCT00159822|560078276|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
155174761|NCT01133990|560078278|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
155174762|NCT01133990|560078279|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155174763|NCT01133990|560078280|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155174764|NCT01133990|560078281|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155174765|NCT01133990|560078282|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155174766|NCT01133990|560078283|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155174767|NCT01133990|560078278|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
155174768|NCT01133990|560078279|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155174769|NCT01133990|560078280|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
154973541|NCT01120691|559326927|FG002|Overall Study|Adverse Event|47|||
154973542|NCT01120691|559326925|FG000|Overall Study|Subject withdrew consent|33|||
154973543|NCT01120691|559326926|FG001|Overall Study|Subject withdrew consent|50|||
155174770|NCT01133990|560078281|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155174771|NCT01133990|560078282|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155174772|NCT01133990|560078283|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
155174773|NCT01133990|560078278|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155174774|NCT01133990|560078279|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155174775|NCT01133990|560078280|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
154973544|NCT01120691|559326927|FG002|Overall Study|Subject withdrew consent|44|||
155174776|NCT01133990|560078281|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155174777|NCT01133990|560078282|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155174778|NCT01133990|560078283|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
154973545|NCT01120691|559326925|FG000|Overall Study|Death|21|||
154973546|NCT01120691|559326926|FG001|Overall Study|Death|22|||
154973547|NCT01120691|559326927|FG002|Overall Study|Death|24|||
154973548|NCT01120691|559326925|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
154973549|NCT01120691|559326926|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
154973550|NCT01120691|559326927|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
154973551|NCT01120691|559326925|FG000|Overall Study|Administrative problems|15|||
154973552|NCT01120691|559326926|FG001|Overall Study|Administrative problems|8|||
154973553|NCT01120691|559326927|FG002|Overall Study|Administrative problems|9|||
154973554|NCT01120691|559326925|FG000|Overall Study|Protocol deviation|13|||
154973555|NCT01120691|559326926|FG001|Overall Study|Protocol deviation|12|||
154973556|NCT01120691|559326927|FG002|Overall Study|Protocol deviation|12|||
154973557|NCT01120691|559326925|FG000|Overall Study|Lost to Follow-up|5|||
154973558|NCT01120691|559326926|FG001|Overall Study|Lost to Follow-up|6|||
154973559|NCT01120691|559326927|FG002|Overall Study|Lost to Follow-up|4|||
154973560|NCT01120691|559326925|FG000|Overall Study|Abnormal test procedure result(s)|3|||
154973561|NCT01120691|559326926|FG001|Overall Study|Abnormal test procedure result(s)|2|||
154973562|NCT01120691|559326927|FG002|Overall Study|Abnormal test procedure result(s)|1|||
154973563|NCT01120691|559326925|FG000|Overall Study|Patient's inability to use the device|3|||
154973564|NCT01120691|559326926|FG001|Overall Study|Patient's inability to use the device|1|||
154973565|NCT01120691|559326927|FG002|Overall Study|Patient's inability to use the device|0|||
154973566|NCT01120691|559326925|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154973567|NCT01120691|559326926|FG001|Overall Study|Abnormal laboratory value(s)|3|||
154973568|NCT01120691|559326927|FG002|Overall Study|Abnormal laboratory value(s)|4|||
154973569|NCT03370510|559326931|FG000|Overall Study|COVID-19|2|||
154973570|NCT03370510|559326932|FG001|Overall Study|COVID-19|0|||
154973571|NCT00688844|559326933|FG000|Overall Study|Lost to Follow-up|10|||
154973572|NCT01223027|559326936|FG000|Overall Study|Adverse Event|20|||
154973573|NCT01223027|559326937|FG001|Overall Study|Adverse Event|10|||
154973574|NCT01223027|559326936|FG000|Overall Study|Death|42|||
154973575|NCT01223027|559326937|FG001|Overall Study|Death|42|||
154973576|NCT01223027|559326936|FG000|Overall Study|Lost to Follow-up|2|||
154973577|NCT01223027|559326937|FG001|Overall Study|Lost to Follow-up|1|||
154973578|NCT01223027|559326936|FG000|Overall Study|Physician Decision|4|||
154973579|NCT01223027|559326937|FG001|Overall Study|Physician Decision|8|||
154973580|NCT01223027|559326936|FG000|Overall Study|Progressive Disease|167|||
154973581|NCT01223027|559326937|FG001|Overall Study|Progressive Disease|183|||
154973582|NCT01223027|559326936|FG000|Overall Study|Protocol Violation|2|||
154973583|NCT01223027|559326937|FG001|Overall Study|Protocol Violation|1|||
154973584|NCT01223027|559326936|FG000|Overall Study|Subject/guardian decicion|18|||
154973585|NCT01223027|559326937|FG001|Overall Study|Subject/guardian decicion|16|||
154973586|NCT01223027|559326936|FG000|Overall Study|New therapy for study indication|17|||
154973587|NCT01223027|559326937|FG001|Overall Study|New therapy for study indication|8|||
154973588|NCT01223027|559326936|FG000|Overall Study|Study terminated by sponsor|2|||
154973589|NCT01223027|559326937|FG001|Overall Study|Study terminated by sponsor|8|||
154973590|NCT01475487|559326938|FG000|Overall Study|had to leave early for personal reasons|2|||
154973591|NCT01475487|559326939|FG001|Overall Study|had to leave early for personal reasons|1|||
154973592|NCT04428645|559326942|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
154973593|NCT01321697|559326943|FG000|Overall Study|Study Terminated|7|||
154973594|NCT00857818|559326944|FG000|Overall Study|Lack of Efficacy|1|||
154973595|NCT00857818|559326945|FG001|Overall Study|Lack of Efficacy|0|||
154973596|NCT00857818|559326944|FG000|Overall Study|Adverse Event|3|||
154973597|NCT00857818|559326945|FG001|Overall Study|Adverse Event|0|||
154973598|NCT00857818|559326944|FG000|Overall Study|Withdrawal by Subject|0|||
154973599|NCT00857818|559326945|FG001|Overall Study|Withdrawal by Subject|4|||
154973600|NCT00857818|559326944|FG000|Overall Study|Sponsor terminated study|6|||
154973601|NCT00857818|559326945|FG001|Overall Study|Sponsor terminated study|4|||
154973602|NCT00857818|559326944|FG000|Overall Study|Investigator decision|1|||
154973603|NCT00857818|559326945|FG001|Overall Study|Investigator decision|0|||
154973604|NCT01049581|559326946|FG000|Overall Study|Lost to Follow-up|2|||
154973605|NCT01049581|559326947|FG001|Overall Study|Lost to Follow-up|1|||
154973606|NCT02061280|559326951|FG000|Overall Study|Protocol Violation|12|||
154973607|NCT02061280|559326952|FG001|Overall Study|Protocol Violation|8|||
154973608|NCT02061280|559326951|FG000|Overall Study|moved out of state|0|||
154973609|NCT02061280|559326952|FG001|Overall Study|moved out of state|1|||
154973610|NCT02061280|559326951|FG000|Overall Study|Withdrawal by Subject|1|||
154973611|NCT02061280|559326952|FG001|Overall Study|Withdrawal by Subject|2|||
154973612|NCT02061280|559326951|FG000|Overall Study|Lost to Follow-up|5|||
154973613|NCT02061280|559326952|FG001|Overall Study|Lost to Follow-up|1|||
154973614|NCT01977456|559326953|FG000|Overall Study|Death|5|||
154973615|NCT00683592|559328871|FG000|Overall Study|Adverse Event|12|||
154973616|NCT00683592|559328872|FG001|Overall Study|Adverse Event|4|||
154973617|NCT00683592|559328871|FG000|Overall Study|Withdrawal by Subject|11|||
154973618|NCT00683592|559328872|FG001|Overall Study|Withdrawal by Subject|11|||
154973619|NCT00683592|559328871|FG000|Overall Study|Lost to Follow-up|17|||
154973620|NCT00683592|559328872|FG001|Overall Study|Lost to Follow-up|17|||
154973621|NCT00683592|559328871|FG000|Overall Study|Lack of Efficacy|3|||
154973622|NCT00683592|559328872|FG001|Overall Study|Lack of Efficacy|7|||
154973623|NCT00683592|559328871|FG000|Overall Study|Physician Decision|0|||
154973624|NCT00683592|559328872|FG001|Overall Study|Physician Decision|1|||
154973625|NCT00683592|559328871|FG000|Overall Study|Non-compliance|3|||
154973626|NCT00683592|559328872|FG001|Overall Study|Non-compliance|5|||
154973627|NCT00683592|559328871|FG000|Overall Study|Other|1|||
154973628|NCT00683592|559328872|FG001|Overall Study|Other|1|||
154973629|NCT03303417|559328880|FG000|Overall Study|Withdrawal by Subject|1|||
154973630|NCT03303417|559328881|FG001|Overall Study|Withdrawal by Subject|1|||
154973631|NCT02697617|559328882|FG000|Overall Study|Withdrawal by Subject|0|||
154973632|NCT02697617|559328883|FG001|Overall Study|Withdrawal by Subject|2|||
154973633|NCT02697617|559328882|FG000|Overall Study|Pregnancy|1|||
154973634|NCT02697617|559328883|FG001|Overall Study|Pregnancy|0|||
154973635|NCT00381849|559328886|FG000|Wash Out|Withdrawal by Subject|0|||
154973636|NCT00381849|559328887|FG001|Wash Out|Withdrawal by Subject|1|||
154973637|NCT01765270|559328889|FG000|Overall Study|Physician Decision|1|||
154973638|NCT01765270|559328890|FG001|Overall Study|Physician Decision|0|||
154973639|NCT01765270|559328889|FG000|Overall Study|Withdrawal by Subject|0|||
154973640|NCT01765270|559328890|FG001|Overall Study|Withdrawal by Subject|1|||
154973641|NCT02419573|559328891|FG000|Overall Study|Lost to Follow-up|3|||
154973642|NCT02419573|559328892|FG001|Overall Study|Lost to Follow-up|0|||
154973643|NCT02419573|559328891|FG000|Overall Study|Withdrawal by Subject|1|||
154973644|NCT02419573|559328892|FG001|Overall Study|Withdrawal by Subject|0|||
154973645|NCT00329160|559328893|FG000|Overall Study|Adverse Event|27|||
154973646|NCT00329160|559328893|FG000|Overall Study|Withdrawal by Subject|13|||
154973647|NCT00329160|559328893|FG000|Overall Study|Protocol Violation|2|||
154973648|NCT00329160|559328893|FG000|Overall Study|Did not Receive Study Drug|1|||
154868191|NCT00467649|558945471|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
154868192|NCT00467649|558945472|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
154868193|NCT00467649|558945473|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
154868194|NCT00467649|558945474|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
154868195|NCT00467649|558945475|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
154868196|NCT01633060|558945476|FG000|Randomization Phase|Protocol deviation|1|||
154868197|NCT01633060|558945477|FG001|Randomization Phase|Protocol deviation|2|||
154868198|NCT01633060|558945476|FG000|Randomization Phase|Technical problem|0|||
154868199|NCT01633060|558945477|FG001|Randomization Phase|Technical problem|1|||
154868200|NCT01633060|558945476|FG000|Treatment Phase|Adverse Event|24|||
154868201|NCT01633060|558945477|FG001|Treatment Phase|Adverse Event|3|||
154868202|NCT01633060|558945476|FG000|Treatment Phase|Lost to Follow-up|1|||
154868203|NCT01633060|558945477|FG001|Treatment Phase|Lost to Follow-up|0|||
154868204|NCT01633060|558945476|FG000|Treatment Phase|Physician Decision|16|||
154868205|NCT01633060|558945477|FG001|Treatment Phase|Physician Decision|7|||
154868206|NCT01633060|558945476|FG000|Treatment Phase|Progressive Disease|210|||
154868207|NCT01633060|558945477|FG001|Treatment Phase|Progressive Disease|120|||
154868208|NCT01633060|558945476|FG000|Treatment Phase|Protocol Deviation|1|||
154868209|NCT01633060|558945477|FG001|Treatment Phase|Protocol Deviation|0|||
154868210|NCT01633060|558945476|FG000|Treatment Phase|Study Terminated by sponsor|7|||
154868211|NCT01633060|558945477|FG001|Treatment Phase|Study Terminated by sponsor|3|||
154868212|NCT01633060|558945476|FG000|Treatment Phase|Subject/guardian decision|25|||
154868213|NCT01633060|558945477|FG001|Treatment Phase|Subject/guardian decision|4|||
154868214|NCT01633060|558945476|FG000|Treatment Phase|Death|4|||
154868215|NCT01633060|558945477|FG001|Treatment Phase|Death|3|||
154868216|NCT01633060|558945476|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
154868217|NCT01633060|558945477|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
154868218|NCT01633060|558945476|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
154868219|NCT01633060|558945477|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
154868220|NCT01633060|558945476|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
154868221|NCT01633060|558945477|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
154868222|NCT01633060|558945476|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
154868223|NCT01633060|558945477|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
154868224|NCT01633060|558945476|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
154868225|NCT01633060|558945477|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
154868226|NCT01633060|558945476|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
154868227|NCT01633060|558945477|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
154868228|NCT03233048|558945480|FG000|Overall Study|Withdrawal by Subject|1|||
154868229|NCT01856673|558945481|FG000|Overall Study|Withdrawal by Subject|44|||
154868230|NCT01856673|558945482|FG001|Overall Study|Withdrawal by Subject|50|||
154868231|NCT01856673|558945483|FG002|Overall Study|Withdrawal by Subject|33|||
154868232|NCT01856673|558945481|FG000|Overall Study|Lost to Follow-up|31|||
154973649|NCT00329160|559328893|FG000|Overall Study|Incomplete IVUS|45|||
154973650|NCT00493792|559328894|FG000|Overall Study|Death|55|||
154973651|NCT00493792|559328895|FG001|Overall Study|Death|50|||
154973652|NCT00493792|559328894|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
154973653|NCT00493792|559328895|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
154973654|NCT02426541|559328898|FG000|Overall Study|Protocol Violation|1|||
154973655|NCT02426541|559328899|FG001|Overall Study|Protocol Violation|0|||
154868233|NCT01856673|558945482|FG001|Overall Study|Lost to Follow-up|34|||
154868234|NCT01856673|558945483|FG002|Overall Study|Lost to Follow-up|0|||
154868235|NCT01856673|558945481|FG000|Overall Study|Unknown reasons|9|||
154868236|NCT01856673|558945482|FG001|Overall Study|Unknown reasons|0|||
154868237|NCT01856673|558945483|FG002|Overall Study|Unknown reasons|0|||
154868238|NCT01856673|558945481|FG000|Overall Study|Psychologist decision|1|||
154868239|NCT01856673|558945482|FG001|Overall Study|Psychologist decision|0|||
154868240|NCT01856673|558945483|FG002|Overall Study|Psychologist decision|0|||
154868241|NCT01856673|558945481|FG000|Overall Study|Paperwork errors|8|||
154868242|NCT01856673|558945482|FG001|Overall Study|Paperwork errors|0|||
154868243|NCT01856673|558945483|FG002|Overall Study|Paperwork errors|0|||
154868244|NCT01856673|558945481|FG000|Overall Study|Death|1|||
154868245|NCT01856673|558945482|FG001|Overall Study|Death|1|||
154868246|NCT01856673|558945483|FG002|Overall Study|Death|0|||
154868247|NCT01856673|558945481|FG000|Overall Study|Protocol Violation|1|||
154868248|NCT01856673|558945482|FG001|Overall Study|Protocol Violation|0|||
154868249|NCT01856673|558945483|FG002|Overall Study|Protocol Violation|1|||
154868250|NCT00491530|558945484|FG000|Overall Study|Adverse Event|6|||
154868251|NCT00491530|558945485|FG001|Overall Study|Adverse Event|1|||
154868252|NCT00491530|558945486|FG002|Overall Study|Adverse Event|2|||
154868253|NCT00491530|558945484|FG000|Overall Study|Withdrawal by Subject|3|||
154868254|NCT00491530|558945485|FG001|Overall Study|Withdrawal by Subject|0|||
154868255|NCT00491530|558945486|FG002|Overall Study|Withdrawal by Subject|0|||
154868256|NCT00491530|558945484|FG000|Overall Study|Lost to Follow-up|3|||
154868257|NCT00491530|558945485|FG001|Overall Study|Lost to Follow-up|2|||
154868258|NCT00491530|558945486|FG002|Overall Study|Lost to Follow-up|2|||
154868259|NCT00491530|558945484|FG000|Overall Study|Lack of Efficacy|0|||
154868260|NCT00491530|558945485|FG001|Overall Study|Lack of Efficacy|1|||
154868261|NCT00491530|558945486|FG002|Overall Study|Lack of Efficacy|0|||
154868262|NCT00491530|558945484|FG000|Overall Study|Investigator Discretion|0|||
154868263|NCT00491530|558945485|FG001|Overall Study|Investigator Discretion|1|||
154868264|NCT00491530|558945486|FG002|Overall Study|Investigator Discretion|0|||
154868265|NCT00491530|558945484|FG000|Overall Study|Patient Request|0|||
154868266|NCT00491530|558945485|FG001|Overall Study|Patient Request|1|||
154868267|NCT00491530|558945486|FG002|Overall Study|Patient Request|0|||
154868268|NCT00491530|558945484|FG000|Overall Study|Use of Prohibited Medication|0|||
154868269|NCT00491530|558945485|FG001|Overall Study|Use of Prohibited Medication|0|||
154868270|NCT00491530|558945486|FG002|Overall Study|Use of Prohibited Medication|1|||
154973656|NCT02674633|559328902|FG000|Overall Study|Lost to Follow-up|3|||
154973657|NCT02674633|559328903|FG001|Overall Study|Lost to Follow-up|2|||
154973658|NCT02674633|559328902|FG000|Overall Study|Physician Decision|1|||
154973659|NCT02674633|559328903|FG001|Overall Study|Physician Decision|0|||
154973660|NCT02674633|559328902|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
154973661|NCT02674633|559328903|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
154973662|NCT04167618|559328904|FG000|Overall Study|Trial terminated by sponsor|1|||
154973663|NCT04167618|559328905|FG001|Overall Study|Trial terminated by sponsor|1|||
154973664|NCT02994394|559328906|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
154973665|NCT02994394|559328907|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
154973666|NCT02994394|559328908|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
154973667|NCT02994394|559328909|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
154973668|NCT02994394|559328910|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
154973669|NCT02994394|559328911|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
154973670|NCT02994394|559328906|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
154973671|NCT02994394|559328907|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
154973672|NCT02994394|559328908|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
154973673|NCT02994394|559328909|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
154973674|NCT02994394|559328910|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
154973675|NCT02994394|559328911|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
154973676|NCT04982445|559328915|FG000|Overall Study|Protocol Violation|1|||
154973677|NCT04982445|559328915|FG000|Overall Study|Withdrawal by Subject|4|||
154973678|NCT04982445|559328915|FG000|Overall Study|Lost to Follow-up|1|||
154973679|NCT04968925|559328918|FG000|Phase I- Period 1|COVID-19 related|0|||
154973680|NCT04968925|559328919|FG001|Phase I- Period 1|COVID-19 related|1|||
154973681|NCT04968925|559328920|FG002|Phase I- Period 1|COVID-19 related|0|||
154973682|NCT04968925|559328921|FG003|Phase I- Period 1|COVID-19 related|0|||
154973683|NCT04968925|559328918|FG000|Phase I- Period 1|Subject enrolled in error|1|||
154973684|NCT04968925|559328919|FG001|Phase I- Period 1|Subject enrolled in error|1|||
154973685|NCT04968925|559328920|FG002|Phase I- Period 1|Subject enrolled in error|0|||
154973686|NCT04968925|559328921|FG003|Phase I- Period 1|Subject enrolled in error|0|||
154973687|NCT04968925|559328918|FG000|Phase II- Period 1|COVID-19 Related|0|||
154973688|NCT04968925|559328919|FG001|Phase II- Period 1|COVID-19 Related|0|||
154868271|NCT03240081|558945487|FG000|Overall Study|Withdrawal by Subject|0|||
154868272|NCT03240081|558945488|FG001|Overall Study|Withdrawal by Subject|2|||
154868273|NCT03240081|558945487|FG000|Overall Study|Lost to Follow-up|0|||
154868274|NCT03240081|558945488|FG001|Overall Study|Lost to Follow-up|1|||
154973689|NCT04968925|559328920|FG002|Phase II- Period 1|COVID-19 Related|6|||
154973690|NCT04968925|559328921|FG003|Phase II- Period 1|COVID-19 Related|6|||
154868275|NCT00883753|558945489|FG000|Overall Study|Adverse Event|37|||
154868276|NCT00883753|558945489|FG000|Overall Study|Death|2|||
154868277|NCT00883753|558945489|FG000|Overall Study|Insufficient therapeutic response|16|||
154868278|NCT00883753|558945489|FG000|Overall Study|Lost to Follow-up|4|||
154868279|NCT00883753|558945489|FG000|Overall Study|Violation of selection criteria at entry|7|||
154868280|NCT00883753|558945489|FG000|Overall Study|Protocol Violation|2|||
154868281|NCT00883753|558945489|FG000|Overall Study|Refused treatment|4|||
154868282|NCT00883753|558945489|FG000|Overall Study|Withdrew consent|10|||
154868283|NCT00883753|558945489|FG000|Overall Study|Investigator's decision|17|||
154868284|NCT00883753|558945489|FG000|Overall Study|Administrative/Other|8|||
154868285|NCT02859415|558945490|FG000|Overall Study|Physician Decision|1|||
154868286|NCT02859415|558945491|FG001|Overall Study|Physician Decision|0|||
154868287|NCT02859415|558945490|FG000|Overall Study|Off treatment due to cardiac event|0|||
154868288|NCT02859415|558945491|FG001|Overall Study|Off treatment due to cardiac event|1|||
154868289|NCT01396525|558945494|FG000|Overall Study|Withdrawal by Subject|8|||
154868290|NCT01396525|558945494|FG000|Overall Study|Death|14|||
154868291|NCT01396525|558945494|FG000|Overall Study|Lost to Follow-up|4|||
154868292|NCT03114969|558945495|FG000|Overall Study|Lost to Follow-up|0|||
154868293|NCT03114969|558945496|FG001|Overall Study|Lost to Follow-up|0|||
154868294|NCT03114969|558945497|FG002|Overall Study|Lost to Follow-up|3|||
154868295|NCT03114969|558945498|FG003|Overall Study|Lost to Follow-up|2|||
154868296|NCT03114969|558945499|FG004|Overall Study|Lost to Follow-up|0|||
154868297|NCT03114969|558945500|FG005|Overall Study|Lost to Follow-up|0|||
154868298|NCT03114969|558945501|FG006|Overall Study|Lost to Follow-up|0|||
154868299|NCT03114969|558945502|FG007|Overall Study|Lost to Follow-up|0|||
154868300|NCT03114969|558945503|FG008|Overall Study|Lost to Follow-up|0|||
154868301|NCT03114969|558945495|FG000|Overall Study|Adverse Event|0|||
154868302|NCT03114969|558945496|FG001|Overall Study|Adverse Event|0|||
154868303|NCT03114969|558945497|FG002|Overall Study|Adverse Event|1|||
154868304|NCT03114969|558945498|FG003|Overall Study|Adverse Event|0|||
154868305|NCT03114969|558945499|FG004|Overall Study|Adverse Event|0|||
154868306|NCT03114969|558945500|FG005|Overall Study|Adverse Event|1|||
154868307|NCT03114969|558945501|FG006|Overall Study|Adverse Event|1|||
154868308|NCT03114969|558945502|FG007|Overall Study|Adverse Event|0|||
154868309|NCT03114969|558945503|FG008|Overall Study|Adverse Event|2|||
154868310|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Adverse Event|12|||
154868311|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Adverse Event|3|||
154868312|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Adverse Event|4|||
154868313|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Adverse Event|2|||
154868314|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
154868315|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
154868316|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
154868317|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
154868318|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
154868319|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
154868320|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
154868321|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
154868322|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
154868323|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
154868324|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
154868325|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
154868326|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
154868327|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
154868328|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
154868329|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
154868330|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
154868331|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
154973691|NCT04968925|559328918|FG000|Phase II- Period 1|Subject enrolled in error|0|||
154973692|NCT04968925|559328919|FG001|Phase II- Period 1|Subject enrolled in error|0|||
154973693|NCT04968925|559328920|FG002|Phase II- Period 1|Subject enrolled in error|1|||
154868332|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
154868333|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
154868334|NCT02436239|558945507|FG000|Open-Lable Treatment Period|Other Reason|1|||
154868335|NCT02436239|558945508|FG001|Open-Lable Treatment Period|Other Reason|1|||
154868336|NCT02436239|558945509|FG002|Open-Lable Treatment Period|Other Reason|0|||
154868337|NCT02436239|558945510|FG003|Open-Lable Treatment Period|Other Reason|0|||
154868338|NCT02436239|558945507|FG000|Down-Taper Period|Withdrawal by Subject|4|||
154868339|NCT02436239|558945508|FG001|Down-Taper Period|Withdrawal by Subject|4|||
154868340|NCT02436239|558945509|FG002|Down-Taper Period|Withdrawal by Subject|1|||
154868341|NCT02436239|558945510|FG003|Down-Taper Period|Withdrawal by Subject|2|||
154868342|NCT02168946|558945511|FG000|Overall Study|Adverse Event|8|||
154868343|NCT02168946|558945512|FG001|Overall Study|Adverse Event|5|||
154868344|NCT02168946|558945511|FG000|Overall Study|Lost to Follow-up|3|||
154868345|NCT02168946|558945512|FG001|Overall Study|Lost to Follow-up|0|||
154868346|NCT02168946|558945511|FG000|Overall Study|Subject unable to come back for visits|1|||
154868347|NCT02168946|558945512|FG001|Overall Study|Subject unable to come back for visits|0|||
154868348|NCT01450137|558945520|FG000|Up to Week 12|Adverse Event|2|||
154868349|NCT01450137|558945521|FG001|Up to Week 12|Adverse Event|1|||
154868350|NCT01450137|558945520|FG000|Up to Week 12|Withdrawal by Subject|0|||
154868351|NCT01450137|558945521|FG001|Up to Week 12|Withdrawal by Subject|2|||
154868352|NCT01450137|558945520|FG000|Week 12 to Study End|Death|0|||
154868353|NCT01450137|558945521|FG001|Week 12 to Study End|Death|1|||
154868354|NCT01450137|558945520|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
154868355|NCT01450137|558945521|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
154868356|NCT01926886|558945522|FG000|Overall Study|Administrative/other|1|||
154868357|NCT01926886|558945523|FG001|Overall Study|Administrative/other|0|||
154868358|NCT01926886|558945522|FG000|Overall Study|Adverse event/intercurrent illness|4|||
154868359|NCT01926886|558945523|FG001|Overall Study|Adverse event/intercurrent illness|0|||
154868360|NCT01926886|558945522|FG000|Overall Study|Disease progression/recurrence|4|||
154868361|NCT01926886|558945523|FG001|Overall Study|Disease progression/recurrence|0|||
154868362|NCT01926886|558945522|FG000|Overall Study|Withdrawal by Subject|15|||
154868363|NCT01926886|558945523|FG001|Overall Study|Withdrawal by Subject|0|||
154868364|NCT01926886|558945522|FG000|Overall Study|Failure to return|3|||
154868365|NCT01926886|558945523|FG001|Overall Study|Failure to return|0|||
154868366|NCT01926886|558945522|FG000|Overall Study|Recurrence of disease|1|||
154868367|NCT01926886|558945523|FG001|Overall Study|Recurrence of disease|0|||
154868368|NCT01926886|558945522|FG000|Overall Study|Progression of disease|2|||
154868369|NCT01926886|558945523|FG001|Overall Study|Progression of disease|0|||
154868370|NCT01926886|558945522|FG000|Overall Study|Death|1|||
154868371|NCT01926886|558945523|FG001|Overall Study|Death|0|||
154868372|NCT01926886|558945522|FG000|Overall Study|Did not cooperate|1|||
154868373|NCT01926886|558945523|FG001|Overall Study|Did not cooperate|0|||
154868374|NCT04458857|558945524|FG000|Overall Study|Adverse Event|0|||
154868375|NCT04458857|558945525|FG001|Overall Study|Adverse Event|1|||
154868376|NCT04458857|558945526|FG002|Overall Study|Adverse Event|0|||
154868377|NCT04458857|558945524|FG000|Overall Study|Withdrawal by Subject|2|||
154868378|NCT04458857|558945525|FG001|Overall Study|Withdrawal by Subject|0|||
154868379|NCT04458857|558945526|FG002|Overall Study|Withdrawal by Subject|0|||
154868380|NCT04458857|558945524|FG000|Overall Study|Withdrawal by parent/guardian|0|||
154868381|NCT04458857|558945525|FG001|Overall Study|Withdrawal by parent/guardian|0|||
154868382|NCT04458857|558945526|FG002|Overall Study|Withdrawal by parent/guardian|1|||
154868383|NCT04458857|558945524|FG000|Overall Study|Non-compliance with study drug|0|||
154868384|NCT04458857|558945525|FG001|Overall Study|Non-compliance with study drug|1|||
154868385|NCT04458857|558945526|FG002|Overall Study|Non-compliance with study drug|0|||
154868386|NCT04458857|558945524|FG000|Overall Study|Lost to Follow-up|4|||
154868387|NCT04458857|558945525|FG001|Overall Study|Lost to Follow-up|1|||
154868388|NCT04458857|558945526|FG002|Overall Study|Lost to Follow-up|0|||
154868389|NCT02986373|558945530|FG000|Overall Study|Adverse Event|4|||
154868390|NCT02986373|558945530|FG000|Overall Study|Lost to Follow-up|1|||
154868391|NCT02986373|558945530|FG000|Overall Study|Withdrawal by Subject|10|||
154868392|NCT02986373|558945530|FG000|Overall Study|Other|24|||
154868393|NCT04800315|558945531|FG000|Randomization|Did not receive study treatment|1|||
154868394|NCT04800315|558945532|FG001|Randomization|Did not receive study treatment|0|||
154868395|NCT04800315|558945533|FG002|Randomization|Did not receive study treatment|0|||
154868396|NCT04800315|558945534|FG003|Randomization|Did not receive study treatment|0|||
154868397|NCT04800315|558945531|FG000|Treatment Period|Adverse Event|4|||
154868398|NCT04800315|558945532|FG001|Treatment Period|Adverse Event|2|||
154868399|NCT04800315|558945533|FG002|Treatment Period|Adverse Event|1|||
154868400|NCT04800315|558945534|FG003|Treatment Period|Adverse Event|2|||
154868401|NCT04800315|558945531|FG000|Treatment Period|Lack of Efficacy|1|||
154868402|NCT04800315|558945532|FG001|Treatment Period|Lack of Efficacy|0|||
154868403|NCT04800315|558945533|FG002|Treatment Period|Lack of Efficacy|0|||
154868404|NCT04800315|558945534|FG003|Treatment Period|Lack of Efficacy|3|||
154868405|NCT04800315|558945531|FG000|Treatment Period|Lost to Follow-up|0|||
154868406|NCT04800315|558945532|FG001|Treatment Period|Lost to Follow-up|1|||
154868407|NCT04800315|558945533|FG002|Treatment Period|Lost to Follow-up|2|||
154868408|NCT04800315|558945534|FG003|Treatment Period|Lost to Follow-up|2|||
154868409|NCT04800315|558945531|FG000|Treatment Period|Withdrawal by participant|0|||
154868410|NCT04800315|558945532|FG001|Treatment Period|Withdrawal by participant|0|||
154868411|NCT04800315|558945533|FG002|Treatment Period|Withdrawal by participant|0|||
154868412|NCT04800315|558945534|FG003|Treatment Period|Withdrawal by participant|4|||
154868413|NCT04800315|558945531|FG000|Treatment Period|Other Reasons|0|||
154868414|NCT04800315|558945532|FG001|Treatment Period|Other Reasons|2|||
154868415|NCT04800315|558945533|FG002|Treatment Period|Other Reasons|0|||
154868416|NCT04800315|558945534|FG003|Treatment Period|Other Reasons|1|||
154868417|NCT00753922|558945535|FG000|Overall Study|Lost to Follow-up|155|||
154868418|NCT00753922|558945536|FG001|Overall Study|Lost to Follow-up|24|||
154868419|NCT00753922|558945537|FG002|Overall Study|Lost to Follow-up|28|||
154868420|NCT00753922|558945538|FG003|Overall Study|Lost to Follow-up|5|||
154868421|NCT00753922|558945535|FG000|Overall Study|Withdrawal by Subject|9|||
154868422|NCT00753922|558945536|FG001|Overall Study|Withdrawal by Subject|11|||
155174779|NCT01133990|560078278|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
155174780|NCT01133990|560078279|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155174781|NCT01133990|560078280|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155174782|NCT01133990|560078281|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155174783|NCT01133990|560078282|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155174784|NCT01133990|560078283|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
155174785|NCT01782469|560078284|FG000|Overall Study|Lost to Follow-up|1|||
155174786|NCT01185301|560078285|FG000|Overall Study|Adverse Event|3|||
155174787|NCT01185301|560078286|FG001|Overall Study|Adverse Event|0|||
155174788|NCT01185301|560078287|FG002|Overall Study|Adverse Event|2|||
155174789|NCT01185301|560078288|FG003|Overall Study|Adverse Event|3|||
155174790|NCT01185301|560078285|FG000|Overall Study|Withdrawal by Subject|7|||
155174791|NCT01185301|560078286|FG001|Overall Study|Withdrawal by Subject|5|||
155174792|NCT01185301|560078287|FG002|Overall Study|Withdrawal by Subject|2|||
155174793|NCT01185301|560078288|FG003|Overall Study|Withdrawal by Subject|3|||
155174794|NCT01185301|560078285|FG000|Overall Study|Lost to Follow-up|2|||
155174795|NCT01185301|560078286|FG001|Overall Study|Lost to Follow-up|0|||
154868423|NCT00753922|558945537|FG002|Overall Study|Withdrawal by Subject|4|||
154868424|NCT00753922|558945538|FG003|Overall Study|Withdrawal by Subject|2|||
154868425|NCT00753922|558945535|FG000|Overall Study|Patient Non-compliance|55|||
154868426|NCT00753922|558945536|FG001|Overall Study|Patient Non-compliance|22|||
154868427|NCT00753922|558945537|FG002|Overall Study|Patient Non-compliance|14|||
154868428|NCT00753922|558945538|FG003|Overall Study|Patient Non-compliance|11|||
154868429|NCT00753922|558945535|FG000|Overall Study|Patients Not Completing Visit|11|||
154868430|NCT00753922|558945536|FG001|Overall Study|Patients Not Completing Visit|0|||
154868431|NCT00753922|558945537|FG002|Overall Study|Patients Not Completing Visit|1|||
154868432|NCT00753922|558945538|FG003|Overall Study|Patients Not Completing Visit|0|||
154868433|NCT00753922|558945535|FG000|Overall Study|Death|2|||
154868434|NCT00753922|558945536|FG001|Overall Study|Death|23|||
154868435|NCT00753922|558945537|FG002|Overall Study|Death|2|||
154868436|NCT00753922|558945538|FG003|Overall Study|Death|1|||
154868437|NCT00753922|558945535|FG000|Overall Study|Discontinuation Due to Explantation|14|||
154868438|NCT00753922|558945536|FG001|Overall Study|Discontinuation Due to Explantation|14|||
154868439|NCT00753922|558945537|FG002|Overall Study|Discontinuation Due to Explantation|14|||
154868440|NCT00753922|558945538|FG003|Overall Study|Discontinuation Due to Explantation|4|||
154868441|NCT00196937|558945539|FG000|Overall Study|Serious Adverse Event|1|||
154868442|NCT00196937|558945540|FG001|Overall Study|Serious Adverse Event|0|||
154868443|NCT00196937|558945541|FG002|Overall Study|Serious Adverse Event|0|||
154868444|NCT00196937|558945539|FG000|Overall Study|Non-serious adverse event|1|||
154868445|NCT00196937|558945540|FG001|Overall Study|Non-serious adverse event|1|||
154868446|NCT00196937|558945541|FG002|Overall Study|Non-serious adverse event|1|||
154868447|NCT00196937|558945539|FG000|Overall Study|Withdrawal by Subject|0|||
154868448|NCT00196937|558945540|FG001|Overall Study|Withdrawal by Subject|0|||
154868449|NCT00196937|558945541|FG002|Overall Study|Withdrawal by Subject|2|||
154868450|NCT00196937|558945539|FG000|Overall Study|Lost to Follow-up|4|||
154868451|NCT00196937|558945540|FG001|Overall Study|Lost to Follow-up|3|||
154868452|NCT00196937|558945541|FG002|Overall Study|Lost to Follow-up|3|||
154868453|NCT00196937|558945539|FG000|Overall Study|Other|3|||
154868454|NCT00196937|558945540|FG001|Overall Study|Other|1|||
154868455|NCT00196937|558945541|FG002|Overall Study|Other|1|||
154868456|NCT02983292|558945549|FG000|Overall Study|Participant unwell & cannot travel|2|||
154868457|NCT02983292|558945549|FG000|Overall Study|Lost to Follow-up|3|||
154868458|NCT02983292|558945549|FG000|Overall Study|Participant withdrew consent|2|||
154868459|NCT02983292|558945549|FG000|Overall Study|Revision|7|||
154868460|NCT02983292|558945549|FG000|Overall Study|Death|1|||
154868461|NCT02983292|558945549|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
154868462|NCT02983292|558945549|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
154868463|NCT02983292|558945549|FG000|Overall Study|Participant relocation|1|||
154868464|NCT04725682|558945550|FG000|Overall Study|Withdrawal by Subject|7|||
155174796|NCT01185301|560078287|FG002|Overall Study|Lost to Follow-up|0|||
155174797|NCT01185301|560078288|FG003|Overall Study|Lost to Follow-up|1|||
155174798|NCT01185301|560078285|FG000|Overall Study|Other Reason|3|||
154868465|NCT04725682|558945551|FG001|Overall Study|Withdrawal by Subject|5|||
154868466|NCT04725682|558945550|FG000|Overall Study|Failed to comply with the requirements|2|||
154868467|NCT04725682|558945551|FG001|Overall Study|Failed to comply with the requirements|1|||
154868468|NCT04725682|558945550|FG000|Overall Study|Adverse Event|1|||
155174799|NCT01185301|560078286|FG001|Overall Study|Other Reason|2|||
155174800|NCT01185301|560078287|FG002|Overall Study|Other Reason|2|||
155174801|NCT01185301|560078288|FG003|Overall Study|Other Reason|2|||
155174802|NCT04987944|560078289|FG000|Overall Study|Adverse Event|0|||
155174803|NCT04987944|560078290|FG001|Overall Study|Adverse Event|1|||
154868469|NCT04725682|558945551|FG001|Overall Study|Adverse Event|1|||
154868470|NCT04725682|558945550|FG000|Overall Study|Death|0|||
154868471|NCT04725682|558945551|FG001|Overall Study|Death|1|||
154868472|NCT00964795|558945552|FG000|Overall Study|Withdrawal by Subject|79|||
154868473|NCT00964795|558945552|FG000|Overall Study|Adverse Event|12|||
155109707|NCT02954406|559831022|FG000|Overall Study|Adverse Event|0|||
155109708|NCT02954406|559831023|FG001|Overall Study|Adverse Event|1|||
155109709|NCT02954406|559831024|FG002|Overall Study|Adverse Event|0|||
155109710|NCT02954406|559831025|FG003|Overall Study|Adverse Event|0|||
155109711|NCT02954406|559831026|FG004|Overall Study|Adverse Event|1|||
155109712|NCT02954406|559831027|FG005|Overall Study|Adverse Event|0|||
155109713|NCT02954406|559831028|FG006|Overall Study|Adverse Event|0|||
155109714|NCT02954406|559831029|FG007|Overall Study|Adverse Event|0|||
155109715|NCT02954406|559831030|FG008|Overall Study|Adverse Event|1|||
155109716|NCT02954406|559831031|FG009|Overall Study|Adverse Event|1|||
155109717|NCT02954406|559831032|FG010|Overall Study|Adverse Event|0|||
155109718|NCT02954406|559831022|FG000|Overall Study|Progressive Disease|3|||
155109719|NCT02954406|559831023|FG001|Overall Study|Progressive Disease|4|||
155109720|NCT02954406|559831024|FG002|Overall Study|Progressive Disease|3|||
154868474|NCT00964795|558945552|FG000|Overall Study|Death|14|||
154868475|NCT00964795|558945552|FG000|Overall Study|Lost to Follow-up|7|||
154868476|NCT00964795|558945552|FG000|Overall Study|Termination of Study by Sponsor|169|||
154868477|NCT00964795|558945552|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
154868478|NCT00964795|558945552|FG000|Overall Study|Other|23|||
154868479|NCT00586690|558945557|FG000|Overall Study|Death|2|||
154868480|NCT00586690|558945558|FG001|Overall Study|Death|0|||
154868481|NCT00586690|558945557|FG000|Overall Study|Disease Progression|10|||
154868482|NCT00586690|558945558|FG001|Overall Study|Disease Progression|0|||
154868483|NCT00586690|558945557|FG000|Overall Study|Adverse Event|1|||
154868484|NCT00586690|558945558|FG001|Overall Study|Adverse Event|0|||
154868485|NCT00586690|558945557|FG000|Overall Study|Lack of Efficacy|2|||
154868486|NCT00586690|558945558|FG001|Overall Study|Lack of Efficacy|0|||
154868487|NCT00586690|558945557|FG000|Overall Study|Lab can't accommodate|1|||
154868488|NCT00586690|558945558|FG001|Overall Study|Lab can't accommodate|0|||
154868489|NCT02453841|558945559|FG000|Overall Study|Protocol Violation|1|||
154868490|NCT02453841|558945559|FG000|Overall Study|Unable to obtain blood samples|2|||
154868491|NCT01151137|558945562|FG000|Overall Study|Death|15|||
154868492|NCT01151137|558945563|FG001|Overall Study|Death|27|||
154868493|NCT01151137|558945562|FG000|Overall Study|Lost to Follow-up|1|||
154868494|NCT01151137|558945563|FG001|Overall Study|Lost to Follow-up|1|||
154868495|NCT00072189|558945564|FG000|Overall Study|Withdrawal by Subject|1|||
154868496|NCT02973815|558945565|FG000|Post Intervention|Death|1|||
154868497|NCT02973815|558945566|FG001|Post Intervention|Death|0|||
154868498|NCT02973815|558945565|FG000|Post Intervention|Lost to Follow-up|7|||
154868499|NCT02973815|558945566|FG001|Post Intervention|Lost to Follow-up|24|||
154868500|NCT02973815|558945565|FG000|Follow-up|Lost to Follow-up|2|||
154868501|NCT02973815|558945566|FG001|Follow-up|Lost to Follow-up|0|||
154868502|NCT02273973|558945568|FG000|Overall Study|Adverse Event|4|||
154868503|NCT02273973|558945569|FG001|Overall Study|Adverse Event|0|||
154868504|NCT02273973|558945568|FG000|Overall Study|Withdrawal by Subject|2|||
154868505|NCT02273973|558945569|FG001|Overall Study|Withdrawal by Subject|3|||
154868506|NCT02273973|558945568|FG000|Overall Study|Death|1|||
154868507|NCT02273973|558945569|FG001|Overall Study|Death|0|||
154868508|NCT02273973|558945568|FG000|Overall Study|Non-compliance|1|||
154868509|NCT02273973|558945569|FG001|Overall Study|Non-compliance|0|||
154868510|NCT02273973|558945568|FG000|Overall Study|Protocol Violation|1|||
154868511|NCT02273973|558945569|FG001|Overall Study|Protocol Violation|0|||
154868512|NCT02273973|558945568|FG000|Overall Study|Progression of disease|0|||
154868513|NCT02273973|558945569|FG001|Overall Study|Progression of disease|2|||
154868514|NCT02273973|558945568|FG000|Overall Study|Lost to Follow-up|0|||
154868515|NCT02273973|558945569|FG001|Overall Study|Lost to Follow-up|1|||
154868516|NCT02273973|558945568|FG000|Overall Study|Physician Decision|0|||
154868517|NCT02273973|558945569|FG001|Overall Study|Physician Decision|1|||
154868518|NCT02273973|558945568|FG000|Overall Study|Reason not specified|0|||
154868519|NCT02273973|558945569|FG001|Overall Study|Reason not specified|1|||
154868520|NCT02606877|558945576|FG000|Overall Study|Adverse Event|3|||
155109721|NCT02954406|559831025|FG003|Overall Study|Progressive Disease|4|||
155109722|NCT02954406|559831026|FG004|Overall Study|Progressive Disease|3|||
155109723|NCT02954406|559831027|FG005|Overall Study|Progressive Disease|3|||
155174804|NCT04987944|560078289|FG000|Overall Study|Withdrawal by Subject|0|||
155174805|NCT04987944|560078290|FG001|Overall Study|Withdrawal by Subject|1|||
155174806|NCT00357760|560078293|FG000|Overall Study|Disease progression|44|||
155174807|NCT00357760|560078294|FG001|Overall Study|Disease progression|17|||
154868521|NCT02606877|558945577|FG001|Overall Study|Adverse Event|0|||
154868522|NCT02606877|558945576|FG000|Overall Study|Non-compliance with protocol|0|||
154868523|NCT02606877|558945577|FG001|Overall Study|Non-compliance with protocol|1|||
154868524|NCT02606877|558945576|FG000|Overall Study|Other than listed above|1|||
154868525|NCT02606877|558945577|FG001|Overall Study|Other than listed above|0|||
155109724|NCT02954406|559831028|FG006|Overall Study|Progressive Disease|2|||
154868526|NCT00778999|558945578|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
154868527|NCT00778999|558945579|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
154868528|NCT00778999|558945578|FG000|Overall Study|Did not receive recFSH|14|||
154868529|NCT00778999|558945579|FG001|Overall Study|Did not receive recFSH|20|||
155109725|NCT02954406|559831029|FG007|Overall Study|Progressive Disease|2|||
154868530|NCT02032524|558945580|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
154868531|NCT02032524|558945581|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
154868532|NCT02032524|558945582|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
154868533|NCT02032524|558945583|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
154868534|NCT02032524|558945584|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
154868535|NCT02032524|558945585|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
155109726|NCT02954406|559831030|FG008|Overall Study|Progressive Disease|1|||
155109727|NCT02954406|559831031|FG009|Overall Study|Progressive Disease|1|||
155109728|NCT02954406|559831032|FG010|Overall Study|Progressive Disease|0|||
155109729|NCT02954406|559831022|FG000|Overall Study|Symptomatic Deterioration|0|||
155109730|NCT02954406|559831023|FG001|Overall Study|Symptomatic Deterioration|1|||
155109731|NCT02954406|559831024|FG002|Overall Study|Symptomatic Deterioration|0|||
155109732|NCT02954406|559831025|FG003|Overall Study|Symptomatic Deterioration|0|||
155109733|NCT02954406|559831026|FG004|Overall Study|Symptomatic Deterioration|0|||
155109734|NCT02954406|559831027|FG005|Overall Study|Symptomatic Deterioration|0|||
155109735|NCT02954406|559831028|FG006|Overall Study|Symptomatic Deterioration|0|||
155109736|NCT02954406|559831029|FG007|Overall Study|Symptomatic Deterioration|0|||
155109737|NCT02954406|559831030|FG008|Overall Study|Symptomatic Deterioration|0|||
155109738|NCT02954406|559831031|FG009|Overall Study|Symptomatic Deterioration|0|||
155109739|NCT02954406|559831032|FG010|Overall Study|Symptomatic Deterioration|0|||
155109740|NCT02954406|559831022|FG000|Overall Study|Death|0|||
155109741|NCT02954406|559831023|FG001|Overall Study|Death|0|||
155109742|NCT02954406|559831024|FG002|Overall Study|Death|0|||
155109743|NCT02954406|559831025|FG003|Overall Study|Death|0|||
155109744|NCT02954406|559831026|FG004|Overall Study|Death|1|||
155109745|NCT02954406|559831027|FG005|Overall Study|Death|0|||
155109746|NCT02954406|559831028|FG006|Overall Study|Death|0|||
155109747|NCT02954406|559831029|FG007|Overall Study|Death|0|||
155109748|NCT02954406|559831030|FG008|Overall Study|Death|1|||
155109749|NCT02954406|559831031|FG009|Overall Study|Death|1|||
155109750|NCT02954406|559831032|FG010|Overall Study|Death|0|||
155109751|NCT02954406|559831022|FG000|Overall Study|Reason Not Specified|0|||
155109752|NCT02954406|559831023|FG001|Overall Study|Reason Not Specified|0|||
155109753|NCT02954406|559831024|FG002|Overall Study|Reason Not Specified|3|||
155109754|NCT02954406|559831025|FG003|Overall Study|Reason Not Specified|2|||
155109755|NCT02954406|559831026|FG004|Overall Study|Reason Not Specified|2|||
155109756|NCT02954406|559831027|FG005|Overall Study|Reason Not Specified|0|||
155109757|NCT02954406|559831028|FG006|Overall Study|Reason Not Specified|1|||
155109758|NCT02954406|559831029|FG007|Overall Study|Reason Not Specified|0|||
155109759|NCT02954406|559831030|FG008|Overall Study|Reason Not Specified|1|||
155109760|NCT02954406|559831031|FG009|Overall Study|Reason Not Specified|0|||
155109761|NCT02954406|559831032|FG010|Overall Study|Reason Not Specified|0|||
155109762|NCT00782171|559831033|FG000|Overall Study|Lost to Follow-up|2|||
155109763|NCT00782171|559831034|FG001|Overall Study|Lost to Follow-up|2|||
155109764|NCT00782171|559831033|FG000|Overall Study|Withdrawal by Subject|2|||
155109765|NCT00782171|559831034|FG001|Overall Study|Withdrawal by Subject|1|||
155109766|NCT00782171|559831033|FG000|Overall Study|complications|3|||
155109767|NCT00782171|559831034|FG001|Overall Study|complications|1|||
155109768|NCT00782171|559831033|FG000|Overall Study|others|7|||
155109769|NCT00782171|559831034|FG001|Overall Study|others|9|||
155109770|NCT00782171|559831033|FG000|Overall Study|not eligible|8|||
155109771|NCT00782171|559831034|FG001|Overall Study|not eligible|6|||
155109772|NCT01691014|559831035|FG000|Overall Study|Premature Termination|1|||
155109773|NCT01691014|559831036|FG001|Overall Study|Premature Termination|6|||
155109774|NCT01691014|559831037|FG002|Overall Study|Premature Termination|0|||
155109775|NCT01691014|559831038|FG003|Overall Study|Premature Termination|3|||
155109776|NCT01691014|559831035|FG000|Overall Study|Other|0|||
155109777|NCT01691014|559831036|FG001|Overall Study|Other|0|||
155109778|NCT01691014|559831037|FG002|Overall Study|Other|2|||
155109779|NCT01691014|559831038|FG003|Overall Study|Other|0|||
155109780|NCT01691014|559831035|FG000|Overall Study|Withdrawal by Subject|0|||
155109781|NCT01691014|559831036|FG001|Overall Study|Withdrawal by Subject|1|||
155109782|NCT01691014|559831037|FG002|Overall Study|Withdrawal by Subject|1|||
155109783|NCT01691014|559831038|FG003|Overall Study|Withdrawal by Subject|1|||
155109784|NCT01691014|559831035|FG000|Overall Study|Adverse Event|0|||
155109785|NCT01691014|559831036|FG001|Overall Study|Adverse Event|5|||
155109786|NCT01691014|559831037|FG002|Overall Study|Adverse Event|1|||
155109787|NCT01691014|559831038|FG003|Overall Study|Adverse Event|1|||
155109788|NCT01691014|559831035|FG000|Overall Study|Lack of Efficacy|2|||
155109789|NCT01691014|559831036|FG001|Overall Study|Lack of Efficacy|3|||
155109790|NCT01691014|559831037|FG002|Overall Study|Lack of Efficacy|7|||
155109791|NCT01691014|559831038|FG003|Overall Study|Lack of Efficacy|0|||
155109792|NCT05897242|559831049|FG000|Overall Study|Lost to Follow-up|6|||
155109793|NCT05897242|559831050|FG001|Overall Study|Lost to Follow-up|1|||
155109794|NCT05897242|559831049|FG000|Overall Study|Incomplete|1|||
155109795|NCT05897242|559831050|FG001|Overall Study|Incomplete|0|||
155109796|NCT05897242|559831049|FG000|Overall Study|Withdrawal by Subject|1|||
154868536|NCT02032524|558945580|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
154868537|NCT02032524|558945581|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
154868538|NCT02032524|558945582|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
154868539|NCT02032524|558945583|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
154868540|NCT02032524|558945584|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
154868541|NCT02032524|558945585|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
154868542|NCT02032524|558945580|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
154868543|NCT02032524|558945581|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
154868544|NCT02032524|558945582|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
154868545|NCT02032524|558945583|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
154868546|NCT02032524|558945584|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
154868547|NCT02032524|558945585|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
154868548|NCT02032524|558945580|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
154868549|NCT02032524|558945581|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
154868550|NCT02032524|558945582|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
154868551|NCT02032524|558945583|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
154868552|NCT02032524|558945584|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
154868553|NCT02032524|558945585|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
154868554|NCT02032524|558945580|FG000|Period 2: LTS13769 Study|Other|0|||
154868555|NCT02032524|558945581|FG001|Period 2: LTS13769 Study|Other|0|||
154868556|NCT02032524|558945582|FG002|Period 2: LTS13769 Study|Other|0|||
154868557|NCT02032524|558945583|FG003|Period 2: LTS13769 Study|Other|0|||
154868558|NCT02032524|558945584|FG004|Period 2: LTS13769 Study|Other|0|||
154868559|NCT02032524|558945585|FG005|Period 2: LTS13769 Study|Other|1|||
154868560|NCT04513158|558945586|FG000|Overall Study|Screen Failure|1|||
154868561|NCT01894516|558947304|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
154868562|NCT01894516|558947305|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
154868563|NCT01894516|558947306|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
154868564|NCT01894516|558947307|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
154868565|NCT01894516|558947304|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
154868566|NCT01894516|558947305|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
154868567|NCT01894516|558947306|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
154868568|NCT01894516|558947307|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
154868569|NCT01894516|558947304|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
154868570|NCT01894516|558947305|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
154868571|NCT01894516|558947306|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
154868572|NCT01894516|558947307|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
154868573|NCT01894516|558947304|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
154868574|NCT01894516|558947305|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
154868575|NCT01894516|558947306|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
154868576|NCT01894516|558947307|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
154868577|NCT01894516|558947304|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
154868578|NCT01894516|558947305|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
154868579|NCT01894516|558947306|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
154868580|NCT01894516|558947307|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
154868581|NCT01894516|558947304|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
154868582|NCT01894516|558947305|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
154868583|NCT01894516|558947306|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
154868584|NCT01894516|558947307|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
154868585|NCT01894516|558947304|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
154868586|NCT01894516|558947305|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
154868587|NCT01894516|558947306|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
154868588|NCT01894516|558947307|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
154868589|NCT01894516|558947304|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
154868590|NCT01894516|558947305|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
154868591|NCT01894516|558947306|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
154868592|NCT01894516|558947307|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
154868593|NCT02452970|558947312|FG000|Overall Study|Adverse Event|1|||
154868594|NCT01266148|558947313|FG000|Overall Study|Adverse Event|2|||
154868595|NCT01266148|558947314|FG001|Overall Study|Adverse Event|0|||
154868596|NCT01266148|558947313|FG000|Overall Study|Ongoing rejection|1|||
154868597|NCT01266148|558947314|FG001|Overall Study|Ongoing rejection|0|||
154868598|NCT01266148|558947313|FG000|Overall Study|2 2R rejections|1|||
154868599|NCT01266148|558947314|FG001|Overall Study|2 2R rejections|0|||
154868600|NCT01266148|558947313|FG000|Overall Study|Death|2|||
154868601|NCT01266148|558947314|FG001|Overall Study|Death|3|||
154868602|NCT01266148|558947313|FG000|Overall Study|missing mGFR value + AE|1|||
154868603|NCT01266148|558947314|FG001|Overall Study|missing mGFR value + AE|0|||
154868604|NCT01853228|558947317|FG000|Phase 1|Lack of Efficacy|8|||
154868605|NCT01853228|558947318|FG001|Phase 1|Lack of Efficacy|0|||
154868606|NCT01853228|558947317|FG000|Phase 1|Other|1|||
154868607|NCT01853228|558947318|FG001|Phase 1|Other|0|||
154868608|NCT01853228|558947317|FG000|Phase 2|Physician Decision|0|||
154868609|NCT01853228|558947318|FG001|Phase 2|Physician Decision|1|||
154868610|NCT01853228|558947317|FG000|Phase 2|Proceed To Transplant|0|||
154868611|NCT01853228|558947318|FG001|Phase 2|Proceed To Transplant|3|||
154868612|NCT01853228|558947317|FG000|Phase 2|Lack of Efficacy|0|||
154868613|NCT01853228|558947318|FG001|Phase 2|Lack of Efficacy|4|||
154868614|NCT01269125|558947320|FG000|Overall Study|Adverse Event|3|||
154868615|NCT01269125|558947321|FG001|Overall Study|Adverse Event|5|||
154868616|NCT01269125|558947322|FG002|Overall Study|Adverse Event|0|||
154868617|NCT01269125|558947320|FG000|Overall Study|Lost to Follow-up|4|||
154868618|NCT01269125|558947321|FG001|Overall Study|Lost to Follow-up|0|||
154868619|NCT01269125|558947322|FG002|Overall Study|Lost to Follow-up|0|||
154868620|NCT01040832|558947323|FG000|Overall Study|Adverse Event|4|||
154868621|NCT01040832|558947324|FG001|Overall Study|Adverse Event|5|||
154868622|NCT01040832|558947323|FG000|Overall Study|Death|4|||
154868623|NCT01040832|558947324|FG001|Overall Study|Death|6|||
154868624|NCT01040832|558947323|FG000|Overall Study|Withdrawal by Subject|2|||
154868625|NCT01040832|558947324|FG001|Overall Study|Withdrawal by Subject|3|||
154868626|NCT01040832|558947323|FG000|Overall Study|Progressive disease|32|||
154868627|NCT01040832|558947324|FG001|Overall Study|Progressive disease|17|||
154868628|NCT01040832|558947323|FG000|Overall Study|Symptomatic deterioration|2|||
154868629|NCT01040832|558947324|FG001|Overall Study|Symptomatic deterioration|5|||
154868630|NCT01040832|558947323|FG000|Overall Study|Other|2|||
154868631|NCT01040832|558947324|FG001|Overall Study|Other|1|||
154868632|NCT01300286|558947325|FG000|Overall Study|did not get dosed|1|||
154868633|NCT03635190|558947326|FG000|Overall Study|Lost to Follow-up|4|||
154868634|NCT03635190|558947326|FG000|Overall Study|Death|3|||
154868635|NCT03635190|558947326|FG000|Overall Study|Withdrawal by Subject|1|||
154868636|NCT03635190|558947326|FG000|Overall Study|Patient moved and did not return for follow up|1|||
154868637|NCT02767570|558947329|FG000|Overall Study|Lost to Follow-up|3|||
154868638|NCT02767570|558947330|FG001|Overall Study|Lost to Follow-up|0|||
154868639|NCT02767570|558947329|FG000|Overall Study|COVID shutdown|2|||
154868640|NCT02767570|558947330|FG001|Overall Study|COVID shutdown|5|||
154868641|NCT02767570|558947329|FG000|Overall Study|Increased pain|2|||
154868642|NCT02767570|558947330|FG001|Overall Study|Increased pain|0|||
154868643|NCT02767570|558947329|FG000|Overall Study|Withdrawal by Subject|1|||
154868644|NCT02767570|558947330|FG001|Overall Study|Withdrawal by Subject|3|||
154868645|NCT02767570|558947329|FG000|Overall Study|Unrelated medical issue|1|||
154868646|NCT02767570|558947330|FG001|Overall Study|Unrelated medical issue|1|||
154868647|NCT02767570|558947329|FG000|Overall Study|Received intra-articular injection|0|||
154868648|NCT02767570|558947330|FG001|Overall Study|Received intra-articular injection|1|||
154868649|NCT00417612|558947331|FG000|Overall Study|Errant diagnosis|0|||
154868650|NCT00417612|558947332|FG001|Overall Study|Errant diagnosis|1|||
154868651|NCT00417612|558947331|FG000|Overall Study|Adverse Event|2|||
154868652|NCT00417612|558947332|FG001|Overall Study|Adverse Event|0|||
154868653|NCT00417612|558947331|FG000|Overall Study|Protocol Violation|0|||
154868654|NCT00417612|558947332|FG001|Overall Study|Protocol Violation|2|||
154868655|NCT00417612|558947331|FG000|Overall Study|Lost to Follow-up|1|||
154868656|NCT00417612|558947332|FG001|Overall Study|Lost to Follow-up|0|||
154868657|NCT01712438|558947335|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
154868658|NCT01712438|558947335|FG000|Overall Study|Ongoing ITI treatment|6|||
154868659|NCT01712438|558947335|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
154868660|NCT01712438|558947335|FG000|Overall Study|Prematurely Discontinued|25|||
154868661|NCT04426630|558947336|FG000|Overall Study|Death|4|||
154868662|NCT04426630|558947336|FG000|Overall Study|Lost to Follow-up|2|||
154868663|NCT02786537|558947337|FG000|As Randomized|Adverse Event|0|||
154973694|NCT04968925|559328921|FG003|Phase II- Period 1|Subject enrolled in error|0|||
154973695|NCT04968925|559328918|FG000|Phase II -Period 2|COVID-19 related|0|||
154973696|NCT04968925|559328919|FG001|Phase II -Period 2|COVID-19 related|0|||
154973697|NCT04968925|559328920|FG002|Phase II -Period 2|COVID-19 related|4|||
154973698|NCT04968925|559328921|FG003|Phase II -Period 2|COVID-19 related|3|||
154973699|NCT04968925|559328918|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
154973700|NCT04968925|559328919|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
154973701|NCT04968925|559328920|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
154973702|NCT04968925|559328921|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
154868664|NCT02786537|558947338|FG001|As Randomized|Adverse Event|11|||
154868665|NCT02786537|558947339|FG002|As Randomized|Adverse Event|0|||
154868666|NCT02786537|558947340|FG003|As Randomized|Adverse Event|4|||
154868667|NCT02786537|558947341|FG004|As Randomized|Adverse Event|6|||
154868668|NCT02786537|558947342|FG005|As Randomized|Adverse Event|2|||
154868669|NCT02786537|558947337|FG000|As Randomized|Lack of Efficacy|0|||
154868670|NCT02786537|558947338|FG001|As Randomized|Lack of Efficacy|0|||
154868671|NCT02786537|558947339|FG002|As Randomized|Lack of Efficacy|0|||
154868672|NCT02786537|558947340|FG003|As Randomized|Lack of Efficacy|1|||
154868673|NCT02786537|558947341|FG004|As Randomized|Lack of Efficacy|0|||
154868674|NCT02786537|558947342|FG005|As Randomized|Lack of Efficacy|0|||
154868675|NCT02786537|558947337|FG000|As Randomized|Withdrawal by Subject|1|||
154868676|NCT02786537|558947338|FG001|As Randomized|Withdrawal by Subject|2|||
154868677|NCT02786537|558947339|FG002|As Randomized|Withdrawal by Subject|0|||
154868678|NCT02786537|558947340|FG003|As Randomized|Withdrawal by Subject|1|||
154868679|NCT02786537|558947341|FG004|As Randomized|Withdrawal by Subject|1|||
154868680|NCT02786537|558947342|FG005|As Randomized|Withdrawal by Subject|0|||
154868681|NCT02786537|558947337|FG000|As Randomized|Death|0|||
154868682|NCT02786537|558947338|FG001|As Randomized|Death|2|||
154868683|NCT02786537|558947339|FG002|As Randomized|Death|0|||
154868684|NCT02786537|558947340|FG003|As Randomized|Death|3|||
154868685|NCT02786537|558947341|FG004|As Randomized|Death|1|||
154868686|NCT02786537|558947342|FG005|As Randomized|Death|0|||
154868687|NCT02786537|558947337|FG000|As Randomized|Non-compliance with study drug|1|||
154868688|NCT02786537|558947338|FG001|As Randomized|Non-compliance with study drug|11|||
154868689|NCT02786537|558947339|FG002|As Randomized|Non-compliance with study drug|0|||
154868690|NCT02786537|558947340|FG003|As Randomized|Non-compliance with study drug|1|||
154868691|NCT02786537|558947341|FG004|As Randomized|Non-compliance with study drug|0|||
154868692|NCT02786537|558947342|FG005|As Randomized|Non-compliance with study drug|1|||
154868693|NCT02786537|558947337|FG000|As Randomized|Lost to treatment follow-up|4|||
154868694|NCT02786537|558947338|FG001|As Randomized|Lost to treatment follow-up|32|||
154868695|NCT02786537|558947339|FG002|As Randomized|Lost to treatment follow-up|0|||
154868696|NCT02786537|558947340|FG003|As Randomized|Lost to treatment follow-up|24|||
154868697|NCT02786537|558947341|FG004|As Randomized|Lost to treatment follow-up|4|||
154868698|NCT02786537|558947342|FG005|As Randomized|Lost to treatment follow-up|4|||
154868699|NCT02786537|558947337|FG000|As Randomized|Incarceration|0|||
154868700|NCT02786537|558947338|FG001|As Randomized|Incarceration|1|||
154868701|NCT02786537|558947339|FG002|As Randomized|Incarceration|0|||
154868702|NCT02786537|558947340|FG003|As Randomized|Incarceration|0|||
154868703|NCT02786537|558947341|FG004|As Randomized|Incarceration|0|||
154868704|NCT02786537|558947342|FG005|As Randomized|Incarceration|0|||
154868705|NCT02786537|558947337|FG000|As Randomized|Opiate Dependency Relapse|0|||
154868706|NCT02786537|558947338|FG001|As Randomized|Opiate Dependency Relapse|1|||
154868707|NCT02786537|558947339|FG002|As Randomized|Opiate Dependency Relapse|0|||
154868708|NCT02786537|558947340|FG003|As Randomized|Opiate Dependency Relapse|0|||
154868709|NCT02786537|558947341|FG004|As Randomized|Opiate Dependency Relapse|0|||
154868710|NCT02786537|558947342|FG005|As Randomized|Opiate Dependency Relapse|0|||
154868711|NCT02786537|558947337|FG000|As Randomized|HCV drugs stolen from pt|0|||
154868712|NCT02786537|558947338|FG001|As Randomized|HCV drugs stolen from pt|1|||
154868713|NCT02786537|558947339|FG002|As Randomized|HCV drugs stolen from pt|0|||
154868714|NCT02786537|558947340|FG003|As Randomized|HCV drugs stolen from pt|0|||
154868715|NCT02786537|558947341|FG004|As Randomized|HCV drugs stolen from pt|0|||
154868716|NCT02786537|558947342|FG005|As Randomized|HCV drugs stolen from pt|0|||
154868717|NCT02786537|558947337|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
154868718|NCT02786537|558947338|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
154868719|NCT02786537|558947339|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
154868720|NCT02786537|558947340|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
154868721|NCT02786537|558947341|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
154868722|NCT02786537|558947342|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
154868723|NCT02786537|558947337|FG000|As Randomized|Subject lost insurance|0|||
154868724|NCT02786537|558947338|FG001|As Randomized|Subject lost insurance|0|||
154868725|NCT02786537|558947339|FG002|As Randomized|Subject lost insurance|0|||
154868726|NCT02786537|558947340|FG003|As Randomized|Subject lost insurance|1|||
154868727|NCT02786537|558947341|FG004|As Randomized|Subject lost insurance|0|||
154868728|NCT02786537|558947342|FG005|As Randomized|Subject lost insurance|0|||
154868729|NCT02786537|558947337|FG000|As Treated|Adverse Event|0|||
154868730|NCT02786537|558947338|FG001|As Treated|Adverse Event|11|||
154868731|NCT02786537|558947339|FG002|As Treated|Adverse Event|0|||
154868732|NCT02786537|558947340|FG003|As Treated|Adverse Event|4|||
154868733|NCT02786537|558947341|FG004|As Treated|Adverse Event|6|||
154868734|NCT02786537|558947342|FG005|As Treated|Adverse Event|2|||
154973703|NCT00996437|559328923|FG000|Overall Study|Death|1|||
155109797|NCT05897242|559831050|FG001|Overall Study|Withdrawal by Subject|0|||
155109798|NCT03522246|559831051|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
155109799|NCT03522246|559831052|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
155109800|NCT03522246|559831053|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
155109801|NCT03522246|559831054|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
155109802|NCT03522246|559831055|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
155109803|NCT04299308|559831056|FG000|Overall Study|Withdrawal by Subject|1|||
154868735|NCT02786537|558947337|FG000|As Treated|Death|0|||
154868736|NCT02786537|558947338|FG001|As Treated|Death|2|||
154868737|NCT02786537|558947339|FG002|As Treated|Death|0|||
154868738|NCT02786537|558947340|FG003|As Treated|Death|3|||
154868739|NCT02786537|558947341|FG004|As Treated|Death|1|||
154868740|NCT02786537|558947342|FG005|As Treated|Death|0|||
154868741|NCT02786537|558947337|FG000|As Treated|Lack of Efficacy|0|||
154868742|NCT02786537|558947338|FG001|As Treated|Lack of Efficacy|0|||
154868743|NCT02786537|558947339|FG002|As Treated|Lack of Efficacy|0|||
154868744|NCT02786537|558947340|FG003|As Treated|Lack of Efficacy|1|||
154868745|NCT02786537|558947341|FG004|As Treated|Lack of Efficacy|0|||
154868746|NCT02786537|558947342|FG005|As Treated|Lack of Efficacy|0|||
154868747|NCT02786537|558947337|FG000|As Treated|Lost to Follow-up|4|||
154868748|NCT02786537|558947338|FG001|As Treated|Lost to Follow-up|32|||
154868749|NCT02786537|558947339|FG002|As Treated|Lost to Follow-up|0|||
154868750|NCT02786537|558947340|FG003|As Treated|Lost to Follow-up|25|||
154868751|NCT02786537|558947341|FG004|As Treated|Lost to Follow-up|4|||
154868752|NCT02786537|558947342|FG005|As Treated|Lost to Follow-up|4|||
154868753|NCT02786537|558947337|FG000|As Treated|Non-compliance with study drug|1|||
154868754|NCT02786537|558947338|FG001|As Treated|Non-compliance with study drug|11|||
154868755|NCT02786537|558947339|FG002|As Treated|Non-compliance with study drug|0|||
154868756|NCT02786537|558947340|FG003|As Treated|Non-compliance with study drug|1|||
154868757|NCT02786537|558947341|FG004|As Treated|Non-compliance with study drug|0|||
154868758|NCT02786537|558947342|FG005|As Treated|Non-compliance with study drug|1|||
154868759|NCT02786537|558947337|FG000|As Treated|Lost insurance|0|||
154868760|NCT02786537|558947338|FG001|As Treated|Lost insurance|0|||
154868761|NCT02786537|558947339|FG002|As Treated|Lost insurance|0|||
154868762|NCT02786537|558947340|FG003|As Treated|Lost insurance|1|||
154868763|NCT02786537|558947341|FG004|As Treated|Lost insurance|0|||
154868764|NCT02786537|558947342|FG005|As Treated|Lost insurance|0|||
154868765|NCT02786537|558947337|FG000|As Treated|Withdrawal by Subject|1|||
154868766|NCT02786537|558947338|FG001|As Treated|Withdrawal by Subject|2|||
154868767|NCT02786537|558947339|FG002|As Treated|Withdrawal by Subject|0|||
154868768|NCT02786537|558947340|FG003|As Treated|Withdrawal by Subject|0|||
154868769|NCT02786537|558947341|FG004|As Treated|Withdrawal by Subject|1|||
154868770|NCT02786537|558947342|FG005|As Treated|Withdrawal by Subject|0|||
154868771|NCT02786537|558947337|FG000|As Treated|Incarceration|0|||
154868772|NCT02786537|558947338|FG001|As Treated|Incarceration|1|||
154868773|NCT02786537|558947339|FG002|As Treated|Incarceration|0|||
154868774|NCT02786537|558947340|FG003|As Treated|Incarceration|0|||
154868775|NCT02786537|558947341|FG004|As Treated|Incarceration|0|||
154868776|NCT02786537|558947342|FG005|As Treated|Incarceration|0|||
154868777|NCT02786537|558947337|FG000|As Treated|Opiate dependency relapse|0|||
154868778|NCT02786537|558947338|FG001|As Treated|Opiate dependency relapse|1|||
154868779|NCT02786537|558947339|FG002|As Treated|Opiate dependency relapse|0|||
154868780|NCT02786537|558947340|FG003|As Treated|Opiate dependency relapse|0|||
154868781|NCT02786537|558947341|FG004|As Treated|Opiate dependency relapse|0|||
154868782|NCT02786537|558947342|FG005|As Treated|Opiate dependency relapse|0|||
154868783|NCT02786537|558947337|FG000|As Treated|Drugs stolen from patient|0|||
154868784|NCT02786537|558947338|FG001|As Treated|Drugs stolen from patient|1|||
154868785|NCT02786537|558947339|FG002|As Treated|Drugs stolen from patient|0|||
154868786|NCT02786537|558947340|FG003|As Treated|Drugs stolen from patient|0|||
154868787|NCT02786537|558947341|FG004|As Treated|Drugs stolen from patient|0|||
154868788|NCT02786537|558947342|FG005|As Treated|Drugs stolen from patient|0|||
154868789|NCT02786537|558947337|FG000|As Treated|Advised to stop tx after loss of meds|0|||
154868790|NCT02786537|558947338|FG001|As Treated|Advised to stop tx after loss of meds|1|||
154868791|NCT02786537|558947339|FG002|As Treated|Advised to stop tx after loss of meds|0|||
154868792|NCT02786537|558947340|FG003|As Treated|Advised to stop tx after loss of meds|0|||
154868793|NCT02786537|558947341|FG004|As Treated|Advised to stop tx after loss of meds|0|||
154868794|NCT02786537|558947342|FG005|As Treated|Advised to stop tx after loss of meds|0|||
154868795|NCT03216265|558947343|FG000|Overall Study|Adverse Event|2|||
154868796|NCT03216265|558947344|FG001|Overall Study|Adverse Event|0|||
154868797|NCT03216265|558947345|FG002|Overall Study|Adverse Event|2|||
154868798|NCT03216265|558947343|FG000|Overall Study|Lost to Follow-up|0|||
154868799|NCT03216265|558947344|FG001|Overall Study|Lost to Follow-up|1|||
154868800|NCT03216265|558947345|FG002|Overall Study|Lost to Follow-up|0|||
154868801|NCT03216265|558947343|FG000|Overall Study|Withdrawal by Subject|0|||
154868802|NCT03216265|558947344|FG001|Overall Study|Withdrawal by Subject|0|||
154868803|NCT03216265|558947345|FG002|Overall Study|Withdrawal by Subject|1|||
154868804|NCT01306058|558947346|FG000|Overall Study|Death|1|||
154868805|NCT01306058|558947346|FG000|Overall Study|Enrolled but did not get treatment|1|||
154868806|NCT01539837|558947347|FG000|Overall Study|reduce neutrophil level|0|||
154868807|NCT01539837|558947348|FG001|Overall Study|reduce neutrophil level|1|||
154868808|NCT01539837|558947349|FG002|Overall Study|reduce neutrophil level|1|||
154868809|NCT01539837|558947347|FG000|Overall Study|bad compliance|0|||
154868810|NCT01539837|558947348|FG001|Overall Study|bad compliance|0|||
154868811|NCT01539837|558947349|FG002|Overall Study|bad compliance|1|||
154868812|NCT00849693|558947350|FG000|Acute Treatment Phase|Adverse Event|12|||
154868813|NCT00849693|558947351|FG001|Acute Treatment Phase|Adverse Event|7|||
154868814|NCT00849693|558947352|FG002|Acute Treatment Phase|Adverse Event|6|||
154868815|NCT00849693|558947353|FG003|Acute Treatment Phase|Adverse Event|4|||
154868816|NCT00849693|558947350|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
154868817|NCT00849693|558947351|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
154868818|NCT00849693|558947352|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
154868819|NCT00849693|558947353|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
154868820|NCT00849693|558947350|FG000|Acute Treatment Phase|Protocol Violation|1|||
154868821|NCT00849693|558947351|FG001|Acute Treatment Phase|Protocol Violation|5|||
154868822|NCT00849693|558947352|FG002|Acute Treatment Phase|Protocol Violation|2|||
154868823|NCT00849693|558947353|FG003|Acute Treatment Phase|Protocol Violation|6|||
155109804|NCT04299308|559831057|FG001|Overall Study|Withdrawal by Subject|0|||
155109805|NCT04299308|559831056|FG000|Overall Study|issue with PET image (1)|1|||
155109806|NCT04299308|559831057|FG001|Overall Study|issue with PET image (1)|0|||
155109807|NCT00301262|559831064|FG000|Double Blind Phase (DB)|Adverse Event|1|||
155109808|NCT00301262|559831065|FG001|Double Blind Phase (DB)|Adverse Event|0|||
155109809|NCT00301262|559831064|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
155109810|NCT00301262|559831065|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
155109811|NCT00301262|559831064|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
155109812|NCT00301262|559831065|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
155109813|NCT00301262|559831064|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
155109814|NCT00301262|559831065|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
155109815|NCT00301262|559831064|FG000|Double Blind Phase (DB)|Other|1|||
155109816|NCT00301262|559831065|FG001|Double Blind Phase (DB)|Other|4|||
155109817|NCT00301262|559831064|FG000|Open Label Phase (OL)|Adverse Event|1|||
155109818|NCT00301262|559831065|FG001|Open Label Phase (OL)|Adverse Event|0|||
155109819|NCT00301262|559831064|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
155109820|NCT00301262|559831065|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
155109821|NCT00301262|559831064|FG000|Open Label Phase (OL)|Other|2|||
155109822|NCT00301262|559831065|FG001|Open Label Phase (OL)|Other|0|||
155109823|NCT04308239|559831073|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
155109824|NCT04308239|559831074|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
155109825|NCT04308239|559831073|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
155109826|NCT04308239|559831074|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
155109827|NCT04308239|559831073|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
155109828|NCT04308239|559831074|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
155109829|NCT04308239|559831073|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
155109830|NCT04308239|559831074|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
155109831|NCT01443364|559831075|FG000|Overall Study|Lack of Efficacy|14|||
155109832|NCT01443364|559831075|FG000|Overall Study|Lost to Follow-up|3|||
155109833|NCT01443364|559831075|FG000|Overall Study|Withdrawal by Subject|5|||
155109834|NCT01443364|559831075|FG000|Overall Study|Other Reason|4|||
155109835|NCT01443364|559831075|FG000|Overall Study|SAE, non-fatal|6|||
155109836|NCT01443364|559831075|FG000|Overall Study|AE, non-serious non-fatal|8|||
155109837|NCT01443364|559831075|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155109838|NCT02150057|559831089|FG000|Overall Study|Lost to Follow-up|6|||
155109839|NCT02150057|559831090|FG001|Overall Study|Lost to Follow-up|4|||
155109840|NCT00489424|559831091|FG000|Overall Study|Adverse Event|3|||
155109841|NCT00489424|559831092|FG001|Overall Study|Adverse Event|3|||
155109842|NCT00489424|559831093|FG002|Overall Study|Adverse Event|4|||
155109843|NCT00489424|559831091|FG000|Overall Study|Lack of Efficacy|1|||
155109844|NCT00489424|559831092|FG001|Overall Study|Lack of Efficacy|0|||
155109845|NCT00489424|559831093|FG002|Overall Study|Lack of Efficacy|0|||
155109846|NCT00489424|559831091|FG000|Overall Study|Administrative problems|0|||
155109847|NCT00489424|559831092|FG001|Overall Study|Administrative problems|2|||
155109848|NCT00489424|559831093|FG002|Overall Study|Administrative problems|1|||
155109849|NCT05791565|559831094|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
155109850|NCT05791565|559831095|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
154868824|NCT00849693|558947350|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
154868825|NCT00849693|558947351|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
154868826|NCT00849693|558947352|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
154868827|NCT00849693|558947353|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
154868828|NCT00849693|558947350|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
154868829|NCT00849693|558947351|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
154868830|NCT00849693|558947352|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
154868831|NCT00849693|558947353|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
154868832|NCT00849693|558947350|FG000|Acute Treatment Phase|Physician Decision|2|||
154868833|NCT00849693|558947351|FG001|Acute Treatment Phase|Physician Decision|1|||
154868834|NCT00849693|558947352|FG002|Acute Treatment Phase|Physician Decision|2|||
154868835|NCT00849693|558947353|FG003|Acute Treatment Phase|Physician Decision|1|||
154868836|NCT00849693|558947350|FG000|Acute Treatment Phase|Sponsor decision|0|||
154868837|NCT00849693|558947351|FG001|Acute Treatment Phase|Sponsor decision|0|||
154868838|NCT00849693|558947352|FG002|Acute Treatment Phase|Sponsor decision|1|||
154868839|NCT00849693|558947353|FG003|Acute Treatment Phase|Sponsor decision|0|||
155109851|NCT01558115|559831096|FG000|Overall Study|Withdrawal by Subject|3|||
155109852|NCT01558115|559831096|FG000|Overall Study|Study closed due to poor enrollment|4|||
155109853|NCT01436656|559831097|FG000|Dose Escalation|Death|1|||
155109854|NCT01436656|559831098|FG001|Dose Escalation|Death|3|||
155109855|NCT01436656|559831099|FG002|Dose Escalation|Death|1|||
155109856|NCT01436656|559831100|FG003|Dose Escalation|Death|0|||
155109857|NCT01436656|559831101|FG004|Dose Escalation|Death|2|||
154868840|NCT00849693|558947350|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
154868841|NCT00849693|558947351|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
154868842|NCT00849693|558947352|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
154868843|NCT00849693|558947353|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
154868844|NCT00849693|558947350|FG000|Extension Phase|Adverse Event|4|||
154868845|NCT00849693|558947351|FG001|Extension Phase|Adverse Event|6|||
154868846|NCT00849693|558947352|FG002|Extension Phase|Adverse Event|3|||
154868847|NCT00849693|558947353|FG003|Extension Phase|Adverse Event|7|||
154868848|NCT00849693|558947350|FG000|Extension Phase|Lost to Follow-up|7|||
154868849|NCT00849693|558947351|FG001|Extension Phase|Lost to Follow-up|5|||
154868850|NCT00849693|558947352|FG002|Extension Phase|Lost to Follow-up|6|||
154868851|NCT00849693|558947353|FG003|Extension Phase|Lost to Follow-up|6|||
154868852|NCT00849693|558947350|FG000|Extension Phase|Protocol Violation|0|||
154868853|NCT00849693|558947351|FG001|Extension Phase|Protocol Violation|3|||
154868854|NCT00849693|558947352|FG002|Extension Phase|Protocol Violation|2|||
154868855|NCT00849693|558947353|FG003|Extension Phase|Protocol Violation|3|||
154868856|NCT00849693|558947350|FG000|Extension Phase|Withdrawal by Subject|6|||
154868857|NCT00849693|558947351|FG001|Extension Phase|Withdrawal by Subject|9|||
154868858|NCT00849693|558947352|FG002|Extension Phase|Withdrawal by Subject|10|||
154868859|NCT00849693|558947353|FG003|Extension Phase|Withdrawal by Subject|15|||
154868860|NCT00849693|558947350|FG000|Extension Phase|Parent or caregiver decision|9|||
154868861|NCT00849693|558947351|FG001|Extension Phase|Parent or caregiver decision|4|||
154868862|NCT00849693|558947352|FG002|Extension Phase|Parent or caregiver decision|10|||
154868863|NCT00849693|558947353|FG003|Extension Phase|Parent or caregiver decision|5|||
154868864|NCT00849693|558947350|FG000|Extension Phase|Physician Decision|1|||
154868865|NCT00849693|558947351|FG001|Extension Phase|Physician Decision|1|||
154868866|NCT00849693|558947352|FG002|Extension Phase|Physician Decision|2|||
154868867|NCT00849693|558947353|FG003|Extension Phase|Physician Decision|0|||
154868868|NCT00849693|558947350|FG000|Extension Phase|Sponsor decision|1|||
154868869|NCT00849693|558947351|FG001|Extension Phase|Sponsor decision|0|||
154868870|NCT00849693|558947352|FG002|Extension Phase|Sponsor decision|0|||
154868871|NCT00849693|558947353|FG003|Extension Phase|Sponsor decision|1|||
154868872|NCT00849693|558947350|FG000|Extension Phase|Lack of Efficacy|2|||
154868873|NCT00849693|558947351|FG001|Extension Phase|Lack of Efficacy|2|||
154868874|NCT00849693|558947352|FG002|Extension Phase|Lack of Efficacy|2|||
154868875|NCT00849693|558947353|FG003|Extension Phase|Lack of Efficacy|1|||
154868876|NCT01978912|558947354|FG000|Overall Study|Adverse Event|0|||
154868877|NCT01978912|558947355|FG001|Overall Study|Adverse Event|1|||
154868878|NCT01978912|558947356|FG002|Overall Study|Adverse Event|0|||
154868879|NCT01978912|558947357|FG003|Overall Study|Adverse Event|0|||
154868880|NCT01978912|558947354|FG000|Overall Study|Lost to Follow-up|1|||
154868881|NCT01978912|558947355|FG001|Overall Study|Lost to Follow-up|1|||
154868882|NCT01978912|558947356|FG002|Overall Study|Lost to Follow-up|0|||
154868883|NCT01978912|558947357|FG003|Overall Study|Lost to Follow-up|1|||
154868884|NCT01978912|558947354|FG000|Overall Study|Withdrawal by Subject|1|||
154868885|NCT01978912|558947355|FG001|Overall Study|Withdrawal by Subject|0|||
154868886|NCT01978912|558947356|FG002|Overall Study|Withdrawal by Subject|2|||
154868887|NCT01978912|558947357|FG003|Overall Study|Withdrawal by Subject|2|||
154868888|NCT01978912|558947354|FG000|Overall Study|Lumbar Surgery|1|||
154868889|NCT01978912|558947355|FG001|Overall Study|Lumbar Surgery|0|||
154868890|NCT01978912|558947356|FG002|Overall Study|Lumbar Surgery|1|||
154868891|NCT01978912|558947357|FG003|Overall Study|Lumbar Surgery|0|||
154868892|NCT01978912|558947354|FG000|Overall Study|Intradiscal Steroid Injection|0|||
154868893|NCT01978912|558947355|FG001|Overall Study|Intradiscal Steroid Injection|1|||
154868894|NCT01978912|558947356|FG002|Overall Study|Intradiscal Steroid Injection|0|||
154868895|NCT01978912|558947357|FG003|Overall Study|Intradiscal Steroid Injection|0|||
154868896|NCT00224107|558947358|FG000|Overall Study|Adverse Event|20|||
154868897|NCT00224107|558947359|FG001|Overall Study|Adverse Event|6|||
154868898|NCT00224107|558947358|FG000|Overall Study|Protocol Violation|2|||
154868899|NCT00224107|558947359|FG001|Overall Study|Protocol Violation|3|||
154868900|NCT00224107|558947358|FG000|Overall Study|Withdrawal by Subject|1|||
154868901|NCT00224107|558947359|FG001|Overall Study|Withdrawal by Subject|4|||
154868902|NCT00224107|558947358|FG000|Overall Study|Lack of Efficacy|2|||
155109858|NCT01436656|559831102|FG005|Dose Escalation|Death|1|||
155109859|NCT01436656|559831103|FG006|Dose Escalation|Death|1|||
155109860|NCT01436656|559831104|FG007|Dose Escalation|Death|1|||
155109861|NCT01436656|559831105|FG008|Dose Escalation|Death|1|||
155109862|NCT01436656|559831106|FG009|Dose Escalation|Death|0|||
154868903|NCT00224107|558947359|FG001|Overall Study|Lack of Efficacy|0|||
154868904|NCT00224107|558947358|FG000|Overall Study|Lost to Follow-up|4|||
154868905|NCT00224107|558947359|FG001|Overall Study|Lost to Follow-up|0|||
154868906|NCT00224107|558947358|FG000|Overall Study|Physician Decision|1|||
154868907|NCT00224107|558947359|FG001|Overall Study|Physician Decision|0|||
154868908|NCT00224107|558947358|FG000|Overall Study|Other|1|||
155109863|NCT01436656|559831107|FG010|Dose Escalation|Death|0|||
154868909|NCT00224107|558947359|FG001|Overall Study|Other|1|||
154868910|NCT01408537|558947360|FG000|Overall Study|Withdrawal by Subject|2|||
154868911|NCT01408537|558947360|FG000|Overall Study|Protocol Violation|3|||
154868912|NCT01408537|558947360|FG000|Overall Study|Lost to Follow-up|3|||
154868913|NCT05523362|558947361|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
154973704|NCT00996437|559328924|FG001|Overall Study|Death|0|||
155109864|NCT01436656|559831108|FG011|Dose Escalation|Death|0|||
154868914|NCT05523362|558947361|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
154868915|NCT05523362|558947361|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
154868916|NCT05523362|558947361|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
154868917|NCT01183858|558947364|FG000|Overall Study|Death not related to Progressive Disease|5|||
154868918|NCT01183858|558947365|FG001|Overall Study|Death not related to Progressive Disease|6|||
154868919|NCT01183858|558947364|FG000|Overall Study|Adverse Event|14|||
154868920|NCT01183858|558947365|FG001|Overall Study|Adverse Event|11|||
154868921|NCT01183858|558947364|FG000|Overall Study|Investigator's Decision|0|||
154868922|NCT01183858|558947365|FG001|Overall Study|Investigator's Decision|3|||
154868923|NCT01183858|558947364|FG000|Overall Study|Insufficient Therapeutic Response|2|||
154868924|NCT01183858|558947365|FG001|Overall Study|Insufficient Therapeutic Response|0|||
154868925|NCT01183858|558947364|FG000|Overall Study|Refused Treatment|1|||
154868926|NCT01183858|558947365|FG001|Overall Study|Refused Treatment|4|||
154868927|NCT01183858|558947364|FG000|Overall Study|Withdrew Consent|4|||
154868928|NCT01183858|558947365|FG001|Overall Study|Withdrew Consent|4|||
154868929|NCT01183858|558947364|FG000|Overall Study|Discontinued Smoking|3|||
154868930|NCT01183858|558947365|FG001|Overall Study|Discontinued Smoking|1|||
154868931|NCT01183858|558947364|FG000|Overall Study|Protocol Violation|1|||
154868932|NCT01183858|558947365|FG001|Overall Study|Protocol Violation|0|||
154868933|NCT01183858|558947364|FG000|Overall Study|Administrative/Other|6|||
154868934|NCT01183858|558947365|FG001|Overall Study|Administrative/Other|6|||
154868935|NCT01183858|558947364|FG000|Overall Study|Progressive Disease|112|||
154868936|NCT01183858|558947365|FG001|Overall Study|Progressive Disease|115|||
154868937|NCT01183858|558947364|FG000|Overall Study|Death related to Progressive Disease|4|||
154868938|NCT01183858|558947365|FG001|Overall Study|Death related to Progressive Disease|5|||
154868939|NCT01183858|558947364|FG000|Overall Study|Lost to Follow-up|1|||
154868940|NCT01183858|558947365|FG001|Overall Study|Lost to Follow-up|1|||
154868941|NCT00098345|558947366|FG000|Overall Study|Adverse Event|7|||
154868942|NCT00098345|558947366|FG000|Overall Study|Withdrawal by Subject|2|||
154868943|NCT00098345|558947366|FG000|Overall Study|progression|4|||
154868944|NCT03707977|558947367|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
154868945|NCT03707977|558947368|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
154868946|NCT03707977|558947369|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
154868947|NCT03707977|558947367|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
154868948|NCT03707977|558947368|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
154868949|NCT03707977|558947369|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
154868950|NCT03842709|558947370|FG000|Overall Study|Withdrawal by Subject|3|||
154868951|NCT03842709|558947371|FG001|Overall Study|Withdrawal by Subject|3|||
154868952|NCT03842709|558947370|FG000|Overall Study|Lost to Follow-up|1|||
154868953|NCT03842709|558947371|FG001|Overall Study|Lost to Follow-up|0|||
154868954|NCT00641147|558947372|FG000|Completed 4 Months.|Physician Decision|1|||
154868955|NCT00641147|558947373|FG001|Completed 4 Months.|Physician Decision|0|||
154868956|NCT00641147|558947372|FG000|Completed 4 Months.|Adverse Event|1|||
154868957|NCT00641147|558947373|FG001|Completed 4 Months.|Adverse Event|0|||
154868958|NCT00641147|558947372|FG000|Completed 8 Months.|Physician Decision|2|||
154868959|NCT00641147|558947373|FG001|Completed 8 Months.|Physician Decision|1|||
154868960|NCT00641147|558947372|FG000|Completed 8 Months.|non compliance|1|||
154868961|NCT00641147|558947373|FG001|Completed 8 Months.|non compliance|0|||
154868962|NCT00641147|558947372|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
154868963|NCT00641147|558947373|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
154868964|NCT00641147|558947372|FG000|Completed 12 Months.|Physician Decision|1|||
154868965|NCT00641147|558947373|FG001|Completed 12 Months.|Physician Decision|1|||
154868966|NCT00641147|558947372|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
154868967|NCT00641147|558947373|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
154868968|NCT00641147|558947372|FG000|Completed 16 Months.|Physician Decision|1|||
154868969|NCT00641147|558947373|FG001|Completed 16 Months.|Physician Decision|0|||
154868970|NCT00641147|558947372|FG000|Completed 16 Months.|Lost to Follow-up|1|||
154868971|NCT00641147|558947373|FG001|Completed 16 Months.|Lost to Follow-up|0|||
154868972|NCT00791128|558947374|FG000|Overall Study|Adverse Event|4|||
154868973|NCT00791128|558947374|FG000|Overall Study|Device migration|2|||
155109865|NCT01436656|559831109|FG012|Dose Escalation|Death|0|||
155109866|NCT01436656|559831110|FG013|Dose Escalation|Death|0|||
154868974|NCT00791128|558947374|FG000|Overall Study|non-compliance by subject|2|||
154868975|NCT00791128|558947374|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
154868976|NCT00984659|558947375|FG000|2-week Run-in Period|Adverse Event|8|||
154868977|NCT00984659|558947376|FG001|2-week Run-in Period|Adverse Event|0|||
154868978|NCT00984659|558947377|FG002|2-week Run-in Period|Adverse Event|0|||
155109867|NCT01436656|559831111|FG014|Dose Escalation|Death|0|||
154868979|NCT00984659|558947378|FG003|2-week Run-in Period|Adverse Event|0|||
154868980|NCT00984659|558947375|FG000|2-week Run-in Period|Protocol Violation|5|||
154868981|NCT00984659|558947376|FG001|2-week Run-in Period|Protocol Violation|0|||
154868982|NCT00984659|558947377|FG002|2-week Run-in Period|Protocol Violation|0|||
155109868|NCT01436656|559831112|FG015|Dose Escalation|Death|0|||
155109869|NCT01436656|559831113|FG016|Dose Escalation|Death|0|||
155109870|NCT01436656|559831114|FG017|Dose Escalation|Death|0|||
155109871|NCT01436656|559831097|FG000|Dose Escalation|Protocol Violation|0|||
154868983|NCT00984659|558947378|FG003|2-week Run-in Period|Protocol Violation|0|||
154868984|NCT00984659|558947375|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
154868985|NCT00984659|558947376|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
154868986|NCT00984659|558947377|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
154868987|NCT00984659|558947378|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
154868988|NCT00984659|558947375|FG000|2-week Run-in Period|Lost to Follow-up|3|||
154868989|NCT00984659|558947376|FG001|2-week Run-in Period|Lost to Follow-up|0|||
154868990|NCT00984659|558947377|FG002|2-week Run-in Period|Lost to Follow-up|0|||
154868991|NCT00984659|558947378|FG003|2-week Run-in Period|Lost to Follow-up|0|||
154868992|NCT00984659|558947375|FG000|2-week Run-in Period|Physician Decision|10|||
154868993|NCT00984659|558947376|FG001|2-week Run-in Period|Physician Decision|0|||
154868994|NCT00984659|558947377|FG002|2-week Run-in Period|Physician Decision|0|||
154868995|NCT00984659|558947378|FG003|2-week Run-in Period|Physician Decision|0|||
154868996|NCT00984659|558947375|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
154868997|NCT00984659|558947376|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
154868998|NCT00984659|558947377|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
154868999|NCT00984659|558947378|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
154869000|NCT00984659|558947375|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
154869001|NCT00984659|558947376|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
154869002|NCT00984659|558947377|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
154869003|NCT00984659|558947378|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
154869004|NCT00984659|558947375|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
154869005|NCT00984659|558947376|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
154869006|NCT00984659|558947377|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
154869007|NCT00984659|558947378|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
154869008|NCT00984659|558947375|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
154869009|NCT00984659|558947376|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
154869010|NCT00984659|558947377|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
154869011|NCT00984659|558947378|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
154869012|NCT00984659|558947375|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
154869013|NCT00984659|558947376|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
154869014|NCT00984659|558947377|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
154869015|NCT00984659|558947378|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
154869016|NCT00984659|558947375|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
154869017|NCT00984659|558947376|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
154869018|NCT00984659|558947377|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
154869019|NCT00984659|558947378|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
154869020|NCT00984659|558947375|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
154869021|NCT00984659|558947376|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
154869022|NCT00984659|558947377|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
154869023|NCT00984659|558947378|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
154869024|NCT01720667|558947382|FG000|Overall Study|Adverse Event|1|||
154869025|NCT01720667|558947383|FG001|Overall Study|Adverse Event|1|||
154869026|NCT01720667|558947382|FG000|Overall Study|Withdrawal by Subject|3|||
154869027|NCT01720667|558947383|FG001|Overall Study|Withdrawal by Subject|0|||
154869028|NCT03472534|558947384|FG000|Overall Study|Withdrawal by Subject|9|||
154869029|NCT03472534|558947384|FG000|Overall Study|Adverse Event|2|||
154869030|NCT02614794|558947385|FG000|Overall Study|Death|258|||
154869031|NCT02614794|558947386|FG001|Overall Study|Death|151|||
154869032|NCT02614794|558947385|FG000|Overall Study|Study closure by Sponsor|119|||
154869033|NCT02614794|558947386|FG001|Overall Study|Study closure by Sponsor|45|||
154869034|NCT02614794|558947385|FG000|Overall Study|Withdrawal by Subject|24|||
154869035|NCT02614794|558947386|FG001|Overall Study|Withdrawal by Subject|5|||
154869036|NCT02614794|558947385|FG000|Overall Study|Lost to Follow-up|7|||
154869037|NCT02614794|558947386|FG001|Overall Study|Lost to Follow-up|0|||
154869038|NCT02614794|558947385|FG000|Overall Study|Physician Decision|1|||
154869039|NCT02614794|558947386|FG001|Overall Study|Physician Decision|1|||
154869040|NCT02614794|558947385|FG000|Overall Study|Hospital closure|1|||
154869041|NCT02614794|558947386|FG001|Overall Study|Hospital closure|0|||
154869042|NCT00234104|558947387|FG000|Overall Study|Adverse Event|4|||
154869043|NCT00234104|558947388|FG001|Overall Study|Adverse Event|0|||
154869044|NCT00234104|558947389|FG002|Overall Study|Adverse Event|3|||
154869045|NCT00234104|558947390|FG003|Overall Study|Adverse Event|5|||
154869046|NCT00234104|558947387|FG000|Overall Study|Protocol Violation|0|||
154869047|NCT00234104|558947388|FG001|Overall Study|Protocol Violation|0|||
154869048|NCT00234104|558947389|FG002|Overall Study|Protocol Violation|0|||
154869049|NCT00234104|558947390|FG003|Overall Study|Protocol Violation|1|||
154869050|NCT00234104|558947387|FG000|Overall Study|Physician Decision|0|||
155109872|NCT01436656|559831098|FG001|Dose Escalation|Protocol Violation|0|||
154869051|NCT00234104|558947388|FG001|Overall Study|Physician Decision|1|||
154869052|NCT00234104|558947389|FG002|Overall Study|Physician Decision|2|||
154869053|NCT00234104|558947390|FG003|Overall Study|Physician Decision|2|||
154869054|NCT02052960|558947392|FG000|Overall Study|Adverse Event|19|||
154869055|NCT02052960|558947393|FG001|Overall Study|Adverse Event|17|||
154869056|NCT02052960|558947392|FG000|Overall Study|Protocol Violation|4|||
154869057|NCT02052960|558947393|FG001|Overall Study|Protocol Violation|3|||
154869058|NCT02052960|558947392|FG000|Overall Study|Withdrawal by Subject|6|||
154869059|NCT02052960|558947393|FG001|Overall Study|Withdrawal by Subject|11|||
154869060|NCT02052960|558947392|FG000|Overall Study|Other|25|||
154869061|NCT02052960|558947393|FG001|Overall Study|Other|15|||
154869062|NCT04045613|558947394|FG000|Overall Study|Adverse Event|2|||
154869063|NCT04045613|558947395|FG001|Overall Study|Adverse Event|2|||
154869064|NCT04045613|558947396|FG002|Overall Study|Adverse Event|1|||
155174808|NCT00357760|560078293|FG000|Overall Study|Adverse Event|10|||
155174809|NCT00357760|560078294|FG001|Overall Study|Adverse Event|7|||
155174810|NCT00357760|560078293|FG000|Overall Study|Death|0|||
155174811|NCT00357760|560078294|FG001|Overall Study|Death|3|||
155174812|NCT00357760|560078293|FG000|Overall Study|Alternative therapy|1|||
155174813|NCT00357760|560078294|FG001|Overall Study|Alternative therapy|0|||
155174814|NCT00357760|560078293|FG000|Overall Study|Withdrawal by Subject|0|||
155174815|NCT00357760|560078294|FG001|Overall Study|Withdrawal by Subject|2|||
155174816|NCT00357760|560078293|FG000|Overall Study|Never started treatment|2|||
155174817|NCT00357760|560078294|FG001|Overall Study|Never started treatment|1|||
155174818|NCT00357760|560078293|FG000|Overall Study|Ineligible|0|||
155174819|NCT00357760|560078294|FG001|Overall Study|Ineligible|2|||
155174820|NCT00357760|560078293|FG000|Overall Study|Physician Decision|2|||
155174821|NCT00357760|560078294|FG001|Overall Study|Physician Decision|1|||
155174822|NCT00357760|560078293|FG000|Overall Study|Protocol Violation|0|||
155174823|NCT00357760|560078294|FG001|Overall Study|Protocol Violation|1|||
155174824|NCT00357760|560078293|FG000|Overall Study|To receive hospice care|0|||
155174825|NCT00357760|560078294|FG001|Overall Study|To receive hospice care|1|||
155174826|NCT04136444|560078295|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
155174827|NCT04136444|560078296|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
155174828|NCT01328444|560078297|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155174829|NCT01328444|560078298|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155174830|NCT01328444|560078299|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
155174831|NCT01328444|560078300|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
155174832|NCT01328444|560078301|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
155174833|NCT01328444|560078302|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
155174834|NCT01328444|560078297|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
155174835|NCT01328444|560078298|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155174836|NCT01328444|560078299|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155174837|NCT01328444|560078300|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
155174838|NCT01328444|560078301|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
155174839|NCT01328444|560078302|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
155174840|NCT01328444|560078297|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155174841|NCT01328444|560078298|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155174842|NCT01328444|560078299|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155174843|NCT01328444|560078300|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155174844|NCT01328444|560078301|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
155174845|NCT01328444|560078302|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
155174846|NCT01328444|560078297|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155174847|NCT01328444|560078298|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
154869065|NCT04045613|558947397|FG003|Overall Study|Adverse Event|1|||
154869066|NCT04045613|558947398|FG004|Overall Study|Adverse Event|0|||
154869067|NCT04045613|558947399|FG005|Overall Study|Adverse Event|0|||
154869068|NCT04045613|558947400|FG006|Overall Study|Adverse Event|1|||
154869069|NCT04045613|558947394|FG000|Overall Study|Withdrawal by Subject|0|||
154869070|NCT04045613|558947395|FG001|Overall Study|Withdrawal by Subject|5|||
154869071|NCT04045613|558947396|FG002|Overall Study|Withdrawal by Subject|0|||
154869072|NCT04045613|558947397|FG003|Overall Study|Withdrawal by Subject|0|||
154869073|NCT04045613|558947398|FG004|Overall Study|Withdrawal by Subject|0|||
154869074|NCT04045613|558947399|FG005|Overall Study|Withdrawal by Subject|1|||
154869075|NCT04045613|558947400|FG006|Overall Study|Withdrawal by Subject|0|||
154869076|NCT04045613|558947394|FG000|Overall Study|Physician Decision|2|||
154869077|NCT04045613|558947395|FG001|Overall Study|Physician Decision|0|||
154869078|NCT04045613|558947396|FG002|Overall Study|Physician Decision|0|||
154869079|NCT04045613|558947397|FG003|Overall Study|Physician Decision|0|||
154869080|NCT04045613|558947398|FG004|Overall Study|Physician Decision|1|||
154869081|NCT04045613|558947399|FG005|Overall Study|Physician Decision|0|||
154869082|NCT04045613|558947400|FG006|Overall Study|Physician Decision|0|||
155174848|NCT01328444|560078299|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
154869083|NCT04045613|558947394|FG000|Overall Study|Death|3|||
154869084|NCT04045613|558947395|FG001|Overall Study|Death|0|||
154869085|NCT04045613|558947396|FG002|Overall Study|Death|0|||
154869086|NCT04045613|558947397|FG003|Overall Study|Death|0|||
154869087|NCT04045613|558947398|FG004|Overall Study|Death|0|||
154869088|NCT04045613|558947399|FG005|Overall Study|Death|0|||
154869089|NCT04045613|558947400|FG006|Overall Study|Death|1|||
154869090|NCT04045613|558947394|FG000|Overall Study|Other reasons|0|||
154869091|NCT04045613|558947395|FG001|Overall Study|Other reasons|1|||
154869092|NCT04045613|558947396|FG002|Overall Study|Other reasons|0|||
154869093|NCT04045613|558947397|FG003|Overall Study|Other reasons|0|||
154869094|NCT04045613|558947398|FG004|Overall Study|Other reasons|0|||
154869095|NCT04045613|558947399|FG005|Overall Study|Other reasons|0|||
154869096|NCT04045613|558947400|FG006|Overall Study|Other reasons|1|||
154869097|NCT04045613|558947394|FG000|Overall Study|Progressive disease: Clinical progression|1|||
154869098|NCT04045613|558947395|FG001|Overall Study|Progressive disease: Clinical progression|0|||
154869099|NCT04045613|558947396|FG002|Overall Study|Progressive disease: Clinical progression|3|||
154869100|NCT04045613|558947397|FG003|Overall Study|Progressive disease: Clinical progression|1|||
154869101|NCT04045613|558947398|FG004|Overall Study|Progressive disease: Clinical progression|1|||
154869102|NCT04045613|558947399|FG005|Overall Study|Progressive disease: Clinical progression|3|||
154869103|NCT04045613|558947400|FG006|Overall Study|Progressive disease: Clinical progression|3|||
154869104|NCT04045613|558947394|FG000|Overall Study|Progressive disease: Radiological progression|24|||
154869105|NCT04045613|558947395|FG001|Overall Study|Progressive disease: Radiological progression|6|||
154869106|NCT04045613|558947396|FG002|Overall Study|Progressive disease: Radiological progression|8|||
154869107|NCT04045613|558947397|FG003|Overall Study|Progressive disease: Radiological progression|0|||
154869108|NCT04045613|558947398|FG004|Overall Study|Progressive disease: Radiological progression|6|||
154869109|NCT04045613|558947399|FG005|Overall Study|Progressive disease: Radiological progression|6|||
154869110|NCT04045613|558947400|FG006|Overall Study|Progressive disease: Radiological progression|11|||
154869111|NCT03633331|558947411|FG000|Overall Study|Withdrawal by Subject|1|||
154869112|NCT00949650|558947412|FG000|Overall Study|Progressive disease|188|||
154869113|NCT00949650|558947413|FG001|Overall Study|Progressive disease|19|||
154869114|NCT00949650|558947412|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
154869115|NCT00949650|558947413|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
154869116|NCT00949650|558947412|FG000|Overall Study|Other Adverse Event (AE)|28|||
154869117|NCT00949650|558947413|FG001|Overall Study|Other Adverse Event (AE)|17|||
154869118|NCT00949650|558947412|FG000|Overall Study|Protocol Violation|1|||
154869119|NCT00949650|558947413|FG001|Overall Study|Protocol Violation|4|||
154869120|NCT00949650|558947412|FG000|Overall Study|Refusal to continue medication|7|||
154869121|NCT00949650|558947413|FG001|Overall Study|Refusal to continue medication|11|||
154869122|NCT00949650|558947412|FG000|Overall Study|Not treated|1|||
154869123|NCT00949650|558947413|FG001|Overall Study|Not treated|4|||
154869124|NCT00949650|558947412|FG000|Overall Study|Other not specified above|5|||
154869125|NCT00949650|558947413|FG001|Overall Study|Other not specified above|0|||
154869126|NCT03671369|558947416|FG000|Overall Study|Other|1|||
154869127|NCT03671369|558947416|FG000|Overall Study|Withdrawal by Subject|289|||
154869128|NCT03671369|558947416|FG000|Overall Study|Not willing to be vaccinated|1|||
154869129|NCT00450866|558947421|FG000|Overall Study|Adverse Event|0|||
154869130|NCT00450866|558947422|FG001|Overall Study|Adverse Event|1|||
154869131|NCT00450866|558947421|FG000|Overall Study|Withdrawal by Subject|5|||
154869132|NCT00450866|558947422|FG001|Overall Study|Withdrawal by Subject|2|||
154869133|NCT00450866|558947421|FG000|Overall Study|Death|1|||
154869134|NCT00450866|558947422|FG001|Overall Study|Death|0|||
154869135|NCT00450866|558947421|FG000|Overall Study|Physician Decision|1|||
154869136|NCT00450866|558947422|FG001|Overall Study|Physician Decision|0|||
154869137|NCT01743027|558947423|FG000|Overall Study|Adverse Event|2|||
154869138|NCT01743027|558947424|FG001|Overall Study|Adverse Event|0|||
154869139|NCT01743027|558947425|FG002|Overall Study|Adverse Event|0|||
154869140|NCT01743027|558947426|FG003|Overall Study|Adverse Event|0|||
154869141|NCT01743027|558947423|FG000|Overall Study|Lost to Follow-up|0|||
154869142|NCT01743027|558947424|FG001|Overall Study|Lost to Follow-up|0|||
154869143|NCT01743027|558947425|FG002|Overall Study|Lost to Follow-up|2|||
154869144|NCT01743027|558947426|FG003|Overall Study|Lost to Follow-up|0|||
154869145|NCT01743027|558947423|FG000|Overall Study|Progressive Disease|1|||
154869146|NCT01743027|558947424|FG001|Overall Study|Progressive Disease|4|||
154869147|NCT01743027|558947425|FG002|Overall Study|Progressive Disease|3|||
154869148|NCT01743027|558947426|FG003|Overall Study|Progressive Disease|0|||
154869149|NCT01743027|558947423|FG000|Overall Study|Protocol Violation|1|||
154869150|NCT01743027|558947424|FG001|Overall Study|Protocol Violation|1|||
154869151|NCT01743027|558947425|FG002|Overall Study|Protocol Violation|1|||
154869152|NCT01743027|558947426|FG003|Overall Study|Protocol Violation|0|||
154869153|NCT01743027|558947423|FG000|Overall Study|Withdrawal by Subject|1|||
154869154|NCT01743027|558947424|FG001|Overall Study|Withdrawal by Subject|0|||
155109873|NCT01436656|559831099|FG002|Dose Escalation|Protocol Violation|0|||
155109874|NCT01436656|559831100|FG003|Dose Escalation|Protocol Violation|0|||
154869155|NCT01743027|558947425|FG002|Overall Study|Withdrawal by Subject|3|||
154869156|NCT01743027|558947426|FG003|Overall Study|Withdrawal by Subject|1|||
154869157|NCT01753518|558947427|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
155109875|NCT01436656|559831101|FG004|Dose Escalation|Protocol Violation|0|||
154869158|NCT01753518|558947428|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
154869159|NCT01753518|558947427|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
155109876|NCT01436656|559831102|FG005|Dose Escalation|Protocol Violation|1|||
155109877|NCT01436656|559831103|FG006|Dose Escalation|Protocol Violation|0|||
155109878|NCT01436656|559831104|FG007|Dose Escalation|Protocol Violation|0|||
155109879|NCT01436656|559831105|FG008|Dose Escalation|Protocol Violation|0|||
155109880|NCT01436656|559831106|FG009|Dose Escalation|Protocol Violation|0|||
155109881|NCT01436656|559831107|FG010|Dose Escalation|Protocol Violation|0|||
155109882|NCT01436656|559831108|FG011|Dose Escalation|Protocol Violation|0|||
155109883|NCT01436656|559831109|FG012|Dose Escalation|Protocol Violation|0|||
155109884|NCT01436656|559831110|FG013|Dose Escalation|Protocol Violation|0|||
155109885|NCT01436656|559831111|FG014|Dose Escalation|Protocol Violation|0|||
155109886|NCT01436656|559831112|FG015|Dose Escalation|Protocol Violation|0|||
155109887|NCT01436656|559831113|FG016|Dose Escalation|Protocol Violation|0|||
155109888|NCT01436656|559831114|FG017|Dose Escalation|Protocol Violation|0|||
155109889|NCT01436656|559831097|FG000|Dose Escalation|Withdrawal by Subject|0|||
155109890|NCT01436656|559831098|FG001|Dose Escalation|Withdrawal by Subject|0|||
155109891|NCT01436656|559831099|FG002|Dose Escalation|Withdrawal by Subject|0|||
155109892|NCT01436656|559831100|FG003|Dose Escalation|Withdrawal by Subject|0|||
155109893|NCT01436656|559831101|FG004|Dose Escalation|Withdrawal by Subject|1|||
155109894|NCT01436656|559831102|FG005|Dose Escalation|Withdrawal by Subject|0|||
155109895|NCT01436656|559831103|FG006|Dose Escalation|Withdrawal by Subject|0|||
155109896|NCT01436656|559831104|FG007|Dose Escalation|Withdrawal by Subject|2|||
155109897|NCT01436656|559831105|FG008|Dose Escalation|Withdrawal by Subject|0|||
155109898|NCT01436656|559831106|FG009|Dose Escalation|Withdrawal by Subject|1|||
155109899|NCT01436656|559831107|FG010|Dose Escalation|Withdrawal by Subject|1|||
155109900|NCT01436656|559831108|FG011|Dose Escalation|Withdrawal by Subject|0|||
155109901|NCT01436656|559831109|FG012|Dose Escalation|Withdrawal by Subject|0|||
155109902|NCT01436656|559831110|FG013|Dose Escalation|Withdrawal by Subject|0|||
155109903|NCT01436656|559831111|FG014|Dose Escalation|Withdrawal by Subject|0|||
154869160|NCT01753518|558947428|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
154869161|NCT01753518|558947427|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
154869162|NCT01753518|558947428|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
154869163|NCT01753518|558947427|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
154869164|NCT01753518|558947428|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
154869165|NCT01971476|558947429|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
154869166|NCT01971476|558947430|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
154869167|NCT01971476|558947431|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
154869168|NCT01971476|558947429|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
154869169|NCT01971476|558947430|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
154869170|NCT01971476|558947431|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
154869171|NCT01971476|558947429|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
154869172|NCT01971476|558947430|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
154869173|NCT01971476|558947431|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
154869174|NCT00138151|558947432|FG000|Overall Study|Withdrawal by Subject|3|||
154869175|NCT00138151|558947432|FG000|Overall Study|Physician Decision|1|||
154869176|NCT04925570|558947435|FG000|Overall Study|Protocol Violation|24|||
154869177|NCT04925570|558947436|FG001|Overall Study|Protocol Violation|30|||
154869178|NCT04925570|558947435|FG000|Overall Study|Withdrawal by Subject|0|||
154869179|NCT04925570|558947436|FG001|Overall Study|Withdrawal by Subject|2|||
154869180|NCT02675517|558947437|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
154869181|NCT02675517|558947437|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
154869182|NCT03249350|558947440|FG000|Overall Study|Participant did not initiate treatment|5|||
154869183|NCT03249350|558947441|FG001|Overall Study|Participant did not initiate treatment|8|||
154869184|NCT02111811|558947442|FG000|Treatment Phase|Lost to Follow-up|22|||
154869185|NCT02111811|558947443|FG001|Treatment Phase|Lost to Follow-up|18|||
154869186|NCT02111811|558947442|FG000|Treatment Phase|Death|2|||
154869187|NCT02111811|558947443|FG001|Treatment Phase|Death|0|||
154869188|NCT02111811|558947442|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
154869189|NCT02111811|558947443|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
154869190|NCT02111811|558947442|FG000|Follow up Period (Aim 2)|Death|2|||
154869191|NCT02111811|558947443|FG001|Follow up Period (Aim 2)|Death|0|||
154869192|NCT03443024|558947446|FG000|Overall Study|Adverse Event|2|||
154869193|NCT03443024|558947447|FG001|Overall Study|Adverse Event|4|||
154869194|NCT03443024|558947448|FG002|Overall Study|Adverse Event|3|||
155109904|NCT01436656|559831112|FG015|Dose Escalation|Withdrawal by Subject|0|||
155109905|NCT01436656|559831113|FG016|Dose Escalation|Withdrawal by Subject|0|||
155109906|NCT01436656|559831114|FG017|Dose Escalation|Withdrawal by Subject|0|||
154869195|NCT03443024|558947449|FG003|Overall Study|Adverse Event|1|||
154869196|NCT03443024|558947446|FG000|Overall Study|Lost to Follow-up|9|||
154869197|NCT03443024|558947447|FG001|Overall Study|Lost to Follow-up|9|||
154869198|NCT03443024|558947448|FG002|Overall Study|Lost to Follow-up|7|||
154869199|NCT03443024|558947449|FG003|Overall Study|Lost to Follow-up|5|||
154869200|NCT03443024|558947446|FG000|Overall Study|Withdrawal by Subject|8|||
154869201|NCT03443024|558947447|FG001|Overall Study|Withdrawal by Subject|15|||
154869202|NCT03443024|558947448|FG002|Overall Study|Withdrawal by Subject|9|||
154869203|NCT03443024|558947449|FG003|Overall Study|Withdrawal by Subject|23|||
154869204|NCT03443024|558947446|FG000|Overall Study|Physician Decision|1|||
154869205|NCT03443024|558947447|FG001|Overall Study|Physician Decision|2|||
154869206|NCT03443024|558947448|FG002|Overall Study|Physician Decision|0|||
154869207|NCT03443024|558947449|FG003|Overall Study|Physician Decision|1|||
154869208|NCT03443024|558947446|FG000|Overall Study|Sponsor Decision|1|||
154869209|NCT03443024|558947447|FG001|Overall Study|Sponsor Decision|1|||
154869210|NCT03443024|558947448|FG002|Overall Study|Sponsor Decision|0|||
154869211|NCT03443024|558947449|FG003|Overall Study|Sponsor Decision|0|||
154869212|NCT03443024|558947446|FG000|Overall Study|Protocol Deviation|0|||
154869213|NCT03443024|558947447|FG001|Overall Study|Protocol Deviation|0|||
154869214|NCT03443024|558947448|FG002|Overall Study|Protocol Deviation|0|||
154869215|NCT03443024|558947449|FG003|Overall Study|Protocol Deviation|2|||
154869216|NCT00149825|558947450|FG000|Overall Study|Intolerance to medication side effects|1|||
154869217|NCT00149825|558947451|FG001|Overall Study|Intolerance to medication side effects|2|||
154869218|NCT00149825|558947450|FG000|Overall Study|Time commitments|2|||
154869219|NCT00149825|558947451|FG001|Overall Study|Time commitments|1|||
154869220|NCT00149825|558947450|FG000|Overall Study|Not liking insomnia therapy|1|||
154869221|NCT00149825|558947451|FG001|Overall Study|Not liking insomnia therapy|0|||
154869222|NCT00149825|558947450|FG000|Overall Study|Other|1|||
154869223|NCT00149825|558947451|FG001|Overall Study|Other|0|||
154869224|NCT05897853|558947452|FG000|Overall Study|Lost to Follow-up|2|||
154869225|NCT05897853|558947453|FG001|Overall Study|Lost to Follow-up|0|||
154869226|NCT05897853|558947452|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
154869227|NCT05897853|558947453|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
154869228|NCT03851510|558947454|FG000|Overall Study|Screen Fail|1|||
154869229|NCT03851510|558947454|FG000|Overall Study|Adverse Event|1|||
154869230|NCT03851510|558947454|FG000|Overall Study|Withdrawal by Subject|1|||
154869231|NCT00970294|558947457|FG000|Overall Study|Physician Decision|4|||
154869232|NCT00970294|558947457|FG000|Overall Study|Withdrawal by Subject|1|||
154869233|NCT01333189|558947458|FG000|Overall Study|Time constraints|1|||
154869234|NCT01333189|558947459|FG001|Overall Study|Time constraints|0|||
154869235|NCT01333189|558947458|FG000|Overall Study|Adverse Event|1|||
154869236|NCT01333189|558947459|FG001|Overall Study|Adverse Event|0|||
154869237|NCT01333189|558947458|FG000|Overall Study|Transportation difficulties|0|||
154869238|NCT01333189|558947459|FG001|Overall Study|Transportation difficulties|1|||
154869239|NCT01333189|558947458|FG000|Overall Study|Moved from region|0|||
154869240|NCT01333189|558947459|FG001|Overall Study|Moved from region|1|||
154869241|NCT01739595|558947460|FG000|Overall Study|Adverse Event|3|||
154869242|NCT01739595|558947461|FG001|Overall Study|Adverse Event|0|||
154869243|NCT01739595|558947462|FG002|Overall Study|Adverse Event|0|||
154869244|NCT01739595|558947460|FG000|Overall Study|Lost to Follow-up|2|||
154869245|NCT01739595|558947461|FG001|Overall Study|Lost to Follow-up|0|||
154869246|NCT01739595|558947462|FG002|Overall Study|Lost to Follow-up|0|||
154869247|NCT01739595|558947460|FG000|Overall Study|Withdrawal by Subject|2|||
154869248|NCT01739595|558947461|FG001|Overall Study|Withdrawal by Subject|1|||
154869249|NCT01739595|558947462|FG002|Overall Study|Withdrawal by Subject|2|||
154869250|NCT01739595|558947460|FG000|Overall Study|Eligibility issue|3|||
154869251|NCT01739595|558947461|FG001|Overall Study|Eligibility issue|0|||
154869252|NCT01739595|558947462|FG002|Overall Study|Eligibility issue|0|||
154869253|NCT01739595|558947460|FG000|Overall Study|Protocol Violation|1|||
154869254|NCT01739595|558947461|FG001|Overall Study|Protocol Violation|0|||
154869255|NCT01739595|558947462|FG002|Overall Study|Protocol Violation|0|||
154869256|NCT01739595|558947460|FG000|Overall Study|Lab assessment|1|||
154869257|NCT01739595|558947461|FG001|Overall Study|Lab assessment|0|||
154869258|NCT01739595|558947462|FG002|Overall Study|Lab assessment|0|||
154869259|NCT01739595|558947460|FG000|Overall Study|Drug discrepancy|1|||
154869260|NCT01739595|558947461|FG001|Overall Study|Drug discrepancy|0|||
154869261|NCT01739595|558947462|FG002|Overall Study|Drug discrepancy|0|||
154869262|NCT02104180|558947463|FG000|Overall Study|Protocol Violation|1|||
154869263|NCT02104180|558947464|FG001|Overall Study|Protocol Violation|0|||
154869264|NCT00793585|558947465|FG000|Overall Study|Adverse Event|1|||
154869265|NCT00793585|558947466|FG001|Overall Study|Adverse Event|1|||
154869266|NCT00793585|558947465|FG000|Overall Study|Protocol Violation|1|||
154869267|NCT00793585|558947466|FG001|Overall Study|Protocol Violation|2|||
154869268|NCT00035815|558947467|FG000|Overall Study|Withdrawal by Subject|17|||
154869269|NCT00035815|558947468|FG001|Overall Study|Withdrawal by Subject|11|||
154869270|NCT04952389|558947470|FG000|Overall Study|Withdrawal by Subject|8|||
154869271|NCT04952389|558947471|FG001|Overall Study|Withdrawal by Subject|4|||
154869272|NCT04075604|558948389|FG000|Overall Study|Adverse Event|0|||
154869273|NCT04075604|558948390|FG001|Overall Study|Adverse Event|0|||
154869274|NCT04075604|558948391|FG002|Overall Study|Adverse Event|3|||
154869275|NCT04075604|558948389|FG000|Overall Study|Participant request to discontinue study treatment|0|||
154869276|NCT04075604|558948390|FG001|Overall Study|Participant request to discontinue study treatment|0|||
154869277|NCT04075604|558948391|FG002|Overall Study|Participant request to discontinue study treatment|1|||
154869278|NCT04075604|558948389|FG000|Overall Study|Participant withdrew consent|0|||
154869279|NCT04075604|558948390|FG001|Overall Study|Participant withdrew consent|0|||
154869280|NCT04075604|558948391|FG002|Overall Study|Participant withdrew consent|1|||
154869281|NCT04075604|558948389|FG000|Overall Study|Other reasons|1|||
154869282|NCT04075604|558948390|FG001|Overall Study|Other reasons|0|||
154869283|NCT04075604|558948391|FG002|Overall Study|Other reasons|0|||
154869284|NCT04075604|558948389|FG000|Overall Study|Disease progression|0|||
154869285|NCT04075604|558948390|FG001|Overall Study|Disease progression|1|||
154869286|NCT04075604|558948391|FG002|Overall Study|Disease progression|0|||
154869287|NCT04075604|558948389|FG000|Overall Study|Study drug toxicity|0|||
154869288|NCT04075604|558948390|FG001|Overall Study|Study drug toxicity|5|||
154869289|NCT04075604|558948391|FG002|Overall Study|Study drug toxicity|1|||
154869290|NCT02717546|558948402|FG000|Overall Study|Lost to Follow-up|12|||
154869291|NCT01009294|558948403|FG000|Overall Study|Study discontinued by Sponsor|6|||
154869292|NCT00414440|558948406|FG000|Core Period|Withdrawal by Subject|70|||
154869293|NCT00414440|558948407|FG001|Core Period|Withdrawal by Subject|32|||
154869294|NCT00414440|558948406|FG000|Extension Period|Lost to Follow-up|44|||
154869295|NCT00414440|558948407|FG001|Extension Period|Lost to Follow-up|52|||
154869296|NCT00414440|558948406|FG000|Extension Period|Did not consent to continue follow up|61|||
154869297|NCT00414440|558948407|FG001|Extension Period|Did not consent to continue follow up|54|||
154869298|NCT00414440|558948406|FG000|Extension Period|Other|1|||
154869299|NCT00414440|558948407|FG001|Extension Period|Other|1|||
154869300|NCT00414440|558948406|FG000|Extension Period|Administrative|16|||
154869301|NCT00414440|558948407|FG001|Extension Period|Administrative|16|||
154869302|NCT00414440|558948406|FG000|Extension Period|Death|1|||
154869303|NCT00414440|558948407|FG001|Extension Period|Death|2|||
154869304|NCT00414440|558948406|FG000|Extension Period|Withdrawal by Subject|9|||
154869305|NCT00414440|558948407|FG001|Extension Period|Withdrawal by Subject|7|||
154869306|NCT00414440|558948406|FG000|Extension Period|Not included in follow up period|18|||
154869307|NCT00414440|558948407|FG001|Extension Period|Not included in follow up period|8|||
154869308|NCT04382651|558948408|FG000|Overall Study|Death|26|||
154869309|NCT04382651|558948409|FG001|Overall Study|Death|23|||
154869310|NCT04382651|558948408|FG000|Overall Study|Lost to Follow-up|3|||
154869311|NCT04382651|558948409|FG001|Overall Study|Lost to Follow-up|4|||
154869312|NCT04382651|558948408|FG000|Overall Study|Withdrawal by Subject|2|||
154869313|NCT04382651|558948409|FG001|Overall Study|Withdrawal by Subject|0|||
154869314|NCT04382651|558948408|FG000|Overall Study|Physician Decision|0|||
154869315|NCT04382651|558948409|FG001|Overall Study|Physician Decision|1|||
154869316|NCT01507545|558948410|FG000|Overall Study|Withdrawal by Subject|6|||
154869317|NCT01507545|558948411|FG001|Overall Study|Withdrawal by Subject|2|||
154869318|NCT01507545|558948410|FG000|Overall Study|Lost to Follow-up|1|||
154869319|NCT01507545|558948411|FG001|Overall Study|Lost to Follow-up|0|||
154869320|NCT01507545|558948410|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
154869321|NCT01507545|558948411|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
154869322|NCT01507545|558948410|FG000|Overall Study|Progressive disease|60|||
154869323|NCT01507545|558948411|FG001|Overall Study|Progressive disease|27|||
154869324|NCT01507545|558948410|FG000|Overall Study|Other|6|||
154869325|NCT01507545|558948411|FG001|Overall Study|Other|4|||
154869326|NCT00790296|558948413|FG000|Overall Study|Did not meet study eligibility criteria|1|||
154869327|NCT00790296|558948414|FG001|Overall Study|Did not meet study eligibility criteria|1|||
154869328|NCT00790296|558948413|FG000|Overall Study|Adverse Event|0|||
154869329|NCT00790296|558948414|FG001|Overall Study|Adverse Event|1|||
154869330|NCT02612077|558948415|FG000|Overall Study|Adverse Event|3|||
154869331|NCT02612077|558948415|FG000|Overall Study|Withdrawal by Subject|9|||
154869332|NCT02612077|558948415|FG000|Overall Study|Protocol Violation|28|||
154869333|NCT02612077|558948415|FG000|Overall Study|Lost to Follow-up|20|||
154869334|NCT02612077|558948415|FG000|Overall Study|Death|377|||
154869335|NCT02612077|558948415|FG000|Overall Study|Moved or Changed Medical Team|23|||
154869336|NCT02612077|558948415|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
154869337|NCT02612077|558948415|FG000|Overall Study|Disease Progression|3|||
154869338|NCT02612077|558948415|FG000|Overall Study|Unknown reason|2|||
154869339|NCT00940342|558948416|FG000|Overall Study|Adverse Event|0|||
154973705|NCT00996437|559328923|FG000|Overall Study|Dropped|2|||
154973706|NCT00996437|559328924|FG001|Overall Study|Dropped|2|||
154973707|NCT00996437|559328923|FG000|Overall Study|Missed|2|||
154869340|NCT00940342|558948417|FG001|Overall Study|Adverse Event|2|||
154869341|NCT00940342|558948418|FG002|Overall Study|Adverse Event|1|||
154869342|NCT01716169|558948420|FG000|Overall Study|Adverse Event|1|||
154869343|NCT01716169|558948420|FG000|Overall Study|Lost to Follow-up|1|||
154869344|NCT01716169|558948420|FG000|Overall Study|Withdrawal by Subject|1|||
154869345|NCT01716169|558948420|FG000|Overall Study|inconsistent dressing application|1|||
154973708|NCT00996437|559328924|FG001|Overall Study|Missed|5|||
154869346|NCT00553787|558948421|FG000|Overall Study|Adverse Event|34|||
154869347|NCT00553787|558948422|FG001|Overall Study|Adverse Event|21|||
154869348|NCT00553787|558948423|FG002|Overall Study|Adverse Event|67|||
154869349|NCT00553787|558948421|FG000|Overall Study|Lost to Follow-up|132|||
154869350|NCT00553787|558948422|FG001|Overall Study|Lost to Follow-up|44|||
154869351|NCT00553787|558948423|FG002|Overall Study|Lost to Follow-up|78|||
154869352|NCT00553787|558948421|FG000|Overall Study|Withdrawal by Subject|151|||
154869353|NCT00553787|558948422|FG001|Overall Study|Withdrawal by Subject|40|||
154869354|NCT00553787|558948423|FG002|Overall Study|Withdrawal by Subject|83|||
154973709|NCT05552261|559328927|FG000|Overall Study|Withdrawal by Subject|1|||
154869355|NCT00553787|558948421|FG000|Overall Study|Lack of Efficacy|31|||
154869356|NCT00553787|558948422|FG001|Overall Study|Lack of Efficacy|1|||
154869357|NCT00553787|558948423|FG002|Overall Study|Lack of Efficacy|3|||
154869358|NCT00553787|558948421|FG000|Overall Study|Pregnancy|0|||
154869359|NCT00553787|558948422|FG001|Overall Study|Pregnancy|1|||
154869360|NCT00553787|558948423|FG002|Overall Study|Pregnancy|2|||
154869361|NCT00553787|558948421|FG000|Overall Study|non compliance|4|||
154869362|NCT00553787|558948422|FG001|Overall Study|non compliance|0|||
154869363|NCT00553787|558948423|FG002|Overall Study|non compliance|11|||
154869364|NCT00553787|558948421|FG000|Overall Study|Requirement for restricted medication|8|||
154869365|NCT00553787|558948422|FG001|Overall Study|Requirement for restricted medication|7|||
154869366|NCT00553787|558948423|FG002|Overall Study|Requirement for restricted medication|5|||
154869367|NCT00553787|558948421|FG000|Overall Study|Other|18|||
154869368|NCT00553787|558948422|FG001|Overall Study|Other|10|||
154869369|NCT00553787|558948423|FG002|Overall Study|Other|13|||
154869370|NCT01088412|558948424|FG000|Overall Study|Adverse Event|38|||
154869371|NCT01088412|558948425|FG001|Overall Study|Adverse Event|0|||
154869372|NCT01088412|558948426|FG002|Overall Study|Adverse Event|0|||
154869373|NCT01088412|558948424|FG000|Overall Study|Death|42|||
154869374|NCT01088412|558948425|FG001|Overall Study|Death|6|||
154869375|NCT01088412|558948426|FG002|Overall Study|Death|0|||
154869376|NCT01088412|558948424|FG000|Overall Study|Other Reason per Case Report Form|2089|||
154869377|NCT01088412|558948425|FG001|Overall Study|Other Reason per Case Report Form|103|||
154869378|NCT01088412|558948426|FG002|Overall Study|Other Reason per Case Report Form|9|||
154869379|NCT01088412|558948424|FG000|Overall Study|Withdrawal by Subject|1761|||
154869380|NCT01088412|558948425|FG001|Overall Study|Withdrawal by Subject|25|||
154869381|NCT01088412|558948426|FG002|Overall Study|Withdrawal by Subject|1|||
154869382|NCT01088412|558948424|FG000|Overall Study|Received Another GH Product|79|||
154869383|NCT01088412|558948425|FG001|Overall Study|Received Another GH Product|0|||
154869384|NCT01088412|558948426|FG002|Overall Study|Received Another GH Product|0|||
154869385|NCT01088412|558948424|FG000|Overall Study|Participant Moved|601|||
154869386|NCT01088412|558948425|FG001|Overall Study|Participant Moved|21|||
154869387|NCT01088412|558948426|FG002|Overall Study|Participant Moved|2|||
154869388|NCT01088412|558948424|FG000|Overall Study|Physician Decision|1041|||
154869389|NCT01088412|558948425|FG001|Overall Study|Physician Decision|8|||
154869390|NCT01088412|558948426|FG002|Overall Study|Physician Decision|4|||
154869391|NCT01088412|558948424|FG000|Overall Study|Sponsor Decision|4467|||
154869392|NCT01088412|558948425|FG001|Overall Study|Sponsor Decision|79|||
154869393|NCT01088412|558948426|FG002|Overall Study|Sponsor Decision|23|||
154869394|NCT01088412|558948424|FG000|Overall Study|Third Party Required to Change Brand|487|||
154869395|NCT01088412|558948425|FG001|Overall Study|Third Party Required to Change Brand|0|||
154869396|NCT01088412|558948426|FG002|Overall Study|Third Party Required to Change Brand|0|||
154869397|NCT01088412|558948424|FG000|Overall Study|Lost to Follow-up|3052|||
154869398|NCT01088412|558948425|FG001|Overall Study|Lost to Follow-up|130|||
154869399|NCT01088412|558948426|FG002|Overall Study|Lost to Follow-up|11|||
154869400|NCT01088412|558948424|FG000|Overall Study|Study Summary Not Completed|4360|||
154869401|NCT01088412|558948425|FG001|Overall Study|Study Summary Not Completed|64|||
154869402|NCT01088412|558948426|FG002|Overall Study|Study Summary Not Completed|22|||
154869403|NCT00793104|558948427|FG000|Overall Study|Lost to Follow-up|1|||
154869404|NCT05121103|558948430|FG000|Overall Study|Progressive disease|2|||
154869405|NCT05121103|558948431|FG001|Overall Study|Progressive disease|1|||
154869406|NCT05121103|558948432|FG002|Overall Study|Progressive disease|6|||
154869407|NCT05121103|558948430|FG000|Overall Study|Physician Decision|2|||
154869408|NCT05121103|558948431|FG001|Overall Study|Physician Decision|1|||
154869409|NCT05121103|558948432|FG002|Overall Study|Physician Decision|0|||
154869410|NCT05121103|558948430|FG000|Overall Study|Withdrawal by Subject|0|||
154869411|NCT05121103|558948431|FG001|Overall Study|Withdrawal by Subject|1|||
154869412|NCT05121103|558948432|FG002|Overall Study|Withdrawal by Subject|0|||
154869413|NCT03494725|558948435|FG000|Overall Study|Withdrawal by Subject|0|||
154869414|NCT03494725|558948436|FG001|Overall Study|Withdrawal by Subject|2|||
155109907|NCT01436656|559831097|FG000|Dose Escalation|Administrative problems|0|||
155109908|NCT01436656|559831098|FG001|Dose Escalation|Administrative problems|1|||
154869415|NCT03494725|558948435|FG000|Overall Study|Antibiotic use|1|||
154869416|NCT03494725|558948436|FG001|Overall Study|Antibiotic use|0|||
154869417|NCT02619253|558948437|FG000|Overall Study|Adverse Event|0|||
154869418|NCT02619253|558948438|FG001|Overall Study|Adverse Event|0|||
154869419|NCT02619253|558948439|FG002|Overall Study|Adverse Event|1|||
154973710|NCT05552261|559328927|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
155109909|NCT01436656|559831099|FG002|Dose Escalation|Administrative problems|0|||
154869420|NCT02619253|558948440|FG003|Overall Study|Adverse Event|1|||
154869421|NCT02619253|558948441|FG004|Overall Study|Adverse Event|3|||
154869422|NCT02619253|558948437|FG000|Overall Study|Alternative Therapy|0|||
154869423|NCT02619253|558948438|FG001|Overall Study|Alternative Therapy|0|||
154869424|NCT02619253|558948439|FG002|Overall Study|Alternative Therapy|1|||
154869425|NCT02619253|558948440|FG003|Overall Study|Alternative Therapy|0|||
154869426|NCT02619253|558948441|FG004|Overall Study|Alternative Therapy|0|||
154869427|NCT02619253|558948437|FG000|Overall Study|Death|0|||
154869428|NCT02619253|558948438|FG001|Overall Study|Death|0|||
155109910|NCT01436656|559831100|FG003|Dose Escalation|Administrative problems|0|||
155109911|NCT01436656|559831101|FG004|Dose Escalation|Administrative problems|0|||
155109912|NCT01436656|559831102|FG005|Dose Escalation|Administrative problems|0|||
155109913|NCT01436656|559831103|FG006|Dose Escalation|Administrative problems|0|||
155109914|NCT01436656|559831104|FG007|Dose Escalation|Administrative problems|0|||
155109915|NCT01436656|559831105|FG008|Dose Escalation|Administrative problems|0|||
155109916|NCT01436656|559831106|FG009|Dose Escalation|Administrative problems|0|||
155109917|NCT01436656|559831107|FG010|Dose Escalation|Administrative problems|0|||
155109918|NCT01436656|559831108|FG011|Dose Escalation|Administrative problems|0|||
155109919|NCT01436656|559831109|FG012|Dose Escalation|Administrative problems|0|||
155109920|NCT01436656|559831110|FG013|Dose Escalation|Administrative problems|0|||
155109921|NCT01436656|559831111|FG014|Dose Escalation|Administrative problems|0|||
155109922|NCT01436656|559831112|FG015|Dose Escalation|Administrative problems|0|||
155109923|NCT01436656|559831113|FG016|Dose Escalation|Administrative problems|0|||
155109924|NCT01436656|559831114|FG017|Dose Escalation|Administrative problems|0|||
155109925|NCT01436656|559831097|FG000|Dose Escalation|Lost to Follow-up|1|||
155109926|NCT01436656|559831098|FG001|Dose Escalation|Lost to Follow-up|0|||
155109927|NCT01436656|559831099|FG002|Dose Escalation|Lost to Follow-up|0|||
155109928|NCT01436656|559831100|FG003|Dose Escalation|Lost to Follow-up|0|||
155109929|NCT01436656|559831101|FG004|Dose Escalation|Lost to Follow-up|1|||
155109930|NCT01436656|559831102|FG005|Dose Escalation|Lost to Follow-up|0|||
155109931|NCT01436656|559831103|FG006|Dose Escalation|Lost to Follow-up|0|||
155109932|NCT01436656|559831104|FG007|Dose Escalation|Lost to Follow-up|0|||
155109933|NCT01436656|559831105|FG008|Dose Escalation|Lost to Follow-up|0|||
155109934|NCT01436656|559831106|FG009|Dose Escalation|Lost to Follow-up|0|||
155109935|NCT01436656|559831107|FG010|Dose Escalation|Lost to Follow-up|0|||
155109936|NCT01436656|559831108|FG011|Dose Escalation|Lost to Follow-up|0|||
155109937|NCT01436656|559831109|FG012|Dose Escalation|Lost to Follow-up|0|||
155109938|NCT01436656|559831110|FG013|Dose Escalation|Lost to Follow-up|0|||
155109939|NCT01436656|559831111|FG014|Dose Escalation|Lost to Follow-up|0|||
155109940|NCT01436656|559831112|FG015|Dose Escalation|Lost to Follow-up|0|||
155109941|NCT01436656|559831113|FG016|Dose Escalation|Lost to Follow-up|0|||
155109942|NCT01436656|559831114|FG017|Dose Escalation|Lost to Follow-up|0|||
155109943|NCT01436656|559831097|FG000|Dose Escalation|New anti-cancer therapy|1|||
155109944|NCT01436656|559831098|FG001|Dose Escalation|New anti-cancer therapy|0|||
155109945|NCT01436656|559831099|FG002|Dose Escalation|New anti-cancer therapy|0|||
155109946|NCT01436656|559831100|FG003|Dose Escalation|New anti-cancer therapy|0|||
155109947|NCT01436656|559831101|FG004|Dose Escalation|New anti-cancer therapy|0|||
155109948|NCT01436656|559831102|FG005|Dose Escalation|New anti-cancer therapy|0|||
155109949|NCT01436656|559831103|FG006|Dose Escalation|New anti-cancer therapy|0|||
155109950|NCT01436656|559831104|FG007|Dose Escalation|New anti-cancer therapy|0|||
155109951|NCT01436656|559831105|FG008|Dose Escalation|New anti-cancer therapy|1|||
155109952|NCT01436656|559831106|FG009|Dose Escalation|New anti-cancer therapy|1|||
155109953|NCT01436656|559831107|FG010|Dose Escalation|New anti-cancer therapy|0|||
155109954|NCT01436656|559831108|FG011|Dose Escalation|New anti-cancer therapy|0|||
155109955|NCT01436656|559831109|FG012|Dose Escalation|New anti-cancer therapy|0|||
155109956|NCT01436656|559831110|FG013|Dose Escalation|New anti-cancer therapy|0|||
155109957|NCT01436656|559831111|FG014|Dose Escalation|New anti-cancer therapy|0|||
155109958|NCT01436656|559831112|FG015|Dose Escalation|New anti-cancer therapy|0|||
155109959|NCT01436656|559831113|FG016|Dose Escalation|New anti-cancer therapy|0|||
155109960|NCT01436656|559831114|FG017|Dose Escalation|New anti-cancer therapy|0|||
155109961|NCT01436656|559831097|FG000|Dose Expansion|Adverse Event|0|||
155109962|NCT01436656|559831098|FG001|Dose Expansion|Adverse Event|0|||
155109963|NCT01436656|559831099|FG002|Dose Expansion|Adverse Event|0|||
155109964|NCT01436656|559831100|FG003|Dose Expansion|Adverse Event|0|||
155109965|NCT01436656|559831101|FG004|Dose Expansion|Adverse Event|0|||
155109966|NCT01436656|559831102|FG005|Dose Expansion|Adverse Event|0|||
155109967|NCT01436656|559831103|FG006|Dose Expansion|Adverse Event|0|||
155109968|NCT01436656|559831104|FG007|Dose Expansion|Adverse Event|0|||
155109969|NCT01436656|559831105|FG008|Dose Expansion|Adverse Event|0|||
155109970|NCT01436656|559831106|FG009|Dose Expansion|Adverse Event|0|||
155109971|NCT01436656|559831107|FG010|Dose Expansion|Adverse Event|0|||
155109972|NCT01436656|559831108|FG011|Dose Expansion|Adverse Event|1|||
155109973|NCT01436656|559831109|FG012|Dose Expansion|Adverse Event|0|||
155109974|NCT01436656|559831110|FG013|Dose Expansion|Adverse Event|0|||
155109975|NCT01436656|559831111|FG014|Dose Expansion|Adverse Event|0|||
155109976|NCT01436656|559831112|FG015|Dose Expansion|Adverse Event|0|||
155109977|NCT01436656|559831113|FG016|Dose Expansion|Adverse Event|0|||
155109978|NCT01436656|559831114|FG017|Dose Expansion|Adverse Event|0|||
155109979|NCT01436656|559831097|FG000|Dose Expansion|Withdrawal by Subject|0|||
155109980|NCT01436656|559831098|FG001|Dose Expansion|Withdrawal by Subject|0|||
155109981|NCT01436656|559831099|FG002|Dose Expansion|Withdrawal by Subject|0|||
155109982|NCT01436656|559831100|FG003|Dose Expansion|Withdrawal by Subject|0|||
155109983|NCT01436656|559831101|FG004|Dose Expansion|Withdrawal by Subject|0|||
155198469|NCT00745823|560164973|FG001|Overall Study|Withdrawal by Subject|8|||
155109984|NCT01436656|559831102|FG005|Dose Expansion|Withdrawal by Subject|0|||
155109985|NCT01436656|559831103|FG006|Dose Expansion|Withdrawal by Subject|0|||
155109986|NCT01436656|559831104|FG007|Dose Expansion|Withdrawal by Subject|0|||
155174849|NCT01328444|560078300|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155174850|NCT01328444|560078301|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
155174851|NCT01328444|560078302|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
155174852|NCT01328444|560078297|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
155174853|NCT01328444|560078298|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155174854|NCT01328444|560078299|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155174855|NCT01328444|560078300|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155174856|NCT01328444|560078301|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155174857|NCT01328444|560078302|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155174858|NCT01328444|560078297|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155174859|NCT01328444|560078298|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
155174860|NCT01328444|560078299|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155174861|NCT01328444|560078300|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
155174862|NCT01328444|560078301|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155174863|NCT01328444|560078302|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155174864|NCT01328444|560078297|FG000|Washout Period (14 Days)|Adverse Event|1|||
155174865|NCT01328444|560078298|FG001|Washout Period (14 Days)|Adverse Event|1|||
155174866|NCT01328444|560078299|FG002|Washout Period (14 Days)|Adverse Event|0|||
155174867|NCT01328444|560078300|FG003|Washout Period (14 Days)|Adverse Event|1|||
155174868|NCT01328444|560078301|FG004|Washout Period (14 Days)|Adverse Event|1|||
155174869|NCT01328444|560078302|FG005|Washout Period (14 Days)|Adverse Event|2|||
155174870|NCT01328444|560078297|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
155174871|NCT01328444|560078298|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
155174872|NCT01328444|560078299|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
155174873|NCT01328444|560078300|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
155174874|NCT01328444|560078301|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
155174875|NCT01328444|560078302|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
155174876|NCT01328444|560078297|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
155174877|NCT01328444|560078298|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
155174878|NCT01328444|560078299|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
155174879|NCT01328444|560078300|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
155174880|NCT01328444|560078301|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
155174881|NCT01328444|560078302|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
155174882|NCT01328444|560078297|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
155174883|NCT01328444|560078298|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155174884|NCT01328444|560078299|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155174885|NCT01328444|560078300|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
154869429|NCT02619253|558948439|FG002|Overall Study|Death|0|||
154869430|NCT02619253|558948440|FG003|Overall Study|Death|1|||
154869431|NCT02619253|558948441|FG004|Overall Study|Death|0|||
154869432|NCT02619253|558948437|FG000|Overall Study|Disease Progression|4|||
154869433|NCT02619253|558948438|FG001|Overall Study|Disease Progression|2|||
154869434|NCT02619253|558948439|FG002|Overall Study|Disease Progression|8|||
154869435|NCT02619253|558948440|FG003|Overall Study|Disease Progression|9|||
154869436|NCT02619253|558948441|FG004|Overall Study|Disease Progression|10|||
154869437|NCT02619253|558948437|FG000|Overall Study|Needed a disqualifying therapy|0|||
154869438|NCT02619253|558948438|FG001|Overall Study|Needed a disqualifying therapy|0|||
154869439|NCT02619253|558948439|FG002|Overall Study|Needed a disqualifying therapy|1|||
154869440|NCT02619253|558948440|FG003|Overall Study|Needed a disqualifying therapy|0|||
154869441|NCT02619253|558948441|FG004|Overall Study|Needed a disqualifying therapy|0|||
154869442|NCT02619253|558948437|FG000|Overall Study|Transferred to hospice|0|||
154869443|NCT02619253|558948438|FG001|Overall Study|Transferred to hospice|0|||
154869444|NCT02619253|558948439|FG002|Overall Study|Transferred to hospice|1|||
154869445|NCT02619253|558948440|FG003|Overall Study|Transferred to hospice|0|||
154869446|NCT02619253|558948441|FG004|Overall Study|Transferred to hospice|0|||
154869447|NCT02619253|558948437|FG000|Overall Study|Physician Decision|0|||
154869448|NCT02619253|558948438|FG001|Overall Study|Physician Decision|1|||
154869449|NCT02619253|558948439|FG002|Overall Study|Physician Decision|2|||
154869450|NCT02619253|558948440|FG003|Overall Study|Physician Decision|3|||
154869451|NCT02619253|558948441|FG004|Overall Study|Physician Decision|0|||
154869452|NCT02619253|558948437|FG000|Overall Study|Withdrawal by Subject|0|||
154869453|NCT02619253|558948438|FG001|Overall Study|Withdrawal by Subject|1|||
154869454|NCT02619253|558948439|FG002|Overall Study|Withdrawal by Subject|0|||
154869455|NCT02619253|558948440|FG003|Overall Study|Withdrawal by Subject|0|||
154869456|NCT02619253|558948441|FG004|Overall Study|Withdrawal by Subject|2|||
154869457|NCT00514449|558948442|FG000|Overall Study|Withdrawal by Subject|1|||
154869458|NCT00514449|558948443|FG001|Overall Study|Withdrawal by Subject|2|||
154869459|NCT00514449|558948442|FG000|Overall Study|Protocol Violation|1|||
154869460|NCT00514449|558948443|FG001|Overall Study|Protocol Violation|2|||
154869461|NCT00514449|558948442|FG000|Overall Study|Lost to Follow-up|1|||
154869462|NCT00514449|558948443|FG001|Overall Study|Lost to Follow-up|0|||
154869463|NCT00301067|558948451|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
154869464|NCT00301067|558948452|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
155174886|NCT01328444|560078301|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
155174887|NCT01328444|560078302|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
155174888|NCT01328444|560078297|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
155174889|NCT01328444|560078298|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155174890|NCT01328444|560078299|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
155174891|NCT01328444|560078300|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
155174892|NCT01328444|560078301|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
155174893|NCT01328444|560078302|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
155174894|NCT01328444|560078297|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
155174895|NCT01328444|560078298|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155174896|NCT01328444|560078299|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155174897|NCT01328444|560078300|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155174898|NCT01328444|560078301|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
155174899|NCT01328444|560078302|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
155174900|NCT01328444|560078297|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155174901|NCT01328444|560078298|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155174902|NCT01328444|560078299|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155174903|NCT01328444|560078300|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
155174904|NCT01328444|560078301|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
155174905|NCT01328444|560078302|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
155174906|NCT01328444|560078297|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155174907|NCT01328444|560078298|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
155174908|NCT01328444|560078299|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155174909|NCT01328444|560078300|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155174910|NCT01328444|560078301|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
155174911|NCT01328444|560078302|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
155174912|NCT01328444|560078297|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155174913|NCT01328444|560078298|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155174914|NCT01328444|560078299|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155174915|NCT01328444|560078300|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155174916|NCT01328444|560078301|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155174917|NCT01328444|560078302|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
155174918|NCT03241368|560078307|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
155174919|NCT03241368|560078307|FG000|Overall Study|Lost to Follow-up|1|||
155174920|NCT03241368|560078307|FG000|Overall Study|Physician Decision|6|||
155174921|NCT03241368|560078307|FG000|Overall Study|Withdrawal by Subject|6|||
155174922|NCT03241368|560078307|FG000|Overall Study|Protocol Violation|1|||
155174923|NCT04740905|560078308|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
155174924|NCT04740905|560078309|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
155174925|NCT04740905|560078308|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
155174926|NCT04740905|560078309|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
155174927|NCT04740905|560078308|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
155174928|NCT04740905|560078309|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
155174929|NCT04740905|560078308|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
155174930|NCT04740905|560078309|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
155174931|NCT04740905|560078308|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
155174932|NCT04740905|560078309|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
155174933|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
155174934|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
155174935|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
155174936|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
155174937|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
155174938|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
155174939|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
155174940|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
155174941|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
155174942|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
155174943|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
155174944|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
155174945|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
154869465|NCT00301067|558948453|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
154869466|NCT00301067|558948454|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
154869467|NCT00301067|558948451|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
154869468|NCT00301067|558948452|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
154869469|NCT00301067|558948453|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
155174946|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
154869470|NCT00301067|558948454|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
154973711|NCT00979212|559328928|FG000|Overall Study|Protocol Violation|1|||
154869471|NCT00301067|558948451|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
154869472|NCT00301067|558948452|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
154869473|NCT00301067|558948453|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
154869474|NCT00301067|558948454|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
155109987|NCT01436656|559831105|FG008|Dose Expansion|Withdrawal by Subject|0|||
155109988|NCT01436656|559831106|FG009|Dose Expansion|Withdrawal by Subject|0|||
155109989|NCT01436656|559831107|FG010|Dose Expansion|Withdrawal by Subject|0|||
155109990|NCT01436656|559831108|FG011|Dose Expansion|Withdrawal by Subject|1|||
155109991|NCT01436656|559831109|FG012|Dose Expansion|Withdrawal by Subject|3|||
155109992|NCT01436656|559831110|FG013|Dose Expansion|Withdrawal by Subject|1|||
155109993|NCT01436656|559831111|FG014|Dose Expansion|Withdrawal by Subject|2|||
155109994|NCT01436656|559831112|FG015|Dose Expansion|Withdrawal by Subject|0|||
155109995|NCT01436656|559831113|FG016|Dose Expansion|Withdrawal by Subject|1|||
155109996|NCT01436656|559831114|FG017|Dose Expansion|Withdrawal by Subject|1|||
155109997|NCT01436656|559831097|FG000|Dose Expansion|Death|0|||
155109998|NCT01436656|559831098|FG001|Dose Expansion|Death|0|||
155109999|NCT01436656|559831099|FG002|Dose Expansion|Death|0|||
155110000|NCT01436656|559831100|FG003|Dose Expansion|Death|0|||
155110001|NCT01436656|559831101|FG004|Dose Expansion|Death|0|||
155110002|NCT01436656|559831102|FG005|Dose Expansion|Death|0|||
155110003|NCT01436656|559831103|FG006|Dose Expansion|Death|0|||
155110004|NCT01436656|559831104|FG007|Dose Expansion|Death|0|||
155110005|NCT01436656|559831105|FG008|Dose Expansion|Death|0|||
155110006|NCT01436656|559831106|FG009|Dose Expansion|Death|0|||
155110007|NCT01436656|559831107|FG010|Dose Expansion|Death|0|||
155110008|NCT01436656|559831108|FG011|Dose Expansion|Death|0|||
155110009|NCT01436656|559831109|FG012|Dose Expansion|Death|1|||
155110010|NCT01436656|559831110|FG013|Dose Expansion|Death|0|||
155110011|NCT01436656|559831111|FG014|Dose Expansion|Death|3|||
155110012|NCT01436656|559831112|FG015|Dose Expansion|Death|0|||
155110013|NCT01436656|559831113|FG016|Dose Expansion|Death|3|||
155110014|NCT01436656|559831114|FG017|Dose Expansion|Death|3|||
155110015|NCT01436656|559831097|FG000|Dose Expansion|Lost to Follow-up|0|||
155110016|NCT01436656|559831098|FG001|Dose Expansion|Lost to Follow-up|0|||
155110017|NCT01436656|559831099|FG002|Dose Expansion|Lost to Follow-up|0|||
155110018|NCT01436656|559831100|FG003|Dose Expansion|Lost to Follow-up|0|||
155110019|NCT01436656|559831101|FG004|Dose Expansion|Lost to Follow-up|0|||
155110020|NCT01436656|559831102|FG005|Dose Expansion|Lost to Follow-up|0|||
155110021|NCT01436656|559831103|FG006|Dose Expansion|Lost to Follow-up|0|||
155110022|NCT01436656|559831104|FG007|Dose Expansion|Lost to Follow-up|0|||
155110023|NCT01436656|559831105|FG008|Dose Expansion|Lost to Follow-up|0|||
155110024|NCT01436656|559831106|FG009|Dose Expansion|Lost to Follow-up|0|||
155110025|NCT01436656|559831107|FG010|Dose Expansion|Lost to Follow-up|0|||
155110026|NCT01436656|559831108|FG011|Dose Expansion|Lost to Follow-up|0|||
155110027|NCT01436656|559831109|FG012|Dose Expansion|Lost to Follow-up|0|||
155110028|NCT01436656|559831110|FG013|Dose Expansion|Lost to Follow-up|0|||
155110029|NCT01436656|559831111|FG014|Dose Expansion|Lost to Follow-up|0|||
155110030|NCT01436656|559831112|FG015|Dose Expansion|Lost to Follow-up|0|||
155110031|NCT01436656|559831113|FG016|Dose Expansion|Lost to Follow-up|0|||
155110032|NCT01436656|559831114|FG017|Dose Expansion|Lost to Follow-up|3|||
155110033|NCT01436656|559831097|FG000|Dose Expansion|Disease progression|0|||
155110034|NCT01436656|559831098|FG001|Dose Expansion|Disease progression|0|||
155110035|NCT01436656|559831099|FG002|Dose Expansion|Disease progression|0|||
155110036|NCT01436656|559831100|FG003|Dose Expansion|Disease progression|0|||
155110037|NCT01436656|559831101|FG004|Dose Expansion|Disease progression|0|||
155110038|NCT01436656|559831102|FG005|Dose Expansion|Disease progression|0|||
155110039|NCT01436656|559831103|FG006|Dose Expansion|Disease progression|0|||
155110040|NCT01436656|559831104|FG007|Dose Expansion|Disease progression|0|||
155110041|NCT01436656|559831105|FG008|Dose Expansion|Disease progression|0|||
155110042|NCT01436656|559831106|FG009|Dose Expansion|Disease progression|0|||
155110043|NCT01436656|559831107|FG010|Dose Expansion|Disease progression|0|||
154869475|NCT00301067|558948451|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
154869476|NCT00301067|558948452|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
155110044|NCT01436656|559831108|FG011|Dose Expansion|Disease progression|3|||
155110045|NCT01436656|559831109|FG012|Dose Expansion|Disease progression|1|||
155110046|NCT01436656|559831110|FG013|Dose Expansion|Disease progression|0|||
155110047|NCT01436656|559831111|FG014|Dose Expansion|Disease progression|1|||
155110048|NCT01436656|559831112|FG015|Dose Expansion|Disease progression|0|||
155110049|NCT01436656|559831113|FG016|Dose Expansion|Disease progression|0|||
155110050|NCT01436656|559831114|FG017|Dose Expansion|Disease progression|1|||
155110051|NCT01436656|559831097|FG000|Dose Expansion|New cancer therapy|0|||
155110052|NCT01436656|559831098|FG001|Dose Expansion|New cancer therapy|0|||
154869477|NCT00301067|558948453|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
155110053|NCT01436656|559831099|FG002|Dose Expansion|New cancer therapy|0|||
155110054|NCT01436656|559831100|FG003|Dose Expansion|New cancer therapy|0|||
155110055|NCT01436656|559831101|FG004|Dose Expansion|New cancer therapy|0|||
155110056|NCT01436656|559831102|FG005|Dose Expansion|New cancer therapy|0|||
155110057|NCT01436656|559831103|FG006|Dose Expansion|New cancer therapy|0|||
155110058|NCT01436656|559831104|FG007|Dose Expansion|New cancer therapy|0|||
154869478|NCT00301067|558948454|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
154869479|NCT00301067|558948451|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
154869480|NCT00301067|558948452|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
154869481|NCT00301067|558948453|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
154869482|NCT00301067|558948454|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
154869483|NCT00301067|558948451|FG000|Follow up Until Death|Alive at last data cut point|1|||
154869484|NCT00301067|558948452|FG001|Follow up Until Death|Alive at last data cut point|0|||
154869485|NCT00301067|558948453|FG002|Follow up Until Death|Alive at last data cut point|0|||
154869486|NCT00301067|558948454|FG003|Follow up Until Death|Alive at last data cut point|1|||
154869487|NCT01359982|558948455|FG000|Overall Study|Adverse Event|2|||
154869488|NCT01359982|558948456|FG001|Overall Study|Adverse Event|0|||
154869489|NCT01359982|558948457|FG002|Overall Study|Adverse Event|0|||
154869490|NCT01359982|558948458|FG003|Overall Study|Adverse Event|1|||
154869491|NCT01359982|558948459|FG004|Overall Study|Adverse Event|0|||
154869492|NCT01359982|558948460|FG005|Overall Study|Adverse Event|0|||
154869493|NCT01359982|558948455|FG000|Overall Study|Death|1|||
154869494|NCT01359982|558948456|FG001|Overall Study|Death|0|||
154869495|NCT01359982|558948457|FG002|Overall Study|Death|0|||
154869496|NCT01359982|558948458|FG003|Overall Study|Death|0|||
154869497|NCT01359982|558948459|FG004|Overall Study|Death|0|||
154869498|NCT01359982|558948460|FG005|Overall Study|Death|0|||
154869499|NCT05593432|558948461|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
154869500|NCT05593432|558948462|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
154869501|NCT05593432|558948463|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
154869502|NCT05593432|558948464|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
154869503|NCT05593432|558948461|FG000|16-Week OLE Period|Lack of Efficacy|0|||
154869504|NCT05593432|558948462|FG001|16-Week OLE Period|Lack of Efficacy|0|||
154869505|NCT05593432|558948463|FG002|16-Week OLE Period|Lack of Efficacy|0|||
154869506|NCT05593432|558948464|FG003|16-Week OLE Period|Lack of Efficacy|1|||
154869507|NCT05593432|558948461|FG000|16-Week OLE Period|Lost to Follow-up|0|||
154869508|NCT05593432|558948462|FG001|16-Week OLE Period|Lost to Follow-up|0|||
154869509|NCT05593432|558948463|FG002|16-Week OLE Period|Lost to Follow-up|1|||
154869510|NCT05593432|558948464|FG003|16-Week OLE Period|Lost to Follow-up|2|||
154869511|NCT05593432|558948461|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
154869512|NCT05593432|558948462|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
154869513|NCT05593432|558948463|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
154869514|NCT05593432|558948464|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
154869515|NCT02609399|558948469|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
154869516|NCT02609399|558948470|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
154869517|NCT02609399|558948469|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
154869518|NCT02609399|558948470|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
154869519|NCT02609399|558948469|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
154869520|NCT02609399|558948470|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
154869521|NCT00069121|558948471|FG000|Overall Study|Death|286|||
154869522|NCT00069121|558948472|FG001|Overall Study|Death|242|||
154869523|NCT00069121|558948471|FG000|Overall Study|Withdrawal by Subject|18|||
154869524|NCT00069121|558948472|FG001|Overall Study|Withdrawal by Subject|20|||
154869525|NCT00069121|558948471|FG000|Overall Study|Lost to Follow-up|63|||
154869526|NCT00069121|558948472|FG001|Overall Study|Lost to Follow-up|63|||
154869527|NCT00306891|558948473|FG000|Part A|Withdrawal by Subject|1|||
154869528|NCT00306891|558948474|FG001|Part A|Withdrawal by Subject|1|||
154869529|NCT00306891|558948475|FG002|Part A|Withdrawal by Subject|0|||
154869530|NCT00306891|558948476|FG003|Part A|Withdrawal by Subject|0|||
154869531|NCT00306891|558948473|FG000|Part A|Condition under investigation worsened|2|||
154869532|NCT00306891|558948474|FG001|Part A|Condition under investigation worsened|2|||
154869533|NCT00306891|558948475|FG002|Part A|Condition under investigation worsened|0|||
154869534|NCT00306891|558948476|FG003|Part A|Condition under investigation worsened|0|||
154869535|NCT00306891|558948473|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
154869536|NCT00306891|558948474|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
154869537|NCT00306891|558948475|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
154869538|NCT00306891|558948476|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
154869539|NCT00306891|558948473|FG000|Part A|Partial bowel obstruction|1|||
154869540|NCT00306891|558948474|FG001|Part A|Partial bowel obstruction|0|||
154869541|NCT00306891|558948475|FG002|Part A|Partial bowel obstruction|0|||
154973712|NCT00979212|559328929|FG001|Overall Study|Protocol Violation|8|||
154869542|NCT00306891|558948476|FG003|Part A|Partial bowel obstruction|0|||
154869543|NCT00306891|558948473|FG000|Part A|Reaccumul. of ascites following drainage|0|||
154973713|NCT00979212|559328928|FG000|Overall Study|No protocol therapy received|1|||
154973714|NCT00979212|559328929|FG001|Overall Study|No protocol therapy received|0|||
154869544|NCT00306891|558948474|FG001|Part A|Reaccumul. of ascites following drainage|1|||
154869545|NCT00306891|558948475|FG002|Part A|Reaccumul. of ascites following drainage|0|||
154869546|NCT00306891|558948476|FG003|Part A|Reaccumul. of ascites following drainage|0|||
154869547|NCT00306891|558948473|FG000|Part A|Suspicion of second malignancy|0|||
154869548|NCT00306891|558948474|FG001|Part A|Suspicion of second malignancy|1|||
155110059|NCT01436656|559831105|FG008|Dose Expansion|New cancer therapy|0|||
154869549|NCT00306891|558948475|FG002|Part A|Suspicion of second malignancy|0|||
154869550|NCT00306891|558948476|FG003|Part A|Suspicion of second malignancy|0|||
154869551|NCT00306891|558948473|FG000|Part A|QTC interval outwith elig. criteria|1|||
154869552|NCT00306891|558948474|FG001|Part A|QTC interval outwith elig. criteria|0|||
154869553|NCT00306891|558948475|FG002|Part A|QTC interval outwith elig. criteria|0|||
154869554|NCT00306891|558948476|FG003|Part A|QTC interval outwith elig. criteria|0|||
154869555|NCT00306891|558948473|FG000|Part B|Death|0|||
154869556|NCT00306891|558948474|FG001|Part B|Death|0|||
154869557|NCT00306891|558948475|FG002|Part B|Death|1|||
154869558|NCT00306891|558948476|FG003|Part B|Death|2|||
154869559|NCT00306891|558948473|FG000|Part B|Adverse Event|0|||
154869560|NCT00306891|558948474|FG001|Part B|Adverse Event|0|||
154869561|NCT00306891|558948475|FG002|Part B|Adverse Event|5|||
154869562|NCT00306891|558948476|FG003|Part B|Adverse Event|5|||
154869563|NCT00306891|558948473|FG000|Part B|Withdrawal by Subject|0|||
154869564|NCT00306891|558948474|FG001|Part B|Withdrawal by Subject|0|||
154869565|NCT00306891|558948475|FG002|Part B|Withdrawal by Subject|3|||
154869566|NCT00306891|558948476|FG003|Part B|Withdrawal by Subject|1|||
154869567|NCT00306891|558948473|FG000|Part B|Condition under investigation worsened|0|||
154869568|NCT00306891|558948474|FG001|Part B|Condition under investigation worsened|0|||
154869569|NCT00306891|558948475|FG002|Part B|Condition under investigation worsened|2|||
154869570|NCT00306891|558948476|FG003|Part B|Condition under investigation worsened|8|||
154869571|NCT00306891|558948473|FG000|Part B|Development of study specific disc crit.|0|||
154869572|NCT00306891|558948474|FG001|Part B|Development of study specific disc crit.|0|||
154869573|NCT00306891|558948475|FG002|Part B|Development of study specific disc crit.|0|||
154869574|NCT00306891|558948476|FG003|Part B|Development of study specific disc crit.|1|||
154869575|NCT00206518|558948478|FG000|Overall Study|Lack of Efficacy|6|||
154869576|NCT00206518|558948479|FG001|Overall Study|Lack of Efficacy|4|||
154869577|NCT00206518|558948478|FG000|Overall Study|Adverse Event|2|||
154869578|NCT00206518|558948479|FG001|Overall Study|Adverse Event|1|||
154869579|NCT00206518|558948478|FG000|Overall Study|Physician Decision|1|||
154869580|NCT00206518|558948479|FG001|Overall Study|Physician Decision|0|||
154869581|NCT00206518|558948478|FG000|Overall Study|Protocol Violation|1|||
154869582|NCT00206518|558948479|FG001|Overall Study|Protocol Violation|1|||
154869583|NCT02335450|558948480|FG000|Overall Study|Pregnancy|1|||
154869584|NCT02613572|558948481|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
154869585|NCT02613572|558948482|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
154869586|NCT02613572|558948483|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
154869587|NCT02613572|558948481|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
154869588|NCT02613572|558948482|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
154869589|NCT02613572|558948483|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
154869590|NCT00231478|558948485|FG000|Overall Study|Protocol Violation|3|||
154869591|NCT00231478|558948486|FG001|Overall Study|Protocol Violation|2|||
154869592|NCT00231478|558948485|FG000|Overall Study|Refused Treatment|1|||
154869593|NCT00231478|558948486|FG001|Overall Study|Refused Treatment|1|||
154869594|NCT00231478|558948485|FG000|Overall Study|Withdrawal by Subject|1|||
155110060|NCT01436656|559831106|FG009|Dose Expansion|New cancer therapy|0|||
155110061|NCT01436656|559831107|FG010|Dose Expansion|New cancer therapy|0|||
155110062|NCT01436656|559831108|FG011|Dose Expansion|New cancer therapy|1|||
155110063|NCT01436656|559831109|FG012|Dose Expansion|New cancer therapy|1|||
155110064|NCT01436656|559831110|FG013|Dose Expansion|New cancer therapy|0|||
155110065|NCT01436656|559831111|FG014|Dose Expansion|New cancer therapy|2|||
155110066|NCT01436656|559831112|FG015|Dose Expansion|New cancer therapy|0|||
155110067|NCT01436656|559831113|FG016|Dose Expansion|New cancer therapy|0|||
155110068|NCT01436656|559831114|FG017|Dose Expansion|New cancer therapy|0|||
155110069|NCT01696994|559831115|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
155110070|NCT01696994|559831116|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
155110071|NCT01696994|559831115|FG000|Overall Study|Died Before Randomization|1|||
155110072|NCT01696994|559831116|FG001|Overall Study|Died Before Randomization|2|||
155110073|NCT01696994|559831115|FG000|Overall Study|Died Before ASU (Control)|73|||
155110074|NCT01696994|559831116|FG001|Overall Study|Died Before ASU (Control)|0|||
155110075|NCT01696994|559831115|FG000|Overall Study|No Ovaries at Baseline|4807|||
155110076|NCT01696994|559831116|FG001|Overall Study|No Ovaries at Baseline|4851|||
155110077|NCT01696994|559831115|FG000|Overall Study|Refused ASU (Control)|311|||
155110078|NCT01696994|559831116|FG001|Overall Study|Refused ASU (Control)|0|||
154869595|NCT00231478|558948486|FG001|Overall Study|Withdrawal by Subject|0|||
154869596|NCT00231478|558948485|FG000|Overall Study|Adverse Event|0|||
155110079|NCT01696994|559831115|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
155110080|NCT01696994|559831116|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
155110081|NCT02388165|559831119|FG000|Overall Study|Study terminated by sponsor|5|||
154869597|NCT00231478|558948486|FG001|Overall Study|Adverse Event|1|||
154869598|NCT00231478|558948485|FG000|Overall Study|Administrative|3|||
154869599|NCT00231478|558948486|FG001|Overall Study|Administrative|2|||
154869600|NCT04538950|558948487|FG000|Overall Study|Pulmonary Issues|2|||
154869601|NCT04538950|558948487|FG000|Overall Study|illness|2|||
155110082|NCT02388165|559831120|FG001|Overall Study|Study terminated by sponsor|5|||
155110083|NCT02388165|559831119|FG000|Overall Study|Other|11|||
154869602|NCT00853905|558948488|FG000|Overall Study|Lost to Follow-up|1|||
154869603|NCT00853905|558948489|FG001|Overall Study|Lost to Follow-up|3|||
154869604|NCT00853905|558948488|FG000|Overall Study|Withdrawal by Subject|0|||
154869605|NCT00853905|558948489|FG001|Overall Study|Withdrawal by Subject|1|||
154869606|NCT00853905|558948488|FG000|Overall Study|never had surgery|1|||
154869607|NCT00853905|558948489|FG001|Overall Study|never had surgery|0|||
154869608|NCT00847561|558948490|FG000|Overall Study|Withdrawal by Subject|4|||
154869609|NCT00847561|558948491|FG001|Overall Study|Withdrawal by Subject|3|||
154869610|NCT00847561|558948490|FG000|Overall Study|Unable to schedule|9|||
154869611|NCT00847561|558948491|FG001|Overall Study|Unable to schedule|1|||
155110084|NCT02388165|559831120|FG001|Overall Study|Other|13|||
155110085|NCT02388165|559831119|FG000|Overall Study|No longer meet eligibility criteria|40|||
155110086|NCT02388165|559831120|FG001|Overall Study|No longer meet eligibility criteria|43|||
155110087|NCT02388165|559831119|FG000|Overall Study|Withdrawal of consent|31|||
154869612|NCT00393458|558948493|FG000|Overall Study|Adverse Event|35|||
154869613|NCT00393458|558948494|FG001|Overall Study|Adverse Event|24|||
154869614|NCT00393458|558948495|FG002|Overall Study|Adverse Event|40|||
154869615|NCT00393458|558948496|FG003|Overall Study|Adverse Event|35|||
154869616|NCT00393458|558948493|FG000|Overall Study|Subject withdrew consent|27|||
154869617|NCT00393458|558948494|FG001|Overall Study|Subject withdrew consent|40|||
154869618|NCT00393458|558948495|FG002|Overall Study|Subject withdrew consent|33|||
154869619|NCT00393458|558948496|FG003|Overall Study|Subject withdrew consent|50|||
154869620|NCT00393458|558948493|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
154869621|NCT00393458|558948494|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
154869622|NCT00393458|558948495|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
154869623|NCT00393458|558948496|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
154869624|NCT00393458|558948493|FG000|Overall Study|Protocol deviation|11|||
154869625|NCT00393458|558948494|FG001|Overall Study|Protocol deviation|11|||
154869626|NCT00393458|558948495|FG002|Overall Study|Protocol deviation|11|||
154869627|NCT00393458|558948496|FG003|Overall Study|Protocol deviation|10|||
154869628|NCT00393458|558948493|FG000|Overall Study|Administrative problems|7|||
154869629|NCT00393458|558948494|FG001|Overall Study|Administrative problems|8|||
154869630|NCT00393458|558948495|FG002|Overall Study|Administrative problems|5|||
154869631|NCT00393458|558948496|FG003|Overall Study|Administrative problems|2|||
154869632|NCT00393458|558948493|FG000|Overall Study|Lost to Follow-up|5|||
154869633|NCT00393458|558948494|FG001|Overall Study|Lost to Follow-up|6|||
154869634|NCT00393458|558948495|FG002|Overall Study|Lost to Follow-up|5|||
154869635|NCT00393458|558948496|FG003|Overall Study|Lost to Follow-up|3|||
154869636|NCT00393458|558948493|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154869637|NCT00393458|558948494|FG001|Overall Study|Abnormal laboratory value(s)|1|||
154869638|NCT00393458|558948495|FG002|Overall Study|Abnormal laboratory value(s)|0|||
154869639|NCT00393458|558948496|FG003|Overall Study|Abnormal laboratory value(s)|0|||
154869640|NCT00393458|558948493|FG000|Overall Study|Death|1|||
154869641|NCT00393458|558948494|FG001|Overall Study|Death|1|||
154869642|NCT00393458|558948495|FG002|Overall Study|Death|5|||
154869643|NCT00393458|558948496|FG003|Overall Study|Death|5|||
154869644|NCT00393458|558948493|FG000|Overall Study|Abnormal test procedure result(s)|0|||
154869645|NCT00393458|558948494|FG001|Overall Study|Abnormal test procedure result(s)|1|||
154869646|NCT00393458|558948495|FG002|Overall Study|Abnormal test procedure result(s)|1|||
155110088|NCT02388165|559831120|FG001|Overall Study|Withdrawal of consent|32|||
155110089|NCT02388165|559831119|FG000|Overall Study|Lost to Follow-up|19|||
155110090|NCT02388165|559831120|FG001|Overall Study|Lost to Follow-up|20|||
155110091|NCT02388165|559831119|FG000|Overall Study|Death|13|||
155110092|NCT02388165|559831120|FG001|Overall Study|Death|10|||
155110093|NCT02388165|559831119|FG000|Overall Study|Adverse Event|3|||
155110094|NCT02388165|559831120|FG001|Overall Study|Adverse Event|5|||
155110095|NCT02388165|559831119|FG000|Overall Study|Did not meet entrance criteria|5|||
155110096|NCT02388165|559831120|FG001|Overall Study|Did not meet entrance criteria|2|||
155110097|NCT00705250|559831121|FG000|Overall Study|Withdrawal by Subject|1|||
155110098|NCT00705250|559831121|FG000|Overall Study|Patient died in car accident|1|||
154869647|NCT00393458|558948496|FG003|Overall Study|Abnormal test procedure result(s)|2|||
154869648|NCT00393458|558948493|FG000|Overall Study|Subject no longer requires study drug|0|||
154869649|NCT00393458|558948494|FG001|Overall Study|Subject no longer requires study drug|1|||
154869650|NCT00393458|558948495|FG002|Overall Study|Subject no longer requires study drug|0|||
154869651|NCT00393458|558948496|FG003|Overall Study|Subject no longer requires study drug|0|||
154869652|NCT02100657|558950189|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
154869653|NCT02100657|558950190|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
154869654|NCT02100657|558950191|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
154869655|NCT02100657|558950189|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
154869656|NCT02100657|558950190|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
154869657|NCT02100657|558950191|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
154869658|NCT02100657|558950189|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
155110099|NCT00880269|559831122|FG000|Overall Study|Protocol Violation|1|||
154869659|NCT02100657|558950190|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
155110100|NCT00880269|559831123|FG001|Overall Study|Protocol Violation|0|||
154869660|NCT02100657|558950191|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
154869661|NCT02100657|558950189|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
154869662|NCT02100657|558950190|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
154869663|NCT02100657|558950191|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
155110101|NCT00880269|559831122|FG000|Overall Study|Disease Progression|13|||
155110102|NCT00880269|559831123|FG001|Overall Study|Disease Progression|11|||
155110103|NCT00880269|559831122|FG000|Overall Study|New Cancer Therapy|1|||
155110104|NCT00880269|559831123|FG001|Overall Study|New Cancer Therapy|0|||
155110105|NCT00880269|559831122|FG000|Overall Study|Death|4|||
155110106|NCT00880269|559831123|FG001|Overall Study|Death|2|||
155110107|NCT00880269|559831122|FG000|Overall Study|Lost to Follow-up|0|||
155110108|NCT00880269|559831123|FG001|Overall Study|Lost to Follow-up|1|||
155110109|NCT00880269|559831122|FG000|Overall Study|Withdrawal by Subject|3|||
155110110|NCT00880269|559831123|FG001|Overall Study|Withdrawal by Subject|4|||
155110111|NCT00880269|559831122|FG000|Overall Study|Adverse Event|10|||
155110112|NCT00880269|559831123|FG001|Overall Study|Adverse Event|9|||
155110113|NCT01406938|559831124|FG000|Induction Period|Subject/guardian decision|6|||
155110114|NCT01406938|559831125|FG001|Induction Period|Subject/guardian decision|8|||
155110115|NCT01406938|559831126|FG002|Induction Period|Subject/guardian decision|0|||
155110116|NCT01406938|559831127|FG003|Induction Period|Subject/guardian decision|0|||
155110117|NCT01406938|559831128|FG004|Induction Period|Subject/guardian decision|0|||
155110118|NCT01406938|559831129|FG005|Induction Period|Subject/guardian decision|0|||
155110119|NCT01406938|559831124|FG000|Induction Period|Protocol deviation|1|||
155110120|NCT01406938|559831125|FG001|Induction Period|Protocol deviation|0|||
155110121|NCT01406938|559831126|FG002|Induction Period|Protocol deviation|0|||
155110122|NCT01406938|559831127|FG003|Induction Period|Protocol deviation|0|||
155110123|NCT01406938|559831128|FG004|Induction Period|Protocol deviation|0|||
155110124|NCT01406938|559831129|FG005|Induction Period|Protocol deviation|0|||
155110125|NCT01406938|559831124|FG000|Induction Period|Adverse Event|8|||
155110126|NCT01406938|559831125|FG001|Induction Period|Adverse Event|9|||
155110127|NCT01406938|559831126|FG002|Induction Period|Adverse Event|0|||
155110128|NCT01406938|559831127|FG003|Induction Period|Adverse Event|0|||
155110129|NCT01406938|559831128|FG004|Induction Period|Adverse Event|0|||
155110130|NCT01406938|559831129|FG005|Induction Period|Adverse Event|0|||
155110131|NCT01406938|559831124|FG000|Induction Period|Lack of Efficacy|1|||
155110132|NCT01406938|559831125|FG001|Induction Period|Lack of Efficacy|0|||
155110133|NCT01406938|559831126|FG002|Induction Period|Lack of Efficacy|0|||
155110134|NCT01406938|559831127|FG003|Induction Period|Lack of Efficacy|0|||
155110135|NCT01406938|559831128|FG004|Induction Period|Lack of Efficacy|0|||
155110136|NCT01406938|559831129|FG005|Induction Period|Lack of Efficacy|0|||
155110137|NCT01406938|559831124|FG000|Induction Period|Lost to Follow-up|2|||
155110138|NCT01406938|559831125|FG001|Induction Period|Lost to Follow-up|3|||
155110139|NCT01406938|559831126|FG002|Induction Period|Lost to Follow-up|0|||
155110140|NCT01406938|559831127|FG003|Induction Period|Lost to Follow-up|0|||
155110141|NCT01406938|559831128|FG004|Induction Period|Lost to Follow-up|0|||
155110142|NCT01406938|559831129|FG005|Induction Period|Lost to Follow-up|0|||
155110143|NCT01406938|559831124|FG000|Maintenance Period|Adverse Event|0|||
155110144|NCT01406938|559831125|FG001|Maintenance Period|Adverse Event|0|||
155110145|NCT01406938|559831126|FG002|Maintenance Period|Adverse Event|2|||
155110146|NCT01406938|559831127|FG003|Maintenance Period|Adverse Event|8|||
155110147|NCT01406938|559831128|FG004|Maintenance Period|Adverse Event|4|||
155110148|NCT01406938|559831129|FG005|Maintenance Period|Adverse Event|2|||
155110149|NCT01406938|559831124|FG000|Maintenance Period|Death|0|||
155110150|NCT01406938|559831125|FG001|Maintenance Period|Death|0|||
155110151|NCT01406938|559831126|FG002|Maintenance Period|Death|0|||
154869664|NCT02100657|558950189|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
154869665|NCT02100657|558950190|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
154869666|NCT02100657|558950191|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
155110152|NCT01406938|559831127|FG003|Maintenance Period|Death|0|||
155110153|NCT01406938|559831128|FG004|Maintenance Period|Death|1|||
155110154|NCT01406938|559831129|FG005|Maintenance Period|Death|0|||
155110155|NCT01406938|559831124|FG000|Maintenance Period|Subject/guardian decision|0|||
155110156|NCT01406938|559831125|FG001|Maintenance Period|Subject/guardian decision|0|||
155110157|NCT01406938|559831126|FG002|Maintenance Period|Subject/guardian decision|11|||
155110158|NCT01406938|559831127|FG003|Maintenance Period|Subject/guardian decision|7|||
155110159|NCT01406938|559831128|FG004|Maintenance Period|Subject/guardian decision|10|||
154869667|NCT02100657|558950189|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
155110160|NCT01406938|559831129|FG005|Maintenance Period|Subject/guardian decision|7|||
155110161|NCT01406938|559831124|FG000|Maintenance Period|Protocol Violation|0|||
155110162|NCT01406938|559831125|FG001|Maintenance Period|Protocol Violation|0|||
155110163|NCT01406938|559831126|FG002|Maintenance Period|Protocol Violation|2|||
155110164|NCT01406938|559831127|FG003|Maintenance Period|Protocol Violation|2|||
155110165|NCT01406938|559831128|FG004|Maintenance Period|Protocol Violation|2|||
155110166|NCT01406938|559831129|FG005|Maintenance Period|Protocol Violation|2|||
155110167|NCT01406938|559831124|FG000|Maintenance Period|Pregnancy|0|||
155110168|NCT01406938|559831125|FG001|Maintenance Period|Pregnancy|0|||
155110169|NCT01406938|559831126|FG002|Maintenance Period|Pregnancy|0|||
154869668|NCT02100657|558950190|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
154869669|NCT02100657|558950191|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
154869670|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
154869671|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
154869672|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
154869673|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Death|0|||
154869674|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Death|0|||
154869675|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Death|1|||
154869676|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
154869677|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
154869678|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
154869679|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
154869680|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
154869681|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
154869682|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
154869683|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
154869684|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
154869685|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
154869686|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
154869687|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
154869688|NCT02100657|558950189|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
154869689|NCT02100657|558950190|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
154869690|NCT02100657|558950191|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
154869691|NCT01543490|558950192|FG000|Overall Study|Adverse Event|4|||
154869692|NCT01543490|558950193|FG001|Overall Study|Adverse Event|0|||
154869693|NCT01543490|558950192|FG000|Overall Study|Physician Decision|1|||
154869694|NCT01543490|558950193|FG001|Overall Study|Physician Decision|0|||
154869695|NCT01543490|558950192|FG000|Overall Study|Lack of Efficacy|3|||
154869696|NCT01543490|558950193|FG001|Overall Study|Lack of Efficacy|3|||
154869697|NCT01543490|558950192|FG000|Overall Study|Lost to Follow-up|5|||
154869698|NCT01543490|558950193|FG001|Overall Study|Lost to Follow-up|0|||
154869699|NCT01543490|558950192|FG000|Overall Study|Withdrawal by Subject|2|||
154869700|NCT01543490|558950193|FG001|Overall Study|Withdrawal by Subject|0|||
154869701|NCT01543490|558950192|FG000|Overall Study|Other-Various Administrative Reasons|1|||
154869702|NCT01543490|558950193|FG001|Overall Study|Other-Various Administrative Reasons|2|||
154869703|NCT04168645|558950195|FG000|Overall Study|Lost to Follow-up|23|||
154869704|NCT04168645|558950196|FG001|Overall Study|Lost to Follow-up|28|||
154869705|NCT04168645|558950197|FG002|Overall Study|Lost to Follow-up|15|||
154869706|NCT04168645|558950198|FG003|Overall Study|Lost to Follow-up|12|||
154869707|NCT04168645|558950195|FG000|Overall Study|Death|1|||
154869708|NCT04168645|558950196|FG001|Overall Study|Death|1|||
154869709|NCT04168645|558950197|FG002|Overall Study|Death|0|||
154869710|NCT04168645|558950198|FG003|Overall Study|Death|0|||
154869711|NCT04168645|558950195|FG000|Overall Study|Withdrawal by Subject|5|||
154869712|NCT04168645|558950196|FG001|Overall Study|Withdrawal by Subject|2|||
154869713|NCT04168645|558950197|FG002|Overall Study|Withdrawal by Subject|2|||
154869714|NCT04168645|558950198|FG003|Overall Study|Withdrawal by Subject|2|||
154869715|NCT04168645|558950195|FG000|Overall Study|Administrative Withdrawal|3|||
154869716|NCT04168645|558950196|FG001|Overall Study|Administrative Withdrawal|1|||
154869717|NCT04168645|558950197|FG002|Overall Study|Administrative Withdrawal|1|||
154869718|NCT04168645|558950198|FG003|Overall Study|Administrative Withdrawal|3|||
154869719|NCT03692910|558950201|FG000|Overall Study|Lost to Follow-up|4|||
154869720|NCT03692910|558950202|FG001|Overall Study|Lost to Follow-up|0|||
154869721|NCT03692910|558950203|FG002|Overall Study|Lost to Follow-up|0|||
154869722|NCT03692910|558950201|FG000|Overall Study|Withdrawal by Subject|2|||
154869723|NCT03692910|558950202|FG001|Overall Study|Withdrawal by Subject|0|||
154869724|NCT03692910|558950203|FG002|Overall Study|Withdrawal by Subject|0|||
154869725|NCT00151411|558950204|FG000|Overall Study|Lost to Follow-up|15|||
154869726|NCT00151411|558950205|FG001|Overall Study|Lost to Follow-up|19|||
154869727|NCT00151411|558950204|FG000|Overall Study|Withdrawal by Subject|12|||
154869728|NCT00151411|558950205|FG001|Overall Study|Withdrawal by Subject|20|||
154869729|NCT00151411|558950204|FG000|Overall Study|Adverse Event|6|||
154869730|NCT00151411|558950205|FG001|Overall Study|Adverse Event|0|||
154869731|NCT00151411|558950204|FG000|Overall Study|Pregnancy|0|||
154869732|NCT00151411|558950205|FG001|Overall Study|Pregnancy|4|||
154869733|NCT01283581|558950206|FG000|Overall Study|Lost to Follow-up|8|||
154869734|NCT01283581|558950207|FG001|Overall Study|Lost to Follow-up|6|||
154869735|NCT01283581|558950208|FG002|Overall Study|Lost to Follow-up|8|||
154869736|NCT01283581|558950206|FG000|Overall Study|Withdrawal by Subject|2|||
154869737|NCT01283581|558950207|FG001|Overall Study|Withdrawal by Subject|5|||
154869738|NCT01283581|558950208|FG002|Overall Study|Withdrawal by Subject|2|||
154869739|NCT01283581|558950206|FG000|Overall Study|Adverse Event|1|||
154869740|NCT01283581|558950207|FG001|Overall Study|Adverse Event|1|||
154869741|NCT01283581|558950208|FG002|Overall Study|Adverse Event|4|||
154869742|NCT01283581|558950206|FG000|Overall Study|Physician Decision|0|||
154869743|NCT01283581|558950207|FG001|Overall Study|Physician Decision|1|||
155110170|NCT01406938|559831127|FG003|Maintenance Period|Pregnancy|0|||
155110171|NCT01406938|559831128|FG004|Maintenance Period|Pregnancy|1|||
155110172|NCT01406938|559831129|FG005|Maintenance Period|Pregnancy|0|||
155110173|NCT01406938|559831124|FG000|Maintenance Period|Lost to Follow-up|0|||
155110174|NCT01406938|559831125|FG001|Maintenance Period|Lost to Follow-up|0|||
155110175|NCT01406938|559831126|FG002|Maintenance Period|Lost to Follow-up|0|||
155110176|NCT01406938|559831127|FG003|Maintenance Period|Lost to Follow-up|0|||
155110177|NCT01406938|559831128|FG004|Maintenance Period|Lost to Follow-up|4|||
155110178|NCT01406938|559831129|FG005|Maintenance Period|Lost to Follow-up|0|||
155110179|NCT01406938|559831124|FG000|Maintenance Period|Lack of Efficacy|0|||
155110180|NCT01406938|559831125|FG001|Maintenance Period|Lack of Efficacy|0|||
155110181|NCT01406938|559831126|FG002|Maintenance Period|Lack of Efficacy|2|||
155110182|NCT01406938|559831127|FG003|Maintenance Period|Lack of Efficacy|1|||
155110183|NCT01406938|559831128|FG004|Maintenance Period|Lack of Efficacy|3|||
155110184|NCT01406938|559831129|FG005|Maintenance Period|Lack of Efficacy|5|||
155110185|NCT01406938|559831124|FG000|Follow up|Lack of Efficacy|3|||
155110186|NCT01406938|559831125|FG001|Follow up|Lack of Efficacy|2|||
155110187|NCT01406938|559831126|FG002|Follow up|Lack of Efficacy|1|||
155110188|NCT01406938|559831127|FG003|Follow up|Lack of Efficacy|0|||
154869744|NCT01283581|558950208|FG002|Overall Study|Physician Decision|2|||
154869745|NCT01283581|558950206|FG000|Overall Study|Protocol Violation|0|||
154869746|NCT01283581|558950207|FG001|Overall Study|Protocol Violation|1|||
154869747|NCT01283581|558950208|FG002|Overall Study|Protocol Violation|2|||
154869748|NCT01283581|558950206|FG000|Overall Study|Noncompliance|1|||
154869749|NCT01283581|558950207|FG001|Overall Study|Noncompliance|0|||
154869750|NCT01283581|558950208|FG002|Overall Study|Noncompliance|0|||
154869751|NCT01283581|558950206|FG000|Overall Study|Investigator unblinded|0|||
154869752|NCT01283581|558950207|FG001|Overall Study|Investigator unblinded|0|||
154869753|NCT01283581|558950208|FG002|Overall Study|Investigator unblinded|1|||
154869754|NCT01283581|558950206|FG000|Overall Study|"Early termination"|0|||
154869755|NCT01283581|558950207|FG001|Overall Study|"Early termination"|0|||
154869756|NCT01283581|558950208|FG002|Overall Study|"Early termination"|1|||
154869757|NCT01259492|558950209|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
154869758|NCT01259492|558950210|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
154869759|NCT01259492|558950211|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
154869760|NCT01259492|558950212|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
154869761|NCT01259492|558950209|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
154869762|NCT01259492|558950210|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
154869763|NCT01259492|558950211|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
154869764|NCT01259492|558950212|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
154869765|NCT01259492|558950209|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
154869766|NCT01259492|558950210|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
154869767|NCT01259492|558950211|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
154869768|NCT01259492|558950212|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
154869769|NCT01259492|558950209|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
154869770|NCT01259492|558950210|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
154869771|NCT01259492|558950211|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
154869772|NCT01259492|558950212|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
154869773|NCT01259492|558950209|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
154869774|NCT01259492|558950210|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
154869775|NCT01259492|558950211|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
154869776|NCT01259492|558950212|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
154869777|NCT01259492|558950209|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
154869778|NCT01259492|558950210|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
154869779|NCT01259492|558950211|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
154869780|NCT01259492|558950212|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
154869781|NCT01259492|558950209|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
154869782|NCT01259492|558950210|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
154869783|NCT01259492|558950211|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
154869784|NCT01259492|558950212|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
154869785|NCT01259492|558950209|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
154869786|NCT01259492|558950210|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
154973715|NCT00177164|559328939|FG000|Overall Study|Protocol Violation|0|||
154869787|NCT01259492|558950211|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
154973716|NCT00177164|559328940|FG001|Overall Study|Protocol Violation|7|||
154973717|NCT00177164|559328939|FG000|Overall Study|Lost to Follow-up|4|||
155110189|NCT01406938|559831128|FG004|Follow up|Lack of Efficacy|0|||
155110190|NCT01406938|559831129|FG005|Follow up|Lack of Efficacy|0|||
155198470|NCT00745823|560164972|FG000|Overall Study|Study Terminated by Sponsor|326|||
154869788|NCT01259492|558950212|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
154869789|NCT01259492|558950209|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
154869790|NCT01259492|558950210|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
154869791|NCT01259492|558950211|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
154973718|NCT00177164|559328940|FG001|Overall Study|Lost to Follow-up|5|||
155110191|NCT01406938|559831124|FG000|Follow up|Patient/guardian decision|4|||
155110192|NCT01406938|559831125|FG001|Follow up|Patient/guardian decision|2|||
155110193|NCT01406938|559831126|FG002|Follow up|Patient/guardian decision|4|||
155110194|NCT01406938|559831127|FG003|Follow up|Patient/guardian decision|2|||
154869792|NCT01259492|558950212|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
154869793|NCT01259492|558950209|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
154869794|NCT01259492|558950210|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
154869795|NCT01259492|558950211|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
154869796|NCT01259492|558950212|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
154869797|NCT01259492|558950209|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
154869798|NCT01259492|558950210|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
154869799|NCT01259492|558950211|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
154869800|NCT01259492|558950212|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
154869801|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
154869802|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
154869803|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
154869804|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
154869805|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
154869806|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
154869807|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
154869808|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
154869809|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
154869810|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
154869811|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
154869812|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
154869813|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
154869814|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
154869815|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
154869816|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
154869817|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
154869818|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
154869819|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
154869820|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
154869821|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
154869822|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
154869823|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
154869824|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
154869825|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
154869826|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
154869827|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
154869828|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
154869829|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
154869830|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
154869831|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
154869832|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
154869833|NCT01259492|558950209|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
154869834|NCT01259492|558950210|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
154869835|NCT01259492|558950211|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
154869836|NCT01259492|558950212|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
154869837|NCT00089843|558950213|FG000|Overall Study|Withdrawal by Subject|1|||
154869838|NCT00089843|558950214|FG001|Overall Study|Withdrawal by Subject|4|||
154869839|NCT00089843|558950215|FG002|Overall Study|Withdrawal by Subject|5|||
154869840|NCT00089843|558950216|FG003|Overall Study|Withdrawal by Subject|6|||
154869841|NCT00089843|558950213|FG000|Overall Study|Physician Decision|1|||
154869842|NCT00089843|558950214|FG001|Overall Study|Physician Decision|0|||
154869843|NCT00089843|558950215|FG002|Overall Study|Physician Decision|0|||
154869844|NCT00089843|558950216|FG003|Overall Study|Physician Decision|1|||
154869845|NCT03846947|558950217|FG000|Overall Study|technical issues with imaging sequence|2|||
154869846|NCT03060577|558950218|FG000|Overall Study|Withdrawal by Subject|25|||
154869847|NCT03060577|558950219|FG001|Overall Study|Withdrawal by Subject|5|||
154869848|NCT03060577|558950218|FG000|Overall Study|Physician Decision|4|||
154869849|NCT03060577|558950219|FG001|Overall Study|Physician Decision|3|||
154869850|NCT03060577|558950218|FG000|Overall Study|Lost to Follow-up|3|||
154869851|NCT03060577|558950219|FG001|Overall Study|Lost to Follow-up|0|||
154973719|NCT00177164|559328939|FG000|Overall Study|increase in alcohol and drug use|1|||
155110195|NCT01406938|559831128|FG004|Follow up|Patient/guardian decision|4|||
155110196|NCT01406938|559831129|FG005|Follow up|Patient/guardian decision|1|||
154869852|NCT03060577|558950218|FG000|Overall Study|Death|7|||
154973720|NCT00177164|559328940|FG001|Overall Study|increase in alcohol and drug use|2|||
154869853|NCT03060577|558950219|FG001|Overall Study|Death|1|||
154869854|NCT03060577|558950218|FG000|Overall Study|Adverse Event|9|||
154869855|NCT03060577|558950219|FG001|Overall Study|Adverse Event|1|||
154869856|NCT03060577|558950218|FG000|Overall Study|Inclusion/Exclusion|1|||
154869857|NCT03060577|558950219|FG001|Overall Study|Inclusion/Exclusion|0|||
154869858|NCT03060577|558950218|FG000|Overall Study|Other|8|||
154869859|NCT03060577|558950219|FG001|Overall Study|Other|2|||
154869860|NCT02584634|558950222|FG000|Overall Study|Adverse Event|3|||
154869861|NCT02584634|558950223|FG001|Overall Study|Adverse Event|5|||
154869862|NCT02584634|558950222|FG000|Overall Study|Death|0|||
154869863|NCT02584634|558950223|FG001|Overall Study|Death|1|||
154869864|NCT02584634|558950222|FG000|Overall Study|Lost to Follow-up|0|||
154869865|NCT02584634|558950223|FG001|Overall Study|Lost to Follow-up|1|||
154869866|NCT02584634|558950222|FG000|Overall Study|Physician Decision|1|||
154869867|NCT02584634|558950223|FG001|Overall Study|Physician Decision|2|||
154869868|NCT02584634|558950222|FG000|Overall Study|Progressive disease|7|||
154869869|NCT02584634|558950223|FG001|Overall Study|Progressive disease|15|||
154869870|NCT02584634|558950222|FG000|Overall Study|Withdrawal by Subject|1|||
154869871|NCT02584634|558950223|FG001|Overall Study|Withdrawal by Subject|1|||
154869872|NCT02584634|558950222|FG000|Overall Study|Other|0|||
154869873|NCT02584634|558950223|FG001|Overall Study|Other|6|||
154869874|NCT01295905|558950225|FG000|Overall Study|Did not meet inclusion criteria|1|||
154869875|NCT01295905|558950226|FG001|Overall Study|Did not meet inclusion criteria|0|||
154869876|NCT01295905|558950225|FG000|Overall Study|Met exclusion criteria|1|||
154869877|NCT01295905|558950226|FG001|Overall Study|Met exclusion criteria|0|||
154869878|NCT03069690|558950227|FG000|Pregnancy Intervention|Pregnancy loss|9|||
154869879|NCT03069690|558950228|FG001|Pregnancy Intervention|Pregnancy loss|4|||
154869880|NCT03069690|558950229|FG002|Pregnancy Intervention|Pregnancy loss|0|||
154869881|NCT03069690|558950230|FG003|Pregnancy Intervention|Pregnancy loss|0|||
154869882|NCT03069690|558950231|FG004|Pregnancy Intervention|Pregnancy loss|0|||
154869883|NCT03069690|558950232|FG005|Pregnancy Intervention|Pregnancy loss|0|||
154869884|NCT03069690|558950227|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
154869885|NCT03069690|558950228|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
154869886|NCT03069690|558950229|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
154869887|NCT03069690|558950230|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
154869888|NCT03069690|558950231|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
154869889|NCT03069690|558950232|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
154869890|NCT03069690|558950227|FG000|Postpartum Intervention|Lost to Follow-up|0|||
154869891|NCT03069690|558950228|FG001|Postpartum Intervention|Lost to Follow-up|0|||
154869892|NCT03069690|558950229|FG002|Postpartum Intervention|Lost to Follow-up|5|||
154869893|NCT03069690|558950230|FG003|Postpartum Intervention|Lost to Follow-up|5|||
154869894|NCT03069690|558950231|FG004|Postpartum Intervention|Lost to Follow-up|2|||
154869895|NCT03069690|558950232|FG005|Postpartum Intervention|Lost to Follow-up|4|||
154869896|NCT02564120|558950233|FG000|Overall Study|Did not return release forms|160|||
154869897|NCT02564120|558950233|FG000|Overall Study|Death|58|||
154869898|NCT02564120|558950233|FG000|Overall Study|Withdrawal by Subject|204|||
154869899|NCT02564120|558950233|FG000|Overall Study|Other medical condition|24|||
154869900|NCT01629667|558950234|FG000|Overall Study|Lost to Follow-up|0|||
154869901|NCT01629667|558950235|FG001|Overall Study|Lost to Follow-up|1|||
154869902|NCT01629667|558950236|FG002|Overall Study|Lost to Follow-up|1|||
154869903|NCT01629667|558950234|FG000|Overall Study|Withdrawal by Subject|31|||
154869904|NCT01629667|558950235|FG001|Overall Study|Withdrawal by Subject|20|||
154869905|NCT01629667|558950236|FG002|Overall Study|Withdrawal by Subject|28|||
154869906|NCT01629667|558950234|FG000|Overall Study|Death|1|||
154869907|NCT01629667|558950235|FG001|Overall Study|Death|5|||
154869908|NCT01629667|558950236|FG002|Overall Study|Death|3|||
154869909|NCT01629667|558950234|FG000|Overall Study|Randomized, not treated|2|||
154869910|NCT01629667|558950235|FG001|Overall Study|Randomized, not treated|1|||
154869911|NCT01629667|558950236|FG002|Overall Study|Randomized, not treated|0|||
154869912|NCT01629667|558950234|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
154869913|NCT01629667|558950235|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
154869914|NCT01629667|558950236|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
154869915|NCT01629667|558950234|FG000|Overall Study|Requiring lung transplant|2|||
154869916|NCT01629667|558950235|FG001|Overall Study|Requiring lung transplant|1|||
154869917|NCT01629667|558950236|FG002|Overall Study|Requiring lung transplant|3|||
154973721|NCT00177164|559328939|FG000|Overall Study|Adverse Event|1|||
155110197|NCT01406938|559831124|FG000|Follow up|Protocol Violation|0|||
155110198|NCT01406938|559831125|FG001|Follow up|Protocol Violation|0|||
155110199|NCT01406938|559831126|FG002|Follow up|Protocol Violation|1|||
155110200|NCT01406938|559831127|FG003|Follow up|Protocol Violation|0|||
155110201|NCT01406938|559831128|FG004|Follow up|Protocol Violation|0|||
155110202|NCT01406938|559831129|FG005|Follow up|Protocol Violation|0|||
155110203|NCT01406938|559831124|FG000|Follow up|Physician Decision|0|||
154973722|NCT00177164|559328940|FG001|Overall Study|Adverse Event|0|||
154869918|NCT01629667|558950234|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
154869919|NCT01629667|558950235|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
154869920|NCT01629667|558950236|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
155110204|NCT01406938|559831125|FG001|Follow up|Physician Decision|0|||
154869921|NCT01629667|558950234|FG000|Overall Study|Started other medicine|1|||
154869922|NCT01629667|558950235|FG001|Overall Study|Started other medicine|0|||
154869923|NCT01629667|558950236|FG002|Overall Study|Started other medicine|1|||
154869924|NCT01629667|558950234|FG000|Overall Study|Site error in safety follow-up|0|||
154869925|NCT01629667|558950235|FG001|Overall Study|Site error in safety follow-up|0|||
154869926|NCT01629667|558950236|FG002|Overall Study|Site error in safety follow-up|1|||
154869927|NCT01629667|558950234|FG000|Overall Study|Enrolled in another clinical study|0|||
154869928|NCT01629667|558950235|FG001|Overall Study|Enrolled in another clinical study|1|||
154869929|NCT01629667|558950236|FG002|Overall Study|Enrolled in another clinical study|0|||
154869930|NCT01629667|558950234|FG000|Overall Study|Code break|1|||
154869931|NCT01629667|558950235|FG001|Overall Study|Code break|0|||
154869932|NCT01629667|558950236|FG002|Overall Study|Code break|0|||
154869933|NCT00891657|558950237|FG000|Overall Study|Withdrawal by Subject|1|||
154869934|NCT00891657|558950238|FG001|Overall Study|Withdrawal by Subject|1|||
154869935|NCT03455543|558950242|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
154869936|NCT03455543|558950243|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
154869937|NCT03455543|558950244|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
154869938|NCT03455543|558950242|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
154869939|NCT03455543|558950243|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
154869940|NCT03455543|558950244|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
154869941|NCT03455543|558950242|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
154869942|NCT03455543|558950243|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
154869943|NCT03455543|558950244|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
154869944|NCT03455543|558950242|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
154869945|NCT03455543|558950243|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
154869946|NCT03455543|558950244|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
154869947|NCT03455543|558950242|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
154869948|NCT03455543|558950243|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
154869949|NCT03455543|558950244|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
154869950|NCT03455543|558950242|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
154869951|NCT03455543|558950243|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
154869952|NCT03455543|558950244|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
154869953|NCT03455543|558950242|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
154869954|NCT03455543|558950243|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
154869955|NCT03455543|558950244|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
154869956|NCT03455543|558950242|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
154869957|NCT03455543|558950243|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
154869958|NCT03455543|558950244|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
154869959|NCT03455543|558950242|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
154869960|NCT03455543|558950243|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
154869961|NCT03455543|558950244|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
154869962|NCT00909090|558950248|FG000|Overall Study|Lost to Follow-up|17|||
154869963|NCT00909090|558950249|FG001|Overall Study|Lost to Follow-up|17|||
154869964|NCT02926573|558950251|FG000|Overall Study|Nausea|1|||
154869965|NCT02926573|558950252|FG001|Overall Study|Nausea|0|||
154869966|NCT02926573|558950251|FG000|Overall Study|Remain intubated|2|||
154869967|NCT02926573|558950252|FG001|Overall Study|Remain intubated|2|||
154869968|NCT02926573|558950251|FG000|Overall Study|Change in surgery plan|3|||
154869969|NCT02926573|558950252|FG001|Overall Study|Change in surgery plan|1|||
154869970|NCT02926573|558950251|FG000|Overall Study|Change to outpatient status|5|||
154869971|NCT02926573|558950252|FG001|Overall Study|Change to outpatient status|1|||
154869972|NCT02926573|558950251|FG000|Overall Study|Withdrawal by Subject|0|||
154869973|NCT02926573|558950252|FG001|Overall Study|Withdrawal by Subject|2|||
154869974|NCT02926573|558950251|FG000|Overall Study|Return to operating room|0|||
154869975|NCT02926573|558950252|FG001|Overall Study|Return to operating room|2|||
154869976|NCT02926573|558950251|FG000|Overall Study|Delirium|0|||
154869977|NCT02926573|558950252|FG001|Overall Study|Delirium|1|||
154869978|NCT00611455|558950255|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
154869979|NCT00611455|558950256|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
154869980|NCT00611455|558950257|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
154869981|NCT00611455|558950255|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
154869982|NCT00611455|558950256|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
154869983|NCT00611455|558950257|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
154869984|NCT00611455|558950255|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
154869985|NCT00611455|558950256|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
154869986|NCT00611455|558950257|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
155110205|NCT01406938|559831126|FG002|Follow up|Physician Decision|2|||
155110206|NCT01406938|559831127|FG003|Follow up|Physician Decision|0|||
155110207|NCT01406938|559831128|FG004|Follow up|Physician Decision|3|||
155110208|NCT01406938|559831129|FG005|Follow up|Physician Decision|1|||
154869987|NCT00611455|558950255|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
154869988|NCT00611455|558950256|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
154869989|NCT00611455|558950257|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154869990|NCT00611455|558950255|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
154869991|NCT00611455|558950256|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
154869992|NCT00611455|558950257|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
154869993|NCT00611455|558950255|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
154869994|NCT00611455|558950256|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
154869995|NCT00611455|558950257|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
154869996|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
154869997|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
154869998|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
154869999|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
154870000|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
154870001|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
154870002|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
154870003|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
154870004|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
154870005|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
154870006|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
154870007|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
154870008|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
154870009|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
154870010|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
154870011|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
154870012|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
154870013|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
154870014|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
154870015|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
154870016|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
154870017|NCT00611455|558950255|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
154870018|NCT00611455|558950256|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
154870019|NCT00611455|558950257|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
154870020|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
154870021|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
154870022|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
154870023|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
154870024|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
154870025|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
154870026|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
154870027|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
154870028|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
154870029|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
154870030|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
154870031|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
154870032|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
154870033|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
154870034|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
154870035|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
154870036|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
154870037|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
154870038|NCT00611455|558950255|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
154870039|NCT00611455|558950256|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
154870040|NCT00611455|558950257|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
154870041|NCT04601272|558950258|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
154870042|NCT04601272|558950259|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
154870043|NCT04601272|558950260|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
154870044|NCT00942708|558950262|FG000|Overall Study|Withdrawal by Subject|1|||
154870045|NCT00995371|558950263|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
154870046|NCT00995371|558950264|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
154870047|NCT00673673|558950265|FG000|Overall Study|Progressive disease|27|||
154870048|NCT00673673|558950265|FG000|Overall Study|Adverse Event|4|||
154870049|NCT00673673|558950265|FG000|Overall Study|Withdrawal by Subject|3|||
155174947|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
155174948|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
155174949|NCT04740905|560078308|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
155174950|NCT04740905|560078309|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
155174951|NCT01534182|560078312|FG000|Overall Study|Administrative problems|1|||
155174952|NCT01534182|560078313|FG001|Overall Study|Administrative problems|0|||
155174953|NCT01534182|560078312|FG000|Overall Study|Withdrawal by Subject|4|||
155174954|NCT01534182|560078313|FG001|Overall Study|Withdrawal by Subject|7|||
155174955|NCT01534182|560078312|FG000|Overall Study|Adverse Event|7|||
155174956|NCT01534182|560078313|FG001|Overall Study|Adverse Event|3|||
155174957|NCT03077087|560078314|FG000|Overall Study|Physician Decision|2|||
155174958|NCT02412488|560078315|FG000|Overall Study|Lost to Follow-up|10|||
155174959|NCT02412488|560078315|FG000|Overall Study|Withdrawal by Subject|5|||
155174960|NCT02412488|560078315|FG000|Overall Study|Physician Decision|1|||
155174961|NCT02412488|560078315|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
155174962|NCT02412488|560078315|FG000|Overall Study|Reveal LINQ explant|1|||
155174963|NCT01989468|560078316|FG000|Overall Study|Adverse Event|10|||
155174964|NCT01989468|560078317|FG001|Overall Study|Adverse Event|15|||
155174965|NCT01989468|560078318|FG002|Overall Study|Adverse Event|4|||
155174966|NCT01989468|560078319|FG003|Overall Study|Adverse Event|5|||
155174967|NCT01989468|560078320|FG004|Overall Study|Adverse Event|4|||
155174968|NCT01989468|560078316|FG000|Overall Study|Lack of Efficacy|11|||
155174969|NCT01989468|560078317|FG001|Overall Study|Lack of Efficacy|11|||
155174970|NCT01989468|560078318|FG002|Overall Study|Lack of Efficacy|7|||
155174971|NCT01989468|560078319|FG003|Overall Study|Lack of Efficacy|4|||
155174972|NCT01989468|560078320|FG004|Overall Study|Lack of Efficacy|2|||
155174973|NCT01989468|560078316|FG000|Overall Study|Lost to Follow-up|5|||
155174974|NCT01989468|560078317|FG001|Overall Study|Lost to Follow-up|2|||
155174975|NCT01989468|560078318|FG002|Overall Study|Lost to Follow-up|0|||
155174976|NCT01989468|560078319|FG003|Overall Study|Lost to Follow-up|1|||
155174977|NCT01989468|560078320|FG004|Overall Study|Lost to Follow-up|1|||
155174978|NCT01989468|560078316|FG000|Overall Study|Physician Decision|4|||
155174979|NCT01989468|560078317|FG001|Overall Study|Physician Decision|1|||
155174980|NCT01989468|560078318|FG002|Overall Study|Physician Decision|0|||
155174981|NCT01989468|560078319|FG003|Overall Study|Physician Decision|1|||
155174982|NCT01989468|560078320|FG004|Overall Study|Physician Decision|0|||
155174983|NCT01989468|560078316|FG000|Overall Study|Pregnancy|0|||
155174984|NCT01989468|560078317|FG001|Overall Study|Pregnancy|1|||
155174985|NCT01989468|560078318|FG002|Overall Study|Pregnancy|0|||
155174986|NCT01989468|560078319|FG003|Overall Study|Pregnancy|0|||
155174987|NCT01989468|560078320|FG004|Overall Study|Pregnancy|0|||
155174988|NCT01989468|560078316|FG000|Overall Study|Technical Problems|3|||
155174989|NCT01989468|560078317|FG001|Overall Study|Technical Problems|1|||
155174990|NCT01989468|560078318|FG002|Overall Study|Technical Problems|3|||
155174991|NCT01989468|560078319|FG003|Overall Study|Technical Problems|1|||
155174992|NCT01989468|560078320|FG004|Overall Study|Technical Problems|0|||
155174993|NCT01989468|560078316|FG000|Overall Study|Subject Guardian Decision|11|||
155174994|NCT01989468|560078317|FG001|Overall Study|Subject Guardian Decision|6|||
155110209|NCT01406938|559831124|FG000|Follow up|Lost to Follow-up|1|||
155110210|NCT01406938|559831125|FG001|Follow up|Lost to Follow-up|1|||
155110211|NCT01406938|559831126|FG002|Follow up|Lost to Follow-up|0|||
155110212|NCT01406938|559831127|FG003|Follow up|Lost to Follow-up|1|||
155110213|NCT01406938|559831128|FG004|Follow up|Lost to Follow-up|2|||
155110214|NCT01406938|559831129|FG005|Follow up|Lost to Follow-up|1|||
155110215|NCT00962741|559831134|FG000|Overall Study|Failed to return|3|||
155110216|NCT00962741|559831134|FG000|Overall Study|Lost to Follow-up|2|||
155110217|NCT00962741|559831134|FG000|Overall Study|Withdrawal by Subject|1|||
155110218|NCT00962741|559831134|FG000|Overall Study|Lack of Efficacy|1|||
155110219|NCT00962741|559831134|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
155174995|NCT01989468|560078318|FG002|Overall Study|Subject Guardian Decision|4|||
155174996|NCT01989468|560078319|FG003|Overall Study|Subject Guardian Decision|4|||
155174997|NCT01989468|560078320|FG004|Overall Study|Subject Guardian Decision|1|||
155174998|NCT01989468|560078316|FG000|Overall Study|Death|3|||
155174999|NCT01989468|560078317|FG001|Overall Study|Death|0|||
155175000|NCT01989468|560078318|FG002|Overall Study|Death|1|||
155110220|NCT00316225|559831135|FG000|Overall Study|Adverse Event|2|||
155110221|NCT00316225|559831135|FG000|Overall Study|Physician Decision|3|||
155110222|NCT00316225|559831135|FG000|Overall Study|Progressive Disease|15|||
155110223|NCT00316225|559831135|FG000|Overall Study|Withdrawal by Subject|3|||
155175001|NCT01989468|560078319|FG003|Overall Study|Death|0|||
155175002|NCT01989468|560078320|FG004|Overall Study|Death|0|||
155175003|NCT01960907|560078325|FG000|Overall Study|Death|4|||
155175004|NCT01960907|560078326|FG001|Overall Study|Death|3|||
155175005|NCT01960907|560078325|FG000|Overall Study|Withdrawal by Subject|32|||
155175006|NCT01960907|560078326|FG001|Overall Study|Withdrawal by Subject|42|||
155175007|NCT00065429|560078329|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155110224|NCT00316225|559831135|FG000|Overall Study|Death|2|||
155175008|NCT00065429|560078330|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
154870050|NCT00673673|558950265|FG000|Overall Study|Investigators' discretion|2|||
154870051|NCT04579393|558950278|FG000|Overall Study|Withdrawal by Subject|2|||
154870052|NCT04579393|558950279|FG001|Overall Study|Withdrawal by Subject|2|||
154870053|NCT04579393|558950278|FG000|Overall Study|Death|1|||
154870054|NCT04579393|558950279|FG001|Overall Study|Death|3|||
154870055|NCT01282814|558950280|FG000|First Intervention|Emesis During Dosing Interval|0|||
154870056|NCT01282814|558950281|FG001|First Intervention|Emesis During Dosing Interval|3|||
154870057|NCT01282814|558950280|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
154870058|NCT01282814|558950281|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
154870059|NCT01524289|558950282|FG000|Overall Study|Lost to Follow-up|0|||
154870060|NCT01524289|558950283|FG001|Overall Study|Lost to Follow-up|1|||
154870061|NCT01524289|558950282|FG000|Overall Study|Physician Decision|1|||
154870062|NCT01524289|558950283|FG001|Overall Study|Physician Decision|0|||
154870063|NCT01524289|558950282|FG000|Overall Study|Protocol Violation|5|||
154870064|NCT01524289|558950283|FG001|Overall Study|Protocol Violation|1|||
154870065|NCT01524289|558950282|FG000|Overall Study|Withdrawal by Subject|11|||
154870066|NCT01524289|558950283|FG001|Overall Study|Withdrawal by Subject|7|||
154870067|NCT01524289|558950282|FG000|Overall Study|Adverse Event|12|||
154870068|NCT01524289|558950283|FG001|Overall Study|Adverse Event|5|||
154870069|NCT01524289|558950282|FG000|Overall Study|Did not take study medication|1|||
154870070|NCT01524289|558950283|FG001|Overall Study|Did not take study medication|0|||
154870071|NCT02519231|558950284|FG000|Overall Study|Lost to Follow-up|2|||
154870072|NCT02519231|558950285|FG001|Overall Study|Lost to Follow-up|5|||
154870073|NCT02519231|558950284|FG000|Overall Study|Withdrawal by Subject|0|||
154870074|NCT02519231|558950285|FG001|Overall Study|Withdrawal by Subject|1|||
154870075|NCT02704429|558950286|FG000|Part A: 24 Weeks|Adverse Event|3|||
154870076|NCT02704429|558950287|FG001|Part A: 24 Weeks|Adverse Event|0|||
154870077|NCT02704429|558950286|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
154870078|NCT02704429|558950287|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
154870079|NCT00104104|558950289|FG000|Overall Study|Adverse Event|8|||
154870080|NCT00104104|558950290|FG001|Overall Study|Adverse Event|8|||
154870081|NCT00104104|558950289|FG000|Overall Study|Abnormal laboratory value(s)|20|||
154870082|NCT00104104|558950290|FG001|Overall Study|Abnormal laboratory value(s)|14|||
154870083|NCT00104104|558950289|FG000|Overall Study|Lack of Efficacy|0|||
154870084|NCT00104104|558950290|FG001|Overall Study|Lack of Efficacy|3|||
154870085|NCT00104104|558950289|FG000|Overall Study|Condition no longer requires study drug|7|||
154870086|NCT00104104|558950290|FG001|Overall Study|Condition no longer requires study drug|4|||
154870087|NCT00104104|558950289|FG000|Overall Study|Protocol Violation|5|||
154870088|NCT00104104|558950290|FG001|Overall Study|Protocol Violation|2|||
154870089|NCT00104104|558950289|FG000|Overall Study|Withdrawal by Subject|11|||
154870090|NCT00104104|558950290|FG001|Overall Study|Withdrawal by Subject|15|||
154870091|NCT00104104|558950289|FG000|Overall Study|Lost to Follow-up|3|||
154870092|NCT00104104|558950290|FG001|Overall Study|Lost to Follow-up|7|||
154870093|NCT00104104|558950289|FG000|Overall Study|Administrative problems|12|||
154870094|NCT00104104|558950290|FG001|Overall Study|Administrative problems|13|||
154870095|NCT00104104|558950289|FG000|Overall Study|Death|9|||
154870096|NCT00104104|558950290|FG001|Overall Study|Death|6|||
154870097|NCT00447421|558950291|FG000|Overall Study|Lack of Efficacy|1|||
154870098|NCT00447421|558950291|FG000|Overall Study|Adverse Event|3|||
154870099|NCT00447421|558950291|FG000|Overall Study|Sponsor Decision|2|||
154870100|NCT01707147|558950292|FG000|Overall Study|Administered Trajenta prior to contract|5|||
154870101|NCT01707147|558950292|FG000|Overall Study|Patients who have not taken Trajenta|1|||
154870102|NCT01707147|558950292|FG000|Overall Study|Follow-up failure|17|||
154870103|NCT01707147|558950292|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
154870104|NCT02725177|558950294|FG000|Overall Study|Physician Decision|4|||
154870105|NCT02725177|558950294|FG000|Overall Study|Adverse Event|1|||
154870106|NCT01326962|558950297|FG000|Overall Study|Adverse Event|1|||
154870107|NCT01326962|558950297|FG000|Overall Study|Withdrawal by Subject|1|||
154870108|NCT01326962|558950297|FG000|Overall Study|Lost to Follow-up|3|||
154870109|NCT01326962|558950297|FG000|Overall Study|Other|2|||
154870110|NCT02053246|558950298|FG000|Overall Study|Withdrawal by Subject|3|||
154870111|NCT02053246|558950298|FG000|Overall Study|Physician Decision|1|||
154870112|NCT02707757|558950299|FG000|Overall Study|Protocol Violation|3|||
154870113|NCT02707757|558950300|FG001|Overall Study|Protocol Violation|2|||
154870114|NCT02707757|558950299|FG000|Overall Study|Withdrawal by Subject|2|||
154870115|NCT02707757|558950300|FG001|Overall Study|Withdrawal by Subject|0|||
154870116|NCT02707757|558950299|FG000|Overall Study|Death|0|||
155110225|NCT01814878|559831137|FG000|Overall Study|Adverse Event|16|||
154870117|NCT02707757|558950300|FG001|Overall Study|Death|1|||
154870118|NCT02707757|558950299|FG000|Overall Study|Adverse Event|6|||
154870119|NCT02707757|558950300|FG001|Overall Study|Adverse Event|4|||
154870120|NCT02707757|558950299|FG000|Overall Study|Renal transplant/elective operation|1|||
154870121|NCT02707757|558950300|FG001|Overall Study|Renal transplant/elective operation|5|||
154870122|NCT01056523|558950301|FG000|Overall Study|Death|1|||
154870123|NCT01056523|558950302|FG001|Overall Study|Death|0|||
154870124|NCT01056523|558950303|FG002|Overall Study|Death|2|||
154870125|NCT01056523|558950304|FG003|Overall Study|Death|3|||
154870126|NCT01056523|558950305|FG004|Overall Study|Death|0|||
155110226|NCT01814878|559831138|FG001|Overall Study|Adverse Event|5|||
155110227|NCT01814878|559831137|FG000|Overall Study|Withdrawal by Subject|20|||
155110228|NCT01814878|559831138|FG001|Overall Study|Withdrawal by Subject|16|||
155110229|NCT01814878|559831137|FG000|Overall Study|Protocol Violation|5|||
155110230|NCT01814878|559831138|FG001|Overall Study|Protocol Violation|5|||
155110231|NCT01814878|559831137|FG000|Overall Study|Physician Decision|3|||
155110232|NCT01814878|559831138|FG001|Overall Study|Physician Decision|1|||
155110233|NCT01814878|559831137|FG000|Overall Study|Screening failure (drop-out)|0|||
155110234|NCT01814878|559831138|FG001|Overall Study|Screening failure (drop-out)|3|||
155110235|NCT01814878|559831137|FG000|Overall Study|Other|2|||
155110236|NCT01814878|559831138|FG001|Overall Study|Other|0|||
155110237|NCT01545934|559831139|FG000|Overall Study|Withdrawal by Subject|4|||
155110238|NCT01545934|559831140|FG001|Overall Study|Withdrawal by Subject|3|||
155110239|NCT01545934|559831139|FG000|Overall Study|Lost to Follow-up|1|||
155110240|NCT01545934|559831140|FG001|Overall Study|Lost to Follow-up|0|||
155110241|NCT03654404|559831141|FG000|Overall Study|Death|1|||
155110242|NCT03654404|559831141|FG000|Overall Study|Lost to Follow-up|2|||
155110243|NCT03654404|559831141|FG000|Overall Study|Withdrawal by Subject|5|||
155110244|NCT02003638|559831148|FG000|Overall Study|Withdrawal by Subject|1|||
155110245|NCT02003638|559831149|FG001|Overall Study|Withdrawal by Subject|0|||
155110246|NCT00654745|559831152|FG000|Overall Study|Adverse Event|12|||
155110247|NCT00654745|559831152|FG000|Overall Study|Lost to Follow-up|7|||
155110248|NCT00654745|559831152|FG000|Overall Study|Protocol Violation|11|||
155110249|NCT00654745|559831152|FG000|Overall Study|Withdrawal by Subject|10|||
155110250|NCT00654745|559831152|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
155110251|NCT04551963|559831153|FG000|Overall Study|Physician Decision|1|||
155110252|NCT04551963|559831154|FG001|Overall Study|Physician Decision|1|||
155110253|NCT04551963|559831153|FG000|Overall Study|Death|1|||
155110254|NCT04551963|559831154|FG001|Overall Study|Death|0|||
155110255|NCT00748618|559831155|FG000|Overall Study|Adverse Event|1|||
155110256|NCT00748618|559831156|FG001|Overall Study|Adverse Event|0|||
155110257|NCT00466947|559831157|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
155110258|NCT00466947|559831158|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
155110259|NCT00466947|559831157|FG000|Study End Analysis Period|Adverse Event|35|||
155110260|NCT00466947|559831158|FG001|Study End Analysis Period|Adverse Event|43|||
155110261|NCT00466947|559831157|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
155110262|NCT00466947|559831158|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
155110263|NCT00466947|559831157|FG000|Study End Analysis Period|Physician Decision|29|||
155110264|NCT00466947|559831158|FG001|Study End Analysis Period|Physician Decision|29|||
155110265|NCT00466947|559831157|FG000|Study End Analysis Period|Protocol Violation|9|||
155110266|NCT00466947|559831158|FG001|Study End Analysis Period|Protocol Violation|17|||
155110267|NCT00466947|559831157|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
155110268|NCT00466947|559831158|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
155110269|NCT00466947|559831157|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
155110270|NCT00466947|559831158|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
155110271|NCT00466947|559831157|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
155110272|NCT00466947|559831158|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
155110273|NCT00466947|559831157|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
155110274|NCT00466947|559831158|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
155110275|NCT00878254|559831159|FG000|Overall Study|Physician Decision|1|||
155110276|NCT00878254|559831159|FG000|Overall Study|Death|1|||
155110277|NCT00878254|559831159|FG000|Overall Study|Withdrawal by Subject|1|||
155110278|NCT01977729|559831163|FG000|Overall Study|Study terminated|1|||
155110279|NCT05730335|559831168|FG000|Overall Study|Lost to Follow-up|8|||
155110280|NCT05730335|559831168|FG000|Overall Study|Withdrawal by Subject|6|||
155110281|NCT00606034|559831171|FG000|Overall Study|incarceration|1|||
155110282|NCT00765037|559831173|FG000|Overall Study|Lost to Follow-up|5|||
155110283|NCT00765037|559831173|FG000|Overall Study|Adverse Event|1|||
155110284|NCT02300558|559831174|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
155110285|NCT02300558|559831174|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
155110286|NCT02300558|559831174|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
154870127|NCT01056523|558950306|FG005|Overall Study|Death|0|||
154870128|NCT01056523|558950307|FG006|Overall Study|Death|1|||
154870129|NCT03429556|558950308|FG000|Overall Study|Lost to Follow-up|0|||
155110287|NCT02300558|559831174|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
155110288|NCT01471028|559831175|FG000|VTI-208|Adverse Event|39|||
155110289|NCT01471028|559831176|FG001|VTI-208|Adverse Event|41|||
155110290|NCT01471028|559831175|FG000|VTI-208|Withdrawal by Subject|0|||
155110291|NCT01471028|559831176|FG001|VTI-208|Withdrawal by Subject|2|||
155110292|NCT01471028|559831175|FG000|VTI-208|Lost to Follow-up|1|||
155110293|NCT01471028|559831176|FG001|VTI-208|Lost to Follow-up|1|||
155110294|NCT01471028|559831175|FG000|VTI-208E|Death|7|||
155110295|NCT01471028|559831176|FG001|VTI-208E|Death|10|||
155110296|NCT01471028|559831175|FG000|VTI-208E|Withdrawal by Subject|1|||
155110297|NCT01471028|559831176|FG001|VTI-208E|Withdrawal by Subject|0|||
155110298|NCT01471028|559831175|FG000|VTI-208E|Lost to Follow-up|0|||
155110299|NCT01471028|559831176|FG001|VTI-208E|Lost to Follow-up|2|||
155110300|NCT00964002|559831177|FG000|Overall Study|Protocol Violation|8|||
155110301|NCT03213938|559831189|FG000|Overall Study|Lost to Follow-up|4|||
155110302|NCT03213938|559831190|FG001|Overall Study|Lost to Follow-up|3|||
155110303|NCT03213938|559831189|FG000|Overall Study|Lack of Efficacy|1|||
155110304|NCT03213938|559831190|FG001|Overall Study|Lack of Efficacy|0|||
155110305|NCT03213938|559831189|FG000|Overall Study|Decline to participate|5|||
155110306|NCT03213938|559831190|FG001|Overall Study|Decline to participate|4|||
155110307|NCT03213938|559831189|FG000|Overall Study|Without reason|4|||
155110308|NCT03213938|559831190|FG001|Overall Study|Without reason|5|||
155110309|NCT02443116|559831192|FG000|Part 1|Adverse Event|2|||
155110310|NCT02443116|559831193|FG001|Part 1|Adverse Event|3|||
155110311|NCT02443116|559831194|FG002|Part 1|Adverse Event|0|||
155110312|NCT02443116|559831195|FG003|Part 1|Adverse Event|0|||
155110313|NCT02443116|559831196|FG004|Part 1|Adverse Event|0|||
155110314|NCT02443116|559831197|FG005|Part 1|Adverse Event|0|||
155110315|NCT02443116|559831198|FG006|Part 1|Adverse Event|0|||
155110316|NCT02443116|559831199|FG007|Part 1|Adverse Event|0|||
155110317|NCT02443116|559831200|FG008|Part 1|Adverse Event|0|||
155110318|NCT02443116|559831192|FG000|Part 1|Withdrew informed consent|0|||
155110319|NCT02443116|559831193|FG001|Part 1|Withdrew informed consent|1|||
155110320|NCT02443116|559831194|FG002|Part 1|Withdrew informed consent|0|||
155110321|NCT02443116|559831195|FG003|Part 1|Withdrew informed consent|0|||
155110322|NCT02443116|559831196|FG004|Part 1|Withdrew informed consent|0|||
155110323|NCT02443116|559831197|FG005|Part 1|Withdrew informed consent|0|||
155110324|NCT02443116|559831198|FG006|Part 1|Withdrew informed consent|0|||
155110325|NCT02443116|559831199|FG007|Part 1|Withdrew informed consent|0|||
155110326|NCT02443116|559831200|FG008|Part 1|Withdrew informed consent|0|||
155110327|NCT02443116|559831192|FG000|Part 1|Lost to Follow-up|0|||
155110328|NCT02443116|559831193|FG001|Part 1|Lost to Follow-up|0|||
155110329|NCT02443116|559831194|FG002|Part 1|Lost to Follow-up|2|||
155110330|NCT02443116|559831195|FG003|Part 1|Lost to Follow-up|0|||
155110331|NCT02443116|559831196|FG004|Part 1|Lost to Follow-up|0|||
155110332|NCT02443116|559831197|FG005|Part 1|Lost to Follow-up|0|||
155110333|NCT02443116|559831198|FG006|Part 1|Lost to Follow-up|0|||
155110334|NCT02443116|559831199|FG007|Part 1|Lost to Follow-up|0|||
155110335|NCT02443116|559831200|FG008|Part 1|Lost to Follow-up|0|||
155110336|NCT02443116|559831192|FG000|Part 1|Participant moved out of state|0|||
155110337|NCT02443116|559831193|FG001|Part 1|Participant moved out of state|0|||
155110338|NCT02443116|559831194|FG002|Part 1|Participant moved out of state|1|||
155110339|NCT02443116|559831195|FG003|Part 1|Participant moved out of state|0|||
155110340|NCT02443116|559831196|FG004|Part 1|Participant moved out of state|0|||
155110341|NCT02443116|559831197|FG005|Part 1|Participant moved out of state|0|||
155110342|NCT02443116|559831198|FG006|Part 1|Participant moved out of state|0|||
155110343|NCT02443116|559831199|FG007|Part 1|Participant moved out of state|0|||
155175009|NCT00065429|560078331|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
154870130|NCT03429556|558950309|FG001|Overall Study|Lost to Follow-up|1|||
154870131|NCT03429556|558950310|FG002|Overall Study|Lost to Follow-up|0|||
154870132|NCT03429556|558950311|FG003|Overall Study|Lost to Follow-up|0|||
154870133|NCT01863758|558950319|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
154870134|NCT01863758|558950319|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
154870135|NCT02369510|558950320|FG000|Overall Study|Spilled Medication|1|||
154870136|NCT02369510|558950321|FG001|Overall Study|Spilled Medication|2|||
154870137|NCT02369510|558950322|FG002|Overall Study|Spilled Medication|1|||
154870138|NCT02369510|558950320|FG000|Overall Study|Epidural Activation|1|||
154870139|NCT02369510|558950321|FG001|Overall Study|Epidural Activation|1|||
154870140|NCT02369510|558950322|FG002|Overall Study|Epidural Activation|5|||
154870141|NCT04285723|558950329|FG000|Overall Study|Subject decision|1|||
154870142|NCT04285723|558950330|FG001|Overall Study|Subject decision|2|||
154870143|NCT04285723|558950329|FG000|Overall Study|Physician Decision|1|||
154870144|NCT04285723|558950330|FG001|Overall Study|Physician Decision|0|||
154870145|NCT04285723|558950329|FG000|Overall Study|No efficiency|1|||
155110344|NCT02443116|559831200|FG008|Part 1|Participant moved out of state|0|||
155110345|NCT02443116|559831192|FG000|Part 1|Participant enrolled in another clinical trial|0|||
155110346|NCT02443116|559831193|FG001|Part 1|Participant enrolled in another clinical trial|0|||
155110347|NCT02443116|559831194|FG002|Part 1|Participant enrolled in another clinical trial|1|||
155110348|NCT02443116|559831195|FG003|Part 1|Participant enrolled in another clinical trial|0|||
154870146|NCT04285723|558950330|FG001|Overall Study|No efficiency|0|||
155110349|NCT02443116|559831196|FG004|Part 1|Participant enrolled in another clinical trial|0|||
155110350|NCT02443116|559831197|FG005|Part 1|Participant enrolled in another clinical trial|0|||
155110351|NCT02443116|559831198|FG006|Part 1|Participant enrolled in another clinical trial|0|||
154870147|NCT03067311|558950332|FG000|Overall Study|Lost to Follow-up|1|||
154870148|NCT03067311|558950333|FG001|Overall Study|Lost to Follow-up|1|||
154870149|NCT03067311|558950332|FG000|Overall Study|Moved away|1|||
154870150|NCT03067311|558950333|FG001|Overall Study|Moved away|1|||
154870151|NCT01089725|558950337|FG000|Overall Study|Adverse Event|1|||
155110352|NCT02443116|559831199|FG007|Part 1|Participant enrolled in another clinical trial|0|||
155110353|NCT02443116|559831200|FG008|Part 1|Participant enrolled in another clinical trial|0|||
155110354|NCT02443116|559831192|FG000|Part 2|Adverse Event|0|||
155110355|NCT02443116|559831193|FG001|Part 2|Adverse Event|0|||
155110356|NCT02443116|559831194|FG002|Part 2|Adverse Event|0|||
155110357|NCT02443116|559831195|FG003|Part 2|Adverse Event|0|||
155110358|NCT02443116|559831196|FG004|Part 2|Adverse Event|1|||
155110359|NCT02443116|559831197|FG005|Part 2|Adverse Event|1|||
155110360|NCT02443116|559831198|FG006|Part 2|Adverse Event|2|||
155110361|NCT02443116|559831199|FG007|Part 2|Adverse Event|0|||
155110362|NCT02443116|559831200|FG008|Part 2|Adverse Event|0|||
155110363|NCT02443116|559831192|FG000|Part 2|Withdrew informed consent|0|||
155110364|NCT02443116|559831193|FG001|Part 2|Withdrew informed consent|0|||
155110365|NCT02443116|559831194|FG002|Part 2|Withdrew informed consent|0|||
155110366|NCT02443116|559831195|FG003|Part 2|Withdrew informed consent|0|||
155110367|NCT02443116|559831196|FG004|Part 2|Withdrew informed consent|0|||
155110368|NCT02443116|559831197|FG005|Part 2|Withdrew informed consent|1|||
155110369|NCT02443116|559831198|FG006|Part 2|Withdrew informed consent|1|||
155110370|NCT02443116|559831199|FG007|Part 2|Withdrew informed consent|0|||
155110371|NCT02443116|559831200|FG008|Part 2|Withdrew informed consent|0|||
155110372|NCT02443116|559831192|FG000|Part 2|Inability to comply with protocol|0|||
155110373|NCT02443116|559831193|FG001|Part 2|Inability to comply with protocol|0|||
155110374|NCT02443116|559831194|FG002|Part 2|Inability to comply with protocol|0|||
155110375|NCT02443116|559831195|FG003|Part 2|Inability to comply with protocol|1|||
155110376|NCT02443116|559831196|FG004|Part 2|Inability to comply with protocol|0|||
155110377|NCT02443116|559831197|FG005|Part 2|Inability to comply with protocol|0|||
155110378|NCT02443116|559831198|FG006|Part 2|Inability to comply with protocol|0|||
155110379|NCT02443116|559831199|FG007|Part 2|Inability to comply with protocol|0|||
155110380|NCT02443116|559831200|FG008|Part 2|Inability to comply with protocol|0|||
155110381|NCT02443116|559831192|FG000|Part 2|Lost to Follow-up|0|||
155110382|NCT02443116|559831193|FG001|Part 2|Lost to Follow-up|0|||
155110383|NCT02443116|559831194|FG002|Part 2|Lost to Follow-up|0|||
155110384|NCT02443116|559831195|FG003|Part 2|Lost to Follow-up|1|||
155110385|NCT02443116|559831196|FG004|Part 2|Lost to Follow-up|0|||
155110386|NCT02443116|559831197|FG005|Part 2|Lost to Follow-up|0|||
155110387|NCT02443116|559831198|FG006|Part 2|Lost to Follow-up|0|||
155110388|NCT02443116|559831199|FG007|Part 2|Lost to Follow-up|0|||
155110389|NCT02443116|559831200|FG008|Part 2|Lost to Follow-up|0|||
155110390|NCT02443116|559831192|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110391|NCT02443116|559831193|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110392|NCT02443116|559831194|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110393|NCT02443116|559831195|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110394|NCT02443116|559831196|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110395|NCT02443116|559831197|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
155110396|NCT02443116|559831198|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110397|NCT02443116|559831199|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110398|NCT02443116|559831200|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
155110399|NCT02443116|559831192|FG000|Part 3|Adverse Event|0|||
155110400|NCT02443116|559831193|FG001|Part 3|Adverse Event|0|||
155110401|NCT02443116|559831194|FG002|Part 3|Adverse Event|0|||
155110402|NCT02443116|559831195|FG003|Part 3|Adverse Event|0|||
155110403|NCT02443116|559831196|FG004|Part 3|Adverse Event|0|||
155110404|NCT02443116|559831197|FG005|Part 3|Adverse Event|0|||
155110405|NCT02443116|559831198|FG006|Part 3|Adverse Event|0|||
155110406|NCT02443116|559831199|FG007|Part 3|Adverse Event|0|||
155110407|NCT02443116|559831200|FG008|Part 3|Adverse Event|1|||
155110408|NCT02443116|559831192|FG000|Part 3|Withdrew informed consent|0|||
155110409|NCT02443116|559831193|FG001|Part 3|Withdrew informed consent|0|||
155110410|NCT02443116|559831194|FG002|Part 3|Withdrew informed consent|0|||
154870152|NCT01089725|558950338|FG001|Overall Study|Adverse Event|1|||
154870153|NCT01089725|558950339|FG002|Overall Study|Adverse Event|0|||
154870154|NCT01089725|558950340|FG003|Overall Study|Adverse Event|0|||
154870155|NCT01089725|558950341|FG004|Overall Study|Adverse Event|2|||
154870156|NCT01089725|558950337|FG000|Overall Study|Lack of Efficacy|4|||
154870157|NCT01089725|558950338|FG001|Overall Study|Lack of Efficacy|3|||
155110411|NCT02443116|559831195|FG003|Part 3|Withdrew informed consent|0|||
155110412|NCT02443116|559831196|FG004|Part 3|Withdrew informed consent|0|||
155110413|NCT02443116|559831197|FG005|Part 3|Withdrew informed consent|0|||
155110414|NCT02443116|559831198|FG006|Part 3|Withdrew informed consent|0|||
155110415|NCT02443116|559831199|FG007|Part 3|Withdrew informed consent|3|||
155110416|NCT02443116|559831200|FG008|Part 3|Withdrew informed consent|2|||
155110417|NCT02443116|559831192|FG000|Part 3|Lost to Follow-up|0|||
155110418|NCT02443116|559831193|FG001|Part 3|Lost to Follow-up|0|||
155110419|NCT02443116|559831194|FG002|Part 3|Lost to Follow-up|0|||
155110420|NCT02443116|559831195|FG003|Part 3|Lost to Follow-up|0|||
155110421|NCT02443116|559831196|FG004|Part 3|Lost to Follow-up|0|||
154870158|NCT01089725|558950339|FG002|Overall Study|Lack of Efficacy|1|||
155110422|NCT02443116|559831197|FG005|Part 3|Lost to Follow-up|0|||
155110423|NCT02443116|559831198|FG006|Part 3|Lost to Follow-up|0|||
154870159|NCT01089725|558950340|FG003|Overall Study|Lack of Efficacy|0|||
154870160|NCT01089725|558950341|FG004|Overall Study|Lack of Efficacy|4|||
154870161|NCT01089725|558950337|FG000|Overall Study|Lost to Follow-up|2|||
154870162|NCT01089725|558950338|FG001|Overall Study|Lost to Follow-up|2|||
154870163|NCT01089725|558950339|FG002|Overall Study|Lost to Follow-up|0|||
154870164|NCT01089725|558950340|FG003|Overall Study|Lost to Follow-up|3|||
154870165|NCT01089725|558950341|FG004|Overall Study|Lost to Follow-up|0|||
154870166|NCT01089725|558950337|FG000|Overall Study|Protocol Violation|0|||
154870167|NCT01089725|558950338|FG001|Overall Study|Protocol Violation|0|||
154870168|NCT01089725|558950339|FG002|Overall Study|Protocol Violation|1|||
154870169|NCT01089725|558950340|FG003|Overall Study|Protocol Violation|1|||
154870170|NCT01089725|558950341|FG004|Overall Study|Protocol Violation|0|||
154870171|NCT01089725|558950337|FG000|Overall Study|Withdrawal by Subject|5|||
154870172|NCT01089725|558950338|FG001|Overall Study|Withdrawal by Subject|5|||
154870173|NCT01089725|558950339|FG002|Overall Study|Withdrawal by Subject|4|||
154870174|NCT01089725|558950340|FG003|Overall Study|Withdrawal by Subject|5|||
154870175|NCT01089725|558950341|FG004|Overall Study|Withdrawal by Subject|4|||
154870176|NCT01089725|558950337|FG000|Overall Study|Study Terminated by Sponsor|51|||
154870177|NCT01089725|558950338|FG001|Overall Study|Study Terminated by Sponsor|56|||
154870178|NCT01089725|558950339|FG002|Overall Study|Study Terminated by Sponsor|53|||
154870179|NCT01089725|558950340|FG003|Overall Study|Study Terminated by Sponsor|68|||
154870180|NCT01089725|558950341|FG004|Overall Study|Study Terminated by Sponsor|68|||
154870181|NCT01089725|558950337|FG000|Overall Study|Randomized, but not treated|0|||
154870182|NCT01089725|558950338|FG001|Overall Study|Randomized, but not treated|1|||
154870183|NCT01089725|558950339|FG002|Overall Study|Randomized, but not treated|2|||
154870184|NCT01089725|558950340|FG003|Overall Study|Randomized, but not treated|1|||
154870185|NCT01089725|558950341|FG004|Overall Study|Randomized, but not treated|2|||
154870186|NCT01089725|558950337|FG000|Overall Study|Other|3|||
154870187|NCT01089725|558950338|FG001|Overall Study|Other|0|||
154870188|NCT01089725|558950339|FG002|Overall Study|Other|0|||
154870189|NCT01089725|558950340|FG003|Overall Study|Other|1|||
154870190|NCT01089725|558950341|FG004|Overall Study|Other|0|||
154870191|NCT01486316|558951498|FG000|Overall Study|Device explanted with/without re-implant|3|||
154870192|NCT01486316|558951499|FG001|Overall Study|Device explanted with/without re-implant|2|||
154870193|NCT01486316|558951500|FG002|Overall Study|Device explanted with/without re-implant|0|||
154870194|NCT01486316|558951501|FG003|Overall Study|Device explanted with/without re-implant|2|||
154870195|NCT01486316|558951498|FG000|Overall Study|Not meeting eligibility criteria|0|||
154870196|NCT01486316|558951499|FG001|Overall Study|Not meeting eligibility criteria|0|||
154870197|NCT01486316|558951500|FG002|Overall Study|Not meeting eligibility criteria|1|||
154870198|NCT01486316|558951501|FG003|Overall Study|Not meeting eligibility criteria|0|||
154870199|NCT01486316|558951498|FG000|Overall Study|Withdrawal by Subject|1|||
154870200|NCT01486316|558951499|FG001|Overall Study|Withdrawal by Subject|0|||
154870201|NCT01486316|558951500|FG002|Overall Study|Withdrawal by Subject|3|||
154870202|NCT01486316|558951501|FG003|Overall Study|Withdrawal by Subject|0|||
154870203|NCT01486316|558951498|FG000|Overall Study|Physician Decision|0|||
154870204|NCT01486316|558951499|FG001|Overall Study|Physician Decision|0|||
154870205|NCT01486316|558951500|FG002|Overall Study|Physician Decision|1|||
154870206|NCT01486316|558951501|FG003|Overall Study|Physician Decision|0|||
154870207|NCT01486316|558951498|FG000|Overall Study|Death|0|||
154870208|NCT01486316|558951499|FG001|Overall Study|Death|1|||
154870209|NCT01486316|558951500|FG002|Overall Study|Death|0|||
154870210|NCT01486316|558951501|FG003|Overall Study|Death|0|||
154870211|NCT03191396|558951502|FG000|Overall Study|Lost to Follow-up|0|||
154870212|NCT03191396|558951503|FG001|Overall Study|Lost to Follow-up|3|||
154870213|NCT03191396|558951502|FG000|Overall Study|Withdrawal by Subject|3|||
154870214|NCT03191396|558951503|FG001|Overall Study|Withdrawal by Subject|2|||
154870215|NCT05094154|558951504|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
154870216|NCT05094154|558951505|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
154870217|NCT05094154|558951504|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
154870218|NCT05094154|558951505|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
154870219|NCT00893113|558951512|FG000|Overall Study|Lost to Follow-up|4|||
154870220|NCT00893113|558951513|FG001|Overall Study|Lost to Follow-up|8|||
154870221|NCT00893113|558951512|FG000|Overall Study|Early Termination|1|||
154870222|NCT00893113|558951513|FG001|Overall Study|Early Termination|1|||
154870223|NCT00893113|558951512|FG000|Overall Study|Withdrew Consent|8|||
154870224|NCT00893113|558951513|FG001|Overall Study|Withdrew Consent|7|||
154870225|NCT02531035|558951516|FG000|Overall Study|Death|0|||
154870226|NCT02531035|558951517|FG001|Overall Study|Death|1|||
154870227|NCT02531035|558951516|FG000|Overall Study|Protocol Violation|1|||
154870228|NCT02531035|558951517|FG001|Overall Study|Protocol Violation|1|||
154870229|NCT02531035|558951516|FG000|Overall Study|Noncompliance with study drug|8|||
154870230|NCT02531035|558951517|FG001|Overall Study|Noncompliance with study drug|3|||
154870231|NCT02531035|558951516|FG000|Overall Study|Physician Decision|1|||
154870232|NCT02531035|558951517|FG001|Overall Study|Physician Decision|0|||
154870233|NCT02531035|558951516|FG000|Overall Study|Adverse Event|16|||
154870234|NCT02531035|558951517|FG001|Overall Study|Adverse Event|45|||
154870235|NCT02531035|558951516|FG000|Overall Study|Other|3|||
154870236|NCT02531035|558951517|FG001|Overall Study|Other|2|||
154870237|NCT02531035|558951516|FG000|Overall Study|Withdrawal by Subject|42|||
154870238|NCT02531035|558951517|FG001|Overall Study|Withdrawal by Subject|32|||
154870239|NCT02531035|558951516|FG000|Overall Study|Lost to Follow-up|8|||
154870240|NCT02531035|558951517|FG001|Overall Study|Lost to Follow-up|10|||
154870241|NCT02531035|558951516|FG000|Overall Study|Randomized, not treated|2|||
155110424|NCT02443116|559831199|FG007|Part 3|Lost to Follow-up|1|||
155110425|NCT02443116|559831200|FG008|Part 3|Lost to Follow-up|2|||
155110426|NCT01917929|559831201|FG000|Overall Study|Death|8|||
155110427|NCT01917929|559831201|FG000|Overall Study|Lost to Follow-up|19|||
155110428|NCT01917929|559831201|FG000|Overall Study|Withdrawal by Subject|33|||
155110429|NCT01917929|559831201|FG000|Overall Study|Adverse Event|6|||
155110430|NCT01917929|559831201|FG000|Overall Study|Investigative Site Terminated|35|||
155110431|NCT01917929|559831201|FG000|Overall Study|Censored because study device not implanted|6|||
155110432|NCT01917929|559831201|FG000|Overall Study|Censored because surgery not performed|3|||
155110433|NCT01917929|559831201|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
155110434|NCT01917929|559831201|FG000|Overall Study|Sponsor terminated study|175|||
155110435|NCT04295759|559831202|FG000|Overall Study|Lack of Efficacy|9|||
155110436|NCT04295759|559831202|FG000|Overall Study|Death|1|||
155110437|NCT04295759|559831202|FG000|Overall Study|Withdrawal by Subject|2|||
155110438|NCT04295759|559831202|FG000|Overall Study|Deemed ineligible|1|||
155110439|NCT01696981|559831203|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
155110440|NCT01696981|559831204|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
155110441|NCT01696981|559831203|FG000|Overall Study|Died Before Randomization|3|||
155110442|NCT01696981|559831204|FG001|Overall Study|Died Before Randomization|8|||
155110443|NCT01696981|559831203|FG000|Overall Study|Died Before ASU (Control)|278|||
155110444|NCT01696981|559831204|FG001|Overall Study|Died Before ASU (Control)|0|||
155110445|NCT01696981|559831203|FG000|Overall Study|Refused ASU (Control)|920|||
155110446|NCT01696981|559831204|FG001|Overall Study|Refused ASU (Control)|0|||
155110447|NCT01696981|559831203|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
155110448|NCT01696981|559831204|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
155110449|NCT01108731|559831207|FG000|Overall Study|Withdrawal by Subject|1|||
155110450|NCT01108731|559831208|FG001|Overall Study|Withdrawal by Subject|1|||
155110451|NCT01108731|559831207|FG000|Overall Study|Adverse Event|3|||
155110452|NCT01108731|559831208|FG001|Overall Study|Adverse Event|3|||
155110453|NCT01063062|559831209|FG000|Overall Study|Patient withdrew consent|0|||
155110454|NCT01063062|559831210|FG001|Overall Study|Patient withdrew consent|1|||
155110455|NCT01063062|559831209|FG000|Overall Study|Adverse Event|2|||
155110456|NCT01063062|559831210|FG001|Overall Study|Adverse Event|4|||
155110457|NCT01063062|559831209|FG000|Overall Study|Protocol Violation|5|||
155110458|NCT01063062|559831210|FG001|Overall Study|Protocol Violation|4|||
155110459|NCT01063062|559831209|FG000|Overall Study|Investigator's request|1|||
155110460|NCT01063062|559831210|FG001|Overall Study|Investigator's request|0|||
155110461|NCT01063062|559831209|FG000|Overall Study|Lost to Follow-up|0|||
155110462|NCT01063062|559831210|FG001|Overall Study|Lost to Follow-up|2|||
155110463|NCT01063062|559831209|FG000|Overall Study|Miscellaneous reason|0|||
155110464|NCT01063062|559831210|FG001|Overall Study|Miscellaneous reason|1|||
155110465|NCT03479541|559831218|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
155110466|NCT03479541|559831219|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
155110467|NCT03479541|559831220|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
155110468|NCT03479541|559831221|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
155110469|NCT03479541|559831218|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
155110470|NCT03479541|559831219|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
155110471|NCT03479541|559831220|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
155110472|NCT03479541|559831221|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
155110473|NCT03479541|559831218|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
155110474|NCT03479541|559831219|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
155110475|NCT03479541|559831220|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
155110476|NCT03479541|559831221|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
155110477|NCT03479541|559831218|FG000|Home Monitoring|Lost to Follow-up|0|||
155110478|NCT03479541|559831219|FG001|Home Monitoring|Lost to Follow-up|0|||
155110479|NCT03479541|559831220|FG002|Home Monitoring|Lost to Follow-up|8|||
155110480|NCT03479541|559831221|FG003|Home Monitoring|Lost to Follow-up|12|||
155110481|NCT03479541|559831218|FG000|Home Monitoring|Withdrawal by Subject|0|||
155110482|NCT03479541|559831219|FG001|Home Monitoring|Withdrawal by Subject|0|||
155110483|NCT03479541|559831220|FG002|Home Monitoring|Withdrawal by Subject|17|||
155110484|NCT03479541|559831221|FG003|Home Monitoring|Withdrawal by Subject|30|||
155110485|NCT03479541|559831218|FG000|Home Monitoring|Early Termination - PI Decision|0|||
155110486|NCT03479541|559831219|FG001|Home Monitoring|Early Termination - PI Decision|0|||
155110487|NCT03479541|559831220|FG002|Home Monitoring|Early Termination - PI Decision|4|||
155110488|NCT03479541|559831221|FG003|Home Monitoring|Early Termination - PI Decision|6|||
155110489|NCT01271010|559833005|FG000|Overall Study|Reason not specified|11|||
154870242|NCT02531035|558951517|FG001|Overall Study|Randomized, not treated|1|||
154870243|NCT01240811|558951518|FG000|Overall Study|Physician Decision|0|||
155110490|NCT01271010|559833005|FG000|Overall Study|Start of new CLL therapy|1|||
155110491|NCT01271010|559833005|FG000|Overall Study|Protocol Violation|1|||
155110492|NCT01271010|559833005|FG000|Overall Study|Death|2|||
155110493|NCT01271010|559833005|FG000|Overall Study|Progression and relapse of disease|1|||
155110494|NCT01271010|559833005|FG000|Overall Study|Withdrawal by Subject|18|||
155110495|NCT01271010|559833005|FG000|Overall Study|Disease progression|27|||
155110496|NCT01631747|559833006|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
155110497|NCT01631747|559833007|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
155110498|NCT01631747|559833006|FG000|Live Birth|Pregnancy Termination|1|||
155110499|NCT01631747|559833007|FG001|Live Birth|Pregnancy Termination|0|||
155110500|NCT01631747|559833006|FG000|Live Birth|MIscarriage|2|||
155110501|NCT01631747|559833007|FG001|Live Birth|MIscarriage|0|||
155110502|NCT01631747|559833006|FG000|Live Birth|Stillbirth|1|||
155110503|NCT01631747|559833007|FG001|Live Birth|Stillbirth|1|||
155110504|NCT01631747|559833006|FG000|One Year Infant Outcomes|Patient Refused|13|||
155110505|NCT01631747|559833007|FG001|One Year Infant Outcomes|Patient Refused|9|||
155110506|NCT01456195|559833008|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155110507|NCT01456195|559833009|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
155110508|NCT01456195|559833010|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155110509|NCT01456195|559833008|FG000|Overall Study|Lost to Follow-up|3|||
155110510|NCT01456195|559833009|FG001|Overall Study|Lost to Follow-up|1|||
154870244|NCT01240811|558951519|FG001|Overall Study|Physician Decision|1|||
154870245|NCT01240811|558951520|FG002|Overall Study|Physician Decision|0|||
154870246|NCT01240811|558951518|FG000|Overall Study|Withdrawal by Subject|0|||
154870247|NCT01240811|558951519|FG001|Overall Study|Withdrawal by Subject|0|||
154870248|NCT01240811|558951520|FG002|Overall Study|Withdrawal by Subject|1|||
154870249|NCT02400346|558951540|FG000|Overall Study|Adverse Event|24|||
154870250|NCT02400346|558951540|FG000|Overall Study|Lack of Efficacy|9|||
154870251|NCT02400346|558951540|FG000|Overall Study|Non-compliance with IMP|1|||
154870252|NCT02400346|558951540|FG000|Overall Study|Withdrawal by Subject|7|||
154870253|NCT02400346|558951540|FG000|Overall Study|Administrative or other reason(s)|2|||
154870254|NCT02400346|558951540|FG000|Overall Study|Lost to Follow-up|1|||
154870255|NCT02114203|558951541|FG000|Overall Study|Adverse Event|0|||
154870256|NCT02114203|558951542|FG001|Overall Study|Adverse Event|1|||
154870257|NCT02114203|558951543|FG002|Overall Study|Adverse Event|0|||
154870258|NCT02114203|558951541|FG000|Overall Study|Withdrawal by Subject|0|||
154870259|NCT02114203|558951542|FG001|Overall Study|Withdrawal by Subject|1|||
154870260|NCT02114203|558951543|FG002|Overall Study|Withdrawal by Subject|0|||
154870261|NCT01518699|558951544|FG000|Period 2|Protocol Violation|1|||
154870262|NCT01518699|558951545|FG001|Period 2|Protocol Violation|1|||
154870263|NCT01518699|558951546|FG002|Period 2|Protocol Violation|0|||
154870264|NCT01518699|558951547|FG003|Period 2|Protocol Violation|0|||
154870265|NCT01518699|558951548|FG004|Period 2|Protocol Violation|0|||
154870266|NCT01518699|558951549|FG005|Period 2|Protocol Violation|0|||
154870267|NCT01518699|558951544|FG000|Period 2|Lost to Follow-up|0|||
154870268|NCT01518699|558951545|FG001|Period 2|Lost to Follow-up|1|||
154870269|NCT01518699|558951546|FG002|Period 2|Lost to Follow-up|0|||
154870270|NCT01518699|558951547|FG003|Period 2|Lost to Follow-up|0|||
154870271|NCT01518699|558951548|FG004|Period 2|Lost to Follow-up|0|||
154870272|NCT01518699|558951549|FG005|Period 2|Lost to Follow-up|0|||
154870273|NCT01518699|558951544|FG000|Period 2|Adverse Event|1|||
154870274|NCT01518699|558951545|FG001|Period 2|Adverse Event|0|||
154870275|NCT01518699|558951546|FG002|Period 2|Adverse Event|0|||
154870276|NCT01518699|558951547|FG003|Period 2|Adverse Event|0|||
154870277|NCT01518699|558951548|FG004|Period 2|Adverse Event|0|||
154870278|NCT01518699|558951549|FG005|Period 2|Adverse Event|0|||
154870279|NCT00486226|558951554|FG000|Overall Study|Death|3|||
154870280|NCT00486226|558951554|FG000|Overall Study|Adverse Event|1|||
154870281|NCT00486226|558951554|FG000|Overall Study|Withdrawal by Subject|1|||
154870282|NCT00486226|558951554|FG000|Overall Study|Lost to Follow-up|8|||
154870283|NCT01981122|558951556|FG000|Overall Study|Withdrawal by Subject|0|||
154870284|NCT01981122|558951557|FG001|Overall Study|Withdrawal by Subject|2|||
154870285|NCT01981122|558951556|FG000|Overall Study|Protocol Violation|0|||
154870286|NCT01981122|558951557|FG001|Overall Study|Protocol Violation|1|||
155110511|NCT01456195|559833010|FG002|Overall Study|Lost to Follow-up|3|||
155110512|NCT01456195|559833008|FG000|Overall Study|Voluntary Withdrawal|5|||
155110513|NCT01456195|559833009|FG001|Overall Study|Voluntary Withdrawal|3|||
155110514|NCT01456195|559833010|FG002|Overall Study|Voluntary Withdrawal|7|||
155110515|NCT01456195|559833008|FG000|Overall Study|Lack of Efficacy|0|||
155110516|NCT01456195|559833009|FG001|Overall Study|Lack of Efficacy|1|||
155110517|NCT01456195|559833010|FG002|Overall Study|Lack of Efficacy|0|||
155110518|NCT01456195|559833008|FG000|Overall Study|Other Reasons|2|||
154870287|NCT01981122|558951556|FG000|Overall Study|Lost to Follow-up|0|||
154870288|NCT01981122|558951557|FG001|Overall Study|Lost to Follow-up|1|||
154870289|NCT01981122|558951556|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
154870290|NCT01981122|558951557|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
154870291|NCT01981122|558951556|FG000|Overall Study|Death|14|||
154870292|NCT01981122|558951557|FG001|Overall Study|Death|15|||
155110519|NCT01456195|559833009|FG001|Overall Study|Other Reasons|1|||
154870293|NCT00283712|558951559|FG000|Overall Study|Death|0|||
154870294|NCT00283712|558951560|FG001|Overall Study|Death|1|||
154870295|NCT02747043|558951565|FG000|Overall Study|Other|1|||
154870296|NCT02747043|558951566|FG001|Overall Study|Other|1|||
154870297|NCT02747043|558951565|FG000|Overall Study|Adverse Event|3|||
154870298|NCT02747043|558951566|FG001|Overall Study|Adverse Event|1|||
154870299|NCT02747043|558951565|FG000|Overall Study|Withdrawal by Subject|1|||
154870300|NCT02747043|558951566|FG001|Overall Study|Withdrawal by Subject|1|||
154870301|NCT02747043|558951565|FG000|Overall Study|Physician Decision|1|||
154870302|NCT02747043|558951566|FG001|Overall Study|Physician Decision|1|||
154870303|NCT02747043|558951565|FG000|Overall Study|Protocol Violation|0|||
154870304|NCT02747043|558951566|FG001|Overall Study|Protocol Violation|1|||
154870305|NCT02747043|558951565|FG000|Overall Study|Disease progression|4|||
154870306|NCT02747043|558951566|FG001|Overall Study|Disease progression|0|||
154870307|NCT02046564|558951567|FG000|Overall Study|Adverse Event|6|||
154870308|NCT02046564|558951568|FG001|Overall Study|Adverse Event|3|||
154870309|NCT02046564|558951567|FG000|Overall Study|Physician Decision|0|||
154870310|NCT02046564|558951568|FG001|Overall Study|Physician Decision|1|||
154870311|NCT02046564|558951567|FG000|Overall Study|Protocol Violation|3|||
154870312|NCT02046564|558951568|FG001|Overall Study|Protocol Violation|1|||
154870313|NCT02046564|558951567|FG000|Overall Study|Withdrawal by Subject|4|||
154870314|NCT02046564|558951568|FG001|Overall Study|Withdrawal by Subject|10|||
154870315|NCT02046564|558951567|FG000|Overall Study|Subject met withdrawal criteria|2|||
154870316|NCT02046564|558951568|FG001|Overall Study|Subject met withdrawal criteria|5|||
154870317|NCT00553059|558951570|FG000|Overall Study|Deemed ineligible|1|||
154870318|NCT00553059|558951571|FG001|Overall Study|Deemed ineligible|1|||
154870319|NCT00553059|558951570|FG000|Overall Study|Drug supply not available|0|||
154870320|NCT00553059|558951571|FG001|Overall Study|Drug supply not available|1|||
154870321|NCT00670111|558951577|FG000|Enrollment to One Month|Testing Failure|0|||
154870322|NCT00670111|558951578|FG001|Enrollment to One Month|Testing Failure|0|||
154870323|NCT00670111|558951579|FG002|Enrollment to One Month|Testing Failure|13|||
154870324|NCT00670111|558951577|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
154870325|NCT00670111|558951578|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
154870326|NCT00670111|558951579|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
154870327|NCT00670111|558951577|FG000|Enrollment to One Month|Physician Decision|1|||
154870328|NCT00670111|558951578|FG001|Enrollment to One Month|Physician Decision|0|||
154870329|NCT00670111|558951579|FG002|Enrollment to One Month|Physician Decision|0|||
154870330|NCT01749735|558951580|FG000|Overall Study|Withdrawal by Subject|1|||
154870331|NCT01749735|558951581|FG001|Overall Study|Withdrawal by Subject|0|||
154870332|NCT01873742|558951582|FG000|Overall Study|Lost to Follow-up|68|||
154870333|NCT01873742|558951583|FG001|Overall Study|Lost to Follow-up|76|||
154870334|NCT02498821|558951584|FG000|Overall Study|Screen failure|3|||
154870335|NCT02498821|558951585|FG001|Overall Study|Screen failure|5|||
154870336|NCT01457339|558951592|FG000|Period 3 (100 mg)|Adverse Event|0|||
154870337|NCT01457339|558951593|FG001|Period 3 (100 mg)|Adverse Event|1|||
154870338|NCT01457339|558951592|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
154870339|NCT01457339|558951593|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
154870340|NCT01457339|558951592|FG000|Period 6 (250 mg)|Family Emergency|1|||
154870341|NCT01457339|558951593|FG001|Period 6 (250 mg)|Family Emergency|0|||
154870342|NCT01457339|558951592|FG000|Period 6 (250 mg)|Personal appointment|0|||
154870343|NCT01457339|558951593|FG001|Period 6 (250 mg)|Personal appointment|1|||
154870344|NCT01164501|558951595|FG000|Overall Study|Not treated|2|||
154870345|NCT01164501|558951596|FG001|Overall Study|Not treated|0|||
154870346|NCT01164501|558951597|FG002|Overall Study|Not treated|1|||
154870347|NCT01164501|558951595|FG000|Overall Study|Adverse Event|18|||
154870348|NCT01164501|558951596|FG001|Overall Study|Adverse Event|4|||
154870349|NCT01164501|558951597|FG002|Overall Study|Adverse Event|21|||
154870350|NCT01164501|558951595|FG000|Overall Study|Lack of Efficacy|0|||
154870351|NCT01164501|558951596|FG001|Overall Study|Lack of Efficacy|0|||
154870352|NCT01164501|558951597|FG002|Overall Study|Lack of Efficacy|1|||
154870353|NCT01164501|558951595|FG000|Overall Study|Non compliant with protocol|1|||
154870354|NCT01164501|558951596|FG001|Overall Study|Non compliant with protocol|1|||
154870355|NCT01164501|558951597|FG002|Overall Study|Non compliant with protocol|4|||
155110520|NCT01456195|559833010|FG002|Overall Study|Other Reasons|3|||
155110521|NCT02109432|559833011|FG000|Overall Study|Withdrawal by Subject|1|||
155110522|NCT03372551|559833018|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
154870356|NCT01164501|558951595|FG000|Overall Study|Lost to Follow-up|3|||
154870357|NCT01164501|558951596|FG001|Overall Study|Lost to Follow-up|0|||
154870358|NCT01164501|558951597|FG002|Overall Study|Lost to Follow-up|3|||
154870359|NCT01164501|558951595|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
155110523|NCT03372551|559833019|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
154870360|NCT01164501|558951596|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
154870361|NCT01164501|558951597|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
154870362|NCT01164501|558951595|FG000|Overall Study|Other reason not defined above|9|||
154870363|NCT01164501|558951596|FG001|Overall Study|Other reason not defined above|1|||
154870364|NCT01164501|558951597|FG002|Overall Study|Other reason not defined above|4|||
154870365|NCT01845077|558951598|FG000|Washout Period|Lost to Follow-up|0|||
154870366|NCT01845077|558951599|FG001|Washout Period|Lost to Follow-up|1|||
154870367|NCT01845077|558951600|FG002|Washout Period|Lost to Follow-up|0|||
154870368|NCT01845077|558951601|FG003|Washout Period|Lost to Follow-up|1|||
154870369|NCT01845077|558951602|FG004|Washout Period|Lost to Follow-up|0|||
154870370|NCT01845077|558951603|FG005|Washout Period|Lost to Follow-up|1|||
154870371|NCT01845077|558951598|FG000|Washout Period|Adverse Event|1|||
154870372|NCT01845077|558951599|FG001|Washout Period|Adverse Event|0|||
154870373|NCT01845077|558951600|FG002|Washout Period|Adverse Event|0|||
154870374|NCT01845077|558951601|FG003|Washout Period|Adverse Event|0|||
154870375|NCT01845077|558951602|FG004|Washout Period|Adverse Event|0|||
154870376|NCT01845077|558951603|FG005|Washout Period|Adverse Event|0|||
154870377|NCT01845077|558951598|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
154870378|NCT01845077|558951599|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
154870379|NCT01845077|558951600|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
154870380|NCT01845077|558951601|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
154870381|NCT01845077|558951602|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
154870382|NCT01845077|558951603|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
154870383|NCT01845077|558951598|FG000|Washout Period|Protocol Violation|0|||
154870384|NCT01845077|558951599|FG001|Washout Period|Protocol Violation|0|||
154870385|NCT01845077|558951600|FG002|Washout Period|Protocol Violation|0|||
154870386|NCT01845077|558951601|FG003|Washout Period|Protocol Violation|1|||
154870387|NCT01845077|558951602|FG004|Washout Period|Protocol Violation|1|||
154870388|NCT01845077|558951603|FG005|Washout Period|Protocol Violation|0|||
154870389|NCT00312377|558951605|FG000|Overall Study|Death|403|||
154870390|NCT00312377|558951606|FG001|Overall Study|Death|418|||
154870391|NCT00312377|558951605|FG000|Overall Study|Withdrawal by Subject|23|||
154870392|NCT00312377|558951606|FG001|Overall Study|Withdrawal by Subject|30|||
154870393|NCT00312377|558951605|FG000|Overall Study|Lost to Follow-up|9|||
154870394|NCT00312377|558951606|FG001|Overall Study|Lost to Follow-up|12|||
154870395|NCT00312377|558951605|FG000|Overall Study|Non-compliance|0|||
154870396|NCT00312377|558951606|FG001|Overall Study|Non-compliance|2|||
154870397|NCT00312377|558951605|FG000|Overall Study|Randomised but never received treatment|6|||
154870398|NCT00312377|558951606|FG001|Overall Study|Randomised but never received treatment|6|||
154870399|NCT00312377|558951605|FG000|Overall Study|Discontinue treatment survival follow up|202|||
154870400|NCT00312377|558951606|FG001|Overall Study|Discontinue treatment survival follow up|200|||
154870401|NCT00312377|558951605|FG000|Overall Study|Site ended participation in study|1|||
154870402|NCT00312377|558951606|FG001|Overall Study|Site ended participation in study|0|||
154870403|NCT05258058|558951607|FG000|Overall Study|Withdrawal by Subject|2|||
154870404|NCT00408681|558951610|FG000|Overall Study|Lack of Efficacy|2|||
154870405|NCT00408681|558951610|FG000|Overall Study|Adverse Event|7|||
154870406|NCT02209597|558951615|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
154870407|NCT02209597|558951615|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
154870408|NCT02209597|558951615|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
154870409|NCT02209597|558951615|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
154870410|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Adverse Event|37|||
154870411|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Adverse Event|0|||
154870412|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Adverse Event|0|||
154870413|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Adverse Event|0|||
154870414|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Death|2|||
154870415|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Death|0|||
154870416|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Death|0|||
154870417|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Death|0|||
154870418|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
154870419|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
154870420|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
154870421|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
154870422|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
154870423|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
154870424|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
154870425|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
154870426|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
154870427|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
154870428|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
154870429|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
154870430|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
154870431|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
154870432|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
154870433|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
154973723|NCT00177164|559328939|FG000|Overall Study|discharge from hospital|1|||
154870434|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Physician Decision|4|||
154870435|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Physician Decision|0|||
154870436|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Physician Decision|0|||
154870437|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Physician Decision|0|||
154973724|NCT00177164|559328940|FG001|Overall Study|discharge from hospital|0|||
155110524|NCT04683029|559833020|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
155110525|NCT04683029|559833021|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
155110526|NCT04683029|559833022|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
155110527|NCT04683029|559833023|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
155110528|NCT04683029|559833020|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
155110529|NCT04683029|559833021|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
155110530|NCT04683029|559833022|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
155110531|NCT04683029|559833023|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
155110532|NCT04683029|559833020|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
155110533|NCT04683029|559833021|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
155110534|NCT04683029|559833022|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
155110535|NCT04683029|559833023|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
155110536|NCT02920528|559833026|FG000|Overall Study|Incomplete Data|1|||
155110537|NCT02920528|559833027|FG001|Overall Study|Incomplete Data|1|||
155110538|NCT02920528|559833028|FG002|Overall Study|Incomplete Data|1|||
155110539|NCT02920528|559833026|FG000|Overall Study|Adverse Event|0|||
155110540|NCT02920528|559833027|FG001|Overall Study|Adverse Event|0|||
155110541|NCT02920528|559833028|FG002|Overall Study|Adverse Event|3|||
155110542|NCT02920528|559833026|FG000|Overall Study|Did not meet inclusion criteria|2|||
155110543|NCT02920528|559833027|FG001|Overall Study|Did not meet inclusion criteria|0|||
155110544|NCT02920528|559833028|FG002|Overall Study|Did not meet inclusion criteria|1|||
155110545|NCT00066703|559833029|FG000|Overall Study|Adverse Event|80|||
155110546|NCT00066703|559833030|FG001|Overall Study|Adverse Event|111|||
155110547|NCT00066703|559833029|FG000|Overall Study|Death|3|||
155110548|NCT00066703|559833030|FG001|Overall Study|Death|0|||
155110549|NCT00066703|559833029|FG000|Overall Study|Lack of Efficacy|114|||
155110550|NCT00066703|559833030|FG001|Overall Study|Lack of Efficacy|69|||
155110551|NCT00066703|559833029|FG000|Overall Study|Lost to Follow-up|31|||
155110552|NCT00066703|559833030|FG001|Overall Study|Lost to Follow-up|28|||
155110553|NCT00066703|559833029|FG000|Overall Study|Withdrawal by Subject|38|||
155110554|NCT00066703|559833030|FG001|Overall Study|Withdrawal by Subject|63|||
155110555|NCT00066703|559833029|FG000|Overall Study|Treatment ongoing|346|||
155110556|NCT00066703|559833030|FG001|Overall Study|Treatment ongoing|311|||
155110557|NCT05924165|559833033|FG000|Overall Study|Physician Decision|2|||
155110558|NCT05924165|559833034|FG001|Overall Study|Physician Decision|3|||
155110559|NCT01681186|559833035|FG000|Washout Period From Second Intervention|Adverse Event|0|||
155110560|NCT01681186|559833036|FG001|Washout Period From Second Intervention|Adverse Event|0|||
155110561|NCT01681186|559833037|FG002|Washout Period From Second Intervention|Adverse Event|0|||
155110562|NCT01681186|559833038|FG003|Washout Period From Second Intervention|Adverse Event|0|||
155110563|NCT01681186|559833039|FG004|Washout Period From Second Intervention|Adverse Event|0|||
155110564|NCT01681186|559833040|FG005|Washout Period From Second Intervention|Adverse Event|0|||
155110565|NCT01681186|559833041|FG006|Washout Period From Second Intervention|Adverse Event|1|||
155110566|NCT01681186|559833042|FG007|Washout Period From Second Intervention|Adverse Event|0|||
154870438|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Pregnancy|1|||
154870439|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Pregnancy|0|||
154870440|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Pregnancy|0|||
154870441|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Pregnancy|0|||
154870442|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
154870443|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
154870444|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
154870445|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
154870446|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
154870447|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
154870448|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
154870449|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
154870450|NCT01855789|558951617|FG000|1) Baseline up to Week 24|Other|4|||
154870451|NCT01855789|558951618|FG001|1) Baseline up to Week 24|Other|0|||
154870452|NCT01855789|558951619|FG002|1) Baseline up to Week 24|Other|0|||
154870453|NCT01855789|558951620|FG003|1) Baseline up to Week 24|Other|0|||
154870454|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
154870455|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
154870456|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
154870457|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
154870458|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
154870459|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
154870460|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
154870461|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
154870462|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
155110567|NCT01681186|559833035|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
155110568|NCT01681186|559833036|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
154870463|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
154870464|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
154870465|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
154870466|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
154870467|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
154870468|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
154870469|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
154870470|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
154870471|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
154870472|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
154870473|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
154870474|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
154870475|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
154870476|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
154870477|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
154870478|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
154870479|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
154870480|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
154870481|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
154870482|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
154870483|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
154870484|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
154870485|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
154870486|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
154870487|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
154870488|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
154870489|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
154870490|NCT01855789|558951617|FG000|2) Week 24 up to End of Study|Other|0|||
154870491|NCT01855789|558951618|FG001|2) Week 24 up to End of Study|Other|0|||
154870492|NCT01855789|558951619|FG002|2) Week 24 up to End of Study|Other|0|||
154870493|NCT01855789|558951620|FG003|2) Week 24 up to End of Study|Other|1|||
154870494|NCT02050048|558951621|FG000|Overall Study|Lost to Follow-up|0|||
154870495|NCT02050048|558951622|FG001|Overall Study|Lost to Follow-up|1|||
154870496|NCT02050048|558951621|FG000|Overall Study|Death|1|||
154870497|NCT02050048|558951622|FG001|Overall Study|Death|0|||
154870498|NCT02050048|558951621|FG000|Overall Study|Ineligible after ERCP|4|||
154870499|NCT02050048|558951622|FG001|Overall Study|Ineligible after ERCP|1|||
154870500|NCT02903511|558951628|FG000|Overall Study|Withdrawal by Subject|1|||
154870501|NCT02903511|558951629|FG001|Overall Study|Withdrawal by Subject|0|||
154870502|NCT02903511|558951628|FG000|Overall Study|Lost to Follow-up|3|||
154870503|NCT02903511|558951629|FG001|Overall Study|Lost to Follow-up|2|||
154870504|NCT02699515|558953492|FG000|Overall Study|Death|3|||
154870505|NCT02699515|558953493|FG001|Overall Study|Death|3|||
154870506|NCT02699515|558953494|FG002|Overall Study|Death|3|||
154870507|NCT02699515|558953495|FG003|Overall Study|Death|23|||
154870508|NCT02699515|558953496|FG004|Overall Study|Death|22|||
154870509|NCT02699515|558953497|FG005|Overall Study|Death|23|||
154870510|NCT02699515|558953498|FG006|Overall Study|Death|3|||
154870511|NCT02699515|558953499|FG007|Overall Study|Death|5|||
154870512|NCT02699515|558953492|FG000|Overall Study|Withdrawal by Subject|0|||
154870513|NCT02699515|558953493|FG001|Overall Study|Withdrawal by Subject|0|||
154870514|NCT02699515|558953494|FG002|Overall Study|Withdrawal by Subject|3|||
154870515|NCT02699515|558953495|FG003|Overall Study|Withdrawal by Subject|1|||
154870516|NCT02699515|558953496|FG004|Overall Study|Withdrawal by Subject|5|||
154870517|NCT02699515|558953497|FG005|Overall Study|Withdrawal by Subject|3|||
154870518|NCT02699515|558953498|FG006|Overall Study|Withdrawal by Subject|0|||
154870519|NCT02699515|558953499|FG007|Overall Study|Withdrawal by Subject|1|||
154870520|NCT02699515|558953492|FG000|Overall Study|Other|1|||
154870521|NCT02699515|558953493|FG001|Overall Study|Other|0|||
154870522|NCT02699515|558953494|FG002|Overall Study|Other|1|||
154870523|NCT02699515|558953495|FG003|Overall Study|Other|6|||
154870524|NCT02699515|558953496|FG004|Overall Study|Other|4|||
155110569|NCT01681186|559833037|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
154870525|NCT02699515|558953497|FG005|Overall Study|Other|3|||
154870526|NCT02699515|558953498|FG006|Overall Study|Other|0|||
154870527|NCT02699515|558953499|FG007|Overall Study|Other|0|||
154870528|NCT05243550|558953500|FG000|Overall Study|Ongoing in the Study|171|||
154870529|NCT05243550|558953500|FG000|Overall Study|Withdrawal by Subject|10|||
155110570|NCT01681186|559833038|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
154870530|NCT05243550|558953500|FG000|Overall Study|Lost to Follow-up|7|||
154870531|NCT05243550|558953500|FG000|Overall Study|Adverse Event|3|||
154870532|NCT05243550|558953500|FG000|Overall Study|Noncompliance|1|||
154870533|NCT05243550|558953500|FG000|Overall Study|Physician Decision|1|||
154870534|NCT05243550|558953500|FG000|Overall Study|Other Reason|4|||
154870535|NCT00375934|558953509|FG000|Overall Study|Adverse Event|1|||
154870536|NCT00375934|558953510|FG001|Overall Study|Adverse Event|1|||
154870537|NCT00375934|558953509|FG000|Overall Study|Withdrawal by Subject|2|||
155175010|NCT00065429|560078332|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155175011|NCT00065429|560078333|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155175012|NCT00065429|560078334|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
155175013|NCT00065429|560078335|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
155175014|NCT00065429|560078329|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155175015|NCT00065429|560078330|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155175016|NCT00065429|560078331|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
155175017|NCT00065429|560078332|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155175018|NCT00065429|560078333|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155175019|NCT00065429|560078334|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155175020|NCT00065429|560078335|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
155175021|NCT00065429|560078329|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
155175022|NCT00065429|560078330|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155175023|NCT00065429|560078331|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155175024|NCT00065429|560078332|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155175025|NCT00065429|560078333|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155175026|NCT00065429|560078334|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155175027|NCT00065429|560078335|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
155175028|NCT00065429|560078329|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
155175029|NCT00065429|560078330|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
155175030|NCT00065429|560078331|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
155175031|NCT00065429|560078332|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
155175032|NCT00065429|560078333|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
155175033|NCT00065429|560078334|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
155175034|NCT00065429|560078335|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
155175035|NCT00065429|560078329|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155175036|NCT00065429|560078330|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155175037|NCT00065429|560078331|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155175038|NCT00065429|560078332|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
155175039|NCT00065429|560078333|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
155175040|NCT00065429|560078334|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
155175041|NCT00065429|560078335|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
155175042|NCT00065429|560078329|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155175043|NCT00065429|560078330|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155175044|NCT00065429|560078331|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155175045|NCT00065429|560078332|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155175046|NCT00065429|560078333|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
155175047|NCT00065429|560078334|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155175048|NCT00065429|560078335|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
155175049|NCT00065429|560078329|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155175050|NCT00065429|560078330|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155175051|NCT00065429|560078331|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155175052|NCT00065429|560078332|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155175053|NCT00065429|560078333|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
155175054|NCT00065429|560078334|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155175055|NCT00065429|560078335|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
155175056|NCT00441116|560078338|FG000|Overall Study|Adverse Event|1|||
155175057|NCT00441116|560078339|FG001|Overall Study|Adverse Event|1|||
155175058|NCT00441116|560078338|FG000|Overall Study|Withdrawal by Subject|1|||
155175059|NCT00441116|560078339|FG001|Overall Study|Withdrawal by Subject|0|||
155175060|NCT00441116|560078338|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
155175061|NCT00441116|560078339|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
155175062|NCT00636363|560078340|FG000|Overall Study|Conjunctivitis|0|||
155175063|NCT00636363|560078341|FG001|Overall Study|Conjunctivitis|0|||
155175064|NCT00636363|560078342|FG002|Overall Study|Conjunctivitis|1|||
155175065|NCT00636363|560078340|FG000|Overall Study|Adverse Event|0|||
155175066|NCT00636363|560078341|FG001|Overall Study|Adverse Event|0|||
155175067|NCT00636363|560078342|FG002|Overall Study|Adverse Event|1|||
155175068|NCT00636363|560078340|FG000|Overall Study|Positive slit lamp finding|0|||
155175069|NCT00636363|560078341|FG001|Overall Study|Positive slit lamp finding|2|||
155175070|NCT00636363|560078342|FG002|Overall Study|Positive slit lamp finding|1|||
155175071|NCT00636363|560078340|FG000|Overall Study|Study related symptoms/complaints|8|||
155175072|NCT00636363|560078341|FG001|Overall Study|Study related symptoms/complaints|7|||
155175073|NCT00636363|560078342|FG002|Overall Study|Study related symptoms/complaints|4|||
155175074|NCT00636363|560078340|FG000|Overall Study|Met ineligibility criteria|0|||
155175075|NCT00636363|560078341|FG001|Overall Study|Met ineligibility criteria|0|||
155175076|NCT00636363|560078342|FG002|Overall Study|Met ineligibility criteria|3|||
155175077|NCT00636363|560078340|FG000|Overall Study|Missed > 1 visit|0|||
155175078|NCT00636363|560078341|FG001|Overall Study|Missed > 1 visit|1|||
155175079|NCT00636363|560078342|FG002|Overall Study|Missed > 1 visit|3|||
155175080|NCT00636363|560078340|FG000|Overall Study|Lack of motivation|1|||
154973725|NCT00177164|559328939|FG000|Overall Study|Lack of Efficacy|2|||
154870538|NCT00375934|558953510|FG001|Overall Study|Withdrawal by Subject|2|||
154870539|NCT00375934|558953509|FG000|Overall Study|Lack of Efficacy|0|||
154870540|NCT00375934|558953510|FG001|Overall Study|Lack of Efficacy|2|||
154870541|NCT00375934|558953509|FG000|Overall Study|Physician Decision|0|||
154870542|NCT00375934|558953510|FG001|Overall Study|Physician Decision|1|||
154870543|NCT00500149|558953521|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
154870544|NCT00500149|558953522|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
154870545|NCT00500149|558953521|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
154870546|NCT00500149|558953522|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
154870547|NCT00500149|558953521|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
154870548|NCT00500149|558953522|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
154870549|NCT00500149|558953521|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
154870550|NCT00500149|558953522|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
154870551|NCT00500149|558953521|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
154870552|NCT00500149|558953522|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
154870553|NCT00500149|558953521|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
154870554|NCT00500149|558953522|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
154870555|NCT00500149|558953521|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
154870556|NCT00500149|558953522|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
154870557|NCT00521339|558953525|FG000|Treatment Phase|Adverse Event|2|||
154870558|NCT00521339|558953526|FG001|Treatment Phase|Adverse Event|0|||
154870559|NCT00521339|558953527|FG002|Treatment Phase|Adverse Event|0|||
154870560|NCT00521339|558953525|FG000|Treatment Phase|Intolerability to study drug|2|||
154870561|NCT00521339|558953526|FG001|Treatment Phase|Intolerability to study drug|0|||
154870562|NCT00521339|558953527|FG002|Treatment Phase|Intolerability to study drug|0|||
154870563|NCT00521339|558953525|FG000|Treatment Phase|Lack of Efficacy|3|||
154870564|NCT00521339|558953526|FG001|Treatment Phase|Lack of Efficacy|0|||
154870565|NCT00521339|558953527|FG002|Treatment Phase|Lack of Efficacy|0|||
154870566|NCT00521339|558953525|FG000|Treatment Phase|Withdrawal by Subject|3|||
154870567|NCT00521339|558953526|FG001|Treatment Phase|Withdrawal by Subject|0|||
154870568|NCT00521339|558953527|FG002|Treatment Phase|Withdrawal by Subject|0|||
154870569|NCT00521339|558953525|FG000|Treatment Phase|Lost to Follow-up|1|||
154870570|NCT00521339|558953526|FG001|Treatment Phase|Lost to Follow-up|0|||
154870571|NCT00521339|558953527|FG002|Treatment Phase|Lost to Follow-up|0|||
154870572|NCT00521339|558953525|FG000|Treatment Phase|Protocol Violation|1|||
154870573|NCT00521339|558953526|FG001|Treatment Phase|Protocol Violation|0|||
154870574|NCT00521339|558953527|FG002|Treatment Phase|Protocol Violation|0|||
154870575|NCT00521339|558953525|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
154870576|NCT00521339|558953526|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
154870577|NCT00521339|558953527|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
154870578|NCT00521339|558953525|FG000|Treatment Extension Phase|Death|0|||
154870579|NCT00521339|558953526|FG001|Treatment Extension Phase|Death|0|||
154870580|NCT00521339|558953527|FG002|Treatment Extension Phase|Death|1|||
154870581|NCT01988012|558953528|FG000|Overall Study|Adverse Event|5|||
154870582|NCT01988012|558953528|FG000|Overall Study|Insufficient Therapeutic Response|3|||
154870583|NCT01988012|558953528|FG000|Overall Study|Patient Withdrawal of Consent|4|||
154870584|NCT01988012|558953528|FG000|Overall Study|Lost to Follow-up|1|||
154870585|NCT01988012|558953528|FG000|Overall Study|Physician Decision|1|||
154870586|NCT01988012|558953528|FG000|Overall Study|Protocol Violation|1|||
154870587|NCT01058369|558953529|FG000|Overall Study|Adverse Event|1|||
154870588|NCT01058369|558953529|FG000|Overall Study|Early termination study|1|||
154870589|NCT03314519|558953530|FG000|Overall Study|Protocol Violation|3|||
154870590|NCT03314519|558953531|FG001|Overall Study|Protocol Violation|2|||
154870591|NCT01157169|558953534|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
154870592|NCT01157169|558953535|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
154870593|NCT01157169|558953534|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
154870594|NCT01157169|558953535|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
154870595|NCT00663858|558953538|FG000|Overall Study|Adverse Event|9|||
154870596|NCT00663858|558953539|FG001|Overall Study|Adverse Event|1|||
154870597|NCT00663858|558953540|FG002|Overall Study|Adverse Event|6|||
154870598|NCT00663858|558953538|FG000|Overall Study|Lack of Efficacy|5|||
154870599|NCT00663858|558953539|FG001|Overall Study|Lack of Efficacy|1|||
154870600|NCT00663858|558953540|FG002|Overall Study|Lack of Efficacy|3|||
154870601|NCT00663858|558953538|FG000|Overall Study|Withdrawal by Subject|7|||
154870602|NCT00663858|558953539|FG001|Overall Study|Withdrawal by Subject|3|||
154870603|NCT00663858|558953540|FG002|Overall Study|Withdrawal by Subject|3|||
154870604|NCT00663858|558953538|FG000|Overall Study|Protocol Violation|5|||
154870605|NCT00663858|558953539|FG001|Overall Study|Protocol Violation|3|||
154870606|NCT00663858|558953540|FG002|Overall Study|Protocol Violation|4|||
154870607|NCT00663858|558953538|FG000|Overall Study|Other|8|||
154870608|NCT00663858|558953539|FG001|Overall Study|Other|2|||
154870609|NCT00663858|558953540|FG002|Overall Study|Other|4|||
154870610|NCT02940886|558953541|FG000|Overall Study|Adverse Event|7|||
154870611|NCT02940886|558953542|FG001|Overall Study|Adverse Event|3|||
154870612|NCT02940886|558953541|FG000|Overall Study|Protocol Violation|0|||
154870613|NCT02940886|558953542|FG001|Overall Study|Protocol Violation|2|||
154870614|NCT02940886|558953541|FG000|Overall Study|Withdrawal by Subject|28|||
154870615|NCT02940886|558953542|FG001|Overall Study|Withdrawal by Subject|20|||
154870616|NCT02940886|558953541|FG000|Overall Study|Death|1|||
154870617|NCT02940886|558953542|FG001|Overall Study|Death|0|||
154870618|NCT02940886|558953541|FG000|Overall Study|Lack of Efficacy|1|||
154870619|NCT02940886|558953542|FG001|Overall Study|Lack of Efficacy|0|||
154870620|NCT02940886|558953541|FG000|Overall Study|Lost to Follow-up|49|||
154870621|NCT02940886|558953542|FG001|Overall Study|Lost to Follow-up|21|||
154870622|NCT02940886|558953541|FG000|Overall Study|Physician Decision|9|||
154870623|NCT02940886|558953542|FG001|Overall Study|Physician Decision|4|||
154870624|NCT02940886|558953541|FG000|Overall Study|Sponsor decision|0|||
154870625|NCT02940886|558953542|FG001|Overall Study|Sponsor decision|1|||
154870626|NCT02940886|558953541|FG000|Overall Study|No treatment|7|||
154870627|NCT02940886|558953542|FG001|Overall Study|No treatment|2|||
154870628|NCT02940886|558953541|FG000|Overall Study|Enrolment error|0|||
154870629|NCT02940886|558953542|FG001|Overall Study|Enrolment error|1|||
154870630|NCT03042611|558953543|FG000|Core Phase|Withdrawal by Subject|13|||
154870631|NCT03042611|558953544|FG001|Core Phase|Withdrawal by Subject|4|||
154870632|NCT03042611|558953545|FG002|Core Phase|Withdrawal by Subject|0|||
154870633|NCT03042611|558953546|FG003|Core Phase|Withdrawal by Subject|0|||
154870634|NCT03042611|558953543|FG000|Core Phase|Death|232|||
154870635|NCT03042611|558953544|FG001|Core Phase|Death|110|||
154870636|NCT03042611|558953545|FG002|Core Phase|Death|0|||
154870637|NCT03042611|558953546|FG003|Core Phase|Death|0|||
154870638|NCT03042611|558953543|FG000|Core Phase|Lost to Follow-up|4|||
154870639|NCT03042611|558953544|FG001|Core Phase|Lost to Follow-up|7|||
154870640|NCT03042611|558953545|FG002|Core Phase|Lost to Follow-up|0|||
154870641|NCT03042611|558953546|FG003|Core Phase|Lost to Follow-up|0|||
154870642|NCT03042611|558953543|FG000|Core Phase|Physician Decision|7|||
154870643|NCT03042611|558953544|FG001|Core Phase|Physician Decision|2|||
154870644|NCT03042611|558953545|FG002|Core Phase|Physician Decision|0|||
154870645|NCT03042611|558953546|FG003|Core Phase|Physician Decision|0|||
154870646|NCT03042611|558953543|FG000|Core Phase|Study Closed|0|||
154870647|NCT03042611|558953544|FG001|Core Phase|Study Closed|1|||
154870648|NCT03042611|558953545|FG002|Core Phase|Study Closed|0|||
154870649|NCT03042611|558953546|FG003|Core Phase|Study Closed|0|||
154870650|NCT03042611|558953543|FG000|Extension Phase|Death|0|||
154870651|NCT03042611|558953544|FG001|Extension Phase|Death|0|||
154870652|NCT03042611|558953545|FG002|Extension Phase|Death|34|||
154870653|NCT03042611|558953546|FG003|Extension Phase|Death|16|||
154870654|NCT03042611|558953543|FG000|Extension Phase|Lost to Follow-up|0|||
154870655|NCT03042611|558953544|FG001|Extension Phase|Lost to Follow-up|0|||
154870656|NCT03042611|558953545|FG002|Extension Phase|Lost to Follow-up|1|||
154870657|NCT03042611|558953546|FG003|Extension Phase|Lost to Follow-up|1|||
154870658|NCT03042611|558953543|FG000|Extension Phase|Study Closed|0|||
154870659|NCT03042611|558953544|FG001|Extension Phase|Study Closed|0|||
154870660|NCT03042611|558953545|FG002|Extension Phase|Study Closed|17|||
154870661|NCT03042611|558953546|FG003|Extension Phase|Study Closed|11|||
154870662|NCT01277289|558953548|FG000|Overall Study|fragile vein|1|||
154870663|NCT01277289|558953549|FG001|Overall Study|fragile vein|0|||
154870664|NCT01277289|558953548|FG000|Overall Study|Physician Decision|1|||
154870665|NCT01277289|558953549|FG001|Overall Study|Physician Decision|0|||
154870666|NCT01277289|558953548|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
154870667|NCT01277289|558953549|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
154870668|NCT01277289|558953548|FG000|Overall Study|Protocol Violation|1|||
154870669|NCT01277289|558953549|FG001|Overall Study|Protocol Violation|1|||
154870670|NCT01277289|558953548|FG000|Overall Study|Adverse Event|2|||
154870671|NCT01277289|558953549|FG001|Overall Study|Adverse Event|1|||
154870672|NCT01277289|558953548|FG000|Overall Study|consent withdrawn|1|||
154870673|NCT01277289|558953549|FG001|Overall Study|consent withdrawn|1|||
154870674|NCT01277289|558953548|FG000|Overall Study|premature closure of the study|4|||
154870675|NCT01277289|558953549|FG001|Overall Study|premature closure of the study|2|||
154870676|NCT00084682|558953554|FG000|Overall Study|Withdrawal by Subject|1|||
154870677|NCT00474630|558953559|FG000|Overall Study|Adverse Event|98|||
154870678|NCT00474630|558953560|FG001|Overall Study|Adverse Event|26|||
154870679|NCT00474630|558953559|FG000|Overall Study|Lost to Follow-up|22|||
154973726|NCT00177164|559328940|FG001|Overall Study|Lack of Efficacy|1|||
154870680|NCT00474630|558953560|FG001|Overall Study|Lost to Follow-up|15|||
154870681|NCT00474630|558953559|FG000|Overall Study|Withdrawal by Subject|21|||
154870682|NCT00474630|558953560|FG001|Overall Study|Withdrawal by Subject|15|||
154973727|NCT00177164|559328939|FG000|Overall Study|Pregnancy|0|||
154870683|NCT00474630|558953559|FG000|Overall Study|Protocol Violation|3|||
154870684|NCT00474630|558953560|FG001|Overall Study|Protocol Violation|4|||
154870685|NCT00474630|558953559|FG000|Overall Study|Lack of Efficacy|5|||
154870686|NCT00474630|558953560|FG001|Overall Study|Lack of Efficacy|6|||
154870687|NCT00474630|558953559|FG000|Overall Study|Drug noncompliance, other|11|||
154870688|NCT00474630|558953560|FG001|Overall Study|Drug noncompliance, other|4|||
154870689|NCT03088605|558953561|FG000|Overall Study|Withdrawal by Subject|1|||
154870690|NCT03088605|558953562|FG001|Overall Study|Withdrawal by Subject|0|||
154870691|NCT03666143|558953567|FG000|Overall Study|Death|158|||
155110571|NCT01681186|559833039|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
155110572|NCT01681186|559833040|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
155110573|NCT01681186|559833041|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
155110574|NCT01681186|559833042|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
155110575|NCT01681186|559833035|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110576|NCT01681186|559833036|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110577|NCT01681186|559833037|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110578|NCT01681186|559833038|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110579|NCT01681186|559833039|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110580|NCT01681186|559833040|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110581|NCT01681186|559833041|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
155110582|NCT01681186|559833042|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
155110583|NCT01681186|559833035|FG000|Fourth Intervention|Protocol Violation|0|||
155110584|NCT01681186|559833036|FG001|Fourth Intervention|Protocol Violation|0|||
155110585|NCT01681186|559833037|FG002|Fourth Intervention|Protocol Violation|0|||
155110586|NCT01681186|559833038|FG003|Fourth Intervention|Protocol Violation|0|||
155110587|NCT01681186|559833039|FG004|Fourth Intervention|Protocol Violation|0|||
155110588|NCT01681186|559833040|FG005|Fourth Intervention|Protocol Violation|0|||
155110589|NCT01681186|559833041|FG006|Fourth Intervention|Protocol Violation|0|||
155110590|NCT01681186|559833042|FG007|Fourth Intervention|Protocol Violation|1|||
155110591|NCT03530995|559833043|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
155110592|NCT03530995|559833044|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
155110593|NCT03530995|559833043|FG000|Part 1 Period 3|Protocol Violation|1|||
155110594|NCT03530995|559833044|FG001|Part 1 Period 3|Protocol Violation|0|||
155110595|NCT03530995|559833043|FG000|Part 1 Period 4|Physician Decision|1|||
155110596|NCT03530995|559833044|FG001|Part 1 Period 4|Physician Decision|0|||
155110597|NCT03530995|559833043|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
155110598|NCT03530995|559833044|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
155110599|NCT04848220|559833046|FG000|Overall Study|Unable to proceed to study procedure|0|||
155110600|NCT04848220|559833047|FG001|Overall Study|Unable to proceed to study procedure|1|||
155110601|NCT04848220|559833048|FG002|Overall Study|Unable to proceed to study procedure|0|||
155110602|NCT04848220|559833046|FG000|Overall Study|Fractional flow not significant|0|||
155110603|NCT04848220|559833047|FG001|Overall Study|Fractional flow not significant|1|||
154870692|NCT03666143|558953567|FG000|Overall Study|Sponsor Decision|31|||
154870693|NCT03666143|558953567|FG000|Overall Study|Withdrawal by Subject|11|||
154870694|NCT03666143|558953567|FG000|Overall Study|Lost to Follow-up|5|||
154870695|NCT03666143|558953567|FG000|Overall Study|Physician Decision|1|||
154870696|NCT03666143|558953567|FG000|Overall Study|Rolled into extension study|9|||
154870697|NCT03666143|558953567|FG000|Overall Study|Progressive Disease|1|||
154870698|NCT01103349|558953568|FG000|Overall Study|Adverse Event|8|||
154870699|NCT01103349|558953569|FG001|Overall Study|Adverse Event|5|||
154870700|NCT01103349|558953570|FG002|Overall Study|Adverse Event|3|||
154870701|NCT01103349|558953568|FG000|Overall Study|Consent withdrawn|1|||
154870702|NCT01103349|558953569|FG001|Overall Study|Consent withdrawn|0|||
154870703|NCT01103349|558953570|FG002|Overall Study|Consent withdrawn|0|||
154870704|NCT01103349|558953568|FG000|Overall Study|Incorrectly included in the trial|1|||
154870705|NCT01103349|558953569|FG001|Overall Study|Incorrectly included in the trial|0|||
154870706|NCT01103349|558953570|FG002|Overall Study|Incorrectly included in the trial|0|||
154870707|NCT01103349|558953568|FG000|Overall Study|Withdrawal by Subject|1|||
154870708|NCT01103349|558953569|FG001|Overall Study|Withdrawal by Subject|1|||
154870709|NCT01103349|558953570|FG002|Overall Study|Withdrawal by Subject|0|||
154870710|NCT01103349|558953568|FG000|Overall Study|did not want to take trial medication|0|||
154870711|NCT01103349|558953569|FG001|Overall Study|did not want to take trial medication|1|||
154870712|NCT01103349|558953570|FG002|Overall Study|did not want to take trial medication|0|||
154870713|NCT01103349|558953568|FG000|Overall Study|forgot to take medication|0|||
154870714|NCT01103349|558953569|FG001|Overall Study|forgot to take medication|0|||
154870715|NCT01103349|558953570|FG002|Overall Study|forgot to take medication|1|||
154870716|NCT02397655|558953572|FG000|Overall Study|data not completed|1301|||
154870717|NCT01736683|558953573|FG000|Overall Study|Disease Relapse|0|||
154870718|NCT01736683|558953574|FG001|Overall Study|Disease Relapse|0|||
154870719|NCT01736683|558953575|FG002|Overall Study|Disease Relapse|2|||
154870720|NCT01736683|558953576|FG003|Overall Study|Disease Relapse|1|||
154973728|NCT00177164|559328940|FG001|Overall Study|Pregnancy|1|||
154973729|NCT00965757|559328943|FG000|Double-blind Phase|Progression of concomitant disease|1|||
155110604|NCT04848220|559833048|FG002|Overall Study|Fractional flow not significant|0|||
155110605|NCT01986231|559833049|FG000|Overall Study|Adverse Event|1|||
154870721|NCT01736683|558953577|FG004|Overall Study|Disease Relapse|0|||
154870722|NCT01736683|558953573|FG000|Overall Study|Adverse Event|0|||
154870723|NCT01736683|558953574|FG001|Overall Study|Adverse Event|2|||
154870724|NCT01736683|558953575|FG002|Overall Study|Adverse Event|2|||
154870725|NCT01736683|558953576|FG003|Overall Study|Adverse Event|3|||
154870726|NCT01736683|558953577|FG004|Overall Study|Adverse Event|2|||
154870727|NCT01736683|558953573|FG000|Overall Study|Withdrawal by Subject|0|||
154870728|NCT01736683|558953574|FG001|Overall Study|Withdrawal by Subject|0|||
154870729|NCT01736683|558953575|FG002|Overall Study|Withdrawal by Subject|3|||
154870730|NCT01736683|558953576|FG003|Overall Study|Withdrawal by Subject|1|||
154870731|NCT01736683|558953577|FG004|Overall Study|Withdrawal by Subject|1|||
154870732|NCT01736683|558953573|FG000|Overall Study|Lack of Therapeutic Effect|7|||
154870733|NCT01736683|558953574|FG001|Overall Study|Lack of Therapeutic Effect|4|||
154870734|NCT01736683|558953575|FG002|Overall Study|Lack of Therapeutic Effect|13|||
154870735|NCT01736683|558953576|FG003|Overall Study|Lack of Therapeutic Effect|20|||
154870736|NCT01736683|558953577|FG004|Overall Study|Lack of Therapeutic Effect|1|||
154870737|NCT01736683|558953573|FG000|Overall Study|Progressive Disease|0|||
154870738|NCT01736683|558953574|FG001|Overall Study|Progressive Disease|0|||
154870739|NCT01736683|558953575|FG002|Overall Study|Progressive Disease|0|||
154870740|NCT01736683|558953576|FG003|Overall Study|Progressive Disease|1|||
154870741|NCT01736683|558953577|FG004|Overall Study|Progressive Disease|0|||
154870742|NCT01736683|558953573|FG000|Overall Study|Other|0|||
154870743|NCT01736683|558953574|FG001|Overall Study|Other|0|||
154870744|NCT01736683|558953575|FG002|Overall Study|Other|1|||
154870745|NCT01736683|558953576|FG003|Overall Study|Other|9|||
154870746|NCT01736683|558953577|FG004|Overall Study|Other|1|||
154870747|NCT01966731|558953584|FG000|Overall Study|Death|2|||
154870748|NCT01966731|558953584|FG000|Overall Study|Lost to Follow-up|1|||
154870749|NCT01966731|558953584|FG000|Overall Study|Physician Decision|2|||
154870750|NCT01966731|558953584|FG000|Overall Study|Follow up is not complete|600|||
154870751|NCT01966731|558953584|FG000|Overall Study|Screening Failure|29|||
154870752|NCT01966731|558953584|FG000|Overall Study|Found to be ineligible|1|||
154870753|NCT03952650|558953585|FG000|Overall Study|TRAVEL|0|||
154870754|NCT03952650|558953586|FG001|Overall Study|TRAVEL|4|||
154870755|NCT03952650|558953587|FG002|Overall Study|TRAVEL|0|||
154870756|NCT03952650|558953588|FG003|Overall Study|TRAVEL|4|||
154870757|NCT03952650|558953589|FG004|Overall Study|TRAVEL|0|||
154870758|NCT03952650|558953590|FG005|Overall Study|TRAVEL|3|||
154870759|NCT03952650|558953591|FG006|Overall Study|TRAVEL|2|||
154870760|NCT03952650|558953585|FG000|Overall Study|Withdrawal by Subject|0|||
154870761|NCT03952650|558953586|FG001|Overall Study|Withdrawal by Subject|2|||
154870762|NCT03952650|558953587|FG002|Overall Study|Withdrawal by Subject|0|||
154870763|NCT03952650|558953588|FG003|Overall Study|Withdrawal by Subject|3|||
154870764|NCT03952650|558953589|FG004|Overall Study|Withdrawal by Subject|0|||
154870765|NCT03952650|558953590|FG005|Overall Study|Withdrawal by Subject|1|||
154870766|NCT03952650|558953591|FG006|Overall Study|Withdrawal by Subject|1|||
154870767|NCT03952650|558953585|FG000|Overall Study|Lost to Follow-up|0|||
154870768|NCT03952650|558953586|FG001|Overall Study|Lost to Follow-up|1|||
154870769|NCT03952650|558953587|FG002|Overall Study|Lost to Follow-up|0|||
154870770|NCT03952650|558953588|FG003|Overall Study|Lost to Follow-up|0|||
154870771|NCT03952650|558953589|FG004|Overall Study|Lost to Follow-up|0|||
154870772|NCT03952650|558953590|FG005|Overall Study|Lost to Follow-up|1|||
154870773|NCT03952650|558953591|FG006|Overall Study|Lost to Follow-up|1|||
154870774|NCT03952650|558953585|FG000|Overall Study|Received wrong vaccine and travelled|0|||
154870775|NCT03952650|558953586|FG001|Overall Study|Received wrong vaccine and travelled|0|||
154870776|NCT03952650|558953587|FG002|Overall Study|Received wrong vaccine and travelled|0|||
154870777|NCT03952650|558953588|FG003|Overall Study|Received wrong vaccine and travelled|0|||
154870778|NCT03952650|558953589|FG004|Overall Study|Received wrong vaccine and travelled|0|||
154870779|NCT03952650|558953590|FG005|Overall Study|Received wrong vaccine and travelled|1|||
154870780|NCT03952650|558953591|FG006|Overall Study|Received wrong vaccine and travelled|0|||
154870781|NCT03952650|558953585|FG000|Overall Study|Unable to make study visit|0|||
154870782|NCT03952650|558953586|FG001|Overall Study|Unable to make study visit|0|||
154870783|NCT03952650|558953587|FG002|Overall Study|Unable to make study visit|0|||
154870784|NCT03952650|558953588|FG003|Overall Study|Unable to make study visit|0|||
154870785|NCT03952650|558953589|FG004|Overall Study|Unable to make study visit|0|||
154870786|NCT03952650|558953590|FG005|Overall Study|Unable to make study visit|1|||
154870787|NCT03952650|558953591|FG006|Overall Study|Unable to make study visit|0|||
154870788|NCT00592683|558953592|FG000|Overall Study|Found ineligible|0|||
154870789|NCT00592683|558953593|FG001|Overall Study|Found ineligible|1|||
154870790|NCT00592683|558953592|FG000|Overall Study|Withdrawal by Subject|1|||
154870791|NCT00592683|558953593|FG001|Overall Study|Withdrawal by Subject|0|||
154870792|NCT00592683|558953592|FG000|Overall Study|Adverse Event|0|||
154870793|NCT00592683|558953593|FG001|Overall Study|Adverse Event|2|||
154870794|NCT00592683|558953592|FG000|Overall Study|Protocol Violation|1|||
154870795|NCT00592683|558953593|FG001|Overall Study|Protocol Violation|0|||
154870796|NCT00592683|558953592|FG000|Overall Study|Study drug expired|1|||
154870797|NCT00592683|558953593|FG001|Overall Study|Study drug expired|0|||
154870798|NCT00592683|558953592|FG000|Overall Study|Other|1|||
154870799|NCT00592683|558953593|FG001|Overall Study|Other|0|||
154870800|NCT00592683|558953592|FG000|Overall Study|Lost to Follow-up|0|||
154870801|NCT00592683|558953593|FG001|Overall Study|Lost to Follow-up|1|||
154870802|NCT00201201|558953594|FG000|Overall Study|Death|0|||
154870803|NCT00201201|558953595|FG001|Overall Study|Death|2|||
154870804|NCT00201201|558953594|FG000|Overall Study|Withdrawal by Subject|5|||
154870805|NCT00201201|558953595|FG001|Overall Study|Withdrawal by Subject|5|||
154870806|NCT00545818|558953596|FG000|Overall Study|Protocol Violation|1|||
154870807|NCT00545818|558953597|FG001|Overall Study|Protocol Violation|0|||
155110606|NCT02557100|559833060|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
154870808|NCT00545818|558953596|FG000|Overall Study|Adverse Event|1|||
154870809|NCT00545818|558953597|FG001|Overall Study|Adverse Event|1|||
154870810|NCT00545818|558953596|FG000|Overall Study|Lost to Follow-up|1|||
154870811|NCT00545818|558953597|FG001|Overall Study|Lost to Follow-up|6|||
154870812|NCT02623361|558953598|FG000|Overall Study|Protocol Violation|0|||
154870813|NCT02623361|558953599|FG001|Overall Study|Protocol Violation|1|||
154870814|NCT02623361|558953598|FG000|Overall Study|Withdrawal by Subject|0|||
154870815|NCT02623361|558953599|FG001|Overall Study|Withdrawal by Subject|1|||
154870816|NCT02441803|558953601|FG000|Overall Study|Physician Decision|0|||
154870817|NCT02441803|558953602|FG001|Overall Study|Physician Decision|2|||
154870818|NCT02441803|558953603|FG002|Overall Study|Physician Decision|2|||
154870819|NCT00537823|558953607|FG000|Overall Study|Adverse Event|2|||
154870820|NCT00537823|558953608|FG001|Overall Study|Adverse Event|0|||
154870821|NCT02873221|558953609|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
154870822|NCT02873221|558953610|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
154870823|NCT02873221|558953611|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
154870824|NCT02873221|558953609|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
154870825|NCT02873221|558953610|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
154870826|NCT02873221|558953611|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
154870827|NCT02873221|558953609|FG000|Treatment Period|Protocol Violation|2|||
154870828|NCT02873221|558953610|FG001|Treatment Period|Protocol Violation|5|||
154870829|NCT02873221|558953611|FG002|Treatment Period|Protocol Violation|8|||
154870830|NCT02873221|558953609|FG000|Treatment Period|Pregnancy|4|||
154870831|NCT02873221|558953610|FG001|Treatment Period|Pregnancy|6|||
154870832|NCT02873221|558953611|FG002|Treatment Period|Pregnancy|3|||
154870833|NCT02873221|558953609|FG000|Treatment Period|Lack of Qualifying Event|0|||
154870834|NCT02873221|558953610|FG001|Treatment Period|Lack of Qualifying Event|3|||
154870835|NCT02873221|558953611|FG002|Treatment Period|Lack of Qualifying Event|1|||
154870836|NCT02873221|558953609|FG000|Treatment Period|Withdrawal of Consent|52|||
154870837|NCT02873221|558953610|FG001|Treatment Period|Withdrawal of Consent|51|||
154870838|NCT02873221|558953611|FG002|Treatment Period|Withdrawal of Consent|41|||
154870839|NCT02873221|558953609|FG000|Treatment Period|Lack of Efficacy|0|||
154870840|NCT02873221|558953610|FG001|Treatment Period|Lack of Efficacy|17|||
154870841|NCT02873221|558953611|FG002|Treatment Period|Lack of Efficacy|12|||
154870842|NCT02873221|558953609|FG000|Treatment Period|Adverse Event|4|||
154870843|NCT02873221|558953610|FG001|Treatment Period|Adverse Event|9|||
154870844|NCT02873221|558953611|FG002|Treatment Period|Adverse Event|11|||
154870845|NCT02873221|558953609|FG000|Treatment Period|Lost to Follow-up|26|||
154870846|NCT02873221|558953610|FG001|Treatment Period|Lost to Follow-up|30|||
154870847|NCT02873221|558953611|FG002|Treatment Period|Lost to Follow-up|26|||
154870848|NCT02873221|558953609|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
154870849|NCT02873221|558953610|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
154870850|NCT02873221|558953611|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
154870851|NCT02873221|558953609|FG000|Safety Follow-up Period|Protocol Violation|0|||
155110607|NCT02557100|559833061|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
155110608|NCT02557100|559833062|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
155110609|NCT02557100|559833060|FG000|Single Blind Treatment Period|Death|0|||
155110610|NCT02557100|559833061|FG001|Single Blind Treatment Period|Death|1|||
155110611|NCT02557100|559833062|FG002|Single Blind Treatment Period|Death|0|||
155110612|NCT02557100|559833060|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
155110613|NCT02557100|559833061|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
155110614|NCT02557100|559833062|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
155110615|NCT02557100|559833060|FG000|Single Blind Treatment Period|Adverse Event|0|||
155110616|NCT02557100|559833061|FG001|Single Blind Treatment Period|Adverse Event|1|||
155110617|NCT02557100|559833062|FG002|Single Blind Treatment Period|Adverse Event|0|||
155110618|NCT02557100|559833060|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
155110619|NCT02557100|559833061|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
155110620|NCT02557100|559833062|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
155110621|NCT02557100|559833060|FG000|Cumulative Abatacept Period|Other Reasons|0|||
155110622|NCT02557100|559833061|FG001|Cumulative Abatacept Period|Other Reasons|0|||
155110623|NCT02557100|559833062|FG002|Cumulative Abatacept Period|Other Reasons|1|||
155110624|NCT02557100|559833060|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
155110625|NCT02557100|559833061|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
154870852|NCT02873221|558953610|FG001|Safety Follow-up Period|Protocol Violation|0|||
154870853|NCT02873221|558953611|FG002|Safety Follow-up Period|Protocol Violation|1|||
154870854|NCT02873221|558953609|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
154870855|NCT02873221|558953610|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
154870856|NCT02873221|558953611|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
154870857|NCT02873221|558953609|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
154870858|NCT02873221|558953610|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
154870859|NCT02873221|558953611|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
154870860|NCT01325493|558953612|FG000|Overall Study|Protocol Violation|0|||
155110626|NCT02557100|559833062|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
155110627|NCT02557100|559833060|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
155110628|NCT02557100|559833061|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
155110629|NCT02557100|559833062|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
155110630|NCT00510718|559833063|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
155110631|NCT00510718|559833064|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
155110632|NCT00510718|559833063|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
155110633|NCT00510718|559833064|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
155110634|NCT00510718|559833063|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
155110635|NCT00510718|559833064|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
155110636|NCT00510718|559833063|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
155110637|NCT00510718|559833064|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
155110638|NCT00510718|559833063|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
155110639|NCT00510718|559833064|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
155110640|NCT00510718|559833063|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
155110641|NCT00510718|559833064|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
155110642|NCT04644276|559833065|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
155110643|NCT04644276|559833066|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
155110644|NCT04644276|559833067|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
155110645|NCT01576146|559833068|FG000|Extension Period 1|Adverse Event|2|||
155110646|NCT01576146|559833068|FG000|Extension Period 1|Death|2|||
155110647|NCT01576146|559833068|FG000|Extension Period 1|Physician Decision|2|||
155110648|NCT01576146|559833068|FG000|Extension Period 1|Withdrawal by Subject|1|||
155110649|NCT01576146|559833068|FG000|Extension Period 1|Lost to Follow-up|1|||
155110650|NCT01576146|559833068|FG000|Extension Period 1|Parathyroidectomy|1|||
155110651|NCT01576146|559833068|FG000|Extension Period 1|Renal Transplant|1|||
155110652|NCT01576146|559833068|FG000|Extension Period 2|Sponsor Decision|13|||
155110653|NCT01576146|559833068|FG000|Extension Period 2|Death|1|||
155110654|NCT01576146|559833068|FG000|Extension Period 2|Adverse Event|1|||
155110655|NCT01576146|559833068|FG000|Extension Period 2|Renal Transplant|1|||
155110656|NCT01576146|559833068|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
155110657|NCT01995526|559833069|FG000|Overall Study|Physician Decision|1|||
155110658|NCT03367403|559833070|FG000|Overall Study|Adverse Event|20|||
155110659|NCT03367403|559833071|FG001|Overall Study|Adverse Event|6|||
155110660|NCT03367403|559833072|FG002|Overall Study|Adverse Event|2|||
155110661|NCT03367403|559833070|FG000|Overall Study|Withdrawal by Subject|12|||
155110662|NCT03367403|559833071|FG001|Overall Study|Withdrawal by Subject|13|||
155110663|NCT03367403|559833072|FG002|Overall Study|Withdrawal by Subject|1|||
155110664|NCT03367403|559833070|FG000|Overall Study|Death|1|||
155110665|NCT03367403|559833071|FG001|Overall Study|Death|2|||
155110666|NCT03367403|559833072|FG002|Overall Study|Death|0|||
155110667|NCT03367403|559833070|FG000|Overall Study|Physician Decision|0|||
155110668|NCT03367403|559833071|FG001|Overall Study|Physician Decision|1|||
155110669|NCT03367403|559833072|FG002|Overall Study|Physician Decision|0|||
155110670|NCT03367403|559833070|FG000|Overall Study|Protocol Violation|1|||
154870861|NCT01325493|558953613|FG001|Overall Study|Protocol Violation|1|||
154870862|NCT01325493|558953612|FG000|Overall Study|loss of neuromonitoring signals|0|||
154870863|NCT01325493|558953613|FG001|Overall Study|loss of neuromonitoring signals|2|||
154870864|NCT01325493|558953612|FG000|Overall Study|Allergy|1|||
154870865|NCT01325493|558953613|FG001|Overall Study|Allergy|0|||
154870866|NCT02240628|558953614|FG000|Overall Study|Physician Decision|6|||
154870867|NCT02240628|558953615|FG001|Overall Study|Physician Decision|5|||
154870868|NCT02732912|558953616|FG000|Overall Study|Discharged before night|2|||
154870869|NCT02732912|558953617|FG001|Overall Study|Discharged before night|6|||
154870870|NCT02732912|558953616|FG000|Overall Study|Incomplete completion of questionnaire|2|||
154870871|NCT02732912|558953617|FG001|Overall Study|Incomplete completion of questionnaire|3|||
154870872|NCT02732912|558953616|FG000|Overall Study|No outcome; discharged or refused|6|||
154870873|NCT02732912|558953617|FG001|Overall Study|No outcome; discharged or refused|9|||
154870874|NCT02285010|558953618|FG000|Overall Study|not abdominal hysterectomy|2|||
154870875|NCT02285010|558953619|FG001|Overall Study|not abdominal hysterectomy|0|||
154870876|NCT02285010|558953618|FG000|Overall Study|Not spinal anesthesia|3|||
154870877|NCT02285010|558953619|FG001|Overall Study|Not spinal anesthesia|1|||
154870878|NCT01208181|558953622|FG000|Part 1|Withdrawal by Subject|11|||
154870879|NCT01208181|558953623|FG001|Part 1|Withdrawal by Subject|10|||
155110671|NCT03367403|559833071|FG001|Overall Study|Protocol Violation|1|||
155110672|NCT03367403|559833072|FG002|Overall Study|Protocol Violation|0|||
155110673|NCT03367403|559833070|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
154870880|NCT01208181|558953624|FG002|Part 1|Withdrawal by Subject|0|||
154870881|NCT01208181|558953625|FG003|Part 1|Withdrawal by Subject|0|||
154870882|NCT01208181|558953626|FG004|Part 1|Withdrawal by Subject|0|||
154870883|NCT01208181|558953622|FG000|Part 1|Technical problem|5|||
155110674|NCT03367403|559833071|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
155110675|NCT03367403|559833072|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
154870884|NCT01208181|558953623|FG001|Part 1|Technical problem|0|||
154870885|NCT01208181|558953624|FG002|Part 1|Technical problem|0|||
154870886|NCT01208181|558953625|FG003|Part 1|Technical problem|0|||
154870887|NCT01208181|558953626|FG004|Part 1|Technical problem|0|||
154870888|NCT01208181|558953622|FG000|Part 1|Protocol Violation|10|||
154870889|NCT01208181|558953623|FG001|Part 1|Protocol Violation|5|||
154870890|NCT01208181|558953624|FG002|Part 1|Protocol Violation|0|||
154870891|NCT01208181|558953625|FG003|Part 1|Protocol Violation|0|||
154870892|NCT01208181|558953626|FG004|Part 1|Protocol Violation|0|||
154870893|NCT01208181|558953622|FG000|Part 1|Physician Decision|4|||
154870894|NCT01208181|558953623|FG001|Part 1|Physician Decision|0|||
154870895|NCT01208181|558953624|FG002|Part 1|Physician Decision|0|||
154870896|NCT01208181|558953625|FG003|Part 1|Physician Decision|0|||
154870897|NCT01208181|558953626|FG004|Part 1|Physician Decision|0|||
154870898|NCT01208181|558953622|FG000|Part 1|Non-compliance with study drug|1|||
154870899|NCT01208181|558953623|FG001|Part 1|Non-compliance with study drug|1|||
154870900|NCT01208181|558953624|FG002|Part 1|Non-compliance with study drug|0|||
154870901|NCT01208181|558953625|FG003|Part 1|Non-compliance with study drug|0|||
154870902|NCT01208181|558953626|FG004|Part 1|Non-compliance with study drug|0|||
154870903|NCT01208181|558953622|FG000|Part 1|Lost to Follow-up|5|||
154870904|NCT01208181|558953623|FG001|Part 1|Lost to Follow-up|3|||
154870905|NCT01208181|558953624|FG002|Part 1|Lost to Follow-up|0|||
154870906|NCT01208181|558953625|FG003|Part 1|Lost to Follow-up|0|||
154870907|NCT01208181|558953626|FG004|Part 1|Lost to Follow-up|1|||
154870908|NCT01208181|558953622|FG000|Part 1|Lack of Efficacy|37|||
154870909|NCT01208181|558953623|FG001|Part 1|Lack of Efficacy|12|||
154870910|NCT01208181|558953624|FG002|Part 1|Lack of Efficacy|0|||
154870911|NCT01208181|558953625|FG003|Part 1|Lack of Efficacy|0|||
154870912|NCT01208181|558953626|FG004|Part 1|Lack of Efficacy|17|||
154870913|NCT01208181|558953622|FG000|Part 1|Adverse Event|26|||
154870914|NCT01208181|558953623|FG001|Part 1|Adverse Event|24|||
154870915|NCT01208181|558953624|FG002|Part 1|Adverse Event|0|||
154870916|NCT01208181|558953625|FG003|Part 1|Adverse Event|0|||
154870917|NCT01208181|558953626|FG004|Part 1|Adverse Event|4|||
154870918|NCT01208181|558953622|FG000|Part 2|Adverse Event|0|||
154870919|NCT01208181|558953623|FG001|Part 2|Adverse Event|0|||
154870920|NCT01208181|558953624|FG002|Part 2|Adverse Event|6|||
154870921|NCT01208181|558953625|FG003|Part 2|Adverse Event|7|||
154870922|NCT01208181|558953626|FG004|Part 2|Adverse Event|0|||
154870923|NCT01208181|558953622|FG000|Part 2|Withdrawal by Subject|0|||
154870924|NCT01208181|558953623|FG001|Part 2|Withdrawal by Subject|0|||
154870925|NCT01208181|558953624|FG002|Part 2|Withdrawal by Subject|1|||
154870926|NCT01208181|558953625|FG003|Part 2|Withdrawal by Subject|1|||
154870927|NCT01208181|558953626|FG004|Part 2|Withdrawal by Subject|0|||
154870928|NCT01208181|558953622|FG000|Part 2|Protocol Violation|0|||
154870929|NCT01208181|558953623|FG001|Part 2|Protocol Violation|0|||
154870930|NCT01208181|558953624|FG002|Part 2|Protocol Violation|1|||
154870931|NCT01208181|558953625|FG003|Part 2|Protocol Violation|0|||
154870932|NCT01208181|558953626|FG004|Part 2|Protocol Violation|0|||
154870933|NCT01208181|558953622|FG000|Part 2|Physician Decision|0|||
154870934|NCT01208181|558953623|FG001|Part 2|Physician Decision|0|||
154870935|NCT01208181|558953624|FG002|Part 2|Physician Decision|1|||
154870936|NCT01208181|558953625|FG003|Part 2|Physician Decision|2|||
154870937|NCT01208181|558953626|FG004|Part 2|Physician Decision|0|||
154870938|NCT01208181|558953622|FG000|Part 2|Non-compliance with study drug|0|||
154870939|NCT01208181|558953623|FG001|Part 2|Non-compliance with study drug|0|||
154870940|NCT01208181|558953624|FG002|Part 2|Non-compliance with study drug|1|||
154870941|NCT01208181|558953625|FG003|Part 2|Non-compliance with study drug|1|||
154870942|NCT01208181|558953626|FG004|Part 2|Non-compliance with study drug|0|||
154870943|NCT01208181|558953622|FG000|Part 2|Lost to Follow-up|0|||
154870944|NCT01208181|558953623|FG001|Part 2|Lost to Follow-up|0|||
154870945|NCT01208181|558953624|FG002|Part 2|Lost to Follow-up|1|||
154870946|NCT01208181|558953625|FG003|Part 2|Lost to Follow-up|2|||
154870947|NCT01208181|558953626|FG004|Part 2|Lost to Follow-up|0|||
154870948|NCT01208181|558953622|FG000|Part 2|Lack of Efficacy|0|||
155175081|NCT00636363|560078341|FG001|Overall Study|Lack of motivation|0|||
154870949|NCT01208181|558953623|FG001|Part 2|Lack of Efficacy|0|||
154870950|NCT01208181|558953624|FG002|Part 2|Lack of Efficacy|5|||
154870951|NCT01208181|558953625|FG003|Part 2|Lack of Efficacy|7|||
154870952|NCT01208181|558953626|FG004|Part 2|Lack of Efficacy|0|||
154870953|NCT01096667|558953629|FG000|Overall Study|Lost to Follow-up|1|||
154870954|NCT01096667|558953630|FG001|Overall Study|Lost to Follow-up|1|||
154870955|NCT01096667|558953631|FG002|Overall Study|Lost to Follow-up|1|||
154870956|NCT01096667|558953632|FG003|Overall Study|Lost to Follow-up|0|||
154870957|NCT01096667|558953633|FG004|Overall Study|Lost to Follow-up|0|||
154870958|NCT01096667|558953629|FG000|Overall Study|Withdrawal by Subject|1|||
154870959|NCT01096667|558953630|FG001|Overall Study|Withdrawal by Subject|0|||
154870960|NCT01096667|558953631|FG002|Overall Study|Withdrawal by Subject|0|||
154870961|NCT01096667|558953632|FG003|Overall Study|Withdrawal by Subject|1|||
154870962|NCT01096667|558953633|FG004|Overall Study|Withdrawal by Subject|0|||
154870963|NCT01096667|558953629|FG000|Overall Study|Reason not available|0|||
154870964|NCT01096667|558953630|FG001|Overall Study|Reason not available|1|||
154870965|NCT01096667|558953631|FG002|Overall Study|Reason not available|1|||
154870966|NCT01096667|558953632|FG003|Overall Study|Reason not available|1|||
154870967|NCT01096667|558953633|FG004|Overall Study|Reason not available|0|||
154870968|NCT01096667|558953629|FG000|Overall Study|Protocol Violation|0|||
154870969|NCT01096667|558953630|FG001|Overall Study|Protocol Violation|0|||
154870970|NCT01096667|558953631|FG002|Overall Study|Protocol Violation|0|||
154870971|NCT01096667|558953632|FG003|Overall Study|Protocol Violation|1|||
154870972|NCT01096667|558953633|FG004|Overall Study|Protocol Violation|0|||
154870973|NCT01096667|558953629|FG000|Overall Study|Not treated|1|||
154870974|NCT01096667|558953630|FG001|Overall Study|Not treated|0|||
154870975|NCT01096667|558953631|FG002|Overall Study|Not treated|0|||
154870976|NCT01096667|558953632|FG003|Overall Study|Not treated|0|||
154870977|NCT01096667|558953633|FG004|Overall Study|Not treated|0|||
154870978|NCT00394914|558953636|FG000|Treatment Period|Adverse Event|0|||
154870979|NCT00394914|558953637|FG001|Treatment Period|Adverse Event|3|||
154870980|NCT00394914|558953638|FG002|Treatment Period|Adverse Event|1|||
154870981|NCT00394914|558953636|FG000|Treatment Period|Lost to Follow-up|0|||
154870982|NCT00394914|558953637|FG001|Treatment Period|Lost to Follow-up|1|||
154870983|NCT00394914|558953638|FG002|Treatment Period|Lost to Follow-up|0|||
154870984|NCT00394914|558953636|FG000|Treatment Period|Withdrawal by Subject|0|||
154870985|NCT00394914|558953637|FG001|Treatment Period|Withdrawal by Subject|2|||
154870986|NCT00394914|558953638|FG002|Treatment Period|Withdrawal by Subject|2|||
154870987|NCT00394914|558953636|FG000|Treatment Period|Noncompliance with protocol|0|||
154870988|NCT00394914|558953637|FG001|Treatment Period|Noncompliance with protocol|3|||
154870989|NCT00394914|558953638|FG002|Treatment Period|Noncompliance with protocol|2|||
154870990|NCT00394914|558953636|FG000|Treatment Period|Did not meet protocol eligibility|0|||
154870991|NCT00394914|558953637|FG001|Treatment Period|Did not meet protocol eligibility|1|||
154870992|NCT00394914|558953638|FG002|Treatment Period|Did not meet protocol eligibility|1|||
154870993|NCT02179398|558953646|FG000|Overall Study|Lack of obligatory data|3|||
154870994|NCT02179398|558953647|FG001|Overall Study|Lack of obligatory data|3|||
154870995|NCT02179398|558953646|FG000|Overall Study|Lost to Follow-up|0|||
154870996|NCT02179398|558953647|FG001|Overall Study|Lost to Follow-up|1|||
154870997|NCT01787591|558953655|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
154870998|NCT01787591|558953656|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
154870999|NCT01787591|558953657|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
154871000|NCT01787591|558953658|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
155110676|NCT03367403|559833070|FG000|Overall Study|COVID-19|3|||
155110677|NCT03367403|559833071|FG001|Overall Study|COVID-19|6|||
155110678|NCT03367403|559833072|FG002|Overall Study|COVID-19|0|||
154871001|NCT02489630|558953661|FG000|Overall Study|Oversedation|1|||
154871002|NCT02489630|558953662|FG001|Overall Study|Oversedation|1|||
155110679|NCT03367403|559833070|FG000|Overall Study|Abuse of Alcohol Intake|0|||
155110680|NCT03367403|559833071|FG001|Overall Study|Abuse of Alcohol Intake|1|||
154871003|NCT02489630|558953661|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
154871004|NCT02489630|558953662|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
154871005|NCT00815308|558953663|FG000|Overall Study|Adverse Event|4|||
154871006|NCT00815308|558953663|FG000|Overall Study|Withdrawal by Subject|0|||
154871007|NCT00815308|558953663|FG000|Overall Study|Protocol Violation|6|||
154871008|NCT00377299|558953664|FG000|Overall Study|Lost to Follow-up|14|||
154871009|NCT00377299|558953665|FG001|Overall Study|Lost to Follow-up|19|||
154871010|NCT00377299|558953664|FG000|Overall Study|Adverse Event|0|||
154871011|NCT00377299|558953665|FG001|Overall Study|Adverse Event|1|||
154871012|NCT00377299|558953664|FG000|Overall Study|Withdrawal by Subject|5|||
154871013|NCT00377299|558953665|FG001|Overall Study|Withdrawal by Subject|4|||
154871014|NCT04799782|558953666|FG000|Washout|Physician Decision|2|||
154871015|NCT04799782|558953667|FG001|Washout|Physician Decision|0|||
155110681|NCT03367403|559833072|FG002|Overall Study|Abuse of Alcohol Intake|0|||
155110682|NCT03367403|559833070|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
155110683|NCT03367403|559833071|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
155110684|NCT03367403|559833072|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
155110685|NCT00194077|559833073|FG000|Overall Study|Lack of Efficacy|22|||
155110686|NCT00194077|559833074|FG001|Overall Study|Lack of Efficacy|29|||
155110687|NCT00194077|559833073|FG000|Overall Study|Study nonadherence|1|||
155110688|NCT00194077|559833074|FG001|Overall Study|Study nonadherence|0|||
155110689|NCT00194077|559833073|FG000|Overall Study|Withdrawal by Subject|1|||
155110690|NCT00194077|559833074|FG001|Overall Study|Withdrawal by Subject|1|||
155175082|NCT00636363|560078342|FG002|Overall Study|Lack of motivation|1|||
155175083|NCT00636363|560078340|FG000|Overall Study|Protocol Violation|0|||
154871016|NCT04799782|558953666|FG000|Washout|Withdrawal by Subject|0|||
154871017|NCT04799782|558953667|FG001|Washout|Withdrawal by Subject|2|||
155110691|NCT03470194|559833075|FG000|Overall Study|Lost to Follow-up|11|||
154871018|NCT04799782|558953666|FG000|Washout|Lost to Follow-up|0|||
154871019|NCT04799782|558953667|FG001|Washout|Lost to Follow-up|1|||
154871020|NCT01589094|558953670|FG000|Overall Study|Did not receive treatment|2|||
154871021|NCT02975349|558953671|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154871022|NCT02975349|558953672|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155110692|NCT03470194|559833076|FG001|Overall Study|Lost to Follow-up|17|||
154871023|NCT02975349|558953673|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154871024|NCT02975349|558953674|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
154871025|NCT02975349|558953675|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
154871026|NCT02975349|558953676|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154871027|NCT02975349|558953677|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154871028|NCT02975349|558953671|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154871029|NCT02975349|558953672|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154871030|NCT02975349|558953673|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154871031|NCT02975349|558953674|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154871032|NCT02975349|558953675|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154871033|NCT02975349|558953676|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154871034|NCT02975349|558953677|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154871035|NCT02975349|558953671|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
154871036|NCT02975349|558953672|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
154871037|NCT02975349|558953673|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
154871038|NCT02975349|558953674|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
154871039|NCT02975349|558953675|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
154871040|NCT02975349|558953676|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
154871041|NCT02975349|558953677|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
154871042|NCT02975349|558953671|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
154871043|NCT02975349|558953672|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
154871044|NCT02975349|558953673|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
154871045|NCT02975349|558953674|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
154871046|NCT02975349|558953675|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
154871047|NCT02975349|558953676|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
154871048|NCT02975349|558953677|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
154871049|NCT02975349|558953671|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
154871050|NCT02975349|558953672|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
154871051|NCT02975349|558953673|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
154871052|NCT02975349|558953674|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
154871053|NCT02975349|558953675|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
154871054|NCT02975349|558953676|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
154871055|NCT02975349|558953677|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
154871056|NCT02975349|558953671|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
154871057|NCT02975349|558953672|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
154871058|NCT02975349|558953673|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
154871059|NCT02975349|558953674|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
154871060|NCT02975349|558953675|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
154871061|NCT02975349|558953676|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
154871062|NCT02975349|558953677|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
154871063|NCT02975349|558953671|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
154871064|NCT02975349|558953672|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
154871065|NCT02975349|558953673|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
154871066|NCT02975349|558953674|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
154871067|NCT02975349|558953675|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
154871068|NCT02975349|558953676|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
154871069|NCT02975349|558953677|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
154871070|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
154871071|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
154871072|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
154871073|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
154871074|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
154871075|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
154871076|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
154871077|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
154871078|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
154871079|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
154871080|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
154973730|NCT00965757|559328944|FG001|Double-blind Phase|Progression of concomitant disease|2|||
154973731|NCT00965757|559328945|FG002|Double-blind Phase|Progression of concomitant disease|0|||
154973732|NCT00965757|559328946|FG003|Double-blind Phase|Progression of concomitant disease|0|||
154973733|NCT00965757|559328943|FG000|Double-blind Phase|Adverse drug reaction|2|||
154973734|NCT00965757|559328944|FG001|Double-blind Phase|Adverse drug reaction|1|||
154973735|NCT00965757|559328945|FG002|Double-blind Phase|Adverse drug reaction|0|||
154973736|NCT00965757|559328946|FG003|Double-blind Phase|Adverse drug reaction|0|||
154871081|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
154973737|NCT00965757|559328943|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
154973738|NCT00965757|559328944|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
154973739|NCT00965757|559328945|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
154973740|NCT00965757|559328946|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
154973741|NCT00965757|559328943|FG000|Double-blind Phase|Lack of Efficacy|7|||
154973742|NCT00965757|559328944|FG001|Double-blind Phase|Lack of Efficacy|11|||
154973743|NCT00965757|559328945|FG002|Double-blind Phase|Lack of Efficacy|0|||
154973744|NCT00965757|559328946|FG003|Double-blind Phase|Lack of Efficacy|0|||
154973745|NCT00965757|559328943|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
154973746|NCT00965757|559328944|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
154973747|NCT00965757|559328945|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
154973748|NCT00965757|559328946|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
155110693|NCT01822899|559833077|FG000|Overall Study|Adverse Event|6|||
155110694|NCT01822899|559833078|FG001|Overall Study|Adverse Event|5|||
155110695|NCT01822899|559833077|FG000|Overall Study|Lack of Efficacy|6|||
154871082|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
154871083|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
154871084|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
154871085|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
154871086|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
154871087|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
154871088|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
154871089|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
154871090|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
154871091|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
154871092|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
154871093|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
154871094|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
154871095|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
154871096|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
154871097|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
154871098|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
154871099|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
154871100|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
154871101|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
154871102|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
154871103|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
154871104|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
154871105|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
154871106|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
154871107|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
154871108|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
154871109|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
154871110|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
154871111|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
154871112|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
154973749|NCT00965757|559328943|FG000|Double-blind Phase|Lost to Follow-up|0|||
154973750|NCT00965757|559328944|FG001|Double-blind Phase|Lost to Follow-up|1|||
154973751|NCT00965757|559328945|FG002|Double-blind Phase|Lost to Follow-up|0|||
154973752|NCT00965757|559328946|FG003|Double-blind Phase|Lost to Follow-up|0|||
154973753|NCT00965757|559328943|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
154973754|NCT00965757|559328944|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
155110696|NCT01822899|559833078|FG001|Overall Study|Lack of Efficacy|3|||
155110697|NCT01822899|559833077|FG000|Overall Study|Protocol Violation|6|||
155110698|NCT01822899|559833078|FG001|Overall Study|Protocol Violation|3|||
155110699|NCT01822899|559833077|FG000|Overall Study|Lost to Follow-up|1|||
155110700|NCT01822899|559833078|FG001|Overall Study|Lost to Follow-up|0|||
155110701|NCT01822899|559833077|FG000|Overall Study|Withdrawal by Subject|5|||
155110702|NCT01822899|559833078|FG001|Overall Study|Withdrawal by Subject|7|||
155110703|NCT00759876|559833080|FG000|Overall Study|Sponsor terminated study early|36|||
155110704|NCT01450696|559833081|FG000|Overall Study|Never Treated|1|||
155110705|NCT01450696|559833082|FG001|Overall Study|Never Treated|1|||
155110706|NCT01450696|559833081|FG000|Overall Study|Death|77|||
155110707|NCT01450696|559833082|FG001|Overall Study|Death|84|||
155110708|NCT01450696|559833081|FG000|Overall Study|Lost to Follow-up|3|||
155110709|NCT01450696|559833082|FG001|Overall Study|Lost to Follow-up|3|||
155110710|NCT01450696|559833081|FG000|Overall Study|Non-Compliance|1|||
155110711|NCT01450696|559833082|FG001|Overall Study|Non-Compliance|0|||
155110712|NCT01450696|559833081|FG000|Overall Study|Withdrawal by Subject|13|||
155110713|NCT01450696|559833082|FG001|Overall Study|Withdrawal by Subject|2|||
155110714|NCT01450696|559833081|FG000|Overall Study|Study Terminated by Sponsor|53|||
154973755|NCT00965757|559328945|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
154973756|NCT00965757|559328946|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
154973757|NCT00965757|559328943|FG000|Double-blind Phase|Other|1|||
154973758|NCT00965757|559328944|FG001|Double-blind Phase|Other|0|||
154973759|NCT00965757|559328945|FG002|Double-blind Phase|Other|0|||
154973760|NCT00965757|559328946|FG003|Double-blind Phase|Other|0|||
154973761|NCT00965757|559328943|FG000|Extension Phase|Progression of concomitant disease|0|||
154973762|NCT00965757|559328944|FG001|Extension Phase|Progression of concomitant disease|0|||
154973763|NCT00965757|559328945|FG002|Extension Phase|Progression of concomitant disease|4|||
154973764|NCT00965757|559328946|FG003|Extension Phase|Progression of concomitant disease|2|||
154973765|NCT00965757|559328943|FG000|Extension Phase|Adverse drug reaction|0|||
154973766|NCT00965757|559328944|FG001|Extension Phase|Adverse drug reaction|0|||
154973767|NCT00965757|559328945|FG002|Extension Phase|Adverse drug reaction|6|||
154973768|NCT00965757|559328946|FG003|Extension Phase|Adverse drug reaction|3|||
154973769|NCT00965757|559328943|FG000|Extension Phase|Abnormal Laboratory Value|0|||
154973770|NCT00965757|559328944|FG001|Extension Phase|Abnormal Laboratory Value|0|||
154973771|NCT00965757|559328945|FG002|Extension Phase|Abnormal Laboratory Value|6|||
154973772|NCT00965757|559328946|FG003|Extension Phase|Abnormal Laboratory Value|1|||
154973773|NCT00965757|559328943|FG000|Extension Phase|Lack of Efficacy|0|||
154973774|NCT00965757|559328944|FG001|Extension Phase|Lack of Efficacy|0|||
154973775|NCT00965757|559328945|FG002|Extension Phase|Lack of Efficacy|8|||
154973776|NCT00965757|559328946|FG003|Extension Phase|Lack of Efficacy|12|||
154973777|NCT00965757|559328943|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
154973778|NCT00965757|559328944|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
154973779|NCT00965757|559328945|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
154973780|NCT00965757|559328946|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
154973781|NCT00965757|559328943|FG000|Extension Phase|Lost to Follow-up|0|||
154973782|NCT00965757|559328944|FG001|Extension Phase|Lost to Follow-up|0|||
154973783|NCT00965757|559328945|FG002|Extension Phase|Lost to Follow-up|0|||
154973784|NCT00965757|559328946|FG003|Extension Phase|Lost to Follow-up|1|||
154973785|NCT00965757|559328943|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
154973786|NCT00965757|559328944|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
154973787|NCT00965757|559328945|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
154973788|NCT00965757|559328946|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
154973789|NCT00965757|559328943|FG000|Extension Phase|Protocol Violation|0|||
154973790|NCT00965757|559328944|FG001|Extension Phase|Protocol Violation|0|||
154973791|NCT00965757|559328945|FG002|Extension Phase|Protocol Violation|0|||
154973792|NCT00965757|559328946|FG003|Extension Phase|Protocol Violation|1|||
154871113|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
154871114|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
154871115|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
154871116|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
154871117|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
154871118|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
154871119|NCT02975349|558953671|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
154871120|NCT02975349|558953672|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
154871121|NCT02975349|558953673|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
154871122|NCT02975349|558953674|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
154871123|NCT02975349|558953675|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
154871124|NCT02975349|558953676|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
154871125|NCT02975349|558953677|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
154871126|NCT00969618|558953683|FG000|Overall Study|Adverse Event|29|||
154871127|NCT00969618|558953683|FG000|Overall Study|Entry Criteria Not Met|3|||
154871128|NCT00969618|558953683|FG000|Overall Study|Lack of Efficacy|2|||
154871129|NCT00969618|558953683|FG000|Overall Study|Lost to Follow-up|7|||
154871130|NCT00969618|558953683|FG000|Overall Study|Physician Decision|1|||
154871131|NCT00969618|558953683|FG000|Overall Study|Protocol Violation|9|||
154871132|NCT00969618|558953683|FG000|Overall Study|Withdrawal by Subject|27|||
154871133|NCT00907738|558953686|FG000|Overall Study|Adverse Event|2|||
154871134|NCT00907738|558953687|FG001|Overall Study|Adverse Event|0|||
154871135|NCT00907738|558953688|FG002|Overall Study|Adverse Event|1|||
154871136|NCT00907738|558953689|FG003|Overall Study|Adverse Event|0|||
154871137|NCT00907738|558953690|FG004|Overall Study|Adverse Event|0|||
154973793|NCT00965757|559328943|FG000|Extension Phase|Other|0|||
154973794|NCT00965757|559328944|FG001|Extension Phase|Other|0|||
154973795|NCT00965757|559328945|FG002|Extension Phase|Other|2|||
154973796|NCT00965757|559328946|FG003|Extension Phase|Other|1|||
154973797|NCT03807440|559328947|FG000|Overall Study|No documentation of index date 2|320|||
154871138|NCT00907738|558953686|FG000|Overall Study|not specified or withdrew consent|3|||
154871139|NCT00907738|558953687|FG001|Overall Study|not specified or withdrew consent|0|||
154973798|NCT03807440|559328947|FG000|Overall Study|No informed consent for index date 2|117|||
154973799|NCT02451358|559328948|FG000|Overall Study|Withdrawal by Subject|1|||
154973800|NCT02451358|559328949|FG001|Overall Study|Withdrawal by Subject|1|||
154973801|NCT02451358|559328950|FG002|Overall Study|Withdrawal by Subject|0|||
154871140|NCT00907738|558953688|FG002|Overall Study|not specified or withdrew consent|0|||
154871141|NCT00907738|558953689|FG003|Overall Study|not specified or withdrew consent|0|||
154871142|NCT00907738|558953690|FG004|Overall Study|not specified or withdrew consent|0|||
154871143|NCT00907738|558953686|FG000|Overall Study|Disease progression|8|||
154871144|NCT00907738|558953687|FG001|Overall Study|Disease progression|1|||
155175084|NCT00636363|560078341|FG001|Overall Study|Protocol Violation|3|||
155175085|NCT00636363|560078342|FG002|Overall Study|Protocol Violation|0|||
155175086|NCT00636363|560078340|FG000|Overall Study|Lost to Follow-up|3|||
155175087|NCT00636363|560078341|FG001|Overall Study|Lost to Follow-up|4|||
155175088|NCT00636363|560078342|FG002|Overall Study|Lost to Follow-up|2|||
155175089|NCT00636363|560078340|FG000|Overall Study|Withdrawal by Subject|1|||
155175090|NCT00636363|560078341|FG001|Overall Study|Withdrawal by Subject|3|||
155175091|NCT00636363|560078342|FG002|Overall Study|Withdrawal by Subject|2|||
155175092|NCT01144299|560078343|FG000|Overall Study|Lost to Follow-up|1|||
154871145|NCT00907738|558953688|FG002|Overall Study|Disease progression|6|||
154871146|NCT00907738|558953689|FG003|Overall Study|Disease progression|4|||
154871147|NCT00907738|558953690|FG004|Overall Study|Disease progression|2|||
154871148|NCT05363293|558953691|FG000|Overall Study|Withdrawal by Subject|1|||
154871149|NCT05363293|558953692|FG001|Overall Study|Withdrawal by Subject|0|||
154871150|NCT05363293|558953693|FG002|Overall Study|Withdrawal by Subject|0|||
154871151|NCT05363293|558953694|FG003|Overall Study|Withdrawal by Subject|0|||
154871152|NCT05363293|558953695|FG004|Overall Study|Withdrawal by Subject|0|||
154871153|NCT05363293|558953696|FG005|Overall Study|Withdrawal by Subject|0|||
154871154|NCT05363293|558953697|FG006|Overall Study|Withdrawal by Subject|0|||
154871155|NCT05363293|558953698|FG007|Overall Study|Withdrawal by Subject|0|||
154871156|NCT05363293|558953699|FG008|Overall Study|Withdrawal by Subject|0|||
154871157|NCT05363293|558953700|FG009|Overall Study|Withdrawal by Subject|0|||
154871158|NCT04773041|558953701|FG000|Overall Study|Unable to data match|1|||
154871159|NCT04773041|558953702|FG001|Overall Study|Unable to data match|0|||
154871160|NCT04773041|558953703|FG002|Overall Study|Unable to data match|0|||
154871161|NCT03270085|558955400|FG000|Overall Study|Withdrawal by Subject|1|||
154871162|NCT03270085|558955401|FG001|Overall Study|Withdrawal by Subject|0|||
154871163|NCT03825042|558955402|FG000|Overall Study|Adverse Event|1|||
154871164|NCT03825042|558955403|FG001|Overall Study|Adverse Event|0|||
154871165|NCT03825042|558955402|FG000|Overall Study|Withdrawal by Subject|1|||
154871166|NCT03825042|558955403|FG001|Overall Study|Withdrawal by Subject|0|||
154871167|NCT01158534|558955410|FG000|Overall Study|Withdrawal by Subject|1|||
154871168|NCT01158534|558955410|FG000|Overall Study|Death|1|||
154871169|NCT01158534|558955410|FG000|Overall Study|Other|1|||
154871170|NCT01666444|558955415|FG000|Overall Study|Did not initiate treatment|2|||
154871171|NCT01666444|558955416|FG001|Overall Study|Did not initiate treatment|1|||
154871172|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
154871173|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
154871174|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
154871175|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
154871176|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
154871177|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
154871178|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
154871179|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
154871180|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
154871181|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
154871182|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
154871183|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
154871184|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
154871185|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
154871186|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
154871187|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
154871188|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
154871189|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
154871190|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
154871191|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
154871192|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
154871193|NCT00092547|558955417|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
154871194|NCT00092547|558955418|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
154871195|NCT00092547|558955419|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
154871196|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
154871197|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
154871198|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
155175093|NCT01144299|560078344|FG001|Overall Study|Lost to Follow-up|0|||
155175094|NCT01144299|560078343|FG000|Overall Study|Withdrawal by Subject|1|||
155175095|NCT01144299|560078344|FG001|Overall Study|Withdrawal by Subject|0|||
154871199|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
154871200|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
154871201|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
154871202|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
154871203|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
154871204|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
154871205|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
154871206|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
154871207|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
154871208|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
154871209|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
154871210|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
154871211|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
154871212|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
154871213|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
154871214|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
154871215|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
154871216|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
154871217|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
154871218|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
154871219|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
154871220|NCT00092547|558955417|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
154871221|NCT00092547|558955418|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
154871222|NCT00092547|558955419|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
154871223|NCT00092547|558955417|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
154871224|NCT00092547|558955418|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
154871225|NCT00092547|558955419|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
154871226|NCT00092547|558955417|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
154871227|NCT00092547|558955418|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
154871228|NCT00092547|558955419|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
154871229|NCT00092547|558955417|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
154871230|NCT00092547|558955418|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
154871231|NCT00092547|558955419|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
154871232|NCT00092547|558955417|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
154871233|NCT00092547|558955418|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
154871234|NCT00092547|558955419|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
154871235|NCT01166659|558955420|FG000|Overall Study|Subject Decision|8|||
154871236|NCT01166659|558955420|FG000|Overall Study|Investigator Decision|2|||
154871237|NCT01166659|558955420|FG000|Overall Study|Death|1|||
154871238|NCT01166659|558955420|FG000|Overall Study|Lost to Follow-up|1|||
154871239|NCT01166659|558955420|FG000|Overall Study|Study Closed at Site|1|||
154871240|NCT00634543|558955424|FG000|Overall Study|Other|1|||
154871241|NCT00634543|558955425|FG001|Overall Study|Other|2|||
154871242|NCT00634543|558955424|FG000|Overall Study|Protocol Violation|3|||
154871243|NCT00634543|558955425|FG001|Overall Study|Protocol Violation|3|||
154871244|NCT00634543|558955424|FG000|Overall Study|Adverse Event|11|||
154871245|NCT00634543|558955425|FG001|Overall Study|Adverse Event|11|||
154871246|NCT00634543|558955424|FG000|Overall Study|Withdrawal by Subject|4|||
154871247|NCT00634543|558955425|FG001|Overall Study|Withdrawal by Subject|4|||
154871248|NCT00634543|558955424|FG000|Overall Study|Lost to Follow-up|0|||
154871249|NCT00634543|558955425|FG001|Overall Study|Lost to Follow-up|1|||
154871250|NCT03515538|558955428|FG000|Overall Study|Lack of Efficacy|2|||
154871251|NCT03515538|558955429|FG001|Overall Study|Lack of Efficacy|0|||
154871252|NCT03515538|558955430|FG002|Overall Study|Lack of Efficacy|2|||
154871253|NCT03515538|558955431|FG003|Overall Study|Lack of Efficacy|0|||
154871254|NCT03515538|558955428|FG000|Overall Study|Death|0|||
154871255|NCT03515538|558955429|FG001|Overall Study|Death|0|||
154871256|NCT03515538|558955430|FG002|Overall Study|Death|1|||
154871257|NCT03515538|558955431|FG003|Overall Study|Death|0|||
154871258|NCT03515538|558955428|FG000|Overall Study|Protocol Violation|0|||
154871259|NCT03515538|558955429|FG001|Overall Study|Protocol Violation|0|||
154871260|NCT03515538|558955430|FG002|Overall Study|Protocol Violation|0|||
154871261|NCT03515538|558955431|FG003|Overall Study|Protocol Violation|1|||
154871262|NCT03515538|558955428|FG000|Overall Study|Screen failure (baseline dropout)|0|||
154871263|NCT03515538|558955429|FG001|Overall Study|Screen failure (baseline dropout)|1|||
154871264|NCT03515538|558955430|FG002|Overall Study|Screen failure (baseline dropout)|0|||
154871265|NCT03515538|558955431|FG003|Overall Study|Screen failure (baseline dropout)|0|||
154871266|NCT03515538|558955428|FG000|Overall Study|Withdrawal by Subject|2|||
154871267|NCT03515538|558955429|FG001|Overall Study|Withdrawal by Subject|2|||
154871268|NCT03515538|558955430|FG002|Overall Study|Withdrawal by Subject|1|||
154871269|NCT03515538|558955431|FG003|Overall Study|Withdrawal by Subject|3|||
154871270|NCT03515538|558955428|FG000|Overall Study|Physician Decision|1|||
154871271|NCT03515538|558955429|FG001|Overall Study|Physician Decision|0|||
154871272|NCT03515538|558955430|FG002|Overall Study|Physician Decision|0|||
154871273|NCT03515538|558955431|FG003|Overall Study|Physician Decision|1|||
154871274|NCT00915005|558955440|FG000|Overall Study|Withdrawal by Subject|4|||
154871275|NCT00915005|558955441|FG001|Overall Study|Withdrawal by Subject|4|||
154871276|NCT00915005|558955440|FG000|Overall Study|Patient preferred protons therapy|6|||
154871277|NCT00915005|558955441|FG001|Overall Study|Patient preferred protons therapy|0|||
154871278|NCT00915005|558955440|FG000|Overall Study|Insurance denial|3|||
154871279|NCT00915005|558955441|FG001|Overall Study|Insurance denial|15|||
154871280|NCT00090285|558955444|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
154871281|NCT00090285|558955445|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
154871282|NCT00090285|558955446|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
154871283|NCT00090285|558955447|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
154871284|NCT00090285|558955448|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
154871285|NCT00090285|558955449|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
154871286|NCT00090285|558955444|FG000|Base Study Vaccination Period|Adverse Event|2|||
154871287|NCT00090285|558955445|FG001|Base Study Vaccination Period|Adverse Event|4|||
154871288|NCT00090285|558955446|FG002|Base Study Vaccination Period|Adverse Event|0|||
154871289|NCT00090285|558955447|FG003|Base Study Vaccination Period|Adverse Event|0|||
154871290|NCT00090285|558955448|FG004|Base Study Vaccination Period|Adverse Event|0|||
154871291|NCT00090285|558955449|FG005|Base Study Vaccination Period|Adverse Event|0|||
154871292|NCT00090285|558955444|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
154871293|NCT00090285|558955445|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
154871294|NCT00090285|558955446|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
154871295|NCT00090285|558955447|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
154871296|NCT00090285|558955448|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
154871297|NCT00090285|558955449|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
154871298|NCT00090285|558955444|FG000|Base Study Vaccination Period|Protocol Violation|2|||
154871299|NCT00090285|558955445|FG001|Base Study Vaccination Period|Protocol Violation|3|||
154871300|NCT00090285|558955446|FG002|Base Study Vaccination Period|Protocol Violation|0|||
154871301|NCT00090285|558955447|FG003|Base Study Vaccination Period|Protocol Violation|0|||
154871302|NCT00090285|558955448|FG004|Base Study Vaccination Period|Protocol Violation|0|||
154871303|NCT00090285|558955449|FG005|Base Study Vaccination Period|Protocol Violation|0|||
154871304|NCT00090285|558955444|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
154871305|NCT00090285|558955445|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
154871306|NCT00090285|558955446|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
154871307|NCT00090285|558955447|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
154871308|NCT00090285|558955448|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
154871309|NCT00090285|558955449|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
154871310|NCT00090285|558955444|FG000|Base Study Vaccination Period|Uncooperative|2|||
154871311|NCT00090285|558955445|FG001|Base Study Vaccination Period|Uncooperative|2|||
154871312|NCT00090285|558955446|FG002|Base Study Vaccination Period|Uncooperative|0|||
154871313|NCT00090285|558955447|FG003|Base Study Vaccination Period|Uncooperative|0|||
154871314|NCT00090285|558955448|FG004|Base Study Vaccination Period|Uncooperative|0|||
154871315|NCT00090285|558955449|FG005|Base Study Vaccination Period|Uncooperative|0|||
154871316|NCT00090285|558955444|FG000|Base Study Vaccination Period|Moved|20|||
154871317|NCT00090285|558955445|FG001|Base Study Vaccination Period|Moved|21|||
154871318|NCT00090285|558955446|FG002|Base Study Vaccination Period|Moved|0|||
154871319|NCT00090285|558955447|FG003|Base Study Vaccination Period|Moved|0|||
154871320|NCT00090285|558955448|FG004|Base Study Vaccination Period|Moved|0|||
154871321|NCT00090285|558955449|FG005|Base Study Vaccination Period|Moved|0|||
154871322|NCT00090285|558955444|FG000|Base Study Vaccination Period|Site Terminated|1|||
154871323|NCT00090285|558955445|FG001|Base Study Vaccination Period|Site Terminated|0|||
154871324|NCT00090285|558955446|FG002|Base Study Vaccination Period|Site Terminated|0|||
154871325|NCT00090285|558955447|FG003|Base Study Vaccination Period|Site Terminated|0|||
154871326|NCT00090285|558955448|FG004|Base Study Vaccination Period|Site Terminated|0|||
154871327|NCT00090285|558955449|FG005|Base Study Vaccination Period|Site Terminated|0|||
154871328|NCT00090285|558955444|FG000|Base Study Vaccination Period|Other|2|||
154871329|NCT00090285|558955445|FG001|Base Study Vaccination Period|Other|2|||
154871330|NCT00090285|558955446|FG002|Base Study Vaccination Period|Other|0|||
154871331|NCT00090285|558955447|FG003|Base Study Vaccination Period|Other|0|||
155110715|NCT01450696|559833082|FG001|Overall Study|Study Terminated by Sponsor|58|||
155110716|NCT02321319|559833084|FG000|Overall Study|Product discontinued|5|||
154871332|NCT00090285|558955448|FG004|Base Study Vaccination Period|Other|0|||
154871333|NCT00090285|558955449|FG005|Base Study Vaccination Period|Other|0|||
154871334|NCT00090285|558955444|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
154871335|NCT00090285|558955445|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
154871336|NCT00090285|558955446|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
154871337|NCT00090285|558955447|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
155110717|NCT02570152|559833087|FG000|Overall Study|Protocol Violation|2|||
154973802|NCT02451358|559328951|FG003|Overall Study|Withdrawal by Subject|0|||
154973803|NCT02451358|559328948|FG000|Overall Study|Protocol Violation|0|||
154973804|NCT02451358|559328949|FG001|Overall Study|Protocol Violation|1|||
154973805|NCT02451358|559328950|FG002|Overall Study|Protocol Violation|1|||
154973806|NCT02451358|559328951|FG003|Overall Study|Protocol Violation|0|||
154973807|NCT05070754|559328952|FG000|Overall Study|Withdrawal by Subject|0|||
154973808|NCT05070754|559328953|FG001|Overall Study|Withdrawal by Subject|0|||
154973809|NCT05070754|559328954|FG002|Overall Study|Withdrawal by Subject|0|||
154973810|NCT05070754|559328955|FG003|Overall Study|Withdrawal by Subject|1|||
154973811|NCT05070754|559328952|FG000|Overall Study|Protocol Violation|0|||
154973812|NCT05070754|559328953|FG001|Overall Study|Protocol Violation|0|||
154973813|NCT05070754|559328954|FG002|Overall Study|Protocol Violation|0|||
154973814|NCT05070754|559328955|FG003|Overall Study|Protocol Violation|1|||
154973815|NCT01398787|559328956|FG000|Overall Study|Adverse Event|1|||
154973816|NCT03414034|559328957|FG000|Overall Study|Adverse Event|6|||
154973817|NCT03414034|559328958|FG001|Overall Study|Adverse Event|1|||
154973818|NCT03414034|559328959|FG002|Overall Study|Adverse Event|1|||
154973819|NCT03414034|559328957|FG000|Overall Study|Death|0|||
154973820|NCT03414034|559328958|FG001|Overall Study|Death|0|||
154973821|NCT03414034|559328959|FG002|Overall Study|Death|1|||
154973822|NCT03414034|559328957|FG000|Overall Study|Non-compliance With Study Drug|0|||
154973823|NCT03414034|559328958|FG001|Overall Study|Non-compliance With Study Drug|0|||
154973824|NCT03414034|559328959|FG002|Overall Study|Non-compliance With Study Drug|1|||
154973825|NCT03414034|559328957|FG000|Overall Study|Physician Decision|1|||
154973826|NCT03414034|559328958|FG001|Overall Study|Physician Decision|3|||
154973827|NCT03414034|559328959|FG002|Overall Study|Physician Decision|2|||
154973828|NCT03414034|559328957|FG000|Overall Study|Withdrawal of Informed Consent|2|||
154973829|NCT03414034|559328958|FG001|Overall Study|Withdrawal of Informed Consent|1|||
154973830|NCT03414034|559328959|FG002|Overall Study|Withdrawal of Informed Consent|4|||
154973831|NCT03414034|559328957|FG000|Overall Study|Progressive Disease|15|||
154973832|NCT03414034|559328958|FG001|Overall Study|Progressive Disease|15|||
154973833|NCT03414034|559328959|FG002|Overall Study|Progressive Disease|17|||
154973834|NCT03414034|559328957|FG000|Overall Study|Miscellaneous|0|||
154973835|NCT03414034|559328958|FG001|Overall Study|Miscellaneous|0|||
154973836|NCT03414034|559328959|FG002|Overall Study|Miscellaneous|2|||
154973837|NCT04010227|559328960|FG000|Overall Study|Death|1|||
154973838|NCT04010227|559328961|FG001|Overall Study|Death|2|||
154973839|NCT04010227|559328960|FG000|Overall Study|Medical Reasons|4|||
154973840|NCT04010227|559328961|FG001|Overall Study|Medical Reasons|3|||
154973841|NCT04010227|559328960|FG000|Overall Study|Withdrawal by Subject|2|||
154973842|NCT04010227|559328961|FG001|Overall Study|Withdrawal by Subject|0|||
154973843|NCT04010227|559328960|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
154973844|NCT04010227|559328961|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
154973845|NCT00702507|559328962|FG000|Initial Treatment Phase|Adverse Event|2|||
154973846|NCT00702507|559328962|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
154973847|NCT00702507|559328962|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
154973848|NCT00702507|559328962|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
154973849|NCT00702507|559328962|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
154973850|NCT00702507|559328962|FG000|Follow-up Phase|Protocol Violation|2|||
154973851|NCT00702507|559328962|FG000|Follow-up Phase|Lost to Follow-up|23|||
155175096|NCT02342418|560078347|FG000|Overall Study|Adverse Event|0|||
154871338|NCT00090285|558955448|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
154871339|NCT00090285|558955449|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
154871340|NCT00090285|558955444|FG000|Base Study Vaccination Period|HIV positive|1|||
154871341|NCT00090285|558955445|FG001|Base Study Vaccination Period|HIV positive|1|||
154871342|NCT00090285|558955446|FG002|Base Study Vaccination Period|HIV positive|0|||
154871343|NCT00090285|558955447|FG003|Base Study Vaccination Period|HIV positive|0|||
154871344|NCT00090285|558955448|FG004|Base Study Vaccination Period|HIV positive|0|||
154871345|NCT00090285|558955449|FG005|Base Study Vaccination Period|HIV positive|0|||
154871346|NCT00090285|558955444|FG000|Base Study Follow-up Period|Adverse Event|3|||
154871347|NCT00090285|558955445|FG001|Base Study Follow-up Period|Adverse Event|10|||
154871348|NCT00090285|558955446|FG002|Base Study Follow-up Period|Adverse Event|0|||
154871349|NCT00090285|558955447|FG003|Base Study Follow-up Period|Adverse Event|0|||
154871350|NCT00090285|558955448|FG004|Base Study Follow-up Period|Adverse Event|0|||
154871351|NCT00090285|558955449|FG005|Base Study Follow-up Period|Adverse Event|0|||
154871352|NCT00090285|558955444|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
154871353|NCT00090285|558955445|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
154973852|NCT00702507|559328962|FG000|Follow-up Phase|Late Enrollment|1|||
154973853|NCT02308696|559328963|FG000|Overall Study|Lost to Follow-up|28|||
154973854|NCT02308696|559328964|FG001|Overall Study|Lost to Follow-up|21|||
154973855|NCT02308696|559328963|FG000|Overall Study|Death|8|||
154973856|NCT02308696|559328964|FG001|Overall Study|Death|4|||
154973857|NCT02308696|559328963|FG000|Overall Study|Moved to a Higher Level of Care|17|||
154973858|NCT02308696|559328964|FG001|Overall Study|Moved to a Higher Level of Care|6|||
154973859|NCT00113919|559328965|FG000|Overall Study|Physician Decision|8|||
154973860|NCT00113919|559328965|FG000|Overall Study|Death|6|||
154871354|NCT00090285|558955446|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
154871355|NCT00090285|558955447|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
154871356|NCT00090285|558955448|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
154871357|NCT00090285|558955449|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
154871358|NCT00090285|558955444|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
154871359|NCT00090285|558955445|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
154871360|NCT00090285|558955446|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
154871361|NCT00090285|558955447|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
154871362|NCT00090285|558955448|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
154871363|NCT00090285|558955449|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
154871364|NCT00090285|558955444|FG000|Base Study Follow-up Period|Moved|41|||
154871365|NCT00090285|558955445|FG001|Base Study Follow-up Period|Moved|36|||
154871366|NCT00090285|558955446|FG002|Base Study Follow-up Period|Moved|0|||
154871367|NCT00090285|558955447|FG003|Base Study Follow-up Period|Moved|0|||
154871368|NCT00090285|558955448|FG004|Base Study Follow-up Period|Moved|0|||
154871369|NCT00090285|558955449|FG005|Base Study Follow-up Period|Moved|0|||
154871370|NCT00090285|558955444|FG000|Base Study Follow-up Period|Other|2|||
154871371|NCT00090285|558955445|FG001|Base Study Follow-up Period|Other|0|||
154871372|NCT00090285|558955446|FG002|Base Study Follow-up Period|Other|0|||
154871373|NCT00090285|558955447|FG003|Base Study Follow-up Period|Other|0|||
154871374|NCT00090285|558955448|FG004|Base Study Follow-up Period|Other|0|||
154871375|NCT00090285|558955449|FG005|Base Study Follow-up Period|Other|0|||
154871376|NCT00090285|558955444|FG000|Base Study Follow-up Period|Protocol Violation|1|||
154871377|NCT00090285|558955445|FG001|Base Study Follow-up Period|Protocol Violation|0|||
154871378|NCT00090285|558955446|FG002|Base Study Follow-up Period|Protocol Violation|0|||
154871379|NCT00090285|558955447|FG003|Base Study Follow-up Period|Protocol Violation|0|||
154871380|NCT00090285|558955448|FG004|Base Study Follow-up Period|Protocol Violation|0|||
154871381|NCT00090285|558955449|FG005|Base Study Follow-up Period|Protocol Violation|0|||
154871382|NCT00090285|558955444|FG000|Base Study Follow-up Period|Uncooperative|3|||
154871383|NCT00090285|558955445|FG001|Base Study Follow-up Period|Uncooperative|4|||
154871384|NCT00090285|558955446|FG002|Base Study Follow-up Period|Uncooperative|0|||
154871385|NCT00090285|558955447|FG003|Base Study Follow-up Period|Uncooperative|0|||
154871386|NCT00090285|558955448|FG004|Base Study Follow-up Period|Uncooperative|0|||
154871387|NCT00090285|558955449|FG005|Base Study Follow-up Period|Uncooperative|0|||
154871388|NCT00090285|558955444|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
154871389|NCT00090285|558955445|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
154871390|NCT00090285|558955446|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
154871391|NCT00090285|558955447|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
154871392|NCT00090285|558955448|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
154871393|NCT00090285|558955449|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
154871394|NCT00090285|558955444|FG000|Extension 1|Adverse Event|0|||
154871395|NCT00090285|558955445|FG001|Extension 1|Adverse Event|0|||
154871396|NCT00090285|558955446|FG002|Extension 1|Adverse Event|2|||
154871397|NCT00090285|558955447|FG003|Extension 1|Adverse Event|0|||
154871398|NCT00090285|558955448|FG004|Extension 1|Adverse Event|0|||
154871399|NCT00090285|558955449|FG005|Extension 1|Adverse Event|0|||
154871400|NCT00090285|558955444|FG000|Extension 1|Lost to Follow-up|0|||
154871401|NCT00090285|558955445|FG001|Extension 1|Lost to Follow-up|0|||
154871402|NCT00090285|558955446|FG002|Extension 1|Lost to Follow-up|35|||
154871403|NCT00090285|558955447|FG003|Extension 1|Lost to Follow-up|0|||
154871404|NCT00090285|558955448|FG004|Extension 1|Lost to Follow-up|0|||
154871405|NCT00090285|558955449|FG005|Extension 1|Lost to Follow-up|0|||
154871406|NCT00090285|558955444|FG000|Extension 1|Withdrawal by Subject|0|||
154871407|NCT00090285|558955445|FG001|Extension 1|Withdrawal by Subject|0|||
154871408|NCT00090285|558955446|FG002|Extension 1|Withdrawal by Subject|13|||
154871409|NCT00090285|558955447|FG003|Extension 1|Withdrawal by Subject|1|||
154871410|NCT00090285|558955448|FG004|Extension 1|Withdrawal by Subject|0|||
154871411|NCT00090285|558955449|FG005|Extension 1|Withdrawal by Subject|0|||
154871412|NCT00090285|558955444|FG000|Extension 1|Other|0|||
154871413|NCT00090285|558955445|FG001|Extension 1|Other|0|||
154973861|NCT02340962|559328970|FG000|Overall Study|Lost to Follow-up|1|||
155175097|NCT02342418|560078348|FG001|Overall Study|Adverse Event|1|||
155175098|NCT04255394|560078349|FG000|Overall Study|Death|35|||
155175099|NCT04255394|560078350|FG001|Overall Study|Death|25|||
155175100|NCT04255394|560078349|FG000|Overall Study|Device removed|2|||
155175101|NCT04255394|560078350|FG001|Overall Study|Device removed|10|||
155175102|NCT04255394|560078349|FG000|Overall Study|Withdrawal by Subject|9|||
155175103|NCT04255394|560078350|FG001|Overall Study|Withdrawal by Subject|8|||
155175104|NCT04255394|560078349|FG000|Overall Study|Screen Failure/Not treated|12|||
155175105|NCT04255394|560078350|FG001|Overall Study|Screen Failure/Not treated|8|||
155175106|NCT04255394|560078349|FG000|Overall Study|Lost to Follow-up|123|||
155175107|NCT04255394|560078350|FG001|Overall Study|Lost to Follow-up|265|||
154871414|NCT00090285|558955446|FG002|Extension 1|Other|4|||
154871415|NCT00090285|558955447|FG003|Extension 1|Other|0|||
154871416|NCT00090285|558955448|FG004|Extension 1|Other|0|||
154871417|NCT00090285|558955449|FG005|Extension 1|Other|0|||
154871418|NCT00090285|558955444|FG000|Extension 1|Moved|0|||
154871419|NCT00090285|558955445|FG001|Extension 1|Moved|0|||
154871420|NCT00090285|558955446|FG002|Extension 1|Moved|3|||
154871421|NCT00090285|558955447|FG003|Extension 1|Moved|0|||
154871422|NCT00090285|558955448|FG004|Extension 1|Moved|0|||
154871423|NCT00090285|558955449|FG005|Extension 1|Moved|0|||
154871424|NCT00090285|558955444|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
154871425|NCT00090285|558955445|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
154871426|NCT00090285|558955446|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
154871427|NCT00090285|558955447|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
154871428|NCT00090285|558955448|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
154871429|NCT00090285|558955449|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
154871430|NCT00090285|558955444|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
154871431|NCT00090285|558955445|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
154871432|NCT00090285|558955446|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
154871433|NCT00090285|558955447|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
154871434|NCT00090285|558955448|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
154871435|NCT00090285|558955449|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
154871436|NCT00090285|558955444|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
154871437|NCT00090285|558955445|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
154871438|NCT00090285|558955446|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
154871439|NCT00090285|558955447|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
154871440|NCT00090285|558955448|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
154871441|NCT00090285|558955449|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
154871442|NCT00090285|558955444|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
154871443|NCT00090285|558955445|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
154871444|NCT00090285|558955446|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
154871445|NCT00090285|558955447|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
154871446|NCT00090285|558955448|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
154871447|NCT00090285|558955449|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
154871448|NCT01936649|558955450|FG000|Overall Study|Withdrawal by Subject|4|||
154871449|NCT01936649|558955450|FG000|Overall Study|Physician Decision|2|||
154871450|NCT01936649|558955450|FG000|Overall Study|Protocol Violation|2|||
154973862|NCT02340962|559328971|FG001|Overall Study|Lost to Follow-up|0|||
154973863|NCT04194008|559328976|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
154973864|NCT04194008|559328976|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
154973865|NCT04194008|559328976|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
154973866|NCT04194008|559328976|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
154973867|NCT04194008|559328976|FG000|Treatment Phase With Nerivio|Missing data|4|||
154973868|NCT04194008|559328976|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
154973869|NCT01785615|559328977|FG000|Dietary Phase|Lost to Follow-up|0|||
154973870|NCT01785615|559328978|FG001|Dietary Phase|Lost to Follow-up|0|||
155110718|NCT02570152|559833087|FG000|Overall Study|Migrated/moved from study area|13|||
154871451|NCT01936649|558955450|FG000|Overall Study|Other than specified above|5|||
154871452|NCT00631488|558955455|FG000|Overall Study|Adverse Event|1|||
154871453|NCT00631488|558955456|FG001|Overall Study|Adverse Event|0|||
154871454|NCT00631488|558955457|FG002|Overall Study|Adverse Event|0|||
154871455|NCT00631488|558955455|FG000|Overall Study|Lost to Follow-up|2|||
154871456|NCT00631488|558955456|FG001|Overall Study|Lost to Follow-up|2|||
154871457|NCT00631488|558955457|FG002|Overall Study|Lost to Follow-up|0|||
154871458|NCT00631488|558955455|FG000|Overall Study|Physician Decision|1|||
154871459|NCT00631488|558955456|FG001|Overall Study|Physician Decision|0|||
154871460|NCT00631488|558955457|FG002|Overall Study|Physician Decision|1|||
154871461|NCT00631488|558955455|FG000|Overall Study|Protocol Violation|0|||
154871462|NCT00631488|558955456|FG001|Overall Study|Protocol Violation|0|||
154871463|NCT00631488|558955457|FG002|Overall Study|Protocol Violation|1|||
154871464|NCT03648476|558955458|FG000|Overall Study|Withdrawal by Subject|2|||
154871465|NCT03648476|558955459|FG001|Overall Study|Withdrawal by Subject|1|||
154871466|NCT02855411|558955465|FG000|Overall Study|Study terminated by sponsor|21|||
154871467|NCT02855411|558955465|FG000|Overall Study|Does not meet entrance criteria|14|||
154871468|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
154871469|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
154871470|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
154871471|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154871472|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154871473|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154871474|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154871475|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
154871476|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
154871477|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
154973871|NCT01785615|559328979|FG002|Dietary Phase|Lost to Follow-up|0|||
154973872|NCT01785615|559328980|FG003|Dietary Phase|Lost to Follow-up|24|||
154973873|NCT01881737|559328981|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
154871478|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
154871479|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154973874|NCT01881737|559328981|FG000|Overall Study|Withdrawal by Subject|1|||
154871480|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154871481|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154871482|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154871483|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
154871484|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
154871485|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
154871486|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
154871487|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154871488|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154871489|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154871490|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154871491|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
154871492|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
154871493|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
154871494|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154871495|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154871496|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154871497|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154871498|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154871499|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
154871500|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
154871501|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
154871502|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
154871503|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154871504|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154871505|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154871506|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154871507|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
154871508|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
154871509|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
154871510|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
154871511|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
154871512|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
154871513|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
154871514|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
154871515|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
154871516|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
154871517|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
154871518|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154871519|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154871520|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154871521|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154871522|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154871523|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
154871524|NCT01097616|558955468|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154871525|NCT01097616|558955469|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154871526|NCT01097616|558955470|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
154871527|NCT01097616|558955471|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154871528|NCT01097616|558955472|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
155175108|NCT04255394|560078349|FG000|Overall Study|Adverse Event|1|||
155175109|NCT04255394|560078350|FG001|Overall Study|Adverse Event|3|||
155175110|NCT03612856|560078353|FG000|Pre-dose Period|Physician Decision|0|||
155175111|NCT03612856|560078354|FG001|Pre-dose Period|Physician Decision|1|||
155175112|NCT03612856|560078355|FG002|Pre-dose Period|Physician Decision|1|||
155175113|NCT03612856|560078353|FG000|Pre-dose Period|Withdrawal by Subject|0|||
155175114|NCT03612856|560078354|FG001|Pre-dose Period|Withdrawal by Subject|1|||
155175115|NCT03612856|560078355|FG002|Pre-dose Period|Withdrawal by Subject|0|||
155175116|NCT01181986|560078356|FG000|Phase 1|Lost to Follow-up|0|||
155175117|NCT01181986|560078357|FG001|Phase 1|Lost to Follow-up|1|||
155175118|NCT01181986|560078358|FG002|Phase 1|Lost to Follow-up|1|||
155175119|NCT01181986|560078356|FG000|Phase 1|Adverse Event|0|||
155175120|NCT01181986|560078357|FG001|Phase 1|Adverse Event|0|||
155175121|NCT01181986|560078358|FG002|Phase 1|Adverse Event|1|||
155175122|NCT01181986|560078356|FG000|Phase 1|Protocol Violation|1|||
154871529|NCT01097616|558955473|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154973875|NCT01881737|559328981|FG000|Overall Study|Worsening of baseline behavior|1|||
155175123|NCT01181986|560078357|FG001|Phase 1|Protocol Violation|0|||
155175124|NCT01181986|560078358|FG002|Phase 1|Protocol Violation|0|||
154871530|NCT01097616|558955474|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154871531|NCT01097616|558955475|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
154871532|NCT01097616|558955468|FG000|Optional DB EXT Phase|Adverse Event|0|||
154871533|NCT01097616|558955469|FG001|Optional DB EXT Phase|Adverse Event|7|||
154871534|NCT01097616|558955470|FG002|Optional DB EXT Phase|Adverse Event|2|||
154871535|NCT01097616|558955471|FG003|Optional DB EXT Phase|Adverse Event|0|||
154871536|NCT01097616|558955472|FG004|Optional DB EXT Phase|Adverse Event|0|||
154871537|NCT01097616|558955473|FG005|Optional DB EXT Phase|Adverse Event|0|||
154871538|NCT01097616|558955474|FG006|Optional DB EXT Phase|Adverse Event|0|||
154871539|NCT01097616|558955475|FG007|Optional DB EXT Phase|Adverse Event|0|||
154871540|NCT01097616|558955468|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
154871541|NCT01097616|558955469|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
154871542|NCT01097616|558955470|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
154871543|NCT01097616|558955471|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
154871544|NCT01097616|558955472|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
154871545|NCT01097616|558955473|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
154871546|NCT01097616|558955474|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
154871547|NCT01097616|558955475|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
154871548|NCT01097616|558955468|FG000|Optional DB EXT Phase|Protocol Violation|0|||
154871549|NCT01097616|558955469|FG001|Optional DB EXT Phase|Protocol Violation|2|||
154871550|NCT01097616|558955470|FG002|Optional DB EXT Phase|Protocol Violation|3|||
154871551|NCT01097616|558955471|FG003|Optional DB EXT Phase|Protocol Violation|0|||
154871552|NCT01097616|558955472|FG004|Optional DB EXT Phase|Protocol Violation|0|||
154871553|NCT01097616|558955473|FG005|Optional DB EXT Phase|Protocol Violation|0|||
154871554|NCT01097616|558955474|FG006|Optional DB EXT Phase|Protocol Violation|0|||
154871555|NCT01097616|558955475|FG007|Optional DB EXT Phase|Protocol Violation|0|||
154871556|NCT01097616|558955468|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
154871557|NCT01097616|558955469|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
154871558|NCT01097616|558955470|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
154871559|NCT01097616|558955471|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
154871560|NCT01097616|558955472|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
154871561|NCT01097616|558955473|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
154871562|NCT01097616|558955474|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
154871563|NCT01097616|558955475|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
154871564|NCT01097616|558955468|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
154871565|NCT01097616|558955469|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
154871566|NCT01097616|558955470|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
154871567|NCT01097616|558955471|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
154871568|NCT01097616|558955472|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
154871569|NCT01097616|558955473|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
154871570|NCT01097616|558955474|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
154871571|NCT01097616|558955475|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
154871572|NCT01097616|558955468|FG000|Optional DB EXT Phase|Physician Decision|1|||
154871573|NCT01097616|558955469|FG001|Optional DB EXT Phase|Physician Decision|0|||
154871574|NCT01097616|558955470|FG002|Optional DB EXT Phase|Physician Decision|0|||
154871575|NCT01097616|558955471|FG003|Optional DB EXT Phase|Physician Decision|0|||
154871576|NCT01097616|558955472|FG004|Optional DB EXT Phase|Physician Decision|0|||
154871577|NCT01097616|558955473|FG005|Optional DB EXT Phase|Physician Decision|0|||
154871578|NCT01097616|558955474|FG006|Optional DB EXT Phase|Physician Decision|0|||
154871579|NCT01097616|558955475|FG007|Optional DB EXT Phase|Physician Decision|0|||
154871580|NCT01097616|558955468|FG000|DB RO Phase|Adverse Event|0|||
154871581|NCT01097616|558955469|FG001|DB RO Phase|Adverse Event|0|||
154871582|NCT01097616|558955470|FG002|DB RO Phase|Adverse Event|0|||
154871583|NCT01097616|558955471|FG003|DB RO Phase|Adverse Event|0|||
154871584|NCT01097616|558955472|FG004|DB RO Phase|Adverse Event|0|||
154871585|NCT01097616|558955473|FG005|DB RO Phase|Adverse Event|0|||
154871586|NCT01097616|558955474|FG006|DB RO Phase|Adverse Event|1|||
154871587|NCT01097616|558955475|FG007|DB RO Phase|Adverse Event|0|||
154871588|NCT01097616|558955468|FG000|DB RO Phase|Withdrawal by Subject|0|||
154871589|NCT01097616|558955469|FG001|DB RO Phase|Withdrawal by Subject|0|||
154871590|NCT01097616|558955470|FG002|DB RO Phase|Withdrawal by Subject|0|||
154871591|NCT01097616|558955471|FG003|DB RO Phase|Withdrawal by Subject|0|||
154871592|NCT01097616|558955472|FG004|DB RO Phase|Withdrawal by Subject|0|||
154871593|NCT01097616|558955473|FG005|DB RO Phase|Withdrawal by Subject|1|||
154871594|NCT01097616|558955474|FG006|DB RO Phase|Withdrawal by Subject|0|||
154871595|NCT01097616|558955475|FG007|DB RO Phase|Withdrawal by Subject|0|||
154871596|NCT01097616|558955468|FG000|DB RO Phase|Lost to Follow-up|0|||
154871597|NCT01097616|558955469|FG001|DB RO Phase|Lost to Follow-up|0|||
155110719|NCT00853242|559833088|FG000|Overall Study|Adverse Event|0|||
154871598|NCT01097616|558955470|FG002|DB RO Phase|Lost to Follow-up|0|||
154871599|NCT01097616|558955471|FG003|DB RO Phase|Lost to Follow-up|1|||
154871600|NCT01097616|558955472|FG004|DB RO Phase|Lost to Follow-up|1|||
154871601|NCT01097616|558955473|FG005|DB RO Phase|Lost to Follow-up|0|||
154871602|NCT01097616|558955474|FG006|DB RO Phase|Lost to Follow-up|0|||
155110720|NCT00853242|559833089|FG001|Overall Study|Adverse Event|1|||
155110721|NCT00853242|559833090|FG002|Overall Study|Adverse Event|1|||
155110722|NCT00853242|559833091|FG003|Overall Study|Adverse Event|0|||
154871603|NCT01097616|558955475|FG007|DB RO Phase|Lost to Follow-up|1|||
154871604|NCT01097616|558955468|FG000|DB RO Phase|Not Treated in RO|0|||
154871605|NCT01097616|558955469|FG001|DB RO Phase|Not Treated in RO|0|||
154871606|NCT01097616|558955470|FG002|DB RO Phase|Not Treated in RO|0|||
154871607|NCT01097616|558955471|FG003|DB RO Phase|Not Treated in RO|0|||
154871608|NCT01097616|558955472|FG004|DB RO Phase|Not Treated in RO|0|||
154871609|NCT01097616|558955473|FG005|DB RO Phase|Not Treated in RO|1|||
154871610|NCT01097616|558955474|FG006|DB RO Phase|Not Treated in RO|0|||
154871611|NCT01097616|558955475|FG007|DB RO Phase|Not Treated in RO|0|||
154871612|NCT00130208|558955478|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
154871613|NCT00130208|558955479|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
154871614|NCT00130208|558955478|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
154871615|NCT00130208|558955479|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
154871616|NCT00130208|558955478|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
154871617|NCT00130208|558955479|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
154871618|NCT00130208|558955478|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
154871619|NCT00130208|558955479|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
154871620|NCT00130208|558955478|FG000|Maintenance Period (26 Weeks)|Other|1|||
154871621|NCT00130208|558955479|FG001|Maintenance Period (26 Weeks)|Other|1|||
154871622|NCT00130208|558955478|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
154871623|NCT00130208|558955479|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
154871624|NCT00130208|558955478|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
154871625|NCT00130208|558955479|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
154871626|NCT00130208|558955478|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
154871627|NCT00130208|558955479|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
154871628|NCT00130208|558955478|FG000|Washout Period (8 Weeks)|Other|1|||
154871629|NCT00130208|558955479|FG001|Washout Period (8 Weeks)|Other|1|||
154871630|NCT04655586|558955484|FG000|Overall Study|Physician Decision|1|||
154871631|NCT04655586|558955485|FG001|Overall Study|Physician Decision|3|||
154871632|NCT04655586|558955486|FG002|Overall Study|Physician Decision|4|||
154871633|NCT04655586|558955484|FG000|Overall Study|Withdrawal by Subject|1|||
154871634|NCT04655586|558955485|FG001|Overall Study|Withdrawal by Subject|3|||
154871635|NCT04655586|558955486|FG002|Overall Study|Withdrawal by Subject|1|||
154871636|NCT00117338|558955493|FG000|Overall Study|Adverse Event|0|||
154871637|NCT00117338|558955494|FG001|Overall Study|Adverse Event|1|||
154871638|NCT00117338|558955493|FG000|Overall Study|Protocol Violation|3|||
154871639|NCT00117338|558955494|FG001|Overall Study|Protocol Violation|2|||
154871640|NCT00117338|558955493|FG000|Overall Study|Withdrawal by Subject|1|||
154871641|NCT00117338|558955494|FG001|Overall Study|Withdrawal by Subject|0|||
154871642|NCT00117338|558955493|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
154871643|NCT00117338|558955494|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
154871644|NCT00117338|558955493|FG000|Overall Study|Lack of Efficacy|0|||
154871645|NCT00117338|558955494|FG001|Overall Study|Lack of Efficacy|1|||
154871646|NCT04734873|558955495|FG000|Overall Study|Lost to Follow-up|1|||
154871647|NCT04734873|558955496|FG001|Overall Study|Lost to Follow-up|3|||
154871648|NCT04734873|558955497|FG002|Overall Study|Lost to Follow-up|2|||
154871649|NCT04734873|558955495|FG000|Overall Study|Randomized but not dosed|1|||
154871650|NCT04734873|558955496|FG001|Overall Study|Randomized but not dosed|0|||
154871651|NCT04734873|558955497|FG002|Overall Study|Randomized but not dosed|1|||
154871652|NCT01342640|558955499|FG000|Overall Study|Adverse Event|3|||
154871653|NCT01342640|558955499|FG000|Overall Study|Protocol Violation|16|||
154871654|NCT01342640|558955499|FG000|Overall Study|Lost to Follow-up|21|||
154871655|NCT01342640|558955499|FG000|Overall Study|Other|1|||
154871656|NCT02616029|558955500|FG000|Overall Study|Adverse Event|1|||
154871657|NCT02616029|558955501|FG001|Overall Study|Adverse Event|0|||
154871658|NCT02616029|558955500|FG000|Overall Study|Death|0|||
154871659|NCT02616029|558955501|FG001|Overall Study|Death|1|||
154871660|NCT02616029|558955500|FG000|Overall Study|Protocol Violation|1|||
154871661|NCT02616029|558955501|FG001|Overall Study|Protocol Violation|0|||
154871662|NCT02616029|558955500|FG000|Overall Study|Withdrew Consent|1|||
154871663|NCT02616029|558955501|FG001|Overall Study|Withdrew Consent|0|||
154871664|NCT02616029|558955500|FG000|Overall Study|Enrolled and Never Treated|1|||
154871665|NCT02616029|558955501|FG001|Overall Study|Enrolled and Never Treated|1|||
154871666|NCT00609609|558955502|FG000|Overall Study|Withdrawal by Subject|2|||
154871667|NCT00609609|558955503|FG001|Overall Study|Withdrawal by Subject|0|||
154871668|NCT00609609|558955502|FG000|Overall Study|Progression|4|||
154871669|NCT00609609|558955503|FG001|Overall Study|Progression|2|||
155110723|NCT00853242|559833092|FG004|Overall Study|Adverse Event|3|||
154871670|NCT03988751|558955506|FG000|Overall Study|Withdrawal by Subject|1|||
154871671|NCT03988751|558955507|FG001|Overall Study|Withdrawal by Subject|0|||
154871672|NCT03988751|558955506|FG000|Overall Study|Protocol Violation|0|||
154871673|NCT03988751|558955507|FG001|Overall Study|Protocol Violation|1|||
154871674|NCT00844883|558955508|FG000|Overall Study|Bridged to liver transplant|3|||
154871675|NCT00844883|558955508|FG000|Overall Study|Bridged to resection|1|||
154871676|NCT03065530|558955513|FG000|Overall Study|Lack of Efficacy|1|||
154871677|NCT03065530|558955514|FG001|Overall Study|Lack of Efficacy|1|||
154871678|NCT03065530|558955515|FG002|Overall Study|Lack of Efficacy|0|||
154871679|NCT03065530|558955516|FG003|Overall Study|Lack of Efficacy|1|||
155175125|NCT01181986|560078356|FG000|Phase 2|Adverse Event|0|||
155175126|NCT01181986|560078357|FG001|Phase 2|Adverse Event|3|||
155175127|NCT01181986|560078358|FG002|Phase 2|Adverse Event|0|||
155175128|NCT01181986|560078356|FG000|Phase 2|Medical condition|0|||
155175129|NCT01181986|560078357|FG001|Phase 2|Medical condition|1|||
155175130|NCT01181986|560078358|FG002|Phase 2|Medical condition|0|||
155175131|NCT00831493|560078360|FG000|Overall Study|Intractable nausea and vomiting|1|||
155175132|NCT03658876|560080145|FG000|Overall Study|Protocol Violation|3|||
154871680|NCT03065530|558955513|FG000|Overall Study|Protocol Violation|1|||
154871681|NCT03065530|558955514|FG001|Overall Study|Protocol Violation|0|||
154871682|NCT03065530|558955515|FG002|Overall Study|Protocol Violation|1|||
154871683|NCT03065530|558955516|FG003|Overall Study|Protocol Violation|1|||
154871684|NCT00479466|558955519|FG000|Overall Study|Adverse Event|5|||
154871685|NCT00479466|558955520|FG001|Overall Study|Adverse Event|1|||
154871686|NCT00479466|558955521|FG002|Overall Study|Adverse Event|0|||
154871687|NCT00479466|558955522|FG003|Overall Study|Adverse Event|1|||
154871688|NCT00479466|558955523|FG004|Overall Study|Adverse Event|2|||
154871689|NCT00479466|558955524|FG005|Overall Study|Adverse Event|0|||
154871690|NCT00479466|558955519|FG000|Overall Study|Hyperglycemia|0|||
154871691|NCT00479466|558955520|FG001|Overall Study|Hyperglycemia|0|||
154871692|NCT00479466|558955521|FG002|Overall Study|Hyperglycemia|0|||
154871693|NCT00479466|558955522|FG003|Overall Study|Hyperglycemia|0|||
154871694|NCT00479466|558955523|FG004|Overall Study|Hyperglycemia|0|||
154871695|NCT00479466|558955524|FG005|Overall Study|Hyperglycemia|1|||
154871696|NCT00479466|558955519|FG000|Overall Study|Lack of Efficacy|2|||
154871697|NCT00479466|558955520|FG001|Overall Study|Lack of Efficacy|0|||
154871698|NCT00479466|558955521|FG002|Overall Study|Lack of Efficacy|1|||
154871699|NCT00479466|558955522|FG003|Overall Study|Lack of Efficacy|0|||
154871700|NCT00479466|558955523|FG004|Overall Study|Lack of Efficacy|0|||
154871701|NCT00479466|558955524|FG005|Overall Study|Lack of Efficacy|0|||
154871702|NCT00479466|558955519|FG000|Overall Study|Lost to Follow-up|0|||
154871703|NCT00479466|558955520|FG001|Overall Study|Lost to Follow-up|1|||
154871704|NCT00479466|558955521|FG002|Overall Study|Lost to Follow-up|1|||
154973876|NCT00926367|559328985|FG000|Overall Study|Withdrawal by Subject|0|||
154973877|NCT00926367|559328986|FG001|Overall Study|Withdrawal by Subject|1|||
154973878|NCT00926367|559328985|FG000|Overall Study|Lost to Follow-up|1|||
154973879|NCT00926367|559328986|FG001|Overall Study|Lost to Follow-up|0|||
154973880|NCT00926367|559328985|FG000|Overall Study|Skin Irritation|1|||
154973881|NCT00926367|559328986|FG001|Overall Study|Skin Irritation|2|||
154973882|NCT01517867|559328987|FG000|Overall Study|never started treatment|29|||
154973883|NCT01517867|559328988|FG001|Overall Study|never started treatment|32|||
154973884|NCT01517867|559328987|FG000|Overall Study|Withdrawal by Subject|34|||
154973885|NCT01517867|559328988|FG001|Overall Study|Withdrawal by Subject|30|||
154973886|NCT01517867|559328987|FG000|Overall Study|Still in treatment at study end|0|||
154973887|NCT01517867|559328988|FG001|Overall Study|Still in treatment at study end|3|||
154973888|NCT03847974|559328989|FG000|Overall Study|relocated out of region|3|||
154973889|NCT03847974|559328989|FG000|Overall Study|Withdrawal by Subject|2|||
154973890|NCT03847974|559328989|FG000|Overall Study|Adverse Event|1|||
154973891|NCT01685216|559328992|FG000|Overall Study|Did not receive study drug|1|||
154973892|NCT01294449|559328993|FG000|Overall Study|Death|11|||
154973893|NCT01294449|559328994|FG001|Overall Study|Death|12|||
154973894|NCT01294449|559328993|FG000|Overall Study|Withdrawal by Subject|1|||
154973895|NCT01294449|559328994|FG001|Overall Study|Withdrawal by Subject|3|||
154973896|NCT02654015|559328995|FG000|Overall Study|Death|12|||
154973897|NCT02654015|559328995|FG000|Overall Study|Lost to Follow-up|3|||
154973898|NCT02466386|559328998|FG000|Overall Study|Adverse Event|5|||
154973899|NCT02466386|559328998|FG000|Overall Study|Protocol Violation|2|||
154973900|NCT02466386|559328998|FG000|Overall Study|Withdrawal by Subject|14|||
154973901|NCT02466386|559328998|FG000|Overall Study|Lost to Follow-up|5|||
154973902|NCT02466386|559328998|FG000|Overall Study|Lack of Efficacy|8|||
154973903|NCT02466386|559328998|FG000|Overall Study|Other|10|||
154973904|NCT05317195|559328999|FG000|Randomization|Withdrawal by Subject|1|||
154973905|NCT05317195|559328999|FG000|Randomization|Discontinued|6|||
154973906|NCT05317195|559328999|FG000|Admission|Withdrawal by Subject|2|||
154973907|NCT03259789|559329000|FG000|Overall Study|Adverse Event|3|||
154973908|NCT03259789|559329001|FG001|Overall Study|Adverse Event|2|||
154973909|NCT03259789|559329002|FG002|Overall Study|Adverse Event|1|||
155110724|NCT00853242|559833093|FG005|Overall Study|Adverse Event|1|||
155110725|NCT00853242|559833094|FG006|Overall Study|Adverse Event|1|||
155110726|NCT00853242|559833088|FG000|Overall Study|Noncompliant|0|||
155110727|NCT00853242|559833089|FG001|Overall Study|Noncompliant|0|||
155110728|NCT00853242|559833090|FG002|Overall Study|Noncompliant|0|||
155110729|NCT00853242|559833091|FG003|Overall Study|Noncompliant|0|||
155110730|NCT00853242|559833092|FG004|Overall Study|Noncompliant|1|||
155110731|NCT00853242|559833093|FG005|Overall Study|Noncompliant|0|||
155110732|NCT00853242|559833094|FG006|Overall Study|Noncompliant|0|||
155110733|NCT00853242|559833088|FG000|Overall Study|Withdrawal by Subject|1|||
155110734|NCT00853242|559833089|FG001|Overall Study|Withdrawal by Subject|2|||
155110735|NCT00853242|559833090|FG002|Overall Study|Withdrawal by Subject|0|||
155175133|NCT03658876|560080146|FG001|Overall Study|Protocol Violation|2|||
154973910|NCT03259789|559329000|FG000|Overall Study|Withdrawal by Subject|9|||
154973911|NCT03259789|559329001|FG001|Overall Study|Withdrawal by Subject|5|||
154973912|NCT03259789|559329002|FG002|Overall Study|Withdrawal by Subject|1|||
154973913|NCT03259789|559329000|FG000|Overall Study|Lost to Follow-up|5|||
154973914|NCT03259789|559329001|FG001|Overall Study|Lost to Follow-up|9|||
154973915|NCT03259789|559329002|FG002|Overall Study|Lost to Follow-up|4|||
154973916|NCT03259789|559329000|FG000|Overall Study|Physician Decision|0|||
154973917|NCT03259789|559329001|FG001|Overall Study|Physician Decision|1|||
154973918|NCT03259789|559329002|FG002|Overall Study|Physician Decision|0|||
154973919|NCT02063217|559329003|FG000|Overall Study|Withdrawal by Subject|1|||
154973920|NCT02063217|559329004|FG001|Overall Study|Withdrawal by Subject|0|||
154973921|NCT02063217|559329005|FG002|Overall Study|Withdrawal by Subject|0|||
154973922|NCT00889252|559329006|FG000|Overall Study|Adverse Event|2|||
154973923|NCT00889252|559329007|FG001|Overall Study|Adverse Event|4|||
154973924|NCT00889252|559329006|FG000|Overall Study|Withdrawal by Subject|3|||
154973925|NCT00889252|559329007|FG001|Overall Study|Withdrawal by Subject|0|||
154973926|NCT00889252|559329006|FG000|Overall Study|Protocol Violation|2|||
154973927|NCT00889252|559329007|FG001|Overall Study|Protocol Violation|0|||
154973928|NCT04291508|559329008|FG000|Overall Study|Withdrawal by Subject|1|||
154973929|NCT04291508|559329009|FG001|Overall Study|Withdrawal by Subject|0|||
154973930|NCT04291508|559329010|FG002|Overall Study|Withdrawal by Subject|1|||
154973931|NCT04291508|559329011|FG003|Overall Study|Withdrawal by Subject|0|||
154973932|NCT04291508|559329008|FG000|Overall Study|lost to follow up|4|||
154973933|NCT04291508|559329009|FG001|Overall Study|lost to follow up|0|||
154973934|NCT04291508|559329010|FG002|Overall Study|lost to follow up|1|||
154973935|NCT04291508|559329011|FG003|Overall Study|lost to follow up|0|||
154973936|NCT01833169|559329018|FG000|Overall Study|Disease Progression|99|||
154973937|NCT01833169|559329018|FG000|Overall Study|Adverse Event|33|||
154973938|NCT01833169|559329018|FG000|Overall Study|Withdrawal by Subject|9|||
154973939|NCT01833169|559329018|FG000|Overall Study|Death|3|||
154973940|NCT01833169|559329018|FG000|Overall Study|Physician Decision|2|||
154871705|NCT00479466|558955522|FG003|Overall Study|Lost to Follow-up|0|||
154871706|NCT00479466|558955523|FG004|Overall Study|Lost to Follow-up|2|||
154871707|NCT00479466|558955524|FG005|Overall Study|Lost to Follow-up|2|||
154871708|NCT00479466|558955519|FG000|Overall Study|Physician Decision|2|||
154871709|NCT00479466|558955520|FG001|Overall Study|Physician Decision|1|||
154871710|NCT00479466|558955521|FG002|Overall Study|Physician Decision|1|||
154871711|NCT00479466|558955522|FG003|Overall Study|Physician Decision|0|||
154871712|NCT00479466|558955523|FG004|Overall Study|Physician Decision|0|||
154871713|NCT00479466|558955524|FG005|Overall Study|Physician Decision|0|||
154871714|NCT00479466|558955519|FG000|Overall Study|Pregnancy|0|||
154871715|NCT00479466|558955520|FG001|Overall Study|Pregnancy|0|||
154871716|NCT00479466|558955521|FG002|Overall Study|Pregnancy|0|||
154871717|NCT00479466|558955522|FG003|Overall Study|Pregnancy|0|||
154871718|NCT00479466|558955523|FG004|Overall Study|Pregnancy|1|||
154871719|NCT00479466|558955524|FG005|Overall Study|Pregnancy|0|||
154871720|NCT00479466|558955519|FG000|Overall Study|Protocol Violation|1|||
154871721|NCT00479466|558955520|FG001|Overall Study|Protocol Violation|0|||
154871722|NCT00479466|558955521|FG002|Overall Study|Protocol Violation|0|||
154871723|NCT00479466|558955522|FG003|Overall Study|Protocol Violation|0|||
154871724|NCT00479466|558955523|FG004|Overall Study|Protocol Violation|0|||
154871725|NCT00479466|558955524|FG005|Overall Study|Protocol Violation|0|||
154871726|NCT00479466|558955519|FG000|Overall Study|Withdrawal by Subject|3|||
154871727|NCT00479466|558955520|FG001|Overall Study|Withdrawal by Subject|5|||
154973941|NCT01183884|559329022|FG000|Overall Study|Progressive Disease|26|||
154973942|NCT01183884|559329022|FG000|Overall Study|Adverse Event|3|||
154973943|NCT01183884|559329022|FG000|Overall Study|Withdrawal by Subject|1|||
154973944|NCT01183884|559329022|FG000|Overall Study|Other Complicating Disease|3|||
154973945|NCT01183884|559329022|FG000|Overall Study|Not Treated|1|||
154973946|NCT01183884|559329022|FG000|Overall Study|Other|4|||
154973947|NCT00772148|559329023|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
154973948|NCT00772148|559329024|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
154973949|NCT00772148|559329023|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
154973950|NCT00772148|559329024|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
154973951|NCT00772148|559329023|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
154973952|NCT00772148|559329024|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
154973953|NCT00772148|559329023|FG000|Maintenance Phase (Week 52)|Death|2|||
154871728|NCT00479466|558955521|FG002|Overall Study|Withdrawal by Subject|0|||
154871729|NCT00479466|558955522|FG003|Overall Study|Withdrawal by Subject|2|||
154871730|NCT00479466|558955523|FG004|Overall Study|Withdrawal by Subject|3|||
154871731|NCT00479466|558955524|FG005|Overall Study|Withdrawal by Subject|1|||
154871732|NCT02927171|558955525|FG000|Overall Study|Lost to Follow-up|0|||
154973954|NCT00772148|559329024|FG001|Maintenance Phase (Week 52)|Death|2|||
154973955|NCT00772148|559329023|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
154973956|NCT00772148|559329024|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
154973957|NCT00772148|559329023|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
154973958|NCT00772148|559329024|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
154973959|NCT00772148|559329023|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
154871733|NCT02927171|558955526|FG001|Overall Study|Lost to Follow-up|1|||
154871734|NCT04530825|558955531|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
154871735|NCT04530825|558955532|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
154871736|NCT04530825|558955533|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
154871737|NCT04530825|558955534|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
154871738|NCT04530825|558955531|FG000|Overall Study|Did not complete follow-up|3|||
154871739|NCT04530825|558955532|FG001|Overall Study|Did not complete follow-up|0|||
154871740|NCT04530825|558955533|FG002|Overall Study|Did not complete follow-up|0|||
154871741|NCT04530825|558955534|FG003|Overall Study|Did not complete follow-up|0|||
154871742|NCT04101422|558955536|FG000|Overall Study|Ineligible|1|||
154871743|NCT04101422|558955537|FG001|Overall Study|Ineligible|0|||
154871744|NCT04101422|558955538|FG002|Overall Study|Ineligible|9|||
154871745|NCT04101422|558955539|FG003|Overall Study|Ineligible|0|||
154871746|NCT04101422|558955536|FG000|Overall Study|Withdrawal by Subject|0|||
154871747|NCT04101422|558955537|FG001|Overall Study|Withdrawal by Subject|0|||
154871748|NCT04101422|558955538|FG002|Overall Study|Withdrawal by Subject|1|||
154871749|NCT04101422|558955539|FG003|Overall Study|Withdrawal by Subject|0|||
154871750|NCT04101422|558955536|FG000|Overall Study|Not attending to the stimuli|0|||
154871751|NCT04101422|558955537|FG001|Overall Study|Not attending to the stimuli|0|||
154871752|NCT04101422|558955538|FG002|Overall Study|Not attending to the stimuli|4|||
154871753|NCT04101422|558955539|FG003|Overall Study|Not attending to the stimuli|0|||
154871754|NCT04101422|558955536|FG000|Overall Study|Did not download app|0|||
154871755|NCT04101422|558955537|FG001|Overall Study|Did not download app|0|||
154871756|NCT04101422|558955538|FG002|Overall Study|Did not download app|0|||
154871757|NCT04101422|558955539|FG003|Overall Study|Did not download app|17|||
154871758|NCT04101422|558955536|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
154871759|NCT04101422|558955537|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
154871760|NCT04101422|558955538|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
154871761|NCT04101422|558955539|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
154871762|NCT00850499|558955540|FG000|Overall Study|Adverse Event|3|||
154871763|NCT00850499|558955541|FG001|Overall Study|Adverse Event|1|||
154871764|NCT00850499|558955540|FG000|Overall Study|Lack of Efficacy|0|||
154871765|NCT00850499|558955541|FG001|Overall Study|Lack of Efficacy|1|||
154871766|NCT00552305|558955542|FG000|Overall Study|Adverse Event|43|||
154871767|NCT00552305|558955542|FG000|Overall Study|Lack of Efficacy|120|||
154871768|NCT00552305|558955542|FG000|Overall Study|Lost to Follow-up|4|||
154973960|NCT00772148|559329024|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
154871769|NCT00552305|558955542|FG000|Overall Study|Protocol Violation|3|||
154871770|NCT00552305|558955542|FG000|Overall Study|Withdrawal by Subject|44|||
154973961|NCT01214239|559329025|FG000|Overall Study|Adverse Event|3|||
154973962|NCT01214239|559329026|FG001|Overall Study|Adverse Event|4|||
154973963|NCT01214239|559329025|FG000|Overall Study|Protocol Violation|2|||
154973964|NCT01214239|559329026|FG001|Overall Study|Protocol Violation|1|||
154973965|NCT01214239|559329025|FG000|Overall Study|Lost to Follow-up|1|||
154973966|NCT01214239|559329026|FG001|Overall Study|Lost to Follow-up|1|||
154973967|NCT01214239|559329025|FG000|Overall Study|Withdrawal by Subject|4|||
154973968|NCT01214239|559329026|FG001|Overall Study|Withdrawal by Subject|9|||
154973969|NCT01214239|559329025|FG000|Overall Study|Lack of Efficacy|1|||
154973970|NCT01214239|559329026|FG001|Overall Study|Lack of Efficacy|2|||
154973971|NCT01214239|559329025|FG000|Overall Study|patient's private reason|1|||
154871771|NCT00552305|558955542|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
154871772|NCT00552305|558955542|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
154871773|NCT00552305|558955542|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
154871774|NCT00552305|558955542|FG000|Overall Study|Unsatisfactory compliance|11|||
154871775|NCT00552305|558955542|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
154871776|NCT00552305|558955542|FG000|Overall Study|AE/Other: prohibited drug required|1|||
154871777|NCT00552305|558955542|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
154871778|NCT00552305|558955542|FG000|Overall Study|Other: Site closed|4|||
154871779|NCT00552305|558955542|FG000|Overall Study|Other: Personal problems|1|||
154973972|NCT01214239|559329026|FG001|Overall Study|patient's private reason|1|||
154973973|NCT00559637|559331128|FG000|Overall Study|Adverse Event|22|||
154973974|NCT00559637|559331128|FG000|Overall Study|Withdrawal by Subject|4|||
154973975|NCT00559637|559331128|FG000|Overall Study|Protocol Violation|6|||
154973976|NCT00559637|559331128|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
154871780|NCT00552305|558955542|FG000|Overall Study|Other: Unable to attend visits|1|||
154871781|NCT00552305|558955542|FG000|Overall Study|Other: Subject underwent surgery|4|||
154871782|NCT00552305|558955542|FG000|Overall Study|Other: Subject became pregnant|1|||
154871783|NCT00552305|558955542|FG000|Overall Study|Other: Health problems, not drug related|1|||
154871784|NCT00552305|558955542|FG000|Overall Study|Other: Subject moved from area|2|||
154871785|NCT00552305|558955542|FG000|Overall Study|Other: Subject incarcerated|1|||
154973977|NCT00559637|559331128|FG000|Overall Study|Failure to return|6|||
154973978|NCT00559637|559331128|FG000|Overall Study|Insufficient response|3|||
154973979|NCT00559637|559331128|FG000|Overall Study|Started requiring dialysis after month 7|2|||
154973980|NCT00559637|559331128|FG000|Overall Study|Suspected lung cancer|1|||
154871786|NCT00552305|558955542|FG000|Overall Study|Other: Subject went to rehab|1|||
154871787|NCT00718861|558955543|FG000|Overall Study|Withdrawal by Subject|15|||
154871788|NCT00718861|558955544|FG001|Overall Study|Withdrawal by Subject|10|||
154871789|NCT00718861|558955543|FG000|Overall Study|Adverse Event|2|||
154871790|NCT00718861|558955544|FG001|Overall Study|Adverse Event|1|||
154871791|NCT00718861|558955543|FG000|Overall Study|Lost to Follow-up|2|||
154871792|NCT00718861|558955544|FG001|Overall Study|Lost to Follow-up|1|||
154871793|NCT00718861|558955543|FG000|Overall Study|Administrative Problems|1|||
154871794|NCT00718861|558955544|FG001|Overall Study|Administrative Problems|1|||
154871795|NCT00718861|558955543|FG000|Overall Study|Death|1|||
154871796|NCT00718861|558955544|FG001|Overall Study|Death|5|||
154871797|NCT01703819|558955545|FG000|Overall Study|Adverse Event|0|||
154871798|NCT01703819|558955546|FG001|Overall Study|Adverse Event|1|||
154871799|NCT01703819|558955545|FG000|Overall Study|Withdrawal by Subject|0|||
154871800|NCT01703819|558955546|FG001|Overall Study|Withdrawal by Subject|1|||
154871801|NCT01302041|558955547|FG000|Overall Study|Death|5|||
154871802|NCT01302041|558955547|FG000|Overall Study|Withdrawal by Subject|4|||
154871803|NCT01302041|558955547|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
154871804|NCT01302041|558955547|FG000|Overall Study|Other-Miscellaneous Reason|2|||
154871805|NCT02234583|558955552|FG000|Overall Study|Adverse Event|172|||
154871806|NCT02234583|558955553|FG001|Overall Study|Adverse Event|156|||
154871807|NCT02234583|558955552|FG000|Overall Study|Withdrawal by Subject|109|||
154871808|NCT02234583|558955553|FG001|Overall Study|Withdrawal by Subject|157|||
154871809|NCT02234583|558955552|FG000|Overall Study|Lost to Follow-up|0|||
154871810|NCT02234583|558955553|FG001|Overall Study|Lost to Follow-up|1|||
154871811|NCT02234583|558955552|FG000|Overall Study|Lack of Efficacy|58|||
154871812|NCT02234583|558955553|FG001|Overall Study|Lack of Efficacy|103|||
154871813|NCT02234583|558955552|FG000|Overall Study|Protocol Violation|35|||
154871814|NCT02234583|558955553|FG001|Overall Study|Protocol Violation|42|||
154871815|NCT02234583|558955552|FG000|Overall Study|Other|39|||
154871816|NCT02234583|558955553|FG001|Overall Study|Other|97|||
154871817|NCT01849250|558955554|FG000|Overall Study|Withdrawal by Subject|1|||
154871818|NCT01849250|558955555|FG001|Overall Study|Withdrawal by Subject|0|||
154871819|NCT01849250|558955554|FG000|Overall Study|Not Evaluable|5|||
154871820|NCT01849250|558955555|FG001|Overall Study|Not Evaluable|3|||
154871821|NCT01849250|558955554|FG000|Overall Study|Screen Failure|1|||
154871822|NCT01849250|558955555|FG001|Overall Study|Screen Failure|0|||
154871823|NCT04504032|558955558|FG000|Overall Study|Adverse Event|1|||
154871824|NCT04504032|558955559|FG001|Overall Study|Adverse Event|2|||
154871825|NCT04504032|558955558|FG000|Overall Study|Lost to Follow-up|6|||
154871826|NCT04504032|558955559|FG001|Overall Study|Lost to Follow-up|9|||
154871827|NCT04504032|558955558|FG000|Overall Study|Protocol Violation|2|||
154871828|NCT04504032|558955559|FG001|Overall Study|Protocol Violation|0|||
154871829|NCT04504032|558955558|FG000|Overall Study|Study terminated by sponsor|1|||
154871830|NCT04504032|558955559|FG001|Overall Study|Study terminated by sponsor|2|||
154871831|NCT04504032|558955558|FG000|Overall Study|Withdrawal by Subject|9|||
154871832|NCT04504032|558955559|FG001|Overall Study|Withdrawal by Subject|11|||
154871833|NCT04504032|558955558|FG000|Overall Study|Disease progression prior to dosing|15|||
154871834|NCT04504032|558955559|FG001|Overall Study|Disease progression prior to dosing|3|||
154871835|NCT04504032|558955558|FG000|Overall Study|Drug supply issues|1|||
154871836|NCT04504032|558955559|FG001|Overall Study|Drug supply issues|1|||
154871837|NCT04504032|558955558|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
154871838|NCT04504032|558955559|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
154871839|NCT00771030|558955560|FG000|Overall Study|Adverse Event|0|||
154871840|NCT00771030|558955561|FG001|Overall Study|Adverse Event|1|||
154871841|NCT00771030|558955562|FG002|Overall Study|Adverse Event|0|||
154871842|NCT00771030|558955563|FG003|Overall Study|Adverse Event|0|||
154871843|NCT00771030|558955564|FG004|Overall Study|Adverse Event|0|||
154871844|NCT00771030|558955565|FG005|Overall Study|Adverse Event|0|||
154871845|NCT00771030|558955566|FG006|Overall Study|Adverse Event|0|||
154871846|NCT01174784|558955567|FG000|Overall Study|Screen fails|4|||
154871847|NCT00465738|558955570|FG000|Overall Study|Lost to Follow-up|2|||
154871848|NCT00465738|558955571|FG001|Overall Study|Lost to Follow-up|0|||
154871849|NCT00465738|558955570|FG000|Overall Study|Adverse Event|0|||
154871850|NCT00465738|558955571|FG001|Overall Study|Adverse Event|1|||
154871851|NCT00465738|558955570|FG000|Overall Study|Withdrawal by Subject|2|||
154871852|NCT00465738|558955571|FG001|Overall Study|Withdrawal by Subject|0|||
154871853|NCT00465738|558955570|FG000|Overall Study|Other|2|||
154871854|NCT00465738|558955571|FG001|Overall Study|Other|5|||
154871855|NCT01318902|558955574|FG000|Overall Study|Symptomatic Deterioration|0|||
154871856|NCT01318902|558955575|FG001|Overall Study|Symptomatic Deterioration|1|||
154871857|NCT01318902|558955576|FG002|Overall Study|Symptomatic Deterioration|1|||
154871858|NCT01318902|558955577|FG003|Overall Study|Symptomatic Deterioration|2|||
154871859|NCT01318902|558955574|FG000|Overall Study|Withdrawal by Patient|0|||
154871860|NCT01318902|558955575|FG001|Overall Study|Withdrawal by Patient|1|||
154871861|NCT01318902|558955576|FG002|Overall Study|Withdrawal by Patient|0|||
154871862|NCT01318902|558955577|FG003|Overall Study|Withdrawal by Patient|3|||
154871863|NCT01318902|558955574|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
154871864|NCT01318902|558955575|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
154871865|NCT01318902|558955576|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
154871866|NCT01318902|558955577|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
154871867|NCT01318902|558955574|FG000|Overall Study|Adverse Event|0|||
154871868|NCT01318902|558955575|FG001|Overall Study|Adverse Event|1|||
154871869|NCT01318902|558955576|FG002|Overall Study|Adverse Event|0|||
154871870|NCT01318902|558955577|FG003|Overall Study|Adverse Event|0|||
154871871|NCT01318902|558955574|FG000|Overall Study|Terminated by Sponsor|0|||
154871872|NCT01318902|558955575|FG001|Overall Study|Terminated by Sponsor|0|||
154871873|NCT01318902|558955576|FG002|Overall Study|Terminated by Sponsor|1|||
154871874|NCT01318902|558955577|FG003|Overall Study|Terminated by Sponsor|0|||
154871875|NCT04003155|558958100|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
154871876|NCT04003155|558958101|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
154871877|NCT04003155|558958102|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
154871878|NCT04003155|558958103|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
154871879|NCT04003155|558958104|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
154871880|NCT04003155|558958100|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
154871881|NCT04003155|558958101|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
154871882|NCT04003155|558958102|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
154871883|NCT04003155|558958103|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
154871884|NCT04003155|558958104|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
154871885|NCT04003155|558958100|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
154871886|NCT04003155|558958101|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
154871887|NCT04003155|558958102|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
154871888|NCT04003155|558958103|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
154871889|NCT04003155|558958104|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
154871890|NCT04003155|558958100|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
154871891|NCT04003155|558958101|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
154871892|NCT04003155|558958102|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
154871893|NCT04003155|558958103|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
154871894|NCT04003155|558958104|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
154871895|NCT04003155|558958100|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
154871896|NCT04003155|558958101|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
154871897|NCT04003155|558958102|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
154871898|NCT04003155|558958103|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
154871899|NCT04003155|558958104|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
154871900|NCT04003155|558958100|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
154871901|NCT04003155|558958101|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
154871902|NCT04003155|558958102|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
154871903|NCT04003155|558958103|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
154871904|NCT04003155|558958104|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
154871905|NCT04003155|558958100|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
154871906|NCT04003155|558958101|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
154871907|NCT04003155|558958102|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
154871908|NCT04003155|558958103|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
154871909|NCT04003155|558958104|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
154871910|NCT04003155|558958100|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
154871911|NCT04003155|558958101|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
154871912|NCT04003155|558958102|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
154871913|NCT04003155|558958103|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
154871914|NCT04003155|558958104|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
154871915|NCT04003155|558958100|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
154871916|NCT04003155|558958101|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
154871917|NCT04003155|558958102|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
154871918|NCT04003155|558958103|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
154871919|NCT04003155|558958104|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
154871920|NCT01912872|558958105|FG000|Overall Study|Lost to Follow-up|2|||
154871921|NCT01912872|558958106|FG001|Overall Study|Lost to Follow-up|3|||
154871922|NCT01912872|558958107|FG002|Overall Study|Lost to Follow-up|5|||
154871923|NCT01912872|558958108|FG003|Overall Study|Lost to Follow-up|5|||
154871924|NCT01912872|558958105|FG000|Overall Study|Other unspecified|3|||
154871925|NCT01912872|558958106|FG001|Overall Study|Other unspecified|1|||
154871926|NCT01912872|558958107|FG002|Overall Study|Other unspecified|3|||
154871927|NCT01912872|558958108|FG003|Overall Study|Other unspecified|0|||
154871928|NCT01912872|558958105|FG000|Overall Study|Informed consent withdrawn|0|||
154871929|NCT01912872|558958106|FG001|Overall Study|Informed consent withdrawn|0|||
154871930|NCT01912872|558958107|FG002|Overall Study|Informed consent withdrawn|1|||
154871931|NCT01912872|558958108|FG003|Overall Study|Informed consent withdrawn|1|||
154871932|NCT01912872|558958105|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
154871933|NCT01912872|558958106|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
154973981|NCT00559637|559331128|FG000|Overall Study|Participation in another study|1|||
154973982|NCT00559637|559331128|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
154973983|NCT00559637|559331128|FG000|Overall Study|Change of center|1|||
154973984|NCT00559637|559331128|FG000|Overall Study|Change of home|1|||
154973985|NCT00559637|559331128|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
154973986|NCT00784979|559331135|FG000|Overall Study|incomplete data|6|||
154973987|NCT00894933|559331139|FG000|Overall Study|Lost to Follow-up|2|||
154973988|NCT00894933|559331139|FG000|Overall Study|Cancelled Procedure|1|||
154973989|NCT00894933|559331139|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
154973990|NCT04241133|559331141|FG000|Overall Study|COVID19 Precautions|14|||
154973991|NCT04241133|559331142|FG001|Overall Study|COVID19 Precautions|34|||
154973992|NCT00631007|559331144|FG000|Overall Study|Adverse Event|0|||
154973993|NCT00631007|559331145|FG001|Overall Study|Adverse Event|2|||
154973994|NCT00631007|559331146|FG002|Overall Study|Adverse Event|0|||
154973995|NCT00631007|559331147|FG003|Overall Study|Adverse Event|2|||
154973996|NCT00631007|559331148|FG004|Overall Study|Adverse Event|3|||
154973997|NCT00631007|559331149|FG005|Overall Study|Adverse Event|2|||
154973998|NCT00631007|559331144|FG000|Overall Study|Lost to Follow-up|2|||
154973999|NCT00631007|559331145|FG001|Overall Study|Lost to Follow-up|1|||
154974000|NCT00631007|559331146|FG002|Overall Study|Lost to Follow-up|2|||
154974001|NCT00631007|559331147|FG003|Overall Study|Lost to Follow-up|4|||
154974002|NCT00631007|559331148|FG004|Overall Study|Lost to Follow-up|5|||
154974003|NCT00631007|559331149|FG005|Overall Study|Lost to Follow-up|3|||
154974004|NCT00631007|559331144|FG000|Overall Study|Physician Decision|1|||
154974005|NCT00631007|559331145|FG001|Overall Study|Physician Decision|0|||
154974006|NCT00631007|559331146|FG002|Overall Study|Physician Decision|1|||
154974007|NCT00631007|559331147|FG003|Overall Study|Physician Decision|0|||
154974008|NCT00631007|559331148|FG004|Overall Study|Physician Decision|0|||
154974009|NCT00631007|559331149|FG005|Overall Study|Physician Decision|2|||
154974010|NCT00631007|559331144|FG000|Overall Study|Persistent Hyperglycemia|2|||
154974011|NCT00631007|559331145|FG001|Overall Study|Persistent Hyperglycemia|2|||
154974012|NCT00631007|559331146|FG002|Overall Study|Persistent Hyperglycemia|5|||
154974013|NCT00631007|559331147|FG003|Overall Study|Persistent Hyperglycemia|1|||
154974014|NCT00631007|559331148|FG004|Overall Study|Persistent Hyperglycemia|2|||
154974015|NCT00631007|559331149|FG005|Overall Study|Persistent Hyperglycemia|5|||
154974016|NCT00631007|559331144|FG000|Overall Study|Withdrawal by Subject|4|||
154974017|NCT00631007|559331145|FG001|Overall Study|Withdrawal by Subject|5|||
154974018|NCT00631007|559331146|FG002|Overall Study|Withdrawal by Subject|2|||
154974019|NCT00631007|559331147|FG003|Overall Study|Withdrawal by Subject|2|||
154974020|NCT00631007|559331148|FG004|Overall Study|Withdrawal by Subject|1|||
154974021|NCT00631007|559331149|FG005|Overall Study|Withdrawal by Subject|3|||
154974022|NCT00631007|559331144|FG000|Overall Study|Other|2|||
154974023|NCT00631007|559331145|FG001|Overall Study|Other|1|||
154974024|NCT00631007|559331146|FG002|Overall Study|Other|0|||
154974025|NCT00631007|559331147|FG003|Overall Study|Other|0|||
154974026|NCT00631007|559331148|FG004|Overall Study|Other|1|||
154974027|NCT00631007|559331149|FG005|Overall Study|Other|0|||
154974028|NCT00683787|559331150|FG000|Overall Study|Progression|3|||
154974029|NCT00683787|559331151|FG001|Overall Study|Progression|3|||
154974030|NCT00683787|559331152|FG002|Overall Study|Progression|0|||
154974031|NCT00683787|559331150|FG000|Overall Study|Adverse Event|0|||
154974032|NCT00683787|559331151|FG001|Overall Study|Adverse Event|0|||
154974033|NCT00683787|559331152|FG002|Overall Study|Adverse Event|2|||
154974034|NCT00460109|559331153|FG000|Overall Study|Death|1|||
154974035|NCT01235715|559331154|FG000|Overall Study|Physician Decision|0|||
154974036|NCT01235715|559331155|FG001|Overall Study|Physician Decision|2|||
154974037|NCT03619876|559331156|FG000|Overall Study|Withdrawal by Subject|1|||
155110736|NCT00853242|559833091|FG003|Overall Study|Withdrawal by Subject|4|||
155110737|NCT00853242|559833092|FG004|Overall Study|Withdrawal by Subject|0|||
155110738|NCT00853242|559833093|FG005|Overall Study|Withdrawal by Subject|0|||
155110739|NCT00853242|559833094|FG006|Overall Study|Withdrawal by Subject|2|||
155110740|NCT00853242|559833088|FG000|Overall Study|Other|2|||
155110741|NCT00853242|559833089|FG001|Overall Study|Other|0|||
155110742|NCT00853242|559833090|FG002|Overall Study|Other|2|||
155110743|NCT00853242|559833091|FG003|Overall Study|Other|0|||
154974038|NCT03619876|559331157|FG001|Overall Study|Withdrawal by Subject|2|||
154974039|NCT03619876|559331156|FG000|Overall Study|Withdrawal due to incidental finding|0|||
154974040|NCT03619876|559331157|FG001|Overall Study|Withdrawal due to incidental finding|2|||
154974041|NCT02344745|559331158|FG000|Overall Study|Data collection sheets were lost|2|||
154974042|NCT02344745|559331159|FG001|Overall Study|Data collection sheets were lost|0|||
154974043|NCT02788513|559331160|FG000|Overall Study|Withdrawal by Subject|3|||
154974044|NCT02788513|559331161|FG001|Overall Study|Withdrawal by Subject|0|||
154974045|NCT02788513|559331162|FG002|Overall Study|Withdrawal by Subject|2|||
154974046|NCT02788513|559331163|FG003|Overall Study|Withdrawal by Subject|3|||
154974047|NCT02788513|559331164|FG004|Overall Study|Withdrawal by Subject|1|||
154974048|NCT02788513|559331160|FG000|Overall Study|Lost to Follow-up|1|||
154974049|NCT02788513|559331161|FG001|Overall Study|Lost to Follow-up|0|||
154974050|NCT02788513|559331162|FG002|Overall Study|Lost to Follow-up|0|||
155110744|NCT00853242|559833092|FG004|Overall Study|Other|0|||
155175134|NCT03658876|560080145|FG000|Overall Study|Withdrawal by Subject|2|||
154871934|NCT01912872|558958107|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
154871935|NCT01912872|558958108|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
154871936|NCT01912872|558958105|FG000|Overall Study|Protocol Violation|0|||
154871937|NCT01912872|558958106|FG001|Overall Study|Protocol Violation|0|||
154871938|NCT01912872|558958107|FG002|Overall Study|Protocol Violation|1|||
154871939|NCT01912872|558958108|FG003|Overall Study|Protocol Violation|0|||
154871940|NCT01912872|558958105|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
154871941|NCT01912872|558958106|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154871942|NCT01912872|558958107|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
154871943|NCT01912872|558958108|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
154871944|NCT01912872|558958105|FG000|Overall Study|Withdrawal of study medication|0|||
154871945|NCT01912872|558958106|FG001|Overall Study|Withdrawal of study medication|0|||
154871946|NCT01912872|558958107|FG002|Overall Study|Withdrawal of study medication|0|||
154871947|NCT01912872|558958108|FG003|Overall Study|Withdrawal of study medication|2|||
155175135|NCT03658876|560080146|FG001|Overall Study|Withdrawal by Subject|0|||
155175136|NCT03658876|560080145|FG000|Overall Study|Death|0|||
155175137|NCT03658876|560080146|FG001|Overall Study|Death|1|||
155175138|NCT03658876|560080145|FG000|Overall Study|Intercurrent illness|6|||
155175139|NCT03658876|560080146|FG001|Overall Study|Intercurrent illness|4|||
155175140|NCT03658876|560080145|FG000|Overall Study|Transplantation/other operation|1|||
155175141|NCT03658876|560080146|FG001|Overall Study|Transplantation/other operation|5|||
155175142|NCT00576420|560080147|FG000|Overall Study|Death|0|||
155175143|NCT00576420|560080148|FG001|Overall Study|Death|0|||
155175144|NCT00576420|560080149|FG002|Overall Study|Death|1|||
155175145|NCT02616146|560080150|FG000|Overall Study|Adverse Event|64|||
155175146|NCT02616146|560080151|FG001|Overall Study|Adverse Event|24|||
155175147|NCT02616146|560080150|FG000|Overall Study|Lost to Follow-up|23|||
155175148|NCT02616146|560080151|FG001|Overall Study|Lost to Follow-up|13|||
155175149|NCT02616146|560080150|FG000|Overall Study|Non-compliance with study protocol|2|||
155175150|NCT02616146|560080151|FG001|Overall Study|Non-compliance with study protocol|0|||
155175151|NCT02616146|560080150|FG000|Overall Study|Non-compliance with study drug|4|||
155175152|NCT02616146|560080151|FG001|Overall Study|Non-compliance with study drug|2|||
155175153|NCT02616146|560080150|FG000|Overall Study|Pregnancy|2|||
154871948|NCT01912872|558958105|FG000|Overall Study|Missing|0|||
154871949|NCT01912872|558958106|FG001|Overall Study|Missing|0|||
154871950|NCT01912872|558958107|FG002|Overall Study|Missing|0|||
154871951|NCT01912872|558958108|FG003|Overall Study|Missing|1|||
154871952|NCT00950690|558958113|FG000|Overall Study|Death|4|||
154871953|NCT00950690|558958113|FG000|Overall Study|Adverse Event|15|||
154871954|NCT00950690|558958113|FG000|Overall Study|Lack of Efficacy|22|||
154871955|NCT00950690|558958113|FG000|Overall Study|Lost to Follow-up|40|||
154871956|NCT00950690|558958113|FG000|Overall Study|Other|163|||
154871957|NCT01713036|558958114|FG000|Overall Study|Death|1|||
154871958|NCT00592358|558958115|FG000|Overall Study|Withdrawal by Subject|2|||
154871959|NCT00592358|558958115|FG000|Overall Study|Adverse Event|1|||
154871960|NCT00592358|558958115|FG000|Overall Study|Lack of Efficacy|2|||
154871961|NCT00592358|558958115|FG000|Overall Study|Inability to swallow pills|1|||
154871962|NCT04760314|558958118|FG000|Induction Period|Withdrawal by Subject|0|||
154871963|NCT04760314|558958119|FG001|Induction Period|Withdrawal by Subject|1|||
154871964|NCT04760314|558958120|FG002|Induction Period|Withdrawal by Subject|1|||
154871965|NCT04760314|558958121|FG003|Induction Period|Withdrawal by Subject|0|||
154871966|NCT04760314|558958122|FG004|Induction Period|Withdrawal by Subject|0|||
154871967|NCT04760314|558958123|FG005|Induction Period|Withdrawal by Subject|0|||
154871968|NCT04760314|558958124|FG006|Induction Period|Withdrawal by Subject|0|||
154871969|NCT04760314|558958125|FG007|Induction Period|Withdrawal by Subject|0|||
154871970|NCT04760314|558958126|FG008|Induction Period|Withdrawal by Subject|0|||
154871971|NCT04760314|558958127|FG009|Induction Period|Withdrawal by Subject|0|||
154871972|NCT04760314|558958128|FG010|Induction Period|Withdrawal by Subject|0|||
154871973|NCT04760314|558958118|FG000|Induction Period|Adverse Event|0|||
154871974|NCT04760314|558958119|FG001|Induction Period|Adverse Event|0|||
154871975|NCT04760314|558958120|FG002|Induction Period|Adverse Event|2|||
154871976|NCT04760314|558958121|FG003|Induction Period|Adverse Event|0|||
154871977|NCT04760314|558958122|FG004|Induction Period|Adverse Event|0|||
154871978|NCT04760314|558958123|FG005|Induction Period|Adverse Event|0|||
154871979|NCT04760314|558958124|FG006|Induction Period|Adverse Event|0|||
154871980|NCT04760314|558958125|FG007|Induction Period|Adverse Event|0|||
154871981|NCT04760314|558958126|FG008|Induction Period|Adverse Event|0|||
154871982|NCT04760314|558958127|FG009|Induction Period|Adverse Event|0|||
155175154|NCT02616146|560080151|FG001|Overall Study|Pregnancy|2|||
155175155|NCT02616146|560080150|FG000|Overall Study|Pregnancy wish|3|||
155175156|NCT02616146|560080151|FG001|Overall Study|Pregnancy wish|0|||
154871983|NCT04760314|558958128|FG010|Induction Period|Adverse Event|0|||
154871984|NCT04760314|558958118|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
154871985|NCT04760314|558958119|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
155175157|NCT02616146|560080150|FG000|Overall Study|Protocol Violation|6|||
155175158|NCT02616146|560080151|FG001|Overall Study|Protocol Violation|3|||
155175159|NCT02616146|560080150|FG000|Overall Study|Study terminated by sponsor|1372|||
154871986|NCT04760314|558958120|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
154871987|NCT04760314|558958121|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
154871988|NCT04760314|558958122|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
154871989|NCT04760314|558958123|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
154871990|NCT04760314|558958124|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
154871991|NCT04760314|558958125|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
154974051|NCT02788513|559331163|FG003|Overall Study|Lost to Follow-up|0|||
154974052|NCT02788513|559331164|FG004|Overall Study|Lost to Follow-up|1|||
154974053|NCT02788513|559331160|FG000|Overall Study|Adverse Event|5|||
154974054|NCT02788513|559331161|FG001|Overall Study|Adverse Event|8|||
154974055|NCT02788513|559331162|FG002|Overall Study|Adverse Event|4|||
154871992|NCT04760314|558958126|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
154871993|NCT04760314|558958127|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
154871994|NCT04760314|558958128|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
154871995|NCT04760314|558958118|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154871996|NCT04760314|558958119|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154871997|NCT04760314|558958120|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154871998|NCT04760314|558958121|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
154871999|NCT04760314|558958122|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154872000|NCT04760314|558958123|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
154872001|NCT04760314|558958124|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
154872002|NCT04760314|558958125|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154872003|NCT04760314|558958126|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154872004|NCT04760314|558958127|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154872005|NCT04760314|558958128|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
154872006|NCT04760314|558958118|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872007|NCT04760314|558958119|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872008|NCT04760314|558958120|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872009|NCT04760314|558958121|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872010|NCT04760314|558958122|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
154872011|NCT04760314|558958123|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872012|NCT04760314|558958124|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872013|NCT04760314|558958125|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872014|NCT04760314|558958126|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872015|NCT04760314|558958127|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872016|NCT04760314|558958128|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
154872017|NCT04760314|558958118|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
154872018|NCT04760314|558958119|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
154872019|NCT04760314|558958120|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
154872020|NCT04760314|558958121|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
154872021|NCT04760314|558958122|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
154872022|NCT04760314|558958123|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
154872023|NCT04760314|558958124|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
154872024|NCT04760314|558958125|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
154872025|NCT04760314|558958126|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
154872026|NCT04760314|558958127|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
154872027|NCT04760314|558958128|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
154872028|NCT04760314|558958118|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872029|NCT04760314|558958119|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872030|NCT04760314|558958120|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872031|NCT04760314|558958121|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872032|NCT04760314|558958122|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872033|NCT04760314|558958123|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872034|NCT04760314|558958124|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872035|NCT04760314|558958125|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
154872036|NCT04760314|558958126|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154872037|NCT04760314|558958127|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
154872038|NCT04760314|558958128|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
154872039|NCT04760314|558958118|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872040|NCT04760314|558958119|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872041|NCT04760314|558958120|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872042|NCT04760314|558958121|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872043|NCT04760314|558958122|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872044|NCT04760314|558958123|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872045|NCT04760314|558958124|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872046|NCT04760314|558958125|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
154974056|NCT02788513|559331163|FG003|Overall Study|Adverse Event|2|||
154974057|NCT02788513|559331164|FG004|Overall Study|Adverse Event|2|||
154974058|NCT02788513|559331160|FG000|Overall Study|Protocol Violation|0|||
155175160|NCT02616146|560080151|FG001|Overall Study|Study terminated by sponsor|432|||
155175161|NCT02616146|560080150|FG000|Overall Study|Participant moved|4|||
155175162|NCT02616146|560080151|FG001|Overall Study|Participant moved|3|||
155175163|NCT02616146|560080150|FG000|Overall Study|Withdrawal by Subject|30|||
155175164|NCT02616146|560080151|FG001|Overall Study|Withdrawal by Subject|24|||
155175165|NCT02616146|560080150|FG000|Overall Study|Physician Decision|2|||
155175166|NCT02616146|560080151|FG001|Overall Study|Physician Decision|1|||
155175167|NCT01221272|560080153|FG000|Period 1|Adverse Event|2|||
155175168|NCT01221272|560080154|FG001|Period 1|Adverse Event|0|||
155175169|NCT01221272|560080153|FG000|Period 1|Consent Withdrawal|0|||
155175170|NCT01221272|560080154|FG001|Period 1|Consent Withdrawal|1|||
155175171|NCT01221272|560080153|FG000|Period 1|Significant Dosing Noncompliance|0|||
155175172|NCT01221272|560080154|FG001|Period 1|Significant Dosing Noncompliance|1|||
155175173|NCT01221272|560080153|FG000|Period 2|Adverse Event|0|||
155175174|NCT01221272|560080154|FG001|Period 2|Adverse Event|2|||
155175175|NCT01340872|560080155|FG000|Double-blind Phase|Adverse Event|6|||
155175176|NCT01340872|560080156|FG001|Double-blind Phase|Adverse Event|4|||
155175177|NCT01340872|560080157|FG002|Double-blind Phase|Adverse Event|0|||
155175178|NCT01340872|560080158|FG003|Double-blind Phase|Adverse Event|0|||
155175179|NCT01340872|560080155|FG000|Double-blind Phase|Withdrawal by Subject|3|||
155175180|NCT01340872|560080156|FG001|Double-blind Phase|Withdrawal by Subject|5|||
155175181|NCT01340872|560080157|FG002|Double-blind Phase|Withdrawal by Subject|0|||
155175182|NCT01340872|560080158|FG003|Double-blind Phase|Withdrawal by Subject|0|||
154872047|NCT04760314|558958126|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
154872048|NCT04760314|558958127|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
154872049|NCT04760314|558958128|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154872050|NCT04760314|558958118|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155110745|NCT00853242|559833093|FG005|Overall Study|Other|1|||
155110746|NCT00853242|559833094|FG006|Overall Study|Other|2|||
155110747|NCT03497975|559833095|FG000|Overall Study|Withdrew Consent|34|||
155110748|NCT03497975|559833096|FG001|Overall Study|Withdrew Consent|35|||
155110749|NCT03497975|559833095|FG000|Overall Study|Lost to Follow-up|7|||
155110750|NCT03497975|559833096|FG001|Overall Study|Lost to Follow-up|7|||
155110751|NCT03497975|559833095|FG000|Overall Study|Physician Decision|4|||
155110752|NCT03497975|559833096|FG001|Overall Study|Physician Decision|5|||
155110753|NCT03497975|559833095|FG000|Overall Study|Discontinued|42|||
155110754|NCT03497975|559833096|FG001|Overall Study|Discontinued|39|||
155110755|NCT03497975|559833095|FG000|Overall Study|Reason Not Specified|15|||
155110756|NCT03497975|559833096|FG001|Overall Study|Reason Not Specified|14|||
155110757|NCT02516098|559833097|FG000|Period 1|Protocol Violation|1|||
155110758|NCT02516098|559833098|FG001|Period 1|Protocol Violation|0|||
155110759|NCT02516098|559833097|FG000|Washout After Period 1|Adverse Event|0|||
155110760|NCT02516098|559833098|FG001|Washout After Period 1|Adverse Event|1|||
155110761|NCT02516098|559833097|FG000|Period 2|Withdrawal by Subject|0|||
155110762|NCT02516098|559833098|FG001|Period 2|Withdrawal by Subject|1|||
155110763|NCT01355679|559833100|FG000|Overall Study|benign tumor types found at biopsy|2|||
155110764|NCT02466425|559833104|FG000|Overall Study|Adverse Event|3|||
155110765|NCT02466425|559833105|FG001|Overall Study|Adverse Event|11|||
155110766|NCT02466425|559833104|FG000|Overall Study|Lack of Efficacy|4|||
155110767|NCT02466425|559833105|FG001|Overall Study|Lack of Efficacy|1|||
155110768|NCT02466425|559833104|FG000|Overall Study|Lost to Follow-up|3|||
155110769|NCT02466425|559833105|FG001|Overall Study|Lost to Follow-up|0|||
155110770|NCT02466425|559833104|FG000|Overall Study|Protocol Violation|1|||
155110771|NCT02466425|559833105|FG001|Overall Study|Protocol Violation|0|||
155110772|NCT02466425|559833104|FG000|Overall Study|Withdrawal by Subject|0|||
155110773|NCT02466425|559833105|FG001|Overall Study|Withdrawal by Subject|1|||
155110774|NCT02466425|559833104|FG000|Overall Study|Other|1|||
155110775|NCT02466425|559833105|FG001|Overall Study|Other|3|||
155110776|NCT02466425|559833104|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155175183|NCT01340872|560080155|FG000|Double-blind Phase|Lost to Follow-up|0|||
155175184|NCT01340872|560080156|FG001|Double-blind Phase|Lost to Follow-up|1|||
155175185|NCT01340872|560080157|FG002|Double-blind Phase|Lost to Follow-up|0|||
154872051|NCT04760314|558958119|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872052|NCT04760314|558958120|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872053|NCT04760314|558958121|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
155110777|NCT02466425|559833105|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155110778|NCT00582712|559833106|FG000|Overall Study|Adverse Event|1|||
155110779|NCT00582712|559833106|FG000|Overall Study|Lack of Efficacy|1|||
155110780|NCT00582712|559833106|FG000|Overall Study|Withdrawal by Subject|1|||
155110781|NCT00582712|559833106|FG000|Overall Study|Complicating disease requiring treatment|1|||
155110782|NCT05141175|559833113|FG000|Overall Study|Withdrawal by Subject|1|||
155110783|NCT01813058|559833120|FG000|Overall Study|Withdrawal by Subject|5|||
155110784|NCT01813058|559833121|FG001|Overall Study|Withdrawal by Subject|4|||
155110785|NCT03585764|559833122|FG000|Overall Study|Death|3|||
155175186|NCT01340872|560080158|FG003|Double-blind Phase|Lost to Follow-up|0|||
155175187|NCT01340872|560080155|FG000|Double-blind Phase|Protocol Violation|0|||
155175188|NCT01340872|560080156|FG001|Double-blind Phase|Protocol Violation|1|||
154872054|NCT04760314|558958122|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872055|NCT04760314|558958123|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872056|NCT04760314|558958124|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872057|NCT04760314|558958125|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
154872058|NCT04760314|558958126|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872059|NCT04760314|558958127|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872060|NCT04760314|558958128|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154872061|NCT04760314|558958118|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872062|NCT04760314|558958119|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872063|NCT04760314|558958120|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872064|NCT04760314|558958121|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872065|NCT04760314|558958122|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872066|NCT04760314|558958123|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872067|NCT04760314|558958124|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872068|NCT04760314|558958125|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872069|NCT04760314|558958126|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
154872070|NCT04760314|558958127|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
154872071|NCT04760314|558958128|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
154872072|NCT01013883|558958134|FG000|Overall Study|Lost to Follow-up|2|||
154872073|NCT01013883|558958135|FG001|Overall Study|Lost to Follow-up|2|||
154872074|NCT01371838|558958136|FG000|Overall Study|Withdrawal by Subject|27|||
154872075|NCT01371838|558958137|FG001|Overall Study|Withdrawal by Subject|33|||
154872076|NCT01371838|558958136|FG000|Overall Study|Lost to Follow-up|10|||
154872077|NCT01371838|558958137|FG001|Overall Study|Lost to Follow-up|20|||
154872078|NCT01371838|558958136|FG000|Overall Study|Death|3|||
154872079|NCT01371838|558958137|FG001|Overall Study|Death|4|||
154872080|NCT01371838|558958136|FG000|Overall Study|Protocol Violation|3|||
154872081|NCT01371838|558958137|FG001|Overall Study|Protocol Violation|0|||
154872082|NCT01371838|558958136|FG000|Overall Study|Investigator Decision|3|||
154872083|NCT01371838|558958137|FG001|Overall Study|Investigator Decision|8|||
154872084|NCT01371838|558958136|FG000|Overall Study|Last follow-up visit not conducted|2|||
154872085|NCT01371838|558958137|FG001|Overall Study|Last follow-up visit not conducted|0|||
154872086|NCT01371838|558958136|FG000|Overall Study|Lack of therapeutic response|0|||
154872087|NCT01371838|558958137|FG001|Overall Study|Lack of therapeutic response|1|||
154872088|NCT01371838|558958136|FG000|Overall Study|Surgery|1|||
154872089|NCT01371838|558958137|FG001|Overall Study|Surgery|0|||
154872090|NCT00641043|558958142|FG000|Overall Study|Adverse Event|6|||
154872091|NCT00641043|558958143|FG001|Overall Study|Adverse Event|4|||
154872092|NCT00641043|558958142|FG000|Overall Study|Protocol Violation|2|||
154872093|NCT00641043|558958143|FG001|Overall Study|Protocol Violation|3|||
154872094|NCT00641043|558958142|FG000|Overall Study|Lost to Follow-up|3|||
154872095|NCT00641043|558958143|FG001|Overall Study|Lost to Follow-up|2|||
154872096|NCT00641043|558958142|FG000|Overall Study|Withdrawal by Subject|4|||
154872097|NCT00641043|558958143|FG001|Overall Study|Withdrawal by Subject|4|||
154872098|NCT00641043|558958142|FG000|Overall Study|Other incl. lack of efficacy|4|||
154872099|NCT00641043|558958143|FG001|Overall Study|Other incl. lack of efficacy|2|||
154872100|NCT04275310|558958146|FG000|Overall Study|Non-randomized due to running out of funding|4|||
154872101|NCT04275310|558958147|FG001|Overall Study|Non-randomized due to running out of funding|0|||
154872102|NCT02345161|558958150|FG000|Overall Study|Withdrawal by Subject|25|||
154872103|NCT02345161|558958151|FG001|Overall Study|Withdrawal by Subject|33|||
154872104|NCT02345161|558958150|FG000|Overall Study|Adverse Event|16|||
154872105|NCT02345161|558958151|FG001|Overall Study|Adverse Event|19|||
154872106|NCT02345161|558958150|FG000|Overall Study|Physician Decision|4|||
154872107|NCT02345161|558958151|FG001|Overall Study|Physician Decision|4|||
154872108|NCT02345161|558958150|FG000|Overall Study|Lost to Follow-up|0|||
154872109|NCT02345161|558958151|FG001|Overall Study|Lost to Follow-up|1|||
154872110|NCT02225223|558958152|FG000|Overall Study|Death|10|||
154872111|NCT02225223|558958153|FG001|Overall Study|Death|1|||
154872112|NCT02225223|558958152|FG000|Overall Study|Lost to Follow-up|5|||
154872113|NCT02225223|558958153|FG001|Overall Study|Lost to Follow-up|0|||
154872114|NCT02225223|558958152|FG000|Overall Study|Other|1|||
154872115|NCT02225223|558958153|FG001|Overall Study|Other|2|||
154872116|NCT02225223|558958152|FG000|Overall Study|Physician Decision|1|||
154872117|NCT02225223|558958153|FG001|Overall Study|Physician Decision|0|||
154872118|NCT02225223|558958152|FG000|Overall Study|Withdrawal by Subject|2|||
154872119|NCT02225223|558958153|FG001|Overall Study|Withdrawal by Subject|2|||
154872120|NCT01650779|558958154|FG000|Overall Study|Withdrawal by Subject|1|||
154872121|NCT03567291|558958155|FG000|Period I|Adverse Event|14|||
154872122|NCT03567291|558958156|FG001|Period I|Adverse Event|0|||
154872123|NCT03567291|558958157|FG002|Period I|Adverse Event|0|||
154872124|NCT03567291|558958158|FG003|Period I|Adverse Event|0|||
154872125|NCT03567291|558958155|FG000|Period I|Protocol Violation|1|||
154872126|NCT03567291|558958156|FG001|Period I|Protocol Violation|0|||
154872127|NCT03567291|558958157|FG002|Period I|Protocol Violation|0|||
154872128|NCT03567291|558958158|FG003|Period I|Protocol Violation|0|||
154872129|NCT03567291|558958155|FG000|Period I|Withdrawal by Subject|23|||
154872130|NCT03567291|558958156|FG001|Period I|Withdrawal by Subject|0|||
154872131|NCT03567291|558958157|FG002|Period I|Withdrawal by Subject|0|||
154872132|NCT03567291|558958158|FG003|Period I|Withdrawal by Subject|0|||
154872133|NCT03567291|558958155|FG000|Period I|Lost to Follow-up|2|||
154872134|NCT03567291|558958156|FG001|Period I|Lost to Follow-up|0|||
154872135|NCT03567291|558958157|FG002|Period I|Lost to Follow-up|0|||
154872136|NCT03567291|558958158|FG003|Period I|Lost to Follow-up|0|||
154872137|NCT03567291|558958155|FG000|Period I|Terminated by sponsor|44|||
154872138|NCT03567291|558958156|FG001|Period I|Terminated by sponsor|0|||
154872139|NCT03567291|558958157|FG002|Period I|Terminated by sponsor|0|||
154872140|NCT03567291|558958158|FG003|Period I|Terminated by sponsor|0|||
154872141|NCT03567291|558958155|FG000|Period I|Missing or unknown|7|||
154872142|NCT03567291|558958156|FG001|Period I|Missing or unknown|0|||
154872143|NCT03567291|558958157|FG002|Period I|Missing or unknown|0|||
154872144|NCT03567291|558958158|FG003|Period I|Missing or unknown|0|||
154872145|NCT03567291|558958155|FG000|Period II|Adverse Event|0|||
154872146|NCT03567291|558958156|FG001|Period II|Adverse Event|1|||
154872147|NCT03567291|558958157|FG002|Period II|Adverse Event|0|||
154872148|NCT03567291|558958158|FG003|Period II|Adverse Event|0|||
154872149|NCT03567291|558958155|FG000|Period II|Missing or unknown|0|||
154872150|NCT03567291|558958156|FG001|Period II|Missing or unknown|2|||
154872151|NCT03567291|558958157|FG002|Period II|Missing or unknown|1|||
154872152|NCT03567291|558958158|FG003|Period II|Missing or unknown|0|||
154872153|NCT03567291|558958155|FG000|Period III|Adverse Event|0|||
154872154|NCT03567291|558958156|FG001|Period III|Adverse Event|0|||
154872155|NCT03567291|558958157|FG002|Period III|Adverse Event|0|||
154872156|NCT03567291|558958158|FG003|Period III|Adverse Event|4|||
154872157|NCT03567291|558958155|FG000|Period III|Withdrawal by Subject|0|||
154872158|NCT03567291|558958156|FG001|Period III|Withdrawal by Subject|0|||
154872159|NCT03567291|558958157|FG002|Period III|Withdrawal by Subject|0|||
154872160|NCT03567291|558958158|FG003|Period III|Withdrawal by Subject|4|||
154872161|NCT03567291|558958155|FG000|Period III|Lost to Follow-up|0|||
154872162|NCT03567291|558958156|FG001|Period III|Lost to Follow-up|0|||
154872163|NCT03567291|558958157|FG002|Period III|Lost to Follow-up|0|||
154872164|NCT03567291|558958158|FG003|Period III|Lost to Follow-up|1|||
154872165|NCT03567291|558958155|FG000|Period III|Terminated by sponsor|0|||
154872166|NCT03567291|558958156|FG001|Period III|Terminated by sponsor|0|||
154872167|NCT03567291|558958157|FG002|Period III|Terminated by sponsor|0|||
154872168|NCT03567291|558958158|FG003|Period III|Terminated by sponsor|68|||
154872169|NCT03567291|558958155|FG000|Period III|Missing or unknown|0|||
154872170|NCT03567291|558958156|FG001|Period III|Missing or unknown|0|||
154872171|NCT03567291|558958157|FG002|Period III|Missing or unknown|0|||
154872172|NCT03567291|558958158|FG003|Period III|Missing or unknown|8|||
154872173|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
154872174|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
154872175|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
154872176|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
154872177|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
154872178|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
154872179|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
154872180|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
154872181|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
154872182|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
154872183|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
154872184|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
154872185|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
154872186|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
154872187|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
154872188|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
154872189|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
154872190|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
154872191|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
154872192|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
154872193|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
154872194|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
154872195|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
154872196|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
154872197|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
154872198|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
154872199|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
154872200|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
154872201|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
154872202|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
154872203|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
154872204|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
155110786|NCT03585764|559833123|FG001|Overall Study|Death|2|||
155110787|NCT03585764|559833124|FG002|Overall Study|Death|3|||
155110788|NCT03585764|559833125|FG003|Overall Study|Death|0|||
155110789|NCT03585764|559833122|FG000|Overall Study|Lost to Follow-up|0|||
154974059|NCT02788513|559331161|FG001|Overall Study|Protocol Violation|0|||
154974060|NCT02788513|559331162|FG002|Overall Study|Protocol Violation|1|||
154974061|NCT02788513|559331163|FG003|Overall Study|Protocol Violation|1|||
154974062|NCT02788513|559331164|FG004|Overall Study|Protocol Violation|0|||
154974063|NCT02788513|559331160|FG000|Overall Study|Subject decided to stop taking treatment|0|||
154974064|NCT02788513|559331161|FG001|Overall Study|Subject decided to stop taking treatment|0|||
154974065|NCT02788513|559331162|FG002|Overall Study|Subject decided to stop taking treatment|1|||
154974066|NCT02788513|559331163|FG003|Overall Study|Subject decided to stop taking treatment|0|||
154974067|NCT02788513|559331164|FG004|Overall Study|Subject decided to stop taking treatment|0|||
154974068|NCT02788513|559331160|FG000|Overall Study|Decision by the study team|0|||
154974069|NCT02788513|559331161|FG001|Overall Study|Decision by the study team|0|||
155110790|NCT03585764|559833123|FG001|Overall Study|Lost to Follow-up|1|||
155110791|NCT03585764|559833124|FG002|Overall Study|Lost to Follow-up|0|||
154872205|NCT00958568|558958159|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
154872206|NCT00958568|558958160|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
154872207|NCT00958568|558958161|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
154872208|NCT00958568|558958162|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
154872209|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
154872210|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
154872211|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
154872212|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
154872213|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
154872214|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
154872215|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
154872216|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
154872217|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
154872218|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
154872219|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
154872220|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
154872221|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
154872222|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
154872223|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
154872224|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
154872225|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
154872226|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
154872227|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
154872228|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
154872229|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
154872230|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
154872231|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
154872232|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
154872233|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
154872234|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
154872235|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
154974070|NCT02788513|559331162|FG002|Overall Study|Decision by the study team|0|||
154974071|NCT02788513|559331163|FG003|Overall Study|Decision by the study team|0|||
155110792|NCT03585764|559833125|FG003|Overall Study|Lost to Follow-up|0|||
155110793|NCT03585764|559833122|FG000|Overall Study|Physician Decision|0|||
155110794|NCT03585764|559833123|FG001|Overall Study|Physician Decision|0|||
155110795|NCT03585764|559833124|FG002|Overall Study|Physician Decision|2|||
155110796|NCT03585764|559833125|FG003|Overall Study|Physician Decision|0|||
155110797|NCT01581021|559833127|FG000|Overall Study|Lost to Follow-up|4|||
155110798|NCT01581021|559833128|FG001|Overall Study|Lost to Follow-up|6|||
155110799|NCT01581021|559833127|FG000|Overall Study|More than 2 hooks in thoracic|3|||
155110800|NCT01581021|559833128|FG001|Overall Study|More than 2 hooks in thoracic|0|||
155110801|NCT01581021|559833127|FG000|Overall Study|Neuromuscular|2|||
155110802|NCT01581021|559833128|FG001|Overall Study|Neuromuscular|1|||
155110803|NCT01581021|559833127|FG000|Overall Study|Not Randomized|1|||
155110804|NCT01581021|559833128|FG001|Overall Study|Not Randomized|2|||
155110805|NCT01581021|559833127|FG000|Overall Study|Lenke 6 Classification|0|||
155110806|NCT01581021|559833128|FG001|Overall Study|Lenke 6 Classification|1|||
155110807|NCT01581021|559833127|FG000|Overall Study|Lack of Efficacy|0|||
155110808|NCT01581021|559833128|FG001|Overall Study|Lack of Efficacy|1|||
155110809|NCT03604172|559833129|FG000|Overall Study|Lost to Follow-up|1|||
155110810|NCT03604172|559833130|FG001|Overall Study|Lost to Follow-up|2|||
154872236|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
154872237|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
154872238|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
154872239|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
154872240|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
154872241|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
154872242|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
154872243|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
154872244|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
154872245|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
154872246|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
154872247|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
154872248|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
154872249|NCT00958568|558958159|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
154872250|NCT00958568|558958160|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
154872251|NCT00958568|558958161|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
154872252|NCT00958568|558958162|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
154872253|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
154872254|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
154872255|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
154872256|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
154872257|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
154872258|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
154872259|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
154872260|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
154872261|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
154872262|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
154872263|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
154872264|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
154872265|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
154872266|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
154872267|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
154872268|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
154872269|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
154872270|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
154872271|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
154872272|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
154872273|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
154872274|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
154872275|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
154872276|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
154872277|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
154872278|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
154872279|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
154872280|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
155110811|NCT02676895|559833131|FG000|Overall Study|Administrative reason|1|||
155110812|NCT02676895|559833132|FG001|Overall Study|Administrative reason|0|||
155110813|NCT02676895|559833133|FG002|Overall Study|Administrative reason|0|||
155110814|NCT02676895|559833131|FG000|Overall Study|Protocol Violation|1|||
155110815|NCT02676895|559833132|FG001|Overall Study|Protocol Violation|0|||
155110816|NCT02676895|559833133|FG002|Overall Study|Protocol Violation|0|||
155110817|NCT02676895|559833131|FG000|Overall Study|Adverse Event|0|||
155110818|NCT02676895|559833132|FG001|Overall Study|Adverse Event|3|||
155110819|NCT02676895|559833133|FG002|Overall Study|Adverse Event|1|||
155110820|NCT02676895|559833131|FG000|Overall Study|Lost to Follow-up|0|||
155110821|NCT02676895|559833132|FG001|Overall Study|Lost to Follow-up|0|||
155110822|NCT02676895|559833133|FG002|Overall Study|Lost to Follow-up|1|||
155110823|NCT02676895|559833131|FG000|Overall Study|Withdrawal by Subject|0|||
155110824|NCT02676895|559833132|FG001|Overall Study|Withdrawal by Subject|0|||
155110825|NCT02676895|559833133|FG002|Overall Study|Withdrawal by Subject|1|||
155110826|NCT00054327|559833134|FG000|Overall Study|Engraftment failure|1|||
155110827|NCT00054327|559833135|FG001|Overall Study|Engraftment failure|0|||
155110828|NCT00054327|559833136|FG002|Overall Study|Engraftment failure|0|||
155110829|NCT00054327|559833137|FG003|Overall Study|Engraftment failure|0|||
155110830|NCT00054327|559833138|FG004|Overall Study|Engraftment failure|0|||
155110831|NCT00054327|559833139|FG005|Overall Study|Engraftment failure|0|||
155110832|NCT03028129|559833145|FG000|Overall Study|Adverse Event|13|||
155110833|NCT03028129|559833146|FG001|Overall Study|Adverse Event|2|||
155110834|NCT03028129|559833145|FG000|Overall Study|Lost to Follow-up|50|||
155110835|NCT03028129|559833146|FG001|Overall Study|Lost to Follow-up|38|||
155110836|NCT03028129|559833145|FG000|Overall Study|Physician Decision|0|||
155110837|NCT03028129|559833146|FG001|Overall Study|Physician Decision|1|||
155110838|NCT03028129|559833145|FG000|Overall Study|Protocol Violation|1|||
155110839|NCT03028129|559833146|FG001|Overall Study|Protocol Violation|1|||
155110840|NCT03028129|559833145|FG000|Overall Study|Withdrawal by Subject|62|||
155110841|NCT03028129|559833146|FG001|Overall Study|Withdrawal by Subject|45|||
155110842|NCT00923351|559833147|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
155110843|NCT00923351|559833148|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
155110844|NCT00923351|559833149|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
155110845|NCT00182078|559833150|FG000|Overall Study|Withdrawal by Subject|1|||
155110846|NCT00182078|559833151|FG001|Overall Study|Withdrawal by Subject|0|||
155110847|NCT01076205|559833152|FG000|Overall Study|Adverse Drug Reaction|299|||
155110848|NCT01076205|559833152|FG000|Overall Study|Lack of Effectiveness|1423|||
155110849|NCT01076205|559833152|FG000|Overall Study|Other Reason|1075|||
155110850|NCT01076205|559833152|FG000|Overall Study|Unknown Reason|71|||
155110851|NCT01076205|559833152|FG000|Overall Study|Lost to Follow-up|3151|||
155110852|NCT00361231|559833153|FG000|Overall Study|Physician Decision|3|||
155110853|NCT00361231|559833153|FG000|Overall Study|Symptomatic deterioration|5|||
155110854|NCT00361231|559833153|FG000|Overall Study|Radiographic disease progression|16|||
155110855|NCT00361231|559833153|FG000|Overall Study|Withdrawal by Subject|4|||
155110856|NCT00361231|559833153|FG000|Overall Study|Adverse Event|6|||
155110857|NCT01732510|559833154|FG000|Overall Study|Adverse Event|0|||
155110858|NCT01732510|559833155|FG001|Overall Study|Adverse Event|1|||
155110859|NCT01732510|559833156|FG002|Overall Study|Adverse Event|1|||
155110860|NCT01732510|559833157|FG003|Overall Study|Adverse Event|0|||
155110861|NCT01732510|559833158|FG004|Overall Study|Adverse Event|0|||
155110862|NCT01732510|559833159|FG005|Overall Study|Adverse Event|0|||
155110863|NCT01732510|559833160|FG006|Overall Study|Adverse Event|1|||
155110864|NCT01732510|559833154|FG000|Overall Study|Protocol Violation|0|||
155110865|NCT01732510|559833155|FG001|Overall Study|Protocol Violation|0|||
155110866|NCT01732510|559833156|FG002|Overall Study|Protocol Violation|0|||
155110867|NCT01732510|559833157|FG003|Overall Study|Protocol Violation|1|||
155110868|NCT01732510|559833158|FG004|Overall Study|Protocol Violation|0|||
155110869|NCT01732510|559833159|FG005|Overall Study|Protocol Violation|0|||
155110870|NCT01732510|559833160|FG006|Overall Study|Protocol Violation|0|||
155110871|NCT01732510|559833154|FG000|Overall Study|Withdrawal by Subject|1|||
155110872|NCT01732510|559833155|FG001|Overall Study|Withdrawal by Subject|3|||
155110873|NCT01732510|559833156|FG002|Overall Study|Withdrawal by Subject|2|||
155110874|NCT01732510|559833157|FG003|Overall Study|Withdrawal by Subject|1|||
155110875|NCT01732510|559833158|FG004|Overall Study|Withdrawal by Subject|5|||
155110876|NCT01732510|559833159|FG005|Overall Study|Withdrawal by Subject|0|||
155110877|NCT01732510|559833160|FG006|Overall Study|Withdrawal by Subject|1|||
155110878|NCT01732510|559833154|FG000|Overall Study|Lost to Follow-up|0|||
155110879|NCT01732510|559833155|FG001|Overall Study|Lost to Follow-up|0|||
155110880|NCT01732510|559833156|FG002|Overall Study|Lost to Follow-up|1|||
155110881|NCT01732510|559833157|FG003|Overall Study|Lost to Follow-up|1|||
155110882|NCT01732510|559833158|FG004|Overall Study|Lost to Follow-up|0|||
155110883|NCT01732510|559833159|FG005|Overall Study|Lost to Follow-up|1|||
155110884|NCT01732510|559833160|FG006|Overall Study|Lost to Follow-up|0|||
155110885|NCT01732510|559833154|FG000|Overall Study|Physician Decision|0|||
155110886|NCT01732510|559833155|FG001|Overall Study|Physician Decision|1|||
155110887|NCT01732510|559833156|FG002|Overall Study|Physician Decision|0|||
155110888|NCT01732510|559833157|FG003|Overall Study|Physician Decision|0|||
155110889|NCT01732510|559833158|FG004|Overall Study|Physician Decision|0|||
155110890|NCT01732510|559833159|FG005|Overall Study|Physician Decision|0|||
155110891|NCT01732510|559833160|FG006|Overall Study|Physician Decision|0|||
155110892|NCT01732510|559833154|FG000|Overall Study|Pregnancy|0|||
155110893|NCT01732510|559833155|FG001|Overall Study|Pregnancy|0|||
155110894|NCT01732510|559833156|FG002|Overall Study|Pregnancy|0|||
155110895|NCT01732510|559833157|FG003|Overall Study|Pregnancy|1|||
155110896|NCT01732510|559833158|FG004|Overall Study|Pregnancy|0|||
155110897|NCT01732510|559833159|FG005|Overall Study|Pregnancy|0|||
155110898|NCT01732510|559833160|FG006|Overall Study|Pregnancy|0|||
155110899|NCT01732510|559833154|FG000|Overall Study|Study Terminated By Sponsor|0|||
155110900|NCT01732510|559833155|FG001|Overall Study|Study Terminated By Sponsor|0|||
155110901|NCT01732510|559833156|FG002|Overall Study|Study Terminated By Sponsor|0|||
155110902|NCT01732510|559833157|FG003|Overall Study|Study Terminated By Sponsor|1|||
155110903|NCT01732510|559833158|FG004|Overall Study|Study Terminated By Sponsor|0|||
155110904|NCT01732510|559833159|FG005|Overall Study|Study Terminated By Sponsor|12|||
155110905|NCT01732510|559833160|FG006|Overall Study|Study Terminated By Sponsor|6|||
155110906|NCT01262560|559833162|FG000|Overall Study|Protocol Violation|0|||
155110907|NCT01262560|559833163|FG001|Overall Study|Protocol Violation|1|||
155110908|NCT01262560|559833164|FG002|Overall Study|Protocol Violation|2|||
155110909|NCT01932372|559833169|FG000|Overall Study|Not meeting eligibility criteria|33|||
155110910|NCT01932372|559833170|FG001|Overall Study|Not meeting eligibility criteria|179|||
155110911|NCT03594747|559833171|FG000|Overall Study|Death|78|||
155110912|NCT03594747|559833172|FG001|Overall Study|Death|86|||
154872281|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
154872282|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
154872283|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
154872284|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
154872285|NCT00958568|558958159|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
154872286|NCT00958568|558958160|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
154872287|NCT00958568|558958161|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
154872288|NCT00958568|558958162|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
154872289|NCT00972244|558958163|FG000|Overall Study|Incorrect Enrolment|1|||
154872290|NCT00972244|558958164|FG001|Overall Study|Incorrect Enrolment|0|||
154872291|NCT00972244|558958165|FG002|Overall Study|Incorrect Enrolment|0|||
154872292|NCT00972244|558958166|FG003|Overall Study|Incorrect Enrolment|0|||
154974072|NCT02788513|559331164|FG004|Overall Study|Decision by the study team|1|||
154974073|NCT02943993|559331165|FG000|Overall Study|Withdrawal by Subject|52|||
155110913|NCT03594747|559833173|FG002|Overall Study|Death|87|||
155110914|NCT03594747|559833171|FG000|Overall Study|Withdrawal by Subject|5|||
155110915|NCT03594747|559833172|FG001|Overall Study|Withdrawal by Subject|2|||
155110916|NCT03594747|559833173|FG002|Overall Study|Withdrawal by Subject|11|||
155110917|NCT03594747|559833171|FG000|Overall Study|Lost to Follow-up|4|||
155110918|NCT03594747|559833172|FG001|Overall Study|Lost to Follow-up|1|||
155110919|NCT03594747|559833173|FG002|Overall Study|Lost to Follow-up|1|||
155110920|NCT03594747|559833171|FG000|Overall Study|Physician Decision|0|||
154872293|NCT00972244|558958167|FG004|Overall Study|Incorrect Enrolment|0|||
154872294|NCT00972244|558958163|FG000|Overall Study|Adverse Event|0|||
154872295|NCT00972244|558958164|FG001|Overall Study|Adverse Event|1|||
154872296|NCT00972244|558958165|FG002|Overall Study|Adverse Event|1|||
154974074|NCT02943993|559331165|FG000|Overall Study|Transfer to another institution|6|||
154974075|NCT02943993|559331165|FG000|Overall Study|Lost to Follow-up|135|||
154974076|NCT02943993|559331165|FG000|Overall Study|Death|98|||
154974077|NCT02943993|559331165|FG000|Overall Study|Other reason for premature termination|32|||
154974078|NCT02943993|559331165|FG000|Overall Study|Missing reason for termination|7|||
154974079|NCT00835796|559331171|FG000|First Intervention|Withdrawal by Subject|0|||
154872297|NCT00972244|558958166|FG003|Overall Study|Adverse Event|0|||
154872298|NCT00972244|558958167|FG004|Overall Study|Adverse Event|0|||
154974080|NCT00835796|559331172|FG001|First Intervention|Withdrawal by Subject|1|||
154974081|NCT00396630|559331173|FG000|Overall Study|Lost to Follow-up|1|||
154974082|NCT00396630|559331174|FG001|Overall Study|Lost to Follow-up|1|||
154974083|NCT00396630|559331173|FG000|Overall Study|Withdrawal by Subject|1|||
154974084|NCT00396630|559331174|FG001|Overall Study|Withdrawal by Subject|1|||
154872299|NCT00972244|558958163|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
154872300|NCT00972244|558958164|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
154872301|NCT00972244|558958165|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
154872302|NCT00972244|558958166|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
154872303|NCT00972244|558958167|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
154872304|NCT00972244|558958163|FG000|Overall Study|Withdrawal by Subject|1|||
154872305|NCT00972244|558958164|FG001|Overall Study|Withdrawal by Subject|2|||
154872306|NCT00972244|558958165|FG002|Overall Study|Withdrawal by Subject|1|||
155110921|NCT03594747|559833172|FG001|Overall Study|Physician Decision|1|||
155110922|NCT03594747|559833173|FG002|Overall Study|Physician Decision|0|||
155110923|NCT03594747|559833171|FG000|Overall Study|Sponsor decision|23|||
155110924|NCT03594747|559833172|FG001|Overall Study|Sponsor decision|17|||
155110925|NCT03594747|559833173|FG002|Overall Study|Sponsor decision|16|||
155110926|NCT03594747|559833171|FG000|Overall Study|Did not meet inclusion criteria|0|||
155110927|NCT03594747|559833172|FG001|Overall Study|Did not meet inclusion criteria|0|||
155110928|NCT03594747|559833173|FG002|Overall Study|Did not meet inclusion criteria|1|||
155110929|NCT03594747|559833171|FG000|Overall Study|Transfer to long term extension study|10|||
155110930|NCT03594747|559833172|FG001|Overall Study|Transfer to long term extension study|12|||
155110931|NCT03594747|559833173|FG002|Overall Study|Transfer to long term extension study|5|||
155110932|NCT00349349|559833174|FG000|Overall Study|Adverse Event|5|||
155110933|NCT00349349|559833175|FG001|Overall Study|Adverse Event|6|||
155110934|NCT00349349|559833176|FG002|Overall Study|Adverse Event|2|||
155110935|NCT00349349|559833174|FG000|Overall Study|Withdrawal by Subject|5|||
155110936|NCT00349349|559833175|FG001|Overall Study|Withdrawal by Subject|2|||
155110937|NCT00349349|559833176|FG002|Overall Study|Withdrawal by Subject|1|||
155110938|NCT00349349|559833174|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
155110939|NCT00349349|559833175|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
155110940|NCT00349349|559833176|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
155110941|NCT00349349|559833174|FG000|Overall Study|Death|13|||
155110942|NCT00349349|559833175|FG001|Overall Study|Death|10|||
155110943|NCT00349349|559833176|FG002|Overall Study|Death|1|||
154974085|NCT00396630|559331173|FG000|Overall Study|Not vaccinated at Visit 3|3|||
154974086|NCT00396630|559331174|FG001|Overall Study|Not vaccinated at Visit 3|3|||
154974087|NCT00876265|559331175|FG000|Overall Study|Miscellaneous reasons|4|||
155110944|NCT00349349|559833174|FG000|Overall Study|Other Treatment Selected|2|||
155110945|NCT00349349|559833175|FG001|Overall Study|Other Treatment Selected|0|||
155110946|NCT00349349|559833176|FG002|Overall Study|Other Treatment Selected|0|||
155110947|NCT00349349|559833174|FG000|Overall Study|Participant Reduced General Condition|0|||
155110948|NCT00349349|559833175|FG001|Overall Study|Participant Reduced General Condition|1|||
155110949|NCT00349349|559833176|FG002|Overall Study|Participant Reduced General Condition|0|||
155110950|NCT00349349|559833174|FG000|Overall Study|Physician Decision|1|||
155110951|NCT00349349|559833175|FG001|Overall Study|Physician Decision|2|||
155110952|NCT00349349|559833176|FG002|Overall Study|Physician Decision|1|||
155110953|NCT00349349|559833174|FG000|Overall Study|No Response|0|||
155110954|NCT00349349|559833175|FG001|Overall Study|No Response|3|||
155110955|NCT00349349|559833176|FG002|Overall Study|No Response|0|||
155110956|NCT00349349|559833174|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
155110957|NCT00349349|559833175|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
155110958|NCT00349349|559833176|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
155110959|NCT03596047|559835795|FG000|Overall Study|Withdrawal by Subject|7|||
155110960|NCT03596047|559835796|FG001|Overall Study|Withdrawal by Subject|4|||
155110961|NCT03596047|559835795|FG000|Overall Study|Lost to Follow-up|0|||
155110962|NCT03596047|559835796|FG001|Overall Study|Lost to Follow-up|2|||
155110963|NCT01696968|559835797|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
155110964|NCT01696968|559835798|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
155110965|NCT01696968|559835797|FG000|Overall Study|Died Before Randomization|3|||
155110966|NCT01696968|559835798|FG001|Overall Study|Died Before Randomization|8|||
155110967|NCT01696968|559835797|FG000|Overall Study|Died Before ASU (Control)|278|||
155110968|NCT01696968|559835798|FG001|Overall Study|Died Before ASU (Control)|0|||
155110969|NCT01696968|559835797|FG000|Overall Study|Refused ASU (Control)|920|||
155110970|NCT01696968|559835798|FG001|Overall Study|Refused ASU (Control)|0|||
155110971|NCT01696968|559835797|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
155110972|NCT01696968|559835798|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
155110973|NCT03727646|559835799|FG000|Overall Study|Adverse Event|1|||
155110974|NCT03727646|559835800|FG001|Overall Study|Adverse Event|0|||
155110975|NCT04753658|559835801|FG000|Overall Study|Progressive disease|7|||
155110976|NCT04753658|559835801|FG000|Overall Study|Other|7|||
155110977|NCT04753658|559835801|FG000|Overall Study|Adverse Event|1|||
155110978|NCT02582814|559835808|FG000|Overall Study|Study-specific withdrawal criteria|1|||
155110979|NCT02582814|559835809|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155110980|NCT02582814|559835808|FG000|Overall Study|Withdrawal by Subject|4|||
155110981|NCT02582814|559835809|FG001|Overall Study|Withdrawal by Subject|3|||
155110982|NCT02582814|559835808|FG000|Overall Study|Adverse Event|4|||
155110983|NCT02582814|559835809|FG001|Overall Study|Adverse Event|4|||
155110984|NCT00306293|559835810|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
155110985|NCT00306293|559835811|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
155110986|NCT00306293|559835810|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
155110987|NCT00306293|559835811|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
155110988|NCT00306293|559835810|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
155110989|NCT00306293|559835811|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
155110990|NCT00306293|559835810|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
155110991|NCT00306293|559835811|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
155110992|NCT00306293|559835810|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
155110993|NCT00306293|559835811|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
155110994|NCT00306293|559835810|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
155110995|NCT00306293|559835811|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
155110996|NCT00306293|559835810|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
155110997|NCT00306293|559835811|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
155110998|NCT00306293|559835810|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
155110999|NCT00306293|559835811|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
155111000|NCT00176488|559835812|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
155111001|NCT02650804|559835813|FG000|Overall Study|Adverse Event|3|||
155111002|NCT02650804|559835814|FG001|Overall Study|Adverse Event|2|||
155111003|NCT02650804|559835813|FG000|Overall Study|Death|1|||
155111004|NCT02650804|559835814|FG001|Overall Study|Death|2|||
155111005|NCT02650804|559835813|FG000|Overall Study|Progressive Disease|7|||
155111006|NCT02650804|559835814|FG001|Overall Study|Progressive Disease|10|||
155111007|NCT02650804|559835813|FG000|Overall Study|Physician Decision|0|||
155111008|NCT02650804|559835814|FG001|Overall Study|Physician Decision|2|||
155111009|NCT02650804|559835813|FG000|Overall Study|Withdrawal by Subject|1|||
155111010|NCT02650804|559835814|FG001|Overall Study|Withdrawal by Subject|4|||
155111011|NCT02650804|559835813|FG000|Overall Study|Symptomatic deterioration|5|||
155111012|NCT02650804|559835814|FG001|Overall Study|Symptomatic deterioration|7|||
155111013|NCT02650804|559835813|FG000|Overall Study|Protocol Violation|0|||
155111014|NCT02650804|559835814|FG001|Overall Study|Protocol Violation|1|||
155111015|NCT01811485|559835821|FG000|Overall Study|Adverse Event|1|||
155111016|NCT01811485|559835822|FG001|Overall Study|Adverse Event|3|||
155111017|NCT01811485|559835823|FG002|Overall Study|Adverse Event|2|||
155111018|NCT01811485|559835821|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155111019|NCT01811485|559835822|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155175189|NCT01340872|560080157|FG002|Double-blind Phase|Protocol Violation|0|||
155175190|NCT01340872|560080158|FG003|Double-blind Phase|Protocol Violation|0|||
155175191|NCT01340872|560080155|FG000|Open-label Phase|Physician Decision|0|||
155175192|NCT01340872|560080156|FG001|Open-label Phase|Physician Decision|0|||
155175193|NCT01340872|560080157|FG002|Open-label Phase|Physician Decision|2|||
155175194|NCT01340872|560080158|FG003|Open-label Phase|Physician Decision|1|||
155175195|NCT01340872|560080155|FG000|Open-label Phase|Pregnancy|0|||
155175196|NCT01340872|560080156|FG001|Open-label Phase|Pregnancy|0|||
155175197|NCT01340872|560080157|FG002|Open-label Phase|Pregnancy|1|||
155175198|NCT01340872|560080158|FG003|Open-label Phase|Pregnancy|0|||
155175199|NCT01340872|560080155|FG000|Open-label Phase|Adverse Event|0|||
155175200|NCT01340872|560080156|FG001|Open-label Phase|Adverse Event|0|||
155175201|NCT01340872|560080157|FG002|Open-label Phase|Adverse Event|8|||
155175202|NCT01340872|560080158|FG003|Open-label Phase|Adverse Event|4|||
155175203|NCT01340872|560080155|FG000|Open-label Phase|Withdrawal by Subject|0|||
155175204|NCT01340872|560080156|FG001|Open-label Phase|Withdrawal by Subject|0|||
155175205|NCT01340872|560080157|FG002|Open-label Phase|Withdrawal by Subject|1|||
155175206|NCT01340872|560080158|FG003|Open-label Phase|Withdrawal by Subject|6|||
155175207|NCT01340872|560080155|FG000|Open-label Phase|Worsening of IBD|0|||
155175208|NCT01340872|560080156|FG001|Open-label Phase|Worsening of IBD|0|||
155175209|NCT01340872|560080157|FG002|Open-label Phase|Worsening of IBD|1|||
155175210|NCT01340872|560080158|FG003|Open-label Phase|Worsening of IBD|0|||
155175211|NCT03039621|560080163|FG000|Overall Study|Violation of inclusion criteria|3|||
155175212|NCT03039621|560080164|FG001|Overall Study|Violation of inclusion criteria|2|||
155175213|NCT03039621|560080163|FG000|Overall Study|Non-compliance with protocol requirement|4|||
155175214|NCT03039621|560080164|FG001|Overall Study|Non-compliance with protocol requirement|5|||
155175215|NCT03039621|560080163|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
155175216|NCT03039621|560080164|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
155175217|NCT03039621|560080163|FG000|Overall Study|Violation of non-inclusion criteria|1|||
155175218|NCT03039621|560080164|FG001|Overall Study|Violation of non-inclusion criteria|2|||
155175219|NCT03254108|560080165|FG000|Overall Study|Adverse Event|0|||
155175220|NCT03254108|560080166|FG001|Overall Study|Adverse Event|2|||
155175221|NCT03254108|560080167|FG002|Overall Study|Adverse Event|0|||
155175222|NCT03254108|560080168|FG003|Overall Study|Adverse Event|1|||
155175223|NCT03254108|560080169|FG004|Overall Study|Adverse Event|1|||
155175224|NCT03254108|560080165|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155175225|NCT03254108|560080166|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155175226|NCT03254108|560080167|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155175227|NCT03254108|560080168|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
155175228|NCT03254108|560080169|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
155175229|NCT01771809|560080170|FG000|Overall Study|Adverse Event|4|||
155175230|NCT01771809|560080171|FG001|Overall Study|Adverse Event|12|||
155175231|NCT01771809|560080170|FG000|Overall Study|Protocol Violation|0|||
155175232|NCT01771809|560080171|FG001|Overall Study|Protocol Violation|1|||
155175233|NCT01771809|560080170|FG000|Overall Study|Withdrawal by Subject|34|||
155175234|NCT01771809|560080171|FG001|Overall Study|Withdrawal by Subject|42|||
155175235|NCT01771809|560080170|FG000|Overall Study|Lost to Follow-up|1|||
155175236|NCT01771809|560080171|FG001|Overall Study|Lost to Follow-up|3|||
155111020|NCT01811485|559835823|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
155111021|NCT01811485|559835821|FG000|Overall Study|Administrative problems|1|||
155111022|NCT01811485|559835822|FG001|Overall Study|Administrative problems|0|||
155111023|NCT01811485|559835823|FG002|Overall Study|Administrative problems|0|||
155111024|NCT01811485|559835821|FG000|Overall Study|Protocol Deviation|0|||
155111025|NCT01811485|559835822|FG001|Overall Study|Protocol Deviation|1|||
155111026|NCT01811485|559835823|FG002|Overall Study|Protocol Deviation|0|||
155111027|NCT03299881|559835824|FG000|Overall Study|Study Termination|17|||
155111028|NCT03299881|559835825|FG001|Overall Study|Study Termination|13|||
155175237|NCT01771809|560080170|FG000|Overall Study|Other (Insufficient clinical response)|22|||
155175238|NCT01771809|560080171|FG001|Overall Study|Other (Insufficient clinical response)|20|||
155175239|NCT01771809|560080170|FG000|Overall Study|Death|1|||
155175240|NCT01771809|560080171|FG001|Overall Study|Death|0|||
155175241|NCT01771809|560080170|FG000|Overall Study|Other (other)|9|||
154872307|NCT00972244|558958166|FG003|Overall Study|Withdrawal by Subject|0|||
155111029|NCT02974855|559835826|FG000|Overall Study|Adverse Event|0|||
155111030|NCT02974855|559835827|FG001|Overall Study|Adverse Event|1|||
155175242|NCT01771809|560080171|FG001|Overall Study|Other (other)|5|||
155175243|NCT00362180|560080172|FG000|Treated Period|Withdrawal by Subject|1|||
155111031|NCT02974855|559835828|FG002|Overall Study|Adverse Event|0|||
155111032|NCT02974855|559835829|FG003|Overall Study|Adverse Event|1|||
155111033|NCT01474772|559835830|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
155111034|NCT01474772|559835831|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
155111035|NCT01474772|559835830|FG000|Period 1|AE not Related to Study Drug|1|||
155175244|NCT00362180|560080173|FG001|Treated Period|Withdrawal by Subject|0|||
155175245|NCT00362180|560080174|FG002|Treated Period|Withdrawal by Subject|0|||
154872308|NCT00972244|558958167|FG004|Overall Study|Withdrawal by Subject|1|||
154872309|NCT00972244|558958163|FG000|Overall Study|Safety|0|||
154872310|NCT00972244|558958164|FG001|Overall Study|Safety|0|||
154872311|NCT00972244|558958165|FG002|Overall Study|Safety|0|||
154872312|NCT00972244|558958166|FG003|Overall Study|Safety|0|||
154872313|NCT00972244|558958167|FG004|Overall Study|Safety|1|||
154872314|NCT00972244|558958163|FG000|Overall Study|Death|1|||
154872315|NCT00972244|558958164|FG001|Overall Study|Death|0|||
154872316|NCT00972244|558958165|FG002|Overall Study|Death|0|||
154872317|NCT00972244|558958166|FG003|Overall Study|Death|0|||
154872318|NCT00972244|558958167|FG004|Overall Study|Death|0|||
154872319|NCT00972244|558958163|FG000|Overall Study|Various|0|||
154872320|NCT00972244|558958164|FG001|Overall Study|Various|0|||
154872321|NCT00972244|558958165|FG002|Overall Study|Various|0|||
154872322|NCT00972244|558958166|FG003|Overall Study|Various|0|||
154872323|NCT00972244|558958167|FG004|Overall Study|Various|2|||
154872324|NCT00907478|558958169|FG000|Overall Study|Ineligibility determined|0|||
154872325|NCT00907478|558958170|FG001|Overall Study|Ineligibility determined|0|||
154872326|NCT00907478|558958171|FG002|Overall Study|Ineligibility determined|1|||
154872327|NCT00907478|558958169|FG000|Overall Study|Noncompliance|0|||
154872328|NCT00907478|558958170|FG001|Overall Study|Noncompliance|0|||
154872329|NCT00907478|558958171|FG002|Overall Study|Noncompliance|1|||
154872330|NCT00907478|558958169|FG000|Overall Study|Adverse Event|3|||
154872331|NCT00907478|558958170|FG001|Overall Study|Adverse Event|1|||
154872332|NCT00907478|558958171|FG002|Overall Study|Adverse Event|2|||
154872333|NCT00907478|558958169|FG000|Overall Study|Withdrawal by Subject|8|||
154872334|NCT00907478|558958170|FG001|Overall Study|Withdrawal by Subject|9|||
154872335|NCT00907478|558958171|FG002|Overall Study|Withdrawal by Subject|6|||
154872336|NCT00907478|558958169|FG000|Overall Study|Requirement for alternative therapy|1|||
154872337|NCT00907478|558958170|FG001|Overall Study|Requirement for alternative therapy|2|||
154872338|NCT00907478|558958171|FG002|Overall Study|Requirement for alternative therapy|3|||
154872339|NCT00907478|558958169|FG000|Overall Study|Physician Decision|2|||
154872340|NCT00907478|558958170|FG001|Overall Study|Physician Decision|0|||
154872341|NCT00907478|558958171|FG002|Overall Study|Physician Decision|3|||
154872342|NCT00907478|558958169|FG000|Overall Study|Death|4|||
154872343|NCT00907478|558958170|FG001|Overall Study|Death|2|||
154872344|NCT00907478|558958171|FG002|Overall Study|Death|1|||
154872345|NCT00907478|558958169|FG000|Overall Study|Protocol-specified criteria|5|||
154872346|NCT00907478|558958170|FG001|Overall Study|Protocol-specified criteria|2|||
154872347|NCT00907478|558958171|FG002|Overall Study|Protocol-specified criteria|3|||
154872348|NCT00907478|558958169|FG000|Overall Study|Pregnancy|0|||
154872349|NCT00907478|558958170|FG001|Overall Study|Pregnancy|1|||
154872350|NCT00907478|558958171|FG002|Overall Study|Pregnancy|1|||
154872351|NCT00907478|558958169|FG000|Overall Study|Lost to Follow-up|1|||
154872352|NCT00907478|558958170|FG001|Overall Study|Lost to Follow-up|0|||
154872353|NCT00907478|558958171|FG002|Overall Study|Lost to Follow-up|0|||
154872354|NCT00907478|558958169|FG000|Overall Study|Other|3|||
154872355|NCT00907478|558958170|FG001|Overall Study|Other|0|||
154872356|NCT00907478|558958171|FG002|Overall Study|Other|1|||
154872357|NCT03554005|558958180|FG000|Overall Study|Not in participant's best interest|0|||
154872358|NCT03554005|558958181|FG001|Overall Study|Not in participant's best interest|0|||
154872359|NCT03554005|558958182|FG002|Overall Study|Not in participant's best interest|0|||
154872360|NCT03554005|558958183|FG003|Overall Study|Not in participant's best interest|0|||
154872361|NCT03554005|558958184|FG004|Overall Study|Not in participant's best interest|0|||
154872362|NCT03554005|558958185|FG005|Overall Study|Not in participant's best interest|1|||
154872363|NCT03554005|558958180|FG000|Overall Study|Disease Progression|1|||
154872364|NCT03554005|558958181|FG001|Overall Study|Disease Progression|1|||
154872365|NCT03554005|558958182|FG002|Overall Study|Disease Progression|1|||
154872366|NCT03554005|558958183|FG003|Overall Study|Disease Progression|1|||
154872367|NCT03554005|558958184|FG004|Overall Study|Disease Progression|5|||
154872368|NCT03554005|558958185|FG005|Overall Study|Disease Progression|6|||
154872369|NCT03554005|558958180|FG000|Overall Study|Adverse Event|0|||
154872370|NCT03554005|558958181|FG001|Overall Study|Adverse Event|0|||
154872371|NCT03554005|558958182|FG002|Overall Study|Adverse Event|0|||
154872372|NCT03554005|558958183|FG003|Overall Study|Adverse Event|0|||
154872373|NCT03554005|558958184|FG004|Overall Study|Adverse Event|0|||
154872374|NCT03554005|558958185|FG005|Overall Study|Adverse Event|3|||
154872375|NCT03554005|558958180|FG000|Overall Study|Physician Decision|0|||
154872376|NCT03554005|558958181|FG001|Overall Study|Physician Decision|0|||
154872377|NCT03554005|558958182|FG002|Overall Study|Physician Decision|0|||
154872378|NCT03554005|558958183|FG003|Overall Study|Physician Decision|0|||
154872379|NCT03554005|558958184|FG004|Overall Study|Physician Decision|1|||
154872380|NCT03554005|558958185|FG005|Overall Study|Physician Decision|0|||
154872381|NCT03554005|558958180|FG000|Overall Study|Other|0|||
154872382|NCT03554005|558958181|FG001|Overall Study|Other|0|||
154872383|NCT03554005|558958182|FG002|Overall Study|Other|0|||
154872384|NCT03554005|558958183|FG003|Overall Study|Other|0|||
154872385|NCT03554005|558958184|FG004|Overall Study|Other|0|||
154872386|NCT03554005|558958185|FG005|Overall Study|Other|1|||
154872387|NCT02639182|558958189|FG000|Overall Study|Disease Progression|50|||
154872388|NCT02639182|558958190|FG001|Overall Study|Disease Progression|49|||
154872389|NCT02639182|558958189|FG000|Overall Study|Adverse Event|7|||
154872390|NCT02639182|558958190|FG001|Overall Study|Adverse Event|5|||
154872391|NCT02639182|558958189|FG000|Overall Study|Physician Decision|3|||
154872392|NCT02639182|558958190|FG001|Overall Study|Physician Decision|3|||
154872393|NCT02639182|558958189|FG000|Overall Study|Withdrew Consent|5|||
154872394|NCT02639182|558958190|FG001|Overall Study|Withdrew Consent|4|||
154872395|NCT02639182|558958189|FG000|Overall Study|Lost to Follow-up|0|||
154872396|NCT02639182|558958190|FG001|Overall Study|Lost to Follow-up|1|||
154872397|NCT02639182|558958189|FG000|Overall Study|Study Closure|1|||
154872398|NCT02639182|558958190|FG001|Overall Study|Study Closure|2|||
154872399|NCT02639182|558958189|FG000|Overall Study|Sponsor Ended Study|0|||
154872400|NCT02639182|558958190|FG001|Overall Study|Sponsor Ended Study|1|||
154872401|NCT02639182|558958189|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
154872402|NCT02639182|558958190|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
154872403|NCT00907881|558958191|FG000|Overall Study|Lost to Follow-up|59|||
154872404|NCT00907881|558958191|FG000|Overall Study|Noncompliance|5|||
154872405|NCT00907881|558958191|FG000|Overall Study|Withdrawal by Subject|5|||
154872406|NCT00907881|558958191|FG000|Overall Study|Protocol Violation|1|||
154872407|NCT00907881|558958191|FG000|Overall Study|Missing discontinuation information|15|||
154872408|NCT02546856|558958194|FG000|4 Months Evaluation|Death|2|||
154872409|NCT02546856|558958195|FG001|4 Months Evaluation|Death|3|||
154872410|NCT02546856|558958194|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
154872411|NCT02546856|558958195|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
154872412|NCT02546856|558958194|FG000|4 Months Evaluation|Lost to Follow-up|3|||
154872413|NCT02546856|558958195|FG001|4 Months Evaluation|Lost to Follow-up|3|||
154872414|NCT02546856|558958194|FG000|4 Months Evaluation|Physician Decision|3|||
154872415|NCT02546856|558958195|FG001|4 Months Evaluation|Physician Decision|0|||
154872416|NCT02546856|558958194|FG000|4 Months Evaluation|Working or living abroad|5|||
154872417|NCT02546856|558958195|FG001|4 Months Evaluation|Working or living abroad|1|||
154872418|NCT02546856|558958194|FG000|4 Months Evaluation|reasons not due to titration|4|||
154872419|NCT02546856|558958195|FG001|4 Months Evaluation|reasons not due to titration|1|||
154872420|NCT02546856|558958194|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
154872421|NCT02546856|558958195|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
154872422|NCT02546856|558958194|FG000|6 Months Evaluation|Death|1|||
154872423|NCT02546856|558958195|FG001|6 Months Evaluation|Death|1|||
154872424|NCT02546856|558958194|FG000|6 Months Evaluation|Lost to Follow-up|1|||
154872425|NCT02546856|558958195|FG001|6 Months Evaluation|Lost to Follow-up|1|||
154872426|NCT02546856|558958194|FG000|6 Months Evaluation|Working or living abroad|6|||
154872427|NCT02546856|558958195|FG001|6 Months Evaluation|Working or living abroad|4|||
154872428|NCT02546856|558958194|FG000|6 Months Evaluation|reasons not due to titration|0|||
154872429|NCT02546856|558958195|FG001|6 Months Evaluation|reasons not due to titration|1|||
154872430|NCT03268746|558958199|FG000|Overall Study|Withdrawal by Subject|1|||
154872431|NCT00589472|558958200|FG000|Overall Study|Adverse Event|1|||
154872432|NCT01372878|558958201|FG000|Overall Study|Withdrawal by Subject|63|||
154872433|NCT01372878|558958201|FG000|Overall Study|Protocol Violation|17|||
154872434|NCT01372878|558958201|FG000|Overall Study|incomplete study procedure|104|||
154872435|NCT01380093|558958202|FG000|Naloxone Challenge Phase|Screen failures|21|||
154872436|NCT01380093|558958203|FG001|Naloxone Challenge Phase|Screen failures|0|||
154872437|NCT01380093|558958204|FG002|Naloxone Challenge Phase|Screen failures|0|||
154872438|NCT01380093|558958205|FG003|Naloxone Challenge Phase|Screen failures|0|||
154872439|NCT01380093|558958206|FG004|Naloxone Challenge Phase|Screen failures|0|||
154872440|NCT01380093|558958207|FG005|Naloxone Challenge Phase|Screen failures|0|||
154872441|NCT01380093|558958208|FG006|Naloxone Challenge Phase|Screen failures|0|||
154872442|NCT01380093|558958209|FG007|Naloxone Challenge Phase|Screen failures|0|||
154872443|NCT01380093|558958210|FG008|Naloxone Challenge Phase|Screen failures|0|||
154872444|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872445|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
155111036|NCT01474772|559835831|FG001|Period 1|AE not Related to Study Drug|0|||
155111037|NCT01474772|559835830|FG000|Period 1|Withdrawal by Subject|3|||
155111038|NCT01474772|559835831|FG001|Period 1|Withdrawal by Subject|1|||
155111039|NCT01474772|559835830|FG000|Period 1|Lost to Follow-up|1|||
155111040|NCT01474772|559835831|FG001|Period 1|Lost to Follow-up|0|||
155111041|NCT01474772|559835830|FG000|Period 1|Reason not Specified|1|||
155111042|NCT01474772|559835831|FG001|Period 1|Reason not Specified|1|||
154872446|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872447|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872448|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
155111043|NCT01474772|559835830|FG000|Washout|AE not Related to Study Drug|2|||
155111044|NCT01474772|559835831|FG001|Washout|AE not Related to Study Drug|0|||
155111045|NCT01474772|559835830|FG000|Washout|Withdrawal by Subject|1|||
155111046|NCT01474772|559835831|FG001|Washout|Withdrawal by Subject|0|||
154872449|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872450|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872451|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872452|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
154872453|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
155111047|NCT01474772|559835830|FG000|Washout|Lost to Follow-up|0|||
155111048|NCT01474772|559835831|FG001|Washout|Lost to Follow-up|1|||
155111049|NCT01474772|559835830|FG000|Washout|Reason not Specified|0|||
155111050|NCT01474772|559835831|FG001|Washout|Reason not Specified|1|||
155111051|NCT01474772|559835830|FG000|Period 2|Death|0|||
155111052|NCT01474772|559835831|FG001|Period 2|Death|1|||
155111053|NCT01474772|559835830|FG000|Period 2|AE Related to Study Drug|0|||
155111054|NCT01474772|559835831|FG001|Period 2|AE Related to Study Drug|1|||
155111055|NCT01474772|559835830|FG000|Period 2|AE not Related to Study Drug|4|||
155111056|NCT01474772|559835831|FG001|Period 2|AE not Related to Study Drug|1|||
155111057|NCT01474772|559835830|FG000|Period 2|Lack of Efficacy|1|||
155111058|NCT01474772|559835831|FG001|Period 2|Lack of Efficacy|0|||
155111059|NCT01474772|559835830|FG000|Period 2|Withdrawal by Subject|3|||
155111060|NCT01474772|559835831|FG001|Period 2|Withdrawal by Subject|4|||
155111061|NCT01474772|559835830|FG000|Period 2|Lost to Follow-up|1|||
155111062|NCT01474772|559835831|FG001|Period 2|Lost to Follow-up|1|||
155111063|NCT01474772|559835830|FG000|Period 2|Reason not Specified|0|||
155111064|NCT01474772|559835831|FG001|Period 2|Reason not Specified|2|||
155111065|NCT01474772|559835830|FG000|Follow-up|AE not Related to Study Drug|0|||
155111066|NCT01474772|559835831|FG001|Follow-up|AE not Related to Study Drug|1|||
155111067|NCT00633074|559835832|FG000|Overall Study|Adverse Event|1|||
155111068|NCT00633074|559835833|FG001|Overall Study|Adverse Event|0|||
155111069|NCT02752633|559835838|FG000|Overall Study|Withdrawal by Subject|1|||
155111070|NCT00433966|559835841|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
155111071|NCT00433966|559835842|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
155111072|NCT00433966|559835843|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
155111073|NCT00433966|559835844|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
155111074|NCT00433966|559835841|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
155111075|NCT00433966|559835842|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
155111076|NCT00433966|559835843|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
155111077|NCT00433966|559835844|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
155111078|NCT00433966|559835841|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
155111079|NCT00433966|559835842|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
155111080|NCT00433966|559835843|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
155111081|NCT00433966|559835844|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
155111082|NCT00433966|559835841|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
155111083|NCT00433966|559835842|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
155111084|NCT00433966|559835843|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
155111085|NCT00433966|559835844|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
155111086|NCT00433966|559835841|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
155111087|NCT00433966|559835842|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
155111088|NCT00433966|559835843|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
155111089|NCT00433966|559835844|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
154872454|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
154872455|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
154872456|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
154872457|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
154872458|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
154872459|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
154872460|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
154872461|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
154872462|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
154872463|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
154872464|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
154872465|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
154872466|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
154872467|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155111090|NCT04952597|559835846|FG000|Overall Study|Death|12|||
154872468|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155111091|NCT04952597|559835847|FG001|Overall Study|Death|13|||
155111092|NCT04952597|559835848|FG002|Overall Study|Death|14|||
155111093|NCT04952597|559835846|FG000|Overall Study|Withdrawal by Subject|1|||
155111094|NCT04952597|559835847|FG001|Overall Study|Withdrawal by Subject|0|||
155111095|NCT04952597|559835848|FG002|Overall Study|Withdrawal by Subject|3|||
155111096|NCT04952597|559835846|FG000|Overall Study|Lost to Follow-up|0|||
155111097|NCT04952597|559835847|FG001|Overall Study|Lost to Follow-up|1|||
155111098|NCT04952597|559835848|FG002|Overall Study|Lost to Follow-up|1|||
155111099|NCT01296711|559835849|FG000|Overall Study|Adverse Event|3|||
155111100|NCT01296711|559835850|FG001|Overall Study|Adverse Event|1|||
155111101|NCT01296711|559835851|FG002|Overall Study|Adverse Event|4|||
155111102|NCT01296711|559835852|FG003|Overall Study|Adverse Event|3|||
155111103|NCT01296711|559835853|FG004|Overall Study|Adverse Event|1|||
155175246|NCT00362180|560080175|FG003|Treated Period|Withdrawal by Subject|0|||
155175247|NCT00362180|560080176|FG004|Treated Period|Withdrawal by Subject|0|||
155175248|NCT00362180|560080177|FG005|Treated Period|Withdrawal by Subject|0|||
155175249|NCT00362180|560080178|FG006|Treated Period|Withdrawal by Subject|0|||
155175250|NCT00362180|560080179|FG007|Treated Period|Withdrawal by Subject|0|||
155175251|NCT00362180|560080180|FG008|Treated Period|Withdrawal by Subject|0|||
155175252|NCT00362180|560080172|FG000|Treated Period|Adverse Event|0|||
155175253|NCT00362180|560080173|FG001|Treated Period|Adverse Event|0|||
154872469|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
155111104|NCT01296711|559835854|FG005|Overall Study|Adverse Event|6|||
155111105|NCT01296711|559835855|FG006|Overall Study|Adverse Event|11|||
155111106|NCT01296711|559835856|FG007|Overall Study|Adverse Event|3|||
155111107|NCT01296711|559835849|FG000|Overall Study|Lack of Efficacy|1|||
155111108|NCT01296711|559835850|FG001|Overall Study|Lack of Efficacy|4|||
155111109|NCT01296711|559835851|FG002|Overall Study|Lack of Efficacy|1|||
155111110|NCT01296711|559835852|FG003|Overall Study|Lack of Efficacy|1|||
155111111|NCT01296711|559835853|FG004|Overall Study|Lack of Efficacy|1|||
155111112|NCT01296711|559835854|FG005|Overall Study|Lack of Efficacy|0|||
155111113|NCT01296711|559835855|FG006|Overall Study|Lack of Efficacy|2|||
155111114|NCT01296711|559835856|FG007|Overall Study|Lack of Efficacy|3|||
155111115|NCT01296711|559835849|FG000|Overall Study|Lost to Follow-up|0|||
155111116|NCT01296711|559835850|FG001|Overall Study|Lost to Follow-up|0|||
155111117|NCT01296711|559835851|FG002|Overall Study|Lost to Follow-up|1|||
155111118|NCT01296711|559835852|FG003|Overall Study|Lost to Follow-up|1|||
155111119|NCT01296711|559835853|FG004|Overall Study|Lost to Follow-up|2|||
155111120|NCT01296711|559835854|FG005|Overall Study|Lost to Follow-up|0|||
155111121|NCT01296711|559835855|FG006|Overall Study|Lost to Follow-up|4|||
155111122|NCT01296711|559835856|FG007|Overall Study|Lost to Follow-up|2|||
155111123|NCT01296711|559835849|FG000|Overall Study|Protocol Violation|0|||
155111124|NCT01296711|559835850|FG001|Overall Study|Protocol Violation|0|||
155111125|NCT01296711|559835851|FG002|Overall Study|Protocol Violation|0|||
155111126|NCT01296711|559835852|FG003|Overall Study|Protocol Violation|1|||
155111127|NCT01296711|559835853|FG004|Overall Study|Protocol Violation|1|||
155111128|NCT01296711|559835854|FG005|Overall Study|Protocol Violation|0|||
155111129|NCT01296711|559835855|FG006|Overall Study|Protocol Violation|0|||
155175254|NCT00362180|560080174|FG002|Treated Period|Adverse Event|0|||
154872470|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
154872471|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872472|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
154872473|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
154872474|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872475|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872476|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872477|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872478|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872479|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
154872480|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872481|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
154872482|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
154872483|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872484|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872485|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872486|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872487|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872488|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
154872489|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872490|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872491|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
155175255|NCT00362180|560080175|FG003|Treated Period|Adverse Event|0|||
155111130|NCT01296711|559835856|FG007|Overall Study|Protocol Violation|0|||
155111131|NCT01296711|559835849|FG000|Overall Study|Withdrawal by Subject|4|||
155111132|NCT01296711|559835850|FG001|Overall Study|Withdrawal by Subject|2|||
155111133|NCT01296711|559835851|FG002|Overall Study|Withdrawal by Subject|2|||
155111134|NCT01296711|559835852|FG003|Overall Study|Withdrawal by Subject|1|||
155111135|NCT01296711|559835853|FG004|Overall Study|Withdrawal by Subject|1|||
155111136|NCT01296711|559835854|FG005|Overall Study|Withdrawal by Subject|1|||
155111137|NCT01296711|559835855|FG006|Overall Study|Withdrawal by Subject|2|||
155111138|NCT01296711|559835856|FG007|Overall Study|Withdrawal by Subject|1|||
155111139|NCT01296711|559835849|FG000|Overall Study|Study termination|8|||
155111140|NCT01296711|559835850|FG001|Overall Study|Study termination|1|||
155175256|NCT00362180|560080176|FG004|Treated Period|Adverse Event|0|||
155111141|NCT01296711|559835851|FG002|Overall Study|Study termination|5|||
155111142|NCT01296711|559835852|FG003|Overall Study|Study termination|4|||
155111143|NCT01296711|559835853|FG004|Overall Study|Study termination|4|||
155175257|NCT00362180|560080177|FG005|Treated Period|Adverse Event|1|||
155175258|NCT00362180|560080178|FG006|Treated Period|Adverse Event|0|||
155175259|NCT00362180|560080179|FG007|Treated Period|Adverse Event|1|||
155175260|NCT00362180|560080180|FG008|Treated Period|Adverse Event|0|||
155175261|NCT02656680|560080183|FG000|Overall Study|Lost to Follow-up|0|||
155175262|NCT02656680|560080184|FG001|Overall Study|Lost to Follow-up|1|||
155175263|NCT02656680|560080185|FG002|Overall Study|Lost to Follow-up|7|||
155175264|NCT02600871|560080188|FG000|Overall Study|Lost to Follow-up|13|||
155175265|NCT02600871|560080189|FG001|Overall Study|Lost to Follow-up|10|||
155175266|NCT00002931|560080190|FG000|Overall Study|rapidly progressing disease during|2|||
155175267|NCT01246466|560080193|FG000|Overall Study|Death|1|||
155175268|NCT01246466|560080193|FG000|Overall Study|Withdrawal by Subject|1|||
155175269|NCT01142089|560080199|FG000|Overall Study|Physician Decision|1|||
155175270|NCT01142089|560080200|FG001|Overall Study|Physician Decision|0|||
155175271|NCT01142089|560080199|FG000|Overall Study|Withdrawal by Subject|1|||
155175272|NCT01142089|560080200|FG001|Overall Study|Withdrawal by Subject|2|||
155175273|NCT01142089|560080199|FG000|Overall Study|Use of prohibited medications|0|||
155175274|NCT01142089|560080200|FG001|Overall Study|Use of prohibited medications|1|||
155175275|NCT01142089|560080199|FG000|Overall Study|Noncompliance with study procedures|2|||
155175276|NCT01142089|560080200|FG001|Overall Study|Noncompliance with study procedures|1|||
155175277|NCT01142089|560080199|FG000|Overall Study|Patient required rescue medication|8|||
155175278|NCT01142089|560080200|FG001|Overall Study|Patient required rescue medication|17|||
155175279|NCT01974765|560080201|FG000|Overall Study|Withdrawal by Subject|1|||
155175280|NCT01974765|560080201|FG000|Overall Study|Death|1|||
155175281|NCT01974765|560080201|FG000|Overall Study|Adverse Event|2|||
155175282|NCT00003472|560080206|FG000|Overall Study|Not evaluable|3|||
155175283|NCT01012219|560080207|FG000|Period 1|Withdrawal by Subject|1|||
155175284|NCT01012219|560080207|FG000|Period 2|Withdrawal by Subject|1|||
155175285|NCT00874939|560080208|FG000|Overall Study|Study terminated|4|||
155175286|NCT01909791|560080209|FG000|Overall Study|Death|9|||
155175287|NCT01909791|560080210|FG001|Overall Study|Death|8|||
155175288|NCT01909791|560080211|FG002|Overall Study|Death|4|||
155175289|NCT01909791|560080209|FG000|Overall Study|Withdrawal by Subject|5|||
155175290|NCT01909791|560080210|FG001|Overall Study|Withdrawal by Subject|9|||
155175291|NCT01909791|560080211|FG002|Overall Study|Withdrawal by Subject|13|||
155175292|NCT01909791|560080209|FG000|Overall Study|Lost to Follow-up|5|||
155175293|NCT01909791|560080210|FG001|Overall Study|Lost to Follow-up|11|||
155175294|NCT01909791|560080211|FG002|Overall Study|Lost to Follow-up|10|||
155175295|NCT01909791|560080209|FG000|Overall Study|Missed Visit|2|||
154872492|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872493|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872494|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872495|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872496|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872497|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
154872498|NCT01380093|558958202|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872499|NCT01380093|558958203|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872500|NCT01380093|558958204|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
154872501|NCT01380093|558958205|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872502|NCT01380093|558958206|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872503|NCT01380093|558958207|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872504|NCT01380093|558958208|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872505|NCT01380093|558958209|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872506|NCT01380093|558958210|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
154872507|NCT01380093|558958202|FG000|Treatment Phase: Second Intervention|Other|0|||
154872508|NCT01380093|558958203|FG001|Treatment Phase: Second Intervention|Other|0|||
154872509|NCT01380093|558958204|FG002|Treatment Phase: Second Intervention|Other|0|||
154872510|NCT01380093|558958205|FG003|Treatment Phase: Second Intervention|Other|1|||
154872511|NCT01380093|558958206|FG004|Treatment Phase: Second Intervention|Other|0|||
154872512|NCT01380093|558958207|FG005|Treatment Phase: Second Intervention|Other|0|||
154872513|NCT01380093|558958208|FG006|Treatment Phase: Second Intervention|Other|0|||
155175296|NCT01909791|560080210|FG001|Overall Study|Missed Visit|0|||
155175297|NCT01909791|560080211|FG002|Overall Study|Missed Visit|1|||
155175298|NCT02168387|560080212|FG000|Overall Study|Planned exubation|6|||
154872514|NCT01380093|558958209|FG007|Treatment Phase: Second Intervention|Other|0|||
154872515|NCT01380093|558958210|FG008|Treatment Phase: Second Intervention|Other|0|||
154872516|NCT01380093|558958202|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
154974088|NCT00876265|559331175|FG000|Overall Study|Lost to Follow-up|6|||
155175299|NCT02168387|560080213|FG001|Overall Study|Planned exubation|3|||
155175300|NCT02168387|560080212|FG000|Overall Study|Death|1|||
155175301|NCT02168387|560080213|FG001|Overall Study|Death|0|||
155175302|NCT01350544|560080217|FG000|Overall Study|Administrative Withdrawal|0|||
155175303|NCT01350544|560080218|FG001|Overall Study|Administrative Withdrawal|1|||
155175304|NCT01350544|560080217|FG000|Overall Study|Death|1|||
155175305|NCT01350544|560080218|FG001|Overall Study|Death|2|||
154872517|NCT01380093|558958203|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
154872518|NCT01380093|558958204|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
154872519|NCT01380093|558958205|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
154872520|NCT01380093|558958206|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
154872521|NCT01380093|558958207|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
154872522|NCT01380093|558958208|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
154872523|NCT01380093|558958209|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
154872524|NCT01380093|558958210|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
154872525|NCT01380093|558958202|FG000|Treatment Phase: Third Intervention|Other|0|||
155111144|NCT01296711|559835854|FG005|Overall Study|Study termination|4|||
155111145|NCT01296711|559835855|FG006|Overall Study|Study termination|8|||
155111146|NCT01296711|559835856|FG007|Overall Study|Study termination|10|||
155111147|NCT01296711|559835849|FG000|Overall Study|Continued elevated liver enzymes|0|||
155111148|NCT01296711|559835850|FG001|Overall Study|Continued elevated liver enzymes|0|||
155111149|NCT01296711|559835851|FG002|Overall Study|Continued elevated liver enzymes|0|||
155111150|NCT01296711|559835852|FG003|Overall Study|Continued elevated liver enzymes|1|||
155111151|NCT01296711|559835853|FG004|Overall Study|Continued elevated liver enzymes|0|||
155111152|NCT01296711|559835854|FG005|Overall Study|Continued elevated liver enzymes|0|||
155111153|NCT01296711|559835855|FG006|Overall Study|Continued elevated liver enzymes|0|||
155111154|NCT01296711|559835856|FG007|Overall Study|Continued elevated liver enzymes|0|||
155111155|NCT01296711|559835849|FG000|Overall Study|Methotrexate discontinued|0|||
155111156|NCT01296711|559835850|FG001|Overall Study|Methotrexate discontinued|0|||
155111157|NCT01296711|559835851|FG002|Overall Study|Methotrexate discontinued|0|||
155111158|NCT01296711|559835852|FG003|Overall Study|Methotrexate discontinued|1|||
155111159|NCT01296711|559835853|FG004|Overall Study|Methotrexate discontinued|0|||
155111160|NCT01296711|559835854|FG005|Overall Study|Methotrexate discontinued|0|||
155111161|NCT01296711|559835855|FG006|Overall Study|Methotrexate discontinued|0|||
155111162|NCT01296711|559835856|FG007|Overall Study|Methotrexate discontinued|0|||
154872526|NCT01380093|558958203|FG001|Treatment Phase: Third Intervention|Other|0|||
154872527|NCT01380093|558958204|FG002|Treatment Phase: Third Intervention|Other|0|||
154872528|NCT01380093|558958205|FG003|Treatment Phase: Third Intervention|Other|0|||
154872529|NCT01380093|558958206|FG004|Treatment Phase: Third Intervention|Other|0|||
154872530|NCT01380093|558958207|FG005|Treatment Phase: Third Intervention|Other|0|||
154872531|NCT01380093|558958208|FG006|Treatment Phase: Third Intervention|Other|0|||
154872532|NCT01380093|558958209|FG007|Treatment Phase: Third Intervention|Other|0|||
154872533|NCT01380093|558958210|FG008|Treatment Phase: Third Intervention|Other|1|||
154872534|NCT00546351|558958211|FG000|Overall Study|Adverse Event|76|||
154872535|NCT00546351|558958211|FG000|Overall Study|Lack of Efficacy|15|||
154872536|NCT00546351|558958211|FG000|Overall Study|Withdrawal by Subject|109|||
154872537|NCT00546351|558958211|FG000|Overall Study|Lost to Follow-up|9|||
154872538|NCT00546351|558958211|FG000|Overall Study|Protocol Deviation|1|||
154872539|NCT00546351|558958211|FG000|Overall Study|Unsatisfactory compliance|9|||
154872540|NCT00546351|558958211|FG000|Overall Study|Other reasons for premature termination|17|||
154872541|NCT04230486|558958221|FG000|Overall Study|Screen Failure|1|||
154872542|NCT01839188|558958222|FG000|Overall Study|Withdrawal by Subject|1|||
154872543|NCT04983901|558958223|FG000|Overall Study|Death|1|||
154872544|NCT04983901|558958224|FG001|Overall Study|Death|4|||
154872545|NCT04983901|558958223|FG000|Overall Study|Lost to Follow-up|3|||
154872546|NCT04983901|558958224|FG001|Overall Study|Lost to Follow-up|0|||
154872547|NCT04983901|558958223|FG000|Overall Study|Protocol Violation|1|||
154872548|NCT04983901|558958224|FG001|Overall Study|Protocol Violation|0|||
154872549|NCT04983901|558958223|FG000|Overall Study|Withdrawal by Subject|1|||
154872550|NCT04983901|558958224|FG001|Overall Study|Withdrawal by Subject|2|||
154872551|NCT02805907|558958225|FG000|Overall Study|Lost to Follow-up|3|||
154872552|NCT02805907|558958226|FG001|Overall Study|Lost to Follow-up|3|||
154872553|NCT01022853|558958233|FG000|Overall Study|Progressive disease|2|||
154872554|NCT01022853|558958234|FG001|Overall Study|Progressive disease|3|||
154872555|NCT01022853|558958235|FG002|Overall Study|Progressive disease|11|||
154872556|NCT01022853|558958236|FG003|Overall Study|Progressive disease|7|||
154872557|NCT01022853|558958237|FG004|Overall Study|Progressive disease|1|||
155111163|NCT01296711|559835849|FG000|Overall Study|Investigator discretion|0|||
155111164|NCT01296711|559835850|FG001|Overall Study|Investigator discretion|0|||
155111165|NCT01296711|559835851|FG002|Overall Study|Investigator discretion|0|||
155111166|NCT01296711|559835852|FG003|Overall Study|Investigator discretion|0|||
155111167|NCT01296711|559835853|FG004|Overall Study|Investigator discretion|0|||
155111168|NCT01296711|559835854|FG005|Overall Study|Investigator discretion|0|||
154872558|NCT01022853|558958233|FG000|Overall Study|Dose-limiting toxicity|0|||
154872559|NCT01022853|558958234|FG001|Overall Study|Dose-limiting toxicity|0|||
154872560|NCT01022853|558958235|FG002|Overall Study|Dose-limiting toxicity|0|||
154872561|NCT01022853|558958236|FG003|Overall Study|Dose-limiting toxicity|0|||
154872562|NCT01022853|558958237|FG004|Overall Study|Dose-limiting toxicity|1|||
154872563|NCT01022853|558958233|FG000|Overall Study|Withdrawal by Subject|0|||
154872564|NCT01022853|558958234|FG001|Overall Study|Withdrawal by Subject|1|||
155111169|NCT01296711|559835855|FG006|Overall Study|Investigator discretion|1|||
155111170|NCT01296711|559835856|FG007|Overall Study|Investigator discretion|0|||
154872565|NCT01022853|558958235|FG002|Overall Study|Withdrawal by Subject|1|||
154872566|NCT01022853|558958236|FG003|Overall Study|Withdrawal by Subject|1|||
154872567|NCT01022853|558958237|FG004|Overall Study|Withdrawal by Subject|0|||
155111171|NCT01296711|559835849|FG000|Overall Study|Other|0|||
155111172|NCT01296711|559835850|FG001|Overall Study|Other|0|||
155111173|NCT01296711|559835851|FG002|Overall Study|Other|0|||
154872568|NCT01022853|558958233|FG000|Overall Study|Other not stated above|1|||
154872569|NCT01022853|558958234|FG001|Overall Study|Other not stated above|0|||
154872570|NCT01022853|558958235|FG002|Overall Study|Other not stated above|1|||
154872571|NCT01022853|558958236|FG003|Overall Study|Other not stated above|0|||
154872572|NCT01022853|558958237|FG004|Overall Study|Other not stated above|0|||
155111174|NCT01296711|559835852|FG003|Overall Study|Other|0|||
155111175|NCT01296711|559835853|FG004|Overall Study|Other|0|||
155111176|NCT01296711|559835854|FG005|Overall Study|Other|0|||
155111177|NCT01296711|559835855|FG006|Overall Study|Other|1|||
154872573|NCT00532883|558958238|FG000|Overall Study|Adverse Event|1|||
154872574|NCT00532883|558958239|FG001|Overall Study|Adverse Event|0|||
154872575|NCT00532883|558958240|FG002|Overall Study|Adverse Event|0|||
154872576|NCT00532883|558958241|FG003|Overall Study|Adverse Event|1|||
154872577|NCT00532883|558958238|FG000|Overall Study|Lost to Follow-up|1|||
154872578|NCT00532883|558958239|FG001|Overall Study|Lost to Follow-up|1|||
154872579|NCT00532883|558958240|FG002|Overall Study|Lost to Follow-up|1|||
155111178|NCT01296711|559835856|FG007|Overall Study|Other|0|||
155111179|NCT01296711|559835849|FG000|Overall Study|Required restricted steroid injections|0|||
155111180|NCT01296711|559835850|FG001|Overall Study|Required restricted steroid injections|0|||
155111181|NCT01296711|559835851|FG002|Overall Study|Required restricted steroid injections|0|||
155111182|NCT01296711|559835852|FG003|Overall Study|Required restricted steroid injections|0|||
155111183|NCT01296711|559835853|FG004|Overall Study|Required restricted steroid injections|0|||
155111184|NCT01296711|559835854|FG005|Overall Study|Required restricted steroid injections|0|||
155111185|NCT01296711|559835855|FG006|Overall Study|Required restricted steroid injections|1|||
155111186|NCT01296711|559835856|FG007|Overall Study|Required restricted steroid injections|0|||
155111187|NCT01296711|559835849|FG000|Overall Study|Ongoing missed appointments|0|||
155111188|NCT01296711|559835850|FG001|Overall Study|Ongoing missed appointments|0|||
155111189|NCT01296711|559835851|FG002|Overall Study|Ongoing missed appointments|0|||
155111190|NCT01296711|559835852|FG003|Overall Study|Ongoing missed appointments|0|||
155111191|NCT01296711|559835853|FG004|Overall Study|Ongoing missed appointments|0|||
155111192|NCT01296711|559835854|FG005|Overall Study|Ongoing missed appointments|0|||
155111193|NCT01296711|559835855|FG006|Overall Study|Ongoing missed appointments|1|||
155111194|NCT01296711|559835856|FG007|Overall Study|Ongoing missed appointments|0|||
155111195|NCT01296711|559835849|FG000|Overall Study|Failure to comply with visits|0|||
154872580|NCT00532883|558958241|FG003|Overall Study|Lost to Follow-up|0|||
154872581|NCT00532883|558958238|FG000|Overall Study|Withdrawal by Subject|0|||
154872582|NCT00532883|558958239|FG001|Overall Study|Withdrawal by Subject|1|||
154872583|NCT00532883|558958240|FG002|Overall Study|Withdrawal by Subject|1|||
154872584|NCT00532883|558958241|FG003|Overall Study|Withdrawal by Subject|0|||
154872585|NCT00532883|558958238|FG000|Overall Study|Subject was Nonadherent|0|||
154872586|NCT00532883|558958239|FG001|Overall Study|Subject was Nonadherent|1|||
154974089|NCT00876265|559331175|FG000|Overall Study|Withdrawal by Subject|2|||
154974090|NCT02327325|559331176|FG000|Overall Study|Withdrawal by Subject|1|||
154974091|NCT02327325|559331177|FG001|Overall Study|Withdrawal by Subject|4|||
154974092|NCT02327325|559331178|FG002|Overall Study|Withdrawal by Subject|4|||
154974093|NCT02327325|559331176|FG000|Overall Study|Excluded by Study Team|0|||
154974094|NCT02327325|559331177|FG001|Overall Study|Excluded by Study Team|0|||
154974095|NCT02327325|559331178|FG002|Overall Study|Excluded by Study Team|1|||
154974096|NCT00651183|559331181|FG000|Overall Study|Lack of Efficacy|1|||
154974097|NCT00651183|559331182|FG001|Overall Study|Lack of Efficacy|0|||
154974098|NCT00651183|559331181|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
154974099|NCT00651183|559331182|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
155111196|NCT01296711|559835850|FG001|Overall Study|Failure to comply with visits|0|||
155111197|NCT01296711|559835851|FG002|Overall Study|Failure to comply with visits|0|||
155111198|NCT01296711|559835852|FG003|Overall Study|Failure to comply with visits|0|||
155111199|NCT01296711|559835853|FG004|Overall Study|Failure to comply with visits|0|||
154872587|NCT00532883|558958240|FG002|Overall Study|Subject was Nonadherent|1|||
154872588|NCT00532883|558958241|FG003|Overall Study|Subject was Nonadherent|0|||
154872589|NCT00532883|558958238|FG000|Overall Study|Early Study Termination|4|||
154872590|NCT00532883|558958239|FG001|Overall Study|Early Study Termination|4|||
154872591|NCT00532883|558958240|FG002|Overall Study|Early Study Termination|1|||
154872592|NCT00532883|558958241|FG003|Overall Study|Early Study Termination|4|||
155111200|NCT01296711|559835854|FG005|Overall Study|Failure to comply with visits|0|||
154872593|NCT01214434|558958244|FG000|Overall Study|Withdrawal by Subject|1|||
154872594|NCT01214434|558958245|FG001|Overall Study|Withdrawal by Subject|0|||
154974100|NCT00651183|559331181|FG000|Overall Study|Tolerability insufficient|5|||
154974101|NCT00651183|559331182|FG001|Overall Study|Tolerability insufficient|2|||
155111201|NCT01296711|559835855|FG006|Overall Study|Failure to comply with visits|0|||
155111202|NCT01296711|559835856|FG007|Overall Study|Failure to comply with visits|1|||
154872595|NCT01214434|558958244|FG000|Overall Study|Lost to Follow-up|2|||
154872596|NCT01214434|558958245|FG001|Overall Study|Lost to Follow-up|2|||
154872597|NCT01214434|558958244|FG000|Overall Study|Site error|1|||
154872598|NCT01214434|558958245|FG001|Overall Study|Site error|0|||
154872599|NCT02075255|558958247|FG000|Overall Study|Study specific withdrawal criteria|0|||
154872600|NCT02075255|558958248|FG001|Overall Study|Study specific withdrawal criteria|1|||
154872601|NCT02075255|558958249|FG002|Overall Study|Study specific withdrawal criteria|1|||
154872602|NCT02075255|558958247|FG000|Overall Study|Withdrawal by Subject|4|||
154872603|NCT02075255|558958248|FG001|Overall Study|Withdrawal by Subject|1|||
154872604|NCT02075255|558958249|FG002|Overall Study|Withdrawal by Subject|0|||
154872605|NCT02075255|558958247|FG000|Overall Study|Lost to Follow-up|0|||
154872606|NCT02075255|558958248|FG001|Overall Study|Lost to Follow-up|0|||
154872607|NCT02075255|558958249|FG002|Overall Study|Lost to Follow-up|1|||
154872608|NCT02075255|558958247|FG000|Overall Study|Adverse Event|0|||
154872609|NCT02075255|558958248|FG001|Overall Study|Adverse Event|0|||
154872610|NCT02075255|558958249|FG002|Overall Study|Adverse Event|1|||
154872611|NCT02075255|558958247|FG000|Overall Study|Death|0|||
154872612|NCT02075255|558958248|FG001|Overall Study|Death|2|||
154872613|NCT02075255|558958249|FG002|Overall Study|Death|0|||
154872614|NCT03792750|558958250|FG000|Overall Study|Death|3|||
154872615|NCT01651052|558958251|FG000|Overall Study|Death|21|||
154872616|NCT01651052|558958251|FG000|Overall Study|Explant|1|||
154872617|NCT01651052|558958251|FG000|Overall Study|Withdrawal by Subject|1|||
154872618|NCT01651052|558958251|FG000|Overall Study|Lost to Follow-up|3|||
154872619|NCT03503773|558958252|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
154872620|NCT03503773|558958253|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
154872621|NCT03503773|558958252|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
154872622|NCT03503773|558958253|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
154872623|NCT03503773|558958252|FG000|Overall Study|Not completing the primary ABPM|3|||
154872624|NCT03503773|558958253|FG001|Overall Study|Not completing the primary ABPM|1|||
154872625|NCT03503773|558958252|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
154872626|NCT03503773|558958253|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
154872627|NCT00425438|558958257|FG000|Overall Study|Termination by Sponsor|25|||
154872628|NCT00425438|558958258|FG001|Overall Study|Termination by Sponsor|27|||
154872629|NCT02902809|558958259|FG000|Overall Study|Discontinuation of asthma program|28|||
154872630|NCT00532259|558958260|FG000|Overall Study|Withdrawal by Subject|2|||
154872631|NCT00532259|558958260|FG000|Overall Study|Adverse Event|1|||
154872632|NCT00532259|558958260|FG000|Overall Study|Death|1|||
154872633|NCT00532259|558958260|FG000|Overall Study|Lack of Efficacy|21|||
154872634|NCT00532259|558958260|FG000|Overall Study|Lost to Follow-up|3|||
154872635|NCT00532259|558958260|FG000|Overall Study|Physician Decision|3|||
154872636|NCT00532259|558958260|FG000|Overall Study|Protocol Violation|1|||
154872637|NCT01188798|558958261|FG000|Overall Study|Death|0|||
154872638|NCT01188798|558958262|FG001|Overall Study|Death|1|||
154872639|NCT01188798|558958261|FG000|Overall Study|Required additional transplant|1|||
154872640|NCT01188798|558958262|FG001|Overall Study|Required additional transplant|1|||
154872641|NCT01188798|558958261|FG000|Overall Study|Protocol closure|1|||
154872642|NCT01188798|558958262|FG001|Overall Study|Protocol closure|1|||
154872643|NCT02795767|558958263|FG000|Overall Study|Received Commercial Emicizumab|1|||
154872644|NCT02795767|558958264|FG001|Overall Study|Received Commercial Emicizumab|0|||
154872645|NCT02795767|558958265|FG002|Overall Study|Received Commercial Emicizumab|0|||
154872646|NCT03964415|558958266|FG000|Overall Study|Sponsor's decision|1563|||
154872647|NCT03964415|558958267|FG001|Overall Study|Sponsor's decision|1528|||
154872648|NCT03964415|558958266|FG000|Overall Study|Lost to Follow-up|139|||
154872649|NCT03964415|558958267|FG001|Overall Study|Lost to Follow-up|146|||
154872650|NCT03964415|558958266|FG000|Overall Study|Withdrawal by Subject|68|||
154872651|NCT03964415|558958267|FG001|Overall Study|Withdrawal by Subject|72|||
154872652|NCT03964415|558958266|FG000|Overall Study|Physician Decision|34|||
154872653|NCT03964415|558958267|FG001|Overall Study|Physician Decision|48|||
154872654|NCT03964415|558958266|FG000|Overall Study|Adverse Event|3|||
154872655|NCT03964415|558958267|FG001|Overall Study|Adverse Event|0|||
154872656|NCT03964415|558958266|FG000|Overall Study|Death|4|||
154872657|NCT03964415|558958267|FG001|Overall Study|Death|6|||
154872658|NCT03964415|558958266|FG000|Overall Study|Protocol Violation|1|||
154872659|NCT03964415|558958267|FG001|Overall Study|Protocol Violation|4|||
154872660|NCT03964415|558958266|FG000|Overall Study|Other|35|||
154872661|NCT03964415|558958267|FG001|Overall Study|Other|38|||
154872662|NCT03964415|558958266|FG000|Overall Study|Randomized but not treated|6|||
154872663|NCT03964415|558958267|FG001|Overall Study|Randomized but not treated|7|||
154872664|NCT04983940|558958272|FG000|Overall Study|Lost to Follow-up|14|||
154872665|NCT04983940|558958272|FG000|Overall Study|Lack of Efficacy|2|||
154872666|NCT01097330|558958273|FG000|Overall Study|Study terminated early|7|||
154872667|NCT01097330|558958274|FG001|Overall Study|Study terminated early|5|||
154872668|NCT04156646|558958280|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
154872669|NCT04156646|558958281|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
154872670|NCT05270694|558959580|FG000|Overall Study|Death|1|||
154872671|NCT05270694|558959580|FG000|Overall Study|Medical issues impacted ability to participate|2|||
154872672|NCT05270694|558959580|FG000|Overall Study|Lost to Follow-up|3|||
154872673|NCT05270694|558959580|FG000|Overall Study|Withdrawal by Subject|3|||
154872674|NCT02345434|558959587|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
154872675|NCT02345434|558959588|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
154872676|NCT02064439|558959589|FG000|Overall Study|Adverse Event|51|||
154872677|NCT02064439|558959590|FG001|Overall Study|Adverse Event|47|||
154872678|NCT02064439|558959591|FG002|Overall Study|Adverse Event|46|||
154872679|NCT02064439|558959589|FG000|Overall Study|Death|0|||
154872680|NCT02064439|558959590|FG001|Overall Study|Death|2|||
154872681|NCT02064439|558959591|FG002|Overall Study|Death|3|||
154872682|NCT02064439|558959589|FG000|Overall Study|Withdrawal by Subject|29|||
154872683|NCT02064439|558959590|FG001|Overall Study|Withdrawal by Subject|18|||
154872684|NCT02064439|558959591|FG002|Overall Study|Withdrawal by Subject|26|||
154872685|NCT02064439|558959589|FG000|Overall Study|Protocol Violation|3|||
154872686|NCT02064439|558959590|FG001|Overall Study|Protocol Violation|5|||
154872687|NCT02064439|558959591|FG002|Overall Study|Protocol Violation|3|||
154872688|NCT02064439|558959589|FG000|Overall Study|Lost to Follow-up|1|||
154872689|NCT02064439|558959590|FG001|Overall Study|Lost to Follow-up|3|||
154872690|NCT02064439|558959591|FG002|Overall Study|Lost to Follow-up|4|||
154872691|NCT02064439|558959589|FG000|Overall Study|Non-compliance with study medication|21|||
154872692|NCT02064439|558959590|FG001|Overall Study|Non-compliance with study medication|19|||
154872693|NCT02064439|558959591|FG002|Overall Study|Non-compliance with study medication|23|||
154872694|NCT02064439|558959589|FG000|Overall Study|Physician Decision|0|||
154872695|NCT02064439|558959590|FG001|Overall Study|Physician Decision|1|||
154872696|NCT02064439|558959591|FG002|Overall Study|Physician Decision|1|||
154872697|NCT02064439|558959589|FG000|Overall Study|Logistical difficulties|6|||
154872698|NCT02064439|558959590|FG001|Overall Study|Logistical difficulties|5|||
154872699|NCT02064439|558959591|FG002|Overall Study|Logistical difficulties|2|||
154872700|NCT02064439|558959589|FG000|Overall Study|Efficacy outcome reached|18|||
154872701|NCT02064439|558959590|FG001|Overall Study|Efficacy outcome reached|16|||
154872702|NCT02064439|558959591|FG002|Overall Study|Efficacy outcome reached|57|||
154872703|NCT02064439|558959589|FG000|Overall Study|Safety outcome reached|12|||
154872704|NCT02064439|558959590|FG001|Overall Study|Safety outcome reached|20|||
154872705|NCT02064439|558959591|FG002|Overall Study|Safety outcome reached|10|||
154872706|NCT02064439|558959589|FG000|Overall Study|Other|2|||
154872707|NCT02064439|558959590|FG001|Overall Study|Other|2|||
154872708|NCT02064439|558959591|FG002|Overall Study|Other|7|||
154872709|NCT02433288|558959592|FG000|Overall Study|Severe non-compliance to protocol|13|||
154872710|NCT02433288|558959593|FG001|Overall Study|Severe non-compliance to protocol|7|||
154872711|NCT02433288|558959592|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
154872712|NCT02433288|558959593|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
154872713|NCT02433288|558959592|FG000|Overall Study|Withdrawal by Subject|101|||
154872714|NCT02433288|558959593|FG001|Overall Study|Withdrawal by Subject|99|||
154872715|NCT02433288|558959592|FG000|Overall Study|Lost to Follow-up|2|||
154872716|NCT02433288|558959593|FG001|Overall Study|Lost to Follow-up|14|||
154872717|NCT02433288|558959592|FG000|Overall Study|Death|0|||
154974102|NCT00651183|559331181|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
154974103|NCT00651183|559331182|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
154974104|NCT00651183|559331181|FG000|Overall Study|Withdrawal by Subject|6|||
154974105|NCT00651183|559331182|FG001|Overall Study|Withdrawal by Subject|3|||
154974106|NCT00651183|559331181|FG000|Overall Study|Lost to Follow-up|3|||
154974107|NCT00651183|559331182|FG001|Overall Study|Lost to Follow-up|1|||
154974108|NCT00651183|559331181|FG000|Overall Study|Other reasons|4|||
154974109|NCT00651183|559331182|FG001|Overall Study|Other reasons|2|||
154974110|NCT00651183|559331181|FG000|Overall Study|missing|1|||
154974111|NCT00651183|559331182|FG001|Overall Study|missing|0|||
154974112|NCT02014441|559331186|FG000|Overall Study|Withdrawal by Subject|12|||
154974113|NCT02576717|559331188|FG000|Overall Study|Other Reasons|16|||
154872718|NCT02433288|558959593|FG001|Overall Study|Death|3|||
154872719|NCT00858702|558959596|FG000|Overall Study|Lack of Efficacy|1|||
154974114|NCT02576717|559331189|FG001|Overall Study|Other Reasons|18|||
154974115|NCT02576717|559331190|FG002|Overall Study|Other Reasons|15|||
155175306|NCT01350544|560080217|FG000|Overall Study|Moved out of LA County|2|||
155175307|NCT01350544|560080218|FG001|Overall Study|Moved out of LA County|2|||
154872720|NCT00858702|558959597|FG001|Overall Study|Lack of Efficacy|0|||
154872721|NCT00858702|558959596|FG000|Overall Study|Protocol Violation|1|||
154872722|NCT00858702|558959597|FG001|Overall Study|Protocol Violation|1|||
154872723|NCT00858702|558959596|FG000|Overall Study|Other|2|||
154872724|NCT00858702|558959597|FG001|Overall Study|Other|1|||
154872725|NCT00858702|558959596|FG000|Overall Study|Withdrawal by Subject|1|||
154872726|NCT00858702|558959597|FG001|Overall Study|Withdrawal by Subject|0|||
154974116|NCT02576717|559331188|FG000|Overall Study|Covid-19 Pandemic|0|||
154974117|NCT02576717|559331189|FG001|Overall Study|Covid-19 Pandemic|1|||
154974118|NCT02576717|559331190|FG002|Overall Study|Covid-19 Pandemic|1|||
155175308|NCT01350544|560080217|FG000|Overall Study|Medical Issues|1|||
154872727|NCT00367640|558959598|FG000|Overall Study|Adverse Event|3|||
154872728|NCT00367640|558959599|FG001|Overall Study|Adverse Event|6|||
154872729|NCT00367640|558959600|FG002|Overall Study|Adverse Event|8|||
154872730|NCT00367640|558959601|FG003|Overall Study|Adverse Event|0|||
154872731|NCT00367640|558959598|FG000|Overall Study|Withdrawal by Subject|8|||
154872732|NCT00367640|558959599|FG001|Overall Study|Withdrawal by Subject|11|||
154872733|NCT00367640|558959600|FG002|Overall Study|Withdrawal by Subject|8|||
154872734|NCT00367640|558959601|FG003|Overall Study|Withdrawal by Subject|6|||
154872735|NCT00367640|558959598|FG000|Overall Study|Any other reason not above-mentioned|7|||
154872736|NCT00367640|558959599|FG001|Overall Study|Any other reason not above-mentioned|5|||
154872737|NCT00367640|558959600|FG002|Overall Study|Any other reason not above-mentioned|3|||
154872738|NCT00367640|558959601|FG003|Overall Study|Any other reason not above-mentioned|4|||
154872739|NCT02417233|558959602|FG000|Overall Study|Death|4|||
154872740|NCT02417233|558959603|FG001|Overall Study|Death|10|||
154872741|NCT02417233|558959604|FG002|Overall Study|Death|14|||
154872742|NCT02417233|558959602|FG000|Overall Study|Lost to Follow-up|27|||
154872743|NCT02417233|558959603|FG001|Overall Study|Lost to Follow-up|39|||
154872744|NCT02417233|558959604|FG002|Overall Study|Lost to Follow-up|34|||
154872745|NCT02417233|558959602|FG000|Overall Study|Protocol Violation|2|||
154872746|NCT02417233|558959603|FG001|Overall Study|Protocol Violation|0|||
154872747|NCT02417233|558959604|FG002|Overall Study|Protocol Violation|2|||
154872748|NCT02417233|558959602|FG000|Overall Study|Withdrawal by Subject|2|||
154872749|NCT02417233|558959603|FG001|Overall Study|Withdrawal by Subject|1|||
154872750|NCT02417233|558959604|FG002|Overall Study|Withdrawal by Subject|8|||
154872751|NCT02417233|558959602|FG000|Overall Study|Relocation out of study area|1|||
154872752|NCT02417233|558959603|FG001|Overall Study|Relocation out of study area|0|||
154872753|NCT02417233|558959604|FG002|Overall Study|Relocation out of study area|1|||
154872754|NCT02417233|558959602|FG000|Overall Study|Mentally unstable|0|||
154872755|NCT02417233|558959603|FG001|Overall Study|Mentally unstable|1|||
154872756|NCT02417233|558959604|FG002|Overall Study|Mentally unstable|0|||
154872757|NCT01063751|558959606|FG000|Overall Study|Censored from analyses|42|||
154872758|NCT01063751|558959606|FG000|Overall Study|Withdrawal by Subject|34|||
154872759|NCT01063751|558959606|FG000|Overall Study|Lost to Follow-up|30|||
154872760|NCT01063751|558959606|FG000|Overall Study|Death|13|||
154872761|NCT01063751|558959606|FG000|Overall Study|Sponsored Terminated Study|60|||
154872762|NCT01063751|558959606|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
154872763|NCT01063751|558959606|FG000|Overall Study|Investigator site closed|10|||
154872764|NCT01063751|558959606|FG000|Overall Study|Revision|6|||
154872765|NCT01063751|558959606|FG000|Overall Study|Physician Decision|4|||
154872766|NCT01671488|558959622|FG000|Overall Study|Withdrawal by Subject|1|||
154872767|NCT02416908|558959623|FG000|Dose Escalation Phase|Adverse Event|0|||
154872768|NCT02416908|558959624|FG001|Dose Escalation Phase|Adverse Event|0|||
154872769|NCT02416908|558959625|FG002|Dose Escalation Phase|Adverse Event|3|||
154872770|NCT02416908|558959626|FG003|Dose Escalation Phase|Adverse Event|0|||
154872771|NCT02416908|558959623|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
154872772|NCT02416908|558959624|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
154872773|NCT02416908|558959625|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
154872774|NCT02416908|558959626|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
154872775|NCT03799718|558959627|FG000|Overall Study|Adverse Event|2|||
154872776|NCT03662334|558959634|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
154872777|NCT03662334|558959635|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
154872778|NCT01478347|558959645|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
154872779|NCT01478347|558959645|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
154872780|NCT01478347|558959645|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
154872781|NCT01645930|558959646|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
154872782|NCT01645930|558959646|FG000|Overall Study|Progressive Disease|12|||
154872783|NCT01645930|558959646|FG000|Overall Study|Adverse Event|4|||
154872784|NCT01645930|558959646|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
154872785|NCT01645930|558959646|FG000|Overall Study|Withdrawal by Participant|2|||
154872786|NCT01645930|558959646|FG000|Overall Study|Reason not Defined|1|||
154872787|NCT01748760|558959647|FG000|Overall Study|Withdrawal by Subject|1|||
154872788|NCT01748760|558959648|FG001|Overall Study|Withdrawal by Subject|1|||
154872789|NCT01748760|558959647|FG000|Overall Study|Lost to Follow-up|5|||
154872790|NCT01748760|558959648|FG001|Overall Study|Lost to Follow-up|1|||
154872791|NCT03245814|558959649|FG000|Overall Study|Lost to Follow-up|5|||
154872792|NCT03245814|558959650|FG001|Overall Study|Lost to Follow-up|8|||
154872793|NCT03245814|558959649|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
154872794|NCT03245814|558959650|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
154872795|NCT02263365|558959655|FG000|Overall Study|Physician Decision|22|||
154872796|NCT02263365|558959656|FG001|Overall Study|Physician Decision|18|||
154872797|NCT00510692|558959657|FG000|Overall Study|Adverse Event|1|||
154872798|NCT00510692|558959658|FG001|Overall Study|Adverse Event|3|||
154872799|NCT00510692|558959657|FG000|Overall Study|Withdrawal by Subject|1|||
154872800|NCT00510692|558959658|FG001|Overall Study|Withdrawal by Subject|0|||
154872801|NCT00945191|558959659|FG000|Overall Study|Did not achieve a complete response|18|||
154872802|NCT00945191|558959659|FG000|Overall Study|Participant relocated to another state|1|||
154872803|NCT00945191|558959659|FG000|Overall Study|Disease progression|3|||
154872804|NCT00945191|558959659|FG000|Overall Study|Serious adverse event or adverse event|1|||
154872805|NCT00945191|558959659|FG000|Overall Study|Investigator's discretion|1|||
154872806|NCT02116972|558959660|FG000|Overall Study|Adverse Event|4|||
154872807|NCT02116972|558959661|FG001|Overall Study|Adverse Event|4|||
154872808|NCT02116972|558959662|FG002|Overall Study|Adverse Event|1|||
154872809|NCT02116972|558959660|FG000|Overall Study|Withdrawal by Subject|1|||
154872810|NCT02116972|558959661|FG001|Overall Study|Withdrawal by Subject|1|||
154872811|NCT02116972|558959662|FG002|Overall Study|Withdrawal by Subject|5|||
154872812|NCT02116972|558959660|FG000|Overall Study|Protocol Violation|1|||
154872813|NCT02116972|558959661|FG001|Overall Study|Protocol Violation|0|||
154872814|NCT02116972|558959662|FG002|Overall Study|Protocol Violation|1|||
154872815|NCT02116972|558959660|FG000|Overall Study|Lost to Follow-up|4|||
154872816|NCT02116972|558959661|FG001|Overall Study|Lost to Follow-up|3|||
154872817|NCT02116972|558959662|FG002|Overall Study|Lost to Follow-up|1|||
154872818|NCT02116972|558959660|FG000|Overall Study|Lack of Efficacy|6|||
154872819|NCT02116972|558959661|FG001|Overall Study|Lack of Efficacy|6|||
154872820|NCT02116972|558959662|FG002|Overall Study|Lack of Efficacy|5|||
154872821|NCT02116972|558959660|FG000|Overall Study|scheduling conflicts and relocation|3|||
154872822|NCT02116972|558959661|FG001|Overall Study|scheduling conflicts and relocation|3|||
154872823|NCT02116972|558959662|FG002|Overall Study|scheduling conflicts and relocation|6|||
154872824|NCT00784784|558959663|FG000|Overall Study|Withdrawal by Subject|2|||
154872825|NCT00784784|558959664|FG001|Overall Study|Withdrawal by Subject|2|||
154872826|NCT01879618|558959667|FG000|Overall Study|Does not meet entrance criteria|1|||
154872827|NCT01879618|558959667|FG000|Overall Study|Withdrawal by Subject|1|||
154872828|NCT01879618|558959667|FG000|Overall Study|Surgery;changed schedule; not available|8|||
154872829|NCT01879618|558959667|FG000|Overall Study|Protocol Violation|6|||
154872830|NCT01879618|558959667|FG000|Overall Study|Adverse Event|5|||
154872831|NCT00872898|558959672|FG000|Part Two - Double Blind|Adverse Event|4|||
154872832|NCT00872898|558959673|FG001|Part Two - Double Blind|Adverse Event|3|||
154872833|NCT00872898|558959672|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
154872834|NCT00872898|558959673|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
154872835|NCT00872898|558959672|FG000|Part Two - Double Blind|Protocol Violation|1|||
154872836|NCT00872898|558959673|FG001|Part Two - Double Blind|Protocol Violation|0|||
154872837|NCT00872898|558959672|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
154872838|NCT00872898|558959673|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
154872839|NCT00872898|558959672|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
154872840|NCT00872898|558959673|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
154872841|NCT00872898|558959672|FG000|Part Two - Double Blind|Other reasons|2|||
154872842|NCT00872898|558959673|FG001|Part Two - Double Blind|Other reasons|0|||
154872843|NCT01004146|558959675|FG000|Overall Study|Withdrawal by Subject|4|||
154872844|NCT01004146|558959676|FG001|Overall Study|Withdrawal by Subject|5|||
154872845|NCT00863928|558959680|FG000|Overall Study|Protocol Violation|26|||
154872846|NCT00863928|558959681|FG001|Overall Study|Protocol Violation|0|||
154872847|NCT00863928|558959680|FG000|Overall Study|Withdrawal by Subject|3|||
154872848|NCT00863928|558959681|FG001|Overall Study|Withdrawal by Subject|0|||
154872849|NCT00863928|558959680|FG000|Overall Study|surgery cancellation|4|||
154872850|NCT00863928|558959681|FG001|Overall Study|surgery cancellation|0|||
154872851|NCT00863928|558959680|FG000|Overall Study|medication allergy|3|||
154872852|NCT00863928|558959681|FG001|Overall Study|medication allergy|0|||
154872853|NCT01001494|558959686|FG000|Overall Study|Adverse Event|8|||
154872854|NCT01001494|558959687|FG001|Overall Study|Adverse Event|4|||
154872855|NCT01001494|558959688|FG002|Overall Study|Adverse Event|6|||
154872856|NCT01001494|558959686|FG000|Overall Study|Protocol Violation|0|||
154872857|NCT01001494|558959687|FG001|Overall Study|Protocol Violation|1|||
154872858|NCT01001494|558959688|FG002|Overall Study|Protocol Violation|1|||
154872859|NCT01001494|558959686|FG000|Overall Study|Lost to Follow-up|2|||
154872860|NCT01001494|558959687|FG001|Overall Study|Lost to Follow-up|0|||
154872861|NCT01001494|558959688|FG002|Overall Study|Lost to Follow-up|1|||
154872862|NCT01001494|558959686|FG000|Overall Study|Withdrawal by Subject|9|||
154872863|NCT01001494|558959687|FG001|Overall Study|Withdrawal by Subject|7|||
154872864|NCT01001494|558959688|FG002|Overall Study|Withdrawal by Subject|17|||
154872865|NCT01001494|558959686|FG000|Overall Study|COPD exacerbation|3|||
154872866|NCT01001494|558959687|FG001|Overall Study|COPD exacerbation|4|||
154872867|NCT01001494|558959688|FG002|Overall Study|COPD exacerbation|5|||
154872868|NCT01001494|558959686|FG000|Overall Study|Lack of Efficacy|2|||
154872869|NCT01001494|558959687|FG001|Overall Study|Lack of Efficacy|0|||
154872870|NCT01001494|558959688|FG002|Overall Study|Lack of Efficacy|8|||
154872871|NCT01001494|558959686|FG000|Overall Study|Other|0|||
154872872|NCT01001494|558959687|FG001|Overall Study|Other|1|||
154872873|NCT01001494|558959688|FG002|Overall Study|Other|3|||
154872874|NCT02795156|558959690|FG000|Overall Study|Progressive Disease|22|||
154872875|NCT02795156|558959691|FG001|Overall Study|Progressive Disease|7|||
154872876|NCT02795156|558959692|FG002|Overall Study|Progressive Disease|34|||
154872877|NCT02795156|558959693|FG003|Overall Study|Progressive Disease|7|||
154872878|NCT02795156|558959690|FG000|Overall Study|Adverse Event|13|||
154872879|NCT02795156|558959691|FG001|Overall Study|Adverse Event|2|||
154872880|NCT02795156|558959692|FG002|Overall Study|Adverse Event|3|||
154872881|NCT02795156|558959693|FG003|Overall Study|Adverse Event|2|||
154872882|NCT02795156|558959690|FG000|Overall Study|Death|1|||
154872883|NCT02795156|558959691|FG001|Overall Study|Death|1|||
154872884|NCT02795156|558959692|FG002|Overall Study|Death|1|||
154872885|NCT02795156|558959693|FG003|Overall Study|Death|0|||
154872886|NCT02795156|558959690|FG000|Overall Study|Physician Decision|1|||
154872887|NCT02795156|558959691|FG001|Overall Study|Physician Decision|0|||
154872888|NCT02795156|558959692|FG002|Overall Study|Physician Decision|1|||
154872889|NCT02795156|558959693|FG003|Overall Study|Physician Decision|0|||
154872890|NCT02795156|558959690|FG000|Overall Study|Withdrawal by Subject|2|||
154872891|NCT02795156|558959691|FG001|Overall Study|Withdrawal by Subject|0|||
154872892|NCT02795156|558959692|FG002|Overall Study|Withdrawal by Subject|3|||
154872893|NCT02795156|558959693|FG003|Overall Study|Withdrawal by Subject|0|||
154872894|NCT00734929|558959697|FG000|Overall Study|Lost to Follow-up|1|||
155111203|NCT01296711|559835849|FG000|Overall Study|Patient decision due to transport|0|||
155111204|NCT01296711|559835850|FG001|Overall Study|Patient decision due to transport|0|||
155111205|NCT01296711|559835851|FG002|Overall Study|Patient decision due to transport|0|||
155111206|NCT01296711|559835852|FG003|Overall Study|Patient decision due to transport|0|||
155111207|NCT01296711|559835853|FG004|Overall Study|Patient decision due to transport|0|||
155111208|NCT01296711|559835854|FG005|Overall Study|Patient decision due to transport|0|||
155111209|NCT01296711|559835855|FG006|Overall Study|Patient decision due to transport|0|||
155111210|NCT01296711|559835856|FG007|Overall Study|Patient decision due to transport|1|||
155111211|NCT01005316|559835866|FG000|Overall Study|Adverse Event|0|||
155111212|NCT01005316|559835867|FG001|Overall Study|Adverse Event|0|||
155111213|NCT01005316|559835868|FG002|Overall Study|Adverse Event|0|||
155111214|NCT01005316|559835869|FG003|Overall Study|Adverse Event|1|||
155111215|NCT01005316|559835866|FG000|Overall Study|Death|20|||
155111216|NCT01005316|559835867|FG001|Overall Study|Death|5|||
155111217|NCT01005316|559835868|FG002|Overall Study|Death|1|||
155111218|NCT01005316|559835869|FG003|Overall Study|Death|15|||
155111219|NCT01005316|559835866|FG000|Overall Study|Study Termination|5|||
155111220|NCT01005316|559835867|FG001|Overall Study|Study Termination|63|||
155111221|NCT01005316|559835868|FG002|Overall Study|Study Termination|9|||
155111222|NCT01005316|559835869|FG003|Overall Study|Study Termination|85|||
155111223|NCT01005316|559835866|FG000|Overall Study|Lost to Follow-up|1|||
155111224|NCT01005316|559835867|FG001|Overall Study|Lost to Follow-up|3|||
155111225|NCT01005316|559835868|FG002|Overall Study|Lost to Follow-up|0|||
155111226|NCT01005316|559835869|FG003|Overall Study|Lost to Follow-up|2|||
155111227|NCT01005316|559835866|FG000|Overall Study|Physician Decision|6|||
155111228|NCT01005316|559835867|FG001|Overall Study|Physician Decision|0|||
155111229|NCT01005316|559835868|FG002|Overall Study|Physician Decision|0|||
155111230|NCT01005316|559835869|FG003|Overall Study|Physician Decision|0|||
155111231|NCT01005316|559835866|FG000|Overall Study|Sponsor Decision|6|||
155111232|NCT01005316|559835867|FG001|Overall Study|Sponsor Decision|3|||
155111233|NCT01005316|559835868|FG002|Overall Study|Sponsor Decision|0|||
155111234|NCT01005316|559835869|FG003|Overall Study|Sponsor Decision|0|||
155111235|NCT01005316|559835866|FG000|Overall Study|Withdrawal by Subject|1|||
155111236|NCT01005316|559835867|FG001|Overall Study|Withdrawal by Subject|1|||
155111237|NCT01005316|559835868|FG002|Overall Study|Withdrawal by Subject|0|||
155111238|NCT01005316|559835869|FG003|Overall Study|Withdrawal by Subject|2|||
155111239|NCT01005316|559835866|FG000|Overall Study|Consented to Another Study|2|||
155111240|NCT01005316|559835867|FG001|Overall Study|Consented to Another Study|0|||
155111241|NCT01005316|559835868|FG002|Overall Study|Consented to Another Study|0|||
155111242|NCT01005316|559835869|FG003|Overall Study|Consented to Another Study|0|||
155111243|NCT01005316|559835866|FG000|Overall Study|Delisted|8|||
155111244|NCT01005316|559835867|FG001|Overall Study|Delisted|0|||
155111245|NCT01005316|559835868|FG002|Overall Study|Delisted|0|||
155111246|NCT01005316|559835869|FG003|Overall Study|Delisted|0|||
155111247|NCT01005316|559835866|FG000|Overall Study|Transferred Care|1|||
155111248|NCT01005316|559835867|FG001|Overall Study|Transferred Care|0|||
155111249|NCT01005316|559835868|FG002|Overall Study|Transferred Care|1|||
155111250|NCT01005316|559835869|FG003|Overall Study|Transferred Care|3|||
155111251|NCT01005316|559835866|FG000|Overall Study|Retransplanted|0|||
155111252|NCT01005316|559835867|FG001|Overall Study|Retransplanted|1|||
155175309|NCT01350544|560080218|FG001|Overall Study|Medical Issues|1|||
155175310|NCT01350544|560080217|FG000|Overall Study|Withdrawal by Subject|0|||
155175311|NCT01350544|560080218|FG001|Overall Study|Withdrawal by Subject|1|||
154872895|NCT00734929|558959698|FG001|Overall Study|Lost to Follow-up|2|||
155111253|NCT01005316|559835868|FG002|Overall Study|Retransplanted|0|||
155111254|NCT01005316|559835869|FG003|Overall Study|Retransplanted|0|||
155111255|NCT00632827|559835872|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
155111256|NCT00632827|559835872|FG000|Overall Study|Death|2|||
155111257|NCT00632827|559835872|FG000|Overall Study|Adverse Event|5|||
155111258|NCT00632827|559835872|FG000|Overall Study|Lost to Follow-up|1|||
155111259|NCT01035463|559835873|FG000|Overall Study|Adverse Event|0|||
155111260|NCT01035463|559835874|FG001|Overall Study|Adverse Event|0|||
155111261|NCT01035463|559835875|FG002|Overall Study|Adverse Event|4|||
155111262|NCT01035463|559835876|FG003|Overall Study|Adverse Event|1|||
155111263|NCT01035463|559835877|FG004|Overall Study|Adverse Event|5|||
155175312|NCT01350544|560080217|FG000|Overall Study|Incarceration|1|||
154872896|NCT00734929|558959697|FG000|Overall Study|No intervention/ screen fail|5|||
154872897|NCT00734929|558959698|FG001|Overall Study|No intervention/ screen fail|3|||
154872898|NCT02961764|558959702|FG000|Overall Study|Protocol Violation|0|||
154872899|NCT02961764|558959703|FG001|Overall Study|Protocol Violation|1|||
154872900|NCT02961764|558959702|FG000|Overall Study|Death|2|||
154872901|NCT02961764|558959703|FG001|Overall Study|Death|0|||
154872902|NCT02961764|558959702|FG000|Overall Study|Lost to Follow-up|35|||
154872903|NCT02961764|558959703|FG001|Overall Study|Lost to Follow-up|24|||
154872904|NCT02961764|558959702|FG000|Overall Study|Withdrawal by Subject|2|||
154872905|NCT02961764|558959703|FG001|Overall Study|Withdrawal by Subject|0|||
154872906|NCT01903434|558959711|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
154872907|NCT01903434|558959712|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
154872908|NCT01903434|558959711|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
154872909|NCT01903434|558959712|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
154872910|NCT04267562|558961084|FG000|Assessed for Eligibility|Screen Failure|64|||
154872911|NCT04267562|558961084|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
154872912|NCT04267562|558961084|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
154872913|NCT04267562|558961084|FG000|Assessed for Eligibility|Site closure|6|||
154872914|NCT04267562|558961084|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
154872915|NCT04267562|558961084|FG000|Assessed for Eligibility|Physician Decision|1|||
154872916|NCT04267562|558961084|FG000|Month 24|Elective hysterectomy|1|||
154872917|NCT04267562|558961084|FG000|Month 24|Lost to Follow-up|1|||
154872918|NCT04267562|558961084|FG000|Month 36|Elective hysterectomy|2|||
154872919|NCT04267562|558961084|FG000|Month 36|Lost to Follow-up|3|||
154872920|NCT00128206|558961088|FG000|Overall Study|Lost to Follow-up|137|||
154872921|NCT00128206|558961089|FG001|Overall Study|Lost to Follow-up|118|||
154872922|NCT00128206|558961088|FG000|Overall Study|Adverse Event|0|||
154872923|NCT00128206|558961089|FG001|Overall Study|Adverse Event|2|||
154872924|NCT03032068|558961098|FG000|Overall Study|Adverse Event|1|||
154872925|NCT01597622|558961099|FG000|Overall Study|Adverse Event|7|||
154872926|NCT01597622|558961099|FG000|Overall Study|Lack of Efficacy|3|||
154872927|NCT01597622|558961099|FG000|Overall Study|Protocol Violation|1|||
154872928|NCT01597622|558961099|FG000|Overall Study|Lost to Follow-up|1|||
154872929|NCT01597622|558961099|FG000|Overall Study|Investigator Discretion|5|||
154872930|NCT01597622|558961099|FG000|Overall Study|Withdrawal by Subject|20|||
154872931|NCT01597622|558961099|FG000|Overall Study|Death|1|||
154872932|NCT00408421|558961100|FG000|Treatment Initial Randomization|Adverse Event|5|||
154872933|NCT00408421|558961101|FG001|Treatment Initial Randomization|Adverse Event|9|||
154872934|NCT00408421|558961102|FG002|Treatment Initial Randomization|Adverse Event|0|||
154872935|NCT00408421|558961100|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
154872936|NCT00408421|558961101|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
154872937|NCT00408421|558961102|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
154872938|NCT00408421|558961100|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
154872939|NCT00408421|558961101|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
154872940|NCT00408421|558961102|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
154872941|NCT00408421|558961100|FG000|Treatment Initial Randomization|Physician Decision|1|||
154872942|NCT00408421|558961101|FG001|Treatment Initial Randomization|Physician Decision|0|||
154872943|NCT00408421|558961102|FG002|Treatment Initial Randomization|Physician Decision|0|||
154872944|NCT00408421|558961100|FG000|Treatment Initial Randomization|Protocol Violation|0|||
154872945|NCT00408421|558961101|FG001|Treatment Initial Randomization|Protocol Violation|1|||
154872946|NCT00408421|558961102|FG002|Treatment Initial Randomization|Protocol Violation|0|||
154872947|NCT00408421|558961100|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
154872948|NCT00408421|558961101|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
154872949|NCT00408421|558961102|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
154872950|NCT00408421|558961100|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
154872951|NCT00408421|558961101|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
154872952|NCT00408421|558961102|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
154872953|NCT00408421|558961100|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
154872954|NCT00408421|558961101|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
154872955|NCT00408421|558961102|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
154872956|NCT00408421|558961100|FG000|Treatment Re-Randomization|Adverse Event|2|||
154872957|NCT00408421|558961101|FG001|Treatment Re-Randomization|Adverse Event|2|||
155111264|NCT01035463|559835878|FG005|Overall Study|Adverse Event|7|||
154872958|NCT00408421|558961102|FG002|Treatment Re-Randomization|Adverse Event|4|||
154872959|NCT00408421|558961100|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
154872960|NCT00408421|558961101|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
154872961|NCT00408421|558961102|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
154872962|NCT00408421|558961100|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
154872963|NCT00408421|558961101|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
154872964|NCT00408421|558961102|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
154872965|NCT00408421|558961100|FG000|Treatment Re-Randomization|Physician Decision|1|||
154872966|NCT00408421|558961101|FG001|Treatment Re-Randomization|Physician Decision|3|||
154974119|NCT02576717|559331188|FG000|Overall Study|Sponsor Decision|0|||
155111265|NCT01035463|559835873|FG000|Overall Study|Withdrawal by Subject|0|||
155111266|NCT01035463|559835874|FG001|Overall Study|Withdrawal by Subject|2|||
155111267|NCT01035463|559835875|FG002|Overall Study|Withdrawal by Subject|1|||
155111268|NCT01035463|559835876|FG003|Overall Study|Withdrawal by Subject|0|||
155111269|NCT01035463|559835877|FG004|Overall Study|Withdrawal by Subject|1|||
155111270|NCT01035463|559835878|FG005|Overall Study|Withdrawal by Subject|4|||
155111271|NCT01035463|559835873|FG000|Overall Study|Disease progression|0|||
155111272|NCT01035463|559835874|FG001|Overall Study|Disease progression|0|||
155111273|NCT01035463|559835875|FG002|Overall Study|Disease progression|0|||
155111274|NCT01035463|559835876|FG003|Overall Study|Disease progression|0|||
155111275|NCT01035463|559835877|FG004|Overall Study|Disease progression|0|||
155111276|NCT01035463|559835878|FG005|Overall Study|Disease progression|3|||
155111277|NCT01035463|559835873|FG000|Overall Study|Other Malignancy|0|||
155111278|NCT01035463|559835874|FG001|Overall Study|Other Malignancy|0|||
155111279|NCT01035463|559835875|FG002|Overall Study|Other Malignancy|0|||
155111280|NCT01035463|559835876|FG003|Overall Study|Other Malignancy|0|||
155111281|NCT01035463|559835877|FG004|Overall Study|Other Malignancy|0|||
155111282|NCT01035463|559835878|FG005|Overall Study|Other Malignancy|2|||
155111283|NCT01035463|559835873|FG000|Overall Study|Other|0|||
155111284|NCT01035463|559835874|FG001|Overall Study|Other|0|||
155111285|NCT01035463|559835875|FG002|Overall Study|Other|0|||
155111286|NCT01035463|559835876|FG003|Overall Study|Other|1|||
155111287|NCT01035463|559835877|FG004|Overall Study|Other|0|||
155111288|NCT01035463|559835878|FG005|Overall Study|Other|2|||
155111289|NCT01092780|559835881|FG000|Washout Period 1|Adverse Event|0|||
155111290|NCT01092780|559835882|FG001|Washout Period 1|Adverse Event|1|||
155111291|NCT01092780|559835883|FG002|Washout Period 1|Adverse Event|0|||
155111292|NCT01092780|559835884|FG003|Washout Period 1|Adverse Event|0|||
155111293|NCT01092780|559835881|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
155111294|NCT01092780|559835882|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
155111295|NCT01092780|559835883|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
155111296|NCT01092780|559835884|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
155111297|NCT01092780|559835881|FG000|Washout Period 2|Adverse Event|0|||
155111298|NCT01092780|559835882|FG001|Washout Period 2|Adverse Event|1|||
155111299|NCT01092780|559835883|FG002|Washout Period 2|Adverse Event|1|||
155111300|NCT01092780|559835884|FG003|Washout Period 2|Adverse Event|0|||
155111301|NCT01734395|559835885|FG000|Overall Study|Other|65|||
155111302|NCT01734395|559835885|FG000|Overall Study|Lost to Follow-up|287|||
155111303|NCT01734395|559835885|FG000|Overall Study|Lack of Efficacy|5|||
155111304|NCT01734395|559835885|FG000|Overall Study|Adverse Event|40|||
155111305|NCT01734395|559835885|FG000|Overall Study|Withdrawal by Subject|10|||
155111306|NCT01734395|559835885|FG000|Overall Study|Missing the reasons for not completed|3|||
155111307|NCT04026009|559835886|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155111308|NCT04026009|559835887|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155111309|NCT04026009|559835888|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155111310|NCT04026009|559835889|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155111311|NCT04026009|559835890|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155111312|NCT04026009|559835886|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
155111313|NCT04026009|559835887|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
155175313|NCT01350544|560080218|FG001|Overall Study|Incarceration|0|||
155175314|NCT01350544|560080217|FG000|Overall Study|Lost to Follow-up|18|||
155175315|NCT01350544|560080218|FG001|Overall Study|Lost to Follow-up|15|||
155175316|NCT01444092|560080219|FG000|Overall Study|Adverse Event|8|||
155175317|NCT01444092|560080219|FG000|Overall Study|Protocol Violation|1|||
155175318|NCT01444092|560080219|FG000|Overall Study|Withdrawal by Subject|1|||
155175319|NCT01444092|560080219|FG000|Overall Study|Other Eligibility criteria|7|||
155175320|NCT01328366|560080220|FG000|Overall Study|Death|1|||
155111314|NCT04026009|559835888|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
155111315|NCT04026009|559835889|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
155111316|NCT04026009|559835890|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
155111317|NCT01177553|559835896|FG000|Overall Study|babies not yet 6 months of age|1|||
155175321|NCT01328366|560080220|FG000|Overall Study|Withdrawal by Subject|2|||
154974120|NCT02576717|559331189|FG001|Overall Study|Sponsor Decision|0|||
155111318|NCT01177553|559835897|FG001|Overall Study|babies not yet 6 months of age|0|||
155111319|NCT02957747|559835898|FG000|Overall Study|Withdrawal by Subject|0|||
155111320|NCT02957747|559835899|FG001|Overall Study|Withdrawal by Subject|3|||
155111321|NCT02957747|559835898|FG000|Overall Study|Lost to Follow-up|10|||
155111322|NCT02957747|559835899|FG001|Overall Study|Lost to Follow-up|5|||
155111323|NCT00610857|559835901|FG000|Overall Study|Not evaluable for response|2|||
155111324|NCT00888329|559835902|FG000|Overall Study|Physician Decision|6|||
155111325|NCT00888329|559835903|FG001|Overall Study|Physician Decision|9|||
155111326|NCT00002540|559835904|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
155111327|NCT00002540|559835905|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
155111328|NCT00002540|559835904|FG000|Overall Study|Died Before Randomization|2|||
155175322|NCT01328366|560080220|FG000|Overall Study|Lost to Follow-up|7|||
155175323|NCT00603590|560080221|FG000|Overall Study|Did not attend study clinic|39|||
155175324|NCT00603590|560080222|FG001|Overall Study|Did not attend study clinic|30|||
154872967|NCT00408421|558961102|FG002|Treatment Re-Randomization|Physician Decision|0|||
154872968|NCT00408421|558961100|FG000|Treatment Re-Randomization|Protocol Violation|1|||
154872969|NCT00408421|558961101|FG001|Treatment Re-Randomization|Protocol Violation|1|||
154872970|NCT00408421|558961102|FG002|Treatment Re-Randomization|Protocol Violation|0|||
154872971|NCT00408421|558961100|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
154872972|NCT00408421|558961101|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
154872973|NCT00408421|558961102|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
154872974|NCT03132805|558961105|FG000|Overall Study|Lost to Follow-up|142|||
154872975|NCT03132805|558961106|FG001|Overall Study|Lost to Follow-up|141|||
154872976|NCT03132805|558961107|FG002|Overall Study|Lost to Follow-up|113|||
154872977|NCT03009539|558961108|FG000|Overall Study|Lost to Follow-up|132|||
154872978|NCT03009539|558961109|FG001|Overall Study|Lost to Follow-up|113|||
154872979|NCT03009539|558961110|FG002|Overall Study|Lost to Follow-up|132|||
154872980|NCT03009539|558961111|FG003|Overall Study|Lost to Follow-up|113|||
154872981|NCT03151148|558961112|FG000|Overall Study|Lost to Follow-up|1|||
154872982|NCT03151148|558961113|FG001|Overall Study|Lost to Follow-up|0|||
154872983|NCT03151148|558961112|FG000|Overall Study|Withdrawal by Subject|1|||
154872984|NCT03151148|558961113|FG001|Overall Study|Withdrawal by Subject|0|||
154872985|NCT00710034|558961114|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
154872986|NCT00710034|558961115|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
154872987|NCT00710034|558961114|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
154872988|NCT00710034|558961115|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
154872989|NCT00710034|558961114|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
154872990|NCT00710034|558961115|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
154872991|NCT00710034|558961114|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
154872992|NCT00710034|558961115|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
154872993|NCT00710034|558961114|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
154872994|NCT00710034|558961115|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
154872995|NCT00710034|558961114|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
154872996|NCT00710034|558961115|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
154872997|NCT00710034|558961114|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
154872998|NCT00710034|558961115|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
154872999|NCT00710034|558961114|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
154873000|NCT00710034|558961115|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
154873001|NCT00710034|558961114|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
154873002|NCT00710034|558961115|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
154873003|NCT00710034|558961114|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
154873004|NCT00710034|558961115|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
154873005|NCT00710034|558961114|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
154873006|NCT00710034|558961115|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
154873007|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
154873008|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
154873009|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
154873010|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
154873011|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Death|8|||
154873012|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Death|3|||
154873013|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
154873014|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
154873015|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
154873016|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
154873017|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
154873018|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
154873019|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
154873020|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
154873021|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
154873022|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
154873023|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
154873024|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
154873025|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
154873026|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
154873027|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
154873028|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
154873029|NCT00494871|558961116|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
154873030|NCT00494871|558961117|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
154873031|NCT00494871|558961116|FG000|Follow-up (FU) Period|Adverse Event|1|||
154873032|NCT00494871|558961117|FG001|Follow-up (FU) Period|Adverse Event|1|||
154873033|NCT00494871|558961116|FG000|Follow-up (FU) Period|Death|13|||
154873034|NCT00494871|558961117|FG001|Follow-up (FU) Period|Death|12|||
154873035|NCT00494871|558961116|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
154873036|NCT00494871|558961117|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
154873037|NCT00494871|558961116|FG000|Follow-up (FU) Period|Physician Decision|0|||
154873038|NCT00494871|558961117|FG001|Follow-up (FU) Period|Physician Decision|1|||
154873039|NCT00494871|558961116|FG000|Follow-up (FU) Period|Protocol Violation|1|||
154873040|NCT00494871|558961117|FG001|Follow-up (FU) Period|Protocol Violation|0|||
154873041|NCT00494871|558961116|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
154873042|NCT00494871|558961117|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
154873043|NCT00494871|558961116|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
154873044|NCT00494871|558961117|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
154873045|NCT03238248|558961120|FG000|Overall Study|Death|5|||
154873046|NCT03238248|558961120|FG000|Overall Study|Withdrawal by Subject|7|||
154873047|NCT03238248|558961120|FG000|Overall Study|Participant proceeding to transplant|10|||
154873048|NCT03238248|558961120|FG000|Overall Study|Lack of Efficacy|4|||
154873049|NCT03238248|558961120|FG000|Overall Study|Physician Decision|3|||
154873050|NCT03238248|558961120|FG000|Overall Study|Transitioning to another study|1|||
154873051|NCT03238248|558961120|FG000|Overall Study|No longer benefiting|1|||
154873052|NCT03238248|558961120|FG000|Overall Study|Other complicating disease|1|||
154873053|NCT03238248|558961120|FG000|Overall Study|Adverse Event|5|||
154873054|NCT03238248|558961120|FG000|Overall Study|Disease progression|26|||
154873055|NCT03238248|558961120|FG000|Overall Study|N/A participant is still on treatment|1|||
154873056|NCT03238248|558961120|FG000|Overall Study|Decline in condition|1|||
154873057|NCT03238248|558961120|FG000|Overall Study|Alternative therapy|2|||
154873058|NCT02241512|558961127|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
154873059|NCT02241512|558961128|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
154873060|NCT02385123|558961133|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
154873061|NCT04498910|558961134|FG000|Overall Study|Lost to Follow-up|0|||
154873062|NCT04498910|558961135|FG001|Overall Study|Lost to Follow-up|1|||
154873063|NCT04498910|558961134|FG000|Overall Study|Withdrawal by Subject|2|||
154873064|NCT04498910|558961135|FG001|Overall Study|Withdrawal by Subject|1|||
154873065|NCT04498910|558961134|FG000|Overall Study|Adverse Event|1|||
154873066|NCT04498910|558961135|FG001|Overall Study|Adverse Event|0|||
154873067|NCT03215264|558961137|FG000|Dose Level 2|Adverse Event|0|||
154873068|NCT03215264|558961138|FG001|Dose Level 2|Adverse Event|1|||
154873069|NCT03215264|558961139|FG002|Dose Level 2|Adverse Event|0|||
154873070|NCT03215264|558961137|FG000|Dose Level 3|Withdrawal by Subject|0|||
154873071|NCT03215264|558961138|FG001|Dose Level 3|Withdrawal by Subject|0|||
154873072|NCT03215264|558961139|FG002|Dose Level 3|Withdrawal by Subject|1|||
154873073|NCT02145156|558961140|FG000|Overall Study|No match to vaccination records|60|||
154873074|NCT02145156|558961141|FG001|Overall Study|No match to vaccination records|52|||
154873075|NCT02145156|558961142|FG002|Overall Study|No match to vaccination records|41|||
154873076|NCT01740440|558961143|FG000|Overall Study|Lost to Follow-up|3|||
154873077|NCT03408873|558961152|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
154873078|NCT03408873|558961152|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
154873079|NCT03408873|558961152|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
154873080|NCT03408873|558961152|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
154873081|NCT03408873|558961152|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
154873082|NCT03408873|558961152|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
154873083|NCT01264965|558961153|FG000|Overall Study|Withdrawal by Subject|10|||
154873084|NCT00406315|558961155|FG000|Overall Study|Death|1|||
155111329|NCT00002540|559835905|FG001|Overall Study|Died Before Randomization|6|||
155111330|NCT00002540|559835904|FG000|Overall Study|Died Before ASU (Control)|202|||
155111331|NCT00002540|559835905|FG001|Overall Study|Died Before ASU (Control)|0|||
155111332|NCT00002540|559835904|FG000|Overall Study|Refused ASU (Control)|597|||
155111333|NCT00002540|559835905|FG001|Overall Study|Refused ASU (Control)|0|||
154873085|NCT00406315|558961155|FG000|Overall Study|Adverse Event|39|||
154873086|NCT00406315|558961155|FG000|Overall Study|Laboratory Abnormality|4|||
154873087|NCT00406315|558961155|FG000|Overall Study|Lack of Efficacy|13|||
154873088|NCT00406315|558961155|FG000|Overall Study|Other|33|||
154873089|NCT00406315|558961155|FG000|Overall Study|Lost to Follow-up|21|||
154873090|NCT00406315|558961155|FG000|Overall Study|Withdrawal by Subject|30|||
154974121|NCT02576717|559331190|FG002|Overall Study|Sponsor Decision|1|||
154974122|NCT02576717|559331188|FG000|Overall Study|Physician Decision|3|||
154974123|NCT02576717|559331189|FG001|Overall Study|Physician Decision|8|||
155111334|NCT00002540|559835904|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
154873091|NCT01469013|558961157|FG000|Part A (Treatment Period)|Adverse Event|1|||
154873092|NCT01469013|558961158|FG001|Part A (Treatment Period)|Adverse Event|0|||
154974124|NCT02576717|559331190|FG002|Overall Study|Physician Decision|9|||
154974125|NCT02576717|559331188|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
154873093|NCT01469013|558961159|FG002|Part A (Treatment Period)|Adverse Event|0|||
154873094|NCT01469013|558961160|FG003|Part A (Treatment Period)|Adverse Event|0|||
154873095|NCT01469013|558961161|FG004|Part A (Treatment Period)|Adverse Event|1|||
154873096|NCT01469013|558961162|FG005|Part A (Treatment Period)|Adverse Event|0|||
154974126|NCT02576717|559331189|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
155111335|NCT00002540|559835905|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
155111336|NCT04826094|559835906|FG000|Overall Study|Lost to Follow-up|2|||
155111337|NCT04826094|559835907|FG001|Overall Study|Lost to Follow-up|1|||
155111338|NCT04826094|559835908|FG002|Overall Study|Lost to Follow-up|0|||
155111339|NCT04826094|559835909|FG003|Overall Study|Lost to Follow-up|0|||
155111340|NCT04826094|559835910|FG004|Overall Study|Lost to Follow-up|1|||
155111341|NCT04826094|559835911|FG005|Overall Study|Lost to Follow-up|3|||
155111342|NCT04826094|559835912|FG006|Overall Study|Lost to Follow-up|1|||
155111343|NCT04826094|559835913|FG007|Overall Study|Lost to Follow-up|1|||
155111344|NCT04826094|559835906|FG000|Overall Study|Participant withdrew consent|1|||
155111345|NCT04826094|559835907|FG001|Overall Study|Participant withdrew consent|0|||
155111346|NCT04826094|559835908|FG002|Overall Study|Participant withdrew consent|0|||
155111347|NCT04826094|559835909|FG003|Overall Study|Participant withdrew consent|1|||
155111348|NCT04826094|559835910|FG004|Overall Study|Participant withdrew consent|1|||
155111349|NCT04826094|559835911|FG005|Overall Study|Participant withdrew consent|1|||
155111350|NCT04826094|559835912|FG006|Overall Study|Participant withdrew consent|0|||
155111351|NCT04826094|559835913|FG007|Overall Study|Participant withdrew consent|1|||
155111352|NCT04826094|559835906|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
155111353|NCT04826094|559835907|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
155111354|NCT04826094|559835908|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
155111355|NCT04826094|559835909|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
155111356|NCT04826094|559835910|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
155111357|NCT04826094|559835911|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
155111358|NCT04826094|559835912|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
155111359|NCT04826094|559835913|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
155111360|NCT04826094|559835906|FG000|Overall Study|Withdrawn by Investigator|0|||
155111361|NCT04826094|559835907|FG001|Overall Study|Withdrawn by Investigator|0|||
155111362|NCT04826094|559835908|FG002|Overall Study|Withdrawn by Investigator|0|||
155111363|NCT04826094|559835909|FG003|Overall Study|Withdrawn by Investigator|0|||
155111364|NCT04826094|559835910|FG004|Overall Study|Withdrawn by Investigator|0|||
155111365|NCT04826094|559835911|FG005|Overall Study|Withdrawn by Investigator|1|||
155111366|NCT04826094|559835912|FG006|Overall Study|Withdrawn by Investigator|0|||
155111367|NCT04826094|559835913|FG007|Overall Study|Withdrawn by Investigator|1|||
155111368|NCT04826094|559835906|FG000|Overall Study|Other: Moved from area|1|||
155111369|NCT04826094|559835907|FG001|Overall Study|Other: Moved from area|1|||
155111370|NCT04826094|559835908|FG002|Overall Study|Other: Moved from area|1|||
155111371|NCT04826094|559835909|FG003|Overall Study|Other: Moved from area|0|||
155111372|NCT04826094|559835910|FG004|Overall Study|Other: Moved from area|0|||
155111373|NCT04826094|559835911|FG005|Overall Study|Other: Moved from area|0|||
155111374|NCT04826094|559835912|FG006|Overall Study|Other: Moved from area|0|||
155111375|NCT04826094|559835913|FG007|Overall Study|Other: Moved from area|0|||
155111376|NCT04826094|559835906|FG000|Overall Study|Other: Declined|0|||
155111377|NCT04826094|559835907|FG001|Overall Study|Other: Declined|0|||
155111378|NCT04826094|559835908|FG002|Overall Study|Other: Declined|0|||
155111379|NCT04826094|559835909|FG003|Overall Study|Other: Declined|0|||
155111380|NCT04826094|559835910|FG004|Overall Study|Other: Declined|1|||
155111381|NCT04826094|559835911|FG005|Overall Study|Other: Declined|0|||
155111382|NCT04826094|559835912|FG006|Overall Study|Other: Declined|0|||
154873097|NCT01469013|558961163|FG006|Part A (Treatment Period)|Adverse Event|0|||
154873098|NCT01469013|558961164|FG007|Part A (Treatment Period)|Adverse Event|0|||
154873099|NCT01469013|558961165|FG008|Part A (Treatment Period)|Adverse Event|0|||
154873100|NCT01469013|558961166|FG009|Part A (Treatment Period)|Adverse Event|0|||
154873101|NCT01469013|558961167|FG010|Part A (Treatment Period)|Adverse Event|0|||
154873102|NCT01469013|558961168|FG011|Part A (Treatment Period)|Adverse Event|0|||
154873103|NCT01469013|558961169|FG012|Part A (Treatment Period)|Adverse Event|0|||
154873104|NCT01469013|558961157|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873105|NCT01469013|558961158|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873106|NCT01469013|558961159|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
154873107|NCT01469013|558961160|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873108|NCT01469013|558961161|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873109|NCT01469013|558961162|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
154974127|NCT02576717|559331190|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
155111383|NCT04826094|559835913|FG007|Overall Study|Other: Declined|0|||
155111384|NCT04826094|559835906|FG000|Overall Study|Other: Vaccine not administered|0|||
155111385|NCT04826094|559835907|FG001|Overall Study|Other: Vaccine not administered|0|||
154873110|NCT01469013|558961163|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873111|NCT01469013|558961164|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
154974128|NCT02576717|559331188|FG000|Overall Study|Death|3|||
155111386|NCT04826094|559835908|FG002|Overall Study|Other: Vaccine not administered|1|||
155111387|NCT04826094|559835909|FG003|Overall Study|Other: Vaccine not administered|0|||
155111388|NCT04826094|559835910|FG004|Overall Study|Other: Vaccine not administered|0|||
155111389|NCT04826094|559835911|FG005|Overall Study|Other: Vaccine not administered|1|||
155111390|NCT04826094|559835912|FG006|Overall Study|Other: Vaccine not administered|1|||
155111391|NCT04826094|559835913|FG007|Overall Study|Other: Vaccine not administered|3|||
155111392|NCT02151903|559835914|FG000|Overall Study|Withdrawal by Subject|1|||
155111393|NCT02151903|559835915|FG001|Overall Study|Withdrawal by Subject|0|||
154873112|NCT01469013|558961165|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873113|NCT01469013|558961166|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873114|NCT01469013|558961167|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873115|NCT01469013|558961168|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873116|NCT01469013|558961169|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
154873117|NCT01469013|558961157|FG000|Part B (Extension Period)|Adverse Event|0|||
154873118|NCT01469013|558961158|FG001|Part B (Extension Period)|Adverse Event|0|||
154873119|NCT01469013|558961159|FG002|Part B (Extension Period)|Adverse Event|0|||
154873120|NCT01469013|558961160|FG003|Part B (Extension Period)|Adverse Event|0|||
154873121|NCT01469013|558961161|FG004|Part B (Extension Period)|Adverse Event|0|||
154873122|NCT01469013|558961162|FG005|Part B (Extension Period)|Adverse Event|2|||
154873123|NCT01469013|558961163|FG006|Part B (Extension Period)|Adverse Event|5|||
154873124|NCT01469013|558961164|FG007|Part B (Extension Period)|Adverse Event|5|||
154873125|NCT01469013|558961165|FG008|Part B (Extension Period)|Adverse Event|3|||
154873126|NCT01469013|558961166|FG009|Part B (Extension Period)|Adverse Event|3|||
154873127|NCT01469013|558961167|FG010|Part B (Extension Period)|Adverse Event|1|||
154873128|NCT01469013|558961168|FG011|Part B (Extension Period)|Adverse Event|6|||
154873129|NCT01469013|558961169|FG012|Part B (Extension Period)|Adverse Event|3|||
154873130|NCT01469013|558961157|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
154873131|NCT01469013|558961158|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
154873132|NCT01469013|558961159|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
154873133|NCT01469013|558961160|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
154873134|NCT01469013|558961161|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
154873135|NCT01469013|558961162|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
154873136|NCT01469013|558961163|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
154873137|NCT01469013|558961164|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
154873138|NCT01469013|558961165|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
154873139|NCT01469013|558961166|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
154873140|NCT01469013|558961167|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
154873141|NCT01469013|558961168|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
154873142|NCT01469013|558961169|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
154873143|NCT05232097|558961170|FG000|Overall Study|Physician Decision|1|||
154873144|NCT01327339|558961173|FG000|Overall Study|Protocol Violation|8|||
154873145|NCT01172288|558961174|FG000|Overall Study|Adverse Event|1|||
154873146|NCT01172288|558961175|FG001|Overall Study|Adverse Event|0|||
154873147|NCT01172288|558961174|FG000|Overall Study|Protocol Violation|0|||
154873148|NCT01172288|558961175|FG001|Overall Study|Protocol Violation|1|||
154873149|NCT00871858|558961176|FG000|Overall Study|Protocol Violation|3|||
154873150|NCT00871858|558961177|FG001|Overall Study|Protocol Violation|4|||
154873151|NCT00871858|558961176|FG000|Overall Study|Adverse Event|1|||
154873152|NCT00871858|558961177|FG001|Overall Study|Adverse Event|1|||
154873153|NCT00871858|558961176|FG000|Overall Study|Withdrawal by Subject|1|||
154873154|NCT00871858|558961177|FG001|Overall Study|Withdrawal by Subject|1|||
154873155|NCT00871858|558961176|FG000|Overall Study|Lost to Follow-up|0|||
154873156|NCT00871858|558961177|FG001|Overall Study|Lost to Follow-up|1|||
154873157|NCT00700752|558961178|FG000|First Intervention|Withdrawal by Subject|0|||
154873158|NCT00700752|558961179|FG001|First Intervention|Withdrawal by Subject|2|||
154873159|NCT01302769|558961180|FG000|Overall Study|Lost to Follow-up|1|||
154873160|NCT01302769|558961181|FG001|Overall Study|Lost to Follow-up|1|||
154873161|NCT01734993|558961185|FG000|Overall Study|Adverse Event|1|||
154873162|NCT01734993|558961185|FG000|Overall Study|Lack of Efficacy|1|||
154873163|NCT01426386|558961186|FG000|Overall Study|Adverse Event|0|||
154873164|NCT01426386|558961187|FG001|Overall Study|Adverse Event|1|||
154873165|NCT01426386|558961188|FG002|Overall Study|Adverse Event|0|||
154873166|NCT01426386|558961189|FG003|Overall Study|Adverse Event|0|||
154873167|NCT01426386|558961190|FG004|Overall Study|Adverse Event|0|||
154873168|NCT01426386|558961191|FG005|Overall Study|Adverse Event|0|||
154873169|NCT01426386|558961186|FG000|Overall Study|Did not attend scheduled visit|1|||
154873170|NCT01426386|558961187|FG001|Overall Study|Did not attend scheduled visit|4|||
154873171|NCT01426386|558961188|FG002|Overall Study|Did not attend scheduled visit|0|||
154873172|NCT01426386|558961189|FG003|Overall Study|Did not attend scheduled visit|0|||
154873173|NCT01426386|558961190|FG004|Overall Study|Did not attend scheduled visit|2|||
155111394|NCT02151903|559835914|FG000|Overall Study|Progressive disease|2|||
155111395|NCT02151903|559835915|FG001|Overall Study|Progressive disease|1|||
155111396|NCT00778375|559835916|FG000|Overall Study|Ineligible|3|||
154873174|NCT01426386|558961191|FG005|Overall Study|Did not attend scheduled visit|1|||
154873175|NCT01426386|558961186|FG000|Overall Study|Poor response|2|||
155111397|NCT01421303|559835917|FG000|Overall Study|Lost to Follow-up|13|||
154873176|NCT01426386|558961187|FG001|Overall Study|Poor response|1|||
154873177|NCT01426386|558961188|FG002|Overall Study|Poor response|2|||
154873178|NCT01426386|558961189|FG003|Overall Study|Poor response|0|||
154873179|NCT01426386|558961190|FG004|Overall Study|Poor response|1|||
154873180|NCT01426386|558961191|FG005|Overall Study|Poor response|0|||
154873181|NCT01426386|558961186|FG000|Overall Study|Personal reasons|0|||
154873182|NCT01426386|558961187|FG001|Overall Study|Personal reasons|0|||
155111398|NCT01421303|559835917|FG000|Overall Study|Non compliance with study procedure|1|||
154873183|NCT01426386|558961188|FG002|Overall Study|Personal reasons|0|||
154873184|NCT01426386|558961189|FG003|Overall Study|Personal reasons|0|||
154873185|NCT01426386|558961190|FG004|Overall Study|Personal reasons|1|||
155111399|NCT01421303|559835917|FG000|Overall Study|Other|7|||
155111400|NCT01421303|559835917|FG000|Overall Study|Withdrawal by Subject|1|||
155111401|NCT06003777|559835918|FG000|Period 1|Adverse Event|0|||
155111402|NCT06003777|559835919|FG001|Period 1|Adverse Event|0|||
155111403|NCT06003777|559835920|FG002|Period 1|Adverse Event|1|||
155111404|NCT06003777|559835921|FG003|Period 1|Adverse Event|0|||
155111405|NCT06003777|559835922|FG004|Period 1|Adverse Event|0|||
155111406|NCT06003777|559835923|FG005|Period 1|Adverse Event|0|||
155111407|NCT06003777|559835924|FG006|Period 1|Adverse Event|0|||
155111408|NCT06003777|559835925|FG007|Period 1|Adverse Event|0|||
155111409|NCT06003777|559835926|FG008|Period 1|Adverse Event|0|||
155111410|NCT06003777|559835927|FG009|Period 1|Adverse Event|0|||
155111411|NCT06003777|559835928|FG010|Period 1|Adverse Event|0|||
155111412|NCT06003777|559835929|FG011|Period 1|Adverse Event|0|||
155111413|NCT06003777|559835918|FG000|Period 1|Withdrawal by Subject|0|||
155111414|NCT06003777|559835919|FG001|Period 1|Withdrawal by Subject|0|||
155111415|NCT06003777|559835920|FG002|Period 1|Withdrawal by Subject|0|||
155111416|NCT06003777|559835921|FG003|Period 1|Withdrawal by Subject|0|||
155111417|NCT06003777|559835922|FG004|Period 1|Withdrawal by Subject|1|||
155111418|NCT06003777|559835923|FG005|Period 1|Withdrawal by Subject|0|||
155111419|NCT06003777|559835924|FG006|Period 1|Withdrawal by Subject|0|||
155111420|NCT06003777|559835925|FG007|Period 1|Withdrawal by Subject|0|||
155111421|NCT06003777|559835926|FG008|Period 1|Withdrawal by Subject|0|||
155111422|NCT06003777|559835927|FG009|Period 1|Withdrawal by Subject|0|||
155111423|NCT06003777|559835928|FG010|Period 1|Withdrawal by Subject|0|||
155111424|NCT06003777|559835929|FG011|Period 1|Withdrawal by Subject|0|||
155111425|NCT06003777|559835918|FG000|Period 2|Withdrawal by Subject|0|||
155111426|NCT06003777|559835919|FG001|Period 2|Withdrawal by Subject|0|||
155111427|NCT06003777|559835920|FG002|Period 2|Withdrawal by Subject|0|||
155111428|NCT06003777|559835921|FG003|Period 2|Withdrawal by Subject|0|||
155111429|NCT06003777|559835922|FG004|Period 2|Withdrawal by Subject|0|||
155111430|NCT06003777|559835923|FG005|Period 2|Withdrawal by Subject|0|||
155111431|NCT06003777|559835924|FG006|Period 2|Withdrawal by Subject|0|||
155111432|NCT06003777|559835925|FG007|Period 2|Withdrawal by Subject|0|||
155111433|NCT06003777|559835926|FG008|Period 2|Withdrawal by Subject|1|||
155111434|NCT06003777|559835927|FG009|Period 2|Withdrawal by Subject|0|||
155111435|NCT06003777|559835928|FG010|Period 2|Withdrawal by Subject|0|||
155111436|NCT06003777|559835929|FG011|Period 2|Withdrawal by Subject|0|||
155111437|NCT06003777|559835918|FG000|Period 3|Adverse Event|0|||
155111438|NCT06003777|559835919|FG001|Period 3|Adverse Event|0|||
155111439|NCT06003777|559835920|FG002|Period 3|Adverse Event|0|||
155111440|NCT06003777|559835921|FG003|Period 3|Adverse Event|0|||
155111441|NCT06003777|559835922|FG004|Period 3|Adverse Event|0|||
155111442|NCT06003777|559835923|FG005|Period 3|Adverse Event|0|||
155111443|NCT06003777|559835924|FG006|Period 3|Adverse Event|1|||
155111444|NCT06003777|559835925|FG007|Period 3|Adverse Event|0|||
155111445|NCT06003777|559835926|FG008|Period 3|Adverse Event|0|||
155111446|NCT06003777|559835927|FG009|Period 3|Adverse Event|0|||
155111447|NCT06003777|559835928|FG010|Period 3|Adverse Event|0|||
155111448|NCT06003777|559835929|FG011|Period 3|Adverse Event|0|||
155111449|NCT06003777|559835918|FG000|Period 4|No longer met eligibility criteria|0|||
155111450|NCT06003777|559835919|FG001|Period 4|No longer met eligibility criteria|0|||
155111451|NCT06003777|559835920|FG002|Period 4|No longer met eligibility criteria|1|||
155111452|NCT06003777|559835921|FG003|Period 4|No longer met eligibility criteria|0|||
155111453|NCT06003777|559835922|FG004|Period 4|No longer met eligibility criteria|0|||
155111454|NCT06003777|559835923|FG005|Period 4|No longer met eligibility criteria|0|||
155111455|NCT06003777|559835924|FG006|Period 4|No longer met eligibility criteria|0|||
155111456|NCT06003777|559835925|FG007|Period 4|No longer met eligibility criteria|0|||
154873186|NCT01426386|558961191|FG005|Overall Study|Personal reasons|0|||
154873187|NCT01797432|558961194|FG000|Overall Study|Lost to Follow-up|1|||
154873188|NCT01797432|558961194|FG000|Overall Study|Adverse Event|1|||
154873189|NCT01797432|558961194|FG000|Overall Study|Withdrawal by Subject|1|||
155111457|NCT06003777|559835926|FG008|Period 4|No longer met eligibility criteria|0|||
155111458|NCT06003777|559835927|FG009|Period 4|No longer met eligibility criteria|0|||
155111459|NCT06003777|559835928|FG010|Period 4|No longer met eligibility criteria|0|||
155111460|NCT06003777|559835929|FG011|Period 4|No longer met eligibility criteria|0|||
155111461|NCT06003777|559835918|FG000|Period 4|Withdrawal by Subject|0|||
155111462|NCT06003777|559835919|FG001|Period 4|Withdrawal by Subject|1|||
155111463|NCT06003777|559835920|FG002|Period 4|Withdrawal by Subject|0|||
155111464|NCT06003777|559835921|FG003|Period 4|Withdrawal by Subject|0|||
155111465|NCT06003777|559835922|FG004|Period 4|Withdrawal by Subject|0|||
155111466|NCT06003777|559835923|FG005|Period 4|Withdrawal by Subject|0|||
155111467|NCT06003777|559835924|FG006|Period 4|Withdrawal by Subject|0|||
155111468|NCT06003777|559835925|FG007|Period 4|Withdrawal by Subject|0|||
155111469|NCT06003777|559835926|FG008|Period 4|Withdrawal by Subject|0|||
155111470|NCT06003777|559835927|FG009|Period 4|Withdrawal by Subject|0|||
155111471|NCT06003777|559835928|FG010|Period 4|Withdrawal by Subject|0|||
155111472|NCT06003777|559835929|FG011|Period 4|Withdrawal by Subject|0|||
154974129|NCT02576717|559331189|FG001|Overall Study|Death|5|||
154873190|NCT01797432|558961194|FG000|Overall Study|lived too far from study site|1|||
154873191|NCT02792777|558961195|FG000|Overall Study|Withdrawal by Subject|2|||
154873192|NCT02792777|558961196|FG001|Overall Study|Withdrawal by Subject|0|||
154873193|NCT02792777|558961195|FG000|Overall Study|Recording malfunction|2|||
154873194|NCT02792777|558961196|FG001|Overall Study|Recording malfunction|0|||
154873195|NCT02792777|558961195|FG000|Overall Study|Later determined to be ineligible|2|||
154873196|NCT02792777|558961196|FG001|Overall Study|Later determined to be ineligible|0|||
154873197|NCT02792777|558961195|FG000|Overall Study|Participant interviewed twice|1|||
154873198|NCT02792777|558961196|FG001|Overall Study|Participant interviewed twice|0|||
154873199|NCT00638846|558961197|FG000|Overall Study|Adverse Event|0|||
154873200|NCT00638846|558961198|FG001|Overall Study|Adverse Event|1|||
154873201|NCT00638846|558961197|FG000|Overall Study|Lost to Follow-up|3|||
154873202|NCT00638846|558961198|FG001|Overall Study|Lost to Follow-up|2|||
154873203|NCT00638846|558961197|FG000|Overall Study|lens issue|1|||
154873204|NCT00638846|558961198|FG001|Overall Study|lens issue|3|||
154873205|NCT03176966|558961202|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
154873206|NCT03176966|558961203|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
154873207|NCT03176966|558961202|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
154873208|NCT03176966|558961203|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
154873209|NCT03176966|558961202|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
154873210|NCT03176966|558961203|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
154873211|NCT03176966|558961202|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
154873212|NCT03176966|558961203|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
154873213|NCT03176966|558961202|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
154873214|NCT03176966|558961203|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
154873215|NCT03176966|558961202|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
154873216|NCT03176966|558961203|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
154873217|NCT03176966|558961202|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
154974130|NCT02576717|559331190|FG002|Overall Study|Death|3|||
154974131|NCT02576717|559331188|FG000|Overall Study|Lost to Follow-up|9|||
154974132|NCT02576717|559331189|FG001|Overall Study|Lost to Follow-up|10|||
154974133|NCT02576717|559331190|FG002|Overall Study|Lost to Follow-up|19|||
154974134|NCT02576717|559331188|FG000|Overall Study|Protocol Violation|4|||
155111473|NCT05319600|559835930|FG000|Overall Study|Withdrawal by Subject|1|||
155111474|NCT05319600|559835931|FG001|Overall Study|Withdrawal by Subject|0|||
155111475|NCT05319600|559835930|FG000|Overall Study|Lost to Follow-up|0|||
155111476|NCT05319600|559835931|FG001|Overall Study|Lost to Follow-up|4|||
155111477|NCT00904670|559835932|FG000|Open Label Phase|Withdrawal by Subject|2|||
155111478|NCT00904670|559835933|FG001|Open Label Phase|Withdrawal by Subject|0|||
155111479|NCT00904670|559835932|FG000|Open Label Phase|Adverse Event|2|||
155111480|NCT00904670|559835933|FG001|Open Label Phase|Adverse Event|0|||
155111481|NCT00904670|559835932|FG000|Open Label Phase|Lack of Efficacy|1|||
155111482|NCT00904670|559835933|FG001|Open Label Phase|Lack of Efficacy|0|||
155111483|NCT00904670|559835932|FG000|Open Label Phase|Lost to Follow-up|1|||
155111484|NCT00904670|559835933|FG001|Open Label Phase|Lost to Follow-up|0|||
155111485|NCT02120300|559835938|FG000|Overall Study|Enrolled but Never Treated|2|||
155111486|NCT02120300|559835939|FG001|Overall Study|Enrolled but Never Treated|0|||
155111487|NCT02120300|559835940|FG002|Overall Study|Enrolled but Never Treated|0|||
155111488|NCT02120300|559835941|FG003|Overall Study|Enrolled but Never Treated|0|||
155111489|NCT02120300|559835938|FG000|Overall Study|Lack of Efficacy|0|||
155111490|NCT02120300|559835939|FG001|Overall Study|Lack of Efficacy|0|||
155111491|NCT02120300|559835940|FG002|Overall Study|Lack of Efficacy|0|||
155111492|NCT02120300|559835941|FG003|Overall Study|Lack of Efficacy|1|||
155111493|NCT02120300|559835938|FG000|Overall Study|Lost to Follow-up|1|||
155111494|NCT02120300|559835939|FG001|Overall Study|Lost to Follow-up|0|||
155111495|NCT02120300|559835940|FG002|Overall Study|Lost to Follow-up|0|||
155111496|NCT02120300|559835941|FG003|Overall Study|Lost to Follow-up|0|||
155111497|NCT01721486|559835948|FG000|Overall Study|Protocol Violation|1|||
155111498|NCT01721486|559835949|FG001|Overall Study|Protocol Violation|0|||
155111499|NCT01721486|559835948|FG000|Overall Study|Physician Decision|0|||
155111500|NCT01721486|559835949|FG001|Overall Study|Physician Decision|1|||
155111501|NCT00613327|559835950|FG000|Overall Study|Adverse Event|38|||
154873218|NCT03176966|558961203|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
154873219|NCT01507246|558961204|FG000|Overall Study|Required different surgical procedures|2|||
154873220|NCT01507246|558961205|FG001|Overall Study|Required different surgical procedures|1|||
154974135|NCT02576717|559331189|FG001|Overall Study|Protocol Violation|0|||
154974136|NCT02576717|559331190|FG002|Overall Study|Protocol Violation|5|||
155111502|NCT00613327|559835950|FG000|Overall Study|Lost to Follow-up|8|||
155111503|NCT00613327|559835950|FG000|Overall Study|Withdrawal by Subject|6|||
155111504|NCT00613327|559835950|FG000|Overall Study|Protocol Violation|2|||
155111505|NCT00613327|559835950|FG000|Overall Study|Other|47|||
155111506|NCT01814397|559835951|FG000|Overall Study|Adverse Event|7|||
155111507|NCT01814397|559835951|FG000|Overall Study|Withdrawal by Subject|7|||
155111508|NCT00313144|559835952|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
155111509|NCT00313144|559835952|FG000|Overall Study|Death|7|||
154873221|NCT03103750|558961206|FG000|Overall Study|Adverse Event|1|||
154873222|NCT03103750|558961207|FG001|Overall Study|Adverse Event|0|||
154873223|NCT03103750|558961206|FG000|Overall Study|Lost to Follow-up|1|||
154873224|NCT03103750|558961207|FG001|Overall Study|Lost to Follow-up|0|||
154873225|NCT03103750|558961206|FG000|Overall Study|PET Equipment Related|2|||
154873226|NCT03103750|558961207|FG001|Overall Study|PET Equipment Related|2|||
154873227|NCT01663740|558961209|FG000|Overall Study|Lost to Follow-up|1|||
154873228|NCT01663740|558961210|FG001|Overall Study|Lost to Follow-up|4|||
154873229|NCT01663740|558961209|FG000|Overall Study|Other|9|||
154873230|NCT01663740|558961210|FG001|Overall Study|Other|2|||
154873231|NCT01663740|558961209|FG000|Overall Study|Inclusion/Exclusion not met|1|||
154873232|NCT01663740|558961210|FG001|Overall Study|Inclusion/Exclusion not met|0|||
154873233|NCT01663740|558961209|FG000|Overall Study|Death|0|||
154873234|NCT01663740|558961210|FG001|Overall Study|Death|1|||
154873235|NCT01663740|558961209|FG000|Overall Study|Withdrawal by Subject|2|||
154873236|NCT01663740|558961210|FG001|Overall Study|Withdrawal by Subject|1|||
154873237|NCT01663740|558961209|FG000|Overall Study|No end of study status|3|||
154873238|NCT01663740|558961210|FG001|Overall Study|No end of study status|0|||
154873239|NCT00404768|558961213|FG000|Part A and B|Withdrawn due to labor progression|1|||
154873240|NCT00404768|558961214|FG001|Part A and B|Withdrawn due to labor progression|0|||
154873241|NCT00404768|558961215|FG002|Part A and B|Withdrawn due to labor progression|0|||
154873242|NCT00404768|558961216|FG003|Part A and B|Withdrawn due to labor progression|0|||
154873243|NCT00404768|558961213|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
154873244|NCT00404768|558961214|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
154873245|NCT00404768|558961215|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
154873246|NCT00404768|558961216|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
154873247|NCT00404768|558961213|FG000|Part C|Adverse Event|0|||
154873248|NCT00404768|558961214|FG001|Part C|Adverse Event|0|||
154873249|NCT00404768|558961215|FG002|Part C|Adverse Event|0|||
154873250|NCT00404768|558961216|FG003|Part C|Adverse Event|3|||
154873251|NCT00404768|558961213|FG000|Part C|Lost to Follow-up|0|||
154873252|NCT00404768|558961214|FG001|Part C|Lost to Follow-up|0|||
154873253|NCT00404768|558961215|FG002|Part C|Lost to Follow-up|3|||
154873254|NCT00404768|558961216|FG003|Part C|Lost to Follow-up|1|||
154873255|NCT00404768|558961213|FG000|Part C|Withdrawal by Subject|0|||
154873256|NCT00404768|558961214|FG001|Part C|Withdrawal by Subject|0|||
154873257|NCT00404768|558961215|FG002|Part C|Withdrawal by Subject|2|||
154873258|NCT00404768|558961216|FG003|Part C|Withdrawal by Subject|1|||
154873259|NCT00404768|558961213|FG000|Part C|Early withdrawal from study medication|0|||
154873260|NCT00404768|558961214|FG001|Part C|Early withdrawal from study medication|0|||
154873261|NCT00404768|558961215|FG002|Part C|Early withdrawal from study medication|1|||
154873262|NCT00404768|558961216|FG003|Part C|Early withdrawal from study medication|0|||
154873263|NCT00404768|558961213|FG000|Part C|Participant did not respond to therapy|0|||
154873264|NCT00404768|558961214|FG001|Part C|Participant did not respond to therapy|0|||
155111510|NCT00313144|559835952|FG000|Overall Study|Lost to Follow-up|5|||
155111511|NCT00313144|559835952|FG000|Overall Study|Withdrawal by Subject|4|||
155111512|NCT00313144|559835952|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
155111513|NCT00313144|559835952|FG000|Overall Study|Physician Decision|4|||
155111514|NCT00313144|559835952|FG000|Overall Study|Adverse event - transient|5|||
155111515|NCT00313144|559835952|FG000|Overall Study|Liver transplant|1|||
155111516|NCT00313144|559835952|FG000|Overall Study|Insurance (homecare provider) change|1|||
155111517|NCT00313144|559835952|FG000|Overall Study|Change to different product|1|||
155111518|NCT00313144|559835952|FG000|Overall Study|Due to termination of the study|66|||
155111519|NCT04154293|559835955|FG000|Overall Study|Withdrawal by Subject|2|||
155111520|NCT04154293|559835956|FG001|Overall Study|Withdrawal by Subject|3|||
155111521|NCT04154293|559835957|FG002|Overall Study|Withdrawal by Subject|1|||
155111522|NCT04154293|559835955|FG000|Overall Study|Physician Decision|0|||
155111523|NCT04154293|559835956|FG001|Overall Study|Physician Decision|0|||
155111524|NCT04154293|559835957|FG002|Overall Study|Physician Decision|1|||
155111525|NCT04731298|559835958|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
154873265|NCT00404768|558961215|FG002|Part C|Participant did not respond to therapy|1|||
154873266|NCT00404768|558961216|FG003|Part C|Participant did not respond to therapy|1|||
155111526|NCT04731298|559835959|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
155175325|NCT00603590|560080221|FG000|Overall Study|Refused blood test|5|||
155175326|NCT00603590|560080222|FG001|Overall Study|Refused blood test|1|||
155175327|NCT00603590|560080221|FG000|Overall Study|Patient discontinued study drug|22|||
154873267|NCT00404768|558961213|FG000|Part C|Physician withdrew the study medication|0|||
154873268|NCT00404768|558961214|FG001|Part C|Physician withdrew the study medication|0|||
154873269|NCT00404768|558961215|FG002|Part C|Physician withdrew the study medication|1|||
154873270|NCT00404768|558961216|FG003|Part C|Physician withdrew the study medication|0|||
154873271|NCT00404768|558961213|FG000|Part C|Participant delivered baby|0|||
154873272|NCT00404768|558961214|FG001|Part C|Participant delivered baby|0|||
155111527|NCT01208961|559835960|FG000|High-Fat Period III|Protocol Violation|1|||
155111528|NCT01208961|559835961|FG001|High-Fat Period III|Protocol Violation|0|||
155111529|NCT03403361|559835970|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
155175328|NCT00603590|560080222|FG001|Overall Study|Patient discontinued study drug|15|||
154873273|NCT00404768|558961215|FG002|Part C|Participant delivered baby|0|||
154873274|NCT00404768|558961216|FG003|Part C|Participant delivered baby|1|||
154873275|NCT00404768|558961213|FG000|Part C|Unsatisfactory uterine response to IP|0|||
154873276|NCT00404768|558961214|FG001|Part C|Unsatisfactory uterine response to IP|0|||
154873277|NCT00404768|558961215|FG002|Part C|Unsatisfactory uterine response to IP|0|||
154873278|NCT00404768|558961216|FG003|Part C|Unsatisfactory uterine response to IP|1|||
154873279|NCT00404768|558961213|FG000|Part C|Active labor|0|||
154873280|NCT00404768|558961214|FG001|Part C|Active labor|0|||
154873281|NCT00404768|558961215|FG002|Part C|Active labor|0|||
154873282|NCT00404768|558961216|FG003|Part C|Active labor|1|||
154873283|NCT00404768|558961213|FG000|Part C|Lack of Efficacy|0|||
154873284|NCT00404768|558961214|FG001|Part C|Lack of Efficacy|0|||
154873285|NCT00404768|558961215|FG002|Part C|Lack of Efficacy|0|||
154873286|NCT00404768|558961216|FG003|Part C|Lack of Efficacy|2|||
154873287|NCT00404768|558961213|FG000|Part C|Treatment failure|0|||
154873288|NCT00404768|558961214|FG001|Part C|Treatment failure|0|||
154873289|NCT00404768|558961215|FG002|Part C|Treatment failure|0|||
154873290|NCT00404768|558961216|FG003|Part C|Treatment failure|1|||
154873291|NCT00404768|558961213|FG000|Part C|Investigator discretion|0|||
154873292|NCT00404768|558961214|FG001|Part C|Investigator discretion|0|||
154873293|NCT00404768|558961215|FG002|Part C|Investigator discretion|0|||
154873294|NCT00404768|558961216|FG003|Part C|Investigator discretion|1|||
154873295|NCT00404768|558961213|FG000|Part C|Researcher suspended study medication|0|||
154873296|NCT00404768|558961214|FG001|Part C|Researcher suspended study medication|0|||
154873297|NCT00404768|558961215|FG002|Part C|Researcher suspended study medication|0|||
154873298|NCT00404768|558961216|FG003|Part C|Researcher suspended study medication|1|||
154873299|NCT03575468|558961217|FG000|Overall Study|Withdrawal by Subject|3|||
154873300|NCT03575468|558961218|FG001|Overall Study|Withdrawal by Subject|0|||
154873301|NCT03575468|558961217|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
154873302|NCT03575468|558961218|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
154873303|NCT03575468|558961217|FG000|Overall Study|Lost to Follow-up|13|||
154873304|NCT03575468|558961218|FG001|Overall Study|Lost to Follow-up|17|||
154873305|NCT01522651|558961219|FG000|Overall Study|Adverse Event|3|||
154873306|NCT01522651|558961220|FG001|Overall Study|Adverse Event|4|||
154873307|NCT01522651|558961221|FG002|Overall Study|Adverse Event|4|||
154873308|NCT01522651|558961222|FG003|Overall Study|Adverse Event|5|||
154873309|NCT01522651|558961223|FG004|Overall Study|Adverse Event|4|||
154873310|NCT01522651|558961219|FG000|Overall Study|Cardioversion|1|||
154873311|NCT01522651|558961220|FG001|Overall Study|Cardioversion|0|||
154873312|NCT01522651|558961221|FG002|Overall Study|Cardioversion|0|||
154873313|NCT01522651|558961222|FG003|Overall Study|Cardioversion|0|||
154873314|NCT01522651|558961223|FG004|Overall Study|Cardioversion|0|||
154873315|NCT01522651|558961219|FG000|Overall Study|Device Malfunction|0|||
154873316|NCT01522651|558961220|FG001|Overall Study|Device Malfunction|1|||
154873317|NCT01522651|558961221|FG002|Overall Study|Device Malfunction|0|||
154873318|NCT01522651|558961222|FG003|Overall Study|Device Malfunction|0|||
154873319|NCT01522651|558961223|FG004|Overall Study|Device Malfunction|0|||
154873320|NCT01522651|558961219|FG000|Overall Study|Investigator's Discretion|0|||
154873321|NCT01522651|558961220|FG001|Overall Study|Investigator's Discretion|1|||
154873322|NCT01522651|558961221|FG002|Overall Study|Investigator's Discretion|0|||
154873323|NCT01522651|558961222|FG003|Overall Study|Investigator's Discretion|0|||
154873324|NCT01522651|558961223|FG004|Overall Study|Investigator's Discretion|0|||
154873325|NCT01522651|558961219|FG000|Overall Study|Protocol Violation|3|||
154873326|NCT01522651|558961220|FG001|Overall Study|Protocol Violation|0|||
154873327|NCT01522651|558961221|FG002|Overall Study|Protocol Violation|0|||
154873328|NCT01522651|558961222|FG003|Overall Study|Protocol Violation|0|||
154873329|NCT01522651|558961223|FG004|Overall Study|Protocol Violation|0|||
154873330|NCT01522651|558961219|FG000|Overall Study|Reason Not Specified|0|||
154873331|NCT01522651|558961220|FG001|Overall Study|Reason Not Specified|0|||
154873332|NCT01522651|558961221|FG002|Overall Study|Reason Not Specified|0|||
154873333|NCT01522651|558961222|FG003|Overall Study|Reason Not Specified|1|||
154873334|NCT01522651|558961223|FG004|Overall Study|Reason Not Specified|0|||
154873335|NCT01522651|558961219|FG000|Overall Study|Participant Non-Compliance|1|||
154873336|NCT01522651|558961220|FG001|Overall Study|Participant Non-Compliance|0|||
154873337|NCT01522651|558961221|FG002|Overall Study|Participant Non-Compliance|0|||
154873338|NCT01522651|558961222|FG003|Overall Study|Participant Non-Compliance|0|||
154873339|NCT01522651|558961223|FG004|Overall Study|Participant Non-Compliance|0|||
154873340|NCT01522651|558961219|FG000|Overall Study|Withdrew Consent|1|||
154873341|NCT01522651|558961220|FG001|Overall Study|Withdrew Consent|1|||
154873342|NCT01522651|558961221|FG002|Overall Study|Withdrew Consent|0|||
154873343|NCT01522651|558961222|FG003|Overall Study|Withdrew Consent|1|||
154873344|NCT01522651|558961223|FG004|Overall Study|Withdrew Consent|1|||
154873345|NCT01522651|558961219|FG000|Overall Study|Randomized but Never Treated|0|||
154873346|NCT01522651|558961220|FG001|Overall Study|Randomized but Never Treated|1|||
154873347|NCT01522651|558961221|FG002|Overall Study|Randomized but Never Treated|0|||
154873348|NCT01522651|558961222|FG003|Overall Study|Randomized but Never Treated|1|||
154873349|NCT01522651|558961223|FG004|Overall Study|Randomized but Never Treated|1|||
154873350|NCT02658656|558961224|FG000|Screening|Failed eligibility criteria|0|||
154873351|NCT02658656|558961225|FG001|Screening|Failed eligibility criteria|0|||
154873352|NCT02658656|558961226|FG002|Screening|Failed eligibility criteria|263|||
154873353|NCT02658656|558961224|FG000|Randomization|Withdrawal by Subject|8|||
154873354|NCT02658656|558961225|FG001|Randomization|Withdrawal by Subject|7|||
154873355|NCT02658656|558961226|FG002|Randomization|Withdrawal by Subject|0|||
154873356|NCT02658656|558961224|FG000|Randomization|Lost to Follow-up|1|||
154873357|NCT02658656|558961225|FG001|Randomization|Lost to Follow-up|3|||
154873358|NCT02658656|558961226|FG002|Randomization|Lost to Follow-up|0|||
154873359|NCT02658656|558961224|FG000|Randomization|Adverse Event|4|||
154873360|NCT02658656|558961225|FG001|Randomization|Adverse Event|0|||
154873361|NCT02658656|558961226|FG002|Randomization|Adverse Event|0|||
154873362|NCT02658656|558961224|FG000|Randomization|Administrative Termination|3|||
154873363|NCT02658656|558961225|FG001|Randomization|Administrative Termination|1|||
154873364|NCT02658656|558961226|FG002|Randomization|Administrative Termination|0|||
154873365|NCT02658656|558961224|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
154873366|NCT02658656|558961225|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
154873367|NCT02658656|558961226|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
154873368|NCT02658656|558961224|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
154873369|NCT02658656|558961225|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
154873370|NCT02658656|558961226|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
154873371|NCT02658656|558961224|FG000|Randomization|Not eligible for Randomization|1|||
154873372|NCT02658656|558961225|FG001|Randomization|Not eligible for Randomization|0|||
154873373|NCT02658656|558961226|FG002|Randomization|Not eligible for Randomization|0|||
154873374|NCT02658656|558961224|FG000|Randomization|Protocol Violation|1|||
154873375|NCT02658656|558961225|FG001|Randomization|Protocol Violation|0|||
154873376|NCT02658656|558961226|FG002|Randomization|Protocol Violation|0|||
155111530|NCT02487654|559835971|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
155111531|NCT02487654|559835972|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
155111532|NCT02487654|559835971|FG000|Overall Study|Withdrawal by Subject|3|||
155111533|NCT02487654|559835972|FG001|Overall Study|Withdrawal by Subject|7|||
155111534|NCT04238481|559835973|FG000|Overall Study|Miscellaneous|0|||
155111535|NCT04238481|559835974|FG001|Overall Study|Miscellaneous|1|||
155111536|NCT04238481|559835975|FG002|Overall Study|Miscellaneous|0|||
155111537|NCT04238481|559835976|FG003|Overall Study|Miscellaneous|0|||
155111538|NCT02152371|559835977|FG000|Overall Study|Adverse Event|6|||
155111539|NCT02152371|559835978|FG001|Overall Study|Adverse Event|2|||
155111540|NCT02152371|559835977|FG000|Overall Study|Withdrawal by Subject|3|||
155111541|NCT02152371|559835978|FG001|Overall Study|Withdrawal by Subject|7|||
155111542|NCT02152371|559835977|FG000|Overall Study|Protocol Violation|2|||
155111543|NCT02152371|559835978|FG001|Overall Study|Protocol Violation|3|||
155111544|NCT02152371|559835977|FG000|Overall Study|Lost to Follow-up|1|||
155111545|NCT02152371|559835978|FG001|Overall Study|Lost to Follow-up|0|||
155111546|NCT02152371|559835977|FG000|Overall Study|Lack of Efficacy|0|||
155111547|NCT02152371|559835978|FG001|Overall Study|Lack of Efficacy|1|||
155111548|NCT02152371|559835977|FG000|Overall Study|Physician Decision|0|||
155111549|NCT02152371|559835978|FG001|Overall Study|Physician Decision|2|||
155111550|NCT02152371|559835977|FG000|Overall Study|Reason Not Given|0|||
155111551|NCT02152371|559835978|FG001|Overall Study|Reason Not Given|1|||
155111552|NCT00350870|559835979|FG000|Overall Study|Withdrawal by Subject|21|||
155111553|NCT00350870|559835980|FG001|Overall Study|Withdrawal by Subject|17|||
155111554|NCT00350870|559835981|FG002|Overall Study|Withdrawal by Subject|15|||
155111555|NCT00350870|559835982|FG003|Overall Study|Withdrawal by Subject|14|||
155111556|NCT00350870|559835979|FG000|Overall Study|Physician Decision|1|||
155111557|NCT00350870|559835980|FG001|Overall Study|Physician Decision|0|||
155111558|NCT00350870|559835981|FG002|Overall Study|Physician Decision|1|||
155111559|NCT00350870|559835982|FG003|Overall Study|Physician Decision|1|||
155111560|NCT00349921|559835983|FG000|First Spinal Injection|Physician Decision|1|||
155111561|NCT00349921|559835984|FG001|First Spinal Injection|Physician Decision|0|||
154873377|NCT01118143|558961227|FG000|Overall Study|Withdrawal by Subject|2|||
154873378|NCT01118143|558961228|FG001|Overall Study|Withdrawal by Subject|5|||
154873379|NCT02112448|558961229|FG000|Overall Study|lab values precluding use of ketorolac|2|||
154873380|NCT02112448|558961230|FG001|Overall Study|lab values precluding use of ketorolac|2|||
154873381|NCT02112448|558961229|FG000|Overall Study|Protocol Violation|1|||
154873382|NCT02112448|558961230|FG001|Overall Study|Protocol Violation|2|||
155111562|NCT00349921|559835985|FG002|First Spinal Injection|Physician Decision|0|||
155111563|NCT00349921|559835986|FG003|First Spinal Injection|Physician Decision|0|||
155111564|NCT00349921|559835983|FG000|First Spinal Injection|Adverse Event|0|||
155111565|NCT00349921|559835984|FG001|First Spinal Injection|Adverse Event|0|||
155111566|NCT00349921|559835985|FG002|First Spinal Injection|Adverse Event|1|||
155111567|NCT00349921|559835986|FG003|First Spinal Injection|Adverse Event|0|||
155111568|NCT05285644|559835991|FG000|Overall Study|Adverse Event|3|||
155111569|NCT05285644|559835992|FG001|Overall Study|Adverse Event|3|||
155111570|NCT05285644|559835991|FG000|Overall Study|Withdrawal of Consent|2|||
155111571|NCT05285644|559835992|FG001|Overall Study|Withdrawal of Consent|5|||
155111572|NCT05285644|559835991|FG000|Overall Study|Noncompliance|0|||
155111573|NCT05285644|559835992|FG001|Overall Study|Noncompliance|4|||
155111574|NCT05285644|559835991|FG000|Overall Study|Lost to Follow-up|4|||
155111575|NCT05285644|559835992|FG001|Overall Study|Lost to Follow-up|6|||
155111576|NCT05285644|559835991|FG000|Overall Study|Disallowed Concurrent Medication|1|||
155111577|NCT05285644|559835992|FG001|Overall Study|Disallowed Concurrent Medication|1|||
155111578|NCT05285644|559835991|FG000|Overall Study|Investigator Decision|2|||
155111579|NCT05285644|559835992|FG001|Overall Study|Investigator Decision|0|||
155111580|NCT05285644|559835991|FG000|Overall Study|Protocol Deviation|1|||
155111581|NCT05285644|559835992|FG001|Overall Study|Protocol Deviation|0|||
155111582|NCT05285644|559835991|FG000|Overall Study|As specified in the Clinical Study Report|7|||
155111583|NCT05285644|559835992|FG001|Overall Study|As specified in the Clinical Study Report|3|||
155111584|NCT04382586|559835996|FG000|Overall Study|Death|3|||
155111585|NCT04382586|559835997|FG001|Overall Study|Death|4|||
155111586|NCT04382586|559835996|FG000|Overall Study|Lost to Follow-up|11|||
155111587|NCT04382586|559835997|FG001|Overall Study|Lost to Follow-up|8|||
155111588|NCT04382586|559835996|FG000|Overall Study|Withdrawal by Subject|3|||
155111589|NCT04382586|559835997|FG001|Overall Study|Withdrawal by Subject|1|||
155111590|NCT04382586|559835996|FG000|Overall Study|Physician Decision|0|||
155111591|NCT04382586|559835997|FG001|Overall Study|Physician Decision|3|||
155111592|NCT02470585|559835999|FG000|Overall Study|Death|224|||
155111593|NCT02470585|559836000|FG001|Overall Study|Death|227|||
155111594|NCT02470585|559836001|FG002|Overall Study|Death|199|||
155111595|NCT02470585|559835999|FG000|Overall Study|Withdrew consent|21|||
155111596|NCT02470585|559836000|FG001|Overall Study|Withdrew consent|22|||
155111597|NCT02470585|559836001|FG002|Overall Study|Withdrew consent|31|||
155111598|NCT02470585|559835999|FG000|Overall Study|Lost to Follow-up|8|||
155111599|NCT02470585|559836000|FG001|Overall Study|Lost to Follow-up|15|||
155111600|NCT02470585|559836001|FG002|Overall Study|Lost to Follow-up|13|||
155111601|NCT02470585|559835999|FG000|Overall Study|Sponsor discontinued study|117|||
155111602|NCT02470585|559836000|FG001|Overall Study|Sponsor discontinued study|110|||
155111603|NCT02470585|559836001|FG002|Overall Study|Sponsor discontinued study|122|||
155111604|NCT02470585|559835999|FG000|Overall Study|Other, not specified|5|||
155111605|NCT02470585|559836000|FG001|Overall Study|Other, not specified|7|||
155111606|NCT02470585|559836001|FG002|Overall Study|Other, not specified|14|||
155111607|NCT02470585|559835999|FG000|Overall Study|Missing due to site non-compliance|0|||
155111608|NCT02470585|559836000|FG001|Overall Study|Missing due to site non-compliance|2|||
155111609|NCT02470585|559836001|FG002|Overall Study|Missing due to site non-compliance|3|||
155111610|NCT03028415|559836002|FG000|Overall Study|Lost to Follow-up|6|||
155111611|NCT03028415|559836003|FG001|Overall Study|Lost to Follow-up|3|||
155111612|NCT03028415|559836002|FG000|Overall Study|Withdrawal by Subject|1|||
155111613|NCT03028415|559836003|FG001|Overall Study|Withdrawal by Subject|0|||
155111614|NCT03028415|559836002|FG000|Overall Study|Discontinued due to COVID-19|1|||
155111615|NCT03028415|559836003|FG001|Overall Study|Discontinued due to COVID-19|0|||
155111616|NCT03763656|559836006|FG000|Overall Study|Physician Decision|1|||
155111617|NCT03763656|559836006|FG000|Overall Study|Protocol Violation|1|||
155111618|NCT03763656|559836006|FG000|Overall Study|Withdrawal by Subject|7|||
155111619|NCT00107900|559836010|FG000|Overall Study|Adverse Event|3|||
155111620|NCT00107900|559836011|FG001|Overall Study|Adverse Event|2|||
155111621|NCT00107900|559836012|FG002|Overall Study|Adverse Event|10|||
155111622|NCT00107900|559836013|FG003|Overall Study|Adverse Event|3|||
155111623|NCT00107900|559836014|FG004|Overall Study|Adverse Event|5|||
155111624|NCT00107900|559836015|FG005|Overall Study|Adverse Event|3|||
155111625|NCT00107900|559836010|FG000|Overall Study|Death|0|||
155111626|NCT00107900|559836011|FG001|Overall Study|Death|0|||
155111627|NCT00107900|559836012|FG002|Overall Study|Death|0|||
155111628|NCT00107900|559836013|FG003|Overall Study|Death|0|||
155111629|NCT00107900|559836014|FG004|Overall Study|Death|1|||
155111630|NCT00107900|559836015|FG005|Overall Study|Death|0|||
155111631|NCT00107900|559836010|FG000|Overall Study|Lost to Follow-up|4|||
154974137|NCT02576717|559331188|FG000|Overall Study|Lack of Efficacy|24|||
154974138|NCT02576717|559331189|FG001|Overall Study|Lack of Efficacy|28|||
154974139|NCT02576717|559331190|FG002|Overall Study|Lack of Efficacy|20|||
155111632|NCT00107900|559836011|FG001|Overall Study|Lost to Follow-up|1|||
155111633|NCT00107900|559836012|FG002|Overall Study|Lost to Follow-up|3|||
155111634|NCT00107900|559836013|FG003|Overall Study|Lost to Follow-up|2|||
155111635|NCT00107900|559836014|FG004|Overall Study|Lost to Follow-up|5|||
155111636|NCT00107900|559836015|FG005|Overall Study|Lost to Follow-up|5|||
155111637|NCT00107900|559836010|FG000|Overall Study|Protocol Violation|1|||
155111638|NCT00107900|559836011|FG001|Overall Study|Protocol Violation|0|||
155111639|NCT00107900|559836012|FG002|Overall Study|Protocol Violation|5|||
155111640|NCT00107900|559836013|FG003|Overall Study|Protocol Violation|5|||
155111641|NCT00107900|559836014|FG004|Overall Study|Protocol Violation|7|||
155111642|NCT00107900|559836015|FG005|Overall Study|Protocol Violation|0|||
155111643|NCT00107900|559836010|FG000|Overall Study|Withdrawal by Subject|1|||
155111644|NCT00107900|559836011|FG001|Overall Study|Withdrawal by Subject|0|||
155111645|NCT00107900|559836012|FG002|Overall Study|Withdrawal by Subject|5|||
155111646|NCT00107900|559836013|FG003|Overall Study|Withdrawal by Subject|0|||
154873383|NCT02112448|558961229|FG000|Overall Study|Physician Decision|4|||
154873384|NCT02112448|558961230|FG001|Overall Study|Physician Decision|6|||
154873385|NCT02112448|558961229|FG000|Overall Study|required heparin so could not use ketoro|1|||
154873386|NCT02112448|558961230|FG001|Overall Study|required heparin so could not use ketoro|0|||
154873387|NCT03918642|558962862|FG000|Overall Study|Lost to Follow-up|12|||
154873388|NCT03918642|558962863|FG001|Overall Study|Lost to Follow-up|10|||
154873389|NCT01115569|558962866|FG000|Conversion/Titration Phase|Adverse Event|59|||
154873390|NCT01115569|558962867|FG001|Conversion/Titration Phase|Adverse Event|0|||
154873391|NCT01115569|558962866|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
154873392|NCT01115569|558962867|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
154873393|NCT01115569|558962866|FG000|Conversion/Titration Phase|Physician Decision|5|||
155111647|NCT00107900|559836014|FG004|Overall Study|Withdrawal by Subject|1|||
155111648|NCT00107900|559836015|FG005|Overall Study|Withdrawal by Subject|1|||
155111649|NCT00107900|559836010|FG000|Overall Study|Administrative Reasons|1|||
155111650|NCT00107900|559836011|FG001|Overall Study|Administrative Reasons|0|||
155111651|NCT00107900|559836012|FG002|Overall Study|Administrative Reasons|2|||
155111652|NCT00107900|559836013|FG003|Overall Study|Administrative Reasons|2|||
155111653|NCT00107900|559836014|FG004|Overall Study|Administrative Reasons|2|||
155111654|NCT00107900|559836015|FG005|Overall Study|Administrative Reasons|0|||
155111655|NCT02640625|559838407|FG000|Overall Study|Adverse Event|1|||
155111656|NCT02370537|559838408|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
155111657|NCT02370537|559838409|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
155111658|NCT02370537|559838410|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
155111659|NCT02370537|559838408|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
155111660|NCT02370537|559838409|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
155111661|NCT02370537|559838410|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
155111662|NCT02370537|559838408|FG000|Part B|Not randomised to receive treatment|1|||
155111663|NCT02370537|559838409|FG001|Part B|Not randomised to receive treatment|2|||
155111664|NCT02370537|559838410|FG002|Part B|Not randomised to receive treatment|259|||
155111665|NCT02370537|559838408|FG000|Part B|Withdrawal by Subject|0|||
155111666|NCT02370537|559838409|FG001|Part B|Withdrawal by Subject|1|||
155111667|NCT02370537|559838410|FG002|Part B|Withdrawal by Subject|0|||
155111668|NCT03100539|559838415|FG000|Overall Study|Lost to Follow-up|60|||
155111669|NCT03100539|559838416|FG001|Overall Study|Lost to Follow-up|54|||
155111670|NCT03100539|559838417|FG002|Overall Study|Lost to Follow-up|17|||
155111671|NCT03100539|559838415|FG000|Overall Study|Uncollected|8|||
155111672|NCT03100539|559838416|FG001|Overall Study|Uncollected|8|||
155111673|NCT03100539|559838417|FG002|Overall Study|Uncollected|0|||
154873394|NCT01115569|558962867|FG001|Conversion/Titration Phase|Physician Decision|0|||
154873395|NCT01115569|558962866|FG000|Conversion/Titration Phase|Protocol Violation|68|||
154873396|NCT01115569|558962867|FG001|Conversion/Titration Phase|Protocol Violation|0|||
155111674|NCT03100539|559838415|FG000|Overall Study|Ally Health|0|||
155111675|NCT03100539|559838416|FG001|Overall Study|Ally Health|0|||
155111676|NCT03100539|559838417|FG002|Overall Study|Ally Health|3|||
155111677|NCT03100539|559838415|FG000|Overall Study|Disinterest|0|||
155111678|NCT03100539|559838416|FG001|Overall Study|Disinterest|0|||
155111679|NCT03100539|559838417|FG002|Overall Study|Disinterest|22|||
155111680|NCT03100539|559838415|FG000|Overall Study|Veteran Health|0|||
154873397|NCT01115569|558962866|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
154873398|NCT01115569|558962867|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
154873399|NCT01115569|558962866|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
154873400|NCT01115569|558962867|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
154873401|NCT01115569|558962866|FG000|Maintenance Phase|Adverse Event|0|||
154873402|NCT01115569|558962867|FG001|Maintenance Phase|Adverse Event|43|||
154873403|NCT01115569|558962866|FG000|Maintenance Phase|Lost to Follow-up|0|||
154873404|NCT01115569|558962867|FG001|Maintenance Phase|Lost to Follow-up|8|||
154873405|NCT01115569|558962866|FG000|Maintenance Phase|Physician Decision|0|||
155111681|NCT03100539|559838416|FG001|Overall Study|Veteran Health|0|||
155111682|NCT03100539|559838417|FG002|Overall Study|Veteran Health|8|||
155111683|NCT03100539|559838415|FG000|Overall Study|Moved|0|||
155111684|NCT03100539|559838416|FG001|Overall Study|Moved|0|||
155111685|NCT03100539|559838417|FG002|Overall Study|Moved|1|||
155111686|NCT03100539|559838415|FG000|Overall Study|Scheduling Conflicts|0|||
155111687|NCT03100539|559838416|FG001|Overall Study|Scheduling Conflicts|0|||
155111688|NCT03100539|559838417|FG002|Overall Study|Scheduling Conflicts|12|||
155111689|NCT05659719|559838421|FG000|Overall Study|At sponsor's request|0|||
155111690|NCT05659719|559838422|FG001|Overall Study|At sponsor's request|0|||
154873406|NCT01115569|558962867|FG001|Maintenance Phase|Physician Decision|3|||
154873407|NCT01115569|558962866|FG000|Maintenance Phase|Protocol Violation|0|||
155111691|NCT05659719|559838423|FG002|Overall Study|At sponsor's request|0|||
154873408|NCT01115569|558962867|FG001|Maintenance Phase|Protocol Violation|9|||
154873409|NCT01115569|558962866|FG000|Maintenance Phase|Withdrawal by Subject|0|||
154873410|NCT01115569|558962867|FG001|Maintenance Phase|Withdrawal by Subject|27|||
155111692|NCT05659719|559838424|FG003|Overall Study|At sponsor's request|95|||
155111693|NCT05659719|559838421|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
154873411|NCT01115569|558962866|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
154873412|NCT01115569|558962867|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
154873413|NCT01115569|558962866|FG000|Maintenance Phase|Administrative|0|||
154873414|NCT01115569|558962867|FG001|Maintenance Phase|Administrative|1|||
154873415|NCT01070303|558962869|FG000|Overall Study|Adverse Event|39|||
154873416|NCT01070303|558962869|FG000|Overall Study|Withdrawal by Subject|20|||
154873417|NCT01070303|558962869|FG000|Overall Study|Lost to Follow-up|9|||
154873418|NCT01070303|558962869|FG000|Overall Study|Protocol Violation|0|||
154873419|NCT01070303|558962869|FG000|Overall Study|Lack of Efficacy|2|||
154873420|NCT01070303|558962869|FG000|Overall Study|Administrative Reason|1|||
154873421|NCT01070303|558962869|FG000|Overall Study|Other|18|||
154873422|NCT00859898|558962872|FG000|Overall Study|Lack of Efficacy|0|||
154873423|NCT00859898|558962873|FG001|Overall Study|Lack of Efficacy|1|||
154873424|NCT00859898|558962874|FG002|Overall Study|Lack of Efficacy|1|||
154873425|NCT00859898|558962872|FG000|Overall Study|Adverse Event|4|||
154873426|NCT00859898|558962873|FG001|Overall Study|Adverse Event|9|||
154873427|NCT00859898|558962874|FG002|Overall Study|Adverse Event|8|||
154873428|NCT00859898|558962872|FG000|Overall Study|Withdrawal by Subject|11|||
154873429|NCT00859898|558962873|FG001|Overall Study|Withdrawal by Subject|8|||
154873430|NCT00859898|558962874|FG002|Overall Study|Withdrawal by Subject|11|||
154873431|NCT00859898|558962872|FG000|Overall Study|Death|0|||
154873432|NCT00859898|558962873|FG001|Overall Study|Death|0|||
154873433|NCT00859898|558962874|FG002|Overall Study|Death|1|||
154873434|NCT00859898|558962872|FG000|Overall Study|Lost to Follow-up|10|||
154873435|NCT00859898|558962873|FG001|Overall Study|Lost to Follow-up|11|||
154873436|NCT00859898|558962874|FG002|Overall Study|Lost to Follow-up|5|||
154873437|NCT00859898|558962872|FG000|Overall Study|poor/non-compliance|2|||
154873438|NCT00859898|558962873|FG001|Overall Study|poor/non-compliance|0|||
154873439|NCT00859898|558962874|FG002|Overall Study|poor/non-compliance|0|||
154873440|NCT00859898|558962872|FG000|Overall Study|No longer meets criteria|0|||
154873441|NCT00859898|558962873|FG001|Overall Study|No longer meets criteria|1|||
154873442|NCT00859898|558962874|FG002|Overall Study|No longer meets criteria|0|||
154873443|NCT00859898|558962872|FG000|Overall Study|non-specified|1|||
154873444|NCT00859898|558962873|FG001|Overall Study|non-specified|1|||
154873445|NCT00859898|558962874|FG002|Overall Study|non-specified|1|||
154873446|NCT03350750|558962876|FG000|Overall Study|Death|1|||
154873447|NCT03350750|558962877|FG001|Overall Study|Death|1|||
154873448|NCT02202031|558962880|FG000|Overall Study|Lost to Follow-up|1|||
154873449|NCT02202031|558962881|FG001|Overall Study|Lost to Follow-up|0|||
154873450|NCT02202031|558962880|FG000|Overall Study|Too Busy|1|||
154873451|NCT02202031|558962881|FG001|Overall Study|Too Busy|3|||
154873452|NCT02202031|558962880|FG000|Overall Study|Illness/Medical Reason|0|||
154873453|NCT02202031|558962881|FG001|Overall Study|Illness/Medical Reason|2|||
154873454|NCT02202031|558962880|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
154873455|NCT02202031|558962881|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
154873456|NCT02184143|558962882|FG000|Overall Study|Withdrawal by Subject|4|||
154873457|NCT02184143|558962883|FG001|Overall Study|Withdrawal by Subject|4|||
155111694|NCT05659719|559838422|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
154873458|NCT02184143|558962882|FG000|Overall Study|Lost to Follow-up|5|||
154873459|NCT02184143|558962883|FG001|Overall Study|Lost to Follow-up|3|||
154873460|NCT02184143|558962882|FG000|Overall Study|Death|1|||
154873461|NCT02184143|558962883|FG001|Overall Study|Death|0|||
154873462|NCT00321984|558962885|FG000|Overall Study|Adverse Event|9|||
154873463|NCT00321984|558962886|FG001|Overall Study|Adverse Event|6|||
154873464|NCT00321984|558962887|FG002|Overall Study|Adverse Event|8|||
154873465|NCT00321984|558962885|FG000|Overall Study|Protocol Violation|0|||
154873466|NCT00321984|558962886|FG001|Overall Study|Protocol Violation|1|||
154873467|NCT00321984|558962887|FG002|Overall Study|Protocol Violation|1|||
154873468|NCT00321984|558962885|FG000|Overall Study|Lost to Follow-up|2|||
154873469|NCT00321984|558962886|FG001|Overall Study|Lost to Follow-up|4|||
155111695|NCT05659719|559838423|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
155111696|NCT05659719|559838424|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
155111697|NCT05659719|559838421|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
154873470|NCT00321984|558962887|FG002|Overall Study|Lost to Follow-up|2|||
154873471|NCT00321984|558962885|FG000|Overall Study|Withdrawal by Subject|8|||
154873472|NCT00321984|558962886|FG001|Overall Study|Withdrawal by Subject|6|||
154873473|NCT00321984|558962887|FG002|Overall Study|Withdrawal by Subject|5|||
154873474|NCT00321984|558962885|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
155111698|NCT05659719|559838422|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
155111699|NCT05659719|559838423|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
155111700|NCT05659719|559838424|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
154873475|NCT00321984|558962886|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
154873476|NCT00321984|558962887|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
154873477|NCT00321984|558962885|FG000|Overall Study|Lack of Efficacy|3|||
154873478|NCT00321984|558962886|FG001|Overall Study|Lack of Efficacy|1|||
154873479|NCT00321984|558962887|FG002|Overall Study|Lack of Efficacy|3|||
154873480|NCT00321984|558962885|FG000|Overall Study|Noncompliant|0|||
154873481|NCT00321984|558962886|FG001|Overall Study|Noncompliant|0|||
154873482|NCT00321984|558962887|FG002|Overall Study|Noncompliant|2|||
154873483|NCT00321984|558962885|FG000|Overall Study|Pregnancy|0|||
154873484|NCT00321984|558962886|FG001|Overall Study|Pregnancy|1|||
154873485|NCT00321984|558962887|FG002|Overall Study|Pregnancy|0|||
154873486|NCT00321984|558962885|FG000|Overall Study|Per Subject Request|1|||
154873487|NCT00321984|558962886|FG001|Overall Study|Per Subject Request|0|||
154873488|NCT00321984|558962887|FG002|Overall Study|Per Subject Request|0|||
154873489|NCT00321984|558962885|FG000|Overall Study|Per Investigator Request|1|||
154873490|NCT00321984|558962886|FG001|Overall Study|Per Investigator Request|0|||
154873491|NCT00321984|558962887|FG002|Overall Study|Per Investigator Request|0|||
154873492|NCT00321984|558962885|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
154873493|NCT00321984|558962886|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
154873494|NCT00321984|558962887|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
154873495|NCT02214186|558962890|FG000|Overall Study|Lost to Follow-up|1|||
154873496|NCT02214186|558962891|FG001|Overall Study|Lost to Follow-up|1|||
154873497|NCT02214186|558962890|FG000|Overall Study|Protocol Violation|1|||
154873498|NCT02214186|558962891|FG001|Overall Study|Protocol Violation|1|||
154873499|NCT01525849|558962892|FG000|Overall Study|Lost to Follow-up|3|||
154873500|NCT01525849|558962893|FG001|Overall Study|Lost to Follow-up|2|||
154873501|NCT01525849|558962892|FG000|Overall Study|Withdrawal by Subject|1|||
154873502|NCT01525849|558962893|FG001|Overall Study|Withdrawal by Subject|9|||
154873503|NCT01525849|558962892|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
154873504|NCT01525849|558962893|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
154873505|NCT01525849|558962892|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
154873506|NCT01525849|558962893|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
154873507|NCT00611130|558962904|FG000|Overall Study|Lost to Follow-up|25|||
154873508|NCT00611130|558962905|FG001|Overall Study|Lost to Follow-up|29|||
154873509|NCT00611130|558962904|FG000|Overall Study|Protocol noncompliance|7|||
154873510|NCT00611130|558962905|FG001|Overall Study|Protocol noncompliance|6|||
154873511|NCT00611130|558962904|FG000|Overall Study|Withdrawal by Subject|6|||
154873512|NCT00611130|558962905|FG001|Overall Study|Withdrawal by Subject|5|||
154873513|NCT00611130|558962904|FG000|Overall Study|Other|5|||
154873514|NCT00611130|558962905|FG001|Overall Study|Other|4|||
154873515|NCT00611130|558962904|FG000|Overall Study|Incarceration|3|||
154873516|NCT00611130|558962905|FG001|Overall Study|Incarceration|2|||
154873517|NCT00611130|558962904|FG000|Overall Study|Administrative|1|||
154873518|NCT00611130|558962905|FG001|Overall Study|Administrative|1|||
154873519|NCT00611130|558962904|FG000|Overall Study|Adverse Event|1|||
154873520|NCT00611130|558962905|FG001|Overall Study|Adverse Event|0|||
154873521|NCT00611130|558962904|FG000|Overall Study|Death|1|||
154873522|NCT00611130|558962905|FG001|Overall Study|Death|0|||
154873523|NCT03303339|558962907|FG000|Overall Study|Death|2|||
154873524|NCT03303339|558962908|FG001|Overall Study|Death|2|||
154873525|NCT03303339|558962909|FG002|Overall Study|Death|2|||
154873526|NCT03303339|558962910|FG003|Overall Study|Death|1|||
154873527|NCT03303339|558962911|FG004|Overall Study|Death|4|||
154873528|NCT03303339|558962912|FG005|Overall Study|Death|2|||
154873529|NCT03303339|558962913|FG006|Overall Study|Death|2|||
154873530|NCT03303339|558962914|FG007|Overall Study|Death|2|||
154873531|NCT03303339|558962915|FG008|Overall Study|Death|3|||
154873532|NCT03303339|558962916|FG009|Overall Study|Death|3|||
154873533|NCT03303339|558962917|FG010|Overall Study|Death|4|||
154873534|NCT03303339|558962918|FG011|Overall Study|Death|24|||
154873535|NCT03303339|558962907|FG000|Overall Study|Study Terminated by Sponsor|0|||
154873536|NCT03303339|558962908|FG001|Overall Study|Study Terminated by Sponsor|0|||
154873537|NCT03303339|558962909|FG002|Overall Study|Study Terminated by Sponsor|0|||
154974140|NCT02576717|559331188|FG000|Overall Study|Adverse Event|26|||
154974141|NCT02576717|559331189|FG001|Overall Study|Adverse Event|32|||
154974142|NCT02576717|559331190|FG002|Overall Study|Adverse Event|26|||
154974143|NCT01363011|559331191|FG000|Main Study|Adverse Event|2|||
154974144|NCT01363011|559331192|FG001|Main Study|Adverse Event|3|||
154974145|NCT01363011|559331191|FG000|Main Study|Investigator's Discretion|1|||
154974146|NCT01363011|559331192|FG001|Main Study|Investigator's Discretion|1|||
154873538|NCT03303339|558962910|FG003|Overall Study|Study Terminated by Sponsor|0|||
154873539|NCT03303339|558962911|FG004|Overall Study|Study Terminated by Sponsor|0|||
154873540|NCT03303339|558962912|FG005|Overall Study|Study Terminated by Sponsor|0|||
154873541|NCT03303339|558962913|FG006|Overall Study|Study Terminated by Sponsor|0|||
154873542|NCT03303339|558962914|FG007|Overall Study|Study Terminated by Sponsor|0|||
154873543|NCT03303339|558962915|FG008|Overall Study|Study Terminated by Sponsor|1|||
154873544|NCT03303339|558962916|FG009|Overall Study|Study Terminated by Sponsor|0|||
154873545|NCT03303339|558962917|FG010|Overall Study|Study Terminated by Sponsor|1|||
154873546|NCT03303339|558962918|FG011|Overall Study|Study Terminated by Sponsor|1|||
154873547|NCT03303339|558962907|FG000|Overall Study|Withdrawal by Subject|1|||
154873548|NCT03303339|558962908|FG001|Overall Study|Withdrawal by Subject|0|||
154873549|NCT03303339|558962909|FG002|Overall Study|Withdrawal by Subject|0|||
154873550|NCT03303339|558962910|FG003|Overall Study|Withdrawal by Subject|0|||
154873551|NCT03303339|558962911|FG004|Overall Study|Withdrawal by Subject|0|||
154974147|NCT01363011|559331191|FG000|Main Study|Withdrew Consent|1|||
155111701|NCT05659719|559838421|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
155111702|NCT05659719|559838422|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
155111703|NCT05659719|559838423|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
155111704|NCT05659719|559838424|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
155111705|NCT05659719|559838421|FG000|Overall Study|Lost to Follow-up|0|||
155111706|NCT05659719|559838422|FG001|Overall Study|Lost to Follow-up|0|||
155111707|NCT05659719|559838423|FG002|Overall Study|Lost to Follow-up|0|||
155111708|NCT05659719|559838424|FG003|Overall Study|Lost to Follow-up|2|||
155111709|NCT05659719|559838421|FG000|Overall Study|Moved to another observational study|0|||
155111710|NCT05659719|559838422|FG001|Overall Study|Moved to another observational study|0|||
155111711|NCT05659719|559838423|FG002|Overall Study|Moved to another observational study|0|||
155111712|NCT05659719|559838424|FG003|Overall Study|Moved to another observational study|1|||
155111713|NCT05659719|559838421|FG000|Overall Study|The child was enrolled in an interventional study|0|||
155111714|NCT05659719|559838422|FG001|Overall Study|The child was enrolled in an interventional study|0|||
155111715|NCT05659719|559838423|FG002|Overall Study|The child was enrolled in an interventional study|0|||
155111716|NCT05659719|559838424|FG003|Overall Study|The child was enrolled in an interventional study|55|||
155111717|NCT05659719|559838421|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
155111718|NCT05659719|559838422|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
155111719|NCT05659719|559838423|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
155111720|NCT05659719|559838424|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
155111721|NCT05659719|559838421|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
155111722|NCT05659719|559838422|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
155111723|NCT05659719|559838423|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
155111724|NCT05659719|559838424|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
155111725|NCT02290691|559838425|FG000|Overall Study|Noncompliance|0|||
155111726|NCT02290691|559838426|FG001|Overall Study|Noncompliance|1|||
155111727|NCT02290691|559838425|FG000|Overall Study|Withdrawal by Subject|1|||
155111728|NCT02290691|559838426|FG001|Overall Study|Withdrawal by Subject|1|||
155111729|NCT02290691|559838425|FG000|Overall Study|Lost to Follow-up|7|||
155111730|NCT02290691|559838426|FG001|Overall Study|Lost to Follow-up|7|||
155111731|NCT00185380|559838430|FG000|Overall Study|Adverse Event|41|||
155111732|NCT00185380|559838431|FG001|Overall Study|Adverse Event|43|||
155111733|NCT00185380|559838432|FG002|Overall Study|Adverse Event|48|||
155111734|NCT00185380|559838430|FG000|Overall Study|Lost to Follow-up|0|||
155111735|NCT00185380|559838431|FG001|Overall Study|Lost to Follow-up|4|||
155111736|NCT00185380|559838432|FG002|Overall Study|Lost to Follow-up|3|||
155111737|NCT00185380|559838430|FG000|Overall Study|Pregnancy|1|||
155111738|NCT00185380|559838431|FG001|Overall Study|Pregnancy|4|||
155111739|NCT00185380|559838432|FG002|Overall Study|Pregnancy|0|||
155111740|NCT00185380|559838430|FG000|Overall Study|Protocol Violation|2|||
155111741|NCT00185380|559838431|FG001|Overall Study|Protocol Violation|2|||
155111742|NCT00185380|559838432|FG002|Overall Study|Protocol Violation|1|||
155111743|NCT00185380|559838430|FG000|Overall Study|Withdrawal by Subject|1|||
155111744|NCT00185380|559838431|FG001|Overall Study|Withdrawal by Subject|2|||
155111745|NCT00185380|559838432|FG002|Overall Study|Withdrawal by Subject|0|||
155111746|NCT00185380|559838430|FG000|Overall Study|Failed insertion|1|||
155111747|NCT00185380|559838431|FG001|Overall Study|Failed insertion|1|||
154873552|NCT03303339|558962912|FG005|Overall Study|Withdrawal by Subject|1|||
154873553|NCT03303339|558962913|FG006|Overall Study|Withdrawal by Subject|1|||
154873554|NCT03303339|558962914|FG007|Overall Study|Withdrawal by Subject|0|||
154873555|NCT03303339|558962915|FG008|Overall Study|Withdrawal by Subject|0|||
154873556|NCT03303339|558962916|FG009|Overall Study|Withdrawal by Subject|0|||
154873557|NCT03303339|558962917|FG010|Overall Study|Withdrawal by Subject|0|||
154873558|NCT03303339|558962918|FG011|Overall Study|Withdrawal by Subject|2|||
154873559|NCT03303339|558962907|FG000|Overall Study|Physician Decision|0|||
154873560|NCT03303339|558962908|FG001|Overall Study|Physician Decision|0|||
154873561|NCT03303339|558962909|FG002|Overall Study|Physician Decision|0|||
154873562|NCT03303339|558962910|FG003|Overall Study|Physician Decision|0|||
154873563|NCT03303339|558962911|FG004|Overall Study|Physician Decision|1|||
154873564|NCT03303339|558962912|FG005|Overall Study|Physician Decision|0|||
155111748|NCT00185380|559838432|FG002|Overall Study|Failed insertion|2|||
155111749|NCT00185380|559838430|FG000|Overall Study|Planned pregnancy|9|||
155111750|NCT00185380|559838431|FG001|Overall Study|Planned pregnancy|12|||
155111751|NCT00185380|559838432|FG002|Overall Study|Planned pregnancy|12|||
155111752|NCT00185380|559838430|FG000|Overall Study|No need for contraception|3|||
154873565|NCT03303339|558962913|FG006|Overall Study|Physician Decision|0|||
154873566|NCT03303339|558962914|FG007|Overall Study|Physician Decision|0|||
154873567|NCT03303339|558962915|FG008|Overall Study|Physician Decision|0|||
154873568|NCT03303339|558962916|FG009|Overall Study|Physician Decision|0|||
154873569|NCT03303339|558962917|FG010|Overall Study|Physician Decision|0|||
154873570|NCT03303339|558962918|FG011|Overall Study|Physician Decision|0|||
154873571|NCT03303339|558962907|FG000|Overall Study|Safety/Non-compliance|0|||
154873572|NCT03303339|558962908|FG001|Overall Study|Safety/Non-compliance|0|||
154873573|NCT03303339|558962909|FG002|Overall Study|Safety/Non-compliance|0|||
154873574|NCT03303339|558962910|FG003|Overall Study|Safety/Non-compliance|0|||
154873575|NCT03303339|558962911|FG004|Overall Study|Safety/Non-compliance|0|||
154873576|NCT03303339|558962912|FG005|Overall Study|Safety/Non-compliance|0|||
154873577|NCT03303339|558962913|FG006|Overall Study|Safety/Non-compliance|0|||
154873578|NCT03303339|558962914|FG007|Overall Study|Safety/Non-compliance|0|||
154873579|NCT03303339|558962915|FG008|Overall Study|Safety/Non-compliance|0|||
154873580|NCT03303339|558962916|FG009|Overall Study|Safety/Non-compliance|0|||
154873581|NCT03303339|558962917|FG010|Overall Study|Safety/Non-compliance|0|||
154873582|NCT03303339|558962918|FG011|Overall Study|Safety/Non-compliance|1|||
154873583|NCT03694522|558962919|FG000|Overall Study|Withdrawal by Subject|8|||
154873584|NCT03694522|558962920|FG001|Overall Study|Withdrawal by Subject|10|||
154873585|NCT03694522|558962919|FG000|Overall Study|Physician Decision|53|||
154873586|NCT03694522|558962920|FG001|Overall Study|Physician Decision|54|||
154873587|NCT03694522|558962919|FG000|Overall Study|Other|1|||
154873588|NCT03694522|558962920|FG001|Overall Study|Other|1|||
154873589|NCT03694522|558962919|FG000|Overall Study|Lost to Follow-up|0|||
154873590|NCT03694522|558962920|FG001|Overall Study|Lost to Follow-up|1|||
154873591|NCT02760407|558962921|FG000|Overall Study|Death|2|||
154873592|NCT02760407|558962922|FG001|Overall Study|Death|3|||
154873593|NCT02760407|558962923|FG002|Overall Study|Death|1|||
154873594|NCT02760407|558962924|FG003|Overall Study|Death|1|||
154873595|NCT02760407|558962921|FG000|Overall Study|Lost to Follow-up|1|||
154873596|NCT02760407|558962922|FG001|Overall Study|Lost to Follow-up|7|||
154873597|NCT02760407|558962923|FG002|Overall Study|Lost to Follow-up|4|||
154873598|NCT02760407|558962924|FG003|Overall Study|Lost to Follow-up|6|||
154873599|NCT02760407|558962921|FG000|Overall Study|Withdrawal by Subject|25|||
154873600|NCT02760407|558962922|FG001|Overall Study|Withdrawal by Subject|31|||
154873601|NCT02760407|558962923|FG002|Overall Study|Withdrawal by Subject|37|||
154873602|NCT02760407|558962924|FG003|Overall Study|Withdrawal by Subject|25|||
154873603|NCT02760407|558962921|FG000|Overall Study|Violation of Eligibility criteria|0|||
154873604|NCT02760407|558962922|FG001|Overall Study|Violation of Eligibility criteria|0|||
154873605|NCT02760407|558962923|FG002|Overall Study|Violation of Eligibility criteria|1|||
154873606|NCT02760407|558962924|FG003|Overall Study|Violation of Eligibility criteria|1|||
154873607|NCT02760407|558962921|FG000|Overall Study|Personal reasons|0|||
154873608|NCT02760407|558962922|FG001|Overall Study|Personal reasons|0|||
154873609|NCT02760407|558962923|FG002|Overall Study|Personal reasons|0|||
154873610|NCT02760407|558962924|FG003|Overall Study|Personal reasons|1|||
154873611|NCT02760407|558962921|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
154873612|NCT02760407|558962922|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
154873613|NCT02760407|558962923|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
154873614|NCT02760407|558962924|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
154873615|NCT02760407|558962921|FG000|Overall Study|Use of prohibited Medication|0|||
154873616|NCT02760407|558962922|FG001|Overall Study|Use of prohibited Medication|0|||
154873617|NCT02760407|558962923|FG002|Overall Study|Use of prohibited Medication|1|||
154873618|NCT02760407|558962924|FG003|Overall Study|Use of prohibited Medication|0|||
155111753|NCT00185380|559838431|FG001|Overall Study|No need for contraception|3|||
155111754|NCT00185380|559838432|FG002|Overall Study|No need for contraception|3|||
155111755|NCT00185380|559838430|FG000|Overall Study|Could not attend visits|2|||
155111756|NCT00185380|559838431|FG001|Overall Study|Could not attend visits|0|||
154873619|NCT02760407|558962921|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
154873620|NCT02760407|558962922|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
154873621|NCT02760407|558962923|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
154873622|NCT02760407|558962924|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
154873623|NCT02760407|558962921|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
154873624|NCT02760407|558962922|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
154873625|NCT02760407|558962923|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
154873626|NCT02760407|558962924|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
154873627|NCT02760407|558962921|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
154873628|NCT02760407|558962922|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
154974148|NCT01363011|559331192|FG001|Main Study|Withdrew Consent|4|||
155111757|NCT00185380|559838432|FG002|Overall Study|Could not attend visits|4|||
154873629|NCT02760407|558962923|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
154873630|NCT02760407|558962924|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
154873631|NCT02760407|558962921|FG000|Overall Study|Inadequately Enrolled|0|||
155111758|NCT00185380|559838430|FG000|Overall Study|personal reason|6|||
155111759|NCT00185380|559838431|FG001|Overall Study|personal reason|1|||
154873632|NCT02760407|558962922|FG001|Overall Study|Inadequately Enrolled|0|||
154873633|NCT02760407|558962923|FG002|Overall Study|Inadequately Enrolled|0|||
154873634|NCT02760407|558962924|FG003|Overall Study|Inadequately Enrolled|1|||
154873635|NCT02760407|558962921|FG000|Overall Study|Withdrawal By PI's Decision|0|||
154873636|NCT02760407|558962922|FG001|Overall Study|Withdrawal By PI's Decision|1|||
154873637|NCT02760407|558962923|FG002|Overall Study|Withdrawal By PI's Decision|0|||
154873638|NCT02760407|558962924|FG003|Overall Study|Withdrawal By PI's Decision|0|||
155111760|NCT00185380|559838432|FG002|Overall Study|personal reason|1|||
155111761|NCT02242435|559838435|FG000|Overall Study|Lost to Follow-up|3|||
155111762|NCT02242435|559838436|FG001|Overall Study|Lost to Follow-up|4|||
155111763|NCT02242435|559838435|FG000|Overall Study|Adverse Event|3|||
155111764|NCT02242435|559838436|FG001|Overall Study|Adverse Event|2|||
155111765|NCT02242435|559838435|FG000|Overall Study|Withdrawal by Subject|13|||
155111766|NCT02242435|559838436|FG001|Overall Study|Withdrawal by Subject|8|||
155111767|NCT02242435|559838435|FG000|Overall Study|Death|0|||
155111768|NCT02242435|559838436|FG001|Overall Study|Death|1|||
155111769|NCT02242435|559838435|FG000|Overall Study|Protocol Violation|1|||
155111770|NCT02242435|559838436|FG001|Overall Study|Protocol Violation|0|||
155111771|NCT02242435|559838435|FG000|Overall Study|Physician Decision|0|||
155111772|NCT02242435|559838436|FG001|Overall Study|Physician Decision|1|||
155111773|NCT01110330|559838439|FG000|Overall Study|Adverse Event|0|||
155111774|NCT01110330|559838440|FG001|Overall Study|Adverse Event|4|||
155111775|NCT01110330|559838441|FG002|Overall Study|Adverse Event|3|||
155111776|NCT01110330|559838439|FG000|Overall Study|Lack of Efficacy|3|||
155111777|NCT01110330|559838440|FG001|Overall Study|Lack of Efficacy|1|||
155111778|NCT01110330|559838441|FG002|Overall Study|Lack of Efficacy|1|||
155111779|NCT01110330|559838439|FG000|Overall Study|Lost to Follow-up|9|||
155111780|NCT01110330|559838440|FG001|Overall Study|Lost to Follow-up|10|||
155111781|NCT01110330|559838441|FG002|Overall Study|Lost to Follow-up|15|||
155111782|NCT01110330|559838439|FG000|Overall Study|Physician Decision|0|||
155111783|NCT01110330|559838440|FG001|Overall Study|Physician Decision|1|||
155111784|NCT01110330|559838441|FG002|Overall Study|Physician Decision|0|||
155111785|NCT01110330|559838439|FG000|Overall Study|Protocol Violation|2|||
155111786|NCT01110330|559838440|FG001|Overall Study|Protocol Violation|0|||
155111787|NCT01110330|559838441|FG002|Overall Study|Protocol Violation|4|||
155111788|NCT01110330|559838439|FG000|Overall Study|Withdrawal by Subject|0|||
155111789|NCT01110330|559838440|FG001|Overall Study|Withdrawal by Subject|6|||
155111790|NCT01110330|559838441|FG002|Overall Study|Withdrawal by Subject|2|||
155111791|NCT01110330|559838439|FG000|Overall Study|Other|1|||
155111792|NCT01110330|559838440|FG001|Overall Study|Other|1|||
155111793|NCT01110330|559838441|FG002|Overall Study|Other|1|||
155111794|NCT01089413|559838448|FG000|Overall Study|Lost to Follow-up|1|||
155111795|NCT01089413|559838448|FG000|Overall Study|Progressive Disease|93|||
155111796|NCT01089413|559838448|FG000|Overall Study|Participant Withdrew Consent|1|||
155111797|NCT01089413|559838448|FG000|Overall Study|Unacceptable Toxicity|12|||
155111798|NCT01089413|559838448|FG000|Overall Study|Death|10|||
155111799|NCT01089413|559838448|FG000|Overall Study|Metastasectomy|13|||
155111800|NCT01089413|559838448|FG000|Overall Study|Other|71|||
155111801|NCT02513485|559838449|FG000|Overall Study|Adverse Event|1|||
155111802|NCT02513485|559838450|FG001|Overall Study|Adverse Event|0|||
155111803|NCT00394251|559838458|FG000|Overall Study|Adverse Event|7|||
155111804|NCT00394251|559838459|FG001|Overall Study|Adverse Event|5|||
155111805|NCT00394251|559838458|FG000|Overall Study|Unacceptable Toxicity|20|||
155111806|NCT00394251|559838459|FG001|Overall Study|Unacceptable Toxicity|18|||
155111807|NCT00394251|559838458|FG000|Overall Study|Physician Decision|1|||
155111808|NCT00394251|559838459|FG001|Overall Study|Physician Decision|1|||
155111809|NCT00394251|559838458|FG000|Overall Study|Protocol Violation|0|||
155111810|NCT00394251|559838459|FG001|Overall Study|Protocol Violation|1|||
154974149|NCT01363011|559331191|FG000|Main Study|Protocol Violation|0|||
154974150|NCT01363011|559331192|FG001|Main Study|Protocol Violation|1|||
155111811|NCT00394251|559838458|FG000|Overall Study|Withdrawal by Subject|7|||
154974151|NCT01363011|559331191|FG000|Extension Phase|Adverse Event|1|||
155111812|NCT00394251|559838459|FG001|Overall Study|Withdrawal by Subject|11|||
155111813|NCT00394251|559838458|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
155111814|NCT00394251|559838459|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
155111815|NCT01667224|559838462|FG000|Overall Study|Withdrawal by Subject|3|||
155111816|NCT01667224|559838463|FG001|Overall Study|Withdrawal by Subject|1|||
155111817|NCT01667224|559838462|FG000|Overall Study|Protocol Violation|1|||
155111818|NCT01667224|559838463|FG001|Overall Study|Protocol Violation|1|||
155111819|NCT03350035|559838464|FG000|Overall Study|Lack of Efficacy|2|||
155111820|NCT03350035|559838465|FG001|Overall Study|Lack of Efficacy|0|||
154873639|NCT02760407|558962921|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
154873640|NCT02760407|558962922|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
155111821|NCT03350035|559838466|FG002|Overall Study|Lack of Efficacy|0|||
155111822|NCT03350035|559838464|FG000|Overall Study|Subject discharged to hospice|0|||
155111823|NCT03350035|559838465|FG001|Overall Study|Subject discharged to hospice|0|||
155111824|NCT03350035|559838466|FG002|Overall Study|Subject discharged to hospice|1|||
155111825|NCT01610557|559838467|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155111826|NCT01610557|559838468|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
155111827|NCT01610557|559838469|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
154873641|NCT02760407|558962923|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
154873642|NCT02760407|558962924|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
154873643|NCT02760407|558962921|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
154873644|NCT02760407|558962922|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
154873645|NCT02760407|558962923|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
154873646|NCT02760407|558962924|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
154873647|NCT02760407|558962921|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
154873648|NCT02760407|558962922|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
154873649|NCT02760407|558962923|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
154873650|NCT02760407|558962924|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
154873651|NCT02760407|558962921|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
154873652|NCT02760407|558962922|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
154873653|NCT02760407|558962923|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
154873654|NCT02760407|558962924|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
154873655|NCT02760407|558962921|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
154873656|NCT02760407|558962922|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
154873657|NCT02760407|558962923|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
154873658|NCT02760407|558962924|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
154873659|NCT02760407|558962921|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
154873660|NCT02760407|558962922|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
154873661|NCT02760407|558962923|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
154873662|NCT02760407|558962924|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
154873663|NCT02760407|558962921|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
154873664|NCT02760407|558962922|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
154873665|NCT02760407|558962923|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
154873666|NCT02760407|558962924|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
154873667|NCT02760407|558962921|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
154873668|NCT02760407|558962922|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
154873669|NCT02760407|558962923|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
154873670|NCT02760407|558962924|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
154873671|NCT02760407|558962921|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
154873672|NCT02760407|558962922|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
154873673|NCT02760407|558962923|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
154873674|NCT02760407|558962924|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
154873675|NCT02522377|558962925|FG000|Overall Study|Withdrawal by Subject|1|||
154873676|NCT02522377|558962926|FG001|Overall Study|Withdrawal by Subject|0|||
154873677|NCT02522377|558962925|FG000|Overall Study|Remission Achieved|3|||
154873678|NCT02522377|558962926|FG001|Overall Study|Remission Achieved|0|||
154873679|NCT01158950|558962927|FG000|1st Intervention (1 Day)|Physician Decision|1|||
154873680|NCT01158950|558962928|FG001|1st Intervention (1 Day)|Physician Decision|2|||
154873681|NCT02137772|558962931|FG000|Overall Study|Adverse Event|6|||
154873682|NCT02137772|558962932|FG001|Overall Study|Adverse Event|3|||
154873683|NCT02137772|558962931|FG000|Overall Study|Death|71|||
154873684|NCT02137772|558962932|FG001|Overall Study|Death|44|||
154873685|NCT02137772|558962931|FG000|Overall Study|Lost to Follow-up|8|||
154873686|NCT02137772|558962932|FG001|Overall Study|Lost to Follow-up|4|||
154873687|NCT02137772|558962931|FG000|Overall Study|Physician Decision|15|||
154873688|NCT02137772|558962932|FG001|Overall Study|Physician Decision|5|||
154873689|NCT02137772|558962931|FG000|Overall Study|Withdrawal by Subject|28|||
154873690|NCT02137772|558962932|FG001|Overall Study|Withdrawal by Subject|17|||
154873691|NCT02137772|558962931|FG000|Overall Study|Non-compliance with study drug|1|||
154873692|NCT02137772|558962932|FG001|Overall Study|Non-compliance with study drug|0|||
154873693|NCT02137772|558962931|FG000|Overall Study|Not treated|3|||
154974152|NCT01363011|559331192|FG001|Extension Phase|Adverse Event|1|||
155111828|NCT01610557|559838470|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155111829|NCT01610557|559838471|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
155111830|NCT01610557|559838467|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155111831|NCT01610557|559838468|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155111832|NCT01610557|559838469|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155111833|NCT01610557|559838470|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
155111834|NCT01610557|559838471|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
154873694|NCT02137772|558962932|FG001|Overall Study|Not treated|2|||
154873695|NCT01844700|558962933|FG000|Overall Study|Lack of Efficacy|1|||
154873696|NCT01844700|558962934|FG001|Overall Study|Lack of Efficacy|0|||
154873697|NCT01844700|558962933|FG000|Overall Study|refused medication switch|1|||
154873698|NCT01844700|558962934|FG001|Overall Study|refused medication switch|0|||
154873699|NCT01844700|558962933|FG000|Overall Study|Withdrawal by Subject|1|||
154873700|NCT01844700|558962934|FG001|Overall Study|Withdrawal by Subject|0|||
154873701|NCT01844700|558962933|FG000|Overall Study|stopped taking meds|0|||
154873702|NCT01844700|558962934|FG001|Overall Study|stopped taking meds|1|||
154873703|NCT03290300|558962935|FG000|Overall Study|Lost to Follow-up|3|||
154873704|NCT00864227|558962936|FG000|Overall Study|Withdrawal by Subject|1|||
154873705|NCT00864227|558962936|FG000|Overall Study|Disease Relapse/Progression|3|||
154873706|NCT02124798|558962937|FG000|Overall Study|Adverse Event|3|||
154873707|NCT02124798|558962937|FG000|Overall Study|Lost to Follow-up|1|||
154873708|NCT02746679|558962945|FG000|Overall Study|Lost to Follow-up|4|||
154873709|NCT02746679|558962946|FG001|Overall Study|Lost to Follow-up|6|||
154873710|NCT00487279|558962947|FG000|Overall Study|Death|1|||
154873711|NCT00487279|558962948|FG001|Overall Study|Death|0|||
154873712|NCT00487279|558962947|FG000|Overall Study|Withdrawal by Subject|0|||
154873713|NCT00487279|558962948|FG001|Overall Study|Withdrawal by Subject|2|||
154873714|NCT00501852|558962949|FG000|Overall Study|Adverse Event|3|||
154873715|NCT00501852|558962949|FG000|Overall Study|Withdrawal by Subject|2|||
154873716|NCT01171521|558962952|FG000|Overall Study|Lost to Follow-up|5|||
154873717|NCT01171521|558962952|FG000|Overall Study|screen failure|1|||
154873718|NCT01416610|558962953|FG000|Overall Study|Adverse Event|4|||
154873719|NCT01416610|558962953|FG000|Overall Study|Adverse Event -Patient decision|3|||
154873720|NCT01416610|558962953|FG000|Overall Study|Lack of Efficacy|4|||
154873721|NCT01416610|558962953|FG000|Overall Study|No reason given|5|||
154873722|NCT01416610|558962953|FG000|Overall Study|Withdrawal by Subject|13|||
154873723|NCT01416610|558962953|FG000|Overall Study|Lost to Follow-up|7|||
154873724|NCT01416610|558962953|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
154873725|NCT01520922|558962955|FG000|Treatment Phase|Physician Decision|2|||
154873726|NCT01520922|558962956|FG001|Treatment Phase|Physician Decision|1|||
154873727|NCT01520922|558962955|FG000|Treatment Phase|Progression|0|||
154873728|NCT01520922|558962956|FG001|Treatment Phase|Progression|2|||
154873729|NCT01520922|558962955|FG000|Treatment Phase|Adverse Event|3|||
154873730|NCT01520922|558962956|FG001|Treatment Phase|Adverse Event|5|||
154873731|NCT01520922|558962955|FG000|Follow up|Lost to Follow-up|0|||
154873732|NCT01520922|558962956|FG001|Follow up|Lost to Follow-up|1|||
154873733|NCT01520922|558962955|FG000|Survival Follow-up|Withdrawal by Subject|1|||
154873734|NCT01520922|558962956|FG001|Survival Follow-up|Withdrawal by Subject|0|||
154873735|NCT01696877|558962959|FG000|Overall Study|Adverse Event|0|||
154873736|NCT01696877|558962960|FG001|Overall Study|Adverse Event|1|||
154873737|NCT01422304|558962963|FG000|Overall Study|Adverse Event|0|||
154873738|NCT01422304|558962964|FG001|Overall Study|Adverse Event|1|||
154873739|NCT01422304|558962963|FG000|Overall Study|Lost to Follow-up|14|||
154873740|NCT01422304|558962964|FG001|Overall Study|Lost to Follow-up|20|||
154873741|NCT01422304|558962963|FG000|Overall Study|Never Entered Follow-up|2|||
154873742|NCT01422304|558962964|FG001|Overall Study|Never Entered Follow-up|1|||
154873743|NCT01422304|558962963|FG000|Overall Study|Protocol Violation|1|||
154873744|NCT01422304|558962964|FG001|Overall Study|Protocol Violation|0|||
154873745|NCT01422304|558962963|FG000|Overall Study|Withdrawal by Subject|4|||
154873746|NCT01422304|558962964|FG001|Overall Study|Withdrawal by Subject|2|||
154873747|NCT01422304|558962963|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
154974153|NCT01363011|559331191|FG000|Extension Phase|Lack of Efficacy|0|||
154873748|NCT01422304|558962964|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
154974154|NCT01363011|559331192|FG001|Extension Phase|Lack of Efficacy|1|||
154974155|NCT01363011|559331191|FG000|Extension Phase|Investigator's Discretion|2|||
154974156|NCT01363011|559331192|FG001|Extension Phase|Investigator's Discretion|2|||
154974157|NCT01363011|559331191|FG000|Extension Phase|Withdrew Consent|0|||
155111835|NCT03215758|559838477|FG000|Overall Study|Technical Problems|1|||
154873749|NCT01422304|558962963|FG000|Overall Study|Not Treated|3|||
154873750|NCT01422304|558962964|FG001|Overall Study|Not Treated|11|||
154873751|NCT00469014|558962965|FG000|Initial Phase Randomization|Disease Progression|0|||
154873752|NCT00469014|558962966|FG001|Initial Phase Randomization|Disease Progression|1|||
154873753|NCT00469014|558962967|FG002|Initial Phase Randomization|Disease Progression|1|||
155111836|NCT03215758|559838478|FG001|Overall Study|Technical Problems|0|||
154873754|NCT00469014|558962968|FG003|Initial Phase Randomization|Disease Progression|0|||
154873755|NCT00469014|558962965|FG000|Initial Phase Randomization|No Response|1|||
154873756|NCT00469014|558962966|FG001|Initial Phase Randomization|No Response|0|||
154873757|NCT00469014|558962967|FG002|Initial Phase Randomization|No Response|0|||
154873758|NCT00469014|558962968|FG003|Initial Phase Randomization|No Response|1|||
154873759|NCT00469014|558962965|FG000|Adaptive Randomization|Not Evaluable|1|||
154873760|NCT00469014|558962966|FG001|Adaptive Randomization|Not Evaluable|0|||
154873761|NCT00469014|558962967|FG002|Adaptive Randomization|Not Evaluable|0|||
154873762|NCT00469014|558962968|FG003|Adaptive Randomization|Not Evaluable|1|||
154873763|NCT00469014|558962965|FG000|Adaptive Randomization|No Response|0|||
154974158|NCT01363011|559331192|FG001|Extension Phase|Withdrew Consent|1|||
154873764|NCT00469014|558962966|FG001|Adaptive Randomization|No Response|1|||
154873765|NCT00469014|558962967|FG002|Adaptive Randomization|No Response|0|||
154873766|NCT00469014|558962968|FG003|Adaptive Randomization|No Response|0|||
154873767|NCT00469014|558962965|FG000|Adaptive Randomization|Death|0|||
154873768|NCT00469014|558962966|FG001|Adaptive Randomization|Death|0|||
154873769|NCT00469014|558962967|FG002|Adaptive Randomization|Death|1|||
154873770|NCT00469014|558962968|FG003|Adaptive Randomization|Death|0|||
154873771|NCT03461289|558962972|FG000|Overall Study|Death|1|||
154873772|NCT00866294|558962975|FG000|Overall Study|Adverse Event|12|||
154873773|NCT00866294|558962976|FG001|Overall Study|Adverse Event|13|||
154873774|NCT00866294|558962977|FG002|Overall Study|Adverse Event|9|||
154873775|NCT00866294|558962975|FG000|Overall Study|Lack of Efficacy|7|||
154873776|NCT00866294|558962976|FG001|Overall Study|Lack of Efficacy|1|||
154873777|NCT00866294|558962977|FG002|Overall Study|Lack of Efficacy|0|||
154873778|NCT00866294|558962975|FG000|Overall Study|Protocol Violation|2|||
154873779|NCT00866294|558962976|FG001|Overall Study|Protocol Violation|0|||
154873780|NCT00866294|558962977|FG002|Overall Study|Protocol Violation|0|||
154873781|NCT00866294|558962975|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
154873782|NCT00866294|558962976|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
154873783|NCT00866294|558962977|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
154873784|NCT00866294|558962975|FG000|Overall Study|Lost to Follow-up|1|||
154873785|NCT00866294|558962976|FG001|Overall Study|Lost to Follow-up|3|||
154873786|NCT00866294|558962977|FG002|Overall Study|Lost to Follow-up|0|||
154873787|NCT00866294|558962975|FG000|Overall Study|Physician Decision|6|||
154873788|NCT00866294|558962976|FG001|Overall Study|Physician Decision|2|||
154873789|NCT00866294|558962977|FG002|Overall Study|Physician Decision|1|||
154873790|NCT03241173|558962978|FG000|Overall Study|Death|3|||
154873791|NCT03241173|558962979|FG001|Overall Study|Death|2|||
154873792|NCT03241173|558962980|FG002|Overall Study|Death|4|||
154873793|NCT03241173|558962981|FG003|Overall Study|Death|4|||
154873794|NCT03241173|558962982|FG004|Overall Study|Death|2|||
154873795|NCT03241173|558962983|FG005|Overall Study|Death|2|||
154873796|NCT03241173|558962984|FG006|Overall Study|Death|3|||
154873797|NCT03241173|558962985|FG007|Overall Study|Death|1|||
154873798|NCT03241173|558962986|FG008|Overall Study|Death|0|||
154873799|NCT03241173|558962987|FG009|Overall Study|Death|5|||
154873800|NCT03241173|558962988|FG010|Overall Study|Death|4|||
154873801|NCT03241173|558962989|FG011|Overall Study|Death|3|||
154873802|NCT03241173|558962990|FG012|Overall Study|Death|0|||
154873803|NCT03241173|558962991|FG013|Overall Study|Death|0|||
154873804|NCT03241173|558962992|FG014|Overall Study|Death|0|||
154873805|NCT03241173|558962978|FG000|Overall Study|Withdrawal by Subject|0|||
154873806|NCT03241173|558962979|FG001|Overall Study|Withdrawal by Subject|0|||
154873807|NCT03241173|558962980|FG002|Overall Study|Withdrawal by Subject|1|||
154873808|NCT03241173|558962981|FG003|Overall Study|Withdrawal by Subject|0|||
154873809|NCT03241173|558962982|FG004|Overall Study|Withdrawal by Subject|0|||
154873810|NCT03241173|558962983|FG005|Overall Study|Withdrawal by Subject|1|||
154873811|NCT03241173|558962984|FG006|Overall Study|Withdrawal by Subject|0|||
154873812|NCT03241173|558962985|FG007|Overall Study|Withdrawal by Subject|0|||
154873813|NCT03241173|558962986|FG008|Overall Study|Withdrawal by Subject|0|||
154873814|NCT03241173|558962987|FG009|Overall Study|Withdrawal by Subject|0|||
154873815|NCT03241173|558962988|FG010|Overall Study|Withdrawal by Subject|0|||
154873816|NCT03241173|558962989|FG011|Overall Study|Withdrawal by Subject|0|||
154873817|NCT03241173|558962990|FG012|Overall Study|Withdrawal by Subject|0|||
154873818|NCT03241173|558962991|FG013|Overall Study|Withdrawal by Subject|0|||
154873819|NCT03241173|558962992|FG014|Overall Study|Withdrawal by Subject|0|||
154873820|NCT03241173|558962978|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
154873821|NCT03241173|558962979|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
154873822|NCT03241173|558962980|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
154873823|NCT03241173|558962981|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
154873824|NCT03241173|558962982|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
154873825|NCT03241173|558962983|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
154873826|NCT03241173|558962984|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
154873827|NCT03241173|558962985|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
154873828|NCT03241173|558962986|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
154873829|NCT03241173|558962987|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
154873830|NCT03241173|558962988|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
154873831|NCT03241173|558962989|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
154873832|NCT03241173|558962990|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
154873833|NCT03241173|558962991|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
154873834|NCT03241173|558962992|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
154873835|NCT03241173|558962978|FG000|Overall Study|Lost to Follow-up|0|||
154873836|NCT03241173|558962979|FG001|Overall Study|Lost to Follow-up|0|||
155111837|NCT03215758|559838477|FG000|Overall Study|Protocol deviation|0|||
155111838|NCT03215758|559838478|FG001|Overall Study|Protocol deviation|1|||
155111839|NCT03215758|559838477|FG000|Overall Study|Physician Decision|0|||
155111840|NCT03215758|559838478|FG001|Overall Study|Physician Decision|1|||
155111841|NCT03215758|559838477|FG000|Overall Study|Death|0|||
155111842|NCT03215758|559838478|FG001|Overall Study|Death|1|||
155111843|NCT03215758|559838477|FG000|Overall Study|Adverse Event|1|||
155111844|NCT03215758|559838478|FG001|Overall Study|Adverse Event|2|||
155111845|NCT03215758|559838477|FG000|Overall Study|Subject/Guardian Decision|3|||
155111846|NCT03215758|559838478|FG001|Overall Study|Subject/Guardian Decision|3|||
155111847|NCT04115748|559838479|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
155111848|NCT04115748|559838480|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
155111849|NCT04115748|559838481|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
154873837|NCT03241173|558962980|FG002|Overall Study|Lost to Follow-up|0|||
154873838|NCT03241173|558962981|FG003|Overall Study|Lost to Follow-up|0|||
154873839|NCT03241173|558962982|FG004|Overall Study|Lost to Follow-up|1|||
154873840|NCT03241173|558962983|FG005|Overall Study|Lost to Follow-up|0|||
154873841|NCT03241173|558962984|FG006|Overall Study|Lost to Follow-up|0|||
154873842|NCT03241173|558962985|FG007|Overall Study|Lost to Follow-up|0|||
154873843|NCT03241173|558962986|FG008|Overall Study|Lost to Follow-up|0|||
154873844|NCT03241173|558962987|FG009|Overall Study|Lost to Follow-up|1|||
154873845|NCT03241173|558962988|FG010|Overall Study|Lost to Follow-up|0|||
154873846|NCT03241173|558962989|FG011|Overall Study|Lost to Follow-up|0|||
154873847|NCT03241173|558962990|FG012|Overall Study|Lost to Follow-up|0|||
154873848|NCT03241173|558962991|FG013|Overall Study|Lost to Follow-up|0|||
154873849|NCT03241173|558962992|FG014|Overall Study|Lost to Follow-up|0|||
154873850|NCT00515463|558962993|FG000|Overall Study|Physician Decision|4|||
154873851|NCT00515463|558962994|FG001|Overall Study|Physician Decision|2|||
154873852|NCT00515463|558962993|FG000|Overall Study|Adverse Event|1|||
154873853|NCT00515463|558962994|FG001|Overall Study|Adverse Event|2|||
154873854|NCT00515463|558962993|FG000|Overall Study|Withdrawal by Subject|3|||
154873855|NCT00515463|558962994|FG001|Overall Study|Withdrawal by Subject|4|||
154873856|NCT00515463|558962993|FG000|Overall Study|Lost to Follow-up|6|||
154873857|NCT00515463|558962994|FG001|Overall Study|Lost to Follow-up|5|||
154873858|NCT00515463|558962993|FG000|Overall Study|Other|0|||
154873859|NCT00515463|558962994|FG001|Overall Study|Other|1|||
154873860|NCT00916721|558962995|FG000|Overall Study|Lost to Follow-up|0|||
154873861|NCT00916721|558962996|FG001|Overall Study|Lost to Follow-up|1|||
154873862|NCT00916721|558962995|FG000|Overall Study|Adverse Event|6|||
154873863|NCT00916721|558962996|FG001|Overall Study|Adverse Event|3|||
154873864|NCT00916721|558962995|FG000|Overall Study|Withdrawal by Subject|2|||
154873865|NCT00916721|558962996|FG001|Overall Study|Withdrawal by Subject|2|||
154873866|NCT00916721|558962995|FG000|Overall Study|Protocol Violation|2|||
154873867|NCT00916721|558962996|FG001|Overall Study|Protocol Violation|4|||
154873868|NCT01469052|558962999|FG000|Overall Study|Adverse Event|2|||
154873869|NCT01469052|558963000|FG001|Overall Study|Adverse Event|3|||
154873870|NCT01469052|558963001|FG002|Overall Study|Adverse Event|0|||
154873871|NCT01469052|558963002|FG003|Overall Study|Adverse Event|2|||
154873872|NCT01469052|558963003|FG004|Overall Study|Adverse Event|0|||
154873873|NCT01469052|558963004|FG005|Overall Study|Adverse Event|1|||
154873874|NCT01469052|558962999|FG000|Overall Study|Progressive disease|3|||
154873875|NCT01469052|558963000|FG001|Overall Study|Progressive disease|0|||
154873876|NCT01469052|558963001|FG002|Overall Study|Progressive disease|5|||
155111850|NCT04115748|559838482|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
155111851|NCT04115748|559838483|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
154873877|NCT01469052|558963002|FG003|Overall Study|Progressive disease|3|||
154873878|NCT01469052|558963003|FG004|Overall Study|Progressive disease|7|||
154873879|NCT01469052|558963004|FG005|Overall Study|Progressive disease|2|||
154873880|NCT01469052|558962999|FG000|Overall Study|Lack of Efficacy|0|||
154873881|NCT01469052|558963000|FG001|Overall Study|Lack of Efficacy|0|||
154873882|NCT01469052|558963001|FG002|Overall Study|Lack of Efficacy|0|||
154873883|NCT01469052|558963002|FG003|Overall Study|Lack of Efficacy|0|||
154873884|NCT01469052|558963003|FG004|Overall Study|Lack of Efficacy|0|||
154873885|NCT01469052|558963004|FG005|Overall Study|Lack of Efficacy|2|||
154873886|NCT01469052|558962999|FG000|Overall Study|Moved to rollover protocol|1|||
154873887|NCT01469052|558963000|FG001|Overall Study|Moved to rollover protocol|0|||
154873888|NCT01469052|558963001|FG002|Overall Study|Moved to rollover protocol|1|||
155111852|NCT04115748|559838484|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155111853|NCT04115748|559838485|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155111854|NCT04115748|559838486|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155111855|NCT04115748|559838487|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
155111856|NCT04115748|559838488|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
154873889|NCT01469052|558963002|FG003|Overall Study|Moved to rollover protocol|0|||
154873890|NCT01469052|558963003|FG004|Overall Study|Moved to rollover protocol|0|||
154873891|NCT01469052|558963004|FG005|Overall Study|Moved to rollover protocol|1|||
154873892|NCT01469052|558962999|FG000|Overall Study|Other|0|||
154873893|NCT01469052|558963000|FG001|Overall Study|Other|1|||
154873894|NCT01469052|558963001|FG002|Overall Study|Other|0|||
155111857|NCT04115748|559838479|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111858|NCT04115748|559838480|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111859|NCT04115748|559838481|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111860|NCT04115748|559838482|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
154873895|NCT01469052|558963002|FG003|Overall Study|Other|0|||
154873896|NCT01469052|558963003|FG004|Overall Study|Other|1|||
154873897|NCT01469052|558963004|FG005|Overall Study|Other|0|||
154873898|NCT03648996|558963006|FG000|Overall Study|Withdrawal by Subject|0|||
155111861|NCT04115748|559838483|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111862|NCT04115748|559838484|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111863|NCT04115748|559838485|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111864|NCT04115748|559838486|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111865|NCT04115748|559838487|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111866|NCT04115748|559838488|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
155111867|NCT04115748|559838479|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155111868|NCT04115748|559838480|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155111869|NCT04115748|559838481|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155111870|NCT04115748|559838482|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
155111871|NCT04115748|559838483|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
155111872|NCT04115748|559838484|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
155111873|NCT04115748|559838485|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
155111874|NCT04115748|559838486|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
155111875|NCT04115748|559838487|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
155111876|NCT04115748|559838488|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
155111877|NCT04115748|559838479|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111878|NCT04115748|559838480|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111879|NCT04115748|559838481|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111880|NCT04115748|559838482|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111881|NCT04115748|559838483|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111882|NCT04115748|559838484|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111883|NCT04115748|559838485|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111884|NCT04115748|559838486|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111885|NCT04115748|559838487|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
155111886|NCT04115748|559838488|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
155111887|NCT00713349|559838489|FG000|Overall Study|Protocol Violation|1|||
155111888|NCT01200407|559838490|FG000|Overall Study|Lost to Follow-up|56|||
155111889|NCT01200407|559838490|FG000|Overall Study|Adverse Event|3|||
155111890|NCT01200407|559838490|FG000|Overall Study|Withdrawal by Subject|4|||
155111891|NCT01200407|559838490|FG000|Overall Study|Other|19|||
155111892|NCT01843673|559838491|FG000|Overall Study|Lack of Efficacy|2|||
154873899|NCT03648996|558963007|FG001|Overall Study|Withdrawal by Subject|2|||
154873900|NCT03648996|558963008|FG002|Overall Study|Withdrawal by Subject|2|||
154873901|NCT03648996|558963006|FG000|Overall Study|Physician Decision|2|||
154873902|NCT03648996|558963007|FG001|Overall Study|Physician Decision|0|||
154873903|NCT03648996|558963008|FG002|Overall Study|Physician Decision|0|||
154873904|NCT02749370|558963010|FG000|Overall Study|Withdrawal by Subject|11|||
154873905|NCT02749370|558963010|FG000|Overall Study|Lost to Follow-up|3|||
154873906|NCT01519427|558963014|FG000|Overall Study|disease progression|2|||
154873907|NCT03894904|558963015|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
154873908|NCT03894904|558963016|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
154873909|NCT03894904|558963015|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
154873910|NCT03894904|558963016|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
154873911|NCT00633139|558963024|FG000|Overall Study|Non compliance|0|||
155111893|NCT01843673|559838491|FG000|Overall Study|Withdrawal by Subject|4|||
155111894|NCT03275246|559838492|FG000|Overall Study|Protocol Violation|5|||
155111895|NCT03275246|559838492|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
154873912|NCT00633139|558963025|FG001|Overall Study|Non compliance|0|||
154873913|NCT00633139|558963026|FG002|Overall Study|Non compliance|1|||
154873914|NCT00633139|558963024|FG000|Overall Study|Withdrawal by Subject|0|||
154974159|NCT01363011|559331191|FG000|Extension Phase|Lost to Follow-up|0|||
154974160|NCT01363011|559331192|FG001|Extension Phase|Lost to Follow-up|2|||
155111896|NCT05059301|559838493|FG000|Overall Study|Adverse Event|0|||
155111897|NCT05059301|559838494|FG001|Overall Study|Adverse Event|2|||
155111898|NCT05059301|559838495|FG002|Overall Study|Adverse Event|2|||
155111899|NCT05059301|559838493|FG000|Overall Study|Lost to Follow-up|2|||
155111900|NCT05059301|559838494|FG001|Overall Study|Lost to Follow-up|3|||
155111901|NCT05059301|559838495|FG002|Overall Study|Lost to Follow-up|3|||
155111902|NCT00923975|559838496|FG000|Overall Study|Did not meet inclusion criteria|1|||
154873915|NCT00633139|558963025|FG001|Overall Study|Withdrawal by Subject|1|||
155111903|NCT01205061|559838499|FG000|Overall Study|Adverse Event|4|||
155111904|NCT01205061|559838499|FG000|Overall Study|Withdrawal by Subject|11|||
154873916|NCT00633139|558963026|FG002|Overall Study|Withdrawal by Subject|0|||
154873917|NCT02160977|558963027|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
154873918|NCT02160977|558963028|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
154873919|NCT02160977|558963027|FG000|Three Months After Surgery|Lost to Follow-up|0|||
154873920|NCT02160977|558963028|FG001|Three Months After Surgery|Lost to Follow-up|2|||
154873921|NCT02160977|558963027|FG000|Six Months After Surgery|Lost to Follow-up|2|||
154873922|NCT02160977|558963028|FG001|Six Months After Surgery|Lost to Follow-up|1|||
154873923|NCT02269319|558963029|FG000|Overall Study|Lost to Follow-up|4|||
154873924|NCT02269319|558963030|FG001|Overall Study|Lost to Follow-up|3|||
154873925|NCT02269319|558963029|FG000|Overall Study|Adverse Event|0|||
154873926|NCT02269319|558963030|FG001|Overall Study|Adverse Event|1|||
154873927|NCT02269319|558963029|FG000|Overall Study|Instructions not followed|1|||
154873928|NCT02269319|558963030|FG001|Overall Study|Instructions not followed|0|||
154873929|NCT04543955|558964774|FG000|Overall Study|Company cancelled study|1|||
154873930|NCT04543955|558964775|FG001|Overall Study|Company cancelled study|0|||
154873931|NCT01614769|558964776|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
154873932|NCT01614769|558964777|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
154873933|NCT01614769|558964778|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
154873934|NCT01614769|558964779|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
154873935|NCT01614769|558964780|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
154873936|NCT01614769|558964781|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
154873937|NCT01614769|558964776|FG000|Period 1|Protocol Violation|0|||
154873938|NCT01614769|558964777|FG001|Period 1|Protocol Violation|0|||
154873939|NCT01614769|558964778|FG002|Period 1|Protocol Violation|0|||
154873940|NCT01614769|558964779|FG003|Period 1|Protocol Violation|1|||
154873941|NCT01614769|558964780|FG004|Period 1|Protocol Violation|0|||
154873942|NCT01614769|558964781|FG005|Period 1|Protocol Violation|0|||
154873943|NCT01614769|558964776|FG000|Period 1|Withdrawal by Subject|1|||
154873944|NCT01614769|558964777|FG001|Period 1|Withdrawal by Subject|0|||
154873945|NCT01614769|558964778|FG002|Period 1|Withdrawal by Subject|0|||
154873946|NCT01614769|558964779|FG003|Period 1|Withdrawal by Subject|0|||
154873947|NCT01614769|558964780|FG004|Period 1|Withdrawal by Subject|0|||
154873948|NCT01614769|558964781|FG005|Period 1|Withdrawal by Subject|0|||
154873949|NCT01614769|558964776|FG000|Period 3|Withdrawal by Subject|0|||
154873950|NCT01614769|558964777|FG001|Period 3|Withdrawal by Subject|0|||
154873951|NCT01614769|558964778|FG002|Period 3|Withdrawal by Subject|1|||
154873952|NCT01614769|558964779|FG003|Period 3|Withdrawal by Subject|0|||
154873953|NCT01614769|558964780|FG004|Period 3|Withdrawal by Subject|0|||
154873954|NCT01614769|558964781|FG005|Period 3|Withdrawal by Subject|0|||
154873955|NCT02115815|558964782|FG000|Overall Study|Withdrawal by Subject|2|||
154873956|NCT02115815|558964783|FG001|Overall Study|Withdrawal by Subject|0|||
154873957|NCT02115815|558964784|FG002|Overall Study|Withdrawal by Subject|0|||
154873958|NCT02115815|558964785|FG003|Overall Study|Withdrawal by Subject|0|||
154873959|NCT02115815|558964786|FG004|Overall Study|Withdrawal by Subject|0|||
154873960|NCT02115815|558964787|FG005|Overall Study|Withdrawal by Subject|0|||
154873961|NCT02115815|558964788|FG006|Overall Study|Withdrawal by Subject|0|||
154873962|NCT02115815|558964782|FG000|Overall Study|Not enough drug to dose participant|0|||
154873963|NCT02115815|558964783|FG001|Overall Study|Not enough drug to dose participant|0|||
154873964|NCT02115815|558964784|FG002|Overall Study|Not enough drug to dose participant|0|||
154873965|NCT02115815|558964785|FG003|Overall Study|Not enough drug to dose participant|0|||
154873966|NCT02115815|558964786|FG004|Overall Study|Not enough drug to dose participant|0|||
154873967|NCT02115815|558964787|FG005|Overall Study|Not enough drug to dose participant|1|||
154873968|NCT02115815|558964788|FG006|Overall Study|Not enough drug to dose participant|0|||
154873969|NCT02115815|558964782|FG000|Overall Study|Missed appointment, randomized in error|0|||
154873970|NCT02115815|558964783|FG001|Overall Study|Missed appointment, randomized in error|0|||
154873971|NCT02115815|558964784|FG002|Overall Study|Missed appointment, randomized in error|0|||
154873972|NCT02115815|558964785|FG003|Overall Study|Missed appointment, randomized in error|0|||
154873973|NCT02115815|558964786|FG004|Overall Study|Missed appointment, randomized in error|0|||
154873974|NCT02115815|558964787|FG005|Overall Study|Missed appointment, randomized in error|1|||
154873975|NCT02115815|558964788|FG006|Overall Study|Missed appointment, randomized in error|0|||
154873976|NCT01228071|558964789|FG000|Overall Study|Protocol Violation|1|||
154873977|NCT01228071|558964789|FG000|Overall Study|Withdrawal by Subject|1|||
154873978|NCT01989546|558964790|FG000|Overall Study|Clinical Progression|1|||
154873979|NCT01989546|558964790|FG000|Overall Study|Disease progression on study|8|||
154873980|NCT02819310|558964793|FG000|Overall Study|Withdrawal by Subject|37|||
154873981|NCT02819310|558964793|FG000|Overall Study|Lost to Follow-up|16|||
154873982|NCT02819310|558964793|FG000|Overall Study|Adverse Event|13|||
154873983|NCT02819310|558964793|FG000|Overall Study|Lack of Efficacy|5|||
154873984|NCT02819310|558964793|FG000|Overall Study|Physician Decision|8|||
154873985|NCT02819310|558964793|FG000|Overall Study|Protocol Violation|30|||
154873986|NCT01793051|558964798|FG000|Overall Study|Withdrawal by Subject|6|||
154873987|NCT01793051|558964799|FG001|Overall Study|Withdrawal by Subject|4|||
154873988|NCT01793051|558964798|FG000|Overall Study|Adverse Event|0|||
154873989|NCT01793051|558964799|FG001|Overall Study|Adverse Event|2|||
154873990|NCT01793051|558964798|FG000|Overall Study|Too ill to continue|1|||
154873991|NCT01793051|558964799|FG001|Overall Study|Too ill to continue|0|||
154873992|NCT01793051|558964798|FG000|Overall Study|Switched chemo|1|||
154873993|NCT01793051|558964799|FG001|Overall Study|Switched chemo|1|||
154873994|NCT01793051|558964798|FG000|Overall Study|Lack of compliance|1|||
154873995|NCT01793051|558964799|FG001|Overall Study|Lack of compliance|0|||
154873996|NCT01793051|558964798|FG000|Overall Study|Requested to be removed from the study|1|||
154873997|NCT01793051|558964799|FG001|Overall Study|Requested to be removed from the study|1|||
154873998|NCT00059215|558964802|FG000|Overall Study|Adverse Event|5|||
154873999|NCT00059215|558964803|FG001|Overall Study|Adverse Event|5|||
154874000|NCT00059215|558964804|FG002|Overall Study|Adverse Event|9|||
154874001|NCT00059215|558964805|FG003|Overall Study|Adverse Event|9|||
154874002|NCT00059215|558964802|FG000|Overall Study|Death|0|||
154874003|NCT00059215|558964803|FG001|Overall Study|Death|0|||
154874004|NCT00059215|558964804|FG002|Overall Study|Death|3|||
154874005|NCT00059215|558964805|FG003|Overall Study|Death|0|||
154874006|NCT00059215|558964802|FG000|Overall Study|Lost to Follow-up|1|||
154874007|NCT00059215|558964803|FG001|Overall Study|Lost to Follow-up|2|||
154874008|NCT00059215|558964804|FG002|Overall Study|Lost to Follow-up|0|||
154874009|NCT00059215|558964805|FG003|Overall Study|Lost to Follow-up|0|||
154874010|NCT00059215|558964802|FG000|Overall Study|Withdrawal by Subject|4|||
154874011|NCT00059215|558964803|FG001|Overall Study|Withdrawal by Subject|4|||
154874012|NCT00059215|558964804|FG002|Overall Study|Withdrawal by Subject|1|||
154874013|NCT00059215|558964805|FG003|Overall Study|Withdrawal by Subject|3|||
154874014|NCT00059215|558964802|FG000|Overall Study|Protocol Violation|1|||
154874015|NCT00059215|558964803|FG001|Overall Study|Protocol Violation|0|||
154874016|NCT00059215|558964804|FG002|Overall Study|Protocol Violation|1|||
154874017|NCT00059215|558964805|FG003|Overall Study|Protocol Violation|0|||
154874018|NCT00059215|558964802|FG000|Overall Study|Protocol entry criteria not met|1|||
154874019|NCT00059215|558964803|FG001|Overall Study|Protocol entry criteria not met|1|||
154874020|NCT00059215|558964804|FG002|Overall Study|Protocol entry criteria not met|0|||
154874021|NCT00059215|558964805|FG003|Overall Study|Protocol entry criteria not met|2|||
154874022|NCT00059215|558964802|FG000|Overall Study|Physician Decision|1|||
154874023|NCT00059215|558964803|FG001|Overall Study|Physician Decision|2|||
154874024|NCT00059215|558964804|FG002|Overall Study|Physician Decision|1|||
154874025|NCT00059215|558964805|FG003|Overall Study|Physician Decision|1|||
154874026|NCT04439838|558964806|FG000|Overall Study|Withdrawal by Subject|0|||
154874027|NCT04439838|558964807|FG001|Overall Study|Withdrawal by Subject|0|||
154874028|NCT04439838|558964808|FG002|Overall Study|Withdrawal by Subject|0|||
154874029|NCT04439838|558964809|FG003|Overall Study|Withdrawal by Subject|0|||
154874030|NCT04439838|558964810|FG004|Overall Study|Withdrawal by Subject|0|||
154874031|NCT04439838|558964811|FG005|Overall Study|Withdrawal by Subject|0|||
154874032|NCT04439838|558964812|FG006|Overall Study|Withdrawal by Subject|0|||
154874033|NCT04439838|558964813|FG007|Overall Study|Withdrawal by Subject|0|||
154874034|NCT04439838|558964814|FG008|Overall Study|Withdrawal by Subject|1|||
154874035|NCT01958671|558964819|FG000|Overall Study|Adverse Event|1|||
154874036|NCT01958671|558964820|FG001|Overall Study|Adverse Event|1|||
154874037|NCT01958671|558964821|FG002|Overall Study|Adverse Event|5|||
154874038|NCT01958671|558964819|FG000|Overall Study|Death|1|||
154874039|NCT01958671|558964820|FG001|Overall Study|Death|0|||
154874040|NCT01958671|558964821|FG002|Overall Study|Death|0|||
154874041|NCT01958671|558964819|FG000|Overall Study|Excluded medication|0|||
154874042|NCT01958671|558964820|FG001|Overall Study|Excluded medication|0|||
154874043|NCT01958671|558964821|FG002|Overall Study|Excluded medication|1|||
154874044|NCT01958671|558964819|FG000|Overall Study|Hyperglycemia|0|||
154874045|NCT01958671|558964820|FG001|Overall Study|Hyperglycemia|0|||
154874046|NCT01958671|558964821|FG002|Overall Study|Hyperglycemia|2|||
154874047|NCT01958671|558964819|FG000|Overall Study|Lost to Follow-up|7|||
154874048|NCT01958671|558964820|FG001|Overall Study|Lost to Follow-up|11|||
154874049|NCT01958671|558964821|FG002|Overall Study|Lost to Follow-up|7|||
154874050|NCT01958671|558964819|FG000|Overall Study|Non-compliance with study drug|1|||
154874051|NCT01958671|558964820|FG001|Overall Study|Non-compliance with study drug|1|||
154874052|NCT01958671|558964821|FG002|Overall Study|Non-compliance with study drug|1|||
154874053|NCT01958671|558964819|FG000|Overall Study|Pregnancy|0|||
154874054|NCT01958671|558964820|FG001|Overall Study|Pregnancy|0|||
154874055|NCT01958671|558964821|FG002|Overall Study|Pregnancy|1|||
154874056|NCT01958671|558964819|FG000|Overall Study|Protocol Violation|0|||
154874057|NCT01958671|558964820|FG001|Overall Study|Protocol Violation|1|||
154874058|NCT01958671|558964821|FG002|Overall Study|Protocol Violation|0|||
154874059|NCT01958671|558964819|FG000|Overall Study|Study site terminated by sponsor|1|||
154874060|NCT01958671|558964820|FG001|Overall Study|Study site terminated by sponsor|0|||
154874061|NCT01958671|558964821|FG002|Overall Study|Study site terminated by sponsor|1|||
154874062|NCT01958671|558964819|FG000|Overall Study|Participant moved|0|||
154874063|NCT01958671|558964820|FG001|Overall Study|Participant moved|0|||
154874064|NCT01958671|558964821|FG002|Overall Study|Participant moved|1|||
154874065|NCT01958671|558964819|FG000|Overall Study|Withdrawal by Subject|8|||
154874066|NCT01958671|558964820|FG001|Overall Study|Withdrawal by Subject|10|||
154874067|NCT01958671|558964821|FG002|Overall Study|Withdrawal by Subject|13|||
154874068|NCT02778867|558964822|FG000|Phase 1|Withdrawal by Subject|2|||
154874069|NCT02778867|558964823|FG001|Phase 1|Withdrawal by Subject|3|||
154874070|NCT02778867|558964824|FG002|Phase 1|Withdrawal by Subject|0|||
154874071|NCT02778867|558964825|FG003|Phase 1|Withdrawal by Subject|0|||
154874072|NCT02778867|558964822|FG000|Phase 2|Withdrawal by Subject|0|||
154874073|NCT02778867|558964823|FG001|Phase 2|Withdrawal by Subject|0|||
154874074|NCT02778867|558964824|FG002|Phase 2|Withdrawal by Subject|1|||
154874075|NCT02778867|558964825|FG003|Phase 2|Withdrawal by Subject|0|||
154874076|NCT02778867|558964822|FG000|Phase 2|Physician Decision|0|||
154874077|NCT02778867|558964823|FG001|Phase 2|Physician Decision|0|||
154874078|NCT02778867|558964824|FG002|Phase 2|Physician Decision|0|||
154874079|NCT02778867|558964825|FG003|Phase 2|Physician Decision|1|||
154874080|NCT02778867|558964822|FG000|Phase 2|Adverse Event|0|||
154874081|NCT02778867|558964823|FG001|Phase 2|Adverse Event|0|||
154874082|NCT02778867|558964824|FG002|Phase 2|Adverse Event|0|||
154874083|NCT02778867|558964825|FG003|Phase 2|Adverse Event|1|||
154874084|NCT02948777|558964826|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
154874085|NCT03242928|558964828|FG000|Overall Study|Adverse Event|2|||
154874086|NCT03242928|558964829|FG001|Overall Study|Adverse Event|1|||
154874087|NCT03242928|558964828|FG000|Overall Study|Lost to Follow-up|2|||
154874088|NCT03242928|558964829|FG001|Overall Study|Lost to Follow-up|0|||
154874089|NCT03242928|558964828|FG000|Overall Study|Physician Decision|0|||
154874090|NCT03242928|558964829|FG001|Overall Study|Physician Decision|1|||
154874091|NCT03242928|558964828|FG000|Overall Study|Withdrawal by Subject|5|||
154874092|NCT03242928|558964829|FG001|Overall Study|Withdrawal by Subject|3|||
154874093|NCT00960440|558964830|FG000|Overall Study|Death|0|||
154874094|NCT00960440|558964831|FG001|Overall Study|Death|0|||
154874095|NCT00960440|558964832|FG002|Overall Study|Death|0|||
154874096|NCT00960440|558964833|FG003|Overall Study|Death|1|||
154874097|NCT00960440|558964830|FG000|Overall Study|Adverse Event|12|||
154874098|NCT00960440|558964831|FG001|Overall Study|Adverse Event|12|||
154874099|NCT00960440|558964832|FG002|Overall Study|Adverse Event|4|||
154874100|NCT00960440|558964833|FG003|Overall Study|Adverse Event|4|||
154874101|NCT00960440|558964830|FG000|Overall Study|Lack of Efficacy|2|||
154874102|NCT00960440|558964831|FG001|Overall Study|Lack of Efficacy|5|||
154874103|NCT00960440|558964832|FG002|Overall Study|Lack of Efficacy|3|||
154874104|NCT00960440|558964833|FG003|Overall Study|Lack of Efficacy|8|||
154874105|NCT00960440|558964830|FG000|Overall Study|Protocol Violation|2|||
154874106|NCT00960440|558964831|FG001|Overall Study|Protocol Violation|8|||
154874107|NCT00960440|558964832|FG002|Overall Study|Protocol Violation|3|||
154874108|NCT00960440|558964833|FG003|Overall Study|Protocol Violation|4|||
154874109|NCT00960440|558964830|FG000|Overall Study|Withdrawal by Subject|9|||
154874110|NCT00960440|558964831|FG001|Overall Study|Withdrawal by Subject|5|||
154874111|NCT00960440|558964832|FG002|Overall Study|Withdrawal by Subject|2|||
154874112|NCT00960440|558964833|FG003|Overall Study|Withdrawal by Subject|1|||
154874113|NCT00960440|558964830|FG000|Overall Study|Other|1|||
154874114|NCT00960440|558964831|FG001|Overall Study|Other|1|||
154874115|NCT00960440|558964832|FG002|Overall Study|Other|1|||
154874116|NCT00960440|558964833|FG003|Overall Study|Other|0|||
154874117|NCT03504774|558964837|FG000|Overall Study|Adverse Event|2|||
154874118|NCT03504774|558964838|FG001|Overall Study|Adverse Event|0|||
154874119|NCT03504774|558964837|FG000|Overall Study|Lost to Follow-up|0|||
154874120|NCT03504774|558964838|FG001|Overall Study|Lost to Follow-up|1|||
154874121|NCT03504774|558964837|FG000|Overall Study|Protocol Violation|11|||
154874122|NCT03504774|558964838|FG001|Overall Study|Protocol Violation|3|||
154874123|NCT03504774|558964837|FG000|Overall Study|failed wk 52 DBPCFC|1|||
154874124|NCT03504774|558964838|FG001|Overall Study|failed wk 52 DBPCFC|0|||
154874125|NCT00625365|558964839|FG000|Overall Study|Withdrawal by Subject|1|||
154874126|NCT00625365|558964839|FG000|Overall Study|No IV access|5|||
154874127|NCT00625365|558964839|FG000|Overall Study|VSD|1|||
154874128|NCT01781429|558964840|FG000|Overall Study|Death|0|||
154874129|NCT01781429|558964841|FG001|Overall Study|Death|0|||
154874130|NCT01781429|558964842|FG002|Overall Study|Death|0|||
154874131|NCT01781429|558964843|FG003|Overall Study|Death|0|||
154874132|NCT01781429|558964844|FG004|Overall Study|Death|0|||
154874133|NCT01781429|558964845|FG005|Overall Study|Death|0|||
154874134|NCT01781429|558964846|FG006|Overall Study|Death|0|||
155175329|NCT00603590|560080221|FG000|Overall Study|Adverse Event|2|||
154874135|NCT01781429|558964847|FG007|Overall Study|Death|0|||
154874136|NCT01781429|558964848|FG008|Overall Study|Death|0|||
154874137|NCT01781429|558964849|FG009|Overall Study|Death|1|||
154874138|NCT01781429|558964850|FG010|Overall Study|Death|0|||
154874139|NCT01781429|558964851|FG011|Overall Study|Death|0|||
154874140|NCT01781429|558964852|FG012|Overall Study|Death|1|||
154874141|NCT01781429|558964853|FG013|Overall Study|Death|0|||
154874142|NCT01781429|558964854|FG014|Overall Study|Death|1|||
155175330|NCT00603590|560080222|FG001|Overall Study|Adverse Event|0|||
154874143|NCT01781429|558964855|FG015|Overall Study|Death|0|||
154874144|NCT01781429|558964840|FG000|Overall Study|Withdrawal by Subject|0|||
154874145|NCT01781429|558964841|FG001|Overall Study|Withdrawal by Subject|0|||
154874146|NCT01781429|558964842|FG002|Overall Study|Withdrawal by Subject|0|||
154874147|NCT01781429|558964843|FG003|Overall Study|Withdrawal by Subject|0|||
154874148|NCT01781429|558964844|FG004|Overall Study|Withdrawal by Subject|0|||
154874149|NCT01781429|558964845|FG005|Overall Study|Withdrawal by Subject|0|||
155175331|NCT00603590|560080221|FG000|Overall Study|Lost to Follow-up|8|||
154874150|NCT01781429|558964846|FG006|Overall Study|Withdrawal by Subject|0|||
154874151|NCT01781429|558964847|FG007|Overall Study|Withdrawal by Subject|0|||
154874152|NCT01781429|558964848|FG008|Overall Study|Withdrawal by Subject|1|||
154874153|NCT01781429|558964849|FG009|Overall Study|Withdrawal by Subject|3|||
154874154|NCT01781429|558964850|FG010|Overall Study|Withdrawal by Subject|1|||
154874155|NCT01781429|558964851|FG011|Overall Study|Withdrawal by Subject|1|||
154874156|NCT01781429|558964852|FG012|Overall Study|Withdrawal by Subject|5|||
154874157|NCT01781429|558964853|FG013|Overall Study|Withdrawal by Subject|2|||
154874158|NCT01781429|558964854|FG014|Overall Study|Withdrawal by Subject|3|||
154874159|NCT01781429|558964855|FG015|Overall Study|Withdrawal by Subject|0|||
154874160|NCT01781429|558964840|FG000|Overall Study|Disease Progression|1|||
154874161|NCT01781429|558964841|FG001|Overall Study|Disease Progression|0|||
154874162|NCT01781429|558964842|FG002|Overall Study|Disease Progression|1|||
154874163|NCT01781429|558964843|FG003|Overall Study|Disease Progression|1|||
154874164|NCT01781429|558964844|FG004|Overall Study|Disease Progression|1|||
154874165|NCT01781429|558964845|FG005|Overall Study|Disease Progression|4|||
154874166|NCT01781429|558964846|FG006|Overall Study|Disease Progression|7|||
154874167|NCT01781429|558964847|FG007|Overall Study|Disease Progression|4|||
154874168|NCT01781429|558964848|FG008|Overall Study|Disease Progression|6|||
154874169|NCT01781429|558964849|FG009|Overall Study|Disease Progression|15|||
154874170|NCT01781429|558964850|FG010|Overall Study|Disease Progression|15|||
154874171|NCT01781429|558964851|FG011|Overall Study|Disease Progression|15|||
154874172|NCT01781429|558964852|FG012|Overall Study|Disease Progression|15|||
154874173|NCT01781429|558964853|FG013|Overall Study|Disease Progression|4|||
154874174|NCT01781429|558964854|FG014|Overall Study|Disease Progression|11|||
154874175|NCT01781429|558964855|FG015|Overall Study|Disease Progression|0|||
154874176|NCT01781429|558964840|FG000|Overall Study|Unacceptable Toxicity|0|||
154874177|NCT01781429|558964841|FG001|Overall Study|Unacceptable Toxicity|0|||
154874178|NCT01781429|558964842|FG002|Overall Study|Unacceptable Toxicity|0|||
154874179|NCT01781429|558964843|FG003|Overall Study|Unacceptable Toxicity|0|||
154874180|NCT01781429|558964844|FG004|Overall Study|Unacceptable Toxicity|0|||
154874181|NCT01781429|558964845|FG005|Overall Study|Unacceptable Toxicity|0|||
154874182|NCT01781429|558964846|FG006|Overall Study|Unacceptable Toxicity|0|||
154874183|NCT01781429|558964847|FG007|Overall Study|Unacceptable Toxicity|0|||
154874184|NCT01781429|558964848|FG008|Overall Study|Unacceptable Toxicity|0|||
154874185|NCT01781429|558964849|FG009|Overall Study|Unacceptable Toxicity|0|||
154874186|NCT01781429|558964850|FG010|Overall Study|Unacceptable Toxicity|0|||
154874187|NCT01781429|558964851|FG011|Overall Study|Unacceptable Toxicity|2|||
154874188|NCT01781429|558964852|FG012|Overall Study|Unacceptable Toxicity|0|||
154874189|NCT01781429|558964853|FG013|Overall Study|Unacceptable Toxicity|0|||
154874190|NCT01781429|558964854|FG014|Overall Study|Unacceptable Toxicity|0|||
154874191|NCT01781429|558964855|FG015|Overall Study|Unacceptable Toxicity|0|||
154874192|NCT01781429|558964840|FG000|Overall Study|Patient Condition Changed|0|||
154874193|NCT01781429|558964841|FG001|Overall Study|Patient Condition Changed|0|||
154874194|NCT01781429|558964842|FG002|Overall Study|Patient Condition Changed|0|||
154874195|NCT01781429|558964843|FG003|Overall Study|Patient Condition Changed|0|||
154874196|NCT01781429|558964844|FG004|Overall Study|Patient Condition Changed|0|||
154874197|NCT01781429|558964845|FG005|Overall Study|Patient Condition Changed|0|||
154874198|NCT01781429|558964846|FG006|Overall Study|Patient Condition Changed|0|||
154874199|NCT01781429|558964847|FG007|Overall Study|Patient Condition Changed|0|||
154874200|NCT01781429|558964848|FG008|Overall Study|Patient Condition Changed|0|||
154874201|NCT01781429|558964849|FG009|Overall Study|Patient Condition Changed|4|||
154874202|NCT01781429|558964850|FG010|Overall Study|Patient Condition Changed|0|||
154874203|NCT01781429|558964851|FG011|Overall Study|Patient Condition Changed|1|||
154874204|NCT01781429|558964852|FG012|Overall Study|Patient Condition Changed|0|||
154874205|NCT01781429|558964853|FG013|Overall Study|Patient Condition Changed|1|||
154874206|NCT01781429|558964854|FG014|Overall Study|Patient Condition Changed|0|||
154874207|NCT01781429|558964855|FG015|Overall Study|Patient Condition Changed|0|||
154874208|NCT01781429|558964840|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
154874209|NCT01781429|558964841|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
155111905|NCT01205061|559838499|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
155111906|NCT01205061|559838499|FG000|Overall Study|Lost to Follow-up|9|||
155111907|NCT01205061|559838499|FG000|Overall Study|Other|1|||
154874210|NCT01781429|558964842|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
154874211|NCT01781429|558964843|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
154874212|NCT01781429|558964844|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
154874213|NCT01781429|558964845|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
154874214|NCT01781429|558964846|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
154874215|NCT01781429|558964847|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
154874216|NCT01781429|558964848|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
154874217|NCT01781429|558964849|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
154874218|NCT01781429|558964850|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
154874219|NCT01781429|558964851|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
154874220|NCT01781429|558964852|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
154874221|NCT01781429|558964853|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
154874222|NCT01781429|558964854|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
154874223|NCT01781429|558964855|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
154874224|NCT01781429|558964840|FG000|Overall Study|Enrolled, but not treated|0|||
154874225|NCT01781429|558964841|FG001|Overall Study|Enrolled, but not treated|0|||
154874226|NCT01781429|558964842|FG002|Overall Study|Enrolled, but not treated|0|||
154874227|NCT01781429|558964843|FG003|Overall Study|Enrolled, but not treated|0|||
154874228|NCT01781429|558964844|FG004|Overall Study|Enrolled, but not treated|0|||
154874229|NCT01781429|558964845|FG005|Overall Study|Enrolled, but not treated|0|||
154874230|NCT01781429|558964846|FG006|Overall Study|Enrolled, but not treated|0|||
154874231|NCT01781429|558964847|FG007|Overall Study|Enrolled, but not treated|0|||
154874232|NCT01781429|558964848|FG008|Overall Study|Enrolled, but not treated|0|||
154874233|NCT01781429|558964849|FG009|Overall Study|Enrolled, but not treated|0|||
154874234|NCT01781429|558964850|FG010|Overall Study|Enrolled, but not treated|1|||
154874235|NCT01781429|558964851|FG011|Overall Study|Enrolled, but not treated|0|||
154874236|NCT01781429|558964852|FG012|Overall Study|Enrolled, but not treated|0|||
154874237|NCT01781429|558964853|FG013|Overall Study|Enrolled, but not treated|0|||
154874238|NCT01781429|558964854|FG014|Overall Study|Enrolled, but not treated|0|||
154874239|NCT01781429|558964855|FG015|Overall Study|Enrolled, but not treated|0|||
154874240|NCT01703286|558964857|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
154874241|NCT01703286|558964858|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
154874242|NCT01703286|558964859|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
154874243|NCT01703286|558964860|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
154874244|NCT01703286|558964861|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
154874245|NCT01703286|558964862|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
154874246|NCT01703286|558964857|FG000|Period 2 Including Washout|Adverse Event|0|||
154874247|NCT01703286|558964858|FG001|Period 2 Including Washout|Adverse Event|0|||
154874248|NCT01703286|558964859|FG002|Period 2 Including Washout|Adverse Event|0|||
154874249|NCT01703286|558964860|FG003|Period 2 Including Washout|Adverse Event|1|||
154874250|NCT01703286|558964861|FG004|Period 2 Including Washout|Adverse Event|0|||
154874251|NCT01703286|558964862|FG005|Period 2 Including Washout|Adverse Event|0|||
154874252|NCT00931892|558964863|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
154874253|NCT00931892|558964864|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
154874254|NCT02207530|558964867|FG000|Overall Study|Worsening condition under investigation|78|||
154874255|NCT02207530|558964867|FG000|Overall Study|Patient decision to stop study treatment|5|||
154874256|NCT02207530|558964867|FG000|Overall Study|Adverse Event|8|||
154874257|NCT06094296|558964870|FG000|Overall Study|Progressive Disease|1|||
154874258|NCT06094296|558964871|FG001|Overall Study|Progressive Disease|0|||
154874259|NCT06094296|558964872|FG002|Overall Study|Progressive Disease|0|||
154874260|NCT06094296|558964873|FG003|Overall Study|Progressive Disease|0|||
154874261|NCT00986258|558964874|FG000|Observation Period|Not eligible to be dosed|11|||
154874262|NCT00986258|558964874|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
154874263|NCT00986258|558964874|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
154874264|NCT00986258|558964874|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
154874265|NCT00986258|558964874|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
154874266|NCT00986258|558964874|FG000|Titration and Optimal Dose Period|Other|1|||
154874267|NCT00986258|558964874|FG000|Maintenance Period|Adverse Event|5|||
154874268|NCT00986258|558964874|FG000|Maintenance Period|Lack of Efficacy|2|||
154874269|NCT00986258|558964874|FG000|Maintenance Period|Withdrawal by Subject|2|||
154874270|NCT03332667|558964875|FG000|Overall Study|Adverse Event|0|||
154874271|NCT03332667|558964876|FG001|Overall Study|Adverse Event|0|||
154874272|NCT03332667|558964877|FG002|Overall Study|Adverse Event|2|||
154874273|NCT03332667|558964878|FG003|Overall Study|Adverse Event|1|||
154874274|NCT03332667|558964875|FG000|Overall Study|Withdrawal by Subject|2|||
154874275|NCT03332667|558964876|FG001|Overall Study|Withdrawal by Subject|1|||
154874276|NCT03332667|558964877|FG002|Overall Study|Withdrawal by Subject|5|||
154874277|NCT03332667|558964878|FG003|Overall Study|Withdrawal by Subject|1|||
154874278|NCT03332667|558964875|FG000|Overall Study|Disease Progression or Relapse|2|||
154874279|NCT03332667|558964876|FG001|Overall Study|Disease Progression or Relapse|1|||
154874280|NCT03332667|558964877|FG002|Overall Study|Disease Progression or Relapse|3|||
154874281|NCT03332667|558964878|FG003|Overall Study|Disease Progression or Relapse|0|||
154874282|NCT03332667|558964875|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
154874283|NCT03332667|558964876|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
154874284|NCT03332667|558964877|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
154874285|NCT03332667|558964878|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
154874286|NCT03332667|558964875|FG000|Overall Study|No Treatment Received|0|||
154874287|NCT03332667|558964876|FG001|Overall Study|No Treatment Received|0|||
154874288|NCT03332667|558964877|FG002|Overall Study|No Treatment Received|1|||
154874289|NCT03332667|558964878|FG003|Overall Study|No Treatment Received|0|||
155111908|NCT01988662|559838504|FG000|Overall Study|Subject/guardian decision|1|||
154874290|NCT01035606|558964879|FG000|Overall Study|change in health, job demands,family|3|||
154874291|NCT01035606|558964880|FG001|Overall Study|change in health, job demands,family|3|||
154874292|NCT01035606|558964881|FG002|Overall Study|change in health, job demands,family|4|||
154874293|NCT01809262|558964882|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874294|NCT01809262|558964883|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874295|NCT01809262|558964884|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874296|NCT01809262|558964885|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874297|NCT01809262|558964886|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
154874298|NCT01809262|558964887|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874299|NCT01809262|558964888|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874300|NCT01809262|558964889|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874301|NCT01809262|558964890|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874302|NCT01809262|558964891|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
154874303|NCT01809262|558964882|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874304|NCT01809262|558964883|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
154874305|NCT01809262|558964884|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874306|NCT01809262|558964885|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874307|NCT01809262|558964886|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874308|NCT01809262|558964887|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874309|NCT01809262|558964888|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874310|NCT01809262|558964889|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874311|NCT01809262|558964890|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874312|NCT01809262|558964891|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
154874313|NCT01505491|558964892|FG000|Overall Study|Other reason not listed|1|||
154874314|NCT01505491|558964893|FG001|Overall Study|Other reason not listed|0|||
154874315|NCT01505491|558964894|FG002|Overall Study|Other reason not listed|0|||
154874316|NCT01505491|558964892|FG000|Overall Study|Withdrawal by Subject|1|||
154874317|NCT01505491|558964893|FG001|Overall Study|Withdrawal by Subject|1|||
154874318|NCT01505491|558964894|FG002|Overall Study|Withdrawal by Subject|4|||
154874319|NCT01505491|558964892|FG000|Overall Study|Lost to Follow-up|0|||
154874320|NCT01505491|558964893|FG001|Overall Study|Lost to Follow-up|0|||
154874321|NCT01505491|558964894|FG002|Overall Study|Lost to Follow-up|1|||
154874322|NCT01797783|558964898|FG000|Overall Study|Adverse Event|1|||
154874323|NCT01797783|558964899|FG001|Overall Study|Adverse Event|1|||
154874324|NCT01797783|558964898|FG000|Overall Study|Withdrawal by Subject|1|||
154874325|NCT01797783|558964899|FG001|Overall Study|Withdrawal by Subject|0|||
154874326|NCT00431847|558964903|FG000|Overall Study|completion of less than two study visits|6|||
154874327|NCT00431847|558964904|FG001|Overall Study|completion of less than two study visits|3|||
154874328|NCT00431847|558964905|FG002|Overall Study|completion of less than two study visits|4|||
154874329|NCT00431847|558964906|FG003|Overall Study|completion of less than two study visits|14|||
154874330|NCT00431847|558964907|FG004|Overall Study|completion of less than two study visits|0|||
154874331|NCT00431847|558964903|FG000|Overall Study|Protocol Violation|0|||
154874332|NCT00431847|558964904|FG001|Overall Study|Protocol Violation|0|||
154874333|NCT00431847|558964905|FG002|Overall Study|Protocol Violation|0|||
154874334|NCT00431847|558964906|FG003|Overall Study|Protocol Violation|0|||
154874335|NCT00431847|558964907|FG004|Overall Study|Protocol Violation|1|||
154874336|NCT00339183|558964908|FG000|Overall Study|Adverse Event|5|||
154874337|NCT00339183|558964909|FG001|Overall Study|Adverse Event|3|||
154874338|NCT00339183|558964908|FG000|Overall Study|Withdrawal by Subject|16|||
154874339|NCT00339183|558964909|FG001|Overall Study|Withdrawal by Subject|19|||
154874340|NCT00339183|558964908|FG000|Overall Study|Physician Decision|2|||
154874341|NCT00339183|558964909|FG001|Overall Study|Physician Decision|4|||
154874342|NCT00339183|558964908|FG000|Overall Study|Lost to Follow-up|17|||
154874343|NCT00339183|558964909|FG001|Overall Study|Lost to Follow-up|17|||
154874344|NCT00339183|558964908|FG000|Overall Study|Protocol-specified criteria|12|||
154874345|NCT00339183|558964909|FG001|Overall Study|Protocol-specified criteria|8|||
154874346|NCT00339183|558964908|FG000|Overall Study|Missing reason|3|||
154974161|NCT01363011|559331191|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
154974162|NCT01363011|559331192|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
154974163|NCT02457819|559331193|FG000|Overall Study|reason not given|8|||
155175332|NCT00603590|560080222|FG001|Overall Study|Lost to Follow-up|4|||
154874347|NCT00339183|558964909|FG001|Overall Study|Missing reason|1|||
154874348|NCT00339183|558964908|FG000|Overall Study|Other|46|||
154874349|NCT00339183|558964909|FG001|Overall Study|Other|40|||
154874350|NCT00339183|558964908|FG000|Overall Study|Ongoing|20|||
154874351|NCT00339183|558964909|FG001|Overall Study|Ongoing|13|||
154874352|NCT00446446|558964910|FG000|Overall Study|Death|10|||
154874353|NCT00446446|558964910|FG000|Overall Study|Withdrawal by Subject|6|||
154874354|NCT00446446|558964910|FG000|Overall Study|Other|4|||
154874355|NCT00446446|558964910|FG000|Overall Study|Disease Progession|2|||
155175333|NCT00603590|560080221|FG000|Overall Study|Cardiovascular event|0|||
154874356|NCT00446446|558964910|FG000|Overall Study|Adverse Event|1|||
154874357|NCT00446446|558964910|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
154874358|NCT02142894|558964911|FG000|Overall Study|Protocol Violation|8|||
154874359|NCT01024465|558964917|FG000|Overall Study|Adverse Event|2|||
154874360|NCT01024465|558964917|FG000|Overall Study|Physician Decision|1|||
154874361|NCT03078608|558964920|FG000|Overall Study|Death|1|||
154874362|NCT03078608|558964921|FG001|Overall Study|Death|2|||
154874363|NCT03078608|558964922|FG002|Overall Study|Death|0|||
154874364|NCT03078608|558964923|FG003|Overall Study|Death|0|||
154874365|NCT03078608|558964920|FG000|Overall Study|Withdrawal by Subject|8|||
154874366|NCT03078608|558964921|FG001|Overall Study|Withdrawal by Subject|1|||
154874367|NCT03078608|558964922|FG002|Overall Study|Withdrawal by Subject|0|||
154874368|NCT03078608|558964923|FG003|Overall Study|Withdrawal by Subject|0|||
154874369|NCT03078608|558964920|FG000|Overall Study|Lost to Follow-up|5|||
154874370|NCT03078608|558964921|FG001|Overall Study|Lost to Follow-up|8|||
154874371|NCT03078608|558964922|FG002|Overall Study|Lost to Follow-up|4|||
154874372|NCT03078608|558964923|FG003|Overall Study|Lost to Follow-up|1|||
154874373|NCT01137435|558964924|FG000|Overall Study|Lost to Follow-up|24|||
154874374|NCT01137435|558964924|FG000|Overall Study|Off label usage|4|||
154874375|NCT00492921|558964925|FG000|Overall Study|Death|1|||
154874376|NCT00492921|558964926|FG001|Overall Study|Death|0|||
154874377|NCT00492921|558964927|FG002|Overall Study|Death|1|||
154874378|NCT00652093|558964928|FG000|Overall Study|Withdrawal by Subject|0|||
154874379|NCT00652093|558964929|FG001|Overall Study|Withdrawal by Subject|0|||
154874380|NCT00652093|558964930|FG002|Overall Study|Withdrawal by Subject|1|||
154874381|NCT00652093|558964931|FG003|Overall Study|Withdrawal by Subject|0|||
154874382|NCT00652093|558964932|FG004|Overall Study|Withdrawal by Subject|1|||
154874383|NCT00652093|558964933|FG005|Overall Study|Withdrawal by Subject|0|||
154874384|NCT00652093|558964928|FG000|Overall Study|Physician Decision|0|||
154874385|NCT00652093|558964929|FG001|Overall Study|Physician Decision|0|||
154874386|NCT00652093|558964930|FG002|Overall Study|Physician Decision|0|||
154874387|NCT00652093|558964931|FG003|Overall Study|Physician Decision|0|||
154874388|NCT00652093|558964932|FG004|Overall Study|Physician Decision|1|||
154874389|NCT00652093|558964933|FG005|Overall Study|Physician Decision|0|||
154874390|NCT00564629|558964936|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
154874391|NCT00564629|558964937|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
154874392|NCT03117049|558964942|FG000|Overall Study|Continued the follow-up period|109|||
154874393|NCT03117049|558964943|FG001|Overall Study|Continued the follow-up period|129|||
154874394|NCT03117049|558964942|FG000|Overall Study|Died|82|||
154874395|NCT03117049|558964943|FG001|Overall Study|Died|93|||
154874396|NCT03117049|558964942|FG000|Overall Study|Consent withdrawal|7|||
154874397|NCT03117049|558964943|FG001|Overall Study|Consent withdrawal|6|||
154874398|NCT03117049|558964942|FG000|Overall Study|Missing contact|3|||
154874399|NCT03117049|558964943|FG001|Overall Study|Missing contact|3|||
154874400|NCT00651118|558964944|FG000|Overall Study|Adverse Event|4|||
154874401|NCT00651118|558964945|FG001|Overall Study|Adverse Event|0|||
154874402|NCT00651118|558964946|FG002|Overall Study|Adverse Event|1|||
154874403|NCT00651118|558964947|FG003|Overall Study|Adverse Event|1|||
154874404|NCT00651118|558964944|FG000|Overall Study|Protocol Violation|2|||
154874405|NCT00651118|558964945|FG001|Overall Study|Protocol Violation|2|||
154874406|NCT00651118|558964946|FG002|Overall Study|Protocol Violation|6|||
154874407|NCT00651118|558964947|FG003|Overall Study|Protocol Violation|2|||
154874408|NCT00651118|558964944|FG000|Overall Study|Lost to Follow-up|2|||
154874409|NCT00651118|558964945|FG001|Overall Study|Lost to Follow-up|0|||
154974164|NCT02457819|559331193|FG000|Overall Study|Withdrawal by Subject|24|||
154974165|NCT02457819|559331193|FG000|Overall Study|Protocol Violation|1|||
154974166|NCT02457819|559331193|FG000|Overall Study|non compliance with study drug|4|||
154974167|NCT02457819|559331193|FG000|Overall Study|Lost to Follow-up|10|||
154974168|NCT02457819|559331193|FG000|Overall Study|Lack of Efficacy|19|||
154974169|NCT02457819|559331193|FG000|Overall Study|Adverse Event|33|||
154974170|NCT03330236|559331194|FG000|Overall Study|Death|2|||
154874410|NCT00651118|558964946|FG002|Overall Study|Lost to Follow-up|1|||
154874411|NCT00651118|558964947|FG003|Overall Study|Lost to Follow-up|2|||
154874412|NCT00651118|558964944|FG000|Overall Study|administrative|1|||
154874413|NCT00651118|558964945|FG001|Overall Study|administrative|4|||
154874414|NCT00651118|558964946|FG002|Overall Study|administrative|2|||
154874415|NCT00651118|558964947|FG003|Overall Study|administrative|1|||
154874416|NCT00651118|558964944|FG000|Overall Study|Withdrawal by Subject|0|||
154874417|NCT00651118|558964945|FG001|Overall Study|Withdrawal by Subject|1|||
154874418|NCT00651118|558964946|FG002|Overall Study|Withdrawal by Subject|1|||
154874419|NCT00651118|558964947|FG003|Overall Study|Withdrawal by Subject|1|||
154874420|NCT00839098|558964948|FG000|Overall Study|Withdrawal by Subject|2|||
154874421|NCT00839098|558964949|FG001|Overall Study|Withdrawal by Subject|1|||
154874422|NCT00839098|558964950|FG002|Overall Study|Withdrawal by Subject|7|||
154874423|NCT00365976|558964951|FG000|Overall Study|Withdrawal by Subject|1|||
154874424|NCT00365976|558964952|FG001|Overall Study|Withdrawal by Subject|5|||
154874425|NCT02190435|558964953|FG000|Overall Study|First 12 patients were lead-ins|12|||
154874426|NCT02190435|558964954|FG001|Overall Study|First 12 patients were lead-ins|0|||
154874427|NCT02190435|558964953|FG000|Overall Study|3 consented screen fails|3|||
154974171|NCT03330236|559331195|FG001|Overall Study|Death|1|||
154874428|NCT02190435|558964954|FG001|Overall Study|3 consented screen fails|0|||
154874429|NCT02399475|558964963|FG000|Overall Study|Physician Decision|1|||
154974172|NCT03330236|559331194|FG000|Overall Study|Withdrawal by Subject|2|||
154974173|NCT03330236|559331195|FG001|Overall Study|Withdrawal by Subject|4|||
154874430|NCT02399475|558964964|FG001|Overall Study|Physician Decision|0|||
154874431|NCT02260193|558964965|FG000|Overall Study|Lack of Efficacy|0|||
154974174|NCT03330236|559331194|FG000|Overall Study|Lost to Follow-up|0|||
154974175|NCT03330236|559331195|FG001|Overall Study|Lost to Follow-up|2|||
154974176|NCT03330236|559331194|FG000|Overall Study|Physician Decision|2|||
154974177|NCT03330236|559331195|FG001|Overall Study|Physician Decision|0|||
154974178|NCT03330236|559331194|FG000|Overall Study|Protocol Violation|4|||
154974179|NCT03330236|559331195|FG001|Overall Study|Protocol Violation|3|||
154974180|NCT03330236|559331194|FG000|Overall Study|SedLine malfunction/blinding|19|||
154974181|NCT03330236|559331195|FG001|Overall Study|SedLine malfunction/blinding|14|||
154974182|NCT03330236|559331194|FG000|Overall Study|Volatile anesthetics used|11|||
154974183|NCT03330236|559331195|FG001|Overall Study|Volatile anesthetics used|8|||
154974184|NCT03330236|559331194|FG000|Overall Study|Surgery aborted/converted to open|60|||
154974185|NCT03330236|559331195|FG001|Overall Study|Surgery aborted/converted to open|52|||
154974186|NCT00763555|559331196|FG000|Overall Study|Adverse Event|2|||
154974187|NCT00763555|559331197|FG001|Overall Study|Adverse Event|1|||
154974188|NCT00763555|559331196|FG000|Overall Study|Withdrawal by Subject|2|||
154974189|NCT00763555|559331197|FG001|Overall Study|Withdrawal by Subject|6|||
155111909|NCT01988662|559838505|FG001|Overall Study|Subject/guardian decision|1|||
155111910|NCT01988662|559838504|FG000|Overall Study|Adverse Event|3|||
155111911|NCT01988662|559838505|FG001|Overall Study|Adverse Event|1|||
155111912|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
155111913|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
155111914|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
155111915|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
155111916|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155111917|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
155111918|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
155111919|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
155111920|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
155111921|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
155111922|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
155111923|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
155111924|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
155111925|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
155111926|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
155111927|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
155111928|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
155111929|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
154874432|NCT02260193|558964966|FG001|Overall Study|Lack of Efficacy|1|||
154874433|NCT02260193|558964967|FG002|Overall Study|Lack of Efficacy|6|||
154874434|NCT02260193|558964965|FG000|Overall Study|Adverse Event|3|||
154874435|NCT02260193|558964966|FG001|Overall Study|Adverse Event|4|||
154874436|NCT02260193|558964967|FG002|Overall Study|Adverse Event|1|||
154874437|NCT02260193|558964965|FG000|Overall Study|Protocol Violation|0|||
154874438|NCT02260193|558964966|FG001|Overall Study|Protocol Violation|4|||
154874439|NCT02260193|558964967|FG002|Overall Study|Protocol Violation|0|||
154874440|NCT02260193|558964965|FG000|Overall Study|Withdrawal by Subject|3|||
154874441|NCT02260193|558964966|FG001|Overall Study|Withdrawal by Subject|0|||
154874442|NCT02260193|558964967|FG002|Overall Study|Withdrawal by Subject|2|||
154874443|NCT02260193|558964965|FG000|Overall Study|Kidney Transplantation|0|||
154874444|NCT02260193|558964966|FG001|Overall Study|Kidney Transplantation|0|||
154874445|NCT02260193|558964967|FG002|Overall Study|Kidney Transplantation|1|||
154874446|NCT01780389|558964968|FG000|Overall Study|Adverse Event|1|||
154874447|NCT00935220|558964969|FG000|Overall Study|Adverse Event|1|||
154874448|NCT00935220|558964969|FG000|Overall Study|Other reason (not specified)|1|||
154874449|NCT03625986|558966704|FG000|Randomization Period|Lost to Follow-up|7|||
154874450|NCT03625986|558966705|FG001|Randomization Period|Lost to Follow-up|12|||
154874451|NCT03625986|558966704|FG000|Randomization Period|Withdrawal by Subject|10|||
154874452|NCT03625986|558966705|FG001|Randomization Period|Withdrawal by Subject|6|||
155111930|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111931|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
154874453|NCT04359823|558966706|FG000|Overall Study|Lost to Follow-up|0|||
154874454|NCT04359823|558966707|FG001|Overall Study|Lost to Follow-up|1|||
154874455|NCT04359823|558966706|FG000|Overall Study|Withdrawal by Subject|0|||
154874456|NCT04359823|558966707|FG001|Overall Study|Withdrawal by Subject|1|||
154874457|NCT01850563|558966708|FG000|Overall Study|Not eligible|3|||
154874458|NCT01850563|558966709|FG001|Overall Study|Not eligible|0|||
154974190|NCT00763555|559331196|FG000|Overall Study|Lost to Follow-up|0|||
154874459|NCT02078713|558966710|FG000|Overall Study|Lost to Follow-up|49|||
154974191|NCT00763555|559331197|FG001|Overall Study|Lost to Follow-up|3|||
154974192|NCT00407745|559331198|FG000|Overall Study|Lack of Efficacy|1|||
154974193|NCT00407745|559331199|FG001|Overall Study|Lack of Efficacy|2|||
154974194|NCT00407745|559331198|FG000|Overall Study|Withdrawal by Subject|3|||
155111932|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111933|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111934|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111935|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111936|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
154874460|NCT02078713|558966711|FG001|Overall Study|Lost to Follow-up|55|||
154874461|NCT02078713|558966712|FG002|Overall Study|Lost to Follow-up|0|||
154874462|NCT02078713|558966713|FG003|Overall Study|Lost to Follow-up|0|||
154874463|NCT02078713|558966710|FG000|Overall Study|Pregnant at baseline|3|||
154874464|NCT02078713|558966711|FG001|Overall Study|Pregnant at baseline|5|||
154874465|NCT02078713|558966712|FG002|Overall Study|Pregnant at baseline|0|||
154874466|NCT02078713|558966713|FG003|Overall Study|Pregnant at baseline|0|||
154874467|NCT02078713|558966710|FG000|Overall Study|Enrolled twice|0|||
154874468|NCT02078713|558966711|FG001|Overall Study|Enrolled twice|1|||
154874469|NCT02078713|558966712|FG002|Overall Study|Enrolled twice|0|||
154874470|NCT02078713|558966713|FG003|Overall Study|Enrolled twice|0|||
154874471|NCT04494633|558966724|FG000|Overall Study|Lost to Follow-up|5|||
154874472|NCT04494633|558966725|FG001|Overall Study|Lost to Follow-up|3|||
154874473|NCT04494633|558966724|FG000|Overall Study|Protocol Violation|1|||
154874474|NCT04494633|558966725|FG001|Overall Study|Protocol Violation|1|||
154874475|NCT01254604|558966726|FG000|Overall Study|Lost to Follow-up|1|||
154874476|NCT01254604|558966727|FG001|Overall Study|Lost to Follow-up|1|||
154874477|NCT01254604|558966726|FG000|Overall Study|Protocol Violation|2|||
154874478|NCT01254604|558966727|FG001|Overall Study|Protocol Violation|2|||
154874479|NCT01254604|558966726|FG000|Overall Study|Withdrawal by Subject|2|||
154874480|NCT01254604|558966727|FG001|Overall Study|Withdrawal by Subject|4|||
154874481|NCT01254604|558966726|FG000|Overall Study|Adverse Event|3|||
154874482|NCT01254604|558966727|FG001|Overall Study|Adverse Event|2|||
154874483|NCT03074162|558966728|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
154874484|NCT03074162|558966729|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
154874485|NCT03074162|558966730|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
154874486|NCT03074162|558966731|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
154874487|NCT03074162|558966732|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
154874488|NCT03074162|558966733|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
154874489|NCT03074162|558966728|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
154874490|NCT03074162|558966729|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
154874491|NCT03074162|558966730|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
154874492|NCT03074162|558966731|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
154874493|NCT03074162|558966732|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
154874494|NCT03074162|558966733|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
154874495|NCT03074162|558966728|FG000|Period 3|Withdrawal by Subject|1|||
154874496|NCT03074162|558966729|FG001|Period 3|Withdrawal by Subject|0|||
154874497|NCT03074162|558966730|FG002|Period 3|Withdrawal by Subject|0|||
154874498|NCT03074162|558966731|FG003|Period 3|Withdrawal by Subject|0|||
154874499|NCT03074162|558966732|FG004|Period 3|Withdrawal by Subject|1|||
154874500|NCT03074162|558966733|FG005|Period 3|Withdrawal by Subject|0|||
154874501|NCT02421120|558966739|FG000|Overall Study|Adverse Event|1|||
154874502|NCT00273858|558966741|FG000|Overall Study|Not completed 24 month observation time|334|||
154874503|NCT00273858|558966741|FG000|Overall Study|Lost to Follow-up|101|||
154874504|NCT00273858|558966741|FG000|Overall Study|Withdrawal by Subject|21|||
154874505|NCT00273858|558966741|FG000|Overall Study|Adverse Event|81|||
154874506|NCT01070550|558966747|FG000|Overall Study|Adverse Event|43|||
154874507|NCT01070550|558966748|FG001|Overall Study|Adverse Event|1|||
154874508|NCT01070550|558966749|FG002|Overall Study|Adverse Event|3|||
154874509|NCT01070550|558966750|FG003|Overall Study|Adverse Event|0|||
154974195|NCT00407745|559331199|FG001|Overall Study|Withdrawal by Subject|3|||
154974196|NCT00407745|559331198|FG000|Overall Study|Protocol Violation|5|||
154974197|NCT00407745|559331199|FG001|Overall Study|Protocol Violation|3|||
154974198|NCT00407745|559331198|FG000|Overall Study|Adverse Event|8|||
154974199|NCT00407745|559331199|FG001|Overall Study|Adverse Event|8|||
154974200|NCT00407745|559331198|FG000|Overall Study|Other|2|||
154974201|NCT00407745|559331199|FG001|Overall Study|Other|0|||
154974202|NCT00407745|559331198|FG000|Overall Study|Randomized, unknown if treated|0|||
154974203|NCT00407745|559331199|FG001|Overall Study|Randomized, unknown if treated|1|||
154974204|NCT03449199|559331200|FG000|Overall Study|Lost to Follow-up|1|||
154974205|NCT03449199|559331201|FG001|Overall Study|Lost to Follow-up|1|||
154974206|NCT03449199|559331202|FG002|Overall Study|Lost to Follow-up|0|||
154974207|NCT03449199|559331200|FG000|Overall Study|Protocol Deviation|0|||
154974208|NCT03449199|559331201|FG001|Overall Study|Protocol Deviation|0|||
154874510|NCT01070550|558966751|FG004|Overall Study|Adverse Event|0|||
154874511|NCT01070550|558966752|FG005|Overall Study|Adverse Event|0|||
154874512|NCT01070550|558966747|FG000|Overall Study|Death|20|||
154874513|NCT01070550|558966748|FG001|Overall Study|Death|4|||
154974209|NCT03449199|559331202|FG002|Overall Study|Protocol Deviation|1|||
154974210|NCT03449199|559331200|FG000|Overall Study|Withdrawal by Subject|0|||
154974211|NCT03449199|559331201|FG001|Overall Study|Withdrawal by Subject|0|||
154974212|NCT03449199|559331202|FG002|Overall Study|Withdrawal by Subject|1|||
154974213|NCT01091103|559331203|FG000|Overall Study|Adverse Event|1|||
154874514|NCT01070550|558966749|FG002|Overall Study|Death|3|||
154874515|NCT01070550|558966750|FG003|Overall Study|Death|0|||
154874516|NCT01070550|558966751|FG004|Overall Study|Death|0|||
154874517|NCT01070550|558966752|FG005|Overall Study|Death|0|||
154974214|NCT01091103|559331203|FG000|Overall Study|Progressive Disease|3|||
155111937|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111938|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111939|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111940|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111941|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
155111942|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
155111943|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
155111944|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
155111945|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
155111946|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
155111947|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
155111948|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
155111949|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
155111950|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
155111951|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
155111952|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
155111953|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
155111954|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
155111955|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
155111956|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
155111957|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
155111958|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
155111959|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
155111960|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
155111961|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
155111962|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
155111963|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
155111964|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
155111965|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
155111966|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
155111967|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
155111968|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
155111969|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
155111970|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
155111971|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
155111972|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
155111973|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
155111974|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
155111975|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
155111976|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
154874518|NCT01070550|558966747|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
154874519|NCT01070550|558966748|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
154874520|NCT01070550|558966749|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
154874521|NCT01070550|558966750|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
154874522|NCT01070550|558966751|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
154874523|NCT01070550|558966752|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
154874524|NCT01070550|558966747|FG000|Overall Study|Early termination|3|||
154874525|NCT01070550|558966748|FG001|Overall Study|Early termination|0|||
154874526|NCT01070550|558966749|FG002|Overall Study|Early termination|0|||
154874527|NCT01070550|558966750|FG003|Overall Study|Early termination|0|||
154874528|NCT01070550|558966751|FG004|Overall Study|Early termination|0|||
154874529|NCT01070550|558966752|FG005|Overall Study|Early termination|0|||
154874530|NCT01070550|558966747|FG000|Overall Study|Failed to return|450|||
154874531|NCT01070550|558966748|FG001|Overall Study|Failed to return|33|||
155111977|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111978|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111979|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111980|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111981|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111982|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111983|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111984|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111985|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111986|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155111987|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
155111988|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
155175334|NCT00603590|560080222|FG001|Overall Study|Cardiovascular event|1|||
154874532|NCT01070550|558966749|FG002|Overall Study|Failed to return|144|||
154874533|NCT01070550|558966750|FG003|Overall Study|Failed to return|40|||
155111989|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
155111990|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
154874534|NCT01070550|558966751|FG004|Overall Study|Failed to return|1|||
154874535|NCT01070550|558966752|FG005|Overall Study|Failed to return|2|||
154874536|NCT01070550|558966747|FG000|Overall Study|Incomplete treatment|2|||
154874537|NCT01070550|558966748|FG001|Overall Study|Incomplete treatment|0|||
154874538|NCT01070550|558966749|FG002|Overall Study|Incomplete treatment|0|||
154874539|NCT01070550|558966750|FG003|Overall Study|Incomplete treatment|0|||
154874540|NCT01070550|558966751|FG004|Overall Study|Incomplete treatment|0|||
154874541|NCT01070550|558966752|FG005|Overall Study|Incomplete treatment|0|||
154874542|NCT01070550|558966747|FG000|Overall Study|Lab test not done|22|||
154874543|NCT01070550|558966748|FG001|Overall Study|Lab test not done|3|||
154874544|NCT01070550|558966749|FG002|Overall Study|Lab test not done|4|||
154874545|NCT01070550|558966750|FG003|Overall Study|Lab test not done|1|||
154874546|NCT01070550|558966751|FG004|Overall Study|Lab test not done|0|||
154874547|NCT01070550|558966752|FG005|Overall Study|Lab test not done|1|||
154874548|NCT01070550|558966747|FG000|Overall Study|Lack of Efficacy|65|||
154874549|NCT01070550|558966748|FG001|Overall Study|Lack of Efficacy|1|||
154874550|NCT01070550|558966749|FG002|Overall Study|Lack of Efficacy|5|||
154874551|NCT01070550|558966750|FG003|Overall Study|Lack of Efficacy|5|||
155111991|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111992|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111993|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111994|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111995|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111996|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111997|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111998|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155111999|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155112000|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155112001|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
155112002|NCT03831191|559838507|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112003|NCT03831191|559838508|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112004|NCT03831191|559838509|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112005|NCT03831191|559838510|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
155112006|NCT03831191|559838511|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112007|NCT03831191|559838512|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112008|NCT03831191|559838513|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112009|NCT03831191|559838514|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112010|NCT03831191|559838515|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112011|NCT03831191|559838516|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112012|NCT03831191|559838517|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112013|NCT03831191|559838518|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112014|NCT03831191|559838519|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112015|NCT03831191|559838520|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112016|NCT03831191|559838521|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
155112017|NCT03831191|559838507|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155112018|NCT03831191|559838508|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155112019|NCT03831191|559838509|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155112020|NCT03831191|559838510|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
155112021|NCT03831191|559838511|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
155112022|NCT03831191|559838512|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
155112023|NCT03831191|559838513|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
155112024|NCT03831191|559838514|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
155112025|NCT03831191|559838515|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
155112026|NCT03831191|559838516|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
155112027|NCT03831191|559838517|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
155112028|NCT03831191|559838518|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
155112029|NCT03831191|559838519|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
155112030|NCT03831191|559838520|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
155112031|NCT03831191|559838521|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
154874552|NCT01070550|558966751|FG004|Overall Study|Lack of Efficacy|0|||
155112032|NCT03831191|559838507|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112033|NCT03831191|559838508|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112034|NCT03831191|559838509|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112035|NCT03831191|559838510|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112036|NCT03831191|559838511|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
154874553|NCT01070550|558966752|FG005|Overall Study|Lack of Efficacy|1|||
154874554|NCT01070550|558966747|FG000|Overall Study|Miscellaneous|12|||
154874555|NCT01070550|558966748|FG001|Overall Study|Miscellaneous|2|||
154874556|NCT01070550|558966749|FG002|Overall Study|Miscellaneous|3|||
154874557|NCT01070550|558966750|FG003|Overall Study|Miscellaneous|1|||
155175335|NCT00910624|560080226|FG000|Treatment Phase|Adverse Event|2|||
154874558|NCT01070550|558966751|FG004|Overall Study|Miscellaneous|0|||
155112037|NCT03831191|559838512|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
154874559|NCT01070550|558966752|FG005|Overall Study|Miscellaneous|0|||
154874560|NCT01070550|558966747|FG000|Overall Study|New treatment started|3|||
154874561|NCT01070550|558966748|FG001|Overall Study|New treatment started|1|||
154874562|NCT01070550|558966749|FG002|Overall Study|New treatment started|0|||
154874563|NCT01070550|558966750|FG003|Overall Study|New treatment started|2|||
154874564|NCT01070550|558966751|FG004|Overall Study|New treatment started|0|||
154874565|NCT01070550|558966752|FG005|Overall Study|New treatment started|0|||
154874566|NCT01070550|558966747|FG000|Overall Study|Non-responders|493|||
154874567|NCT01070550|558966748|FG001|Overall Study|Non-responders|4|||
154874568|NCT01070550|558966749|FG002|Overall Study|Non-responders|21|||
154874569|NCT01070550|558966750|FG003|Overall Study|Non-responders|20|||
154874570|NCT01070550|558966751|FG004|Overall Study|Non-responders|0|||
154874571|NCT01070550|558966752|FG005|Overall Study|Non-responders|2|||
154874572|NCT01070550|558966747|FG000|Overall Study|Not categorized|33|||
154874573|NCT01070550|558966748|FG001|Overall Study|Not categorized|2|||
154874574|NCT01070550|558966749|FG002|Overall Study|Not categorized|6|||
154874575|NCT01070550|558966750|FG003|Overall Study|Not categorized|1|||
154874576|NCT01070550|558966751|FG004|Overall Study|Not categorized|0|||
154874577|NCT01070550|558966752|FG005|Overall Study|Not categorized|1|||
154874578|NCT01070550|558966747|FG000|Overall Study|Protocol Violation|15|||
154874579|NCT01070550|558966748|FG001|Overall Study|Protocol Violation|1|||
154874580|NCT01070550|558966749|FG002|Overall Study|Protocol Violation|1|||
154874581|NCT01070550|558966750|FG003|Overall Study|Protocol Violation|1|||
154874582|NCT01070550|558966751|FG004|Overall Study|Protocol Violation|0|||
154874583|NCT01070550|558966752|FG005|Overall Study|Protocol Violation|0|||
154874584|NCT01070550|558966747|FG000|Overall Study|Relapse|44|||
154874585|NCT01070550|558966748|FG001|Overall Study|Relapse|5|||
154874586|NCT01070550|558966749|FG002|Overall Study|Relapse|14|||
154874587|NCT01070550|558966750|FG003|Overall Study|Relapse|4|||
154874588|NCT01070550|558966751|FG004|Overall Study|Relapse|0|||
154874589|NCT01070550|558966752|FG005|Overall Study|Relapse|0|||
154874590|NCT01070550|558966747|FG000|Overall Study|Result not available|3|||
154874591|NCT01070550|558966748|FG001|Overall Study|Result not available|1|||
154874592|NCT01070550|558966749|FG002|Overall Study|Result not available|3|||
154874593|NCT01070550|558966750|FG003|Overall Study|Result not available|0|||
154874594|NCT01070550|558966751|FG004|Overall Study|Result not available|0|||
154874595|NCT01070550|558966752|FG005|Overall Study|Result not available|0|||
154874596|NCT01070550|558966747|FG000|Overall Study|Screen failure|1|||
154874597|NCT01070550|558966748|FG001|Overall Study|Screen failure|0|||
154874598|NCT01070550|558966749|FG002|Overall Study|Screen failure|0|||
154874599|NCT01070550|558966750|FG003|Overall Study|Screen failure|0|||
154874600|NCT01070550|558966751|FG004|Overall Study|Screen failure|0|||
154874601|NCT01070550|558966752|FG005|Overall Study|Screen failure|0|||
154874602|NCT01070550|558966747|FG000|Overall Study|Sponsor decision|1|||
154874603|NCT01070550|558966748|FG001|Overall Study|Sponsor decision|0|||
154874604|NCT01070550|558966749|FG002|Overall Study|Sponsor decision|0|||
154874605|NCT01070550|558966750|FG003|Overall Study|Sponsor decision|0|||
154874606|NCT01070550|558966751|FG004|Overall Study|Sponsor decision|0|||
154874607|NCT01070550|558966752|FG005|Overall Study|Sponsor decision|0|||
154874608|NCT01070550|558966747|FG000|Overall Study|Treatment duration shortened|1|||
154874609|NCT01070550|558966748|FG001|Overall Study|Treatment duration shortened|0|||
154874610|NCT01070550|558966749|FG002|Overall Study|Treatment duration shortened|0|||
154874611|NCT01070550|558966750|FG003|Overall Study|Treatment duration shortened|0|||
154874612|NCT01070550|558966751|FG004|Overall Study|Treatment duration shortened|0|||
154874613|NCT01070550|558966752|FG005|Overall Study|Treatment duration shortened|0|||
154874614|NCT01070550|558966747|FG000|Overall Study|Treatment interrupted|7|||
155112038|NCT03831191|559838513|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112039|NCT03831191|559838514|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112040|NCT03831191|559838515|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112041|NCT03831191|559838516|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112042|NCT03831191|559838517|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112043|NCT03831191|559838518|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155112044|NCT03831191|559838519|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
154874615|NCT01070550|558966748|FG001|Overall Study|Treatment interrupted|0|||
154874616|NCT01070550|558966749|FG002|Overall Study|Treatment interrupted|1|||
154874617|NCT01070550|558966750|FG003|Overall Study|Treatment interrupted|1|||
154874618|NCT01070550|558966751|FG004|Overall Study|Treatment interrupted|0|||
154874619|NCT01070550|558966752|FG005|Overall Study|Treatment interrupted|0|||
154874620|NCT01070550|558966747|FG000|Overall Study|Treatment not started|14|||
154874621|NCT01070550|558966748|FG001|Overall Study|Treatment not started|2|||
154874622|NCT01070550|558966749|FG002|Overall Study|Treatment not started|4|||
154874623|NCT01070550|558966750|FG003|Overall Study|Treatment not started|0|||
154874624|NCT01070550|558966751|FG004|Overall Study|Treatment not started|0|||
154874625|NCT01070550|558966752|FG005|Overall Study|Treatment not started|0|||
154874626|NCT01070550|558966747|FG000|Overall Study|Treatment restarted|0|||
154874627|NCT01070550|558966748|FG001|Overall Study|Treatment restarted|1|||
154874628|NCT01070550|558966749|FG002|Overall Study|Treatment restarted|0|||
154874629|NCT01070550|558966750|FG003|Overall Study|Treatment restarted|0|||
154874630|NCT01070550|558966751|FG004|Overall Study|Treatment restarted|0|||
154874631|NCT01070550|558966752|FG005|Overall Study|Treatment restarted|0|||
154874632|NCT01070550|558966747|FG000|Overall Study|Treatment stopped|3|||
154874633|NCT01070550|558966748|FG001|Overall Study|Treatment stopped|0|||
154874634|NCT01070550|558966749|FG002|Overall Study|Treatment stopped|0|||
154874635|NCT01070550|558966750|FG003|Overall Study|Treatment stopped|0|||
154874636|NCT01070550|558966751|FG004|Overall Study|Treatment stopped|0|||
154874637|NCT01070550|558966752|FG005|Overall Study|Treatment stopped|0|||
154874638|NCT01070550|558966747|FG000|Overall Study|Treatment unavailable|1|||
154874639|NCT01070550|558966748|FG001|Overall Study|Treatment unavailable|0|||
154874640|NCT01070550|558966749|FG002|Overall Study|Treatment unavailable|0|||
154874641|NCT01070550|558966750|FG003|Overall Study|Treatment unavailable|0|||
154874642|NCT01070550|558966751|FG004|Overall Study|Treatment unavailable|0|||
154874643|NCT01070550|558966752|FG005|Overall Study|Treatment unavailable|0|||
154874644|NCT01070550|558966747|FG000|Overall Study|Treatment was stopped early|7|||
154874645|NCT01070550|558966748|FG001|Overall Study|Treatment was stopped early|0|||
154874646|NCT01070550|558966749|FG002|Overall Study|Treatment was stopped early|0|||
154874647|NCT01070550|558966750|FG003|Overall Study|Treatment was stopped early|0|||
154874648|NCT01070550|558966751|FG004|Overall Study|Treatment was stopped early|0|||
154874649|NCT01070550|558966752|FG005|Overall Study|Treatment was stopped early|0|||
154874650|NCT01070550|558966747|FG000|Overall Study|Other|5|||
154874651|NCT01070550|558966748|FG001|Overall Study|Other|0|||
154874652|NCT01070550|558966749|FG002|Overall Study|Other|0|||
154874653|NCT01070550|558966750|FG003|Overall Study|Other|1|||
154874654|NCT01070550|558966751|FG004|Overall Study|Other|0|||
154874655|NCT01070550|558966752|FG005|Overall Study|Other|0|||
154874656|NCT01070550|558966747|FG000|Overall Study|Withdrawal by Subject|35|||
154874657|NCT01070550|558966748|FG001|Overall Study|Withdrawal by Subject|0|||
154874658|NCT01070550|558966749|FG002|Overall Study|Withdrawal by Subject|3|||
154874659|NCT01070550|558966750|FG003|Overall Study|Withdrawal by Subject|0|||
154874660|NCT01070550|558966751|FG004|Overall Study|Withdrawal by Subject|0|||
154874661|NCT01070550|558966752|FG005|Overall Study|Withdrawal by Subject|0|||
154874662|NCT00305006|558966753|FG000|Overall Study|Withdrawal by Subject|1|||
154874663|NCT00305006|558966754|FG001|Overall Study|Withdrawal by Subject|0|||
154874664|NCT00305006|558966753|FG000|Overall Study|Failure to complete pretest|0|||
154874665|NCT00305006|558966754|FG001|Overall Study|Failure to complete pretest|1|||
154874666|NCT04964063|558966755|FG000|Overall Study|Adverse Event|4|||
154874667|NCT04964063|558966755|FG000|Overall Study|Lost to Follow-up|47|||
154874668|NCT04964063|558966755|FG000|Overall Study|Withdrawal by Subject|5|||
154874669|NCT04964063|558966755|FG000|Overall Study|Baseline Tasks Expired|41|||
154874670|NCT04964063|558966755|FG000|Overall Study|Participant withdrawn in error|1|||
154874671|NCT01849848|558966758|FG000|Overall Study|Physician Decision|1|||
154874672|NCT01849848|558966758|FG000|Overall Study|Progression of the primary disease|3|||
154874673|NCT01702363|558966759|FG000|Overall Study|Adverse Event|14|||
154874674|NCT01702363|558966759|FG000|Overall Study|Lack of Efficacy|4|||
154874675|NCT01702363|558966759|FG000|Overall Study|Withdrawal by Subject|2|||
154874676|NCT01312428|558966760|FG000|Overall Study|Study Termination|3|||
154874677|NCT01312428|558966761|FG001|Overall Study|Study Termination|4|||
154874678|NCT00793819|558966767|FG000|Overall Study|Adverse Event|8|||
154874679|NCT00793819|558966768|FG001|Overall Study|Adverse Event|4|||
154874680|NCT00793819|558966767|FG000|Overall Study|Lack of Efficacy|1|||
154874681|NCT00793819|558966768|FG001|Overall Study|Lack of Efficacy|1|||
154874682|NCT00793819|558966767|FG000|Overall Study|Withdrawal by Subject|4|||
154874683|NCT00793819|558966768|FG001|Overall Study|Withdrawal by Subject|3|||
154874684|NCT00793819|558966767|FG000|Overall Study|Lost to Follow-up|1|||
154874685|NCT00793819|558966768|FG001|Overall Study|Lost to Follow-up|1|||
154874686|NCT00723840|558966772|FG000|Overall Study|Lost to Follow-up|2|||
154874687|NCT00723840|558966772|FG000|Overall Study|Failure to return|18|||
154874688|NCT00723840|558966772|FG000|Overall Study|Withdrawal by Subject|55|||
154974215|NCT01270620|559331204|FG000|Overall Study|Withdrawal by Subject|1|||
154874689|NCT00723840|558966772|FG000|Overall Study|Serious Adverse Events|3|||
154874690|NCT00723840|558966772|FG000|Overall Study|Other Medical Event|2|||
154874691|NCT00723840|558966772|FG000|Overall Study|Unspecified reason|2|||
154874692|NCT05100199|558966779|FG000|Overall Study|Lost to Follow-up|5|||
154874693|NCT05100199|558966780|FG001|Overall Study|Lost to Follow-up|8|||
154874694|NCT05100199|558966781|FG002|Overall Study|Lost to Follow-up|3|||
154874695|NCT05100199|558966782|FG003|Overall Study|Lost to Follow-up|6|||
154874696|NCT05100199|558966779|FG000|Overall Study|Withdrawal by Subject|3|||
154874697|NCT05100199|558966780|FG001|Overall Study|Withdrawal by Subject|3|||
154874698|NCT05100199|558966781|FG002|Overall Study|Withdrawal by Subject|9|||
154874699|NCT05100199|558966782|FG003|Overall Study|Withdrawal by Subject|7|||
154874700|NCT05100199|558966779|FG000|Overall Study|Other|0|||
154874701|NCT05100199|558966780|FG001|Overall Study|Other|0|||
154874702|NCT05100199|558966781|FG002|Overall Study|Other|1|||
154874703|NCT05100199|558966782|FG003|Overall Study|Other|1|||
154874704|NCT02853331|558966783|FG000|Overall Study|Death|59|||
154874705|NCT02853331|558966784|FG001|Overall Study|Death|95|||
154874706|NCT02853331|558966783|FG000|Overall Study|Withdrawal by Subject|5|||
154874707|NCT02853331|558966784|FG001|Overall Study|Withdrawal by Subject|9|||
154874708|NCT02853331|558966783|FG000|Overall Study|Ongoing in study|368|||
154874709|NCT02853331|558966784|FG001|Overall Study|Ongoing in study|325|||
154874710|NCT01455428|558966785|FG000|Overall Study|Protocol Violation|2|||
154874711|NCT01455428|558966786|FG001|Overall Study|Protocol Violation|1|||
154874712|NCT01455428|558966785|FG000|Overall Study|Adverse Event|6|||
154874713|NCT01455428|558966786|FG001|Overall Study|Adverse Event|2|||
154874714|NCT01455428|558966785|FG000|Overall Study|Lost to Follow-up|1|||
154874715|NCT01455428|558966786|FG001|Overall Study|Lost to Follow-up|1|||
154874716|NCT01455428|558966785|FG000|Overall Study|Withdrawal by Subject|2|||
154874717|NCT01455428|558966786|FG001|Overall Study|Withdrawal by Subject|5|||
154874718|NCT01455428|558966785|FG000|Overall Study|Did not meet entrance criteria|0|||
154874719|NCT01455428|558966786|FG001|Overall Study|Did not meet entrance criteria|2|||
154874720|NCT01455428|558966785|FG000|Overall Study|Insufficient clinical response|0|||
154874721|NCT01455428|558966786|FG001|Overall Study|Insufficient clinical response|2|||
154874722|NCT01455428|558966785|FG000|Overall Study|Did not receive treatment|1|||
154874723|NCT01455428|558966786|FG001|Overall Study|Did not receive treatment|1|||
154874724|NCT01455428|558966785|FG000|Overall Study|Other|2|||
154874725|NCT01455428|558966786|FG001|Overall Study|Other|4|||
154974216|NCT01270620|559331205|FG001|Overall Study|Withdrawal by Subject|3|||
154974217|NCT01597479|559331207|FG000|Overall Study|Protocol Violation|1|||
154974218|NCT01597479|559331208|FG001|Overall Study|Protocol Violation|0|||
154974219|NCT01597479|559331207|FG000|Overall Study|Lost to Follow-up|1|||
154974220|NCT01597479|559331208|FG001|Overall Study|Lost to Follow-up|0|||
154974221|NCT01045707|559331209|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
154974222|NCT01045707|559331210|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
154974223|NCT01045707|559331209|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
154974224|NCT01045707|559331210|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
154974225|NCT01045707|559331209|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
154974226|NCT01045707|559331210|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
154974227|NCT01045707|559331209|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
154974228|NCT01045707|559331210|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
154974229|NCT01045707|559331209|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
154974230|NCT01045707|559331210|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
154974231|NCT01045707|559331209|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
154974232|NCT01045707|559331210|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
154974233|NCT01045707|559331209|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
154974234|NCT01045707|559331210|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
154974235|NCT01045707|559331209|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
154974236|NCT01045707|559331210|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
154974237|NCT01045707|559331209|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
154974238|NCT01045707|559331210|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
154974239|NCT00348816|559331211|FG000|Overall Study|Noncompliance with radiation treatment|1|||
154974240|NCT01628549|559331217|FG000|Overall Study|Adverse Event|1|||
154974241|NCT01628549|559331218|FG001|Overall Study|Adverse Event|1|||
154974242|NCT01628549|559331219|FG002|Overall Study|Adverse Event|0|||
154974243|NCT01628549|559331220|FG003|Overall Study|Adverse Event|4|||
154974244|NCT01628549|559331217|FG000|Overall Study|Lost to Follow-up|3|||
154974245|NCT01628549|559331218|FG001|Overall Study|Lost to Follow-up|4|||
154974246|NCT01628549|559331219|FG002|Overall Study|Lost to Follow-up|3|||
154974247|NCT01628549|559331220|FG003|Overall Study|Lost to Follow-up|3|||
154974248|NCT01628549|559331217|FG000|Overall Study|Withdrawal by Subject|3|||
154974249|NCT01628549|559331218|FG001|Overall Study|Withdrawal by Subject|4|||
154974250|NCT01628549|559331219|FG002|Overall Study|Withdrawal by Subject|4|||
154974251|NCT01628549|559331220|FG003|Overall Study|Withdrawal by Subject|1|||
154974252|NCT01628549|559331217|FG000|Overall Study|Protocol Violation|2|||
154974253|NCT01628549|559331218|FG001|Overall Study|Protocol Violation|1|||
154974254|NCT01628549|559331219|FG002|Overall Study|Protocol Violation|1|||
154974255|NCT01628549|559331220|FG003|Overall Study|Protocol Violation|0|||
155112045|NCT03831191|559838520|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155175336|NCT00910624|560080227|FG001|Treatment Phase|Adverse Event|6|||
154874726|NCT02062151|558966790|FG000|Overall Study|screen failure|1|||
154874727|NCT00257192|558966791|FG000|Overall Study|Adverse Event|21|||
154874728|NCT00257192|558966792|FG001|Overall Study|Adverse Event|10|||
154874729|NCT00257192|558966791|FG000|Overall Study|Laboratory abnormality|1|||
154874730|NCT00257192|558966792|FG001|Overall Study|Laboratory abnormality|1|||
154874731|NCT00257192|558966791|FG000|Overall Study|Lost to Follow-up|3|||
154874732|NCT00257192|558966792|FG001|Overall Study|Lost to Follow-up|3|||
154974256|NCT01628549|559331217|FG000|Overall Study|withdrawn for noncompliance|0|||
154974257|NCT01628549|559331218|FG001|Overall Study|withdrawn for noncompliance|2|||
154974258|NCT01628549|559331219|FG002|Overall Study|withdrawn for noncompliance|1|||
154974259|NCT01628549|559331220|FG003|Overall Study|withdrawn for noncompliance|0|||
154974260|NCT01628549|559331217|FG000|Overall Study|abnormal laboratory test results|0|||
154974261|NCT01628549|559331218|FG001|Overall Study|abnormal laboratory test results|0|||
154874733|NCT00257192|558966791|FG000|Overall Study|Insufficient clinical response|18|||
154874734|NCT00257192|558966792|FG001|Overall Study|Insufficient clinical response|18|||
154874735|NCT00257192|558966791|FG000|Overall Study|Withdrawal by Subject|14|||
154874736|NCT00257192|558966792|FG001|Overall Study|Withdrawal by Subject|2|||
154874737|NCT00257192|558966791|FG000|Overall Study|Randomized but not treated|0|||
154874738|NCT00257192|558966792|FG001|Overall Study|Randomized but not treated|1|||
154874739|NCT00257192|558966791|FG000|Overall Study|Study terminated by sponsor|1|||
154874740|NCT00257192|558966792|FG001|Overall Study|Study terminated by sponsor|0|||
154874741|NCT00257192|558966791|FG000|Overall Study|Miscellaneous|0|||
154874742|NCT00257192|558966792|FG001|Overall Study|Miscellaneous|4|||
154874743|NCT01161524|558966796|FG000|Core Study (23 Weeks)|Adverse Event|3|||
154874744|NCT01161524|558966797|FG001|Core Study (23 Weeks)|Adverse Event|0|||
154874745|NCT01161524|558966798|FG002|Core Study (23 Weeks)|Adverse Event|0|||
154874746|NCT01161524|558966796|FG000|Core Study (23 Weeks)|Other|1|||
154874747|NCT01161524|558966797|FG001|Core Study (23 Weeks)|Other|0|||
154874748|NCT01161524|558966798|FG002|Core Study (23 Weeks)|Other|0|||
154874749|NCT01161524|558966796|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
154874750|NCT01161524|558966797|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
154874751|NCT01161524|558966798|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
155112046|NCT03831191|559838521|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
154874752|NCT01161524|558966796|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
154874753|NCT01161524|558966797|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
154874754|NCT01161524|558966798|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
154874755|NCT01161524|558966796|FG000|Core Study (23 Weeks)|Subject Choice|3|||
154874756|NCT01161524|558966797|FG001|Core Study (23 Weeks)|Subject Choice|2|||
154874757|NCT01161524|558966798|FG002|Core Study (23 Weeks)|Subject Choice|0|||
154874758|NCT01161524|558966796|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
154874759|NCT01161524|558966797|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
154874760|NCT01161524|558966798|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
154874761|NCT01161524|558966796|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
154874762|NCT01161524|558966797|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
154874763|NCT01161524|558966798|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
154874764|NCT01161524|558966796|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
154874765|NCT01161524|558966797|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
154874766|NCT01161524|558966798|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
155112047|NCT03831191|559838507|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
154974262|NCT01628549|559331219|FG002|Overall Study|abnormal laboratory test results|1|||
154974263|NCT01628549|559331220|FG003|Overall Study|abnormal laboratory test results|0|||
155112048|NCT03831191|559838508|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112049|NCT03831191|559838509|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112050|NCT03831191|559838510|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112051|NCT03831191|559838511|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112052|NCT03831191|559838512|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112053|NCT03831191|559838513|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
154874767|NCT01161524|558966796|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
154874768|NCT01161524|558966797|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
154874769|NCT01161524|558966798|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
154874770|NCT01161524|558966796|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
154874771|NCT01161524|558966797|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
154874772|NCT01161524|558966798|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
154874773|NCT01618656|558966801|FG000|Overall Study|Withdrawal by Subject|7|||
154874774|NCT01618656|558966802|FG001|Overall Study|Withdrawal by Subject|3|||
154874775|NCT01618656|558966801|FG000|Overall Study|Physician Decision|1|||
155112054|NCT03831191|559838514|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112055|NCT03831191|559838515|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112056|NCT03831191|559838516|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
154874776|NCT01618656|558966802|FG001|Overall Study|Physician Decision|1|||
154874777|NCT01899144|558966803|FG000|Treatment Period 2|Other|1|||
154874778|NCT01899144|558966803|FG000|Treatment Period 3|Other|2|||
154874779|NCT01899144|558966803|FG000|Treatment Period 5|Other|1|||
154874780|NCT02119104|558966804|FG000|Overall Study|Protocol Violation|16|||
154874781|NCT00081289|558966808|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
155112057|NCT03831191|559838517|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112058|NCT03831191|559838518|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112059|NCT03831191|559838519|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155112060|NCT03831191|559838520|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
154874782|NCT00081289|558966809|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
154874783|NCT00081289|558966808|FG000|Overall Study|Ineligible / no protocol treatment|3|||
155112061|NCT03831191|559838521|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
154874784|NCT00081289|558966809|FG001|Overall Study|Ineligible / no protocol treatment|4|||
155112062|NCT03748706|559838522|FG000|Overall Study|Lost to Follow-up|1|||
155112063|NCT00695955|559838525|FG000|Cohort 1|Adverse Event|26|||
154874785|NCT01952015|558966812|FG000|Induction|Protocol Violation|1|||
154874786|NCT01952015|558966812|FG000|Maintenance|Adverse Event|2|||
154874787|NCT01952015|558966812|FG000|Treatment Period 3|Physician Decision|9|||
154874788|NCT02239094|558966813|FG000|Overall Study|Withdrawal by Subject|1|||
154874789|NCT02239094|558966813|FG000|Overall Study|Remitted before started|1|||
154874790|NCT02508701|558966816|FG000|Overall Study|Lost to Follow-up|9|||
154874791|NCT02508701|558966817|FG001|Overall Study|Lost to Follow-up|5|||
154874792|NCT02508701|558966818|FG002|Overall Study|Lost to Follow-up|5|||
154874793|NCT02508701|558966819|FG003|Overall Study|Lost to Follow-up|3|||
154874794|NCT00530712|558966824|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
154874795|NCT00530712|558966824|FG000|30 Day Follow-up Visit|Missed Visit|5|||
154874796|NCT00530712|558966824|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
154874797|NCT00530712|558966824|FG000|6 Month Follow-up Visit|Missed Visit|3|||
154874798|NCT00530712|558966824|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
154874799|NCT00530712|558966824|FG000|6 Month Follow-up Visit|Death|2|||
154874800|NCT00530712|558966824|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
154874801|NCT00530712|558966824|FG000|12 Month Follow-up Visit|Missed Visit|3|||
154874802|NCT00530712|558966824|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
154874803|NCT00530712|558966824|FG000|12 Month Follow-up Visit|Death|9|||
154874804|NCT03242759|558966827|FG000|Overall Study|Adverse Event|5|||
154874805|NCT03242759|558966828|FG001|Overall Study|Adverse Event|1|||
154874806|NCT03242759|558966827|FG000|Overall Study|Withdrawal by Subject|4|||
154874807|NCT03242759|558966828|FG001|Overall Study|Withdrawal by Subject|3|||
154874808|NCT03242759|558966827|FG000|Overall Study|Lost to Follow-up|3|||
154874809|NCT03242759|558966828|FG001|Overall Study|Lost to Follow-up|1|||
154874810|NCT03242759|558966827|FG000|Overall Study|Administrative problems|1|||
154874811|NCT03242759|558966828|FG001|Overall Study|Administrative problems|1|||
154874812|NCT03242759|558966827|FG000|Overall Study|Death|22|||
154874813|NCT03242759|558966828|FG001|Overall Study|Death|0|||
154874814|NCT03242759|558966827|FG000|Overall Study|Change visit schedule|0|||
154874815|NCT03242759|558966828|FG001|Overall Study|Change visit schedule|1|||
154874816|NCT01095250|558966831|FG000|Overall Study|administrative reasons|8|||
154874817|NCT01095250|558966832|FG001|Overall Study|administrative reasons|10|||
154874818|NCT01095250|558966833|FG002|Overall Study|administrative reasons|7|||
154874819|NCT01095250|558966834|FG003|Overall Study|administrative reasons|5|||
154874820|NCT01095250|558966831|FG000|Overall Study|Withdrawal by Subject|0|||
154874821|NCT01095250|558966832|FG001|Overall Study|Withdrawal by Subject|0|||
154874822|NCT01095250|558966833|FG002|Overall Study|Withdrawal by Subject|1|||
154874823|NCT01095250|558966834|FG003|Overall Study|Withdrawal by Subject|0|||
154874824|NCT01000064|558966835|FG000|Overall Study|Withdrawal by Subject|1|||
154874825|NCT01000064|558966836|FG001|Overall Study|Withdrawal by Subject|1|||
154874826|NCT02518620|558966837|FG000|Overall Study|Adverse Event|23|||
154874827|NCT02518620|558966838|FG001|Overall Study|Adverse Event|11|||
154874828|NCT02518620|558966837|FG000|Overall Study|Lack of Efficacy|2|||
154874829|NCT02518620|558966838|FG001|Overall Study|Lack of Efficacy|0|||
154874830|NCT02518620|558966837|FG000|Overall Study|Non-Compliance with Study Drug|1|||
154874831|NCT02518620|558966838|FG001|Overall Study|Non-Compliance with Study Drug|0|||
154874832|NCT02518620|558966837|FG000|Overall Study|Physician Decision|1|||
154874833|NCT02518620|558966838|FG001|Overall Study|Physician Decision|1|||
154874834|NCT02518620|558966837|FG000|Overall Study|Sponsor's Decision|0|||
154874835|NCT02518620|558966838|FG001|Overall Study|Sponsor's Decision|3|||
154874836|NCT02518620|558966837|FG000|Overall Study|Lost to Follow-up|1|||
154874837|NCT02518620|558966838|FG001|Overall Study|Lost to Follow-up|1|||
154874838|NCT02518620|558966837|FG000|Overall Study|Withdrawal by Subject|17|||
154874839|NCT02518620|558966838|FG001|Overall Study|Withdrawal by Subject|9|||
154874840|NCT02518620|558966837|FG000|Overall Study|Death|1|||
154874841|NCT02518620|558966838|FG001|Overall Study|Death|0|||
154874842|NCT02518620|558966837|FG000|Overall Study|Pregnancy Wish|3|||
154874843|NCT02518620|558966838|FG001|Overall Study|Pregnancy Wish|0|||
154874844|NCT02518620|558966837|FG000|Overall Study|Pregnancy|1|||
154874845|NCT02518620|558966838|FG001|Overall Study|Pregnancy|0|||
154874846|NCT02518620|558966837|FG000|Overall Study|Relocation|2|||
154874847|NCT02518620|558966838|FG001|Overall Study|Relocation|1|||
154874848|NCT00798967|558966839|FG000|Overall Study|Adverse Event|2|||
154874849|NCT00798967|558966840|FG001|Overall Study|Adverse Event|3|||
154874850|NCT00798967|558966839|FG000|Overall Study|Withdrawal by Subject|0|||
154874851|NCT00798967|558966840|FG001|Overall Study|Withdrawal by Subject|1|||
154874852|NCT00798967|558966839|FG000|Overall Study|Physician Decision|1|||
154874853|NCT00798967|558966840|FG001|Overall Study|Physician Decision|0|||
154874854|NCT00798967|558966839|FG000|Overall Study|Randomized in error by site|1|||
154874855|NCT00798967|558966840|FG001|Overall Study|Randomized in error by site|0|||
154874856|NCT00336492|558966847|FG000|Overall Study|Adverse Event|4|||
154874857|NCT00336492|558966848|FG001|Overall Study|Adverse Event|3|||
154874858|NCT00336492|558966849|FG002|Overall Study|Adverse Event|6|||
154874859|NCT00336492|558966847|FG000|Overall Study|Lack of Efficacy|6|||
154874860|NCT00336492|558966848|FG001|Overall Study|Lack of Efficacy|1|||
154874861|NCT00336492|558966849|FG002|Overall Study|Lack of Efficacy|4|||
154874862|NCT00336492|558966847|FG000|Overall Study|Other|5|||
154874863|NCT00336492|558966848|FG001|Overall Study|Other|0|||
154874864|NCT00336492|558966849|FG002|Overall Study|Other|1|||
154874865|NCT01415440|558966850|FG000|Overall Study|Lost to Follow-up|0|||
154874866|NCT01415440|558966851|FG001|Overall Study|Lost to Follow-up|1|||
154874867|NCT01415440|558966852|FG002|Overall Study|Lost to Follow-up|2|||
154874868|NCT01415440|558966850|FG000|Overall Study|Physician Decision|3|||
154874869|NCT01415440|558966851|FG001|Overall Study|Physician Decision|0|||
154874870|NCT01415440|558966852|FG002|Overall Study|Physician Decision|0|||
154874871|NCT01415440|558966850|FG000|Overall Study|Withdrawal by Subject|1|||
154874872|NCT01415440|558966851|FG001|Overall Study|Withdrawal by Subject|0|||
154874873|NCT01415440|558966852|FG002|Overall Study|Withdrawal by Subject|0|||
154874874|NCT01781026|558966855|FG000|Overall Study|Lack of Efficacy|2|||
154874875|NCT03141307|558966856|FG000|In-Hospital|Withdrawal by Subject|0|||
154874876|NCT03141307|558966857|FG001|In-Hospital|Withdrawal by Subject|2|||
154874877|NCT03141307|558966856|FG000|In-Hospital|Protocol Violation|4|||
154874878|NCT03141307|558966857|FG001|In-Hospital|Protocol Violation|0|||
154874879|NCT03141307|558966856|FG000|Follow-Up|Lost to Follow-up|97|||
154874880|NCT03141307|558966857|FG001|Follow-Up|Lost to Follow-up|54|||
154874881|NCT00227877|558966858|FG000|Pre-visit Assessment|Technical difficulties|7|||
154874882|NCT00227877|558966859|FG001|Pre-visit Assessment|Technical difficulties|3|||
154874883|NCT00227877|558966860|FG002|Pre-visit Assessment|Technical difficulties|0|||
154874884|NCT00227877|558966861|FG003|Pre-visit Assessment|Technical difficulties|0|||
154874885|NCT00227877|558966858|FG000|Post-visit Checklist|Lost to Follow-up|24|||
154874886|NCT00227877|558966859|FG001|Post-visit Checklist|Lost to Follow-up|13|||
154874887|NCT00227877|558966860|FG002|Post-visit Checklist|Lost to Follow-up|1|||
154874888|NCT00227877|558966861|FG003|Post-visit Checklist|Lost to Follow-up|0|||
154874889|NCT00227877|558966858|FG000|3-months Follow-up|Completed late|135|||
154874890|NCT00227877|558966859|FG001|3-months Follow-up|Completed late|128|||
154874891|NCT00227877|558966860|FG002|3-months Follow-up|Completed late|34|||
154874892|NCT00227877|558966861|FG003|3-months Follow-up|Completed late|8|||
154874893|NCT00227877|558966858|FG000|3-months Follow-up|Lost to Follow-up|178|||
154874894|NCT00227877|558966859|FG001|3-months Follow-up|Lost to Follow-up|139|||
154874895|NCT00227877|558966860|FG002|3-months Follow-up|Lost to Follow-up|18|||
154874896|NCT00227877|558966861|FG003|3-months Follow-up|Lost to Follow-up|13|||
154874897|NCT00227877|558966858|FG000|12-months Follow-up|Completed late|78|||
154874898|NCT00227877|558966859|FG001|12-months Follow-up|Completed late|74|||
154874899|NCT00227877|558966860|FG002|12-months Follow-up|Completed late|1|||
154874900|NCT00227877|558966861|FG003|12-months Follow-up|Completed late|0|||
154874901|NCT00227877|558966858|FG000|12-months Follow-up|Lost to Follow-up|232|||
154874902|NCT00227877|558966859|FG001|12-months Follow-up|Lost to Follow-up|189|||
154874903|NCT00227877|558966860|FG002|12-months Follow-up|Lost to Follow-up|30|||
154874904|NCT00227877|558966861|FG003|12-months Follow-up|Lost to Follow-up|26|||
154874905|NCT03090737|558966862|FG000|Overall Study|Other reasons|1|||
154874906|NCT03090737|558966862|FG000|Overall Study|Completed treatment as per protocol|17|||
154874907|NCT03090737|558966862|FG000|Overall Study|Maximum clinical benefit|2|||
154874908|NCT03090737|558966862|FG000|Overall Study|Adverse event unrelated to study drug|7|||
154874909|NCT03090737|558966862|FG000|Overall Study|Study drug toxicity|4|||
154874910|NCT03090737|558966862|FG000|Overall Study|Disease progression|98|||
154874911|NCT03596177|558966867|FG000|Single Blind Period|Withdrawal by Subject|1|||
154874912|NCT03596177|558966868|FG001|Single Blind Period|Withdrawal by Subject|1|||
154874913|NCT03596177|558966867|FG000|Single Blind Period|Other|1|||
154874914|NCT03596177|558966868|FG001|Single Blind Period|Other|0|||
154874915|NCT03596177|558966867|FG000|Double Blind Period|Withdrawal by Subject|0|||
154874916|NCT03596177|558966868|FG001|Double Blind Period|Withdrawal by Subject|1|||
154874917|NCT03596177|558966867|FG000|Double Blind Period|Other|0|||
154874918|NCT03596177|558966868|FG001|Double Blind Period|Other|4|||
154874919|NCT03596177|558966867|FG000|Double Blind Period|Death during safety follow-up|0|||
154874920|NCT03596177|558966868|FG001|Double Blind Period|Death during safety follow-up|1|||
154874921|NCT02522481|558966871|FG000|Overall Study|discontinued|1|||
154874922|NCT02522481|558966871|FG000|Overall Study|Not dosed|2|||
154874923|NCT04400318|558968525|FG000|Overall Study|Adverse Event|1|||
154874924|NCT04400318|558968526|FG001|Overall Study|Adverse Event|0|||
154874925|NCT04400318|558968525|FG000|Overall Study|Withdrawal by Subject|1|||
154874926|NCT04400318|558968526|FG001|Overall Study|Withdrawal by Subject|1|||
154874927|NCT04400318|558968525|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
154874928|NCT04400318|558968526|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
154874929|NCT00165646|558968527|FG000|Overall Study|Adverse Event|1|||
154874930|NCT00165646|558968528|FG001|Overall Study|Adverse Event|1|||
154874931|NCT00165646|558968529|FG002|Overall Study|Adverse Event|1|||
154874932|NCT00165646|558968527|FG000|Overall Study|Lack of Efficacy|1|||
154874933|NCT00165646|558968528|FG001|Overall Study|Lack of Efficacy|2|||
154874934|NCT00165646|558968529|FG002|Overall Study|Lack of Efficacy|0|||
154874935|NCT00165646|558968527|FG000|Overall Study|Withdrawal by Subject|0|||
154874936|NCT00165646|558968528|FG001|Overall Study|Withdrawal by Subject|2|||
154874937|NCT00165646|558968529|FG002|Overall Study|Withdrawal by Subject|1|||
154874938|NCT00165646|558968527|FG000|Overall Study|Physician Decision|2|||
154874939|NCT00165646|558968528|FG001|Overall Study|Physician Decision|0|||
154874940|NCT00165646|558968529|FG002|Overall Study|Physician Decision|2|||
154874941|NCT00165646|558968527|FG000|Overall Study|Protocol Violation|1|||
154874942|NCT00165646|558968528|FG001|Overall Study|Protocol Violation|0|||
154874943|NCT00165646|558968529|FG002|Overall Study|Protocol Violation|0|||
154874944|NCT01790438|558968530|FG000|Overall Study|Adverse Event|3|||
154874945|NCT01790438|558968531|FG001|Overall Study|Adverse Event|2|||
154874946|NCT01790438|558968530|FG000|Overall Study|Death|4|||
154874947|NCT01790438|558968531|FG001|Overall Study|Death|0|||
155112064|NCT00695955|559838525|FG000|Cohort 1|Protocol Violation|2|||
155112065|NCT00695955|559838525|FG000|Cohort 1|Lost to Follow-up|30|||
155112066|NCT00695955|559838525|FG000|Cohort 1|Withdrawal by Subject|25|||
155112067|NCT00695955|559838525|FG000|Cohort 1|Lack of Efficacy|3|||
154874948|NCT01790438|558968530|FG000|Overall Study|Lost to Follow-up|5|||
154874949|NCT01790438|558968531|FG001|Overall Study|Lost to Follow-up|2|||
154874950|NCT01790438|558968530|FG000|Overall Study|Withdrawal by Subject|13|||
154874951|NCT01790438|558968531|FG001|Overall Study|Withdrawal by Subject|2|||
154874952|NCT01790438|558968530|FG000|Overall Study|Physician Decision|3|||
154874953|NCT01790438|558968531|FG001|Overall Study|Physician Decision|1|||
154874954|NCT01790438|558968530|FG000|Overall Study|Sponsor Decision|0|||
154874955|NCT01790438|558968531|FG001|Overall Study|Sponsor Decision|3|||
154874956|NCT01790438|558968530|FG000|Overall Study|Protocol Required Discontinuation|7|||
154874957|NCT01790438|558968531|FG001|Overall Study|Protocol Required Discontinuation|1|||
154874958|NCT02433210|558968534|FG000|Overall Study|Physician Decision|1|||
154874959|NCT02433210|558968535|FG001|Overall Study|Physician Decision|0|||
154874960|NCT02433210|558968536|FG002|Overall Study|Physician Decision|0|||
154874961|NCT04907539|558968537|FG000|Overall Study|Consent withdrawn|1|||
154874962|NCT04907539|558968538|FG001|Overall Study|Consent withdrawn|0|||
154874963|NCT04907539|558968537|FG000|Overall Study|Death|14|||
154874964|NCT04907539|558968538|FG001|Overall Study|Death|3|||
154874965|NCT01701583|558968539|FG000|Overall Study|Withdrawal by Subject|2|||
154874966|NCT01701583|558968540|FG001|Overall Study|Withdrawal by Subject|0|||
154874967|NCT05070429|558968541|FG000|Overall Study|Death|0|||
154874968|NCT05070429|558968542|FG001|Overall Study|Death|4|||
154874969|NCT05070429|558968541|FG000|Overall Study|Withdrawal by Subject|2|||
154874970|NCT05070429|558968542|FG001|Overall Study|Withdrawal by Subject|1|||
154874971|NCT05070429|558968541|FG000|Overall Study|Other|15|||
154874972|NCT05070429|558968542|FG001|Overall Study|Other|5|||
154874973|NCT02311478|558968543|FG000|Overall Study|Withdrawal by Subject|1|||
154874974|NCT02311478|558968543|FG000|Overall Study|Lost to Follow-up|5|||
154874975|NCT02311478|558968543|FG000|Overall Study|Failed IUD Insertion|1|||
154874976|NCT03276936|558968544|FG000|Overall Study|Adverse Event|4|||
154874977|NCT03276936|558968545|FG001|Overall Study|Adverse Event|2|||
154874978|NCT03276936|558968544|FG000|Overall Study|Lost to Follow-up|16|||
154874979|NCT03276936|558968545|FG001|Overall Study|Lost to Follow-up|13|||
154874980|NCT03276936|558968544|FG000|Overall Study|Withdrawal by Subject|30|||
154874981|NCT03276936|558968545|FG001|Overall Study|Withdrawal by Subject|20|||
154874982|NCT03276936|558968544|FG000|Overall Study|Not mentioned|6|||
154874983|NCT03276936|558968545|FG001|Overall Study|Not mentioned|3|||
154874984|NCT03041116|558968546|FG000|Double-blind|Death|0|||
154874985|NCT03041116|558968547|FG001|Double-blind|Death|2|||
155112068|NCT00695955|559838525|FG000|Cohort 1|Other|16|||
155112069|NCT00695955|559838525|FG000|Cohort 2|Adverse Event|24|||
155112070|NCT00695955|559838525|FG000|Cohort 2|Protocol Violation|5|||
155112071|NCT00695955|559838525|FG000|Cohort 2|Lost to Follow-up|38|||
155112072|NCT00695955|559838525|FG000|Cohort 2|Withdrawal by Subject|28|||
155112073|NCT00695955|559838525|FG000|Cohort 2|Lack of Efficacy|4|||
155112074|NCT00695955|559838525|FG000|Cohort 2|Other|5|||
154874986|NCT03041116|558968546|FG000|Double-blind|Withdrawal by Subject|0|||
154874987|NCT03041116|558968547|FG001|Double-blind|Withdrawal by Subject|4|||
154874988|NCT03041116|558968546|FG000|Open-label|Death|1|||
154874989|NCT03041116|558968547|FG001|Open-label|Death|0|||
154874990|NCT03041116|558968546|FG000|Open-label|Termination of the study by Sponsor|39|||
155112075|NCT00673231|559838530|FG000|Overall Study|Withdrawal by Subject|14|||
155112076|NCT00673231|559838531|FG001|Overall Study|Withdrawal by Subject|10|||
155112077|NCT00673231|559838532|FG002|Overall Study|Withdrawal by Subject|8|||
154874991|NCT03041116|558968547|FG001|Open-label|Termination of the study by Sponsor|37|||
154874992|NCT03041116|558968546|FG000|Open-label|Withdrawal by Subject|1|||
154874993|NCT03041116|558968547|FG001|Open-label|Withdrawal by Subject|0|||
154874994|NCT00943319|558968548|FG000|Overall Study|Death|1|||
154874995|NCT02043301|558968549|FG000|Overall Study|Discontinued|0|||
155112078|NCT00673231|559838533|FG003|Overall Study|Withdrawal by Subject|6|||
155112079|NCT00673231|559838530|FG000|Overall Study|Adverse Event|6|||
155112080|NCT00673231|559838531|FG001|Overall Study|Adverse Event|5|||
155112081|NCT00673231|559838532|FG002|Overall Study|Adverse Event|9|||
155112082|NCT00673231|559838533|FG003|Overall Study|Adverse Event|6|||
155112083|NCT00673231|559838530|FG000|Overall Study|Lost to Follow-up|1|||
154874996|NCT02043301|558968550|FG001|Overall Study|Discontinued|1|||
154874997|NCT02043301|558968551|FG002|Overall Study|Discontinued|0|||
154874998|NCT01798134|558968552|FG000|Overall Study|Lost to Follow-up|1|||
154874999|NCT01798134|558968552|FG000|Overall Study|Withdrawal by Subject|3|||
154875000|NCT01798134|558968552|FG000|Overall Study|Death|2|||
154875001|NCT01798134|558968552|FG000|Overall Study|Adverse Event|3|||
154875002|NCT01798134|558968552|FG000|Overall Study|Physician Decision|3|||
154875003|NCT01798134|558968552|FG000|Overall Study|Liver transplant/surgery|4|||
154875004|NCT02653976|558968553|FG000|Overall Study|Withdrawal by Subject|5|||
154875005|NCT02653976|558968553|FG000|Overall Study|Death|4|||
154875006|NCT02023164|558968554|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
154875007|NCT02023164|558968555|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
154875008|NCT02436577|558968556|FG000|Overall Study|Protocol Deviation|0|||
154875009|NCT02436577|558968557|FG001|Overall Study|Protocol Deviation|1|||
154875010|NCT02436577|558968558|FG002|Overall Study|Protocol Deviation|0|||
154875011|NCT02436577|558968559|FG003|Overall Study|Protocol Deviation|0|||
154875012|NCT02436577|558968560|FG004|Overall Study|Protocol Deviation|0|||
154875013|NCT02436577|558968561|FG005|Overall Study|Protocol Deviation|0|||
154875014|NCT03703375|558968562|FG000|Randomization Period|Withdrawal by Subject|0|||
154875015|NCT03703375|558968563|FG001|Randomization Period|Withdrawal by Subject|0|||
154875016|NCT03703375|558968564|FG002|Randomization Period|Withdrawal by Subject|0|||
154875017|NCT03703375|558968565|FG003|Randomization Period|Withdrawal by Subject|1|||
154875018|NCT03703375|558968562|FG000|Randomization Period|Completed safety run-in treatment|7|||
154875019|NCT03703375|558968563|FG001|Randomization Period|Completed safety run-in treatment|0|||
154875020|NCT03703375|558968564|FG002|Randomization Period|Completed safety run-in treatment|0|||
154875021|NCT03703375|558968565|FG003|Randomization Period|Completed safety run-in treatment|0|||
154875022|NCT03703375|558968562|FG000|Treatment Period|Other Reasons|0|||
154875023|NCT03703375|558968563|FG001|Treatment Period|Other Reasons|1|||
154875024|NCT03703375|558968564|FG002|Treatment Period|Other Reasons|0|||
154875025|NCT03703375|558968565|FG003|Treatment Period|Other Reasons|3|||
154875026|NCT03703375|558968562|FG000|Treatment Period|Consent Withdrawal|0|||
154875027|NCT03703375|558968563|FG001|Treatment Period|Consent Withdrawal|0|||
154875028|NCT03703375|558968564|FG002|Treatment Period|Consent Withdrawal|0|||
154875029|NCT03703375|558968565|FG003|Treatment Period|Consent Withdrawal|1|||
154875030|NCT03703375|558968562|FG000|Treatment Period|Death|1|||
154875031|NCT03703375|558968563|FG001|Treatment Period|Death|0|||
154875032|NCT03703375|558968564|FG002|Treatment Period|Death|1|||
154875033|NCT03703375|558968565|FG003|Treatment Period|Death|2|||
154875034|NCT03703375|558968562|FG000|Treatment Period|Toxicity of Study Treatment|2|||
154875035|NCT03703375|558968563|FG001|Treatment Period|Toxicity of Study Treatment|0|||
154875036|NCT03703375|558968564|FG002|Treatment Period|Toxicity of Study Treatment|4|||
154875037|NCT03703375|558968565|FG003|Treatment Period|Toxicity of Study Treatment|1|||
154875038|NCT03703375|558968562|FG000|Treatment Period|Progression|32|||
154875039|NCT03703375|558968563|FG001|Treatment Period|Progression|1|||
154875040|NCT03703375|558968564|FG002|Treatment Period|Progression|7|||
154875041|NCT03703375|558968565|FG003|Treatment Period|Progression|11|||
154875042|NCT03703375|558968562|FG000|Treatment Period|Completed treatment|7|||
154875043|NCT03703375|558968563|FG001|Treatment Period|Completed treatment|2|||
154875044|NCT03703375|558968564|FG002|Treatment Period|Completed treatment|0|||
154875045|NCT03703375|558968565|FG003|Treatment Period|Completed treatment|0|||
154875046|NCT01675011|558968566|FG000|Overall Study|Trial terminated by Sponsor|3|||
154875047|NCT01675011|558968567|FG001|Overall Study|Trial terminated by Sponsor|1|||
154875048|NCT00615290|558968568|FG000|Overall Study|Adverse Event|2|||
154875049|NCT00615290|558968568|FG000|Overall Study|Lost to Follow-up|3|||
154875050|NCT00615290|558968568|FG000|Overall Study|Withdrawal by Subject|1|||
154875051|NCT00615290|558968568|FG000|Overall Study|Other|2|||
154875052|NCT02849990|558968569|FG000|Overall Study|Adverse Event|1|||
154875053|NCT02849990|558968569|FG000|Overall Study|Withdrawal by Subject|1|||
154875054|NCT01252134|558968570|FG000|Period 1, 8 Hours|Personal Reasons|0|||
154875055|NCT01252134|558968571|FG001|Period 1, 8 Hours|Personal Reasons|1|||
154875056|NCT01252134|558968572|FG002|Period 1, 8 Hours|Personal Reasons|1|||
154875057|NCT01252134|558968573|FG003|Period 1, 8 Hours|Personal Reasons|0|||
154875058|NCT01252134|558968574|FG004|Period 1, 8 Hours|Personal Reasons|0|||
154875059|NCT01252134|558968575|FG005|Period 1, 8 Hours|Personal Reasons|0|||
154875060|NCT02678741|558968577|FG000|Overall Study|Death|4|||
154875061|NCT02678741|558968577|FG000|Overall Study|Withdrawal by Subject|1|||
154875062|NCT02678741|558968577|FG000|Overall Study|ineligible|3|||
154875063|NCT02678741|558968577|FG000|Overall Study|Not RECIST Measurable|2|||
154875064|NCT02678741|558968577|FG000|Overall Study|Lack of Efficacy|10|||
154875065|NCT01795898|558968578|FG000|Overall Study|Adverse Event|27|||
154875066|NCT01795898|558968578|FG000|Overall Study|Lost to Follow-up|20|||
154875067|NCT01795898|558968578|FG000|Overall Study|Withdrawal of consent|6|||
154875068|NCT01795898|558968578|FG000|Overall Study|Diagnosed with metastasis|1|||
155112084|NCT00673231|559838531|FG001|Overall Study|Lost to Follow-up|2|||
154875069|NCT01795898|558968578|FG000|Overall Study|No pain|1|||
154875070|NCT01795898|558968578|FG000|Overall Study|Death|1|||
154875071|NCT01795898|558968578|FG000|Overall Study|Withdrew consent & had adverse events|3|||
154875072|NCT01795898|558968578|FG000|Overall Study|Physician Decision|1|||
154875073|NCT00372190|558968591|FG000|Overall Study|Lost to Follow-up|3|||
154875074|NCT00372190|558968592|FG001|Overall Study|Lost to Follow-up|1|||
154875075|NCT00623467|558968593|FG000|Overall Study|Lost to Follow-up|1|||
154875076|NCT00623467|558968593|FG000|Overall Study|Protocol Violation|4|||
154875077|NCT00623467|558968593|FG000|Overall Study|Withdrawal by Subject|2|||
154875078|NCT02606045|558968608|FG000|Overall Study|Study closed before treament could begin|1|||
154875079|NCT02606045|558968609|FG001|Overall Study|Study closed before treament could begin|2|||
154875080|NCT03952468|558968610|FG000|Overall Study|Death|0|||
154875081|NCT03952468|558968611|FG001|Overall Study|Death|1|||
154875082|NCT03952468|558968610|FG000|Overall Study|Adverse Event|0|||
154875083|NCT03952468|558968611|FG001|Overall Study|Adverse Event|1|||
154875084|NCT03952468|558968610|FG000|Overall Study|Physician Decision|1|||
154875085|NCT03952468|558968611|FG001|Overall Study|Physician Decision|0|||
154875086|NCT03952468|558968610|FG000|Overall Study|Lost to Follow-up|3|||
154875087|NCT03952468|558968611|FG001|Overall Study|Lost to Follow-up|4|||
154875088|NCT03952468|558968610|FG000|Overall Study|Withdrawal by Subject|2|||
154875089|NCT03952468|558968611|FG001|Overall Study|Withdrawal by Subject|1|||
154875090|NCT01996319|558968612|FG000|Overall Study|Protocol Violation|1|||
154875091|NCT01996319|558968613|FG001|Overall Study|Protocol Violation|0|||
154875092|NCT01996319|558968612|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
154875093|NCT01996319|558968613|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
154875094|NCT01996319|558968612|FG000|Overall Study|Adverse Event|2|||
154875095|NCT01996319|558968613|FG001|Overall Study|Adverse Event|2|||
154875096|NCT01671085|558968615|FG000|Overall Study|Withdrawal by Subject|1|||
154875097|NCT01671085|558968616|FG001|Overall Study|Withdrawal by Subject|0|||
154875098|NCT00637273|558968617|FG000|Overall Study|Adverse Event|11|||
154875099|NCT00637273|558968618|FG001|Overall Study|Adverse Event|5|||
154875100|NCT00637273|558968619|FG002|Overall Study|Adverse Event|7|||
154875101|NCT00637273|558968617|FG000|Overall Study|Lost to Follow-up|8|||
154875102|NCT00637273|558968618|FG001|Overall Study|Lost to Follow-up|9|||
154875103|NCT00637273|558968619|FG002|Overall Study|Lost to Follow-up|13|||
154875104|NCT00637273|558968617|FG000|Overall Study|Protocol Violation|2|||
154875105|NCT00637273|558968618|FG001|Overall Study|Protocol Violation|4|||
154875106|NCT00637273|558968619|FG002|Overall Study|Protocol Violation|1|||
154875107|NCT00637273|558968617|FG000|Overall Study|Withdrawal of Consent|18|||
154875108|NCT00637273|558968618|FG001|Overall Study|Withdrawal of Consent|6|||
154875109|NCT00637273|558968619|FG002|Overall Study|Withdrawal of Consent|18|||
154875110|NCT00637273|558968617|FG000|Overall Study|Investigator Decision|1|||
154875111|NCT00637273|558968618|FG001|Overall Study|Investigator Decision|3|||
154875112|NCT00637273|558968619|FG002|Overall Study|Investigator Decision|1|||
154875113|NCT00637273|558968617|FG000|Overall Study|Administrative|2|||
154875114|NCT00637273|558968618|FG001|Overall Study|Administrative|0|||
154875115|NCT00637273|558968619|FG002|Overall Study|Administrative|0|||
154875116|NCT00637273|558968617|FG000|Overall Study|Loss of Glucose Control|1|||
154875117|NCT00637273|558968618|FG001|Overall Study|Loss of Glucose Control|1|||
154875118|NCT00637273|558968619|FG002|Overall Study|Loss of Glucose Control|1|||
154875119|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
154875120|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
154875121|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
154875122|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
154875123|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
154875124|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
154875125|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
154875126|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
154875127|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
154875128|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
154875129|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
154875130|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
154875131|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
154875132|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
154875133|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
154875134|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
154875135|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
154875136|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
154875137|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
154875138|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
154875139|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
154875140|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Other|0|||
154875141|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Other|1|||
154875142|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Other|0|||
154875143|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Other|0|||
154875144|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Other|0|||
155112085|NCT00673231|559838532|FG002|Overall Study|Lost to Follow-up|1|||
154875145|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Other|0|||
154875146|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Other|0|||
154875147|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
154875148|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
154875149|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
154875150|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
155112086|NCT00673231|559838533|FG003|Overall Study|Lost to Follow-up|2|||
155112087|NCT00673231|559838530|FG000|Overall Study|Death|0|||
155112088|NCT00673231|559838531|FG001|Overall Study|Death|0|||
155112089|NCT00673231|559838532|FG002|Overall Study|Death|1|||
155112090|NCT00673231|559838533|FG003|Overall Study|Death|0|||
155112091|NCT00673231|559838530|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
155112092|NCT00673231|559838531|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
155112093|NCT00673231|559838532|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
155112094|NCT00673231|559838533|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
155112095|NCT02952313|559838534|FG000|Primary Endpoint|Lost to Follow-up|4|||
155112096|NCT02952313|559838534|FG000|Primary Endpoint|Withdrawal by Subject|1|||
155112097|NCT02952313|559838534|FG000|Primary Endpoint|Lack of Efficacy|1|||
155112098|NCT02952313|559838534|FG000|Primary Endpoint|Missed visit|1|||
155112099|NCT02952313|559838534|FG000|Long-term Follow-up|Lost to Follow-up|12|||
155112100|NCT02952313|559838534|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
155112101|NCT02952313|559838534|FG000|Long-term Follow-up|Lack of Efficacy|6|||
155112102|NCT02952313|559838534|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
155112103|NCT02952313|559838534|FG000|Long-term Follow-up|Physician Decision|1|||
155112104|NCT02952313|559838534|FG000|Long-term Follow-up|Death|1|||
155112105|NCT02265536|559838541|FG000|Overall Study|Adverse Event|1|||
155112106|NCT02265536|559838542|FG001|Overall Study|Adverse Event|0|||
155112107|NCT02265536|559838543|FG002|Overall Study|Adverse Event|0|||
155112108|NCT02265536|559838544|FG003|Overall Study|Adverse Event|0|||
155112109|NCT02265536|559838545|FG004|Overall Study|Adverse Event|1|||
155112110|NCT02265536|559838546|FG005|Overall Study|Adverse Event|0|||
155112111|NCT02265536|559838541|FG000|Overall Study|Physician Decision|0|||
155112112|NCT02265536|559838542|FG001|Overall Study|Physician Decision|0|||
155112113|NCT02265536|559838543|FG002|Overall Study|Physician Decision|0|||
155112114|NCT02265536|559838544|FG003|Overall Study|Physician Decision|0|||
155112115|NCT02265536|559838545|FG004|Overall Study|Physician Decision|2|||
155112116|NCT02265536|559838546|FG005|Overall Study|Physician Decision|0|||
155112117|NCT02265536|559838541|FG000|Overall Study|Withdrawal by Subject|0|||
154974264|NCT01628549|559331217|FG000|Overall Study|positive pregnancy test|0|||
154974265|NCT01628549|559331218|FG001|Overall Study|positive pregnancy test|0|||
154974266|NCT01628549|559331219|FG002|Overall Study|positive pregnancy test|0|||
154974267|NCT01628549|559331220|FG003|Overall Study|positive pregnancy test|1|||
154974268|NCT06128525|559331221|FG000|Overall Study|Patient withdrew consent|1|||
154974269|NCT01344018|559331229|FG000|Overall Study|Death|22|||
155112118|NCT02265536|559838542|FG001|Overall Study|Withdrawal by Subject|3|||
155112119|NCT02265536|559838543|FG002|Overall Study|Withdrawal by Subject|0|||
155112120|NCT02265536|559838544|FG003|Overall Study|Withdrawal by Subject|0|||
155112121|NCT02265536|559838545|FG004|Overall Study|Withdrawal by Subject|0|||
155112122|NCT02265536|559838546|FG005|Overall Study|Withdrawal by Subject|0|||
155112123|NCT02907216|559838549|FG000|Overall Study|No benefit to be obtained by continuing|0|||
155112124|NCT02907216|559838550|FG001|Overall Study|No benefit to be obtained by continuing|1|||
155112125|NCT02907216|559838549|FG000|Overall Study|Withdrawal by Subject|1|||
155112126|NCT02907216|559838550|FG001|Overall Study|Withdrawal by Subject|0|||
155112127|NCT02095873|559838552|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155112128|NCT02095873|559838553|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155112129|NCT02095873|559838552|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
155112130|NCT02095873|559838553|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
155112131|NCT02095873|559838552|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
155112132|NCT02095873|559838553|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
155112133|NCT02791516|559838558|FG000|Overall Study|Withdrawal by Subject|1|||
155112134|NCT02791516|559838559|FG001|Overall Study|Withdrawal by Subject|1|||
155112135|NCT02524275|559838560|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
155112136|NCT00511433|559840708|FG000|Overall Study|Adverse Event|5|||
155112137|NCT00511433|559840709|FG001|Overall Study|Adverse Event|0|||
155112138|NCT00511433|559840708|FG000|Overall Study|Other Reason|1|||
155112139|NCT00511433|559840709|FG001|Overall Study|Other Reason|1|||
155112140|NCT00197145|559840710|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
155112141|NCT00197145|559840711|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
154974270|NCT01344018|559331230|FG001|Overall Study|Death|25|||
154974271|NCT01344018|559331229|FG000|Overall Study|Lost to Follow-up|4|||
155112142|NCT00197145|559840710|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
155112143|NCT00197145|559840711|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
155112144|NCT00197145|559840710|FG000|Period 1: Randomized Treatment Phase|Other|2|||
155112145|NCT00197145|559840711|FG001|Period 1: Randomized Treatment Phase|Other|2|||
155112146|NCT00197145|559840710|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
155112147|NCT00197145|559840711|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
155112148|NCT00197145|559840710|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
155112149|NCT00197145|559840711|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
155112150|NCT00197145|559840710|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
154974272|NCT01344018|559331230|FG001|Overall Study|Lost to Follow-up|7|||
155112151|NCT00197145|559840711|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
155112152|NCT00197145|559840710|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
155112153|NCT00197145|559840711|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
155112154|NCT00197145|559840710|FG000|Period 2 : Open Label Phase|Other|1|||
155112155|NCT00197145|559840711|FG001|Period 2 : Open Label Phase|Other|0|||
155112156|NCT00978380|559840712|FG000|Overall Study|Protocol Violation|2|||
155112157|NCT00978380|559840712|FG000|Overall Study|Withdrawal criteria|9|||
155112158|NCT00978380|559840712|FG000|Overall Study|Unclassified|8|||
155112159|NCT02199314|559840713|FG000|Overall Study|Withdrawal by Subject|6|||
155112160|NCT02199314|559840713|FG000|Overall Study|Physician Decision|10|||
155112161|NCT03764631|559840719|FG000|Overall Study|Personal Reasons|3|||
155112162|NCT03764631|559840720|FG001|Overall Study|Personal Reasons|2|||
155112163|NCT03764631|559840719|FG000|Overall Study|Switching Therapy|3|||
155112164|NCT03764631|559840720|FG001|Overall Study|Switching Therapy|3|||
155112165|NCT03764631|559840719|FG000|Overall Study|Adverse Event|0|||
155112166|NCT03764631|559840720|FG001|Overall Study|Adverse Event|1|||
155112167|NCT03764631|559840719|FG000|Overall Study|Lost to Follow-up|33|||
155112168|NCT03764631|559840720|FG001|Overall Study|Lost to Follow-up|41|||
155112169|NCT03764631|559840719|FG000|Overall Study|No data as study site was closed|2|||
155112170|NCT03764631|559840720|FG001|Overall Study|No data as study site was closed|6|||
155112171|NCT01289353|559840721|FG000|Overall Study|Lost to Follow-up|2|||
155112172|NCT01549886|559840722|FG000|Overall Study|Sponsor's decision|2|||
154875151|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
154875152|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
154875153|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
154875154|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
154875155|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
154875156|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
154875157|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
154875158|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
154875159|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
154875160|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
154875161|NCT00365716|558968620|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
154875162|NCT00365716|558968621|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
154875163|NCT00365716|558968622|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
154875164|NCT00365716|558968623|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
154875165|NCT00365716|558968624|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
154875166|NCT00365716|558968625|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
154875167|NCT00365716|558968626|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
154875168|NCT00365716|558968620|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
154875169|NCT00365716|558968621|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
154875170|NCT00365716|558968622|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
154875171|NCT00365716|558968623|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
154875172|NCT00365716|558968624|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
154875173|NCT00365716|558968625|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
154875174|NCT00365716|558968626|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
154875175|NCT00365716|558968620|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
154875176|NCT00365716|558968621|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
154875177|NCT00365716|558968622|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
154875178|NCT00365716|558968623|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
154875179|NCT00365716|558968624|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
154875180|NCT00365716|558968625|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
154875181|NCT00365716|558968626|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
154875182|NCT00365716|558968620|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
154875183|NCT00365716|558968621|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
154875184|NCT00365716|558968622|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
154875185|NCT00365716|558968623|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
154875186|NCT00365716|558968624|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
154875187|NCT00365716|558968625|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
154875188|NCT00365716|558968626|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
155112173|NCT01549886|559840723|FG001|Overall Study|Sponsor's decision|3|||
155112174|NCT01466660|559840731|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
155112175|NCT01466660|559840732|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
154875189|NCT00365716|558968620|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
155112176|NCT01466660|559840731|FG000|Overall Study|Worsening of underlying cancer disease|5|||
155112177|NCT01466660|559840732|FG001|Overall Study|Worsening of underlying cancer disease|2|||
155112178|NCT01466660|559840731|FG000|Overall Study|Other adverse event|19|||
155112179|NCT01466660|559840732|FG001|Overall Study|Other adverse event|18|||
155112180|NCT01466660|559840731|FG000|Overall Study|Protocol Violation|2|||
155112181|NCT01466660|559840732|FG001|Overall Study|Protocol Violation|1|||
154875190|NCT00365716|558968621|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
154875191|NCT00365716|558968622|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
154875192|NCT00365716|558968623|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
154875193|NCT00365716|558968624|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
154875194|NCT00365716|558968625|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
154875195|NCT00365716|558968626|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
154875196|NCT00365716|558968620|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
154875197|NCT00365716|558968621|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
154875198|NCT00365716|558968622|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
154875199|NCT00365716|558968623|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
154875200|NCT00365716|558968624|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
154875201|NCT00365716|558968625|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
154875202|NCT00365716|558968626|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
154875203|NCT00365716|558968620|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
154875204|NCT00365716|558968621|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
154875205|NCT00365716|558968622|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
154875206|NCT00365716|558968623|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
154974273|NCT01332968|559331232|FG000|Induction Period|Adverse Event|23|||
154974274|NCT01332968|559331233|FG001|Induction Period|Adverse Event|26|||
154974275|NCT01332968|559331234|FG002|Induction Period|Adverse Event|0|||
154974276|NCT01332968|559331235|FG003|Induction Period|Adverse Event|0|||
154974277|NCT01332968|559331236|FG004|Induction Period|Adverse Event|0|||
155112182|NCT01466660|559840731|FG000|Overall Study|Refused continuation of trial medication|4|||
155112183|NCT01466660|559840732|FG001|Overall Study|Refused continuation of trial medication|3|||
155112184|NCT01466660|559840731|FG000|Overall Study|Other reason not defined above|10|||
155112185|NCT01466660|559840732|FG001|Overall Study|Other reason not defined above|8|||
155112186|NCT03576066|559840733|FG000|Overall Study|Noncompliance with study drug|0|||
155112187|NCT03576066|559840734|FG001|Overall Study|Noncompliance with study drug|1|||
155112188|NCT00365105|559840735|FG000|Overall Study|Protocol Violation|5|||
155112189|NCT00365105|559840736|FG001|Overall Study|Protocol Violation|8|||
155112190|NCT06004895|559840737|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
155112191|NCT06004895|559840737|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
155112192|NCT00425698|559840738|FG000|Overall Study|Adverse Event|3|||
155112193|NCT00425698|559840739|FG001|Overall Study|Adverse Event|1|||
155112194|NCT00425698|559840738|FG000|Overall Study|Withdrawal by Subject|0|||
155112195|NCT00425698|559840739|FG001|Overall Study|Withdrawal by Subject|1|||
155112196|NCT01328535|559840740|FG000|Overall Study|Ineligible|1|||
155112197|NCT01257230|559840741|FG000|Overall Study|Not Treated|0|||
155112198|NCT01257230|559840742|FG001|Overall Study|Not Treated|0|||
155112199|NCT01257230|559840743|FG002|Overall Study|Not Treated|1|||
155112200|NCT01257230|559840741|FG000|Overall Study|Adverse Event|2|||
155112201|NCT01257230|559840742|FG001|Overall Study|Adverse Event|0|||
155112202|NCT01257230|559840743|FG002|Overall Study|Adverse Event|0|||
155112203|NCT01257230|559840741|FG000|Overall Study|Lack of Efficacy|0|||
155112204|NCT01257230|559840742|FG001|Overall Study|Lack of Efficacy|1|||
155112205|NCT01257230|559840743|FG002|Overall Study|Lack of Efficacy|0|||
154974278|NCT01332968|559331237|FG005|Induction Period|Adverse Event|0|||
154974279|NCT01332968|559331238|FG006|Induction Period|Adverse Event|0|||
154974280|NCT01332968|559331239|FG007|Induction Period|Adverse Event|0|||
154974281|NCT01332968|559331232|FG000|Induction Period|Death|1|||
154974282|NCT01332968|559331233|FG001|Induction Period|Death|4|||
154974283|NCT01332968|559331234|FG002|Induction Period|Death|0|||
154974284|NCT01332968|559331235|FG003|Induction Period|Death|0|||
154974285|NCT01332968|559331236|FG004|Induction Period|Death|0|||
154974286|NCT01332968|559331237|FG005|Induction Period|Death|0|||
155112206|NCT01257230|559840741|FG000|Overall Study|Protocol Violation|3|||
154974287|NCT01332968|559331238|FG006|Induction Period|Death|0|||
154974288|NCT01332968|559331239|FG007|Induction Period|Death|0|||
154974289|NCT01332968|559331232|FG000|Induction Period|Non-compliance|1|||
154974290|NCT01332968|559331233|FG001|Induction Period|Non-compliance|0|||
154974291|NCT01332968|559331234|FG002|Induction Period|Non-compliance|0|||
154974292|NCT01332968|559331235|FG003|Induction Period|Non-compliance|0|||
155112207|NCT01257230|559840742|FG001|Overall Study|Protocol Violation|0|||
155112208|NCT01257230|559840743|FG002|Overall Study|Protocol Violation|1|||
155112209|NCT01257230|559840741|FG000|Overall Study|Withdrawal by Subject|0|||
155112210|NCT01257230|559840742|FG001|Overall Study|Withdrawal by Subject|4|||
155175337|NCT00910624|560080228|FG002|Treatment Phase|Adverse Event|6|||
155175338|NCT00910624|560080229|FG003|Treatment Phase|Adverse Event|0|||
154974293|NCT01332968|559331236|FG004|Induction Period|Non-compliance|0|||
154974294|NCT01332968|559331237|FG005|Induction Period|Non-compliance|0|||
154974295|NCT01332968|559331238|FG006|Induction Period|Non-compliance|0|||
154974296|NCT01332968|559331239|FG007|Induction Period|Non-compliance|0|||
154974297|NCT01332968|559331232|FG000|Induction Period|Other|2|||
155112211|NCT01257230|559840743|FG002|Overall Study|Withdrawal by Subject|1|||
155175339|NCT00910624|560080226|FG000|Treatment Phase|Treatment Failure|23|||
154875207|NCT00365716|558968624|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
154875208|NCT00365716|558968625|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
154875209|NCT00365716|558968626|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
154875210|NCT00365716|558968620|FG000|Extension 1|Lost to Follow-up|0|||
154875211|NCT00365716|558968621|FG001|Extension 1|Lost to Follow-up|0|||
154875212|NCT00365716|558968622|FG002|Extension 1|Lost to Follow-up|0|||
154875213|NCT00365716|558968623|FG003|Extension 1|Lost to Follow-up|0|||
154875214|NCT00365716|558968624|FG004|Extension 1|Lost to Follow-up|0|||
154875215|NCT00365716|558968625|FG005|Extension 1|Lost to Follow-up|1|||
154875216|NCT00365716|558968626|FG006|Extension 1|Lost to Follow-up|0|||
154875217|NCT00365716|558968620|FG000|Extension 1|Other|0|||
154875218|NCT00365716|558968621|FG001|Extension 1|Other|0|||
154875219|NCT00365716|558968622|FG002|Extension 1|Other|0|||
154875220|NCT00365716|558968623|FG003|Extension 1|Other|0|||
154875221|NCT00365716|558968624|FG004|Extension 1|Other|0|||
154875222|NCT00365716|558968625|FG005|Extension 1|Other|9|||
154875223|NCT00365716|558968626|FG006|Extension 1|Other|0|||
154875224|NCT00365716|558968620|FG000|Extension 1|Moved|0|||
154875225|NCT00365716|558968621|FG001|Extension 1|Moved|0|||
154875226|NCT00365716|558968622|FG002|Extension 1|Moved|0|||
154875227|NCT00365716|558968623|FG003|Extension 1|Moved|0|||
154875228|NCT00365716|558968624|FG004|Extension 1|Moved|0|||
154875229|NCT00365716|558968625|FG005|Extension 1|Moved|4|||
154875230|NCT00365716|558968626|FG006|Extension 1|Moved|0|||
154875231|NCT00365716|558968620|FG000|Extension 1|Withdrawal by Subject|0|||
154875232|NCT00365716|558968621|FG001|Extension 1|Withdrawal by Subject|0|||
154875233|NCT00365716|558968622|FG002|Extension 1|Withdrawal by Subject|0|||
154875234|NCT00365716|558968623|FG003|Extension 1|Withdrawal by Subject|0|||
154875235|NCT00365716|558968624|FG004|Extension 1|Withdrawal by Subject|0|||
154875236|NCT00365716|558968625|FG005|Extension 1|Withdrawal by Subject|3|||
154875237|NCT00365716|558968626|FG006|Extension 1|Withdrawal by Subject|0|||
154875238|NCT00365716|558968620|FG000|Extension 1|Pregnancy|0|||
154875239|NCT00365716|558968621|FG001|Extension 1|Pregnancy|0|||
154875240|NCT00365716|558968622|FG002|Extension 1|Pregnancy|0|||
154875241|NCT00365716|558968623|FG003|Extension 1|Pregnancy|0|||
154875242|NCT00365716|558968624|FG004|Extension 1|Pregnancy|0|||
154875243|NCT00365716|558968625|FG005|Extension 1|Pregnancy|4|||
154875244|NCT00365716|558968626|FG006|Extension 1|Pregnancy|0|||
154875245|NCT00365716|558968620|FG000|Extension 1|Protocol Violation|0|||
154875246|NCT00365716|558968621|FG001|Extension 1|Protocol Violation|0|||
154875247|NCT00365716|558968622|FG002|Extension 1|Protocol Violation|0|||
154875248|NCT00365716|558968623|FG003|Extension 1|Protocol Violation|0|||
154875249|NCT00365716|558968624|FG004|Extension 1|Protocol Violation|0|||
154875250|NCT00365716|558968625|FG005|Extension 1|Protocol Violation|1|||
154875251|NCT00365716|558968626|FG006|Extension 1|Protocol Violation|0|||
154875252|NCT00365716|558968620|FG000|Extension 2|Lost to Follow-up|0|||
154875253|NCT00365716|558968621|FG001|Extension 2|Lost to Follow-up|0|||
154875254|NCT00365716|558968622|FG002|Extension 2|Lost to Follow-up|0|||
154875255|NCT00365716|558968623|FG003|Extension 2|Lost to Follow-up|0|||
154875256|NCT00365716|558968624|FG004|Extension 2|Lost to Follow-up|0|||
154875257|NCT00365716|558968625|FG005|Extension 2|Lost to Follow-up|0|||
154875258|NCT00365716|558968626|FG006|Extension 2|Lost to Follow-up|2|||
154875259|NCT00365716|558968620|FG000|Extension 2|Other|0|||
154875260|NCT00365716|558968621|FG001|Extension 2|Other|0|||
154875261|NCT00365716|558968622|FG002|Extension 2|Other|0|||
154875262|NCT00365716|558968623|FG003|Extension 2|Other|0|||
154875263|NCT00365716|558968624|FG004|Extension 2|Other|0|||
154875264|NCT00365716|558968625|FG005|Extension 2|Other|0|||
154875265|NCT00365716|558968626|FG006|Extension 2|Other|3|||
154875266|NCT00365716|558968620|FG000|Extension 2|Withdrawal by Subject|0|||
154875267|NCT00365716|558968621|FG001|Extension 2|Withdrawal by Subject|0|||
154875268|NCT00365716|558968622|FG002|Extension 2|Withdrawal by Subject|0|||
154875269|NCT00365716|558968623|FG003|Extension 2|Withdrawal by Subject|0|||
154875270|NCT00365716|558968624|FG004|Extension 2|Withdrawal by Subject|0|||
154875271|NCT00365716|558968625|FG005|Extension 2|Withdrawal by Subject|0|||
154875272|NCT00365716|558968626|FG006|Extension 2|Withdrawal by Subject|5|||
154875273|NCT03649321|558968628|FG000|Overall Study|Withdrawal by Subject|1|||
154875274|NCT03649321|558968629|FG001|Overall Study|Withdrawal by Subject|0|||
154875275|NCT03649321|558968628|FG000|Overall Study|Death|1|||
154875276|NCT03649321|558968629|FG001|Overall Study|Death|0|||
154875277|NCT00002663|558968630|FG000|Overall Study|Death|4|||
154875278|NCT00002663|558968631|FG001|Overall Study|Death|1|||
154875279|NCT00002663|558968632|FG002|Overall Study|Death|1|||
154875280|NCT00002663|558968633|FG003|Overall Study|Death|0|||
154875281|NCT00002663|558968634|FG004|Overall Study|Death|0|||
154875282|NCT00002663|558968635|FG005|Overall Study|Death|13|||
154875283|NCT00002663|558968636|FG006|Overall Study|Death|0|||
154875284|NCT00002663|558968637|FG007|Overall Study|Death|1|||
154875285|NCT00002663|558968638|FG008|Overall Study|Death|1|||
154875286|NCT00002663|558968639|FG009|Overall Study|Death|1|||
154875287|NCT00002663|558968630|FG000|Overall Study|Lost to Follow-up|3|||
154875288|NCT00002663|558968631|FG001|Overall Study|Lost to Follow-up|0|||
154875289|NCT00002663|558968632|FG002|Overall Study|Lost to Follow-up|0|||
154875290|NCT00002663|558968633|FG003|Overall Study|Lost to Follow-up|1|||
154875291|NCT00002663|558968634|FG004|Overall Study|Lost to Follow-up|0|||
154974298|NCT01332968|559331233|FG001|Induction Period|Other|2|||
154974299|NCT01332968|559331234|FG002|Induction Period|Other|0|||
154974300|NCT01332968|559331235|FG003|Induction Period|Other|0|||
154974301|NCT01332968|559331236|FG004|Induction Period|Other|0|||
154974302|NCT01332968|559331237|FG005|Induction Period|Other|0|||
154974303|NCT01332968|559331238|FG006|Induction Period|Other|0|||
154974304|NCT01332968|559331239|FG007|Induction Period|Other|0|||
154974305|NCT01332968|559331232|FG000|Induction Period|Physician Decision|6|||
154974306|NCT01332968|559331233|FG001|Induction Period|Physician Decision|1|||
154974307|NCT01332968|559331234|FG002|Induction Period|Physician Decision|0|||
154974308|NCT01332968|559331235|FG003|Induction Period|Physician Decision|0|||
154974309|NCT01332968|559331236|FG004|Induction Period|Physician Decision|0|||
154974310|NCT01332968|559331237|FG005|Induction Period|Physician Decision|0|||
154974311|NCT01332968|559331238|FG006|Induction Period|Physician Decision|0|||
154974312|NCT01332968|559331239|FG007|Induction Period|Physician Decision|0|||
154974313|NCT01332968|559331232|FG000|Induction Period|Progressive Disease|15|||
154974314|NCT01332968|559331233|FG001|Induction Period|Progressive Disease|7|||
154974315|NCT01332968|559331234|FG002|Induction Period|Progressive Disease|0|||
154974316|NCT01332968|559331235|FG003|Induction Period|Progressive Disease|0|||
154974317|NCT01332968|559331236|FG004|Induction Period|Progressive Disease|0|||
154974318|NCT01332968|559331237|FG005|Induction Period|Progressive Disease|0|||
154974319|NCT01332968|559331238|FG006|Induction Period|Progressive Disease|0|||
154974320|NCT01332968|559331239|FG007|Induction Period|Progressive Disease|0|||
154875292|NCT00002663|558968635|FG005|Overall Study|Lost to Follow-up|1|||
154875293|NCT00002663|558968636|FG006|Overall Study|Lost to Follow-up|0|||
154875294|NCT00002663|558968637|FG007|Overall Study|Lost to Follow-up|0|||
154875295|NCT00002663|558968638|FG008|Overall Study|Lost to Follow-up|0|||
154875296|NCT00002663|558968639|FG009|Overall Study|Lost to Follow-up|0|||
154875297|NCT00002663|558968630|FG000|Overall Study|Other|0|||
154875298|NCT00002663|558968631|FG001|Overall Study|Other|1|||
154875299|NCT00002663|558968632|FG002|Overall Study|Other|0|||
154875300|NCT00002663|558968633|FG003|Overall Study|Other|0|||
154875301|NCT00002663|558968634|FG004|Overall Study|Other|0|||
154875302|NCT00002663|558968635|FG005|Overall Study|Other|1|||
154875303|NCT00002663|558968636|FG006|Overall Study|Other|1|||
154875304|NCT00002663|558968637|FG007|Overall Study|Other|0|||
154875305|NCT00002663|558968638|FG008|Overall Study|Other|0|||
154875306|NCT00002663|558968639|FG009|Overall Study|Other|0|||
154875307|NCT00002663|558968630|FG000|Overall Study|Physician Decision|0|||
154875308|NCT00002663|558968631|FG001|Overall Study|Physician Decision|0|||
154875309|NCT00002663|558968632|FG002|Overall Study|Physician Decision|0|||
154875310|NCT00002663|558968633|FG003|Overall Study|Physician Decision|0|||
154875311|NCT00002663|558968634|FG004|Overall Study|Physician Decision|1|||
154875312|NCT00002663|558968635|FG005|Overall Study|Physician Decision|0|||
154875313|NCT00002663|558968636|FG006|Overall Study|Physician Decision|0|||
154875314|NCT00002663|558968637|FG007|Overall Study|Physician Decision|0|||
154875315|NCT00002663|558968638|FG008|Overall Study|Physician Decision|1|||
154875316|NCT00002663|558968639|FG009|Overall Study|Physician Decision|1|||
154875317|NCT00002663|558968630|FG000|Overall Study|Adverse Event|0|||
154875318|NCT00002663|558968631|FG001|Overall Study|Adverse Event|0|||
154875319|NCT00002663|558968632|FG002|Overall Study|Adverse Event|0|||
154875320|NCT00002663|558968633|FG003|Overall Study|Adverse Event|1|||
154875321|NCT00002663|558968634|FG004|Overall Study|Adverse Event|0|||
154875322|NCT00002663|558968635|FG005|Overall Study|Adverse Event|0|||
154875323|NCT00002663|558968636|FG006|Overall Study|Adverse Event|0|||
154875324|NCT00002663|558968637|FG007|Overall Study|Adverse Event|1|||
154875325|NCT00002663|558968638|FG008|Overall Study|Adverse Event|0|||
154875326|NCT00002663|558968639|FG009|Overall Study|Adverse Event|0|||
154875327|NCT00751101|558968640|FG000|Overall Study|Withdrawal by Subject|1|||
154875328|NCT00751101|558968641|FG001|Overall Study|Withdrawal by Subject|0|||
154875329|NCT00751101|558968640|FG000|Overall Study|No HFS / Never Started Patch/|0|||
154974321|NCT01332968|559331232|FG000|Induction Period|Protocol Violation|3|||
154974322|NCT01332968|559331233|FG001|Induction Period|Protocol Violation|4|||
154974323|NCT01332968|559331234|FG002|Induction Period|Protocol Violation|0|||
154974324|NCT01332968|559331235|FG003|Induction Period|Protocol Violation|0|||
154974325|NCT01332968|559331236|FG004|Induction Period|Protocol Violation|0|||
154875330|NCT00751101|558968641|FG001|Overall Study|No HFS / Never Started Patch/|4|||
154974326|NCT01332968|559331237|FG005|Induction Period|Protocol Violation|0|||
155112212|NCT01257230|559840741|FG000|Overall Study|Other reason not defined above|1|||
154875331|NCT00751101|558968640|FG000|Overall Study|Never began capecitabine|1|||
154875332|NCT00751101|558968641|FG001|Overall Study|Never began capecitabine|0|||
154875333|NCT00751101|558968640|FG000|Overall Study|Physician Decision|0|||
154875334|NCT00751101|558968641|FG001|Overall Study|Physician Decision|1|||
154875335|NCT01905397|558968642|FG000|Overall Study|Death|0|||
154875336|NCT01905397|558968643|FG001|Overall Study|Death|1|||
154875337|NCT01905397|558968642|FG000|Overall Study|Withdrawal by Subject|2|||
154875338|NCT01905397|558968643|FG001|Overall Study|Withdrawal by Subject|0|||
154974327|NCT01332968|559331238|FG006|Induction Period|Protocol Violation|0|||
154974328|NCT01332968|559331239|FG007|Induction Period|Protocol Violation|0|||
154974329|NCT01332968|559331232|FG000|Induction Period|Withdrawal by Subject|3|||
154974330|NCT01332968|559331233|FG001|Induction Period|Withdrawal by Subject|5|||
154974331|NCT01332968|559331234|FG002|Induction Period|Withdrawal by Subject|0|||
154974332|NCT01332968|559331235|FG003|Induction Period|Withdrawal by Subject|0|||
154974333|NCT01332968|559331236|FG004|Induction Period|Withdrawal by Subject|0|||
154974334|NCT01332968|559331237|FG005|Induction Period|Withdrawal by Subject|0|||
154974335|NCT01332968|559331238|FG006|Induction Period|Withdrawal by Subject|0|||
154974336|NCT01332968|559331239|FG007|Induction Period|Withdrawal by Subject|0|||
154974337|NCT01332968|559331232|FG000|Induction Period|Randomised but not treated|4|||
154974338|NCT01332968|559331233|FG001|Induction Period|Randomised but not treated|7|||
154974339|NCT01332968|559331234|FG002|Induction Period|Randomised but not treated|0|||
154974340|NCT01332968|559331235|FG003|Induction Period|Randomised but not treated|0|||
154974341|NCT01332968|559331236|FG004|Induction Period|Randomised but not treated|0|||
154974342|NCT01332968|559331237|FG005|Induction Period|Randomised but not treated|0|||
154875339|NCT01905397|558968642|FG000|Overall Study|Surgery canceled/aborted|9|||
154875340|NCT01905397|558968643|FG001|Overall Study|Surgery canceled/aborted|5|||
154875341|NCT01905397|558968642|FG000|Overall Study|Incision < 7 cm|2|||
154875342|NCT01905397|558968643|FG001|Overall Study|Incision < 7 cm|0|||
154875343|NCT01905397|558968642|FG000|Overall Study|Wrong treatment|1|||
154875344|NCT01905397|558968643|FG001|Overall Study|Wrong treatment|1|||
154875345|NCT01905397|558968642|FG000|Overall Study|Device not applied|3|||
154875346|NCT01905397|558968643|FG001|Overall Study|Device not applied|0|||
154875347|NCT01905397|558968642|FG000|Overall Study|Dressing not applied in operating room|1|||
154875348|NCT01905397|558968643|FG001|Overall Study|Dressing not applied in operating room|0|||
154875349|NCT01905397|558968642|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
154875350|NCT01905397|558968643|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
154875351|NCT01921270|558968647|FG000|Overall Study|Withdrawal by Subject|1|||
154875352|NCT00844428|558968648|FG000|Screening Period|Screen Failure|3|||
154875353|NCT00844428|558968648|FG000|Extension Treatment Period|Death|1|||
154875354|NCT00844428|558968648|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
154875355|NCT00789477|558968649|FG000|Overall Study|Withdrawal by Subject|2|||
154974343|NCT01332968|559331238|FG006|Induction Period|Randomised but not treated|0|||
154974344|NCT01332968|559331239|FG007|Induction Period|Randomised but not treated|0|||
154974345|NCT01332968|559331232|FG000|Maintenance/Observation Period|Adverse Event|0|||
154974346|NCT01332968|559331233|FG001|Maintenance/Observation Period|Adverse Event|0|||
154974347|NCT01332968|559331234|FG002|Maintenance/Observation Period|Adverse Event|53|||
154974348|NCT01332968|559331235|FG003|Maintenance/Observation Period|Adverse Event|66|||
154974349|NCT01332968|559331236|FG004|Maintenance/Observation Period|Adverse Event|0|||
154974350|NCT01332968|559331237|FG005|Maintenance/Observation Period|Adverse Event|0|||
154974351|NCT01332968|559331238|FG006|Maintenance/Observation Period|Adverse Event|0|||
154974352|NCT01332968|559331239|FG007|Maintenance/Observation Period|Adverse Event|0|||
154974353|NCT01332968|559331232|FG000|Maintenance/Observation Period|Death|0|||
154974354|NCT01332968|559331233|FG001|Maintenance/Observation Period|Death|0|||
154974355|NCT01332968|559331234|FG002|Maintenance/Observation Period|Death|5|||
154974356|NCT01332968|559331235|FG003|Maintenance/Observation Period|Death|6|||
154974357|NCT01332968|559331236|FG004|Maintenance/Observation Period|Death|0|||
154974358|NCT01332968|559331237|FG005|Maintenance/Observation Period|Death|0|||
154974359|NCT01332968|559331238|FG006|Maintenance/Observation Period|Death|0|||
154974360|NCT01332968|559331239|FG007|Maintenance/Observation Period|Death|0|||
154974361|NCT01332968|559331232|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
154974362|NCT01332968|559331233|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
154974363|NCT01332968|559331234|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
154974364|NCT01332968|559331235|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
154974365|NCT01332968|559331236|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
155112213|NCT01257230|559840742|FG001|Overall Study|Other reason not defined above|5|||
155112214|NCT01257230|559840743|FG002|Overall Study|Other reason not defined above|3|||
154974366|NCT01332968|559331237|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
154974367|NCT01332968|559331238|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
154974368|NCT01332968|559331239|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
154974369|NCT01332968|559331232|FG000|Maintenance/Observation Period|Non-compliance|0|||
154974370|NCT01332968|559331233|FG001|Maintenance/Observation Period|Non-compliance|0|||
154974371|NCT01332968|559331234|FG002|Maintenance/Observation Period|Non-compliance|4|||
154974372|NCT01332968|559331235|FG003|Maintenance/Observation Period|Non-compliance|3|||
154974373|NCT01332968|559331236|FG004|Maintenance/Observation Period|Non-compliance|0|||
155112215|NCT01126268|559840751|FG000|Overall Study|Adverse Event|1|||
155112216|NCT03425006|559840752|FG000|Overall Study|Withdrawal by Subject|1|||
155112217|NCT03425006|559840752|FG000|Overall Study|Physician Decision|1|||
154875356|NCT00789477|558968650|FG001|Overall Study|Withdrawal by Subject|1|||
154875357|NCT00789477|558968651|FG002|Overall Study|Withdrawal by Subject|3|||
155112218|NCT03425006|559840752|FG000|Overall Study|Death|1|||
154875358|NCT00789477|558968652|FG003|Overall Study|Withdrawal by Subject|2|||
154875359|NCT00789477|558968653|FG004|Overall Study|Withdrawal by Subject|3|||
154974374|NCT01332968|559331237|FG005|Maintenance/Observation Period|Non-compliance|0|||
154974375|NCT01332968|559331238|FG006|Maintenance/Observation Period|Non-compliance|0|||
155112219|NCT03070171|559840760|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
155112220|NCT03070171|559840761|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
155112221|NCT03070171|559840760|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
155112222|NCT03070171|559840761|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
155112223|NCT03655054|559840764|FG000|Overall Study|Lost to Follow-up|1|||
155112224|NCT01626118|559840765|FG000|Overall Study|Lack of Efficacy|1|||
155112225|NCT01626118|559840766|FG001|Overall Study|Lack of Efficacy|0|||
155112226|NCT01626118|559840767|FG002|Overall Study|Lack of Efficacy|1|||
155112227|NCT01626118|559840768|FG003|Overall Study|Lack of Efficacy|3|||
155112228|NCT01626118|559840765|FG000|Overall Study|Lost to Follow-up|1|||
155112229|NCT01626118|559840766|FG001|Overall Study|Lost to Follow-up|0|||
155112230|NCT01626118|559840767|FG002|Overall Study|Lost to Follow-up|0|||
155112231|NCT01626118|559840768|FG003|Overall Study|Lost to Follow-up|0|||
155112232|NCT01626118|559840765|FG000|Overall Study|Adverse Event|0|||
155112233|NCT01626118|559840766|FG001|Overall Study|Adverse Event|1|||
155112234|NCT01626118|559840767|FG002|Overall Study|Adverse Event|1|||
154875360|NCT00789477|558968649|FG000|Overall Study|Protocol Violation|1|||
154875361|NCT00789477|558968650|FG001|Overall Study|Protocol Violation|0|||
154875362|NCT00789477|558968651|FG002|Overall Study|Protocol Violation|0|||
154875363|NCT00789477|558968652|FG003|Overall Study|Protocol Violation|1|||
154875364|NCT00789477|558968653|FG004|Overall Study|Protocol Violation|0|||
154875365|NCT00789477|558968649|FG000|Overall Study|Adverse Event|3|||
154875366|NCT00789477|558968650|FG001|Overall Study|Adverse Event|3|||
154875367|NCT00789477|558968651|FG002|Overall Study|Adverse Event|1|||
154875368|NCT00789477|558968652|FG003|Overall Study|Adverse Event|0|||
154875369|NCT00789477|558968653|FG004|Overall Study|Adverse Event|0|||
154875370|NCT00789477|558968649|FG000|Overall Study|Death|1|||
154875371|NCT00789477|558968650|FG001|Overall Study|Death|1|||
154875372|NCT00789477|558968651|FG002|Overall Study|Death|2|||
154875373|NCT00789477|558968652|FG003|Overall Study|Death|2|||
154875374|NCT00789477|558968653|FG004|Overall Study|Death|0|||
154875375|NCT00789477|558968649|FG000|Overall Study|Lost to Follow-up|0|||
154875376|NCT00789477|558968650|FG001|Overall Study|Lost to Follow-up|1|||
154875377|NCT00789477|558968651|FG002|Overall Study|Lost to Follow-up|4|||
154875378|NCT00789477|558968652|FG003|Overall Study|Lost to Follow-up|2|||
154875379|NCT00789477|558968653|FG004|Overall Study|Lost to Follow-up|4|||
154875380|NCT00789477|558968649|FG000|Overall Study|Lack of Efficacy|2|||
154875381|NCT00789477|558968650|FG001|Overall Study|Lack of Efficacy|0|||
154875382|NCT00789477|558968651|FG002|Overall Study|Lack of Efficacy|0|||
154875383|NCT00789477|558968652|FG003|Overall Study|Lack of Efficacy|0|||
154875384|NCT00789477|558968653|FG004|Overall Study|Lack of Efficacy|0|||
154875385|NCT00789477|558968649|FG000|Overall Study|Other|2|||
154875386|NCT00789477|558968650|FG001|Overall Study|Other|0|||
154875387|NCT00789477|558968651|FG002|Overall Study|Other|1|||
154875388|NCT00789477|558968652|FG003|Overall Study|Other|3|||
154875389|NCT00789477|558968653|FG004|Overall Study|Other|0|||
154875390|NCT00455858|558968654|FG000|Overall Study|Lost to Follow-up|2|||
154875391|NCT00455858|558968654|FG000|Overall Study|Protocol Violation|1|||
154875392|NCT00455858|558968654|FG000|Overall Study|Lack of Efficacy|1|||
154875393|NCT00455858|558968654|FG000|Overall Study|Well controlled FPG without insulin|1|||
154875394|NCT00455858|558968654|FG000|Overall Study|Withdrawal|1|||
154875395|NCT01927562|558968655|FG000|Overall Study|Lost to Follow-up|30|||
154875396|NCT01927562|558968655|FG000|Overall Study|Withdrawal by Subject|3|||
154875397|NCT01927562|558968655|FG000|Overall Study|Physician Decision|5|||
154875398|NCT00642616|558968656|FG000|Overall Study|Adverse Event|2|||
154875399|NCT00642616|558968657|FG001|Overall Study|Adverse Event|0|||
154875400|NCT00642616|558968658|FG002|Overall Study|Adverse Event|1|||
154875401|NCT00642616|558968659|FG003|Overall Study|Adverse Event|0|||
154875402|NCT00642616|558968656|FG000|Overall Study|Study Terminated by Sponsor|7|||
154875403|NCT00642616|558968657|FG001|Overall Study|Study Terminated by Sponsor|6|||
154875404|NCT00642616|558968658|FG002|Overall Study|Study Terminated by Sponsor|4|||
154875405|NCT00642616|558968659|FG003|Overall Study|Study Terminated by Sponsor|5|||
154875406|NCT00642616|558968656|FG000|Overall Study|Withdrawal by Subject|0|||
154875407|NCT00642616|558968657|FG001|Overall Study|Withdrawal by Subject|1|||
154875408|NCT00642616|558968658|FG002|Overall Study|Withdrawal by Subject|1|||
155112235|NCT01626118|559840768|FG003|Overall Study|Adverse Event|0|||
155112236|NCT01626118|559840765|FG000|Overall Study|Investigator Decision|0|||
155112237|NCT01626118|559840766|FG001|Overall Study|Investigator Decision|1|||
155112238|NCT01626118|559840767|FG002|Overall Study|Investigator Decision|0|||
155112239|NCT01626118|559840768|FG003|Overall Study|Investigator Decision|0|||
155112240|NCT03931382|559840770|FG000|Overall Study|Equipment malfunction|2|||
154875409|NCT00642616|558968659|FG003|Overall Study|Withdrawal by Subject|1|||
154875410|NCT00642616|558968656|FG000|Overall Study|Protocol Violation|0|||
155112241|NCT03931382|559840771|FG001|Overall Study|Equipment malfunction|0|||
155112242|NCT03931382|559840772|FG002|Overall Study|Equipment malfunction|2|||
155112243|NCT03931382|559840770|FG000|Overall Study|Withdrawal by Subject|0|||
154875411|NCT00642616|558968657|FG001|Overall Study|Protocol Violation|0|||
154875412|NCT00642616|558968658|FG002|Overall Study|Protocol Violation|2|||
154875413|NCT00642616|558968659|FG003|Overall Study|Protocol Violation|0|||
154875414|NCT00642616|558968656|FG000|Overall Study|Physician Decision|0|||
155112244|NCT03931382|559840771|FG001|Overall Study|Withdrawal by Subject|1|||
155112245|NCT03931382|559840772|FG002|Overall Study|Withdrawal by Subject|0|||
155112246|NCT01864148|559840774|FG000|Overall Study|Other|2|||
154875415|NCT00642616|558968657|FG001|Overall Study|Physician Decision|0|||
154875416|NCT00642616|558968658|FG002|Overall Study|Physician Decision|1|||
154875417|NCT00642616|558968659|FG003|Overall Study|Physician Decision|1|||
154875418|NCT00399802|558968660|FG000|Overall Study|Adverse Event|0|||
154875419|NCT00399802|558968661|FG001|Overall Study|Adverse Event|2|||
154875420|NCT00399802|558968660|FG000|Overall Study|Participant discontinued by mistake|0|||
154875421|NCT00399802|558968661|FG001|Overall Study|Participant discontinued by mistake|1|||
154875422|NCT00542815|558968662|FG000|Overall Study|Adverse Event|19|||
154875423|NCT00542815|558968663|FG001|Overall Study|Adverse Event|6|||
154875424|NCT00542815|558968664|FG002|Overall Study|Adverse Event|9|||
154875425|NCT00542815|558968662|FG000|Overall Study|Death|10|||
154875426|NCT00542815|558968663|FG001|Overall Study|Death|7|||
154875427|NCT00542815|558968664|FG002|Overall Study|Death|3|||
154875428|NCT00542815|558968662|FG000|Overall Study|Lack of Efficacy|9|||
154875429|NCT00542815|558968663|FG001|Overall Study|Lack of Efficacy|2|||
154875430|NCT00542815|558968664|FG002|Overall Study|Lack of Efficacy|0|||
154875431|NCT00542815|558968662|FG000|Overall Study|Physician Decision|2|||
154875432|NCT00542815|558968663|FG001|Overall Study|Physician Decision|1|||
154875433|NCT00542815|558968664|FG002|Overall Study|Physician Decision|0|||
154875434|NCT00542815|558968662|FG000|Overall Study|Protocol Violation|1|||
154875435|NCT00542815|558968663|FG001|Overall Study|Protocol Violation|1|||
154875436|NCT00542815|558968664|FG002|Overall Study|Protocol Violation|2|||
154875437|NCT00542815|558968662|FG000|Overall Study|Withdrawal by Subject|41|||
154875438|NCT00542815|558968663|FG001|Overall Study|Withdrawal by Subject|5|||
154875439|NCT00542815|558968664|FG002|Overall Study|Withdrawal by Subject|8|||
154875440|NCT00542815|558968662|FG000|Overall Study|Other reasons|24|||
154875441|NCT00542815|558968663|FG001|Overall Study|Other reasons|10|||
154875442|NCT00542815|558968664|FG002|Overall Study|Other reasons|10|||
154875443|NCT04172831|558968665|FG000|Overall Study|Adverse Event|21|||
154875444|NCT04172831|558968666|FG001|Overall Study|Adverse Event|9|||
154875445|NCT04172831|558968665|FG000|Overall Study|Lack of Efficacy|2|||
154875446|NCT04172831|558968666|FG001|Overall Study|Lack of Efficacy|8|||
154875447|NCT04172831|558968665|FG000|Overall Study|Physician Decision|0|||
154875448|NCT04172831|558968666|FG001|Overall Study|Physician Decision|1|||
154875449|NCT04172831|558968665|FG000|Overall Study|Withdrawal by Subject|12|||
154875450|NCT04172831|558968666|FG001|Overall Study|Withdrawal by Subject|11|||
154875451|NCT04172831|558968665|FG000|Overall Study|Lost to Follow-up|4|||
154875452|NCT04172831|558968666|FG001|Overall Study|Lost to Follow-up|9|||
154875453|NCT04172831|558968665|FG000|Overall Study|COVID-19 related crisis|3|||
154875454|NCT04172831|558968666|FG001|Overall Study|COVID-19 related crisis|3|||
154875455|NCT04172831|558968665|FG000|Overall Study|Subject non-compliance|1|||
154875456|NCT04172831|558968666|FG001|Overall Study|Subject non-compliance|1|||
154875457|NCT04172831|558968665|FG000|Overall Study|Family emergency|1|||
154875458|NCT04172831|558968666|FG001|Overall Study|Family emergency|0|||
154875459|NCT01041573|558968667|FG000|Overall Study|Withdrawal by Subject|2|||
154875460|NCT01041573|558968668|FG001|Overall Study|Withdrawal by Subject|5|||
154875461|NCT01041573|558968669|FG002|Overall Study|Withdrawal by Subject|2|||
154875462|NCT01041573|558968670|FG003|Overall Study|Withdrawal by Subject|0|||
154875463|NCT01041573|558968667|FG000|Overall Study|Death|1|||
154875464|NCT01041573|558968668|FG001|Overall Study|Death|0|||
154875465|NCT01041573|558968669|FG002|Overall Study|Death|0|||
154875466|NCT01041573|558968670|FG003|Overall Study|Death|0|||
154875467|NCT01041573|558968667|FG000|Overall Study|Lost to Follow-up|0|||
154875468|NCT01041573|558968668|FG001|Overall Study|Lost to Follow-up|1|||
154875469|NCT01041573|558968669|FG002|Overall Study|Lost to Follow-up|2|||
154875470|NCT01041573|558968670|FG003|Overall Study|Lost to Follow-up|1|||
154875471|NCT01041573|558968667|FG000|Overall Study|Adverse Event|0|||
154875472|NCT01041573|558968668|FG001|Overall Study|Adverse Event|2|||
154974376|NCT01332968|559331239|FG007|Maintenance/Observation Period|Non-compliance|0|||
155112247|NCT01864148|559840775|FG001|Overall Study|Other|1|||
155112248|NCT01864148|559840776|FG002|Overall Study|Other|1|||
154875473|NCT01041573|558968669|FG002|Overall Study|Adverse Event|0|||
154875474|NCT01041573|558968670|FG003|Overall Study|Adverse Event|0|||
154875475|NCT01041573|558968667|FG000|Overall Study|relocation|1|||
154875476|NCT01041573|558968668|FG001|Overall Study|relocation|4|||
154875477|NCT01041573|558968669|FG002|Overall Study|relocation|3|||
154875478|NCT01041573|558968670|FG003|Overall Study|relocation|1|||
154875479|NCT01041573|558968667|FG000|Overall Study|further blood extraction|0|||
154875480|NCT01041573|558968668|FG001|Overall Study|further blood extraction|1|||
154875481|NCT01041573|558968669|FG002|Overall Study|further blood extraction|0|||
154875482|NCT01041573|558968670|FG003|Overall Study|further blood extraction|0|||
154875483|NCT01041573|558968667|FG000|Overall Study|positive to anti-HCV|1|||
154875484|NCT01041573|558968668|FG001|Overall Study|positive to anti-HCV|0|||
154875485|NCT01041573|558968669|FG002|Overall Study|positive to anti-HCV|0|||
154875486|NCT01041573|558968670|FG003|Overall Study|positive to anti-HCV|0|||
154875487|NCT02955186|558968671|FG000|Overall Study|Withdrawal by Subject|6|||
155112249|NCT01864148|559840777|FG003|Overall Study|Other|3|||
154875488|NCT02955186|558968672|FG001|Overall Study|Withdrawal by Subject|2|||
154875489|NCT02955186|558968671|FG000|Overall Study|Protocol Violation|1|||
154875490|NCT02955186|558968672|FG001|Overall Study|Protocol Violation|0|||
154875491|NCT01276847|558968675|FG000|Overall Study|Withdrawal by Subject|1|||
154875492|NCT01276847|558968676|FG001|Overall Study|Withdrawal by Subject|0|||
154875493|NCT01276847|558968677|FG002|Overall Study|Withdrawal by Subject|0|||
154875494|NCT02021812|558968681|FG000|Overall Study|Death|8|||
154875495|NCT02021812|558968681|FG000|Overall Study|Withdrawal by Subject|3|||
154875496|NCT02021812|558968681|FG000|Overall Study|Lost to Follow-up|2|||
154875497|NCT02021812|558968681|FG000|Overall Study|Refuse to return, COVD 19|2|||
154875498|NCT02698423|558968682|FG000|Overall Study|Lost to Follow-up|19|||
155112250|NCT01864148|559840778|FG004|Overall Study|Other|1|||
155112251|NCT01864148|559840774|FG000|Overall Study|Death|0|||
155112252|NCT01864148|559840775|FG001|Overall Study|Death|0|||
155112253|NCT01864148|559840776|FG002|Overall Study|Death|0|||
155112254|NCT01864148|559840777|FG003|Overall Study|Death|1|||
155112255|NCT01864148|559840778|FG004|Overall Study|Death|0|||
155112256|NCT01864148|559840774|FG000|Overall Study|Investigator Decision|5|||
155112257|NCT01864148|559840775|FG001|Overall Study|Investigator Decision|0|||
155112258|NCT01864148|559840776|FG002|Overall Study|Investigator Decision|0|||
155112259|NCT01864148|559840777|FG003|Overall Study|Investigator Decision|4|||
155112260|NCT01864148|559840778|FG004|Overall Study|Investigator Decision|6|||
155112261|NCT01864148|559840774|FG000|Overall Study|Withdrawal by Subject|9|||
155112262|NCT01864148|559840775|FG001|Overall Study|Withdrawal by Subject|2|||
155112263|NCT01864148|559840776|FG002|Overall Study|Withdrawal by Subject|6|||
155112264|NCT01864148|559840777|FG003|Overall Study|Withdrawal by Subject|8|||
155112265|NCT01864148|559840778|FG004|Overall Study|Withdrawal by Subject|8|||
155112266|NCT01864148|559840774|FG000|Overall Study|Lost to Follow-up|0|||
155112267|NCT01864148|559840775|FG001|Overall Study|Lost to Follow-up|0|||
155112268|NCT01864148|559840776|FG002|Overall Study|Lost to Follow-up|0|||
155112269|NCT01864148|559840777|FG003|Overall Study|Lost to Follow-up|2|||
155112270|NCT01864148|559840778|FG004|Overall Study|Lost to Follow-up|1|||
155112271|NCT01864148|559840774|FG000|Overall Study|Adverse Event|4|||
155112272|NCT01864148|559840775|FG001|Overall Study|Adverse Event|2|||
155112273|NCT01864148|559840776|FG002|Overall Study|Adverse Event|4|||
155112274|NCT01864148|559840777|FG003|Overall Study|Adverse Event|7|||
155112275|NCT01864148|559840778|FG004|Overall Study|Adverse Event|7|||
155112276|NCT01864148|559840774|FG000|Overall Study|Not Dosed|0|||
155112277|NCT01864148|559840775|FG001|Overall Study|Not Dosed|0|||
155112278|NCT01864148|559840776|FG002|Overall Study|Not Dosed|0|||
155112279|NCT01864148|559840777|FG003|Overall Study|Not Dosed|1|||
155112280|NCT01864148|559840778|FG004|Overall Study|Not Dosed|0|||
155112281|NCT01500252|559840783|FG000|Overall Study|Death|4|||
155112282|NCT01500252|559840784|FG001|Overall Study|Death|2|||
155112283|NCT01500252|559840783|FG000|Overall Study|Lost to Follow-up|5|||
155112284|NCT01500252|559840784|FG001|Overall Study|Lost to Follow-up|4|||
155112285|NCT03490292|559840785|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
154875499|NCT02698423|558968683|FG001|Overall Study|Lost to Follow-up|24|||
154875500|NCT01651260|558968686|FG000|Overall Study|unable to apply product|3|||
154875501|NCT00064662|558968687|FG000|Overall Study|Death|1|||
154875502|NCT00064662|558968688|FG001|Overall Study|Death|1|||
154875503|NCT00064662|558968687|FG000|Overall Study|Lost to Follow-up|57|||
154875504|NCT00064662|558968688|FG001|Overall Study|Lost to Follow-up|44|||
154875505|NCT00064662|558968687|FG000|Overall Study|Withdrawal by Subject|14|||
154875506|NCT00064662|558968688|FG001|Overall Study|Withdrawal by Subject|14|||
154875507|NCT00064662|558968687|FG000|Overall Study|Administratively withdrawn|2|||
154875508|NCT00064662|558968688|FG001|Overall Study|Administratively withdrawn|2|||
154875509|NCT01963117|558968691|FG000|Overall Study|Death|1|||
154875510|NCT03844633|558968692|FG000|1 Week FU|Lost to Follow-up|0|||
154875511|NCT03844633|558968693|FG001|1 Week FU|Lost to Follow-up|1|||
155112286|NCT03490292|559840786|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
155112287|NCT03490292|559840785|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
155112288|NCT03490292|559840786|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
155112289|NCT03490292|559840785|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
155112290|NCT03490292|559840786|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
155112291|NCT03490292|559840785|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
155112292|NCT03490292|559840786|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
155112293|NCT03490292|559840785|FG000|1 Year Follow Up Post Last Dose|Death|1|||
155112294|NCT03490292|559840786|FG001|1 Year Follow Up Post Last Dose|Death|1|||
155112295|NCT01106651|559840787|FG000|Overall Study|Adverse Event|17|||
155112296|NCT01106651|559840788|FG001|Overall Study|Adverse Event|9|||
155112297|NCT01106651|559840789|FG002|Overall Study|Adverse Event|23|||
155112298|NCT01106651|559840787|FG000|Overall Study|Lost to Follow-up|8|||
154875512|NCT03844633|558968694|FG002|1 Week FU|Lost to Follow-up|4|||
154875513|NCT03844633|558968692|FG000|12-month Follow-up|Lost to Follow-up|7|||
154875514|NCT03844633|558968693|FG001|12-month Follow-up|Lost to Follow-up|5|||
154875515|NCT03844633|558968694|FG002|12-month Follow-up|Lost to Follow-up|8|||
154875516|NCT04083222|558968698|FG000|Overall Study|Voluntary Withdrawal|0|||
154875517|NCT04083222|558968699|FG001|Overall Study|Voluntary Withdrawal|1|||
154875518|NCT04083222|558968698|FG000|Overall Study|Reason not Specified|0|||
154875519|NCT04083222|558968699|FG001|Overall Study|Reason not Specified|1|||
154875520|NCT03123939|558968702|FG000|Overall Study|Lack of Efficacy|6|||
154875521|NCT03123939|558968702|FG000|Overall Study|Death|5|||
154875522|NCT03123939|558968702|FG000|Overall Study|Physician Decision|2|||
154875523|NCT03123939|558968702|FG000|Overall Study|Subject/guardian decision|2|||
154875524|NCT03123939|558968702|FG000|Overall Study|Lost to Follow-up|1|||
154875525|NCT03123939|558968702|FG000|Overall Study|New therapy for study indication|1|||
154875526|NCT03123939|558968702|FG000|Overall Study|Protocol deviation|1|||
154875527|NCT03123939|558968702|FG000|Overall Study|Progressive disease|18|||
154875528|NCT03123939|558968702|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
154875529|NCT03123939|558968702|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
154875530|NCT01937130|558971013|FG000|Overall Study|Withdrawal by Subject|0|||
154875531|NCT01937130|558971014|FG001|Overall Study|Withdrawal by Subject|0|||
154875532|NCT01937130|558971015|FG002|Overall Study|Withdrawal by Subject|0|||
154875533|NCT01937130|558971016|FG003|Overall Study|Withdrawal by Subject|1|||
154875534|NCT01937130|558971013|FG000|Overall Study|Adverse Event|0|||
154875535|NCT01937130|558971014|FG001|Overall Study|Adverse Event|1|||
154875536|NCT01937130|558971015|FG002|Overall Study|Adverse Event|0|||
154875537|NCT01937130|558971016|FG003|Overall Study|Adverse Event|1|||
154875538|NCT01937130|558971013|FG000|Overall Study|Death|1|||
154875539|NCT01937130|558971014|FG001|Overall Study|Death|1|||
154875540|NCT01937130|558971015|FG002|Overall Study|Death|1|||
154875541|NCT01937130|558971016|FG003|Overall Study|Death|0|||
154875542|NCT01937130|558971013|FG000|Overall Study|Lost to Follow-up|2|||
154875543|NCT01937130|558971014|FG001|Overall Study|Lost to Follow-up|0|||
154875544|NCT01937130|558971015|FG002|Overall Study|Lost to Follow-up|2|||
154875545|NCT01937130|558971016|FG003|Overall Study|Lost to Follow-up|0|||
154875546|NCT01937130|558971013|FG000|Overall Study|Physician Decision|0|||
154875547|NCT01937130|558971014|FG001|Overall Study|Physician Decision|1|||
154875548|NCT01937130|558971015|FG002|Overall Study|Physician Decision|0|||
154875549|NCT01937130|558971016|FG003|Overall Study|Physician Decision|0|||
154875550|NCT01937130|558971013|FG000|Overall Study|Patients unable to swallow|0|||
154875551|NCT01937130|558971014|FG001|Overall Study|Patients unable to swallow|1|||
154875552|NCT01937130|558971015|FG002|Overall Study|Patients unable to swallow|0|||
154875553|NCT01937130|558971016|FG003|Overall Study|Patients unable to swallow|0|||
154875554|NCT01937130|558971013|FG000|Overall Study|Patient lost to FU due to death|2|||
154875555|NCT01937130|558971014|FG001|Overall Study|Patient lost to FU due to death|0|||
154875556|NCT01937130|558971015|FG002|Overall Study|Patient lost to FU due to death|0|||
154875557|NCT01937130|558971016|FG003|Overall Study|Patient lost to FU due to death|0|||
154875558|NCT04191967|558971017|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
154875559|NCT04191967|558971017|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
154875560|NCT01431144|558971018|FG000|Overall Study|Implant mobility and removal|2|||
154875561|NCT01431144|558971019|FG001|Overall Study|Implant mobility and removal|0|||
154875562|NCT00953043|558971025|FG000|Overall Study|Withdrawal by Subject|4|||
154875563|NCT00953043|558971026|FG001|Overall Study|Withdrawal by Subject|0|||
154875564|NCT00953043|558971025|FG000|Overall Study|Physician Decision|0|||
154875565|NCT00953043|558971026|FG001|Overall Study|Physician Decision|2|||
154875566|NCT02322892|558971028|FG000|Overall Study|Surgery cancelled|1|||
154875567|NCT02322892|558971029|FG001|Overall Study|Surgery cancelled|2|||
154875568|NCT02322892|558971028|FG000|Overall Study|Met exclusion criteria|0|||
154875569|NCT02322892|558971029|FG001|Overall Study|Met exclusion criteria|1|||
154875570|NCT02322892|558971028|FG000|Overall Study|Protocol Violation|1|||
154875571|NCT02322892|558971029|FG001|Overall Study|Protocol Violation|0|||
154875572|NCT00747617|558971030|FG000|Overall Study|Lost to Follow-up|3|||
154875573|NCT00747617|558971031|FG001|Overall Study|Lost to Follow-up|1|||
154875574|NCT03509207|558971032|FG000|Overall Study|Death|2|||
154875575|NCT02125331|558971033|FG000|Overall Study|Protocol Violation|1|||
154875576|NCT02125331|558971034|FG001|Overall Study|Protocol Violation|0|||
154875577|NCT02125331|558971033|FG000|Overall Study|technical problem|2|||
154875578|NCT02125331|558971034|FG001|Overall Study|technical problem|0|||
154875579|NCT02125331|558971033|FG000|Overall Study|screen failure|2|||
154875580|NCT02125331|558971034|FG001|Overall Study|screen failure|0|||
154875581|NCT01432262|558971035|FG000|Overall Study|Withdrawal by Subject|2|||
154875582|NCT01432262|558971036|FG001|Overall Study|Withdrawal by Subject|1|||
154875583|NCT04657016|558971037|FG000|Overall Study|Adverse Event|2|||
154875584|NCT04657016|558971038|FG001|Overall Study|Adverse Event|4|||
154875585|NCT04657016|558971037|FG000|Overall Study|Death|1|||
154875586|NCT04657016|558971038|FG001|Overall Study|Death|1|||
154875587|NCT04657016|558971037|FG000|Overall Study|Lost to Follow-up|24|||
154875588|NCT04657016|558971038|FG001|Overall Study|Lost to Follow-up|12|||
154875589|NCT04657016|558971037|FG000|Overall Study|Physician Decision|1|||
154875590|NCT04657016|558971038|FG001|Overall Study|Physician Decision|2|||
154875591|NCT04657016|558971037|FG000|Overall Study|Pregnancy|2|||
154875592|NCT04657016|558971038|FG001|Overall Study|Pregnancy|2|||
154875593|NCT04657016|558971037|FG000|Overall Study|Protocol Deviation|1|||
155112299|NCT01106651|559840788|FG001|Overall Study|Lost to Follow-up|2|||
155112300|NCT01106651|559840789|FG002|Overall Study|Lost to Follow-up|6|||
155112301|NCT01106651|559840787|FG000|Overall Study|Physician Decision|4|||
155112302|NCT01106651|559840788|FG001|Overall Study|Physician Decision|3|||
155112303|NCT01106651|559840789|FG002|Overall Study|Physician Decision|1|||
155112304|NCT01106651|559840787|FG000|Overall Study|Protocol Violation|1|||
155112305|NCT01106651|559840788|FG001|Overall Study|Protocol Violation|2|||
155112306|NCT01106651|559840789|FG002|Overall Study|Protocol Violation|1|||
155112307|NCT01106651|559840787|FG000|Overall Study|Withdrawal by Subject|14|||
155112308|NCT01106651|559840788|FG001|Overall Study|Withdrawal by Subject|7|||
155112309|NCT01106651|559840789|FG002|Overall Study|Withdrawal by Subject|4|||
155112310|NCT01106651|559840787|FG000|Overall Study|Noncompliance with study drug|1|||
155112311|NCT01106651|559840788|FG001|Overall Study|Noncompliance with study drug|0|||
155112312|NCT01106651|559840789|FG002|Overall Study|Noncompliance with study drug|2|||
155112313|NCT01106651|559840787|FG000|Overall Study|Other|34|||
155112314|NCT01106651|559840788|FG001|Overall Study|Other|31|||
155112315|NCT01106651|559840789|FG002|Overall Study|Other|21|||
155112316|NCT01106651|559840787|FG000|Overall Study|Death|0|||
155112317|NCT01106651|559840788|FG001|Overall Study|Death|3|||
155112318|NCT01106651|559840789|FG002|Overall Study|Death|0|||
155112319|NCT03768089|559840793|FG000|Part A|Lost to Follow-up|0|||
155112320|NCT03768089|559840794|FG001|Part A|Lost to Follow-up|0|||
155112321|NCT03768089|559840795|FG002|Part A|Lost to Follow-up|0|||
155112322|NCT03768089|559840796|FG003|Part A|Lost to Follow-up|0|||
155112323|NCT03768089|559840797|FG004|Part A|Lost to Follow-up|1|||
155112324|NCT03768089|559840798|FG005|Part A|Lost to Follow-up|0|||
154875594|NCT04657016|558971038|FG001|Overall Study|Protocol Deviation|0|||
154875595|NCT04657016|558971037|FG000|Overall Study|Withdrawal by Subject|28|||
154875596|NCT04657016|558971038|FG001|Overall Study|Withdrawal by Subject|14|||
154875597|NCT04657016|558971037|FG000|Overall Study|Other - as reported by the investigator|6|||
154875598|NCT04657016|558971038|FG001|Overall Study|Other - as reported by the investigator|0|||
154875599|NCT01104558|558971041|FG000|Overall Study|Protocol Violation|6|||
154875600|NCT01104558|558971041|FG000|Overall Study|Missing of primary efficacy assessment|10|||
154875601|NCT01104558|558971041|FG000|Overall Study|Missing of genetic analysis results|1|||
154875602|NCT00696657|558971042|FG000|Overall Study|Protocol Violation|0|||
154875603|NCT00696657|558971043|FG001|Overall Study|Protocol Violation|0|||
154875604|NCT00696657|558971044|FG002|Overall Study|Protocol Violation|0|||
154875605|NCT00696657|558971045|FG003|Overall Study|Protocol Violation|0|||
154875606|NCT00696657|558971046|FG004|Overall Study|Protocol Violation|0|||
154875607|NCT00696657|558971047|FG005|Overall Study|Protocol Violation|1|||
154875608|NCT00696657|558971048|FG006|Overall Study|Protocol Violation|0|||
154875609|NCT00696657|558971049|FG007|Overall Study|Protocol Violation|0|||
154875610|NCT00696657|558971050|FG008|Overall Study|Protocol Violation|1|||
154875611|NCT00696657|558971042|FG000|Overall Study|Lack of Efficacy|0|||
154875612|NCT00696657|558971043|FG001|Overall Study|Lack of Efficacy|1|||
154875613|NCT00696657|558971044|FG002|Overall Study|Lack of Efficacy|0|||
154875614|NCT00696657|558971045|FG003|Overall Study|Lack of Efficacy|0|||
154875615|NCT00696657|558971046|FG004|Overall Study|Lack of Efficacy|0|||
154875616|NCT00696657|558971047|FG005|Overall Study|Lack of Efficacy|0|||
154875617|NCT00696657|558971048|FG006|Overall Study|Lack of Efficacy|0|||
154875618|NCT00696657|558971049|FG007|Overall Study|Lack of Efficacy|0|||
154875619|NCT00696657|558971050|FG008|Overall Study|Lack of Efficacy|0|||
154875620|NCT00696657|558971042|FG000|Overall Study|Withdrawal criteria|1|||
154875621|NCT00696657|558971043|FG001|Overall Study|Withdrawal criteria|3|||
154875622|NCT00696657|558971044|FG002|Overall Study|Withdrawal criteria|2|||
154875623|NCT00696657|558971045|FG003|Overall Study|Withdrawal criteria|2|||
154875624|NCT00696657|558971046|FG004|Overall Study|Withdrawal criteria|0|||
154875625|NCT00696657|558971047|FG005|Overall Study|Withdrawal criteria|0|||
154875626|NCT00696657|558971048|FG006|Overall Study|Withdrawal criteria|1|||
154875627|NCT00696657|558971049|FG007|Overall Study|Withdrawal criteria|1|||
154875628|NCT00696657|558971050|FG008|Overall Study|Withdrawal criteria|2|||
154875629|NCT00696657|558971042|FG000|Overall Study|Unclassified|0|||
155112325|NCT03768089|559840799|FG006|Part A|Lost to Follow-up|0|||
155112326|NCT03768089|559840800|FG007|Part A|Lost to Follow-up|0|||
155112327|NCT03768089|559840801|FG008|Part A|Lost to Follow-up|0|||
155112328|NCT03768089|559840802|FG009|Part A|Lost to Follow-up|0|||
155112329|NCT03768089|559840803|FG010|Part A|Lost to Follow-up|0|||
155112330|NCT03768089|559840804|FG011|Part A|Lost to Follow-up|0|||
155112331|NCT03768089|559840805|FG012|Part A|Lost to Follow-up|0|||
154875630|NCT00696657|558971043|FG001|Overall Study|Unclassified|1|||
154875631|NCT00696657|558971044|FG002|Overall Study|Unclassified|3|||
154875632|NCT00696657|558971045|FG003|Overall Study|Unclassified|2|||
155112332|NCT03768089|559840806|FG013|Part A|Lost to Follow-up|0|||
155112333|NCT03768089|559840807|FG014|Part A|Lost to Follow-up|0|||
155112334|NCT03768089|559840808|FG015|Part A|Lost to Follow-up|0|||
154875633|NCT00696657|558971046|FG004|Overall Study|Unclassified|4|||
155112335|NCT03768089|559840809|FG016|Part A|Lost to Follow-up|0|||
154875634|NCT00696657|558971047|FG005|Overall Study|Unclassified|2|||
154875635|NCT00696657|558971048|FG006|Overall Study|Unclassified|0|||
155112336|NCT03768089|559840810|FG017|Part A|Lost to Follow-up|0|||
155112337|NCT03768089|559840793|FG000|Part C|Randomized, Never Dosed|0|||
154875636|NCT00696657|558971049|FG007|Overall Study|Unclassified|0|||
154875637|NCT00696657|558971050|FG008|Overall Study|Unclassified|1|||
154875638|NCT00696657|558971042|FG000|Overall Study|Adverse Event|0|||
154875639|NCT00696657|558971043|FG001|Overall Study|Adverse Event|0|||
154875640|NCT00696657|558971044|FG002|Overall Study|Adverse Event|3|||
154875641|NCT00696657|558971045|FG003|Overall Study|Adverse Event|7|||
154875642|NCT00696657|558971046|FG004|Overall Study|Adverse Event|6|||
154875643|NCT00696657|558971047|FG005|Overall Study|Adverse Event|9|||
154875644|NCT00696657|558971048|FG006|Overall Study|Adverse Event|14|||
154875645|NCT00696657|558971049|FG007|Overall Study|Adverse Event|2|||
154875646|NCT00696657|558971050|FG008|Overall Study|Adverse Event|5|||
154875647|NCT00523341|558971054|FG000|Overall Study|Withdrawal by Subject|399|||
154875648|NCT00523341|558971055|FG001|Overall Study|Withdrawal by Subject|427|||
154875649|NCT00523341|558971054|FG000|Overall Study|Other|181|||
154875650|NCT00523341|558971055|FG001|Overall Study|Other|198|||
154875651|NCT00523341|558971054|FG000|Overall Study|Adverse Event|122|||
154875652|NCT00523341|558971055|FG001|Overall Study|Adverse Event|155|||
154875653|NCT00523341|558971054|FG000|Overall Study|Death|101|||
154875654|NCT00523341|558971055|FG001|Overall Study|Death|110|||
154875655|NCT00523341|558971054|FG000|Overall Study|Lost to Follow-up|73|||
154875656|NCT00523341|558971055|FG001|Overall Study|Lost to Follow-up|61|||
154875657|NCT00523341|558971054|FG000|Overall Study|Non-compliance|20|||
154875658|NCT00523341|558971055|FG001|Overall Study|Non-compliance|13|||
154875659|NCT00523341|558971054|FG000|Overall Study|Physician Decision|14|||
154875660|NCT00523341|558971055|FG001|Overall Study|Physician Decision|13|||
154875661|NCT00523341|558971054|FG000|Overall Study|Requirement for Alternative Therapy|4|||
154875662|NCT00523341|558971055|FG001|Overall Study|Requirement for Alternative Therapy|14|||
154875663|NCT00523341|558971054|FG000|Overall Study|Protocol Deviation|6|||
154875664|NCT00523341|558971055|FG001|Overall Study|Protocol Deviation|5|||
154875665|NCT00523341|558971054|FG000|Overall Study|Ineligibility Determined|3|||
154875666|NCT00523341|558971055|FG001|Overall Study|Ineligibility Determined|4|||
154875667|NCT00523341|558971054|FG000|Overall Study|Disease Progression|1|||
154875668|NCT00523341|558971055|FG001|Overall Study|Disease Progression|0|||
154875669|NCT02601001|558971058|FG000|Dosing Period 2|Adverse Event|0|||
154875670|NCT02601001|558971059|FG001|Dosing Period 2|Adverse Event|0|||
154875671|NCT02601001|558971060|FG002|Dosing Period 2|Adverse Event|0|||
154875672|NCT02601001|558971061|FG003|Dosing Period 2|Adverse Event|0|||
154875673|NCT02601001|558971062|FG004|Dosing Period 2|Adverse Event|0|||
154875674|NCT02601001|558971063|FG005|Dosing Period 2|Adverse Event|0|||
154875675|NCT02601001|558971064|FG006|Dosing Period 2|Adverse Event|1|||
154875676|NCT01356602|558971065|FG000|Overall Study|Protocol Deviation|0|||
154875677|NCT01356602|558971066|FG001|Overall Study|Protocol Deviation|1|||
154875678|NCT01356602|558971067|FG002|Overall Study|Protocol Deviation|1|||
154875679|NCT01356602|558971065|FG000|Overall Study|Administrative Problems|1|||
154875680|NCT01356602|558971066|FG001|Overall Study|Administrative Problems|4|||
154875681|NCT01356602|558971067|FG002|Overall Study|Administrative Problems|5|||
154875682|NCT01356602|558971065|FG000|Overall Study|Lost to Follow-up|4|||
154875683|NCT01356602|558971066|FG001|Overall Study|Lost to Follow-up|5|||
154875684|NCT01356602|558971067|FG002|Overall Study|Lost to Follow-up|6|||
154875685|NCT01356602|558971065|FG000|Overall Study|Withdrawal by Subject|4|||
154875686|NCT01356602|558971066|FG001|Overall Study|Withdrawal by Subject|3|||
154875687|NCT01356602|558971067|FG002|Overall Study|Withdrawal by Subject|7|||
154875688|NCT01356602|558971065|FG000|Overall Study|Lack of Efficacy|0|||
154875689|NCT01356602|558971066|FG001|Overall Study|Lack of Efficacy|1|||
154875690|NCT01356602|558971067|FG002|Overall Study|Lack of Efficacy|4|||
154875691|NCT01356602|558971065|FG000|Overall Study|Adverse Event|0|||
154875692|NCT01356602|558971066|FG001|Overall Study|Adverse Event|1|||
154875693|NCT01356602|558971067|FG002|Overall Study|Adverse Event|1|||
154875694|NCT03123354|558971068|FG000|Overall Study|Physician Decision|6|||
154875695|NCT01931462|558971069|FG000|Overall Study|Withdrawal by Subject|1|||
154875696|NCT00366548|558971070|FG000|Infant Series|Adverse Event|1|||
154875697|NCT00366548|558971071|FG001|Infant Series|Adverse Event|3|||
155112338|NCT03768089|559840794|FG001|Part C|Randomized, Never Dosed|0|||
155112339|NCT03768089|559840795|FG002|Part C|Randomized, Never Dosed|0|||
155112340|NCT03768089|559840796|FG003|Part C|Randomized, Never Dosed|0|||
154875698|NCT00366548|558971070|FG000|Infant Series|Protocol Violation|0|||
154875699|NCT00366548|558971071|FG001|Infant Series|Protocol Violation|1|||
154875700|NCT00366548|558971070|FG000|Infant Series|Withdrawal by Subject|3|||
154875701|NCT00366548|558971071|FG001|Infant Series|Withdrawal by Subject|1|||
154875702|NCT00366548|558971070|FG000|After Infant Series|Withdrawal by Subject|3|||
155112341|NCT03768089|559840797|FG004|Part C|Randomized, Never Dosed|0|||
154875703|NCT00366548|558971071|FG001|After Infant Series|Withdrawal by Subject|1|||
154875704|NCT00366548|558971070|FG000|After Infant Series|Adverse Event|2|||
154875705|NCT00366548|558971071|FG001|After Infant Series|Adverse Event|0|||
154875706|NCT00366548|558971070|FG000|After Infant Series|Lost to Follow-up|1|||
154875707|NCT00366548|558971071|FG001|After Infant Series|Lost to Follow-up|0|||
154875708|NCT02531373|558971072|FG000|Overall Study|Lack of Efficacy|0|||
154875709|NCT02531373|558971073|FG001|Overall Study|Lack of Efficacy|0|||
154875710|NCT02531373|558971074|FG002|Overall Study|Lack of Efficacy|0|||
154875711|NCT02531373|558971075|FG003|Overall Study|Lack of Efficacy|0|||
154875712|NCT02531373|558971076|FG004|Overall Study|Lack of Efficacy|3|||
154875713|NCT02531373|558971077|FG005|Overall Study|Lack of Efficacy|2|||
154875714|NCT02531373|558971078|FG006|Overall Study|Lack of Efficacy|4|||
154875715|NCT02531373|558971079|FG007|Overall Study|Lack of Efficacy|8|||
154875716|NCT02531373|558971080|FG008|Overall Study|Lack of Efficacy|5|||
154875717|NCT02531373|558971072|FG000|Overall Study|Lost to Follow-up|0|||
154875718|NCT02531373|558971073|FG001|Overall Study|Lost to Follow-up|0|||
154875719|NCT02531373|558971074|FG002|Overall Study|Lost to Follow-up|0|||
154875720|NCT02531373|558971075|FG003|Overall Study|Lost to Follow-up|0|||
154875721|NCT02531373|558971076|FG004|Overall Study|Lost to Follow-up|0|||
154875722|NCT02531373|558971077|FG005|Overall Study|Lost to Follow-up|2|||
154875723|NCT02531373|558971078|FG006|Overall Study|Lost to Follow-up|2|||
154875724|NCT02531373|558971079|FG007|Overall Study|Lost to Follow-up|0|||
154875725|NCT02531373|558971080|FG008|Overall Study|Lost to Follow-up|0|||
154875726|NCT02531373|558971072|FG000|Overall Study|Physician Decision|0|||
154875727|NCT02531373|558971073|FG001|Overall Study|Physician Decision|0|||
154875728|NCT02531373|558971074|FG002|Overall Study|Physician Decision|0|||
154875729|NCT02531373|558971075|FG003|Overall Study|Physician Decision|0|||
154875730|NCT02531373|558971076|FG004|Overall Study|Physician Decision|2|||
154875731|NCT02531373|558971077|FG005|Overall Study|Physician Decision|1|||
154875732|NCT02531373|558971078|FG006|Overall Study|Physician Decision|0|||
154875733|NCT02531373|558971079|FG007|Overall Study|Physician Decision|0|||
154875734|NCT02531373|558971080|FG008|Overall Study|Physician Decision|0|||
154875735|NCT02531373|558971072|FG000|Overall Study|Protocol Violation|0|||
154875736|NCT02531373|558971073|FG001|Overall Study|Protocol Violation|0|||
154875737|NCT02531373|558971074|FG002|Overall Study|Protocol Violation|0|||
154875738|NCT02531373|558971075|FG003|Overall Study|Protocol Violation|0|||
154875739|NCT02531373|558971076|FG004|Overall Study|Protocol Violation|0|||
154875740|NCT02531373|558971077|FG005|Overall Study|Protocol Violation|1|||
154875741|NCT02531373|558971078|FG006|Overall Study|Protocol Violation|1|||
154875742|NCT02531373|558971079|FG007|Overall Study|Protocol Violation|0|||
154875743|NCT02531373|558971080|FG008|Overall Study|Protocol Violation|1|||
154875744|NCT02531373|558971072|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154875745|NCT02531373|558971073|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154875746|NCT02531373|558971074|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
154875747|NCT02531373|558971075|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
154875748|NCT02531373|558971076|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
154875749|NCT02531373|558971077|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
154875750|NCT02531373|558971078|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
154875751|NCT02531373|558971079|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
154875752|NCT02531373|558971080|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
154875753|NCT02531373|558971072|FG000|Overall Study|Withdrawal by Subject|0|||
154875754|NCT02531373|558971073|FG001|Overall Study|Withdrawal by Subject|0|||
154875755|NCT02531373|558971074|FG002|Overall Study|Withdrawal by Subject|0|||
154875756|NCT02531373|558971075|FG003|Overall Study|Withdrawal by Subject|0|||
154875757|NCT02531373|558971076|FG004|Overall Study|Withdrawal by Subject|3|||
154875758|NCT02531373|558971077|FG005|Overall Study|Withdrawal by Subject|0|||
154875759|NCT02531373|558971078|FG006|Overall Study|Withdrawal by Subject|0|||
154875760|NCT02531373|558971079|FG007|Overall Study|Withdrawal by Subject|0|||
154875761|NCT02531373|558971080|FG008|Overall Study|Withdrawal by Subject|0|||
154875762|NCT01623531|558971081|FG000|Overall Study|Death|1|||
154875763|NCT01623531|558971082|FG001|Overall Study|Death|0|||
154875764|NCT01623531|558971081|FG000|Overall Study|Protocol Violation|2|||
154974377|NCT01332968|559331232|FG000|Maintenance/Observation Period|Other|0|||
154974378|NCT01332968|559331233|FG001|Maintenance/Observation Period|Other|0|||
154974379|NCT01332968|559331234|FG002|Maintenance/Observation Period|Other|4|||
154974380|NCT01332968|559331235|FG003|Maintenance/Observation Period|Other|7|||
154974381|NCT01332968|559331236|FG004|Maintenance/Observation Period|Other|0|||
154974382|NCT01332968|559331237|FG005|Maintenance/Observation Period|Other|0|||
154974383|NCT01332968|559331238|FG006|Maintenance/Observation Period|Other|0|||
154974384|NCT01332968|559331239|FG007|Maintenance/Observation Period|Other|0|||
154974385|NCT01332968|559331232|FG000|Maintenance/Observation Period|Physician Decision|0|||
154974386|NCT01332968|559331233|FG001|Maintenance/Observation Period|Physician Decision|0|||
154974387|NCT01332968|559331234|FG002|Maintenance/Observation Period|Physician Decision|14|||
154974388|NCT01332968|559331235|FG003|Maintenance/Observation Period|Physician Decision|19|||
154974389|NCT01332968|559331236|FG004|Maintenance/Observation Period|Physician Decision|0|||
154875765|NCT01623531|558971082|FG001|Overall Study|Protocol Violation|1|||
154875766|NCT01623531|558971081|FG000|Overall Study|Missing data at primary outcome time poi|1|||
154875767|NCT01623531|558971082|FG001|Overall Study|Missing data at primary outcome time poi|1|||
154875768|NCT02834403|558971087|FG000|Overall Study|Physician Decision|2|||
154875769|NCT02834403|558971088|FG001|Overall Study|Physician Decision|1|||
154875770|NCT02834403|558971089|FG002|Overall Study|Physician Decision|2|||
154875771|NCT02834403|558971090|FG003|Overall Study|Physician Decision|1|||
154875772|NCT02834403|558971091|FG004|Overall Study|Physician Decision|1|||
154875773|NCT02834403|558971092|FG005|Overall Study|Physician Decision|2|||
154875774|NCT02834403|558971093|FG006|Overall Study|Physician Decision|12|||
154875775|NCT02834403|558971087|FG000|Overall Study|Adverse Event|0|||
154875776|NCT02834403|558971088|FG001|Overall Study|Adverse Event|0|||
154875777|NCT02834403|558971089|FG002|Overall Study|Adverse Event|0|||
154875778|NCT02834403|558971090|FG003|Overall Study|Adverse Event|0|||
154875779|NCT02834403|558971091|FG004|Overall Study|Adverse Event|1|||
154875780|NCT02834403|558971092|FG005|Overall Study|Adverse Event|1|||
154875781|NCT02834403|558971093|FG006|Overall Study|Adverse Event|3|||
154875782|NCT02834403|558971087|FG000|Overall Study|Withdrawal by Subject|0|||
154875783|NCT02834403|558971088|FG001|Overall Study|Withdrawal by Subject|1|||
154875784|NCT02834403|558971089|FG002|Overall Study|Withdrawal by Subject|0|||
154875785|NCT02834403|558971090|FG003|Overall Study|Withdrawal by Subject|0|||
154875786|NCT02834403|558971091|FG004|Overall Study|Withdrawal by Subject|1|||
154875787|NCT02834403|558971092|FG005|Overall Study|Withdrawal by Subject|0|||
154875788|NCT02834403|558971093|FG006|Overall Study|Withdrawal by Subject|0|||
154875789|NCT02834403|558971087|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
154875790|NCT02834403|558971088|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
154875791|NCT02834403|558971089|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
154875792|NCT02834403|558971090|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
154875793|NCT02834403|558971091|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
154875794|NCT02834403|558971092|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
154875795|NCT02834403|558971093|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
154875796|NCT04705597|558971094|FG000|Overall Study|Death|16|||
154875797|NCT04705597|558971095|FG001|Overall Study|Death|9|||
154875798|NCT04705597|558971094|FG000|Overall Study|Lost to Follow-up|1|||
154875799|NCT04705597|558971095|FG001|Overall Study|Lost to Follow-up|0|||
154875800|NCT04705597|558971094|FG000|Overall Study|Withdrawal by Subject|1|||
154875801|NCT04705597|558971095|FG001|Overall Study|Withdrawal by Subject|2|||
154875802|NCT00390780|558971096|FG000|Overall Study|Not completed|10|||
154875803|NCT00390780|558971097|FG001|Overall Study|Not completed|4|||
154875804|NCT00390780|558971096|FG000|Overall Study|Protocol Violation|6|||
154875805|NCT00390780|558971097|FG001|Overall Study|Protocol Violation|4|||
154875806|NCT00390780|558971096|FG000|Overall Study|Lost to Follow-up|3|||
154875807|NCT00390780|558971097|FG001|Overall Study|Lost to Follow-up|6|||
154875808|NCT00390780|558971096|FG000|Overall Study|Adverse Event|2|||
154875809|NCT00390780|558971097|FG001|Overall Study|Adverse Event|3|||
154875810|NCT00390780|558971096|FG000|Overall Study|Death|1|||
154875811|NCT00390780|558971097|FG001|Overall Study|Death|3|||
155112342|NCT03768089|559840798|FG005|Part C|Randomized, Never Dosed|0|||
155112343|NCT03768089|559840799|FG006|Part C|Randomized, Never Dosed|0|||
154875812|NCT00390780|558971096|FG000|Overall Study|Withdrawal by Subject|1|||
154875813|NCT00390780|558971097|FG001|Overall Study|Withdrawal by Subject|2|||
154875814|NCT00390780|558971096|FG000|Overall Study|Inclusion criteria not satisfied|0|||
155112344|NCT03768089|559840800|FG007|Part C|Randomized, Never Dosed|0|||
155112345|NCT03768089|559840801|FG008|Part C|Randomized, Never Dosed|0|||
155112346|NCT03768089|559840802|FG009|Part C|Randomized, Never Dosed|0|||
155112347|NCT03768089|559840803|FG010|Part C|Randomized, Never Dosed|0|||
155112348|NCT03768089|559840804|FG011|Part C|Randomized, Never Dosed|0|||
155112349|NCT03768089|559840805|FG012|Part C|Randomized, Never Dosed|0|||
155112350|NCT03768089|559840806|FG013|Part C|Randomized, Never Dosed|0|||
155112351|NCT03768089|559840807|FG014|Part C|Randomized, Never Dosed|1|||
155112352|NCT03768089|559840808|FG015|Part C|Randomized, Never Dosed|0|||
155112353|NCT03768089|559840809|FG016|Part C|Randomized, Never Dosed|0|||
154875815|NCT00390780|558971097|FG001|Overall Study|Inclusion criteria not satisfied|2|||
154875816|NCT00390780|558971096|FG000|Overall Study|Lost to follow up and other reasons|0|||
154875817|NCT00390780|558971097|FG001|Overall Study|Lost to follow up and other reasons|1|||
154875818|NCT00390780|558971096|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
155112354|NCT03768089|559840810|FG017|Part C|Randomized, Never Dosed|0|||
155112355|NCT00712725|559840811|FG000|Overall Study|Adverse Event|1|||
155112356|NCT00712725|559840812|FG001|Overall Study|Adverse Event|0|||
155112357|NCT00712725|559840813|FG002|Overall Study|Adverse Event|0|||
155112358|NCT00712725|559840814|FG003|Overall Study|Adverse Event|1|||
155112359|NCT00712725|559840815|FG004|Overall Study|Adverse Event|0|||
155112360|NCT00712725|559840816|FG005|Overall Study|Adverse Event|0|||
155112361|NCT00712725|559840817|FG006|Overall Study|Adverse Event|0|||
155112362|NCT00712725|559840818|FG007|Overall Study|Adverse Event|0|||
155112363|NCT00712725|559840811|FG000|Overall Study|Lost to Follow-up|3|||
155112364|NCT00712725|559840812|FG001|Overall Study|Lost to Follow-up|2|||
155112365|NCT00712725|559840813|FG002|Overall Study|Lost to Follow-up|1|||
155112366|NCT00712725|559840814|FG003|Overall Study|Lost to Follow-up|1|||
154875819|NCT00390780|558971097|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
154875820|NCT00390780|558971096|FG000|Overall Study|SAE, death|0|||
154875821|NCT00390780|558971097|FG001|Overall Study|SAE, death|1|||
154875822|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
154875823|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
154875824|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
154875825|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
154875826|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
154875827|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
154875828|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
154875829|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
154875830|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
154875831|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
154875832|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
154875833|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
154875834|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
154875835|NCT02232516|558971098|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
154875836|NCT02232516|558971098|FG000|Survival Follow-up|Death|15|||
154875837|NCT02232516|558971098|FG000|Survival Follow-up|Withdrawal by Subject|3|||
154875838|NCT02232516|558971098|FG000|Survival Follow-up|Lost to Follow-up|1|||
154875839|NCT02232516|558971098|FG000|Survival Follow-up|Still in follow-up|5|||
154875840|NCT01585961|558971099|FG000|Overall Study|Death|6|||
154875841|NCT01585961|558971099|FG000|Overall Study|Physician Decision|1|||
154875842|NCT01585961|558971099|FG000|Overall Study|Decision to use non-study catheter|1|||
154875843|NCT01585961|558971099|FG000|Overall Study|Withdrawal by Subject|1|||
154875844|NCT01585961|558971099|FG000|Overall Study|Lost to Follow-up|23|||
154875845|NCT01585961|558971099|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
154875846|NCT01258348|558971100|FG000|Overall Study|Adverse Event|1|||
154875847|NCT01258348|558971101|FG001|Overall Study|Adverse Event|1|||
154875848|NCT01258348|558971102|FG002|Overall Study|Adverse Event|3|||
154875849|NCT01258348|558971103|FG003|Overall Study|Adverse Event|2|||
154875850|NCT01258348|558971104|FG004|Overall Study|Adverse Event|4|||
154875851|NCT01258348|558971100|FG000|Overall Study|Progressive Disease|0|||
154875852|NCT01258348|558971101|FG001|Overall Study|Progressive Disease|3|||
154875853|NCT01258348|558971102|FG002|Overall Study|Progressive Disease|0|||
154875854|NCT01258348|558971103|FG003|Overall Study|Progressive Disease|2|||
154875855|NCT01258348|558971104|FG004|Overall Study|Progressive Disease|2|||
154875856|NCT01258348|558971100|FG000|Overall Study|Physician Decision|0|||
154875857|NCT01258348|558971101|FG001|Overall Study|Physician Decision|0|||
154875858|NCT01258348|558971102|FG002|Overall Study|Physician Decision|0|||
154875859|NCT01258348|558971103|FG003|Overall Study|Physician Decision|2|||
154875860|NCT01258348|558971104|FG004|Overall Study|Physician Decision|0|||
154875861|NCT01258348|558971100|FG000|Overall Study|Withdrawal by Subject|0|||
154875862|NCT01258348|558971101|FG001|Overall Study|Withdrawal by Subject|1|||
154875863|NCT01258348|558971102|FG002|Overall Study|Withdrawal by Subject|0|||
154875864|NCT01258348|558971103|FG003|Overall Study|Withdrawal by Subject|0|||
154875865|NCT01258348|558971104|FG004|Overall Study|Withdrawal by Subject|0|||
154875866|NCT01120093|558971113|FG000|Treatment Period 1|Adverse Event|0|||
154875867|NCT01120093|558971114|FG001|Treatment Period 1|Adverse Event|0|||
154875868|NCT01120093|558971115|FG002|Treatment Period 1|Adverse Event|1|||
154875869|NCT01120093|558971116|FG003|Treatment Period 1|Adverse Event|0|||
154875870|NCT01120093|558971117|FG004|Treatment Period 1|Adverse Event|1|||
154875871|NCT01120093|558971113|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154875872|NCT01120093|558971114|FG001|Treatment Period 1|Withdrawal by Subject|1|||
154875873|NCT01120093|558971115|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154875874|NCT01120093|558971116|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154875875|NCT01120093|558971117|FG004|Treatment Period 1|Withdrawal by Subject|0|||
154875876|NCT01120093|558971113|FG000|Treatment Period 2|Adverse Event|0|||
154875877|NCT01120093|558971114|FG001|Treatment Period 2|Adverse Event|0|||
154875878|NCT01120093|558971115|FG002|Treatment Period 2|Adverse Event|0|||
154875879|NCT01120093|558971116|FG003|Treatment Period 2|Adverse Event|1|||
154875880|NCT01120093|558971117|FG004|Treatment Period 2|Adverse Event|0|||
154875881|NCT01120093|558971113|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154875882|NCT01120093|558971114|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154875883|NCT01120093|558971115|FG002|Treatment Period 2|Withdrawal by Subject|0|||
154875884|NCT01120093|558971116|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154875885|NCT01120093|558971117|FG004|Treatment Period 2|Withdrawal by Subject|1|||
154875886|NCT01120093|558971113|FG000|Treatment Period 3|Lack of Efficacy|0|||
154875887|NCT01120093|558971114|FG001|Treatment Period 3|Lack of Efficacy|0|||
154875888|NCT01120093|558971115|FG002|Treatment Period 3|Lack of Efficacy|0|||
154875889|NCT01120093|558971116|FG003|Treatment Period 3|Lack of Efficacy|1|||
154875890|NCT01120093|558971117|FG004|Treatment Period 3|Lack of Efficacy|0|||
154875891|NCT01120093|558971113|FG000|Treatment Period 3|Adverse Event|0|||
155112367|NCT00712725|559840815|FG004|Overall Study|Lost to Follow-up|2|||
154875892|NCT01120093|558971114|FG001|Treatment Period 3|Adverse Event|0|||
154875893|NCT01120093|558971115|FG002|Treatment Period 3|Adverse Event|0|||
154875894|NCT01120093|558971116|FG003|Treatment Period 3|Adverse Event|0|||
154875895|NCT01120093|558971117|FG004|Treatment Period 3|Adverse Event|1|||
154875896|NCT01120093|558971113|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155112368|NCT00712725|559840816|FG005|Overall Study|Lost to Follow-up|2|||
154875897|NCT01120093|558971114|FG001|Treatment Period 3|Withdrawal by Subject|0|||
154875898|NCT01120093|558971115|FG002|Treatment Period 3|Withdrawal by Subject|1|||
154875899|NCT01120093|558971116|FG003|Treatment Period 3|Withdrawal by Subject|0|||
154875900|NCT01120093|558971117|FG004|Treatment Period 3|Withdrawal by Subject|0|||
154875901|NCT01120093|558971113|FG000|Treatment Period 4|Adverse Event|1|||
154875902|NCT01120093|558971114|FG001|Treatment Period 4|Adverse Event|0|||
155112369|NCT00712725|559840817|FG006|Overall Study|Lost to Follow-up|3|||
155112370|NCT00712725|559840818|FG007|Overall Study|Lost to Follow-up|1|||
155112371|NCT00712725|559840811|FG000|Overall Study|Physician Decision|2|||
155112372|NCT00712725|559840812|FG001|Overall Study|Physician Decision|0|||
155112373|NCT00712725|559840813|FG002|Overall Study|Physician Decision|0|||
155112374|NCT00712725|559840814|FG003|Overall Study|Physician Decision|0|||
155112375|NCT00712725|559840815|FG004|Overall Study|Physician Decision|1|||
155112376|NCT00712725|559840816|FG005|Overall Study|Physician Decision|0|||
155112377|NCT00712725|559840817|FG006|Overall Study|Physician Decision|2|||
155112378|NCT00712725|559840818|FG007|Overall Study|Physician Decision|0|||
155112379|NCT00712725|559840811|FG000|Overall Study|Pregnancy|0|||
155112380|NCT00712725|559840812|FG001|Overall Study|Pregnancy|1|||
155112381|NCT00712725|559840813|FG002|Overall Study|Pregnancy|0|||
155112382|NCT00712725|559840814|FG003|Overall Study|Pregnancy|0|||
155112383|NCT00712725|559840815|FG004|Overall Study|Pregnancy|1|||
155112384|NCT00712725|559840816|FG005|Overall Study|Pregnancy|0|||
155112385|NCT00712725|559840817|FG006|Overall Study|Pregnancy|2|||
155112386|NCT00712725|559840818|FG007|Overall Study|Pregnancy|0|||
155112387|NCT00712725|559840811|FG000|Overall Study|Protocol Violation|2|||
155112388|NCT00712725|559840812|FG001|Overall Study|Protocol Violation|0|||
154875903|NCT01120093|558971115|FG002|Treatment Period 4|Adverse Event|0|||
154875904|NCT01120093|558971116|FG003|Treatment Period 4|Adverse Event|0|||
154875905|NCT01120093|558971117|FG004|Treatment Period 4|Adverse Event|0|||
154875906|NCT01120093|558971113|FG000|Treatment Period 5|Adverse Event|0|||
154875907|NCT01120093|558971114|FG001|Treatment Period 5|Adverse Event|1|||
154875908|NCT01120093|558971115|FG002|Treatment Period 5|Adverse Event|0|||
154875909|NCT01120093|558971116|FG003|Treatment Period 5|Adverse Event|1|||
154875910|NCT01120093|558971117|FG004|Treatment Period 5|Adverse Event|0|||
155112389|NCT00712725|559840813|FG002|Overall Study|Protocol Violation|1|||
155112390|NCT00712725|559840814|FG003|Overall Study|Protocol Violation|3|||
155112391|NCT00712725|559840815|FG004|Overall Study|Protocol Violation|2|||
155112392|NCT00712725|559840816|FG005|Overall Study|Protocol Violation|0|||
155112393|NCT00712725|559840817|FG006|Overall Study|Protocol Violation|1|||
155112394|NCT00712725|559840818|FG007|Overall Study|Protocol Violation|1|||
155112395|NCT00712725|559840811|FG000|Overall Study|Withdrawal by Subject|2|||
155112396|NCT00712725|559840812|FG001|Overall Study|Withdrawal by Subject|1|||
155112397|NCT00712725|559840813|FG002|Overall Study|Withdrawal by Subject|1|||
155112398|NCT00712725|559840814|FG003|Overall Study|Withdrawal by Subject|2|||
154875911|NCT00525148|558971122|FG000|Overall Study|Other Adverse Event|3|||
154875912|NCT00525148|558971123|FG001|Overall Study|Other Adverse Event|5|||
154875913|NCT00525148|558971124|FG002|Overall Study|Other Adverse Event|1|||
154875914|NCT00525148|558971125|FG003|Overall Study|Other Adverse Event|8|||
154875915|NCT00525148|558971122|FG000|Overall Study|Progressive disease|18|||
154875916|NCT00525148|558971123|FG001|Overall Study|Progressive disease|30|||
154875917|NCT00525148|558971124|FG002|Overall Study|Progressive disease|6|||
154875918|NCT00525148|558971125|FG003|Overall Study|Progressive disease|49|||
154875919|NCT00525148|558971122|FG000|Overall Study|Refused continuation of study medication|0|||
154875920|NCT00525148|558971123|FG001|Overall Study|Refused continuation of study medication|2|||
154875921|NCT00525148|558971124|FG002|Overall Study|Refused continuation of study medication|0|||
154875922|NCT00525148|558971125|FG003|Overall Study|Refused continuation of study medication|1|||
154875923|NCT00525148|558971122|FG000|Overall Study|Other than stated|2|||
154875924|NCT00525148|558971123|FG001|Overall Study|Other than stated|1|||
154875925|NCT00525148|558971124|FG002|Overall Study|Other than stated|0|||
154875926|NCT00525148|558971125|FG003|Overall Study|Other than stated|3|||
154875927|NCT00570739|558971126|FG000|Overall Study|Adverse Event|8|||
154875928|NCT00570739|558971127|FG001|Overall Study|Adverse Event|6|||
154875929|NCT00570739|558971128|FG002|Overall Study|Adverse Event|2|||
155112399|NCT00712725|559840815|FG004|Overall Study|Withdrawal by Subject|1|||
155112400|NCT00712725|559840816|FG005|Overall Study|Withdrawal by Subject|1|||
155112401|NCT00712725|559840817|FG006|Overall Study|Withdrawal by Subject|1|||
155112402|NCT00712725|559840818|FG007|Overall Study|Withdrawal by Subject|2|||
155112403|NCT00712725|559840811|FG000|Overall Study|Lack of Qualifying Event|16|||
155112404|NCT00712725|559840812|FG001|Overall Study|Lack of Qualifying Event|2|||
155112405|NCT00712725|559840813|FG002|Overall Study|Lack of Qualifying Event|6|||
155112406|NCT00712725|559840814|FG003|Overall Study|Lack of Qualifying Event|8|||
154875930|NCT00570739|558971129|FG003|Overall Study|Adverse Event|2|||
154875931|NCT00570739|558971126|FG000|Overall Study|Lost to Follow-up|4|||
154875932|NCT00570739|558971127|FG001|Overall Study|Lost to Follow-up|5|||
154875933|NCT00570739|558971128|FG002|Overall Study|Lost to Follow-up|4|||
155112407|NCT00712725|559840815|FG004|Overall Study|Lack of Qualifying Event|11|||
154875934|NCT00570739|558971129|FG003|Overall Study|Lost to Follow-up|1|||
155112408|NCT00712725|559840816|FG005|Overall Study|Lack of Qualifying Event|13|||
155112409|NCT00712725|559840817|FG006|Overall Study|Lack of Qualifying Event|11|||
155112410|NCT00712725|559840818|FG007|Overall Study|Lack of Qualifying Event|6|||
155112411|NCT00712725|559840811|FG000|Overall Study|Protocol Specified Criteria|3|||
155112412|NCT00712725|559840812|FG001|Overall Study|Protocol Specified Criteria|0|||
155112413|NCT00712725|559840813|FG002|Overall Study|Protocol Specified Criteria|1|||
155112414|NCT00712725|559840814|FG003|Overall Study|Protocol Specified Criteria|2|||
154875935|NCT00570739|558971126|FG000|Overall Study|Physician Decision|1|||
154875936|NCT00570739|558971127|FG001|Overall Study|Physician Decision|1|||
154875937|NCT00570739|558971128|FG002|Overall Study|Physician Decision|0|||
154875938|NCT00570739|558971129|FG003|Overall Study|Physician Decision|0|||
154875939|NCT00570739|558971126|FG000|Overall Study|Withdrawal by Subject|7|||
154875940|NCT00570739|558971127|FG001|Overall Study|Withdrawal by Subject|7|||
154875941|NCT00570739|558971128|FG002|Overall Study|Withdrawal by Subject|3|||
154875942|NCT00570739|558971129|FG003|Overall Study|Withdrawal by Subject|5|||
154875943|NCT00570739|558971126|FG000|Overall Study|Required restricted medication|0|||
154875944|NCT00570739|558971127|FG001|Overall Study|Required restricted medication|0|||
154875945|NCT00570739|558971128|FG002|Overall Study|Required restricted medication|1|||
154875946|NCT00570739|558971129|FG003|Overall Study|Required restricted medication|0|||
154875947|NCT00570739|558971126|FG000|Overall Study|Met discontinuation criteria|1|||
154875948|NCT00570739|558971127|FG001|Overall Study|Met discontinuation criteria|0|||
154875949|NCT00570739|558971128|FG002|Overall Study|Met discontinuation criteria|1|||
154875950|NCT00570739|558971129|FG003|Overall Study|Met discontinuation criteria|1|||
154875951|NCT00570739|558971126|FG000|Overall Study|Other|0|||
154875952|NCT00570739|558971127|FG001|Overall Study|Other|2|||
154875953|NCT00570739|558971128|FG002|Overall Study|Other|5|||
154875954|NCT00570739|558971129|FG003|Overall Study|Other|3|||
154875955|NCT02086565|558971131|FG000|Overall Study|Lost to Follow-up|9|||
154875956|NCT02086565|558971132|FG001|Overall Study|Lost to Follow-up|7|||
154875957|NCT02086565|558971131|FG000|Overall Study|Withdrawal by Subject|2|||
154875958|NCT02086565|558971132|FG001|Overall Study|Withdrawal by Subject|1|||
154875959|NCT02086565|558971131|FG000|Overall Study|Death|3|||
154875960|NCT02086565|558971132|FG001|Overall Study|Death|2|||
154875961|NCT02086565|558971131|FG000|Overall Study|withdrawn by research team|2|||
154875962|NCT02086565|558971132|FG001|Overall Study|withdrawn by research team|2|||
154875963|NCT00739297|558971133|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
154875964|NCT00739297|558971134|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
154875965|NCT00739297|558971135|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
154875966|NCT00739297|558971136|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
154875967|NCT00739297|558971137|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
154875968|NCT00739297|558971138|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
154875969|NCT00739297|558971139|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
154875970|NCT00739297|558971133|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
154875971|NCT00739297|558971134|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
154875972|NCT00739297|558971135|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
154875973|NCT00739297|558971136|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
154875974|NCT00739297|558971137|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
154875975|NCT00739297|558971138|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
154875976|NCT00739297|558971139|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
154875977|NCT01400971|558971140|FG000|Overall Study|Death|82|||
154875978|NCT01400971|558971140|FG000|Overall Study|Lost to Follow-up|196|||
154875979|NCT01400971|558971140|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
154875980|NCT01400971|558971140|FG000|Overall Study|Physician Decision|57|||
154875981|NCT01400971|558971140|FG000|Overall Study|Withdrawal by Subject|158|||
154875982|NCT01400971|558971140|FG000|Overall Study|Other|422|||
154875983|NCT02092389|558971145|FG000|Overall Study|Adverse Event|1|||
154875984|NCT02092389|558971145|FG000|Overall Study|Other|5|||
154875985|NCT01242020|558971146|FG000|Overall Study|Withdrawal by Subject|2|||
154875986|NCT01242020|558971147|FG001|Overall Study|Withdrawal by Subject|0|||
154875987|NCT01242020|558971146|FG000|Overall Study|Failed screening|1|||
154875988|NCT01242020|558971147|FG001|Overall Study|Failed screening|0|||
154875989|NCT02680847|558971148|FG000|Overall Study|Other|2|||
154875990|NCT02680847|558971149|FG001|Overall Study|Other|0|||
154875991|NCT02680847|558971150|FG002|Overall Study|Other|0|||
154875992|NCT02680847|558971148|FG000|Overall Study|No longer met eligibility criteria|2|||
154875993|NCT02680847|558971149|FG001|Overall Study|No longer met eligibility criteria|2|||
154875994|NCT02680847|558971150|FG002|Overall Study|No longer met eligibility criteria|0|||
154875995|NCT02680847|558971148|FG000|Overall Study|Unwilling to participate in study|1|||
154875996|NCT02680847|558971149|FG001|Overall Study|Unwilling to participate in study|1|||
154875997|NCT02680847|558971150|FG002|Overall Study|Unwilling to participate in study|0|||
154875998|NCT02680847|558971148|FG000|Overall Study|Lack of Efficacy|0|||
154875999|NCT02680847|558971149|FG001|Overall Study|Lack of Efficacy|0|||
154876000|NCT02680847|558971150|FG002|Overall Study|Lack of Efficacy|2|||
154876001|NCT02680847|558971148|FG000|Overall Study|Adverse Event|0|||
154876002|NCT02680847|558971149|FG001|Overall Study|Adverse Event|0|||
155175340|NCT00910624|560080227|FG001|Treatment Phase|Treatment Failure|10|||
154876003|NCT02680847|558971150|FG002|Overall Study|Adverse Event|1|||
154876004|NCT01595646|558971156|FG000|Overall Study|Withdrawal by Subject|1|||
154876005|NCT01595646|558971157|FG001|Overall Study|Withdrawal by Subject|0|||
154876006|NCT01595646|558971158|FG002|Overall Study|Withdrawal by Subject|0|||
154876007|NCT00751881|558971164|FG000|Core Treatment Period|Not treated|1|||
154876008|NCT00751881|558971165|FG001|Core Treatment Period|Not treated|1|||
154876009|NCT00751881|558971166|FG002|Core Treatment Period|Not treated|2|||
154876010|NCT00751881|558971164|FG000|Core Treatment Period|Adverse Event|26|||
154876011|NCT00751881|558971165|FG001|Core Treatment Period|Adverse Event|54|||
154876012|NCT00751881|558971166|FG002|Core Treatment Period|Adverse Event|58|||
154876013|NCT00751881|558971164|FG000|Core Treatment Period|Lack of Efficacy|37|||
154876014|NCT00751881|558971165|FG001|Core Treatment Period|Lack of Efficacy|30|||
154876015|NCT00751881|558971166|FG002|Core Treatment Period|Lack of Efficacy|20|||
154876016|NCT00751881|558971164|FG000|Core Treatment Period|Poor compliance to protocol|15|||
154876017|NCT00751881|558971165|FG001|Core Treatment Period|Poor compliance to protocol|3|||
154876018|NCT00751881|558971166|FG002|Core Treatment Period|Poor compliance to protocol|4|||
154876019|NCT00751881|558971164|FG000|Core Treatment Period|Lost to Follow-up|6|||
154876020|NCT00751881|558971165|FG001|Core Treatment Period|Lost to Follow-up|4|||
154876021|NCT00751881|558971166|FG002|Core Treatment Period|Lost to Follow-up|3|||
154876022|NCT00751881|558971164|FG000|Core Treatment Period|Other: protocol deviation|3|||
154876023|NCT00751881|558971165|FG001|Core Treatment Period|Other: protocol deviation|3|||
154876024|NCT00751881|558971166|FG002|Core Treatment Period|Other: protocol deviation|7|||
154876025|NCT00751881|558971164|FG000|Core Treatment Period|Other: wish to parent|5|||
154876026|NCT00751881|558971165|FG001|Core Treatment Period|Other: wish to parent|7|||
154876027|NCT00751881|558971166|FG002|Core Treatment Period|Other: wish to parent|4|||
154876028|NCT00751881|558971164|FG000|Core Treatment Period|Other: personal/family constraints|6|||
154876029|NCT00751881|558971165|FG001|Core Treatment Period|Other: personal/family constraints|7|||
155112415|NCT00712725|559840815|FG004|Overall Study|Protocol Specified Criteria|1|||
154876030|NCT00751881|558971166|FG002|Core Treatment Period|Other: personal/family constraints|10|||
154876031|NCT00751881|558971164|FG000|Core Treatment Period|Other: MS treatment change|6|||
154876032|NCT00751881|558971165|FG001|Core Treatment Period|Other: MS treatment change|4|||
154876033|NCT00751881|558971166|FG002|Core Treatment Period|Other: MS treatment change|4|||
154876034|NCT00751881|558971164|FG000|Core Treatment Period|Other: tolerability complaints|2|||
154876035|NCT00751881|558971165|FG001|Core Treatment Period|Other: tolerability complaints|0|||
154876036|NCT00751881|558971166|FG002|Core Treatment Period|Other: tolerability complaints|0|||
154876037|NCT00751881|558971164|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
154876038|NCT00751881|558971165|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
154876039|NCT00751881|558971166|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
154876040|NCT00751881|558971164|FG000|Extension Study Period|Adverse Event|18|||
154876041|NCT00751881|558971165|FG001|Extension Study Period|Adverse Event|20|||
154876042|NCT00751881|558971166|FG002|Extension Study Period|Adverse Event|21|||
154876043|NCT00751881|558971164|FG000|Extension Study Period|Lack of Efficacy|14|||
154876044|NCT00751881|558971165|FG001|Extension Study Period|Lack of Efficacy|10|||
154876045|NCT00751881|558971166|FG002|Extension Study Period|Lack of Efficacy|20|||
154876046|NCT00751881|558971164|FG000|Extension Study Period|Lost to Follow-up|4|||
154876047|NCT00751881|558971165|FG001|Extension Study Period|Lost to Follow-up|9|||
154876048|NCT00751881|558971166|FG002|Extension Study Period|Lost to Follow-up|6|||
154876049|NCT00751881|558971164|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
154876050|NCT00751881|558971165|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
155112416|NCT00712725|559840816|FG005|Overall Study|Protocol Specified Criteria|0|||
155112417|NCT00712725|559840817|FG006|Overall Study|Protocol Specified Criteria|2|||
155112418|NCT00712725|559840818|FG007|Overall Study|Protocol Specified Criteria|1|||
155112419|NCT01901289|559840819|FG000|Overall Study|Death|32|||
155112420|NCT01901289|559840819|FG000|Overall Study|Lost to Follow-up|16|||
155112421|NCT01901289|559840819|FG000|Overall Study|Withdrawal by Subject|35|||
155112422|NCT01901289|559840819|FG000|Overall Study|Other type of endpoint met|2|||
155112423|NCT00344318|559840820|FG000|Overall Study|Adverse Event|0|||
155112424|NCT00344318|559840821|FG001|Overall Study|Adverse Event|3|||
155112425|NCT00344318|559840822|FG002|Overall Study|Adverse Event|0|||
155112426|NCT00344318|559840823|FG003|Overall Study|Adverse Event|1|||
155112427|NCT00344318|559840820|FG000|Overall Study|Withdrawal by Subject|2|||
155112428|NCT00344318|559840821|FG001|Overall Study|Withdrawal by Subject|2|||
155112429|NCT00344318|559840822|FG002|Overall Study|Withdrawal by Subject|0|||
155112430|NCT00344318|559840823|FG003|Overall Study|Withdrawal by Subject|2|||
155112431|NCT00344318|559840820|FG000|Overall Study|Lost to Follow-up|2|||
155112432|NCT00344318|559840821|FG001|Overall Study|Lost to Follow-up|0|||
155112433|NCT00344318|559840822|FG002|Overall Study|Lost to Follow-up|1|||
155112434|NCT00344318|559840823|FG003|Overall Study|Lost to Follow-up|0|||
154876051|NCT00751881|558971166|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
154876052|NCT00751881|558971164|FG000|Extension Study Period|Other than specified above|26|||
155112435|NCT00700882|559840829|FG000|Overall Study|Never received treatment|6|||
155112436|NCT00700882|559840829|FG000|Overall Study|Ineligible|2|||
155112437|NCT00700882|559840829|FG000|Overall Study|No KIT mutation|51|||
155112438|NCT01606176|559840833|FG000|Overall Study|Adverse Event|2|||
155112439|NCT01606176|559840834|FG001|Overall Study|Adverse Event|3|||
155112440|NCT01606176|559840833|FG000|Overall Study|Disease progression|1|||
155112441|NCT01606176|559840834|FG001|Overall Study|Disease progression|0|||
155112442|NCT01606176|559840833|FG000|Overall Study|Withdrawal by Subject|1|||
155112443|NCT01606176|559840834|FG001|Overall Study|Withdrawal by Subject|0|||
154876053|NCT00751881|558971165|FG001|Extension Study Period|Other than specified above|30|||
154876054|NCT00751881|558971166|FG002|Extension Study Period|Other than specified above|18|||
154876055|NCT04770155|558971167|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876056|NCT04770155|558971168|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876057|NCT04770155|558971169|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876058|NCT04770155|558971170|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876059|NCT04770155|558971171|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876060|NCT04770155|558971172|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876061|NCT04770155|558971173|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876062|NCT04770155|558971174|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
154876063|NCT01765764|558971175|FG000|Treatment Period|Adverse Event|1|||
154876064|NCT01765764|558971176|FG001|Treatment Period|Adverse Event|2|||
154876065|NCT01765764|558971177|FG002|Treatment Period|Adverse Event|1|||
154876066|NCT01765764|558971175|FG000|Treatment Period|Lost to Follow-up|0|||
154876067|NCT01765764|558971176|FG001|Treatment Period|Lost to Follow-up|3|||
154876068|NCT01765764|558971177|FG002|Treatment Period|Lost to Follow-up|2|||
154876069|NCT01765764|558971175|FG000|Treatment Period|Personal Reasons|1|||
154876070|NCT01765764|558971176|FG001|Treatment Period|Personal Reasons|2|||
154876071|NCT01765764|558971177|FG002|Treatment Period|Personal Reasons|1|||
154876072|NCT01765764|558971175|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
154876073|NCT01765764|558971176|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
154876074|NCT01765764|558971177|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
154876075|NCT01597193|558971179|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
154876076|NCT01597193|558971180|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
154876077|NCT01597193|558971181|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
154876078|NCT01597193|558971182|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
154876079|NCT01597193|558971183|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
154876080|NCT01597193|558971184|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
154974390|NCT01332968|559331237|FG005|Maintenance/Observation Period|Physician Decision|1|||
154974391|NCT01332968|559331238|FG006|Maintenance/Observation Period|Physician Decision|0|||
154974392|NCT01332968|559331239|FG007|Maintenance/Observation Period|Physician Decision|0|||
154974393|NCT01332968|559331232|FG000|Maintenance/Observation Period|Progressive Disease|0|||
154974394|NCT01332968|559331233|FG001|Maintenance/Observation Period|Progressive Disease|0|||
154974395|NCT01332968|559331234|FG002|Maintenance/Observation Period|Progressive Disease|72|||
154974396|NCT01332968|559331235|FG003|Maintenance/Observation Period|Progressive Disease|40|||
154974397|NCT01332968|559331236|FG004|Maintenance/Observation Period|Progressive Disease|0|||
154974398|NCT01332968|559331237|FG005|Maintenance/Observation Period|Progressive Disease|0|||
154974399|NCT01332968|559331238|FG006|Maintenance/Observation Period|Progressive Disease|0|||
154974400|NCT01332968|559331239|FG007|Maintenance/Observation Period|Progressive Disease|0|||
154974401|NCT01332968|559331232|FG000|Maintenance/Observation Period|Protocol Violation|0|||
154974402|NCT01332968|559331233|FG001|Maintenance/Observation Period|Protocol Violation|0|||
154974403|NCT01332968|559331234|FG002|Maintenance/Observation Period|Protocol Violation|1|||
154974404|NCT01332968|559331235|FG003|Maintenance/Observation Period|Protocol Violation|1|||
154974405|NCT01332968|559331236|FG004|Maintenance/Observation Period|Protocol Violation|0|||
154974406|NCT01332968|559331237|FG005|Maintenance/Observation Period|Protocol Violation|0|||
154974407|NCT01332968|559331238|FG006|Maintenance/Observation Period|Protocol Violation|0|||
154974408|NCT01332968|559331239|FG007|Maintenance/Observation Period|Protocol Violation|0|||
154974409|NCT01332968|559331232|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
154974410|NCT01332968|559331233|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
154974411|NCT01332968|559331234|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
154974412|NCT01332968|559331235|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
154974413|NCT01332968|559331236|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
154974414|NCT01332968|559331237|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
154974415|NCT01332968|559331238|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
154974416|NCT01332968|559331239|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
154974417|NCT01332968|559331232|FG000|Follow-Up Period|Adverse Event|0|||
154974418|NCT01332968|559331233|FG001|Follow-Up Period|Adverse Event|0|||
154974419|NCT01332968|559331234|FG002|Follow-Up Period|Adverse Event|0|||
154974420|NCT01332968|559331235|FG003|Follow-Up Period|Adverse Event|0|||
154974421|NCT01332968|559331236|FG004|Follow-Up Period|Adverse Event|0|||
154974422|NCT01332968|559331237|FG005|Follow-Up Period|Adverse Event|0|||
154974423|NCT01332968|559331238|FG006|Follow-Up Period|Adverse Event|0|||
154974424|NCT01332968|559331239|FG007|Follow-Up Period|Adverse Event|4|||
154974425|NCT01332968|559331232|FG000|Follow-Up Period|Death|0|||
154974426|NCT01332968|559331233|FG001|Follow-Up Period|Death|0|||
154974427|NCT01332968|559331234|FG002|Follow-Up Period|Death|0|||
154974428|NCT01332968|559331235|FG003|Follow-Up Period|Death|0|||
154974429|NCT01332968|559331236|FG004|Follow-Up Period|Death|0|||
154876081|NCT01597193|558971185|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
154876082|NCT01597193|558971179|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
154876083|NCT01597193|558971180|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
154876084|NCT01597193|558971181|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
154876085|NCT01597193|558971182|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
154876086|NCT01597193|558971183|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
154876087|NCT01597193|558971184|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
154876088|NCT01597193|558971185|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
154876089|NCT01597193|558971179|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
154876090|NCT01597193|558971180|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
154876091|NCT01597193|558971181|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
154876092|NCT01597193|558971182|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
154876093|NCT01597193|558971183|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
154876094|NCT01597193|558971184|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
154876095|NCT01597193|558971185|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
154876096|NCT01597193|558971179|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
154876097|NCT01597193|558971180|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
154876098|NCT01597193|558971181|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
154876099|NCT01597193|558971182|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
154876100|NCT01597193|558971183|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
154876101|NCT01597193|558971184|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
154876102|NCT01597193|558971185|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
154876103|NCT01597193|558971179|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
154876104|NCT01597193|558971180|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
154876105|NCT01597193|558971181|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
154974430|NCT01332968|559331237|FG005|Follow-Up Period|Death|0|||
154974431|NCT01332968|559331238|FG006|Follow-Up Period|Death|27|||
154974432|NCT01332968|559331239|FG007|Follow-Up Period|Death|30|||
154974433|NCT01332968|559331232|FG000|Follow-Up Period|Lost to Follow-up|0|||
154974434|NCT01332968|559331233|FG001|Follow-Up Period|Lost to Follow-up|0|||
154974435|NCT01332968|559331234|FG002|Follow-Up Period|Lost to Follow-up|0|||
154974436|NCT01332968|559331235|FG003|Follow-Up Period|Lost to Follow-up|0|||
154974437|NCT01332968|559331236|FG004|Follow-Up Period|Lost to Follow-up|0|||
154974438|NCT01332968|559331237|FG005|Follow-Up Period|Lost to Follow-up|0|||
154974439|NCT01332968|559331238|FG006|Follow-Up Period|Lost to Follow-up|11|||
154974440|NCT01332968|559331239|FG007|Follow-Up Period|Lost to Follow-up|15|||
154974441|NCT01332968|559331232|FG000|Follow-Up Period|Non-compliance|0|||
154974442|NCT01332968|559331233|FG001|Follow-Up Period|Non-compliance|0|||
154974443|NCT01332968|559331234|FG002|Follow-Up Period|Non-compliance|0|||
154974444|NCT01332968|559331235|FG003|Follow-Up Period|Non-compliance|0|||
154974445|NCT01332968|559331236|FG004|Follow-Up Period|Non-compliance|0|||
154974446|NCT01332968|559331237|FG005|Follow-Up Period|Non-compliance|0|||
154974447|NCT01332968|559331238|FG006|Follow-Up Period|Non-compliance|4|||
154974448|NCT01332968|559331239|FG007|Follow-Up Period|Non-compliance|9|||
154974449|NCT01332968|559331232|FG000|Follow-Up Period|Other|0|||
154974450|NCT01332968|559331233|FG001|Follow-Up Period|Other|0|||
154974451|NCT01332968|559331234|FG002|Follow-Up Period|Other|0|||
154974452|NCT01332968|559331235|FG003|Follow-Up Period|Other|0|||
154974453|NCT01332968|559331236|FG004|Follow-Up Period|Other|0|||
154974454|NCT01332968|559331237|FG005|Follow-Up Period|Other|0|||
154974455|NCT01332968|559331238|FG006|Follow-Up Period|Other|18|||
154974456|NCT01332968|559331239|FG007|Follow-Up Period|Other|21|||
154974457|NCT01332968|559331232|FG000|Follow-Up Period|Physician Decision|0|||
154974458|NCT01332968|559331233|FG001|Follow-Up Period|Physician Decision|0|||
154974459|NCT01332968|559331234|FG002|Follow-Up Period|Physician Decision|0|||
154974460|NCT01332968|559331235|FG003|Follow-Up Period|Physician Decision|0|||
154876106|NCT01597193|558971182|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
154876107|NCT01597193|558971183|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
154876108|NCT01597193|558971184|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
154876109|NCT01597193|558971185|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
154876110|NCT01345786|558971194|FG000|Overall Study|Adverse Event|0|||
154876111|NCT01345786|558971195|FG001|Overall Study|Adverse Event|1|||
154974461|NCT01332968|559331236|FG004|Follow-Up Period|Physician Decision|0|||
154974462|NCT01332968|559331237|FG005|Follow-Up Period|Physician Decision|0|||
154974463|NCT01332968|559331238|FG006|Follow-Up Period|Physician Decision|12|||
154974464|NCT01332968|559331239|FG007|Follow-Up Period|Physician Decision|15|||
154974465|NCT01332968|559331232|FG000|Follow-Up Period|Progressive Disease|0|||
154876112|NCT01345786|558971196|FG002|Overall Study|Adverse Event|3|||
154876113|NCT01345786|558971197|FG003|Overall Study|Adverse Event|1|||
154876114|NCT01345786|558971194|FG000|Overall Study|Subject withdrew consent|2|||
154974466|NCT01332968|559331233|FG001|Follow-Up Period|Progressive Disease|0|||
154974467|NCT01332968|559331234|FG002|Follow-Up Period|Progressive Disease|0|||
154974468|NCT01332968|559331235|FG003|Follow-Up Period|Progressive Disease|0|||
154974469|NCT01332968|559331236|FG004|Follow-Up Period|Progressive Disease|0|||
155112444|NCT01832493|559840836|FG000|Overall Study|Physician Decision|2|||
155112445|NCT01832493|559840836|FG000|Overall Study|Protocol Violation|4|||
155112446|NCT01832493|559840836|FG000|Overall Study|Unable to place LV lead|2|||
155112447|NCT00290771|559840845|FG000|Overall Study|Disease progression|95|||
155112448|NCT00290771|559840846|FG001|Overall Study|Disease progression|73|||
155112449|NCT00290771|559840845|FG000|Overall Study|Death|11|||
155112450|NCT00290771|559840846|FG001|Overall Study|Death|10|||
155112451|NCT00290771|559840845|FG000|Overall Study|Adverse Event|12|||
155112452|NCT00290771|559840846|FG001|Overall Study|Adverse Event|6|||
155112453|NCT00290771|559840845|FG000|Overall Study|Withdrawal by Subject|5|||
155112454|NCT00290771|559840846|FG001|Overall Study|Withdrawal by Subject|6|||
155112455|NCT00290771|559840845|FG000|Overall Study|Administrative problems|2|||
155112456|NCT00290771|559840846|FG001|Overall Study|Administrative problems|1|||
155112457|NCT00290771|559840845|FG000|Overall Study|Protocol Violation|2|||
155112458|NCT00290771|559840846|FG001|Overall Study|Protocol Violation|0|||
155112459|NCT00290771|559840845|FG000|Overall Study|Lost to Follow-up|0|||
155112460|NCT00290771|559840846|FG001|Overall Study|Lost to Follow-up|1|||
155112461|NCT00792740|559840847|FG000|Overall Study|Disease Worsening|3|||
155112462|NCT00792740|559840848|FG001|Overall Study|Disease Worsening|2|||
155112463|NCT00792740|559840847|FG000|Overall Study|Personal Reason|1|||
155112464|NCT00792740|559840848|FG001|Overall Study|Personal Reason|0|||
155112465|NCT00792740|559840847|FG000|Overall Study|Adverse Event|1|||
155112466|NCT00792740|559840848|FG001|Overall Study|Adverse Event|3|||
155112467|NCT00792740|559840847|FG000|Overall Study|Patient's withdrawal of consent|0|||
155112468|NCT00792740|559840848|FG001|Overall Study|Patient's withdrawal of consent|1|||
155112469|NCT00792740|559840847|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
155112470|NCT00792740|559840848|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
155112471|NCT00792740|559840847|FG000|Overall Study|Other reasons|0|||
155112472|NCT00792740|559840848|FG001|Overall Study|Other reasons|1|||
155112473|NCT02485639|559840849|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
155112474|NCT02485639|559840849|FG000|Overall Study|Early termination|4|||
155112475|NCT02485639|559840849|FG000|Overall Study|Withdrawal by Subject|4|||
155112476|NCT01439971|559840850|FG000|Overall Study|Required number in cohort dosed|0|||
155112477|NCT01439971|559840851|FG001|Overall Study|Required number in cohort dosed|1|||
155112478|NCT01439971|559840852|FG002|Overall Study|Required number in cohort dosed|2|||
155112479|NCT01439971|559840853|FG003|Overall Study|Required number in cohort dosed|0|||
155112480|NCT01439971|559840854|FG004|Overall Study|Required number in cohort dosed|1|||
155112481|NCT02628600|559840855|FG000|Overall Study|Death|2|||
155112482|NCT02628600|559840856|FG001|Overall Study|Death|1|||
155112483|NCT02628600|559840855|FG000|Overall Study|Adverse Event|3|||
155112484|NCT02628600|559840856|FG001|Overall Study|Adverse Event|20|||
155112485|NCT02628600|559840855|FG000|Overall Study|Protocol Violation|0|||
155112486|NCT02628600|559840856|FG001|Overall Study|Protocol Violation|1|||
155112487|NCT02628600|559840855|FG000|Overall Study|Lack of Efficacy|2|||
154876115|NCT01345786|558971195|FG001|Overall Study|Subject withdrew consent|2|||
154876116|NCT01345786|558971196|FG002|Overall Study|Subject withdrew consent|1|||
154876117|NCT01345786|558971197|FG003|Overall Study|Subject withdrew consent|0|||
154876118|NCT01345786|558971194|FG000|Overall Study|Noncompliance with protocol|1|||
154876119|NCT01345786|558971195|FG001|Overall Study|Noncompliance with protocol|0|||
154876120|NCT01345786|558971196|FG002|Overall Study|Noncompliance with protocol|1|||
154876121|NCT01345786|558971197|FG003|Overall Study|Noncompliance with protocol|0|||
154876122|NCT01345786|558971194|FG000|Overall Study|Administrative|3|||
154876123|NCT01345786|558971195|FG001|Overall Study|Administrative|5|||
154876124|NCT01345786|558971196|FG002|Overall Study|Administrative|0|||
154876125|NCT01345786|558971197|FG003|Overall Study|Administrative|0|||
154876126|NCT01345786|558971194|FG000|Overall Study|Lost to Follow-up|0|||
154974470|NCT01332968|559331237|FG005|Follow-Up Period|Progressive Disease|0|||
154974471|NCT01332968|559331238|FG006|Follow-Up Period|Progressive Disease|126|||
154974472|NCT01332968|559331239|FG007|Follow-Up Period|Progressive Disease|106|||
154974473|NCT01332968|559331232|FG000|Follow-Up Period|Protocol Violation|0|||
154974474|NCT01332968|559331233|FG001|Follow-Up Period|Protocol Violation|0|||
155112488|NCT02628600|559840856|FG001|Overall Study|Lack of Efficacy|0|||
155112489|NCT02628600|559840855|FG000|Overall Study|Withdrawal by Subject|13|||
155112490|NCT02628600|559840856|FG001|Overall Study|Withdrawal by Subject|8|||
155112491|NCT02628600|559840855|FG000|Overall Study|Lost to Follow-up|1|||
155112492|NCT02628600|559840856|FG001|Overall Study|Lost to Follow-up|0|||
155112493|NCT02628600|559840855|FG000|Overall Study|Physician Decision|2|||
155112494|NCT02628600|559840856|FG001|Overall Study|Physician Decision|2|||
155112495|NCT02628600|559840855|FG000|Overall Study|Other not specified|1|||
155112496|NCT02628600|559840856|FG001|Overall Study|Other not specified|0|||
155112497|NCT04283994|559840858|FG000|Overall Study|Death|11|||
155112498|NCT04283994|559840859|FG001|Overall Study|Death|20|||
155112499|NCT04283994|559840860|FG002|Overall Study|Death|11|||
155112500|NCT04283994|559840861|FG003|Overall Study|Death|0|||
155112501|NCT04283994|559840862|FG004|Overall Study|Death|0|||
155112502|NCT04283994|559840863|FG005|Overall Study|Death|0|||
155112503|NCT04283994|559840864|FG006|Overall Study|Death|0|||
154974475|NCT01332968|559331234|FG002|Follow-Up Period|Protocol Violation|0|||
154876127|NCT01345786|558971195|FG001|Overall Study|Lost to Follow-up|0|||
154876128|NCT01345786|558971196|FG002|Overall Study|Lost to Follow-up|0|||
154876129|NCT01345786|558971197|FG003|Overall Study|Lost to Follow-up|2|||
154876130|NCT01070784|558971198|FG000|Overall Study|Withdrawal by Subject|6|||
154876131|NCT01070784|558971199|FG001|Overall Study|Withdrawal by Subject|9|||
154876132|NCT01070784|558971198|FG000|Overall Study|Adverse Event|14|||
154876133|NCT01070784|558971199|FG001|Overall Study|Adverse Event|9|||
154876134|NCT01323673|558971200|FG000|Overall Study|Adverse Event|0|||
154876135|NCT01323673|558971201|FG001|Overall Study|Adverse Event|1|||
154876136|NCT01323673|558971200|FG000|Overall Study|Lost to Follow-up|0|||
154876137|NCT01323673|558971201|FG001|Overall Study|Lost to Follow-up|1|||
154876138|NCT01323673|558971200|FG000|Overall Study|Protocol Violation|1|||
154876139|NCT01323673|558971201|FG001|Overall Study|Protocol Violation|0|||
154876140|NCT01323673|558971200|FG000|Overall Study|Withdrawal by Subject|2|||
154876141|NCT01323673|558971201|FG001|Overall Study|Withdrawal by Subject|3|||
154876142|NCT02588248|558971203|FG000|Overall Study|Physician Decision|4|||
154876143|NCT02588248|558971204|FG001|Overall Study|Physician Decision|3|||
154876144|NCT01355068|558971207|FG000|First Intervention Period|Adverse Event|0|||
154876145|NCT01355068|558971208|FG001|First Intervention Period|Adverse Event|1|||
154876146|NCT01355068|558971207|FG000|First Intervention Period|Withdrawal by Subject|0|||
154876147|NCT01355068|558971208|FG001|First Intervention Period|Withdrawal by Subject|1|||
154876148|NCT04229446|558971209|FG000|Overall Study|Death|12|||
154876149|NCT04229446|558971210|FG001|Overall Study|Death|10|||
154876150|NCT04229446|558971209|FG000|Overall Study|Lost to Follow-up|5|||
154876151|NCT04229446|558971210|FG001|Overall Study|Lost to Follow-up|8|||
154876152|NCT00705224|558971211|FG000|Overall Study|Adverse Event|1|||
154876153|NCT00705224|558971211|FG000|Overall Study|Lack of Efficacy|2|||
154876154|NCT00705224|558971211|FG000|Overall Study|Withdrawal by Subject|3|||
154876155|NCT00705224|558971211|FG000|Overall Study|Lost to Follow-up|5|||
154876156|NCT03283163|558971212|FG000|Overall Study|Lost to Follow-up|1|||
154876157|NCT03283163|558971212|FG000|Overall Study|other life commitments|6|||
154876158|NCT03283163|558971212|FG000|Overall Study|COVID-19 institution wide halting|1|||
154876159|NCT03283163|558971212|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
154876160|NCT03283163|558971212|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
154876161|NCT02566525|558971213|FG000|Overall Study|Protocol Violation|3|||
154876162|NCT02566525|558971214|FG001|Overall Study|Protocol Violation|5|||
154876163|NCT03141086|558971215|FG000|Overall Study|Study Terminated By Sponsor|1|||
154876164|NCT03141086|558971216|FG001|Overall Study|Study Terminated By Sponsor|1|||
154876165|NCT03141086|558971215|FG000|Overall Study|Withdrawal by Subject|0|||
154876166|NCT03141086|558971216|FG001|Overall Study|Withdrawal by Subject|1|||
154876167|NCT03141086|558971215|FG000|Overall Study|Protocol Violation|0|||
154876168|NCT03141086|558971216|FG001|Overall Study|Protocol Violation|1|||
154876169|NCT03141086|558971215|FG000|Overall Study|Adverse Event|0|||
154876170|NCT03141086|558971216|FG001|Overall Study|Adverse Event|2|||
154876171|NCT01441440|558972598|FG000|Overall Study|Death|1|||
154876172|NCT01441440|558972599|FG001|Overall Study|Death|0|||
154876173|NCT01441440|558972600|FG002|Overall Study|Death|1|||
154876174|NCT01441440|558972598|FG000|Overall Study|Adverse Event|2|||
154876175|NCT01441440|558972599|FG001|Overall Study|Adverse Event|9|||
154876176|NCT01441440|558972600|FG002|Overall Study|Adverse Event|9|||
154876177|NCT01441440|558972598|FG000|Overall Study|Lost to Follow-up|0|||
154876178|NCT01441440|558972599|FG001|Overall Study|Lost to Follow-up|2|||
154876179|NCT01441440|558972600|FG002|Overall Study|Lost to Follow-up|1|||
154876180|NCT01441440|558972598|FG000|Overall Study|Withdrawal by Subject|11|||
155112504|NCT04283994|559840858|FG000|Overall Study|Withdrawal by Subject|16|||
155112505|NCT04283994|559840859|FG001|Overall Study|Withdrawal by Subject|4|||
155112506|NCT04283994|559840860|FG002|Overall Study|Withdrawal by Subject|6|||
155112507|NCT04283994|559840861|FG003|Overall Study|Withdrawal by Subject|1|||
154876181|NCT01441440|558972599|FG001|Overall Study|Withdrawal by Subject|9|||
154876182|NCT01441440|558972600|FG002|Overall Study|Withdrawal by Subject|9|||
154876183|NCT01441440|558972598|FG000|Overall Study|Pregnancy|1|||
154876184|NCT01441440|558972599|FG001|Overall Study|Pregnancy|0|||
154876185|NCT01441440|558972600|FG002|Overall Study|Pregnancy|0|||
154876186|NCT01441440|558972598|FG000|Overall Study|Lack of Efficacy|1|||
154876187|NCT01441440|558972599|FG001|Overall Study|Lack of Efficacy|0|||
154876188|NCT01441440|558972600|FG002|Overall Study|Lack of Efficacy|1|||
154876189|NCT01441440|558972598|FG000|Overall Study|Moving|0|||
155112508|NCT04283994|559840862|FG004|Overall Study|Withdrawal by Subject|0|||
154876190|NCT01441440|558972599|FG001|Overall Study|Moving|1|||
154876191|NCT01441440|558972600|FG002|Overall Study|Moving|1|||
155112509|NCT04283994|559840863|FG005|Overall Study|Withdrawal by Subject|1|||
155112510|NCT04283994|559840864|FG006|Overall Study|Withdrawal by Subject|0|||
155112511|NCT00583752|559840865|FG000|Overall Study|Lost to Follow-up|5|||
154876192|NCT01441440|558972598|FG000|Overall Study|Work-related matter|0|||
154876193|NCT01441440|558972599|FG001|Overall Study|Work-related matter|1|||
154876194|NCT01441440|558972600|FG002|Overall Study|Work-related matter|0|||
154876195|NCT01441440|558972598|FG000|Overall Study|Difficllty in keeping the schedule|1|||
154876196|NCT01441440|558972599|FG001|Overall Study|Difficllty in keeping the schedule|1|||
155112512|NCT00583752|559840866|FG001|Overall Study|Lost to Follow-up|5|||
155112513|NCT02867813|559842547|FG000|Overall Study|Withdrawal by Subject|57|||
155112514|NCT02867813|559842548|FG001|Overall Study|Withdrawal by Subject|56|||
155112515|NCT02867813|559842547|FG000|Overall Study|Decision by Sponsor|7|||
155112516|NCT02867813|559842548|FG001|Overall Study|Decision by Sponsor|7|||
155112517|NCT02867813|559842547|FG000|Overall Study|Lost to Follow-up|91|||
155112518|NCT02867813|559842548|FG001|Overall Study|Lost to Follow-up|78|||
155112519|NCT02867813|559842547|FG000|Overall Study|Missing|2|||
155112520|NCT02867813|559842548|FG001|Overall Study|Missing|1|||
155112521|NCT02867813|559842547|FG000|Overall Study|Death|294|||
155112522|NCT02867813|559842548|FG001|Overall Study|Death|268|||
155112523|NCT02013206|559842552|FG000|Overall Study|Progressive disease (PD)|14|||
155112524|NCT02013206|559842553|FG001|Overall Study|Progressive disease (PD)|17|||
155112525|NCT02013206|559842552|FG000|Overall Study|Symptomatic deterioration|3|||
155112526|NCT02013206|559842553|FG001|Overall Study|Symptomatic deterioration|1|||
155112527|NCT02013206|559842552|FG000|Overall Study|Adverse Event|1|||
155112528|NCT02013206|559842553|FG001|Overall Study|Adverse Event|0|||
155112529|NCT02013206|559842552|FG000|Overall Study|Patient refusal|2|||
155112530|NCT02013206|559842553|FG001|Overall Study|Patient refusal|0|||
155112531|NCT02013206|559842552|FG000|Overall Study|Patient non-compliance|1|||
155112532|NCT02013206|559842553|FG001|Overall Study|Patient non-compliance|0|||
155112533|NCT02013206|559842552|FG000|Overall Study|Death|1|||
155112534|NCT02013206|559842553|FG001|Overall Study|Death|2|||
155112535|NCT02013206|559842552|FG000|Overall Study|Other reasons off treatment|5|||
155112536|NCT02013206|559842553|FG001|Overall Study|Other reasons off treatment|2|||
155112537|NCT01952665|559842556|FG000|Overall Study|Physician Decision|3|||
155112538|NCT01952665|559842557|FG001|Overall Study|Physician Decision|2|||
155112539|NCT01952665|559842556|FG000|Overall Study|Lost to Follow-up|1|||
155112540|NCT01952665|559842557|FG001|Overall Study|Lost to Follow-up|2|||
155112541|NCT01952665|559842556|FG000|Overall Study|Adverse Event|2|||
155112542|NCT01952665|559842557|FG001|Overall Study|Adverse Event|1|||
155112543|NCT01952665|559842556|FG000|Overall Study|Protocol Violation|0|||
155112544|NCT01952665|559842557|FG001|Overall Study|Protocol Violation|1|||
155112545|NCT01537081|559842559|FG000|Overall Study|Adverse Event|5|||
155112546|NCT01537081|559842560|FG001|Overall Study|Adverse Event|2|||
155112547|NCT01537081|559842561|FG002|Overall Study|Adverse Event|2|||
155112548|NCT01537081|559842559|FG000|Overall Study|Lack of Efficacy|2|||
155112549|NCT01537081|559842560|FG001|Overall Study|Lack of Efficacy|1|||
155112550|NCT01537081|559842561|FG002|Overall Study|Lack of Efficacy|0|||
155112551|NCT01537081|559842559|FG000|Overall Study|Lost to Follow-up|17|||
155112552|NCT01537081|559842560|FG001|Overall Study|Lost to Follow-up|15|||
155112553|NCT01537081|559842561|FG002|Overall Study|Lost to Follow-up|9|||
155112554|NCT01537081|559842559|FG000|Overall Study|Protocol Violation|3|||
155112555|NCT01537081|559842560|FG001|Overall Study|Protocol Violation|2|||
155112556|NCT01537081|559842561|FG002|Overall Study|Protocol Violation|2|||
155112557|NCT01537081|559842559|FG000|Overall Study|Withdrawal by Subject|6|||
155112558|NCT01537081|559842560|FG001|Overall Study|Withdrawal by Subject|11|||
155112559|NCT01537081|559842561|FG002|Overall Study|Withdrawal by Subject|3|||
155112560|NCT01537081|559842559|FG000|Overall Study|Physician Decision|5|||
155112561|NCT01537081|559842560|FG001|Overall Study|Physician Decision|6|||
155112562|NCT01537081|559842561|FG002|Overall Study|Physician Decision|0|||
155112563|NCT01537081|559842559|FG000|Overall Study|Sponsor decision|0|||
155112564|NCT01537081|559842560|FG001|Overall Study|Sponsor decision|1|||
155112565|NCT01537081|559842561|FG002|Overall Study|Sponsor decision|0|||
155112566|NCT01537081|559842559|FG000|Overall Study|Assigned but never dosed|1|||
154876197|NCT01441440|558972600|FG002|Overall Study|Difficllty in keeping the schedule|0|||
154876198|NCT01345123|558972601|FG000|Overall Study|participants no longer with health plan|79|||
154876199|NCT01345123|558972602|FG001|Overall Study|participants no longer with health plan|85|||
155112567|NCT01537081|559842560|FG001|Overall Study|Assigned but never dosed|0|||
155112568|NCT01537081|559842561|FG002|Overall Study|Assigned but never dosed|0|||
155112569|NCT00882583|559842566|FG000|Overall Study|Physician Decision|1|||
155112570|NCT00882583|559842567|FG001|Overall Study|Physician Decision|0|||
155112571|NCT00882583|559842566|FG000|Overall Study|Adverse Event|0|||
155112572|NCT00882583|559842567|FG001|Overall Study|Adverse Event|1|||
155112573|NCT02596958|559842574|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
155112574|NCT02596958|559842574|FG000|Overall Study|Cancer Progression|441|||
155112575|NCT02596958|559842574|FG000|Overall Study|Death From Cancer|112|||
155112576|NCT02596958|559842574|FG000|Overall Study|Death From Other Cause|33|||
155112577|NCT02596958|559842574|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
154876200|NCT01345123|558972603|FG002|Overall Study|participants no longer with health plan|88|||
155112578|NCT02596958|559842574|FG000|Overall Study|Administrative Reasons/Other|231|||
154876201|NCT03097328|558972604|FG000|Overall Study|Still on Therapy|2|||
155112579|NCT02596958|559842574|FG000|Overall Study|Lost to Follow-up|33|||
155112580|NCT02596958|559842574|FG000|Overall Study|Missing|32|||
155112581|NCT02596958|559842574|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
155112582|NCT01559259|559842575|FG000|Overall Study|Withdrawal by Subject|0|||
155112583|NCT01559259|559842576|FG001|Overall Study|Withdrawal by Subject|0|||
155112584|NCT01559259|559842577|FG002|Overall Study|Withdrawal by Subject|0|||
154876202|NCT03097328|558972604|FG000|Overall Study|Progressive Disease|29|||
154876203|NCT03097328|558972604|FG000|Overall Study|Adverse Event|4|||
154876204|NCT03097328|558972604|FG000|Overall Study|Withdrawal by Subject|1|||
154876205|NCT03097328|558972604|FG000|Overall Study|Physician Decision|1|||
154876206|NCT03097328|558972604|FG000|Overall Study|Patient Decision|1|||
154876207|NCT03097328|558972604|FG000|Overall Study|Ineligible for Study Drug|1|||
154876208|NCT00883558|558972605|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
154876209|NCT00883558|558972606|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
154876210|NCT00883558|558972607|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
154876211|NCT00883558|558972605|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
154876212|NCT00883558|558972606|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
154876213|NCT00883558|558972607|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
154876214|NCT00883558|558972605|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
154876215|NCT00883558|558972606|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
154876216|NCT00883558|558972607|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
154876217|NCT00883558|558972605|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
154876218|NCT00883558|558972606|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
154876219|NCT00883558|558972607|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
154876220|NCT00883558|558972605|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
154876221|NCT00883558|558972606|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
154876222|NCT00883558|558972607|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
154876223|NCT03650452|558972608|FG000|Overall Study|Physician Decision|1|||
154876224|NCT03650452|558972609|FG001|Overall Study|Physician Decision|0|||
154876225|NCT03650452|558972608|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
154876226|NCT03650452|558972609|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
154876227|NCT03650452|558972608|FG000|Overall Study|Adverse Event|3|||
154876228|NCT03650452|558972609|FG001|Overall Study|Adverse Event|4|||
154876229|NCT03650452|558972608|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
154876230|NCT03650452|558972609|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
154876231|NCT03539458|558972611|FG000|Overall Study|Death|1|||
154876232|NCT01984346|558972613|FG000|Overall Study|Physician Decision|4|||
154876233|NCT01984346|558972614|FG001|Overall Study|Physician Decision|2|||
154876234|NCT01984346|558972613|FG000|Overall Study|Withdrawal by Subject|2|||
154876235|NCT01984346|558972614|FG001|Overall Study|Withdrawal by Subject|2|||
154876236|NCT01984346|558972613|FG000|Overall Study|Enrollment Closed|8|||
154876237|NCT01984346|558972614|FG001|Overall Study|Enrollment Closed|1|||
154876238|NCT01984346|558972613|FG000|Overall Study|Insurance Coverage|1|||
154876239|NCT01984346|558972614|FG001|Overall Study|Insurance Coverage|0|||
154876240|NCT01984346|558972613|FG000|Overall Study|Intra-operative Exclusion|2|||
154876241|NCT01984346|558972614|FG001|Overall Study|Intra-operative Exclusion|0|||
154876242|NCT02042404|558972617|FG000|Overall Study|Death|1|||
154876243|NCT02042404|558972618|FG001|Overall Study|Death|0|||
154876244|NCT02042404|558972617|FG000|Overall Study|Unrelated Adverse Event|3|||
154876245|NCT02042404|558972618|FG001|Overall Study|Unrelated Adverse Event|0|||
154876246|NCT02042404|558972617|FG000|Overall Study|Inability to meet time requirements|1|||
154876247|NCT02042404|558972618|FG001|Overall Study|Inability to meet time requirements|0|||
154876248|NCT03100942|558972619|FG000|Randomized Treatment Period|Withdrew Consent|4|||
154876249|NCT03100942|558972620|FG001|Randomized Treatment Period|Withdrew Consent|5|||
154876250|NCT03100942|558972621|FG002|Randomized Treatment Period|Withdrew Consent|3|||
154876251|NCT03100942|558972622|FG003|Randomized Treatment Period|Withdrew Consent|3|||
154876252|NCT03100942|558972623|FG004|Randomized Treatment Period|Withdrew Consent|0|||
154876253|NCT03100942|558972624|FG005|Randomized Treatment Period|Withdrew Consent|0|||
154876254|NCT03100942|558972625|FG006|Randomized Treatment Period|Withdrew Consent|0|||
154876255|NCT03100942|558972619|FG000|Randomized Treatment Period|Adverse Event|5|||
154876256|NCT03100942|558972620|FG001|Randomized Treatment Period|Adverse Event|2|||
154876257|NCT03100942|558972621|FG002|Randomized Treatment Period|Adverse Event|1|||
155112585|NCT01559259|559842578|FG003|Overall Study|Withdrawal by Subject|1|||
154876258|NCT03100942|558972622|FG003|Randomized Treatment Period|Adverse Event|0|||
154876259|NCT03100942|558972623|FG004|Randomized Treatment Period|Adverse Event|0|||
154876260|NCT03100942|558972624|FG005|Randomized Treatment Period|Adverse Event|0|||
154876261|NCT03100942|558972625|FG006|Randomized Treatment Period|Adverse Event|0|||
154876262|NCT03100942|558972619|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
154876263|NCT03100942|558972620|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
154876264|NCT03100942|558972621|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
154876265|NCT03100942|558972622|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
154876266|NCT03100942|558972623|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
154876267|NCT03100942|558972624|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
154876268|NCT03100942|558972625|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
154876269|NCT03100942|558972619|FG000|Randomized Treatment Period|Protocol Violation|0|||
154876270|NCT03100942|558972620|FG001|Randomized Treatment Period|Protocol Violation|1|||
154876271|NCT03100942|558972621|FG002|Randomized Treatment Period|Protocol Violation|1|||
155112586|NCT01559259|559842579|FG004|Overall Study|Withdrawal by Subject|0|||
154876272|NCT03100942|558972622|FG003|Randomized Treatment Period|Protocol Violation|1|||
154876273|NCT03100942|558972623|FG004|Randomized Treatment Period|Protocol Violation|0|||
154876274|NCT03100942|558972624|FG005|Randomized Treatment Period|Protocol Violation|0|||
154876275|NCT03100942|558972625|FG006|Randomized Treatment Period|Protocol Violation|0|||
154876276|NCT03100942|558972619|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
154876277|NCT03100942|558972620|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
154876278|NCT03100942|558972621|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
154876279|NCT03100942|558972622|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
154876280|NCT03100942|558972623|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
154876281|NCT03100942|558972624|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
154876282|NCT03100942|558972625|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
154876283|NCT03100942|558972619|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
154876284|NCT03100942|558972620|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
154876285|NCT03100942|558972621|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
154876286|NCT03100942|558972622|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
154876287|NCT03100942|558972623|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
154876288|NCT03100942|558972624|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
154876289|NCT03100942|558972625|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
154876290|NCT03100942|558972619|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
154876291|NCT03100942|558972620|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
154876292|NCT03100942|558972621|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
154876293|NCT03100942|558972622|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
154876294|NCT03100942|558972623|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
154876295|NCT03100942|558972624|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
154876296|NCT03100942|558972625|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
154876297|NCT01876732|558972630|FG000|Overall Study|MMA was not over 800mg/dL|75|||
154876298|NCT00536731|558972631|FG000|Overall Study|Adverse Event|3|||
154876299|NCT00536731|558972632|FG001|Overall Study|Adverse Event|2|||
154876300|NCT00536731|558972633|FG002|Overall Study|Adverse Event|3|||
154876301|NCT00536731|558972631|FG000|Overall Study|Withdrawal by Subject|0|||
154876302|NCT00536731|558972632|FG001|Overall Study|Withdrawal by Subject|2|||
154876303|NCT00536731|558972633|FG002|Overall Study|Withdrawal by Subject|0|||
154876304|NCT00536731|558972631|FG000|Overall Study|Intake of prohibited conc. medication|0|||
154876305|NCT00536731|558972632|FG001|Overall Study|Intake of prohibited conc. medication|0|||
154876306|NCT00536731|558972633|FG002|Overall Study|Intake of prohibited conc. medication|1|||
154876307|NCT00536731|558972631|FG000|Overall Study|Safety reasons|0|||
154876308|NCT00536731|558972632|FG001|Overall Study|Safety reasons|0|||
154876309|NCT00536731|558972633|FG002|Overall Study|Safety reasons|1|||
154876310|NCT00536731|558972631|FG000|Overall Study|Other|1|||
154876311|NCT00536731|558972632|FG001|Overall Study|Other|1|||
154876312|NCT00536731|558972633|FG002|Overall Study|Other|0|||
154876313|NCT00718419|558972634|FG000|Overall Study|Adverse Event|2|||
154876314|NCT00718419|558972635|FG001|Overall Study|Adverse Event|1|||
154876315|NCT00718419|558972634|FG000|Overall Study|Physician Decision|1|||
154876316|NCT00718419|558972635|FG001|Overall Study|Physician Decision|6|||
154876317|NCT00718419|558972634|FG000|Overall Study|Sponsor decision|0|||
154876318|NCT00718419|558972635|FG001|Overall Study|Sponsor decision|1|||
154876319|NCT00718419|558972634|FG000|Overall Study|Withdrawal by Subject|0|||
154876320|NCT00718419|558972635|FG001|Overall Study|Withdrawal by Subject|5|||
154876321|NCT00718419|558972634|FG000|Overall Study|Progressive Disease|7|||
154876322|NCT00718419|558972635|FG001|Overall Study|Progressive Disease|25|||
154876323|NCT00718419|558972634|FG000|Overall Study|Death Due to Progressive Disease|2|||
154876324|NCT00718419|558972635|FG001|Overall Study|Death Due to Progressive Disease|0|||
154876325|NCT00718419|558972634|FG000|Overall Study|Death Due to Study Drug Related|0|||
154876326|NCT00718419|558972635|FG001|Overall Study|Death Due to Study Drug Related|1|||
154876327|NCT00718419|558972634|FG000|Overall Study|Death Due to Adverse Events|1|||
154876328|NCT00718419|558972635|FG001|Overall Study|Death Due to Adverse Events|0|||
154876329|NCT01675531|558972638|FG000|Overall Study|Adverse Event|9|||
154876330|NCT01675531|558972638|FG000|Overall Study|Withdrawal by Subject|7|||
154974476|NCT01332968|559331235|FG003|Follow-Up Period|Protocol Violation|0|||
154974477|NCT01332968|559331236|FG004|Follow-Up Period|Protocol Violation|0|||
154876331|NCT01675531|558972638|FG000|Overall Study|Lack of Efficacy|1|||
154876332|NCT01675531|558972638|FG000|Overall Study|Protocol Violation|8|||
154876333|NCT04184622|558972639|FG000|Primary Treatment Period|Adverse Event|6|||
154876334|NCT04184622|558972640|FG001|Primary Treatment Period|Adverse Event|4|||
154876335|NCT04184622|558972641|FG002|Primary Treatment Period|Adverse Event|8|||
154876336|NCT04184622|558972642|FG003|Primary Treatment Period|Adverse Event|6|||
154876337|NCT04184622|558972639|FG000|Primary Treatment Period|Death|4|||
154876338|NCT04184622|558972640|FG001|Primary Treatment Period|Death|4|||
154876339|NCT04184622|558972641|FG002|Primary Treatment Period|Death|2|||
154876340|NCT04184622|558972642|FG003|Primary Treatment Period|Death|1|||
154876341|NCT04184622|558972639|FG000|Primary Treatment Period|Lost to Follow-up|41|||
154876342|NCT04184622|558972640|FG001|Primary Treatment Period|Lost to Follow-up|17|||
155112587|NCT01559259|559842575|FG000|Overall Study|Adverse Event|0|||
155112588|NCT01559259|559842576|FG001|Overall Study|Adverse Event|1|||
155112589|NCT01559259|559842577|FG002|Overall Study|Adverse Event|1|||
155112590|NCT01559259|559842578|FG003|Overall Study|Adverse Event|0|||
155112591|NCT01559259|559842579|FG004|Overall Study|Adverse Event|0|||
155112592|NCT01995669|559842580|FG000|Overall Study|Progression|2|||
155112593|NCT01995669|559842581|FG001|Overall Study|Progression|1|||
155112594|NCT01995669|559842582|FG002|Overall Study|Progression|1|||
155112595|NCT01995669|559842583|FG003|Overall Study|Progression|13|||
155112596|NCT01995669|559842580|FG000|Overall Study|Adverse Event|0|||
155112597|NCT01995669|559842581|FG001|Overall Study|Adverse Event|0|||
155112598|NCT01995669|559842582|FG002|Overall Study|Adverse Event|0|||
155112599|NCT01995669|559842583|FG003|Overall Study|Adverse Event|3|||
155112600|NCT01995669|559842580|FG000|Overall Study|Death|0|||
155112601|NCT01995669|559842581|FG001|Overall Study|Death|0|||
155112602|NCT01995669|559842582|FG002|Overall Study|Death|0|||
155112603|NCT01995669|559842583|FG003|Overall Study|Death|6|||
155112604|NCT01995669|559842580|FG000|Overall Study|Withdrawal by Subject|0|||
155112605|NCT01995669|559842581|FG001|Overall Study|Withdrawal by Subject|0|||
155112606|NCT01995669|559842582|FG002|Overall Study|Withdrawal by Subject|0|||
155112607|NCT01995669|559842583|FG003|Overall Study|Withdrawal by Subject|6|||
155112608|NCT01995669|559842580|FG000|Overall Study|Insurance Expired|0|||
154876343|NCT04184622|558972641|FG002|Primary Treatment Period|Lost to Follow-up|15|||
154876344|NCT04184622|558972642|FG003|Primary Treatment Period|Lost to Follow-up|13|||
154876345|NCT04184622|558972639|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
154876346|NCT04184622|558972640|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
154876347|NCT04184622|558972641|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
154876348|NCT04184622|558972642|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
154876349|NCT04184622|558972639|FG000|Primary Treatment Period|Physician Decision|0|||
154876350|NCT04184622|558972640|FG001|Primary Treatment Period|Physician Decision|0|||
154876351|NCT04184622|558972641|FG002|Primary Treatment Period|Physician Decision|3|||
154876352|NCT04184622|558972642|FG003|Primary Treatment Period|Physician Decision|1|||
154876353|NCT04184622|558972639|FG000|Primary Treatment Period|Pregnancy|4|||
154876354|NCT04184622|558972640|FG001|Primary Treatment Period|Pregnancy|3|||
154876355|NCT04184622|558972641|FG002|Primary Treatment Period|Pregnancy|4|||
154876356|NCT04184622|558972642|FG003|Primary Treatment Period|Pregnancy|1|||
154876357|NCT04184622|558972639|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
154876358|NCT04184622|558972640|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
154876359|NCT04184622|558972641|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
154876360|NCT04184622|558972642|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
154974478|NCT01332968|559331237|FG005|Follow-Up Period|Protocol Violation|0|||
154974479|NCT01332968|559331238|FG006|Follow-Up Period|Protocol Violation|1|||
154974480|NCT01332968|559331239|FG007|Follow-Up Period|Protocol Violation|0|||
154974481|NCT01332968|559331232|FG000|Follow-Up Period|Withdrawal by Subject|0|||
154974482|NCT01332968|559331233|FG001|Follow-Up Period|Withdrawal by Subject|0|||
154974483|NCT01332968|559331234|FG002|Follow-Up Period|Withdrawal by Subject|0|||
154974484|NCT01332968|559331235|FG003|Follow-Up Period|Withdrawal by Subject|0|||
154974485|NCT01332968|559331236|FG004|Follow-Up Period|Withdrawal by Subject|0|||
154974486|NCT01332968|559331237|FG005|Follow-Up Period|Withdrawal by Subject|0|||
154974487|NCT01332968|559331238|FG006|Follow-Up Period|Withdrawal by Subject|29|||
154974488|NCT01332968|559331239|FG007|Follow-Up Period|Withdrawal by Subject|32|||
154974489|NCT01332968|559331232|FG000|Follow-Up Period|No reason provided|0|||
154974490|NCT01332968|559331233|FG001|Follow-Up Period|No reason provided|0|||
154974491|NCT01332968|559331234|FG002|Follow-Up Period|No reason provided|0|||
154974492|NCT01332968|559331235|FG003|Follow-Up Period|No reason provided|0|||
154974493|NCT01332968|559331236|FG004|Follow-Up Period|No reason provided|0|||
154974494|NCT01332968|559331237|FG005|Follow-Up Period|No reason provided|0|||
154974495|NCT01332968|559331238|FG006|Follow-Up Period|No reason provided|2|||
154974496|NCT01332968|559331239|FG007|Follow-Up Period|No reason provided|3|||
154974497|NCT02351167|559331240|FG000|Overall Study|Withdrawal by Subject|19|||
154974498|NCT02351167|559331241|FG001|Overall Study|Withdrawal by Subject|18|||
154974499|NCT02351167|559331242|FG002|Overall Study|Withdrawal by Subject|21|||
154974500|NCT00194792|559331243|FG000|Overall Study|Withdrawal by Subject|1|||
154974501|NCT02448563|559331244|FG000|Overall Study|Lost to Follow-up|16|||
154974502|NCT02448563|559331245|FG001|Overall Study|Lost to Follow-up|10|||
154974503|NCT02448563|559331244|FG000|Overall Study|Withdrawal by Subject|0|||
154974504|NCT02448563|559331245|FG001|Overall Study|Withdrawal by Subject|1|||
154974505|NCT01292837|559331252|FG000|Overall Study|Adverse Event|1|||
154974506|NCT01292837|559331252|FG000|Overall Study|Further treatment determined|1|||
154974507|NCT02174276|559331255|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
154974508|NCT02174276|559331256|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
154974509|NCT02174276|559331257|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
155112609|NCT01995669|559842581|FG001|Overall Study|Insurance Expired|0|||
154974510|NCT02174276|559331258|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
155112610|NCT01995669|559842582|FG002|Overall Study|Insurance Expired|0|||
155112611|NCT01995669|559842583|FG003|Overall Study|Insurance Expired|1|||
155112612|NCT05425732|559842584|FG000|Overall Study|Death|4|||
155112613|NCT05425732|559842585|FG001|Overall Study|Death|2|||
155112614|NCT05425732|559842586|FG002|Overall Study|Death|0|||
155112615|NCT05425732|559842587|FG003|Overall Study|Death|0|||
155112616|NCT05425732|559842584|FG000|Overall Study|Lost to Follow-up|10|||
155112617|NCT05425732|559842585|FG001|Overall Study|Lost to Follow-up|15|||
155112618|NCT05425732|559842586|FG002|Overall Study|Lost to Follow-up|5|||
155112619|NCT05425732|559842587|FG003|Overall Study|Lost to Follow-up|3|||
155112620|NCT05425732|559842584|FG000|Overall Study|Physician Decision|0|||
155112621|NCT05425732|559842585|FG001|Overall Study|Physician Decision|2|||
155112622|NCT05425732|559842586|FG002|Overall Study|Physician Decision|0|||
155112623|NCT05425732|559842587|FG003|Overall Study|Physician Decision|0|||
155112624|NCT05425732|559842584|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155112625|NCT05425732|559842585|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155112626|NCT05425732|559842586|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155112627|NCT05425732|559842587|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155112628|NCT05425732|559842584|FG000|Overall Study|Withdrawal by Subject|4|||
155112629|NCT05425732|559842585|FG001|Overall Study|Withdrawal by Subject|8|||
155112630|NCT05425732|559842586|FG002|Overall Study|Withdrawal by Subject|1|||
155112631|NCT05425732|559842587|FG003|Overall Study|Withdrawal by Subject|1|||
155112632|NCT05425732|559842584|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
155112633|NCT05425732|559842585|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
155112634|NCT05425732|559842586|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
155112635|NCT05425732|559842587|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
155112636|NCT00327015|559842591|FG000|Overall Study|Lack of Efficacy|18|||
155112637|NCT00327015|559842592|FG001|Overall Study|Lack of Efficacy|18|||
155112638|NCT00327015|559842593|FG002|Overall Study|Lack of Efficacy|35|||
155112639|NCT00327015|559842594|FG003|Overall Study|Lack of Efficacy|29|||
155112640|NCT00327015|559842591|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
155112641|NCT00327015|559842592|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
155112642|NCT00327015|559842593|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
155112643|NCT00327015|559842594|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
155112644|NCT00327015|559842591|FG000|Overall Study|Lost to Follow-up|22|||
155112645|NCT00327015|559842592|FG001|Overall Study|Lost to Follow-up|23|||
155112646|NCT00327015|559842593|FG002|Overall Study|Lost to Follow-up|29|||
155112647|NCT00327015|559842594|FG003|Overall Study|Lost to Follow-up|22|||
155112648|NCT00327015|559842591|FG000|Overall Study|Adverse Event|14|||
155112649|NCT00327015|559842592|FG001|Overall Study|Adverse Event|10|||
154876361|NCT04184622|558972639|FG000|Additional Treatment Period|Adverse Event|1|||
154876362|NCT04184622|558972640|FG001|Additional Treatment Period|Adverse Event|2|||
154876363|NCT04184622|558972641|FG002|Additional Treatment Period|Adverse Event|1|||
154876364|NCT04184622|558972642|FG003|Additional Treatment Period|Adverse Event|0|||
154876365|NCT04184622|558972639|FG000|Additional Treatment Period|Death|0|||
154876366|NCT04184622|558972640|FG001|Additional Treatment Period|Death|0|||
154876367|NCT04184622|558972641|FG002|Additional Treatment Period|Death|1|||
154876368|NCT04184622|558972642|FG003|Additional Treatment Period|Death|1|||
154876369|NCT04184622|558972639|FG000|Additional Treatment Period|Lost to Follow-up|6|||
154876370|NCT04184622|558972640|FG001|Additional Treatment Period|Lost to Follow-up|4|||
155112650|NCT00327015|559842593|FG002|Overall Study|Adverse Event|14|||
155112651|NCT00327015|559842594|FG003|Overall Study|Adverse Event|14|||
155112652|NCT00327015|559842591|FG000|Overall Study|Subject no longer meets study criteria|4|||
155112653|NCT00327015|559842592|FG001|Overall Study|Subject no longer meets study criteria|2|||
155112654|NCT00327015|559842593|FG002|Overall Study|Subject no longer meets study criteria|8|||
155112655|NCT00327015|559842594|FG003|Overall Study|Subject no longer meets study criteria|7|||
155112656|NCT00327015|559842591|FG000|Overall Study|Poor/Noncompliance|11|||
155112657|NCT00327015|559842592|FG001|Overall Study|Poor/Noncompliance|8|||
155112658|NCT00327015|559842593|FG002|Overall Study|Poor/Noncompliance|4|||
155112659|NCT00327015|559842594|FG003|Overall Study|Poor/Noncompliance|5|||
155112660|NCT00327015|559842591|FG000|Overall Study|Physician Decision|0|||
155112661|NCT00327015|559842592|FG001|Overall Study|Physician Decision|1|||
155112662|NCT00327015|559842593|FG002|Overall Study|Physician Decision|3|||
154876371|NCT04184622|558972641|FG002|Additional Treatment Period|Lost to Follow-up|8|||
154876372|NCT04184622|558972642|FG003|Additional Treatment Period|Lost to Follow-up|6|||
154876373|NCT04184622|558972639|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
154876374|NCT04184622|558972640|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
155112663|NCT00327015|559842594|FG003|Overall Study|Physician Decision|2|||
155112664|NCT00327015|559842591|FG000|Overall Study|Death|1|||
155112665|NCT00327015|559842592|FG001|Overall Study|Death|2|||
155112666|NCT00327015|559842593|FG002|Overall Study|Death|2|||
155112667|NCT00327015|559842594|FG003|Overall Study|Death|3|||
155112668|NCT00327015|559842591|FG000|Overall Study|Pregnancy|0|||
155112669|NCT00327015|559842592|FG001|Overall Study|Pregnancy|2|||
154876375|NCT04184622|558972641|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
155112670|NCT00327015|559842593|FG002|Overall Study|Pregnancy|1|||
155112671|NCT00327015|559842594|FG003|Overall Study|Pregnancy|1|||
155112672|NCT00327015|559842591|FG000|Overall Study|Administrative Reason by Sponsor|1|||
155112673|NCT00327015|559842592|FG001|Overall Study|Administrative Reason by Sponsor|2|||
155112674|NCT00327015|559842593|FG002|Overall Study|Administrative Reason by Sponsor|2|||
155112675|NCT00327015|559842594|FG003|Overall Study|Administrative Reason by Sponsor|1|||
155112676|NCT04569136|559842595|FG000|Overall Study|Lost to Follow-up|2|||
155112677|NCT04569136|559842596|FG001|Overall Study|Lost to Follow-up|0|||
155112678|NCT04569136|559842597|FG002|Overall Study|Lost to Follow-up|1|||
155112679|NCT00129701|559842598|FG000|Overall Study|Withdrawal by Subject|33|||
155112680|NCT00889603|559842609|FG000|Overall Study|Adverse Event|7|||
155112681|NCT00889603|559842609|FG000|Overall Study|Death|3|||
155112682|NCT00889603|559842609|FG000|Overall Study|Lost to Follow-up|19|||
155112683|NCT00889603|559842609|FG000|Overall Study|No longer willing to participant in stud|4|||
155112684|NCT00889603|559842609|FG000|Overall Study|Other|4|||
155112685|NCT03525600|559842610|FG000|Overall Study|Adverse Event|9|||
155112686|NCT03525600|559842611|FG001|Overall Study|Adverse Event|6|||
155112687|NCT03525600|559842612|FG002|Overall Study|Adverse Event|5|||
155112688|NCT03525600|559842613|FG003|Overall Study|Adverse Event|3|||
155112689|NCT03525600|559842610|FG000|Overall Study|Lost to Follow-up|2|||
155112690|NCT03525600|559842611|FG001|Overall Study|Lost to Follow-up|4|||
155112691|NCT03525600|559842612|FG002|Overall Study|Lost to Follow-up|4|||
155112692|NCT03525600|559842613|FG003|Overall Study|Lost to Follow-up|0|||
155112693|NCT03525600|559842610|FG000|Overall Study|Physician Decision|1|||
155112694|NCT03525600|559842611|FG001|Overall Study|Physician Decision|0|||
155112695|NCT03525600|559842612|FG002|Overall Study|Physician Decision|2|||
155112696|NCT03525600|559842613|FG003|Overall Study|Physician Decision|0|||
155112697|NCT03525600|559842610|FG000|Overall Study|Consent withdrawal|36|||
155112698|NCT03525600|559842611|FG001|Overall Study|Consent withdrawal|20|||
155112699|NCT03525600|559842612|FG002|Overall Study|Consent withdrawal|6|||
155112700|NCT03525600|559842613|FG003|Overall Study|Consent withdrawal|13|||
155112701|NCT03525600|559842610|FG000|Overall Study|Death|7|||
155112702|NCT03525600|559842611|FG001|Overall Study|Death|6|||
154876376|NCT04184622|558972642|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
154876377|NCT04184622|558972639|FG000|Additional Treatment Period|Physician Decision|0|||
154876378|NCT04184622|558972640|FG001|Additional Treatment Period|Physician Decision|0|||
154876379|NCT04184622|558972641|FG002|Additional Treatment Period|Physician Decision|1|||
154876380|NCT04184622|558972642|FG003|Additional Treatment Period|Physician Decision|0|||
154876381|NCT04184622|558972639|FG000|Additional Treatment Period|Pregnancy|0|||
154876382|NCT04184622|558972640|FG001|Additional Treatment Period|Pregnancy|0|||
154876383|NCT04184622|558972641|FG002|Additional Treatment Period|Pregnancy|0|||
154876384|NCT04184622|558972642|FG003|Additional Treatment Period|Pregnancy|1|||
154876385|NCT04184622|558972639|FG000|Additional Treatment Period|Protocol deviation|0|||
154876386|NCT04184622|558972640|FG001|Additional Treatment Period|Protocol deviation|0|||
154876387|NCT04184622|558972641|FG002|Additional Treatment Period|Protocol deviation|1|||
154876388|NCT04184622|558972642|FG003|Additional Treatment Period|Protocol deviation|0|||
154876389|NCT04184622|558972639|FG000|Additional Treatment Period|Site closed|1|||
154876390|NCT04184622|558972640|FG001|Additional Treatment Period|Site closed|0|||
154876391|NCT04184622|558972641|FG002|Additional Treatment Period|Site closed|1|||
154876392|NCT04184622|558972642|FG003|Additional Treatment Period|Site closed|0|||
154876393|NCT04184622|558972639|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
155112703|NCT03525600|559842612|FG002|Overall Study|Death|4|||
155112704|NCT03525600|559842613|FG003|Overall Study|Death|3|||
155112705|NCT03525600|559842610|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
155112706|NCT03525600|559842611|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
155112707|NCT03525600|559842612|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
155112708|NCT03525600|559842613|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
155112709|NCT03525600|559842610|FG000|Overall Study|Other|0|||
155112710|NCT03525600|559842611|FG001|Overall Study|Other|1|||
155112711|NCT03525600|559842612|FG002|Overall Study|Other|0|||
154876394|NCT04184622|558972640|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
154876395|NCT04184622|558972641|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
154876396|NCT04184622|558972642|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
154876397|NCT04184622|558972639|FG000|Safety Follow-up Period|Adverse Event|6|||
154876398|NCT04184622|558972640|FG001|Safety Follow-up Period|Adverse Event|8|||
154876399|NCT04184622|558972641|FG002|Safety Follow-up Period|Adverse Event|9|||
154876400|NCT04184622|558972642|FG003|Safety Follow-up Period|Adverse Event|16|||
154876401|NCT04184622|558972639|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
155112712|NCT03525600|559842613|FG003|Overall Study|Other|0|||
155112713|NCT00244933|559842622|FG000|Overall Study|Not response evaluable|2|||
155112714|NCT03703817|559842624|FG000|Overall Study|Not meeting eligibility criteria|7|||
155112715|NCT03703817|559842625|FG001|Overall Study|Not meeting eligibility criteria|4|||
155112716|NCT05129449|559842627|FG000|Overall Study|Protocol Violation|1|||
155175341|NCT00910624|560080228|FG002|Treatment Phase|Treatment Failure|0|||
155112717|NCT02247011|559842630|FG000|Overall Study|Poor quality of radiological results|125|||
155112718|NCT00656058|559842633|FG000|Overall Study|Withdrawal by Subject|2|||
155112719|NCT00656058|559842633|FG000|Overall Study|Withdrawal by Subject|4|||
155112720|NCT00616018|559842634|FG000|Overall Study|Protocol Violation|3|||
155112721|NCT00404755|559842635|FG000|Phase I (Bupropion)|Adverse Event|3|||
155112722|NCT00404755|559842635|FG000|Phase I (Bupropion)|Other|1|||
155112723|NCT00404755|559842635|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
155112724|NCT05145322|559842636|FG000|Overall Study|Lost to Follow-up|4|||
155112725|NCT05145322|559842637|FG001|Overall Study|Lost to Follow-up|5|||
155112726|NCT06359028|559842638|FG000|Overall Study|Adverse Event|1|||
155112727|NCT06359028|559842639|FG001|Overall Study|Adverse Event|0|||
155112728|NCT06359028|559842638|FG000|Overall Study|Withdrawal by Subject|1|||
155112729|NCT06359028|559842639|FG001|Overall Study|Withdrawal by Subject|0|||
155112730|NCT05248997|559842640|FG000|Overall Study|Lost to Follow-up|1|||
155112731|NCT05248997|559842641|FG001|Overall Study|Lost to Follow-up|1|||
155112732|NCT05248997|559842640|FG000|Overall Study|Randomized but not treated|32|||
155112733|NCT05248997|559842641|FG001|Overall Study|Randomized but not treated|25|||
155112734|NCT00920387|559842642|FG000|Stage 1|Adverse Event|1|||
155112735|NCT00920387|559842643|FG001|Stage 1|Adverse Event|0|||
155112736|NCT00920387|559842644|FG002|Stage 1|Adverse Event|0|||
155112737|NCT04470908|559842645|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
155112738|NCT02602275|559842656|FG000|Day 1|Physician Decision|0|||
155112739|NCT02602275|559842657|FG001|Day 1|Physician Decision|1|||
155112740|NCT02241733|559842660|FG000|Overall Study|Lost to Follow-up|9|||
155112741|NCT02241733|559842661|FG001|Overall Study|Lost to Follow-up|4|||
155112742|NCT02241733|559842660|FG000|Overall Study|Physician Decision|6|||
155112743|NCT02241733|559842661|FG001|Overall Study|Physician Decision|2|||
155112744|NCT02241733|559842660|FG000|Overall Study|Withdrawal by Subject|0|||
155112745|NCT02241733|559842661|FG001|Overall Study|Withdrawal by Subject|2|||
155112746|NCT02241733|559842660|FG000|Overall Study|Death|0|||
155112747|NCT02241733|559842661|FG001|Overall Study|Death|2|||
155112748|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
155112749|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
155112750|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
155112751|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
155112752|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
155112753|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
155112754|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
155112755|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
155112756|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
155112757|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
155112758|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
155112759|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
155112760|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
155112761|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
154876402|NCT04184622|558972640|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
154876403|NCT04184622|558972641|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
154876404|NCT04184622|558972642|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
154876405|NCT04184622|558972639|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
154876406|NCT04184622|558972640|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
154876407|NCT04184622|558972641|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
154876408|NCT04184622|558972642|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
154876409|NCT04184622|558972639|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
154876410|NCT04184622|558972640|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
154876411|NCT04184622|558972641|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
154876412|NCT04184622|558972642|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
154876413|NCT04184622|558972639|FG000|Safety Follow-up Period|Physician Decision|1|||
154876414|NCT04184622|558972640|FG001|Safety Follow-up Period|Physician Decision|0|||
154876415|NCT04184622|558972641|FG002|Safety Follow-up Period|Physician Decision|0|||
154876416|NCT04184622|558972642|FG003|Safety Follow-up Period|Physician Decision|1|||
154876417|NCT04184622|558972639|FG000|Safety Follow-up Period|Pregnancy|1|||
154876418|NCT04184622|558972640|FG001|Safety Follow-up Period|Pregnancy|3|||
154876419|NCT04184622|558972641|FG002|Safety Follow-up Period|Pregnancy|0|||
154876420|NCT04184622|558972642|FG003|Safety Follow-up Period|Pregnancy|6|||
154876421|NCT04184622|558972639|FG000|Safety Follow-up Period|Protocol deviation|1|||
154876422|NCT04184622|558972640|FG001|Safety Follow-up Period|Protocol deviation|0|||
155112762|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
154876423|NCT04184622|558972641|FG002|Safety Follow-up Period|Protocol deviation|0|||
154876424|NCT04184622|558972642|FG003|Safety Follow-up Period|Protocol deviation|0|||
154876425|NCT04184622|558972639|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
155112763|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
155112764|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
155112765|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
155112766|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
154876426|NCT04184622|558972640|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
154876427|NCT04184622|558972641|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
154876428|NCT04184622|558972642|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
154876429|NCT02795988|558972643|FG000|Phase 1b|Withdrawal by Subject|0|||
154876430|NCT02795988|558972644|FG001|Phase 1b|Withdrawal by Subject|1|||
154876431|NCT02795988|558972645|FG002|Phase 1b|Withdrawal by Subject|0|||
154876432|NCT02795988|558972646|FG003|Phase 1b|Withdrawal by Subject|0|||
154876433|NCT02795988|558972647|FG004|Phase 1b|Withdrawal by Subject|0|||
154876434|NCT02795988|558972648|FG005|Phase 1b|Withdrawal by Subject|0|||
155112767|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
155112768|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
155112769|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
155112770|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
154876435|NCT02795988|558972649|FG006|Phase 1b|Withdrawal by Subject|0|||
154876436|NCT02795988|558972643|FG000|Phase 1b|Death|1|||
154876437|NCT02795988|558972644|FG001|Phase 1b|Death|2|||
154876438|NCT02795988|558972645|FG002|Phase 1b|Death|1|||
154876439|NCT02795988|558972646|FG003|Phase 1b|Death|0|||
154876440|NCT02795988|558972647|FG004|Phase 1b|Death|0|||
154876441|NCT02795988|558972648|FG005|Phase 1b|Death|0|||
154876442|NCT02795988|558972649|FG006|Phase 1b|Death|0|||
154876443|NCT02795988|558972643|FG000|Phase 1b|Physician Decision|0|||
154876444|NCT02795988|558972644|FG001|Phase 1b|Physician Decision|0|||
154876445|NCT02795988|558972645|FG002|Phase 1b|Physician Decision|1|||
154876446|NCT02795988|558972646|FG003|Phase 1b|Physician Decision|0|||
154876447|NCT02795988|558972647|FG004|Phase 1b|Physician Decision|0|||
154876448|NCT02795988|558972648|FG005|Phase 1b|Physician Decision|0|||
154876449|NCT02795988|558972649|FG006|Phase 1b|Physician Decision|0|||
154876450|NCT02795988|558972643|FG000|Phase 1b|Progressive Disease|2|||
154876451|NCT02795988|558972644|FG001|Phase 1b|Progressive Disease|2|||
154876452|NCT02795988|558972645|FG002|Phase 1b|Progressive Disease|0|||
154876453|NCT02795988|558972646|FG003|Phase 1b|Progressive Disease|0|||
154876454|NCT02795988|558972647|FG004|Phase 1b|Progressive Disease|0|||
154876455|NCT02795988|558972648|FG005|Phase 1b|Progressive Disease|0|||
154876456|NCT02795988|558972649|FG006|Phase 1b|Progressive Disease|0|||
154876457|NCT02795988|558972643|FG000|Phase 2|Withdrawal by Subject|0|||
154876458|NCT02795988|558972644|FG001|Phase 2|Withdrawal by Subject|0|||
154876459|NCT02795988|558972645|FG002|Phase 2|Withdrawal by Subject|0|||
154876460|NCT02795988|558972646|FG003|Phase 2|Withdrawal by Subject|1|||
154876461|NCT02795988|558972647|FG004|Phase 2|Withdrawal by Subject|0|||
154876462|NCT02795988|558972648|FG005|Phase 2|Withdrawal by Subject|0|||
154876463|NCT02795988|558972649|FG006|Phase 2|Withdrawal by Subject|0|||
154876464|NCT02795988|558972643|FG000|Phase 2|Death|0|||
154876465|NCT02795988|558972644|FG001|Phase 2|Death|0|||
154876466|NCT02795988|558972645|FG002|Phase 2|Death|0|||
154876467|NCT02795988|558972646|FG003|Phase 2|Death|17|||
154876468|NCT02795988|558972647|FG004|Phase 2|Death|17|||
154876469|NCT02795988|558972648|FG005|Phase 2|Death|0|||
154876470|NCT02795988|558972649|FG006|Phase 2|Death|0|||
154876471|NCT02795988|558972643|FG000|Phase 2|Other|0|||
154876472|NCT02795988|558972644|FG001|Phase 2|Other|0|||
154876473|NCT02795988|558972645|FG002|Phase 2|Other|0|||
154876474|NCT02795988|558972646|FG003|Phase 2|Other|1|||
154876475|NCT02795988|558972647|FG004|Phase 2|Other|0|||
154876476|NCT02795988|558972648|FG005|Phase 2|Other|0|||
154876477|NCT02795988|558972649|FG006|Phase 2|Other|0|||
154876478|NCT02795988|558972643|FG000|Phase 2 Extension|Death|0|||
154876479|NCT02795988|558972644|FG001|Phase 2 Extension|Death|0|||
155112771|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
155112772|NCT01866111|559842662|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
154876480|NCT02795988|558972645|FG002|Phase 2 Extension|Death|0|||
154876481|NCT02795988|558972646|FG003|Phase 2 Extension|Death|0|||
154876482|NCT02795988|558972647|FG004|Phase 2 Extension|Death|0|||
154876483|NCT02795988|558972648|FG005|Phase 2 Extension|Death|5|||
155112773|NCT01866111|559842663|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
154876484|NCT02795988|558972649|FG006|Phase 2 Extension|Death|6|||
154876485|NCT02795988|558972643|FG000|Phase 2 Extension|Other reasons|0|||
154876486|NCT02795988|558972644|FG001|Phase 2 Extension|Other reasons|0|||
154876487|NCT02795988|558972645|FG002|Phase 2 Extension|Other reasons|0|||
154876488|NCT02795988|558972646|FG003|Phase 2 Extension|Other reasons|0|||
154876489|NCT02795988|558972647|FG004|Phase 2 Extension|Other reasons|0|||
154876490|NCT02795988|558972648|FG005|Phase 2 Extension|Other reasons|2|||
154876491|NCT02795988|558972649|FG006|Phase 2 Extension|Other reasons|1|||
154876492|NCT02341014|558972650|FG000|Overall Study|Adverse Event|0|||
154876493|NCT02341014|558972651|FG001|Overall Study|Adverse Event|1|||
154876494|NCT02341014|558972652|FG002|Overall Study|Adverse Event|0|||
155175342|NCT00910624|560080229|FG003|Treatment Phase|Treatment Failure|0|||
154876495|NCT02341014|558972653|FG003|Overall Study|Adverse Event|0|||
154876496|NCT02341014|558972654|FG004|Overall Study|Adverse Event|2|||
154876497|NCT00726323|558972655|FG000|Overall Study|Withdrawal by Subject|3|||
154876498|NCT00726323|558972656|FG001|Overall Study|Withdrawal by Subject|1|||
154876499|NCT00726323|558972655|FG000|Overall Study|Physician Decision|1|||
154876500|NCT00726323|558972656|FG001|Overall Study|Physician Decision|0|||
154876501|NCT00726323|558972655|FG000|Overall Study|Progressive disease|23|||
154876502|NCT00726323|558972656|FG001|Overall Study|Progressive disease|16|||
154876503|NCT00726323|558972655|FG000|Overall Study|Clinical progression|0|||
154876504|NCT00726323|558972656|FG001|Overall Study|Clinical progression|3|||
154876505|NCT00726323|558972655|FG000|Overall Study|Adverse Event|9|||
154876506|NCT00726323|558972656|FG001|Overall Study|Adverse Event|9|||
154876507|NCT00726323|558972655|FG000|Overall Study|Death|1|||
154876508|NCT00726323|558972656|FG001|Overall Study|Death|0|||
154876509|NCT00726323|558972655|FG000|Overall Study|Participant wished to discontinue|0|||
154876510|NCT00726323|558972656|FG001|Overall Study|Participant wished to discontinue|1|||
154876511|NCT00726323|558972655|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
154876512|NCT00726323|558972656|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
154876513|NCT05058664|558972657|FG000|Overall Study|No follow-up data provided|4|||
154876514|NCT05058664|558972658|FG001|Overall Study|No follow-up data provided|0|||
154876515|NCT05058664|558972659|FG002|Overall Study|No follow-up data provided|2|||
154876516|NCT05058664|558972657|FG000|Overall Study|Withdrawal by Subject|0|||
154876517|NCT05058664|558972658|FG001|Overall Study|Withdrawal by Subject|0|||
154876518|NCT05058664|558972659|FG002|Overall Study|Withdrawal by Subject|1|||
154876519|NCT01617681|558972661|FG000|Period 1 Double Blind|Adverse Event|2|||
154876520|NCT01617681|558972662|FG001|Period 1 Double Blind|Adverse Event|0|||
154876521|NCT01617681|558972663|FG002|Period 1 Double Blind|Adverse Event|0|||
154876522|NCT01617681|558972664|FG003|Period 1 Double Blind|Adverse Event|2|||
154876523|NCT01617681|558972665|FG004|Period 1 Double Blind|Adverse Event|0|||
154876524|NCT01617681|558972661|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
154876525|NCT01617681|558972662|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
154876526|NCT01617681|558972663|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
154876527|NCT01617681|558972664|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
154876528|NCT01617681|558972665|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
154876529|NCT01617681|558972661|FG000|Period 2 Open Label|Adverse Event|0|||
154876530|NCT01617681|558972662|FG001|Period 2 Open Label|Adverse Event|0|||
154876531|NCT01617681|558972663|FG002|Period 2 Open Label|Adverse Event|0|||
154876532|NCT01617681|558972664|FG003|Period 2 Open Label|Adverse Event|0|||
154876533|NCT01617681|558972665|FG004|Period 2 Open Label|Adverse Event|3|||
154876534|NCT01617681|558972661|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
154876535|NCT01617681|558972662|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
154876536|NCT01617681|558972663|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
154876537|NCT01617681|558972664|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
154876538|NCT01617681|558972665|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
154876539|NCT00316303|558972670|FG000|Overall Study|Lost to Follow-up|11|||
154876540|NCT00316303|558972671|FG001|Overall Study|Lost to Follow-up|16|||
154876541|NCT03838367|558972672|FG000|Overall Study|Early termination of study|3|||
154876542|NCT03838367|558972673|FG001|Overall Study|Early termination of study|4|||
154876543|NCT03838367|558972674|FG002|Overall Study|Early termination of study|3|||
154876544|NCT03838367|558972675|FG003|Overall Study|Early termination of study|0|||
154876545|NCT03015610|558972676|FG000|Overall Study|Lost to Follow-up|1|||
154876546|NCT03015610|558972677|FG001|Overall Study|Lost to Follow-up|5|||
154876547|NCT02375698|558972681|FG000|Overall Study|Withdrawal by Subject|0|||
154876548|NCT02375698|558972682|FG001|Overall Study|Withdrawal by Subject|2|||
154876549|NCT02375698|558972681|FG000|Overall Study|Physician Decision|2|||
154876550|NCT02375698|558972682|FG001|Overall Study|Physician Decision|0|||
154876551|NCT01632878|558972683|FG000|Screening|Physician Decision|268|||
154876552|NCT01632878|558972683|FG000|Treatment|Lost to Follow-up|41|||
154876553|NCT01632878|558972683|FG000|Treatment|Withdrawal by Subject|36|||
154876554|NCT01632878|558972683|FG000|Treatment|Physician Decision|34|||
154876555|NCT01632878|558972683|FG000|Treatment|missing information|4|||
154876556|NCT01632878|558972683|FG000|Treatment|no information on study completion|43|||
154876557|NCT03634072|558972684|FG000|Overall Study|Early termination of overall study|1|||
154876558|NCT03634072|558972685|FG001|Overall Study|Early termination of overall study|0|||
154876559|NCT03184701|558972688|FG000|Overall Study|Death|3|||
154876560|NCT03184701|558972688|FG000|Overall Study|Physician Decision|3|||
154876561|NCT03184701|558972688|FG000|Overall Study|Withdrawal by Subject|6|||
154876562|NCT03184701|558972688|FG000|Overall Study|Lost to Follow-up|5|||
154876563|NCT01259297|558972689|FG000|Double Blind Randomized Period|Death|1|||
154876564|NCT01259297|558972690|FG001|Double Blind Randomized Period|Death|1|||
154876565|NCT01259297|558972691|FG002|Double Blind Randomized Period|Death|1|||
154876566|NCT01259297|558972692|FG003|Double Blind Randomized Period|Death|2|||
154876567|NCT01259297|558972693|FG004|Double Blind Randomized Period|Death|1|||
154876568|NCT01259297|558972694|FG005|Double Blind Randomized Period|Death|5|||
154876569|NCT01259297|558972695|FG006|Double Blind Randomized Period|Death|2|||
154876570|NCT01259297|558972696|FG007|Double Blind Randomized Period|Death|1|||
154876571|NCT01259297|558972689|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
154876572|NCT01259297|558972690|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
154876573|NCT01259297|558972691|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
154876574|NCT01259297|558972692|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
154876575|NCT01259297|558972693|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
154876576|NCT01259297|558972694|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
154876577|NCT01259297|558972695|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
154876578|NCT01259297|558972696|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
154876579|NCT01259297|558972689|FG000|Double Blind Randomized Period|Other reasons|0|||
154876580|NCT01259297|558972690|FG001|Double Blind Randomized Period|Other reasons|1|||
154876581|NCT01259297|558972691|FG002|Double Blind Randomized Period|Other reasons|0|||
154876582|NCT01259297|558972692|FG003|Double Blind Randomized Period|Other reasons|0|||
154876583|NCT01259297|558972693|FG004|Double Blind Randomized Period|Other reasons|1|||
154876584|NCT01259297|558972694|FG005|Double Blind Randomized Period|Other reasons|2|||
154876585|NCT01259297|558972695|FG006|Double Blind Randomized Period|Other reasons|3|||
154876586|NCT01259297|558972696|FG007|Double Blind Randomized Period|Other reasons|1|||
154876587|NCT00504166|558972700|FG000|Overall Study|Adverse Event|1|||
154876588|NCT00504166|558972701|FG001|Overall Study|Adverse Event|4|||
154876589|NCT00504166|558972700|FG000|Overall Study|Withdrawal by Subject|3|||
154876590|NCT00504166|558972701|FG001|Overall Study|Withdrawal by Subject|6|||
154876591|NCT00504166|558972700|FG000|Overall Study|Physician Decision|1|||
154876592|NCT00504166|558972701|FG001|Overall Study|Physician Decision|1|||
154876593|NCT00504166|558972700|FG000|Overall Study|Lost to Follow-up|1|||
154876594|NCT00504166|558972701|FG001|Overall Study|Lost to Follow-up|3|||
154876595|NCT01096550|558972702|FG000|Overall Study|discontinued site|10|||
154876596|NCT01096550|558972703|FG001|Overall Study|discontinued site|11|||
154876597|NCT01096550|558972702|FG000|Overall Study|non-regular treatment track at clinic|1|||
154876598|NCT01096550|558972703|FG001|Overall Study|non-regular treatment track at clinic|1|||
154876599|NCT01096550|558972702|FG000|Overall Study|clinic readmission|1|||
154876600|NCT01096550|558972703|FG001|Overall Study|clinic readmission|1|||
154876601|NCT01096550|558972702|FG000|Overall Study|Withdrawal by Subject|0|||
154876602|NCT01096550|558972703|FG001|Overall Study|Withdrawal by Subject|1|||
154876603|NCT01096550|558972702|FG000|Overall Study|non-African American participant|13|||
154876604|NCT01096550|558972703|FG001|Overall Study|non-African American participant|6|||
154876605|NCT01096550|558972702|FG000|Overall Study|Lost to Follow-up|12|||
154876606|NCT01096550|558972703|FG001|Overall Study|Lost to Follow-up|9|||
154876607|NCT01555463|558972704|FG000|Treatment|Adverse Event|6|||
154876608|NCT01555463|558972705|FG001|Treatment|Adverse Event|12|||
154876609|NCT01555463|558972704|FG000|Treatment|Withdrawal by Subject|24|||
154876610|NCT01555463|558972705|FG001|Treatment|Withdrawal by Subject|36|||
154876611|NCT01555463|558972704|FG000|Treatment|Lost to Follow-up|28|||
154876612|NCT01555463|558972705|FG001|Treatment|Lost to Follow-up|23|||
154876613|NCT01555463|558972704|FG000|Treatment|Protocol Violation|4|||
154876614|NCT01555463|558972705|FG001|Treatment|Protocol Violation|5|||
154876615|NCT01555463|558972704|FG000|Treatment|Other reason|2|||
154876616|NCT01555463|558972705|FG001|Treatment|Other reason|3|||
154876617|NCT01555463|558972704|FG000|Follow up|Adverse Event|2|||
154876618|NCT01555463|558972705|FG001|Follow up|Adverse Event|5|||
154876619|NCT01555463|558972704|FG000|Follow up|Death|0|||
154876620|NCT01555463|558972705|FG001|Follow up|Death|1|||
154876621|NCT01555463|558972704|FG000|Follow up|Withdrawal by Subject|22|||
154876622|NCT01555463|558972705|FG001|Follow up|Withdrawal by Subject|22|||
154876623|NCT01555463|558972704|FG000|Follow up|Lost to Follow-up|9|||
154876624|NCT01555463|558972705|FG001|Follow up|Lost to Follow-up|10|||
154876625|NCT01555463|558972704|FG000|Follow up|Protocol Violation|2|||
154876626|NCT01555463|558972705|FG001|Follow up|Protocol Violation|4|||
154876627|NCT01555463|558972704|FG000|Follow up|Other reason|3|||
154876628|NCT01555463|558972705|FG001|Follow up|Other reason|3|||
154876629|NCT01165203|558972706|FG000|Active Phase|Serious Adverse Event|1|||
154876630|NCT01165203|558972707|FG001|Active Phase|Serious Adverse Event|0|||
154876631|NCT01165203|558972706|FG000|Active Phase|Withdrawal by Subject|2|||
154876632|NCT01165203|558972707|FG001|Active Phase|Withdrawal by Subject|1|||
154876633|NCT01165203|558972706|FG000|Active Phase|Migrated/moved from study area|0|||
154876634|NCT01165203|558972707|FG001|Active Phase|Migrated/moved from study area|1|||
154876635|NCT01165203|558972706|FG000|Active Phase|Lost to Follow-up|2|||
154876636|NCT01165203|558972707|FG001|Active Phase|Lost to Follow-up|0|||
154876637|NCT01165203|558972706|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
154876638|NCT01165203|558972707|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
155112774|NCT01866111|559842664|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
155112775|NCT01866111|559842665|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
154876639|NCT01165203|558972706|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
154876640|NCT01165203|558972707|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
154876641|NCT01165203|558972706|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
154876642|NCT01165203|558972707|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
154876643|NCT01165203|558972706|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
154876644|NCT01165203|558972707|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
154876645|NCT01165203|558972706|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
154876646|NCT01165203|558972707|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
154876647|NCT02815397|558972711|FG000|Overall Study|Physician Decision|2|||
154876648|NCT00085540|558972714|FG000|Overall Study|Withdrawal by Subject|0|||
155112776|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
154876649|NCT00085540|558972715|FG001|Overall Study|Withdrawal by Subject|1|||
154876650|NCT00085540|558972714|FG000|Overall Study|Protocol Violation|0|||
154876651|NCT00085540|558972715|FG001|Overall Study|Protocol Violation|1|||
154876652|NCT01605396|558972716|FG000|Overall Study|Adverse Event|5|||
154876653|NCT01605396|558972717|FG001|Overall Study|Adverse Event|3|||
154876654|NCT01605396|558972716|FG000|Overall Study|Lost to Follow-up|1|||
154876655|NCT01605396|558972717|FG001|Overall Study|Lost to Follow-up|0|||
154876656|NCT01605396|558972716|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154876657|NCT01605396|558972717|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154876658|NCT01605396|558972716|FG000|Overall Study|Physician Decision|2|||
154876659|NCT01605396|558972717|FG001|Overall Study|Physician Decision|2|||
154876660|NCT01605396|558972716|FG000|Overall Study|Progressive Disease|23|||
154876661|NCT01605396|558972717|FG001|Overall Study|Progressive Disease|27|||
154876662|NCT01605396|558972716|FG000|Overall Study|Withdrawal by Subject|4|||
154876663|NCT01605396|558972717|FG001|Overall Study|Withdrawal by Subject|2|||
154876664|NCT01605396|558972716|FG000|Overall Study|Transfer Off Study|4|||
154876665|NCT01605396|558972717|FG001|Overall Study|Transfer Off Study|5|||
154876666|NCT04598165|558972718|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
154876667|NCT04598165|558972719|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
154876668|NCT04598165|558972718|FG000|Completed 6-week Follow-up|Death|2|||
154876669|NCT04598165|558972719|FG001|Completed 6-week Follow-up|Death|1|||
154876670|NCT04598165|558972718|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
154876671|NCT04598165|558972719|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
154876672|NCT04598165|558972718|FG000|Completed 6-week Follow-up|Ineligible|4|||
154876673|NCT04598165|558972719|FG001|Completed 6-week Follow-up|Ineligible|3|||
154876674|NCT04598165|558972718|FG000|Completed 6-week Follow-up|Partner refusal|0|||
154876675|NCT04598165|558972719|FG001|Completed 6-week Follow-up|Partner refusal|1|||
154876676|NCT04598165|558972718|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
154876677|NCT04598165|558972719|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
154876678|NCT00426751|558972722|FG000|Overall Study|Adverse Event|8|||
154876679|NCT00426751|558972723|FG001|Overall Study|Adverse Event|1|||
154876680|NCT00426751|558972722|FG000|Overall Study|Lost to Follow-up|7|||
154876681|NCT00426751|558972723|FG001|Overall Study|Lost to Follow-up|6|||
154876682|NCT00426751|558972722|FG000|Overall Study|Consent Withdrawn|0|||
154876683|NCT00426751|558972723|FG001|Overall Study|Consent Withdrawn|1|||
154876684|NCT00426751|558972722|FG000|Overall Study|Other Reasons|7|||
154876685|NCT00426751|558972723|FG001|Overall Study|Other Reasons|12|||
154876686|NCT04238663|558972724|FG000|Overall Study|Lost to Follow-up|0|||
154876687|NCT04238663|558972725|FG001|Overall Study|Lost to Follow-up|1|||
154876688|NCT04238663|558972726|FG002|Overall Study|Lost to Follow-up|0|||
154876689|NCT00337467|558972727|FG000|Overall Study|Adverse Event|3|||
154876690|NCT00337467|558972727|FG000|Overall Study|Subject Withdrew Consent|2|||
154876691|NCT00337467|558972727|FG000|Overall Study|Pregnancy|1|||
154876692|NCT00337467|558972727|FG000|Overall Study|Lost to Follow-up|2|||
154876693|NCT00337467|558972727|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
154876694|NCT04430582|558972731|FG000|Overall Study|Found to meet exclusionary criteria|1|||
154876695|NCT04430582|558972732|FG001|Overall Study|Found to meet exclusionary criteria|0|||
154876696|NCT04430582|558972731|FG000|Overall Study|Withdrawal by Subject|0|||
154876697|NCT04430582|558972732|FG001|Overall Study|Withdrawal by Subject|1|||
154876698|NCT03607682|558972733|FG000|Overall Study|Withdrawal by Subject|1|||
154876699|NCT03607682|558972733|FG000|Overall Study|Disease progression|1|||
154876700|NCT01770353|558972734|FG000|Overall Study|Progressive disease|2|||
154876701|NCT01770353|558972735|FG001|Overall Study|Progressive disease|1|||
154876702|NCT01770353|558972734|FG000|Overall Study|Adverse Event|0|||
154876703|NCT01770353|558972735|FG001|Overall Study|Adverse Event|1|||
155112777|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
155175343|NCT00910624|560080226|FG000|Treatment Phase|Lost to Follow-up|0|||
154876704|NCT01770353|558972734|FG000|Overall Study|Protocol Violation|1|||
154876705|NCT01770353|558972735|FG001|Overall Study|Protocol Violation|0|||
154876706|NCT01770353|558972734|FG000|Overall Study|Physician Decision|0|||
154876707|NCT01770353|558972735|FG001|Overall Study|Physician Decision|3|||
154876708|NCT01770353|558972734|FG000|Overall Study|Clinical deterioration|3|||
154876709|NCT01770353|558972735|FG001|Overall Study|Clinical deterioration|6|||
154876710|NCT01770353|558972734|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
154876711|NCT01770353|558972735|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
154876712|NCT00620321|558974384|FG000|Overall Study|Adverse Event|1|||
154876713|NCT00620321|558974385|FG001|Overall Study|Adverse Event|1|||
154876714|NCT00620321|558974384|FG000|Overall Study|Death|1|||
154876715|NCT00620321|558974385|FG001|Overall Study|Death|1|||
154876716|NCT00620321|558974384|FG000|Overall Study|Physician Decision|0|||
154876717|NCT00620321|558974385|FG001|Overall Study|Physician Decision|7|||
154876718|NCT00620321|558974384|FG000|Overall Study|Progressive Disease|5|||
154876719|NCT00620321|558974385|FG001|Overall Study|Progressive Disease|5|||
154876720|NCT00620321|558974384|FG000|Overall Study|Sponsor Decision|0|||
154876721|NCT00620321|558974385|FG001|Overall Study|Sponsor Decision|1|||
154876722|NCT00620321|558974384|FG000|Overall Study|Withdrawal by Subject|1|||
154876723|NCT00620321|558974385|FG001|Overall Study|Withdrawal by Subject|1|||
154876724|NCT02410902|558974389|FG000|Overall Study|Adverse Event|2|||
154876725|NCT02410902|558974390|FG001|Overall Study|Adverse Event|3|||
154876726|NCT02410902|558974389|FG000|Overall Study|Lost to Follow-up|4|||
154876727|NCT02410902|558974390|FG001|Overall Study|Lost to Follow-up|1|||
154876728|NCT02410902|558974389|FG000|Overall Study|Protocol Violation|1|||
154876729|NCT02410902|558974390|FG001|Overall Study|Protocol Violation|4|||
154876730|NCT02410902|558974389|FG000|Overall Study|Withdrawal by Subject|6|||
154876731|NCT02410902|558974390|FG001|Overall Study|Withdrawal by Subject|8|||
154876732|NCT02410902|558974389|FG000|Overall Study|Non-Compliance|8|||
154876733|NCT02410902|558974390|FG001|Overall Study|Non-Compliance|2|||
154876734|NCT02279524|558974391|FG000|Overall Study|Withdrawal by Subject|3|||
154876735|NCT02279524|558974392|FG001|Overall Study|Withdrawal by Subject|6|||
154876736|NCT02279524|558974393|FG002|Overall Study|Withdrawal by Subject|3|||
154876737|NCT02279524|558974391|FG000|Overall Study|Adverse Event|4|||
154876738|NCT02279524|558974392|FG001|Overall Study|Adverse Event|3|||
154876739|NCT02279524|558974393|FG002|Overall Study|Adverse Event|2|||
154876740|NCT02279524|558974391|FG000|Overall Study|Lost to Follow-up|1|||
154876741|NCT02279524|558974392|FG001|Overall Study|Lost to Follow-up|1|||
154876742|NCT02279524|558974393|FG002|Overall Study|Lost to Follow-up|0|||
154876743|NCT02279524|558974391|FG000|Overall Study|Disallowed medication|1|||
154876744|NCT02279524|558974392|FG001|Overall Study|Disallowed medication|1|||
154876745|NCT02279524|558974393|FG002|Overall Study|Disallowed medication|2|||
154876746|NCT02279524|558974391|FG000|Overall Study|Bariatric surgery|1|||
154876747|NCT02279524|558974392|FG001|Overall Study|Bariatric surgery|0|||
154876748|NCT02279524|558974393|FG002|Overall Study|Bariatric surgery|0|||
154876749|NCT01746732|558974394|FG000|Lead-In Period|Withdrawal by Subject|1|||
154876750|NCT01746732|558974395|FG001|Lead-In Period|Withdrawal by Subject|0|||
154876751|NCT01746732|558974396|FG002|Lead-In Period|Withdrawal by Subject|0|||
154876752|NCT01746732|558974394|FG000|Period 1|Physician Decision|0|||
154876753|NCT01746732|558974395|FG001|Period 1|Physician Decision|1|||
154876754|NCT01746732|558974396|FG002|Period 1|Physician Decision|0|||
154876755|NCT01746732|558974394|FG000|Period 2|Withdrawal by Subject|0|||
154876756|NCT01746732|558974395|FG001|Period 2|Withdrawal by Subject|0|||
154876757|NCT01746732|558974396|FG002|Period 2|Withdrawal by Subject|2|||
154876758|NCT01746732|558974394|FG000|Period 2|Adverse Event|0|||
154876759|NCT01746732|558974395|FG001|Period 2|Adverse Event|0|||
154876760|NCT01746732|558974396|FG002|Period 2|Adverse Event|1|||
154876761|NCT01746732|558974394|FG000|Period 2|Lost to Follow-up|0|||
154876762|NCT01746732|558974395|FG001|Period 2|Lost to Follow-up|0|||
154876763|NCT01746732|558974396|FG002|Period 2|Lost to Follow-up|1|||
154876764|NCT02817555|558974397|FG000|Overall Study|Death|1|||
154876765|NCT02817555|558974398|FG001|Overall Study|Death|3|||
154876766|NCT02817555|558974397|FG000|Overall Study|moved away|1|||
154876767|NCT02817555|558974398|FG001|Overall Study|moved away|0|||
154876768|NCT02817555|558974397|FG000|Overall Study|transplant|1|||
154876769|NCT02817555|558974398|FG001|Overall Study|transplant|1|||
154876770|NCT02817555|558974397|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
154876771|NCT02817555|558974398|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
154876772|NCT00137436|558974399|FG000|Overall Study|Adverse Event|13|||
154876773|NCT00137436|558974399|FG000|Overall Study|Death|2|||
154876774|NCT00137436|558974399|FG000|Overall Study|Lack of Efficacy|17|||
154876775|NCT00137436|558974399|FG000|Overall Study|Withdrawal by Subject|6|||
154876776|NCT00137436|558974399|FG000|Overall Study|Other|5|||
154876777|NCT00701727|558974400|FG000|First Treatment Period|Adverse Event|0|||
154876778|NCT00701727|558974401|FG001|First Treatment Period|Adverse Event|0|||
154876779|NCT00701727|558974400|FG000|First Treatment Period|Withdrawal by Subject|1|||
154876780|NCT00701727|558974401|FG001|First Treatment Period|Withdrawal by Subject|0|||
154876781|NCT00701727|558974400|FG000|First Treatment Period|sponsor decision|0|||
154876782|NCT00701727|558974401|FG001|First Treatment Period|sponsor decision|1|||
154876783|NCT00701727|558974400|FG000|First Treatment Period|Lost to Follow-up|0|||
154876784|NCT00701727|558974401|FG001|First Treatment Period|Lost to Follow-up|1|||
154876785|NCT00701727|558974400|FG000|Second Treatment Period|Withdrawal by Subject|2|||
154876786|NCT00701727|558974401|FG001|Second Treatment Period|Withdrawal by Subject|0|||
154876787|NCT00912015|558974402|FG000|Overall Study|Lack of Efficacy|1|||
154876788|NCT00912015|558974403|FG001|Overall Study|Lack of Efficacy|0|||
154876789|NCT00912015|558974404|FG002|Overall Study|Lack of Efficacy|0|||
154876790|NCT00912015|558974405|FG003|Overall Study|Lack of Efficacy|0|||
154876791|NCT00912015|558974402|FG000|Overall Study|Withdrawal by Subject|8|||
154876792|NCT00912015|558974403|FG001|Overall Study|Withdrawal by Subject|8|||
154876793|NCT00912015|558974404|FG002|Overall Study|Withdrawal by Subject|3|||
154876794|NCT00912015|558974405|FG003|Overall Study|Withdrawal by Subject|0|||
154876795|NCT00912015|558974402|FG000|Overall Study|Protocol Violation|1|||
154876796|NCT00912015|558974403|FG001|Overall Study|Protocol Violation|0|||
154876797|NCT00912015|558974404|FG002|Overall Study|Protocol Violation|0|||
154876798|NCT00912015|558974405|FG003|Overall Study|Protocol Violation|1|||
154876799|NCT00912015|558974402|FG000|Overall Study|Adverse Event|6|||
154876800|NCT00912015|558974403|FG001|Overall Study|Adverse Event|0|||
154876801|NCT00912015|558974404|FG002|Overall Study|Adverse Event|0|||
154876802|NCT00912015|558974405|FG003|Overall Study|Adverse Event|1|||
154876803|NCT05137041|558974408|FG000|Overall Study|Lost to Follow-up|1|||
154876804|NCT05137041|558974409|FG001|Overall Study|Lost to Follow-up|1|||
154876805|NCT05137041|558974408|FG000|Overall Study|Withdrawal by Subject|0|||
154876806|NCT05137041|558974409|FG001|Overall Study|Withdrawal by Subject|2|||
154876807|NCT05137041|558974408|FG000|Overall Study|Reason not Specified|0|||
154876808|NCT05137041|558974409|FG001|Overall Study|Reason not Specified|1|||
155112778|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
155112779|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
155112780|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
155112781|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
155112782|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
155112783|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
155112784|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
155112785|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
155112786|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
155112787|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
155112788|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
155112789|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
155112790|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
155112791|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
155112792|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Death|1|||
155112793|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Death|1|||
154876809|NCT02090114|558974410|FG000|Overall Study|Withdrawal by Subject|3|||
154876810|NCT02090114|558974411|FG001|Overall Study|Withdrawal by Subject|6|||
154876811|NCT02090114|558974412|FG002|Overall Study|Withdrawal by Subject|2|||
154876812|NCT02090114|558974413|FG003|Overall Study|Withdrawal by Subject|1|||
154876813|NCT02090114|558974410|FG000|Overall Study|Physician Decision|5|||
154876814|NCT02090114|558974411|FG001|Overall Study|Physician Decision|0|||
154876815|NCT02090114|558974412|FG002|Overall Study|Physician Decision|1|||
154876816|NCT02090114|558974413|FG003|Overall Study|Physician Decision|1|||
154876817|NCT02090114|558974410|FG000|Overall Study|Adverse Event|1|||
154876818|NCT02090114|558974411|FG001|Overall Study|Adverse Event|2|||
154876819|NCT02090114|558974412|FG002|Overall Study|Adverse Event|2|||
154876820|NCT02090114|558974413|FG003|Overall Study|Adverse Event|0|||
154876821|NCT02090114|558974410|FG000|Overall Study|Progressive Disease|20|||
154876822|NCT02090114|558974411|FG001|Overall Study|Progressive Disease|21|||
154876823|NCT02090114|558974412|FG002|Overall Study|Progressive Disease|23|||
154876824|NCT02090114|558974413|FG003|Overall Study|Progressive Disease|6|||
154876825|NCT02090114|558974410|FG000|Overall Study|Death|1|||
154876826|NCT02090114|558974411|FG001|Overall Study|Death|0|||
154876827|NCT02090114|558974412|FG002|Overall Study|Death|1|||
154876828|NCT02090114|558974413|FG003|Overall Study|Death|0|||
154876829|NCT00392171|558974414|FG000|Overall Study|Did not meet inclusion criteria|4|||
154876830|NCT00392171|558974414|FG000|Overall Study|Disease progression|101|||
154876831|NCT01605071|558974415|FG000|Overall Study|Withdrawal by Subject|3|||
154876832|NCT01605071|558974416|FG001|Overall Study|Withdrawal by Subject|2|||
154876833|NCT00051558|558974419|FG000|Overall Study|Adverse Event|30|||
154876834|NCT00051558|558974420|FG001|Overall Study|Adverse Event|18|||
154876835|NCT00051558|558974419|FG000|Overall Study|Withdrawal by Subject|29|||
154876836|NCT00051558|558974420|FG001|Overall Study|Withdrawal by Subject|42|||
154876837|NCT00051558|558974419|FG000|Overall Study|Death|9|||
154876838|NCT00051558|558974420|FG001|Overall Study|Death|15|||
154876839|NCT00051558|558974419|FG000|Overall Study|Lost to Follow-up|4|||
154876840|NCT00051558|558974420|FG001|Overall Study|Lost to Follow-up|13|||
154876841|NCT00051558|558974419|FG000|Overall Study|Protocol Violation|3|||
154876842|NCT00051558|558974420|FG001|Overall Study|Protocol Violation|4|||
155112794|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Death|3|||
154876843|NCT00051558|558974419|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
154876844|NCT00051558|558974420|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
154876845|NCT00051558|558974419|FG000|Overall Study|Sponsor Decision|6|||
154876846|NCT00051558|558974420|FG001|Overall Study|Sponsor Decision|1|||
154876847|NCT00051558|558974419|FG000|Overall Study|Other|2|||
154876848|NCT00051558|558974420|FG001|Overall Study|Other|1|||
154876849|NCT00051558|558974419|FG000|Overall Study|Significant Lab Value|2|||
154876850|NCT00051558|558974420|FG001|Overall Study|Significant Lab Value|0|||
155112795|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Death|2|||
154876851|NCT00051558|558974419|FG000|Overall Study|Physician Decision|5|||
154876852|NCT00051558|558974420|FG001|Overall Study|Physician Decision|0|||
154876853|NCT01881620|558974423|FG000|Overall Study|Protocol Violation|4|||
154876854|NCT02163993|558974424|FG000|Treatment Period|Adverse Event|0|||
154876855|NCT02163993|558974425|FG001|Treatment Period|Adverse Event|1|||
154876856|NCT02163993|558974426|FG002|Treatment Period|Adverse Event|0|||
154876857|NCT02163993|558974427|FG003|Treatment Period|Adverse Event|0|||
154876858|NCT02163993|558974428|FG004|Treatment Period|Adverse Event|1|||
154876859|NCT02163993|558974424|FG000|Treatment Period|Lost to Follow-up|2|||
154876860|NCT02163993|558974425|FG001|Treatment Period|Lost to Follow-up|3|||
154876861|NCT02163993|558974426|FG002|Treatment Period|Lost to Follow-up|1|||
154876862|NCT02163993|558974427|FG003|Treatment Period|Lost to Follow-up|3|||
154876863|NCT02163993|558974428|FG004|Treatment Period|Lost to Follow-up|1|||
154876864|NCT02163993|558974424|FG000|Treatment Period|Physician Decision|1|||
154876865|NCT02163993|558974425|FG001|Treatment Period|Physician Decision|0|||
154876866|NCT02163993|558974426|FG002|Treatment Period|Physician Decision|0|||
154876867|NCT02163993|558974427|FG003|Treatment Period|Physician Decision|0|||
154876868|NCT02163993|558974428|FG004|Treatment Period|Physician Decision|0|||
154876869|NCT02163993|558974424|FG000|Treatment Period|Protocol Violation|2|||
154876870|NCT02163993|558974425|FG001|Treatment Period|Protocol Violation|1|||
154876871|NCT02163993|558974426|FG002|Treatment Period|Protocol Violation|0|||
154876872|NCT02163993|558974427|FG003|Treatment Period|Protocol Violation|1|||
154876873|NCT02163993|558974428|FG004|Treatment Period|Protocol Violation|2|||
154876874|NCT02163993|558974424|FG000|Treatment Period|Withdrawal by Subject|6|||
154876875|NCT02163993|558974425|FG001|Treatment Period|Withdrawal by Subject|4|||
154876876|NCT02163993|558974426|FG002|Treatment Period|Withdrawal by Subject|1|||
154876877|NCT02163993|558974427|FG003|Treatment Period|Withdrawal by Subject|4|||
154876878|NCT02163993|558974428|FG004|Treatment Period|Withdrawal by Subject|1|||
154876879|NCT02163993|558974424|FG000|Treatment Period|Not treated|1|||
154876880|NCT02163993|558974425|FG001|Treatment Period|Not treated|0|||
154876881|NCT02163993|558974426|FG002|Treatment Period|Not treated|0|||
154876882|NCT02163993|558974427|FG003|Treatment Period|Not treated|1|||
154876883|NCT02163993|558974428|FG004|Treatment Period|Not treated|2|||
154876884|NCT02163993|558974424|FG000|Post-treatment Period|Adverse Event|0|||
154876885|NCT02163993|558974425|FG001|Post-treatment Period|Adverse Event|0|||
154876886|NCT02163993|558974426|FG002|Post-treatment Period|Adverse Event|1|||
154876887|NCT02163993|558974427|FG003|Post-treatment Period|Adverse Event|0|||
154876888|NCT02163993|558974428|FG004|Post-treatment Period|Adverse Event|0|||
154876889|NCT02163993|558974424|FG000|Post-treatment Period|Lost to Follow-up|2|||
154876890|NCT02163993|558974425|FG001|Post-treatment Period|Lost to Follow-up|2|||
154876891|NCT02163993|558974426|FG002|Post-treatment Period|Lost to Follow-up|3|||
154876892|NCT02163993|558974427|FG003|Post-treatment Period|Lost to Follow-up|1|||
154876893|NCT02163993|558974428|FG004|Post-treatment Period|Lost to Follow-up|0|||
154876894|NCT02163993|558974424|FG000|Post-treatment Period|Protocol Violation|0|||
154876895|NCT02163993|558974425|FG001|Post-treatment Period|Protocol Violation|0|||
154876896|NCT02163993|558974426|FG002|Post-treatment Period|Protocol Violation|0|||
154876897|NCT02163993|558974427|FG003|Post-treatment Period|Protocol Violation|0|||
154876898|NCT02163993|558974428|FG004|Post-treatment Period|Protocol Violation|1|||
154876899|NCT02163993|558974424|FG000|Post-treatment Period|Withdrawal by Subject|2|||
154876900|NCT02163993|558974425|FG001|Post-treatment Period|Withdrawal by Subject|4|||
154876901|NCT02163993|558974426|FG002|Post-treatment Period|Withdrawal by Subject|0|||
154876902|NCT02163993|558974427|FG003|Post-treatment Period|Withdrawal by Subject|1|||
154876903|NCT02163993|558974428|FG004|Post-treatment Period|Withdrawal by Subject|2|||
154876904|NCT01808118|558974429|FG000|Period 1|Adverse Event|15|||
154876905|NCT01808118|558974430|FG001|Period 1|Adverse Event|0|||
154876906|NCT01808118|558974431|FG002|Period 1|Adverse Event|0|||
154876907|NCT01808118|558974429|FG000|Period 1|Withdrew consent|24|||
154876908|NCT01808118|558974430|FG001|Period 1|Withdrew consent|0|||
154876909|NCT01808118|558974431|FG002|Period 1|Withdrew consent|0|||
154876910|NCT01808118|558974429|FG000|Period 1|Lost to Follow-up|9|||
154876911|NCT01808118|558974430|FG001|Period 1|Lost to Follow-up|0|||
154876912|NCT01808118|558974431|FG002|Period 1|Lost to Follow-up|0|||
154876913|NCT01808118|558974429|FG000|Period 1|Did not meet criteria for remission|303|||
154876914|NCT01808118|558974430|FG001|Period 1|Did not meet criteria for remission|0|||
154876915|NCT01808118|558974431|FG002|Period 1|Did not meet criteria for remission|0|||
154876916|NCT01808118|558974429|FG000|Period 1|Enrolled in error|7|||
154876917|NCT01808118|558974430|FG001|Period 1|Enrolled in error|0|||
154876918|NCT01808118|558974431|FG002|Period 1|Enrolled in error|0|||
154876919|NCT01808118|558974429|FG000|Period 1|Did not meet inclusion criteria|3|||
154876920|NCT01808118|558974430|FG001|Period 1|Did not meet inclusion criteria|0|||
154876921|NCT01808118|558974431|FG002|Period 1|Did not meet inclusion criteria|0|||
154876922|NCT01808118|558974429|FG000|Period 1|Non-conformance with inclusion criteria|3|||
154876923|NCT01808118|558974430|FG001|Period 1|Non-conformance with inclusion criteria|0|||
154876924|NCT01808118|558974431|FG002|Period 1|Non-conformance with inclusion criteria|0|||
154876925|NCT01808118|558974429|FG000|Period 1|Investigator decision: site closure|2|||
154876926|NCT01808118|558974430|FG001|Period 1|Investigator decision: site closure|0|||
154876927|NCT01808118|558974431|FG002|Period 1|Investigator decision: site closure|0|||
154876928|NCT01808118|558974429|FG000|Period 1|Non-compliance per sponsor|1|||
154974511|NCT02174276|559331255|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
154876929|NCT01808118|558974430|FG001|Period 1|Non-compliance per sponsor|0|||
154876930|NCT01808118|558974431|FG002|Period 1|Non-compliance per sponsor|0|||
154876931|NCT01808118|558974429|FG000|Period 1|Lack of Efficacy|1|||
154876932|NCT01808118|558974430|FG001|Period 1|Lack of Efficacy|0|||
154876933|NCT01808118|558974431|FG002|Period 1|Lack of Efficacy|0|||
154876934|NCT01808118|558974429|FG000|Period 2|Adverse Event|0|||
155112796|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
155112797|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
155112798|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
155112799|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
155112800|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
155112801|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
155112802|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
155112803|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
155112804|NCT01866111|559842662|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
155112805|NCT01866111|559842663|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
155112806|NCT01866111|559842664|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
155112807|NCT01866111|559842665|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
155112808|NCT04113018|559842668|FG000|Overall Study|Death|2|||
155112809|NCT04113018|559842668|FG000|Overall Study|Lost to Follow-up|1|||
155112810|NCT04113018|559842668|FG000|Overall Study|Still On Study (on study treatment)|24|||
155112811|NCT04113018|559842668|FG000|Overall Study|Still On Study (in follow up)|12|||
155112812|NCT03802630|559842669|FG000|Overall Study|Study terminated by sponsor|130|||
155112813|NCT03802630|559842670|FG001|Overall Study|Study terminated by sponsor|134|||
155112814|NCT03802630|559842669|FG000|Overall Study|Subject decision|16|||
155112815|NCT03802630|559842670|FG001|Overall Study|Subject decision|9|||
155112816|NCT03802630|559842669|FG000|Overall Study|Adverse Event|3|||
155112817|NCT03802630|559842670|FG001|Overall Study|Adverse Event|1|||
155112818|NCT03802630|559842669|FG000|Overall Study|Lost to Follow-up|2|||
155112819|NCT03802630|559842670|FG001|Overall Study|Lost to Follow-up|2|||
155112820|NCT03802630|559842669|FG000|Overall Study|Physician Decision|2|||
155112821|NCT03802630|559842670|FG001|Overall Study|Physician Decision|0|||
155112822|NCT03802630|559842669|FG000|Overall Study|Death|0|||
155112823|NCT03802630|559842670|FG001|Overall Study|Death|2|||
155112824|NCT00157196|559842671|FG000|Overall Study|Ongoing at data cut-off|9|||
155112825|NCT05005013|559842672|FG000|Overall Study|Withdrawal by Subject|5|||
155112826|NCT05005013|559842673|FG001|Overall Study|Withdrawal by Subject|1|||
155112827|NCT05005013|559842672|FG000|Overall Study|Lost to Follow-up|3|||
155112828|NCT05005013|559842673|FG001|Overall Study|Lost to Follow-up|1|||
155112829|NCT05005013|559842672|FG000|Overall Study|Ineligibility|1|||
155112830|NCT05005013|559842673|FG001|Overall Study|Ineligibility|1|||
155112831|NCT06099223|559842674|FG000|Overall Study|Preoperative surveys missed|0|||
155112832|NCT06099223|559842675|FG001|Overall Study|Preoperative surveys missed|1|||
155112833|NCT01252186|559842676|FG000|Overall Study|Adverse Event|9|||
155112834|NCT01252186|559842677|FG001|Overall Study|Adverse Event|6|||
155112835|NCT01252186|559842678|FG002|Overall Study|Adverse Event|8|||
155112836|NCT01252186|559842676|FG000|Overall Study|Withdrawal by Subject|2|||
155112837|NCT01252186|559842677|FG001|Overall Study|Withdrawal by Subject|5|||
154876935|NCT01808118|558974430|FG001|Period 2|Adverse Event|4|||
154876936|NCT01808118|558974431|FG002|Period 2|Adverse Event|0|||
154876937|NCT01808118|558974429|FG000|Period 2|Withdrew consent|0|||
154876938|NCT01808118|558974430|FG001|Period 2|Withdrew consent|7|||
154876939|NCT01808118|558974431|FG002|Period 2|Withdrew consent|6|||
154876940|NCT01808118|558974429|FG000|Period 2|Lost to Follow-up|0|||
154876941|NCT01808118|558974430|FG001|Period 2|Lost to Follow-up|0|||
154876942|NCT01808118|558974431|FG002|Period 2|Lost to Follow-up|2|||
154876943|NCT01808118|558974429|FG000|Period 2|Investigator no longer conducting trials|0|||
154876944|NCT01808118|558974430|FG001|Period 2|Investigator no longer conducting trials|1|||
154876945|NCT01808118|558974431|FG002|Period 2|Investigator no longer conducting trials|0|||
154876946|NCT01808118|558974429|FG000|Period 2|Switched to other therapy|0|||
154876947|NCT01808118|558974430|FG001|Period 2|Switched to other therapy|1|||
154876948|NCT01808118|558974431|FG002|Period 2|Switched to other therapy|0|||
154876949|NCT00414310|558974432|FG000|Overall Study|Not treated|1|||
154876950|NCT00414310|558974433|FG001|Overall Study|Not treated|0|||
154876951|NCT01993329|558974437|FG000|Period 2|Adverse Event|0|||
154876952|NCT01993329|558974438|FG001|Period 2|Adverse Event|0|||
154876953|NCT01993329|558974439|FG002|Period 2|Adverse Event|0|||
155112838|NCT01252186|559842678|FG002|Overall Study|Withdrawal by Subject|2|||
155112839|NCT01252186|559842676|FG000|Overall Study|Physician Decision|0|||
155112840|NCT01252186|559842677|FG001|Overall Study|Physician Decision|0|||
155112841|NCT01252186|559842678|FG002|Overall Study|Physician Decision|1|||
155112842|NCT01252186|559842676|FG000|Overall Study|Non-compliance|0|||
155112843|NCT01252186|559842677|FG001|Overall Study|Non-compliance|3|||
155112844|NCT01252186|559842678|FG002|Overall Study|Non-compliance|4|||
155112845|NCT01252186|559842676|FG000|Overall Study|Protocol Violation|0|||
154876954|NCT01993329|558974440|FG003|Period 2|Adverse Event|0|||
154876955|NCT01993329|558974441|FG004|Period 2|Adverse Event|0|||
154876956|NCT01993329|558974442|FG005|Period 2|Adverse Event|1|||
155112846|NCT01252186|559842677|FG001|Overall Study|Protocol Violation|0|||
155112847|NCT01252186|559842678|FG002|Overall Study|Protocol Violation|1|||
155112848|NCT01252186|559842676|FG000|Overall Study|Pregnancy|2|||
155112849|NCT01252186|559842677|FG001|Overall Study|Pregnancy|2|||
155112850|NCT01252186|559842678|FG002|Overall Study|Pregnancy|0|||
154876957|NCT01993329|558974437|FG000|Wash-out|Personal reasons|0|||
154876958|NCT01993329|558974438|FG001|Wash-out|Personal reasons|1|||
154876959|NCT01993329|558974439|FG002|Wash-out|Personal reasons|0|||
154876960|NCT01993329|558974440|FG003|Wash-out|Personal reasons|0|||
154876961|NCT01993329|558974441|FG004|Wash-out|Personal reasons|0|||
154876962|NCT01993329|558974442|FG005|Wash-out|Personal reasons|0|||
154876963|NCT00109733|558974447|FG000|Overall Study|Protocol Violation|0|||
154876964|NCT00109733|558974448|FG001|Overall Study|Protocol Violation|1|||
154876965|NCT00109733|558974447|FG000|Overall Study|Stopped taking study drug|1|||
154876966|NCT00109733|558974448|FG001|Overall Study|Stopped taking study drug|1|||
154876967|NCT00109733|558974447|FG000|Overall Study|Non-compliant|0|||
154876968|NCT00109733|558974448|FG001|Overall Study|Non-compliant|1|||
154876969|NCT00109733|558974447|FG000|Overall Study|Could not commit time for study|1|||
154876970|NCT00109733|558974448|FG001|Overall Study|Could not commit time for study|1|||
154876971|NCT00879814|558974460|FG000|Overall Study|Adverse Event|0|||
154876972|NCT00879814|558974461|FG001|Overall Study|Adverse Event|1|||
154876973|NCT00879814|558974462|FG002|Overall Study|Adverse Event|0|||
154876974|NCT00879814|558974463|FG003|Overall Study|Adverse Event|0|||
154876975|NCT00879814|558974460|FG000|Overall Study|Lost to Follow-up|1|||
154876976|NCT00879814|558974461|FG001|Overall Study|Lost to Follow-up|0|||
154876977|NCT00879814|558974462|FG002|Overall Study|Lost to Follow-up|0|||
154876978|NCT00879814|558974463|FG003|Overall Study|Lost to Follow-up|2|||
154876979|NCT00879814|558974460|FG000|Overall Study|Participant Failed to Return|0|||
154876980|NCT00879814|558974461|FG001|Overall Study|Participant Failed to Return|0|||
154876981|NCT00879814|558974462|FG002|Overall Study|Participant Failed to Return|0|||
154876982|NCT00879814|558974463|FG003|Overall Study|Participant Failed to Return|1|||
154876983|NCT00879814|558974460|FG000|Overall Study|Withdrawal by Subject|3|||
154876984|NCT00879814|558974461|FG001|Overall Study|Withdrawal by Subject|1|||
154876985|NCT00879814|558974462|FG002|Overall Study|Withdrawal by Subject|1|||
154876986|NCT00879814|558974463|FG003|Overall Study|Withdrawal by Subject|2|||
154876987|NCT00879814|558974460|FG000|Overall Study|Physician Decision|0|||
154876988|NCT00879814|558974461|FG001|Overall Study|Physician Decision|0|||
154876989|NCT00879814|558974462|FG002|Overall Study|Physician Decision|1|||
154876990|NCT00879814|558974463|FG003|Overall Study|Physician Decision|0|||
154876991|NCT00879814|558974460|FG000|Overall Study|Other|0|||
154876992|NCT00879814|558974461|FG001|Overall Study|Other|0|||
154876993|NCT00879814|558974462|FG002|Overall Study|Other|1|||
154876994|NCT00879814|558974463|FG003|Overall Study|Other|0|||
154876995|NCT00630812|558974464|FG000|Randomisation to First Dose|Adverse Event|1|||
154876996|NCT00630812|558974465|FG001|Randomisation to First Dose|Adverse Event|1|||
154876997|NCT00630812|558974464|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
154876998|NCT00630812|558974465|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
154876999|NCT00630812|558974464|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
154877000|NCT00630812|558974465|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
154877001|NCT00630812|558974464|FG000|Randomisation to First Dose|Protocol Violation|4|||
154877002|NCT00630812|558974465|FG001|Randomisation to First Dose|Protocol Violation|1|||
154877003|NCT00630812|558974464|FG000|Double Blind Treatment Period|Adverse Event|13|||
154877004|NCT00630812|558974465|FG001|Double Blind Treatment Period|Adverse Event|5|||
154877005|NCT00630812|558974464|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
154877006|NCT00630812|558974465|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
154877007|NCT00630812|558974464|FG000|Double Blind Treatment Period|Physician Decision|2|||
154877008|NCT00630812|558974465|FG001|Double Blind Treatment Period|Physician Decision|1|||
154877009|NCT00630812|558974464|FG000|Double Blind Treatment Period|Protocol Violation|1|||
154877010|NCT00630812|558974465|FG001|Double Blind Treatment Period|Protocol Violation|0|||
154877011|NCT00630812|558974464|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
154877012|NCT00630812|558974465|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
154877013|NCT00630812|558974464|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
154877014|NCT00630812|558974465|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
155112851|NCT01252186|559842676|FG000|Overall Study|Sponsor Request|2|||
154877015|NCT00630812|558974464|FG000|Double Blind Treatment Period|Non-compliance|0|||
154877016|NCT00630812|558974465|FG001|Double Blind Treatment Period|Non-compliance|1|||
154877017|NCT00972478|558974466|FG000|Overall Study|Adverse Event|3|||
154877018|NCT00972478|558974467|FG001|Overall Study|Adverse Event|16|||
154877019|NCT00972478|558974466|FG000|Overall Study|Withdrawal by Subject|1|||
154877020|NCT00972478|558974467|FG001|Overall Study|Withdrawal by Subject|8|||
154877021|NCT00972478|558974466|FG000|Overall Study|Progression/Relapse|0|||
154877022|NCT00972478|558974467|FG001|Overall Study|Progression/Relapse|2|||
154877023|NCT00972478|558974466|FG000|Overall Study|Death|0|||
154877024|NCT00972478|558974467|FG001|Overall Study|Death|2|||
154877025|NCT00972478|558974466|FG000|Overall Study|Not protocol specified|1|||
154877026|NCT00972478|558974467|FG001|Overall Study|Not protocol specified|1|||
154877027|NCT00972478|558974466|FG000|Overall Study|Ineligible|1|||
154877028|NCT00972478|558974467|FG001|Overall Study|Ineligible|7|||
154877029|NCT00972478|558974466|FG000|Overall Study|Not start protocol treatment|1|||
154877030|NCT00972478|558974467|FG001|Overall Study|Not start protocol treatment|2|||
154877031|NCT02561000|558974468|FG000|Overall Study|Withdrawal by Subject|2|||
154877032|NCT02561000|558974469|FG001|Overall Study|Withdrawal by Subject|3|||
154877033|NCT02561000|558974470|FG002|Overall Study|Withdrawal by Subject|0|||
154877034|NCT02561000|558974468|FG000|Overall Study|Adverse Event|0|||
154877035|NCT02561000|558974469|FG001|Overall Study|Adverse Event|1|||
154877036|NCT02561000|558974470|FG002|Overall Study|Adverse Event|0|||
154877037|NCT01234402|558974471|FG000|Overall Study|Lost to Follow-up|0|||
154877038|NCT01234402|558974472|FG001|Overall Study|Lost to Follow-up|1|||
154877039|NCT01234402|558974473|FG002|Overall Study|Lost to Follow-up|3|||
154877040|NCT01234402|558974471|FG000|Overall Study|Withdrawal by Subject|1|||
154877041|NCT01234402|558974472|FG001|Overall Study|Withdrawal by Subject|3|||
154877042|NCT01234402|558974473|FG002|Overall Study|Withdrawal by Subject|4|||
154877043|NCT01234402|558974471|FG000|Overall Study|Never treated: Death|0|||
154877044|NCT01234402|558974472|FG001|Overall Study|Never treated: Death|0|||
154877045|NCT01234402|558974473|FG002|Overall Study|Never treated: Death|1|||
154877046|NCT01234402|558974471|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
154877047|NCT01234402|558974472|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
154877048|NCT01234402|558974473|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
154877049|NCT01234402|558974471|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
154877050|NCT01234402|558974472|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
154877051|NCT01234402|558974473|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
154877052|NCT02280291|558974475|FG000|Overall Study|Lost to Follow-up|2|||
154877053|NCT02280291|558974476|FG001|Overall Study|Lost to Follow-up|1|||
154877054|NCT02280291|558974477|FG002|Overall Study|Lost to Follow-up|3|||
154877055|NCT02280291|558974478|FG003|Overall Study|Lost to Follow-up|8|||
154877056|NCT02280291|558974475|FG000|Overall Study|Protocol Violation|1|||
154877057|NCT02280291|558974476|FG001|Overall Study|Protocol Violation|0|||
154877058|NCT02280291|558974477|FG002|Overall Study|Protocol Violation|0|||
154877059|NCT02280291|558974478|FG003|Overall Study|Protocol Violation|0|||
154877060|NCT02280291|558974475|FG000|Overall Study|Other|1|||
154877061|NCT02280291|558974476|FG001|Overall Study|Other|1|||
154877062|NCT02280291|558974477|FG002|Overall Study|Other|0|||
154877063|NCT02280291|558974478|FG003|Overall Study|Other|0|||
154877064|NCT00506077|558974480|FG000|Treatment Period 1|Adverse Event|2|||
154877065|NCT00506077|558974481|FG001|Treatment Period 1|Adverse Event|1|||
154877066|NCT00506077|558974480|FG000|Treatment Period 1|Lost to Follow-up|0|||
154877067|NCT00506077|558974481|FG001|Treatment Period 1|Lost to Follow-up|2|||
154877068|NCT00506077|558974480|FG000|Treatment Period 1|Withdrawal by Subject|2|||
154877069|NCT00506077|558974481|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154877070|NCT00506077|558974480|FG000|Treatment Period 2|Adverse Event|0|||
154877071|NCT00506077|558974481|FG001|Treatment Period 2|Adverse Event|1|||
154877072|NCT00506077|558974480|FG000|Treatment Period 2|Withdrawal by Subject|1|||
154877073|NCT00506077|558974481|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154877074|NCT02918266|558974482|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
154877075|NCT02918266|558974483|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877076|NCT02918266|558974484|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877077|NCT02918266|558974485|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877078|NCT02918266|558974486|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877079|NCT02918266|558974487|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877080|NCT02918266|558974488|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
154877081|NCT02918266|558974489|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877082|NCT02918266|558974490|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
154877083|NCT02918266|558974491|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877084|NCT02918266|558974492|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
154877085|NCT01293032|558974493|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
154877086|NCT01293032|558974494|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
154877087|NCT01293032|558974495|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
154877088|NCT01293032|558974496|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
154877089|NCT01293032|558974493|FG000|Treatment|Adverse Event|0|||
155112852|NCT01252186|559842677|FG001|Overall Study|Sponsor Request|1|||
154877090|NCT01293032|558974494|FG001|Treatment|Adverse Event|0|||
154877091|NCT01293032|558974495|FG002|Treatment|Adverse Event|1|||
154877092|NCT01293032|558974496|FG003|Treatment|Adverse Event|1|||
154877093|NCT01293032|558974493|FG000|Treatment|Withdrawal by Subject|2|||
154877094|NCT01293032|558974494|FG001|Treatment|Withdrawal by Subject|4|||
154877095|NCT01293032|558974495|FG002|Treatment|Withdrawal by Subject|0|||
154877096|NCT01293032|558974496|FG003|Treatment|Withdrawal by Subject|0|||
154877097|NCT01293032|558974493|FG000|Treatment|Disease Progression, relapse|0|||
154877098|NCT01293032|558974494|FG001|Treatment|Disease Progression, relapse|1|||
154877099|NCT01293032|558974495|FG002|Treatment|Disease Progression, relapse|0|||
154877100|NCT01293032|558974496|FG003|Treatment|Disease Progression, relapse|0|||
154877101|NCT01106534|558974499|FG000|Overall Study|Withdrawal by Subject|18|||
154877102|NCT01106534|558974499|FG000|Overall Study|Lost to Follow-up|2|||
154877103|NCT01106534|558974499|FG000|Overall Study|Death|16|||
154877104|NCT01106534|558974499|FG000|Overall Study|Physician Decision|1|||
154877105|NCT01603641|558974503|FG000|Overall Study|Did not Receive Treatment|3|||
154877106|NCT01603641|558974503|FG000|Overall Study|Adverse Event|1|||
154877107|NCT01603641|558974503|FG000|Overall Study|Lack of Efficacy|1|||
154877108|NCT01603641|558974503|FG000|Overall Study|Lost to Follow-up|6|||
154877109|NCT01603641|558974503|FG000|Overall Study|Personal Reasons|18|||
154877110|NCT01603641|558974503|FG000|Overall Study|Other Miscellaneous Reasons|6|||
154877111|NCT00114972|558974504|FG000|Overall Study|Withdrawal by Subject|40|||
154877112|NCT00114972|558974505|FG001|Overall Study|Withdrawal by Subject|7|||
154877113|NCT00114972|558974504|FG000|Overall Study|Lost to Follow-up|8|||
154877114|NCT00114972|558974505|FG001|Overall Study|Lost to Follow-up|5|||
154877115|NCT00772967|558974514|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
154877116|NCT00772967|558974515|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
154974512|NCT02174276|559331256|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
154974513|NCT02174276|559331257|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
154974514|NCT02174276|559331258|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
155112853|NCT01252186|559842678|FG002|Overall Study|Sponsor Request|0|||
155112854|NCT01252186|559842676|FG000|Overall Study|Lost to Follow-up|10|||
155112855|NCT01252186|559842677|FG001|Overall Study|Lost to Follow-up|10|||
155112856|NCT01252186|559842678|FG002|Overall Study|Lost to Follow-up|11|||
155112857|NCT01252186|559842676|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
155112858|NCT01252186|559842677|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
155112859|NCT01252186|559842678|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
155112860|NCT01700959|559842679|FG000|Overall Study|Adverse Event|0|||
155112861|NCT01700959|559842680|FG001|Overall Study|Adverse Event|1|||
155112862|NCT01700959|559842681|FG002|Overall Study|Adverse Event|1|||
155112863|NCT01700959|559842682|FG003|Overall Study|Adverse Event|2|||
155112864|NCT01700959|559842683|FG004|Overall Study|Adverse Event|0|||
155112865|NCT01700959|559842684|FG005|Overall Study|Adverse Event|2|||
155112866|NCT01700959|559842679|FG000|Overall Study|Withdrawal by Subject|15|||
155112867|NCT01700959|559842680|FG001|Overall Study|Withdrawal by Subject|9|||
155112868|NCT01700959|559842681|FG002|Overall Study|Withdrawal by Subject|12|||
155112869|NCT01700959|559842682|FG003|Overall Study|Withdrawal by Subject|11|||
155112870|NCT01700959|559842683|FG004|Overall Study|Withdrawal by Subject|8|||
155112871|NCT01700959|559842684|FG005|Overall Study|Withdrawal by Subject|12|||
155112872|NCT01700959|559842679|FG000|Overall Study|Ineligible|2|||
154974515|NCT02174276|559331255|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
154974516|NCT02174276|559331256|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
154974517|NCT02174276|559331257|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
155112873|NCT01700959|559842680|FG001|Overall Study|Ineligible|1|||
155112874|NCT01700959|559842681|FG002|Overall Study|Ineligible|2|||
155112875|NCT01700959|559842682|FG003|Overall Study|Ineligible|0|||
155112876|NCT01700959|559842683|FG004|Overall Study|Ineligible|0|||
155112877|NCT01700959|559842684|FG005|Overall Study|Ineligible|1|||
155112878|NCT01700959|559842679|FG000|Overall Study|Noncompliant|9|||
155112879|NCT01700959|559842680|FG001|Overall Study|Noncompliant|9|||
155112880|NCT01700959|559842681|FG002|Overall Study|Noncompliant|17|||
155112881|NCT01700959|559842682|FG003|Overall Study|Noncompliant|18|||
155112882|NCT01700959|559842683|FG004|Overall Study|Noncompliant|15|||
155112883|NCT01700959|559842684|FG005|Overall Study|Noncompliant|9|||
155112884|NCT01700959|559842679|FG000|Overall Study|Side effects|1|||
155112885|NCT01700959|559842680|FG001|Overall Study|Side effects|4|||
155112886|NCT01700959|559842681|FG002|Overall Study|Side effects|8|||
155112887|NCT01700959|559842682|FG003|Overall Study|Side effects|4|||
155112888|NCT01700959|559842683|FG004|Overall Study|Side effects|4|||
155112889|NCT01700959|559842684|FG005|Overall Study|Side effects|1|||
155112890|NCT00830375|559842685|FG000|Overall Study|Lost to Follow-up|1|||
155112891|NCT01331837|559842686|FG000|Overall Study|Death|30|||
155112892|NCT01331837|559842687|FG001|Overall Study|Death|34|||
155112893|NCT01331837|559842686|FG000|Overall Study|Lost to Follow-up|3|||
155112894|NCT01331837|559842687|FG001|Overall Study|Lost to Follow-up|1|||
154974518|NCT02174276|559331258|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
154974519|NCT02174276|559331255|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
155112895|NCT01331837|559842686|FG000|Overall Study|Info not recorded|10|||
155112896|NCT01331837|559842687|FG001|Overall Study|Info not recorded|16|||
155112897|NCT01331837|559842686|FG000|Overall Study|Withdrawal by Subject|13|||
154877117|NCT00772967|558974516|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
154877118|NCT00772967|558974517|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
154877119|NCT00772967|558974518|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
155112898|NCT01331837|559842687|FG001|Overall Study|Withdrawal by Subject|16|||
155112899|NCT03724981|559844697|FG000|First Device|Protocol Violation|1|||
155112900|NCT03724981|559844698|FG001|First Device|Protocol Violation|1|||
155112901|NCT01380535|559844700|FG000|Overall Study|Adverse Event|3|||
155112902|NCT01380535|559844701|FG001|Overall Study|Adverse Event|3|||
155112903|NCT01380535|559844700|FG000|Overall Study|Death|3|||
155112904|NCT01380535|559844701|FG001|Overall Study|Death|0|||
155112905|NCT01380535|559844700|FG000|Overall Study|Study site closed|0|||
155112906|NCT01380535|559844701|FG001|Overall Study|Study site closed|5|||
155112907|NCT01380535|559844700|FG000|Overall Study|Withdrawal by Subject|1|||
155112908|NCT01380535|559844701|FG001|Overall Study|Withdrawal by Subject|2|||
154877120|NCT00772967|558974519|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
154877121|NCT00772967|558974514|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
154877122|NCT00772967|558974515|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
154877123|NCT00772967|558974516|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
154877124|NCT00772967|558974517|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
154877125|NCT00772967|558974518|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
154877126|NCT00772967|558974519|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
154877127|NCT00772967|558974514|FG000|Crossover Treatment 3|Adverse Event|0|||
154877128|NCT00772967|558974515|FG001|Crossover Treatment 3|Adverse Event|0|||
154877129|NCT00772967|558974516|FG002|Crossover Treatment 3|Adverse Event|0|||
154877130|NCT00772967|558974517|FG003|Crossover Treatment 3|Adverse Event|0|||
154877131|NCT00772967|558974518|FG004|Crossover Treatment 3|Adverse Event|1|||
154877132|NCT00772967|558974519|FG005|Crossover Treatment 3|Adverse Event|0|||
154877133|NCT01558089|558974520|FG000|Overall Study|Adverse Event|1|||
154877134|NCT01558089|558974520|FG000|Overall Study|Lack of Efficacy|1|||
154877135|NCT01558089|558974520|FG000|Overall Study|Lost to Follow-up|5|||
154877136|NCT01558089|558974520|FG000|Overall Study|Withdrawal by Subject|6|||
154877137|NCT02144220|558974521|FG000|Overall Study|technology incompatibility|9|||
154877138|NCT02144220|558974521|FG000|Overall Study|Lack of Efficacy|4|||
154877139|NCT02144220|558974521|FG000|Overall Study|Physician Decision|3|||
154877140|NCT02144220|558974521|FG000|Overall Study|Withdrawal by Subject|2|||
154877141|NCT02144220|558974521|FG000|Overall Study|Protocol Violation|1|||
154877142|NCT00592501|558974522|FG000|Overall Study|Withdrawal by Subject|1|||
154877143|NCT00592501|558974522|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
154877144|NCT00053846|558974523|FG000|Overall Study|Changed mind|8|||
154877145|NCT00053846|558974524|FG001|Overall Study|Changed mind|13|||
154877146|NCT00053846|558974523|FG000|Overall Study|Became too ill|8|||
154877147|NCT00053846|558974524|FG001|Overall Study|Became too ill|7|||
154877148|NCT00053846|558974523|FG000|Overall Study|Expired|5|||
154877149|NCT00053846|558974524|FG001|Overall Study|Expired|0|||
154877150|NCT00053846|558974523|FG000|Overall Study|Became ineligible|3|||
154877151|NCT00053846|558974524|FG001|Overall Study|Became ineligible|1|||
154877152|NCT00053846|558974523|FG000|Overall Study|Did not return data|1|||
154877153|NCT00053846|558974524|FG001|Overall Study|Did not return data|2|||
154877154|NCT00053846|558974523|FG000|Overall Study|Quit due to side effects|1|||
154877155|NCT00053846|558974524|FG001|Overall Study|Quit due to side effects|3|||
154877156|NCT00053846|558974523|FG000|Overall Study|Pills too large|0|||
154877157|NCT00053846|558974524|FG001|Overall Study|Pills too large|1|||
154877158|NCT02229864|558974525|FG000|Overall Study|Death|2|||
154877159|NCT02229864|558974525|FG000|Overall Study|Lost to Follow-up|1|||
154877160|NCT02650284|558974528|FG000|Overall Study|Lost to Follow-up|3|||
154877161|NCT02650284|558974529|FG001|Overall Study|Lost to Follow-up|3|||
154877162|NCT02650284|558974528|FG000|Overall Study|Consent incorrectly taken|0|||
154877163|NCT02650284|558974529|FG001|Overall Study|Consent incorrectly taken|1|||
154877164|NCT02807454|558974536|FG000|Overall Study|Adverse Event|1|||
155112909|NCT01380535|559844700|FG000|Overall Study|Protocol Violation|0|||
155112910|NCT01380535|559844701|FG001|Overall Study|Protocol Violation|2|||
155112911|NCT01380535|559844700|FG000|Overall Study|Lack of Efficacy|0|||
155112912|NCT01380535|559844701|FG001|Overall Study|Lack of Efficacy|3|||
155112913|NCT02791191|559844702|FG000|Overall Study|Adverse Event|2|||
155112914|NCT02791191|559844703|FG001|Overall Study|Adverse Event|4|||
155112915|NCT02791191|559844704|FG002|Overall Study|Adverse Event|5|||
155112916|NCT02791191|559844702|FG000|Overall Study|Lack of Efficacy|0|||
155112917|NCT02791191|559844703|FG001|Overall Study|Lack of Efficacy|1|||
155112918|NCT02791191|559844704|FG002|Overall Study|Lack of Efficacy|0|||
155112919|NCT02791191|559844702|FG000|Overall Study|Study Drug Non-Compliance|0|||
155112920|NCT02791191|559844703|FG001|Overall Study|Study Drug Non-Compliance|2|||
155112921|NCT02791191|559844704|FG002|Overall Study|Study Drug Non-Compliance|0|||
155112922|NCT02791191|559844702|FG000|Overall Study|Site Closed by Sponsor|1|||
155112923|NCT02791191|559844703|FG001|Overall Study|Site Closed by Sponsor|1|||
155112924|NCT02791191|559844704|FG002|Overall Study|Site Closed by Sponsor|3|||
154877165|NCT02807454|558974537|FG001|Overall Study|Adverse Event|0|||
154877166|NCT02807454|558974536|FG000|Overall Study|Withdrawal by Subject|0|||
154877167|NCT02807454|558974537|FG001|Overall Study|Withdrawal by Subject|1|||
154877168|NCT02807454|558974536|FG000|Overall Study|Progressive Disease|30|||
155112925|NCT02791191|559844702|FG000|Overall Study|Progressive Disease|1|||
155112926|NCT02791191|559844703|FG001|Overall Study|Progressive Disease|0|||
155112927|NCT02791191|559844704|FG002|Overall Study|Progressive Disease|0|||
154877169|NCT02807454|558974537|FG001|Overall Study|Progressive Disease|3|||
154877170|NCT02807454|558974536|FG000|Overall Study|Other Reasons|1|||
154877171|NCT02807454|558974537|FG001|Overall Study|Other Reasons|1|||
154877172|NCT02275026|558974540|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
154877173|NCT02275026|558974540|FG000|Overall Study|Withdrawal by Subject|4|||
154877174|NCT02275026|558974540|FG000|Overall Study|Ineligible due to medical history|13|||
155112928|NCT02791191|559844702|FG000|Overall Study|Study Terminated by Sponsor|29|||
155112929|NCT02791191|559844703|FG001|Overall Study|Study Terminated by Sponsor|101|||
155112930|NCT02791191|559844704|FG002|Overall Study|Study Terminated by Sponsor|109|||
155112931|NCT02791191|559844702|FG000|Overall Study|Withdrawal by Subject|3|||
154877175|NCT02275026|558974540|FG000|Overall Study|MRI malfunction precluded testing|1|||
154877176|NCT02275026|558974540|FG000|Overall Study|Ineligible after MRI findings|1|||
154877177|NCT02275026|558974540|FG000|Overall Study|Lost to Follow-up|2|||
154877178|NCT02275026|558974540|FG000|Overall Study|Scanner failure|1|||
154877179|NCT05468086|558974541|FG000|Overall Study|Withdrawal by Subject|3|||
154877180|NCT05468086|558974541|FG000|Overall Study|Subject was found ineligible after consent|1|||
154877181|NCT00374907|558974542|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
154877182|NCT00374907|558974543|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
154877183|NCT00374907|558974542|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
154877184|NCT00374907|558974543|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
154877185|NCT00374907|558974542|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
154877186|NCT00374907|558974543|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
154877187|NCT00374907|558974542|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
154877188|NCT00374907|558974543|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
154877189|NCT00374907|558974542|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
154877190|NCT00374907|558974543|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
154877191|NCT01200511|558974547|FG000|Overall Study|Lost to Follow-up|3|||
154877192|NCT01200511|558974547|FG000|Overall Study|Withdrawal by Subject|1|||
154877193|NCT01200511|558974547|FG000|Overall Study|Adverse Event|1|||
154877194|NCT03382899|558974552|FG000|Overall Study|Ineligibility Determined|0|||
154877195|NCT03382899|558974553|FG001|Overall Study|Ineligibility Determined|1|||
154877196|NCT03382899|558974552|FG000|Overall Study|Lost to Follow-up|0|||
154877197|NCT03382899|558974553|FG001|Overall Study|Lost to Follow-up|1|||
154877198|NCT03382899|558974552|FG000|Overall Study|Sponsor's decision|31|||
154877199|NCT03382899|558974553|FG001|Overall Study|Sponsor's decision|28|||
154877200|NCT03382899|558974552|FG000|Overall Study|Withdrawal by Subject|0|||
154877201|NCT03382899|558974553|FG001|Overall Study|Withdrawal by Subject|5|||
154877202|NCT00524745|558974555|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
154877203|NCT00524745|558974556|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
154877204|NCT00524745|558974557|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
154877205|NCT00524745|558974558|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
154877206|NCT02504892|558974559|FG000|Overall Study|Adverse event-pneumonitis|2|||
154877207|NCT01413178|558974560|FG000|Overall Study|Toxicity|1|||
154877208|NCT01413178|558974561|FG001|Overall Study|Toxicity|0|||
154877209|NCT01413178|558974560|FG000|Overall Study|Ineligible|0|||
154877210|NCT01413178|558974561|FG001|Overall Study|Ineligible|2|||
154877211|NCT00576693|558974562|FG000|Overall Study|Lost to Follow-up|7|||
154877212|NCT00576693|558974563|FG001|Overall Study|Lost to Follow-up|11|||
154877213|NCT00576693|558974562|FG000|Overall Study|Withdrawal by Subject|3|||
154877214|NCT00576693|558974563|FG001|Overall Study|Withdrawal by Subject|13|||
154877215|NCT00540449|558974564|FG000|Overall Study|Adverse Event|12|||
154877216|NCT00540449|558974565|FG001|Overall Study|Adverse Event|32|||
154877217|NCT00540449|558974564|FG000|Overall Study|Sponsor's Decision|1|||
154877218|NCT00540449|558974565|FG001|Overall Study|Sponsor's Decision|1|||
154877219|NCT00540449|558974564|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
154877220|NCT00540449|558974565|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
154877221|NCT00540449|558974564|FG000|Overall Study|Lost to Follow-up|19|||
154877222|NCT00540449|558974565|FG001|Overall Study|Lost to Follow-up|17|||
154877223|NCT00540449|558974564|FG000|Overall Study|Subject Non-Compliant|7|||
154877224|NCT00540449|558974565|FG001|Overall Study|Subject Non-Compliant|5|||
154877225|NCT00540449|558974564|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
154877226|NCT00540449|558974565|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
154877227|NCT00540449|558974564|FG000|Overall Study|Withdrawal by Subject|10|||
154877228|NCT00540449|558974565|FG001|Overall Study|Withdrawal by Subject|10|||
154877229|NCT00540449|558974564|FG000|Overall Study|Other|1|||
155112932|NCT02791191|559844703|FG001|Overall Study|Withdrawal by Subject|1|||
155112933|NCT02791191|559844704|FG002|Overall Study|Withdrawal by Subject|3|||
155112934|NCT02791191|559844702|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
155112935|NCT02791191|559844703|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
155112936|NCT02791191|559844704|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
155112937|NCT01448824|559844705|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
154877230|NCT00540449|558974565|FG001|Overall Study|Other|4|||
154877231|NCT00376688|558974566|FG000|Overall Study|Adverse Event|3|||
154877232|NCT00376688|558974566|FG000|Overall Study|Death|1|||
154877233|NCT05128162|558974567|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
154877234|NCT05128162|558974567|FG000|Overall Study|Physician Decision|1|||
154877235|NCT02985450|558975492|FG000|Overall Study|Lost to Follow-up|7|||
154877236|NCT00069576|558975493|FG000|Original Trial|Lost to Follow-up|25|||
154877237|NCT00069576|558975494|FG001|Original Trial|Lost to Follow-up|33|||
154877238|NCT00069576|558975493|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
154877239|NCT00069576|558975494|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
154877240|NCT00905307|558975495|FG000|Overall Study|Switched to Open Label Rescue|7|||
154877241|NCT00905307|558975496|FG001|Overall Study|Switched to Open Label Rescue|17|||
154877242|NCT00905307|558975497|FG002|Overall Study|Switched to Open Label Rescue|11|||
154877243|NCT00905307|558975498|FG003|Overall Study|Switched to Open Label Rescue|11|||
154877244|NCT00905307|558975499|FG004|Overall Study|Switched to Open Label Rescue|4|||
154877245|NCT00905307|558975500|FG005|Overall Study|Switched to Open Label Rescue|15|||
154877246|NCT00905307|558975495|FG000|Overall Study|Lost to Follow-up|0|||
154877247|NCT00905307|558975496|FG001|Overall Study|Lost to Follow-up|0|||
154877248|NCT00905307|558975497|FG002|Overall Study|Lost to Follow-up|0|||
154877249|NCT00905307|558975498|FG003|Overall Study|Lost to Follow-up|0|||
154877250|NCT00905307|558975499|FG004|Overall Study|Lost to Follow-up|1|||
154877251|NCT00905307|558975500|FG005|Overall Study|Lost to Follow-up|1|||
154877252|NCT00905307|558975495|FG000|Overall Study|Adverse Event|3|||
154877253|NCT00905307|558975496|FG001|Overall Study|Adverse Event|4|||
154877254|NCT00905307|558975497|FG002|Overall Study|Adverse Event|5|||
154877255|NCT00905307|558975498|FG003|Overall Study|Adverse Event|11|||
154877256|NCT00905307|558975499|FG004|Overall Study|Adverse Event|3|||
154877257|NCT00905307|558975500|FG005|Overall Study|Adverse Event|5|||
154877258|NCT00905307|558975495|FG000|Overall Study|Withdrawal by Subject|5|||
154877259|NCT00905307|558975496|FG001|Overall Study|Withdrawal by Subject|13|||
154877260|NCT00905307|558975497|FG002|Overall Study|Withdrawal by Subject|15|||
155112938|NCT01448824|559844706|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
154877261|NCT00905307|558975498|FG003|Overall Study|Withdrawal by Subject|11|||
154877262|NCT00905307|558975499|FG004|Overall Study|Withdrawal by Subject|4|||
154877263|NCT00905307|558975500|FG005|Overall Study|Withdrawal by Subject|13|||
154877264|NCT00905307|558975495|FG000|Overall Study|Protocol Violation|1|||
154877265|NCT00905307|558975496|FG001|Overall Study|Protocol Violation|0|||
155112939|NCT01448824|559844707|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155112940|NCT01448824|559844708|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155112941|NCT01448824|559844709|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155112942|NCT01448824|559844710|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155112943|NCT01448824|559844711|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
155112944|NCT01448824|559844712|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
155112945|NCT01448824|559844705|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
154877266|NCT00905307|558975497|FG002|Overall Study|Protocol Violation|1|||
154877267|NCT00905307|558975498|FG003|Overall Study|Protocol Violation|0|||
154877268|NCT00905307|558975499|FG004|Overall Study|Protocol Violation|0|||
154877269|NCT00905307|558975500|FG005|Overall Study|Protocol Violation|0|||
154877270|NCT00905307|558975495|FG000|Overall Study|Lack of Efficacy|6|||
154877271|NCT00905307|558975496|FG001|Overall Study|Lack of Efficacy|3|||
154877272|NCT00905307|558975497|FG002|Overall Study|Lack of Efficacy|5|||
154877273|NCT00905307|558975498|FG003|Overall Study|Lack of Efficacy|4|||
154877274|NCT00905307|558975499|FG004|Overall Study|Lack of Efficacy|4|||
154877275|NCT00905307|558975500|FG005|Overall Study|Lack of Efficacy|8|||
154877276|NCT05590793|558975501|FG000|Overall Study|Withdrawal by Subject|6|||
154877277|NCT05590793|558975501|FG000|Overall Study|Physician Decision|1|||
154877278|NCT04060667|558975502|FG000|Overall Study|Lost to Follow-up|75|||
154877279|NCT04060667|558975503|FG001|Overall Study|Lost to Follow-up|10|||
154877280|NCT04488822|558975504|FG000|Overall Study|Adverse Event|8|||
154877281|NCT04488822|558975504|FG000|Overall Study|Withdrawal by Subject|1|||
154877282|NCT03406104|558975505|FG000|Overall Study|Lost to Follow-up|2|||
154877283|NCT03406104|558975505|FG000|Overall Study|Withdrawal by Subject|2|||
154877284|NCT03406104|558975505|FG000|Overall Study|due to Covid patient did not want to travel|1|||
154877285|NCT03406104|558975505|FG000|Overall Study|Death|2|||
154877286|NCT00358917|558975513|FG000|Overall Study|Adverse Event|14|||
154877287|NCT00358917|558975514|FG001|Overall Study|Adverse Event|21|||
154877288|NCT00358917|558975513|FG000|Overall Study|Withdrawal by Subject|5|||
154877289|NCT00358917|558975514|FG001|Overall Study|Withdrawal by Subject|7|||
154877290|NCT00358917|558975513|FG000|Overall Study|Lost to Follow-up|20|||
154877291|NCT00358917|558975514|FG001|Overall Study|Lost to Follow-up|17|||
155112946|NCT01448824|559844706|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155112947|NCT01448824|559844707|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155175344|NCT00910624|560080227|FG001|Treatment Phase|Lost to Follow-up|0|||
155175345|NCT00910624|560080228|FG002|Treatment Phase|Lost to Follow-up|1|||
154877292|NCT00358917|558975513|FG000|Overall Study|Noncompliance|12|||
154877293|NCT00358917|558975514|FG001|Overall Study|Noncompliance|11|||
154877294|NCT00358917|558975513|FG000|Overall Study|Death|2|||
154877295|NCT00358917|558975514|FG001|Overall Study|Death|3|||
154877296|NCT00358917|558975513|FG000|Overall Study|Virologic failure|11|||
154877297|NCT00358917|558975514|FG001|Overall Study|Virologic failure|8|||
154974520|NCT02174276|559331256|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
154877298|NCT00358917|558975513|FG000|Overall Study|Unable to Continue Participation|2|||
154877299|NCT00358917|558975514|FG001|Overall Study|Unable to Continue Participation|2|||
154877300|NCT02890329|558975518|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
154877301|NCT02890329|558975519|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
154877302|NCT02890329|558975520|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
154974521|NCT02174276|559331257|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
155175346|NCT00910624|560080229|FG003|Treatment Phase|Lost to Follow-up|0|||
155112948|NCT01448824|559844708|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
155112949|NCT01448824|559844709|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
155112950|NCT01448824|559844710|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
155112951|NCT01448824|559844711|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155112952|NCT01448824|559844712|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
155112953|NCT01448824|559844705|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112954|NCT01448824|559844706|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112955|NCT01448824|559844707|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112956|NCT01448824|559844708|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112957|NCT01448824|559844709|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112958|NCT01448824|559844710|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
155112959|NCT01448824|559844711|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112960|NCT01448824|559844712|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
155112961|NCT01448824|559844705|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
155112962|NCT01448824|559844706|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
155112963|NCT01448824|559844707|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
155112964|NCT01448824|559844708|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
155112965|NCT01448824|559844709|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
155112966|NCT01448824|559844710|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
155112967|NCT01448824|559844711|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
155112968|NCT01448824|559844712|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
155112969|NCT01448824|559844705|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112970|NCT01448824|559844706|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112971|NCT01448824|559844707|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112972|NCT01448824|559844708|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112973|NCT01448824|559844709|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112974|NCT01448824|559844710|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112975|NCT01448824|559844711|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
155112976|NCT01448824|559844712|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
155112977|NCT01448824|559844705|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112978|NCT01448824|559844706|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112979|NCT01448824|559844707|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112980|NCT01448824|559844708|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112981|NCT01448824|559844709|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112982|NCT01448824|559844710|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112983|NCT01448824|559844711|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
155112984|NCT01448824|559844712|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
155112985|NCT01448824|559844705|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112986|NCT01448824|559844706|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112987|NCT01448824|559844707|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112988|NCT01448824|559844708|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112989|NCT01448824|559844709|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112990|NCT01448824|559844710|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112991|NCT01448824|559844711|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
155112992|NCT01448824|559844712|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
155112993|NCT01448824|559844705|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155112994|NCT01448824|559844706|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155112995|NCT01448824|559844707|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155112996|NCT01448824|559844708|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155112997|NCT01448824|559844709|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155112998|NCT01448824|559844710|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155112999|NCT01448824|559844711|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
155113000|NCT01448824|559844712|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
155113001|NCT01463111|559844713|FG000|Overall Study|Withdrawal by Subject|2|||
154877303|NCT02890329|558975521|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
154877304|NCT02890329|558975522|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
154877305|NCT02890329|558975523|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
154877306|NCT02890329|558975518|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
154877307|NCT02890329|558975519|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
154877308|NCT02890329|558975520|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
155113002|NCT01463111|559844713|FG000|Overall Study|Lost to Follow-up|5|||
155113003|NCT01463111|559844713|FG000|Overall Study|Physician Decision|2|||
155113004|NCT02578680|559844714|FG000|Overall Study|Death|329|||
155113005|NCT02578680|559844715|FG001|Overall Study|Death|181|||
155113006|NCT02578680|559844714|FG000|Overall Study|Lost to Follow-up|3|||
155113007|NCT02578680|559844715|FG001|Overall Study|Lost to Follow-up|1|||
155113008|NCT02578680|559844714|FG000|Overall Study|Physician Decision|0|||
155113009|NCT02578680|559844715|FG001|Overall Study|Physician Decision|1|||
154877309|NCT02890329|558975521|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
154877310|NCT02890329|558975522|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
154877311|NCT02890329|558975523|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
154877312|NCT02890329|558975518|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
154877313|NCT02890329|558975519|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
154877314|NCT02890329|558975520|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
154877315|NCT02890329|558975521|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
154877316|NCT02890329|558975522|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
154877317|NCT02890329|558975523|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
154877318|NCT02890329|558975518|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
154877319|NCT02890329|558975519|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
154877320|NCT02890329|558975520|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
154877321|NCT02890329|558975521|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
154877322|NCT02890329|558975522|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
154877323|NCT02890329|558975523|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
154877324|NCT01035255|558975525|FG000|Overall Study|Death|724|||
154877325|NCT01035255|558975526|FG001|Overall Study|Death|844|||
154877326|NCT01035255|558975525|FG000|Overall Study|Lost to Follow-up|2|||
154877327|NCT01035255|558975526|FG001|Overall Study|Lost to Follow-up|5|||
154877328|NCT01035255|558975525|FG000|Overall Study|patient's request|15|||
154877329|NCT01035255|558975526|FG001|Overall Study|patient's request|13|||
154877330|NCT00231062|558975531|FG000|Overall Study|Physician Decision|6|||
154877331|NCT03321929|558975532|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
154877332|NCT00616239|558975533|FG000|Overall Study|Withdrawal by Subject|2|||
154877333|NCT02873715|558975534|FG000|Overall Study|Lost to Follow-up|84|||
154877334|NCT02873715|558975535|FG001|Overall Study|Lost to Follow-up|94|||
154877335|NCT02873715|558975534|FG000|Overall Study|Withdrawal by Subject|7|||
154877336|NCT02873715|558975535|FG001|Overall Study|Withdrawal by Subject|26|||
154877337|NCT00590681|558975536|FG000|Overall Study|Withdrawal by Subject|7|||
154877338|NCT00590681|558975536|FG000|Overall Study|Adverse Event|8|||
154877339|NCT00590681|558975536|FG000|Overall Study|Death|3|||
154877340|NCT00590681|558975536|FG000|Overall Study|Lost to Follow-up|1|||
154877341|NCT00590681|558975536|FG000|Overall Study|disease progression|1|||
154877342|NCT00933335|558975539|FG000|Overall Study|Lost to Follow-up|1|||
154877343|NCT00933335|558975540|FG001|Overall Study|Lost to Follow-up|3|||
154877344|NCT00933335|558975539|FG000|Overall Study|Withdrawal by Subject|0|||
154877345|NCT00933335|558975540|FG001|Overall Study|Withdrawal by Subject|1|||
154877346|NCT00933335|558975539|FG000|Overall Study|Progressive Disease|0|||
154877347|NCT00933335|558975540|FG001|Overall Study|Progressive Disease|11|||
154877348|NCT00933335|558975539|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
154877349|NCT00933335|558975540|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
154877350|NCT00933335|558975539|FG000|Overall Study|Co-morbid Illness|1|||
154877351|NCT00933335|558975540|FG001|Overall Study|Co-morbid Illness|0|||
154877352|NCT03880227|558975541|FG000|First Visit|Withdrawal by Subject|1|||
154877353|NCT03880227|558975542|FG001|First Visit|Withdrawal by Subject|0|||
154877354|NCT03880227|558975543|FG002|First Visit|Withdrawal by Subject|0|||
154877355|NCT03880227|558975544|FG003|First Visit|Withdrawal by Subject|0|||
154877356|NCT03880227|558975541|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
154877357|NCT03880227|558975542|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
154877358|NCT03880227|558975543|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
154877359|NCT03880227|558975544|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
154877360|NCT03880227|558975541|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
154877361|NCT03880227|558975542|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
154877362|NCT03880227|558975543|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
154877363|NCT03880227|558975544|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
154877364|NCT03880227|558975541|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
154877365|NCT03880227|558975542|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
154877366|NCT03880227|558975543|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
154877367|NCT03880227|558975544|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
154877368|NCT04590937|558975545|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
154877369|NCT01929044|558975546|FG000|Overall Study|Adverse Event|1|||
154877370|NCT01929044|558975547|FG001|Overall Study|Adverse Event|0|||
154877371|NCT01929044|558975546|FG000|Overall Study|Protocol Violation|9|||
154877372|NCT01929044|558975547|FG001|Overall Study|Protocol Violation|14|||
154974522|NCT02174276|559331258|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
154974523|NCT02174276|559331255|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
154974524|NCT02174276|559331256|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
154974525|NCT02174276|559331257|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
155113010|NCT02578680|559844714|FG000|Overall Study|Protocol Violation|1|||
154974526|NCT02174276|559331258|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
155113011|NCT02578680|559844715|FG001|Overall Study|Protocol Violation|1|||
155113012|NCT02578680|559844714|FG000|Overall Study|Sponsor Decision|64|||
155113013|NCT02578680|559844715|FG001|Overall Study|Sponsor Decision|13|||
155113014|NCT02578680|559844714|FG000|Overall Study|Withdrawal by Subject|13|||
155113015|NCT02578680|559844715|FG001|Overall Study|Withdrawal by Subject|9|||
155113016|NCT00218634|559844718|FG000|Overall Study|Lost to Follow-up|8|||
155113017|NCT00218634|559844719|FG001|Overall Study|Lost to Follow-up|15|||
155113018|NCT00734604|559844720|FG000|Overall Study|Adverse Event|0|||
155113019|NCT00734604|559844721|FG001|Overall Study|Adverse Event|2|||
155113020|NCT00734604|559844722|FG002|Overall Study|Adverse Event|0|||
155113021|NCT00734604|559844723|FG003|Overall Study|Adverse Event|2|||
155113022|NCT00734604|559844724|FG004|Overall Study|Adverse Event|1|||
154974527|NCT02174276|559331255|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
154974528|NCT02174276|559331256|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
154974529|NCT02174276|559331257|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
154877373|NCT01929044|558975546|FG000|Overall Study|Not Treated|1|||
154974530|NCT02174276|559331258|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
154974531|NCT02522780|559331259|FG000|Overall Study|Consent withdrawn by subject|5|||
154974532|NCT02522780|559331260|FG001|Overall Study|Consent withdrawn by subject|7|||
154974533|NCT02522780|559331259|FG000|Overall Study|Protocol deviation|1|||
154974534|NCT02522780|559331260|FG001|Overall Study|Protocol deviation|3|||
154974535|NCT02522780|559331259|FG000|Overall Study|Subject refused endoscopic procedure|0|||
154974536|NCT02522780|559331260|FG001|Overall Study|Subject refused endoscopic procedure|1|||
155113023|NCT00734604|559844725|FG005|Overall Study|Adverse Event|1|||
154877374|NCT01929044|558975547|FG001|Overall Study|Not Treated|3|||
154877375|NCT02084134|558975550|FG000|Overall Study|Protocol Violation|4|||
154877376|NCT02084134|558975551|FG001|Overall Study|Protocol Violation|2|||
155113024|NCT00734604|559844720|FG000|Overall Study|Serious Adverse Event|1|||
155113025|NCT00734604|559844721|FG001|Overall Study|Serious Adverse Event|0|||
155113026|NCT00734604|559844722|FG002|Overall Study|Serious Adverse Event|1|||
155113027|NCT00734604|559844723|FG003|Overall Study|Serious Adverse Event|2|||
155113028|NCT00734604|559844724|FG004|Overall Study|Serious Adverse Event|0|||
155113029|NCT00734604|559844725|FG005|Overall Study|Serious Adverse Event|1|||
155113030|NCT00734604|559844720|FG000|Overall Study|Lost to Follow-up|1|||
155113031|NCT00734604|559844721|FG001|Overall Study|Lost to Follow-up|2|||
155113032|NCT00734604|559844722|FG002|Overall Study|Lost to Follow-up|2|||
155113033|NCT00734604|559844723|FG003|Overall Study|Lost to Follow-up|4|||
155113034|NCT00734604|559844724|FG004|Overall Study|Lost to Follow-up|2|||
155113035|NCT00734604|559844725|FG005|Overall Study|Lost to Follow-up|3|||
155113036|NCT00734604|559844720|FG000|Overall Study|Physician Decision|0|||
155113037|NCT00734604|559844721|FG001|Overall Study|Physician Decision|1|||
155113038|NCT00734604|559844722|FG002|Overall Study|Physician Decision|1|||
155113039|NCT00734604|559844723|FG003|Overall Study|Physician Decision|0|||
155113040|NCT00734604|559844724|FG004|Overall Study|Physician Decision|0|||
155113041|NCT00734604|559844725|FG005|Overall Study|Physician Decision|0|||
155113042|NCT00734604|559844720|FG000|Overall Study|Protocol Violation|0|||
154877377|NCT02084134|558975550|FG000|Overall Study|Death|0|||
154877378|NCT02084134|558975551|FG001|Overall Study|Death|1|||
154877379|NCT04333433|558975552|FG000|Overall Study|Withdrawal by Subject|6|||
154877380|NCT04333433|558975553|FG001|Overall Study|Withdrawal by Subject|3|||
154877381|NCT04333433|558975552|FG000|Overall Study|Death|3|||
154877382|NCT04333433|558975553|FG001|Overall Study|Death|0|||
154877383|NCT04333433|558975552|FG000|Overall Study|Lost to Follow-up|6|||
154877384|NCT04333433|558975553|FG001|Overall Study|Lost to Follow-up|1|||
155113043|NCT00734604|559844721|FG001|Overall Study|Protocol Violation|2|||
155113044|NCT00734604|559844722|FG002|Overall Study|Protocol Violation|0|||
155113045|NCT00734604|559844723|FG003|Overall Study|Protocol Violation|0|||
155113046|NCT00734604|559844724|FG004|Overall Study|Protocol Violation|1|||
155113047|NCT00734604|559844725|FG005|Overall Study|Protocol Violation|0|||
155113048|NCT00734604|559844720|FG000|Overall Study|Sponsor Decision|1|||
155113049|NCT00734604|559844721|FG001|Overall Study|Sponsor Decision|2|||
155113050|NCT00734604|559844722|FG002|Overall Study|Sponsor Decision|1|||
155113051|NCT00734604|559844723|FG003|Overall Study|Sponsor Decision|0|||
155113052|NCT00734604|559844724|FG004|Overall Study|Sponsor Decision|2|||
155113053|NCT00734604|559844725|FG005|Overall Study|Sponsor Decision|0|||
155113054|NCT00734604|559844720|FG000|Overall Study|Withdrawal by Subject|0|||
155113055|NCT00734604|559844721|FG001|Overall Study|Withdrawal by Subject|2|||
155113056|NCT00734604|559844722|FG002|Overall Study|Withdrawal by Subject|0|||
155113057|NCT00734604|559844723|FG003|Overall Study|Withdrawal by Subject|1|||
154877385|NCT04333433|558975552|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
154877386|NCT04333433|558975553|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
154974537|NCT02522780|559331259|FG000|Overall Study|Adverse event, non-fatal|11|||
154974538|NCT02522780|559331260|FG001|Overall Study|Adverse event, non-fatal|16|||
155113058|NCT00734604|559844724|FG004|Overall Study|Withdrawal by Subject|2|||
155113059|NCT00734604|559844725|FG005|Overall Study|Withdrawal by Subject|1|||
155113060|NCT00734604|559844720|FG000|Overall Study|Lack of Efficacy|0|||
154877387|NCT02026271|558975554|FG000|Overall Study|Adverse Event|2|||
154877388|NCT02026271|558975555|FG001|Overall Study|Adverse Event|3|||
154877389|NCT02026271|558975556|FG002|Overall Study|Adverse Event|2|||
154877390|NCT02026271|558975557|FG003|Overall Study|Adverse Event|3|||
154877391|NCT02026271|558975558|FG004|Overall Study|Adverse Event|0|||
154877392|NCT02026271|558975554|FG000|Overall Study|Withdrawal by Subject|0|||
154877393|NCT02026271|558975555|FG001|Overall Study|Withdrawal by Subject|0|||
154877394|NCT02026271|558975556|FG002|Overall Study|Withdrawal by Subject|0|||
154877395|NCT02026271|558975557|FG003|Overall Study|Withdrawal by Subject|0|||
154877396|NCT02026271|558975558|FG004|Overall Study|Withdrawal by Subject|1|||
154877397|NCT00878072|558975559|FG000|Overall Study|Withdrew consent|2|||
154877398|NCT03288779|558975560|FG000|Overall Study|Withdrawal by Subject|3|||
154877399|NCT00237796|558975561|FG000|Overall Study|Baseline and one other ILSS required|10|||
154877400|NCT00237796|558975562|FG001|Overall Study|Baseline and one other ILSS required|5|||
154877401|NCT00968253|558975563|FG000|Overall Study|Death|0|||
154877402|NCT00968253|558975564|FG001|Overall Study|Death|0|||
154877403|NCT00968253|558975565|FG002|Overall Study|Death|2|||
154877404|NCT00968253|558975563|FG000|Overall Study|Withdrawal by Subject|0|||
154877405|NCT00968253|558975564|FG001|Overall Study|Withdrawal by Subject|0|||
154877406|NCT00968253|558975565|FG002|Overall Study|Withdrawal by Subject|1|||
154877407|NCT00968253|558975563|FG000|Overall Study|Disease Progression|0|||
154877408|NCT00968253|558975564|FG001|Overall Study|Disease Progression|3|||
154877409|NCT00968253|558975565|FG002|Overall Study|Disease Progression|3|||
154877410|NCT00968253|558975563|FG000|Overall Study|Adverse Event|0|||
154877411|NCT00968253|558975564|FG001|Overall Study|Adverse Event|0|||
154877412|NCT00968253|558975565|FG002|Overall Study|Adverse Event|1|||
154877413|NCT01721408|558975566|FG000|Overall Study|Adverse Event|6|||
154877414|NCT01721408|558975567|FG001|Overall Study|Adverse Event|1|||
154877415|NCT01721408|558975566|FG000|Overall Study|Death|1|||
154877416|NCT01721408|558975567|FG001|Overall Study|Death|0|||
154877417|NCT01721408|558975566|FG000|Overall Study|Insufficient clinical response|15|||
154877418|NCT01721408|558975567|FG001|Overall Study|Insufficient clinical response|6|||
154877419|NCT01721408|558975566|FG000|Overall Study|No longer willing to participate study|9|||
154877420|NCT01721408|558975567|FG001|Overall Study|No longer willing to participate study|10|||
154877421|NCT01721408|558975566|FG000|Overall Study|Protocol Violation|0|||
154877422|NCT01721408|558975567|FG001|Overall Study|Protocol Violation|2|||
154877423|NCT01721408|558975566|FG000|Overall Study|Other|3|||
154877424|NCT01721408|558975567|FG001|Overall Study|Other|3|||
154877425|NCT01721408|558975566|FG000|Overall Study|Lost to Follow-up|1|||
154877426|NCT01721408|558975567|FG001|Overall Study|Lost to Follow-up|2|||
154877427|NCT01721408|558975566|FG000|Overall Study|Does not meet entrance criteria|1|||
154877428|NCT01721408|558975567|FG001|Overall Study|Does not meet entrance criteria|0|||
154877429|NCT04160468|558975570|FG000|Overall Study|Lost to Follow-up|19|||
154877430|NCT04160468|558975571|FG001|Overall Study|Lost to Follow-up|4|||
154877431|NCT04160468|558975570|FG000|Overall Study|Randomized but not dosed|6|||
154877432|NCT04160468|558975571|FG001|Overall Study|Randomized but not dosed|0|||
154877433|NCT04160468|558975570|FG000|Overall Study|Withdrawal by Subject|4|||
154877434|NCT04160468|558975571|FG001|Overall Study|Withdrawal by Subject|1|||
154877435|NCT04160468|558975570|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
154877436|NCT04160468|558975571|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
155113061|NCT00734604|559844721|FG001|Overall Study|Lack of Efficacy|1|||
155113062|NCT00734604|559844722|FG002|Overall Study|Lack of Efficacy|1|||
155113063|NCT00734604|559844723|FG003|Overall Study|Lack of Efficacy|0|||
155113064|NCT00734604|559844724|FG004|Overall Study|Lack of Efficacy|0|||
155113065|NCT00734604|559844725|FG005|Overall Study|Lack of Efficacy|0|||
155113066|NCT02589665|559844726|FG000|Induction Period|Did not receive drug|0|||
155113067|NCT02589665|559844727|FG001|Induction Period|Did not receive drug|0|||
155113068|NCT02589665|559844728|FG002|Induction Period|Did not receive drug|0|||
155113069|NCT02589665|559844729|FG003|Induction Period|Did not receive drug|1|||
155113070|NCT02589665|559844730|FG004|Induction Period|Did not receive drug|0|||
155113071|NCT02589665|559844731|FG005|Induction Period|Did not receive drug|0|||
155113072|NCT02589665|559844732|FG006|Induction Period|Did not receive drug|0|||
155113073|NCT02589665|559844733|FG007|Induction Period|Did not receive drug|0|||
154877437|NCT04160468|558975570|FG000|Overall Study|Participant incarcerated|1|||
154877438|NCT04160468|558975571|FG001|Overall Study|Participant incarcerated|0|||
154877439|NCT01187901|558975572|FG000|Overall Study|Protocol Violation|1|||
154877440|NCT01187901|558975573|FG001|Overall Study|Protocol Violation|0|||
154877441|NCT01187901|558975572|FG000|Overall Study|Lost to Follow-up|1|||
155113074|NCT02589665|559844734|FG008|Induction Period|Did not receive drug|0|||
155113075|NCT02589665|559844735|FG009|Induction Period|Did not receive drug|0|||
154877442|NCT01187901|558975573|FG001|Overall Study|Lost to Follow-up|2|||
154877443|NCT01187901|558975572|FG000|Overall Study|Unrelated Health Reasons|1|||
154877444|NCT01187901|558975573|FG001|Overall Study|Unrelated Health Reasons|2|||
154877445|NCT01187901|558975572|FG000|Overall Study|Suspected Allergic Reaction|1|||
154877446|NCT01187901|558975573|FG001|Overall Study|Suspected Allergic Reaction|1|||
154877447|NCT01187901|558975572|FG000|Overall Study|Adverse Event|3|||
154877448|NCT01187901|558975573|FG001|Overall Study|Adverse Event|0|||
154877449|NCT01187901|558975572|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
154974539|NCT04106817|559331261|FG000|Overall Study|Lost to Follow-up|1|||
154877450|NCT01187901|558975573|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
154877451|NCT01187901|558975572|FG000|Overall Study|Pregnancy|0|||
154877452|NCT01187901|558975573|FG001|Overall Study|Pregnancy|2|||
154877453|NCT03987620|558975574|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
154877454|NCT03987620|558975575|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
154877455|NCT03987620|558975574|FG000|Overall Study|Adverse Event|3|||
154877456|NCT03987620|558975575|FG001|Overall Study|Adverse Event|0|||
154877457|NCT03987620|558975574|FG000|Overall Study|Lost to Follow-up|1|||
154877458|NCT03987620|558975575|FG001|Overall Study|Lost to Follow-up|2|||
155113076|NCT02589665|559844726|FG000|Induction Period|Adverse Event|3|||
155113077|NCT02589665|559844727|FG001|Induction Period|Adverse Event|0|||
155113078|NCT02589665|559844728|FG002|Induction Period|Adverse Event|2|||
155113079|NCT02589665|559844729|FG003|Induction Period|Adverse Event|2|||
155113080|NCT02589665|559844730|FG004|Induction Period|Adverse Event|0|||
155113081|NCT02589665|559844731|FG005|Induction Period|Adverse Event|0|||
155113082|NCT02589665|559844732|FG006|Induction Period|Adverse Event|0|||
155113083|NCT02589665|559844733|FG007|Induction Period|Adverse Event|0|||
155113084|NCT02589665|559844734|FG008|Induction Period|Adverse Event|0|||
155113085|NCT02589665|559844735|FG009|Induction Period|Adverse Event|0|||
155113086|NCT02589665|559844726|FG000|Induction Period|Withdrawal by Subject|0|||
155113087|NCT02589665|559844727|FG001|Induction Period|Withdrawal by Subject|1|||
155113088|NCT02589665|559844728|FG002|Induction Period|Withdrawal by Subject|0|||
155113089|NCT02589665|559844729|FG003|Induction Period|Withdrawal by Subject|1|||
155113090|NCT02589665|559844730|FG004|Induction Period|Withdrawal by Subject|0|||
155113091|NCT02589665|559844731|FG005|Induction Period|Withdrawal by Subject|0|||
155113092|NCT02589665|559844732|FG006|Induction Period|Withdrawal by Subject|0|||
155113093|NCT02589665|559844733|FG007|Induction Period|Withdrawal by Subject|0|||
155113094|NCT02589665|559844734|FG008|Induction Period|Withdrawal by Subject|0|||
155113095|NCT02589665|559844735|FG009|Induction Period|Withdrawal by Subject|0|||
155113096|NCT02589665|559844726|FG000|Induction Period|Protocol Violation|0|||
155113097|NCT02589665|559844727|FG001|Induction Period|Protocol Violation|1|||
155113098|NCT02589665|559844728|FG002|Induction Period|Protocol Violation|0|||
155113099|NCT02589665|559844729|FG003|Induction Period|Protocol Violation|0|||
155113100|NCT02589665|559844730|FG004|Induction Period|Protocol Violation|0|||
155113101|NCT02589665|559844731|FG005|Induction Period|Protocol Violation|0|||
155113102|NCT02589665|559844732|FG006|Induction Period|Protocol Violation|0|||
155113103|NCT02589665|559844733|FG007|Induction Period|Protocol Violation|0|||
155113104|NCT02589665|559844734|FG008|Induction Period|Protocol Violation|0|||
155113105|NCT02589665|559844735|FG009|Induction Period|Protocol Violation|0|||
155113106|NCT02589665|559844726|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113107|NCT02589665|559844727|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113108|NCT02589665|559844728|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113109|NCT02589665|559844729|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113110|NCT02589665|559844730|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
155113111|NCT02589665|559844731|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
154877459|NCT03987620|558975574|FG000|Overall Study|Physician Decision|0|||
154877460|NCT03987620|558975575|FG001|Overall Study|Physician Decision|1|||
154877461|NCT03987620|558975574|FG000|Overall Study|Pregnancy|1|||
154877462|NCT03987620|558975575|FG001|Overall Study|Pregnancy|0|||
154877463|NCT03987620|558975574|FG000|Overall Study|Withdrawal by Subject|7|||
154877464|NCT03987620|558975575|FG001|Overall Study|Withdrawal by Subject|1|||
154877465|NCT03987620|558975574|FG000|Overall Study|Other|2|||
154877466|NCT03987620|558975575|FG001|Overall Study|Other|5|||
154877467|NCT02149836|558975576|FG000|Overall Study|Withdrawal by Subject|1|||
154877468|NCT00370149|558975583|FG000|Overall Study|Physician Decision|16|||
154877469|NCT00370149|558975584|FG001|Overall Study|Physician Decision|16|||
154877470|NCT00370149|558975583|FG000|Overall Study|Protocol Violation|1|||
154877471|NCT00370149|558975584|FG001|Overall Study|Protocol Violation|0|||
154877472|NCT00370149|558975583|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
154877473|NCT00370149|558975584|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
154877474|NCT00370149|558975583|FG000|Overall Study|Pre-existing infection|0|||
154877475|NCT00370149|558975584|FG001|Overall Study|Pre-existing infection|1|||
155113112|NCT02589665|559844732|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
155113113|NCT02589665|559844733|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
154877476|NCT00370149|558975583|FG000|Overall Study|Antibiotic coated dressing placed|0|||
154877477|NCT00370149|558975584|FG001|Overall Study|Antibiotic coated dressing placed|1|||
155113114|NCT02589665|559844734|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113115|NCT02589665|559844735|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155175347|NCT00910624|560080226|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
154877478|NCT01043185|558977157|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
154877479|NCT01043185|558977158|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
154877480|NCT01043185|558977159|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
154974540|NCT04106817|559331262|FG001|Overall Study|Lost to Follow-up|0|||
155113116|NCT02589665|559844726|FG000|Maintenance Period|Withdrawal by Subject|0|||
154877481|NCT01043185|558977160|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
154877482|NCT01043185|558977161|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
154877483|NCT01043185|558977162|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
154877484|NCT01043185|558977163|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
154877485|NCT01043185|558977164|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
154877486|NCT01043185|558977165|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
154877487|NCT01043185|558977166|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
154877488|NCT03488472|558977167|FG000|Overall Study|disease progression additional mets|1|||
154877489|NCT00028002|558977168|FG000|Overall Study|Withdrawal by Subject|3|||
154877490|NCT00028002|558977168|FG000|Overall Study|Ineligible|8|||
154877491|NCT02750800|558977175|FG000|Overall Study|Adverse Event|18|||
154877492|NCT02750800|558977175|FG000|Overall Study|Lost to Follow-up|12|||
154877493|NCT02750800|558977175|FG000|Overall Study|Investigator decision|53|||
154877494|NCT02750800|558977175|FG000|Overall Study|Patient request|12|||
154877495|NCT02750800|558977175|FG000|Overall Study|Other, not specified|3|||
154877496|NCT03430245|558977193|FG000|Overall Study|Withdrawal by Subject|6|||
154877497|NCT03430245|558977193|FG000|Overall Study|Lost to Follow-up|1|||
154877498|NCT05628181|558977194|FG000|Overall Study|Death|2|||
154877499|NCT05628181|558977195|FG001|Overall Study|Death|4|||
154877500|NCT05628181|558977196|FG002|Overall Study|Death|0|||
154877501|NCT04742907|558977203|FG000|Overall Study|Adverse Event|1|||
154877502|NCT04742907|558977204|FG001|Overall Study|Adverse Event|0|||
154877503|NCT04742907|558977205|FG002|Overall Study|Adverse Event|1|||
154877504|NCT04742907|558977203|FG000|Overall Study|Lost to Follow-up|3|||
154877505|NCT04742907|558977204|FG001|Overall Study|Lost to Follow-up|3|||
154877506|NCT04742907|558977205|FG002|Overall Study|Lost to Follow-up|2|||
154877507|NCT04742907|558977203|FG000|Overall Study|Physician Decision|0|||
154877508|NCT04742907|558977204|FG001|Overall Study|Physician Decision|1|||
154877509|NCT04742907|558977205|FG002|Overall Study|Physician Decision|0|||
154877510|NCT04742907|558977203|FG000|Overall Study|Protocol Violation|1|||
154877511|NCT04742907|558977204|FG001|Overall Study|Protocol Violation|1|||
154877512|NCT04742907|558977205|FG002|Overall Study|Protocol Violation|1|||
154877513|NCT04742907|558977203|FG000|Overall Study|Withdrawal by Subject|5|||
154877514|NCT04742907|558977204|FG001|Overall Study|Withdrawal by Subject|6|||
154877515|NCT04742907|558977205|FG002|Overall Study|Withdrawal by Subject|4|||
154877516|NCT04742907|558977203|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
154877517|NCT04742907|558977204|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
154877518|NCT04742907|558977205|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
154877519|NCT04742907|558977203|FG000|Overall Study|Did Not Receive the Study Drug|2|||
154877520|NCT04742907|558977204|FG001|Overall Study|Did Not Receive the Study Drug|4|||
154877521|NCT04742907|558977205|FG002|Overall Study|Did Not Receive the Study Drug|4|||
154877522|NCT01428063|558977206|FG000|Overall Study|Lack of Efficacy|8|||
154877523|NCT01428063|558977207|FG001|Overall Study|Lack of Efficacy|4|||
154877524|NCT01428063|558977208|FG002|Overall Study|Lack of Efficacy|1|||
154877525|NCT01428063|558977206|FG000|Overall Study|Adverse Event|2|||
154877526|NCT01428063|558977207|FG001|Overall Study|Adverse Event|3|||
154877527|NCT01428063|558977208|FG002|Overall Study|Adverse Event|0|||
154877528|NCT01428063|558977206|FG000|Overall Study|Lost to Follow-up|0|||
154877529|NCT01428063|558977207|FG001|Overall Study|Lost to Follow-up|2|||
154877530|NCT01428063|558977208|FG002|Overall Study|Lost to Follow-up|0|||
154877531|NCT01428063|558977206|FG000|Overall Study|No longer meets study criteria|0|||
154877532|NCT01428063|558977207|FG001|Overall Study|No longer meets study criteria|1|||
154877533|NCT01428063|558977208|FG002|Overall Study|No longer meets study criteria|0|||
154877534|NCT05761444|558977209|FG000|Overall Study|Protocol Violation|2|||
154877535|NCT05761444|558977210|FG001|Overall Study|Protocol Violation|1|||
154877536|NCT05761444|558977209|FG000|Overall Study|Adverse Event|2|||
154877537|NCT05761444|558977210|FG001|Overall Study|Adverse Event|2|||
154877538|NCT05761444|558977209|FG000|Overall Study|Withdrawal by Subject|3|||
154877539|NCT05761444|558977210|FG001|Overall Study|Withdrawal by Subject|2|||
154877540|NCT05761444|558977209|FG000|Overall Study|Other|1|||
155113117|NCT02589665|559844727|FG001|Maintenance Period|Withdrawal by Subject|0|||
155113118|NCT02589665|559844728|FG002|Maintenance Period|Withdrawal by Subject|0|||
155113119|NCT02589665|559844729|FG003|Maintenance Period|Withdrawal by Subject|0|||
155113120|NCT02589665|559844730|FG004|Maintenance Period|Withdrawal by Subject|4|||
155113121|NCT02589665|559844731|FG005|Maintenance Period|Withdrawal by Subject|2|||
155113122|NCT02589665|559844732|FG006|Maintenance Period|Withdrawal by Subject|4|||
155113123|NCT02589665|559844733|FG007|Maintenance Period|Withdrawal by Subject|0|||
154877541|NCT05761444|558977210|FG001|Overall Study|Other|0|||
154877542|NCT03508622|558977211|FG000|Overall Study|Protocol Violation|1|||
154877543|NCT03508622|558977212|FG001|Overall Study|Protocol Violation|0|||
154877544|NCT03508622|558977211|FG000|Overall Study|Withdrawal by Subject|1|||
154877545|NCT03508622|558977212|FG001|Overall Study|Withdrawal by Subject|0|||
154877546|NCT03508622|558977211|FG000|Overall Study|Lost to Follow-up|16|||
154877547|NCT03508622|558977212|FG001|Overall Study|Lost to Follow-up|0|||
154877548|NCT03508622|558977211|FG000|Overall Study|Incomplete data|0|||
155113124|NCT02589665|559844734|FG008|Maintenance Period|Withdrawal by Subject|0|||
154877549|NCT03508622|558977212|FG001|Overall Study|Incomplete data|24|||
154877550|NCT03196505|558977215|FG000|Overall Study|Physician Decision|26|||
154877551|NCT03196505|558977216|FG001|Overall Study|Physician Decision|26|||
154877552|NCT01005719|558977217|FG000|Period 1|Adverse Event|0|||
154877553|NCT01005719|558977218|FG001|Period 1|Adverse Event|0|||
154877554|NCT01005719|558977219|FG002|Period 1|Adverse Event|0|||
154877555|NCT01005719|558977220|FG003|Period 1|Adverse Event|1|||
154877556|NCT01005719|558977221|FG004|Period 1|Adverse Event|0|||
154877557|NCT01005719|558977222|FG005|Period 1|Adverse Event|0|||
154877558|NCT01005719|558977217|FG000|Period 1|Delay in completing study procedures|0|||
154877559|NCT01005719|558977218|FG001|Period 1|Delay in completing study procedures|0|||
154877560|NCT01005719|558977219|FG002|Period 1|Delay in completing study procedures|0|||
154877561|NCT01005719|558977220|FG003|Period 1|Delay in completing study procedures|0|||
154877562|NCT01005719|558977221|FG004|Period 1|Delay in completing study procedures|0|||
154877563|NCT01005719|558977222|FG005|Period 1|Delay in completing study procedures|1|||
154877564|NCT01005719|558977217|FG000|Period 2|Adverse Event|0|||
154877565|NCT01005719|558977218|FG001|Period 2|Adverse Event|0|||
154877566|NCT01005719|558977219|FG002|Period 2|Adverse Event|0|||
154877567|NCT01005719|558977220|FG003|Period 2|Adverse Event|0|||
154877568|NCT01005719|558977221|FG004|Period 2|Adverse Event|1|||
154877569|NCT01005719|558977222|FG005|Period 2|Adverse Event|1|||
154877570|NCT01753076|558977223|FG000|Overall Study|Adverse Event|17|||
154877571|NCT01753076|558977224|FG001|Overall Study|Adverse Event|18|||
154877572|NCT01753076|558977223|FG000|Overall Study|Lack of Efficacy|3|||
154877573|NCT01753076|558977224|FG001|Overall Study|Lack of Efficacy|1|||
154877574|NCT01753076|558977223|FG000|Overall Study|Lost to Follow-up|2|||
154877575|NCT01753076|558977224|FG001|Overall Study|Lost to Follow-up|1|||
154877576|NCT01753076|558977223|FG000|Overall Study|Physician Decision|4|||
154877577|NCT01753076|558977224|FG001|Overall Study|Physician Decision|2|||
154877578|NCT01753076|558977223|FG000|Overall Study|Withdrawal by Subject|14|||
154877579|NCT01753076|558977224|FG001|Overall Study|Withdrawal by Subject|24|||
154877580|NCT01753076|558977223|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
154877581|NCT01753076|558977224|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
154877582|NCT02575079|558977225|FG000|Overall Study|Death|3|||
154877583|NCT02575079|558977226|FG001|Overall Study|Death|0|||
154877584|NCT02575079|558977225|FG000|Overall Study|Withdrawal by Subject|3|||
154877585|NCT02575079|558977226|FG001|Overall Study|Withdrawal by Subject|0|||
154877586|NCT01259856|558977227|FG000|Overall Study|Adverse Event|12|||
154877587|NCT01259856|558977228|FG001|Overall Study|Adverse Event|9|||
154877588|NCT01259856|558977227|FG000|Overall Study|Death|0|||
154877589|NCT01259856|558977228|FG001|Overall Study|Death|1|||
154877590|NCT01259856|558977227|FG000|Overall Study|Lack of Efficacy|3|||
154877591|NCT01259856|558977228|FG001|Overall Study|Lack of Efficacy|1|||
154877592|NCT01259856|558977227|FG000|Overall Study|Lost to Follow-up|1|||
154877593|NCT01259856|558977228|FG001|Overall Study|Lost to Follow-up|1|||
154877594|NCT01259856|558977227|FG000|Overall Study|Physician Decision|2|||
154877595|NCT01259856|558977228|FG001|Overall Study|Physician Decision|1|||
154877596|NCT01259856|558977227|FG000|Overall Study|Withdrawal by Subject|9|||
154877597|NCT01259856|558977228|FG001|Overall Study|Withdrawal by Subject|10|||
154877598|NCT01259856|558977227|FG000|Overall Study|Treatment never started|0|||
154877599|NCT01259856|558977228|FG001|Overall Study|Treatment never started|6|||
154877600|NCT01259856|558977227|FG000|Overall Study|Study closure by sponsor|40|||
154877601|NCT01259856|558977228|FG001|Overall Study|Study closure by sponsor|41|||
154877602|NCT01259856|558977227|FG000|Overall Study|Patient developed other disease|0|||
154877603|NCT01259856|558977228|FG001|Overall Study|Patient developed other disease|1|||
154877604|NCT01259856|558977227|FG000|Overall Study|Transfer to another study|0|||
154877605|NCT01259856|558977228|FG001|Overall Study|Transfer to another study|1|||
154877606|NCT01259856|558977227|FG000|Overall Study|Unknown/missing|2|||
154877607|NCT01259856|558977228|FG001|Overall Study|Unknown/missing|2|||
154877608|NCT00788775|558977231|FG000|Overall Study|Progressive Disease|8|||
154877609|NCT00788775|558977232|FG001|Overall Study|Progressive Disease|6|||
154877610|NCT00788775|558977231|FG000|Overall Study|Withdrawal by Subject|0|||
154877611|NCT00788775|558977232|FG001|Overall Study|Withdrawal by Subject|2|||
154877612|NCT00788775|558977231|FG000|Overall Study|Patient Non-Compliance|1|||
154877613|NCT00788775|558977232|FG001|Overall Study|Patient Non-Compliance|0|||
154877614|NCT00788775|558977231|FG000|Overall Study|Patient's measurable disease resected.|1|||
154877615|NCT00788775|558977232|FG001|Overall Study|Patient's measurable disease resected.|0|||
154877616|NCT01757704|558977235|FG000|Overall Study|Protocol Violation|1|||
154877617|NCT01757704|558977236|FG001|Overall Study|Protocol Violation|3|||
154877618|NCT00938327|558977237|FG000|Overall Study|Adverse Event|2|||
154877619|NCT00938327|558977237|FG000|Overall Study|Protocol Violation|1|||
154877620|NCT00938327|558977237|FG000|Overall Study|Withdrawal by Subject|4|||
154877621|NCT00938327|558977237|FG000|Overall Study|Lost to Follow-up|37|||
154877622|NCT00938327|558977237|FG000|Overall Study|2nd dose received outside of the study|7|||
154877623|NCT00938327|558977237|FG000|Overall Study|Vaccine not received as out of stock|9|||
154877624|NCT00803244|558977240|FG000|Overall Study|Adverse Event|1|||
154877625|NCT00803244|558977241|FG001|Overall Study|Adverse Event|2|||
154877626|NCT00803244|558977240|FG000|Overall Study|Withdrawal by Subject|2|||
154877627|NCT00803244|558977241|FG001|Overall Study|Withdrawal by Subject|3|||
154877628|NCT00803244|558977240|FG000|Overall Study|Any other reason not above-mentioned|4|||
154877629|NCT00803244|558977241|FG001|Overall Study|Any other reason not above-mentioned|10|||
154877630|NCT00443430|558977250|FG000|Overall Study|Lack of Efficacy|3|||
154877631|NCT00443430|558977251|FG001|Overall Study|Lack of Efficacy|3|||
154877632|NCT00443430|558977250|FG000|Overall Study|Adverse Event|1|||
154877633|NCT00443430|558977251|FG001|Overall Study|Adverse Event|1|||
154877634|NCT01635933|558977252|FG000|Overall Study|Adverse Event|1|||
154877635|NCT01635933|558977253|FG001|Overall Study|Adverse Event|0|||
154877636|NCT01635933|558977252|FG000|Overall Study|Lost to Follow-up|0|||
154877637|NCT01635933|558977253|FG001|Overall Study|Lost to Follow-up|5|||
154877638|NCT01635933|558977252|FG000|Overall Study|Subject decision|1|||
154877639|NCT01635933|558977253|FG001|Overall Study|Subject decision|1|||
154877640|NCT01635933|558977252|FG000|Overall Study|Noncompliance|0|||
154877641|NCT01635933|558977253|FG001|Overall Study|Noncompliance|1|||
154877642|NCT01635933|558977252|FG000|Overall Study|No longer had transportation|0|||
154877643|NCT01635933|558977253|FG001|Overall Study|No longer had transportation|1|||
154877644|NCT01544595|558977254|FG000|Status at Week 68|Adverse Event|3|||
154877645|NCT01544595|558977255|FG001|Status at Week 68|Adverse Event|2|||
154877646|NCT01544595|558977256|FG002|Status at Week 68|Adverse Event|1|||
154877647|NCT01544595|558977257|FG003|Status at Week 68|Adverse Event|0|||
154877648|NCT01544595|558977258|FG004|Status at Week 68|Adverse Event|0|||
154877649|NCT01544595|558977259|FG005|Status at Week 68|Adverse Event|0|||
154877650|NCT01544595|558977254|FG000|Status at Week 68|Lack of Efficacy|1|||
154877651|NCT01544595|558977255|FG001|Status at Week 68|Lack of Efficacy|0|||
154877652|NCT01544595|558977256|FG002|Status at Week 68|Lack of Efficacy|0|||
154877653|NCT01544595|558977257|FG003|Status at Week 68|Lack of Efficacy|0|||
154877654|NCT01544595|558977258|FG004|Status at Week 68|Lack of Efficacy|0|||
154877655|NCT01544595|558977259|FG005|Status at Week 68|Lack of Efficacy|0|||
154877656|NCT01544595|558977254|FG000|Status at Week 68|Lost to Follow-up|1|||
154877657|NCT01544595|558977255|FG001|Status at Week 68|Lost to Follow-up|1|||
154877658|NCT01544595|558977256|FG002|Status at Week 68|Lost to Follow-up|0|||
154877659|NCT01544595|558977257|FG003|Status at Week 68|Lost to Follow-up|0|||
154877660|NCT01544595|558977258|FG004|Status at Week 68|Lost to Follow-up|0|||
154877661|NCT01544595|558977259|FG005|Status at Week 68|Lost to Follow-up|0|||
154877662|NCT01544595|558977254|FG000|Status at Week 68|Non-compliance with study treatment|1|||
154877663|NCT01544595|558977255|FG001|Status at Week 68|Non-compliance with study treatment|0|||
154877664|NCT01544595|558977256|FG002|Status at Week 68|Non-compliance with study treatment|0|||
154877665|NCT01544595|558977257|FG003|Status at Week 68|Non-compliance with study treatment|1|||
154877666|NCT01544595|558977258|FG004|Status at Week 68|Non-compliance with study treatment|0|||
154877667|NCT01544595|558977259|FG005|Status at Week 68|Non-compliance with study treatment|0|||
154877668|NCT01544595|558977254|FG000|Status at Week 68|Protocol Violation|2|||
154877669|NCT01544595|558977255|FG001|Status at Week 68|Protocol Violation|0|||
154877670|NCT01544595|558977256|FG002|Status at Week 68|Protocol Violation|1|||
154877671|NCT01544595|558977257|FG003|Status at Week 68|Protocol Violation|1|||
154877672|NCT01544595|558977258|FG004|Status at Week 68|Protocol Violation|0|||
154877673|NCT01544595|558977259|FG005|Status at Week 68|Protocol Violation|0|||
154877674|NCT01544595|558977254|FG000|Status at Week 68|Technical problems|1|||
154877675|NCT01544595|558977255|FG001|Status at Week 68|Technical problems|0|||
154877676|NCT01544595|558977256|FG002|Status at Week 68|Technical problems|0|||
154877677|NCT01544595|558977257|FG003|Status at Week 68|Technical problems|1|||
154877678|NCT01544595|558977258|FG004|Status at Week 68|Technical problems|0|||
154877679|NCT01544595|558977259|FG005|Status at Week 68|Technical problems|0|||
154877680|NCT01544595|558977254|FG000|Status at Week 68|Withdrawal by Subject|0|||
154877681|NCT01544595|558977255|FG001|Status at Week 68|Withdrawal by Subject|1|||
154877682|NCT01544595|558977256|FG002|Status at Week 68|Withdrawal by Subject|1|||
154877683|NCT01544595|558977257|FG003|Status at Week 68|Withdrawal by Subject|2|||
154877684|NCT01544595|558977258|FG004|Status at Week 68|Withdrawal by Subject|0|||
154974541|NCT04106817|559331263|FG002|Overall Study|Lost to Follow-up|0|||
155113125|NCT02589665|559844735|FG009|Maintenance Period|Withdrawal by Subject|0|||
155113126|NCT02589665|559844726|FG000|Maintenance Period|Lack of Efficacy|0|||
154877685|NCT01544595|558977259|FG005|Status at Week 68|Withdrawal by Subject|0|||
154877686|NCT01544595|558977254|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
154877687|NCT01544595|558977255|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
154877688|NCT01544595|558977256|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
154877689|NCT01544595|558977257|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
154877690|NCT01544595|558977258|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
154877691|NCT01544595|558977259|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
154877692|NCT01544595|558977254|FG000|Status at Week 156|Withdrawal by Subject|9|||
154877693|NCT01544595|558977255|FG001|Status at Week 156|Withdrawal by Subject|10|||
154877694|NCT01544595|558977256|FG002|Status at Week 156|Withdrawal by Subject|4|||
154877695|NCT01544595|558977257|FG003|Status at Week 156|Withdrawal by Subject|9|||
154877696|NCT01544595|558977258|FG004|Status at Week 156|Withdrawal by Subject|20|||
154974542|NCT02260635|559331264|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
154877697|NCT01544595|558977259|FG005|Status at Week 156|Withdrawal by Subject|6|||
154877698|NCT01544595|558977254|FG000|Status at Week 156|Adverse Event|9|||
154877699|NCT01544595|558977255|FG001|Status at Week 156|Adverse Event|11|||
154877700|NCT01544595|558977256|FG002|Status at Week 156|Adverse Event|1|||
154877701|NCT01544595|558977257|FG003|Status at Week 156|Adverse Event|3|||
154877702|NCT01544595|558977258|FG004|Status at Week 156|Adverse Event|4|||
154877703|NCT01544595|558977259|FG005|Status at Week 156|Adverse Event|2|||
154877704|NCT01544595|558977254|FG000|Status at Week 156|Lost to Follow-up|4|||
154877705|NCT01544595|558977255|FG001|Status at Week 156|Lost to Follow-up|4|||
154877706|NCT01544595|558977256|FG002|Status at Week 156|Lost to Follow-up|0|||
154877707|NCT01544595|558977257|FG003|Status at Week 156|Lost to Follow-up|1|||
154877708|NCT01544595|558977258|FG004|Status at Week 156|Lost to Follow-up|4|||
154877709|NCT01544595|558977259|FG005|Status at Week 156|Lost to Follow-up|1|||
154877710|NCT01544595|558977254|FG000|Status at Week 156|Non-compliance with study treatement|0|||
154877711|NCT01544595|558977255|FG001|Status at Week 156|Non-compliance with study treatement|1|||
154877712|NCT01544595|558977256|FG002|Status at Week 156|Non-compliance with study treatement|0|||
154877713|NCT01544595|558977257|FG003|Status at Week 156|Non-compliance with study treatement|1|||
154877714|NCT01544595|558977258|FG004|Status at Week 156|Non-compliance with study treatement|0|||
154877715|NCT01544595|558977259|FG005|Status at Week 156|Non-compliance with study treatement|1|||
154877716|NCT01544595|558977254|FG000|Status at Week 156|Physician Decision|0|||
154877717|NCT01544595|558977255|FG001|Status at Week 156|Physician Decision|3|||
154877718|NCT01544595|558977256|FG002|Status at Week 156|Physician Decision|1|||
154877719|NCT01544595|558977257|FG003|Status at Week 156|Physician Decision|0|||
154877720|NCT01544595|558977258|FG004|Status at Week 156|Physician Decision|0|||
154877721|NCT01544595|558977259|FG005|Status at Week 156|Physician Decision|0|||
154877722|NCT01544595|558977254|FG000|Status at Week 156|Pregnancy|2|||
154877723|NCT01544595|558977255|FG001|Status at Week 156|Pregnancy|3|||
154877724|NCT01544595|558977256|FG002|Status at Week 156|Pregnancy|0|||
154877725|NCT01544595|558977257|FG003|Status at Week 156|Pregnancy|0|||
154877726|NCT01544595|558977258|FG004|Status at Week 156|Pregnancy|0|||
154877727|NCT01544595|558977259|FG005|Status at Week 156|Pregnancy|0|||
154877728|NCT01544595|558977254|FG000|Status at Week 156|Protocol Violation|3|||
154877729|NCT01544595|558977255|FG001|Status at Week 156|Protocol Violation|1|||
154877730|NCT01544595|558977256|FG002|Status at Week 156|Protocol Violation|2|||
154877731|NCT01544595|558977257|FG003|Status at Week 156|Protocol Violation|2|||
154877732|NCT01544595|558977258|FG004|Status at Week 156|Protocol Violation|0|||
154877733|NCT01544595|558977259|FG005|Status at Week 156|Protocol Violation|0|||
154877734|NCT01544595|558977254|FG000|Status at Week 156|Technical problems|3|||
154877735|NCT01544595|558977255|FG001|Status at Week 156|Technical problems|1|||
154877736|NCT01544595|558977256|FG002|Status at Week 156|Technical problems|0|||
154877737|NCT01544595|558977257|FG003|Status at Week 156|Technical problems|1|||
154877738|NCT01544595|558977258|FG004|Status at Week 156|Technical problems|0|||
154877739|NCT01544595|558977259|FG005|Status at Week 156|Technical problems|0|||
154877740|NCT01544595|558977254|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
155113127|NCT02589665|559844727|FG001|Maintenance Period|Lack of Efficacy|0|||
155113128|NCT02589665|559844728|FG002|Maintenance Period|Lack of Efficacy|0|||
154877741|NCT01544595|558977255|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
154877742|NCT01544595|558977256|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
154877743|NCT01544595|558977257|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
154877744|NCT01544595|558977258|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
154877745|NCT01544595|558977259|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
154877746|NCT01544595|558977254|FG000|Status at Week 156|Lack of Efficacy|1|||
154877747|NCT01544595|558977255|FG001|Status at Week 156|Lack of Efficacy|0|||
154877748|NCT01544595|558977256|FG002|Status at Week 156|Lack of Efficacy|1|||
154877749|NCT01544595|558977257|FG003|Status at Week 156|Lack of Efficacy|4|||
154877750|NCT01544595|558977258|FG004|Status at Week 156|Lack of Efficacy|10|||
154877751|NCT01544595|558977259|FG005|Status at Week 156|Lack of Efficacy|5|||
154877752|NCT01108809|558977262|FG000|Overall Study|Adverse Event|3|||
154877753|NCT01108809|558977262|FG000|Overall Study|Lost to Follow-up|1|||
154877754|NCT02379923|558977274|FG000|Overall Study|Death|5|||
154877755|NCT03643432|558977275|FG000|Overall Study|Lost to Follow-up|1|||
154877756|NCT03643432|558977276|FG001|Overall Study|Lost to Follow-up|0|||
154877757|NCT00804193|558977277|FG000|Overall Study|Lack of baseline fungus|32|||
154877758|NCT00804193|558977278|FG001|Overall Study|Lack of baseline fungus|31|||
154877759|NCT00804193|558977279|FG002|Overall Study|Lack of baseline fungus|19|||
154877760|NCT00804193|558977277|FG000|Overall Study|Adverse Event|0|||
154877761|NCT00804193|558977278|FG001|Overall Study|Adverse Event|0|||
154877762|NCT00804193|558977279|FG002|Overall Study|Adverse Event|2|||
154877763|NCT00804193|558977277|FG000|Overall Study|Lack of Efficacy|1|||
154877764|NCT00804193|558977278|FG001|Overall Study|Lack of Efficacy|1|||
154877765|NCT00804193|558977279|FG002|Overall Study|Lack of Efficacy|3|||
154877766|NCT00804193|558977277|FG000|Overall Study|Protocol Violation|0|||
154877767|NCT00804193|558977278|FG001|Overall Study|Protocol Violation|8|||
154877768|NCT00804193|558977279|FG002|Overall Study|Protocol Violation|2|||
154877769|NCT00804193|558977277|FG000|Overall Study|Lost to Follow-up|3|||
154877770|NCT00804193|558977278|FG001|Overall Study|Lost to Follow-up|3|||
154877771|NCT00804193|558977279|FG002|Overall Study|Lost to Follow-up|4|||
154877772|NCT00804193|558977277|FG000|Overall Study|Withdrawal by Subject|3|||
154877773|NCT00804193|558977278|FG001|Overall Study|Withdrawal by Subject|1|||
154877774|NCT00804193|558977279|FG002|Overall Study|Withdrawal by Subject|2|||
154877775|NCT01193348|558977282|FG000|Screening Period|Screen Failure|5|||
154877776|NCT01193348|558977282|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
154877777|NCT01193348|558977282|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
154877778|NCT01193348|558977282|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
154877779|NCT01193348|558977282|FG000|Extension Treatment Period|Physician Decision|1|||
154877780|NCT01193348|558977282|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
154877781|NCT02928406|558977283|FG000|Overall Study|Death|780|||
154877782|NCT02928406|558977283|FG000|Overall Study|Progressive disease|3|||
154877783|NCT02928406|558977283|FG000|Overall Study|Lost to Follow-up|49|||
154877784|NCT02928406|558977283|FG000|Overall Study|Non-compliance|2|||
154877785|NCT02928406|558977283|FG000|Overall Study|Withdrawal by Subject|40|||
154877786|NCT02928406|558977283|FG000|Overall Study|Study terminated by sponsor|57|||
154877787|NCT02928406|558977283|FG000|Overall Study|Physician Decision|1|||
154877788|NCT02928406|558977283|FG000|Overall Study|Various reasons|72|||
154877789|NCT01745393|558977284|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
154877790|NCT01745393|558977285|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
154877791|NCT01745393|558977284|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
154877792|NCT01745393|558977285|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
154877793|NCT01745393|558977284|FG000|12-month Follow-up|Lost to Follow-up|6|||
154877794|NCT01745393|558977285|FG001|12-month Follow-up|Lost to Follow-up|5|||
154877795|NCT00905021|558977286|FG000|Overall Study|Adverse Event|2|||
154877796|NCT00786838|558977287|FG000|Overall Study|Physician Decision|4|||
154877797|NCT00786838|558977287|FG000|Overall Study|Death|4|||
154877798|NCT00786838|558977287|FG000|Overall Study|Adverse Event|6|||
154877799|NCT00786838|558977287|FG000|Overall Study|Progressive disease|31|||
154877800|NCT00786838|558977287|FG000|Overall Study|Withdrawal by Subject|4|||
154877801|NCT04937816|558977288|FG000|Overall Study|Study drug stopped, reason missing|5|||
154877802|NCT04937816|558977289|FG001|Overall Study|Study drug stopped, reason missing|3|||
154877803|NCT04937816|558977290|FG002|Overall Study|Study drug stopped, reason missing|4|||
154877804|NCT04937816|558977291|FG003|Overall Study|Study drug stopped, reason missing|6|||
154877805|NCT04937816|558977292|FG004|Overall Study|Study drug stopped, reason missing|1|||
154877806|NCT04937816|558977293|FG005|Overall Study|Study drug stopped, reason missing|0|||
154877807|NCT04937816|558977294|FG006|Overall Study|Study drug stopped, reason missing|0|||
154877808|NCT04937816|558977288|FG000|Overall Study|Other than stated below|173|||
154877809|NCT04937816|558977289|FG001|Overall Study|Other than stated below|143|||
154877810|NCT04937816|558977290|FG002|Overall Study|Other than stated below|125|||
154877811|NCT04937816|558977291|FG003|Overall Study|Other than stated below|44|||
154877812|NCT04937816|558977292|FG004|Overall Study|Other than stated below|45|||
154877813|NCT04937816|558977293|FG005|Overall Study|Other than stated below|28|||
154877814|NCT04937816|558977294|FG006|Overall Study|Other than stated below|31|||
154877815|NCT04937816|558977288|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
154877816|NCT04937816|558977289|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
154877817|NCT04937816|558977290|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
154877818|NCT04937816|558977291|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
154877819|NCT04937816|558977292|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
154877820|NCT04937816|558977293|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
154877821|NCT04937816|558977294|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
154877822|NCT04937816|558977288|FG000|Overall Study|Lost to Follow-up|15|||
154877823|NCT04937816|558977289|FG001|Overall Study|Lost to Follow-up|9|||
154877824|NCT04937816|558977290|FG002|Overall Study|Lost to Follow-up|6|||
154877825|NCT04937816|558977291|FG003|Overall Study|Lost to Follow-up|6|||
154877826|NCT04937816|558977292|FG004|Overall Study|Lost to Follow-up|16|||
154877827|NCT04937816|558977293|FG005|Overall Study|Lost to Follow-up|11|||
154877828|NCT04937816|558977294|FG006|Overall Study|Lost to Follow-up|17|||
154877829|NCT04937816|558977288|FG000|Overall Study|Protocol Violation|15|||
154877830|NCT04937816|558977289|FG001|Overall Study|Protocol Violation|15|||
154877831|NCT04937816|558977290|FG002|Overall Study|Protocol Violation|12|||
154877832|NCT04937816|558977291|FG003|Overall Study|Protocol Violation|30|||
154877833|NCT04937816|558977292|FG004|Overall Study|Protocol Violation|24|||
154877834|NCT04937816|558977293|FG005|Overall Study|Protocol Violation|5|||
154877835|NCT04937816|558977294|FG006|Overall Study|Protocol Violation|5|||
154877836|NCT04937816|558977288|FG000|Overall Study|Adverse Event|303|||
154877837|NCT04937816|558977289|FG001|Overall Study|Adverse Event|267|||
154877838|NCT04937816|558977290|FG002|Overall Study|Adverse Event|273|||
154877839|NCT04937816|558977291|FG003|Overall Study|Adverse Event|553|||
154877840|NCT04937816|558977292|FG004|Overall Study|Adverse Event|575|||
154877841|NCT04937816|558977293|FG005|Overall Study|Adverse Event|343|||
154877842|NCT04937816|558977294|FG006|Overall Study|Adverse Event|337|||
154877843|NCT04937816|558977288|FG000|Overall Study|Not treated|4|||
154877844|NCT04937816|558977289|FG001|Overall Study|Not treated|2|||
154877845|NCT04937816|558977290|FG002|Overall Study|Not treated|2|||
154877846|NCT04937816|558977291|FG003|Overall Study|Not treated|2|||
154877847|NCT04937816|558977292|FG004|Overall Study|Not treated|1|||
154877848|NCT04937816|558977293|FG005|Overall Study|Not treated|4|||
154877849|NCT04937816|558977294|FG006|Overall Study|Not treated|0|||
154877850|NCT02488759|558977296|FG000|Overall Study|Disease progression|73|||
154877851|NCT02488759|558977297|FG001|Overall Study|Disease progression|111|||
154877852|NCT02488759|558977298|FG002|Overall Study|Disease progression|62|||
154877853|NCT02488759|558977299|FG003|Overall Study|Disease progression|7|||
154877854|NCT02488759|558977300|FG004|Overall Study|Disease progression|4|||
154877855|NCT02488759|558977301|FG005|Overall Study|Disease progression|2|||
154877856|NCT02488759|558977296|FG000|Overall Study|Study drug toxicity|11|||
154877857|NCT02488759|558977297|FG001|Overall Study|Study drug toxicity|33|||
154877858|NCT02488759|558977298|FG002|Overall Study|Study drug toxicity|31|||
154877859|NCT02488759|558977299|FG003|Overall Study|Study drug toxicity|0|||
154877860|NCT02488759|558977300|FG004|Overall Study|Study drug toxicity|0|||
154877861|NCT02488759|558977301|FG005|Overall Study|Study drug toxicity|2|||
154877862|NCT02488759|558977296|FG000|Overall Study|Adverse event unrelated to study drug|9|||
154877863|NCT02488759|558977297|FG001|Overall Study|Adverse event unrelated to study drug|11|||
154877864|NCT02488759|558977298|FG002|Overall Study|Adverse event unrelated to study drug|7|||
154877865|NCT02488759|558977299|FG003|Overall Study|Adverse event unrelated to study drug|0|||
154877866|NCT02488759|558977300|FG004|Overall Study|Adverse event unrelated to study drug|1|||
154877867|NCT02488759|558977301|FG005|Overall Study|Adverse event unrelated to study drug|0|||
154877868|NCT02488759|558977296|FG000|Overall Study|Participant request to discontinue study treatment|6|||
154877869|NCT02488759|558977297|FG001|Overall Study|Participant request to discontinue study treatment|8|||
154877870|NCT02488759|558977298|FG002|Overall Study|Participant request to discontinue study treatment|4|||
154877871|NCT02488759|558977299|FG003|Overall Study|Participant request to discontinue study treatment|0|||
154877872|NCT02488759|558977300|FG004|Overall Study|Participant request to discontinue study treatment|0|||
154877873|NCT02488759|558977301|FG005|Overall Study|Participant request to discontinue study treatment|0|||
154877874|NCT02488759|558977296|FG000|Overall Study|Withdrawal by Subject|4|||
154877875|NCT02488759|558977297|FG001|Overall Study|Withdrawal by Subject|0|||
154877876|NCT02488759|558977298|FG002|Overall Study|Withdrawal by Subject|3|||
154877877|NCT02488759|558977299|FG003|Overall Study|Withdrawal by Subject|0|||
154877878|NCT02488759|558977300|FG004|Overall Study|Withdrawal by Subject|0|||
154877879|NCT02488759|558977301|FG005|Overall Study|Withdrawal by Subject|2|||
154877880|NCT02488759|558977296|FG000|Overall Study|Lost to Follow-up|0|||
154877881|NCT02488759|558977297|FG001|Overall Study|Lost to Follow-up|0|||
154877882|NCT02488759|558977298|FG002|Overall Study|Lost to Follow-up|2|||
154877883|NCT02488759|558977299|FG003|Overall Study|Lost to Follow-up|0|||
154877884|NCT02488759|558977300|FG004|Overall Study|Lost to Follow-up|0|||
154877885|NCT02488759|558977301|FG005|Overall Study|Lost to Follow-up|0|||
154877886|NCT02488759|558977296|FG000|Overall Study|Maximum clinical benefit|3|||
154877887|NCT02488759|558977297|FG001|Overall Study|Maximum clinical benefit|0|||
154877888|NCT02488759|558977298|FG002|Overall Study|Maximum clinical benefit|1|||
154877889|NCT02488759|558977299|FG003|Overall Study|Maximum clinical benefit|0|||
154877890|NCT02488759|558977300|FG004|Overall Study|Maximum clinical benefit|0|||
154877891|NCT02488759|558977301|FG005|Overall Study|Maximum clinical benefit|0|||
154877892|NCT02488759|558977296|FG000|Overall Study|Other reasons|7|||
154877893|NCT02488759|558977297|FG001|Overall Study|Other reasons|32|||
154877894|NCT02488759|558977298|FG002|Overall Study|Other reasons|23|||
154877895|NCT02488759|558977299|FG003|Overall Study|Other reasons|1|||
154877896|NCT02488759|558977300|FG004|Overall Study|Other reasons|1|||
154877897|NCT02488759|558977301|FG005|Overall Study|Other reasons|1|||
154877898|NCT03860844|558977302|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
154877899|NCT03860844|558977303|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
154877900|NCT03860844|558977304|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
154877901|NCT03860844|558977302|FG000|Overall Study|Progressive disease|5|||
154877902|NCT03860844|558977303|FG001|Overall Study|Progressive disease|3|||
154877903|NCT03860844|558977304|FG002|Overall Study|Progressive disease|4|||
154877904|NCT03860844|558977302|FG000|Overall Study|Other, Not related to COVID-19|0|||
154877905|NCT03860844|558977303|FG001|Overall Study|Other, Not related to COVID-19|1|||
155113129|NCT02589665|559844729|FG003|Maintenance Period|Lack of Efficacy|0|||
154877906|NCT03860844|558977304|FG002|Overall Study|Other, Not related to COVID-19|0|||
155113130|NCT02589665|559844730|FG004|Maintenance Period|Lack of Efficacy|2|||
155113131|NCT02589665|559844731|FG005|Maintenance Period|Lack of Efficacy|1|||
154877907|NCT01678807|558977310|FG000|Overall Study|Adverse Event|4|||
154877908|NCT01678807|558977311|FG001|Overall Study|Adverse Event|4|||
154877909|NCT01678807|558977312|FG002|Overall Study|Adverse Event|0|||
154877910|NCT01678807|558977310|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
154877911|NCT01678807|558977311|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
154877912|NCT01678807|558977312|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
154877913|NCT02574312|558977313|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
154877914|NCT02574312|558977314|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
154877915|NCT05306873|558978676|FG000|Stage 2|Study stopped|1|||
154877916|NCT05306873|558978677|FG001|Stage 2|Study stopped|1|||
154877917|NCT05306873|558978678|FG002|Stage 2|Study stopped|0|||
154877918|NCT05306873|558978679|FG003|Stage 2|Study stopped|0|||
154877919|NCT05306873|558978676|FG000|Stage 2|Stage 2 Treatment Failure|2|||
154877920|NCT05306873|558978677|FG001|Stage 2|Stage 2 Treatment Failure|3|||
154877921|NCT05306873|558978678|FG002|Stage 2|Stage 2 Treatment Failure|0|||
154877922|NCT05306873|558978679|FG003|Stage 2|Stage 2 Treatment Failure|0|||
154877923|NCT05306873|558978676|FG000|Stage 2|Logistical issues due to participant moving|1|||
154877924|NCT05306873|558978677|FG001|Stage 2|Logistical issues due to participant moving|0|||
154877925|NCT05306873|558978678|FG002|Stage 2|Logistical issues due to participant moving|0|||
154877926|NCT05306873|558978679|FG003|Stage 2|Logistical issues due to participant moving|0|||
154877927|NCT05306873|558978676|FG000|Stage 3|Stage 3 Treatment Failure|0|||
154877928|NCT05306873|558978677|FG001|Stage 3|Stage 3 Treatment Failure|0|||
154877929|NCT05306873|558978678|FG002|Stage 3|Stage 3 Treatment Failure|0|||
154877930|NCT05306873|558978679|FG003|Stage 3|Stage 3 Treatment Failure|1|||
154877931|NCT05306873|558978676|FG000|Stage 3|Study Stopped|0|||
154877932|NCT05306873|558978677|FG001|Stage 3|Study Stopped|0|||
154877933|NCT05306873|558978678|FG002|Stage 3|Study Stopped|1|||
154877934|NCT05306873|558978679|FG003|Stage 3|Study Stopped|0|||
154877935|NCT04920084|558978685|FG000|Overall Study|Adverse Event|1|||
154877936|NCT04920084|558978685|FG000|Overall Study|Lost to Follow-up|2|||
154877937|NCT04920084|558978685|FG000|Overall Study|Withdrawal by Subject|2|||
154877938|NCT01096446|558978686|FG000|Overall Study|Death|1|||
154877939|NCT01096446|558978687|FG001|Overall Study|Death|0|||
154877940|NCT01096446|558978686|FG000|Overall Study|Protocol Violation|2|||
154877941|NCT01096446|558978687|FG001|Overall Study|Protocol Violation|0|||
154877942|NCT00074412|558978688|FG000|Overall Study|Death|30|||
154877943|NCT00074412|558978689|FG001|Overall Study|Death|26|||
154877944|NCT00074412|558978688|FG000|Overall Study|Lost to Follow-up|52|||
154877945|NCT00074412|558978689|FG001|Overall Study|Lost to Follow-up|58|||
154877946|NCT00418834|558978692|FG000|Overall Study|Adverse Event|16|||
154877947|NCT00418834|558978693|FG001|Overall Study|Adverse Event|9|||
154877948|NCT00418834|558978692|FG000|Overall Study|Lost to Follow-up|0|||
154877949|NCT00418834|558978693|FG001|Overall Study|Lost to Follow-up|1|||
154877950|NCT00418834|558978692|FG000|Overall Study|Protocol Violation|4|||
154877951|NCT00418834|558978693|FG001|Overall Study|Protocol Violation|3|||
154877952|NCT00418834|558978692|FG000|Overall Study|Withdrawal by Subject|3|||
154877953|NCT00418834|558978693|FG001|Overall Study|Withdrawal by Subject|7|||
154877954|NCT01755195|558978696|FG000|Overall Study|Participant noncompliance|2|||
154877955|NCT01755195|558978696|FG000|Overall Study|Switched to alternative treatment|4|||
154877956|NCT01755195|558978696|FG000|Overall Study|Withdrawal by Subject|1|||
154877957|NCT01755195|558978696|FG000|Overall Study|Participant refused to start treatment|1|||
154877958|NCT01755195|558978696|FG000|Overall Study|Participant has been consented for another trial|1|||
154877959|NCT01755195|558978696|FG000|Overall Study|Refused further treatment|3|||
154877960|NCT01755195|558978696|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
154877961|NCT05113953|558978697|FG000|Overall Study|Adverse Event|5|||
154877962|NCT05113953|558978698|FG001|Overall Study|Adverse Event|0|||
154877963|NCT05113953|558978699|FG002|Overall Study|Adverse Event|3|||
154877964|NCT05113953|558978697|FG000|Overall Study|Lost to Follow-up|3|||
154877965|NCT05113953|558978698|FG001|Overall Study|Lost to Follow-up|4|||
154877966|NCT05113953|558978699|FG002|Overall Study|Lost to Follow-up|2|||
154877967|NCT05113953|558978697|FG000|Overall Study|Non-compliance with Study Drug|1|||
154877968|NCT05113953|558978698|FG001|Overall Study|Non-compliance with Study Drug|0|||
154877969|NCT05113953|558978699|FG002|Overall Study|Non-compliance with Study Drug|0|||
154877970|NCT05113953|558978697|FG000|Overall Study|Withdrawal by Subject|2|||
154877971|NCT05113953|558978698|FG001|Overall Study|Withdrawal by Subject|6|||
155175348|NCT00910624|560080227|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
154877972|NCT05113953|558978699|FG002|Overall Study|Withdrawal by Subject|4|||
154877973|NCT05113953|558978697|FG000|Overall Study|Reason not Specified|2|||
154877974|NCT05113953|558978698|FG001|Overall Study|Reason not Specified|0|||
154877975|NCT05113953|558978699|FG002|Overall Study|Reason not Specified|0|||
154974543|NCT02260635|559331265|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
154974544|NCT02260635|559331264|FG000|Open-Label Extension|Study Termination|25|||
154974545|NCT02260635|559331265|FG001|Open-Label Extension|Study Termination|25|||
154974546|NCT02260635|559331264|FG000|Open-Label Extension|Withdrawal by Subject|1|||
154877976|NCT03470922|558978705|FG000|Overall Study|Death|107|||
154877977|NCT03470922|558978706|FG001|Overall Study|Death|118|||
154877978|NCT03470922|558978705|FG000|Overall Study|Lost to Follow-up|5|||
154877979|NCT03470922|558978706|FG001|Overall Study|Lost to Follow-up|5|||
154877980|NCT03470922|558978705|FG000|Overall Study|Participant Withdrew Consent|4|||
154877981|NCT03470922|558978706|FG001|Overall Study|Participant Withdrew Consent|9|||
154877982|NCT03470922|558978705|FG000|Overall Study|Other reasons|1|||
154877983|NCT03470922|558978706|FG001|Overall Study|Other reasons|0|||
154877984|NCT03470922|558978705|FG000|Overall Study|Not reported|1|||
154877985|NCT03470922|558978706|FG001|Overall Study|Not reported|0|||
154877986|NCT02340819|558978707|FG000|Overall Study|Adverse Event|1|||
154877987|NCT02340819|558978707|FG000|Overall Study|Withdrawal by Subject|2|||
154877988|NCT02340819|558978707|FG000|Overall Study|Discontinued with other reason|1|||
154877989|NCT02626819|558978708|FG000|Overall Study|Lost to Follow-up|3|||
154877990|NCT02626819|558978709|FG001|Overall Study|Lost to Follow-up|2|||
154877991|NCT02626819|558978708|FG000|Overall Study|Withdrawal by Subject|1|||
154877992|NCT02626819|558978709|FG001|Overall Study|Withdrawal by Subject|0|||
154877993|NCT02626819|558978708|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
154877994|NCT02626819|558978709|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
154877995|NCT02361762|558978710|FG000|Overall Study|Withdrawal by Subject|0|||
154877996|NCT02361762|558978711|FG001|Overall Study|Withdrawal by Subject|1|||
154877997|NCT02361762|558978710|FG000|Overall Study|Lost to Follow-up|0|||
154877998|NCT02361762|558978711|FG001|Overall Study|Lost to Follow-up|1|||
154877999|NCT00502307|558978714|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
154878000|NCT00502307|558978715|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
154878001|NCT00502307|558978716|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
154878002|NCT00502307|558978714|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
154878003|NCT00502307|558978715|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
154878004|NCT00502307|558978716|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
154878005|NCT00502307|558978714|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
154878006|NCT00502307|558978715|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
154878007|NCT00502307|558978716|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
154878008|NCT00502307|558978714|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
154878009|NCT00502307|558978715|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
154878010|NCT00502307|558978716|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
154878011|NCT00502307|558978714|FG000|Maintenance Period|Progressive disease|80|||
154878012|NCT00502307|558978715|FG001|Maintenance Period|Progressive disease|0|||
154878013|NCT00502307|558978716|FG002|Maintenance Period|Progressive disease|0|||
154878014|NCT00502307|558978714|FG000|Maintenance Period|Discontinued due to other reasons|68|||
154878015|NCT00502307|558978715|FG001|Maintenance Period|Discontinued due to other reasons|0|||
154878016|NCT00502307|558978716|FG002|Maintenance Period|Discontinued due to other reasons|0|||
154878017|NCT04467164|558978719|FG000|Washout (1 Week)|Lost to Follow-up|2|||
154878018|NCT04467164|558978720|FG001|Washout (1 Week)|Lost to Follow-up|0|||
154878019|NCT02750813|558978721|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
154878020|NCT02750813|558978722|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
154878021|NCT02750813|558978721|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
154878022|NCT02750813|558978722|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
154878023|NCT01998581|558978723|FG000|Overall Study|Refused repeat treatment|20|||
154878024|NCT01998581|558978724|FG001|Overall Study|Refused repeat treatment|4|||
154878025|NCT01998581|558978723|FG000|Overall Study|Protocol Violation|1|||
154878026|NCT01998581|558978724|FG001|Overall Study|Protocol Violation|0|||
154878027|NCT01998581|558978723|FG000|Overall Study|Withdrawal by Subject|8|||
154878028|NCT01998581|558978724|FG001|Overall Study|Withdrawal by Subject|1|||
154878029|NCT01998581|558978723|FG000|Overall Study|Lost to Follow-up|12|||
154878030|NCT01998581|558978724|FG001|Overall Study|Lost to Follow-up|4|||
154974547|NCT02260635|559331265|FG001|Open-Label Extension|Withdrawal by Subject|0|||
155113132|NCT02589665|559844732|FG006|Maintenance Period|Lack of Efficacy|0|||
155113133|NCT02589665|559844733|FG007|Maintenance Period|Lack of Efficacy|0|||
155113134|NCT02589665|559844734|FG008|Maintenance Period|Lack of Efficacy|0|||
155113135|NCT02589665|559844735|FG009|Maintenance Period|Lack of Efficacy|0|||
155113136|NCT02589665|559844726|FG000|Maintenance Period|Adverse Event|0|||
155113137|NCT02589665|559844727|FG001|Maintenance Period|Adverse Event|0|||
155113138|NCT02589665|559844728|FG002|Maintenance Period|Adverse Event|0|||
155113139|NCT02589665|559844729|FG003|Maintenance Period|Adverse Event|0|||
155113140|NCT02589665|559844730|FG004|Maintenance Period|Adverse Event|0|||
155113141|NCT02589665|559844731|FG005|Maintenance Period|Adverse Event|0|||
155113142|NCT02589665|559844732|FG006|Maintenance Period|Adverse Event|2|||
155113143|NCT02589665|559844733|FG007|Maintenance Period|Adverse Event|0|||
155113144|NCT02589665|559844734|FG008|Maintenance Period|Adverse Event|0|||
155113145|NCT02589665|559844735|FG009|Maintenance Period|Adverse Event|0|||
155113146|NCT02589665|559844726|FG000|Maintenance Period|Lost to Follow-up|0|||
155113147|NCT02589665|559844727|FG001|Maintenance Period|Lost to Follow-up|0|||
154878031|NCT01998581|558978723|FG000|Overall Study|Adverse Event|1|||
154878032|NCT01998581|558978724|FG001|Overall Study|Adverse Event|1|||
154878033|NCT01998581|558978723|FG000|Overall Study|Other reasons|3|||
154878034|NCT01998581|558978724|FG001|Overall Study|Other reasons|2|||
154974548|NCT03310619|559331266|FG000|Pre-Treatment Period|Death|1|||
154878035|NCT01998581|558978723|FG000|Overall Study|Randomized but withdrew before treatment|1|||
154974549|NCT03310619|559331267|FG001|Pre-Treatment Period|Death|0|||
154974550|NCT03310619|559331268|FG002|Pre-Treatment Period|Death|0|||
154974551|NCT03310619|559331269|FG003|Pre-Treatment Period|Death|0|||
155113148|NCT02589665|559844728|FG002|Maintenance Period|Lost to Follow-up|0|||
155113149|NCT02589665|559844729|FG003|Maintenance Period|Lost to Follow-up|0|||
155113150|NCT02589665|559844730|FG004|Maintenance Period|Lost to Follow-up|0|||
155113151|NCT02589665|559844731|FG005|Maintenance Period|Lost to Follow-up|1|||
154878036|NCT01998581|558978724|FG001|Overall Study|Randomized but withdrew before treatment|0|||
154878037|NCT02273050|558978727|FG000|Overall Study|Adverse Event|4|||
154878038|NCT02273050|558978728|FG001|Overall Study|Adverse Event|3|||
154878039|NCT02273050|558978729|FG002|Overall Study|Adverse Event|3|||
154878040|NCT02273050|558978727|FG000|Overall Study|Death|0|||
154878041|NCT02273050|558978728|FG001|Overall Study|Death|0|||
154878042|NCT02273050|558978729|FG002|Overall Study|Death|1|||
154878043|NCT02273050|558978727|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
154878044|NCT02273050|558978728|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
154878045|NCT02273050|558978729|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
154878046|NCT02273050|558978727|FG000|Overall Study|Lack of Efficacy|0|||
154878047|NCT02273050|558978728|FG001|Overall Study|Lack of Efficacy|1|||
154878048|NCT02273050|558978729|FG002|Overall Study|Lack of Efficacy|1|||
154878049|NCT02273050|558978727|FG000|Overall Study|Withdrawal by Subject|17|||
154878050|NCT02273050|558978728|FG001|Overall Study|Withdrawal by Subject|14|||
154878051|NCT02273050|558978729|FG002|Overall Study|Withdrawal by Subject|16|||
154878052|NCT02273050|558978727|FG000|Overall Study|Lost to Follow-up|0|||
154878053|NCT02273050|558978728|FG001|Overall Study|Lost to Follow-up|2|||
154878054|NCT02273050|558978729|FG002|Overall Study|Lost to Follow-up|3|||
154878055|NCT02273050|558978727|FG000|Overall Study|Protocol Violation|3|||
154878056|NCT02273050|558978728|FG001|Overall Study|Protocol Violation|1|||
154878057|NCT02273050|558978729|FG002|Overall Study|Protocol Violation|4|||
154878058|NCT02273752|558978730|FG000|Overall Study|Trial was terminated early|2|||
154878059|NCT00903032|558978731|FG000|Overall Study|Withdrawal by Subject|5|||
154878060|NCT00903032|558978732|FG001|Overall Study|Withdrawal by Subject|3|||
154878061|NCT00903032|558978731|FG000|Overall Study|Lost to Follow-up|2|||
154878062|NCT00903032|558978732|FG001|Overall Study|Lost to Follow-up|2|||
154878063|NCT01429792|558978733|FG000|Overall Study|Other Reasons|67|||
154878064|NCT01429792|558978733|FG000|Overall Study|Unknown Disposition|94|||
154878065|NCT01429792|558978733|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
154878066|NCT01429792|558978733|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
154878067|NCT01429792|558978733|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
154878068|NCT01429792|558978733|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
154878069|NCT01429792|558978733|FG000|Overall Study|Withdrawal by Subject|70|||
154878070|NCT01429792|558978733|FG000|Overall Study|Lost to Follow-up|88|||
154878071|NCT01763905|558978736|FG000|Overall Study|Withdrawal by Subject|1|||
154878072|NCT01763905|558978737|FG001|Overall Study|Withdrawal by Subject|1|||
154878073|NCT01763905|558978738|FG002|Overall Study|Withdrawal by Subject|0|||
154878074|NCT01763905|558978739|FG003|Overall Study|Withdrawal by Subject|1|||
154878075|NCT01763905|558978736|FG000|Overall Study|Decision by sponsor|5|||
154878076|NCT01763905|558978737|FG001|Overall Study|Decision by sponsor|0|||
154878077|NCT01763905|558978738|FG002|Overall Study|Decision by sponsor|8|||
154878078|NCT01763905|558978739|FG003|Overall Study|Decision by sponsor|0|||
154878079|NCT01763905|558978736|FG000|Overall Study|Lost to Follow-up|0|||
154878080|NCT01763905|558978737|FG001|Overall Study|Lost to Follow-up|0|||
154878081|NCT01763905|558978738|FG002|Overall Study|Lost to Follow-up|1|||
154878082|NCT01763905|558978739|FG003|Overall Study|Lost to Follow-up|0|||
154878083|NCT04346628|558978740|FG000|Overall Study|Lost to Follow-up|4|||
154878084|NCT04346628|558978741|FG001|Overall Study|Lost to Follow-up|4|||
154878085|NCT04346628|558978740|FG000|Overall Study|Withdrew (had personal reasons)|2|||
154878086|NCT04346628|558978741|FG001|Overall Study|Withdrew (had personal reasons)|5|||
154878087|NCT04346628|558978740|FG000|Overall Study|Withdrew (medication intolerant)|0|||
154878088|NCT04346628|558978741|FG001|Overall Study|Withdrew (medication intolerant)|3|||
154878089|NCT04346628|558978740|FG000|Overall Study|Withdrew (declined intervention)|0|||
154878090|NCT04346628|558978741|FG001|Overall Study|Withdrew (declined intervention)|1|||
154878091|NCT02324842|558978742|FG000|Overall Study|Lost to Follow-up|1|||
154878092|NCT02324842|558978743|FG001|Overall Study|Lost to Follow-up|1|||
154878093|NCT02324842|558978744|FG002|Overall Study|Lost to Follow-up|2|||
154878094|NCT01263691|558978749|FG000|Overall Study|Lost to Follow-up|1|||
154878095|NCT01263691|558978750|FG001|Overall Study|Lost to Follow-up|0|||
154878096|NCT01263691|558978751|FG002|Overall Study|Lost to Follow-up|1|||
154878097|NCT01263691|558978752|FG003|Overall Study|Lost to Follow-up|1|||
154878098|NCT01263691|558978753|FG004|Overall Study|Lost to Follow-up|0|||
154878099|NCT01263691|558978754|FG005|Overall Study|Lost to Follow-up|0|||
154878100|NCT01263691|558978749|FG000|Overall Study|Withdrawal by Subject|1|||
154878101|NCT01263691|558978750|FG001|Overall Study|Withdrawal by Subject|0|||
154878102|NCT01263691|558978751|FG002|Overall Study|Withdrawal by Subject|0|||
154878103|NCT01263691|558978752|FG003|Overall Study|Withdrawal by Subject|0|||
154878104|NCT01263691|558978753|FG004|Overall Study|Withdrawal by Subject|0|||
154878105|NCT01263691|558978754|FG005|Overall Study|Withdrawal by Subject|0|||
154878106|NCT01263691|558978749|FG000|Overall Study|Adverse Event|1|||
154878107|NCT01263691|558978750|FG001|Overall Study|Adverse Event|0|||
154878108|NCT01263691|558978751|FG002|Overall Study|Adverse Event|0|||
154878109|NCT01263691|558978752|FG003|Overall Study|Adverse Event|0|||
154878110|NCT01263691|558978753|FG004|Overall Study|Adverse Event|0|||
154878111|NCT01263691|558978754|FG005|Overall Study|Adverse Event|0|||
154878112|NCT01202227|558978755|FG000|Overall Study|Adverse Event|16|||
154878113|NCT01202227|558978755|FG000|Overall Study|Withdrawal by Subject|2|||
154878114|NCT01202227|558978755|FG000|Overall Study|Lack of Efficacy|1|||
154878115|NCT00643487|558978756|FG000|Overall Study|Technical difficulty|3|||
154878116|NCT01894477|558978757|FG000|Overall Study|Protocol Violation|0|||
154878117|NCT01894477|558978758|FG001|Overall Study|Protocol Violation|1|||
154878118|NCT01894477|558978757|FG000|Overall Study|protocol changed due SC changed to cord|0|||
154878119|NCT01894477|558978758|FG001|Overall Study|protocol changed due SC changed to cord|1|||
154878120|NCT00850759|558978761|FG000|Overall Study|Lost to Follow-up|7|||
154878121|NCT00850759|558978762|FG001|Overall Study|Lost to Follow-up|5|||
154878122|NCT00850759|558978763|FG002|Overall Study|Lost to Follow-up|5|||
154878123|NCT00850759|558978764|FG003|Overall Study|Lost to Follow-up|3|||
154878124|NCT02389816|558978765|FG000|Overall Study|Randomized but Not Treated|1|||
154878125|NCT02389816|558978766|FG001|Overall Study|Randomized but Not Treated|0|||
154878126|NCT02389816|558978767|FG002|Overall Study|Randomized but Not Treated|0|||
154878127|NCT02389816|558978765|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
154878128|NCT02389816|558978766|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
154878129|NCT02389816|558978767|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
154878130|NCT02389816|558978765|FG000|Overall Study|Major Protocol Deviation|1|||
154878131|NCT02389816|558978766|FG001|Overall Study|Major Protocol Deviation|0|||
155175349|NCT00910624|560080228|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
155175350|NCT00910624|560080229|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
155175351|NCT00910624|560080226|FG000|Treatment Phase|Withdrawal by Subject|2|||
155175352|NCT00910624|560080227|FG001|Treatment Phase|Withdrawal by Subject|1|||
155175353|NCT00910624|560080228|FG002|Treatment Phase|Withdrawal by Subject|0|||
155175354|NCT00910624|560080229|FG003|Treatment Phase|Withdrawal by Subject|0|||
155175355|NCT00910624|560080226|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
155175356|NCT00910624|560080227|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
154878132|NCT02389816|558978767|FG002|Overall Study|Major Protocol Deviation|0|||
154878133|NCT02389816|558978765|FG000|Overall Study|Lost to Follow-up|1|||
154878134|NCT02389816|558978766|FG001|Overall Study|Lost to Follow-up|0|||
154878135|NCT02389816|558978767|FG002|Overall Study|Lost to Follow-up|0|||
154878136|NCT02389816|558978765|FG000|Overall Study|Withdrawal of Consent|6|||
154878137|NCT02389816|558978766|FG001|Overall Study|Withdrawal of Consent|4|||
154878138|NCT02389816|558978767|FG002|Overall Study|Withdrawal of Consent|4|||
154878139|NCT02389816|558978765|FG000|Overall Study|Lack of Efficacy|1|||
154878140|NCT02389816|558978766|FG001|Overall Study|Lack of Efficacy|0|||
154878141|NCT02389816|558978767|FG002|Overall Study|Lack of Efficacy|0|||
154878142|NCT02389816|558978765|FG000|Overall Study|Non Compliance with Study Drug|1|||
154878143|NCT02389816|558978766|FG001|Overall Study|Non Compliance with Study Drug|1|||
154878144|NCT02389816|558978767|FG002|Overall Study|Non Compliance with Study Drug|1|||
154878145|NCT02389816|558978765|FG000|Overall Study|Reason not Specified|0|||
154878146|NCT02389816|558978766|FG001|Overall Study|Reason not Specified|2|||
154878147|NCT02389816|558978767|FG002|Overall Study|Reason not Specified|0|||
154878148|NCT00578864|558978768|FG000|Overall Study|Death|1|||
154878149|NCT00578864|558978769|FG001|Overall Study|Death|0|||
154878150|NCT01253044|558978770|FG000|Overall Study|Lost to Follow-up|38|||
154878151|NCT01253044|558978771|FG001|Overall Study|Lost to Follow-up|29|||
154878152|NCT01087528|558978772|FG000|Overall Study|Withdrawal by Subject|1|||
154878153|NCT01087528|558978772|FG000|Overall Study|Incomplete CE procedure|6|||
154878154|NCT03116399|558978773|FG000|Overall Study|Death|8|||
154878155|NCT03116399|558978774|FG001|Overall Study|Death|3|||
154878156|NCT03116399|558978773|FG000|Overall Study|Lost to Follow-up|7|||
154878157|NCT03116399|558978774|FG001|Overall Study|Lost to Follow-up|11|||
154878158|NCT03116399|558978773|FG000|Overall Study|Investigator Decision|1|||
155175357|NCT00910624|560080228|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
155175358|NCT00910624|560080229|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
154878159|NCT03116399|558978774|FG001|Overall Study|Investigator Decision|1|||
154878160|NCT03116399|558978773|FG000|Overall Study|Withdrawal by Subject|24|||
154878161|NCT03116399|558978774|FG001|Overall Study|Withdrawal by Subject|9|||
154878162|NCT02868216|558978776|FG000|Overall Study|Death|0|||
154878163|NCT02868216|558978777|FG001|Overall Study|Death|1|||
154878164|NCT02868216|558978776|FG000|Overall Study|coronary artery bypass|1|||
154878165|NCT02868216|558978777|FG001|Overall Study|coronary artery bypass|0|||
154878166|NCT02868216|558978776|FG000|Overall Study|Withdrawal by Subject|7|||
154878167|NCT02868216|558978777|FG001|Overall Study|Withdrawal by Subject|5|||
154878168|NCT00987623|558978778|FG000|Overall Study|Lost to Follow-up|2|||
154878169|NCT00987623|558978779|FG001|Overall Study|Lost to Follow-up|1|||
154878170|NCT00987623|558978778|FG000|Overall Study|Time/job conflict|2|||
154878171|NCT00987623|558978779|FG001|Overall Study|Time/job conflict|0|||
154878172|NCT00987623|558978778|FG000|Overall Study|Discomfort|1|||
154878173|NCT00987623|558978779|FG001|Overall Study|Discomfort|0|||
154878174|NCT00987623|558978778|FG000|Overall Study|Biomicroscopy|0|||
154878175|NCT00987623|558978779|FG001|Overall Study|Biomicroscopy|1|||
154878176|NCT00987623|558978778|FG000|Overall Study|Influenza|0|||
154878177|NCT00987623|558978779|FG001|Overall Study|Influenza|1|||
154878178|NCT00752609|558978780|FG000|Overall Study|Adverse Event|2|||
155175359|NCT00910624|560080226|FG000|Follow-Up Phase|Adverse Event|0|||
155175360|NCT00910624|560080227|FG001|Follow-Up Phase|Adverse Event|0|||
154878179|NCT00752609|558978781|FG001|Overall Study|Adverse Event|2|||
154878180|NCT00752609|558978780|FG000|Overall Study|Withdrawal by Subject|3|||
154878181|NCT00752609|558978781|FG001|Overall Study|Withdrawal by Subject|0|||
154878182|NCT00752609|558978780|FG000|Overall Study|Physician Decision|1|||
154878183|NCT00752609|558978781|FG001|Overall Study|Physician Decision|0|||
154878184|NCT00752609|558978780|FG000|Overall Study|Death|1|||
154878185|NCT00752609|558978781|FG001|Overall Study|Death|0|||
154878186|NCT00752609|558978780|FG000|Overall Study|Met exclusion criteria|1|||
154878187|NCT00752609|558978781|FG001|Overall Study|Met exclusion criteria|0|||
154878188|NCT00752609|558978780|FG000|Overall Study|Received Aranesp in error|1|||
154878189|NCT00752609|558978781|FG001|Overall Study|Received Aranesp in error|0|||
154878190|NCT05114590|558978782|FG000|Overall Study|Adverse Event|1|||
154878191|NCT05114590|558978782|FG000|Overall Study|Investigator decision|1|||
154878192|NCT05114590|558978782|FG000|Overall Study|Lost to Follow-up|5|||
154878193|NCT05114590|558978782|FG000|Overall Study|Withdrawal by Subject|5|||
154878194|NCT05114590|558978782|FG000|Overall Study|Other|2|||
154878195|NCT01425190|558978783|FG000|Overall Study|Full dose not consumed.|1|||
154878196|NCT01425190|558978784|FG001|Overall Study|Full dose not consumed.|0|||
154878197|NCT01425190|558978785|FG002|Overall Study|Full dose not consumed.|0|||
154878198|NCT00195260|558978786|FG000|Part 1: Dose Escalation|Adverse Event|0|||
154878199|NCT00195260|558978787|FG001|Part 1: Dose Escalation|Adverse Event|1|||
154878200|NCT00195260|558978788|FG002|Part 1: Dose Escalation|Adverse Event|0|||
154878201|NCT00195260|558978789|FG003|Part 1: Dose Escalation|Adverse Event|1|||
154878202|NCT00195260|558978790|FG004|Part 1: Dose Escalation|Adverse Event|1|||
154878203|NCT00195260|558978791|FG005|Part 1: Dose Escalation|Adverse Event|0|||
154878204|NCT00195260|558978792|FG006|Part 1: Dose Escalation|Adverse Event|3|||
154878205|NCT00195260|558978793|FG007|Part 1: Dose Escalation|Adverse Event|0|||
154878206|NCT00195260|558978794|FG008|Part 1: Dose Escalation|Adverse Event|0|||
154878207|NCT00195260|558978795|FG009|Part 1: Dose Escalation|Adverse Event|0|||
154878208|NCT00195260|558978796|FG010|Part 1: Dose Escalation|Adverse Event|0|||
154878209|NCT00195260|558978786|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878210|NCT00195260|558978787|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878211|NCT00195260|558978788|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878212|NCT00195260|558978789|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878213|NCT00195260|558978790|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
154878214|NCT00195260|558978791|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878215|NCT00195260|558978792|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878216|NCT00195260|558978793|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
154878217|NCT00195260|558978794|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878218|NCT00195260|558978795|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878219|NCT00195260|558978796|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
154878220|NCT00195260|558978786|FG000|Part 1: Dose Escalation|Death|0|||
154878221|NCT00195260|558978787|FG001|Part 1: Dose Escalation|Death|0|||
154878222|NCT00195260|558978788|FG002|Part 1: Dose Escalation|Death|0|||
154878223|NCT00195260|558978789|FG003|Part 1: Dose Escalation|Death|0|||
154878224|NCT00195260|558978790|FG004|Part 1: Dose Escalation|Death|0|||
154878225|NCT00195260|558978791|FG005|Part 1: Dose Escalation|Death|0|||
154878226|NCT00195260|558978792|FG006|Part 1: Dose Escalation|Death|0|||
154878227|NCT00195260|558978793|FG007|Part 1: Dose Escalation|Death|1|||
154878228|NCT00195260|558978794|FG008|Part 1: Dose Escalation|Death|0|||
154878229|NCT00195260|558978795|FG009|Part 1: Dose Escalation|Death|0|||
154878230|NCT00195260|558978796|FG010|Part 1: Dose Escalation|Death|0|||
154878231|NCT00195260|558978786|FG000|Part 1: Dose Escalation|Disease Progression|3|||
154878232|NCT00195260|558978787|FG001|Part 1: Dose Escalation|Disease Progression|2|||
154878233|NCT00195260|558978788|FG002|Part 1: Dose Escalation|Disease Progression|5|||
154878234|NCT00195260|558978789|FG003|Part 1: Dose Escalation|Disease Progression|6|||
154878235|NCT00195260|558978790|FG004|Part 1: Dose Escalation|Disease Progression|4|||
154878236|NCT00195260|558978791|FG005|Part 1: Dose Escalation|Disease Progression|6|||
154878237|NCT00195260|558978792|FG006|Part 1: Dose Escalation|Disease Progression|7|||
154878238|NCT00195260|558978793|FG007|Part 1: Dose Escalation|Disease Progression|4|||
154878239|NCT00195260|558978794|FG008|Part 1: Dose Escalation|Disease Progression|0|||
154878240|NCT00195260|558978795|FG009|Part 1: Dose Escalation|Disease Progression|0|||
154878241|NCT00195260|558978796|FG010|Part 1: Dose Escalation|Disease Progression|0|||
154878242|NCT00195260|558978786|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
154878243|NCT00195260|558978787|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
154878244|NCT00195260|558978788|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
155113152|NCT02589665|559844732|FG006|Maintenance Period|Lost to Follow-up|0|||
154878245|NCT00195260|558978789|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878246|NCT00195260|558978790|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878247|NCT00195260|558978791|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
154878248|NCT00195260|558978792|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878249|NCT00195260|558978793|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878250|NCT00195260|558978794|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878251|NCT00195260|558978795|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878252|NCT00195260|558978796|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
154878253|NCT00195260|558978786|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878254|NCT00195260|558978787|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878255|NCT00195260|558978788|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878256|NCT00195260|558978789|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878257|NCT00195260|558978790|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878258|NCT00195260|558978791|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878259|NCT00195260|558978792|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878260|NCT00195260|558978793|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
154878261|NCT00195260|558978794|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
154878262|NCT00195260|558978795|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
154878263|NCT00195260|558978796|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
154878264|NCT00195260|558978786|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154974552|NCT03310619|559331270|FG004|Pre-Treatment Period|Death|1|||
154974553|NCT03310619|559331271|FG005|Pre-Treatment Period|Death|0|||
154974554|NCT03310619|559331272|FG006|Pre-Treatment Period|Death|0|||
154878265|NCT00195260|558978787|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878266|NCT00195260|558978788|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878267|NCT00195260|558978789|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878268|NCT00195260|558978790|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878269|NCT00195260|558978791|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878270|NCT00195260|558978792|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878271|NCT00195260|558978793|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
154878272|NCT00195260|558978794|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
154878273|NCT00195260|558978795|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
154878274|NCT00195260|558978796|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
154878275|NCT00195260|558978786|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878276|NCT00195260|558978787|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878277|NCT00195260|558978788|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878278|NCT00195260|558978789|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878279|NCT00195260|558978790|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878280|NCT00195260|558978791|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878281|NCT00195260|558978792|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878282|NCT00195260|558978793|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
154878283|NCT00195260|558978794|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
154878284|NCT00195260|558978795|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
154878285|NCT00195260|558978796|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
154878286|NCT00195260|558978786|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878287|NCT00195260|558978787|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878288|NCT00195260|558978788|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154974555|NCT03310619|559331273|FG007|Pre-Treatment Period|Death|0|||
154974556|NCT03310619|559331266|FG000|Pre-Treatment Period|Other reasons|2|||
154974557|NCT03310619|559331267|FG001|Pre-Treatment Period|Other reasons|1|||
154974558|NCT03310619|559331268|FG002|Pre-Treatment Period|Other reasons|2|||
154974559|NCT03310619|559331269|FG003|Pre-Treatment Period|Other reasons|0|||
154974560|NCT03310619|559331270|FG004|Pre-Treatment Period|Other reasons|0|||
154974561|NCT03310619|559331271|FG005|Pre-Treatment Period|Other reasons|0|||
154974562|NCT03310619|559331272|FG006|Pre-Treatment Period|Other reasons|2|||
154974563|NCT03310619|559331273|FG007|Pre-Treatment Period|Other reasons|0|||
154974564|NCT03310619|559331266|FG000|Treatment Period|Death|1|||
154974565|NCT03310619|559331267|FG001|Treatment Period|Death|2|||
154974566|NCT03310619|559331268|FG002|Treatment Period|Death|0|||
154974567|NCT03310619|559331269|FG003|Treatment Period|Death|0|||
154974568|NCT03310619|559331270|FG004|Treatment Period|Death|1|||
154974569|NCT03310619|559331271|FG005|Treatment Period|Death|0|||
154974570|NCT03310619|559331272|FG006|Treatment Period|Death|2|||
154974571|NCT03310619|559331273|FG007|Treatment Period|Death|0|||
154974572|NCT03310619|559331266|FG000|Treatment Period|Adverse Event|0|||
154974573|NCT03310619|559331267|FG001|Treatment Period|Adverse Event|1|||
154974574|NCT03310619|559331268|FG002|Treatment Period|Adverse Event|4|||
154974575|NCT03310619|559331269|FG003|Treatment Period|Adverse Event|1|||
154974576|NCT03310619|559331270|FG004|Treatment Period|Adverse Event|0|||
154974577|NCT03310619|559331271|FG005|Treatment Period|Adverse Event|0|||
154974578|NCT03310619|559331272|FG006|Treatment Period|Adverse Event|0|||
154974579|NCT03310619|559331273|FG007|Treatment Period|Adverse Event|0|||
154974580|NCT03310619|559331266|FG000|Treatment Period|Withdrawal by participant|0|||
154974581|NCT03310619|559331267|FG001|Treatment Period|Withdrawal by participant|0|||
154974582|NCT03310619|559331268|FG002|Treatment Period|Withdrawal by participant|1|||
154974583|NCT03310619|559331269|FG003|Treatment Period|Withdrawal by participant|0|||
154974584|NCT03310619|559331270|FG004|Treatment Period|Withdrawal by participant|0|||
154974585|NCT03310619|559331271|FG005|Treatment Period|Withdrawal by participant|0|||
154974586|NCT03310619|559331272|FG006|Treatment Period|Withdrawal by participant|0|||
154878289|NCT00195260|558978789|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878290|NCT00195260|558978790|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878291|NCT00195260|558978791|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878292|NCT00195260|558978792|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878293|NCT00195260|558978793|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
154878294|NCT00195260|558978794|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
154878295|NCT00195260|558978795|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
154878296|NCT00195260|558978796|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
154878297|NCT02749721|558978797|FG000|Screening|Withdrawal by Subject|1|||
154878298|NCT02749721|558978797|FG000|Screening|Lost to Follow-up|2|||
154878299|NCT02749721|558978797|FG000|Screening|Protocol Violation|3|||
154878300|NCT02749721|558978797|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
154878301|NCT02749721|558978797|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
154878302|NCT01379534|558978798|FG000|Treatment Phase|Withdrawal by Subject|2|||
154878303|NCT01379534|558978799|FG001|Treatment Phase|Withdrawal by Subject|2|||
154878304|NCT01379534|558978798|FG000|Treatment Phase|Progressive disease|13|||
154878305|NCT01379534|558978799|FG001|Treatment Phase|Progressive disease|22|||
154878306|NCT01379534|558978798|FG000|Treatment Phase|Adverse Event|7|||
154878307|NCT01379534|558978799|FG001|Treatment Phase|Adverse Event|7|||
154878308|NCT01379534|558978798|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
154878309|NCT01379534|558978799|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
154878310|NCT01379534|558978798|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
154878311|NCT01379534|558978799|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
154878312|NCT01379534|558978798|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
154878313|NCT01379534|558978799|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
154878314|NCT01379534|558978798|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
154878315|NCT01379534|558978799|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
154878316|NCT02691247|558978800|FG000|Overall Study|Withdrawal by Subject|1|||
154878317|NCT02691247|558978801|FG001|Overall Study|Withdrawal by Subject|2|||
154878318|NCT02691247|558978802|FG002|Overall Study|Withdrawal by Subject|2|||
154878319|NCT02691247|558978800|FG000|Overall Study|Lost to Follow-up|2|||
154878320|NCT02691247|558978801|FG001|Overall Study|Lost to Follow-up|0|||
154878321|NCT02691247|558978802|FG002|Overall Study|Lost to Follow-up|1|||
154878322|NCT01519245|558978803|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
154878323|NCT01519245|558978804|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
154878324|NCT02582749|558978805|FG000|Overall Study|Study terminated by funder|5|||
154878325|NCT02582749|558978806|FG001|Overall Study|Study terminated by funder|10|||
154878326|NCT02582749|558978805|FG000|Overall Study|Withdrawal by Subject|0|||
154878327|NCT02582749|558978806|FG001|Overall Study|Withdrawal by Subject|1|||
154878328|NCT02213198|558978807|FG000|Baseline|No show for intake|7|||
154878329|NCT02213198|558978808|FG001|Baseline|No show for intake|9|||
154878330|NCT02213198|558978807|FG000|Baseline|Withdrawal by Subject|34|||
154878331|NCT02213198|558978808|FG001|Baseline|Withdrawal by Subject|11|||
154878332|NCT02213198|558978807|FG000|Baseline|transferred out of clinic|7|||
154878333|NCT02213198|558978808|FG001|Baseline|transferred out of clinic|9|||
154878334|NCT02213198|558978807|FG000|Baseline|Lost to Follow-up|40|||
154878335|NCT02213198|558978808|FG001|Baseline|Lost to Follow-up|21|||
154878336|NCT02213198|558978807|FG000|Baseline|incarcerated,violent|0|||
154878337|NCT02213198|558978808|FG001|Baseline|incarcerated,violent|1|||
154878338|NCT02213198|558978807|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
154878339|NCT02213198|558978808|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
154878340|NCT02213198|558978807|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
154878341|NCT02213198|558978808|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
154878342|NCT02213198|558978807|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
154878343|NCT02213198|558978808|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
154878344|NCT02213198|558978807|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
154878345|NCT02213198|558978808|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
154878346|NCT02213198|558978807|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
154878347|NCT02213198|558978808|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
154878348|NCT02213198|558978807|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
154878349|NCT02213198|558978808|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
154878350|NCT01518192|558978809|FG000|Overall Study|Lost to Follow-up|29|||
155113153|NCT02589665|559844733|FG007|Maintenance Period|Lost to Follow-up|0|||
155113154|NCT02589665|559844734|FG008|Maintenance Period|Lost to Follow-up|0|||
155113155|NCT02589665|559844735|FG009|Maintenance Period|Lost to Follow-up|0|||
155113156|NCT02589665|559844726|FG000|Maintenance Period|Physician Decision|0|||
154878351|NCT01518192|558978810|FG001|Overall Study|Lost to Follow-up|26|||
154878352|NCT01518192|558978811|FG002|Overall Study|Lost to Follow-up|35|||
154878353|NCT00001262|558978812|FG000|Overall Study|Death|10|||
154878354|NCT00001262|558978813|FG001|Overall Study|Death|11|||
154878355|NCT00001262|558978814|FG002|Overall Study|Death|0|||
154878356|NCT00001262|558978812|FG000|Overall Study|Withdrawal by Subject|0|||
154878357|NCT00001262|558978813|FG001|Overall Study|Withdrawal by Subject|3|||
154878358|NCT00001262|558978814|FG002|Overall Study|Withdrawal by Subject|0|||
154878359|NCT00783705|558978815|FG000|Overall Study|Adverse Event|2|||
154878360|NCT00783705|558978816|FG001|Overall Study|Adverse Event|0|||
154878361|NCT00783705|558978815|FG000|Overall Study|Withdrawal by Subject|3|||
154878362|NCT00783705|558978816|FG001|Overall Study|Withdrawal by Subject|2|||
154878363|NCT00783705|558978815|FG000|Overall Study|Lost to Follow-up|1|||
154878364|NCT00783705|558978816|FG001|Overall Study|Lost to Follow-up|3|||
154878365|NCT01402284|558978817|FG000|Overall Study|Withdrawal consent|2|||
154878366|NCT01402284|558978817|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
154878367|NCT01402284|558978817|FG000|Overall Study|Physician Decision|1|||
154878368|NCT01402284|558978817|FG000|Overall Study|Disease progression on study|10|||
154878369|NCT04038255|558980517|FG000|Overall Study|Lost to Follow-up|0|||
154878370|NCT04038255|558980518|FG001|Overall Study|Lost to Follow-up|9|||
154878371|NCT04038255|558980519|FG002|Overall Study|Lost to Follow-up|5|||
154878372|NCT04038255|558980517|FG000|Overall Study|Withdrawal by Subject|0|||
154878373|NCT04038255|558980518|FG001|Overall Study|Withdrawal by Subject|0|||
154878374|NCT04038255|558980519|FG002|Overall Study|Withdrawal by Subject|1|||
154878375|NCT05183867|558980520|FG000|Overall Study|Withdrawal by Subject|3|||
154878376|NCT05183867|558980521|FG001|Overall Study|Withdrawal by Subject|2|||
154878377|NCT05183867|558980522|FG002|Overall Study|Withdrawal by Subject|0|||
154878378|NCT04491877|558980523|FG000|Overall Study|Protocol Deviation|1|||
154878379|NCT04491877|558980524|FG001|Overall Study|Protocol Deviation|0|||
154878380|NCT04491877|558980525|FG002|Overall Study|Protocol Deviation|2|||
154878381|NCT04491877|558980526|FG003|Overall Study|Protocol Deviation|0|||
154878382|NCT04491877|558980527|FG004|Overall Study|Protocol Deviation|0|||
154878383|NCT04491877|558980528|FG005|Overall Study|Protocol Deviation|0|||
154878384|NCT04491877|558980529|FG006|Overall Study|Protocol Deviation|1|||
154878385|NCT04491877|558980530|FG007|Overall Study|Protocol Deviation|1|||
154878386|NCT04491877|558980531|FG008|Overall Study|Protocol Deviation|0|||
154878387|NCT04491877|558980523|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
154878388|NCT04491877|558980524|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154878389|NCT04491877|558980525|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
154878390|NCT04491877|558980526|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
154878391|NCT04491877|558980527|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
154878392|NCT04491877|558980528|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
154878393|NCT04491877|558980529|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
154878394|NCT04491877|558980530|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
154878395|NCT04491877|558980531|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
154878396|NCT04491877|558980523|FG000|Overall Study|Lost to Follow-up|0|||
154878397|NCT04491877|558980524|FG001|Overall Study|Lost to Follow-up|2|||
154878398|NCT04491877|558980525|FG002|Overall Study|Lost to Follow-up|0|||
154878399|NCT04491877|558980526|FG003|Overall Study|Lost to Follow-up|0|||
154878400|NCT04491877|558980527|FG004|Overall Study|Lost to Follow-up|0|||
154878401|NCT04491877|558980528|FG005|Overall Study|Lost to Follow-up|0|||
154878402|NCT04491877|558980529|FG006|Overall Study|Lost to Follow-up|2|||
154878403|NCT04491877|558980530|FG007|Overall Study|Lost to Follow-up|1|||
154878404|NCT04491877|558980531|FG008|Overall Study|Lost to Follow-up|1|||
155113157|NCT02589665|559844727|FG001|Maintenance Period|Physician Decision|0|||
155113158|NCT02589665|559844728|FG002|Maintenance Period|Physician Decision|0|||
154878405|NCT00441441|558980534|FG000|Overall Study|Adverse Event|2|||
154878406|NCT00441441|558980535|FG001|Overall Study|Adverse Event|1|||
154878407|NCT00441441|558980534|FG000|Overall Study|Protocol Violation|4|||
154878408|NCT00441441|558980535|FG001|Overall Study|Protocol Violation|6|||
154878409|NCT00441441|558980534|FG000|Overall Study|Exacerbation of asthma|1|||
154878410|NCT00441441|558980535|FG001|Overall Study|Exacerbation of asthma|2|||
154878411|NCT00441441|558980534|FG000|Overall Study|Withdrawal by Subject|1|||
154878412|NCT00441441|558980535|FG001|Overall Study|Withdrawal by Subject|2|||
154878413|NCT00441441|558980534|FG000|Overall Study|Other|3|||
154878414|NCT00441441|558980535|FG001|Overall Study|Other|3|||
154878415|NCT05619172|558980539|FG000|Safety Cohort 1|Death|7|||
154878416|NCT05619172|558980540|FG001|Safety Cohort 1|Death|0|||
154878417|NCT05619172|558980539|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
154878418|NCT05619172|558980540|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
154878419|NCT05619172|558980539|FG000|Safety Cohort 2|Death|0|||
154878420|NCT05619172|558980540|FG001|Safety Cohort 2|Death|1|||
154878421|NCT05619172|558980539|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
154878422|NCT05619172|558980540|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
154878423|NCT05151471|558980541|FG000|Overall Study|Adverse Event|21|||
154878424|NCT05151471|558980542|FG001|Overall Study|Adverse Event|16|||
154974587|NCT03310619|559331273|FG007|Treatment Period|Withdrawal by participant|0|||
154878425|NCT05151471|558980541|FG000|Overall Study|Death|1|||
154878426|NCT05151471|558980542|FG001|Overall Study|Death|0|||
154878427|NCT05151471|558980541|FG000|Overall Study|Lost to Follow-up|0|||
154878428|NCT05151471|558980542|FG001|Overall Study|Lost to Follow-up|1|||
154878429|NCT05151471|558980541|FG000|Overall Study|Withdrawal by Subject|7|||
154878430|NCT05151471|558980542|FG001|Overall Study|Withdrawal by Subject|9|||
155113159|NCT02589665|559844729|FG003|Maintenance Period|Physician Decision|0|||
154878431|NCT05151471|558980541|FG000|Overall Study|Study terminated by sponsor|49|||
154878432|NCT05151471|558980542|FG001|Overall Study|Study terminated by sponsor|47|||
154878433|NCT05151471|558980541|FG000|Overall Study|Other|2|||
154878434|NCT05151471|558980542|FG001|Overall Study|Other|1|||
154878435|NCT03165721|558980543|FG000|Overall Study|Refused further treatment|3|||
154878436|NCT03165721|558980544|FG001|Overall Study|Refused further treatment|0|||
154878437|NCT03165721|558980545|FG002|Overall Study|Refused further treatment|0|||
154878438|NCT03165721|558980543|FG000|Overall Study|Physician Decision|1|||
154878439|NCT03165721|558980544|FG001|Overall Study|Physician Decision|0|||
154878440|NCT03165721|558980545|FG002|Overall Study|Physician Decision|0|||
154878441|NCT01457118|558980547|FG000|Overall Study|Adverse Event|1|||
154878442|NCT01457118|558980548|FG001|Overall Study|Adverse Event|0|||
154878443|NCT01457118|558980549|FG002|Overall Study|Adverse Event|0|||
154878444|NCT01457118|558980550|FG003|Overall Study|Adverse Event|1|||
154878445|NCT01457118|558980547|FG000|Overall Study|Clinical Progression|0|||
154878446|NCT01457118|558980548|FG001|Overall Study|Clinical Progression|1|||
154878447|NCT01457118|558980549|FG002|Overall Study|Clinical Progression|0|||
154878448|NCT01457118|558980550|FG003|Overall Study|Clinical Progression|1|||
154878449|NCT01457118|558980547|FG000|Overall Study|Physician Decision|2|||
154878450|NCT01457118|558980548|FG001|Overall Study|Physician Decision|0|||
154878451|NCT01457118|558980549|FG002|Overall Study|Physician Decision|0|||
154878452|NCT01457118|558980550|FG003|Overall Study|Physician Decision|0|||
154878453|NCT01457118|558980547|FG000|Overall Study|Progressive Disease by RECIST|12|||
154878454|NCT01457118|558980548|FG001|Overall Study|Progressive Disease by RECIST|3|||
154878455|NCT01457118|558980549|FG002|Overall Study|Progressive Disease by RECIST|1|||
154878456|NCT01457118|558980550|FG003|Overall Study|Progressive Disease by RECIST|0|||
154878457|NCT01457118|558980547|FG000|Overall Study|Withdrawal by Subject|5|||
154878458|NCT01457118|558980548|FG001|Overall Study|Withdrawal by Subject|0|||
154878459|NCT01457118|558980549|FG002|Overall Study|Withdrawal by Subject|0|||
154878460|NCT01457118|558980550|FG003|Overall Study|Withdrawal by Subject|0|||
154878461|NCT03298412|558980551|FG000|Run-in Period|Other, Not Specified|1|||
154878462|NCT03298412|558980551|FG000|Run-in Period|Disease Progression|1|||
154878463|NCT03298412|558980551|FG000|Run-in Period|Ineligibility Determined|1|||
154878464|NCT03298412|558980551|FG000|Run-in Period|Decision by Sponsor|6|||
154878465|NCT03456713|558980552|FG000|Overall Study|Lost to Follow-up|1|||
154878466|NCT03456713|558980553|FG001|Overall Study|Lost to Follow-up|0|||
154878467|NCT03456713|558980554|FG002|Overall Study|Lost to Follow-up|0|||
154878468|NCT03456713|558980555|FG003|Overall Study|Lost to Follow-up|0|||
154878469|NCT03656926|558980556|FG000|Overall Study|Adverse Event|5|||
154878470|NCT03656926|558980557|FG001|Overall Study|Adverse Event|4|||
154878471|NCT03656926|558980556|FG000|Overall Study|Withdrawal by Subject|7|||
154878472|NCT03656926|558980557|FG001|Overall Study|Withdrawal by Subject|2|||
154878473|NCT03656926|558980556|FG000|Overall Study|Screen fail after randomization|1|||
155113160|NCT02589665|559844730|FG004|Maintenance Period|Physician Decision|0|||
155113161|NCT02589665|559844731|FG005|Maintenance Period|Physician Decision|1|||
155113162|NCT02589665|559844732|FG006|Maintenance Period|Physician Decision|0|||
155113163|NCT02589665|559844733|FG007|Maintenance Period|Physician Decision|0|||
155113164|NCT02589665|559844734|FG008|Maintenance Period|Physician Decision|0|||
155113165|NCT02589665|559844735|FG009|Maintenance Period|Physician Decision|0|||
155113166|NCT02589665|559844726|FG000|Maintenance Period|Reason Not Collected|0|||
155113167|NCT02589665|559844727|FG001|Maintenance Period|Reason Not Collected|0|||
155113168|NCT02589665|559844728|FG002|Maintenance Period|Reason Not Collected|0|||
155113169|NCT02589665|559844729|FG003|Maintenance Period|Reason Not Collected|0|||
154878474|NCT03656926|558980557|FG001|Overall Study|Screen fail after randomization|0|||
154878475|NCT03656926|558980556|FG000|Overall Study|PI decision due to patient condition|1|||
154878476|NCT03656926|558980557|FG001|Overall Study|PI decision due to patient condition|0|||
154878477|NCT03656926|558980556|FG000|Overall Study|Patient unresponsiveness|1|||
154878478|NCT03656926|558980557|FG001|Overall Study|Patient unresponsiveness|0|||
154878479|NCT00069095|558980558|FG000|Primary Treatment Phase|Ongoing|0|||
154878480|NCT00069095|558980559|FG001|Primary Treatment Phase|Ongoing|0|||
154878481|NCT00069095|558980560|FG002|Primary Treatment Phase|Ongoing|5|||
154878482|NCT00069095|558980561|FG003|Primary Treatment Phase|Ongoing|7|||
154878483|NCT00069095|558980562|FG004|Primary Treatment Phase|Ongoing|7|||
154878484|NCT00069095|558980563|FG005|Primary Treatment Phase|Ongoing|4|||
154878485|NCT00069095|558980558|FG000|Primary Treatment Phase|Admin/Other|29|||
154878486|NCT00069095|558980559|FG001|Primary Treatment Phase|Admin/Other|38|||
154878487|NCT00069095|558980560|FG002|Primary Treatment Phase|Admin/Other|31|||
154878488|NCT00069095|558980561|FG003|Primary Treatment Phase|Admin/Other|45|||
154878489|NCT00069095|558980562|FG004|Primary Treatment Phase|Admin/Other|48|||
154878490|NCT00069095|558980563|FG005|Primary Treatment Phase|Admin/Other|42|||
155113170|NCT02589665|559844730|FG004|Maintenance Period|Reason Not Collected|0|||
155113171|NCT02589665|559844731|FG005|Maintenance Period|Reason Not Collected|1|||
154878491|NCT00069095|558980558|FG000|Primary Treatment Phase|Adverse Event|99|||
154878492|NCT00069095|558980559|FG001|Primary Treatment Phase|Adverse Event|92|||
154878493|NCT00069095|558980560|FG002|Primary Treatment Phase|Adverse Event|71|||
154878494|NCT00069095|558980561|FG003|Primary Treatment Phase|Adverse Event|72|||
155113172|NCT02589665|559844732|FG006|Maintenance Period|Reason Not Collected|1|||
154878495|NCT00069095|558980562|FG004|Primary Treatment Phase|Adverse Event|109|||
154878496|NCT00069095|558980563|FG005|Primary Treatment Phase|Adverse Event|101|||
154878497|NCT00069095|558980558|FG000|Primary Treatment Phase|Death|14|||
154878498|NCT00069095|558980559|FG001|Primary Treatment Phase|Death|8|||
154878499|NCT00069095|558980560|FG002|Primary Treatment Phase|Death|2|||
154878500|NCT00069095|558980561|FG003|Primary Treatment Phase|Death|5|||
154878501|NCT00069095|558980562|FG004|Primary Treatment Phase|Death|8|||
154878502|NCT00069095|558980563|FG005|Primary Treatment Phase|Death|8|||
154878503|NCT00069095|558980558|FG000|Primary Treatment Phase|Failure to return|5|||
154878504|NCT00069095|558980559|FG001|Primary Treatment Phase|Failure to return|5|||
154878505|NCT00069095|558980560|FG002|Primary Treatment Phase|Failure to return|0|||
154878506|NCT00069095|558980561|FG003|Primary Treatment Phase|Failure to return|0|||
154878507|NCT00069095|558980562|FG004|Primary Treatment Phase|Failure to return|0|||
154878508|NCT00069095|558980563|FG005|Primary Treatment Phase|Failure to return|2|||
154878509|NCT00069095|558980558|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
154878510|NCT00069095|558980559|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
154878511|NCT00069095|558980560|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
154878512|NCT00069095|558980561|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
154878513|NCT00069095|558980562|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
154878514|NCT00069095|558980563|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
154878515|NCT00069095|558980558|FG000|Primary Treatment Phase|Refused treatment|15|||
154878516|NCT00069095|558980559|FG001|Primary Treatment Phase|Refused treatment|26|||
154878517|NCT00069095|558980560|FG002|Primary Treatment Phase|Refused treatment|17|||
154878518|NCT00069095|558980561|FG003|Primary Treatment Phase|Refused treatment|31|||
154878519|NCT00069095|558980562|FG004|Primary Treatment Phase|Refused treatment|24|||
154878520|NCT00069095|558980563|FG005|Primary Treatment Phase|Refused treatment|27|||
154878521|NCT00069095|558980558|FG000|Primary Treatment Phase|Withdrew|2|||
154878522|NCT00069095|558980559|FG001|Primary Treatment Phase|Withdrew|3|||
154878523|NCT00069095|558980560|FG002|Primary Treatment Phase|Withdrew|8|||
154878524|NCT00069095|558980561|FG003|Primary Treatment Phase|Withdrew|2|||
154878525|NCT00069095|558980562|FG004|Primary Treatment Phase|Withdrew|4|||
154878526|NCT00069095|558980563|FG005|Primary Treatment Phase|Withdrew|9|||
154878527|NCT00069095|558980558|FG000|Primary Treatment Phase|Other Violation|0|||
154878528|NCT00069095|558980559|FG001|Primary Treatment Phase|Other Violation|1|||
154878529|NCT00069095|558980560|FG002|Primary Treatment Phase|Other Violation|1|||
154878530|NCT00069095|558980561|FG003|Primary Treatment Phase|Other Violation|1|||
154878531|NCT00069095|558980562|FG004|Primary Treatment Phase|Other Violation|0|||
154878532|NCT00069095|558980563|FG005|Primary Treatment Phase|Other Violation|1|||
154878533|NCT00069095|558980558|FG000|Primary Treatment Phase|Violation criteria|0|||
154878534|NCT00069095|558980559|FG001|Primary Treatment Phase|Violation criteria|2|||
154878535|NCT00069095|558980560|FG002|Primary Treatment Phase|Violation criteria|4|||
154878536|NCT00069095|558980561|FG003|Primary Treatment Phase|Violation criteria|3|||
154878537|NCT00069095|558980562|FG004|Primary Treatment Phase|Violation criteria|1|||
154878538|NCT00069095|558980563|FG005|Primary Treatment Phase|Violation criteria|5|||
154878539|NCT00069095|558980558|FG000|Post-study Treatment Phase|Missing reason|1|||
154878540|NCT00069095|558980559|FG001|Post-study Treatment Phase|Missing reason|3|||
154878541|NCT00069095|558980560|FG002|Post-study Treatment Phase|Missing reason|12|||
154878542|NCT00069095|558980561|FG003|Post-study Treatment Phase|Missing reason|8|||
154878543|NCT00069095|558980562|FG004|Post-study Treatment Phase|Missing reason|18|||
154878544|NCT00069095|558980563|FG005|Post-study Treatment Phase|Missing reason|17|||
154878545|NCT00069095|558980558|FG000|Post-study Treatment Phase|Adverse Event|2|||
154878546|NCT00069095|558980559|FG001|Post-study Treatment Phase|Adverse Event|3|||
154878547|NCT00069095|558980560|FG002|Post-study Treatment Phase|Adverse Event|1|||
154878548|NCT00069095|558980561|FG003|Post-study Treatment Phase|Adverse Event|0|||
154878549|NCT00069095|558980562|FG004|Post-study Treatment Phase|Adverse Event|5|||
154878550|NCT00069095|558980563|FG005|Post-study Treatment Phase|Adverse Event|1|||
154878551|NCT00069095|558980558|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
154878552|NCT00069095|558980559|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
154878553|NCT00069095|558980560|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
154878554|NCT00069095|558980561|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
154878555|NCT00069095|558980562|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
154878556|NCT00069095|558980563|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
154878557|NCT00069095|558980558|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
154878558|NCT00069095|558980559|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
154878559|NCT00069095|558980560|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
154878560|NCT00069095|558980561|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
154878561|NCT00069095|558980562|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
154878562|NCT00069095|558980563|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
154878563|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
155175361|NCT00910624|560080228|FG002|Follow-Up Phase|Adverse Event|1|||
154878564|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
154878565|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
154878566|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
154878567|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
154878568|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
154878569|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant had complete response|1|||
154878570|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant had complete response|1|||
154878571|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant had complete response|0|||
154878572|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant had complete response|0|||
154878573|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant had complete response|0|||
154878574|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant had complete response|0|||
154878575|NCT00069095|558980558|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
154878576|NCT00069095|558980559|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
154878577|NCT00069095|558980560|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
154878578|NCT00069095|558980561|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
154878579|NCT00069095|558980562|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
154878580|NCT00069095|558980563|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
154878581|NCT00069095|558980558|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
154878582|NCT00069095|558980559|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
154878583|NCT00069095|558980560|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
154878584|NCT00069095|558980561|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
154878585|NCT00069095|558980562|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
154878586|NCT00069095|558980563|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
154878587|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
154878588|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
154878589|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
154878590|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
154878591|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
154878592|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
154878593|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
154878594|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
154878595|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
154878596|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
154878597|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
154878598|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
154878599|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
154878600|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
154878601|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
154878602|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
154878603|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
154878604|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
154878605|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
154878606|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
154878607|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
154878608|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
154878609|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
154878610|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
154878611|NCT00069095|558980558|FG000|Post-study Treatment Phase|Surgery|0|||
154878612|NCT00069095|558980559|FG001|Post-study Treatment Phase|Surgery|0|||
154878613|NCT00069095|558980560|FG002|Post-study Treatment Phase|Surgery|0|||
154878614|NCT00069095|558980561|FG003|Post-study Treatment Phase|Surgery|1|||
154878615|NCT00069095|558980562|FG004|Post-study Treatment Phase|Surgery|1|||
154878616|NCT00069095|558980563|FG005|Post-study Treatment Phase|Surgery|0|||
154878617|NCT00069095|558980558|FG000|Post-study Treatment Phase|Death|0|||
154878618|NCT00069095|558980559|FG001|Post-study Treatment Phase|Death|0|||
154878619|NCT00069095|558980560|FG002|Post-study Treatment Phase|Death|0|||
154878620|NCT00069095|558980561|FG003|Post-study Treatment Phase|Death|0|||
154878621|NCT00069095|558980562|FG004|Post-study Treatment Phase|Death|1|||
154878622|NCT00069095|558980563|FG005|Post-study Treatment Phase|Death|0|||
154878623|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
154878624|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
154878625|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
154878626|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
154878627|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
154974588|NCT03310619|559331266|FG000|Treatment Period|Lost to Follow-up|0|||
154974589|NCT03310619|559331267|FG001|Treatment Period|Lost to Follow-up|0|||
154878628|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
154878629|NCT00069095|558980558|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
154878630|NCT00069095|558980559|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
154878631|NCT00069095|558980560|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
154878632|NCT00069095|558980561|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
154878633|NCT00069095|558980562|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
154878634|NCT00069095|558980563|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
154878635|NCT00069095|558980558|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
154878636|NCT00069095|558980559|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
154878637|NCT00069095|558980560|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
154878638|NCT00069095|558980561|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
154878639|NCT00069095|558980562|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
154878640|NCT00069095|558980563|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
154878641|NCT00069095|558980558|FG000|Post-study Treatment Phase|Investigator decision|0|||
154878642|NCT00069095|558980559|FG001|Post-study Treatment Phase|Investigator decision|0|||
154878643|NCT00069095|558980560|FG002|Post-study Treatment Phase|Investigator decision|0|||
154878644|NCT00069095|558980561|FG003|Post-study Treatment Phase|Investigator decision|0|||
154878645|NCT00069095|558980562|FG004|Post-study Treatment Phase|Investigator decision|0|||
154878646|NCT00069095|558980563|FG005|Post-study Treatment Phase|Investigator decision|1|||
154878647|NCT00069095|558980558|FG000|Follow-up Phase|Death|174|||
154878648|NCT00069095|558980559|FG001|Follow-up Phase|Death|206|||
154878649|NCT00069095|558980560|FG002|Follow-up Phase|Death|120|||
154878650|NCT00069095|558980561|FG003|Follow-up Phase|Death|112|||
154878651|NCT00069095|558980562|FG004|Follow-up Phase|Death|92|||
154878652|NCT00069095|558980563|FG005|Follow-up Phase|Death|101|||
154878653|NCT05610176|558980564|FG000|Overall Study|Death|6|||
154878654|NCT01217190|558980576|FG000|Second Dosing|Withdrawal by Subject|0|||
154878655|NCT01217190|558980577|FG001|Second Dosing|Withdrawal by Subject|2|||
154878656|NCT01594476|558980578|FG000|Overall Study|Protocol Violation|1|||
154878657|NCT01594476|558980579|FG001|Overall Study|Protocol Violation|3|||
154878658|NCT03161678|558980584|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
154878659|NCT03161678|558980585|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
154878660|NCT03161678|558980586|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
154878661|NCT03161678|558980587|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
154878662|NCT03161678|558980588|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
154878663|NCT03161678|558980589|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
154878664|NCT03161678|558980584|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
154878665|NCT03161678|558980585|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
154878666|NCT03161678|558980586|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
154878667|NCT03161678|558980587|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
154878668|NCT03161678|558980588|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
154878669|NCT03161678|558980589|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
154878670|NCT03161678|558980584|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
154878671|NCT03161678|558980585|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
154878672|NCT03161678|558980586|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
154878673|NCT03161678|558980587|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
154878674|NCT03161678|558980588|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
154878675|NCT03161678|558980589|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
154878676|NCT03161678|558980584|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
154878677|NCT03161678|558980585|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
154878678|NCT03161678|558980586|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
154878679|NCT03161678|558980587|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
154878680|NCT03161678|558980588|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
154878681|NCT03161678|558980589|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
154878682|NCT02552355|558980590|FG000|Overall Study|Adverse Event|0|||
154878683|NCT02552355|558980591|FG001|Overall Study|Adverse Event|2|||
154878684|NCT02552355|558980592|FG002|Overall Study|Adverse Event|2|||
154878685|NCT02552355|558980593|FG003|Overall Study|Adverse Event|0|||
154878686|NCT02552355|558980590|FG000|Overall Study|Withdrawal by Subject|0|||
154878687|NCT02552355|558980591|FG001|Overall Study|Withdrawal by Subject|0|||
154878688|NCT02552355|558980592|FG002|Overall Study|Withdrawal by Subject|0|||
154878689|NCT02552355|558980593|FG003|Overall Study|Withdrawal by Subject|1|||
154878690|NCT00850460|558980596|FG000|Overall Study|Lost to Follow-up|4|||
154878691|NCT00850460|558980597|FG001|Overall Study|Lost to Follow-up|4|||
154878692|NCT03007953|558980600|FG000|Overall Study|Withdrawal by Subject|5|||
154878693|NCT03007953|558980601|FG001|Overall Study|Withdrawal by Subject|2|||
154878694|NCT03007953|558980600|FG000|Overall Study|Death|5|||
154878695|NCT03007953|558980601|FG001|Overall Study|Death|7|||
154878696|NCT03007953|558980600|FG000|Overall Study|Lost to Follow-up|3|||
154878697|NCT03007953|558980601|FG001|Overall Study|Lost to Follow-up|2|||
154878698|NCT03007953|558980600|FG000|Overall Study|Enrolled in Hospice|3|||
154878699|NCT03007953|558980601|FG001|Overall Study|Enrolled in Hospice|2|||
154878700|NCT01052012|558980602|FG000|Overall Study|Not treated|2|||
154878701|NCT01052012|558980603|FG001|Overall Study|Not treated|5|||
154878702|NCT01052012|558980604|FG002|Overall Study|Not treated|0|||
154878703|NCT01052012|558980605|FG003|Overall Study|Not treated|0|||
154878704|NCT01052012|558980606|FG004|Overall Study|Not treated|11|||
154878705|NCT01052012|558980607|FG005|Overall Study|Not treated|8|||
154878706|NCT01052012|558980602|FG000|Overall Study|Adverse Event|1|||
154878707|NCT01052012|558980603|FG001|Overall Study|Adverse Event|0|||
154878708|NCT01052012|558980604|FG002|Overall Study|Adverse Event|0|||
154878709|NCT01052012|558980605|FG003|Overall Study|Adverse Event|1|||
154878710|NCT01052012|558980606|FG004|Overall Study|Adverse Event|0|||
154878711|NCT01052012|558980607|FG005|Overall Study|Adverse Event|0|||
154878712|NCT01052012|558980602|FG000|Overall Study|Lost to Follow-up|0|||
154878713|NCT01052012|558980603|FG001|Overall Study|Lost to Follow-up|0|||
154878714|NCT01052012|558980604|FG002|Overall Study|Lost to Follow-up|0|||
154878715|NCT01052012|558980605|FG003|Overall Study|Lost to Follow-up|0|||
154878716|NCT01052012|558980606|FG004|Overall Study|Lost to Follow-up|1|||
154878717|NCT01052012|558980607|FG005|Overall Study|Lost to Follow-up|0|||
154878718|NCT01052012|558980602|FG000|Overall Study|Withdrawal by Subject|1|||
154878719|NCT01052012|558980603|FG001|Overall Study|Withdrawal by Subject|1|||
154878720|NCT01052012|558980604|FG002|Overall Study|Withdrawal by Subject|0|||
154878721|NCT01052012|558980605|FG003|Overall Study|Withdrawal by Subject|0|||
154878722|NCT01052012|558980606|FG004|Overall Study|Withdrawal by Subject|3|||
154878723|NCT01052012|558980607|FG005|Overall Study|Withdrawal by Subject|1|||
154878724|NCT01052012|558980602|FG000|Overall Study|Physician Decision|0|||
154878725|NCT01052012|558980603|FG001|Overall Study|Physician Decision|0|||
154878726|NCT01052012|558980604|FG002|Overall Study|Physician Decision|0|||
154878727|NCT01052012|558980605|FG003|Overall Study|Physician Decision|0|||
154878728|NCT01052012|558980606|FG004|Overall Study|Physician Decision|0|||
154878729|NCT01052012|558980607|FG005|Overall Study|Physician Decision|1|||
154878730|NCT01052012|558980602|FG000|Overall Study|Other|0|||
154878731|NCT01052012|558980603|FG001|Overall Study|Other|0|||
154878732|NCT01052012|558980604|FG002|Overall Study|Other|0|||
154878733|NCT01052012|558980605|FG003|Overall Study|Other|0|||
154878734|NCT01052012|558980606|FG004|Overall Study|Other|1|||
154878735|NCT01052012|558980607|FG005|Overall Study|Other|0|||
154878736|NCT02224846|558980608|FG000|Period 1 (Month 3)|Adverse Event|2|||
154878737|NCT02224846|558980609|FG001|Period 1 (Month 3)|Adverse Event|1|||
154878738|NCT02224846|558980608|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
154878739|NCT02224846|558980609|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
154878740|NCT02224846|558980608|FG000|Period 1 (Month 3)|Protocol Violation|4|||
154878741|NCT02224846|558980609|FG001|Period 1 (Month 3)|Protocol Violation|8|||
154878742|NCT02224846|558980608|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
154878743|NCT02224846|558980609|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
154878744|NCT02224846|558980608|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
154878745|NCT02224846|558980609|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
154878746|NCT02224846|558980608|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
154878747|NCT02224846|558980609|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
154878748|NCT02224846|558980608|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
154878749|NCT02224846|558980609|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
154878750|NCT02224846|558980608|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
154878751|NCT02224846|558980609|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
154878752|NCT02224846|558980608|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
154878753|NCT02224846|558980609|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
154878754|NCT02224846|558980608|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
154974590|NCT03310619|559331268|FG002|Treatment Period|Lost to Follow-up|0|||
154878755|NCT02224846|558980609|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
154878756|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
154878757|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
154878758|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
154878759|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
154878760|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
154878761|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
154878762|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
154878763|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
154878764|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
154878765|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
154878766|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
154974591|NCT03310619|559331269|FG003|Treatment Period|Lost to Follow-up|0|||
154878767|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
154878768|NCT02224846|558980608|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
154974592|NCT03310619|559331270|FG004|Treatment Period|Lost to Follow-up|0|||
154878769|NCT02224846|558980609|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
154878770|NCT03196297|558980613|FG000|Main Period|Withdrawal by Subject|4|||
154878771|NCT03196297|558980613|FG000|Extension Period|Withdrawal by Subject|1|||
154974593|NCT03310619|559331271|FG005|Treatment Period|Lost to Follow-up|0|||
154878772|NCT03196297|558980613|FG000|Extension Period|Lack of Efficacy|2|||
154878773|NCT02538666|558980614|FG000|Pre-Treatment|Disease progression|1|||
154878774|NCT02538666|558980615|FG001|Pre-Treatment|Disease progression|0|||
154878775|NCT02538666|558980616|FG002|Pre-Treatment|Disease progression|0|||
154878776|NCT02538666|558980614|FG000|Pre-Treatment|no longer meets study criteria|1|||
154878777|NCT02538666|558980615|FG001|Pre-Treatment|no longer meets study criteria|0|||
154878778|NCT02538666|558980616|FG002|Pre-Treatment|no longer meets study criteria|0|||
154878779|NCT02538666|558980614|FG000|Pre-Treatment|Withdrew Consent|0|||
154878780|NCT02538666|558980615|FG001|Pre-Treatment|Withdrew Consent|1|||
154878781|NCT02538666|558980616|FG002|Pre-Treatment|Withdrew Consent|1|||
154878782|NCT02538666|558980614|FG000|Treatment|Disease progression|270|||
154878783|NCT02538666|558980615|FG001|Treatment|Disease progression|227|||
154878784|NCT02538666|558980616|FG002|Treatment|Disease progression|165|||
154878785|NCT02538666|558980614|FG000|Treatment|Study drug toxicity|1|||
154878786|NCT02538666|558980615|FG001|Treatment|Study drug toxicity|29|||
154878787|NCT02538666|558980616|FG002|Treatment|Study drug toxicity|92|||
154878788|NCT02538666|558980614|FG000|Treatment|Death|0|||
154878789|NCT02538666|558980615|FG001|Treatment|Death|2|||
154878790|NCT02538666|558980616|FG002|Treatment|Death|3|||
154878791|NCT02538666|558980614|FG000|Treatment|Adverse event unrelated to study drug|8|||
154878792|NCT02538666|558980615|FG001|Treatment|Adverse event unrelated to study drug|10|||
154878793|NCT02538666|558980616|FG002|Treatment|Adverse event unrelated to study drug|15|||
154878794|NCT02538666|558980614|FG000|Treatment|Participant request to discontinue study treatment|3|||
154878795|NCT02538666|558980615|FG001|Treatment|Participant request to discontinue study treatment|6|||
154878796|NCT02538666|558980616|FG002|Treatment|Participant request to discontinue study treatment|11|||
154878797|NCT02538666|558980614|FG000|Treatment|Participant withdrew consent|2|||
154878798|NCT02538666|558980615|FG001|Treatment|Participant withdrew consent|5|||
154878799|NCT02538666|558980616|FG002|Treatment|Participant withdrew consent|3|||
154878800|NCT02538666|558980614|FG000|Treatment|Lost to Follow-up|0|||
154878801|NCT02538666|558980615|FG001|Treatment|Lost to Follow-up|1|||
154878802|NCT02538666|558980616|FG002|Treatment|Lost to Follow-up|1|||
154878803|NCT02538666|558980614|FG000|Treatment|Maximum clinical benefit|4|||
154878804|NCT02538666|558980615|FG001|Treatment|Maximum clinical benefit|3|||
154878805|NCT02538666|558980616|FG002|Treatment|Maximum clinical benefit|4|||
154878806|NCT02538666|558980614|FG000|Treatment|Poor/non-compliance|0|||
154878807|NCT02538666|558980615|FG001|Treatment|Poor/non-compliance|1|||
154878808|NCT02538666|558980616|FG002|Treatment|Poor/non-compliance|0|||
154878809|NCT02538666|558980614|FG000|Treatment|Participant no longer meets study criteria|0|||
154878810|NCT02538666|558980615|FG001|Treatment|Participant no longer meets study criteria|2|||
154878811|NCT02538666|558980616|FG002|Treatment|Participant no longer meets study criteria|0|||
154878812|NCT02538666|558980614|FG000|Treatment|Administrative reason by sponsor|0|||
154878813|NCT02538666|558980615|FG001|Treatment|Administrative reason by sponsor|0|||
154878814|NCT02538666|558980616|FG002|Treatment|Administrative reason by sponsor|1|||
154878815|NCT02538666|558980614|FG000|Treatment|Other reasons|8|||
154878816|NCT02538666|558980615|FG001|Treatment|Other reasons|15|||
154878817|NCT02538666|558980616|FG002|Treatment|Other reasons|5|||
154878818|NCT02538666|558980614|FG000|Treatment|Not reported|2|||
154878819|NCT02538666|558980615|FG001|Treatment|Not reported|2|||
154878820|NCT02538666|558980616|FG002|Treatment|Not reported|2|||
154878821|NCT00320385|558980621|FG000|Overall Study|Lost to Follow-up|7|||
154878822|NCT00320385|558980622|FG001|Overall Study|Lost to Follow-up|10|||
154878823|NCT00320385|558980621|FG000|Overall Study|Withdrawal by Subject|6|||
154878824|NCT00320385|558980622|FG001|Overall Study|Withdrawal by Subject|7|||
154878825|NCT00320385|558980621|FG000|Overall Study|Sponsor Terminated Study|2|||
154878826|NCT00320385|558980622|FG001|Overall Study|Sponsor Terminated Study|1|||
154878827|NCT00320385|558980621|FG000|Overall Study|Investigator Decision|0|||
154878828|NCT00320385|558980622|FG001|Overall Study|Investigator Decision|1|||
154878829|NCT00320385|558980621|FG000|Overall Study|Death|1|||
154878830|NCT00320385|558980622|FG001|Overall Study|Death|2|||
154878831|NCT00320385|558980621|FG000|Overall Study|Serious Adverse Event|1|||
154878832|NCT00320385|558980622|FG001|Overall Study|Serious Adverse Event|0|||
154878833|NCT00320385|558980621|FG000|Overall Study|Withdrew Consent|1|||
154878834|NCT00320385|558980622|FG001|Overall Study|Withdrew Consent|0|||
155113173|NCT02589665|559844733|FG007|Maintenance Period|Reason Not Collected|0|||
155113174|NCT02589665|559844734|FG008|Maintenance Period|Reason Not Collected|0|||
154878835|NCT00320385|558980621|FG000|Overall Study|Adverse Event|0|||
154878836|NCT00320385|558980622|FG001|Overall Study|Adverse Event|1|||
154878837|NCT04370028|558980623|FG000|Overall Study|Withdrawal by Subject|695|||
154878838|NCT04370028|558980623|FG000|Overall Study|Protocol Violation|9|||
154878839|NCT04370028|558980623|FG000|Overall Study|Adverse Event|3|||
154878840|NCT00748540|558980631|FG000|Overall Study|Physician Decision|1|||
154878841|NCT04743635|558980632|FG000|Overall Study|Lost to Follow-up|2|||
154878842|NCT04743635|558980633|FG001|Overall Study|Lost to Follow-up|0|||
154878843|NCT01954121|558980635|FG000|Overall Study|Lack of Efficacy|94|||
154878844|NCT01954121|558980636|FG001|Overall Study|Lack of Efficacy|41|||
154878845|NCT01954121|558980635|FG000|Overall Study|Protocol Violation|0|||
154878846|NCT01954121|558980636|FG001|Overall Study|Protocol Violation|2|||
154878847|NCT01954121|558980635|FG000|Overall Study|Lost to Follow-up|5|||
154878848|NCT01954121|558980636|FG001|Overall Study|Lost to Follow-up|6|||
154878849|NCT01954121|558980635|FG000|Overall Study|Withdrawal by Subject|18|||
154878850|NCT01954121|558980636|FG001|Overall Study|Withdrawal by Subject|12|||
154878851|NCT01954121|558980635|FG000|Overall Study|Pregnancy|1|||
154878852|NCT01954121|558980636|FG001|Overall Study|Pregnancy|1|||
154878853|NCT01954121|558980635|FG000|Overall Study|AE, serious fatal|1|||
154878854|NCT01954121|558980636|FG001|Overall Study|AE, serious fatal|0|||
154878855|NCT01954121|558980635|FG000|Overall Study|AE, non-serious non-fatal|5|||
154878856|NCT01954121|558980636|FG001|Overall Study|AE, non-serious non-fatal|22|||
154878857|NCT01954121|558980635|FG000|Overall Study|SAE, non-fatal|1|||
154878858|NCT01954121|558980636|FG001|Overall Study|SAE, non-fatal|4|||
154878859|NCT01954121|558980635|FG000|Overall Study|Non-compliant with study procedures|1|||
154878860|NCT01954121|558980636|FG001|Overall Study|Non-compliant with study procedures|0|||
154878861|NCT01954121|558980635|FG000|Overall Study|Non-compliant patient|1|||
154878862|NCT01954121|558980636|FG001|Overall Study|Non-compliant patient|1|||
154878863|NCT01954121|558980635|FG000|Overall Study|Subject did not follow instructions|0|||
154878864|NCT01954121|558980636|FG001|Overall Study|Subject did not follow instructions|2|||
154878865|NCT00872170|558980637|FG000|Overall Study|Adverse Event|1|||
154878866|NCT00872170|558980638|FG001|Overall Study|Adverse Event|0|||
154878867|NCT00601523|558980639|FG000|Overall Study|Adverse Event|42|||
154878868|NCT00601523|558980640|FG001|Overall Study|Adverse Event|14|||
154878869|NCT00601523|558980639|FG000|Overall Study|Lack of Efficacy|3|||
154878870|NCT00601523|558980640|FG001|Overall Study|Lack of Efficacy|0|||
154878871|NCT00601523|558980639|FG000|Overall Study|Protocol Violation|5|||
154878872|NCT00601523|558980640|FG001|Overall Study|Protocol Violation|1|||
154878873|NCT00601523|558980639|FG000|Overall Study|Lost to Follow-up|0|||
154878874|NCT00601523|558980640|FG001|Overall Study|Lost to Follow-up|1|||
154878875|NCT00601523|558980639|FG000|Overall Study|Withdrawal by Subject|18|||
154878876|NCT00601523|558980640|FG001|Overall Study|Withdrawal by Subject|9|||
154878877|NCT00601523|558980639|FG000|Overall Study|Other|9|||
154878878|NCT00601523|558980640|FG001|Overall Study|Other|1|||
154878879|NCT04072146|558980641|FG000|Overall Study|Adverse Event|0|||
154878880|NCT04072146|558980642|FG001|Overall Study|Adverse Event|1|||
154878881|NCT01617434|558980643|FG000|Overall Study|Adverse Event|12|||
154878882|NCT01617434|558980644|FG001|Overall Study|Adverse Event|3|||
154878883|NCT01617434|558980643|FG000|Overall Study|Protocol Violation|8|||
154878884|NCT01617434|558980644|FG001|Overall Study|Protocol Violation|7|||
154878885|NCT01617434|558980643|FG000|Overall Study|Withdrawal Criteria|12|||
154878886|NCT01617434|558980644|FG001|Overall Study|Withdrawal Criteria|37|||
154878887|NCT01617434|558980643|FG000|Overall Study|Unclassified|3|||
154878888|NCT01617434|558980644|FG001|Overall Study|Unclassified|4|||
154878889|NCT01987986|558980645|FG000|Overall Study|Lost to Follow-up|1|||
154878890|NCT01987986|558980646|FG001|Overall Study|Lost to Follow-up|0|||
154878891|NCT01987986|558980647|FG002|Overall Study|Lost to Follow-up|0|||
154878892|NCT01987986|558980648|FG003|Overall Study|Lost to Follow-up|0|||
154878893|NCT01987986|558980645|FG000|Overall Study|Adverse Event|1|||
154878894|NCT01987986|558980646|FG001|Overall Study|Adverse Event|0|||
154878895|NCT01987986|558980647|FG002|Overall Study|Adverse Event|2|||
154878896|NCT01987986|558980648|FG003|Overall Study|Adverse Event|0|||
154878897|NCT00540436|558980655|FG000|First 12-Week Treatment Period|Adverse Event|1|||
154878898|NCT00540436|558980655|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
154878899|NCT00540436|558980655|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
154878900|NCT00540436|558980655|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
154878901|NCT01064648|558980656|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
154878902|NCT01064648|558980657|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
154878903|NCT01064648|558980658|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
154878904|NCT01064648|558980659|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
154878905|NCT01064648|558980656|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
154878906|NCT01064648|558980657|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
154878907|NCT01064648|558980658|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
154878908|NCT01064648|558980659|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
154878909|NCT01064648|558980656|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
154878910|NCT01064648|558980657|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
154878911|NCT01064648|558980658|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
154878912|NCT01064648|558980659|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
154878913|NCT01064648|558980656|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
154878914|NCT01064648|558980657|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
154878915|NCT01064648|558980658|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
154878916|NCT01064648|558980659|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
154878917|NCT01064648|558980656|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
154878918|NCT01064648|558980657|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
154878919|NCT01064648|558980658|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
154878920|NCT01064648|558980659|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
154878921|NCT01064648|558980656|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
154878922|NCT01064648|558980657|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
154878923|NCT01064648|558980658|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
154878924|NCT01064648|558980659|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
154878925|NCT01064648|558980656|FG000|Phase II|Adverse Event|0|||
154878926|NCT01064648|558980657|FG001|Phase II|Adverse Event|0|||
154878927|NCT01064648|558980658|FG002|Phase II|Adverse Event|15|||
154878928|NCT01064648|558980659|FG003|Phase II|Adverse Event|8|||
154878929|NCT01064648|558980656|FG000|Phase II|Death|0|||
154878930|NCT01064648|558980657|FG001|Phase II|Death|0|||
154878931|NCT01064648|558980658|FG002|Phase II|Death|4|||
154878932|NCT01064648|558980659|FG003|Phase II|Death|5|||
154878933|NCT01064648|558980656|FG000|Phase II|Withdrawal by Subject|0|||
154878934|NCT01064648|558980657|FG001|Phase II|Withdrawal by Subject|0|||
154878935|NCT01064648|558980658|FG002|Phase II|Withdrawal by Subject|2|||
154878936|NCT01064648|558980659|FG003|Phase II|Withdrawal by Subject|5|||
154878937|NCT01064648|558980656|FG000|Phase II|Progression|0|||
154878938|NCT01064648|558980657|FG001|Phase II|Progression|0|||
154878939|NCT01064648|558980658|FG002|Phase II|Progression|21|||
154878940|NCT01064648|558980659|FG003|Phase II|Progression|27|||
154878941|NCT01064648|558980656|FG000|Phase II|Non-protocol specified|0|||
154878942|NCT01064648|558980657|FG001|Phase II|Non-protocol specified|0|||
154878943|NCT01064648|558980658|FG002|Phase II|Non-protocol specified|5|||
154878944|NCT01064648|558980659|FG003|Phase II|Non-protocol specified|3|||
154878945|NCT01064648|558980656|FG000|Phase II|Under Review|0|||
154878946|NCT01064648|558980657|FG001|Phase II|Under Review|0|||
154878947|NCT01064648|558980658|FG002|Phase II|Under Review|2|||
154878948|NCT01064648|558980659|FG003|Phase II|Under Review|0|||
154878949|NCT05281523|558980660|FG000|Overall Study|Adverse Event|1|||
154878950|NCT05281523|558980661|FG001|Overall Study|Adverse Event|1|||
154878951|NCT05281523|558980660|FG000|Overall Study|Physician Decision|1|||
154878952|NCT05281523|558980661|FG001|Overall Study|Physician Decision|1|||
154878953|NCT05281523|558980660|FG000|Overall Study|Withdrawal by Subject|5|||
154878954|NCT05281523|558980661|FG001|Overall Study|Withdrawal by Subject|15|||
154878955|NCT05281523|558980660|FG000|Overall Study|GCP violations|3|||
154878956|NCT05281523|558980661|FG001|Overall Study|GCP violations|4|||
154878957|NCT05513391|558980662|FG000|Overall Study|Adverse Event|1|||
154878958|NCT05513391|558980663|FG001|Overall Study|Adverse Event|0|||
154878959|NCT05513391|558980662|FG000|Overall Study|Protocol Deviation|0|||
154878960|NCT05513391|558980663|FG001|Overall Study|Protocol Deviation|1|||
154878961|NCT05513391|558980662|FG000|Overall Study|Withdrawal by Subject|3|||
154878962|NCT05513391|558980663|FG001|Overall Study|Withdrawal by Subject|1|||
154878963|NCT05513391|558980662|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
154878964|NCT05513391|558980663|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
154878965|NCT05513391|558980662|FG000|Overall Study|Lost to Follow-up|0|||
154878966|NCT05513391|558980663|FG001|Overall Study|Lost to Follow-up|2|||
154878967|NCT02429427|558980664|FG000|Overall Study|Adverse Event|220|||
154878968|NCT02429427|558980665|FG001|Overall Study|Adverse Event|92|||
154878969|NCT02429427|558980664|FG000|Overall Study|Protocol Violation|10|||
154878970|NCT02429427|558980665|FG001|Overall Study|Protocol Violation|6|||
154878971|NCT02429427|558980664|FG000|Overall Study|Lost to Follow-up|15|||
154878972|NCT02429427|558980665|FG001|Overall Study|Lost to Follow-up|6|||
154878973|NCT02429427|558980664|FG000|Overall Study|Withdrawal by Subject|64|||
154878974|NCT02429427|558980665|FG001|Overall Study|Withdrawal by Subject|34|||
154878975|NCT02429427|558980664|FG000|Overall Study|Other|62|||
154878976|NCT02429427|558980665|FG001|Overall Study|Other|41|||
154878977|NCT00719732|558980666|FG000|Overall Study|Lost to Follow-up|20|||
154878978|NCT00719732|558980666|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
154878979|NCT00719732|558980666|FG000|Overall Study|Illness not associated with device|1|||
154878980|NCT00436215|558980667|FG000|Overall Study|Refused further treatment|3|||
154878981|NCT00436215|558980667|FG000|Overall Study|Small bowel obstruction|1|||
154878982|NCT02614287|558982240|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
154878983|NCT02614287|558982241|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
154878984|NCT02614287|558982240|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
154878985|NCT02614287|558982241|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
154878986|NCT02614287|558982240|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
154878987|NCT02614287|558982241|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
154878988|NCT02614287|558982240|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
154878989|NCT02614287|558982241|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
154878990|NCT02614287|558982240|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
154878991|NCT02614287|558982241|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
154878992|NCT02614287|558982240|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
154878993|NCT02614287|558982241|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
154878994|NCT02614287|558982240|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
154878995|NCT02614287|558982241|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
154878996|NCT02614287|558982240|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
154878997|NCT02614287|558982241|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
155113175|NCT02589665|559844735|FG009|Maintenance Period|Reason Not Collected|0|||
154878998|NCT03364335|558982246|FG000|Overall Study|Adverse Event|3|||
154878999|NCT03364335|558982247|FG001|Overall Study|Adverse Event|4|||
154879000|NCT03364335|558982248|FG002|Overall Study|Adverse Event|1|||
154879001|NCT03364335|558982249|FG003|Overall Study|Adverse Event|2|||
154879002|NCT03364335|558982250|FG004|Overall Study|Adverse Event|0|||
154879003|NCT03364335|558982246|FG000|Overall Study|Lost to Follow-up|7|||
154879004|NCT03364335|558982247|FG001|Overall Study|Lost to Follow-up|7|||
154879005|NCT03364335|558982248|FG002|Overall Study|Lost to Follow-up|10|||
154879006|NCT03364335|558982249|FG003|Overall Study|Lost to Follow-up|11|||
154879007|NCT03364335|558982250|FG004|Overall Study|Lost to Follow-up|11|||
154879008|NCT00492856|558982251|FG000|Induction|Adverse Event|2|||
154879009|NCT00492856|558982252|FG001|Induction|Adverse Event|0|||
154879010|NCT00492856|558982253|FG002|Induction|Adverse Event|0|||
154879011|NCT00492856|558982254|FG003|Induction|Adverse Event|0|||
154879012|NCT00492856|558982251|FG000|Induction|Withdrawal by Subject|1|||
154879013|NCT00492856|558982252|FG001|Induction|Withdrawal by Subject|0|||
154879014|NCT00492856|558982253|FG002|Induction|Withdrawal by Subject|0|||
154879015|NCT00492856|558982254|FG003|Induction|Withdrawal by Subject|0|||
154879016|NCT00492856|558982251|FG000|Induction|Death|3|||
154879017|NCT00492856|558982252|FG001|Induction|Death|0|||
154879018|NCT00492856|558982253|FG002|Induction|Death|0|||
154879019|NCT00492856|558982254|FG003|Induction|Death|0|||
154879020|NCT00492856|558982251|FG000|Consolidation|Adverse Event|6|||
154879021|NCT00492856|558982252|FG001|Consolidation|Adverse Event|0|||
154879022|NCT00492856|558982253|FG002|Consolidation|Adverse Event|0|||
154879023|NCT00492856|558982254|FG003|Consolidation|Adverse Event|0|||
154879024|NCT00492856|558982251|FG000|Consolidation|Not protocol specified|2|||
154879025|NCT00492856|558982252|FG001|Consolidation|Not protocol specified|0|||
154879026|NCT00492856|558982253|FG002|Consolidation|Not protocol specified|0|||
154879027|NCT00492856|558982254|FG003|Consolidation|Not protocol specified|0|||
154879028|NCT00492856|558982251|FG000|Consolidation|Lost to Follow-up|1|||
154879029|NCT00492856|558982252|FG001|Consolidation|Lost to Follow-up|0|||
154879030|NCT00492856|558982253|FG002|Consolidation|Lost to Follow-up|0|||
154879031|NCT00492856|558982254|FG003|Consolidation|Lost to Follow-up|0|||
154879032|NCT00492856|558982251|FG000|Post-consolidation|Adverse Event|0|||
154879033|NCT00492856|558982252|FG001|Post-consolidation|Adverse Event|4|||
154879034|NCT00492856|558982253|FG002|Post-consolidation|Adverse Event|0|||
154879035|NCT00492856|558982254|FG003|Post-consolidation|Adverse Event|1|||
154879036|NCT00492856|558982251|FG000|Post-consolidation|Withdrawal by Subject|0|||
154879037|NCT00492856|558982252|FG001|Post-consolidation|Withdrawal by Subject|4|||
154879038|NCT00492856|558982253|FG002|Post-consolidation|Withdrawal by Subject|0|||
154879039|NCT00492856|558982254|FG003|Post-consolidation|Withdrawal by Subject|0|||
154879040|NCT00492856|558982251|FG000|Post-consolidation|Death|0|||
154879041|NCT00492856|558982252|FG001|Post-consolidation|Death|1|||
154879042|NCT00492856|558982253|FG002|Post-consolidation|Death|0|||
154879043|NCT00492856|558982254|FG003|Post-consolidation|Death|0|||
154879044|NCT00492856|558982251|FG000|Post-consolidation|Not protocol specified|0|||
154879045|NCT00492856|558982252|FG001|Post-consolidation|Not protocol specified|1|||
154879046|NCT00492856|558982253|FG002|Post-consolidation|Not protocol specified|0|||
154879047|NCT00492856|558982254|FG003|Post-consolidation|Not protocol specified|0|||
154879048|NCT00492856|558982251|FG000|Post-consolidation|Lost to Follow-up|0|||
154879049|NCT00492856|558982252|FG001|Post-consolidation|Lost to Follow-up|2|||
154879050|NCT00492856|558982253|FG002|Post-consolidation|Lost to Follow-up|0|||
154879051|NCT00492856|558982254|FG003|Post-consolidation|Lost to Follow-up|0|||
154879052|NCT00492856|558982251|FG000|Post-consolidation|Observation Arm|0|||
154879053|NCT00492856|558982252|FG001|Post-consolidation|Observation Arm|0|||
154879054|NCT00492856|558982253|FG002|Post-consolidation|Observation Arm|27|||
154879055|NCT00492856|558982254|FG003|Post-consolidation|Observation Arm|0|||
154879056|NCT01520324|558982257|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
154879057|NCT00745368|558982258|FG000|Overall Study|Unable to provide sample|3|||
154879058|NCT02364947|558982259|FG000|Overall Study|Withdrawal by Subject|10|||
154879059|NCT02364947|558982260|FG001|Overall Study|Withdrawal by Subject|8|||
154879060|NCT02364947|558982261|FG002|Overall Study|Withdrawal by Subject|9|||
154879061|NCT02364947|558982259|FG000|Overall Study|Adverse Event|45|||
154879062|NCT02364947|558982260|FG001|Overall Study|Adverse Event|33|||
154974594|NCT03310619|559331272|FG006|Treatment Period|Lost to Follow-up|0|||
154974595|NCT03310619|559331273|FG007|Treatment Period|Lost to Follow-up|1|||
154974596|NCT03310619|559331266|FG000|Treatment Period|Study terminated by sponsor|0|||
154974597|NCT03310619|559331267|FG001|Treatment Period|Study terminated by sponsor|0|||
154974598|NCT03310619|559331268|FG002|Treatment Period|Study terminated by sponsor|0|||
154974599|NCT03310619|559331269|FG003|Treatment Period|Study terminated by sponsor|0|||
154879063|NCT02364947|558982261|FG002|Overall Study|Adverse Event|11|||
154879064|NCT02364947|558982259|FG000|Overall Study|Protocol Violation|1|||
154879065|NCT02364947|558982260|FG001|Overall Study|Protocol Violation|1|||
154879066|NCT02364947|558982261|FG002|Overall Study|Protocol Violation|1|||
154879067|NCT02364947|558982259|FG000|Overall Study|Physician Decision|3|||
154879068|NCT02364947|558982260|FG001|Overall Study|Physician Decision|2|||
154879069|NCT02364947|558982261|FG002|Overall Study|Physician Decision|5|||
154879070|NCT02364947|558982259|FG000|Overall Study|Death|0|||
154974600|NCT03310619|559331270|FG004|Treatment Period|Study terminated by sponsor|0|||
154879071|NCT02364947|558982260|FG001|Overall Study|Death|1|||
154879072|NCT02364947|558982261|FG002|Overall Study|Death|0|||
154879073|NCT00853489|558982262|FG000|Overall Study|Lost to Follow-up|5|||
155113176|NCT02589665|559844726|FG000|Induction Extension Period|Adverse Event|0|||
155113177|NCT02589665|559844727|FG001|Induction Extension Period|Adverse Event|0|||
155113178|NCT02589665|559844728|FG002|Induction Extension Period|Adverse Event|0|||
155113179|NCT02589665|559844729|FG003|Induction Extension Period|Adverse Event|0|||
155113180|NCT02589665|559844730|FG004|Induction Extension Period|Adverse Event|0|||
155113181|NCT02589665|559844731|FG005|Induction Extension Period|Adverse Event|0|||
155113182|NCT02589665|559844732|FG006|Induction Extension Period|Adverse Event|0|||
155113183|NCT02589665|559844733|FG007|Induction Extension Period|Adverse Event|0|||
155113184|NCT02589665|559844734|FG008|Induction Extension Period|Adverse Event|4|||
155113185|NCT02589665|559844735|FG009|Induction Extension Period|Adverse Event|0|||
155113186|NCT02589665|559844726|FG000|Induction Extension Period|Lack of Efficacy|0|||
155113187|NCT02589665|559844727|FG001|Induction Extension Period|Lack of Efficacy|0|||
155113188|NCT02589665|559844728|FG002|Induction Extension Period|Lack of Efficacy|0|||
155113189|NCT02589665|559844729|FG003|Induction Extension Period|Lack of Efficacy|0|||
155113190|NCT02589665|559844730|FG004|Induction Extension Period|Lack of Efficacy|0|||
155113191|NCT02589665|559844731|FG005|Induction Extension Period|Lack of Efficacy|0|||
155113192|NCT02589665|559844732|FG006|Induction Extension Period|Lack of Efficacy|0|||
155113193|NCT02589665|559844733|FG007|Induction Extension Period|Lack of Efficacy|0|||
155113194|NCT02589665|559844734|FG008|Induction Extension Period|Lack of Efficacy|3|||
155113195|NCT02589665|559844735|FG009|Induction Extension Period|Lack of Efficacy|0|||
155113196|NCT02589665|559844726|FG000|Induction Extension Period|Withdrawal by Subject|0|||
155113197|NCT02589665|559844727|FG001|Induction Extension Period|Withdrawal by Subject|0|||
155113198|NCT02589665|559844728|FG002|Induction Extension Period|Withdrawal by Subject|0|||
155113199|NCT02589665|559844729|FG003|Induction Extension Period|Withdrawal by Subject|0|||
155113200|NCT02589665|559844730|FG004|Induction Extension Period|Withdrawal by Subject|0|||
155113201|NCT02589665|559844731|FG005|Induction Extension Period|Withdrawal by Subject|0|||
155113202|NCT02589665|559844732|FG006|Induction Extension Period|Withdrawal by Subject|0|||
155113203|NCT02589665|559844733|FG007|Induction Extension Period|Withdrawal by Subject|2|||
155113204|NCT02589665|559844734|FG008|Induction Extension Period|Withdrawal by Subject|3|||
155113205|NCT02589665|559844735|FG009|Induction Extension Period|Withdrawal by Subject|0|||
155113206|NCT02589665|559844726|FG000|Induction Extension Period|Physician Decision|0|||
155113207|NCT02589665|559844727|FG001|Induction Extension Period|Physician Decision|0|||
155113208|NCT02589665|559844728|FG002|Induction Extension Period|Physician Decision|0|||
155113209|NCT02589665|559844729|FG003|Induction Extension Period|Physician Decision|0|||
155113210|NCT02589665|559844730|FG004|Induction Extension Period|Physician Decision|0|||
155113211|NCT02589665|559844731|FG005|Induction Extension Period|Physician Decision|0|||
155113212|NCT02589665|559844732|FG006|Induction Extension Period|Physician Decision|0|||
155113213|NCT02589665|559844733|FG007|Induction Extension Period|Physician Decision|0|||
155113214|NCT02589665|559844734|FG008|Induction Extension Period|Physician Decision|1|||
155113215|NCT02589665|559844735|FG009|Induction Extension Period|Physician Decision|0|||
155113216|NCT02589665|559844726|FG000|Induction Extension Period|Reason Not Collected|0|||
155113217|NCT02589665|559844727|FG001|Induction Extension Period|Reason Not Collected|0|||
155113218|NCT02589665|559844728|FG002|Induction Extension Period|Reason Not Collected|0|||
155113219|NCT02589665|559844729|FG003|Induction Extension Period|Reason Not Collected|0|||
155113220|NCT02589665|559844730|FG004|Induction Extension Period|Reason Not Collected|0|||
155113221|NCT02589665|559844731|FG005|Induction Extension Period|Reason Not Collected|0|||
155113222|NCT02589665|559844732|FG006|Induction Extension Period|Reason Not Collected|0|||
155113223|NCT02589665|559844733|FG007|Induction Extension Period|Reason Not Collected|0|||
155113224|NCT02589665|559844734|FG008|Induction Extension Period|Reason Not Collected|1|||
155113225|NCT02589665|559844735|FG009|Induction Extension Period|Reason Not Collected|0|||
155113226|NCT02589665|559844726|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113227|NCT02589665|559844727|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113228|NCT02589665|559844728|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113229|NCT02589665|559844729|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113230|NCT02589665|559844730|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113231|NCT02589665|559844731|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113232|NCT02589665|559844732|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113233|NCT02589665|559844733|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113234|NCT02589665|559844734|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
155113235|NCT02589665|559844735|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
155113236|NCT02589665|559844726|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
155113237|NCT02589665|559844727|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
155113238|NCT02589665|559844728|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
155113239|NCT02589665|559844729|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
155113240|NCT02589665|559844730|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
155113241|NCT02589665|559844731|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
155113242|NCT02589665|559844732|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
155113243|NCT02589665|559844733|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
155113244|NCT02589665|559844734|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
155113245|NCT02589665|559844735|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
155113246|NCT02589665|559844726|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
155113247|NCT02589665|559844727|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
155113248|NCT02589665|559844728|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
155113249|NCT02589665|559844729|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
155113250|NCT02589665|559844730|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
155113251|NCT02589665|559844731|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
155113252|NCT02589665|559844732|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
155113253|NCT02589665|559844733|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
155113254|NCT02589665|559844734|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
155113255|NCT02589665|559844735|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
155113256|NCT02589665|559844726|FG000|Maintenance Extension Period|Adverse Event|0|||
155113257|NCT02589665|559844727|FG001|Maintenance Extension Period|Adverse Event|0|||
155113258|NCT02589665|559844728|FG002|Maintenance Extension Period|Adverse Event|0|||
155113259|NCT02589665|559844729|FG003|Maintenance Extension Period|Adverse Event|0|||
155113260|NCT02589665|559844730|FG004|Maintenance Extension Period|Adverse Event|0|||
155113261|NCT02589665|559844731|FG005|Maintenance Extension Period|Adverse Event|0|||
155113262|NCT02589665|559844732|FG006|Maintenance Extension Period|Adverse Event|0|||
155113263|NCT02589665|559844733|FG007|Maintenance Extension Period|Adverse Event|0|||
155113264|NCT02589665|559844734|FG008|Maintenance Extension Period|Adverse Event|0|||
155113265|NCT02589665|559844735|FG009|Maintenance Extension Period|Adverse Event|2|||
155113266|NCT02589665|559844726|FG000|Maintenance Extension Period|Non-responder|0|||
155113267|NCT02589665|559844727|FG001|Maintenance Extension Period|Non-responder|0|||
155113268|NCT02589665|559844728|FG002|Maintenance Extension Period|Non-responder|0|||
155113269|NCT02589665|559844729|FG003|Maintenance Extension Period|Non-responder|0|||
155113270|NCT02589665|559844730|FG004|Maintenance Extension Period|Non-responder|0|||
155113271|NCT02589665|559844731|FG005|Maintenance Extension Period|Non-responder|0|||
154879074|NCT00853489|558982263|FG001|Overall Study|Lost to Follow-up|2|||
154879075|NCT02326467|558982264|FG000|Overall Study|Withdrawal by Subject|1|||
154879076|NCT00434512|558982265|FG000|Overall Study|Migrated/moved from study area|0|||
154879077|NCT00434512|558982266|FG001|Overall Study|Migrated/moved from study area|0|||
154879078|NCT00434512|558982267|FG002|Overall Study|Migrated/moved from study area|0|||
154879079|NCT00434512|558982268|FG003|Overall Study|Migrated/moved from study area|1|||
154879080|NCT00434512|558982269|FG004|Overall Study|Migrated/moved from study area|1|||
154879081|NCT00434512|558982270|FG005|Overall Study|Migrated/moved from study area|1|||
154879082|NCT00434512|558982265|FG000|Overall Study|Other|0|||
154879083|NCT00434512|558982266|FG001|Overall Study|Other|1|||
154879084|NCT00434512|558982267|FG002|Overall Study|Other|0|||
154879085|NCT00434512|558982268|FG003|Overall Study|Other|0|||
154879086|NCT00434512|558982269|FG004|Overall Study|Other|0|||
154879087|NCT00434512|558982270|FG005|Overall Study|Other|0|||
154879088|NCT01251276|558982274|FG000|Overall Study|Protocol Violation|1|||
154879089|NCT01251276|558982275|FG001|Overall Study|Protocol Violation|0|||
154879090|NCT01251276|558982274|FG000|Overall Study|Lost to Follow-up|0|||
154879091|NCT01251276|558982275|FG001|Overall Study|Lost to Follow-up|1|||
154879092|NCT02245568|558982276|FG000|Overall Study|Study terminated by Sponsor|346|||
154879093|NCT02245568|558982276|FG000|Overall Study|Adverse Event|144|||
154879094|NCT02245568|558982276|FG000|Overall Study|Lack of Efficacy|98|||
154879095|NCT02245568|558982276|FG000|Overall Study|Withdrawal by Caregiver|85|||
154879096|NCT02245568|558982276|FG000|Overall Study|Withdrawal by Subject|77|||
154879097|NCT02245568|558982276|FG000|Overall Study|Withdrawal by Legal Representative|31|||
154879098|NCT02245568|558982276|FG000|Overall Study|Missing (Site closure)|16|||
154879099|NCT02245568|558982276|FG000|Overall Study|Physician Decision|14|||
154879100|NCT02245568|558982276|FG000|Overall Study|Non-compliance with study drug|11|||
154879101|NCT02245568|558982276|FG000|Overall Study|Death|9|||
154879102|NCT02245568|558982276|FG000|Overall Study|Blue staining|6|||
154879103|NCT02245568|558982276|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
155113272|NCT02589665|559844732|FG006|Maintenance Extension Period|Non-responder|0|||
155113273|NCT02589665|559844733|FG007|Maintenance Extension Period|Non-responder|0|||
155113274|NCT02589665|559844734|FG008|Maintenance Extension Period|Non-responder|0|||
155113275|NCT02589665|559844735|FG009|Maintenance Extension Period|Non-responder|1|||
155113276|NCT01159171|559844738|FG000|Overall Study|Adverse Event|11|||
155113277|NCT01159171|559844738|FG000|Overall Study|Progression of Disease|28|||
154879104|NCT02245568|558982276|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
154879105|NCT02245568|558982276|FG000|Overall Study|Lost to Follow-up|5|||
154879106|NCT01725152|558982280|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
154879107|NCT01725152|558982281|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
154879108|NCT01725152|558982280|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
154879109|NCT01725152|558982281|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
154879110|NCT01725152|558982280|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
155113278|NCT01159171|559844738|FG000|Overall Study|Protocol Violation|1|||
155113279|NCT01159171|559844738|FG000|Overall Study|Need for Surgery|5|||
154879111|NCT01725152|558982281|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
154879112|NCT01725152|558982280|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
154879113|NCT01725152|558982281|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
154879114|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
154879115|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
154879116|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
154879117|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
154879118|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
154879119|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
154879120|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
154879121|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
154879122|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
154879123|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
154879124|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
154879125|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
154879126|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
154879127|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
154879128|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
154879129|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
154879130|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
154879131|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
154879132|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
154879133|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
154879134|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
154879135|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
154879136|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
154879137|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
154879138|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
154879139|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
154879140|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
154879141|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
154879142|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
154879143|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
154879144|NCT01111539|558982284|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
154879145|NCT01111539|558982285|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
154879146|NCT01111539|558982286|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
154879147|NCT01111539|558982287|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
154879148|NCT01111539|558982288|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
154879149|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
154879150|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
154879151|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
154879152|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
154879153|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
154879154|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
154879155|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
154879156|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
154879157|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
154879158|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
154879159|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
154879160|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
154879161|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
154879162|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
154879163|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
154879164|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
154879165|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
154879166|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
154879167|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
154879168|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
154879169|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
155113280|NCT01159171|559844738|FG000|Overall Study|Medical Decision|4|||
155113281|NCT01159171|559844738|FG000|Overall Study|Death|1|||
155113282|NCT01892436|559844739|FG000|Overall Study|Withdrawal by Subject|8|||
155113283|NCT01892436|559844740|FG001|Overall Study|Withdrawal by Subject|15|||
155113284|NCT01892436|559844741|FG002|Overall Study|Withdrawal by Subject|4|||
155113285|NCT01892436|559844742|FG003|Overall Study|Withdrawal by Subject|4|||
155113286|NCT01892436|559844739|FG000|Overall Study|Death|1|||
154879170|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
154879171|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
154879172|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
154879173|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
154879174|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
154879175|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
154879176|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
154879177|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
154879178|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
154879179|NCT01111539|558982284|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
154879180|NCT01111539|558982285|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
154879181|NCT01111539|558982286|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
154879182|NCT01111539|558982287|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
154879183|NCT01111539|558982288|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
154879184|NCT03580382|558982293|FG000|Overall Study|Early Termination of Study|0|||
154879185|NCT03580382|558982294|FG001|Overall Study|Early Termination of Study|3|||
154879186|NCT02808312|558982295|FG000|Overall Study|Enrolled but Never Treated|0|||
154879187|NCT02808312|558982296|FG001|Overall Study|Enrolled but Never Treated|0|||
154879188|NCT02808312|558982297|FG002|Overall Study|Enrolled but Never Treated|1|||
154879189|NCT02808312|558982298|FG003|Overall Study|Enrolled but Never Treated|0|||
154879190|NCT02808312|558982299|FG004|Overall Study|Enrolled but Never Treated|0|||
154879191|NCT03628417|558982300|FG000|Overall Study|Death|1|||
154879192|NCT03628417|558982301|FG001|Overall Study|Death|1|||
154879193|NCT02420223|558982302|FG000|Overall Study|Adverse Event|1|||
154879194|NCT02420223|558982303|FG001|Overall Study|Adverse Event|0|||
154879195|NCT02420223|558982302|FG000|Overall Study|Physician Decision|0|||
154879196|NCT02420223|558982303|FG001|Overall Study|Physician Decision|2|||
154879197|NCT01826422|558982304|FG000|Overall Study|Withdrawal by Subject|1|||
154879198|NCT01826422|558982305|FG001|Overall Study|Withdrawal by Subject|3|||
154879199|NCT00769704|558982309|FG000|Overall Study|Lost to Follow-up|3|||
154879200|NCT00769704|558982310|FG001|Overall Study|Lost to Follow-up|2|||
154879201|NCT00769704|558982309|FG000|Overall Study|Death|95|||
154879202|NCT00769704|558982310|FG001|Overall Study|Death|190|||
154879203|NCT00769704|558982309|FG000|Overall Study|Withdrawal by Subject|12|||
154879204|NCT00769704|558982310|FG001|Overall Study|Withdrawal by Subject|5|||
154879205|NCT00769704|558982309|FG000|Overall Study|Other|1|||
154879206|NCT00769704|558982310|FG001|Overall Study|Other|2|||
154879207|NCT00450372|558982311|FG000|Overall Study|Physician Decision|1|||
154879208|NCT05131451|558982312|FG000|Overall Study|Protocol Violation|1|||
154879209|NCT05131451|558982313|FG001|Overall Study|Protocol Violation|0|||
154879210|NCT01856595|558982321|FG000|Overall Study|Withdrawal by Subject|0|||
154879211|NCT01856595|558982322|FG001|Overall Study|Withdrawal by Subject|1|||
154879212|NCT01856595|558982323|FG002|Overall Study|Withdrawal by Subject|0|||
154879213|NCT01856595|558982324|FG003|Overall Study|Withdrawal by Subject|0|||
154879214|NCT01856595|558982325|FG004|Overall Study|Withdrawal by Subject|0|||
154879215|NCT01856595|558982326|FG005|Overall Study|Withdrawal by Subject|0|||
154879216|NCT01856595|558982327|FG006|Overall Study|Withdrawal by Subject|1|||
154879217|NCT01856595|558982328|FG007|Overall Study|Withdrawal by Subject|0|||
154879218|NCT01856595|558982329|FG008|Overall Study|Withdrawal by Subject|0|||
154879219|NCT04426825|558982330|FG000|Overall Study|Death|17|||
154879220|NCT04426825|558982330|FG000|Overall Study|Lost to Follow-up|1|||
154879221|NCT04426825|558982330|FG000|Overall Study|Study terminated by sponsor|5|||
154879222|NCT01863849|558982338|FG000|Overall Study|Lost to Follow-up|1|||
154879223|NCT01863849|558982339|FG001|Overall Study|Lost to Follow-up|0|||
154879224|NCT01727713|558982347|FG000|Overall Study|Lost to Follow-up|5|||
154879225|NCT01727713|558982347|FG000|Overall Study|Adverse Event|10|||
154879226|NCT01727713|558982347|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
154879227|NCT01727713|558982347|FG000|Overall Study|Withdrawal by Subject|13|||
154879228|NCT01727713|558982347|FG000|Overall Study|Protocol Deviation|2|||
154879229|NCT00532948|558982348|FG000|Overall Study|Protocol Violation|1|||
154879230|NCT00532948|558982349|FG001|Overall Study|Protocol Violation|0|||
154879231|NCT00532948|558982350|FG002|Overall Study|Protocol Violation|0|||
154879232|NCT00532948|558982348|FG000|Overall Study|Death|3|||
154879233|NCT00532948|558982349|FG001|Overall Study|Death|3|||
155113287|NCT01892436|559844740|FG001|Overall Study|Death|1|||
155113288|NCT01892436|559844741|FG002|Overall Study|Death|0|||
154879234|NCT00532948|558982350|FG002|Overall Study|Death|4|||
154879235|NCT00532948|558982348|FG000|Overall Study|Violation of selection criteria at entry|0|||
154879236|NCT00532948|558982349|FG001|Overall Study|Violation of selection criteria at entry|1|||
154879237|NCT00532948|558982350|FG002|Overall Study|Violation of selection criteria at entry|0|||
154879238|NCT00532948|558982348|FG000|Overall Study|Failure to return|0|||
154879239|NCT00532948|558982349|FG001|Overall Study|Failure to return|1|||
154879240|NCT00532948|558982350|FG002|Overall Study|Failure to return|0|||
154974601|NCT03310619|559331271|FG005|Treatment Period|Study terminated by sponsor|0|||
155113289|NCT01892436|559844742|FG003|Overall Study|Death|0|||
155113290|NCT01892436|559844739|FG000|Overall Study|Physician Decision|2|||
154879241|NCT01842308|558982352|FG000|Overall Study|Withdrawal by Subject|0|||
154879242|NCT01842308|558982353|FG001|Overall Study|Withdrawal by Subject|0|||
154879243|NCT01842308|558982354|FG002|Overall Study|Withdrawal by Subject|0|||
154879244|NCT01842308|558982355|FG003|Overall Study|Withdrawal by Subject|0|||
154879245|NCT01842308|558982356|FG004|Overall Study|Withdrawal by Subject|1|||
154879246|NCT03885726|558982358|FG000|Overall Study|Staffing issues/lost interest|1|||
154879247|NCT03885726|558982358|FG000|Overall Study|Early discharge from hospital|3|||
154879248|NCT02702193|558982359|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
154879249|NCT02702193|558982360|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
154879250|NCT02702193|558982359|FG000|4 Month Follow up|Withdrawal by Subject|1|||
154879251|NCT02702193|558982360|FG001|4 Month Follow up|Withdrawal by Subject|0|||
154879252|NCT02702193|558982359|FG000|4 Month Follow up|Lost to Follow-up|17|||
154879253|NCT02702193|558982360|FG001|4 Month Follow up|Lost to Follow-up|18|||
154879254|NCT02702193|558982359|FG000|8 Month Follow up|Withdrawal by Subject|1|||
154879255|NCT02702193|558982360|FG001|8 Month Follow up|Withdrawal by Subject|0|||
154879256|NCT02702193|558982359|FG000|8 Month Follow up|Lost to Follow-up|14|||
154879257|NCT02702193|558982360|FG001|8 Month Follow up|Lost to Follow-up|18|||
154879258|NCT02702193|558982359|FG000|12 Month Follow up|Withdrawal by Subject|1|||
154879259|NCT02702193|558982360|FG001|12 Month Follow up|Withdrawal by Subject|0|||
154879260|NCT02702193|558982359|FG000|12 Month Follow up|Lost to Follow-up|16|||
154879261|NCT02702193|558982360|FG001|12 Month Follow up|Lost to Follow-up|18|||
154879262|NCT05692154|558982362|FG000|Overall Study|Adverse Event|0|||
154879263|NCT05692154|558982363|FG001|Overall Study|Adverse Event|1|||
154879264|NCT01912729|558982366|FG000|Overall Study|Withdrawal by Subject|0|||
154879265|NCT01912729|558982367|FG001|Overall Study|Withdrawal by Subject|1|||
154879266|NCT05513053|558982375|FG000|Overall Study|Lost to Follow-up|9|||
154879267|NCT05513053|558982376|FG001|Overall Study|Lost to Follow-up|11|||
154879268|NCT05513053|558982375|FG000|Overall Study|Withdrawal by parent/guardian|2|||
154879269|NCT05513053|558982376|FG001|Overall Study|Withdrawal by parent/guardian|0|||
154879270|NCT05513053|558982375|FG000|Overall Study|Withdrawal by Subject|2|||
154879271|NCT05513053|558982376|FG001|Overall Study|Withdrawal by Subject|9|||
154879272|NCT05513053|558982375|FG000|Overall Study|Protocol Violation|6|||
154879273|NCT05513053|558982376|FG001|Overall Study|Protocol Violation|3|||
154879274|NCT05513053|558982375|FG000|Overall Study|Adverse Event|0|||
154879275|NCT05513053|558982376|FG001|Overall Study|Adverse Event|2|||
154879276|NCT00683475|558984035|FG000|Overall Study|Withdrawal by Subject|1|||
154879277|NCT00683475|558984036|FG001|Overall Study|Withdrawal by Subject|0|||
154879278|NCT00683475|558984035|FG000|Overall Study|Never Treated: Adverse Event|2|||
154879279|NCT00683475|558984036|FG001|Overall Study|Never Treated: Adverse Event|3|||
154879280|NCT00683475|558984035|FG000|Overall Study|Never Treated: Progressive Disease|1|||
154879281|NCT00683475|558984036|FG001|Overall Study|Never Treated: Progressive Disease|0|||
154879282|NCT01953328|558984037|FG000|Overall Study|Withdrawal by Subject|0|||
154879283|NCT01953328|558984038|FG001|Overall Study|Withdrawal by Subject|0|||
154879284|NCT01953328|558984039|FG002|Overall Study|Withdrawal by Subject|0|||
154879285|NCT01953328|558984040|FG003|Overall Study|Withdrawal by Subject|0|||
154879286|NCT01953328|558984041|FG004|Overall Study|Withdrawal by Subject|1|||
154879287|NCT01953328|558984042|FG005|Overall Study|Withdrawal by Subject|0|||
154879288|NCT01953328|558984043|FG006|Overall Study|Withdrawal by Subject|0|||
154879289|NCT01953328|558984044|FG007|Overall Study|Withdrawal by Subject|0|||
154879290|NCT01953328|558984037|FG000|Overall Study|Lost to Follow-up|0|||
154879291|NCT01953328|558984038|FG001|Overall Study|Lost to Follow-up|0|||
154879292|NCT01953328|558984039|FG002|Overall Study|Lost to Follow-up|0|||
155113291|NCT01892436|559844740|FG001|Overall Study|Physician Decision|1|||
155113292|NCT01892436|559844741|FG002|Overall Study|Physician Decision|0|||
155113293|NCT01892436|559844742|FG003|Overall Study|Physician Decision|1|||
155113294|NCT01892436|559844739|FG000|Overall Study|Pregnancy|0|||
155113295|NCT01892436|559844740|FG001|Overall Study|Pregnancy|2|||
155113296|NCT01892436|559844741|FG002|Overall Study|Pregnancy|1|||
155113297|NCT01892436|559844742|FG003|Overall Study|Pregnancy|0|||
155113298|NCT01892436|559844739|FG000|Overall Study|Technical problems|2|||
155113299|NCT01892436|559844740|FG001|Overall Study|Technical problems|1|||
155113300|NCT01892436|559844741|FG002|Overall Study|Technical problems|1|||
154879293|NCT01953328|558984040|FG003|Overall Study|Lost to Follow-up|0|||
154879294|NCT01953328|558984041|FG004|Overall Study|Lost to Follow-up|1|||
154879295|NCT01953328|558984042|FG005|Overall Study|Lost to Follow-up|0|||
154879296|NCT01953328|558984043|FG006|Overall Study|Lost to Follow-up|0|||
154879297|NCT01953328|558984044|FG007|Overall Study|Lost to Follow-up|0|||
154879298|NCT02429258|558984047|FG000|Overall Study|Withdrawal by Subject|2|||
154879299|NCT02429258|558984048|FG001|Overall Study|Withdrawal by Subject|0|||
154879300|NCT02429258|558984047|FG000|Overall Study|Protocol Violation|0|||
154879301|NCT02429258|558984048|FG001|Overall Study|Protocol Violation|1|||
154879302|NCT03987919|558984050|FG000|Overall Study|Adverse Event|1|||
154879303|NCT03987919|558984051|FG001|Overall Study|Adverse Event|4|||
155113301|NCT01892436|559844742|FG003|Overall Study|Technical problems|1|||
155113302|NCT01892436|559844739|FG000|Overall Study|Lack of Efficacy|1|||
155113303|NCT01892436|559844740|FG001|Overall Study|Lack of Efficacy|2|||
154879304|NCT03987919|558984052|FG002|Overall Study|Adverse Event|1|||
155113304|NCT01892436|559844741|FG002|Overall Study|Lack of Efficacy|2|||
155113305|NCT01892436|559844742|FG003|Overall Study|Lack of Efficacy|2|||
155113306|NCT01892436|559844739|FG000|Overall Study|Lost to Follow-up|1|||
155113307|NCT01892436|559844740|FG001|Overall Study|Lost to Follow-up|1|||
155113308|NCT01892436|559844741|FG002|Overall Study|Lost to Follow-up|1|||
155113309|NCT01892436|559844742|FG003|Overall Study|Lost to Follow-up|3|||
155113310|NCT01892436|559844739|FG000|Overall Study|non-compliance with treatment|1|||
154974602|NCT03310619|559331272|FG006|Treatment Period|Study terminated by sponsor|0|||
154974603|NCT03310619|559331273|FG007|Treatment Period|Study terminated by sponsor|1|||
154974604|NCT03310619|559331266|FG000|Treatment Period|Physician Decision|0|||
154974605|NCT03310619|559331267|FG001|Treatment Period|Physician Decision|0|||
155113311|NCT01892436|559844740|FG001|Overall Study|non-compliance with treatment|0|||
155113312|NCT01892436|559844741|FG002|Overall Study|non-compliance with treatment|0|||
155113313|NCT01892436|559844742|FG003|Overall Study|non-compliance with treatment|0|||
155113314|NCT01892436|559844739|FG000|Overall Study|Adverse Event|7|||
155113315|NCT01892436|559844740|FG001|Overall Study|Adverse Event|6|||
155113316|NCT01892436|559844741|FG002|Overall Study|Adverse Event|2|||
155113317|NCT01892436|559844742|FG003|Overall Study|Adverse Event|3|||
155113318|NCT02923830|559844746|FG000|Overall Study|Physician Decision|13|||
155113319|NCT02923830|559844747|FG001|Overall Study|Physician Decision|15|||
155113320|NCT00837265|559844748|FG000|Pilot Phase|Withdrawal by Subject|0|||
155113321|NCT00837265|559844749|FG001|Pilot Phase|Withdrawal by Subject|2|||
155113322|NCT00837265|559844750|FG002|Pilot Phase|Withdrawal by Subject|3|||
155113323|NCT00837265|559844751|FG003|Pilot Phase|Withdrawal by Subject|2|||
155113324|NCT00837265|559844752|FG004|Pilot Phase|Withdrawal by Subject|0|||
155113325|NCT00837265|559844753|FG005|Pilot Phase|Withdrawal by Subject|0|||
155113326|NCT00837265|559844754|FG006|Pilot Phase|Withdrawal by Subject|0|||
155113327|NCT00837265|559844748|FG000|Pilot Phase|Decision of the investigator|2|||
155113328|NCT00837265|559844749|FG001|Pilot Phase|Decision of the investigator|1|||
155113329|NCT00837265|559844750|FG002|Pilot Phase|Decision of the investigator|0|||
155113330|NCT00837265|559844751|FG003|Pilot Phase|Decision of the investigator|0|||
155113331|NCT00837265|559844752|FG004|Pilot Phase|Decision of the investigator|0|||
155113332|NCT00837265|559844753|FG005|Pilot Phase|Decision of the investigator|0|||
154879305|NCT03987919|558984053|FG003|Overall Study|Adverse Event|3|||
154879306|NCT03987919|558984050|FG000|Overall Study|Death|4|||
154879307|NCT03987919|558984051|FG001|Overall Study|Death|4|||
154879308|NCT03987919|558984052|FG002|Overall Study|Death|4|||
154879309|NCT03987919|558984053|FG003|Overall Study|Death|1|||
154879310|NCT03987919|558984050|FG000|Overall Study|Lost to Follow-up|5|||
154879311|NCT03987919|558984051|FG001|Overall Study|Lost to Follow-up|6|||
154879312|NCT03987919|558984052|FG002|Overall Study|Lost to Follow-up|8|||
154879313|NCT03987919|558984053|FG003|Overall Study|Lost to Follow-up|12|||
154879314|NCT03987919|558984050|FG000|Overall Study|Physician Decision|0|||
154879315|NCT03987919|558984051|FG001|Overall Study|Physician Decision|2|||
154879316|NCT03987919|558984052|FG002|Overall Study|Physician Decision|0|||
154879317|NCT03987919|558984053|FG003|Overall Study|Physician Decision|4|||
154879318|NCT03987919|558984050|FG000|Overall Study|Pregnancy|1|||
154879319|NCT03987919|558984051|FG001|Overall Study|Pregnancy|0|||
154879320|NCT03987919|558984052|FG002|Overall Study|Pregnancy|1|||
154879321|NCT03987919|558984053|FG003|Overall Study|Pregnancy|1|||
154879322|NCT03987919|558984050|FG000|Overall Study|Protocol Violation|0|||
154879323|NCT03987919|558984051|FG001|Overall Study|Protocol Violation|1|||
154879324|NCT03987919|558984052|FG002|Overall Study|Protocol Violation|0|||
154879325|NCT03987919|558984053|FG003|Overall Study|Protocol Violation|0|||
154879326|NCT03987919|558984050|FG000|Overall Study|Site terminated by Sponsor|0|||
154879327|NCT03987919|558984051|FG001|Overall Study|Site terminated by Sponsor|0|||
154879328|NCT03987919|558984052|FG002|Overall Study|Site terminated by Sponsor|0|||
154879329|NCT03987919|558984053|FG003|Overall Study|Site terminated by Sponsor|1|||
154879330|NCT03987919|558984050|FG000|Overall Study|Withdrawal by Subject|7|||
154879331|NCT03987919|558984051|FG001|Overall Study|Withdrawal by Subject|7|||
154879332|NCT03987919|558984052|FG002|Overall Study|Withdrawal by Subject|8|||
154974606|NCT03310619|559331268|FG002|Treatment Period|Physician Decision|0|||
155113333|NCT00837265|559844754|FG006|Pilot Phase|Decision of the investigator|0|||
155113334|NCT00837265|559844748|FG000|Pilot Phase|Adverse Event|1|||
155113335|NCT00837265|559844749|FG001|Pilot Phase|Adverse Event|0|||
155113336|NCT00837265|559844750|FG002|Pilot Phase|Adverse Event|0|||
154974607|NCT03310619|559331269|FG003|Treatment Period|Physician Decision|0|||
154879333|NCT03987919|558984053|FG003|Overall Study|Withdrawal by Subject|4|||
154879334|NCT03987919|558984050|FG000|Overall Study|Other - as reported by the investigator|1|||
154879335|NCT03987919|558984051|FG001|Overall Study|Other - as reported by the investigator|3|||
154879336|NCT03987919|558984052|FG002|Overall Study|Other - as reported by the investigator|2|||
154879337|NCT03987919|558984053|FG003|Overall Study|Other - as reported by the investigator|0|||
154879338|NCT03725202|558984054|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
154879339|NCT03725202|558984055|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
154879340|NCT03725202|558984056|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
155113337|NCT00837265|559844751|FG003|Pilot Phase|Adverse Event|0|||
154879341|NCT03725202|558984057|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
155113338|NCT00837265|559844752|FG004|Pilot Phase|Adverse Event|0|||
155113339|NCT00837265|559844753|FG005|Pilot Phase|Adverse Event|0|||
155113340|NCT00837265|559844754|FG006|Pilot Phase|Adverse Event|0|||
155113341|NCT00837265|559844748|FG000|Pilot Phase|Disease progression|0|||
155113342|NCT00837265|559844749|FG001|Pilot Phase|Disease progression|0|||
155113343|NCT00837265|559844750|FG002|Pilot Phase|Disease progression|0|||
155113344|NCT00837265|559844751|FG003|Pilot Phase|Disease progression|1|||
155113345|NCT00837265|559844752|FG004|Pilot Phase|Disease progression|0|||
155113346|NCT00837265|559844753|FG005|Pilot Phase|Disease progression|0|||
155113347|NCT00837265|559844754|FG006|Pilot Phase|Disease progression|0|||
155113348|NCT00837265|559844748|FG000|Pilot Phase|Participant left the city|0|||
155113349|NCT00837265|559844749|FG001|Pilot Phase|Participant left the city|0|||
155113350|NCT00837265|559844750|FG002|Pilot Phase|Participant left the city|0|||
155113351|NCT00837265|559844751|FG003|Pilot Phase|Participant left the city|1|||
155113352|NCT00837265|559844752|FG004|Pilot Phase|Participant left the city|0|||
155113353|NCT00837265|559844753|FG005|Pilot Phase|Participant left the city|0|||
155113354|NCT00837265|559844754|FG006|Pilot Phase|Participant left the city|0|||
155113355|NCT00837265|559844748|FG000|Main Phase|Withdrawal by Subject|0|||
155113356|NCT00837265|559844749|FG001|Main Phase|Withdrawal by Subject|0|||
155113357|NCT00837265|559844750|FG002|Main Phase|Withdrawal by Subject|0|||
155113358|NCT00837265|559844751|FG003|Main Phase|Withdrawal by Subject|0|||
155113359|NCT00837265|559844752|FG004|Main Phase|Withdrawal by Subject|4|||
155113360|NCT00837265|559844753|FG005|Main Phase|Withdrawal by Subject|2|||
155113361|NCT00837265|559844754|FG006|Main Phase|Withdrawal by Subject|1|||
155113362|NCT00837265|559844748|FG000|Main Phase|Decision of the investigator|0|||
155113363|NCT00837265|559844749|FG001|Main Phase|Decision of the investigator|0|||
155113364|NCT00837265|559844750|FG002|Main Phase|Decision of the investigator|0|||
155113365|NCT00837265|559844751|FG003|Main Phase|Decision of the investigator|0|||
155113366|NCT00837265|559844752|FG004|Main Phase|Decision of the investigator|0|||
155113367|NCT00837265|559844753|FG005|Main Phase|Decision of the investigator|2|||
155113368|NCT00837265|559844754|FG006|Main Phase|Decision of the investigator|1|||
155113369|NCT00837265|559844748|FG000|Main Phase|Adverse Event|0|||
155113370|NCT00837265|559844749|FG001|Main Phase|Adverse Event|0|||
155113371|NCT00837265|559844750|FG002|Main Phase|Adverse Event|0|||
155113372|NCT00837265|559844751|FG003|Main Phase|Adverse Event|0|||
155113373|NCT00837265|559844752|FG004|Main Phase|Adverse Event|0|||
155113374|NCT00837265|559844753|FG005|Main Phase|Adverse Event|1|||
155113375|NCT00837265|559844754|FG006|Main Phase|Adverse Event|0|||
155113376|NCT00837265|559844748|FG000|Main Phase|Death|0|||
155113377|NCT00837265|559844749|FG001|Main Phase|Death|0|||
155113378|NCT00837265|559844750|FG002|Main Phase|Death|0|||
155113379|NCT00837265|559844751|FG003|Main Phase|Death|0|||
155113380|NCT00837265|559844752|FG004|Main Phase|Death|2|||
155113381|NCT00837265|559844753|FG005|Main Phase|Death|0|||
155113382|NCT00837265|559844754|FG006|Main Phase|Death|1|||
155113383|NCT00837265|559844748|FG000|Main Phase|Lost to Follow-up|0|||
154879342|NCT03725202|558984058|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
154879343|NCT03725202|558984059|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
154879344|NCT03725202|558984060|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
154879345|NCT03725202|558984061|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
154879346|NCT03725202|558984054|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
155113384|NCT00837265|559844749|FG001|Main Phase|Lost to Follow-up|0|||
155113385|NCT00837265|559844750|FG002|Main Phase|Lost to Follow-up|0|||
155113386|NCT00837265|559844751|FG003|Main Phase|Lost to Follow-up|0|||
155113387|NCT00837265|559844752|FG004|Main Phase|Lost to Follow-up|1|||
155113388|NCT00837265|559844753|FG005|Main Phase|Lost to Follow-up|0|||
155113389|NCT00837265|559844754|FG006|Main Phase|Lost to Follow-up|0|||
155113390|NCT00837265|559844748|FG000|Main Phase|Principal investigator resignation|0|||
155113391|NCT00837265|559844749|FG001|Main Phase|Principal investigator resignation|0|||
155113392|NCT00837265|559844750|FG002|Main Phase|Principal investigator resignation|0|||
155113393|NCT00837265|559844751|FG003|Main Phase|Principal investigator resignation|0|||
155113394|NCT00837265|559844752|FG004|Main Phase|Principal investigator resignation|2|||
155113395|NCT00837265|559844753|FG005|Main Phase|Principal investigator resignation|0|||
154879347|NCT03725202|558984055|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
155113396|NCT00837265|559844754|FG006|Main Phase|Principal investigator resignation|0|||
155113397|NCT00837265|559844748|FG000|Main Phase|Participant's personal reason|0|||
155113398|NCT00837265|559844749|FG001|Main Phase|Participant's personal reason|0|||
154879348|NCT03725202|558984056|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
155113399|NCT00837265|559844750|FG002|Main Phase|Participant's personal reason|0|||
155113400|NCT00837265|559844751|FG003|Main Phase|Participant's personal reason|0|||
155113401|NCT00837265|559844752|FG004|Main Phase|Participant's personal reason|1|||
155113402|NCT00837265|559844753|FG005|Main Phase|Participant's personal reason|0|||
155113403|NCT00837265|559844754|FG006|Main Phase|Participant's personal reason|0|||
155113404|NCT01751906|559844762|FG000|Overall Study|Lost to Follow-up|151|||
155113405|NCT01751906|559844763|FG001|Overall Study|Lost to Follow-up|68|||
155113406|NCT01751906|559844762|FG000|Overall Study|Withdrawal by Subject|22|||
154879349|NCT03725202|558984057|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
155113407|NCT01751906|559844763|FG001|Overall Study|Withdrawal by Subject|18|||
155113408|NCT01751906|559844762|FG000|Overall Study|Physician Decision|5|||
154879350|NCT03725202|558984058|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
154879351|NCT03725202|558984059|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
154879352|NCT03725202|558984060|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
154879353|NCT03725202|558984061|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
154879354|NCT03725202|558984054|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
154879355|NCT03725202|558984055|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879356|NCT03725202|558984056|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879357|NCT03725202|558984057|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879358|NCT03725202|558984058|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879359|NCT03725202|558984059|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879360|NCT03725202|558984060|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879361|NCT03725202|558984061|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
154879362|NCT03725202|558984054|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
154879363|NCT03725202|558984055|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879364|NCT03725202|558984056|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879365|NCT03725202|558984057|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879366|NCT03725202|558984058|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879367|NCT03725202|558984059|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879368|NCT03725202|558984060|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879369|NCT03725202|558984061|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
154879370|NCT03725202|558984054|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
154879371|NCT03725202|558984055|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
154879372|NCT03725202|558984056|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
154879373|NCT03725202|558984057|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
154879374|NCT03725202|558984058|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
154879375|NCT03725202|558984059|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
154879376|NCT03725202|558984060|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
154879377|NCT03725202|558984061|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
154879378|NCT03725202|558984054|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879379|NCT03725202|558984055|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879380|NCT03725202|558984056|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
154879381|NCT03725202|558984057|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879382|NCT03725202|558984058|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879383|NCT03725202|558984059|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879384|NCT03725202|558984060|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879385|NCT03725202|558984061|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
154879386|NCT03725202|558984054|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
154879387|NCT03725202|558984055|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
154879388|NCT03725202|558984056|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
154879389|NCT03725202|558984057|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
154879390|NCT03725202|558984058|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
154879391|NCT03725202|558984059|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
154879392|NCT03725202|558984060|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
154879393|NCT03725202|558984061|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
154879394|NCT03725202|558984054|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
154879395|NCT03725202|558984055|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
154879396|NCT03725202|558984056|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
154879397|NCT03725202|558984057|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
154879398|NCT03725202|558984058|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
154879399|NCT03725202|558984059|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
154879400|NCT03725202|558984060|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
154879401|NCT03725202|558984061|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
154879402|NCT03725202|558984054|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
154879403|NCT03725202|558984055|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
154879404|NCT03725202|558984056|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
154879405|NCT03725202|558984057|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
154879406|NCT03725202|558984058|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
154879407|NCT03725202|558984059|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
154879408|NCT03725202|558984060|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
154879409|NCT03725202|558984061|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
154879410|NCT03725202|558984054|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879411|NCT03725202|558984055|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879412|NCT03725202|558984056|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879413|NCT03725202|558984057|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879414|NCT03725202|558984058|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879415|NCT03725202|558984059|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879416|NCT03725202|558984060|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
154879417|NCT03725202|558984061|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
154879418|NCT03725202|558984054|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879419|NCT03725202|558984055|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879420|NCT03725202|558984056|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879421|NCT03725202|558984057|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879422|NCT03725202|558984058|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879423|NCT03725202|558984059|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
154879424|NCT03725202|558984060|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879425|NCT03725202|558984061|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
154879426|NCT03725202|558984054|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
154879427|NCT03725202|558984055|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
154879428|NCT03725202|558984056|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
154879429|NCT03725202|558984057|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
154879430|NCT03725202|558984058|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
154879431|NCT03725202|558984059|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
154879432|NCT03725202|558984060|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
154879433|NCT03725202|558984061|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
154879434|NCT01328249|558984064|FG000|Overall Study|Adverse Event|3|||
154879435|NCT01328249|558984065|FG001|Overall Study|Adverse Event|0|||
154879436|NCT01328249|558984064|FG000|Overall Study|Disease progression|1|||
154879437|NCT01328249|558984065|FG001|Overall Study|Disease progression|0|||
154879438|NCT01328249|558984064|FG000|Overall Study|Withdrawal by Subject|1|||
154879439|NCT01328249|558984065|FG001|Overall Study|Withdrawal by Subject|1|||
154879440|NCT01328249|558984064|FG000|Overall Study|Moved before end of treatment visit|1|||
154879441|NCT01328249|558984065|FG001|Overall Study|Moved before end of treatment visit|0|||
154879442|NCT01328249|558984064|FG000|Overall Study|Subject choice|1|||
154879443|NCT01328249|558984065|FG001|Overall Study|Subject choice|1|||
154879444|NCT01328249|558984064|FG000|Overall Study|Protocol Violation|0|||
154879445|NCT01328249|558984065|FG001|Overall Study|Protocol Violation|1|||
154879446|NCT00748553|558984066|FG000|Overall Study|Adverse Event|0|||
154879447|NCT00748553|558984067|FG001|Overall Study|Adverse Event|1|||
154879448|NCT00748553|558984066|FG000|Overall Study|disease progression|2|||
154879449|NCT00748553|558984067|FG001|Overall Study|disease progression|0|||
154879450|NCT00748553|558984066|FG000|Overall Study|noncompliance|1|||
154879451|NCT00748553|558984067|FG001|Overall Study|noncompliance|0|||
154879452|NCT00948818|558984069|FG000|Overall Study|Adverse Event|10|||
154879453|NCT00948818|558984070|FG001|Overall Study|Adverse Event|32|||
154879454|NCT00948818|558984069|FG000|Overall Study|Protocol Violation|9|||
154879455|NCT00948818|558984070|FG001|Overall Study|Protocol Violation|10|||
154879456|NCT00948818|558984069|FG000|Overall Study|Withdrawal by Subject|25|||
154879457|NCT00948818|558984070|FG001|Overall Study|Withdrawal by Subject|25|||
154879458|NCT00948818|558984069|FG000|Overall Study|Lost to Follow-up|10|||
154879459|NCT00948818|558984070|FG001|Overall Study|Lost to Follow-up|17|||
154879460|NCT00948818|558984069|FG000|Overall Study|Lack of Efficacy|4|||
154879461|NCT00948818|558984070|FG001|Overall Study|Lack of Efficacy|5|||
154879462|NCT00948818|558984069|FG000|Overall Study|Other Reason|4|||
154879463|NCT00948818|558984070|FG001|Overall Study|Other Reason|5|||
154879464|NCT02330549|558984071|FG000|Overall Study|Adverse Event|1|||
154879465|NCT02330549|558984072|FG001|Overall Study|Adverse Event|0|||
154879466|NCT02330549|558984071|FG000|Overall Study|Subject withdrew consent|2|||
154879467|NCT02330549|558984072|FG001|Overall Study|Subject withdrew consent|1|||
154879468|NCT02330549|558984071|FG000|Overall Study|Failure to meet randomization criteria|1|||
154879469|NCT02330549|558984072|FG001|Overall Study|Failure to meet randomization criteria|0|||
154879470|NCT00495495|558984073|FG000|Overall Study|Protocol Violation|99|||
154879471|NCT02702518|558984079|FG000|Overall Study|Lost to Follow-up|3|||
154879472|NCT02702518|558984080|FG001|Overall Study|Lost to Follow-up|4|||
154879473|NCT00423085|558984081|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
154879474|NCT00423085|558984082|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
154879475|NCT00423085|558984083|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
154879476|NCT00423085|558984084|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
154879477|NCT00423085|558984081|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
154879478|NCT00423085|558984082|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
154879479|NCT00423085|558984083|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
154879480|NCT00423085|558984084|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
154879481|NCT00423085|558984081|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
154879482|NCT00423085|558984082|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
154879483|NCT00423085|558984083|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
154879484|NCT00423085|558984084|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
155113409|NCT01751906|559844763|FG001|Overall Study|Physician Decision|2|||
155113410|NCT01751906|559844762|FG000|Overall Study|Death|84|||
155113411|NCT01751906|559844763|FG001|Overall Study|Death|43|||
155113412|NCT01751906|559844762|FG000|Overall Study|Denied on premises for follow-up by law|1|||
155113413|NCT01751906|559844763|FG001|Overall Study|Denied on premises for follow-up by law|0|||
155113414|NCT00733291|559844764|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
155113415|NCT00733291|559844765|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
155113416|NCT00733291|559844766|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
155113417|NCT00733291|559844767|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
155113418|NCT02759107|559844768|FG000|Overall Study|Adverse Event|0|||
155113419|NCT02759107|559844769|FG001|Overall Study|Adverse Event|0|||
155113420|NCT02759107|559844770|FG002|Overall Study|Adverse Event|0|||
155113421|NCT02759107|559844771|FG003|Overall Study|Adverse Event|0|||
155113422|NCT02759107|559844772|FG004|Overall Study|Adverse Event|0|||
155113423|NCT02759107|559844773|FG005|Overall Study|Adverse Event|0|||
155113424|NCT02759107|559844774|FG006|Overall Study|Adverse Event|0|||
155113425|NCT02759107|559844775|FG007|Overall Study|Adverse Event|0|||
155113426|NCT02759107|559844776|FG008|Overall Study|Adverse Event|0|||
155113427|NCT02759107|559844777|FG009|Overall Study|Adverse Event|0|||
155113428|NCT02759107|559844778|FG010|Overall Study|Adverse Event|0|||
154879485|NCT00423085|558984081|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
154879486|NCT00423085|558984082|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
154879487|NCT00423085|558984083|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
154879488|NCT00423085|558984084|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
154879489|NCT00423085|558984081|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
154879490|NCT00423085|558984082|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
154879491|NCT00423085|558984083|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
154879492|NCT00423085|558984084|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
154879493|NCT00423085|558984081|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
154879494|NCT00423085|558984082|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
154879495|NCT00423085|558984083|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
154879496|NCT00423085|558984084|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
154879497|NCT00423085|558984081|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
154879498|NCT00423085|558984082|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
154879499|NCT00423085|558984083|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
154879500|NCT00423085|558984084|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
154879501|NCT00423085|558984081|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
154879502|NCT00423085|558984082|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
154879503|NCT00423085|558984083|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
154879504|NCT00423085|558984084|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
154879505|NCT00423085|558984081|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
154879506|NCT00423085|558984082|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
154879507|NCT00423085|558984083|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
154879508|NCT00423085|558984084|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
154879509|NCT00423085|558984081|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
154879510|NCT00423085|558984082|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
154879511|NCT00423085|558984083|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
154879512|NCT00423085|558984084|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
154879513|NCT00423085|558984081|FG000|52-Week Open-Label Extension Phase|Death|0|||
155113429|NCT02759107|559844779|FG011|Overall Study|Adverse Event|0|||
155113430|NCT02759107|559844780|FG012|Overall Study|Adverse Event|2|||
154879514|NCT00423085|558984082|FG001|52-Week Open-Label Extension Phase|Death|0|||
154879515|NCT00423085|558984083|FG002|52-Week Open-Label Extension Phase|Death|0|||
154879516|NCT00423085|558984084|FG003|52-Week Open-Label Extension Phase|Death|2|||
154879517|NCT03331666|558984085|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
154879518|NCT03331666|558984086|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
154879519|NCT05525975|558984087|FG000|Overall Study|Surgery cancellation|4|||
154879520|NCT05525975|558984088|FG001|Overall Study|Surgery cancellation|5|||
154879521|NCT05525975|558984087|FG000|Overall Study|didn't fill prescription|1|||
154879522|NCT05525975|558984088|FG001|Overall Study|didn't fill prescription|0|||
154879523|NCT05525975|558984087|FG000|Overall Study|Withdrawal by Subject|0|||
154879524|NCT05525975|558984088|FG001|Overall Study|Withdrawal by Subject|3|||
154879525|NCT00262080|558984090|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
154879526|NCT00262080|558984091|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
154879527|NCT00262080|558984092|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
154879528|NCT00262080|558984090|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
154879529|NCT00262080|558984091|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
154879530|NCT00262080|558984092|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
155113431|NCT02759107|559844781|FG013|Overall Study|Adverse Event|0|||
155113432|NCT02759107|559844782|FG014|Overall Study|Adverse Event|0|||
154974608|NCT03310619|559331270|FG004|Treatment Period|Physician Decision|3|||
154974609|NCT03310619|559331271|FG005|Treatment Period|Physician Decision|0|||
154974610|NCT03310619|559331272|FG006|Treatment Period|Physician Decision|0|||
154974611|NCT03310619|559331273|FG007|Treatment Period|Physician Decision|0|||
154974612|NCT03310619|559331266|FG000|Treatment Period|Other reasons|1|||
154974613|NCT03310619|559331267|FG001|Treatment Period|Other reasons|0|||
154974614|NCT03310619|559331268|FG002|Treatment Period|Other reasons|2|||
154974615|NCT03310619|559331269|FG003|Treatment Period|Other reasons|0|||
154974616|NCT03310619|559331270|FG004|Treatment Period|Other reasons|0|||
154974617|NCT03310619|559331271|FG005|Treatment Period|Other reasons|0|||
154974618|NCT03310619|559331272|FG006|Treatment Period|Other reasons|0|||
154974619|NCT03310619|559331273|FG007|Treatment Period|Other reasons|0|||
154974620|NCT04307849|559331276|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
154974621|NCT04307849|559331277|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
154974622|NCT04307849|559331278|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
154974623|NCT04307849|559331279|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
154974624|NCT04307849|559331280|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
154974625|NCT04307849|559331281|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
154974626|NCT04307849|559331276|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
154974627|NCT04307849|559331277|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
154974628|NCT04307849|559331278|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
154974629|NCT04307849|559331279|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
154974630|NCT04307849|559331280|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
154974631|NCT04307849|559331281|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
154974632|NCT04307849|559331276|FG000|Overall Study|Family member did not want them to continue|0|||
154974633|NCT04307849|559331277|FG001|Overall Study|Family member did not want them to continue|0|||
154974634|NCT04307849|559331278|FG002|Overall Study|Family member did not want them to continue|1|||
154974635|NCT04307849|559331279|FG003|Overall Study|Family member did not want them to continue|0|||
154974636|NCT04307849|559331280|FG004|Overall Study|Family member did not want them to continue|0|||
154974637|NCT04307849|559331281|FG005|Overall Study|Family member did not want them to continue|0|||
154974638|NCT04307849|559331276|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
154974639|NCT04307849|559331277|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
154974640|NCT04307849|559331278|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
154974641|NCT04307849|559331279|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
154974642|NCT04307849|559331280|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
154974643|NCT04307849|559331281|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
154974644|NCT02418754|559331284|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
154974645|NCT02418754|559331285|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
154974646|NCT02418754|559331286|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
154974647|NCT02418754|559331287|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
154974648|NCT02418754|559331288|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
154974649|NCT02418754|559331284|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
154974650|NCT02418754|559331285|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
154974651|NCT02418754|559331286|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
154974652|NCT02418754|559331287|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
154974653|NCT02418754|559331288|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
154879531|NCT00262080|558984090|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
154879532|NCT00262080|558984091|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
154879533|NCT00262080|558984092|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
154879534|NCT00262080|558984090|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
154879535|NCT00262080|558984091|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
154879536|NCT00262080|558984092|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
154879537|NCT00262080|558984090|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
154879538|NCT00262080|558984091|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
154879539|NCT00262080|558984092|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
154974654|NCT02418754|559331284|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
154974655|NCT02418754|559331285|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
154974656|NCT02418754|559331286|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
154974657|NCT02418754|559331287|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
154974658|NCT02418754|559331288|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
154974659|NCT02418754|559331284|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
154974660|NCT02418754|559331285|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
154974661|NCT02418754|559331286|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
154974662|NCT02418754|559331287|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
154974663|NCT02418754|559331288|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
154974664|NCT02418754|559331284|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
154974665|NCT02418754|559331285|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
154974666|NCT02418754|559331286|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
154879540|NCT00262080|558984090|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
154879541|NCT00262080|558984091|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
154879542|NCT00262080|558984092|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
154879543|NCT01051986|558984093|FG000|Overall Study|Death|1|||
154879544|NCT01051986|558984094|FG001|Overall Study|Death|0|||
154879545|NCT01051986|558984093|FG000|Overall Study|Withdrawal by Subject|2|||
154879546|NCT01051986|558984094|FG001|Overall Study|Withdrawal by Subject|1|||
154879547|NCT01051986|558984093|FG000|Overall Study|Protocol Violation|2|||
154879548|NCT01051986|558984094|FG001|Overall Study|Protocol Violation|3|||
154879549|NCT02044159|558984096|FG000|Overall Study|Consent declined (deferred consent)|2|||
154879550|NCT02044159|558984097|FG001|Overall Study|Consent declined (deferred consent)|4|||
154879551|NCT02044159|558984096|FG000|Overall Study|No longer eligible, drug not given|1|||
154879552|NCT02044159|558984097|FG001|Overall Study|No longer eligible, drug not given|0|||
154879553|NCT02044159|558984096|FG000|Overall Study|Nurse declined to give study drug|1|||
154879554|NCT02044159|558984097|FG001|Overall Study|Nurse declined to give study drug|0|||
154879555|NCT01361009|558984098|FG000|Overall Study|Protocol Violation|116|||
154879556|NCT04009096|558984099|FG000|Overall Study|Withdrawal by Subject|0|||
154879557|NCT04009096|558984100|FG001|Overall Study|Withdrawal by Subject|7|||
154879558|NCT04009096|558984101|FG002|Overall Study|Withdrawal by Subject|0|||
154879559|NCT04009096|558984099|FG000|Overall Study|Physician Decision|0|||
154879560|NCT04009096|558984100|FG001|Overall Study|Physician Decision|1|||
154879561|NCT04009096|558984101|FG002|Overall Study|Physician Decision|0|||
154879562|NCT04263142|558984102|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
154879563|NCT04263142|558984103|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
154879564|NCT04263142|558984104|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
154879565|NCT04263142|558984105|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
154879566|NCT04263142|558984106|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
154879567|NCT04263142|558984102|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
154879568|NCT04263142|558984103|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
154879569|NCT04263142|558984104|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
154879570|NCT04263142|558984105|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
154879571|NCT04263142|558984106|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
154879572|NCT03010423|558984110|FG000|Overall Study|Study termination|8|||
154879573|NCT01597557|558984111|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
154879574|NCT01597557|558984112|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
154879575|NCT00115349|558984115|FG000|Overall Study|Study closed due to low enrollment.|11|||
154879576|NCT00115349|558984116|FG001|Overall Study|Study closed due to low enrollment.|9|||
154879577|NCT04402008|558984119|FG000|Overall Study|Adverse Event|0|||
154879578|NCT04402008|558984120|FG001|Overall Study|Adverse Event|0|||
154879579|NCT04402008|558984121|FG002|Overall Study|Adverse Event|0|||
154879580|NCT04402008|558984122|FG003|Overall Study|Adverse Event|1|||
154879581|NCT04402008|558984123|FG004|Overall Study|Adverse Event|0|||
154879582|NCT04402008|558984124|FG005|Overall Study|Adverse Event|0|||
154879583|NCT04402008|558984125|FG006|Overall Study|Adverse Event|0|||
154879584|NCT04402008|558984119|FG000|Overall Study|Disease Progression|3|||
154879585|NCT04402008|558984120|FG001|Overall Study|Disease Progression|2|||
154879586|NCT04402008|558984121|FG002|Overall Study|Disease Progression|3|||
154879587|NCT04402008|558984122|FG003|Overall Study|Disease Progression|3|||
154879588|NCT04402008|558984123|FG004|Overall Study|Disease Progression|4|||
154879589|NCT04402008|558984124|FG005|Overall Study|Disease Progression|3|||
154879590|NCT04402008|558984125|FG006|Overall Study|Disease Progression|10|||
154879591|NCT04402008|558984119|FG000|Overall Study|Withdrawal by Subject|0|||
154879592|NCT04402008|558984120|FG001|Overall Study|Withdrawal by Subject|1|||
154879593|NCT04402008|558984121|FG002|Overall Study|Withdrawal by Subject|0|||
154879594|NCT04402008|558984122|FG003|Overall Study|Withdrawal by Subject|0|||
154879595|NCT04402008|558984123|FG004|Overall Study|Withdrawal by Subject|1|||
154879596|NCT04402008|558984124|FG005|Overall Study|Withdrawal by Subject|0|||
154879597|NCT04402008|558984125|FG006|Overall Study|Withdrawal by Subject|0|||
154879598|NCT04402008|558984119|FG000|Overall Study|Sponsor Decision|0|||
154879599|NCT04402008|558984120|FG001|Overall Study|Sponsor Decision|0|||
154879600|NCT04402008|558984121|FG002|Overall Study|Sponsor Decision|0|||
154879601|NCT04402008|558984122|FG003|Overall Study|Sponsor Decision|0|||
154879602|NCT04402008|558984123|FG004|Overall Study|Sponsor Decision|0|||
154879603|NCT04402008|558984124|FG005|Overall Study|Sponsor Decision|0|||
154879604|NCT04402008|558984125|FG006|Overall Study|Sponsor Decision|3|||
154879605|NCT04402008|558984119|FG000|Overall Study|Death|0|||
154879606|NCT04402008|558984120|FG001|Overall Study|Death|0|||
154879607|NCT04402008|558984121|FG002|Overall Study|Death|0|||
154879608|NCT04402008|558984122|FG003|Overall Study|Death|0|||
154879609|NCT04402008|558984123|FG004|Overall Study|Death|1|||
154879610|NCT04402008|558984124|FG005|Overall Study|Death|0|||
154879611|NCT04402008|558984125|FG006|Overall Study|Death|2|||
154879612|NCT04402008|558984119|FG000|Overall Study|Other|0|||
154879613|NCT04402008|558984120|FG001|Overall Study|Other|0|||
154879614|NCT04402008|558984121|FG002|Overall Study|Other|0|||
154879615|NCT04402008|558984122|FG003|Overall Study|Other|0|||
154879616|NCT04402008|558984123|FG004|Overall Study|Other|0|||
154879617|NCT04402008|558984124|FG005|Overall Study|Other|0|||
154879618|NCT04402008|558984125|FG006|Overall Study|Other|5|||
154879619|NCT01533935|558984127|FG000|Overall Study|Adverse Event|5|||
154879620|NCT01533935|558984128|FG001|Overall Study|Adverse Event|7|||
154879621|NCT01533935|558984129|FG002|Overall Study|Adverse Event|1|||
154879622|NCT01533935|558984130|FG003|Overall Study|Adverse Event|5|||
154879623|NCT01533935|558984131|FG004|Overall Study|Adverse Event|3|||
154974667|NCT02418754|559331287|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
154974668|NCT02418754|559331288|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
154974669|NCT02418754|559331284|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
154974670|NCT02418754|559331285|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
154974671|NCT02418754|559331286|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
154974672|NCT02418754|559331287|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
154974673|NCT02418754|559331288|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
154974674|NCT02418754|559331284|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
154974675|NCT02418754|559331285|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
154974676|NCT02418754|559331286|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
154974677|NCT02418754|559331287|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
154974678|NCT02418754|559331288|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
154974679|NCT02418754|559331284|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
154974680|NCT02418754|559331285|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
154974681|NCT02418754|559331286|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
154974682|NCT02418754|559331287|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
154974683|NCT02418754|559331288|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
154974684|NCT02418754|559331284|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
154974685|NCT02418754|559331285|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
154974686|NCT02418754|559331286|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
154974687|NCT02418754|559331287|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
154974688|NCT02418754|559331288|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
154879624|NCT01533935|558984127|FG000|Overall Study|Protocol Violation|0|||
154879625|NCT01533935|558984128|FG001|Overall Study|Protocol Violation|2|||
154879626|NCT01533935|558984129|FG002|Overall Study|Protocol Violation|0|||
154879627|NCT01533935|558984130|FG003|Overall Study|Protocol Violation|0|||
154879628|NCT01533935|558984131|FG004|Overall Study|Protocol Violation|0|||
154879629|NCT01533935|558984127|FG000|Overall Study|Lost to Follow-up|0|||
154879630|NCT01533935|558984128|FG001|Overall Study|Lost to Follow-up|0|||
154879631|NCT01533935|558984129|FG002|Overall Study|Lost to Follow-up|1|||
154879632|NCT01533935|558984130|FG003|Overall Study|Lost to Follow-up|0|||
154879633|NCT01533935|558984131|FG004|Overall Study|Lost to Follow-up|0|||
154879634|NCT01533935|558984127|FG000|Overall Study|Withdrawal by Subject|0|||
154879635|NCT01533935|558984128|FG001|Overall Study|Withdrawal by Subject|4|||
154879636|NCT01533935|558984129|FG002|Overall Study|Withdrawal by Subject|5|||
154879637|NCT01533935|558984130|FG003|Overall Study|Withdrawal by Subject|2|||
154879638|NCT01533935|558984131|FG004|Overall Study|Withdrawal by Subject|4|||
154879639|NCT01533935|558984127|FG000|Overall Study|Other reason not defined above|1|||
154879640|NCT01533935|558984128|FG001|Overall Study|Other reason not defined above|0|||
154879641|NCT01533935|558984129|FG002|Overall Study|Other reason not defined above|1|||
154879642|NCT01533935|558984130|FG003|Overall Study|Other reason not defined above|0|||
154879643|NCT01533935|558984131|FG004|Overall Study|Other reason not defined above|1|||
154879644|NCT05132569|558984132|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
154879645|NCT05132569|558984133|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
154879646|NCT05132569|558984132|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
154974689|NCT02418754|559331284|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
154974690|NCT02418754|559331285|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
154974691|NCT02418754|559331286|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
155113433|NCT02759107|559844783|FG015|Overall Study|Adverse Event|1|||
155113434|NCT02759107|559844784|FG016|Overall Study|Adverse Event|0|||
155113435|NCT02759107|559844785|FG017|Overall Study|Adverse Event|2|||
155113436|NCT02759107|559844768|FG000|Overall Study|Scheduling Conflict|0|||
155113437|NCT02759107|559844769|FG001|Overall Study|Scheduling Conflict|0|||
155113438|NCT02759107|559844770|FG002|Overall Study|Scheduling Conflict|0|||
155113439|NCT02759107|559844771|FG003|Overall Study|Scheduling Conflict|0|||
155113440|NCT02759107|559844772|FG004|Overall Study|Scheduling Conflict|0|||
155113441|NCT02759107|559844773|FG005|Overall Study|Scheduling Conflict|0|||
155113442|NCT02759107|559844774|FG006|Overall Study|Scheduling Conflict|0|||
155113443|NCT02759107|559844775|FG007|Overall Study|Scheduling Conflict|0|||
155113444|NCT02759107|559844776|FG008|Overall Study|Scheduling Conflict|0|||
155113445|NCT02759107|559844777|FG009|Overall Study|Scheduling Conflict|1|||
155113446|NCT02759107|559844778|FG010|Overall Study|Scheduling Conflict|0|||
155113447|NCT02759107|559844779|FG011|Overall Study|Scheduling Conflict|0|||
155113448|NCT02759107|559844780|FG012|Overall Study|Scheduling Conflict|0|||
154879647|NCT05132569|558984133|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
155113449|NCT02759107|559844781|FG013|Overall Study|Scheduling Conflict|0|||
155113450|NCT02759107|559844782|FG014|Overall Study|Scheduling Conflict|0|||
154974692|NCT02418754|559331287|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
154974693|NCT02418754|559331288|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
154974694|NCT02418754|559331284|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
154974695|NCT02418754|559331285|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
154974696|NCT02418754|559331286|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
154974697|NCT02418754|559331287|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
154974698|NCT02418754|559331288|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
154974699|NCT01896505|559331289|FG000|Overall Study|Adverse Event|1|||
154974700|NCT01896505|559331290|FG001|Overall Study|Adverse Event|0|||
154974701|NCT01896505|559331291|FG002|Overall Study|Adverse Event|2|||
154974702|NCT01896505|559331292|FG003|Overall Study|Adverse Event|1|||
154974703|NCT01896505|559331293|FG004|Overall Study|Adverse Event|1|||
154974704|NCT01896505|559331294|FG005|Overall Study|Adverse Event|0|||
154974705|NCT01896505|559331289|FG000|Overall Study|Physician Decision|1|||
154974706|NCT01896505|559331290|FG001|Overall Study|Physician Decision|3|||
154974707|NCT01896505|559331291|FG002|Overall Study|Physician Decision|2|||
154974708|NCT01896505|559331292|FG003|Overall Study|Physician Decision|0|||
154974709|NCT01896505|559331293|FG004|Overall Study|Physician Decision|0|||
154974710|NCT01896505|559331294|FG005|Overall Study|Physician Decision|1|||
154974711|NCT01896505|559331289|FG000|Overall Study|Withdrawal by Subject|1|||
154974712|NCT01896505|559331290|FG001|Overall Study|Withdrawal by Subject|0|||
154974713|NCT01896505|559331291|FG002|Overall Study|Withdrawal by Subject|3|||
154974714|NCT01896505|559331292|FG003|Overall Study|Withdrawal by Subject|1|||
154974715|NCT01896505|559331293|FG004|Overall Study|Withdrawal by Subject|0|||
154974716|NCT01896505|559331294|FG005|Overall Study|Withdrawal by Subject|0|||
154974717|NCT01896505|559331289|FG000|Overall Study|Disease Progression|7|||
154974718|NCT01896505|559331290|FG001|Overall Study|Disease Progression|5|||
154974719|NCT01896505|559331291|FG002|Overall Study|Disease Progression|8|||
154974720|NCT01896505|559331292|FG003|Overall Study|Disease Progression|4|||
154974721|NCT01896505|559331293|FG004|Overall Study|Disease Progression|4|||
154974722|NCT01896505|559331294|FG005|Overall Study|Disease Progression|4|||
154974723|NCT01896505|559331289|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
154974724|NCT01896505|559331290|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
154974725|NCT01896505|559331291|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
154974726|NCT01896505|559331292|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
154974727|NCT01896505|559331293|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
154974728|NCT01896505|559331294|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
154974729|NCT01896505|559331289|FG000|Overall Study|Intercurrent illness|0|||
154974730|NCT01896505|559331290|FG001|Overall Study|Intercurrent illness|1|||
154974731|NCT01896505|559331291|FG002|Overall Study|Intercurrent illness|0|||
154974732|NCT01896505|559331292|FG003|Overall Study|Intercurrent illness|0|||
154974733|NCT01896505|559331293|FG004|Overall Study|Intercurrent illness|0|||
154974734|NCT01896505|559331294|FG005|Overall Study|Intercurrent illness|0|||
154974735|NCT01896505|559331289|FG000|Overall Study|Death|0|||
154974736|NCT01896505|559331290|FG001|Overall Study|Death|0|||
154974737|NCT01896505|559331291|FG002|Overall Study|Death|1|||
154974738|NCT01896505|559331292|FG003|Overall Study|Death|1|||
154974739|NCT01896505|559331293|FG004|Overall Study|Death|0|||
154974740|NCT01896505|559331294|FG005|Overall Study|Death|1|||
154974741|NCT02387762|559331295|FG000|Overall Study|Withdrawal by Subject|1|||
154974742|NCT02387762|559331296|FG001|Overall Study|Withdrawal by Subject|0|||
154974743|NCT04203667|559331297|FG000|Overall Study|Withdrawal by Subject|1|||
154974744|NCT04203667|559331297|FG000|Overall Study|Lost to Follow-up|1|||
154974745|NCT04203667|559331297|FG000|Overall Study|Death|1|||
154974746|NCT04203667|559331297|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
154974747|NCT00593827|559331298|FG000|Overall Study|On Active Treatment/Pending|0|||
154974748|NCT00593827|559331299|FG001|Overall Study|On Active Treatment/Pending|2|||
154974749|NCT01160640|559331300|FG000|Overall Study|Physician Decision|3|||
154974750|NCT01160640|559331301|FG001|Overall Study|Physician Decision|3|||
154974751|NCT01160640|559331300|FG000|Overall Study|Incarceration|1|||
154974752|NCT01160640|559331301|FG001|Overall Study|Incarceration|0|||
155113451|NCT02759107|559844783|FG015|Overall Study|Scheduling Conflict|0|||
155113452|NCT02759107|559844784|FG016|Overall Study|Scheduling Conflict|0|||
155113453|NCT02759107|559844785|FG017|Overall Study|Scheduling Conflict|0|||
155113454|NCT00420004|559844794|FG000|Overall Study|Adverse Event|4|||
155113455|NCT00420004|559844795|FG001|Overall Study|Adverse Event|1|||
154974753|NCT01160640|559331300|FG000|Overall Study|Withdrawal by Subject|0|||
155113456|NCT00420004|559844796|FG002|Overall Study|Adverse Event|1|||
154974754|NCT01160640|559331301|FG001|Overall Study|Withdrawal by Subject|3|||
155113457|NCT00420004|559844794|FG000|Overall Study|Lack of Efficacy|5|||
154974755|NCT02212457|559331302|FG000|Overall Study|Adverse Event|1|||
154974756|NCT02212457|559331303|FG001|Overall Study|Adverse Event|2|||
154974757|NCT02212457|559331304|FG002|Overall Study|Adverse Event|2|||
154974758|NCT02212457|559331305|FG003|Overall Study|Adverse Event|2|||
154974759|NCT02212457|559331306|FG004|Overall Study|Adverse Event|0|||
154974760|NCT02212457|559331307|FG005|Overall Study|Adverse Event|1|||
154879648|NCT05132569|558984132|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
154879649|NCT05132569|558984133|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
154879650|NCT01554956|558984134|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
154879651|NCT01554956|558984135|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
155113458|NCT00420004|559844795|FG001|Overall Study|Lack of Efficacy|4|||
155113459|NCT00420004|559844796|FG002|Overall Study|Lack of Efficacy|1|||
155113460|NCT00420004|559844794|FG000|Overall Study|Lost to Follow-up|31|||
154879652|NCT01554956|558984136|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
154879653|NCT01554956|558984134|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
154879654|NCT01554956|558984135|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
154879655|NCT01554956|558984136|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
154879656|NCT01554956|558984134|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
154879657|NCT01554956|558984135|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
154879658|NCT01554956|558984136|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
154879659|NCT00913978|558984137|FG000|Overall Study|Surgeon choice|1|||
154879660|NCT00913978|558984138|FG001|Overall Study|Surgeon choice|3|||
154879661|NCT04716933|558984139|FG000|Overall Study|Sponsor Decision|36|||
154879662|NCT04716933|558984140|FG001|Overall Study|Sponsor Decision|33|||
154879663|NCT04716933|558984139|FG000|Overall Study|Death|65|||
154879664|NCT04716933|558984140|FG001|Overall Study|Death|67|||
154879665|NCT00740779|558984146|FG000|Overall Study|Adverse Event|4|||
154879666|NCT00740779|558984147|FG001|Overall Study|Adverse Event|6|||
154879667|NCT00740779|558984148|FG002|Overall Study|Adverse Event|3|||
154879668|NCT00740779|558984146|FG000|Overall Study|Protocol Violation|1|||
154879669|NCT00740779|558984147|FG001|Overall Study|Protocol Violation|1|||
154879670|NCT00740779|558984148|FG002|Overall Study|Protocol Violation|1|||
154879671|NCT00740779|558984146|FG000|Overall Study|Lack of Efficacy|0|||
154879672|NCT00740779|558984147|FG001|Overall Study|Lack of Efficacy|0|||
154879673|NCT00740779|558984148|FG002|Overall Study|Lack of Efficacy|2|||
154879674|NCT00740779|558984146|FG000|Overall Study|Withdrawal by Subject|2|||
154879675|NCT00740779|558984147|FG001|Overall Study|Withdrawal by Subject|4|||
154879676|NCT00740779|558984148|FG002|Overall Study|Withdrawal by Subject|2|||
154879677|NCT00740779|558984146|FG000|Overall Study|Lost to Follow-up|2|||
154879678|NCT00740779|558984147|FG001|Overall Study|Lost to Follow-up|3|||
154879679|NCT00740779|558984148|FG002|Overall Study|Lost to Follow-up|5|||
154879680|NCT00988559|558984149|FG000|Overall Study|Withdrawal by Subject|1|||
154879681|NCT00988559|558984150|FG001|Overall Study|Withdrawal by Subject|1|||
154879682|NCT00988559|558984151|FG002|Overall Study|Withdrawal by Subject|0|||
154879683|NCT00988559|558984152|FG003|Overall Study|Withdrawal by Subject|1|||
154879684|NCT00988559|558984149|FG000|Overall Study|Pregnancy|0|||
154879685|NCT00988559|558984150|FG001|Overall Study|Pregnancy|1|||
154879686|NCT00988559|558984151|FG002|Overall Study|Pregnancy|1|||
154879687|NCT00988559|558984152|FG003|Overall Study|Pregnancy|0|||
154879688|NCT00988559|558984149|FG000|Overall Study|Lost to Follow-up|0|||
154879689|NCT00988559|558984150|FG001|Overall Study|Lost to Follow-up|0|||
154879690|NCT00988559|558984151|FG002|Overall Study|Lost to Follow-up|1|||
154879691|NCT00988559|558984152|FG003|Overall Study|Lost to Follow-up|0|||
154879692|NCT05372575|558984153|FG000|Overall Study|Protocol Violation|7|||
154879693|NCT05372575|558984154|FG001|Overall Study|Protocol Violation|16|||
154879694|NCT00829166|558984155|FG000|Overall Study|Death|305|||
154879695|NCT00829166|558984156|FG001|Overall Study|Death|333|||
154879696|NCT00829166|558984155|FG000|Overall Study|Lost to Follow-up|5|||
154879697|NCT00829166|558984156|FG001|Overall Study|Lost to Follow-up|4|||
154879698|NCT00829166|558984155|FG000|Overall Study|Physician's Decision|4|||
154879699|NCT00829166|558984156|FG001|Overall Study|Physician's Decision|3|||
154879700|NCT00829166|558984155|FG000|Overall Study|Subject's Decision|41|||
154879701|NCT00829166|558984156|FG001|Overall Study|Subject's Decision|55|||
154879702|NCT00829166|558984155|FG000|Overall Study|Sponsor's Decision|137|||
154879703|NCT00829166|558984156|FG001|Overall Study|Sponsor's Decision|98|||
154879704|NCT00829166|558984155|FG000|Overall Study|Reason Not Specified|3|||
154879705|NCT00829166|558984156|FG001|Overall Study|Reason Not Specified|3|||
154879706|NCT03510663|558984157|FG000|Overall Study|Withdrawal by Subject|0|||
154879707|NCT03510663|558984158|FG001|Overall Study|Withdrawal by Subject|1|||
154879708|NCT03510663|558984159|FG002|Overall Study|Withdrawal by Subject|0|||
154879709|NCT03510663|558984160|FG003|Overall Study|Withdrawal by Subject|0|||
154879710|NCT03510663|558984161|FG004|Overall Study|Withdrawal by Subject|0|||
154879711|NCT03510663|558984162|FG005|Overall Study|Withdrawal by Subject|0|||
155113461|NCT00420004|559844795|FG001|Overall Study|Lost to Follow-up|12|||
154879712|NCT03510663|558984163|FG006|Overall Study|Withdrawal by Subject|0|||
154879713|NCT03510663|558984164|FG007|Overall Study|Withdrawal by Subject|0|||
154879714|NCT01465178|558984170|FG000|Overall Study|Withdrawal by Subject|1|||
154879715|NCT01465178|558984171|FG001|Overall Study|Withdrawal by Subject|0|||
154879716|NCT02426658|558984174|FG000|Overall Study|Withdrawal by Subject|1|||
154879717|NCT02426658|558984174|FG000|Overall Study|Patient expired before treatment|2|||
155113462|NCT00420004|559844796|FG002|Overall Study|Lost to Follow-up|10|||
154879718|NCT01204658|558984177|FG000|Primary Phase|Adverse Event|0|||
154879719|NCT01204658|558984178|FG001|Primary Phase|Adverse Event|0|||
154879720|NCT01204658|558984179|FG002|Primary Phase|Adverse Event|1|||
154879721|NCT01204658|558984180|FG003|Primary Phase|Adverse Event|0|||
154879722|NCT04594239|558984181|FG000|Overall Study|Withdrawal by Subject|3|||
154879723|NCT04594239|558984182|FG001|Overall Study|Withdrawal by Subject|4|||
154879724|NCT04594239|558984183|FG002|Overall Study|Withdrawal by Subject|2|||
154879725|NCT04594239|558984184|FG003|Overall Study|Withdrawal by Subject|4|||
154879726|NCT04594239|558984181|FG000|Overall Study|Lost to Follow-up|8|||
154879727|NCT04594239|558984182|FG001|Overall Study|Lost to Follow-up|5|||
154879728|NCT04594239|558984183|FG002|Overall Study|Lost to Follow-up|4|||
154879729|NCT04594239|558984184|FG003|Overall Study|Lost to Follow-up|6|||
154879730|NCT04594239|558984181|FG000|Overall Study|Subject relocated|0|||
154879731|NCT04594239|558984182|FG001|Overall Study|Subject relocated|0|||
154879732|NCT04594239|558984183|FG002|Overall Study|Subject relocated|0|||
154879733|NCT04594239|558984184|FG003|Overall Study|Subject relocated|1|||
154879734|NCT00309777|558984197|FG000|Overall Study|Adverse Event|13|||
154879735|NCT00309777|558984198|FG001|Overall Study|Adverse Event|2|||
154879736|NCT00309777|558984199|FG002|Overall Study|Adverse Event|8|||
154879737|NCT00309777|558984200|FG003|Overall Study|Adverse Event|1|||
154879738|NCT00309777|558984197|FG000|Overall Study|Protocol Violation|4|||
154879739|NCT00309777|558984198|FG001|Overall Study|Protocol Violation|1|||
154879740|NCT00309777|558984199|FG002|Overall Study|Protocol Violation|3|||
154879741|NCT00309777|558984200|FG003|Overall Study|Protocol Violation|1|||
154879742|NCT00309777|558984197|FG000|Overall Study|Withdrawal by Subject|6|||
154879743|NCT00309777|558984198|FG001|Overall Study|Withdrawal by Subject|5|||
154879744|NCT00309777|558984199|FG002|Overall Study|Withdrawal by Subject|7|||
154879745|NCT00309777|558984200|FG003|Overall Study|Withdrawal by Subject|2|||
154879746|NCT00309777|558984197|FG000|Overall Study|Lost to Follow-up|0|||
154879747|NCT00309777|558984198|FG001|Overall Study|Lost to Follow-up|0|||
154879748|NCT00309777|558984199|FG002|Overall Study|Lost to Follow-up|1|||
154879749|NCT00309777|558984200|FG003|Overall Study|Lost to Follow-up|0|||
154879750|NCT00309777|558984197|FG000|Overall Study|Death|0|||
154879751|NCT00309777|558984198|FG001|Overall Study|Death|1|||
154879752|NCT00309777|558984199|FG002|Overall Study|Death|0|||
154879753|NCT00309777|558984200|FG003|Overall Study|Death|0|||
154879754|NCT00520676|558985722|FG000|Overall Study|Death|84|||
154879755|NCT00520676|558985723|FG001|Overall Study|Death|81|||
154879756|NCT00520676|558985722|FG000|Overall Study|Lost to Follow-up|6|||
154879757|NCT00520676|558985723|FG001|Overall Study|Lost to Follow-up|10|||
154974761|NCT02212457|559331302|FG000|Overall Study|Withdrawal by Subject|8|||
154974762|NCT02212457|559331303|FG001|Overall Study|Withdrawal by Subject|10|||
154974763|NCT02212457|559331304|FG002|Overall Study|Withdrawal by Subject|8|||
154974764|NCT02212457|559331305|FG003|Overall Study|Withdrawal by Subject|6|||
154974765|NCT02212457|559331306|FG004|Overall Study|Withdrawal by Subject|5|||
154974766|NCT02212457|559331307|FG005|Overall Study|Withdrawal by Subject|4|||
154974767|NCT02212457|559331302|FG000|Overall Study|Lost to Follow-up|6|||
154974768|NCT02212457|559331303|FG001|Overall Study|Lost to Follow-up|7|||
154974769|NCT02212457|559331304|FG002|Overall Study|Lost to Follow-up|4|||
154974770|NCT02212457|559331305|FG003|Overall Study|Lost to Follow-up|1|||
154974771|NCT02212457|559331306|FG004|Overall Study|Lost to Follow-up|8|||
154974772|NCT02212457|559331307|FG005|Overall Study|Lost to Follow-up|4|||
154974773|NCT02212457|559331302|FG000|Overall Study|Protocol Violation|2|||
154974774|NCT02212457|559331303|FG001|Overall Study|Protocol Violation|1|||
154974775|NCT02212457|559331304|FG002|Overall Study|Protocol Violation|0|||
154974776|NCT02212457|559331305|FG003|Overall Study|Protocol Violation|1|||
154974777|NCT02212457|559331306|FG004|Overall Study|Protocol Violation|2|||
154879758|NCT00520676|558985722|FG000|Overall Study|Physician Decision|4|||
154879759|NCT00520676|558985723|FG001|Overall Study|Physician Decision|1|||
154974778|NCT02212457|559331307|FG005|Overall Study|Protocol Violation|3|||
154879760|NCT00520676|558985722|FG000|Overall Study|Withdrawal by Subject|7|||
154879761|NCT00520676|558985723|FG001|Overall Study|Withdrawal by Subject|11|||
154879762|NCT03484923|558985726|FG000|Overall Study|Adverse Event|3|||
154974779|NCT02212457|559331302|FG000|Overall Study|Other|2|||
154974780|NCT02212457|559331303|FG001|Overall Study|Other|1|||
155113463|NCT00420004|559844794|FG000|Overall Study|Entry Criteria Not Met|0|||
155113464|NCT00420004|559844795|FG001|Overall Study|Entry Criteria Not Met|1|||
155113465|NCT00420004|559844796|FG002|Overall Study|Entry Criteria Not Met|0|||
154879763|NCT03484923|558985727|FG001|Overall Study|Adverse Event|3|||
154879764|NCT03484923|558985728|FG002|Overall Study|Adverse Event|5|||
154879765|NCT03484923|558985729|FG003|Overall Study|Adverse Event|11|||
154879766|NCT03484923|558985730|FG004|Overall Study|Adverse Event|1|||
154879767|NCT03484923|558985726|FG000|Overall Study|Death|2|||
154879768|NCT03484923|558985727|FG001|Overall Study|Death|2|||
154879769|NCT03484923|558985728|FG002|Overall Study|Death|3|||
154879770|NCT03484923|558985729|FG003|Overall Study|Death|0|||
154974781|NCT02212457|559331304|FG002|Overall Study|Other|2|||
154974782|NCT02212457|559331305|FG003|Overall Study|Other|1|||
154974783|NCT02212457|559331306|FG004|Overall Study|Other|0|||
154974784|NCT02212457|559331307|FG005|Overall Study|Other|1|||
154974785|NCT00642811|559331309|FG000|Overall Study|Adverse Event|2|||
154879771|NCT03484923|558985730|FG004|Overall Study|Death|1|||
154879772|NCT03484923|558985726|FG000|Overall Study|Physician Decision|6|||
154879773|NCT03484923|558985727|FG001|Overall Study|Physician Decision|7|||
154879774|NCT03484923|558985728|FG002|Overall Study|Physician Decision|6|||
154879775|NCT03484923|558985729|FG003|Overall Study|Physician Decision|3|||
154879776|NCT03484923|558985730|FG004|Overall Study|Physician Decision|2|||
154879777|NCT03484923|558985726|FG000|Overall Study|Progressive disease|33|||
154879778|NCT03484923|558985727|FG001|Overall Study|Progressive disease|28|||
154879779|NCT03484923|558985728|FG002|Overall Study|Progressive disease|26|||
154879780|NCT03484923|558985729|FG003|Overall Study|Progressive disease|30|||
154879781|NCT03484923|558985730|FG004|Overall Study|Progressive disease|16|||
154879782|NCT03484923|558985726|FG000|Overall Study|Subject Decision|1|||
154879783|NCT03484923|558985727|FG001|Overall Study|Subject Decision|3|||
154879784|NCT03484923|558985728|FG002|Overall Study|Subject Decision|3|||
154879785|NCT03484923|558985729|FG003|Overall Study|Subject Decision|0|||
154879786|NCT03484923|558985730|FG004|Overall Study|Subject Decision|1|||
154879787|NCT03439748|558985731|FG000|Overall Study|Withdrawal by Subject|11|||
154879788|NCT03439748|558985732|FG001|Overall Study|Withdrawal by Subject|17|||
154879789|NCT01028651|558985737|FG000|Overall Study|Death|2|||
154879790|NCT01028651|558985737|FG000|Overall Study|Adverse Event|1|||
154879791|NCT06150573|558985738|FG000|Overall Study|Did not meet study criteria|1|||
154879792|NCT06150573|558985739|FG001|Overall Study|Did not meet study criteria|0|||
154879793|NCT06150573|558985738|FG000|Overall Study|Adverse Event|1|||
154879794|NCT06150573|558985739|FG001|Overall Study|Adverse Event|0|||
154879795|NCT06150573|558985738|FG000|Overall Study|Lost to Follow-up|0|||
154879796|NCT06150573|558985739|FG001|Overall Study|Lost to Follow-up|1|||
154879797|NCT06150573|558985738|FG000|Overall Study|Protocol Violation|0|||
154879798|NCT06150573|558985739|FG001|Overall Study|Protocol Violation|1|||
154879799|NCT06150573|558985738|FG000|Overall Study|Withdrawal by Subject|2|||
154879800|NCT06150573|558985739|FG001|Overall Study|Withdrawal by Subject|0|||
154879801|NCT00210158|558985740|FG000|Overall Study|Protocol Violation|0|||
154879802|NCT00210158|558985741|FG001|Overall Study|Protocol Violation|2|||
154879803|NCT01327651|558985742|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
154879804|NCT01327651|558985743|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
154879805|NCT01327651|558985744|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
154879806|NCT01327651|558985745|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
154879807|NCT01327651|558985746|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
154879808|NCT01327651|558985747|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
154879809|NCT01327651|558985748|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
154879810|NCT01327651|558985749|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
154879811|NCT01327651|558985750|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
154879812|NCT01327651|558985742|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
154879813|NCT01327651|558985743|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879814|NCT01327651|558985744|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879815|NCT01327651|558985745|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879816|NCT01327651|558985746|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879817|NCT01327651|558985747|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879818|NCT01327651|558985748|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879819|NCT01327651|558985749|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879820|NCT01327651|558985750|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
154879821|NCT01327651|558985742|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
154879822|NCT01327651|558985743|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
154879823|NCT01327651|558985744|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
154879824|NCT01327651|558985745|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
154879825|NCT01327651|558985746|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
154879826|NCT01327651|558985747|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
154879827|NCT01327651|558985748|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
154879828|NCT01327651|558985749|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
154879829|NCT01327651|558985750|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
154879830|NCT01327651|558985742|FG000|Post Study Follow-up|Lost to Follow-up|0|||
154879831|NCT01327651|558985743|FG001|Post Study Follow-up|Lost to Follow-up|1|||
154879832|NCT01327651|558985744|FG002|Post Study Follow-up|Lost to Follow-up|1|||
154879833|NCT01327651|558985745|FG003|Post Study Follow-up|Lost to Follow-up|0|||
154879834|NCT01327651|558985746|FG004|Post Study Follow-up|Lost to Follow-up|0|||
154879835|NCT01327651|558985747|FG005|Post Study Follow-up|Lost to Follow-up|0|||
154879836|NCT01327651|558985748|FG006|Post Study Follow-up|Lost to Follow-up|4|||
154879837|NCT01327651|558985749|FG007|Post Study Follow-up|Lost to Follow-up|1|||
154879838|NCT01327651|558985750|FG008|Post Study Follow-up|Lost to Follow-up|2|||
154879839|NCT03249792|558985751|FG000|Arms 1, 2, and 4|Death|1|||
154879840|NCT03249792|558985752|FG001|Arms 1, 2, and 4|Death|1|||
154879841|NCT03249792|558985753|FG002|Arms 1, 2, and 4|Death|0|||
154879842|NCT03249792|558985754|FG003|Arms 1, 2, and 4|Death|2|||
154879843|NCT03249792|558985755|FG004|Arms 1, 2, and 4|Death|3|||
154879844|NCT03249792|558985756|FG005|Arms 1, 2, and 4|Death|2|||
154879845|NCT03249792|558985757|FG006|Arms 1, 2, and 4|Death|2|||
154879846|NCT03249792|558985758|FG007|Arms 1, 2, and 4|Death|4|||
154879847|NCT03249792|558985759|FG008|Arms 1, 2, and 4|Death|2|||
154879848|NCT03249792|558985760|FG009|Arms 1, 2, and 4|Death|1|||
154879849|NCT03249792|558985761|FG010|Arms 1, 2, and 4|Death|7|||
154879850|NCT03249792|558985762|FG011|Arms 1, 2, and 4|Death|7|||
154879851|NCT03249792|558985763|FG012|Arms 1, 2, and 4|Death|12|||
154879852|NCT03249792|558985764|FG013|Arms 1, 2, and 4|Death|7|||
154879853|NCT03249792|558985765|FG014|Arms 1, 2, and 4|Death|0|||
154879854|NCT03249792|558985766|FG015|Arms 1, 2, and 4|Death|4|||
154879855|NCT03249792|558985767|FG016|Arms 1, 2, and 4|Death|4|||
154879856|NCT03249792|558985768|FG017|Arms 1, 2, and 4|Death|12|||
154879857|NCT03249792|558985769|FG018|Arms 1, 2, and 4|Death|6|||
154879858|NCT03249792|558985770|FG019|Arms 1, 2, and 4|Death|4|||
154879859|NCT03249792|558985771|FG020|Arms 1, 2, and 4|Death|2|||
154879860|NCT03249792|558985772|FG021|Arms 1, 2, and 4|Death|3|||
154879861|NCT03249792|558985773|FG022|Arms 1, 2, and 4|Death|1|||
154879862|NCT03249792|558985774|FG023|Arms 1, 2, and 4|Death|1|||
154879863|NCT03249792|558985775|FG024|Arms 1, 2, and 4|Death|4|||
154879864|NCT03249792|558985776|FG025|Arms 1, 2, and 4|Death|0|||
154879865|NCT03249792|558985777|FG026|Arms 1, 2, and 4|Death|0|||
154879866|NCT03249792|558985778|FG027|Arms 1, 2, and 4|Death|0|||
154879867|NCT03249792|558985779|FG028|Arms 1, 2, and 4|Death|0|||
154879868|NCT03249792|558985780|FG029|Arms 1, 2, and 4|Death|0|||
154879869|NCT03249792|558985781|FG030|Arms 1, 2, and 4|Death|0|||
154879870|NCT03249792|558985782|FG031|Arms 1, 2, and 4|Death|0|||
154879871|NCT03249792|558985783|FG032|Arms 1, 2, and 4|Death|0|||
154879872|NCT03249792|558985751|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879873|NCT03249792|558985752|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879874|NCT03249792|558985753|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
154879875|NCT03249792|558985754|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879876|NCT03249792|558985755|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879877|NCT03249792|558985756|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
154879878|NCT03249792|558985757|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
154879879|NCT03249792|558985758|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879880|NCT03249792|558985759|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
154879881|NCT03249792|558985760|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
154879882|NCT03249792|558985761|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
154879883|NCT03249792|558985762|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
154879884|NCT03249792|558985763|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
154879885|NCT03249792|558985764|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
154879886|NCT03249792|558985765|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879887|NCT03249792|558985766|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879888|NCT03249792|558985767|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
154879889|NCT03249792|558985768|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879890|NCT03249792|558985769|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
154879891|NCT03249792|558985770|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879892|NCT03249792|558985771|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879893|NCT03249792|558985772|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154974786|NCT00642811|559331310|FG001|Overall Study|Adverse Event|3|||
154879894|NCT03249792|558985773|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
154879895|NCT03249792|558985774|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
154879896|NCT03249792|558985775|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879897|NCT03249792|558985776|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879898|NCT03249792|558985777|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879899|NCT03249792|558985778|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879900|NCT03249792|558985779|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879901|NCT03249792|558985780|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879902|NCT03249792|558985781|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879903|NCT03249792|558985782|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879904|NCT03249792|558985783|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
154879905|NCT03249792|558985751|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
154879906|NCT03249792|558985752|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
154879907|NCT03249792|558985753|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
154879908|NCT03249792|558985754|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
154879909|NCT03249792|558985755|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
154879910|NCT03249792|558985756|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
154879911|NCT03249792|558985757|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
154879912|NCT03249792|558985758|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
154879913|NCT03249792|558985759|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
154879914|NCT03249792|558985760|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
154879915|NCT03249792|558985761|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
154879916|NCT03249792|558985762|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
154879917|NCT03249792|558985763|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
154879918|NCT03249792|558985764|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
154879919|NCT03249792|558985765|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
154879920|NCT03249792|558985766|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
154879921|NCT03249792|558985767|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
154879922|NCT03249792|558985768|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
154879923|NCT03249792|558985769|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
154974787|NCT00642811|559331311|FG002|Overall Study|Adverse Event|0|||
154879924|NCT03249792|558985770|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
154879925|NCT03249792|558985771|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
154879926|NCT03249792|558985772|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
154879927|NCT03249792|558985773|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
154879928|NCT03249792|558985774|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
154879929|NCT03249792|558985775|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
154879930|NCT03249792|558985776|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
154879931|NCT03249792|558985777|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
154879932|NCT03249792|558985778|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
154879933|NCT03249792|558985779|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
154879934|NCT03249792|558985780|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
154879935|NCT03249792|558985781|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
154879936|NCT03249792|558985782|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
154879937|NCT03249792|558985783|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
154879938|NCT03249792|558985751|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879939|NCT03249792|558985752|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879940|NCT03249792|558985753|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879941|NCT03249792|558985754|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879942|NCT03249792|558985755|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879943|NCT03249792|558985756|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879944|NCT03249792|558985757|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879945|NCT03249792|558985758|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879946|NCT03249792|558985759|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
154879947|NCT03249792|558985760|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879948|NCT03249792|558985761|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879949|NCT03249792|558985762|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879950|NCT03249792|558985763|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879951|NCT03249792|558985764|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879952|NCT03249792|558985765|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879953|NCT03249792|558985766|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879954|NCT03249792|558985767|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
154879955|NCT03249792|558985768|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
154879956|NCT03249792|558985769|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879957|NCT03249792|558985770|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
154879958|NCT03249792|558985771|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879959|NCT03249792|558985772|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879960|NCT03249792|558985773|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879961|NCT03249792|558985774|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879962|NCT03249792|558985775|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879963|NCT03249792|558985776|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879964|NCT03249792|558985777|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879965|NCT03249792|558985778|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879966|NCT03249792|558985779|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879967|NCT03249792|558985780|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879968|NCT03249792|558985781|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879969|NCT03249792|558985782|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879970|NCT03249792|558985783|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
154879971|NCT03249792|558985751|FG000|Switch Over Period|Withdrawal by Subject|0|||
154879972|NCT03249792|558985752|FG001|Switch Over Period|Withdrawal by Subject|0|||
154879973|NCT03249792|558985753|FG002|Switch Over Period|Withdrawal by Subject|0|||
154879974|NCT03249792|558985754|FG003|Switch Over Period|Withdrawal by Subject|0|||
154974788|NCT00642811|559331312|FG003|Overall Study|Adverse Event|0|||
154974789|NCT00642811|559331313|FG004|Overall Study|Adverse Event|0|||
154974790|NCT00642811|559331314|FG005|Overall Study|Adverse Event|1|||
154974791|NCT00642811|559331309|FG000|Overall Study|Developement of discontinuation criteria|0|||
154879975|NCT03249792|558985755|FG004|Switch Over Period|Withdrawal by Subject|0|||
154879976|NCT03249792|558985756|FG005|Switch Over Period|Withdrawal by Subject|0|||
154879977|NCT03249792|558985757|FG006|Switch Over Period|Withdrawal by Subject|0|||
154879978|NCT03249792|558985758|FG007|Switch Over Period|Withdrawal by Subject|0|||
154879979|NCT03249792|558985759|FG008|Switch Over Period|Withdrawal by Subject|0|||
154879980|NCT03249792|558985760|FG009|Switch Over Period|Withdrawal by Subject|0|||
154879981|NCT03249792|558985761|FG010|Switch Over Period|Withdrawal by Subject|0|||
154879982|NCT03249792|558985762|FG011|Switch Over Period|Withdrawal by Subject|0|||
154879983|NCT03249792|558985763|FG012|Switch Over Period|Withdrawal by Subject|0|||
154879984|NCT03249792|558985764|FG013|Switch Over Period|Withdrawal by Subject|0|||
154879985|NCT03249792|558985765|FG014|Switch Over Period|Withdrawal by Subject|0|||
154879986|NCT03249792|558985766|FG015|Switch Over Period|Withdrawal by Subject|0|||
154879987|NCT03249792|558985767|FG016|Switch Over Period|Withdrawal by Subject|0|||
154879988|NCT03249792|558985768|FG017|Switch Over Period|Withdrawal by Subject|0|||
154879989|NCT03249792|558985769|FG018|Switch Over Period|Withdrawal by Subject|0|||
154879990|NCT03249792|558985770|FG019|Switch Over Period|Withdrawal by Subject|0|||
154879991|NCT03249792|558985771|FG020|Switch Over Period|Withdrawal by Subject|0|||
154879992|NCT03249792|558985772|FG021|Switch Over Period|Withdrawal by Subject|0|||
154879993|NCT03249792|558985773|FG022|Switch Over Period|Withdrawal by Subject|0|||
154879994|NCT03249792|558985774|FG023|Switch Over Period|Withdrawal by Subject|0|||
154974792|NCT00642811|559331310|FG001|Overall Study|Developement of discontinuation criteria|0|||
154879995|NCT03249792|558985775|FG024|Switch Over Period|Withdrawal by Subject|0|||
154879996|NCT03249792|558985776|FG025|Switch Over Period|Withdrawal by Subject|0|||
154879997|NCT03249792|558985777|FG026|Switch Over Period|Withdrawal by Subject|0|||
154879998|NCT03249792|558985778|FG027|Switch Over Period|Withdrawal by Subject|0|||
154879999|NCT03249792|558985779|FG028|Switch Over Period|Withdrawal by Subject|0|||
154880000|NCT03249792|558985780|FG029|Switch Over Period|Withdrawal by Subject|0|||
154880001|NCT03249792|558985781|FG030|Switch Over Period|Withdrawal by Subject|0|||
154880002|NCT03249792|558985782|FG031|Switch Over Period|Withdrawal by Subject|1|||
154880003|NCT03249792|558985783|FG032|Switch Over Period|Withdrawal by Subject|0|||
154880004|NCT03249792|558985751|FG000|Switch Over Period|Progressive Disease|0|||
154880005|NCT03249792|558985752|FG001|Switch Over Period|Progressive Disease|0|||
154880006|NCT03249792|558985753|FG002|Switch Over Period|Progressive Disease|0|||
154880007|NCT03249792|558985754|FG003|Switch Over Period|Progressive Disease|0|||
154880008|NCT03249792|558985755|FG004|Switch Over Period|Progressive Disease|0|||
154880009|NCT03249792|558985756|FG005|Switch Over Period|Progressive Disease|0|||
154880010|NCT03249792|558985757|FG006|Switch Over Period|Progressive Disease|0|||
154880011|NCT03249792|558985758|FG007|Switch Over Period|Progressive Disease|0|||
154880012|NCT03249792|558985759|FG008|Switch Over Period|Progressive Disease|0|||
154880013|NCT03249792|558985760|FG009|Switch Over Period|Progressive Disease|0|||
154880014|NCT03249792|558985761|FG010|Switch Over Period|Progressive Disease|0|||
154880015|NCT03249792|558985762|FG011|Switch Over Period|Progressive Disease|0|||
154880016|NCT03249792|558985763|FG012|Switch Over Period|Progressive Disease|0|||
154880017|NCT03249792|558985764|FG013|Switch Over Period|Progressive Disease|0|||
154880018|NCT03249792|558985765|FG014|Switch Over Period|Progressive Disease|0|||
154880019|NCT03249792|558985766|FG015|Switch Over Period|Progressive Disease|0|||
154880020|NCT03249792|558985767|FG016|Switch Over Period|Progressive Disease|0|||
154880021|NCT03249792|558985768|FG017|Switch Over Period|Progressive Disease|0|||
154880022|NCT03249792|558985769|FG018|Switch Over Period|Progressive Disease|0|||
154880023|NCT03249792|558985770|FG019|Switch Over Period|Progressive Disease|0|||
154880024|NCT03249792|558985771|FG020|Switch Over Period|Progressive Disease|0|||
154880025|NCT03249792|558985772|FG021|Switch Over Period|Progressive Disease|0|||
154880026|NCT03249792|558985773|FG022|Switch Over Period|Progressive Disease|0|||
154880027|NCT03249792|558985774|FG023|Switch Over Period|Progressive Disease|0|||
154880028|NCT03249792|558985775|FG024|Switch Over Period|Progressive Disease|0|||
154880029|NCT03249792|558985776|FG025|Switch Over Period|Progressive Disease|0|||
154880030|NCT03249792|558985777|FG026|Switch Over Period|Progressive Disease|1|||
154880031|NCT03249792|558985778|FG027|Switch Over Period|Progressive Disease|0|||
154880032|NCT03249792|558985779|FG028|Switch Over Period|Progressive Disease|1|||
154880033|NCT03249792|558985780|FG029|Switch Over Period|Progressive Disease|2|||
154880034|NCT03249792|558985781|FG030|Switch Over Period|Progressive Disease|1|||
154880035|NCT03249792|558985782|FG031|Switch Over Period|Progressive Disease|0|||
154880036|NCT03249792|558985783|FG032|Switch Over Period|Progressive Disease|1|||
154880037|NCT03249792|558985751|FG000|Switch Over Period|Adverse Event|0|||
154880038|NCT03249792|558985752|FG001|Switch Over Period|Adverse Event|0|||
154880039|NCT03249792|558985753|FG002|Switch Over Period|Adverse Event|0|||
154880040|NCT03249792|558985754|FG003|Switch Over Period|Adverse Event|0|||
154880041|NCT03249792|558985755|FG004|Switch Over Period|Adverse Event|0|||
154880042|NCT03249792|558985756|FG005|Switch Over Period|Adverse Event|0|||
154880043|NCT03249792|558985757|FG006|Switch Over Period|Adverse Event|0|||
154880044|NCT03249792|558985758|FG007|Switch Over Period|Adverse Event|0|||
154880045|NCT03249792|558985759|FG008|Switch Over Period|Adverse Event|0|||
154880046|NCT03249792|558985760|FG009|Switch Over Period|Adverse Event|0|||
154880047|NCT03249792|558985761|FG010|Switch Over Period|Adverse Event|0|||
154880048|NCT03249792|558985762|FG011|Switch Over Period|Adverse Event|0|||
154880049|NCT03249792|558985763|FG012|Switch Over Period|Adverse Event|0|||
154880050|NCT03249792|558985764|FG013|Switch Over Period|Adverse Event|0|||
154880051|NCT03249792|558985765|FG014|Switch Over Period|Adverse Event|0|||
154880052|NCT03249792|558985766|FG015|Switch Over Period|Adverse Event|0|||
154880053|NCT03249792|558985767|FG016|Switch Over Period|Adverse Event|0|||
154880054|NCT03249792|558985768|FG017|Switch Over Period|Adverse Event|0|||
154880055|NCT03249792|558985769|FG018|Switch Over Period|Adverse Event|0|||
154880056|NCT03249792|558985770|FG019|Switch Over Period|Adverse Event|0|||
154880057|NCT03249792|558985771|FG020|Switch Over Period|Adverse Event|0|||
154880058|NCT03249792|558985772|FG021|Switch Over Period|Adverse Event|0|||
154880059|NCT03249792|558985773|FG022|Switch Over Period|Adverse Event|0|||
154880060|NCT03249792|558985774|FG023|Switch Over Period|Adverse Event|0|||
154974793|NCT00642811|559331311|FG002|Overall Study|Developement of discontinuation criteria|0|||
154974794|NCT00642811|559331312|FG003|Overall Study|Developement of discontinuation criteria|0|||
155113466|NCT00420004|559844794|FG000|Overall Study|Physician Decision|14|||
155113467|NCT00420004|559844795|FG001|Overall Study|Physician Decision|4|||
154880061|NCT03249792|558985775|FG024|Switch Over Period|Adverse Event|0|||
155113468|NCT00420004|559844796|FG002|Overall Study|Physician Decision|2|||
154880062|NCT03249792|558985776|FG025|Switch Over Period|Adverse Event|1|||
154880063|NCT03249792|558985777|FG026|Switch Over Period|Adverse Event|0|||
154880064|NCT03249792|558985778|FG027|Switch Over Period|Adverse Event|1|||
155113469|NCT00420004|559844794|FG000|Overall Study|Protocol Violation|5|||
154880065|NCT03249792|558985779|FG028|Switch Over Period|Adverse Event|0|||
154880066|NCT03249792|558985780|FG029|Switch Over Period|Adverse Event|0|||
154880067|NCT03249792|558985781|FG030|Switch Over Period|Adverse Event|0|||
154880068|NCT03249792|558985782|FG031|Switch Over Period|Adverse Event|0|||
154880069|NCT03249792|558985783|FG032|Switch Over Period|Adverse Event|0|||
154880070|NCT02284906|558985786|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
154880071|NCT02284906|558985787|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
154880072|NCT02284906|558985788|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
154880073|NCT02284906|558985786|FG000|Overall Study|Major Protocol Deviation|0|||
154880074|NCT02284906|558985787|FG001|Overall Study|Major Protocol Deviation|1|||
154880075|NCT02284906|558985788|FG002|Overall Study|Major Protocol Deviation|0|||
154880076|NCT02284906|558985786|FG000|Overall Study|Voluntary Withdrawal|2|||
154880077|NCT02284906|558985787|FG001|Overall Study|Voluntary Withdrawal|4|||
154880078|NCT02284906|558985788|FG002|Overall Study|Voluntary Withdrawal|5|||
154880079|NCT02284906|558985786|FG000|Overall Study|Study Termination|0|||
154880080|NCT02284906|558985787|FG001|Overall Study|Study Termination|11|||
154880081|NCT02284906|558985788|FG002|Overall Study|Study Termination|14|||
154880082|NCT02284906|558985786|FG000|Overall Study|Reason not Specified|1|||
154880083|NCT02284906|558985787|FG001|Overall Study|Reason not Specified|1|||
154880084|NCT02284906|558985788|FG002|Overall Study|Reason not Specified|0|||
154880085|NCT00995345|558985789|FG000|Overall Study|Withdrawal by Subject|4|||
154880086|NCT00995345|558985790|FG001|Overall Study|Withdrawal by Subject|2|||
154880087|NCT00995345|558985791|FG002|Overall Study|Withdrawal by Subject|1|||
154880088|NCT00995345|558985792|FG003|Overall Study|Withdrawal by Subject|3|||
154880089|NCT00995345|558985793|FG004|Overall Study|Withdrawal by Subject|1|||
154880090|NCT00995345|558985789|FG000|Overall Study|Adverse Event|3|||
154880091|NCT00995345|558985790|FG001|Overall Study|Adverse Event|1|||
154880092|NCT00995345|558985791|FG002|Overall Study|Adverse Event|2|||
154880093|NCT00995345|558985792|FG003|Overall Study|Adverse Event|0|||
154880094|NCT00995345|558985793|FG004|Overall Study|Adverse Event|1|||
154880095|NCT00995345|558985789|FG000|Overall Study|Lost to Follow-up|2|||
154880096|NCT00995345|558985790|FG001|Overall Study|Lost to Follow-up|2|||
154880097|NCT00995345|558985791|FG002|Overall Study|Lost to Follow-up|2|||
154880098|NCT00995345|558985792|FG003|Overall Study|Lost to Follow-up|1|||
154880099|NCT00995345|558985793|FG004|Overall Study|Lost to Follow-up|0|||
154880100|NCT00995345|558985789|FG000|Overall Study|all other reasons combined|2|||
154880101|NCT00995345|558985790|FG001|Overall Study|all other reasons combined|2|||
154880102|NCT00995345|558985791|FG002|Overall Study|all other reasons combined|2|||
154880103|NCT00995345|558985792|FG003|Overall Study|all other reasons combined|1|||
154880104|NCT00995345|558985793|FG004|Overall Study|all other reasons combined|3|||
154880105|NCT01201798|558985799|FG000|Overall Study|Adverse Event|2|||
154880106|NCT01201798|558985800|FG001|Overall Study|Adverse Event|0|||
154880107|NCT01201798|558985799|FG000|Overall Study|Lost to Follow-up|3|||
154880108|NCT01201798|558985800|FG001|Overall Study|Lost to Follow-up|5|||
154880109|NCT01201798|558985799|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
154880110|NCT01201798|558985800|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
154880111|NCT01201798|558985799|FG000|Overall Study|Noncompliance|1|||
154880112|NCT01201798|558985800|FG001|Overall Study|Noncompliance|0|||
154880113|NCT01201798|558985799|FG000|Overall Study|Protocol Violation|1|||
154880114|NCT01201798|558985800|FG001|Overall Study|Protocol Violation|1|||
154880115|NCT01201798|558985799|FG000|Overall Study|Treatment Failure|1|||
154880116|NCT01201798|558985800|FG001|Overall Study|Treatment Failure|8|||
154974795|NCT00642811|559331313|FG004|Overall Study|Developement of discontinuation criteria|1|||
155113470|NCT00420004|559844795|FG001|Overall Study|Protocol Violation|4|||
155113471|NCT00420004|559844796|FG002|Overall Study|Protocol Violation|3|||
154880117|NCT03521687|558985802|FG000|Overall Study|Adverse Event|4|||
154880118|NCT03521687|558985802|FG000|Overall Study|Physician Decision|1|||
154880119|NCT05122650|558985809|FG000|Overall Study|Adverse Event|4|||
154880120|NCT05122650|558985810|FG001|Overall Study|Adverse Event|16|||
154880121|NCT05122650|558985811|FG002|Overall Study|Adverse Event|11|||
154880122|NCT05122650|558985812|FG003|Overall Study|Adverse Event|12|||
154880123|NCT05122650|558985809|FG000|Overall Study|Lack of Efficacy|0|||
154880124|NCT05122650|558985810|FG001|Overall Study|Lack of Efficacy|1|||
154880125|NCT05122650|558985811|FG002|Overall Study|Lack of Efficacy|1|||
154880126|NCT05122650|558985812|FG003|Overall Study|Lack of Efficacy|2|||
154880127|NCT05122650|558985809|FG000|Overall Study|Lost to Follow-up|1|||
154880128|NCT05122650|558985810|FG001|Overall Study|Lost to Follow-up|1|||
154880129|NCT05122650|558985811|FG002|Overall Study|Lost to Follow-up|3|||
154880130|NCT05122650|558985812|FG003|Overall Study|Lost to Follow-up|0|||
154880131|NCT05122650|558985809|FG000|Overall Study|Non-compliance with study intervention|0|||
154880132|NCT05122650|558985810|FG001|Overall Study|Non-compliance with study intervention|0|||
154880133|NCT05122650|558985811|FG002|Overall Study|Non-compliance with study intervention|0|||
154880134|NCT05122650|558985812|FG003|Overall Study|Non-compliance with study intervention|2|||
154880135|NCT05122650|558985809|FG000|Overall Study|Protocol Violation|0|||
154880136|NCT05122650|558985810|FG001|Overall Study|Protocol Violation|1|||
154880137|NCT05122650|558985811|FG002|Overall Study|Protocol Violation|0|||
154880138|NCT05122650|558985812|FG003|Overall Study|Protocol Violation|1|||
154880139|NCT05122650|558985809|FG000|Overall Study|Randomized by mistake|0|||
154880140|NCT05122650|558985810|FG001|Overall Study|Randomized by mistake|0|||
154880141|NCT05122650|558985811|FG002|Overall Study|Randomized by mistake|3|||
154880142|NCT05122650|558985812|FG003|Overall Study|Randomized by mistake|2|||
154880143|NCT05122650|558985809|FG000|Overall Study|Sponsor request|0|||
154880144|NCT05122650|558985810|FG001|Overall Study|Sponsor request|1|||
154880145|NCT05122650|558985811|FG002|Overall Study|Sponsor request|1|||
154880146|NCT05122650|558985812|FG003|Overall Study|Sponsor request|2|||
154880147|NCT05122650|558985809|FG000|Overall Study|Withdrawal by Subject|3|||
154880148|NCT05122650|558985810|FG001|Overall Study|Withdrawal by Subject|7|||
154880149|NCT05122650|558985811|FG002|Overall Study|Withdrawal by Subject|4|||
154880150|NCT05122650|558985812|FG003|Overall Study|Withdrawal by Subject|8|||
154880151|NCT05122650|558985809|FG000|Overall Study|Other|5|||
154880152|NCT05122650|558985810|FG001|Overall Study|Other|0|||
154880153|NCT05122650|558985811|FG002|Overall Study|Other|0|||
154880154|NCT05122650|558985812|FG003|Overall Study|Other|0|||
154880155|NCT03609359|558985815|FG000|Overall Study|Progression of primary disease (PD)|25|||
154880156|NCT03609359|558985815|FG000|Overall Study|Patient's refusal|1|||
154880157|NCT03609359|558985815|FG000|Overall Study|Physician Decision|1|||
154880158|NCT03609359|558985815|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
154880159|NCT04285346|558985817|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
154880160|NCT04285346|558985818|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
154880161|NCT04285346|558985817|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
154880162|NCT04285346|558985818|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
154880163|NCT04285346|558985817|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
154880164|NCT04285346|558985818|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
154880165|NCT01975272|558985821|FG000|Overall Study|Excluded after protocol amendment|1|||
154880166|NCT01975272|558985822|FG001|Overall Study|Excluded after protocol amendment|1|||
154880167|NCT01975272|558985823|FG002|Overall Study|Excluded after protocol amendment|2|||
154880168|NCT00610935|558985824|FG000|Overall Study|Lost to Follow-up|0|||
154880169|NCT00610935|558985825|FG001|Overall Study|Lost to Follow-up|1|||
154880170|NCT00610935|558985824|FG000|Overall Study|Withdrawal by Subject|0|||
154880171|NCT00610935|558985825|FG001|Overall Study|Withdrawal by Subject|2|||
154880172|NCT00610935|558985824|FG000|Overall Study|Sponsor Discontinuation|1|||
154880173|NCT00610935|558985825|FG001|Overall Study|Sponsor Discontinuation|0|||
154880174|NCT02399813|558985831|FG000|Overall Study|Progressive Disease-Radiographic|2|||
154880175|NCT02399813|558985831|FG000|Overall Study|Death|20|||
154880176|NCT02399813|558985831|FG000|Overall Study|Withdrawal by Subject|3|||
154880177|NCT02399813|558985831|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
154880178|NCT02399813|558985831|FG000|Overall Study|Lost to Follow-up|2|||
154880179|NCT02399813|558985831|FG000|Overall Study|Other than specified|5|||
154880180|NCT03280550|558985832|FG000|Overall Study|Withdrawal by Subject|2|||
154880181|NCT03280550|558985833|FG001|Overall Study|Withdrawal by Subject|2|||
154880182|NCT03280550|558985832|FG000|Overall Study|Physician Decision|0|||
154880183|NCT03280550|558985833|FG001|Overall Study|Physician Decision|1|||
154880184|NCT03345836|558985836|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
154880185|NCT03345836|558985837|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
154880186|NCT03345836|558985838|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
154880187|NCT03345836|558985839|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
154880188|NCT03345836|558985840|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
154880189|NCT03345836|558985841|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
154880190|NCT03345836|558985836|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
154880191|NCT03345836|558985837|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
154880192|NCT03345836|558985838|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
154880193|NCT03345836|558985839|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
154880194|NCT03345836|558985840|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
154880195|NCT03345836|558985841|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
154880196|NCT03345836|558985836|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
154880197|NCT03345836|558985837|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
154880198|NCT03345836|558985838|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
154880199|NCT03345836|558985839|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
154880200|NCT03345836|558985840|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
154880201|NCT03345836|558985841|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
154880202|NCT03345836|558985836|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
154880203|NCT03345836|558985837|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
154880204|NCT03345836|558985838|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
154880205|NCT03345836|558985839|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
154880206|NCT03345836|558985840|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
154880207|NCT03345836|558985841|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
155175362|NCT00910624|560080229|FG003|Follow-Up Phase|Adverse Event|0|||
154880208|NCT03345836|558985836|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
154880209|NCT03345836|558985837|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
155113472|NCT00420004|559844794|FG000|Overall Study|Withdrawal by Subject|67|||
155113473|NCT00420004|559844795|FG001|Overall Study|Withdrawal by Subject|42|||
155113474|NCT00420004|559844796|FG002|Overall Study|Withdrawal by Subject|14|||
155113475|NCT00420004|559844794|FG000|Overall Study|Sponsor Decision|3|||
154880210|NCT03345836|558985838|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
154880211|NCT03345836|558985839|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
154880212|NCT03345836|558985840|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
154880213|NCT03345836|558985841|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
154880214|NCT03345836|558985836|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
154880215|NCT03345836|558985837|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
154880216|NCT03345836|558985838|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
154880217|NCT03345836|558985839|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
154880218|NCT03345836|558985840|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
154880219|NCT03345836|558985841|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
154880220|NCT03345836|558985836|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
154880221|NCT03345836|558985837|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
154880222|NCT03345836|558985838|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
154880223|NCT03345836|558985839|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
154880224|NCT03345836|558985840|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
154880225|NCT03345836|558985841|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
154880226|NCT03345836|558985836|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
154880227|NCT03345836|558985837|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
154880228|NCT03345836|558985838|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
154880229|NCT03345836|558985839|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
154880230|NCT03345836|558985840|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
154880231|NCT03345836|558985841|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
154880232|NCT03345836|558985836|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
154880233|NCT03345836|558985837|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
154880234|NCT03345836|558985838|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
154880235|NCT03345836|558985839|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
154880236|NCT03345836|558985840|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
154880237|NCT03345836|558985841|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
154880238|NCT03345836|558985836|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
154880239|NCT03345836|558985837|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
154880240|NCT03345836|558985838|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
154880241|NCT03345836|558985839|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
154880242|NCT03345836|558985840|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
154924226|NCT04527380|559146419|FG000|Overall Study|Withdrawal by Subject|1|||
155113476|NCT00420004|559844795|FG001|Overall Study|Sponsor Decision|3|||
155113477|NCT00420004|559844796|FG002|Overall Study|Sponsor Decision|1|||
155113478|NCT00470093|559844797|FG000|Overall Study|Adverse Event|2|||
155113479|NCT00664560|559844798|FG000|Overall Study|Adverse Event|19|||
155113480|NCT00664560|559844799|FG001|Overall Study|Adverse Event|16|||
155113481|NCT00664560|559844800|FG002|Overall Study|Adverse Event|7|||
155113482|NCT00664560|559844798|FG000|Overall Study|Withdrawal by Subject|9|||
155113483|NCT00664560|559844799|FG001|Overall Study|Withdrawal by Subject|13|||
155113484|NCT00664560|559844800|FG002|Overall Study|Withdrawal by Subject|7|||
155113485|NCT00664560|559844798|FG000|Overall Study|Lost to Follow-up|0|||
155113486|NCT00664560|559844799|FG001|Overall Study|Lost to Follow-up|2|||
155113487|NCT00664560|559844800|FG002|Overall Study|Lost to Follow-up|0|||
155113488|NCT00664560|559844798|FG000|Overall Study|Other|11|||
155113489|NCT00664560|559844799|FG001|Overall Study|Other|4|||
155113490|NCT00664560|559844800|FG002|Overall Study|Other|5|||
155113491|NCT00473668|559844803|FG000|Overall Study|Withdrawal by Subject|0|||
155113492|NCT00473668|559844804|FG001|Overall Study|Withdrawal by Subject|2|||
155113493|NCT00473668|559844805|FG002|Overall Study|Withdrawal by Subject|0|||
155113494|NCT00473668|559844803|FG000|Overall Study|Migrated/moved from study area|3|||
155113495|NCT00473668|559844804|FG001|Overall Study|Migrated/moved from study area|2|||
155113496|NCT00473668|559844805|FG002|Overall Study|Migrated/moved from study area|0|||
155113497|NCT00473668|559844803|FG000|Overall Study|Lost to Follow-up|0|||
155113498|NCT00473668|559844804|FG001|Overall Study|Lost to Follow-up|4|||
155113499|NCT00473668|559844805|FG002|Overall Study|Lost to Follow-up|6|||
154924227|NCT04527380|559146420|FG001|Overall Study|Withdrawal by Subject|0|||
154924228|NCT05116241|559146423|FG000|Study|Withdrawal by Subject|5|||
154924229|NCT05116241|559146424|FG001|Study|Withdrawal by Subject|2|||
154924230|NCT05116241|559146425|FG002|Study|Withdrawal by Subject|1|||
154924231|NCT05116241|559146423|FG000|Study|Lost to Follow-up|0|||
154924232|NCT05116241|559146424|FG001|Study|Lost to Follow-up|2|||
154924233|NCT05116241|559146425|FG002|Study|Lost to Follow-up|2|||
154924234|NCT00938366|559146437|FG000|Overall Study|Withdrawal by Subject|1|||
154880243|NCT03345836|558985841|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
154880244|NCT03345836|558985836|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
154880245|NCT03345836|558985837|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
154880246|NCT03345836|558985838|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
154880247|NCT03345836|558985839|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
154880248|NCT03345836|558985840|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
154880249|NCT03345836|558985841|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
154880250|NCT00222729|558985842|FG000|Overall Study|Adverse Event|3|||
154880251|NCT01915849|558985845|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
154880252|NCT01915849|558985846|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
154880253|NCT01915849|558985847|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
154880254|NCT01915849|558985848|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
154880255|NCT01915849|558985845|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
154880256|NCT01915849|558985846|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
154880257|NCT01915849|558985847|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
154880258|NCT01915849|558985848|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
154880259|NCT02775864|558985849|FG000|Overall Study|Data ended end of 2010|1764|||
154880260|NCT02775864|558985850|FG001|Overall Study|Data ended end of 2010|2880|||
154880261|NCT02775864|558985851|FG002|Overall Study|Data ended end of 2010|1140|||
154880262|NCT02775864|558985852|FG003|Overall Study|Data ended end of 2010|1194|||
154880263|NCT02775864|558985849|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
154880264|NCT02775864|558985850|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
154880265|NCT02775864|558985851|FG002|Overall Study|Medicaid eligibility discontinued|720|||
154880266|NCT02775864|558985852|FG003|Overall Study|Medicaid eligibility discontinued|890|||
154880267|NCT03552549|558985856|FG000|Overall Study|Disease progression|25|||
154880268|NCT03552549|558985857|FG001|Overall Study|Disease progression|17|||
154880269|NCT03552549|558985856|FG000|Overall Study|Adverse event in first 12 months|12|||
154880270|NCT03552549|558985857|FG001|Overall Study|Adverse event in first 12 months|8|||
154880271|NCT03552549|558985856|FG000|Overall Study|Withdrawal by Subject|7|||
154880272|NCT03552549|558985857|FG001|Overall Study|Withdrawal by Subject|7|||
154880273|NCT03552549|558985856|FG000|Overall Study|Unknown (no reason provided)|4|||
154880274|NCT03552549|558985857|FG001|Overall Study|Unknown (no reason provided)|2|||
154880275|NCT03552549|558985856|FG000|Overall Study|Not in participant's best interest|2|||
154880276|NCT03552549|558985857|FG001|Overall Study|Not in participant's best interest|1|||
154880277|NCT03552549|558985856|FG000|Overall Study|Did not complete study treatment|2|||
154880278|NCT03552549|558985857|FG001|Overall Study|Did not complete study treatment|3|||
154880279|NCT03552549|558985856|FG000|Overall Study|Did not meet eligibility criteria|1|||
154880280|NCT03552549|558985857|FG001|Overall Study|Did not meet eligibility criteria|0|||
154880281|NCT03552549|558985856|FG000|Overall Study|Administrative|0|||
154880282|NCT03552549|558985857|FG001|Overall Study|Administrative|14|||
154880283|NCT02761993|558985858|FG000|Overall Study|Adverse Event|0|||
154880284|NCT02761993|558985859|FG001|Overall Study|Adverse Event|2|||
154880285|NCT02761993|558985860|FG002|Overall Study|Adverse Event|0|||
154880286|NCT02761993|558985858|FG000|Overall Study|Lost to Follow-up|1|||
154880287|NCT02761993|558985859|FG001|Overall Study|Lost to Follow-up|3|||
154880288|NCT02761993|558985860|FG002|Overall Study|Lost to Follow-up|2|||
154880289|NCT02761993|558985858|FG000|Overall Study|Withdrawal by Subject|1|||
154880290|NCT02761993|558985859|FG001|Overall Study|Withdrawal by Subject|1|||
154880291|NCT02761993|558985860|FG002|Overall Study|Withdrawal by Subject|2|||
154880292|NCT02993224|558985863|FG000|Core Phase - Period 1|Adverse Event|4|||
154880293|NCT02993224|558985863|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
154880294|NCT02993224|558985863|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
154880295|NCT02993224|558985863|FG000|Core Phase- Period 2|Adverse Event|1|||
154880296|NCT02993224|558985863|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
154880297|NCT02993224|558985863|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
154880298|NCT02993224|558985863|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
154880299|NCT02993224|558985863|FG000|Extension Phase|Adverse Event|3|||
154880300|NCT02993224|558985863|FG000|Extension Phase|Withdrawal by Subject|3|||
154880301|NCT02993224|558985863|FG000|Extension Phase|Lost to Follow-up|2|||
154880302|NCT02993224|558985863|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
154880303|NCT03342469|558985866|FG000|Overall Study|Withdrawal by Subject|0|||
154880304|NCT03342469|558985867|FG001|Overall Study|Withdrawal by Subject|1|||
154880305|NCT03342469|558985868|FG002|Overall Study|Withdrawal by Subject|0|||
154880306|NCT03342469|558985869|FG003|Overall Study|Withdrawal by Subject|0|||
154880307|NCT01921257|558985872|FG000|Overall Study|Adverse Event|1|||
154880308|NCT01921257|558985872|FG000|Overall Study|Protocol Violation|1|||
154880309|NCT01921257|558985872|FG000|Overall Study|Withdrawal by Subject|1|||
154880310|NCT05515601|558985874|FG000|Overall Study|Withdrawal by Subject|1|||
154880311|NCT05515601|558985875|FG001|Overall Study|Withdrawal by Subject|3|||
154880312|NCT05515601|558985876|FG002|Overall Study|Withdrawal by Subject|2|||
154880313|NCT05515601|558985877|FG003|Overall Study|Withdrawal by Subject|1|||
154880314|NCT05515601|558985878|FG004|Overall Study|Withdrawal by Subject|1|||
154880315|NCT05515601|558985879|FG005|Overall Study|Withdrawal by Subject|1|||
154880316|NCT05515601|558985874|FG000|Overall Study|Lost to Follow-up|0|||
154880317|NCT05515601|558985875|FG001|Overall Study|Lost to Follow-up|0|||
154880318|NCT05515601|558985876|FG002|Overall Study|Lost to Follow-up|0|||
154880319|NCT05515601|558985877|FG003|Overall Study|Lost to Follow-up|0|||
154880320|NCT05515601|558985878|FG004|Overall Study|Lost to Follow-up|1|||
154880321|NCT05515601|558985879|FG005|Overall Study|Lost to Follow-up|0|||
154880322|NCT00364845|558985880|FG000|Overall Study|Adverse Event|1|||
154880323|NCT00364845|558985881|FG001|Overall Study|Adverse Event|0|||
154880324|NCT00364845|558985880|FG000|Overall Study|Withdrawal by Subject|2|||
154880325|NCT00364845|558985881|FG001|Overall Study|Withdrawal by Subject|1|||
154880326|NCT00364845|558985880|FG000|Overall Study|Physician Decision|8|||
154880327|NCT00364845|558985881|FG001|Overall Study|Physician Decision|8|||
154880328|NCT00364845|558985880|FG000|Overall Study|Lost to Follow-up|0|||
154880329|NCT00364845|558985881|FG001|Overall Study|Lost to Follow-up|1|||
154880330|NCT00364845|558985880|FG000|Overall Study|Death|0|||
154880331|NCT00364845|558985881|FG001|Overall Study|Death|1|||
154880332|NCT01423617|558985882|FG000|Overall Study|Lost to Follow-up|0|||
154880333|NCT01423617|558985883|FG001|Overall Study|Lost to Follow-up|1|||
154880334|NCT01515306|558985884|FG000|Overall Study|Adverse Event|3|||
154880335|NCT01515306|558985885|FG001|Overall Study|Adverse Event|2|||
154880336|NCT01515306|558985884|FG000|Overall Study|Progressive Disease|19|||
154880337|NCT01515306|558985885|FG001|Overall Study|Progressive Disease|9|||
154880338|NCT01515306|558985884|FG000|Overall Study|Withdrawal by Subject|1|||
154880339|NCT01515306|558985885|FG001|Overall Study|Withdrawal by Subject|2|||
154880340|NCT01515306|558985884|FG000|Overall Study|Physician Decision|1|||
154880341|NCT01515306|558985885|FG001|Overall Study|Physician Decision|1|||
154880342|NCT00634244|558985886|FG000|Overall Study|Never started treatment|0|||
154880343|NCT00634244|558985887|FG001|Overall Study|Never started treatment|1|||
154880344|NCT00634244|558985888|FG002|Overall Study|Never started treatment|0|||
154880345|NCT00634244|558985886|FG000|Overall Study|Death|1|||
154880346|NCT00634244|558985887|FG001|Overall Study|Death|6|||
154880347|NCT00634244|558985888|FG002|Overall Study|Death|0|||
154880348|NCT00634244|558985886|FG000|Overall Study|Adverse Event|0|||
154880349|NCT00634244|558985887|FG001|Overall Study|Adverse Event|2|||
154880350|NCT00634244|558985888|FG002|Overall Study|Adverse Event|0|||
154880351|NCT00634244|558985886|FG000|Overall Study|Withdrawal by Subject|0|||
154880352|NCT00634244|558985887|FG001|Overall Study|Withdrawal by Subject|1|||
154880353|NCT00634244|558985888|FG002|Overall Study|Withdrawal by Subject|0|||
154880354|NCT00634244|558985886|FG000|Overall Study|Physician Decision|0|||
154880355|NCT00634244|558985887|FG001|Overall Study|Physician Decision|1|||
154880356|NCT00634244|558985888|FG002|Overall Study|Physician Decision|0|||
154880357|NCT00634244|558985886|FG000|Overall Study|Disease progression/relapse|0|||
154880358|NCT00634244|558985887|FG001|Overall Study|Disease progression/relapse|1|||
154880359|NCT00634244|558985888|FG002|Overall Study|Disease progression/relapse|0|||
154880360|NCT00634244|558985886|FG000|Overall Study|Other complicating disease|0|||
154880361|NCT00634244|558985887|FG001|Overall Study|Other complicating disease|1|||
154880362|NCT00634244|558985888|FG002|Overall Study|Other complicating disease|0|||
154880363|NCT04737031|558985894|FG000|Overall Study|Patients who did not have a treatment visit|0|||
154880364|NCT04737031|558985895|FG001|Overall Study|Patients who did not have a treatment visit|31|||
154880365|NCT04737031|558985896|FG002|Overall Study|Patients who did not have a treatment visit|93|||
154880366|NCT04737031|558985897|FG003|Overall Study|Patients who did not have a treatment visit|227|||
154880367|NCT03453151|558985898|FG000|Overall Study|Withdrawal by Subject|1|||
154880368|NCT03453151|558985898|FG000|Overall Study|Physician Decision|3|||
154880369|NCT02678780|558985903|FG000|Overall Study|Adverse Event|11|||
154880370|NCT02678780|558985904|FG001|Overall Study|Adverse Event|14|||
154880371|NCT02678780|558985903|FG000|Overall Study|Withdrawal by Subject|2|||
154880372|NCT02678780|558985904|FG001|Overall Study|Withdrawal by Subject|1|||
154880373|NCT02678780|558985903|FG000|Overall Study|Sponsor discontinuation|7|||
154880374|NCT02678780|558985904|FG001|Overall Study|Sponsor discontinuation|4|||
154880375|NCT02678780|558985903|FG000|Overall Study|Death|1|||
154880376|NCT02678780|558985904|FG001|Overall Study|Death|1|||
154880377|NCT02678780|558985903|FG000|Overall Study|Other|6|||
154880378|NCT02678780|558985904|FG001|Overall Study|Other|8|||
154880379|NCT03229759|558985905|FG000|Overall Study|Screen Failure|30|||
154880380|NCT02020031|558987269|FG000|Overall Study|Physician Decision|1|||
154880381|NCT02020031|558987270|FG001|Overall Study|Physician Decision|1|||
155113500|NCT00473668|559844803|FG000|Overall Study|Other|2|||
155113501|NCT00473668|559844804|FG001|Overall Study|Other|3|||
155113502|NCT00473668|559844805|FG002|Overall Study|Other|4|||
154880382|NCT01830543|558987271|FG000|Overall Study|Subject Decision|19|||
154880383|NCT01830543|558987272|FG001|Overall Study|Subject Decision|21|||
154880384|NCT01830543|558987273|FG002|Overall Study|Subject Decision|57|||
154880385|NCT01830543|558987271|FG000|Overall Study|Adverse Event|91|||
154880386|NCT01830543|558987272|FG001|Overall Study|Adverse Event|77|||
154880387|NCT01830543|558987273|FG002|Overall Study|Adverse Event|76|||
154880388|NCT01830543|558987271|FG000|Overall Study|Death|20|||
154880389|NCT01830543|558987272|FG001|Overall Study|Death|22|||
154880390|NCT01830543|558987273|FG002|Overall Study|Death|22|||
155113503|NCT02039219|559844806|FG000|Treatment|Withdrawal by Subject|1|||
154880391|NCT01830543|558987271|FG000|Overall Study|Protocol Violation|3|||
154880392|NCT01830543|558987272|FG001|Overall Study|Protocol Violation|7|||
154880393|NCT01830543|558987273|FG002|Overall Study|Protocol Violation|7|||
154880394|NCT01830543|558987271|FG000|Overall Study|Physician Decision|11|||
154880395|NCT01830543|558987272|FG001|Overall Study|Physician Decision|5|||
154880396|NCT01830543|558987273|FG002|Overall Study|Physician Decision|12|||
154880397|NCT01830543|558987271|FG000|Overall Study|Withdrawal by consent|3|||
154880398|NCT01830543|558987272|FG001|Overall Study|Withdrawal by consent|3|||
154880399|NCT01830543|558987273|FG002|Overall Study|Withdrawal by consent|3|||
154880400|NCT01830543|558987271|FG000|Overall Study|Other|12|||
154880401|NCT01830543|558987272|FG001|Overall Study|Other|17|||
154880402|NCT01830543|558987273|FG002|Overall Study|Other|37|||
154880403|NCT01030458|558987280|FG000|Overall Study|Lost to Follow-up|9|||
154880404|NCT01030458|558987281|FG001|Overall Study|Lost to Follow-up|10|||
154880405|NCT01030458|558987280|FG000|Overall Study|Withdrawal by Subject|2|||
154880406|NCT01030458|558987281|FG001|Overall Study|Withdrawal by Subject|3|||
154880407|NCT01030458|558987280|FG000|Overall Study|Logistical reasons|9|||
154880408|NCT01030458|558987281|FG001|Overall Study|Logistical reasons|5|||
154880409|NCT01030458|558987280|FG000|Overall Study|Moved or changed job|6|||
154880410|NCT01030458|558987281|FG001|Overall Study|Moved or changed job|13|||
154880411|NCT01030458|558987280|FG000|Overall Study|Side effect of medication|1|||
154880412|NCT01030458|558987281|FG001|Overall Study|Side effect of medication|1|||
154880413|NCT05631548|558987288|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
154880414|NCT05631548|558987289|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
154880415|NCT01592409|558987290|FG000|Overall Study|Withdrawal by Subject|0|||
154880416|NCT01592409|558987291|FG001|Overall Study|Withdrawal by Subject|1|||
154880417|NCT02935634|558987292|FG000|Randomization|Participant withdrew consent|0|||
154880418|NCT02935634|558987293|FG001|Randomization|Participant withdrew consent|1|||
154880419|NCT02935634|558987294|FG002|Randomization|Participant withdrew consent|0|||
154880420|NCT02935634|558987295|FG003|Randomization|Participant withdrew consent|0|||
154880421|NCT02935634|558987296|FG004|Randomization|Participant withdrew consent|0|||
154880422|NCT02935634|558987297|FG005|Randomization|Participant withdrew consent|0|||
154880423|NCT02935634|558987292|FG000|Randomization|Death|2|||
154880424|NCT02935634|558987293|FG001|Randomization|Death|1|||
154880425|NCT02935634|558987294|FG002|Randomization|Death|1|||
154880426|NCT02935634|558987295|FG003|Randomization|Death|0|||
154880427|NCT02935634|558987296|FG004|Randomization|Death|0|||
154880428|NCT02935634|558987297|FG005|Randomization|Death|0|||
154880429|NCT02935634|558987292|FG000|Randomization|Other reasons|0|||
154880430|NCT02935634|558987293|FG001|Randomization|Other reasons|2|||
154880431|NCT02935634|558987294|FG002|Randomization|Other reasons|2|||
154880432|NCT02935634|558987295|FG003|Randomization|Other reasons|0|||
154880433|NCT02935634|558987296|FG004|Randomization|Other reasons|0|||
154880434|NCT02935634|558987297|FG005|Randomization|Other reasons|0|||
154880435|NCT02935634|558987292|FG000|Treatment: Track 1|Disease progression|15|||
154880436|NCT02935634|558987293|FG001|Treatment: Track 1|Disease progression|17|||
154880437|NCT02935634|558987294|FG002|Treatment: Track 1|Disease progression|28|||
154880438|NCT02935634|558987295|FG003|Treatment: Track 1|Disease progression|4|||
154880439|NCT02935634|558987296|FG004|Treatment: Track 1|Disease progression|6|||
154880440|NCT02935634|558987297|FG005|Treatment: Track 1|Disease progression|2|||
154880441|NCT02935634|558987292|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
154880442|NCT02935634|558987293|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
154880443|NCT02935634|558987294|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
154880444|NCT02935634|558987295|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
154880445|NCT02935634|558987296|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
154880446|NCT02935634|558987297|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
154880447|NCT02935634|558987292|FG000|Treatment: Track 1|Lost to Follow-up|1|||
154880448|NCT02935634|558987293|FG001|Treatment: Track 1|Lost to Follow-up|0|||
154880449|NCT02935634|558987294|FG002|Treatment: Track 1|Lost to Follow-up|0|||
154880450|NCT02935634|558987295|FG003|Treatment: Track 1|Lost to Follow-up|0|||
154880451|NCT02935634|558987296|FG004|Treatment: Track 1|Lost to Follow-up|0|||
154880452|NCT02935634|558987297|FG005|Treatment: Track 1|Lost to Follow-up|0|||
154880453|NCT02935634|558987292|FG000|Treatment: Track 1|Study drug toxicity|2|||
154880454|NCT02935634|558987293|FG001|Treatment: Track 1|Study drug toxicity|1|||
154880455|NCT02935634|558987294|FG002|Treatment: Track 1|Study drug toxicity|3|||
154880456|NCT02935634|558987295|FG003|Treatment: Track 1|Study drug toxicity|0|||
154880457|NCT02935634|558987296|FG004|Treatment: Track 1|Study drug toxicity|0|||
154880458|NCT02935634|558987297|FG005|Treatment: Track 1|Study drug toxicity|1|||
154880459|NCT02935634|558987292|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
154880460|NCT02935634|558987293|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
154880461|NCT02935634|558987294|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
154880462|NCT02935634|558987295|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
154880463|NCT02935634|558987296|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
154880464|NCT02935634|558987297|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
154880465|NCT02935634|558987292|FG000|Treatment: Track 1|Participant withdrew consent|2|||
154880466|NCT02935634|558987293|FG001|Treatment: Track 1|Participant withdrew consent|0|||
154880467|NCT02935634|558987294|FG002|Treatment: Track 1|Participant withdrew consent|1|||
154880468|NCT02935634|558987295|FG003|Treatment: Track 1|Participant withdrew consent|0|||
154880469|NCT02935634|558987296|FG004|Treatment: Track 1|Participant withdrew consent|1|||
154880470|NCT02935634|558987297|FG005|Treatment: Track 1|Participant withdrew consent|0|||
154880471|NCT02935634|558987292|FG000|Treatment: Track 1|Other reasons|0|||
154880472|NCT02935634|558987293|FG001|Treatment: Track 1|Other reasons|0|||
154880473|NCT02935634|558987294|FG002|Treatment: Track 1|Other reasons|2|||
154880474|NCT02935634|558987295|FG003|Treatment: Track 1|Other reasons|0|||
154880475|NCT02935634|558987296|FG004|Treatment: Track 1|Other reasons|0|||
154880476|NCT02935634|558987297|FG005|Treatment: Track 1|Other reasons|0|||
154880477|NCT02935634|558987292|FG000|Treatment: Track 2|Disease progression|13|||
154880478|NCT02935634|558987293|FG001|Treatment: Track 2|Disease progression|26|||
154880479|NCT02935634|558987294|FG002|Treatment: Track 2|Disease progression|20|||
154880480|NCT02935634|558987295|FG003|Treatment: Track 2|Disease progression|5|||
154880481|NCT02935634|558987296|FG004|Treatment: Track 2|Disease progression|1|||
154880482|NCT02935634|558987297|FG005|Treatment: Track 2|Disease progression|4|||
154880483|NCT02935634|558987292|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
154880484|NCT02935634|558987293|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
154880485|NCT02935634|558987294|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
154880486|NCT02935634|558987295|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
154880487|NCT02935634|558987296|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
154880488|NCT02935634|558987297|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
154880489|NCT02935634|558987292|FG000|Treatment: Track 2|Study drug toxicity|7|||
154880490|NCT02935634|558987293|FG001|Treatment: Track 2|Study drug toxicity|3|||
154880491|NCT02935634|558987294|FG002|Treatment: Track 2|Study drug toxicity|0|||
154880492|NCT02935634|558987295|FG003|Treatment: Track 2|Study drug toxicity|0|||
154880493|NCT02935634|558987296|FG004|Treatment: Track 2|Study drug toxicity|0|||
154880494|NCT02935634|558987297|FG005|Treatment: Track 2|Study drug toxicity|0|||
154880495|NCT02935634|558987292|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
154880496|NCT02935634|558987293|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
154880497|NCT02935634|558987294|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
154880498|NCT02935634|558987295|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
154880499|NCT02935634|558987296|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
154880500|NCT02935634|558987297|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
154880501|NCT02935634|558987292|FG000|Treatment: Track 2|Participant withdrew consent|0|||
154880502|NCT02935634|558987293|FG001|Treatment: Track 2|Participant withdrew consent|1|||
154880503|NCT02935634|558987294|FG002|Treatment: Track 2|Participant withdrew consent|1|||
154880504|NCT02935634|558987295|FG003|Treatment: Track 2|Participant withdrew consent|0|||
154880505|NCT02935634|558987296|FG004|Treatment: Track 2|Participant withdrew consent|1|||
154880506|NCT02935634|558987297|FG005|Treatment: Track 2|Participant withdrew consent|0|||
154880507|NCT02509598|558987305|FG000|Overall Study|Withdrawal by Subject|1|||
154880508|NCT04056455|558987306|FG000|Overall Study|Adverse Event|1|||
154880509|NCT04056455|558987307|FG001|Overall Study|Adverse Event|0|||
154880510|NCT04891770|558987311|FG000|Overall Study|Withdrew consent|1|||
154880511|NCT04891770|558987312|FG001|Overall Study|Withdrew consent|3|||
154880512|NCT04891770|558987313|FG002|Overall Study|Withdrew consent|0|||
154880513|NCT04891770|558987311|FG000|Overall Study|Enrolled but never treated|0|||
154880514|NCT04891770|558987312|FG001|Overall Study|Enrolled but never treated|0|||
154880515|NCT04891770|558987313|FG002|Overall Study|Enrolled but never treated|1|||
154880516|NCT04891770|558987311|FG000|Overall Study|Investigator's discretion|0|||
154880517|NCT04891770|558987312|FG001|Overall Study|Investigator's discretion|1|||
154880518|NCT04891770|558987313|FG002|Overall Study|Investigator's discretion|0|||
154880519|NCT00830037|558987317|FG000|Overall Study|Withdrawal by Subject|2|||
154880520|NCT00830037|558987318|FG001|Overall Study|Withdrawal by Subject|3|||
154880521|NCT00830037|558987317|FG000|Overall Study|Lost to Follow-up|1|||
154880522|NCT00830037|558987318|FG001|Overall Study|Lost to Follow-up|2|||
154880523|NCT00830037|558987317|FG000|Overall Study|Active when terminated by DSMB|15|||
154880524|NCT00830037|558987318|FG001|Overall Study|Active when terminated by DSMB|14|||
154880525|NCT01401010|558987321|FG000|Overall Study|Could not interpret assay results|1|||
154880526|NCT01401010|558987322|FG001|Overall Study|Could not interpret assay results|0|||
154880527|NCT01952834|558987323|FG000|Overall Study|Adverse Event|1|||
154880528|NCT05091060|558987333|FG000|Overall Study|Lost to Follow-up|1|||
154880529|NCT01318083|558987334|FG000|Overall Study|Adverse Event|4|||
154880530|NCT01318083|558987335|FG001|Overall Study|Adverse Event|1|||
154880531|NCT01318083|558987336|FG002|Overall Study|Adverse Event|2|||
154880532|NCT01318083|558987334|FG000|Overall Study|Withdrawal by Subject|1|||
154880533|NCT01318083|558987335|FG001|Overall Study|Withdrawal by Subject|0|||
154880534|NCT01318083|558987336|FG002|Overall Study|Withdrawal by Subject|2|||
154880535|NCT01318083|558987334|FG000|Overall Study|Lack of Efficacy|0|||
154880536|NCT01318083|558987335|FG001|Overall Study|Lack of Efficacy|0|||
154880537|NCT01318083|558987336|FG002|Overall Study|Lack of Efficacy|1|||
154880538|NCT01318083|558987334|FG000|Overall Study|Treatment Complications|1|||
154880539|NCT01318083|558987335|FG001|Overall Study|Treatment Complications|0|||
154880540|NCT01318083|558987336|FG002|Overall Study|Treatment Complications|0|||
154880541|NCT01318083|558987334|FG000|Overall Study|Lack of Study Medication Compliance|0|||
154880542|NCT01318083|558987335|FG001|Overall Study|Lack of Study Medication Compliance|1|||
154880543|NCT01318083|558987336|FG002|Overall Study|Lack of Study Medication Compliance|0|||
154880544|NCT02028338|558987337|FG000|Overall Study|Withdrawal by Subject|3|||
154880545|NCT02028338|558987338|FG001|Overall Study|Withdrawal by Subject|1|||
154880546|NCT02028338|558987337|FG000|Overall Study|Unable to contact participant|1|||
154880547|NCT02028338|558987338|FG001|Overall Study|Unable to contact participant|0|||
154880548|NCT00256867|558987343|FG000|Overall Study|Adverse Event|0|||
154880549|NCT00256867|558987344|FG001|Overall Study|Adverse Event|1|||
154880550|NCT00256867|558987345|FG002|Overall Study|Adverse Event|1|||
154880551|NCT00256867|558987346|FG003|Overall Study|Adverse Event|1|||
154880552|NCT00256867|558987347|FG004|Overall Study|Adverse Event|2|||
154880553|NCT00256867|558987348|FG005|Overall Study|Adverse Event|2|||
154880554|NCT00256867|558987349|FG006|Overall Study|Adverse Event|1|||
154880555|NCT00256867|558987350|FG007|Overall Study|Adverse Event|4|||
154880556|NCT00256867|558987343|FG000|Overall Study|Lost to Follow-up|2|||
154880557|NCT00256867|558987344|FG001|Overall Study|Lost to Follow-up|2|||
154880558|NCT00256867|558987345|FG002|Overall Study|Lost to Follow-up|2|||
154880559|NCT00256867|558987346|FG003|Overall Study|Lost to Follow-up|3|||
154880560|NCT00256867|558987347|FG004|Overall Study|Lost to Follow-up|2|||
154880561|NCT00256867|558987348|FG005|Overall Study|Lost to Follow-up|0|||
154880562|NCT00256867|558987349|FG006|Overall Study|Lost to Follow-up|1|||
154880563|NCT00256867|558987350|FG007|Overall Study|Lost to Follow-up|2|||
154880564|NCT00256867|558987343|FG000|Overall Study|Protocol Violation|0|||
154880565|NCT00256867|558987344|FG001|Overall Study|Protocol Violation|0|||
154880566|NCT00256867|558987345|FG002|Overall Study|Protocol Violation|0|||
154880567|NCT00256867|558987346|FG003|Overall Study|Protocol Violation|1|||
154880568|NCT00256867|558987347|FG004|Overall Study|Protocol Violation|0|||
154880569|NCT00256867|558987348|FG005|Overall Study|Protocol Violation|1|||
154880570|NCT00256867|558987349|FG006|Overall Study|Protocol Violation|0|||
154880571|NCT00256867|558987350|FG007|Overall Study|Protocol Violation|1|||
154880572|NCT00256867|558987343|FG000|Overall Study|Withdrawal by Subject|0|||
154880573|NCT00256867|558987344|FG001|Overall Study|Withdrawal by Subject|0|||
154880574|NCT00256867|558987345|FG002|Overall Study|Withdrawal by Subject|1|||
154880575|NCT00256867|558987346|FG003|Overall Study|Withdrawal by Subject|1|||
154880576|NCT00256867|558987347|FG004|Overall Study|Withdrawal by Subject|2|||
154880577|NCT00256867|558987348|FG005|Overall Study|Withdrawal by Subject|2|||
154880578|NCT00256867|558987349|FG006|Overall Study|Withdrawal by Subject|3|||
154880579|NCT00256867|558987350|FG007|Overall Study|Withdrawal by Subject|2|||
154880580|NCT00256867|558987343|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880581|NCT00256867|558987344|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
154880582|NCT00256867|558987345|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880583|NCT00256867|558987346|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880584|NCT00256867|558987347|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880585|NCT00256867|558987348|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880586|NCT00256867|558987349|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880587|NCT00256867|558987350|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
154880588|NCT00256867|558987343|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880589|NCT00256867|558987344|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880590|NCT00256867|558987345|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880591|NCT00256867|558987346|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880592|NCT00256867|558987347|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880593|NCT00256867|558987348|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880594|NCT00256867|558987349|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
154880595|NCT00256867|558987350|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
154880596|NCT00256867|558987343|FG000|Overall Study|Investigator's Decision|0|||
154880597|NCT00256867|558987344|FG001|Overall Study|Investigator's Decision|0|||
154880598|NCT00256867|558987345|FG002|Overall Study|Investigator's Decision|0|||
154880599|NCT00256867|558987346|FG003|Overall Study|Investigator's Decision|0|||
154880600|NCT00256867|558987347|FG004|Overall Study|Investigator's Decision|1|||
154880601|NCT00256867|558987348|FG005|Overall Study|Investigator's Decision|0|||
154880602|NCT00256867|558987349|FG006|Overall Study|Investigator's Decision|0|||
154880603|NCT00256867|558987350|FG007|Overall Study|Investigator's Decision|0|||
154880604|NCT00256867|558987343|FG000|Overall Study|Non-compliance with study medication|0|||
154880605|NCT00256867|558987344|FG001|Overall Study|Non-compliance with study medication|0|||
154880606|NCT00256867|558987345|FG002|Overall Study|Non-compliance with study medication|0|||
154880607|NCT00256867|558987346|FG003|Overall Study|Non-compliance with study medication|0|||
154880608|NCT00256867|558987347|FG004|Overall Study|Non-compliance with study medication|0|||
154880609|NCT00256867|558987348|FG005|Overall Study|Non-compliance with study medication|0|||
154880610|NCT00256867|558987349|FG006|Overall Study|Non-compliance with study medication|0|||
154880611|NCT00256867|558987350|FG007|Overall Study|Non-compliance with study medication|1|||
154974796|NCT00642811|559331314|FG005|Overall Study|Developement of discontinuation criteria|0|||
155113504|NCT02039219|559844807|FG001|Treatment|Withdrawal by Subject|0|||
154880612|NCT00256867|558987343|FG000|Overall Study|Participant travelled Overseas|0|||
154880613|NCT00256867|558987344|FG001|Overall Study|Participant travelled Overseas|1|||
154880614|NCT00256867|558987345|FG002|Overall Study|Participant travelled Overseas|0|||
154880615|NCT00256867|558987346|FG003|Overall Study|Participant travelled Overseas|0|||
154880616|NCT00256867|558987347|FG004|Overall Study|Participant travelled Overseas|0|||
154880617|NCT00256867|558987348|FG005|Overall Study|Participant travelled Overseas|0|||
154880618|NCT00256867|558987349|FG006|Overall Study|Participant travelled Overseas|0|||
154880619|NCT00256867|558987350|FG007|Overall Study|Participant travelled Overseas|0|||
154880620|NCT00256867|558987343|FG000|Overall Study|Participant out of assessment window|0|||
154880621|NCT00256867|558987344|FG001|Overall Study|Participant out of assessment window|0|||
154880622|NCT00256867|558987345|FG002|Overall Study|Participant out of assessment window|1|||
154880623|NCT00256867|558987346|FG003|Overall Study|Participant out of assessment window|0|||
154880624|NCT00256867|558987347|FG004|Overall Study|Participant out of assessment window|0|||
154880625|NCT00256867|558987348|FG005|Overall Study|Participant out of assessment window|0|||
154880626|NCT00256867|558987349|FG006|Overall Study|Participant out of assessment window|0|||
154880627|NCT00256867|558987350|FG007|Overall Study|Participant out of assessment window|0|||
154880628|NCT00256867|558987343|FG000|Overall Study|Withdrawal by participant|0|||
154880629|NCT00256867|558987344|FG001|Overall Study|Withdrawal by participant|0|||
154880630|NCT00256867|558987345|FG002|Overall Study|Withdrawal by participant|0|||
154880631|NCT00256867|558987346|FG003|Overall Study|Withdrawal by participant|0|||
154880632|NCT00256867|558987347|FG004|Overall Study|Withdrawal by participant|0|||
154880633|NCT00256867|558987348|FG005|Overall Study|Withdrawal by participant|1|||
154880634|NCT00256867|558987349|FG006|Overall Study|Withdrawal by participant|0|||
154880635|NCT00256867|558987350|FG007|Overall Study|Withdrawal by participant|0|||
154880636|NCT01930799|558987354|FG000|Overall Study|Withdrawal by Subject|3|||
154880637|NCT01930799|558987354|FG000|Overall Study|Lost to Follow-up|5|||
154880638|NCT00875017|558987357|FG000|First Intervention|Withdrawal by Subject|1|||
154880639|NCT00875017|558987358|FG001|First Intervention|Withdrawal by Subject|0|||
154880640|NCT00875017|558987359|FG002|First Intervention|Withdrawal by Subject|1|||
154880641|NCT00875017|558987360|FG003|First Intervention|Withdrawal by Subject|0|||
154880642|NCT00875017|558987361|FG004|First Intervention|Withdrawal by Subject|0|||
154880643|NCT00875017|558987362|FG005|First Intervention|Withdrawal by Subject|0|||
154880644|NCT00875017|558987357|FG000|First Intervention|Adverse Event|0|||
154880645|NCT00875017|558987358|FG001|First Intervention|Adverse Event|0|||
154880646|NCT00875017|558987359|FG002|First Intervention|Adverse Event|0|||
154880647|NCT00875017|558987360|FG003|First Intervention|Adverse Event|1|||
154880648|NCT00875017|558987361|FG004|First Intervention|Adverse Event|0|||
154880649|NCT00875017|558987362|FG005|First Intervention|Adverse Event|0|||
154880650|NCT00875017|558987357|FG000|First Intervention|Problems collecting rectal effluent|1|||
154880651|NCT00875017|558987358|FG001|First Intervention|Problems collecting rectal effluent|0|||
154880652|NCT00875017|558987359|FG002|First Intervention|Problems collecting rectal effluent|0|||
154880653|NCT00875017|558987360|FG003|First Intervention|Problems collecting rectal effluent|0|||
154880654|NCT00875017|558987361|FG004|First Intervention|Problems collecting rectal effluent|0|||
154880655|NCT00875017|558987362|FG005|First Intervention|Problems collecting rectal effluent|0|||
154880656|NCT00875017|558987357|FG000|First Intervention|Intolerance to nasogastric tube|0|||
154880657|NCT00875017|558987358|FG001|First Intervention|Intolerance to nasogastric tube|0|||
154880658|NCT00875017|558987359|FG002|First Intervention|Intolerance to nasogastric tube|0|||
154880659|NCT00875017|558987360|FG003|First Intervention|Intolerance to nasogastric tube|0|||
154880660|NCT00875017|558987361|FG004|First Intervention|Intolerance to nasogastric tube|1|||
154880661|NCT00875017|558987362|FG005|First Intervention|Intolerance to nasogastric tube|0|||
154880662|NCT00875017|558987357|FG000|Washout|Problem collecting rectal effluent|0|||
154880663|NCT00875017|558987358|FG001|Washout|Problem collecting rectal effluent|0|||
154880664|NCT00875017|558987359|FG002|Washout|Problem collecting rectal effluent|1|||
154880665|NCT00875017|558987360|FG003|Washout|Problem collecting rectal effluent|0|||
154880666|NCT00875017|558987361|FG004|Washout|Problem collecting rectal effluent|0|||
154880667|NCT00875017|558987362|FG005|Washout|Problem collecting rectal effluent|0|||
154880668|NCT00875017|558987357|FG000|Second Intervention|Adverse Event|0|||
154880669|NCT00875017|558987358|FG001|Second Intervention|Adverse Event|0|||
154880670|NCT00875017|558987359|FG002|Second Intervention|Adverse Event|0|||
154880671|NCT00875017|558987360|FG003|Second Intervention|Adverse Event|1|||
154880672|NCT00875017|558987361|FG004|Second Intervention|Adverse Event|0|||
154880673|NCT00875017|558987362|FG005|Second Intervention|Adverse Event|0|||
154880674|NCT00875017|558987357|FG000|Washout|Problems collecting rectal effluent|0|||
154880675|NCT00875017|558987358|FG001|Washout|Problems collecting rectal effluent|1|||
154880676|NCT00875017|558987359|FG002|Washout|Problems collecting rectal effluent|0|||
154880677|NCT00875017|558987360|FG003|Washout|Problems collecting rectal effluent|0|||
154880678|NCT00875017|558987361|FG004|Washout|Problems collecting rectal effluent|0|||
154880679|NCT00875017|558987362|FG005|Washout|Problems collecting rectal effluent|0|||
154880680|NCT00875017|558987357|FG000|Third Intervention|Adverse Event|0|||
154974797|NCT00642811|559331309|FG000|Overall Study|Severe Non-compliance to protocol|1|||
154880681|NCT00875017|558987358|FG001|Third Intervention|Adverse Event|1|||
154880682|NCT00875017|558987359|FG002|Third Intervention|Adverse Event|1|||
154880683|NCT00875017|558987360|FG003|Third Intervention|Adverse Event|0|||
154880684|NCT00875017|558987361|FG004|Third Intervention|Adverse Event|0|||
154880685|NCT00875017|558987362|FG005|Third Intervention|Adverse Event|0|||
154880686|NCT00875017|558987357|FG000|Washout|Withdrawal by Subject|0|||
154880687|NCT00875017|558987358|FG001|Washout|Withdrawal by Subject|0|||
154880688|NCT00875017|558987359|FG002|Washout|Withdrawal by Subject|0|||
154880689|NCT00875017|558987360|FG003|Washout|Withdrawal by Subject|0|||
154880690|NCT00875017|558987361|FG004|Washout|Withdrawal by Subject|1|||
154880691|NCT00875017|558987362|FG005|Washout|Withdrawal by Subject|0|||
154880692|NCT00875017|558987357|FG000|Fourth Intervention|Inability to comply with fasting|0|||
154880693|NCT00875017|558987358|FG001|Fourth Intervention|Inability to comply with fasting|0|||
154880694|NCT00875017|558987359|FG002|Fourth Intervention|Inability to comply with fasting|0|||
154880695|NCT00875017|558987360|FG003|Fourth Intervention|Inability to comply with fasting|0|||
154880696|NCT00875017|558987361|FG004|Fourth Intervention|Inability to comply with fasting|0|||
154880697|NCT00875017|558987362|FG005|Fourth Intervention|Inability to comply with fasting|1|||
154880698|NCT02689219|558987363|FG000|Overall Study|Death|1|||
154880699|NCT02689219|558987364|FG001|Overall Study|Death|1|||
154880700|NCT02689219|558987363|FG000|Overall Study|Disease Progression|10|||
154880701|NCT02689219|558987364|FG001|Overall Study|Disease Progression|6|||
154880702|NCT01477892|558987365|FG000|Overall Study|Withdrawal by Subject|0|||
154880703|NCT01477892|558987366|FG001|Overall Study|Withdrawal by Subject|2|||
154880704|NCT03255291|558987373|FG000|Overall Study|Determined to be ineligible|10|||
154880705|NCT03255291|558987374|FG001|Overall Study|Determined to be ineligible|12|||
154880706|NCT03255291|558987375|FG002|Overall Study|Determined to be ineligible|6|||
154880707|NCT03255291|558987376|FG003|Overall Study|Determined to be ineligible|6|||
154880708|NCT03255291|558987377|FG004|Overall Study|Determined to be ineligible|5|||
154880709|NCT03255291|558987378|FG005|Overall Study|Determined to be ineligible|10|||
154880710|NCT03255291|558987373|FG000|Overall Study|Baseline data collection issues|3|||
154880711|NCT03255291|558987374|FG001|Overall Study|Baseline data collection issues|0|||
154880712|NCT03255291|558987375|FG002|Overall Study|Baseline data collection issues|0|||
154880713|NCT03255291|558987376|FG003|Overall Study|Baseline data collection issues|0|||
154880714|NCT03255291|558987377|FG004|Overall Study|Baseline data collection issues|2|||
154880715|NCT03255291|558987378|FG005|Overall Study|Baseline data collection issues|0|||
154880716|NCT03591146|558987383|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
154880717|NCT03591146|558987384|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
154880718|NCT03591146|558987385|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
154880719|NCT03591146|558987386|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
154880720|NCT03591146|558987387|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
154880721|NCT03591146|558987383|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
154880722|NCT03591146|558987384|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
154880723|NCT03591146|558987385|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
154880724|NCT03591146|558987386|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
154880725|NCT03591146|558987387|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
154880726|NCT03591146|558987383|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
154880727|NCT03591146|558987384|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
154880728|NCT03591146|558987385|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
154880729|NCT03591146|558987386|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
154880730|NCT03591146|558987387|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
154880731|NCT03591146|558987383|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
154880732|NCT03591146|558987384|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
154880733|NCT03591146|558987385|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
154880734|NCT03591146|558987386|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
154880735|NCT03591146|558987387|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
154880736|NCT04369430|558987388|FG000|Overall Study|Adverse Event|2|||
154880737|NCT04369430|558987389|FG001|Overall Study|Adverse Event|3|||
154880738|NCT04369430|558987388|FG000|Overall Study|Death|1|||
154880739|NCT04369430|558987389|FG001|Overall Study|Death|0|||
154880740|NCT04369430|558987388|FG000|Overall Study|Withdrawal by Subject|4|||
154880741|NCT04369430|558987389|FG001|Overall Study|Withdrawal by Subject|3|||
154880742|NCT04369430|558987388|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
154880743|NCT04369430|558987389|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
154880744|NCT04369430|558987388|FG000|Overall Study|Lost to Follow-up|0|||
154880745|NCT04369430|558987389|FG001|Overall Study|Lost to Follow-up|1|||
154880746|NCT00142519|558987392|FG000|Overall Study|Not Treated|7|||
154880747|NCT00142519|558987393|FG001|Overall Study|Not Treated|9|||
154880748|NCT00142519|558987392|FG000|Overall Study|Protocol Violation|1|||
154880749|NCT00142519|558987393|FG001|Overall Study|Protocol Violation|0|||
154880750|NCT00142519|558987392|FG000|Overall Study|Withdrawal by Subject|10|||
154880751|NCT00142519|558987393|FG001|Overall Study|Withdrawal by Subject|7|||
154880752|NCT01468909|558987394|FG000|Overall Study|Never Treated|2|||
154880753|NCT01468909|558987395|FG001|Overall Study|Never Treated|2|||
154880754|NCT01511419|558987399|FG000|Dose 2|Physician Decision|1|||
154880755|NCT01511419|558987400|FG001|Dose 2|Physician Decision|0|||
154974798|NCT00642811|559331310|FG001|Overall Study|Severe Non-compliance to protocol|0|||
154974799|NCT00642811|559331311|FG002|Overall Study|Severe Non-compliance to protocol|0|||
154974800|NCT00642811|559331312|FG003|Overall Study|Severe Non-compliance to protocol|0|||
154974801|NCT00642811|559331313|FG004|Overall Study|Severe Non-compliance to protocol|0|||
154974802|NCT00642811|559331314|FG005|Overall Study|Severe Non-compliance to protocol|0|||
154974803|NCT00642811|559331309|FG000|Overall Study|Other|0|||
154974804|NCT00642811|559331310|FG001|Overall Study|Other|1|||
154974805|NCT00642811|559331311|FG002|Overall Study|Other|0|||
154974806|NCT00642811|559331312|FG003|Overall Study|Other|1|||
154974807|NCT00642811|559331313|FG004|Overall Study|Other|0|||
154974808|NCT00642811|559331314|FG005|Overall Study|Other|0|||
154974809|NCT04553406|559331315|FG000|Overall Study|Study Discontinuation|0|||
154974810|NCT04553406|559331316|FG001|Overall Study|Study Discontinuation|1|||
154974811|NCT03168906|559331317|FG000|Overall Study|Lack of Efficacy|6|||
154974812|NCT03168906|559331318|FG001|Overall Study|Lack of Efficacy|6|||
154974813|NCT01841060|559333738|FG000|Overall Study|Protocol Violation|10|||
154974814|NCT01848210|559333739|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
154974815|NCT01848210|559333740|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
154974816|NCT01848210|559333739|FG000|Overall Study|Lost to Follow-up|24|||
154974817|NCT01848210|559333740|FG001|Overall Study|Lost to Follow-up|12|||
154974818|NCT01848210|559333739|FG000|Overall Study|Protocol Violation|3|||
154974819|NCT01848210|559333740|FG001|Overall Study|Protocol Violation|5|||
154974820|NCT01848210|559333739|FG000|Overall Study|Use of Forbidden Drugs|9|||
154974821|NCT01848210|559333740|FG001|Overall Study|Use of Forbidden Drugs|10|||
154974822|NCT01848210|559333739|FG000|Overall Study|Impedition Condition|5|||
154974823|NCT01848210|559333740|FG001|Overall Study|Impedition Condition|9|||
154974824|NCT01848210|559333739|FG000|Overall Study|Adverse Event|7|||
154974825|NCT01848210|559333740|FG001|Overall Study|Adverse Event|9|||
154974826|NCT01848210|559333739|FG000|Overall Study|Discontinuation Criterion|5|||
154974827|NCT01848210|559333740|FG001|Overall Study|Discontinuation Criterion|7|||
154974828|NCT01848210|559333739|FG000|Overall Study|Hypesensitivity|1|||
154974829|NCT01848210|559333740|FG001|Overall Study|Hypesensitivity|0|||
154974830|NCT01848210|559333739|FG000|Overall Study|Hepatic Function Alteration|4|||
154974831|NCT01848210|559333740|FG001|Overall Study|Hepatic Function Alteration|0|||
154974832|NCT01848210|559333739|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
154974833|NCT01848210|559333740|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
154974834|NCT01848210|559333739|FG000|Overall Study|Administrative|1|||
154974835|NCT01848210|559333740|FG001|Overall Study|Administrative|0|||
154974836|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
154974837|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
154974838|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
154974839|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
154974840|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
154974841|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
154974842|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
154974843|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
154974844|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
154974845|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
154974846|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
154974847|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
154974848|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
154974849|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
154974850|NCT04592419|559333741|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
154974851|NCT04592419|559333742|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
154974852|NCT04592419|559333741|FG000|Open-Label Extension Period|Adverse Event|1|||
154974853|NCT04592419|559333742|FG001|Open-Label Extension Period|Adverse Event|2|||
154974854|NCT04592419|559333741|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
154974855|NCT04592419|559333742|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
154974856|NCT04592419|559333741|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
154974857|NCT04592419|559333742|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
154974858|NCT04592419|559333741|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
154974859|NCT04592419|559333742|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
154974860|NCT04592419|559333741|FG000|Open-Label Extension Period|Sponsor Request|73|||
154974861|NCT04592419|559333742|FG001|Open-Label Extension Period|Sponsor Request|84|||
154974862|NCT04501094|559333745|FG000|Overall Study|Death (unrelated to research)|1|||
154974863|NCT04501094|559333746|FG001|Overall Study|Death (unrelated to research)|0|||
154974864|NCT00685035|559333751|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
154974865|NCT00685035|559333752|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
154974866|NCT01901848|559333758|FG000|Randomized and Treated|Lost to Follow-up|3|||
154974867|NCT01901848|559333759|FG001|Randomized and Treated|Lost to Follow-up|6|||
154974868|NCT01901848|559333758|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
155113505|NCT02039219|559844806|FG000|Treatment|Adverse Event|0|||
154974869|NCT01901848|559333759|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
154974870|NCT01729026|559333760|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
154974871|NCT01729026|559333761|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
154974872|NCT01729026|559333760|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
154974873|NCT01729026|559333761|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
154974874|NCT00108082|559333763|FG000|Overall Study|Adverse Event|14|||
154974875|NCT00108082|559333764|FG001|Overall Study|Adverse Event|12|||
154974876|NCT00108082|559333765|FG002|Overall Study|Adverse Event|17|||
154974877|NCT00108082|559333763|FG000|Overall Study|Lost to Follow-up|6|||
154974878|NCT00108082|559333764|FG001|Overall Study|Lost to Follow-up|3|||
154974879|NCT00108082|559333765|FG002|Overall Study|Lost to Follow-up|7|||
154974880|NCT00108082|559333763|FG000|Overall Study|Consent Withdrawn|3|||
154974881|NCT00108082|559333764|FG001|Overall Study|Consent Withdrawn|3|||
154974882|NCT00108082|559333765|FG002|Overall Study|Consent Withdrawn|5|||
154974883|NCT00108082|559333763|FG000|Overall Study|Protocol Violation|1|||
154974884|NCT00108082|559333764|FG001|Overall Study|Protocol Violation|2|||
154974885|NCT00108082|559333765|FG002|Overall Study|Protocol Violation|0|||
154974886|NCT00108082|559333763|FG000|Overall Study|Lack of Efficacy|3|||
154974887|NCT00108082|559333764|FG001|Overall Study|Lack of Efficacy|1|||
154974888|NCT00108082|559333765|FG002|Overall Study|Lack of Efficacy|2|||
154974889|NCT00108082|559333763|FG000|Overall Study|Amendment 4: > Month 12|5|||
154974890|NCT00108082|559333764|FG001|Overall Study|Amendment 4: > Month 12|7|||
154974891|NCT00108082|559333765|FG002|Overall Study|Amendment 4: > Month 12|5|||
154974892|NCT00108082|559333763|FG000|Overall Study|Woman of Child-bearing Potential|2|||
154974893|NCT00108082|559333764|FG001|Overall Study|Woman of Child-bearing Potential|0|||
154974894|NCT00108082|559333765|FG002|Overall Study|Woman of Child-bearing Potential|2|||
154974895|NCT00108082|559333763|FG000|Overall Study|Incorrectly Randomized|0|||
154974896|NCT00108082|559333764|FG001|Overall Study|Incorrectly Randomized|0|||
154974897|NCT00108082|559333765|FG002|Overall Study|Incorrectly Randomized|2|||
154974898|NCT00108082|559333763|FG000|Overall Study|Non-compliance|1|||
154974899|NCT00108082|559333764|FG001|Overall Study|Non-compliance|0|||
154974900|NCT00108082|559333765|FG002|Overall Study|Non-compliance|2|||
154974901|NCT00108082|559333763|FG000|Overall Study|Stopped Study Medication|0|||
154974902|NCT00108082|559333764|FG001|Overall Study|Stopped Study Medication|0|||
154974903|NCT00108082|559333765|FG002|Overall Study|Stopped Study Medication|1|||
154974904|NCT00108082|559333763|FG000|Overall Study|Site Closed Study|0|||
154974905|NCT00108082|559333764|FG001|Overall Study|Site Closed Study|2|||
154974906|NCT00108082|559333765|FG002|Overall Study|Site Closed Study|0|||
154974907|NCT00108082|559333763|FG000|Overall Study|Protocol Amendment|0|||
154974908|NCT00108082|559333764|FG001|Overall Study|Protocol Amendment|1|||
154974909|NCT00108082|559333765|FG002|Overall Study|Protocol Amendment|0|||
154974910|NCT00108082|559333763|FG000|Overall Study|Study Medication Not Tapered|0|||
154974911|NCT00108082|559333764|FG001|Overall Study|Study Medication Not Tapered|1|||
154974912|NCT00108082|559333765|FG002|Overall Study|Study Medication Not Tapered|0|||
154974913|NCT00108082|559333763|FG000|Overall Study|Subject Left Site Location|1|||
154974914|NCT00108082|559333764|FG001|Overall Study|Subject Left Site Location|0|||
154974915|NCT00108082|559333765|FG002|Overall Study|Subject Left Site Location|0|||
154974916|NCT00108082|559333763|FG000|Overall Study|Investigator Not at Site|1|||
154974917|NCT00108082|559333764|FG001|Overall Study|Investigator Not at Site|0|||
154974918|NCT00108082|559333765|FG002|Overall Study|Investigator Not at Site|0|||
154974919|NCT00108082|559333763|FG000|Overall Study|Blood Pressure Not Controlled|1|||
154974920|NCT00108082|559333764|FG001|Overall Study|Blood Pressure Not Controlled|0|||
154974921|NCT00108082|559333765|FG002|Overall Study|Blood Pressure Not Controlled|0|||
154974922|NCT02940730|559333769|FG000|Intervention 2|Physician Decision|7|||
154974923|NCT02940730|559333770|FG001|Intervention 2|Physician Decision|0|||
154974924|NCT00298740|559333771|FG000|Overall Study|Lack of Efficacy|6|||
154974925|NCT00298740|559333771|FG000|Overall Study|Withdrawal by Subject|3|||
154974926|NCT01064531|559333772|FG000|Overall Study|Lost to Follow-up|0|||
154974927|NCT01064531|559333773|FG001|Overall Study|Lost to Follow-up|2|||
154974928|NCT01064531|559333772|FG000|Overall Study|Physician Decision|0|||
154974929|NCT01064531|559333773|FG001|Overall Study|Physician Decision|1|||
154974930|NCT01064531|559333772|FG000|Overall Study|Withdrawal by Subject|2|||
154974931|NCT01064531|559333773|FG001|Overall Study|Withdrawal by Subject|2|||
154974932|NCT01064531|559333772|FG000|Overall Study|Revision due to femoral stem loosening|1|||
154974933|NCT01064531|559333773|FG001|Overall Study|Revision due to femoral stem loosening|0|||
154974934|NCT01064531|559333772|FG000|Overall Study|Revision due to dislocation|0|||
155113506|NCT02039219|559844807|FG001|Treatment|Adverse Event|1|||
154974935|NCT01064531|559333773|FG001|Overall Study|Revision due to dislocation|1|||
154974936|NCT01064531|559333772|FG000|Overall Study|Death|0|||
154974937|NCT01064531|559333773|FG001|Overall Study|Death|1|||
154974938|NCT00684567|559333778|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
154974939|NCT00684567|559333778|FG000|Monotherapy Period|Adverse Event|2|||
154974940|NCT00684567|559333778|FG000|Monotherapy Period|Death|1|||
154974941|NCT00684567|559333778|FG000|Monotherapy Period|Progression of primary disease|11|||
154974942|NCT01201759|559333779|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
154974943|NCT01201759|559333780|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
154880756|NCT00937768|558987401|FG000|Overall Study|Refused Further Treatment|3|||
154880757|NCT00937768|558987402|FG001|Overall Study|Refused Further Treatment|2|||
154880758|NCT00937768|558987401|FG000|Overall Study|Disease Progression|1|||
154880759|NCT00937768|558987402|FG001|Overall Study|Disease Progression|1|||
154880760|NCT00937768|558987401|FG000|Overall Study|Alternate Treatment|0|||
154880761|NCT00937768|558987402|FG001|Overall Study|Alternate Treatment|1|||
154880762|NCT00937768|558987401|FG000|Overall Study|No Further Funding|4|||
154880763|NCT00937768|558987402|FG001|Overall Study|No Further Funding|4|||
154880764|NCT01687413|558987405|FG000|Overall Study|Withdrawal by Subject|0|||
154880765|NCT01687413|558987406|FG001|Overall Study|Withdrawal by Subject|2|||
154880766|NCT01687413|558987405|FG000|Overall Study|Not eligible|0|||
154880767|NCT01687413|558987406|FG001|Overall Study|Not eligible|2|||
154880768|NCT01687413|558987405|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
154880769|NCT01687413|558987406|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
154880770|NCT04973228|558987409|FG000|Overall Study|Adverse Event|2|||
154880771|NCT04973228|558987410|FG001|Overall Study|Adverse Event|3|||
154880772|NCT04973228|558987409|FG000|Overall Study|Lack of Efficacy|1|||
154880773|NCT04973228|558987410|FG001|Overall Study|Lack of Efficacy|3|||
154880774|NCT04973228|558987409|FG000|Overall Study|Lost to Follow-up|12|||
154880775|NCT04973228|558987410|FG001|Overall Study|Lost to Follow-up|4|||
154880776|NCT04973228|558987409|FG000|Overall Study|Withdrawal by Subject|11|||
154880777|NCT04973228|558987410|FG001|Overall Study|Withdrawal by Subject|4|||
154880778|NCT04973228|558987409|FG000|Overall Study|Did not tolerate application|1|||
154880779|NCT04973228|558987410|FG001|Overall Study|Did not tolerate application|0|||
154880780|NCT04973228|558987409|FG000|Overall Study|Wanted to early terminate and use own product|0|||
154880781|NCT04973228|558987410|FG001|Overall Study|Wanted to early terminate and use own product|1|||
154880782|NCT04973228|558987409|FG000|Overall Study|Missed visits due to new work schedule|1|||
154880783|NCT04973228|558987410|FG001|Overall Study|Missed visits due to new work schedule|0|||
154880784|NCT00091390|558987415|FG000|Overall Study|Protocol Violation|1|||
154880785|NCT00091390|558987415|FG000|Overall Study|No protocol treatment|3|||
154880786|NCT00406640|558987416|FG000|Acute Phase|Adverse Event|18|||
154880787|NCT00406640|558987417|FG001|Acute Phase|Adverse Event|13|||
154880788|NCT00406640|558987416|FG000|Acute Phase|Failed to Return|5|||
154880789|NCT00406640|558987417|FG001|Acute Phase|Failed to Return|1|||
154880790|NCT00406640|558987416|FG000|Acute Phase|Physician Decision|0|||
154880791|NCT00406640|558987417|FG001|Acute Phase|Physician Decision|1|||
154880792|NCT00406640|558987416|FG000|Acute Phase|Lost to Follow-up|7|||
154880793|NCT00406640|558987417|FG001|Acute Phase|Lost to Follow-up|4|||
154880794|NCT00406640|558987416|FG000|Acute Phase|Protocol deviation|4|||
154880795|NCT00406640|558987417|FG001|Acute Phase|Protocol deviation|10|||
154880796|NCT00406640|558987416|FG000|Acute Phase|Protocol Violation|3|||
154880797|NCT00406640|558987417|FG001|Acute Phase|Protocol Violation|2|||
154880798|NCT00406640|558987416|FG000|Acute Phase|Withdrawal by Subject|11|||
154880799|NCT00406640|558987417|FG001|Acute Phase|Withdrawal by Subject|9|||
154880800|NCT00406640|558987416|FG000|Acute Phase|Lack of Efficacy|3|||
154880801|NCT00406640|558987417|FG001|Acute Phase|Lack of Efficacy|3|||
154880802|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
154880803|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
154880804|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Death|1|||
154880805|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Death|0|||
154880806|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
154880807|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
154880808|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
154880809|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
154880810|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
154880811|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
154880812|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|non-compliance|7|||
154880813|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|non-compliance|5|||
154880814|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
154880815|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
154880816|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
154880817|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
154880818|NCT00406640|558987416|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
154880819|NCT00406640|558987417|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
154880820|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
154880821|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
154880822|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
154880823|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
154880824|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
154880825|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
154880826|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
154880827|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
154974944|NCT01201759|559333779|FG000|Visit 3 - Washout|Adverse Event|0|||
154974945|NCT01201759|559333780|FG001|Visit 3 - Washout|Adverse Event|3|||
154974946|NCT01201759|559333779|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
154974947|NCT01201759|559333780|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
154974948|NCT01201759|559333779|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
154880828|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
154880829|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
154880830|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
154880831|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
154880832|NCT00406640|558987416|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
154880833|NCT00406640|558987417|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
154880834|NCT03050359|558989943|FG000|Overall Study|Randomized But Not Treated|2|||
154880835|NCT03050359|558989944|FG001|Overall Study|Randomized But Not Treated|0|||
154880836|NCT03050359|558989943|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
154880837|NCT03050359|558989944|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
154880838|NCT03050359|558989943|FG000|Overall Study|Significant Protocol Deviation|2|||
154880839|NCT03050359|558989944|FG001|Overall Study|Significant Protocol Deviation|3|||
154880840|NCT03050359|558989943|FG000|Overall Study|Lost to Follow-up|2|||
154880841|NCT03050359|558989944|FG001|Overall Study|Lost to Follow-up|1|||
154880842|NCT03050359|558989943|FG000|Overall Study|Voluntary Withdrawal|4|||
154880843|NCT03050359|558989944|FG001|Overall Study|Voluntary Withdrawal|6|||
154880844|NCT03050359|558989943|FG000|Overall Study|Pregnancy|1|||
154880845|NCT03050359|558989944|FG001|Overall Study|Pregnancy|0|||
154880846|NCT03050359|558989943|FG000|Overall Study|Reason Not Specified|1|||
154880847|NCT03050359|558989944|FG001|Overall Study|Reason Not Specified|0|||
154880848|NCT00755846|558989947|FG000|Overall Study|Adverse Event|0|||
154880849|NCT00755846|558989948|FG001|Overall Study|Adverse Event|0|||
154880850|NCT00755846|558989949|FG002|Overall Study|Adverse Event|0|||
154880851|NCT00755846|558989950|FG003|Overall Study|Adverse Event|1|||
154880852|NCT00755846|558989951|FG004|Overall Study|Adverse Event|3|||
154880853|NCT00755846|558989952|FG005|Overall Study|Adverse Event|2|||
154880854|NCT00755846|558989947|FG000|Overall Study|Protocol Violation|1|||
154880855|NCT00755846|558989948|FG001|Overall Study|Protocol Violation|1|||
154880856|NCT00755846|558989949|FG002|Overall Study|Protocol Violation|1|||
154880857|NCT00755846|558989950|FG003|Overall Study|Protocol Violation|1|||
154880858|NCT00755846|558989951|FG004|Overall Study|Protocol Violation|1|||
154880859|NCT00755846|558989952|FG005|Overall Study|Protocol Violation|1|||
154880860|NCT00755846|558989947|FG000|Overall Study|Lost to Follow-up|0|||
154880861|NCT00755846|558989948|FG001|Overall Study|Lost to Follow-up|2|||
154880862|NCT00755846|558989949|FG002|Overall Study|Lost to Follow-up|1|||
154880863|NCT00755846|558989950|FG003|Overall Study|Lost to Follow-up|0|||
154880864|NCT00755846|558989951|FG004|Overall Study|Lost to Follow-up|4|||
154880865|NCT00755846|558989952|FG005|Overall Study|Lost to Follow-up|2|||
154880866|NCT00755846|558989947|FG000|Overall Study|Withdrawal by Subject|2|||
154880867|NCT00755846|558989948|FG001|Overall Study|Withdrawal by Subject|3|||
154880868|NCT00755846|558989949|FG002|Overall Study|Withdrawal by Subject|5|||
154880869|NCT00755846|558989950|FG003|Overall Study|Withdrawal by Subject|2|||
154880870|NCT00755846|558989951|FG004|Overall Study|Withdrawal by Subject|0|||
154880871|NCT00755846|558989952|FG005|Overall Study|Withdrawal by Subject|1|||
154880872|NCT00755846|558989947|FG000|Overall Study|Hyperglycemic Rescue|21|||
154880873|NCT00755846|558989948|FG001|Overall Study|Hyperglycemic Rescue|7|||
154880874|NCT00755846|558989949|FG002|Overall Study|Hyperglycemic Rescue|5|||
154880875|NCT00755846|558989950|FG003|Overall Study|Hyperglycemic Rescue|8|||
154880876|NCT00755846|558989951|FG004|Overall Study|Hyperglycemic Rescue|8|||
154880877|NCT00755846|558989952|FG005|Overall Study|Hyperglycemic Rescue|7|||
154880878|NCT00755846|558989947|FG000|Overall Study|Physician Decision|1|||
154880879|NCT00755846|558989948|FG001|Overall Study|Physician Decision|3|||
154880880|NCT00755846|558989949|FG002|Overall Study|Physician Decision|0|||
154974949|NCT01201759|559333780|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
154974950|NCT00906373|559333781|FG000|Overall Study|Withdrawal by Subject|0|||
154974951|NCT00906373|559333782|FG001|Overall Study|Withdrawal by Subject|5|||
154974952|NCT00906373|559333781|FG000|Overall Study|Other|0|||
155113507|NCT02039219|559844806|FG000|Treatment|Physician Decision|1|||
155113508|NCT02039219|559844807|FG001|Treatment|Physician Decision|0|||
155113509|NCT02039219|559844806|FG000|Treatment|Lost to Follow-up|0|||
154880881|NCT00755846|558989950|FG003|Overall Study|Physician Decision|1|||
154880882|NCT00755846|558989951|FG004|Overall Study|Physician Decision|0|||
154880883|NCT00755846|558989952|FG005|Overall Study|Physician Decision|1|||
154880884|NCT00755846|558989947|FG000|Overall Study|Administrative Error|0|||
154880885|NCT00755846|558989948|FG001|Overall Study|Administrative Error|1|||
154974953|NCT00906373|559333782|FG001|Overall Study|Other|1|||
155113510|NCT02039219|559844807|FG001|Treatment|Lost to Follow-up|1|||
154880886|NCT00755846|558989949|FG002|Overall Study|Administrative Error|0|||
154880887|NCT00755846|558989950|FG003|Overall Study|Administrative Error|0|||
155113511|NCT02039219|559844806|FG000|Treatment|Protocol Violation|1|||
154880888|NCT00755846|558989951|FG004|Overall Study|Administrative Error|0|||
154880889|NCT00755846|558989952|FG005|Overall Study|Administrative Error|0|||
154974954|NCT00906373|559333781|FG000|Overall Study|Still on treatment at cutoff date|0|||
154974955|NCT00906373|559333782|FG001|Overall Study|Still on treatment at cutoff date|2|||
154974956|NCT00848042|559333783|FG000|Overall Study|Death|1|||
154974957|NCT00848042|559333784|FG001|Overall Study|Death|2|||
154974958|NCT00848042|559333785|FG002|Overall Study|Death|0|||
154974959|NCT00848042|559333783|FG000|Overall Study|Other Therapy|3|||
154880890|NCT00755846|558989947|FG000|Overall Study|Participant Non-compliance|0|||
154880891|NCT00755846|558989948|FG001|Overall Study|Participant Non-compliance|0|||
154880892|NCT00755846|558989949|FG002|Overall Study|Participant Non-compliance|0|||
154880893|NCT00755846|558989950|FG003|Overall Study|Participant Non-compliance|0|||
154880894|NCT00755846|558989951|FG004|Overall Study|Participant Non-compliance|1|||
154880895|NCT00755846|558989952|FG005|Overall Study|Participant Non-compliance|0|||
154880896|NCT02723604|558989965|FG000|Overall Study|ineligible|1|||
154880897|NCT02723604|558989965|FG000|Overall Study|never received treatment|1|||
154880898|NCT02669862|558989966|FG000|Overall Study|Lost to Follow-up|0|||
154880899|NCT02669862|558989967|FG001|Overall Study|Lost to Follow-up|2|||
154880900|NCT02669862|558989968|FG002|Overall Study|Lost to Follow-up|1|||
154880901|NCT02669862|558989966|FG000|Overall Study|Withdrawal by Subject|2|||
154880902|NCT02669862|558989967|FG001|Overall Study|Withdrawal by Subject|2|||
154880903|NCT02669862|558989968|FG002|Overall Study|Withdrawal by Subject|3|||
154880904|NCT02669862|558989966|FG000|Overall Study|moved|0|||
154880905|NCT02669862|558989967|FG001|Overall Study|moved|1|||
154880906|NCT02669862|558989968|FG002|Overall Study|moved|0|||
154880907|NCT02669862|558989966|FG000|Overall Study|Protocol Violation|0|||
154880908|NCT02669862|558989967|FG001|Overall Study|Protocol Violation|0|||
154880909|NCT02669862|558989968|FG002|Overall Study|Protocol Violation|1|||
154880910|NCT00311181|558989969|FG000|Overall Study|Final DFTs were not obtained|96|||
154880911|NCT02294318|558989970|FG000|Overall Study|Worsening of drinking|3|||
154880912|NCT02294318|558989971|FG001|Overall Study|Worsening of drinking|0|||
154880913|NCT02294318|558989970|FG000|Overall Study|Not exposed to intervention|0|||
154880914|NCT02294318|558989971|FG001|Overall Study|Not exposed to intervention|2|||
154880915|NCT00506948|558989976|FG000|Overall Study|Death|4|||
154880916|NCT00506948|558989976|FG000|Overall Study|Adverse Event|5|||
154880917|NCT00506948|558989976|FG000|Overall Study|Physician Decision|1|||
154880918|NCT02395653|558989977|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
154880919|NCT02395653|558989977|FG000|Overall Study|Consent Withdrawn at Screening|1|||
154880920|NCT02395653|558989977|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
154880921|NCT02395653|558989977|FG000|Overall Study|Investigator Decision at Screening|1|||
154880922|NCT02395653|558989977|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
154974960|NCT00848042|559333784|FG001|Overall Study|Other Therapy|0|||
154974961|NCT00848042|559333785|FG002|Overall Study|Other Therapy|0|||
154974962|NCT02744755|559333786|FG000|Study Period 1|Protocol Violation|2|||
154974963|NCT02744755|559333787|FG001|Study Period 1|Protocol Violation|1|||
154974964|NCT02744755|559333786|FG000|Study Period 1|not defined|0|||
154974965|NCT02744755|559333787|FG001|Study Period 1|not defined|1|||
154974966|NCT02744755|559333786|FG000|Study Period 1|Pregnancy|1|||
154974967|NCT02744755|559333787|FG001|Study Period 1|Pregnancy|0|||
154974968|NCT02744755|559333786|FG000|Study Period 1|Adverse Event|1|||
154974969|NCT02744755|559333787|FG001|Study Period 1|Adverse Event|1|||
154974970|NCT02744755|559333786|FG000|Study Period 1|Lost to Follow-up|1|||
154974971|NCT02744755|559333787|FG001|Study Period 1|Lost to Follow-up|1|||
154974972|NCT02744755|559333786|FG000|Study Period 1|Lack of Efficacy|1|||
154974973|NCT02744755|559333787|FG001|Study Period 1|Lack of Efficacy|0|||
154974974|NCT02744755|559333786|FG000|Study Period 1|Withdrawal by Subject|8|||
154974975|NCT02744755|559333787|FG001|Study Period 1|Withdrawal by Subject|4|||
154974976|NCT02744755|559333786|FG000|Study Period 2|Adverse Event|5|||
154974977|NCT02744755|559333787|FG001|Study Period 2|Adverse Event|0|||
154974978|NCT02744755|559333786|FG000|Study Period 2|Protocol Violation|1|||
154974979|NCT02744755|559333787|FG001|Study Period 2|Protocol Violation|0|||
154974980|NCT02744755|559333786|FG000|Study Period 2|not defined|3|||
154974981|NCT02744755|559333787|FG001|Study Period 2|not defined|2|||
154974982|NCT02744755|559333786|FG000|Study Period 2|Lost to Follow-up|0|||
154974983|NCT02744755|559333787|FG001|Study Period 2|Lost to Follow-up|2|||
154974984|NCT02744755|559333786|FG000|Study Period 2|Withdrawal by Subject|2|||
154974985|NCT02744755|559333787|FG001|Study Period 2|Withdrawal by Subject|2|||
154974986|NCT02744755|559333786|FG000|Study Period 2|Lack of Efficacy|3|||
154880923|NCT02395653|558989977|FG000|Overall Study|Withdrawal by Subject|1|||
154880924|NCT02395653|558989977|FG000|Overall Study|Lost to Follow-up|1|||
154880925|NCT01194804|558989978|FG000|Overall Study|Withdrawal by Subject|1|||
154880926|NCT02670915|558989979|FG000|Overall Study|Withdrawal by Subject|0|||
154880927|NCT02670915|558989980|FG001|Overall Study|Withdrawal by Subject|1|||
154974987|NCT02744755|559333787|FG001|Study Period 2|Lack of Efficacy|2|||
154974988|NCT00809965|559333788|FG000|Overall Study|Death|194|||
154974989|NCT00809965|559333789|FG001|Overall Study|Death|147|||
154974990|NCT00809965|559333790|FG002|Overall Study|Death|196|||
154880928|NCT02670915|558989981|FG002|Overall Study|Withdrawal by Subject|4|||
154880929|NCT02670915|558989979|FG000|Overall Study|Withdrawal by parent/guardian|4|||
154880930|NCT02670915|558989980|FG001|Overall Study|Withdrawal by parent/guardian|4|||
154974991|NCT00809965|559333788|FG000|Overall Study|Lost to Follow-up|17|||
154974992|NCT00809965|559333789|FG001|Overall Study|Lost to Follow-up|10|||
154974993|NCT00809965|559333790|FG002|Overall Study|Lost to Follow-up|18|||
154974994|NCT00809965|559333788|FG000|Overall Study|Withdrawal by Subject|405|||
154974995|NCT00809965|559333789|FG001|Overall Study|Withdrawal by Subject|448|||
154974996|NCT00809965|559333790|FG002|Overall Study|Withdrawal by Subject|441|||
154974997|NCT00809965|559333788|FG000|Overall Study|Other Reason|167|||
154974998|NCT00809965|559333789|FG001|Overall Study|Other Reason|170|||
154974999|NCT00809965|559333790|FG002|Overall Study|Other Reason|189|||
154975000|NCT02780167|559333791|FG000|Overall Study|Adverse Event|9|||
154975001|NCT02780167|559333792|FG001|Overall Study|Adverse Event|8|||
154975002|NCT02780167|559333793|FG002|Overall Study|Adverse Event|8|||
154975003|NCT02780167|559333794|FG003|Overall Study|Adverse Event|12|||
154975004|NCT02780167|559333795|FG004|Overall Study|Adverse Event|8|||
154975005|NCT02780167|559333791|FG000|Overall Study|Lack of Efficacy|6|||
154975006|NCT02780167|559333792|FG001|Overall Study|Lack of Efficacy|5|||
154975007|NCT02780167|559333793|FG002|Overall Study|Lack of Efficacy|6|||
154975008|NCT02780167|559333794|FG003|Overall Study|Lack of Efficacy|1|||
154975009|NCT02780167|559333795|FG004|Overall Study|Lack of Efficacy|0|||
154975010|NCT02780167|559333791|FG000|Overall Study|Lost to Follow-up|2|||
154975011|NCT02780167|559333792|FG001|Overall Study|Lost to Follow-up|0|||
154975012|NCT02780167|559333793|FG002|Overall Study|Lost to Follow-up|1|||
154975013|NCT02780167|559333794|FG003|Overall Study|Lost to Follow-up|0|||
154975014|NCT02780167|559333795|FG004|Overall Study|Lost to Follow-up|0|||
154975015|NCT02780167|559333791|FG000|Overall Study|Does not meet entrance criteria|0|||
154975016|NCT02780167|559333792|FG001|Overall Study|Does not meet entrance criteria|0|||
154975017|NCT02780167|559333793|FG002|Overall Study|Does not meet entrance criteria|1|||
154975018|NCT02780167|559333794|FG003|Overall Study|Does not meet entrance criteria|0|||
154975019|NCT02780167|559333795|FG004|Overall Study|Does not meet entrance criteria|0|||
154975020|NCT02780167|559333791|FG000|Overall Study|No longer meets eligibility criteria|0|||
154975021|NCT02780167|559333792|FG001|Overall Study|No longer meets eligibility criteria|0|||
154975022|NCT02780167|559333793|FG002|Overall Study|No longer meets eligibility criteria|0|||
154975023|NCT02780167|559333794|FG003|Overall Study|No longer meets eligibility criteria|1|||
154975024|NCT02780167|559333795|FG004|Overall Study|No longer meets eligibility criteria|1|||
154975025|NCT02780167|559333791|FG000|Overall Study|Protocol Violation|5|||
154975026|NCT02780167|559333792|FG001|Overall Study|Protocol Violation|5|||
154975027|NCT02780167|559333793|FG002|Overall Study|Protocol Violation|1|||
154975028|NCT02780167|559333794|FG003|Overall Study|Protocol Violation|1|||
154975029|NCT02780167|559333795|FG004|Overall Study|Protocol Violation|2|||
154975030|NCT02780167|559333791|FG000|Overall Study|Withdrawal by Subject|6|||
154975031|NCT02780167|559333792|FG001|Overall Study|Withdrawal by Subject|4|||
154975032|NCT02780167|559333793|FG002|Overall Study|Withdrawal by Subject|4|||
154975033|NCT02780167|559333794|FG003|Overall Study|Withdrawal by Subject|3|||
154975034|NCT02780167|559333795|FG004|Overall Study|Withdrawal by Subject|4|||
154880931|NCT02670915|558989981|FG002|Overall Study|Withdrawal by parent/guardian|1|||
154880932|NCT02670915|558989979|FG000|Overall Study|Unclassified|0|||
154880933|NCT02670915|558989980|FG001|Overall Study|Unclassified|3|||
154880934|NCT02670915|558989981|FG002|Overall Study|Unclassified|0|||
154880935|NCT00818207|558989982|FG000|Overall Study|Adverse Event|6|||
154880936|NCT00818207|558989983|FG001|Overall Study|Adverse Event|0|||
154880937|NCT00818207|558989982|FG000|Overall Study|Lost to Follow-up|160|||
154880938|NCT00818207|558989983|FG001|Overall Study|Lost to Follow-up|146|||
154880939|NCT00818207|558989982|FG000|Overall Study|Multiple reasons|11|||
154880940|NCT00818207|558989983|FG001|Overall Study|Multiple reasons|12|||
154880941|NCT00818207|558989982|FG000|Overall Study|Withdrawal by Subject|42|||
154880942|NCT00818207|558989983|FG001|Overall Study|Withdrawal by Subject|104|||
154880943|NCT00818207|558989982|FG000|Overall Study|Death|3|||
154880944|NCT00818207|558989983|FG001|Overall Study|Death|5|||
154880945|NCT02616185|558989984|FG000|Overall Study|Death|0|||
154880946|NCT02616185|558989985|FG001|Overall Study|Death|0|||
154880947|NCT02616185|558989986|FG002|Overall Study|Death|0|||
154975035|NCT02780167|559333791|FG000|Overall Study|Other|0|||
154975036|NCT02780167|559333792|FG001|Overall Study|Other|0|||
154975037|NCT02780167|559333793|FG002|Overall Study|Other|3|||
154975038|NCT02780167|559333794|FG003|Overall Study|Other|1|||
154975039|NCT02780167|559333795|FG004|Overall Study|Other|2|||
154975040|NCT02315066|559333797|FG000|Overall Study|Lost to Follow-up|0|||
154975041|NCT02315066|559333798|FG001|Overall Study|Lost to Follow-up|1|||
154975042|NCT02315066|559333799|FG002|Overall Study|Lost to Follow-up|1|||
154975043|NCT02315066|559333800|FG003|Overall Study|Lost to Follow-up|0|||
155113512|NCT02039219|559844807|FG001|Treatment|Protocol Violation|0|||
154975044|NCT02315066|559333801|FG004|Overall Study|Lost to Follow-up|1|||
154975045|NCT02315066|559333802|FG005|Overall Study|Lost to Follow-up|0|||
154975046|NCT02315066|559333803|FG006|Overall Study|Lost to Follow-up|2|||
154975047|NCT02315066|559333804|FG007|Overall Study|Lost to Follow-up|1|||
154975048|NCT02315066|559333805|FG008|Overall Study|Lost to Follow-up|0|||
154880948|NCT02616185|558989987|FG003|Overall Study|Death|1|||
154880949|NCT02616185|558989988|FG004|Overall Study|Death|2|||
154880950|NCT02616185|558989989|FG005|Overall Study|Death|0|||
154880951|NCT02616185|558989990|FG006|Overall Study|Death|0|||
155113513|NCT02039219|559844806|FG000|Treatment|Death|1|||
154880952|NCT02616185|558989991|FG007|Overall Study|Death|2|||
154880953|NCT02616185|558989992|FG008|Overall Study|Death|1|||
154880954|NCT02616185|558989984|FG000|Overall Study|Study terminated by sponsor|0|||
154880955|NCT02616185|558989985|FG001|Overall Study|Study terminated by sponsor|0|||
154880956|NCT02616185|558989986|FG002|Overall Study|Study terminated by sponsor|1|||
154880957|NCT02616185|558989987|FG003|Overall Study|Study terminated by sponsor|0|||
154880958|NCT02616185|558989988|FG004|Overall Study|Study terminated by sponsor|0|||
154880959|NCT02616185|558989989|FG005|Overall Study|Study terminated by sponsor|0|||
154880960|NCT02616185|558989990|FG006|Overall Study|Study terminated by sponsor|5|||
154880961|NCT02616185|558989991|FG007|Overall Study|Study terminated by sponsor|2|||
154880962|NCT02616185|558989992|FG008|Overall Study|Study terminated by sponsor|0|||
154880963|NCT02616185|558989984|FG000|Overall Study|Participant refused further follow-up|1|||
154880964|NCT02616185|558989985|FG001|Overall Study|Participant refused further follow-up|1|||
154880965|NCT02616185|558989986|FG002|Overall Study|Participant refused further follow-up|2|||
154880966|NCT02616185|558989987|FG003|Overall Study|Participant refused further follow-up|3|||
154880967|NCT02616185|558989988|FG004|Overall Study|Participant refused further follow-up|4|||
154880968|NCT02616185|558989989|FG005|Overall Study|Participant refused further follow-up|0|||
154880969|NCT02616185|558989990|FG006|Overall Study|Participant refused further follow-up|3|||
154880970|NCT02616185|558989991|FG007|Overall Study|Participant refused further follow-up|4|||
154880971|NCT02616185|558989992|FG008|Overall Study|Participant refused further follow-up|3|||
154880972|NCT02616185|558989984|FG000|Overall Study|Not reported|0|||
154880973|NCT02616185|558989985|FG001|Overall Study|Not reported|0|||
154880974|NCT02616185|558989986|FG002|Overall Study|Not reported|0|||
154880975|NCT02616185|558989987|FG003|Overall Study|Not reported|1|||
154880976|NCT02616185|558989988|FG004|Overall Study|Not reported|3|||
154880977|NCT02616185|558989989|FG005|Overall Study|Not reported|1|||
154880978|NCT02616185|558989990|FG006|Overall Study|Not reported|0|||
154880979|NCT02616185|558989991|FG007|Overall Study|Not reported|5|||
154880980|NCT02616185|558989992|FG008|Overall Study|Not reported|2|||
154880981|NCT03621943|558989993|FG000|First Randomized Intervention|Lost to Follow-up|51|||
154880982|NCT03621943|558989994|FG001|First Randomized Intervention|Lost to Follow-up|54|||
154880983|NCT03621943|558989993|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
154880984|NCT03621943|558989994|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
154880985|NCT03621943|558989993|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
154880986|NCT03621943|558989994|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
154880987|NCT03621943|558989993|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
154880988|NCT03621943|558989994|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
154880989|NCT01215734|558989995|FG000|Overall Study|Death|0|||
154880990|NCT01215734|558989996|FG001|Overall Study|Death|1|||
154880991|NCT00315705|558989997|FG000|Phase 1|Refused further treatment|1|||
154880992|NCT00315705|558989997|FG000|Phase 1|Failure to achieve response|8|||
154880993|NCT00315705|558989997|FG000|Phase 1|Disease relapse|4|||
154880994|NCT00315705|558989997|FG000|Phase 1|Scheduled for transplant|9|||
154880995|NCT00315705|558989997|FG000|Phase 1|Death|3|||
154880996|NCT00315705|558989997|FG000|Phase 2|Physician Decision|4|||
154880997|NCT00315705|558989997|FG000|Phase 2|Adverse Event|1|||
154880998|NCT00315705|558989997|FG000|Phase 2|Failure to achieve response|3|||
154880999|NCT00315705|558989997|FG000|Phase 2|Disease relapse|1|||
154881000|NCT00315705|558989997|FG000|Phase 2|Scheduled for transplant|8|||
154881001|NCT00315705|558989997|FG000|Phase 2|Other|1|||
154881002|NCT00315705|558989997|FG000|Phase 2|Death|7|||
154881003|NCT01346371|558989998|FG000|Overall Study|Lost to Follow-up|2|||
154881004|NCT01346371|558989999|FG001|Overall Study|Lost to Follow-up|0|||
154881005|NCT00833248|558990006|FG000|Overall Study|Adverse Event|3|||
154881006|NCT00833248|558990007|FG001|Overall Study|Adverse Event|0|||
154881007|NCT00833248|558990006|FG000|Overall Study|Protocol Violation|1|||
154881008|NCT00833248|558990007|FG001|Overall Study|Protocol Violation|2|||
154881009|NCT00833248|558990006|FG000|Overall Study|Withdrawal by Subject|0|||
154881010|NCT00833248|558990007|FG001|Overall Study|Withdrawal by Subject|1|||
154881011|NCT00839423|558990008|FG000|Overall Study|Adverse Event|4|||
154881012|NCT00839423|558990009|FG001|Overall Study|Adverse Event|3|||
154881013|NCT00839423|558990010|FG002|Overall Study|Adverse Event|7|||
154881014|NCT00839423|558990011|FG003|Overall Study|Adverse Event|16|||
154881015|NCT00839423|558990008|FG000|Overall Study|Lack of Efficacy|6|||
154881016|NCT00839423|558990009|FG001|Overall Study|Lack of Efficacy|6|||
154881017|NCT00839423|558990010|FG002|Overall Study|Lack of Efficacy|3|||
154881018|NCT00839423|558990011|FG003|Overall Study|Lack of Efficacy|2|||
154881019|NCT00839423|558990008|FG000|Overall Study|Non-compliance|0|||
154881020|NCT00839423|558990009|FG001|Overall Study|Non-compliance|0|||
154881021|NCT00839423|558990010|FG002|Overall Study|Non-compliance|0|||
154881022|NCT00839423|558990011|FG003|Overall Study|Non-compliance|1|||
154881023|NCT00839423|558990008|FG000|Overall Study|Protocol Violation|0|||
154881024|NCT00839423|558990009|FG001|Overall Study|Protocol Violation|1|||
154881025|NCT00839423|558990010|FG002|Overall Study|Protocol Violation|2|||
154881026|NCT00839423|558990011|FG003|Overall Study|Protocol Violation|0|||
154881027|NCT00839423|558990008|FG000|Overall Study|Withdrawal of consent|4|||
154881028|NCT00839423|558990009|FG001|Overall Study|Withdrawal of consent|0|||
154881029|NCT00839423|558990010|FG002|Overall Study|Withdrawal of consent|4|||
154881030|NCT00839423|558990011|FG003|Overall Study|Withdrawal of consent|1|||
154881031|NCT00839423|558990008|FG000|Overall Study|Lost to Follow-up|1|||
154881032|NCT00839423|558990009|FG001|Overall Study|Lost to Follow-up|0|||
154881033|NCT00839423|558990010|FG002|Overall Study|Lost to Follow-up|1|||
154881034|NCT00839423|558990011|FG003|Overall Study|Lost to Follow-up|0|||
154881035|NCT00839423|558990008|FG000|Overall Study|Administrative or other reasons|3|||
154881036|NCT00839423|558990009|FG001|Overall Study|Administrative or other reasons|0|||
154881037|NCT00839423|558990010|FG002|Overall Study|Administrative or other reasons|1|||
154881038|NCT00839423|558990011|FG003|Overall Study|Administrative or other reasons|0|||
154881039|NCT01071096|558990012|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
154881040|NCT01071096|558990013|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
154881041|NCT02585999|558990014|FG000|Overall Study|Lost to Follow-up|1|||
154881042|NCT02585999|558990014|FG000|Overall Study|Protocol Violation|1|||
154881043|NCT01332019|558990015|FG000|Overall Study|Was Not Dosed|1|||
154881044|NCT01332019|558990016|FG001|Overall Study|Was Not Dosed|0|||
154881045|NCT01332019|558990015|FG000|Overall Study|Other|16|||
154881046|NCT01332019|558990016|FG001|Overall Study|Other|18|||
154881047|NCT01332019|558990015|FG000|Overall Study|Death|2|||
154881048|NCT01332019|558990016|FG001|Overall Study|Death|1|||
154881049|NCT01332019|558990015|FG000|Overall Study|Physician Decision|4|||
154881050|NCT01332019|558990016|FG001|Overall Study|Physician Decision|3|||
154881051|NCT01332019|558990015|FG000|Overall Study|Withdrawal by Subject|73|||
154881052|NCT01332019|558990016|FG001|Overall Study|Withdrawal by Subject|71|||
154881053|NCT01332019|558990015|FG000|Overall Study|Lost to Follow-up|4|||
154881054|NCT01332019|558990016|FG001|Overall Study|Lost to Follow-up|7|||
154881055|NCT01332019|558990015|FG000|Overall Study|Adverse Event|13|||
154881056|NCT01332019|558990016|FG001|Overall Study|Adverse Event|22|||
154881057|NCT01369849|558990019|FG000|Overall Study|Ineligible prior to treatment|0|||
154881058|NCT01369849|558990020|FG001|Overall Study|Ineligible prior to treatment|0|||
154881059|NCT01369849|558990021|FG002|Overall Study|Ineligible prior to treatment|1|||
154881060|NCT01369849|558990019|FG000|Overall Study|Ineligible after receiving treatment|0|||
154881061|NCT01369849|558990020|FG001|Overall Study|Ineligible after receiving treatment|1|||
154881062|NCT01369849|558990021|FG002|Overall Study|Ineligible after receiving treatment|0|||
154881063|NCT00871377|558990022|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
154881064|NCT00871377|558990023|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
154881065|NCT00871377|558990024|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
154881066|NCT00871377|558990025|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
154881067|NCT00871377|558990026|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
154881068|NCT00871377|558990027|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
154881069|NCT00871377|558990022|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
154881070|NCT00871377|558990023|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
154975049|NCT02315066|559333806|FG009|Overall Study|Lost to Follow-up|0|||
154975050|NCT02315066|559333807|FG010|Overall Study|Lost to Follow-up|1|||
154975051|NCT02315066|559333808|FG011|Overall Study|Lost to Follow-up|2|||
154975052|NCT02315066|559333809|FG012|Overall Study|Lost to Follow-up|0|||
154975053|NCT02315066|559333810|FG013|Overall Study|Lost to Follow-up|4|||
154975054|NCT02315066|559333797|FG000|Overall Study|Death|2|||
154975055|NCT02315066|559333798|FG001|Overall Study|Death|7|||
154975056|NCT02315066|559333799|FG002|Overall Study|Death|6|||
154975057|NCT02315066|559333800|FG003|Overall Study|Death|11|||
154975058|NCT02315066|559333801|FG004|Overall Study|Death|10|||
154975059|NCT02315066|559333802|FG005|Overall Study|Death|3|||
154975060|NCT02315066|559333803|FG006|Overall Study|Death|9|||
154975061|NCT02315066|559333804|FG007|Overall Study|Death|9|||
154975062|NCT02315066|559333805|FG008|Overall Study|Death|10|||
154975063|NCT02315066|559333806|FG009|Overall Study|Death|8|||
154975064|NCT02315066|559333807|FG010|Overall Study|Death|10|||
154975065|NCT02315066|559333808|FG011|Overall Study|Death|7|||
154975066|NCT02315066|559333809|FG012|Overall Study|Death|8|||
154975067|NCT02315066|559333810|FG013|Overall Study|Death|21|||
154975068|NCT02315066|559333797|FG000|Overall Study|Other|0|||
154975069|NCT02315066|559333798|FG001|Overall Study|Other|0|||
155113514|NCT02039219|559844807|FG001|Treatment|Death|0|||
155113515|NCT02039219|559844806|FG000|Follow up|Adverse Event|0|||
154975070|NCT02315066|559333799|FG002|Overall Study|Other|0|||
155113516|NCT02039219|559844807|FG001|Follow up|Adverse Event|1|||
154975071|NCT02315066|559333800|FG003|Overall Study|Other|0|||
154975072|NCT02315066|559333801|FG004|Overall Study|Other|0|||
154975073|NCT02315066|559333802|FG005|Overall Study|Other|0|||
154881071|NCT00871377|558990024|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
154881072|NCT00871377|558990025|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
154881073|NCT00871377|558990026|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
154975074|NCT02315066|559333803|FG006|Overall Study|Other|0|||
154975075|NCT02315066|559333804|FG007|Overall Study|Other|1|||
154975076|NCT02315066|559333805|FG008|Overall Study|Other|1|||
155113517|NCT02226562|559844808|FG000|Overall Study|Lost to Follow-up|0|||
154975077|NCT02315066|559333806|FG009|Overall Study|Other|2|||
154975078|NCT02315066|559333807|FG010|Overall Study|Other|0|||
154881074|NCT00871377|558990027|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
154881075|NCT00871377|558990022|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
154881076|NCT00871377|558990023|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881077|NCT00871377|558990024|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881078|NCT00871377|558990025|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881079|NCT00871377|558990026|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881080|NCT00871377|558990027|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881081|NCT00871377|558990022|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881082|NCT00871377|558990023|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881083|NCT00871377|558990024|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881084|NCT00871377|558990025|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881085|NCT00871377|558990026|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
154881086|NCT00871377|558990027|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
154881087|NCT00871377|558990022|FG000|Third Intervention (10 Weeks)|Death|0|||
154881088|NCT00871377|558990023|FG001|Third Intervention (10 Weeks)|Death|0|||
154881089|NCT00871377|558990024|FG002|Third Intervention (10 Weeks)|Death|0|||
154881090|NCT00871377|558990025|FG003|Third Intervention (10 Weeks)|Death|1|||
154881091|NCT00871377|558990026|FG004|Third Intervention (10 Weeks)|Death|0|||
154881092|NCT00871377|558990027|FG005|Third Intervention (10 Weeks)|Death|0|||
154881093|NCT04281030|558990028|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
154881094|NCT04281030|558990029|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
154881095|NCT04281030|558990028|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
154881096|NCT04281030|558990029|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
154881097|NCT00288860|558990034|FG000|Overall Study|Did not complete intake|4|||
154881098|NCT00288860|558990035|FG001|Overall Study|Did not complete intake|8|||
154881099|NCT00288860|558990034|FG000|Overall Study|Death|4|||
154881100|NCT00288860|558990035|FG001|Overall Study|Death|3|||
154881101|NCT00288860|558990034|FG000|Overall Study|Withdrawal by Subject|20|||
154881102|NCT00288860|558990035|FG001|Overall Study|Withdrawal by Subject|15|||
154881103|NCT00288860|558990034|FG000|Overall Study|Lost to Follow-up|74|||
154881104|NCT00288860|558990035|FG001|Overall Study|Lost to Follow-up|71|||
154881105|NCT05142332|558990036|FG000|Overall Study|Withdrawal by Subject|0|||
154881106|NCT05142332|558990037|FG001|Overall Study|Withdrawal by Subject|1|||
154881107|NCT05142332|558990038|FG002|Overall Study|Withdrawal by Subject|2|||
154881108|NCT05142332|558990039|FG003|Overall Study|Withdrawal by Subject|0|||
154881109|NCT05142332|558990040|FG004|Overall Study|Withdrawal by Subject|0|||
154881110|NCT05142332|558990041|FG005|Overall Study|Withdrawal by Subject|2|||
154881111|NCT05142332|558990042|FG006|Overall Study|Withdrawal by Subject|6|||
154881112|NCT05142332|558990036|FG000|Overall Study|Left ED|3|||
154881113|NCT05142332|558990037|FG001|Overall Study|Left ED|0|||
154881114|NCT05142332|558990038|FG002|Overall Study|Left ED|4|||
154881115|NCT05142332|558990039|FG003|Overall Study|Left ED|6|||
154881116|NCT05142332|558990040|FG004|Overall Study|Left ED|1|||
154881117|NCT05142332|558990041|FG005|Overall Study|Left ED|2|||
154881118|NCT05142332|558990042|FG006|Overall Study|Left ED|6|||
154881119|NCT05142332|558990036|FG000|Overall Study|Physician Decision|0|||
154881120|NCT05142332|558990037|FG001|Overall Study|Physician Decision|0|||
154881121|NCT05142332|558990038|FG002|Overall Study|Physician Decision|2|||
154881122|NCT05142332|558990039|FG003|Overall Study|Physician Decision|1|||
154881123|NCT05142332|558990040|FG004|Overall Study|Physician Decision|0|||
154881124|NCT05142332|558990041|FG005|Overall Study|Physician Decision|0|||
154881125|NCT05142332|558990042|FG006|Overall Study|Physician Decision|3|||
154881126|NCT05142332|558990036|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
154881127|NCT05142332|558990037|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
154881128|NCT05142332|558990038|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
154881129|NCT05142332|558990039|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
154881130|NCT05142332|558990040|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
154881131|NCT05142332|558990041|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
154881132|NCT05142332|558990042|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
154881133|NCT02116660|558990043|FG000|Overall Study|Deteriorating renal function|0|||
154881134|NCT02116660|558990044|FG001|Overall Study|Deteriorating renal function|1|||
154881135|NCT02116660|558990043|FG000|Overall Study|Adverse Event|1|||
154881136|NCT02116660|558990044|FG001|Overall Study|Adverse Event|1|||
154881137|NCT02116660|558990043|FG000|Overall Study|Withdrawal by Subject|0|||
154881138|NCT02116660|558990044|FG001|Overall Study|Withdrawal by Subject|2|||
154881139|NCT02116660|558990043|FG000|Overall Study|Organization reason|1|||
154881140|NCT02116660|558990044|FG001|Overall Study|Organization reason|0|||
154881141|NCT01718509|558990045|FG000|Overall Study|Lost to Follow-up|18|||
154881142|NCT01718509|558990046|FG001|Overall Study|Lost to Follow-up|15|||
154881143|NCT01718509|558990045|FG000|Overall Study|Withdrawal by Subject|7|||
154881144|NCT01718509|558990046|FG001|Overall Study|Withdrawal by Subject|13|||
154881145|NCT01718509|558990045|FG000|Overall Study|Adverse Event|5|||
154881146|NCT01718509|558990046|FG001|Overall Study|Adverse Event|7|||
154881147|NCT01718509|558990045|FG000|Overall Study|Other|13|||
154881148|NCT01718509|558990046|FG001|Overall Study|Other|11|||
154881149|NCT01718509|558990045|FG000|Overall Study|Protocol Violation|4|||
154881150|NCT01718509|558990046|FG001|Overall Study|Protocol Violation|2|||
154881151|NCT01718509|558990045|FG000|Overall Study|Lack of Efficacy|1|||
154881152|NCT01718509|558990046|FG001|Overall Study|Lack of Efficacy|0|||
154881153|NCT00411788|558990049|FG000|Overall Study|Protocol Violation|1|||
154881154|NCT00411788|558990049|FG000|Overall Study|Adverse Event|1|||
154881155|NCT00390416|558990050|FG000|Overall Study|Withdrawal by Subject|1|||
154881156|NCT00390416|558990050|FG000|Overall Study|Not treated|3|||
154881157|NCT01219959|558990051|FG000|Overall Study|Adverse Event|6|||
154881158|NCT01219959|558990052|FG001|Overall Study|Adverse Event|14|||
154881159|NCT01219959|558990051|FG000|Overall Study|Physician Decision|0|||
154881160|NCT01219959|558990052|FG001|Overall Study|Physician Decision|4|||
154881161|NCT01219959|558990051|FG000|Overall Study|Withdrawal by Subject|0|||
154881162|NCT01219959|558990052|FG001|Overall Study|Withdrawal by Subject|2|||
154881163|NCT01219959|558990051|FG000|Overall Study|Renal Transplantation|0|||
154881164|NCT01219959|558990052|FG001|Overall Study|Renal Transplantation|3|||
154881165|NCT01219959|558990051|FG000|Overall Study|Other|1|||
154881166|NCT01219959|558990052|FG001|Overall Study|Other|0|||
154881167|NCT01728584|558990053|FG000|Overall Study|Adverse Event|1|||
154881168|NCT01728584|558990054|FG001|Overall Study|Adverse Event|0|||
154881169|NCT01728584|558990055|FG002|Overall Study|Adverse Event|0|||
154881170|NCT01728584|558990056|FG003|Overall Study|Adverse Event|0|||
154881171|NCT01728584|558990053|FG000|Overall Study|Physician Decision|4|||
154881172|NCT01728584|558990054|FG001|Overall Study|Physician Decision|0|||
154881173|NCT01728584|558990055|FG002|Overall Study|Physician Decision|1|||
154881174|NCT01728584|558990056|FG003|Overall Study|Physician Decision|0|||
154881175|NCT01728584|558990053|FG000|Overall Study|Withdrawal by Subject|1|||
154881176|NCT01728584|558990054|FG001|Overall Study|Withdrawal by Subject|0|||
154881177|NCT01728584|558990055|FG002|Overall Study|Withdrawal by Subject|0|||
154881178|NCT01728584|558990056|FG003|Overall Study|Withdrawal by Subject|0|||
154881179|NCT01728584|558990053|FG000|Overall Study|Screen failure|1|||
154881180|NCT01728584|558990054|FG001|Overall Study|Screen failure|0|||
154881181|NCT01728584|558990055|FG002|Overall Study|Screen failure|0|||
154881182|NCT01728584|558990056|FG003|Overall Study|Screen failure|0|||
154881183|NCT01728584|558990053|FG000|Overall Study|Other reason (not specified)|1|||
154881184|NCT01728584|558990054|FG001|Overall Study|Other reason (not specified)|0|||
154881185|NCT01728584|558990055|FG002|Overall Study|Other reason (not specified)|0|||
154881186|NCT01728584|558990056|FG003|Overall Study|Other reason (not specified)|1|||
154881187|NCT01409031|558990062|FG000|Overall Study|transferred to other hosp|1|||
154881188|NCT01409031|558990063|FG001|Overall Study|transferred to other hosp|0|||
154881189|NCT00471536|558990068|FG000|Overall Study|Withdrawal by Subject|1|||
154881190|NCT02651194|558990069|FG000|Overall Study|Lost to Follow-up|3|||
154881191|NCT02651194|558990069|FG000|Overall Study|Other|2|||
154881192|NCT01980706|558990070|FG000|Overall Study|Withdrawal by Subject|9|||
154881193|NCT01980706|558990071|FG001|Overall Study|Withdrawal by Subject|6|||
154881194|NCT01980706|558990072|FG002|Overall Study|Withdrawal by Subject|2|||
154881195|NCT01980706|558990070|FG000|Overall Study|Adverse Event|1|||
154881196|NCT01980706|558990071|FG001|Overall Study|Adverse Event|2|||
154881197|NCT01980706|558990072|FG002|Overall Study|Adverse Event|5|||
154881198|NCT01980706|558990070|FG000|Overall Study|Lost to Follow-up|3|||
154881199|NCT01980706|558990071|FG001|Overall Study|Lost to Follow-up|4|||
154881200|NCT01980706|558990072|FG002|Overall Study|Lost to Follow-up|3|||
154881201|NCT01980706|558990070|FG000|Overall Study|miscellaneous|4|||
154881202|NCT01980706|558990071|FG001|Overall Study|miscellaneous|5|||
154881203|NCT01980706|558990072|FG002|Overall Study|miscellaneous|3|||
154881204|NCT02546674|558990075|FG000|Overall Study|Adverse Event|19|||
154881205|NCT02546674|558990075|FG000|Overall Study|Death|1|||
154881206|NCT02546674|558990075|FG000|Overall Study|Lost to Follow-up|1|||
154881207|NCT02546674|558990075|FG000|Overall Study|Physician Decision|13|||
154881208|NCT02546674|558990075|FG000|Overall Study|Pregnancy|1|||
154881209|NCT02546674|558990075|FG000|Overall Study|Progressive Disease|2|||
154881210|NCT02546674|558990075|FG000|Overall Study|Protocol Deviation|2|||
154881211|NCT02546674|558990075|FG000|Overall Study|Subject/Guardian Decision|6|||
154881212|NCT02546674|558990075|FG000|Overall Study|Withdrawal of Informed Consent|3|||
154975079|NCT02315066|559333808|FG011|Overall Study|Other|0|||
154975080|NCT02315066|559333809|FG012|Overall Study|Other|0|||
154881213|NCT01094730|558990078|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
154881214|NCT01094730|558990079|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
154881215|NCT01094730|558990078|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
154881216|NCT01094730|558990079|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
154881217|NCT01094730|558990078|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
154881218|NCT01094730|558990079|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
154881219|NCT01094730|558990078|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
154881220|NCT01094730|558990079|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
154881221|NCT01094730|558990078|FG000|Period 2 (14 Days)|Protocol Violation|2|||
154881222|NCT01094730|558990079|FG001|Period 2 (14 Days)|Protocol Violation|0|||
154881223|NCT01094730|558990078|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
154881224|NCT01094730|558990079|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
154881225|NCT01094730|558990078|FG000|Period 2 (14 Days)|Adverse Event|0|||
154881226|NCT01094730|558990079|FG001|Period 2 (14 Days)|Adverse Event|1|||
154881227|NCT01094730|558990078|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
154881228|NCT01094730|558990079|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
154881229|NCT01864018|558990082|FG000|Overall Study|Ineligible|3|||
154881230|NCT01864018|558990083|FG001|Overall Study|Ineligible|1|||
154881231|NCT02512068|558990085|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
154881232|NCT02512068|558990086|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
154881233|NCT02512068|558990085|FG000|Overall Study|Major Protocol Deviation|1|||
154881234|NCT02512068|558990086|FG001|Overall Study|Major Protocol Deviation|0|||
154881235|NCT02512068|558990085|FG000|Overall Study|Voluntary Withdrawal|0|||
154881236|NCT02512068|558990086|FG001|Overall Study|Voluntary Withdrawal|1|||
154881237|NCT02512068|558990085|FG000|Overall Study|Lack of Efficacy|0|||
154881238|NCT02512068|558990086|FG001|Overall Study|Lack of Efficacy|1|||
154881239|NCT02512068|558990085|FG000|Overall Study|Reason Not Specified|3|||
154881240|NCT02512068|558990086|FG001|Overall Study|Reason Not Specified|5|||
154881241|NCT01798706|558990087|FG000|Overall Study|Adverse Event|15|||
154881242|NCT01798706|558990088|FG001|Overall Study|Adverse Event|10|||
154881243|NCT01798706|558990087|FG000|Overall Study|Lack of Efficacy|0|||
154881244|NCT01798706|558990088|FG001|Overall Study|Lack of Efficacy|2|||
154881245|NCT01798706|558990087|FG000|Overall Study|Poor compliance to protocol|1|||
154881246|NCT01798706|558990088|FG001|Overall Study|Poor compliance to protocol|0|||
154881247|NCT01798706|558990087|FG000|Overall Study|Other than specified above|5|||
154881248|NCT01798706|558990088|FG001|Overall Study|Other than specified above|9|||
154881249|NCT05896761|558990089|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
154881250|NCT05896761|558990090|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
154881251|NCT05896761|558990089|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
154881252|NCT05896761|558990090|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
154881253|NCT02739594|558990095|FG000|Overall Study|Undesired Event|3|||
154881254|NCT02739594|558990096|FG001|Overall Study|Undesired Event|4|||
154881255|NCT02739594|558990095|FG000|Overall Study|Violation of Eligibility Criteria|1|||
154881256|NCT02739594|558990096|FG001|Overall Study|Violation of Eligibility Criteria|2|||
154881257|NCT02739594|558990095|FG000|Overall Study|Protocol Violation|5|||
154881258|NCT02739594|558990096|FG001|Overall Study|Protocol Violation|6|||
154881259|NCT02739594|558990095|FG000|Overall Study|Death|4|||
154881260|NCT02739594|558990096|FG001|Overall Study|Death|2|||
154881261|NCT02739594|558990095|FG000|Overall Study|Renal Insufficiency|4|||
154881262|NCT02739594|558990096|FG001|Overall Study|Renal Insufficiency|6|||
154881263|NCT02739594|558990095|FG000|Overall Study|Administrative Reasons|1|||
154881264|NCT02739594|558990096|FG001|Overall Study|Administrative Reasons|3|||
154881265|NCT02739594|558990095|FG000|Overall Study|Withdrawal by Subject|1|||
154881266|NCT02739594|558990096|FG001|Overall Study|Withdrawal by Subject|1|||
154881267|NCT02739594|558990095|FG000|Overall Study|Lost to Follow-up|0|||
154881268|NCT02739594|558990096|FG001|Overall Study|Lost to Follow-up|1|||
154881269|NCT02739594|558990095|FG000|Overall Study|Elevated Serum Creatinine|0|||
154881270|NCT02739594|558990096|FG001|Overall Study|Elevated Serum Creatinine|1|||
154881271|NCT02739594|558990095|FG000|Overall Study|Other|6|||
154881272|NCT02739594|558990096|FG001|Overall Study|Other|2|||
154881273|NCT00527111|558990097|FG000|Overall Study|Adverse Event|14|||
154881274|NCT00527111|558990098|FG001|Overall Study|Adverse Event|13|||
154881275|NCT00527111|558990097|FG000|Overall Study|Death|0|||
154881276|NCT00527111|558990098|FG001|Overall Study|Death|1|||
154881277|NCT00527111|558990097|FG000|Overall Study|Investigator Request|2|||
154881278|NCT00527111|558990098|FG001|Overall Study|Investigator Request|1|||
154881279|NCT00527111|558990097|FG000|Overall Study|Patient Request|2|||
154881280|NCT00527111|558990098|FG001|Overall Study|Patient Request|5|||
154881281|NCT00527111|558990097|FG000|Overall Study|Other|2|||
154881282|NCT00527111|558990098|FG001|Overall Study|Other|2|||
154881283|NCT00952289|558990101|FG000|All Participants|Death|9|||
154881284|NCT00952289|558990102|FG001|All Participants|Death|9|||
154881285|NCT00952289|558990101|FG000|All Participants|Adverse Event|8|||
154881286|NCT00952289|558990102|FG001|All Participants|Adverse Event|8|||
154881287|NCT00952289|558990101|FG000|All Participants|Disease progression|3|||
154881288|NCT00952289|558990102|FG001|All Participants|Disease progression|12|||
154881289|NCT00952289|558990101|FG000|All Participants|Withdrawal by Subject|1|||
154881290|NCT00952289|558990102|FG001|All Participants|Withdrawal by Subject|10|||
154881291|NCT00952289|558990101|FG000|All Participants|Data lost during site relocation|0|||
154881292|NCT00952289|558990102|FG001|All Participants|Data lost during site relocation|1|||
154881293|NCT00952289|558990101|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
154881294|NCT00952289|558990102|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
154881295|NCT00952289|558990101|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
154881296|NCT00952289|558990102|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
154881297|NCT00952289|558990101|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
154881298|NCT00952289|558990102|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
154881299|NCT00952289|558990101|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
154881300|NCT00952289|558990102|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
154881301|NCT00952289|558990101|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
154881302|NCT00952289|558990102|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
154881303|NCT03259334|558990103|FG000|Overall Study|Adverse Event|3|||
154881304|NCT03259334|558990104|FG001|Overall Study|Adverse Event|8|||
154881305|NCT03259334|558990105|FG002|Overall Study|Adverse Event|5|||
154881306|NCT03259334|558990103|FG000|Overall Study|Withdrawal by Subject|4|||
154881307|NCT03259334|558990104|FG001|Overall Study|Withdrawal by Subject|2|||
154881308|NCT03259334|558990105|FG002|Overall Study|Withdrawal by Subject|4|||
154881309|NCT03259334|558990103|FG000|Overall Study|Physician Decision|1|||
154881310|NCT03259334|558990104|FG001|Overall Study|Physician Decision|0|||
154881311|NCT03259334|558990105|FG002|Overall Study|Physician Decision|0|||
154881312|NCT03259334|558990103|FG000|Overall Study|Lost to Follow-up|0|||
154881313|NCT03259334|558990104|FG001|Overall Study|Lost to Follow-up|2|||
154881314|NCT03259334|558990105|FG002|Overall Study|Lost to Follow-up|1|||
154881315|NCT03259334|558990103|FG000|Overall Study|Protocol Deviation|0|||
154881316|NCT03259334|558990104|FG001|Overall Study|Protocol Deviation|3|||
154881317|NCT03259334|558990105|FG002|Overall Study|Protocol Deviation|2|||
154881318|NCT03259334|558990103|FG000|Overall Study|Lack of Efficacy|2|||
154881319|NCT03259334|558990104|FG001|Overall Study|Lack of Efficacy|0|||
154881320|NCT03259334|558990105|FG002|Overall Study|Lack of Efficacy|1|||
154881321|NCT03259334|558990103|FG000|Overall Study|Randomized but never treated|0|||
154881322|NCT03259334|558990104|FG001|Overall Study|Randomized but never treated|2|||
154881323|NCT03259334|558990105|FG002|Overall Study|Randomized but never treated|0|||
154881324|NCT00777491|558990106|FG000|Overall Study|Protocol Violation|0|||
154881325|NCT00777491|558990107|FG001|Overall Study|Protocol Violation|2|||
154881326|NCT00777491|558990106|FG000|Overall Study|Did not receive any protocol treatment|2|||
154881327|NCT00777491|558990107|FG001|Overall Study|Did not receive any protocol treatment|0|||
154881328|NCT01689207|558990108|FG000|Overall Study|Adverse Event|0|||
154881329|NCT01689207|558990109|FG001|Overall Study|Adverse Event|1|||
154881330|NCT01689207|558990110|FG002|Overall Study|Adverse Event|0|||
154881331|NCT01689207|558990111|FG003|Overall Study|Adverse Event|0|||
154881332|NCT01689207|558990112|FG004|Overall Study|Adverse Event|2|||
154881333|NCT01689207|558990113|FG005|Overall Study|Adverse Event|1|||
154881334|NCT01689207|558990114|FG006|Overall Study|Adverse Event|0|||
154881335|NCT01689207|558990115|FG007|Overall Study|Adverse Event|0|||
154881336|NCT01689207|558990116|FG008|Overall Study|Adverse Event|1|||
154881337|NCT01689207|558990117|FG009|Overall Study|Adverse Event|0|||
154881338|NCT01689207|558990118|FG010|Overall Study|Adverse Event|0|||
154881339|NCT01912768|558990119|FG000|Overall Study|Adverse Event|2|||
154881340|NCT01912768|558990120|FG001|Overall Study|Adverse Event|0|||
154881341|NCT01912768|558990119|FG000|Overall Study|Lost to Follow-up|2|||
154881342|NCT01912768|558990120|FG001|Overall Study|Lost to Follow-up|1|||
154881343|NCT01912768|558990119|FG000|Overall Study|Withdrawal by Subject|5|||
154881344|NCT01912768|558990120|FG001|Overall Study|Withdrawal by Subject|3|||
154881345|NCT01912768|558990119|FG000|Overall Study|Randomized in error|1|||
154881346|NCT01912768|558990120|FG001|Overall Study|Randomized in error|0|||
154881347|NCT00524316|558990121|FG000|Overall Study|Withdrawal by Subject|2|||
154881348|NCT00524316|558990121|FG000|Overall Study|Adverse Event|7|||
154881349|NCT00524316|558990121|FG000|Overall Study|Disease Progression|7|||
154881350|NCT01199263|558990122|FG000|Overall Study|Ineligible|0|||
154881351|NCT01199263|558990123|FG001|Overall Study|Ineligible|2|||
154881352|NCT01199263|558990122|FG000|Overall Study|Never Treated|6|||
154881353|NCT01199263|558990123|FG001|Overall Study|Never Treated|0|||
154881354|NCT00488033|558990124|FG000|Overall Study|Withdrawal by Subject|1|||
154881355|NCT00488033|558990125|FG001|Overall Study|Withdrawal by Subject|0|||
154881356|NCT00444626|558990132|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
154881357|NCT00444626|558990132|FG000|Initial Treatment Period|Adverse Event|1|||
154881358|NCT00444626|558990132|FG000|Initial Treatment Period|Lost to Follow-up|9|||
154881359|NCT00008138|558990133|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
154881360|NCT00008138|558990133|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
154881361|NCT00008138|558990133|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
154881362|NCT00008138|558990133|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
154881363|NCT00008138|558990133|FG000|Interval Debulking|Withdrawal by Subject|2|||
154881364|NCT00008138|558990133|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
154881365|NCT00008138|558990133|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
154881366|NCT00008138|558990133|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
154881367|NCT01694420|558992241|FG000|Overall Study|Lost to Follow-up|3|||
154881368|NCT00762372|558992242|FG000|Overall Study|Adverse Event|1|||
154881369|NCT00762372|558992243|FG001|Overall Study|Adverse Event|0|||
154881370|NCT00762372|558992244|FG002|Overall Study|Adverse Event|0|||
154881371|NCT02494778|558992245|FG000|Overall Study|Death|3|||
154881372|NCT02494778|558992245|FG000|Overall Study|Other|173|||
154881373|NCT02494778|558992245|FG000|Overall Study|Lack of Efficacy|4|||
154881374|NCT02494778|558992245|FG000|Overall Study|Adverse Event|18|||
154881375|NCT02494778|558992245|FG000|Overall Study|Withdrawal by Subject|20|||
154881376|NCT02494778|558992245|FG000|Overall Study|Lost to Follow-up|2|||
154881377|NCT02494778|558992245|FG000|Overall Study|Noncompliant with study drug admin.|1|||
154881378|NCT01303380|558992246|FG000|Overall Study|Lack of compliance to study procedures|1|||
154881379|NCT00967226|558992247|FG000|Overall Study|Adverse Event|0|||
154881380|NCT00967226|558992248|FG001|Overall Study|Adverse Event|5|||
154881381|NCT00967226|558992247|FG000|Overall Study|Protocol Violation|2|||
154881382|NCT00967226|558992248|FG001|Overall Study|Protocol Violation|0|||
154881383|NCT00967226|558992247|FG000|Overall Study|Physician Decision|0|||
154881384|NCT00967226|558992248|FG001|Overall Study|Physician Decision|1|||
154881385|NCT02174861|558992249|FG000|Overall Study|Decision by sponsor|8|||
154881386|NCT02174861|558992249|FG000|Overall Study|Withdrawal by Subject|124|||
154881387|NCT02174861|558992249|FG000|Overall Study|Lost to Follow-up|26|||
154881388|NCT01716533|558992253|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
154881389|NCT01716533|558992254|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
154881390|NCT01716533|558992255|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
154881391|NCT01716533|558992256|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
154881392|NCT01716533|558992253|FG000|Overall Study|Withdrawal by Subject|0|||
154881393|NCT01716533|558992254|FG001|Overall Study|Withdrawal by Subject|0|||
154881394|NCT01716533|558992255|FG002|Overall Study|Withdrawal by Subject|0|||
154881395|NCT01716533|558992256|FG003|Overall Study|Withdrawal by Subject|5|||
154881396|NCT01716533|558992253|FG000|Overall Study|Death|0|||
154881397|NCT01716533|558992254|FG001|Overall Study|Death|0|||
154881398|NCT01716533|558992255|FG002|Overall Study|Death|0|||
154881399|NCT01716533|558992256|FG003|Overall Study|Death|2|||
154881400|NCT01716533|558992253|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
154881401|NCT01716533|558992254|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
154881402|NCT01716533|558992255|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
154881403|NCT01716533|558992256|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
154881404|NCT01670656|558992260|FG000|Overall Study|Non-compliance with study drug|0|||
154881405|NCT01670656|558992261|FG001|Overall Study|Non-compliance with study drug|0|||
154881406|NCT01670656|558992262|FG002|Overall Study|Non-compliance with study drug|3|||
154881407|NCT01670656|558992263|FG003|Overall Study|Non-compliance with study drug|0|||
154881408|NCT01670656|558992264|FG004|Overall Study|Non-compliance with study drug|1|||
154881409|NCT01670656|558992260|FG000|Overall Study|Pregnancy|0|||
154881410|NCT01670656|558992261|FG001|Overall Study|Pregnancy|0|||
154881411|NCT01670656|558992262|FG002|Overall Study|Pregnancy|0|||
154881412|NCT01670656|558992263|FG003|Overall Study|Pregnancy|0|||
154881413|NCT01670656|558992264|FG004|Overall Study|Pregnancy|1|||
154881414|NCT01670656|558992260|FG000|Overall Study|Withdrawal by Subject|1|||
154881415|NCT01670656|558992261|FG001|Overall Study|Withdrawal by Subject|1|||
154881416|NCT01670656|558992262|FG002|Overall Study|Withdrawal by Subject|0|||
154881417|NCT01670656|558992263|FG003|Overall Study|Withdrawal by Subject|0|||
154881418|NCT01670656|558992264|FG004|Overall Study|Withdrawal by Subject|0|||
154881419|NCT01670656|558992260|FG000|Overall Study|Non-compliance with protocol|0|||
154881420|NCT01670656|558992261|FG001|Overall Study|Non-compliance with protocol|3|||
154881421|NCT01670656|558992262|FG002|Overall Study|Non-compliance with protocol|1|||
154881422|NCT01670656|558992263|FG003|Overall Study|Non-compliance with protocol|1|||
154881423|NCT01670656|558992264|FG004|Overall Study|Non-compliance with protocol|2|||
154881424|NCT01670656|558992260|FG000|Overall Study|Adverse Event|2|||
154881425|NCT01670656|558992261|FG001|Overall Study|Adverse Event|2|||
154881426|NCT01670656|558992262|FG002|Overall Study|Adverse Event|2|||
154881427|NCT01670656|558992263|FG003|Overall Study|Adverse Event|3|||
154881428|NCT01670656|558992264|FG004|Overall Study|Adverse Event|3|||
154881429|NCT01670656|558992260|FG000|Overall Study|Subject withdrew consent|0|||
154881430|NCT01670656|558992261|FG001|Overall Study|Subject withdrew consent|1|||
154881431|NCT01670656|558992262|FG002|Overall Study|Subject withdrew consent|2|||
154881432|NCT01670656|558992263|FG003|Overall Study|Subject withdrew consent|1|||
154881433|NCT01670656|558992264|FG004|Overall Study|Subject withdrew consent|1|||
154881434|NCT01670656|558992260|FG000|Overall Study|Lost to Follow-up|0|||
154881435|NCT01670656|558992261|FG001|Overall Study|Lost to Follow-up|0|||
155113518|NCT02226562|559844809|FG001|Overall Study|Lost to Follow-up|1|||
155113519|NCT02750345|559844815|FG000|Intervention 1|Adverse Event|0|||
155113520|NCT02750345|559844816|FG001|Intervention 1|Adverse Event|0|||
154881436|NCT01670656|558992262|FG002|Overall Study|Lost to Follow-up|0|||
154881437|NCT01670656|558992263|FG003|Overall Study|Lost to Follow-up|0|||
154881438|NCT01670656|558992264|FG004|Overall Study|Lost to Follow-up|3|||
155113521|NCT02750345|559844817|FG002|Intervention 1|Adverse Event|0|||
154881439|NCT01670656|558992260|FG000|Overall Study|Subject moved|0|||
154881440|NCT01670656|558992261|FG001|Overall Study|Subject moved|0|||
154881441|NCT01670656|558992262|FG002|Overall Study|Subject moved|0|||
154881442|NCT01670656|558992263|FG003|Overall Study|Subject moved|1|||
154881443|NCT01670656|558992264|FG004|Overall Study|Subject moved|0|||
154881444|NCT00789958|558992265|FG000|Overall Study|Adverse Event|3|||
154881445|NCT00789958|558992265|FG000|Overall Study|Withdrawal by Subject|4|||
154881446|NCT00789958|558992265|FG000|Overall Study|Progression|3|||
154881447|NCT00789958|558992265|FG000|Overall Study|not protocol specified|1|||
154881448|NCT00789958|558992265|FG000|Overall Study|Not eligible/not analyzable|26|||
154881449|NCT02622724|558992266|FG000|Overall Study|Death|51|||
154881450|NCT02622724|558992267|FG001|Overall Study|Death|53|||
154881451|NCT02622724|558992266|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
154881452|NCT02622724|558992267|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
154881453|NCT02622724|558992266|FG000|Overall Study|Early termination of study|38|||
154881454|NCT02622724|558992267|FG001|Overall Study|Early termination of study|43|||
154881455|NCT00487084|558992268|FG000|Overall Study|Did not receive intervention|4|||
154881456|NCT00487084|558992269|FG001|Overall Study|Did not receive intervention|3|||
154881457|NCT00487084|558992270|FG002|Overall Study|Did not receive intervention|5|||
154881458|NCT00254293|558992271|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
154881459|NCT00254293|558992272|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
154881460|NCT00254293|558992273|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
154881461|NCT00254293|558992274|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
154881462|NCT00254293|558992275|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
154881463|NCT00254293|558992276|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
154881464|NCT00254293|558992277|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
154881465|NCT00254293|558992271|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
154881466|NCT00254293|558992272|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
154881467|NCT00254293|558992273|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
154881468|NCT00254293|558992274|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
154881469|NCT00254293|558992275|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
154881470|NCT00254293|558992276|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
154881471|NCT00254293|558992277|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
154881472|NCT00254293|558992271|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
154881473|NCT00254293|558992272|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
154881474|NCT00254293|558992273|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
154881475|NCT00254293|558992274|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
154881476|NCT00254293|558992275|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
154881477|NCT00254293|558992276|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
154881478|NCT00254293|558992277|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
154881479|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Death|0|||
154881480|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Death|0|||
154881481|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Death|1|||
154881482|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Death|0|||
154881483|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Death|0|||
154881484|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Death|0|||
154881485|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Death|0|||
154881486|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
154881487|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
154881488|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
154881489|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
154881490|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
154881491|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
154881492|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
154881493|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
154881494|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
154881495|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
154881496|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
154881497|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
154881498|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
154881499|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
154881500|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
154881501|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
154881502|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
154881503|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
154881504|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
154881505|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
154881506|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
154881507|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
154881508|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
154881509|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
154881510|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
154881511|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
154881512|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
154881513|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
154881514|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
155113522|NCT02750345|559844818|FG003|Intervention 1|Adverse Event|0|||
155113523|NCT02750345|559844819|FG004|Intervention 1|Adverse Event|1|||
154881515|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
154881516|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
154881517|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
154881518|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
154881519|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
154881520|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
154881521|NCT00254293|558992271|FG000|LTE Open Label Variable SC Dosing|Other|0|||
154881522|NCT00254293|558992272|FG001|LTE Open Label Variable SC Dosing|Other|0|||
154881523|NCT00254293|558992273|FG002|LTE Open Label Variable SC Dosing|Other|2|||
154881524|NCT00254293|558992274|FG003|LTE Open Label Variable SC Dosing|Other|0|||
154881525|NCT00254293|558992275|FG004|LTE Open Label Variable SC Dosing|Other|0|||
154881526|NCT00254293|558992276|FG005|LTE Open Label Variable SC Dosing|Other|0|||
154881527|NCT00254293|558992277|FG006|LTE Open Label Variable SC Dosing|Other|0|||
154881528|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Death|0|||
154881529|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Death|0|||
154881530|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Death|0|||
154881531|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Death|0|||
154881532|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Death|0|||
154881533|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Death|0|||
154881534|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Death|3|||
154881535|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
154881536|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
154881537|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
154881538|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
154881539|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
154881540|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
154881541|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
154881542|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
154881543|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
154881544|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
154881545|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
154881546|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
154881547|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
154881548|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
154881549|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
154881550|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
154881551|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
154881552|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
154881553|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
154881554|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
154881555|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
154881556|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
154881557|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
154881558|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
154881559|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
154881560|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
154881561|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
154881562|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
154881563|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
154881564|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
154881565|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
154881566|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
154881567|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
154881568|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
154881569|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
154881570|NCT00254293|558992271|FG000|LTE Open Label Fixed Dosing|Other|0|||
154881571|NCT00254293|558992272|FG001|LTE Open Label Fixed Dosing|Other|0|||
154881572|NCT00254293|558992273|FG002|LTE Open Label Fixed Dosing|Other|0|||
154881573|NCT00254293|558992274|FG003|LTE Open Label Fixed Dosing|Other|0|||
154881574|NCT00254293|558992275|FG004|LTE Open Label Fixed Dosing|Other|0|||
154881575|NCT00254293|558992276|FG005|LTE Open Label Fixed Dosing|Other|0|||
154881576|NCT00254293|558992277|FG006|LTE Open Label Fixed Dosing|Other|1|||
154881577|NCT01575197|558992278|FG000|Overall Study|Migration out of study area|1|||
154881578|NCT01575197|558992279|FG001|Overall Study|Migration out of study area|5|||
154881579|NCT01575197|558992280|FG002|Overall Study|Migration out of study area|4|||
154881580|NCT01575197|558992278|FG000|Overall Study|SAE|0|||
154881581|NCT01575197|558992279|FG001|Overall Study|SAE|1|||
154881582|NCT01575197|558992280|FG002|Overall Study|SAE|0|||
154881583|NCT01575197|558992278|FG000|Overall Study|Lost to Follow-up|0|||
154881584|NCT01575197|558992279|FG001|Overall Study|Lost to Follow-up|1|||
154881585|NCT01575197|558992280|FG002|Overall Study|Lost to Follow-up|0|||
154881586|NCT01575197|558992278|FG000|Overall Study|Withdrawal by Subject|0|||
154881587|NCT01575197|558992279|FG001|Overall Study|Withdrawal by Subject|1|||
154881588|NCT01575197|558992280|FG002|Overall Study|Withdrawal by Subject|1|||
154881589|NCT01575197|558992278|FG000|Overall Study|Protocol Violation|2|||
154881590|NCT01575197|558992279|FG001|Overall Study|Protocol Violation|1|||
154881591|NCT01575197|558992280|FG002|Overall Study|Protocol Violation|1|||
154881592|NCT02709083|558992281|FG000|Overall Study|Original PI left institution|7|||
154881593|NCT00111475|558992282|FG000|Overall Study|Lost to Follow-up|0|||
154881594|NCT00111475|558992283|FG001|Overall Study|Lost to Follow-up|0|||
154881595|NCT00111475|558992284|FG002|Overall Study|Lost to Follow-up|0|||
154881596|NCT00111475|558992285|FG003|Overall Study|Lost to Follow-up|0|||
154881597|NCT00111475|558992286|FG004|Overall Study|Lost to Follow-up|0|||
154881598|NCT00111475|558992287|FG005|Overall Study|Lost to Follow-up|1|||
154881599|NCT00111475|558992288|FG006|Overall Study|Lost to Follow-up|0|||
154881600|NCT00111475|558992289|FG007|Overall Study|Lost to Follow-up|0|||
154881601|NCT00111475|558992290|FG008|Overall Study|Lost to Follow-up|0|||
154881602|NCT00111475|558992291|FG009|Overall Study|Lost to Follow-up|0|||
154881603|NCT03303092|558992292|FG000|Overall Study|Adverse Event|1|||
154881604|NCT03303092|558992293|FG001|Overall Study|Adverse Event|0|||
154881605|NCT03303092|558992294|FG002|Overall Study|Adverse Event|1|||
154881606|NCT03303092|558992292|FG000|Overall Study|Protocol Violation|1|||
154881607|NCT03303092|558992293|FG001|Overall Study|Protocol Violation|5|||
154881608|NCT03303092|558992294|FG002|Overall Study|Protocol Violation|1|||
154881609|NCT03303092|558992292|FG000|Overall Study|Withdrawal by Subject|1|||
154881610|NCT03303092|558992293|FG001|Overall Study|Withdrawal by Subject|1|||
154881611|NCT03303092|558992294|FG002|Overall Study|Withdrawal by Subject|3|||
154881612|NCT01995136|558992300|FG000|Overall Study|Change in residence|1|||
154881613|NCT01626352|558992304|FG000|Overall Study|Disease Progression|3|||
154881614|NCT01626352|558992304|FG000|Overall Study|Intercurrent Illness|2|||
154881615|NCT01626352|558992304|FG000|Overall Study|Death|2|||
154881616|NCT01626352|558992304|FG000|Overall Study|Withdrawal by Subject|1|||
154881617|NCT01626352|558992304|FG000|Overall Study|Non-Compliance|1|||
154881618|NCT01626352|558992304|FG000|Overall Study|Never Treated|1|||
154881619|NCT02681055|558992305|FG000|Weeks 5-12|Adverse Event|1|||
154881620|NCT03446651|558992310|FG000|Overall Study|Lost to Follow-up|4|||
154881621|NCT03446651|558992311|FG001|Overall Study|Lost to Follow-up|0|||
154881622|NCT03446651|558992310|FG000|Overall Study|Open Label Participants|5|||
154881623|NCT03446651|558992311|FG001|Overall Study|Open Label Participants|0|||
154881624|NCT00343291|558992312|FG000|Overall Study|Adverse Event|13|||
154881625|NCT00343291|558992313|FG001|Overall Study|Adverse Event|13|||
154881626|NCT00343291|558992312|FG000|Overall Study|Death|3|||
154881627|NCT00343291|558992313|FG001|Overall Study|Death|2|||
154881628|NCT00343291|558992312|FG000|Overall Study|Progressive disease|33|||
154881629|NCT00343291|558992313|FG001|Overall Study|Progressive disease|34|||
154881630|NCT00343291|558992312|FG000|Overall Study|Withdrawal by Subject|0|||
154881631|NCT00343291|558992313|FG001|Overall Study|Withdrawal by Subject|2|||
154881632|NCT00343291|558992312|FG000|Overall Study|Other|8|||
154881633|NCT00343291|558992313|FG001|Overall Study|Other|5|||
154881634|NCT00882999|558992318|FG000|Overall Study|Adverse Event|0|||
154881635|NCT00882999|558992319|FG001|Overall Study|Adverse Event|0|||
154881636|NCT00882999|558992320|FG002|Overall Study|Adverse Event|0|||
154881637|NCT00882999|558992321|FG003|Overall Study|Adverse Event|0|||
154881638|NCT00882999|558992322|FG004|Overall Study|Adverse Event|1|||
154881639|NCT00882999|558992323|FG005|Overall Study|Adverse Event|0|||
154881640|NCT00882999|558992324|FG006|Overall Study|Adverse Event|0|||
154881641|NCT00882999|558992318|FG000|Overall Study|Death|0|||
154881642|NCT00882999|558992319|FG001|Overall Study|Death|1|||
154881643|NCT00882999|558992320|FG002|Overall Study|Death|0|||
154881644|NCT00882999|558992321|FG003|Overall Study|Death|0|||
154881645|NCT00882999|558992322|FG004|Overall Study|Death|0|||
154881646|NCT00882999|558992323|FG005|Overall Study|Death|0|||
154881647|NCT00882999|558992324|FG006|Overall Study|Death|0|||
154881648|NCT00882999|558992318|FG000|Overall Study|Withdrawal by Subject|7|||
154881649|NCT00882999|558992319|FG001|Overall Study|Withdrawal by Subject|6|||
154881650|NCT00882999|558992320|FG002|Overall Study|Withdrawal by Subject|3|||
154881651|NCT00882999|558992321|FG003|Overall Study|Withdrawal by Subject|3|||
154881652|NCT00882999|558992322|FG004|Overall Study|Withdrawal by Subject|6|||
155113524|NCT02750345|559844820|FG005|Intervention 1|Adverse Event|0|||
155113525|NCT00006164|559844821|FG000|Overall Study|Withdrew or lost to follow-up|70|||
155113526|NCT00006164|559844822|FG001|Overall Study|Withdrew or lost to follow-up|81|||
154881653|NCT00882999|558992323|FG005|Overall Study|Withdrawal by Subject|5|||
154881654|NCT00882999|558992324|FG006|Overall Study|Withdrawal by Subject|5|||
154881655|NCT00882999|558992318|FG000|Overall Study|Lost to Follow-up|0|||
154881656|NCT00882999|558992319|FG001|Overall Study|Lost to Follow-up|1|||
154881657|NCT00882999|558992320|FG002|Overall Study|Lost to Follow-up|1|||
154881658|NCT00882999|558992321|FG003|Overall Study|Lost to Follow-up|2|||
154881659|NCT00882999|558992322|FG004|Overall Study|Lost to Follow-up|1|||
154881660|NCT00882999|558992323|FG005|Overall Study|Lost to Follow-up|1|||
154881661|NCT00882999|558992324|FG006|Overall Study|Lost to Follow-up|2|||
154881662|NCT00882999|558992318|FG000|Overall Study|Physician Decision|1|||
154881663|NCT00882999|558992319|FG001|Overall Study|Physician Decision|0|||
154881664|NCT00882999|558992320|FG002|Overall Study|Physician Decision|0|||
154881665|NCT00882999|558992321|FG003|Overall Study|Physician Decision|0|||
154881666|NCT00882999|558992322|FG004|Overall Study|Physician Decision|0|||
154881667|NCT00882999|558992323|FG005|Overall Study|Physician Decision|1|||
154881668|NCT00882999|558992324|FG006|Overall Study|Physician Decision|1|||
154881669|NCT01757405|558992327|FG000|Overall Study|Lost to Follow-up|1|||
154881670|NCT01757405|558992328|FG001|Overall Study|Lost to Follow-up|1|||
154881671|NCT01757405|558992327|FG000|Overall Study|Withdrawal by Subject|0|||
154881672|NCT01757405|558992328|FG001|Overall Study|Withdrawal by Subject|1|||
154881673|NCT00082758|558992329|FG000|Overall Study|Adverse Event|0|||
154881674|NCT00082758|558992330|FG001|Overall Study|Adverse Event|2|||
154881675|NCT00082758|558992331|FG002|Overall Study|Adverse Event|0|||
154881676|NCT00082758|558992329|FG000|Overall Study|Lack of Efficacy|12|||
154881677|NCT00082758|558992330|FG001|Overall Study|Lack of Efficacy|13|||
154881678|NCT00082758|558992331|FG002|Overall Study|Lack of Efficacy|0|||
154881679|NCT00082758|558992329|FG000|Overall Study|Physician Decision|0|||
154881680|NCT00082758|558992330|FG001|Overall Study|Physician Decision|1|||
154881681|NCT00082758|558992331|FG002|Overall Study|Physician Decision|0|||
154881682|NCT00082758|558992329|FG000|Overall Study|Withdrawal by Subject|3|||
154881683|NCT00082758|558992330|FG001|Overall Study|Withdrawal by Subject|0|||
154881684|NCT00082758|558992331|FG002|Overall Study|Withdrawal by Subject|0|||
154881685|NCT00082758|558992329|FG000|Overall Study|Protocol Violation|0|||
154881686|NCT00082758|558992330|FG001|Overall Study|Protocol Violation|1|||
154881687|NCT00082758|558992331|FG002|Overall Study|Protocol Violation|0|||
154881688|NCT00238303|558992332|FG000|Overall Study|Withdrawal by Subject|11|||
154881689|NCT00238303|558992333|FG001|Overall Study|Withdrawal by Subject|1|||
154881690|NCT00238303|558992334|FG002|Overall Study|Withdrawal by Subject|2|||
154881691|NCT00238303|558992332|FG000|Overall Study|Death|1|||
154881692|NCT00238303|558992333|FG001|Overall Study|Death|0|||
154881693|NCT00238303|558992334|FG002|Overall Study|Death|1|||
154881694|NCT00238303|558992332|FG000|Overall Study|Other Medical Problems|2|||
154881695|NCT00238303|558992333|FG001|Overall Study|Other Medical Problems|0|||
154881696|NCT00238303|558992334|FG002|Overall Study|Other Medical Problems|2|||
154881697|NCT00238303|558992332|FG000|Overall Study|Poor tolerance of study treatment|1|||
154881698|NCT00238303|558992333|FG001|Overall Study|Poor tolerance of study treatment|0|||
154881699|NCT00238303|558992334|FG002|Overall Study|Poor tolerance of study treatment|1|||
154881700|NCT00238303|558992332|FG000|Overall Study|Adverse Event|0|||
154881701|NCT00238303|558992333|FG001|Overall Study|Adverse Event|1|||
154881702|NCT00238303|558992334|FG002|Overall Study|Adverse Event|3|||
154881703|NCT00937560|558992336|FG000|Initial Treatment|Death|6|||
154881704|NCT00937560|558992336|FG000|Initial Treatment|Withdraw consent|3|||
154881705|NCT00937560|558992336|FG000|Initial Treatment|Adverse Event|1|||
154881706|NCT00937560|558992336|FG000|Initial Treatment|Lost to Follow-up|1|||
154881707|NCT00937560|558992336|FG000|Initial Treatment|No end of study page|10|||
154881708|NCT00937560|558992336|FG000|Maintenance Treatment|Death|12|||
154881709|NCT00937560|558992336|FG000|Maintenance Treatment|Withdraw consent|5|||
154881710|NCT00937560|558992336|FG000|Maintenance Treatment|According to protocol|1|||
154881711|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
154881712|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
154881713|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
154881714|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
154881715|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
154881716|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
154881717|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
154881718|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
154881719|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
154881720|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
154881721|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
154881722|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
154881723|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
154881724|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
154881725|NCT00848549|558992337|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
154881726|NCT00848549|558992338|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
154881727|NCT00848549|558992337|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
154975081|NCT02315066|559333810|FG013|Overall Study|Other|0|||
154975082|NCT02315066|559333797|FG000|Overall Study|Subject refused further follow-up|0|||
154975083|NCT02315066|559333798|FG001|Overall Study|Subject refused further follow-up|2|||
154881728|NCT00848549|558992338|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
154881729|NCT00848549|558992337|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
154881730|NCT00848549|558992338|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
154881731|NCT00848549|558992337|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
154881732|NCT00848549|558992338|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
154881733|NCT00848549|558992337|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
154881734|NCT00848549|558992338|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
154975084|NCT02315066|559333799|FG002|Overall Study|Subject refused further follow-up|2|||
154881735|NCT00848549|558992337|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
154881736|NCT00848549|558992338|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
154881737|NCT00848549|558992337|FG000|E2090-E044-314 (Extension Study)|Other|5|||
154881738|NCT00848549|558992338|FG001|E2090-E044-314 (Extension Study)|Other|6|||
154881739|NCT02561299|558992339|FG000|Overall Study|Death|2|||
154881740|NCT02561299|558992340|FG001|Overall Study|Death|4|||
154881741|NCT02561299|558992339|FG000|Overall Study|Lost to Follow-up|1|||
154881742|NCT02561299|558992340|FG001|Overall Study|Lost to Follow-up|0|||
154881743|NCT02561299|558992339|FG000|Overall Study|Withdrawal by Subject|2|||
154881744|NCT02561299|558992340|FG001|Overall Study|Withdrawal by Subject|2|||
154881745|NCT05906732|558992343|FG000|Overall Study|Withdrawal by Subject|1|||
154881746|NCT05906732|558992344|FG001|Overall Study|Withdrawal by Subject|0|||
154881747|NCT05906732|558992345|FG002|Overall Study|Withdrawal by Subject|0|||
154881748|NCT05906732|558992346|FG003|Overall Study|Withdrawal by Subject|0|||
154881749|NCT05906732|558992343|FG000|Overall Study|Physician Decision|2|||
154881750|NCT05906732|558992344|FG001|Overall Study|Physician Decision|4|||
154881751|NCT05906732|558992345|FG002|Overall Study|Physician Decision|0|||
154881752|NCT05906732|558992346|FG003|Overall Study|Physician Decision|0|||
154881753|NCT01248130|558992347|FG000|Overall Study|Protocol Violation|1|||
154881754|NCT01248130|558992348|FG001|Overall Study|Protocol Violation|0|||
154881755|NCT01248130|558992347|FG000|Overall Study|Ineligible|1|||
154881756|NCT01248130|558992348|FG001|Overall Study|Ineligible|0|||
154881757|NCT02052778|558992349|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
154881758|NCT02052778|558992350|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
154881759|NCT02052778|558992351|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
154881760|NCT02052778|558992352|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
154881761|NCT02052778|558992353|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
154881762|NCT02052778|558992354|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
154881763|NCT02052778|558992355|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881764|NCT02052778|558992356|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
154881765|NCT02052778|558992357|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
154881766|NCT02052778|558992358|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
154881767|NCT02052778|558992359|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
154881768|NCT02052778|558992360|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
154881769|NCT02052778|558992361|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
154881770|NCT02052778|558992362|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
154881771|NCT02052778|558992363|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881772|NCT02052778|558992364|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881773|NCT02052778|558992365|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881774|NCT02052778|558992366|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881775|NCT02052778|558992367|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881776|NCT02052778|558992368|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881777|NCT02052778|558992369|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881778|NCT02052778|558992370|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881779|NCT02052778|558992371|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
154881780|NCT02052778|558992349|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
154881781|NCT02052778|558992350|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
154881782|NCT02052778|558992351|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
154881783|NCT02052778|558992352|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
154881784|NCT02052778|558992353|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
154881785|NCT02052778|558992354|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
154881786|NCT02052778|558992355|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
154881787|NCT02052778|558992356|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
154881788|NCT02052778|558992357|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
154881789|NCT02052778|558992358|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881790|NCT02052778|558992359|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881791|NCT02052778|558992360|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
154881792|NCT02052778|558992361|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
154881793|NCT02052778|558992362|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
154881794|NCT02052778|558992363|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881795|NCT02052778|558992364|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881796|NCT02052778|558992365|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881797|NCT02052778|558992366|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
155113527|NCT00223808|559844823|FG000|Overall Study|<5 hrs therapy before discharge|3|||
155113528|NCT00223808|559844824|FG001|Overall Study|<5 hrs therapy before discharge|5|||
155175363|NCT00910624|560080226|FG000|Follow-Up Phase|Lost to Follow-up|3|||
155113529|NCT00223808|559844825|FG002|Overall Study|<5 hrs therapy before discharge|5|||
155113530|NCT00191724|559844828|FG000|Overall Study|Adverse Event|0|||
155113531|NCT00191724|559844829|FG001|Overall Study|Adverse Event|0|||
155113532|NCT00191724|559844830|FG002|Overall Study|Adverse Event|1|||
155113533|NCT00191724|559844831|FG003|Overall Study|Adverse Event|0|||
154881798|NCT02052778|558992367|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881799|NCT02052778|558992368|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881800|NCT02052778|558992369|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881801|NCT02052778|558992370|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881802|NCT02052778|558992371|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
154881803|NCT02052778|558992349|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881804|NCT02052778|558992350|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881805|NCT02052778|558992351|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881806|NCT02052778|558992352|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154975085|NCT02315066|559333800|FG003|Overall Study|Subject refused further follow-up|0|||
154975086|NCT02315066|559333801|FG004|Overall Study|Subject refused further follow-up|0|||
154975087|NCT02315066|559333802|FG005|Overall Study|Subject refused further follow-up|0|||
154975088|NCT02315066|559333803|FG006|Overall Study|Subject refused further follow-up|2|||
154975089|NCT02315066|559333804|FG007|Overall Study|Subject refused further follow-up|3|||
154975090|NCT02315066|559333805|FG008|Overall Study|Subject refused further follow-up|0|||
154975091|NCT02315066|559333806|FG009|Overall Study|Subject refused further follow-up|1|||
154975092|NCT02315066|559333807|FG010|Overall Study|Subject refused further follow-up|1|||
154975093|NCT02315066|559333808|FG011|Overall Study|Subject refused further follow-up|2|||
154975094|NCT02315066|559333809|FG012|Overall Study|Subject refused further follow-up|2|||
154975095|NCT02315066|559333810|FG013|Overall Study|Subject refused further follow-up|4|||
154975096|NCT02315066|559333797|FG000|Overall Study|Study ongoing at date of cut-off|0|||
154975097|NCT02315066|559333798|FG001|Overall Study|Study ongoing at date of cut-off|0|||
154975098|NCT02315066|559333799|FG002|Overall Study|Study ongoing at date of cut-off|0|||
154975099|NCT02315066|559333800|FG003|Overall Study|Study ongoing at date of cut-off|0|||
154975100|NCT02315066|559333801|FG004|Overall Study|Study ongoing at date of cut-off|0|||
154975101|NCT02315066|559333802|FG005|Overall Study|Study ongoing at date of cut-off|0|||
154975102|NCT02315066|559333803|FG006|Overall Study|Study ongoing at date of cut-off|0|||
154975103|NCT02315066|559333804|FG007|Overall Study|Study ongoing at date of cut-off|0|||
154975104|NCT02315066|559333805|FG008|Overall Study|Study ongoing at date of cut-off|0|||
154975105|NCT02315066|559333806|FG009|Overall Study|Study ongoing at date of cut-off|0|||
154975106|NCT02315066|559333807|FG010|Overall Study|Study ongoing at date of cut-off|0|||
154975107|NCT02315066|559333808|FG011|Overall Study|Study ongoing at date of cut-off|0|||
154975108|NCT02315066|559333809|FG012|Overall Study|Study ongoing at date of cut-off|0|||
154975109|NCT02315066|559333810|FG013|Overall Study|Study ongoing at date of cut-off|1|||
154975110|NCT02916693|559333811|FG000|Overall Study|Lost to Follow-up|7|||
154975111|NCT01190930|559333812|FG000|Induction|Adverse Event|17|||
154975112|NCT01190930|559333813|FG001|Induction|Adverse Event|0|||
154975113|NCT01190930|559333814|FG002|Induction|Adverse Event|0|||
154975114|NCT01190930|559333815|FG003|Induction|Adverse Event|0|||
154975115|NCT01190930|559333816|FG004|Induction|Adverse Event|0|||
154975116|NCT01190930|559333817|FG005|Induction|Adverse Event|0|||
154975117|NCT01190930|559333818|FG006|Induction|Adverse Event|0|||
154975118|NCT01190930|559333819|FG007|Induction|Adverse Event|0|||
154975119|NCT01190930|559333820|FG008|Induction|Adverse Event|0|||
154975120|NCT01190930|559333821|FG009|Induction|Adverse Event|0|||
154975121|NCT01190930|559333812|FG000|Induction|Death|34|||
154975122|NCT01190930|559333813|FG001|Induction|Death|0|||
154975123|NCT01190930|559333814|FG002|Induction|Death|0|||
154975124|NCT01190930|559333815|FG003|Induction|Death|0|||
154975125|NCT01190930|559333816|FG004|Induction|Death|0|||
154975126|NCT01190930|559333817|FG005|Induction|Death|0|||
154975127|NCT01190930|559333818|FG006|Induction|Death|0|||
154975128|NCT01190930|559333819|FG007|Induction|Death|0|||
154975129|NCT01190930|559333820|FG008|Induction|Death|0|||
154975130|NCT01190930|559333821|FG009|Induction|Death|0|||
154975131|NCT01190930|559333812|FG000|Induction|Lost to Follow-up|1|||
154975132|NCT01190930|559333813|FG001|Induction|Lost to Follow-up|0|||
154975133|NCT01190930|559333814|FG002|Induction|Lost to Follow-up|0|||
154975134|NCT01190930|559333815|FG003|Induction|Lost to Follow-up|0|||
155113534|NCT00191724|559844832|FG004|Overall Study|Adverse Event|0|||
154975135|NCT01190930|559333816|FG004|Induction|Lost to Follow-up|0|||
154975136|NCT01190930|559333817|FG005|Induction|Lost to Follow-up|0|||
155113535|NCT00191724|559844828|FG000|Overall Study|Lost to Follow-up|1|||
155113536|NCT00191724|559844829|FG001|Overall Study|Lost to Follow-up|1|||
154975137|NCT01190930|559333818|FG006|Induction|Lost to Follow-up|0|||
154975138|NCT01190930|559333819|FG007|Induction|Lost to Follow-up|0|||
154975139|NCT01190930|559333820|FG008|Induction|Lost to Follow-up|0|||
154975140|NCT01190930|559333821|FG009|Induction|Lost to Follow-up|0|||
154975141|NCT01190930|559333812|FG000|Induction|Physician Decision|125|||
154975142|NCT01190930|559333813|FG001|Induction|Physician Decision|3|||
154975143|NCT01190930|559333814|FG002|Induction|Physician Decision|0|||
154975144|NCT01190930|559333815|FG003|Induction|Physician Decision|0|||
154975145|NCT01190930|559333816|FG004|Induction|Physician Decision|0|||
154975146|NCT01190930|559333817|FG005|Induction|Physician Decision|0|||
154975147|NCT01190930|559333818|FG006|Induction|Physician Decision|0|||
154975148|NCT01190930|559333819|FG007|Induction|Physician Decision|0|||
154975149|NCT01190930|559333820|FG008|Induction|Physician Decision|0|||
154975150|NCT01190930|559333821|FG009|Induction|Physician Decision|0|||
154975151|NCT01190930|559333812|FG000|Induction|Withdrawal by Subject|9|||
154975152|NCT01190930|559333813|FG001|Induction|Withdrawal by Subject|0|||
154975153|NCT01190930|559333814|FG002|Induction|Withdrawal by Subject|0|||
154975154|NCT01190930|559333815|FG003|Induction|Withdrawal by Subject|0|||
154975155|NCT01190930|559333816|FG004|Induction|Withdrawal by Subject|0|||
154975156|NCT01190930|559333817|FG005|Induction|Withdrawal by Subject|0|||
154975157|NCT01190930|559333818|FG006|Induction|Withdrawal by Subject|0|||
154975158|NCT01190930|559333819|FG007|Induction|Withdrawal by Subject|0|||
154975159|NCT01190930|559333820|FG008|Induction|Withdrawal by Subject|0|||
154975160|NCT01190930|559333821|FG009|Induction|Withdrawal by Subject|0|||
154975161|NCT01190930|559333812|FG000|Induction|Refusal|235|||
154975162|NCT01190930|559333813|FG001|Induction|Refusal|0|||
154975163|NCT01190930|559333814|FG002|Induction|Refusal|0|||
154975164|NCT01190930|559333815|FG003|Induction|Refusal|0|||
154975165|NCT01190930|559333816|FG004|Induction|Refusal|0|||
154975166|NCT01190930|559333817|FG005|Induction|Refusal|0|||
154975167|NCT01190930|559333818|FG006|Induction|Refusal|0|||
154975168|NCT01190930|559333819|FG007|Induction|Refusal|0|||
154975169|NCT01190930|559333820|FG008|Induction|Refusal|0|||
154975170|NCT01190930|559333821|FG009|Induction|Refusal|0|||
154975171|NCT01190930|559333812|FG000|Induction|Inevaluable|23|||
154975172|NCT01190930|559333813|FG001|Induction|Inevaluable|1|||
154975173|NCT01190930|559333814|FG002|Induction|Inevaluable|0|||
154975174|NCT01190930|559333815|FG003|Induction|Inevaluable|0|||
154975175|NCT01190930|559333816|FG004|Induction|Inevaluable|0|||
154975176|NCT01190930|559333817|FG005|Induction|Inevaluable|0|||
154975177|NCT01190930|559333818|FG006|Induction|Inevaluable|0|||
154975178|NCT01190930|559333819|FG007|Induction|Inevaluable|0|||
154975179|NCT01190930|559333820|FG008|Induction|Inevaluable|0|||
154975180|NCT01190930|559333821|FG009|Induction|Inevaluable|0|||
154975181|NCT01190930|559333812|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
154975182|NCT01190930|559333813|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975183|NCT01190930|559333814|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975184|NCT01190930|559333815|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975185|NCT01190930|559333816|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975186|NCT01190930|559333817|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975187|NCT01190930|559333818|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975188|NCT01190930|559333819|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975189|NCT01190930|559333820|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975190|NCT01190930|559333821|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
154975191|NCT01190930|559333812|FG000|Induction|High Risk Downs|80|||
154975192|NCT01190930|559333813|FG001|Induction|High Risk Downs|0|||
154975193|NCT01190930|559333814|FG002|Induction|High Risk Downs|0|||
154975194|NCT01190930|559333815|FG003|Induction|High Risk Downs|0|||
154975195|NCT01190930|559333816|FG004|Induction|High Risk Downs|0|||
154975196|NCT01190930|559333817|FG005|Induction|High Risk Downs|0|||
154975197|NCT01190930|559333818|FG006|Induction|High Risk Downs|0|||
154975198|NCT01190930|559333819|FG007|Induction|High Risk Downs|0|||
154975199|NCT01190930|559333820|FG008|Induction|High Risk Downs|0|||
154975200|NCT01190930|559333821|FG009|Induction|High Risk Downs|0|||
154975201|NCT01190930|559333812|FG000|Induction|Enrollment onto another COG Protocol|1|||
154975202|NCT01190930|559333813|FG001|Induction|Enrollment onto another COG Protocol|0|||
154975203|NCT01190930|559333814|FG002|Induction|Enrollment onto another COG Protocol|0|||
154975204|NCT01190930|559333815|FG003|Induction|Enrollment onto another COG Protocol|0|||
154975205|NCT01190930|559333816|FG004|Induction|Enrollment onto another COG Protocol|0|||
154975206|NCT01190930|559333817|FG005|Induction|Enrollment onto another COG Protocol|0|||
154975207|NCT01190930|559333818|FG006|Induction|Enrollment onto another COG Protocol|0|||
154975208|NCT01190930|559333819|FG007|Induction|Enrollment onto another COG Protocol|0|||
154975209|NCT01190930|559333820|FG008|Induction|Enrollment onto another COG Protocol|0|||
154975210|NCT01190930|559333821|FG009|Induction|Enrollment onto another COG Protocol|0|||
154975211|NCT01190930|559333812|FG000|Induction|Average Risk|1847|||
154975212|NCT01190930|559333813|FG001|Induction|Average Risk|0|||
154975213|NCT01190930|559333814|FG002|Induction|Average Risk|0|||
154975214|NCT01190930|559333815|FG003|Induction|Average Risk|0|||
154975215|NCT01190930|559333816|FG004|Induction|Average Risk|0|||
154975216|NCT01190930|559333817|FG005|Induction|Average Risk|0|||
154975217|NCT01190930|559333818|FG006|Induction|Average Risk|0|||
154975218|NCT01190930|559333819|FG007|Induction|Average Risk|0|||
154975219|NCT01190930|559333820|FG008|Induction|Average Risk|0|||
154975220|NCT01190930|559333821|FG009|Induction|Average Risk|0|||
154975221|NCT01190930|559333812|FG000|Induction|High Risk|1227|||
154975222|NCT01190930|559333813|FG001|Induction|High Risk|0|||
154975223|NCT01190930|559333814|FG002|Induction|High Risk|0|||
154975224|NCT01190930|559333815|FG003|Induction|High Risk|0|||
154975225|NCT01190930|559333816|FG004|Induction|High Risk|0|||
154975226|NCT01190930|559333817|FG005|Induction|High Risk|0|||
154975227|NCT01190930|559333818|FG006|Induction|High Risk|0|||
154975228|NCT01190930|559333819|FG007|Induction|High Risk|0|||
154975229|NCT01190930|559333820|FG008|Induction|High Risk|0|||
154975230|NCT01190930|559333821|FG009|Induction|High Risk|0|||
154975231|NCT01190930|559333812|FG000|Induction|Low Risk|443|||
154975232|NCT01190930|559333813|FG001|Induction|Low Risk|0|||
154975233|NCT01190930|559333814|FG002|Induction|Low Risk|0|||
154975234|NCT01190930|559333815|FG003|Induction|Low Risk|0|||
154975235|NCT01190930|559333816|FG004|Induction|Low Risk|0|||
154975236|NCT01190930|559333817|FG005|Induction|Low Risk|0|||
154975237|NCT01190930|559333818|FG006|Induction|Low Risk|0|||
154975238|NCT01190930|559333819|FG007|Induction|Low Risk|0|||
154975239|NCT01190930|559333820|FG008|Induction|Low Risk|0|||
154975240|NCT01190930|559333821|FG009|Induction|Low Risk|0|||
154975241|NCT01190930|559333812|FG000|Induction|Very High Risk|1012|||
154881807|NCT02052778|558992353|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881808|NCT02052778|558992354|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881809|NCT02052778|558992355|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881810|NCT02052778|558992356|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881811|NCT02052778|558992357|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881812|NCT02052778|558992358|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881813|NCT02052778|558992359|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881814|NCT02052778|558992360|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881815|NCT02052778|558992361|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881816|NCT02052778|558992362|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
154881817|NCT02052778|558992363|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881818|NCT02052778|558992364|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881819|NCT02052778|558992365|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881820|NCT02052778|558992366|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881821|NCT02052778|558992367|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881822|NCT02052778|558992368|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881823|NCT02052778|558992369|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881824|NCT02052778|558992370|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881825|NCT02052778|558992371|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
154881826|NCT02052778|558992349|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
154881827|NCT02052778|558992350|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
154881828|NCT02052778|558992351|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
154881829|NCT02052778|558992352|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
154881830|NCT02052778|558992353|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
154881831|NCT02052778|558992354|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
154881832|NCT02052778|558992355|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
154881833|NCT02052778|558992356|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
154881834|NCT02052778|558992357|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
154881835|NCT02052778|558992358|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
154881836|NCT02052778|558992359|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
154881837|NCT02052778|558992360|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
154881838|NCT02052778|558992361|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
154881839|NCT02052778|558992362|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
154881840|NCT02052778|558992363|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
154881841|NCT02052778|558992364|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
154881842|NCT02052778|558992365|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
154881843|NCT02052778|558992366|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
154881844|NCT02052778|558992367|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
154881845|NCT02052778|558992368|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
154881846|NCT02052778|558992369|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
154881847|NCT02052778|558992370|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
154881848|NCT02052778|558992371|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
154881849|NCT02052778|558992349|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881850|NCT02052778|558992350|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881851|NCT02052778|558992351|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881852|NCT02052778|558992352|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881853|NCT02052778|558992353|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881854|NCT02052778|558992354|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881855|NCT02052778|558992355|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154975242|NCT01190930|559333813|FG001|Induction|Very High Risk|0|||
154975243|NCT01190930|559333814|FG002|Induction|Very High Risk|0|||
154975244|NCT01190930|559333815|FG003|Induction|Very High Risk|0|||
154975245|NCT01190930|559333816|FG004|Induction|Very High Risk|0|||
154975246|NCT01190930|559333817|FG005|Induction|Very High Risk|0|||
154975247|NCT01190930|559333818|FG006|Induction|Very High Risk|0|||
154975248|NCT01190930|559333819|FG007|Induction|Very High Risk|0|||
154975249|NCT01190930|559333820|FG008|Induction|Very High Risk|0|||
154975250|NCT01190930|559333821|FG009|Induction|Very High Risk|0|||
154975251|NCT01190930|559333812|FG000|Induction|Philadelphia chromosome-positive|99|||
154975252|NCT01190930|559333813|FG001|Induction|Philadelphia chromosome-positive|0|||
154975253|NCT01190930|559333814|FG002|Induction|Philadelphia chromosome-positive|0|||
154975254|NCT01190930|559333815|FG003|Induction|Philadelphia chromosome-positive|0|||
154975255|NCT01190930|559333816|FG004|Induction|Philadelphia chromosome-positive|0|||
154975256|NCT01190930|559333817|FG005|Induction|Philadelphia chromosome-positive|0|||
154975257|NCT01190930|559333818|FG006|Induction|Philadelphia chromosome-positive|0|||
154975258|NCT01190930|559333819|FG007|Induction|Philadelphia chromosome-positive|0|||
154975259|NCT01190930|559333820|FG008|Induction|Philadelphia chromosome-positive|0|||
154975260|NCT01190930|559333821|FG009|Induction|Philadelphia chromosome-positive|0|||
154975261|NCT01190930|559333812|FG000|Induction|Incomplete Induction data|63|||
154975262|NCT01190930|559333813|FG001|Induction|Incomplete Induction data|0|||
154975263|NCT01190930|559333814|FG002|Induction|Incomplete Induction data|0|||
154975264|NCT01190930|559333815|FG003|Induction|Incomplete Induction data|0|||
154975265|NCT01190930|559333816|FG004|Induction|Incomplete Induction data|0|||
154975266|NCT01190930|559333817|FG005|Induction|Incomplete Induction data|0|||
154975267|NCT01190930|559333818|FG006|Induction|Incomplete Induction data|0|||
154975268|NCT01190930|559333819|FG007|Induction|Incomplete Induction data|0|||
154975269|NCT01190930|559333820|FG008|Induction|Incomplete Induction data|0|||
154975270|NCT01190930|559333821|FG009|Induction|Incomplete Induction data|0|||
154975271|NCT01190930|559333812|FG000|Induction|Progressive disease|0|||
154975272|NCT01190930|559333813|FG001|Induction|Progressive disease|1|||
154975273|NCT01190930|559333814|FG002|Induction|Progressive disease|0|||
154975274|NCT01190930|559333815|FG003|Induction|Progressive disease|0|||
154975275|NCT01190930|559333816|FG004|Induction|Progressive disease|0|||
154975276|NCT01190930|559333817|FG005|Induction|Progressive disease|0|||
154975277|NCT01190930|559333818|FG006|Induction|Progressive disease|0|||
154881856|NCT02052778|558992356|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881857|NCT02052778|558992357|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
154881858|NCT02052778|558992358|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881859|NCT02052778|558992359|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881860|NCT02052778|558992360|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881861|NCT02052778|558992361|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881862|NCT02052778|558992362|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
154881863|NCT02052778|558992363|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881864|NCT02052778|558992364|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154975278|NCT01190930|559333819|FG007|Induction|Progressive disease|0|||
154975279|NCT01190930|559333820|FG008|Induction|Progressive disease|0|||
154975280|NCT01190930|559333821|FG009|Induction|Progressive disease|0|||
154975281|NCT01190930|559333812|FG000|Induction|No treatment|3|||
154975282|NCT01190930|559333813|FG001|Induction|No treatment|0|||
154975283|NCT01190930|559333814|FG002|Induction|No treatment|0|||
154975284|NCT01190930|559333815|FG003|Induction|No treatment|0|||
154975285|NCT01190930|559333816|FG004|Induction|No treatment|0|||
154975286|NCT01190930|559333817|FG005|Induction|No treatment|0|||
154975287|NCT01190930|559333818|FG006|Induction|No treatment|0|||
154975288|NCT01190930|559333819|FG007|Induction|No treatment|0|||
154975289|NCT01190930|559333820|FG008|Induction|No treatment|0|||
154975290|NCT01190930|559333821|FG009|Induction|No treatment|0|||
154975291|NCT01190930|559333812|FG000|Induction|Ineligible|69|||
154975292|NCT01190930|559333813|FG001|Induction|Ineligible|4|||
154975293|NCT01190930|559333814|FG002|Induction|Ineligible|0|||
154975294|NCT01190930|559333815|FG003|Induction|Ineligible|0|||
154975295|NCT01190930|559333816|FG004|Induction|Ineligible|0|||
154975296|NCT01190930|559333817|FG005|Induction|Ineligible|0|||
154975297|NCT01190930|559333818|FG006|Induction|Ineligible|0|||
154975298|NCT01190930|559333819|FG007|Induction|Ineligible|0|||
154975299|NCT01190930|559333820|FG008|Induction|Ineligible|0|||
154975300|NCT01190930|559333821|FG009|Induction|Ineligible|0|||
154975301|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
154975302|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
155113537|NCT00191724|559844830|FG002|Overall Study|Lost to Follow-up|0|||
154881865|NCT02052778|558992365|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881866|NCT02052778|558992366|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154975303|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
154975304|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
154975305|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
154975306|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
154975307|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
154975308|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
154975309|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
154975310|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
155113538|NCT00191724|559844831|FG003|Overall Study|Lost to Follow-up|2|||
154881867|NCT02052778|558992367|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881868|NCT02052778|558992368|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881869|NCT02052778|558992369|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881870|NCT02052778|558992370|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881871|NCT02052778|558992371|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
154881872|NCT02052778|558992349|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881873|NCT02052778|558992350|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881874|NCT02052778|558992351|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881875|NCT02052778|558992352|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881876|NCT02052778|558992353|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154975311|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Death|0|||
154975312|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Death|0|||
154975313|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Death|8|||
154975314|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Death|4|||
154975315|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Death|0|||
154975316|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Death|0|||
154975317|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Death|0|||
154975318|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Death|0|||
154975319|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Death|0|||
154975320|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Death|0|||
154975321|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
154975322|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
154975323|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
154975324|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
154975325|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
154975326|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
154975327|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
154975328|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
154975329|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
154975330|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
154975331|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975332|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
154975333|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
154975334|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
154975335|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975336|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975337|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975338|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975339|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975340|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
154975341|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Refusal|0|||
154975342|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Refusal|2|||
154975343|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Refusal|694|||
154975344|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Refusal|4|||
154975345|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Refusal|0|||
154975346|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Refusal|3|||
154975347|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Refusal|0|||
154975348|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Refusal|0|||
154975349|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Refusal|0|||
154975350|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Refusal|0|||
154975351|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
154975352|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
154975353|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
154975354|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
154975355|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
154975356|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
154975357|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
154975358|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
154975359|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
154975360|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
154975361|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975362|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
154975363|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975364|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975365|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975366|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975367|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
155113539|NCT00191724|559844832|FG004|Overall Study|Lost to Follow-up|3|||
154881877|NCT02052778|558992354|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
154881878|NCT02052778|558992355|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881879|NCT02052778|558992356|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881880|NCT02052778|558992357|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881881|NCT02052778|558992358|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881882|NCT02052778|558992359|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881883|NCT02052778|558992360|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881884|NCT02052778|558992361|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
154881885|NCT02052778|558992362|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881886|NCT02052778|558992363|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881887|NCT02052778|558992364|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881888|NCT02052778|558992365|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881889|NCT02052778|558992366|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881890|NCT02052778|558992367|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881891|NCT02052778|558992368|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881892|NCT02052778|558992369|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881893|NCT02052778|558992370|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881894|NCT02052778|558992371|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
154881895|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881896|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881897|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881898|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881899|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881900|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881901|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881902|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881903|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881904|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881905|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881906|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881907|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881908|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881909|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
154881910|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
154881911|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
154881912|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
154881913|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
154881914|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
154881915|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
154881916|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
154881917|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
154881918|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881919|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881920|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881921|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881922|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881923|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881924|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881925|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881926|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881927|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881928|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881929|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881930|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881931|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881932|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
154881933|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
154881934|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154975368|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154881935|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
155113540|NCT00191724|559844828|FG000|Overall Study|Withdrawal by Subject|0|||
155113541|NCT00191724|559844829|FG001|Overall Study|Withdrawal by Subject|0|||
155113542|NCT00191724|559844830|FG002|Overall Study|Withdrawal by Subject|0|||
154881936|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
154881937|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
154881938|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
154881939|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
154881940|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
154881941|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881942|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881943|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881944|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881945|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881946|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881947|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881948|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881949|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881950|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881951|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881952|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881953|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881954|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881955|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
154881956|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
154881957|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
154881958|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881959|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
154881960|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
154881961|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881962|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881963|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
154881964|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881965|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881966|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881967|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881968|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881969|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881970|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881971|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881972|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881973|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881974|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881975|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881976|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881977|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881978|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
154881979|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
154881980|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881981|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881982|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881983|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881984|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881985|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881986|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
154881987|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881988|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881989|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881990|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881991|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881992|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881993|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
155113543|NCT00191724|559844831|FG003|Overall Study|Withdrawal by Subject|1|||
155113544|NCT00191724|559844832|FG004|Overall Study|Withdrawal by Subject|0|||
155113545|NCT01231321|559844835|FG000|Overall Study|Adverse Event|3|||
154881994|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881995|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881996|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881997|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881998|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154881999|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882000|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882001|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
154882002|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
154882003|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882004|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882005|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882006|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
154882007|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882008|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882009|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
154882010|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
154882011|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
154882012|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
154882013|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
154882014|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
154882015|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
154882016|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
154882017|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
154882018|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
154882019|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
154882020|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
154882021|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
154882022|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
154882023|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
154882024|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
154882025|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
154882026|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
154882027|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
154882028|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
154882029|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
154882030|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
154882031|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
154882032|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
154882033|NCT02052778|558992349|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882034|NCT02052778|558992350|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882035|NCT02052778|558992351|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882036|NCT02052778|558992352|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882037|NCT02052778|558992353|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882038|NCT02052778|558992354|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882039|NCT02052778|558992355|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882040|NCT02052778|558992356|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882041|NCT02052778|558992357|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882042|NCT02052778|558992358|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882043|NCT02052778|558992359|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882044|NCT02052778|558992360|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882045|NCT02052778|558992361|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882046|NCT02052778|558992362|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882047|NCT02052778|558992363|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
154882048|NCT02052778|558992364|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
154882049|NCT02052778|558992365|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
154882050|NCT02052778|558992366|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882051|NCT02052778|558992367|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
154882052|NCT02052778|558992368|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882053|NCT02052778|558992369|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882054|NCT02052778|558992370|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882055|NCT02052778|558992371|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
154882056|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882057|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882058|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882059|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
155113546|NCT01231321|559844835|FG000|Overall Study|Lack of Efficacy|2|||
155113547|NCT00489736|559844836|FG000|Overall Study|Lack of Efficacy|53|||
154882060|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882061|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882062|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882063|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882064|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882065|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882066|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882067|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882068|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882069|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882070|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882071|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882072|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882073|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882074|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882075|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882076|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882077|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
154882078|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
154882079|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882080|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882081|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882082|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882083|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882084|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882085|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882086|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882087|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882088|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882089|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882090|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882091|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882092|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882093|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882094|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882095|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882096|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882097|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882098|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882099|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882100|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
154882101|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
154882102|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882103|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882104|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882105|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882106|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882107|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882108|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882109|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882110|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882111|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882112|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882113|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882114|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882115|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882116|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882117|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882118|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882119|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155113548|NCT00489736|559844837|FG001|Overall Study|Lack of Efficacy|14|||
154882120|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882121|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
155113549|NCT00489736|559844836|FG000|Overall Study|Adverse Event|32|||
154882122|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882123|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
154882124|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
154882125|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882126|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882127|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882128|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882129|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882130|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882131|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882132|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882133|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882134|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882135|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882136|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882137|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882138|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882139|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882140|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882141|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882142|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882143|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882144|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882145|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882146|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
154882147|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
154882148|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882149|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882150|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882151|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882152|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882153|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882154|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882155|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882156|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882157|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882158|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882159|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882160|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882161|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882162|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882163|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882164|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882165|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882166|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882167|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882168|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882169|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
154882170|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
154882171|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
154882172|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
154882173|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
154882174|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
154882175|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
154882176|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
154882177|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
154882178|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
154882179|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
154882180|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
154882181|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
154882182|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
154882183|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
154882184|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
154882185|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
155113550|NCT00489736|559844837|FG001|Overall Study|Adverse Event|45|||
154882186|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
154975369|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975370|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
154975371|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
154975372|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
154975373|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
154975374|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
154975375|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
154975376|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
154975377|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
154975378|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
154975379|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
154975380|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
154975381|NCT01190930|559333812|FG000|Post Induction Pre-Maintenance|Relapse|0|||
154975382|NCT01190930|559333813|FG001|Post Induction Pre-Maintenance|Relapse|0|||
154975383|NCT01190930|559333814|FG002|Post Induction Pre-Maintenance|Relapse|1|||
154975384|NCT01190930|559333815|FG003|Post Induction Pre-Maintenance|Relapse|0|||
154975385|NCT01190930|559333816|FG004|Post Induction Pre-Maintenance|Relapse|0|||
154975386|NCT01190930|559333817|FG005|Post Induction Pre-Maintenance|Relapse|0|||
154975387|NCT01190930|559333818|FG006|Post Induction Pre-Maintenance|Relapse|0|||
154975388|NCT01190930|559333819|FG007|Post Induction Pre-Maintenance|Relapse|0|||
154975389|NCT01190930|559333820|FG008|Post Induction Pre-Maintenance|Relapse|0|||
154975390|NCT01190930|559333821|FG009|Post Induction Pre-Maintenance|Relapse|0|||
154975391|NCT01190930|559333812|FG000|Maintenance|Adverse Event|0|||
154975392|NCT01190930|559333813|FG001|Maintenance|Adverse Event|0|||
154975393|NCT01190930|559333814|FG002|Maintenance|Adverse Event|0|||
154975394|NCT01190930|559333815|FG003|Maintenance|Adverse Event|0|||
154975395|NCT01190930|559333816|FG004|Maintenance|Adverse Event|0|||
154975396|NCT01190930|559333817|FG005|Maintenance|Adverse Event|1|||
154975397|NCT01190930|559333818|FG006|Maintenance|Adverse Event|1|||
154975398|NCT01190930|559333819|FG007|Maintenance|Adverse Event|3|||
154975399|NCT01190930|559333820|FG008|Maintenance|Adverse Event|3|||
154975400|NCT01190930|559333821|FG009|Maintenance|Adverse Event|0|||
154975401|NCT01190930|559333812|FG000|Maintenance|Death|0|||
154975402|NCT01190930|559333813|FG001|Maintenance|Death|0|||
154975403|NCT01190930|559333814|FG002|Maintenance|Death|0|||
154975404|NCT01190930|559333815|FG003|Maintenance|Death|1|||
154975405|NCT01190930|559333816|FG004|Maintenance|Death|0|||
154975406|NCT01190930|559333817|FG005|Maintenance|Death|0|||
154975407|NCT01190930|559333818|FG006|Maintenance|Death|2|||
154975408|NCT01190930|559333819|FG007|Maintenance|Death|2|||
154975409|NCT01190930|559333820|FG008|Maintenance|Death|2|||
154975410|NCT01190930|559333821|FG009|Maintenance|Death|2|||
154975411|NCT01190930|559333812|FG000|Maintenance|Lost to Follow-up|0|||
154975412|NCT01190930|559333813|FG001|Maintenance|Lost to Follow-up|0|||
154975413|NCT01190930|559333814|FG002|Maintenance|Lost to Follow-up|0|||
154975414|NCT01190930|559333815|FG003|Maintenance|Lost to Follow-up|0|||
154975415|NCT01190930|559333816|FG004|Maintenance|Lost to Follow-up|0|||
154975416|NCT01190930|559333817|FG005|Maintenance|Lost to Follow-up|0|||
154975417|NCT01190930|559333818|FG006|Maintenance|Lost to Follow-up|1|||
154975418|NCT01190930|559333819|FG007|Maintenance|Lost to Follow-up|1|||
154975419|NCT01190930|559333820|FG008|Maintenance|Lost to Follow-up|1|||
154975420|NCT01190930|559333821|FG009|Maintenance|Lost to Follow-up|0|||
154975421|NCT01190930|559333812|FG000|Maintenance|Physician Decision|0|||
154975422|NCT01190930|559333813|FG001|Maintenance|Physician Decision|1|||
154975423|NCT01190930|559333814|FG002|Maintenance|Physician Decision|0|||
154975424|NCT01190930|559333815|FG003|Maintenance|Physician Decision|5|||
154975425|NCT01190930|559333816|FG004|Maintenance|Physician Decision|9|||
154975426|NCT01190930|559333817|FG005|Maintenance|Physician Decision|4|||
154975427|NCT01190930|559333818|FG006|Maintenance|Physician Decision|8|||
154975428|NCT01190930|559333819|FG007|Maintenance|Physician Decision|8|||
154975429|NCT01190930|559333820|FG008|Maintenance|Physician Decision|10|||
154975430|NCT01190930|559333821|FG009|Maintenance|Physician Decision|17|||
154975431|NCT01190930|559333812|FG000|Maintenance|Withdrawal by Subject|0|||
154975432|NCT01190930|559333813|FG001|Maintenance|Withdrawal by Subject|0|||
154975433|NCT01190930|559333814|FG002|Maintenance|Withdrawal by Subject|0|||
154975434|NCT01190930|559333815|FG003|Maintenance|Withdrawal by Subject|0|||
154975435|NCT01190930|559333816|FG004|Maintenance|Withdrawal by Subject|0|||
154975436|NCT01190930|559333817|FG005|Maintenance|Withdrawal by Subject|0|||
155113551|NCT00489736|559844836|FG000|Overall Study|Poor compliance|6|||
155113552|NCT00489736|559844837|FG001|Overall Study|Poor compliance|2|||
154975437|NCT01190930|559333818|FG006|Maintenance|Withdrawal by Subject|2|||
154975438|NCT01190930|559333819|FG007|Maintenance|Withdrawal by Subject|1|||
154975439|NCT01190930|559333820|FG008|Maintenance|Withdrawal by Subject|4|||
154975440|NCT01190930|559333821|FG009|Maintenance|Withdrawal by Subject|1|||
154975441|NCT01190930|559333812|FG000|Maintenance|Refusal|0|||
154975442|NCT01190930|559333813|FG001|Maintenance|Refusal|1|||
154975443|NCT01190930|559333814|FG002|Maintenance|Refusal|0|||
154975444|NCT01190930|559333815|FG003|Maintenance|Refusal|2|||
154975445|NCT01190930|559333816|FG004|Maintenance|Refusal|0|||
154975446|NCT01190930|559333817|FG005|Maintenance|Refusal|4|||
154975447|NCT01190930|559333818|FG006|Maintenance|Refusal|5|||
154975448|NCT01190930|559333819|FG007|Maintenance|Refusal|17|||
154975449|NCT01190930|559333820|FG008|Maintenance|Refusal|13|||
154975450|NCT01190930|559333821|FG009|Maintenance|Refusal|6|||
154975451|NCT01190930|559333812|FG000|Maintenance|second malignant neoplasm|0|||
154975452|NCT01190930|559333813|FG001|Maintenance|second malignant neoplasm|0|||
154975453|NCT01190930|559333814|FG002|Maintenance|second malignant neoplasm|0|||
154975454|NCT01190930|559333815|FG003|Maintenance|second malignant neoplasm|1|||
154975455|NCT01190930|559333816|FG004|Maintenance|second malignant neoplasm|0|||
154975456|NCT01190930|559333817|FG005|Maintenance|second malignant neoplasm|1|||
154975457|NCT01190930|559333818|FG006|Maintenance|second malignant neoplasm|0|||
154975458|NCT01190930|559333819|FG007|Maintenance|second malignant neoplasm|0|||
154975459|NCT01190930|559333820|FG008|Maintenance|second malignant neoplasm|1|||
154975460|NCT01190930|559333821|FG009|Maintenance|second malignant neoplasm|0|||
154975461|NCT01190930|559333812|FG000|Maintenance|Inevaluable|0|||
154975462|NCT01190930|559333813|FG001|Maintenance|Inevaluable|0|||
154975463|NCT01190930|559333814|FG002|Maintenance|Inevaluable|0|||
154975464|NCT01190930|559333815|FG003|Maintenance|Inevaluable|0|||
154975465|NCT01190930|559333816|FG004|Maintenance|Inevaluable|0|||
154975466|NCT01190930|559333817|FG005|Maintenance|Inevaluable|1|||
154975467|NCT01190930|559333818|FG006|Maintenance|Inevaluable|1|||
154975468|NCT01190930|559333819|FG007|Maintenance|Inevaluable|1|||
154975469|NCT01190930|559333820|FG008|Maintenance|Inevaluable|0|||
154975470|NCT01190930|559333821|FG009|Maintenance|Inevaluable|0|||
154975471|NCT01190930|559333812|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
154975472|NCT01190930|559333813|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
154975473|NCT01190930|559333814|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
154975474|NCT01190930|559333815|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
154975475|NCT01190930|559333816|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
154975476|NCT01190930|559333817|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
154975477|NCT01190930|559333818|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
154975478|NCT01190930|559333819|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
154975479|NCT01190930|559333820|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
154975480|NCT01190930|559333821|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
154975481|NCT01190930|559333812|FG000|Maintenance|Relapse|0|||
154975482|NCT01190930|559333813|FG001|Maintenance|Relapse|0|||
154975483|NCT01190930|559333814|FG002|Maintenance|Relapse|0|||
154975484|NCT01190930|559333815|FG003|Maintenance|Relapse|2|||
154975485|NCT01190930|559333816|FG004|Maintenance|Relapse|0|||
154975486|NCT01190930|559333817|FG005|Maintenance|Relapse|1|||
154975487|NCT01190930|559333818|FG006|Maintenance|Relapse|6|||
154975488|NCT01190930|559333819|FG007|Maintenance|Relapse|13|||
154975489|NCT01190930|559333820|FG008|Maintenance|Relapse|11|||
154975490|NCT01190930|559333821|FG009|Maintenance|Relapse|11|||
154975491|NCT01190930|559333812|FG000|Maintenance|Still on therapy|0|||
154975492|NCT01190930|559333813|FG001|Maintenance|Still on therapy|8|||
154975493|NCT01190930|559333814|FG002|Maintenance|Still on therapy|0|||
154975494|NCT01190930|559333815|FG003|Maintenance|Still on therapy|29|||
154975495|NCT01190930|559333816|FG004|Maintenance|Still on therapy|0|||
154975496|NCT01190930|559333817|FG005|Maintenance|Still on therapy|0|||
154975497|NCT01190930|559333818|FG006|Maintenance|Still on therapy|0|||
154975498|NCT01190930|559333819|FG007|Maintenance|Still on therapy|0|||
154975499|NCT01190930|559333820|FG008|Maintenance|Still on therapy|0|||
154975500|NCT01190930|559333821|FG009|Maintenance|Still on therapy|0|||
154975501|NCT00035555|559333822|FG000|Overall Study|Adverse Event|5|||
154975502|NCT00035555|559333823|FG001|Overall Study|Adverse Event|8|||
155113553|NCT00489736|559844836|FG000|Overall Study|Not coded/ Not pre-specified|5|||
155113554|NCT00489736|559844837|FG001|Overall Study|Not coded/ Not pre-specified|8|||
155113555|NCT04021524|559844838|FG000|Overall Study|Change in surgical intervention|0|||
155113556|NCT04021524|559844839|FG001|Overall Study|Change in surgical intervention|1|||
155113557|NCT03458910|559844840|FG000|Overall Study|Withdrawal by Subject|7|||
155113558|NCT03458910|559844841|FG001|Overall Study|Withdrawal by Subject|8|||
155175364|NCT00910624|560080227|FG001|Follow-Up Phase|Lost to Follow-up|1|||
154975503|NCT00035555|559333824|FG002|Overall Study|Adverse Event|9|||
154975504|NCT00035555|559333822|FG000|Overall Study|Allograft loss|1|||
154975505|NCT00035555|559333823|FG001|Overall Study|Allograft loss|1|||
154975506|NCT00035555|559333824|FG002|Overall Study|Allograft loss|2|||
154975507|NCT00035555|559333822|FG000|Overall Study|Death|0|||
154975508|NCT00035555|559333823|FG001|Overall Study|Death|0|||
154975509|NCT00035555|559333824|FG002|Overall Study|Death|2|||
155113559|NCT03458910|559844842|FG002|Overall Study|Withdrawal by Subject|6|||
155113560|NCT03458910|559844843|FG003|Overall Study|Withdrawal by Subject|4|||
155113561|NCT03458910|559844840|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
155175365|NCT00910624|560080228|FG002|Follow-Up Phase|Lost to Follow-up|2|||
154975510|NCT00035555|559333822|FG000|Overall Study|Lost to Follow-up|0|||
154975511|NCT00035555|559333823|FG001|Overall Study|Lost to Follow-up|0|||
154975512|NCT00035555|559333824|FG002|Overall Study|Lost to Follow-up|1|||
154975513|NCT00035555|559333822|FG000|Overall Study|Noncompliance|0|||
154975514|NCT00035555|559333823|FG001|Overall Study|Noncompliance|1|||
154975515|NCT00035555|559333824|FG002|Overall Study|Noncompliance|1|||
155175366|NCT00910624|560080229|FG003|Follow-Up Phase|Lost to Follow-up|0|||
155175367|NCT00910624|560080226|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
155175368|NCT00910624|560080227|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
155175369|NCT00910624|560080228|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
155175370|NCT00910624|560080229|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
154882187|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
154882188|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
154882189|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
154882190|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
154882191|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
154882192|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
154882193|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
154882194|NCT02052778|558992349|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882195|NCT02052778|558992350|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882196|NCT02052778|558992351|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882197|NCT02052778|558992352|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882198|NCT02052778|558992353|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882199|NCT02052778|558992354|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882200|NCT02052778|558992355|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882201|NCT02052778|558992356|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882202|NCT02052778|558992357|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882203|NCT02052778|558992358|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882204|NCT02052778|558992359|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882205|NCT02052778|558992360|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882206|NCT02052778|558992361|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882207|NCT02052778|558992362|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882208|NCT02052778|558992363|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882209|NCT02052778|558992364|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882210|NCT02052778|558992365|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882211|NCT02052778|558992366|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882212|NCT02052778|558992367|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882213|NCT02052778|558992368|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882214|NCT02052778|558992369|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882215|NCT02052778|558992370|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
154882216|NCT02052778|558992371|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
154882217|NCT01994226|558992378|FG000|Overall Study|Protocol Violation|13|||
154882218|NCT01994226|558992379|FG001|Overall Study|Protocol Violation|10|||
154882219|NCT01994226|558992378|FG000|Overall Study|Early Cessation of treatment|6|||
154882220|NCT01994226|558992379|FG001|Overall Study|Early Cessation of treatment|11|||
154882221|NCT02345252|558992385|FG000|Double-Blind Phase|Adverse Event|2|||
154882222|NCT02345252|558992386|FG001|Double-Blind Phase|Adverse Event|3|||
154882223|NCT02345252|558992385|FG000|Double-Blind Phase|Death|1|||
154882224|NCT02345252|558992386|FG001|Double-Blind Phase|Death|2|||
154882225|NCT02345252|558992385|FG000|Double-Blind Phase|Lack of Efficacy|1|||
154882226|NCT02345252|558992386|FG001|Double-Blind Phase|Lack of Efficacy|0|||
154882227|NCT02345252|558992385|FG000|Double-Blind Phase|Investigator's Discretion|4|||
154882228|NCT02345252|558992386|FG001|Double-Blind Phase|Investigator's Discretion|6|||
154882229|NCT02345252|558992385|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
154882230|NCT02345252|558992386|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
154882231|NCT02345252|558992385|FG000|Double-Blind Phase|Protocol Violation|2|||
154882232|NCT02345252|558992386|FG001|Double-Blind Phase|Protocol Violation|1|||
154882233|NCT02345252|558992385|FG000|Double-Blind Phase|Withdrew Consent|21|||
154882234|NCT02345252|558992386|FG001|Double-Blind Phase|Withdrew Consent|23|||
154882235|NCT02345252|558992385|FG000|Double-Blind Phase|Lost to Follow-up|8|||
154882236|NCT02345252|558992386|FG001|Double-Blind Phase|Lost to Follow-up|10|||
154882237|NCT02345252|558992385|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
154882238|NCT02345252|558992386|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
154882239|NCT02864940|558992387|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
154882240|NCT02864940|558992388|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
154882241|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
154882242|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154975516|NCT00035555|559333822|FG000|Overall Study|Prohibited medication|1|||
154975517|NCT00035555|559333823|FG001|Overall Study|Prohibited medication|1|||
154882243|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154882244|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154882245|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154882246|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154882247|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154882248|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155175371|NCT00910624|560080226|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
154882249|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154882250|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
154882251|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882252|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882253|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882254|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882255|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882256|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882257|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882258|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154882259|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
154882260|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882261|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882262|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882263|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882264|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882265|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882266|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882267|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154882268|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
154882269|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882270|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882271|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882272|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882273|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882274|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882275|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882276|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
154882277|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
154882278|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882279|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882280|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882281|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882282|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882283|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882284|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882285|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154882286|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
154882287|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882288|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882289|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882290|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882291|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882292|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882293|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882294|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154882295|NCT02175771|558992389|FG000|Run-In Period (Pre-assignment)|Other|8|||
154882296|NCT02175771|558992390|FG001|Run-In Period (Pre-assignment)|Other|0|||
154882297|NCT02175771|558992391|FG002|Run-In Period (Pre-assignment)|Other|0|||
154882298|NCT02175771|558992392|FG003|Run-In Period (Pre-assignment)|Other|0|||
154882299|NCT02175771|558992393|FG004|Run-In Period (Pre-assignment)|Other|0|||
154882300|NCT02175771|558992394|FG005|Run-In Period (Pre-assignment)|Other|0|||
154882301|NCT02175771|558992395|FG006|Run-In Period (Pre-assignment)|Other|0|||
154882302|NCT02175771|558992396|FG007|Run-In Period (Pre-assignment)|Other|0|||
154882303|NCT02175771|558992397|FG008|Run-In Period (Pre-assignment)|Other|0|||
154882304|NCT02175771|558992389|FG000|Treatment Period|Adverse Event|0|||
154882305|NCT02175771|558992390|FG001|Treatment Period|Adverse Event|2|||
154882306|NCT02175771|558992391|FG002|Treatment Period|Adverse Event|1|||
154882307|NCT02175771|558992392|FG003|Treatment Period|Adverse Event|1|||
154882308|NCT02175771|558992393|FG004|Treatment Period|Adverse Event|1|||
154882309|NCT02175771|558992394|FG005|Treatment Period|Adverse Event|3|||
154882310|NCT02175771|558992395|FG006|Treatment Period|Adverse Event|2|||
154882311|NCT02175771|558992396|FG007|Treatment Period|Adverse Event|0|||
154882312|NCT02175771|558992397|FG008|Treatment Period|Adverse Event|1|||
154882313|NCT02175771|558992389|FG000|Treatment Period|Withdrawal by Subject|0|||
154882314|NCT02175771|558992390|FG001|Treatment Period|Withdrawal by Subject|9|||
154882315|NCT02175771|558992391|FG002|Treatment Period|Withdrawal by Subject|3|||
154882316|NCT02175771|558992392|FG003|Treatment Period|Withdrawal by Subject|6|||
154882317|NCT02175771|558992393|FG004|Treatment Period|Withdrawal by Subject|2|||
154882318|NCT02175771|558992394|FG005|Treatment Period|Withdrawal by Subject|4|||
154882319|NCT02175771|558992395|FG006|Treatment Period|Withdrawal by Subject|2|||
154882320|NCT02175771|558992396|FG007|Treatment Period|Withdrawal by Subject|9|||
154882321|NCT02175771|558992397|FG008|Treatment Period|Withdrawal by Subject|2|||
154882322|NCT02175771|558992389|FG000|Treatment Period|Noncompliance|0|||
154882323|NCT02175771|558992390|FG001|Treatment Period|Noncompliance|1|||
154882324|NCT02175771|558992391|FG002|Treatment Period|Noncompliance|2|||
154882325|NCT02175771|558992392|FG003|Treatment Period|Noncompliance|0|||
154882326|NCT02175771|558992393|FG004|Treatment Period|Noncompliance|0|||
154882327|NCT02175771|558992394|FG005|Treatment Period|Noncompliance|0|||
154882328|NCT02175771|558992395|FG006|Treatment Period|Noncompliance|0|||
154882329|NCT02175771|558992396|FG007|Treatment Period|Noncompliance|0|||
154882330|NCT02175771|558992397|FG008|Treatment Period|Noncompliance|1|||
154882331|NCT02175771|558992389|FG000|Treatment Period|Protocol Violation|0|||
154882332|NCT02175771|558992390|FG001|Treatment Period|Protocol Violation|0|||
154882333|NCT02175771|558992391|FG002|Treatment Period|Protocol Violation|0|||
154882334|NCT02175771|558992392|FG003|Treatment Period|Protocol Violation|0|||
154882335|NCT02175771|558992393|FG004|Treatment Period|Protocol Violation|0|||
154882336|NCT02175771|558992394|FG005|Treatment Period|Protocol Violation|0|||
154882337|NCT02175771|558992395|FG006|Treatment Period|Protocol Violation|0|||
154882338|NCT02175771|558992396|FG007|Treatment Period|Protocol Violation|1|||
154882339|NCT02175771|558992397|FG008|Treatment Period|Protocol Violation|0|||
154882340|NCT02175771|558992389|FG000|Treatment Period|Disease progression|0|||
154882341|NCT02175771|558992390|FG001|Treatment Period|Disease progression|0|||
154882342|NCT02175771|558992391|FG002|Treatment Period|Disease progression|0|||
154882343|NCT02175771|558992392|FG003|Treatment Period|Disease progression|0|||
154882344|NCT02175771|558992393|FG004|Treatment Period|Disease progression|0|||
154882345|NCT02175771|558992394|FG005|Treatment Period|Disease progression|0|||
154882346|NCT02175771|558992395|FG006|Treatment Period|Disease progression|0|||
154882347|NCT02175771|558992396|FG007|Treatment Period|Disease progression|2|||
154882348|NCT02175771|558992397|FG008|Treatment Period|Disease progression|0|||
154882349|NCT02175771|558992389|FG000|Treatment Period|Lost to Follow-up|0|||
154882350|NCT02175771|558992390|FG001|Treatment Period|Lost to Follow-up|3|||
154882351|NCT02175771|558992391|FG002|Treatment Period|Lost to Follow-up|1|||
154882352|NCT02175771|558992392|FG003|Treatment Period|Lost to Follow-up|3|||
154882353|NCT02175771|558992393|FG004|Treatment Period|Lost to Follow-up|1|||
154882354|NCT02175771|558992394|FG005|Treatment Period|Lost to Follow-up|2|||
154882355|NCT02175771|558992395|FG006|Treatment Period|Lost to Follow-up|1|||
154882356|NCT02175771|558992396|FG007|Treatment Period|Lost to Follow-up|2|||
154882357|NCT02175771|558992397|FG008|Treatment Period|Lost to Follow-up|2|||
154882358|NCT02175771|558992389|FG000|Treatment Period|Lack of Efficacy|0|||
154882359|NCT02175771|558992390|FG001|Treatment Period|Lack of Efficacy|0|||
154882360|NCT02175771|558992391|FG002|Treatment Period|Lack of Efficacy|0|||
154882361|NCT02175771|558992392|FG003|Treatment Period|Lack of Efficacy|0|||
154882362|NCT02175771|558992393|FG004|Treatment Period|Lack of Efficacy|0|||
154882363|NCT02175771|558992394|FG005|Treatment Period|Lack of Efficacy|1|||
154882364|NCT02175771|558992395|FG006|Treatment Period|Lack of Efficacy|0|||
154882365|NCT02175771|558992396|FG007|Treatment Period|Lack of Efficacy|1|||
154882366|NCT02175771|558992397|FG008|Treatment Period|Lack of Efficacy|0|||
154882367|NCT02175771|558992389|FG000|Treatment Period|Other|0|||
154882368|NCT02175771|558992390|FG001|Treatment Period|Other|1|||
154882369|NCT02175771|558992391|FG002|Treatment Period|Other|0|||
154882370|NCT02175771|558992392|FG003|Treatment Period|Other|3|||
154882371|NCT02175771|558992393|FG004|Treatment Period|Other|1|||
154882372|NCT02175771|558992394|FG005|Treatment Period|Other|0|||
154882373|NCT02175771|558992395|FG006|Treatment Period|Other|0|||
154882374|NCT02175771|558992396|FG007|Treatment Period|Other|2|||
154882375|NCT02175771|558992397|FG008|Treatment Period|Other|0|||
154882376|NCT02232087|558992398|FG000|Overall Study|Withdrawal by Subject|2|||
154882377|NCT02232087|558992399|FG001|Overall Study|Withdrawal by Subject|0|||
154882378|NCT02232087|558992400|FG002|Overall Study|Withdrawal by Subject|0|||
154882379|NCT02232087|558992401|FG003|Overall Study|Withdrawal by Subject|0|||
154882380|NCT02232087|558992402|FG004|Overall Study|Withdrawal by Subject|0|||
154882381|NCT02232087|558992403|FG005|Overall Study|Withdrawal by Subject|1|||
154882382|NCT02232087|558992398|FG000|Overall Study|poor inhalation technique|0|||
154882383|NCT02232087|558992399|FG001|Overall Study|poor inhalation technique|1|||
154882384|NCT02232087|558992400|FG002|Overall Study|poor inhalation technique|0|||
154882385|NCT02232087|558992401|FG003|Overall Study|poor inhalation technique|0|||
154882386|NCT02232087|558992402|FG004|Overall Study|poor inhalation technique|0|||
154882387|NCT02232087|558992403|FG005|Overall Study|poor inhalation technique|2|||
154882388|NCT02232087|558992398|FG000|Overall Study|protocol stop criteria|0|||
154882389|NCT02232087|558992399|FG001|Overall Study|protocol stop criteria|1|||
154882390|NCT02232087|558992400|FG002|Overall Study|protocol stop criteria|0|||
154882391|NCT02232087|558992401|FG003|Overall Study|protocol stop criteria|1|||
154882392|NCT02232087|558992402|FG004|Overall Study|protocol stop criteria|0|||
154882393|NCT02232087|558992403|FG005|Overall Study|protocol stop criteria|0|||
154882394|NCT02232087|558992398|FG000|Overall Study|Adverse Event|0|||
154882395|NCT02232087|558992399|FG001|Overall Study|Adverse Event|0|||
154882396|NCT02232087|558992400|FG002|Overall Study|Adverse Event|0|||
154975518|NCT00035555|559333824|FG002|Overall Study|Prohibited medication|0|||
154975519|NCT00035555|559333822|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
154882397|NCT02232087|558992401|FG003|Overall Study|Adverse Event|0|||
154882398|NCT02232087|558992402|FG004|Overall Study|Adverse Event|1|||
154882399|NCT02232087|558992403|FG005|Overall Study|Adverse Event|0|||
154882400|NCT01958125|558992404|FG000|Overall Study|Missing diary data|2|||
154882401|NCT01958125|558992405|FG001|Overall Study|Missing diary data|6|||
154882402|NCT01958125|558992404|FG000|Overall Study|No headache attacks|0|||
154882403|NCT01958125|558992405|FG001|Overall Study|No headache attacks|2|||
154882404|NCT04096326|558992406|FG000|Overall Study|Withdrawal by Subject|0|||
154882405|NCT04096326|558992407|FG001|Overall Study|Withdrawal by Subject|0|||
154882406|NCT04096326|558992408|FG002|Overall Study|Withdrawal by Subject|0|||
154882407|NCT04096326|558992409|FG003|Overall Study|Withdrawal by Subject|0|||
154882408|NCT04096326|558992410|FG004|Overall Study|Withdrawal by Subject|0|||
154882409|NCT04096326|558992411|FG005|Overall Study|Withdrawal by Subject|0|||
154882410|NCT04096326|558992412|FG006|Overall Study|Withdrawal by Subject|1|||
154882411|NCT04096326|558992413|FG007|Overall Study|Withdrawal by Subject|0|||
154882412|NCT04096326|558992414|FG008|Overall Study|Withdrawal by Subject|0|||
154882413|NCT04096326|558992415|FG009|Overall Study|Withdrawal by Subject|0|||
154882414|NCT04096326|558992406|FG000|Overall Study|Lost to Follow-up|0|||
154882415|NCT04096326|558992407|FG001|Overall Study|Lost to Follow-up|1|||
154882416|NCT04096326|558992408|FG002|Overall Study|Lost to Follow-up|0|||
154882417|NCT04096326|558992409|FG003|Overall Study|Lost to Follow-up|0|||
154882418|NCT04096326|558992410|FG004|Overall Study|Lost to Follow-up|0|||
154882419|NCT04096326|558992411|FG005|Overall Study|Lost to Follow-up|0|||
154882420|NCT04096326|558992412|FG006|Overall Study|Lost to Follow-up|0|||
154882421|NCT04096326|558992413|FG007|Overall Study|Lost to Follow-up|0|||
154882422|NCT04096326|558992414|FG008|Overall Study|Lost to Follow-up|0|||
154882423|NCT04096326|558992415|FG009|Overall Study|Lost to Follow-up|0|||
154882424|NCT04096326|558992406|FG000|Overall Study|COVID-19-related reasons|0|||
154882425|NCT04096326|558992407|FG001|Overall Study|COVID-19-related reasons|0|||
154882426|NCT04096326|558992408|FG002|Overall Study|COVID-19-related reasons|0|||
154882427|NCT04096326|558992409|FG003|Overall Study|COVID-19-related reasons|0|||
154882428|NCT04096326|558992410|FG004|Overall Study|COVID-19-related reasons|1|||
154882429|NCT04096326|558992411|FG005|Overall Study|COVID-19-related reasons|5|||
154882430|NCT04096326|558992412|FG006|Overall Study|COVID-19-related reasons|0|||
154882431|NCT04096326|558992413|FG007|Overall Study|COVID-19-related reasons|0|||
154882432|NCT04096326|558992414|FG008|Overall Study|COVID-19-related reasons|0|||
154882433|NCT04096326|558992415|FG009|Overall Study|COVID-19-related reasons|0|||
154882434|NCT04804033|558992416|FG000|Period 1: DBT Phase|Adverse Event|1|||
154882435|NCT04804033|558992417|FG001|Period 1: DBT Phase|Adverse Event|5|||
154882436|NCT04804033|558992418|FG002|Period 1: DBT Phase|Adverse Event|3|||
154882437|NCT04804033|558992419|FG003|Period 1: DBT Phase|Adverse Event|4|||
154882438|NCT04804033|558992416|FG000|Period 1: DBT Phase|Death|1|||
154882439|NCT04804033|558992417|FG001|Period 1: DBT Phase|Death|0|||
154975520|NCT00035555|559333823|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
154975521|NCT00035555|559333824|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
154975522|NCT00035555|559333822|FG000|Overall Study|Withdrawal by Subject|2|||
154975523|NCT00035555|559333823|FG001|Overall Study|Withdrawal by Subject|0|||
154975524|NCT00035555|559333824|FG002|Overall Study|Withdrawal by Subject|2|||
154975525|NCT00035555|559333822|FG000|Overall Study|Investigator deemed not a good candidate|0|||
154975526|NCT00035555|559333823|FG001|Overall Study|Investigator deemed not a good candidate|0|||
154975527|NCT00035555|559333824|FG002|Overall Study|Investigator deemed not a good candidate|1|||
154975528|NCT00035555|559333822|FG000|Overall Study|Received cyclosporin in error|0|||
154975529|NCT00035555|559333823|FG001|Overall Study|Received cyclosporin in error|0|||
154975530|NCT00035555|559333824|FG002|Overall Study|Received cyclosporin in error|1|||
155113562|NCT03458910|559844841|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
155113563|NCT03458910|559844842|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
155113564|NCT03458910|559844843|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
155113565|NCT05275010|559844844|FG000|Overall Study|Reason Not Specified|4|||
155113566|NCT05275010|559844845|FG001|Overall Study|Reason Not Specified|1|||
154882440|NCT04804033|558992418|FG002|Period 1: DBT Phase|Death|0|||
154882441|NCT04804033|558992419|FG003|Period 1: DBT Phase|Death|0|||
154882442|NCT04804033|558992416|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
154882443|NCT04804033|558992417|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
154882444|NCT04804033|558992418|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
154882445|NCT04804033|558992419|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
154882446|NCT04804033|558992416|FG000|Period 1: DBT Phase|Non-compliance|1|||
154882447|NCT04804033|558992417|FG001|Period 1: DBT Phase|Non-compliance|0|||
154975531|NCT00337428|559333825|FG000|Overall Study|Withdrawal by Subject|1|||
154975532|NCT00337428|559333826|FG001|Overall Study|Withdrawal by Subject|2|||
154882448|NCT04804033|558992418|FG002|Period 1: DBT Phase|Non-compliance|1|||
154882449|NCT04804033|558992419|FG003|Period 1: DBT Phase|Non-compliance|2|||
154882450|NCT04804033|558992416|FG000|Period 1: DBT Phase|Other|0|||
154882451|NCT04804033|558992417|FG001|Period 1: DBT Phase|Other|1|||
154882452|NCT04804033|558992418|FG002|Period 1: DBT Phase|Other|0|||
154882453|NCT04804033|558992419|FG003|Period 1: DBT Phase|Other|0|||
154882454|NCT04804033|558992416|FG000|Period 1: DBT Phase|Pregnancy|2|||
154882455|NCT04804033|558992417|FG001|Period 1: DBT Phase|Pregnancy|0|||
154882456|NCT04804033|558992418|FG002|Period 1: DBT Phase|Pregnancy|0|||
154882457|NCT04804033|558992419|FG003|Period 1: DBT Phase|Pregnancy|0|||
154882458|NCT04804033|558992416|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
154882459|NCT04804033|558992417|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
154882460|NCT04804033|558992418|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
154882461|NCT04804033|558992419|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
154882462|NCT04804033|558992416|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
154882463|NCT04804033|558992417|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
154882464|NCT04804033|558992418|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
154882465|NCT04804033|558992419|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
154882466|NCT04804033|558992416|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
154882467|NCT04804033|558992417|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
154882468|NCT04804033|558992418|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
154882469|NCT04804033|558992419|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
154882470|NCT04804033|558992416|FG000|Period 2: OLE Phase|Adverse Event|3|||
154882471|NCT04804033|558992417|FG001|Period 2: OLE Phase|Adverse Event|4|||
154882472|NCT04804033|558992418|FG002|Period 2: OLE Phase|Adverse Event|2|||
154882473|NCT04804033|558992419|FG003|Period 2: OLE Phase|Adverse Event|0|||
154882474|NCT04804033|558992416|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
154882475|NCT04804033|558992417|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
154882476|NCT04804033|558992418|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
154882477|NCT04804033|558992419|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
154975533|NCT00337428|559333825|FG000|Overall Study|Lack of Time|1|||
154975534|NCT00337428|559333826|FG001|Overall Study|Lack of Time|1|||
154975535|NCT00337428|559333825|FG000|Overall Study|Unwilling to Continue|1|||
154975536|NCT00337428|559333826|FG001|Overall Study|Unwilling to Continue|0|||
154975537|NCT00337428|559333825|FG000|Overall Study|Anorexia|1|||
154975538|NCT00337428|559333826|FG001|Overall Study|Anorexia|0|||
154975539|NCT02618382|559333827|FG000|Overall Study|Physician Decision|1|||
154975540|NCT02618382|559333827|FG000|Overall Study|Withdrawal by Subject|1|||
154975541|NCT02618382|559333827|FG000|Overall Study|Protocol Violation|1|||
154975542|NCT04886063|559333830|FG000|Overall Study|Adverse Event|50|||
154975543|NCT04886063|559333830|FG000|Overall Study|Lack of Efficacy|31|||
154975544|NCT04886063|559333830|FG000|Overall Study|Withdrawal by Subject|45|||
154975545|NCT04886063|559333830|FG000|Overall Study|Physician Decision|3|||
154975546|NCT04886063|559333830|FG000|Overall Study|Protocol Violation|3|||
154975547|NCT04886063|559333830|FG000|Overall Study|Site closure|4|||
154975548|NCT04886063|559333830|FG000|Overall Study|Nursing home replacement|3|||
154975549|NCT04886063|559333830|FG000|Overall Study|Lost to Follow-up|5|||
154975550|NCT04886063|559333830|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
154975551|NCT04886063|559333830|FG000|Overall Study|>1 reason|20|||
154975552|NCT02914457|559333831|FG000|Overall Study|Withdrawal by Subject|1|||
154975553|NCT02914457|559333831|FG000|Overall Study|Physician Decision|1|||
154975554|NCT02914457|559333831|FG000|Overall Study|No veins available for lead placement|1|||
154975555|NCT02914457|559333831|FG000|Overall Study|Electrical instability of patient|1|||
154975556|NCT02914457|559333831|FG000|Overall Study|ECG acquisition error due to sweating|1|||
154975557|NCT02914457|559333831|FG000|Overall Study|Protocol Violation|1|||
154975558|NCT00721955|559333834|FG000|Overall Study|Adverse Event|0|||
154975559|NCT00721955|559333835|FG001|Overall Study|Adverse Event|0|||
154975560|NCT00721955|559333836|FG002|Overall Study|Adverse Event|2|||
154975561|NCT01206439|559333837|FG000|Overall Study|subject did not meet inclusion criteria|1|||
154975562|NCT01055886|559333839|FG000|Overall Study|Withdrawal by Subject|4|||
155113567|NCT05275010|559844844|FG000|Overall Study|Withdrawal by Subject|1|||
155113568|NCT05275010|559844845|FG001|Overall Study|Withdrawal by Subject|0|||
154882478|NCT04804033|558992416|FG000|Period 2: OLE Phase|Non-compliance|2|||
154882479|NCT04804033|558992417|FG001|Period 2: OLE Phase|Non-compliance|2|||
154882480|NCT04804033|558992418|FG002|Period 2: OLE Phase|Non-compliance|0|||
154882481|NCT04804033|558992419|FG003|Period 2: OLE Phase|Non-compliance|1|||
154882482|NCT04804033|558992416|FG000|Period 2: OLE Phase|Other|0|||
154882483|NCT04804033|558992417|FG001|Period 2: OLE Phase|Other|2|||
154882484|NCT04804033|558992418|FG002|Period 2: OLE Phase|Other|0|||
154882485|NCT04804033|558992419|FG003|Period 2: OLE Phase|Other|0|||
154882486|NCT04804033|558992416|FG000|Period 2: OLE Phase|Physician Decision|1|||
154882487|NCT04804033|558992417|FG001|Period 2: OLE Phase|Physician Decision|1|||
154975563|NCT01055886|559333840|FG001|Overall Study|Withdrawal by Subject|9|||
154975564|NCT01055886|559333839|FG000|Overall Study|Lost to Follow-up|1|||
155113569|NCT05275010|559844844|FG000|Overall Study|Lost to Follow-up|0|||
155113570|NCT05275010|559844845|FG001|Overall Study|Lost to Follow-up|1|||
154882488|NCT04804033|558992418|FG002|Period 2: OLE Phase|Physician Decision|0|||
154882489|NCT04804033|558992419|FG003|Period 2: OLE Phase|Physician Decision|0|||
154882490|NCT04804033|558992416|FG000|Period 2: OLE Phase|Pregnancy|0|||
154882491|NCT04804033|558992417|FG001|Period 2: OLE Phase|Pregnancy|0|||
154975565|NCT01055886|559333840|FG001|Overall Study|Lost to Follow-up|1|||
154975566|NCT01055886|559333839|FG000|Overall Study|Withdrawal by PI|0|||
155113571|NCT00967694|559844848|FG000|Overall Study|Withdrawal by Subject|6|||
155113572|NCT00152477|559844851|FG000|Chemotherapy Period|Adverse Event|9|||
155113573|NCT00152477|559844852|FG001|Chemotherapy Period|Adverse Event|4|||
155113574|NCT00152477|559844853|FG002|Chemotherapy Period|Adverse Event|5|||
155113575|NCT00152477|559844851|FG000|Chemotherapy Period|Death|1|||
155113576|NCT00152477|559844852|FG001|Chemotherapy Period|Death|3|||
154882492|NCT04804033|558992418|FG002|Period 2: OLE Phase|Pregnancy|2|||
154882493|NCT04804033|558992419|FG003|Period 2: OLE Phase|Pregnancy|0|||
154882494|NCT04804033|558992416|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
154882495|NCT04804033|558992417|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
154882496|NCT04804033|558992418|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
154882497|NCT04804033|558992419|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
154882498|NCT04804033|558992416|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
154882499|NCT04804033|558992417|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
154882500|NCT04804033|558992418|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
154882501|NCT04804033|558992419|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
154882502|NCT04804033|558992416|FG000|Period 2: OLE Phase|Not reported|0|||
154882503|NCT04804033|558992417|FG001|Period 2: OLE Phase|Not reported|2|||
154882504|NCT04804033|558992418|FG002|Period 2: OLE Phase|Not reported|0|||
154882505|NCT04804033|558992419|FG003|Period 2: OLE Phase|Not reported|0|||
154882506|NCT04804033|558992416|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
154882507|NCT04804033|558992417|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
154882508|NCT04804033|558992418|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
154882509|NCT04804033|558992419|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
154882510|NCT04804033|558992416|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
154882511|NCT04804033|558992417|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
154882512|NCT04804033|558992418|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
154882513|NCT04804033|558992419|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
154882514|NCT04804033|558992416|FG000|Period 3: Follow-up Phase|Other|0|||
154882515|NCT04804033|558992417|FG001|Period 3: Follow-up Phase|Other|1|||
154882516|NCT04804033|558992418|FG002|Period 3: Follow-up Phase|Other|2|||
154882517|NCT04804033|558992419|FG003|Period 3: Follow-up Phase|Other|1|||
154882518|NCT04804033|558992416|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
154882519|NCT04804033|558992417|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
154882520|NCT04804033|558992418|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
154882521|NCT04804033|558992419|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
154882522|NCT04804033|558992416|FG000|Period 3: Follow-up Phase|Not reported|18|||
154882523|NCT04804033|558992417|FG001|Period 3: Follow-up Phase|Not reported|15|||
154882524|NCT04804033|558992418|FG002|Period 3: Follow-up Phase|Not reported|1|||
154882525|NCT04804033|558992419|FG003|Period 3: Follow-up Phase|Not reported|4|||
154882526|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
154882527|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
154882528|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
154882529|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
154882530|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
154882531|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
154882532|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
154882533|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
154882534|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
154882535|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
154882536|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
154882537|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
154882538|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
154882539|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
154882540|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
154882541|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
154882542|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
154882543|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
154882544|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
154882545|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
154882546|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
154882547|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
154882548|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
154882549|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
154882550|NCT01106625|558992422|FG000|Core Period: Baseline to Week 26|Other|8|||
154882551|NCT01106625|558992423|FG001|Core Period: Baseline to Week 26|Other|7|||
154882552|NCT01106625|558992424|FG002|Core Period: Baseline to Week 26|Other|4|||
154882553|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
154882554|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
154882555|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
154975567|NCT01055886|559333840|FG001|Overall Study|Withdrawal by PI|1|||
154975568|NCT04254809|559333843|FG000|Overall Study|Lost to Follow-up|5|||
154975569|NCT04254809|559333844|FG001|Overall Study|Lost to Follow-up|10|||
154975570|NCT01928615|559333845|FG000|Overall Study|Study Terminated by Sponsor|2|||
154975571|NCT00434837|559333850|FG000|Overall Study|Lost to Follow-up|20|||
154975572|NCT00434837|559333851|FG001|Overall Study|Lost to Follow-up|23|||
154975573|NCT00434837|559333852|FG002|Overall Study|Lost to Follow-up|30|||
154975574|NCT01077258|559333853|FG000|Overall Study|Lost to Follow-up|1390|||
154975575|NCT01077258|559333853|FG000|Overall Study|Adverse drug reaction|218|||
154975576|NCT01077258|559333853|FG000|Overall Study|Lack of Efficacy|663|||
154975577|NCT01077258|559333853|FG000|Overall Study|Clinical remission|37|||
154975578|NCT01077258|559333853|FG000|Overall Study|Other reasons|260|||
154975579|NCT00726895|559333854|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
154975580|NCT00726895|559333855|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
154975581|NCT02608476|559333866|FG000|Overall Study|Withdrawal by Subject|30|||
154975582|NCT02608476|559333867|FG001|Overall Study|Withdrawal by Subject|37|||
154975583|NCT02608476|559333866|FG000|Overall Study|Lost to Follow-up|24|||
154975584|NCT02608476|559333867|FG001|Overall Study|Lost to Follow-up|24|||
154975585|NCT02608476|559333866|FG000|Overall Study|Adverse Event|2|||
154975586|NCT02608476|559333867|FG001|Overall Study|Adverse Event|8|||
154975587|NCT02608476|559333866|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
154975588|NCT02608476|559333867|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
154975589|NCT02608476|559333866|FG000|Overall Study|Noncompliance with treatment|1|||
154975590|NCT02608476|559333867|FG001|Overall Study|Noncompliance with treatment|5|||
154975591|NCT02608476|559333866|FG000|Overall Study|Lack of Efficacy|3|||
154975592|NCT02608476|559333867|FG001|Overall Study|Lack of Efficacy|1|||
154975593|NCT02608476|559333866|FG000|Overall Study|Other|0|||
154975594|NCT02608476|559333867|FG001|Overall Study|Other|1|||
154975595|NCT02608476|559333866|FG000|Overall Study|Physician Decision|1|||
154975596|NCT02608476|559333867|FG001|Overall Study|Physician Decision|0|||
154975597|NCT02608476|559333866|FG000|Overall Study|Pregnancy|0|||
154975598|NCT02608476|559333867|FG001|Overall Study|Pregnancy|1|||
155113577|NCT00152477|559844853|FG002|Chemotherapy Period|Death|3|||
155113578|NCT00152477|559844851|FG000|Chemotherapy Period|Lack of Efficacy|4|||
154882556|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
154882557|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
154882558|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
154882559|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
154882560|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
154882561|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
154882562|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
154882563|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
154882564|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
154882565|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
154882566|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
154882567|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
154882568|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
154882569|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
154882570|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
154882571|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
154882572|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
154882573|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
154882574|NCT01106625|558992422|FG000|Extension Period: Week 26 to Week 52|Other|5|||
154882575|NCT01106625|558992423|FG001|Extension Period: Week 26 to Week 52|Other|5|||
154882576|NCT01106625|558992424|FG002|Extension Period: Week 26 to Week 52|Other|4|||
154882577|NCT02496585|558992425|FG000|Overall Study|Death|3|||
154882578|NCT02496585|558992426|FG001|Overall Study|Death|0|||
154975599|NCT02608476|559333866|FG000|Overall Study|Progressive disease|1|||
154975600|NCT02608476|559333867|FG001|Overall Study|Progressive disease|0|||
154975601|NCT04660032|559333873|FG000|Overall Study|Protocol Violation|1|||
154975602|NCT04660032|559333874|FG001|Overall Study|Protocol Violation|1|||
154975603|NCT01266603|559333877|FG000|Overall Study|Adverse Event|1|||
154975604|NCT01266603|559333877|FG000|Overall Study|Lack of Efficacy|14|||
154975605|NCT01266603|559333877|FG000|Overall Study|Withdrawal by Subject|1|||
154975606|NCT01266603|559333877|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
154975607|NCT02725411|559333878|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
154975608|NCT02725411|559333879|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
155113579|NCT00152477|559844852|FG001|Chemotherapy Period|Lack of Efficacy|5|||
154975609|NCT02725411|559333880|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
154975610|NCT02725411|559333878|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
154975611|NCT02725411|559333879|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
154975612|NCT02725411|559333880|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
155113580|NCT00152477|559844853|FG002|Chemotherapy Period|Lack of Efficacy|6|||
154882579|NCT02496585|558992425|FG000|Overall Study|Lost to Follow-up|2|||
154882580|NCT02496585|558992426|FG001|Overall Study|Lost to Follow-up|0|||
154882581|NCT02496585|558992425|FG000|Overall Study|Withdrawal by Subject|1|||
154882582|NCT02496585|558992426|FG001|Overall Study|Withdrawal by Subject|2|||
154882583|NCT02496585|558992425|FG000|Overall Study|Progression of Malignancy|4|||
154882584|NCT02496585|558992426|FG001|Overall Study|Progression of Malignancy|1|||
154882585|NCT01276457|558992427|FG000|Core Study|Adverse Event|6|||
154882586|NCT01276457|558992428|FG001|Core Study|Adverse Event|3|||
154882587|NCT01276457|558992427|FG000|Core Study|Lost to Follow-up|1|||
154882588|NCT01276457|558992428|FG001|Core Study|Lost to Follow-up|2|||
154882589|NCT01276457|558992427|FG000|Core Study|Administrative problems|1|||
154882590|NCT01276457|558992428|FG001|Core Study|Administrative problems|1|||
154882591|NCT01276457|558992427|FG000|Core Study|Death|2|||
154882592|NCT01276457|558992428|FG001|Core Study|Death|2|||
154882593|NCT01276457|558992427|FG000|Core Study|Lack of Efficacy|3|||
154882594|NCT01276457|558992428|FG001|Core Study|Lack of Efficacy|12|||
154882595|NCT01276457|558992427|FG000|Extension Study|Lost to Follow-up|3|||
154882596|NCT01276457|558992428|FG001|Extension Study|Lost to Follow-up|0|||
154882597|NCT01276457|558992427|FG000|Extension Study|Death|0|||
154882598|NCT01276457|558992428|FG001|Extension Study|Death|1|||
154882599|NCT01276457|558992427|FG000|Extension Study|Lack of Efficacy|3|||
154882600|NCT01276457|558992428|FG001|Extension Study|Lack of Efficacy|1|||
154882601|NCT04360187|558992429|FG000|Double-Blind Treatment|Adverse Event|9|||
154882602|NCT04360187|558992430|FG001|Double-Blind Treatment|Adverse Event|11|||
154882603|NCT04360187|558992429|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
154882604|NCT04360187|558992430|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
154882605|NCT04360187|558992429|FG000|Double-Blind Treatment|Physician Decision|1|||
154882606|NCT04360187|558992430|FG001|Double-Blind Treatment|Physician Decision|0|||
154882607|NCT04360187|558992429|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
154882608|NCT04360187|558992430|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
154882609|NCT04360187|558992429|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
154882610|NCT04360187|558992430|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
154882611|NCT04360187|558992429|FG000|Follow-Up|Lost to Follow-up|1|||
154882612|NCT04360187|558992430|FG001|Follow-Up|Lost to Follow-up|0|||
154882613|NCT02203838|558992431|FG000|Overall Study|Lack of Efficacy|7|||
154882614|NCT02203838|558992432|FG001|Overall Study|Lack of Efficacy|0|||
154882615|NCT02203838|558992433|FG002|Overall Study|Lack of Efficacy|1|||
154882616|NCT02203838|558992434|FG003|Overall Study|Lack of Efficacy|1|||
154882617|NCT02203838|558992431|FG000|Overall Study|Adverse Event|46|||
154882618|NCT02203838|558992432|FG001|Overall Study|Adverse Event|6|||
154882619|NCT02203838|558992433|FG002|Overall Study|Adverse Event|3|||
154882620|NCT02203838|558992434|FG003|Overall Study|Adverse Event|2|||
154882621|NCT02203838|558992431|FG000|Overall Study|Lost to Follow-up|39|||
154882622|NCT02203838|558992432|FG001|Overall Study|Lost to Follow-up|3|||
154882623|NCT02203838|558992433|FG002|Overall Study|Lost to Follow-up|2|||
154882624|NCT02203838|558992434|FG003|Overall Study|Lost to Follow-up|1|||
154882625|NCT02203838|558992431|FG000|Overall Study|Protocol Violation|7|||
154882626|NCT02203838|558992432|FG001|Overall Study|Protocol Violation|3|||
154882627|NCT02203838|558992433|FG002|Overall Study|Protocol Violation|0|||
154882628|NCT02203838|558992434|FG003|Overall Study|Protocol Violation|0|||
154882629|NCT02203838|558992431|FG000|Overall Study|Withdrawal by Subject|83|||
154882630|NCT02203838|558992432|FG001|Overall Study|Withdrawal by Subject|10|||
154882631|NCT02203838|558992433|FG002|Overall Study|Withdrawal by Subject|8|||
154882632|NCT02203838|558992434|FG003|Overall Study|Withdrawal by Subject|11|||
154882633|NCT02203838|558992431|FG000|Overall Study|Physician Decision|27|||
154882634|NCT02203838|558992432|FG001|Overall Study|Physician Decision|0|||
154882635|NCT02203838|558992433|FG002|Overall Study|Physician Decision|2|||
154882636|NCT02203838|558992434|FG003|Overall Study|Physician Decision|3|||
154882637|NCT02203838|558992431|FG000|Overall Study|Other|1|||
154882638|NCT02203838|558992432|FG001|Overall Study|Other|0|||
154882639|NCT02203838|558992433|FG002|Overall Study|Other|0|||
154882640|NCT02203838|558992434|FG003|Overall Study|Other|0|||
154882641|NCT00496873|558992435|FG000|Overall Study|Ineligible|2|||
154882642|NCT00496873|558992435|FG000|Overall Study|Death|2|||
154882643|NCT00496873|558992435|FG000|Overall Study|Withdrawal by Subject|3|||
154882644|NCT01842620|558992436|FG000|Period 1|Withdrawal by Subject|1|||
154882645|NCT01842620|558992437|FG001|Period 1|Withdrawal by Subject|0|||
154882646|NCT02435277|558992440|FG000|Overall Study|Adverse Event|1|||
154882647|NCT02435277|558992441|FG001|Overall Study|Adverse Event|1|||
154882648|NCT02435277|558992442|FG002|Overall Study|Adverse Event|0|||
154882649|NCT02435277|558992443|FG003|Overall Study|Adverse Event|0|||
154882650|NCT02435277|558992440|FG000|Overall Study|Withdrawal by Subject|1|||
154882651|NCT02435277|558992441|FG001|Overall Study|Withdrawal by Subject|0|||
154882652|NCT02435277|558992442|FG002|Overall Study|Withdrawal by Subject|0|||
154882653|NCT02435277|558992443|FG003|Overall Study|Withdrawal by Subject|0|||
154882654|NCT02635737|558992446|FG000|Overall Study|Protocol Violation|1|||
154882655|NCT00165841|558994210|FG000|Overall Study|Adverse Event|2|||
154882656|NCT00165841|558994211|FG001|Overall Study|Adverse Event|3|||
154882657|NCT00165841|558994210|FG000|Overall Study|Lack of Efficacy|6|||
154882658|NCT00165841|558994211|FG001|Overall Study|Lack of Efficacy|33|||
155113581|NCT00152477|559844851|FG000|Chemotherapy Period|Lost to Follow-up|1|||
155113582|NCT00152477|559844852|FG001|Chemotherapy Period|Lost to Follow-up|0|||
154882659|NCT00165841|558994210|FG000|Overall Study|Lost to Follow-up|4|||
154882660|NCT00165841|558994211|FG001|Overall Study|Lost to Follow-up|4|||
154882661|NCT00165841|558994210|FG000|Overall Study|Withdrawal by Subject|7|||
154882662|NCT00165841|558994211|FG001|Overall Study|Withdrawal by Subject|8|||
154882663|NCT00165841|558994210|FG000|Overall Study|Physician Decision|1|||
154882664|NCT00165841|558994211|FG001|Overall Study|Physician Decision|0|||
154882665|NCT00165841|558994210|FG000|Overall Study|Protocol Violation|6|||
154882666|NCT00165841|558994211|FG001|Overall Study|Protocol Violation|8|||
154882667|NCT00165841|558994210|FG000|Overall Study|Other|3|||
154882668|NCT00165841|558994211|FG001|Overall Study|Other|5|||
154882669|NCT00165841|558994210|FG000|Overall Study|Medication Noncompliance|1|||
154882670|NCT00165841|558994211|FG001|Overall Study|Medication Noncompliance|1|||
154882671|NCT01000727|558994212|FG000|Overall Study|Lost to Follow-up|41|||
154882672|NCT01000727|558994213|FG001|Overall Study|Lost to Follow-up|43|||
154882673|NCT01000727|558994212|FG000|Overall Study|Withdrawal by Subject|111|||
154882674|NCT01000727|558994213|FG001|Overall Study|Withdrawal by Subject|109|||
154882675|NCT01000727|558994212|FG000|Overall Study|Study closed/terminated|23|||
154882676|NCT01000727|558994213|FG001|Overall Study|Study closed/terminated|24|||
154882677|NCT01026389|558994217|FG000|Overall Study|Withdrawal by Subject|1|||
154882678|NCT01026389|558994218|FG001|Overall Study|Withdrawal by Subject|3|||
154882679|NCT01026389|558994217|FG000|Overall Study|change of treatment, patient moved|4|||
154882680|NCT01026389|558994218|FG001|Overall Study|change of treatment, patient moved|2|||
154882681|NCT01697267|558994219|FG000|Overall Study|Death|3|||
154882682|NCT01697267|558994220|FG001|Overall Study|Death|1|||
154882683|NCT01697267|558994219|FG000|Overall Study|Withdrawal by Subject|5|||
154882684|NCT01697267|558994220|FG001|Overall Study|Withdrawal by Subject|5|||
154882685|NCT01697267|558994219|FG000|Overall Study|Adverse Event|2|||
154882686|NCT01697267|558994220|FG001|Overall Study|Adverse Event|1|||
154882687|NCT01697267|558994219|FG000|Overall Study|Lost to Follow-up|2|||
154882688|NCT01697267|558994220|FG001|Overall Study|Lost to Follow-up|4|||
154882689|NCT01697267|558994219|FG000|Overall Study|Physician Decision|2|||
154882690|NCT01697267|558994220|FG001|Overall Study|Physician Decision|4|||
154882691|NCT03544268|558994221|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
154882692|NCT03544268|558994222|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
154882693|NCT04410198|558994223|FG000|Overall Study|Death|10|||
154882694|NCT04410198|558994223|FG000|Overall Study|Withdrawal by Subject|7|||
154882695|NCT04410198|558994223|FG000|Overall Study|Transferred/Relocation|4|||
154882696|NCT04410198|558994223|FG000|Overall Study|Kidney Transplant|9|||
154882697|NCT04410198|558994223|FG000|Overall Study|Adverse Event|4|||
154882698|NCT04410198|558994223|FG000|Overall Study|Physician Decision|2|||
154882699|NCT04410198|558994223|FG000|Overall Study|Other than specified|1|||
154882700|NCT02006667|558994224|FG000|Overall Study|Adverse Event|3|||
154882701|NCT02006667|558994224|FG000|Overall Study|Death|2|||
154882702|NCT02006667|558994224|FG000|Overall Study|Withdrawal by Subject|1|||
154882703|NCT02796391|558994227|FG000|Overall Study|Lost to Follow-up|2|||
154882704|NCT02796391|558994228|FG001|Overall Study|Lost to Follow-up|2|||
154882705|NCT02796391|558994229|FG002|Overall Study|Lost to Follow-up|13|||
154882706|NCT02796391|558994230|FG003|Overall Study|Lost to Follow-up|8|||
154882707|NCT02796391|558994231|FG004|Overall Study|Lost to Follow-up|14|||
154882708|NCT02796391|558994232|FG005|Overall Study|Lost to Follow-up|13|||
154882709|NCT02796391|558994227|FG000|Overall Study|COVID|0|||
154882710|NCT02796391|558994228|FG001|Overall Study|COVID|0|||
154882711|NCT02796391|558994229|FG002|Overall Study|COVID|5|||
154882712|NCT02796391|558994230|FG003|Overall Study|COVID|5|||
154882713|NCT02796391|558994231|FG004|Overall Study|COVID|2|||
154882714|NCT02796391|558994232|FG005|Overall Study|COVID|4|||
154882715|NCT02796391|558994227|FG000|Overall Study|Participant did not like study cigarettes|0|||
154882716|NCT02796391|558994228|FG001|Overall Study|Participant did not like study cigarettes|0|||
154882717|NCT02796391|558994229|FG002|Overall Study|Participant did not like study cigarettes|3|||
155113583|NCT00152477|559844853|FG002|Chemotherapy Period|Lost to Follow-up|1|||
155113584|NCT00152477|559844851|FG000|Chemotherapy Period|Protocol Violation|1|||
155113585|NCT00152477|559844852|FG001|Chemotherapy Period|Protocol Violation|1|||
155113586|NCT00152477|559844853|FG002|Chemotherapy Period|Protocol Violation|0|||
155113587|NCT00152477|559844851|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
155113588|NCT00152477|559844852|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
154882718|NCT02796391|558994230|FG003|Overall Study|Participant did not like study cigarettes|0|||
154882719|NCT02796391|558994231|FG004|Overall Study|Participant did not like study cigarettes|0|||
154882720|NCT02796391|558994232|FG005|Overall Study|Participant did not like study cigarettes|0|||
154882721|NCT02796391|558994227|FG000|Overall Study|Withdrawal by Subject|1|||
154882722|NCT02796391|558994228|FG001|Overall Study|Withdrawal by Subject|1|||
154882723|NCT02796391|558994229|FG002|Overall Study|Withdrawal by Subject|4|||
154882724|NCT02796391|558994230|FG003|Overall Study|Withdrawal by Subject|3|||
154882725|NCT02796391|558994231|FG004|Overall Study|Withdrawal by Subject|4|||
154882726|NCT02796391|558994232|FG005|Overall Study|Withdrawal by Subject|3|||
155113589|NCT00152477|559844853|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
154882727|NCT02796391|558994227|FG000|Overall Study|Adverse Event|0|||
154882728|NCT02796391|558994228|FG001|Overall Study|Adverse Event|0|||
154882729|NCT02796391|558994229|FG002|Overall Study|Adverse Event|0|||
154882730|NCT02796391|558994230|FG003|Overall Study|Adverse Event|1|||
154882731|NCT02796391|558994231|FG004|Overall Study|Adverse Event|0|||
154882732|NCT02796391|558994232|FG005|Overall Study|Adverse Event|0|||
154882733|NCT02796391|558994227|FG000|Overall Study|Protocol Violation|0|||
154882734|NCT02796391|558994228|FG001|Overall Study|Protocol Violation|0|||
154882735|NCT02796391|558994229|FG002|Overall Study|Protocol Violation|0|||
154882736|NCT02796391|558994230|FG003|Overall Study|Protocol Violation|1|||
154882737|NCT02796391|558994231|FG004|Overall Study|Protocol Violation|0|||
154882738|NCT02796391|558994232|FG005|Overall Study|Protocol Violation|0|||
154882739|NCT02695524|558994233|FG000|Overall Study|Lost to Follow-up|3|||
154882740|NCT02695524|558994234|FG001|Overall Study|Lost to Follow-up|2|||
154882741|NCT02695524|558994233|FG000|Overall Study|Death|0|||
154882742|NCT02695524|558994234|FG001|Overall Study|Death|1|||
154882743|NCT00377611|558994235|FG000|Overall Study|Adverse Event|2|||
154882744|NCT00377611|558994236|FG001|Overall Study|Adverse Event|9|||
154882745|NCT00377611|558994235|FG000|Overall Study|Protocol Violation|2|||
154882746|NCT00377611|558994236|FG001|Overall Study|Protocol Violation|0|||
154882747|NCT00377611|558994235|FG000|Overall Study|Withdrawal by Subject|0|||
154882748|NCT00377611|558994236|FG001|Overall Study|Withdrawal by Subject|5|||
154882749|NCT00377611|558994235|FG000|Overall Study|Lost to Follow-up|18|||
154882750|NCT00377611|558994236|FG001|Overall Study|Lost to Follow-up|16|||
154882751|NCT00377611|558994235|FG000|Overall Study|Other|0|||
154882752|NCT00377611|558994236|FG001|Overall Study|Other|3|||
154882753|NCT00798655|558994242|FG000|Overall Study|Did not receive at least one dose of pan|2|||
154882754|NCT03712345|558994243|FG000|Overall Study|Failure to meet randomization criteria|0|||
154882755|NCT03712345|558994244|FG001|Overall Study|Failure to meet randomization criteria|0|||
154882756|NCT03712345|558994245|FG002|Overall Study|Failure to meet randomization criteria|1|||
154882757|NCT00960934|558994246|FG000|Overall Study|Adverse Event|2|||
154882758|NCT00960934|558994247|FG001|Overall Study|Adverse Event|3|||
154882759|NCT00960934|558994248|FG002|Overall Study|Adverse Event|3|||
154882760|NCT00960934|558994249|FG003|Overall Study|Adverse Event|2|||
154882761|NCT00960934|558994250|FG004|Overall Study|Adverse Event|4|||
154882762|NCT00960934|558994251|FG005|Overall Study|Adverse Event|3|||
154882763|NCT00960934|558994246|FG000|Overall Study|Lack of Efficacy|1|||
154882764|NCT00960934|558994247|FG001|Overall Study|Lack of Efficacy|0|||
154882765|NCT00960934|558994248|FG002|Overall Study|Lack of Efficacy|0|||
154882766|NCT00960934|558994249|FG003|Overall Study|Lack of Efficacy|0|||
154882767|NCT00960934|558994250|FG004|Overall Study|Lack of Efficacy|0|||
154882768|NCT00960934|558994251|FG005|Overall Study|Lack of Efficacy|0|||
154882769|NCT00960934|558994246|FG000|Overall Study|Lost to Follow-up|0|||
154882770|NCT00960934|558994247|FG001|Overall Study|Lost to Follow-up|1|||
154882771|NCT00960934|558994248|FG002|Overall Study|Lost to Follow-up|0|||
154882772|NCT00960934|558994249|FG003|Overall Study|Lost to Follow-up|0|||
154882773|NCT00960934|558994250|FG004|Overall Study|Lost to Follow-up|0|||
154882774|NCT00960934|558994251|FG005|Overall Study|Lost to Follow-up|0|||
154882775|NCT00960934|558994246|FG000|Overall Study|Other|2|||
154882776|NCT00960934|558994247|FG001|Overall Study|Other|1|||
154882777|NCT00960934|558994248|FG002|Overall Study|Other|5|||
154882778|NCT00960934|558994249|FG003|Overall Study|Other|4|||
154882779|NCT00960934|558994250|FG004|Overall Study|Other|2|||
154882780|NCT00960934|558994251|FG005|Overall Study|Other|2|||
154882781|NCT00960934|558994246|FG000|Overall Study|Physician Decision|0|||
154882782|NCT00960934|558994247|FG001|Overall Study|Physician Decision|1|||
154882783|NCT00960934|558994248|FG002|Overall Study|Physician Decision|0|||
154882784|NCT00960934|558994249|FG003|Overall Study|Physician Decision|0|||
154882785|NCT00960934|558994250|FG004|Overall Study|Physician Decision|0|||
154882786|NCT00960934|558994251|FG005|Overall Study|Physician Decision|0|||
154882787|NCT00960934|558994246|FG000|Overall Study|Progressive Disease|1|||
154882788|NCT00960934|558994247|FG001|Overall Study|Progressive Disease|1|||
154882789|NCT00960934|558994248|FG002|Overall Study|Progressive Disease|0|||
154882790|NCT00960934|558994249|FG003|Overall Study|Progressive Disease|0|||
154882791|NCT00960934|558994250|FG004|Overall Study|Progressive Disease|1|||
154882792|NCT00960934|558994251|FG005|Overall Study|Progressive Disease|1|||
154882793|NCT00960934|558994246|FG000|Overall Study|Protocol Violation|3|||
154882794|NCT00960934|558994247|FG001|Overall Study|Protocol Violation|4|||
154882795|NCT00960934|558994248|FG002|Overall Study|Protocol Violation|0|||
154882796|NCT00960934|558994249|FG003|Overall Study|Protocol Violation|3|||
154882797|NCT00960934|558994250|FG004|Overall Study|Protocol Violation|3|||
154882798|NCT00960934|558994251|FG005|Overall Study|Protocol Violation|2|||
154882799|NCT00960934|558994246|FG000|Overall Study|Withdrawal by Subject|5|||
154882800|NCT00960934|558994247|FG001|Overall Study|Withdrawal by Subject|6|||
154882801|NCT00960934|558994248|FG002|Overall Study|Withdrawal by Subject|4|||
154882802|NCT00960934|558994249|FG003|Overall Study|Withdrawal by Subject|5|||
154882803|NCT00960934|558994250|FG004|Overall Study|Withdrawal by Subject|5|||
154882804|NCT00960934|558994251|FG005|Overall Study|Withdrawal by Subject|7|||
154882805|NCT00960934|558994246|FG000|Overall Study|Study Terminated by Sponsor|50|||
154882806|NCT00960934|558994247|FG001|Overall Study|Study Terminated by Sponsor|46|||
154975613|NCT02725411|559333878|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
154975614|NCT02725411|559333879|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
154975615|NCT02725411|559333880|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
154975616|NCT02725411|559333878|FG000|Treatment Period (56 Weeks)|Other|1|||
154975617|NCT02725411|559333879|FG001|Treatment Period (56 Weeks)|Other|4|||
154975618|NCT02725411|559333880|FG002|Treatment Period (56 Weeks)|Other|5|||
154975619|NCT02725411|559333878|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
154975620|NCT02725411|559333879|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
154975621|NCT02725411|559333880|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
154975622|NCT02725411|559333878|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
154975623|NCT02725411|559333879|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
154975624|NCT02725411|559333880|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
154975625|NCT02725411|559333878|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
154975626|NCT02725411|559333879|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
154975627|NCT02725411|559333880|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
154975628|NCT02725411|559333878|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
154975629|NCT02725411|559333879|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
154975630|NCT02725411|559333880|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
154975631|NCT02725411|559333878|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
154975632|NCT02725411|559333879|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
154975633|NCT02725411|559333880|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
154975634|NCT02725411|559333878|FG000|Follow-up Period (24 Weeks)|Other|1|||
154975635|NCT02725411|559333879|FG001|Follow-up Period (24 Weeks)|Other|4|||
154975636|NCT02725411|559333880|FG002|Follow-up Period (24 Weeks)|Other|2|||
154975637|NCT02725411|559333878|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
154975638|NCT02725411|559333879|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
154975639|NCT02725411|559333880|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
154975640|NCT00819767|559333881|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154975641|NCT00819767|559333882|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
154975642|NCT00756717|559333883|FG000|Overall Study|Withdrawal by Subject|2|||
154975643|NCT02762994|559333884|FG000|Overall Study|Withdrawal by Subject|0|||
154975644|NCT02762994|559333885|FG001|Overall Study|Withdrawal by Subject|1|||
154975645|NCT02762994|559333886|FG002|Overall Study|Withdrawal by Subject|2|||
154975646|NCT02762994|559333887|FG003|Overall Study|Withdrawal by Subject|0|||
154975647|NCT02762994|559333884|FG000|Overall Study|Protocol Violation|1|||
154975648|NCT02762994|559333885|FG001|Overall Study|Protocol Violation|0|||
154975649|NCT02762994|559333886|FG002|Overall Study|Protocol Violation|0|||
154975650|NCT02762994|559333887|FG003|Overall Study|Protocol Violation|2|||
154975651|NCT03573336|559333900|FG000|Overall Study|Study terminated|2|||
154975652|NCT03573336|559333901|FG001|Overall Study|Study terminated|4|||
154975653|NCT03573336|559333902|FG002|Overall Study|Study terminated|2|||
154975654|NCT01525628|559333903|FG000|Overall Study|Adverse Event|1|||
154975655|NCT01525628|559333904|FG001|Overall Study|Adverse Event|1|||
154975656|NCT01525628|559333905|FG002|Overall Study|Adverse Event|2|||
154975657|NCT01525628|559333906|FG003|Overall Study|Adverse Event|0|||
154975658|NCT01525628|559333907|FG004|Overall Study|Adverse Event|1|||
155175372|NCT00910624|560080227|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
155175373|NCT00910624|560080228|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
154975659|NCT01525628|559333903|FG000|Overall Study|Lack of Efficacy|0|||
154975660|NCT01525628|559333904|FG001|Overall Study|Lack of Efficacy|2|||
154975661|NCT01525628|559333905|FG002|Overall Study|Lack of Efficacy|2|||
154975662|NCT01525628|559333906|FG003|Overall Study|Lack of Efficacy|1|||
154975663|NCT01525628|559333907|FG004|Overall Study|Lack of Efficacy|2|||
154975664|NCT01525628|559333903|FG000|Overall Study|Protocol Violation|0|||
154975665|NCT01525628|559333904|FG001|Overall Study|Protocol Violation|0|||
154975666|NCT01525628|559333905|FG002|Overall Study|Protocol Violation|1|||
154975667|NCT01525628|559333906|FG003|Overall Study|Protocol Violation|0|||
154975668|NCT01525628|559333907|FG004|Overall Study|Protocol Violation|0|||
154975669|NCT01525628|559333903|FG000|Overall Study|Lost to Follow-up|1|||
154975670|NCT01525628|559333904|FG001|Overall Study|Lost to Follow-up|1|||
154975671|NCT01525628|559333905|FG002|Overall Study|Lost to Follow-up|0|||
155175374|NCT00910624|560080229|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
155175375|NCT00910624|560080226|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
155175376|NCT00910624|560080227|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
154975672|NCT01525628|559333906|FG003|Overall Study|Lost to Follow-up|0|||
154975673|NCT01525628|559333907|FG004|Overall Study|Lost to Follow-up|0|||
154975674|NCT01525628|559333903|FG000|Overall Study|Withdrawal by Subject|0|||
154975675|NCT01525628|559333904|FG001|Overall Study|Withdrawal by Subject|1|||
154975676|NCT01525628|559333905|FG002|Overall Study|Withdrawal by Subject|0|||
154975677|NCT01525628|559333906|FG003|Overall Study|Withdrawal by Subject|0|||
154975678|NCT01525628|559333907|FG004|Overall Study|Withdrawal by Subject|0|||
154975679|NCT01525628|559333903|FG000|Overall Study|Other reason not defined above|0|||
154975680|NCT01525628|559333904|FG001|Overall Study|Other reason not defined above|0|||
154975681|NCT01525628|559333905|FG002|Overall Study|Other reason not defined above|0|||
154975682|NCT01525628|559333906|FG003|Overall Study|Other reason not defined above|3|||
154975683|NCT01525628|559333907|FG004|Overall Study|Other reason not defined above|0|||
154975684|NCT00239005|559333908|FG000|Overall Study|Adverse Event|6|||
154975685|NCT00239005|559333909|FG001|Overall Study|Adverse Event|6|||
154975686|NCT00239005|559333908|FG000|Overall Study|Withdrawal by Subject|3|||
154975687|NCT00239005|559333909|FG001|Overall Study|Withdrawal by Subject|4|||
154975688|NCT00239005|559333908|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
154975689|NCT00239005|559333909|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
154975690|NCT00239005|559333908|FG000|Overall Study|Protocol Violation|1|||
154975691|NCT00239005|559333909|FG001|Overall Study|Protocol Violation|0|||
154975692|NCT00239005|559333908|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
154975693|NCT00239005|559333909|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
154975694|NCT00239005|559333908|FG000|Overall Study|Lost to Follow-up|0|||
154975695|NCT00239005|559333909|FG001|Overall Study|Lost to Follow-up|1|||
154975696|NCT02614898|559333910|FG000|Overall Study|Participated until study termination|10|||
154975697|NCT02614898|559333911|FG001|Overall Study|Participated until study termination|26|||
154975698|NCT02614898|559333910|FG000|Overall Study|Lost to Follow-up|0|||
154975699|NCT02614898|559333911|FG001|Overall Study|Lost to Follow-up|2|||
154975700|NCT02614898|559333910|FG000|Overall Study|Physician Decision|1|||
154975701|NCT02614898|559333911|FG001|Overall Study|Physician Decision|8|||
154975702|NCT02614898|559333910|FG000|Overall Study|Study Terminated by Sponsor|3|||
154975703|NCT02614898|559333911|FG001|Overall Study|Study Terminated by Sponsor|0|||
154975704|NCT02614898|559333910|FG000|Overall Study|Withdrawal by Subject|0|||
154975705|NCT02614898|559333911|FG001|Overall Study|Withdrawal by Subject|2|||
154975706|NCT02614898|559333910|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
154975707|NCT02614898|559333911|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
154975708|NCT02614898|559333910|FG000|Overall Study|Other-Additional Information Unavailable|0|||
154975709|NCT02614898|559333911|FG001|Overall Study|Other-Additional Information Unavailable|11|||
154975710|NCT02614898|559333910|FG000|Overall Study|Missing|0|||
154975711|NCT02614898|559333911|FG001|Overall Study|Missing|1|||
154975712|NCT00787605|559333912|FG000|Overall Study|Administrative Problems|3|||
154975713|NCT00787605|559333913|FG001|Overall Study|Administrative Problems|0|||
154882807|NCT00960934|558994248|FG002|Overall Study|Study Terminated by Sponsor|52|||
154882808|NCT00960934|558994249|FG003|Overall Study|Study Terminated by Sponsor|50|||
154882809|NCT00960934|558994250|FG004|Overall Study|Study Terminated by Sponsor|49|||
154882810|NCT00960934|558994251|FG005|Overall Study|Study Terminated by Sponsor|49|||
154882811|NCT04348656|558994256|FG000|Overall Study|Withdrawal by Subject|2|||
154882812|NCT04348656|558994257|FG001|Overall Study|Withdrawal by Subject|0|||
154882813|NCT04348656|558994256|FG000|Overall Study|Lost to Follow-up|11|||
154882814|NCT04348656|558994257|FG001|Overall Study|Lost to Follow-up|6|||
154882815|NCT01395368|558994258|FG000|Overall Study|Physician Decision|14|||
154882816|NCT01395368|558994258|FG000|Overall Study|Withdrawal by Subject|2|||
154882817|NCT00310388|558994259|FG000|Primary Reporting Phase|Adverse Event|101|||
154882818|NCT00310388|558994260|FG001|Primary Reporting Phase|Adverse Event|0|||
154882819|NCT00310388|558994259|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
154882820|NCT00310388|558994260|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
154882821|NCT00310388|558994259|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
154882822|NCT00310388|558994260|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
154882823|NCT00310388|558994259|FG000|Primary Reporting Phase|Protocol Violation|10|||
154882824|NCT00310388|558994260|FG001|Primary Reporting Phase|Protocol Violation|0|||
154882825|NCT00310388|558994259|FG000|Primary Reporting Phase|Pregnancy|3|||
154882826|NCT00310388|558994260|FG001|Primary Reporting Phase|Pregnancy|0|||
154882827|NCT00310388|558994259|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
154882828|NCT00310388|558994260|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
154882829|NCT00310388|558994259|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
154882830|NCT00310388|558994260|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
154882831|NCT00310388|558994259|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
154882832|NCT00310388|558994260|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
154882833|NCT00310388|558994259|FG000|Primary Reporting Phase|Physician Decision|2|||
154975714|NCT00787605|559333912|FG000|Overall Study|Adverse Event|14|||
154975715|NCT00787605|559333913|FG001|Overall Study|Adverse Event|25|||
154975716|NCT00787605|559333912|FG000|Overall Study|Lost to Follow-up|3|||
154975717|NCT00787605|559333913|FG001|Overall Study|Lost to Follow-up|6|||
154975718|NCT00787605|559333912|FG000|Overall Study|Protocol Violation|7|||
154975719|NCT00787605|559333913|FG001|Overall Study|Protocol Violation|3|||
154975720|NCT00787605|559333912|FG000|Overall Study|Withdrawal by Subject|6|||
154975721|NCT00787605|559333913|FG001|Overall Study|Withdrawal by Subject|13|||
154975722|NCT00787605|559333912|FG000|Overall Study|Lack of Efficacy|13|||
154975723|NCT00787605|559333913|FG001|Overall Study|Lack of Efficacy|9|||
154975724|NCT03108820|559333914|FG000|Overall Study|Lost to Follow-up|30|||
154882834|NCT00310388|558994260|FG001|Primary Reporting Phase|Physician Decision|0|||
154882835|NCT00310388|558994259|FG000|Primary Reporting Phase|Request of the sponsor|19|||
154882836|NCT00310388|558994260|FG001|Primary Reporting Phase|Request of the sponsor|0|||
154975725|NCT03108820|559333915|FG001|Overall Study|Lost to Follow-up|28|||
154975726|NCT03108820|559333914|FG000|Overall Study|Withdrawal by Subject|32|||
154975727|NCT03108820|559333915|FG001|Overall Study|Withdrawal by Subject|24|||
154975728|NCT03108820|559333914|FG000|Overall Study|Death|6|||
154975729|NCT03108820|559333915|FG001|Overall Study|Death|11|||
154975730|NCT01488448|559333917|FG000|Overall Study|Withdrawal by Subject|3|||
154975731|NCT01488448|559333918|FG001|Overall Study|Withdrawal by Subject|1|||
154975732|NCT01488448|559333917|FG000|Overall Study|Adverse Event|9|||
154975733|NCT01488448|559333918|FG001|Overall Study|Adverse Event|4|||
154975734|NCT01488448|559333917|FG000|Overall Study|Physician Decision|4|||
154975735|NCT01488448|559333918|FG001|Overall Study|Physician Decision|9|||
154975736|NCT01488448|559333917|FG000|Overall Study|Protocol Violation|4|||
154975737|NCT01488448|559333918|FG001|Overall Study|Protocol Violation|3|||
154975738|NCT00654641|559333919|FG000|Overall Study|Lost to Follow-up|2|||
154975739|NCT00654641|559333920|FG001|Overall Study|Lost to Follow-up|3|||
154975740|NCT01992094|559333921|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
154975741|NCT01992094|559333922|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
154975742|NCT01992094|559333923|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
154975743|NCT01992094|559333921|FG000|Overall Study|Adverse Event|1|||
154975744|NCT01992094|559333922|FG001|Overall Study|Adverse Event|0|||
154975745|NCT01992094|559333923|FG002|Overall Study|Adverse Event|0|||
154975746|NCT01992094|559333921|FG000|Overall Study|Death|5|||
154975747|NCT01992094|559333922|FG001|Overall Study|Death|5|||
154975748|NCT01992094|559333923|FG002|Overall Study|Death|2|||
154975749|NCT01992094|559333921|FG000|Overall Study|Lost to Follow-up|26|||
154975750|NCT01992094|559333922|FG001|Overall Study|Lost to Follow-up|9|||
154975751|NCT01992094|559333923|FG002|Overall Study|Lost to Follow-up|13|||
154975752|NCT01992094|559333921|FG000|Overall Study|OTHER|4|||
154975753|NCT01992094|559333922|FG001|Overall Study|OTHER|0|||
154975754|NCT01992094|559333923|FG002|Overall Study|OTHER|0|||
154975755|NCT01992094|559333921|FG000|Overall Study|Protocol Violation|1|||
154975756|NCT01992094|559333922|FG001|Overall Study|Protocol Violation|0|||
154975757|NCT01992094|559333923|FG002|Overall Study|Protocol Violation|1|||
154975758|NCT01992094|559333921|FG000|Overall Study|Withdrawal by Subject|7|||
154975759|NCT01992094|559333922|FG001|Overall Study|Withdrawal by Subject|3|||
154975760|NCT01992094|559333923|FG002|Overall Study|Withdrawal by Subject|4|||
154975761|NCT00965731|559333926|FG000|Overall Study|Death|0|||
154975762|NCT00965731|559333927|FG001|Overall Study|Death|4|||
154975763|NCT00965731|559333926|FG000|Overall Study|Withdrawal by Subject|0|||
154975764|NCT00965731|559333927|FG001|Overall Study|Withdrawal by Subject|1|||
154975765|NCT00965731|559333926|FG000|Overall Study|Other|7|||
154975766|NCT00965731|559333927|FG001|Overall Study|Other|15|||
154975767|NCT01560819|559335194|FG000|Overall Study|Physician Decision|1|||
154975768|NCT01560819|559335195|FG001|Overall Study|Physician Decision|0|||
154975769|NCT00399893|559335200|FG000|Overall Study|Withdrawal by Subject|1|||
154975770|NCT00399893|559335201|FG001|Overall Study|Withdrawal by Subject|0|||
154975771|NCT04412057|559335202|FG000|Overall Study|Death|3|||
154975772|NCT04412057|559335203|FG001|Overall Study|Death|7|||
154975773|NCT04412057|559335202|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
154975774|NCT04412057|559335203|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
154975775|NCT01961882|559335208|FG000|Overall Study|Adverse Event|3|||
154975776|NCT01961882|559335209|FG001|Overall Study|Adverse Event|2|||
154882837|NCT00310388|558994259|FG000|Primary Reporting Phase|Failed to return|8|||
154882838|NCT00310388|558994260|FG001|Primary Reporting Phase|Failed to return|0|||
154882839|NCT00310388|558994259|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
154882840|NCT00310388|558994260|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
154882841|NCT00310388|558994259|FG000|Primary Reporting Phase|Participant request|2|||
154882842|NCT00310388|558994260|FG001|Primary Reporting Phase|Participant request|0|||
154882843|NCT00310388|558994259|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
154882844|NCT00310388|558994260|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
154882845|NCT00310388|558994259|FG000|Primary Reporting Phase|Discontinuation of study|1|||
154882846|NCT00310388|558994260|FG001|Primary Reporting Phase|Discontinuation of study|0|||
154882847|NCT00310388|558994259|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
154882848|NCT00310388|558994260|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
154882849|NCT00310388|558994259|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
154975777|NCT01961882|559335208|FG000|Overall Study|Physician Decision|1|||
154975778|NCT01961882|559335209|FG001|Overall Study|Physician Decision|0|||
154975779|NCT01961882|559335208|FG000|Overall Study|Withdrawal by Subject|4|||
154975780|NCT01961882|559335209|FG001|Overall Study|Withdrawal by Subject|1|||
154975781|NCT01961882|559335208|FG000|Overall Study|Relapse of AML|39|||
154975782|NCT01961882|559335209|FG001|Overall Study|Relapse of AML|37|||
154975783|NCT01961882|559335208|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
154975784|NCT01961882|559335209|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
154975785|NCT01961882|559335208|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
154975786|NCT01961882|559335209|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
154975787|NCT02668822|559335218|FG000|Overall Study|Protocol Violation|2|||
154975788|NCT02668822|559335219|FG001|Overall Study|Protocol Violation|0|||
154975789|NCT02668822|559335218|FG000|Overall Study|Study Terminated by Sponsor|7|||
154882850|NCT00310388|558994260|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
154882851|NCT00310388|558994259|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
154882852|NCT00310388|558994260|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
154882853|NCT00310388|558994259|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
154882854|NCT00310388|558994260|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
154882855|NCT00310388|558994259|FG000|Primary Reporting Phase|Participant passed away|1|||
154882856|NCT00310388|558994260|FG001|Primary Reporting Phase|Participant passed away|0|||
154882857|NCT00310388|558994259|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
154882858|NCT00310388|558994260|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
154882859|NCT00310388|558994259|FG000|Primary Reporting Phase|Missing|1|||
154882860|NCT00310388|558994260|FG001|Primary Reporting Phase|Missing|0|||
154882861|NCT00310388|558994259|FG000|Primary Reporting Phase|Other|1|||
154882862|NCT00310388|558994260|FG001|Primary Reporting Phase|Other|0|||
154882863|NCT00310388|558994259|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
154882864|NCT00310388|558994260|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
154882865|NCT00310388|558994259|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
154882866|NCT00310388|558994260|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
154882867|NCT00310388|558994259|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
154882868|NCT00310388|558994260|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
154882869|NCT00310388|558994259|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
154882870|NCT00310388|558994260|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
155113590|NCT00152477|559844851|FG000|Chemotherapy Period|Progression of Disease|6|||
155113591|NCT00152477|559844852|FG001|Chemotherapy Period|Progression of Disease|8|||
155113592|NCT00152477|559844853|FG002|Chemotherapy Period|Progression of Disease|4|||
155113593|NCT00152477|559844851|FG000|Chemotherapy Period|Investigator decision|0|||
155113594|NCT00152477|559844852|FG001|Chemotherapy Period|Investigator decision|0|||
155113595|NCT00152477|559844853|FG002|Chemotherapy Period|Investigator decision|1|||
155113596|NCT00152477|559844851|FG000|Chemotherapy Period|Patient condition worsened|1|||
155113597|NCT00152477|559844852|FG001|Chemotherapy Period|Patient condition worsened|0|||
155113598|NCT00152477|559844853|FG002|Chemotherapy Period|Patient condition worsened|0|||
155113599|NCT00152477|559844851|FG000|Monotherapy Period|Adverse Event|1|||
155113600|NCT00152477|559844852|FG001|Monotherapy Period|Adverse Event|0|||
155113601|NCT00152477|559844853|FG002|Monotherapy Period|Adverse Event|5|||
155113602|NCT00152477|559844851|FG000|Monotherapy Period|Death|2|||
155113603|NCT00152477|559844852|FG001|Monotherapy Period|Death|0|||
155113604|NCT00152477|559844853|FG002|Monotherapy Period|Death|1|||
155175377|NCT00910624|560080228|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
154882871|NCT02179515|558994263|FG000|Overall Study|switched to alternative treatment|0|||
154882872|NCT02179515|558994264|FG001|Overall Study|switched to alternative treatment|1|||
154882873|NCT02179515|558994265|FG002|Overall Study|switched to alternative treatment|1|||
154882874|NCT02179515|558994263|FG000|Overall Study|Death|0|||
154882875|NCT02179515|558994264|FG001|Overall Study|Death|1|||
154882876|NCT02179515|558994265|FG002|Overall Study|Death|1|||
154882877|NCT02179515|558994263|FG000|Overall Study|refused further treatment|0|||
154882878|NCT02179515|558994264|FG001|Overall Study|refused further treatment|3|||
154882879|NCT02179515|558994265|FG002|Overall Study|refused further treatment|4|||
154882880|NCT02179515|558994263|FG000|Overall Study|Disease progression on study|2|||
154882881|NCT02179515|558994264|FG001|Overall Study|Disease progression on study|11|||
154882882|NCT02179515|558994265|FG002|Overall Study|Disease progression on study|8|||
154882883|NCT00782418|558994270|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
154882884|NCT00782418|558994271|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
154882885|NCT00782418|558994272|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
154882886|NCT00782418|558994273|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
154882887|NCT00782418|558994274|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
154882888|NCT00782418|558994275|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
154882889|NCT00782418|558994276|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
154882890|NCT00782418|558994270|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
154882891|NCT00782418|558994271|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
154882892|NCT00782418|558994272|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
154882893|NCT00782418|558994273|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
154882894|NCT00782418|558994274|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
154882895|NCT00782418|558994275|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
155113605|NCT00152477|559844851|FG000|Monotherapy Period|Lack of Efficacy|7|||
155175378|NCT00910624|560080229|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
154882896|NCT00782418|558994276|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
154882897|NCT00501046|558994280|FG000|Overall Study|Adverse Event|21|||
154882898|NCT00501046|558994281|FG001|Overall Study|Adverse Event|25|||
155113606|NCT00152477|559844852|FG001|Monotherapy Period|Lack of Efficacy|16|||
155113607|NCT00152477|559844853|FG002|Monotherapy Period|Lack of Efficacy|10|||
155113608|NCT00152477|559844851|FG000|Monotherapy Period|Protocol Violation|0|||
154882899|NCT00501046|558994280|FG000|Overall Study|Death|23|||
154882900|NCT00501046|558994281|FG001|Overall Study|Death|30|||
154882901|NCT00501046|558994280|FG000|Overall Study|Lost to Follow-up|14|||
154882902|NCT00501046|558994281|FG001|Overall Study|Lost to Follow-up|13|||
154882903|NCT00501046|558994280|FG000|Overall Study|Physician Decision|7|||
154882904|NCT00501046|558994281|FG001|Overall Study|Physician Decision|2|||
154882905|NCT00501046|558994280|FG000|Overall Study|Pregnancy|0|||
154882906|NCT00501046|558994281|FG001|Overall Study|Pregnancy|3|||
154882907|NCT00501046|558994280|FG000|Overall Study|Protocol Violation|2|||
154882908|NCT00501046|558994281|FG001|Overall Study|Protocol Violation|1|||
154882909|NCT00501046|558994280|FG000|Overall Study|Withdrawal by Subject|84|||
154882910|NCT00501046|558994281|FG001|Overall Study|Withdrawal by Subject|83|||
154882911|NCT00501046|558994280|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
154882912|NCT00501046|558994281|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
154882913|NCT02488551|558994284|FG000|Overall Study|Lost to Follow-up|4|||
154882914|NCT02488551|558994285|FG001|Overall Study|Lost to Follow-up|7|||
154882915|NCT02488551|558994286|FG002|Overall Study|Lost to Follow-up|0|||
154882916|NCT02488551|558994287|FG003|Overall Study|Lost to Follow-up|0|||
154882917|NCT02488551|558994284|FG000|Overall Study|Military Deployment|1|||
154882918|NCT02488551|558994285|FG001|Overall Study|Military Deployment|1|||
154882919|NCT02488551|558994286|FG002|Overall Study|Military Deployment|0|||
154882920|NCT02488551|558994287|FG003|Overall Study|Military Deployment|0|||
154882921|NCT01188564|558994294|FG000|Double-blind Phase|randomized not treated|1|||
154882922|NCT01188564|558994295|FG001|Double-blind Phase|randomized not treated|0|||
154882923|NCT04171037|558994296|FG000|Overall Study|Lost to Follow-up|1|||
154882924|NCT04171037|558994297|FG001|Overall Study|Lost to Follow-up|0|||
154882925|NCT04171037|558994296|FG000|Overall Study|Physician Decision|3|||
154882926|NCT04171037|558994297|FG001|Overall Study|Physician Decision|3|||
154882927|NCT01934894|558994298|FG000|Overall Study|Adverse Event|1|||
154882928|NCT01934894|558994299|FG001|Overall Study|Adverse Event|2|||
154882929|NCT01934894|558994298|FG000|Overall Study|Death|2|||
154882930|NCT01934894|558994299|FG001|Overall Study|Death|0|||
154882931|NCT01934894|558994298|FG000|Overall Study|Withdrawal by Subject|0|||
154882932|NCT01934894|558994299|FG001|Overall Study|Withdrawal by Subject|1|||
154882933|NCT01934894|558994298|FG000|Overall Study|Progressive Disease|3|||
154882934|NCT01934894|558994299|FG001|Overall Study|Progressive Disease|2|||
154882935|NCT01954251|558994304|FG000|Overall Study|Adverse Event|5|||
154882936|NCT01954251|558994305|FG001|Overall Study|Adverse Event|7|||
154882937|NCT01954251|558994304|FG000|Overall Study|Lost to Follow-up|6|||
154882938|NCT01954251|558994305|FG001|Overall Study|Lost to Follow-up|6|||
154882939|NCT01954251|558994304|FG000|Overall Study|Withdrawal by Subject|2|||
154882940|NCT01954251|558994305|FG001|Overall Study|Withdrawal by Subject|6|||
154882941|NCT03364673|558994306|FG000|Overall Study|Withdrawal by Subject|2|||
154882942|NCT03364673|558994306|FG000|Overall Study|Injury unrelated to study|3|||
154882943|NCT02208024|558994307|FG000|Overall Study|Withdrawal by Subject|1|||
154882944|NCT02207556|558994308|FG000|Overall Study|Physician Decision|1|||
154882945|NCT02207556|558994309|FG001|Overall Study|Physician Decision|0|||
154882946|NCT02207556|558994308|FG000|Overall Study|Withdrawal by Subject|1|||
154882947|NCT02207556|558994309|FG001|Overall Study|Withdrawal by Subject|0|||
154882948|NCT02207556|558994308|FG000|Overall Study|Death|0|||
154882949|NCT02207556|558994309|FG001|Overall Study|Death|5|||
154882950|NCT03558555|558994310|FG000|Overall Study|Lost to Follow-up|2|||
154882951|NCT03558555|558994311|FG001|Overall Study|Lost to Follow-up|1|||
154882952|NCT00194025|558994312|FG000|Overall Study|Adverse Event|1|||
154882953|NCT00194025|558994312|FG000|Overall Study|non-adherence with study medication|4|||
154882954|NCT00511342|558994327|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
154882955|NCT00511342|558994328|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
154882956|NCT00511342|558994327|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
154882957|NCT00511342|558994328|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
154882958|NCT00511342|558994327|FG000|Overall Study|Pregnancy|0|||
154882959|NCT00511342|558994328|FG001|Overall Study|Pregnancy|1|||
154882960|NCT00511342|558994327|FG000|Overall Study|Pregnancy wish|0|||
154882961|NCT00511342|558994328|FG001|Overall Study|Pregnancy wish|1|||
154882962|NCT00511342|558994327|FG000|Overall Study|Lost to Follow-up|1|||
154882963|NCT00511342|558994328|FG001|Overall Study|Lost to Follow-up|5|||
154882964|NCT00511342|558994327|FG000|Overall Study|Other Reason|2|||
154882965|NCT00511342|558994328|FG001|Overall Study|Other Reason|2|||
154882966|NCT02432040|558994329|FG000|Overall Study|Lack of Efficacy|3|||
154882967|NCT02432040|558994330|FG001|Overall Study|Lack of Efficacy|0|||
154882968|NCT02432040|558994329|FG000|Overall Study|Lost to Follow-up|4|||
154882969|NCT02432040|558994330|FG001|Overall Study|Lost to Follow-up|5|||
154882970|NCT02432040|558994329|FG000|Overall Study|Physician Decision|1|||
154882971|NCT02432040|558994330|FG001|Overall Study|Physician Decision|1|||
154882972|NCT01100307|558994331|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
154882973|NCT01100307|558994332|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
154882974|NCT01100307|558994331|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
154882975|NCT01100307|558994332|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
154882976|NCT01100307|558994331|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
154882977|NCT01100307|558994332|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
154882978|NCT01100307|558994331|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
154882979|NCT01100307|558994332|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
154882980|NCT01100307|558994331|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
154882981|NCT01100307|558994332|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
154882982|NCT01100307|558994331|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
154882983|NCT01100307|558994332|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
154882984|NCT00997321|558994333|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
154882985|NCT00997321|558994334|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
154882986|NCT04544709|558994339|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
154882987|NCT03135028|558994340|FG000|Overall Study|Death|6|||
154882988|NCT03135028|558994340|FG000|Overall Study|Study Terminated by Sponsor|2|||
154882989|NCT03135028|558994340|FG000|Overall Study|Withdrew Consent|1|||
154882990|NCT02065869|558994341|FG000|Overall Study|Death|7|||
154882991|NCT02065869|558994341|FG000|Overall Study|Disease relapse|16|||
154882992|NCT02065869|558994341|FG000|Overall Study|Lost to Follow-up|4|||
154882993|NCT02065869|558994341|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
154882994|NCT02065869|558994341|FG000|Overall Study|Withdrawal by Subject|1|||
154882995|NCT01814800|558994342|FG000|Overall Study|Adverse Event|2|||
154882996|NCT01814800|558994342|FG000|Overall Study|Pregnancy|1|||
154882997|NCT01814800|558994342|FG000|Overall Study|Sponsor decision|1|||
154882998|NCT01814800|558994342|FG000|Overall Study|Subject relocation|1|||
154882999|NCT02402218|558994343|FG000|Overall Study|Did not pickup study medication|12|||
154883000|NCT02402218|558994344|FG001|Overall Study|Did not pickup study medication|9|||
154883001|NCT02402218|558994345|FG002|Overall Study|Did not pickup study medication|13|||
154883002|NCT02402218|558994343|FG000|Overall Study|Lack of Efficacy|0|||
154883003|NCT02402218|558994344|FG001|Overall Study|Lack of Efficacy|1|||
154883004|NCT02402218|558994345|FG002|Overall Study|Lack of Efficacy|1|||
154883005|NCT02402218|558994343|FG000|Overall Study|Death|1|||
154883006|NCT02402218|558994344|FG001|Overall Study|Death|0|||
154883007|NCT02402218|558994345|FG002|Overall Study|Death|0|||
154883008|NCT02402218|558994343|FG000|Overall Study|Reinfection|0|||
154883009|NCT02402218|558994344|FG001|Overall Study|Reinfection|0|||
154883010|NCT02402218|558994345|FG002|Overall Study|Reinfection|1|||
154883011|NCT02402218|558994343|FG000|Overall Study|Adverse Event|0|||
154883012|NCT02402218|558994344|FG001|Overall Study|Adverse Event|2|||
154883013|NCT02402218|558994345|FG002|Overall Study|Adverse Event|1|||
154883014|NCT02402218|558994343|FG000|Overall Study|Withdrawal by Subject|1|||
154883015|NCT02402218|558994344|FG001|Overall Study|Withdrawal by Subject|1|||
154883016|NCT02402218|558994345|FG002|Overall Study|Withdrawal by Subject|1|||
154883017|NCT03827473|558994346|FG000|Overall Study|Withdrawal by Subject|1|||
154975790|NCT02668822|559335219|FG001|Overall Study|Study Terminated by Sponsor|9|||
154975791|NCT01522950|559335220|FG000|Overall Study|Withdrawal by Subject|3|||
154975792|NCT01522950|559335221|FG001|Overall Study|Withdrawal by Subject|2|||
154975793|NCT01522950|559335222|FG002|Overall Study|Withdrawal by Subject|1|||
154975794|NCT01522950|559335220|FG000|Overall Study|Adverse Event|3|||
154975795|NCT01522950|559335221|FG001|Overall Study|Adverse Event|1|||
154975796|NCT01522950|559335222|FG002|Overall Study|Adverse Event|1|||
154975797|NCT01522950|559335220|FG000|Overall Study|Protocol Violation|0|||
154975798|NCT01522950|559335221|FG001|Overall Study|Protocol Violation|0|||
154975799|NCT01522950|559335222|FG002|Overall Study|Protocol Violation|2|||
154975800|NCT01522950|559335220|FG000|Overall Study|Death|0|||
154975801|NCT01522950|559335221|FG001|Overall Study|Death|1|||
154975802|NCT01522950|559335222|FG002|Overall Study|Death|1|||
154975803|NCT01522950|559335220|FG000|Overall Study|Study Medication Sensitivity|0|||
154975804|NCT01522950|559335221|FG001|Overall Study|Study Medication Sensitivity|1|||
154975805|NCT01522950|559335222|FG002|Overall Study|Study Medication Sensitivity|0|||
154975806|NCT03036839|559335225|FG000|Overall Study|Adverse Event|0|||
154975807|NCT03036839|559335226|FG001|Overall Study|Adverse Event|0|||
154975808|NCT03036839|559335227|FG002|Overall Study|Adverse Event|1|||
154975809|NCT03036839|559335225|FG000|Overall Study|Death|3|||
154975810|NCT03036839|559335226|FG001|Overall Study|Death|0|||
154975811|NCT03036839|559335227|FG002|Overall Study|Death|3|||
154975812|NCT03036839|559335225|FG000|Overall Study|Withdrew Consent|0|||
154975813|NCT03036839|559335226|FG001|Overall Study|Withdrew Consent|0|||
154975814|NCT03036839|559335227|FG002|Overall Study|Withdrew Consent|1|||
154975815|NCT03136406|559335228|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
154883018|NCT03827473|558994347|FG001|Overall Study|Withdrawal by Subject|0|||
154883019|NCT04436822|558994348|FG000|Overall Study|Physician Decision|2|||
154975816|NCT04317599|559335229|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
154975817|NCT04317599|559335229|FG000|Overall Study|treatment outside standard of care|4|||
154975818|NCT03843125|559335233|FG000|Overall Study|Adverse Event|17|||
154883020|NCT04436822|558994349|FG001|Overall Study|Physician Decision|0|||
154883021|NCT04436822|558994348|FG000|Overall Study|Sponsor request|1|||
154883022|NCT04436822|558994349|FG001|Overall Study|Sponsor request|0|||
154883023|NCT04436822|558994348|FG000|Overall Study|Withdrawal by parent/guardian|0|||
154975819|NCT03843125|559335234|FG001|Overall Study|Adverse Event|13|||
154883024|NCT04436822|558994349|FG001|Overall Study|Withdrawal by parent/guardian|3|||
154883025|NCT04436822|558994348|FG000|Overall Study|Unsuccessful procedure|0|||
154883026|NCT04436822|558994349|FG001|Overall Study|Unsuccessful procedure|1|||
154883027|NCT04436822|558994348|FG000|Overall Study|Withdrawal due to Covid-19|8|||
154883028|NCT04436822|558994349|FG001|Overall Study|Withdrawal due to Covid-19|1|||
154883029|NCT04436822|558994348|FG000|Overall Study|Withdrawal by Subject|1|||
154883030|NCT04436822|558994349|FG001|Overall Study|Withdrawal by Subject|0|||
154883031|NCT04436822|558994348|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
154883032|NCT04436822|558994349|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
154883033|NCT03807739|558994350|FG000|Overall Study|Adverse Event|1|||
154883034|NCT03807739|558994351|FG001|Overall Study|Adverse Event|0|||
154883035|NCT03807739|558994352|FG002|Overall Study|Adverse Event|0|||
154883036|NCT03807739|558994353|FG003|Overall Study|Adverse Event|0|||
154883037|NCT03807739|558994350|FG000|Overall Study|Withdrawal by Subject|1|||
154883038|NCT03807739|558994351|FG001|Overall Study|Withdrawal by Subject|0|||
154883039|NCT03807739|558994352|FG002|Overall Study|Withdrawal by Subject|0|||
154883040|NCT03807739|558994353|FG003|Overall Study|Withdrawal by Subject|0|||
154883041|NCT02371759|558994354|FG000|Overall Study|Protocol Violation|3|||
154883042|NCT02371759|558994355|FG001|Overall Study|Protocol Violation|1|||
154883043|NCT02371759|558994356|FG002|Overall Study|Protocol Violation|1|||
154883044|NCT02371759|558994357|FG003|Overall Study|Protocol Violation|0|||
154883045|NCT02371759|558994358|FG004|Overall Study|Protocol Violation|3|||
154883046|NCT02371759|558994359|FG005|Overall Study|Protocol Violation|1|||
154883047|NCT02371759|558994360|FG006|Overall Study|Protocol Violation|0|||
154883048|NCT02371759|558994361|FG007|Overall Study|Protocol Violation|3|||
154883049|NCT02371759|558994354|FG000|Overall Study|Withdrawal by Subject|0|||
154883050|NCT02371759|558994355|FG001|Overall Study|Withdrawal by Subject|0|||
154883051|NCT02371759|558994356|FG002|Overall Study|Withdrawal by Subject|0|||
154883052|NCT02371759|558994357|FG003|Overall Study|Withdrawal by Subject|0|||
154883053|NCT02371759|558994358|FG004|Overall Study|Withdrawal by Subject|0|||
154883054|NCT02371759|558994359|FG005|Overall Study|Withdrawal by Subject|0|||
154883055|NCT02371759|558994360|FG006|Overall Study|Withdrawal by Subject|0|||
154883056|NCT02371759|558994361|FG007|Overall Study|Withdrawal by Subject|1|||
154883057|NCT03375112|558994362|FG000|Overall Study|Withdrawal by Subject|3|||
154883058|NCT03375112|558994363|FG001|Overall Study|Withdrawal by Subject|0|||
154883059|NCT03599141|558994366|FG000|Overall Study|Lost to Follow-up|3|||
154883060|NCT03599141|558994367|FG001|Overall Study|Lost to Follow-up|1|||
154883061|NCT03136185|558994368|FG000|Overall Study|Adverse Event|0|||
154883062|NCT03136185|558994369|FG001|Overall Study|Adverse Event|1|||
154883063|NCT03136185|558994370|FG002|Overall Study|Adverse Event|3|||
154883064|NCT03136185|558994371|FG003|Overall Study|Adverse Event|1|||
154883065|NCT03136185|558994372|FG004|Overall Study|Adverse Event|2|||
154883066|NCT03136185|558994373|FG005|Overall Study|Adverse Event|2|||
154883067|NCT03136185|558994374|FG006|Overall Study|Adverse Event|5|||
154883068|NCT03136185|558994375|FG007|Overall Study|Adverse Event|1|||
154883069|NCT03136185|558994376|FG008|Overall Study|Adverse Event|1|||
154883070|NCT03136185|558994368|FG000|Overall Study|Death|0|||
154883071|NCT03136185|558994369|FG001|Overall Study|Death|0|||
154883072|NCT03136185|558994370|FG002|Overall Study|Death|0|||
154883073|NCT03136185|558994371|FG003|Overall Study|Death|1|||
154883074|NCT03136185|558994372|FG004|Overall Study|Death|1|||
154883075|NCT03136185|558994373|FG005|Overall Study|Death|0|||
154883076|NCT03136185|558994374|FG006|Overall Study|Death|1|||
154883077|NCT03136185|558994375|FG007|Overall Study|Death|0|||
154883078|NCT03136185|558994376|FG008|Overall Study|Death|0|||
154883079|NCT03136185|558994368|FG000|Overall Study|Physician Decision|3|||
154883080|NCT03136185|558994369|FG001|Overall Study|Physician Decision|1|||
154883081|NCT03136185|558994370|FG002|Overall Study|Physician Decision|1|||
154883082|NCT03136185|558994371|FG003|Overall Study|Physician Decision|2|||
154883083|NCT03136185|558994372|FG004|Overall Study|Physician Decision|1|||
154883084|NCT03136185|558994373|FG005|Overall Study|Physician Decision|2|||
154883085|NCT03136185|558994374|FG006|Overall Study|Physician Decision|1|||
154883086|NCT03136185|558994375|FG007|Overall Study|Physician Decision|0|||
154883087|NCT03136185|558994376|FG008|Overall Study|Physician Decision|1|||
154883088|NCT03136185|558994368|FG000|Overall Study|Protocol Defined Disease Progression|0|||
154883089|NCT03136185|558994369|FG001|Overall Study|Protocol Defined Disease Progression|0|||
154883090|NCT03136185|558994370|FG002|Overall Study|Protocol Defined Disease Progression|1|||
154883091|NCT03136185|558994371|FG003|Overall Study|Protocol Defined Disease Progression|0|||
154883092|NCT03136185|558994372|FG004|Overall Study|Protocol Defined Disease Progression|0|||
154883093|NCT03136185|558994373|FG005|Overall Study|Protocol Defined Disease Progression|1|||
154883094|NCT03136185|558994374|FG006|Overall Study|Protocol Defined Disease Progression|0|||
154883095|NCT03136185|558994375|FG007|Overall Study|Protocol Defined Disease Progression|1|||
154883096|NCT03136185|558994376|FG008|Overall Study|Protocol Defined Disease Progression|1|||
154883097|NCT03136185|558994368|FG000|Overall Study|Withdrawal by Subject|1|||
154883098|NCT03136185|558994369|FG001|Overall Study|Withdrawal by Subject|0|||
154883099|NCT03136185|558994370|FG002|Overall Study|Withdrawal by Subject|1|||
154975820|NCT03843125|559335235|FG002|Overall Study|Adverse Event|5|||
154883100|NCT03136185|558994371|FG003|Overall Study|Withdrawal by Subject|1|||
154883101|NCT03136185|558994372|FG004|Overall Study|Withdrawal by Subject|1|||
154883102|NCT03136185|558994373|FG005|Overall Study|Withdrawal by Subject|1|||
154883103|NCT03136185|558994374|FG006|Overall Study|Withdrawal by Subject|2|||
154883104|NCT03136185|558994375|FG007|Overall Study|Withdrawal by Subject|3|||
154883105|NCT03136185|558994376|FG008|Overall Study|Withdrawal by Subject|3|||
154883106|NCT03136185|558994368|FG000|Overall Study|Not Reported|4|||
154883107|NCT03136185|558994369|FG001|Overall Study|Not Reported|1|||
154883108|NCT03136185|558994370|FG002|Overall Study|Not Reported|0|||
154883109|NCT03136185|558994371|FG003|Overall Study|Not Reported|1|||
154883110|NCT03136185|558994372|FG004|Overall Study|Not Reported|0|||
154883111|NCT03136185|558994373|FG005|Overall Study|Not Reported|2|||
154883112|NCT03136185|558994374|FG006|Overall Study|Not Reported|1|||
154883113|NCT03136185|558994375|FG007|Overall Study|Not Reported|1|||
154883114|NCT03136185|558994376|FG008|Overall Study|Not Reported|0|||
154883115|NCT00303108|558994382|FG000|Overall Study|Adverse Event|5|||
154883116|NCT00303108|558994383|FG001|Overall Study|Adverse Event|6|||
154883117|NCT00303108|558994384|FG002|Overall Study|Adverse Event|7|||
154883118|NCT00303108|558994382|FG000|Overall Study|Patient Request|4|||
154883119|NCT00303108|558994383|FG001|Overall Study|Patient Request|2|||
154883120|NCT00303108|558994384|FG002|Overall Study|Patient Request|8|||
154883121|NCT00303108|558994382|FG000|Overall Study|Failed Entry|1|||
154883122|NCT00303108|558994383|FG001|Overall Study|Failed Entry|0|||
154883123|NCT00303108|558994384|FG002|Overall Study|Failed Entry|1|||
154883124|NCT00303108|558994382|FG000|Overall Study|ineligible|2|||
154883125|NCT00303108|558994383|FG001|Overall Study|ineligible|1|||
154883126|NCT00303108|558994384|FG002|Overall Study|ineligible|0|||
154883127|NCT00894413|558994387|FG000|Overall Study|Physician Decision|0|||
154883128|NCT00894413|558994388|FG001|Overall Study|Physician Decision|2|||
154883129|NCT00894413|558994387|FG000|Overall Study|Adverse Event|0|||
154883130|NCT00894413|558994388|FG001|Overall Study|Adverse Event|2|||
154883131|NCT00894413|558994387|FG000|Overall Study|Withdrawal by Subject|0|||
154883132|NCT00894413|558994388|FG001|Overall Study|Withdrawal by Subject|4|||
154883133|NCT02349789|558995918|FG000|Overall Study|Withdrawal by Subject|2|||
154883134|NCT00786032|558995921|FG000|Overall Study|Death|4|||
154883135|NCT00786032|558995921|FG000|Overall Study|Withdrawal by Subject|14|||
154883136|NCT00786032|558995921|FG000|Overall Study|Did not complete in the timeframe|6|||
154883137|NCT02457182|558995922|FG000|Overall Study|Lost to Follow-up|1|||
154883138|NCT02457182|558995923|FG001|Overall Study|Lost to Follow-up|0|||
154883139|NCT02397694|558995926|FG000|Double-Blinded Phase|Adverse Event|1|||
154883140|NCT02397694|558995927|FG001|Double-Blinded Phase|Adverse Event|0|||
154883141|NCT02397694|558995926|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
154883142|NCT02397694|558995927|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
154883143|NCT02397694|558995926|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
154883144|NCT02397694|558995927|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
154883145|NCT02397694|558995926|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
154883146|NCT02397694|558995927|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
154883147|NCT02397694|558995926|FG000|Open Label Extension Phase|Protocol Violation|1|||
154883148|NCT02397694|558995927|FG001|Open Label Extension Phase|Protocol Violation|0|||
154883149|NCT02397694|558995926|FG000|Open Label Extension Phase|Withdrew Consent|3|||
154883150|NCT02397694|558995927|FG001|Open Label Extension Phase|Withdrew Consent|1|||
154883151|NCT02397694|558995926|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
154883152|NCT02397694|558995927|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
154883153|NCT01116687|558995928|FG000|Overall Study|Withdrawal by Subject|4|||
154883154|NCT00424528|558995929|FG000|Overall Study|Adverse Event|2|||
154883155|NCT00424528|558995930|FG001|Overall Study|Adverse Event|1|||
154883156|NCT00424528|558995931|FG002|Overall Study|Adverse Event|2|||
154883157|NCT00424528|558995929|FG000|Overall Study|Protocol Violation|1|||
154883158|NCT00424528|558995930|FG001|Overall Study|Protocol Violation|1|||
154883159|NCT00424528|558995931|FG002|Overall Study|Protocol Violation|0|||
154883160|NCT00424528|558995929|FG000|Overall Study|Lost to Follow-up|0|||
154883161|NCT00424528|558995930|FG001|Overall Study|Lost to Follow-up|1|||
155113609|NCT00152477|559844852|FG001|Monotherapy Period|Protocol Violation|1|||
154883162|NCT00424528|558995931|FG002|Overall Study|Lost to Follow-up|0|||
154883163|NCT00424528|558995929|FG000|Overall Study|noncompliance with study requirements|2|||
154883164|NCT00424528|558995930|FG001|Overall Study|noncompliance with study requirements|1|||
154883165|NCT00424528|558995931|FG002|Overall Study|noncompliance with study requirements|2|||
154883166|NCT02115113|558995932|FG000|Participants in Run-in Period|Death|0|||
154883167|NCT02115113|558995933|FG001|Participants in Run-in Period|Death|0|||
154883168|NCT02115113|558995934|FG002|Participants in Run-in Period|Death|1|||
154883169|NCT02115113|558995932|FG000|Participants in Run-in Period|Administrative problems|0|||
154883170|NCT02115113|558995933|FG001|Participants in Run-in Period|Administrative problems|0|||
154883171|NCT02115113|558995934|FG002|Participants in Run-in Period|Administrative problems|1|||
154883172|NCT02115113|558995932|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
154883173|NCT02115113|558995933|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
154883174|NCT02115113|558995934|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
154883175|NCT02115113|558995932|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
154883176|NCT02115113|558995933|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
154883177|NCT02115113|558995934|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
154883178|NCT02115113|558995932|FG000|Participants Randomized|Lost to Follow-up|1|||
154883179|NCT02115113|558995933|FG001|Participants Randomized|Lost to Follow-up|0|||
154883180|NCT02115113|558995934|FG002|Participants Randomized|Lost to Follow-up|0|||
154883181|NCT02115113|558995932|FG000|Participants Randomized|Death|1|||
154883182|NCT02115113|558995933|FG001|Participants Randomized|Death|0|||
154883183|NCT02115113|558995934|FG002|Participants Randomized|Death|0|||
154883184|NCT01009983|558995935|FG000|Overall Study|necessary scans not completed|1|||
154883185|NCT00296725|558995940|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
154883186|NCT00296725|558995940|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
154883187|NCT00296725|558995940|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
154883188|NCT03196193|558995948|FG000|Overall Study|Adverse Event|1|||
154883189|NCT03196193|558995949|FG001|Overall Study|Adverse Event|0|||
154883190|NCT03196193|558995948|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
154883191|NCT03196193|558995949|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
154883192|NCT03583372|558995950|FG000|Overall Study|Withdrawal by Subject|6|||
154883193|NCT03583372|558995951|FG001|Overall Study|Withdrawal by Subject|11|||
154883194|NCT03583372|558995952|FG002|Overall Study|Withdrawal by Subject|7|||
154883195|NCT03583372|558995953|FG003|Overall Study|Withdrawal by Subject|8|||
154883196|NCT03583372|558995950|FG000|Overall Study|Lost to Follow-up|4|||
154883197|NCT03583372|558995951|FG001|Overall Study|Lost to Follow-up|6|||
154883198|NCT03583372|558995952|FG002|Overall Study|Lost to Follow-up|3|||
154883199|NCT03583372|558995953|FG003|Overall Study|Lost to Follow-up|2|||
154883200|NCT03583372|558995950|FG000|Overall Study|Adverse Event|1|||
154883201|NCT03583372|558995951|FG001|Overall Study|Adverse Event|3|||
154883202|NCT03583372|558995952|FG002|Overall Study|Adverse Event|4|||
154883203|NCT03583372|558995953|FG003|Overall Study|Adverse Event|4|||
154883204|NCT03583372|558995950|FG000|Overall Study|Physician Decision|0|||
154883205|NCT03583372|558995951|FG001|Overall Study|Physician Decision|1|||
154883206|NCT03583372|558995952|FG002|Overall Study|Physician Decision|1|||
154883207|NCT03583372|558995953|FG003|Overall Study|Physician Decision|1|||
154883208|NCT03583372|558995950|FG000|Overall Study|Lack of Efficacy|0|||
154883209|NCT03583372|558995951|FG001|Overall Study|Lack of Efficacy|1|||
154883210|NCT03583372|558995952|FG002|Overall Study|Lack of Efficacy|0|||
154883211|NCT03583372|558995953|FG003|Overall Study|Lack of Efficacy|1|||
154883212|NCT03583372|558995950|FG000|Overall Study|Death|1|||
154883213|NCT03583372|558995951|FG001|Overall Study|Death|0|||
154883214|NCT03583372|558995952|FG002|Overall Study|Death|0|||
154883215|NCT03583372|558995953|FG003|Overall Study|Death|0|||
154883216|NCT03583372|558995950|FG000|Overall Study|Protocol Violation|0|||
154883217|NCT03583372|558995951|FG001|Overall Study|Protocol Violation|1|||
154883218|NCT03583372|558995952|FG002|Overall Study|Protocol Violation|0|||
154883219|NCT03583372|558995953|FG003|Overall Study|Protocol Violation|0|||
154883220|NCT03583372|558995950|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
154883221|NCT03583372|558995951|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
154883222|NCT03583372|558995952|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
154883223|NCT03583372|558995953|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
154883224|NCT03583372|558995950|FG000|Overall Study|Did Not Receive Study Drug|0|||
154883225|NCT03583372|558995951|FG001|Overall Study|Did Not Receive Study Drug|1|||
154883226|NCT03583372|558995952|FG002|Overall Study|Did Not Receive Study Drug|0|||
154883227|NCT03583372|558995953|FG003|Overall Study|Did Not Receive Study Drug|0|||
154883228|NCT03583372|558995950|FG000|Overall Study|Captured as Other in the Database|1|||
154883229|NCT03583372|558995951|FG001|Overall Study|Captured as Other in the Database|2|||
154883230|NCT03583372|558995952|FG002|Overall Study|Captured as Other in the Database|4|||
154883231|NCT03583372|558995953|FG003|Overall Study|Captured as Other in the Database|1|||
154883232|NCT04831515|558995954|FG000|First Intervention|Adverse Event|0|||
154883233|NCT04831515|558995955|FG001|First Intervention|Adverse Event|1|||
154883234|NCT02338492|558995963|FG000|Overall Study|Death|32|||
154883235|NCT02338492|558995963|FG000|Overall Study|Adverse Event|3|||
154883236|NCT02338492|558995963|FG000|Overall Study|Lost to Follow-up|4|||
154883237|NCT02338492|558995963|FG000|Overall Study|Reason not captured above|6|||
154883238|NCT00756886|558995967|FG000|Overall Study|Lost to Follow-up|1|||
155113610|NCT00152477|559844853|FG002|Monotherapy Period|Protocol Violation|0|||
155113611|NCT00152477|559844851|FG000|Monotherapy Period|Withdrawal by Subject|0|||
154883239|NCT00756886|558995968|FG001|Overall Study|Lost to Follow-up|0|||
154883240|NCT00756886|558995967|FG000|Overall Study|Adverse Event|0|||
154883241|NCT00756886|558995968|FG001|Overall Study|Adverse Event|3|||
154883242|NCT00756886|558995967|FG000|Overall Study|Lack of Efficacy|1|||
154883243|NCT00756886|558995968|FG001|Overall Study|Lack of Efficacy|0|||
154883244|NCT00756886|558995967|FG000|Overall Study|Ineligible|9|||
154883245|NCT00756886|558995968|FG001|Overall Study|Ineligible|4|||
154883246|NCT00174785|558995969|FG000|Overall Study|Adverse Event|293|||
154883247|NCT00174785|558995970|FG001|Overall Study|Adverse Event|191|||
154883248|NCT00174785|558995969|FG000|Overall Study|Protocol Violation|14|||
154883249|NCT00174785|558995970|FG001|Overall Study|Protocol Violation|14|||
154975821|NCT03843125|559335236|FG003|Overall Study|Adverse Event|9|||
154883250|NCT00174785|558995969|FG000|Overall Study|Withdrawal by Subject|173|||
154883251|NCT00174785|558995970|FG001|Overall Study|Withdrawal by Subject|175|||
154883252|NCT00174785|558995969|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
154883253|NCT00174785|558995970|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
154883254|NCT00174785|558995969|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
154883255|NCT00174785|558995970|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
154883256|NCT00174785|558995969|FG000|Overall Study|Other prohibited medication|5|||
154883257|NCT00174785|558995970|FG001|Overall Study|Other prohibited medication|3|||
154883258|NCT00174785|558995969|FG000|Overall Study|Family request|6|||
154883259|NCT00174785|558995970|FG001|Overall Study|Family request|8|||
154883260|NCT00174785|558995969|FG000|Overall Study|Not pre-specified/Not coded|56|||
154883261|NCT00174785|558995970|FG001|Overall Study|Not pre-specified/Not coded|70|||
154883262|NCT00120289|558995972|FG000|Overall Study|Death|96|||
154883263|NCT00120289|558995973|FG001|Overall Study|Death|82|||
154883264|NCT00120289|558995972|FG000|Overall Study|Lost to Follow-up|11|||
154883265|NCT00120289|558995973|FG001|Overall Study|Lost to Follow-up|14|||
154883266|NCT00120289|558995972|FG000|Overall Study|Withdrawal by Subject|14|||
154883267|NCT00120289|558995973|FG001|Overall Study|Withdrawal by Subject|13|||
154883268|NCT00779324|558995976|FG000|Overall Study|Lost to Follow-up|2|||
154883269|NCT00779324|558995977|FG001|Overall Study|Lost to Follow-up|1|||
154883270|NCT00779324|558995976|FG000|Overall Study|Withdrawal by Subject|4|||
154883271|NCT00779324|558995977|FG001|Overall Study|Withdrawal by Subject|2|||
154883272|NCT00779324|558995976|FG000|Overall Study|Missed visit|1|||
154883273|NCT00779324|558995977|FG001|Overall Study|Missed visit|1|||
154883274|NCT00543569|558995978|FG000|Overall Study|Death|2|||
154883275|NCT00543569|558995979|FG001|Overall Study|Death|2|||
154883276|NCT00543569|558995980|FG002|Overall Study|Death|3|||
154883277|NCT00543569|558995981|FG003|Overall Study|Death|1|||
154883278|NCT00543569|558995978|FG000|Overall Study|Lost to Follow-up|0|||
154883279|NCT00543569|558995979|FG001|Overall Study|Lost to Follow-up|0|||
154883280|NCT00543569|558995980|FG002|Overall Study|Lost to Follow-up|1|||
154883281|NCT00543569|558995981|FG003|Overall Study|Lost to Follow-up|1|||
154883282|NCT00543569|558995978|FG000|Overall Study|Miscellaneous Reasons|7|||
154883283|NCT00543569|558995979|FG001|Overall Study|Miscellaneous Reasons|3|||
154883284|NCT00543569|558995980|FG002|Overall Study|Miscellaneous Reasons|11|||
154883285|NCT00543569|558995981|FG003|Overall Study|Miscellaneous Reasons|4|||
154883286|NCT00543569|558995978|FG000|Overall Study|Randomized but never received study drug|3|||
154883287|NCT00543569|558995979|FG001|Overall Study|Randomized but never received study drug|3|||
154883288|NCT00543569|558995980|FG002|Overall Study|Randomized but never received study drug|5|||
154883289|NCT00543569|558995981|FG003|Overall Study|Randomized but never received study drug|3|||
154883290|NCT00862849|558995982|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
154883291|NCT00862849|558995983|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
154883292|NCT00862849|558995984|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
154883293|NCT00862849|558995985|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
154883294|NCT00862849|558995986|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
154883295|NCT00862849|558995987|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
154883296|NCT00862849|558995982|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
154883297|NCT00862849|558995983|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
154883298|NCT00862849|558995984|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
154883299|NCT00862849|558995985|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
154883300|NCT00862849|558995986|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
154883301|NCT00862849|558995987|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
154883302|NCT00608530|558995993|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
154883303|NCT00608530|558995994|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
154883304|NCT00608530|558995995|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
154883305|NCT00608530|558995996|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
154975822|NCT03843125|559335233|FG000|Overall Study|Death|0|||
154975823|NCT03843125|559335234|FG001|Overall Study|Death|6|||
154975824|NCT03843125|559335235|FG002|Overall Study|Death|2|||
154883306|NCT00608530|558995993|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
154883307|NCT00608530|558995994|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
154883308|NCT00608530|558995995|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
154883309|NCT00608530|558995996|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
154975825|NCT03843125|559335236|FG003|Overall Study|Death|0|||
154883310|NCT00608530|558995993|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
154883311|NCT00608530|558995994|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
154975826|NCT03843125|559335233|FG000|Overall Study|Lack of Efficacy|14|||
154975827|NCT03843125|559335234|FG001|Overall Study|Lack of Efficacy|11|||
154975828|NCT03843125|559335235|FG002|Overall Study|Lack of Efficacy|9|||
154975829|NCT03843125|559335236|FG003|Overall Study|Lack of Efficacy|4|||
155113612|NCT00152477|559844852|FG001|Monotherapy Period|Withdrawal by Subject|0|||
154883312|NCT00608530|558995995|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
154975830|NCT03843125|559335233|FG000|Overall Study|Lost to Follow-up|3|||
155175379|NCT00910624|560080226|FG000|Follow-Up Phase|Administrative|0|||
155175380|NCT00910624|560080227|FG001|Follow-Up Phase|Administrative|1|||
155175381|NCT00910624|560080228|FG002|Follow-Up Phase|Administrative|1|||
155175382|NCT00910624|560080229|FG003|Follow-Up Phase|Administrative|0|||
154883313|NCT00608530|558995996|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
154883314|NCT00608530|558995993|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
154883315|NCT00608530|558995994|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
154883316|NCT00608530|558995995|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
154883317|NCT00608530|558995996|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
154883318|NCT00608530|558995993|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
154883319|NCT00608530|558995994|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
154883320|NCT00608530|558995995|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
154883321|NCT00608530|558995996|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
154883322|NCT00608530|558995993|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
154883323|NCT00608530|558995994|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
154883324|NCT00608530|558995995|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
154883325|NCT00608530|558995996|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
154883326|NCT00077610|558995997|FG000|Overall Study|Adverse Event|9|||
154883327|NCT00077610|558995998|FG001|Overall Study|Adverse Event|7|||
154883328|NCT00077610|558995999|FG002|Overall Study|Adverse Event|1|||
154883329|NCT00077610|558995997|FG000|Overall Study|Lost to Follow-up|0|||
154883330|NCT00077610|558995998|FG001|Overall Study|Lost to Follow-up|1|||
154883331|NCT00077610|558995999|FG002|Overall Study|Lost to Follow-up|2|||
154883332|NCT00077610|558995997|FG000|Overall Study|Withdrawal by Subject|4|||
154883333|NCT00077610|558995998|FG001|Overall Study|Withdrawal by Subject|10|||
154883334|NCT00077610|558995999|FG002|Overall Study|Withdrawal by Subject|6|||
154883335|NCT00077610|558995997|FG000|Overall Study|Death|17|||
154883336|NCT00077610|558995998|FG001|Overall Study|Death|13|||
154883337|NCT00077610|558995999|FG002|Overall Study|Death|13|||
154883338|NCT00077610|558995997|FG000|Overall Study|Renal transplant|12|||
154883339|NCT00077610|558995998|FG001|Overall Study|Renal transplant|15|||
154883340|NCT00077610|558995999|FG002|Overall Study|Renal transplant|11|||
154883341|NCT00077610|558995997|FG000|Overall Study|Withdrew from dialysis care|5|||
154883342|NCT00077610|558995998|FG001|Overall Study|Withdrew from dialysis care|0|||
154883343|NCT00077610|558995999|FG002|Overall Study|Withdrew from dialysis care|3|||
154883344|NCT00077610|558995997|FG000|Overall Study|Insufficient Therapeutic Response|1|||
154883345|NCT00077610|558995998|FG001|Overall Study|Insufficient Therapeutic Response|0|||
154883346|NCT00077610|558995999|FG002|Overall Study|Insufficient Therapeutic Response|0|||
154883347|NCT00077610|558995997|FG000|Overall Study|Multiple blood transfusions|0|||
154883348|NCT00077610|558995998|FG001|Overall Study|Multiple blood transfusions|0|||
154883349|NCT00077610|558995999|FG002|Overall Study|Multiple blood transfusions|1|||
154883350|NCT00077610|558995997|FG000|Overall Study|Principal Investigator's decision|1|||
154883351|NCT00077610|558995998|FG001|Overall Study|Principal Investigator's decision|0|||
154883352|NCT00077610|558995999|FG002|Overall Study|Principal Investigator's decision|1|||
154883353|NCT00077610|558995997|FG000|Overall Study|Worsening of health condition|1|||
154883354|NCT00077610|558995998|FG001|Overall Study|Worsening of health condition|1|||
154883355|NCT00077610|558995999|FG002|Overall Study|Worsening of health condition|0|||
154883356|NCT00077610|558995997|FG000|Overall Study|Given Epogen in hospital|1|||
154883357|NCT00077610|558995998|FG001|Overall Study|Given Epogen in hospital|0|||
154883358|NCT00077610|558995999|FG002|Overall Study|Given Epogen in hospital|0|||
154883359|NCT00077610|558995997|FG000|Overall Study|Transferred to other unit|0|||
154883360|NCT00077610|558995998|FG001|Overall Study|Transferred to other unit|0|||
154883361|NCT00077610|558995999|FG002|Overall Study|Transferred to other unit|1|||
154883362|NCT00077610|558995997|FG000|Overall Study|Transferred to nursing home|0|||
154883363|NCT00077610|558995998|FG001|Overall Study|Transferred to nursing home|0|||
155175383|NCT03005873|560080230|FG000|Overall Study|Prohibited medication use post radnomization|1|||
154883364|NCT00077610|558995999|FG002|Overall Study|Transferred to nursing home|1|||
154883365|NCT00077610|558995997|FG000|Overall Study|Transfer to satellite unit|1|||
154883366|NCT00077610|558995998|FG001|Overall Study|Transfer to satellite unit|0|||
154883367|NCT00077610|558995999|FG002|Overall Study|Transfer to satellite unit|0|||
154883368|NCT00077610|558995997|FG000|Overall Study|Transfer to other center for surgery|1|||
154883369|NCT00077610|558995998|FG001|Overall Study|Transfer to other center for surgery|0|||
154883370|NCT00077610|558995999|FG002|Overall Study|Transfer to other center for surgery|0|||
154883371|NCT00077610|558995997|FG000|Overall Study|Change in dialysis modality|1|||
154883372|NCT00077610|558995998|FG001|Overall Study|Change in dialysis modality|0|||
154883373|NCT00077610|558995999|FG002|Overall Study|Change in dialysis modality|0|||
154883374|NCT00077610|558995997|FG000|Overall Study|Relocation|0|||
154883375|NCT00077610|558995998|FG001|Overall Study|Relocation|8|||
154883376|NCT00077610|558995999|FG002|Overall Study|Relocation|5|||
154883377|NCT00077610|558995997|FG000|Overall Study|Financial issues|0|||
154883378|NCT00077610|558995998|FG001|Overall Study|Financial issues|1|||
154883379|NCT00077610|558995999|FG002|Overall Study|Financial issues|0|||
154975831|NCT03843125|559335234|FG001|Overall Study|Lost to Follow-up|4|||
155175384|NCT03005873|560080231|FG001|Overall Study|Prohibited medication use post radnomization|1|||
155113613|NCT00152477|559844853|FG002|Monotherapy Period|Withdrawal by Subject|4|||
155113614|NCT00152477|559844851|FG000|Monotherapy Period|Progression of Disease|5|||
155113615|NCT00152477|559844852|FG001|Monotherapy Period|Progression of Disease|11|||
155113616|NCT00152477|559844853|FG002|Monotherapy Period|Progression of Disease|12|||
155113617|NCT00152477|559844851|FG000|Monotherapy Period|Patient decision|0|||
155113618|NCT00152477|559844852|FG001|Monotherapy Period|Patient decision|1|||
155113619|NCT00152477|559844853|FG002|Monotherapy Period|Patient decision|1|||
154883380|NCT00077610|558995997|FG000|Overall Study|Sponsors decision to withdraw|0|||
154883381|NCT00077610|558995998|FG001|Overall Study|Sponsors decision to withdraw|0|||
154883382|NCT00077610|558995999|FG002|Overall Study|Sponsors decision to withdraw|1|||
154883383|NCT01357915|558996001|FG000|Overall Study|Lost to Follow-up|3|||
154883384|NCT01357915|558996002|FG001|Overall Study|Lost to Follow-up|0|||
154883385|NCT00305253|558996003|FG000|Overall Study|Withdrawal by Subject|0|||
154883386|NCT00305253|558996004|FG001|Overall Study|Withdrawal by Subject|1|||
154883387|NCT01153763|558996007|FG000|Overall Study|Study Closed|16|||
154883388|NCT01153763|558996007|FG000|Overall Study|Lost to Follow-up|1|||
154883389|NCT01153763|558996007|FG000|Overall Study|Physician Decision|2|||
154883390|NCT01153763|558996007|FG000|Overall Study|Withdrawal by Subject|2|||
154883391|NCT02841787|558996008|FG000|Overall Study|Lost to Follow-up|1|||
154883392|NCT02841787|558996009|FG001|Overall Study|Lost to Follow-up|0|||
154883393|NCT02841787|558996010|FG002|Overall Study|Lost to Follow-up|0|||
154883394|NCT02841787|558996008|FG000|Overall Study|Symptoms dropped below threshold|1|||
154883395|NCT02841787|558996009|FG001|Overall Study|Symptoms dropped below threshold|0|||
154883396|NCT02841787|558996010|FG002|Overall Study|Symptoms dropped below threshold|0|||
154883397|NCT02841787|558996008|FG000|Overall Study|Withdrawal by Subject|1|||
154883398|NCT02841787|558996009|FG001|Overall Study|Withdrawal by Subject|4|||
154883399|NCT02841787|558996010|FG002|Overall Study|Withdrawal by Subject|0|||
154883400|NCT01474746|558996011|FG000|Overall Study|Lost to Follow-up|1|||
154883401|NCT01474746|558996012|FG001|Overall Study|Lost to Follow-up|1|||
154883402|NCT01474746|558996011|FG000|Overall Study|Withdrawal by Subject|2|||
154883403|NCT01474746|558996012|FG001|Overall Study|Withdrawal by Subject|1|||
154883404|NCT05118386|558996021|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
154883405|NCT05118386|558996022|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
154883406|NCT05118386|558996023|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
154883407|NCT05118386|558996024|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
154883408|NCT05118386|558996025|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
154883409|NCT05118386|558996026|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
154883410|NCT05118386|558996021|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
154883411|NCT05118386|558996022|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
154883412|NCT05118386|558996023|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
154883413|NCT05118386|558996024|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
154883414|NCT05118386|558996025|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
154883415|NCT05118386|558996026|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
154883416|NCT00369668|558996027|FG000|Overall Study|Lack of Efficacy|4|||
154883417|NCT00369668|558996028|FG001|Overall Study|Lack of Efficacy|5|||
154883418|NCT00369668|558996029|FG002|Overall Study|Lack of Efficacy|7|||
154883419|NCT03855137|558996030|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
154883420|NCT03855137|558996031|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
154883421|NCT03855137|558996032|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
154883422|NCT03855137|558996030|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
154883423|NCT03855137|558996031|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
154883424|NCT03855137|558996032|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
154883425|NCT03855137|558996030|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
154883426|NCT03855137|558996031|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
154883427|NCT03855137|558996032|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
154883428|NCT03855137|558996030|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
154883429|NCT03855137|558996031|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
154883430|NCT03855137|558996032|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
154883431|NCT03855137|558996030|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
154883432|NCT03855137|558996031|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
154883433|NCT03855137|558996032|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
154883434|NCT03855137|558996030|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
154883435|NCT03855137|558996031|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
154883436|NCT03855137|558996032|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
154883437|NCT03855137|558996030|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
155113620|NCT00152477|559844851|FG000|Monotherapy Period|Study personel decision|0|||
155113621|NCT00152477|559844852|FG001|Monotherapy Period|Study personel decision|0|||
155113622|NCT00152477|559844853|FG002|Monotherapy Period|Study personel decision|1|||
155113623|NCT03905265|559844855|FG000|Overall Study|Withdrawal by Subject|1|||
154883438|NCT03855137|558996031|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
154883439|NCT03855137|558996032|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
154883440|NCT03855137|558996030|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
154883441|NCT03855137|558996031|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
154883442|NCT03855137|558996032|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
154883443|NCT03855137|558996030|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
154883444|NCT03855137|558996031|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
154883445|NCT03855137|558996032|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
154883446|NCT03855137|558996030|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
154883447|NCT03855137|558996031|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
154883448|NCT03855137|558996032|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
154883449|NCT02427477|558996035|FG000|Period 1|Adverse Event|1|||
154883450|NCT02427477|558996036|FG001|Period 1|Adverse Event|0|||
154883451|NCT01067508|558996037|FG000|Overall Study|Physician Decision|0|||
154883452|NCT01067508|558996038|FG001|Overall Study|Physician Decision|1|||
154883453|NCT01067508|558996037|FG000|Overall Study|Withdrawal by Subject|0|||
154883454|NCT01067508|558996038|FG001|Overall Study|Withdrawal by Subject|1|||
154883455|NCT03213626|558996039|FG000|Overall Study|Adverse Event|1|||
154883456|NCT03213626|558996039|FG000|Overall Study|Progressive Disease|6|||
154883457|NCT01005732|558996043|FG000|Overall Study|Lost to Follow-up|10|||
154883458|NCT01005732|558996043|FG000|Overall Study|Death|1|||
154883459|NCT01552928|558996044|FG000|Period 3|Adverse Event|0|||
154883460|NCT01552928|558996045|FG001|Period 3|Adverse Event|0|||
154883461|NCT01552928|558996046|FG002|Period 3|Adverse Event|1|||
154883462|NCT01552928|558996047|FG003|Period 3|Adverse Event|0|||
154883463|NCT00632463|558996049|FG000|Overall Study|Adverse Event|0|||
154883464|NCT00632463|558996050|FG001|Overall Study|Adverse Event|1|||
154883465|NCT00632463|558996051|FG002|Overall Study|Adverse Event|0|||
154883466|NCT02065622|558996052|FG000|Induction Study|Adverse Event|13|||
154883467|NCT02065622|558996053|FG001|Induction Study|Adverse Event|19|||
154883468|NCT02065622|558996054|FG002|Induction Study|Adverse Event|0|||
154883469|NCT02065622|558996055|FG003|Induction Study|Adverse Event|0|||
154883470|NCT02065622|558996056|FG004|Induction Study|Adverse Event|0|||
154883471|NCT02065622|558996052|FG000|Induction Study|Withdrawal by Subject|3|||
154883472|NCT02065622|558996053|FG001|Induction Study|Withdrawal by Subject|5|||
154883473|NCT02065622|558996054|FG002|Induction Study|Withdrawal by Subject|0|||
154883474|NCT02065622|558996055|FG003|Induction Study|Withdrawal by Subject|0|||
154883475|NCT02065622|558996056|FG004|Induction Study|Withdrawal by Subject|0|||
154883476|NCT02065622|558996052|FG000|Induction Study|Lost to Follow-up|1|||
154883477|NCT02065622|558996053|FG001|Induction Study|Lost to Follow-up|0|||
154883478|NCT02065622|558996054|FG002|Induction Study|Lost to Follow-up|0|||
154883479|NCT02065622|558996055|FG003|Induction Study|Lost to Follow-up|0|||
154883480|NCT02065622|558996056|FG004|Induction Study|Lost to Follow-up|0|||
154883481|NCT02065622|558996052|FG000|Induction Study|Lack of Efficacy|22|||
154883482|NCT02065622|558996053|FG001|Induction Study|Lack of Efficacy|27|||
154883483|NCT02065622|558996054|FG002|Induction Study|Lack of Efficacy|0|||
154883484|NCT02065622|558996055|FG003|Induction Study|Lack of Efficacy|0|||
154883485|NCT02065622|558996056|FG004|Induction Study|Lack of Efficacy|0|||
154883486|NCT02065622|558996052|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
154883487|NCT02065622|558996053|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
154883488|NCT02065622|558996054|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
154883489|NCT02065622|558996055|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
154883490|NCT02065622|558996056|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
154883491|NCT02065622|558996052|FG000|Induction Study|Subject Noncompliance|1|||
154883492|NCT02065622|558996053|FG001|Induction Study|Subject Noncompliance|1|||
154883493|NCT02065622|558996054|FG002|Induction Study|Subject Noncompliance|0|||
154883494|NCT02065622|558996055|FG003|Induction Study|Subject Noncompliance|0|||
154883495|NCT02065622|558996056|FG004|Induction Study|Subject Noncompliance|0|||
154883496|NCT02065622|558996052|FG000|Induction Study|Other, Not Specified|3|||
154883497|NCT02065622|558996053|FG001|Induction Study|Other, Not Specified|2|||
154883498|NCT02065622|558996054|FG002|Induction Study|Other, Not Specified|0|||
154883499|NCT02065622|558996055|FG003|Induction Study|Other, Not Specified|0|||
155113624|NCT03905265|559844856|FG001|Overall Study|Withdrawal by Subject|1|||
154883500|NCT02065622|558996056|FG004|Induction Study|Other, Not Specified|0|||
154883501|NCT02065622|558996052|FG000|Maintenance Study|Adverse Event|0|||
154883502|NCT02065622|558996053|FG001|Maintenance Study|Adverse Event|0|||
154883503|NCT02065622|558996054|FG002|Maintenance Study|Adverse Event|25|||
154883504|NCT02065622|558996055|FG003|Maintenance Study|Adverse Event|22|||
154883505|NCT02065622|558996056|FG004|Maintenance Study|Adverse Event|11|||
154883506|NCT02065622|558996052|FG000|Maintenance Study|Withdrawal by Subject|0|||
154883507|NCT02065622|558996053|FG001|Maintenance Study|Withdrawal by Subject|0|||
154883508|NCT02065622|558996054|FG002|Maintenance Study|Withdrawal by Subject|11|||
154975832|NCT03843125|559335235|FG002|Overall Study|Lost to Follow-up|0|||
154975833|NCT03843125|559335236|FG003|Overall Study|Lost to Follow-up|2|||
154883509|NCT02065622|558996055|FG003|Maintenance Study|Withdrawal by Subject|5|||
154883510|NCT02065622|558996056|FG004|Maintenance Study|Withdrawal by Subject|7|||
154883511|NCT02065622|558996052|FG000|Maintenance Study|Lost to Follow-up|0|||
154883512|NCT02065622|558996053|FG001|Maintenance Study|Lost to Follow-up|0|||
154883513|NCT02065622|558996054|FG002|Maintenance Study|Lost to Follow-up|4|||
154883514|NCT02065622|558996055|FG003|Maintenance Study|Lost to Follow-up|1|||
154883515|NCT02065622|558996056|FG004|Maintenance Study|Lost to Follow-up|1|||
154883516|NCT02065622|558996052|FG000|Maintenance Study|Lack of Efficacy|0|||
154883517|NCT02065622|558996053|FG001|Maintenance Study|Lack of Efficacy|0|||
154883518|NCT02065622|558996054|FG002|Maintenance Study|Lack of Efficacy|70|||
154883519|NCT02065622|558996055|FG003|Maintenance Study|Lack of Efficacy|55|||
154883520|NCT02065622|558996056|FG004|Maintenance Study|Lack of Efficacy|19|||
154883521|NCT02065622|558996052|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
154883522|NCT02065622|558996053|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
154883523|NCT02065622|558996054|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
154883524|NCT02065622|558996055|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
154883525|NCT02065622|558996056|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
154883526|NCT02065622|558996052|FG000|Maintenance Study|Subject Non-Compliance|0|||
154883527|NCT02065622|558996053|FG001|Maintenance Study|Subject Non-Compliance|0|||
154883528|NCT02065622|558996054|FG002|Maintenance Study|Subject Non-Compliance|1|||
154883529|NCT02065622|558996055|FG003|Maintenance Study|Subject Non-Compliance|3|||
154883530|NCT02065622|558996056|FG004|Maintenance Study|Subject Non-Compliance|2|||
154883531|NCT02065622|558996052|FG000|Maintenance Study|Other, Not Specified|0|||
154883532|NCT02065622|558996053|FG001|Maintenance Study|Other, Not Specified|0|||
154883533|NCT02065622|558996054|FG002|Maintenance Study|Other, Not Specified|6|||
154883534|NCT02065622|558996055|FG003|Maintenance Study|Other, Not Specified|14|||
154883535|NCT02065622|558996056|FG004|Maintenance Study|Other, Not Specified|2|||
154883536|NCT02065622|558996052|FG000|Maintenance Study|Unknown Reason|0|||
154883537|NCT02065622|558996053|FG001|Maintenance Study|Unknown Reason|0|||
154883538|NCT02065622|558996054|FG002|Maintenance Study|Unknown Reason|0|||
154883539|NCT02065622|558996055|FG003|Maintenance Study|Unknown Reason|1|||
154883540|NCT02065622|558996056|FG004|Maintenance Study|Unknown Reason|0|||
154883541|NCT00488618|558996069|FG000|Overall Study|Adverse Event|13|||
154883542|NCT00488618|558996070|FG001|Overall Study|Adverse Event|17|||
154883543|NCT00488618|558996069|FG000|Overall Study|Insufficient Therapeutic Response|18|||
154883544|NCT00488618|558996070|FG001|Overall Study|Insufficient Therapeutic Response|11|||
154883545|NCT00488618|558996069|FG000|Overall Study|Protocol Violation|0|||
154883546|NCT00488618|558996070|FG001|Overall Study|Protocol Violation|2|||
154883547|NCT00488618|558996069|FG000|Overall Study|Withdrawal of Consent|15|||
154883548|NCT00488618|558996070|FG001|Overall Study|Withdrawal of Consent|13|||
154883549|NCT00488618|558996069|FG000|Overall Study|Lost to Follow-up|1|||
154883550|NCT00488618|558996070|FG001|Overall Study|Lost to Follow-up|0|||
154883551|NCT00992446|558996071|FG000|Overall Study|Disease Progression|1|||
154883552|NCT00992446|558996071|FG000|Overall Study|Withdrawal by Subject|2|||
154883553|NCT00992446|558996071|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
154883554|NCT02922634|558997682|FG000|Overall Study|Withdrawal by Subject|5|||
154883555|NCT02922634|558997682|FG000|Overall Study|Did not have their surgery|5|||
154883556|NCT02625324|558997683|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
154883557|NCT02625324|558997683|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
154883558|NCT02625324|558997683|FG000|6-Month Follow-up Subject Accountability|Death|5|||
154883559|NCT02625324|558997683|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
154883560|NCT02625324|558997683|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
155113625|NCT03905265|559844857|FG002|Overall Study|Withdrawal by Subject|0|||
155113626|NCT03905265|559844858|FG003|Overall Study|Withdrawal by Subject|0|||
155113627|NCT00960011|559844859|FG000|Overall Study|Death|5|||
155113628|NCT00960011|559844860|FG001|Overall Study|Death|0|||
155113629|NCT00960011|559844859|FG000|Overall Study|Lost to Follow-up|6|||
155113630|NCT00960011|559844860|FG001|Overall Study|Lost to Follow-up|2|||
155113631|NCT04417218|559844861|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
155113632|NCT04417218|559844862|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
155175385|NCT03005873|560080232|FG002|Overall Study|Prohibited medication use post radnomization|1|||
155175386|NCT03005873|560080230|FG000|Overall Study|Withdrew consent|0|||
154883561|NCT02625324|558997683|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
154883562|NCT02625324|558997683|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
154883563|NCT02625324|558997683|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
154883564|NCT02625324|558997683|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
154883565|NCT02625324|558997683|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
154883566|NCT02625324|558997683|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
154883567|NCT02625324|558997683|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
154883568|NCT02625324|558997683|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
154883569|NCT02625324|558997683|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
154883570|NCT02625324|558997683|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155113633|NCT00758264|559844865|FG000|Active Phase|Withdrawal by Subject|0|||
155113634|NCT00758264|559844866|FG001|Active Phase|Withdrawal by Subject|0|||
155175387|NCT03005873|560080231|FG001|Overall Study|Withdrew consent|1|||
154883571|NCT02625324|558997683|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
154883572|NCT02625324|558997683|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
154883573|NCT00352755|558997684|FG000|Overall Study|Physician Decision|1|||
154883574|NCT00352755|558997684|FG000|Overall Study|Adverse Event|1|||
154883575|NCT00789191|558997686|FG000|Overall Study|Adverse Event|2|||
154883576|NCT00789191|558997687|FG001|Overall Study|Adverse Event|4|||
154883577|NCT00789191|558997686|FG000|Overall Study|Lack of Efficacy|0|||
154883578|NCT00789191|558997687|FG001|Overall Study|Lack of Efficacy|5|||
154883579|NCT00789191|558997686|FG000|Overall Study|Protocol Violation|5|||
154883580|NCT00789191|558997687|FG001|Overall Study|Protocol Violation|3|||
154883581|NCT00789191|558997686|FG000|Overall Study|Withdrawal Criteria|2|||
154883582|NCT00789191|558997687|FG001|Overall Study|Withdrawal Criteria|4|||
154883583|NCT00789191|558997686|FG000|Overall Study|Unclassified|5|||
154883584|NCT00789191|558997687|FG001|Overall Study|Unclassified|3|||
154883585|NCT03497429|558997689|FG000|Overall Study|Progressive disease|3|||
154883586|NCT03497429|558997690|FG001|Overall Study|Progressive disease|4|||
154883587|NCT03497429|558997689|FG000|Overall Study|Adverse Event|0|||
154883588|NCT03497429|558997690|FG001|Overall Study|Adverse Event|2|||
154883589|NCT03137121|558997693|FG000|Overall Study|Withdrawal by Subject|0|||
154883590|NCT03137121|558997694|FG001|Overall Study|Withdrawal by Subject|1|||
154883591|NCT00280150|558997698|FG000|Overall Study|Adverse Event|0|||
154883592|NCT00280150|558997699|FG001|Overall Study|Adverse Event|1|||
154883593|NCT00280150|558997700|FG002|Overall Study|Adverse Event|2|||
154883594|NCT00280150|558997701|FG003|Overall Study|Adverse Event|3|||
154883595|NCT00280150|558997698|FG000|Overall Study|Lack of Efficacy|0|||
154883596|NCT00280150|558997699|FG001|Overall Study|Lack of Efficacy|0|||
154883597|NCT00280150|558997700|FG002|Overall Study|Lack of Efficacy|0|||
154883598|NCT00280150|558997701|FG003|Overall Study|Lack of Efficacy|3|||
154883599|NCT00280150|558997698|FG000|Overall Study|Physician Decision|0|||
154883600|NCT00280150|558997699|FG001|Overall Study|Physician Decision|0|||
154883601|NCT00280150|558997700|FG002|Overall Study|Physician Decision|0|||
154883602|NCT00280150|558997701|FG003|Overall Study|Physician Decision|1|||
154883603|NCT00280150|558997698|FG000|Overall Study|Protocol Violation|0|||
154883604|NCT00280150|558997699|FG001|Overall Study|Protocol Violation|0|||
154883605|NCT00280150|558997700|FG002|Overall Study|Protocol Violation|0|||
154883606|NCT00280150|558997701|FG003|Overall Study|Protocol Violation|1|||
154883607|NCT00280150|558997698|FG000|Overall Study|Withdrawal by Subject|0|||
154883608|NCT00280150|558997699|FG001|Overall Study|Withdrawal by Subject|0|||
154883609|NCT00280150|558997700|FG002|Overall Study|Withdrawal by Subject|0|||
154883610|NCT00280150|558997701|FG003|Overall Study|Withdrawal by Subject|1|||
154883611|NCT00280150|558997698|FG000|Overall Study|Did not get consolidation therapy|3|||
154883612|NCT00280150|558997699|FG001|Overall Study|Did not get consolidation therapy|0|||
154883613|NCT00280150|558997700|FG002|Overall Study|Did not get consolidation therapy|3|||
154883614|NCT00280150|558997701|FG003|Overall Study|Did not get consolidation therapy|0|||
154883615|NCT00280150|558997698|FG000|Overall Study|Declining Performance Status|0|||
154883616|NCT00280150|558997699|FG001|Overall Study|Declining Performance Status|0|||
154883617|NCT00280150|558997700|FG002|Overall Study|Declining Performance Status|0|||
154883618|NCT00280150|558997701|FG003|Overall Study|Declining Performance Status|1|||
154883619|NCT02939937|558997708|FG000|Overall Study|Adverse Event|5|||
154883620|NCT02939937|558997709|FG001|Overall Study|Adverse Event|0|||
154883621|NCT02939937|558997708|FG000|Overall Study|Lost to Follow-up|1|||
154883622|NCT02939937|558997709|FG001|Overall Study|Lost to Follow-up|3|||
154883623|NCT00568958|558997711|FG000|Allocation|Withdrawal by Subject|7|||
154883624|NCT00568958|558997712|FG001|Allocation|Withdrawal by Subject|3|||
154883625|NCT00568958|558997711|FG000|Allocation|Physician Decision|2|||
154883626|NCT00568958|558997712|FG001|Allocation|Physician Decision|0|||
154883627|NCT00568958|558997711|FG000|Follow-Up|Withdrawal by Subject|6|||
154883628|NCT00568958|558997712|FG001|Follow-Up|Withdrawal by Subject|6|||
154883629|NCT00568958|558997711|FG000|Follow-Up|Physician Decision|1|||
154883630|NCT00568958|558997712|FG001|Follow-Up|Physician Decision|1|||
154883631|NCT00568958|558997711|FG000|Follow-Up|Family Emergency|1|||
154883632|NCT00568958|558997712|FG001|Follow-Up|Family Emergency|0|||
154975834|NCT03843125|559335233|FG000|Overall Study|Other|12|||
154975835|NCT03843125|559335234|FG001|Overall Study|Other|14|||
154883633|NCT00568958|558997711|FG000|Follow-Up|Adverse Event|1|||
154883634|NCT00568958|558997712|FG001|Follow-Up|Adverse Event|0|||
154883635|NCT05254613|558997724|FG000|Overall Study|Lost to Follow-up|0|||
154883636|NCT05254613|558997725|FG001|Overall Study|Lost to Follow-up|0|||
154883637|NCT05254613|558997726|FG002|Overall Study|Lost to Follow-up|1|||
154883638|NCT02387372|558997727|FG000|Overall Study|Not Treated|1|||
154883639|NCT02387372|558997728|FG001|Overall Study|Not Treated|0|||
154883640|NCT01911845|558997730|FG000|Overall Study|Adverse Event|2|||
154883641|NCT01911845|558997730|FG000|Overall Study|Lost to Follow-up|1|||
154883642|NCT01911845|558997730|FG000|Overall Study|Other (not specified)|3|||
154883643|NCT01576016|558997731|FG000|Lead Safety|Death|132|||
154883644|NCT01576016|558997732|FG001|Lead Safety|Death|0|||
154883645|NCT01576016|558997731|FG000|Lead Safety|Withdrawal by Subject|81|||
154883646|NCT01576016|558997732|FG001|Lead Safety|Withdrawal by Subject|0|||
154883647|NCT01576016|558997731|FG000|Lead Safety|System Explanted without Replacement|24|||
154975836|NCT03843125|559335235|FG002|Overall Study|Other|3|||
154883648|NCT01576016|558997732|FG001|Lead Safety|System Explanted without Replacement|0|||
154883649|NCT01576016|558997731|FG000|Lead Safety|Physician Decision|14|||
154883650|NCT01576016|558997732|FG001|Lead Safety|Physician Decision|0|||
154883651|NCT01576016|558997731|FG000|Lead Safety|Lost to Follow-up|13|||
154883652|NCT01576016|558997732|FG001|Lead Safety|Lost to Follow-up|0|||
154883653|NCT01576016|558997731|FG000|Lead Safety|Unsuccessful implant|2|||
154883654|NCT01576016|558997732|FG001|Lead Safety|Unsuccessful implant|0|||
154883655|NCT01576016|558997731|FG000|Lead Safety|Sponsor request|1|||
154883656|NCT01576016|558997732|FG001|Lead Safety|Sponsor request|0|||
154883657|NCT01576016|558997731|FG000|Lead Safety|Device replaced with CRT-D|1|||
154883658|NCT01576016|558997732|FG001|Lead Safety|Device replaced with CRT-D|0|||
154883659|NCT01576016|558997731|FG000|Lead Safety|Patient on Palliative Care|1|||
154883660|NCT01576016|558997732|FG001|Lead Safety|Patient on Palliative Care|0|||
154883661|NCT01576016|558997731|FG000|Lead Safety|Patient noncompliance|1|||
154883662|NCT01576016|558997732|FG001|Lead Safety|Patient noncompliance|0|||
154883663|NCT01576016|558997731|FG000|Lead Safety|Too far from study site|1|||
154883664|NCT01576016|558997732|FG001|Lead Safety|Too far from study site|0|||
154883665|NCT01576016|558997731|FG000|Lead Safety|System deactivated|1|||
154883666|NCT01576016|558997732|FG001|Lead Safety|System deactivated|0|||
154883667|NCT01576016|558997731|FG000|Lead Safety|Patient no longer followed by study PI|1|||
154883668|NCT01576016|558997732|FG001|Lead Safety|Patient no longer followed by study PI|0|||
154883669|NCT01576016|558997731|FG000|MRI Safety|Withdrawal by Subject|0|||
154883670|NCT01576016|558997732|FG001|MRI Safety|Withdrawal by Subject|10|||
154883671|NCT01576016|558997731|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
154883672|NCT01576016|558997732|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
154883673|NCT01576016|558997731|FG000|MRI Safety|Has not yet completed MRI scan|0|||
154883674|NCT01576016|558997732|FG001|MRI Safety|Has not yet completed MRI scan|56|||
154883675|NCT01576016|558997731|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
154883676|NCT01576016|558997732|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
154883677|NCT01774344|558997733|FG000|Overall Study|Withdrawal by Subject|3|||
154883678|NCT01774344|558997734|FG001|Overall Study|Withdrawal by Subject|10|||
154883679|NCT01774344|558997733|FG000|Overall Study|Protocol Violation|0|||
154883680|NCT01774344|558997734|FG001|Overall Study|Protocol Violation|1|||
154883681|NCT01774344|558997733|FG000|Overall Study|Lost to Follow-up|4|||
154883682|NCT01774344|558997734|FG001|Overall Study|Lost to Follow-up|10|||
154883683|NCT01774344|558997733|FG000|Overall Study|End of survival follow-up not available|2|||
154883684|NCT01774344|558997734|FG001|Overall Study|End of survival follow-up not available|2|||
154883685|NCT01774344|558997733|FG000|Overall Study|Data collection finished|4|||
154883686|NCT01774344|558997734|FG001|Overall Study|Data collection finished|14|||
154883687|NCT01774344|558997733|FG000|Overall Study|Other|0|||
154883688|NCT01774344|558997734|FG001|Overall Study|Other|1|||
154883689|NCT01774344|558997733|FG000|Overall Study|Did not enter Survival Follow up|49|||
154883690|NCT01774344|558997734|FG001|Overall Study|Did not enter Survival Follow up|83|||
154883691|NCT00436566|558997745|FG000|Overall Study|Withdrawal by Subject|2|||
154883692|NCT00436566|558997745|FG000|Overall Study|Protocol Violation|1|||
154883693|NCT04507867|558997748|FG000|Overall Study|Death|7|||
154883694|NCT04507867|558997749|FG001|Overall Study|Death|1|||
154883695|NCT01860534|558997752|FG000|ROP #1|Needed treatment for ROP|0|||
154883696|NCT01860534|558997753|FG001|ROP #1|Needed treatment for ROP|1|||
154883697|NCT01860534|558997752|FG000|ROP #2|discharged prior to ROP #2|1|||
154883698|NCT01860534|558997753|FG001|ROP #2|discharged prior to ROP #2|0|||
154883699|NCT00502320|558997755|FG000|Overall Study|Lost to Follow-up|1|||
154883700|NCT00502320|558997756|FG001|Overall Study|Lost to Follow-up|1|||
154883701|NCT00502320|558997755|FG000|Overall Study|Withdrew Consent|1|||
154883702|NCT00502320|558997756|FG001|Overall Study|Withdrew Consent|0|||
154883703|NCT00502320|558997755|FG000|Overall Study|No longer met criteria|1|||
154883704|NCT00502320|558997756|FG001|Overall Study|No longer met criteria|0|||
154883705|NCT00502320|558997755|FG000|Overall Study|Screen Failure|0|||
154883706|NCT00502320|558997756|FG001|Overall Study|Screen Failure|1|||
154883707|NCT00502320|558997755|FG000|Overall Study|Adverse Event|3|||
154883708|NCT00502320|558997756|FG001|Overall Study|Adverse Event|5|||
154883709|NCT02124707|558997759|FG000|Overall Study|Adverse Event|5|||
154883710|NCT02124707|558997759|FG000|Overall Study|Physician Decision|1|||
154883711|NCT02124707|558997759|FG000|Overall Study|Death|1|||
154883712|NCT02196038|558997771|FG000|Overall Study|Death|16|||
155113635|NCT00758264|559844867|FG002|Active Phase|Withdrawal by Subject|1|||
154883713|NCT02196038|558997772|FG001|Overall Study|Death|21|||
154883714|NCT02196038|558997771|FG000|Overall Study|Withdrawal by Subject|0|||
154883715|NCT02196038|558997772|FG001|Overall Study|Withdrawal by Subject|1|||
154883716|NCT02196038|558997771|FG000|Overall Study|Lost to Follow-up|1|||
154883717|NCT02196038|558997772|FG001|Overall Study|Lost to Follow-up|0|||
154883718|NCT01151579|558997776|FG000|Overall Study|Physician Decision|3|||
154883719|NCT01151579|558997777|FG001|Overall Study|Physician Decision|1|||
154883720|NCT01151579|558997776|FG000|Overall Study|Withdrawal by Subject|3|||
154883721|NCT01151579|558997777|FG001|Overall Study|Withdrawal by Subject|2|||
154883722|NCT01151579|558997776|FG000|Overall Study|Not meet inclusion criteria|6|||
154883723|NCT01151579|558997777|FG001|Overall Study|Not meet inclusion criteria|4|||
154975837|NCT03843125|559335236|FG003|Overall Study|Other|4|||
154883724|NCT01098461|558997780|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
154883725|NCT01098461|558997781|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
154883726|NCT01098461|558997782|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
154883727|NCT01098461|558997783|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
154883728|NCT01098461|558997780|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
154883729|NCT01098461|558997781|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
154883730|NCT01098461|558997782|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
154883731|NCT01098461|558997783|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
154883732|NCT01098461|558997780|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
154883733|NCT01098461|558997781|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
154883734|NCT01098461|558997782|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
154883735|NCT01098461|558997783|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
154883736|NCT01098461|558997780|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
154883737|NCT01098461|558997781|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
154883738|NCT01098461|558997782|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
154883739|NCT01098461|558997783|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
154883740|NCT01098461|558997780|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
154883741|NCT01098461|558997781|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
154883742|NCT01098461|558997782|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
154883743|NCT01098461|558997783|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
154883744|NCT01098461|558997780|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
154883745|NCT01098461|558997781|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
154883746|NCT01098461|558997782|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
154883747|NCT01098461|558997783|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
154883748|NCT01098461|558997780|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
154883749|NCT01098461|558997781|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
154883750|NCT01098461|558997782|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
154883751|NCT01098461|558997783|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
154883752|NCT03491553|558997784|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
154883753|NCT03491553|558997785|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
154883754|NCT03491553|558997786|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
154883755|NCT03491553|558997787|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
154883756|NCT03491553|558997788|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
154883757|NCT03491553|558997789|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
154883758|NCT03491553|558997784|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
154883759|NCT03491553|558997785|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
154883760|NCT03491553|558997786|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
154883761|NCT03491553|558997787|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
154883762|NCT03491553|558997788|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
154883763|NCT03491553|558997789|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
154883764|NCT01766336|558997794|FG000|Overall Study|Adverse Event|11|||
154883765|NCT01766336|558997795|FG001|Overall Study|Adverse Event|8|||
154883766|NCT01766336|558997794|FG000|Overall Study|Death|4|||
154883767|NCT01766336|558997795|FG001|Overall Study|Death|3|||
154883768|NCT01766336|558997794|FG000|Overall Study|Lost to Follow-up|1|||
154883769|NCT01766336|558997795|FG001|Overall Study|Lost to Follow-up|3|||
154883770|NCT01766336|558997794|FG000|Overall Study|Physician Decision|4|||
154883771|NCT01766336|558997795|FG001|Overall Study|Physician Decision|2|||
154883772|NCT01766336|558997794|FG000|Overall Study|Protocol Violation|0|||
154883773|NCT01766336|558997795|FG001|Overall Study|Protocol Violation|1|||
154883774|NCT01766336|558997794|FG000|Overall Study|Sponsor Decision|52|||
154883775|NCT01766336|558997795|FG001|Overall Study|Sponsor Decision|43|||
154883776|NCT01766336|558997794|FG000|Overall Study|Withdrawal by Subject|18|||
154883777|NCT01766336|558997795|FG001|Overall Study|Withdrawal by Subject|15|||
154883778|NCT03029650|558997796|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
154883779|NCT03029650|558997797|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
154883780|NCT03029650|558997796|FG000|Washout (1 Week)|Physician Decision|0|||
154883781|NCT03029650|558997797|FG001|Washout (1 Week)|Physician Decision|1|||
154883782|NCT01606761|558997799|FG000|Prior to Week 24|Lost to Follow-up|0|||
154883783|NCT01606761|558997800|FG001|Prior to Week 24|Lost to Follow-up|3|||
154883784|NCT01606761|558997801|FG002|Prior to Week 24|Lost to Follow-up|2|||
154883785|NCT01606761|558997802|FG003|Prior to Week 24|Lost to Follow-up|0|||
154883786|NCT01606761|558997803|FG004|Prior to Week 24|Lost to Follow-up|0|||
154883787|NCT01606761|558997799|FG000|Prior to Week 24|Withdrawal by Subject|12|||
154883788|NCT01606761|558997800|FG001|Prior to Week 24|Withdrawal by Subject|10|||
154883789|NCT01606761|558997801|FG002|Prior to Week 24|Withdrawal by Subject|9|||
154883790|NCT01606761|558997802|FG003|Prior to Week 24|Withdrawal by Subject|0|||
155113636|NCT00758264|559844865|FG000|Active Phase|Lost to Follow-up|1|||
154883791|NCT01606761|558997803|FG004|Prior to Week 24|Withdrawal by Subject|0|||
154883792|NCT01606761|558997799|FG000|Prior to Week 24|Adverse Event|11|||
154883793|NCT01606761|558997800|FG001|Prior to Week 24|Adverse Event|18|||
154883794|NCT01606761|558997801|FG002|Prior to Week 24|Adverse Event|22|||
154883795|NCT01606761|558997802|FG003|Prior to Week 24|Adverse Event|0|||
154883796|NCT01606761|558997803|FG004|Prior to Week 24|Adverse Event|0|||
154883797|NCT01606761|558997799|FG000|Prior to Week 24|Lack of Efficacy|15|||
154883798|NCT01606761|558997800|FG001|Prior to Week 24|Lack of Efficacy|14|||
154883799|NCT01606761|558997801|FG002|Prior to Week 24|Lack of Efficacy|8|||
154883800|NCT01606761|558997802|FG003|Prior to Week 24|Lack of Efficacy|0|||
154883801|NCT01606761|558997803|FG004|Prior to Week 24|Lack of Efficacy|0|||
154883802|NCT01606761|558997799|FG000|Prior to Week 24|Physician Decision|0|||
154883803|NCT01606761|558997800|FG001|Prior to Week 24|Physician Decision|3|||
154883804|NCT01606761|558997801|FG002|Prior to Week 24|Physician Decision|1|||
154883805|NCT01606761|558997802|FG003|Prior to Week 24|Physician Decision|0|||
154883806|NCT01606761|558997803|FG004|Prior to Week 24|Physician Decision|0|||
154883807|NCT01606761|558997799|FG000|Prior to Week 24|Other|4|||
154883808|NCT01606761|558997800|FG001|Prior to Week 24|Other|7|||
154883809|NCT01606761|558997801|FG002|Prior to Week 24|Other|5|||
154883810|NCT01606761|558997802|FG003|Prior to Week 24|Other|0|||
154883811|NCT01606761|558997803|FG004|Prior to Week 24|Other|0|||
154883812|NCT01606761|558997799|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
154883813|NCT01606761|558997800|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
154883814|NCT01606761|558997801|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
154883815|NCT01606761|558997802|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
154883816|NCT01606761|558997803|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
154883817|NCT01606761|558997799|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
154883818|NCT01606761|558997800|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
154883819|NCT01606761|558997801|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
154883820|NCT01606761|558997802|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
154883821|NCT01606761|558997803|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
154883822|NCT01606761|558997799|FG000|Week 24 to Week 52|Adverse Event|0|||
154883823|NCT01606761|558997800|FG001|Week 24 to Week 52|Adverse Event|11|||
154883824|NCT01606761|558997801|FG002|Week 24 to Week 52|Adverse Event|14|||
154883825|NCT01606761|558997802|FG003|Week 24 to Week 52|Adverse Event|3|||
154883826|NCT01606761|558997803|FG004|Week 24 to Week 52|Adverse Event|15|||
154883827|NCT01606761|558997799|FG000|Week 24 to Week 52|Death|0|||
154883828|NCT01606761|558997800|FG001|Week 24 to Week 52|Death|0|||
154883829|NCT01606761|558997801|FG002|Week 24 to Week 52|Death|2|||
154883830|NCT01606761|558997802|FG003|Week 24 to Week 52|Death|1|||
154883831|NCT01606761|558997803|FG004|Week 24 to Week 52|Death|0|||
154883832|NCT01606761|558997799|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
154883833|NCT01606761|558997800|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
154883834|NCT01606761|558997801|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
154883835|NCT01606761|558997802|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
154883836|NCT01606761|558997803|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
154883837|NCT01606761|558997799|FG000|Week 24 to Week 52|Physician Decision|0|||
154883838|NCT01606761|558997800|FG001|Week 24 to Week 52|Physician Decision|1|||
154883839|NCT01606761|558997801|FG002|Week 24 to Week 52|Physician Decision|1|||
154883840|NCT01606761|558997802|FG003|Week 24 to Week 52|Physician Decision|0|||
154883841|NCT01606761|558997803|FG004|Week 24 to Week 52|Physician Decision|0|||
154883842|NCT01606761|558997799|FG000|Week 24 to Week 52|Other|0|||
154883843|NCT01606761|558997800|FG001|Week 24 to Week 52|Other|1|||
154883844|NCT01606761|558997801|FG002|Week 24 to Week 52|Other|5|||
154883845|NCT01606761|558997802|FG003|Week 24 to Week 52|Other|2|||
154883846|NCT01606761|558997803|FG004|Week 24 to Week 52|Other|2|||
154883847|NCT01606761|558997799|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
154883848|NCT01606761|558997800|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
154883849|NCT01606761|558997801|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
154883850|NCT01606761|558997802|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
154883851|NCT01606761|558997803|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
154883852|NCT01606761|558997799|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
154883853|NCT01606761|558997800|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
154883854|NCT01606761|558997801|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
154883855|NCT01606761|558997802|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
154883856|NCT01606761|558997803|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
154883857|NCT01606761|558997799|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
154883858|NCT01606761|558997800|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
154883859|NCT01606761|558997801|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
154883860|NCT01606761|558997802|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
155113637|NCT00758264|559844866|FG001|Active Phase|Lost to Follow-up|0|||
154883861|NCT01606761|558997803|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
154883862|NCT01606761|558997799|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
154883863|NCT01606761|558997800|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
154883864|NCT01606761|558997801|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
154883865|NCT01606761|558997802|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
154883866|NCT01606761|558997803|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
154883867|NCT05086289|558997804|FG000|Overall Study|Adverse Event|4|||
154883868|NCT05086289|558997805|FG001|Overall Study|Adverse Event|2|||
154975838|NCT03843125|559335233|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
154975839|NCT03843125|559335234|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
154975840|NCT03843125|559335235|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
154975841|NCT03843125|559335236|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
154975842|NCT03843125|559335233|FG000|Overall Study|Study Terminated by Sponsor|318|||
154975843|NCT03843125|559335234|FG001|Overall Study|Study Terminated by Sponsor|318|||
154975844|NCT03843125|559335235|FG002|Overall Study|Study Terminated by Sponsor|163|||
154975845|NCT03843125|559335236|FG003|Overall Study|Study Terminated by Sponsor|163|||
154975846|NCT03843125|559335233|FG000|Overall Study|Withdrawal by Subject|23|||
155175388|NCT03005873|560080232|FG002|Overall Study|Withdrew consent|2|||
155175389|NCT03005873|560080230|FG000|Overall Study|Lost to Follow-up|0|||
154883869|NCT05086289|558997804|FG000|Overall Study|Lost to Follow-up|2|||
154883870|NCT05086289|558997805|FG001|Overall Study|Lost to Follow-up|0|||
154883871|NCT05086289|558997804|FG000|Overall Study|Non-compliance with study drug|2|||
154883872|NCT05086289|558997805|FG001|Overall Study|Non-compliance with study drug|1|||
154883873|NCT05086289|558997804|FG000|Overall Study|Physician Decision|2|||
154883874|NCT05086289|558997805|FG001|Overall Study|Physician Decision|0|||
154883875|NCT05086289|558997804|FG000|Overall Study|Withdrawal by Subject|5|||
154883876|NCT05086289|558997805|FG001|Overall Study|Withdrawal by Subject|2|||
154883877|NCT00515008|558997811|FG000|Overall Study|Lost to Follow-up|1|||
154883878|NCT00515008|558997812|FG001|Overall Study|Lost to Follow-up|0|||
154883879|NCT00515008|558997811|FG000|Overall Study|Declined|0|||
154883880|NCT00515008|558997812|FG001|Overall Study|Declined|3|||
154883881|NCT00515008|558997811|FG000|Overall Study|Left the Boston Area|1|||
154883882|NCT00515008|558997812|FG001|Overall Study|Left the Boston Area|1|||
154883883|NCT00515008|558997811|FG000|Overall Study|Scheduling conflict|1|||
154883884|NCT00515008|558997812|FG001|Overall Study|Scheduling conflict|0|||
154883885|NCT03238235|558997813|FG000|Overall Study|Adverse Event|2|||
154883886|NCT03238235|558997814|FG001|Overall Study|Adverse Event|0|||
154883887|NCT03238235|558997813|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
154883888|NCT03238235|558997814|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
154883889|NCT03201198|558997825|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
154883890|NCT03201198|558997826|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
154883891|NCT03201198|558997825|FG000|Overall Study|Withdrawal by Subject|2|||
154883892|NCT03201198|558997826|FG001|Overall Study|Withdrawal by Subject|3|||
154883893|NCT00471445|558997827|FG000|Overall Study|Withdrawal by Subject|1|||
154883894|NCT00471445|558997828|FG001|Overall Study|Withdrawal by Subject|1|||
154883895|NCT00471445|558997827|FG000|Overall Study|Ineligible|1|||
154883896|NCT00471445|558997828|FG001|Overall Study|Ineligible|0|||
154883897|NCT00471445|558997827|FG000|Overall Study|Protocol Violation|0|||
154883898|NCT00471445|558997828|FG001|Overall Study|Protocol Violation|1|||
154883899|NCT04715230|558997834|FG000|Overall Study|Withdrawal by Subject|1|||
154883900|NCT04715230|558997835|FG001|Overall Study|Withdrawal by Subject|0|||
154883901|NCT04715230|558997836|FG002|Overall Study|Withdrawal by Subject|0|||
154883902|NCT04715230|558997834|FG000|Overall Study|Lost to Follow-up|0|||
154883903|NCT04715230|558997835|FG001|Overall Study|Lost to Follow-up|5|||
154883904|NCT04715230|558997836|FG002|Overall Study|Lost to Follow-up|1|||
154883905|NCT02596711|558997843|FG000|Overall Study|Lost to Follow-up|1|||
154883906|NCT02596711|558997844|FG001|Overall Study|Lost to Follow-up|2|||
154883907|NCT02596711|558997845|FG002|Overall Study|Lost to Follow-up|3|||
154883908|NCT00586924|558997846|FG000|Overall Study|Adverse event/serious adverse event|0|||
154883909|NCT00586924|558997847|FG001|Overall Study|Adverse event/serious adverse event|0|||
154883910|NCT00586924|558997848|FG002|Overall Study|Adverse event/serious adverse event|0|||
154883911|NCT00586924|558997849|FG003|Overall Study|Adverse event/serious adverse event|1|||
154883912|NCT00586924|558997850|FG004|Overall Study|Adverse event/serious adverse event|0|||
154883913|NCT00586924|558997851|FG005|Overall Study|Adverse event/serious adverse event|2|||
154883914|NCT00586924|558997846|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
154883915|NCT00586924|558997847|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
154883916|NCT00586924|558997848|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
154883917|NCT00586924|558997849|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
154883918|NCT00586924|558997850|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
154883919|NCT00586924|558997851|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
154883920|NCT00586924|558997846|FG000|Overall Study|Disease progression|0|||
154883921|NCT00586924|558997847|FG001|Overall Study|Disease progression|0|||
154883922|NCT00586924|558997848|FG002|Overall Study|Disease progression|0|||
154883923|NCT00586924|558997849|FG003|Overall Study|Disease progression|1|||
154883924|NCT00586924|558997850|FG004|Overall Study|Disease progression|1|||
154883925|NCT00586924|558997851|FG005|Overall Study|Disease progression|0|||
154883926|NCT00586924|558997846|FG000|Overall Study|Development of neutralizing antibodies|2|||
154883927|NCT00586924|558997847|FG001|Overall Study|Development of neutralizing antibodies|2|||
154883928|NCT00586924|558997848|FG002|Overall Study|Development of neutralizing antibodies|2|||
154975847|NCT03843125|559335234|FG001|Overall Study|Withdrawal by Subject|12|||
154975848|NCT03843125|559335235|FG002|Overall Study|Withdrawal by Subject|6|||
154883929|NCT00586924|558997849|FG003|Overall Study|Development of neutralizing antibodies|0|||
154883930|NCT00586924|558997850|FG004|Overall Study|Development of neutralizing antibodies|0|||
154883931|NCT00586924|558997851|FG005|Overall Study|Development of neutralizing antibodies|22|||
154883932|NCT00586924|558997846|FG000|Overall Study|Complete response|0|||
154883933|NCT00586924|558997847|FG001|Overall Study|Complete response|1|||
154883934|NCT00586924|558997848|FG002|Overall Study|Complete response|0|||
154883935|NCT00586924|558997849|FG003|Overall Study|Complete response|0|||
154883936|NCT00586924|558997850|FG004|Overall Study|Complete response|2|||
154883937|NCT00586924|558997851|FG005|Overall Study|Complete response|2|||
154883938|NCT00586924|558997846|FG000|Overall Study|Other|1|||
154883939|NCT00586924|558997847|FG001|Overall Study|Other|0|||
154883940|NCT00586924|558997848|FG002|Overall Study|Other|1|||
154883941|NCT00586924|558997849|FG003|Overall Study|Other|1|||
154883942|NCT00586924|558997850|FG004|Overall Study|Other|1|||
154883943|NCT00586924|558997851|FG005|Overall Study|Other|6|||
154883944|NCT01767194|558997853|FG000|Overall Study|Adverse Event|1|||
154883945|NCT01767194|558997854|FG001|Overall Study|Adverse Event|1|||
154883946|NCT01767194|558997853|FG000|Overall Study|Death|0|||
154883947|NCT01767194|558997854|FG001|Overall Study|Death|1|||
154883948|NCT01767194|558997853|FG000|Overall Study|Lack of Efficacy|12|||
154883949|NCT01767194|558997854|FG001|Overall Study|Lack of Efficacy|11|||
154883950|NCT01767194|558997853|FG000|Overall Study|Physician Decision|2|||
154883951|NCT01767194|558997854|FG001|Overall Study|Physician Decision|23|||
154883952|NCT01767194|558997853|FG000|Overall Study|Withdrawal by Subject|0|||
154883953|NCT01767194|558997854|FG001|Overall Study|Withdrawal by Subject|1|||
154883954|NCT01767194|558997853|FG000|Overall Study|Ineligible|1|||
154883955|NCT01767194|558997854|FG001|Overall Study|Ineligible|1|||
154883956|NCT01767194|558997853|FG000|Overall Study|Refusal by patient/parent|2|||
154883957|NCT01767194|558997854|FG001|Overall Study|Refusal by patient/parent|4|||
154883958|NCT01767194|558997853|FG000|Overall Study|Criteria not met on time for next cycle|0|||
154883959|NCT01767194|558997854|FG001|Overall Study|Criteria not met on time for next cycle|1|||
154883960|NCT00605722|558999944|FG000|Overall Study|Adverse Event|6|||
154883961|NCT00605722|558999944|FG000|Overall Study|Insufficient therapeutic response|44|||
154883962|NCT00605722|558999944|FG000|Overall Study|Failure to return|1|||
154883963|NCT00356863|558999947|FG000|Overall Study|Death|16|||
154883964|NCT00356863|558999948|FG001|Overall Study|Death|32|||
154883965|NCT00356863|558999947|FG000|Overall Study|Lost to Follow-up|76|||
154883966|NCT00356863|558999948|FG001|Overall Study|Lost to Follow-up|43|||
154883967|NCT00836277|558999949|FG000|Overall Study|Not evaluable for response|6|||
154883968|NCT02871401|558999951|FG000|Overall Study|Adverse Event|1|||
154883969|NCT02871401|558999952|FG001|Overall Study|Adverse Event|0|||
154883970|NCT03162055|558999953|FG000|Overall Study|Adverse Event|6|||
154883971|NCT03162055|558999954|FG001|Overall Study|Adverse Event|5|||
154883972|NCT03162055|558999953|FG000|Overall Study|Death|3|||
154883973|NCT03162055|558999954|FG001|Overall Study|Death|3|||
154883974|NCT03162055|558999953|FG000|Overall Study|Lost to Follow-up|0|||
154883975|NCT03162055|558999954|FG001|Overall Study|Lost to Follow-up|1|||
154883976|NCT03162055|558999953|FG000|Overall Study|Study-specific withdrawal criteria|22|||
154883977|NCT03162055|558999954|FG001|Overall Study|Study-specific withdrawal criteria|14|||
154883978|NCT03162055|558999953|FG000|Overall Study|Withdrawal by Subject|17|||
154883979|NCT03162055|558999954|FG001|Overall Study|Withdrawal by Subject|2|||
154883980|NCT03162055|558999953|FG000|Overall Study|Did not receive treatment|2|||
154883981|NCT03162055|558999954|FG001|Overall Study|Did not receive treatment|0|||
154883982|NCT03162055|558999953|FG000|Overall Study|Incorrect randomization|4|||
154883983|NCT03162055|558999954|FG001|Overall Study|Incorrect randomization|3|||
154883984|NCT03162055|558999953|FG000|Overall Study|Other|8|||
154883985|NCT03162055|558999954|FG001|Overall Study|Other|15|||
154883986|NCT00831441|558999958|FG000|Randomized|Death|82|||
154883987|NCT00831441|558999959|FG001|Randomized|Death|81|||
154883988|NCT00831441|558999958|FG000|Randomized|Adverse Event|248|||
154883989|NCT00831441|558999959|FG001|Randomized|Adverse Event|321|||
154883990|NCT00831441|558999958|FG000|Randomized|Emergency procedure|2|||
154883991|NCT00831441|558999959|FG001|Randomized|Emergency procedure|2|||
154883992|NCT00831441|558999958|FG000|Randomized|Elective procedure|26|||
154883993|NCT00831441|558999959|FG001|Randomized|Elective procedure|25|||
154883994|NCT00831441|558999958|FG000|Randomized|Physician Decision|26|||
154883995|NCT00831441|558999959|FG001|Randomized|Physician Decision|35|||
154883996|NCT00831441|558999958|FG000|Randomized|No longer met criteria|13|||
154883997|NCT00831441|558999959|FG001|Randomized|No longer met criteria|19|||
155175390|NCT03005873|560080231|FG001|Overall Study|Lost to Follow-up|1|||
154883998|NCT00831441|558999958|FG000|Randomized|Withdrawal by Subject|178|||
154883999|NCT00831441|558999959|FG001|Randomized|Withdrawal by Subject|212|||
154884000|NCT00831441|558999958|FG000|Randomized|Lost to Follow-up|26|||
154884001|NCT00831441|558999959|FG001|Randomized|Lost to Follow-up|35|||
154884002|NCT00831441|558999958|FG000|Randomized|Administrative reason by sponsor|2780|||
154884003|NCT00831441|558999959|FG001|Randomized|Administrative reason by sponsor|2671|||
154884004|NCT00831441|558999958|FG000|Randomized|poor/non-compliance|30|||
154975849|NCT03843125|559335236|FG003|Overall Study|Withdrawal by Subject|9|||
154975850|NCT03843125|559335233|FG000|Overall Study|Missing data|0|||
154884005|NCT00831441|558999959|FG001|Randomized|poor/non-compliance|38|||
154884006|NCT00831441|558999958|FG000|Randomized|non-specified|276|||
154884007|NCT00831441|558999959|FG001|Randomized|non-specified|266|||
154884008|NCT00831441|558999958|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
154884009|NCT00831441|558999959|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
154884010|NCT00831441|558999958|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
154884011|NCT00831441|558999959|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
154884012|NCT00831441|558999958|FG000|Follow Up (30 Days)|Death|63|||
154884013|NCT00831441|558999959|FG001|Follow Up (30 Days)|Death|86|||
154884014|NCT00831441|558999958|FG000|Follow Up (30 Days)|non-specified|16|||
154884015|NCT00831441|558999959|FG001|Follow Up (30 Days)|non-specified|26|||
154884016|NCT00831441|558999958|FG000|Follow Up (30 Days)|missing end of study status|0|||
154884017|NCT00831441|558999959|FG001|Follow Up (30 Days)|missing end of study status|1|||
154884018|NCT00485589|558999962|FG000|Overall Study|Death|2|||
154884019|NCT00485589|558999963|FG001|Overall Study|Death|2|||
154884020|NCT00485589|558999964|FG002|Overall Study|Death|0|||
154884021|NCT00485589|558999962|FG000|Overall Study|Failure to return|6|||
154884022|NCT00485589|558999963|FG001|Overall Study|Failure to return|5|||
154884023|NCT00485589|558999964|FG002|Overall Study|Failure to return|1|||
154884024|NCT00485589|558999962|FG000|Overall Study|Protocol Violation|1|||
154884025|NCT00485589|558999963|FG001|Overall Study|Protocol Violation|0|||
154884026|NCT00485589|558999964|FG002|Overall Study|Protocol Violation|0|||
154884027|NCT00485589|558999962|FG000|Overall Study|Violation of selection criteria at entry|0|||
154884028|NCT00485589|558999963|FG001|Overall Study|Violation of selection criteria at entry|3|||
154884029|NCT00485589|558999964|FG002|Overall Study|Violation of selection criteria at entry|1|||
154884030|NCT00485589|558999962|FG000|Overall Study|Administrative/Other|1|||
154884031|NCT00485589|558999963|FG001|Overall Study|Administrative/Other|2|||
154884032|NCT00485589|558999964|FG002|Overall Study|Administrative/Other|1|||
154884033|NCT00485589|558999962|FG000|Overall Study|Insufficient therapeutic response|10|||
154884034|NCT00485589|558999963|FG001|Overall Study|Insufficient therapeutic response|3|||
154884035|NCT00485589|558999964|FG002|Overall Study|Insufficient therapeutic response|1|||
154884036|NCT00485589|558999962|FG000|Overall Study|Refused treatment/did not cooperate|1|||
154884037|NCT00485589|558999963|FG001|Overall Study|Refused treatment/did not cooperate|0|||
154884038|NCT00485589|558999964|FG002|Overall Study|Refused treatment/did not cooperate|2|||
154884039|NCT00485589|558999962|FG000|Overall Study|Withdrawal by Subject|3|||
154884040|NCT00485589|558999963|FG001|Overall Study|Withdrawal by Subject|2|||
154884041|NCT00485589|558999964|FG002|Overall Study|Withdrawal by Subject|2|||
154884042|NCT00485589|558999962|FG000|Overall Study|Adverse Event|3|||
154884043|NCT00485589|558999963|FG001|Overall Study|Adverse Event|3|||
154884044|NCT00485589|558999964|FG002|Overall Study|Adverse Event|10|||
154884045|NCT01944969|558999965|FG000|Overall Study|Adverse Event|1|||
154884046|NCT01944969|558999965|FG000|Overall Study|Lack of Efficacy|1|||
154884047|NCT01944969|558999965|FG000|Overall Study|Non-compliance with IMP|1|||
154884048|NCT01944969|558999965|FG000|Overall Study|Administrative or other reasons|23|||
154884049|NCT01104584|558999967|FG000|Overall Study|Study drug never administered|21|||
154884050|NCT01104584|558999967|FG000|Overall Study|Study prematurely discontinued|2|||
154884051|NCT02370498|558999968|FG000|Overall Study|Adverse Event|10|||
154884052|NCT02370498|558999969|FG001|Overall Study|Adverse Event|8|||
154884053|NCT02370498|558999968|FG000|Overall Study|Death|263|||
154884054|NCT02370498|558999969|FG001|Overall Study|Death|265|||
154884055|NCT02370498|558999968|FG000|Overall Study|Protocol Violation|1|||
154884056|NCT02370498|558999969|FG001|Overall Study|Protocol Violation|2|||
154884057|NCT02370498|558999968|FG000|Overall Study|Withdrawal by Subject|7|||
154884058|NCT02370498|558999969|FG001|Overall Study|Withdrawal by Subject|12|||
154884059|NCT02370498|558999968|FG000|Overall Study|Sponsor's decision|15|||
154884060|NCT02370498|558999969|FG001|Overall Study|Sponsor's decision|9|||
154884061|NCT04017442|558999970|FG000|Overall Study|Withdrawal by Subject|0|||
154884062|NCT04017442|558999971|FG001|Overall Study|Withdrawal by Subject|3|||
154884063|NCT04017442|558999970|FG000|Overall Study|Lost to Follow-up|21|||
154884064|NCT04017442|558999971|FG001|Overall Study|Lost to Follow-up|19|||
154884065|NCT02586233|558999975|FG000|Overall Study|Randomized but did not receive treatment|0|||
154884066|NCT02586233|558999976|FG001|Overall Study|Randomized but did not receive treatment|1|||
154884067|NCT02586233|558999977|FG002|Overall Study|Randomized but did not receive treatment|0|||
154884068|NCT02586233|558999978|FG003|Overall Study|Randomized but did not receive treatment|0|||
154884069|NCT02586233|558999979|FG004|Overall Study|Randomized but did not receive treatment|0|||
154884070|NCT02586233|558999980|FG005|Overall Study|Randomized but did not receive treatment|2|||
154884071|NCT02586233|558999981|FG006|Overall Study|Randomized but did not receive treatment|2|||
154884072|NCT02586233|558999975|FG000|Overall Study|Death|0|||
154884073|NCT02586233|558999976|FG001|Overall Study|Death|1|||
154884074|NCT02586233|558999977|FG002|Overall Study|Death|0|||
154884075|NCT02586233|558999978|FG003|Overall Study|Death|0|||
154884076|NCT02586233|558999979|FG004|Overall Study|Death|2|||
154884077|NCT02586233|558999980|FG005|Overall Study|Death|0|||
154884078|NCT02586233|558999981|FG006|Overall Study|Death|0|||
154884079|NCT03225716|558999982|FG000|Overall Study|Withdrawal by Subject|2|||
154884080|NCT03225716|558999983|FG001|Overall Study|Withdrawal by Subject|2|||
154975851|NCT03843125|559335234|FG001|Overall Study|Missing data|1|||
154975852|NCT03843125|559335235|FG002|Overall Study|Missing data|1|||
154975853|NCT03843125|559335236|FG003|Overall Study|Missing data|0|||
154975854|NCT05889039|559335237|FG000|Overall Study|error in completing survey|0|||
154975855|NCT05889039|559335238|FG001|Overall Study|error in completing survey|2|||
154975856|NCT05889039|559335239|FG002|Overall Study|error in completing survey|0|||
154975857|NCT05889039|559335240|FG003|Overall Study|error in completing survey|0|||
154975858|NCT05889039|559335237|FG000|Overall Study|Lost to Follow-up|4|||
154975859|NCT05889039|559335238|FG001|Overall Study|Lost to Follow-up|0|||
154975860|NCT05889039|559335239|FG002|Overall Study|Lost to Follow-up|0|||
154975861|NCT05889039|559335240|FG003|Overall Study|Lost to Follow-up|0|||
154975862|NCT02661022|559335241|FG000|Overall Study|Withdrawal by Subject|3|||
154975863|NCT02661022|559335242|FG001|Overall Study|Withdrawal by Subject|0|||
154975864|NCT02661022|559335241|FG000|Overall Study|Adverse Event|1|||
154975865|NCT02661022|559335242|FG001|Overall Study|Adverse Event|1|||
154975866|NCT02661022|559335241|FG000|Overall Study|Physician Decision|1|||
154975867|NCT02661022|559335242|FG001|Overall Study|Physician Decision|0|||
154975868|NCT02661022|559335241|FG000|Overall Study|Progressive Disease|2|||
154975869|NCT02661022|559335242|FG001|Overall Study|Progressive Disease|1|||
154975870|NCT02972515|559335243|FG000|Overall Study|Lost to Follow-up|78|||
154975871|NCT00609154|559335244|FG000|Overall Study|Protocol Violation|1|||
154975872|NCT00609154|559335245|FG001|Overall Study|Protocol Violation|2|||
154975873|NCT00609154|559335244|FG000|Overall Study|Unable to establish IV access|0|||
154975874|NCT00609154|559335245|FG001|Overall Study|Unable to establish IV access|4|||
154975875|NCT00609154|559335244|FG000|Overall Study|Adverse Event|0|||
154975876|NCT00609154|559335245|FG001|Overall Study|Adverse Event|2|||
154975877|NCT04531527|559335246|FG000|Overall Study|Found to be Ineligible|3|||
154975878|NCT01450800|559335254|FG000|Overall Study|Protocol Violation|1|||
154975879|NCT01450800|559335255|FG001|Overall Study|Protocol Violation|3|||
154975880|NCT03496298|559335256|FG000|Overall Study|Adverse Event|49|||
154975881|NCT03496298|559335257|FG001|Overall Study|Adverse Event|68|||
154975882|NCT03496298|559335258|FG002|Overall Study|Adverse Event|79|||
154975883|NCT03496298|559335256|FG000|Overall Study|Study terminated by Sponsor|1050|||
154975884|NCT03496298|559335257|FG001|Overall Study|Study terminated by Sponsor|1063|||
154975885|NCT03496298|559335258|FG002|Overall Study|Study terminated by Sponsor|1071|||
154884081|NCT03225716|558999984|FG002|Overall Study|Withdrawal by Subject|0|||
154884082|NCT03225716|558999982|FG000|Overall Study|Lack of Efficacy|1|||
154884083|NCT03225716|558999983|FG001|Overall Study|Lack of Efficacy|0|||
154884084|NCT03225716|558999984|FG002|Overall Study|Lack of Efficacy|0|||
154884085|NCT03225716|558999982|FG000|Overall Study|Adverse Event|2|||
154884086|NCT03225716|558999983|FG001|Overall Study|Adverse Event|0|||
154884087|NCT03225716|558999984|FG002|Overall Study|Adverse Event|1|||
154884088|NCT03225716|558999982|FG000|Overall Study|Study early termination by Sponsor|0|||
154884089|NCT03225716|558999983|FG001|Overall Study|Study early termination by Sponsor|0|||
154884090|NCT03225716|558999984|FG002|Overall Study|Study early termination by Sponsor|2|||
154884091|NCT01205451|558999985|FG000|Overall Study|Lost to Follow-up|1|||
154884092|NCT01205451|558999986|FG001|Overall Study|Lost to Follow-up|1|||
154884093|NCT01205451|558999985|FG000|Overall Study|Withdrawal by Subject|5|||
154884094|NCT01205451|558999986|FG001|Overall Study|Withdrawal by Subject|9|||
154884095|NCT03421964|558999994|FG000|Overall Study|Lost to Follow-up|11|||
154884096|NCT03421964|558999995|FG001|Overall Study|Lost to Follow-up|21|||
154884097|NCT03421964|558999994|FG000|Overall Study|Withdrawal by Subject|9|||
154884098|NCT03421964|558999995|FG001|Overall Study|Withdrawal by Subject|3|||
154975886|NCT03496298|559335256|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
154975887|NCT03496298|559335257|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
154975888|NCT03496298|559335258|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
154975889|NCT03496298|559335256|FG000|Overall Study|Withdrawal by Subject|176|||
154975890|NCT03496298|559335257|FG001|Overall Study|Withdrawal by Subject|154|||
154884099|NCT03421964|558999994|FG000|Overall Study|Incarcerated|1|||
154884100|NCT03421964|558999995|FG001|Overall Study|Incarcerated|0|||
154975891|NCT03496298|559335258|FG002|Overall Study|Withdrawal by Subject|151|||
154975892|NCT03496298|559335256|FG000|Overall Study|Other|29|||
154975893|NCT03496298|559335257|FG001|Overall Study|Other|20|||
154975894|NCT03496298|559335258|FG002|Overall Study|Other|23|||
154975895|NCT03496298|559335256|FG000|Overall Study|Randomized and not treated|1|||
154884101|NCT03421964|558999994|FG000|Overall Study|Inpt Treatment Facility|1|||
154884102|NCT03421964|558999995|FG001|Overall Study|Inpt Treatment Facility|1|||
154884103|NCT03421964|558999994|FG000|Overall Study|Virtual Platform Issues|1|||
154884104|NCT03421964|558999995|FG001|Overall Study|Virtual Platform Issues|1|||
154884105|NCT02938585|558999996|FG000|Overall Study|Withdrawal by parent or guardian|0|||
154975896|NCT03496298|559335257|FG001|Overall Study|Randomized and not treated|1|||
154975897|NCT03496298|559335258|FG002|Overall Study|Randomized and not treated|1|||
154975898|NCT00761176|559335271|FG000|Overall Study|Death|1|||
154975899|NCT00761176|559335272|FG001|Overall Study|Death|0|||
154975900|NCT00761176|559335271|FG000|Overall Study|Withdrawal by Subject|1|||
154975901|NCT00761176|559335272|FG001|Overall Study|Withdrawal by Subject|1|||
154884106|NCT02938585|558999997|FG001|Overall Study|Withdrawal by parent or guardian|1|||
154884107|NCT02938585|558999998|FG002|Overall Study|Withdrawal by parent or guardian|0|||
154884108|NCT02938585|558999999|FG003|Overall Study|Withdrawal by parent or guardian|0|||
154884109|NCT02938585|558999996|FG000|Overall Study|Withdrawal by Subject|0|||
154884110|NCT02938585|558999997|FG001|Overall Study|Withdrawal by Subject|0|||
154884111|NCT02938585|558999998|FG002|Overall Study|Withdrawal by Subject|0|||
154884112|NCT02938585|558999999|FG003|Overall Study|Withdrawal by Subject|5|||
154884113|NCT02106455|559000007|FG000|Overall Study|Case Report Form Uncollected|6|||
154884114|NCT02106455|559000007|FG000|Overall Study|Protocol Deviation|2|||
154884115|NCT00213980|559000008|FG000|Overall Study|Withdrawal by Subject|3|||
154884116|NCT00213980|559000009|FG001|Overall Study|Withdrawal by Subject|1|||
154884117|NCT00213980|559000008|FG000|Overall Study|Adverse Event|1|||
154884118|NCT00213980|559000009|FG001|Overall Study|Adverse Event|1|||
154884119|NCT00213980|559000008|FG000|Overall Study|Disease progression|0|||
154884120|NCT00213980|559000009|FG001|Overall Study|Disease progression|2|||
154884121|NCT00213980|559000008|FG000|Overall Study|Developed ovarian cancer|1|||
154884122|NCT00213980|559000009|FG001|Overall Study|Developed ovarian cancer|0|||
154884123|NCT00213980|559000008|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
154884124|NCT00213980|559000009|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
154884125|NCT03607838|559000010|FG000|Overall Study|Lack of Efficacy|14|||
154884126|NCT03607838|559000011|FG001|Overall Study|Lack of Efficacy|20|||
154884127|NCT03607838|559000010|FG000|Overall Study|Withdrawal by Subject|13|||
154884128|NCT03607838|559000011|FG001|Overall Study|Withdrawal by Subject|8|||
154884129|NCT03607838|559000010|FG000|Overall Study|Lost to Follow-up|6|||
154884130|NCT03607838|559000011|FG001|Overall Study|Lost to Follow-up|11|||
154884131|NCT03607838|559000010|FG000|Overall Study|Adverse Event|2|||
154884132|NCT03607838|559000011|FG001|Overall Study|Adverse Event|2|||
154884133|NCT03607838|559000010|FG000|Overall Study|Physician Decision|2|||
154884134|NCT03607838|559000011|FG001|Overall Study|Physician Decision|0|||
154884135|NCT03607838|559000010|FG000|Overall Study|Failure to meet randomization criteria|1|||
154884136|NCT03607838|559000011|FG001|Overall Study|Failure to meet randomization criteria|2|||
154884137|NCT03607838|559000010|FG000|Overall Study|Pregnancy|1|||
154884138|NCT03607838|559000011|FG001|Overall Study|Pregnancy|0|||
154884139|NCT03607838|559000010|FG000|Overall Study|Protocol Violation|1|||
154884140|NCT03607838|559000011|FG001|Overall Study|Protocol Violation|0|||
154884141|NCT03607838|559000010|FG000|Overall Study|Due to work|1|||
154884142|NCT03607838|559000011|FG001|Overall Study|Due to work|0|||
154884143|NCT03607838|559000010|FG000|Overall Study|Litigation|0|||
154884144|NCT03607838|559000011|FG001|Overall Study|Litigation|1|||
154884145|NCT03607838|559000010|FG000|Overall Study|Temperature excursion for study drug|0|||
154884146|NCT03607838|559000011|FG001|Overall Study|Temperature excursion for study drug|1|||
154884147|NCT03607838|559000010|FG000|Overall Study|Change of mind|0|||
154884148|NCT03607838|559000011|FG001|Overall Study|Change of mind|1|||
154884149|NCT02411201|559000012|FG000|Overall Study|Adverse Event|2|||
154884150|NCT02411201|559000012|FG000|Overall Study|Withdrawal by Subject|2|||
154884151|NCT02411201|559000012|FG000|Overall Study|Age group completed|2|||
154884152|NCT01260467|559000013|FG000|Overall Study|Withdrawal by Subject|2|||
154884153|NCT00798694|559000014|FG000|Overall Study|Lost to Follow-up|1|||
154884154|NCT00798694|559000015|FG001|Overall Study|Lost to Follow-up|1|||
154884155|NCT00798694|559000014|FG000|Overall Study|Physician Decision|1|||
154884156|NCT00798694|559000015|FG001|Overall Study|Physician Decision|0|||
154884157|NCT03364608|559000019|FG000|Overall Study|Withdrawal by Subject|4|||
154884158|NCT03364608|559000019|FG000|Overall Study|Protocol Violation|2|||
154884159|NCT03364608|559000019|FG000|Overall Study|Lost to Follow-up|2|||
154884160|NCT03888391|559000022|FG000|Overall Study|Lost to Follow-up|15|||
154884161|NCT02504268|559000025|FG000|Overall Study|Adverse Event|18|||
154884162|NCT02504268|559000026|FG001|Overall Study|Adverse Event|8|||
154884163|NCT02504268|559000027|FG002|Overall Study|Adverse Event|14|||
154884164|NCT02504268|559000028|FG003|Overall Study|Adverse Event|0|||
154884165|NCT02504268|559000029|FG004|Overall Study|Adverse Event|0|||
154884166|NCT02504268|559000030|FG005|Overall Study|Adverse Event|0|||
154884167|NCT02504268|559000031|FG006|Overall Study|Adverse Event|0|||
154884168|NCT02504268|559000032|FG007|Overall Study|Adverse Event|0|||
154884169|NCT02504268|559000033|FG008|Overall Study|Adverse Event|0|||
154884170|NCT02504268|559000025|FG000|Overall Study|Withdrawal of Consent|11|||
154884171|NCT02504268|559000026|FG001|Overall Study|Withdrawal of Consent|10|||
154884172|NCT02504268|559000027|FG002|Overall Study|Withdrawal of Consent|3|||
154884173|NCT02504268|559000028|FG003|Overall Study|Withdrawal of Consent|0|||
154884174|NCT02504268|559000029|FG004|Overall Study|Withdrawal of Consent|0|||
154884175|NCT02504268|559000030|FG005|Overall Study|Withdrawal of Consent|0|||
154884176|NCT02504268|559000031|FG006|Overall Study|Withdrawal of Consent|0|||
154884177|NCT02504268|559000032|FG007|Overall Study|Withdrawal of Consent|0|||
154884178|NCT02504268|559000033|FG008|Overall Study|Withdrawal of Consent|0|||
154884179|NCT02504268|559000025|FG000|Overall Study|Pregnancy|2|||
154884180|NCT02504268|559000026|FG001|Overall Study|Pregnancy|0|||
154884181|NCT02504268|559000027|FG002|Overall Study|Pregnancy|0|||
154884182|NCT02504268|559000028|FG003|Overall Study|Pregnancy|0|||
154884183|NCT02504268|559000029|FG004|Overall Study|Pregnancy|0|||
154884184|NCT02504268|559000030|FG005|Overall Study|Pregnancy|0|||
154884185|NCT02504268|559000031|FG006|Overall Study|Pregnancy|0|||
154884186|NCT02504268|559000032|FG007|Overall Study|Pregnancy|0|||
154884187|NCT02504268|559000033|FG008|Overall Study|Pregnancy|0|||
154884188|NCT02504268|559000025|FG000|Overall Study|Lost to Follow-up|3|||
154884189|NCT02504268|559000026|FG001|Overall Study|Lost to Follow-up|6|||
154884190|NCT02504268|559000027|FG002|Overall Study|Lost to Follow-up|4|||
154884191|NCT02504268|559000028|FG003|Overall Study|Lost to Follow-up|0|||
154884192|NCT02504268|559000029|FG004|Overall Study|Lost to Follow-up|0|||
154884193|NCT02504268|559000030|FG005|Overall Study|Lost to Follow-up|0|||
154884194|NCT02504268|559000031|FG006|Overall Study|Lost to Follow-up|0|||
154884195|NCT02504268|559000032|FG007|Overall Study|Lost to Follow-up|0|||
154884196|NCT02504268|559000033|FG008|Overall Study|Lost to Follow-up|0|||
154884197|NCT02504268|559000025|FG000|Overall Study|Death|1|||
154884198|NCT02504268|559000026|FG001|Overall Study|Death|1|||
154884199|NCT02504268|559000027|FG002|Overall Study|Death|0|||
154884200|NCT02504268|559000028|FG003|Overall Study|Death|0|||
154884201|NCT02504268|559000029|FG004|Overall Study|Death|0|||
154884202|NCT02504268|559000030|FG005|Overall Study|Death|0|||
154884203|NCT02504268|559000031|FG006|Overall Study|Death|0|||
154884204|NCT02504268|559000032|FG007|Overall Study|Death|0|||
154884205|NCT02504268|559000033|FG008|Overall Study|Death|0|||
154884206|NCT02504268|559000025|FG000|Overall Study|Subject Request to Discontinue|11|||
154884207|NCT02504268|559000026|FG001|Overall Study|Subject Request to Discontinue|3|||
154884208|NCT02504268|559000027|FG002|Overall Study|Subject Request to Discontinue|6|||
154884209|NCT02504268|559000028|FG003|Overall Study|Subject Request to Discontinue|0|||
154884210|NCT02504268|559000029|FG004|Overall Study|Subject Request to Discontinue|0|||
154884211|NCT02504268|559000030|FG005|Overall Study|Subject Request to Discontinue|0|||
154884212|NCT02504268|559000031|FG006|Overall Study|Subject Request to Discontinue|0|||
154884213|NCT02504268|559000032|FG007|Overall Study|Subject Request to Discontinue|0|||
154884214|NCT02504268|559000033|FG008|Overall Study|Subject Request to Discontinue|0|||
154884215|NCT02504268|559000025|FG000|Overall Study|No Longer Meets Study Criteria|2|||
154884216|NCT02504268|559000026|FG001|Overall Study|No Longer Meets Study Criteria|3|||
154884217|NCT02504268|559000027|FG002|Overall Study|No Longer Meets Study Criteria|0|||
154884218|NCT02504268|559000028|FG003|Overall Study|No Longer Meets Study Criteria|0|||
154884219|NCT02504268|559000029|FG004|Overall Study|No Longer Meets Study Criteria|0|||
154884220|NCT02504268|559000030|FG005|Overall Study|No Longer Meets Study Criteria|0|||
154884221|NCT02504268|559000031|FG006|Overall Study|No Longer Meets Study Criteria|0|||
154884222|NCT02504268|559000032|FG007|Overall Study|No Longer Meets Study Criteria|0|||
154884223|NCT02504268|559000033|FG008|Overall Study|No Longer Meets Study Criteria|0|||
154884224|NCT02504268|559000025|FG000|Overall Study|Lack of Efficacy|11|||
154884225|NCT02504268|559000026|FG001|Overall Study|Lack of Efficacy|35|||
154884226|NCT02504268|559000027|FG002|Overall Study|Lack of Efficacy|9|||
154884227|NCT02504268|559000028|FG003|Overall Study|Lack of Efficacy|0|||
154884228|NCT02504268|559000029|FG004|Overall Study|Lack of Efficacy|0|||
154884229|NCT02504268|559000030|FG005|Overall Study|Lack of Efficacy|0|||
154884230|NCT02504268|559000031|FG006|Overall Study|Lack of Efficacy|0|||
154884231|NCT02504268|559000032|FG007|Overall Study|Lack of Efficacy|0|||
154884232|NCT02504268|559000033|FG008|Overall Study|Lack of Efficacy|0|||
154884233|NCT02504268|559000025|FG000|Overall Study|Poor/Non-Compliance|3|||
154884234|NCT02504268|559000026|FG001|Overall Study|Poor/Non-Compliance|2|||
154884235|NCT02504268|559000027|FG002|Overall Study|Poor/Non-Compliance|3|||
154884236|NCT02504268|559000028|FG003|Overall Study|Poor/Non-Compliance|0|||
154884237|NCT02504268|559000029|FG004|Overall Study|Poor/Non-Compliance|0|||
154884238|NCT02504268|559000030|FG005|Overall Study|Poor/Non-Compliance|0|||
154884239|NCT02504268|559000031|FG006|Overall Study|Poor/Non-Compliance|0|||
154884240|NCT02504268|559000032|FG007|Overall Study|Poor/Non-Compliance|0|||
154884241|NCT02504268|559000033|FG008|Overall Study|Poor/Non-Compliance|0|||
154884242|NCT02504268|559000025|FG000|Overall Study|Not Disclosed|1|||
154884243|NCT02504268|559000026|FG001|Overall Study|Not Disclosed|0|||
154884244|NCT02504268|559000027|FG002|Overall Study|Not Disclosed|2|||
154884245|NCT02504268|559000028|FG003|Overall Study|Not Disclosed|0|||
154884246|NCT02504268|559000029|FG004|Overall Study|Not Disclosed|0|||
154884247|NCT02504268|559000030|FG005|Overall Study|Not Disclosed|0|||
154884248|NCT02504268|559000031|FG006|Overall Study|Not Disclosed|0|||
154884249|NCT02504268|559000032|FG007|Overall Study|Not Disclosed|0|||
154884250|NCT02504268|559000033|FG008|Overall Study|Not Disclosed|0|||
154884251|NCT03025217|559000034|FG000|Overall Study|Pregnancy|1|||
154884252|NCT03025217|559000034|FG000|Overall Study|Lost to Follow-up|1|||
154884253|NCT03025217|559000034|FG000|Overall Study|Not eligible, poor English|2|||
154884254|NCT03654755|559000035|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
154884255|NCT03654755|559000036|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
154884256|NCT03654755|559000037|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
154884257|NCT03654755|559000035|FG000|Overall Study|Withdrawal by Subject|2|||
154884258|NCT03654755|559000036|FG001|Overall Study|Withdrawal by Subject|4|||
154884259|NCT03654755|559000037|FG002|Overall Study|Withdrawal by Subject|8|||
154884260|NCT03654755|559000035|FG000|Overall Study|Lost to Follow-up|1|||
154884261|NCT03654755|559000036|FG001|Overall Study|Lost to Follow-up|3|||
154884262|NCT03654755|559000037|FG002|Overall Study|Lost to Follow-up|7|||
154884263|NCT03654755|559000035|FG000|Overall Study|Physician Decision|0|||
155175391|NCT03005873|560080232|FG002|Overall Study|Lost to Follow-up|0|||
154884264|NCT03654755|559000036|FG001|Overall Study|Physician Decision|1|||
154884265|NCT03654755|559000037|FG002|Overall Study|Physician Decision|0|||
154884266|NCT03654755|559000035|FG000|Overall Study|Adverse Event|0|||
154884267|NCT03654755|559000036|FG001|Overall Study|Adverse Event|0|||
154884268|NCT03654755|559000037|FG002|Overall Study|Adverse Event|4|||
154884269|NCT03654755|559000035|FG000|Overall Study|Lack of Efficacy|0|||
154884270|NCT03654755|559000036|FG001|Overall Study|Lack of Efficacy|0|||
154884271|NCT03654755|559000037|FG002|Overall Study|Lack of Efficacy|1|||
154884272|NCT00617409|559000040|FG000|Overall Study|Withdrawal by Subject|4|||
154884273|NCT00617409|559000041|FG001|Overall Study|Withdrawal by Subject|1|||
154884274|NCT00617409|559000042|FG002|Overall Study|Withdrawal by Subject|2|||
154884275|NCT00617409|559000040|FG000|Overall Study|Adverse Event|0|||
154884276|NCT00617409|559000041|FG001|Overall Study|Adverse Event|2|||
154884277|NCT00617409|559000042|FG002|Overall Study|Adverse Event|3|||
154884278|NCT00617409|559000040|FG000|Overall Study|Disease Progression|8|||
154884279|NCT00617409|559000041|FG001|Overall Study|Disease Progression|8|||
154884280|NCT00617409|559000042|FG002|Overall Study|Disease Progression|18|||
154884281|NCT00617409|559000040|FG000|Overall Study|Death|3|||
154884282|NCT00617409|559000041|FG001|Overall Study|Death|5|||
154884283|NCT00617409|559000042|FG002|Overall Study|Death|4|||
154884284|NCT00617409|559000040|FG000|Overall Study|Alternative Therapy|1|||
154884285|NCT00617409|559000041|FG001|Overall Study|Alternative Therapy|2|||
154884286|NCT00617409|559000042|FG002|Overall Study|Alternative Therapy|0|||
154884287|NCT03198754|559000046|FG000|Overall Study|Withdrawal by Subject|5|||
154884288|NCT03198754|559000047|FG001|Overall Study|Withdrawal by Subject|4|||
154884289|NCT03198754|559000046|FG000|Overall Study|Lost to Follow-up|4|||
154884290|NCT03198754|559000047|FG001|Overall Study|Lost to Follow-up|3|||
154884291|NCT03198754|559000046|FG000|Overall Study|Ineligible|2|||
154884292|NCT03198754|559000047|FG001|Overall Study|Ineligible|1|||
154884293|NCT03806179|559000061|FG000|Overall Study|Progressive disease|0|||
154884294|NCT03806179|559000062|FG001|Overall Study|Progressive disease|2|||
154884295|NCT02662985|559000065|FG000|Treatment Period 1|Adverse Event|0|||
154884296|NCT02662985|559000066|FG001|Treatment Period 1|Adverse Event|2|||
154884297|NCT02662985|559000065|FG000|Treatment Period 1|Protocol Violation|0|||
154884298|NCT02662985|559000066|FG001|Treatment Period 1|Protocol Violation|1|||
154884299|NCT02662985|559000065|FG000|Treatment Period 1|Physician Decision|1|||
154884300|NCT02662985|559000066|FG001|Treatment Period 1|Physician Decision|0|||
154884301|NCT02662985|559000065|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154884302|NCT02662985|559000066|FG001|Treatment Period 1|Withdrawal by Subject|1|||
154884303|NCT02662985|559000065|FG000|Treatment Period 2|Lack of Efficacy|0|||
154884304|NCT02662985|559000066|FG001|Treatment Period 2|Lack of Efficacy|1|||
154884305|NCT02662985|559000065|FG000|Treatment Period 2|Lost to Follow-up|1|||
154884306|NCT02662985|559000066|FG001|Treatment Period 2|Lost to Follow-up|0|||
154884307|NCT02662985|559000065|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
154884308|NCT02662985|559000066|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
154884309|NCT02662985|559000065|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
154884310|NCT02662985|559000066|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
154884311|NCT02662985|559000065|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
154884312|NCT02662985|559000066|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
154884313|NCT02662985|559000065|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
154884314|NCT02662985|559000066|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
154884315|NCT02662985|559000065|FG000|Treatment Period 3 (Extension Period)|Death|0|||
154884316|NCT02662985|559000066|FG001|Treatment Period 3 (Extension Period)|Death|1|||
154884317|NCT05373706|559000071|FG000|Overall Study|Lost to Follow-up|2|||
154884318|NCT05373706|559000072|FG001|Overall Study|Lost to Follow-up|2|||
154884319|NCT01486784|559000073|FG000|Overall Study|Withdrawal by Subject|0|||
154884320|NCT01486784|559000074|FG001|Overall Study|Withdrawal by Subject|0|||
154884321|NCT01486784|559000075|FG002|Overall Study|Withdrawal by Subject|1|||
154884322|NCT01486784|559000076|FG003|Overall Study|Withdrawal by Subject|0|||
154884323|NCT01486784|559000077|FG004|Overall Study|Withdrawal by Subject|1|||
154884324|NCT01486784|559000078|FG005|Overall Study|Withdrawal by Subject|2|||
154884325|NCT01486784|559000073|FG000|Overall Study|Subject did not meet entry criteria|0|||
154884326|NCT01486784|559000074|FG001|Overall Study|Subject did not meet entry criteria|0|||
154884327|NCT01486784|559000075|FG002|Overall Study|Subject did not meet entry criteria|0|||
154884328|NCT01486784|559000076|FG003|Overall Study|Subject did not meet entry criteria|0|||
154884329|NCT01486784|559000077|FG004|Overall Study|Subject did not meet entry criteria|1|||
154884330|NCT01486784|559000078|FG005|Overall Study|Subject did not meet entry criteria|0|||
154884331|NCT01486784|559000073|FG000|Overall Study|Death|0|||
154884332|NCT01486784|559000074|FG001|Overall Study|Death|0|||
154884333|NCT01486784|559000075|FG002|Overall Study|Death|0|||
154884334|NCT01486784|559000076|FG003|Overall Study|Death|0|||
154884335|NCT01486784|559000077|FG004|Overall Study|Death|0|||
155175392|NCT03005873|560080230|FG000|Overall Study|Ineligible post randomization|0|||
155175393|NCT03005873|560080231|FG001|Overall Study|Ineligible post randomization|0|||
155175394|NCT03005873|560080232|FG002|Overall Study|Ineligible post randomization|1|||
155175395|NCT04585009|560080233|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
155175396|NCT04585009|560080234|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175397|NCT04585009|560080235|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175398|NCT04585009|560080236|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175399|NCT04585009|560080237|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
154884336|NCT01486784|559000078|FG005|Overall Study|Death|1|||
154884337|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
154884338|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
154884339|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Death|2|||
154884340|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Death|1|||
154884341|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
154884342|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
154884343|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
154884344|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
154884345|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
154884346|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
154884347|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
154884348|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
154884349|NCT03633227|559000079|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
154884350|NCT03633227|559000080|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
154884351|NCT03633227|559000079|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
154884352|NCT03633227|559000080|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
154884353|NCT03633227|559000079|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
154884354|NCT03633227|559000080|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
154884355|NCT03633227|559000079|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
154884356|NCT03633227|559000080|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
154884357|NCT03633227|559000079|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
154884358|NCT03633227|559000080|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
154884359|NCT03633227|559000079|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
154884360|NCT03633227|559000080|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
154884361|NCT01479374|559000086|FG000|Overall Study|Adverse Event|2|||
154884362|NCT01479374|559000087|FG001|Overall Study|Adverse Event|1|||
154884363|NCT01479374|559000088|FG002|Overall Study|Adverse Event|0|||
154884364|NCT01479374|559000086|FG000|Overall Study|Lost to Follow-up|1|||
154884365|NCT01479374|559000087|FG001|Overall Study|Lost to Follow-up|2|||
154884366|NCT01479374|559000088|FG002|Overall Study|Lost to Follow-up|0|||
154884367|NCT01479374|559000086|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
154884368|NCT01479374|559000087|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
154884369|NCT01479374|559000088|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
154884370|NCT01479374|559000086|FG000|Overall Study|Other|0|||
154884371|NCT01479374|559000087|FG001|Overall Study|Other|4|||
154884372|NCT01479374|559000088|FG002|Overall Study|Other|5|||
154884373|NCT01996748|559000089|FG000|Overall Study|Personal reason|1|||
154884374|NCT01996748|559000090|FG001|Overall Study|Personal reason|0|||
154884375|NCT01996748|559000089|FG000|Overall Study|Physician Decision|2|||
154884376|NCT01996748|559000090|FG001|Overall Study|Physician Decision|0|||
154884377|NCT01996748|559000089|FG000|Overall Study|Adverse Event|1|||
154884378|NCT01996748|559000090|FG001|Overall Study|Adverse Event|4|||
154884379|NCT01996748|559000089|FG000|Overall Study|Withdrawal by Subject|0|||
154884380|NCT01996748|559000090|FG001|Overall Study|Withdrawal by Subject|1|||
154884381|NCT01996748|559000089|FG000|Overall Study|Lost to Follow-up|4|||
154884382|NCT01996748|559000090|FG001|Overall Study|Lost to Follow-up|1|||
154884383|NCT03628508|559000091|FG000|Overall Study|Lost to Follow-up|1|||
154884384|NCT00243230|559000092|FG000|Double-Blind Period|Adverse Event|0|||
154884385|NCT00243230|559000093|FG001|Double-Blind Period|Adverse Event|2|||
154884386|NCT00243230|559000094|FG002|Double-Blind Period|Adverse Event|2|||
154884387|NCT00243230|559000095|FG003|Double-Blind Period|Adverse Event|0|||
154884388|NCT00243230|559000092|FG000|Double-Blind Period|Withdrawal by Subject|1|||
154884389|NCT00243230|559000093|FG001|Double-Blind Period|Withdrawal by Subject|0|||
154884390|NCT00243230|559000094|FG002|Double-Blind Period|Withdrawal by Subject|0|||
154884391|NCT00243230|559000095|FG003|Double-Blind Period|Withdrawal by Subject|0|||
154884392|NCT00243230|559000092|FG000|Double-Blind Period|Protocol Violation|0|||
154884393|NCT00243230|559000093|FG001|Double-Blind Period|Protocol Violation|0|||
154884394|NCT00243230|559000094|FG002|Double-Blind Period|Protocol Violation|1|||
154884395|NCT00243230|559000095|FG003|Double-Blind Period|Protocol Violation|0|||
154884396|NCT00243230|559000092|FG000|Double-Blind Period|Randomized but Not Treated|0|||
154884397|NCT00243230|559000093|FG001|Double-Blind Period|Randomized but Not Treated|0|||
154884398|NCT00243230|559000094|FG002|Double-Blind Period|Randomized but Not Treated|2|||
154975902|NCT02020967|559335273|FG000|Overall Study|Withdrawal by Subject|51|||
154975903|NCT03507686|559335274|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
154975904|NCT03507686|559335275|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
154975905|NCT03507686|559335274|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
154975906|NCT03507686|559335275|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
154975907|NCT03507686|559335274|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
154975908|NCT03507686|559335275|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
154975909|NCT03507686|559335274|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
154975910|NCT03507686|559335275|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
154975911|NCT03507686|559335274|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
154975912|NCT03507686|559335275|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
154975913|NCT03507686|559335274|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
154975914|NCT03507686|559335275|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
154975915|NCT00585312|559335276|FG000|Overall Study|Adverse Event|3|||
154975916|NCT00585312|559335277|FG001|Overall Study|Adverse Event|0|||
154975917|NCT00585312|559335276|FG000|Overall Study|Lack of Efficacy|6|||
154975918|NCT00585312|559335277|FG001|Overall Study|Lack of Efficacy|11|||
154975919|NCT00585312|559335276|FG000|Overall Study|Lost to Follow-up|1|||
154975920|NCT00585312|559335277|FG001|Overall Study|Lost to Follow-up|1|||
154975921|NCT00585312|559335276|FG000|Overall Study|Reason not specified|2|||
154975922|NCT00585312|559335277|FG001|Overall Study|Reason not specified|0|||
154975923|NCT00585312|559335276|FG000|Overall Study|Withdrawal by Subject|5|||
154975924|NCT00585312|559335277|FG001|Overall Study|Withdrawal by Subject|1|||
154975925|NCT00585312|559335276|FG000|Overall Study|Study terminated by the sponsor|34|||
154975926|NCT00585312|559335277|FG001|Overall Study|Study terminated by the sponsor|31|||
154975927|NCT02539368|559335280|FG000|Overall Study|Death|4|||
154975928|NCT02539368|559335281|FG001|Overall Study|Death|2|||
154975929|NCT02539368|559335282|FG002|Overall Study|Death|1|||
154975930|NCT02539368|559335283|FG003|Overall Study|Death|0|||
154975931|NCT02539368|559335284|FG004|Overall Study|Death|0|||
154975932|NCT02539368|559335280|FG000|Overall Study|Withdrawal by Subject|44|||
154975933|NCT02539368|559335281|FG001|Overall Study|Withdrawal by Subject|35|||
154975934|NCT02539368|559335282|FG002|Overall Study|Withdrawal by Subject|9|||
154975935|NCT02539368|559335283|FG003|Overall Study|Withdrawal by Subject|1|||
154975936|NCT02539368|559335284|FG004|Overall Study|Withdrawal by Subject|3|||
154975937|NCT02539368|559335280|FG000|Overall Study|Physician Decision|49|||
154975938|NCT02539368|559335281|FG001|Overall Study|Physician Decision|15|||
154975939|NCT02539368|559335282|FG002|Overall Study|Physician Decision|7|||
154884399|NCT00243230|559000095|FG003|Double-Blind Period|Randomized but Not Treated|0|||
154884400|NCT00243230|559000092|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
154884401|NCT00243230|559000093|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
154884402|NCT00243230|559000094|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
154884403|NCT00243230|559000095|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
154884404|NCT00243230|559000092|FG000|Open Label Period|Adverse Event|0|||
154884405|NCT00243230|559000093|FG001|Open Label Period|Adverse Event|0|||
154884406|NCT00243230|559000094|FG002|Open Label Period|Adverse Event|0|||
154884407|NCT00243230|559000095|FG003|Open Label Period|Adverse Event|2|||
154884408|NCT00243230|559000092|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
154884409|NCT00243230|559000093|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
154884410|NCT00243230|559000094|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
154884411|NCT00243230|559000095|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
154884412|NCT00243230|559000092|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
154884413|NCT00243230|559000093|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
154884414|NCT00243230|559000094|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
154884415|NCT00243230|559000095|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
154884416|NCT00243230|559000092|FG000|Open Label Period|Lost to Follow-up|0|||
154884417|NCT00243230|559000093|FG001|Open Label Period|Lost to Follow-up|0|||
154884418|NCT00243230|559000094|FG002|Open Label Period|Lost to Follow-up|0|||
154884419|NCT00243230|559000095|FG003|Open Label Period|Lost to Follow-up|2|||
154884420|NCT00243230|559000092|FG000|Open Label Period|Withdrawal by Subject|0|||
154975940|NCT02539368|559335283|FG003|Overall Study|Physician Decision|0|||
154975941|NCT02539368|559335284|FG004|Overall Study|Physician Decision|2|||
154975942|NCT02539368|559335280|FG000|Overall Study|Lost to Follow-up|96|||
154975943|NCT02539368|559335281|FG001|Overall Study|Lost to Follow-up|21|||
154975944|NCT02539368|559335282|FG002|Overall Study|Lost to Follow-up|16|||
154975945|NCT02539368|559335283|FG003|Overall Study|Lost to Follow-up|4|||
154975946|NCT02539368|559335284|FG004|Overall Study|Lost to Follow-up|3|||
154975947|NCT02539368|559335280|FG000|Overall Study|Adverse Event|44|||
154975948|NCT02539368|559335281|FG001|Overall Study|Adverse Event|5|||
154975949|NCT02539368|559335282|FG002|Overall Study|Adverse Event|9|||
154884421|NCT00243230|559000093|FG001|Open Label Period|Withdrawal by Subject|0|||
154884422|NCT00243230|559000094|FG002|Open Label Period|Withdrawal by Subject|0|||
154975950|NCT02539368|559335283|FG003|Overall Study|Adverse Event|0|||
154975951|NCT02539368|559335284|FG004|Overall Study|Adverse Event|3|||
154975952|NCT02539368|559335280|FG000|Overall Study|Participant Non-compliant|13|||
154975953|NCT02539368|559335281|FG001|Overall Study|Participant Non-compliant|2|||
154975954|NCT02539368|559335282|FG002|Overall Study|Participant Non-compliant|1|||
154975955|NCT02539368|559335283|FG003|Overall Study|Participant Non-compliant|1|||
154975956|NCT02539368|559335284|FG004|Overall Study|Participant Non-compliant|0|||
154975957|NCT02539368|559335280|FG000|Overall Study|Other|145|||
154975958|NCT02539368|559335281|FG001|Overall Study|Other|18|||
154975959|NCT02539368|559335282|FG002|Overall Study|Other|24|||
154975960|NCT02539368|559335283|FG003|Overall Study|Other|1|||
154975961|NCT02539368|559335284|FG004|Overall Study|Other|3|||
154975962|NCT02539368|559335280|FG000|Overall Study|Missing|10|||
154975963|NCT02539368|559335281|FG001|Overall Study|Missing|3|||
154975964|NCT02539368|559335282|FG002|Overall Study|Missing|0|||
154975965|NCT02539368|559335283|FG003|Overall Study|Missing|0|||
154975966|NCT02539368|559335284|FG004|Overall Study|Missing|0|||
154975967|NCT00398073|559335286|FG000|Overall Study|Withdrawal by Subject|1|||
154975968|NCT00398073|559335287|FG001|Overall Study|Withdrawal by Subject|0|||
154975969|NCT01263561|559335288|FG000|Overall Study|Death|1|||
154975970|NCT01263561|559335289|FG001|Overall Study|Death|2|||
154975971|NCT00879684|559335290|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
154975972|NCT00879684|559335291|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
154975973|NCT00879684|559335292|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
154975974|NCT00879684|559335293|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
154975975|NCT00879684|559335294|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
154975976|NCT00879684|559335295|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
154975977|NCT00879684|559335296|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
154975978|NCT00879684|559335290|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
154975979|NCT00879684|559335291|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
154975980|NCT00879684|559335292|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
154975981|NCT00879684|559335293|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
154975982|NCT00879684|559335294|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
154975983|NCT00879684|559335295|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
154975984|NCT00879684|559335296|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
154975985|NCT00879684|559335290|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
154975986|NCT00879684|559335291|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
154975987|NCT00879684|559335292|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
154975988|NCT00879684|559335293|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
154975989|NCT00879684|559335294|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
154975990|NCT00879684|559335295|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
154975991|NCT00879684|559335296|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
154975992|NCT00879684|559335290|FG000|Stage 1: Dose Escalation|Death|0|||
154884423|NCT00243230|559000095|FG003|Open Label Period|Withdrawal by Subject|2|||
154884424|NCT00243230|559000092|FG000|Open Label Period|Protocol Violation|0|||
154884425|NCT00243230|559000093|FG001|Open Label Period|Protocol Violation|0|||
154884426|NCT00243230|559000094|FG002|Open Label Period|Protocol Violation|0|||
154884427|NCT00243230|559000095|FG003|Open Label Period|Protocol Violation|2|||
154884428|NCT00243230|559000092|FG000|Open Label Period|Administrative Reason|0|||
154884429|NCT00243230|559000093|FG001|Open Label Period|Administrative Reason|0|||
154884430|NCT00243230|559000094|FG002|Open Label Period|Administrative Reason|0|||
154884431|NCT00243230|559000095|FG003|Open Label Period|Administrative Reason|63|||
154884432|NCT03011840|559000096|FG000|Overall Study|Not received PIL in post PIL phase|0|||
154884433|NCT03011840|559000097|FG001|Overall Study|Not received PIL in post PIL phase|21|||
154884434|NCT02112994|559000098|FG000|Overall Study|Progressive Disease|0|||
154884435|NCT02112994|559000099|FG001|Overall Study|Progressive Disease|0|||
154884436|NCT02112994|559000100|FG002|Overall Study|Progressive Disease|1|||
154884437|NCT02112994|559000098|FG000|Overall Study|Pregnancy|0|||
154884438|NCT02112994|559000099|FG001|Overall Study|Pregnancy|1|||
154884439|NCT02112994|559000100|FG002|Overall Study|Pregnancy|1|||
154975993|NCT00879684|559335291|FG001|Stage 1: Dose Escalation|Death|0|||
154975994|NCT00879684|559335292|FG002|Stage 1: Dose Escalation|Death|1|||
154975995|NCT00879684|559335293|FG003|Stage 1: Dose Escalation|Death|0|||
154975996|NCT00879684|559335294|FG004|Stage 1: Dose Escalation|Death|0|||
154975997|NCT00879684|559335295|FG005|Stage 1: Dose Escalation|Death|0|||
154975998|NCT00879684|559335296|FG006|Stage 1: Dose Escalation|Death|0|||
154975999|NCT00879684|559335290|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
154884440|NCT02112994|559000098|FG000|Overall Study|Liver Transplant|0|||
154976000|NCT00879684|559335291|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
154976001|NCT00879684|559335292|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
154976002|NCT00879684|559335293|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
154976003|NCT00879684|559335294|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
154976004|NCT00879684|559335295|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
154884441|NCT02112994|559000099|FG001|Overall Study|Liver Transplant|1|||
154884442|NCT02112994|559000100|FG002|Overall Study|Liver Transplant|0|||
154884443|NCT02112994|559000098|FG000|Overall Study|Withdrawal by Subject|0|||
154884444|NCT02112994|559000099|FG001|Overall Study|Withdrawal by Subject|0|||
154884445|NCT02112994|559000100|FG002|Overall Study|Withdrawal by Subject|1|||
154884446|NCT01683071|559000101|FG000|Part 1|Lack of Efficacy|1|||
154976005|NCT00879684|559335296|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
154976006|NCT00879684|559335290|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
154976007|NCT00879684|559335291|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
154976008|NCT00879684|559335292|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
154976009|NCT00879684|559335293|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
154976010|NCT00879684|559335294|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
154976011|NCT00879684|559335295|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
154976012|NCT00879684|559335296|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
154976013|NCT00879684|559335290|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
154976014|NCT00879684|559335291|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
154976015|NCT00879684|559335292|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
154976016|NCT00879684|559335293|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
154976017|NCT00879684|559335294|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
154976018|NCT00879684|559335295|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
154976019|NCT00879684|559335296|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
154976020|NCT03185741|559335302|FG000|Baseline|Withdrawal by Subject|1|||
154976021|NCT03185741|559335303|FG001|Baseline|Withdrawal by Subject|3|||
154976022|NCT03185741|559335304|FG002|Baseline|Withdrawal by Subject|2|||
154976023|NCT03185741|559335302|FG000|Baseline|Lost to Follow-up|1|||
154976024|NCT03185741|559335303|FG001|Baseline|Lost to Follow-up|2|||
154976025|NCT03185741|559335304|FG002|Baseline|Lost to Follow-up|3|||
154976026|NCT03185741|559335302|FG000|3Month|Death|1|||
154976027|NCT03185741|559335303|FG001|3Month|Death|1|||
154976028|NCT03185741|559335304|FG002|3Month|Death|2|||
154976029|NCT03185741|559335302|FG000|3Month|Withdrawal by Subject|1|||
154976030|NCT03185741|559335303|FG001|3Month|Withdrawal by Subject|5|||
154976031|NCT03185741|559335304|FG002|3Month|Withdrawal by Subject|1|||
154976032|NCT03185741|559335302|FG000|3Month|Lost to Follow-up|7|||
154976033|NCT03185741|559335303|FG001|3Month|Lost to Follow-up|9|||
154976034|NCT03185741|559335304|FG002|3Month|Lost to Follow-up|8|||
154976035|NCT03185741|559335302|FG000|3Month|Unavailable for 3Month|11|||
154976036|NCT03185741|559335303|FG001|3Month|Unavailable for 3Month|10|||
154976037|NCT03185741|559335304|FG002|3Month|Unavailable for 3Month|11|||
154976038|NCT03185741|559335302|FG000|3Month|Protocol Violation|0|||
154976039|NCT03185741|559335303|FG001|3Month|Protocol Violation|0|||
154976040|NCT03185741|559335304|FG002|3Month|Protocol Violation|3|||
154976041|NCT03185741|559335302|FG000|6Month|Death|1|||
154976042|NCT03185741|559335303|FG001|6Month|Death|1|||
154976043|NCT03185741|559335304|FG002|6Month|Death|2|||
154976044|NCT03185741|559335302|FG000|6Month|Withdrawal by Subject|2|||
154976045|NCT03185741|559335303|FG001|6Month|Withdrawal by Subject|3|||
154976046|NCT03185741|559335304|FG002|6Month|Withdrawal by Subject|1|||
154976047|NCT03185741|559335302|FG000|6Month|Lost to Follow-up|16|||
154976048|NCT03185741|559335303|FG001|6Month|Lost to Follow-up|15|||
154976049|NCT03185741|559335304|FG002|6Month|Lost to Follow-up|16|||
154976050|NCT00810602|559335310|FG000|Overall Study|Withdrawal by Subject|8|||
154976051|NCT00810602|559335311|FG001|Overall Study|Withdrawal by Subject|3|||
154976052|NCT03840382|559335312|FG000|Overall Study|Lost to Follow-up|11|||
154976053|NCT02625974|559335313|FG000|Part 1|Lost to Follow-up|9|||
154976054|NCT02625974|559335314|FG001|Part 1|Lost to Follow-up|3|||
154976055|NCT02625974|559335313|FG000|Part 2|Lost to Follow-up|4|||
154976056|NCT02625974|559335314|FG001|Part 2|Lost to Follow-up|6|||
154976057|NCT02625974|559335313|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
154976058|NCT02625974|559335314|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
154976059|NCT01142661|559335315|FG000|Overall Study|Adverse Event|2|||
154976060|NCT01142661|559335315|FG000|Overall Study|Withdrawal by Subject|1|||
154976061|NCT01142661|559335315|FG000|Overall Study|Physician Decision|1|||
154976062|NCT00434590|559335316|FG000|Overall Study|Administrative problems|5|||
154884447|NCT01683071|559000102|FG001|Part 1|Lack of Efficacy|0|||
154884448|NCT01683071|559000103|FG002|Part 1|Lack of Efficacy|0|||
154884449|NCT01683071|559000104|FG003|Part 1|Lack of Efficacy|3|||
154884450|NCT01683071|559000105|FG004|Part 1|Lack of Efficacy|0|||
154976063|NCT00434590|559335317|FG001|Overall Study|Administrative problems|5|||
154976064|NCT04773600|559335320|FG000|Overall Study|Withdrawal by Subject|15|||
154976065|NCT04773600|559335321|FG001|Overall Study|Withdrawal by Subject|9|||
154976066|NCT04773600|559335320|FG000|Overall Study|Lost to Follow-up|10|||
154976067|NCT04773600|559335321|FG001|Overall Study|Lost to Follow-up|6|||
154976068|NCT04773600|559335320|FG000|Overall Study|Adverse Event|8|||
154976069|NCT04773600|559335321|FG001|Overall Study|Adverse Event|2|||
154976070|NCT04773600|559335320|FG000|Overall Study|Lack of Efficacy|2|||
154884451|NCT01683071|559000106|FG005|Part 1|Lack of Efficacy|0|||
154884452|NCT01683071|559000101|FG000|Part 1|Withdrawal by Subject|1|||
154976071|NCT04773600|559335321|FG001|Overall Study|Lack of Efficacy|3|||
154976072|NCT04773600|559335320|FG000|Overall Study|Noncompliance|2|||
154976073|NCT04773600|559335321|FG001|Overall Study|Noncompliance|0|||
154976074|NCT04773600|559335320|FG000|Overall Study|Protocol Violation|2|||
154884453|NCT01683071|559000102|FG001|Part 1|Withdrawal by Subject|2|||
154884454|NCT01683071|559000103|FG002|Part 1|Withdrawal by Subject|2|||
154884455|NCT01683071|559000104|FG003|Part 1|Withdrawal by Subject|1|||
154884456|NCT01683071|559000105|FG004|Part 1|Withdrawal by Subject|0|||
154884457|NCT01683071|559000106|FG005|Part 1|Withdrawal by Subject|0|||
154884458|NCT01683071|559000101|FG000|Part 1|Surgery Cancelled|1|||
154884459|NCT01683071|559000102|FG001|Part 1|Surgery Cancelled|0|||
154884460|NCT01683071|559000103|FG002|Part 1|Surgery Cancelled|0|||
154884461|NCT01683071|559000104|FG003|Part 1|Surgery Cancelled|0|||
154884462|NCT01683071|559000105|FG004|Part 1|Surgery Cancelled|0|||
154884463|NCT01683071|559000106|FG005|Part 1|Surgery Cancelled|0|||
154884464|NCT01683071|559000101|FG000|Part 1|Did not receive study drug|1|||
154884465|NCT01683071|559000102|FG001|Part 1|Did not receive study drug|0|||
154884466|NCT01683071|559000103|FG002|Part 1|Did not receive study drug|0|||
154884467|NCT01683071|559000104|FG003|Part 1|Did not receive study drug|1|||
154884468|NCT01683071|559000105|FG004|Part 1|Did not receive study drug|0|||
154884469|NCT01683071|559000106|FG005|Part 1|Did not receive study drug|0|||
154884470|NCT01683071|559000101|FG000|Part 1|Early termination; met exclusion criteria|0|||
154884471|NCT01683071|559000102|FG001|Part 1|Early termination; met exclusion criteria|2|||
154884472|NCT01683071|559000103|FG002|Part 1|Early termination; met exclusion criteria|1|||
154884473|NCT01683071|559000104|FG003|Part 1|Early termination; met exclusion criteria|0|||
154884474|NCT01683071|559000105|FG004|Part 1|Early termination; met exclusion criteria|0|||
154884475|NCT01683071|559000106|FG005|Part 1|Early termination; met exclusion criteria|0|||
154884476|NCT01683071|559000101|FG000|Part 2|Lack of Efficacy|0|||
154884477|NCT01683071|559000102|FG001|Part 2|Lack of Efficacy|0|||
154884478|NCT01683071|559000103|FG002|Part 2|Lack of Efficacy|0|||
154884479|NCT01683071|559000104|FG003|Part 2|Lack of Efficacy|0|||
154884480|NCT01683071|559000105|FG004|Part 2|Lack of Efficacy|3|||
154884481|NCT01683071|559000106|FG005|Part 2|Lack of Efficacy|4|||
154884482|NCT01683071|559000101|FG000|Part 2|Lost to Follow-up|0|||
154884483|NCT01683071|559000102|FG001|Part 2|Lost to Follow-up|0|||
154884484|NCT01683071|559000103|FG002|Part 2|Lost to Follow-up|0|||
154884485|NCT01683071|559000104|FG003|Part 2|Lost to Follow-up|0|||
154884486|NCT01683071|559000105|FG004|Part 2|Lost to Follow-up|2|||
154884487|NCT01683071|559000106|FG005|Part 2|Lost to Follow-up|0|||
154884488|NCT01683071|559000101|FG000|Part 2|Withdrawal by Subject|0|||
154884489|NCT01683071|559000102|FG001|Part 2|Withdrawal by Subject|0|||
154884490|NCT01683071|559000103|FG002|Part 2|Withdrawal by Subject|0|||
154884491|NCT01683071|559000104|FG003|Part 2|Withdrawal by Subject|0|||
154884492|NCT01683071|559000105|FG004|Part 2|Withdrawal by Subject|3|||
154884493|NCT01683071|559000106|FG005|Part 2|Withdrawal by Subject|3|||
154884494|NCT01683071|559000101|FG000|Part 2|Surgery cancelled|0|||
154884495|NCT01683071|559000102|FG001|Part 2|Surgery cancelled|0|||
154884496|NCT01683071|559000103|FG002|Part 2|Surgery cancelled|0|||
154884497|NCT01683071|559000104|FG003|Part 2|Surgery cancelled|0|||
154884498|NCT01683071|559000105|FG004|Part 2|Surgery cancelled|4|||
154884499|NCT01683071|559000106|FG005|Part 2|Surgery cancelled|2|||
154884500|NCT01683071|559000101|FG000|Part 2|Did not receive study drug|0|||
154884501|NCT01683071|559000102|FG001|Part 2|Did not receive study drug|0|||
154884502|NCT01683071|559000103|FG002|Part 2|Did not receive study drug|0|||
154884503|NCT01683071|559000104|FG003|Part 2|Did not receive study drug|0|||
154884504|NCT01683071|559000105|FG004|Part 2|Did not receive study drug|2|||
154884505|NCT01683071|559000106|FG005|Part 2|Did not receive study drug|1|||
154884506|NCT01683071|559000101|FG000|Part 2|Met exclusion criterion|0|||
154884507|NCT01683071|559000102|FG001|Part 2|Met exclusion criterion|0|||
154884508|NCT01683071|559000103|FG002|Part 2|Met exclusion criterion|0|||
154884509|NCT01683071|559000104|FG003|Part 2|Met exclusion criterion|0|||
154884510|NCT01683071|559000105|FG004|Part 2|Met exclusion criterion|1|||
154884511|NCT01683071|559000106|FG005|Part 2|Met exclusion criterion|1|||
154884512|NCT01683071|559000101|FG000|Part 2|Protocol deviation|0|||
154884513|NCT01683071|559000102|FG001|Part 2|Protocol deviation|0|||
154884514|NCT01683071|559000103|FG002|Part 2|Protocol deviation|0|||
154884515|NCT01683071|559000104|FG003|Part 2|Protocol deviation|0|||
154884516|NCT01683071|559000105|FG004|Part 2|Protocol deviation|1|||
154884517|NCT01683071|559000106|FG005|Part 2|Protocol deviation|2|||
154884518|NCT01683071|559000101|FG000|Part 2|Withdrawal by investigator decision|0|||
154884519|NCT01683071|559000102|FG001|Part 2|Withdrawal by investigator decision|0|||
154884520|NCT01683071|559000103|FG002|Part 2|Withdrawal by investigator decision|0|||
154884521|NCT01683071|559000104|FG003|Part 2|Withdrawal by investigator decision|0|||
154884522|NCT01683071|559000105|FG004|Part 2|Withdrawal by investigator decision|1|||
154884523|NCT01683071|559000106|FG005|Part 2|Withdrawal by investigator decision|2|||
154884524|NCT04031404|559001494|FG000|Baseline|Lost to Follow-up|0|||
154884525|NCT04031404|559001495|FG001|Baseline|Lost to Follow-up|1|||
154884526|NCT04031404|559001494|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
154884527|NCT04031404|559001495|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
154884528|NCT04031404|559001494|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
154884529|NCT04031404|559001495|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
154884530|NCT04031404|559001494|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
154884531|NCT04031404|559001495|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
154884532|NCT04031404|559001494|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
154884533|NCT04031404|559001495|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
154884534|NCT01993615|559001496|FG000|Overall Study|Death|1|||
154884535|NCT01993615|559001497|FG001|Overall Study|Death|0|||
154884536|NCT02282982|559001503|FG000|Overall Study|Lost to Follow-up|15|||
154884537|NCT02282982|559001503|FG000|Overall Study|Withdrew consent|2|||
154884538|NCT02282982|559001503|FG000|Overall Study|Death|4|||
154884539|NCT02282982|559001503|FG000|Overall Study|Lack of product|156|||
154884540|NCT02282982|559001503|FG000|Overall Study|Palivizumab is ended|11|||
154884541|NCT02282982|559001503|FG000|Overall Study|Other, not specified|18|||
154884542|NCT01354353|559001504|FG000|Overall Study|Adverse Event|1|||
154884543|NCT01354353|559001505|FG001|Overall Study|Adverse Event|0|||
154884544|NCT01354353|559001506|FG002|Overall Study|Adverse Event|0|||
154884545|NCT01354353|559001507|FG003|Overall Study|Adverse Event|4|||
154884546|NCT01354353|559001508|FG004|Overall Study|Adverse Event|0|||
154884547|NCT01354353|559001509|FG005|Overall Study|Adverse Event|5|||
154884548|NCT01354353|559001504|FG000|Overall Study|Entry Criteria Not Met|0|||
154884549|NCT01354353|559001505|FG001|Overall Study|Entry Criteria Not Met|0|||
154884550|NCT01354353|559001506|FG002|Overall Study|Entry Criteria Not Met|0|||
154884551|NCT01354353|559001507|FG003|Overall Study|Entry Criteria Not Met|1|||
154884552|NCT01354353|559001508|FG004|Overall Study|Entry Criteria Not Met|1|||
154884553|NCT01354353|559001509|FG005|Overall Study|Entry Criteria Not Met|0|||
154884554|NCT01354353|559001504|FG000|Overall Study|Physician Decision|0|||
154884555|NCT01354353|559001505|FG001|Overall Study|Physician Decision|1|||
154884556|NCT01354353|559001506|FG002|Overall Study|Physician Decision|1|||
154884557|NCT01354353|559001507|FG003|Overall Study|Physician Decision|0|||
154884558|NCT01354353|559001508|FG004|Overall Study|Physician Decision|0|||
154884559|NCT01354353|559001509|FG005|Overall Study|Physician Decision|0|||
154884560|NCT01354353|559001504|FG000|Overall Study|Withdrawal by Subject|2|||
154884561|NCT01354353|559001505|FG001|Overall Study|Withdrawal by Subject|0|||
154884562|NCT01354353|559001506|FG002|Overall Study|Withdrawal by Subject|1|||
154884563|NCT01354353|559001507|FG003|Overall Study|Withdrawal by Subject|0|||
154884564|NCT01354353|559001508|FG004|Overall Study|Withdrawal by Subject|0|||
154884565|NCT01354353|559001509|FG005|Overall Study|Withdrawal by Subject|1|||
154884566|NCT05674344|559001510|FG000|Overall Study|Screen Fail|21|||
154884567|NCT05674344|559001510|FG000|Overall Study|Incomplete study procedures|3|||
154884568|NCT00111917|559001511|FG000|Overall Study|Withdrawal by Subject|1|||
154884569|NCT00111917|559001512|FG001|Overall Study|Withdrawal by Subject|1|||
154884570|NCT01640925|559001513|FG000|Overall Study|Withdrawal by Subject|1|||
154884571|NCT01640925|559001514|FG001|Overall Study|Withdrawal by Subject|0|||
154884572|NCT01640925|559001513|FG000|Overall Study|Previously enrolled in this trial|13|||
154884573|NCT01640925|559001514|FG001|Overall Study|Previously enrolled in this trial|11|||
154884574|NCT02156492|559001515|FG000|Period 1|No Reason Given|0|||
154884575|NCT02156492|559001516|FG001|Period 1|No Reason Given|1|||
154884576|NCT02156492|559001517|FG002|Period 1|No Reason Given|0|||
154884577|NCT02156492|559001515|FG000|Period 3|Adverse Event|0|||
154884578|NCT02156492|559001516|FG001|Period 3|Adverse Event|1|||
154884579|NCT02156492|559001517|FG002|Period 3|Adverse Event|0|||
154884580|NCT02924688|559001526|FG000|Overall Study|Adverse Event|9|||
154884581|NCT02924688|559001527|FG001|Overall Study|Adverse Event|3|||
154884582|NCT02924688|559001528|FG002|Overall Study|Adverse Event|2|||
154884583|NCT02924688|559001529|FG003|Overall Study|Adverse Event|2|||
154884584|NCT02924688|559001530|FG004|Overall Study|Adverse Event|3|||
154884585|NCT02924688|559001531|FG005|Overall Study|Adverse Event|2|||
154884586|NCT02924688|559001526|FG000|Overall Study|Lack of Efficacy|2|||
154884587|NCT02924688|559001527|FG001|Overall Study|Lack of Efficacy|3|||
154884588|NCT02924688|559001528|FG002|Overall Study|Lack of Efficacy|4|||
154884589|NCT02924688|559001529|FG003|Overall Study|Lack of Efficacy|2|||
154884590|NCT02924688|559001530|FG004|Overall Study|Lack of Efficacy|1|||
154884591|NCT02924688|559001531|FG005|Overall Study|Lack of Efficacy|1|||
154884592|NCT02924688|559001526|FG000|Overall Study|Protocol Violation|3|||
154884593|NCT02924688|559001527|FG001|Overall Study|Protocol Violation|7|||
154884594|NCT02924688|559001528|FG002|Overall Study|Protocol Violation|5|||
154884595|NCT02924688|559001529|FG003|Overall Study|Protocol Violation|6|||
154884596|NCT02924688|559001530|FG004|Overall Study|Protocol Violation|2|||
154884597|NCT02924688|559001531|FG005|Overall Study|Protocol Violation|2|||
154884598|NCT02924688|559001526|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
154884599|NCT02924688|559001527|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
154884600|NCT02924688|559001528|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
154884601|NCT02924688|559001529|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
154884602|NCT02924688|559001530|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
154884603|NCT02924688|559001531|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
154884604|NCT02924688|559001526|FG000|Overall Study|Lost to Follow-up|2|||
154884605|NCT02924688|559001527|FG001|Overall Study|Lost to Follow-up|4|||
154884606|NCT02924688|559001528|FG002|Overall Study|Lost to Follow-up|2|||
154884607|NCT02924688|559001529|FG003|Overall Study|Lost to Follow-up|4|||
154884608|NCT02924688|559001530|FG004|Overall Study|Lost to Follow-up|2|||
154884609|NCT02924688|559001531|FG005|Overall Study|Lost to Follow-up|4|||
154884610|NCT02924688|559001526|FG000|Overall Study|Physician Decision|2|||
154884611|NCT02924688|559001527|FG001|Overall Study|Physician Decision|1|||
155113638|NCT00758264|559844867|FG002|Active Phase|Lost to Follow-up|0|||
154884612|NCT02924688|559001528|FG002|Overall Study|Physician Decision|0|||
154884613|NCT02924688|559001529|FG003|Overall Study|Physician Decision|1|||
154884614|NCT02924688|559001530|FG004|Overall Study|Physician Decision|1|||
154884615|NCT02924688|559001531|FG005|Overall Study|Physician Decision|1|||
154884616|NCT02924688|559001526|FG000|Overall Study|Withdrawal by Subject|14|||
154884617|NCT02924688|559001527|FG001|Overall Study|Withdrawal by Subject|13|||
154884618|NCT02924688|559001528|FG002|Overall Study|Withdrawal by Subject|9|||
154884619|NCT02924688|559001529|FG003|Overall Study|Withdrawal by Subject|12|||
154884620|NCT02924688|559001530|FG004|Overall Study|Withdrawal by Subject|13|||
154884621|NCT02924688|559001531|FG005|Overall Study|Withdrawal by Subject|14|||
154884622|NCT03072719|559001534|FG000|Overall Study|Adverse Event|1|||
154884623|NCT03072719|559001535|FG001|Overall Study|Adverse Event|1|||
154884624|NCT00992784|559001542|FG000|Overall Study|Adverse Event|2|||
154884625|NCT00992784|559001543|FG001|Overall Study|Adverse Event|1|||
154884626|NCT00992784|559001544|FG002|Overall Study|Adverse Event|0|||
154884627|NCT00992784|559001542|FG000|Overall Study|Withdrawal by Subject|1|||
154884628|NCT00992784|559001543|FG001|Overall Study|Withdrawal by Subject|1|||
154884629|NCT00992784|559001544|FG002|Overall Study|Withdrawal by Subject|1|||
154884630|NCT00781599|559001545|FG000|Overall Study|Lost to Follow-up|7|||
154884631|NCT00781599|559001546|FG001|Overall Study|Lost to Follow-up|4|||
154884632|NCT01088438|559001547|FG000|Overall Study|Withdrawal by Subject|11|||
154884633|NCT01088438|559001548|FG001|Overall Study|Withdrawal by Subject|6|||
154884634|NCT01088438|559001547|FG000|Overall Study|Lost to Follow-up|18|||
154884635|NCT01088438|559001548|FG001|Overall Study|Lost to Follow-up|30|||
154884636|NCT01363713|559001549|FG000|Overall Study|Adverse Event|1|||
154884637|NCT01363713|559001549|FG000|Overall Study|Protocol Violation|3|||
154884638|NCT01363713|559001549|FG000|Overall Study|Withdrawal by Subject|2|||
154884639|NCT01199055|559001550|FG000|Overall Study|Death|0|||
154884640|NCT01199055|559001551|FG001|Overall Study|Death|1|||
154884641|NCT01199055|559001552|FG002|Overall Study|Death|0|||
154884642|NCT01199055|559001550|FG000|Overall Study|Physician Decision|0|||
154884643|NCT01199055|559001551|FG001|Overall Study|Physician Decision|1|||
154884644|NCT01199055|559001552|FG002|Overall Study|Physician Decision|1|||
154884645|NCT01199055|559001550|FG000|Overall Study|Progressive disease|2|||
154884646|NCT01199055|559001551|FG001|Overall Study|Progressive disease|1|||
154884647|NCT01199055|559001552|FG002|Overall Study|Progressive disease|2|||
154884648|NCT01199055|559001550|FG000|Overall Study|Withdrawal by Subject|0|||
154884649|NCT01199055|559001551|FG001|Overall Study|Withdrawal by Subject|0|||
154884650|NCT01199055|559001552|FG002|Overall Study|Withdrawal by Subject|1|||
154884651|NCT03247413|559001556|FG000|Overall Study|Lost to Follow-up|28|||
154884652|NCT00668200|559001557|FG000|Overall Study|Withdrawal by Subject|2|||
154884653|NCT00668200|559001557|FG000|Overall Study|Lost to Follow-up|1|||
154884654|NCT00424294|559001559|FG000|Overall Study|Adverse Event|4|||
154884655|NCT00424294|559001560|FG001|Overall Study|Adverse Event|10|||
154884656|NCT00424294|559001559|FG000|Overall Study|Lack of Efficacy|2|||
154884657|NCT00424294|559001560|FG001|Overall Study|Lack of Efficacy|1|||
154884658|NCT00424294|559001559|FG000|Overall Study|Withdrawal by Subject|1|||
154884659|NCT00424294|559001560|FG001|Overall Study|Withdrawal by Subject|2|||
154884660|NCT00424294|559001559|FG000|Overall Study|Other|0|||
154884661|NCT00424294|559001560|FG001|Overall Study|Other|2|||
154884662|NCT00424294|559001559|FG000|Overall Study|Randomized but not Treated|1|||
154884663|NCT00424294|559001560|FG001|Overall Study|Randomized but not Treated|0|||
154884664|NCT01496430|559001561|FG000|Overall Study|Adverse Event|0|||
154884665|NCT01496430|559001562|FG001|Overall Study|Adverse Event|0|||
154884666|NCT01496430|559001563|FG002|Overall Study|Adverse Event|1|||
154884667|NCT01496430|559001561|FG000|Overall Study|Major Protocol Deviation|0|||
154884668|NCT01496430|559001562|FG001|Overall Study|Major Protocol Deviation|0|||
154884669|NCT01496430|559001563|FG002|Overall Study|Major Protocol Deviation|1|||
154884670|NCT01496430|559001561|FG000|Overall Study|Lost to Follow-up|2|||
154884671|NCT01496430|559001562|FG001|Overall Study|Lost to Follow-up|3|||
154884672|NCT01496430|559001563|FG002|Overall Study|Lost to Follow-up|1|||
154884673|NCT01496430|559001561|FG000|Overall Study|Voluntary Withdrawal|2|||
154884674|NCT01496430|559001562|FG001|Overall Study|Voluntary Withdrawal|1|||
155113639|NCT00758264|559844865|FG000|Active Phase|Other|0|||
155113640|NCT00758264|559844866|FG001|Active Phase|Other|0|||
154884675|NCT01496430|559001563|FG002|Overall Study|Voluntary Withdrawal|6|||
154884676|NCT01496430|559001561|FG000|Overall Study|Principal Investigator Discretion|0|||
154884677|NCT01496430|559001562|FG001|Overall Study|Principal Investigator Discretion|1|||
154884678|NCT01496430|559001563|FG002|Overall Study|Principal Investigator Discretion|1|||
154884679|NCT01496430|559001561|FG000|Overall Study|Other|2|||
154884680|NCT01496430|559001562|FG001|Overall Study|Other|0|||
154884681|NCT01496430|559001563|FG002|Overall Study|Other|0|||
154884682|NCT00718666|559001564|FG000|Booster Phase Year 5|No active participation request|0|||
154884683|NCT00718666|559001565|FG001|Booster Phase Year 5|No active participation request|0|||
154884684|NCT00718666|559001566|FG002|Booster Phase Year 5|No active participation request|1|||
154884685|NCT00718666|559001564|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
154976075|NCT04773600|559335321|FG001|Overall Study|Protocol Violation|0|||
155113641|NCT00758264|559844867|FG002|Active Phase|Other|4|||
154884686|NCT00718666|559001565|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
154884687|NCT00718666|559001566|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
154884688|NCT00718666|559001564|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
154884689|NCT00718666|559001565|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
154884690|NCT00718666|559001566|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
154884691|NCT00718666|559001564|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
154884692|NCT00718666|559001565|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
154884693|NCT00718666|559001566|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
154884694|NCT03337152|559001567|FG000|Overall Study|Physician Decision|1|||
154884695|NCT03337152|559001568|FG001|Overall Study|Physician Decision|0|||
154884696|NCT03337152|559001567|FG000|Overall Study|Lost to Follow-up|1|||
154884697|NCT03337152|559001568|FG001|Overall Study|Lost to Follow-up|3|||
154884698|NCT03337152|559001567|FG000|Overall Study|Adverse Event|3|||
154884699|NCT03337152|559001568|FG001|Overall Study|Adverse Event|1|||
154884700|NCT03337152|559001567|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
154884701|NCT03337152|559001568|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
154884702|NCT00421343|559001571|FG000|Overall Study|Death|1|||
154884703|NCT00421343|559001571|FG000|Overall Study|Withdrawal by Subject|2|||
154884704|NCT00421343|559001571|FG000|Overall Study|Lost to Follow-up|3|||
154884705|NCT03471767|559001572|FG000|Overall Study|Withdrawal by Subject|3|||
154884706|NCT03471767|559001573|FG001|Overall Study|Withdrawal by Subject|1|||
154884707|NCT03471767|559001572|FG000|Overall Study|Adverse Event|1|||
154884708|NCT03471767|559001573|FG001|Overall Study|Adverse Event|0|||
154884709|NCT03471767|559001572|FG000|Overall Study|Lost to Follow-up|1|||
154884710|NCT03471767|559001573|FG001|Overall Study|Lost to Follow-up|0|||
154884711|NCT03471767|559001572|FG000|Overall Study|PI Withdrawal|1|||
154884712|NCT03471767|559001573|FG001|Overall Study|PI Withdrawal|3|||
154884713|NCT01952730|559001576|FG000|Overall Study|FDA shut down core lab used by study|1|||
154884714|NCT01019486|559001583|FG000|Overall Study|Withdrawal by Subject|1|||
154884715|NCT01019486|559001584|FG001|Overall Study|Withdrawal by Subject|1|||
154884716|NCT01019486|559001585|FG002|Overall Study|Withdrawal by Subject|1|||
154884717|NCT03442829|559001587|FG000|Overall Study|Scheduling clash|3|||
154884718|NCT03442829|559001588|FG001|Overall Study|Scheduling clash|1|||
154884719|NCT03442829|559001587|FG000|Overall Study|Illness unrelated to study|1|||
154884720|NCT03442829|559001588|FG001|Overall Study|Illness unrelated to study|1|||
154884721|NCT02605447|559001591|FG000|Overall Study|Death|66|||
154884722|NCT02605447|559001591|FG000|Overall Study|Physician Decision|1|||
154884723|NCT02605447|559001591|FG000|Overall Study|Lost to Follow-up|24|||
154884724|NCT02605447|559001591|FG000|Overall Study|Withdrawal by Subject|10|||
154884725|NCT02605447|559001591|FG000|Overall Study|Not disclosed|1|||
154884726|NCT02237157|559001592|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
154884727|NCT02237157|559001593|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
154884728|NCT02237157|559001594|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
154884729|NCT02237157|559001595|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
154884730|NCT02237157|559001592|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
154884731|NCT02237157|559001593|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
154884732|NCT02237157|559001594|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
154884733|NCT02237157|559001595|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
154884734|NCT02045212|559001597|FG000|Overall Study|Adverse Event|0|||
154884735|NCT02045212|559001598|FG001|Overall Study|Adverse Event|1|||
154884736|NCT02045212|559001597|FG000|Overall Study|Withdrawal by Subject|1|||
154884737|NCT02045212|559001598|FG001|Overall Study|Withdrawal by Subject|0|||
154884738|NCT02045212|559001597|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
154884739|NCT02045212|559001598|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
154884740|NCT03126539|559001600|FG000|Overall Study|Lost to Follow-up|1|||
154884741|NCT03126539|559001601|FG001|Overall Study|Lost to Follow-up|1|||
154884742|NCT03126539|559001602|FG002|Overall Study|Lost to Follow-up|1|||
154884743|NCT03126539|559001603|FG003|Overall Study|Lost to Follow-up|0|||
154884744|NCT03126539|559001604|FG004|Overall Study|Lost to Follow-up|0|||
154884745|NCT00926796|559001605|FG000|Overall Study|Did not receive randomized treatment|4|||
154884746|NCT00926796|559001606|FG001|Overall Study|Did not receive randomized treatment|7|||
154884747|NCT00926796|559001605|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
154884748|NCT00926796|559001606|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
154884749|NCT00926796|559001605|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
154884750|NCT00926796|559001606|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
154884751|NCT00926796|559001605|FG000|Overall Study|Adverse Event|7|||
154884752|NCT00926796|559001606|FG001|Overall Study|Adverse Event|14|||
154884753|NCT00926796|559001605|FG000|Overall Study|Lost to Follow-up|22|||
154884754|NCT00926796|559001606|FG001|Overall Study|Lost to Follow-up|13|||
154884755|NCT00926796|559001605|FG000|Overall Study|Protocol Violation|15|||
154884756|NCT00926796|559001606|FG001|Overall Study|Protocol Violation|11|||
155113642|NCT04154605|559844873|FG000|Overall Study|Procedure Canceled|1|||
155113643|NCT04154605|559844874|FG001|Overall Study|Procedure Canceled|1|||
154884757|NCT00926796|559001605|FG000|Overall Study|Withdrawal by Subject|1|||
155113644|NCT04154605|559844873|FG000|Overall Study|Missed follow up|1|||
154976076|NCT04773600|559335320|FG000|Overall Study|Physician Decision|0|||
154976077|NCT04773600|559335321|FG001|Overall Study|Physician Decision|1|||
154976078|NCT04773600|559335320|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
154976079|NCT04773600|559335321|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
154976080|NCT04773600|559335320|FG000|Overall Study|Emergency Travel Out of Country|1|||
154976081|NCT04773600|559335321|FG001|Overall Study|Emergency Travel Out of Country|0|||
154976082|NCT01923311|559336695|FG000|Overall Study|Pregnancy|1|||
154976083|NCT01923311|559336696|FG001|Overall Study|Pregnancy|0|||
154976084|NCT01923311|559336695|FG000|Overall Study|Investigator's Discretion|1|||
154976085|NCT01923311|559336696|FG001|Overall Study|Investigator's Discretion|0|||
154976086|NCT01923311|559336695|FG000|Overall Study|Non-Compliance with Study Drug|2|||
154976087|NCT01923311|559336696|FG001|Overall Study|Non-Compliance with Study Drug|1|||
154976088|NCT01923311|559336695|FG000|Overall Study|Withdrew Consent|1|||
154976089|NCT01923311|559336696|FG001|Overall Study|Withdrew Consent|0|||
154976090|NCT01923311|559336695|FG000|Overall Study|Study Terminated by Sponsor|12|||
154976091|NCT01923311|559336696|FG001|Overall Study|Study Terminated by Sponsor|0|||
154976092|NCT02839798|559336700|FG000|Overall Study|Withdrawal by Subject|2|||
154976093|NCT03429049|559336701|FG000|Overall Study|Adverse Event|2|||
154976094|NCT03429049|559336702|FG001|Overall Study|Adverse Event|3|||
154976095|NCT03429049|559336701|FG000|Overall Study|Death|0|||
154976096|NCT03429049|559336702|FG001|Overall Study|Death|1|||
154976097|NCT03429049|559336701|FG000|Overall Study|Lack of Efficacy|4|||
154976098|NCT03429049|559336702|FG001|Overall Study|Lack of Efficacy|2|||
154976099|NCT03429049|559336701|FG000|Overall Study|Lost to Follow-up|9|||
154976100|NCT03429049|559336702|FG001|Overall Study|Lost to Follow-up|8|||
154976101|NCT03429049|559336701|FG000|Overall Study|Physician Decision|1|||
154976102|NCT03429049|559336702|FG001|Overall Study|Physician Decision|0|||
154976103|NCT03429049|559336701|FG000|Overall Study|Protocol Violation|3|||
154976104|NCT03429049|559336702|FG001|Overall Study|Protocol Violation|0|||
154976105|NCT03429049|559336701|FG000|Overall Study|Sponsor Decision|2|||
154976106|NCT03429049|559336702|FG001|Overall Study|Sponsor Decision|0|||
154976107|NCT03429049|559336701|FG000|Overall Study|Withdrawal by Subject|4|||
154976108|NCT03429049|559336702|FG001|Overall Study|Withdrawal by Subject|20|||
154976109|NCT03429049|559336701|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
154976110|NCT03429049|559336702|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
154976111|NCT04703855|559336703|FG000|Overall Study|Heart Transplant|1|||
154976112|NCT05258630|559336705|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
154976113|NCT05258630|559336706|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
154976114|NCT05258630|559336705|FG000|Overall Study|Lost to Follow-up|0|||
154976115|NCT05258630|559336706|FG001|Overall Study|Lost to Follow-up|2|||
154976116|NCT04129944|559336707|FG000|Overall Study|Death|0|||
154976117|NCT04129944|559336708|FG001|Overall Study|Death|0|||
154976118|NCT04129944|559336709|FG002|Overall Study|Death|0|||
154976119|NCT04129944|559336710|FG003|Overall Study|Death|1|||
154976120|NCT04129944|559336707|FG000|Overall Study|Lost to Follow-up|1|||
154976121|NCT04129944|559336708|FG001|Overall Study|Lost to Follow-up|0|||
154976122|NCT04129944|559336709|FG002|Overall Study|Lost to Follow-up|0|||
154976123|NCT04129944|559336710|FG003|Overall Study|Lost to Follow-up|0|||
154976124|NCT04129944|559336707|FG000|Overall Study|Withdrawal by Subject|1|||
154976125|NCT04129944|559336708|FG001|Overall Study|Withdrawal by Subject|0|||
154976126|NCT04129944|559336709|FG002|Overall Study|Withdrawal by Subject|1|||
154976127|NCT04129944|559336710|FG003|Overall Study|Withdrawal by Subject|2|||
154976128|NCT03431337|559336711|FG000|Overall Study|Lost to Follow-up|21|||
154976129|NCT03431337|559336712|FG001|Overall Study|Lost to Follow-up|19|||
154976130|NCT03431337|559336711|FG000|Overall Study|Withdrawal by Subject|8|||
154976131|NCT03431337|559336712|FG001|Overall Study|Withdrawal by Subject|3|||
154976132|NCT00401245|559336713|FG000|Double Blind Titration Phase|Adverse Event|3|||
154976133|NCT00401245|559336714|FG001|Double Blind Titration Phase|Adverse Event|2|||
154976134|NCT00401245|559336715|FG002|Double Blind Titration Phase|Adverse Event|5|||
154976135|NCT00401245|559336716|FG003|Double Blind Titration Phase|Adverse Event|12|||
154976136|NCT00401245|559336717|FG004|Double Blind Titration Phase|Adverse Event|0|||
154976137|NCT00401245|559336718|FG005|Double Blind Titration Phase|Adverse Event|0|||
154976138|NCT00401245|559336719|FG006|Double Blind Titration Phase|Adverse Event|0|||
154976139|NCT00401245|559336720|FG007|Double Blind Titration Phase|Adverse Event|0|||
154976140|NCT00401245|559336713|FG000|Double Blind Titration Phase|Other|0|||
154976141|NCT00401245|559336714|FG001|Double Blind Titration Phase|Other|0|||
154976142|NCT00401245|559336715|FG002|Double Blind Titration Phase|Other|1|||
154976143|NCT00401245|559336716|FG003|Double Blind Titration Phase|Other|0|||
154976144|NCT00401245|559336717|FG004|Double Blind Titration Phase|Other|0|||
154976145|NCT00401245|559336718|FG005|Double Blind Titration Phase|Other|0|||
154976146|NCT00401245|559336719|FG006|Double Blind Titration Phase|Other|0|||
154976147|NCT00401245|559336720|FG007|Double Blind Titration Phase|Other|0|||
154976148|NCT00401245|559336713|FG000|Double Blind Titration Phase|Protocol Violation|0|||
154976149|NCT00401245|559336714|FG001|Double Blind Titration Phase|Protocol Violation|0|||
154976150|NCT00401245|559336715|FG002|Double Blind Titration Phase|Protocol Violation|0|||
154976151|NCT00401245|559336716|FG003|Double Blind Titration Phase|Protocol Violation|1|||
154884758|NCT00926796|559001606|FG001|Overall Study|Withdrawal by Subject|0|||
154884759|NCT00946530|559001612|FG000|Overall Study|Withdrawal by Subject|0|||
154884760|NCT00946530|559001613|FG001|Overall Study|Withdrawal by Subject|3|||
154884761|NCT00946530|559001614|FG002|Overall Study|Withdrawal by Subject|0|||
154884762|NCT00946530|559001615|FG003|Overall Study|Withdrawal by Subject|3|||
154884763|NCT00946530|559001612|FG000|Overall Study|Physician Decision|1|||
154884764|NCT00946530|559001613|FG001|Overall Study|Physician Decision|1|||
154884765|NCT00946530|559001614|FG002|Overall Study|Physician Decision|1|||
154884766|NCT00946530|559001615|FG003|Overall Study|Physician Decision|1|||
154884767|NCT00115804|559001616|FG000|Overall Study|Adverse Event|2|||
154884768|NCT00621855|559001617|FG000|Overall Study|Adverse Event|32|||
154884769|NCT00621855|559001618|FG001|Overall Study|Adverse Event|31|||
154884770|NCT00621855|559001619|FG002|Overall Study|Adverse Event|48|||
154884771|NCT00621855|559001620|FG003|Overall Study|Adverse Event|34|||
154884772|NCT00621855|559001621|FG004|Overall Study|Adverse Event|31|||
154884773|NCT00621855|559001617|FG000|Overall Study|Lost to Follow-up|0|||
154884774|NCT00621855|559001618|FG001|Overall Study|Lost to Follow-up|1|||
154884775|NCT00621855|559001619|FG002|Overall Study|Lost to Follow-up|3|||
154884776|NCT00621855|559001620|FG003|Overall Study|Lost to Follow-up|4|||
154884777|NCT00621855|559001621|FG004|Overall Study|Lost to Follow-up|1|||
154884778|NCT00621855|559001617|FG000|Overall Study|Protocol Violation|16|||
154884779|NCT00621855|559001618|FG001|Overall Study|Protocol Violation|8|||
154884780|NCT00621855|559001619|FG002|Overall Study|Protocol Violation|6|||
154884781|NCT00621855|559001620|FG003|Overall Study|Protocol Violation|7|||
154884782|NCT00621855|559001621|FG004|Overall Study|Protocol Violation|8|||
154884783|NCT00621855|559001617|FG000|Overall Study|Withdrawal by Subject|16|||
154884784|NCT00621855|559001618|FG001|Overall Study|Withdrawal by Subject|11|||
154884785|NCT00621855|559001619|FG002|Overall Study|Withdrawal by Subject|13|||
154884786|NCT00621855|559001620|FG003|Overall Study|Withdrawal by Subject|13|||
154884787|NCT00621855|559001621|FG004|Overall Study|Withdrawal by Subject|9|||
154884788|NCT00621855|559001617|FG000|Overall Study|Other|9|||
154884789|NCT00621855|559001618|FG001|Overall Study|Other|7|||
154884790|NCT00621855|559001619|FG002|Overall Study|Other|6|||
154884791|NCT00621855|559001620|FG003|Overall Study|Other|5|||
154884792|NCT00621855|559001621|FG004|Overall Study|Other|4|||
154884793|NCT00621855|559001617|FG000|Overall Study|Patients did not receive study drug|3|||
154884794|NCT00621855|559001618|FG001|Overall Study|Patients did not receive study drug|3|||
154884795|NCT00621855|559001619|FG002|Overall Study|Patients did not receive study drug|5|||
154884796|NCT00621855|559001620|FG003|Overall Study|Patients did not receive study drug|4|||
154884797|NCT00621855|559001621|FG004|Overall Study|Patients did not receive study drug|2|||
154884798|NCT03095521|559001622|FG000|Overall Study|Withdrawal by Subject|0|||
154884799|NCT03095521|559001623|FG001|Overall Study|Withdrawal by Subject|1|||
154884800|NCT03095521|559001622|FG000|Overall Study|Lost to Follow-up|0|||
154884801|NCT03095521|559001623|FG001|Overall Study|Lost to Follow-up|1|||
154884802|NCT00430521|559001626|FG000|Overall Study|Adverse Event|0|||
154884803|NCT00430521|559001627|FG001|Overall Study|Adverse Event|0|||
154884804|NCT00430521|559001628|FG002|Overall Study|Adverse Event|0|||
154884805|NCT00430521|559001629|FG003|Overall Study|Adverse Event|0|||
154884806|NCT00430521|559001630|FG004|Overall Study|Adverse Event|0|||
154884807|NCT00430521|559001631|FG005|Overall Study|Adverse Event|2|||
154884808|NCT00430521|559001632|FG006|Overall Study|Adverse Event|1|||
154884809|NCT00430521|559001633|FG007|Overall Study|Adverse Event|0|||
154884810|NCT00430521|559001626|FG000|Overall Study|Lost to Follow-up|7|||
154884811|NCT00430521|559001627|FG001|Overall Study|Lost to Follow-up|8|||
154884812|NCT00430521|559001628|FG002|Overall Study|Lost to Follow-up|3|||
154884813|NCT00430521|559001629|FG003|Overall Study|Lost to Follow-up|5|||
154884814|NCT00430521|559001630|FG004|Overall Study|Lost to Follow-up|5|||
154884815|NCT00430521|559001631|FG005|Overall Study|Lost to Follow-up|2|||
154884816|NCT00430521|559001632|FG006|Overall Study|Lost to Follow-up|8|||
154884817|NCT00430521|559001633|FG007|Overall Study|Lost to Follow-up|10|||
154884818|NCT00430521|559001626|FG000|Overall Study|Pregnancy|0|||
154884819|NCT00430521|559001627|FG001|Overall Study|Pregnancy|0|||
154976152|NCT00401245|559336717|FG004|Double Blind Titration Phase|Protocol Violation|0|||
154884820|NCT00430521|559001628|FG002|Overall Study|Pregnancy|0|||
154884821|NCT00430521|559001629|FG003|Overall Study|Pregnancy|0|||
154884822|NCT00430521|559001630|FG004|Overall Study|Pregnancy|0|||
154884823|NCT00430521|559001631|FG005|Overall Study|Pregnancy|0|||
154884824|NCT00430521|559001632|FG006|Overall Study|Pregnancy|1|||
154884825|NCT00430521|559001633|FG007|Overall Study|Pregnancy|0|||
154884826|NCT00430521|559001626|FG000|Overall Study|Vaccine Expired|0|||
154884827|NCT00430521|559001627|FG001|Overall Study|Vaccine Expired|0|||
154884828|NCT00430521|559001628|FG002|Overall Study|Vaccine Expired|0|||
154884829|NCT00430521|559001629|FG003|Overall Study|Vaccine Expired|0|||
154884830|NCT00430521|559001630|FG004|Overall Study|Vaccine Expired|0|||
154884831|NCT00430521|559001631|FG005|Overall Study|Vaccine Expired|1|||
154884832|NCT00430521|559001632|FG006|Overall Study|Vaccine Expired|0|||
154884833|NCT00430521|559001633|FG007|Overall Study|Vaccine Expired|0|||
154884834|NCT00430521|559001626|FG000|Overall Study|Protocol Violation|1|||
154884835|NCT00430521|559001627|FG001|Overall Study|Protocol Violation|0|||
154884836|NCT00430521|559001628|FG002|Overall Study|Protocol Violation|0|||
154884837|NCT00430521|559001629|FG003|Overall Study|Protocol Violation|0|||
154884838|NCT00430521|559001630|FG004|Overall Study|Protocol Violation|0|||
154884839|NCT00430521|559001631|FG005|Overall Study|Protocol Violation|0|||
154884840|NCT00430521|559001632|FG006|Overall Study|Protocol Violation|0|||
154884841|NCT00430521|559001633|FG007|Overall Study|Protocol Violation|0|||
154884842|NCT00430521|559001626|FG000|Overall Study|Withdrawal by Subject|3|||
154884843|NCT00430521|559001627|FG001|Overall Study|Withdrawal by Subject|1|||
154884844|NCT00430521|559001628|FG002|Overall Study|Withdrawal by Subject|0|||
154884845|NCT00430521|559001629|FG003|Overall Study|Withdrawal by Subject|3|||
154884846|NCT00430521|559001630|FG004|Overall Study|Withdrawal by Subject|0|||
154884847|NCT00430521|559001631|FG005|Overall Study|Withdrawal by Subject|0|||
154884848|NCT00430521|559001632|FG006|Overall Study|Withdrawal by Subject|0|||
154884849|NCT00430521|559001633|FG007|Overall Study|Withdrawal by Subject|2|||
154884850|NCT02198651|559003513|FG000|Lead-in Period|Withdrew consent|13|||
154884851|NCT02198651|559003514|FG001|Lead-in Period|Withdrew consent|0|||
154884852|NCT02198651|559003515|FG002|Lead-in Period|Withdrew consent|0|||
154884853|NCT02198651|559003516|FG003|Lead-in Period|Withdrew consent|0|||
154884854|NCT02198651|559003517|FG004|Lead-in Period|Withdrew consent|0|||
154884855|NCT02198651|559003513|FG000|Lead-in Period|Adverse Event|2|||
154884856|NCT02198651|559003514|FG001|Lead-in Period|Adverse Event|0|||
154884857|NCT02198651|559003515|FG002|Lead-in Period|Adverse Event|0|||
154884858|NCT02198651|559003516|FG003|Lead-in Period|Adverse Event|0|||
154884859|NCT02198651|559003517|FG004|Lead-in Period|Adverse Event|0|||
154884860|NCT02198651|559003513|FG000|Lead-in Period|Other, not specified|22|||
154884861|NCT02198651|559003514|FG001|Lead-in Period|Other, not specified|0|||
154884862|NCT02198651|559003515|FG002|Lead-in Period|Other, not specified|0|||
154884863|NCT02198651|559003516|FG003|Lead-in Period|Other, not specified|0|||
154884864|NCT02198651|559003517|FG004|Lead-in Period|Other, not specified|0|||
154884865|NCT02198651|559003513|FG000|Double-blind Period|Withdrew consent|0|||
154884866|NCT02198651|559003514|FG001|Double-blind Period|Withdrew consent|4|||
154884867|NCT02198651|559003515|FG002|Double-blind Period|Withdrew consent|0|||
154884868|NCT02198651|559003516|FG003|Double-blind Period|Withdrew consent|0|||
154884869|NCT02198651|559003517|FG004|Double-blind Period|Withdrew consent|0|||
154884870|NCT02198651|559003513|FG000|Double-blind Period|Adverse Event|0|||
154884871|NCT02198651|559003514|FG001|Double-blind Period|Adverse Event|1|||
154884872|NCT02198651|559003515|FG002|Double-blind Period|Adverse Event|0|||
154884873|NCT02198651|559003516|FG003|Double-blind Period|Adverse Event|0|||
154884874|NCT02198651|559003517|FG004|Double-blind Period|Adverse Event|0|||
154884875|NCT02198651|559003513|FG000|Double-blind Period|Other, not specified|0|||
154884876|NCT02198651|559003514|FG001|Double-blind Period|Other, not specified|4|||
154884877|NCT02198651|559003515|FG002|Double-blind Period|Other, not specified|1|||
154884878|NCT02198651|559003516|FG003|Double-blind Period|Other, not specified|0|||
154884879|NCT02198651|559003517|FG004|Double-blind Period|Other, not specified|0|||
154884880|NCT02198651|559003513|FG000|Open-label Rescue Period|Withdrew consent|0|||
154884881|NCT02198651|559003514|FG001|Open-label Rescue Period|Withdrew consent|0|||
154884882|NCT02198651|559003515|FG002|Open-label Rescue Period|Withdrew consent|0|||
154884883|NCT02198651|559003516|FG003|Open-label Rescue Period|Withdrew consent|2|||
154884884|NCT02198651|559003517|FG004|Open-label Rescue Period|Withdrew consent|0|||
154884885|NCT02198651|559003513|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
154884886|NCT02198651|559003514|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
154884887|NCT02198651|559003515|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
154884888|NCT02198651|559003516|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
154884889|NCT02198651|559003517|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
154884890|NCT00333619|559003527|FG000|Overall Study|Death|12|||
154884891|NCT00333619|559003528|FG001|Overall Study|Death|6|||
154884892|NCT00333619|559003527|FG000|Overall Study|Withdrawal by Subject|6|||
154884893|NCT00333619|559003528|FG001|Overall Study|Withdrawal by Subject|1|||
154884894|NCT00333619|559003527|FG000|Overall Study|Lost to Follow-up|3|||
154884895|NCT00333619|559003528|FG001|Overall Study|Lost to Follow-up|3|||
154884896|NCT01120379|559003537|FG000|One Year Timepoint|Withdrawal by Subject|41|||
154976153|NCT00401245|559336718|FG005|Double Blind Titration Phase|Protocol Violation|0|||
154976154|NCT00401245|559336719|FG006|Double Blind Titration Phase|Protocol Violation|0|||
154884897|NCT01120379|559003537|FG000|One Year Timepoint|Lost to Follow-up|115|||
154884898|NCT01120379|559003537|FG000|One Year Timepoint|Death|108|||
154884899|NCT01120379|559003537|FG000|One Year Timepoint|Physician Decision|9|||
154884900|NCT01120379|559003537|FG000|One Year Timepoint|Any other reason for early termination|5|||
154884901|NCT01120379|559003537|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
154884902|NCT01120379|559003537|FG000|Two Year Timepoint|Lost to Follow-up|87|||
154884903|NCT01120379|559003537|FG000|Two Year Timepoint|Death|123|||
154884904|NCT01120379|559003537|FG000|Two Year Timepoint|Physician Decision|12|||
154884905|NCT01120379|559003537|FG000|Two Year Timepoint|Any other reason for early termination|4|||
154884906|NCT01120379|559003537|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
154884907|NCT01120379|559003537|FG000|Three Year Timepoint|Lost to Follow-up|43|||
154884908|NCT01120379|559003537|FG000|Three Year Timepoint|Death|120|||
154884909|NCT01120379|559003537|FG000|Three Year Timepoint|Physician Decision|9|||
154976155|NCT00401245|559336720|FG007|Double Blind Titration Phase|Protocol Violation|0|||
154976156|NCT00401245|559336713|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
154976157|NCT00401245|559336714|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
154976158|NCT00401245|559336715|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
154976159|NCT00401245|559336716|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
154976160|NCT00401245|559336717|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
154976161|NCT00401245|559336718|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
154976162|NCT00401245|559336719|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
154976163|NCT00401245|559336720|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
154976164|NCT00401245|559336713|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
154976165|NCT00401245|559336714|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
154976166|NCT00401245|559336715|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
154976167|NCT00401245|559336716|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
154976168|NCT00401245|559336717|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
154976169|NCT00401245|559336718|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
154976170|NCT00401245|559336719|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
154976171|NCT00401245|559336720|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
154976172|NCT00401245|559336713|FG000|Open Label Phase|Adverse Event|5|||
154976173|NCT00401245|559336714|FG001|Open Label Phase|Adverse Event|14|||
154976174|NCT00401245|559336715|FG002|Open Label Phase|Adverse Event|6|||
154976175|NCT00401245|559336716|FG003|Open Label Phase|Adverse Event|7|||
154976176|NCT00401245|559336717|FG004|Open Label Phase|Adverse Event|0|||
154976177|NCT00401245|559336718|FG005|Open Label Phase|Adverse Event|0|||
154976178|NCT00401245|559336719|FG006|Open Label Phase|Adverse Event|0|||
154976179|NCT00401245|559336720|FG007|Open Label Phase|Adverse Event|0|||
154976180|NCT00401245|559336713|FG000|Open Label Phase|Lost to Follow-up|5|||
154976181|NCT00401245|559336714|FG001|Open Label Phase|Lost to Follow-up|7|||
154884910|NCT01120379|559003537|FG000|Three Year Timepoint|Any other reason for early termination|17|||
154884911|NCT01120379|559003537|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
154884912|NCT01120379|559003537|FG000|Four Year Timepoint|Lost to Follow-up|10|||
154884913|NCT01120379|559003537|FG000|Four Year Timepoint|Death|131|||
154884914|NCT01120379|559003537|FG000|Four Year Timepoint|Physician Decision|5|||
154884915|NCT01120379|559003537|FG000|Four Year Timepoint|Any other reason for early termination|217|||
154884916|NCT00848250|559003541|FG000|Overall Study|surgery was completed without cardiopulm|0|||
154884917|NCT00848250|559003542|FG001|Overall Study|surgery was completed without cardiopulm|1|||
154884918|NCT04032171|559003551|FG000|Overall Study|Study Termination|1|||
154884919|NCT04032171|559003552|FG001|Overall Study|Study Termination|0|||
154884920|NCT00642746|559003553|FG000|Overall Study|Patient unevaluable|1|||
154884921|NCT00642746|559003554|FG001|Overall Study|Patient unevaluable|0|||
154976182|NCT00401245|559336715|FG002|Open Label Phase|Lost to Follow-up|5|||
154976183|NCT00401245|559336716|FG003|Open Label Phase|Lost to Follow-up|4|||
154976184|NCT00401245|559336717|FG004|Open Label Phase|Lost to Follow-up|0|||
154976185|NCT00401245|559336718|FG005|Open Label Phase|Lost to Follow-up|0|||
154976186|NCT00401245|559336719|FG006|Open Label Phase|Lost to Follow-up|0|||
154976187|NCT00401245|559336720|FG007|Open Label Phase|Lost to Follow-up|0|||
154976188|NCT00401245|559336713|FG000|Open Label Phase|Other|4|||
154976189|NCT00401245|559336714|FG001|Open Label Phase|Other|8|||
154976190|NCT00401245|559336715|FG002|Open Label Phase|Other|7|||
154976191|NCT00401245|559336716|FG003|Open Label Phase|Other|8|||
154976192|NCT00401245|559336717|FG004|Open Label Phase|Other|0|||
154976193|NCT00401245|559336718|FG005|Open Label Phase|Other|0|||
154976194|NCT00401245|559336719|FG006|Open Label Phase|Other|0|||
154976195|NCT00401245|559336720|FG007|Open Label Phase|Other|0|||
154976196|NCT00401245|559336713|FG000|Open Label Phase|Protocol Violation|0|||
154976197|NCT00401245|559336714|FG001|Open Label Phase|Protocol Violation|1|||
154976198|NCT00401245|559336715|FG002|Open Label Phase|Protocol Violation|0|||
154976199|NCT00401245|559336716|FG003|Open Label Phase|Protocol Violation|1|||
154976200|NCT00401245|559336717|FG004|Open Label Phase|Protocol Violation|0|||
154976201|NCT00401245|559336718|FG005|Open Label Phase|Protocol Violation|0|||
155113645|NCT04154605|559844874|FG001|Overall Study|Missed follow up|1|||
154884922|NCT02108951|559003557|FG000|Overall Study|Lost to Follow-up|1|||
154884923|NCT02108951|559003557|FG000|Overall Study|Patient's/guardian's decision|1|||
154884924|NCT02108951|559003557|FG000|Overall Study|Study Terminated by Sponsor|14|||
154884925|NCT00678587|559003558|FG000|Overall Study|Adverse Event|3|||
154884926|NCT00678587|559003559|FG001|Overall Study|Adverse Event|3|||
154884927|NCT00678587|559003558|FG000|Overall Study|Lack of Efficacy|1|||
154884928|NCT00678587|559003559|FG001|Overall Study|Lack of Efficacy|0|||
154976202|NCT00401245|559336719|FG006|Open Label Phase|Protocol Violation|0|||
154976203|NCT00401245|559336720|FG007|Open Label Phase|Protocol Violation|0|||
154976204|NCT00401245|559336713|FG000|Open Label Phase|Withdrawal by Subject|3|||
154976205|NCT00401245|559336714|FG001|Open Label Phase|Withdrawal by Subject|3|||
154976206|NCT00401245|559336715|FG002|Open Label Phase|Withdrawal by Subject|2|||
154976207|NCT00401245|559336716|FG003|Open Label Phase|Withdrawal by Subject|1|||
154976208|NCT00401245|559336717|FG004|Open Label Phase|Withdrawal by Subject|0|||
154884929|NCT00678587|559003558|FG000|Overall Study|Protocol Violation|2|||
154884930|NCT00678587|559003559|FG001|Overall Study|Protocol Violation|1|||
154884931|NCT00678587|559003558|FG000|Overall Study|Study Closed/Terminated|1|||
154884932|NCT00678587|559003559|FG001|Overall Study|Study Closed/Terminated|0|||
154884933|NCT00678587|559003558|FG000|Overall Study|Lost to Follow-up|3|||
154884934|NCT00678587|559003559|FG001|Overall Study|Lost to Follow-up|5|||
154884935|NCT00678587|559003558|FG000|Overall Study|Investigator Discretion|2|||
154884936|NCT00678587|559003559|FG001|Overall Study|Investigator Discretion|6|||
154884937|NCT00678587|559003558|FG000|Overall Study|Withdrew Consent|8|||
154884938|NCT00678587|559003559|FG001|Overall Study|Withdrew Consent|3|||
154884939|NCT01514188|559003560|FG000|Overall Study|Adverse Event|3|||
154884940|NCT01514188|559003561|FG001|Overall Study|Adverse Event|5|||
154884941|NCT01514188|559003560|FG000|Overall Study|Withdrawal by Subject|2|||
154884942|NCT01514188|559003561|FG001|Overall Study|Withdrawal by Subject|4|||
154884943|NCT01514188|559003560|FG000|Overall Study|Protocol Violation|2|||
154884944|NCT01514188|559003561|FG001|Overall Study|Protocol Violation|4|||
154884945|NCT01514188|559003560|FG000|Overall Study|Physician Decision|0|||
154884946|NCT01514188|559003561|FG001|Overall Study|Physician Decision|2|||
154884947|NCT01514188|559003560|FG000|Overall Study|Disease Progression|13|||
154884948|NCT01514188|559003561|FG001|Overall Study|Disease Progression|14|||
154884949|NCT01514188|559003560|FG000|Overall Study|Death|1|||
154884950|NCT01514188|559003561|FG001|Overall Study|Death|3|||
154884951|NCT01514188|559003560|FG000|Overall Study|Other|2|||
154884952|NCT01514188|559003561|FG001|Overall Study|Other|1|||
154884953|NCT02932332|559003562|FG000|Overall Study|Withdrawal by Subject|1|||
154884954|NCT02932332|559003563|FG001|Overall Study|Withdrawal by Subject|1|||
154884955|NCT02932332|559003564|FG002|Overall Study|Withdrawal by Subject|0|||
154884956|NCT02932332|559003565|FG003|Overall Study|Withdrawal by Subject|1|||
154884957|NCT02932332|559003562|FG000|Overall Study|Chest pain|0|||
154884958|NCT02932332|559003563|FG001|Overall Study|Chest pain|0|||
154884959|NCT02932332|559003564|FG002|Overall Study|Chest pain|0|||
154884960|NCT02932332|559003565|FG003|Overall Study|Chest pain|1|||
154884961|NCT02932332|559003562|FG000|Overall Study|Not Dyspneic cough|1|||
154884962|NCT02932332|559003563|FG001|Overall Study|Not Dyspneic cough|2|||
154884963|NCT02932332|559003564|FG002|Overall Study|Not Dyspneic cough|1|||
154884964|NCT02932332|559003565|FG003|Overall Study|Not Dyspneic cough|0|||
154884965|NCT02493426|559003566|FG000|Overall Study|Withdrawal by Subject|0|||
154884966|NCT02493426|559003567|FG001|Overall Study|Withdrawal by Subject|1|||
154884967|NCT01069523|559003568|FG000|Overall Study|Withdrawal by Subject|4|||
154884968|NCT01069523|559003569|FG001|Overall Study|Withdrawal by Subject|7|||
154884969|NCT01875367|559003570|FG000|Overall Study|Not complete at least 2 questionaries|4|||
154884970|NCT01875367|559003571|FG001|Overall Study|Not complete at least 2 questionaries|2|||
154884971|NCT01875367|559003570|FG000|Overall Study|Not receive study treatment|1|||
154884972|NCT01875367|559003571|FG001|Overall Study|Not receive study treatment|0|||
154884973|NCT04533815|559003577|FG000|Overall Study|Adverse Event|2|||
154884974|NCT04533815|559003577|FG000|Overall Study|Site withdrew|5|||
154884975|NCT00488592|559003578|FG000|Overall Study|Withdrawal by Subject|1|||
154884976|NCT00488592|559003578|FG000|Overall Study|Disease progression|1|||
154884977|NCT00488592|559003578|FG000|Overall Study|Enrolled but not treated|1|||
154884978|NCT00441103|559003579|FG000|Overall Study|Adverse Event|2|||
154884979|NCT00441103|559003580|FG001|Overall Study|Adverse Event|1|||
154884980|NCT00441103|559003579|FG000|Overall Study|Death|1|||
154884981|NCT00441103|559003580|FG001|Overall Study|Death|0|||
154884982|NCT00441103|559003579|FG000|Overall Study|Disease Progression|2|||
154884983|NCT00441103|559003580|FG001|Overall Study|Disease Progression|0|||
154884984|NCT00441103|559003579|FG000|Overall Study|Lost to Follow-up|1|||
154884985|NCT00441103|559003580|FG001|Overall Study|Lost to Follow-up|0|||
154884986|NCT00441103|559003579|FG000|Overall Study|Protocol Violation|1|||
154884987|NCT00441103|559003580|FG001|Overall Study|Protocol Violation|0|||
154884988|NCT00441103|559003579|FG000|Overall Study|Participant unable to use Rebiject II|1|||
154884989|NCT00441103|559003580|FG001|Overall Study|Participant unable to use Rebiject II|0|||
154884990|NCT00441103|559003579|FG000|Overall Study|Participant refused MRI|1|||
154884991|NCT00441103|559003580|FG001|Overall Study|Participant refused MRI|0|||
154884992|NCT00441103|559003579|FG000|Overall Study|Inclusion criteria absent|1|||
154884993|NCT00441103|559003580|FG001|Overall Study|Inclusion criteria absent|0|||
154884994|NCT00441103|559003579|FG000|Overall Study|Non-compliant|0|||
154884995|NCT00441103|559003580|FG001|Overall Study|Non-compliant|1|||
154884996|NCT00441103|559003579|FG000|Overall Study|Participant decided to withdraw|1|||
154884997|NCT00441103|559003580|FG001|Overall Study|Participant decided to withdraw|0|||
154884998|NCT00441103|559003579|FG000|Overall Study|Participant's reason|0|||
154884999|NCT00441103|559003580|FG001|Overall Study|Participant's reason|1|||
154885000|NCT00441103|559003579|FG000|Overall Study|Participant decided to stop|0|||
154885001|NCT00441103|559003580|FG001|Overall Study|Participant decided to stop|1|||
154885002|NCT02951988|559003581|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
154885003|NCT02951988|559003582|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
154885004|NCT02951988|559003583|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
154885005|NCT02951988|559003584|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
154885006|NCT02951988|559003581|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
154885007|NCT02951988|559003582|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
154885008|NCT02951988|559003583|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
154885009|NCT02951988|559003584|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
154885010|NCT02951988|559003581|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
154885011|NCT02951988|559003582|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
154885012|NCT02951988|559003583|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
154885013|NCT02951988|559003584|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
154885014|NCT02951988|559003581|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
154885015|NCT02951988|559003582|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
154885016|NCT02951988|559003583|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
154885017|NCT02951988|559003584|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
154885018|NCT02951988|559003581|FG000|Open-Label Treatment Period|Protocol Violation|22|||
154885019|NCT02951988|559003582|FG001|Open-Label Treatment Period|Protocol Violation|0|||
154885020|NCT02951988|559003583|FG002|Open-Label Treatment Period|Protocol Violation|0|||
154885021|NCT02951988|559003584|FG003|Open-Label Treatment Period|Protocol Violation|0|||
154885022|NCT02951988|559003581|FG000|Open-Label Treatment Period|Pregnancy|2|||
154885023|NCT02951988|559003582|FG001|Open-Label Treatment Period|Pregnancy|0|||
154885024|NCT02951988|559003583|FG002|Open-Label Treatment Period|Pregnancy|0|||
154885025|NCT02951988|559003584|FG003|Open-Label Treatment Period|Pregnancy|0|||
154885026|NCT02951988|559003581|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
154885027|NCT02951988|559003582|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
154885028|NCT02951988|559003583|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
154885029|NCT02951988|559003584|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
154885030|NCT02951988|559003581|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
154885031|NCT02951988|559003582|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
154885032|NCT02951988|559003583|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
154885033|NCT02951988|559003584|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
154885034|NCT02951988|559003581|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
154885035|NCT02951988|559003582|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
154885036|NCT02951988|559003583|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
154885037|NCT02951988|559003584|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
154885038|NCT02951988|559003581|FG000|Open-Label Treatment Period|Adverse Event|45|||
154885039|NCT02951988|559003582|FG001|Open-Label Treatment Period|Adverse Event|0|||
154885040|NCT02951988|559003583|FG002|Open-Label Treatment Period|Adverse Event|0|||
154885041|NCT02951988|559003584|FG003|Open-Label Treatment Period|Adverse Event|0|||
154885042|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
154885043|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
154885044|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
154885045|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
154885046|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
154885047|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
154885048|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
154885049|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
154885050|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
154885051|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
154885052|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
154885053|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
154885054|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
154885055|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
154885056|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
154885057|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
154885058|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Pregnancy|0|||
154885059|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Pregnancy|1|||
154885060|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Pregnancy|1|||
154885061|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Pregnancy|0|||
154885062|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
154885063|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
154885064|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
154885065|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
154885066|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154885067|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
154885068|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
154885069|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
154885070|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Adverse Event|0|||
154885071|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Adverse Event|8|||
154885072|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Adverse Event|3|||
154885073|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Adverse Event|6|||
154885074|NCT02951988|559003581|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
154976209|NCT00401245|559336718|FG005|Open Label Phase|Withdrawal by Subject|0|||
154976210|NCT00401245|559336719|FG006|Open Label Phase|Withdrawal by Subject|0|||
154976211|NCT00401245|559336720|FG007|Open Label Phase|Withdrawal by Subject|0|||
154976212|NCT00401245|559336713|FG000|Open Label Phase|Lack of Efficacy|4|||
154976213|NCT00401245|559336714|FG001|Open Label Phase|Lack of Efficacy|2|||
154976214|NCT00401245|559336715|FG002|Open Label Phase|Lack of Efficacy|3|||
154976215|NCT00401245|559336716|FG003|Open Label Phase|Lack of Efficacy|0|||
154976216|NCT00401245|559336717|FG004|Open Label Phase|Lack of Efficacy|0|||
154976217|NCT00401245|559336718|FG005|Open Label Phase|Lack of Efficacy|0|||
154976218|NCT00401245|559336719|FG006|Open Label Phase|Lack of Efficacy|0|||
154976219|NCT00401245|559336720|FG007|Open Label Phase|Lack of Efficacy|0|||
154976220|NCT00401245|559336713|FG000|Double Blind Tapering Phase|Adverse Event|0|||
154976221|NCT00401245|559336714|FG001|Double Blind Tapering Phase|Adverse Event|0|||
154976222|NCT00401245|559336715|FG002|Double Blind Tapering Phase|Adverse Event|0|||
154976223|NCT00401245|559336716|FG003|Double Blind Tapering Phase|Adverse Event|0|||
154976224|NCT00401245|559336717|FG004|Double Blind Tapering Phase|Adverse Event|1|||
154976225|NCT00401245|559336718|FG005|Double Blind Tapering Phase|Adverse Event|1|||
154976226|NCT00401245|559336719|FG006|Double Blind Tapering Phase|Adverse Event|2|||
154976227|NCT00401245|559336720|FG007|Double Blind Tapering Phase|Adverse Event|4|||
154976228|NCT00401245|559336713|FG000|Double Blind Tapering Phase|Investigator request|0|||
154976229|NCT00401245|559336714|FG001|Double Blind Tapering Phase|Investigator request|0|||
154976230|NCT00401245|559336715|FG002|Double Blind Tapering Phase|Investigator request|0|||
154976231|NCT00401245|559336716|FG003|Double Blind Tapering Phase|Investigator request|0|||
154976232|NCT00401245|559336717|FG004|Double Blind Tapering Phase|Investigator request|0|||
154976233|NCT00401245|559336718|FG005|Double Blind Tapering Phase|Investigator request|0|||
154976234|NCT00401245|559336719|FG006|Double Blind Tapering Phase|Investigator request|0|||
154976235|NCT00401245|559336720|FG007|Double Blind Tapering Phase|Investigator request|1|||
154976236|NCT00401245|559336713|FG000|Double Blind Tapering Phase|Other|0|||
154976237|NCT00401245|559336714|FG001|Double Blind Tapering Phase|Other|0|||
154976238|NCT00401245|559336715|FG002|Double Blind Tapering Phase|Other|0|||
154976239|NCT00401245|559336716|FG003|Double Blind Tapering Phase|Other|0|||
154976240|NCT00401245|559336717|FG004|Double Blind Tapering Phase|Other|1|||
154976241|NCT00401245|559336718|FG005|Double Blind Tapering Phase|Other|0|||
154976242|NCT00401245|559336719|FG006|Double Blind Tapering Phase|Other|2|||
154976243|NCT00401245|559336720|FG007|Double Blind Tapering Phase|Other|2|||
154976244|NCT00401245|559336713|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
154976245|NCT00401245|559336714|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
154976246|NCT00401245|559336715|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
154976247|NCT00401245|559336716|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
154976248|NCT00401245|559336717|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
154976249|NCT00401245|559336718|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
154976250|NCT00401245|559336719|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
154976251|NCT00401245|559336720|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
154976252|NCT00401245|559336713|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976253|NCT00401245|559336714|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976254|NCT00401245|559336715|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976255|NCT00401245|559336716|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976256|NCT00401245|559336717|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976257|NCT00401245|559336718|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
154976258|NCT00401245|559336719|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976259|NCT00401245|559336720|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
154976260|NCT00114231|559336721|FG000|Overall Study|No consent|2|||
155113646|NCT04154605|559844873|FG000|Overall Study|Withdrawal by Subject|1|||
155113647|NCT04154605|559844874|FG001|Overall Study|Withdrawal by Subject|0|||
155113648|NCT00675441|559844875|FG000|Overall Study|Withdrawal by Subject|2|||
155113649|NCT00675441|559844875|FG000|Overall Study|Death|1|||
155113650|NCT03718884|559844880|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
155113651|NCT03718884|559844881|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
155113652|NCT03718884|559844880|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
155113653|NCT03718884|559844881|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
155113654|NCT01818258|559844883|FG000|Overall Study|Death|3|||
155113655|NCT01818258|559844884|FG001|Overall Study|Death|0|||
155113656|NCT01818258|559844883|FG000|Overall Study|Withdrawal by Subject|0|||
155113657|NCT01818258|559844884|FG001|Overall Study|Withdrawal by Subject|1|||
155113658|NCT01818258|559844883|FG000|Overall Study|Lost to Follow-up|0|||
155113659|NCT01818258|559844884|FG001|Overall Study|Lost to Follow-up|1|||
155113660|NCT01818258|559844883|FG000|Overall Study|Unable to Travel to Clinic|0|||
155113661|NCT01818258|559844884|FG001|Overall Study|Unable to Travel to Clinic|1|||
155113662|NCT02099344|559844887|FG000|Overall Study|Physician Decision|1|||
155113663|NCT02099344|559844888|FG001|Overall Study|Physician Decision|0|||
155113664|NCT02839720|559844889|FG000|Overall Study|Adverse Event|2|||
155113665|NCT02839720|559844889|FG000|Overall Study|Non-compliance|2|||
155113666|NCT02839720|559844889|FG000|Overall Study|Intercurrent Illness|1|||
155113667|NCT02839720|559844889|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
155113668|NCT04700540|559844892|FG000|Overall Study|Withdrawal by Subject|12|||
154885075|NCT02951988|559003582|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
154885076|NCT02951988|559003583|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
154885077|NCT02951988|559003584|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
154885078|NCT05836818|559003585|FG000|Overall Study|Physician Decision|1|||
154885079|NCT05836818|559003586|FG001|Overall Study|Physician Decision|1|||
154885080|NCT05836818|559003587|FG002|Overall Study|Physician Decision|0|||
154885081|NCT05836818|559003585|FG000|Overall Study|Withdrawal by Subject|0|||
154885082|NCT05836818|559003586|FG001|Overall Study|Withdrawal by Subject|0|||
154885083|NCT05836818|559003587|FG002|Overall Study|Withdrawal by Subject|1|||
154885084|NCT05836818|559003585|FG000|Overall Study|Later found to be previously vaccinated|0|||
154885085|NCT05836818|559003586|FG001|Overall Study|Later found to be previously vaccinated|1|||
154885086|NCT05836818|559003587|FG002|Overall Study|Later found to be previously vaccinated|3|||
154885087|NCT05836818|559003585|FG000|Overall Study|Pregnancy|0|||
154885088|NCT05836818|559003586|FG001|Overall Study|Pregnancy|1|||
154885089|NCT05836818|559003587|FG002|Overall Study|Pregnancy|0|||
154885090|NCT05836818|559003585|FG000|Overall Study|Allergic to vaccines|0|||
154885091|NCT05836818|559003586|FG001|Overall Study|Allergic to vaccines|1|||
154885092|NCT05836818|559003587|FG002|Overall Study|Allergic to vaccines|0|||
154885093|NCT03738566|559003588|FG000|Initial Study Phase|Withdrawal by Subject|1|||
154885094|NCT03738566|559003589|FG001|Initial Study Phase|Withdrawal by Subject|1|||
154885095|NCT03738566|559003590|FG002|Initial Study Phase|Withdrawal by Subject|2|||
154885096|NCT03738566|559003591|FG003|Initial Study Phase|Withdrawal by Subject|0|||
154885097|NCT03738566|559003588|FG000|Initial Study Phase|Death|0|||
154885098|NCT03738566|559003589|FG001|Initial Study Phase|Death|1|||
154885099|NCT03738566|559003590|FG002|Initial Study Phase|Death|0|||
154885100|NCT03738566|559003591|FG003|Initial Study Phase|Death|0|||
154885101|NCT03738566|559003588|FG000|Initial Study Phase|Treatment failure|5|||
154885102|NCT03738566|559003589|FG001|Initial Study Phase|Treatment failure|0|||
154885103|NCT03738566|559003590|FG002|Initial Study Phase|Treatment failure|0|||
154885104|NCT03738566|559003591|FG003|Initial Study Phase|Treatment failure|0|||
154885105|NCT03738566|559003588|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
154885106|NCT03738566|559003589|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
154885107|NCT03738566|559003590|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
154885108|NCT03738566|559003591|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
154885109|NCT01627067|559003594|FG000|Overall Study|Screen Failure|1|||
154885110|NCT00516269|559003595|FG000|Overall Study|Adverse Event|2|||
154885111|NCT00516269|559003596|FG001|Overall Study|Adverse Event|1|||
154885112|NCT00516269|559003595|FG000|Overall Study|Lost to Follow-up|0|||
154885113|NCT00516269|559003596|FG001|Overall Study|Lost to Follow-up|1|||
154885114|NCT00516269|559003595|FG000|Overall Study|Protocol Violation|0|||
154976261|NCT00114231|559336722|FG001|Overall Study|No consent|0|||
154976262|NCT00114231|559336721|FG000|Overall Study|QARC requirement not met|1|||
154976263|NCT00114231|559336722|FG001|Overall Study|QARC requirement not met|0|||
154976264|NCT00114231|559336721|FG000|Overall Study|Suspected metastatic disease|1|||
154976265|NCT00114231|559336722|FG001|Overall Study|Suspected metastatic disease|0|||
154976266|NCT00114231|559336721|FG000|Overall Study|No adenocarcinoma|1|||
154976267|NCT00114231|559336722|FG001|Overall Study|No adenocarcinoma|0|||
154976268|NCT00114231|559336721|FG000|Overall Study|Low creatinine clearance|0|||
154976269|NCT00114231|559336722|FG001|Overall Study|Low creatinine clearance|1|||
154976270|NCT00114231|559336721|FG000|Overall Study|Tumor size > 4cm|1|||
154976271|NCT00114231|559336722|FG001|Overall Study|Tumor size > 4cm|0|||
154976272|NCT00114231|559336721|FG000|Overall Study|Tumor fixed on digital exam|0|||
155113669|NCT04700540|559844893|FG001|Overall Study|Withdrawal by Subject|8|||
155113670|NCT04700540|559844892|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
155113671|NCT04700540|559844893|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
155113672|NCT03194568|559844894|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
155113673|NCT03515551|559844899|FG000|Overall Study|Death|4|||
155113674|NCT03515551|559844900|FG001|Overall Study|Death|1|||
155113675|NCT03515551|559844901|FG002|Overall Study|Death|2|||
155113676|NCT03515551|559844902|FG003|Overall Study|Death|2|||
155113677|NCT03515551|559844903|FG004|Overall Study|Death|2|||
155113678|NCT03515551|559844904|FG005|Overall Study|Death|4|||
155113679|NCT03515551|559844905|FG006|Overall Study|Death|1|||
155113680|NCT03515551|559844899|FG000|Overall Study|Lost to Follow-up|0|||
155113681|NCT03515551|559844900|FG001|Overall Study|Lost to Follow-up|0|||
155113682|NCT03515551|559844901|FG002|Overall Study|Lost to Follow-up|1|||
155113683|NCT03515551|559844902|FG003|Overall Study|Lost to Follow-up|0|||
155113684|NCT03515551|559844903|FG004|Overall Study|Lost to Follow-up|0|||
155113685|NCT03515551|559844904|FG005|Overall Study|Lost to Follow-up|0|||
155113686|NCT03515551|559844905|FG006|Overall Study|Lost to Follow-up|0|||
155113687|NCT03515551|559844899|FG000|Overall Study|Withdrawal by Subject|0|||
155113688|NCT03515551|559844900|FG001|Overall Study|Withdrawal by Subject|1|||
155113689|NCT03515551|559844901|FG002|Overall Study|Withdrawal by Subject|0|||
155113690|NCT03515551|559844902|FG003|Overall Study|Withdrawal by Subject|0|||
155113691|NCT03515551|559844903|FG004|Overall Study|Withdrawal by Subject|0|||
154976273|NCT00114231|559336722|FG001|Overall Study|Tumor fixed on digital exam|1|||
154976274|NCT00114231|559336721|FG000|Overall Study|No Absolute Neutrophil Count|2|||
154976275|NCT00114231|559336722|FG001|Overall Study|No Absolute Neutrophil Count|0|||
154976276|NCT00114231|559336721|FG000|Overall Study|Biopsy done after registration|1|||
154976277|NCT00114231|559336722|FG001|Overall Study|Biopsy done after registration|0|||
154976278|NCT03710590|559336723|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
154976279|NCT03710590|559336724|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
154976280|NCT02488824|559336725|FG000|Overall Study|Adverse Event|1|||
154976281|NCT02488824|559336726|FG001|Overall Study|Adverse Event|1|||
154976282|NCT00412737|559336730|FG000|Overall Study|Death|1|||
154976283|NCT00412737|559336731|FG001|Overall Study|Death|0|||
154976284|NCT00412737|559336730|FG000|Overall Study|Adverse Event|3|||
154976285|NCT00412737|559336731|FG001|Overall Study|Adverse Event|2|||
154976286|NCT00412737|559336730|FG000|Overall Study|Refused Treatment|6|||
154976287|NCT00412737|559336731|FG001|Overall Study|Refused Treatment|2|||
154976288|NCT00412737|559336730|FG000|Overall Study|Failure to Return|6|||
154976289|NCT00412737|559336731|FG001|Overall Study|Failure to Return|2|||
154976290|NCT04364737|559336740|FG000|Overall Study|Withdrawal by Subject|4|||
154976291|NCT04364737|559336741|FG001|Overall Study|Withdrawal by Subject|9|||
154976292|NCT04364737|559336740|FG000|Overall Study|Lost to Follow-up|1|||
154976293|NCT04364737|559336741|FG001|Overall Study|Lost to Follow-up|1|||
154976294|NCT01220609|559336742|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
154976295|NCT01220609|559336742|FG000|Overall Study|Ineligible- Wrong cell type|1|||
154976296|NCT01220609|559336742|FG000|Overall Study|Ineligible-Never treated|1|||
154976297|NCT00112294|559336743|FG000|Overall Study|Still on study|5|||
154976298|NCT00112294|559336744|FG001|Overall Study|Still on study|0|||
154976299|NCT04205162|559336753|FG000|Overall Study|Lost to Follow-up|1|||
154976300|NCT04205162|559336754|FG001|Overall Study|Lost to Follow-up|0|||
154976301|NCT04205162|559336753|FG000|Overall Study|Withdrawal by Subject|2|||
154976302|NCT04205162|559336754|FG001|Overall Study|Withdrawal by Subject|0|||
154976303|NCT04205162|559336753|FG000|Overall Study|University closure due to COVID-19|1|||
154976304|NCT04205162|559336754|FG001|Overall Study|University closure due to COVID-19|0|||
154976305|NCT00372996|559336756|FG000|Overall Study|Death|11|||
154976306|NCT00372996|559336757|FG001|Overall Study|Death|4|||
154976307|NCT00372996|559336758|FG002|Overall Study|Death|8|||
154976308|NCT00372996|559336759|FG003|Overall Study|Death|7|||
154976309|NCT00372996|559336756|FG000|Overall Study|Lost to Follow-up|0|||
154976310|NCT00372996|559336757|FG001|Overall Study|Lost to Follow-up|2|||
154976311|NCT00372996|559336758|FG002|Overall Study|Lost to Follow-up|0|||
154976312|NCT00372996|559336759|FG003|Overall Study|Lost to Follow-up|1|||
154976313|NCT00372996|559336756|FG000|Overall Study|Withdrawal by Subject|12|||
154976314|NCT00372996|559336757|FG001|Overall Study|Withdrawal by Subject|6|||
154976315|NCT00372996|559336758|FG002|Overall Study|Withdrawal by Subject|9|||
154976316|NCT00372996|559336759|FG003|Overall Study|Withdrawal by Subject|5|||
154976317|NCT00372996|559336756|FG000|Overall Study|Study Terminated by Sponsor|4|||
154976318|NCT00372996|559336757|FG001|Overall Study|Study Terminated by Sponsor|0|||
154976319|NCT00372996|559336758|FG002|Overall Study|Study Terminated by Sponsor|4|||
154976320|NCT00372996|559336759|FG003|Overall Study|Study Terminated by Sponsor|0|||
154976321|NCT00372996|559336756|FG000|Overall Study|Other|10|||
154976322|NCT00372996|559336757|FG001|Overall Study|Other|2|||
154976323|NCT00372996|559336758|FG002|Overall Study|Other|7|||
154976324|NCT00372996|559336759|FG003|Overall Study|Other|7|||
154976325|NCT01186016|559336760|FG000|Overall Study|Withdrawal by Subject|46|||
154976326|NCT01186016|559336761|FG001|Overall Study|Withdrawal by Subject|29|||
154976327|NCT01098539|559336763|FG000|Overall Study|Adverse Event|26|||
154976328|NCT01098539|559336764|FG001|Overall Study|Adverse Event|26|||
154976329|NCT01098539|559336763|FG000|Overall Study|Protocol Violation|1|||
154976330|NCT01098539|559336764|FG001|Overall Study|Protocol Violation|4|||
154976331|NCT01098539|559336763|FG000|Overall Study|Noncompliance|3|||
154976332|NCT01098539|559336764|FG001|Overall Study|Noncompliance|5|||
154976333|NCT01098539|559336763|FG000|Overall Study|Lost to Follow-up|4|||
154976334|NCT01098539|559336764|FG001|Overall Study|Lost to Follow-up|4|||
154976335|NCT01098539|559336763|FG000|Overall Study|Withdrawal by Subject|12|||
154976336|NCT01098539|559336764|FG001|Overall Study|Withdrawal by Subject|26|||
154976337|NCT01098539|559336763|FG000|Overall Study|Physician Decision|5|||
154976338|NCT01098539|559336764|FG001|Overall Study|Physician Decision|3|||
154976339|NCT01386125|559336765|FG000|Overall Study|Lost to Follow-up|3|||
154976340|NCT01386125|559336766|FG001|Overall Study|Lost to Follow-up|9|||
154976341|NCT01386125|559336765|FG000|Overall Study|Physician Decision|0|||
154976342|NCT01386125|559336766|FG001|Overall Study|Physician Decision|1|||
154976343|NCT01386125|559336765|FG000|Overall Study|Protocol Violation|5|||
154976344|NCT01386125|559336766|FG001|Overall Study|Protocol Violation|7|||
154976345|NCT01386125|559336765|FG000|Overall Study|Disease Progress|1|||
154976346|NCT01386125|559336766|FG001|Overall Study|Disease Progress|2|||
154976347|NCT01386125|559336765|FG000|Overall Study|Withdrawal by Subject|13|||
154976348|NCT01386125|559336766|FG001|Overall Study|Withdrawal by Subject|12|||
154976349|NCT01386125|559336765|FG000|Overall Study|Adverse Event|2|||
154976350|NCT01386125|559336766|FG001|Overall Study|Adverse Event|5|||
154885115|NCT00516269|559003596|FG001|Overall Study|Protocol Violation|1|||
154885116|NCT04570657|559003598|FG000|Overall Study|Adverse Event|0|||
154885117|NCT04570657|559003599|FG001|Overall Study|Adverse Event|0|||
154885118|NCT04570657|559003600|FG002|Overall Study|Adverse Event|1|||
154885119|NCT04570657|559003598|FG000|Overall Study|Lost to Follow-up|0|||
154885120|NCT04570657|559003599|FG001|Overall Study|Lost to Follow-up|0|||
154885121|NCT04570657|559003600|FG002|Overall Study|Lost to Follow-up|1|||
154885122|NCT04570657|559003598|FG000|Overall Study|Physician Decision|0|||
154885123|NCT04570657|559003599|FG001|Overall Study|Physician Decision|1|||
154885124|NCT04570657|559003600|FG002|Overall Study|Physician Decision|0|||
154885125|NCT04570657|559003598|FG000|Overall Study|Withdrawal by Subject|1|||
154885126|NCT04570657|559003599|FG001|Overall Study|Withdrawal by Subject|2|||
154885127|NCT04570657|559003600|FG002|Overall Study|Withdrawal by Subject|2|||
154885128|NCT01079962|559003601|FG000|Overall Study|Adverse Event|2|||
154885129|NCT01079962|559003602|FG001|Overall Study|Adverse Event|2|||
154885130|NCT01079962|559003601|FG000|Overall Study|Withdrawal by Subject|5|||
154885131|NCT01079962|559003602|FG001|Overall Study|Withdrawal by Subject|7|||
154885132|NCT01079962|559003601|FG000|Overall Study|Protocol Violation|2|||
154885133|NCT01079962|559003602|FG001|Overall Study|Protocol Violation|2|||
154885134|NCT01079962|559003601|FG000|Overall Study|No blood pressure (BP) control|3|||
154885135|NCT01079962|559003602|FG001|Overall Study|No blood pressure (BP) control|0|||
154885136|NCT01079962|559003601|FG000|Overall Study|Inclusion/exclusion criteria|1|||
154885137|NCT01079962|559003602|FG001|Overall Study|Inclusion/exclusion criteria|3|||
154885138|NCT01079962|559003601|FG000|Overall Study|Participant not returning for next visit|1|||
154885139|NCT01079962|559003602|FG001|Overall Study|Participant not returning for next visit|0|||
154885140|NCT01079962|559003601|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
154885141|NCT01079962|559003602|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
154885142|NCT01072539|559003603|FG000|Overall Study|Treated prior to the Site Initiation|1|||
154885143|NCT01072539|559003603|FG000|Overall Study|Protocol Violation|2|||
154885144|NCT01331239|559003604|FG000|Part II: Core Study|Adverse Event|0|||
154885145|NCT01331239|559003605|FG001|Part II: Core Study|Adverse Event|3|||
154885146|NCT01331239|559003606|FG002|Part II: Core Study|Adverse Event|0|||
154885147|NCT01331239|559003604|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
154885148|NCT01331239|559003605|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
154885149|NCT01331239|559003606|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
154885150|NCT01331239|559003604|FG000|Part II: Core Study|Withdrawal by Subject|0|||
154885151|NCT01331239|559003605|FG001|Part II: Core Study|Withdrawal by Subject|2|||
154885152|NCT01331239|559003606|FG002|Part II: Core Study|Withdrawal by Subject|0|||
154885153|NCT01331239|559003604|FG000|Part II: Core Study|Administrative problems|0|||
154885154|NCT01331239|559003605|FG001|Part II: Core Study|Administrative problems|1|||
154885155|NCT01331239|559003606|FG002|Part II: Core Study|Administrative problems|0|||
154885156|NCT01008995|559003607|FG000|Controlled Period|Adverse Event|1|||
154885157|NCT01008995|559003608|FG001|Controlled Period|Adverse Event|2|||
154885158|NCT01008995|559003609|FG002|Controlled Period|Adverse Event|0|||
154885159|NCT01008995|559003610|FG003|Controlled Period|Adverse Event|0|||
154885160|NCT01008995|559003607|FG000|Controlled Period|Other|2|||
154885161|NCT01008995|559003608|FG001|Controlled Period|Other|1|||
154885162|NCT01008995|559003609|FG002|Controlled Period|Other|0|||
154885163|NCT01008995|559003610|FG003|Controlled Period|Other|0|||
154885164|NCT01008995|559003607|FG000|After Controlled Period|Adverse Event|0|||
154885165|NCT01008995|559003608|FG001|After Controlled Period|Adverse Event|0|||
154885166|NCT01008995|559003609|FG002|After Controlled Period|Adverse Event|1|||
154885167|NCT01008995|559003610|FG003|After Controlled Period|Adverse Event|1|||
154885168|NCT01008995|559003607|FG000|After Controlled Period|Other|0|||
154885169|NCT01008995|559003608|FG001|After Controlled Period|Other|0|||
154885170|NCT01008995|559003609|FG002|After Controlled Period|Other|1|||
154885171|NCT01008995|559003610|FG003|After Controlled Period|Other|0|||
154885172|NCT04167306|559003611|FG000|Overall Study|Lost to Follow-up|2|||
154885173|NCT04167306|559003612|FG001|Overall Study|Lost to Follow-up|2|||
154885174|NCT04167306|559003613|FG002|Overall Study|Lost to Follow-up|5|||
154885175|NCT04167306|559003614|FG003|Overall Study|Lost to Follow-up|5|||
154885176|NCT04167306|559003611|FG000|Overall Study|Adverse Event|13|||
154885177|NCT04167306|559003612|FG001|Overall Study|Adverse Event|14|||
154885178|NCT04167306|559003613|FG002|Overall Study|Adverse Event|5|||
154885179|NCT04167306|559003614|FG003|Overall Study|Adverse Event|4|||
154885180|NCT04167306|559003611|FG000|Overall Study|Withdrawal by Subject|4|||
154885181|NCT04167306|559003612|FG001|Overall Study|Withdrawal by Subject|6|||
154885182|NCT04167306|559003613|FG002|Overall Study|Withdrawal by Subject|8|||
154885183|NCT04167306|559003614|FG003|Overall Study|Withdrawal by Subject|3|||
154885184|NCT04167306|559003611|FG000|Overall Study|covid|1|||
154885185|NCT04167306|559003612|FG001|Overall Study|covid|1|||
154885186|NCT04167306|559003613|FG002|Overall Study|covid|2|||
154885187|NCT04167306|559003614|FG003|Overall Study|covid|1|||
154885188|NCT04167306|559003611|FG000|Overall Study|concomitant medication|0|||
154976351|NCT01386125|559336765|FG000|Overall Study|Lack of Efficacy|0|||
154976352|NCT01386125|559336766|FG001|Overall Study|Lack of Efficacy|1|||
154976353|NCT01386125|559336765|FG000|Overall Study|Participant Leaving Country|1|||
154976354|NCT01386125|559336766|FG001|Overall Study|Participant Leaving Country|0|||
154976355|NCT03173560|559336767|FG000|Overall Study|Death|70|||
154976356|NCT03173560|559336768|FG001|Overall Study|Death|60|||
154976357|NCT03173560|559336767|FG000|Overall Study|Lost to Follow-up|1|||
154976358|NCT03173560|559336768|FG001|Overall Study|Lost to Follow-up|4|||
154976359|NCT03173560|559336767|FG000|Overall Study|Withdrawal by Subject|10|||
154976360|NCT03173560|559336768|FG001|Overall Study|Withdrawal by Subject|5|||
154976361|NCT03173560|559336767|FG000|Overall Study|Other|0|||
154885189|NCT04167306|559003612|FG001|Overall Study|concomitant medication|0|||
154885190|NCT04167306|559003613|FG002|Overall Study|concomitant medication|0|||
154885191|NCT04167306|559003614|FG003|Overall Study|concomitant medication|1|||
154885192|NCT04167306|559003611|FG000|Overall Study|Alcohol treatment|0|||
154885193|NCT04167306|559003612|FG001|Overall Study|Alcohol treatment|4|||
154885194|NCT04167306|559003613|FG002|Overall Study|Alcohol treatment|3|||
154885195|NCT04167306|559003614|FG003|Overall Study|Alcohol treatment|2|||
154885196|NCT04167306|559003611|FG000|Overall Study|non-compliance|0|||
154885197|NCT04167306|559003612|FG001|Overall Study|non-compliance|0|||
154885198|NCT04167306|559003613|FG002|Overall Study|non-compliance|1|||
154885199|NCT04167306|559003614|FG003|Overall Study|non-compliance|0|||
154885200|NCT04167306|559003611|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
154885201|NCT04167306|559003612|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
154885202|NCT04167306|559003613|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
154885203|NCT04167306|559003614|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
154885204|NCT03731364|559003617|FG000|Overall Study|Adverse Event|0|||
154885205|NCT03731364|559003618|FG001|Overall Study|Adverse Event|0|||
154885206|NCT03731364|559003619|FG002|Overall Study|Adverse Event|1|||
154885207|NCT03731364|559003620|FG003|Overall Study|Adverse Event|2|||
154885208|NCT03731364|559003621|FG004|Overall Study|Adverse Event|1|||
154885209|NCT01934192|559003624|FG000|Overall Study|Protocol Violation|0|||
154885210|NCT01934192|559003625|FG001|Overall Study|Protocol Violation|0|||
154885211|NCT01934192|559003626|FG002|Overall Study|Protocol Violation|0|||
154885212|NCT01934192|559003627|FG003|Overall Study|Protocol Violation|1|||
154885213|NCT01934192|559003624|FG000|Overall Study|Other: reached stopping criteria|6|||
154885214|NCT01934192|559003625|FG001|Overall Study|Other: reached stopping criteria|5|||
154885215|NCT01934192|559003626|FG002|Overall Study|Other: reached stopping criteria|1|||
154885216|NCT01934192|559003627|FG003|Overall Study|Other: reached stopping criteria|0|||
154885217|NCT01934192|559003624|FG000|Overall Study|Physician Decision|3|||
154885218|NCT01934192|559003625|FG001|Overall Study|Physician Decision|2|||
154885219|NCT01934192|559003626|FG002|Overall Study|Physician Decision|0|||
154885220|NCT01934192|559003627|FG003|Overall Study|Physician Decision|0|||
154885221|NCT01189435|559003628|FG000|Overall Study|Withdrawal by Subject|1|||
154885222|NCT01189435|559003628|FG000|Overall Study|Physician Decision|1|||
154885223|NCT00403559|559003629|FG000|Overall Study|Adverse Event|0|||
154885224|NCT00403559|559003630|FG001|Overall Study|Adverse Event|1|||
154885225|NCT00403559|559003629|FG000|Overall Study|Lost to Follow-up|3|||
154885226|NCT00403559|559003630|FG001|Overall Study|Lost to Follow-up|3|||
154885227|NCT00403559|559003629|FG000|Overall Study|Withdrawal by Subject|1|||
154885228|NCT00403559|559003630|FG001|Overall Study|Withdrawal by Subject|0|||
154885229|NCT00547378|559003631|FG000|Randomized Cohort|Withdrawal by Subject|7|||
154885230|NCT00547378|559003632|FG001|Randomized Cohort|Withdrawal by Subject|5|||
154885231|NCT00547378|559003633|FG002|Randomized Cohort|Withdrawal by Subject|0|||
154885232|NCT00547378|559003631|FG000|Randomized Cohort|Death|0|||
154976362|NCT03173560|559336768|FG001|Overall Study|Other|1|||
154976363|NCT02359864|559336769|FG000|Overall Study|Withdrawal by Subject|1|||
154976364|NCT02359864|559336770|FG001|Overall Study|Withdrawal by Subject|0|||
154976365|NCT00725764|559336771|FG000|Overall Study|Withdrawal by Subject|2|||
154976366|NCT00725764|559336771|FG000|Overall Study|Physician Decision|1|||
154976367|NCT00725764|559336771|FG000|Overall Study|Progressive Disease|7|||
154976368|NCT00725764|559336771|FG000|Overall Study|Lost to Follow-up|1|||
154976369|NCT00725764|559336771|FG000|Overall Study|Death|1|||
154885233|NCT00547378|559003632|FG001|Randomized Cohort|Death|1|||
154885234|NCT00547378|559003633|FG002|Randomized Cohort|Death|0|||
154885235|NCT00547378|559003631|FG000|Randomized Cohort|Lost to Follow-up|1|||
154885236|NCT00547378|559003632|FG001|Randomized Cohort|Lost to Follow-up|0|||
154885237|NCT00547378|559003633|FG002|Randomized Cohort|Lost to Follow-up|0|||
154885238|NCT00547378|559003631|FG000|Randomized Cohort|Adverse Event|1|||
154885239|NCT00547378|559003632|FG001|Randomized Cohort|Adverse Event|0|||
154885240|NCT00547378|559003633|FG002|Randomized Cohort|Adverse Event|0|||
154976370|NCT00725764|559336771|FG000|Overall Study|Participant non compliant with protocol|1|||
154885241|NCT00547378|559003631|FG000|Randomized Cohort|Other reasons|2|||
154885242|NCT00547378|559003632|FG001|Randomized Cohort|Other reasons|0|||
154885243|NCT00547378|559003633|FG002|Randomized Cohort|Other reasons|0|||
154976371|NCT00725764|559336771|FG000|Overall Study|Decline in performance status|1|||
154976372|NCT04480307|559336772|FG000|Overall Study|Withdrawal by Subject|0|||
154976373|NCT04480307|559336773|FG001|Overall Study|Withdrawal by Subject|1|||
154885244|NCT00547378|559003631|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
154885245|NCT00547378|559003632|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
154885246|NCT00547378|559003633|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
154885247|NCT00547378|559003631|FG000|All Implanted Cohort|Adverse Event|4|||
154885248|NCT00547378|559003632|FG001|All Implanted Cohort|Adverse Event|10|||
154885249|NCT00547378|559003633|FG002|All Implanted Cohort|Adverse Event|17|||
154885250|NCT00547378|559003631|FG000|All Implanted Cohort|Lost to Follow-up|0|||
154885251|NCT00547378|559003632|FG001|All Implanted Cohort|Lost to Follow-up|1|||
154885252|NCT00547378|559003633|FG002|All Implanted Cohort|Lost to Follow-up|14|||
154885253|NCT00547378|559003631|FG000|All Implanted Cohort|Death|3|||
154885254|NCT00547378|559003632|FG001|All Implanted Cohort|Death|1|||
154885255|NCT00547378|559003633|FG002|All Implanted Cohort|Death|4|||
154885256|NCT00547378|559003631|FG000|All Implanted Cohort|Physician Decision|0|||
154885257|NCT00547378|559003632|FG001|All Implanted Cohort|Physician Decision|2|||
154885258|NCT00547378|559003633|FG002|All Implanted Cohort|Physician Decision|6|||
154885259|NCT00547378|559003631|FG000|All Implanted Cohort|Site closure|2|||
154885260|NCT00547378|559003632|FG001|All Implanted Cohort|Site closure|0|||
154885261|NCT00547378|559003633|FG002|All Implanted Cohort|Site closure|1|||
154885262|NCT00547378|559003631|FG000|All Implanted Cohort|Other reasons|1|||
154885263|NCT00547378|559003632|FG001|All Implanted Cohort|Other reasons|0|||
154885264|NCT00547378|559003633|FG002|All Implanted Cohort|Other reasons|1|||
154885265|NCT04105244|559003634|FG000|Overall Study|Withdrawal by Subject|10|||
154885266|NCT04105244|559003635|FG001|Overall Study|Withdrawal by Subject|12|||
154885267|NCT04105244|559003634|FG000|Overall Study|Lost to Follow-up|20|||
154885268|NCT04105244|559003635|FG001|Overall Study|Lost to Follow-up|15|||
154885269|NCT04105244|559003634|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
154885270|NCT04105244|559003635|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
154885271|NCT04105244|559003634|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
154885272|NCT04105244|559003635|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
154885273|NCT02768194|559003636|FG000|Period 1|Adverse Event|0|||
154885274|NCT02768194|559003637|FG001|Period 1|Adverse Event|0|||
154885275|NCT02768194|559003638|FG002|Period 1|Adverse Event|0|||
154885276|NCT02768194|559003639|FG003|Period 1|Adverse Event|1|||
154885277|NCT02768194|559003640|FG004|Period 1|Adverse Event|0|||
154885278|NCT02768194|559003641|FG005|Period 1|Adverse Event|0|||
154885279|NCT02768194|559003636|FG000|Period 2|Other (Reason not specified)|1|||
154885280|NCT02768194|559003637|FG001|Period 2|Other (Reason not specified)|0|||
154885281|NCT02768194|559003638|FG002|Period 2|Other (Reason not specified)|0|||
154885282|NCT02768194|559003639|FG003|Period 2|Other (Reason not specified)|0|||
154885283|NCT02768194|559003640|FG004|Period 2|Other (Reason not specified)|0|||
154885284|NCT02768194|559003641|FG005|Period 2|Other (Reason not specified)|0|||
154885285|NCT02768194|559003636|FG000|Period 3|Other (Reason not specified)|0|||
154885286|NCT02768194|559003637|FG001|Period 3|Other (Reason not specified)|1|||
154885287|NCT02768194|559003638|FG002|Period 3|Other (Reason not specified)|0|||
154885288|NCT02768194|559003639|FG003|Period 3|Other (Reason not specified)|0|||
154885289|NCT02768194|559003640|FG004|Period 3|Other (Reason not specified)|0|||
154885290|NCT02768194|559003641|FG005|Period 3|Other (Reason not specified)|0|||
154885291|NCT04863014|559003642|FG000|Overall Study|Lost to Follow-up|3|||
154885292|NCT04863014|559003643|FG001|Overall Study|Lost to Follow-up|2|||
154885293|NCT04863014|559003642|FG000|Overall Study|Subject Decision|0|||
154885294|NCT04863014|559003643|FG001|Overall Study|Subject Decision|4|||
154885295|NCT04387136|559003644|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
154885296|NCT04387136|559003645|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
154885297|NCT01982773|559003646|FG000|Overall Study|Withdrawal by Subject|1|||
154885298|NCT01982773|559003647|FG001|Overall Study|Withdrawal by Subject|3|||
154885299|NCT01982773|559003646|FG000|Overall Study|Lost to Follow-up|7|||
154885300|NCT01982773|559003647|FG001|Overall Study|Lost to Follow-up|1|||
154885301|NCT01029886|559003650|FG000|Overall Study|Adverse Event|12|||
154885302|NCT01029886|559003651|FG001|Overall Study|Adverse Event|25|||
154885303|NCT01029886|559003650|FG000|Overall Study|Lost to Follow-up|1|||
154885304|NCT01029886|559003651|FG001|Overall Study|Lost to Follow-up|0|||
154885305|NCT01029886|559003650|FG000|Overall Study|Physician Decision|2|||
154885306|NCT01029886|559003651|FG001|Overall Study|Physician Decision|6|||
154885307|NCT01029886|559003650|FG000|Overall Study|Protocol Violation|17|||
155113692|NCT03515551|559844904|FG005|Overall Study|Withdrawal by Subject|0|||
155113693|NCT03515551|559844905|FG006|Overall Study|Withdrawal by Subject|1|||
155113694|NCT03515551|559844899|FG000|Overall Study|Study ended by sponsor|0|||
154885308|NCT01029886|559003651|FG001|Overall Study|Protocol Violation|5|||
154885309|NCT01029886|559003650|FG000|Overall Study|Withdrawal by Subject|8|||
154885310|NCT01029886|559003651|FG001|Overall Study|Withdrawal by Subject|18|||
154885311|NCT01029886|559003650|FG000|Overall Study|Entry Criteria Not Met|13|||
154885312|NCT01029886|559003651|FG001|Overall Study|Entry Criteria Not Met|5|||
154885313|NCT01029886|559003650|FG000|Overall Study|Sponsor Decision|1|||
154885314|NCT01029886|559003651|FG001|Overall Study|Sponsor Decision|0|||
154885315|NCT01029886|559003650|FG000|Overall Study|Loss Glucose Control|7|||
154885316|NCT01029886|559003651|FG001|Overall Study|Loss Glucose Control|1|||
155113695|NCT03515551|559844900|FG001|Overall Study|Study ended by sponsor|0|||
154976374|NCT04480307|559336774|FG002|Overall Study|Withdrawal by Subject|0|||
154976375|NCT04480307|559336775|FG003|Overall Study|Withdrawal by Subject|0|||
154976376|NCT04480307|559336772|FG000|Overall Study|Adverse Event|0|||
154976377|NCT04480307|559336773|FG001|Overall Study|Adverse Event|0|||
154976378|NCT04480307|559336774|FG002|Overall Study|Adverse Event|0|||
154976379|NCT04480307|559336775|FG003|Overall Study|Adverse Event|1|||
154976380|NCT00515216|559336780|FG000|Overall Study|Withdrawal by Subject|1|||
154976381|NCT03023137|559336781|FG000|Overall Study|Multiple pregnancy|2|||
154976382|NCT03023137|559336782|FG001|Overall Study|Multiple pregnancy|4|||
154976383|NCT03023137|559336781|FG000|Overall Study|Lost to Follow-up|1|||
154976384|NCT03023137|559336782|FG001|Overall Study|Lost to Follow-up|1|||
154976385|NCT03023137|559336781|FG000|Overall Study|Protocol Violation|0|||
154976386|NCT03023137|559336782|FG001|Overall Study|Protocol Violation|4|||
154976387|NCT03023137|559336781|FG000|Overall Study|Lost the baby in a car accident|1|||
154976388|NCT03023137|559336782|FG001|Overall Study|Lost the baby in a car accident|0|||
154976389|NCT02250651|559336783|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
154976390|NCT02250651|559336784|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
154976391|NCT02250651|559336785|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
154976392|NCT02250651|559336783|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
154976393|NCT02250651|559336784|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
154976394|NCT02250651|559336785|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
154976395|NCT02250651|559336783|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
154976396|NCT02250651|559336784|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
154976397|NCT02250651|559336785|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
154976398|NCT02250651|559336783|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
154976399|NCT02250651|559336784|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
154976400|NCT02250651|559336785|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
154976401|NCT02250651|559336783|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
154976402|NCT02250651|559336784|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
154976403|NCT02250651|559336785|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
154976404|NCT02250651|559336783|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
154976405|NCT02250651|559336784|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
154976406|NCT02250651|559336785|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
154976407|NCT02250651|559336783|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
154976408|NCT02250651|559336784|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
154976409|NCT02250651|559336785|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
154976410|NCT02250651|559336783|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
154976411|NCT02250651|559336784|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
154976412|NCT02250651|559336785|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
154976413|NCT02250651|559336783|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
154976414|NCT02250651|559336784|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
155175400|NCT04585009|560080238|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175401|NCT04585009|560080239|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175402|NCT04585009|560080240|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175403|NCT04585009|560080241|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175404|NCT04585009|560080242|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175405|NCT04585009|560080243|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175406|NCT04585009|560080244|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
155175407|NCT04585009|560080233|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
155175408|NCT04585009|560080234|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155175409|NCT04585009|560080235|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
154976415|NCT02250651|559336785|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
154976416|NCT02250651|559336783|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
154976417|NCT02250651|559336784|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
154976418|NCT02250651|559336785|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
154976419|NCT02250651|559336783|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
154976420|NCT02250651|559336784|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
154976421|NCT02250651|559336785|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
154976422|NCT02250651|559336783|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
154976423|NCT02250651|559336784|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
154976424|NCT02250651|559336785|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
154976425|NCT02250651|559336783|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
155175410|NCT04585009|560080236|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
154976426|NCT02250651|559336784|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
154976427|NCT02250651|559336785|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
154976428|NCT02250651|559336783|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
154885317|NCT03294681|559003652|FG000|Overall Study|Withdrawal by Subject|1|||
154885318|NCT03089216|559003655|FG000|Overall Study|Adverse Event|0|||
154885319|NCT03089216|559003656|FG001|Overall Study|Adverse Event|0|||
154885320|NCT03089216|559003657|FG002|Overall Study|Adverse Event|0|||
154885321|NCT03089216|559003658|FG003|Overall Study|Adverse Event|1|||
154885322|NCT00417976|559003659|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
154885323|NCT00417976|559003659|FG000|Overall Study|Treatment -related toxicity|2|||
154885324|NCT04501679|559003660|FG000|Overall Study|Pregnancy|0|||
154885325|NCT04501679|559003661|FG001|Overall Study|Pregnancy|1|||
154885326|NCT04501679|559003660|FG000|Overall Study|Adverse Event|4|||
154885327|NCT04501679|559003661|FG001|Overall Study|Adverse Event|2|||
154885328|NCT04501679|559003660|FG000|Overall Study|Withdrawal by Subject|2|||
154885329|NCT04501679|559003661|FG001|Overall Study|Withdrawal by Subject|0|||
154885330|NCT04501679|559003660|FG000|Overall Study|Physician Decision|1|||
154885331|NCT04501679|559003661|FG001|Overall Study|Physician Decision|0|||
154885332|NCT04501679|559003660|FG000|Overall Study|Lost to Follow-up|2|||
154885333|NCT04501679|559003661|FG001|Overall Study|Lost to Follow-up|0|||
154885334|NCT02121756|559003664|FG000|Overall Study|Adverse Event|3|||
154885335|NCT02121756|559003665|FG001|Overall Study|Adverse Event|0|||
154885336|NCT02121756|559003664|FG000|Overall Study|Protocol Violation|1|||
154885337|NCT02121756|559003665|FG001|Overall Study|Protocol Violation|1|||
154885338|NCT02121756|559003664|FG000|Overall Study|Physician Decision|2|||
154885339|NCT02121756|559003665|FG001|Overall Study|Physician Decision|1|||
154885340|NCT00751114|559003666|FG000|Overall Study|Adverse Event|2|||
154885341|NCT00751114|559003667|FG001|Overall Study|Adverse Event|4|||
154885342|NCT00751114|559003666|FG000|Overall Study|Protocol Violation|8|||
154885343|NCT00751114|559003667|FG001|Overall Study|Protocol Violation|9|||
154885344|NCT00751114|559003666|FG000|Overall Study|Withdrawal by Subject|9|||
154885345|NCT00751114|559003667|FG001|Overall Study|Withdrawal by Subject|4|||
154885346|NCT00751114|559003666|FG000|Overall Study|Lost to Follow-up|4|||
154885347|NCT00751114|559003667|FG001|Overall Study|Lost to Follow-up|7|||
154885348|NCT00751114|559003666|FG000|Overall Study|Lack of Efficacy|0|||
154885349|NCT00751114|559003667|FG001|Overall Study|Lack of Efficacy|7|||
154885350|NCT00751114|559003666|FG000|Overall Study|Not Treated|13|||
154885351|NCT00751114|559003667|FG001|Overall Study|Not Treated|1|||
154885352|NCT00751114|559003666|FG000|Overall Study|Out of country for 2 months|1|||
154885353|NCT00751114|559003667|FG001|Overall Study|Out of country for 2 months|0|||
154885354|NCT00751114|559003666|FG000|Overall Study|Move to another city|1|||
154885355|NCT00751114|559003667|FG001|Overall Study|Move to another city|0|||
154885356|NCT02358369|559003668|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
154885357|NCT02358369|559003669|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
154885358|NCT02358369|559003670|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
154885359|NCT02358369|559003671|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
154885360|NCT02358369|559003672|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
154885361|NCT02358369|559003668|FG000|Treatment Period A/B|Adverse Event|0|||
154885362|NCT02358369|559003669|FG001|Treatment Period A/B|Adverse Event|0|||
154885363|NCT02358369|559003670|FG002|Treatment Period A/B|Adverse Event|1|||
154885364|NCT02358369|559003671|FG003|Treatment Period A/B|Adverse Event|2|||
154885365|NCT02358369|559003672|FG004|Treatment Period A/B|Adverse Event|0|||
154885366|NCT02358369|559003668|FG000|Treatment Period A/B|Death|0|||
154885367|NCT02358369|559003669|FG001|Treatment Period A/B|Death|0|||
154885368|NCT02358369|559003670|FG002|Treatment Period A/B|Death|1|||
154885369|NCT02358369|559003671|FG003|Treatment Period A/B|Death|0|||
154885370|NCT02358369|559003672|FG004|Treatment Period A/B|Death|0|||
154885371|NCT02358369|559003668|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
154885372|NCT02358369|559003669|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
154885373|NCT02358369|559003670|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
154885374|NCT02358369|559003671|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
154885375|NCT02358369|559003672|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
154885376|NCT02358369|559003668|FG000|Treatment Period C|Adverse Event|0|||
155113696|NCT03515551|559844901|FG002|Overall Study|Study ended by sponsor|2|||
155113697|NCT03515551|559844902|FG003|Overall Study|Study ended by sponsor|1|||
155113698|NCT03515551|559844903|FG004|Overall Study|Study ended by sponsor|3|||
154885377|NCT02358369|559003669|FG001|Treatment Period C|Adverse Event|0|||
154885378|NCT02358369|559003670|FG002|Treatment Period C|Adverse Event|0|||
154885379|NCT02358369|559003671|FG003|Treatment Period C|Adverse Event|0|||
154885380|NCT02358369|559003672|FG004|Treatment Period C|Adverse Event|7|||
155113699|NCT03515551|559844904|FG005|Overall Study|Study ended by sponsor|0|||
154885381|NCT01536119|559003675|FG000|Overall Study|Lost to Follow-up|17|||
154885382|NCT01536119|559003676|FG001|Overall Study|Lost to Follow-up|14|||
154885383|NCT04191577|559003677|FG000|Overall Study|Withdrawal by Subject|2|||
154885384|NCT04191577|559003678|FG001|Overall Study|Withdrawal by Subject|2|||
154885385|NCT04191577|559003679|FG002|Overall Study|Withdrawal by Subject|1|||
154885386|NCT04191577|559003677|FG000|Overall Study|Physician Decision|1|||
154885387|NCT04191577|559003678|FG001|Overall Study|Physician Decision|1|||
154885388|NCT04191577|559003679|FG002|Overall Study|Physician Decision|0|||
155113700|NCT03515551|559844905|FG006|Overall Study|Study ended by sponsor|3|||
154976429|NCT02250651|559336784|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
154976430|NCT02250651|559336785|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
154976431|NCT02250651|559336783|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
154976432|NCT02250651|559336784|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
154976433|NCT02250651|559336785|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
154976434|NCT00732160|559336789|FG000|Overall Study|Adverse Event|1|||
154976435|NCT00732160|559336790|FG001|Overall Study|Adverse Event|0|||
154976436|NCT00732160|559336791|FG002|Overall Study|Adverse Event|1|||
154976437|NCT00732160|559336792|FG003|Overall Study|Adverse Event|1|||
154976438|NCT00732160|559336789|FG000|Overall Study|scheduling|4|||
154976439|NCT00732160|559336790|FG001|Overall Study|scheduling|4|||
154976440|NCT00732160|559336791|FG002|Overall Study|scheduling|2|||
154976441|NCT00732160|559336792|FG003|Overall Study|scheduling|1|||
154976442|NCT00676494|559336793|FG000|Overall Study|Missed Visit|8|||
154976443|NCT00676494|559336793|FG000|Overall Study|Withdrawal by Subject|6|||
154976444|NCT02795676|559336794|FG000|Overall Study|Adverse Event|2|||
154976445|NCT02795676|559336795|FG001|Overall Study|Adverse Event|0|||
154976446|NCT02795676|559336794|FG000|Overall Study|Withdrawal by Subject|3|||
154976447|NCT02795676|559336795|FG001|Overall Study|Withdrawal by Subject|1|||
154976448|NCT02058160|559336796|FG000|Overall Study|Randomized but not treated|2|||
154976449|NCT02058160|559336797|FG001|Overall Study|Randomized but not treated|4|||
154976450|NCT02058160|559336796|FG000|Overall Study|Poor compliance to protocol|4|||
154976451|NCT02058160|559336797|FG001|Overall Study|Poor compliance to protocol|1|||
154976452|NCT02058160|559336796|FG000|Overall Study|Adverse Event|12|||
154976453|NCT02058160|559336797|FG001|Overall Study|Adverse Event|3|||
154976454|NCT02058160|559336796|FG000|Overall Study|Lost to Follow-up|1|||
154976455|NCT02058160|559336797|FG001|Overall Study|Lost to Follow-up|0|||
154976456|NCT02058160|559336796|FG000|Overall Study|Other than specified above|12|||
154976457|NCT02058160|559336797|FG001|Overall Study|Other than specified above|6|||
154976458|NCT01203917|559336798|FG000|Overall Study|Death|29|||
154976459|NCT01203917|559336798|FG000|Overall Study|Lost to Follow-up|2|||
154976460|NCT01203917|559336798|FG000|Overall Study|Withdrawal by Subject|3|||
154976461|NCT01203917|559336798|FG000|Overall Study|Due to objective disease progression|1|||
154976462|NCT01203917|559336798|FG000|Overall Study|Due to EGFR M+I patient|1|||
154976463|NCT00152516|559336799|FG000|Overall Study|Adverse Event|18|||
154976464|NCT00152516|559336799|FG000|Overall Study|Lack and Loss of Efficacy|30|||
154976465|NCT00152516|559336799|FG000|Overall Study|Lost to Follow-up|5|||
154976466|NCT00152516|559336799|FG000|Overall Study|Withdrawal by Subject|8|||
154976467|NCT00152516|559336799|FG000|Overall Study|Protocol Violation|3|||
154976468|NCT00152516|559336799|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
154976469|NCT00152516|559336799|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
154976470|NCT00152516|559336799|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
154976471|NCT00152516|559336799|FG000|Overall Study|Other: Non-Compliance|2|||
154976472|NCT00152516|559336799|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
154976473|NCT00152516|559336799|FG000|Overall Study|Other: Moved Out Of State|1|||
154976474|NCT00152516|559336799|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
154976475|NCT00152516|559336799|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
154976476|NCT00090753|559336800|FG000|First Treatment Period|Adverse Event|20|||
154976477|NCT00090753|559336801|FG001|First Treatment Period|Adverse Event|8|||
154976478|NCT00090753|559336800|FG000|First Treatment Period|Death|88|||
154976479|NCT00090753|559336801|FG001|First Treatment Period|Death|62|||
154976480|NCT00090753|559336800|FG000|First Treatment Period|Lack of Efficacy|2|||
154976481|NCT00090753|559336801|FG001|First Treatment Period|Lack of Efficacy|1|||
154976482|NCT00090753|559336800|FG000|First Treatment Period|Refused Treatment|32|||
154976483|NCT00090753|559336801|FG001|First Treatment Period|Refused Treatment|25|||
154976484|NCT00090753|559336800|FG000|First Treatment Period|Lost to Follow-up|4|||
154976485|NCT00090753|559336801|FG001|First Treatment Period|Lost to Follow-up|4|||
154976486|NCT00090753|559336800|FG000|First Treatment Period|Renal Transplant|70|||
154976487|NCT00090753|559336801|FG001|First Treatment Period|Renal Transplant|50|||
154976488|NCT00090753|559336800|FG000|First Treatment Period|Mircera Commercialization|1|||
154976489|NCT00090753|559336801|FG001|First Treatment Period|Mircera Commercialization|0|||
154976490|NCT00090753|559336800|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
154976491|NCT00090753|559336801|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
154976492|NCT00090753|559336800|FG000|Extended Treatment Period|Adverse Event|11|||
154976493|NCT00090753|559336801|FG001|Extended Treatment Period|Adverse Event|0|||
154976494|NCT00090753|559336800|FG000|Extended Treatment Period|Death|58|||
154976495|NCT00090753|559336801|FG001|Extended Treatment Period|Death|30|||
154976496|NCT00090753|559336800|FG000|Extended Treatment Period|Lack of Efficacy|1|||
154976497|NCT00090753|559336801|FG001|Extended Treatment Period|Lack of Efficacy|0|||
154976498|NCT00090753|559336800|FG000|Extended Treatment Period|Refused Treatment|18|||
154976499|NCT00090753|559336801|FG001|Extended Treatment Period|Refused Treatment|12|||
154976500|NCT00090753|559336800|FG000|Extended Treatment Period|Lost to Follow-up|3|||
154976501|NCT00090753|559336801|FG001|Extended Treatment Period|Lost to Follow-up|1|||
154976502|NCT00090753|559336800|FG000|Extended Treatment Period|Renal Transplant|15|||
154885389|NCT04191577|559003677|FG000|Overall Study|Adverse Event|0|||
154885390|NCT04191577|559003678|FG001|Overall Study|Adverse Event|0|||
154885391|NCT04191577|559003679|FG002|Overall Study|Adverse Event|1|||
154885392|NCT04191577|559003677|FG000|Overall Study|Death|0|||
154885393|NCT04191577|559003678|FG001|Overall Study|Death|0|||
154885394|NCT04191577|559003679|FG002|Overall Study|Death|1|||
154885395|NCT00448916|559003680|FG000|Overall Study|Adverse Event|2|||
154885396|NCT00448916|559003681|FG001|Overall Study|Adverse Event|2|||
154885397|NCT00448916|559003682|FG002|Overall Study|Adverse Event|3|||
154885398|NCT00448916|559003683|FG003|Overall Study|Adverse Event|2|||
154885399|NCT00448916|559003680|FG000|Overall Study|Lack of Efficacy|1|||
154885400|NCT00448916|559003681|FG001|Overall Study|Lack of Efficacy|0|||
154885401|NCT00448916|559003682|FG002|Overall Study|Lack of Efficacy|2|||
154885402|NCT00448916|559003683|FG003|Overall Study|Lack of Efficacy|1|||
154885403|NCT00448916|559003680|FG000|Overall Study|Withdrawal by Subject|3|||
154885404|NCT00448916|559003681|FG001|Overall Study|Withdrawal by Subject|3|||
154885405|NCT00448916|559003682|FG002|Overall Study|Withdrawal by Subject|1|||
154885406|NCT00448916|559003683|FG003|Overall Study|Withdrawal by Subject|1|||
154885407|NCT00448916|559003680|FG000|Overall Study|Other|1|||
154885408|NCT00448916|559003681|FG001|Overall Study|Other|0|||
154885409|NCT00448916|559003682|FG002|Overall Study|Other|0|||
154885410|NCT00448916|559003683|FG003|Overall Study|Other|0|||
154885411|NCT00448916|559003680|FG000|Overall Study|Lost to Follow-up|0|||
154885412|NCT00448916|559003681|FG001|Overall Study|Lost to Follow-up|1|||
154885413|NCT00448916|559003682|FG002|Overall Study|Lost to Follow-up|0|||
154885414|NCT00448916|559003683|FG003|Overall Study|Lost to Follow-up|1|||
154885415|NCT00448916|559003680|FG000|Overall Study|Protocol Violation|0|||
154885416|NCT00448916|559003681|FG001|Overall Study|Protocol Violation|0|||
154885417|NCT00448916|559003682|FG002|Overall Study|Protocol Violation|0|||
154885418|NCT00448916|559003683|FG003|Overall Study|Protocol Violation|1|||
154885419|NCT03655717|559003684|FG000|Overall Study|Withdrawal by Subject|4|||
154885420|NCT03655717|559003685|FG001|Overall Study|Withdrawal by Subject|8|||
154885421|NCT03655717|559003686|FG002|Overall Study|Withdrawal by Subject|1|||
154885422|NCT03655717|559003687|FG003|Overall Study|Withdrawal by Subject|0|||
154885423|NCT03655717|559003688|FG004|Overall Study|Withdrawal by Subject|0|||
154885424|NCT03655717|559003689|FG005|Overall Study|Withdrawal by Subject|1|||
154885425|NCT03655717|559003690|FG006|Overall Study|Withdrawal by Subject|3|||
154885426|NCT03655717|559003691|FG007|Overall Study|Withdrawal by Subject|1|||
154885427|NCT03655717|559003692|FG008|Overall Study|Withdrawal by Subject|2|||
154885428|NCT03655717|559003693|FG009|Overall Study|Withdrawal by Subject|0|||
154885429|NCT03655717|559003694|FG010|Overall Study|Withdrawal by Subject|0|||
154885430|NCT03655717|559003695|FG011|Overall Study|Withdrawal by Subject|1|||
154885431|NCT03655717|559003696|FG012|Overall Study|Withdrawal by Subject|0|||
154885432|NCT03655717|559003697|FG013|Overall Study|Withdrawal by Subject|3|||
154885433|NCT03655717|559003698|FG014|Overall Study|Withdrawal by Subject|0|||
154885434|NCT03655717|559003699|FG015|Overall Study|Withdrawal by Subject|1|||
154885435|NCT03655717|559003700|FG016|Overall Study|Withdrawal by Subject|0|||
154885436|NCT03655717|559003701|FG017|Overall Study|Withdrawal by Subject|0|||
154885437|NCT03655717|559003702|FG018|Overall Study|Withdrawal by Subject|1|||
154885438|NCT03655717|559003703|FG019|Overall Study|Withdrawal by Subject|0|||
154885439|NCT03655717|559003704|FG020|Overall Study|Withdrawal by Subject|0|||
154885440|NCT03655717|559003705|FG021|Overall Study|Withdrawal by Subject|1|||
154885441|NCT03655717|559003706|FG022|Overall Study|Withdrawal by Subject|2|||
154885442|NCT03655717|559003707|FG023|Overall Study|Withdrawal by Subject|1|||
154885443|NCT03655717|559003708|FG024|Overall Study|Withdrawal by Subject|1|||
154885444|NCT03655717|559003709|FG025|Overall Study|Withdrawal by Subject|0|||
154885445|NCT03655717|559003684|FG000|Overall Study|Physician Decision|3|||
154885446|NCT03655717|559003685|FG001|Overall Study|Physician Decision|3|||
154885447|NCT03655717|559003686|FG002|Overall Study|Physician Decision|0|||
154885448|NCT03655717|559003687|FG003|Overall Study|Physician Decision|0|||
154885449|NCT03655717|559003688|FG004|Overall Study|Physician Decision|0|||
154885450|NCT03655717|559003689|FG005|Overall Study|Physician Decision|0|||
154885451|NCT03655717|559003690|FG006|Overall Study|Physician Decision|0|||
154885452|NCT03655717|559003691|FG007|Overall Study|Physician Decision|0|||
154976503|NCT00090753|559336801|FG001|Extended Treatment Period|Renal Transplant|12|||
154885453|NCT03655717|559003692|FG008|Overall Study|Physician Decision|0|||
154885454|NCT03655717|559003693|FG009|Overall Study|Physician Decision|1|||
154885455|NCT03655717|559003694|FG010|Overall Study|Physician Decision|0|||
154885456|NCT03655717|559003695|FG011|Overall Study|Physician Decision|0|||
154885457|NCT03655717|559003696|FG012|Overall Study|Physician Decision|0|||
154885458|NCT03655717|559003697|FG013|Overall Study|Physician Decision|0|||
154885459|NCT03655717|559003698|FG014|Overall Study|Physician Decision|0|||
154885460|NCT03655717|559003699|FG015|Overall Study|Physician Decision|0|||
154885461|NCT03655717|559003700|FG016|Overall Study|Physician Decision|0|||
154885462|NCT03655717|559003701|FG017|Overall Study|Physician Decision|0|||
154885463|NCT03655717|559003702|FG018|Overall Study|Physician Decision|0|||
154885464|NCT03655717|559003703|FG019|Overall Study|Physician Decision|1|||
154885465|NCT03655717|559003704|FG020|Overall Study|Physician Decision|0|||
154885466|NCT03655717|559003705|FG021|Overall Study|Physician Decision|0|||
154885467|NCT03655717|559003706|FG022|Overall Study|Physician Decision|0|||
154885468|NCT03655717|559003707|FG023|Overall Study|Physician Decision|1|||
154885469|NCT03655717|559003708|FG024|Overall Study|Physician Decision|0|||
154885470|NCT03655717|559003709|FG025|Overall Study|Physician Decision|0|||
154885471|NCT03655717|559003684|FG000|Overall Study|Lost to Follow-up|3|||
154885472|NCT03655717|559003685|FG001|Overall Study|Lost to Follow-up|1|||
154885473|NCT03655717|559003686|FG002|Overall Study|Lost to Follow-up|0|||
154885474|NCT03655717|559003687|FG003|Overall Study|Lost to Follow-up|1|||
154885475|NCT03655717|559003688|FG004|Overall Study|Lost to Follow-up|0|||
154885476|NCT03655717|559003689|FG005|Overall Study|Lost to Follow-up|1|||
154885477|NCT03655717|559003690|FG006|Overall Study|Lost to Follow-up|0|||
154885478|NCT03655717|559003691|FG007|Overall Study|Lost to Follow-up|0|||
154885479|NCT03655717|559003692|FG008|Overall Study|Lost to Follow-up|0|||
154885480|NCT03655717|559003693|FG009|Overall Study|Lost to Follow-up|0|||
154885481|NCT03655717|559003694|FG010|Overall Study|Lost to Follow-up|0|||
154885482|NCT03655717|559003695|FG011|Overall Study|Lost to Follow-up|1|||
154885483|NCT03655717|559003696|FG012|Overall Study|Lost to Follow-up|0|||
154885484|NCT03655717|559003697|FG013|Overall Study|Lost to Follow-up|0|||
154885485|NCT03655717|559003698|FG014|Overall Study|Lost to Follow-up|0|||
154885486|NCT03655717|559003699|FG015|Overall Study|Lost to Follow-up|0|||
154885487|NCT03655717|559003700|FG016|Overall Study|Lost to Follow-up|0|||
154885488|NCT03655717|559003701|FG017|Overall Study|Lost to Follow-up|0|||
154885489|NCT03655717|559003702|FG018|Overall Study|Lost to Follow-up|0|||
154885490|NCT03655717|559003703|FG019|Overall Study|Lost to Follow-up|0|||
154885491|NCT03655717|559003704|FG020|Overall Study|Lost to Follow-up|0|||
154885492|NCT03655717|559003705|FG021|Overall Study|Lost to Follow-up|0|||
154885493|NCT03655717|559003706|FG022|Overall Study|Lost to Follow-up|0|||
154885494|NCT03655717|559003707|FG023|Overall Study|Lost to Follow-up|0|||
154885495|NCT03655717|559003708|FG024|Overall Study|Lost to Follow-up|0|||
154885496|NCT03655717|559003709|FG025|Overall Study|Lost to Follow-up|0|||
154885497|NCT02365584|559003710|FG000|Overall Study|Adverse Event|2|||
154885498|NCT02365584|559003711|FG001|Overall Study|Adverse Event|2|||
154885499|NCT02365584|559003710|FG000|Overall Study|Withdrawal by Subject|1|||
154885500|NCT02365584|559003711|FG001|Overall Study|Withdrawal by Subject|0|||
154885501|NCT02365584|559003710|FG000|Overall Study|Disease Progression|9|||
154885502|NCT02365584|559003711|FG001|Overall Study|Disease Progression|12|||
154885503|NCT01185249|559003712|FG000|Overall Study|Patients discharged or change in status|42|||
154885504|NCT01973452|559003713|FG000|Overall Study|Lack of Efficacy|0|||
154885505|NCT01973452|559003714|FG001|Overall Study|Lack of Efficacy|1|||
154885506|NCT01973452|559003713|FG000|Overall Study|Lost to Follow-up|1|||
154885507|NCT01973452|559003714|FG001|Overall Study|Lost to Follow-up|0|||
154885508|NCT01973452|559003713|FG000|Overall Study|Withdrawal by Subject|10|||
154885509|NCT01973452|559003714|FG001|Overall Study|Withdrawal by Subject|9|||
154885510|NCT01973452|559003713|FG000|Overall Study|Ineligible|1|||
154885511|NCT01973452|559003714|FG001|Overall Study|Ineligible|1|||
154885512|NCT01973452|559003713|FG000|Overall Study|Surgery canceled by participant|5|||
154885513|NCT01973452|559003714|FG001|Overall Study|Surgery canceled by participant|3|||
154885514|NCT03521193|559003715|FG000|Overall Study|Withdrawal by Subject|8|||
154885515|NCT03521193|559003716|FG001|Overall Study|Withdrawal by Subject|0|||
154885516|NCT03521193|559003715|FG000|Overall Study|non compliant to ASA treatment|8|||
154885517|NCT03521193|559003716|FG001|Overall Study|non compliant to ASA treatment|0|||
154885518|NCT03675737|559003718|FG000|Overall Study|Death|593|||
154885519|NCT03675737|559003719|FG001|Overall Study|Death|660|||
154885520|NCT03675737|559003718|FG000|Overall Study|Lost to Follow-up|1|||
154885521|NCT03675737|559003719|FG001|Overall Study|Lost to Follow-up|5|||
154885522|NCT03675737|559003718|FG000|Overall Study|Physician Decision|1|||
154885523|NCT03675737|559003719|FG001|Overall Study|Physician Decision|0|||
154885524|NCT03675737|559003718|FG000|Overall Study|Withdrawal by Subject|14|||
154885525|NCT03675737|559003719|FG001|Overall Study|Withdrawal by Subject|12|||
154885526|NCT03675737|559003718|FG000|Overall Study|Ongoing in Study|181|||
154885527|NCT03675737|559003719|FG001|Overall Study|Ongoing in Study|112|||
154885528|NCT00369967|559005318|FG000|Overall Study|Lost to Follow-up|23|||
154885529|NCT00369967|559005319|FG001|Overall Study|Lost to Follow-up|12|||
154885530|NCT02226146|559005320|FG000|Overall Study|Received rescue therapy|1|||
154885531|NCT02226146|559005320|FG000|Overall Study|Withdrawal by Subject|2|||
154885532|NCT05464836|559005321|FG000|Overall Study|Progression of Disease|1|||
154885533|NCT05464836|559005321|FG000|Overall Study|Physician Decision|1|||
154885534|NCT02883049|559005322|FG000|Induction|Adverse Event|52|||
154885535|NCT02883049|559005323|FG001|Induction|Adverse Event|2|||
154885536|NCT02883049|559005324|FG002|Induction|Adverse Event|0|||
154885537|NCT02883049|559005325|FG003|Induction|Adverse Event|0|||
154885538|NCT02883049|559005326|FG004|Induction|Adverse Event|0|||
154885539|NCT02883049|559005327|FG005|Induction|Adverse Event|0|||
154885540|NCT02883049|559005328|FG006|Induction|Adverse Event|0|||
154885541|NCT02883049|559005329|FG007|Induction|Adverse Event|0|||
154885542|NCT02883049|559005330|FG008|Induction|Adverse Event|0|||
154885543|NCT02883049|559005331|FG009|Induction|Adverse Event|0|||
154885544|NCT02883049|559005332|FG010|Induction|Adverse Event|0|||
154885545|NCT02883049|559005333|FG011|Induction|Adverse Event|0|||
154885546|NCT02883049|559005334|FG012|Induction|Adverse Event|0|||
154885547|NCT02883049|559005335|FG013|Induction|Adverse Event|0|||
154885548|NCT02883049|559005336|FG014|Induction|Adverse Event|0|||
154885549|NCT02883049|559005337|FG015|Induction|Adverse Event|0|||
154885550|NCT02883049|559005322|FG000|Induction|Death|76|||
154885551|NCT02883049|559005323|FG001|Induction|Death|8|||
154885552|NCT02883049|559005324|FG002|Induction|Death|0|||
154885553|NCT02883049|559005325|FG003|Induction|Death|0|||
154885554|NCT02883049|559005326|FG004|Induction|Death|0|||
154885555|NCT02883049|559005327|FG005|Induction|Death|0|||
154885556|NCT02883049|559005328|FG006|Induction|Death|0|||
154885557|NCT02883049|559005329|FG007|Induction|Death|0|||
154885558|NCT02883049|559005330|FG008|Induction|Death|0|||
154885559|NCT02883049|559005331|FG009|Induction|Death|0|||
154885560|NCT02883049|559005332|FG010|Induction|Death|0|||
154885561|NCT02883049|559005333|FG011|Induction|Death|0|||
154885562|NCT02883049|559005334|FG012|Induction|Death|0|||
154885563|NCT02883049|559005335|FG013|Induction|Death|0|||
154885564|NCT02883049|559005336|FG014|Induction|Death|0|||
154885565|NCT02883049|559005337|FG015|Induction|Death|0|||
154885566|NCT02883049|559005322|FG000|Induction|Lost to Follow-up|2|||
154885567|NCT02883049|559005323|FG001|Induction|Lost to Follow-up|0|||
154885568|NCT02883049|559005324|FG002|Induction|Lost to Follow-up|0|||
154885569|NCT02883049|559005325|FG003|Induction|Lost to Follow-up|0|||
154885570|NCT02883049|559005326|FG004|Induction|Lost to Follow-up|0|||
154885571|NCT02883049|559005327|FG005|Induction|Lost to Follow-up|0|||
154885572|NCT02883049|559005328|FG006|Induction|Lost to Follow-up|0|||
154885573|NCT02883049|559005329|FG007|Induction|Lost to Follow-up|0|||
154885574|NCT02883049|559005330|FG008|Induction|Lost to Follow-up|0|||
154885575|NCT02883049|559005331|FG009|Induction|Lost to Follow-up|0|||
154885576|NCT02883049|559005332|FG010|Induction|Lost to Follow-up|0|||
154885577|NCT02883049|559005333|FG011|Induction|Lost to Follow-up|0|||
154885578|NCT02883049|559005334|FG012|Induction|Lost to Follow-up|0|||
154885579|NCT02883049|559005335|FG013|Induction|Lost to Follow-up|0|||
154885580|NCT02883049|559005336|FG014|Induction|Lost to Follow-up|0|||
154885581|NCT02883049|559005337|FG015|Induction|Lost to Follow-up|0|||
154885582|NCT02883049|559005322|FG000|Induction|Physician Decision|1407|||
154885583|NCT02883049|559005323|FG001|Induction|Physician Decision|8|||
154885584|NCT02883049|559005324|FG002|Induction|Physician Decision|0|||
154885585|NCT02883049|559005325|FG003|Induction|Physician Decision|0|||
154885586|NCT02883049|559005326|FG004|Induction|Physician Decision|0|||
154885587|NCT02883049|559005327|FG005|Induction|Physician Decision|0|||
154885588|NCT02883049|559005328|FG006|Induction|Physician Decision|0|||
154885589|NCT02883049|559005329|FG007|Induction|Physician Decision|0|||
154885590|NCT02883049|559005330|FG008|Induction|Physician Decision|0|||
154885591|NCT02883049|559005331|FG009|Induction|Physician Decision|0|||
154885592|NCT02883049|559005332|FG010|Induction|Physician Decision|0|||
154885593|NCT02883049|559005333|FG011|Induction|Physician Decision|0|||
154885594|NCT02883049|559005334|FG012|Induction|Physician Decision|0|||
154885595|NCT02883049|559005335|FG013|Induction|Physician Decision|0|||
154885596|NCT02883049|559005336|FG014|Induction|Physician Decision|0|||
154885597|NCT02883049|559005337|FG015|Induction|Physician Decision|0|||
154885598|NCT02883049|559005322|FG000|Induction|Protocol Violation|6|||
154885599|NCT02883049|559005323|FG001|Induction|Protocol Violation|0|||
154885600|NCT02883049|559005324|FG002|Induction|Protocol Violation|0|||
154885601|NCT02883049|559005325|FG003|Induction|Protocol Violation|0|||
154885602|NCT02883049|559005326|FG004|Induction|Protocol Violation|0|||
154885603|NCT02883049|559005327|FG005|Induction|Protocol Violation|0|||
154885604|NCT02883049|559005328|FG006|Induction|Protocol Violation|0|||
154885605|NCT02883049|559005329|FG007|Induction|Protocol Violation|0|||
154885606|NCT02883049|559005330|FG008|Induction|Protocol Violation|0|||
154885607|NCT02883049|559005331|FG009|Induction|Protocol Violation|0|||
154885608|NCT02883049|559005332|FG010|Induction|Protocol Violation|0|||
154885609|NCT02883049|559005333|FG011|Induction|Protocol Violation|0|||
154885610|NCT02883049|559005334|FG012|Induction|Protocol Violation|0|||
155175411|NCT04585009|560080237|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
154885611|NCT02883049|559005335|FG013|Induction|Protocol Violation|0|||
154885612|NCT02883049|559005336|FG014|Induction|Protocol Violation|0|||
154885613|NCT02883049|559005337|FG015|Induction|Protocol Violation|0|||
154885614|NCT02883049|559005322|FG000|Induction|Withdrawal by Subject|6|||
154976504|NCT00090753|559336800|FG000|Extended Treatment Period|Mircera Commercialization|188|||
154885615|NCT02883049|559005323|FG001|Induction|Withdrawal by Subject|0|||
154885616|NCT02883049|559005324|FG002|Induction|Withdrawal by Subject|0|||
154885617|NCT02883049|559005325|FG003|Induction|Withdrawal by Subject|0|||
154885618|NCT02883049|559005326|FG004|Induction|Withdrawal by Subject|0|||
154885619|NCT02883049|559005327|FG005|Induction|Withdrawal by Subject|0|||
154885620|NCT02883049|559005328|FG006|Induction|Withdrawal by Subject|0|||
154885621|NCT02883049|559005329|FG007|Induction|Withdrawal by Subject|0|||
154976505|NCT00090753|559336801|FG001|Extended Treatment Period|Mircera Commercialization|93|||
154885622|NCT02883049|559005330|FG008|Induction|Withdrawal by Subject|0|||
154885623|NCT02883049|559005331|FG009|Induction|Withdrawal by Subject|0|||
154885624|NCT02883049|559005332|FG010|Induction|Withdrawal by Subject|0|||
154885625|NCT02883049|559005333|FG011|Induction|Withdrawal by Subject|0|||
154885626|NCT02883049|559005334|FG012|Induction|Withdrawal by Subject|0|||
154885627|NCT02883049|559005335|FG013|Induction|Withdrawal by Subject|0|||
154885628|NCT02883049|559005336|FG014|Induction|Withdrawal by Subject|0|||
154885629|NCT02883049|559005337|FG015|Induction|Withdrawal by Subject|0|||
154885630|NCT02883049|559005322|FG000|Induction|Ineligible|35|||
154885631|NCT02883049|559005323|FG001|Induction|Ineligible|1|||
154885632|NCT02883049|559005324|FG002|Induction|Ineligible|0|||
154885633|NCT02883049|559005325|FG003|Induction|Ineligible|0|||
154885634|NCT02883049|559005326|FG004|Induction|Ineligible|0|||
154885635|NCT02883049|559005327|FG005|Induction|Ineligible|0|||
154885636|NCT02883049|559005328|FG006|Induction|Ineligible|0|||
154885637|NCT02883049|559005329|FG007|Induction|Ineligible|0|||
154885638|NCT02883049|559005330|FG008|Induction|Ineligible|0|||
154885639|NCT02883049|559005331|FG009|Induction|Ineligible|0|||
154885640|NCT02883049|559005332|FG010|Induction|Ineligible|0|||
154885641|NCT02883049|559005333|FG011|Induction|Ineligible|0|||
154885642|NCT02883049|559005334|FG012|Induction|Ineligible|0|||
154885643|NCT02883049|559005335|FG013|Induction|Ineligible|0|||
154885644|NCT02883049|559005336|FG014|Induction|Ineligible|0|||
154885645|NCT02883049|559005337|FG015|Induction|Ineligible|0|||
154885646|NCT02883049|559005322|FG000|Induction|Refusal of further protocol therapy|466|||
154885647|NCT02883049|559005323|FG001|Induction|Refusal of further protocol therapy|2|||
154885648|NCT02883049|559005324|FG002|Induction|Refusal of further protocol therapy|0|||
154885649|NCT02883049|559005325|FG003|Induction|Refusal of further protocol therapy|0|||
154885650|NCT02883049|559005326|FG004|Induction|Refusal of further protocol therapy|0|||
154885651|NCT02883049|559005327|FG005|Induction|Refusal of further protocol therapy|0|||
154885652|NCT02883049|559005328|FG006|Induction|Refusal of further protocol therapy|0|||
154885653|NCT02883049|559005329|FG007|Induction|Refusal of further protocol therapy|0|||
154885654|NCT02883049|559005330|FG008|Induction|Refusal of further protocol therapy|0|||
154885655|NCT02883049|559005331|FG009|Induction|Refusal of further protocol therapy|0|||
154885656|NCT02883049|559005332|FG010|Induction|Refusal of further protocol therapy|0|||
154885657|NCT02883049|559005333|FG011|Induction|Refusal of further protocol therapy|0|||
154885658|NCT02883049|559005334|FG012|Induction|Refusal of further protocol therapy|0|||
154885659|NCT02883049|559005335|FG013|Induction|Refusal of further protocol therapy|0|||
154885660|NCT02883049|559005336|FG014|Induction|Refusal of further protocol therapy|0|||
154885661|NCT02883049|559005337|FG015|Induction|Refusal of further protocol therapy|0|||
154885662|NCT02883049|559005322|FG000|Induction|Identified as Ph+ patients|279|||
154885663|NCT02883049|559005323|FG001|Induction|Identified as Ph+ patients|1|||
154885664|NCT02883049|559005324|FG002|Induction|Identified as Ph+ patients|0|||
154885665|NCT02883049|559005325|FG003|Induction|Identified as Ph+ patients|0|||
154885666|NCT02883049|559005326|FG004|Induction|Identified as Ph+ patients|0|||
154885667|NCT02883049|559005327|FG005|Induction|Identified as Ph+ patients|0|||
154885668|NCT02883049|559005328|FG006|Induction|Identified as Ph+ patients|0|||
154885669|NCT02883049|559005329|FG007|Induction|Identified as Ph+ patients|0|||
154885670|NCT02883049|559005330|FG008|Induction|Identified as Ph+ patients|0|||
154885671|NCT02883049|559005331|FG009|Induction|Identified as Ph+ patients|0|||
154885672|NCT02883049|559005332|FG010|Induction|Identified as Ph+ patients|0|||
154885673|NCT02883049|559005333|FG011|Induction|Identified as Ph+ patients|0|||
154885674|NCT02883049|559005334|FG012|Induction|Identified as Ph+ patients|0|||
154885675|NCT02883049|559005335|FG013|Induction|Identified as Ph+ patients|0|||
154885676|NCT02883049|559005336|FG014|Induction|Identified as Ph+ patients|0|||
154885677|NCT02883049|559005337|FG015|Induction|Identified as Ph+ patients|0|||
154885678|NCT02883049|559005322|FG000|Induction|M3 Marrow at Day29|8|||
154885679|NCT02883049|559005323|FG001|Induction|M3 Marrow at Day29|1|||
154885680|NCT02883049|559005324|FG002|Induction|M3 Marrow at Day29|0|||
154885681|NCT02883049|559005325|FG003|Induction|M3 Marrow at Day29|0|||
154885682|NCT02883049|559005326|FG004|Induction|M3 Marrow at Day29|0|||
154885683|NCT02883049|559005327|FG005|Induction|M3 Marrow at Day29|0|||
154885684|NCT02883049|559005328|FG006|Induction|M3 Marrow at Day29|0|||
154885685|NCT02883049|559005329|FG007|Induction|M3 Marrow at Day29|0|||
154885686|NCT02883049|559005330|FG008|Induction|M3 Marrow at Day29|0|||
154885687|NCT02883049|559005331|FG009|Induction|M3 Marrow at Day29|0|||
154885688|NCT02883049|559005332|FG010|Induction|M3 Marrow at Day29|0|||
154885689|NCT02883049|559005333|FG011|Induction|M3 Marrow at Day29|0|||
154885690|NCT02883049|559005334|FG012|Induction|M3 Marrow at Day29|0|||
154885691|NCT02883049|559005335|FG013|Induction|M3 Marrow at Day29|0|||
154885692|NCT02883049|559005336|FG014|Induction|M3 Marrow at Day29|0|||
154885693|NCT02883049|559005337|FG015|Induction|M3 Marrow at Day29|0|||
154885694|NCT02883049|559005322|FG000|Induction|Inevaluable|33|||
154885695|NCT02883049|559005323|FG001|Induction|Inevaluable|1|||
154885696|NCT02883049|559005324|FG002|Induction|Inevaluable|0|||
154885697|NCT02883049|559005325|FG003|Induction|Inevaluable|0|||
154885698|NCT02883049|559005326|FG004|Induction|Inevaluable|0|||
154885699|NCT02883049|559005327|FG005|Induction|Inevaluable|0|||
154885700|NCT02883049|559005328|FG006|Induction|Inevaluable|0|||
154885701|NCT02883049|559005329|FG007|Induction|Inevaluable|0|||
154885702|NCT02883049|559005330|FG008|Induction|Inevaluable|0|||
154885703|NCT02883049|559005331|FG009|Induction|Inevaluable|0|||
154885704|NCT02883049|559005332|FG010|Induction|Inevaluable|0|||
154885705|NCT02883049|559005333|FG011|Induction|Inevaluable|0|||
154885706|NCT02883049|559005334|FG012|Induction|Inevaluable|0|||
154885707|NCT02883049|559005335|FG013|Induction|Inevaluable|0|||
155113701|NCT03515551|559844899|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
154885708|NCT02883049|559005336|FG014|Induction|Inevaluable|0|||
154885709|NCT02883049|559005337|FG015|Induction|Inevaluable|0|||
154885710|NCT02883049|559005322|FG000|Induction|Identified as VHR at end of Induction|244|||
154885711|NCT02883049|559005323|FG001|Induction|Identified as VHR at end of Induction|0|||
154885712|NCT02883049|559005324|FG002|Induction|Identified as VHR at end of Induction|0|||
154885713|NCT02883049|559005325|FG003|Induction|Identified as VHR at end of Induction|0|||
154885714|NCT02883049|559005326|FG004|Induction|Identified as VHR at end of Induction|0|||
154885715|NCT02883049|559005327|FG005|Induction|Identified as VHR at end of Induction|0|||
154885716|NCT02883049|559005328|FG006|Induction|Identified as VHR at end of Induction|0|||
154885717|NCT02883049|559005329|FG007|Induction|Identified as VHR at end of Induction|0|||
154885718|NCT02883049|559005330|FG008|Induction|Identified as VHR at end of Induction|0|||
154885719|NCT02883049|559005331|FG009|Induction|Identified as VHR at end of Induction|0|||
154885720|NCT02883049|559005332|FG010|Induction|Identified as VHR at end of Induction|0|||
154885721|NCT02883049|559005333|FG011|Induction|Identified as VHR at end of Induction|0|||
154885722|NCT02883049|559005334|FG012|Induction|Identified as VHR at end of Induction|0|||
154885723|NCT02883049|559005335|FG013|Induction|Identified as VHR at end of Induction|0|||
154885724|NCT02883049|559005336|FG014|Induction|Identified as VHR at end of Induction|0|||
154885725|NCT02883049|559005337|FG015|Induction|Identified as VHR at end of Induction|0|||
154885726|NCT02883049|559005322|FG000|Induction|Moved to another non-COG institution|3|||
154885727|NCT02883049|559005323|FG001|Induction|Moved to another non-COG institution|0|||
154885728|NCT02883049|559005324|FG002|Induction|Moved to another non-COG institution|0|||
154885729|NCT02883049|559005325|FG003|Induction|Moved to another non-COG institution|0|||
154885730|NCT02883049|559005326|FG004|Induction|Moved to another non-COG institution|0|||
154885731|NCT02883049|559005327|FG005|Induction|Moved to another non-COG institution|0|||
154885732|NCT02883049|559005328|FG006|Induction|Moved to another non-COG institution|0|||
154885733|NCT02883049|559005329|FG007|Induction|Moved to another non-COG institution|0|||
154885734|NCT02883049|559005330|FG008|Induction|Moved to another non-COG institution|0|||
154885735|NCT02883049|559005331|FG009|Induction|Moved to another non-COG institution|0|||
154885736|NCT02883049|559005332|FG010|Induction|Moved to another non-COG institution|0|||
154885737|NCT02883049|559005333|FG011|Induction|Moved to another non-COG institution|0|||
154885738|NCT02883049|559005334|FG012|Induction|Moved to another non-COG institution|0|||
154885739|NCT02883049|559005335|FG013|Induction|Moved to another non-COG institution|0|||
154885740|NCT02883049|559005336|FG014|Induction|Moved to another non-COG institution|0|||
154885741|NCT02883049|559005337|FG015|Induction|Moved to another non-COG institution|0|||
154885742|NCT02883049|559005322|FG000|Induction|Randomization closed|41|||
154885743|NCT02883049|559005323|FG001|Induction|Randomization closed|0|||
154885744|NCT02883049|559005324|FG002|Induction|Randomization closed|0|||
154885745|NCT02883049|559005325|FG003|Induction|Randomization closed|0|||
154885746|NCT02883049|559005326|FG004|Induction|Randomization closed|0|||
154885747|NCT02883049|559005327|FG005|Induction|Randomization closed|0|||
154885748|NCT02883049|559005328|FG006|Induction|Randomization closed|0|||
154885749|NCT02883049|559005329|FG007|Induction|Randomization closed|0|||
154885750|NCT02883049|559005330|FG008|Induction|Randomization closed|0|||
154885751|NCT02883049|559005331|FG009|Induction|Randomization closed|0|||
154885752|NCT02883049|559005332|FG010|Induction|Randomization closed|0|||
154885753|NCT02883049|559005333|FG011|Induction|Randomization closed|0|||
154885754|NCT02883049|559005334|FG012|Induction|Randomization closed|0|||
154885755|NCT02883049|559005335|FG013|Induction|Randomization closed|0|||
154885756|NCT02883049|559005336|FG014|Induction|Randomization closed|0|||
154885757|NCT02883049|559005337|FG015|Induction|Randomization closed|0|||
154885758|NCT02883049|559005322|FG000|Induction|MRD negative|36|||
154885759|NCT02883049|559005323|FG001|Induction|MRD negative|0|||
154885760|NCT02883049|559005324|FG002|Induction|MRD negative|0|||
154885761|NCT02883049|559005325|FG003|Induction|MRD negative|0|||
154885762|NCT02883049|559005326|FG004|Induction|MRD negative|0|||
154885763|NCT02883049|559005327|FG005|Induction|MRD negative|0|||
154885764|NCT02883049|559005328|FG006|Induction|MRD negative|0|||
154885765|NCT02883049|559005329|FG007|Induction|MRD negative|0|||
154885766|NCT02883049|559005330|FG008|Induction|MRD negative|0|||
154885767|NCT02883049|559005331|FG009|Induction|MRD negative|0|||
154885768|NCT02883049|559005332|FG010|Induction|MRD negative|0|||
154885769|NCT02883049|559005333|FG011|Induction|MRD negative|0|||
154885770|NCT02883049|559005334|FG012|Induction|MRD negative|0|||
154885771|NCT02883049|559005335|FG013|Induction|MRD negative|0|||
154885772|NCT02883049|559005336|FG014|Induction|MRD negative|0|||
154885773|NCT02883049|559005337|FG015|Induction|MRD negative|0|||
154885774|NCT02883049|559005322|FG000|Induction|Identified as HR patients|165|||
154885775|NCT02883049|559005323|FG001|Induction|Identified as HR patients|0|||
154885776|NCT02883049|559005324|FG002|Induction|Identified as HR patients|0|||
154885777|NCT02883049|559005325|FG003|Induction|Identified as HR patients|0|||
154885778|NCT02883049|559005326|FG004|Induction|Identified as HR patients|0|||
154885779|NCT02883049|559005327|FG005|Induction|Identified as HR patients|0|||
154885780|NCT02883049|559005328|FG006|Induction|Identified as HR patients|0|||
154885781|NCT02883049|559005329|FG007|Induction|Identified as HR patients|0|||
154885782|NCT02883049|559005330|FG008|Induction|Identified as HR patients|0|||
154885783|NCT02883049|559005331|FG009|Induction|Identified as HR patients|0|||
154885784|NCT02883049|559005332|FG010|Induction|Identified as HR patients|0|||
154885785|NCT02883049|559005333|FG011|Induction|Identified as HR patients|0|||
154885786|NCT02883049|559005334|FG012|Induction|Identified as HR patients|0|||
154885787|NCT02883049|559005335|FG013|Induction|Identified as HR patients|0|||
154885788|NCT02883049|559005336|FG014|Induction|Identified as HR patients|0|||
154885789|NCT02883049|559005337|FG015|Induction|Identified as HR patients|0|||
154885790|NCT02883049|559005322|FG000|Induction|Developed SMN|0|||
154885791|NCT02883049|559005323|FG001|Induction|Developed SMN|1|||
154885792|NCT02883049|559005324|FG002|Induction|Developed SMN|0|||
154885793|NCT02883049|559005325|FG003|Induction|Developed SMN|0|||
154885794|NCT02883049|559005326|FG004|Induction|Developed SMN|0|||
154885795|NCT02883049|559005327|FG005|Induction|Developed SMN|0|||
154885796|NCT02883049|559005328|FG006|Induction|Developed SMN|0|||
154885797|NCT02883049|559005329|FG007|Induction|Developed SMN|0|||
154885798|NCT02883049|559005330|FG008|Induction|Developed SMN|0|||
154885799|NCT02883049|559005331|FG009|Induction|Developed SMN|0|||
154885800|NCT02883049|559005332|FG010|Induction|Developed SMN|0|||
154885801|NCT02883049|559005333|FG011|Induction|Developed SMN|0|||
154885802|NCT02883049|559005334|FG012|Induction|Developed SMN|0|||
154885803|NCT02883049|559005335|FG013|Induction|Developed SMN|0|||
154885804|NCT02883049|559005336|FG014|Induction|Developed SMN|0|||
154885805|NCT02883049|559005337|FG015|Induction|Developed SMN|0|||
154885806|NCT02883049|559005322|FG000|Induction|Enrolled onto another COG study|72|||
154885807|NCT02883049|559005323|FG001|Induction|Enrolled onto another COG study|0|||
154885808|NCT02883049|559005324|FG002|Induction|Enrolled onto another COG study|0|||
154885809|NCT02883049|559005325|FG003|Induction|Enrolled onto another COG study|0|||
154885810|NCT02883049|559005326|FG004|Induction|Enrolled onto another COG study|0|||
154885811|NCT02883049|559005327|FG005|Induction|Enrolled onto another COG study|0|||
154885812|NCT02883049|559005328|FG006|Induction|Enrolled onto another COG study|0|||
154885813|NCT02883049|559005329|FG007|Induction|Enrolled onto another COG study|0|||
154885814|NCT02883049|559005330|FG008|Induction|Enrolled onto another COG study|0|||
154885815|NCT02883049|559005331|FG009|Induction|Enrolled onto another COG study|0|||
154885816|NCT02883049|559005332|FG010|Induction|Enrolled onto another COG study|0|||
154885817|NCT02883049|559005333|FG011|Induction|Enrolled onto another COG study|0|||
154885818|NCT02883049|559005334|FG012|Induction|Enrolled onto another COG study|0|||
154885819|NCT02883049|559005335|FG013|Induction|Enrolled onto another COG study|0|||
154885820|NCT02883049|559005336|FG014|Induction|Enrolled onto another COG study|0|||
154885821|NCT02883049|559005337|FG015|Induction|Enrolled onto another COG study|0|||
154885822|NCT02883049|559005322|FG000|Induction|Incomplete induction data|17|||
154885823|NCT02883049|559005323|FG001|Induction|Incomplete induction data|0|||
154885824|NCT02883049|559005324|FG002|Induction|Incomplete induction data|0|||
154885825|NCT02883049|559005325|FG003|Induction|Incomplete induction data|0|||
154885826|NCT02883049|559005326|FG004|Induction|Incomplete induction data|0|||
154885827|NCT02883049|559005327|FG005|Induction|Incomplete induction data|0|||
154885828|NCT02883049|559005328|FG006|Induction|Incomplete induction data|0|||
154885829|NCT02883049|559005329|FG007|Induction|Incomplete induction data|0|||
154885830|NCT02883049|559005330|FG008|Induction|Incomplete induction data|0|||
154885831|NCT02883049|559005331|FG009|Induction|Incomplete induction data|0|||
154885832|NCT02883049|559005332|FG010|Induction|Incomplete induction data|0|||
154885833|NCT02883049|559005333|FG011|Induction|Incomplete induction data|0|||
154885834|NCT02883049|559005334|FG012|Induction|Incomplete induction data|0|||
154885835|NCT02883049|559005335|FG013|Induction|Incomplete induction data|0|||
154885836|NCT02883049|559005336|FG014|Induction|Incomplete induction data|0|||
154885837|NCT02883049|559005337|FG015|Induction|Incomplete induction data|0|||
154885838|NCT02883049|559005322|FG000|Post Induction|Adverse Event|0|||
154885839|NCT02883049|559005323|FG001|Post Induction|Adverse Event|0|||
154885840|NCT02883049|559005324|FG002|Post Induction|Adverse Event|0|||
154885841|NCT02883049|559005325|FG003|Post Induction|Adverse Event|7|||
154885842|NCT02883049|559005326|FG004|Post Induction|Adverse Event|8|||
154885843|NCT02883049|559005327|FG005|Post Induction|Adverse Event|3|||
154885844|NCT02883049|559005328|FG006|Post Induction|Adverse Event|4|||
154885845|NCT02883049|559005329|FG007|Post Induction|Adverse Event|5|||
154885846|NCT02883049|559005330|FG008|Post Induction|Adverse Event|6|||
154885847|NCT02883049|559005331|FG009|Post Induction|Adverse Event|7|||
154885848|NCT02883049|559005332|FG010|Post Induction|Adverse Event|2|||
154885849|NCT02883049|559005333|FG011|Post Induction|Adverse Event|2|||
154885850|NCT02883049|559005334|FG012|Post Induction|Adverse Event|0|||
154885851|NCT02883049|559005335|FG013|Post Induction|Adverse Event|0|||
154885852|NCT02883049|559005336|FG014|Post Induction|Adverse Event|5|||
154885853|NCT02883049|559005337|FG015|Post Induction|Adverse Event|2|||
154885854|NCT02883049|559005322|FG000|Post Induction|Death|0|||
154885855|NCT02883049|559005323|FG001|Post Induction|Death|0|||
154885856|NCT02883049|559005324|FG002|Post Induction|Death|0|||
154885857|NCT02883049|559005325|FG003|Post Induction|Death|9|||
154885858|NCT02883049|559005326|FG004|Post Induction|Death|9|||
154885859|NCT02883049|559005327|FG005|Post Induction|Death|0|||
154885860|NCT02883049|559005328|FG006|Post Induction|Death|1|||
154885861|NCT02883049|559005329|FG007|Post Induction|Death|6|||
154885862|NCT02883049|559005330|FG008|Post Induction|Death|5|||
154885863|NCT02883049|559005331|FG009|Post Induction|Death|3|||
154885864|NCT02883049|559005332|FG010|Post Induction|Death|1|||
154885865|NCT02883049|559005333|FG011|Post Induction|Death|0|||
154885866|NCT02883049|559005334|FG012|Post Induction|Death|1|||
154885867|NCT02883049|559005335|FG013|Post Induction|Death|1|||
154885868|NCT02883049|559005336|FG014|Post Induction|Death|10|||
154885869|NCT02883049|559005337|FG015|Post Induction|Death|2|||
154885870|NCT02883049|559005322|FG000|Post Induction|Lost to Follow-up|0|||
154885871|NCT02883049|559005323|FG001|Post Induction|Lost to Follow-up|0|||
154885872|NCT02883049|559005324|FG002|Post Induction|Lost to Follow-up|0|||
154885873|NCT02883049|559005325|FG003|Post Induction|Lost to Follow-up|0|||
154885874|NCT02883049|559005326|FG004|Post Induction|Lost to Follow-up|1|||
154885875|NCT02883049|559005327|FG005|Post Induction|Lost to Follow-up|1|||
154885876|NCT02883049|559005328|FG006|Post Induction|Lost to Follow-up|0|||
154885877|NCT02883049|559005329|FG007|Post Induction|Lost to Follow-up|0|||
154885878|NCT02883049|559005330|FG008|Post Induction|Lost to Follow-up|3|||
154885879|NCT02883049|559005331|FG009|Post Induction|Lost to Follow-up|0|||
154885880|NCT02883049|559005332|FG010|Post Induction|Lost to Follow-up|1|||
154885881|NCT02883049|559005333|FG011|Post Induction|Lost to Follow-up|0|||
154885882|NCT02883049|559005334|FG012|Post Induction|Lost to Follow-up|0|||
154885883|NCT02883049|559005335|FG013|Post Induction|Lost to Follow-up|0|||
154885884|NCT02883049|559005336|FG014|Post Induction|Lost to Follow-up|0|||
154885885|NCT02883049|559005337|FG015|Post Induction|Lost to Follow-up|0|||
154885886|NCT02883049|559005322|FG000|Post Induction|Physician Decision|0|||
154885887|NCT02883049|559005323|FG001|Post Induction|Physician Decision|0|||
154885888|NCT02883049|559005324|FG002|Post Induction|Physician Decision|0|||
154885889|NCT02883049|559005325|FG003|Post Induction|Physician Decision|27|||
154885890|NCT02883049|559005326|FG004|Post Induction|Physician Decision|27|||
154885891|NCT02883049|559005327|FG005|Post Induction|Physician Decision|23|||
154885892|NCT02883049|559005328|FG006|Post Induction|Physician Decision|30|||
154885893|NCT02883049|559005329|FG007|Post Induction|Physician Decision|56|||
154885894|NCT02883049|559005330|FG008|Post Induction|Physician Decision|85|||
154885895|NCT02883049|559005331|FG009|Post Induction|Physician Decision|12|||
154885896|NCT02883049|559005332|FG010|Post Induction|Physician Decision|5|||
154885897|NCT02883049|559005333|FG011|Post Induction|Physician Decision|14|||
154885898|NCT02883049|559005334|FG012|Post Induction|Physician Decision|1|||
154885899|NCT02883049|559005335|FG013|Post Induction|Physician Decision|11|||
154885900|NCT02883049|559005336|FG014|Post Induction|Physician Decision|19|||
154885901|NCT02883049|559005337|FG015|Post Induction|Physician Decision|5|||
154885902|NCT02883049|559005322|FG000|Post Induction|Protocol Violation|0|||
154885903|NCT02883049|559005323|FG001|Post Induction|Protocol Violation|0|||
154885904|NCT02883049|559005324|FG002|Post Induction|Protocol Violation|0|||
154885905|NCT02883049|559005325|FG003|Post Induction|Protocol Violation|0|||
154885906|NCT02883049|559005326|FG004|Post Induction|Protocol Violation|0|||
154885907|NCT02883049|559005327|FG005|Post Induction|Protocol Violation|0|||
154885908|NCT02883049|559005328|FG006|Post Induction|Protocol Violation|0|||
154885909|NCT02883049|559005329|FG007|Post Induction|Protocol Violation|1|||
154885910|NCT02883049|559005330|FG008|Post Induction|Protocol Violation|0|||
154885911|NCT02883049|559005331|FG009|Post Induction|Protocol Violation|0|||
154885912|NCT02883049|559005332|FG010|Post Induction|Protocol Violation|0|||
154885913|NCT02883049|559005333|FG011|Post Induction|Protocol Violation|0|||
154885914|NCT02883049|559005334|FG012|Post Induction|Protocol Violation|0|||
154885915|NCT02883049|559005335|FG013|Post Induction|Protocol Violation|0|||
154885916|NCT02883049|559005336|FG014|Post Induction|Protocol Violation|0|||
154885917|NCT02883049|559005337|FG015|Post Induction|Protocol Violation|0|||
154885918|NCT02883049|559005322|FG000|Post Induction|Withdrawal by Subject|0|||
154885919|NCT02883049|559005323|FG001|Post Induction|Withdrawal by Subject|0|||
154885920|NCT02883049|559005324|FG002|Post Induction|Withdrawal by Subject|0|||
154885921|NCT02883049|559005325|FG003|Post Induction|Withdrawal by Subject|5|||
154885922|NCT02883049|559005326|FG004|Post Induction|Withdrawal by Subject|2|||
154885923|NCT02883049|559005327|FG005|Post Induction|Withdrawal by Subject|1|||
154885924|NCT02883049|559005328|FG006|Post Induction|Withdrawal by Subject|0|||
154885925|NCT02883049|559005329|FG007|Post Induction|Withdrawal by Subject|0|||
154885926|NCT02883049|559005330|FG008|Post Induction|Withdrawal by Subject|2|||
154885927|NCT02883049|559005331|FG009|Post Induction|Withdrawal by Subject|0|||
154885928|NCT02883049|559005332|FG010|Post Induction|Withdrawal by Subject|1|||
154885929|NCT02883049|559005333|FG011|Post Induction|Withdrawal by Subject|1|||
154885930|NCT02883049|559005334|FG012|Post Induction|Withdrawal by Subject|0|||
154885931|NCT02883049|559005335|FG013|Post Induction|Withdrawal by Subject|0|||
154885932|NCT02883049|559005336|FG014|Post Induction|Withdrawal by Subject|1|||
154885933|NCT02883049|559005337|FG015|Post Induction|Withdrawal by Subject|0|||
154885934|NCT02883049|559005322|FG000|Post Induction|Ineligible|0|||
154885935|NCT02883049|559005323|FG001|Post Induction|Ineligible|0|||
154885936|NCT02883049|559005324|FG002|Post Induction|Ineligible|2|||
154885937|NCT02883049|559005325|FG003|Post Induction|Ineligible|0|||
154885938|NCT02883049|559005326|FG004|Post Induction|Ineligible|0|||
154885939|NCT02883049|559005327|FG005|Post Induction|Ineligible|0|||
154885940|NCT02883049|559005328|FG006|Post Induction|Ineligible|1|||
154885941|NCT02883049|559005329|FG007|Post Induction|Ineligible|0|||
154885942|NCT02883049|559005330|FG008|Post Induction|Ineligible|0|||
154885943|NCT02883049|559005331|FG009|Post Induction|Ineligible|0|||
154976506|NCT00090753|559336800|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
154976507|NCT00090753|559336801|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
154976508|NCT01086969|559336804|FG000|Overall Study|Withdrawal by Subject|1|||
154976509|NCT01086969|559336805|FG001|Overall Study|Withdrawal by Subject|2|||
154976510|NCT01086969|559336806|FG002|Overall Study|Withdrawal by Subject|0|||
154976511|NCT01466036|559336809|FG000|Overall Study|Death|1|||
154976512|NCT01466036|559336810|FG001|Overall Study|Death|1|||
154976513|NCT01466036|559336809|FG000|Overall Study|Physician Decision|0|||
154976514|NCT01466036|559336810|FG001|Overall Study|Physician Decision|4|||
154976515|NCT01466036|559336809|FG000|Overall Study|Adverse Event|2|||
154976516|NCT01466036|559336810|FG001|Overall Study|Adverse Event|6|||
154976517|NCT01466036|559336809|FG000|Overall Study|Withdrawal by Subject|2|||
154976518|NCT01466036|559336810|FG001|Overall Study|Withdrawal by Subject|8|||
154976519|NCT01466036|559336809|FG000|Overall Study|progression/relapse|14|||
154976520|NCT01466036|559336810|FG001|Overall Study|progression/relapse|21|||
154976521|NCT01466036|559336809|FG000|Overall Study|prolonged treatment delay|1|||
154976522|NCT01466036|559336810|FG001|Overall Study|prolonged treatment delay|1|||
154976523|NCT01609582|559336813|FG000|Overall Study|Adverse Event|20|||
154976524|NCT01609582|559336814|FG001|Overall Study|Adverse Event|18|||
154976525|NCT01609582|559336813|FG000|Overall Study|Lost to Follow-up|10|||
154976526|NCT01609582|559336814|FG001|Overall Study|Lost to Follow-up|10|||
154976527|NCT01609582|559336813|FG000|Overall Study|Withdrawal by Subject|21|||
154976528|NCT01609582|559336814|FG001|Overall Study|Withdrawal by Subject|15|||
154976529|NCT01609582|559336813|FG000|Overall Study|Study Terminated by Sponsor|1543|||
154976530|NCT01609582|559336814|FG001|Overall Study|Study Terminated by Sponsor|1548|||
154976531|NCT01609582|559336813|FG000|Overall Study|Other|9|||
154976532|NCT01609582|559336814|FG001|Overall Study|Other|10|||
154976533|NCT01609582|559336813|FG000|Overall Study|Randomized, but not treated|0|||
154976534|NCT01609582|559336814|FG001|Overall Study|Randomized, but not treated|3|||
154976535|NCT00250705|559336817|FG000|Overall Study|Lack of Efficacy|2|||
154976536|NCT05103657|559336820|FG000|Overall Study|Other reasons than listed|9|||
154976537|NCT05103657|559336821|FG001|Overall Study|Other reasons than listed|8|||
154976538|NCT05103657|559336820|FG000|Overall Study|Protocol deviation|2|||
154976539|NCT05103657|559336821|FG001|Overall Study|Protocol deviation|2|||
154976540|NCT05103657|559336820|FG000|Overall Study|No reason available|5|||
154976541|NCT05103657|559336821|FG001|Overall Study|No reason available|4|||
154976542|NCT05103657|559336820|FG000|Overall Study|Burden of study procedures|3|||
154976543|NCT05103657|559336821|FG001|Overall Study|Burden of study procedures|1|||
154976544|NCT05103657|559336820|FG000|Overall Study|Perceived lack of efficacy|1|||
154976545|NCT05103657|559336821|FG001|Overall Study|Perceived lack of efficacy|1|||
154976546|NCT05103657|559336820|FG000|Overall Study|Adverse Event|6|||
154976547|NCT05103657|559336821|FG001|Overall Study|Adverse Event|14|||
154976548|NCT05103657|559336820|FG000|Overall Study|Not Treated|1|||
154976549|NCT05103657|559336821|FG001|Overall Study|Not Treated|1|||
154976550|NCT00129116|559336822|FG000|Primary Phase|Lost to Follow-up|1|||
154976551|NCT00129116|559336823|FG001|Primary Phase|Lost to Follow-up|1|||
154976552|NCT00129116|559336824|FG002|Primary Phase|Lost to Follow-up|0|||
154976553|NCT00129116|559336825|FG003|Primary Phase|Lost to Follow-up|1|||
154976554|NCT00129116|559336826|FG004|Primary Phase|Lost to Follow-up|1|||
154976555|NCT00129116|559336822|FG000|Primary Phase|Protocol Violation|0|||
154976556|NCT00129116|559336823|FG001|Primary Phase|Protocol Violation|1|||
154976557|NCT00129116|559336824|FG002|Primary Phase|Protocol Violation|0|||
154976558|NCT00129116|559336825|FG003|Primary Phase|Protocol Violation|0|||
154976559|NCT00129116|559336826|FG004|Primary Phase|Protocol Violation|0|||
154976560|NCT00129116|559336822|FG000|Primary Phase|Adverse Event|1|||
154976561|NCT00129116|559336823|FG001|Primary Phase|Adverse Event|1|||
154976562|NCT00129116|559336824|FG002|Primary Phase|Adverse Event|0|||
154976563|NCT00129116|559336825|FG003|Primary Phase|Adverse Event|0|||
154976564|NCT00129116|559336826|FG004|Primary Phase|Adverse Event|0|||
154976565|NCT00129116|559336822|FG000|Primary Phase|Withdrawal by Subject|0|||
154976566|NCT00129116|559336823|FG001|Primary Phase|Withdrawal by Subject|1|||
154976567|NCT00129116|559336824|FG002|Primary Phase|Withdrawal by Subject|0|||
154976568|NCT00129116|559336825|FG003|Primary Phase|Withdrawal by Subject|0|||
154976569|NCT00129116|559336826|FG004|Primary Phase|Withdrawal by Subject|0|||
154976570|NCT00129116|559336822|FG000|Primary Phase|Other|0|||
154976571|NCT00129116|559336823|FG001|Primary Phase|Other|0|||
154976572|NCT00129116|559336824|FG002|Primary Phase|Other|1|||
154976573|NCT00129116|559336825|FG003|Primary Phase|Other|0|||
154976574|NCT00129116|559336826|FG004|Primary Phase|Other|0|||
154976575|NCT00129116|559336822|FG000|Booster Phase|Lost to Follow-up|2|||
154976576|NCT00129116|559336823|FG001|Booster Phase|Lost to Follow-up|0|||
154976577|NCT00129116|559336824|FG002|Booster Phase|Lost to Follow-up|0|||
154976578|NCT00129116|559336825|FG003|Booster Phase|Lost to Follow-up|0|||
154976579|NCT00129116|559336826|FG004|Booster Phase|Lost to Follow-up|1|||
154976580|NCT00708682|559336827|FG000|Infant Series|Adverse Event|1|||
154976581|NCT00708682|559336827|FG000|Infant Series|Lost to Follow-up|4|||
154976582|NCT00708682|559336827|FG000|Infant Series|Protocol Violation|1|||
154976583|NCT00708682|559336827|FG000|Infant Series|Parent/legal guardian request|6|||
154976584|NCT00708682|559336827|FG000|Infant Series|Failed to return|2|||
154976585|NCT00708682|559336827|FG000|Infant Series|Other|19|||
154976586|NCT00708682|559336827|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
154976587|NCT00708682|559336827|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
154976588|NCT00708682|559336827|FG000|Toddler Dose|Lost to Follow-up|3|||
154976589|NCT00708682|559336827|FG000|Toddler Dose|Failed to Return|4|||
154976590|NCT03180528|559338626|FG000|Overall Study|Adverse Event|1|||
154976591|NCT03180528|559338626|FG000|Overall Study|Withdrawal by Subject|1|||
154976592|NCT03180528|559338626|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
154976593|NCT04100096|559338627|FG000|Overall Study|Adverse Event|19|||
154976594|NCT04100096|559338628|FG001|Overall Study|Adverse Event|7|||
154976595|NCT04100096|559338627|FG000|Overall Study|Lack of Efficacy|0|||
154976596|NCT04100096|559338628|FG001|Overall Study|Lack of Efficacy|1|||
154976597|NCT04100096|559338627|FG000|Overall Study|Lost to Follow-up|13|||
154976598|NCT04100096|559338628|FG001|Overall Study|Lost to Follow-up|11|||
154976599|NCT04100096|559338627|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154976600|NCT04100096|559338628|FG001|Overall Study|Non-Compliance With Study Drug|3|||
154976601|NCT04100096|559338627|FG000|Overall Study|Protocol Deviation|1|||
154976602|NCT04100096|559338628|FG001|Overall Study|Protocol Deviation|1|||
154976603|NCT04100096|559338627|FG000|Overall Study|Withdrawal by Participant|13|||
154976604|NCT04100096|559338628|FG001|Overall Study|Withdrawal by Participant|15|||
154976605|NCT00991510|559338631|FG000|Period I (Days 1-14)|Adverse Event|1|||
154976606|NCT00991510|559338632|FG001|Period I (Days 1-14)|Adverse Event|0|||
154976607|NCT00991510|559338631|FG000|Period III (Days 29-112)|Adverse Event|1|||
154976608|NCT00991510|559338632|FG001|Period III (Days 29-112)|Adverse Event|1|||
154976609|NCT01976728|559338633|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
154976610|NCT01976728|559338634|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
154976611|NCT01976728|559338635|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
154976612|NCT01976728|559338636|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
154976613|NCT02356211|559338637|FG000|Overall Study|Withdrawal by Subject|2|||
154976614|NCT02356211|559338638|FG001|Overall Study|Withdrawal by Subject|2|||
154976615|NCT02356211|559338637|FG000|Overall Study|ineligible|1|||
154976616|NCT02356211|559338638|FG001|Overall Study|ineligible|8|||
154976617|NCT01563237|559338639|FG000|Overall Study|Lost to Follow-up|6|||
154976618|NCT01563237|559338640|FG001|Overall Study|Lost to Follow-up|0|||
154976619|NCT01563237|559338639|FG000|Overall Study|Withdrawal by Subject|1|||
154976620|NCT01563237|559338640|FG001|Overall Study|Withdrawal by Subject|0|||
154976621|NCT01563237|559338639|FG000|Overall Study|Adverse Event|1|||
154976622|NCT01563237|559338640|FG001|Overall Study|Adverse Event|0|||
154976623|NCT01563237|559338639|FG000|Overall Study|Medical Reasons|1|||
154976624|NCT01563237|559338640|FG001|Overall Study|Medical Reasons|0|||
154976625|NCT01563237|559338639|FG000|Overall Study|Death|1|||
154976626|NCT01563237|559338640|FG001|Overall Study|Death|0|||
154976627|NCT01124695|559338644|FG000|Overall Study|Disease progression|77|||
154976628|NCT01124695|559338644|FG000|Overall Study|Adverse Event|11|||
154976629|NCT01124695|559338644|FG000|Overall Study|Death|1|||
154976630|NCT01124695|559338644|FG000|Overall Study|Withdrawal by Subject|7|||
154976631|NCT01124695|559338644|FG000|Overall Study|Physician Decision|3|||
154976632|NCT01124695|559338644|FG000|Overall Study|Alternative therapy|9|||
154976633|NCT01124695|559338644|FG000|Overall Study|No documentation that patient went off treatment|4|||
154976634|NCT01124695|559338644|FG000|Overall Study|Ineligible|9|||
154976635|NCT01124695|559338644|FG000|Overall Study|Ineligible and never start treatment|2|||
154976636|NCT02960438|559338645|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
154976637|NCT02960438|559338646|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
154976638|NCT02960438|559338647|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
154976639|NCT02960438|559338648|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
154976640|NCT02960438|559338645|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
154976641|NCT02960438|559338646|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
154976642|NCT02960438|559338647|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
154976643|NCT02960438|559338648|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
154976644|NCT02960438|559338645|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
154976645|NCT02960438|559338646|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
154976646|NCT02960438|559338647|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
154976647|NCT02960438|559338648|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
155175412|NCT04585009|560080238|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
154976648|NCT02960438|559338645|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
154976649|NCT02960438|559338646|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
154976650|NCT02960438|559338647|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
154976651|NCT02960438|559338648|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
154976652|NCT02960438|559338645|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
154976653|NCT02960438|559338646|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
154976654|NCT02960438|559338647|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
154976655|NCT02960438|559338648|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
154885944|NCT02883049|559005332|FG010|Post Induction|Ineligible|1|||
154885945|NCT02883049|559005333|FG011|Post Induction|Ineligible|0|||
154885946|NCT02883049|559005334|FG012|Post Induction|Ineligible|0|||
154885947|NCT02883049|559005335|FG013|Post Induction|Ineligible|0|||
154885948|NCT02883049|559005336|FG014|Post Induction|Ineligible|0|||
154885949|NCT02883049|559005337|FG015|Post Induction|Ineligible|1|||
154885950|NCT02883049|559005322|FG000|Post Induction|Refusal of further protocol therapy|0|||
154885951|NCT02883049|559005323|FG001|Post Induction|Refusal of further protocol therapy|0|||
154885952|NCT02883049|559005324|FG002|Post Induction|Refusal of further protocol therapy|0|||
154885953|NCT02883049|559005325|FG003|Post Induction|Refusal of further protocol therapy|11|||
154885954|NCT02883049|559005326|FG004|Post Induction|Refusal of further protocol therapy|15|||
154885955|NCT02883049|559005327|FG005|Post Induction|Refusal of further protocol therapy|9|||
154885956|NCT02883049|559005328|FG006|Post Induction|Refusal of further protocol therapy|13|||
154885957|NCT02883049|559005329|FG007|Post Induction|Refusal of further protocol therapy|5|||
154885958|NCT02883049|559005330|FG008|Post Induction|Refusal of further protocol therapy|21|||
154885959|NCT02883049|559005331|FG009|Post Induction|Refusal of further protocol therapy|7|||
154885960|NCT02883049|559005332|FG010|Post Induction|Refusal of further protocol therapy|0|||
154885961|NCT02883049|559005333|FG011|Post Induction|Refusal of further protocol therapy|7|||
154885962|NCT02883049|559005334|FG012|Post Induction|Refusal of further protocol therapy|3|||
154885963|NCT02883049|559005335|FG013|Post Induction|Refusal of further protocol therapy|0|||
154885964|NCT02883049|559005336|FG014|Post Induction|Refusal of further protocol therapy|4|||
154885965|NCT02883049|559005337|FG015|Post Induction|Refusal of further protocol therapy|1|||
154885966|NCT02883049|559005322|FG000|Post Induction|Inevaluable|0|||
154885967|NCT02883049|559005323|FG001|Post Induction|Inevaluable|0|||
154885968|NCT02883049|559005324|FG002|Post Induction|Inevaluable|0|||
154885969|NCT02883049|559005325|FG003|Post Induction|Inevaluable|1|||
154885970|NCT02883049|559005326|FG004|Post Induction|Inevaluable|1|||
154885971|NCT02883049|559005327|FG005|Post Induction|Inevaluable|2|||
154885972|NCT02883049|559005328|FG006|Post Induction|Inevaluable|7|||
154885973|NCT02883049|559005329|FG007|Post Induction|Inevaluable|6|||
154885974|NCT02883049|559005330|FG008|Post Induction|Inevaluable|4|||
154885975|NCT02883049|559005331|FG009|Post Induction|Inevaluable|4|||
154885976|NCT02883049|559005332|FG010|Post Induction|Inevaluable|1|||
154885977|NCT02883049|559005333|FG011|Post Induction|Inevaluable|1|||
154885978|NCT02883049|559005334|FG012|Post Induction|Inevaluable|2|||
154885979|NCT02883049|559005335|FG013|Post Induction|Inevaluable|0|||
154885980|NCT02883049|559005336|FG014|Post Induction|Inevaluable|0|||
154885981|NCT02883049|559005337|FG015|Post Induction|Inevaluable|1|||
154885982|NCT02883049|559005322|FG000|Post Induction|Moved to another non-COG institution|0|||
154885983|NCT02883049|559005323|FG001|Post Induction|Moved to another non-COG institution|0|||
154885984|NCT02883049|559005324|FG002|Post Induction|Moved to another non-COG institution|0|||
154885985|NCT02883049|559005325|FG003|Post Induction|Moved to another non-COG institution|0|||
154885986|NCT02883049|559005326|FG004|Post Induction|Moved to another non-COG institution|0|||
154885987|NCT02883049|559005327|FG005|Post Induction|Moved to another non-COG institution|0|||
154885988|NCT02883049|559005328|FG006|Post Induction|Moved to another non-COG institution|0|||
154885989|NCT02883049|559005329|FG007|Post Induction|Moved to another non-COG institution|2|||
154885990|NCT02883049|559005330|FG008|Post Induction|Moved to another non-COG institution|2|||
154885991|NCT02883049|559005331|FG009|Post Induction|Moved to another non-COG institution|0|||
154885992|NCT02883049|559005332|FG010|Post Induction|Moved to another non-COG institution|0|||
154885993|NCT02883049|559005333|FG011|Post Induction|Moved to another non-COG institution|1|||
154885994|NCT02883049|559005334|FG012|Post Induction|Moved to another non-COG institution|0|||
154885995|NCT02883049|559005335|FG013|Post Induction|Moved to another non-COG institution|0|||
154885996|NCT02883049|559005336|FG014|Post Induction|Moved to another non-COG institution|0|||
154885997|NCT02883049|559005337|FG015|Post Induction|Moved to another non-COG institution|0|||
154885998|NCT02883049|559005322|FG000|Post Induction|Randomization closed|0|||
154885999|NCT02883049|559005323|FG001|Post Induction|Randomization closed|0|||
154886000|NCT02883049|559005324|FG002|Post Induction|Randomization closed|0|||
154886001|NCT02883049|559005325|FG003|Post Induction|Randomization closed|0|||
154886002|NCT02883049|559005326|FG004|Post Induction|Randomization closed|0|||
154886003|NCT02883049|559005327|FG005|Post Induction|Randomization closed|0|||
154886004|NCT02883049|559005328|FG006|Post Induction|Randomization closed|0|||
154886005|NCT02883049|559005329|FG007|Post Induction|Randomization closed|20|||
154886006|NCT02883049|559005330|FG008|Post Induction|Randomization closed|0|||
154886007|NCT02883049|559005331|FG009|Post Induction|Randomization closed|0|||
154886008|NCT02883049|559005332|FG010|Post Induction|Randomization closed|0|||
154886009|NCT02883049|559005333|FG011|Post Induction|Randomization closed|0|||
154886010|NCT02883049|559005334|FG012|Post Induction|Randomization closed|0|||
154886011|NCT02883049|559005335|FG013|Post Induction|Randomization closed|0|||
154886012|NCT02883049|559005336|FG014|Post Induction|Randomization closed|0|||
154886013|NCT02883049|559005337|FG015|Post Induction|Randomization closed|0|||
154886014|NCT02883049|559005322|FG000|Post Induction|MRD negative|0|||
154886015|NCT02883049|559005323|FG001|Post Induction|MRD negative|0|||
154886016|NCT02883049|559005324|FG002|Post Induction|MRD negative|0|||
154886017|NCT02883049|559005325|FG003|Post Induction|MRD negative|0|||
154886018|NCT02883049|559005326|FG004|Post Induction|MRD negative|0|||
154886019|NCT02883049|559005327|FG005|Post Induction|MRD negative|0|||
154886020|NCT02883049|559005328|FG006|Post Induction|MRD negative|0|||
154886021|NCT02883049|559005329|FG007|Post Induction|MRD negative|11|||
154886022|NCT02883049|559005330|FG008|Post Induction|MRD negative|0|||
154886023|NCT02883049|559005331|FG009|Post Induction|MRD negative|0|||
154886024|NCT02883049|559005332|FG010|Post Induction|MRD negative|0|||
154886025|NCT02883049|559005333|FG011|Post Induction|MRD negative|0|||
154886026|NCT02883049|559005334|FG012|Post Induction|MRD negative|0|||
154886027|NCT02883049|559005335|FG013|Post Induction|MRD negative|0|||
154886028|NCT02883049|559005336|FG014|Post Induction|MRD negative|0|||
154976656|NCT02960438|559338645|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
154976657|NCT02960438|559338646|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
154976658|NCT02960438|559338647|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
154976659|NCT02960438|559338648|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
154976660|NCT02960438|559338645|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
154976661|NCT02960438|559338646|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
154976662|NCT02960438|559338647|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
154976663|NCT02960438|559338648|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
154976664|NCT02960438|559338645|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
154976665|NCT02960438|559338646|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
154976666|NCT02960438|559338647|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
154976667|NCT02960438|559338648|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
154976668|NCT02960438|559338645|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
154976669|NCT02960438|559338646|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
154976670|NCT02960438|559338647|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
154976671|NCT02960438|559338648|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
154976672|NCT02960438|559338645|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
154976673|NCT02960438|559338646|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
154976674|NCT02960438|559338647|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
154976675|NCT02960438|559338648|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
154976676|NCT02960438|559338645|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
154976677|NCT02960438|559338646|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
154976678|NCT02960438|559338647|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
154976679|NCT02960438|559338648|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
154976680|NCT02960438|559338645|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
154976681|NCT02960438|559338646|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
154976682|NCT02960438|559338647|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
154976683|NCT02960438|559338648|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
154976684|NCT02695719|559338660|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
154976685|NCT02695719|559338661|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
154976686|NCT02695719|559338660|FG000|Overall Study|Significant Protocol Deviation|0|||
154976687|NCT02695719|559338661|FG001|Overall Study|Significant Protocol Deviation|1|||
154976688|NCT02695719|559338660|FG000|Overall Study|Voluntary Withdrawal|1|||
154976689|NCT02695719|559338661|FG001|Overall Study|Voluntary Withdrawal|0|||
154976690|NCT01652729|559338662|FG000|Overall Study|Withdrawal by Subject|14|||
154976691|NCT01652729|559338663|FG001|Overall Study|Withdrawal by Subject|7|||
154976692|NCT01652729|559338664|FG002|Overall Study|Withdrawal by Subject|7|||
154976693|NCT01652729|559338662|FG000|Overall Study|Adverse Event|4|||
154976694|NCT01652729|559338663|FG001|Overall Study|Adverse Event|0|||
154976695|NCT01652729|559338664|FG002|Overall Study|Adverse Event|3|||
154976696|NCT01652729|559338662|FG000|Overall Study|Physician Decision|1|||
154976697|NCT01652729|559338663|FG001|Overall Study|Physician Decision|0|||
154976698|NCT01652729|559338664|FG002|Overall Study|Physician Decision|1|||
154976699|NCT01652729|559338662|FG000|Overall Study|Protocol Violation|1|||
154976700|NCT01652729|559338663|FG001|Overall Study|Protocol Violation|0|||
155175413|NCT04585009|560080239|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155175414|NCT04585009|560080240|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155175415|NCT04585009|560080241|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155175416|NCT04585009|560080242|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
154886029|NCT02883049|559005337|FG015|Post Induction|MRD negative|0|||
154886030|NCT02883049|559005322|FG000|Post Induction|Developed SMN|0|||
154886031|NCT02883049|559005323|FG001|Post Induction|Developed SMN|0|||
154886032|NCT02883049|559005324|FG002|Post Induction|Developed SMN|0|||
154886033|NCT02883049|559005325|FG003|Post Induction|Developed SMN|0|||
154886034|NCT02883049|559005326|FG004|Post Induction|Developed SMN|1|||
154886035|NCT02883049|559005327|FG005|Post Induction|Developed SMN|0|||
154886036|NCT02883049|559005328|FG006|Post Induction|Developed SMN|1|||
154976701|NCT01652729|559338664|FG002|Overall Study|Protocol Violation|0|||
154976702|NCT01652729|559338662|FG000|Overall Study|Lost to Follow-up|6|||
154976703|NCT01652729|559338663|FG001|Overall Study|Lost to Follow-up|6|||
154976704|NCT01652729|559338664|FG002|Overall Study|Lost to Follow-up|3|||
154976705|NCT01652729|559338662|FG000|Overall Study|Administrative|1|||
154976706|NCT01652729|559338663|FG001|Overall Study|Administrative|0|||
154976707|NCT01652729|559338664|FG002|Overall Study|Administrative|0|||
154976708|NCT00483548|559338665|FG000|Overall Study|Randomized; not treated with study drug|1|||
154976709|NCT00483548|559338666|FG001|Overall Study|Randomized; not treated with study drug|3|||
154976710|NCT00483548|559338665|FG000|Overall Study|Adverse Event|25|||
154976711|NCT00483548|559338666|FG001|Overall Study|Adverse Event|14|||
154976712|NCT00483548|559338665|FG000|Overall Study|Laboratory abnormality|1|||
154976713|NCT00483548|559338666|FG001|Overall Study|Laboratory abnormality|2|||
154976714|NCT00483548|559338665|FG000|Overall Study|Lack of Efficacy|4|||
154976715|NCT00483548|559338666|FG001|Overall Study|Lack of Efficacy|8|||
154976716|NCT00483548|559338665|FG000|Overall Study|Protocol Violation|11|||
154976717|NCT00483548|559338666|FG001|Overall Study|Protocol Violation|7|||
154976718|NCT00483548|559338665|FG000|Overall Study|Pregnancy|1|||
154976719|NCT00483548|559338666|FG001|Overall Study|Pregnancy|0|||
154976720|NCT00483548|559338665|FG000|Overall Study|Protocol required discontinuation|6|||
154976721|NCT00483548|559338666|FG001|Overall Study|Protocol required discontinuation|6|||
154976722|NCT00483548|559338665|FG000|Overall Study|Unable to comply with protocol schedule|1|||
154976723|NCT00483548|559338666|FG001|Overall Study|Unable to comply with protocol schedule|0|||
154976724|NCT00483548|559338665|FG000|Overall Study|Non-compliance with medication|2|||
154976725|NCT00483548|559338666|FG001|Overall Study|Non-compliance with medication|0|||
154976726|NCT00483548|559338665|FG000|Overall Study|Lost to Follow-up|3|||
154976727|NCT00483548|559338666|FG001|Overall Study|Lost to Follow-up|4|||
154976728|NCT00483548|559338665|FG000|Overall Study|Withdrawal by Subject|5|||
154976729|NCT00483548|559338666|FG001|Overall Study|Withdrawal by Subject|2|||
154976730|NCT03180801|559338669|FG000|Overall Study|Physician Decision|3|||
154976731|NCT03180801|559338670|FG001|Overall Study|Physician Decision|3|||
154976732|NCT03180801|559338671|FG002|Overall Study|Physician Decision|1|||
154976733|NCT03180801|559338669|FG000|Overall Study|Non-compliance|1|||
154976734|NCT03180801|559338670|FG001|Overall Study|Non-compliance|4|||
154976735|NCT03180801|559338671|FG002|Overall Study|Non-compliance|0|||
154976736|NCT03180801|559338669|FG000|Overall Study|Inoculation Target Reached|1|||
154976737|NCT03180801|559338670|FG001|Overall Study|Inoculation Target Reached|1|||
154976738|NCT03180801|559338671|FG002|Overall Study|Inoculation Target Reached|3|||
154976739|NCT03180801|559338669|FG000|Overall Study|Adverse Event|1|||
154976740|NCT03180801|559338670|FG001|Overall Study|Adverse Event|0|||
154976741|NCT03180801|559338671|FG002|Overall Study|Adverse Event|2|||
154976742|NCT03180801|559338669|FG000|Overall Study|Withdrawal by Subject|2|||
154976743|NCT03180801|559338670|FG001|Overall Study|Withdrawal by Subject|2|||
154976744|NCT03180801|559338671|FG002|Overall Study|Withdrawal by Subject|1|||
154976745|NCT03180801|559338669|FG000|Overall Study|Lost to Follow-up|0|||
154976746|NCT03180801|559338670|FG001|Overall Study|Lost to Follow-up|2|||
154976747|NCT03180801|559338671|FG002|Overall Study|Lost to Follow-up|3|||
154976748|NCT00868296|559338674|FG000|Overall Study|Adverse Event|0|||
154976749|NCT00868296|559338675|FG001|Overall Study|Adverse Event|2|||
155113702|NCT03515551|559844900|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
155113703|NCT03515551|559844901|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155113704|NCT03515551|559844902|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155113705|NCT03515551|559844903|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155113706|NCT03515551|559844904|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155113707|NCT03515551|559844905|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
155113708|NCT01221623|559844911|FG000|Overall Study|Withdrawal by Subject|19|||
155113709|NCT01221623|559844912|FG001|Overall Study|Withdrawal by Subject|8|||
155113710|NCT01221623|559844911|FG000|Overall Study|Lost to Follow-up|7|||
155113711|NCT01221623|559844912|FG001|Overall Study|Lost to Follow-up|1|||
155113712|NCT01221623|559844911|FG000|Overall Study|Adverse Event|6|||
155113713|NCT01221623|559844912|FG001|Overall Study|Adverse Event|3|||
155113714|NCT01221623|559844911|FG000|Overall Study|Death|1|||
155113715|NCT01221623|559844912|FG001|Overall Study|Death|0|||
155113716|NCT01221623|559844911|FG000|Overall Study|Other|5|||
155113717|NCT01221623|559844912|FG001|Overall Study|Other|2|||
155113718|NCT00661726|559844913|FG000|Overall Study|Adverse Event|1|||
154976750|NCT00868296|559338674|FG000|Overall Study|Withdrawal by Subject|0|||
154976751|NCT00868296|559338675|FG001|Overall Study|Withdrawal by Subject|1|||
154976752|NCT01142908|559338681|FG000|Overall Study|Lost to Follow-up|19|||
154976753|NCT01142908|559338682|FG001|Overall Study|Lost to Follow-up|13|||
154976754|NCT01142908|559338681|FG000|Overall Study|Death|1|||
154976755|NCT01142908|559338682|FG001|Overall Study|Death|4|||
154976756|NCT01142908|559338681|FG000|Overall Study|Excluded - did not meet criteria|9|||
154976757|NCT01142908|559338682|FG001|Overall Study|Excluded - did not meet criteria|5|||
155113719|NCT02147197|559844914|FG000|Overall Study|Adverse Event|1|||
155113720|NCT02147197|559844915|FG001|Overall Study|Adverse Event|0|||
155113721|NCT02147197|559844916|FG002|Overall Study|Adverse Event|0|||
155113722|NCT02147197|559844914|FG000|Overall Study|Withdrawal of Consent|4|||
155113723|NCT02147197|559844915|FG001|Overall Study|Withdrawal of Consent|3|||
154886037|NCT02883049|559005329|FG007|Post Induction|Developed SMN|0|||
154886038|NCT02883049|559005330|FG008|Post Induction|Developed SMN|0|||
154886039|NCT02883049|559005331|FG009|Post Induction|Developed SMN|0|||
154886040|NCT02883049|559005332|FG010|Post Induction|Developed SMN|1|||
154886041|NCT02883049|559005333|FG011|Post Induction|Developed SMN|1|||
154886042|NCT02883049|559005334|FG012|Post Induction|Developed SMN|0|||
154886043|NCT02883049|559005335|FG013|Post Induction|Developed SMN|0|||
154886044|NCT02883049|559005336|FG014|Post Induction|Developed SMN|1|||
154886045|NCT02883049|559005337|FG015|Post Induction|Developed SMN|0|||
154886046|NCT02883049|559005322|FG000|Post Induction|Enrolled onto another COG study|0|||
154886047|NCT02883049|559005323|FG001|Post Induction|Enrolled onto another COG study|0|||
154886048|NCT02883049|559005324|FG002|Post Induction|Enrolled onto another COG study|0|||
154886049|NCT02883049|559005325|FG003|Post Induction|Enrolled onto another COG study|1|||
154886050|NCT02883049|559005326|FG004|Post Induction|Enrolled onto another COG study|1|||
154886051|NCT02883049|559005327|FG005|Post Induction|Enrolled onto another COG study|0|||
154886052|NCT02883049|559005328|FG006|Post Induction|Enrolled onto another COG study|0|||
154886053|NCT02883049|559005329|FG007|Post Induction|Enrolled onto another COG study|4|||
154886054|NCT02883049|559005330|FG008|Post Induction|Enrolled onto another COG study|0|||
154886055|NCT02883049|559005331|FG009|Post Induction|Enrolled onto another COG study|0|||
154886056|NCT02883049|559005332|FG010|Post Induction|Enrolled onto another COG study|0|||
154886057|NCT02883049|559005333|FG011|Post Induction|Enrolled onto another COG study|2|||
154886058|NCT02883049|559005334|FG012|Post Induction|Enrolled onto another COG study|0|||
154886059|NCT02883049|559005335|FG013|Post Induction|Enrolled onto another COG study|1|||
154886060|NCT02883049|559005336|FG014|Post Induction|Enrolled onto another COG study|0|||
154886061|NCT02883049|559005337|FG015|Post Induction|Enrolled onto another COG study|0|||
154886062|NCT02883049|559005322|FG000|Post Induction|Recurrent leukemia|0|||
154886063|NCT02883049|559005323|FG001|Post Induction|Recurrent leukemia|0|||
154886064|NCT02883049|559005324|FG002|Post Induction|Recurrent leukemia|0|||
154886065|NCT02883049|559005325|FG003|Post Induction|Recurrent leukemia|17|||
154886066|NCT02883049|559005326|FG004|Post Induction|Recurrent leukemia|12|||
154886067|NCT02883049|559005327|FG005|Post Induction|Recurrent leukemia|4|||
154886068|NCT02883049|559005328|FG006|Post Induction|Recurrent leukemia|1|||
154886069|NCT02883049|559005329|FG007|Post Induction|Recurrent leukemia|13|||
154886070|NCT02883049|559005330|FG008|Post Induction|Recurrent leukemia|27|||
154886071|NCT02883049|559005331|FG009|Post Induction|Recurrent leukemia|5|||
154886072|NCT02883049|559005332|FG010|Post Induction|Recurrent leukemia|3|||
154886073|NCT02883049|559005333|FG011|Post Induction|Recurrent leukemia|12|||
154886074|NCT02883049|559005334|FG012|Post Induction|Recurrent leukemia|1|||
154886075|NCT02883049|559005335|FG013|Post Induction|Recurrent leukemia|1|||
154886076|NCT02883049|559005336|FG014|Post Induction|Recurrent leukemia|9|||
154886077|NCT02883049|559005337|FG015|Post Induction|Recurrent leukemia|3|||
154886078|NCT02883049|559005322|FG000|Post Induction|Induction Failure|0|||
154886079|NCT02883049|559005323|FG001|Post Induction|Induction Failure|0|||
154886080|NCT02883049|559005324|FG002|Post Induction|Induction Failure|0|||
154886081|NCT02883049|559005325|FG003|Post Induction|Induction Failure|0|||
154886082|NCT02883049|559005326|FG004|Post Induction|Induction Failure|0|||
154886083|NCT02883049|559005327|FG005|Post Induction|Induction Failure|0|||
154886084|NCT02883049|559005328|FG006|Post Induction|Induction Failure|0|||
154886085|NCT02883049|559005329|FG007|Post Induction|Induction Failure|2|||
154886086|NCT02883049|559005330|FG008|Post Induction|Induction Failure|2|||
154886087|NCT02883049|559005331|FG009|Post Induction|Induction Failure|0|||
154886088|NCT02883049|559005332|FG010|Post Induction|Induction Failure|0|||
154886089|NCT02883049|559005333|FG011|Post Induction|Induction Failure|0|||
154886090|NCT02883049|559005334|FG012|Post Induction|Induction Failure|0|||
154886091|NCT02883049|559005335|FG013|Post Induction|Induction Failure|2|||
154886092|NCT02883049|559005336|FG014|Post Induction|Induction Failure|0|||
154886093|NCT02883049|559005337|FG015|Post Induction|Induction Failure|0|||
154886094|NCT00229203|559005338|FG000|Overall Study|Progressive disease|18|||
154886095|NCT00229203|559005339|FG001|Overall Study|Progressive disease|9|||
154886096|NCT00229203|559005338|FG000|Overall Study|Toxicity|6|||
154886097|NCT00229203|559005339|FG001|Overall Study|Toxicity|1|||
154886098|NCT00229203|559005338|FG000|Overall Study|Death|4|||
154886099|NCT00229203|559005339|FG001|Overall Study|Death|2|||
154976758|NCT01142908|559338681|FG000|Overall Study|Withdrawal by Subject|3|||
154886100|NCT00229203|559005338|FG000|Overall Study|Other|3|||
154976759|NCT01142908|559338682|FG001|Overall Study|Withdrawal by Subject|0|||
154976760|NCT01999894|559338687|FG000|Overall Study|Adverse Event|9|||
154886101|NCT00229203|559005339|FG001|Overall Study|Other|3|||
154886102|NCT00229203|559005338|FG000|Overall Study|Withdrawal by Subject|1|||
154886103|NCT00229203|559005339|FG001|Overall Study|Withdrawal by Subject|4|||
154886104|NCT03457103|559005340|FG000|Overall Study|illness/hospitalization|4|||
154886105|NCT03457103|559005341|FG001|Overall Study|illness/hospitalization|2|||
154886106|NCT03457103|559005340|FG000|Overall Study|Lost to Follow-up|2|||
154886107|NCT03457103|559005341|FG001|Overall Study|Lost to Follow-up|1|||
154886108|NCT03457103|559005340|FG000|Overall Study|Withdrawal by Subject|1|||
154886109|NCT03457103|559005341|FG001|Overall Study|Withdrawal by Subject|2|||
154886110|NCT03457103|559005340|FG000|Overall Study|financial/ insurance issues|1|||
154886111|NCT03457103|559005341|FG001|Overall Study|financial/ insurance issues|1|||
154886112|NCT03004469|559005344|FG000|Overall Study|Adverse Event|6|||
154886113|NCT03004469|559005345|FG001|Overall Study|Adverse Event|4|||
154886114|NCT03004469|559005346|FG002|Overall Study|Adverse Event|6|||
154886115|NCT03004469|559005344|FG000|Overall Study|Lack of Efficacy|1|||
154886116|NCT03004469|559005345|FG001|Overall Study|Lack of Efficacy|0|||
154886117|NCT03004469|559005346|FG002|Overall Study|Lack of Efficacy|1|||
154886118|NCT03004469|559005344|FG000|Overall Study|Lost to Follow-up|23|||
154886119|NCT03004469|559005345|FG001|Overall Study|Lost to Follow-up|14|||
154886120|NCT03004469|559005346|FG002|Overall Study|Lost to Follow-up|6|||
154886121|NCT03004469|559005344|FG000|Overall Study|Non-Compliance with Study Drug|2|||
154886122|NCT03004469|559005345|FG001|Overall Study|Non-Compliance with Study Drug|0|||
154886123|NCT03004469|559005346|FG002|Overall Study|Non-Compliance with Study Drug|0|||
154886124|NCT03004469|559005344|FG000|Overall Study|Protocol Violation|0|||
154886125|NCT03004469|559005345|FG001|Overall Study|Protocol Violation|0|||
154886126|NCT03004469|559005346|FG002|Overall Study|Protocol Violation|1|||
154886127|NCT03004469|559005344|FG000|Overall Study|Withdrawal by Subject|29|||
154886128|NCT03004469|559005345|FG001|Overall Study|Withdrawal by Subject|27|||
154886129|NCT03004469|559005346|FG002|Overall Study|Withdrawal by Subject|10|||
154886130|NCT03004469|559005344|FG000|Overall Study|Other unspecified reason|0|||
154886131|NCT03004469|559005345|FG001|Overall Study|Other unspecified reason|4|||
154886132|NCT03004469|559005346|FG002|Overall Study|Other unspecified reason|1|||
154886133|NCT01163253|559005347|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
154886134|NCT01163253|559005348|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
154886135|NCT01163253|559005347|FG000|Overall Study|Study Terminated by Sponsor|978|||
154886136|NCT01163253|559005348|FG001|Overall Study|Study Terminated by Sponsor|349|||
154886137|NCT01163253|559005347|FG000|Overall Study|Protocol Violation|43|||
154886138|NCT01163253|559005348|FG001|Overall Study|Protocol Violation|12|||
154886139|NCT01163253|559005347|FG000|Overall Study|Withdrawal by Subject|199|||
154886140|NCT01163253|559005348|FG001|Overall Study|Withdrawal by Subject|50|||
154886141|NCT01163253|559005347|FG000|Overall Study|Medication Error|1|||
154886142|NCT01163253|559005348|FG001|Overall Study|Medication Error|0|||
154886143|NCT01163253|559005347|FG000|Overall Study|Lost to Follow-up|125|||
154886144|NCT01163253|559005348|FG001|Overall Study|Lost to Follow-up|23|||
154886145|NCT01163253|559005347|FG000|Overall Study|Insufficient Clinical Response|423|||
154886146|NCT01163253|559005348|FG001|Overall Study|Insufficient Clinical Response|29|||
154886147|NCT01163253|559005347|FG000|Overall Study|Adverse Event|300|||
154886148|NCT01163253|559005348|FG001|Overall Study|Adverse Event|78|||
154886149|NCT01163253|559005347|FG000|Overall Study|Death|17|||
154886150|NCT01163253|559005348|FG001|Overall Study|Death|5|||
154886151|NCT01163253|559005347|FG000|Overall Study|Ongoing|13|||
154886152|NCT01163253|559005348|FG001|Overall Study|Ongoing|4|||
154886153|NCT01163253|559005347|FG000|Overall Study|Other Unspecified|170|||
154886154|NCT01163253|559005348|FG001|Overall Study|Other Unspecified|34|||
154886155|NCT01397552|559005349|FG000|Overall Study|Adverse Event|1|||
154886156|NCT01397552|559005350|FG001|Overall Study|Adverse Event|0|||
154886157|NCT01397552|559005349|FG000|Overall Study|Withdrawal by Subject|2|||
154886158|NCT01397552|559005350|FG001|Overall Study|Withdrawal by Subject|1|||
154886159|NCT00423735|559005351|FG000|Overall Study|Ineligible / No protocol treatment|8|||
154886160|NCT00423735|559005352|FG001|Overall Study|Ineligible / No protocol treatment|6|||
154886161|NCT00423735|559005353|FG002|Overall Study|Ineligible / No protocol treatment|0|||
154886162|NCT01089582|559005359|FG000|Overall Study|Death|2|||
154886163|NCT01089582|559005359|FG000|Overall Study|Adverse Event|15|||
154886164|NCT01089582|559005359|FG000|Overall Study|Lost to Follow-up|8|||
154886165|NCT01089582|559005359|FG000|Overall Study|Other|4|||
154886166|NCT01089582|559005359|FG000|Overall Study|Withdrawal by Subject|1|||
154886167|NCT02394808|559005360|FG000|Period 1|Unsatisfactory lens fitting|0|||
154886168|NCT02394808|559005361|FG001|Period 1|Unsatisfactory lens fitting|1|||
154886169|NCT02394808|559005360|FG000|Period 2|Lost to Follow-up|1|||
154886170|NCT02394808|559005361|FG001|Period 2|Lost to Follow-up|0|||
154886171|NCT00289185|559005362|FG000|Overall Study|Withdrawal by Subject|4|||
154886172|NCT00289185|559005363|FG001|Overall Study|Withdrawal by Subject|8|||
154886173|NCT00289185|559005362|FG000|Overall Study|Lost to Follow-up|23|||
154886174|NCT00289185|559005363|FG001|Overall Study|Lost to Follow-up|17|||
154886175|NCT00289185|559005362|FG000|Overall Study|Death|1|||
154886176|NCT00289185|559005363|FG001|Overall Study|Death|1|||
154886177|NCT01124448|559005366|FG000|Overall Study|Lost to Follow-up|0|||
154886178|NCT01124448|559005367|FG001|Overall Study|Lost to Follow-up|3|||
154886179|NCT01124448|559005366|FG000|Overall Study|Protocol Violation|2|||
154886180|NCT01124448|559005367|FG001|Overall Study|Protocol Violation|0|||
154886181|NCT05025787|559005368|FG000|Overall Study|Lack of Efficacy|0|||
154886182|NCT05025787|559005369|FG001|Overall Study|Lack of Efficacy|1|||
154886183|NCT05025787|559005368|FG000|Overall Study|Adverse Event|2|||
154886184|NCT05025787|559005369|FG001|Overall Study|Adverse Event|4|||
154886185|NCT05025787|559005368|FG000|Overall Study|Non compliance|0|||
154886186|NCT05025787|559005369|FG001|Overall Study|Non compliance|1|||
154886187|NCT05025787|559005368|FG000|Overall Study|Protocol Violation|3|||
154886188|NCT05025787|559005369|FG001|Overall Study|Protocol Violation|1|||
154886189|NCT05025787|559005368|FG000|Overall Study|Stopping criteria met|1|||
154886190|NCT05025787|559005369|FG001|Overall Study|Stopping criteria met|1|||
154886191|NCT05025787|559005368|FG000|Overall Study|Withdrawal by Subject|3|||
154886192|NCT05025787|559005369|FG001|Overall Study|Withdrawal by Subject|1|||
154886193|NCT00976950|559005370|FG000|Overall Study|Adverse Event|3|||
154886194|NCT00976950|559005370|FG000|Overall Study|Events with no relationship to Aptivus|3|||
154886195|NCT01025817|559005378|FG000|Completed Study Medication|Adverse Event|66|||
154886196|NCT01025817|559005379|FG001|Completed Study Medication|Adverse Event|39|||
154886197|NCT01025817|559005378|FG000|Completed Study Medication|Protocol Deviation|9|||
154886198|NCT01025817|559005379|FG001|Completed Study Medication|Protocol Deviation|8|||
154886199|NCT01025817|559005378|FG000|Completed Study Medication|Withdrawal by Subject|8|||
154886200|NCT01025817|559005379|FG001|Completed Study Medication|Withdrawal by Subject|9|||
154886201|NCT01025817|559005378|FG000|Completed Study Medication|Administrative problems|7|||
154886202|NCT01025817|559005379|FG001|Completed Study Medication|Administrative problems|5|||
154886203|NCT01025817|559005378|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
154886204|NCT01025817|559005379|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
154886205|NCT01025817|559005378|FG000|Completed Study Medication|Abnormal test procedure|4|||
154886206|NCT01025817|559005379|FG001|Completed Study Medication|Abnormal test procedure|0|||
154886207|NCT01025817|559005378|FG000|Completed Study Medication|Graft loss|2|||
154886208|NCT01025817|559005379|FG001|Completed Study Medication|Graft loss|5|||
154886209|NCT01025817|559005378|FG000|Completed Study Medication|Death|2|||
154886210|NCT01025817|559005379|FG001|Completed Study Medication|Death|2|||
154886211|NCT01025817|559005378|FG000|Completed Study Medication|Abnormal lab values|0|||
154886212|NCT01025817|559005379|FG001|Completed Study Medication|Abnormal lab values|2|||
154886213|NCT01025817|559005378|FG000|Completed Study Medication|Subject no longer required study drug|0|||
154886214|NCT01025817|559005379|FG001|Completed Study Medication|Subject no longer required study drug|1|||
154886215|NCT01025817|559005378|FG000|Completed Study Medication|Lost to Follow-up|0|||
154886216|NCT01025817|559005379|FG001|Completed Study Medication|Lost to Follow-up|1|||
154886217|NCT01025817|559005378|FG000|Completed Study|Withdrawal by Subject|8|||
154886218|NCT01025817|559005379|FG001|Completed Study|Withdrawal by Subject|16|||
154886219|NCT01025817|559005378|FG000|Completed Study|Death|6|||
154886220|NCT01025817|559005379|FG001|Completed Study|Death|5|||
154886221|NCT01025817|559005378|FG000|Completed Study|Missing|2|||
154886222|NCT01025817|559005379|FG001|Completed Study|Missing|0|||
154886223|NCT01025817|559005378|FG000|Completed Study|Lost to Follow-up|0|||
154886224|NCT01025817|559005379|FG001|Completed Study|Lost to Follow-up|1|||
154886225|NCT00807846|559005382|FG000|Overall Study|Adverse Event|5|||
154886226|NCT00807846|559005383|FG001|Overall Study|Adverse Event|0|||
154886227|NCT00807846|559005382|FG000|Overall Study|Lack of Efficacy|2|||
154886228|NCT00807846|559005383|FG001|Overall Study|Lack of Efficacy|0|||
154886229|NCT00807846|559005382|FG000|Overall Study|Protocol Violation|2|||
154886230|NCT00807846|559005383|FG001|Overall Study|Protocol Violation|1|||
154886231|NCT00807846|559005382|FG000|Overall Study|Withdrawal by Subject|2|||
154886232|NCT00807846|559005383|FG001|Overall Study|Withdrawal by Subject|1|||
154886233|NCT00807846|559005382|FG000|Overall Study|Other|1|||
154886234|NCT00807846|559005383|FG001|Overall Study|Other|2|||
154886235|NCT01081873|559005384|FG000|Overall Study|Death|86|||
154886236|NCT01081873|559005384|FG000|Overall Study|Withdrawal by Subject|10|||
154886237|NCT01081873|559005384|FG000|Overall Study|Lost to Follow-up|142|||
154886238|NCT01081873|559005384|FG000|Overall Study|Progression of prostate cancer|13|||
154886239|NCT01081873|559005384|FG000|Overall Study|Other|47|||
154886240|NCT01165021|559005386|FG000|Overall Study|Death|1|||
154886241|NCT02491073|559005387|FG000|Overall Study|screen failure|1|||
154886242|NCT02491073|559005388|FG001|Overall Study|screen failure|0|||
154886243|NCT01419665|559005389|FG000|Combination Treatment|Adverse Event|7|||
154886244|NCT01419665|559005390|FG001|Combination Treatment|Adverse Event|10|||
154886245|NCT01419665|559005389|FG000|Combination Treatment|Physician Decision|5|||
154886246|NCT01419665|559005390|FG001|Combination Treatment|Physician Decision|8|||
154886247|NCT01419665|559005389|FG000|Combination Treatment|Protocol Violation|6|||
154886248|NCT01419665|559005390|FG001|Combination Treatment|Protocol Violation|2|||
154886249|NCT01419665|559005389|FG000|Combination Treatment|disease progression|10|||
154886250|NCT01419665|559005390|FG001|Combination Treatment|disease progression|9|||
154886251|NCT01419665|559005389|FG000|Combination Treatment|Death|5|||
154886252|NCT01419665|559005390|FG001|Combination Treatment|Death|7|||
154886253|NCT01419665|559005389|FG000|Combination Treatment|administrative problems|0|||
154886254|NCT01419665|559005390|FG001|Combination Treatment|administrative problems|1|||
154886255|NCT01419665|559005389|FG000|Combination Treatment|Withdrawal by Subject|5|||
154886256|NCT01419665|559005390|FG001|Combination Treatment|Withdrawal by Subject|4|||
154886257|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
154886258|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
154886259|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
154886260|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
154886261|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
154976761|NCT01999894|559338687|FG000|Overall Study|Lack of Efficacy|5|||
154886262|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
154976762|NCT01999894|559338687|FG000|Overall Study|Protocol Violation|1|||
154976763|NCT01999894|559338687|FG000|Overall Study|Withdrawal by Subject|7|||
154976764|NCT01999894|559338687|FG000|Overall Study|Lost to Follow-up|10|||
154976765|NCT01999894|559338687|FG000|Overall Study|Other Reason|3|||
154976766|NCT01999894|559338687|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
154976767|NCT01519947|559338688|FG000|Overall Study|Death|0|||
154976768|NCT01519947|559338689|FG001|Overall Study|Death|0|||
154976769|NCT01519947|559338690|FG002|Overall Study|Death|0|||
154976770|NCT01519947|559338691|FG003|Overall Study|Death|1|||
154976771|NCT01519947|559338688|FG000|Overall Study|Protocol Violation|0|||
154976772|NCT01519947|559338689|FG001|Overall Study|Protocol Violation|0|||
154976773|NCT01519947|559338690|FG002|Overall Study|Protocol Violation|2|||
154976774|NCT01519947|559338691|FG003|Overall Study|Protocol Violation|1|||
154976775|NCT01519947|559338688|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
154976776|NCT01519947|559338689|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
154976777|NCT01519947|559338690|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
154976778|NCT01519947|559338691|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
154976779|NCT01519947|559338688|FG000|Overall Study|Development of Anemia|0|||
154976780|NCT01519947|559338689|FG001|Overall Study|Development of Anemia|1|||
154976781|NCT01519947|559338690|FG002|Overall Study|Development of Anemia|0|||
154976782|NCT01519947|559338691|FG003|Overall Study|Development of Anemia|1|||
154976783|NCT01519947|559338688|FG000|Overall Study|Blood Transfusion|0|||
154976784|NCT01519947|559338689|FG001|Overall Study|Blood Transfusion|1|||
154976785|NCT01519947|559338690|FG002|Overall Study|Blood Transfusion|1|||
154976786|NCT01519947|559338691|FG003|Overall Study|Blood Transfusion|0|||
154976787|NCT01519947|559338688|FG000|Overall Study|Withdrawal by Subject|0|||
154976788|NCT01519947|559338689|FG001|Overall Study|Withdrawal by Subject|1|||
154976789|NCT01519947|559338690|FG002|Overall Study|Withdrawal by Subject|0|||
154976790|NCT01519947|559338691|FG003|Overall Study|Withdrawal by Subject|1|||
154976791|NCT01519947|559338688|FG000|Overall Study|Lost to Follow-up|0|||
154976792|NCT01519947|559338689|FG001|Overall Study|Lost to Follow-up|0|||
154976793|NCT01519947|559338690|FG002|Overall Study|Lost to Follow-up|3|||
154976794|NCT01519947|559338691|FG003|Overall Study|Lost to Follow-up|2|||
154976795|NCT01519947|559338688|FG000|Overall Study|Poor Response|1|||
154976796|NCT01519947|559338689|FG001|Overall Study|Poor Response|0|||
154976797|NCT01519947|559338690|FG002|Overall Study|Poor Response|0|||
154976798|NCT01519947|559338691|FG003|Overall Study|Poor Response|1|||
154976799|NCT01519947|559338688|FG000|Overall Study|Adverse Event|1|||
154976800|NCT01519947|559338689|FG001|Overall Study|Adverse Event|0|||
154976801|NCT01519947|559338690|FG002|Overall Study|Adverse Event|1|||
154976802|NCT01519947|559338691|FG003|Overall Study|Adverse Event|1|||
154976803|NCT03750695|559338692|FG000|Overall Study|Lost to Follow-up|0|||
154976804|NCT03750695|559338693|FG001|Overall Study|Lost to Follow-up|1|||
154976805|NCT01264835|559338698|FG000|Overall Study|Lost to Follow-up|1|||
154976806|NCT01115933|559338704|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
154976807|NCT02427399|559338705|FG000|Overall Study|Protocol Violation|14|||
154976808|NCT02427399|559338706|FG001|Overall Study|Protocol Violation|16|||
154976809|NCT02427399|559338707|FG002|Overall Study|Protocol Violation|12|||
154976810|NCT02427399|559338708|FG003|Overall Study|Protocol Violation|18|||
154976811|NCT02427399|559338709|FG004|Overall Study|Protocol Violation|15|||
154976812|NCT00605176|559338710|FG000|Overall Study|Adverse Event|2|||
154976813|NCT00605176|559338711|FG001|Overall Study|Adverse Event|1|||
154976814|NCT00605176|559338712|FG002|Overall Study|Adverse Event|3|||
154976815|NCT00605176|559338710|FG000|Overall Study|Withdrawal by Subject|4|||
154976816|NCT00605176|559338711|FG001|Overall Study|Withdrawal by Subject|2|||
154976817|NCT00605176|559338712|FG002|Overall Study|Withdrawal by Subject|4|||
154976818|NCT00605176|559338710|FG000|Overall Study|Lost to Follow-up|2|||
154976819|NCT00605176|559338711|FG001|Overall Study|Lost to Follow-up|2|||
154976820|NCT00605176|559338712|FG002|Overall Study|Lost to Follow-up|1|||
154976821|NCT00605176|559338710|FG000|Overall Study|Non-complicance with study procedures|1|||
154976822|NCT00605176|559338711|FG001|Overall Study|Non-complicance with study procedures|0|||
155113724|NCT02147197|559844916|FG002|Overall Study|Withdrawal of Consent|2|||
155113725|NCT02147197|559844914|FG000|Overall Study|Lost to Follow-up|2|||
155113726|NCT02147197|559844915|FG001|Overall Study|Lost to Follow-up|3|||
155113727|NCT02147197|559844916|FG002|Overall Study|Lost to Follow-up|1|||
154976823|NCT00605176|559338712|FG002|Overall Study|Non-complicance with study procedures|0|||
154976824|NCT00605176|559338710|FG000|Overall Study|Use of concomitant therapy|1|||
154976825|NCT00605176|559338711|FG001|Overall Study|Use of concomitant therapy|0|||
154976826|NCT00605176|559338712|FG002|Overall Study|Use of concomitant therapy|1|||
155113728|NCT02147197|559844914|FG000|Overall Study|Protocol Violation|1|||
154976827|NCT00605176|559338710|FG000|Overall Study|Other (not due to AE)|1|||
154976828|NCT00605176|559338711|FG001|Overall Study|Other (not due to AE)|1|||
154976829|NCT00605176|559338712|FG002|Overall Study|Other (not due to AE)|0|||
154976830|NCT00685750|559338713|FG000|Overall Study|Tumor sampling failure|0|||
154976831|NCT00685750|559338714|FG001|Overall Study|Tumor sampling failure|0|||
154976832|NCT00685750|559338715|FG002|Overall Study|Tumor sampling failure|1|||
154976833|NCT00685750|559338716|FG003|Overall Study|Tumor sampling failure|0|||
154976834|NCT00685750|559338717|FG004|Overall Study|Tumor sampling failure|0|||
155113729|NCT02147197|559844915|FG001|Overall Study|Protocol Violation|0|||
154886263|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
154886264|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
154886265|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
154886266|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
154886267|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
154886268|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
154886269|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|Death|1|||
154886270|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|Death|2|||
154886271|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
154886272|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
154886273|NCT01419665|559005389|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
154886274|NCT01419665|559005390|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
154886275|NCT01419665|559005389|FG000|Open Label Phase|Death|1|||
154886276|NCT01419665|559005390|FG001|Open Label Phase|Death|0|||
154886277|NCT01419665|559005389|FG000|Open Label Phase|disease progression|0|||
154886278|NCT01419665|559005390|FG001|Open Label Phase|disease progression|1|||
154886279|NCT03977727|559005391|FG000|Second Treatment|Lost to Follow-up|0|||
154886280|NCT03977727|559005392|FG001|Second Treatment|Lost to Follow-up|3|||
154886281|NCT02683525|559005394|FG000|Overall Study|Lost to Follow-up|1|||
154886282|NCT02683525|559005394|FG000|Overall Study|Physician Decision|1|||
154886283|NCT02683525|559005394|FG000|Overall Study|Disease Progression|6|||
154886284|NCT03352414|559005398|FG000|Overall Study|Ineligible by operative criteria|12|||
154886285|NCT03352414|559005399|FG001|Overall Study|Ineligible by operative criteria|10|||
154886286|NCT01341652|559005403|FG000|Overall Study|Incorrect Random Assignment|0|||
154886287|NCT01341652|559005404|FG001|Overall Study|Incorrect Random Assignment|1|||
154886288|NCT01341652|559005403|FG000|Overall Study|ineligible; presence metastatic disease|0|||
154886289|NCT01341652|559005404|FG001|Overall Study|ineligible; presence metastatic disease|1|||
154886290|NCT02998554|559005405|FG000|Overall Study|Adverse Event|8|||
154886291|NCT02998554|559005406|FG001|Overall Study|Adverse Event|3|||
154886292|NCT02998554|559005405|FG000|Overall Study|Protocol deviation|1|||
154886293|NCT02998554|559005406|FG001|Overall Study|Protocol deviation|0|||
154886294|NCT02998554|559005405|FG000|Overall Study|Withdrawal by Subject|2|||
154886295|NCT02998554|559005406|FG001|Overall Study|Withdrawal by Subject|6|||
154886296|NCT02998554|559005405|FG000|Overall Study|Lost to Follow-up|0|||
154886297|NCT02998554|559005406|FG001|Overall Study|Lost to Follow-up|1|||
154886298|NCT02998554|559005405|FG000|Overall Study|Lack of Efficacy|0|||
154886299|NCT02998554|559005406|FG001|Overall Study|Lack of Efficacy|1|||
154886300|NCT02953782|559005407|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
154886301|NCT02953782|559005408|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
154886302|NCT02953782|559005409|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
154886303|NCT02953782|559005410|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
154886304|NCT02953782|559005411|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
154886305|NCT02953782|559005412|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
154886306|NCT02953782|559005413|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
154886307|NCT02953782|559005414|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
154886308|NCT02953782|559005407|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
154886309|NCT02953782|559005408|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
154886310|NCT02953782|559005409|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
154886311|NCT02953782|559005410|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
154886312|NCT02953782|559005411|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
154886313|NCT02953782|559005412|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
154886314|NCT02953782|559005413|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
154886315|NCT02953782|559005414|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
154886316|NCT02953782|559005407|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
154886317|NCT02953782|559005408|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
154886318|NCT02953782|559005409|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
154886319|NCT02953782|559005410|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
154886320|NCT02953782|559005411|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
154886321|NCT02953782|559005412|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
154886322|NCT02953782|559005413|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
154886323|NCT02953782|559005414|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
154976835|NCT00685750|559338718|FG005|Overall Study|Tumor sampling failure|0|||
154976836|NCT00685750|559338719|FG006|Overall Study|Tumor sampling failure|0|||
154886324|NCT02953782|559005407|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
154886325|NCT02953782|559005408|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
154886326|NCT02953782|559005409|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
154976837|NCT00685750|559338713|FG000|Overall Study|Patient didn't receive the treatment|0|||
154976838|NCT00685750|559338714|FG001|Overall Study|Patient didn't receive the treatment|0|||
155113730|NCT02147197|559844916|FG002|Overall Study|Protocol Violation|3|||
154976839|NCT00685750|559338715|FG002|Overall Study|Patient didn't receive the treatment|0|||
154976840|NCT00685750|559338716|FG003|Overall Study|Patient didn't receive the treatment|0|||
154976841|NCT00685750|559338717|FG004|Overall Study|Patient didn't receive the treatment|0|||
154976842|NCT00685750|559338718|FG005|Overall Study|Patient didn't receive the treatment|0|||
154976843|NCT00685750|559338719|FG006|Overall Study|Patient didn't receive the treatment|1|||
154976844|NCT00685750|559338713|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
154976845|NCT00685750|559338714|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
154976846|NCT00685750|559338715|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
154976847|NCT00685750|559338716|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
154976848|NCT00685750|559338717|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
154976849|NCT00685750|559338718|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
154976850|NCT00685750|559338719|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
154976851|NCT04974580|559338720|FG000|Overall Study|Lost to Follow-up|33|||
154976852|NCT04974580|559338721|FG001|Overall Study|Lost to Follow-up|39|||
154976853|NCT04974580|559338722|FG002|Overall Study|Lost to Follow-up|30|||
154976854|NCT04974580|559338723|FG003|Overall Study|Lost to Follow-up|29|||
154976855|NCT00587431|559338724|FG000|Overall Study|Adverse Event|1|||
154976856|NCT00587431|559338725|FG001|Overall Study|Adverse Event|0|||
154976857|NCT00587431|559338724|FG000|Overall Study|Withdrawal by Subject|0|||
154976858|NCT00587431|559338725|FG001|Overall Study|Withdrawal by Subject|1|||
154976859|NCT05467982|559338726|FG000|Overall Study|Death|0|||
154976860|NCT05467982|559338727|FG001|Overall Study|Death|1|||
154976861|NCT05467982|559338726|FG000|Overall Study|Lost to Follow-up|3|||
154976862|NCT05467982|559338727|FG001|Overall Study|Lost to Follow-up|1|||
154976863|NCT00220727|559338752|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
154976864|NCT00220727|559338753|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
154976865|NCT02508116|559338756|FG000|Overall Study|Lost to Follow-up|2|||
154976866|NCT02508116|559338757|FG001|Overall Study|Lost to Follow-up|3|||
154976867|NCT02508116|559338756|FG000|Overall Study|Withdrawal by Subject|3|||
154976868|NCT02508116|559338757|FG001|Overall Study|Withdrawal by Subject|2|||
154976869|NCT02508116|559338756|FG000|Overall Study|Protocol Violation|1|||
154976870|NCT02508116|559338757|FG001|Overall Study|Protocol Violation|2|||
154976871|NCT02508116|559338756|FG000|Overall Study|Physician Decision|2|||
154976872|NCT02508116|559338757|FG001|Overall Study|Physician Decision|0|||
154976873|NCT00109850|559338758|FG000|Overall Study|Adverse Event|1|||
154976874|NCT00109850|559338758|FG000|Overall Study|Death|2|||
154976875|NCT00109850|559338758|FG000|Overall Study|Ineligible|1|||
154976876|NCT04234464|559338759|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
154976877|NCT04234464|559338760|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
154976878|NCT00476593|559338761|FG000|Overall Study|Lost to Follow-up|10|||
154976879|NCT00476593|559338762|FG001|Overall Study|Lost to Follow-up|2|||
154976880|NCT00476593|559338763|FG002|Overall Study|Lost to Follow-up|8|||
154976881|NCT00476593|559338764|FG003|Overall Study|Lost to Follow-up|22|||
154976882|NCT00983528|559338765|FG000|Overall Study|Death|4|||
154976883|NCT00983528|559338765|FG000|Overall Study|Lost to Follow-up|1|||
154976884|NCT00983528|559338765|FG000|Overall Study|Study Terminated|1|||
154976885|NCT03430011|559338767|FG000|Pre-Treatment|Death|1|||
154976886|NCT03430011|559338768|FG001|Pre-Treatment|Death|0|||
154976887|NCT03430011|559338769|FG002|Pre-Treatment|Death|0|||
154976888|NCT03430011|559338770|FG003|Pre-Treatment|Death|0|||
154976889|NCT03430011|559338771|FG004|Pre-Treatment|Death|1|||
154976890|NCT03430011|559338772|FG005|Pre-Treatment|Death|0|||
154976891|NCT03430011|559338773|FG006|Pre-Treatment|Death|1|||
154976892|NCT03430011|559338774|FG007|Pre-Treatment|Death|0|||
154976893|NCT03430011|559338767|FG000|Pre-Treatment|Screen Fail|0|||
154976894|NCT03430011|559338768|FG001|Pre-Treatment|Screen Fail|0|||
154976895|NCT03430011|559338769|FG002|Pre-Treatment|Screen Fail|0|||
154976896|NCT03430011|559338770|FG003|Pre-Treatment|Screen Fail|0|||
154976897|NCT03430011|559338771|FG004|Pre-Treatment|Screen Fail|1|||
154976898|NCT03430011|559338772|FG005|Pre-Treatment|Screen Fail|0|||
154976899|NCT03430011|559338773|FG006|Pre-Treatment|Screen Fail|0|||
154976900|NCT03430011|559338774|FG007|Pre-Treatment|Screen Fail|0|||
154976901|NCT03430011|559338767|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976902|NCT03430011|559338768|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976903|NCT03430011|559338769|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
154976904|NCT03430011|559338770|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976905|NCT03430011|559338771|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976906|NCT03430011|559338772|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976907|NCT03430011|559338773|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976908|NCT03430011|559338774|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
154976909|NCT03430011|559338767|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
154976910|NCT03430011|559338768|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
154976911|NCT03430011|559338769|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
154976912|NCT03430011|559338770|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
154886327|NCT02953782|559005410|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
155113731|NCT02147197|559844914|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155113732|NCT02147197|559844915|FG001|Overall Study|Other Miscellaneous Reasons|0|||
154886328|NCT02953782|559005411|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
154886329|NCT02953782|559005412|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
154886330|NCT02953782|559005413|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
154886331|NCT02953782|559005414|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
154886332|NCT02953782|559005407|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
154886333|NCT02953782|559005408|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
154886334|NCT02953782|559005409|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
154886335|NCT02953782|559005410|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
154886336|NCT02953782|559005411|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
154886337|NCT02953782|559005412|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
154886338|NCT02953782|559005413|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
154886339|NCT02953782|559005414|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
154886340|NCT02953782|559005407|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
154886341|NCT02953782|559005408|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
154886342|NCT02953782|559005409|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
154886343|NCT02953782|559005410|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
154886344|NCT02953782|559005411|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
154886345|NCT02953782|559005412|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
154886346|NCT02953782|559005413|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
154886347|NCT02953782|559005414|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
154886348|NCT02953782|559005407|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
154886349|NCT02953782|559005408|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
154886350|NCT02953782|559005409|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
154886351|NCT02953782|559005410|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
154886352|NCT02953782|559005411|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
154886353|NCT02953782|559005412|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
154886354|NCT02953782|559005413|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
154886355|NCT02953782|559005414|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
154886356|NCT02953782|559005407|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886357|NCT02953782|559005408|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886358|NCT02953782|559005409|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886359|NCT02953782|559005410|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886360|NCT02953782|559005411|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886361|NCT02953782|559005412|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886362|NCT02953782|559005413|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
154886363|NCT02953782|559005414|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
154886364|NCT01737840|559005415|FG000|Overall Study|Diagnosed with an other pathology|2|||
154886365|NCT01737840|559005416|FG001|Overall Study|Diagnosed with an other pathology|2|||
154886366|NCT03105700|559005417|FG000|Overall Study|screen fail|3|||
154886367|NCT03105700|559005417|FG000|Overall Study|Lost to Follow-up|4|||
154886368|NCT01449682|559005420|FG000|Overall Study|Death|0|||
154886369|NCT01449682|559005421|FG001|Overall Study|Death|1|||
154886370|NCT01449682|559005420|FG000|Overall Study|Adverse Event|1|||
154886371|NCT01449682|559005421|FG001|Overall Study|Adverse Event|0|||
154886372|NCT02720016|559005422|FG000|Overall Study|Separation of couple|6|||
154886373|NCT02720016|559005423|FG001|Overall Study|Separation of couple|8|||
154886374|NCT02720016|559005424|FG002|Overall Study|Separation of couple|2|||
154886375|NCT02720016|559005422|FG000|Overall Study|Withdrawal by Subject|6|||
154886376|NCT02720016|559005423|FG001|Overall Study|Withdrawal by Subject|6|||
154886377|NCT02720016|559005424|FG002|Overall Study|Withdrawal by Subject|4|||
154886378|NCT02720016|559005422|FG000|Overall Study|Scheduling issues|2|||
154886379|NCT02720016|559005423|FG001|Overall Study|Scheduling issues|4|||
154886380|NCT02720016|559005424|FG002|Overall Study|Scheduling issues|7|||
154886381|NCT02720016|559005422|FG000|Overall Study|Childcare|2|||
154886382|NCT02720016|559005423|FG001|Overall Study|Childcare|0|||
154886383|NCT02720016|559005424|FG002|Overall Study|Childcare|2|||
154886384|NCT02720016|559005422|FG000|Overall Study|Withdrawal by PI|2|||
154886385|NCT02720016|559005423|FG001|Overall Study|Withdrawal by PI|2|||
154886386|NCT02720016|559005424|FG002|Overall Study|Withdrawal by PI|0|||
154886387|NCT02720016|559005422|FG000|Overall Study|Moved away|2|||
154886388|NCT02720016|559005423|FG001|Overall Study|Moved away|0|||
154886389|NCT02720016|559005424|FG002|Overall Study|Moved away|0|||
154886390|NCT02720016|559005422|FG000|Overall Study|Not Primary Health Concern|0|||
154886391|NCT02720016|559005423|FG001|Overall Study|Not Primary Health Concern|0|||
154976913|NCT03430011|559338771|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
155113733|NCT02147197|559844916|FG002|Overall Study|Other Miscellaneous Reasons|3|||
155113734|NCT04091581|559844918|FG000|Overall Study|Lost to Follow-up|0|||
154976914|NCT03430011|559338772|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
154976915|NCT03430011|559338773|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
154976916|NCT03430011|559338774|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
154976917|NCT03430011|559338767|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
154976918|NCT03430011|559338768|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
154976919|NCT03430011|559338769|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
154976920|NCT03430011|559338770|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
154976921|NCT03430011|559338771|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
154976922|NCT03430011|559338772|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
154976923|NCT03430011|559338773|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
154976924|NCT03430011|559338774|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
154976925|NCT03430011|559338767|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
154976926|NCT03430011|559338768|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
154976927|NCT03430011|559338769|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
154976928|NCT03430011|559338770|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
154976929|NCT03430011|559338771|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
154976930|NCT03430011|559338772|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
154976931|NCT03430011|559338773|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
154976932|NCT03430011|559338774|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
154976933|NCT03430011|559338767|FG000|JCARH125 Treatment|Death|4|||
154976934|NCT03430011|559338768|FG001|JCARH125 Treatment|Death|19|||
154976935|NCT03430011|559338769|FG002|JCARH125 Treatment|Death|10|||
154976936|NCT03430011|559338770|FG003|JCARH125 Treatment|Death|8|||
155113735|NCT04091581|559844919|FG001|Overall Study|Lost to Follow-up|1|||
155113736|NCT03315793|559844920|FG000|Overall Study|Adverse Event|4|||
154886392|NCT02720016|559005424|FG002|Overall Study|Not Primary Health Concern|2|||
154886393|NCT02720016|559005422|FG000|Overall Study|Transportation issues|0|||
154886394|NCT02720016|559005423|FG001|Overall Study|Transportation issues|0|||
154886395|NCT02720016|559005424|FG002|Overall Study|Transportation issues|1|||
154886396|NCT02720016|559005422|FG000|Overall Study|Other|0|||
154886397|NCT02720016|559005423|FG001|Overall Study|Other|0|||
154886398|NCT02720016|559005424|FG002|Overall Study|Other|2|||
154886399|NCT05319080|559005426|FG000|Overall Study|Withdrawal by Subject|2|||
154886400|NCT05319080|559005426|FG000|Overall Study|Physician Decision|4|||
154886401|NCT00406783|559005427|FG000|Overall Study|Adverse Event|4|||
154886402|NCT00406783|559005428|FG001|Overall Study|Adverse Event|4|||
154886403|NCT00406783|559005427|FG000|Overall Study|Treatment Failure|2|||
154886404|NCT00406783|559005428|FG001|Overall Study|Treatment Failure|3|||
154886405|NCT00406783|559005427|FG000|Overall Study|Lost to Follow-up|3|||
154886406|NCT00406783|559005428|FG001|Overall Study|Lost to Follow-up|0|||
154886407|NCT00406783|559005427|FG000|Overall Study|Withdrawal by Subject|1|||
154886408|NCT00406783|559005428|FG001|Overall Study|Withdrawal by Subject|4|||
154886409|NCT00406783|559005427|FG000|Overall Study|Protocol Violation|4|||
154886410|NCT00406783|559005428|FG001|Overall Study|Protocol Violation|4|||
154886411|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
154886412|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
154886413|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
154886414|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
154886415|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
154886416|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
154886417|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
154886418|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
154886419|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
154886420|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
154886421|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
154886422|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
154886423|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
154886424|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
154886425|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
154886426|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
154886427|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Missing|3|||
154886428|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Missing|1|||
154886429|NCT00838916|559005429|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
154886430|NCT00838916|559005430|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
154886431|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
154886432|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
154886433|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
154886434|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
154886435|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
154886436|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
154886437|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
154886438|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
154976937|NCT03430011|559338771|FG004|JCARH125 Treatment|Death|5|||
154976938|NCT03430011|559338772|FG005|JCARH125 Treatment|Death|3|||
155113737|NCT03315793|559844921|FG001|Overall Study|Adverse Event|2|||
154886439|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
154886440|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
154886441|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
154886442|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
154886443|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
154886444|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
154886445|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
154886446|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
154886447|NCT00838916|559005429|FG000|Follow-up Period (8 Weeks)|Missing|3|||
154886448|NCT00838916|559005430|FG001|Follow-up Period (8 Weeks)|Missing|0|||
154886449|NCT03488251|559005431|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
154886450|NCT03488251|559005432|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
154886451|NCT03488251|559005433|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
154886452|NCT03488251|559005434|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
154886453|NCT03488251|559005431|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
154886454|NCT03488251|559005432|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
154886455|NCT03488251|559005433|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
154886456|NCT03488251|559005434|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
154886457|NCT03488251|559005431|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
154886458|NCT03488251|559005432|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
154886459|NCT03488251|559005433|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
154886460|NCT03488251|559005434|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
154886461|NCT03488251|559005431|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
154886462|NCT03488251|559005432|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
154886463|NCT03488251|559005433|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
154886464|NCT03488251|559005434|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
154886465|NCT03488251|559005431|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
154886466|NCT03488251|559005432|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
154886467|NCT03488251|559005433|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
154886468|NCT03488251|559005434|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
154886469|NCT03600714|559005435|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
154886470|NCT01935336|559005436|FG000|Overall Study|Adverse Event|1|||
154886471|NCT01935336|559005437|FG001|Overall Study|Adverse Event|0|||
154886472|NCT01935336|559005438|FG002|Overall Study|Adverse Event|0|||
154886473|NCT01935336|559005439|FG003|Overall Study|Adverse Event|0|||
154886474|NCT01935336|559005436|FG000|Overall Study|Progressive disease|5|||
154886475|NCT01935336|559005437|FG001|Overall Study|Progressive disease|3|||
154886476|NCT01935336|559005438|FG002|Overall Study|Progressive disease|47|||
154886477|NCT01935336|559005439|FG003|Overall Study|Progressive disease|66|||
154886478|NCT01810042|559005440|FG000|Overall Study|Lost to Follow-up|10|||
154886479|NCT03707158|559005441|FG000|Midtreatment|Lost to Follow-up|16|||
154886480|NCT03707158|559005442|FG001|Midtreatment|Lost to Follow-up|7|||
154886481|NCT03707158|559005441|FG000|Midtreatment|Withdrawal by Subject|28|||
154886482|NCT03707158|559005442|FG001|Midtreatment|Withdrawal by Subject|19|||
154886483|NCT03707158|559005441|FG000|Posttreatment|Lost to Follow-up|0|||
154886484|NCT03707158|559005442|FG001|Posttreatment|Lost to Follow-up|5|||
154886485|NCT03707158|559005441|FG000|Follow-up|Lost to Follow-up|19|||
154886486|NCT03707158|559005442|FG001|Follow-up|Lost to Follow-up|18|||
154886487|NCT03707158|559005441|FG000|Follow-up|Withdrawal by Subject|13|||
154886488|NCT03707158|559005442|FG001|Follow-up|Withdrawal by Subject|6|||
154886489|NCT01454401|559005446|FG000|Overall Study|Death|1|||
154886490|NCT01454401|559005446|FG000|Overall Study|hospitalised|1|||
154886491|NCT01454401|559005446|FG000|Overall Study|osteomyelitis|2|||
154886492|NCT01454401|559005446|FG000|Overall Study|non-adherence|1|||
154886493|NCT01968187|559005447|FG000|Overall Study|Adverse Event|0|||
154886494|NCT01968187|559005448|FG001|Overall Study|Adverse Event|1|||
154886495|NCT01968187|559005447|FG000|Overall Study|Randomized but not treated|1|||
154886496|NCT01968187|559005448|FG001|Overall Study|Randomized but not treated|0|||
154886497|NCT05108805|559005453|FG000|Overall Study|T-cell expansion was not successful.|5|||
154886498|NCT03422133|559005456|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
154886499|NCT03422133|559005457|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
154886500|NCT01274338|559007313|FG000|Overall Study|Lack of Efficacy|72|||
154886501|NCT01274338|559007314|FG001|Overall Study|Lack of Efficacy|108|||
154886502|NCT01274338|559007315|FG002|Overall Study|Lack of Efficacy|116|||
154886503|NCT01274338|559007316|FG003|Overall Study|Lack of Efficacy|0|||
154886504|NCT01274338|559007317|FG004|Overall Study|Lack of Efficacy|0|||
154886505|NCT01274338|559007318|FG005|Overall Study|Lack of Efficacy|0|||
154886506|NCT01274338|559007313|FG000|Overall Study|Adverse Event|272|||
154886507|NCT01274338|559007314|FG001|Overall Study|Adverse Event|105|||
154886508|NCT01274338|559007315|FG002|Overall Study|Adverse Event|180|||
154976939|NCT03430011|559338773|FG006|JCARH125 Treatment|Death|4|||
154976940|NCT03430011|559338774|FG007|JCARH125 Treatment|Death|2|||
154976941|NCT03430011|559338767|FG000|JCARH125 Treatment|Other reasons|1|||
154886509|NCT01274338|559007316|FG003|Overall Study|Adverse Event|1|||
154886510|NCT01274338|559007317|FG004|Overall Study|Adverse Event|0|||
154976942|NCT03430011|559338768|FG001|JCARH125 Treatment|Other reasons|0|||
154976943|NCT03430011|559338769|FG002|JCARH125 Treatment|Other reasons|4|||
154976944|NCT03430011|559338770|FG003|JCARH125 Treatment|Other reasons|2|||
154976945|NCT03430011|559338771|FG004|JCARH125 Treatment|Other reasons|2|||
154976946|NCT03430011|559338772|FG005|JCARH125 Treatment|Other reasons|1|||
154976947|NCT03430011|559338773|FG006|JCARH125 Treatment|Other reasons|3|||
154976948|NCT03430011|559338774|FG007|JCARH125 Treatment|Other reasons|2|||
154976949|NCT00330460|559338779|FG000|Overall Study|Physician Decision|1|||
154976950|NCT00330460|559338780|FG001|Overall Study|Physician Decision|0|||
154976951|NCT00330460|559338779|FG000|Overall Study|Adverse Event|10|||
154976952|NCT00330460|559338780|FG001|Overall Study|Adverse Event|8|||
154976953|NCT00330460|559338779|FG000|Overall Study|Withdrawal by Subject|18|||
154976954|NCT00330460|559338780|FG001|Overall Study|Withdrawal by Subject|17|||
154976955|NCT00330460|559338779|FG000|Overall Study|Death|1|||
154976956|NCT00330460|559338780|FG001|Overall Study|Death|1|||
154976957|NCT00330460|559338779|FG000|Overall Study|Ineligibility determined|1|||
154976958|NCT00330460|559338780|FG001|Overall Study|Ineligibility determined|3|||
154976959|NCT00330460|559338779|FG000|Overall Study|Lost to Follow-up|8|||
154976960|NCT00330460|559338780|FG001|Overall Study|Lost to Follow-up|3|||
154976961|NCT00330460|559338779|FG000|Overall Study|Noncompliance|2|||
154976962|NCT00330460|559338780|FG001|Overall Study|Noncompliance|1|||
154976963|NCT00330460|559338779|FG000|Overall Study|Other|1|||
154976964|NCT00330460|559338780|FG001|Overall Study|Other|0|||
154976965|NCT03712124|559338781|FG000|Overall Study|Protocol Violation|1|||
154976966|NCT03712124|559338782|FG001|Overall Study|Protocol Violation|0|||
154976967|NCT00602537|559338784|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
154976968|NCT00602537|559338785|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
154976969|NCT00602537|559338784|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
154976970|NCT00602537|559338785|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
154976971|NCT00602537|559338784|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
154976972|NCT00602537|559338785|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
154976973|NCT00602537|559338784|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
154976974|NCT00602537|559338785|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
154886511|NCT01274338|559007318|FG005|Overall Study|Adverse Event|0|||
154886512|NCT01274338|559007313|FG000|Overall Study|Death|8|||
154886513|NCT01274338|559007314|FG001|Overall Study|Death|1|||
154886514|NCT01274338|559007315|FG002|Overall Study|Death|0|||
154886515|NCT01274338|559007316|FG003|Overall Study|Death|0|||
154886516|NCT01274338|559007317|FG004|Overall Study|Death|0|||
154886517|NCT01274338|559007318|FG005|Overall Study|Death|0|||
154886518|NCT01274338|559007313|FG000|Overall Study|Withdrawal by Subject|27|||
154886519|NCT01274338|559007314|FG001|Overall Study|Withdrawal by Subject|99|||
154886520|NCT01274338|559007315|FG002|Overall Study|Withdrawal by Subject|17|||
154886521|NCT01274338|559007316|FG003|Overall Study|Withdrawal by Subject|0|||
154886522|NCT01274338|559007317|FG004|Overall Study|Withdrawal by Subject|0|||
154886523|NCT01274338|559007318|FG005|Overall Study|Withdrawal by Subject|0|||
154886524|NCT01274338|559007313|FG000|Overall Study|Did not start treatment|8|||
154886525|NCT01274338|559007314|FG001|Overall Study|Did not start treatment|116|||
154886526|NCT01274338|559007315|FG002|Overall Study|Did not start treatment|7|||
155175417|NCT04585009|560080243|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155175418|NCT04585009|560080244|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
155175419|NCT04585009|560080233|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175420|NCT04585009|560080234|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175421|NCT04585009|560080235|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175422|NCT04585009|560080236|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175423|NCT04585009|560080237|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175424|NCT04585009|560080238|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175425|NCT04585009|560080239|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
154886527|NCT01274338|559007316|FG003|Overall Study|Did not start treatment|0|||
155175426|NCT04585009|560080240|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
155175427|NCT04585009|560080241|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175428|NCT04585009|560080242|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175429|NCT04585009|560080243|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
154886528|NCT01274338|559007317|FG004|Overall Study|Did not start treatment|0|||
154886529|NCT01274338|559007318|FG005|Overall Study|Did not start treatment|0|||
154886530|NCT01274338|559007313|FG000|Overall Study|Alternative therapy|0|||
154886531|NCT01274338|559007314|FG001|Overall Study|Alternative therapy|1|||
154886532|NCT01274338|559007315|FG002|Overall Study|Alternative therapy|0|||
154886533|NCT01274338|559007316|FG003|Overall Study|Alternative therapy|0|||
154976975|NCT00602537|559338784|FG000|Follow Up Study Comparison|Adverse Event|1|||
154976976|NCT00602537|559338785|FG001|Follow Up Study Comparison|Adverse Event|0|||
155175430|NCT04585009|560080244|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
155175431|NCT04585009|560080233|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175432|NCT04585009|560080234|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175433|NCT04585009|560080235|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175434|NCT04585009|560080236|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175435|NCT04585009|560080237|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
155175436|NCT04585009|560080238|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175437|NCT04585009|560080239|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175438|NCT04585009|560080240|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175439|NCT04585009|560080241|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175440|NCT04585009|560080242|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175441|NCT04585009|560080243|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
155175442|NCT04585009|560080244|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
154976977|NCT00602537|559338784|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
154976978|NCT00602537|559338785|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
154976979|NCT00602537|559338784|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
154976980|NCT00602537|559338785|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
154976981|NCT00388037|559338786|FG000|Overall Study|Protocol Violation|1|||
154976982|NCT02941523|559338789|FG000|Monotherapy|Withdrawal by Subject|0|||
154976983|NCT02941523|559338790|FG001|Monotherapy|Withdrawal by Subject|1|||
154976984|NCT02941523|559338789|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
154976985|NCT02941523|559338790|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
154976986|NCT02941523|559338789|FG000|Carboplatin Combination Therapy|Death|1|||
154976987|NCT02941523|559338790|FG001|Carboplatin Combination Therapy|Death|2|||
154976988|NCT02941523|559338789|FG000|Carboplatin Combination Therapy|Disease progression|2|||
154976989|NCT02941523|559338790|FG001|Carboplatin Combination Therapy|Disease progression|0|||
154976990|NCT02941523|559338789|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
154976991|NCT02941523|559338790|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
154976992|NCT04330157|559338791|FG000|Overall Study|Protocol Violation|4|||
154976993|NCT04330157|559338791|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
154976994|NCT01899326|559338793|FG000|Overall Study|Withdrawal by Subject|1|||
154976995|NCT01899326|559338793|FG000|Overall Study|Adverse Event|2|||
154976996|NCT01899326|559338793|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
154976997|NCT03558139|559338794|FG000|Overall Study|Consent Withdrawn|1|||
154976998|NCT03558139|559338795|FG001|Overall Study|Consent Withdrawn|1|||
154976999|NCT03558139|559338796|FG002|Overall Study|Consent Withdrawn|4|||
154977000|NCT03558139|559338794|FG000|Overall Study|Death|5|||
154977001|NCT03558139|559338795|FG001|Overall Study|Death|3|||
154977002|NCT03558139|559338796|FG002|Overall Study|Death|8|||
154977003|NCT03558139|559338794|FG000|Overall Study|Lost to Follow-up|0|||
154977004|NCT03558139|559338795|FG001|Overall Study|Lost to Follow-up|0|||
154977005|NCT03558139|559338796|FG002|Overall Study|Lost to Follow-up|3|||
154977006|NCT03558139|559338794|FG000|Overall Study|Study Ended Per Protocol|0|||
154977007|NCT03558139|559338795|FG001|Overall Study|Study Ended Per Protocol|3|||
154977008|NCT03558139|559338796|FG002|Overall Study|Study Ended Per Protocol|6|||
154977009|NCT00373425|559338797|FG000|Overall Study|Relapse of NSCLC|116|||
154977010|NCT00373425|559338798|FG001|Overall Study|Relapse of NSCLC|104|||
154977011|NCT00373425|559338799|FG002|Overall Study|Relapse of NSCLC|19|||
154977012|NCT00373425|559338800|FG003|Overall Study|Relapse of NSCLC|2|||
154977013|NCT00373425|559338801|FG004|Overall Study|Relapse of NSCLC|26|||
154977014|NCT00373425|559338797|FG000|Overall Study|Adverse Event|191|||
154977015|NCT00373425|559338798|FG001|Overall Study|Adverse Event|22|||
154977016|NCT00373425|559338799|FG002|Overall Study|Adverse Event|59|||
154977017|NCT00373425|559338800|FG003|Overall Study|Adverse Event|0|||
154977018|NCT00373425|559338801|FG004|Overall Study|Adverse Event|34|||
154977019|NCT00373425|559338797|FG000|Overall Study|Patient request|35|||
154977020|NCT00373425|559338798|FG001|Overall Study|Patient request|18|||
154977021|NCT00373425|559338799|FG002|Overall Study|Patient request|43|||
154977022|NCT00373425|559338800|FG003|Overall Study|Patient request|6|||
154977023|NCT00373425|559338801|FG004|Overall Study|Patient request|7|||
154977024|NCT00373425|559338797|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
154977025|NCT00373425|559338798|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
154977026|NCT00373425|559338799|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
154977027|NCT00373425|559338800|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
154977028|NCT00373425|559338801|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
154977029|NCT00373425|559338797|FG000|Overall Study|Death|7|||
154977030|NCT00373425|559338798|FG001|Overall Study|Death|0|||
154977031|NCT00373425|559338799|FG002|Overall Study|Death|3|||
154977032|NCT00373425|559338800|FG003|Overall Study|Death|1|||
154977033|NCT00373425|559338801|FG004|Overall Study|Death|0|||
154977034|NCT02808819|559338802|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
154977035|NCT02808819|559338803|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
154977036|NCT02808819|559338802|FG000|Overall Study|Withdrawal by Subject|10|||
154886534|NCT01274338|559007317|FG004|Overall Study|Alternative therapy|0|||
154886535|NCT01274338|559007318|FG005|Overall Study|Alternative therapy|0|||
154886536|NCT01274338|559007313|FG000|Overall Study|Other complicating diseases|0|||
154886537|NCT01274338|559007314|FG001|Overall Study|Other complicating diseases|3|||
154886538|NCT01274338|559007315|FG002|Overall Study|Other complicating diseases|1|||
154886539|NCT01274338|559007316|FG003|Overall Study|Other complicating diseases|0|||
154886540|NCT01274338|559007317|FG004|Overall Study|Other complicating diseases|0|||
154886541|NCT01274338|559007318|FG005|Overall Study|Other complicating diseases|0|||
154886542|NCT01274338|559007313|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
154886543|NCT01274338|559007314|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
154886544|NCT01274338|559007315|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
154886545|NCT01274338|559007316|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
154886546|NCT01274338|559007317|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
154886547|NCT01274338|559007318|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
154886548|NCT01274338|559007313|FG000|Overall Study|Pregnancy|0|||
154886549|NCT01274338|559007314|FG001|Overall Study|Pregnancy|0|||
154886550|NCT01274338|559007315|FG002|Overall Study|Pregnancy|1|||
154886551|NCT01274338|559007316|FG003|Overall Study|Pregnancy|0|||
154886552|NCT01274338|559007317|FG004|Overall Study|Pregnancy|0|||
154886553|NCT01274338|559007318|FG005|Overall Study|Pregnancy|0|||
154886554|NCT01274338|559007313|FG000|Overall Study|Reason not reported|12|||
154886555|NCT01274338|559007314|FG001|Overall Study|Reason not reported|21|||
154886556|NCT01274338|559007315|FG002|Overall Study|Reason not reported|3|||
154886557|NCT01274338|559007316|FG003|Overall Study|Reason not reported|0|||
154886558|NCT01274338|559007317|FG004|Overall Study|Reason not reported|1|||
154886559|NCT01274338|559007318|FG005|Overall Study|Reason not reported|0|||
154886560|NCT01927744|559007319|FG000|Overall Study|Death|2|||
154886561|NCT01927744|559007320|FG001|Overall Study|Death|9|||
154886562|NCT02064205|559007321|FG000|Overall Study|Withdrawal by Subject|1|||
154886563|NCT01708941|559007323|FG000|Overall Study|Adverse Event|4|||
154886564|NCT01708941|559007324|FG001|Overall Study|Adverse Event|6|||
154886565|NCT01708941|559007325|FG002|Overall Study|Adverse Event|1|||
154886566|NCT01708941|559007326|FG003|Overall Study|Adverse Event|0|||
154886567|NCT01708941|559007323|FG000|Overall Study|Death|1|||
154886568|NCT01708941|559007324|FG001|Overall Study|Death|1|||
154886569|NCT01708941|559007325|FG002|Overall Study|Death|2|||
154886570|NCT01708941|559007326|FG003|Overall Study|Death|14|||
154886571|NCT01708941|559007323|FG000|Overall Study|Withdrawal by Subject|1|||
154886572|NCT01708941|559007324|FG001|Overall Study|Withdrawal by Subject|0|||
154886573|NCT01708941|559007325|FG002|Overall Study|Withdrawal by Subject|3|||
154886574|NCT01708941|559007326|FG003|Overall Study|Withdrawal by Subject|4|||
154886575|NCT01708941|559007323|FG000|Overall Study|Disease progression|9|||
154886576|NCT01708941|559007324|FG001|Overall Study|Disease progression|10|||
154886577|NCT01708941|559007325|FG002|Overall Study|Disease progression|8|||
154886578|NCT01708941|559007326|FG003|Overall Study|Disease progression|0|||
154886579|NCT01708941|559007323|FG000|Overall Study|Alternative therapy|0|||
154886580|NCT01708941|559007324|FG001|Overall Study|Alternative therapy|0|||
154886581|NCT01708941|559007325|FG002|Overall Study|Alternative therapy|2|||
154886582|NCT01708941|559007326|FG003|Overall Study|Alternative therapy|0|||
154886583|NCT01708941|559007323|FG000|Overall Study|Ineligible and never started treatment|1|||
154886584|NCT01708941|559007324|FG001|Overall Study|Ineligible and never started treatment|0|||
154886585|NCT01708941|559007325|FG002|Overall Study|Ineligible and never started treatment|1|||
154886586|NCT01708941|559007326|FG003|Overall Study|Ineligible and never started treatment|0|||
154886587|NCT01708941|559007323|FG000|Overall Study|Never started treatment|2|||
154886588|NCT01708941|559007324|FG001|Overall Study|Never started treatment|1|||
154886589|NCT01708941|559007325|FG002|Overall Study|Never started treatment|0|||
154886590|NCT01708941|559007326|FG003|Overall Study|Never started treatment|0|||
154886591|NCT01708941|559007323|FG000|Overall Study|Ineligible|0|||
154886592|NCT01708941|559007324|FG001|Overall Study|Ineligible|0|||
154977037|NCT02808819|559338803|FG001|Overall Study|Withdrawal by Subject|13|||
155175443|NCT04585009|560080233|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
154886593|NCT01708941|559007325|FG002|Overall Study|Ineligible|2|||
154886594|NCT01708941|559007326|FG003|Overall Study|Ineligible|0|||
154886595|NCT01522976|559007327|FG000|Overall Study|Ineligible|4|||
154886596|NCT01522976|559007328|FG001|Overall Study|Ineligible|0|||
154886597|NCT01522976|559007329|FG002|Overall Study|Ineligible|1|||
154886598|NCT01522976|559007327|FG000|Overall Study|Death|7|||
154886599|NCT01522976|559007328|FG001|Overall Study|Death|6|||
154886600|NCT01522976|559007329|FG002|Overall Study|Death|2|||
154886601|NCT01522976|559007327|FG000|Overall Study|Still on treatment|9|||
154977038|NCT02808819|559338802|FG000|Overall Study|Site terminated by sponsor|2|||
154886602|NCT01522976|559007328|FG001|Overall Study|Still on treatment|9|||
154886603|NCT01522976|559007329|FG002|Overall Study|Still on treatment|6|||
154886604|NCT01522976|559007327|FG000|Overall Study|Disease progression|28|||
154886605|NCT01522976|559007328|FG001|Overall Study|Disease progression|30|||
154886606|NCT01522976|559007329|FG002|Overall Study|Disease progression|25|||
154886607|NCT01522976|559007327|FG000|Overall Study|Adverse Event|17|||
154886608|NCT01522976|559007328|FG001|Overall Study|Adverse Event|7|||
154886609|NCT01522976|559007329|FG002|Overall Study|Adverse Event|18|||
154977039|NCT02808819|559338803|FG001|Overall Study|Site terminated by sponsor|0|||
154977040|NCT02808819|559338802|FG000|Overall Study|Pregnancy|1|||
154977041|NCT02808819|559338803|FG001|Overall Study|Pregnancy|0|||
154977042|NCT02808819|559338802|FG000|Overall Study|Lost to Follow-up|1|||
154977043|NCT02808819|559338803|FG001|Overall Study|Lost to Follow-up|6|||
154977044|NCT02808819|559338802|FG000|Overall Study|Protocol Violation|0|||
154977045|NCT02808819|559338803|FG001|Overall Study|Protocol Violation|1|||
154977046|NCT02808819|559338802|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
154977047|NCT02808819|559338803|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
154977048|NCT02808819|559338802|FG000|Overall Study|Death|1|||
154977049|NCT02808819|559338803|FG001|Overall Study|Death|0|||
154977050|NCT02808819|559338802|FG000|Overall Study|Adverse Event|3|||
154977051|NCT02808819|559338803|FG001|Overall Study|Adverse Event|4|||
154977052|NCT02752802|559338804|FG000|Overall Study|Contrast Volume Not Collected|1|||
154977053|NCT02752802|559338805|FG001|Overall Study|Contrast Volume Not Collected|0|||
154977054|NCT00251316|559338806|FG000|Overall Study|Physician Decision|2|||
154886610|NCT01522976|559007327|FG000|Overall Study|Refusal unrelated to adverse event|10|||
154886611|NCT01522976|559007328|FG001|Overall Study|Refusal unrelated to adverse event|13|||
154886612|NCT01522976|559007329|FG002|Overall Study|Refusal unrelated to adverse event|14|||
154886613|NCT01522976|559007327|FG000|Overall Study|Not protocol specified|22|||
154886614|NCT01522976|559007328|FG001|Overall Study|Not protocol specified|27|||
154886615|NCT01522976|559007329|FG002|Overall Study|Not protocol specified|27|||
154886616|NCT00190983|559007330|FG000|Overall Study|Inevaluable (never treated)|2|||
154886617|NCT02287402|559007331|FG000|Treatment Period|Adverse Event|17|||
154886618|NCT02287402|559007331|FG000|Treatment Period|Voluntary Withdrawal|10|||
154886619|NCT02287402|559007331|FG000|Follow-up|Lost to Follow-up|1|||
154886620|NCT02287402|559007331|FG000|Follow-up|Voluntary Withdrawal|2|||
154886621|NCT04069156|559007332|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
154886622|NCT04069156|559007333|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
154886623|NCT04069156|559007332|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
154886624|NCT04069156|559007333|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
154886625|NCT04069156|559007332|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
154886626|NCT04069156|559007333|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
154886627|NCT04069156|559007332|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
154886628|NCT04069156|559007333|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
154886629|NCT04247815|559007334|FG000|Overall Study|Adverse Event|1|||
154886630|NCT04247815|559007335|FG001|Overall Study|Adverse Event|0|||
154886631|NCT04247815|559007334|FG000|Overall Study|Withdrawal by Subject|1|||
154886632|NCT04247815|559007335|FG001|Overall Study|Withdrawal by Subject|0|||
154886633|NCT04247815|559007334|FG000|Overall Study|Protocol Violation|0|||
154886634|NCT04247815|559007335|FG001|Overall Study|Protocol Violation|1|||
154886635|NCT00209170|559007336|FG000|Overall Study|Adverse Event|0|||
154886636|NCT00209170|559007337|FG001|Overall Study|Adverse Event|1|||
154886637|NCT00209170|559007336|FG000|Overall Study|Withdrawal by Subject|2|||
154886638|NCT00209170|559007337|FG001|Overall Study|Withdrawal by Subject|1|||
154886639|NCT00209170|559007336|FG000|Overall Study|Lack of Efficacy|0|||
154886640|NCT00209170|559007337|FG001|Overall Study|Lack of Efficacy|1|||
154886641|NCT02108600|559007338|FG000|Overall Study|Withdrawal by Subject|2|||
154886642|NCT02108600|559007339|FG001|Overall Study|Withdrawal by Subject|0|||
154886643|NCT02108600|559007338|FG000|Overall Study|Lost to Follow-up|1|||
154886644|NCT02108600|559007339|FG001|Overall Study|Lost to Follow-up|1|||
154886645|NCT01295580|559007340|FG000|Overall Study|Protocol Violation|4|||
154886646|NCT01295580|559007341|FG001|Overall Study|Protocol Violation|2|||
154886647|NCT01295580|559007340|FG000|Overall Study|Withdrawal by Subject|1|||
154886648|NCT01295580|559007341|FG001|Overall Study|Withdrawal by Subject|4|||
154886649|NCT01295580|559007340|FG000|Overall Study|Adverse Event|2|||
154886650|NCT01295580|559007341|FG001|Overall Study|Adverse Event|1|||
154886651|NCT01295580|559007340|FG000|Overall Study|Lost to Follow-up|1|||
154886652|NCT01295580|559007341|FG001|Overall Study|Lost to Follow-up|0|||
154886653|NCT01295580|559007340|FG000|Overall Study|Lack of Efficacy|1|||
154977055|NCT00251316|559338807|FG001|Overall Study|Physician Decision|3|||
155175444|NCT04585009|560080234|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175445|NCT04585009|560080235|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
154886654|NCT01295580|559007341|FG001|Overall Study|Lack of Efficacy|0|||
154886655|NCT01295580|559007340|FG000|Overall Study|Other: inconvenience|1|||
154886656|NCT01295580|559007341|FG001|Overall Study|Other: inconvenience|0|||
154886657|NCT01295580|559007340|FG000|Overall Study|Other: family objection|0|||
154886658|NCT01295580|559007341|FG001|Overall Study|Other: family objection|1|||
154886659|NCT00089479|559007342|FG000|Overall Study|Death|108|||
154886660|NCT00089479|559007343|FG001|Overall Study|Death|75|||
154886661|NCT00089479|559007342|FG000|Overall Study|Withdrawal by Subject|86|||
154977056|NCT00569777|559338810|FG000|Overall Study|Withdrawal by Subject|4|||
154977057|NCT00569777|559338811|FG001|Overall Study|Withdrawal by Subject|0|||
154977058|NCT00569777|559338810|FG000|Overall Study|Adverse Event|3|||
154886662|NCT00089479|559007343|FG001|Overall Study|Withdrawal by Subject|107|||
154886663|NCT00089479|559007342|FG000|Overall Study|Lost to Follow-up|137|||
155113738|NCT03315793|559844920|FG000|Overall Study|Protocol Deviation|1|||
154886664|NCT00089479|559007343|FG001|Overall Study|Lost to Follow-up|107|||
154886665|NCT03943953|559007344|FG000|Trial of ITG 1|Lost to Follow-up|19|||
154886666|NCT03943953|559007345|FG001|Trial of ITG 1|Lost to Follow-up|1|||
154886667|NCT03943953|559007344|FG000|Trial of ITG 2|Lost to Follow-up|8|||
154886668|NCT03943953|559007345|FG001|Trial of ITG 2|Lost to Follow-up|0|||
154886669|NCT03943953|559007344|FG000|Trial of ITG 3|Lost to Follow-up|2|||
154886670|NCT03943953|559007345|FG001|Trial of ITG 3|Lost to Follow-up|0|||
154886671|NCT03943953|559007344|FG000|Trial of ITG 4|Lost to Follow-up|2|||
154886672|NCT03943953|559007345|FG001|Trial of ITG 4|Lost to Follow-up|0|||
154886673|NCT01742078|559007348|FG000|Overall Study|Withdrawal by Subject|0|||
154886674|NCT01742078|559007349|FG001|Overall Study|Withdrawal by Subject|0|||
154886675|NCT01742078|559007350|FG002|Overall Study|Withdrawal by Subject|0|||
154886676|NCT01742078|559007351|FG003|Overall Study|Withdrawal by Subject|1|||
154886677|NCT01742078|559007352|FG004|Overall Study|Withdrawal by Subject|0|||
154886678|NCT01742078|559007353|FG005|Overall Study|Withdrawal by Subject|0|||
154886679|NCT01742078|559007354|FG006|Overall Study|Withdrawal by Subject|0|||
154886680|NCT01742078|559007355|FG007|Overall Study|Withdrawal by Subject|0|||
154886681|NCT01742078|559007356|FG008|Overall Study|Withdrawal by Subject|0|||
154886682|NCT05600309|559007359|FG000|Overall Study|Death|41|||
154886683|NCT05600309|559007360|FG001|Overall Study|Death|38|||
154886684|NCT05600309|559007359|FG000|Overall Study|Sponsor Decision|9|||
154886685|NCT05600309|559007360|FG001|Overall Study|Sponsor Decision|6|||
154886686|NCT05822830|559007361|FG000|Overall Study|Adverse Event|6|||
154886687|NCT05822830|559007362|FG001|Overall Study|Adverse Event|6|||
154886688|NCT05822830|559007361|FG000|Overall Study|Assigned Treatment by Mistake|5|||
154886689|NCT05822830|559007362|FG001|Overall Study|Assigned Treatment by Mistake|3|||
154886690|NCT05822830|559007361|FG000|Overall Study|Lost to Follow-up|16|||
154886691|NCT05822830|559007362|FG001|Overall Study|Lost to Follow-up|18|||
154886692|NCT05822830|559007361|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154886693|NCT05822830|559007362|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154886694|NCT05822830|559007361|FG000|Overall Study|Participant was Out of the Country|0|||
154886695|NCT05822830|559007362|FG001|Overall Study|Participant was Out of the Country|1|||
154886696|NCT05822830|559007361|FG000|Overall Study|Pregnancy|1|||
154886697|NCT05822830|559007362|FG001|Overall Study|Pregnancy|2|||
154886698|NCT05822830|559007361|FG000|Overall Study|Withdrawal by Subject|27|||
154886699|NCT05822830|559007362|FG001|Overall Study|Withdrawal by Subject|26|||
154886700|NCT03368664|559007363|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
154886701|NCT03368664|559007363|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
154886702|NCT03368664|559007363|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
154886703|NCT03368664|559007363|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
154886704|NCT05441592|559007364|FG000|Overall Study|Lost to Follow-up|1|||
154886705|NCT05441592|559007365|FG001|Overall Study|Lost to Follow-up|5|||
154886706|NCT01021852|559007366|FG000|Treatment Period 1|Adverse Event|3|||
154886707|NCT01021852|559007367|FG001|Treatment Period 1|Adverse Event|1|||
154886708|NCT01021852|559007368|FG002|Treatment Period 1|Adverse Event|1|||
154886709|NCT01021852|559007369|FG003|Treatment Period 1|Adverse Event|0|||
154886710|NCT01021852|559007370|FG004|Treatment Period 1|Adverse Event|2|||
154886711|NCT01021852|559007371|FG005|Treatment Period 1|Adverse Event|2|||
154886712|NCT01021852|559007372|FG006|Treatment Period 1|Adverse Event|0|||
154886713|NCT01021852|559007373|FG007|Treatment Period 1|Adverse Event|0|||
154886714|NCT01021852|559007366|FG000|Treatment Period 1|Pregnancy|0|||
154886715|NCT01021852|559007367|FG001|Treatment Period 1|Pregnancy|0|||
154886716|NCT01021852|559007368|FG002|Treatment Period 1|Pregnancy|1|||
154886717|NCT01021852|559007369|FG003|Treatment Period 1|Pregnancy|0|||
154886718|NCT01021852|559007370|FG004|Treatment Period 1|Pregnancy|0|||
154886719|NCT01021852|559007371|FG005|Treatment Period 1|Pregnancy|0|||
154886720|NCT01021852|559007372|FG006|Treatment Period 1|Pregnancy|0|||
154886721|NCT01021852|559007373|FG007|Treatment Period 1|Pregnancy|0|||
154886722|NCT01021852|559007366|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154886723|NCT01021852|559007367|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154886724|NCT01021852|559007368|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154886725|NCT01021852|559007369|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154886726|NCT01021852|559007370|FG004|Treatment Period 1|Withdrawal by Subject|1|||
154886727|NCT01021852|559007371|FG005|Treatment Period 1|Withdrawal by Subject|0|||
154886728|NCT01021852|559007372|FG006|Treatment Period 1|Withdrawal by Subject|0|||
154886729|NCT01021852|559007373|FG007|Treatment Period 1|Withdrawal by Subject|1|||
154886730|NCT01021852|559007366|FG000|Treatment Period 1|Not Treated|0|||
154886731|NCT01021852|559007367|FG001|Treatment Period 1|Not Treated|0|||
154886732|NCT01021852|559007368|FG002|Treatment Period 1|Not Treated|0|||
155113739|NCT03315793|559844921|FG001|Overall Study|Protocol Deviation|0|||
154886733|NCT01021852|559007369|FG003|Treatment Period 1|Not Treated|2|||
154886734|NCT01021852|559007370|FG004|Treatment Period 1|Not Treated|0|||
154886735|NCT01021852|559007371|FG005|Treatment Period 1|Not Treated|0|||
154886736|NCT01021852|559007372|FG006|Treatment Period 1|Not Treated|0|||
154886737|NCT01021852|559007373|FG007|Treatment Period 1|Not Treated|0|||
154886738|NCT01021852|559007366|FG000|Washout Period-Placebo|Adverse Event|0|||
154886739|NCT01021852|559007367|FG001|Washout Period-Placebo|Adverse Event|0|||
154886740|NCT01021852|559007368|FG002|Washout Period-Placebo|Adverse Event|0|||
154886741|NCT01021852|559007369|FG003|Washout Period-Placebo|Adverse Event|1|||
154886742|NCT01021852|559007370|FG004|Washout Period-Placebo|Adverse Event|0|||
154886743|NCT01021852|559007371|FG005|Washout Period-Placebo|Adverse Event|1|||
154886744|NCT01021852|559007372|FG006|Washout Period-Placebo|Adverse Event|0|||
154886745|NCT01021852|559007373|FG007|Washout Period-Placebo|Adverse Event|0|||
154886746|NCT01021852|559007366|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
154886747|NCT01021852|559007367|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
154886748|NCT01021852|559007368|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
154886749|NCT01021852|559007369|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
154886750|NCT01021852|559007370|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
154886751|NCT01021852|559007371|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
154886752|NCT01021852|559007372|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
154886753|NCT01021852|559007373|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
154886754|NCT01021852|559007366|FG000|Washout Period-Placebo|Protocol Violation|0|||
154886755|NCT01021852|559007367|FG001|Washout Period-Placebo|Protocol Violation|0|||
154886756|NCT01021852|559007368|FG002|Washout Period-Placebo|Protocol Violation|0|||
154886757|NCT01021852|559007369|FG003|Washout Period-Placebo|Protocol Violation|0|||
154886758|NCT01021852|559007370|FG004|Washout Period-Placebo|Protocol Violation|0|||
154886759|NCT01021852|559007371|FG005|Washout Period-Placebo|Protocol Violation|0|||
154886760|NCT01021852|559007372|FG006|Washout Period-Placebo|Protocol Violation|1|||
154886761|NCT01021852|559007373|FG007|Washout Period-Placebo|Protocol Violation|0|||
154886762|NCT01021852|559007366|FG000|Washout Period-No Drug|Adverse Event|1|||
154886763|NCT01021852|559007367|FG001|Washout Period-No Drug|Adverse Event|0|||
154886764|NCT01021852|559007368|FG002|Washout Period-No Drug|Adverse Event|0|||
154886765|NCT01021852|559007369|FG003|Washout Period-No Drug|Adverse Event|0|||
154886766|NCT01021852|559007370|FG004|Washout Period-No Drug|Adverse Event|0|||
154886767|NCT01021852|559007371|FG005|Washout Period-No Drug|Adverse Event|1|||
154886768|NCT01021852|559007372|FG006|Washout Period-No Drug|Adverse Event|0|||
154886769|NCT01021852|559007373|FG007|Washout Period-No Drug|Adverse Event|0|||
154886770|NCT01021852|559007366|FG000|Treatment Period 2|Adverse Event|0|||
154886771|NCT01021852|559007367|FG001|Treatment Period 2|Adverse Event|1|||
154886772|NCT01021852|559007368|FG002|Treatment Period 2|Adverse Event|0|||
154886773|NCT01021852|559007369|FG003|Treatment Period 2|Adverse Event|0|||
154886774|NCT01021852|559007370|FG004|Treatment Period 2|Adverse Event|1|||
154886775|NCT01021852|559007371|FG005|Treatment Period 2|Adverse Event|0|||
154886776|NCT01021852|559007372|FG006|Treatment Period 2|Adverse Event|1|||
154886777|NCT01021852|559007373|FG007|Treatment Period 2|Adverse Event|0|||
154886778|NCT01021852|559007366|FG000|Treatment Period 2|Lack of Efficacy|0|||
154886779|NCT01021852|559007367|FG001|Treatment Period 2|Lack of Efficacy|0|||
154886780|NCT01021852|559007368|FG002|Treatment Period 2|Lack of Efficacy|0|||
154886781|NCT01021852|559007369|FG003|Treatment Period 2|Lack of Efficacy|0|||
154886782|NCT01021852|559007370|FG004|Treatment Period 2|Lack of Efficacy|0|||
154886783|NCT01021852|559007371|FG005|Treatment Period 2|Lack of Efficacy|1|||
154886784|NCT01021852|559007372|FG006|Treatment Period 2|Lack of Efficacy|0|||
154886785|NCT01021852|559007373|FG007|Treatment Period 2|Lack of Efficacy|0|||
154886786|NCT01021852|559007366|FG000|Treatment Period 2|Physician Decision|0|||
154886787|NCT01021852|559007367|FG001|Treatment Period 2|Physician Decision|0|||
154886788|NCT01021852|559007368|FG002|Treatment Period 2|Physician Decision|1|||
154886789|NCT01021852|559007369|FG003|Treatment Period 2|Physician Decision|0|||
154886790|NCT01021852|559007370|FG004|Treatment Period 2|Physician Decision|0|||
154886791|NCT01021852|559007371|FG005|Treatment Period 2|Physician Decision|0|||
154886792|NCT01021852|559007372|FG006|Treatment Period 2|Physician Decision|0|||
154886793|NCT01021852|559007373|FG007|Treatment Period 2|Physician Decision|0|||
154886794|NCT01021852|559007366|FG000|Treatment Period 2|Protocol Violation|0|||
154886795|NCT01021852|559007367|FG001|Treatment Period 2|Protocol Violation|0|||
154886796|NCT01021852|559007368|FG002|Treatment Period 2|Protocol Violation|0|||
154886797|NCT01021852|559007369|FG003|Treatment Period 2|Protocol Violation|0|||
154886798|NCT01021852|559007370|FG004|Treatment Period 2|Protocol Violation|1|||
155113740|NCT03315793|559844920|FG000|Overall Study|Difficult for regular visit|0|||
154886799|NCT01021852|559007371|FG005|Treatment Period 2|Protocol Violation|0|||
154886800|NCT01021852|559007372|FG006|Treatment Period 2|Protocol Violation|1|||
154886801|NCT01021852|559007373|FG007|Treatment Period 2|Protocol Violation|0|||
154977059|NCT00569777|559338811|FG001|Overall Study|Adverse Event|0|||
154977060|NCT00569777|559338810|FG000|Overall Study|Lost to Follow-up|1|||
154886802|NCT01021852|559007366|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154886803|NCT01021852|559007367|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154886804|NCT01021852|559007368|FG002|Treatment Period 2|Withdrawal by Subject|0|||
154886805|NCT01021852|559007369|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154886806|NCT01021852|559007370|FG004|Treatment Period 2|Withdrawal by Subject|0|||
154886807|NCT01021852|559007371|FG005|Treatment Period 2|Withdrawal by Subject|0|||
154886808|NCT01021852|559007372|FG006|Treatment Period 2|Withdrawal by Subject|1|||
154886809|NCT01021852|559007373|FG007|Treatment Period 2|Withdrawal by Subject|2|||
154977061|NCT00569777|559338811|FG001|Overall Study|Lost to Follow-up|0|||
154977062|NCT00569777|559338810|FG000|Overall Study|scheduled eye surgery|0|||
155113741|NCT03315793|559844921|FG001|Overall Study|Difficult for regular visit|1|||
155113742|NCT00790868|559846150|FG000|Overall Study|Withdrawal by Subject|4|||
155113743|NCT00790868|559846151|FG001|Overall Study|Withdrawal by Subject|5|||
155113744|NCT00790868|559846150|FG000|Overall Study|Lost to Follow-up|2|||
155113745|NCT00790868|559846151|FG001|Overall Study|Lost to Follow-up|12|||
154886810|NCT01371981|559007374|FG000|Overall Study|Adverse Event|12|||
154886811|NCT01371981|559007375|FG001|Overall Study|Adverse Event|17|||
154886812|NCT01371981|559007376|FG002|Overall Study|Adverse Event|0|||
154886813|NCT01371981|559007377|FG003|Overall Study|Adverse Event|4|||
154886814|NCT01371981|559007378|FG004|Overall Study|Adverse Event|1|||
154886815|NCT01371981|559007379|FG005|Overall Study|Adverse Event|0|||
154886816|NCT01371981|559007374|FG000|Overall Study|Death|22|||
154886817|NCT01371981|559007375|FG001|Overall Study|Death|16|||
154886818|NCT01371981|559007376|FG002|Overall Study|Death|0|||
154886819|NCT01371981|559007377|FG003|Overall Study|Death|0|||
154886820|NCT01371981|559007378|FG004|Overall Study|Death|2|||
154886821|NCT01371981|559007379|FG005|Overall Study|Death|2|||
154886822|NCT01371981|559007374|FG000|Overall Study|Lack of Efficacy|69|||
154886823|NCT01371981|559007375|FG001|Overall Study|Lack of Efficacy|61|||
154886824|NCT01371981|559007376|FG002|Overall Study|Lack of Efficacy|4|||
154886825|NCT01371981|559007377|FG003|Overall Study|Lack of Efficacy|8|||
154886826|NCT01371981|559007378|FG004|Overall Study|Lack of Efficacy|5|||
154886827|NCT01371981|559007379|FG005|Overall Study|Lack of Efficacy|0|||
154886828|NCT01371981|559007374|FG000|Overall Study|Physician Decision|48|||
154886829|NCT01371981|559007375|FG001|Overall Study|Physician Decision|63|||
154886830|NCT01371981|559007376|FG002|Overall Study|Physician Decision|1|||
154886831|NCT01371981|559007377|FG003|Overall Study|Physician Decision|7|||
154886832|NCT01371981|559007378|FG004|Overall Study|Physician Decision|14|||
154886833|NCT01371981|559007379|FG005|Overall Study|Physician Decision|3|||
154886834|NCT01371981|559007374|FG000|Overall Study|Withdrawal by Subject|12|||
154886835|NCT01371981|559007375|FG001|Overall Study|Withdrawal by Subject|19|||
154886836|NCT01371981|559007376|FG002|Overall Study|Withdrawal by Subject|1|||
154886837|NCT01371981|559007377|FG003|Overall Study|Withdrawal by Subject|2|||
154886838|NCT01371981|559007378|FG004|Overall Study|Withdrawal by Subject|10|||
154886839|NCT01371981|559007379|FG005|Overall Study|Withdrawal by Subject|3|||
154886840|NCT01371981|559007374|FG000|Overall Study|Ineligible|19|||
154886841|NCT01371981|559007375|FG001|Overall Study|Ineligible|13|||
154886842|NCT01371981|559007376|FG002|Overall Study|Ineligible|0|||
154886843|NCT01371981|559007377|FG003|Overall Study|Ineligible|0|||
154886844|NCT01371981|559007378|FG004|Overall Study|Ineligible|0|||
154886845|NCT01371981|559007379|FG005|Overall Study|Ineligible|4|||
154886846|NCT01371981|559007374|FG000|Overall Study|Did not start treatment|2|||
154886847|NCT01371981|559007375|FG001|Overall Study|Did not start treatment|3|||
154886848|NCT01371981|559007376|FG002|Overall Study|Did not start treatment|0|||
154886849|NCT01371981|559007377|FG003|Overall Study|Did not start treatment|0|||
154886850|NCT01371981|559007378|FG004|Overall Study|Did not start treatment|0|||
154886851|NCT01371981|559007379|FG005|Overall Study|Did not start treatment|2|||
154886852|NCT01655823|559007380|FG000|Overall Study|Lost to Follow-up|0|||
154886853|NCT01655823|559007381|FG001|Overall Study|Lost to Follow-up|1|||
154886854|NCT01655823|559007382|FG002|Overall Study|Lost to Follow-up|0|||
154886855|NCT01655823|559007383|FG003|Overall Study|Lost to Follow-up|0|||
154886856|NCT01655823|559007384|FG004|Overall Study|Lost to Follow-up|1|||
154886857|NCT01655823|559007380|FG000|Overall Study|Withdrawal by Subject|0|||
154886858|NCT01655823|559007381|FG001|Overall Study|Withdrawal by Subject|1|||
154886859|NCT01655823|559007382|FG002|Overall Study|Withdrawal by Subject|0|||
154886860|NCT01655823|559007383|FG003|Overall Study|Withdrawal by Subject|1|||
154886861|NCT01655823|559007384|FG004|Overall Study|Withdrawal by Subject|0|||
154886862|NCT00603980|559007385|FG000|Study Qualification|Protocol Violation|3|||
154886863|NCT00603980|559007385|FG000|Study Qualification|Inconsistent data reporting|13|||
154886864|NCT00603980|559007385|FG000|Main Study|14th subject completed trial|1|||
154886865|NCT02632110|559007390|FG000|Overall Study|Withdrawal by Subject|1|||
154886866|NCT02632110|559007391|FG001|Overall Study|Withdrawal by Subject|1|||
154886867|NCT02632110|559007392|FG002|Overall Study|Withdrawal by Subject|0|||
154886868|NCT02632110|559007393|FG003|Overall Study|Withdrawal by Subject|0|||
154886869|NCT02632110|559007394|FG004|Overall Study|Withdrawal by Subject|1|||
154886870|NCT02632110|559007395|FG005|Overall Study|Withdrawal by Subject|1|||
154886871|NCT02632110|559007396|FG006|Overall Study|Withdrawal by Subject|3|||
154886872|NCT02632110|559007397|FG007|Overall Study|Withdrawal by Subject|3|||
154886873|NCT02632110|559007398|FG008|Overall Study|Withdrawal by Subject|1|||
154886874|NCT02632110|559007399|FG009|Overall Study|Withdrawal by Subject|1|||
154886875|NCT02618928|559007402|FG000|Overall Study|Failure to Return|28|||
154886876|NCT02618928|559007402|FG000|Overall Study|Insufficient Virological Response|1|||
154886877|NCT02618928|559007402|FG000|Overall Study|Withdrawal by Subject|2|||
154886878|NCT02618928|559007402|FG000|Overall Study|Death|3|||
154886879|NCT02618928|559007402|FG000|Overall Study|Other|11|||
154886880|NCT02618928|559007402|FG000|Overall Study|Missing|6|||
154886881|NCT02618928|559007402|FG000|Overall Study|Treatment Never Started|7|||
154886882|NCT02357849|559007406|FG000|Overall Study|Withdrawal by Subject|2|||
154886883|NCT02357849|559007407|FG001|Overall Study|Withdrawal by Subject|3|||
154977063|NCT00569777|559338811|FG001|Overall Study|scheduled eye surgery|1|||
154886884|NCT00064350|559007421|FG000|Induction Treatment|Disease Progression|5|||
154886885|NCT00064350|559007422|FG001|Induction Treatment|Disease Progression|1|||
154886886|NCT00064350|559007423|FG002|Induction Treatment|Disease Progression|110|||
154886887|NCT00064350|559007421|FG000|Induction Treatment|Adverse Event|0|||
154886888|NCT00064350|559007422|FG001|Induction Treatment|Adverse Event|2|||
154886889|NCT00064350|559007423|FG002|Induction Treatment|Adverse Event|49|||
154886890|NCT00064350|559007421|FG000|Induction Treatment|Death|0|||
154886891|NCT00064350|559007422|FG001|Induction Treatment|Death|0|||
154886892|NCT00064350|559007423|FG002|Induction Treatment|Death|9|||
154886893|NCT00064350|559007421|FG000|Induction Treatment|Withdrawal by Subject|0|||
154886894|NCT00064350|559007422|FG001|Induction Treatment|Withdrawal by Subject|0|||
154886895|NCT00064350|559007423|FG002|Induction Treatment|Withdrawal by Subject|21|||
154886896|NCT00064350|559007421|FG000|Induction Treatment|Ineligible or never started treatment|3|||
154886897|NCT00064350|559007422|FG001|Induction Treatment|Ineligible or never started treatment|6|||
154886898|NCT00064350|559007423|FG002|Induction Treatment|Ineligible or never started treatment|34|||
154886899|NCT00064350|559007421|FG000|Induction Treatment|Other|0|||
154886900|NCT00064350|559007422|FG001|Induction Treatment|Other|0|||
154886901|NCT00064350|559007423|FG002|Induction Treatment|Other|13|||
154886902|NCT00064350|559007421|FG000|Randomization|Adverse Event|8|||
154886903|NCT00064350|559007422|FG001|Randomization|Adverse Event|3|||
154886904|NCT00064350|559007423|FG002|Randomization|Adverse Event|0|||
154886905|NCT00064350|559007421|FG000|Randomization|Death|3|||
154886906|NCT00064350|559007422|FG001|Randomization|Death|0|||
154886907|NCT00064350|559007423|FG002|Randomization|Death|0|||
154886908|NCT00064350|559007421|FG000|Randomization|Withdrawal by Subject|1|||
154886909|NCT00064350|559007422|FG001|Randomization|Withdrawal by Subject|0|||
154886910|NCT00064350|559007423|FG002|Randomization|Withdrawal by Subject|0|||
154886911|NCT00064350|559007421|FG000|Randomization|Ineligible or never started treatment|9|||
154886912|NCT00064350|559007422|FG001|Randomization|Ineligible or never started treatment|15|||
154886913|NCT00064350|559007423|FG002|Randomization|Ineligible or never started treatment|0|||
154886914|NCT00064350|559007421|FG000|Randomization|Other|5|||
154886915|NCT00064350|559007422|FG001|Randomization|Other|0|||
154886916|NCT00064350|559007423|FG002|Randomization|Other|0|||
154886917|NCT00064350|559007421|FG000|Cross-Over|Adverse Event|0|||
154886918|NCT00064350|559007422|FG001|Cross-Over|Adverse Event|1|||
154886919|NCT00064350|559007423|FG002|Cross-Over|Adverse Event|0|||
154886920|NCT00064350|559007421|FG000|Cross-Over|Death|1|||
154886921|NCT00064350|559007422|FG001|Cross-Over|Death|3|||
154886922|NCT00064350|559007423|FG002|Cross-Over|Death|0|||
154886923|NCT00064350|559007421|FG000|Cross-Over|Withdrawal by Subject|2|||
154886924|NCT00064350|559007422|FG001|Cross-Over|Withdrawal by Subject|2|||
154886925|NCT00064350|559007423|FG002|Cross-Over|Withdrawal by Subject|0|||
154886926|NCT00064350|559007421|FG000|Cross-Over|Ineligible or never started treatment|3|||
154886927|NCT00064350|559007422|FG001|Cross-Over|Ineligible or never started treatment|6|||
154886928|NCT00064350|559007423|FG002|Cross-Over|Ineligible or never started treatment|0|||
154886929|NCT00064350|559007421|FG000|Cross-Over|Other|0|||
154886930|NCT00064350|559007422|FG001|Cross-Over|Other|2|||
154886931|NCT00064350|559007423|FG002|Cross-Over|Other|0|||
154886932|NCT01927419|559007424|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
154886933|NCT01927419|559007425|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
154886934|NCT01927419|559007424|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
154886935|NCT01927419|559007425|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
154886936|NCT01927419|559007424|FG000|Treatment Period|Disease progression|17|||
154886937|NCT01927419|559007425|FG001|Treatment Period|Disease progression|20|||
154886938|NCT01927419|559007424|FG000|Treatment Period|Study drug toxicity|48|||
154977064|NCT00569777|559338810|FG000|Overall Study|did not meet exclusion criteria|1|||
154977065|NCT00569777|559338811|FG001|Overall Study|did not meet exclusion criteria|2|||
154977066|NCT00569777|559338810|FG000|Overall Study|pregnant|1|||
154977067|NCT00569777|559338811|FG001|Overall Study|pregnant|0|||
154977068|NCT02030535|559338812|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
154977069|NCT02447887|559340764|FG000|Overall Study|Study was terminated|3|||
154977070|NCT03941834|559340765|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
154886939|NCT01927419|559007425|FG001|Treatment Period|Study drug toxicity|10|||
154886940|NCT01927419|559007424|FG000|Treatment Period|Death|0|||
154886941|NCT01927419|559007425|FG001|Treatment Period|Death|1|||
154886942|NCT01927419|559007424|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
154886943|NCT01927419|559007425|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
154886944|NCT01927419|559007424|FG000|Treatment Period|Participant request to discontinue|12|||
154886945|NCT01927419|559007425|FG001|Treatment Period|Participant request to discontinue|4|||
154886946|NCT01927419|559007424|FG000|Treatment Period|Withdrawal by Subject|1|||
154886947|NCT01927419|559007425|FG001|Treatment Period|Withdrawal by Subject|1|||
154886948|NCT01927419|559007424|FG000|Treatment Period|Maximum Clinical Benefit|6|||
154886949|NCT01927419|559007425|FG001|Treatment Period|Maximum Clinical Benefit|2|||
154886950|NCT01927419|559007424|FG000|Treatment Period|Other reasons|3|||
154886951|NCT01927419|559007425|FG001|Treatment Period|Other reasons|4|||
154977071|NCT03941834|559340766|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
155175446|NCT04585009|560080236|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
154886952|NCT01927419|559007424|FG000|Treatment Period|Not Reported|1|||
154886953|NCT01927419|559007425|FG001|Treatment Period|Not Reported|1|||
154886954|NCT00115765|559007428|FG000|Overall Study|Withdrawal by Subject|22|||
154886955|NCT00115765|559007429|FG001|Overall Study|Withdrawal by Subject|53|||
154886956|NCT00115765|559007430|FG002|Overall Study|Withdrawal by Subject|76|||
154886957|NCT00115765|559007431|FG003|Overall Study|Withdrawal by Subject|15|||
154886958|NCT00115765|559007428|FG000|Overall Study|Physician Decision|4|||
154886959|NCT00115765|559007429|FG001|Overall Study|Physician Decision|15|||
154886960|NCT00115765|559007430|FG002|Overall Study|Physician Decision|18|||
154886961|NCT00115765|559007431|FG003|Overall Study|Physician Decision|13|||
154886962|NCT00115765|559007428|FG000|Overall Study|Lost to Follow-up|3|||
154886963|NCT00115765|559007429|FG001|Overall Study|Lost to Follow-up|20|||
154886964|NCT00115765|559007430|FG002|Overall Study|Lost to Follow-up|18|||
154886965|NCT00115765|559007431|FG003|Overall Study|Lost to Follow-up|1|||
154886966|NCT00115765|559007428|FG000|Overall Study|Other|6|||
154886967|NCT00115765|559007429|FG001|Overall Study|Other|12|||
154886968|NCT00115765|559007430|FG002|Overall Study|Other|9|||
154886969|NCT00115765|559007431|FG003|Overall Study|Other|2|||
154886970|NCT00995670|559007432|FG000|Overall Study|Failed arterial cannulation|1|||
154886971|NCT00995670|559007433|FG001|Overall Study|Failed arterial cannulation|0|||
154886972|NCT00995670|559007434|FG002|Overall Study|Failed arterial cannulation|3|||
154886973|NCT00675103|559007435|FG000|Overall Study|Lack of Efficacy|2|||
154886974|NCT00675103|559007435|FG000|Overall Study|Adverse Event|1|||
154886975|NCT00592553|559007438|FG000|Overall Study|Protocol Noncompliance|1|||
154886976|NCT00592553|559007439|FG001|Overall Study|Protocol Noncompliance|0|||
154886977|NCT00592553|559007440|FG002|Overall Study|Protocol Noncompliance|0|||
154886978|NCT01208038|559007443|FG000|Overall Study|Withdrawal by Subject|1|||
154886979|NCT02773238|559007444|FG000|Overall Study|Lack of Efficacy|4|||
154886980|NCT01877382|559007447|FG000|Dose Escalation|Progressive disease|2|||
154886981|NCT01877382|559007448|FG001|Dose Escalation|Progressive disease|0|||
154886982|NCT01877382|559007449|FG002|Dose Escalation|Progressive disease|1|||
154886983|NCT01877382|559007450|FG003|Dose Escalation|Progressive disease|6|||
154886984|NCT01877382|559007451|FG004|Dose Escalation|Progressive disease|1|||
154886985|NCT01877382|559007452|FG005|Dose Escalation|Progressive disease|0|||
154886986|NCT01877382|559007453|FG006|Dose Escalation|Progressive disease|3|||
154886987|NCT01877382|559007454|FG007|Dose Escalation|Progressive disease|10|||
154886988|NCT01877382|559007455|FG008|Dose Escalation|Progressive disease|4|||
154886989|NCT01877382|559007456|FG009|Dose Escalation|Progressive disease|2|||
154886990|NCT01877382|559007457|FG010|Dose Escalation|Progressive disease|3|||
154886991|NCT01877382|559007458|FG011|Dose Escalation|Progressive disease|3|||
154886992|NCT01877382|559007459|FG012|Dose Escalation|Progressive disease|13|||
154886993|NCT01877382|559007460|FG013|Dose Escalation|Progressive disease|1|||
154886994|NCT01877382|559007461|FG014|Dose Escalation|Progressive disease|0|||
154886995|NCT01877382|559007447|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
154886996|NCT01877382|559007448|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154886997|NCT01877382|559007449|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154886998|NCT01877382|559007450|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
155175447|NCT04585009|560080237|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175448|NCT04585009|560080238|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175449|NCT04585009|560080239|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175450|NCT04585009|560080240|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175451|NCT04585009|560080241|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175452|NCT04585009|560080242|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
155175453|NCT04585009|560080243|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175454|NCT04585009|560080244|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
155175455|NCT04585009|560080233|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175456|NCT04585009|560080234|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175457|NCT04585009|560080235|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175458|NCT04585009|560080236|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175459|NCT04585009|560080237|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175460|NCT04585009|560080238|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175461|NCT04585009|560080239|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
155175462|NCT04585009|560080240|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
154886999|NCT01877382|559007451|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887000|NCT01877382|559007452|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887001|NCT01877382|559007453|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
155175463|NCT04585009|560080241|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
154887002|NCT01877382|559007454|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887003|NCT01877382|559007455|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
155175464|NCT04585009|560080242|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
154887004|NCT01877382|559007456|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887005|NCT01877382|559007457|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887006|NCT01877382|559007458|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887007|NCT01877382|559007459|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887008|NCT01877382|559007460|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887009|NCT01877382|559007461|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887010|NCT01877382|559007447|FG000|Dose Escalation|Clinical progression|0|||
154887011|NCT01877382|559007448|FG001|Dose Escalation|Clinical progression|1|||
154887012|NCT01877382|559007449|FG002|Dose Escalation|Clinical progression|0|||
154887013|NCT01877382|559007450|FG003|Dose Escalation|Clinical progression|2|||
154887014|NCT01877382|559007451|FG004|Dose Escalation|Clinical progression|0|||
154887015|NCT01877382|559007452|FG005|Dose Escalation|Clinical progression|0|||
154887016|NCT01877382|559007453|FG006|Dose Escalation|Clinical progression|1|||
154887017|NCT01877382|559007454|FG007|Dose Escalation|Clinical progression|0|||
154887018|NCT01877382|559007455|FG008|Dose Escalation|Clinical progression|0|||
154887019|NCT01877382|559007456|FG009|Dose Escalation|Clinical progression|1|||
154887020|NCT01877382|559007457|FG010|Dose Escalation|Clinical progression|0|||
154887021|NCT01877382|559007458|FG011|Dose Escalation|Clinical progression|0|||
154887022|NCT01877382|559007459|FG012|Dose Escalation|Clinical progression|2|||
154887023|NCT01877382|559007460|FG013|Dose Escalation|Clinical progression|1|||
154887024|NCT01877382|559007461|FG014|Dose Escalation|Clinical progression|0|||
154887025|NCT01877382|559007447|FG000|Dose Escalation|Adverse Event|0|||
154887026|NCT01877382|559007448|FG001|Dose Escalation|Adverse Event|0|||
154887027|NCT01877382|559007449|FG002|Dose Escalation|Adverse Event|0|||
154887028|NCT01877382|559007450|FG003|Dose Escalation|Adverse Event|4|||
154887029|NCT01877382|559007451|FG004|Dose Escalation|Adverse Event|1|||
154887030|NCT01877382|559007452|FG005|Dose Escalation|Adverse Event|2|||
154887031|NCT01877382|559007453|FG006|Dose Escalation|Adverse Event|1|||
154887032|NCT01877382|559007454|FG007|Dose Escalation|Adverse Event|2|||
154887033|NCT01877382|559007455|FG008|Dose Escalation|Adverse Event|0|||
154887034|NCT01877382|559007456|FG009|Dose Escalation|Adverse Event|0|||
154887035|NCT01877382|559007457|FG010|Dose Escalation|Adverse Event|0|||
154887036|NCT01877382|559007458|FG011|Dose Escalation|Adverse Event|0|||
154887037|NCT01877382|559007459|FG012|Dose Escalation|Adverse Event|1|||
154887038|NCT01877382|559007460|FG013|Dose Escalation|Adverse Event|0|||
154887039|NCT01877382|559007461|FG014|Dose Escalation|Adverse Event|0|||
154887040|NCT01877382|559007447|FG000|Dose Escalation|Withdrawal by Subject|0|||
154887041|NCT01877382|559007448|FG001|Dose Escalation|Withdrawal by Subject|0|||
154887042|NCT01877382|559007449|FG002|Dose Escalation|Withdrawal by Subject|0|||
154887043|NCT01877382|559007450|FG003|Dose Escalation|Withdrawal by Subject|0|||
154887044|NCT01877382|559007451|FG004|Dose Escalation|Withdrawal by Subject|0|||
154887045|NCT01877382|559007452|FG005|Dose Escalation|Withdrawal by Subject|3|||
154887046|NCT01877382|559007453|FG006|Dose Escalation|Withdrawal by Subject|2|||
154887047|NCT01877382|559007454|FG007|Dose Escalation|Withdrawal by Subject|1|||
154887048|NCT01877382|559007455|FG008|Dose Escalation|Withdrawal by Subject|1|||
154887049|NCT01877382|559007456|FG009|Dose Escalation|Withdrawal by Subject|0|||
154887050|NCT01877382|559007457|FG010|Dose Escalation|Withdrawal by Subject|0|||
154887051|NCT01877382|559007458|FG011|Dose Escalation|Withdrawal by Subject|0|||
154887052|NCT01877382|559007459|FG012|Dose Escalation|Withdrawal by Subject|0|||
154887053|NCT01877382|559007460|FG013|Dose Escalation|Withdrawal by Subject|0|||
154887054|NCT01877382|559007461|FG014|Dose Escalation|Withdrawal by Subject|0|||
154887055|NCT01877382|559007447|FG000|Dose Escalation|Protocol Violation|0|||
154887056|NCT01877382|559007448|FG001|Dose Escalation|Protocol Violation|0|||
154887057|NCT01877382|559007449|FG002|Dose Escalation|Protocol Violation|0|||
154887058|NCT01877382|559007450|FG003|Dose Escalation|Protocol Violation|0|||
154887059|NCT01877382|559007451|FG004|Dose Escalation|Protocol Violation|0|||
154887060|NCT01877382|559007452|FG005|Dose Escalation|Protocol Violation|0|||
154887061|NCT01877382|559007453|FG006|Dose Escalation|Protocol Violation|1|||
154887062|NCT01877382|559007454|FG007|Dose Escalation|Protocol Violation|0|||
154887063|NCT01877382|559007455|FG008|Dose Escalation|Protocol Violation|0|||
154887064|NCT01877382|559007456|FG009|Dose Escalation|Protocol Violation|0|||
154977072|NCT03941834|559340767|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
154977073|NCT03941834|559340765|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
154887065|NCT01877382|559007457|FG010|Dose Escalation|Protocol Violation|0|||
154887066|NCT01877382|559007458|FG011|Dose Escalation|Protocol Violation|0|||
154887067|NCT01877382|559007459|FG012|Dose Escalation|Protocol Violation|0|||
154887068|NCT01877382|559007460|FG013|Dose Escalation|Protocol Violation|0|||
154887069|NCT01877382|559007461|FG014|Dose Escalation|Protocol Violation|0|||
154887070|NCT01877382|559007447|FG000|Dose Escalation|Study terminated by sponsor|0|||
154887071|NCT01877382|559007448|FG001|Dose Escalation|Study terminated by sponsor|0|||
154887072|NCT01877382|559007449|FG002|Dose Escalation|Study terminated by sponsor|0|||
154887073|NCT01877382|559007450|FG003|Dose Escalation|Study terminated by sponsor|0|||
154977074|NCT03941834|559340766|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
154887074|NCT01877382|559007451|FG004|Dose Escalation|Study terminated by sponsor|0|||
154887075|NCT01877382|559007452|FG005|Dose Escalation|Study terminated by sponsor|0|||
154887076|NCT01877382|559007453|FG006|Dose Escalation|Study terminated by sponsor|0|||
154887077|NCT01877382|559007454|FG007|Dose Escalation|Study terminated by sponsor|1|||
154887078|NCT01877382|559007455|FG008|Dose Escalation|Study terminated by sponsor|1|||
154887079|NCT01877382|559007456|FG009|Dose Escalation|Study terminated by sponsor|0|||
154887080|NCT01877382|559007457|FG010|Dose Escalation|Study terminated by sponsor|0|||
154887081|NCT01877382|559007458|FG011|Dose Escalation|Study terminated by sponsor|0|||
154887082|NCT01877382|559007459|FG012|Dose Escalation|Study terminated by sponsor|3|||
154887083|NCT01877382|559007460|FG013|Dose Escalation|Study terminated by sponsor|0|||
154887084|NCT01877382|559007461|FG014|Dose Escalation|Study terminated by sponsor|0|||
154887085|NCT01877382|559007447|FG000|Dose Escalation|Death|0|||
154887086|NCT01877382|559007448|FG001|Dose Escalation|Death|0|||
154887087|NCT01877382|559007449|FG002|Dose Escalation|Death|0|||
154887088|NCT01877382|559007450|FG003|Dose Escalation|Death|0|||
154887089|NCT01877382|559007451|FG004|Dose Escalation|Death|0|||
154887090|NCT01877382|559007452|FG005|Dose Escalation|Death|0|||
154887091|NCT01877382|559007453|FG006|Dose Escalation|Death|0|||
154887092|NCT01877382|559007454|FG007|Dose Escalation|Death|1|||
154887093|NCT01877382|559007455|FG008|Dose Escalation|Death|0|||
154887094|NCT01877382|559007456|FG009|Dose Escalation|Death|0|||
154887095|NCT01877382|559007457|FG010|Dose Escalation|Death|0|||
154887096|NCT01877382|559007458|FG011|Dose Escalation|Death|0|||
154887097|NCT01877382|559007459|FG012|Dose Escalation|Death|1|||
154887098|NCT01877382|559007460|FG013|Dose Escalation|Death|1|||
154887099|NCT01877382|559007461|FG014|Dose Escalation|Death|0|||
154887100|NCT01877382|559007447|FG000|Dose Expansion|Progressive disease|0|||
154887101|NCT01877382|559007448|FG001|Dose Expansion|Progressive disease|0|||
154887102|NCT01877382|559007449|FG002|Dose Expansion|Progressive disease|0|||
154887103|NCT01877382|559007450|FG003|Dose Expansion|Progressive disease|0|||
154887104|NCT01877382|559007451|FG004|Dose Expansion|Progressive disease|0|||
154887105|NCT01877382|559007452|FG005|Dose Expansion|Progressive disease|0|||
154887106|NCT01877382|559007453|FG006|Dose Expansion|Progressive disease|0|||
154887107|NCT01877382|559007454|FG007|Dose Expansion|Progressive disease|0|||
154887108|NCT01877382|559007455|FG008|Dose Expansion|Progressive disease|0|||
154887109|NCT01877382|559007456|FG009|Dose Expansion|Progressive disease|0|||
154887110|NCT01877382|559007457|FG010|Dose Expansion|Progressive disease|0|||
154887111|NCT01877382|559007458|FG011|Dose Expansion|Progressive disease|0|||
154887112|NCT01877382|559007459|FG012|Dose Expansion|Progressive disease|0|||
154887113|NCT01877382|559007460|FG013|Dose Expansion|Progressive disease|0|||
154887114|NCT01877382|559007461|FG014|Dose Expansion|Progressive disease|11|||
154887115|NCT01877382|559007447|FG000|Dose Expansion|Clinical progression|0|||
154887116|NCT01877382|559007448|FG001|Dose Expansion|Clinical progression|0|||
154887117|NCT01877382|559007449|FG002|Dose Expansion|Clinical progression|0|||
154887118|NCT01877382|559007450|FG003|Dose Expansion|Clinical progression|0|||
154887119|NCT01877382|559007451|FG004|Dose Expansion|Clinical progression|0|||
154887120|NCT01877382|559007452|FG005|Dose Expansion|Clinical progression|0|||
154887121|NCT01877382|559007453|FG006|Dose Expansion|Clinical progression|0|||
154887122|NCT01877382|559007454|FG007|Dose Expansion|Clinical progression|0|||
154887123|NCT01877382|559007455|FG008|Dose Expansion|Clinical progression|0|||
154887124|NCT01877382|559007456|FG009|Dose Expansion|Clinical progression|0|||
154887125|NCT01877382|559007457|FG010|Dose Expansion|Clinical progression|0|||
154887126|NCT01877382|559007458|FG011|Dose Expansion|Clinical progression|0|||
154887127|NCT01877382|559007459|FG012|Dose Expansion|Clinical progression|0|||
154887128|NCT01877382|559007460|FG013|Dose Expansion|Clinical progression|0|||
154887129|NCT01877382|559007461|FG014|Dose Expansion|Clinical progression|6|||
154887130|NCT01877382|559007447|FG000|Dose Expansion|Adverse Event|0|||
154887131|NCT01877382|559007448|FG001|Dose Expansion|Adverse Event|0|||
154887132|NCT01877382|559007449|FG002|Dose Expansion|Adverse Event|0|||
154887133|NCT01877382|559007450|FG003|Dose Expansion|Adverse Event|0|||
154887134|NCT01877382|559007451|FG004|Dose Expansion|Adverse Event|0|||
154887135|NCT01877382|559007452|FG005|Dose Expansion|Adverse Event|0|||
154887136|NCT01877382|559007453|FG006|Dose Expansion|Adverse Event|0|||
154887137|NCT01877382|559007454|FG007|Dose Expansion|Adverse Event|0|||
154887138|NCT01877382|559007455|FG008|Dose Expansion|Adverse Event|0|||
154887139|NCT01877382|559007456|FG009|Dose Expansion|Adverse Event|0|||
154887140|NCT01877382|559007457|FG010|Dose Expansion|Adverse Event|0|||
154887141|NCT01877382|559007458|FG011|Dose Expansion|Adverse Event|0|||
154887142|NCT01877382|559007459|FG012|Dose Expansion|Adverse Event|0|||
154887143|NCT01877382|559007460|FG013|Dose Expansion|Adverse Event|0|||
154887144|NCT01877382|559007461|FG014|Dose Expansion|Adverse Event|1|||
154887145|NCT01877382|559007447|FG000|Dose Expansion|Death|0|||
154887146|NCT01877382|559007448|FG001|Dose Expansion|Death|0|||
154887147|NCT01877382|559007449|FG002|Dose Expansion|Death|0|||
154887148|NCT01877382|559007450|FG003|Dose Expansion|Death|0|||
154887149|NCT01877382|559007451|FG004|Dose Expansion|Death|0|||
154887150|NCT01877382|559007452|FG005|Dose Expansion|Death|0|||
154887151|NCT01877382|559007453|FG006|Dose Expansion|Death|0|||
154887152|NCT01877382|559007454|FG007|Dose Expansion|Death|0|||
154977075|NCT03941834|559340767|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
154977076|NCT03941834|559340765|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
154977077|NCT03941834|559340766|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
154977078|NCT03941834|559340767|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
154977079|NCT03941834|559340765|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
154977080|NCT03941834|559340766|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
154977081|NCT03941834|559340767|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
154977082|NCT03941834|559340765|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
154977083|NCT03941834|559340766|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
154977084|NCT03941834|559340767|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
154977085|NCT03941834|559340765|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
154977086|NCT03941834|559340766|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
154977087|NCT03941834|559340767|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
154977088|NCT02688387|559340768|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977089|NCT02688387|559340769|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977090|NCT02688387|559340770|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
154977091|NCT02688387|559340771|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977092|NCT02688387|559340772|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977093|NCT02688387|559340773|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977094|NCT02688387|559340774|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977095|NCT02688387|559340775|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977096|NCT02688387|559340776|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977097|NCT02688387|559340777|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977098|NCT02688387|559340778|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977099|NCT02688387|559340779|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977100|NCT02688387|559340780|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977101|NCT02688387|559340781|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977102|NCT02688387|559340782|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977103|NCT02688387|559340783|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977104|NCT02688387|559340784|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977105|NCT02688387|559340785|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977106|NCT02688387|559340786|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977107|NCT02688387|559340787|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977108|NCT02688387|559340788|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977109|NCT02688387|559340789|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
154977110|NCT02688387|559340768|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977111|NCT02688387|559340769|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977112|NCT02688387|559340770|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977113|NCT02688387|559340771|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
154977114|NCT02688387|559340772|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977115|NCT02688387|559340773|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977116|NCT02688387|559340774|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977117|NCT02688387|559340775|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977118|NCT02688387|559340776|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977119|NCT02688387|559340777|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977120|NCT02688387|559340778|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977121|NCT02688387|559340779|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977122|NCT02688387|559340780|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977123|NCT02688387|559340781|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977124|NCT02688387|559340782|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977125|NCT02688387|559340783|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154887153|NCT01877382|559007455|FG008|Dose Expansion|Death|0|||
154887154|NCT01877382|559007456|FG009|Dose Expansion|Death|0|||
154887155|NCT01877382|559007457|FG010|Dose Expansion|Death|0|||
154887156|NCT01877382|559007458|FG011|Dose Expansion|Death|0|||
154887157|NCT01877382|559007459|FG012|Dose Expansion|Death|0|||
154887158|NCT01877382|559007460|FG013|Dose Expansion|Death|0|||
154887159|NCT01877382|559007461|FG014|Dose Expansion|Death|1|||
154887160|NCT01877382|559007447|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887161|NCT01877382|559007448|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887162|NCT01877382|559007449|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887163|NCT01877382|559007450|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887164|NCT01877382|559007451|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887165|NCT01877382|559007452|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887166|NCT01877382|559007453|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887167|NCT01877382|559007454|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154977126|NCT02688387|559340784|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977127|NCT02688387|559340785|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154887168|NCT01877382|559007455|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887169|NCT01877382|559007456|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887170|NCT01877382|559007457|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887171|NCT01877382|559007458|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887172|NCT01877382|559007459|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887173|NCT01877382|559007460|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
154887174|NCT01877382|559007461|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
154887175|NCT03829332|559007462|FG000|Overall Study|Death|225|||
154887176|NCT03829332|559007463|FG001|Overall Study|Death|230|||
154887177|NCT03829332|559007462|FG000|Overall Study|Lost to Follow-up|1|||
154887178|NCT03829332|559007463|FG001|Overall Study|Lost to Follow-up|3|||
154887179|NCT03829332|559007462|FG000|Overall Study|Physician Decision|1|||
154887180|NCT03829332|559007463|FG001|Overall Study|Physician Decision|0|||
154887181|NCT03829332|559007462|FG000|Overall Study|Sponsor Decision|71|||
154887182|NCT03829332|559007463|FG001|Overall Study|Sponsor Decision|72|||
154887183|NCT03829332|559007462|FG000|Overall Study|Withdrawal by Subject|11|||
154887184|NCT03829332|559007463|FG001|Overall Study|Withdrawal by Subject|9|||
154887185|NCT00479557|559007464|FG000|Overall Study|Death|0|||
154887186|NCT00479557|559007465|FG001|Overall Study|Death|0|||
154887187|NCT00479557|559007466|FG002|Overall Study|Death|0|||
154887188|NCT00479557|559007467|FG003|Overall Study|Death|0|||
154887189|NCT00479557|559007468|FG004|Overall Study|Death|0|||
154887190|NCT00479557|559007469|FG005|Overall Study|Death|1|||
154887191|NCT00479557|559007470|FG006|Overall Study|Death|0|||
154887192|NCT00479557|559007464|FG000|Overall Study|Lack of Efficacy|1|||
154887193|NCT00479557|559007465|FG001|Overall Study|Lack of Efficacy|0|||
154887194|NCT00479557|559007466|FG002|Overall Study|Lack of Efficacy|0|||
154887195|NCT00479557|559007467|FG003|Overall Study|Lack of Efficacy|0|||
154887196|NCT00479557|559007468|FG004|Overall Study|Lack of Efficacy|0|||
154887197|NCT00479557|559007469|FG005|Overall Study|Lack of Efficacy|0|||
154887198|NCT00479557|559007470|FG006|Overall Study|Lack of Efficacy|0|||
154887199|NCT00479557|559007464|FG000|Overall Study|Lost to Follow-up|0|||
154887200|NCT00479557|559007465|FG001|Overall Study|Lost to Follow-up|2|||
154887201|NCT00479557|559007466|FG002|Overall Study|Lost to Follow-up|0|||
154887202|NCT00479557|559007467|FG003|Overall Study|Lost to Follow-up|2|||
154887203|NCT00479557|559007468|FG004|Overall Study|Lost to Follow-up|0|||
154887204|NCT00479557|559007469|FG005|Overall Study|Lost to Follow-up|0|||
154887205|NCT00479557|559007470|FG006|Overall Study|Lost to Follow-up|0|||
154887206|NCT00479557|559007464|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
154887207|NCT00479557|559007465|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
154887208|NCT00479557|559007466|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
154887209|NCT00479557|559007467|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
154887210|NCT00479557|559007468|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
154887211|NCT00479557|559007469|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
154887212|NCT00479557|559007470|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
154887213|NCT00479557|559007464|FG000|Overall Study|AE not related to Study Drug|1|||
154887214|NCT00479557|559007465|FG001|Overall Study|AE not related to Study Drug|3|||
154887215|NCT00479557|559007466|FG002|Overall Study|AE not related to Study Drug|0|||
154887216|NCT00479557|559007467|FG003|Overall Study|AE not related to Study Drug|0|||
154887217|NCT00479557|559007468|FG004|Overall Study|AE not related to Study Drug|2|||
154887218|NCT00479557|559007469|FG005|Overall Study|AE not related to Study Drug|2|||
154977128|NCT02688387|559340786|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977129|NCT02688387|559340787|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977130|NCT02688387|559340788|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977131|NCT02688387|559340789|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977132|NCT02688387|559340768|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977133|NCT02688387|559340769|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
155175465|NCT04585009|560080243|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
154887219|NCT00479557|559007470|FG006|Overall Study|AE not related to Study Drug|1|||
154887220|NCT00479557|559007464|FG000|Overall Study|Caregiver Request|2|||
154887221|NCT00479557|559007465|FG001|Overall Study|Caregiver Request|2|||
154887222|NCT00479557|559007466|FG002|Overall Study|Caregiver Request|2|||
154887223|NCT00479557|559007467|FG003|Overall Study|Caregiver Request|0|||
154887224|NCT00479557|559007468|FG004|Overall Study|Caregiver Request|1|||
154887225|NCT00479557|559007469|FG005|Overall Study|Caregiver Request|2|||
154887226|NCT00479557|559007470|FG006|Overall Study|Caregiver Request|0|||
154887227|NCT00479557|559007464|FG000|Overall Study|Investigator Request|0|||
154887228|NCT00479557|559007465|FG001|Overall Study|Investigator Request|0|||
154887229|NCT00479557|559007466|FG002|Overall Study|Investigator Request|1|||
154887230|NCT00479557|559007467|FG003|Overall Study|Investigator Request|0|||
154887231|NCT00479557|559007468|FG004|Overall Study|Investigator Request|0|||
154887232|NCT00479557|559007469|FG005|Overall Study|Investigator Request|0|||
154887233|NCT00479557|559007470|FG006|Overall Study|Investigator Request|0|||
154887234|NCT00479557|559007464|FG000|Overall Study|Subject Request|3|||
154887235|NCT00479557|559007465|FG001|Overall Study|Subject Request|0|||
154887236|NCT00479557|559007466|FG002|Overall Study|Subject Request|1|||
154887237|NCT00479557|559007467|FG003|Overall Study|Subject Request|1|||
154887238|NCT00479557|559007468|FG004|Overall Study|Subject Request|1|||
154887239|NCT00479557|559007469|FG005|Overall Study|Subject Request|4|||
154887240|NCT00479557|559007470|FG006|Overall Study|Subject Request|1|||
154887241|NCT00479557|559007464|FG000|Overall Study|Other|2|||
154887242|NCT00479557|559007465|FG001|Overall Study|Other|3|||
154887243|NCT00479557|559007466|FG002|Overall Study|Other|1|||
154887244|NCT00479557|559007467|FG003|Overall Study|Other|0|||
154887245|NCT00479557|559007468|FG004|Overall Study|Other|0|||
154887246|NCT00479557|559007469|FG005|Overall Study|Other|3|||
154887247|NCT00479557|559007470|FG006|Overall Study|Other|0|||
154887248|NCT01511107|559007471|FG000|Overall Study|Ineligible|3|||
154887249|NCT01511107|559007472|FG001|Overall Study|Ineligible|2|||
154887250|NCT01511107|559007471|FG000|Overall Study|Lost to Follow-up|10|||
154887251|NCT01511107|559007472|FG001|Overall Study|Lost to Follow-up|19|||
154887252|NCT01511107|559007471|FG000|Overall Study|Withdrawal by Subject|9|||
154887253|NCT01511107|559007472|FG001|Overall Study|Withdrawal by Subject|20|||
154887254|NCT02598661|559007473|FG000|Overall Study|Death|27|||
154887255|NCT02598661|559007474|FG001|Overall Study|Death|34|||
154887256|NCT02598661|559007475|FG002|Overall Study|Death|14|||
154887257|NCT02598661|559007476|FG003|Overall Study|Death|1|||
154887258|NCT02598661|559007477|FG004|Overall Study|Death|0|||
154887259|NCT02598661|559007473|FG000|Overall Study|Lost to Follow-up|2|||
154887260|NCT02598661|559007474|FG001|Overall Study|Lost to Follow-up|3|||
155113746|NCT01579565|559846152|FG000|Randomized|Adverse Event|1|||
155113747|NCT01579565|559846153|FG001|Randomized|Adverse Event|3|||
155113748|NCT01579565|559846152|FG000|Randomized|Withdrawal by Subject|3|||
155113749|NCT01579565|559846153|FG001|Randomized|Withdrawal by Subject|0|||
155113750|NCT01579565|559846152|FG000|Randomized|inadequate preoperative pupil dilation|0|||
154887261|NCT02598661|559007475|FG002|Overall Study|Lost to Follow-up|2|||
154887262|NCT02598661|559007476|FG003|Overall Study|Lost to Follow-up|0|||
154887263|NCT02598661|559007477|FG004|Overall Study|Lost to Follow-up|0|||
154887264|NCT02598661|559007473|FG000|Overall Study|Withdrawal by Subject|13|||
154887265|NCT02598661|559007474|FG001|Overall Study|Withdrawal by Subject|24|||
154887266|NCT02598661|559007475|FG002|Overall Study|Withdrawal by Subject|14|||
154887267|NCT02598661|559007476|FG003|Overall Study|Withdrawal by Subject|1|||
154887268|NCT02598661|559007477|FG004|Overall Study|Withdrawal by Subject|1|||
154887269|NCT02598661|559007473|FG000|Overall Study|Adverse Event|0|||
154887270|NCT02598661|559007474|FG001|Overall Study|Adverse Event|0|||
154887271|NCT02598661|559007475|FG002|Overall Study|Adverse Event|1|||
154887272|NCT02598661|559007476|FG003|Overall Study|Adverse Event|0|||
154887273|NCT02598661|559007477|FG004|Overall Study|Adverse Event|0|||
154887274|NCT02598661|559007473|FG000|Overall Study|Randomized, Never Treated|0|||
154887275|NCT02598661|559007474|FG001|Overall Study|Randomized, Never Treated|0|||
155113751|NCT01579565|559846153|FG001|Randomized|inadequate preoperative pupil dilation|1|||
155113752|NCT01579565|559846152|FG000|Randomized|prohibited preoperative eating|1|||
155113753|NCT01579565|559846153|FG001|Randomized|prohibited preoperative eating|0|||
155113754|NCT01579565|559846152|FG000|Randomized|prohibited preoperative medication|0|||
155113755|NCT01579565|559846153|FG001|Randomized|prohibited preoperative medication|1|||
155113756|NCT01579565|559846152|FG000|Treated|Physician Decision|0|||
155113757|NCT01579565|559846153|FG001|Treated|Physician Decision|1|||
155113758|NCT01579565|559846152|FG000|Treated|Lost to Follow-up|2|||
155113759|NCT01579565|559846153|FG001|Treated|Lost to Follow-up|1|||
155113760|NCT01579565|559846152|FG000|Treated|declined to return for final visit|0|||
155113761|NCT01579565|559846153|FG001|Treated|declined to return for final visit|1|||
155113762|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Adverse Event|76|||
155113763|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Adverse Event|0|||
155113764|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Adverse Event|0|||
155113765|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Death|3|||
155113766|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Death|0|||
155113767|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Death|0|||
154887276|NCT02598661|559007475|FG002|Overall Study|Randomized, Never Treated|0|||
154887277|NCT02598661|559007476|FG003|Overall Study|Randomized, Never Treated|0|||
154887278|NCT02598661|559007477|FG004|Overall Study|Randomized, Never Treated|1|||
154887279|NCT05195359|559009124|FG000|Overall Study|Lost to Follow-up|124|||
154887280|NCT05195359|559009125|FG001|Overall Study|Lost to Follow-up|34|||
154887281|NCT01146951|559009130|FG000|Overall Study|Adverse Event|4|||
154887282|NCT01146951|559009131|FG001|Overall Study|Adverse Event|1|||
154887283|NCT04092816|559009135|FG000|Overall Study|Lost to Follow-up|1|||
154887284|NCT04092816|559009136|FG001|Overall Study|Lost to Follow-up|2|||
154887285|NCT01747811|559009138|FG000|Overall Study|Lack of Efficacy|2|||
154887286|NCT01747811|559009139|FG001|Overall Study|Lack of Efficacy|4|||
154887287|NCT03073213|559009140|FG000|Multiple Dose Period|Protocol Violation|0|||
154887288|NCT03073213|559009141|FG001|Multiple Dose Period|Protocol Violation|0|||
154887289|NCT03073213|559009142|FG002|Multiple Dose Period|Protocol Violation|1|||
155113768|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
155113769|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
154977134|NCT02688387|559340770|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977135|NCT02688387|559340771|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977136|NCT02688387|559340772|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977137|NCT02688387|559340773|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977138|NCT02688387|559340774|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977139|NCT02688387|559340775|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977140|NCT02688387|559340776|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977141|NCT02688387|559340777|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977142|NCT02688387|559340778|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977143|NCT02688387|559340779|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977144|NCT02688387|559340780|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977145|NCT02688387|559340781|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977146|NCT02688387|559340782|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977147|NCT02688387|559340783|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977148|NCT02688387|559340784|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977149|NCT02688387|559340785|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977150|NCT02688387|559340786|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977151|NCT02688387|559340787|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977152|NCT02688387|559340788|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977153|NCT02688387|559340789|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
154977154|NCT02688387|559340768|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977155|NCT02688387|559340769|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977156|NCT02688387|559340770|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
154977157|NCT02688387|559340771|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977158|NCT02688387|559340772|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
154977159|NCT02688387|559340773|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977160|NCT02688387|559340774|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977161|NCT02688387|559340775|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977162|NCT02688387|559340776|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977163|NCT02688387|559340777|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977164|NCT02688387|559340778|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977165|NCT02688387|559340779|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977166|NCT02688387|559340780|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977167|NCT02688387|559340781|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977168|NCT02688387|559340782|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977169|NCT02688387|559340783|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977170|NCT02688387|559340784|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977171|NCT02688387|559340785|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977172|NCT02688387|559340786|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977173|NCT02688387|559340787|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977174|NCT02688387|559340788|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977175|NCT02688387|559340789|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
154977176|NCT02688387|559340768|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
154977177|NCT02688387|559340769|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977178|NCT02688387|559340770|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977179|NCT02688387|559340771|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977180|NCT02688387|559340772|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977181|NCT02688387|559340773|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977182|NCT02688387|559340774|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977183|NCT02688387|559340775|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977184|NCT02688387|559340776|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977185|NCT02688387|559340777|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977186|NCT02688387|559340778|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977187|NCT02688387|559340779|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977188|NCT02688387|559340780|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977189|NCT02688387|559340781|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977190|NCT02688387|559340782|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977191|NCT02688387|559340783|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977192|NCT02688387|559340784|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155113770|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
154887290|NCT01617655|559009145|FG000|Overall Study|Adverse Event|2|||
154887291|NCT01617655|559009146|FG001|Overall Study|Adverse Event|3|||
154887292|NCT01617655|559009145|FG000|Overall Study|Poor compliance to protocol|1|||
154887293|NCT01617655|559009146|FG001|Overall Study|Poor compliance to protocol|4|||
154887294|NCT01617655|559009145|FG000|Overall Study|Participants moved|0|||
154887295|NCT01617655|559009146|FG001|Overall Study|Participants moved|4|||
154887296|NCT01617655|559009145|FG000|Overall Study|Consent withdrawn by participant|1|||
154887297|NCT01617655|559009146|FG001|Overall Study|Consent withdrawn by participant|1|||
154887298|NCT01617655|559009145|FG000|Overall Study|Last visit outside protocol visit window|1|||
154887299|NCT01617655|559009146|FG001|Overall Study|Last visit outside protocol visit window|10|||
154887300|NCT01617655|559009145|FG000|Overall Study|Site closure|3|||
154887301|NCT01617655|559009146|FG001|Overall Study|Site closure|5|||
154887302|NCT01617655|559009145|FG000|Overall Study|Other than specified above|1|||
154887303|NCT01617655|559009146|FG001|Overall Study|Other than specified above|2|||
154887304|NCT01175213|559009149|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
154887305|NCT01175213|559009150|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
154887306|NCT01175213|559009149|FG000|IGSC, 10%/rHuPH20|Death|1|||
154887307|NCT01175213|559009150|FG001|IGSC, 10%/rHuPH20|Death|0|||
154887308|NCT01175213|559009149|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
154887309|NCT01175213|559009150|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
154887310|NCT01175213|559009149|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
154887311|NCT01175213|559009150|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
154887312|NCT01175213|559009149|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
154887313|NCT01175213|559009150|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
154887314|NCT01175213|559009149|FG000|Safety Follow-up|Adverse Event|1|||
154887315|NCT01175213|559009150|FG001|Safety Follow-up|Adverse Event|0|||
154887316|NCT03057951|559009152|FG000|Overall Study|Adverse Event|553|||
154887317|NCT03057951|559009153|FG001|Overall Study|Adverse Event|575|||
154887318|NCT03057951|559009152|FG000|Overall Study|Protocol Violation|30|||
154887319|NCT03057951|559009153|FG001|Overall Study|Protocol Violation|24|||
154887320|NCT03057951|559009152|FG000|Overall Study|Lost to Follow-up|6|||
154887321|NCT03057951|559009153|FG001|Overall Study|Lost to Follow-up|16|||
154887322|NCT03057951|559009152|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
154887323|NCT03057951|559009153|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
154887324|NCT03057951|559009152|FG000|Overall Study|Study drug stopped, reason missing|6|||
154887325|NCT03057951|559009153|FG001|Overall Study|Study drug stopped, reason missing|1|||
154887326|NCT03057951|559009152|FG000|Overall Study|Medical advice|6|||
154887327|NCT03057951|559009153|FG001|Overall Study|Medical advice|2|||
154887328|NCT03057951|559009152|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
154887329|NCT03057951|559009153|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
154887330|NCT03057951|559009152|FG000|Overall Study|Investigator decision|2|||
154887331|NCT03057951|559009153|FG001|Overall Study|Investigator decision|0|||
154887332|NCT03057951|559009152|FG000|Overall Study|Patient decision|5|||
154887333|NCT03057951|559009153|FG001|Overall Study|Patient decision|2|||
154887334|NCT03057951|559009152|FG000|Overall Study|Not attending study visits|3|||
154887335|NCT03057951|559009153|FG001|Overall Study|Not attending study visits|0|||
154887336|NCT03057951|559009152|FG000|Overall Study|Patient moved away|3|||
154887337|NCT03057951|559009153|FG001|Overall Study|Patient moved away|4|||
154887338|NCT03057951|559009152|FG000|Overall Study|Other reason than stated above|23|||
154887339|NCT03057951|559009153|FG001|Overall Study|Other reason than stated above|29|||
154887340|NCT03057951|559009152|FG000|Overall Study|Not treated|2|||
154887341|NCT03057951|559009153|FG001|Overall Study|Not treated|1|||
154887342|NCT02700919|559009154|FG000|Overall Study|Physician Decision|1|||
154887343|NCT02700919|559009155|FG001|Overall Study|Physician Decision|0|||
154887344|NCT02700919|559009156|FG002|Overall Study|Physician Decision|0|||
154887345|NCT02700919|559009154|FG000|Overall Study|Protocol Violation|1|||
154887346|NCT02700919|559009155|FG001|Overall Study|Protocol Violation|0|||
154887347|NCT02700919|559009156|FG002|Overall Study|Protocol Violation|0|||
155113771|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Physician Decision|9|||
154887348|NCT02700919|559009154|FG000|Overall Study|Adverse Event|1|||
154887349|NCT02700919|559009155|FG001|Overall Study|Adverse Event|3|||
154887350|NCT02700919|559009156|FG002|Overall Study|Adverse Event|1|||
154887351|NCT02700919|559009154|FG000|Overall Study|Withdrawal by Subject|5|||
154887352|NCT02700919|559009155|FG001|Overall Study|Withdrawal by Subject|8|||
154887353|NCT02700919|559009156|FG002|Overall Study|Withdrawal by Subject|2|||
154887354|NCT02700919|559009154|FG000|Overall Study|Lost to Follow-up|2|||
154887355|NCT02700919|559009155|FG001|Overall Study|Lost to Follow-up|0|||
154887356|NCT02700919|559009156|FG002|Overall Study|Lost to Follow-up|0|||
154887357|NCT02700919|559009154|FG000|Overall Study|Other|2|||
154887358|NCT02700919|559009155|FG001|Overall Study|Other|1|||
154887359|NCT02700919|559009156|FG002|Overall Study|Other|1|||
154887360|NCT02680587|559009157|FG000|Overall Study|Withdrawal by Subject|1|||
154887361|NCT02680587|559009158|FG001|Overall Study|Withdrawal by Subject|0|||
154887362|NCT00259740|559009160|FG000|Overall Study|Physician Decision|1|||
154887363|NCT00259740|559009161|FG001|Overall Study|Physician Decision|1|||
154887364|NCT00259740|559009160|FG000|Overall Study|Adverse Event|0|||
154887365|NCT00259740|559009161|FG001|Overall Study|Adverse Event|2|||
154887366|NCT00259740|559009160|FG000|Overall Study|Withdrawal by Subject|2|||
154887367|NCT00259740|559009161|FG001|Overall Study|Withdrawal by Subject|6|||
154887368|NCT00259740|559009160|FG000|Overall Study|Death|1|||
154887369|NCT00259740|559009161|FG001|Overall Study|Death|1|||
154887370|NCT00259740|559009160|FG000|Overall Study|Disease progression|19|||
154887371|NCT00259740|559009161|FG001|Overall Study|Disease progression|36|||
154887372|NCT00259740|559009160|FG000|Overall Study|Ongoing|17|||
154887373|NCT00259740|559009161|FG001|Overall Study|Ongoing|3|||
154887374|NCT00259740|559009160|FG000|Overall Study|Other|3|||
154887375|NCT00259740|559009161|FG001|Overall Study|Other|0|||
154887376|NCT00259740|559009160|FG000|Overall Study|Requirement for alternative therapy|0|||
154887377|NCT00259740|559009161|FG001|Overall Study|Requirement for alternative therapy|4|||
154887378|NCT02492997|559009162|FG000|Overall Study|Withdrawal by Subject|1|||
154887379|NCT02492997|559009163|FG001|Overall Study|Withdrawal by Subject|0|||
154887380|NCT02492997|559009162|FG000|Overall Study|Gained Weight|1|||
154887381|NCT02492997|559009163|FG001|Overall Study|Gained Weight|0|||
154887382|NCT02492997|559009162|FG000|Overall Study|Lost to Follow-up|0|||
154887383|NCT02492997|559009163|FG001|Overall Study|Lost to Follow-up|1|||
154887384|NCT00579501|559009167|FG000|Overall Study|Death|1|||
154887385|NCT00579501|559009167|FG000|Overall Study|End of neoadjuvant therapy|25|||
154887386|NCT00579501|559009167|FG000|Overall Study|toxicity|1|||
154887387|NCT00579501|559009167|FG000|Overall Study|Secondary lesion|1|||
154887388|NCT00579501|559009167|FG000|Overall Study|Radiation therapy before surgery|1|||
154887389|NCT01844830|559009169|FG000|Overall Study|Withdrawal by Subject|1|||
154887390|NCT01844830|559009170|FG001|Overall Study|Withdrawal by Subject|0|||
154887391|NCT04735393|559009176|FG000|Overall Study|Lost to Follow-up|46|||
154887392|NCT04735393|559009177|FG001|Overall Study|Lost to Follow-up|24|||
154887393|NCT04735393|559009176|FG000|Overall Study|Physician Decision|2|||
154887394|NCT04735393|559009177|FG001|Overall Study|Physician Decision|1|||
154887395|NCT04735393|559009176|FG000|Overall Study|Not Detailed|1|||
154887396|NCT04735393|559009177|FG001|Overall Study|Not Detailed|2|||
154887397|NCT04735393|559009176|FG000|Overall Study|Withdrawal by Subject|71|||
154887398|NCT04735393|559009177|FG001|Overall Study|Withdrawal by Subject|28|||
154887399|NCT04735393|559009176|FG000|Overall Study|Adverse Event|56|||
154887400|NCT04735393|559009177|FG001|Overall Study|Adverse Event|7|||
154887401|NCT04735393|559009176|FG000|Overall Study|Protocol Violation|6|||
154887402|NCT04735393|559009177|FG001|Overall Study|Protocol Violation|1|||
154887403|NCT04735393|559009176|FG000|Overall Study|Trial terminated by Sponsor|49|||
154887404|NCT04735393|559009177|FG001|Overall Study|Trial terminated by Sponsor|29|||
154887405|NCT02130427|559009178|FG000|Overall Study|Imaging results not interpretable|30|||
154887406|NCT03150095|559009185|FG000|Overall Study|Death|0|||
154887407|NCT03150095|559009186|FG001|Overall Study|Death|1|||
154887408|NCT03150095|559009185|FG000|Overall Study|Lost to Follow-up|1|||
154887409|NCT03150095|559009186|FG001|Overall Study|Lost to Follow-up|1|||
154887410|NCT03150095|559009185|FG000|Overall Study|Withdrawal by Subject|4|||
154887411|NCT03150095|559009186|FG001|Overall Study|Withdrawal by Subject|0|||
154887412|NCT03150095|559009185|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
154887413|NCT03150095|559009186|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
154887414|NCT04580394|559009198|FG000|First Intervention|Incorrectly Randomized|1|||
154887415|NCT04580394|559009198|FG000|First Intervention|Physician Decision|1|||
154887416|NCT04580394|559009198|FG000|First Intervention|Lost to Follow-up|1|||
154887417|NCT04580394|559009198|FG000|Washout (One Week)|Withdrawal by Subject|1|||
154887418|NCT04580394|559009198|FG000|Washout (One Week)|Adverse Event|1|||
154887419|NCT04580394|559009198|FG000|Washout (One Week)|Withdrawal by Subject|2|||
154887420|NCT04580394|559009198|FG000|Third Intervention|Adverse Event|1|||
154887421|NCT04580394|559009198|FG000|Third Intervention|Withdrawal by Subject|1|||
154887422|NCT04580394|559009198|FG000|Washout (One Week)|Withdrawal by Subject|2|||
154887423|NCT03589326|559009199|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
154887424|NCT03589326|559009200|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
154887425|NCT03589326|559009199|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
154887426|NCT03589326|559009200|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
154887427|NCT03589326|559009199|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
154887428|NCT03589326|559009200|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
154887429|NCT03589326|559009199|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
155113772|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Physician Decision|0|||
155113773|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Physician Decision|0|||
154887430|NCT03589326|559009200|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
154887431|NCT03589326|559009199|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
154887432|NCT03589326|559009200|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
154887433|NCT01029002|559009201|FG000|Overall Study|Lost to Follow-up|2|||
154887434|NCT01029002|559009202|FG001|Overall Study|Lost to Follow-up|4|||
154887435|NCT01096849|559009207|FG000|Overall Study|Consent Withdrawn|1|||
155113774|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
154887436|NCT01096849|559009208|FG001|Overall Study|Consent Withdrawn|4|||
154887437|NCT01096849|559009209|FG002|Overall Study|Consent Withdrawn|2|||
155113775|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
154887438|NCT01096849|559009207|FG000|Overall Study|Lack of Efficacy|0|||
154887439|NCT01096849|559009208|FG001|Overall Study|Lack of Efficacy|2|||
154887440|NCT01096849|559009209|FG002|Overall Study|Lack of Efficacy|0|||
154887441|NCT01096849|559009207|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
154887442|NCT01096849|559009208|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
154887443|NCT01096849|559009209|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
154887444|NCT01096849|559009207|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
154887445|NCT01096849|559009208|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
154887446|NCT01096849|559009209|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
154887447|NCT01096849|559009207|FG000|Overall Study|Administrative Reasons|0|||
154887448|NCT01096849|559009208|FG001|Overall Study|Administrative Reasons|1|||
154887449|NCT01096849|559009209|FG002|Overall Study|Administrative Reasons|2|||
154887450|NCT01096849|559009207|FG000|Overall Study|Lost to Follow-up|1|||
154887451|NCT01096849|559009208|FG001|Overall Study|Lost to Follow-up|3|||
154887452|NCT01096849|559009209|FG002|Overall Study|Lost to Follow-up|1|||
154887453|NCT04146467|559009215|FG000|Overall Study|Adverse Event|0|||
154887454|NCT04146467|559009216|FG001|Overall Study|Adverse Event|1|||
154887455|NCT04146467|559009215|FG000|Overall Study|Lost to Follow-up|0|||
154887456|NCT04146467|559009216|FG001|Overall Study|Lost to Follow-up|2|||
154887457|NCT02128763|559009217|FG000|Overall Study|Death|1|||
154887458|NCT02128763|559009218|FG001|Overall Study|Death|0|||
154887459|NCT02128763|559009217|FG000|Overall Study|Lost to Follow-up|19|||
154887460|NCT02128763|559009218|FG001|Overall Study|Lost to Follow-up|16|||
154887461|NCT01253421|559009219|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
154887462|NCT01253421|559009220|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
154887463|NCT01253421|559009221|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
154887464|NCT01253421|559009222|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
154887465|NCT01253421|559009223|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
154887466|NCT01253421|559009219|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
154887467|NCT01253421|559009220|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
154887468|NCT01253421|559009221|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
154887469|NCT01253421|559009222|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
154887470|NCT01253421|559009223|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
154887471|NCT01253421|559009219|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
154887472|NCT01253421|559009220|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
154887473|NCT01253421|559009221|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
154887474|NCT01253421|559009222|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
154887475|NCT01253421|559009223|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
154887476|NCT01253421|559009219|FG000|Assessment and Scheduling|Physician Decision|1|||
154887477|NCT01253421|559009220|FG001|Assessment and Scheduling|Physician Decision|0|||
154887478|NCT01253421|559009221|FG002|Assessment and Scheduling|Physician Decision|0|||
154887479|NCT01253421|559009222|FG003|Assessment and Scheduling|Physician Decision|0|||
154887480|NCT01253421|559009223|FG004|Assessment and Scheduling|Physician Decision|0|||
154887481|NCT01253421|559009219|FG000|Drug+Scanning Visit|Physician Decision|0|||
154887482|NCT01253421|559009220|FG001|Drug+Scanning Visit|Physician Decision|0|||
154887483|NCT01253421|559009221|FG002|Drug+Scanning Visit|Physician Decision|0|||
154887484|NCT01253421|559009222|FG003|Drug+Scanning Visit|Physician Decision|0|||
154887485|NCT01253421|559009223|FG004|Drug+Scanning Visit|Physician Decision|1|||
154887486|NCT01608724|559009225|FG000|Overall Study|Withdrawal by Subject|131|||
154887487|NCT01608724|559009225|FG000|Overall Study|Lost to Follow-up|41|||
154887488|NCT01608724|559009225|FG000|Overall Study|Study-specific discontinuation criteria|32|||
154887489|NCT01608724|559009225|FG000|Overall Study|Adverse Event|29|||
154887490|NCT01608724|559009225|FG000|Overall Study|Protocol Violation|6|||
154887491|NCT01608724|559009225|FG000|Overall Study|bood sugar too high, etc.|3|||
154887492|NCT01608724|559009225|FG000|Overall Study|Safety reasons|1|||
154887493|NCT04633473|559009226|FG000|Overall Study|Withdrawal by Subject|6|||
154887494|NCT00099359|559009228|FG000|Overall Study|Death|11|||
154887495|NCT00099359|559009229|FG001|Overall Study|Death|15|||
154887496|NCT00099359|559009230|FG002|Overall Study|Death|17|||
154887497|NCT00099359|559009228|FG000|Overall Study|Withdrawal by Subject|19|||
154887498|NCT00099359|559009229|FG001|Overall Study|Withdrawal by Subject|19|||
154887499|NCT00099359|559009230|FG002|Overall Study|Withdrawal by Subject|23|||
154887500|NCT00099359|559009228|FG000|Overall Study|Lost to Follow-up|15|||
154887501|NCT00099359|559009229|FG001|Overall Study|Lost to Follow-up|24|||
154887502|NCT00099359|559009230|FG002|Overall Study|Lost to Follow-up|24|||
154887503|NCT00099359|559009228|FG000|Overall Study|moved out of area|9|||
154887504|NCT00099359|559009229|FG001|Overall Study|moved out of area|7|||
154887505|NCT00099359|559009230|FG002|Overall Study|moved out of area|4|||
154887506|NCT01822691|559009231|FG000|Overall Study|Withdrawal by Subject|2|||
154887507|NCT01778127|559009234|FG000|Overall Study|Lost to Follow-up|5|||
154887508|NCT01778127|559009235|FG001|Overall Study|Lost to Follow-up|1|||
154887509|NCT01778127|559009236|FG002|Overall Study|Lost to Follow-up|2|||
154887510|NCT01778127|559009234|FG000|Overall Study|Withdrawal by Subject|3|||
154887511|NCT01778127|559009235|FG001|Overall Study|Withdrawal by Subject|1|||
154887512|NCT01778127|559009236|FG002|Overall Study|Withdrawal by Subject|4|||
154887513|NCT02104804|559009237|FG000|Overall Study|Did not take study medication|0|||
154887514|NCT02104804|559009238|FG001|Overall Study|Did not take study medication|1|||
154887515|NCT02104804|559009237|FG000|Overall Study|Study specific discontinuation criteria|6|||
154887516|NCT02104804|559009238|FG001|Overall Study|Study specific discontinuation criteria|1|||
154887517|NCT02104804|559009237|FG000|Overall Study|Other listed|2|||
154887518|NCT02104804|559009238|FG001|Overall Study|Other listed|1|||
154887519|NCT02104804|559009237|FG000|Overall Study|Protocol Violation|0|||
154887520|NCT02104804|559009238|FG001|Overall Study|Protocol Violation|1|||
154887521|NCT02104804|559009237|FG000|Overall Study|Adverse Event|4|||
154887522|NCT02104804|559009238|FG001|Overall Study|Adverse Event|3|||
154887523|NCT02104804|559009237|FG000|Overall Study|Withdrawal by Subject|4|||
154887524|NCT02104804|559009238|FG001|Overall Study|Withdrawal by Subject|12|||
154887525|NCT01348425|559009239|FG000|Overall Study|Imaging was not taken.|1|||
154887526|NCT01348425|559009240|FG001|Overall Study|Imaging was not taken.|1|||
154887527|NCT01968954|559009244|FG000|Overall Study|Adverse Event|6|||
154887528|NCT01968954|559009245|FG001|Overall Study|Adverse Event|3|||
154887529|NCT01968954|559009244|FG000|Overall Study|Death|1|||
154887530|NCT01968954|559009245|FG001|Overall Study|Death|2|||
154887531|NCT01968954|559009244|FG000|Overall Study|Lost to Follow-up|6|||
154887532|NCT01968954|559009245|FG001|Overall Study|Lost to Follow-up|4|||
154887533|NCT01968954|559009244|FG000|Overall Study|Withdrawal by Subject|20|||
154887534|NCT01968954|559009245|FG001|Overall Study|Withdrawal by Subject|23|||
154887535|NCT01968954|559009244|FG000|Overall Study|Other|7|||
154887536|NCT01968954|559009245|FG001|Overall Study|Other|8|||
154887537|NCT01968954|559009244|FG000|Overall Study|Protocol Violation|0|||
154887538|NCT01968954|559009245|FG001|Overall Study|Protocol Violation|1|||
154887539|NCT01968954|559009244|FG000|Overall Study|Did not met inclusion criteria|0|||
154887540|NCT01968954|559009245|FG001|Overall Study|Did not met inclusion criteria|2|||
154887541|NCT03260205|559009249|FG000|Overall Study|Adverse Event|2|||
154887542|NCT03260205|559009250|FG001|Overall Study|Adverse Event|0|||
154887543|NCT03260205|559009251|FG002|Overall Study|Adverse Event|2|||
154887544|NCT03260205|559009252|FG003|Overall Study|Adverse Event|2|||
154887545|NCT03260205|559009253|FG004|Overall Study|Adverse Event|4|||
154887546|NCT03260205|559009249|FG000|Overall Study|Lost to Follow-up|2|||
154887547|NCT03260205|559009250|FG001|Overall Study|Lost to Follow-up|2|||
154887548|NCT03260205|559009251|FG002|Overall Study|Lost to Follow-up|1|||
154887549|NCT03260205|559009252|FG003|Overall Study|Lost to Follow-up|1|||
154887550|NCT03260205|559009253|FG004|Overall Study|Lost to Follow-up|5|||
154887551|NCT03260205|559009249|FG000|Overall Study|Protocol Violation|0|||
154887552|NCT03260205|559009250|FG001|Overall Study|Protocol Violation|0|||
154887553|NCT03260205|559009251|FG002|Overall Study|Protocol Violation|2|||
154887554|NCT03260205|559009252|FG003|Overall Study|Protocol Violation|0|||
154887555|NCT03260205|559009253|FG004|Overall Study|Protocol Violation|1|||
154887556|NCT03260205|559009249|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
154887557|NCT03260205|559009250|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
154887558|NCT03260205|559009251|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
154887559|NCT03260205|559009252|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
154887560|NCT03260205|559009253|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
154887561|NCT03260205|559009249|FG000|Overall Study|Other: Unspecified|0|||
154887562|NCT03260205|559009250|FG001|Overall Study|Other: Unspecified|0|||
154887563|NCT03260205|559009251|FG002|Overall Study|Other: Unspecified|3|||
154887564|NCT03260205|559009252|FG003|Overall Study|Other: Unspecified|1|||
154887565|NCT03260205|559009253|FG004|Overall Study|Other: Unspecified|1|||
154887566|NCT03260205|559009249|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
154887567|NCT03260205|559009250|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
154887568|NCT03260205|559009251|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
154887569|NCT03260205|559009252|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
154887570|NCT03260205|559009253|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
154887571|NCT03423979|559009254|FG000|Overall Study|Death|5|||
154887572|NCT03423979|559009254|FG000|Overall Study|Adverse Event|4|||
154977193|NCT02688387|559340785|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
155175466|NCT04585009|560080244|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
155175467|NCT02882152|560080245|FG000|Overall Study|Lost to Follow-up|1|||
154887573|NCT03423979|559009254|FG000|Overall Study|Withdrawal by Subject|3|||
154887574|NCT03423979|559009254|FG000|Overall Study|Lost to Follow-up|16|||
154887575|NCT00808249|559009255|FG000|Overall Study|Adverse Event|4|||
154887576|NCT00808249|559009256|FG001|Overall Study|Adverse Event|7|||
154887577|NCT00808249|559009257|FG002|Overall Study|Adverse Event|10|||
154887578|NCT00808249|559009258|FG003|Overall Study|Adverse Event|6|||
154887579|NCT00808249|559009255|FG000|Overall Study|Lost to Follow-up|2|||
154887580|NCT00808249|559009256|FG001|Overall Study|Lost to Follow-up|3|||
154887581|NCT00808249|559009257|FG002|Overall Study|Lost to Follow-up|3|||
154887582|NCT00808249|559009258|FG003|Overall Study|Lost to Follow-up|5|||
154887583|NCT00808249|559009255|FG000|Overall Study|Withdrawal by Subject|4|||
154887584|NCT00808249|559009256|FG001|Overall Study|Withdrawal by Subject|0|||
154887585|NCT00808249|559009257|FG002|Overall Study|Withdrawal by Subject|2|||
154887586|NCT00808249|559009258|FG003|Overall Study|Withdrawal by Subject|4|||
155113776|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
155113777|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Disease progression|45|||
155113778|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Disease progression|0|||
155113779|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Disease progression|0|||
155113780|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
154887587|NCT00808249|559009255|FG000|Overall Study|Protocol Violation|3|||
154887588|NCT00808249|559009256|FG001|Overall Study|Protocol Violation|3|||
154887589|NCT00808249|559009257|FG002|Overall Study|Protocol Violation|3|||
154887590|NCT00808249|559009258|FG003|Overall Study|Protocol Violation|0|||
154887591|NCT00808249|559009255|FG000|Overall Study|Lack of Efficacy|1|||
154887592|NCT00808249|559009256|FG001|Overall Study|Lack of Efficacy|1|||
154887593|NCT00808249|559009257|FG002|Overall Study|Lack of Efficacy|0|||
154887594|NCT00808249|559009258|FG003|Overall Study|Lack of Efficacy|0|||
154887595|NCT00808249|559009255|FG000|Overall Study|study specific discontinuation criteria|1|||
154887596|NCT00808249|559009256|FG001|Overall Study|study specific discontinuation criteria|0|||
154887597|NCT00808249|559009257|FG002|Overall Study|study specific discontinuation criteria|1|||
154887598|NCT00808249|559009258|FG003|Overall Study|study specific discontinuation criteria|0|||
154887599|NCT00808249|559009255|FG000|Overall Study|All other reasons|2|||
154887600|NCT00808249|559009256|FG001|Overall Study|All other reasons|1|||
154887601|NCT00808249|559009257|FG002|Overall Study|All other reasons|3|||
154887602|NCT00808249|559009258|FG003|Overall Study|All other reasons|1|||
154887603|NCT04095286|559009259|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887604|NCT04095286|559009260|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
154887605|NCT04095286|559009261|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887606|NCT04095286|559009262|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887607|NCT04095286|559009263|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887608|NCT04095286|559009264|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887609|NCT04095286|559009259|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
154887610|NCT04095286|559009260|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
154887611|NCT04095286|559009261|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
154887612|NCT04095286|559009262|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
154887613|NCT04095286|559009263|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
154887614|NCT04095286|559009264|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
154887615|NCT04095286|559009259|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
154887616|NCT04095286|559009260|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
154887617|NCT04095286|559009261|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
154887618|NCT04095286|559009262|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
154887619|NCT04095286|559009263|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
154887620|NCT04095286|559009264|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
154887621|NCT04095286|559009259|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887622|NCT04095286|559009260|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887623|NCT04095286|559009261|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
154887624|NCT04095286|559009262|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887625|NCT04095286|559009263|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887626|NCT04095286|559009264|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
154887627|NCT04095286|559009259|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
154887628|NCT04095286|559009260|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
154887629|NCT04095286|559009261|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
154887630|NCT04095286|559009262|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
154887631|NCT04095286|559009263|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
154887632|NCT04095286|559009264|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
154887633|NCT02509494|559009265|FG000|Overall Study|Lost to Follow-up|8|||
154887634|NCT02509494|559009266|FG001|Overall Study|Lost to Follow-up|47|||
154887635|NCT02509494|559009267|FG002|Overall Study|Lost to Follow-up|19|||
154887636|NCT02509494|559009268|FG003|Overall Study|Lost to Follow-up|6|||
154887637|NCT02509494|559009269|FG004|Overall Study|Lost to Follow-up|3|||
154887638|NCT02509494|559009270|FG005|Overall Study|Lost to Follow-up|3|||
154887639|NCT02509494|559009271|FG006|Overall Study|Lost to Follow-up|1|||
154887640|NCT02509494|559009272|FG007|Overall Study|Lost to Follow-up|3|||
154887641|NCT02509494|559009273|FG008|Overall Study|Lost to Follow-up|1|||
154887642|NCT02509494|559009265|FG000|Overall Study|Physician Decision|2|||
154887643|NCT02509494|559009266|FG001|Overall Study|Physician Decision|1|||
154887644|NCT02509494|559009267|FG002|Overall Study|Physician Decision|0|||
155113781|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
155113782|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
155175468|NCT02882152|560080246|FG001|Overall Study|Lost to Follow-up|0|||
154887645|NCT02509494|559009268|FG003|Overall Study|Physician Decision|0|||
154887646|NCT02509494|559009269|FG004|Overall Study|Physician Decision|0|||
154887647|NCT02509494|559009270|FG005|Overall Study|Physician Decision|0|||
154887648|NCT02509494|559009271|FG006|Overall Study|Physician Decision|0|||
155175469|NCT01104376|560080247|FG000|Overall Study|Withdrawal by Subject|15|||
155175470|NCT01104376|560080247|FG000|Overall Study|Consented but excluded after labs|13|||
155175471|NCT01673347|560080248|FG000|Overall Study|failure of allograft|7|||
154887649|NCT02509494|559009272|FG007|Overall Study|Physician Decision|0|||
154887650|NCT02509494|559009273|FG008|Overall Study|Physician Decision|0|||
154887651|NCT02509494|559009265|FG000|Overall Study|Withdrawal by Subject|4|||
154887652|NCT02509494|559009266|FG001|Overall Study|Withdrawal by Subject|17|||
154887653|NCT02509494|559009267|FG002|Overall Study|Withdrawal by Subject|7|||
154887654|NCT02509494|559009268|FG003|Overall Study|Withdrawal by Subject|5|||
154887655|NCT02509494|559009269|FG004|Overall Study|Withdrawal by Subject|0|||
154887656|NCT02509494|559009270|FG005|Overall Study|Withdrawal by Subject|6|||
154887657|NCT02509494|559009271|FG006|Overall Study|Withdrawal by Subject|1|||
154887658|NCT02509494|559009272|FG007|Overall Study|Withdrawal by Subject|2|||
154887659|NCT02509494|559009273|FG008|Overall Study|Withdrawal by Subject|1|||
154887660|NCT02509494|559009265|FG000|Overall Study|Death|0|||
154887661|NCT02509494|559009266|FG001|Overall Study|Death|1|||
154887662|NCT02509494|559009267|FG002|Overall Study|Death|0|||
154887663|NCT02509494|559009268|FG003|Overall Study|Death|0|||
154887664|NCT02509494|559009269|FG004|Overall Study|Death|1|||
154887665|NCT02509494|559009270|FG005|Overall Study|Death|0|||
154887666|NCT02509494|559009271|FG006|Overall Study|Death|0|||
154887667|NCT02509494|559009272|FG007|Overall Study|Death|1|||
154887668|NCT02509494|559009273|FG008|Overall Study|Death|0|||
154887669|NCT02509494|559009265|FG000|Overall Study|Other|0|||
154887670|NCT02509494|559009266|FG001|Overall Study|Other|4|||
154887671|NCT02509494|559009267|FG002|Overall Study|Other|5|||
154887672|NCT02509494|559009268|FG003|Overall Study|Other|0|||
154887673|NCT02509494|559009269|FG004|Overall Study|Other|0|||
154887674|NCT02509494|559009270|FG005|Overall Study|Other|0|||
154887675|NCT02509494|559009271|FG006|Overall Study|Other|0|||
154887676|NCT02509494|559009272|FG007|Overall Study|Other|0|||
154887677|NCT02509494|559009273|FG008|Overall Study|Other|0|||
154887678|NCT02509494|559009265|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154887679|NCT02509494|559009266|FG001|Overall Study|Non-Compliance With Study Drug|11|||
154887680|NCT02509494|559009267|FG002|Overall Study|Non-Compliance With Study Drug|7|||
154887681|NCT02509494|559009268|FG003|Overall Study|Non-Compliance With Study Drug|0|||
154887682|NCT02509494|559009269|FG004|Overall Study|Non-Compliance With Study Drug|1|||
154887683|NCT02509494|559009270|FG005|Overall Study|Non-Compliance With Study Drug|2|||
154887684|NCT02509494|559009271|FG006|Overall Study|Non-Compliance With Study Drug|1|||
154887685|NCT02509494|559009272|FG007|Overall Study|Non-Compliance With Study Drug|1|||
154887686|NCT02509494|559009273|FG008|Overall Study|Non-Compliance With Study Drug|0|||
154887687|NCT05371912|559009274|FG000|Overall Study|Lost to Follow-up|3|||
154887688|NCT05371912|559009275|FG001|Overall Study|Lost to Follow-up|2|||
154887689|NCT04752189|559009276|FG000|Overall Study|Withdrawal by Subject|0|||
154887690|NCT04752189|559009277|FG001|Overall Study|Withdrawal by Subject|150|||
154887691|NCT04752189|559009276|FG000|Overall Study|Lost to Follow-up|261|||
154887692|NCT04752189|559009277|FG001|Overall Study|Lost to Follow-up|126|||
154887693|NCT00975195|559009278|FG000|Overall Study|Adverse Event|108|||
154887694|NCT00975195|559009279|FG001|Overall Study|Adverse Event|101|||
154887695|NCT00975195|559009278|FG000|Overall Study|Lack of Efficacy|6|||
154887696|NCT00975195|559009279|FG001|Overall Study|Lack of Efficacy|6|||
154887697|NCT00975195|559009278|FG000|Overall Study|Protocol Violation|27|||
154887698|NCT00975195|559009279|FG001|Overall Study|Protocol Violation|23|||
154887699|NCT00975195|559009278|FG000|Overall Study|Lost to Follow-up|9|||
154887700|NCT00975195|559009279|FG001|Overall Study|Lost to Follow-up|7|||
154887701|NCT00975195|559009278|FG000|Overall Study|Withdrawal by Subject|48|||
154887702|NCT00975195|559009279|FG001|Overall Study|Withdrawal by Subject|61|||
155175472|NCT00895011|560080254|FG000|Overall Study|Withdrawal by Subject|14|||
155175473|NCT00895011|560080255|FG001|Overall Study|Withdrawal by Subject|7|||
154887703|NCT00975195|559009278|FG000|Overall Study|Other reason not defined above|29|||
154887704|NCT00975195|559009279|FG001|Overall Study|Other reason not defined above|33|||
154887705|NCT00975195|559009278|FG000|Overall Study|Not treated|1|||
154887706|NCT00975195|559009279|FG001|Overall Study|Not treated|2|||
154887707|NCT03003403|559009284|FG000|Overall Study|Ineligible|8|||
154887708|NCT03003403|559009285|FG001|Overall Study|Ineligible|7|||
154887709|NCT03003403|559009284|FG000|Overall Study|Withdrawal by Subject|3|||
154887710|NCT03003403|559009285|FG001|Overall Study|Withdrawal by Subject|1|||
154887711|NCT02690207|559010664|FG000|Overall Study|Lost to Follow-up|48|||
154887712|NCT02690207|559010664|FG000|Overall Study|Withdrawal by Subject|46|||
154887713|NCT02690207|559010664|FG000|Overall Study|Protocol Violation|2|||
154887714|NCT02690207|559010664|FG000|Overall Study|Serious adverse event|110|||
154887715|NCT02690207|559010664|FG000|Overall Study|Non-serious Adverse Event|18|||
154887716|NCT02690207|559010664|FG000|Overall Study|Migrated/moved from study area|5|||
154887717|NCT02690207|559010664|FG000|Overall Study|Suspected HZ Episode|1|||
154887718|NCT02690207|559010664|FG000|Overall Study|Other reasons for withdrawal|23|||
154887719|NCT02475850|559010665|FG000|Overall Study|Death|155|||
154887720|NCT02475850|559010666|FG001|Overall Study|Death|141|||
154887721|NCT02475850|559010665|FG000|Overall Study|Lost to Follow-up|217|||
154887722|NCT02475850|559010666|FG001|Overall Study|Lost to Follow-up|188|||
154887723|NCT02475850|559010665|FG000|Overall Study|Withdrawal by Subject|221|||
154887724|NCT02475850|559010666|FG001|Overall Study|Withdrawal by Subject|155|||
154887725|NCT03434418|559010672|FG000|Overall Study|Disease Progression|11|||
154887726|NCT03434418|559010672|FG000|Overall Study|Adverse Event|2|||
154887727|NCT03434418|559010672|FG000|Overall Study|Physician Decision|1|||
154887728|NCT03434418|559010672|FG000|Overall Study|Decline in Performance Status (PS)|1|||
154887729|NCT03569449|559010675|FG000|Overall Study|Lost to Follow-up|0|||
154887730|NCT03569449|559010676|FG001|Overall Study|Lost to Follow-up|1|||
154887731|NCT03569449|559010677|FG002|Overall Study|Lost to Follow-up|0|||
154887732|NCT03569449|559010678|FG003|Overall Study|Lost to Follow-up|2|||
154887733|NCT03569449|559010679|FG004|Overall Study|Lost to Follow-up|0|||
154887734|NCT03569449|559010680|FG005|Overall Study|Lost to Follow-up|0|||
154887735|NCT03569449|559010681|FG006|Overall Study|Lost to Follow-up|0|||
154887736|NCT03569449|559010682|FG007|Overall Study|Lost to Follow-up|0|||
154887737|NCT03569449|559010683|FG008|Overall Study|Lost to Follow-up|0|||
154887738|NCT03569449|559010684|FG009|Overall Study|Lost to Follow-up|0|||
154887739|NCT03569449|559010685|FG010|Overall Study|Lost to Follow-up|0|||
154887740|NCT03569449|559010686|FG011|Overall Study|Lost to Follow-up|0|||
154887741|NCT03569449|559010687|FG012|Overall Study|Lost to Follow-up|0|||
154887742|NCT03569449|559010688|FG013|Overall Study|Lost to Follow-up|0|||
154887743|NCT03569449|559010689|FG014|Overall Study|Lost to Follow-up|1|||
154887744|NCT03569449|559010690|FG015|Overall Study|Lost to Follow-up|0|||
154887745|NCT03569449|559010675|FG000|Overall Study|Withdrawal by Subject|0|||
154887746|NCT03569449|559010676|FG001|Overall Study|Withdrawal by Subject|1|||
154887747|NCT03569449|559010677|FG002|Overall Study|Withdrawal by Subject|0|||
154887748|NCT03569449|559010678|FG003|Overall Study|Withdrawal by Subject|0|||
154887749|NCT03569449|559010679|FG004|Overall Study|Withdrawal by Subject|1|||
154887750|NCT03569449|559010680|FG005|Overall Study|Withdrawal by Subject|0|||
154887751|NCT03569449|559010681|FG006|Overall Study|Withdrawal by Subject|0|||
154887752|NCT03569449|559010682|FG007|Overall Study|Withdrawal by Subject|0|||
154887753|NCT03569449|559010683|FG008|Overall Study|Withdrawal by Subject|0|||
154887754|NCT03569449|559010684|FG009|Overall Study|Withdrawal by Subject|0|||
154887755|NCT03569449|559010685|FG010|Overall Study|Withdrawal by Subject|0|||
154887756|NCT03569449|559010686|FG011|Overall Study|Withdrawal by Subject|0|||
154887757|NCT03569449|559010687|FG012|Overall Study|Withdrawal by Subject|0|||
154887758|NCT03569449|559010688|FG013|Overall Study|Withdrawal by Subject|0|||
154887759|NCT03569449|559010689|FG014|Overall Study|Withdrawal by Subject|0|||
154887760|NCT03569449|559010690|FG015|Overall Study|Withdrawal by Subject|0|||
154887761|NCT04124692|559010691|FG000|Overall Study|Medical reason|0|||
154887762|NCT04124692|559010692|FG001|Overall Study|Medical reason|1|||
154887763|NCT04124692|559010691|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
154887764|NCT04124692|559010692|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
154887765|NCT04124692|559010691|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
154887766|NCT04124692|559010692|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
154887767|NCT04124692|559010691|FG000|Overall Study|Lost to Follow-up|2|||
154887768|NCT04124692|559010692|FG001|Overall Study|Lost to Follow-up|4|||
154887769|NCT04124692|559010691|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
154887770|NCT04124692|559010692|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
154887771|NCT05279898|559010706|FG000|Overall Study|Withdrawal by Subject|1|||
154887772|NCT05279898|559010707|FG001|Overall Study|Withdrawal by Subject|0|||
154887773|NCT05279898|559010706|FG000|Overall Study|Physician Decision|1|||
154887774|NCT05279898|559010707|FG001|Overall Study|Physician Decision|1|||
154887775|NCT05136170|559010708|FG000|Overall Study|Withdrawal by Subject|2|||
154887776|NCT05136170|559010709|FG001|Overall Study|Withdrawal by Subject|2|||
154887777|NCT05136170|559010708|FG000|Overall Study|Can no longer make office visits|1|||
154887778|NCT05136170|559010709|FG001|Overall Study|Can no longer make office visits|0|||
154887779|NCT04393038|559010710|FG000|Overall Study|Adverse Event|11|||
154887780|NCT04393038|559010711|FG001|Overall Study|Adverse Event|2|||
154887781|NCT04393038|559010710|FG000|Overall Study|Protocol Violation|1|||
154887782|NCT04393038|559010711|FG001|Overall Study|Protocol Violation|0|||
154887783|NCT04393038|559010710|FG000|Overall Study|Death|6|||
154887784|NCT04393038|559010711|FG001|Overall Study|Death|4|||
154887785|NCT04393038|559010710|FG000|Overall Study|Withdrawal by Subject|24|||
154887786|NCT04393038|559010711|FG001|Overall Study|Withdrawal by Subject|8|||
154887787|NCT04393038|559010710|FG000|Overall Study|Lost to Follow-up|5|||
154887788|NCT04393038|559010711|FG001|Overall Study|Lost to Follow-up|4|||
154887789|NCT04393038|559010710|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
154887790|NCT04393038|559010711|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
154887791|NCT04393038|559010710|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
154887792|NCT04393038|559010711|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
154887793|NCT05168813|559010712|FG000|Part A (Open-label)|Lost to Follow-up|21|||
154887794|NCT05168813|559010713|FG001|Part A (Open-label)|Lost to Follow-up|39|||
154887795|NCT05168813|559010714|FG002|Part A (Open-label)|Lost to Follow-up|8|||
154887796|NCT05168813|559010715|FG003|Part A (Open-label)|Lost to Follow-up|26|||
154977194|NCT02688387|559340786|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977195|NCT02688387|559340787|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977196|NCT02688387|559340788|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977197|NCT02688387|559340789|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
154977198|NCT02688387|559340768|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977199|NCT02688387|559340769|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977200|NCT02688387|559340770|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977201|NCT02688387|559340771|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977202|NCT02688387|559340772|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977203|NCT02688387|559340773|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977204|NCT02688387|559340774|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977205|NCT02688387|559340775|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977206|NCT02688387|559340776|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977207|NCT02688387|559340777|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977208|NCT02688387|559340778|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
154977209|NCT02688387|559340779|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977210|NCT02688387|559340780|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977211|NCT02688387|559340781|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977212|NCT02688387|559340782|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977213|NCT02688387|559340783|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977214|NCT02688387|559340784|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977215|NCT02688387|559340785|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977216|NCT02688387|559340786|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977217|NCT02688387|559340787|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977218|NCT02688387|559340788|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977219|NCT02688387|559340789|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
154977220|NCT02688387|559340768|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977221|NCT02688387|559340769|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154887797|NCT05168813|559010716|FG004|Part A (Open-label)|Lost to Follow-up|0|||
154887798|NCT05168813|559010717|FG005|Part A (Open-label)|Lost to Follow-up|0|||
154887799|NCT05168813|559010712|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
154887800|NCT05168813|559010713|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
154887801|NCT05168813|559010714|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
154887802|NCT05168813|559010715|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
154887803|NCT05168813|559010716|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
154887804|NCT05168813|559010717|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
154887805|NCT05168813|559010712|FG000|Part A (Open-label)|Death|23|||
154887806|NCT05168813|559010713|FG001|Part A (Open-label)|Death|28|||
154887807|NCT05168813|559010714|FG002|Part A (Open-label)|Death|1|||
154887808|NCT05168813|559010715|FG003|Part A (Open-label)|Death|9|||
154887809|NCT05168813|559010716|FG004|Part A (Open-label)|Death|0|||
154887810|NCT05168813|559010717|FG005|Part A (Open-label)|Death|0|||
154887811|NCT05168813|559010712|FG000|Part A (Open-label)|Physician Decision|0|||
154887812|NCT05168813|559010713|FG001|Part A (Open-label)|Physician Decision|1|||
154887813|NCT05168813|559010714|FG002|Part A (Open-label)|Physician Decision|0|||
154887814|NCT05168813|559010715|FG003|Part A (Open-label)|Physician Decision|2|||
154887815|NCT05168813|559010716|FG004|Part A (Open-label)|Physician Decision|0|||
154887816|NCT05168813|559010717|FG005|Part A (Open-label)|Physician Decision|0|||
154887817|NCT05168813|559010712|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
154887818|NCT05168813|559010713|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
154977222|NCT02688387|559340770|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977223|NCT02688387|559340771|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977224|NCT02688387|559340772|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977225|NCT02688387|559340773|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977226|NCT02688387|559340774|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977227|NCT02688387|559340775|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977228|NCT02688387|559340776|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
155113783|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
155113784|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
155113785|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
155113786|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
155113787|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
155113788|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
155113789|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
155113790|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
155113791|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
154887819|NCT05168813|559010714|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
154887820|NCT05168813|559010715|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
154977229|NCT02688387|559340777|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154887821|NCT05168813|559010716|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
154887822|NCT05168813|559010717|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
154887823|NCT05168813|559010712|FG000|Part A (Open-label)|Protocol Violation|0|||
154887824|NCT05168813|559010713|FG001|Part A (Open-label)|Protocol Violation|1|||
154887825|NCT05168813|559010714|FG002|Part A (Open-label)|Protocol Violation|0|||
154887826|NCT05168813|559010715|FG003|Part A (Open-label)|Protocol Violation|0|||
154887827|NCT05168813|559010716|FG004|Part A (Open-label)|Protocol Violation|0|||
154887828|NCT05168813|559010717|FG005|Part A (Open-label)|Protocol Violation|0|||
154887829|NCT05168813|559010712|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
154887830|NCT05168813|559010713|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
154887831|NCT05168813|559010714|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
154887832|NCT05168813|559010715|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
154887833|NCT05168813|559010716|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
154887834|NCT05168813|559010717|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
154887835|NCT05168813|559010712|FG000|Part A (Open-label)|Other|0|||
154887836|NCT05168813|559010713|FG001|Part A (Open-label)|Other|1|||
154887837|NCT05168813|559010714|FG002|Part A (Open-label)|Other|0|||
154887838|NCT05168813|559010715|FG003|Part A (Open-label)|Other|0|||
154887839|NCT05168813|559010716|FG004|Part A (Open-label)|Other|0|||
154887840|NCT05168813|559010717|FG005|Part A (Open-label)|Other|0|||
154887841|NCT05168813|559010712|FG000|Part B (Blinded)|Lost to Follow-up|0|||
154887842|NCT05168813|559010713|FG001|Part B (Blinded)|Lost to Follow-up|0|||
154887843|NCT05168813|559010714|FG002|Part B (Blinded)|Lost to Follow-up|0|||
154887844|NCT05168813|559010715|FG003|Part B (Blinded)|Lost to Follow-up|0|||
154887845|NCT05168813|559010716|FG004|Part B (Blinded)|Lost to Follow-up|219|||
154887846|NCT05168813|559010717|FG005|Part B (Blinded)|Lost to Follow-up|88|||
154887847|NCT05168813|559010712|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
154887848|NCT05168813|559010713|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
154887849|NCT05168813|559010714|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
154887850|NCT05168813|559010715|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
154887851|NCT05168813|559010716|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
154887852|NCT05168813|559010717|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
154887853|NCT05168813|559010712|FG000|Part B (Blinded)|Death|0|||
154887854|NCT05168813|559010713|FG001|Part B (Blinded)|Death|0|||
154887855|NCT05168813|559010714|FG002|Part B (Blinded)|Death|0|||
154887856|NCT05168813|559010715|FG003|Part B (Blinded)|Death|0|||
154887857|NCT05168813|559010716|FG004|Part B (Blinded)|Death|63|||
154887858|NCT05168813|559010717|FG005|Part B (Blinded)|Death|19|||
154887859|NCT05168813|559010712|FG000|Part B (Blinded)|Physician Decision|0|||
154887860|NCT05168813|559010713|FG001|Part B (Blinded)|Physician Decision|0|||
154887861|NCT05168813|559010714|FG002|Part B (Blinded)|Physician Decision|0|||
154887862|NCT05168813|559010715|FG003|Part B (Blinded)|Physician Decision|0|||
154887863|NCT05168813|559010716|FG004|Part B (Blinded)|Physician Decision|6|||
154887864|NCT05168813|559010717|FG005|Part B (Blinded)|Physician Decision|1|||
154887865|NCT05168813|559010712|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
154887866|NCT05168813|559010713|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
154887867|NCT05168813|559010714|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
154887868|NCT05168813|559010715|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
154887869|NCT05168813|559010716|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
154887870|NCT05168813|559010717|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
154887871|NCT05168813|559010712|FG000|Part B (Blinded)|Pregnancy|0|||
154887872|NCT05168813|559010713|FG001|Part B (Blinded)|Pregnancy|0|||
154887873|NCT05168813|559010714|FG002|Part B (Blinded)|Pregnancy|0|||
154887874|NCT05168813|559010715|FG003|Part B (Blinded)|Pregnancy|0|||
154887875|NCT05168813|559010716|FG004|Part B (Blinded)|Pregnancy|1|||
154887876|NCT05168813|559010717|FG005|Part B (Blinded)|Pregnancy|0|||
154887877|NCT05168813|559010712|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
154887878|NCT05168813|559010713|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
154887879|NCT05168813|559010714|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
154887880|NCT05168813|559010715|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
154887881|NCT05168813|559010716|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
154887882|NCT05168813|559010717|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
154887883|NCT05168813|559010712|FG000|Part B (Blinded)|Other|0|||
154887884|NCT05168813|559010713|FG001|Part B (Blinded)|Other|0|||
154887885|NCT05168813|559010714|FG002|Part B (Blinded)|Other|0|||
154887886|NCT05168813|559010715|FG003|Part B (Blinded)|Other|0|||
154887887|NCT05168813|559010716|FG004|Part B (Blinded)|Other|41|||
154887888|NCT05168813|559010717|FG005|Part B (Blinded)|Other|27|||
154887889|NCT01754922|559010719|FG000|Overall Study|Adverse Event|0|||
154977230|NCT02688387|559340778|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977231|NCT02688387|559340779|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154887890|NCT01754922|559010720|FG001|Overall Study|Adverse Event|1|||
154887891|NCT01207388|559010723|FG000|Overall Study|Death|67|||
154887892|NCT01207388|559010723|FG000|Overall Study|Withdrawal by Subject|1|||
154887893|NCT00571688|559010730|FG000|Overall Study|Lost to Follow-up|3|||
154887894|NCT00571688|559010731|FG001|Overall Study|Lost to Follow-up|6|||
154887895|NCT00571688|559010730|FG000|Overall Study|subject did not tolerate Consta|1|||
154887896|NCT00571688|559010731|FG001|Overall Study|subject did not tolerate Consta|0|||
154887897|NCT00571688|559010730|FG000|Overall Study|subject moved out of the area|1|||
154887898|NCT00571688|559010731|FG001|Overall Study|subject moved out of the area|0|||
154887899|NCT01194869|559010732|FG000|Overall Study|Disease Progression|2|||
154887900|NCT01194869|559010732|FG000|Overall Study|Toxicity|2|||
154887901|NCT01048853|559010733|FG000|Overall Study|Death|1|||
154887902|NCT01048853|559010734|FG001|Overall Study|Death|0|||
154887903|NCT01048853|559010735|FG002|Overall Study|Death|0|||
154887904|NCT01048853|559010733|FG000|Overall Study|Lost to Follow-up|1|||
154887905|NCT01048853|559010734|FG001|Overall Study|Lost to Follow-up|4|||
154887906|NCT01048853|559010735|FG002|Overall Study|Lost to Follow-up|0|||
154887907|NCT06964165|559010739|FG000|Overall Study|Death|4|||
154887908|NCT06964165|559010740|FG001|Overall Study|Death|4|||
154887909|NCT06964165|559010739|FG000|Overall Study|Physician Decision|1|||
154887910|NCT06964165|559010740|FG001|Overall Study|Physician Decision|1|||
154887911|NCT06964165|559010739|FG000|Overall Study|Withdrawal by Subject|0|||
154887912|NCT06964165|559010740|FG001|Overall Study|Withdrawal by Subject|2|||
154887913|NCT06964165|559010739|FG000|Overall Study|Study terminated by sponsor|12|||
154887914|NCT06964165|559010740|FG001|Overall Study|Study terminated by sponsor|10|||
154887915|NCT06964165|559010739|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
154887916|NCT06964165|559010740|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
154887917|NCT06964165|559010739|FG000|Overall Study|Participant removed due to non-compliance|0|||
154887918|NCT06964165|559010740|FG001|Overall Study|Participant removed due to non-compliance|1|||
154887919|NCT03224104|559010746|FG000|Overall Study|Lack of Efficacy|2|||
154887920|NCT03224104|559010747|FG001|Overall Study|Lack of Efficacy|6|||
154887921|NCT03224104|559010748|FG002|Overall Study|Lack of Efficacy|3|||
154887922|NCT03224104|559010749|FG003|Overall Study|Lack of Efficacy|4|||
154887923|NCT03224104|559010750|FG004|Overall Study|Lack of Efficacy|42|||
154887924|NCT03224104|559010746|FG000|Overall Study|Withdrawal by Subject|0|||
154887925|NCT03224104|559010747|FG001|Overall Study|Withdrawal by Subject|2|||
154887926|NCT03224104|559010748|FG002|Overall Study|Withdrawal by Subject|0|||
154887927|NCT03224104|559010749|FG003|Overall Study|Withdrawal by Subject|1|||
154887928|NCT03224104|559010750|FG004|Overall Study|Withdrawal by Subject|3|||
154887929|NCT03224104|559010746|FG000|Overall Study|Death|0|||
154887930|NCT03224104|559010747|FG001|Overall Study|Death|1|||
154887931|NCT03224104|559010748|FG002|Overall Study|Death|0|||
154887932|NCT03224104|559010749|FG003|Overall Study|Death|0|||
154887933|NCT03224104|559010750|FG004|Overall Study|Death|0|||
154887934|NCT03224104|559010746|FG000|Overall Study|Adverse Event|1|||
154887935|NCT03224104|559010747|FG001|Overall Study|Adverse Event|0|||
154887936|NCT03224104|559010748|FG002|Overall Study|Adverse Event|0|||
154887937|NCT03224104|559010749|FG003|Overall Study|Adverse Event|1|||
154887938|NCT03224104|559010750|FG004|Overall Study|Adverse Event|3|||
154887939|NCT03224104|559010746|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
154887940|NCT03224104|559010747|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
154887941|NCT03224104|559010748|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
154887942|NCT03224104|559010749|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
154887943|NCT03224104|559010750|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
154887944|NCT03224104|559010746|FG000|Overall Study|Treatment ongoing|0|||
154887945|NCT03224104|559010747|FG001|Overall Study|Treatment ongoing|0|||
154887946|NCT03224104|559010748|FG002|Overall Study|Treatment ongoing|0|||
154887947|NCT03224104|559010749|FG003|Overall Study|Treatment ongoing|0|||
154887948|NCT03224104|559010750|FG004|Overall Study|Treatment ongoing|1|||
154887949|NCT04397718|559010753|FG000|Overall Study|Death|7|||
154887950|NCT04397718|559010754|FG001|Overall Study|Death|11|||
154887951|NCT04397718|559010753|FG000|Overall Study|Lost to Follow-up|0|||
154887952|NCT04397718|559010754|FG001|Overall Study|Lost to Follow-up|4|||
154887953|NCT06087328|559010755|FG000|28-Day Treatment|Lost to Follow-up|7|||
154887954|NCT06087328|559010756|FG001|28-Day Treatment|Lost to Follow-up|3|||
154887955|NCT06087328|559010757|FG002|28-Day Treatment|Lost to Follow-up|4|||
154887956|NCT06087328|559010755|FG000|1-month Follow-up|Lost to Follow-up|0|||
154887957|NCT06087328|559010756|FG001|1-month Follow-up|Lost to Follow-up|1|||
154887958|NCT06087328|559010757|FG002|1-month Follow-up|Lost to Follow-up|1|||
154887959|NCT03201965|559010760|FG000|Overall Study|Death|5|||
154887960|NCT03201965|559010761|FG001|Overall Study|Death|65|||
154887961|NCT03201965|559010762|FG002|Overall Study|Death|47|||
154887962|NCT03201965|559010760|FG000|Overall Study|Lost to Follow-up|0|||
154887963|NCT03201965|559010761|FG001|Overall Study|Lost to Follow-up|6|||
154887964|NCT03201965|559010762|FG002|Overall Study|Lost to Follow-up|0|||
154887965|NCT03201965|559010760|FG000|Overall Study|Withdrawal by Subject|3|||
154887966|NCT03201965|559010761|FG001|Overall Study|Withdrawal by Subject|23|||
154977232|NCT02688387|559340780|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154887967|NCT03201965|559010762|FG002|Overall Study|Withdrawal by Subject|8|||
154887968|NCT03201965|559010760|FG000|Overall Study|Sponsor's Decision|20|||
154887969|NCT03201965|559010761|FG001|Overall Study|Sponsor's Decision|99|||
154887970|NCT03201965|559010762|FG002|Overall Study|Sponsor's Decision|140|||
154887971|NCT01153893|559010772|FG000|Overall Study|Adverse Event|1|||
154887972|NCT01153893|559010773|FG001|Overall Study|Adverse Event|0|||
154887973|NCT04799405|559010774|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
154887974|NCT00118482|559010775|FG000|Overall Study|Lost to Follow-up|7|||
154887975|NCT00118482|559010776|FG001|Overall Study|Lost to Follow-up|7|||
154887976|NCT00118482|559010775|FG000|Overall Study|Withdrawal by Subject|23|||
154887977|NCT00118482|559010776|FG001|Overall Study|Withdrawal by Subject|22|||
154887978|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
154887979|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
154887980|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
154887981|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
154887982|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
154887983|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
154887984|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
154887985|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
154887986|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
154887987|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
154887988|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
154887989|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
154887990|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
154887991|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
154887992|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
154887993|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
154887994|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
154887995|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
154887996|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
154887997|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
154887998|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
154887999|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
154888000|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
154888001|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
154888002|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
154888003|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
154888004|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
154888005|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
154888006|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
154888007|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
154888008|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
154888009|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
154888010|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
154888011|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
154888012|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
154888013|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
154888014|NCT01963208|559010777|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
154888015|NCT01963208|559010778|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
154888016|NCT01963208|559010779|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
154888017|NCT01963208|559010780|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
154888018|NCT01963208|559010781|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
154888019|NCT01963208|559010782|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
154888020|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
154888021|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
154888022|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
154888023|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
154888024|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
154888025|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
154888026|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
154888027|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
154888028|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
154888029|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
154888030|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
154888031|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
154888032|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
154977233|NCT02688387|559340781|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977234|NCT02688387|559340782|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
155113792|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
155113793|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
155113794|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
155113795|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
154977235|NCT02688387|559340783|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977236|NCT02688387|559340784|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977237|NCT02688387|559340785|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977238|NCT02688387|559340786|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977239|NCT02688387|559340787|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154888033|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
154888034|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
154888035|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
154977240|NCT02688387|559340788|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977241|NCT02688387|559340789|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
154977242|NCT02688387|559340768|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977243|NCT02688387|559340769|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977244|NCT02688387|559340770|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977245|NCT02688387|559340771|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977246|NCT02688387|559340772|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977247|NCT02688387|559340773|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977248|NCT02688387|559340774|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977249|NCT02688387|559340775|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977250|NCT02688387|559340776|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977251|NCT02688387|559340777|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977252|NCT02688387|559340778|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977253|NCT02688387|559340779|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977254|NCT02688387|559340780|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977255|NCT02688387|559340781|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977256|NCT02688387|559340782|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977257|NCT02688387|559340783|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977258|NCT02688387|559340784|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977259|NCT02688387|559340785|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977260|NCT02688387|559340786|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977261|NCT02688387|559340787|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977262|NCT02688387|559340788|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
154977263|NCT02688387|559340789|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
154977264|NCT02688387|559340768|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977265|NCT02688387|559340769|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977266|NCT02688387|559340770|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977267|NCT02688387|559340771|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977268|NCT02688387|559340772|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977269|NCT02688387|559340773|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977270|NCT02688387|559340774|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977271|NCT02688387|559340775|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977272|NCT02688387|559340776|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154888036|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
154888037|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
154888038|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
154888039|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
154888040|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
154888041|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
154888042|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
154888043|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
154977273|NCT02688387|559340777|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977274|NCT02688387|559340778|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977275|NCT02688387|559340779|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977276|NCT02688387|559340780|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977277|NCT02688387|559340781|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977278|NCT02688387|559340782|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977279|NCT02688387|559340783|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977280|NCT02688387|559340784|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977281|NCT02688387|559340785|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977282|NCT02688387|559340786|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
154977283|NCT02688387|559340787|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977284|NCT02688387|559340788|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
154977285|NCT02688387|559340789|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
154977286|NCT02688387|559340768|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977287|NCT02688387|559340769|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977288|NCT02688387|559340770|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977289|NCT02688387|559340771|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155113796|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
154888044|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
154888045|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
154888046|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
154888047|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
154888048|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
154888049|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
154888050|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
154888051|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
154888052|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
154888053|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
154888054|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
154888055|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
154888056|NCT01963208|559010777|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
154888057|NCT01963208|559010778|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
154888058|NCT01963208|559010779|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
154888059|NCT01963208|559010780|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
154888060|NCT01963208|559010781|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
154888061|NCT01963208|559010782|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
154888062|NCT00438399|559010783|FG000|Overall Study|Lost to Follow-up|2|||
154888063|NCT00438399|559010784|FG001|Overall Study|Lost to Follow-up|2|||
154888064|NCT00438399|559010785|FG002|Overall Study|Lost to Follow-up|1|||
154888065|NCT00438399|559010786|FG003|Overall Study|Lost to Follow-up|1|||
154888066|NCT00438399|559010787|FG004|Overall Study|Lost to Follow-up|1|||
154888067|NCT00438399|559010788|FG005|Overall Study|Lost to Follow-up|1|||
154888068|NCT00438399|559010783|FG000|Overall Study|Adverse Event|0|||
154888069|NCT00438399|559010784|FG001|Overall Study|Adverse Event|0|||
154888070|NCT00438399|559010785|FG002|Overall Study|Adverse Event|1|||
154888071|NCT00438399|559010786|FG003|Overall Study|Adverse Event|1|||
154888072|NCT00438399|559010787|FG004|Overall Study|Adverse Event|0|||
154888073|NCT00438399|559010788|FG005|Overall Study|Adverse Event|1|||
154888074|NCT00438399|559010783|FG000|Overall Study|Withdrawal by Subject|5|||
154888075|NCT00438399|559010784|FG001|Overall Study|Withdrawal by Subject|6|||
154888076|NCT00438399|559010785|FG002|Overall Study|Withdrawal by Subject|3|||
154888077|NCT00438399|559010786|FG003|Overall Study|Withdrawal by Subject|2|||
154888078|NCT00438399|559010787|FG004|Overall Study|Withdrawal by Subject|2|||
154888079|NCT00438399|559010788|FG005|Overall Study|Withdrawal by Subject|2|||
154888080|NCT00438399|559010783|FG000|Overall Study|Protocol Violation|0|||
154888081|NCT00438399|559010784|FG001|Overall Study|Protocol Violation|0|||
154888082|NCT00438399|559010785|FG002|Overall Study|Protocol Violation|1|||
154888083|NCT00438399|559010786|FG003|Overall Study|Protocol Violation|0|||
154888084|NCT00438399|559010787|FG004|Overall Study|Protocol Violation|0|||
154888085|NCT00438399|559010788|FG005|Overall Study|Protocol Violation|1|||
154888086|NCT00438399|559010783|FG000|Overall Study|Subje stopped study|0|||
154888087|NCT00438399|559010784|FG001|Overall Study|Subje stopped study|0|||
154888088|NCT00438399|559010785|FG002|Overall Study|Subje stopped study|1|||
154888089|NCT00438399|559010786|FG003|Overall Study|Subje stopped study|0|||
154888090|NCT00438399|559010787|FG004|Overall Study|Subje stopped study|0|||
154888091|NCT00438399|559010788|FG005|Overall Study|Subje stopped study|0|||
154888092|NCT00438399|559010783|FG000|Overall Study|Pregnancy|0|||
154888093|NCT00438399|559010784|FG001|Overall Study|Pregnancy|0|||
154888094|NCT00438399|559010785|FG002|Overall Study|Pregnancy|0|||
154888095|NCT00438399|559010786|FG003|Overall Study|Pregnancy|0|||
154888096|NCT00438399|559010787|FG004|Overall Study|Pregnancy|0|||
154888097|NCT00438399|559010788|FG005|Overall Study|Pregnancy|1|||
154888098|NCT00438399|559010783|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
154888099|NCT00438399|559010784|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
154888100|NCT00438399|559010785|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
155175474|NCT00895011|560080256|FG002|Overall Study|Withdrawal by Subject|2|||
154888101|NCT00438399|559010786|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
154888102|NCT00438399|559010787|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
154888103|NCT00438399|559010788|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
154888104|NCT05294211|559010792|FG000|Overall Study|Withdrawal by Subject|3|||
154888105|NCT05294211|559010792|FG000|Overall Study|Physician Decision|2|||
154888106|NCT05294211|559010792|FG000|Overall Study|Progressed to active labor|1|||
154888107|NCT05294211|559010792|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
154888108|NCT05294211|559010792|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
154888109|NCT00012012|559010795|FG000|Overall Study|Protocol Violation|1|||
154888110|NCT00012012|559010796|FG001|Overall Study|Protocol Violation|1|||
154888111|NCT00012012|559010795|FG000|Overall Study|Withdrawal by Subject|0|||
154888112|NCT00012012|559010796|FG001|Overall Study|Withdrawal by Subject|2|||
154888113|NCT02159469|559010797|FG000|Overall Study|Missing Completion status|1|||
154888114|NCT02159469|559010797|FG000|Overall Study|Adverse Event|5|||
154888115|NCT02159469|559010797|FG000|Overall Study|Non-compliance|2|||
154888116|NCT02159469|559010797|FG000|Overall Study|Withdrawal by Subject|9|||
154888117|NCT02159469|559010797|FG000|Overall Study|Lost to Follow-up|1|||
155175475|NCT00895011|560080254|FG000|Overall Study|Lost to Follow-up|5|||
154888118|NCT02159469|559010797|FG000|Overall Study|Sponsor's request|2|||
154888119|NCT02159469|559010797|FG000|Overall Study|Met Stopping Criteria|3|||
154888120|NCT02159469|559010797|FG000|Overall Study|Other|1|||
154888121|NCT02159469|559010797|FG000|Overall Study|Multiple|29|||
154888122|NCT02034474|559010798|FG000|Overall Study|Adverse Event|3|||
154888123|NCT02034474|559010799|FG001|Overall Study|Adverse Event|2|||
154888124|NCT02034474|559010798|FG000|Overall Study|Withdrawal by Subject|1|||
154888125|NCT02034474|559010799|FG001|Overall Study|Withdrawal by Subject|2|||
154888126|NCT01391819|559010800|FG000|Overall Study|Withdrawal by Subject|56|||
154888127|NCT01391819|559010800|FG000|Overall Study|Migrated/moved from study area|82|||
154888128|NCT01391819|559010800|FG000|Overall Study|Lost to Follow-up|252|||
154888129|NCT01391819|559010800|FG000|Overall Study|Death|3|||
154888130|NCT01391819|559010800|FG000|Overall Study|Other|9|||
154888131|NCT03730194|559010807|FG000|First Stage Treatment|Withdrawal by Subject|1|||
154888132|NCT03730194|559010808|FG001|First Stage Treatment|Withdrawal by Subject|1|||
154888133|NCT03730194|559010809|FG002|First Stage Treatment|Withdrawal by Subject|0|||
154888134|NCT03730194|559010810|FG003|First Stage Treatment|Withdrawal by Subject|0|||
154888135|NCT03730194|559010811|FG004|First Stage Treatment|Withdrawal by Subject|0|||
154888136|NCT03730194|559010812|FG005|First Stage Treatment|Withdrawal by Subject|0|||
154888137|NCT03730194|559010807|FG000|First Stage Treatment|Protocol Violation|3|||
154888138|NCT03730194|559010808|FG001|First Stage Treatment|Protocol Violation|3|||
154888139|NCT03730194|559010809|FG002|First Stage Treatment|Protocol Violation|0|||
154888140|NCT03730194|559010810|FG003|First Stage Treatment|Protocol Violation|0|||
154888141|NCT03730194|559010811|FG004|First Stage Treatment|Protocol Violation|0|||
154888142|NCT03730194|559010812|FG005|First Stage Treatment|Protocol Violation|0|||
154888143|NCT01244191|559010815|FG000|Overall Study|Progressive disease|295|||
154888144|NCT01244191|559010816|FG001|Overall Study|Progressive disease|350|||
154888145|NCT01244191|559010815|FG000|Overall Study|Clinical disease progression|54|||
154888146|NCT01244191|559010816|FG001|Overall Study|Clinical disease progression|36|||
154888147|NCT01244191|559010815|FG000|Overall Study|Adverse Event|65|||
154888148|NCT01244191|559010816|FG001|Overall Study|Adverse Event|48|||
154888149|NCT01244191|559010815|FG000|Overall Study|Death|22|||
154888150|NCT01244191|559010816|FG001|Overall Study|Death|29|||
154888151|NCT01244191|559010815|FG000|Overall Study|Lost to Follow-up|0|||
154888152|NCT01244191|559010816|FG001|Overall Study|Lost to Follow-up|2|||
154888153|NCT01244191|559010815|FG000|Overall Study|Protocol Violation|1|||
154888154|NCT01244191|559010816|FG001|Overall Study|Protocol Violation|2|||
154888155|NCT01244191|559010815|FG000|Overall Study|Withdrawal by Subject|31|||
154888156|NCT01244191|559010816|FG001|Overall Study|Withdrawal by Subject|23|||
154888157|NCT01244191|559010815|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
154888158|NCT01244191|559010816|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
154888159|NCT01752842|559010817|FG000|Overall Study|Adverse Event|3|||
154888160|NCT01752842|559010818|FG001|Overall Study|Adverse Event|0|||
154888161|NCT01752842|559010817|FG000|Overall Study|Withdrawal by Subject|0|||
154888162|NCT01752842|559010818|FG001|Overall Study|Withdrawal by Subject|2|||
154888163|NCT02164513|559010819|FG000|Overall Study|Adverse Event|162|||
154888164|NCT02164513|559010820|FG001|Overall Study|Adverse Event|180|||
154888165|NCT02164513|559010821|FG002|Overall Study|Adverse Event|111|||
154888166|NCT02164513|559010819|FG000|Overall Study|Other: Study Closed or terminated|5|||
154888167|NCT02164513|559010820|FG001|Overall Study|Other: Study Closed or terminated|2|||
154888168|NCT02164513|559010821|FG002|Overall Study|Other: Study Closed or terminated|4|||
154888169|NCT02164513|559010819|FG000|Overall Study|Lost to Follow-up|30|||
154888170|NCT02164513|559010820|FG001|Overall Study|Lost to Follow-up|36|||
154888171|NCT02164513|559010821|FG002|Overall Study|Lost to Follow-up|22|||
154888172|NCT02164513|559010819|FG000|Overall Study|Physician Decision|47|||
154888173|NCT02164513|559010820|FG001|Overall Study|Physician Decision|57|||
154888174|NCT02164513|559010821|FG002|Overall Study|Physician Decision|28|||
154888175|NCT02164513|559010819|FG000|Overall Study|Withdrawal by Subject|192|||
154888176|NCT02164513|559010820|FG001|Overall Study|Withdrawal by Subject|261|||
154888177|NCT02164513|559010821|FG002|Overall Study|Withdrawal by Subject|130|||
154888178|NCT02164513|559010819|FG000|Overall Study|Other: Reason not provided by site|1|||
154888179|NCT02164513|559010820|FG001|Overall Study|Other: Reason not provided by site|0|||
154888180|NCT02164513|559010821|FG002|Overall Study|Other: Reason not provided by site|0|||
154888181|NCT05584202|559010822|FG000|Overall Study|Withdrawal of Consent|3|||
154888182|NCT05584202|559010823|FG001|Overall Study|Withdrawal of Consent|2|||
154888183|NCT05584202|559010822|FG000|Overall Study|Lost to Follow-up|2|||
154888184|NCT05584202|559010823|FG001|Overall Study|Lost to Follow-up|1|||
154888185|NCT05584202|559010822|FG000|Overall Study|Death|0|||
154888186|NCT05584202|559010823|FG001|Overall Study|Death|1|||
154888187|NCT05301322|559010824|FG000|Overall Study|Adverse Event|7|||
154888188|NCT05301322|559010825|FG001|Overall Study|Adverse Event|3|||
154888189|NCT05301322|559010824|FG000|Overall Study|Death|0|||
154888190|NCT05301322|559010825|FG001|Overall Study|Death|1|||
154888191|NCT05301322|559010824|FG000|Overall Study|Lost to Follow-up|2|||
154888192|NCT05301322|559010825|FG001|Overall Study|Lost to Follow-up|1|||
154888193|NCT05301322|559010824|FG000|Overall Study|Protocol Violation|3|||
154888194|NCT05301322|559010825|FG001|Overall Study|Protocol Violation|1|||
154888195|NCT05301322|559010824|FG000|Overall Study|Withdrawal by Subject|3|||
154888196|NCT05301322|559010825|FG001|Overall Study|Withdrawal by Subject|0|||
154888197|NCT05301322|559010824|FG000|Overall Study|Other|4|||
154888198|NCT05301322|559010825|FG001|Overall Study|Other|0|||
154888199|NCT05084053|559013360|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
154888200|NCT05084053|559013361|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
154888201|NCT05084053|559013362|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
154888202|NCT05084053|559013363|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
154888203|NCT05084053|559013360|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
154888204|NCT05084053|559013361|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
154888205|NCT05084053|559013362|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
154888206|NCT05084053|559013363|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
154888207|NCT05084053|559013360|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
154888208|NCT05084053|559013361|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
154888209|NCT05084053|559013362|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
154888210|NCT05084053|559013363|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
154888211|NCT02180724|559013364|FG000|Overall Study|Death|26|||
154888212|NCT02180724|559013365|FG001|Overall Study|Death|1|||
154888213|NCT02180724|559013364|FG000|Overall Study|Lost to Follow-up|3|||
154888214|NCT02180724|559013365|FG001|Overall Study|Lost to Follow-up|1|||
154888215|NCT02180724|559013364|FG000|Overall Study|Withdrawal by Subject|4|||
154888216|NCT02180724|559013365|FG001|Overall Study|Withdrawal by Subject|2|||
154888217|NCT02180724|559013364|FG000|Overall Study|PI Decision|5|||
154888218|NCT02180724|559013365|FG001|Overall Study|PI Decision|2|||
154888219|NCT02180724|559013364|FG000|Overall Study|Study terminated by sponsor|54|||
154888220|NCT02180724|559013365|FG001|Overall Study|Study terminated by sponsor|8|||
154888221|NCT00571519|559013366|FG000|Overall Study|Subject withdrew consent|0|||
154888222|NCT00571519|559013367|FG001|Overall Study|Subject withdrew consent|1|||
154888223|NCT00571519|559013368|FG002|Overall Study|Subject withdrew consent|0|||
154888224|NCT00571519|559013369|FG003|Overall Study|Subject withdrew consent|2|||
154888225|NCT00571519|559013370|FG004|Overall Study|Subject withdrew consent|1|||
154888226|NCT00571519|559013371|FG005|Overall Study|Subject withdrew consent|1|||
154888227|NCT00571519|559013372|FG006|Overall Study|Subject withdrew consent|2|||
154888228|NCT00571519|559013366|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
154888229|NCT00571519|559013367|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
154888230|NCT00571519|559013368|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
154888231|NCT00571519|559013369|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
154888232|NCT00571519|559013370|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
154888233|NCT00571519|559013371|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
154888234|NCT00571519|559013372|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
154888235|NCT00571519|559013366|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
154888236|NCT00571519|559013367|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
154888237|NCT00571519|559013368|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
154888238|NCT00571519|559013369|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
154888239|NCT00571519|559013370|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
154888240|NCT00571519|559013371|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
154888241|NCT00571519|559013372|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
154888242|NCT00571519|559013366|FG000|Overall Study|Termination of study by Sponsor|2|||
154888243|NCT00571519|559013367|FG001|Overall Study|Termination of study by Sponsor|7|||
154888244|NCT00571519|559013368|FG002|Overall Study|Termination of study by Sponsor|10|||
154888245|NCT00571519|559013369|FG003|Overall Study|Termination of study by Sponsor|24|||
154888246|NCT00571519|559013370|FG004|Overall Study|Termination of study by Sponsor|8|||
154888247|NCT00571519|559013371|FG005|Overall Study|Termination of study by Sponsor|9|||
154888248|NCT00571519|559013372|FG006|Overall Study|Termination of study by Sponsor|22|||
154888249|NCT00571519|559013366|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
154888250|NCT00571519|559013367|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
154888251|NCT00571519|559013368|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
154888252|NCT00571519|559013369|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
154888253|NCT00571519|559013370|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
154888254|NCT00571519|559013371|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
154888255|NCT00571519|559013372|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
154888256|NCT05458011|559013373|FG000|DB Period (12 Weeks)|Adverse Event|2|||
154888257|NCT05458011|559013374|FG001|DB Period (12 Weeks)|Adverse Event|1|||
154888258|NCT05458011|559013375|FG002|DB Period (12 Weeks)|Adverse Event|1|||
154888259|NCT05458011|559013373|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
154888260|NCT05458011|559013374|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
154888261|NCT05458011|559013375|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
154888262|NCT05458011|559013373|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
155175476|NCT00895011|560080255|FG001|Overall Study|Lost to Follow-up|4|||
155175477|NCT00895011|560080256|FG002|Overall Study|Lost to Follow-up|1|||
154888263|NCT05458011|559013374|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
154888264|NCT05458011|559013375|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
154888265|NCT05458011|559013373|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
154888266|NCT05458011|559013374|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
154888267|NCT05458011|559013375|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
154888268|NCT05458011|559013373|FG000|OL Period (12 Weeks)|Adverse Event|1|||
154888269|NCT05458011|559013374|FG001|OL Period (12 Weeks)|Adverse Event|2|||
154888270|NCT05458011|559013375|FG002|OL Period (12 Weeks)|Adverse Event|1|||
154888271|NCT05458011|559013373|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
154888272|NCT05458011|559013374|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
154888273|NCT05458011|559013375|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
154888274|NCT00574119|559013376|FG000|Overall Study|Adverse Event|1|||
154888275|NCT00574119|559013376|FG000|Overall Study|Protocol Violation|1|||
154888276|NCT00574119|559013376|FG000|Overall Study|Withdrawal by Subject|1|||
154888277|NCT00574119|559013376|FG000|Overall Study|Physician Decision|1|||
154888278|NCT04656418|559013380|FG000|Overall Study|Withdrawal by Subject|1|||
154888279|NCT04656418|559013381|FG001|Overall Study|Withdrawal by Subject|3|||
154888280|NCT02586077|559013382|FG000|Overall Study|Withdrawal by Subject|1|||
154888281|NCT02586077|559013382|FG000|Overall Study|Physician Decision|4|||
154888282|NCT02586077|559013382|FG000|Overall Study|Lost to Follow-up|3|||
154888283|NCT03287245|559013383|FG000|Overall Study|Study terminated by sponsor|3|||
154888284|NCT03287245|559013384|FG001|Overall Study|Study terminated by sponsor|0|||
154888285|NCT03287245|559013385|FG002|Overall Study|Study terminated by sponsor|3|||
154888286|NCT03287245|559013386|FG003|Overall Study|Study terminated by sponsor|1|||
154888287|NCT03287245|559013383|FG000|Overall Study|Adverse Event|1|||
154888288|NCT03287245|559013384|FG001|Overall Study|Adverse Event|0|||
154888289|NCT03287245|559013385|FG002|Overall Study|Adverse Event|0|||
154888290|NCT03287245|559013386|FG003|Overall Study|Adverse Event|0|||
154888291|NCT03287245|559013383|FG000|Overall Study|Withdrawal by Subject|8|||
154888292|NCT03287245|559013384|FG001|Overall Study|Withdrawal by Subject|3|||
154888293|NCT03287245|559013385|FG002|Overall Study|Withdrawal by Subject|3|||
154888294|NCT03287245|559013386|FG003|Overall Study|Withdrawal by Subject|0|||
154888295|NCT03287245|559013383|FG000|Overall Study|Physician Decision|3|||
154888296|NCT03287245|559013384|FG001|Overall Study|Physician Decision|2|||
154888297|NCT03287245|559013385|FG002|Overall Study|Physician Decision|0|||
154888298|NCT03287245|559013386|FG003|Overall Study|Physician Decision|0|||
154888299|NCT02701192|559013387|FG000|Overall Study|Protocol Violation|2|||
154888300|NCT02701192|559013387|FG000|Overall Study|Lost to Follow-up|4|||
154888301|NCT02862548|559013388|FG000|Randomized Phase (Up to Week 48)|Death|0|||
154888302|NCT02862548|559013389|FG001|Randomized Phase (Up to Week 48)|Death|1|||
154888303|NCT02862548|559013388|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
154888304|NCT02862548|559013389|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
154888305|NCT02862548|559013388|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
154888306|NCT02862548|559013389|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
154888307|NCT02862548|559013388|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
154888308|NCT02862548|559013389|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
155113797|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
155113798|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
155113799|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
155113800|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
155113801|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
155113802|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
155113803|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
155113804|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
155113805|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
155113806|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
155113807|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Promotor request|1|||
155113808|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Promotor request|0|||
155113809|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Promotor request|0|||
155113810|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
155113811|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
155113812|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
154888309|NCT00880763|559013390|FG000|Extension Period (Part 2)|Adverse Event|0|||
155113813|NCT01461928|559846156|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
154888310|NCT00880763|559013391|FG001|Extension Period (Part 2)|Adverse Event|0|||
154888311|NCT00880763|559013392|FG002|Extension Period (Part 2)|Adverse Event|1|||
154888312|NCT00880763|559013393|FG003|Extension Period (Part 2)|Adverse Event|1|||
154888313|NCT00880763|559013390|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
154888314|NCT00880763|559013391|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
154888315|NCT00880763|559013392|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
154888316|NCT00880763|559013393|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
154888317|NCT00880763|559013390|FG000|Extension Period (Part 2)|Physician Decision|0|||
154888318|NCT00880763|559013391|FG001|Extension Period (Part 2)|Physician Decision|1|||
154888319|NCT00880763|559013392|FG002|Extension Period (Part 2)|Physician Decision|1|||
154888320|NCT00880763|559013393|FG003|Extension Period (Part 2)|Physician Decision|0|||
154888321|NCT00880763|559013390|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
154888322|NCT00880763|559013391|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
154888323|NCT00880763|559013392|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
154888324|NCT00880763|559013393|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
154888325|NCT00003476|559013395|FG000|Overall Study|Not evaluable|1|||
154888326|NCT00696436|559013396|FG000|Overall Study|Adverse Event|7|||
154888327|NCT00696436|559013397|FG001|Overall Study|Adverse Event|9|||
154888328|NCT00696436|559013398|FG002|Overall Study|Adverse Event|8|||
154888329|NCT00696436|559013399|FG003|Overall Study|Adverse Event|6|||
154888330|NCT00696436|559013400|FG004|Overall Study|Adverse Event|4|||
154888331|NCT00696436|559013396|FG000|Overall Study|Protocol Violation|3|||
154888332|NCT00696436|559013397|FG001|Overall Study|Protocol Violation|2|||
154888333|NCT00696436|559013398|FG002|Overall Study|Protocol Violation|2|||
154888334|NCT00696436|559013399|FG003|Overall Study|Protocol Violation|0|||
154888335|NCT00696436|559013400|FG004|Overall Study|Protocol Violation|1|||
154888336|NCT00696436|559013396|FG000|Overall Study|Lost to Follow-up|1|||
154888337|NCT00696436|559013397|FG001|Overall Study|Lost to Follow-up|6|||
154888338|NCT00696436|559013398|FG002|Overall Study|Lost to Follow-up|2|||
154888339|NCT00696436|559013399|FG003|Overall Study|Lost to Follow-up|4|||
154888340|NCT00696436|559013400|FG004|Overall Study|Lost to Follow-up|3|||
154888341|NCT00696436|559013396|FG000|Overall Study|Withdrawal by Subject|4|||
154888342|NCT00696436|559013397|FG001|Overall Study|Withdrawal by Subject|11|||
154888343|NCT00696436|559013398|FG002|Overall Study|Withdrawal by Subject|5|||
154888344|NCT00696436|559013399|FG003|Overall Study|Withdrawal by Subject|7|||
154888345|NCT00696436|559013400|FG004|Overall Study|Withdrawal by Subject|1|||
154888346|NCT00696436|559013396|FG000|Overall Study|Lack of Efficacy|3|||
154888347|NCT00696436|559013397|FG001|Overall Study|Lack of Efficacy|1|||
154888348|NCT00696436|559013398|FG002|Overall Study|Lack of Efficacy|5|||
154888349|NCT00696436|559013399|FG003|Overall Study|Lack of Efficacy|2|||
154888350|NCT00696436|559013400|FG004|Overall Study|Lack of Efficacy|4|||
154888351|NCT00696436|559013396|FG000|Overall Study|Participant Unavailability|2|||
154888352|NCT00696436|559013397|FG001|Overall Study|Participant Unavailability|0|||
154888353|NCT00696436|559013398|FG002|Overall Study|Participant Unavailability|2|||
154888354|NCT00696436|559013399|FG003|Overall Study|Participant Unavailability|1|||
154888355|NCT00696436|559013400|FG004|Overall Study|Participant Unavailability|0|||
154888356|NCT00696436|559013396|FG000|Overall Study|Administrative Error|2|||
154888357|NCT00696436|559013397|FG001|Overall Study|Administrative Error|0|||
154888358|NCT00696436|559013398|FG002|Overall Study|Administrative Error|2|||
154888359|NCT00696436|559013399|FG003|Overall Study|Administrative Error|0|||
154888360|NCT00696436|559013400|FG004|Overall Study|Administrative Error|0|||
154888361|NCT00696436|559013396|FG000|Overall Study|Participant Non-compliance|0|||
154888362|NCT00696436|559013397|FG001|Overall Study|Participant Non-compliance|0|||
154888363|NCT00696436|559013398|FG002|Overall Study|Participant Non-compliance|1|||
154888364|NCT00696436|559013399|FG003|Overall Study|Participant Non-compliance|2|||
154888365|NCT00696436|559013400|FG004|Overall Study|Participant Non-compliance|0|||
154888366|NCT00696436|559013396|FG000|Overall Study|Administrative Decision|1|||
154888367|NCT00696436|559013397|FG001|Overall Study|Administrative Decision|0|||
154888368|NCT00696436|559013398|FG002|Overall Study|Administrative Decision|0|||
154888369|NCT00696436|559013399|FG003|Overall Study|Administrative Decision|0|||
154888370|NCT00696436|559013400|FG004|Overall Study|Administrative Decision|0|||
154888371|NCT00696436|559013396|FG000|Overall Study|Missing|0|||
154977290|NCT02688387|559340772|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977291|NCT02688387|559340773|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977292|NCT02688387|559340774|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154888372|NCT00696436|559013397|FG001|Overall Study|Missing|1|||
154888373|NCT00696436|559013398|FG002|Overall Study|Missing|1|||
154888374|NCT00696436|559013399|FG003|Overall Study|Missing|0|||
154977293|NCT02688387|559340775|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977294|NCT02688387|559340776|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977295|NCT02688387|559340777|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977296|NCT02688387|559340778|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
155113814|NCT01461928|559846157|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
155113815|NCT01461928|559846158|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
155113816|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Death|3|||
155113817|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Death|0|||
154888375|NCT00696436|559013400|FG004|Overall Study|Missing|0|||
154888376|NCT03039738|559013404|FG000|Overall Study|Incomplete data sets|54|||
154888377|NCT03039738|559013405|FG001|Overall Study|Incomplete data sets|0|||
154888378|NCT00912340|559013406|FG000|Overall Study|Adverse Event|2|||
154888379|NCT00912340|559013407|FG001|Overall Study|Adverse Event|4|||
154888380|NCT00912340|559013408|FG002|Overall Study|Adverse Event|0|||
154888381|NCT00912340|559013406|FG000|Overall Study|Protocol revised to remove arm|0|||
154888382|NCT00912340|559013407|FG001|Overall Study|Protocol revised to remove arm|0|||
154888383|NCT00912340|559013408|FG002|Overall Study|Protocol revised to remove arm|4|||
154888384|NCT01517412|559013411|FG000|Overall Study|Adverse Event|10|||
154888385|NCT01517412|559013412|FG001|Overall Study|Adverse Event|11|||
154888386|NCT01517412|559013411|FG000|Overall Study|Lack of Efficacy|10|||
154888387|NCT01517412|559013412|FG001|Overall Study|Lack of Efficacy|5|||
154888388|NCT01517412|559013411|FG000|Overall Study|Poor compliance to protocol|8|||
154888389|NCT01517412|559013412|FG001|Overall Study|Poor compliance to protocol|3|||
154888390|NCT01517412|559013411|FG000|Overall Study|Other than specified above|8|||
154888391|NCT01517412|559013412|FG001|Overall Study|Other than specified above|5|||
154888392|NCT01253187|559013413|FG000|Period 2|Withdrawal by Subject|0|||
154888393|NCT01253187|559013414|FG001|Period 2|Withdrawal by Subject|0|||
154888394|NCT01253187|559013415|FG002|Period 2|Withdrawal by Subject|0|||
154888395|NCT01253187|559013416|FG003|Period 2|Withdrawal by Subject|0|||
154888396|NCT01253187|559013417|FG004|Period 2|Withdrawal by Subject|1|||
154888397|NCT01253187|559013418|FG005|Period 2|Withdrawal by Subject|0|||
154888398|NCT01253187|559013413|FG000|Period 3|Pregnancy|1|||
154888399|NCT01253187|559013414|FG001|Period 3|Pregnancy|0|||
154888400|NCT01253187|559013415|FG002|Period 3|Pregnancy|0|||
154888401|NCT01253187|559013416|FG003|Period 3|Pregnancy|0|||
154888402|NCT01253187|559013417|FG004|Period 3|Pregnancy|0|||
154888403|NCT01253187|559013418|FG005|Period 3|Pregnancy|0|||
154888404|NCT01253187|559013413|FG000|Period 3|difficulty with blood sampling|0|||
154888405|NCT01253187|559013414|FG001|Period 3|difficulty with blood sampling|1|||
154888406|NCT01253187|559013415|FG002|Period 3|difficulty with blood sampling|0|||
154888407|NCT01253187|559013416|FG003|Period 3|difficulty with blood sampling|0|||
154888408|NCT01253187|559013417|FG004|Period 3|difficulty with blood sampling|0|||
154888409|NCT01253187|559013418|FG005|Period 3|difficulty with blood sampling|0|||
154888410|NCT01253187|559013413|FG000|Period 3|non-compliance|0|||
154888411|NCT01253187|559013414|FG001|Period 3|non-compliance|0|||
154888412|NCT01253187|559013415|FG002|Period 3|non-compliance|0|||
154888413|NCT01253187|559013416|FG003|Period 3|non-compliance|0|||
154888414|NCT01253187|559013417|FG004|Period 3|non-compliance|1|||
154888415|NCT01253187|559013418|FG005|Period 3|non-compliance|0|||
154888416|NCT01293006|559013422|FG000|Period 2|Lost to Follow-up|1|||
154888417|NCT01293006|559013423|FG001|Period 2|Lost to Follow-up|0|||
154888418|NCT01293006|559013424|FG002|Period 2|Lost to Follow-up|0|||
154888419|NCT01293006|559013425|FG003|Period 2|Lost to Follow-up|0|||
154888420|NCT01494987|559013426|FG000|Overall Study|Adverse Event|6|||
154888421|NCT01494987|559013427|FG001|Overall Study|Adverse Event|5|||
154888422|NCT01494987|559013426|FG000|Overall Study|Hyperglycemia|6|||
154888423|NCT01494987|559013427|FG001|Overall Study|Hyperglycemia|4|||
154888424|NCT01494987|559013426|FG000|Overall Study|Investigator's Discretion|1|||
154888425|NCT01494987|559013427|FG001|Overall Study|Investigator's Discretion|2|||
154888426|NCT01494987|559013426|FG000|Overall Study|Lost to Follow-up|1|||
154888427|NCT01494987|559013427|FG001|Overall Study|Lost to Follow-up|1|||
154888428|NCT01494987|559013426|FG000|Overall Study|Protocol Violation|3|||
154888429|NCT01494987|559013427|FG001|Overall Study|Protocol Violation|3|||
154888430|NCT01494987|559013426|FG000|Overall Study|Subject Non-Compliance|9|||
154888431|NCT01494987|559013427|FG001|Overall Study|Subject Non-Compliance|10|||
154888432|NCT01494987|559013426|FG000|Overall Study|Subject Withdrew Consent|2|||
154888433|NCT01494987|559013427|FG001|Overall Study|Subject Withdrew Consent|3|||
154888434|NCT02254551|559013430|FG000|Dose Escalation|Physician Decision|1|||
154888435|NCT02254551|559013430|FG000|Dose Escalation|Dose-limiting toxicity|2|||
154888436|NCT00205699|559013434|FG000|Overall Study|Lost to Follow-up|1|||
154888437|NCT00205699|559013435|FG001|Overall Study|Lost to Follow-up|3|||
154888438|NCT00205699|559013436|FG002|Overall Study|Lost to Follow-up|5|||
154888439|NCT00205699|559013434|FG000|Overall Study|Adverse Event|1|||
154888440|NCT00205699|559013435|FG001|Overall Study|Adverse Event|0|||
154888441|NCT00205699|559013436|FG002|Overall Study|Adverse Event|0|||
154977297|NCT02688387|559340779|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977298|NCT02688387|559340780|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977299|NCT02688387|559340781|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154888442|NCT00205699|559013434|FG000|Overall Study|Withdrawal by Subject|1|||
154888443|NCT00205699|559013435|FG001|Overall Study|Withdrawal by Subject|2|||
154888444|NCT00205699|559013436|FG002|Overall Study|Withdrawal by Subject|1|||
154888445|NCT00205699|559013434|FG000|Overall Study|Lack of Efficacy|0|||
154888446|NCT00205699|559013435|FG001|Overall Study|Lack of Efficacy|1|||
154888447|NCT00205699|559013436|FG002|Overall Study|Lack of Efficacy|0|||
154888448|NCT01885078|559013437|FG000|Treatment Period|Adverse Event|52|||
154888449|NCT01885078|559013438|FG001|Treatment Period|Adverse Event|136|||
155113818|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Death|0|||
154888450|NCT01885078|559013439|FG002|Treatment Period|Adverse Event|30|||
154888451|NCT01885078|559013440|FG003|Treatment Period|Adverse Event|73|||
154888452|NCT01885078|559013441|FG004|Treatment Period|Adverse Event|17|||
154888453|NCT01885078|559013442|FG005|Treatment Period|Adverse Event|72|||
154888454|NCT01885078|559013443|FG006|Treatment Period|Adverse Event|24|||
154888455|NCT01885078|559013444|FG007|Treatment Period|Adverse Event|5|||
154888456|NCT01885078|559013445|FG008|Treatment Period|Adverse Event|0|||
154888457|NCT01885078|559013446|FG009|Treatment Period|Adverse Event|0|||
154888458|NCT01885078|559013437|FG000|Treatment Period|Death|13|||
154888459|NCT01885078|559013438|FG001|Treatment Period|Death|33|||
154888460|NCT01885078|559013439|FG002|Treatment Period|Death|5|||
154888461|NCT01885078|559013440|FG003|Treatment Period|Death|9|||
154888462|NCT01885078|559013441|FG004|Treatment Period|Death|2|||
154888463|NCT01885078|559013442|FG005|Treatment Period|Death|10|||
154888464|NCT01885078|559013443|FG006|Treatment Period|Death|3|||
154888465|NCT01885078|559013444|FG007|Treatment Period|Death|2|||
154888466|NCT01885078|559013445|FG008|Treatment Period|Death|0|||
154888467|NCT01885078|559013446|FG009|Treatment Period|Death|0|||
154888468|NCT01885078|559013437|FG000|Treatment Period|Lack of Efficacy|12|||
154888469|NCT01885078|559013438|FG001|Treatment Period|Lack of Efficacy|33|||
154888470|NCT01885078|559013439|FG002|Treatment Period|Lack of Efficacy|10|||
154888471|NCT01885078|559013440|FG003|Treatment Period|Lack of Efficacy|23|||
154888472|NCT01885078|559013441|FG004|Treatment Period|Lack of Efficacy|24|||
154888473|NCT01885078|559013442|FG005|Treatment Period|Lack of Efficacy|58|||
154888474|NCT01885078|559013443|FG006|Treatment Period|Lack of Efficacy|9|||
154888475|NCT01885078|559013444|FG007|Treatment Period|Lack of Efficacy|5|||
154888476|NCT01885078|559013445|FG008|Treatment Period|Lack of Efficacy|0|||
154888477|NCT01885078|559013446|FG009|Treatment Period|Lack of Efficacy|0|||
154888478|NCT01885078|559013437|FG000|Treatment Period|Lost to Follow-up|16|||
154888479|NCT01885078|559013438|FG001|Treatment Period|Lost to Follow-up|19|||
154888480|NCT01885078|559013439|FG002|Treatment Period|Lost to Follow-up|7|||
154888481|NCT01885078|559013440|FG003|Treatment Period|Lost to Follow-up|9|||
154888482|NCT01885078|559013441|FG004|Treatment Period|Lost to Follow-up|2|||
154888483|NCT01885078|559013442|FG005|Treatment Period|Lost to Follow-up|8|||
154888484|NCT01885078|559013443|FG006|Treatment Period|Lost to Follow-up|2|||
154888485|NCT01885078|559013444|FG007|Treatment Period|Lost to Follow-up|0|||
154888486|NCT01885078|559013445|FG008|Treatment Period|Lost to Follow-up|0|||
154888487|NCT01885078|559013446|FG009|Treatment Period|Lost to Follow-up|0|||
154888488|NCT01885078|559013437|FG000|Treatment Period|Physician Decision|19|||
154888489|NCT01885078|559013438|FG001|Treatment Period|Physician Decision|21|||
154888490|NCT01885078|559013439|FG002|Treatment Period|Physician Decision|5|||
154888491|NCT01885078|559013440|FG003|Treatment Period|Physician Decision|12|||
154888492|NCT01885078|559013441|FG004|Treatment Period|Physician Decision|9|||
154888493|NCT01885078|559013442|FG005|Treatment Period|Physician Decision|24|||
154888494|NCT01885078|559013443|FG006|Treatment Period|Physician Decision|4|||
154888495|NCT01885078|559013444|FG007|Treatment Period|Physician Decision|3|||
154888496|NCT01885078|559013445|FG008|Treatment Period|Physician Decision|0|||
154888497|NCT01885078|559013446|FG009|Treatment Period|Physician Decision|0|||
154888498|NCT01885078|559013437|FG000|Treatment Period|Protocol Violation|3|||
154888499|NCT01885078|559013438|FG001|Treatment Period|Protocol Violation|5|||
154888500|NCT01885078|559013439|FG002|Treatment Period|Protocol Violation|0|||
154888501|NCT01885078|559013440|FG003|Treatment Period|Protocol Violation|3|||
154888502|NCT01885078|559013441|FG004|Treatment Period|Protocol Violation|1|||
154888503|NCT01885078|559013442|FG005|Treatment Period|Protocol Violation|6|||
154888504|NCT01885078|559013443|FG006|Treatment Period|Protocol Violation|0|||
154888505|NCT01885078|559013444|FG007|Treatment Period|Protocol Violation|0|||
154888506|NCT01885078|559013445|FG008|Treatment Period|Protocol Violation|0|||
154888507|NCT01885078|559013446|FG009|Treatment Period|Protocol Violation|0|||
154888508|NCT01885078|559013437|FG000|Treatment Period|Sponsor Decision|245|||
154888509|NCT01885078|559013438|FG001|Treatment Period|Sponsor Decision|648|||
154888510|NCT01885078|559013439|FG002|Treatment Period|Sponsor Decision|49|||
154888511|NCT01885078|559013440|FG003|Treatment Period|Sponsor Decision|90|||
154888512|NCT01885078|559013441|FG004|Treatment Period|Sponsor Decision|20|||
154888513|NCT01885078|559013442|FG005|Treatment Period|Sponsor Decision|38|||
154888514|NCT01885078|559013443|FG006|Treatment Period|Sponsor Decision|162|||
155175478|NCT00895011|560080254|FG000|Overall Study|Protocol Violation|3|||
155175479|NCT00895011|560080255|FG001|Overall Study|Protocol Violation|1|||
154888515|NCT01885078|559013444|FG007|Treatment Period|Sponsor Decision|3|||
154888516|NCT01885078|559013445|FG008|Treatment Period|Sponsor Decision|0|||
154888517|NCT01885078|559013446|FG009|Treatment Period|Sponsor Decision|0|||
154888518|NCT01885078|559013437|FG000|Treatment Period|Withdrawal by Subject|72|||
154888519|NCT01885078|559013438|FG001|Treatment Period|Withdrawal by Subject|132|||
154888520|NCT01885078|559013439|FG002|Treatment Period|Withdrawal by Subject|25|||
154888521|NCT01885078|559013440|FG003|Treatment Period|Withdrawal by Subject|63|||
154888522|NCT01885078|559013441|FG004|Treatment Period|Withdrawal by Subject|15|||
154888523|NCT01885078|559013442|FG005|Treatment Period|Withdrawal by Subject|34|||
154888524|NCT01885078|559013443|FG006|Treatment Period|Withdrawal by Subject|17|||
154888525|NCT01885078|559013444|FG007|Treatment Period|Withdrawal by Subject|10|||
154888526|NCT01885078|559013445|FG008|Treatment Period|Withdrawal by Subject|0|||
154888527|NCT01885078|559013446|FG009|Treatment Period|Withdrawal by Subject|0|||
154888528|NCT01885078|559013437|FG000|Treatment Period|Other|0|||
155175480|NCT00895011|560080256|FG002|Overall Study|Protocol Violation|3|||
154888529|NCT01885078|559013438|FG001|Treatment Period|Other|0|||
154888530|NCT01885078|559013439|FG002|Treatment Period|Other|0|||
154888531|NCT01885078|559013440|FG003|Treatment Period|Other|1|||
154888532|NCT01885078|559013441|FG004|Treatment Period|Other|0|||
154888533|NCT01885078|559013442|FG005|Treatment Period|Other|0|||
154888534|NCT01885078|559013443|FG006|Treatment Period|Other|0|||
154888535|NCT01885078|559013444|FG007|Treatment Period|Other|0|||
154888536|NCT01885078|559013445|FG008|Treatment Period|Other|0|||
154888537|NCT01885078|559013446|FG009|Treatment Period|Other|0|||
154888538|NCT01885078|559013437|FG000|Step-down Period|Sponsor Decision|0|||
154888539|NCT01885078|559013438|FG001|Step-down Period|Sponsor Decision|0|||
154888540|NCT01885078|559013439|FG002|Step-down Period|Sponsor Decision|0|||
154888541|NCT01885078|559013440|FG003|Step-down Period|Sponsor Decision|0|||
154888542|NCT01885078|559013441|FG004|Step-down Period|Sponsor Decision|0|||
154888543|NCT01885078|559013442|FG005|Step-down Period|Sponsor Decision|0|||
155113819|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
155113820|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
154888544|NCT01885078|559013443|FG006|Step-down Period|Sponsor Decision|0|||
154888545|NCT01885078|559013444|FG007|Step-down Period|Sponsor Decision|0|||
154888546|NCT01885078|559013445|FG008|Step-down Period|Sponsor Decision|1|||
154888547|NCT01885078|559013446|FG009|Step-down Period|Sponsor Decision|1|||
154888548|NCT01885078|559013437|FG000|Step-down Period|Adverse Event|0|||
154888549|NCT01885078|559013438|FG001|Step-down Period|Adverse Event|0|||
154888550|NCT01885078|559013439|FG002|Step-down Period|Adverse Event|0|||
154888551|NCT01885078|559013440|FG003|Step-down Period|Adverse Event|0|||
154888552|NCT01885078|559013441|FG004|Step-down Period|Adverse Event|0|||
154888553|NCT01885078|559013442|FG005|Step-down Period|Adverse Event|0|||
154888554|NCT01885078|559013443|FG006|Step-down Period|Adverse Event|0|||
154888555|NCT01885078|559013444|FG007|Step-down Period|Adverse Event|0|||
154888556|NCT01885078|559013445|FG008|Step-down Period|Adverse Event|29|||
154888557|NCT01885078|559013446|FG009|Step-down Period|Adverse Event|38|||
154888558|NCT01885078|559013437|FG000|Step-down Period|Withdrawal by Subject|0|||
154888559|NCT01885078|559013438|FG001|Step-down Period|Withdrawal by Subject|0|||
154888560|NCT01885078|559013439|FG002|Step-down Period|Withdrawal by Subject|0|||
154888561|NCT01885078|559013440|FG003|Step-down Period|Withdrawal by Subject|0|||
154888562|NCT01885078|559013441|FG004|Step-down Period|Withdrawal by Subject|0|||
154888563|NCT01885078|559013442|FG005|Step-down Period|Withdrawal by Subject|0|||
154888564|NCT01885078|559013443|FG006|Step-down Period|Withdrawal by Subject|0|||
154888565|NCT01885078|559013444|FG007|Step-down Period|Withdrawal by Subject|0|||
154888566|NCT01885078|559013445|FG008|Step-down Period|Withdrawal by Subject|25|||
154888567|NCT01885078|559013446|FG009|Step-down Period|Withdrawal by Subject|15|||
154888568|NCT01885078|559013437|FG000|Step-down Period|Physician Decision|0|||
154888569|NCT01885078|559013438|FG001|Step-down Period|Physician Decision|0|||
154888570|NCT01885078|559013439|FG002|Step-down Period|Physician Decision|0|||
154888571|NCT01885078|559013440|FG003|Step-down Period|Physician Decision|0|||
154888572|NCT01885078|559013441|FG004|Step-down Period|Physician Decision|0|||
154888573|NCT01885078|559013442|FG005|Step-down Period|Physician Decision|0|||
154888574|NCT01885078|559013443|FG006|Step-down Period|Physician Decision|0|||
154888575|NCT01885078|559013444|FG007|Step-down Period|Physician Decision|0|||
154888576|NCT01885078|559013445|FG008|Step-down Period|Physician Decision|7|||
154888577|NCT01885078|559013446|FG009|Step-down Period|Physician Decision|2|||
154888578|NCT01885078|559013437|FG000|Step-down Period|Death|0|||
154888579|NCT01885078|559013438|FG001|Step-down Period|Death|0|||
154888580|NCT01885078|559013439|FG002|Step-down Period|Death|0|||
154888581|NCT01885078|559013440|FG003|Step-down Period|Death|0|||
154888582|NCT01885078|559013441|FG004|Step-down Period|Death|0|||
154888583|NCT01885078|559013442|FG005|Step-down Period|Death|0|||
154888584|NCT01885078|559013443|FG006|Step-down Period|Death|0|||
154888585|NCT01885078|559013444|FG007|Step-down Period|Death|0|||
155113821|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
155113822|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
155113823|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
155113824|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
154888586|NCT01885078|559013445|FG008|Step-down Period|Death|4|||
154888587|NCT01885078|559013446|FG009|Step-down Period|Death|3|||
155113825|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Diseases progression|91|||
155113826|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Diseases progression|0|||
155113827|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Diseases progression|0|||
154888588|NCT01885078|559013437|FG000|Step-down Period|Lost to Follow-up|0|||
154888589|NCT01885078|559013438|FG001|Step-down Period|Lost to Follow-up|0|||
154888590|NCT01885078|559013439|FG002|Step-down Period|Lost to Follow-up|0|||
154888591|NCT01885078|559013440|FG003|Step-down Period|Lost to Follow-up|0|||
154888592|NCT01885078|559013441|FG004|Step-down Period|Lost to Follow-up|0|||
154888593|NCT01885078|559013442|FG005|Step-down Period|Lost to Follow-up|0|||
154888594|NCT01885078|559013443|FG006|Step-down Period|Lost to Follow-up|0|||
154888595|NCT01885078|559013444|FG007|Step-down Period|Lost to Follow-up|0|||
154888596|NCT01885078|559013445|FG008|Step-down Period|Lost to Follow-up|1|||
154888597|NCT01885078|559013446|FG009|Step-down Period|Lost to Follow-up|1|||
154888598|NCT01885078|559013437|FG000|Step-down Period|Lack of Efficacy|0|||
154888599|NCT01885078|559013438|FG001|Step-down Period|Lack of Efficacy|0|||
154888600|NCT01885078|559013439|FG002|Step-down Period|Lack of Efficacy|0|||
154888601|NCT01885078|559013440|FG003|Step-down Period|Lack of Efficacy|0|||
154888602|NCT01885078|559013441|FG004|Step-down Period|Lack of Efficacy|0|||
154888603|NCT01885078|559013442|FG005|Step-down Period|Lack of Efficacy|0|||
155113828|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Adverse Event|70|||
154888604|NCT01885078|559013443|FG006|Step-down Period|Lack of Efficacy|0|||
154888605|NCT01885078|559013444|FG007|Step-down Period|Lack of Efficacy|0|||
154888606|NCT01885078|559013445|FG008|Step-down Period|Lack of Efficacy|1|||
154888607|NCT01885078|559013446|FG009|Step-down Period|Lack of Efficacy|0|||
154888608|NCT01885078|559013437|FG000|Step-down Period|Protocol Violation|0|||
154888609|NCT01885078|559013438|FG001|Step-down Period|Protocol Violation|0|||
154888610|NCT01885078|559013439|FG002|Step-down Period|Protocol Violation|0|||
154888611|NCT01885078|559013440|FG003|Step-down Period|Protocol Violation|0|||
154888612|NCT01885078|559013441|FG004|Step-down Period|Protocol Violation|0|||
154888613|NCT01885078|559013442|FG005|Step-down Period|Protocol Violation|0|||
154888614|NCT01885078|559013443|FG006|Step-down Period|Protocol Violation|0|||
154888615|NCT01885078|559013444|FG007|Step-down Period|Protocol Violation|0|||
154888616|NCT01885078|559013445|FG008|Step-down Period|Protocol Violation|1|||
154888617|NCT01885078|559013446|FG009|Step-down Period|Protocol Violation|1|||
154888618|NCT01895452|559013447|FG000|Overall Study|Adverse Event|1|||
154888619|NCT01895452|559013448|FG001|Overall Study|Adverse Event|4|||
154888620|NCT01895452|559013447|FG000|Overall Study|Lost to Follow-up|1|||
154888621|NCT01895452|559013448|FG001|Overall Study|Lost to Follow-up|5|||
154888622|NCT01895452|559013447|FG000|Overall Study|Pregnancy|0|||
154888623|NCT01895452|559013448|FG001|Overall Study|Pregnancy|1|||
154888624|NCT01895452|559013447|FG000|Overall Study|Withdrawal by Subject|2|||
154888625|NCT01895452|559013448|FG001|Overall Study|Withdrawal by Subject|14|||
154888626|NCT01895452|559013447|FG000|Overall Study|Underlying disease|0|||
154888627|NCT01895452|559013448|FG001|Overall Study|Underlying disease|3|||
154888628|NCT01895452|559013447|FG000|Overall Study|Noncompliance with study drug|0|||
154888629|NCT01895452|559013448|FG001|Overall Study|Noncompliance with study drug|1|||
154888630|NCT01653158|559013449|FG000|Overall Study|Death|0|||
154888631|NCT01653158|559013450|FG001|Overall Study|Death|0|||
154888632|NCT01653158|559013451|FG002|Overall Study|Death|0|||
154888633|NCT01653158|559013452|FG003|Overall Study|Death|1|||
154888634|NCT01653158|559013453|FG004|Overall Study|Death|0|||
154888635|NCT01653158|559013454|FG005|Overall Study|Death|0|||
154888636|NCT01653158|559013455|FG006|Overall Study|Death|0|||
154888637|NCT01653158|559013456|FG007|Overall Study|Death|2|||
154888638|NCT01653158|559013449|FG000|Overall Study|Adverse Event|0|||
154888639|NCT01653158|559013450|FG001|Overall Study|Adverse Event|0|||
154888640|NCT01653158|559013451|FG002|Overall Study|Adverse Event|0|||
154888641|NCT01653158|559013452|FG003|Overall Study|Adverse Event|1|||
154888642|NCT01653158|559013453|FG004|Overall Study|Adverse Event|0|||
154888643|NCT01653158|559013454|FG005|Overall Study|Adverse Event|0|||
154888644|NCT01653158|559013455|FG006|Overall Study|Adverse Event|0|||
154888645|NCT01653158|559013456|FG007|Overall Study|Adverse Event|3|||
154888646|NCT01653158|559013449|FG000|Overall Study|Other|0|||
154888647|NCT01653158|559013450|FG001|Overall Study|Other|0|||
154888648|NCT01653158|559013451|FG002|Overall Study|Other|0|||
154888649|NCT01653158|559013452|FG003|Overall Study|Other|0|||
154888650|NCT01653158|559013453|FG004|Overall Study|Other|0|||
154888651|NCT01653158|559013454|FG005|Overall Study|Other|0|||
154888652|NCT01653158|559013455|FG006|Overall Study|Other|0|||
154888653|NCT01653158|559013456|FG007|Overall Study|Other|1|||
154888654|NCT01653158|559013449|FG000|Overall Study|Progressive disease|0|||
154888655|NCT01653158|559013450|FG001|Overall Study|Progressive disease|0|||
154888656|NCT01653158|559013451|FG002|Overall Study|Progressive disease|0|||
154888657|NCT01653158|559013452|FG003|Overall Study|Progressive disease|0|||
154888658|NCT01653158|559013453|FG004|Overall Study|Progressive disease|1|||
154888659|NCT01653158|559013454|FG005|Overall Study|Progressive disease|1|||
154888660|NCT01653158|559013455|FG006|Overall Study|Progressive disease|2|||
154888661|NCT01653158|559013456|FG007|Overall Study|Progressive disease|9|||
154888662|NCT01653158|559013449|FG000|Overall Study|Withdrawal by Subject|1|||
154888663|NCT01653158|559013450|FG001|Overall Study|Withdrawal by Subject|0|||
154888664|NCT01653158|559013451|FG002|Overall Study|Withdrawal by Subject|0|||
154888665|NCT01653158|559013452|FG003|Overall Study|Withdrawal by Subject|0|||
154888666|NCT01653158|559013453|FG004|Overall Study|Withdrawal by Subject|0|||
154888667|NCT01653158|559013454|FG005|Overall Study|Withdrawal by Subject|0|||
154888668|NCT01653158|559013455|FG006|Overall Study|Withdrawal by Subject|0|||
154888669|NCT01653158|559013456|FG007|Overall Study|Withdrawal by Subject|0|||
154888670|NCT04999969|559013457|FG000|Overall Study|Death|76|||
154888671|NCT04999969|559013457|FG000|Overall Study|Progressive Disease|1|||
154888672|NCT04999969|559013457|FG000|Overall Study|Withdrawal by Subject|8|||
154888673|NCT04321252|559013459|FG000|Overall Study|Withdrawal by Subject|0|||
154888674|NCT04321252|559013460|FG001|Overall Study|Withdrawal by Subject|0|||
154888675|NCT04321252|559013461|FG002|Overall Study|Withdrawal by Subject|0|||
154888676|NCT04321252|559013462|FG003|Overall Study|Withdrawal by Subject|0|||
154888677|NCT04321252|559013463|FG004|Overall Study|Withdrawal by Subject|0|||
154888678|NCT04321252|559013464|FG005|Overall Study|Withdrawal by Subject|1|||
154888679|NCT04321252|559013465|FG006|Overall Study|Withdrawal by Subject|0|||
154888680|NCT04321252|559013466|FG007|Overall Study|Withdrawal by Subject|0|||
154888681|NCT04321252|559013467|FG008|Overall Study|Withdrawal by Subject|0|||
154888682|NCT06245044|559013468|FG000|No MI help|Technical issues|18|||
154977300|NCT02688387|559340782|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977301|NCT02688387|559340783|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977302|NCT02688387|559340784|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977303|NCT02688387|559340785|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977304|NCT02688387|559340786|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977305|NCT02688387|559340787|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
154977306|NCT02688387|559340788|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977307|NCT02688387|559340789|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
154977308|NCT00418522|559340790|FG000|Overall Study|Adverse Event|7|||
154977309|NCT00418522|559340791|FG001|Overall Study|Adverse Event|1|||
154977310|NCT00418522|559340790|FG000|Overall Study|Lack of Efficacy|1|||
154977311|NCT00418522|559340791|FG001|Overall Study|Lack of Efficacy|3|||
154977312|NCT00418522|559340790|FG000|Overall Study|Lost to Follow-up|10|||
154977313|NCT00418522|559340791|FG001|Overall Study|Lost to Follow-up|4|||
154977314|NCT00418522|559340790|FG000|Overall Study|Withdrawal by Subject|31|||
154977315|NCT00418522|559340791|FG001|Overall Study|Withdrawal by Subject|7|||
154977316|NCT00418522|559340790|FG000|Overall Study|Other|27|||
154977317|NCT00418522|559340791|FG001|Overall Study|Other|23|||
154977318|NCT00418522|559340790|FG000|Overall Study|Randomized but did not receive treatment|7|||
154977319|NCT00418522|559340791|FG001|Overall Study|Randomized but did not receive treatment|4|||
154977320|NCT01049412|559340794|FG000|Period I|Withdrawal by Subject|4|||
154977321|NCT01049412|559340795|FG001|Period I|Withdrawal by Subject|6|||
154977322|NCT01049412|559340794|FG000|Period I|Lost to Follow-up|2|||
154977323|NCT01049412|559340795|FG001|Period I|Lost to Follow-up|2|||
154977324|NCT01049412|559340794|FG000|Period I|Physician Decision|0|||
154977325|NCT01049412|559340795|FG001|Period I|Physician Decision|3|||
154977326|NCT01049412|559340794|FG000|Period I|Protocol Violation|1|||
154977327|NCT01049412|559340795|FG001|Period I|Protocol Violation|2|||
154977328|NCT01049412|559340794|FG000|Period I|Adverse Event|1|||
154977329|NCT01049412|559340795|FG001|Period I|Adverse Event|0|||
154977330|NCT01049412|559340794|FG000|Period II|Withdrawal by Subject|2|||
154977331|NCT01049412|559340795|FG001|Period II|Withdrawal by Subject|3|||
154977332|NCT01049412|559340794|FG000|Period II|Adverse Event|1|||
154977333|NCT01049412|559340795|FG001|Period II|Adverse Event|0|||
154977334|NCT01049412|559340794|FG000|Period II|Lost to Follow-up|1|||
154977335|NCT01049412|559340795|FG001|Period II|Lost to Follow-up|0|||
154977336|NCT00804141|559340796|FG000|Overall Study|Adverse Event|157|||
154977337|NCT00804141|559340796|FG000|Overall Study|Death|4|||
154977338|NCT00804141|559340796|FG000|Overall Study|Failed to return|96|||
154977339|NCT00804141|559340796|FG000|Overall Study|Investigator request|8|||
154977340|NCT00804141|559340796|FG000|Overall Study|Protocol Violation|85|||
154977341|NCT00804141|559340796|FG000|Overall Study|Withdrawal by Subject|131|||
154977342|NCT00804141|559340796|FG000|Overall Study|Lack of Efficacy|46|||
154977343|NCT00804141|559340796|FG000|Overall Study|Other than specified|30|||
154977344|NCT00804141|559340796|FG000|Overall Study|Enrolled but not treated|6|||
154977345|NCT02418455|559340798|FG000|48-Week Treatment Period|Other- Not Specified|1|||
154977346|NCT02418455|559340798|FG000|Continuation Period|Sponsor Decision|7|||
154977347|NCT03235479|559340801|FG000|Overall Study|Lost to Follow-up|8|||
154977348|NCT03235479|559340802|FG001|Overall Study|Lost to Follow-up|11|||
154977349|NCT03235479|559340801|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
154977350|NCT03235479|559340802|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
154977351|NCT03235479|559340801|FG000|Overall Study|Pregnancy|1|||
154977352|NCT03235479|559340802|FG001|Overall Study|Pregnancy|0|||
154977353|NCT03235479|559340801|FG000|Overall Study|Protocol Deviation|1|||
154977354|NCT03235479|559340802|FG001|Overall Study|Protocol Deviation|3|||
154977355|NCT03235479|559340801|FG000|Overall Study|Technical Problems|3|||
154977356|NCT03235479|559340802|FG001|Overall Study|Technical Problems|2|||
154977357|NCT03235479|559340801|FG000|Overall Study|Withdrawal by Subject|2|||
154977358|NCT03235479|559340802|FG001|Overall Study|Withdrawal by Subject|2|||
154977359|NCT03235479|559340801|FG000|Overall Study|Other Reasons|3|||
154977360|NCT03235479|559340802|FG001|Overall Study|Other Reasons|5|||
154977361|NCT02001051|559340805|FG000|Overall Study|Deemed not eligible following enrollment|0|||
154977362|NCT02001051|559340806|FG001|Overall Study|Deemed not eligible following enrollment|1|||
154977363|NCT00529217|559340816|FG000|Overall Study|Lack of Efficacy|2|||
154977364|NCT00529217|559340816|FG000|Overall Study|Unable to adhere to study schedule|2|||
154977365|NCT01546519|559340817|FG000|Overall Study|Adverse Event|0|||
154977366|NCT01546519|559340818|FG001|Overall Study|Adverse Event|0|||
154977367|NCT01546519|559340819|FG002|Overall Study|Adverse Event|1|||
154977368|NCT01546519|559340820|FG003|Overall Study|Adverse Event|1|||
154977369|NCT01546519|559340817|FG000|Overall Study|Death|0|||
154977370|NCT01546519|559340818|FG001|Overall Study|Death|1|||
154977371|NCT01546519|559340819|FG002|Overall Study|Death|3|||
154977372|NCT01546519|559340820|FG003|Overall Study|Death|1|||
154977373|NCT01546519|559340817|FG000|Overall Study|related to disease progression|2|||
155175481|NCT00895011|560080254|FG000|Overall Study|Adverse Event|1|||
154977374|NCT01546519|559340818|FG001|Overall Study|related to disease progression|2|||
154977375|NCT01546519|559340819|FG002|Overall Study|related to disease progression|2|||
154977376|NCT01546519|559340820|FG003|Overall Study|related to disease progression|1|||
154977377|NCT01546519|559340817|FG000|Overall Study|Physician Decision|6|||
154977378|NCT01546519|559340818|FG001|Overall Study|Physician Decision|5|||
154977379|NCT01546519|559340819|FG002|Overall Study|Physician Decision|2|||
154977380|NCT01546519|559340820|FG003|Overall Study|Physician Decision|3|||
154977381|NCT01546519|559340817|FG000|Overall Study|Withdrawal by Subject|1|||
154977382|NCT01546519|559340818|FG001|Overall Study|Withdrawal by Subject|0|||
154977383|NCT01546519|559340819|FG002|Overall Study|Withdrawal by Subject|0|||
154977384|NCT01546519|559340820|FG003|Overall Study|Withdrawal by Subject|0|||
154977385|NCT00779402|559340821|FG000|Treatment Phase 1|Disease Progression|1|||
154977386|NCT00779402|559340822|FG001|Treatment Phase 1|Disease Progression|0|||
154977387|NCT00779402|559340821|FG000|Treatment Phase 1|Adverse Event|2|||
154977388|NCT00779402|559340822|FG001|Treatment Phase 1|Adverse Event|0|||
154977389|NCT00779402|559340821|FG000|Treatment Phase 1|Protocol Violation|1|||
154977390|NCT00779402|559340822|FG001|Treatment Phase 1|Protocol Violation|0|||
154977391|NCT00779402|559340821|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
154977392|NCT00779402|559340822|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
154977393|NCT00779402|559340821|FG000|Treatment Phase 1|Lost to Follow-up|0|||
154977394|NCT00779402|559340822|FG001|Treatment Phase 1|Lost to Follow-up|1|||
154977395|NCT00779402|559340821|FG000|Treatment Phase 1|Death|0|||
154977396|NCT00779402|559340822|FG001|Treatment Phase 1|Death|1|||
154977397|NCT00779402|559340821|FG000|Treatment Phase 1|Intercurrent Illness|1|||
154977398|NCT00779402|559340822|FG001|Treatment Phase 1|Intercurrent Illness|1|||
154977399|NCT00779402|559340821|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
154977400|NCT00779402|559340822|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
154977401|NCT00779402|559340821|FG000|Treatment Phase 1|Other|4|||
154977402|NCT00779402|559340822|FG001|Treatment Phase 1|Other|2|||
154977403|NCT00779402|559340821|FG000|Treatment Phase 1|Closure of Study|3|||
154977404|NCT00779402|559340822|FG001|Treatment Phase 1|Closure of Study|2|||
154977405|NCT00779402|559340821|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
154977406|NCT00779402|559340822|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
154977407|NCT00779402|559340821|FG000|Surveillance Phase|Protocol Violation|0|||
154977408|NCT00779402|559340822|FG001|Surveillance Phase|Protocol Violation|1|||
154977409|NCT00779402|559340821|FG000|Surveillance Phase|Patient refused to continue|22|||
154977410|NCT00779402|559340822|FG001|Surveillance Phase|Patient refused to continue|14|||
154977411|NCT00779402|559340821|FG000|Surveillance Phase|Lost to Follow-up|2|||
154977412|NCT00779402|559340822|FG001|Surveillance Phase|Lost to Follow-up|1|||
154977413|NCT00779402|559340821|FG000|Surveillance Phase|Death|0|||
154977414|NCT00779402|559340822|FG001|Surveillance Phase|Death|1|||
154977415|NCT00779402|559340821|FG000|Surveillance Phase|Intercurrent Illness|2|||
154977416|NCT00779402|559340822|FG001|Surveillance Phase|Intercurrent Illness|0|||
154977417|NCT00779402|559340821|FG000|Surveillance Phase|Other|5|||
154977418|NCT00779402|559340822|FG001|Surveillance Phase|Other|5|||
154977419|NCT00779402|559340821|FG000|Surveillance Phase|Withdrawal by Subject|4|||
154977420|NCT00779402|559340822|FG001|Surveillance Phase|Withdrawal by Subject|1|||
154977421|NCT00779402|559340821|FG000|Surveillance Phase|Closure of study|5|||
154977422|NCT00779402|559340822|FG001|Surveillance Phase|Closure of study|6|||
154977423|NCT00779402|559340821|FG000|Surveillance Phase|Completed Protocol Visits|3|||
154977424|NCT00779402|559340822|FG001|Surveillance Phase|Completed Protocol Visits|2|||
154977425|NCT00779402|559340821|FG000|Long-term Follow-up|Patient refused to continue|2|||
154977426|NCT00779402|559340822|FG001|Long-term Follow-up|Patient refused to continue|0|||
154977427|NCT00779402|559340821|FG000|Long-term Follow-up|Other|5|||
154977428|NCT00779402|559340822|FG001|Long-term Follow-up|Other|0|||
154977429|NCT00779402|559340821|FG000|Long-term Follow-up|Closure of Study|8|||
154977430|NCT00779402|559340822|FG001|Long-term Follow-up|Closure of Study|4|||
154977431|NCT00779402|559340821|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
154977432|NCT00779402|559340822|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
154977433|NCT00693225|559340827|FG000|Overall Study|Lost to Follow-up|1|||
154977434|NCT00693225|559340828|FG001|Overall Study|Lost to Follow-up|2|||
154977435|NCT00693225|559340827|FG000|Overall Study|Adverse Event|1|||
154977436|NCT00693225|559340828|FG001|Overall Study|Adverse Event|3|||
155113829|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Adverse Event|0|||
154977437|NCT01315028|559340829|FG000|Overall Study|Lost to Follow-up|1|||
154977438|NCT01315028|559340830|FG001|Overall Study|Lost to Follow-up|0|||
154977439|NCT01315028|559340829|FG000|Overall Study|Death|0|||
154977440|NCT01315028|559340830|FG001|Overall Study|Death|1|||
154977441|NCT01808248|559340848|FG000|Overall Study|Lack of Efficacy|3|||
154977442|NCT01808248|559340848|FG000|Overall Study|Withdrawal by Subject|1|||
154977443|NCT01808248|559340848|FG000|Overall Study|Lost to Follow-up|1|||
154977444|NCT04126343|559340857|FG000|Overall Study|Adverse Event|0|||
154977445|NCT04126343|559340858|FG001|Overall Study|Adverse Event|0|||
154977446|NCT04126343|559340859|FG002|Overall Study|Adverse Event|0|||
154977447|NCT04126343|559340860|FG003|Overall Study|Adverse Event|0|||
154977448|NCT04126343|559340861|FG004|Overall Study|Adverse Event|0|||
154977449|NCT04126343|559340862|FG005|Overall Study|Adverse Event|1|||
154977450|NCT04126343|559340857|FG000|Overall Study|Withdrawal by Subject|0|||
154977451|NCT04126343|559340858|FG001|Overall Study|Withdrawal by Subject|0|||
154888683|NCT01658579|559013472|FG000|Treatment Period A|Other|0|||
154888684|NCT01658579|559013473|FG001|Treatment Period A|Other|0|||
154888685|NCT01658579|559013474|FG002|Treatment Period A|Other|1|||
154888686|NCT01658579|559013475|FG003|Treatment Period A|Other|1|||
154888687|NCT01658579|559013472|FG000|Treatment Period A|Adverse Event|1|||
154888688|NCT01658579|559013473|FG001|Treatment Period A|Adverse Event|0|||
154888689|NCT01658579|559013474|FG002|Treatment Period A|Adverse Event|0|||
154888690|NCT01658579|559013475|FG003|Treatment Period A|Adverse Event|0|||
154888691|NCT01658579|559013472|FG000|Treatment Period B|Other|0|||
154888692|NCT01658579|559013473|FG001|Treatment Period B|Other|0|||
154888693|NCT01658579|559013474|FG002|Treatment Period B|Other|0|||
154888694|NCT01658579|559013475|FG003|Treatment Period B|Other|1|||
154888695|NCT05590767|559013476|FG000|Overall Study|Protocol Violation|1|||
154888696|NCT05590767|559013476|FG000|Overall Study|surgery canceled|1|||
154888697|NCT05590767|559013476|FG000|Overall Study|interscalene brachial block not performed|1|||
154888698|NCT01464788|559013477|FG000|Overall Study|Lost to Follow-up|0|||
154888699|NCT01464788|559013478|FG001|Overall Study|Lost to Follow-up|1|||
154888700|NCT01464788|559013479|FG002|Overall Study|Lost to Follow-up|0|||
154888701|NCT01464788|559013477|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
154888702|NCT01464788|559013478|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
154888703|NCT01464788|559013479|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
154888704|NCT01577160|559013481|FG000|Overall Study|Adverse Event|9|||
154888705|NCT01577160|559013481|FG000|Overall Study|Lack of Efficacy|15|||
154888706|NCT01577160|559013481|FG000|Overall Study|Lost to Follow-up|40|||
154888707|NCT01577160|559013481|FG000|Overall Study|Withdrawal by Subject|18|||
154888708|NCT01577160|559013481|FG000|Overall Study|Subject Uncooperative|7|||
154888709|NCT01577160|559013481|FG000|Overall Study|Other|9|||
154888710|NCT01551758|559013482|FG000|Overall Study|Adverse Event|29|||
154888711|NCT01551758|559013483|FG001|Overall Study|Adverse Event|43|||
154888712|NCT01551758|559013482|FG000|Overall Study|Lack of Efficacy|0|||
154888713|NCT01551758|559013483|FG001|Overall Study|Lack of Efficacy|1|||
154888714|NCT01551758|559013482|FG000|Overall Study|Protocol Violation|5|||
154888715|NCT01551758|559013483|FG001|Overall Study|Protocol Violation|6|||
154888716|NCT01551758|559013482|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
154888717|NCT01551758|559013483|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
154888718|NCT01551758|559013482|FG000|Overall Study|Lost to Follow-up|29|||
154888719|NCT01551758|559013483|FG001|Overall Study|Lost to Follow-up|25|||
154888720|NCT01551758|559013482|FG000|Overall Study|Physician Decision|9|||
154888721|NCT01551758|559013483|FG001|Overall Study|Physician Decision|3|||
154888722|NCT01551758|559013482|FG000|Overall Study|Withdrawal by Subject|14|||
154888723|NCT01551758|559013483|FG001|Overall Study|Withdrawal by Subject|17|||
154888724|NCT01586156|559013485|FG000|Overall Study|Pregnancy|0|||
154888725|NCT01586156|559013486|FG001|Overall Study|Pregnancy|1|||
154888726|NCT01586156|559013487|FG002|Overall Study|Pregnancy|0|||
154888727|NCT00363246|559013488|FG000|Overall Study|Death|40|||
154888728|NCT00363246|559013488|FG000|Overall Study|Withdrawal by Subject|19|||
154888729|NCT00363246|559013488|FG000|Overall Study|Lost to Follow-up|14|||
154888730|NCT00363246|559013488|FG000|Overall Study|Bad health|6|||
154888731|NCT00363246|559013488|FG000|Overall Study|Stopped using wheelchair|11|||
154888732|NCT00363246|559013488|FG000|Overall Study|Subject expressed security concerns|2|||
154888733|NCT00363246|559013488|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
154888734|NCT00264849|559013489|FG000|Overall Study|Adverse Event|7|||
154888735|NCT00264849|559013490|FG001|Overall Study|Adverse Event|2|||
154888736|NCT00264849|559013489|FG000|Overall Study|Withdrawal by Subject|7|||
154888737|NCT00264849|559013490|FG001|Overall Study|Withdrawal by Subject|11|||
154888738|NCT00264849|559013489|FG000|Overall Study|Protocol Violation|5|||
154888739|NCT00264849|559013490|FG001|Overall Study|Protocol Violation|3|||
154888740|NCT00264849|559013489|FG000|Overall Study|Lack of Efficacy|1|||
154888741|NCT00264849|559013490|FG001|Overall Study|Lack of Efficacy|6|||
154888742|NCT00264849|559013489|FG000|Overall Study|Lost to Follow-up|0|||
154888743|NCT00264849|559013490|FG001|Overall Study|Lost to Follow-up|2|||
154888744|NCT00264849|559013489|FG000|Overall Study|Death|0|||
154888745|NCT00264849|559013490|FG001|Overall Study|Death|1|||
154888746|NCT00264849|559013489|FG000|Overall Study|Administrative Problems|2|||
154977452|NCT04126343|559340859|FG002|Overall Study|Withdrawal by Subject|0|||
154977453|NCT04126343|559340860|FG003|Overall Study|Withdrawal by Subject|1|||
154977454|NCT04126343|559340861|FG004|Overall Study|Withdrawal by Subject|0|||
155113830|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Adverse Event|0|||
155113831|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Physician Decision|9|||
155113832|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Physician Decision|0|||
154888747|NCT00264849|559013490|FG001|Overall Study|Administrative Problems|0|||
154888748|NCT00717366|559013493|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
154888749|NCT00717366|559013494|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
155113833|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Physician Decision|0|||
154888750|NCT00717366|559013493|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
154888751|NCT00717366|559013494|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
154888752|NCT00717366|559013493|FG000|Core Study Period (20 Weeks)|Death|0|||
154888753|NCT00717366|559013494|FG001|Core Study Period (20 Weeks)|Death|1|||
154888754|NCT00717366|559013493|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
154888755|NCT00717366|559013494|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
154888756|NCT00717366|559013493|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
154888757|NCT00717366|559013494|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
154888758|NCT00717366|559013493|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
154888759|NCT00717366|559013494|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
154888760|NCT00717366|559013493|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
154888761|NCT00717366|559013494|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
154888762|NCT01553916|559013495|FG000|Overall Study|Withdrawal by Subject|2|||
154888763|NCT01553916|559013495|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
154888764|NCT00645567|559013497|FG000|Overall Study|Adverse Event|1|||
154888765|NCT03259490|559013502|FG000|Period 1|Withdrawal by Subject|0|||
154888766|NCT03259490|559013503|FG001|Period 1|Withdrawal by Subject|1|||
154888767|NCT03259490|559013502|FG000|Period 2|Protocol Violation|1|||
154888768|NCT03259490|559013503|FG001|Period 2|Protocol Violation|0|||
154888769|NCT00434122|559013505|FG000|Overall Study|Non-compliance with protocol|0|||
154888770|NCT00434122|559013506|FG001|Overall Study|Non-compliance with protocol|1|||
154888771|NCT00434122|559013505|FG000|Overall Study|loss of subject contact|1|||
154888772|NCT00434122|559013506|FG001|Overall Study|loss of subject contact|1|||
154888773|NCT00434122|559013505|FG000|Overall Study|Personal reasons|1|||
154888774|NCT00434122|559013506|FG001|Overall Study|Personal reasons|1|||
154888775|NCT00434122|559013505|FG000|Overall Study|Large follicle size|2|||
154888776|NCT00434122|559013506|FG001|Overall Study|Large follicle size|2|||
154888777|NCT00434122|559013505|FG000|Overall Study|Low follicular response.|1|||
154888778|NCT00434122|559013506|FG001|Overall Study|Low follicular response.|2|||
154888779|NCT00434122|559013505|FG000|Overall Study|Travelling of subject.|1|||
154888780|NCT00434122|559013506|FG001|Overall Study|Travelling of subject.|0|||
154888781|NCT00255086|559013507|FG000|Overall Study|Adverse Event|1|||
154888782|NCT00255086|559013508|FG001|Overall Study|Adverse Event|1|||
154888783|NCT00255086|559013507|FG000|Overall Study|Protocol Violation|1|||
154888784|NCT00255086|559013508|FG001|Overall Study|Protocol Violation|1|||
154888785|NCT01364233|559013509|FG000|Overall Study|Lost to Follow-up|1|||
154888786|NCT00819585|559013511|FG000|Core Study|Adverse Event|2|||
154888787|NCT00819585|559013512|FG001|Core Study|Adverse Event|1|||
154888788|NCT00819585|559013513|FG002|Core Study|Adverse Event|1|||
154888789|NCT00819585|559013514|FG003|Core Study|Adverse Event|4|||
154888790|NCT00819585|559013515|FG004|Core Study|Adverse Event|1|||
154888791|NCT00819585|559013516|FG005|Core Study|Adverse Event|0|||
154888792|NCT00819585|559013517|FG006|Core Study|Adverse Event|2|||
154888793|NCT00819585|559013518|FG007|Core Study|Adverse Event|0|||
154888794|NCT00819585|559013519|FG008|Core Study|Adverse Event|0|||
154888795|NCT00819585|559013520|FG009|Core Study|Adverse Event|0|||
154888796|NCT00819585|559013521|FG010|Core Study|Adverse Event|0|||
154888797|NCT00819585|559013511|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
154888798|NCT00819585|559013512|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
154888799|NCT00819585|559013513|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
154888800|NCT00819585|559013514|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
154888801|NCT00819585|559013515|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
154888802|NCT00819585|559013516|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
154888803|NCT00819585|559013517|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
154888804|NCT00819585|559013518|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
154977455|NCT04126343|559340862|FG005|Overall Study|Withdrawal by Subject|0|||
154977456|NCT04126343|559340857|FG000|Overall Study|Related to COVID-19 pandemic|3|||
154888805|NCT00819585|559013519|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
154888806|NCT00819585|559013520|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
154888807|NCT00819585|559013521|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
154888808|NCT00819585|559013511|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888809|NCT00819585|559013512|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
154888810|NCT00819585|559013513|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888811|NCT00819585|559013514|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888812|NCT00819585|559013515|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888813|NCT00819585|559013516|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888814|NCT00819585|559013517|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
154888815|NCT00819585|559013518|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888816|NCT00819585|559013519|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
154977457|NCT04126343|559340858|FG001|Overall Study|Related to COVID-19 pandemic|4|||
154977458|NCT04126343|559340859|FG002|Overall Study|Related to COVID-19 pandemic|3|||
154888817|NCT00819585|559013520|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888818|NCT00819585|559013521|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
154888819|NCT00819585|559013511|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
154888820|NCT00819585|559013512|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
154888821|NCT00819585|559013513|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
154888822|NCT00819585|559013514|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
154888823|NCT00819585|559013515|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
154888824|NCT00819585|559013516|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
155175482|NCT00895011|560080255|FG001|Overall Study|Adverse Event|2|||
155175483|NCT00895011|560080256|FG002|Overall Study|Adverse Event|2|||
155175484|NCT00895011|560080254|FG000|Overall Study|schedule conflict|1|||
154888825|NCT00819585|559013517|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
154888826|NCT00819585|559013518|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
154888827|NCT00819585|559013519|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
154888828|NCT00819585|559013520|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
154888829|NCT00819585|559013521|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
154888830|NCT00819585|559013511|FG000|Core Study|Subject Withdrew Consent|0|||
154888831|NCT00819585|559013512|FG001|Core Study|Subject Withdrew Consent|3|||
154888832|NCT00819585|559013513|FG002|Core Study|Subject Withdrew Consent|2|||
154888833|NCT00819585|559013514|FG003|Core Study|Subject Withdrew Consent|1|||
154888834|NCT00819585|559013515|FG004|Core Study|Subject Withdrew Consent|0|||
154888835|NCT00819585|559013516|FG005|Core Study|Subject Withdrew Consent|0|||
154888836|NCT00819585|559013517|FG006|Core Study|Subject Withdrew Consent|3|||
154888837|NCT00819585|559013518|FG007|Core Study|Subject Withdrew Consent|0|||
154888838|NCT00819585|559013519|FG008|Core Study|Subject Withdrew Consent|0|||
154888839|NCT00819585|559013520|FG009|Core Study|Subject Withdrew Consent|0|||
154888840|NCT00819585|559013521|FG010|Core Study|Subject Withdrew Consent|0|||
154888841|NCT00819585|559013511|FG000|Core Study|Lost to Follow-up|2|||
154888842|NCT00819585|559013512|FG001|Core Study|Lost to Follow-up|1|||
154888843|NCT00819585|559013513|FG002|Core Study|Lost to Follow-up|2|||
154888844|NCT00819585|559013514|FG003|Core Study|Lost to Follow-up|0|||
154888845|NCT00819585|559013515|FG004|Core Study|Lost to Follow-up|1|||
154888846|NCT00819585|559013516|FG005|Core Study|Lost to Follow-up|1|||
154888847|NCT00819585|559013517|FG006|Core Study|Lost to Follow-up|1|||
154888848|NCT00819585|559013518|FG007|Core Study|Lost to Follow-up|0|||
154888849|NCT00819585|559013519|FG008|Core Study|Lost to Follow-up|0|||
154888850|NCT00819585|559013520|FG009|Core Study|Lost to Follow-up|0|||
154888851|NCT00819585|559013521|FG010|Core Study|Lost to Follow-up|0|||
154888852|NCT00819585|559013511|FG000|Core Study|Administrative Problems|0|||
154888853|NCT00819585|559013512|FG001|Core Study|Administrative Problems|0|||
154888854|NCT00819585|559013513|FG002|Core Study|Administrative Problems|0|||
154888855|NCT00819585|559013514|FG003|Core Study|Administrative Problems|0|||
154888856|NCT00819585|559013515|FG004|Core Study|Administrative Problems|0|||
154888857|NCT00819585|559013516|FG005|Core Study|Administrative Problems|0|||
154888858|NCT00819585|559013517|FG006|Core Study|Administrative Problems|2|||
154888859|NCT00819585|559013518|FG007|Core Study|Administrative Problems|0|||
154888860|NCT00819585|559013519|FG008|Core Study|Administrative Problems|0|||
154888861|NCT00819585|559013520|FG009|Core Study|Administrative Problems|0|||
154888862|NCT00819585|559013521|FG010|Core Study|Administrative Problems|0|||
154888863|NCT00819585|559013511|FG000|Core Study|Death|0|||
154888864|NCT00819585|559013512|FG001|Core Study|Death|0|||
154888865|NCT00819585|559013513|FG002|Core Study|Death|0|||
154888866|NCT00819585|559013514|FG003|Core Study|Death|0|||
154888867|NCT00819585|559013515|FG004|Core Study|Death|0|||
154888868|NCT00819585|559013516|FG005|Core Study|Death|0|||
154888869|NCT00819585|559013517|FG006|Core Study|Death|1|||
154888870|NCT00819585|559013518|FG007|Core Study|Death|0|||
154888871|NCT00819585|559013519|FG008|Core Study|Death|0|||
154888872|NCT00819585|559013520|FG009|Core Study|Death|0|||
154888873|NCT00819585|559013521|FG010|Core Study|Death|0|||
154888874|NCT00819585|559013511|FG000|Core Study|Protocol Violation|0|||
154888875|NCT00819585|559013512|FG001|Core Study|Protocol Violation|0|||
154888876|NCT00819585|559013513|FG002|Core Study|Protocol Violation|1|||
154888877|NCT00819585|559013514|FG003|Core Study|Protocol Violation|0|||
154888878|NCT00819585|559013515|FG004|Core Study|Protocol Violation|0|||
154888879|NCT00819585|559013516|FG005|Core Study|Protocol Violation|1|||
154888880|NCT00819585|559013517|FG006|Core Study|Protocol Violation|3|||
154888881|NCT00819585|559013518|FG007|Core Study|Protocol Violation|0|||
154888882|NCT00819585|559013519|FG008|Core Study|Protocol Violation|0|||
154888883|NCT00819585|559013520|FG009|Core Study|Protocol Violation|0|||
154888884|NCT00819585|559013521|FG010|Core Study|Protocol Violation|0|||
154888885|NCT00819585|559013511|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
154888886|NCT00819585|559013512|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
154888887|NCT00819585|559013513|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
154888888|NCT00819585|559013514|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
154888889|NCT00819585|559013515|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
154888890|NCT00819585|559013516|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
154888891|NCT00819585|559013517|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
154888892|NCT00819585|559013518|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
154888893|NCT00819585|559013519|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
154888894|NCT00819585|559013520|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
154888895|NCT00819585|559013521|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
154888896|NCT00819585|559013511|FG000|Extension Study|Subject Withdrew Consent|0|||
154888897|NCT00819585|559013512|FG001|Extension Study|Subject Withdrew Consent|0|||
154888898|NCT00819585|559013513|FG002|Extension Study|Subject Withdrew Consent|0|||
154888899|NCT00819585|559013514|FG003|Extension Study|Subject Withdrew Consent|0|||
154888900|NCT00819585|559013515|FG004|Extension Study|Subject Withdrew Consent|0|||
154888901|NCT00819585|559013516|FG005|Extension Study|Subject Withdrew Consent|0|||
154888902|NCT00819585|559013517|FG006|Extension Study|Subject Withdrew Consent|0|||
154888903|NCT00819585|559013518|FG007|Extension Study|Subject Withdrew Consent|0|||
154888904|NCT00819585|559013519|FG008|Extension Study|Subject Withdrew Consent|3|||
154888905|NCT00819585|559013520|FG009|Extension Study|Subject Withdrew Consent|0|||
154888906|NCT00819585|559013521|FG010|Extension Study|Subject Withdrew Consent|1|||
154888907|NCT00819585|559013511|FG000|Extension Study|Lost to Follow-up|0|||
154888908|NCT00819585|559013512|FG001|Extension Study|Lost to Follow-up|0|||
154888909|NCT00819585|559013513|FG002|Extension Study|Lost to Follow-up|0|||
154888910|NCT00819585|559013514|FG003|Extension Study|Lost to Follow-up|0|||
154888911|NCT00819585|559013515|FG004|Extension Study|Lost to Follow-up|0|||
154888912|NCT00819585|559013516|FG005|Extension Study|Lost to Follow-up|0|||
154888913|NCT00819585|559013517|FG006|Extension Study|Lost to Follow-up|0|||
154888914|NCT00819585|559013518|FG007|Extension Study|Lost to Follow-up|0|||
154888915|NCT00819585|559013519|FG008|Extension Study|Lost to Follow-up|2|||
154888916|NCT00819585|559013520|FG009|Extension Study|Lost to Follow-up|1|||
154888917|NCT00819585|559013521|FG010|Extension Study|Lost to Follow-up|1|||
154888918|NCT00819585|559013511|FG000|Extension Study|Death|0|||
154888919|NCT00819585|559013512|FG001|Extension Study|Death|0|||
154888920|NCT00819585|559013513|FG002|Extension Study|Death|0|||
154888921|NCT00819585|559013514|FG003|Extension Study|Death|0|||
154888922|NCT00819585|559013515|FG004|Extension Study|Death|0|||
154888923|NCT00819585|559013516|FG005|Extension Study|Death|0|||
154888924|NCT00819585|559013517|FG006|Extension Study|Death|0|||
154888925|NCT00819585|559013518|FG007|Extension Study|Death|0|||
154888926|NCT00819585|559013519|FG008|Extension Study|Death|2|||
154888927|NCT00819585|559013520|FG009|Extension Study|Death|0|||
154888928|NCT00819585|559013521|FG010|Extension Study|Death|0|||
154888929|NCT00349752|559013522|FG000|Overall Study|Adverse Event|8|||
154888930|NCT00349752|559013523|FG001|Overall Study|Adverse Event|12|||
154888931|NCT00349752|559013522|FG000|Overall Study|Lack of Efficacy|37|||
154888932|NCT00349752|559013523|FG001|Overall Study|Lack of Efficacy|42|||
154888933|NCT00349752|559013522|FG000|Overall Study|Lost to Follow-up|4|||
154888934|NCT00349752|559013523|FG001|Overall Study|Lost to Follow-up|2|||
154888935|NCT00349752|559013522|FG000|Overall Study|Personal reasons|6|||
154888936|NCT00349752|559013523|FG001|Overall Study|Personal reasons|5|||
154888937|NCT00349752|559013522|FG000|Overall Study|Other: Required exclusionary medication|0|||
154888938|NCT00349752|559013523|FG001|Overall Study|Other: Required exclusionary medication|1|||
154888939|NCT00349752|559013522|FG000|Overall Study|Other: Non compliance|0|||
154888940|NCT00349752|559013523|FG001|Overall Study|Other: Non compliance|1|||
154888941|NCT00349752|559013522|FG000|Overall Study|Other: Patient stopped steroids|0|||
154888942|NCT00349752|559013523|FG001|Overall Study|Other: Patient stopped steroids|1|||
154888943|NCT00349752|559013522|FG000|Overall Study|Other: Patient's steroid use|1|||
154888944|NCT00349752|559013523|FG001|Overall Study|Other: Patient's steroid use|0|||
154888945|NCT00349752|559013522|FG000|Overall Study|Other: Ineligible|1|||
154888946|NCT00349752|559013523|FG001|Overall Study|Other: Ineligible|0|||
154888947|NCT00349752|559013522|FG000|Overall Study|Other: Inadvertently unblinded|1|||
154888948|NCT00349752|559013523|FG001|Overall Study|Other: Inadvertently unblinded|0|||
154888949|NCT00349752|559013522|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
154888950|NCT00349752|559013523|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
154888951|NCT03334396|559013524|FG000|Overall Study|Adverse Event|1|||
154888952|NCT03334396|559013525|FG001|Overall Study|Adverse Event|0|||
154888953|NCT03334396|559013526|FG002|Overall Study|Adverse Event|1|||
154888954|NCT03334396|559013527|FG003|Overall Study|Adverse Event|0|||
154888955|NCT03334396|559013528|FG004|Overall Study|Adverse Event|0|||
154888956|NCT03334396|559013529|FG005|Overall Study|Adverse Event|0|||
154888957|NCT03334396|559013530|FG006|Overall Study|Adverse Event|0|||
154888958|NCT03334396|559013531|FG007|Overall Study|Adverse Event|0|||
154888959|NCT03334396|559013524|FG000|Overall Study|Lack of Efficacy|10|||
154888960|NCT03334396|559013525|FG001|Overall Study|Lack of Efficacy|4|||
154888961|NCT03334396|559013526|FG002|Overall Study|Lack of Efficacy|1|||
154888962|NCT03334396|559013527|FG003|Overall Study|Lack of Efficacy|3|||
154888963|NCT03334396|559013528|FG004|Overall Study|Lack of Efficacy|1|||
154888964|NCT03334396|559013529|FG005|Overall Study|Lack of Efficacy|0|||
154888965|NCT03334396|559013530|FG006|Overall Study|Lack of Efficacy|0|||
154888966|NCT03334396|559013531|FG007|Overall Study|Lack of Efficacy|1|||
154888967|NCT03334396|559013524|FG000|Overall Study|Lost to Follow-up|0|||
154888968|NCT03334396|559013525|FG001|Overall Study|Lost to Follow-up|0|||
154888969|NCT03334396|559013526|FG002|Overall Study|Lost to Follow-up|1|||
154888970|NCT03334396|559013527|FG003|Overall Study|Lost to Follow-up|0|||
154888971|NCT03334396|559013528|FG004|Overall Study|Lost to Follow-up|0|||
154888972|NCT03334396|559013529|FG005|Overall Study|Lost to Follow-up|0|||
154888973|NCT03334396|559013530|FG006|Overall Study|Lost to Follow-up|1|||
154888974|NCT03334396|559013531|FG007|Overall Study|Lost to Follow-up|0|||
154888975|NCT03334396|559013524|FG000|Overall Study|Physician Decision|1|||
154888976|NCT03334396|559013525|FG001|Overall Study|Physician Decision|0|||
154888977|NCT03334396|559013526|FG002|Overall Study|Physician Decision|0|||
154888978|NCT03334396|559013527|FG003|Overall Study|Physician Decision|0|||
154977459|NCT04126343|559340860|FG003|Overall Study|Related to COVID-19 pandemic|3|||
154977460|NCT04126343|559340861|FG004|Overall Study|Related to COVID-19 pandemic|3|||
154977461|NCT04126343|559340862|FG005|Overall Study|Related to COVID-19 pandemic|3|||
154977462|NCT01857973|559340863|FG000|Overall Study|Subject did not meet required BG range|3|||
154977463|NCT01857973|559340863|FG000|Overall Study|drop out after 3 failed attempts|1|||
154977464|NCT01857973|559340863|FG000|Overall Study|Physician Decision|1|||
154977465|NCT01701973|559340866|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977466|NCT01701973|559340867|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
154977467|NCT01701973|559340868|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977468|NCT01701973|559340869|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977469|NCT01701973|559340870|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977470|NCT01701973|559340871|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977471|NCT01701973|559340872|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977472|NCT01701973|559340873|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
154977473|NCT02412722|559340878|FG000|Overall Study|Adverse Event|0|||
154977474|NCT02412722|559340879|FG001|Overall Study|Adverse Event|2|||
154977475|NCT02412722|559340880|FG002|Overall Study|Adverse Event|0|||
154977476|NCT02412722|559340881|FG003|Overall Study|Adverse Event|3|||
154977477|NCT02412722|559340882|FG004|Overall Study|Adverse Event|0|||
154977478|NCT02412722|559340883|FG005|Overall Study|Adverse Event|3|||
154977479|NCT02412722|559340878|FG000|Overall Study|Progressive Disease|6|||
154977480|NCT02412722|559340879|FG001|Overall Study|Progressive Disease|4|||
154977481|NCT02412722|559340880|FG002|Overall Study|Progressive Disease|4|||
154977482|NCT02412722|559340881|FG003|Overall Study|Progressive Disease|9|||
154977483|NCT02412722|559340882|FG004|Overall Study|Progressive Disease|3|||
154977484|NCT02412722|559340883|FG005|Overall Study|Progressive Disease|3|||
154977485|NCT02412722|559340878|FG000|Overall Study|Withdrawal by Subject|2|||
154977486|NCT02412722|559340879|FG001|Overall Study|Withdrawal by Subject|0|||
154977487|NCT02412722|559340880|FG002|Overall Study|Withdrawal by Subject|1|||
154977488|NCT02412722|559340881|FG003|Overall Study|Withdrawal by Subject|2|||
154977489|NCT02412722|559340882|FG004|Overall Study|Withdrawal by Subject|1|||
154977490|NCT02412722|559340883|FG005|Overall Study|Withdrawal by Subject|1|||
154977491|NCT02412722|559340878|FG000|Overall Study|Lost to Follow-up|0|||
154977492|NCT02412722|559340879|FG001|Overall Study|Lost to Follow-up|0|||
155175485|NCT00895011|560080255|FG001|Overall Study|schedule conflict|0|||
154888979|NCT03334396|559013528|FG004|Overall Study|Physician Decision|0|||
154888980|NCT03334396|559013529|FG005|Overall Study|Physician Decision|0|||
154888981|NCT03334396|559013530|FG006|Overall Study|Physician Decision|0|||
154888982|NCT03334396|559013531|FG007|Overall Study|Physician Decision|0|||
154888983|NCT03334396|559013524|FG000|Overall Study|Withdrawal by Subject|10|||
154888984|NCT03334396|559013525|FG001|Overall Study|Withdrawal by Subject|5|||
154888985|NCT03334396|559013526|FG002|Overall Study|Withdrawal by Subject|7|||
154888986|NCT03334396|559013527|FG003|Overall Study|Withdrawal by Subject|2|||
154888987|NCT03334396|559013528|FG004|Overall Study|Withdrawal by Subject|2|||
154888988|NCT03334396|559013529|FG005|Overall Study|Withdrawal by Subject|1|||
154888989|NCT03334396|559013530|FG006|Overall Study|Withdrawal by Subject|2|||
154888990|NCT03334396|559013531|FG007|Overall Study|Withdrawal by Subject|0|||
154888991|NCT03334396|559013524|FG000|Overall Study|Pregnancy|0|||
154888992|NCT03334396|559013525|FG001|Overall Study|Pregnancy|1|||
154888993|NCT03334396|559013526|FG002|Overall Study|Pregnancy|0|||
154888994|NCT03334396|559013527|FG003|Overall Study|Pregnancy|0|||
154888995|NCT03334396|559013528|FG004|Overall Study|Pregnancy|0|||
154888996|NCT03334396|559013529|FG005|Overall Study|Pregnancy|0|||
154888997|NCT03334396|559013530|FG006|Overall Study|Pregnancy|0|||
154888998|NCT03334396|559013531|FG007|Overall Study|Pregnancy|0|||
154888999|NCT03334396|559013524|FG000|Overall Study|Ineligible|0|||
154889000|NCT03334396|559013525|FG001|Overall Study|Ineligible|1|||
154889001|NCT03334396|559013526|FG002|Overall Study|Ineligible|0|||
154889002|NCT03334396|559013527|FG003|Overall Study|Ineligible|0|||
154889003|NCT03334396|559013528|FG004|Overall Study|Ineligible|0|||
154889004|NCT03334396|559013529|FG005|Overall Study|Ineligible|0|||
154889005|NCT03334396|559013530|FG006|Overall Study|Ineligible|0|||
154889006|NCT03334396|559013531|FG007|Overall Study|Ineligible|0|||
154889007|NCT03334396|559013524|FG000|Overall Study|Started New Job|1|||
154889008|NCT03334396|559013525|FG001|Overall Study|Started New Job|0|||
154977493|NCT02412722|559340880|FG002|Overall Study|Lost to Follow-up|0|||
154977494|NCT02412722|559340881|FG003|Overall Study|Lost to Follow-up|0|||
154977495|NCT02412722|559340882|FG004|Overall Study|Lost to Follow-up|1|||
154977496|NCT02412722|559340883|FG005|Overall Study|Lost to Follow-up|0|||
154977497|NCT02412722|559340878|FG000|Overall Study|Received drug in run-in and discontinued|0|||
154977498|NCT02412722|559340879|FG001|Overall Study|Received drug in run-in and discontinued|2|||
154977499|NCT02412722|559340880|FG002|Overall Study|Received drug in run-in and discontinued|0|||
154977500|NCT02412722|559340881|FG003|Overall Study|Received drug in run-in and discontinued|0|||
154977501|NCT02412722|559340882|FG004|Overall Study|Received drug in run-in and discontinued|0|||
154977502|NCT02412722|559340883|FG005|Overall Study|Received drug in run-in and discontinued|0|||
154889009|NCT03334396|559013526|FG002|Overall Study|Started New Job|0|||
154889010|NCT03334396|559013527|FG003|Overall Study|Started New Job|0|||
154889011|NCT03334396|559013528|FG004|Overall Study|Started New Job|0|||
154889012|NCT03334396|559013529|FG005|Overall Study|Started New Job|0|||
154889013|NCT03334396|559013530|FG006|Overall Study|Started New Job|0|||
154889014|NCT03334396|559013531|FG007|Overall Study|Started New Job|0|||
154889015|NCT01842607|559013533|FG000|Overall Study|Adverse Event|11|||
154889016|NCT01842607|559013533|FG000|Overall Study|Lack of Efficacy|19|||
154889017|NCT01842607|559013533|FG000|Overall Study|Protocol Violation|8|||
154889018|NCT01842607|559013533|FG000|Overall Study|Protocol defined stopping criteria|2|||
154889019|NCT01842607|559013533|FG000|Overall Study|Lost to Follow-up|3|||
154889020|NCT01842607|559013533|FG000|Overall Study|Physician Decision|9|||
154889021|NCT01842607|559013533|FG000|Overall Study|Withdrawal by Subject|14|||
154889022|NCT03629041|559013534|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
154889023|NCT03629041|559013535|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
154889024|NCT03629041|559013536|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
154889025|NCT03629041|559013537|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
154889026|NCT04971785|559013539|FG000|Overall Study|Withdrew Consent|5|||
154889027|NCT04971785|559013540|FG001|Overall Study|Withdrew Consent|5|||
154889028|NCT04971785|559013541|FG002|Overall Study|Withdrew Consent|17|||
154889029|NCT04971785|559013542|FG003|Overall Study|Withdrew Consent|7|||
154889030|NCT04971785|559013539|FG000|Overall Study|Adverse Event|7|||
154889031|NCT04971785|559013540|FG001|Overall Study|Adverse Event|8|||
154889032|NCT04971785|559013541|FG002|Overall Study|Adverse Event|6|||
154889033|NCT04971785|559013542|FG003|Overall Study|Adverse Event|3|||
154889034|NCT04971785|559013539|FG000|Overall Study|Lost to Follow-up|2|||
154889035|NCT04971785|559013540|FG001|Overall Study|Lost to Follow-up|1|||
154889036|NCT04971785|559013541|FG002|Overall Study|Lost to Follow-up|6|||
154889037|NCT04971785|559013542|FG003|Overall Study|Lost to Follow-up|7|||
154889038|NCT04971785|559013539|FG000|Overall Study|Protocol Violation|3|||
154889039|NCT04971785|559013540|FG001|Overall Study|Protocol Violation|1|||
154889040|NCT04971785|559013541|FG002|Overall Study|Protocol Violation|1|||
154889041|NCT04971785|559013542|FG003|Overall Study|Protocol Violation|2|||
154889042|NCT04971785|559013539|FG000|Overall Study|Investigator's Discretion|3|||
154889043|NCT04971785|559013540|FG001|Overall Study|Investigator's Discretion|1|||
154889044|NCT04971785|559013541|FG002|Overall Study|Investigator's Discretion|1|||
154889045|NCT04971785|559013542|FG003|Overall Study|Investigator's Discretion|0|||
154889046|NCT04971785|559013539|FG000|Overall Study|Randomized but Never Treated|1|||
154889047|NCT04971785|559013540|FG001|Overall Study|Randomized but Never Treated|2|||
154889048|NCT04971785|559013541|FG002|Overall Study|Randomized but Never Treated|0|||
154889049|NCT04971785|559013542|FG003|Overall Study|Randomized but Never Treated|1|||
154889050|NCT04971785|559013539|FG000|Overall Study|Death|0|||
154889051|NCT04971785|559013540|FG001|Overall Study|Death|1|||
154889052|NCT04971785|559013541|FG002|Overall Study|Death|1|||
154889053|NCT04971785|559013542|FG003|Overall Study|Death|0|||
154889054|NCT04971785|559013539|FG000|Overall Study|Site Terminated by Sponsor|1|||
154889055|NCT04971785|559013540|FG001|Overall Study|Site Terminated by Sponsor|1|||
154889056|NCT04971785|559013541|FG002|Overall Study|Site Terminated by Sponsor|0|||
154889057|NCT04971785|559013542|FG003|Overall Study|Site Terminated by Sponsor|0|||
154889058|NCT01255306|559015317|FG000|Overall Study|Physician Decision|1|||
154889059|NCT01255306|559015318|FG001|Overall Study|Physician Decision|1|||
154889060|NCT03363919|559015326|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
154889061|NCT03363919|559015327|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
154889062|NCT03363919|559015326|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
154889063|NCT03363919|559015327|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
154889064|NCT01975246|559015328|FG000|Overall Study|Adverse Event|2|||
154889065|NCT01975246|559015329|FG001|Overall Study|Adverse Event|1|||
154889066|NCT01975246|559015328|FG000|Overall Study|Lack of Efficacy|1|||
154889067|NCT01975246|559015329|FG001|Overall Study|Lack of Efficacy|0|||
154889068|NCT01975246|559015328|FG000|Overall Study|Protocol Violation|1|||
154889069|NCT01975246|559015329|FG001|Overall Study|Protocol Violation|0|||
154889070|NCT01975246|559015328|FG000|Overall Study|Other than stated|0|||
154889071|NCT01975246|559015329|FG001|Overall Study|Other than stated|1|||
154889072|NCT01646398|559015330|FG000|Overall Study|Withdrawal by Subject|1|||
154889073|NCT01646398|559015331|FG001|Overall Study|Withdrawal by Subject|0|||
154889074|NCT01263093|559015332|FG000|Washout|Physician Decision|1|||
154889075|NCT01263093|559015333|FG001|Washout|Physician Decision|0|||
154889076|NCT01263093|559015332|FG000|Period 2|Adverse Event|1|||
154889077|NCT01263093|559015333|FG001|Period 2|Adverse Event|0|||
154889078|NCT01827319|559015334|FG000|Overall Study|Lost to Follow-up|3|||
154889079|NCT02062463|559015339|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
154889080|NCT02062463|559015340|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
154889081|NCT02062463|559015341|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
154889082|NCT02062463|559015342|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
154889083|NCT02062463|559015339|FG000|Stage 2|Adverse Event|0|||
154889084|NCT02062463|559015340|FG001|Stage 2|Adverse Event|0|||
154889085|NCT02062463|559015341|FG002|Stage 2|Adverse Event|12|||
154889086|NCT02062463|559015342|FG003|Stage 2|Adverse Event|20|||
154889087|NCT02062463|559015339|FG000|Stage 2|Lack of Efficacy|0|||
154889088|NCT02062463|559015340|FG001|Stage 2|Lack of Efficacy|0|||
154889089|NCT02062463|559015341|FG002|Stage 2|Lack of Efficacy|3|||
154889090|NCT02062463|559015342|FG003|Stage 2|Lack of Efficacy|4|||
154889091|NCT02062463|559015339|FG000|Stage 2|Lost to Follow-up|0|||
154889092|NCT02062463|559015340|FG001|Stage 2|Lost to Follow-up|0|||
154889093|NCT02062463|559015341|FG002|Stage 2|Lost to Follow-up|20|||
154889094|NCT02062463|559015342|FG003|Stage 2|Lost to Follow-up|20|||
154889095|NCT02062463|559015339|FG000|Stage 2|Non-Compliance|0|||
154889096|NCT02062463|559015340|FG001|Stage 2|Non-Compliance|0|||
154889097|NCT02062463|559015341|FG002|Stage 2|Non-Compliance|0|||
154889098|NCT02062463|559015342|FG003|Stage 2|Non-Compliance|1|||
154889099|NCT02062463|559015339|FG000|Stage 2|Other than specified|0|||
154889100|NCT02062463|559015340|FG001|Stage 2|Other than specified|0|||
154889101|NCT02062463|559015341|FG002|Stage 2|Other than specified|3|||
154889102|NCT02062463|559015342|FG003|Stage 2|Other than specified|1|||
154889103|NCT02062463|559015339|FG000|Stage 2|Withdrawal by Subject|0|||
154889104|NCT02062463|559015340|FG001|Stage 2|Withdrawal by Subject|0|||
154889105|NCT02062463|559015341|FG002|Stage 2|Withdrawal by Subject|15|||
154889106|NCT02062463|559015342|FG003|Stage 2|Withdrawal by Subject|10|||
154889107|NCT00600028|559015353|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
154889108|NCT00600028|559015354|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
154889109|NCT00600028|559015353|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
154889110|NCT00600028|559015354|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
154889111|NCT00600028|559015353|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
154889112|NCT00600028|559015354|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
154889113|NCT02716194|559015355|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
154889114|NCT02716194|559015356|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
154889115|NCT02716194|559015357|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
154889116|NCT00363051|559015358|FG000|Overall Study|Adminstrative problems|1|||
154889117|NCT00363051|559015359|FG001|Overall Study|Adminstrative problems|1|||
154889118|NCT00363051|559015358|FG000|Overall Study|Adverse Event|21|||
154889119|NCT00363051|559015359|FG001|Overall Study|Adverse Event|12|||
154889120|NCT00363051|559015358|FG000|Overall Study|New Cancer Therapy|2|||
154889121|NCT00363051|559015359|FG001|Overall Study|New Cancer Therapy|1|||
154889122|NCT00363051|559015358|FG000|Overall Study|Withdrawal by Subject|11|||
154889123|NCT00363051|559015359|FG001|Overall Study|Withdrawal by Subject|3|||
154889124|NCT00363051|559015358|FG000|Overall Study|Lost to Follow-up|0|||
154889125|NCT00363051|559015359|FG001|Overall Study|Lost to Follow-up|1|||
154889126|NCT00363051|559015358|FG000|Overall Study|Protocol Violation|0|||
154889127|NCT00363051|559015359|FG001|Overall Study|Protocol Violation|2|||
154889128|NCT00363051|559015358|FG000|Overall Study|Death|3|||
154889129|NCT00363051|559015359|FG001|Overall Study|Death|2|||
154889130|NCT01107405|559015363|FG000|Overall Study|Adverse Event|1|||
154889131|NCT01107405|559015364|FG001|Overall Study|Adverse Event|1|||
154889132|NCT01107405|559015365|FG002|Overall Study|Adverse Event|0|||
154889133|NCT01107405|559015366|FG003|Overall Study|Adverse Event|0|||
154889134|NCT01107405|559015367|FG004|Overall Study|Adverse Event|2|||
154889135|NCT01107405|559015363|FG000|Overall Study|Withdrawal by Subject|1|||
154889136|NCT01107405|559015364|FG001|Overall Study|Withdrawal by Subject|0|||
154889137|NCT01107405|559015365|FG002|Overall Study|Withdrawal by Subject|1|||
154889138|NCT01107405|559015366|FG003|Overall Study|Withdrawal by Subject|2|||
154889139|NCT01107405|559015367|FG004|Overall Study|Withdrawal by Subject|1|||
154889140|NCT01107405|559015363|FG000|Overall Study|Protocol Violation|0|||
154889141|NCT01107405|559015364|FG001|Overall Study|Protocol Violation|0|||
154889142|NCT01107405|559015365|FG002|Overall Study|Protocol Violation|1|||
154889143|NCT01107405|559015366|FG003|Overall Study|Protocol Violation|1|||
154889144|NCT01107405|559015367|FG004|Overall Study|Protocol Violation|0|||
154889145|NCT01170702|559015375|FG000|Overall Study|Exclusion criteria met after consent|1|||
154889146|NCT01170702|559015376|FG001|Overall Study|Exclusion criteria met after consent|2|||
154889147|NCT01170702|559015377|FG002|Overall Study|Exclusion criteria met after consent|0|||
154889148|NCT01170702|559015378|FG003|Overall Study|Exclusion criteria met after consent|2|||
154889149|NCT01677507|559015379|FG000|Initial Assignment|Adverse Event|0|||
154889150|NCT01677507|559015380|FG001|Initial Assignment|Adverse Event|1|||
154889151|NCT01677507|559015379|FG000|Initial Assignment|Protocol Violation|0|||
154889152|NCT01677507|559015380|FG001|Initial Assignment|Protocol Violation|1|||
154889153|NCT01677507|559015379|FG000|Second Assigment|Withdrawal by Subject|2|||
155113834|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
155113835|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
154889154|NCT01677507|559015380|FG001|Second Assigment|Withdrawal by Subject|2|||
154889155|NCT01677507|559015379|FG000|Second Assigment|Adverse Event|1|||
154889156|NCT01677507|559015380|FG001|Second Assigment|Adverse Event|3|||
154889157|NCT03779334|559015381|FG000|Overall Study|Withdrawal by Subject|3|||
154889158|NCT03779334|559015382|FG001|Overall Study|Withdrawal by Subject|0|||
154889159|NCT03779334|559015383|FG002|Overall Study|Withdrawal by Subject|0|||
154889160|NCT03779334|559015381|FG000|Overall Study|Ongoing in Study|5|||
154889161|NCT03779334|559015382|FG001|Overall Study|Ongoing in Study|13|||
154889162|NCT03779334|559015383|FG002|Overall Study|Ongoing in Study|5|||
154889163|NCT00085917|559015384|FG000|Overall Study|Adverse Event|4|||
154889164|NCT00085917|559015385|FG001|Overall Study|Adverse Event|3|||
154889165|NCT01103778|559015388|FG000|Overall Study|Lost to Follow-up|1|||
154889166|NCT01103778|559015388|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
154889167|NCT01103778|559015388|FG000|Overall Study|Screen failure|1|||
154889168|NCT03670641|559015393|FG000|Overall Study|Lost to Follow-up|3|||
154889169|NCT00125190|559015399|FG000|Overall Study|Subject/Parent Decision|7|||
154889170|NCT00125190|559015399|FG000|Overall Study|Non-compliance|2|||
154889171|NCT00125190|559015399|FG000|Overall Study|Adverse Event|1|||
154889172|NCT00125190|559015399|FG000|Overall Study|Other|1|||
154889173|NCT00125190|559015399|FG000|Overall Study|Lost to Follow-up|4|||
154889174|NCT00916370|559015400|FG000|Overall Study|Death|3|||
154889175|NCT00916370|559015401|FG001|Overall Study|Death|1|||
154889176|NCT00916370|559015400|FG000|Overall Study|Withdrawal by Subject|2|||
154889177|NCT00916370|559015401|FG001|Overall Study|Withdrawal by Subject|0|||
154889178|NCT00916370|559015400|FG000|Overall Study|Physician Decision|0|||
154889179|NCT00916370|559015401|FG001|Overall Study|Physician Decision|1|||
154889180|NCT00414960|559015402|FG000|Overall Study|Adverse Event|4|||
154889181|NCT00414960|559015403|FG001|Overall Study|Adverse Event|0|||
154889182|NCT00414960|559015402|FG000|Overall Study|Withdrawal by Subject|3|||
154889183|NCT00414960|559015403|FG001|Overall Study|Withdrawal by Subject|0|||
154889184|NCT00414960|559015402|FG000|Overall Study|Physician Decision|0|||
154889185|NCT00414960|559015403|FG001|Overall Study|Physician Decision|1|||
154889186|NCT03722784|559015404|FG000|Overall Study|Withdrawal by Subject|1|||
154889187|NCT03722784|559015405|FG001|Overall Study|Withdrawal by Subject|0|||
154889188|NCT03722784|559015404|FG000|Overall Study|Physician Decision|1|||
154889189|NCT03722784|559015405|FG001|Overall Study|Physician Decision|1|||
154889190|NCT03722784|559015404|FG000|Overall Study|Protocol Violation|0|||
154889191|NCT03722784|559015405|FG001|Overall Study|Protocol Violation|1|||
154889192|NCT04465396|559015406|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
154889193|NCT04465396|559015407|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
154889194|NCT04465396|559015408|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
154889195|NCT04465396|559015409|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
154889196|NCT01766817|559015411|FG000|Overall Study|Drug-related adverse event|1|||
154889197|NCT01766817|559015412|FG001|Overall Study|Drug-related adverse event|2|||
154889198|NCT01766817|559015413|FG002|Overall Study|Drug-related adverse event|1|||
154889199|NCT01766817|559015411|FG000|Overall Study|Drug-unrelated adverse event|3|||
154889200|NCT01766817|559015412|FG001|Overall Study|Drug-unrelated adverse event|3|||
154889201|NCT01766817|559015413|FG002|Overall Study|Drug-unrelated adverse event|3|||
154889202|NCT01766817|559015411|FG000|Overall Study|Death|1|||
154889203|NCT01766817|559015412|FG001|Overall Study|Death|1|||
154889204|NCT01766817|559015413|FG002|Overall Study|Death|0|||
154889205|NCT01766817|559015411|FG000|Overall Study|Unable to take study drug|0|||
154889206|NCT01766817|559015412|FG001|Overall Study|Unable to take study drug|1|||
154889207|NCT01766817|559015413|FG002|Overall Study|Unable to take study drug|0|||
154889208|NCT01766817|559015411|FG000|Overall Study|Withdrawal by Subject|2|||
154889209|NCT01766817|559015412|FG001|Overall Study|Withdrawal by Subject|0|||
154889210|NCT01766817|559015413|FG002|Overall Study|Withdrawal by Subject|3|||
154889211|NCT01766817|559015411|FG000|Overall Study|Subject non-compliance|0|||
154889212|NCT01766817|559015412|FG001|Overall Study|Subject non-compliance|1|||
154889213|NCT01766817|559015413|FG002|Overall Study|Subject non-compliance|2|||
154889214|NCT01766817|559015411|FG000|Overall Study|Physician Decision|3|||
154889215|NCT01766817|559015412|FG001|Overall Study|Physician Decision|3|||
154889216|NCT01766817|559015413|FG002|Overall Study|Physician Decision|4|||
154889217|NCT01766817|559015411|FG000|Overall Study|Other|1|||
154889218|NCT01766817|559015412|FG001|Overall Study|Other|0|||
154889219|NCT01766817|559015413|FG002|Overall Study|Other|0|||
154889220|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
154889221|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
154889222|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
155113836|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
155113837|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
155113838|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
155113839|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
155113840|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
154889223|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
154889224|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
154889225|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
154889226|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
154889227|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
154889228|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
154889229|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
154889230|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
154889231|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
154889232|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
154977503|NCT02412722|559340878|FG000|Overall Study|Reason not Specified|3|||
154977504|NCT02412722|559340879|FG001|Overall Study|Reason not Specified|0|||
154889233|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
154889234|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
154889235|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
154889236|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
154889237|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
154889238|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
154977505|NCT02412722|559340880|FG002|Overall Study|Reason not Specified|2|||
154977506|NCT02412722|559340881|FG003|Overall Study|Reason not Specified|1|||
154977507|NCT02412722|559340882|FG004|Overall Study|Reason not Specified|2|||
154977508|NCT02412722|559340883|FG005|Overall Study|Reason not Specified|6|||
154977509|NCT00869440|559340884|FG000|Overall Study|Withdrawal by Subject|1|||
154977510|NCT00869440|559340885|FG001|Overall Study|Withdrawal by Subject|0|||
154977511|NCT00869440|559340886|FG002|Overall Study|Withdrawal by Subject|0|||
154977512|NCT00869440|559340887|FG003|Overall Study|Withdrawal by Subject|0|||
154977513|NCT00869440|559340884|FG000|Overall Study|Physician Decision|1|||
154977514|NCT00869440|559340885|FG001|Overall Study|Physician Decision|1|||
154977515|NCT00869440|559340886|FG002|Overall Study|Physician Decision|0|||
154977516|NCT00869440|559340887|FG003|Overall Study|Physician Decision|0|||
154977517|NCT04314843|559340888|FG000|Overall Study|Death|2|||
154977518|NCT04314843|559340889|FG001|Overall Study|Death|2|||
154977519|NCT04314843|559340888|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
154977520|NCT04314843|559340889|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
154977521|NCT00551616|559340892|FG000|Overall Study|Lost to Follow-up|48|||
154977522|NCT00551616|559340893|FG001|Overall Study|Lost to Follow-up|40|||
154977523|NCT02692482|559340894|FG000|Overall Study|Death|2|||
154977524|NCT02692482|559340895|FG001|Overall Study|Death|2|||
154977525|NCT02692482|559340894|FG000|Overall Study|Withdrawal by Subject|1|||
154977526|NCT02692482|559340895|FG001|Overall Study|Withdrawal by Subject|2|||
154977527|NCT00105157|559340896|FG000|Double-Blind (DB)|Never Treated|1|||
154977528|NCT00105157|559340897|FG001|Double-Blind (DB)|Never Treated|0|||
154977529|NCT00105157|559340898|FG002|Double-Blind (DB)|Never Treated|0|||
154977530|NCT00105157|559340899|FG003|Double-Blind (DB)|Never Treated|0|||
154977531|NCT00105157|559340896|FG000|Double-Blind (DB)|Adverse Event|2|||
154977532|NCT00105157|559340897|FG001|Double-Blind (DB)|Adverse Event|0|||
154977533|NCT00105157|559340898|FG002|Double-Blind (DB)|Adverse Event|1|||
154977534|NCT00105157|559340899|FG003|Double-Blind (DB)|Adverse Event|1|||
154977535|NCT00105157|559340896|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
154977536|NCT00105157|559340897|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
154977537|NCT00105157|559340898|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
154977538|NCT00105157|559340899|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
154977539|NCT00105157|559340896|FG000|Open-Label Continuation of DB|Adverse Event|3|||
154977540|NCT00105157|559340897|FG001|Open-Label Continuation of DB|Adverse Event|1|||
154977541|NCT00105157|559340898|FG002|Open-Label Continuation of DB|Adverse Event|0|||
154977542|NCT00105157|559340899|FG003|Open-Label Continuation of DB|Adverse Event|0|||
154977543|NCT00105157|559340896|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
154977544|NCT00105157|559340897|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
154977545|NCT00105157|559340898|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
154977546|NCT00105157|559340899|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
154977547|NCT00105157|559340896|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
154977548|NCT00105157|559340897|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
154977549|NCT00105157|559340898|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
155113841|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
154889239|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
154889240|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
154977550|NCT00105157|559340899|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
154977551|NCT00105157|559340896|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
154977552|NCT00105157|559340897|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
154977553|NCT00105157|559340898|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
154977554|NCT00105157|559340899|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
154977555|NCT00105157|559340896|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
154977556|NCT00105157|559340897|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
154977557|NCT00105157|559340898|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
154977558|NCT00105157|559340899|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
155113842|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
155113843|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Not compliant|1|||
155113844|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Not compliant|0|||
155113845|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Not compliant|0|||
155113846|NCT01461928|559846156|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
155113847|NCT01461928|559846157|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
154977559|NCT00105157|559340896|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
154977560|NCT00105157|559340897|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
154977561|NCT00105157|559340898|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
154977562|NCT00105157|559340899|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
154977563|NCT00105157|559340896|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
154977564|NCT00105157|559340897|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
154977565|NCT00105157|559340898|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
154977566|NCT00105157|559340899|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
154977567|NCT00105157|559340896|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
154977568|NCT00105157|559340897|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
154977569|NCT00105157|559340898|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
154977570|NCT00105157|559340899|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
154977571|NCT00105157|559340896|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
154977572|NCT00105157|559340897|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
154977573|NCT00105157|559340898|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
154977574|NCT00105157|559340899|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
154977575|NCT00105157|559340896|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
154977576|NCT00105157|559340897|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
154977577|NCT00105157|559340898|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
154977578|NCT00105157|559340899|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
154977579|NCT00105157|559340896|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
154977580|NCT00105157|559340897|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
154977581|NCT00105157|559340898|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
154977582|NCT00105157|559340899|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
154977583|NCT03689894|559340900|FG000|Overall Study|Adverse Event|1|||
154977584|NCT01610063|559340905|FG000|Overall Study|Lost to Follow-up|42|||
154977585|NCT01610063|559340906|FG001|Overall Study|Lost to Follow-up|20|||
154977586|NCT04405739|559340911|FG000|Overall Study|Adverse Event|0|||
154977587|NCT04405739|559340912|FG001|Overall Study|Adverse Event|1|||
154977588|NCT04405739|559340913|FG002|Overall Study|Adverse Event|0|||
154977589|NCT04405739|559340914|FG003|Overall Study|Adverse Event|0|||
154977590|NCT04405739|559340911|FG000|Overall Study|Lost to Follow-up|0|||
154977591|NCT04405739|559340912|FG001|Overall Study|Lost to Follow-up|2|||
154977592|NCT04405739|559340913|FG002|Overall Study|Lost to Follow-up|1|||
154977593|NCT04405739|559340914|FG003|Overall Study|Lost to Follow-up|3|||
154977594|NCT04405739|559340911|FG000|Overall Study|Withdrawal by Subject|0|||
154977595|NCT04405739|559340912|FG001|Overall Study|Withdrawal by Subject|2|||
154977596|NCT04405739|559340913|FG002|Overall Study|Withdrawal by Subject|1|||
154977597|NCT04405739|559340914|FG003|Overall Study|Withdrawal by Subject|1|||
154977598|NCT04405739|559340911|FG000|Overall Study|Death|0|||
154977599|NCT04405739|559340912|FG001|Overall Study|Death|0|||
154977600|NCT04405739|559340913|FG002|Overall Study|Death|1|||
154977601|NCT04405739|559340914|FG003|Overall Study|Death|0|||
154977602|NCT04405739|559340911|FG000|Overall Study|Transferred to rehab|0|||
154977603|NCT04405739|559340912|FG001|Overall Study|Transferred to rehab|0|||
154977604|NCT04405739|559340913|FG002|Overall Study|Transferred to rehab|0|||
154977605|NCT04405739|559340914|FG003|Overall Study|Transferred to rehab|1|||
154977606|NCT04405739|559340911|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
154977607|NCT04405739|559340912|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
154977608|NCT04405739|559340913|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
154977609|NCT04405739|559340914|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
155113848|NCT01461928|559846158|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
154889241|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
154889242|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
154889243|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
154889244|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
154889245|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
154889246|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
154889247|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
154889248|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
154889249|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
154889250|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
154889251|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
154889252|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
154889253|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
154889254|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
154889255|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
154889256|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
154889257|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
154889258|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
154889259|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
154889260|NCT00383721|559015414|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
154889261|NCT00383721|559015415|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
154889262|NCT00383721|559015416|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
154889263|NCT00383721|559015417|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
154889264|NCT00383721|559015418|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
154889265|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
154889266|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
154889267|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
154889268|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
154889269|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
154889270|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
154889271|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
154889272|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
154889273|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
154889274|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
154889275|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
154889276|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
154889277|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
154889278|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
154889279|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
154889280|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
154889281|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
154889282|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
154889283|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
154889284|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
154889285|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
154889286|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
154889287|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
154889288|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
154889289|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
154889290|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
154889291|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
154889292|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
154889293|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
154889294|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
154889295|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
154889296|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
154889297|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
154889298|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
154889299|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
154889300|NCT00383721|559015414|FG000|26-Week Treatment Safety Extension|Administrative|1|||
154889301|NCT00383721|559015415|FG001|26-Week Treatment Safety Extension|Administrative|2|||
154889302|NCT00383721|559015416|FG002|26-Week Treatment Safety Extension|Administrative|3|||
154889303|NCT00383721|559015417|FG003|26-Week Treatment Safety Extension|Administrative|1|||
154889304|NCT00383721|559015418|FG004|26-Week Treatment Safety Extension|Administrative|0|||
154889305|NCT03814590|559015419|FG000|Overall Study|Adverse Event|0|||
154889306|NCT03814590|559015420|FG001|Overall Study|Adverse Event|0|||
154889307|NCT03814590|559015421|FG002|Overall Study|Adverse Event|0|||
154889308|NCT03814590|559015422|FG003|Overall Study|Adverse Event|0|||
154889309|NCT03814590|559015423|FG004|Overall Study|Adverse Event|0|||
154889310|NCT03814590|559015424|FG005|Overall Study|Adverse Event|1|||
154889311|NCT03814590|559015425|FG006|Overall Study|Adverse Event|1|||
154889312|NCT03814590|559015426|FG007|Overall Study|Adverse Event|1|||
154889313|NCT03814590|559015427|FG008|Overall Study|Adverse Event|0|||
154889314|NCT03814590|559015428|FG009|Overall Study|Adverse Event|0|||
154889315|NCT03814590|559015429|FG010|Overall Study|Adverse Event|1|||
154889316|NCT03814590|559015430|FG011|Overall Study|Adverse Event|0|||
154889317|NCT03814590|559015431|FG012|Overall Study|Adverse Event|3|||
154889318|NCT03814590|559015432|FG013|Overall Study|Adverse Event|0|||
154889319|NCT03814590|559015419|FG000|Overall Study|Lost to Follow-up|0|||
154889320|NCT03814590|559015420|FG001|Overall Study|Lost to Follow-up|2|||
154889321|NCT03814590|559015421|FG002|Overall Study|Lost to Follow-up|1|||
154889322|NCT03814590|559015422|FG003|Overall Study|Lost to Follow-up|0|||
154889323|NCT03814590|559015423|FG004|Overall Study|Lost to Follow-up|1|||
155113849|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Adverse Event|0|||
155113850|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Adverse Event|2|||
155113851|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Adverse Event|0|||
155113852|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Death|0|||
155113853|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Death|10|||
155113854|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Death|8|||
155113855|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Physician Decision|0|||
155113856|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Physician Decision|0|||
155113857|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Physician Decision|4|||
155175486|NCT00895011|560080256|FG002|Overall Study|schedule conflict|0|||
154889324|NCT03814590|559015424|FG005|Overall Study|Lost to Follow-up|1|||
154889325|NCT03814590|559015425|FG006|Overall Study|Lost to Follow-up|1|||
154889326|NCT03814590|559015426|FG007|Overall Study|Lost to Follow-up|1|||
154889327|NCT03814590|559015427|FG008|Overall Study|Lost to Follow-up|0|||
154889328|NCT03814590|559015428|FG009|Overall Study|Lost to Follow-up|0|||
154889329|NCT03814590|559015429|FG010|Overall Study|Lost to Follow-up|1|||
154889330|NCT03814590|559015430|FG011|Overall Study|Lost to Follow-up|0|||
154889331|NCT03814590|559015431|FG012|Overall Study|Lost to Follow-up|0|||
154889332|NCT03814590|559015432|FG013|Overall Study|Lost to Follow-up|1|||
154889333|NCT03814590|559015419|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889334|NCT03814590|559015420|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889335|NCT03814590|559015421|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889336|NCT03814590|559015422|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889337|NCT03814590|559015423|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889338|NCT03814590|559015424|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889339|NCT03814590|559015425|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889340|NCT03814590|559015426|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889341|NCT03814590|559015427|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889342|NCT03814590|559015428|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
154889343|NCT03814590|559015429|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889344|NCT03814590|559015430|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889345|NCT03814590|559015431|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889346|NCT03814590|559015432|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
154889347|NCT03814590|559015419|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889348|NCT03814590|559015420|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889349|NCT03814590|559015421|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889350|NCT03814590|559015422|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889351|NCT03814590|559015423|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889352|NCT03814590|559015424|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
154889353|NCT03814590|559015425|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
154889354|NCT03814590|559015426|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
154889355|NCT03814590|559015427|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889356|NCT03814590|559015428|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
154889357|NCT03814590|559015429|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
154889358|NCT03814590|559015430|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
154889359|NCT03814590|559015431|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
154889360|NCT03814590|559015432|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
154889361|NCT03814590|559015419|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889362|NCT03814590|559015420|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889363|NCT03814590|559015421|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889364|NCT03814590|559015422|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889365|NCT03814590|559015423|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889366|NCT03814590|559015424|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889367|NCT03814590|559015425|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889368|NCT03814590|559015426|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154889369|NCT03814590|559015427|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889370|NCT03814590|559015428|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154977610|NCT01378962|559340916|FG000|Overall Study|Death|14|||
155113858|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
155113859|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
155113860|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
155175487|NCT03859973|560080257|FG000|Overall Study|Other reason than listed|3|||
155175488|NCT03859973|560080258|FG001|Overall Study|Other reason than listed|2|||
155175489|NCT03859973|560080257|FG000|Overall Study|COVID-19 related, not due to AE|3|||
155175490|NCT03859973|560080258|FG001|Overall Study|COVID-19 related, not due to AE|4|||
155175491|NCT03859973|560080257|FG000|Overall Study|Withdrawal by Subject|8|||
155175492|NCT03859973|560080258|FG001|Overall Study|Withdrawal by Subject|9|||
155175493|NCT03859973|560080257|FG000|Overall Study|Lost to Follow-up|2|||
154889371|NCT03814590|559015429|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889372|NCT03814590|559015430|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889373|NCT03814590|559015431|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889374|NCT03814590|559015432|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154889375|NCT03814590|559015419|FG000|Overall Study|UNKNOWN REASON|0|||
154889376|NCT03814590|559015420|FG001|Overall Study|UNKNOWN REASON|0|||
154889377|NCT03814590|559015421|FG002|Overall Study|UNKNOWN REASON|0|||
154889378|NCT03814590|559015422|FG003|Overall Study|UNKNOWN REASON|0|||
154889379|NCT03814590|559015423|FG004|Overall Study|UNKNOWN REASON|0|||
154889380|NCT03814590|559015424|FG005|Overall Study|UNKNOWN REASON|0|||
154889381|NCT03814590|559015425|FG006|Overall Study|UNKNOWN REASON|0|||
154889382|NCT03814590|559015426|FG007|Overall Study|UNKNOWN REASON|1|||
154889383|NCT03814590|559015427|FG008|Overall Study|UNKNOWN REASON|0|||
154889384|NCT03814590|559015428|FG009|Overall Study|UNKNOWN REASON|0|||
154889385|NCT03814590|559015429|FG010|Overall Study|UNKNOWN REASON|0|||
154889386|NCT03814590|559015430|FG011|Overall Study|UNKNOWN REASON|0|||
154889387|NCT03814590|559015431|FG012|Overall Study|UNKNOWN REASON|0|||
154889388|NCT03814590|559015432|FG013|Overall Study|UNKNOWN REASON|0|||
154889389|NCT03519516|559015438|FG000|Overall Study|Adverse Event|0|||
154889390|NCT03519516|559015439|FG001|Overall Study|Adverse Event|1|||
154889391|NCT05757427|559015443|FG000|Overall Study|Adverse Event|1|||
154889392|NCT05757427|559015443|FG000|Overall Study|Device deficiency|1|||
154889393|NCT05757427|559015443|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
154889394|NCT05757427|559015443|FG000|Overall Study|MWBI scan of only 1 breast|3|||
154889395|NCT05757427|559015443|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
154889396|NCT01283997|559017182|FG000|Overall Study|Physician Decision|8|||
154889397|NCT01283997|559017183|FG001|Overall Study|Physician Decision|10|||
154889398|NCT01283997|559017182|FG000|Overall Study|Withdrawal by Subject|3|||
154889399|NCT01283997|559017183|FG001|Overall Study|Withdrawal by Subject|2|||
154889400|NCT01283997|559017182|FG000|Overall Study|Physically unable to continue|0|||
154889401|NCT01283997|559017183|FG001|Overall Study|Physically unable to continue|1|||
154889402|NCT01283997|559017182|FG000|Overall Study|Progressive disease|1|||
154889403|NCT01283997|559017183|FG001|Overall Study|Progressive disease|0|||
154889404|NCT01283997|559017182|FG000|Overall Study|Other|4|||
154889405|NCT01283997|559017183|FG001|Overall Study|Other|4|||
154889406|NCT01179347|559017184|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
154889407|NCT01179347|559017185|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
154889408|NCT01179347|559017184|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
154889409|NCT01179347|559017185|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
154889410|NCT01179347|559017184|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
154889411|NCT01179347|559017185|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
154889412|NCT01179347|559017184|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
154889413|NCT01179347|559017185|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
154889414|NCT01179347|559017184|FG000|Double-blind Period (12 Weeks)|Other|2|||
154889415|NCT01179347|559017185|FG001|Double-blind Period (12 Weeks)|Other|4|||
154889416|NCT01179347|559017184|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
154889417|NCT01179347|559017185|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
154889418|NCT01179347|559017184|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
154889419|NCT01179347|559017185|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
154889420|NCT01179347|559017184|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
154889421|NCT01179347|559017185|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
154889422|NCT01179347|559017184|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
154889423|NCT01179347|559017185|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
154889424|NCT01179347|559017184|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
154889425|NCT01179347|559017185|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
154889426|NCT01179347|559017184|FG000|Open-label Period (12 Weeks)|Other|7|||
154889427|NCT01179347|559017185|FG001|Open-label Period (12 Weeks)|Other|4|||
154889428|NCT02109744|559017186|FG000|Overall Study|Death|1|||
155175494|NCT03859973|560080258|FG001|Overall Study|Lost to Follow-up|3|||
155175495|NCT03859973|560080257|FG000|Overall Study|Protocol Violation|1|||
154889429|NCT02109744|559017187|FG001|Overall Study|Death|1|||
154889430|NCT02109744|559017186|FG000|Overall Study|no marrow exam|1|||
154889431|NCT02109744|559017187|FG001|Overall Study|no marrow exam|0|||
154889432|NCT04095442|559017191|FG000|Overall Study|Lost to Follow-up|0|||
154889433|NCT04095442|559017192|FG001|Overall Study|Lost to Follow-up|1|||
154889434|NCT04095442|559017191|FG000|Overall Study|Screen failure|1|||
154889435|NCT04095442|559017192|FG001|Overall Study|Screen failure|0|||
154889436|NCT01677624|559017193|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
154889437|NCT01337167|559017194|FG000|Infant Series|Adverse Event|1|||
155175496|NCT03859973|560080258|FG001|Overall Study|Protocol Violation|3|||
154977611|NCT01378962|559340916|FG000|Overall Study|Lost to Follow-up|1|||
154977612|NCT01378962|559340916|FG000|Overall Study|Other|2|||
155175497|NCT03859973|560080257|FG000|Overall Study|Adverse Event|3|||
155175498|NCT03859973|560080258|FG001|Overall Study|Adverse Event|5|||
155175499|NCT03085914|560080259|FG000|Overall Study|Death|6|||
155175500|NCT03085914|560080260|FG001|Overall Study|Death|6|||
155175501|NCT03085914|560080261|FG002|Overall Study|Death|4|||
155175502|NCT03085914|560080262|FG003|Overall Study|Death|1|||
155175503|NCT03085914|560080263|FG004|Overall Study|Death|5|||
155175504|NCT03085914|560080264|FG005|Overall Study|Death|2|||
155175505|NCT03085914|560080265|FG006|Overall Study|Death|2|||
155175506|NCT03085914|560080259|FG000|Overall Study|Withdrawal by Subject|1|||
155175507|NCT03085914|560080260|FG001|Overall Study|Withdrawal by Subject|1|||
155175508|NCT03085914|560080261|FG002|Overall Study|Withdrawal by Subject|2|||
155175509|NCT03085914|560080262|FG003|Overall Study|Withdrawal by Subject|2|||
155175510|NCT03085914|560080263|FG004|Overall Study|Withdrawal by Subject|2|||
155175511|NCT03085914|560080264|FG005|Overall Study|Withdrawal by Subject|0|||
155175512|NCT03085914|560080265|FG006|Overall Study|Withdrawal by Subject|1|||
155175513|NCT03085914|560080259|FG000|Overall Study|Lost to Follow-up|0|||
155175514|NCT03085914|560080260|FG001|Overall Study|Lost to Follow-up|0|||
154889438|NCT01337167|559017195|FG001|Infant Series|Adverse Event|1|||
155175515|NCT03085914|560080261|FG002|Overall Study|Lost to Follow-up|1|||
155175516|NCT03085914|560080262|FG003|Overall Study|Lost to Follow-up|0|||
155175517|NCT03085914|560080263|FG004|Overall Study|Lost to Follow-up|0|||
155175518|NCT03085914|560080264|FG005|Overall Study|Lost to Follow-up|1|||
155175519|NCT03085914|560080265|FG006|Overall Study|Lost to Follow-up|1|||
155175520|NCT03085914|560080259|FG000|Overall Study|Reason was not specified,|2|||
155175521|NCT03085914|560080260|FG001|Overall Study|Reason was not specified,|2|||
155175522|NCT03085914|560080261|FG002|Overall Study|Reason was not specified,|2|||
155175523|NCT03085914|560080262|FG003|Overall Study|Reason was not specified,|3|||
155175524|NCT03085914|560080263|FG004|Overall Study|Reason was not specified,|3|||
155175525|NCT03085914|560080264|FG005|Overall Study|Reason was not specified,|3|||
154889439|NCT01337167|559017194|FG000|Infant Series|Death|1|||
154889440|NCT01337167|559017195|FG001|Infant Series|Death|1|||
154889441|NCT01337167|559017194|FG000|Infant Series|Lost to Follow-up|13|||
154889442|NCT01337167|559017195|FG001|Infant Series|Lost to Follow-up|7|||
154889443|NCT01337167|559017194|FG000|Infant Series|Non-compliance with study drug|2|||
154889444|NCT01337167|559017195|FG001|Infant Series|Non-compliance with study drug|1|||
154889445|NCT01337167|559017194|FG000|Infant Series|Physician Decision|3|||
154889446|NCT01337167|559017195|FG001|Infant Series|Physician Decision|1|||
154889447|NCT01337167|559017194|FG000|Infant Series|Protocol Violation|22|||
154889448|NCT01337167|559017195|FG001|Infant Series|Protocol Violation|9|||
154889449|NCT01337167|559017194|FG000|Infant Series|Withdrawal by Subject|15|||
154889450|NCT01337167|559017195|FG001|Infant Series|Withdrawal by Subject|4|||
154889451|NCT01337167|559017194|FG000|Infant Series|Randomized but not vaccinated|5|||
154889452|NCT01337167|559017195|FG001|Infant Series|Randomized but not vaccinated|3|||
154889453|NCT01337167|559017194|FG000|Interim Period|Lost to Follow-up|51|||
154889454|NCT01337167|559017195|FG001|Interim Period|Lost to Follow-up|23|||
154889455|NCT01337167|559017194|FG000|Interim Period|Non-compliance with study drug|1|||
154889456|NCT01337167|559017195|FG001|Interim Period|Non-compliance with study drug|0|||
154889457|NCT01337167|559017194|FG000|Interim Period|Physician Decision|6|||
154889458|NCT01337167|559017195|FG001|Interim Period|Physician Decision|3|||
154889459|NCT01337167|559017194|FG000|Interim Period|Protocol Violation|5|||
154889460|NCT01337167|559017195|FG001|Interim Period|Protocol Violation|3|||
154889461|NCT01337167|559017194|FG000|Interim Period|Withdrawal by Subject|18|||
154889462|NCT01337167|559017195|FG001|Interim Period|Withdrawal by Subject|10|||
154889463|NCT01337167|559017194|FG000|Interim Period|Other protocol criterion not met|0|||
154889464|NCT01337167|559017195|FG001|Interim Period|Other protocol criterion not met|1|||
154889465|NCT01337167|559017194|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
154889466|NCT01337167|559017195|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
154889467|NCT01337167|559017194|FG000|Toddler Vaccinations|Protocol Violation|0|||
154889468|NCT01337167|559017195|FG001|Toddler Vaccinations|Protocol Violation|1|||
154977613|NCT02056652|559340917|FG000|Overall Study|Withdrawal by Subject|1|||
155175526|NCT03085914|560080265|FG006|Overall Study|Reason was not specified,|6|||
155175527|NCT03085914|560080259|FG000|Overall Study|Progressive Disease|0|||
155175528|NCT03085914|560080260|FG001|Overall Study|Progressive Disease|0|||
154889469|NCT01337167|559017194|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
154889470|NCT01337167|559017195|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
154889471|NCT03833817|559017200|FG000|Overall Study|Withdrawal by Subject|3|||
154889472|NCT03833817|559017201|FG001|Overall Study|Withdrawal by Subject|3|||
154889473|NCT03833817|559017200|FG000|Overall Study|Lost to Follow-up|3|||
154889474|NCT03833817|559017201|FG001|Overall Study|Lost to Follow-up|3|||
155175529|NCT03085914|560080261|FG002|Overall Study|Progressive Disease|2|||
155175530|NCT03085914|560080262|FG003|Overall Study|Progressive Disease|2|||
155175531|NCT03085914|560080263|FG004|Overall Study|Progressive Disease|1|||
155175532|NCT03085914|560080264|FG005|Overall Study|Progressive Disease|1|||
155175533|NCT03085914|560080265|FG006|Overall Study|Progressive Disease|1|||
155175534|NCT03085914|560080259|FG000|Overall Study|Study Terminated by the Sponsor|0|||
154889475|NCT00884221|559017202|FG000|Overall Study|Withdrawal by Subject|0|||
154889476|NCT00884221|559017203|FG001|Overall Study|Withdrawal by Subject|3|||
154889477|NCT00884221|559017202|FG000|Overall Study|Adverse Event|6|||
154889478|NCT00884221|559017203|FG001|Overall Study|Adverse Event|3|||
154889479|NCT00884221|559017202|FG000|Overall Study|Protocol Violation|16|||
154889480|NCT00884221|559017203|FG001|Overall Study|Protocol Violation|13|||
154889481|NCT00884221|559017202|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
154889482|NCT00884221|559017203|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
154889483|NCT02126670|559017204|FG000|Overall Study|Withdrawal by Subject|1|||
154889484|NCT02126670|559017205|FG001|Overall Study|Withdrawal by Subject|0|||
154889485|NCT02126670|559017206|FG002|Overall Study|Withdrawal by Subject|0|||
154889486|NCT02126670|559017207|FG003|Overall Study|Withdrawal by Subject|1|||
154889487|NCT00255034|559017210|FG000|Overall Study|Withdrawal by Subject|15|||
154889488|NCT00255034|559017211|FG001|Overall Study|Withdrawal by Subject|38|||
154889489|NCT00424346|559017212|FG000|Core Study|Adverse Event|5|||
154889490|NCT00424346|559017213|FG001|Core Study|Adverse Event|3|||
154889491|NCT00424346|559017214|FG002|Core Study|Adverse Event|1|||
154889492|NCT00424346|559017215|FG003|Core Study|Adverse Event|1|||
154889493|NCT00424346|559017212|FG000|Core Study|Abnormal Laboratory Values|0|||
154889494|NCT00424346|559017213|FG001|Core Study|Abnormal Laboratory Values|1|||
154889495|NCT00424346|559017214|FG002|Core Study|Abnormal Laboratory Values|0|||
154889496|NCT00424346|559017215|FG003|Core Study|Abnormal Laboratory Values|0|||
154889497|NCT00424346|559017212|FG000|Core Study|Lack of Efficacy|1|||
154889498|NCT00424346|559017213|FG001|Core Study|Lack of Efficacy|3|||
154889499|NCT00424346|559017214|FG002|Core Study|Lack of Efficacy|0|||
154889500|NCT00424346|559017215|FG003|Core Study|Lack of Efficacy|4|||
154889501|NCT00424346|559017212|FG000|Core Study|Withdrawal by Subject|1|||
154889502|NCT00424346|559017213|FG001|Core Study|Withdrawal by Subject|0|||
154889503|NCT00424346|559017214|FG002|Core Study|Withdrawal by Subject|0|||
154889504|NCT00424346|559017215|FG003|Core Study|Withdrawal by Subject|2|||
154889505|NCT00424346|559017212|FG000|Core Study|Lost to Follow-up|1|||
154889506|NCT00424346|559017213|FG001|Core Study|Lost to Follow-up|1|||
154889507|NCT00424346|559017214|FG002|Core Study|Lost to Follow-up|0|||
154889508|NCT00424346|559017215|FG003|Core Study|Lost to Follow-up|0|||
154889509|NCT00424346|559017212|FG000|Core Study|Administrative Problems|1|||
154889510|NCT00424346|559017213|FG001|Core Study|Administrative Problems|0|||
154889511|NCT00424346|559017214|FG002|Core Study|Administrative Problems|1|||
154889512|NCT00424346|559017215|FG003|Core Study|Administrative Problems|0|||
154889513|NCT00424346|559017212|FG000|Core Study|Protocol Violation|0|||
154889514|NCT00424346|559017213|FG001|Core Study|Protocol Violation|0|||
154889515|NCT00424346|559017214|FG002|Core Study|Protocol Violation|2|||
154889516|NCT00424346|559017215|FG003|Core Study|Protocol Violation|0|||
154889517|NCT00424346|559017212|FG000|Extension Phase|Adverse Event|0|||
154889518|NCT00424346|559017213|FG001|Extension Phase|Adverse Event|9|||
154889519|NCT00424346|559017214|FG002|Extension Phase|Adverse Event|5|||
154889520|NCT00424346|559017215|FG003|Extension Phase|Adverse Event|4|||
154889521|NCT00424346|559017212|FG000|Extension Phase|Lack of Efficacy|0|||
154889522|NCT00424346|559017213|FG001|Extension Phase|Lack of Efficacy|16|||
154889523|NCT00424346|559017214|FG002|Extension Phase|Lack of Efficacy|14|||
154889524|NCT00424346|559017215|FG003|Extension Phase|Lack of Efficacy|11|||
154889525|NCT00424346|559017212|FG000|Extension Phase|Withdrawal by Subject|0|||
154889526|NCT00424346|559017213|FG001|Extension Phase|Withdrawal by Subject|5|||
154889527|NCT00424346|559017214|FG002|Extension Phase|Withdrawal by Subject|3|||
154889528|NCT00424346|559017215|FG003|Extension Phase|Withdrawal by Subject|4|||
154889529|NCT00424346|559017212|FG000|Extension Phase|Lost to Follow-up|0|||
154889530|NCT00424346|559017213|FG001|Extension Phase|Lost to Follow-up|2|||
154889531|NCT00424346|559017214|FG002|Extension Phase|Lost to Follow-up|0|||
154889532|NCT00424346|559017215|FG003|Extension Phase|Lost to Follow-up|0|||
154889533|NCT00424346|559017212|FG000|Extension Phase|Administrative Problems|0|||
154889534|NCT00424346|559017213|FG001|Extension Phase|Administrative Problems|69|||
154889535|NCT00424346|559017214|FG002|Extension Phase|Administrative Problems|32|||
154977614|NCT02056652|559340918|FG001|Overall Study|Withdrawal by Subject|0|||
154889536|NCT00424346|559017215|FG003|Extension Phase|Administrative Problems|35|||
154889537|NCT00424346|559017212|FG000|Extension Phase|Death|0|||
154889538|NCT00424346|559017213|FG001|Extension Phase|Death|0|||
154889539|NCT00424346|559017214|FG002|Extension Phase|Death|0|||
154889540|NCT00424346|559017215|FG003|Extension Phase|Death|1|||
154889541|NCT00424346|559017212|FG000|Extension Phase|Protocol Violation|0|||
154889542|NCT00424346|559017213|FG001|Extension Phase|Protocol Violation|1|||
154889543|NCT00424346|559017214|FG002|Extension Phase|Protocol Violation|1|||
154889544|NCT00424346|559017215|FG003|Extension Phase|Protocol Violation|0|||
154889545|NCT03947255|559017217|FG000|Overall Study|Study Closure by Sponsor|2|||
154889546|NCT03947255|559017218|FG001|Overall Study|Study Closure by Sponsor|2|||
154889547|NCT03947255|559017217|FG000|Overall Study|Withdrawal by Subject|2|||
154889548|NCT03947255|559017218|FG001|Overall Study|Withdrawal by Subject|2|||
154889549|NCT03947255|559017217|FG000|Overall Study|Lost to Follow-up|2|||
154889550|NCT03947255|559017218|FG001|Overall Study|Lost to Follow-up|0|||
154889551|NCT03947255|559017217|FG000|Overall Study|Death|0|||
154977615|NCT02056652|559340917|FG000|Overall Study|Lost to Follow-up|0|||
154889552|NCT03947255|559017218|FG001|Overall Study|Death|2|||
154889553|NCT02499575|559017219|FG000|Overall Study|Protocol Violation|0|||
154889554|NCT02499575|559017220|FG001|Overall Study|Protocol Violation|1|||
154889555|NCT01245764|559017222|FG000|Study Phase A|Other|3|||
154889556|NCT01245764|559017223|FG001|Study Phase A|Other|2|||
154889557|NCT01245764|559017224|FG002|Study Phase A|Other|3|||
154889558|NCT01245764|559017225|FG003|Study Phase A|Other|1|||
154889559|NCT01245764|559017222|FG000|Study Phase A|Protocol Violation|6|||
154889560|NCT01245764|559017223|FG001|Study Phase A|Protocol Violation|3|||
154889561|NCT01245764|559017224|FG002|Study Phase A|Protocol Violation|2|||
154889562|NCT01245764|559017225|FG003|Study Phase A|Protocol Violation|2|||
154889563|NCT01245764|559017222|FG000|Study Phase A|Lost to Follow-up|0|||
154889564|NCT01245764|559017223|FG001|Study Phase A|Lost to Follow-up|0|||
154889565|NCT01245764|559017224|FG002|Study Phase A|Lost to Follow-up|5|||
154889566|NCT01245764|559017225|FG003|Study Phase A|Lost to Follow-up|0|||
154889567|NCT02667457|559017226|FG000|Overall Study|Withdrawal by Subject|1|||
154889568|NCT02667457|559017227|FG001|Overall Study|Withdrawal by Subject|0|||
154889569|NCT02667457|559017226|FG000|Overall Study|Other Reason|0|||
154889570|NCT02667457|559017227|FG001|Overall Study|Other Reason|2|||
154889571|NCT03297216|559017228|FG000|Overall Study|Death|0|||
154889572|NCT03297216|559017229|FG001|Overall Study|Death|1|||
154889573|NCT03297216|559017228|FG000|Overall Study|Miscarriage|0|||
154889574|NCT03297216|559017229|FG001|Overall Study|Miscarriage|2|||
154889575|NCT03297216|559017228|FG000|Overall Study|Lost to Follow-up|3|||
154889576|NCT03297216|559017229|FG001|Overall Study|Lost to Follow-up|2|||
154889577|NCT00781963|559017230|FG000|Overall Study|Death|3|||
154889578|NCT00781963|559017231|FG001|Overall Study|Death|0|||
154889579|NCT00781963|559017230|FG000|Overall Study|Lost to Follow-up|2|||
154889580|NCT00781963|559017231|FG001|Overall Study|Lost to Follow-up|1|||
154889581|NCT00781963|559017230|FG000|Overall Study|Withdrawal by Subject|3|||
154889582|NCT00781963|559017231|FG001|Overall Study|Withdrawal by Subject|1|||
154889583|NCT00781963|559017230|FG000|Overall Study|Refused follow-up|9|||
154889584|NCT00781963|559017231|FG001|Overall Study|Refused follow-up|0|||
154889585|NCT00436982|559017236|FG000|Overall Study|Withdrawal by Subject|3|||
154889586|NCT00436982|559017237|FG001|Overall Study|Withdrawal by Subject|1|||
154889587|NCT00436982|559017236|FG000|Overall Study|Did not receive allocated intervention|0|||
154889588|NCT00436982|559017237|FG001|Overall Study|Did not receive allocated intervention|1|||
154889589|NCT00436982|559017236|FG000|Overall Study|no RSA data|1|||
154889590|NCT00436982|559017237|FG001|Overall Study|no RSA data|2|||
154889591|NCT00953225|559017238|FG000|Overall Study|Withdrawal by Subject|2|||
154889592|NCT00953225|559017239|FG001|Overall Study|Withdrawal by Subject|0|||
154889593|NCT04058158|559017243|FG000|Period 1|Death|1|||
154889594|NCT04058158|559017244|FG001|Period 1|Death|0|||
154889595|NCT04058158|559017243|FG000|Period 1|Adverse Event|1|||
154889596|NCT04058158|559017244|FG001|Period 1|Adverse Event|1|||
154889597|NCT04058158|559017243|FG000|Period 1|Pregnancy|0|||
154889598|NCT04058158|559017244|FG001|Period 1|Pregnancy|1|||
154889599|NCT03172481|559017250|FG000|Double-blind|Withdrawal by Subject|1|||
154889600|NCT03172481|559017251|FG001|Double-blind|Withdrawal by Subject|0|||
154889601|NCT01830816|559017252|FG000|Overall Study|Progressive Disease|12|||
154889602|NCT01830816|559017253|FG001|Overall Study|Progressive Disease|7|||
154889603|NCT01830816|559017254|FG002|Overall Study|Progressive Disease|7|||
154889604|NCT01830816|559017252|FG000|Overall Study|Adverse Event|3|||
154889605|NCT01830816|559017253|FG001|Overall Study|Adverse Event|4|||
154977616|NCT02056652|559340918|FG001|Overall Study|Lost to Follow-up|3|||
155113861|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Moved to another town|0|||
154889606|NCT01830816|559017254|FG002|Overall Study|Adverse Event|0|||
154889607|NCT01830816|559017252|FG000|Overall Study|Study Terminated by Sponsor|1|||
154889608|NCT01830816|559017253|FG001|Overall Study|Study Terminated by Sponsor|1|||
154889609|NCT01830816|559017254|FG002|Overall Study|Study Terminated by Sponsor|0|||
154889610|NCT01830816|559017252|FG000|Overall Study|Withdrawal by Subject|1|||
154889611|NCT01830816|559017253|FG001|Overall Study|Withdrawal by Subject|1|||
154889612|NCT01830816|559017254|FG002|Overall Study|Withdrawal by Subject|0|||
154889613|NCT01830816|559017252|FG000|Overall Study|Lost to Follow-up|0|||
154889614|NCT01830816|559017253|FG001|Overall Study|Lost to Follow-up|1|||
154889615|NCT01830816|559017254|FG002|Overall Study|Lost to Follow-up|0|||
154889616|NCT01830816|559017252|FG000|Overall Study|Symptomatic Deterioration|1|||
154889617|NCT01830816|559017253|FG001|Overall Study|Symptomatic Deterioration|0|||
154889618|NCT01830816|559017254|FG002|Overall Study|Symptomatic Deterioration|0|||
154889619|NCT01830816|559017252|FG000|Overall Study|Reason not Specified|2|||
154889620|NCT01830816|559017253|FG001|Overall Study|Reason not Specified|0|||
154889621|NCT01830816|559017254|FG002|Overall Study|Reason not Specified|0|||
154889622|NCT02759562|559017255|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
154889623|NCT02759562|559017256|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
154889624|NCT02759562|559017255|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
154889625|NCT02759562|559017256|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
154889626|NCT02293993|559017257|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
154889627|NCT02293993|559017258|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
155175535|NCT03085914|560080260|FG001|Overall Study|Study Terminated by the Sponsor|0|||
155175536|NCT03085914|560080261|FG002|Overall Study|Study Terminated by the Sponsor|0|||
155175537|NCT03085914|560080262|FG003|Overall Study|Study Terminated by the Sponsor|1|||
155175538|NCT03085914|560080263|FG004|Overall Study|Study Terminated by the Sponsor|2|||
155175539|NCT03085914|560080264|FG005|Overall Study|Study Terminated by the Sponsor|1|||
155175540|NCT03085914|560080265|FG006|Overall Study|Study Terminated by the Sponsor|0|||
155175541|NCT01445548|560080267|FG000|Overall Study|Adverse Event|1|||
155175542|NCT00275821|560080269|FG000|Overall Study|Adverse Event|4|||
155175543|NCT00275821|560080270|FG001|Overall Study|Adverse Event|12|||
155175544|NCT00275821|560080271|FG002|Overall Study|Adverse Event|5|||
155175545|NCT00275821|560080269|FG000|Overall Study|Administrative problems|3|||
155175546|NCT00275821|560080270|FG001|Overall Study|Administrative problems|4|||
155175547|NCT00275821|560080271|FG002|Overall Study|Administrative problems|4|||
155175548|NCT00275821|560080269|FG000|Overall Study|Withdrawal by Subject|0|||
155175549|NCT00275821|560080270|FG001|Overall Study|Withdrawal by Subject|2|||
155175550|NCT00275821|560080271|FG002|Overall Study|Withdrawal by Subject|1|||
155175551|NCT00275821|560080269|FG000|Overall Study|Lost to Follow-up|0|||
155175552|NCT00275821|560080270|FG001|Overall Study|Lost to Follow-up|1|||
155175553|NCT00275821|560080271|FG002|Overall Study|Lost to Follow-up|1|||
155175554|NCT00275821|560080269|FG000|Overall Study|Death|0|||
155175555|NCT00275821|560080270|FG001|Overall Study|Death|2|||
155175556|NCT00275821|560080271|FG002|Overall Study|Death|1|||
155175557|NCT00275821|560080269|FG000|Overall Study|Lack of Efficacy|2|||
155175558|NCT00275821|560080270|FG001|Overall Study|Lack of Efficacy|1|||
155175559|NCT00275821|560080271|FG002|Overall Study|Lack of Efficacy|0|||
155175560|NCT00275821|560080269|FG000|Overall Study|Protocol Violation|5|||
154889628|NCT02293993|559017259|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
154889629|NCT02293993|559017260|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
154889630|NCT02293993|559017257|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
154889631|NCT02293993|559017258|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
154889632|NCT02293993|559017259|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
154889633|NCT02293993|559017260|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
154889634|NCT02293993|559017257|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
154889635|NCT02293993|559017258|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
154889636|NCT02293993|559017259|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
154889637|NCT02293993|559017260|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
154889638|NCT02293993|559017257|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
154889639|NCT02293993|559017258|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
154889640|NCT02293993|559017259|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
154889641|NCT02293993|559017260|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
154889642|NCT02293993|559017257|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
154889643|NCT02293993|559017258|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
154889644|NCT02293993|559017259|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
154889645|NCT02293993|559017260|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
154889646|NCT00830115|559017261|FG000|Overall Study|Adverse Event|2|||
154889647|NCT00830115|559017261|FG000|Overall Study|Improvement/recovery|1|||
154889648|NCT01061736|559017271|FG000|Overall Study|Dose regimen not selected|0|||
154889649|NCT01061736|559017272|FG001|Overall Study|Dose regimen not selected|0|||
154889650|NCT01061736|559017273|FG002|Overall Study|Dose regimen not selected|0|||
154889651|NCT01061736|559017274|FG003|Overall Study|Dose regimen not selected|0|||
154889652|NCT01061736|559017275|FG004|Overall Study|Dose regimen not selected|0|||
155175561|NCT00275821|560080270|FG001|Overall Study|Protocol Violation|1|||
155175562|NCT00275821|560080271|FG002|Overall Study|Protocol Violation|0|||
155175563|NCT01215916|560080272|FG000|Overall Study|Progressive Disease|0|||
155175564|NCT01215916|560080273|FG001|Overall Study|Progressive Disease|2|||
155175565|NCT01215916|560080274|FG002|Overall Study|Progressive Disease|1|||
155175566|NCT01215916|560080275|FG003|Overall Study|Progressive Disease|2|||
155175567|NCT01215916|560080276|FG004|Overall Study|Progressive Disease|5|||
155175568|NCT01215916|560080277|FG005|Overall Study|Progressive Disease|4|||
155175569|NCT01215916|560080278|FG006|Overall Study|Progressive Disease|5|||
155175570|NCT01215916|560080279|FG007|Overall Study|Progressive Disease|3|||
155175571|NCT01215916|560080280|FG008|Overall Study|Progressive Disease|1|||
155175572|NCT01215916|560080272|FG000|Overall Study|Adverse Event|1|||
155175573|NCT01215916|560080273|FG001|Overall Study|Adverse Event|1|||
155175574|NCT01215916|560080274|FG002|Overall Study|Adverse Event|0|||
155175575|NCT01215916|560080275|FG003|Overall Study|Adverse Event|1|||
155175576|NCT01215916|560080276|FG004|Overall Study|Adverse Event|0|||
155175577|NCT01215916|560080277|FG005|Overall Study|Adverse Event|0|||
155175578|NCT01215916|560080278|FG006|Overall Study|Adverse Event|3|||
155175579|NCT01215916|560080279|FG007|Overall Study|Adverse Event|0|||
154889653|NCT01061736|559017276|FG005|Overall Study|Dose regimen not selected|0|||
154889654|NCT01061736|559017277|FG006|Overall Study|Dose regimen not selected|79|||
154889655|NCT01061736|559017278|FG007|Overall Study|Dose regimen not selected|0|||
154889656|NCT01061736|559017279|FG008|Overall Study|Dose regimen not selected|0|||
154889657|NCT01061736|559017280|FG009|Overall Study|Dose regimen not selected|0|||
154889658|NCT01061736|559017271|FG000|Overall Study|Adverse Event|13|||
154889659|NCT01061736|559017272|FG001|Overall Study|Adverse Event|1|||
154889660|NCT01061736|559017273|FG002|Overall Study|Adverse Event|3|||
154889661|NCT01061736|559017274|FG003|Overall Study|Adverse Event|2|||
154889662|NCT01061736|559017275|FG004|Overall Study|Adverse Event|4|||
154889663|NCT01061736|559017276|FG005|Overall Study|Adverse Event|1|||
154889664|NCT01061736|559017277|FG006|Overall Study|Adverse Event|4|||
154889665|NCT01061736|559017278|FG007|Overall Study|Adverse Event|63|||
154889666|NCT01061736|559017279|FG008|Overall Study|Adverse Event|67|||
154889667|NCT01061736|559017280|FG009|Overall Study|Adverse Event|34|||
154889668|NCT01061736|559017271|FG000|Overall Study|Lack of Efficacy|0|||
154889669|NCT01061736|559017272|FG001|Overall Study|Lack of Efficacy|2|||
154889670|NCT01061736|559017273|FG002|Overall Study|Lack of Efficacy|1|||
154889671|NCT01061736|559017274|FG003|Overall Study|Lack of Efficacy|1|||
154889672|NCT01061736|559017275|FG004|Overall Study|Lack of Efficacy|1|||
154889673|NCT01061736|559017276|FG005|Overall Study|Lack of Efficacy|2|||
154889674|NCT01061736|559017277|FG006|Overall Study|Lack of Efficacy|1|||
154889675|NCT01061736|559017278|FG007|Overall Study|Lack of Efficacy|9|||
154889676|NCT01061736|559017279|FG008|Overall Study|Lack of Efficacy|9|||
154889677|NCT01061736|559017280|FG009|Overall Study|Lack of Efficacy|10|||
154889678|NCT01061736|559017271|FG000|Overall Study|Poor compliance to protocol|0|||
154889679|NCT01061736|559017272|FG001|Overall Study|Poor compliance to protocol|0|||
154889680|NCT01061736|559017273|FG002|Overall Study|Poor compliance to protocol|0|||
154889681|NCT01061736|559017274|FG003|Overall Study|Poor compliance to protocol|0|||
154889682|NCT01061736|559017275|FG004|Overall Study|Poor compliance to protocol|0|||
154889683|NCT01061736|559017276|FG005|Overall Study|Poor compliance to protocol|0|||
154889684|NCT01061736|559017277|FG006|Overall Study|Poor compliance to protocol|0|||
154889685|NCT01061736|559017278|FG007|Overall Study|Poor compliance to protocol|2|||
154889686|NCT01061736|559017279|FG008|Overall Study|Poor compliance to protocol|5|||
154889687|NCT01061736|559017280|FG009|Overall Study|Poor compliance to protocol|9|||
154889688|NCT01061736|559017271|FG000|Overall Study|Not treated|0|||
154889689|NCT01061736|559017272|FG001|Overall Study|Not treated|0|||
154889690|NCT01061736|559017273|FG002|Overall Study|Not treated|0|||
154889691|NCT01061736|559017274|FG003|Overall Study|Not treated|0|||
154889692|NCT01061736|559017275|FG004|Overall Study|Not treated|1|||
154889693|NCT01061736|559017276|FG005|Overall Study|Not treated|0|||
154889694|NCT01061736|559017277|FG006|Overall Study|Not treated|0|||
154889695|NCT01061736|559017278|FG007|Overall Study|Not treated|2|||
154889696|NCT01061736|559017279|FG008|Overall Study|Not treated|1|||
154889697|NCT01061736|559017280|FG009|Overall Study|Not treated|0|||
154889698|NCT01061736|559017271|FG000|Overall Study|Other than specified above|0|||
154889699|NCT01061736|559017272|FG001|Overall Study|Other than specified above|1|||
154889700|NCT01061736|559017273|FG002|Overall Study|Other than specified above|2|||
154889701|NCT01061736|559017274|FG003|Overall Study|Other than specified above|0|||
154889702|NCT01061736|559017275|FG004|Overall Study|Other than specified above|1|||
154889703|NCT01061736|559017276|FG005|Overall Study|Other than specified above|0|||
154889704|NCT01061736|559017277|FG006|Overall Study|Other than specified above|0|||
154889705|NCT01061736|559017278|FG007|Overall Study|Other than specified above|18|||
154889706|NCT01061736|559017279|FG008|Overall Study|Other than specified above|15|||
154977617|NCT01835548|559340921|FG000|Dose Optimization Period|Adverse Event|0|||
154977618|NCT01835548|559340922|FG001|Dose Optimization Period|Adverse Event|0|||
154977619|NCT01835548|559340923|FG002|Dose Optimization Period|Adverse Event|1|||
155113862|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Moved to another town|1|||
155113863|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Moved to another town|0|||
154889707|NCT01061736|559017280|FG009|Overall Study|Other than specified above|21|||
154889708|NCT03115112|559017281|FG000|Overall Study|Adverse Event|5|||
154889709|NCT03115112|559017282|FG001|Overall Study|Adverse Event|1|||
154889710|NCT03115112|559017281|FG000|Overall Study|Withdrawal by Subject|4|||
154889711|NCT03115112|559017282|FG001|Overall Study|Withdrawal by Subject|2|||
154889712|NCT03115112|559017281|FG000|Overall Study|Lost to Follow-up|0|||
154889713|NCT03115112|559017282|FG001|Overall Study|Lost to Follow-up|1|||
154889714|NCT03115112|559017281|FG000|Overall Study|Death|1|||
154889715|NCT03115112|559017282|FG001|Overall Study|Death|0|||
154889716|NCT03115112|559017281|FG000|Overall Study|Pregnancy|1|||
154889717|NCT03115112|559017282|FG001|Overall Study|Pregnancy|0|||
154889718|NCT03115112|559017281|FG000|Overall Study|Site closure|1|||
154889719|NCT03115112|559017282|FG001|Overall Study|Site closure|1|||
154889720|NCT01610076|559017283|FG000|Overall Study|Technical issue with video|0|||
154889721|NCT01610076|559017284|FG001|Overall Study|Technical issue with video|1|||
154889722|NCT01610076|559017283|FG000|Overall Study|Lost to Follow-up|3|||
154889723|NCT01610076|559017284|FG001|Overall Study|Lost to Follow-up|4|||
154889724|NCT00980343|559017289|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
154889725|NCT00980343|559017290|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
154889726|NCT02899377|559017295|FG000|Overall Study|Adverse Event|1|||
154889727|NCT02899377|559017296|FG001|Overall Study|Adverse Event|0|||
154889728|NCT01231607|559017297|FG000|Overall Study|Adverse Event|0|||
154889729|NCT01231607|559017298|FG001|Overall Study|Adverse Event|8|||
154889730|NCT01231607|559017299|FG002|Overall Study|Adverse Event|4|||
154889731|NCT01231607|559017300|FG003|Overall Study|Adverse Event|4|||
154889732|NCT01231607|559017301|FG004|Overall Study|Adverse Event|5|||
154889733|NCT01231607|559017297|FG000|Overall Study|Lost to Follow-up|13|||
154889734|NCT01231607|559017298|FG001|Overall Study|Lost to Follow-up|11|||
154889735|NCT01231607|559017299|FG002|Overall Study|Lost to Follow-up|10|||
154889736|NCT01231607|559017300|FG003|Overall Study|Lost to Follow-up|10|||
154889737|NCT01231607|559017301|FG004|Overall Study|Lost to Follow-up|4|||
154889738|NCT01231607|559017297|FG000|Overall Study|Physician Decision|4|||
154889739|NCT01231607|559017298|FG001|Overall Study|Physician Decision|4|||
154889740|NCT01231607|559017299|FG002|Overall Study|Physician Decision|3|||
154889741|NCT01231607|559017300|FG003|Overall Study|Physician Decision|5|||
154889742|NCT01231607|559017301|FG004|Overall Study|Physician Decision|4|||
154889743|NCT01231607|559017297|FG000|Overall Study|Protocol Violation|3|||
154889744|NCT01231607|559017298|FG001|Overall Study|Protocol Violation|2|||
154889745|NCT01231607|559017299|FG002|Overall Study|Protocol Violation|0|||
154889746|NCT01231607|559017300|FG003|Overall Study|Protocol Violation|2|||
154889747|NCT01231607|559017301|FG004|Overall Study|Protocol Violation|2|||
154889748|NCT01231607|559017297|FG000|Overall Study|Withdrawal by Subject|9|||
154889749|NCT01231607|559017298|FG001|Overall Study|Withdrawal by Subject|9|||
154889750|NCT01231607|559017299|FG002|Overall Study|Withdrawal by Subject|14|||
154889751|NCT01231607|559017300|FG003|Overall Study|Withdrawal by Subject|17|||
154889752|NCT01231607|559017301|FG004|Overall Study|Withdrawal by Subject|9|||
154889753|NCT00098020|559017313|FG000|Overall Study|Adverse Event|2|||
154889754|NCT00098020|559017313|FG000|Overall Study|Lost to Follow-up|1|||
154889755|NCT00098020|559017313|FG000|Overall Study|elevated liver enzymes|1|||
154889756|NCT00098020|559017313|FG000|Overall Study|Low urine PCR|1|||
154889757|NCT00098020|559017313|FG000|Overall Study|Low epidermal growth factor receptor|1|||
154889758|NCT01453998|559017314|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
154889759|NCT01453998|559017315|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
154889760|NCT01453998|559017316|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
154889761|NCT01840228|559017317|FG000|Overall Study|Lost to Follow-up|1|||
154889762|NCT01840228|559017318|FG001|Overall Study|Lost to Follow-up|1|||
154889763|NCT03495453|559017321|FG000|Overall Study|Withdrawal by Subject|0|||
154889764|NCT03495453|559017322|FG001|Overall Study|Withdrawal by Subject|1|||
154889765|NCT00712933|559017323|FG000|Overall Study|Adverse Event|69|||
154889766|NCT00712933|559017323|FG000|Overall Study|Lack of Efficacy|6|||
154889767|NCT00712933|559017323|FG000|Overall Study|Lost to Follow-up|22|||
154889768|NCT00712933|559017323|FG000|Overall Study|Non-compliance with study drug|13|||
154889769|NCT00712933|559017323|FG000|Overall Study|Other Pregnancy|37|||
154889770|NCT00712933|559017323|FG000|Overall Study|Sponsor decision|14|||
154889771|NCT00712933|559017323|FG000|Overall Study|Withdrew consent|4|||
154889772|NCT00712933|559017323|FG000|Overall Study|Hip replacement surgery|1|||
154889773|NCT00712933|559017323|FG000|Overall Study|Involved in Clinical research|3|||
154889774|NCT00712933|559017323|FG000|Overall Study|Participant hospitalized|1|||
154889775|NCT00712933|559017323|FG000|Overall Study|Participant travelled overseas|2|||
154889776|NCT00712933|559017323|FG000|Overall Study|Death of patient|1|||
154889777|NCT00712933|559017323|FG000|Overall Study|Other Physician decision|1|||
154889778|NCT00712933|559017323|FG000|Overall Study|Not committed to contraception|1|||
154889779|NCT00712933|559017323|FG000|Overall Study|Participant received medication|1|||
154889780|NCT00712933|559017323|FG000|Overall Study|Physician Decision|36|||
154889781|NCT00712933|559017323|FG000|Overall Study|Protocol Violation|4|||
154889782|NCT00712933|559017323|FG000|Overall Study|Withdrawal by Subject|151|||
154889783|NCT01360762|559017326|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
154889784|NCT01360762|559017326|FG000|Main Study Period (12-month Treatment)|Death|5|||
154889785|NCT01360762|559017326|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
154889786|NCT01360762|559017326|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
154889787|NCT01360762|559017326|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
154889788|NCT01360762|559017326|FG000|Whole Study Period|Lost to Follow-up|10|||
154889789|NCT01360762|559017326|FG000|Whole Study Period|Death|7|||
154889790|NCT01360762|559017326|FG000|Whole Study Period|Patient relapsed|18|||
154889791|NCT01360762|559017326|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
154889792|NCT03084718|559017327|FG000|Overall Study|Withdrawal by Subject|4|||
154889793|NCT03084718|559017328|FG001|Overall Study|Withdrawal by Subject|3|||
154889794|NCT03084718|559017329|FG002|Overall Study|Withdrawal by Subject|4|||
154889795|NCT03084718|559017330|FG003|Overall Study|Withdrawal by Subject|0|||
154889796|NCT03084718|559017331|FG004|Overall Study|Withdrawal by Subject|0|||
154889797|NCT03084718|559017327|FG000|Overall Study|Physician Decision|1|||
154889798|NCT03084718|559017328|FG001|Overall Study|Physician Decision|0|||
154889799|NCT03084718|559017329|FG002|Overall Study|Physician Decision|0|||
154889800|NCT03084718|559017330|FG003|Overall Study|Physician Decision|0|||
154889801|NCT03084718|559017331|FG004|Overall Study|Physician Decision|0|||
154889802|NCT03084718|559017327|FG000|Overall Study|Adverse Event|3|||
154889803|NCT03084718|559017328|FG001|Overall Study|Adverse Event|5|||
154889804|NCT03084718|559017329|FG002|Overall Study|Adverse Event|5|||
154889805|NCT03084718|559017330|FG003|Overall Study|Adverse Event|8|||
154889806|NCT03084718|559017331|FG004|Overall Study|Adverse Event|2|||
154889807|NCT03084718|559017327|FG000|Overall Study|Lack of Efficacy|2|||
154889808|NCT03084718|559017328|FG001|Overall Study|Lack of Efficacy|0|||
154889809|NCT03084718|559017329|FG002|Overall Study|Lack of Efficacy|1|||
154889810|NCT03084718|559017330|FG003|Overall Study|Lack of Efficacy|4|||
154889811|NCT03084718|559017331|FG004|Overall Study|Lack of Efficacy|0|||
154889812|NCT03084718|559017327|FG000|Overall Study|Lost to Follow-up|0|||
154889813|NCT03084718|559017328|FG001|Overall Study|Lost to Follow-up|1|||
154889814|NCT03084718|559017329|FG002|Overall Study|Lost to Follow-up|0|||
154889815|NCT03084718|559017330|FG003|Overall Study|Lost to Follow-up|0|||
154889816|NCT03084718|559017331|FG004|Overall Study|Lost to Follow-up|2|||
154889817|NCT03084718|559017327|FG000|Overall Study|Protocol Violation|0|||
154889818|NCT03084718|559017328|FG001|Overall Study|Protocol Violation|0|||
154889819|NCT03084718|559017329|FG002|Overall Study|Protocol Violation|1|||
154889820|NCT03084718|559017330|FG003|Overall Study|Protocol Violation|0|||
154889821|NCT03084718|559017331|FG004|Overall Study|Protocol Violation|0|||
154889822|NCT03084718|559017327|FG000|Overall Study|Death|0|||
154889823|NCT03084718|559017328|FG001|Overall Study|Death|1|||
154889824|NCT03084718|559017329|FG002|Overall Study|Death|0|||
154889825|NCT03084718|559017330|FG003|Overall Study|Death|0|||
154889826|NCT03084718|559017331|FG004|Overall Study|Death|0|||
154889827|NCT03084718|559017327|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
154889828|NCT03084718|559017328|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
154889829|NCT03084718|559017329|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
154889830|NCT03084718|559017330|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
154889831|NCT03084718|559017331|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
154889832|NCT02806947|559017332|FG000|Overall Study|Withdrawal by Subject|5|||
154889833|NCT02806947|559017333|FG001|Overall Study|Withdrawal by Subject|1|||
154889834|NCT00865189|559017334|FG000|Overall Study|Other|1|||
154889835|NCT00865189|559017335|FG001|Overall Study|Other|2|||
154889836|NCT00865189|559017334|FG000|Overall Study|Death|4|||
154889837|NCT00865189|559017335|FG001|Overall Study|Death|11|||
154889838|NCT00865189|559017334|FG000|Overall Study|Lost to Follow-up|6|||
154889839|NCT00865189|559017335|FG001|Overall Study|Lost to Follow-up|6|||
154889840|NCT00865189|559017334|FG000|Overall Study|Withdrawal by Subject|1|||
154889841|NCT00865189|559017335|FG001|Overall Study|Withdrawal by Subject|0|||
154889842|NCT00634114|559017338|FG000|Overall Study|Adverse Event|6|||
154889843|NCT00634114|559017339|FG001|Overall Study|Adverse Event|8|||
154977620|NCT01835548|559340921|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
154977621|NCT01835548|559340922|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
154977622|NCT01835548|559340923|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
154977623|NCT01835548|559340921|FG000|Double-Blind Treatment Period|Adverse Event|0|||
154977624|NCT01835548|559340922|FG001|Double-Blind Treatment Period|Adverse Event|1|||
154977625|NCT01835548|559340923|FG002|Double-Blind Treatment Period|Adverse Event|0|||
154977626|NCT01835548|559340921|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154977627|NCT01835548|559340922|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
154977628|NCT01835548|559340923|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154977629|NCT01634854|559340924|FG000|Overall Study|Cesarean delivery|2|||
154977630|NCT01634854|559340925|FG001|Overall Study|Cesarean delivery|7|||
154977631|NCT00987831|559340926|FG000|Overall Study|Never flared in 12 months|1|||
154977632|NCT00987831|559340927|FG001|Overall Study|Never flared in 12 months|0|||
154977633|NCT00987831|559340928|FG002|Overall Study|Never flared in 12 months|0|||
154977634|NCT00987831|559340926|FG000|Overall Study|Lost to Follow-up|0|||
154977635|NCT00987831|559340927|FG001|Overall Study|Lost to Follow-up|3|||
154977636|NCT00987831|559340928|FG002|Overall Study|Lost to Follow-up|0|||
154977637|NCT03253094|559340929|FG000|Overall Study|Adverse Event|2|||
154977638|NCT03253094|559340930|FG001|Overall Study|Adverse Event|0|||
154889844|NCT00634114|559017340|FG002|Overall Study|Adverse Event|3|||
154889845|NCT00634114|559017338|FG000|Overall Study|Withdrawal by Subject|9|||
154889846|NCT00634114|559017339|FG001|Overall Study|Withdrawal by Subject|6|||
154889847|NCT00634114|559017340|FG002|Overall Study|Withdrawal by Subject|11|||
154889848|NCT00634114|559017338|FG000|Overall Study|Lost to Follow-up|0|||
154977639|NCT03253094|559340931|FG002|Overall Study|Adverse Event|0|||
154977640|NCT03253094|559340932|FG003|Overall Study|Adverse Event|0|||
154977641|NCT03253094|559340933|FG004|Overall Study|Adverse Event|0|||
154977642|NCT03253094|559340934|FG005|Overall Study|Adverse Event|0|||
154889849|NCT00634114|559017339|FG001|Overall Study|Lost to Follow-up|0|||
154889850|NCT00634114|559017340|FG002|Overall Study|Lost to Follow-up|1|||
154889851|NCT00634114|559017338|FG000|Overall Study|Protocol Violation|3|||
154889852|NCT00634114|559017339|FG001|Overall Study|Protocol Violation|3|||
154889853|NCT00634114|559017340|FG002|Overall Study|Protocol Violation|1|||
154889854|NCT00634114|559017338|FG000|Overall Study|Pregnancy|1|||
154889855|NCT00634114|559017339|FG001|Overall Study|Pregnancy|0|||
154889856|NCT00634114|559017340|FG002|Overall Study|Pregnancy|0|||
154889857|NCT00634114|559017338|FG000|Overall Study|Incorrect enrolment|0|||
154889858|NCT00634114|559017339|FG001|Overall Study|Incorrect enrolment|1|||
154889859|NCT00634114|559017340|FG002|Overall Study|Incorrect enrolment|0|||
154889860|NCT00634114|559017338|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
154889861|NCT00634114|559017339|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
154889862|NCT00634114|559017340|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
154889863|NCT00634114|559017338|FG000|Overall Study|Difficult to continue|3|||
154889864|NCT00634114|559017339|FG001|Overall Study|Difficult to continue|1|||
154889865|NCT00634114|559017340|FG002|Overall Study|Difficult to continue|1|||
154889866|NCT00634114|559017338|FG000|Overall Study|Other reason|1|||
154889867|NCT00634114|559017339|FG001|Overall Study|Other reason|1|||
154889868|NCT00634114|559017340|FG002|Overall Study|Other reason|1|||
154889869|NCT01599754|559017341|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
154889870|NCT01599754|559017342|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
154889871|NCT01599754|559017341|FG000|Overall Study|Participant noncompliance|4|||
154889872|NCT01599754|559017342|FG001|Overall Study|Participant noncompliance|4|||
154889873|NCT01599754|559017341|FG000|Overall Study|Lost to Follow-up|13|||
154889874|NCT01599754|559017342|FG001|Overall Study|Lost to Follow-up|6|||
154889875|NCT01599754|559017341|FG000|Overall Study|Death|31|||
154889876|NCT01599754|559017342|FG001|Overall Study|Death|33|||
154889877|NCT01599754|559017341|FG000|Overall Study|Adverse Event|3|||
154889878|NCT01599754|559017342|FG001|Overall Study|Adverse Event|2|||
154889879|NCT01599754|559017341|FG000|Overall Study|Investigator decision|1|||
154889880|NCT01599754|559017342|FG001|Overall Study|Investigator decision|3|||
154889881|NCT01599754|559017341|FG000|Overall Study|Withdrawal by Subject|24|||
154889882|NCT01599754|559017342|FG001|Overall Study|Withdrawal by Subject|25|||
154889883|NCT01599754|559017341|FG000|Overall Study|Study terminated by sponsor|282|||
154889884|NCT01599754|559017342|FG001|Overall Study|Study terminated by sponsor|285|||
154889885|NCT00738374|559017345|FG000|Induction Treatment Phase|Adverse Event|14|||
154889886|NCT00738374|559017346|FG001|Induction Treatment Phase|Adverse Event|0|||
154889887|NCT00738374|559017347|FG002|Induction Treatment Phase|Adverse Event|0|||
154889888|NCT00738374|559017348|FG003|Induction Treatment Phase|Adverse Event|0|||
154889889|NCT00738374|559017345|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
154889890|NCT00738374|559017346|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
154889891|NCT00738374|559017347|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
154889892|NCT00738374|559017348|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
154889893|NCT00738374|559017345|FG000|Induction Treatment Phase|Physician Decision|2|||
154889894|NCT00738374|559017346|FG001|Induction Treatment Phase|Physician Decision|0|||
154889895|NCT00738374|559017347|FG002|Induction Treatment Phase|Physician Decision|0|||
154889896|NCT00738374|559017348|FG003|Induction Treatment Phase|Physician Decision|0|||
154889897|NCT00738374|559017345|FG000|Induction Treatment Phase|Protocol Violation|2|||
154889898|NCT00738374|559017346|FG001|Induction Treatment Phase|Protocol Violation|0|||
154889899|NCT00738374|559017347|FG002|Induction Treatment Phase|Protocol Violation|0|||
154889900|NCT00738374|559017348|FG003|Induction Treatment Phase|Protocol Violation|0|||
154889901|NCT00738374|559017345|FG000|Induction Treatment Phase|Non-compliance|1|||
154889902|NCT00738374|559017346|FG001|Induction Treatment Phase|Non-compliance|0|||
154889903|NCT00738374|559017347|FG002|Induction Treatment Phase|Non-compliance|0|||
154889904|NCT00738374|559017348|FG003|Induction Treatment Phase|Non-compliance|0|||
154889905|NCT00738374|559017345|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
154889906|NCT00738374|559017346|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
154889907|NCT00738374|559017347|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
154889908|NCT00738374|559017348|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
154889909|NCT00738374|559017345|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
154889910|NCT00738374|559017346|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
154889911|NCT00738374|559017347|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
154889912|NCT00738374|559017348|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
154889913|NCT00738374|559017345|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
154889914|NCT00738374|559017346|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
154889915|NCT00738374|559017347|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
154889916|NCT00738374|559017348|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
154889917|NCT00738374|559017345|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
154977643|NCT03253094|559340929|FG000|Overall Study|Lack of Efficacy|0|||
155113864|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Disease progression|0|||
155113865|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Disease progression|0|||
154889918|NCT00738374|559017346|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
154889919|NCT00738374|559017347|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
154889920|NCT00738374|559017348|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
154889921|NCT00738374|559017345|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
154889922|NCT00738374|559017346|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
154889923|NCT00738374|559017347|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
154977644|NCT03253094|559340930|FG001|Overall Study|Lack of Efficacy|0|||
154889924|NCT00738374|559017348|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
154889925|NCT00738374|559017345|FG000|Maintenance Treatment/Observation Phase|Other|0|||
154889926|NCT00738374|559017346|FG001|Maintenance Treatment/Observation Phase|Other|1|||
154889927|NCT00738374|559017347|FG002|Maintenance Treatment/Observation Phase|Other|0|||
154889928|NCT00738374|559017348|FG003|Maintenance Treatment/Observation Phase|Other|0|||
154889929|NCT03097614|559019065|FG000|Overall Study|Adverse Event|3|||
154889930|NCT00603733|559019066|FG000|Active Phase ITT|Adverse Event|8|||
154889931|NCT00603733|559019067|FG001|Active Phase ITT|Adverse Event|7|||
154889932|NCT00603733|559019066|FG000|Active Phase ITT|Withdrawal by Subject|0|||
154889933|NCT00603733|559019067|FG001|Active Phase ITT|Withdrawal by Subject|3|||
154889934|NCT00603733|559019066|FG000|Active Phase ITT|Lost to Follow-up|0|||
154889935|NCT00603733|559019067|FG001|Active Phase ITT|Lost to Follow-up|1|||
154889936|NCT00603733|559019066|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
154889937|NCT00603733|559019067|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
154889938|NCT00603733|559019066|FG000|Active Phase ITT|Lack of Efficacy|1|||
154889939|NCT00603733|559019067|FG001|Active Phase ITT|Lack of Efficacy|2|||
154889940|NCT00603733|559019066|FG000|Active Phase ITT|Subject moved, site closed|1|||
154889941|NCT00603733|559019067|FG001|Active Phase ITT|Subject moved, site closed|1|||
154889942|NCT00603733|559019066|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
154889943|NCT00603733|559019067|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
154889944|NCT00603733|559019066|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
154889945|NCT00603733|559019067|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
154889946|NCT00603733|559019066|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
154889947|NCT00603733|559019067|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
154889948|NCT00603733|559019066|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
154889949|NCT00603733|559019067|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
155113866|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Disease progression|3|||
155113867|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
155113868|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
155113869|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
155113870|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
155113871|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
155113872|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
155113873|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
155113874|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
155113875|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
155113876|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
155113877|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
155113878|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
155113879|NCT01461928|559846156|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
155113880|NCT01461928|559846157|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
155113881|NCT01461928|559846158|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
155113882|NCT00608023|559846159|FG000|Overall Study|Withdrawal by Subject|8|||
155113883|NCT00608023|559846160|FG001|Overall Study|Withdrawal by Subject|10|||
155113884|NCT00608023|559846161|FG002|Overall Study|Withdrawal by Subject|7|||
155113885|NCT00608023|559846159|FG000|Overall Study|Adverse Event|1|||
155113886|NCT00608023|559846160|FG001|Overall Study|Adverse Event|4|||
155113887|NCT00608023|559846161|FG002|Overall Study|Adverse Event|5|||
155113888|NCT00608023|559846159|FG000|Overall Study|Lost to Follow-up|2|||
155113889|NCT00608023|559846160|FG001|Overall Study|Lost to Follow-up|2|||
155113890|NCT00608023|559846161|FG002|Overall Study|Lost to Follow-up|1|||
155113891|NCT00608023|559846159|FG000|Overall Study|Protocol Violation|1|||
155113892|NCT00608023|559846160|FG001|Overall Study|Protocol Violation|3|||
155113893|NCT00608023|559846161|FG002|Overall Study|Protocol Violation|1|||
155113894|NCT00608023|559846159|FG000|Overall Study|Unknown reason|0|||
155113895|NCT00608023|559846160|FG001|Overall Study|Unknown reason|3|||
155113896|NCT00608023|559846161|FG002|Overall Study|Unknown reason|0|||
155113897|NCT06422364|559846162|FG000|Overall Study|Withdrawn due to study closure|0|||
155113898|NCT06422364|559846163|FG001|Overall Study|Withdrawn due to study closure|2|||
155113899|NCT05260073|559846165|FG000|Overall Study|Physician Decision|1|||
155175580|NCT01215916|560080280|FG008|Overall Study|Adverse Event|0|||
154889950|NCT00603733|559019066|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
154889951|NCT00603733|559019067|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
154889952|NCT00603733|559019066|FG000|Maintenance Phase ITT|Adverse Event|3|||
154889953|NCT00603733|559019067|FG001|Maintenance Phase ITT|Adverse Event|6|||
154889954|NCT00603733|559019066|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
154889955|NCT00603733|559019067|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
154889956|NCT00603733|559019066|FG000|Maintenance Phase ITT|Protocol Violation|1|||
154889957|NCT00603733|559019067|FG001|Maintenance Phase ITT|Protocol Violation|1|||
154889958|NCT00603733|559019066|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
154889959|NCT00603733|559019067|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
154889960|NCT00603733|559019066|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
155113900|NCT05260073|559846165|FG000|Overall Study|Withdrawal by Subject|6|||
154889961|NCT00603733|559019067|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
154889962|NCT00603733|559019066|FG000|Maintenance Phase ITT|Physician Decision|0|||
154889963|NCT00603733|559019067|FG001|Maintenance Phase ITT|Physician Decision|1|||
154889964|NCT00603733|559019066|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
154889965|NCT00603733|559019067|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
154889966|NCT02215616|559019072|FG000|Overall Study|Sponsor requested to stop study drug|0|||
154889967|NCT02215616|559019073|FG001|Overall Study|Sponsor requested to stop study drug|0|||
154889968|NCT02215616|559019074|FG002|Overall Study|Sponsor requested to stop study drug|1|||
154889969|NCT02215616|559019075|FG003|Overall Study|Sponsor requested to stop study drug|4|||
154889970|NCT02215616|559019072|FG000|Overall Study|Death|1|||
154889971|NCT02215616|559019073|FG001|Overall Study|Death|0|||
154889972|NCT02215616|559019074|FG002|Overall Study|Death|0|||
154889973|NCT02215616|559019075|FG003|Overall Study|Death|0|||
154889974|NCT02215616|559019072|FG000|Overall Study|Adverse Event|7|||
154889975|NCT02215616|559019073|FG001|Overall Study|Adverse Event|4|||
154889976|NCT02215616|559019074|FG002|Overall Study|Adverse Event|9|||
154889977|NCT02215616|559019075|FG003|Overall Study|Adverse Event|2|||
154889978|NCT02215616|559019072|FG000|Overall Study|Withdrawal by Subject|1|||
154889979|NCT02215616|559019073|FG001|Overall Study|Withdrawal by Subject|8|||
154889980|NCT02215616|559019074|FG002|Overall Study|Withdrawal by Subject|2|||
154889981|NCT02215616|559019075|FG003|Overall Study|Withdrawal by Subject|5|||
154889982|NCT02215616|559019072|FG000|Overall Study|Non-compliance|0|||
154889983|NCT02215616|559019073|FG001|Overall Study|Non-compliance|2|||
154889984|NCT02215616|559019074|FG002|Overall Study|Non-compliance|1|||
154889985|NCT02215616|559019075|FG003|Overall Study|Non-compliance|0|||
154889986|NCT02215616|559019072|FG000|Overall Study|Protocol Violation|0|||
154889987|NCT02215616|559019073|FG001|Overall Study|Protocol Violation|2|||
154889988|NCT02215616|559019074|FG002|Overall Study|Protocol Violation|0|||
154889989|NCT02215616|559019075|FG003|Overall Study|Protocol Violation|0|||
154889990|NCT02215616|559019072|FG000|Overall Study|Lost to Follow-up|1|||
154889991|NCT02215616|559019073|FG001|Overall Study|Lost to Follow-up|1|||
154889992|NCT02215616|559019074|FG002|Overall Study|Lost to Follow-up|0|||
154889993|NCT02215616|559019075|FG003|Overall Study|Lost to Follow-up|1|||
154889994|NCT02215616|559019072|FG000|Overall Study|Other than specified|1|||
154889995|NCT02215616|559019073|FG001|Overall Study|Other than specified|0|||
154889996|NCT02215616|559019074|FG002|Overall Study|Other than specified|1|||
154889997|NCT02215616|559019075|FG003|Overall Study|Other than specified|1|||
154889998|NCT01634113|559019076|FG000|Overall Study|Not treated|0|||
154889999|NCT01634113|559019077|FG001|Overall Study|Not treated|0|||
154890000|NCT01634113|559019078|FG002|Overall Study|Not treated|1|||
154890001|NCT00520299|559019079|FG000|Overall Study|Withdrawal by Subject|0|||
154890002|NCT00520299|559019080|FG001|Overall Study|Withdrawal by Subject|0|||
154890003|NCT00520299|559019081|FG002|Overall Study|Withdrawal by Subject|2|||
154890004|NCT00520299|559019079|FG000|Overall Study|Progressive disease|0|||
154890005|NCT00520299|559019080|FG001|Overall Study|Progressive disease|3|||
154890006|NCT00520299|559019081|FG002|Overall Study|Progressive disease|4|||
154890007|NCT01352845|559019082|FG000|Overall Study|Lost to Follow-up|313|||
154890008|NCT01352845|559019083|FG001|Overall Study|Lost to Follow-up|92|||
154890009|NCT01352845|559019082|FG000|Overall Study|No Longer Willing to Participate|205|||
154890010|NCT01352845|559019083|FG001|Overall Study|No Longer Willing to Participate|58|||
154890011|NCT01352845|559019082|FG000|Overall Study|Withdrawal by Subject|48|||
154890012|NCT01352845|559019083|FG001|Overall Study|Withdrawal by Subject|16|||
155113901|NCT05260073|559846165|FG000|Overall Study|Lost to Follow-up|14|||
155113902|NCT04484649|559846168|FG000|Overall Study|Lost to Follow-up|2|||
154890013|NCT01352845|559019082|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
154890014|NCT01352845|559019083|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
154890015|NCT01352845|559019082|FG000|Overall Study|Pregnancy|27|||
154890016|NCT01352845|559019083|FG001|Overall Study|Pregnancy|7|||
154890017|NCT01352845|559019082|FG000|Overall Study|Adverse Event|22|||
154890018|NCT01352845|559019083|FG001|Overall Study|Adverse Event|6|||
154890019|NCT01352845|559019082|FG000|Overall Study|Other|17|||
154890020|NCT01352845|559019083|FG001|Overall Study|Other|7|||
154890021|NCT01352845|559019082|FG000|Overall Study|Protocol Violation|12|||
154890022|NCT01352845|559019083|FG001|Overall Study|Protocol Violation|6|||
154890023|NCT01352845|559019082|FG000|Overall Study|Death|3|||
154890024|NCT01352845|559019083|FG001|Overall Study|Death|0|||
154890025|NCT01956240|559019084|FG000|Overall Study|Lost to Follow-up|6|||
154890026|NCT01956240|559019085|FG001|Overall Study|Lost to Follow-up|20|||
154890027|NCT01956240|559019084|FG000|Overall Study|Adverse Event|17|||
154890028|NCT01956240|559019085|FG001|Overall Study|Adverse Event|4|||
154890029|NCT01957709|559019089|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
154890030|NCT03587584|559019090|FG000|Overall Study|SOC deviations|4|||
155113903|NCT04484649|559846169|FG001|Overall Study|Lost to Follow-up|1|||
154890031|NCT03587584|559019091|FG001|Overall Study|SOC deviations|6|||
154890032|NCT03587584|559019090|FG000|Overall Study|Incomplete data|0|||
154890033|NCT03587584|559019091|FG001|Overall Study|Incomplete data|3|||
154890034|NCT01925612|559019092|FG000|Overall Study|Progressive Disease|1|||
155175581|NCT01215916|560080272|FG000|Overall Study|Withdrawal by Subject|0|||
155175582|NCT01215916|560080273|FG001|Overall Study|Withdrawal by Subject|1|||
155175583|NCT01215916|560080274|FG002|Overall Study|Withdrawal by Subject|1|||
155175584|NCT01215916|560080275|FG003|Overall Study|Withdrawal by Subject|2|||
155175585|NCT01215916|560080276|FG004|Overall Study|Withdrawal by Subject|0|||
155175586|NCT01215916|560080277|FG005|Overall Study|Withdrawal by Subject|0|||
155175587|NCT01215916|560080278|FG006|Overall Study|Withdrawal by Subject|1|||
155175588|NCT01215916|560080279|FG007|Overall Study|Withdrawal by Subject|0|||
155175589|NCT01215916|560080280|FG008|Overall Study|Withdrawal by Subject|0|||
155175590|NCT01215916|560080272|FG000|Overall Study|Death|0|||
155175591|NCT01215916|560080273|FG001|Overall Study|Death|1|||
155175592|NCT01215916|560080274|FG002|Overall Study|Death|0|||
154890035|NCT01925612|559019093|FG001|Overall Study|Progressive Disease|1|||
154890036|NCT01925612|559019094|FG002|Overall Study|Progressive Disease|1|||
154890037|NCT01925612|559019095|FG003|Overall Study|Progressive Disease|0|||
154890038|NCT01925612|559019096|FG004|Overall Study|Progressive Disease|0|||
154890039|NCT01925612|559019092|FG000|Overall Study|Adverse Event|3|||
154890040|NCT01925612|559019093|FG001|Overall Study|Adverse Event|3|||
154890041|NCT01925612|559019094|FG002|Overall Study|Adverse Event|0|||
154890042|NCT01925612|559019095|FG003|Overall Study|Adverse Event|1|||
154890043|NCT01925612|559019096|FG004|Overall Study|Adverse Event|2|||
154890044|NCT01093755|559019098|FG000|Overall Study|Withdrawal by Subject|3|||
154890045|NCT01093755|559019099|FG001|Overall Study|Withdrawal by Subject|4|||
154890046|NCT02310906|559019102|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
154890047|NCT02310906|559019103|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
154890048|NCT02310906|559019104|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
154890049|NCT02310906|559019105|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
154890050|NCT02310906|559019102|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
154890051|NCT02310906|559019103|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
154890052|NCT02310906|559019104|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
154890053|NCT02310906|559019105|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
154890054|NCT02310906|559019102|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
154890055|NCT02310906|559019103|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
154890056|NCT02310906|559019104|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
154890057|NCT02310906|559019105|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
154890058|NCT02310906|559019102|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
154890059|NCT02310906|559019103|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
154890060|NCT02310906|559019104|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
154890061|NCT02310906|559019105|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
154890062|NCT00433446|559019106|FG000|Overall Study|Adverse Event|4|||
154890063|NCT00433446|559019106|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
154890064|NCT00433446|559019106|FG000|Overall Study|Progression|44|||
154890065|NCT00433446|559019106|FG000|Overall Study|Other - Not Protocol specified|3|||
154890066|NCT00433446|559019106|FG000|Overall Study|Ineligible|9|||
154890067|NCT01188538|559019107|FG000|Overall Study|Lost to Follow-up|0|||
154890068|NCT01188538|559019108|FG001|Overall Study|Lost to Follow-up|1|||
154890069|NCT00469209|559019112|FG000|Overall Study|Adverse Event|1|||
154890070|NCT00469209|559019113|FG001|Overall Study|Adverse Event|0|||
154890071|NCT00469209|559019114|FG002|Overall Study|Adverse Event|1|||
154890072|NCT02022033|559019126|FG000|Overall Study|Physician Decision|1|||
154890073|NCT01429077|559019127|FG000|Overall Study|Lost to Follow-up|0|||
154890074|NCT01429077|559019128|FG001|Overall Study|Lost to Follow-up|3|||
154890075|NCT01413542|559019130|FG000|Overall Study|Physician Decision|1|||
154890076|NCT01413542|559019131|FG001|Overall Study|Physician Decision|0|||
154890077|NCT01413542|559019132|FG002|Overall Study|Physician Decision|3|||
154890078|NCT01413542|559019133|FG003|Overall Study|Physician Decision|0|||
154890079|NCT01413542|559019130|FG000|Overall Study|Adverse Event|0|||
155175593|NCT01215916|560080275|FG003|Overall Study|Death|0|||
155175594|NCT01215916|560080276|FG004|Overall Study|Death|1|||
155175595|NCT01215916|560080277|FG005|Overall Study|Death|0|||
154890080|NCT01413542|559019131|FG001|Overall Study|Adverse Event|0|||
154890081|NCT01413542|559019132|FG002|Overall Study|Adverse Event|0|||
154890082|NCT01413542|559019133|FG003|Overall Study|Adverse Event|1|||
154890083|NCT04929613|559019134|FG000|Overall Study|Withdrawal by Subject|12|||
154890084|NCT00084929|559019138|FG000|Overall Study|ineligible - medical contraindication|1|||
154890085|NCT00084929|559019138|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
154890086|NCT00084929|559019138|FG000|Overall Study|Ineligible - Medical history|6|||
154890087|NCT00084929|559019138|FG000|Overall Study|Withdrawal by Subject|10|||
155175596|NCT01215916|560080278|FG006|Overall Study|Death|0|||
154977645|NCT03253094|559340931|FG002|Overall Study|Lack of Efficacy|2|||
154977646|NCT03253094|559340932|FG003|Overall Study|Lack of Efficacy|1|||
155175597|NCT01215916|560080279|FG007|Overall Study|Death|0|||
154890088|NCT00084929|559019138|FG000|Overall Study|Missing/incomplete CTC exam|9|||
154977647|NCT03253094|559340933|FG004|Overall Study|Lack of Efficacy|2|||
155175598|NCT01215916|560080280|FG008|Overall Study|Death|1|||
154977648|NCT03253094|559340934|FG005|Overall Study|Lack of Efficacy|1|||
154977649|NCT03253094|559340929|FG000|Overall Study|Lost to Follow-up|0|||
154977650|NCT03253094|559340930|FG001|Overall Study|Lost to Follow-up|0|||
154977651|NCT03253094|559340931|FG002|Overall Study|Lost to Follow-up|1|||
154977652|NCT03253094|559340932|FG003|Overall Study|Lost to Follow-up|1|||
154977653|NCT03253094|559340933|FG004|Overall Study|Lost to Follow-up|0|||
154977654|NCT03253094|559340934|FG005|Overall Study|Lost to Follow-up|1|||
154977655|NCT03253094|559340929|FG000|Overall Study|Physician Decision|1|||
154977656|NCT03253094|559340930|FG001|Overall Study|Physician Decision|0|||
154977657|NCT03253094|559340931|FG002|Overall Study|Physician Decision|0|||
154977658|NCT03253094|559340932|FG003|Overall Study|Physician Decision|1|||
154977659|NCT03253094|559340933|FG004|Overall Study|Physician Decision|0|||
154977660|NCT03253094|559340934|FG005|Overall Study|Physician Decision|2|||
154977661|NCT03253094|559340929|FG000|Overall Study|Withdrawal by Subject|1|||
154977662|NCT03253094|559340930|FG001|Overall Study|Withdrawal by Subject|2|||
154977663|NCT03253094|559340931|FG002|Overall Study|Withdrawal by Subject|1|||
154977664|NCT03253094|559340932|FG003|Overall Study|Withdrawal by Subject|0|||
154977665|NCT03253094|559340933|FG004|Overall Study|Withdrawal by Subject|3|||
154977666|NCT03253094|559340934|FG005|Overall Study|Withdrawal by Subject|0|||
154977667|NCT03253094|559340929|FG000|Overall Study|Other|0|||
154977668|NCT03253094|559340930|FG001|Overall Study|Other|1|||
154977669|NCT03253094|559340931|FG002|Overall Study|Other|2|||
154977670|NCT03253094|559340932|FG003|Overall Study|Other|1|||
154977671|NCT03253094|559340933|FG004|Overall Study|Other|0|||
154977672|NCT03253094|559340934|FG005|Overall Study|Other|0|||
154977673|NCT02219308|559340935|FG000|Overall Study|Withdrawal by Subject|1|||
154977674|NCT02219308|559340936|FG001|Overall Study|Withdrawal by Subject|2|||
154977675|NCT00576303|559340937|FG000|Dose Titration Period|Early withdrawal|17|||
154977676|NCT00576303|559340937|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
154977677|NCT00576303|559340937|FG000|Long Term Safety Period|Early withdrawal|16|||
154977678|NCT00824369|559340938|FG000|Overall Study|Nolonger willing to participate in study|1|||
154977679|NCT00824369|559340939|FG001|Overall Study|Nolonger willing to participate in study|0|||
154977680|NCT00824369|559340940|FG002|Overall Study|Nolonger willing to participate in study|1|||
154977681|NCT00824369|559340941|FG003|Overall Study|Nolonger willing to participate in study|2|||
154977682|NCT00824369|559340942|FG004|Overall Study|Nolonger willing to participate in study|0|||
154977683|NCT00824369|559340943|FG005|Overall Study|Nolonger willing to participate in study|1|||
154977684|NCT00824369|559340938|FG000|Overall Study|Lost to Follow-up|0|||
154977685|NCT00824369|559340939|FG001|Overall Study|Lost to Follow-up|0|||
154977686|NCT00824369|559340940|FG002|Overall Study|Lost to Follow-up|0|||
154977687|NCT00824369|559340941|FG003|Overall Study|Lost to Follow-up|0|||
154977688|NCT00824369|559340942|FG004|Overall Study|Lost to Follow-up|1|||
154977689|NCT00824369|559340943|FG005|Overall Study|Lost to Follow-up|0|||
154977690|NCT00442546|559340944|FG000|Overall Study|Adverse Event|11|||
154977691|NCT00442546|559340945|FG001|Overall Study|Adverse Event|17|||
154977692|NCT00442546|559340946|FG002|Overall Study|Adverse Event|13|||
155113904|NCT04484649|559846168|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
155113905|NCT04484649|559846169|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
155113906|NCT01463696|559846170|FG000|Overall Study|Adverse Event|0|||
155113907|NCT01463696|559846171|FG001|Overall Study|Adverse Event|1|||
155113908|NCT01463696|559846172|FG002|Overall Study|Adverse Event|0|||
155113909|NCT01463696|559846173|FG003|Overall Study|Adverse Event|2|||
155113910|NCT01463696|559846174|FG004|Overall Study|Adverse Event|0|||
155113911|NCT01463696|559846175|FG005|Overall Study|Adverse Event|1|||
155113912|NCT01463696|559846176|FG006|Overall Study|Adverse Event|3|||
155113913|NCT01463696|559846177|FG007|Overall Study|Adverse Event|2|||
155113914|NCT01463696|559846170|FG000|Overall Study|Lost to Follow-up|0|||
155113915|NCT01463696|559846171|FG001|Overall Study|Lost to Follow-up|0|||
155113916|NCT01463696|559846172|FG002|Overall Study|Lost to Follow-up|1|||
155175599|NCT01215916|560080272|FG000|Overall Study|Physician Decision|0|||
154977693|NCT00442546|559340944|FG000|Overall Study|Lost to Follow-up|1|||
154977694|NCT00442546|559340945|FG001|Overall Study|Lost to Follow-up|2|||
154977695|NCT00442546|559340946|FG002|Overall Study|Lost to Follow-up|1|||
154977696|NCT00442546|559340944|FG000|Overall Study|Other|4|||
154977697|NCT00442546|559340945|FG001|Overall Study|Other|9|||
154977698|NCT00442546|559340946|FG002|Overall Study|Other|6|||
154977699|NCT00442546|559340944|FG000|Overall Study|Withdrawal by Subject|5|||
155175600|NCT01215916|560080273|FG001|Overall Study|Physician Decision|0|||
155175601|NCT01215916|560080274|FG002|Overall Study|Physician Decision|1|||
154977700|NCT00442546|559340945|FG001|Overall Study|Withdrawal by Subject|5|||
154977701|NCT00442546|559340946|FG002|Overall Study|Withdrawal by Subject|7|||
154977702|NCT00442546|559340944|FG000|Overall Study|Randomized But Not Treated|5|||
155113917|NCT01463696|559846173|FG003|Overall Study|Lost to Follow-up|0|||
155113918|NCT01463696|559846174|FG004|Overall Study|Lost to Follow-up|0|||
155113919|NCT01463696|559846175|FG005|Overall Study|Lost to Follow-up|0|||
155113920|NCT01463696|559846176|FG006|Overall Study|Lost to Follow-up|0|||
154977703|NCT00442546|559340945|FG001|Overall Study|Randomized But Not Treated|4|||
154977704|NCT00442546|559340946|FG002|Overall Study|Randomized But Not Treated|6|||
154977705|NCT01557582|559340951|FG000|Overall Study|Protocol Violation|4|||
154977706|NCT01557582|559340951|FG000|Overall Study|Operator error|2|||
154977707|NCT02843659|559340952|FG000|Overall Study|Subject Withdrew Consent|0|||
154977708|NCT02843659|559340953|FG001|Overall Study|Subject Withdrew Consent|0|||
154977709|NCT02843659|559340954|FG002|Overall Study|Subject Withdrew Consent|1|||
154977710|NCT02843659|559340952|FG000|Overall Study|Administrative Reason by Sponsor|4|||
154977711|NCT02843659|559340953|FG001|Overall Study|Administrative Reason by Sponsor|5|||
154977712|NCT02843659|559340954|FG002|Overall Study|Administrative Reason by Sponsor|4|||
154977713|NCT02843659|559340952|FG000|Overall Study|Adverse Event|0|||
154977714|NCT02843659|559340953|FG001|Overall Study|Adverse Event|1|||
154977715|NCT02843659|559340954|FG002|Overall Study|Adverse Event|0|||
154977716|NCT03203642|559340955|FG000|Overall Study|Adverse Event|3|||
154977717|NCT03203642|559340956|FG001|Overall Study|Adverse Event|1|||
154977718|NCT03203642|559340955|FG000|Overall Study|Withdrawal by Subject|6|||
154977719|NCT03203642|559340956|FG001|Overall Study|Withdrawal by Subject|6|||
154977720|NCT03203642|559340955|FG000|Overall Study|Lost to Follow-up|2|||
154977721|NCT03203642|559340956|FG001|Overall Study|Lost to Follow-up|1|||
154977722|NCT03203642|559340955|FG000|Overall Study|Termination of the study by sponsor|1|||
154977723|NCT03203642|559340956|FG001|Overall Study|Termination of the study by sponsor|1|||
154977724|NCT03203642|559340955|FG000|Overall Study|Participant moved|0|||
154977725|NCT03203642|559340956|FG001|Overall Study|Participant moved|1|||
154977726|NCT03203642|559340955|FG000|Overall Study|Investigator's decision|3|||
154977727|NCT03203642|559340956|FG001|Overall Study|Investigator's decision|0|||
154977728|NCT03203642|559340955|FG000|Overall Study|Other than above specified|0|||
154977729|NCT03203642|559340956|FG001|Overall Study|Other than above specified|1|||
154977730|NCT02413294|559340957|FG000|Overall Study|Withdrawal by Subject|1|||
154977731|NCT04149535|559340961|FG000|Overall Study|Death|11|||
154977732|NCT04149535|559340962|FG001|Overall Study|Death|7|||
154890089|NCT00084929|559019138|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
154890090|NCT02767856|559019149|FG000|Overall Study|Lost to Follow-up|9|||
154890091|NCT02767856|559019150|FG001|Overall Study|Lost to Follow-up|1|||
154890092|NCT02767856|559019149|FG000|Overall Study|Withdrawal by Subject|2|||
154890093|NCT02767856|559019150|FG001|Overall Study|Withdrawal by Subject|1|||
154890094|NCT00091026|559019151|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
154890095|NCT00091026|559019152|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
154890096|NCT00091026|559019151|FG000|Overall Study|Patient withdrew and never received trea|0|||
154890097|NCT00091026|559019152|FG001|Overall Study|Patient withdrew and never received trea|2|||
154890098|NCT00091026|559019151|FG000|Overall Study|Unknown-never received treatment|0|||
154890099|NCT00091026|559019152|FG001|Overall Study|Unknown-never received treatment|1|||
154890100|NCT01797965|559019153|FG000|Overall Study|Adverse Event|104|||
154890101|NCT01797965|559019154|FG001|Overall Study|Adverse Event|129|||
154890102|NCT01797965|559019155|FG002|Overall Study|Adverse Event|4|||
154890103|NCT01797965|559019156|FG003|Overall Study|Adverse Event|21|||
154890104|NCT01797965|559019153|FG000|Overall Study|Lost to Follow-up|9|||
154890105|NCT01797965|559019154|FG001|Overall Study|Lost to Follow-up|8|||
154890106|NCT01797965|559019155|FG002|Overall Study|Lost to Follow-up|1|||
154890107|NCT01797965|559019156|FG003|Overall Study|Lost to Follow-up|2|||
154890108|NCT01797965|559019153|FG000|Overall Study|Consent withdrawn|130|||
154890109|NCT01797965|559019154|FG001|Overall Study|Consent withdrawn|117|||
154890110|NCT01797965|559019155|FG002|Overall Study|Consent withdrawn|3|||
154890111|NCT01797965|559019156|FG003|Overall Study|Consent withdrawn|35|||
154890112|NCT01797965|559019153|FG000|Overall Study|Investigator decision|21|||
154890113|NCT01797965|559019154|FG001|Overall Study|Investigator decision|15|||
154890114|NCT01797965|559019155|FG002|Overall Study|Investigator decision|0|||
154890115|NCT01797965|559019156|FG003|Overall Study|Investigator decision|0|||
154890116|NCT01797965|559019153|FG000|Overall Study|Death|2|||
154890117|NCT01797965|559019154|FG001|Overall Study|Death|4|||
154890118|NCT01797965|559019155|FG002|Overall Study|Death|0|||
154890119|NCT01797965|559019156|FG003|Overall Study|Death|0|||
154890120|NCT01797965|559019153|FG000|Overall Study|Disease progression, defined by protocol|3|||
154890121|NCT01797965|559019154|FG001|Overall Study|Disease progression, defined by protocol|1|||
154890122|NCT01797965|559019155|FG002|Overall Study|Disease progression, defined by protocol|0|||
154977733|NCT04149535|559340961|FG000|Overall Study|Physician Decision|10|||
154977734|NCT04149535|559340962|FG001|Overall Study|Physician Decision|4|||
154977735|NCT04149535|559340961|FG000|Overall Study|Withdrawal by Subject|6|||
155113921|NCT01463696|559846177|FG007|Overall Study|Lost to Follow-up|0|||
154890123|NCT01797965|559019156|FG003|Overall Study|Disease progression, defined by protocol|0|||
154890124|NCT01797965|559019153|FG000|Overall Study|Reason Not Specified|280|||
154890125|NCT01797965|559019154|FG001|Overall Study|Reason Not Specified|295|||
154977736|NCT04149535|559340962|FG001|Overall Study|Withdrawal by Subject|7|||
154977737|NCT04149535|559340961|FG000|Overall Study|Not described|2|||
154977738|NCT04149535|559340962|FG001|Overall Study|Not described|0|||
155113922|NCT01463696|559846170|FG000|Overall Study|Progressive Disease|0|||
154890126|NCT01797965|559019155|FG002|Overall Study|Reason Not Specified|0|||
154977739|NCT02875028|559340963|FG000|Washout Period|Withdrawal by Subject|0|||
154977740|NCT02875028|559340964|FG001|Washout Period|Withdrawal by Subject|1|||
155113923|NCT01463696|559846171|FG001|Overall Study|Progressive Disease|1|||
155113924|NCT01463696|559846172|FG002|Overall Study|Progressive Disease|0|||
154890127|NCT01797965|559019156|FG003|Overall Study|Reason Not Specified|15|||
154890128|NCT00973921|559019157|FG000|Overall Study|IVUS results were not available|9|||
154890129|NCT02670330|559019168|FG000|Overall Study|Protocol Deviation|1|||
154890130|NCT02670330|559019169|FG001|Overall Study|Protocol Deviation|0|||
154890131|NCT02670330|559019168|FG000|Overall Study|Study Terminated By Sponsor|36|||
154890132|NCT02670330|559019169|FG001|Overall Study|Study Terminated By Sponsor|43|||
154890133|NCT02670330|559019168|FG000|Overall Study|Adverse Event|1|||
154890134|NCT02670330|559019169|FG001|Overall Study|Adverse Event|3|||
154890135|NCT02670330|559019168|FG000|Overall Study|Withdrawal by Subject|34|||
154890136|NCT02670330|559019169|FG001|Overall Study|Withdrawal by Subject|29|||
154890137|NCT02670330|559019168|FG000|Overall Study|Lost to Follow-up|3|||
154890138|NCT02670330|559019169|FG001|Overall Study|Lost to Follow-up|2|||
154890139|NCT04404010|559019170|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
154890140|NCT04404010|559019171|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
154890141|NCT02120157|559019172|FG000|Overall Study|Death|8|||
154890142|NCT01354431|559019176|FG000|Pre-Treatment Period|Not reported|1|||
154890143|NCT01354431|559019177|FG001|Pre-Treatment Period|Not reported|0|||
154890144|NCT01354431|559019178|FG002|Pre-Treatment Period|Not reported|0|||
154890145|NCT01354431|559019176|FG000|Treatment Period|Disease Progression|50|||
154890146|NCT01354431|559019177|FG001|Treatment Period|Disease Progression|40|||
154890147|NCT01354431|559019178|FG002|Treatment Period|Disease Progression|44|||
154890148|NCT01354431|559019176|FG000|Treatment Period|Study Drug Toxicity|5|||
154890149|NCT01354431|559019177|FG001|Treatment Period|Study Drug Toxicity|8|||
154890150|NCT01354431|559019178|FG002|Treatment Period|Study Drug Toxicity|4|||
154890151|NCT01354431|559019176|FG000|Treatment Period|Death|0|||
154890152|NCT01354431|559019177|FG001|Treatment Period|Death|1|||
154890153|NCT01354431|559019178|FG002|Treatment Period|Death|0|||
154890154|NCT01354431|559019176|FG000|Treatment Period|AE unrelated to study drug|1|||
154890155|NCT01354431|559019177|FG001|Treatment Period|AE unrelated to study drug|2|||
154890156|NCT01354431|559019178|FG002|Treatment Period|AE unrelated to study drug|5|||
154890157|NCT01354431|559019176|FG000|Treatment Period|Participant request to discontinue|2|||
154890158|NCT01354431|559019177|FG001|Treatment Period|Participant request to discontinue|2|||
154890159|NCT01354431|559019178|FG002|Treatment Period|Participant request to discontinue|1|||
154890160|NCT01354431|559019176|FG000|Treatment Period|Participant withdrew consent|0|||
154890161|NCT01354431|559019177|FG001|Treatment Period|Participant withdrew consent|1|||
154890162|NCT01354431|559019178|FG002|Treatment Period|Participant withdrew consent|0|||
154890163|NCT01354431|559019176|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
154890164|NCT01354431|559019177|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
154890165|NCT01354431|559019178|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
154890166|NCT03176277|559019179|FG000|Part A Dose Escalation Study|Adverse Event|1|||
154890167|NCT03176277|559019180|FG001|Part A Dose Escalation Study|Adverse Event|0|||
154890168|NCT03176277|559019181|FG002|Part A Dose Escalation Study|Adverse Event|1|||
154890169|NCT03176277|559019182|FG003|Part A Dose Escalation Study|Adverse Event|0|||
154890170|NCT03176277|559019179|FG000|Part A Dose Escalation Study|Physician Decision|1|||
154890171|NCT03176277|559019180|FG001|Part A Dose Escalation Study|Physician Decision|1|||
154890172|NCT03176277|559019181|FG002|Part A Dose Escalation Study|Physician Decision|2|||
154890173|NCT03176277|559019182|FG003|Part A Dose Escalation Study|Physician Decision|0|||
154890174|NCT03176277|559019179|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
154890175|NCT03176277|559019180|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
154890176|NCT03176277|559019181|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
154890177|NCT03176277|559019182|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
154890178|NCT03176277|559019179|FG000|Part A Dose Escalation Study|Progressive disease|3|||
154890179|NCT03176277|559019180|FG001|Part A Dose Escalation Study|Progressive disease|1|||
154890180|NCT03176277|559019181|FG002|Part A Dose Escalation Study|Progressive disease|3|||
154890181|NCT03176277|559019182|FG003|Part A Dose Escalation Study|Progressive disease|0|||
154890182|NCT02802878|559019183|FG000|Overall Study|Withdrawal by Subject|3|||
154890183|NCT02802878|559019184|FG001|Overall Study|Withdrawal by Subject|3|||
154890184|NCT02802878|559019183|FG000|Overall Study|Protocol Violation|1|||
154890185|NCT02802878|559019184|FG001|Overall Study|Protocol Violation|0|||
154890186|NCT00702052|559019185|FG000|Overall Study|Adverse Event|23|||
154890187|NCT00702052|559019185|FG000|Overall Study|Disease Progression|30|||
155175602|NCT01215916|560080275|FG003|Overall Study|Physician Decision|1|||
154890188|NCT00702052|559019185|FG000|Overall Study|Withdrawal by Subject|5|||
154890189|NCT00101192|559019186|FG000|Overall Study|Ineligible|6|||
154890190|NCT00101192|559019186|FG000|Overall Study|Inevaluable|1|||
154890191|NCT03691610|559019187|FG000|Overall Study|Adverse Event|0|||
154890192|NCT03691610|559019188|FG001|Overall Study|Adverse Event|1|||
154890193|NCT03691610|559019189|FG002|Overall Study|Adverse Event|0|||
154890194|NCT03691610|559019190|FG003|Overall Study|Adverse Event|0|||
155175603|NCT01215916|560080276|FG004|Overall Study|Physician Decision|0|||
154890195|NCT03691610|559019187|FG000|Overall Study|Protocol Deviation|15|||
154890196|NCT03691610|559019188|FG001|Overall Study|Protocol Deviation|8|||
154890197|NCT03691610|559019189|FG002|Overall Study|Protocol Deviation|1|||
154977741|NCT05068284|559340965|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
154977742|NCT05068284|559340966|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
154977743|NCT05068284|559340967|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
154977744|NCT05068284|559340968|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
154977745|NCT05068284|559340969|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
154977746|NCT05068284|559340970|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
154977747|NCT05068284|559340971|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
154977748|NCT05068284|559340972|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
154977749|NCT05068284|559340965|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977750|NCT05068284|559340966|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977751|NCT05068284|559340967|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
154977752|NCT05068284|559340968|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977753|NCT05068284|559340969|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977754|NCT05068284|559340970|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977755|NCT05068284|559340971|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977756|NCT05068284|559340972|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
154977757|NCT05068284|559340965|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
154977758|NCT05068284|559340966|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
154977759|NCT05068284|559340967|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
154977760|NCT05068284|559340968|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
155113925|NCT01463696|559846173|FG003|Overall Study|Progressive Disease|1|||
155113926|NCT01463696|559846174|FG004|Overall Study|Progressive Disease|0|||
154890198|NCT03691610|559019190|FG003|Overall Study|Protocol Deviation|2|||
154890199|NCT03691610|559019187|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
154890200|NCT03691610|559019188|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
154890201|NCT03691610|559019189|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
154890202|NCT03691610|559019190|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
154890203|NCT03691610|559019187|FG000|Overall Study|Lost to Follow-up|20|||
154890204|NCT03691610|559019188|FG001|Overall Study|Lost to Follow-up|11|||
154890205|NCT03691610|559019189|FG002|Overall Study|Lost to Follow-up|5|||
154890206|NCT03691610|559019190|FG003|Overall Study|Lost to Follow-up|2|||
154890207|NCT00242580|559019191|FG000|Overall Study|Adverse Event|3|||
154890208|NCT00242580|559019192|FG001|Overall Study|Adverse Event|0|||
154890209|NCT00242580|559019193|FG002|Overall Study|Adverse Event|2|||
154890210|NCT00242580|559019191|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154890211|NCT00242580|559019192|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
154890212|NCT00242580|559019193|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
154890213|NCT00242580|559019191|FG000|Overall Study|Protocol Violation|0|||
154890214|NCT00242580|559019192|FG001|Overall Study|Protocol Violation|0|||
154890215|NCT00242580|559019193|FG002|Overall Study|Protocol Violation|1|||
154890216|NCT00242580|559019191|FG000|Overall Study|Subject withdrew consent|2|||
154890217|NCT00242580|559019192|FG001|Overall Study|Subject withdrew consent|2|||
154890218|NCT00242580|559019193|FG002|Overall Study|Subject withdrew consent|5|||
154890219|NCT00242580|559019191|FG000|Overall Study|Lost to Follow-up|0|||
154890220|NCT00242580|559019192|FG001|Overall Study|Lost to Follow-up|3|||
154890221|NCT00242580|559019193|FG002|Overall Study|Lost to Follow-up|0|||
154890222|NCT00242580|559019191|FG000|Overall Study|Death|1|||
154890223|NCT00242580|559019192|FG001|Overall Study|Death|2|||
154890224|NCT00242580|559019193|FG002|Overall Study|Death|1|||
154890225|NCT01232894|559019194|FG000|Overall Study|Lost to Follow-up|0|||
154890226|NCT01232894|559019195|FG001|Overall Study|Lost to Follow-up|1|||
154890227|NCT01232894|559019194|FG000|Overall Study|Death|1|||
154890228|NCT01232894|559019195|FG001|Overall Study|Death|0|||
154890229|NCT01232894|559019194|FG000|Overall Study|Protocol Violation|1|||
154890230|NCT01232894|559019195|FG001|Overall Study|Protocol Violation|1|||
154890231|NCT01232894|559019194|FG000|Overall Study|Withdrawal by Subject|8|||
154890232|NCT01232894|559019195|FG001|Overall Study|Withdrawal by Subject|5|||
154890233|NCT01232894|559019194|FG000|Overall Study|Physician Decision|2|||
154890234|NCT01232894|559019195|FG001|Overall Study|Physician Decision|1|||
154890235|NCT03970395|559019198|FG000|Overall Study|Withdrawal by Subject|3|||
154890236|NCT03970395|559019199|FG001|Overall Study|Withdrawal by Subject|4|||
154890237|NCT03970395|559019198|FG000|Overall Study|Lost to Follow-up|4|||
154890238|NCT03970395|559019199|FG001|Overall Study|Lost to Follow-up|8|||
154977761|NCT05068284|559340969|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
154977762|NCT05068284|559340970|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
154977763|NCT05068284|559340971|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
154977764|NCT05068284|559340972|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
154977765|NCT05068284|559340965|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
154977766|NCT05068284|559340966|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
154890239|NCT00929734|559019200|FG000|Overall Study|Lost to Follow-up|2|||
154890240|NCT00929734|559019201|FG001|Overall Study|Lost to Follow-up|1|||
154890241|NCT00929734|559019200|FG000|Overall Study|Withdrawal by Subject|0|||
154890242|NCT00929734|559019201|FG001|Overall Study|Withdrawal by Subject|2|||
154890243|NCT03666858|559019202|FG000|Cohort 1|Adverse Event|1|||
154890244|NCT03666858|559019203|FG001|Cohort 1|Adverse Event|0|||
154890245|NCT03666858|559019202|FG000|Cohort 2|Adverse Event|0|||
154890246|NCT03666858|559019203|FG001|Cohort 2|Adverse Event|1|||
154890247|NCT02921919|559019204|FG000|Overall Study|Other|5|||
154890248|NCT02921919|559019205|FG001|Overall Study|Other|6|||
154890249|NCT02921919|559019204|FG000|Overall Study|Lost to Follow-up|0|||
154890250|NCT02921919|559019205|FG001|Overall Study|Lost to Follow-up|1|||
154890251|NCT02921919|559019204|FG000|Overall Study|Withdrawal by Subject|5|||
154890252|NCT02921919|559019205|FG001|Overall Study|Withdrawal by Subject|1|||
154890253|NCT02921919|559019204|FG000|Overall Study|Disease Progression|47|||
154890254|NCT02921919|559019205|FG001|Overall Study|Disease Progression|38|||
154890255|NCT02921919|559019204|FG000|Overall Study|Physician Decision|3|||
154890256|NCT02921919|559019205|FG001|Overall Study|Physician Decision|2|||
154890257|NCT02921919|559019204|FG000|Overall Study|Adverse Event|6|||
154890258|NCT02921919|559019205|FG001|Overall Study|Adverse Event|4|||
154890259|NCT00980980|559019206|FG000|Overall Study|Withdrawal by Hospital|0|||
154890260|NCT00980980|559019207|FG001|Overall Study|Withdrawal by Hospital|1|||
154890261|NCT00980980|559019208|FG002|Overall Study|Withdrawal by Hospital|0|||
154890262|NCT00121992|559019210|FG000|Overall Study|Treatment not received|2|||
154890263|NCT00121992|559019211|FG001|Overall Study|Treatment not received|11|||
154890264|NCT03282357|559019212|FG000|Overall Study|Lost to Follow-up|3|||
154890265|NCT03282357|559019212|FG000|Overall Study|Withdrawal by Subject|4|||
154890266|NCT03282357|559019212|FG000|Overall Study|Adverse Event|1|||
154890267|NCT03282357|559019212|FG000|Overall Study|Other|9|||
154890268|NCT03550131|559019213|FG000|Overall Study|Lost to Follow-up|16|||
154890269|NCT03550131|559019214|FG001|Overall Study|Lost to Follow-up|24|||
154890270|NCT03550131|559019213|FG000|Overall Study|Withdrawal by Subject|36|||
154890271|NCT03550131|559019214|FG001|Overall Study|Withdrawal by Subject|28|||
154890272|NCT03550131|559019213|FG000|Overall Study|Illness of dyad member|10|||
154890273|NCT03550131|559019214|FG001|Overall Study|Illness of dyad member|2|||
154890274|NCT03550131|559019213|FG000|Overall Study|Death of person with dementia|4|||
154890275|NCT03550131|559019214|FG001|Overall Study|Death of person with dementia|8|||
154890276|NCT01318512|559019215|FG000|Maintenance Period (6 Months)|Death|2|||
154890277|NCT01318512|559019215|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
154890278|NCT02756650|559019218|FG000|Overall Study|Physician Decision|1|||
154890279|NCT02756650|559019218|FG000|Overall Study|Adverse Event|1|||
154890280|NCT04348591|559019224|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
154890281|NCT04348591|559019225|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
154890282|NCT04348591|559019224|FG000|Imaging Session (120 Min)|Physician Decision|0|||
154890283|NCT04348591|559019225|FG001|Imaging Session (120 Min)|Physician Decision|1|||
154890284|NCT04348591|559019224|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
154890285|NCT04348591|559019225|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
154890286|NCT00910429|559019228|FG000|Overall Study|Death|18|||
154890287|NCT00910429|559019229|FG001|Overall Study|Death|12|||
154890288|NCT00910429|559019228|FG000|Overall Study|Withdrawal by Subject|3|||
154890289|NCT00910429|559019229|FG001|Overall Study|Withdrawal by Subject|2|||
154890290|NCT00910429|559019228|FG000|Overall Study|Protocol Violation|1|||
154890291|NCT00910429|559019229|FG001|Overall Study|Protocol Violation|0|||
154890292|NCT00910429|559019228|FG000|Overall Study|Lost to Follow-up|2|||
154890293|NCT00910429|559019229|FG001|Overall Study|Lost to Follow-up|1|||
154890294|NCT00910429|559019228|FG000|Overall Study|Adverse Event|10|||
154890295|NCT00910429|559019229|FG001|Overall Study|Adverse Event|5|||
154890296|NCT00910429|559019228|FG000|Overall Study|Drug non-compliance|1|||
154890297|NCT00910429|559019229|FG001|Overall Study|Drug non-compliance|0|||
154890298|NCT00910429|559019228|FG000|Overall Study|Lack of Efficacy|4|||
154890299|NCT00910429|559019229|FG001|Overall Study|Lack of Efficacy|1|||
154890300|NCT01317615|559019230|FG000|Overall Study|Disease progression|25|||
154890301|NCT01317615|559019230|FG000|Overall Study|New cancer therapy|5|||
154890302|NCT01317615|559019230|FG000|Overall Study|Death|6|||
154890303|NCT01317615|559019230|FG000|Overall Study|Withdrawal by Subject|5|||
154890304|NCT01317615|559019230|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154890305|NCT01317615|559019230|FG000|Overall Study|Adverse Event|7|||
154890306|NCT02648724|559019234|FG000|Overall Study|Withdrawal by Subject|0|||
154890307|NCT02648724|559019235|FG001|Overall Study|Withdrawal by Subject|1|||
154890308|NCT02648724|559019236|FG002|Overall Study|Withdrawal by Subject|1|||
154890309|NCT02648724|559019237|FG003|Overall Study|Withdrawal by Subject|0|||
154890310|NCT02648724|559019238|FG004|Overall Study|Withdrawal by Subject|1|||
154890311|NCT02648724|559019239|FG005|Overall Study|Withdrawal by Subject|0|||
154890312|NCT02648724|559019240|FG006|Overall Study|Withdrawal by Subject|0|||
154890313|NCT02648724|559019234|FG000|Overall Study|Progressive disease|2|||
154890314|NCT02648724|559019235|FG001|Overall Study|Progressive disease|2|||
154890315|NCT02648724|559019236|FG002|Overall Study|Progressive disease|2|||
154890316|NCT02648724|559019237|FG003|Overall Study|Progressive disease|3|||
154890317|NCT02648724|559019238|FG004|Overall Study|Progressive disease|22|||
154890318|NCT02648724|559019239|FG005|Overall Study|Progressive disease|7|||
154890319|NCT02648724|559019240|FG006|Overall Study|Progressive disease|8|||
154890320|NCT02648724|559019234|FG000|Overall Study|Other reason (unknown)|1|||
154890321|NCT02648724|559019235|FG001|Overall Study|Other reason (unknown)|0|||
154890322|NCT02648724|559019236|FG002|Overall Study|Other reason (unknown)|0|||
154890323|NCT02648724|559019237|FG003|Overall Study|Other reason (unknown)|0|||
154890324|NCT02648724|559019238|FG004|Overall Study|Other reason (unknown)|0|||
154890325|NCT02648724|559019239|FG005|Overall Study|Other reason (unknown)|0|||
154890326|NCT02648724|559019240|FG006|Overall Study|Other reason (unknown)|0|||
154890327|NCT02648724|559019234|FG000|Overall Study|Protocol Violation|0|||
154890328|NCT02648724|559019235|FG001|Overall Study|Protocol Violation|0|||
154890329|NCT02648724|559019236|FG002|Overall Study|Protocol Violation|0|||
154890330|NCT02648724|559019237|FG003|Overall Study|Protocol Violation|0|||
154890331|NCT02648724|559019238|FG004|Overall Study|Protocol Violation|1|||
154890332|NCT02648724|559019239|FG005|Overall Study|Protocol Violation|0|||
154890333|NCT02648724|559019240|FG006|Overall Study|Protocol Violation|0|||
154890334|NCT02648724|559019234|FG000|Overall Study|Death|0|||
154890335|NCT02648724|559019235|FG001|Overall Study|Death|0|||
154890336|NCT02648724|559019236|FG002|Overall Study|Death|0|||
154890337|NCT02648724|559019237|FG003|Overall Study|Death|0|||
154890338|NCT02648724|559019238|FG004|Overall Study|Death|0|||
154890339|NCT02648724|559019239|FG005|Overall Study|Death|0|||
154890340|NCT02648724|559019240|FG006|Overall Study|Death|3|||
154890341|NCT02648724|559019234|FG000|Overall Study|Physician Decision|0|||
154890342|NCT02648724|559019235|FG001|Overall Study|Physician Decision|0|||
154890343|NCT02648724|559019236|FG002|Overall Study|Physician Decision|0|||
154890344|NCT02648724|559019237|FG003|Overall Study|Physician Decision|0|||
154890345|NCT02648724|559019238|FG004|Overall Study|Physician Decision|1|||
154890346|NCT02648724|559019239|FG005|Overall Study|Physician Decision|0|||
154890347|NCT02648724|559019240|FG006|Overall Study|Physician Decision|1|||
154890348|NCT02648724|559019234|FG000|Overall Study|Transferred to named patient program|0|||
154890349|NCT02648724|559019235|FG001|Overall Study|Transferred to named patient program|0|||
154890350|NCT02648724|559019236|FG002|Overall Study|Transferred to named patient program|0|||
154890351|NCT02648724|559019237|FG003|Overall Study|Transferred to named patient program|0|||
154890352|NCT02648724|559019238|FG004|Overall Study|Transferred to named patient program|0|||
154890353|NCT02648724|559019239|FG005|Overall Study|Transferred to named patient program|1|||
154890354|NCT02648724|559019240|FG006|Overall Study|Transferred to named patient program|0|||
154890355|NCT00302718|559019241|FG000|Overall Study|Participant left the hospital|1|||
154890356|NCT00302718|559019242|FG001|Overall Study|Participant left the hospital|0|||
154890357|NCT00302718|559019243|FG002|Overall Study|Participant left the hospital|0|||
154890358|NCT00302718|559019244|FG003|Overall Study|Participant left the hospital|1|||
154890359|NCT00302718|559019241|FG000|Overall Study|Withdrawal by Subject|0|||
154890360|NCT00302718|559019242|FG001|Overall Study|Withdrawal by Subject|1|||
154890361|NCT00302718|559019243|FG002|Overall Study|Withdrawal by Subject|0|||
154890362|NCT00302718|559019244|FG003|Overall Study|Withdrawal by Subject|0|||
154890363|NCT00302718|559019241|FG000|Overall Study|Participant left primary care setting|0|||
154890364|NCT00302718|559019242|FG001|Overall Study|Participant left primary care setting|0|||
154890365|NCT00302718|559019243|FG002|Overall Study|Participant left primary care setting|2|||
154890366|NCT00302718|559019244|FG003|Overall Study|Participant left primary care setting|1|||
154890367|NCT00632541|559019245|FG000|Overall Study|Adverse Event|7|||
154890368|NCT06025396|559020499|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
154890369|NCT06025396|559020500|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
154890370|NCT06025396|559020501|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
154890371|NCT06025396|559020502|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
154890372|NCT06025396|559020503|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
154890373|NCT06025396|559020499|FG000|Overall Study|Withdrawal by Subject|0|||
154890374|NCT06025396|559020500|FG001|Overall Study|Withdrawal by Subject|1|||
154890375|NCT06025396|559020501|FG002|Overall Study|Withdrawal by Subject|1|||
154890376|NCT06025396|559020502|FG003|Overall Study|Withdrawal by Subject|0|||
154890377|NCT06025396|559020503|FG004|Overall Study|Withdrawal by Subject|0|||
154890378|NCT01512108|559020504|FG000|Overall Study|Adverse Event|9|||
154890379|NCT01512108|559020505|FG001|Overall Study|Adverse Event|4|||
154890380|NCT01512108|559020504|FG000|Overall Study|Protocol Violation|1|||
154890381|NCT01512108|559020505|FG001|Overall Study|Protocol Violation|2|||
154890382|NCT01512108|559020504|FG000|Overall Study|Withdrawal Criteria|1|||
154890383|NCT01512108|559020505|FG001|Overall Study|Withdrawal Criteria|0|||
154890384|NCT01512108|559020504|FG000|Overall Study|Unclassified|11|||
154890385|NCT01512108|559020505|FG001|Overall Study|Unclassified|3|||
154890386|NCT06422377|559020506|FG000|Overall Study|Study Terminated by Sponsor|1|||
154890387|NCT02420795|559020508|FG000|Overall Study|Withdrawal by Subject|1|||
154890388|NCT02420795|559020509|FG001|Overall Study|Withdrawal by Subject|0|||
154890389|NCT02420795|559020510|FG002|Overall Study|Withdrawal by Subject|0|||
154890390|NCT02420795|559020508|FG000|Overall Study|Adverse Event|1|||
154890391|NCT02420795|559020509|FG001|Overall Study|Adverse Event|0|||
154890392|NCT02420795|559020510|FG002|Overall Study|Adverse Event|0|||
154890393|NCT02420795|559020508|FG000|Overall Study|Progressive disease|2|||
154890394|NCT02420795|559020509|FG001|Overall Study|Progressive disease|2|||
154890395|NCT02420795|559020510|FG002|Overall Study|Progressive disease|4|||
154890396|NCT02420795|559020508|FG000|Overall Study|Death|0|||
155113927|NCT01463696|559846175|FG005|Overall Study|Progressive Disease|1|||
154890397|NCT02420795|559020509|FG001|Overall Study|Death|0|||
154890398|NCT02420795|559020510|FG002|Overall Study|Death|1|||
154890399|NCT04019795|559020512|FG000|Overall Study|Withdrawal by Subject|1|||
154890400|NCT04019795|559020513|FG001|Overall Study|Withdrawal by Subject|2|||
154890401|NCT04019795|559020514|FG002|Overall Study|Withdrawal by Subject|2|||
154890402|NCT04019795|559020515|FG003|Overall Study|Withdrawal by Subject|1|||
154890403|NCT04019795|559020512|FG000|Overall Study|Lost to Follow-up|0|||
154890404|NCT04019795|559020513|FG001|Overall Study|Lost to Follow-up|1|||
154890405|NCT04019795|559020514|FG002|Overall Study|Lost to Follow-up|1|||
154890406|NCT04019795|559020515|FG003|Overall Study|Lost to Follow-up|2|||
154890407|NCT04019795|559020512|FG000|Overall Study|Treatment non-compliance|3|||
154890408|NCT04019795|559020513|FG001|Overall Study|Treatment non-compliance|1|||
154890409|NCT04019795|559020514|FG002|Overall Study|Treatment non-compliance|2|||
154890410|NCT04019795|559020515|FG003|Overall Study|Treatment non-compliance|0|||
154890411|NCT04019795|559020512|FG000|Overall Study|Physician Decision|0|||
154890412|NCT04019795|559020513|FG001|Overall Study|Physician Decision|0|||
154890413|NCT04019795|559020514|FG002|Overall Study|Physician Decision|1|||
154890414|NCT04019795|559020515|FG003|Overall Study|Physician Decision|0|||
154890415|NCT04019795|559020512|FG000|Overall Study|Adverse Event|1|||
154890416|NCT04019795|559020513|FG001|Overall Study|Adverse Event|0|||
154890417|NCT04019795|559020514|FG002|Overall Study|Adverse Event|0|||
154890418|NCT04019795|559020515|FG003|Overall Study|Adverse Event|0|||
154890419|NCT01280266|559020516|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
154890420|NCT01280266|559020517|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
154890421|NCT01280266|559020516|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
154890422|NCT01280266|559020517|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
154890423|NCT04116073|559020525|FG000|Overall Study|Withdrawal by Subject|2|||
154890424|NCT04116073|559020525|FG000|Overall Study|failed to maintained eligibility|1|||
154890425|NCT01082367|559020528|FG000|Double-blind Period|Administrative problems|0|||
154890426|NCT01082367|559020529|FG001|Double-blind Period|Administrative problems|1|||
154890427|NCT01082367|559020528|FG000|Double-blind Period|Lack of Efficacy|5|||
154890428|NCT01082367|559020529|FG001|Double-blind Period|Lack of Efficacy|11|||
154890429|NCT01082367|559020528|FG000|Double-blind Period|Adverse Event|0|||
154890430|NCT01082367|559020529|FG001|Double-blind Period|Adverse Event|1|||
154890431|NCT01082367|559020528|FG000|Follow-up (F-U) Period|Administrative problems|1|||
154890432|NCT01082367|559020529|FG001|Follow-up (F-U) Period|Administrative problems|0|||
154890433|NCT01082367|559020528|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
154890434|NCT01082367|559020529|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
154890435|NCT01082367|559020528|FG000|Follow-up (F-U) Period|Adverse Event|0|||
154890436|NCT01082367|559020529|FG001|Follow-up (F-U) Period|Adverse Event|1|||
154890437|NCT01879319|559020535|FG000|Overall Study|Withdrawal by Subject|1|||
154890438|NCT01879319|559020536|FG001|Overall Study|Withdrawal by Subject|0|||
154890439|NCT01879319|559020535|FG000|Overall Study|Lost to Follow-up|1|||
154890440|NCT01879319|559020536|FG001|Overall Study|Lost to Follow-up|5|||
154890441|NCT03067129|559020537|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
154890442|NCT03067129|559020538|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
154890443|NCT03067129|559020539|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
154890444|NCT03067129|559020540|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
154890445|NCT03067129|559020537|FG000|Overall Study|Withdrawal by Subject|0|||
154890446|NCT03067129|559020538|FG001|Overall Study|Withdrawal by Subject|0|||
154890447|NCT03067129|559020539|FG002|Overall Study|Withdrawal by Subject|1|||
154890448|NCT03067129|559020540|FG003|Overall Study|Withdrawal by Subject|2|||
154890449|NCT03067129|559020537|FG000|Overall Study|Lost to Follow-up|5|||
154890450|NCT03067129|559020538|FG001|Overall Study|Lost to Follow-up|5|||
154890451|NCT03067129|559020539|FG002|Overall Study|Lost to Follow-up|4|||
154890452|NCT03067129|559020540|FG003|Overall Study|Lost to Follow-up|3|||
154890453|NCT00664209|559020546|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
154890454|NCT00664209|559020546|FG000|Study Treatment Period|Physician Decision|4|||
154890455|NCT00664209|559020546|FG000|Study Treatment Period|Withdrawal by Subject|2|||
155113928|NCT01463696|559846176|FG006|Overall Study|Progressive Disease|4|||
154890456|NCT00843843|559020551|FG000|Overall Study|Physician Decision|1|||
154890457|NCT00843843|559020552|FG001|Overall Study|Physician Decision|1|||
154890458|NCT00843843|559020551|FG000|Overall Study|Protocol Violation|1|||
154890459|NCT00843843|559020552|FG001|Overall Study|Protocol Violation|1|||
154890460|NCT00418379|559020553|FG000|Year 1|Adverse Event|9|||
154890461|NCT00418379|559020554|FG001|Year 1|Adverse Event|15|||
154890462|NCT00418379|559020555|FG002|Year 1|Adverse Event|3|||
154890463|NCT00418379|559020553|FG000|Year 1|Withdrawal by Subject|7|||
154890464|NCT00418379|559020554|FG001|Year 1|Withdrawal by Subject|8|||
154890465|NCT00418379|559020555|FG002|Year 1|Withdrawal by Subject|5|||
154890466|NCT00418379|559020553|FG000|Year 1|Any other reason not above-mentioned|2|||
154890467|NCT00418379|559020554|FG001|Year 1|Any other reason not above-mentioned|5|||
154890468|NCT00418379|559020555|FG002|Year 1|Any other reason not above-mentioned|7|||
154890469|NCT00418379|559020553|FG000|Year 2|Adverse Event|5|||
155113929|NCT01463696|559846177|FG007|Overall Study|Progressive Disease|2|||
154890470|NCT00418379|559020554|FG001|Year 2|Adverse Event|2|||
154890471|NCT00418379|559020555|FG002|Year 2|Adverse Event|1|||
154890472|NCT00418379|559020553|FG000|Year 2|Withdrawal by Subject|1|||
154890473|NCT00418379|559020554|FG001|Year 2|Withdrawal by Subject|1|||
154890474|NCT00418379|559020555|FG002|Year 2|Withdrawal by Subject|3|||
154890475|NCT00418379|559020553|FG000|Year 2|Any other reason not above-mentioned|2|||
154890476|NCT00418379|559020554|FG001|Year 2|Any other reason not above-mentioned|1|||
154890477|NCT00418379|559020555|FG002|Year 2|Any other reason not above-mentioned|6|||
154890478|NCT00418379|559020553|FG000|Year 3|Withdrawal by Subject|1|||
154890479|NCT00418379|559020554|FG001|Year 3|Withdrawal by Subject|1|||
154890480|NCT00418379|559020555|FG002|Year 3|Withdrawal by Subject|2|||
154890481|NCT00418379|559020553|FG000|Year 3|Any other reason not above-mentioned|2|||
154890482|NCT00418379|559020554|FG001|Year 3|Any other reason not above-mentioned|1|||
154890483|NCT00418379|559020555|FG002|Year 3|Any other reason not above-mentioned|1|||
154890484|NCT00418379|559020553|FG000|Year 4|Adverse Event|0|||
154890485|NCT00418379|559020554|FG001|Year 4|Adverse Event|1|||
154890486|NCT00418379|559020555|FG002|Year 4|Adverse Event|0|||
154890487|NCT00418379|559020553|FG000|Year 4|Withdrawal by Subject|2|||
154890488|NCT00418379|559020554|FG001|Year 4|Withdrawal by Subject|3|||
154890489|NCT00418379|559020555|FG002|Year 4|Withdrawal by Subject|2|||
154890490|NCT00418379|559020553|FG000|Year 4|Any other reason not above-mentioned|1|||
154890491|NCT00418379|559020554|FG001|Year 4|Any other reason not above-mentioned|1|||
154890492|NCT00418379|559020555|FG002|Year 4|Any other reason not above-mentioned|0|||
154890493|NCT00418379|559020553|FG000|Year 5|Adverse Event|0|||
154890494|NCT00418379|559020554|FG001|Year 5|Adverse Event|1|||
154890495|NCT00418379|559020555|FG002|Year 5|Adverse Event|0|||
154890496|NCT00418379|559020553|FG000|Year 5|Any other reason not above-mentioned|2|||
154890497|NCT00418379|559020554|FG001|Year 5|Any other reason not above-mentioned|4|||
154890498|NCT00418379|559020555|FG002|Year 5|Any other reason not above-mentioned|3|||
154890499|NCT00065442|559020556|FG000|Overall Study|Lost to Follow-up|1|||
154890500|NCT00065442|559020557|FG001|Overall Study|Lost to Follow-up|1|||
154890501|NCT00065442|559020556|FG000|Overall Study|Death|121|||
154890502|NCT00065442|559020557|FG001|Overall Study|Death|210|||
154890503|NCT00065442|559020556|FG000|Overall Study|Withdrawal by Subject|3|||
154890504|NCT00065442|559020557|FG001|Overall Study|Withdrawal by Subject|9|||
154890505|NCT01594333|559020558|FG000|Overall Study|Death|96|||
154890506|NCT01594333|559020559|FG001|Overall Study|Death|83|||
154890507|NCT01594333|559020558|FG000|Overall Study|Lost to Follow-up|5|||
154890508|NCT01594333|559020559|FG001|Overall Study|Lost to Follow-up|5|||
154890509|NCT01594333|559020558|FG000|Overall Study|Withdrawal by Subject|60|||
154890510|NCT01594333|559020559|FG001|Overall Study|Withdrawal by Subject|63|||
154890511|NCT01764256|559020560|FG000|Received All Vaccinations|Adverse Event|1|||
154890512|NCT01764256|559020561|FG001|Received All Vaccinations|Adverse Event|1|||
154890513|NCT01764256|559020562|FG002|Received All Vaccinations|Adverse Event|0|||
154890514|NCT01764256|559020563|FG003|Received All Vaccinations|Adverse Event|0|||
154890515|NCT01764256|559020560|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
154890516|NCT01764256|559020561|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
154890517|NCT01764256|559020562|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
154890518|NCT01764256|559020563|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
154890519|NCT01764256|559020560|FG000|Received All Vaccinations|Lost to Follow-up|1|||
154890520|NCT01764256|559020561|FG001|Received All Vaccinations|Lost to Follow-up|0|||
154890521|NCT01764256|559020562|FG002|Received All Vaccinations|Lost to Follow-up|0|||
154890522|NCT01764256|559020563|FG003|Received All Vaccinations|Lost to Follow-up|0|||
154890523|NCT01764256|559020560|FG000|Completed Study|Lost to Follow-up|0|||
154890524|NCT01764256|559020561|FG001|Completed Study|Lost to Follow-up|0|||
154890525|NCT01764256|559020562|FG002|Completed Study|Lost to Follow-up|0|||
154890526|NCT01764256|559020563|FG003|Completed Study|Lost to Follow-up|1|||
154890527|NCT00565058|559020564|FG000|Overall Study|Adverse Event|1|||
154890528|NCT00565058|559020565|FG001|Overall Study|Adverse Event|0|||
154977767|NCT05068284|559340967|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
154977768|NCT05068284|559340968|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
154977769|NCT05068284|559340969|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
154890529|NCT00304915|559020566|FG000|Overall Study|Lost to Follow-up|11|||
154890530|NCT00304915|559020567|FG001|Overall Study|Lost to Follow-up|11|||
154890531|NCT00304915|559020566|FG000|Overall Study|Death|4|||
154890532|NCT00304915|559020567|FG001|Overall Study|Death|5|||
154890533|NCT00304915|559020566|FG000|Overall Study|Withdrawal by Subject|3|||
154890534|NCT00304915|559020567|FG001|Overall Study|Withdrawal by Subject|0|||
154890535|NCT02029638|559020568|FG000|Overall Study|Death|0|||
154890536|NCT02029638|559020569|FG001|Overall Study|Death|0|||
154890537|NCT02029638|559020570|FG002|Overall Study|Death|1|||
154890538|NCT02029638|559020568|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
154890539|NCT02029638|559020569|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
154890540|NCT02029638|559020570|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
154890541|NCT05489081|559020572|FG000|Overall Study|student left classroom|0|||
154890542|NCT05489081|559020573|FG001|Overall Study|student left classroom|1|||
154890543|NCT05489081|559020572|FG000|Overall Study|teacher left school|0|||
154890544|NCT05489081|559020573|FG001|Overall Study|teacher left school|2|||
154890545|NCT00712322|559020577|FG000|Overall Study|Protocol deviation|0|||
154890546|NCT00712322|559020578|FG001|Overall Study|Protocol deviation|1|||
154890547|NCT00712322|559020579|FG002|Overall Study|Protocol deviation|0|||
154890548|NCT00400712|559020582|FG000|Overall Study|Death|1|||
154890549|NCT00400712|559020583|FG001|Overall Study|Death|0|||
154890550|NCT00400712|559020582|FG000|Overall Study|Withdrawal by Subject|11|||
154890551|NCT00400712|559020583|FG001|Overall Study|Withdrawal by Subject|12|||
154890552|NCT00400712|559020582|FG000|Overall Study|Physician Decision|5|||
154890553|NCT00400712|559020583|FG001|Overall Study|Physician Decision|4|||
154890554|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
154890555|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
154890556|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
154890557|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
154890558|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
154890559|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
154890560|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Death|1|||
154890561|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Death|3|||
154890562|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
154890563|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
154890564|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
154890565|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
154890566|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
154890567|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
154890568|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
154890569|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
154890570|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
154890571|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
154890572|NCT02553317|559020587|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
154890573|NCT02553317|559020588|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
154890574|NCT00536978|559020592|FG000|Overall Study|Not eligible for Adback Infusion|22|||
154890575|NCT00622869|559020593|FG000|Overall Study|Subject Withdrew Consent|13|||
154890576|NCT00622869|559020594|FG001|Overall Study|Subject Withdrew Consent|17|||
154890577|NCT00622869|559020595|FG002|Overall Study|Subject Withdrew Consent|11|||
154890578|NCT00622869|559020593|FG000|Overall Study|Administrative Problems|11|||
154890579|NCT00622869|559020594|FG001|Overall Study|Administrative Problems|17|||
154890580|NCT00622869|559020595|FG002|Overall Study|Administrative Problems|13|||
154890581|NCT00622869|559020593|FG000|Overall Study|Death|12|||
154890582|NCT00622869|559020594|FG001|Overall Study|Death|15|||
154890583|NCT00622869|559020595|FG002|Overall Study|Death|10|||
154890584|NCT00622869|559020593|FG000|Overall Study|Lost to Follow-up|2|||
154890585|NCT00622869|559020594|FG001|Overall Study|Lost to Follow-up|4|||
154890586|NCT00622869|559020595|FG002|Overall Study|Lost to Follow-up|2|||
154890587|NCT00622869|559020593|FG000|Overall Study|Graft Loss|5|||
154890588|NCT00622869|559020594|FG001|Overall Study|Graft Loss|3|||
154890589|NCT00622869|559020595|FG002|Overall Study|Graft Loss|2|||
154890590|NCT00622869|559020593|FG000|Overall Study|Missing|0|||
154890591|NCT00622869|559020594|FG001|Overall Study|Missing|1|||
154890592|NCT00622869|559020595|FG002|Overall Study|Missing|1|||
154890593|NCT02927873|559020597|FG000|Overall Study|Lost to Follow-up|0|||
154890594|NCT02927873|559020598|FG001|Overall Study|Lost to Follow-up|1|||
154890595|NCT02927873|559020599|FG002|Overall Study|Lost to Follow-up|0|||
154890596|NCT02927873|559020600|FG003|Overall Study|Lost to Follow-up|0|||
154890597|NCT02927873|559020601|FG004|Overall Study|Lost to Follow-up|0|||
154890598|NCT02927873|559020602|FG005|Overall Study|Lost to Follow-up|0|||
154890599|NCT02927873|559020597|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154890600|NCT02927873|559020598|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
154890601|NCT02927873|559020599|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154890602|NCT02927873|559020600|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154890603|NCT02927873|559020601|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154890604|NCT02927873|559020602|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154890605|NCT02927873|559020597|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154890606|NCT02927873|559020598|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154890607|NCT02927873|559020599|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154890608|NCT02927873|559020600|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154890609|NCT02927873|559020601|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154890610|NCT02927873|559020602|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154890611|NCT02927873|559020597|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
154890612|NCT02927873|559020598|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
154890613|NCT02927873|559020599|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
154890614|NCT02927873|559020600|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
154890615|NCT02927873|559020601|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
154977770|NCT05068284|559340970|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
154977771|NCT05068284|559340971|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
154977772|NCT05068284|559340972|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
154977773|NCT05068284|559340965|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977774|NCT05068284|559340966|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977775|NCT05068284|559340967|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977776|NCT05068284|559340968|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
154977777|NCT05068284|559340969|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977778|NCT05068284|559340970|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977779|NCT05068284|559340971|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977780|NCT05068284|559340972|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
154977781|NCT05068284|559340965|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
154977782|NCT05068284|559340966|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
154977783|NCT05068284|559340967|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
154977784|NCT05068284|559340968|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
154977785|NCT05068284|559340969|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
154977786|NCT05068284|559340970|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
154977787|NCT05068284|559340971|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
154977788|NCT05068284|559340972|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
154977789|NCT05068284|559340965|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977790|NCT05068284|559340966|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977791|NCT05068284|559340967|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
154977792|NCT05068284|559340968|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977793|NCT05068284|559340969|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977794|NCT05068284|559340970|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977795|NCT05068284|559340971|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977796|NCT05068284|559340972|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
154977797|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
154977798|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977799|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977800|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977801|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977802|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977803|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977804|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
154977805|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
154977806|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
154977807|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
154977808|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
154977809|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
154977810|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
154977811|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
154977812|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
154977813|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
154977814|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
154977815|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
154977816|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
154977817|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155113930|NCT01463696|559846170|FG000|Overall Study|Withdrawal by Subject|0|||
155113931|NCT01463696|559846171|FG001|Overall Study|Withdrawal by Subject|0|||
155113932|NCT01463696|559846172|FG002|Overall Study|Withdrawal by Subject|0|||
155113933|NCT01463696|559846173|FG003|Overall Study|Withdrawal by Subject|1|||
155113934|NCT01463696|559846174|FG004|Overall Study|Withdrawal by Subject|1|||
155113935|NCT01463696|559846175|FG005|Overall Study|Withdrawal by Subject|1|||
155113936|NCT01463696|559846176|FG006|Overall Study|Withdrawal by Subject|2|||
155113937|NCT01463696|559846177|FG007|Overall Study|Withdrawal by Subject|0|||
155113938|NCT01463696|559846170|FG000|Overall Study|Not Treated|0|||
155113939|NCT01463696|559846171|FG001|Overall Study|Not Treated|0|||
155113940|NCT01463696|559846172|FG002|Overall Study|Not Treated|0|||
154977818|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
155113941|NCT01463696|559846173|FG003|Overall Study|Not Treated|0|||
155113942|NCT01463696|559846174|FG004|Overall Study|Not Treated|0|||
155113943|NCT01463696|559846175|FG005|Overall Study|Not Treated|0|||
154890616|NCT02927873|559020602|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
154890617|NCT02927873|559020597|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
154890618|NCT02927873|559020598|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
154890619|NCT02927873|559020599|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
154890620|NCT02927873|559020600|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
154890621|NCT02927873|559020601|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
154890622|NCT02927873|559020602|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
154890623|NCT02927873|559020597|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
154890624|NCT02927873|559020598|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
154890625|NCT02927873|559020599|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
154890626|NCT02927873|559020600|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
154890627|NCT02927873|559020601|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
154890628|NCT02927873|559020602|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
154890629|NCT01518244|559020603|FG000|Overall Study|Adverse Event|3|||
154890630|NCT00870818|559020604|FG000|Overall Study|Lost to Follow-up|3|||
154890631|NCT00870818|559020605|FG001|Overall Study|Lost to Follow-up|2|||
154890632|NCT00870818|559020606|FG002|Overall Study|Lost to Follow-up|1|||
154890633|NCT00870818|559020607|FG003|Overall Study|Lost to Follow-up|0|||
154890634|NCT00870818|559020608|FG004|Overall Study|Lost to Follow-up|0|||
154890635|NCT00870818|559020604|FG000|Overall Study|Withdrawal by Subject|0|||
154890636|NCT00870818|559020605|FG001|Overall Study|Withdrawal by Subject|0|||
154890637|NCT00870818|559020606|FG002|Overall Study|Withdrawal by Subject|1|||
154890638|NCT00870818|559020607|FG003|Overall Study|Withdrawal by Subject|2|||
154890639|NCT00870818|559020608|FG004|Overall Study|Withdrawal by Subject|0|||
154890640|NCT00870818|559020604|FG000|Overall Study|Terminated by sponsor|29|||
154890641|NCT00870818|559020605|FG001|Overall Study|Terminated by sponsor|70|||
154890642|NCT00870818|559020606|FG002|Overall Study|Terminated by sponsor|36|||
154890643|NCT00870818|559020607|FG003|Overall Study|Terminated by sponsor|36|||
154890644|NCT00870818|559020608|FG004|Overall Study|Terminated by sponsor|38|||
154890645|NCT00870818|559020604|FG000|Overall Study|Other|0|||
154890646|NCT00870818|559020605|FG001|Overall Study|Other|1|||
154890647|NCT00870818|559020606|FG002|Overall Study|Other|0|||
154890648|NCT00870818|559020607|FG003|Overall Study|Other|0|||
154890649|NCT00870818|559020608|FG004|Overall Study|Other|0|||
154890650|NCT04900038|559020611|FG000|Overall Study|Adverse Event|1|||
154890651|NCT04900038|559020612|FG001|Overall Study|Adverse Event|0|||
154890652|NCT04900038|559020613|FG002|Overall Study|Adverse Event|1|||
154890653|NCT04900038|559020614|FG003|Overall Study|Adverse Event|1|||
154890654|NCT04900038|559020611|FG000|Overall Study|Withdrawal by Subject|0|||
154890655|NCT04900038|559020612|FG001|Overall Study|Withdrawal by Subject|1|||
154890656|NCT04900038|559020613|FG002|Overall Study|Withdrawal by Subject|0|||
154890657|NCT04900038|559020614|FG003|Overall Study|Withdrawal by Subject|0|||
154890658|NCT04900038|559020611|FG000|Overall Study|Study terminated by sponsor|18|||
154890659|NCT04900038|559020612|FG001|Overall Study|Study terminated by sponsor|15|||
154890660|NCT04900038|559020613|FG002|Overall Study|Study terminated by sponsor|17|||
154890661|NCT04900038|559020614|FG003|Overall Study|Study terminated by sponsor|14|||
154890662|NCT04900038|559020611|FG000|Overall Study|Protocol Deviation|1|||
154890663|NCT04900038|559020612|FG001|Overall Study|Protocol Deviation|1|||
154890664|NCT04900038|559020613|FG002|Overall Study|Protocol Deviation|0|||
154890665|NCT04900038|559020614|FG003|Overall Study|Protocol Deviation|0|||
154890666|NCT04900038|559020611|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
154890667|NCT04900038|559020612|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
154890668|NCT04900038|559020613|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
154890669|NCT04900038|559020614|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
154890670|NCT04900038|559020611|FG000|Overall Study|Lost to Follow-up|0|||
154890671|NCT04900038|559020612|FG001|Overall Study|Lost to Follow-up|0|||
154890672|NCT04900038|559020613|FG002|Overall Study|Lost to Follow-up|0|||
154890673|NCT04900038|559020614|FG003|Overall Study|Lost to Follow-up|1|||
154890674|NCT03245723|559020624|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
154890675|NCT03245723|559020625|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
154890676|NCT03245723|559020624|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
154890677|NCT03245723|559020625|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
154890678|NCT03245723|559020624|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
154890679|NCT03245723|559020625|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
154890680|NCT03245723|559020624|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
154890681|NCT03245723|559020625|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
154890682|NCT00077376|559020628|FG000|Overall Study|Adverse Event|8|||
154890683|NCT00077376|559020628|FG000|Overall Study|Withdrawal by Subject|2|||
154890684|NCT00077376|559020628|FG000|Overall Study|Death|1|||
154890685|NCT00077376|559020628|FG000|Overall Study|Physician Decision|1|||
154890686|NCT00077376|559020628|FG000|Overall Study|Alternative therapy|5|||
155175604|NCT01215916|560080277|FG005|Overall Study|Physician Decision|0|||
155175605|NCT01215916|560080278|FG006|Overall Study|Physician Decision|0|||
154890687|NCT00077376|559020628|FG000|Overall Study|Complicating disease|1|||
154890688|NCT00077376|559020628|FG000|Overall Study|Still on treatment|1|||
154890689|NCT00077376|559020628|FG000|Overall Study|Symptomatic deterioration|1|||
154890690|NCT00077376|559020628|FG000|Overall Study|Surgery|1|||
154890691|NCT00077376|559020628|FG000|Overall Study|Insurance ran out|1|||
154890692|NCT03784027|559020629|FG000|Period 1|Withdrawal by Subject|0|||
154890693|NCT03784027|559020630|FG001|Period 1|Withdrawal by Subject|1|||
154890694|NCT02017899|559022223|FG000|Overall Study|Withdrawal by Subject|0|||
154890695|NCT02017899|559022224|FG001|Overall Study|Withdrawal by Subject|0|||
154890696|NCT02017899|559022225|FG002|Overall Study|Withdrawal by Subject|0|||
154890697|NCT02017899|559022226|FG003|Overall Study|Withdrawal by Subject|1|||
154890698|NCT02017899|559022227|FG004|Overall Study|Withdrawal by Subject|1|||
154890699|NCT02017899|559022228|FG005|Overall Study|Withdrawal by Subject|0|||
154890700|NCT02843178|559022231|FG000|Overall Study|Lost to Follow-up|8|||
154890701|NCT02843178|559022232|FG001|Overall Study|Lost to Follow-up|8|||
154890702|NCT02843178|559022233|FG002|Overall Study|Lost to Follow-up|6|||
154890703|NCT02843178|559022234|FG003|Overall Study|Lost to Follow-up|3|||
154890704|NCT02843178|559022231|FG000|Overall Study|Withdrawal by Subject|0|||
154890705|NCT02843178|559022232|FG001|Overall Study|Withdrawal by Subject|0|||
154890706|NCT02843178|559022233|FG002|Overall Study|Withdrawal by Subject|1|||
154890707|NCT02843178|559022234|FG003|Overall Study|Withdrawal by Subject|1|||
154890708|NCT00646113|559022235|FG000|Overall Study|Lost to Follow-up|5|||
154890709|NCT00646113|559022235|FG000|Overall Study|Adverse Event|3|||
154890710|NCT02658968|559022244|FG000|Received Rituximab|Adverse Event|0|||
154890711|NCT02658968|559022245|FG001|Received Rituximab|Adverse Event|0|||
154890712|NCT02658968|559022246|FG002|Received Rituximab|Adverse Event|0|||
154890713|NCT02658968|559022247|FG003|Received Rituximab|Adverse Event|0|||
154890714|NCT02658968|559022248|FG004|Received Rituximab|Adverse Event|1|||
154890715|NCT02658968|559022244|FG000|Received Rituximab|Progressive disease|0|||
154890716|NCT02658968|559022245|FG001|Received Rituximab|Progressive disease|0|||
154890717|NCT02658968|559022246|FG002|Received Rituximab|Progressive disease|0|||
154890718|NCT02658968|559022247|FG003|Received Rituximab|Progressive disease|0|||
154890719|NCT02658968|559022248|FG004|Received Rituximab|Progressive disease|1|||
154890720|NCT02658968|559022244|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
154890721|NCT02658968|559022245|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
154890722|NCT02658968|559022246|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
154890723|NCT02658968|559022247|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
154890724|NCT02658968|559022248|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
154890725|NCT02658968|559022244|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
154890726|NCT02658968|559022245|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
154890727|NCT02658968|559022246|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
154890728|NCT02658968|559022247|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
154890729|NCT02658968|559022248|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
154890730|NCT02658968|559022244|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
154890731|NCT02658968|559022245|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
154890732|NCT02658968|559022246|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
154890733|NCT02658968|559022247|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
154890734|NCT02658968|559022248|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
154890735|NCT02658968|559022244|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
154890736|NCT02658968|559022245|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
154890737|NCT02658968|559022246|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
154890738|NCT02658968|559022247|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
154890739|NCT02658968|559022248|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
154890740|NCT02658968|559022244|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
154890741|NCT02658968|559022245|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
154890742|NCT02658968|559022246|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
154890743|NCT02658968|559022247|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
154890744|NCT02658968|559022248|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
154890745|NCT00949910|559022251|FG000|Overall Study|Progressive Disease|3750|||
154890746|NCT00949910|559022251|FG000|Overall Study|Symptomatic Deterioration|1088|||
154890747|NCT00949910|559022251|FG000|Overall Study|Lost to Follow-up|100|||
154890748|NCT00949910|559022251|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
154890749|NCT00949910|559022251|FG000|Overall Study|Participant Refusal|390|||
154890750|NCT00949910|559022251|FG000|Overall Study|Death Due to Malignant Disease|456|||
154890751|NCT00949910|559022251|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
154890752|NCT00949910|559022251|FG000|Overall Study|Death Due to Adverse Event|115|||
154890753|NCT00949910|559022251|FG000|Overall Study|Death Due to Toxicity|3|||
154890754|NCT00949910|559022251|FG000|Overall Study|Death from Unknown Cause|5|||
154890755|NCT00949910|559022251|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
154890756|NCT00949910|559022251|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
154890757|NCT00949910|559022251|FG000|Overall Study|Switched to Commercial Treatment|4|||
154890758|NCT00949910|559022251|FG000|Overall Study|Violation of Eligibility|23|||
154890759|NCT00949910|559022251|FG000|Overall Study|Logistical Reasons|13|||
154890760|NCT00949910|559022251|FG000|Overall Study|Non-Compliance|10|||
154890761|NCT00949910|559022251|FG000|Overall Study|Prolonged Dosing Interruption|4|||
154890762|NCT00949910|559022251|FG000|Overall Study|Adverse Event|83|||
154890763|NCT00949910|559022251|FG000|Overall Study|Serious Adverse Event|6|||
154890764|NCT00949910|559022251|FG000|Overall Study|Physician/Participant Decision|7|||
154890765|NCT00949910|559022251|FG000|Overall Study|Other|4|||
154890766|NCT00949910|559022251|FG000|Overall Study|No Data|9|||
154890767|NCT03287869|559022252|FG000|Overall Study|Adverse Event|14|||
154890768|NCT03287869|559022253|FG001|Overall Study|Adverse Event|12|||
154890769|NCT03287869|559022252|FG000|Overall Study|Lack of Efficacy|1|||
154890770|NCT03287869|559022253|FG001|Overall Study|Lack of Efficacy|0|||
154890771|NCT03287869|559022252|FG000|Overall Study|Lost to Follow-up|13|||
154890772|NCT03287869|559022253|FG001|Overall Study|Lost to Follow-up|19|||
154890773|NCT03287869|559022252|FG000|Overall Study|Non-Compliance With Study Drug|5|||
154890774|NCT03287869|559022253|FG001|Overall Study|Non-Compliance With Study Drug|9|||
154890775|NCT03287869|559022252|FG000|Overall Study|Progressive Disease|1|||
154890776|NCT03287869|559022253|FG001|Overall Study|Progressive Disease|0|||
154890777|NCT03287869|559022252|FG000|Overall Study|Protocol Deviation|2|||
154890778|NCT03287869|559022253|FG001|Overall Study|Protocol Deviation|1|||
154890779|NCT03287869|559022252|FG000|Overall Study|Withdrawal by Subject|36|||
154890780|NCT03287869|559022253|FG001|Overall Study|Withdrawal by Subject|43|||
154890781|NCT03287869|559022252|FG000|Overall Study|Early Closure of the Site|0|||
154890782|NCT03287869|559022253|FG001|Overall Study|Early Closure of the Site|1|||
154890783|NCT03287869|559022252|FG000|Overall Study|Physician Decision|5|||
154890784|NCT03287869|559022253|FG001|Overall Study|Physician Decision|5|||
154890785|NCT03287869|559022252|FG000|Overall Study|Reason not Specified|6|||
154890786|NCT03287869|559022253|FG001|Overall Study|Reason not Specified|3|||
154890787|NCT02591238|559022254|FG000|Overall Study|Pregnancy|1|||
154890788|NCT02591238|559022255|FG001|Overall Study|Pregnancy|0|||
154890789|NCT02591238|559022256|FG002|Overall Study|Pregnancy|0|||
154890790|NCT02591238|559022257|FG003|Overall Study|Pregnancy|0|||
154890791|NCT02591238|559022254|FG000|Overall Study|Withdrawal by Subject|0|||
154890792|NCT02591238|559022255|FG001|Overall Study|Withdrawal by Subject|0|||
154890793|NCT02591238|559022256|FG002|Overall Study|Withdrawal by Subject|0|||
154890794|NCT02591238|559022257|FG003|Overall Study|Withdrawal by Subject|1|||
154890795|NCT02591238|559022254|FG000|Overall Study|influenza|0|||
154890796|NCT02591238|559022255|FG001|Overall Study|influenza|0|||
154890797|NCT02591238|559022256|FG002|Overall Study|influenza|0|||
154890798|NCT02591238|559022257|FG003|Overall Study|influenza|1|||
154890799|NCT02591238|559022254|FG000|Overall Study|personal circumstances|0|||
154890800|NCT02591238|559022255|FG001|Overall Study|personal circumstances|0|||
154890801|NCT02591238|559022256|FG002|Overall Study|personal circumstances|0|||
154890802|NCT02591238|559022257|FG003|Overall Study|personal circumstances|1|||
154890803|NCT02591238|559022254|FG000|Overall Study|personal circumstances|0|||
154890804|NCT02591238|559022255|FG001|Overall Study|personal circumstances|1|||
154890805|NCT02591238|559022256|FG002|Overall Study|personal circumstances|0|||
154890806|NCT02591238|559022257|FG003|Overall Study|personal circumstances|0|||
154890807|NCT00640146|559022258|FG000|Overall Study|Adverse Event|2|||
154890808|NCT00640146|559022259|FG001|Overall Study|Adverse Event|0|||
154890809|NCT00640146|559022258|FG000|Overall Study|Lost to Follow-up|0|||
154890810|NCT00640146|559022259|FG001|Overall Study|Lost to Follow-up|1|||
154890811|NCT00640146|559022258|FG000|Overall Study|Lack of Efficacy|0|||
154890812|NCT00640146|559022259|FG001|Overall Study|Lack of Efficacy|1|||
154890813|NCT00640146|559022258|FG000|Overall Study|Withdrawal by Subject|1|||
154890814|NCT00640146|559022259|FG001|Overall Study|Withdrawal by Subject|1|||
154890815|NCT00640146|559022258|FG000|Overall Study|Randomized but not treated|1|||
155113944|NCT01463696|559846176|FG006|Overall Study|Not Treated|1|||
155113945|NCT01463696|559846177|FG007|Overall Study|Not Treated|0|||
155113946|NCT02301546|559846181|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
154890816|NCT00640146|559022259|FG001|Overall Study|Randomized but not treated|3|||
154890817|NCT02455388|559022260|FG000|Overall Study|Protocol Violation|1|||
154890818|NCT02455388|559022261|FG001|Overall Study|Protocol Violation|0|||
154890819|NCT02455388|559022262|FG002|Overall Study|Protocol Violation|4|||
154890820|NCT02455388|559022260|FG000|Overall Study|Withdrawal by Subject|0|||
154890821|NCT02455388|559022261|FG001|Overall Study|Withdrawal by Subject|0|||
154890822|NCT02455388|559022262|FG002|Overall Study|Withdrawal by Subject|7|||
154890823|NCT00324740|559022263|FG000|Overall Study|Withdrawal by Subject|1|||
154890824|NCT00324740|559022264|FG001|Overall Study|Withdrawal by Subject|0|||
154890825|NCT00324740|559022265|FG002|Overall Study|Withdrawal by Subject|1|||
154890826|NCT00971425|559022268|FG000|Overall Study|Adverse Event|1|||
154890827|NCT00971425|559022269|FG001|Overall Study|Adverse Event|1|||
154890828|NCT00971425|559022268|FG000|Overall Study|Withdrawal by Subject|0|||
154890829|NCT00971425|559022269|FG001|Overall Study|Withdrawal by Subject|1|||
154890830|NCT02528253|559022270|FG000|Overall Study|Adverse Event|3|||
154890831|NCT02528253|559022271|FG001|Overall Study|Adverse Event|4|||
154890832|NCT02528253|559022272|FG002|Overall Study|Adverse Event|4|||
154890833|NCT02528253|559022273|FG003|Overall Study|Adverse Event|8|||
154890834|NCT02528253|559022274|FG004|Overall Study|Adverse Event|18|||
154890835|NCT02528253|559022270|FG000|Overall Study|Death|2|||
154890836|NCT02528253|559022271|FG001|Overall Study|Death|2|||
154890837|NCT02528253|559022272|FG002|Overall Study|Death|1|||
154890838|NCT02528253|559022273|FG003|Overall Study|Death|0|||
154890839|NCT02528253|559022274|FG004|Overall Study|Death|1|||
154890840|NCT02528253|559022270|FG000|Overall Study|Insufficient clinical response|7|||
154890841|NCT02528253|559022271|FG001|Overall Study|Insufficient clinical response|10|||
154890842|NCT02528253|559022272|FG002|Overall Study|Insufficient clinical response|13|||
154890843|NCT02528253|559022273|FG003|Overall Study|Insufficient clinical response|12|||
154890844|NCT02528253|559022274|FG004|Overall Study|Insufficient clinical response|16|||
154890845|NCT02528253|559022270|FG000|Overall Study|Lost to Follow-up|16|||
154890846|NCT02528253|559022271|FG001|Overall Study|Lost to Follow-up|9|||
154890847|NCT02528253|559022272|FG002|Overall Study|Lost to Follow-up|31|||
154890848|NCT02528253|559022273|FG003|Overall Study|Lost to Follow-up|16|||
154890849|NCT02528253|559022274|FG004|Overall Study|Lost to Follow-up|34|||
154890850|NCT02528253|559022270|FG000|Overall Study|Other|21|||
154890851|NCT02528253|559022271|FG001|Overall Study|Other|22|||
154890852|NCT02528253|559022272|FG002|Overall Study|Other|58|||
154890853|NCT02528253|559022273|FG003|Overall Study|Other|52|||
154890854|NCT02528253|559022274|FG004|Overall Study|Other|76|||
154890855|NCT02528253|559022270|FG000|Overall Study|Withdrawal by Subject|25|||
154890856|NCT02528253|559022271|FG001|Overall Study|Withdrawal by Subject|20|||
154890857|NCT02528253|559022272|FG002|Overall Study|Withdrawal by Subject|29|||
154890858|NCT02528253|559022273|FG003|Overall Study|Withdrawal by Subject|48|||
154890859|NCT02528253|559022274|FG004|Overall Study|Withdrawal by Subject|73|||
154890860|NCT02528253|559022270|FG000|Overall Study|Protocol Violation|1|||
154890861|NCT02528253|559022271|FG001|Overall Study|Protocol Violation|2|||
154890862|NCT02528253|559022272|FG002|Overall Study|Protocol Violation|4|||
154890863|NCT02528253|559022273|FG003|Overall Study|Protocol Violation|0|||
154890864|NCT02528253|559022274|FG004|Overall Study|Protocol Violation|4|||
154890865|NCT02528253|559022270|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
154890866|NCT02528253|559022271|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
154890867|NCT02528253|559022272|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
154890868|NCT02528253|559022273|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
154890869|NCT02528253|559022274|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
154890870|NCT00505752|559022275|FG000|Overall Study|Adverse Event|1|||
154890871|NCT00505752|559022276|FG001|Overall Study|Adverse Event|0|||
154890872|NCT00505752|559022277|FG002|Overall Study|Adverse Event|1|||
154890873|NCT00505752|559022278|FG003|Overall Study|Adverse Event|0|||
154890874|NCT00505752|559022275|FG000|Overall Study|Lost to Follow-up|1|||
154890875|NCT00505752|559022276|FG001|Overall Study|Lost to Follow-up|0|||
154890876|NCT00505752|559022277|FG002|Overall Study|Lost to Follow-up|0|||
154890877|NCT00505752|559022278|FG003|Overall Study|Lost to Follow-up|0|||
154890878|NCT00505752|559022275|FG000|Overall Study|Lack of ovarian response|1|||
154890879|NCT00505752|559022276|FG001|Overall Study|Lack of ovarian response|3|||
154890880|NCT00505752|559022277|FG002|Overall Study|Lack of ovarian response|0|||
154977819|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
154890881|NCT00505752|559022278|FG003|Overall Study|Lack of ovarian response|0|||
154890882|NCT00505752|559022275|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
154890883|NCT00505752|559022276|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
154890884|NCT00505752|559022277|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
154890885|NCT00505752|559022278|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
154890886|NCT00505752|559022275|FG000|Overall Study|No oocytes retrieved|0|||
154890887|NCT00505752|559022276|FG001|Overall Study|No oocytes retrieved|2|||
154890888|NCT00505752|559022277|FG002|Overall Study|No oocytes retrieved|0|||
154890889|NCT00505752|559022278|FG003|Overall Study|No oocytes retrieved|1|||
154890890|NCT00505752|559022275|FG000|Overall Study|No Fertilization|1|||
154890891|NCT00505752|559022276|FG001|Overall Study|No Fertilization|1|||
154890892|NCT00505752|559022277|FG002|Overall Study|No Fertilization|2|||
154890893|NCT00505752|559022278|FG003|Overall Study|No Fertilization|1|||
154890894|NCT00505752|559022275|FG000|Overall Study|All embryos/blastocysts discarded|0|||
154890895|NCT00505752|559022276|FG001|Overall Study|All embryos/blastocysts discarded|0|||
154890896|NCT00505752|559022277|FG002|Overall Study|All embryos/blastocysts discarded|1|||
154890897|NCT00505752|559022278|FG003|Overall Study|All embryos/blastocysts discarded|1|||
154890898|NCT00505752|559022275|FG000|Overall Study|Other|1|||
154890899|NCT00505752|559022276|FG001|Overall Study|Other|2|||
154890900|NCT00505752|559022277|FG002|Overall Study|Other|1|||
154890901|NCT00505752|559022278|FG003|Overall Study|Other|2|||
154890902|NCT01624506|559022279|FG000|Overall Study|Lost to Follow-up|29|||
154890903|NCT01624506|559022280|FG001|Overall Study|Lost to Follow-up|15|||
154890904|NCT01624506|559022279|FG000|Overall Study|Withdrawal by Subject|9|||
154890905|NCT01624506|559022280|FG001|Overall Study|Withdrawal by Subject|2|||
155113947|NCT02301546|559846182|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
155113948|NCT02301546|559846181|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
154890906|NCT01624506|559022279|FG000|Overall Study|Death|1|||
154890907|NCT01624506|559022280|FG001|Overall Study|Death|0|||
154890908|NCT01624506|559022279|FG000|Overall Study|LINX explants|23|||
154890909|NCT01624506|559022280|FG001|Overall Study|LINX explants|0|||
154890910|NCT01624506|559022279|FG000|Overall Study|Adverse Event|3|||
154890911|NCT01624506|559022280|FG001|Overall Study|Adverse Event|0|||
154890912|NCT01149343|559022281|FG000|Overall Study|Withdrawal by Subject|1|||
154890913|NCT01149343|559022282|FG001|Overall Study|Withdrawal by Subject|1|||
154890914|NCT01149343|559022283|FG002|Overall Study|Withdrawal by Subject|1|||
154890915|NCT01149343|559022284|FG003|Overall Study|Withdrawal by Subject|5|||
154890916|NCT01149343|559022281|FG000|Overall Study|Death|10|||
154890917|NCT01149343|559022282|FG001|Overall Study|Death|13|||
154890918|NCT01149343|559022283|FG002|Overall Study|Death|18|||
154890919|NCT01149343|559022284|FG003|Overall Study|Death|18|||
154890920|NCT01149343|559022281|FG000|Overall Study|Lost to Follow-up|1|||
154890921|NCT01149343|559022282|FG001|Overall Study|Lost to Follow-up|0|||
154890922|NCT01149343|559022283|FG002|Overall Study|Lost to Follow-up|0|||
154890923|NCT01149343|559022284|FG003|Overall Study|Lost to Follow-up|1|||
154890924|NCT01149343|559022281|FG000|Overall Study|Other|8|||
154890925|NCT01149343|559022282|FG001|Overall Study|Other|10|||
154890926|NCT01149343|559022283|FG002|Overall Study|Other|2|||
154890927|NCT01149343|559022284|FG003|Overall Study|Other|14|||
154890928|NCT01149343|559022281|FG000|Overall Study|Sponsor study termination|0|||
154890929|NCT01149343|559022282|FG001|Overall Study|Sponsor study termination|0|||
154890930|NCT01149343|559022283|FG002|Overall Study|Sponsor study termination|0|||
154890931|NCT01149343|559022284|FG003|Overall Study|Sponsor study termination|2|||
154890932|NCT01149343|559022281|FG000|Overall Study|Recurrence / Progressive disease|0|||
154890933|NCT01149343|559022282|FG001|Overall Study|Recurrence / Progressive disease|0|||
154890934|NCT01149343|559022283|FG002|Overall Study|Recurrence / Progressive disease|1|||
154890935|NCT01149343|559022284|FG003|Overall Study|Recurrence / Progressive disease|0|||
154890936|NCT00132314|559022293|FG000|Overall Study|Lost to Follow-up|70|||
154890937|NCT00132314|559022294|FG001|Overall Study|Lost to Follow-up|62|||
154890938|NCT00132314|559022293|FG000|Overall Study|Lacked SSN|1|||
154890939|NCT00132314|559022294|FG001|Overall Study|Lacked SSN|3|||
154890940|NCT00132314|559022293|FG000|Overall Study|Refused intervention at baseline|2|||
154890941|NCT00132314|559022294|FG001|Overall Study|Refused intervention at baseline|7|||
154890942|NCT03625141|559022308|FG000|Overall Study|Adverse Event|0|||
154890943|NCT03625141|559022309|FG001|Overall Study|Adverse Event|2|||
154890944|NCT03625141|559022308|FG000|Overall Study|Study Terminated By Sponsor|1|||
154890945|NCT03625141|559022309|FG001|Overall Study|Study Terminated By Sponsor|13|||
154890946|NCT03625141|559022308|FG000|Overall Study|Withdrawal by Subject|3|||
154890947|NCT03625141|559022309|FG001|Overall Study|Withdrawal by Subject|0|||
154890948|NCT03625141|559022308|FG000|Overall Study|Withdrawal Of Consent|0|||
154890949|NCT03625141|559022309|FG001|Overall Study|Withdrawal Of Consent|1|||
154890950|NCT03625141|559022308|FG000|Overall Study|Death|11|||
154890951|NCT03625141|559022309|FG001|Overall Study|Death|47|||
154890952|NCT03625141|559022308|FG000|Overall Study|Progressive Disease|0|||
154890953|NCT03625141|559022309|FG001|Overall Study|Progressive Disease|2|||
154890954|NCT03250377|559022310|FG000|Overall Study|Adverse Event|2|||
154890955|NCT03250377|559022311|FG001|Overall Study|Adverse Event|4|||
154890956|NCT03250377|559022312|FG002|Overall Study|Adverse Event|0|||
154890957|NCT03250377|559022313|FG003|Overall Study|Adverse Event|4|||
154890958|NCT03250377|559022310|FG000|Overall Study|Lack of Efficacy|5|||
155113949|NCT02301546|559846182|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
155113950|NCT02301546|559846181|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
155113951|NCT02301546|559846182|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
155113952|NCT02301546|559846181|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
155113953|NCT02301546|559846182|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
155113954|NCT02301546|559846181|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
154890959|NCT03250377|559022311|FG001|Overall Study|Lack of Efficacy|14|||
154890960|NCT03250377|559022312|FG002|Overall Study|Lack of Efficacy|1|||
154890961|NCT03250377|559022313|FG003|Overall Study|Lack of Efficacy|3|||
154890962|NCT03250377|559022310|FG000|Overall Study|Protocol Violation|0|||
154890963|NCT03250377|559022311|FG001|Overall Study|Protocol Violation|2|||
154890964|NCT03250377|559022312|FG002|Overall Study|Protocol Violation|0|||
154890965|NCT03250377|559022313|FG003|Overall Study|Protocol Violation|1|||
154890966|NCT03250377|559022310|FG000|Overall Study|Lost to Follow-up|0|||
154890967|NCT03250377|559022311|FG001|Overall Study|Lost to Follow-up|1|||
154890968|NCT03250377|559022312|FG002|Overall Study|Lost to Follow-up|0|||
154890969|NCT03250377|559022313|FG003|Overall Study|Lost to Follow-up|0|||
154890970|NCT03250377|559022310|FG000|Overall Study|Withdrawal by Subject|7|||
154890971|NCT03250377|559022311|FG001|Overall Study|Withdrawal by Subject|7|||
154890972|NCT03250377|559022312|FG002|Overall Study|Withdrawal by Subject|0|||
154890973|NCT03250377|559022313|FG003|Overall Study|Withdrawal by Subject|4|||
154890974|NCT03250377|559022310|FG000|Overall Study|Investigator's Judgment|1|||
154890975|NCT03250377|559022311|FG001|Overall Study|Investigator's Judgment|0|||
154890976|NCT03250377|559022312|FG002|Overall Study|Investigator's Judgment|0|||
154890977|NCT03250377|559022313|FG003|Overall Study|Investigator's Judgment|0|||
154890978|NCT03250377|559022310|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
154890979|NCT03250377|559022311|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
154890980|NCT03250377|559022312|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
154890981|NCT03250377|559022313|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
154890982|NCT03250377|559022310|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
154890983|NCT03250377|559022311|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
154890984|NCT03250377|559022312|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
154890985|NCT03250377|559022313|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
154890986|NCT03250377|559022310|FG000|Overall Study|Epilepsy Surgery|0|||
154890987|NCT03250377|559022311|FG001|Overall Study|Epilepsy Surgery|1|||
154890988|NCT03250377|559022312|FG002|Overall Study|Epilepsy Surgery|2|||
154890989|NCT03250377|559022313|FG003|Overall Study|Epilepsy Surgery|0|||
154890990|NCT03250377|559022310|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
154890991|NCT03250377|559022311|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
154890992|NCT03250377|559022312|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
154890993|NCT03250377|559022313|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
154890994|NCT03250377|559022310|FG000|Overall Study|Request From The Sponsor|0|||
154890995|NCT03250377|559022311|FG001|Overall Study|Request From The Sponsor|1|||
154890996|NCT03250377|559022312|FG002|Overall Study|Request From The Sponsor|0|||
154890997|NCT03250377|559022313|FG003|Overall Study|Request From The Sponsor|0|||
154890998|NCT03250377|559022310|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
154890999|NCT03250377|559022311|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
154891000|NCT03250377|559022312|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
154891001|NCT03250377|559022313|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
154891002|NCT03250377|559022310|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
154891003|NCT03250377|559022311|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
154891004|NCT03250377|559022312|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
154891005|NCT03250377|559022313|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
154891006|NCT03250377|559022310|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
154891007|NCT03250377|559022311|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
154891008|NCT03250377|559022312|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
154891009|NCT03250377|559022313|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
154891010|NCT03250377|559022310|FG000|Overall Study|Pregnancy Event|0|||
154891011|NCT03250377|559022311|FG001|Overall Study|Pregnancy Event|1|||
154891012|NCT03250377|559022312|FG002|Overall Study|Pregnancy Event|0|||
154891013|NCT03250377|559022313|FG003|Overall Study|Pregnancy Event|0|||
154891014|NCT03250377|559022310|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
154977820|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
154977821|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
154977822|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977823|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977824|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977825|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977826|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977827|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977828|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
154977829|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
154977830|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977831|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977832|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977833|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977834|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977835|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977836|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
154977837|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
154977838|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
155113955|NCT02301546|559846182|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
154891015|NCT03250377|559022311|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
154891016|NCT03250377|559022312|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
154891017|NCT03250377|559022313|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
154891018|NCT03250377|559022310|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
154891019|NCT03250377|559022311|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
154891020|NCT03250377|559022312|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
154891021|NCT03250377|559022313|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
154891022|NCT03250377|559022310|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
154891023|NCT03250377|559022311|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
154891024|NCT03250377|559022312|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
154891025|NCT03250377|559022313|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
154891026|NCT03250377|559022310|FG000|Overall Study|Patient requested to change hospital|0|||
154891027|NCT03250377|559022311|FG001|Overall Study|Patient requested to change hospital|0|||
154891028|NCT03250377|559022312|FG002|Overall Study|Patient requested to change hospital|0|||
154891029|NCT03250377|559022313|FG003|Overall Study|Patient requested to change hospital|1|||
154891030|NCT03250377|559022310|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
154891031|NCT03250377|559022311|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
154891032|NCT03250377|559022312|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
154891033|NCT03250377|559022313|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
154891034|NCT02168803|559022314|FG000|Overall Study|Lost to Follow-up|1|||
154891035|NCT02168803|559022315|FG001|Overall Study|Lost to Follow-up|0|||
154891036|NCT02168803|559022316|FG002|Overall Study|Lost to Follow-up|1|||
154891037|NCT02168803|559022314|FG000|Overall Study|Withdrawal by Subject|1|||
154891038|NCT02168803|559022315|FG001|Overall Study|Withdrawal by Subject|1|||
154891039|NCT02168803|559022316|FG002|Overall Study|Withdrawal by Subject|2|||
154891040|NCT02168803|559022314|FG000|Overall Study|Physician Decision|0|||
154891041|NCT02168803|559022315|FG001|Overall Study|Physician Decision|1|||
154891042|NCT02168803|559022316|FG002|Overall Study|Physician Decision|0|||
154891043|NCT02168803|559022314|FG000|Overall Study|Adverse Event|0|||
154891044|NCT02168803|559022315|FG001|Overall Study|Adverse Event|1|||
154891045|NCT02168803|559022316|FG002|Overall Study|Adverse Event|1|||
154891046|NCT02168803|559022314|FG000|Overall Study|Death|0|||
154891047|NCT02168803|559022315|FG001|Overall Study|Death|0|||
154891048|NCT02168803|559022316|FG002|Overall Study|Death|1|||
154891049|NCT02168803|559022314|FG000|Overall Study|Sponsor Decision|0|||
154891050|NCT02168803|559022315|FG001|Overall Study|Sponsor Decision|0|||
154891051|NCT02168803|559022316|FG002|Overall Study|Sponsor Decision|1|||
154891052|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
154891053|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
154891054|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
154891055|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
154891056|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
154891057|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
154891058|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
154891059|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
154891060|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
154891061|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
154891062|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
154891063|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
154891064|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
154891065|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
154891066|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
154891067|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
154891068|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
154891069|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
154891070|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
154891071|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
154891072|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
154891073|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
154891074|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
154891075|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
154891076|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
154891077|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
154891078|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
154891079|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
154891080|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
154891081|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
154891082|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
154891083|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
154891084|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
154891085|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
154977839|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
154977840|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
154977841|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
154977842|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
154977843|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
154977844|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
154977845|NCT05068284|559340965|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977846|NCT05068284|559340966|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977847|NCT05068284|559340967|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977848|NCT05068284|559340968|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977849|NCT05068284|559340969|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977850|NCT05068284|559340970|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977851|NCT05068284|559340971|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
154977852|NCT05068284|559340972|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
154977853|NCT00109837|559342693|FG000|Overall Study|Adverse Event|2|||
154977854|NCT00109837|559342693|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
154977855|NCT00109837|559342693|FG000|Overall Study|Death|1|||
154977856|NCT00109837|559342693|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
154977857|NCT00109837|559342693|FG000|Overall Study|Not treated|1|||
154977858|NCT00109837|559342693|FG000|Overall Study|Ineligible|1|||
154977859|NCT02012452|559342696|FG000|Overall Study|Lost to Follow-up|2|||
154977860|NCT02012452|559342697|FG001|Overall Study|Lost to Follow-up|1|||
154977861|NCT02012452|559342696|FG000|Overall Study|Withdrawal by Subject|4|||
154977862|NCT02012452|559342697|FG001|Overall Study|Withdrawal by Subject|0|||
154977863|NCT02190279|559342698|FG000|Overall Study|Withdrawal consent|1|||
154977864|NCT02190279|559342699|FG001|Overall Study|Withdrawal consent|0|||
154977865|NCT02190279|559342700|FG002|Overall Study|Withdrawal consent|1|||
154977866|NCT02190279|559342698|FG000|Overall Study|Lost to Follow-up|2|||
154977867|NCT02190279|559342699|FG001|Overall Study|Lost to Follow-up|0|||
154977868|NCT02190279|559342700|FG002|Overall Study|Lost to Follow-up|0|||
154977869|NCT02190279|559342698|FG000|Overall Study|Refused further treatment|0|||
154977870|NCT02190279|559342699|FG001|Overall Study|Refused further treatment|0|||
154977871|NCT02190279|559342700|FG002|Overall Study|Refused further treatment|1|||
154977872|NCT02190279|559342698|FG000|Overall Study|Screening failure|0|||
154977873|NCT02190279|559342699|FG001|Overall Study|Screening failure|0|||
154977874|NCT02190279|559342700|FG002|Overall Study|Screening failure|1|||
154977875|NCT04403399|559342701|FG000|Period 2|Physician Decision|0|||
154977876|NCT04403399|559342702|FG001|Period 2|Physician Decision|1|||
154977877|NCT00802178|559342703|FG000|Overall Study|Lack of Efficacy|36|||
154977878|NCT00802178|559342703|FG000|Overall Study|Insufficient tolerability (IT)|17|||
154977879|NCT00802178|559342703|FG000|Overall Study|Withdrawal by Subject|18|||
154977880|NCT00802178|559342703|FG000|Overall Study|Other|32|||
154977881|NCT00802178|559342703|FG000|Overall Study|Lack of efficacy and patient wish|1|||
154977882|NCT00802178|559342703|FG000|Overall Study|IT and patient wish|8|||
154977883|NCT00802178|559342703|FG000|Overall Study|Patients wish and other reason|1|||
154977884|NCT01606228|559342704|FG000|Overall Study|Lost to Follow-up|20|||
154977885|NCT01606228|559342704|FG000|Overall Study|Withdrawal by Subject|3|||
154977886|NCT01606228|559342704|FG000|Overall Study|Non-compliant|3|||
154977887|NCT01606228|559342704|FG000|Overall Study|Lack of Efficacy|2|||
154977888|NCT01606228|559342704|FG000|Overall Study|Adverse Event|1|||
154977889|NCT00831233|559342705|FG000|Overall Study|Adverse Event|0|||
154977890|NCT00831233|559342706|FG001|Overall Study|Adverse Event|1|||
154977891|NCT00831233|559342705|FG000|Overall Study|Protocol Violation|1|||
154977892|NCT00831233|559342706|FG001|Overall Study|Protocol Violation|0|||
154977893|NCT00831233|559342705|FG000|Overall Study|Selection Criteria Not Met|2|||
154977894|NCT00831233|559342706|FG001|Overall Study|Selection Criteria Not Met|0|||
154977895|NCT00784134|559342707|FG000|Overall Study|Lost to Follow-up|3|||
154977896|NCT00784134|559342708|FG001|Overall Study|Lost to Follow-up|6|||
154977897|NCT03785145|559342709|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
154977898|NCT03785145|559342710|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
154977899|NCT03785145|559342709|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
154977900|NCT03785145|559342710|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
154977901|NCT03785145|559342709|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
154977902|NCT03785145|559342710|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
154977903|NCT03785145|559342709|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
155175606|NCT01215916|560080279|FG007|Overall Study|Physician Decision|0|||
154977904|NCT03785145|559342710|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
154977905|NCT03785145|559342709|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
154977906|NCT03785145|559342710|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
154977907|NCT03785145|559342709|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
154977908|NCT03785145|559342710|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
155175607|NCT01215916|560080280|FG008|Overall Study|Physician Decision|0|||
154891086|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
154891087|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
154891088|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
154891089|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
154891090|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
154891091|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
154891092|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
154891093|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
154891094|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
154891095|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
154891096|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
154891097|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
154891098|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
154891099|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
154891100|NCT03444870|559022317|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
154891101|NCT03444870|559022318|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
154891102|NCT03444870|559022319|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
154891103|NCT03444870|559022320|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
154891104|NCT03444870|559022321|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
154891105|NCT03444870|559022322|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
154891106|NCT03444870|559022317|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
154891107|NCT03444870|559022318|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
154891108|NCT03444870|559022319|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
154891109|NCT03444870|559022320|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
154891110|NCT03444870|559022321|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
154891111|NCT03444870|559022322|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
154891112|NCT03444870|559022317|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
154891113|NCT03444870|559022318|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
154891114|NCT03444870|559022319|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
154891115|NCT03444870|559022320|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
154891116|NCT03444870|559022321|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
154891117|NCT03444870|559022322|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
154891118|NCT03444870|559022317|FG000|Open-Label Extension (OLE) Period|Death|0|||
154891119|NCT03444870|559022318|FG001|Open-Label Extension (OLE) Period|Death|0|||
154891120|NCT03444870|559022319|FG002|Open-Label Extension (OLE) Period|Death|0|||
154891121|NCT03444870|559022320|FG003|Open-Label Extension (OLE) Period|Death|0|||
154891122|NCT03444870|559022321|FG004|Open-Label Extension (OLE) Period|Death|1|||
154891123|NCT03444870|559022322|FG005|Open-Label Extension (OLE) Period|Death|0|||
154891124|NCT02034552|559022323|FG000|Overall Study|Never treated|3|||
154891125|NCT02034552|559022324|FG001|Overall Study|Never treated|2|||
154891126|NCT02034552|559022325|FG002|Overall Study|Never treated|0|||
154891127|NCT02034552|559022323|FG000|Overall Study|Radiological progression|3|||
154891128|NCT02034552|559022324|FG001|Overall Study|Radiological progression|5|||
154891129|NCT02034552|559022325|FG002|Overall Study|Radiological progression|4|||
154891130|NCT02034552|559022323|FG000|Overall Study|AE not assoc. with disease progression|1|||
154891131|NCT02034552|559022324|FG001|Overall Study|AE not assoc. with disease progression|4|||
154891132|NCT02034552|559022325|FG002|Overall Study|AE not assoc. with disease progression|2|||
154891133|NCT02034552|559022323|FG000|Overall Study|AE associated with disease progression|0|||
154891134|NCT02034552|559022324|FG001|Overall Study|AE associated with disease progression|1|||
154891135|NCT02034552|559022325|FG002|Overall Study|AE associated with disease progression|0|||
154891136|NCT02034552|559022323|FG000|Overall Study|Withdrawal by Subject|2|||
154891137|NCT02034552|559022324|FG001|Overall Study|Withdrawal by Subject|1|||
154891138|NCT02034552|559022325|FG002|Overall Study|Withdrawal by Subject|1|||
154891139|NCT02034552|559022323|FG000|Overall Study|Non-compliance with study drug|0|||
154891140|NCT02034552|559022324|FG001|Overall Study|Non-compliance with study drug|0|||
154891141|NCT02034552|559022325|FG002|Overall Study|Non-compliance with study drug|1|||
154891142|NCT02034552|559022323|FG000|Overall Study|Clinical progression|5|||
154891143|NCT02034552|559022324|FG001|Overall Study|Clinical progression|7|||
154891144|NCT02034552|559022325|FG002|Overall Study|Clinical progression|9|||
154891145|NCT04295356|559022333|FG000|Overall Study|Physician Decision|1|||
154891146|NCT04295356|559022334|FG001|Overall Study|Physician Decision|0|||
154891147|NCT04295356|559022333|FG000|Overall Study|Lost to Follow-up|0|||
155113956|NCT02301546|559846181|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
155113957|NCT02301546|559846182|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
154891148|NCT04295356|559022334|FG001|Overall Study|Lost to Follow-up|3|||
154891149|NCT04295356|559022333|FG000|Overall Study|Protocol Violation|0|||
154891150|NCT04295356|559022334|FG001|Overall Study|Protocol Violation|1|||
154891151|NCT03986190|559022340|FG000|Overall Study|Withdrawal by Subject|12|||
155113958|NCT02301546|559846181|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
155113959|NCT02301546|559846182|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
154891152|NCT03986190|559022341|FG001|Overall Study|Withdrawal by Subject|0|||
154891153|NCT04511819|559022342|FG000|Overall Study|Non-compliance with study drug|5|||
154891154|NCT04511819|559022343|FG001|Overall Study|Non-compliance with study drug|1|||
154891155|NCT04511819|559022342|FG000|Overall Study|Withdrawal by Subject|0|||
154891156|NCT04511819|559022343|FG001|Overall Study|Withdrawal by Subject|3|||
154891157|NCT04511819|559022342|FG000|Overall Study|Adverse Event|0|||
154891158|NCT04511819|559022343|FG001|Overall Study|Adverse Event|1|||
154891159|NCT04511819|559022342|FG000|Overall Study|Protocol deviation|1|||
154891160|NCT04511819|559022343|FG001|Overall Study|Protocol deviation|0|||
154891161|NCT02180217|559022349|FG000|Overall Study|Adverse Event|3|||
154891162|NCT02180217|559022350|FG001|Overall Study|Adverse Event|2|||
154891163|NCT02180217|559022351|FG002|Overall Study|Adverse Event|22|||
154891164|NCT02180217|559022349|FG000|Overall Study|Death|1|||
154891165|NCT02180217|559022350|FG001|Overall Study|Death|1|||
154891166|NCT02180217|559022351|FG002|Overall Study|Death|0|||
154891167|NCT02180217|559022349|FG000|Overall Study|Withdrawal by Subject|1|||
154891168|NCT02180217|559022350|FG001|Overall Study|Withdrawal by Subject|1|||
154891169|NCT02180217|559022351|FG002|Overall Study|Withdrawal by Subject|4|||
154891170|NCT02180217|559022349|FG000|Overall Study|Subject/Guardian decision|5|||
154891171|NCT02180217|559022350|FG001|Overall Study|Subject/Guardian decision|3|||
154891172|NCT02180217|559022351|FG002|Overall Study|Subject/Guardian decision|6|||
154891173|NCT02180217|559022349|FG000|Overall Study|Physician Decision|1|||
154891174|NCT02180217|559022350|FG001|Overall Study|Physician Decision|1|||
154891175|NCT02180217|559022351|FG002|Overall Study|Physician Decision|6|||
154891176|NCT02180217|559022349|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154891177|NCT02180217|559022350|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154891178|NCT02180217|559022351|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
154891179|NCT00776555|559022352|FG000|Overall Study|Study terminated|3|||
154891180|NCT00776555|559022353|FG001|Overall Study|Study terminated|0|||
154891181|NCT01181102|559022354|FG000|Overall Study|Adverse Event|28|||
154891182|NCT01181102|559022355|FG001|Overall Study|Adverse Event|26|||
154891183|NCT01181102|559022354|FG000|Overall Study|Lack of Efficacy|3|||
154891184|NCT01181102|559022355|FG001|Overall Study|Lack of Efficacy|1|||
154891185|NCT01181102|559022354|FG000|Overall Study|Lost to Follow-up|2|||
154891186|NCT01181102|559022355|FG001|Overall Study|Lost to Follow-up|0|||
154891187|NCT01181102|559022354|FG000|Overall Study|Physician Decision|3|||
154891188|NCT01181102|559022355|FG001|Overall Study|Physician Decision|1|||
154891189|NCT01181102|559022354|FG000|Overall Study|Protocol Violation|5|||
154891190|NCT01181102|559022355|FG001|Overall Study|Protocol Violation|6|||
154891191|NCT01181102|559022354|FG000|Overall Study|Withdrawal by Subject|10|||
154891192|NCT01181102|559022355|FG001|Overall Study|Withdrawal by Subject|12|||
154891193|NCT00239837|559022356|FG000|Overall Study|Lost to Follow-up|3|||
154891194|NCT00239837|559022357|FG001|Overall Study|Lost to Follow-up|7|||
154891195|NCT01838590|559022358|FG000|Overall Study|Lack of Efficacy|12|||
154891196|NCT01838590|559022359|FG001|Overall Study|Lack of Efficacy|4|||
154891197|NCT01838590|559022358|FG000|Overall Study|Lost to Follow-up|0|||
154891198|NCT01838590|559022359|FG001|Overall Study|Lost to Follow-up|1|||
154891199|NCT04685499|559022360|FG000|Overall Study|Study Terminated Early|1|||
154891200|NCT03076190|559022364|FG000|Overall Study|Lost to Follow-up|9|||
154891201|NCT03076190|559022365|FG001|Overall Study|Lost to Follow-up|34|||
154891202|NCT03076190|559022364|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
154891203|NCT03076190|559022365|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
154891204|NCT00393913|559022366|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
154891205|NCT00393913|559022366|FG000|Initial Assessment|Withdrawal by Subject|16|||
154891206|NCT00393913|559022366|FG000|CPAP|Withdrawal by Subject|3|||
154891207|NCT00393913|559022366|FG000|CPAP|Physician Decision|1|||
154891208|NCT00393913|559022366|FG000|CPAP|TEchnical problem with CPAP|3|||
154891209|NCT01401465|559022367|FG000|Treatment Period 1|Adverse Event|4|||
154891210|NCT01401465|559022368|FG001|Treatment Period 1|Adverse Event|1|||
154891211|NCT01401465|559022367|FG000|Treatment Period 1|Pregnancy|0|||
154891212|NCT01401465|559022368|FG001|Treatment Period 1|Pregnancy|1|||
154891213|NCT01401465|559022367|FG000|Treatment Period 1|Protocol Violation|5|||
154891214|NCT01401465|559022368|FG001|Treatment Period 1|Protocol Violation|0|||
154891215|NCT01401465|559022367|FG000|Treatment Period 1|Withdrawal by Subject|1|||
154891216|NCT01401465|559022368|FG001|Treatment Period 1|Withdrawal by Subject|4|||
154977909|NCT03785145|559342709|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
154977910|NCT03785145|559342710|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
154891217|NCT01401465|559022367|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
154891218|NCT01401465|559022368|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
154891219|NCT01401465|559022367|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
154891220|NCT01401465|559022368|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
154891221|NCT01401465|559022367|FG000|Treatment Period 1|Scheduling Difficulties|1|||
154891222|NCT01401465|559022368|FG001|Treatment Period 1|Scheduling Difficulties|1|||
154891223|NCT01401465|559022367|FG000|Treatment Period 2|Lost to Follow-up|0|||
154891224|NCT01401465|559022368|FG001|Treatment Period 2|Lost to Follow-up|1|||
154891225|NCT01401465|559022367|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154891226|NCT01401465|559022368|FG001|Treatment Period 2|Withdrawal by Subject|1|||
154891227|NCT00772382|559022371|FG000|Overall Study|Adverse Event|19|||
154891228|NCT00772382|559022371|FG000|Overall Study|Death|6|||
154891229|NCT00772382|559022371|FG000|Overall Study|Lack of Efficacy|4|||
154891230|NCT00772382|559022371|FG000|Overall Study|Physician Decision|5|||
154891231|NCT00772382|559022371|FG000|Overall Study|Protocol Violation|1|||
154891232|NCT00772382|559022371|FG000|Overall Study|Withdrawal by Subject|10|||
154891233|NCT00772382|559022371|FG000|Overall Study|Other Reasons|10|||
154891234|NCT03927911|559024090|FG000|Overall Study|problems with eDiary|0|||
154891235|NCT03927911|559024091|FG001|Overall Study|problems with eDiary|1|||
154891236|NCT03927911|559024092|FG002|Overall Study|problems with eDiary|0|||
154891237|NCT03927911|559024093|FG003|Overall Study|problems with eDiary|1|||
154891238|NCT03927911|559024094|FG004|Overall Study|problems with eDiary|0|||
154891239|NCT03927911|559024095|FG005|Overall Study|problems with eDiary|4|||
154891240|NCT03927911|559024090|FG000|Overall Study|Adverse Event|0|||
154891241|NCT03927911|559024091|FG001|Overall Study|Adverse Event|0|||
154891242|NCT03927911|559024092|FG002|Overall Study|Adverse Event|0|||
154891243|NCT03927911|559024093|FG003|Overall Study|Adverse Event|0|||
154891244|NCT03927911|559024094|FG004|Overall Study|Adverse Event|0|||
154891245|NCT03927911|559024095|FG005|Overall Study|Adverse Event|1|||
154891246|NCT03927911|559024090|FG000|Overall Study|not treated -study terminated by sponsor|0|||
154891247|NCT03927911|559024091|FG001|Overall Study|not treated -study terminated by sponsor|1|||
154891248|NCT03927911|559024092|FG002|Overall Study|not treated -study terminated by sponsor|0|||
154891249|NCT03927911|559024093|FG003|Overall Study|not treated -study terminated by sponsor|0|||
154891250|NCT03927911|559024094|FG004|Overall Study|not treated -study terminated by sponsor|0|||
154891251|NCT03927911|559024095|FG005|Overall Study|not treated -study terminated by sponsor|0|||
154891252|NCT03927911|559024090|FG000|Overall Study|Surgery cancelled|0|||
154891253|NCT03927911|559024091|FG001|Overall Study|Surgery cancelled|0|||
154891254|NCT03927911|559024092|FG002|Overall Study|Surgery cancelled|0|||
154891255|NCT03927911|559024093|FG003|Overall Study|Surgery cancelled|1|||
154891256|NCT03927911|559024094|FG004|Overall Study|Surgery cancelled|0|||
154891257|NCT03927911|559024095|FG005|Overall Study|Surgery cancelled|1|||
154891258|NCT03927911|559024090|FG000|Overall Study|Protocol Violation|0|||
154891259|NCT03927911|559024091|FG001|Overall Study|Protocol Violation|0|||
154891260|NCT03927911|559024092|FG002|Overall Study|Protocol Violation|0|||
154891261|NCT03927911|559024093|FG003|Overall Study|Protocol Violation|0|||
154891262|NCT03927911|559024094|FG004|Overall Study|Protocol Violation|0|||
154891263|NCT03927911|559024095|FG005|Overall Study|Protocol Violation|1|||
154891264|NCT01297309|559024097|FG000|Overall Study|Eligibility failure|2|||
154891265|NCT01297309|559024097|FG000|Overall Study|Screen failure|2|||
154891266|NCT01297309|559024097|FG000|Overall Study|Withdrawal by Subject|5|||
154891267|NCT01297309|559024097|FG000|Overall Study|Adverse Event|1|||
154891268|NCT01297309|559024097|FG000|Overall Study|Investigator Decision|2|||
154891269|NCT01297309|559024097|FG000|Overall Study|Death|1|||
154891270|NCT01297309|559024097|FG000|Overall Study|Participant not entering extensionperiod|1|||
154891271|NCT04847141|559024102|FG000|Overall Study|Adverse Event|1|||
154891272|NCT04847141|559024103|FG001|Overall Study|Adverse Event|0|||
154891273|NCT04847141|559024104|FG002|Overall Study|Adverse Event|1|||
154891274|NCT04847141|559024102|FG000|Overall Study|Withdrawal by Subject|2|||
154891275|NCT04847141|559024103|FG001|Overall Study|Withdrawal by Subject|4|||
154891276|NCT04847141|559024104|FG002|Overall Study|Withdrawal by Subject|3|||
154891277|NCT04847141|559024102|FG000|Overall Study|Lost to Follow-up|7|||
154891278|NCT04847141|559024103|FG001|Overall Study|Lost to Follow-up|5|||
154891279|NCT04847141|559024104|FG002|Overall Study|Lost to Follow-up|7|||
154891280|NCT04847141|559024102|FG000|Overall Study|Reason not Specified|0|||
154891281|NCT04847141|559024103|FG001|Overall Study|Reason not Specified|1|||
154891282|NCT04847141|559024104|FG002|Overall Study|Reason not Specified|0|||
154891283|NCT03472040|559024110|FG000|Overall Study|Physician Decision|0|||
154891284|NCT03472040|559024111|FG001|Overall Study|Physician Decision|3|||
154891285|NCT03472040|559024110|FG000|Overall Study|Withdrawal by Subject|10|||
154891286|NCT03472040|559024111|FG001|Overall Study|Withdrawal by Subject|23|||
154891287|NCT03472040|559024110|FG000|Overall Study|Perceived Lack of Efficacy|29|||
154891288|NCT03472040|559024111|FG001|Overall Study|Perceived Lack of Efficacy|30|||
154891289|NCT03472040|559024110|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
154891290|NCT03472040|559024111|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
154891291|NCT03472040|559024110|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
154891292|NCT03472040|559024111|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
154891293|NCT03472040|559024110|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
154891294|NCT03472040|559024111|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
154891295|NCT03472040|559024110|FG000|Overall Study|Subject Non-compliance|2|||
154891296|NCT03472040|559024111|FG001|Overall Study|Subject Non-compliance|5|||
154891297|NCT03472040|559024110|FG000|Overall Study|Discontinuation due to Rash|0|||
154891298|NCT03472040|559024111|FG001|Overall Study|Discontinuation due to Rash|1|||
154891299|NCT03472040|559024110|FG000|Overall Study|Subsequent Ineligibility|0|||
154891300|NCT03472040|559024111|FG001|Overall Study|Subsequent Ineligibility|2|||
154977911|NCT03785145|559342709|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
155113960|NCT01801436|559846185|FG000|Overall Study|Withdrawal by Subject|3|||
154977912|NCT03785145|559342710|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
154977913|NCT03785145|559342709|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
154977914|NCT03785145|559342710|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
154977915|NCT03785145|559342709|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
154977916|NCT03785145|559342710|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
154977917|NCT03785145|559342709|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
154977918|NCT03785145|559342710|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
154977919|NCT02211014|559342711|FG000|Overall Study|Adverse Event|0|||
154977920|NCT02211014|559342712|FG001|Overall Study|Adverse Event|2|||
154977921|NCT02211014|559342711|FG000|Overall Study|Physician Decision|1|||
154977922|NCT02211014|559342712|FG001|Overall Study|Physician Decision|2|||
154977923|NCT02211014|559342711|FG000|Overall Study|Started another cancer therapy|1|||
154977924|NCT02211014|559342712|FG001|Overall Study|Started another cancer therapy|0|||
154891301|NCT03472040|559024110|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
154891302|NCT03472040|559024111|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
154891303|NCT02769832|559024112|FG000|Overall Study|Death|30|||
154891304|NCT00225147|559024113|FG000|Open-label Phase|Lost to Follow-up|0|||
154891305|NCT00225147|559024114|FG001|Open-label Phase|Lost to Follow-up|0|||
154891306|NCT00225147|559024115|FG002|Open-label Phase|Lost to Follow-up|0|||
154891307|NCT00225147|559024116|FG003|Open-label Phase|Lost to Follow-up|4|||
154891308|NCT00225147|559024113|FG000|Open-label Phase|Withdrawal by Subject|0|||
154891309|NCT00225147|559024114|FG001|Open-label Phase|Withdrawal by Subject|0|||
154891310|NCT00225147|559024115|FG002|Open-label Phase|Withdrawal by Subject|0|||
154891311|NCT00225147|559024116|FG003|Open-label Phase|Withdrawal by Subject|6|||
154891312|NCT01114373|559024121|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
154891313|NCT01114373|559024122|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
154891314|NCT01114373|559024121|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
154891315|NCT01114373|559024122|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
154891316|NCT01114373|559024121|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
154891317|NCT01114373|559024122|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
154891318|NCT01114373|559024121|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
154891319|NCT01114373|559024122|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
154891320|NCT00868166|559024123|FG000|Overall Study|Death|58|||
154891321|NCT00868166|559024124|FG001|Overall Study|Death|65|||
154891322|NCT00868166|559024123|FG000|Overall Study|Withdrawal by Subject|33|||
154891323|NCT00868166|559024124|FG001|Overall Study|Withdrawal by Subject|25|||
154891324|NCT00868166|559024123|FG000|Overall Study|Protocol Violation|1|||
154891325|NCT00868166|559024124|FG001|Overall Study|Protocol Violation|0|||
154891326|NCT00868166|559024123|FG000|Overall Study|Lost to Follow-up|1|||
154891327|NCT00868166|559024124|FG001|Overall Study|Lost to Follow-up|3|||
154891328|NCT00868166|559024123|FG000|Overall Study|Adverse Event|9|||
154891329|NCT00868166|559024124|FG001|Overall Study|Adverse Event|10|||
154891330|NCT00868166|559024123|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
154891331|NCT00868166|559024124|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
154891332|NCT00868166|559024123|FG000|Overall Study|Non-compliance with IMP|1|||
154891333|NCT00868166|559024124|FG001|Overall Study|Non-compliance with IMP|1|||
154891334|NCT03819218|559024129|FG000|Overall Study|Protocol Violation|1|||
154891335|NCT02197897|559024133|FG000|Overall Study|not eligible|1|||
154891336|NCT02501902|559024134|FG000|Overall Study|Subject Refused Further Follow-up|0|||
154891337|NCT02501902|559024135|FG001|Overall Study|Subject Refused Further Follow-up|0|||
154891338|NCT02501902|559024136|FG002|Overall Study|Subject Refused Further Follow-up|0|||
154891339|NCT02501902|559024137|FG003|Overall Study|Subject Refused Further Follow-up|0|||
154891340|NCT02501902|559024138|FG004|Overall Study|Subject Refused Further Follow-up|0|||
154891341|NCT02501902|559024139|FG005|Overall Study|Subject Refused Further Follow-up|0|||
154891342|NCT02501902|559024140|FG006|Overall Study|Subject Refused Further Follow-up|0|||
154977925|NCT02211014|559342711|FG000|Overall Study|Withdrawal by Subject|0|||
155113961|NCT01801436|559846185|FG000|Overall Study|Adverse Event|2|||
154891343|NCT02501902|559024141|FG007|Overall Study|Subject Refused Further Follow-up|1|||
154891344|NCT02501902|559024134|FG000|Overall Study|Study Terminated by Sponsor|0|||
154891345|NCT02501902|559024135|FG001|Overall Study|Study Terminated by Sponsor|3|||
154977926|NCT02211014|559342712|FG001|Overall Study|Withdrawal by Subject|1|||
154977927|NCT02211014|559342711|FG000|Overall Study|In agreement with patient, no benefit|0|||
154977928|NCT02211014|559342712|FG001|Overall Study|In agreement with patient, no benefit|1|||
154977929|NCT00097786|559342713|FG000|Overall Study|lost to follow-up for all-cause death|296|||
155113962|NCT01801436|559846185|FG000|Overall Study|Progressive disease|4|||
154891346|NCT02501902|559024136|FG002|Overall Study|Study Terminated by Sponsor|0|||
154891347|NCT02501902|559024137|FG003|Overall Study|Study Terminated by Sponsor|1|||
154891348|NCT02501902|559024138|FG004|Overall Study|Study Terminated by Sponsor|1|||
154977930|NCT00097786|559342714|FG001|Overall Study|lost to follow-up for all-cause death|292|||
154977931|NCT00097786|559342715|FG002|Overall Study|lost to follow-up for all-cause death|313|||
155113963|NCT02447250|559846188|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
154977932|NCT00097786|559342716|FG003|Overall Study|lost to follow-up for all-cause death|310|||
154977933|NCT02443324|559342718|FG000|Overall Study|Death|4|||
154977934|NCT02443324|559342719|FG001|Overall Study|Death|1|||
154977935|NCT02443324|559342720|FG002|Overall Study|Death|0|||
154977936|NCT02443324|559342721|FG003|Overall Study|Death|3|||
154977937|NCT02443324|559342722|FG004|Overall Study|Death|1|||
154977938|NCT02443324|559342723|FG005|Overall Study|Death|3|||
154977939|NCT02443324|559342724|FG006|Overall Study|Death|2|||
154977940|NCT02443324|559342718|FG000|Overall Study|Lost to Follow-up|0|||
154977941|NCT02443324|559342719|FG001|Overall Study|Lost to Follow-up|0|||
154977942|NCT02443324|559342720|FG002|Overall Study|Lost to Follow-up|0|||
154977943|NCT02443324|559342721|FG003|Overall Study|Lost to Follow-up|1|||
154977944|NCT02443324|559342722|FG004|Overall Study|Lost to Follow-up|0|||
154977945|NCT02443324|559342723|FG005|Overall Study|Lost to Follow-up|1|||
154977946|NCT02443324|559342724|FG006|Overall Study|Lost to Follow-up|0|||
154977947|NCT02443324|559342718|FG000|Overall Study|Physician Decision|0|||
154977948|NCT02443324|559342719|FG001|Overall Study|Physician Decision|3|||
154977949|NCT02443324|559342720|FG002|Overall Study|Physician Decision|5|||
154977950|NCT02443324|559342721|FG003|Overall Study|Physician Decision|1|||
154977951|NCT02443324|559342722|FG004|Overall Study|Physician Decision|1|||
154977952|NCT02443324|559342723|FG005|Overall Study|Physician Decision|0|||
154977953|NCT02443324|559342724|FG006|Overall Study|Physician Decision|2|||
154977954|NCT02443324|559342718|FG000|Overall Study|Progressive Disease|20|||
154977955|NCT02443324|559342719|FG001|Overall Study|Progressive Disease|20|||
154977956|NCT02443324|559342720|FG002|Overall Study|Progressive Disease|13|||
154977957|NCT02443324|559342721|FG003|Overall Study|Progressive Disease|10|||
154977958|NCT02443324|559342722|FG004|Overall Study|Progressive Disease|13|||
154977959|NCT02443324|559342723|FG005|Overall Study|Progressive Disease|17|||
154977960|NCT02443324|559342724|FG006|Overall Study|Progressive Disease|10|||
154977961|NCT02443324|559342718|FG000|Overall Study|Withdrawal by Subject|0|||
154977962|NCT02443324|559342719|FG001|Overall Study|Withdrawal by Subject|0|||
154977963|NCT02443324|559342720|FG002|Overall Study|Withdrawal by Subject|3|||
154977964|NCT02443324|559342721|FG003|Overall Study|Withdrawal by Subject|1|||
154977965|NCT02443324|559342722|FG004|Overall Study|Withdrawal by Subject|1|||
154977966|NCT02443324|559342723|FG005|Overall Study|Withdrawal by Subject|0|||
154977967|NCT02443324|559342724|FG006|Overall Study|Withdrawal by Subject|1|||
154977968|NCT02443324|559342718|FG000|Overall Study|Adverse Event|0|||
154977969|NCT02443324|559342719|FG001|Overall Study|Adverse Event|1|||
154977970|NCT02443324|559342720|FG002|Overall Study|Adverse Event|3|||
154977971|NCT02443324|559342721|FG003|Overall Study|Adverse Event|0|||
154977972|NCT02443324|559342722|FG004|Overall Study|Adverse Event|4|||
154977973|NCT02443324|559342723|FG005|Overall Study|Adverse Event|3|||
154977974|NCT02443324|559342724|FG006|Overall Study|Adverse Event|3|||
154891349|NCT02501902|559024139|FG005|Overall Study|Study Terminated by Sponsor|0|||
154891350|NCT02501902|559024140|FG006|Overall Study|Study Terminated by Sponsor|2|||
154891351|NCT02501902|559024141|FG007|Overall Study|Study Terminated by Sponsor|4|||
154891352|NCT02501902|559024134|FG000|Overall Study|Death|3|||
154891353|NCT02501902|559024135|FG001|Overall Study|Death|4|||
154891354|NCT02501902|559024136|FG002|Overall Study|Death|4|||
154891355|NCT02501902|559024137|FG003|Overall Study|Death|10|||
154891356|NCT02501902|559024138|FG004|Overall Study|Death|10|||
154891357|NCT02501902|559024139|FG005|Overall Study|Death|11|||
154891358|NCT02501902|559024140|FG006|Overall Study|Death|7|||
154891359|NCT02501902|559024141|FG007|Overall Study|Death|15|||
154891360|NCT02267278|559024142|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
154891361|NCT02267278|559024142|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
154977975|NCT02443324|559342718|FG000|Overall Study|Enrolled but Never Treated|0|||
154977976|NCT02443324|559342719|FG001|Overall Study|Enrolled but Never Treated|0|||
154977977|NCT02443324|559342720|FG002|Overall Study|Enrolled but Never Treated|1|||
154977978|NCT02443324|559342721|FG003|Overall Study|Enrolled but Never Treated|0|||
154891362|NCT02267278|559024142|FG000|Overall Study|Developed new cancer diagnoses|2|||
154891363|NCT02267278|559024142|FG000|Overall Study|prescribed prohibited medication|1|||
154977979|NCT02443324|559342722|FG004|Overall Study|Enrolled but Never Treated|1|||
154977980|NCT02443324|559342723|FG005|Overall Study|Enrolled but Never Treated|0|||
154977981|NCT02443324|559342724|FG006|Overall Study|Enrolled but Never Treated|1|||
154977982|NCT01647711|559342725|FG000|Overall Study|Progressive disease|6|||
154891364|NCT02513771|559024143|FG000|Overall Study|Lost to Follow-up|1|||
154977983|NCT01647711|559342726|FG001|Overall Study|Progressive disease|2|||
154977984|NCT01647711|559342727|FG002|Overall Study|Progressive disease|6|||
154977985|NCT01647711|559342728|FG003|Overall Study|Progressive disease|8|||
154977986|NCT01647711|559342729|FG004|Overall Study|Progressive disease|2|||
154977987|NCT01647711|559342725|FG000|Overall Study|Other adverse event|0|||
154977988|NCT01647711|559342726|FG001|Overall Study|Other adverse event|0|||
154977989|NCT01647711|559342727|FG002|Overall Study|Other adverse event|2|||
154977990|NCT01647711|559342728|FG003|Overall Study|Other adverse event|0|||
154891365|NCT02513771|559024144|FG001|Overall Study|Lost to Follow-up|1|||
154977991|NCT01647711|559342729|FG004|Overall Study|Other adverse event|2|||
154977992|NCT01647711|559342725|FG000|Overall Study|Protocol Violation|0|||
154977993|NCT01647711|559342726|FG001|Overall Study|Protocol Violation|0|||
154977994|NCT01647711|559342727|FG002|Overall Study|Protocol Violation|0|||
154891366|NCT02513771|559024143|FG000|Overall Study|Not being able to get to clinic|1|||
154891367|NCT02513771|559024144|FG001|Overall Study|Not being able to get to clinic|0|||
154891368|NCT00650091|559024145|FG000|Amended Study Design|Withdrawal by Subject|12|||
154891369|NCT00650091|559024146|FG001|Amended Study Design|Withdrawal by Subject|11|||
154891370|NCT00650091|559024147|FG002|Amended Study Design|Withdrawal by Subject|0|||
154891371|NCT00650091|559024145|FG000|Amended Study Design|Physician Decision|5|||
154891372|NCT00650091|559024146|FG001|Amended Study Design|Physician Decision|0|||
154891373|NCT00650091|559024147|FG002|Amended Study Design|Physician Decision|0|||
154891374|NCT00650091|559024145|FG000|Amended Study Design|Adverse Event|1|||
154891375|NCT00650091|559024146|FG001|Amended Study Design|Adverse Event|4|||
154891376|NCT00650091|559024147|FG002|Amended Study Design|Adverse Event|0|||
154891377|NCT00650091|559024145|FG000|Amended Study Design|Lung transplantation|4|||
154891378|NCT00650091|559024146|FG001|Amended Study Design|Lung transplantation|2|||
154891379|NCT00650091|559024147|FG002|Amended Study Design|Lung transplantation|0|||
154891380|NCT00650091|559024145|FG000|Amended Study Design|Other|1|||
154891381|NCT00650091|559024146|FG001|Amended Study Design|Other|3|||
154891382|NCT00650091|559024147|FG002|Amended Study Design|Other|0|||
154891383|NCT01204697|559024148|FG000|Overall Study|Death|26|||
154891384|NCT01204697|559024149|FG001|Overall Study|Death|27|||
154891385|NCT01204697|559024148|FG000|Overall Study|Lost to Follow-up|3|||
154891386|NCT01204697|559024149|FG001|Overall Study|Lost to Follow-up|4|||
154891387|NCT01204697|559024148|FG000|Overall Study|Withdrawal by Subject|2|||
154891388|NCT01204697|559024149|FG001|Overall Study|Withdrawal by Subject|4|||
154891389|NCT01204697|559024148|FG000|Overall Study|Randomized, but not treated|0|||
154891390|NCT01204697|559024149|FG001|Overall Study|Randomized, but not treated|1|||
154891391|NCT03939637|559024160|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
154891392|NCT03939637|559024161|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
154891393|NCT03939637|559024160|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
154891394|NCT03939637|559024161|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
154891395|NCT04268004|559024162|FG000|Overall Study|Excluded from analyses|0|||
154891396|NCT04268004|559024163|FG001|Overall Study|Excluded from analyses|1|||
154891397|NCT04724733|559024164|FG000|Overall Study|Lost to Follow-up|1|||
154891398|NCT04724733|559024165|FG001|Overall Study|Lost to Follow-up|1|||
154891399|NCT04724733|559024166|FG002|Overall Study|Lost to Follow-up|1|||
154891400|NCT03372603|559024167|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
154891401|NCT03372603|559024168|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
154891402|NCT03372603|559024167|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
154891403|NCT03372603|559024168|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
154891404|NCT03341923|559024169|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
154891405|NCT03341923|559024170|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
154891406|NCT00844649|559024171|FG000|Overall Study|Progressive Disease|196|||
154891407|NCT00844649|559024172|FG001|Overall Study|Progressive Disease|245|||
154891408|NCT00844649|559024171|FG000|Overall Study|Adverse Event|128|||
154891409|NCT00844649|559024172|FG001|Overall Study|Adverse Event|73|||
154891410|NCT00844649|559024171|FG000|Overall Study|Physician Decision|25|||
154891411|NCT00844649|559024172|FG001|Overall Study|Physician Decision|18|||
154891412|NCT00844649|559024171|FG000|Overall Study|Protocol Violation|10|||
154891413|NCT00844649|559024172|FG001|Overall Study|Protocol Violation|6|||
154891414|NCT00844649|559024171|FG000|Overall Study|Withdrawal by Subject|28|||
154891415|NCT00844649|559024172|FG001|Overall Study|Withdrawal by Subject|39|||
154891416|NCT00844649|559024171|FG000|Overall Study|Other|7|||
154891417|NCT00844649|559024172|FG001|Overall Study|Other|10|||
154891418|NCT00844649|559024171|FG000|Overall Study|Withdrew prior to starting treatment|11|||
154891419|NCT00844649|559024172|FG001|Overall Study|Withdrew prior to starting treatment|27|||
154891420|NCT00168064|559024173|FG000|Overall Study|Adverse Event|26|||
154891421|NCT00168064|559024174|FG001|Overall Study|Adverse Event|22|||
154891422|NCT00168064|559024173|FG000|Overall Study|Withdrawal by Subject|3|||
154891423|NCT00168064|559024174|FG001|Overall Study|Withdrawal by Subject|4|||
154891424|NCT00168064|559024173|FG000|Overall Study|Lack of Efficacy|4|||
154891425|NCT00168064|559024174|FG001|Overall Study|Lack of Efficacy|4|||
154891426|NCT00168064|559024173|FG000|Overall Study|Lost to Follow-up|4|||
154891427|NCT00168064|559024174|FG001|Overall Study|Lost to Follow-up|3|||
154891428|NCT00168064|559024173|FG000|Overall Study|Non-compliance|2|||
154891429|NCT00168064|559024174|FG001|Overall Study|Non-compliance|3|||
154891430|NCT00168064|559024173|FG000|Overall Study|Concurrent Illness|4|||
154891431|NCT00168064|559024174|FG001|Overall Study|Concurrent Illness|3|||
154891432|NCT00168064|559024173|FG000|Overall Study|Subject's Best interest|2|||
154891433|NCT00168064|559024174|FG001|Overall Study|Subject's Best interest|2|||
154891434|NCT00168064|559024173|FG000|Overall Study|Various|4|||
154891435|NCT00168064|559024174|FG001|Overall Study|Various|3|||
154891436|NCT00589979|559024176|FG000|Run-In Period|Adverse Event|5|||
154891437|NCT00589979|559024177|FG001|Run-In Period|Adverse Event|0|||
154891438|NCT00589979|559024178|FG002|Run-In Period|Adverse Event|0|||
154891439|NCT00589979|559024176|FG000|Run-In Period|Protocol Violation|3|||
154891440|NCT00589979|559024177|FG001|Run-In Period|Protocol Violation|0|||
154891441|NCT00589979|559024178|FG002|Run-In Period|Protocol Violation|0|||
154891442|NCT00589979|559024176|FG000|Run-In Period|Did not qualify for randomization|54|||
154891443|NCT00589979|559024177|FG001|Run-In Period|Did not qualify for randomization|0|||
154891444|NCT00589979|559024178|FG002|Run-In Period|Did not qualify for randomization|0|||
154891445|NCT00589979|559024176|FG000|Run-In Period|Withdrawal by Subject|10|||
154891446|NCT00589979|559024177|FG001|Run-In Period|Withdrawal by Subject|0|||
154891447|NCT00589979|559024178|FG002|Run-In Period|Withdrawal by Subject|0|||
154891448|NCT00589979|559024176|FG000|Run-In Period|Informed Consent Withdrawn|4|||
154891449|NCT00589979|559024177|FG001|Run-In Period|Informed Consent Withdrawn|0|||
154891450|NCT00589979|559024178|FG002|Run-In Period|Informed Consent Withdrawn|0|||
154891451|NCT00589979|559024176|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
154891452|NCT00589979|559024177|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
154891453|NCT00589979|559024178|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
154891454|NCT00589979|559024176|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
154891455|NCT00589979|559024177|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
154891456|NCT00589979|559024178|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
154891457|NCT00589979|559024176|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
154891458|NCT00589979|559024177|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
154891459|NCT00589979|559024178|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
154891460|NCT00589979|559024176|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
154891461|NCT00589979|559024177|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
154891462|NCT00589979|559024178|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
154891463|NCT00589979|559024176|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
154891464|NCT00589979|559024177|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
154891465|NCT00589979|559024178|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
154891466|NCT00589979|559024176|FG000|Double-Blind Treatment Period 2|Other|0|||
154891467|NCT00589979|559024177|FG001|Double-Blind Treatment Period 2|Other|0|||
154891468|NCT00589979|559024178|FG002|Double-Blind Treatment Period 2|Other|1|||
154891469|NCT00589979|559024176|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
154891470|NCT00589979|559024177|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
154891471|NCT00589979|559024178|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
154891472|NCT00589979|559024176|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
154891473|NCT00589979|559024177|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
154891474|NCT00589979|559024178|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
154891475|NCT01153841|559024179|FG000|Overall Study|Adverse Event|1|||
154891476|NCT01153841|559024180|FG001|Overall Study|Adverse Event|0|||
154891477|NCT01153841|559024179|FG000|Overall Study|Withdrawal by Subject|1|||
154891478|NCT01153841|559024180|FG001|Overall Study|Withdrawal by Subject|0|||
154891479|NCT01153841|559024179|FG000|Overall Study|Protocol Violation|2|||
154891480|NCT01153841|559024180|FG001|Overall Study|Protocol Violation|0|||
154891481|NCT01153841|559024179|FG000|Overall Study|Lost to Follow-up|2|||
154891482|NCT01153841|559024180|FG001|Overall Study|Lost to Follow-up|0|||
154891483|NCT00830804|559024184|FG000|Overall Study|Lost to Follow-up|4|||
154891484|NCT00830804|559024184|FG000|Overall Study|Death|1|||
154891485|NCT00830804|559024184|FG000|Overall Study|Unable to get to clinic|7|||
154891486|NCT00830804|559024184|FG000|Overall Study|Consent withdrawn|2|||
154891487|NCT00830804|559024184|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
154891488|NCT03428997|559024190|FG000|Overall Study|Sponsor decision.|1|||
154891489|NCT03428997|559024190|FG000|Overall Study|Withdrawal by Subject|3|||
154891490|NCT03428997|559024190|FG000|Overall Study|Lost to Follow-up|4|||
154891491|NCT00510068|559024194|FG000|Double-blind Period|Disease progression|98|||
154891492|NCT00510068|559024195|FG001|Double-blind Period|Disease progression|169|||
154891493|NCT00510068|559024194|FG000|Double-blind Period|Final primary analysis|52|||
154891494|NCT00510068|559024195|FG001|Double-blind Period|Final primary analysis|18|||
154891495|NCT00510068|559024194|FG000|Double-blind Period|Adverse Event|37|||
154891496|NCT00510068|559024195|FG001|Double-blind Period|Adverse Event|7|||
154891497|NCT00510068|559024194|FG000|Double-blind Period|Withdrawal by Subject|8|||
154891498|NCT00510068|559024195|FG001|Double-blind Period|Withdrawal by Subject|6|||
154891499|NCT00510068|559024194|FG000|Double-blind Period|Death|4|||
154891500|NCT00510068|559024195|FG001|Double-blind Period|Death|3|||
154891501|NCT00510068|559024194|FG000|Double-blind Period|Abnormal test result (s)|1|||
154891502|NCT00510068|559024195|FG001|Double-blind Period|Abnormal test result (s)|0|||
154891503|NCT00510068|559024194|FG000|Double-blind Period|Lost to Follow-up|1|||
154891504|NCT00510068|559024195|FG001|Double-blind Period|Lost to Follow-up|0|||
154891505|NCT00510068|559024194|FG000|Double-blind Period|Protocol Violation|6|||
154891506|NCT00510068|559024195|FG001|Double-blind Period|Protocol Violation|0|||
154891507|NCT00510068|559024194|FG000|Open-label Period|Disease Progression|124|||
154891508|NCT00510068|559024195|FG001|Open-label Period|Disease Progression|0|||
154891509|NCT00510068|559024194|FG000|Open-label Period|Adverse Event|46|||
154891510|NCT00510068|559024195|FG001|Open-label Period|Adverse Event|0|||
154891511|NCT00510068|559024194|FG000|Open-label Period|Withdrawal by Subject|21|||
154891512|NCT00510068|559024195|FG001|Open-label Period|Withdrawal by Subject|0|||
154891513|NCT00510068|559024194|FG000|Open-label Period|Administrative problems|17|||
154977995|NCT01647711|559342728|FG003|Overall Study|Protocol Violation|0|||
154977996|NCT01647711|559342729|FG004|Overall Study|Protocol Violation|1|||
154977997|NCT01647711|559342725|FG000|Overall Study|Refused to continue taking medication|0|||
154977998|NCT01647711|559342726|FG001|Overall Study|Refused to continue taking medication|0|||
154977999|NCT01647711|559342727|FG002|Overall Study|Refused to continue taking medication|0|||
154978000|NCT01647711|559342728|FG003|Overall Study|Refused to continue taking medication|2|||
154978001|NCT01647711|559342729|FG004|Overall Study|Refused to continue taking medication|1|||
154978002|NCT01647711|559342725|FG000|Overall Study|Other reason not defined|0|||
154978003|NCT01647711|559342726|FG001|Overall Study|Other reason not defined|1|||
154978004|NCT01647711|559342727|FG002|Overall Study|Other reason not defined|1|||
154978005|NCT01647711|559342728|FG003|Overall Study|Other reason not defined|1|||
154978006|NCT01647711|559342729|FG004|Overall Study|Other reason not defined|0|||
154978007|NCT01316419|559342730|FG000|Overall Study|Not treated|103|||
154978008|NCT01316419|559342730|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
154978009|NCT01316419|559342730|FG000|Overall Study|Lost to Follow-up|19|||
154978010|NCT00988208|559342743|FG000|Overall Study|Adverse Event|71|||
154978011|NCT00988208|559342744|FG001|Overall Study|Adverse Event|122|||
154978012|NCT00988208|559342743|FG000|Overall Study|Disease Progression|103|||
154978013|NCT00988208|559342744|FG001|Overall Study|Disease Progression|89|||
154978014|NCT00988208|559342743|FG000|Overall Study|Withdrawal by Subject|50|||
154978015|NCT00988208|559342744|FG001|Overall Study|Withdrawal by Subject|57|||
154978016|NCT00988208|559342743|FG000|Overall Study|Death|9|||
154978017|NCT00988208|559342744|FG001|Overall Study|Death|15|||
154978018|NCT00988208|559342743|FG000|Overall Study|Lost to Follow-up|2|||
154978019|NCT00988208|559342744|FG001|Overall Study|Lost to Follow-up|3|||
154978020|NCT00988208|559342743|FG000|Overall Study|Protocol Violation|9|||
154978021|NCT00988208|559342744|FG001|Overall Study|Protocol Violation|2|||
154978022|NCT00988208|559342743|FG000|Overall Study|Sponsor Decision|102|||
154978023|NCT00988208|559342744|FG001|Overall Study|Sponsor Decision|78|||
154978024|NCT00988208|559342743|FG000|Overall Study|Clinical Progression|17|||
154978025|NCT00988208|559342744|FG001|Overall Study|Clinical Progression|16|||
154978026|NCT00988208|559342743|FG000|Overall Study|Biochemical Progression|21|||
154978027|NCT00988208|559342744|FG001|Overall Study|Biochemical Progression|7|||
154978028|NCT00988208|559342743|FG000|Overall Study|Clinical Deterioration|7|||
154978029|NCT00988208|559342744|FG001|Overall Study|Clinical Deterioration|14|||
154978030|NCT00988208|559342743|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
154978031|NCT00988208|559342744|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
154978032|NCT00988208|559342743|FG000|Overall Study|Other|8|||
154978033|NCT00988208|559342744|FG001|Overall Study|Other|3|||
154978034|NCT01796964|559342745|FG000|Overall Study|Adverse Event|1|||
154978035|NCT01796964|559342746|FG001|Overall Study|Adverse Event|1|||
154978036|NCT01796964|559342745|FG000|Overall Study|Death|1|||
154978037|NCT01796964|559342746|FG001|Overall Study|Death|0|||
154978038|NCT01796964|559342745|FG000|Overall Study|Protocol Violation|0|||
154978039|NCT01796964|559342746|FG001|Overall Study|Protocol Violation|1|||
154978040|NCT01796964|559342745|FG000|Overall Study|Withdrawal by Subject|1|||
154978041|NCT01796964|559342746|FG001|Overall Study|Withdrawal by Subject|1|||
154978042|NCT04025684|559342747|FG000|Overall Study|Withdrawal by Subject|1|||
154978043|NCT04025684|559342748|FG001|Overall Study|Withdrawal by Subject|1|||
154978044|NCT04025684|559342749|FG002|Overall Study|Withdrawal by Subject|0|||
154978045|NCT04025684|559342750|FG003|Overall Study|Withdrawal by Subject|0|||
154978046|NCT04025684|559342747|FG000|Overall Study|Multiple reasons|1|||
154978047|NCT04025684|559342748|FG001|Overall Study|Multiple reasons|3|||
154978048|NCT04025684|559342749|FG002|Overall Study|Multiple reasons|0|||
154978049|NCT04025684|559342750|FG003|Overall Study|Multiple reasons|1|||
154978050|NCT01613378|559342755|FG000|Overall Study|Lack of Efficacy|13|||
154978051|NCT01613378|559342755|FG000|Overall Study|Adverse Event|11|||
154978052|NCT01613378|559342755|FG000|Overall Study|Withdrawal by Subject|8|||
154978053|NCT01613378|559342755|FG000|Overall Study|Death|2|||
154978054|NCT01613378|559342755|FG000|Overall Study|Lost to Follow-up|1|||
154978055|NCT01613378|559342755|FG000|Overall Study|Other Reason|4|||
154978056|NCT02000531|559342756|FG000|Overall Study|Lost to Follow-up|1|||
154978057|NCT02000531|559342757|FG001|Overall Study|Lost to Follow-up|0|||
154978058|NCT02000531|559342756|FG000|Overall Study|Discontinued due to data cut-off|3|||
154978059|NCT02000531|559342757|FG001|Overall Study|Discontinued due to data cut-off|8|||
154978060|NCT00794417|559342758|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
154978061|NCT00794417|559342759|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
154978062|NCT00794417|559342760|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
154978063|NCT00794417|559342761|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
154978064|NCT00794417|559342758|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
154978065|NCT00794417|559342759|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
154978066|NCT00794417|559342760|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
154978067|NCT00794417|559342761|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
154978068|NCT00794417|559342758|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
154978069|NCT00794417|559342759|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
154978070|NCT00794417|559342760|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
154978071|NCT00794417|559342761|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
154978072|NCT00794417|559342758|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
154978073|NCT00794417|559342759|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
154978074|NCT00794417|559342760|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
154978075|NCT00794417|559342761|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
154978076|NCT00794417|559342758|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
154978077|NCT00794417|559342759|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
154978078|NCT00794417|559342760|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
154978079|NCT00794417|559342761|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
154978080|NCT00794417|559342758|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
154978081|NCT00794417|559342759|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
154978082|NCT00794417|559342760|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
154978083|NCT00794417|559342761|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
154978084|NCT00317642|559342762|FG000|Overall Study|Not Received Either Study Drug|1|||
154978085|NCT00317642|559342763|FG001|Overall Study|Not Received Either Study Drug|3|||
154978086|NCT00317642|559342762|FG000|Overall Study|Physician Decision|15|||
154978087|NCT00317642|559342763|FG001|Overall Study|Physician Decision|7|||
154978088|NCT00317642|559342762|FG000|Overall Study|Participant declined treatment|14|||
154978089|NCT00317642|559342763|FG001|Overall Study|Participant declined treatment|3|||
154978090|NCT00317642|559342762|FG000|Overall Study|Adverse Event|17|||
154978091|NCT00317642|559342763|FG001|Overall Study|Adverse Event|5|||
154978092|NCT00317642|559342762|FG000|Overall Study|Treatment Failure|56|||
154978093|NCT00317642|559342763|FG001|Overall Study|Treatment Failure|102|||
154978094|NCT00317642|559342762|FG000|Overall Study|Disease Recurrence|1|||
154978095|NCT00317642|559342763|FG001|Overall Study|Disease Recurrence|2|||
154978096|NCT00317642|559342762|FG000|Overall Study|Death|14|||
154978097|NCT00317642|559342763|FG001|Overall Study|Death|7|||
154978098|NCT00317642|559342762|FG000|Overall Study|Not Continue to Consolidation|2|||
154978099|NCT00317642|559342763|FG001|Overall Study|Not Continue to Consolidation|0|||
154891514|NCT00510068|559024195|FG001|Open-label Period|Administrative problems|0|||
154891515|NCT00510068|559024194|FG000|Open-label Period|Death|7|||
154891516|NCT00510068|559024195|FG001|Open-label Period|Death|0|||
154891517|NCT00510068|559024194|FG000|Open-label Period|New cancer therapy|7|||
154891518|NCT00510068|559024195|FG001|Open-label Period|New cancer therapy|0|||
154891519|NCT00510068|559024194|FG000|Open-label Period|Protocol Violation|2|||
154891520|NCT00510068|559024195|FG001|Open-label Period|Protocol Violation|0|||
154891521|NCT00510068|559024194|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
154891522|NCT00510068|559024195|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
154891523|NCT01397448|559024196|FG000|Overall Study|Adverse Event|4|||
154891524|NCT01397448|559024197|FG001|Overall Study|Adverse Event|4|||
154978100|NCT00317642|559342762|FG000|Overall Study|Withdrawal by Subject|0|||
154978101|NCT00317642|559342763|FG001|Overall Study|Withdrawal by Subject|1|||
154978102|NCT00317642|559342762|FG000|Overall Study|Referred For Transplantation|1|||
154978103|NCT00317642|559342763|FG001|Overall Study|Referred For Transplantation|0|||
154978104|NCT00317642|559342762|FG000|Overall Study|AML Not Centrally Confirmed|1|||
154978105|NCT00317642|559342763|FG001|Overall Study|AML Not Centrally Confirmed|5|||
154978106|NCT00255151|559342764|FG000|Overall Study|Adverse Event|10|||
154978107|NCT00255151|559342765|FG001|Overall Study|Adverse Event|6|||
154978108|NCT00255151|559342766|FG002|Overall Study|Adverse Event|9|||
154978109|NCT00255151|559342764|FG000|Overall Study|Lost to Follow-up|4|||
154978110|NCT00255151|559342765|FG001|Overall Study|Lost to Follow-up|3|||
154978111|NCT00255151|559342766|FG002|Overall Study|Lost to Follow-up|4|||
154978112|NCT00255151|559342764|FG000|Overall Study|Withdrawal by Subject|18|||
154978113|NCT00255151|559342765|FG001|Overall Study|Withdrawal by Subject|17|||
154978114|NCT00255151|559342766|FG002|Overall Study|Withdrawal by Subject|8|||
154978115|NCT00255151|559342764|FG000|Overall Study|Noncompliance|0|||
154978116|NCT00255151|559342765|FG001|Overall Study|Noncompliance|1|||
154978117|NCT00255151|559342766|FG002|Overall Study|Noncompliance|2|||
154978118|NCT00255151|559342764|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
154891525|NCT01397448|559024198|FG002|Overall Study|Adverse Event|6|||
154891526|NCT01397448|559024196|FG000|Overall Study|Withdrawal by Subject|4|||
154891527|NCT01397448|559024197|FG001|Overall Study|Withdrawal by Subject|4|||
154891528|NCT01397448|559024198|FG002|Overall Study|Withdrawal by Subject|3|||
154891529|NCT01397448|559024196|FG000|Overall Study|Lack of Efficacy|2|||
154891530|NCT01397448|559024197|FG001|Overall Study|Lack of Efficacy|0|||
154891531|NCT01397448|559024198|FG002|Overall Study|Lack of Efficacy|5|||
154891532|NCT01397448|559024196|FG000|Overall Study|Other|8|||
154891533|NCT01397448|559024197|FG001|Overall Study|Other|7|||
154978119|NCT00255151|559342765|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
154978120|NCT00255151|559342766|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
154978121|NCT00255151|559342764|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
154978122|NCT00255151|559342765|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
154978123|NCT00255151|559342766|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
154891534|NCT01397448|559024198|FG002|Overall Study|Other|4|||
154891535|NCT03483116|559024202|FG000|Overall Study|Adverse Event|0|||
155175608|NCT00958438|560080286|FG000|Overall Study|Protocol Violation|3|||
155175609|NCT00958438|560080287|FG001|Overall Study|Protocol Violation|2|||
155175610|NCT00958438|560080288|FG002|Overall Study|Protocol Violation|2|||
155175611|NCT00958438|560080286|FG000|Overall Study|Withdrawal by Subject|4|||
155175612|NCT00958438|560080287|FG001|Overall Study|Withdrawal by Subject|2|||
154891536|NCT03483116|559024203|FG001|Overall Study|Adverse Event|1|||
154891537|NCT03483116|559024204|FG002|Overall Study|Adverse Event|0|||
154891538|NCT03483116|559024205|FG003|Overall Study|Adverse Event|1|||
154891539|NCT03483116|559024202|FG000|Overall Study|Protocol Violation|1|||
154891540|NCT03483116|559024203|FG001|Overall Study|Protocol Violation|0|||
154891541|NCT03483116|559024204|FG002|Overall Study|Protocol Violation|0|||
154891542|NCT03483116|559024205|FG003|Overall Study|Protocol Violation|7|||
154891543|NCT03483116|559024202|FG000|Overall Study|Lost to Follow-up|9|||
154891544|NCT03483116|559024203|FG001|Overall Study|Lost to Follow-up|4|||
154891545|NCT03483116|559024204|FG002|Overall Study|Lost to Follow-up|9|||
154891546|NCT03483116|559024205|FG003|Overall Study|Lost to Follow-up|5|||
154891547|NCT03483116|559024202|FG000|Overall Study|Death|1|||
154891548|NCT03483116|559024203|FG001|Overall Study|Death|0|||
154891549|NCT03483116|559024204|FG002|Overall Study|Death|2|||
154891550|NCT03483116|559024205|FG003|Overall Study|Death|1|||
154891551|NCT03483116|559024202|FG000|Overall Study|Withdrawal by Subject|14|||
154891552|NCT03483116|559024203|FG001|Overall Study|Withdrawal by Subject|16|||
154891553|NCT03483116|559024204|FG002|Overall Study|Withdrawal by Subject|14|||
154891554|NCT03483116|559024205|FG003|Overall Study|Withdrawal by Subject|16|||
154891555|NCT03483116|559024202|FG000|Overall Study|Unknown other reason|3|||
154891556|NCT03483116|559024203|FG001|Overall Study|Unknown other reason|2|||
154891557|NCT03483116|559024204|FG002|Overall Study|Unknown other reason|1|||
154891558|NCT03483116|559024205|FG003|Overall Study|Unknown other reason|1|||
154891559|NCT01309841|559024210|FG000|Overall Study|Other|0|||
154891560|NCT01309841|559024211|FG001|Overall Study|Other|1|||
154891561|NCT01309841|559024212|FG002|Overall Study|Other|1|||
154891562|NCT01309841|559024210|FG000|Overall Study|Lost to Follow-up|7|||
154891563|NCT01309841|559024211|FG001|Overall Study|Lost to Follow-up|6|||
154891564|NCT01309841|559024212|FG002|Overall Study|Lost to Follow-up|4|||
154891565|NCT01309841|559024210|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
154891566|NCT01309841|559024211|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
154891567|NCT01309841|559024212|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
154891568|NCT01309841|559024210|FG000|Overall Study|Lack of Efficacy|0|||
154891569|NCT01309841|559024211|FG001|Overall Study|Lack of Efficacy|0|||
154891570|NCT01309841|559024212|FG002|Overall Study|Lack of Efficacy|2|||
154891571|NCT01309841|559024210|FG000|Overall Study|Adverse Event|9|||
154891572|NCT01309841|559024211|FG001|Overall Study|Adverse Event|22|||
154891573|NCT01309841|559024212|FG002|Overall Study|Adverse Event|11|||
154891574|NCT01309841|559024210|FG000|Overall Study|Death|1|||
154891575|NCT01309841|559024211|FG001|Overall Study|Death|0|||
154891576|NCT01309841|559024212|FG002|Overall Study|Death|0|||
154891577|NCT01309841|559024210|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
154891578|NCT01309841|559024211|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
154891579|NCT01309841|559024212|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
154891580|NCT01309841|559024210|FG000|Overall Study|Withdrawal by Subject|17|||
154891581|NCT01309841|559024211|FG001|Overall Study|Withdrawal by Subject|6|||
154891582|NCT01309841|559024212|FG002|Overall Study|Withdrawal by Subject|13|||
154891583|NCT01309841|559024210|FG000|Overall Study|Did Not Receive Treatment|2|||
154891584|NCT01309841|559024211|FG001|Overall Study|Did Not Receive Treatment|0|||
154891585|NCT01309841|559024212|FG002|Overall Study|Did Not Receive Treatment|1|||
154891586|NCT01309841|559024210|FG000|Overall Study|Severe non-compliance with protocol|0|||
154891587|NCT01309841|559024211|FG001|Overall Study|Severe non-compliance with protocol|5|||
154891588|NCT01309841|559024212|FG002|Overall Study|Severe non-compliance with protocol|2|||
154891589|NCT04664855|559024213|FG000|Overall Study|Withdrawal by Subject|0|||
154891590|NCT04664855|559024214|FG001|Overall Study|Withdrawal by Subject|2|||
154891591|NCT01441115|559024215|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
154978124|NCT00255151|559342764|FG000|Overall Study|Possible Barrett's Esophagus|1|||
154978125|NCT00255151|559342765|FG001|Overall Study|Possible Barrett's Esophagus|3|||
154978126|NCT00255151|559342766|FG002|Overall Study|Possible Barrett's Esophagus|8|||
154978127|NCT00255151|559342764|FG000|Overall Study|Esophageal Stricture|0|||
154978128|NCT00255151|559342765|FG001|Overall Study|Esophageal Stricture|0|||
154978129|NCT00255151|559342766|FG002|Overall Study|Esophageal Stricture|1|||
154978130|NCT00255151|559342764|FG000|Overall Study|Therapeutic Failure|11|||
154978131|NCT00255151|559342765|FG001|Overall Study|Therapeutic Failure|2|||
154978132|NCT00255151|559342766|FG002|Overall Study|Therapeutic Failure|3|||
154978133|NCT05966090|559342768|FG000|Overall Study|Lost to Follow-up|6|||
154978134|NCT05966090|559342769|FG001|Overall Study|Lost to Follow-up|6|||
154978135|NCT05966090|559342768|FG000|Overall Study|Adverse Event|1|||
154978136|NCT05966090|559342769|FG001|Overall Study|Adverse Event|1|||
154978137|NCT05966090|559342768|FG000|Overall Study|Withdrawal by Subject|1|||
155175613|NCT00958438|560080288|FG002|Overall Study|Withdrawal by Subject|1|||
154891592|NCT02475395|559024223|FG000|Overall Study|Protocol Violation|30|||
154891593|NCT02475395|559024224|FG001|Overall Study|Protocol Violation|3|||
154978138|NCT05966090|559342769|FG001|Overall Study|Withdrawal by Subject|1|||
154978139|NCT05966090|559342768|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
154978140|NCT05966090|559342769|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
154978141|NCT05966090|559342768|FG000|Overall Study|Other|1|||
154978142|NCT05966090|559342769|FG001|Overall Study|Other|1|||
154978143|NCT03585959|559342772|FG000|Overall Study|Physician Decision|1|||
154978144|NCT03585959|559342772|FG000|Overall Study|Unsuccessful Procedure|2|||
154978145|NCT02531594|559342773|FG000|Overall Study|Withdrawal by Subject|7|||
154978146|NCT02531594|559342774|FG001|Overall Study|Withdrawal by Subject|8|||
154978147|NCT01557920|559342783|FG000|Overall Study|Withdrawal by Subject|2|||
154978148|NCT01557920|559342784|FG001|Overall Study|Withdrawal by Subject|3|||
154978149|NCT01557920|559342783|FG000|Overall Study|Lack of Efficacy|1|||
154978150|NCT01557920|559342784|FG001|Overall Study|Lack of Efficacy|0|||
154978151|NCT01175473|559342786|FG000|Overall Study|Adverse Event|2|||
154978152|NCT01175473|559342787|FG001|Overall Study|Adverse Event|2|||
154978153|NCT03635983|559342790|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
154978154|NCT03635983|559342791|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
154978155|NCT03635983|559342790|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
154978156|NCT03635983|559342791|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
154978157|NCT03635983|559342790|FG000|Pre-Treatment Period|Other reasons|0|||
154978158|NCT03635983|559342791|FG001|Pre-Treatment Period|Other reasons|1|||
154978159|NCT03635983|559342790|FG000|Pre-Treatment Period|Disease Progression|0|||
154978160|NCT03635983|559342791|FG001|Pre-Treatment Period|Disease Progression|1|||
154978161|NCT03635983|559342790|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
154978162|NCT03635983|559342791|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
154978163|NCT03635983|559342790|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
154978164|NCT03635983|559342791|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
154978165|NCT03635983|559342790|FG000|Treatment Period|Withdrawal by Subject|3|||
154978166|NCT03635983|559342791|FG001|Treatment Period|Withdrawal by Subject|5|||
154978167|NCT03635983|559342790|FG000|Treatment Period|Death|3|||
154978168|NCT03635983|559342791|FG001|Treatment Period|Death|5|||
154978169|NCT03635983|559342790|FG000|Treatment Period|Poor/Non-compliance|2|||
154978170|NCT03635983|559342791|FG001|Treatment Period|Poor/Non-compliance|1|||
154978171|NCT03635983|559342790|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
154978172|NCT03635983|559342791|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
154978173|NCT03635983|559342790|FG000|Treatment Period|Other reasons|7|||
154978174|NCT03635983|559342791|FG001|Treatment Period|Other reasons|4|||
154978175|NCT03635983|559342790|FG000|Treatment Period|Disease progression|230|||
154978176|NCT03635983|559342791|FG001|Treatment Period|Disease progression|201|||
154978177|NCT03635983|559342790|FG000|Treatment Period|Study drug toxicity|35|||
154978178|NCT03635983|559342791|FG001|Treatment Period|Study drug toxicity|36|||
154978179|NCT03635983|559342790|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
154978180|NCT03635983|559342791|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
154978181|NCT03635983|559342790|FG000|Treatment Period|Maximum clinical benefit|3|||
154978182|NCT03635983|559342791|FG001|Treatment Period|Maximum clinical benefit|5|||
154978183|NCT03635983|559342790|FG000|Treatment Period|Administrative reason by the sponsor|1|||
154978184|NCT03635983|559342791|FG001|Treatment Period|Administrative reason by the sponsor|2|||
154978185|NCT03635983|559342790|FG000|Treatment Period|Lost to Follow-up|0|||
154978186|NCT03635983|559342791|FG001|Treatment Period|Lost to Follow-up|1|||
154978187|NCT00559364|559342793|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
154978188|NCT00559364|559342794|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
154978189|NCT01235442|559342795|FG000|Overall Study|Lost to Follow-up|12|||
154978190|NCT01235442|559342796|FG001|Overall Study|Lost to Follow-up|10|||
154978191|NCT01235442|559342795|FG000|Overall Study|Death|0|||
154978192|NCT01235442|559342796|FG001|Overall Study|Death|2|||
154978193|NCT01235442|559342795|FG000|Overall Study|Pregnancy|1|||
154978194|NCT01235442|559342796|FG001|Overall Study|Pregnancy|1|||
154978195|NCT01235442|559342795|FG000|Overall Study|Ineligibility determined|5|||
154978196|NCT01235442|559342796|FG001|Overall Study|Ineligibility determined|4|||
154978197|NCT01235442|559342795|FG000|Overall Study|Protocol Violation|3|||
154978198|NCT01235442|559342796|FG001|Overall Study|Protocol Violation|3|||
154978199|NCT01235442|559342795|FG000|Overall Study|Adverse Event|4|||
154978200|NCT01235442|559342796|FG001|Overall Study|Adverse Event|6|||
154978201|NCT01235442|559342795|FG000|Overall Study|Withdrawal by Subject|15|||
154978202|NCT01235442|559342796|FG001|Overall Study|Withdrawal by Subject|9|||
154978203|NCT01235442|559342795|FG000|Overall Study|Lack of Efficacy|1|||
154978204|NCT01235442|559342796|FG001|Overall Study|Lack of Efficacy|3|||
154978205|NCT01235442|559342795|FG000|Overall Study|Noncompliance|1|||
154978206|NCT01235442|559342796|FG001|Overall Study|Noncompliance|2|||
154978207|NCT01235442|559342795|FG000|Overall Study|Administrative decision|1|||
154978208|NCT01235442|559342796|FG001|Overall Study|Administrative decision|2|||
154978209|NCT01235442|559342795|FG000|Overall Study|Other unspecified|1|||
154978210|NCT01235442|559342796|FG001|Overall Study|Other unspecified|2|||
154978211|NCT01020526|559342802|FG000|Overall Study|Withdrawal by Subject|5|||
154978212|NCT01020526|559342802|FG000|Overall Study|Other reasons|3|||
154891594|NCT01086150|559024225|FG000|Overall Study|Withdrawal by Subject|0|||
154891595|NCT01086150|559024226|FG001|Overall Study|Withdrawal by Subject|4|||
154891596|NCT01086150|559024227|FG002|Overall Study|Withdrawal by Subject|1|||
154891597|NCT01086150|559024225|FG000|Overall Study|Lost to Follow-up|0|||
154891598|NCT01086150|559024226|FG001|Overall Study|Lost to Follow-up|1|||
154891599|NCT01086150|559024227|FG002|Overall Study|Lost to Follow-up|0|||
154891600|NCT01086150|559024225|FG000|Overall Study|Screen Failure|0|||
154891601|NCT01086150|559024226|FG001|Overall Study|Screen Failure|1|||
154891602|NCT01086150|559024227|FG002|Overall Study|Screen Failure|0|||
154891603|NCT01681576|559024228|FG000|Period 1|Adverse Event|1|||
154891604|NCT01681576|559024229|FG001|Period 1|Adverse Event|0|||
154891605|NCT01681576|559024228|FG000|Period 1|Protocol Deviation|1|||
154891606|NCT01681576|559024229|FG001|Period 1|Protocol Deviation|0|||
154891607|NCT01681576|559024228|FG000|Period 2|subject/guardian decision|3|||
154891608|NCT01681576|559024229|FG001|Period 2|subject/guardian decision|1|||
154891609|NCT01681576|559024228|FG000|Period 2|Non-compliance with study treatment|1|||
154891610|NCT01681576|559024229|FG001|Period 2|Non-compliance with study treatment|0|||
154891611|NCT03543358|559024231|FG000|Overall Study|Death|1|||
154891612|NCT03543358|559024232|FG001|Overall Study|Death|0|||
154891613|NCT03543358|559024231|FG000|Overall Study|Disease Progression|1|||
154891614|NCT03543358|559024232|FG001|Overall Study|Disease Progression|0|||
154891615|NCT03543358|559024231|FG000|Overall Study|Parent Study Closure|1|||
154891616|NCT03543358|559024232|FG001|Overall Study|Parent Study Closure|0|||
154891617|NCT00178464|559024233|FG000|Overall Study|Withdrawal by Subject|1|||
154891618|NCT00178464|559024233|FG000|Overall Study|Physician Decision|1|||
154891619|NCT02260648|559024234|FG000|Overall Study|Adverse Event|3|||
154891620|NCT02260648|559024235|FG001|Overall Study|Adverse Event|0|||
154891621|NCT02260648|559024236|FG002|Overall Study|Adverse Event|1|||
154891622|NCT02260648|559024234|FG000|Overall Study|Withdrawal by Subject|1|||
154891623|NCT02260648|559024235|FG001|Overall Study|Withdrawal by Subject|1|||
154891624|NCT02260648|559024236|FG002|Overall Study|Withdrawal by Subject|0|||
154891625|NCT02260648|559024234|FG000|Overall Study|Protocol Violation|1|||
154891626|NCT02260648|559024235|FG001|Overall Study|Protocol Violation|0|||
154891627|NCT02260648|559024236|FG002|Overall Study|Protocol Violation|0|||
154891628|NCT02260648|559024234|FG000|Overall Study|Discontinue Due to Study Termination|13|||
154891629|NCT02260648|559024235|FG001|Overall Study|Discontinue Due to Study Termination|12|||
154891630|NCT02260648|559024236|FG002|Overall Study|Discontinue Due to Study Termination|7|||
154891631|NCT04093258|559024237|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
154891632|NCT04093258|559024238|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
154891633|NCT00594204|559024239|FG000|Overall Study|Adverse Event|15|||
154891634|NCT00594204|559024240|FG001|Overall Study|Adverse Event|3|||
154891635|NCT00594204|559024239|FG000|Overall Study|Lost to Follow-up|9|||
154891636|NCT00594204|559024240|FG001|Overall Study|Lost to Follow-up|5|||
154891637|NCT00594204|559024239|FG000|Overall Study|Withdrawal by Subject|23|||
154891638|NCT00594204|559024240|FG001|Overall Study|Withdrawal by Subject|29|||
154891639|NCT00594204|559024239|FG000|Overall Study|Other|4|||
154891640|NCT00594204|559024240|FG001|Overall Study|Other|3|||
154891641|NCT00594204|559024239|FG000|Overall Study|Lack of Efficacy|3|||
154891642|NCT00594204|559024240|FG001|Overall Study|Lack of Efficacy|4|||
154891643|NCT00594204|559024239|FG000|Overall Study|Randomized but not treated|4|||
154891644|NCT00594204|559024240|FG001|Overall Study|Randomized but not treated|1|||
154891645|NCT00567541|559024241|FG000|Overall Study|Adverse Event|0|||
154891646|NCT00567541|559024242|FG001|Overall Study|Adverse Event|1|||
154891647|NCT01890512|559024243|FG000|Overall Study|Physician Decision|1|||
154891648|NCT01890512|559024243|FG000|Overall Study|Withdrawal by Subject|1|||
154891649|NCT01890512|559024243|FG000|Overall Study|Protocol Violation|1|||
154891650|NCT01529385|559024244|FG000|Overall Study|Lost to Follow-up|2|||
154891651|NCT01529385|559024245|FG001|Overall Study|Lost to Follow-up|1|||
154891652|NCT01115738|559024246|FG000|Overall Study|Death|1|||
154891653|NCT01115738|559024247|FG001|Overall Study|Death|0|||
154891654|NCT01115738|559024248|FG002|Overall Study|Death|0|||
154891655|NCT01115738|559024246|FG000|Overall Study|Lost to Follow-up|0|||
154891656|NCT01115738|559024247|FG001|Overall Study|Lost to Follow-up|0|||
154891657|NCT01115738|559024248|FG002|Overall Study|Lost to Follow-up|1|||
154891658|NCT01115738|559024246|FG000|Overall Study|Physician Decision|18|||
154891659|NCT01115738|559024247|FG001|Overall Study|Physician Decision|15|||
155113964|NCT02447250|559846188|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
155113965|NCT02447250|559846188|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
155113966|NCT03632993|559846189|FG000|Overall Study|Withdrawal by Subject|1|||
154891660|NCT01115738|559024248|FG002|Overall Study|Physician Decision|17|||
154891661|NCT01115738|559024246|FG000|Overall Study|Withdrawal by Subject|6|||
154891662|NCT01115738|559024247|FG001|Overall Study|Withdrawal by Subject|6|||
154891663|NCT01115738|559024248|FG002|Overall Study|Withdrawal by Subject|9|||
154891664|NCT02379390|559024251|FG000|Overall Study|Adverse Event|1|||
154891665|NCT02379390|559024252|FG001|Overall Study|Adverse Event|1|||
154891666|NCT02379390|559024251|FG000|Overall Study|Investigator's decision|1|||
154891667|NCT02379390|559024252|FG001|Overall Study|Investigator's decision|0|||
154891668|NCT02379390|559024251|FG000|Overall Study|Study Termination|0|||
154891669|NCT02379390|559024252|FG001|Overall Study|Study Termination|1|||
154891670|NCT00575094|559024253|FG000|Overall Study|Adverse Event|2|||
154891671|NCT00575094|559024253|FG000|Overall Study|Withdrawal by Subject|1|||
154891672|NCT02721251|559024256|FG000|Overall Study|Withdrawal by Subject|8|||
154891673|NCT02721251|559024257|FG001|Overall Study|Withdrawal by Subject|7|||
154891674|NCT02721251|559024258|FG002|Overall Study|Withdrawal by Subject|9|||
154891675|NCT02721251|559024256|FG000|Overall Study|poor adherence|2|||
154891676|NCT02721251|559024257|FG001|Overall Study|poor adherence|2|||
154891677|NCT02721251|559024258|FG002|Overall Study|poor adherence|2|||
154891678|NCT02921763|559024261|FG000|Overall Study|Adverse Event|4|||
154891679|NCT02921763|559024261|FG000|Overall Study|Lost to Follow-up|4|||
154891680|NCT02921763|559024261|FG000|Overall Study|Lack of Efficacy|3|||
154891681|NCT02921763|559024261|FG000|Overall Study|Protocol Violation|2|||
154891682|NCT02921763|559024261|FG000|Overall Study|Withdrawal by Subject|2|||
154891683|NCT02921763|559024261|FG000|Overall Study|Physician Decision|1|||
154891684|NCT02921763|559024261|FG000|Overall Study|No data obtained|2|||
154891685|NCT01740388|559024264|FG000|Overall Study|Withdrawal by Subject|1|||
154891686|NCT01740388|559024265|FG001|Overall Study|Withdrawal by Subject|2|||
154891687|NCT01740388|559024264|FG000|Overall Study|Lost to Follow-up|2|||
154891688|NCT01740388|559024265|FG001|Overall Study|Lost to Follow-up|0|||
154891689|NCT01740388|559024264|FG000|Overall Study|Physician Decision|2|||
154891690|NCT01740388|559024265|FG001|Overall Study|Physician Decision|6|||
154891691|NCT01740388|559024264|FG000|Overall Study|Subjects missing data, completed|41|||
154891692|NCT01740388|559024265|FG001|Overall Study|Subjects missing data, completed|36|||
154891693|NCT04142216|559024266|FG000|Overall Study|Hospitalization|0|||
154891694|NCT04142216|559024267|FG001|Overall Study|Hospitalization|2|||
154891695|NCT04142216|559024266|FG000|Overall Study|Death|3|||
154891696|NCT04142216|559024267|FG001|Overall Study|Death|1|||
154891697|NCT04142216|559024266|FG000|Overall Study|Referral to another hemodialysis unit|3|||
154891698|NCT04142216|559024267|FG001|Overall Study|Referral to another hemodialysis unit|2|||
154891699|NCT04142216|559024266|FG000|Overall Study|Use of clove|0|||
154891700|NCT04142216|559024267|FG001|Overall Study|Use of clove|1|||
154891701|NCT00862121|559024270|FG000|Overall Study|Adverse Event|1|||
154891702|NCT00862121|559024271|FG001|Overall Study|Adverse Event|2|||
154891703|NCT00862121|559024270|FG000|Overall Study|Lack of Efficacy|0|||
154891704|NCT00862121|559024271|FG001|Overall Study|Lack of Efficacy|3|||
154891705|NCT00862121|559024270|FG000|Overall Study|Protocol Violation|0|||
154891706|NCT00862121|559024271|FG001|Overall Study|Protocol Violation|1|||
154891707|NCT00862121|559024270|FG000|Overall Study|Exclusion criterion violation|0|||
154891708|NCT00862121|559024271|FG001|Overall Study|Exclusion criterion violation|1|||
154891709|NCT00862121|559024270|FG000|Overall Study|Incorrect randomisation|0|||
154891710|NCT00862121|559024271|FG001|Overall Study|Incorrect randomisation|1|||
154891711|NCT01582971|559024272|FG000|Overall Study|Death|2|||
154891712|NCT01582971|559024273|FG001|Overall Study|Death|1|||
154891713|NCT01582971|559024272|FG000|Overall Study|Lost to Follow-up|18|||
154891714|NCT01582971|559024273|FG001|Overall Study|Lost to Follow-up|21|||
154891715|NCT01582971|559024272|FG000|Overall Study|Withdrawal by Subject|4|||
154891716|NCT01582971|559024273|FG001|Overall Study|Withdrawal by Subject|2|||
154891717|NCT01582971|559024272|FG000|Overall Study|Other|15|||
154891718|NCT01582971|559024273|FG001|Overall Study|Other|13|||
154891719|NCT05691829|559026142|FG000|Overall Study|Physician Decision|2|||
154891720|NCT05691829|559026142|FG000|Overall Study|Eligibility criteria not met|3|||
154891721|NCT00804843|559026145|FG000|Overall Study|Protocol Violation|1|||
154891722|NCT00804843|559026146|FG001|Overall Study|Protocol Violation|0|||
154891723|NCT00804843|559026145|FG000|Overall Study|Adverse Event|8|||
154891724|NCT00804843|559026146|FG001|Overall Study|Adverse Event|5|||
154891725|NCT00804843|559026145|FG000|Overall Study|Withdrawal by Subject|1|||
154891726|NCT00804843|559026146|FG001|Overall Study|Withdrawal by Subject|2|||
154891727|NCT01357980|559026147|FG000|Overall Study|Lack of Efficacy|0|||
154891728|NCT01357980|559026148|FG001|Overall Study|Lack of Efficacy|1|||
154891729|NCT01357980|559026149|FG002|Overall Study|Lack of Efficacy|0|||
154891730|NCT01357980|559026150|FG003|Overall Study|Lack of Efficacy|0|||
154891731|NCT01357980|559026147|FG000|Overall Study|Consent withdrawn|0|||
154891732|NCT01357980|559026148|FG001|Overall Study|Consent withdrawn|0|||
154891733|NCT01357980|559026149|FG002|Overall Study|Consent withdrawn|1|||
154891734|NCT01357980|559026150|FG003|Overall Study|Consent withdrawn|0|||
154891735|NCT00094835|559026153|FG000|Overall Study|Physician Decision|1|||
154891736|NCT00094835|559026154|FG001|Overall Study|Physician Decision|0|||
154978213|NCT01020526|559342802|FG000|Overall Study|Insufficient clinical response|3|||
154891737|NCT00094835|559026155|FG002|Overall Study|Physician Decision|0|||
154891738|NCT00094835|559026156|FG003|Overall Study|Physician Decision|0|||
154891739|NCT00094835|559026157|FG004|Overall Study|Physician Decision|0|||
154891740|NCT00094835|559026158|FG005|Overall Study|Physician Decision|1|||
154891741|NCT00094835|559026159|FG006|Overall Study|Physician Decision|0|||
154891742|NCT00094835|559026153|FG000|Overall Study|Withdrawal by Subject|0|||
154891743|NCT00094835|559026154|FG001|Overall Study|Withdrawal by Subject|0|||
154891744|NCT00094835|559026155|FG002|Overall Study|Withdrawal by Subject|0|||
154891745|NCT00094835|559026156|FG003|Overall Study|Withdrawal by Subject|0|||
154891746|NCT00094835|559026157|FG004|Overall Study|Withdrawal by Subject|0|||
154891747|NCT00094835|559026158|FG005|Overall Study|Withdrawal by Subject|0|||
154891748|NCT00094835|559026159|FG006|Overall Study|Withdrawal by Subject|1|||
154891749|NCT00094835|559026153|FG000|Overall Study|Lost to Follow-up|0|||
154891750|NCT00094835|559026154|FG001|Overall Study|Lost to Follow-up|0|||
154891751|NCT00094835|559026155|FG002|Overall Study|Lost to Follow-up|0|||
154891752|NCT00094835|559026156|FG003|Overall Study|Lost to Follow-up|0|||
154891753|NCT00094835|559026157|FG004|Overall Study|Lost to Follow-up|1|||
154891754|NCT00094835|559026158|FG005|Overall Study|Lost to Follow-up|0|||
154891755|NCT00094835|559026159|FG006|Overall Study|Lost to Follow-up|0|||
154891756|NCT00094835|559026153|FG000|Overall Study|Death|1|||
154891757|NCT00094835|559026154|FG001|Overall Study|Death|0|||
154891758|NCT00094835|559026155|FG002|Overall Study|Death|0|||
154891759|NCT00094835|559026156|FG003|Overall Study|Death|0|||
154891760|NCT00094835|559026157|FG004|Overall Study|Death|1|||
154891761|NCT00094835|559026158|FG005|Overall Study|Death|0|||
154891762|NCT00094835|559026159|FG006|Overall Study|Death|0|||
154891763|NCT00094835|559026153|FG000|Overall Study|Non-compliance|1|||
154891764|NCT00094835|559026154|FG001|Overall Study|Non-compliance|2|||
154891765|NCT00094835|559026155|FG002|Overall Study|Non-compliance|2|||
154891766|NCT00094835|559026156|FG003|Overall Study|Non-compliance|0|||
154891767|NCT00094835|559026157|FG004|Overall Study|Non-compliance|2|||
154891768|NCT00094835|559026158|FG005|Overall Study|Non-compliance|2|||
154891769|NCT00094835|559026159|FG006|Overall Study|Non-compliance|1|||
154891770|NCT00094835|559026153|FG000|Overall Study|Other|1|||
154891771|NCT00094835|559026154|FG001|Overall Study|Other|1|||
154891772|NCT00094835|559026155|FG002|Overall Study|Other|1|||
154891773|NCT00094835|559026156|FG003|Overall Study|Other|1|||
154891774|NCT00094835|559026157|FG004|Overall Study|Other|0|||
154891775|NCT00094835|559026158|FG005|Overall Study|Other|0|||
154891776|NCT00094835|559026159|FG006|Overall Study|Other|0|||
154891777|NCT00092677|559026170|FG000|Overall Study|Lost to Follow-up|0|||
154891778|NCT00092677|559026171|FG001|Overall Study|Lost to Follow-up|2|||
154891779|NCT00092677|559026170|FG000|Overall Study|Adminstrative|5|||
154891780|NCT00092677|559026171|FG001|Overall Study|Adminstrative|9|||
154891781|NCT04624672|559026172|FG000|Overall Study|Early Study Closure|2|||
154891782|NCT04624672|559026173|FG001|Overall Study|Early Study Closure|1|||
154891783|NCT03024255|559026176|FG000|Overall Study|Adverse Event|1|||
154891784|NCT03024255|559026177|FG001|Overall Study|Adverse Event|4|||
154891785|NCT03024255|559026178|FG002|Overall Study|Adverse Event|8|||
154891786|NCT03024255|559026179|FG003|Overall Study|Adverse Event|0|||
154891787|NCT03024255|559026176|FG000|Overall Study|Withdrawal by Subject|3|||
154891788|NCT03024255|559026177|FG001|Overall Study|Withdrawal by Subject|1|||
154891789|NCT03024255|559026178|FG002|Overall Study|Withdrawal by Subject|0|||
154891790|NCT03024255|559026179|FG003|Overall Study|Withdrawal by Subject|3|||
154891791|NCT03024255|559026176|FG000|Overall Study|Protocol Violation|0|||
154891792|NCT03024255|559026177|FG001|Overall Study|Protocol Violation|0|||
154891793|NCT03024255|559026178|FG002|Overall Study|Protocol Violation|2|||
154891794|NCT03024255|559026179|FG003|Overall Study|Protocol Violation|0|||
154891795|NCT03024255|559026176|FG000|Overall Study|Lost to Follow-up|1|||
154891796|NCT03024255|559026177|FG001|Overall Study|Lost to Follow-up|2|||
154891797|NCT03024255|559026178|FG002|Overall Study|Lost to Follow-up|1|||
154891798|NCT03024255|559026179|FG003|Overall Study|Lost to Follow-up|1|||
154891799|NCT03024255|559026176|FG000|Overall Study|Lack of Efficacy|1|||
154891800|NCT03024255|559026177|FG001|Overall Study|Lack of Efficacy|0|||
154891801|NCT03024255|559026178|FG002|Overall Study|Lack of Efficacy|0|||
154891802|NCT03024255|559026179|FG003|Overall Study|Lack of Efficacy|0|||
154891803|NCT03024255|559026176|FG000|Overall Study|Protocol Noncompliance|1|||
154891804|NCT03024255|559026177|FG001|Overall Study|Protocol Noncompliance|1|||
154891805|NCT03024255|559026178|FG002|Overall Study|Protocol Noncompliance|0|||
154891806|NCT03024255|559026179|FG003|Overall Study|Protocol Noncompliance|1|||
154891807|NCT01415908|559026180|FG000|Overall Study|Withdrawal by Subject|1|||
154891808|NCT01415908|559026181|FG001|Overall Study|Withdrawal by Subject|0|||
154891809|NCT02685995|559026184|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
154891810|NCT02685995|559026185|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
154891811|NCT01188096|559026186|FG000|Overall Study|progression of disease|4|||
154891812|NCT01188096|559026186|FG000|Overall Study|Withdrawal by Subject|2|||
154891813|NCT01797445|559026187|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
154891814|NCT01797445|559026188|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
154891815|NCT01797445|559026187|FG000|Double-Blind Phase|Adverse Event|3|||
154891816|NCT01797445|559026188|FG001|Double-Blind Phase|Adverse Event|0|||
154891817|NCT01797445|559026187|FG000|Double-Blind Phase|Death|5|||
154891818|NCT01797445|559026188|FG001|Double-Blind Phase|Death|4|||
154891819|NCT01797445|559026187|FG000|Double-Blind Phase|Pregnancy|0|||
154891820|NCT01797445|559026188|FG001|Double-Blind Phase|Pregnancy|1|||
154891821|NCT01797445|559026187|FG000|Double-Blind Phase|Lack of Efficacy|1|||
154891822|NCT01797445|559026188|FG001|Double-Blind Phase|Lack of Efficacy|2|||
154891823|NCT01797445|559026187|FG000|Double-Blind Phase|Investigator's Discretion|15|||
154891824|NCT01797445|559026188|FG001|Double-Blind Phase|Investigator's Discretion|17|||
154891825|NCT01797445|559026187|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
154891826|NCT01797445|559026188|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
154891827|NCT01797445|559026187|FG000|Double-Blind Phase|Protocol Violation|0|||
154891828|NCT01797445|559026188|FG001|Double-Blind Phase|Protocol Violation|1|||
154891829|NCT01797445|559026187|FG000|Double-Blind Phase|Withdrew Consent|20|||
154891830|NCT01797445|559026188|FG001|Double-Blind Phase|Withdrew Consent|35|||
154891831|NCT01797445|559026187|FG000|Double-Blind Phase|Lost to Follow-up|34|||
154891832|NCT01797445|559026188|FG001|Double-Blind Phase|Lost to Follow-up|26|||
154891833|NCT01797445|559026187|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
154891834|NCT01797445|559026188|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
154891835|NCT00688545|559026189|FG000|Overall Study|Lost to Follow-up|1|||
154891836|NCT00688545|559026190|FG001|Overall Study|Lost to Follow-up|4|||
154891837|NCT00688545|559026189|FG000|Overall Study|Insurance/cost of drug|0|||
154891838|NCT00688545|559026190|FG001|Overall Study|Insurance/cost of drug|1|||
154891839|NCT00688545|559026189|FG000|Overall Study|Withdrawal by Subject|2|||
154891840|NCT00688545|559026190|FG001|Overall Study|Withdrawal by Subject|3|||
154891841|NCT00688545|559026189|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
154891842|NCT00688545|559026190|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
154891843|NCT01878097|559026193|FG000|Baseline|Surveys not fully completed|2497|||
154891844|NCT01878097|559026194|FG001|Baseline|Surveys not fully completed|1800|||
154891845|NCT01878097|559026193|FG000|Implementation Year 1|Surveys not fully completed|3202|||
154891846|NCT01878097|559026194|FG001|Implementation Year 1|Surveys not fully completed|2549|||
154891847|NCT01878097|559026193|FG000|Implementation Year 2|Surveys not fully completed|3281|||
154891848|NCT01878097|559026194|FG001|Implementation Year 2|Surveys not fully completed|2841|||
154891849|NCT01878097|559026193|FG000|Implementation Year 3|Surveys not fully completed|3494|||
154891850|NCT01878097|559026194|FG001|Implementation Year 3|Surveys not fully completed|2980|||
154891851|NCT01878097|559026193|FG000|Implementation Year 4|Surveys not fully completed|3604|||
154891852|NCT01878097|559026194|FG001|Implementation Year 4|Surveys not fully completed|3007|||
154891853|NCT01595438|559026195|FG000|Overall Study|Lost to Follow-up|20|||
154891854|NCT01595438|559026196|FG001|Overall Study|Lost to Follow-up|20|||
154891855|NCT01595438|559026195|FG000|Overall Study|Withdrawal by Subject|12|||
154891856|NCT01595438|559026196|FG001|Overall Study|Withdrawal by Subject|12|||
154891857|NCT01595438|559026195|FG000|Overall Study|Other Eligibility criteria|11|||
154891858|NCT01595438|559026196|FG001|Overall Study|Other Eligibility criteria|9|||
154891859|NCT03783442|559026202|FG000|Overall Study|Death|252|||
154891860|NCT03783442|559026203|FG001|Overall Study|Death|268|||
154891861|NCT03783442|559026202|FG000|Overall Study|Withdrawal by Subject|19|||
154891862|NCT03783442|559026203|FG001|Overall Study|Withdrawal by Subject|21|||
154891863|NCT03783442|559026202|FG000|Overall Study|Lost to Follow-up|7|||
154891864|NCT03783442|559026203|FG001|Overall Study|Lost to Follow-up|6|||
154891865|NCT03783442|559026202|FG000|Overall Study|Sponsor Ended Study|48|||
154891866|NCT03783442|559026203|FG001|Overall Study|Sponsor Ended Study|28|||
154891867|NCT00973622|559026204|FG000|Overall Study|did not attend MRI|14|||
154891868|NCT00973622|559026205|FG001|Overall Study|did not attend MRI|3|||
154891869|NCT00973622|559026204|FG000|Overall Study|did not pass MRI screen|6|||
154891870|NCT00973622|559026205|FG001|Overall Study|did not pass MRI screen|0|||
154891871|NCT00973622|559026204|FG000|Overall Study|did not complete rTMS sessions|11|||
154891872|NCT00973622|559026205|FG001|Overall Study|did not complete rTMS sessions|2|||
154891873|NCT00171314|559026206|FG000|Overall Study|Adverse Event|44|||
154891874|NCT00171314|559026207|FG001|Overall Study|Adverse Event|41|||
154891875|NCT00171314|559026206|FG000|Overall Study|Lack of Efficacy|19|||
154891876|NCT00171314|559026207|FG001|Overall Study|Lack of Efficacy|14|||
154891877|NCT00171314|559026206|FG000|Overall Study|Withdrawal by Subject|9|||
154891878|NCT00171314|559026207|FG001|Overall Study|Withdrawal by Subject|6|||
154891879|NCT00171314|559026206|FG000|Overall Study|Abnormal Test Procedure Results|9|||
154891880|NCT00171314|559026207|FG001|Overall Study|Abnormal Test Procedure Results|3|||
154891881|NCT00171314|559026206|FG000|Overall Study|Protocol Violation|3|||
154891882|NCT00171314|559026207|FG001|Overall Study|Protocol Violation|7|||
154891883|NCT00171314|559026206|FG000|Overall Study|Administrative Problems|4|||
154891884|NCT00171314|559026207|FG001|Overall Study|Administrative Problems|3|||
154891885|NCT00171314|559026206|FG000|Overall Study|Lost to Follow-up|1|||
154891886|NCT00171314|559026207|FG001|Overall Study|Lost to Follow-up|3|||
154891887|NCT00171314|559026206|FG000|Overall Study|Death|2|||
154891888|NCT00171314|559026207|FG001|Overall Study|Death|1|||
154891889|NCT02855450|559026208|FG000|Overall Study|Adverse Event|1|||
154891890|NCT02855450|559026209|FG001|Overall Study|Adverse Event|0|||
154891891|NCT02855450|559026208|FG000|Overall Study|Lost to Follow-up|4|||
154891892|NCT02855450|559026209|FG001|Overall Study|Lost to Follow-up|0|||
154891893|NCT01996904|559026210|FG000|Overall Study|Lost to Follow-up|38|||
154891894|NCT01996904|559026211|FG001|Overall Study|Lost to Follow-up|27|||
154891895|NCT00585923|559026213|FG000|Overall Study|Physician decided not to continue|31|||
154891896|NCT00585923|559026214|FG001|Overall Study|Physician decided not to continue|33|||
154891897|NCT00878215|559026215|FG000|Overall Study|Determined to be ineligible|0|||
154891898|NCT00878215|559026216|FG001|Overall Study|Determined to be ineligible|10|||
154891899|NCT00878215|559026217|FG002|Overall Study|Determined to be ineligible|0|||
154891900|NCT00878215|559026218|FG003|Overall Study|Determined to be ineligible|0|||
154891901|NCT02815293|559026219|FG000|Overall Study|Study termination by sponsor|10|||
154891902|NCT02815293|559026220|FG001|Overall Study|Study termination by sponsor|7|||
154891903|NCT02815293|559026221|FG002|Overall Study|Study termination by sponsor|0|||
154891904|NCT02815293|559026219|FG000|Overall Study|Participants not randomized|0|||
154891905|NCT02815293|559026220|FG001|Overall Study|Participants not randomized|0|||
154891906|NCT02815293|559026221|FG002|Overall Study|Participants not randomized|18|||
154891907|NCT02815293|559026219|FG000|Overall Study|Adverse Event|0|||
154891908|NCT02815293|559026220|FG001|Overall Study|Adverse Event|1|||
154891909|NCT02815293|559026221|FG002|Overall Study|Adverse Event|0|||
154891910|NCT00805545|559026224|FG000|Overall Study|Protocol Violation|3|||
154891911|NCT00805545|559026225|FG001|Overall Study|Protocol Violation|2|||
154891912|NCT00805545|559026224|FG000|Overall Study|Protocol Violation|3|||
154891913|NCT00805545|559026225|FG001|Overall Study|Protocol Violation|1|||
154891914|NCT00986427|559026230|FG000|Overall Study|Lost to Follow-up|2|||
154891915|NCT00986427|559026231|FG001|Overall Study|Lost to Follow-up|0|||
154891916|NCT00986427|559026230|FG000|Overall Study|Lack of Efficacy|1|||
154891917|NCT00986427|559026231|FG001|Overall Study|Lack of Efficacy|0|||
154891918|NCT00986427|559026230|FG000|Overall Study|Withdrawal by Subject|1|||
154891919|NCT00986427|559026231|FG001|Overall Study|Withdrawal by Subject|0|||
154891920|NCT00643604|559026235|FG000|Overall Study|Death|1|||
154891921|NCT02007954|559026238|FG000|Overall Study|Received liver transplant|3|||
154891922|NCT02007954|559026238|FG000|Overall Study|Switch in treatment modality|2|||
154891923|NCT02007954|559026238|FG000|Overall Study|Disease progression and unrelated AE|1|||
154891924|NCT02007954|559026238|FG000|Overall Study|Death|1|||
154891925|NCT01641991|559026241|FG000|Overall Study|Physician Decision|0|||
154891926|NCT01641991|559026242|FG001|Overall Study|Physician Decision|1|||
154891927|NCT01641991|559026243|FG002|Overall Study|Physician Decision|7|||
154891928|NCT01641991|559026244|FG003|Overall Study|Physician Decision|5|||
154891929|NCT01641991|559026241|FG000|Overall Study|Withdrawal by Subject|4|||
154891930|NCT01641991|559026242|FG001|Overall Study|Withdrawal by Subject|2|||
154891931|NCT01641991|559026243|FG002|Overall Study|Withdrawal by Subject|1|||
154891932|NCT01641991|559026244|FG003|Overall Study|Withdrawal by Subject|5|||
154891933|NCT01641991|559026241|FG000|Overall Study|Adverse Event|2|||
154891934|NCT01641991|559026242|FG001|Overall Study|Adverse Event|1|||
154891935|NCT01641991|559026243|FG002|Overall Study|Adverse Event|2|||
154891936|NCT01641991|559026244|FG003|Overall Study|Adverse Event|1|||
154891937|NCT01641991|559026241|FG000|Overall Study|Lost to Follow-up|0|||
154891938|NCT01641991|559026242|FG001|Overall Study|Lost to Follow-up|2|||
154891939|NCT01641991|559026243|FG002|Overall Study|Lost to Follow-up|3|||
154891940|NCT01641991|559026244|FG003|Overall Study|Lost to Follow-up|1|||
154891941|NCT01641991|559026241|FG000|Overall Study|Protocol Violation|1|||
154891942|NCT01641991|559026242|FG001|Overall Study|Protocol Violation|1|||
154891943|NCT01641991|559026243|FG002|Overall Study|Protocol Violation|3|||
154891944|NCT01641991|559026244|FG003|Overall Study|Protocol Violation|0|||
154891945|NCT01641991|559026241|FG000|Overall Study|Pregnancy|0|||
154891946|NCT01641991|559026242|FG001|Overall Study|Pregnancy|0|||
154891947|NCT01641991|559026243|FG002|Overall Study|Pregnancy|1|||
154891948|NCT01641991|559026244|FG003|Overall Study|Pregnancy|0|||
154891949|NCT01641991|559026241|FG000|Overall Study|no longer eligible|2|||
154891950|NCT01641991|559026242|FG001|Overall Study|no longer eligible|1|||
154891951|NCT01641991|559026243|FG002|Overall Study|no longer eligible|0|||
154891952|NCT01641991|559026244|FG003|Overall Study|no longer eligible|4|||
154891953|NCT01054976|559026245|FG000|Overall Study|Adverse Event|16|||
154891954|NCT01054976|559026245|FG000|Overall Study|Uncooperative participations to study|7|||
154891955|NCT01054976|559026245|FG000|Overall Study|Withdrawal by Subject|4|||
154891956|NCT01054976|559026245|FG000|Overall Study|Other|8|||
154891957|NCT01195363|559026247|FG000|Overall Study|Lost to Follow-up|7|||
154891958|NCT01195363|559026248|FG001|Overall Study|Lost to Follow-up|4|||
154891959|NCT01195363|559026247|FG000|Overall Study|Adverse Event|3|||
154891960|NCT01195363|559026248|FG001|Overall Study|Adverse Event|1|||
154891961|NCT01195363|559026247|FG000|Overall Study|Lack of Efficacy|0|||
154891962|NCT01195363|559026248|FG001|Overall Study|Lack of Efficacy|4|||
154891963|NCT01195363|559026247|FG000|Overall Study|incarceration|1|||
154891964|NCT01195363|559026248|FG001|Overall Study|incarceration|0|||
154891965|NCT01763866|559026250|FG000|Overall Study|Withdrawal by Subject|2|||
154891966|NCT01763866|559026251|FG001|Overall Study|Withdrawal by Subject|1|||
155175614|NCT00958438|560080286|FG000|Overall Study|Adverse Event|0|||
154891967|NCT01763866|559026252|FG002|Overall Study|Withdrawal by Subject|4|||
154891968|NCT01763866|559026253|FG003|Overall Study|Withdrawal by Subject|0|||
154891969|NCT01763866|559026254|FG004|Overall Study|Withdrawal by Subject|0|||
154891970|NCT01763866|559026255|FG005|Overall Study|Withdrawal by Subject|3|||
154891971|NCT01763866|559026256|FG006|Overall Study|Withdrawal by Subject|4|||
154891972|NCT01763866|559026257|FG007|Overall Study|Withdrawal by Subject|0|||
154891973|NCT01763866|559026258|FG008|Overall Study|Withdrawal by Subject|1|||
154978214|NCT01020526|559342802|FG000|Overall Study|Lost to Follow-up|1|||
155175615|NCT00958438|560080287|FG001|Overall Study|Adverse Event|3|||
154891974|NCT01763866|559026259|FG009|Overall Study|Withdrawal by Subject|1|||
154891975|NCT01763866|559026260|FG010|Overall Study|Withdrawal by Subject|2|||
154891976|NCT01763866|559026261|FG011|Overall Study|Withdrawal by Subject|2|||
154891977|NCT01763866|559026262|FG012|Overall Study|Withdrawal by Subject|2|||
154891978|NCT01763866|559026263|FG013|Overall Study|Withdrawal by Subject|0|||
154891979|NCT01763866|559026264|FG014|Overall Study|Withdrawal by Subject|6|||
154891980|NCT01763866|559026265|FG015|Overall Study|Withdrawal by Subject|3|||
155113967|NCT03632993|559846190|FG001|Overall Study|Withdrawal by Subject|0|||
155113968|NCT03632993|559846191|FG002|Overall Study|Withdrawal by Subject|0|||
155113969|NCT03632993|559846192|FG003|Overall Study|Withdrawal by Subject|0|||
155113970|NCT03632993|559846193|FG004|Overall Study|Withdrawal by Subject|0|||
154891981|NCT01763866|559026266|FG016|Overall Study|Withdrawal by Subject|0|||
154891982|NCT01763866|559026267|FG017|Overall Study|Withdrawal by Subject|1|||
154891983|NCT01763866|559026268|FG018|Overall Study|Withdrawal by Subject|1|||
154891984|NCT01763866|559026269|FG019|Overall Study|Withdrawal by Subject|1|||
154891985|NCT01763866|559026270|FG020|Overall Study|Withdrawal by Subject|2|||
154891986|NCT01763866|559026271|FG021|Overall Study|Withdrawal by Subject|1|||
154891987|NCT01763866|559026272|FG022|Overall Study|Withdrawal by Subject|2|||
154891988|NCT01763866|559026273|FG023|Overall Study|Withdrawal by Subject|1|||
154891989|NCT01763866|559026250|FG000|Overall Study|Decision by sponsor|0|||
154891990|NCT01763866|559026251|FG001|Overall Study|Decision by sponsor|0|||
154891991|NCT01763866|559026252|FG002|Overall Study|Decision by sponsor|1|||
154891992|NCT01763866|559026253|FG003|Overall Study|Decision by sponsor|0|||
154891993|NCT01763866|559026254|FG004|Overall Study|Decision by sponsor|2|||
154891994|NCT01763866|559026255|FG005|Overall Study|Decision by sponsor|0|||
154891995|NCT01763866|559026256|FG006|Overall Study|Decision by sponsor|2|||
154891996|NCT01763866|559026257|FG007|Overall Study|Decision by sponsor|0|||
154891997|NCT01763866|559026258|FG008|Overall Study|Decision by sponsor|2|||
154891998|NCT01763866|559026259|FG009|Overall Study|Decision by sponsor|0|||
154891999|NCT01763866|559026260|FG010|Overall Study|Decision by sponsor|6|||
154892000|NCT01763866|559026261|FG011|Overall Study|Decision by sponsor|0|||
154892001|NCT01763866|559026262|FG012|Overall Study|Decision by sponsor|1|||
154892002|NCT01763866|559026263|FG013|Overall Study|Decision by sponsor|0|||
154892003|NCT01763866|559026264|FG014|Overall Study|Decision by sponsor|5|||
154892004|NCT01763866|559026265|FG015|Overall Study|Decision by sponsor|0|||
154892005|NCT01763866|559026266|FG016|Overall Study|Decision by sponsor|0|||
154892006|NCT01763866|559026267|FG017|Overall Study|Decision by sponsor|0|||
154892007|NCT01763866|559026268|FG018|Overall Study|Decision by sponsor|4|||
154892008|NCT01763866|559026269|FG019|Overall Study|Decision by sponsor|0|||
154892009|NCT01763866|559026270|FG020|Overall Study|Decision by sponsor|2|||
154892010|NCT01763866|559026271|FG021|Overall Study|Decision by sponsor|0|||
154892011|NCT01763866|559026272|FG022|Overall Study|Decision by sponsor|1|||
154892012|NCT01763866|559026273|FG023|Overall Study|Decision by sponsor|0|||
154892013|NCT01763866|559026250|FG000|Overall Study|Lost to Follow-up|0|||
154892014|NCT01763866|559026251|FG001|Overall Study|Lost to Follow-up|0|||
154892015|NCT01763866|559026252|FG002|Overall Study|Lost to Follow-up|0|||
154892016|NCT01763866|559026253|FG003|Overall Study|Lost to Follow-up|0|||
154892017|NCT01763866|559026254|FG004|Overall Study|Lost to Follow-up|0|||
154892018|NCT01763866|559026255|FG005|Overall Study|Lost to Follow-up|0|||
154892019|NCT01763866|559026256|FG006|Overall Study|Lost to Follow-up|1|||
154892020|NCT01763866|559026257|FG007|Overall Study|Lost to Follow-up|0|||
154892021|NCT01763866|559026258|FG008|Overall Study|Lost to Follow-up|0|||
154892022|NCT01763866|559026259|FG009|Overall Study|Lost to Follow-up|0|||
154892023|NCT01763866|559026260|FG010|Overall Study|Lost to Follow-up|0|||
154892024|NCT01763866|559026261|FG011|Overall Study|Lost to Follow-up|0|||
154892025|NCT01763866|559026262|FG012|Overall Study|Lost to Follow-up|1|||
154892026|NCT01763866|559026263|FG013|Overall Study|Lost to Follow-up|0|||
154892027|NCT01763866|559026264|FG014|Overall Study|Lost to Follow-up|1|||
154892028|NCT01763866|559026265|FG015|Overall Study|Lost to Follow-up|0|||
154892029|NCT01763866|559026266|FG016|Overall Study|Lost to Follow-up|0|||
154892030|NCT01763866|559026267|FG017|Overall Study|Lost to Follow-up|0|||
154892031|NCT01763866|559026268|FG018|Overall Study|Lost to Follow-up|1|||
154892032|NCT01763866|559026269|FG019|Overall Study|Lost to Follow-up|1|||
154892033|NCT01763866|559026270|FG020|Overall Study|Lost to Follow-up|0|||
155113971|NCT03632993|559846194|FG005|Overall Study|Withdrawal by Subject|0|||
155113972|NCT03632993|559846195|FG006|Overall Study|Withdrawal by Subject|0|||
155113973|NCT03632993|559846196|FG007|Overall Study|Withdrawal by Subject|0|||
154892034|NCT01763866|559026271|FG021|Overall Study|Lost to Follow-up|0|||
155113974|NCT03632993|559846197|FG008|Overall Study|Withdrawal by Subject|0|||
154892035|NCT01763866|559026272|FG022|Overall Study|Lost to Follow-up|0|||
154892036|NCT01763866|559026273|FG023|Overall Study|Lost to Follow-up|1|||
154892037|NCT01763866|559026250|FG000|Overall Study|Death|0|||
154892038|NCT01763866|559026251|FG001|Overall Study|Death|0|||
154892039|NCT01763866|559026252|FG002|Overall Study|Death|0|||
154892040|NCT01763866|559026253|FG003|Overall Study|Death|0|||
154892041|NCT01763866|559026254|FG004|Overall Study|Death|0|||
154892042|NCT01763866|559026255|FG005|Overall Study|Death|0|||
154892043|NCT01763866|559026256|FG006|Overall Study|Death|0|||
154892044|NCT01763866|559026257|FG007|Overall Study|Death|0|||
155113975|NCT03632993|559846198|FG009|Overall Study|Withdrawal by Subject|1|||
155175616|NCT00958438|560080288|FG002|Overall Study|Adverse Event|0|||
154892045|NCT01763866|559026258|FG008|Overall Study|Death|0|||
154892046|NCT01763866|559026259|FG009|Overall Study|Death|0|||
154892047|NCT01763866|559026260|FG010|Overall Study|Death|0|||
154892048|NCT01763866|559026261|FG011|Overall Study|Death|0|||
154892049|NCT01763866|559026262|FG012|Overall Study|Death|0|||
154892050|NCT01763866|559026263|FG013|Overall Study|Death|0|||
154892051|NCT01763866|559026264|FG014|Overall Study|Death|0|||
154892052|NCT01763866|559026265|FG015|Overall Study|Death|0|||
154892053|NCT01763866|559026266|FG016|Overall Study|Death|1|||
154892054|NCT01763866|559026267|FG017|Overall Study|Death|0|||
154892055|NCT01763866|559026268|FG018|Overall Study|Death|0|||
154892056|NCT01763866|559026269|FG019|Overall Study|Death|0|||
154892057|NCT01763866|559026270|FG020|Overall Study|Death|0|||
154892058|NCT01763866|559026271|FG021|Overall Study|Death|0|||
154892059|NCT01763866|559026272|FG022|Overall Study|Death|0|||
154892060|NCT01763866|559026273|FG023|Overall Study|Death|0|||
154892061|NCT01164865|559026282|FG000|Overall Study|Lost to Follow-up|2|||
154892062|NCT01164865|559026283|FG001|Overall Study|Lost to Follow-up|1|||
154892063|NCT00475540|559026285|FG000|36 Months|Lost to Follow-up|4|||
154892064|NCT00475540|559026286|FG001|36 Months|Lost to Follow-up|4|||
154892065|NCT00475540|559026285|FG000|36 Months|Death|1|||
154892066|NCT00475540|559026286|FG001|36 Months|Death|2|||
154892067|NCT00475540|559026285|FG000|36 Months|Censored due to reoperation|3|||
154892068|NCT00475540|559026286|FG001|36 Months|Censored due to reoperation|0|||
154892069|NCT00377429|559026287|FG000|Overall Study|Withdrawal by Subject|5|||
154892070|NCT00377429|559026287|FG000|Overall Study|Adverse Event|8|||
154892071|NCT00377429|559026287|FG000|Overall Study|Physician Decision|1|||
154892072|NCT00377429|559026287|FG000|Overall Study|Patient non-compliance|1|||
154892073|NCT02394795|559026290|FG000|Overall Study|Adverse Event|92|||
154892074|NCT02394795|559026291|FG001|Overall Study|Adverse Event|70|||
154892075|NCT02394795|559026290|FG000|Overall Study|Lost to Follow-up|0|||
154892076|NCT02394795|559026291|FG001|Overall Study|Lost to Follow-up|1|||
154892077|NCT02394795|559026290|FG000|Overall Study|Withdrawal by Subject|17|||
154892078|NCT02394795|559026291|FG001|Overall Study|Withdrawal by Subject|26|||
154892079|NCT02394795|559026290|FG000|Overall Study|Lack of Efficacy|181|||
154892080|NCT02394795|559026291|FG001|Overall Study|Lack of Efficacy|211|||
154892081|NCT02394795|559026290|FG000|Overall Study|Death|4|||
154892082|NCT02394795|559026291|FG001|Overall Study|Death|5|||
154892083|NCT02394795|559026290|FG000|Overall Study|Physician Decision|109|||
154892084|NCT02394795|559026291|FG001|Overall Study|Physician Decision|93|||
154892085|NCT01669811|559026293|FG000|Overall Study|Investigator decision|0|||
154892086|NCT01669811|559026294|FG001|Overall Study|Investigator decision|1|||
154892087|NCT01669811|559026293|FG000|Overall Study|Withdrawal by Subject|1|||
154892088|NCT01669811|559026294|FG001|Overall Study|Withdrawal by Subject|2|||
154892089|NCT01669811|559026293|FG000|Overall Study|Adverse Event|2|||
154892090|NCT01669811|559026294|FG001|Overall Study|Adverse Event|6|||
154892091|NCT01669811|559026293|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
154892092|NCT01669811|559026294|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
154892093|NCT03288493|559026295|FG000|Overall Study|Withdrawal by Subject|4|||
154892094|NCT03288493|559026296|FG001|Overall Study|Withdrawal by Subject|0|||
154892095|NCT03288493|559026297|FG002|Overall Study|Withdrawal by Subject|0|||
154892096|NCT03288493|559026298|FG003|Overall Study|Withdrawal by Subject|0|||
154892097|NCT03288493|559026299|FG004|Overall Study|Withdrawal by Subject|0|||
154892098|NCT03288493|559026300|FG005|Overall Study|Withdrawal by Subject|2|||
154892099|NCT03288493|559026301|FG006|Overall Study|Withdrawal by Subject|0|||
154892100|NCT03288493|559026295|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
154892101|NCT03288493|559026296|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
154892102|NCT03288493|559026297|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
154892103|NCT03288493|559026298|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
154892104|NCT03288493|559026299|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
154892105|NCT03288493|559026300|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
154892106|NCT03288493|559026301|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
154892107|NCT03288493|559026295|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
154892108|NCT03288493|559026296|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
154892109|NCT03288493|559026297|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
154892110|NCT03288493|559026298|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
154892111|NCT03288493|559026299|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
154892112|NCT03288493|559026300|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
154892113|NCT03288493|559026301|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
154892114|NCT03288493|559026295|FG000|Overall Study|Death|2|||
154892115|NCT03288493|559026296|FG001|Overall Study|Death|0|||
154892116|NCT03288493|559026297|FG002|Overall Study|Death|0|||
154892117|NCT03288493|559026298|FG003|Overall Study|Death|0|||
154892118|NCT03288493|559026299|FG004|Overall Study|Death|0|||
154892119|NCT03288493|559026300|FG005|Overall Study|Death|0|||
154892120|NCT03288493|559026301|FG006|Overall Study|Death|0|||
154892121|NCT03288493|559026295|FG000|Overall Study|other reason not listed above|2|||
154892122|NCT03288493|559026296|FG001|Overall Study|other reason not listed above|0|||
154892123|NCT03288493|559026297|FG002|Overall Study|other reason not listed above|0|||
154892124|NCT03288493|559026298|FG003|Overall Study|other reason not listed above|0|||
154892125|NCT03288493|559026299|FG004|Overall Study|other reason not listed above|0|||
154892126|NCT03288493|559026300|FG005|Overall Study|other reason not listed above|0|||
154892127|NCT03288493|559026301|FG006|Overall Study|other reason not listed above|0|||
154892128|NCT01871896|559026302|FG000|Overall Study|Lost to Follow-up|1|||
154892129|NCT00453180|559027973|FG000|Overall Study|Lost to Follow-up|2|||
154892130|NCT00453180|559027974|FG001|Overall Study|Lost to Follow-up|1|||
154892131|NCT00453180|559027973|FG000|Overall Study|Adverse Event|1|||
154892132|NCT00453180|559027974|FG001|Overall Study|Adverse Event|2|||
154892133|NCT03326869|559027980|FG000|Overall Study|Study data has been lost to natural disa|1|||
154892134|NCT03326869|559027981|FG001|Overall Study|Study data has been lost to natural disa|1|||
154892135|NCT01002742|559027984|FG000|Overall Study|Determined to be ineligible|0|||
154892136|NCT01002742|559027985|FG001|Overall Study|Determined to be ineligible|1|||
154892137|NCT00562640|559027986|FG000|Overall Study|Death|0|||
154892138|NCT00562640|559027987|FG001|Overall Study|Death|1|||
154892139|NCT00562640|559027988|FG002|Overall Study|Death|1|||
154892140|NCT00562640|559027989|FG003|Overall Study|Death|0|||
154892141|NCT05263921|559027990|FG000|Overall Study|Other: family emergency.|0|||
154892142|NCT05263921|559027991|FG001|Overall Study|Other: family emergency.|0|||
154892143|NCT05263921|559027992|FG002|Overall Study|Other: family emergency.|1|||
154892144|NCT05263921|559027993|FG003|Overall Study|Other: family emergency.|0|||
154892145|NCT02670928|559027997|FG000|Overall Study|Adverse Event|3|||
154892146|NCT02670928|559027998|FG001|Overall Study|Adverse Event|1|||
154892147|NCT02670928|559027997|FG000|Overall Study|Withdrawal by Subject|4|||
154892148|NCT02670928|559027998|FG001|Overall Study|Withdrawal by Subject|0|||
154892149|NCT02670928|559027997|FG000|Overall Study|Lost to Follow-up|1|||
154892150|NCT02670928|559027998|FG001|Overall Study|Lost to Follow-up|0|||
154892151|NCT02670928|559027997|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
154892152|NCT02670928|559027998|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
154892153|NCT02678312|559027999|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
154892154|NCT02678312|559028000|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
154892155|NCT02678312|559028001|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
154892156|NCT02678312|559028002|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
154892157|NCT02678312|559028003|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
154892158|NCT02678312|559027999|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
154892159|NCT02678312|559028000|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
154892160|NCT02678312|559028001|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
154892161|NCT02678312|559028002|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
154892162|NCT02678312|559028003|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
154892163|NCT02678312|559027999|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
154892164|NCT02678312|559028000|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
154892165|NCT02678312|559028001|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
154892166|NCT02678312|559028002|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
154892167|NCT02678312|559028003|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
154892168|NCT02678312|559027999|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
154892169|NCT02678312|559028000|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
154892170|NCT02678312|559028001|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
154892171|NCT02678312|559028002|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
154892172|NCT02678312|559028003|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
154892173|NCT02678312|559027999|FG000|Part 2 Double Blind Epoch|Death|0|||
154892174|NCT02678312|559028000|FG001|Part 2 Double Blind Epoch|Death|0|||
154892175|NCT02678312|559028001|FG002|Part 2 Double Blind Epoch|Death|0|||
154892176|NCT02678312|559028002|FG003|Part 2 Double Blind Epoch|Death|8|||
154892177|NCT02678312|559028003|FG004|Part 2 Double Blind Epoch|Death|12|||
154892178|NCT02678312|559027999|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
154892179|NCT02678312|559028000|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
154892180|NCT02678312|559028001|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
154892181|NCT02678312|559028002|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
154892182|NCT02678312|559028003|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
154892183|NCT02678312|559027999|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
154892184|NCT02678312|559028000|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
154892185|NCT02678312|559028001|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
154892186|NCT02678312|559028002|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
154892187|NCT02678312|559028003|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
154892188|NCT02678312|559027999|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
154892189|NCT02678312|559028000|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
154892190|NCT02678312|559028001|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
154892191|NCT02678312|559028002|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
154978215|NCT01020526|559342802|FG000|Overall Study|Adverse Event|2|||
154892192|NCT02678312|559028003|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
154892193|NCT00656084|559028004|FG000|Overall Study|Adverse Event|4|||
154892194|NCT00656084|559028004|FG000|Overall Study|Withdrawal by Subject|1|||
154892195|NCT00656084|559028004|FG000|Overall Study|Patient Request|1|||
154892196|NCT00656084|559028004|FG000|Overall Study|Investigator Request|1|||
154892197|NCT00525785|559028007|FG000|Overall Study|Withdrawal by Subject|1|||
154892198|NCT00525785|559028007|FG000|Overall Study|Lack of Efficacy|1|||
154892199|NCT00525785|559028007|FG000|Overall Study|Physician Decision|1|||
154892200|NCT04507776|559028008|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
154892201|NCT00387348|559028009|FG000|Overall Study|Death|1|||
154892202|NCT00387348|559028010|FG001|Overall Study|Death|1|||
154892203|NCT00387348|559028011|FG002|Overall Study|Death|0|||
154892204|NCT00387348|559028009|FG000|Overall Study|Physician Decision|1|||
154892205|NCT00387348|559028010|FG001|Overall Study|Physician Decision|0|||
154892206|NCT00387348|559028011|FG002|Overall Study|Physician Decision|1|||
154892207|NCT00387348|559028009|FG000|Overall Study|Withdrawal by Subject|0|||
154892208|NCT00387348|559028010|FG001|Overall Study|Withdrawal by Subject|2|||
154892209|NCT00387348|559028011|FG002|Overall Study|Withdrawal by Subject|2|||
154892210|NCT00387348|559028009|FG000|Overall Study|Adverse Event|1|||
154892211|NCT00387348|559028010|FG001|Overall Study|Adverse Event|0|||
154892212|NCT00387348|559028011|FG002|Overall Study|Adverse Event|1|||
154892213|NCT03628599|559028012|FG000|Overall Study|Adverse Event|0|||
154892214|NCT03628599|559028013|FG001|Overall Study|Adverse Event|1|||
154892215|NCT00010803|559028022|FG000|Overall Study|Withdrawal by Subject|97|||
154892216|NCT00010803|559028023|FG001|Overall Study|Withdrawal by Subject|98|||
154892217|NCT05905601|559028024|FG000|Overall Study|Lost to Follow-up|1|||
154892218|NCT05905601|559028025|FG001|Overall Study|Lost to Follow-up|3|||
154892219|NCT02384395|559028027|FG000|Overall Study|Physician Decision|4|||
154892220|NCT02384395|559028027|FG000|Overall Study|Withdrawal by Subject|3|||
154892221|NCT02384395|559028027|FG000|Overall Study|Lost to Follow-up|3|||
154892222|NCT01779648|559028028|FG000|Overall Study|Protocol Violation|1|||
154892223|NCT01779648|559028029|FG001|Overall Study|Protocol Violation|0|||
154892224|NCT00985738|559028031|FG000|Overall Study|Study closed prematurely|8|||
154892225|NCT00985738|559028032|FG001|Overall Study|Study closed prematurely|8|||
154892226|NCT02119026|559028033|FG000|1st-line Treatment|Adverse Event|9|||
154892227|NCT02119026|559028034|FG001|1st-line Treatment|Adverse Event|14|||
154892228|NCT02119026|559028033|FG000|1st-line Treatment|Physician Decision|3|||
154892229|NCT02119026|559028034|FG001|1st-line Treatment|Physician Decision|8|||
154892230|NCT02119026|559028033|FG000|1st-line Treatment|Withdrawal by Subject|4|||
154892231|NCT02119026|559028034|FG001|1st-line Treatment|Withdrawal by Subject|10|||
154892232|NCT02119026|559028033|FG000|1st-line Treatment|Patient condition or compliance|6|||
154892233|NCT02119026|559028034|FG001|1st-line Treatment|Patient condition or compliance|4|||
154892234|NCT02119026|559028033|FG000|1st-line Treatment|Surgery of metastases|2|||
154892235|NCT02119026|559028034|FG001|1st-line Treatment|Surgery of metastases|1|||
154892236|NCT02119026|559028033|FG000|1st-line Treatment|Death|2|||
154892237|NCT02119026|559028034|FG001|1st-line Treatment|Death|1|||
154892238|NCT02119026|559028033|FG000|2nd-line Treatment|Lost to Follow-up|2|||
154892239|NCT02119026|559028034|FG001|2nd-line Treatment|Lost to Follow-up|0|||
154892240|NCT02119026|559028033|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
154892241|NCT02119026|559028034|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
154892242|NCT02119026|559028033|FG000|2nd-line Treatment|Adverse Event|4|||
154892243|NCT02119026|559028034|FG001|2nd-line Treatment|Adverse Event|1|||
154892244|NCT00340834|559028037|FG000|Core Phase of Study|Adverse Event|26|||
154892245|NCT00340834|559028038|FG001|Core Phase of Study|Adverse Event|9|||
154892246|NCT00340834|559028039|FG002|Core Phase of Study|Adverse Event|9|||
154892247|NCT00340834|559028040|FG003|Core Phase of Study|Adverse Event|0|||
154892248|NCT00340834|559028041|FG004|Core Phase of Study|Adverse Event|0|||
154892249|NCT00340834|559028037|FG000|Core Phase of Study|Withdrawal by Subject|11|||
154892250|NCT00340834|559028038|FG001|Core Phase of Study|Withdrawal by Subject|9|||
154892251|NCT00340834|559028039|FG002|Core Phase of Study|Withdrawal by Subject|16|||
154892252|NCT00340834|559028040|FG003|Core Phase of Study|Withdrawal by Subject|0|||
154892253|NCT00340834|559028041|FG004|Core Phase of Study|Withdrawal by Subject|0|||
154892254|NCT00340834|559028037|FG000|Core Phase of Study|Administrative Problems|6|||
154892255|NCT00340834|559028038|FG001|Core Phase of Study|Administrative Problems|2|||
154978216|NCT03546647|559342803|FG000|Overall Study|Adverse Event|1|||
154892256|NCT00340834|559028039|FG002|Core Phase of Study|Administrative Problems|7|||
154892257|NCT00340834|559028040|FG003|Core Phase of Study|Administrative Problems|0|||
154892258|NCT00340834|559028041|FG004|Core Phase of Study|Administrative Problems|0|||
154892259|NCT00340834|559028037|FG000|Core Phase of Study|Lack of Efficacy|3|||
154892260|NCT00340834|559028038|FG001|Core Phase of Study|Lack of Efficacy|3|||
154892261|NCT00340834|559028039|FG002|Core Phase of Study|Lack of Efficacy|7|||
154978217|NCT03546647|559342804|FG001|Overall Study|Adverse Event|0|||
154892262|NCT00340834|559028040|FG003|Core Phase of Study|Lack of Efficacy|0|||
154892263|NCT00340834|559028041|FG004|Core Phase of Study|Lack of Efficacy|0|||
154892264|NCT00340834|559028037|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
154892265|NCT00340834|559028038|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
154892266|NCT00340834|559028039|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
154892267|NCT00340834|559028040|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
154892268|NCT00340834|559028041|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
154892269|NCT00340834|559028037|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
154892270|NCT00340834|559028038|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
154892271|NCT00340834|559028039|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
154892272|NCT00340834|559028040|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
154892273|NCT00340834|559028041|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
154892274|NCT00340834|559028037|FG000|Core Phase of Study|Lost to Follow-up|1|||
154892275|NCT00340834|559028038|FG001|Core Phase of Study|Lost to Follow-up|1|||
154892276|NCT00340834|559028039|FG002|Core Phase of Study|Lost to Follow-up|4|||
154892277|NCT00340834|559028040|FG003|Core Phase of Study|Lost to Follow-up|0|||
154892278|NCT00340834|559028041|FG004|Core Phase of Study|Lost to Follow-up|0|||
154892279|NCT00340834|559028037|FG000|Core Phase of Study|Death|2|||
154892280|NCT00340834|559028038|FG001|Core Phase of Study|Death|0|||
154892281|NCT00340834|559028039|FG002|Core Phase of Study|Death|0|||
154892282|NCT00340834|559028040|FG003|Core Phase of Study|Death|0|||
154892283|NCT00340834|559028041|FG004|Core Phase of Study|Death|0|||
154892284|NCT00340834|559028037|FG000|Core Phase of Study|Protocol Violation|0|||
154892285|NCT00340834|559028038|FG001|Core Phase of Study|Protocol Violation|0|||
154892286|NCT00340834|559028039|FG002|Core Phase of Study|Protocol Violation|2|||
154892287|NCT00340834|559028040|FG003|Core Phase of Study|Protocol Violation|0|||
154892288|NCT00340834|559028041|FG004|Core Phase of Study|Protocol Violation|0|||
154892289|NCT00340834|559028037|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
154892290|NCT00340834|559028038|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
154892291|NCT00340834|559028039|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
154892292|NCT00340834|559028040|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
154892293|NCT00340834|559028041|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
154892294|NCT00340834|559028037|FG000|Extension Phase of Study|Subject withdrew consent|26|||
154892295|NCT00340834|559028038|FG001|Extension Phase of Study|Subject withdrew consent|31|||
154892296|NCT00340834|559028039|FG002|Extension Phase of Study|Subject withdrew consent|0|||
154892297|NCT00340834|559028040|FG003|Extension Phase of Study|Subject withdrew consent|12|||
154892298|NCT00340834|559028041|FG004|Extension Phase of Study|Subject withdrew consent|15|||
154892299|NCT00340834|559028037|FG000|Extension Phase of Study|Adverse Event|21|||
154892300|NCT00340834|559028038|FG001|Extension Phase of Study|Adverse Event|22|||
154892301|NCT00340834|559028039|FG002|Extension Phase of Study|Adverse Event|0|||
154892302|NCT00340834|559028040|FG003|Extension Phase of Study|Adverse Event|19|||
154892303|NCT00340834|559028041|FG004|Extension Phase of Study|Adverse Event|7|||
154892304|NCT00340834|559028037|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
154892305|NCT00340834|559028038|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
154892306|NCT00340834|559028039|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
154892307|NCT00340834|559028040|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
154892308|NCT00340834|559028041|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
154892309|NCT00340834|559028037|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
154892310|NCT00340834|559028038|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
154892311|NCT00340834|559028039|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
154892312|NCT00340834|559028040|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
154892313|NCT00340834|559028041|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
154892314|NCT00340834|559028037|FG000|Extension Phase of Study|Lost to Follow-up|1|||
154892315|NCT00340834|559028038|FG001|Extension Phase of Study|Lost to Follow-up|1|||
154892316|NCT00340834|559028039|FG002|Extension Phase of Study|Lost to Follow-up|0|||
154892317|NCT00340834|559028040|FG003|Extension Phase of Study|Lost to Follow-up|2|||
154892318|NCT00340834|559028041|FG004|Extension Phase of Study|Lost to Follow-up|3|||
154892319|NCT00340834|559028037|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
154892320|NCT00340834|559028038|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
154892321|NCT00340834|559028039|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
154892322|NCT00340834|559028040|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
154892323|NCT00340834|559028041|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
154892324|NCT00340834|559028037|FG000|Extension Phase of Study|Administrative problems|3|||
154892325|NCT00340834|559028038|FG001|Extension Phase of Study|Administrative problems|0|||
154892326|NCT00340834|559028039|FG002|Extension Phase of Study|Administrative problems|0|||
154892327|NCT00340834|559028040|FG003|Extension Phase of Study|Administrative problems|1|||
154892328|NCT00340834|559028041|FG004|Extension Phase of Study|Administrative problems|1|||
154892329|NCT00340834|559028037|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
154892330|NCT00340834|559028038|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
154892331|NCT00340834|559028039|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
154892332|NCT00340834|559028040|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
154892333|NCT00340834|559028041|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
154892334|NCT00340834|559028037|FG000|Extension Phase of Study|Protocol Violation|3|||
154892335|NCT00340834|559028038|FG001|Extension Phase of Study|Protocol Violation|0|||
154892336|NCT00340834|559028039|FG002|Extension Phase of Study|Protocol Violation|0|||
154892337|NCT00340834|559028040|FG003|Extension Phase of Study|Protocol Violation|0|||
154892338|NCT00340834|559028041|FG004|Extension Phase of Study|Protocol Violation|0|||
154892339|NCT00340834|559028037|FG000|Extension Phase of Study|Death|0|||
154892340|NCT00340834|559028038|FG001|Extension Phase of Study|Death|0|||
154892341|NCT00340834|559028039|FG002|Extension Phase of Study|Death|0|||
154892342|NCT00340834|559028040|FG003|Extension Phase of Study|Death|0|||
154892343|NCT00340834|559028041|FG004|Extension Phase of Study|Death|1|||
154892344|NCT00291499|559028042|FG000|Overall Study|Adverse Event|3|||
154892345|NCT00291499|559028043|FG001|Overall Study|Adverse Event|8|||
154892346|NCT00291499|559028042|FG000|Overall Study|Change to other therapy|2|||
154892347|NCT00291499|559028043|FG001|Overall Study|Change to other therapy|1|||
154892348|NCT00291499|559028042|FG000|Overall Study|Intercurrent illness|1|||
154892349|NCT00291499|559028043|FG001|Overall Study|Intercurrent illness|0|||
154892350|NCT00291499|559028042|FG000|Overall Study|Protocol Violation|2|||
154892351|NCT00291499|559028043|FG001|Overall Study|Protocol Violation|2|||
154892352|NCT00291499|559028042|FG000|Overall Study|Other reasons|1|||
154892353|NCT00291499|559028043|FG001|Overall Study|Other reasons|4|||
154892354|NCT02786836|559028044|FG000|Overall Study|Death|1|||
154892355|NCT02786836|559028044|FG000|Overall Study|Lack of Efficacy|2|||
154892356|NCT02786836|559028044|FG000|Overall Study|Protocol Violation|3|||
154892357|NCT02786836|559028044|FG000|Overall Study|Withdrawal by Subject|3|||
154892358|NCT02786836|559028044|FG000|Overall Study|Liver Transplantation|2|||
154892359|NCT02786836|559028044|FG000|Overall Study|Device or Pharmacy Issues|3|||
154892360|NCT01143714|559028045|FG000|Overall Study|Adverse Event|4|||
154892361|NCT01143714|559028046|FG001|Overall Study|Adverse Event|2|||
154892362|NCT01143714|559028045|FG000|Overall Study|Withdrawal by Subject|1|||
154892363|NCT01143714|559028046|FG001|Overall Study|Withdrawal by Subject|0|||
154892364|NCT01143714|559028045|FG000|Overall Study|Subject non-compliance|0|||
154892365|NCT01143714|559028046|FG001|Overall Study|Subject non-compliance|1|||
154892366|NCT01143714|559028045|FG000|Overall Study|wound closed = deemed healed|1|||
154892367|NCT01143714|559028046|FG001|Overall Study|wound closed = deemed healed|0|||
154892368|NCT01143714|559028045|FG000|Overall Study|wound size increased|1|||
154892369|NCT01143714|559028046|FG001|Overall Study|wound size increased|0|||
154892370|NCT02016898|559028056|FG000|Overall Study|Death|1|||
154892371|NCT02016898|559028057|FG001|Overall Study|Death|1|||
154892372|NCT02016898|559028056|FG000|Overall Study|Lost to Follow-up|4|||
154892373|NCT02016898|559028057|FG001|Overall Study|Lost to Follow-up|4|||
154892374|NCT01381718|559028058|FG000|Overall Study|Withdrawal by Subject|2|||
154892375|NCT01381718|559028059|FG001|Overall Study|Withdrawal by Subject|5|||
154892376|NCT01381718|559028058|FG000|Overall Study|Lost to Follow-up|3|||
154892377|NCT01381718|559028059|FG001|Overall Study|Lost to Follow-up|5|||
154892378|NCT01381718|559028058|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
154892379|NCT01381718|559028059|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
154892380|NCT01306032|559028062|FG000|First Intervention|Adverse Event|1|||
154892381|NCT01306032|559028063|FG001|First Intervention|Adverse Event|0|||
154892382|NCT01306032|559028064|FG002|First Intervention|Adverse Event|1|||
154892383|NCT01306032|559028065|FG003|First Intervention|Adverse Event|0|||
154892384|NCT01306032|559028066|FG004|First Intervention|Adverse Event|0|||
154892385|NCT01306032|559028067|FG005|First Intervention|Adverse Event|1|||
154892386|NCT01306032|559028062|FG000|First Intervention|Withdrawal by Subject|0|||
154892387|NCT01306032|559028063|FG001|First Intervention|Withdrawal by Subject|2|||
154892388|NCT01306032|559028064|FG002|First Intervention|Withdrawal by Subject|0|||
154892389|NCT01306032|559028065|FG003|First Intervention|Withdrawal by Subject|1|||
154892390|NCT01306032|559028066|FG004|First Intervention|Withdrawal by Subject|0|||
154892391|NCT01306032|559028067|FG005|First Intervention|Withdrawal by Subject|0|||
154892392|NCT01306032|559028062|FG000|First Intervention|Death|0|||
154892393|NCT01306032|559028063|FG001|First Intervention|Death|0|||
154892394|NCT01306032|559028064|FG002|First Intervention|Death|1|||
154978218|NCT01396421|559342805|FG000|Overall Study|Lost to Follow-up|0|||
154978219|NCT01396421|559342806|FG001|Overall Study|Lost to Follow-up|0|||
154892395|NCT01306032|559028065|FG003|First Intervention|Death|0|||
154892396|NCT01306032|559028066|FG004|First Intervention|Death|0|||
154892397|NCT01306032|559028067|FG005|First Intervention|Death|0|||
154978220|NCT01396421|559342807|FG002|Overall Study|Lost to Follow-up|0|||
154978221|NCT01396421|559342808|FG003|Overall Study|Lost to Follow-up|1|||
154892398|NCT01306032|559028062|FG000|First Intervention|Ineligible|0|||
154892399|NCT01306032|559028063|FG001|First Intervention|Ineligible|0|||
154892400|NCT01306032|559028064|FG002|First Intervention|Ineligible|0|||
154892401|NCT01306032|559028065|FG003|First Intervention|Ineligible|0|||
154892402|NCT01306032|559028066|FG004|First Intervention|Ineligible|0|||
154892403|NCT01306032|559028067|FG005|First Intervention|Ineligible|1|||
154892404|NCT01306032|559028062|FG000|First Intervention|Progressive disease|0|||
154978222|NCT01396421|559342805|FG000|Overall Study|Adverse Event|17|||
154892405|NCT01306032|559028063|FG001|First Intervention|Progressive disease|0|||
154892406|NCT01306032|559028064|FG002|First Intervention|Progressive disease|0|||
154892407|NCT01306032|559028065|FG003|First Intervention|Progressive disease|0|||
154978223|NCT01396421|559342806|FG001|Overall Study|Adverse Event|15|||
154892408|NCT01306032|559028066|FG004|First Intervention|Progressive disease|2|||
154892409|NCT01306032|559028067|FG005|First Intervention|Progressive disease|0|||
154892410|NCT01306032|559028062|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
154892411|NCT01306032|559028063|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
154892412|NCT01306032|559028064|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
154892413|NCT01306032|559028065|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
154892414|NCT01306032|559028066|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
154892415|NCT01306032|559028067|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
154892416|NCT01306032|559028062|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
154892417|NCT01306032|559028063|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
154892418|NCT01306032|559028064|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
154892419|NCT01306032|559028065|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
154892420|NCT01306032|559028066|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
154892421|NCT01306032|559028067|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
154892422|NCT00992186|559028068|FG000|Overall Study|Withdrawal by Subject|2|||
154892423|NCT00992186|559028068|FG000|Overall Study|Protocol Violation|1|||
154892424|NCT00992186|559028068|FG000|Overall Study|Physician Decision|1|||
154892425|NCT00992186|559028068|FG000|Overall Study|Adverse Event|9|||
154892426|NCT00992186|559028068|FG000|Overall Study|Progressive Disease|30|||
154892427|NCT00992186|559028068|FG000|Overall Study|Refusal To Receive Study Agent|3|||
154892428|NCT02677220|559028075|FG000|Overall Study|Adverse Event|1|||
154892429|NCT03074149|559028078|FG000|Overall Study|Reason unknown|22|||
154892430|NCT03074149|559028079|FG001|Overall Study|Reason unknown|35|||
154892431|NCT03074149|559028078|FG000|Overall Study|Death|10|||
154892432|NCT03074149|559028079|FG001|Overall Study|Death|45|||
154892433|NCT00830960|559028080|FG000|Overall Study|Death|5|||
154892434|NCT00830960|559028081|FG001|Overall Study|Death|4|||
154892435|NCT00830960|559028082|FG002|Overall Study|Death|3|||
154892436|NCT00830960|559028083|FG003|Overall Study|Death|2|||
154892437|NCT00830960|559028084|FG004|Overall Study|Death|6|||
154892438|NCT00830960|559028085|FG005|Overall Study|Death|1|||
154892439|NCT00830960|559028080|FG000|Overall Study|Lost to Follow-up|1|||
154892440|NCT00830960|559028081|FG001|Overall Study|Lost to Follow-up|1|||
154892441|NCT00830960|559028082|FG002|Overall Study|Lost to Follow-up|1|||
154892442|NCT00830960|559028083|FG003|Overall Study|Lost to Follow-up|0|||
154892443|NCT00830960|559028084|FG004|Overall Study|Lost to Follow-up|0|||
154892444|NCT00830960|559028085|FG005|Overall Study|Lost to Follow-up|1|||
154892445|NCT00830960|559028080|FG000|Overall Study|Withdrawal by Subject|19|||
154892446|NCT00830960|559028081|FG001|Overall Study|Withdrawal by Subject|19|||
154892447|NCT00830960|559028082|FG002|Overall Study|Withdrawal by Subject|18|||
154892448|NCT00830960|559028083|FG003|Overall Study|Withdrawal by Subject|23|||
154892449|NCT00830960|559028084|FG004|Overall Study|Withdrawal by Subject|16|||
154892450|NCT00830960|559028085|FG005|Overall Study|Withdrawal by Subject|21|||
154892451|NCT00830960|559028080|FG000|Overall Study|Sponsor Decision|1|||
154892452|NCT00830960|559028081|FG001|Overall Study|Sponsor Decision|2|||
154892453|NCT00830960|559028082|FG002|Overall Study|Sponsor Decision|3|||
154892454|NCT00830960|559028083|FG003|Overall Study|Sponsor Decision|4|||
154892455|NCT00830960|559028084|FG004|Overall Study|Sponsor Decision|5|||
154892456|NCT00830960|559028085|FG005|Overall Study|Sponsor Decision|7|||
154892457|NCT00830960|559028080|FG000|Overall Study|No study drug received|7|||
154892458|NCT00830960|559028081|FG001|Overall Study|No study drug received|2|||
154892459|NCT00830960|559028082|FG002|Overall Study|No study drug received|4|||
154892460|NCT00830960|559028083|FG003|Overall Study|No study drug received|3|||
154892461|NCT00830960|559028084|FG004|Overall Study|No study drug received|5|||
154892462|NCT00830960|559028085|FG005|Overall Study|No study drug received|7|||
154892463|NCT01376245|559028088|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
154892464|NCT01376245|559028089|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
154892465|NCT01376245|559028090|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
154892466|NCT01376245|559028091|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
154892467|NCT01376245|559028092|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
154892468|NCT01376245|559028088|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
154978224|NCT01396421|559342807|FG002|Overall Study|Adverse Event|12|||
154978225|NCT01396421|559342808|FG003|Overall Study|Adverse Event|32|||
154978226|NCT01396421|559342805|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155175617|NCT00958438|560080286|FG000|Overall Study|Physician Decision|1|||
155175618|NCT00958438|560080287|FG001|Overall Study|Physician Decision|0|||
154892469|NCT01376245|559028089|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
154892470|NCT01376245|559028090|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
154892471|NCT01376245|559028091|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
154892472|NCT01376245|559028092|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
154892473|NCT01376245|559028088|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
154892474|NCT01376245|559028089|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
155175619|NCT00958438|560080288|FG002|Overall Study|Physician Decision|1|||
154892475|NCT01376245|559028090|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
154892476|NCT01376245|559028091|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
154892477|NCT01376245|559028092|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
154892478|NCT01376245|559028088|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
154892479|NCT01376245|559028089|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
154892480|NCT01376245|559028090|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
154892481|NCT01376245|559028091|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
154892482|NCT01376245|559028092|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
154892483|NCT01376245|559028088|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
154892484|NCT01376245|559028089|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
154892485|NCT01376245|559028090|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
154892486|NCT01376245|559028091|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
154892487|NCT01376245|559028092|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
154892488|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
154892489|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
154892490|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
154892491|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
154892492|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
154892493|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
154892494|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
154892495|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
154892496|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
154892497|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
154892498|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
154892499|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
154892500|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
154892501|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
154892502|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
154892503|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
154892504|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
154892505|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
154892506|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
154892507|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
154892508|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154892509|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
154892510|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
154892511|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
154892512|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
154892513|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
154892514|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
154892515|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
154892516|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
154892517|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
154892518|NCT01376245|559028088|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
154892519|NCT01376245|559028089|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
154892520|NCT01376245|559028090|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
154892521|NCT01376245|559028091|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
154892522|NCT01376245|559028092|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
154892523|NCT01170221|559028093|FG000|Overall Study|Lost to Follow-up|22|||
154892524|NCT01170221|559028094|FG001|Overall Study|Lost to Follow-up|21|||
154892525|NCT01170221|559028093|FG000|Overall Study|Withdrawal by Subject|9|||
154892526|NCT01170221|559028094|FG001|Overall Study|Withdrawal by Subject|7|||
154892527|NCT01170221|559028093|FG000|Overall Study|Subject completed only screening and LFU|1|||
154892528|NCT01170221|559028094|FG001|Overall Study|Subject completed only screening and LFU|0|||
154892529|NCT01170221|559028093|FG000|Overall Study|Randomized but not treated|1|||
154892530|NCT01170221|559028094|FG001|Overall Study|Randomized but not treated|0|||
154892531|NCT00050960|559028095|FG000|Overall Study|Progressive Disease|137|||
154892532|NCT00050960|559028096|FG001|Overall Study|Progressive Disease|93|||
154892533|NCT00050960|559028095|FG000|Overall Study|Stable Disease|19|||
154978227|NCT01396421|559342806|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
154978228|NCT01396421|559342807|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
154978229|NCT01396421|559342808|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
154978230|NCT01396421|559342805|FG000|Overall Study|Physician Decision|1|||
154978231|NCT01396421|559342806|FG001|Overall Study|Physician Decision|1|||
154978232|NCT01396421|559342807|FG002|Overall Study|Physician Decision|0|||
154978233|NCT01396421|559342808|FG003|Overall Study|Physician Decision|3|||
154892534|NCT00050960|559028096|FG001|Overall Study|Stable Disease|48|||
154892535|NCT00050960|559028095|FG000|Overall Study|Partial Response|14|||
154892536|NCT00050960|559028096|FG001|Overall Study|Partial Response|19|||
154892537|NCT00050960|559028095|FG000|Overall Study|Complete Response|0|||
154892538|NCT00050960|559028096|FG001|Overall Study|Complete Response|2|||
154892539|NCT00050960|559028095|FG000|Overall Study|Adverse Event|62|||
154892540|NCT00050960|559028096|FG001|Overall Study|Adverse Event|61|||
154892541|NCT00050960|559028095|FG000|Overall Study|Lost to Follow-up|0|||
154892542|NCT00050960|559028096|FG001|Overall Study|Lost to Follow-up|1|||
154892543|NCT00050960|559028095|FG000|Overall Study|Withdrawal by Subject|23|||
154892544|NCT00050960|559028096|FG001|Overall Study|Withdrawal by Subject|18|||
154892545|NCT00050960|559028095|FG000|Overall Study|Administrative|31|||
154892546|NCT00050960|559028096|FG001|Overall Study|Administrative|46|||
154892547|NCT00050960|559028095|FG000|Overall Study|Non-compliance|3|||
154892548|NCT00050960|559028096|FG001|Overall Study|Non-compliance|1|||
154892549|NCT00050960|559028095|FG000|Overall Study|Death|13|||
154892550|NCT00050960|559028096|FG001|Overall Study|Death|15|||
154892551|NCT00764946|559028097|FG000|Overall Study|Lack of Efficacy|1|||
154892552|NCT00764946|559028098|FG001|Overall Study|Lack of Efficacy|0|||
154892553|NCT00764946|559028099|FG002|Overall Study|Lack of Efficacy|0|||
154892554|NCT00764946|559028097|FG000|Overall Study|Lost to Follow-up|3|||
154892555|NCT00764946|559028098|FG001|Overall Study|Lost to Follow-up|4|||
154892556|NCT00764946|559028099|FG002|Overall Study|Lost to Follow-up|0|||
154892557|NCT00764946|559028097|FG000|Overall Study|Physician Decision|2|||
154892558|NCT00764946|559028098|FG001|Overall Study|Physician Decision|4|||
154892559|NCT00764946|559028099|FG002|Overall Study|Physician Decision|0|||
154892560|NCT00764946|559028097|FG000|Overall Study|Adverse Event|3|||
154892561|NCT00764946|559028098|FG001|Overall Study|Adverse Event|2|||
154892562|NCT00764946|559028099|FG002|Overall Study|Adverse Event|1|||
154892563|NCT00764946|559028097|FG000|Overall Study|Withdrawal by Subject|3|||
154892564|NCT00764946|559028098|FG001|Overall Study|Withdrawal by Subject|6|||
154892565|NCT00764946|559028099|FG002|Overall Study|Withdrawal by Subject|2|||
154892566|NCT00764946|559028097|FG000|Overall Study|Never Treated|1|||
154892567|NCT00764946|559028098|FG001|Overall Study|Never Treated|1|||
154892568|NCT00764946|559028099|FG002|Overall Study|Never Treated|1|||
154892569|NCT02219087|559028100|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
154892570|NCT02219087|559028101|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
154892571|NCT04311177|559028102|FG000|Overall Study|Adverse Event|3|||
154892572|NCT04311177|559028103|FG001|Overall Study|Adverse Event|1|||
154892573|NCT04311177|559028102|FG000|Overall Study|Physician Decision|4|||
154892574|NCT04311177|559028103|FG001|Overall Study|Physician Decision|3|||
154892575|NCT04311177|559028102|FG000|Overall Study|Withdrawal by Subject|1|||
154892576|NCT04311177|559028103|FG001|Overall Study|Withdrawal by Subject|0|||
154892577|NCT02176291|559028108|FG000|Overall Study|Death|1|||
154892578|NCT02176291|559028109|FG001|Overall Study|Death|0|||
154892579|NCT02176291|559028108|FG000|Overall Study|non compliance with protocol|2|||
154892580|NCT02176291|559028109|FG001|Overall Study|non compliance with protocol|0|||
154892581|NCT02176291|559028108|FG000|Overall Study|Withdrawal by Subject|2|||
154892582|NCT02176291|559028109|FG001|Overall Study|Withdrawal by Subject|0|||
154892583|NCT01969799|559028110|FG000|Overall Study|Adverse Event|0|||
154892584|NCT01969799|559028111|FG001|Overall Study|Adverse Event|1|||
154892585|NCT01969799|559028110|FG000|Overall Study|Death|16|||
154892586|NCT01969799|559028111|FG001|Overall Study|Death|11|||
154892587|NCT01969799|559028110|FG000|Overall Study|Lost to Follow-up|0|||
154892588|NCT01969799|559028111|FG001|Overall Study|Lost to Follow-up|2|||
154892589|NCT01969799|559028110|FG000|Overall Study|Physician Decision|1|||
154892590|NCT01969799|559028111|FG001|Overall Study|Physician Decision|0|||
154892591|NCT02431468|559028112|FG000|Overall Study|Adverse Event|2|||
154892592|NCT02431468|559028113|FG001|Overall Study|Adverse Event|4|||
154892593|NCT02431468|559028114|FG002|Overall Study|Adverse Event|5|||
154892594|NCT02431468|559028112|FG000|Overall Study|Withdrawal by Subject|4|||
154892595|NCT02431468|559028113|FG001|Overall Study|Withdrawal by Subject|12|||
154892596|NCT02431468|559028114|FG002|Overall Study|Withdrawal by Subject|2|||
154892597|NCT02431468|559028112|FG000|Overall Study|noncompliance, investigator termination,|2|||
154892598|NCT02431468|559028113|FG001|Overall Study|noncompliance, investigator termination,|2|||
154892599|NCT02431468|559028114|FG002|Overall Study|noncompliance, investigator termination,|2|||
154892600|NCT01361919|559028115|FG000|Overall Study|technical issues|10|||
154892601|NCT01361919|559028116|FG001|Overall Study|technical issues|12|||
154892602|NCT01361919|559028117|FG002|Overall Study|technical issues|10|||
154892603|NCT01056341|559028118|FG000|Overall Study|Treatment Intolerance|0|||
154892604|NCT01056341|559028119|FG001|Overall Study|Treatment Intolerance|2|||
154892605|NCT01056341|559028120|FG002|Overall Study|Treatment Intolerance|0|||
154892606|NCT01056341|559028121|FG003|Overall Study|Treatment Intolerance|2|||
154892607|NCT01056341|559028122|FG004|Overall Study|Treatment Intolerance|0|||
154892608|NCT01056341|559028118|FG000|Overall Study|Lack of Efficacy|32|||
154892609|NCT01056341|559028119|FG001|Overall Study|Lack of Efficacy|30|||
154892610|NCT01056341|559028120|FG002|Overall Study|Lack of Efficacy|7|||
154892611|NCT01056341|559028121|FG003|Overall Study|Lack of Efficacy|25|||
154892612|NCT01056341|559028122|FG004|Overall Study|Lack of Efficacy|9|||
154892613|NCT01056341|559028118|FG000|Overall Study|Other reasons|4|||
154892614|NCT01056341|559028119|FG001|Overall Study|Other reasons|4|||
154892615|NCT01056341|559028120|FG002|Overall Study|Other reasons|8|||
154892616|NCT01056341|559028121|FG003|Overall Study|Other reasons|9|||
154892617|NCT01056341|559028122|FG004|Overall Study|Other reasons|5|||
154892618|NCT02227108|559028125|FG000|Overall Study|Did not receive treatment|2|||
154892619|NCT02227108|559028125|FG000|Overall Study|Other|3|||
154892620|NCT02227108|559028125|FG000|Overall Study|Progressive disease|17|||
154892621|NCT02227108|559028125|FG000|Overall Study|Initiation of alternative therapy|2|||
154892622|NCT02227108|559028125|FG000|Overall Study|Investigator discretion|1|||
154892623|NCT02227108|559028125|FG000|Overall Study|Adverse Event|6|||
154892624|NCT02486952|559028126|FG000|Overall Study|Not Started Induction Therapy|3|||
154892625|NCT02486952|559028126|FG000|Overall Study|Adverse Event|1|||
154892626|NCT02486952|559028126|FG000|Overall Study|Death|15|||
154892627|NCT02486952|559028126|FG000|Overall Study|Lack of Efficacy|3|||
154892628|NCT02486952|559028126|FG000|Overall Study|Lost to Follow-up|26|||
154892629|NCT02486952|559028126|FG000|Overall Study|Other|2|||
154892630|NCT03589885|559028127|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
154892631|NCT03589885|559028128|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
154892632|NCT03589885|559028129|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
154892633|NCT03589885|559028130|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
154892634|NCT03589885|559028131|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
154892635|NCT03589885|559028127|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
154892636|NCT03589885|559028128|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
154892637|NCT03589885|559028129|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
154892638|NCT03589885|559028130|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
154892639|NCT03589885|559028131|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
154892640|NCT03589885|559028127|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
154892641|NCT03589885|559028128|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
154892642|NCT03589885|559028129|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
154892643|NCT03589885|559028130|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
154892644|NCT03589885|559028131|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
154892645|NCT03589885|559028127|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
154892646|NCT03589885|559028128|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
154892647|NCT03589885|559028129|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
154892648|NCT03589885|559028130|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
154892649|NCT03589885|559028131|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
154892650|NCT03589885|559028127|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
154892651|NCT03589885|559028128|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
154892652|NCT03589885|559028129|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
154892653|NCT03589885|559028130|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
154892654|NCT03589885|559028131|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
154892655|NCT03589885|559028127|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
154892656|NCT03589885|559028128|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
154892657|NCT03589885|559028129|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
154892658|NCT03589885|559028130|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
154892659|NCT03589885|559028131|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
154892660|NCT03589885|559028127|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
154892661|NCT03589885|559028128|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
154892662|NCT03589885|559028129|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
154892663|NCT03589885|559028130|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
154892664|NCT03589885|559028131|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
154892665|NCT03589885|559028127|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
154892666|NCT03589885|559028128|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
154892667|NCT03589885|559028129|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
154892668|NCT03589885|559028130|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
154892669|NCT03589885|559028131|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
154892670|NCT04111107|559028132|FG000|Overall Study|Withdrawal by Subject|6|||
154892671|NCT04111107|559028132|FG000|Overall Study|Declining Health|5|||
154892672|NCT03956225|559028133|FG000|Overall Study|Lack of Efficacy|1|||
154892673|NCT03956225|559028134|FG001|Overall Study|Lack of Efficacy|1|||
154892674|NCT03956225|559028133|FG000|Overall Study|Lost to Follow-up|0|||
154892675|NCT03956225|559028134|FG001|Overall Study|Lost to Follow-up|1|||
154892676|NCT03956225|559028133|FG000|Overall Study|Withdrawal by Subject|2|||
154892677|NCT03956225|559028134|FG001|Overall Study|Withdrawal by Subject|1|||
154892678|NCT03956225|559028133|FG000|Overall Study|Other Reasons|2|||
154892679|NCT03956225|559028134|FG001|Overall Study|Other Reasons|1|||
154892680|NCT02157506|559028135|FG000|Overall Study|Adverse Event|0|||
154892681|NCT02157506|559028136|FG001|Overall Study|Adverse Event|1|||
154892682|NCT02157506|559028137|FG002|Overall Study|Adverse Event|0|||
154978234|NCT01396421|559342805|FG000|Overall Study|Withdrawal by Subject|31|||
155113976|NCT03632993|559846189|FG000|Overall Study|Protocol Non-compliance|0|||
155113977|NCT03632993|559846190|FG001|Overall Study|Protocol Non-compliance|1|||
155113978|NCT03632993|559846191|FG002|Overall Study|Protocol Non-compliance|0|||
155113979|NCT03632993|559846192|FG003|Overall Study|Protocol Non-compliance|0|||
155113980|NCT03632993|559846193|FG004|Overall Study|Protocol Non-compliance|0|||
155113981|NCT03632993|559846194|FG005|Overall Study|Protocol Non-compliance|0|||
154892683|NCT02157506|559028138|FG003|Overall Study|Adverse Event|0|||
154892684|NCT02157506|559028139|FG004|Overall Study|Adverse Event|0|||
154892685|NCT02157506|559028135|FG000|Overall Study|Lost to Follow-up|0|||
154892686|NCT02157506|559028136|FG001|Overall Study|Lost to Follow-up|0|||
154892687|NCT02157506|559028137|FG002|Overall Study|Lost to Follow-up|1|||
154892688|NCT02157506|559028138|FG003|Overall Study|Lost to Follow-up|0|||
154892689|NCT02157506|559028139|FG004|Overall Study|Lost to Follow-up|0|||
154892690|NCT03448224|559028140|FG000|Overall Study|Provided same answer to every question|1|||
154892691|NCT03448224|559028141|FG001|Overall Study|Provided same answer to every question|0|||
154892692|NCT03103906|559028142|FG000|Overall Study|Adverse Event|2|||
154892693|NCT03103906|559028143|FG001|Overall Study|Adverse Event|3|||
154892694|NCT03103906|559028142|FG000|Overall Study|Other|2|||
154892695|NCT03103906|559028143|FG001|Overall Study|Other|0|||
154892696|NCT00764478|559028144|FG000|Overall Study|Adverse Event|1|||
154892697|NCT00764478|559028145|FG001|Overall Study|Adverse Event|1|||
154892698|NCT00764478|559028146|FG002|Overall Study|Adverse Event|1|||
154892699|NCT00764478|559028144|FG000|Overall Study|Withdrawal by Subject|7|||
154892700|NCT00764478|559028145|FG001|Overall Study|Withdrawal by Subject|12|||
154892701|NCT00764478|559028146|FG002|Overall Study|Withdrawal by Subject|1|||
154892702|NCT00764478|559028144|FG000|Overall Study|Lost to Follow-up|7|||
154892703|NCT00764478|559028145|FG001|Overall Study|Lost to Follow-up|8|||
154892704|NCT00764478|559028146|FG002|Overall Study|Lost to Follow-up|5|||
154892705|NCT00764478|559028144|FG000|Overall Study|Protocol Violation|0|||
154892706|NCT00764478|559028145|FG001|Overall Study|Protocol Violation|1|||
154892707|NCT00764478|559028146|FG002|Overall Study|Protocol Violation|1|||
154892708|NCT02702011|559028149|FG000|Overall Study|Withdrawal by Subject|0|||
154892709|NCT02702011|559028150|FG001|Overall Study|Withdrawal by Subject|1|||
154892710|NCT02702011|559028151|FG002|Overall Study|Withdrawal by Subject|0|||
154892711|NCT02702011|559028152|FG003|Overall Study|Withdrawal by Subject|0|||
154892712|NCT03498287|559028156|FG000|Overall Study|Withdrawal by Subject|3|||
154892713|NCT03498287|559028157|FG001|Overall Study|Withdrawal by Subject|0|||
154892714|NCT03498287|559028156|FG000|Overall Study|Protocol Violation|0|||
154892715|NCT03498287|559028157|FG001|Overall Study|Protocol Violation|4|||
154892716|NCT03498287|559028156|FG000|Overall Study|Adverse Event|0|||
154892717|NCT03498287|559028157|FG001|Overall Study|Adverse Event|1|||
154892718|NCT02939599|559028158|FG000|Overall Study|Adverse Event|1|||
154892719|NCT02939599|559028159|FG001|Overall Study|Adverse Event|0|||
154892720|NCT02939599|559028158|FG000|Overall Study|Study Terminated By Sponsor|2|||
154892721|NCT02939599|559028159|FG001|Overall Study|Study Terminated By Sponsor|2|||
154892722|NCT01136746|559029994|FG000|Overall Study|Lost to Follow-up|0|||
154892723|NCT01136746|559029995|FG001|Overall Study|Lost to Follow-up|2|||
154892724|NCT01136746|559029994|FG000|Overall Study|Protocol Violation|2|||
154892725|NCT01136746|559029995|FG001|Overall Study|Protocol Violation|1|||
154892726|NCT01136746|559029994|FG000|Overall Study|Death|1|||
154892727|NCT01136746|559029995|FG001|Overall Study|Death|0|||
154892728|NCT00093470|559030008|FG000|Overall Study|Disease progression|39|||
154892729|NCT00093470|559030009|FG001|Overall Study|Disease progression|0|||
154892730|NCT00093470|559030008|FG000|Overall Study|Adverse Event|15|||
154892731|NCT00093470|559030009|FG001|Overall Study|Adverse Event|0|||
154892732|NCT00093470|559030008|FG000|Overall Study|Death|2|||
154892733|NCT00093470|559030009|FG001|Overall Study|Death|0|||
154892734|NCT00093470|559030008|FG000|Overall Study|Withdrawal by Subject|8|||
154892735|NCT00093470|559030009|FG001|Overall Study|Withdrawal by Subject|0|||
155113982|NCT03632993|559846195|FG006|Overall Study|Protocol Non-compliance|0|||
155113983|NCT03632993|559846196|FG007|Overall Study|Protocol Non-compliance|0|||
155113984|NCT03632993|559846197|FG008|Overall Study|Protocol Non-compliance|0|||
155113985|NCT03632993|559846198|FG009|Overall Study|Protocol Non-compliance|0|||
154892736|NCT00093470|559030008|FG000|Overall Study|Alternative therapy|2|||
154892737|NCT00093470|559030009|FG001|Overall Study|Alternative therapy|0|||
154892738|NCT00093470|559030008|FG000|Overall Study|Other complicating disease|3|||
154892739|NCT00093470|559030009|FG001|Overall Study|Other complicating disease|0|||
154892740|NCT00093470|559030008|FG000|Overall Study|Physician Decision|2|||
154892741|NCT00093470|559030009|FG001|Overall Study|Physician Decision|0|||
154892742|NCT00093470|559030008|FG000|Overall Study|Never started treatment|1|||
154892743|NCT00093470|559030009|FG001|Overall Study|Never started treatment|0|||
154892744|NCT00093470|559030008|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
154892745|NCT00093470|559030009|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
154892746|NCT02514772|559030015|FG000|Overall Study|Adverse Event|1|||
154892747|NCT02514772|559030016|FG001|Overall Study|Adverse Event|0|||
154892748|NCT02514772|559030015|FG000|Overall Study|Death|0|||
154892749|NCT02514772|559030016|FG001|Overall Study|Death|1|||
154892750|NCT02514772|559030015|FG000|Overall Study|Withdrawal by Subject|2|||
154892751|NCT02514772|559030016|FG001|Overall Study|Withdrawal by Subject|1|||
154892752|NCT00877006|559030017|FG000|Treatment Period|Death|2|||
154892753|NCT00877006|559030018|FG001|Treatment Period|Death|1|||
154892754|NCT00877006|559030017|FG000|Treatment Period|Adverse Event|10|||
154892755|NCT00877006|559030018|FG001|Treatment Period|Adverse Event|3|||
154892756|NCT00877006|559030017|FG000|Treatment Period|Withdrawal by Subject|2|||
154892757|NCT00877006|559030018|FG001|Treatment Period|Withdrawal by Subject|3|||
154892758|NCT00877006|559030017|FG000|Treatment Period|Protocol Violation|1|||
154892759|NCT00877006|559030018|FG001|Treatment Period|Protocol Violation|0|||
154892760|NCT00877006|559030017|FG000|Treatment Period|Lost to Follow-up|0|||
154892761|NCT00877006|559030018|FG001|Treatment Period|Lost to Follow-up|1|||
154892762|NCT00877006|559030017|FG000|Treatment Period|Disease Progression|1|||
154892763|NCT00877006|559030018|FG001|Treatment Period|Disease Progression|2|||
154892764|NCT00877006|559030017|FG000|Treatment Period|Started New Treatment Regimen|2|||
154892765|NCT00877006|559030018|FG001|Treatment Period|Started New Treatment Regimen|5|||
154892766|NCT00877006|559030017|FG000|Treatment Period|Other|4|||
154892767|NCT00877006|559030018|FG001|Treatment Period|Other|4|||
154892768|NCT00877006|559030017|FG000|Treatment Period|Randomized but Not Treated|3|||
154892769|NCT00877006|559030018|FG001|Treatment Period|Randomized but Not Treated|8|||
154892770|NCT00877006|559030017|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
154892771|NCT00877006|559030018|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
154892772|NCT00877006|559030017|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
154892773|NCT00877006|559030018|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
154892774|NCT00877006|559030017|FG000|Long-Term Follow-up Period|Death|26|||
154892775|NCT00877006|559030018|FG001|Long-Term Follow-up Period|Death|18|||
154892776|NCT00877006|559030017|FG000|Long-Term Follow-up Period|Other|7|||
154892777|NCT00877006|559030018|FG001|Long-Term Follow-up Period|Other|9|||
154892778|NCT04671342|559030019|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
154892779|NCT04671342|559030019|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
154892780|NCT04671342|559030019|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
154892781|NCT04671342|559030019|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
154892782|NCT04671342|559030019|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
154892783|NCT04671342|559030019|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
154892784|NCT03583606|559030020|FG000|Overall Study|Lost to Follow-up|0|||
154892785|NCT03583606|559030021|FG001|Overall Study|Lost to Follow-up|1|||
154892786|NCT03583606|559030022|FG002|Overall Study|Lost to Follow-up|0|||
154892787|NCT03583606|559030020|FG000|Overall Study|Ineligible at baseline|1|||
154892788|NCT03583606|559030021|FG001|Overall Study|Ineligible at baseline|0|||
154892789|NCT03583606|559030022|FG002|Overall Study|Ineligible at baseline|0|||
154892790|NCT00817206|559030023|FG000|Overall Study|Adverse Event|10|||
154892791|NCT00817206|559030024|FG001|Overall Study|Adverse Event|3|||
154892792|NCT00817206|559030023|FG000|Overall Study|Protocol Violation|0|||
154892793|NCT00817206|559030024|FG001|Overall Study|Protocol Violation|2|||
154892794|NCT00817206|559030023|FG000|Overall Study|Lost to Follow-up|0|||
154892795|NCT00817206|559030024|FG001|Overall Study|Lost to Follow-up|1|||
154892796|NCT00817206|559030023|FG000|Overall Study|Death|2|||
154892797|NCT00817206|559030024|FG001|Overall Study|Death|0|||
154892798|NCT00817206|559030023|FG000|Overall Study|Withdrawal by Subject|7|||
154892799|NCT00817206|559030024|FG001|Overall Study|Withdrawal by Subject|3|||
154892800|NCT00817206|559030023|FG000|Overall Study|Physician Decision|2|||
154892801|NCT00817206|559030024|FG001|Overall Study|Physician Decision|0|||
154892802|NCT00126581|559030025|FG000|Overall Study|Adverse Event|3|||
154892803|NCT00126581|559030026|FG001|Overall Study|Adverse Event|7|||
154892804|NCT00126581|559030025|FG000|Overall Study|Death|3|||
154892805|NCT00126581|559030026|FG001|Overall Study|Death|2|||
154892806|NCT00126581|559030025|FG000|Overall Study|Withdrawal by Subject|1|||
154892807|NCT00126581|559030026|FG001|Overall Study|Withdrawal by Subject|4|||
154892808|NCT00126581|559030025|FG000|Overall Study|Alternative therapy|3|||
154892809|NCT00126581|559030026|FG001|Overall Study|Alternative therapy|3|||
154892810|NCT00126581|559030025|FG000|Overall Study|Other illness/MD discretion|3|||
154892811|NCT00126581|559030026|FG001|Overall Study|Other illness/MD discretion|4|||
154892812|NCT00793182|559030027|FG000|Overall Study|Adverse Event|0|||
154892813|NCT00793182|559030028|FG001|Overall Study|Adverse Event|1|||
154892814|NCT03728140|559030029|FG000|Overall Study|Abnormal embryo transfer operation|10|||
154892815|NCT03728140|559030030|FG001|Overall Study|Abnormal embryo transfer operation|7|||
154892816|NCT00851253|559030031|FG000|Overall Study|Disease Progression|1|||
154892817|NCT00851253|559030032|FG001|Overall Study|Disease Progression|0|||
154892818|NCT01803711|559030045|FG000|Overall Study|Adverse Event|1|||
154892819|NCT01803711|559030046|FG001|Overall Study|Adverse Event|1|||
154892820|NCT00225212|559030047|FG000|Overall Study|Disease progression|2|||
154892821|NCT00225212|559030047|FG000|Overall Study|Death|1|||
154892822|NCT00225212|559030047|FG000|Overall Study|Adverse Event|2|||
154892823|NCT00225212|559030047|FG000|Overall Study|Intercurrent illness|1|||
154892824|NCT05159362|559030048|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
154892825|NCT05159362|559030049|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
154892826|NCT05159362|559030050|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
154892827|NCT01335698|559030051|FG000|Treatment Stage 1|Lack of Efficacy|3|||
154892828|NCT01335698|559030052|FG001|Treatment Stage 1|Lack of Efficacy|1|||
154892829|NCT01335698|559030053|FG002|Treatment Stage 1|Lack of Efficacy|3|||
154892830|NCT01335698|559030054|FG003|Treatment Stage 1|Lack of Efficacy|3|||
154892831|NCT01335698|559030055|FG004|Treatment Stage 1|Lack of Efficacy|1|||
154892832|NCT01335698|559030051|FG000|Treatment Stage 1|Adverse Event|1|||
154892833|NCT01335698|559030052|FG001|Treatment Stage 1|Adverse Event|2|||
154892834|NCT01335698|559030053|FG002|Treatment Stage 1|Adverse Event|2|||
154892835|NCT01335698|559030054|FG003|Treatment Stage 1|Adverse Event|1|||
154892836|NCT01335698|559030055|FG004|Treatment Stage 1|Adverse Event|1|||
154892837|NCT01335698|559030051|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
154892838|NCT01335698|559030052|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
154892839|NCT01335698|559030053|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
154892840|NCT01335698|559030054|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
154892841|NCT01335698|559030055|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
154892842|NCT01335698|559030051|FG000|Treatment Stage 1|Lost to Follow-up|1|||
154892843|NCT01335698|559030052|FG001|Treatment Stage 1|Lost to Follow-up|1|||
154892844|NCT01335698|559030053|FG002|Treatment Stage 1|Lost to Follow-up|0|||
154892845|NCT01335698|559030054|FG003|Treatment Stage 1|Lost to Follow-up|0|||
154892846|NCT01335698|559030055|FG004|Treatment Stage 1|Lost to Follow-up|0|||
154892847|NCT01335698|559030051|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
154892848|NCT01335698|559030052|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
154892849|NCT01335698|559030053|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
154892850|NCT01335698|559030054|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
154892851|NCT01335698|559030055|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
154892852|NCT01335698|559030051|FG000|Treatment Stage 1|No longer meets study criteria|1|||
154892853|NCT01335698|559030052|FG001|Treatment Stage 1|No longer meets study criteria|1|||
154892854|NCT01335698|559030053|FG002|Treatment Stage 1|No longer meets study criteria|0|||
154892855|NCT01335698|559030054|FG003|Treatment Stage 1|No longer meets study criteria|1|||
154892856|NCT01335698|559030055|FG004|Treatment Stage 1|No longer meets study criteria|0|||
154892857|NCT01335698|559030051|FG000|Treatment Stage 1|Other|1|||
154892858|NCT01335698|559030052|FG001|Treatment Stage 1|Other|0|||
154892859|NCT01335698|559030053|FG002|Treatment Stage 1|Other|0|||
154892860|NCT01335698|559030054|FG003|Treatment Stage 1|Other|1|||
154892861|NCT01335698|559030055|FG004|Treatment Stage 1|Other|0|||
154892862|NCT01335698|559030051|FG000|Treatment Stage 2|Lack of Efficacy|2|||
154892863|NCT01335698|559030052|FG001|Treatment Stage 2|Lack of Efficacy|1|||
154892864|NCT01335698|559030053|FG002|Treatment Stage 2|Lack of Efficacy|3|||
154892865|NCT01335698|559030054|FG003|Treatment Stage 2|Lack of Efficacy|1|||
154892866|NCT01335698|559030055|FG004|Treatment Stage 2|Lack of Efficacy|0|||
154892867|NCT01335698|559030051|FG000|Treatment Stage 2|Adverse Event|2|||
154892868|NCT01335698|559030052|FG001|Treatment Stage 2|Adverse Event|0|||
154892869|NCT01335698|559030053|FG002|Treatment Stage 2|Adverse Event|0|||
154892870|NCT01335698|559030054|FG003|Treatment Stage 2|Adverse Event|3|||
154892871|NCT01335698|559030055|FG004|Treatment Stage 2|Adverse Event|0|||
154892872|NCT01335698|559030051|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
154892873|NCT01335698|559030052|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
154892874|NCT01335698|559030053|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
154892875|NCT01335698|559030054|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
154892876|NCT01335698|559030055|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
154892877|NCT01335698|559030051|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
154892878|NCT01335698|559030052|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
154892879|NCT01335698|559030053|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
154892880|NCT01335698|559030054|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
154892881|NCT01335698|559030055|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
154892882|NCT01335698|559030051|FG000|Treatment Stage 2|Lost to Follow-up|1|||
154892883|NCT01335698|559030052|FG001|Treatment Stage 2|Lost to Follow-up|0|||
154892884|NCT01335698|559030053|FG002|Treatment Stage 2|Lost to Follow-up|0|||
154892885|NCT01335698|559030054|FG003|Treatment Stage 2|Lost to Follow-up|0|||
154892886|NCT01335698|559030055|FG004|Treatment Stage 2|Lost to Follow-up|0|||
154892887|NCT01335698|559030051|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
154892888|NCT01335698|559030052|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
154892889|NCT01335698|559030053|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
154892890|NCT01335698|559030054|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
154892891|NCT01335698|559030055|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
154892892|NCT01335698|559030051|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
154892893|NCT01335698|559030052|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
154892894|NCT01335698|559030053|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
154892895|NCT01335698|559030054|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
154892896|NCT01335698|559030055|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
154892897|NCT01335698|559030051|FG000|Treatment Stage 2|Switched to another formulation|1|||
154892898|NCT01335698|559030052|FG001|Treatment Stage 2|Switched to another formulation|1|||
154892899|NCT01335698|559030053|FG002|Treatment Stage 2|Switched to another formulation|0|||
154892900|NCT01335698|559030054|FG003|Treatment Stage 2|Switched to another formulation|0|||
154892901|NCT01335698|559030055|FG004|Treatment Stage 2|Switched to another formulation|0|||
154892902|NCT01162304|559030059|FG000|Overall Study|Beck scale to high|11|||
154892903|NCT01315847|559030060|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
154892904|NCT01315847|559030061|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
154892905|NCT01315847|559030060|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
154892906|NCT01315847|559030061|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
154892907|NCT02940626|559030062|FG000|Overall Study|Death|40|||
154892908|NCT02940626|559030063|FG001|Overall Study|Death|32|||
154892909|NCT02940626|559030062|FG000|Overall Study|Lost to Follow-up|5|||
154892910|NCT02940626|559030063|FG001|Overall Study|Lost to Follow-up|2|||
154892911|NCT02940626|559030062|FG000|Overall Study|Withdrawal by Subject|1|||
154892912|NCT02940626|559030063|FG001|Overall Study|Withdrawal by Subject|0|||
154892913|NCT02940626|559030062|FG000|Overall Study|Transfer to Hospice Care|1|||
154892914|NCT02940626|559030063|FG001|Overall Study|Transfer to Hospice Care|0|||
154892915|NCT02940626|559030062|FG000|Overall Study|Prohibited Concomitant Medication|0|||
154892916|NCT02940626|559030063|FG001|Overall Study|Prohibited Concomitant Medication|1|||
154892917|NCT01324622|559030064|FG000|Overall Study|Lost to Follow-up|7|||
154892918|NCT01324622|559030065|FG001|Overall Study|Lost to Follow-up|7|||
154892919|NCT01324622|559030064|FG000|Overall Study|Death|1|||
154892920|NCT01324622|559030065|FG001|Overall Study|Death|0|||
154892921|NCT01324622|559030064|FG000|Overall Study|Lack of Efficacy|1|||
154892922|NCT01324622|559030065|FG001|Overall Study|Lack of Efficacy|0|||
154892923|NCT00618449|559030066|FG000|Overall Study|Lost to Follow-up|98|||
154892924|NCT00618449|559030067|FG001|Overall Study|Lost to Follow-up|110|||
154892925|NCT05127421|559030068|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
154892926|NCT05127421|559030069|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
154892927|NCT05127421|559030070|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
154892928|NCT05127421|559030071|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
154892929|NCT05127421|559030068|FG000|4-Week Double-Blind Period|Physician Decision|1|||
154892930|NCT05127421|559030069|FG001|4-Week Double-Blind Period|Physician Decision|0|||
154892931|NCT05127421|559030070|FG002|4-Week Double-Blind Period|Physician Decision|0|||
154892932|NCT05127421|559030071|FG003|4-Week Double-Blind Period|Physician Decision|0|||
154892933|NCT05127421|559030068|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
154892934|NCT05127421|559030069|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
154892935|NCT05127421|559030070|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
154892936|NCT05127421|559030071|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
154892937|NCT05127421|559030068|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
154892938|NCT05127421|559030069|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
154892939|NCT05127421|559030070|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
154892940|NCT05127421|559030071|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
154892941|NCT05127421|559030068|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
154892942|NCT05127421|559030069|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
154892943|NCT05127421|559030070|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
154892944|NCT05127421|559030071|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
154892945|NCT05127421|559030068|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
154892946|NCT05127421|559030069|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
154892947|NCT05127421|559030070|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
154892948|NCT05127421|559030071|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
154892949|NCT05127421|559030068|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
154892950|NCT05127421|559030069|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
154892951|NCT05127421|559030070|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
154892952|NCT05127421|559030071|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
154892953|NCT05127421|559030068|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
154892954|NCT05127421|559030069|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
154892955|NCT05127421|559030070|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
154892956|NCT05127421|559030071|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
154892957|NCT00138424|559030072|FG000|Overall Study|Physician Decision|0|||
154892958|NCT00138424|559030073|FG001|Overall Study|Physician Decision|1|||
154892959|NCT00138424|559030074|FG002|Overall Study|Physician Decision|0|||
154892960|NCT00138424|559030075|FG003|Overall Study|Physician Decision|0|||
154892961|NCT00574496|559030080|FG000|Overall Study|Withdrawal by Subject|1|||
154892962|NCT00413062|559030081|FG000|Overall Study|Adverse event/serious adverse event|289|||
154892963|NCT00413062|559030082|FG001|Overall Study|Adverse event/serious adverse event|56|||
154892964|NCT00413062|559030081|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
154892965|NCT00413062|559030082|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
154892966|NCT00413062|559030081|FG000|Overall Study|Withdrawal of informed consent|111|||
154892967|NCT00413062|559030082|FG001|Overall Study|Withdrawal of informed consent|36|||
154892968|NCT00413062|559030081|FG000|Overall Study|Pregnancy|15|||
154892969|NCT00413062|559030082|FG001|Overall Study|Pregnancy|5|||
154892970|NCT00413062|559030081|FG000|Overall Study|Pregnancy wish|17|||
154892971|NCT00413062|559030082|FG001|Overall Study|Pregnancy wish|6|||
154892972|NCT00413062|559030081|FG000|Overall Study|Lost to Follow-up|175|||
154892973|NCT00413062|559030082|FG001|Overall Study|Lost to Follow-up|73|||
154892974|NCT00413062|559030081|FG000|Overall Study|Other reason|70|||
154892975|NCT00413062|559030082|FG001|Overall Study|Other reason|34|||
154892976|NCT00006604|559030083|FG000|Overall Study|Met study objective - no further FU|1|||
154892977|NCT00006604|559030084|FG001|Overall Study|Met study objective - no further FU|0|||
154892978|NCT00006604|559030085|FG002|Overall Study|Met study objective - no further FU|0|||
154892979|NCT00006604|559030086|FG003|Overall Study|Met study objective - no further FU|0|||
154892980|NCT00006604|559030087|FG004|Overall Study|Met study objective - no further FU|0|||
154892981|NCT00006604|559030088|FG005|Overall Study|Met study objective - no further FU|0|||
154892982|NCT00006604|559030089|FG006|Overall Study|Met study objective - no further FU|0|||
154892983|NCT00006604|559030090|FG007|Overall Study|Met study objective - no further FU|0|||
154892984|NCT00006604|559030091|FG008|Overall Study|Met study objective - no further FU|0|||
154892985|NCT00006604|559030092|FG009|Overall Study|Met study objective - no further FU|0|||
154892986|NCT00006604|559030093|FG010|Overall Study|Met study objective - no further FU|0|||
154892987|NCT00006604|559030094|FG011|Overall Study|Met study objective - no further FU|0|||
154892988|NCT00006604|559030095|FG012|Overall Study|Met study objective - no further FU|0|||
154892989|NCT00006604|559030096|FG013|Overall Study|Met study objective - no further FU|0|||
154892990|NCT00006604|559030097|FG014|Overall Study|Met study objective - no further FU|1|||
154892991|NCT00006604|559030098|FG015|Overall Study|Met study objective - no further FU|1|||
154892992|NCT00006604|559030099|FG016|Overall Study|Met study objective - no further FU|0|||
154892993|NCT00006604|559030083|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
154892994|NCT00006604|559030084|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
154892995|NCT00006604|559030085|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
154892996|NCT00006604|559030086|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
154892997|NCT00006604|559030087|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
154892998|NCT00006604|559030088|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
154892999|NCT00006604|559030089|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
154893000|NCT00006604|559030090|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
154893001|NCT00006604|559030091|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
154893002|NCT00006604|559030092|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
154893003|NCT00006604|559030093|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
154893004|NCT00006604|559030094|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
154893005|NCT00006604|559030095|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
154893006|NCT00006604|559030096|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
154893007|NCT00006604|559030097|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
154893008|NCT00006604|559030098|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
154893009|NCT00006604|559030099|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
154893010|NCT00006604|559030083|FG000|Overall Study|Death|0|||
154893011|NCT00006604|559030084|FG001|Overall Study|Death|0|||
154893012|NCT00006604|559030085|FG002|Overall Study|Death|0|||
154893013|NCT00006604|559030086|FG003|Overall Study|Death|0|||
154893014|NCT00006604|559030087|FG004|Overall Study|Death|0|||
154893015|NCT00006604|559030088|FG005|Overall Study|Death|0|||
154893016|NCT00006604|559030089|FG006|Overall Study|Death|0|||
154893017|NCT00006604|559030090|FG007|Overall Study|Death|0|||
154893018|NCT00006604|559030091|FG008|Overall Study|Death|0|||
154893019|NCT00006604|559030092|FG009|Overall Study|Death|1|||
154893020|NCT00006604|559030093|FG010|Overall Study|Death|1|||
154893021|NCT00006604|559030094|FG011|Overall Study|Death|1|||
154893022|NCT00006604|559030095|FG012|Overall Study|Death|0|||
154893023|NCT00006604|559030096|FG013|Overall Study|Death|0|||
154893024|NCT00006604|559030097|FG014|Overall Study|Death|0|||
154893025|NCT00006604|559030098|FG015|Overall Study|Death|0|||
154893026|NCT00006604|559030099|FG016|Overall Study|Death|0|||
154893027|NCT00006604|559030083|FG000|Overall Study|Severe debilitation, unable to continue|0|||
154893028|NCT00006604|559030084|FG001|Overall Study|Severe debilitation, unable to continue|0|||
154893029|NCT00006604|559030085|FG002|Overall Study|Severe debilitation, unable to continue|0|||
154893030|NCT00006604|559030086|FG003|Overall Study|Severe debilitation, unable to continue|0|||
154893031|NCT00006604|559030087|FG004|Overall Study|Severe debilitation, unable to continue|0|||
154893032|NCT00006604|559030088|FG005|Overall Study|Severe debilitation, unable to continue|0|||
154893033|NCT00006604|559030089|FG006|Overall Study|Severe debilitation, unable to continue|3|||
154893034|NCT00006604|559030090|FG007|Overall Study|Severe debilitation, unable to continue|0|||
154978235|NCT01396421|559342806|FG001|Overall Study|Withdrawal by Subject|24|||
155113986|NCT03632993|559846189|FG000|Overall Study|Lost to Follow-up|0|||
155113987|NCT03632993|559846190|FG001|Overall Study|Lost to Follow-up|0|||
154893035|NCT00006604|559030091|FG008|Overall Study|Severe debilitation, unable to continue|0|||
154893036|NCT00006604|559030092|FG009|Overall Study|Severe debilitation, unable to continue|5|||
154893037|NCT00006604|559030093|FG010|Overall Study|Severe debilitation, unable to continue|0|||
154893038|NCT00006604|559030094|FG011|Overall Study|Severe debilitation, unable to continue|2|||
154893039|NCT00006604|559030095|FG012|Overall Study|Severe debilitation, unable to continue|1|||
154893040|NCT00006604|559030096|FG013|Overall Study|Severe debilitation, unable to continue|0|||
154893041|NCT00006604|559030097|FG014|Overall Study|Severe debilitation, unable to continue|2|||
154893042|NCT00006604|559030098|FG015|Overall Study|Severe debilitation, unable to continue|0|||
154978236|NCT01396421|559342807|FG002|Overall Study|Withdrawal by Subject|13|||
154893043|NCT00006604|559030099|FG016|Overall Study|Severe debilitation, unable to continue|0|||
154893044|NCT00006604|559030083|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
154893045|NCT00006604|559030084|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
154893046|NCT00006604|559030085|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
154893047|NCT00006604|559030086|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
154893048|NCT00006604|559030087|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
154893049|NCT00006604|559030088|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
154893050|NCT00006604|559030089|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
154893051|NCT00006604|559030090|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
154893052|NCT00006604|559030091|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
154893053|NCT00006604|559030092|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
154893054|NCT00006604|559030093|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
154893055|NCT00006604|559030094|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
154893056|NCT00006604|559030095|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
154893057|NCT00006604|559030096|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
154893058|NCT00006604|559030097|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
154893059|NCT00006604|559030098|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
154893060|NCT00006604|559030099|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
154893061|NCT00006604|559030083|FG000|Overall Study|Site closing|0|||
154893062|NCT00006604|559030084|FG001|Overall Study|Site closing|0|||
154893063|NCT00006604|559030085|FG002|Overall Study|Site closing|1|||
154893064|NCT00006604|559030086|FG003|Overall Study|Site closing|1|||
154893065|NCT00006604|559030087|FG004|Overall Study|Site closing|0|||
154893066|NCT00006604|559030088|FG005|Overall Study|Site closing|0|||
154893067|NCT00006604|559030089|FG006|Overall Study|Site closing|0|||
154893068|NCT00006604|559030090|FG007|Overall Study|Site closing|1|||
154893069|NCT00006604|559030091|FG008|Overall Study|Site closing|0|||
154893070|NCT00006604|559030092|FG009|Overall Study|Site closing|0|||
154893071|NCT00006604|559030093|FG010|Overall Study|Site closing|0|||
154893072|NCT00006604|559030094|FG011|Overall Study|Site closing|1|||
154893073|NCT00006604|559030095|FG012|Overall Study|Site closing|1|||
154893074|NCT00006604|559030096|FG013|Overall Study|Site closing|1|||
154893075|NCT00006604|559030097|FG014|Overall Study|Site closing|0|||
154893076|NCT00006604|559030098|FG015|Overall Study|Site closing|0|||
154893077|NCT00006604|559030099|FG016|Overall Study|Site closing|1|||
154893078|NCT00006604|559030083|FG000|Overall Study|Withdrawal by Subject|1|||
154893079|NCT00006604|559030084|FG001|Overall Study|Withdrawal by Subject|0|||
154893080|NCT00006604|559030085|FG002|Overall Study|Withdrawal by Subject|2|||
154893081|NCT00006604|559030086|FG003|Overall Study|Withdrawal by Subject|0|||
154893082|NCT00006604|559030087|FG004|Overall Study|Withdrawal by Subject|1|||
154893083|NCT00006604|559030088|FG005|Overall Study|Withdrawal by Subject|2|||
154893084|NCT00006604|559030089|FG006|Overall Study|Withdrawal by Subject|2|||
154893085|NCT00006604|559030090|FG007|Overall Study|Withdrawal by Subject|0|||
154893086|NCT00006604|559030091|FG008|Overall Study|Withdrawal by Subject|1|||
154893087|NCT00006604|559030092|FG009|Overall Study|Withdrawal by Subject|3|||
154893088|NCT00006604|559030093|FG010|Overall Study|Withdrawal by Subject|2|||
154893089|NCT00006604|559030094|FG011|Overall Study|Withdrawal by Subject|0|||
154893090|NCT00006604|559030095|FG012|Overall Study|Withdrawal by Subject|1|||
154893091|NCT00006604|559030096|FG013|Overall Study|Withdrawal by Subject|2|||
154893092|NCT00006604|559030097|FG014|Overall Study|Withdrawal by Subject|1|||
154893093|NCT00006604|559030098|FG015|Overall Study|Withdrawal by Subject|0|||
154893094|NCT00006604|559030099|FG016|Overall Study|Withdrawal by Subject|1|||
154893095|NCT00006604|559030083|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
154893096|NCT00006604|559030084|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
154893097|NCT00006604|559030085|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
154893098|NCT00006604|559030086|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
154893099|NCT00006604|559030087|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
154893100|NCT00006604|559030088|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
154893101|NCT00006604|559030089|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
155113988|NCT03632993|559846191|FG002|Overall Study|Lost to Follow-up|0|||
155113989|NCT03632993|559846192|FG003|Overall Study|Lost to Follow-up|0|||
155113990|NCT03632993|559846193|FG004|Overall Study|Lost to Follow-up|0|||
155113991|NCT03632993|559846194|FG005|Overall Study|Lost to Follow-up|1|||
154893102|NCT00006604|559030090|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
154893103|NCT00006604|559030091|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
155113992|NCT03632993|559846195|FG006|Overall Study|Lost to Follow-up|0|||
155113993|NCT03632993|559846196|FG007|Overall Study|Lost to Follow-up|1|||
154893104|NCT00006604|559030092|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
154893105|NCT00006604|559030093|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
154893106|NCT00006604|559030094|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
154893107|NCT00006604|559030095|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
154978237|NCT01396421|559342808|FG003|Overall Study|Withdrawal by Subject|21|||
154893108|NCT00006604|559030096|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
154893109|NCT00006604|559030097|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
154893110|NCT00006604|559030098|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
154893111|NCT00006604|559030099|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
154893112|NCT00006604|559030083|FG000|Overall Study|Lost to Follow-up|0|||
154893113|NCT00006604|559030084|FG001|Overall Study|Lost to Follow-up|0|||
154893114|NCT00006604|559030085|FG002|Overall Study|Lost to Follow-up|0|||
154893115|NCT00006604|559030086|FG003|Overall Study|Lost to Follow-up|0|||
154893116|NCT00006604|559030087|FG004|Overall Study|Lost to Follow-up|0|||
154893117|NCT00006604|559030088|FG005|Overall Study|Lost to Follow-up|0|||
154893118|NCT00006604|559030089|FG006|Overall Study|Lost to Follow-up|0|||
154893119|NCT00006604|559030090|FG007|Overall Study|Lost to Follow-up|1|||
154893120|NCT00006604|559030091|FG008|Overall Study|Lost to Follow-up|0|||
154893121|NCT00006604|559030092|FG009|Overall Study|Lost to Follow-up|2|||
154893122|NCT00006604|559030093|FG010|Overall Study|Lost to Follow-up|0|||
154893123|NCT00006604|559030094|FG011|Overall Study|Lost to Follow-up|0|||
154893124|NCT00006604|559030095|FG012|Overall Study|Lost to Follow-up|0|||
154893125|NCT00006604|559030096|FG013|Overall Study|Lost to Follow-up|0|||
154893126|NCT00006604|559030097|FG014|Overall Study|Lost to Follow-up|0|||
154893127|NCT00006604|559030098|FG015|Overall Study|Lost to Follow-up|1|||
154893128|NCT00006604|559030099|FG016|Overall Study|Lost to Follow-up|3|||
154893129|NCT00006604|559030083|FG000|Overall Study|Other Reason|0|||
154893130|NCT00006604|559030084|FG001|Overall Study|Other Reason|0|||
154893131|NCT00006604|559030085|FG002|Overall Study|Other Reason|0|||
154893132|NCT00006604|559030086|FG003|Overall Study|Other Reason|0|||
154893133|NCT00006604|559030087|FG004|Overall Study|Other Reason|0|||
154893134|NCT00006604|559030088|FG005|Overall Study|Other Reason|1|||
154893135|NCT00006604|559030089|FG006|Overall Study|Other Reason|0|||
154893136|NCT00006604|559030090|FG007|Overall Study|Other Reason|0|||
154893137|NCT00006604|559030091|FG008|Overall Study|Other Reason|0|||
154893138|NCT00006604|559030092|FG009|Overall Study|Other Reason|1|||
154893139|NCT00006604|559030093|FG010|Overall Study|Other Reason|0|||
154893140|NCT00006604|559030094|FG011|Overall Study|Other Reason|0|||
154893141|NCT00006604|559030095|FG012|Overall Study|Other Reason|0|||
154893142|NCT00006604|559030096|FG013|Overall Study|Other Reason|0|||
154893143|NCT00006604|559030097|FG014|Overall Study|Other Reason|0|||
154893144|NCT00006604|559030098|FG015|Overall Study|Other Reason|0|||
154893145|NCT00006604|559030099|FG016|Overall Study|Other Reason|0|||
154893146|NCT03454412|559030100|FG000|Baseline Assesment|Physician Decision|12|||
154893147|NCT01167582|559030101|FG000|Overall Study|Lost to Follow-up|0|||
154893148|NCT01167582|559030102|FG001|Overall Study|Lost to Follow-up|1|||
154893149|NCT01928485|559030103|FG000|Overall Study|Physician Decision|0|||
154893150|NCT01928485|559030104|FG001|Overall Study|Physician Decision|1|||
154893151|NCT00946881|559030107|FG000|First Treatment|Withdrawal by Subject|1|||
154893152|NCT00946881|559030107|FG000|First Treatment|Patient relocated to another state|1|||
154893153|NCT00946881|559030107|FG000|Retreatment|Withdrawal by Subject|1|||
154893154|NCT00293423|559030108|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
154893155|NCT00293423|559030109|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
154893156|NCT00293423|559030108|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
154893157|NCT00293423|559030109|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
154893158|NCT00293423|559030108|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
154893159|NCT00293423|559030109|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
154893160|NCT00293423|559030108|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
154893161|NCT00293423|559030109|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
154893162|NCT00293423|559030108|FG000|Surgical Resection|processing error during surgical resection|1|||
154893163|NCT00293423|559030109|FG001|Surgical Resection|processing error during surgical resection|0|||
154893164|NCT00293423|559030108|FG000|Surgical Resection|Withdrawal by Subject|4|||
154893165|NCT00293423|559030109|FG001|Surgical Resection|Withdrawal by Subject|0|||
154893166|NCT00293423|559030108|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
154893167|NCT00293423|559030109|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
154893168|NCT01182337|559030112|FG000|Overall Study|Withdrawal by Subject|3|||
155175620|NCT00958438|560080286|FG000|Overall Study|Other than specified above|2|||
154893169|NCT01182337|559030113|FG001|Overall Study|Withdrawal by Subject|1|||
154893170|NCT01182337|559030112|FG000|Overall Study|Lost to Follow-up|0|||
154893171|NCT01182337|559030113|FG001|Overall Study|Lost to Follow-up|1|||
154893172|NCT01714817|559030117|FG000|Year 1 Period|Lack of Efficacy|11|||
154893173|NCT01714817|559030118|FG001|Year 1 Period|Lack of Efficacy|9|||
154893174|NCT01714817|559030117|FG000|Year 1 Period|Adverse Event|20|||
154893175|NCT01714817|559030118|FG001|Year 1 Period|Adverse Event|17|||
154893176|NCT01714817|559030117|FG000|Year 1 Period|Withdrawal by Subject|6|||
154893177|NCT01714817|559030118|FG001|Year 1 Period|Withdrawal by Subject|7|||
154893178|NCT01714817|559030117|FG000|Year 1 Period|Death|1|||
154893179|NCT01714817|559030118|FG001|Year 1 Period|Death|1|||
154893180|NCT01714817|559030117|FG000|Year 1 Period|Lost to Follow-up|0|||
154893181|NCT01714817|559030118|FG001|Year 1 Period|Lost to Follow-up|2|||
154893182|NCT01714817|559030117|FG000|Year 1 Period|Poor / non-compliance|0|||
154893183|NCT01714817|559030118|FG001|Year 1 Period|Poor / non-compliance|1|||
154893184|NCT01714817|559030117|FG000|Year 1 Period|Pregnancy|2|||
154893185|NCT01714817|559030118|FG001|Year 1 Period|Pregnancy|0|||
154893186|NCT01714817|559030117|FG000|Year 1 Period|Participant no longer meets criteria|6|||
154893187|NCT01714817|559030118|FG001|Year 1 Period|Participant no longer meets criteria|2|||
154893188|NCT01714817|559030117|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
154893189|NCT01714817|559030118|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
154893190|NCT01714817|559030117|FG000|Year 1 Period|Change in Concomitant Medication|0|||
154893191|NCT01714817|559030118|FG001|Year 1 Period|Change in Concomitant Medication|1|||
154893192|NCT01714817|559030117|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
154893193|NCT01714817|559030118|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
154893194|NCT01714817|559030117|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
154893195|NCT01714817|559030118|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
154893196|NCT01714817|559030117|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
154893197|NCT01714817|559030118|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
154893198|NCT01714817|559030117|FG000|Year 2 Period|Lack of Efficacy|4|||
154893199|NCT01714817|559030118|FG001|Year 2 Period|Lack of Efficacy|12|||
154893200|NCT01714817|559030117|FG000|Year 2 Period|Adverse Event|7|||
154893201|NCT01714817|559030118|FG001|Year 2 Period|Adverse Event|6|||
154893202|NCT01714817|559030117|FG000|Year 2 Period|Participant request to stop treatment|4|||
154893203|NCT01714817|559030118|FG001|Year 2 Period|Participant request to stop treatment|4|||
154893204|NCT01714817|559030117|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
154893205|NCT01714817|559030118|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
154893206|NCT01714817|559030117|FG000|Year 2 Period|Participant withdrew consent|1|||
154893207|NCT01714817|559030118|FG001|Year 2 Period|Participant withdrew consent|5|||
154893208|NCT01714817|559030117|FG000|Year 2 Period|Participant no longer meets criteria|1|||
154893209|NCT01714817|559030118|FG001|Year 2 Period|Participant no longer meets criteria|4|||
154893210|NCT01714817|559030117|FG000|Year 2 Period|Lost to Follow-up|2|||
154893211|NCT01714817|559030118|FG001|Year 2 Period|Lost to Follow-up|0|||
154893212|NCT01714817|559030117|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
154893213|NCT01714817|559030118|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
154893214|NCT01714817|559030117|FG000|Year 2 Period|Pregnancy|1|||
154893215|NCT01714817|559030118|FG001|Year 2 Period|Pregnancy|1|||
154893216|NCT01714817|559030117|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
154893217|NCT01714817|559030118|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
154893218|NCT01714817|559030117|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
154893219|NCT01714817|559030118|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
154893220|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
154893221|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
154893222|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
154893223|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
154893224|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
154893225|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
154893226|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
154893227|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
154893228|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
154893229|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
154893230|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
154893231|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
154893232|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
154893233|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
154893234|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
154893235|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
154893236|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
154893237|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
154893238|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
154893239|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
154893240|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
154893241|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
154893242|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
154893243|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
154893244|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
154893245|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
154893246|NCT01714817|559030117|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
154893247|NCT01714817|559030118|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
155113994|NCT03632993|559846197|FG008|Overall Study|Lost to Follow-up|0|||
154893248|NCT04169061|559030121|FG000|Overall Study|Adverse Event|2|||
154893249|NCT04169061|559030121|FG000|Overall Study|Death|1|||
154893250|NCT04169061|559030121|FG000|Overall Study|Withdrawal by Subject|1|||
154893251|NCT04169061|559030121|FG000|Overall Study|Protocol Violation|1|||
154893252|NCT02555657|559030122|FG000|Overall Study|Death|274|||
154893253|NCT02555657|559030123|FG001|Overall Study|Death|262|||
154893254|NCT02555657|559030122|FG000|Overall Study|Physician Decision|0|||
154893255|NCT02555657|559030123|FG001|Overall Study|Physician Decision|1|||
154893256|NCT02555657|559030122|FG000|Overall Study|Sponsor Decision|27|||
154893257|NCT02555657|559030123|FG001|Overall Study|Sponsor Decision|15|||
154893258|NCT02555657|559030122|FG000|Overall Study|Withdrawal by Subject|11|||
154893259|NCT02555657|559030123|FG001|Overall Study|Withdrawal by Subject|32|||
154893260|NCT02807363|559030124|FG000|Dosing Period|Adverse Event|0|||
154893261|NCT02807363|559030125|FG001|Dosing Period|Adverse Event|1|||
154893262|NCT02807363|559030126|FG002|Dosing Period|Adverse Event|0|||
154893263|NCT02807363|559030127|FG003|Dosing Period|Adverse Event|0|||
154893264|NCT02188719|559030129|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
154893265|NCT02188719|559030130|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
154893266|NCT02188719|559030131|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
154893267|NCT02188719|559030132|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
154893268|NCT01578785|559030135|FG000|Overall Study|Withdrawal by Subject|0|||
154893269|NCT01578785|559030136|FG001|Overall Study|Withdrawal by Subject|1|||
154893270|NCT01578785|559030135|FG000|Overall Study|Study terminated by sponsor|59|||
154893271|NCT01578785|559030136|FG001|Overall Study|Study terminated by sponsor|118|||
154893272|NCT00192036|559030137|FG000|Overall Study|Protocol Violation|3|||
154893273|NCT00192036|559030137|FG000|Overall Study|Adverse Event|6|||
154893274|NCT00192036|559030137|FG000|Overall Study|Patient/Physician Perception|1|||
154893275|NCT00192036|559030137|FG000|Overall Study|Objective Tumor Progression|4|||
154893276|NCT00192036|559030137|FG000|Overall Study|Clinical Disease Progression|1|||
154893277|NCT00192036|559030137|FG000|Overall Study|Death|1|||
154893278|NCT00192036|559030137|FG000|Overall Study|Unknown or Not Specified|5|||
154893279|NCT03371732|559030138|FG000|Overall Study|Withdrawal by Subject|9|||
154893280|NCT03371732|559030139|FG001|Overall Study|Withdrawal by Subject|3|||
154893281|NCT03371732|559030138|FG000|Overall Study|Refusal to continue|3|||
154893282|NCT03371732|559030139|FG001|Overall Study|Refusal to continue|4|||
154893283|NCT02581982|559030140|FG000|Overall Study|Lack of Efficacy|12|||
154893284|NCT02581982|559030140|FG000|Overall Study|Adverse Event|3|||
154893285|NCT02581982|559030140|FG000|Overall Study|Physician Decision|1|||
154893286|NCT00599027|559030141|FG000|Overall Study|Withdrawal by Subject|1|||
154893287|NCT00599027|559030142|FG001|Overall Study|Withdrawal by Subject|1|||
154893288|NCT00599027|559030141|FG000|Overall Study|Adverse Event|0|||
154893289|NCT00599027|559030142|FG001|Overall Study|Adverse Event|1|||
154893290|NCT00599027|559030141|FG000|Overall Study|Treatment Failure|0|||
154893291|NCT00599027|559030142|FG001|Overall Study|Treatment Failure|1|||
154893292|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
154893293|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
154893294|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
154893295|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
154893296|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
154893297|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
154893298|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
154893299|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
154893300|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
154893301|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
154893302|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
154893303|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
154893304|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
154893305|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
154893306|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
154893307|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
154893308|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
154893309|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
154893310|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
154893311|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
154893312|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
154893313|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
154893314|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
154893315|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
154893316|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
154893317|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
154893318|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
154893319|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
154893320|NCT00476996|559030147|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
154893321|NCT00476996|559030148|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
154893322|NCT00476996|559030149|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
154893323|NCT00476996|559030150|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
154893324|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
154893325|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
154893326|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
154893327|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
154893328|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
154893329|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
154893330|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
154893331|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
154893332|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Death|0|||
154893333|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Death|0|||
154893334|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Death|0|||
154893335|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Death|7|||
154893336|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
154893337|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
154893338|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
154893339|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
154893340|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
154893341|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
154893342|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
154893343|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
154893344|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
154893345|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
154893346|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
154893347|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
154893348|NCT00476996|559030147|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
154893349|NCT00476996|559030148|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
154893350|NCT00476996|559030149|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
154893351|NCT00476996|559030150|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
154893352|NCT02133742|559030180|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
154893353|NCT02133742|559030180|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
154893354|NCT02133742|559030180|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
154893355|NCT02133742|559030180|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
154893356|NCT02133742|559030180|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
154893357|NCT03479216|559030181|FG000|Overall Study|Withdrawal by Subject|3|||
154893358|NCT03479216|559030182|FG001|Overall Study|Withdrawal by Subject|2|||
154893359|NCT03479216|559030181|FG000|Overall Study|Physician Decision|2|||
154893360|NCT03479216|559030182|FG001|Overall Study|Physician Decision|3|||
154893361|NCT05406440|559032013|FG000|Overall Study|Lost to Follow-up|0|||
154893362|NCT05406440|559032014|FG001|Overall Study|Lost to Follow-up|0|||
154893363|NCT05406440|559032015|FG002|Overall Study|Lost to Follow-up|0|||
154893364|NCT05406440|559032016|FG003|Overall Study|Lost to Follow-up|0|||
154893365|NCT05406440|559032017|FG004|Overall Study|Lost to Follow-up|2|||
154893366|NCT05406440|559032018|FG005|Overall Study|Lost to Follow-up|0|||
154893367|NCT05406440|559032019|FG006|Overall Study|Lost to Follow-up|0|||
154893368|NCT05406440|559032013|FG000|Overall Study|Physician Decision|0|||
154893369|NCT05406440|559032014|FG001|Overall Study|Physician Decision|0|||
154893370|NCT05406440|559032015|FG002|Overall Study|Physician Decision|0|||
154893371|NCT05406440|559032016|FG003|Overall Study|Physician Decision|0|||
154893372|NCT05406440|559032017|FG004|Overall Study|Physician Decision|1|||
154893373|NCT05406440|559032018|FG005|Overall Study|Physician Decision|0|||
154893374|NCT05406440|559032019|FG006|Overall Study|Physician Decision|0|||
154893375|NCT05406440|559032013|FG000|Overall Study|Withdrawal by Subject|0|||
154893376|NCT05406440|559032014|FG001|Overall Study|Withdrawal by Subject|0|||
154893377|NCT05406440|559032015|FG002|Overall Study|Withdrawal by Subject|0|||
154893378|NCT05406440|559032016|FG003|Overall Study|Withdrawal by Subject|0|||
154893379|NCT05406440|559032017|FG004|Overall Study|Withdrawal by Subject|0|||
154978238|NCT01396421|559342805|FG000|Overall Study|Protocol Deviation|2|||
154978239|NCT01396421|559342806|FG001|Overall Study|Protocol Deviation|1|||
154978240|NCT01396421|559342807|FG002|Overall Study|Protocol Deviation|1|||
154893380|NCT05406440|559032018|FG005|Overall Study|Withdrawal by Subject|2|||
154893381|NCT05406440|559032019|FG006|Overall Study|Withdrawal by Subject|0|||
154978241|NCT01396421|559342808|FG003|Overall Study|Protocol Deviation|0|||
155113995|NCT03632993|559846198|FG009|Overall Study|Lost to Follow-up|0|||
154893382|NCT01412151|559032020|FG000|Week 0 - 306 - Treatment Period|Death|1|||
154893383|NCT01412151|559032020|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
154893384|NCT01412151|559032020|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
154893385|NCT01412151|559032020|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
154978242|NCT01396421|559342805|FG000|Overall Study|Lack of Efficacy|7|||
154893386|NCT03127852|559032021|FG000|Overall Study|Withdrawal by Subject|4|||
154893387|NCT03127852|559032022|FG001|Overall Study|Withdrawal by Subject|1|||
154893388|NCT03127852|559032021|FG000|Overall Study|Death|1|||
154893389|NCT03127852|559032022|FG001|Overall Study|Death|1|||
154893390|NCT01824693|559032023|FG000|Overall Study|Death|0|||
154893391|NCT01824693|559032024|FG001|Overall Study|Death|1|||
154893392|NCT01824693|559032025|FG002|Overall Study|Death|0|||
154893393|NCT01824693|559032023|FG000|Overall Study|Physician Decision|1|||
154893394|NCT01824693|559032024|FG001|Overall Study|Physician Decision|1|||
154893395|NCT01824693|559032025|FG002|Overall Study|Physician Decision|1|||
154893396|NCT01824693|559032023|FG000|Overall Study|Withdrawal by Subject|0|||
154893397|NCT01824693|559032024|FG001|Overall Study|Withdrawal by Subject|0|||
154893398|NCT01824693|559032025|FG002|Overall Study|Withdrawal by Subject|1|||
154893399|NCT01824693|559032023|FG000|Overall Study|Progressive Disease|0|||
154893400|NCT01824693|559032024|FG001|Overall Study|Progressive Disease|5|||
154893401|NCT01824693|559032025|FG002|Overall Study|Progressive Disease|0|||
154893402|NCT01824693|559032023|FG000|Overall Study|Ineligible|0|||
154893403|NCT01824693|559032024|FG001|Overall Study|Ineligible|0|||
154893404|NCT01824693|559032025|FG002|Overall Study|Ineligible|3|||
154893405|NCT01824693|559032023|FG000|Overall Study|No Transplant Planned|0|||
154893406|NCT01824693|559032024|FG001|Overall Study|No Transplant Planned|0|||
154893407|NCT01824693|559032025|FG002|Overall Study|No Transplant Planned|10|||
154893408|NCT02150213|559032026|FG000|Overall Study|Lost to Follow-up|1|||
154893409|NCT02150213|559032026|FG000|Overall Study|Withdrawal by Subject|1|||
154893410|NCT01175590|559032027|FG000|Overall Study|Lost to Follow-up|1|||
154893411|NCT01175590|559032028|FG001|Overall Study|Lost to Follow-up|0|||
154893412|NCT01175590|559032027|FG000|Overall Study|Withdrawal by Subject|0|||
154893413|NCT01175590|559032028|FG001|Overall Study|Withdrawal by Subject|2|||
154893414|NCT01175590|559032027|FG000|Overall Study|Adverse Event|4|||
154893415|NCT01175590|559032028|FG001|Overall Study|Adverse Event|0|||
154893416|NCT01175590|559032027|FG000|Overall Study|Physician Decision|1|||
154893417|NCT01175590|559032028|FG001|Overall Study|Physician Decision|4|||
154893418|NCT01175590|559032027|FG000|Overall Study|Lack of Efficacy|1|||
154893419|NCT01175590|559032028|FG001|Overall Study|Lack of Efficacy|1|||
154893420|NCT01175590|559032027|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
154893421|NCT01175590|559032028|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
154893422|NCT01175590|559032027|FG000|Overall Study|Treated not as randomized|3|||
154893423|NCT01175590|559032028|FG001|Overall Study|Treated not as randomized|2|||
154893424|NCT01175590|559032027|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
154893425|NCT01175590|559032028|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
154893426|NCT01175590|559032027|FG000|Overall Study|Protocol Violation|0|||
154893427|NCT01175590|559032028|FG001|Overall Study|Protocol Violation|1|||
154893428|NCT01090102|559032029|FG000|First 12 Weeks|Withdrawal by Subject|1|||
154893429|NCT01090102|559032030|FG001|First 12 Weeks|Withdrawal by Subject|1|||
154893430|NCT01090102|559032029|FG000|First 12 Weeks|Adverse Event|2|||
154893431|NCT01090102|559032030|FG001|First 12 Weeks|Adverse Event|0|||
154893432|NCT01090102|559032029|FG000|First 12 Weeks|Death|1|||
154893433|NCT01090102|559032030|FG001|First 12 Weeks|Death|1|||
154893434|NCT01090102|559032029|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
154893435|NCT01090102|559032030|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
154893436|NCT01019252|559032031|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
154893437|NCT01019252|559032032|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
154893438|NCT01019252|559032031|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
154893439|NCT01019252|559032032|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
154893440|NCT01019252|559032031|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
154893441|NCT01019252|559032032|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
154893442|NCT01019252|559032031|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
154893443|NCT01019252|559032032|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
154893444|NCT02062398|559032034|FG000|Overall Study|Implant removal|1|||
154893445|NCT02227849|559032039|FG000|Overall Study|Adverse Event|4|||
154893446|NCT02227849|559032039|FG000|Overall Study|Physician Decision|1|||
154893447|NCT02227849|559032039|FG000|Overall Study|Withdrawal by Subject|3|||
154893448|NCT00762268|559032041|FG000|Overall Study|Withdrawal by Subject|3|||
154893449|NCT00762268|559032042|FG001|Overall Study|Withdrawal by Subject|3|||
154893450|NCT03004976|559032043|FG000|Overall Study|Lost to Follow-up|7|||
154893451|NCT03004976|559032044|FG001|Overall Study|Lost to Follow-up|5|||
154893452|NCT03004976|559032043|FG000|Overall Study|Physician Decision|1|||
154893453|NCT03004976|559032044|FG001|Overall Study|Physician Decision|0|||
154893454|NCT03004976|559032043|FG000|Overall Study|Withdrawal by Subject|1|||
154893455|NCT03004976|559032044|FG001|Overall Study|Withdrawal by Subject|0|||
154893456|NCT03004976|559032043|FG000|Overall Study|Death|4|||
154893457|NCT03004976|559032044|FG001|Overall Study|Death|1|||
154893458|NCT01106391|559032045|FG000|Overall Study|Death|12|||
154893459|NCT01106391|559032045|FG000|Overall Study|Withdrawal by Subject|7|||
154893460|NCT04190186|559032046|FG000|Overall Study|ILR is no longer functioning|0|||
154893461|NCT04190186|559032047|FG001|Overall Study|ILR is no longer functioning|1|||
154893462|NCT04190186|559032046|FG000|Overall Study|Lost to Follow-up|0|||
154893463|NCT04190186|559032047|FG001|Overall Study|Lost to Follow-up|1|||
154893464|NCT04190186|559032046|FG000|Overall Study|Withdrawal by Subject|2|||
154893465|NCT04190186|559032047|FG001|Overall Study|Withdrawal by Subject|0|||
154893466|NCT04190186|559032046|FG000|Overall Study|Subject choice to explant|1|||
154893467|NCT04190186|559032047|FG001|Overall Study|Subject choice to explant|0|||
154893468|NCT04190186|559032046|FG000|Overall Study|Physician Decision|0|||
154893469|NCT04190186|559032047|FG001|Overall Study|Physician Decision|1|||
154893470|NCT04190186|559032046|FG000|Overall Study|Study was stopped|4|||
154893471|NCT04190186|559032047|FG001|Overall Study|Study was stopped|5|||
154893472|NCT02141217|559032048|FG000|Overall Study|Adverse Event|1|||
154893473|NCT02141217|559032049|FG001|Overall Study|Adverse Event|2|||
154893474|NCT02141217|559032048|FG000|Overall Study|Protocol Violation|1|||
154893475|NCT02141217|559032049|FG001|Overall Study|Protocol Violation|4|||
154893476|NCT02141217|559032048|FG000|Overall Study|Withdrawal by Subject|6|||
154893477|NCT02141217|559032049|FG001|Overall Study|Withdrawal by Subject|0|||
154893478|NCT02141217|559032048|FG000|Overall Study|Lost to Follow-up|1|||
154893479|NCT02141217|559032049|FG001|Overall Study|Lost to Follow-up|1|||
154893480|NCT02141217|559032048|FG000|Overall Study|Physician Decision|1|||
154893481|NCT02141217|559032049|FG001|Overall Study|Physician Decision|0|||
154893482|NCT02141217|559032048|FG000|Overall Study|Surgical Intervention|1|||
154893483|NCT02141217|559032049|FG001|Overall Study|Surgical Intervention|1|||
154893484|NCT02505542|559032050|FG000|Part A: Open-Label Period|Adverse Event|31|||
154893485|NCT02505542|559032051|FG001|Part A: Open-Label Period|Adverse Event|0|||
154893486|NCT02505542|559032052|FG002|Part A: Open-Label Period|Adverse Event|0|||
154893487|NCT02505542|559032053|FG003|Part A: Open-Label Period|Adverse Event|0|||
154893488|NCT02505542|559032050|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
154893489|NCT02505542|559032051|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
154893490|NCT02505542|559032052|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
154893491|NCT02505542|559032053|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
154893492|NCT02505542|559032050|FG000|Part A: Open-Label Period|Protocol Violation|1|||
154893493|NCT02505542|559032051|FG001|Part A: Open-Label Period|Protocol Violation|0|||
154893494|NCT02505542|559032052|FG002|Part A: Open-Label Period|Protocol Violation|0|||
154893495|NCT02505542|559032053|FG003|Part A: Open-Label Period|Protocol Violation|0|||
154893496|NCT02505542|559032050|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
154893497|NCT02505542|559032051|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
154893498|NCT02505542|559032052|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
154893499|NCT02505542|559032053|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
154893500|NCT02505542|559032050|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
154893501|NCT02505542|559032051|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
154893502|NCT02505542|559032052|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
154893503|NCT02505542|559032053|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
154893504|NCT02505542|559032050|FG000|Part A: Open-Label Period|New medical history available|1|||
154893505|NCT02505542|559032051|FG001|Part A: Open-Label Period|New medical history available|0|||
154893506|NCT02505542|559032052|FG002|Part A: Open-Label Period|New medical history available|0|||
154893507|NCT02505542|559032053|FG003|Part A: Open-Label Period|New medical history available|0|||
154893508|NCT02505542|559032050|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
154893509|NCT02505542|559032051|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
154893510|NCT02505542|559032052|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
154893511|NCT02505542|559032053|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
154893512|NCT02505542|559032050|FG000|Part A: Open-Label Period|Pregnancy|2|||
154893513|NCT02505542|559032051|FG001|Part A: Open-Label Period|Pregnancy|0|||
154893514|NCT02505542|559032052|FG002|Part A: Open-Label Period|Pregnancy|0|||
154893515|NCT02505542|559032053|FG003|Part A: Open-Label Period|Pregnancy|0|||
155113996|NCT03632993|559846189|FG000|Overall Study|Adverse Event|0|||
155113997|NCT03632993|559846190|FG001|Overall Study|Adverse Event|0|||
155113998|NCT03632993|559846191|FG002|Overall Study|Adverse Event|0|||
155113999|NCT03632993|559846192|FG003|Overall Study|Adverse Event|0|||
154893516|NCT02505542|559032050|FG000|Part A: Open-Label Period|Sponsor directive|1|||
154893517|NCT02505542|559032051|FG001|Part A: Open-Label Period|Sponsor directive|0|||
155114000|NCT03632993|559846193|FG004|Overall Study|Adverse Event|0|||
154893518|NCT02505542|559032052|FG002|Part A: Open-Label Period|Sponsor directive|0|||
154893519|NCT02505542|559032053|FG003|Part A: Open-Label Period|Sponsor directive|0|||
154893520|NCT02505542|559032050|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
155114001|NCT03632993|559846194|FG005|Overall Study|Adverse Event|1|||
154893521|NCT02505542|559032051|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
154893522|NCT02505542|559032052|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
155114002|NCT03632993|559846195|FG006|Overall Study|Adverse Event|0|||
155114003|NCT03632993|559846196|FG007|Overall Study|Adverse Event|1|||
155114004|NCT03632993|559846197|FG008|Overall Study|Adverse Event|0|||
154893523|NCT02505542|559032053|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
154893524|NCT02505542|559032050|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
155114005|NCT03632993|559846198|FG009|Overall Study|Adverse Event|0|||
155114006|NCT03389555|559846199|FG000|Overall Study|Protocol Violation|1|||
155114007|NCT03389555|559846200|FG001|Overall Study|Protocol Violation|3|||
154893525|NCT02505542|559032051|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
154893526|NCT02505542|559032052|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
154893527|NCT02505542|559032053|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
154893528|NCT02505542|559032050|FG000|Part A: Open-Label Period|Non-compliance|1|||
154893529|NCT02505542|559032051|FG001|Part A: Open-Label Period|Non-compliance|0|||
154893530|NCT02505542|559032052|FG002|Part A: Open-Label Period|Non-compliance|0|||
154893531|NCT02505542|559032053|FG003|Part A: Open-Label Period|Non-compliance|0|||
154893532|NCT02505542|559032050|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
154893533|NCT02505542|559032051|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
154893534|NCT02505542|559032052|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
154893535|NCT02505542|559032053|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
154893536|NCT02505542|559032050|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
154893537|NCT02505542|559032051|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
154893538|NCT02505542|559032052|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
154893539|NCT02505542|559032053|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
154893540|NCT02505542|559032050|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
154893541|NCT02505542|559032051|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
154893542|NCT02505542|559032052|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
154893543|NCT02505542|559032053|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
154893544|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Adverse Event|0|||
154893545|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Adverse Event|0|||
154893546|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Adverse Event|1|||
154893547|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Adverse Event|3|||
154893548|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
154893549|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
154893550|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
154893551|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
154893552|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
154893553|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
154893554|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
154893555|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
154893556|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
154893557|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
154893558|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
154893559|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
154893560|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
154893561|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
154893562|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
154893563|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
154893564|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
154893565|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
154893566|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
154893567|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
154893568|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
154893569|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
154893570|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
154893571|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
154893572|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Miscalculation|0|||
154893573|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Miscalculation|1|||
154893574|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Miscalculation|0|||
154893575|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Miscalculation|0|||
154893576|NCT02505542|559032050|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
154893577|NCT02505542|559032051|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
154893578|NCT02505542|559032052|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
154893579|NCT02505542|559032053|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
154893580|NCT00555568|559032054|FG000|Overall Study|Lost to Follow-up|26|||
154893581|NCT00555568|559032055|FG001|Overall Study|Lost to Follow-up|16|||
154893582|NCT00555568|559032056|FG002|Overall Study|Lost to Follow-up|16|||
154893583|NCT01588353|559032057|FG000|Step2|Withdrawal by Subject|0|||
154893584|NCT01588353|559032058|FG001|Step2|Withdrawal by Subject|1|||
154893585|NCT01588353|559032059|FG002|Step2|Withdrawal by Subject|0|||
154893586|NCT01588353|559032057|FG000|Step3|Adverse Event|0|||
154893587|NCT01588353|559032058|FG001|Step3|Adverse Event|0|||
154978243|NCT01396421|559342806|FG001|Overall Study|Lack of Efficacy|17|||
154893588|NCT01588353|559032059|FG002|Step3|Adverse Event|2|||
154893589|NCT00493467|559032060|FG000|Overall Study|Death|1|||
154893590|NCT01409993|559032061|FG000|Overall Study|Adverse Event|4|||
154893591|NCT01409993|559032062|FG001|Overall Study|Adverse Event|4|||
154893592|NCT01409993|559032063|FG002|Overall Study|Adverse Event|3|||
154893593|NCT01409993|559032064|FG003|Overall Study|Adverse Event|1|||
154893594|NCT01409993|559032061|FG000|Overall Study|Withdrawal by Subject|0|||
154893595|NCT01409993|559032062|FG001|Overall Study|Withdrawal by Subject|0|||
154893596|NCT01409993|559032063|FG002|Overall Study|Withdrawal by Subject|0|||
154893597|NCT01409993|559032064|FG003|Overall Study|Withdrawal by Subject|4|||
154893598|NCT01409993|559032061|FG000|Overall Study|Lost to Follow-up|0|||
154893599|NCT01409993|559032062|FG001|Overall Study|Lost to Follow-up|1|||
154893600|NCT01409993|559032063|FG002|Overall Study|Lost to Follow-up|0|||
154893601|NCT01409993|559032064|FG003|Overall Study|Lost to Follow-up|0|||
154893602|NCT01504971|559032066|FG000|Overall Study|Physician Decision|13|||
154893603|NCT00050622|559032067|FG000|Overall Study|Adverse Event|1|||
154893604|NCT00936117|559032070|FG000|Overall Study|Adverse Event|7|||
154893605|NCT00936117|559032070|FG000|Overall Study|Unable to continue oral medication|3|||
154893606|NCT01342952|559032071|FG000|Overall Study|Adverse Event|0|||
154893607|NCT01342952|559032072|FG001|Overall Study|Adverse Event|5|||
154893608|NCT01342952|559032073|FG002|Overall Study|Adverse Event|1|||
154893609|NCT01342952|559032074|FG003|Overall Study|Adverse Event|0|||
154893610|NCT01342952|559032071|FG000|Overall Study|Lost to Follow-up|0|||
154893611|NCT01342952|559032072|FG001|Overall Study|Lost to Follow-up|2|||
154893612|NCT01342952|559032073|FG002|Overall Study|Lost to Follow-up|0|||
154893613|NCT01342952|559032074|FG003|Overall Study|Lost to Follow-up|0|||
154893614|NCT01342952|559032071|FG000|Overall Study|Withdrawal by Subject|1|||
154893615|NCT01342952|559032072|FG001|Overall Study|Withdrawal by Subject|1|||
154893616|NCT01342952|559032073|FG002|Overall Study|Withdrawal by Subject|0|||
154893617|NCT01342952|559032074|FG003|Overall Study|Withdrawal by Subject|0|||
154893618|NCT01342952|559032071|FG000|Overall Study|Physician Decision|3|||
154893619|NCT01342952|559032072|FG001|Overall Study|Physician Decision|3|||
154893620|NCT01342952|559032073|FG002|Overall Study|Physician Decision|1|||
154893621|NCT01342952|559032074|FG003|Overall Study|Physician Decision|0|||
154893622|NCT04581863|559032075|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
154893623|NCT04581863|559032076|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
154893624|NCT01357889|559032080|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
154893625|NCT01357889|559032081|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
154893626|NCT01357889|559032080|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
154893627|NCT01357889|559032081|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
154893628|NCT01357889|559032080|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
154893629|NCT01357889|559032081|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
154893630|NCT01357889|559032080|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
154893631|NCT01357889|559032081|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
154893632|NCT01357889|559032080|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
154893633|NCT01357889|559032081|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
154893634|NCT01357889|559032080|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
154893635|NCT01357889|559032081|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
154893636|NCT01357889|559032080|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
154893637|NCT01357889|559032081|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
154893638|NCT01357889|559032080|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
154893639|NCT01357889|559032081|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
154893640|NCT01357889|559032080|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
154893641|NCT01357889|559032081|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
154893642|NCT01357889|559032080|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
154893643|NCT01357889|559032081|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
154893644|NCT01357889|559032080|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
154893645|NCT01357889|559032081|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
154893646|NCT01357889|559032080|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
154893647|NCT01357889|559032081|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
154893648|NCT01357889|559032080|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
154893649|NCT01357889|559032081|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
154893650|NCT02693691|559032082|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
154893651|NCT02693691|559032082|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
154893652|NCT02693691|559032082|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
154893653|NCT02693691|559032082|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
154893654|NCT02693691|559032082|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
154893655|NCT02693691|559032082|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
154893656|NCT02693691|559032082|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
154893657|NCT00416312|559032084|FG000|Overall Study|tumors not visible on imaging|2|||
154893658|NCT02727660|559032085|FG000|Overall Study|Lack of Efficacy|40|||
154893659|NCT02727660|559032086|FG001|Overall Study|Lack of Efficacy|40|||
154893660|NCT02727660|559032087|FG002|Overall Study|Lack of Efficacy|70|||
154893661|NCT02727660|559032085|FG000|Overall Study|Adverse Event|28|||
154893662|NCT02727660|559032086|FG001|Overall Study|Adverse Event|21|||
154893663|NCT02727660|559032087|FG002|Overall Study|Adverse Event|32|||
154893664|NCT02727660|559032085|FG000|Overall Study|Withdrawal by Subject|26|||
154893665|NCT02727660|559032086|FG001|Overall Study|Withdrawal by Subject|25|||
154893666|NCT02727660|559032087|FG002|Overall Study|Withdrawal by Subject|30|||
154893667|NCT02727660|559032085|FG000|Overall Study|Physician Decision|3|||
154893668|NCT02727660|559032086|FG001|Overall Study|Physician Decision|8|||
154893669|NCT02727660|559032087|FG002|Overall Study|Physician Decision|14|||
154893670|NCT02727660|559032085|FG000|Overall Study|Lost to Follow-up|5|||
154893671|NCT02727660|559032086|FG001|Overall Study|Lost to Follow-up|9|||
154893672|NCT02727660|559032087|FG002|Overall Study|Lost to Follow-up|8|||
154893673|NCT02727660|559032085|FG000|Overall Study|Protocol Violation|7|||
154893674|NCT02727660|559032086|FG001|Overall Study|Protocol Violation|5|||
154893675|NCT02727660|559032087|FG002|Overall Study|Protocol Violation|5|||
154893676|NCT02727660|559032085|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
154893677|NCT02727660|559032086|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
154893678|NCT02727660|559032087|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
154893679|NCT02727660|559032085|FG000|Overall Study|Administrative Reasons|2|||
154893680|NCT02727660|559032086|FG001|Overall Study|Administrative Reasons|3|||
154893681|NCT02727660|559032087|FG002|Overall Study|Administrative Reasons|4|||
154893682|NCT01192204|559032090|FG000|Overall Study|could not keep recall appointments|1|||
154893683|NCT01192204|559032091|FG001|Overall Study|could not keep recall appointments|0|||
154893684|NCT03571256|559032092|FG000|Overall Study|Adverse Event|3|||
154893685|NCT03571256|559032093|FG001|Overall Study|Adverse Event|0|||
154893686|NCT03571256|559032094|FG002|Overall Study|Adverse Event|1|||
154893687|NCT03571256|559032092|FG000|Overall Study|Withdrawal by Subject|3|||
154893688|NCT03571256|559032093|FG001|Overall Study|Withdrawal by Subject|1|||
154893689|NCT03571256|559032094|FG002|Overall Study|Withdrawal by Subject|1|||
154893690|NCT03571256|559032092|FG000|Overall Study|Other than specified|0|||
154893691|NCT03571256|559032093|FG001|Overall Study|Other than specified|1|||
154893692|NCT03571256|559032094|FG002|Overall Study|Other than specified|1|||
154893693|NCT03571256|559032092|FG000|Overall Study|Protocol Violation|0|||
154893694|NCT03571256|559032093|FG001|Overall Study|Protocol Violation|1|||
154893695|NCT03571256|559032094|FG002|Overall Study|Protocol Violation|1|||
154893696|NCT02270684|559032097|FG000|Overall Study|Lost to Follow-up|0|||
154893697|NCT02270684|559032098|FG001|Overall Study|Lost to Follow-up|3|||
154893698|NCT02270684|559032097|FG000|Overall Study|Study terminated|1|||
154893699|NCT02270684|559032098|FG001|Overall Study|Study terminated|0|||
154893700|NCT02247401|559032101|FG000|Overall Study|Adverse Event|1|||
154893701|NCT02247401|559032102|FG001|Overall Study|Adverse Event|0|||
154893702|NCT02247401|559032103|FG002|Overall Study|Adverse Event|0|||
154893703|NCT02247401|559032101|FG000|Overall Study|Withdrawal by Subject|4|||
154893704|NCT02247401|559032102|FG001|Overall Study|Withdrawal by Subject|1|||
154893705|NCT02247401|559032103|FG002|Overall Study|Withdrawal by Subject|1|||
154893706|NCT02247401|559032101|FG000|Overall Study|Lost to Follow-up|1|||
154893707|NCT02247401|559032102|FG001|Overall Study|Lost to Follow-up|1|||
154893708|NCT02247401|559032103|FG002|Overall Study|Lost to Follow-up|1|||
154893709|NCT01374217|559032104|FG000|Overall Study|Lack of Efficacy|13|||
154893710|NCT03695393|559032108|FG000|Overall Study|Death|3|||
154893711|NCT03695393|559032109|FG001|Overall Study|Death|1|||
154893712|NCT03695393|559032108|FG000|Overall Study|Lost to Follow-up|0|||
154893713|NCT03695393|559032109|FG001|Overall Study|Lost to Follow-up|1|||
154893714|NCT04585451|559032110|FG000|Overall Study|Withdrawal by Subject|26|||
154893715|NCT04585451|559032111|FG001|Overall Study|Withdrawal by Subject|0|||
154893716|NCT00966693|559032112|FG000|Overall Study|Adverse Event|0|||
154978244|NCT01396421|559342807|FG002|Overall Study|Lack of Efficacy|7|||
154978245|NCT01396421|559342808|FG003|Overall Study|Lack of Efficacy|18|||
154978246|NCT03314662|559342809|FG000|Overall Study|Withdrawal by Subject|1|||
154978247|NCT03314662|559342810|FG001|Overall Study|Withdrawal by Subject|1|||
154978248|NCT03314662|559342811|FG002|Overall Study|Withdrawal by Subject|1|||
154978249|NCT03314662|559342809|FG000|Overall Study|Lost to Follow-up|5|||
154978250|NCT03314662|559342810|FG001|Overall Study|Lost to Follow-up|4|||
154978251|NCT03314662|559342811|FG002|Overall Study|Lost to Follow-up|4|||
154978252|NCT03314662|559342809|FG000|Overall Study|Death|2|||
155114008|NCT03389555|559846199|FG000|Overall Study|Death|1|||
154893717|NCT00966693|559032113|FG001|Overall Study|Adverse Event|0|||
154893718|NCT00966693|559032114|FG002|Overall Study|Adverse Event|1|||
154893719|NCT00966693|559032115|FG003|Overall Study|Adverse Event|2|||
154893720|NCT00966693|559032112|FG000|Overall Study|Death|0|||
155114009|NCT03389555|559846200|FG001|Overall Study|Death|0|||
155114010|NCT00873041|559846201|FG000|Core Study|Adverse Event|2|||
154978253|NCT03314662|559342810|FG001|Overall Study|Death|0|||
154978254|NCT03314662|559342811|FG002|Overall Study|Death|0|||
154893721|NCT00966693|559032113|FG001|Overall Study|Death|0|||
154893722|NCT00966693|559032114|FG002|Overall Study|Death|1|||
154893723|NCT00966693|559032115|FG003|Overall Study|Death|0|||
154893724|NCT00966693|559032112|FG000|Overall Study|Withdrawal by Subject|1|||
154893725|NCT00966693|559032113|FG001|Overall Study|Withdrawal by Subject|0|||
154893726|NCT00966693|559032114|FG002|Overall Study|Withdrawal by Subject|0|||
154978255|NCT00925301|559342812|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
155114011|NCT00873041|559846202|FG001|Core Study|Adverse Event|3|||
154893727|NCT00966693|559032115|FG003|Overall Study|Withdrawal by Subject|5|||
154893728|NCT00966693|559032112|FG000|Overall Study|Disease Progression|0|||
154893729|NCT00966693|559032113|FG001|Overall Study|Disease Progression|0|||
154893730|NCT00966693|559032114|FG002|Overall Study|Disease Progression|1|||
154893731|NCT00966693|559032115|FG003|Overall Study|Disease Progression|16|||
154893732|NCT00405821|559032118|FG000|Overall Study|Death|5|||
154893733|NCT00405821|559032119|FG001|Overall Study|Death|7|||
154893734|NCT00405821|559032118|FG000|Overall Study|Lost to Follow-up|7|||
154893735|NCT00405821|559032119|FG001|Overall Study|Lost to Follow-up|7|||
154893736|NCT00405821|559032118|FG000|Overall Study|Protocol Violation|1|||
154893737|NCT00405821|559032119|FG001|Overall Study|Protocol Violation|0|||
154893738|NCT00405821|559032118|FG000|Overall Study|initiated ART|9|||
154893739|NCT00405821|559032119|FG001|Overall Study|initiated ART|8|||
154893740|NCT01769469|559032121|FG000|Overall Study|Consent Withdrawn|5|||
154893741|NCT01769469|559032121|FG000|Overall Study|Moved Out Of Area|3|||
154893742|NCT01769469|559032121|FG000|Overall Study|Lost to Follow-up|17|||
154893743|NCT01769469|559032121|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
154893744|NCT01769469|559032121|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
154893745|NCT02031432|559032124|FG000|Overall Study|Protocol Violation|1|||
154893746|NCT02031432|559032124|FG000|Overall Study|Lack of Efficacy|5|||
154893747|NCT02031432|559032124|FG000|Overall Study|Cancer Progression|2|||
154893748|NCT02031432|559032124|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
154893749|NCT02031432|559032124|FG000|Overall Study|Adverse Event|8|||
154893750|NCT02031432|559032124|FG000|Overall Study|Withdrawal by Subject|5|||
154893751|NCT02031432|559032124|FG000|Overall Study|Lost to Follow-up|1|||
154893752|NCT02031432|559032124|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
154893753|NCT02031432|559032124|FG000|Overall Study|Death|10|||
154893754|NCT02148211|559032125|FG000|Overall Study|Lost to Follow-up|352|||
154893755|NCT01617187|559032127|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
154893756|NCT01617187|559032128|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
154893757|NCT01617187|559032129|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
154893758|NCT01617187|559032130|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
154893759|NCT01617187|559032127|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
154893760|NCT01617187|559032128|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
154893761|NCT01617187|559032129|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
154893762|NCT01617187|559032130|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
154893763|NCT01617187|559032127|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
154893764|NCT01617187|559032128|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
154893765|NCT01617187|559032129|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
154893766|NCT01617187|559032130|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
154893767|NCT01617187|559032127|FG000|Treatment Through Study Completion|Adverse Event|1|||
154893768|NCT01617187|559032128|FG001|Treatment Through Study Completion|Adverse Event|1|||
154893769|NCT01617187|559032129|FG002|Treatment Through Study Completion|Adverse Event|0|||
154893770|NCT01617187|559032130|FG003|Treatment Through Study Completion|Adverse Event|1|||
154893771|NCT01617187|559032127|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
154893772|NCT01617187|559032128|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
154893773|NCT01617187|559032129|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
154893774|NCT01617187|559032130|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
154893775|NCT01617187|559032127|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
154893776|NCT01617187|559032128|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
154893777|NCT01617187|559032129|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
154893778|NCT01617187|559032130|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
154893779|NCT01617187|559032127|FG000|Treatment Through Study Completion|Protocol Violation|1|||
155114012|NCT00873041|559846203|FG002|Core Study|Adverse Event|1|||
155114013|NCT00873041|559846201|FG000|Core Study|Withdrawal by Subject|1|||
154893780|NCT01617187|559032128|FG001|Treatment Through Study Completion|Protocol Violation|0|||
154893781|NCT01617187|559032129|FG002|Treatment Through Study Completion|Protocol Violation|0|||
154893782|NCT01617187|559032130|FG003|Treatment Through Study Completion|Protocol Violation|1|||
154893783|NCT01265420|559032132|FG000|Overall Study|Lost to Follow-up|1|||
155114014|NCT00873041|559846202|FG001|Core Study|Withdrawal by Subject|2|||
155114015|NCT00873041|559846203|FG002|Core Study|Withdrawal by Subject|2|||
155114016|NCT00873041|559846201|FG000|Core Study|Lost to Follow-up|3|||
155114017|NCT00873041|559846202|FG001|Core Study|Lost to Follow-up|1|||
154893784|NCT03337139|559032135|FG000|Phase I|Withdrawal by Subject|10|||
154893785|NCT03337139|559032136|FG001|Phase I|Withdrawal by Subject|0|||
154893786|NCT02554253|559032142|FG000|Overall Study|ineligible after enrollment|1|||
154893787|NCT02554253|559032143|FG001|Overall Study|ineligible after enrollment|0|||
154893788|NCT02554253|559032142|FG000|Overall Study|converted to transcatheter procedure|0|||
154893789|NCT02554253|559032143|FG001|Overall Study|converted to transcatheter procedure|1|||
155114018|NCT00873041|559846203|FG002|Core Study|Lost to Follow-up|0|||
155114019|NCT00873041|559846201|FG000|Core Study|Abnormal laboratory value|0|||
154893790|NCT02554253|559032142|FG000|Overall Study|received both drugs|0|||
154893791|NCT02554253|559032143|FG001|Overall Study|received both drugs|1|||
154893792|NCT01561560|559032145|FG000|First Two Weeks of Wear|Time/job conflict|0|||
154893793|NCT01561560|559032146|FG001|First Two Weeks of Wear|Time/job conflict|1|||
154893794|NCT01561560|559032145|FG000|First Two Weeks of Wear|Adverse Event|0|||
154893795|NCT01561560|559032146|FG001|First Two Weeks of Wear|Adverse Event|1|||
154893796|NCT01561560|559032145|FG000|Second Two Weeks of Wear|Adverse Event|0|||
154893797|NCT01561560|559032146|FG001|Second Two Weeks of Wear|Adverse Event|1|||
154893798|NCT03862131|559032147|FG000|Overall Study|Lost to Follow-up|1|||
154893799|NCT03862131|559032148|FG001|Overall Study|Lost to Follow-up|0|||
154893800|NCT03862131|559032149|FG002|Overall Study|Lost to Follow-up|1|||
154893801|NCT03862131|559032147|FG000|Overall Study|Determined to be ineligible|0|||
154893802|NCT03862131|559032148|FG001|Overall Study|Determined to be ineligible|0|||
154893803|NCT03862131|559032149|FG002|Overall Study|Determined to be ineligible|5|||
154893804|NCT03862131|559032147|FG000|Overall Study|Death|4|||
154893805|NCT03862131|559032148|FG001|Overall Study|Death|4|||
154893806|NCT03862131|559032149|FG002|Overall Study|Death|0|||
154893807|NCT03862131|559032147|FG000|Overall Study|Withdrawal by Subject|5|||
154893808|NCT03862131|559032148|FG001|Overall Study|Withdrawal by Subject|3|||
154893809|NCT03862131|559032149|FG002|Overall Study|Withdrawal by Subject|0|||
154893810|NCT03862131|559032147|FG000|Overall Study|Physician Decision|0|||
154893811|NCT03862131|559032148|FG001|Overall Study|Physician Decision|1|||
154893812|NCT03862131|559032149|FG002|Overall Study|Physician Decision|0|||
154893813|NCT01770145|559034237|FG000|Baseline|Adverse Event|20|||
154893814|NCT01770145|559034237|FG000|Baseline|Withdrawal by Subject|1|||
154893815|NCT01770145|559034237|FG000|Baseline|Lost to Follow-up|1|||
154893816|NCT01770145|559034237|FG000|Baseline|Unable to define optimal dose|4|||
154893817|NCT01770145|559034237|FG000|Treatment|Adverse Event|3|||
154893818|NCT01770145|559034237|FG000|Treatment|Withdrawal by Subject|1|||
154893819|NCT03488238|559034238|FG000|Overall Study|Equipment malfunction|1|||
154893820|NCT03488238|559034238|FG000|Overall Study|Adverse Event|1|||
154893821|NCT01316939|559034239|FG000|Overall Study|Study closed/terminated|26|||
154893822|NCT01316939|559034240|FG001|Overall Study|Study closed/terminated|25|||
154893823|NCT01316939|559034241|FG002|Overall Study|Study closed/terminated|23|||
154893824|NCT01316939|559034239|FG000|Overall Study|Lack of Efficacy|24|||
154893825|NCT01316939|559034240|FG001|Overall Study|Lack of Efficacy|25|||
154893826|NCT01316939|559034241|FG002|Overall Study|Lack of Efficacy|25|||
154893827|NCT01316939|559034239|FG000|Overall Study|Adverse Event|9|||
154893828|NCT01316939|559034240|FG001|Overall Study|Adverse Event|12|||
154893829|NCT01316939|559034241|FG002|Overall Study|Adverse Event|11|||
154893830|NCT01316939|559034239|FG000|Overall Study|Withdrawal by Subject|1|||
154893831|NCT01316939|559034240|FG001|Overall Study|Withdrawal by Subject|3|||
154893832|NCT01316939|559034241|FG002|Overall Study|Withdrawal by Subject|6|||
154893833|NCT01316939|559034239|FG000|Overall Study|Physician Decision|2|||
154893834|NCT01316939|559034240|FG001|Overall Study|Physician Decision|2|||
154893835|NCT01316939|559034241|FG002|Overall Study|Physician Decision|1|||
154893836|NCT01316939|559034239|FG000|Overall Study|Lost to Follow-up|0|||
154893837|NCT01316939|559034240|FG001|Overall Study|Lost to Follow-up|0|||
154893838|NCT01316939|559034241|FG002|Overall Study|Lost to Follow-up|2|||
154893839|NCT01316939|559034239|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
154893840|NCT01316939|559034240|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
154893841|NCT01316939|559034241|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
154893842|NCT01316939|559034239|FG000|Overall Study|Protocol Violation|0|||
154893843|NCT01316939|559034240|FG001|Overall Study|Protocol Violation|1|||
154893844|NCT01316939|559034241|FG002|Overall Study|Protocol Violation|0|||
154893845|NCT01432457|559034242|FG000|Overall Study|Adverse Event|7|||
154893846|NCT01432457|559034243|FG001|Overall Study|Adverse Event|10|||
154893847|NCT01432457|559034244|FG002|Overall Study|Adverse Event|16|||
155114020|NCT00873041|559846202|FG001|Core Study|Abnormal laboratory value|0|||
155114021|NCT00873041|559846203|FG002|Core Study|Abnormal laboratory value|1|||
155114022|NCT00873041|559846201|FG000|Core Study|Protocol deviation|1|||
155114023|NCT00873041|559846202|FG001|Core Study|Protocol deviation|0|||
154978256|NCT00925301|559342813|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
154893848|NCT01432457|559034242|FG000|Overall Study|Lack of Efficacy|2|||
154893849|NCT01432457|559034243|FG001|Overall Study|Lack of Efficacy|1|||
155114024|NCT00873041|559846203|FG002|Core Study|Protocol deviation|1|||
155114025|NCT00873041|559846201|FG000|Extension Study|Adverse Event|1|||
155114026|NCT00873041|559846202|FG001|Extension Study|Adverse Event|0|||
155114027|NCT00873041|559846203|FG002|Extension Study|Adverse Event|1|||
155114028|NCT00873041|559846201|FG000|Extension Study|Administrative reasons|0|||
155114029|NCT00873041|559846202|FG001|Extension Study|Administrative reasons|0|||
154893850|NCT01432457|559034244|FG002|Overall Study|Lack of Efficacy|1|||
154893851|NCT01432457|559034242|FG000|Overall Study|Lost to Follow-up|11|||
154893852|NCT01432457|559034243|FG001|Overall Study|Lost to Follow-up|15|||
155114030|NCT00873041|559846203|FG002|Extension Study|Administrative reasons|1|||
154893853|NCT01432457|559034244|FG002|Overall Study|Lost to Follow-up|20|||
154893854|NCT01432457|559034242|FG000|Overall Study|Protocol Violation|3|||
154893855|NCT01432457|559034243|FG001|Overall Study|Protocol Violation|2|||
154893856|NCT01432457|559034244|FG002|Overall Study|Protocol Violation|6|||
154893857|NCT01432457|559034242|FG000|Overall Study|Withdrawal by Subject|6|||
154893858|NCT01432457|559034243|FG001|Overall Study|Withdrawal by Subject|11|||
154893859|NCT01432457|559034244|FG002|Overall Study|Withdrawal by Subject|9|||
154893860|NCT01432457|559034242|FG000|Overall Study|Reasons not defined|2|||
154893861|NCT01432457|559034243|FG001|Overall Study|Reasons not defined|3|||
154893862|NCT01432457|559034244|FG002|Overall Study|Reasons not defined|4|||
154893863|NCT01432457|559034242|FG000|Overall Study|Did not take study drug|6|||
154893864|NCT01432457|559034243|FG001|Overall Study|Did not take study drug|6|||
154893865|NCT01432457|559034244|FG002|Overall Study|Did not take study drug|3|||
154893866|NCT04134728|559034245|FG000|Overall Study|Adverse Event|3|||
154893867|NCT04134728|559034246|FG001|Overall Study|Adverse Event|2|||
154893868|NCT04134728|559034247|FG002|Overall Study|Adverse Event|9|||
154893869|NCT04134728|559034248|FG003|Overall Study|Adverse Event|0|||
154893870|NCT04134728|559034249|FG004|Overall Study|Adverse Event|0|||
154893871|NCT04134728|559034250|FG005|Overall Study|Adverse Event|0|||
154893872|NCT04134728|559034245|FG000|Overall Study|Lack of Efficacy|3|||
154893873|NCT04134728|559034246|FG001|Overall Study|Lack of Efficacy|3|||
154893874|NCT04134728|559034247|FG002|Overall Study|Lack of Efficacy|1|||
154893875|NCT04134728|559034248|FG003|Overall Study|Lack of Efficacy|2|||
154893876|NCT04134728|559034249|FG004|Overall Study|Lack of Efficacy|0|||
154893877|NCT04134728|559034250|FG005|Overall Study|Lack of Efficacy|0|||
154893878|NCT04134728|559034245|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
154893879|NCT04134728|559034246|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
154893880|NCT04134728|559034247|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
154893881|NCT04134728|559034248|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
154893882|NCT04134728|559034249|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
154893883|NCT04134728|559034250|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
154893884|NCT04134728|559034245|FG000|Overall Study|Protocol Deviation|0|||
154893885|NCT04134728|559034246|FG001|Overall Study|Protocol Deviation|0|||
154893886|NCT04134728|559034247|FG002|Overall Study|Protocol Deviation|1|||
154893887|NCT04134728|559034248|FG003|Overall Study|Protocol Deviation|0|||
154893888|NCT04134728|559034249|FG004|Overall Study|Protocol Deviation|0|||
154893889|NCT04134728|559034250|FG005|Overall Study|Protocol Deviation|0|||
154893890|NCT04134728|559034245|FG000|Overall Study|Informed Consent Withdrawn|3|||
154893891|NCT04134728|559034246|FG001|Overall Study|Informed Consent Withdrawn|6|||
154893892|NCT04134728|559034247|FG002|Overall Study|Informed Consent Withdrawn|8|||
154893893|NCT04134728|559034248|FG003|Overall Study|Informed Consent Withdrawn|1|||
154893894|NCT04134728|559034249|FG004|Overall Study|Informed Consent Withdrawn|1|||
154893895|NCT04134728|559034250|FG005|Overall Study|Informed Consent Withdrawn|0|||
154893896|NCT04134728|559034245|FG000|Overall Study|Physician Decision|2|||
154893897|NCT04134728|559034246|FG001|Overall Study|Physician Decision|0|||
154893898|NCT04134728|559034247|FG002|Overall Study|Physician Decision|0|||
154893899|NCT04134728|559034248|FG003|Overall Study|Physician Decision|0|||
154893900|NCT04134728|559034249|FG004|Overall Study|Physician Decision|0|||
154893901|NCT04134728|559034250|FG005|Overall Study|Physician Decision|0|||
154893902|NCT04134728|559034245|FG000|Overall Study|Lost to Follow-up|1|||
154893903|NCT04134728|559034246|FG001|Overall Study|Lost to Follow-up|2|||
154893904|NCT04134728|559034247|FG002|Overall Study|Lost to Follow-up|1|||
154893905|NCT04134728|559034248|FG003|Overall Study|Lost to Follow-up|0|||
154893906|NCT04134728|559034249|FG004|Overall Study|Lost to Follow-up|0|||
154893907|NCT04134728|559034250|FG005|Overall Study|Lost to Follow-up|1|||
154893908|NCT04134728|559034245|FG000|Overall Study|Investigator Site Closed|0|||
154893909|NCT04134728|559034246|FG001|Overall Study|Investigator Site Closed|1|||
154893910|NCT04134728|559034247|FG002|Overall Study|Investigator Site Closed|1|||
154893911|NCT04134728|559034248|FG003|Overall Study|Investigator Site Closed|0|||
154893912|NCT04134728|559034249|FG004|Overall Study|Investigator Site Closed|0|||
154893913|NCT04134728|559034250|FG005|Overall Study|Investigator Site Closed|0|||
154893914|NCT00801892|559034251|FG000|Main Study Period|Withdrawal by Subject|0|||
154893915|NCT00801892|559034252|FG001|Main Study Period|Withdrawal by Subject|1|||
154893916|NCT00801892|559034251|FG000|Sham Crossover Period|Lost to Follow-up|0|||
154893917|NCT00801892|559034252|FG001|Sham Crossover Period|Lost to Follow-up|2|||
154893918|NCT01711541|559034253|FG000|Overall Study|Cancel prior to treatment|0|||
154893919|NCT01711541|559034254|FG001|Overall Study|Cancel prior to treatment|0|||
154893920|NCT01711541|559034255|FG002|Overall Study|Cancel prior to treatment|0|||
154893921|NCT01711541|559034256|FG003|Overall Study|Cancel prior to treatment|1|||
154893922|NCT01711541|559034257|FG004|Overall Study|Cancel prior to treatment|0|||
154893923|NCT01711541|559034253|FG000|Overall Study|Ineligible|0|||
154893924|NCT01711541|559034254|FG001|Overall Study|Ineligible|1|||
155114031|NCT00313313|559846204|FG000|Overall Study|Lack of Efficacy|14|||
155114032|NCT00313313|559846205|FG001|Overall Study|Lack of Efficacy|9|||
155114033|NCT00313313|559846206|FG002|Overall Study|Lack of Efficacy|20|||
155114034|NCT00313313|559846204|FG000|Overall Study|Withdrawal of consent by subject|18|||
154893925|NCT01711541|559034255|FG002|Overall Study|Ineligible|0|||
154893926|NCT01711541|559034256|FG003|Overall Study|Ineligible|0|||
154893927|NCT01711541|559034257|FG004|Overall Study|Ineligible|0|||
154893928|NCT00728936|559034258|FG000|Overall Study|Withdrawal by Subject|0|||
154893929|NCT00728936|559034259|FG001|Overall Study|Withdrawal by Subject|0|||
154893930|NCT00728936|559034260|FG002|Overall Study|Withdrawal by Subject|0|||
154893931|NCT00728936|559034261|FG003|Overall Study|Withdrawal by Subject|0|||
154893932|NCT00728936|559034262|FG004|Overall Study|Withdrawal by Subject|0|||
154893933|NCT00728936|559034263|FG005|Overall Study|Withdrawal by Subject|1|||
154893934|NCT00728936|559034264|FG006|Overall Study|Withdrawal by Subject|0|||
154893935|NCT05355818|559034269|FG000|Overall Study|Adverse Event|1|||
154893936|NCT05355818|559034270|FG001|Overall Study|Adverse Event|1|||
154893937|NCT05355818|559034269|FG000|Overall Study|Lack of Efficacy|2|||
154893938|NCT05355818|559034270|FG001|Overall Study|Lack of Efficacy|1|||
154893939|NCT05355818|559034269|FG000|Overall Study|Lost to Follow-up|0|||
154893940|NCT05355818|559034270|FG001|Overall Study|Lost to Follow-up|1|||
154893941|NCT02966353|559034271|FG000|Overall Study|Withdrawal by Subject|7|||
154893942|NCT02966353|559034271|FG000|Overall Study|Adverse Event|4|||
154893943|NCT02966353|559034271|FG000|Overall Study|Death|4|||
154893944|NCT02966353|559034271|FG000|Overall Study|Physician Decision|3|||
154893945|NCT02966353|559034271|FG000|Overall Study|Progressive disease|2|||
154893946|NCT02966353|559034271|FG000|Overall Study|Protocol deviation|2|||
154893947|NCT02273037|559034272|FG000|Overall Study|Lost to Follow-up|1|||
154893948|NCT02273037|559034273|FG001|Overall Study|Lost to Follow-up|0|||
154893949|NCT02273037|559034272|FG000|Overall Study|Delivered before monitoring initiated|1|||
154893950|NCT02273037|559034273|FG001|Overall Study|Delivered before monitoring initiated|3|||
154893951|NCT02273037|559034272|FG000|Overall Study|Breech delivery|2|||
154893952|NCT02273037|559034273|FG001|Overall Study|Breech delivery|3|||
154893953|NCT02273037|559034272|FG000|Overall Study|Multiple delivery|2|||
154893954|NCT02273037|559034273|FG001|Overall Study|Multiple delivery|2|||
154893955|NCT02273037|559034272|FG000|Overall Study|Other complication|2|||
154893956|NCT02273037|559034273|FG001|Overall Study|Other complication|0|||
154893957|NCT03351478|559034274|FG000|Overall Study|At the subject's own request|11|||
154893958|NCT03351478|559034275|FG001|Overall Study|At the subject's own request|12|||
154893959|NCT03351478|559034276|FG002|Overall Study|At the subject's own request|5|||
154893960|NCT03351478|559034274|FG000|Overall Study|Adverse Event|1|||
154893961|NCT03351478|559034275|FG001|Overall Study|Adverse Event|2|||
154893962|NCT03351478|559034276|FG002|Overall Study|Adverse Event|1|||
154893963|NCT03351478|559034274|FG000|Overall Study|Poor compliance to protocol|1|||
154893964|NCT03351478|559034275|FG001|Overall Study|Poor compliance to protocol|0|||
154893965|NCT03351478|559034276|FG002|Overall Study|Poor compliance to protocol|0|||
154893966|NCT03351478|559034274|FG000|Overall Study|Reason not Specified|1|||
154893967|NCT03351478|559034275|FG001|Overall Study|Reason not Specified|3|||
154893968|NCT03351478|559034276|FG002|Overall Study|Reason not Specified|0|||
154893969|NCT03351478|559034274|FG000|Overall Study|Lost to Follow-up|0|||
154893970|NCT03351478|559034275|FG001|Overall Study|Lost to Follow-up|0|||
154893971|NCT03351478|559034276|FG002|Overall Study|Lost to Follow-up|1|||
154893972|NCT03657810|559034277|FG000|Overall Study|Adverse Event|0|||
154893973|NCT03657810|559034278|FG001|Overall Study|Adverse Event|1|||
154893974|NCT03657810|559034279|FG002|Overall Study|Adverse Event|0|||
154893975|NCT03657810|559034277|FG000|Overall Study|Lack of Efficacy|4|||
154893976|NCT03657810|559034278|FG001|Overall Study|Lack of Efficacy|1|||
154893977|NCT03657810|559034279|FG002|Overall Study|Lack of Efficacy|3|||
154978257|NCT00925301|559342814|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
154893978|NCT03657810|559034277|FG000|Overall Study|Protocol Violation|1|||
154893979|NCT03657810|559034278|FG001|Overall Study|Protocol Violation|0|||
154893980|NCT03657810|559034279|FG002|Overall Study|Protocol Violation|0|||
154893981|NCT03657810|559034277|FG000|Overall Study|Lost to Follow-up|0|||
154893982|NCT03657810|559034278|FG001|Overall Study|Lost to Follow-up|1|||
154978258|NCT00925301|559342815|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
154978259|NCT00925301|559342812|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
154978260|NCT00925301|559342813|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
155114035|NCT00313313|559846205|FG001|Overall Study|Withdrawal of consent by subject|17|||
155114036|NCT00313313|559846206|FG002|Overall Study|Withdrawal of consent by subject|31|||
155114037|NCT00313313|559846204|FG000|Overall Study|Lost to Follow-up|10|||
155114038|NCT00313313|559846205|FG001|Overall Study|Lost to Follow-up|7|||
155114039|NCT00313313|559846206|FG002|Overall Study|Lost to Follow-up|9|||
155114040|NCT00313313|559846204|FG000|Overall Study|Adverse Event|15|||
154893983|NCT03657810|559034279|FG002|Overall Study|Lost to Follow-up|0|||
154893984|NCT03657810|559034277|FG000|Overall Study|Not provided|0|||
154893985|NCT03657810|559034278|FG001|Overall Study|Not provided|1|||
154893986|NCT03657810|559034279|FG002|Overall Study|Not provided|0|||
154893987|NCT03911869|559034280|FG000|Safety Lead-in Phase|Death|7|||
154893988|NCT03911869|559034281|FG001|Safety Lead-in Phase|Death|0|||
154978261|NCT00925301|559342814|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
155114041|NCT00313313|559846205|FG001|Overall Study|Adverse Event|16|||
154893989|NCT03911869|559034282|FG002|Safety Lead-in Phase|Death|0|||
154893990|NCT03911869|559034280|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
154893991|NCT03911869|559034281|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
154893992|NCT03911869|559034282|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
154893993|NCT03911869|559034280|FG000|Safety Lead-in Phase|Other|1|||
154893994|NCT03911869|559034281|FG001|Safety Lead-in Phase|Other|0|||
154978262|NCT00925301|559342815|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
154978263|NCT00925301|559342812|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
154978264|NCT00925301|559342813|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
154978265|NCT00925301|559342814|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
154978266|NCT00925301|559342815|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
154978267|NCT00925301|559342812|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
154978268|NCT00925301|559342813|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
154978269|NCT00925301|559342814|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
154978270|NCT00925301|559342815|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
154978271|NCT00925301|559342812|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
154978272|NCT00925301|559342813|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
154978273|NCT00925301|559342814|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
154978274|NCT00925301|559342815|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
154978275|NCT00925301|559342812|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
154978276|NCT00925301|559342813|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
154978277|NCT00925301|559342814|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
154978278|NCT00925301|559342815|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
154978279|NCT00925301|559342812|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
154978280|NCT00925301|559342813|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
154978281|NCT00925301|559342814|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
154978282|NCT00925301|559342815|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
154978283|NCT00438659|559342816|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
154893995|NCT03911869|559034282|FG002|Safety Lead-in Phase|Other|0|||
154893996|NCT03911869|559034280|FG000|Phase 2|Death|0|||
154893997|NCT03911869|559034281|FG001|Phase 2|Death|3|||
154893998|NCT03911869|559034282|FG002|Phase 2|Death|0|||
154893999|NCT00367341|559034284|FG000|Overall Study|Physician Decision|1|||
154894000|NCT00367341|559034285|FG001|Overall Study|Physician Decision|0|||
154894001|NCT00367341|559034284|FG000|Overall Study|Protocol Violation|1|||
154894002|NCT00367341|559034285|FG001|Overall Study|Protocol Violation|0|||
154894003|NCT03325556|559034287|FG000|Open-label Period|Lack of Response in OL period|70|||
154894004|NCT03325556|559034288|FG001|Open-label Period|Lack of Response in OL period|0|||
154894005|NCT03325556|559034289|FG002|Open-label Period|Lack of Response in OL period|0|||
154894006|NCT03325556|559034287|FG000|Open-label Period|Adverse Event|27|||
154894007|NCT03325556|559034288|FG001|Open-label Period|Adverse Event|0|||
154894008|NCT03325556|559034289|FG002|Open-label Period|Adverse Event|0|||
154894009|NCT03325556|559034287|FG000|Open-label Period|Death|1|||
154894010|NCT03325556|559034288|FG001|Open-label Period|Death|0|||
154894011|NCT03325556|559034289|FG002|Open-label Period|Death|0|||
154894012|NCT03325556|559034287|FG000|Open-label Period|Lost to Follow-up|1|||
154894013|NCT03325556|559034288|FG001|Open-label Period|Lost to Follow-up|0|||
154894014|NCT03325556|559034289|FG002|Open-label Period|Lost to Follow-up|0|||
154894015|NCT03325556|559034287|FG000|Open-label Period|Non-compliance with study drug|5|||
154894016|NCT03325556|559034288|FG001|Open-label Period|Non-compliance with study drug|0|||
154894017|NCT03325556|559034289|FG002|Open-label Period|Non-compliance with study drug|0|||
154894018|NCT03325556|559034287|FG000|Open-label Period|Use of prohibited medication|1|||
154894019|NCT03325556|559034288|FG001|Open-label Period|Use of prohibited medication|0|||
154894020|NCT03325556|559034289|FG002|Open-label Period|Use of prohibited medication|0|||
154894021|NCT03325556|559034287|FG000|Open-label Period|Protocol Violation|4|||
154894022|NCT03325556|559034288|FG001|Open-label Period|Protocol Violation|0|||
154894023|NCT03325556|559034289|FG002|Open-label Period|Protocol Violation|0|||
154894024|NCT03325556|559034287|FG000|Open-label Period|Withdrawal by Subject|17|||
154894025|NCT03325556|559034288|FG001|Open-label Period|Withdrawal by Subject|0|||
154894026|NCT03325556|559034289|FG002|Open-label Period|Withdrawal by Subject|0|||
154894027|NCT03325556|559034287|FG000|Open-label Period|Not otherwise specified|8|||
154894028|NCT03325556|559034288|FG001|Open-label Period|Not otherwise specified|0|||
154894029|NCT03325556|559034289|FG002|Open-label Period|Not otherwise specified|0|||
154894030|NCT03325556|559034287|FG000|Open-label Period|Administrative discont. at study termination|41|||
154894031|NCT03325556|559034288|FG001|Open-label Period|Administrative discont. at study termination|0|||
154894032|NCT03325556|559034289|FG002|Open-label Period|Administrative discont. at study termination|0|||
154894033|NCT03325556|559034287|FG000|Double-blind Period|Relapse|0|||
154894034|NCT03325556|559034288|FG001|Double-blind Period|Relapse|15|||
154894035|NCT03325556|559034289|FG002|Double-blind Period|Relapse|34|||
154894036|NCT03325556|559034287|FG000|Double-blind Period|Adverse Event|0|||
154894037|NCT03325556|559034288|FG001|Double-blind Period|Adverse Event|3|||
154894038|NCT03325556|559034289|FG002|Double-blind Period|Adverse Event|1|||
155114042|NCT00313313|559846206|FG002|Overall Study|Adverse Event|12|||
155114043|NCT00313313|559846204|FG000|Overall Study|Physician Decision|2|||
155114044|NCT00313313|559846205|FG001|Overall Study|Physician Decision|6|||
154894039|NCT03325556|559034287|FG000|Double-blind Period|Noncompliance with study drug|0|||
154894040|NCT03325556|559034288|FG001|Double-blind Period|Noncompliance with study drug|0|||
154894041|NCT03325556|559034289|FG002|Double-blind Period|Noncompliance with study drug|1|||
155114045|NCT00313313|559846206|FG002|Overall Study|Physician Decision|4|||
155114046|NCT00313313|559846204|FG000|Overall Study|Poor/Noncompliance|3|||
154894042|NCT03325556|559034287|FG000|Double-blind Period|Use of prohibited medication|0|||
154894043|NCT03325556|559034288|FG001|Double-blind Period|Use of prohibited medication|1|||
154894044|NCT03325556|559034289|FG002|Double-blind Period|Use of prohibited medication|0|||
154894045|NCT03325556|559034287|FG000|Double-blind Period|Physician Decision|0|||
154894046|NCT03325556|559034288|FG001|Double-blind Period|Physician Decision|0|||
154894047|NCT03325556|559034289|FG002|Double-blind Period|Physician Decision|1|||
154894048|NCT03325556|559034287|FG000|Double-blind Period|Withdrawal by Subject|0|||
154894049|NCT03325556|559034288|FG001|Double-blind Period|Withdrawal by Subject|6|||
154894050|NCT03325556|559034289|FG002|Double-blind Period|Withdrawal by Subject|4|||
154894051|NCT03325556|559034287|FG000|Double-blind Period|Not otherwise specified|0|||
154894052|NCT03325556|559034288|FG001|Double-blind Period|Not otherwise specified|1|||
154894053|NCT03325556|559034289|FG002|Double-blind Period|Not otherwise specified|5|||
154894054|NCT03325556|559034287|FG000|Double-blind Period|Administrative discont. at study termination|0|||
154894055|NCT03325556|559034288|FG001|Double-blind Period|Administrative discont. at study termination|35|||
154894056|NCT03325556|559034289|FG002|Double-blind Period|Administrative discont. at study termination|31|||
154894057|NCT01705587|559034290|FG000|Overall Study|Withdrawal by Subject|0|||
154894058|NCT01705587|559034291|FG001|Overall Study|Withdrawal by Subject|1|||
154894059|NCT00510484|559034294|FG000|Wash-out Period|Adverse Event|0|||
154894060|NCT00510484|559034295|FG001|Wash-out Period|Adverse Event|1|||
154894061|NCT02533401|559034296|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
154894062|NCT02533401|559034296|FG000|Overall Study|Death|5|||
154894063|NCT02533401|559034296|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
154894064|NCT02533401|559034296|FG000|Overall Study|Lost to Follow-up|1|||
154894065|NCT02533401|559034296|FG000|Overall Study|Violation of Selection Criteria|1|||
154894066|NCT04897594|559034300|FG000|Overall Study|Lost to Follow-up|0|||
154894067|NCT04897594|559034301|FG001|Overall Study|Lost to Follow-up|1|||
154894068|NCT04897594|559034302|FG002|Overall Study|Lost to Follow-up|1|||
154894069|NCT04897594|559034300|FG000|Overall Study|Sponsor Decision|0|||
154894070|NCT04897594|559034301|FG001|Overall Study|Sponsor Decision|0|||
154894071|NCT04897594|559034302|FG002|Overall Study|Sponsor Decision|1|||
154894072|NCT04897594|559034300|FG000|Overall Study|Withdrawal by Subject|1|||
154894073|NCT04897594|559034301|FG001|Overall Study|Withdrawal by Subject|0|||
154894074|NCT04897594|559034302|FG002|Overall Study|Withdrawal by Subject|1|||
154894075|NCT00511108|559034303|FG000|Overall Study|Adverse Event|2|||
154894076|NCT00511108|559034304|FG001|Overall Study|Adverse Event|0|||
154894077|NCT00511108|559034305|FG002|Overall Study|Adverse Event|1|||
154894078|NCT00511108|559034306|FG003|Overall Study|Adverse Event|2|||
154894079|NCT00511108|559034303|FG000|Overall Study|Lost to Follow-up|0|||
154894080|NCT00511108|559034304|FG001|Overall Study|Lost to Follow-up|2|||
154894081|NCT00511108|559034305|FG002|Overall Study|Lost to Follow-up|1|||
154894082|NCT00511108|559034306|FG003|Overall Study|Lost to Follow-up|0|||
154894083|NCT00511108|559034303|FG000|Overall Study|Physician Decision|0|||
154894084|NCT00511108|559034304|FG001|Overall Study|Physician Decision|0|||
154894085|NCT00511108|559034305|FG002|Overall Study|Physician Decision|0|||
154894086|NCT00511108|559034306|FG003|Overall Study|Physician Decision|1|||
154894087|NCT00511108|559034303|FG000|Overall Study|Withdrawal by Subject|4|||
154894088|NCT00511108|559034304|FG001|Overall Study|Withdrawal by Subject|0|||
154894089|NCT00511108|559034305|FG002|Overall Study|Withdrawal by Subject|3|||
154894090|NCT00511108|559034306|FG003|Overall Study|Withdrawal by Subject|2|||
154894091|NCT00150345|559034309|FG000|Overall Study|Death|5|||
154894092|NCT00150345|559034310|FG001|Overall Study|Death|2|||
154894093|NCT00150345|559034309|FG000|Overall Study|Adverse Event|8|||
154894094|NCT00150345|559034310|FG001|Overall Study|Adverse Event|6|||
154894095|NCT00150345|559034309|FG000|Overall Study|Lack of Efficacy|5|||
154894096|NCT00150345|559034310|FG001|Overall Study|Lack of Efficacy|4|||
154894097|NCT00150345|559034309|FG000|Overall Study|Withdrawal by Subject|3|||
154894098|NCT00150345|559034310|FG001|Overall Study|Withdrawal by Subject|4|||
154894099|NCT00150345|559034309|FG000|Overall Study|Laboratory abnormality|1|||
154894100|NCT00150345|559034310|FG001|Overall Study|Laboratory abnormality|2|||
154894101|NCT00150345|559034309|FG000|Overall Study|Other|12|||
154894102|NCT00150345|559034310|FG001|Overall Study|Other|14|||
154894103|NCT01998958|559034311|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894104|NCT01998958|559034312|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
154894105|NCT01998958|559034313|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894106|NCT01998958|559034314|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894107|NCT01998958|559034315|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894108|NCT01998958|559034316|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894109|NCT01998958|559034317|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894110|NCT01998958|559034318|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894111|NCT01998958|559034319|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894112|NCT01998958|559034320|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894113|NCT01998958|559034321|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894114|NCT01998958|559034322|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894115|NCT01998958|559034323|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894116|NCT01998958|559034324|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154978284|NCT00438659|559342817|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
154978285|NCT00438659|559342816|FG000|Overall Study|Cancel|5|||
154978286|NCT00438659|559342817|FG001|Overall Study|Cancel|2|||
154978287|NCT05766787|559342818|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
154978288|NCT05766787|559342819|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
154978289|NCT05766787|559342818|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
154978290|NCT05766787|559342819|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
154978291|NCT05766787|559342818|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
154978292|NCT05766787|559342819|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
154978293|NCT01867606|559342820|FG000|Overall Study|Withdrawal by Subject|10|||
154978294|NCT01867606|559342821|FG001|Overall Study|Withdrawal by Subject|14|||
154978295|NCT01867606|559342820|FG000|Overall Study|Protocol Violation|0|||
154978296|NCT01867606|559342821|FG001|Overall Study|Protocol Violation|1|||
154978297|NCT01588548|559342822|FG000|Overall Study|Withdrawal by Subject|0|||
154978298|NCT01588548|559342823|FG001|Overall Study|Withdrawal by Subject|1|||
154978299|NCT01588548|559342824|FG002|Overall Study|Withdrawal by Subject|1|||
154978300|NCT01588548|559342825|FG003|Overall Study|Withdrawal by Subject|1|||
154978301|NCT01588548|559342826|FG004|Overall Study|Withdrawal by Subject|2|||
154978302|NCT01588548|559342827|FG005|Overall Study|Withdrawal by Subject|3|||
154978303|NCT01588548|559342822|FG000|Overall Study|Adverse Event|0|||
154978304|NCT01588548|559342823|FG001|Overall Study|Adverse Event|0|||
154978305|NCT01588548|559342824|FG002|Overall Study|Adverse Event|1|||
154978306|NCT01588548|559342825|FG003|Overall Study|Adverse Event|2|||
154978307|NCT01588548|559342826|FG004|Overall Study|Adverse Event|1|||
154978308|NCT01588548|559342827|FG005|Overall Study|Adverse Event|0|||
154978309|NCT01588548|559342822|FG000|Overall Study|Condition Under Investigation Worsened|3|||
154978310|NCT01588548|559342823|FG001|Overall Study|Condition Under Investigation Worsened|6|||
154978311|NCT01588548|559342824|FG002|Overall Study|Condition Under Investigation Worsened|4|||
154978312|NCT01588548|559342825|FG003|Overall Study|Condition Under Investigation Worsened|4|||
154978313|NCT01588548|559342826|FG004|Overall Study|Condition Under Investigation Worsened|3|||
154978314|NCT01588548|559342827|FG005|Overall Study|Condition Under Investigation Worsened|3|||
154978315|NCT01169038|559342828|FG000|Overall Study|Death|1|||
154978316|NCT01169038|559342828|FG000|Overall Study|Adverse Event|5|||
154978317|NCT01169038|559342828|FG000|Overall Study|Required antibiotic administration|1|||
154978318|NCT02490800|559342829|FG000|Overall Study|Adverse Event|0|||
154978319|NCT02490800|559342830|FG001|Overall Study|Adverse Event|0|||
154978320|NCT02490800|559342831|FG002|Overall Study|Adverse Event|0|||
154978321|NCT02490800|559342832|FG003|Overall Study|Adverse Event|2|||
154978322|NCT02490800|559342833|FG004|Overall Study|Adverse Event|3|||
154978323|NCT02490800|559342834|FG005|Overall Study|Adverse Event|2|||
154978324|NCT02490800|559342835|FG006|Overall Study|Adverse Event|0|||
154978325|NCT02490800|559342836|FG007|Overall Study|Adverse Event|0|||
154978326|NCT02490800|559342837|FG008|Overall Study|Adverse Event|0|||
154978327|NCT02490800|559342838|FG009|Overall Study|Adverse Event|0|||
154978328|NCT02490800|559342839|FG010|Overall Study|Adverse Event|0|||
154978329|NCT02490800|559342840|FG011|Overall Study|Adverse Event|2|||
154978330|NCT02490800|559342841|FG012|Overall Study|Adverse Event|2|||
154978331|NCT02490800|559342829|FG000|Overall Study|Withdrawal by Subject|0|||
154978332|NCT02490800|559342830|FG001|Overall Study|Withdrawal by Subject|0|||
154978333|NCT02490800|559342831|FG002|Overall Study|Withdrawal by Subject|0|||
155114047|NCT00313313|559846205|FG001|Overall Study|Poor/Noncompliance|6|||
155114048|NCT00313313|559846206|FG002|Overall Study|Poor/Noncompliance|2|||
155114049|NCT00313313|559846204|FG000|Overall Study|Pregnancy|1|||
155114050|NCT00313313|559846205|FG001|Overall Study|Pregnancy|2|||
155114051|NCT00313313|559846206|FG002|Overall Study|Pregnancy|0|||
155114052|NCT00313313|559846204|FG000|Overall Study|Death|0|||
155114053|NCT00313313|559846205|FG001|Overall Study|Death|0|||
155114054|NCT00313313|559846206|FG002|Overall Study|Death|2|||
155114055|NCT00313313|559846204|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155114056|NCT00313313|559846205|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
155114057|NCT00313313|559846206|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
155114058|NCT00368836|559846207|FG000|Phase II|Screen Failure|1|||
155114059|NCT00368836|559846207|FG000|Phase II|Withdrawal by Subject|1|||
155114060|NCT00368836|559846207|FG000|Phase II|unable to collect blood and/or breath|17|||
155114061|NCT00368836|559846207|FG000|Phase II|Protocol Violation|2|||
155114062|NCT01082874|559846208|FG000|Overall Study|Lost to Follow-up|10|||
154978334|NCT02490800|559342832|FG003|Overall Study|Withdrawal by Subject|1|||
154978335|NCT02490800|559342833|FG004|Overall Study|Withdrawal by Subject|0|||
154978336|NCT02490800|559342834|FG005|Overall Study|Withdrawal by Subject|0|||
154978337|NCT02490800|559342835|FG006|Overall Study|Withdrawal by Subject|0|||
154978338|NCT02490800|559342836|FG007|Overall Study|Withdrawal by Subject|0|||
154978339|NCT02490800|559342837|FG008|Overall Study|Withdrawal by Subject|1|||
154978340|NCT02490800|559342838|FG009|Overall Study|Withdrawal by Subject|0|||
154978341|NCT02490800|559342839|FG010|Overall Study|Withdrawal by Subject|0|||
154978342|NCT02490800|559342840|FG011|Overall Study|Withdrawal by Subject|0|||
154978343|NCT02490800|559342841|FG012|Overall Study|Withdrawal by Subject|0|||
154894117|NCT01998958|559034325|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894118|NCT01998958|559034326|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894119|NCT01998958|559034327|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894120|NCT01998958|559034328|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894121|NCT01998958|559034329|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894122|NCT01998958|559034330|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894123|NCT01998958|559034331|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894124|NCT01998958|559034332|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894125|NCT01998958|559034333|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894126|NCT01998958|559034334|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894127|NCT01998958|559034335|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894128|NCT01998958|559034336|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894129|NCT01998958|559034337|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894130|NCT01998958|559034338|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894131|NCT01998958|559034339|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894132|NCT01998958|559034340|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894133|NCT01998958|559034341|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894134|NCT01998958|559034342|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
154894135|NCT01998958|559034311|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894136|NCT01998958|559034312|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
154894137|NCT01998958|559034313|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894138|NCT01998958|559034314|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894139|NCT01998958|559034315|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894140|NCT01998958|559034316|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894141|NCT01998958|559034317|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894142|NCT01998958|559034318|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894143|NCT01998958|559034319|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894144|NCT01998958|559034320|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894145|NCT01998958|559034321|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894146|NCT01998958|559034322|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894147|NCT01998958|559034323|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894148|NCT01998958|559034324|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894149|NCT01998958|559034325|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894150|NCT01998958|559034326|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894151|NCT01998958|559034327|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894152|NCT01998958|559034328|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894153|NCT01998958|559034329|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894154|NCT01998958|559034330|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894155|NCT01998958|559034331|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894156|NCT01998958|559034332|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894157|NCT01998958|559034333|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894158|NCT01998958|559034334|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894159|NCT01998958|559034335|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894160|NCT01998958|559034336|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894161|NCT01998958|559034337|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894162|NCT01998958|559034338|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894163|NCT01998958|559034339|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894164|NCT01998958|559034340|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894165|NCT01998958|559034341|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894166|NCT01998958|559034342|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
154894167|NCT01998958|559034311|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
154894168|NCT01998958|559034312|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
154894169|NCT01998958|559034313|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
154894170|NCT01998958|559034314|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
154894171|NCT01998958|559034315|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
154894172|NCT01998958|559034316|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
154894173|NCT01998958|559034317|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
154894174|NCT01998958|559034318|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
154894175|NCT01998958|559034319|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
154894176|NCT01998958|559034320|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
154894177|NCT01998958|559034321|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
154894178|NCT01998958|559034322|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
154894179|NCT01998958|559034323|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
154894180|NCT01998958|559034324|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
155175621|NCT00958438|560080287|FG001|Overall Study|Other than specified above|3|||
154894181|NCT01998958|559034325|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
154894182|NCT01998958|559034326|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
154894183|NCT01998958|559034327|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
154894184|NCT01998958|559034328|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
154894185|NCT01998958|559034329|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
154894186|NCT01998958|559034330|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
154894187|NCT01998958|559034331|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
154894188|NCT01998958|559034332|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
154894189|NCT01998958|559034333|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
154894190|NCT01998958|559034334|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
154894191|NCT01998958|559034335|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
154894192|NCT01998958|559034336|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
154894193|NCT01998958|559034337|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
154894194|NCT01998958|559034338|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
154894195|NCT01998958|559034339|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
154894196|NCT01998958|559034340|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
154894197|NCT01998958|559034341|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
154894198|NCT01998958|559034342|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
154894199|NCT01998958|559034311|FG000|Period 1 (Panel A and B)|Other|1|||
154894200|NCT01998958|559034312|FG001|Period 1 (Panel A and B)|Other|0|||
154894201|NCT01998958|559034313|FG002|Period 1 (Panel A and B)|Other|0|||
154894202|NCT01998958|559034314|FG003|Period 1 (Panel A and B)|Other|0|||
154894203|NCT01998958|559034315|FG004|Period 1 (Panel A and B)|Other|0|||
154894204|NCT01998958|559034316|FG005|Period 1 (Panel A and B)|Other|0|||
154894205|NCT01998958|559034317|FG006|Period 1 (Panel A and B)|Other|0|||
154894206|NCT01998958|559034318|FG007|Period 1 (Panel A and B)|Other|0|||
154894207|NCT01998958|559034319|FG008|Period 1 (Panel A and B)|Other|0|||
154894208|NCT01998958|559034320|FG009|Period 1 (Panel A and B)|Other|0|||
154894209|NCT01998958|559034321|FG010|Period 1 (Panel A and B)|Other|0|||
154894210|NCT01998958|559034322|FG011|Period 1 (Panel A and B)|Other|0|||
154894211|NCT01998958|559034323|FG012|Period 1 (Panel A and B)|Other|0|||
154894212|NCT01998958|559034324|FG013|Period 1 (Panel A and B)|Other|0|||
154894213|NCT01998958|559034325|FG014|Period 1 (Panel A and B)|Other|0|||
154894214|NCT01998958|559034326|FG015|Period 1 (Panel A and B)|Other|0|||
154894215|NCT01998958|559034327|FG016|Period 1 (Panel A and B)|Other|0|||
154894216|NCT01998958|559034328|FG017|Period 1 (Panel A and B)|Other|0|||
154894217|NCT01998958|559034329|FG018|Period 1 (Panel A and B)|Other|0|||
154894218|NCT01998958|559034330|FG019|Period 1 (Panel A and B)|Other|0|||
154894219|NCT01998958|559034331|FG020|Period 1 (Panel A and B)|Other|0|||
154894220|NCT01998958|559034332|FG021|Period 1 (Panel A and B)|Other|0|||
154894221|NCT01998958|559034333|FG022|Period 1 (Panel A and B)|Other|0|||
154894222|NCT01998958|559034334|FG023|Period 1 (Panel A and B)|Other|0|||
154894223|NCT01998958|559034335|FG024|Period 1 (Panel A and B)|Other|0|||
154894224|NCT01998958|559034336|FG025|Period 1 (Panel A and B)|Other|0|||
154894225|NCT01998958|559034337|FG026|Period 1 (Panel A and B)|Other|0|||
154894226|NCT01998958|559034338|FG027|Period 1 (Panel A and B)|Other|0|||
154894227|NCT01998958|559034339|FG028|Period 1 (Panel A and B)|Other|0|||
154894228|NCT01998958|559034340|FG029|Period 1 (Panel A and B)|Other|0|||
154894229|NCT01998958|559034341|FG030|Period 1 (Panel A and B)|Other|0|||
154894230|NCT01998958|559034342|FG031|Period 1 (Panel A and B)|Other|0|||
154894231|NCT01998958|559034311|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
154894232|NCT01998958|559034312|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
154894233|NCT01998958|559034313|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
154894234|NCT01998958|559034314|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
154894235|NCT01998958|559034315|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
154894236|NCT01998958|559034316|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
154894237|NCT01998958|559034317|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
154894238|NCT01998958|559034318|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
154894239|NCT01998958|559034319|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
154894240|NCT01998958|559034320|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
154894241|NCT01998958|559034321|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
154894242|NCT01998958|559034322|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
154894243|NCT01998958|559034323|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
154894244|NCT01998958|559034324|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
154894245|NCT01998958|559034325|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
154894246|NCT01998958|559034326|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
154894247|NCT01998958|559034327|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
154894248|NCT01998958|559034328|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
154894249|NCT01998958|559034329|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
154894250|NCT01998958|559034330|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
154894251|NCT01998958|559034331|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
154894252|NCT01998958|559034332|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
154894253|NCT01998958|559034333|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
155114063|NCT01082874|559846209|FG001|Overall Study|Lost to Follow-up|10|||
155114064|NCT01082874|559846210|FG002|Overall Study|Lost to Follow-up|6|||
155114065|NCT01082874|559846211|FG003|Overall Study|Lost to Follow-up|10|||
154894254|NCT01998958|559034334|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
154894255|NCT01998958|559034335|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
154894256|NCT01998958|559034336|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
154894257|NCT01998958|559034337|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
154894258|NCT01998958|559034338|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
154894259|NCT01998958|559034339|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
154894260|NCT01998958|559034340|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
154894261|NCT01998958|559034341|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
154894262|NCT01998958|559034342|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
154894263|NCT01998958|559034311|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894264|NCT01998958|559034312|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154978344|NCT02490800|559342829|FG000|Overall Study|Progressive disease|3|||
154978345|NCT02490800|559342830|FG001|Overall Study|Progressive disease|3|||
154978346|NCT02490800|559342831|FG002|Overall Study|Progressive disease|3|||
154978347|NCT02490800|559342832|FG003|Overall Study|Progressive disease|4|||
154978348|NCT02490800|559342833|FG004|Overall Study|Progressive disease|4|||
154978349|NCT02490800|559342834|FG005|Overall Study|Progressive disease|1|||
154894265|NCT01998958|559034313|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894266|NCT01998958|559034314|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894267|NCT01998958|559034315|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894268|NCT01998958|559034316|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894269|NCT01998958|559034317|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894270|NCT01998958|559034318|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894271|NCT01998958|559034319|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894272|NCT01998958|559034320|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894273|NCT01998958|559034321|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894274|NCT01998958|559034322|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894275|NCT01998958|559034323|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894276|NCT01998958|559034324|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894277|NCT01998958|559034325|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
154894278|NCT01998958|559034326|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894279|NCT01998958|559034327|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894280|NCT01998958|559034328|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894281|NCT01998958|559034329|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
154894282|NCT01998958|559034330|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894283|NCT01998958|559034331|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894284|NCT01998958|559034332|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894285|NCT01998958|559034333|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894286|NCT01998958|559034334|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894287|NCT01998958|559034335|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894288|NCT01998958|559034336|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894289|NCT01998958|559034337|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894290|NCT01998958|559034338|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894291|NCT01998958|559034339|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894292|NCT01998958|559034340|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894293|NCT01998958|559034341|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894294|NCT01998958|559034342|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
154894295|NCT01998958|559034311|FG000|Open Label Phase (Optional)|Adverse Event|0|||
154894296|NCT01998958|559034312|FG001|Open Label Phase (Optional)|Adverse Event|0|||
154894297|NCT01998958|559034313|FG002|Open Label Phase (Optional)|Adverse Event|0|||
154894298|NCT01998958|559034314|FG003|Open Label Phase (Optional)|Adverse Event|0|||
154894299|NCT01998958|559034315|FG004|Open Label Phase (Optional)|Adverse Event|0|||
154894300|NCT01998958|559034316|FG005|Open Label Phase (Optional)|Adverse Event|0|||
154894301|NCT01998958|559034317|FG006|Open Label Phase (Optional)|Adverse Event|0|||
154894302|NCT01998958|559034318|FG007|Open Label Phase (Optional)|Adverse Event|0|||
154894303|NCT01998958|559034319|FG008|Open Label Phase (Optional)|Adverse Event|0|||
154894304|NCT01998958|559034320|FG009|Open Label Phase (Optional)|Adverse Event|0|||
154894305|NCT01998958|559034321|FG010|Open Label Phase (Optional)|Adverse Event|0|||
154894306|NCT01998958|559034322|FG011|Open Label Phase (Optional)|Adverse Event|0|||
154894307|NCT01998958|559034323|FG012|Open Label Phase (Optional)|Adverse Event|0|||
154894308|NCT01998958|559034324|FG013|Open Label Phase (Optional)|Adverse Event|0|||
154894309|NCT01998958|559034325|FG014|Open Label Phase (Optional)|Adverse Event|0|||
154894310|NCT01998958|559034326|FG015|Open Label Phase (Optional)|Adverse Event|0|||
154894311|NCT01998958|559034327|FG016|Open Label Phase (Optional)|Adverse Event|0|||
154894312|NCT01998958|559034328|FG017|Open Label Phase (Optional)|Adverse Event|0|||
154894313|NCT01998958|559034329|FG018|Open Label Phase (Optional)|Adverse Event|0|||
154894314|NCT01998958|559034330|FG019|Open Label Phase (Optional)|Adverse Event|0|||
154894315|NCT01998958|559034331|FG020|Open Label Phase (Optional)|Adverse Event|0|||
154894316|NCT01998958|559034332|FG021|Open Label Phase (Optional)|Adverse Event|0|||
154894317|NCT01998958|559034333|FG022|Open Label Phase (Optional)|Adverse Event|0|||
154978350|NCT02490800|559342835|FG006|Overall Study|Progressive disease|4|||
154978351|NCT02490800|559342836|FG007|Overall Study|Progressive disease|3|||
154978352|NCT02490800|559342837|FG008|Overall Study|Progressive disease|6|||
154978353|NCT02490800|559342838|FG009|Overall Study|Progressive disease|2|||
154978354|NCT02490800|559342839|FG010|Overall Study|Progressive disease|7|||
154978355|NCT02490800|559342840|FG011|Overall Study|Progressive disease|1|||
154978356|NCT02490800|559342841|FG012|Overall Study|Progressive disease|10|||
154978357|NCT02490800|559342829|FG000|Overall Study|Patient enrolled in post-trial access|0|||
154894318|NCT01998958|559034334|FG023|Open Label Phase (Optional)|Adverse Event|1|||
154978358|NCT02490800|559342830|FG001|Overall Study|Patient enrolled in post-trial access|0|||
154894319|NCT01998958|559034335|FG024|Open Label Phase (Optional)|Adverse Event|0|||
154894320|NCT01998958|559034336|FG025|Open Label Phase (Optional)|Adverse Event|0|||
154894321|NCT01998958|559034337|FG026|Open Label Phase (Optional)|Adverse Event|0|||
154894322|NCT01998958|559034338|FG027|Open Label Phase (Optional)|Adverse Event|0|||
154894323|NCT01998958|559034339|FG028|Open Label Phase (Optional)|Adverse Event|0|||
154894324|NCT01998958|559034340|FG029|Open Label Phase (Optional)|Adverse Event|0|||
154894325|NCT01998958|559034341|FG030|Open Label Phase (Optional)|Adverse Event|0|||
154894326|NCT01998958|559034342|FG031|Open Label Phase (Optional)|Adverse Event|0|||
155114066|NCT01082874|559846208|FG000|Overall Study|Withdrawal by Subject|1|||
155114067|NCT01082874|559846209|FG001|Overall Study|Withdrawal by Subject|2|||
155114068|NCT01082874|559846210|FG002|Overall Study|Withdrawal by Subject|5|||
155114069|NCT01082874|559846211|FG003|Overall Study|Withdrawal by Subject|3|||
154894327|NCT01998958|559034311|FG000|Open Label Phase (Optional)|Other|0|||
154894328|NCT01998958|559034312|FG001|Open Label Phase (Optional)|Other|0|||
154894329|NCT01998958|559034313|FG002|Open Label Phase (Optional)|Other|0|||
154894330|NCT01998958|559034314|FG003|Open Label Phase (Optional)|Other|0|||
154894331|NCT01998958|559034315|FG004|Open Label Phase (Optional)|Other|0|||
154894332|NCT01998958|559034316|FG005|Open Label Phase (Optional)|Other|0|||
154894333|NCT01998958|559034317|FG006|Open Label Phase (Optional)|Other|0|||
154894334|NCT01998958|559034318|FG007|Open Label Phase (Optional)|Other|0|||
154894335|NCT01998958|559034319|FG008|Open Label Phase (Optional)|Other|0|||
154894336|NCT01998958|559034320|FG009|Open Label Phase (Optional)|Other|0|||
154894337|NCT01998958|559034321|FG010|Open Label Phase (Optional)|Other|0|||
154894338|NCT01998958|559034322|FG011|Open Label Phase (Optional)|Other|0|||
154894339|NCT01998958|559034323|FG012|Open Label Phase (Optional)|Other|0|||
154894340|NCT01998958|559034324|FG013|Open Label Phase (Optional)|Other|0|||
154894341|NCT01998958|559034325|FG014|Open Label Phase (Optional)|Other|0|||
154894342|NCT01998958|559034326|FG015|Open Label Phase (Optional)|Other|0|||
154894343|NCT01998958|559034327|FG016|Open Label Phase (Optional)|Other|0|||
154894344|NCT01998958|559034328|FG017|Open Label Phase (Optional)|Other|0|||
154894345|NCT01998958|559034329|FG018|Open Label Phase (Optional)|Other|0|||
154894346|NCT01998958|559034330|FG019|Open Label Phase (Optional)|Other|0|||
154894347|NCT01998958|559034331|FG020|Open Label Phase (Optional)|Other|0|||
154894348|NCT01998958|559034332|FG021|Open Label Phase (Optional)|Other|0|||
154894349|NCT01998958|559034333|FG022|Open Label Phase (Optional)|Other|5|||
154894350|NCT01998958|559034334|FG023|Open Label Phase (Optional)|Other|1|||
154894351|NCT01998958|559034335|FG024|Open Label Phase (Optional)|Other|0|||
154894352|NCT01998958|559034336|FG025|Open Label Phase (Optional)|Other|0|||
154894353|NCT01998958|559034337|FG026|Open Label Phase (Optional)|Other|0|||
154894354|NCT01998958|559034338|FG027|Open Label Phase (Optional)|Other|0|||
154978359|NCT02490800|559342831|FG002|Overall Study|Patient enrolled in post-trial access|0|||
154978360|NCT02490800|559342832|FG003|Overall Study|Patient enrolled in post-trial access|0|||
154978361|NCT02490800|559342833|FG004|Overall Study|Patient enrolled in post-trial access|0|||
154978362|NCT02490800|559342834|FG005|Overall Study|Patient enrolled in post-trial access|0|||
154978363|NCT02490800|559342835|FG006|Overall Study|Patient enrolled in post-trial access|0|||
154978364|NCT02490800|559342836|FG007|Overall Study|Patient enrolled in post-trial access|0|||
154978365|NCT02490800|559342837|FG008|Overall Study|Patient enrolled in post-trial access|0|||
154978366|NCT02490800|559342838|FG009|Overall Study|Patient enrolled in post-trial access|1|||
154978367|NCT02490800|559342839|FG010|Overall Study|Patient enrolled in post-trial access|1|||
154978368|NCT02490800|559342840|FG011|Overall Study|Patient enrolled in post-trial access|0|||
154978369|NCT02490800|559342841|FG012|Overall Study|Patient enrolled in post-trial access|6|||
154978370|NCT03257254|559342842|FG000|Overall Study|Withdrawal by Subject|7|||
154978371|NCT03257254|559342842|FG000|Overall Study|Lost to Follow-up|9|||
154978372|NCT03257254|559342842|FG000|Overall Study|Study discontinued by sponsor|5|||
154978373|NCT03365791|559342843|FG000|Overall Study|Adverse Event|5|||
154978374|NCT03365791|559342843|FG000|Overall Study|Death|1|||
154978375|NCT03365791|559342843|FG000|Overall Study|Lost to Follow-up|1|||
154978376|NCT03365791|559342843|FG000|Overall Study|Physician Decision|9|||
154978377|NCT03365791|559342843|FG000|Overall Study|Progressive disease|51|||
155114070|NCT01846663|559846214|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
155114071|NCT01846663|559846215|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
155114072|NCT01846663|559846214|FG000|Overall Study|Withdrawal by Subject|1|||
155114073|NCT01846663|559846215|FG001|Overall Study|Withdrawal by Subject|0|||
155114074|NCT01846663|559846214|FG000|Overall Study|Adverse Event|1|||
154978378|NCT03365791|559342843|FG000|Overall Study|Subject/guardian decision|5|||
154978379|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
154978380|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978381|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978382|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978383|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
155114075|NCT01846663|559846215|FG001|Overall Study|Adverse Event|2|||
155114076|NCT03466099|559846229|FG000|Overall Study|Adverse Event|1|||
154894355|NCT01998958|559034339|FG028|Open Label Phase (Optional)|Other|0|||
154894356|NCT01998958|559034340|FG029|Open Label Phase (Optional)|Other|0|||
154894357|NCT01998958|559034341|FG030|Open Label Phase (Optional)|Other|0|||
154894358|NCT01998958|559034342|FG031|Open Label Phase (Optional)|Other|0|||
154894359|NCT01998958|559034311|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894360|NCT01998958|559034312|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894361|NCT01998958|559034313|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894362|NCT01998958|559034314|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
155114077|NCT03466099|559846230|FG001|Overall Study|Adverse Event|1|||
155114078|NCT03466099|559846231|FG002|Overall Study|Adverse Event|1|||
155114079|NCT03466099|559846229|FG000|Overall Study|Withdrawal by Subject|2|||
155114080|NCT03466099|559846230|FG001|Overall Study|Withdrawal by Subject|3|||
154894363|NCT01998958|559034315|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894364|NCT01998958|559034316|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894365|NCT01998958|559034317|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894366|NCT01998958|559034318|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894367|NCT01998958|559034319|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894368|NCT01998958|559034320|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894369|NCT01998958|559034321|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894370|NCT01998958|559034322|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894371|NCT01998958|559034323|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894372|NCT01998958|559034324|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894373|NCT01998958|559034325|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894374|NCT01998958|559034326|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894375|NCT01998958|559034327|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894376|NCT01998958|559034328|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894377|NCT01998958|559034329|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894378|NCT01998958|559034330|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894379|NCT01998958|559034331|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894380|NCT01998958|559034332|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894381|NCT01998958|559034333|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
154894382|NCT01998958|559034334|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894383|NCT01998958|559034335|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894384|NCT01998958|559034336|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894385|NCT01998958|559034337|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894386|NCT01998958|559034338|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894387|NCT01998958|559034339|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894388|NCT01998958|559034340|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894389|NCT01998958|559034341|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894390|NCT01998958|559034342|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
154894391|NCT01998958|559034311|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894392|NCT01998958|559034312|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894393|NCT01998958|559034313|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894394|NCT01998958|559034314|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894395|NCT01998958|559034315|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894396|NCT01998958|559034316|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894397|NCT01998958|559034317|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894398|NCT01998958|559034318|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894399|NCT01998958|559034319|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894400|NCT01998958|559034320|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894401|NCT01998958|559034321|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894402|NCT01998958|559034322|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894403|NCT01998958|559034323|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894404|NCT01998958|559034324|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894405|NCT01998958|559034325|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894406|NCT01998958|559034326|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894407|NCT01998958|559034327|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894408|NCT01998958|559034328|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894409|NCT01998958|559034329|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894410|NCT01998958|559034330|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894411|NCT01998958|559034331|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894412|NCT01998958|559034332|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
154894413|NCT01998958|559034333|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
154894414|NCT01998958|559034334|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894415|NCT01998958|559034335|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894416|NCT01998958|559034336|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894417|NCT01998958|559034337|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894418|NCT01998958|559034338|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894419|NCT01998958|559034339|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894420|NCT01998958|559034340|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
155114081|NCT03466099|559846231|FG002|Overall Study|Withdrawal by Subject|1|||
155114082|NCT03466099|559846229|FG000|Overall Study|Use of rescue medication|8|||
155114083|NCT03466099|559846230|FG001|Overall Study|Use of rescue medication|9|||
154894421|NCT01998958|559034341|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894422|NCT01998958|559034342|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
154894423|NCT01998958|559034311|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894424|NCT01998958|559034312|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894425|NCT01998958|559034313|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
155114084|NCT03466099|559846231|FG002|Overall Study|Use of rescue medication|13|||
154894426|NCT01998958|559034314|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894427|NCT01998958|559034315|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894428|NCT01998958|559034316|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894429|NCT01998958|559034317|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894430|NCT01998958|559034318|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894431|NCT01998958|559034319|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894432|NCT01998958|559034320|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894433|NCT01998958|559034321|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894434|NCT01998958|559034322|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894435|NCT01998958|559034323|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894436|NCT01998958|559034324|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894437|NCT01998958|559034325|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894438|NCT01998958|559034326|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894439|NCT01998958|559034327|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894440|NCT01998958|559034328|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894441|NCT01998958|559034329|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894442|NCT01998958|559034330|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894443|NCT01998958|559034331|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894444|NCT01998958|559034332|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
154894445|NCT01998958|559034333|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
154894446|NCT01998958|559034334|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
154894447|NCT01998958|559034335|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894448|NCT01998958|559034336|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894449|NCT01998958|559034337|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894450|NCT01998958|559034338|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894451|NCT01998958|559034339|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894452|NCT01998958|559034340|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894453|NCT01998958|559034341|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894454|NCT01998958|559034342|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
154894455|NCT03892707|559034352|FG000|Overall Study|Screen failure|6|||
154894456|NCT03892707|559034353|FG001|Overall Study|Screen failure|0|||
154894457|NCT03892707|559034352|FG000|Overall Study|Pain resolution|0|||
154894458|NCT03892707|559034353|FG001|Overall Study|Pain resolution|4|||
154894459|NCT03892707|559034352|FG000|Overall Study|Withdrawal by Subject|0|||
154894460|NCT03892707|559034353|FG001|Overall Study|Withdrawal by Subject|1|||
154894461|NCT03892707|559034352|FG000|Overall Study|Other (long business trip)|0|||
154894462|NCT03892707|559034353|FG001|Overall Study|Other (long business trip)|1|||
154894463|NCT05224076|559034356|FG000|Overall Study|Lost to Follow-up|24|||
154894464|NCT01807949|559034358|FG000|Overall Study|Adverse Event|1|||
154894465|NCT01807949|559034359|FG001|Overall Study|Adverse Event|2|||
154894466|NCT01807949|559034360|FG002|Overall Study|Adverse Event|2|||
154894467|NCT01807949|559034358|FG000|Overall Study|Withdrawal by Subject|1|||
154894468|NCT01807949|559034359|FG001|Overall Study|Withdrawal by Subject|2|||
154894469|NCT01807949|559034360|FG002|Overall Study|Withdrawal by Subject|2|||
154894470|NCT01807949|559034358|FG000|Overall Study|Non-Compliance|0|||
154894471|NCT01807949|559034359|FG001|Overall Study|Non-Compliance|0|||
154894472|NCT01807949|559034360|FG002|Overall Study|Non-Compliance|1|||
154894473|NCT01807949|559034358|FG000|Overall Study|Undefined|0|||
154894474|NCT01807949|559034359|FG001|Overall Study|Undefined|1|||
154894475|NCT01807949|559034360|FG002|Overall Study|Undefined|2|||
154894476|NCT01807949|559034358|FG000|Overall Study|Randomized But Not Treated|0|||
154894477|NCT01807949|559034359|FG001|Overall Study|Randomized But Not Treated|2|||
154894478|NCT01807949|559034360|FG002|Overall Study|Randomized But Not Treated|2|||
154894479|NCT01457924|559034361|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
154894480|NCT01457924|559034362|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
154894481|NCT01457924|559034363|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
154894482|NCT01457924|559034364|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
154894483|NCT01457924|559034365|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
154894484|NCT01457924|559034361|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
154894485|NCT01457924|559034362|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
154894486|NCT01457924|559034363|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
154894487|NCT01457924|559034364|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
154894488|NCT01457924|559034365|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
154894489|NCT01457924|559034361|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
154894490|NCT01457924|559034362|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
154894491|NCT01457924|559034363|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
154894492|NCT01457924|559034364|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
154894493|NCT01457924|559034365|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
154894494|NCT01457924|559034361|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
154894495|NCT01457924|559034362|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
154894496|NCT01457924|559034363|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
154894497|NCT01457924|559034364|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
154894498|NCT01457924|559034365|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
154978384|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978385|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978386|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978387|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
154978388|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
154978389|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978390|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978391|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978392|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978393|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978394|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978395|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978396|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
154978397|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
154978398|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978399|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978400|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978401|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978402|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978403|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978404|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978405|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
154978406|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
154978407|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978408|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978409|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978410|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978411|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978412|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978413|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978414|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
154978415|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
154978416|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978417|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978418|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154894499|NCT01457924|559034361|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
154894500|NCT01457924|559034362|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
154894501|NCT01457924|559034363|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
154894502|NCT01457924|559034364|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
154894503|NCT01457924|559034365|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
154894504|NCT01457924|559034361|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
154894505|NCT01457924|559034362|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
154894506|NCT01457924|559034363|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
154894507|NCT01457924|559034364|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
154894508|NCT01457924|559034365|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
154894509|NCT01457924|559034361|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
154894510|NCT01457924|559034362|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
154894511|NCT01457924|559034363|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
154894512|NCT01457924|559034364|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
154894513|NCT01457924|559034365|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
154894514|NCT01457924|559034361|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
154894515|NCT01457924|559034362|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
154978419|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978420|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978421|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978422|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978423|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
154978424|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
154978425|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154978426|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
155175622|NCT00958438|560080288|FG002|Overall Study|Other than specified above|2|||
154894516|NCT01457924|559034363|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
154894517|NCT01457924|559034364|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
154894518|NCT01457924|559034365|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
154894519|NCT01457924|559034361|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
154894520|NCT01457924|559034362|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
154894521|NCT01457924|559034363|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
154894522|NCT01457924|559034364|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
154894523|NCT01457924|559034365|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
154894524|NCT01457924|559034361|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
154894525|NCT01457924|559034362|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
154894526|NCT01457924|559034363|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
154894527|NCT01457924|559034364|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
154894528|NCT01457924|559034365|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
154894529|NCT01457924|559034361|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
154894530|NCT01457924|559034362|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
154894531|NCT01457924|559034363|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
154894532|NCT01457924|559034364|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
154894533|NCT01457924|559034365|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
154894534|NCT01457924|559034361|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
154894535|NCT01457924|559034362|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
154894536|NCT01457924|559034363|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
154894537|NCT01457924|559034364|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
154894538|NCT01457924|559034365|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
154894539|NCT01457924|559034361|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
154894540|NCT01457924|559034362|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
154894541|NCT01457924|559034363|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
154894542|NCT01457924|559034364|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
154894543|NCT01457924|559034365|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
154894544|NCT01665768|559034368|FG000|Overall Study|Adverse Event|3|||
154894545|NCT01665768|559034368|FG000|Overall Study|Lack of Efficacy|19|||
154894546|NCT01665768|559034368|FG000|Overall Study|Withdrawal by Subject|1|||
154894547|NCT01329341|559034369|FG000|Overall Study|Withdrawal by Subject|44|||
154894548|NCT00448760|559034370|FG000|Overall Study|Death|3|||
154894549|NCT03017846|559034375|FG000|Overall Study|Lost to Follow-up|3|||
154894550|NCT03017846|559034375|FG000|Overall Study|Adverse Event|2|||
154894551|NCT04603391|559034377|FG000|First Intervention (4 Days)|Adverse Event|1|||
154894552|NCT04603391|559034378|FG001|First Intervention (4 Days)|Adverse Event|0|||
154894553|NCT04603391|559034377|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
154894554|NCT04603391|559034378|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
154894555|NCT02759861|559034381|FG000|Overall Study|Death|1|||
154894556|NCT02151682|559034382|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
154894557|NCT02151682|559034383|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
154894558|NCT02151682|559034384|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
154894559|NCT02151682|559034385|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
154894560|NCT02151682|559034386|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
154894561|NCT02151682|559034387|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
154894562|NCT02151682|559034382|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
154894563|NCT02151682|559034383|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
154894564|NCT02151682|559034384|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
154894565|NCT02151682|559034385|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
154894566|NCT02151682|559034386|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
154894567|NCT02151682|559034387|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
154894568|NCT02151682|559034382|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
154894569|NCT02151682|559034383|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
154894570|NCT02151682|559034384|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
154894571|NCT02151682|559034385|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
154894572|NCT02151682|559034386|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
154894573|NCT02151682|559034387|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
154894574|NCT02151682|559034382|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
154894575|NCT02151682|559034383|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
154894576|NCT02151682|559034384|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
154894577|NCT02151682|559034385|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
154894578|NCT02151682|559034386|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
154894579|NCT02151682|559034387|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
154894580|NCT02151682|559034382|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
154894581|NCT02151682|559034383|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
154894582|NCT02151682|559034384|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
154894583|NCT02151682|559034385|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
154894584|NCT02151682|559034386|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
154978427|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154978428|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154894585|NCT02151682|559034387|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
154894586|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
154894587|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
154894588|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
154894589|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
154894590|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
154894591|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
154894592|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
154894593|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
154894594|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
154894595|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
154894596|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
154894597|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
154894598|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
154894599|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
154894600|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
154894601|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
154894602|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
154894603|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
154894604|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
154894605|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
154894606|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
154894607|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
154894608|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
154894609|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
154894610|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
154894611|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
154894612|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
154894613|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
154894614|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
154894615|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
154894616|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
154894617|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
154894618|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
154894619|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
154894620|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
154894621|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
154894622|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
154894623|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
154894624|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
154894625|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
154894626|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
154894627|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
154894628|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
154894629|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
154894630|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
154894631|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
154894632|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
154894633|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
154894634|NCT02151682|559034382|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
154894635|NCT02151682|559034383|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
154894636|NCT02151682|559034384|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
154894637|NCT02151682|559034385|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
154894638|NCT02151682|559034386|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
154894639|NCT02151682|559034387|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
154894640|NCT02151682|559034382|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
154894641|NCT02151682|559034383|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
154894642|NCT02151682|559034384|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
154894643|NCT02151682|559034385|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
154894644|NCT02151682|559034386|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
154894645|NCT02151682|559034387|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
154894646|NCT02151682|559034382|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
154894647|NCT02151682|559034383|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
154894648|NCT02151682|559034384|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
154978429|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154978430|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154978431|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154978432|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
154978433|NCT00739973|559342844|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
154978434|NCT00739973|559342845|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978435|NCT00739973|559342846|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978436|NCT00739973|559342847|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978437|NCT00739973|559342848|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978438|NCT00739973|559342849|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978439|NCT00739973|559342850|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978440|NCT00739973|559342851|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978441|NCT00739973|559342852|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
154978442|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
154978443|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
154978444|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
154978445|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
154978446|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
154978447|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
154978448|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
155114085|NCT03466099|559846229|FG000|Overall Study|Rescued without meeting criteria|4|||
155114086|NCT03466099|559846230|FG001|Overall Study|Rescued without meeting criteria|1|||
155114087|NCT03466099|559846231|FG002|Overall Study|Rescued without meeting criteria|1|||
155114088|NCT03466099|559846229|FG000|Overall Study|Subject compliance|2|||
155114089|NCT03466099|559846230|FG001|Overall Study|Subject compliance|0|||
155114090|NCT03466099|559846231|FG002|Overall Study|Subject compliance|0|||
155175623|NCT02788279|560080290|FG000|Overall Study|Death|62|||
154894649|NCT02151682|559034385|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
154894650|NCT02151682|559034386|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
154894651|NCT02151682|559034387|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
154894652|NCT02151682|559034382|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
154894653|NCT02151682|559034383|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
154894654|NCT02151682|559034384|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
154894655|NCT02151682|559034385|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
154894656|NCT02151682|559034386|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
154894657|NCT02151682|559034387|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
154894658|NCT02151682|559034382|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
154894659|NCT02151682|559034383|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
154894660|NCT02151682|559034384|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
154894661|NCT02151682|559034385|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
154894662|NCT02151682|559034386|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
154894663|NCT02151682|559034387|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
154894664|NCT00618995|559034388|FG000|Period 1|Adverse Event|0|||
154894665|NCT00618995|559034389|FG001|Period 1|Adverse Event|0|||
154894666|NCT00618995|559034390|FG002|Period 1|Adverse Event|1|||
154894667|NCT00618995|559034391|FG003|Period 1|Adverse Event|0|||
154894668|NCT00618995|559034388|FG000|Period 1|Protocol Violation|0|||
154894669|NCT00618995|559034389|FG001|Period 1|Protocol Violation|1|||
154894670|NCT00618995|559034390|FG002|Period 1|Protocol Violation|1|||
154894671|NCT00618995|559034391|FG003|Period 1|Protocol Violation|0|||
154894672|NCT00618995|559034388|FG000|Period 2|Protocol Violation|0|||
154894673|NCT00618995|559034389|FG001|Period 2|Protocol Violation|0|||
154894674|NCT00618995|559034390|FG002|Period 2|Protocol Violation|1|||
154894675|NCT00618995|559034391|FG003|Period 2|Protocol Violation|0|||
154894676|NCT00618995|559034388|FG000|Period 4|Adverse Event|1|||
154894677|NCT00618995|559034389|FG001|Period 4|Adverse Event|0|||
154894678|NCT00618995|559034390|FG002|Period 4|Adverse Event|0|||
154894679|NCT00618995|559034391|FG003|Period 4|Adverse Event|0|||
154894680|NCT01213264|559034392|FG000|Overall Study|Adverse Event|1|||
154894681|NCT01213264|559034393|FG001|Overall Study|Adverse Event|0|||
154894682|NCT01213264|559034394|FG002|Overall Study|Adverse Event|0|||
154894683|NCT01213264|559034392|FG000|Overall Study|Lost to Follow-up|1|||
154894684|NCT01213264|559034393|FG001|Overall Study|Lost to Follow-up|2|||
154894685|NCT01213264|559034394|FG002|Overall Study|Lost to Follow-up|6|||
154894686|NCT00290589|559034395|FG000|Overall Study|Lost to Follow-up|2|||
154894687|NCT00290589|559034396|FG001|Overall Study|Lost to Follow-up|2|||
154894688|NCT05014542|559034397|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
154978449|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
154978450|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
155114091|NCT03466099|559846229|FG000|Overall Study|Worsening disease|0|||
155114092|NCT03466099|559846230|FG001|Overall Study|Worsening disease|0|||
155114093|NCT03466099|559846231|FG002|Overall Study|Worsening disease|1|||
155175624|NCT02788279|560080291|FG001|Overall Study|Death|136|||
154978451|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978452|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978453|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978454|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978455|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
154978456|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978457|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978458|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
154978459|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
154978460|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
154978461|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
154978462|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978463|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978464|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978465|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978466|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978467|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978468|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
154978469|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
154978470|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
154978471|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
154978472|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
154978473|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
154978474|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
154978475|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
154978476|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
154978477|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
154978478|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978479|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978480|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
154978481|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978482|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978483|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978484|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978485|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978486|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
154978487|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
154978488|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
154978489|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
154978490|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
154978491|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
154978492|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
154978493|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
154978494|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
154978495|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
154978496|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
154978497|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
154978498|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
154978499|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
154978500|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
154978501|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
154978502|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
154978503|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
154978504|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
155114094|NCT00075946|559846234|FG000|Overall Study|Path ineligible: undetermined histology|0|||
155114095|NCT00075946|559846235|FG001|Overall Study|Path ineligible: undetermined histology|0|||
155114096|NCT00075946|559846236|FG002|Overall Study|Path ineligible: undetermined histology|0|||
155114097|NCT00075946|559846237|FG003|Overall Study|Path ineligible: undetermined histology|0|||
155175625|NCT02788279|560080292|FG002|Overall Study|Death|72|||
154894689|NCT05014542|559034398|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
154894690|NCT05014542|559034397|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
154894691|NCT05014542|559034398|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
154894692|NCT05014542|559034397|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
154894693|NCT05014542|559034398|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
154894694|NCT05014542|559034397|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
154894695|NCT05014542|559034398|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
154894696|NCT01438307|559034399|FG000|Overall Study|Death|1|||
154894697|NCT01438307|559034400|FG001|Overall Study|Death|1|||
154894698|NCT06000501|559034401|FG000|Overall Study|Screen failure|3|||
154894699|NCT06000501|559034401|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
154894700|NCT06000501|559034401|FG000|Overall Study|Physician Decision|4|||
154894701|NCT06000501|559034401|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
154894702|NCT06000501|559034401|FG000|Overall Study|Scheduling issues|2|||
154894703|NCT02378883|559034402|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
154894704|NCT02378883|559034402|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
154894705|NCT02378883|559034402|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
154894706|NCT02378883|559034402|FG000|30 Day Follow-Up|Physician Decision|2|||
154894707|NCT02378883|559034402|FG000|30 Day Follow-Up|Missed Visit|2|||
154894708|NCT02378883|559034402|FG000|30 Day Follow-Up|Death|1|||
154894709|NCT02378883|559034402|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
154894710|NCT02378883|559034402|FG000|12 Months Follow-Up|Death|2|||
154894711|NCT00318565|559034403|FG000|Overall Study|Excluded per protocol|24|||
154894712|NCT00691093|559034404|FG000|Overall Study|Adverse Event|1|||
154894713|NCT00691093|559034404|FG000|Overall Study|Lost to Follow-up|1|||
154894714|NCT00691093|559034404|FG000|Overall Study|Lack of Efficacy|1|||
154894715|NCT00691093|559034404|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
154894716|NCT01700985|559034408|FG000|Overall Study|Incarcerated|0|||
154894717|NCT01700985|559034409|FG001|Overall Study|Incarcerated|1|||
154894718|NCT00965146|559034410|FG000|Overall Study|Death|7|||
154894719|NCT00965146|559034410|FG000|Overall Study|Lost to Follow-up|22|||
154894720|NCT00965146|559034410|FG000|Overall Study|Withdrawal by Subject|17|||
154894721|NCT00965146|559034410|FG000|Overall Study|Unable to return|1|||
154894722|NCT00965146|559034410|FG000|Overall Study|Unwilling to return|11|||
154894723|NCT00965146|559034410|FG000|Overall Study|Intercurrent illness|1|||
154894724|NCT00965146|559034410|FG000|Overall Study|Revision / Removal of Study Implant|6|||
154894725|NCT00965146|559034410|FG000|Overall Study|Overall Study Termination|145|||
154894726|NCT00067470|559034411|FG000|Overall Study|Withdrawal by Subject|0|||
154894727|NCT00067470|559034412|FG001|Overall Study|Withdrawal by Subject|1|||
154894728|NCT01135017|559034413|FG000|Overall Study|Adverse Event|3|||
154894729|NCT01135017|559034414|FG001|Overall Study|Adverse Event|8|||
154894730|NCT01135017|559034413|FG000|Overall Study|Other than above|3|||
154894731|NCT01135017|559034414|FG001|Overall Study|Other than above|4|||
154894732|NCT01148693|559034415|FG000|Overall Study|Attempts for cannulation were failed|13|||
154894733|NCT01148693|559034416|FG001|Overall Study|Attempts for cannulation were failed|10|||
154894734|NCT03699631|559034420|FG000|Overall Study|Adverse Event|3|||
154894735|NCT00039741|559034421|FG000|Overall Study|Death|0|||
154894736|NCT00039741|559034422|FG001|Overall Study|Death|1|||
154894737|NCT00039741|559034423|FG002|Overall Study|Death|0|||
154894738|NCT00039741|559034424|FG003|Overall Study|Death|0|||
154894739|NCT00039741|559034421|FG000|Overall Study|Lost to Follow-up|3|||
154894740|NCT00039741|559034422|FG001|Overall Study|Lost to Follow-up|1|||
154894741|NCT00039741|559034423|FG002|Overall Study|Lost to Follow-up|5|||
154894742|NCT00039741|559034424|FG003|Overall Study|Lost to Follow-up|2|||
154894743|NCT00039741|559034421|FG000|Overall Study|Confounding medical condition|1|||
154894744|NCT00039741|559034422|FG001|Overall Study|Confounding medical condition|0|||
154894745|NCT00039741|559034423|FG002|Overall Study|Confounding medical condition|0|||
154894746|NCT00039741|559034424|FG003|Overall Study|Confounding medical condition|0|||
154894747|NCT00039741|559034421|FG000|Overall Study|Not able to get to clinic|5|||
154894748|NCT00039741|559034422|FG001|Overall Study|Not able to get to clinic|2|||
154894749|NCT00039741|559034423|FG002|Overall Study|Not able to get to clinic|0|||
154894750|NCT00039741|559034424|FG003|Overall Study|Not able to get to clinic|3|||
154894751|NCT00039741|559034421|FG000|Overall Study|Moved|3|||
154894752|NCT00039741|559034422|FG001|Overall Study|Moved|2|||
154894753|NCT00039741|559034423|FG002|Overall Study|Moved|3|||
154894754|NCT00039741|559034424|FG003|Overall Study|Moved|6|||
154894755|NCT00039741|559034421|FG000|Overall Study|Non-compliance with protocol|1|||
154894756|NCT00039741|559034422|FG001|Overall Study|Non-compliance with protocol|0|||
154894757|NCT00039741|559034423|FG002|Overall Study|Non-compliance with protocol|1|||
154894758|NCT00039741|559034424|FG003|Overall Study|Non-compliance with protocol|0|||
154894759|NCT00039741|559034421|FG000|Overall Study|Withdrew consent|0|||
154894760|NCT00039741|559034422|FG001|Overall Study|Withdrew consent|5|||
154894761|NCT00039741|559034423|FG002|Overall Study|Withdrew consent|0|||
154894762|NCT00039741|559034424|FG003|Overall Study|Withdrew consent|1|||
154894763|NCT00039741|559034421|FG000|Overall Study|Missed final visit|2|||
154894764|NCT00039741|559034422|FG001|Overall Study|Missed final visit|1|||
154894765|NCT00039741|559034423|FG002|Overall Study|Missed final visit|2|||
154894766|NCT00039741|559034424|FG003|Overall Study|Missed final visit|2|||
154894767|NCT00507416|559034425|FG000|Overall Study|Adverse Event|58|||
154894768|NCT00507416|559034426|FG001|Overall Study|Adverse Event|67|||
154894769|NCT00507416|559034427|FG002|Overall Study|Adverse Event|65|||
154894770|NCT00507416|559034425|FG000|Overall Study|Protocol Violation|1|||
154894771|NCT00507416|559034426|FG001|Overall Study|Protocol Violation|2|||
154894772|NCT00507416|559034427|FG002|Overall Study|Protocol Violation|0|||
154894773|NCT00507416|559034425|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
154894774|NCT00507416|559034426|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
154894775|NCT00507416|559034427|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
154894776|NCT00507416|559034425|FG000|Overall Study|Progressive Disease|20|||
154894777|NCT00507416|559034426|FG001|Overall Study|Progressive Disease|10|||
154894778|NCT00507416|559034427|FG002|Overall Study|Progressive Disease|13|||
154894779|NCT00507416|559034425|FG000|Overall Study|Patient declined further treatment|18|||
154894780|NCT00507416|559034426|FG001|Overall Study|Patient declined further treatment|14|||
154894781|NCT00507416|559034427|FG002|Overall Study|Patient declined further treatment|11|||
154894782|NCT00507416|559034425|FG000|Overall Study|Other|11|||
154894783|NCT00507416|559034426|FG001|Overall Study|Other|16|||
154894784|NCT00507416|559034427|FG002|Overall Study|Other|13|||
154894785|NCT00507416|559034425|FG000|Overall Study|Did not Receive Study Treatment|3|||
154894786|NCT00507416|559034426|FG001|Overall Study|Did not Receive Study Treatment|9|||
154894787|NCT00507416|559034427|FG002|Overall Study|Did not Receive Study Treatment|4|||
154894788|NCT00964158|559034428|FG000|Overall Study|Lost to Follow-up|0|||
154894789|NCT00964158|559034429|FG001|Overall Study|Lost to Follow-up|1|||
154894790|NCT00964158|559034430|FG002|Overall Study|Lost to Follow-up|2|||
154894791|NCT00964158|559034428|FG000|Overall Study|Withdrawal by Subject|0|||
154894792|NCT00964158|559034429|FG001|Overall Study|Withdrawal by Subject|0|||
154894793|NCT00964158|559034430|FG002|Overall Study|Withdrawal by Subject|6|||
154894794|NCT03101514|559034431|FG000|Overall Study|Withdrawal by Subject|4|||
154894795|NCT03101514|559034431|FG000|Overall Study|Protocol Violation|2|||
154894796|NCT03101514|559034431|FG000|Overall Study|patient's information was incomplete|1|||
154894797|NCT01736254|559034433|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
154894798|NCT01736254|559034433|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
154894799|NCT02559206|559034434|FG000|Overall Study|Adverse Event|0|||
154894800|NCT02559206|559034435|FG001|Overall Study|Adverse Event|4|||
154894801|NCT02559206|559034436|FG002|Overall Study|Adverse Event|1|||
154894802|NCT02559206|559034437|FG003|Overall Study|Adverse Event|5|||
154894803|NCT02559206|559034438|FG004|Overall Study|Adverse Event|3|||
154894804|NCT02559206|559034439|FG005|Overall Study|Adverse Event|0|||
154894805|NCT02559206|559034440|FG006|Overall Study|Adverse Event|1|||
154894806|NCT02559206|559034441|FG007|Overall Study|Adverse Event|0|||
154894807|NCT02559206|559034434|FG000|Overall Study|Protocol Violation|1|||
154894808|NCT02559206|559034435|FG001|Overall Study|Protocol Violation|0|||
154894809|NCT02559206|559034436|FG002|Overall Study|Protocol Violation|1|||
154894810|NCT02559206|559034437|FG003|Overall Study|Protocol Violation|0|||
154894811|NCT02559206|559034438|FG004|Overall Study|Protocol Violation|0|||
154894812|NCT02559206|559034439|FG005|Overall Study|Protocol Violation|2|||
154894813|NCT02559206|559034440|FG006|Overall Study|Protocol Violation|0|||
154894814|NCT02559206|559034441|FG007|Overall Study|Protocol Violation|0|||
154894815|NCT02559206|559034434|FG000|Overall Study|Withdrawal by Subject|3|||
154894816|NCT02559206|559034435|FG001|Overall Study|Withdrawal by Subject|3|||
154894817|NCT02559206|559034436|FG002|Overall Study|Withdrawal by Subject|1|||
154894818|NCT02559206|559034437|FG003|Overall Study|Withdrawal by Subject|3|||
154894819|NCT02559206|559034438|FG004|Overall Study|Withdrawal by Subject|5|||
154894820|NCT02559206|559034439|FG005|Overall Study|Withdrawal by Subject|4|||
154894821|NCT02559206|559034440|FG006|Overall Study|Withdrawal by Subject|1|||
154894822|NCT02559206|559034441|FG007|Overall Study|Withdrawal by Subject|2|||
154978505|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154978506|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154978507|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154894823|NCT02559206|559034434|FG000|Overall Study|Lost to Follow-up|3|||
154894824|NCT02559206|559034435|FG001|Overall Study|Lost to Follow-up|5|||
154978508|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154978509|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
155114098|NCT00075946|559846238|FG004|Overall Study|Path ineligible: undetermined histology|6|||
155114099|NCT00075946|559846234|FG000|Overall Study|Did not achieve response after induction|0|||
154894825|NCT02559206|559034436|FG002|Overall Study|Lost to Follow-up|3|||
154894826|NCT02559206|559034437|FG003|Overall Study|Lost to Follow-up|3|||
154894827|NCT02559206|559034438|FG004|Overall Study|Lost to Follow-up|2|||
154894828|NCT02559206|559034439|FG005|Overall Study|Lost to Follow-up|5|||
154894829|NCT02559206|559034440|FG006|Overall Study|Lost to Follow-up|1|||
154894830|NCT02559206|559034441|FG007|Overall Study|Lost to Follow-up|4|||
154894831|NCT02559206|559034434|FG000|Overall Study|Lack of Efficacy|1|||
154894832|NCT02559206|559034435|FG001|Overall Study|Lack of Efficacy|0|||
154894833|NCT02559206|559034436|FG002|Overall Study|Lack of Efficacy|3|||
154978510|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154978511|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
154978512|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154978513|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
154978514|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
154978515|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
154978516|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
154978517|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
154978518|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
154978519|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
154978520|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
154978521|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
154978522|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
154978523|NCT00739973|559342844|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978524|NCT00739973|559342845|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
154978525|NCT00739973|559342846|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978526|NCT00739973|559342847|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978527|NCT00739973|559342848|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978528|NCT00739973|559342849|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978529|NCT00739973|559342850|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
154978530|NCT00739973|559342851|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978531|NCT00739973|559342852|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
154978532|NCT02175368|559342853|FG000|Overall Study|Lost to Follow-up|1|||
154978533|NCT00966381|559345642|FG000|Overall Study|Withdrawal by Subject|2|||
154978534|NCT00966381|559345643|FG001|Overall Study|Withdrawal by Subject|2|||
154978535|NCT03686150|559345644|FG000|Overall Study|Withdrawal by Subject|1|||
154978536|NCT03686150|559345645|FG001|Overall Study|Withdrawal by Subject|1|||
154978537|NCT03686150|559345646|FG002|Overall Study|Withdrawal by Subject|1|||
154978538|NCT03686150|559345647|FG003|Overall Study|Withdrawal by Subject|0|||
154978539|NCT03686150|559345648|FG004|Overall Study|Withdrawal by Subject|1|||
154978540|NCT03686150|559345649|FG005|Overall Study|Withdrawal by Subject|2|||
154978541|NCT03686150|559345644|FG000|Overall Study|Physician Decision|1|||
154978542|NCT03686150|559345645|FG001|Overall Study|Physician Decision|0|||
154978543|NCT03686150|559345646|FG002|Overall Study|Physician Decision|0|||
154978544|NCT03686150|559345647|FG003|Overall Study|Physician Decision|0|||
154978545|NCT03686150|559345648|FG004|Overall Study|Physician Decision|0|||
154978546|NCT03686150|559345649|FG005|Overall Study|Physician Decision|1|||
154978547|NCT03686150|559345644|FG000|Overall Study|Lost to Follow-up|0|||
154978548|NCT03686150|559345645|FG001|Overall Study|Lost to Follow-up|1|||
154978549|NCT03686150|559345646|FG002|Overall Study|Lost to Follow-up|0|||
154978550|NCT03686150|559345647|FG003|Overall Study|Lost to Follow-up|0|||
154978551|NCT03686150|559345648|FG004|Overall Study|Lost to Follow-up|0|||
154978552|NCT03686150|559345649|FG005|Overall Study|Lost to Follow-up|0|||
154978553|NCT01844531|559345650|FG000|Overall Study|Withdrawal by Subject|0|||
154978554|NCT01844531|559345651|FG001|Overall Study|Withdrawal by Subject|1|||
154978555|NCT01844531|559345652|FG002|Overall Study|Withdrawal by Subject|0|||
154978556|NCT01844531|559345653|FG003|Overall Study|Withdrawal by Subject|0|||
154978557|NCT01345318|559345660|FG000|Overall Study|Adverse Event|16|||
154978558|NCT01345318|559345660|FG000|Overall Study|Lack of Efficacy|17|||
154978559|NCT01345318|559345660|FG000|Overall Study|Lost to Follow-up|2|||
154978560|NCT01345318|559345660|FG000|Overall Study|Protocol Violation|1|||
154978561|NCT01345318|559345660|FG000|Overall Study|Withdrawal by Subject|41|||
154978562|NCT01345318|559345660|FG000|Overall Study|Other|3|||
154978563|NCT00792623|559345662|FG000|Overall Study|Adverse Event|2|||
154978564|NCT00792623|559345662|FG000|Overall Study|Withdrawal by Subject|5|||
154978565|NCT01685073|559345663|FG000|Overall Study|Lost to Follow-up|6|||
154978566|NCT01685073|559345664|FG001|Overall Study|Lost to Follow-up|8|||
154978567|NCT01685073|559345663|FG000|Overall Study|Withdrawal by Subject|24|||
154978568|NCT01685073|559345664|FG001|Overall Study|Withdrawal by Subject|24|||
154978569|NCT00880087|559345667|FG000|Overall Study|Lost to Follow-up|0|||
154978570|NCT00880087|559345668|FG001|Overall Study|Lost to Follow-up|2|||
154978571|NCT00743509|559345669|FG000|Overall Study|Withdrawal by Subject|2|||
154978572|NCT01239472|559345670|FG000|Overall Study|Withdrawal by Subject|5|||
154978573|NCT01239472|559345671|FG001|Overall Study|Withdrawal by Subject|1|||
154978574|NCT01239472|559345670|FG000|Overall Study|Adverse Event|0|||
154978575|NCT01239472|559345671|FG001|Overall Study|Adverse Event|1|||
154978576|NCT01239472|559345670|FG000|Overall Study|Lack of Efficacy|0|||
155175626|NCT02788279|560080290|FG000|Overall Study|Withdrawal by Subject|10|||
154978577|NCT01239472|559345671|FG001|Overall Study|Lack of Efficacy|1|||
154978578|NCT01280617|559345672|FG000|Overall Study|Adverse Event|0|||
154978579|NCT01280617|559345673|FG001|Overall Study|Adverse Event|1|||
154894834|NCT02559206|559034437|FG003|Overall Study|Lack of Efficacy|2|||
154894835|NCT02559206|559034438|FG004|Overall Study|Lack of Efficacy|2|||
154894836|NCT02559206|559034439|FG005|Overall Study|Lack of Efficacy|3|||
154894837|NCT02559206|559034440|FG006|Overall Study|Lack of Efficacy|3|||
154894838|NCT02559206|559034441|FG007|Overall Study|Lack of Efficacy|3|||
154894839|NCT02559206|559034434|FG000|Overall Study|Other Not Specified|0|||
154894840|NCT02559206|559034435|FG001|Overall Study|Other Not Specified|0|||
154894841|NCT02559206|559034436|FG002|Overall Study|Other Not Specified|0|||
154894842|NCT02559206|559034437|FG003|Overall Study|Other Not Specified|1|||
154894843|NCT02559206|559034438|FG004|Overall Study|Other Not Specified|0|||
154894844|NCT02559206|559034439|FG005|Overall Study|Other Not Specified|0|||
154894845|NCT02559206|559034440|FG006|Overall Study|Other Not Specified|0|||
154894846|NCT02559206|559034441|FG007|Overall Study|Other Not Specified|0|||
154894847|NCT01375647|559036155|FG000|Overall Study|Lost to Follow-up|3|||
154894848|NCT01375647|559036156|FG001|Overall Study|Lost to Follow-up|3|||
154894849|NCT01375647|559036157|FG002|Overall Study|Lost to Follow-up|7|||
154894850|NCT01375647|559036158|FG003|Overall Study|Lost to Follow-up|10|||
154894851|NCT01375647|559036155|FG000|Overall Study|Death|1|||
154894852|NCT01375647|559036156|FG001|Overall Study|Death|2|||
154894853|NCT01375647|559036157|FG002|Overall Study|Death|1|||
154894854|NCT01375647|559036158|FG003|Overall Study|Death|0|||
154894855|NCT01375647|559036155|FG000|Overall Study|Withdrawal by Subject|17|||
154894856|NCT01375647|559036156|FG001|Overall Study|Withdrawal by Subject|20|||
154894857|NCT01375647|559036157|FG002|Overall Study|Withdrawal by Subject|26|||
154894858|NCT01375647|559036158|FG003|Overall Study|Withdrawal by Subject|14|||
154894859|NCT01375647|559036155|FG000|Overall Study|Physician Decision|1|||
154894860|NCT01375647|559036156|FG001|Overall Study|Physician Decision|0|||
154894861|NCT01375647|559036157|FG002|Overall Study|Physician Decision|0|||
154894862|NCT01375647|559036158|FG003|Overall Study|Physician Decision|0|||
154894863|NCT01102140|559036159|FG000|Overall Study|Lost to Follow-up|1|||
154894864|NCT01102140|559036160|FG001|Overall Study|Lost to Follow-up|0|||
154894865|NCT01102140|559036159|FG000|Overall Study|Investigator terminated study|2|||
154894866|NCT01102140|559036160|FG001|Overall Study|Investigator terminated study|2|||
154894867|NCT03788967|559036161|FG000|Overall Study|Lost to Follow-up|14|||
154894868|NCT03788967|559036162|FG001|Overall Study|Lost to Follow-up|10|||
154894869|NCT03788967|559036161|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
154894870|NCT03788967|559036162|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
154894871|NCT03788967|559036161|FG000|Overall Study|Participant Withdrawal of Consent|13|||
154894872|NCT03788967|559036162|FG001|Overall Study|Participant Withdrawal of Consent|5|||
154894873|NCT03788967|559036161|FG000|Overall Study|Adverse Event|1|||
154894874|NCT03788967|559036162|FG001|Overall Study|Adverse Event|1|||
154894875|NCT03788967|559036161|FG000|Overall Study|COVID-19|1|||
154894876|NCT03788967|559036162|FG001|Overall Study|COVID-19|2|||
154894877|NCT04268303|559036163|FG000|Overall Study|Lost to Follow-up|1|||
154894878|NCT04268303|559036164|FG001|Overall Study|Lost to Follow-up|1|||
154894879|NCT04268303|559036165|FG002|Overall Study|Lost to Follow-up|2|||
154894880|NCT04268303|559036163|FG000|Overall Study|Withdrawal by Subject|0|||
154894881|NCT04268303|559036164|FG001|Overall Study|Withdrawal by Subject|1|||
154894882|NCT04268303|559036165|FG002|Overall Study|Withdrawal by Subject|1|||
154894883|NCT04268303|559036163|FG000|Overall Study|Adverse Event|2|||
154894884|NCT04268303|559036164|FG001|Overall Study|Adverse Event|0|||
154894885|NCT04268303|559036165|FG002|Overall Study|Adverse Event|0|||
154894886|NCT00355134|559036166|FG000|Core Phase|Withdrawal by Subject|35|||
154894887|NCT00355134|559036167|FG001|Core Phase|Withdrawal by Subject|24|||
154894888|NCT00355134|559036168|FG002|Core Phase|Withdrawal by Subject|35|||
154894889|NCT00355134|559036169|FG003|Core Phase|Withdrawal by Subject|0|||
154894890|NCT00355134|559036170|FG004|Core Phase|Withdrawal by Subject|0|||
154894891|NCT00355134|559036166|FG000|Core Phase|Adverse Event|28|||
154894892|NCT00355134|559036167|FG001|Core Phase|Adverse Event|22|||
154894893|NCT00355134|559036168|FG002|Core Phase|Adverse Event|16|||
154894894|NCT00355134|559036169|FG003|Core Phase|Adverse Event|0|||
154894895|NCT00355134|559036170|FG004|Core Phase|Adverse Event|0|||
154894896|NCT00355134|559036166|FG000|Core Phase|Lost to Follow-up|17|||
154894897|NCT00355134|559036167|FG001|Core Phase|Lost to Follow-up|13|||
154894898|NCT00355134|559036168|FG002|Core Phase|Lost to Follow-up|21|||
154894899|NCT00355134|559036169|FG003|Core Phase|Lost to Follow-up|0|||
154894900|NCT00355134|559036170|FG004|Core Phase|Lost to Follow-up|0|||
154894901|NCT00355134|559036166|FG000|Core Phase|Abnormal laboratory value(s)|19|||
154894902|NCT00355134|559036167|FG001|Core Phase|Abnormal laboratory value(s)|14|||
154894903|NCT00355134|559036168|FG002|Core Phase|Abnormal laboratory value(s)|2|||
154894904|NCT00355134|559036169|FG003|Core Phase|Abnormal laboratory value(s)|0|||
154894905|NCT00355134|559036170|FG004|Core Phase|Abnormal laboratory value(s)|0|||
154894906|NCT00355134|559036166|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
154894907|NCT00355134|559036167|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
154894908|NCT00355134|559036168|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
154894909|NCT00355134|559036169|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
154894910|NCT00355134|559036170|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
154894911|NCT00355134|559036166|FG000|Core Phase|Administrative problems|5|||
154894912|NCT00355134|559036167|FG001|Core Phase|Administrative problems|3|||
154894913|NCT00355134|559036168|FG002|Core Phase|Administrative problems|5|||
154894914|NCT00355134|559036169|FG003|Core Phase|Administrative problems|0|||
154894915|NCT00355134|559036170|FG004|Core Phase|Administrative problems|0|||
154894916|NCT00355134|559036166|FG000|Core Phase|Protocol Violation|3|||
154894917|NCT00355134|559036167|FG001|Core Phase|Protocol Violation|2|||
154894918|NCT00355134|559036168|FG002|Core Phase|Protocol Violation|2|||
154894919|NCT00355134|559036169|FG003|Core Phase|Protocol Violation|0|||
154894920|NCT00355134|559036170|FG004|Core Phase|Protocol Violation|0|||
154894921|NCT00355134|559036166|FG000|Core Phase|Abnormal test procedure result(s)|1|||
154894922|NCT00355134|559036167|FG001|Core Phase|Abnormal test procedure result(s)|2|||
154894923|NCT00355134|559036168|FG002|Core Phase|Abnormal test procedure result(s)|1|||
154894924|NCT00355134|559036169|FG003|Core Phase|Abnormal test procedure result(s)|0|||
154894925|NCT00355134|559036170|FG004|Core Phase|Abnormal test procedure result(s)|0|||
154894926|NCT00355134|559036166|FG000|Core Phase|Condition no longer requires study drug|1|||
154894927|NCT00355134|559036167|FG001|Core Phase|Condition no longer requires study drug|0|||
154894928|NCT00355134|559036168|FG002|Core Phase|Condition no longer requires study drug|1|||
154894929|NCT00355134|559036169|FG003|Core Phase|Condition no longer requires study drug|0|||
154894930|NCT00355134|559036170|FG004|Core Phase|Condition no longer requires study drug|0|||
154894931|NCT00355134|559036166|FG000|Extension Phase|Withdrawal by Subject|7|||
154894932|NCT00355134|559036167|FG001|Extension Phase|Withdrawal by Subject|11|||
154894933|NCT00355134|559036168|FG002|Extension Phase|Withdrawal by Subject|0|||
154894934|NCT00355134|559036169|FG003|Extension Phase|Withdrawal by Subject|7|||
154894935|NCT00355134|559036170|FG004|Extension Phase|Withdrawal by Subject|5|||
154894936|NCT00355134|559036166|FG000|Extension Phase|Adverse Event|13|||
154894937|NCT00355134|559036167|FG001|Extension Phase|Adverse Event|9|||
154894938|NCT00355134|559036168|FG002|Extension Phase|Adverse Event|0|||
154894939|NCT00355134|559036169|FG003|Extension Phase|Adverse Event|3|||
154894940|NCT00355134|559036170|FG004|Extension Phase|Adverse Event|5|||
154894941|NCT00355134|559036166|FG000|Extension Phase|Lost to Follow-up|2|||
154894942|NCT00355134|559036167|FG001|Extension Phase|Lost to Follow-up|6|||
154894943|NCT00355134|559036168|FG002|Extension Phase|Lost to Follow-up|0|||
154894944|NCT00355134|559036169|FG003|Extension Phase|Lost to Follow-up|2|||
154894945|NCT00355134|559036170|FG004|Extension Phase|Lost to Follow-up|4|||
154894946|NCT00355134|559036166|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
154894947|NCT00355134|559036167|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
154894948|NCT00355134|559036168|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
154894949|NCT00355134|559036169|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
154894950|NCT00355134|559036170|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
154894951|NCT00355134|559036166|FG000|Extension Phase|Administrative problems|2|||
154894952|NCT00355134|559036167|FG001|Extension Phase|Administrative problems|4|||
154894953|NCT00355134|559036168|FG002|Extension Phase|Administrative problems|0|||
154894954|NCT00355134|559036169|FG003|Extension Phase|Administrative problems|1|||
154894955|NCT00355134|559036170|FG004|Extension Phase|Administrative problems|1|||
154894956|NCT00355134|559036166|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
154894957|NCT00355134|559036167|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
154894958|NCT00355134|559036168|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
154894959|NCT00355134|559036169|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
154894960|NCT00355134|559036170|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
154894961|NCT00355134|559036166|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
154894962|NCT00355134|559036167|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
154894963|NCT00355134|559036168|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
154894964|NCT00355134|559036169|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
154894965|NCT00355134|559036170|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
154894966|NCT00355134|559036166|FG000|Extension Phase|Protocol Violation|0|||
154894967|NCT00355134|559036167|FG001|Extension Phase|Protocol Violation|0|||
154894968|NCT00355134|559036168|FG002|Extension Phase|Protocol Violation|0|||
154894969|NCT00355134|559036169|FG003|Extension Phase|Protocol Violation|1|||
154894970|NCT00355134|559036170|FG004|Extension Phase|Protocol Violation|0|||
154894971|NCT03621189|559036183|FG000|Overall Study|Withdrawal by Subject|0|||
154894972|NCT03621189|559036184|FG001|Overall Study|Withdrawal by Subject|3|||
154894973|NCT03621189|559036183|FG000|Overall Study|Physician Decision|0|||
154894974|NCT03621189|559036184|FG001|Overall Study|Physician Decision|2|||
154894975|NCT00233324|559036185|FG000|Main Study|Death|68|||
154894976|NCT00233324|559036186|FG001|Main Study|Death|60|||
154894977|NCT00233324|559036187|FG002|Main Study|Death|62|||
154894978|NCT00233324|559036188|FG003|Main Study|Death|47|||
154894979|NCT00233324|559036185|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
154894980|NCT00233324|559036186|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
154894981|NCT00233324|559036187|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
154894982|NCT00233324|559036188|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
154894983|NCT00233324|559036185|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
154894984|NCT00233324|559036186|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
154894985|NCT00233324|559036187|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
154894986|NCT00233324|559036188|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
154894987|NCT00438464|559036189|FG000|Overall Study|Terminated Early|14|||
154894988|NCT00438464|559036190|FG001|Overall Study|Terminated Early|5|||
154894989|NCT00438464|559036189|FG000|Overall Study|Incomplete data submission|0|||
154894990|NCT00438464|559036190|FG001|Overall Study|Incomplete data submission|2|||
154894991|NCT01281189|559036198|FG000|Overall Study|Adverse Event|7|||
154894992|NCT01281189|559036199|FG001|Overall Study|Adverse Event|9|||
154894993|NCT01281189|559036198|FG000|Overall Study|Lost to Follow-up|6|||
154894994|NCT01281189|559036199|FG001|Overall Study|Lost to Follow-up|4|||
154894995|NCT01281189|559036198|FG000|Overall Study|Withdrawal by Subject|21|||
154894996|NCT01281189|559036199|FG001|Overall Study|Withdrawal by Subject|24|||
154894997|NCT01281189|559036198|FG000|Overall Study|Physician Decision|2|||
154894998|NCT01281189|559036199|FG001|Overall Study|Physician Decision|3|||
154894999|NCT01281189|559036198|FG000|Overall Study|Death|103|||
154895000|NCT01281189|559036199|FG001|Overall Study|Death|91|||
154895001|NCT01281189|559036198|FG000|Overall Study|Other|8|||
154895002|NCT01281189|559036199|FG001|Overall Study|Other|12|||
154895003|NCT03518034|559036200|FG000|Overall Study|Not Treated|5|||
154895004|NCT03518034|559036201|FG001|Overall Study|Not Treated|1|||
154895005|NCT03518034|559036200|FG000|Overall Study|Withdrawal by Subject|309|||
154895006|NCT03518034|559036201|FG001|Overall Study|Withdrawal by Subject|351|||
154895007|NCT03518034|559036200|FG000|Overall Study|Lost to Follow-up|446|||
154895008|NCT03518034|559036201|FG001|Overall Study|Lost to Follow-up|458|||
154895009|NCT03518034|559036200|FG000|Overall Study|Adverse Event|138|||
154895010|NCT03518034|559036201|FG001|Overall Study|Adverse Event|130|||
154895011|NCT03518034|559036200|FG000|Overall Study|Lack of Efficacy|11|||
154895012|NCT03518034|559036201|FG001|Overall Study|Lack of Efficacy|23|||
154895013|NCT03518034|559036200|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
154895014|NCT03518034|559036201|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
154895015|NCT03518034|559036200|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
154895016|NCT03518034|559036201|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
154895017|NCT03518034|559036200|FG000|Overall Study|Other, Not Specified|84|||
154895018|NCT03518034|559036201|FG001|Overall Study|Other, Not Specified|53|||
154895019|NCT03518034|559036200|FG000|Overall Study|Reason Missing|2|||
154895020|NCT03518034|559036201|FG001|Overall Study|Reason Missing|3|||
154895021|NCT00415519|559036202|FG000|Overall Study|Adverse Event|1|||
154895022|NCT00415519|559036203|FG001|Overall Study|Adverse Event|0|||
154895023|NCT00415519|559036202|FG000|Overall Study|Withdrawal by Subject|2|||
154895024|NCT00415519|559036203|FG001|Overall Study|Withdrawal by Subject|0|||
154895025|NCT00415519|559036202|FG000|Overall Study|Patient's convenience|1|||
154895026|NCT00415519|559036203|FG001|Overall Study|Patient's convenience|0|||
154895027|NCT03485222|559036204|FG000|Overall Study|Death|0|||
154895028|NCT03485222|559036205|FG001|Overall Study|Death|1|||
154895029|NCT03485222|559036204|FG000|Overall Study|Lost to Follow-up|2|||
154895030|NCT03485222|559036205|FG001|Overall Study|Lost to Follow-up|1|||
154895031|NCT01527110|559036208|FG000|Overall Study|Adverse Event|1|||
154895032|NCT02007252|559036209|FG000|Overall Study|Administrative problems|3|||
154895033|NCT02007252|559036210|FG001|Overall Study|Administrative problems|7|||
154895034|NCT02007252|559036209|FG000|Overall Study|Abnormal laboratory value(s)|1|||
154895035|NCT02007252|559036210|FG001|Overall Study|Abnormal laboratory value(s)|0|||
154895036|NCT02007252|559036209|FG000|Overall Study|Adverse Event|7|||
154895037|NCT02007252|559036210|FG001|Overall Study|Adverse Event|4|||
154895038|NCT00608881|559036211|FG000|Overall Study|Death|22|||
154895039|NCT00608881|559036212|FG001|Overall Study|Death|13|||
154895040|NCT00608881|559036211|FG000|Overall Study|Adverse Event|5|||
154895041|NCT00608881|559036212|FG001|Overall Study|Adverse Event|3|||
154895042|NCT00608881|559036211|FG000|Overall Study|Lost to Follow-up|28|||
155114100|NCT00075946|559846235|FG001|Overall Study|Did not achieve response after induction|0|||
155114101|NCT00075946|559846236|FG002|Overall Study|Did not achieve response after induction|0|||
155114102|NCT00075946|559846237|FG003|Overall Study|Did not achieve response after induction|0|||
155114103|NCT00075946|559846238|FG004|Overall Study|Did not achieve response after induction|182|||
155114104|NCT00075946|559846234|FG000|Overall Study|Incorrectly randomized (no response)|5|||
155114105|NCT00075946|559846235|FG001|Overall Study|Incorrectly randomized (no response)|5|||
155114106|NCT00075946|559846236|FG002|Overall Study|Incorrectly randomized (no response)|5|||
155114107|NCT00075946|559846237|FG003|Overall Study|Incorrectly randomized (no response)|1|||
155114108|NCT00075946|559846238|FG004|Overall Study|Incorrectly randomized (no response)|0|||
154895043|NCT00608881|559036212|FG001|Overall Study|Lost to Follow-up|14|||
154895044|NCT00608881|559036211|FG000|Overall Study|Withdrawal by Subject|18|||
154895045|NCT00608881|559036212|FG001|Overall Study|Withdrawal by Subject|29|||
154895046|NCT00608881|559036211|FG000|Overall Study|Physician Decision|5|||
154895047|NCT00608881|559036212|FG001|Overall Study|Physician Decision|5|||
154895048|NCT00608881|559036211|FG000|Overall Study|Institutionalized|1|||
154895049|NCT00608881|559036212|FG001|Overall Study|Institutionalized|2|||
154895050|NCT01373918|559036213|FG000|Overall Study|Physician Decision|0|||
154895051|NCT01373918|559036214|FG001|Overall Study|Physician Decision|1|||
154895052|NCT01590212|559036215|FG000|Overall Study|Withdrawal by Subject|2|||
154895053|NCT01590212|559036216|FG001|Overall Study|Withdrawal by Subject|2|||
155114109|NCT00075946|559846234|FG000|Overall Study|Adverse Event|2|||
155175627|NCT02788279|560080291|FG001|Overall Study|Withdrawal by Subject|15|||
155175628|NCT02788279|560080292|FG002|Overall Study|Withdrawal by Subject|5|||
155175629|NCT02788279|560080290|FG000|Overall Study|Lost to Follow-up|0|||
155175630|NCT02788279|560080291|FG001|Overall Study|Lost to Follow-up|3|||
155175631|NCT02788279|560080292|FG002|Overall Study|Lost to Follow-up|2|||
155175632|NCT02788279|560080290|FG000|Overall Study|Sponsor decision|18|||
155175633|NCT02788279|560080291|FG001|Overall Study|Sponsor decision|29|||
155175634|NCT02788279|560080292|FG002|Overall Study|Sponsor decision|11|||
155175635|NCT02683746|560080293|FG000|Overall Study|Adverse Event|3|||
155175636|NCT02683746|560080294|FG001|Overall Study|Adverse Event|2|||
155175637|NCT02683746|560080293|FG000|Overall Study|Lost to Follow-up|5|||
155175638|NCT02683746|560080294|FG001|Overall Study|Lost to Follow-up|6|||
155175639|NCT02683746|560080293|FG000|Overall Study|Withdrawal by Subject|6|||
155175640|NCT02683746|560080294|FG001|Overall Study|Withdrawal by Subject|5|||
155175641|NCT02683746|560080293|FG000|Overall Study|Physician Decision|2|||
155175642|NCT02683746|560080294|FG001|Overall Study|Physician Decision|1|||
155175643|NCT02946931|560080301|FG000|Overall Study|Did not require collection of CRFs|588|||
154895054|NCT01590212|559036217|FG002|Overall Study|Withdrawal by Subject|2|||
154895055|NCT01590212|559036215|FG000|Overall Study|Lost to Follow-up|1|||
154895056|NCT01590212|559036216|FG001|Overall Study|Lost to Follow-up|2|||
154895057|NCT01590212|559036217|FG002|Overall Study|Lost to Follow-up|3|||
154895058|NCT01387074|559036218|FG000|Overall Study|Lost to Follow-up|7|||
154895059|NCT01387074|559036218|FG000|Overall Study|Lack of Efficacy|1|||
154895060|NCT02147691|559036219|FG000|Overall Study|Withdrawal by Subject|2|||
154895061|NCT02147691|559036220|FG001|Overall Study|Withdrawal by Subject|0|||
154895062|NCT02147691|559036219|FG000|Overall Study|Adverse Event|2|||
154895063|NCT02147691|559036220|FG001|Overall Study|Adverse Event|0|||
154895064|NCT02147691|559036219|FG000|Overall Study|Lost to Follow-up|0|||
154895065|NCT02147691|559036220|FG001|Overall Study|Lost to Follow-up|1|||
154895066|NCT01392742|559036221|FG000|Overall Study|Premature study termination|42|||
154895067|NCT01392742|559036221|FG000|Overall Study|Failure to return|35|||
154895068|NCT01392742|559036221|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
154895069|NCT01392742|559036221|FG000|Overall Study|Lost to Follow-up|34|||
154895070|NCT01392742|559036221|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
154895071|NCT01392742|559036221|FG000|Overall Study|ITR and Protocol deviation|1|||
154895072|NCT01392742|559036221|FG000|Overall Study|Adverse event/intercurrent illness|17|||
154895073|NCT01392742|559036221|FG000|Overall Study|Protocol Violation|14|||
154895074|NCT01392742|559036221|FG000|Overall Study|Other|3|||
154895075|NCT01392742|559036221|FG000|Overall Study|Missing information|13|||
154895076|NCT01532570|559036224|FG000|Overall Study|Lack of Efficacy|1|||
154895077|NCT01532570|559036225|FG001|Overall Study|Lack of Efficacy|0|||
154895078|NCT01532570|559036226|FG002|Overall Study|Lack of Efficacy|0|||
154895079|NCT01532570|559036227|FG003|Overall Study|Lack of Efficacy|0|||
154895080|NCT01532570|559036224|FG000|Overall Study|Withdrawal by Subject|0|||
154895081|NCT01532570|559036225|FG001|Overall Study|Withdrawal by Subject|1|||
154895082|NCT01532570|559036226|FG002|Overall Study|Withdrawal by Subject|0|||
154895083|NCT01532570|559036227|FG003|Overall Study|Withdrawal by Subject|0|||
154895084|NCT00881361|559036228|FG000|Overall Study|Terminated prior to surgery|27|||
154895085|NCT00881361|559036229|FG001|Overall Study|Terminated prior to surgery|7|||
154895086|NCT00881361|559036230|FG002|Overall Study|Terminated prior to surgery|0|||
154895087|NCT00881361|559036228|FG000|Overall Study|Ineligible|17|||
154895088|NCT00881361|559036229|FG001|Overall Study|Ineligible|2|||
154895089|NCT00881361|559036230|FG002|Overall Study|Ineligible|2|||
154895090|NCT01628393|559036233|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
154895091|NCT01628393|559036234|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154895092|NCT01628393|559036235|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154895093|NCT01628393|559036236|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154895094|NCT01628393|559036237|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
154895095|NCT01628393|559036233|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
154895096|NCT01628393|559036234|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
154895097|NCT01628393|559036235|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
154895098|NCT01628393|559036236|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
154895099|NCT01628393|559036237|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
154895100|NCT01628393|559036233|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
154895101|NCT01628393|559036234|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
154895102|NCT01628393|559036235|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
154895103|NCT01628393|559036236|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
154895104|NCT01628393|559036237|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
154895105|NCT01628393|559036233|FG000|Blinded Active Extension Period|Adverse Event|0|||
154895106|NCT01628393|559036234|FG001|Blinded Active Extension Period|Adverse Event|1|||
154895107|NCT01628393|559036235|FG002|Blinded Active Extension Period|Adverse Event|0|||
154895108|NCT01628393|559036236|FG003|Blinded Active Extension Period|Adverse Event|2|||
155175644|NCT02946931|560080301|FG000|Overall Study|Other than listed|37|||
155175645|NCT02946931|560080301|FG000|Overall Study|Discharge from hospital|118|||
155175646|NCT02946931|560080301|FG000|Overall Study|Adverse Event|81|||
154895109|NCT01628393|559036237|FG004|Blinded Active Extension Period|Adverse Event|2|||
154895110|NCT01628393|559036233|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
154895111|NCT01628393|559036234|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
154895112|NCT01628393|559036235|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
154895113|NCT01628393|559036236|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
154895114|NCT01628393|559036237|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
154895115|NCT01628393|559036233|FG000|Blinded Active Extension Period|Physician Decision|0|||
154895116|NCT01628393|559036234|FG001|Blinded Active Extension Period|Physician Decision|3|||
154895117|NCT01628393|559036235|FG002|Blinded Active Extension Period|Physician Decision|0|||
154895118|NCT01628393|559036236|FG003|Blinded Active Extension Period|Physician Decision|1|||
154895119|NCT01628393|559036237|FG004|Blinded Active Extension Period|Physician Decision|0|||
154895120|NCT01628393|559036233|FG000|Blinded Active Extension Period|Protocol Violation|0|||
154895121|NCT01628393|559036234|FG001|Blinded Active Extension Period|Protocol Violation|0|||
154895122|NCT01628393|559036235|FG002|Blinded Active Extension Period|Protocol Violation|2|||
154895123|NCT01628393|559036236|FG003|Blinded Active Extension Period|Protocol Violation|1|||
154895124|NCT01628393|559036237|FG004|Blinded Active Extension Period|Protocol Violation|0|||
154895125|NCT01628393|559036233|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
154895126|NCT01628393|559036234|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
154895127|NCT01628393|559036235|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
154895128|NCT01628393|559036236|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
154895129|NCT01628393|559036237|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
154895130|NCT02988219|559036238|FG000|Overall Study|Lack of Efficacy|1|||
154895131|NCT02988219|559036239|FG001|Overall Study|Lack of Efficacy|1|||
154895132|NCT02988219|559036238|FG000|Overall Study|Withdrawal by Subject|0|||
154895133|NCT02988219|559036239|FG001|Overall Study|Withdrawal by Subject|2|||
154895134|NCT01522443|559036241|FG000|Overall Study|No longer receiving clinical benefit|36|||
154895135|NCT01522443|559036242|FG001|Overall Study|No longer receiving clinical benefit|28|||
154895136|NCT01522443|559036241|FG000|Overall Study|Adverse Event|10|||
154895137|NCT01522443|559036242|FG001|Overall Study|Adverse Event|15|||
154895138|NCT01522443|559036241|FG000|Overall Study|Withdrawal by Subject|5|||
154895139|NCT01522443|559036242|FG001|Overall Study|Withdrawal by Subject|8|||
154895140|NCT01522443|559036241|FG000|Overall Study|No study treatment given|1|||
154895141|NCT01522443|559036242|FG001|Overall Study|No study treatment given|1|||
154895142|NCT01522443|559036241|FG000|Overall Study|Other|1|||
154895143|NCT01522443|559036242|FG001|Overall Study|Other|3|||
154895144|NCT03260894|559036243|FG000|Overall Study|Death|6|||
154895145|NCT03260894|559036244|FG001|Overall Study|Death|8|||
154895146|NCT03260894|559036243|FG000|Overall Study|Withdrawal by Subject|4|||
154895147|NCT03260894|559036244|FG001|Overall Study|Withdrawal by Subject|11|||
154895148|NCT03260894|559036243|FG000|Overall Study|On-going at clinical cut off date|36|||
154895149|NCT03260894|559036244|FG001|Overall Study|On-going at clinical cut off date|31|||
154895150|NCT00118911|559036246|FG000|Overall Study|Withdrawal by Subject|2|||
154895151|NCT00118911|559036247|FG001|Overall Study|Withdrawal by Subject|5|||
154895152|NCT03814005|559036249|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
154895153|NCT03814005|559036250|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
154895154|NCT03814005|559036251|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
154895155|NCT03814005|559036249|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
154895156|NCT03814005|559036250|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
154895157|NCT03814005|559036251|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
154895158|NCT03814005|559036249|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
154895159|NCT03814005|559036250|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
154895160|NCT03814005|559036251|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
154895161|NCT03814005|559036249|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
154895162|NCT03814005|559036250|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
154895163|NCT03814005|559036251|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
154895164|NCT03814005|559036249|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
154895165|NCT03814005|559036250|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
154895166|NCT03814005|559036251|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
154895167|NCT03814005|559036249|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
154895168|NCT03814005|559036250|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
154895169|NCT03814005|559036251|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
154895170|NCT01896856|559036252|FG000|Overall Study|Transportation issues / Non-compliance|0|||
154978580|NCT00573170|559345674|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
154978581|NCT00573170|559345675|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
154895171|NCT01896856|559036253|FG001|Overall Study|Transportation issues / Non-compliance|0|||
154895172|NCT01896856|559036254|FG002|Overall Study|Transportation issues / Non-compliance|1|||
154895173|NCT01896856|559036255|FG003|Overall Study|Transportation issues / Non-compliance|0|||
154895174|NCT01896856|559036256|FG004|Overall Study|Transportation issues / Non-compliance|0|||
154895175|NCT01896856|559036257|FG005|Overall Study|Transportation issues / Non-compliance|0|||
154978582|NCT00573170|559345676|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
154978583|NCT00573170|559345677|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
154978584|NCT00573170|559345678|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
154978585|NCT00573170|559345679|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
154978586|NCT00573170|559345674|FG000|First Washout Period|Adverse Event|1|||
154978587|NCT00573170|559345675|FG001|First Washout Period|Adverse Event|1|||
154978588|NCT00573170|559345676|FG002|First Washout Period|Adverse Event|0|||
154978589|NCT00573170|559345677|FG003|First Washout Period|Adverse Event|0|||
154978590|NCT00573170|559345678|FG004|First Washout Period|Adverse Event|0|||
154978591|NCT00573170|559345679|FG005|First Washout Period|Adverse Event|1|||
154978592|NCT00573170|559345674|FG000|First Washout Period|Lack of Efficacy|0|||
154978593|NCT00573170|559345675|FG001|First Washout Period|Lack of Efficacy|0|||
154978594|NCT00573170|559345676|FG002|First Washout Period|Lack of Efficacy|0|||
154978595|NCT00573170|559345677|FG003|First Washout Period|Lack of Efficacy|0|||
154978596|NCT00573170|559345678|FG004|First Washout Period|Lack of Efficacy|0|||
154978597|NCT00573170|559345679|FG005|First Washout Period|Lack of Efficacy|1|||
154978598|NCT00573170|559345674|FG000|First Washout Period|Lost to Follow-up|1|||
154978599|NCT00573170|559345675|FG001|First Washout Period|Lost to Follow-up|1|||
154978600|NCT00573170|559345676|FG002|First Washout Period|Lost to Follow-up|0|||
154978601|NCT00573170|559345677|FG003|First Washout Period|Lost to Follow-up|2|||
154978602|NCT00573170|559345678|FG004|First Washout Period|Lost to Follow-up|0|||
154978603|NCT00573170|559345679|FG005|First Washout Period|Lost to Follow-up|2|||
154978604|NCT00573170|559345674|FG000|First Washout Period|Withdrawal by Subject|2|||
154978605|NCT00573170|559345675|FG001|First Washout Period|Withdrawal by Subject|0|||
154978606|NCT00573170|559345676|FG002|First Washout Period|Withdrawal by Subject|0|||
154978607|NCT00573170|559345677|FG003|First Washout Period|Withdrawal by Subject|2|||
154978608|NCT00573170|559345678|FG004|First Washout Period|Withdrawal by Subject|3|||
154978609|NCT00573170|559345679|FG005|First Washout Period|Withdrawal by Subject|3|||
154978610|NCT00573170|559345674|FG000|First Washout Period|Other|4|||
154978611|NCT00573170|559345675|FG001|First Washout Period|Other|0|||
154978612|NCT00573170|559345676|FG002|First Washout Period|Other|1|||
154978613|NCT00573170|559345677|FG003|First Washout Period|Other|1|||
154978614|NCT00573170|559345678|FG004|First Washout Period|Other|0|||
154978615|NCT00573170|559345679|FG005|First Washout Period|Other|0|||
154978616|NCT00573170|559345674|FG000|Second Washout Period|Adverse Event|1|||
154978617|NCT00573170|559345675|FG001|Second Washout Period|Adverse Event|0|||
154978618|NCT00573170|559345676|FG002|Second Washout Period|Adverse Event|0|||
154978619|NCT00573170|559345677|FG003|Second Washout Period|Adverse Event|0|||
154978620|NCT00573170|559345678|FG004|Second Washout Period|Adverse Event|1|||
154978621|NCT00573170|559345679|FG005|Second Washout Period|Adverse Event|0|||
154978622|NCT00573170|559345674|FG000|Second Washout Period|Protocol Violation|2|||
154978623|NCT00573170|559345675|FG001|Second Washout Period|Protocol Violation|1|||
154978624|NCT00573170|559345676|FG002|Second Washout Period|Protocol Violation|1|||
154978625|NCT00573170|559345677|FG003|Second Washout Period|Protocol Violation|0|||
154978626|NCT00573170|559345678|FG004|Second Washout Period|Protocol Violation|0|||
154978627|NCT00573170|559345679|FG005|Second Washout Period|Protocol Violation|0|||
154978628|NCT00573170|559345674|FG000|Second Washout Period|Withdrawal by Subject|1|||
154978629|NCT00573170|559345675|FG001|Second Washout Period|Withdrawal by Subject|1|||
154978630|NCT00573170|559345676|FG002|Second Washout Period|Withdrawal by Subject|2|||
154978631|NCT00573170|559345677|FG003|Second Washout Period|Withdrawal by Subject|0|||
154978632|NCT00573170|559345678|FG004|Second Washout Period|Withdrawal by Subject|1|||
154978633|NCT00573170|559345679|FG005|Second Washout Period|Withdrawal by Subject|0|||
154978634|NCT00573170|559345674|FG000|Second Washout Period|Lost to Follow-up|0|||
154978635|NCT00573170|559345675|FG001|Second Washout Period|Lost to Follow-up|0|||
154978636|NCT00573170|559345676|FG002|Second Washout Period|Lost to Follow-up|0|||
154978637|NCT00573170|559345677|FG003|Second Washout Period|Lost to Follow-up|1|||
154978638|NCT00573170|559345678|FG004|Second Washout Period|Lost to Follow-up|0|||
154978639|NCT00573170|559345679|FG005|Second Washout Period|Lost to Follow-up|0|||
154978640|NCT00573170|559345674|FG000|Second Washout Period|Other|1|||
154895176|NCT02563925|559036260|FG000|Overall Study|Withdrawal by Subject|2|||
154895177|NCT00282867|559036261|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
154895178|NCT00282867|559036262|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
154895179|NCT00282867|559036263|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
154895180|NCT05067452|559036264|FG000|Overall Study|Lost to Follow-up|0|||
154895181|NCT05067452|559036265|FG001|Overall Study|Lost to Follow-up|4|||
154895182|NCT00426556|559036266|FG000|Phase I - Core Phase|Disease Progression|0|||
154895183|NCT00426556|559036267|FG001|Phase I - Core Phase|Disease Progression|6|||
154895184|NCT00426556|559036268|FG002|Phase I - Core Phase|Disease Progression|2|||
154895185|NCT00426556|559036269|FG003|Phase I - Core Phase|Disease Progression|0|||
154978641|NCT00573170|559345675|FG001|Second Washout Period|Other|2|||
154978642|NCT00573170|559345676|FG002|Second Washout Period|Other|1|||
154978643|NCT00573170|559345677|FG003|Second Washout Period|Other|4|||
154978644|NCT00573170|559345678|FG004|Second Washout Period|Other|6|||
154978645|NCT00573170|559345679|FG005|Second Washout Period|Other|2|||
154978646|NCT00573170|559345674|FG000|Third Treatment Period|Withdrawal by Subject|1|||
155114110|NCT00075946|559846235|FG001|Overall Study|Adverse Event|10|||
154978647|NCT00573170|559345675|FG001|Third Treatment Period|Withdrawal by Subject|0|||
154978648|NCT00573170|559345676|FG002|Third Treatment Period|Withdrawal by Subject|0|||
154978649|NCT00573170|559345677|FG003|Third Treatment Period|Withdrawal by Subject|0|||
154978650|NCT00573170|559345678|FG004|Third Treatment Period|Withdrawal by Subject|0|||
154978651|NCT00573170|559345679|FG005|Third Treatment Period|Withdrawal by Subject|0|||
154978652|NCT00573170|559345674|FG000|Third Treatment Period|Lost to Follow-up|0|||
154978653|NCT00573170|559345675|FG001|Third Treatment Period|Lost to Follow-up|0|||
154978654|NCT00573170|559345676|FG002|Third Treatment Period|Lost to Follow-up|0|||
154978655|NCT00573170|559345677|FG003|Third Treatment Period|Lost to Follow-up|0|||
154978656|NCT00573170|559345678|FG004|Third Treatment Period|Lost to Follow-up|0|||
154978657|NCT00573170|559345679|FG005|Third Treatment Period|Lost to Follow-up|2|||
154978658|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
154978659|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
154978660|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
154978661|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
154978662|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
154978663|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
154978664|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154978665|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154978666|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
154978667|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
154978668|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
154978669|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
154978670|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
154978671|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
154978672|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
154978673|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
154978674|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Death|2|||
154978675|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Death|1|||
154978676|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Death|0|||
154978677|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Death|0|||
154978678|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
154978679|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
154978680|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
154978681|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
154978682|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
154978683|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
154978684|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
154978685|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
154978686|NCT03110380|559345681|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
154978687|NCT03110380|559345682|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
154978688|NCT03110380|559345683|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
154978689|NCT03110380|559345684|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
154978690|NCT03110380|559345681|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
154978691|NCT03110380|559345682|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
154978692|NCT03110380|559345683|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
154978693|NCT03110380|559345684|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
154978694|NCT03110380|559345681|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
154978695|NCT03110380|559345682|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
154978696|NCT03110380|559345683|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
154978697|NCT03110380|559345684|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
154978698|NCT03110380|559345681|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
154978699|NCT03110380|559345682|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
154978700|NCT03110380|559345683|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
154978701|NCT03110380|559345684|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
154978702|NCT02147587|559345685|FG000|Overall Study|Adverse Event|9|||
154978703|NCT02147587|559345686|FG001|Overall Study|Adverse Event|4|||
154978704|NCT02147587|559345685|FG000|Overall Study|Lack of Efficacy|2|||
154978705|NCT02147587|559345686|FG001|Overall Study|Lack of Efficacy|1|||
154978706|NCT01714739|559345687|FG000|Overall Study|Disease progression|3|||
154978707|NCT01714739|559345688|FG001|Overall Study|Disease progression|5|||
154978708|NCT01714739|559345689|FG002|Overall Study|Disease progression|5|||
154978709|NCT01714739|559345690|FG003|Overall Study|Disease progression|204|||
154978710|NCT01714739|559345691|FG004|Overall Study|Disease progression|1|||
154978711|NCT01714739|559345692|FG005|Overall Study|Disease progression|3|||
154978712|NCT01714739|559345693|FG006|Overall Study|Disease progression|5|||
154978713|NCT01714739|559345687|FG000|Overall Study|Study drug toxicity|1|||
154978714|NCT01714739|559345688|FG001|Overall Study|Study drug toxicity|1|||
154978715|NCT01714739|559345689|FG002|Overall Study|Study drug toxicity|1|||
154978716|NCT01714739|559345690|FG003|Overall Study|Study drug toxicity|15|||
155114111|NCT00075946|559846236|FG002|Overall Study|Adverse Event|0|||
154895186|NCT00426556|559036266|FG000|Phase I - Core Phase|Adverse Event|1|||
154895187|NCT00426556|559036267|FG001|Phase I - Core Phase|Adverse Event|3|||
154895188|NCT00426556|559036268|FG002|Phase I - Core Phase|Adverse Event|1|||
154895189|NCT00426556|559036269|FG003|Phase I - Core Phase|Adverse Event|0|||
154895190|NCT00426556|559036266|FG000|Phase I - Core Phase|Death|0|||
154895191|NCT00426556|559036267|FG001|Phase I - Core Phase|Death|1|||
154895192|NCT00426556|559036268|FG002|Phase I - Core Phase|Death|0|||
154895193|NCT00426556|559036269|FG003|Phase I - Core Phase|Death|0|||
154895194|NCT00426556|559036266|FG000|Phase I - Extension Phase|Adverse Event|0|||
154895195|NCT00426556|559036267|FG001|Phase I - Extension Phase|Adverse Event|1|||
154895196|NCT00426556|559036268|FG002|Phase I - Extension Phase|Adverse Event|1|||
154895197|NCT00426556|559036269|FG003|Phase I - Extension Phase|Adverse Event|0|||
154895198|NCT00426556|559036266|FG000|Phase I - Extension Phase|Disease Progression|5|||
154895199|NCT00426556|559036267|FG001|Phase I - Extension Phase|Disease Progression|5|||
154895200|NCT00426556|559036268|FG002|Phase I - Extension Phase|Disease Progression|6|||
154895201|NCT00426556|559036269|FG003|Phase I - Extension Phase|Disease Progression|0|||
154895202|NCT00426556|559036266|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
154895203|NCT00426556|559036267|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
154895204|NCT00426556|559036268|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
154895205|NCT00426556|559036269|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
154895206|NCT00426556|559036266|FG000|Phase II - Core Phase|Disease Progression|0|||
154895207|NCT00426556|559036267|FG001|Phase II - Core Phase|Disease Progression|0|||
154895208|NCT00426556|559036268|FG002|Phase II - Core Phase|Disease Progression|0|||
154895209|NCT00426556|559036269|FG003|Phase II - Core Phase|Disease Progression|16|||
154895210|NCT00426556|559036266|FG000|Phase II - Core Phase|Adverse Event|0|||
154895211|NCT00426556|559036267|FG001|Phase II - Core Phase|Adverse Event|0|||
154895212|NCT00426556|559036268|FG002|Phase II - Core Phase|Adverse Event|0|||
154895213|NCT00426556|559036269|FG003|Phase II - Core Phase|Adverse Event|8|||
154895214|NCT00426556|559036266|FG000|Phase II - Extension Phase|Disease Progression|0|||
154895215|NCT00426556|559036267|FG001|Phase II - Extension Phase|Disease Progression|0|||
154895216|NCT00426556|559036268|FG002|Phase II - Extension Phase|Disease Progression|0|||
154895217|NCT00426556|559036269|FG003|Phase II - Extension Phase|Disease Progression|21|||
154895218|NCT00426556|559036266|FG000|Phase II - Extension Phase|Adverse Event|0|||
154895219|NCT00426556|559036267|FG001|Phase II - Extension Phase|Adverse Event|0|||
154895220|NCT00426556|559036268|FG002|Phase II - Extension Phase|Adverse Event|0|||
154895221|NCT00426556|559036269|FG003|Phase II - Extension Phase|Adverse Event|2|||
154895222|NCT00432562|559036275|FG000|Overall Study|Death|3|||
154895223|NCT00432562|559036276|FG001|Overall Study|Death|0|||
154895224|NCT03970824|559036277|FG000|Overall Study|Withdrawal by Subject|1|||
154895225|NCT03970824|559036278|FG001|Overall Study|Withdrawal by Subject|1|||
154895226|NCT03970824|559036279|FG002|Overall Study|Withdrawal by Subject|3|||
154895227|NCT03970824|559036277|FG000|Overall Study|Lost to Follow-up|0|||
154895228|NCT03970824|559036278|FG001|Overall Study|Lost to Follow-up|2|||
154895229|NCT03970824|559036279|FG002|Overall Study|Lost to Follow-up|1|||
154895230|NCT03970824|559036277|FG000|Overall Study|Adverse Event|1|||
154895231|NCT03970824|559036278|FG001|Overall Study|Adverse Event|0|||
154895232|NCT03970824|559036279|FG002|Overall Study|Adverse Event|0|||
154895233|NCT02146248|559036282|FG000|Overall Study|Withdrawal by Subject|2|||
154895234|NCT00425100|559036283|FG000|Overall Study|Adverse Event|36|||
154895235|NCT00425100|559036283|FG000|Overall Study|Lack of Efficacy|4|||
154895236|NCT00425100|559036283|FG000|Overall Study|Lost to Follow-up|2|||
154895237|NCT00425100|559036283|FG000|Overall Study|Protocol Violation|4|||
154895238|NCT00425100|559036283|FG000|Overall Study|Withdrawal by Subject|7|||
154895239|NCT01767519|559036287|FG000|Overall Study|Other Reasons|4|||
154895240|NCT01767519|559036288|FG001|Overall Study|Other Reasons|4|||
154895241|NCT01767519|559036289|FG002|Overall Study|Other Reasons|2|||
154895242|NCT01767519|559036287|FG000|Overall Study|Protocol Violation|0|||
154895243|NCT01767519|559036288|FG001|Overall Study|Protocol Violation|3|||
154895244|NCT01767519|559036289|FG002|Overall Study|Protocol Violation|0|||
154895245|NCT01767519|559036287|FG000|Overall Study|Personal Reasons|1|||
154895246|NCT01767519|559036288|FG001|Overall Study|Personal Reasons|0|||
154895247|NCT01767519|559036289|FG002|Overall Study|Personal Reasons|0|||
154895248|NCT01767519|559036287|FG000|Overall Study|Lost to Follow-up|3|||
154895249|NCT01767519|559036288|FG001|Overall Study|Lost to Follow-up|1|||
154895250|NCT01767519|559036289|FG002|Overall Study|Lost to Follow-up|2|||
154895251|NCT01767519|559036287|FG000|Overall Study|Lack of Efficacy|1|||
154895252|NCT01767519|559036288|FG001|Overall Study|Lack of Efficacy|0|||
154895253|NCT01767519|559036289|FG002|Overall Study|Lack of Efficacy|0|||
154895254|NCT01767519|559036287|FG000|Overall Study|Adverse Event|5|||
155175647|NCT02946931|560080301|FG000|Overall Study|CRFs not valid|1|||
154895255|NCT01767519|559036288|FG001|Overall Study|Adverse Event|5|||
154895256|NCT01767519|559036289|FG002|Overall Study|Adverse Event|1|||
154895257|NCT00493974|559036292|FG000|Overall Study|Death|1|||
154895258|NCT00493974|559036293|FG001|Overall Study|Death|2|||
154895259|NCT00493974|559036292|FG000|Overall Study|Withdrawal by Subject|8|||
154895260|NCT00493974|559036293|FG001|Overall Study|Withdrawal by Subject|6|||
154895261|NCT00493974|559036292|FG000|Overall Study|Lost to Follow-up|4|||
154895262|NCT00493974|559036293|FG001|Overall Study|Lost to Follow-up|6|||
154895263|NCT00862654|559036294|FG000|Overall Study|Lack of Efficacy|1|||
154895264|NCT00862654|559036295|FG001|Overall Study|Lack of Efficacy|0|||
154895265|NCT00862654|559036296|FG002|Overall Study|Lack of Efficacy|1|||
154895266|NCT00862654|559036297|FG003|Overall Study|Lack of Efficacy|0|||
154895267|NCT00862654|559036294|FG000|Overall Study|Lost to Follow-up|1|||
154895268|NCT00862654|559036295|FG001|Overall Study|Lost to Follow-up|2|||
154895269|NCT00862654|559036296|FG002|Overall Study|Lost to Follow-up|1|||
154895270|NCT00862654|559036297|FG003|Overall Study|Lost to Follow-up|3|||
154895271|NCT00862654|559036294|FG000|Overall Study|Adverse Event|0|||
154895272|NCT00862654|559036295|FG001|Overall Study|Adverse Event|1|||
154895273|NCT00862654|559036296|FG002|Overall Study|Adverse Event|1|||
154895274|NCT00862654|559036297|FG003|Overall Study|Adverse Event|0|||
154895275|NCT00862654|559036294|FG000|Overall Study|Pregnancy|1|||
154895276|NCT00862654|559036295|FG001|Overall Study|Pregnancy|1|||
154895277|NCT00862654|559036296|FG002|Overall Study|Pregnancy|0|||
154895278|NCT00862654|559036297|FG003|Overall Study|Pregnancy|0|||
154895279|NCT00862654|559036294|FG000|Overall Study|Withdrawal by Subject|2|||
154895280|NCT00862654|559036295|FG001|Overall Study|Withdrawal by Subject|2|||
154895281|NCT00862654|559036296|FG002|Overall Study|Withdrawal by Subject|2|||
154895282|NCT00862654|559036297|FG003|Overall Study|Withdrawal by Subject|3|||
154895283|NCT00862654|559036294|FG000|Overall Study|Subject mistake|0|||
154895284|NCT00862654|559036295|FG001|Overall Study|Subject mistake|1|||
154895285|NCT00862654|559036296|FG002|Overall Study|Subject mistake|0|||
154895286|NCT00862654|559036297|FG003|Overall Study|Subject mistake|0|||
154895287|NCT00862654|559036294|FG000|Overall Study|Familly constraint|0|||
154895288|NCT00862654|559036295|FG001|Overall Study|Familly constraint|1|||
154895289|NCT00862654|559036296|FG002|Overall Study|Familly constraint|0|||
154895290|NCT00862654|559036297|FG003|Overall Study|Familly constraint|0|||
154895291|NCT00862654|559036294|FG000|Overall Study|Never used study drugs|1|||
154895292|NCT00862654|559036295|FG001|Overall Study|Never used study drugs|0|||
154895293|NCT00862654|559036296|FG002|Overall Study|Never used study drugs|0|||
154895294|NCT00862654|559036297|FG003|Overall Study|Never used study drugs|0|||
154895295|NCT00862654|559036294|FG000|Overall Study|Included after end of inclusions|0|||
154895296|NCT00862654|559036295|FG001|Overall Study|Included after end of inclusions|0|||
154895297|NCT00862654|559036296|FG002|Overall Study|Included after end of inclusions|1|||
154895298|NCT00862654|559036297|FG003|Overall Study|Included after end of inclusions|0|||
154895299|NCT03219567|559036298|FG000|Overall Study|Withdrawal by Subject|0|||
154895300|NCT03219567|559036299|FG001|Overall Study|Withdrawal by Subject|1|||
154895301|NCT01181778|559036303|FG000|Overall Study|Physician Decision|48|||
154895302|NCT02713789|559036304|FG000|Overall Study|Lost to Follow-up|0|||
154895303|NCT02713789|559036305|FG001|Overall Study|Lost to Follow-up|1|||
154895304|NCT02713789|559036306|FG002|Overall Study|Lost to Follow-up|1|||
154895305|NCT02726113|559036310|FG000|Total Enrollment|Physician Decision|0|||
154895306|NCT02726113|559036311|FG001|Total Enrollment|Physician Decision|1|||
154895307|NCT02726113|559036310|FG000|Total Enrollment|Protocol Violation|1|||
154895308|NCT02726113|559036311|FG001|Total Enrollment|Protocol Violation|0|||
154895309|NCT02726113|559036310|FG000|Total Enrollment|Withdrawal by Subject|2|||
154895310|NCT02726113|559036311|FG001|Total Enrollment|Withdrawal by Subject|1|||
154895311|NCT02726113|559036310|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
154895312|NCT02726113|559036311|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
154895313|NCT02726113|559036310|FG000|Genomic Analysis|Protocol Violation|1|||
154895314|NCT02726113|559036311|FG001|Genomic Analysis|Protocol Violation|0|||
154895315|NCT02726113|559036310|FG000|Genomic Analysis|Withdrawal by Subject|2|||
154895316|NCT02726113|559036311|FG001|Genomic Analysis|Withdrawal by Subject|1|||
154895317|NCT02726113|559036310|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
154895318|NCT02726113|559036311|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
154895319|NCT03148756|559036312|FG000|Overall Study|Study Terminated|0|||
154895320|NCT03148756|559036313|FG001|Overall Study|Study Terminated|1|||
154895321|NCT00637377|559036315|FG000|Overall Study|Adverse Event|2|||
154895322|NCT00637377|559036316|FG001|Overall Study|Adverse Event|6|||
154895323|NCT00637377|559036317|FG002|Overall Study|Adverse Event|8|||
154895324|NCT00637377|559036318|FG003|Overall Study|Adverse Event|9|||
154895325|NCT00637377|559036315|FG000|Overall Study|Death|1|||
154895326|NCT00637377|559036316|FG001|Overall Study|Death|3|||
154895327|NCT00637377|559036317|FG002|Overall Study|Death|2|||
154895328|NCT00637377|559036318|FG003|Overall Study|Death|1|||
155114112|NCT00075946|559846237|FG003|Overall Study|Adverse Event|2|||
154895329|NCT00637377|559036315|FG000|Overall Study|Lack of Efficacy|0|||
154895330|NCT00637377|559036316|FG001|Overall Study|Lack of Efficacy|0|||
154895331|NCT00637377|559036317|FG002|Overall Study|Lack of Efficacy|1|||
155114113|NCT00075946|559846238|FG004|Overall Study|Adverse Event|0|||
154895332|NCT00637377|559036318|FG003|Overall Study|Lack of Efficacy|1|||
154895333|NCT00637377|559036315|FG000|Overall Study|Lost to Follow-up|4|||
154895334|NCT00637377|559036316|FG001|Overall Study|Lost to Follow-up|1|||
154895335|NCT00637377|559036317|FG002|Overall Study|Lost to Follow-up|2|||
154895336|NCT00637377|559036318|FG003|Overall Study|Lost to Follow-up|2|||
154895337|NCT00637377|559036315|FG000|Overall Study|Protocol Violation|2|||
154895338|NCT00637377|559036316|FG001|Overall Study|Protocol Violation|1|||
154895339|NCT00637377|559036317|FG002|Overall Study|Protocol Violation|1|||
154895340|NCT00637377|559036318|FG003|Overall Study|Protocol Violation|0|||
154895341|NCT00637377|559036315|FG000|Overall Study|Withdrawal by Subject|11|||
154895342|NCT00637377|559036316|FG001|Overall Study|Withdrawal by Subject|15|||
154895343|NCT00637377|559036317|FG002|Overall Study|Withdrawal by Subject|13|||
154895344|NCT00637377|559036318|FG003|Overall Study|Withdrawal by Subject|11|||
154895345|NCT00637377|559036315|FG000|Overall Study|Other (no further information available)|7|||
154895346|NCT00637377|559036316|FG001|Overall Study|Other (no further information available)|6|||
154895347|NCT00637377|559036317|FG002|Overall Study|Other (no further information available)|10|||
154895348|NCT00637377|559036318|FG003|Overall Study|Other (no further information available)|5|||
154895349|NCT00859573|559038005|FG000|Overall Study|Withdrawal by Subject|4|||
154895350|NCT00859573|559038006|FG001|Overall Study|Withdrawal by Subject|1|||
154895351|NCT00859573|559038005|FG000|Overall Study|Physician Decision|1|||
154895352|NCT00859573|559038006|FG001|Overall Study|Physician Decision|1|||
154895353|NCT01135394|559038007|FG000|Screening|Lost to Follow-up|2|||
154895354|NCT01135394|559038007|FG000|Screening|Withdrawal by Subject|10|||
154895355|NCT01135394|559038007|FG000|Screening|Screening failure|16|||
154895356|NCT01135394|559038007|FG000|Screening|Physician Decision|5|||
154895357|NCT01135394|559038007|FG000|Baseline Assessment|Withdrawal by Subject|9|||
154895358|NCT01135394|559038007|FG000|Baseline Assessment|Physician Decision|3|||
154895359|NCT01135394|559038007|FG000|Baseline Assessment|Lost to Follow-up|2|||
154895360|NCT01135394|559038007|FG000|Baseline Assessment|Adverse Event|1|||
154895361|NCT01135394|559038007|FG000|Study Treatment|Withdrawal by Subject|1|||
154895362|NCT01135394|559038007|FG000|Study Treatment|Physician Decision|1|||
154895363|NCT01135394|559038007|FG000|Study Treatment|Adverse Event|2|||
154895364|NCT03750240|559038010|FG000|Overall Study|Technical Difficulties|2|||
154895365|NCT03510910|559038011|FG000|Overall Study|Incomplete Survey|2|||
154895366|NCT03510910|559038012|FG001|Overall Study|Incomplete Survey|3|||
154895367|NCT03382262|559038013|FG000|Overall Study|Physician Decision|0|||
154895368|NCT03382262|559038014|FG001|Overall Study|Physician Decision|0|||
154895369|NCT03382262|559038015|FG002|Overall Study|Physician Decision|1|||
154895370|NCT03382262|559038016|FG003|Overall Study|Physician Decision|0|||
154895371|NCT03382262|559038013|FG000|Overall Study|Withdrawal by Subject|0|||
154895372|NCT03382262|559038014|FG001|Overall Study|Withdrawal by Subject|0|||
154895373|NCT03382262|559038015|FG002|Overall Study|Withdrawal by Subject|0|||
154895374|NCT03382262|559038016|FG003|Overall Study|Withdrawal by Subject|1|||
154895375|NCT04914819|559038017|FG000|Overall Study|Pregnancy|3|||
154895376|NCT04914819|559038018|FG001|Overall Study|Pregnancy|1|||
154895377|NCT04914819|559038017|FG000|Overall Study|Discontinued study|4|||
154895378|NCT04914819|559038018|FG001|Overall Study|Discontinued study|1|||
154895379|NCT04914819|559038017|FG000|Overall Study|Lost to Follow-up|7|||
154895380|NCT04914819|559038018|FG001|Overall Study|Lost to Follow-up|0|||
154895381|NCT03943446|559038021|FG000|Overall Study|Lost to Follow-up|0|||
154895382|NCT03943446|559038022|FG001|Overall Study|Lost to Follow-up|0|||
154895383|NCT03943446|559038023|FG002|Overall Study|Lost to Follow-up|1|||
154895384|NCT03943446|559038021|FG000|Overall Study|Withdrawal by Subject|1|||
154895385|NCT03943446|559038022|FG001|Overall Study|Withdrawal by Subject|1|||
154895386|NCT03943446|559038023|FG002|Overall Study|Withdrawal by Subject|2|||
154895387|NCT03943446|559038021|FG000|Overall Study|Study Terminated by Sponsor|1|||
154895388|NCT03943446|559038022|FG001|Overall Study|Study Terminated by Sponsor|2|||
154895389|NCT03943446|559038023|FG002|Overall Study|Study Terminated by Sponsor|1|||
154895390|NCT03943446|559038021|FG000|Overall Study|Reason not Specified|5|||
154895391|NCT03943446|559038022|FG001|Overall Study|Reason not Specified|1|||
154895392|NCT03943446|559038023|FG002|Overall Study|Reason not Specified|3|||
154895393|NCT02905825|559038024|FG000|Overall Study|Protocol Violation|11|||
154895394|NCT02905825|559038024|FG000|Overall Study|Device Malfunction|1|||
154895395|NCT01601704|559038026|FG000|Overall Study|Randomized but not dispensed study med|1|||
154895396|NCT01601704|559038027|FG001|Overall Study|Randomized but not dispensed study med|4|||
154895397|NCT01709708|559038029|FG000|Overall Study|Protocol Violation|1|||
155114114|NCT00075946|559846234|FG000|Overall Study|Death|0|||
155114115|NCT00075946|559846235|FG001|Overall Study|Death|1|||
154895398|NCT01709708|559038030|FG001|Overall Study|Protocol Violation|2|||
154895399|NCT02657434|559038031|FG000|Overall Study|Study Terminated By Sponsor|64|||
154895400|NCT02657434|559038032|FG001|Overall Study|Study Terminated By Sponsor|82|||
154895401|NCT02657434|559038031|FG000|Overall Study|Death|189|||
154895402|NCT02657434|559038032|FG001|Overall Study|Death|190|||
154895403|NCT02657434|559038031|FG000|Overall Study|Lost to Follow-up|2|||
154895404|NCT02657434|559038032|FG001|Overall Study|Lost to Follow-up|2|||
154895405|NCT02657434|559038031|FG000|Overall Study|Randomization by Error|2|||
154895406|NCT02657434|559038032|FG001|Overall Study|Randomization by Error|0|||
154895407|NCT02657434|559038031|FG000|Overall Study|Withdrawal by Subject|28|||
154895408|NCT02657434|559038032|FG001|Overall Study|Withdrawal by Subject|17|||
154895409|NCT02657434|559038031|FG000|Overall Study|Protocol Violation|1|||
154895410|NCT02657434|559038032|FG001|Overall Study|Protocol Violation|0|||
154895411|NCT02657434|559038031|FG000|Overall Study|Physician Decision|0|||
154895412|NCT02657434|559038032|FG001|Overall Study|Physician Decision|1|||
154895413|NCT02432703|559038038|FG000|Overall Study|Adverse Event|1|||
154895414|NCT02432703|559038039|FG001|Overall Study|Adverse Event|4|||
154895415|NCT02432703|559038038|FG000|Overall Study|Lack of Efficacy|1|||
154895416|NCT02432703|559038039|FG001|Overall Study|Lack of Efficacy|0|||
154895417|NCT02432703|559038038|FG000|Overall Study|Lost to Follow-up|5|||
154895418|NCT02432703|559038039|FG001|Overall Study|Lost to Follow-up|3|||
154895419|NCT02432703|559038038|FG000|Overall Study|Withdrawal by Subject|9|||
154895420|NCT02432703|559038039|FG001|Overall Study|Withdrawal by Subject|6|||
154895421|NCT02432703|559038038|FG000|Overall Study|Other|6|||
154895422|NCT02432703|559038039|FG001|Overall Study|Other|5|||
154895423|NCT04325906|559038042|FG000|Overall Study|Withdrawal by Subject|2|||
154895424|NCT04325906|559038043|FG001|Overall Study|Withdrawal by Subject|0|||
154895425|NCT01181141|559038044|FG000|Overall Study|Adverse Event|2|||
154895426|NCT01181141|559038045|FG001|Overall Study|Adverse Event|1|||
154895427|NCT01181141|559038044|FG000|Overall Study|Lack of Efficacy|1|||
154895428|NCT01181141|559038045|FG001|Overall Study|Lack of Efficacy|0|||
154895429|NCT01181141|559038044|FG000|Overall Study|Lost to Follow-up|1|||
154895430|NCT01181141|559038045|FG001|Overall Study|Lost to Follow-up|1|||
154895431|NCT01181141|559038044|FG000|Overall Study|Physician Decision|2|||
154895432|NCT01181141|559038045|FG001|Overall Study|Physician Decision|0|||
154895433|NCT01181141|559038044|FG000|Overall Study|Protocol Violation|3|||
154895434|NCT01181141|559038045|FG001|Overall Study|Protocol Violation|1|||
154895435|NCT01181141|559038044|FG000|Overall Study|Withdrawal by Subject|3|||
154895436|NCT01181141|559038045|FG001|Overall Study|Withdrawal by Subject|1|||
154895437|NCT00561340|559038046|FG000|Overall Study|refused to drink pediasure|6|||
154895438|NCT00561340|559038047|FG001|Overall Study|refused to drink pediasure|0|||
154895439|NCT03496662|559038051|FG000|Overall Study|Adverse Event|0|||
154895440|NCT03496662|559038052|FG001|Overall Study|Adverse Event|0|||
154895441|NCT03496662|559038053|FG002|Overall Study|Adverse Event|4|||
154895442|NCT03496662|559038051|FG000|Overall Study|Withdrawal by Subject|1|||
154895443|NCT03496662|559038052|FG001|Overall Study|Withdrawal by Subject|0|||
154895444|NCT03496662|559038053|FG002|Overall Study|Withdrawal by Subject|2|||
154895445|NCT03496662|559038051|FG000|Overall Study|Death|0|||
154895446|NCT03496662|559038052|FG001|Overall Study|Death|0|||
154895447|NCT03496662|559038053|FG002|Overall Study|Death|2|||
154895448|NCT03496662|559038051|FG000|Overall Study|Noncompliance|0|||
154895449|NCT03496662|559038052|FG001|Overall Study|Noncompliance|0|||
154895450|NCT03496662|559038053|FG002|Overall Study|Noncompliance|1|||
154895451|NCT03395223|559038055|FG000|Overall Study|Lost to Follow-up|3|||
154895452|NCT03395223|559038055|FG000|Overall Study|Other|1|||
154895453|NCT00810810|559038056|FG000|Overall Study|Withdrawal by Subject|0|||
154895454|NCT00810810|559038057|FG001|Overall Study|Withdrawal by Subject|8|||
154895455|NCT00810810|559038058|FG002|Overall Study|Withdrawal by Subject|10|||
154895456|NCT00810810|559038059|FG003|Overall Study|Withdrawal by Subject|8|||
154895457|NCT00810810|559038056|FG000|Overall Study|Physician Decision|0|||
154895458|NCT00810810|559038057|FG001|Overall Study|Physician Decision|3|||
154895459|NCT00810810|559038058|FG002|Overall Study|Physician Decision|1|||
154895460|NCT00810810|559038059|FG003|Overall Study|Physician Decision|5|||
154895461|NCT01156532|559038060|FG000|Overall Study|Family Reasons|1|||
154895462|NCT01156532|559038060|FG000|Overall Study|Lost to Follow-up|1|||
154895463|NCT01074658|559038064|FG000|Overall Study|No implant attempted|19|||
154895464|NCT00105560|559038068|FG000|Overall Study|Lost to Follow-up|1|||
154895465|NCT01248364|559038069|FG000|Overall Study|Adverse Event|0|||
154895466|NCT01248364|559038070|FG001|Overall Study|Adverse Event|1|||
154895467|NCT01248364|559038071|FG002|Overall Study|Adverse Event|0|||
154895468|NCT01248364|559038072|FG003|Overall Study|Adverse Event|0|||
154895469|NCT02559713|559038075|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
154895470|NCT01021813|559038076|FG000|DB Treatment Phase|Adverse Event|60|||
154895471|NCT01021813|559038077|FG001|DB Treatment Phase|Adverse Event|22|||
154895472|NCT01021813|559038078|FG002|DB Treatment Phase|Adverse Event|0|||
154895473|NCT01021813|559038079|FG003|DB Treatment Phase|Adverse Event|0|||
154895474|NCT01021813|559038080|FG004|DB Treatment Phase|Adverse Event|0|||
154895475|NCT01021813|559038076|FG000|DB Treatment Phase|Lack of Efficacy|44|||
154895476|NCT01021813|559038077|FG001|DB Treatment Phase|Lack of Efficacy|28|||
154895477|NCT01021813|559038078|FG002|DB Treatment Phase|Lack of Efficacy|0|||
154895478|NCT01021813|559038079|FG003|DB Treatment Phase|Lack of Efficacy|0|||
154895479|NCT01021813|559038080|FG004|DB Treatment Phase|Lack of Efficacy|0|||
155198471|NCT00745823|560164973|FG001|Overall Study|Study Terminated by Sponsor|349|||
154895480|NCT01021813|559038076|FG000|DB Treatment Phase|Lost to Follow-up|14|||
154895481|NCT01021813|559038077|FG001|DB Treatment Phase|Lost to Follow-up|12|||
154895482|NCT01021813|559038078|FG002|DB Treatment Phase|Lost to Follow-up|0|||
154895483|NCT01021813|559038079|FG003|DB Treatment Phase|Lost to Follow-up|0|||
154895484|NCT01021813|559038080|FG004|DB Treatment Phase|Lost to Follow-up|0|||
154895485|NCT01021813|559038076|FG000|DB Treatment Phase|Physician Decision|17|||
154895486|NCT01021813|559038077|FG001|DB Treatment Phase|Physician Decision|8|||
154895487|NCT01021813|559038078|FG002|DB Treatment Phase|Physician Decision|0|||
154895488|NCT01021813|559038079|FG003|DB Treatment Phase|Physician Decision|0|||
154895489|NCT01021813|559038080|FG004|DB Treatment Phase|Physician Decision|0|||
154895490|NCT01021813|559038076|FG000|DB Treatment Phase|Pregnancy|1|||
154895491|NCT01021813|559038077|FG001|DB Treatment Phase|Pregnancy|0|||
154895492|NCT01021813|559038078|FG002|DB Treatment Phase|Pregnancy|0|||
155114116|NCT00075946|559846236|FG002|Overall Study|Death|0|||
154895493|NCT01021813|559038079|FG003|DB Treatment Phase|Pregnancy|0|||
154895494|NCT01021813|559038080|FG004|DB Treatment Phase|Pregnancy|0|||
154895495|NCT01021813|559038076|FG000|DB Treatment Phase|Protocol Violation|4|||
154895496|NCT01021813|559038077|FG001|DB Treatment Phase|Protocol Violation|3|||
154895497|NCT01021813|559038078|FG002|DB Treatment Phase|Protocol Violation|0|||
154895498|NCT01021813|559038079|FG003|DB Treatment Phase|Protocol Violation|0|||
154895499|NCT01021813|559038080|FG004|DB Treatment Phase|Protocol Violation|0|||
154895500|NCT01021813|559038076|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
154895501|NCT01021813|559038077|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
154895502|NCT01021813|559038078|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
154895503|NCT01021813|559038079|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
154895504|NCT01021813|559038080|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
154895505|NCT01021813|559038076|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
154895506|NCT01021813|559038077|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
154895507|NCT01021813|559038078|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
154895508|NCT01021813|559038079|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
154895509|NCT01021813|559038080|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
154895510|NCT01021813|559038076|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
154895511|NCT01021813|559038077|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
154895512|NCT01021813|559038078|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
154895513|NCT01021813|559038079|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
154895514|NCT01021813|559038080|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
154895515|NCT01021813|559038076|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
154895516|NCT01021813|559038077|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
154895517|NCT01021813|559038078|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
154895518|NCT01021813|559038079|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
154895519|NCT01021813|559038080|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
154895520|NCT01021813|559038076|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
154895521|NCT01021813|559038077|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
154895522|NCT01021813|559038078|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
154895523|NCT01021813|559038079|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
154895524|NCT01021813|559038080|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
154895525|NCT01021813|559038076|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
154895526|NCT01021813|559038077|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
154895527|NCT01021813|559038078|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
154895528|NCT01021813|559038079|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
154895529|NCT01021813|559038080|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
154895530|NCT00673894|559038087|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
154895531|NCT00673894|559038088|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
154895532|NCT00673894|559038087|FG000|First Intervention 4 Weeks|Adverse Event|1|||
154895533|NCT00673894|559038088|FG001|First Intervention 4 Weeks|Adverse Event|0|||
154895534|NCT00326417|559038089|FG000|Overall Study|Withdrawal by Subject|0|||
154895535|NCT00326417|559038090|FG001|Overall Study|Withdrawal by Subject|0|||
154895536|NCT00326417|559038091|FG002|Overall Study|Withdrawal by Subject|1|||
154895537|NCT00326417|559038092|FG003|Overall Study|Withdrawal by Subject|0|||
154895538|NCT00326417|559038089|FG000|Overall Study|Arm Closed|7|||
154895539|NCT00326417|559038090|FG001|Overall Study|Arm Closed|0|||
154895540|NCT00326417|559038091|FG002|Overall Study|Arm Closed|0|||
154895541|NCT00326417|559038092|FG003|Overall Study|Arm Closed|3|||
154895542|NCT00326417|559038089|FG000|Overall Study|Death|7|||
154895543|NCT00326417|559038090|FG001|Overall Study|Death|0|||
154895544|NCT00326417|559038091|FG002|Overall Study|Death|0|||
154895545|NCT00326417|559038092|FG003|Overall Study|Death|0|||
154895546|NCT04682353|559038095|FG000|Overall Study|Lost to Follow-up|0|||
154895547|NCT04682353|559038096|FG001|Overall Study|Lost to Follow-up|1|||
154895548|NCT04682353|559038097|FG002|Overall Study|Lost to Follow-up|0|||
154895549|NCT04682353|559038098|FG003|Overall Study|Lost to Follow-up|1|||
154895550|NCT04682353|559038095|FG000|Overall Study|Personal reasons|0|||
154895551|NCT04682353|559038096|FG001|Overall Study|Personal reasons|1|||
154895552|NCT04682353|559038097|FG002|Overall Study|Personal reasons|0|||
154895553|NCT04682353|559038098|FG003|Overall Study|Personal reasons|0|||
154895554|NCT01586806|559038099|FG000|Overall Study|Protocol Violation|0|||
154895555|NCT01586806|559038100|FG001|Overall Study|Protocol Violation|1|||
154895556|NCT01586806|559038101|FG002|Overall Study|Protocol Violation|0|||
154895557|NCT01586806|559038099|FG000|Overall Study|Withdrawal by Subject|1|||
154895558|NCT01586806|559038100|FG001|Overall Study|Withdrawal by Subject|0|||
154895559|NCT01586806|559038101|FG002|Overall Study|Withdrawal by Subject|0|||
154895560|NCT01586806|559038099|FG000|Overall Study|Lost to Follow-up|2|||
154895561|NCT01586806|559038100|FG001|Overall Study|Lost to Follow-up|3|||
154895562|NCT01586806|559038101|FG002|Overall Study|Lost to Follow-up|2|||
154895563|NCT00555906|559038102|FG000|Phase 1|Objective Progression or Relapse|3|||
154895564|NCT00555906|559038103|FG001|Phase 1|Objective Progression or Relapse|5|||
154895565|NCT00555906|559038104|FG002|Phase 1|Objective Progression or Relapse|3|||
154978717|NCT01714739|559345691|FG004|Overall Study|Study drug toxicity|0|||
154978718|NCT01714739|559345692|FG005|Overall Study|Study drug toxicity|0|||
154895566|NCT00555906|559038105|FG003|Phase 1|Objective Progression or Relapse|1|||
154895567|NCT00555906|559038106|FG004|Phase 1|Objective Progression or Relapse|0|||
154895568|NCT00555906|559038102|FG000|Phase 1|Global Deterioration of Health Status|0|||
154895569|NCT00555906|559038103|FG001|Phase 1|Global Deterioration of Health Status|1|||
154895570|NCT00555906|559038104|FG002|Phase 1|Global Deterioration of Health Status|1|||
154895571|NCT00555906|559038105|FG003|Phase 1|Global Deterioration of Health Status|1|||
154895572|NCT00555906|559038106|FG004|Phase 1|Global Deterioration of Health Status|0|||
154895573|NCT00555906|559038102|FG000|Phase 1|Adverse Event|0|||
154895574|NCT00555906|559038103|FG001|Phase 1|Adverse Event|0|||
154895575|NCT00555906|559038104|FG002|Phase 1|Adverse Event|3|||
154895576|NCT00555906|559038105|FG003|Phase 1|Adverse Event|2|||
154895577|NCT00555906|559038106|FG004|Phase 1|Adverse Event|0|||
154895578|NCT00555906|559038102|FG000|Phase 1|Withdrawal by Subject|0|||
154895579|NCT00555906|559038103|FG001|Phase 1|Withdrawal by Subject|0|||
154895580|NCT00555906|559038104|FG002|Phase 1|Withdrawal by Subject|0|||
154895581|NCT00555906|559038105|FG003|Phase 1|Withdrawal by Subject|1|||
154895582|NCT00555906|559038106|FG004|Phase 1|Withdrawal by Subject|0|||
154895583|NCT00555906|559038102|FG000|Phase 2|Adverse Event|0|||
154895584|NCT00555906|559038103|FG001|Phase 2|Adverse Event|0|||
154895585|NCT00555906|559038104|FG002|Phase 2|Adverse Event|0|||
154895586|NCT00555906|559038105|FG003|Phase 2|Adverse Event|0|||
154895587|NCT00555906|559038106|FG004|Phase 2|Adverse Event|4|||
154895588|NCT00555906|559038102|FG000|Phase 2|Global Deterioration of Health Status|0|||
154895589|NCT00555906|559038103|FG001|Phase 2|Global Deterioration of Health Status|0|||
154895590|NCT00555906|559038104|FG002|Phase 2|Global Deterioration of Health Status|0|||
154895591|NCT00555906|559038105|FG003|Phase 2|Global Deterioration of Health Status|0|||
154895592|NCT00555906|559038106|FG004|Phase 2|Global Deterioration of Health Status|2|||
154895593|NCT00555906|559038102|FG000|Phase 2|Objective Progression or Relapse|0|||
154895594|NCT00555906|559038103|FG001|Phase 2|Objective Progression or Relapse|0|||
154895595|NCT00555906|559038104|FG002|Phase 2|Objective Progression or Relapse|0|||
154895596|NCT00555906|559038105|FG003|Phase 2|Objective Progression or Relapse|0|||
154895597|NCT00555906|559038106|FG004|Phase 2|Objective Progression or Relapse|16|||
154895598|NCT00555906|559038102|FG000|Phase 2|Withdrawal by Subject|0|||
154895599|NCT00555906|559038103|FG001|Phase 2|Withdrawal by Subject|0|||
154895600|NCT00555906|559038104|FG002|Phase 2|Withdrawal by Subject|0|||
154895601|NCT00555906|559038105|FG003|Phase 2|Withdrawal by Subject|0|||
154895602|NCT00555906|559038106|FG004|Phase 2|Withdrawal by Subject|2|||
154895603|NCT00555906|559038102|FG000|Phase 2|Other|0|||
154895604|NCT00555906|559038103|FG001|Phase 2|Other|0|||
154895605|NCT00555906|559038104|FG002|Phase 2|Other|0|||
154895606|NCT00555906|559038105|FG003|Phase 2|Other|0|||
154895607|NCT00555906|559038106|FG004|Phase 2|Other|6|||
154895608|NCT00555906|559038102|FG000|Phase 2|Randomized but not Treated|0|||
154895609|NCT00555906|559038103|FG001|Phase 2|Randomized but not Treated|0|||
154895610|NCT00555906|559038104|FG002|Phase 2|Randomized but not Treated|0|||
154895611|NCT00555906|559038105|FG003|Phase 2|Randomized but not Treated|0|||
154895612|NCT00555906|559038106|FG004|Phase 2|Randomized but not Treated|2|||
154895613|NCT01185704|559038107|FG000|Overall Study|Randomized but not treated|3|||
154895614|NCT01185704|559038108|FG001|Overall Study|Randomized but not treated|3|||
154895615|NCT01185704|559038107|FG000|Overall Study|Lack of ovarian response|5|||
154895616|NCT01185704|559038108|FG001|Overall Study|Lack of ovarian response|1|||
154895617|NCT01185704|559038107|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
154895618|NCT01185704|559038108|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
154895619|NCT01185704|559038107|FG000|Overall Study|Ectopic pregnancy|0|||
154895620|NCT01185704|559038108|FG001|Overall Study|Ectopic pregnancy|1|||
154895621|NCT01313208|559038109|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
154895622|NCT01313208|559038110|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
154895623|NCT01313208|559038109|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
154895624|NCT01313208|559038110|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
154895625|NCT01313208|559038109|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
154978719|NCT01714739|559345693|FG006|Overall Study|Study drug toxicity|5|||
155114117|NCT00075946|559846237|FG003|Overall Study|Death|0|||
155114118|NCT00075946|559846238|FG004|Overall Study|Death|0|||
154895626|NCT01313208|559038110|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
154895627|NCT01313208|559038109|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
154895628|NCT01313208|559038110|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
154895629|NCT01313208|559038109|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
154895630|NCT01313208|559038110|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
154895631|NCT01313208|559038109|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
154978720|NCT01714739|559345687|FG000|Overall Study|Death|0|||
155114119|NCT00075946|559846234|FG000|Overall Study|Withdrawal by Subject|23|||
154895632|NCT01313208|559038110|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
154895633|NCT01313208|559038109|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
154895634|NCT01313208|559038110|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
154978721|NCT01714739|559345688|FG001|Overall Study|Death|0|||
154895635|NCT01313208|559038109|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
154895636|NCT01313208|559038110|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
154895637|NCT01313208|559038109|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
154895638|NCT01313208|559038110|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
154895639|NCT00187889|559038113|FG000|Overall Study|Withdrawal by Subject|6|||
154895640|NCT00187889|559038114|FG001|Overall Study|Withdrawal by Subject|4|||
154895641|NCT01998880|559038119|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
154895642|NCT01998880|559038120|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
154895643|NCT01998880|559038119|FG000|Overall Study|Disease Progression|1|||
154895644|NCT01998880|559038120|FG001|Overall Study|Disease Progression|8|||
154895645|NCT01998880|559038119|FG000|Overall Study|Withdrew Consent|2|||
154895646|NCT01998880|559038120|FG001|Overall Study|Withdrew Consent|1|||
154895647|NCT01998880|559038119|FG000|Overall Study|Death|3|||
154895648|NCT01998880|559038120|FG001|Overall Study|Death|6|||
154895649|NCT01998880|559038119|FG000|Overall Study|Insufficient Therapeutic Response|1|||
154895650|NCT01998880|559038120|FG001|Overall Study|Insufficient Therapeutic Response|5|||
154895651|NCT01998880|559038119|FG000|Overall Study|Administrative/Other|1|||
154895652|NCT01998880|559038120|FG001|Overall Study|Administrative/Other|1|||
154895653|NCT01998880|559038119|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
154895654|NCT01998880|559038120|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
154895655|NCT01998880|559038119|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
154895656|NCT01998880|559038120|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
154895657|NCT01998880|559038119|FG000|Overall Study|Did Not Receive Treatment|3|||
154895658|NCT01998880|559038120|FG001|Overall Study|Did Not Receive Treatment|2|||
154895659|NCT02248857|559038121|FG000|3 Month|Withdrawal by Subject|9|||
154895660|NCT02248857|559038122|FG001|3 Month|Withdrawal by Subject|3|||
154895661|NCT02248857|559038123|FG002|3 Month|Withdrawal by Subject|4|||
154895662|NCT02248857|559038121|FG000|3 Month|Unable to reach for 3 month|35|||
154895663|NCT02248857|559038122|FG001|3 Month|Unable to reach for 3 month|29|||
154895664|NCT02248857|559038123|FG002|3 Month|Unable to reach for 3 month|26|||
154895665|NCT02248857|559038121|FG000|3 Month|Partially completed, unable to finish|2|||
154895666|NCT02248857|559038122|FG001|3 Month|Partially completed, unable to finish|2|||
154895667|NCT02248857|559038123|FG002|3 Month|Partially completed, unable to finish|1|||
154895668|NCT02248857|559038121|FG000|6 Month|Lost to Follow-up|27|||
154895669|NCT02248857|559038122|FG001|6 Month|Lost to Follow-up|26|||
154895670|NCT02248857|559038123|FG002|6 Month|Lost to Follow-up|15|||
154895671|NCT02248857|559038121|FG000|6 Month|Partially completed, unable to finish|0|||
154895672|NCT02248857|559038122|FG001|6 Month|Partially completed, unable to finish|1|||
154895673|NCT02248857|559038123|FG002|6 Month|Partially completed, unable to finish|0|||
154895674|NCT02248857|559038121|FG000|6 Month|Withdrawal by Subject|0|||
154895675|NCT02248857|559038122|FG001|6 Month|Withdrawal by Subject|2|||
154895676|NCT02248857|559038123|FG002|6 Month|Withdrawal by Subject|2|||
154895677|NCT02248857|559038121|FG000|6 Month|Death|1|||
154895678|NCT02248857|559038122|FG001|6 Month|Death|0|||
154895679|NCT02248857|559038123|FG002|6 Month|Death|0|||
154895680|NCT02671461|559038124|FG000|Treatment|Adverse Event|0|||
154895681|NCT02671461|559038125|FG001|Treatment|Adverse Event|0|||
154895682|NCT02671461|559038126|FG002|Treatment|Adverse Event|1|||
154895683|NCT02671461|559038124|FG000|Treatment|Administrative Reason by Sponsor|1|||
154895684|NCT02671461|559038125|FG001|Treatment|Administrative Reason by Sponsor|3|||
154895685|NCT02671461|559038126|FG002|Treatment|Administrative Reason by Sponsor|4|||
154895686|NCT02671461|559038124|FG000|Treatment|Randomized, not treated|1|||
154895687|NCT02671461|559038125|FG001|Treatment|Randomized, not treated|0|||
154895688|NCT02671461|559038126|FG002|Treatment|Randomized, not treated|0|||
154895689|NCT02671461|559038124|FG000|Follow-up|Withdrawal by Subject|1|||
154895690|NCT02671461|559038125|FG001|Follow-up|Withdrawal by Subject|0|||
154895691|NCT02671461|559038126|FG002|Follow-up|Withdrawal by Subject|0|||
154895692|NCT02671461|559038124|FG000|Follow-up|Lost to Follow-up|0|||
154895693|NCT02671461|559038125|FG001|Follow-up|Lost to Follow-up|0|||
154895694|NCT02671461|559038126|FG002|Follow-up|Lost to Follow-up|1|||
154895695|NCT02671461|559038124|FG000|Follow-up|Administrative Reason by Sponsor|0|||
154895696|NCT02671461|559038125|FG001|Follow-up|Administrative Reason by Sponsor|1|||
154895697|NCT02671461|559038126|FG002|Follow-up|Administrative Reason by Sponsor|0|||
154895698|NCT01412060|559038127|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
154895699|NCT01412060|559038128|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
154895700|NCT01412060|559038129|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
154895701|NCT01412060|559038127|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
155114120|NCT00075946|559846235|FG001|Overall Study|Withdrawal by Subject|58|||
155114121|NCT00075946|559846236|FG002|Overall Study|Withdrawal by Subject|4|||
155114122|NCT00075946|559846237|FG003|Overall Study|Withdrawal by Subject|9|||
155114123|NCT00075946|559846238|FG004|Overall Study|Withdrawal by Subject|0|||
155114124|NCT00075946|559846234|FG000|Overall Study|Alternative therapy|16|||
154895702|NCT01412060|559038128|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
154895703|NCT01412060|559038129|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
155114125|NCT00075946|559846235|FG001|Overall Study|Alternative therapy|2|||
154895704|NCT01412060|559038127|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
154978722|NCT01714739|559345689|FG002|Overall Study|Death|0|||
154978723|NCT01714739|559345690|FG003|Overall Study|Death|1|||
154978724|NCT01714739|559345691|FG004|Overall Study|Death|0|||
154978725|NCT01714739|559345692|FG005|Overall Study|Death|0|||
154978726|NCT01714739|559345693|FG006|Overall Study|Death|0|||
154978727|NCT01714739|559345687|FG000|Overall Study|Adverse Event unrelated to drug|0|||
154978728|NCT01714739|559345688|FG001|Overall Study|Adverse Event unrelated to drug|0|||
154978729|NCT01714739|559345689|FG002|Overall Study|Adverse Event unrelated to drug|3|||
154978730|NCT01714739|559345690|FG003|Overall Study|Adverse Event unrelated to drug|21|||
154978731|NCT01714739|559345691|FG004|Overall Study|Adverse Event unrelated to drug|0|||
154978732|NCT01714739|559345692|FG005|Overall Study|Adverse Event unrelated to drug|0|||
154978733|NCT01714739|559345693|FG006|Overall Study|Adverse Event unrelated to drug|0|||
154978734|NCT01714739|559345687|FG000|Overall Study|Participant request to stop therapy|0|||
154978735|NCT01714739|559345688|FG001|Overall Study|Participant request to stop therapy|1|||
154978736|NCT01714739|559345689|FG002|Overall Study|Participant request to stop therapy|0|||
154978737|NCT01714739|559345690|FG003|Overall Study|Participant request to stop therapy|6|||
154978738|NCT01714739|559345691|FG004|Overall Study|Participant request to stop therapy|0|||
154978739|NCT01714739|559345692|FG005|Overall Study|Participant request to stop therapy|0|||
154978740|NCT01714739|559345693|FG006|Overall Study|Participant request to stop therapy|0|||
154978741|NCT01714739|559345687|FG000|Overall Study|Participant withdrew consent|0|||
154978742|NCT01714739|559345688|FG001|Overall Study|Participant withdrew consent|1|||
154978743|NCT01714739|559345689|FG002|Overall Study|Participant withdrew consent|0|||
154978744|NCT01714739|559345690|FG003|Overall Study|Participant withdrew consent|8|||
154978745|NCT01714739|559345691|FG004|Overall Study|Participant withdrew consent|0|||
154978746|NCT01714739|559345692|FG005|Overall Study|Participant withdrew consent|0|||
154978747|NCT01714739|559345693|FG006|Overall Study|Participant withdrew consent|0|||
154978748|NCT01714739|559345687|FG000|Overall Study|Lost to Follow-up|0|||
154978749|NCT01714739|559345688|FG001|Overall Study|Lost to Follow-up|0|||
154978750|NCT01714739|559345689|FG002|Overall Study|Lost to Follow-up|0|||
154978751|NCT01714739|559345690|FG003|Overall Study|Lost to Follow-up|1|||
154978752|NCT01714739|559345691|FG004|Overall Study|Lost to Follow-up|0|||
154978753|NCT01714739|559345692|FG005|Overall Study|Lost to Follow-up|0|||
154978754|NCT01714739|559345693|FG006|Overall Study|Lost to Follow-up|0|||
154978755|NCT01714739|559345687|FG000|Overall Study|Maximum clinical benefit|0|||
154978756|NCT01714739|559345688|FG001|Overall Study|Maximum clinical benefit|1|||
154978757|NCT01714739|559345689|FG002|Overall Study|Maximum clinical benefit|1|||
154978758|NCT01714739|559345690|FG003|Overall Study|Maximum clinical benefit|3|||
154978759|NCT01714739|559345691|FG004|Overall Study|Maximum clinical benefit|0|||
154978760|NCT01714739|559345692|FG005|Overall Study|Maximum clinical benefit|0|||
154978761|NCT01714739|559345693|FG006|Overall Study|Maximum clinical benefit|0|||
154978762|NCT01714739|559345687|FG000|Overall Study|Poor/non-comliance|0|||
154978763|NCT01714739|559345688|FG001|Overall Study|Poor/non-comliance|1|||
154978764|NCT01714739|559345689|FG002|Overall Study|Poor/non-comliance|0|||
154978765|NCT01714739|559345690|FG003|Overall Study|Poor/non-comliance|1|||
154978766|NCT01714739|559345691|FG004|Overall Study|Poor/non-comliance|0|||
154978767|NCT01714739|559345692|FG005|Overall Study|Poor/non-comliance|0|||
154978768|NCT01714739|559345693|FG006|Overall Study|Poor/non-comliance|0|||
154895705|NCT01412060|559038128|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
154895706|NCT01412060|559038129|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
154895707|NCT01412060|559038127|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
154895708|NCT01412060|559038128|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
154895709|NCT01412060|559038129|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
154895710|NCT01412060|559038127|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
154895711|NCT01412060|559038128|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
154895712|NCT01412060|559038129|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
154895713|NCT01412060|559038127|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
154895714|NCT01412060|559038128|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
154895715|NCT01412060|559038129|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
154895716|NCT01412060|559038127|FG000|Period Between RIP and SP|Adverse Event|4|||
154895717|NCT01412060|559038128|FG001|Period Between RIP and SP|Adverse Event|0|||
154978769|NCT01714739|559345687|FG000|Overall Study|No longer meets study criteria|0|||
154978770|NCT01714739|559345688|FG001|Overall Study|No longer meets study criteria|0|||
154978771|NCT01714739|559345689|FG002|Overall Study|No longer meets study criteria|0|||
154978772|NCT01714739|559345690|FG003|Overall Study|No longer meets study criteria|1|||
154978773|NCT01714739|559345691|FG004|Overall Study|No longer meets study criteria|0|||
154978774|NCT01714739|559345692|FG005|Overall Study|No longer meets study criteria|0|||
154978775|NCT01714739|559345693|FG006|Overall Study|No longer meets study criteria|0|||
154978776|NCT01714739|559345687|FG000|Overall Study|Other reason|0|||
154978777|NCT01714739|559345688|FG001|Overall Study|Other reason|0|||
154978778|NCT01714739|559345689|FG002|Overall Study|Other reason|0|||
154978779|NCT01714739|559345690|FG003|Overall Study|Other reason|3|||
154978780|NCT01714739|559345691|FG004|Overall Study|Other reason|1|||
154978781|NCT01714739|559345692|FG005|Overall Study|Other reason|0|||
154978782|NCT01714739|559345693|FG006|Overall Study|Other reason|0|||
154895718|NCT01412060|559038129|FG002|Period Between RIP and SP|Adverse Event|0|||
154978783|NCT00707434|559345696|FG000|Overall Study|Adverse Event|1|||
154978784|NCT01011556|559345697|FG000|Overall Study|Adverse Event|1|||
154978785|NCT01011556|559345698|FG001|Overall Study|Adverse Event|3|||
154978786|NCT01011556|559345699|FG002|Overall Study|Adverse Event|2|||
154978787|NCT01011556|559345700|FG003|Overall Study|Adverse Event|1|||
154978788|NCT01011556|559345697|FG000|Overall Study|Lost to Follow-up|1|||
154978789|NCT01011556|559345698|FG001|Overall Study|Lost to Follow-up|0|||
154978790|NCT01011556|559345699|FG002|Overall Study|Lost to Follow-up|0|||
154978791|NCT01011556|559345700|FG003|Overall Study|Lost to Follow-up|0|||
154978792|NCT01011556|559345697|FG000|Overall Study|Physician Decision|1|||
154978793|NCT01011556|559345698|FG001|Overall Study|Physician Decision|0|||
154978794|NCT01011556|559345699|FG002|Overall Study|Physician Decision|0|||
154978795|NCT01011556|559345700|FG003|Overall Study|Physician Decision|1|||
154978796|NCT01011556|559345697|FG000|Overall Study|Protocol Violation|0|||
154978797|NCT01011556|559345698|FG001|Overall Study|Protocol Violation|1|||
154978798|NCT01011556|559345699|FG002|Overall Study|Protocol Violation|0|||
154978799|NCT01011556|559345700|FG003|Overall Study|Protocol Violation|0|||
154978800|NCT01011556|559345697|FG000|Overall Study|Withdrawal by Subject|1|||
154978801|NCT01011556|559345698|FG001|Overall Study|Withdrawal by Subject|2|||
154978802|NCT01011556|559345699|FG002|Overall Study|Withdrawal by Subject|4|||
154978803|NCT01011556|559345700|FG003|Overall Study|Withdrawal by Subject|4|||
154978804|NCT01011556|559345697|FG000|Overall Study|Sponsor decision|0|||
154978805|NCT01011556|559345698|FG001|Overall Study|Sponsor decision|1|||
154978806|NCT01011556|559345699|FG002|Overall Study|Sponsor decision|1|||
154895719|NCT01412060|559038127|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
154895720|NCT01412060|559038128|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
154895721|NCT01412060|559038129|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
154895722|NCT01412060|559038127|FG000|Period Between RIP and SP|Protocol Violation|2|||
154895723|NCT01412060|559038128|FG001|Period Between RIP and SP|Protocol Violation|0|||
154895724|NCT01412060|559038129|FG002|Period Between RIP and SP|Protocol Violation|0|||
154895725|NCT01412060|559038127|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
154895726|NCT01412060|559038128|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
154895727|NCT01412060|559038129|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
154895728|NCT01412060|559038127|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
154895729|NCT01412060|559038128|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
154895730|NCT01412060|559038129|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
154895731|NCT01412060|559038127|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
154895732|NCT01412060|559038128|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
154895733|NCT01412060|559038129|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
154895734|NCT01412060|559038127|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
154895735|NCT01412060|559038128|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
154895736|NCT01412060|559038129|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
154895737|NCT01412060|559038127|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
154895738|NCT01412060|559038128|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
154895739|NCT01412060|559038129|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
154895740|NCT01412060|559038127|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
154895741|NCT01412060|559038128|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
154895742|NCT01412060|559038129|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
154895743|NCT01412060|559038127|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
154895744|NCT01412060|559038128|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
154895745|NCT01412060|559038129|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
154895746|NCT01412060|559038127|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
154895747|NCT01412060|559038128|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
154895748|NCT01412060|559038129|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
154895749|NCT01412060|559038127|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
154895750|NCT01412060|559038128|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
154895751|NCT01412060|559038129|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
154895752|NCT01412060|559038127|FG000|Period Between SP and DBP|Protocol Violation|2|||
154895753|NCT01412060|559038128|FG001|Period Between SP and DBP|Protocol Violation|0|||
154895754|NCT01412060|559038129|FG002|Period Between SP and DBP|Protocol Violation|0|||
154895755|NCT01412060|559038127|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
154895756|NCT01412060|559038128|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
154895757|NCT01412060|559038129|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
154895758|NCT01412060|559038127|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
154895759|NCT01412060|559038128|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
154895760|NCT01412060|559038129|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
154895761|NCT01412060|559038127|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
154895762|NCT01412060|559038128|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
154895763|NCT01412060|559038129|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
154895764|NCT01412060|559038127|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
154895765|NCT01412060|559038128|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
154895766|NCT01412060|559038129|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
154895767|NCT01412060|559038127|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
154895768|NCT01412060|559038128|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
154895769|NCT01412060|559038129|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
154895770|NCT01412060|559038127|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
154895771|NCT01412060|559038128|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
154895772|NCT01412060|559038129|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
154895773|NCT01412060|559038127|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
154895774|NCT01412060|559038128|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
154895775|NCT01412060|559038129|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
154895776|NCT01412060|559038127|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
154895777|NCT01412060|559038128|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
154895778|NCT01412060|559038129|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
154895779|NCT01412060|559038127|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
154895780|NCT01412060|559038128|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
154895781|NCT01412060|559038129|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
154895782|NCT01412060|559038127|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
154895783|NCT01412060|559038128|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
154895784|NCT01412060|559038129|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
154895785|NCT00004732|559038130|FG000|Overall Study|Withdrawal by Subject|36|||
154895786|NCT00004732|559038131|FG001|Overall Study|Withdrawal by Subject|64|||
154895787|NCT00004732|559038130|FG000|Overall Study|Lost to Follow-up|33|||
154895788|NCT00004732|559038131|FG001|Overall Study|Lost to Follow-up|47|||
154895789|NCT01688635|559038135|FG000|Washout 1|Withdrawal by Subject|1|||
154895790|NCT01688635|559038136|FG001|Washout 1|Withdrawal by Subject|0|||
154895791|NCT01688635|559038135|FG000|Washout 1|Adverse Event|0|||
154895792|NCT01688635|559038136|FG001|Washout 1|Adverse Event|1|||
154895793|NCT01688635|559038135|FG000|Washout 1|Physician Decision|0|||
154895794|NCT01688635|559038136|FG001|Washout 1|Physician Decision|1|||
154895795|NCT01688635|559038135|FG000|Washout 2|Physician Decision|1|||
154895796|NCT01688635|559038136|FG001|Washout 2|Physician Decision|0|||
154895797|NCT01688635|559038135|FG000|Washout 2|Withdrawal by Subject|1|||
154895798|NCT01688635|559038136|FG001|Washout 2|Withdrawal by Subject|0|||
154895799|NCT01688635|559038135|FG000|Washout 2|Sponsor Decision|1|||
154895800|NCT01688635|559038136|FG001|Washout 2|Sponsor Decision|2|||
154895801|NCT01688635|559038135|FG000|Washout 3|Withdrawal by Subject|1|||
154895802|NCT01688635|559038136|FG001|Washout 3|Withdrawal by Subject|0|||
154895803|NCT02674685|559038137|FG000|Overall Study|Withdrawal by Subject|4|||
154895804|NCT03549117|559038140|FG000|Overall Study|Withdrawal by Subject|1|||
154895805|NCT03549117|559038141|FG001|Overall Study|Withdrawal by Subject|0|||
154895806|NCT02661464|559038145|FG000|Overall Study|Lost to Follow-up|28|||
154895807|NCT02661464|559038146|FG001|Overall Study|Lost to Follow-up|0|||
154895808|NCT02661464|559038147|FG002|Overall Study|Lost to Follow-up|0|||
154895809|NCT02661464|559038148|FG003|Overall Study|Lost to Follow-up|0|||
154895810|NCT02661464|559038145|FG000|Overall Study|Withdrawal by Subject|3|||
154895811|NCT02661464|559038146|FG001|Overall Study|Withdrawal by Subject|1|||
154895812|NCT02661464|559038147|FG002|Overall Study|Withdrawal by Subject|0|||
154895813|NCT02661464|559038148|FG003|Overall Study|Withdrawal by Subject|0|||
154895814|NCT02661464|559038145|FG000|Overall Study|Participants terminated prematurely|288|||
154895815|NCT02661464|559038146|FG001|Overall Study|Participants terminated prematurely|52|||
154895816|NCT02661464|559038147|FG002|Overall Study|Participants terminated prematurely|1|||
154895817|NCT02661464|559038148|FG003|Overall Study|Participants terminated prematurely|1|||
154895818|NCT02661464|559038145|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
154895819|NCT02661464|559038146|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
154895820|NCT02661464|559038147|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
154895821|NCT02661464|559038148|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
154895822|NCT02177175|559038149|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
154895823|NCT02177175|559038150|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
154895824|NCT01924299|559038151|FG000|Period 2|Withdrawal by Subject|1|||
154895825|NCT01924299|559038152|FG001|Period 2|Withdrawal by Subject|0|||
154895826|NCT01924299|559038151|FG000|Period 2|Adverse Event|0|||
154895827|NCT01924299|559038152|FG001|Period 2|Adverse Event|1|||
154895828|NCT03820726|559038157|FG000|Overall Study|Other than listed|23|||
154895829|NCT03820726|559038157|FG000|Overall Study|Withdrawal by Subject|37|||
154895830|NCT03820726|559038157|FG000|Overall Study|Lost to Follow-up|3|||
154895831|NCT03820726|559038157|FG000|Overall Study|Protocol deviation|1|||
154895832|NCT03820726|559038157|FG000|Overall Study|Adverse Event|146|||
154895833|NCT03820726|559038157|FG000|Overall Study|Not treated|1|||
154978807|NCT01011556|559345700|FG003|Overall Study|Sponsor decision|2|||
154978808|NCT01011556|559345697|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
154978809|NCT01011556|559345698|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
154978810|NCT01011556|559345699|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
154978811|NCT01011556|559345700|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
154978812|NCT00614822|559345701|FG000|Overall Study|Adverse Event|3|||
154978813|NCT03649412|559345702|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
154978814|NCT03649412|559345703|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
154978815|NCT03649412|559345702|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
154978816|NCT03649412|559345703|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
154978817|NCT03649412|559345702|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
154978818|NCT03649412|559345703|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
154978819|NCT03649412|559345702|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
154978820|NCT03649412|559345703|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
154978821|NCT03649412|559345702|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
154978822|NCT03649412|559345703|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
154978823|NCT03649412|559345702|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
154978824|NCT03649412|559345703|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
154978825|NCT00530348|559345704|FG000|Overall Study|Adverse Event|5|||
154978826|NCT00530348|559345705|FG001|Overall Study|Adverse Event|1|||
154978827|NCT00530348|559345704|FG000|Overall Study|Death|0|||
154978828|NCT00530348|559345705|FG001|Overall Study|Death|1|||
154978829|NCT00530348|559345704|FG000|Overall Study|Lack of Efficacy|2|||
154978830|NCT00530348|559345705|FG001|Overall Study|Lack of Efficacy|0|||
154978831|NCT00530348|559345704|FG000|Overall Study|Lost to Follow-up|0|||
154978832|NCT00530348|559345705|FG001|Overall Study|Lost to Follow-up|2|||
154978833|NCT00530348|559345704|FG000|Overall Study|Physician Decision|1|||
154978834|NCT00530348|559345705|FG001|Overall Study|Physician Decision|2|||
154978835|NCT00530348|559345704|FG000|Overall Study|Pregnancy|1|||
154978836|NCT00530348|559345705|FG001|Overall Study|Pregnancy|0|||
154978837|NCT00530348|559345704|FG000|Overall Study|Withdrawal by Subject|12|||
154978838|NCT00530348|559345705|FG001|Overall Study|Withdrawal by Subject|12|||
154978839|NCT00530348|559345704|FG000|Overall Study|Randomised in error|1|||
154978840|NCT00530348|559345705|FG001|Overall Study|Randomised in error|0|||
154978841|NCT00530348|559345704|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
154978842|NCT00530348|559345705|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
154978843|NCT04364763|559345706|FG000|Overall Study|Death|1|||
154978844|NCT04364763|559345707|FG001|Overall Study|Death|2|||
154978845|NCT04364763|559345706|FG000|Overall Study|Lost to Follow-up|1|||
154978846|NCT04364763|559345707|FG001|Overall Study|Lost to Follow-up|0|||
154978847|NCT01256060|559345709|FG000|Overall Study|Lost to Follow-up|0|||
155114126|NCT00075946|559846236|FG002|Overall Study|Alternative therapy|5|||
155114127|NCT00075946|559846237|FG003|Overall Study|Alternative therapy|0|||
155114128|NCT00075946|559846238|FG004|Overall Study|Alternative therapy|0|||
154895834|NCT01293084|559038161|FG000|Overall Study|Physician Decision|3|||
154895835|NCT01293084|559038161|FG000|Overall Study|Withdrawal by Subject|2|||
154895836|NCT04186663|559038162|FG000|Overall Study|Lost to Follow-up|1|||
154895837|NCT04186663|559038162|FG000|Overall Study|Unable to complete blood draw|3|||
154895838|NCT00719862|559038167|FG000|Overall Study|Adverse Event|1|||
154895839|NCT00719862|559038168|FG001|Overall Study|Adverse Event|2|||
154895840|NCT00719862|559038167|FG000|Overall Study|Lack of Efficacy|3|||
154895841|NCT00719862|559038168|FG001|Overall Study|Lack of Efficacy|0|||
154895842|NCT00719862|559038167|FG000|Overall Study|Non-Compliance|1|||
154895843|NCT00719862|559038168|FG001|Overall Study|Non-Compliance|0|||
154895844|NCT00719862|559038167|FG000|Overall Study|Withdrawal by Subject|1|||
154895845|NCT00719862|559038168|FG001|Overall Study|Withdrawal by Subject|0|||
154895846|NCT00719862|559038167|FG000|Overall Study|Lost to Follow-up|0|||
154895847|NCT00719862|559038168|FG001|Overall Study|Lost to Follow-up|1|||
154895848|NCT00719862|559038167|FG000|Overall Study|Other|2|||
154895849|NCT00719862|559038168|FG001|Overall Study|Other|3|||
154895850|NCT01184846|559038169|FG000|Overall Study|Adverse Event|2|||
154978848|NCT01256060|559345710|FG001|Overall Study|Lost to Follow-up|1|||
154978849|NCT01256060|559345711|FG002|Overall Study|Lost to Follow-up|0|||
154978850|NCT01256060|559345712|FG003|Overall Study|Lost to Follow-up|0|||
154978851|NCT00089076|559345717|FG000|Overall Study|Alternate Therapy|1|||
154978852|NCT00089076|559345717|FG000|Overall Study|Withdrawal by Subject|2|||
154978853|NCT00089076|559345717|FG000|Overall Study|Progression|7|||
154978854|NCT00931463|559345718|FG000|Overall Study|Death|8|||
154978855|NCT00931463|559345719|FG001|Overall Study|Death|4|||
154978856|NCT00931463|559345718|FG000|Overall Study|Withdrawal by Subject|5|||
154978857|NCT00931463|559345719|FG001|Overall Study|Withdrawal by Subject|0|||
154978858|NCT00931463|559345718|FG000|Overall Study|Lost to Follow-up|4|||
154978859|NCT00931463|559345719|FG001|Overall Study|Lost to Follow-up|1|||
154978860|NCT00808509|559345720|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
154978861|NCT00808509|559345721|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
154978862|NCT00808509|559345720|FG000|Randomized Phase|Reduced methotrexate dose|1|||
155114129|NCT00075946|559846234|FG000|Overall Study|Other complicating disease|7|||
154978863|NCT00808509|559345721|FG001|Randomized Phase|Reduced methotrexate dose|2|||
154978864|NCT00808509|559345720|FG000|Randomized Phase|Patient refused rescue therapy|0|||
154978865|NCT00808509|559345721|FG001|Randomized Phase|Patient refused rescue therapy|3|||
154978866|NCT03170869|559345724|FG000|Overall Study|Protocol Violation|5|||
154978867|NCT03170869|559345724|FG000|Overall Study|Early study termination|3|||
154978868|NCT00084799|559345732|FG000|Overall Study|Disease Progression|1|||
154978869|NCT00084799|559345733|FG001|Overall Study|Disease Progression|0|||
154978870|NCT02663882|559345734|FG000|Overall Study|Lost to Follow-up|4|||
154978871|NCT02663882|559345735|FG001|Overall Study|Lost to Follow-up|2|||
154978872|NCT04449341|559345738|FG000|Overall Study|Protocol Violation|1|||
154978873|NCT04449341|559345739|FG001|Overall Study|Protocol Violation|0|||
154978874|NCT04499482|559345740|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
154978875|NCT00124462|559345741|FG000|Overall Study|Lost to Follow-up|3|||
154978876|NCT00124462|559345742|FG001|Overall Study|Lost to Follow-up|3|||
154978877|NCT00124462|559345741|FG000|Overall Study|Physician Decision|3|||
154978878|NCT00124462|559345742|FG001|Overall Study|Physician Decision|4|||
154978879|NCT00124462|559345741|FG000|Overall Study|Withdrawal by Subject|4|||
154978880|NCT00124462|559345742|FG001|Overall Study|Withdrawal by Subject|5|||
154978881|NCT00124462|559345741|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
154978882|NCT00124462|559345742|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
154978883|NCT02487082|559345743|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
154978884|NCT02487082|559345744|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
154978885|NCT02487082|559345743|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
154978886|NCT02487082|559345744|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
154978887|NCT03297294|559345745|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
154978888|NCT03297294|559345746|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
154978889|NCT03297294|559345747|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154978890|NCT03297294|559345748|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154978891|NCT03297294|559345749|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
154978892|NCT03297294|559345745|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
154978893|NCT03297294|559345746|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
154978894|NCT03297294|559345747|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154978895|NCT03297294|559345748|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154978896|NCT03297294|559345749|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
154978897|NCT03297294|559345745|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
154978898|NCT03297294|559345746|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
154978899|NCT03297294|559345747|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154978900|NCT03297294|559345748|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154978901|NCT03297294|559345749|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
154978902|NCT03297294|559345745|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
154978903|NCT03297294|559345746|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
154978904|NCT03297294|559345747|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154978905|NCT03297294|559345748|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154978906|NCT03297294|559345749|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
154978907|NCT03297294|559345745|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
154895851|NCT01184846|559038169|FG000|Overall Study|Insufficient response|1|||
154895852|NCT04021706|559040575|FG000|Overall Study|Adverse Event|2|||
154895853|NCT04021706|559040576|FG001|Overall Study|Adverse Event|0|||
154895854|NCT04021706|559040575|FG000|Overall Study|Withdrawal by Subject|1|||
154895855|NCT04021706|559040576|FG001|Overall Study|Withdrawal by Subject|2|||
154895856|NCT04021706|559040575|FG000|Overall Study|Physician Decision|1|||
154895857|NCT04021706|559040576|FG001|Overall Study|Physician Decision|0|||
154895858|NCT02332798|559040579|FG000|Overall Study|Unwilling to Participate in Study|0|||
154895859|NCT02332798|559040580|FG001|Overall Study|Unwilling to Participate in Study|1|||
154895860|NCT02332798|559040581|FG002|Overall Study|Unwilling to Participate in Study|1|||
154895861|NCT02332798|559040579|FG000|Overall Study|Positive Urine Drug Test|0|||
154895862|NCT02332798|559040580|FG001|Overall Study|Positive Urine Drug Test|1|||
154895863|NCT02332798|559040581|FG002|Overall Study|Positive Urine Drug Test|0|||
154895864|NCT02332798|559040579|FG000|Overall Study|Abnormal Laboratory Findings|1|||
154895865|NCT02332798|559040580|FG001|Overall Study|Abnormal Laboratory Findings|0|||
154895866|NCT02332798|559040581|FG002|Overall Study|Abnormal Laboratory Findings|0|||
154895867|NCT00107172|559040582|FG000|Overall Study|Withdrawal by Subject|1|||
154895868|NCT00107172|559040583|FG001|Overall Study|Withdrawal by Subject|0|||
154895869|NCT00107172|559040582|FG000|Overall Study|Death|0|||
154895870|NCT00107172|559040583|FG001|Overall Study|Death|2|||
154978908|NCT03297294|559345746|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
154978909|NCT03297294|559345747|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
154895871|NCT00107172|559040582|FG000|Overall Study|Other Reason|4|||
154895872|NCT00107172|559040583|FG001|Overall Study|Other Reason|3|||
154895873|NCT00595868|559040584|FG000|Overall Study|Lost to Follow-up|45|||
154895874|NCT00595868|559040585|FG001|Overall Study|Lost to Follow-up|50|||
154895875|NCT02688153|559040586|FG000|Overall Study|Death|7|||
154895876|NCT02688153|559040587|FG001|Overall Study|Death|5|||
154895877|NCT02688153|559040586|FG000|Overall Study|Withdrawal by Subject|4|||
154895878|NCT02688153|559040587|FG001|Overall Study|Withdrawal by Subject|2|||
154895879|NCT02688153|559040586|FG000|Overall Study|Valve Explant|1|||
154895880|NCT02688153|559040587|FG001|Overall Study|Valve Explant|0|||
154895881|NCT02688153|559040586|FG000|Overall Study|Conversion to Commercial Valve|3|||
154895882|NCT02688153|559040587|FG001|Overall Study|Conversion to Commercial Valve|0|||
154895883|NCT04432376|559040591|FG000|Double-blind Treatment Period|Adverse Event|2|||
154895884|NCT04432376|559040592|FG001|Double-blind Treatment Period|Adverse Event|6|||
154895885|NCT04432376|559040593|FG002|Double-blind Treatment Period|Adverse Event|0|||
154895886|NCT04432376|559040591|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
154895887|NCT04432376|559040592|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
154895888|NCT04432376|559040593|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
154895889|NCT04432376|559040591|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
154895890|NCT04432376|559040592|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
154895891|NCT04432376|559040593|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
154895892|NCT04432376|559040591|FG000|Double-blind Treatment Period|Protocol Violation|0|||
154895893|NCT04432376|559040592|FG001|Double-blind Treatment Period|Protocol Violation|1|||
154895894|NCT04432376|559040593|FG002|Double-blind Treatment Period|Protocol Violation|0|||
154895895|NCT04432376|559040591|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
154895896|NCT04432376|559040592|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
154895897|NCT04432376|559040593|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
154895898|NCT00462488|559040594|FG000|Overall Study|Protocol Violation|1|||
154895899|NCT00462488|559040595|FG001|Overall Study|Protocol Violation|0|||
154895900|NCT00462488|559040594|FG000|Overall Study|Lack of Efficacy|19|||
154895901|NCT00462488|559040595|FG001|Overall Study|Lack of Efficacy|17|||
154895902|NCT01742091|559040600|FG000|Overall Study|Adverse Event|0|||
154895903|NCT01742091|559040601|FG001|Overall Study|Adverse Event|0|||
154895904|NCT01742091|559040602|FG002|Overall Study|Adverse Event|0|||
154895905|NCT01742091|559040603|FG003|Overall Study|Adverse Event|0|||
154895906|NCT01742091|559040604|FG004|Overall Study|Adverse Event|1|||
154895907|NCT01742091|559040605|FG005|Overall Study|Adverse Event|0|||
154895908|NCT01742091|559040600|FG000|Overall Study|Physician Decision|0|||
154895909|NCT01742091|559040601|FG001|Overall Study|Physician Decision|0|||
154895910|NCT01742091|559040602|FG002|Overall Study|Physician Decision|0|||
154895911|NCT01742091|559040603|FG003|Overall Study|Physician Decision|0|||
154895912|NCT01742091|559040604|FG004|Overall Study|Physician Decision|0|||
154895913|NCT01742091|559040605|FG005|Overall Study|Physician Decision|1|||
154895914|NCT01742091|559040600|FG000|Overall Study|Withdrawal by Subject|0|||
154895915|NCT01742091|559040601|FG001|Overall Study|Withdrawal by Subject|0|||
154895916|NCT01742091|559040602|FG002|Overall Study|Withdrawal by Subject|0|||
154895917|NCT01742091|559040603|FG003|Overall Study|Withdrawal by Subject|1|||
154895918|NCT01742091|559040604|FG004|Overall Study|Withdrawal by Subject|0|||
154895919|NCT01742091|559040605|FG005|Overall Study|Withdrawal by Subject|0|||
154895920|NCT01742091|559040600|FG000|Overall Study|Lost to Follow-up|0|||
154895921|NCT01742091|559040601|FG001|Overall Study|Lost to Follow-up|0|||
154895922|NCT01742091|559040602|FG002|Overall Study|Lost to Follow-up|0|||
154895923|NCT01742091|559040603|FG003|Overall Study|Lost to Follow-up|0|||
154895924|NCT01742091|559040604|FG004|Overall Study|Lost to Follow-up|0|||
154895925|NCT01742091|559040605|FG005|Overall Study|Lost to Follow-up|1|||
154895926|NCT05742841|559040606|FG000|Overall Study|Withdrawal by Subject|1|||
154895927|NCT05742841|559040606|FG000|Overall Study|Lost to Follow-up|1|||
154895928|NCT02088541|559040607|FG000|Overall Study|Adverse Event|3|||
154895929|NCT02088541|559040608|FG001|Overall Study|Adverse Event|0|||
154895930|NCT02088541|559040609|FG002|Overall Study|Adverse Event|3|||
154895931|NCT02088541|559040610|FG003|Overall Study|Adverse Event|3|||
154895932|NCT02088541|559040611|FG004|Overall Study|Adverse Event|0|||
154895933|NCT02088541|559040607|FG000|Overall Study|Death|51|||
154895934|NCT02088541|559040608|FG001|Overall Study|Death|21|||
154895935|NCT02088541|559040609|FG002|Overall Study|Death|85|||
154895936|NCT02088541|559040610|FG003|Overall Study|Death|28|||
154895937|NCT02088541|559040611|FG004|Overall Study|Death|38|||
154895938|NCT02088541|559040607|FG000|Overall Study|Lost to Follow-up|2|||
154895939|NCT02088541|559040608|FG001|Overall Study|Lost to Follow-up|0|||
154895940|NCT02088541|559040609|FG002|Overall Study|Lost to Follow-up|1|||
154895941|NCT02088541|559040610|FG003|Overall Study|Lost to Follow-up|0|||
154895942|NCT02088541|559040611|FG004|Overall Study|Lost to Follow-up|0|||
154895943|NCT02088541|559040607|FG000|Overall Study|Physician Decision|2|||
154895944|NCT02088541|559040608|FG001|Overall Study|Physician Decision|1|||
154895945|NCT02088541|559040609|FG002|Overall Study|Physician Decision|2|||
154895946|NCT02088541|559040610|FG003|Overall Study|Physician Decision|0|||
154895947|NCT02088541|559040611|FG004|Overall Study|Physician Decision|2|||
154895948|NCT02088541|559040607|FG000|Overall Study|Disease progression|7|||
154895949|NCT02088541|559040608|FG001|Overall Study|Disease progression|1|||
154895950|NCT02088541|559040609|FG002|Overall Study|Disease progression|2|||
155198472|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
154895951|NCT02088541|559040610|FG003|Overall Study|Disease progression|3|||
154895952|NCT02088541|559040611|FG004|Overall Study|Disease progression|1|||
154895953|NCT02088541|559040607|FG000|Overall Study|Study terminated by sponsor|1|||
154895954|NCT02088541|559040608|FG001|Overall Study|Study terminated by sponsor|1|||
154895955|NCT02088541|559040609|FG002|Overall Study|Study terminated by sponsor|12|||
154895956|NCT02088541|559040610|FG003|Overall Study|Study terminated by sponsor|2|||
154895957|NCT02088541|559040611|FG004|Overall Study|Study terminated by sponsor|6|||
154895958|NCT02088541|559040607|FG000|Overall Study|Withdrawal by Subject|3|||
154895959|NCT02088541|559040608|FG001|Overall Study|Withdrawal by Subject|2|||
154895960|NCT02088541|559040609|FG002|Overall Study|Withdrawal by Subject|9|||
154895961|NCT02088541|559040610|FG003|Overall Study|Withdrawal by Subject|7|||
154895962|NCT02088541|559040611|FG004|Overall Study|Withdrawal by Subject|10|||
154895963|NCT02088541|559040607|FG000|Overall Study|Other|2|||
154895964|NCT02088541|559040608|FG001|Overall Study|Other|1|||
154895965|NCT02088541|559040609|FG002|Overall Study|Other|3|||
154895966|NCT02088541|559040610|FG003|Overall Study|Other|1|||
154895967|NCT02088541|559040611|FG004|Overall Study|Other|1|||
154895968|NCT00439725|559040612|FG000|Treatment Period|Withdrawal by Subject|22|||
154895969|NCT00439725|559040613|FG001|Treatment Period|Withdrawal by Subject|19|||
154895970|NCT00439725|559040612|FG000|Treatment Period|Study terminated by sponsor|156|||
154895971|NCT00439725|559040613|FG001|Treatment Period|Study terminated by sponsor|148|||
154895972|NCT00439725|559040612|FG000|Treatment Period|Site closed by investigator|1|||
154895973|NCT00439725|559040613|FG001|Treatment Period|Site closed by investigator|2|||
154895974|NCT00439725|559040612|FG000|Treatment Period|Adverse Event|39|||
154895975|NCT00439725|559040613|FG001|Treatment Period|Adverse Event|18|||
154895976|NCT00439725|559040612|FG000|Treatment Period|Physician Decision|1|||
154895977|NCT00439725|559040613|FG001|Treatment Period|Physician Decision|1|||
154895978|NCT00439725|559040612|FG000|Treatment Period|Protocol Violation|2|||
154895979|NCT00439725|559040613|FG001|Treatment Period|Protocol Violation|1|||
154895980|NCT00439725|559040612|FG000|Treatment Period|Clinical endpoint reached|6|||
154895981|NCT00439725|559040613|FG001|Treatment Period|Clinical endpoint reached|50|||
154895982|NCT00439725|559040612|FG000|Treatment Period|Technical problems|1|||
154895983|NCT00439725|559040613|FG001|Treatment Period|Technical problems|0|||
154895984|NCT00439725|559040612|FG000|Treatment Period|Lost to Follow-up|1|||
154895985|NCT00439725|559040613|FG001|Treatment Period|Lost to Follow-up|1|||
154895986|NCT00439725|559040612|FG000|Treatment Period|Participant convenience|1|||
154895987|NCT00439725|559040613|FG001|Treatment Period|Participant convenience|0|||
154895988|NCT00439725|559040612|FG000|Treatment Period|Protocol driven decision point|1|||
154895989|NCT00439725|559040613|FG001|Treatment Period|Protocol driven decision point|1|||
154895990|NCT00439725|559040612|FG000|Treatment Period|Death|1|||
154895991|NCT00439725|559040613|FG001|Treatment Period|Death|1|||
154895992|NCT00439725|559040612|FG000|Treatment Period|Participant did not receive treatment|4|||
154895993|NCT00439725|559040613|FG001|Treatment Period|Participant did not receive treatment|4|||
154895994|NCT00439725|559040612|FG000|Observational Period|Withdrawal by Subject|2|||
154895995|NCT00439725|559040613|FG001|Observational Period|Withdrawal by Subject|2|||
154895996|NCT00439725|559040612|FG000|Observational Period|Lost to Follow-up|0|||
154895997|NCT00439725|559040613|FG001|Observational Period|Lost to Follow-up|1|||
154895998|NCT00439725|559040612|FG000|Observational Period|Death|0|||
154895999|NCT00439725|559040613|FG001|Observational Period|Death|2|||
154896000|NCT00439725|559040612|FG000|Observational Period|Study termination by sponsor|1|||
154896001|NCT00439725|559040613|FG001|Observational Period|Study termination by sponsor|1|||
154896002|NCT00439725|559040612|FG000|Observational Period|Clinical endpoint reached|3|||
154896003|NCT00439725|559040613|FG001|Observational Period|Clinical endpoint reached|1|||
154896004|NCT00439725|559040612|FG000|Observational Period|Technical problems|1|||
154896005|NCT00439725|559040613|FG001|Observational Period|Technical problems|0|||
154896006|NCT00439725|559040612|FG000|Observational Period|Participant convenience|1|||
154978910|NCT03297294|559345748|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
154978911|NCT03297294|559345749|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
154978912|NCT04569786|559345752|FG000|Overall Study|Lost to Follow-up|1|||
154978913|NCT04569786|559345753|FG001|Overall Study|Lost to Follow-up|0|||
154978914|NCT04569786|559345754|FG002|Overall Study|Lost to Follow-up|4|||
154978915|NCT04569786|559345755|FG003|Overall Study|Lost to Follow-up|1|||
154978916|NCT04569786|559345756|FG004|Overall Study|Lost to Follow-up|0|||
154978917|NCT04569786|559345752|FG000|Overall Study|Withdrawal by Subject|0|||
154978918|NCT04569786|559345753|FG001|Overall Study|Withdrawal by Subject|0|||
154978919|NCT04569786|559345754|FG002|Overall Study|Withdrawal by Subject|0|||
154978920|NCT04569786|559345755|FG003|Overall Study|Withdrawal by Subject|5|||
154896007|NCT00439725|559040613|FG001|Observational Period|Participant convenience|0|||
154896008|NCT02848313|559040614|FG000|Overall Study|Adverse Event|1|||
154896009|NCT02848313|559040615|FG001|Overall Study|Adverse Event|2|||
154896010|NCT02848313|559040614|FG000|Overall Study|Lack of Efficacy|0|||
154896011|NCT02848313|559040615|FG001|Overall Study|Lack of Efficacy|1|||
154896012|NCT02848313|559040614|FG000|Overall Study|Withdrawal by Subject|1|||
154978921|NCT04569786|559345756|FG004|Overall Study|Withdrawal by Subject|1|||
154896013|NCT02848313|559040615|FG001|Overall Study|Withdrawal by Subject|1|||
154896014|NCT02848313|559040614|FG000|Overall Study|Lost to follow up|1|||
154896015|NCT02848313|559040615|FG001|Overall Study|Lost to follow up|0|||
154896016|NCT01673490|559040616|FG000|Overall Study|Lost to Follow-up|1|||
154896017|NCT01673490|559040616|FG000|Overall Study|Adverse Event|3|||
154896018|NCT01673490|559040616|FG000|Overall Study|Withdrawal by Subject|3|||
154896019|NCT00379236|559040617|FG000|Double-blind|Adverse Event|11|||
154896020|NCT00379236|559040618|FG001|Double-blind|Adverse Event|6|||
154896021|NCT00379236|559040619|FG002|Double-blind|Adverse Event|0|||
154896022|NCT00379236|559040617|FG000|Double-blind|Protocol Violation|3|||
154896023|NCT00379236|559040618|FG001|Double-blind|Protocol Violation|3|||
154896024|NCT00379236|559040619|FG002|Double-blind|Protocol Violation|0|||
154896025|NCT00379236|559040617|FG000|Double-blind|Withdrawal by Subject|12|||
154896026|NCT00379236|559040618|FG001|Double-blind|Withdrawal by Subject|13|||
154896027|NCT00379236|559040619|FG002|Double-blind|Withdrawal by Subject|0|||
154896028|NCT00379236|559040617|FG000|Double-blind|Lost to Follow-up|4|||
154896029|NCT00379236|559040618|FG001|Double-blind|Lost to Follow-up|3|||
154896030|NCT00379236|559040619|FG002|Double-blind|Lost to Follow-up|0|||
154896031|NCT00379236|559040617|FG000|Double-blind|Use of exclusionary medication|1|||
154896032|NCT00379236|559040618|FG001|Double-blind|Use of exclusionary medication|2|||
154896033|NCT00379236|559040619|FG002|Double-blind|Use of exclusionary medication|0|||
154896034|NCT00379236|559040617|FG000|Double-blind|Other|3|||
154896035|NCT00379236|559040618|FG001|Double-blind|Other|7|||
154896036|NCT00379236|559040619|FG002|Double-blind|Other|0|||
154896037|NCT00379236|559040617|FG000|Double-blind|Data could not be retrieved|2|||
154896038|NCT00379236|559040618|FG001|Double-blind|Data could not be retrieved|2|||
154896039|NCT00379236|559040619|FG002|Double-blind|Data could not be retrieved|0|||
154896040|NCT00379236|559040617|FG000|Open-label Extension|Adverse Event|0|||
154896041|NCT00379236|559040618|FG001|Open-label Extension|Adverse Event|0|||
154896042|NCT00379236|559040619|FG002|Open-label Extension|Adverse Event|13|||
154896043|NCT00379236|559040617|FG000|Open-label Extension|Protocol Violation|0|||
154896044|NCT00379236|559040618|FG001|Open-label Extension|Protocol Violation|0|||
154896045|NCT00379236|559040619|FG002|Open-label Extension|Protocol Violation|7|||
154896046|NCT00379236|559040617|FG000|Open-label Extension|Withdrawal by Subject|0|||
154896047|NCT00379236|559040618|FG001|Open-label Extension|Withdrawal by Subject|0|||
154896048|NCT00379236|559040619|FG002|Open-label Extension|Withdrawal by Subject|13|||
154896049|NCT00379236|559040617|FG000|Open-label Extension|Lost to Follow-up|0|||
154896050|NCT00379236|559040618|FG001|Open-label Extension|Lost to Follow-up|0|||
154896051|NCT00379236|559040619|FG002|Open-label Extension|Lost to Follow-up|12|||
154896052|NCT00379236|559040617|FG000|Open-label Extension|Use of exclusionary medication|0|||
154896053|NCT00379236|559040618|FG001|Open-label Extension|Use of exclusionary medication|0|||
154896054|NCT00379236|559040619|FG002|Open-label Extension|Use of exclusionary medication|3|||
154896055|NCT00379236|559040617|FG000|Open-label Extension|Other|0|||
154896056|NCT00379236|559040618|FG001|Open-label Extension|Other|0|||
154896057|NCT00379236|559040619|FG002|Open-label Extension|Other|7|||
154896058|NCT02715804|559040625|FG000|Overall Study|Death|222|||
154896059|NCT02715804|559040626|FG001|Overall Study|Death|106|||
154896060|NCT02715804|559040625|FG000|Overall Study|Withdrawal by Subject|5|||
154896061|NCT02715804|559040626|FG001|Overall Study|Withdrawal by Subject|4|||
154896062|NCT02715804|559040625|FG000|Overall Study|Other than specified|2|||
154896063|NCT02715804|559040626|FG001|Overall Study|Other than specified|3|||
154896064|NCT01625611|559040629|FG000|Overall Study|No adlib drinks Lab 1|3|||
154896065|NCT01625611|559040630|FG001|Overall Study|No adlib drinks Lab 1|0|||
154896066|NCT01625611|559040629|FG000|Overall Study|Technical issues with PET|1|||
154896067|NCT01625611|559040630|FG001|Overall Study|Technical issues with PET|0|||
154896068|NCT01625611|559040629|FG000|Overall Study|Unable to complete study procedures|1|||
154896069|NCT01625611|559040630|FG001|Overall Study|Unable to complete study procedures|0|||
154896070|NCT01625611|559040629|FG000|Overall Study|Withdrawal by Subject|3|||
154896071|NCT01625611|559040630|FG001|Overall Study|Withdrawal by Subject|0|||
154896072|NCT00948194|559040631|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
154896073|NCT00948194|559040632|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
154896074|NCT00527072|559040639|FG000|Overall Study|Adverse Event|13|||
154896075|NCT00527072|559040639|FG000|Overall Study|Lack of Efficacy|11|||
154896076|NCT00527072|559040639|FG000|Overall Study|Lost to Follow-up|3|||
154896077|NCT00527072|559040639|FG000|Overall Study|Protocol Violation|2|||
154896078|NCT00527072|559040639|FG000|Overall Study|Withdrawal by Subject|7|||
154896079|NCT02137837|559040640|FG000|Overall Study|Adverse Event|0|||
154896080|NCT02137837|559040641|FG001|Overall Study|Adverse Event|2|||
154896081|NCT02137837|559040642|FG002|Overall Study|Adverse Event|1|||
154896082|NCT02137837|559040640|FG000|Overall Study|Refusal unrelated to adverse event|2|||
154896083|NCT02137837|559040641|FG001|Overall Study|Refusal unrelated to adverse event|2|||
154896084|NCT02137837|559040642|FG002|Overall Study|Refusal unrelated to adverse event|1|||
154896085|NCT02137837|559040640|FG000|Overall Study|Progression/relapse|9|||
154896086|NCT02137837|559040641|FG001|Overall Study|Progression/relapse|7|||
154896087|NCT02137837|559040642|FG002|Overall Study|Progression/relapse|7|||
154896088|NCT02137837|559040640|FG000|Overall Study|Not protocol specified|2|||
154896089|NCT02137837|559040641|FG001|Overall Study|Not protocol specified|1|||
154978922|NCT04569786|559345752|FG000|Overall Study|Physician Decision|0|||
154978923|NCT04569786|559345753|FG001|Overall Study|Physician Decision|0|||
154978924|NCT04569786|559345754|FG002|Overall Study|Physician Decision|0|||
154978925|NCT04569786|559345755|FG003|Overall Study|Physician Decision|1|||
154978926|NCT04569786|559345756|FG004|Overall Study|Physician Decision|0|||
154978927|NCT01684878|559345763|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
154978928|NCT01684878|559345764|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
154978929|NCT01684878|559345765|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
154978930|NCT01684878|559345766|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
154978931|NCT01684878|559345763|FG000|Part 1: Safety Run in Phase|Death|15|||
154978932|NCT01684878|559345764|FG001|Part 1: Safety Run in Phase|Death|20|||
154978933|NCT01684878|559345765|FG002|Part 1: Safety Run in Phase|Death|0|||
154978934|NCT01684878|559345766|FG003|Part 1: Safety Run in Phase|Death|0|||
154978935|NCT01684878|559345763|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
154978936|NCT01684878|559345764|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
154978937|NCT01684878|559345765|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
154978938|NCT01684878|559345766|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
154978939|NCT01684878|559345763|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
154978940|NCT01684878|559345764|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
154978941|NCT01684878|559345765|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
154978942|NCT01684878|559345766|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
154978943|NCT01684878|559345763|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
154896090|NCT02137837|559040642|FG002|Overall Study|Not protocol specified|3|||
154978944|NCT01684878|559345764|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
154978945|NCT01684878|559345765|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
154896091|NCT01467661|559040643|FG000|Overall Study|Adverse Event|16|||
154896092|NCT01467661|559040643|FG000|Overall Study|Withdrawal by Subject|1|||
154896093|NCT01467661|559040643|FG000|Overall Study|Lack of Efficacy|3|||
154896094|NCT01467661|559040643|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
154896095|NCT00270998|559040644|FG000|3 Month Follow-up|Adverse Event|1|||
154896096|NCT00270998|559040645|FG001|3 Month Follow-up|Adverse Event|0|||
154896097|NCT00270998|559040646|FG002|3 Month Follow-up|Adverse Event|0|||
154896098|NCT00270998|559040644|FG000|3 Month Follow-up|Lack of Efficacy|1|||
154896099|NCT00270998|559040645|FG001|3 Month Follow-up|Lack of Efficacy|2|||
154896100|NCT00270998|559040646|FG002|3 Month Follow-up|Lack of Efficacy|1|||
154896101|NCT00270998|559040644|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
154896102|NCT00270998|559040645|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
154896103|NCT00270998|559040646|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
154896104|NCT00270998|559040644|FG000|3 Month Follow-up|Pessary did not fit|12|||
154896105|NCT00270998|559040645|FG001|3 Month Follow-up|Pessary did not fit|0|||
154896106|NCT00270998|559040646|FG002|3 Month Follow-up|Pessary did not fit|0|||
154896107|NCT00270998|559040644|FG000|3 Month Follow-up|Personal/family health|1|||
154896108|NCT00270998|559040645|FG001|3 Month Follow-up|Personal/family health|1|||
154896109|NCT00270998|559040646|FG002|3 Month Follow-up|Personal/family health|0|||
154896110|NCT00270998|559040644|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
154896111|NCT00270998|559040645|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
154896112|NCT00270998|559040646|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
154896113|NCT00270998|559040644|FG000|12 Month Follow-up|Lack of Efficacy|5|||
154896114|NCT00270998|559040645|FG001|12 Month Follow-up|Lack of Efficacy|4|||
154896115|NCT00270998|559040646|FG002|12 Month Follow-up|Lack of Efficacy|3|||
154896116|NCT00270998|559040644|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
154896117|NCT00270998|559040645|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
154896118|NCT00270998|559040646|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
154896119|NCT00270998|559040644|FG000|12 Month Follow-up|Pessary did not fit|1|||
154896120|NCT00270998|559040645|FG001|12 Month Follow-up|Pessary did not fit|0|||
154896121|NCT00270998|559040646|FG002|12 Month Follow-up|Pessary did not fit|0|||
154896122|NCT00270998|559040644|FG000|12 Month Follow-up|Personal/family health|0|||
154896123|NCT00270998|559040645|FG001|12 Month Follow-up|Personal/family health|5|||
154896124|NCT00270998|559040646|FG002|12 Month Follow-up|Personal/family health|1|||
154896125|NCT00270998|559040644|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
154896126|NCT00270998|559040645|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
154978946|NCT01684878|559345766|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
154978947|NCT01684878|559345763|FG000|Part 2: Randomized Phase|Death|0|||
154978948|NCT01684878|559345764|FG001|Part 2: Randomized Phase|Death|0|||
154978949|NCT01684878|559345765|FG002|Part 2: Randomized Phase|Death|62|||
154978950|NCT01684878|559345766|FG003|Part 2: Randomized Phase|Death|68|||
154896127|NCT00270998|559040646|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
155175648|NCT02946931|560080301|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
154896128|NCT04075396|559040649|FG000|Overall Study|Death|11|||
154978951|NCT01684878|559345763|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
154896129|NCT04075396|559040650|FG001|Overall Study|Death|9|||
154896130|NCT04075396|559040649|FG000|Overall Study|Withdrawal by Subject|1|||
154896131|NCT04075396|559040650|FG001|Overall Study|Withdrawal by Subject|2|||
154896132|NCT04075396|559040649|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
154896133|NCT04075396|559040650|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
154896134|NCT04075396|559040649|FG000|Overall Study|Enrolled but not-treated|0|||
154896135|NCT04075396|559040650|FG001|Overall Study|Enrolled but not-treated|1|||
154896136|NCT01855945|559040651|FG000|Overall Study|Adverse Event|0|||
154896137|NCT01855945|559040652|FG001|Overall Study|Adverse Event|0|||
154896138|NCT01855945|559040653|FG002|Overall Study|Adverse Event|0|||
154896139|NCT01855945|559040654|FG003|Overall Study|Adverse Event|0|||
154896140|NCT01855945|559040655|FG004|Overall Study|Adverse Event|0|||
154896141|NCT01855945|559040656|FG005|Overall Study|Adverse Event|0|||
154896142|NCT01855945|559040657|FG006|Overall Study|Adverse Event|1|||
154896143|NCT01855945|559040658|FG007|Overall Study|Adverse Event|0|||
154896144|NCT01855945|559040659|FG008|Overall Study|Adverse Event|0|||
154896145|NCT01855945|559040660|FG009|Overall Study|Adverse Event|0|||
154896146|NCT01855945|559040661|FG010|Overall Study|Adverse Event|0|||
154896147|NCT01855945|559040662|FG011|Overall Study|Adverse Event|0|||
154896148|NCT01855945|559040651|FG000|Overall Study|Death|0|||
154896149|NCT01855945|559040652|FG001|Overall Study|Death|0|||
154896150|NCT01855945|559040653|FG002|Overall Study|Death|0|||
154896151|NCT01855945|559040654|FG003|Overall Study|Death|0|||
154896152|NCT01855945|559040655|FG004|Overall Study|Death|0|||
154896153|NCT01855945|559040656|FG005|Overall Study|Death|0|||
154896154|NCT01855945|559040657|FG006|Overall Study|Death|2|||
154896155|NCT01855945|559040658|FG007|Overall Study|Death|0|||
154896156|NCT01855945|559040659|FG008|Overall Study|Death|0|||
154896157|NCT01855945|559040660|FG009|Overall Study|Death|0|||
154896158|NCT01855945|559040661|FG010|Overall Study|Death|0|||
154896159|NCT01855945|559040662|FG011|Overall Study|Death|0|||
154896160|NCT01855945|559040651|FG000|Overall Study|Lost to Follow-up|11|||
154896161|NCT01855945|559040652|FG001|Overall Study|Lost to Follow-up|10|||
154896162|NCT01855945|559040653|FG002|Overall Study|Lost to Follow-up|7|||
154896163|NCT01855945|559040654|FG003|Overall Study|Lost to Follow-up|3|||
154896164|NCT01855945|559040655|FG004|Overall Study|Lost to Follow-up|0|||
154896165|NCT01855945|559040656|FG005|Overall Study|Lost to Follow-up|3|||
154896166|NCT01855945|559040657|FG006|Overall Study|Lost to Follow-up|4|||
154896167|NCT01855945|559040658|FG007|Overall Study|Lost to Follow-up|7|||
154896168|NCT01855945|559040659|FG008|Overall Study|Lost to Follow-up|2|||
154896169|NCT01855945|559040660|FG009|Overall Study|Lost to Follow-up|0|||
154896170|NCT01855945|559040661|FG010|Overall Study|Lost to Follow-up|0|||
154896171|NCT01855945|559040662|FG011|Overall Study|Lost to Follow-up|2|||
154896172|NCT01855945|559040651|FG000|Overall Study|Other - Unclassified|1|||
154896173|NCT01855945|559040652|FG001|Overall Study|Other - Unclassified|1|||
154896174|NCT01855945|559040653|FG002|Overall Study|Other - Unclassified|1|||
154896175|NCT01855945|559040654|FG003|Overall Study|Other - Unclassified|0|||
154896176|NCT01855945|559040655|FG004|Overall Study|Other - Unclassified|0|||
154896177|NCT01855945|559040656|FG005|Overall Study|Other - Unclassified|0|||
154896178|NCT01855945|559040657|FG006|Overall Study|Other - Unclassified|2|||
154896179|NCT01855945|559040658|FG007|Overall Study|Other - Unclassified|1|||
154896180|NCT01855945|559040659|FG008|Overall Study|Other - Unclassified|0|||
154896181|NCT01855945|559040660|FG009|Overall Study|Other - Unclassified|0|||
154896182|NCT01855945|559040661|FG010|Overall Study|Other - Unclassified|1|||
154896183|NCT01855945|559040662|FG011|Overall Study|Other - Unclassified|0|||
154896184|NCT01855945|559040651|FG000|Overall Study|Withdrawal by Subject|4|||
154896185|NCT01855945|559040652|FG001|Overall Study|Withdrawal by Subject|0|||
154896186|NCT01855945|559040653|FG002|Overall Study|Withdrawal by Subject|4|||
154896187|NCT01855945|559040654|FG003|Overall Study|Withdrawal by Subject|1|||
154896188|NCT01855945|559040655|FG004|Overall Study|Withdrawal by Subject|1|||
154896189|NCT01855945|559040656|FG005|Overall Study|Withdrawal by Subject|0|||
154896190|NCT01855945|559040657|FG006|Overall Study|Withdrawal by Subject|1|||
154896191|NCT01855945|559040658|FG007|Overall Study|Withdrawal by Subject|0|||
155175649|NCT00869778|560080305|FG000|Overall Study|Adverse Event|2|||
154896192|NCT01855945|559040659|FG008|Overall Study|Withdrawal by Subject|0|||
154896193|NCT01855945|559040660|FG009|Overall Study|Withdrawal by Subject|2|||
154896194|NCT01855945|559040661|FG010|Overall Study|Withdrawal by Subject|4|||
154896195|NCT01855945|559040662|FG011|Overall Study|Withdrawal by Subject|1|||
154896196|NCT02156804|559040663|FG000|Overall Study|Withdrawal by Subject|1|||
154896197|NCT03228394|559040664|FG000|Overall Study|Lost to Follow-up|0|||
154896198|NCT03228394|559040665|FG001|Overall Study|Lost to Follow-up|0|||
154896199|NCT03228394|559040666|FG002|Overall Study|Lost to Follow-up|1|||
154896200|NCT03228394|559040667|FG003|Overall Study|Lost to Follow-up|1|||
154896201|NCT03228394|559040668|FG004|Overall Study|Lost to Follow-up|0|||
154896202|NCT03228394|559040669|FG005|Overall Study|Lost to Follow-up|0|||
154896203|NCT03228394|559040670|FG006|Overall Study|Lost to Follow-up|2|||
154896204|NCT03228394|559040671|FG007|Overall Study|Lost to Follow-up|0|||
154896205|NCT03228394|559040664|FG000|Overall Study|Withdrawal by Subject|0|||
154896206|NCT03228394|559040665|FG001|Overall Study|Withdrawal by Subject|0|||
154896207|NCT03228394|559040666|FG002|Overall Study|Withdrawal by Subject|1|||
154896208|NCT03228394|559040667|FG003|Overall Study|Withdrawal by Subject|0|||
154896209|NCT03228394|559040668|FG004|Overall Study|Withdrawal by Subject|0|||
154896210|NCT03228394|559040669|FG005|Overall Study|Withdrawal by Subject|0|||
154896211|NCT03228394|559040670|FG006|Overall Study|Withdrawal by Subject|1|||
154896212|NCT03228394|559040671|FG007|Overall Study|Withdrawal by Subject|3|||
154896213|NCT03228394|559040664|FG000|Overall Study|Protocol Violation|0|||
154896214|NCT03228394|559040665|FG001|Overall Study|Protocol Violation|0|||
154896215|NCT03228394|559040666|FG002|Overall Study|Protocol Violation|0|||
154896216|NCT03228394|559040667|FG003|Overall Study|Protocol Violation|1|||
154896217|NCT03228394|559040668|FG004|Overall Study|Protocol Violation|0|||
154896218|NCT03228394|559040669|FG005|Overall Study|Protocol Violation|0|||
154896219|NCT03228394|559040670|FG006|Overall Study|Protocol Violation|0|||
154896220|NCT03228394|559040671|FG007|Overall Study|Protocol Violation|0|||
154896221|NCT03228394|559040664|FG000|Overall Study|Physician Decision|0|||
154896222|NCT03228394|559040665|FG001|Overall Study|Physician Decision|0|||
154896223|NCT03228394|559040666|FG002|Overall Study|Physician Decision|0|||
154896224|NCT03228394|559040667|FG003|Overall Study|Physician Decision|0|||
154896225|NCT03228394|559040668|FG004|Overall Study|Physician Decision|0|||
154896226|NCT03228394|559040669|FG005|Overall Study|Physician Decision|0|||
154896227|NCT03228394|559040670|FG006|Overall Study|Physician Decision|1|||
154896228|NCT03228394|559040671|FG007|Overall Study|Physician Decision|0|||
154896229|NCT03228394|559040664|FG000|Overall Study|Noncompliance|0|||
154896230|NCT03228394|559040665|FG001|Overall Study|Noncompliance|0|||
154896231|NCT03228394|559040666|FG002|Overall Study|Noncompliance|0|||
154896232|NCT03228394|559040667|FG003|Overall Study|Noncompliance|0|||
154896233|NCT03228394|559040668|FG004|Overall Study|Noncompliance|0|||
154896234|NCT03228394|559040669|FG005|Overall Study|Noncompliance|0|||
154896235|NCT03228394|559040670|FG006|Overall Study|Noncompliance|1|||
154896236|NCT03228394|559040671|FG007|Overall Study|Noncompliance|0|||
154896237|NCT02443805|559040678|FG000|Overall Study|Adverse Event|100|||
154896238|NCT02443805|559040679|FG001|Overall Study|Adverse Event|18|||
154896239|NCT02443805|559040678|FG000|Overall Study|Withdrawal by Subject|73|||
154896240|NCT02443805|559040679|FG001|Overall Study|Withdrawal by Subject|74|||
154896241|NCT02443805|559040678|FG000|Overall Study|Lost to Follow-up|19|||
154896242|NCT02443805|559040679|FG001|Overall Study|Lost to Follow-up|14|||
154896243|NCT02443805|559040678|FG000|Overall Study|Pregnancy|6|||
154896244|NCT02443805|559040679|FG001|Overall Study|Pregnancy|5|||
154896245|NCT02443805|559040678|FG000|Overall Study|Protocol Violation|2|||
154896246|NCT02443805|559040679|FG001|Overall Study|Protocol Violation|4|||
154896247|NCT02443805|559040678|FG000|Overall Study|Lack of Efficacy|1|||
154896248|NCT02443805|559040679|FG001|Overall Study|Lack of Efficacy|1|||
154896249|NCT02443805|559040678|FG000|Overall Study|Non-compliance with study drug|6|||
154896250|NCT02443805|559040679|FG001|Overall Study|Non-compliance with study drug|4|||
154896251|NCT02443805|559040678|FG000|Overall Study|Withdrawal by parent/guardian|3|||
154896252|NCT02443805|559040679|FG001|Overall Study|Withdrawal by parent/guardian|5|||
154896253|NCT02443805|559040678|FG000|Overall Study|Any other reason not above-mentioned|3|||
154896254|NCT02443805|559040679|FG001|Overall Study|Any other reason not above-mentioned|2|||
154896255|NCT00961116|559040680|FG000|Washout Period of 7 Days|Adverse Event|1|||
154896256|NCT00961116|559040681|FG001|Washout Period of 7 Days|Adverse Event|1|||
154896257|NCT00961116|559040680|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
154896258|NCT00961116|559040681|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
154896259|NCT00961116|559040680|FG000|Washout Period of 7 Days|Protocol Violation|0|||
154896260|NCT00961116|559040681|FG001|Washout Period of 7 Days|Protocol Violation|1|||
154896261|NCT00968708|559040682|FG000|Overall Study|Adverse Event|169|||
154896262|NCT00968708|559040683|FG001|Overall Study|Adverse Event|150|||
154896263|NCT00968708|559040682|FG000|Overall Study|Major Protocol Deviation|0|||
154896264|NCT00968708|559040683|FG001|Overall Study|Major Protocol Deviation|1|||
154896265|NCT00968708|559040682|FG000|Overall Study|Lost to Follow-up|19|||
154896266|NCT00968708|559040683|FG001|Overall Study|Lost to Follow-up|11|||
154896267|NCT00968708|559040682|FG000|Overall Study|Voluntary Withdrawal|104|||
154896268|NCT00968708|559040683|FG001|Overall Study|Voluntary Withdrawal|101|||
154896269|NCT00968708|559040682|FG000|Overall Study|Investigator Discretion|0|||
154896270|NCT00968708|559040683|FG001|Overall Study|Investigator Discretion|1|||
154896271|NCT00968708|559040682|FG000|Overall Study|Other|26|||
154896272|NCT00968708|559040683|FG001|Overall Study|Other|34|||
154896273|NCT02708966|559040684|FG000|Overall Study|Lost to Follow-up|2|||
154896274|NCT02708966|559040685|FG001|Overall Study|Lost to Follow-up|2|||
154896275|NCT02260388|559040688|FG000|Overall Study|Lost to Follow-up|2|||
154896276|NCT02260388|559040689|FG001|Overall Study|Lost to Follow-up|8|||
154896277|NCT02260388|559040690|FG002|Overall Study|Lost to Follow-up|3|||
154896278|NCT02260388|559040691|FG003|Overall Study|Lost to Follow-up|4|||
154896279|NCT00389441|559040692|FG000|Overall Study|Adverse Event|7|||
154896280|NCT00389441|559040692|FG000|Overall Study|Death|4|||
154896281|NCT00389441|559040692|FG000|Overall Study|Lost to Follow-up|2|||
154896282|NCT00389441|559040692|FG000|Overall Study|Withdrawal by Subject|4|||
154896283|NCT00389441|559040692|FG000|Overall Study|Physician Decision|1|||
154896284|NCT00389441|559040692|FG000|Overall Study|Protocol Violation|1|||
154978952|NCT01684878|559345764|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
154896285|NCT00389441|559040692|FG000|Overall Study|Global deterioration of health status|4|||
154978953|NCT01684878|559345765|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
154978954|NCT01684878|559345766|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
154978955|NCT01684878|559345763|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
154978956|NCT01684878|559345764|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
154978957|NCT01684878|559345765|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
154978958|NCT01684878|559345766|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
154978959|NCT01435031|559345770|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
154978960|NCT01435031|559345770|FG000|ITT at 1 Month|Death|1|||
154978961|NCT01435031|559345770|FG000|ITT at 1 Month|Lost to Follow-up|4|||
154978962|NCT01435031|559345770|FG000|ITT at 6 Months|Death|2|||
154978963|NCT01435031|559345770|FG000|ITT at 6 Months|Lost to Follow-up|3|||
154978964|NCT01435031|559345770|FG000|ITT at 1 Year|Death|1|||
154978965|NCT01435031|559345770|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
154978966|NCT01435031|559345770|FG000|ITT at 1 Year|Lost to Follow-up|6|||
154978967|NCT01435031|559345770|FG000|ITT at 2 Years|Death|7|||
154978968|NCT01435031|559345770|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
154978969|NCT01435031|559345770|FG000|ITT at 2 Years|Lost to Follow-up|4|||
154978970|NCT01435031|559345770|FG000|ITT at 3 Years|Death|5|||
154978971|NCT01435031|559345770|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
154978972|NCT01435031|559345770|FG000|ITT at 3 Years|Lost to Follow-up|4|||
154978973|NCT01435031|559345770|FG000|ITT at 4 Years|Death|4|||
154978974|NCT01435031|559345770|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
154978975|NCT01435031|559345770|FG000|ITT at 4 Years|Lost to Follow-up|1|||
154978976|NCT03942211|559345773|FG000|Overall Study|Death|1|||
154978977|NCT03942211|559345774|FG001|Overall Study|Death|0|||
154978978|NCT03942211|559345773|FG000|Overall Study|Study terminated by sponsor|5|||
154978979|NCT03942211|559345774|FG001|Overall Study|Study terminated by sponsor|3|||
154978980|NCT03942211|559345773|FG000|Overall Study|Adverse Event|0|||
154978981|NCT03942211|559345774|FG001|Overall Study|Adverse Event|1|||
154978982|NCT00127166|559345775|FG000|Period I|Protocol Violation|0|||
154978983|NCT00127166|559345776|FG001|Period I|Protocol Violation|2|||
154978984|NCT00127166|559345775|FG000|Period I|Withdrawal by Subject|2|||
154978985|NCT00127166|559345776|FG001|Period I|Withdrawal by Subject|0|||
154978986|NCT00127166|559345775|FG000|Period I|Patient did not meet inclusion criteria|1|||
154978987|NCT00127166|559345776|FG001|Period I|Patient did not meet inclusion criteria|0|||
154978988|NCT00127166|559345775|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
154978989|NCT00127166|559345776|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
154978990|NCT00127166|559345775|FG000|Period II|Withdrawal by Subject|2|||
154978991|NCT00127166|559345776|FG001|Period II|Withdrawal by Subject|0|||
154978992|NCT00127166|559345775|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
154978993|NCT00127166|559345776|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
154978994|NCT01148225|559345779|FG000|Overall Study|Other|185|||
154978995|NCT00104247|559345782|FG000|Overall Study|Withdrawal by Subject|1|||
154978996|NCT00104247|559345783|FG001|Overall Study|Withdrawal by Subject|0|||
154978997|NCT00104247|559345782|FG000|Overall Study|Noncompliant with dosing|0|||
154978998|NCT00104247|559345783|FG001|Overall Study|Noncompliant with dosing|1|||
154978999|NCT00605917|559345787|FG000|Overall Study|Protocol Violation|79|||
154979000|NCT01506908|559345788|FG000|Overall Study|Adverse Event|1|||
154979001|NCT01506908|559345789|FG001|Overall Study|Adverse Event|0|||
155114130|NCT00075946|559846235|FG001|Overall Study|Other complicating disease|13|||
155114131|NCT00075946|559846236|FG002|Overall Study|Other complicating disease|1|||
155114132|NCT00075946|559846237|FG003|Overall Study|Other complicating disease|4|||
155114133|NCT00075946|559846238|FG004|Overall Study|Other complicating disease|0|||
155114134|NCT00075946|559846234|FG000|Overall Study|No response to retreatment|23|||
154896286|NCT00389441|559040692|FG000|Overall Study|Objective progression or relapse|26|||
154896287|NCT00389441|559040692|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
154896288|NCT00389441|559040692|FG000|Overall Study|Clinical progression|1|||
154896289|NCT01981109|559040693|FG000|Overall Study|Death|36|||
154896290|NCT01981109|559040693|FG000|Overall Study|Withdrawal by Subject|40|||
154896291|NCT01981109|559040693|FG000|Overall Study|Lost to Follow-up|9|||
154896292|NCT01981109|559040693|FG000|Overall Study|No Discontinuation Documentation|37|||
154896293|NCT01981109|559040693|FG000|Overall Study|Study Termination|100|||
154896294|NCT01981109|559040693|FG000|Overall Study|No data available|2|||
154979002|NCT03043560|559345798|FG000|Overall Study|Discontinued Intervention|1|||
154979003|NCT03043560|559345799|FG001|Overall Study|Discontinued Intervention|2|||
154979004|NCT03043560|559345798|FG000|Overall Study|Lost to Follow-up|0|||
154979005|NCT03043560|559345799|FG001|Overall Study|Lost to Follow-up|1|||
154979006|NCT01117766|559345800|FG000|First Intervention|Adverse Event|0|||
155114135|NCT00075946|559846235|FG001|Overall Study|No response to retreatment|0|||
155114136|NCT00075946|559846236|FG002|Overall Study|No response to retreatment|2|||
154896295|NCT03407170|559040694|FG000|Overall Study|Adverse Event|1|||
154979007|NCT01117766|559345801|FG001|First Intervention|Adverse Event|1|||
154979008|NCT01117766|559345800|FG000|First Intervention|Protocol Violation|1|||
154979009|NCT01117766|559345801|FG001|First Intervention|Protocol Violation|0|||
154979010|NCT01117766|559345800|FG000|Washout Period|Protocol Violation|0|||
154979011|NCT01117766|559345801|FG001|Washout Period|Protocol Violation|2|||
154979012|NCT01117766|559345800|FG000|Second Intervention|Lost to Follow-up|1|||
154979013|NCT01117766|559345801|FG001|Second Intervention|Lost to Follow-up|0|||
154979014|NCT01117766|559345800|FG000|Second Intervention|Other|1|||
154979015|NCT01117766|559345801|FG001|Second Intervention|Other|2|||
154979016|NCT01117766|559345800|FG000|Second Intervention|Adverse Event|0|||
154979017|NCT01117766|559345801|FG001|Second Intervention|Adverse Event|2|||
154979018|NCT01117766|559345800|FG000|Second Intervention|Withdrawal by Subject|0|||
154979019|NCT01117766|559345801|FG001|Second Intervention|Withdrawal by Subject|1|||
154979020|NCT03718117|559345802|FG000|Overall Study|Death|12|||
154979021|NCT03718117|559345803|FG001|Overall Study|Death|11|||
154979022|NCT03718117|559345804|FG002|Overall Study|Death|0|||
154979023|NCT03718117|559345802|FG000|Overall Study|Other|0|||
154979024|NCT03718117|559345803|FG001|Overall Study|Other|1|||
154979025|NCT03718117|559345804|FG002|Overall Study|Other|0|||
154979026|NCT03718117|559345802|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
154979027|NCT03718117|559345803|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
155114137|NCT00075946|559846237|FG003|Overall Study|No response to retreatment|0|||
155114138|NCT00075946|559846238|FG004|Overall Study|No response to retreatment|0|||
155114139|NCT00075946|559846234|FG000|Overall Study|Time to progression less than 6 months|15|||
155114140|NCT00075946|559846235|FG001|Overall Study|Time to progression less than 6 months|30|||
155114141|NCT00075946|559846236|FG002|Overall Study|Time to progression less than 6 months|8|||
154896296|NCT00636441|559040696|FG000|Overall Study|Adverse Event|0|||
154896297|NCT00636441|559040697|FG001|Overall Study|Adverse Event|1|||
154896298|NCT00636441|559040698|FG002|Overall Study|Adverse Event|1|||
154896299|NCT00636441|559040699|FG003|Overall Study|Adverse Event|0|||
154896300|NCT00636441|559040700|FG004|Overall Study|Adverse Event|0|||
154896301|NCT00636441|559040701|FG005|Overall Study|Adverse Event|1|||
154896302|NCT00636441|559040702|FG006|Overall Study|Adverse Event|0|||
154896303|NCT00636441|559040696|FG000|Overall Study|Late, ineligible|0|||
154896304|NCT00636441|559040697|FG001|Overall Study|Late, ineligible|0|||
154896305|NCT00636441|559040698|FG002|Overall Study|Late, ineligible|0|||
154896306|NCT00636441|559040699|FG003|Overall Study|Late, ineligible|0|||
154896307|NCT00636441|559040700|FG004|Overall Study|Late, ineligible|0|||
154896308|NCT00636441|559040701|FG005|Overall Study|Late, ineligible|0|||
154896309|NCT00636441|559040702|FG006|Overall Study|Late, ineligible|1|||
154896310|NCT00636441|559040696|FG000|Overall Study|Screen Failure|0|||
154896311|NCT00636441|559040697|FG001|Overall Study|Screen Failure|0|||
154896312|NCT00636441|559040698|FG002|Overall Study|Screen Failure|0|||
154896313|NCT00636441|559040699|FG003|Overall Study|Screen Failure|0|||
154896314|NCT00636441|559040700|FG004|Overall Study|Screen Failure|0|||
154896315|NCT00636441|559040701|FG005|Overall Study|Screen Failure|0|||
154896316|NCT00636441|559040702|FG006|Overall Study|Screen Failure|17|||
154896317|NCT00305604|559040704|FG000|Overall Study|Adverse Event|6|||
154896318|NCT00305604|559040705|FG001|Overall Study|Adverse Event|3|||
154896319|NCT00305604|559040704|FG000|Overall Study|Lack of Efficacy|11|||
154896320|NCT00305604|559040705|FG001|Overall Study|Lack of Efficacy|18|||
154896321|NCT00305604|559040704|FG000|Overall Study|Lost to Follow-up|0|||
154896322|NCT00305604|559040705|FG001|Overall Study|Lost to Follow-up|4|||
154896323|NCT00305604|559040704|FG000|Overall Study|Protocol Violation|2|||
154896324|NCT00305604|559040705|FG001|Overall Study|Protocol Violation|1|||
154896325|NCT00305604|559040704|FG000|Overall Study|Withdrawal by Subject|12|||
154896326|NCT00305604|559040705|FG001|Overall Study|Withdrawal by Subject|21|||
154896327|NCT00305604|559040704|FG000|Overall Study|Patient moved|1|||
154896328|NCT00305604|559040705|FG001|Overall Study|Patient moved|0|||
154896329|NCT02849626|559040707|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
154896330|NCT02849626|559040708|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
154896331|NCT02849626|559040709|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
154896332|NCT02849626|559040710|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
154896333|NCT02849626|559040707|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
154896334|NCT02849626|559040708|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
154896335|NCT02849626|559040709|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
154896336|NCT02849626|559040710|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
154896337|NCT02849626|559040707|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
154979028|NCT03718117|559345804|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
154979029|NCT03718117|559345802|FG000|Overall Study|Participant not met eligibility criteria|0|||
154896338|NCT02849626|559040708|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
154896339|NCT02849626|559040709|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
154979030|NCT03718117|559345803|FG001|Overall Study|Participant not met eligibility criteria|0|||
155114142|NCT00075946|559846237|FG003|Overall Study|Time to progression less than 6 months|3|||
154896340|NCT02849626|559040710|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
154896341|NCT02849626|559040707|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
154896342|NCT02849626|559040708|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
154896343|NCT02849626|559040709|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
154979031|NCT03718117|559345804|FG002|Overall Study|Participant not met eligibility criteria|2|||
154979032|NCT00206102|559345805|FG000|Overall Study|Adverse Event|119|||
155114143|NCT00075946|559846238|FG004|Overall Study|Time to progression less than 6 months|0|||
154896344|NCT02849626|559040710|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
154979033|NCT00206102|559345806|FG001|Overall Study|Adverse Event|82|||
155114144|NCT00075946|559846234|FG000|Overall Study|Other|57|||
155114145|NCT00075946|559846235|FG001|Overall Study|Other|32|||
155114146|NCT00075946|559846236|FG002|Overall Study|Other|3|||
155114147|NCT00075946|559846237|FG003|Overall Study|Other|11|||
155114148|NCT00075946|559846238|FG004|Overall Study|Other|0|||
155114149|NCT01923363|559846239|FG000|Overall Study|Protocol Violation|1|||
154896345|NCT02849626|559040707|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
154896346|NCT02849626|559040708|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
154896347|NCT02849626|559040709|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
154896348|NCT02849626|559040710|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
154896349|NCT02849626|559040707|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
154896350|NCT02849626|559040708|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
154896351|NCT02849626|559040709|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
154896352|NCT02849626|559040710|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
154896353|NCT02849626|559040707|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
154896354|NCT02849626|559040708|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
154896355|NCT02849626|559040709|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
154896356|NCT02849626|559040710|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
154896357|NCT02849626|559040707|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
154896358|NCT02849626|559040708|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
154896359|NCT02849626|559040709|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
154896360|NCT02849626|559040710|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
154896361|NCT02849626|559040707|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
154896362|NCT02849626|559040708|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
154896363|NCT02849626|559040709|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
154896364|NCT02849626|559040710|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
154896365|NCT02849626|559040707|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
154896366|NCT02849626|559040708|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
154896367|NCT02849626|559040709|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
154896368|NCT02849626|559040710|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
154896369|NCT02849626|559040707|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
154896370|NCT02849626|559040708|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
154896371|NCT02849626|559040709|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
154896372|NCT02849626|559040710|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
154896373|NCT04176445|559040711|FG000|Overall Study|Adverse Event|0|||
154896374|NCT04176445|559040712|FG001|Overall Study|Adverse Event|1|||
154896375|NCT04176445|559040711|FG000|Overall Study|change plans weaning after first intervention|0|||
154896376|NCT04176445|559040712|FG001|Overall Study|change plans weaning after first intervention|1|||
154896377|NCT04046341|559040713|FG000|Overall Study|Lost to Follow-up|2|||
154896378|NCT04046341|559040713|FG000|Overall Study|Withdrawal by Subject|1|||
154896379|NCT04377672|559040714|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
154896380|NCT02447458|559040715|FG000|Overall Study|Other|0|||
154896381|NCT02447458|559040716|FG001|Overall Study|Other|0|||
154896382|NCT02447458|559040717|FG002|Overall Study|Other|1|||
154896383|NCT02447458|559040718|FG003|Overall Study|Other|0|||
154896384|NCT02447458|559040719|FG004|Overall Study|Other|0|||
154896385|NCT02447458|559040720|FG005|Overall Study|Other|0|||
154896386|NCT00435994|559040721|FG000|Overall Study|Lost to Follow-up|7|||
154896387|NCT00435994|559040722|FG001|Overall Study|Lost to Follow-up|0|||
154896388|NCT00435994|559040723|FG002|Overall Study|Lost to Follow-up|0|||
154896389|NCT03505749|559040724|FG000|Overall Study|Lost to Follow-up|7|||
154896390|NCT03505749|559040725|FG001|Overall Study|Lost to Follow-up|11|||
154896391|NCT03505749|559040724|FG000|Overall Study|Withdrawal by Subject|6|||
154896392|NCT03505749|559040725|FG001|Overall Study|Withdrawal by Subject|0|||
154896393|NCT03505749|559040724|FG000|Overall Study|Discharged from treatment|3|||
154896394|NCT03505749|559040725|FG001|Overall Study|Discharged from treatment|6|||
154896395|NCT01151540|559040726|FG000|Overall Study|Other|2|||
154896396|NCT01151540|559040726|FG000|Overall Study|Adverse event, non-fatal|4|||
154896397|NCT01151540|559040726|FG000|Overall Study|Withdrawal by Subject|7|||
154896398|NCT03846219|559040728|FG000|Overall Study|Withdrawal by Subject|3|||
154896399|NCT03846219|559040729|FG001|Overall Study|Withdrawal by Subject|2|||
154896400|NCT03846219|559040730|FG002|Overall Study|Withdrawal by Subject|2|||
154896401|NCT03846219|559040728|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
154896402|NCT03846219|559040729|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
154896403|NCT03846219|559040730|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
154896404|NCT03846219|559040728|FG000|Overall Study|Physician Decision|0|||
154896405|NCT03846219|559040729|FG001|Overall Study|Physician Decision|0|||
155114150|NCT02901054|559846242|FG000|Overall Study|Physician Decision|1|||
155114151|NCT02901054|559846242|FG000|Overall Study|Withdrawal by Subject|3|||
155114152|NCT05593913|559846244|FG000|Overall Study|Insufficient image quality|39|||
155114153|NCT01453205|559846245|FG000|Overall Study|Lost to Follow-up|3|||
155114154|NCT01453205|559846246|FG001|Overall Study|Lost to Follow-up|0|||
154896406|NCT03846219|559040730|FG002|Overall Study|Physician Decision|2|||
154979034|NCT00206102|559345805|FG000|Overall Study|Protocol Violation|0|||
154979035|NCT00206102|559345806|FG001|Overall Study|Protocol Violation|2|||
154979036|NCT00206102|559345805|FG000|Overall Study|Lack of therapeutic response|16|||
154979037|NCT00206102|559345806|FG001|Overall Study|Lack of therapeutic response|11|||
154979038|NCT00206102|559345805|FG000|Overall Study|Lost to Follow-up|95|||
154979039|NCT00206102|559345806|FG001|Overall Study|Lost to Follow-up|66|||
154979040|NCT00206102|559345805|FG000|Overall Study|Withdrawal by Subject|118|||
154979041|NCT00206102|559345806|FG001|Overall Study|Withdrawal by Subject|101|||
154979042|NCT00206102|559345805|FG000|Overall Study|Study-specific discontinuation criteria|18|||
154979043|NCT00206102|559345806|FG001|Overall Study|Study-specific discontinuation criteria|17|||
154979044|NCT00206102|559345805|FG000|Overall Study|None of those categories|42|||
154979045|NCT00206102|559345806|FG001|Overall Study|None of those categories|36|||
154979046|NCT01917968|559345807|FG000|Overall Study|Death|3|||
154979047|NCT01917968|559345808|FG001|Overall Study|Death|2|||
154979048|NCT01917968|559345807|FG000|Overall Study|Lost to Follow-up|21|||
154979049|NCT01917968|559345808|FG001|Overall Study|Lost to Follow-up|39|||
154979050|NCT01917968|559345807|FG000|Overall Study|Physician Decision|1|||
154979051|NCT01917968|559345808|FG001|Overall Study|Physician Decision|2|||
154979052|NCT01917968|559345807|FG000|Overall Study|Withdrawal by Subject|20|||
154979053|NCT01917968|559345808|FG001|Overall Study|Withdrawal by Subject|35|||
154979054|NCT01917968|559345807|FG000|Overall Study|Subject Relocation|5|||
154979055|NCT01917968|559345808|FG001|Overall Study|Subject Relocation|1|||
154979056|NCT01917968|559345807|FG000|Overall Study|36M Missed Visit|3|||
154979057|NCT01917968|559345808|FG001|Overall Study|36M Missed Visit|2|||
154979058|NCT01917968|559345807|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
154979059|NCT01917968|559345808|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
154979060|NCT01917968|559345807|FG000|Overall Study|Change in Family Circumstances|0|||
154979061|NCT01917968|559345808|FG001|Overall Study|Change in Family Circumstances|1|||
154979062|NCT01917968|559345807|FG000|Overall Study|No Data Available|0|||
154979063|NCT01917968|559345808|FG001|Overall Study|No Data Available|2|||
154979064|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
154979065|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
154979066|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
154979067|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
154979068|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
154979069|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
154979070|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
154979071|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
154979072|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
154979073|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
154979074|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
154979075|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
154979076|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
154979077|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
154979078|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
154979079|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
155114155|NCT01453205|559846247|FG002|Overall Study|Lost to Follow-up|1|||
155114156|NCT01453205|559846245|FG000|Overall Study|Withdrawal by Subject|8|||
155114157|NCT01453205|559846246|FG001|Overall Study|Withdrawal by Subject|3|||
155114158|NCT01453205|559846247|FG002|Overall Study|Withdrawal by Subject|0|||
154979080|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
154979081|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
154979082|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
154979083|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
154979084|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
154979085|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
154979086|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
154979087|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
154979088|NCT01435928|559345810|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
154979089|NCT01435928|559345811|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
155114159|NCT01453205|559846245|FG000|Overall Study|Death|24|||
155114160|NCT01453205|559846246|FG001|Overall Study|Death|22|||
155114161|NCT01453205|559846247|FG002|Overall Study|Death|18|||
155114162|NCT01453205|559846245|FG000|Overall Study|Other|45|||
154979090|NCT01435928|559345812|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
155114163|NCT01453205|559846246|FG001|Overall Study|Other|27|||
155114164|NCT01453205|559846247|FG002|Overall Study|Other|35|||
155114165|NCT01666119|559846248|FG000|Overall Study|Adverse Event|6|||
155114166|NCT01666119|559846248|FG000|Overall Study|Withdrawal by Subject|16|||
154979091|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
154979092|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
154979093|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
155114167|NCT01666119|559846248|FG000|Overall Study|Lost to Follow-up|7|||
154896407|NCT05109702|559040731|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
154896408|NCT05109702|559040732|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
154896409|NCT05109702|559040733|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
154896410|NCT05109702|559040731|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
154896411|NCT05109702|559040732|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
154896412|NCT05109702|559040733|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
154896413|NCT05109702|559040731|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
154896414|NCT05109702|559040732|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
154896415|NCT05109702|559040733|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
154896416|NCT05109702|559040731|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
154896417|NCT05109702|559040732|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
154896418|NCT05109702|559040733|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
154896419|NCT05109702|559040731|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
154896420|NCT05109702|559040732|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
154896421|NCT05109702|559040733|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
154896422|NCT02322411|559040736|FG000|Overall Study|Lost to Follow-up|4|||
154896423|NCT02322411|559040737|FG001|Overall Study|Lost to Follow-up|7|||
154896424|NCT02322411|559040736|FG000|Overall Study|Withdrawal by Subject|1|||
154896425|NCT02322411|559040737|FG001|Overall Study|Withdrawal by Subject|0|||
154896426|NCT01392378|559040738|FG000|Infant Series|Adverse Event|0|||
154896427|NCT01392378|559040739|FG001|Infant Series|Adverse Event|0|||
154896428|NCT01392378|559040740|FG002|Infant Series|Adverse Event|0|||
154896429|NCT01392378|559040741|FG003|Infant Series|Adverse Event|1|||
154896430|NCT01392378|559040742|FG004|Infant Series|Adverse Event|0|||
154896431|NCT01392378|559040738|FG000|Infant Series|Lost to Follow-up|0|||
154896432|NCT01392378|559040739|FG001|Infant Series|Lost to Follow-up|0|||
154896433|NCT01392378|559040740|FG002|Infant Series|Lost to Follow-up|0|||
154896434|NCT01392378|559040741|FG003|Infant Series|Lost to Follow-up|1|||
154896435|NCT01392378|559040742|FG004|Infant Series|Lost to Follow-up|0|||
154896436|NCT01392378|559040738|FG000|Infant Series|Protocol Violation|0|||
154896437|NCT01392378|559040739|FG001|Infant Series|Protocol Violation|1|||
154896438|NCT01392378|559040740|FG002|Infant Series|Protocol Violation|0|||
154896439|NCT01392378|559040741|FG003|Infant Series|Protocol Violation|0|||
154896440|NCT01392378|559040742|FG004|Infant Series|Protocol Violation|0|||
154896441|NCT01392378|559040738|FG000|Infant Series|Withdrawal by Parent|4|||
154896442|NCT01392378|559040739|FG001|Infant Series|Withdrawal by Parent|1|||
154896443|NCT01392378|559040740|FG002|Infant Series|Withdrawal by Parent|0|||
154896444|NCT01392378|559040741|FG003|Infant Series|Withdrawal by Parent|0|||
154896445|NCT01392378|559040742|FG004|Infant Series|Withdrawal by Parent|0|||
154896446|NCT01392378|559040738|FG000|After Infant Series|Lost to Follow-up|0|||
154896447|NCT01392378|559040739|FG001|After Infant Series|Lost to Follow-up|0|||
154896448|NCT01392378|559040740|FG002|After Infant Series|Lost to Follow-up|1|||
154896449|NCT01392378|559040741|FG003|After Infant Series|Lost to Follow-up|0|||
154896450|NCT01392378|559040742|FG004|After Infant Series|Lost to Follow-up|0|||
154896451|NCT01392378|559040738|FG000|After Infant Series|Withdrawal by Parent|0|||
154896452|NCT01392378|559040739|FG001|After Infant Series|Withdrawal by Parent|1|||
154896453|NCT01392378|559040740|FG002|After Infant Series|Withdrawal by Parent|1|||
154896454|NCT01392378|559040741|FG003|After Infant Series|Withdrawal by Parent|0|||
154896455|NCT01392378|559040742|FG004|After Infant Series|Withdrawal by Parent|1|||
154896456|NCT01392378|559040738|FG000|Toddler Dose|Lost to Follow-up|0|||
154896457|NCT01392378|559040739|FG001|Toddler Dose|Lost to Follow-up|0|||
154896458|NCT01392378|559040740|FG002|Toddler Dose|Lost to Follow-up|0|||
154896459|NCT01392378|559040741|FG003|Toddler Dose|Lost to Follow-up|1|||
154896460|NCT01392378|559040742|FG004|Toddler Dose|Lost to Follow-up|0|||
154896461|NCT01392378|559040738|FG000|Toddler Dose|Withdrawal by Parent|0|||
154896462|NCT01392378|559040739|FG001|Toddler Dose|Withdrawal by Parent|1|||
154896463|NCT01392378|559040740|FG002|Toddler Dose|Withdrawal by Parent|0|||
154896464|NCT01392378|559040741|FG003|Toddler Dose|Withdrawal by Parent|1|||
154896465|NCT01392378|559040742|FG004|Toddler Dose|Withdrawal by Parent|1|||
154896466|NCT02261883|559040743|FG000|Overall Study|Death|3|||
154896467|NCT02261883|559040744|FG001|Overall Study|Death|2|||
154896468|NCT02261883|559040743|FG000|Overall Study|Physician Decision|1|||
154896469|NCT02261883|559040744|FG001|Overall Study|Physician Decision|0|||
154896470|NCT02261883|559040743|FG000|Overall Study|Protocol Violation|1|||
154896471|NCT02261883|559040744|FG001|Overall Study|Protocol Violation|0|||
154896472|NCT02261883|559040743|FG000|Overall Study|Withdrawal by Subject|0|||
154896473|NCT02261883|559040744|FG001|Overall Study|Withdrawal by Subject|1|||
154896474|NCT02261883|559040743|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
154896475|NCT02261883|559040744|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
154896476|NCT05567393|559040747|FG000|Overall Study|Voluntary Withdrawal|0|||
154896477|NCT05567393|559040748|FG001|Overall Study|Voluntary Withdrawal|0|||
154896478|NCT05567393|559040749|FG002|Overall Study|Voluntary Withdrawal|0|||
154896479|NCT05567393|559040750|FG003|Overall Study|Voluntary Withdrawal|0|||
154896480|NCT05567393|559040751|FG004|Overall Study|Voluntary Withdrawal|0|||
154896481|NCT05567393|559040752|FG005|Overall Study|Voluntary Withdrawal|0|||
155175650|NCT00869778|560080306|FG001|Overall Study|Adverse Event|0|||
154896482|NCT05567393|559040753|FG006|Overall Study|Voluntary Withdrawal|0|||
154896483|NCT05567393|559040754|FG007|Overall Study|Voluntary Withdrawal|0|||
154896484|NCT05567393|559040755|FG008|Overall Study|Voluntary Withdrawal|0|||
154896485|NCT05567393|559040756|FG009|Overall Study|Voluntary Withdrawal|0|||
154896486|NCT05567393|559040757|FG010|Overall Study|Voluntary Withdrawal|0|||
154896487|NCT05567393|559040758|FG011|Overall Study|Voluntary Withdrawal|0|||
154896488|NCT05567393|559040759|FG012|Overall Study|Voluntary Withdrawal|0|||
154896489|NCT05567393|559040760|FG013|Overall Study|Voluntary Withdrawal|1|||
154896490|NCT05567393|559040761|FG014|Overall Study|Voluntary Withdrawal|0|||
154896491|NCT05567393|559040762|FG015|Overall Study|Voluntary Withdrawal|0|||
154896492|NCT05567393|559040763|FG016|Overall Study|Voluntary Withdrawal|0|||
154896493|NCT05567393|559040764|FG017|Overall Study|Voluntary Withdrawal|0|||
154896494|NCT04199793|559040769|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
154896495|NCT04199793|559040770|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
154896496|NCT04199793|559040769|FG000|Overall Study|Withdrawal by Subject|1|||
154896497|NCT04199793|559040770|FG001|Overall Study|Withdrawal by Subject|1|||
154896498|NCT00141037|559040772|FG000|Overall Study|Physician Decision|1|||
154896499|NCT00141037|559040773|FG001|Overall Study|Physician Decision|2|||
154896500|NCT00141037|559040772|FG000|Overall Study|Lost to Follow-up|3|||
154896501|NCT00141037|559040773|FG001|Overall Study|Lost to Follow-up|1|||
154896502|NCT00141037|559040772|FG000|Overall Study|Protocol Violation|0|||
154896503|NCT00141037|559040773|FG001|Overall Study|Protocol Violation|2|||
154896504|NCT00141037|559040772|FG000|Overall Study|Withdrawal by Subject|2|||
154896505|NCT00141037|559040773|FG001|Overall Study|Withdrawal by Subject|1|||
154896506|NCT00141037|559040772|FG000|Overall Study|Other|0|||
154896507|NCT00141037|559040773|FG001|Overall Study|Other|1|||
154896508|NCT00141037|559040772|FG000|Overall Study|Moved from area|1|||
154896509|NCT00141037|559040773|FG001|Overall Study|Moved from area|7|||
154896510|NCT00141037|559040772|FG000|Overall Study|Graft Failure|3|||
154896511|NCT00141037|559040773|FG001|Overall Study|Graft Failure|4|||
154896512|NCT00888615|559040774|FG000|Overall Study|No treatment|2|||
154896513|NCT00861380|559040775|FG000|Overall Study|Withdrawal Information not recorded|8427|||
154896514|NCT00861380|559040776|FG001|Overall Study|Withdrawal Information not recorded|9112|||
154896515|NCT00861380|559040777|FG002|Overall Study|Withdrawal Information not recorded|8872|||
154896516|NCT00861380|559040778|FG003|Overall Study|Withdrawal Information not recorded|3689|||
154896517|NCT00861380|559040779|FG004|Overall Study|Withdrawal Information not recorded|1812|||
154896518|NCT00861380|559040780|FG005|Overall Study|Withdrawal Information not recorded|6249|||
154896519|NCT00861380|559040781|FG006|Overall Study|Withdrawal Information not recorded|3020|||
154896520|NCT00628758|559040782|FG000|Overall Study|Adverse Event|2|||
154896521|NCT00628758|559040783|FG001|Overall Study|Adverse Event|3|||
154896522|NCT00628758|559040782|FG000|Overall Study|Withdrawal by Subject|6|||
154896523|NCT00628758|559040783|FG001|Overall Study|Withdrawal by Subject|3|||
154896524|NCT00628758|559040782|FG000|Overall Study|Death|1|||
154896525|NCT00628758|559040783|FG001|Overall Study|Death|0|||
154896526|NCT00628758|559040782|FG000|Overall Study|Protocol Violation|5|||
154896527|NCT00628758|559040783|FG001|Overall Study|Protocol Violation|1|||
154896528|NCT00628758|559040782|FG000|Overall Study|Lost to Follow-up|25|||
154896529|NCT00628758|559040783|FG001|Overall Study|Lost to Follow-up|31|||
154896530|NCT00628758|559040782|FG000|Overall Study|Pregnancy|2|||
154896531|NCT00628758|559040783|FG001|Overall Study|Pregnancy|2|||
154896532|NCT00628758|559040782|FG000|Overall Study|Investigator Moved|3|||
154896533|NCT00628758|559040783|FG001|Overall Study|Investigator Moved|0|||
154896534|NCT00628758|559040782|FG000|Overall Study|Treatment Failure|0|||
154896535|NCT00628758|559040783|FG001|Overall Study|Treatment Failure|2|||
154924235|NCT00938366|559146438|FG001|Overall Study|Withdrawal by Subject|0|||
154924236|NCT03328325|559146439|FG000|Overall Study|Lost to Follow-up|4|||
154924237|NCT03328325|559146439|FG000|Overall Study|Physician Decision|1|||
154924238|NCT03328325|559146439|FG000|Overall Study|Withdrawal by Subject|3|||
154924239|NCT03328325|559146439|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
154924240|NCT00931515|559146440|FG000|Overall Study|Lost to Follow-up|2|||
154924241|NCT00931515|559146441|FG001|Overall Study|Lost to Follow-up|5|||
154924242|NCT01869959|559146442|FG000|Randomization Period|Physician Decision|0|||
154924243|NCT01869959|559146443|FG001|Randomization Period|Physician Decision|0|||
154924244|NCT01869959|559146444|FG002|Randomization Period|Physician Decision|0|||
154924245|NCT01869959|559146445|FG003|Randomization Period|Physician Decision|0|||
154924246|NCT01869959|559146446|FG004|Randomization Period|Physician Decision|1|||
154924247|NCT01869959|559146442|FG000|Treatment Period|Adverse Event|1|||
154924248|NCT01869959|559146443|FG001|Treatment Period|Adverse Event|0|||
154924249|NCT01869959|559146444|FG002|Treatment Period|Adverse Event|3|||
154924250|NCT01869959|559146445|FG003|Treatment Period|Adverse Event|1|||
154924251|NCT01869959|559146446|FG004|Treatment Period|Adverse Event|0|||
154924252|NCT01869959|559146442|FG000|Treatment Period|Sponsor decision|0|||
154924253|NCT01869959|559146443|FG001|Treatment Period|Sponsor decision|1|||
154924254|NCT01869959|559146444|FG002|Treatment Period|Sponsor decision|0|||
154924255|NCT01869959|559146445|FG003|Treatment Period|Sponsor decision|1|||
154924256|NCT01869959|559146446|FG004|Treatment Period|Sponsor decision|0|||
154924257|NCT01869959|559146442|FG000|Treatment Period|Withdrawal by Subject|0|||
155114168|NCT01666119|559846248|FG000|Overall Study|non compliance with study medication, pa|18|||
155114169|NCT01666119|559846248|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
155114170|NCT03255967|559846253|FG000|Overall Study|Adverse Event|26|||
155114171|NCT03255967|559846254|FG001|Overall Study|Adverse Event|30|||
154896536|NCT03706040|559042547|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
154896537|NCT03706040|559042548|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
154896538|NCT03706040|559042549|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
154896539|NCT03706040|559042550|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
154896540|NCT03706040|559042551|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
154896541|NCT03706040|559042552|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
154896542|NCT03706040|559042553|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
154896543|NCT03706040|559042547|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
154896544|NCT03706040|559042548|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
154896545|NCT03706040|559042549|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
154896546|NCT03706040|559042550|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
154896547|NCT03706040|559042551|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
154896548|NCT03706040|559042552|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
154896549|NCT03706040|559042553|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
154896550|NCT03706040|559042547|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
154896551|NCT03706040|559042548|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
154896552|NCT03706040|559042549|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
154896553|NCT03706040|559042550|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
154896554|NCT03706040|559042551|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
154896555|NCT03706040|559042552|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
154896556|NCT03706040|559042553|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
154896557|NCT03706040|559042547|FG000|Period A (Week 0 to Week 16)|Other|2|||
154896558|NCT03706040|559042548|FG001|Period A (Week 0 to Week 16)|Other|0|||
154896559|NCT03706040|559042549|FG002|Period A (Week 0 to Week 16)|Other|2|||
154896560|NCT03706040|559042550|FG003|Period A (Week 0 to Week 16)|Other|0|||
154896561|NCT03706040|559042551|FG004|Period A (Week 0 to Week 16)|Other|0|||
154896562|NCT03706040|559042552|FG005|Period A (Week 0 to Week 16)|Other|0|||
154896563|NCT03706040|559042553|FG006|Period A (Week 0 to Week 16)|Other|0|||
154896564|NCT03706040|559042547|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
154896565|NCT03706040|559042548|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
154896566|NCT03706040|559042549|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
154896567|NCT03706040|559042550|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
154896568|NCT03706040|559042551|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
154896569|NCT03706040|559042552|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
154896570|NCT03706040|559042553|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
154896571|NCT03706040|559042547|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
154896572|NCT03706040|559042548|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
154896573|NCT03706040|559042549|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
154896574|NCT03706040|559042550|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
154896575|NCT03706040|559042551|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
154896576|NCT03706040|559042552|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
154896577|NCT03706040|559042553|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
154896578|NCT03706040|559042547|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
154896579|NCT03706040|559042548|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
154896580|NCT03706040|559042549|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
154896581|NCT03706040|559042550|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
154896582|NCT03706040|559042551|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
154896583|NCT03706040|559042552|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
154896584|NCT03706040|559042553|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
154896585|NCT03706040|559042547|FG000|Period B (Week 16 to Week 52)|Other|0|||
154896586|NCT03706040|559042548|FG001|Period B (Week 16 to Week 52)|Other|0|||
154896587|NCT03706040|559042549|FG002|Period B (Week 16 to Week 52)|Other|0|||
154896588|NCT03706040|559042550|FG003|Period B (Week 16 to Week 52)|Other|4|||
154896589|NCT03706040|559042551|FG004|Period B (Week 16 to Week 52)|Other|5|||
154896590|NCT03706040|559042552|FG005|Period B (Week 16 to Week 52)|Other|23|||
154896591|NCT03706040|559042553|FG006|Period B (Week 16 to Week 52)|Other|17|||
154896592|NCT00927758|559042554|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
154896593|NCT00927758|559042555|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
154896594|NCT00927758|559042556|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
155114172|NCT03255967|559846253|FG000|Overall Study|Withdrawal by Subject|6|||
155114173|NCT03255967|559846254|FG001|Overall Study|Withdrawal by Subject|6|||
155114174|NCT03255967|559846253|FG000|Overall Study|Schedule conflict|6|||
154896595|NCT00927758|559042557|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
154896596|NCT00927758|559042558|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
154896597|NCT00927758|559042559|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
154896598|NCT00927758|559042554|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
155114175|NCT03255967|559846254|FG001|Overall Study|Schedule conflict|4|||
154896599|NCT00927758|559042555|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
154896600|NCT00927758|559042556|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
154896601|NCT00927758|559042557|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
154896602|NCT00927758|559042558|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
154896603|NCT00927758|559042559|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
154896604|NCT01544478|559042560|FG000|Overall Study|Adverse Event|1|||
154896605|NCT01544478|559042560|FG000|Overall Study|Death|1|||
154896606|NCT01544478|559042560|FG000|Overall Study|Lost to Follow-up|48|||
154896607|NCT01544478|559042560|FG000|Overall Study|Physician Decision|15|||
154896608|NCT01544478|559042560|FG000|Overall Study|Pregnancy|1|||
154896609|NCT01544478|559042560|FG000|Overall Study|Withdrawal by Subject|52|||
154896610|NCT00212758|559042561|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
154896611|NCT00212758|559042562|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
154896612|NCT00212758|559042561|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
154896613|NCT00212758|559042562|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
154896614|NCT02940860|559042565|FG000|Overall Study|Non-serious AE|1|||
154896615|NCT02940860|559042566|FG001|Overall Study|Non-serious AE|2|||
154896616|NCT02940860|559042565|FG000|Overall Study|Serious AE|7|||
154896617|NCT02940860|559042566|FG001|Overall Study|Serious AE|3|||
154896618|NCT02940860|559042565|FG000|Overall Study|Withdrawal by Subject|19|||
154896619|NCT02940860|559042566|FG001|Overall Study|Withdrawal by Subject|9|||
154896620|NCT02940860|559042565|FG000|Overall Study|Lost to Follow-up|13|||
154896621|NCT02940860|559042566|FG001|Overall Study|Lost to Follow-up|7|||
154896622|NCT02940860|559042565|FG000|Overall Study|Physician Decision|5|||
154896623|NCT02940860|559042566|FG001|Overall Study|Physician Decision|3|||
154896624|NCT02940860|559042565|FG000|Overall Study|Sponsor Decision|0|||
154896625|NCT02940860|559042566|FG001|Overall Study|Sponsor Decision|1|||
154896626|NCT02940860|559042565|FG000|Overall Study|Protocol Violation|0|||
154896627|NCT02940860|559042566|FG001|Overall Study|Protocol Violation|2|||
154896628|NCT02940860|559042565|FG000|Overall Study|Death|3|||
154896629|NCT02940860|559042566|FG001|Overall Study|Death|2|||
154896630|NCT02940860|559042565|FG000|Overall Study|Moved, poor venous access, transport|6|||
154896631|NCT02940860|559042566|FG001|Overall Study|Moved, poor venous access, transport|4|||
154896632|NCT02940860|559042565|FG000|Overall Study|Not treated|2|||
154896633|NCT02940860|559042566|FG001|Overall Study|Not treated|2|||
154896634|NCT02431793|559042568|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
154896635|NCT02431793|559042569|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
154896636|NCT02431793|559042570|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
154979094|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
154979095|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
154979096|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
154979097|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
154979098|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
154979099|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
154979100|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
154979101|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
154979102|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
154979103|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
154979104|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
154979105|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
154979106|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
154979107|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
154979108|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
154979109|NCT01435928|559345810|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
154979110|NCT01435928|559345811|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
154979111|NCT01435928|559345812|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
154979112|NCT00292227|559345816|FG000|Patch Period|Adverse Event|1|||
154979113|NCT00292227|559345817|FG001|Patch Period|Adverse Event|0|||
154979114|NCT00292227|559345818|FG002|Patch Period|Adverse Event|2|||
154979115|NCT00292227|559345816|FG000|Patch Period|Withdrawal by Subject|0|||
154979116|NCT00292227|559345817|FG001|Patch Period|Withdrawal by Subject|0|||
154979117|NCT00292227|559345818|FG002|Patch Period|Withdrawal by Subject|1|||
154979118|NCT00537017|559345821|FG000|Treatment Phase|Adverse Event|19|||
154979119|NCT00537017|559345821|FG000|Treatment Phase|Withdrawal by Subject|13|||
154979120|NCT00537017|559345821|FG000|Treatment Phase|Protocol Violation|2|||
154979121|NCT00537017|559345821|FG000|Follow-up Phase|Withdrawal by Subject|9|||
154979122|NCT02329431|559345823|FG000|Overall Study|Lost to Follow-up|20|||
154979123|NCT02329431|559345824|FG001|Overall Study|Lost to Follow-up|13|||
154979124|NCT01989676|559347296|FG000|Overall Study|Death|52|||
154979125|NCT01989676|559347297|FG001|Overall Study|Death|60|||
154979126|NCT01989676|559347296|FG000|Overall Study|Protocol Violation|2|||
154979127|NCT01989676|559347297|FG001|Overall Study|Protocol Violation|1|||
154896637|NCT02431793|559042568|FG000|Overall Study|Withdrawal by Subject|7|||
154896638|NCT02431793|559042569|FG001|Overall Study|Withdrawal by Subject|5|||
155114176|NCT03255967|559846253|FG000|Overall Study|POA did not sign consent form|2|||
155114177|NCT03255967|559846254|FG001|Overall Study|POA did not sign consent form|0|||
155114178|NCT00778258|559846260|FG000|Overall Study|Adverse Event|1|||
155114179|NCT00778258|559846261|FG001|Overall Study|Adverse Event|0|||
155114180|NCT00778258|559846262|FG002|Overall Study|Adverse Event|0|||
155114181|NCT00778258|559846263|FG003|Overall Study|Adverse Event|0|||
155114182|NCT00778258|559846264|FG004|Overall Study|Adverse Event|0|||
154896639|NCT02431793|559042570|FG002|Overall Study|Withdrawal by Subject|5|||
154896640|NCT02431793|559042568|FG000|Overall Study|Lost to Follow-up|101|||
154979128|NCT01989676|559347296|FG000|Overall Study|Lost to Follow-up|8|||
154979129|NCT01989676|559347297|FG001|Overall Study|Lost to Follow-up|18|||
154979130|NCT01989676|559347296|FG000|Overall Study|No longer willing to participate in study|26|||
154979131|NCT01989676|559347297|FG001|Overall Study|No longer willing to participate in study|26|||
154979132|NCT01989676|559347296|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
154979133|NCT01989676|559347297|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
154979134|NCT01989676|559347296|FG000|Overall Study|Other|4|||
154979135|NCT01989676|559347297|FG001|Overall Study|Other|3|||
154979136|NCT02938442|559347298|FG000|Overall Study|Death|0|||
154979137|NCT02938442|559347299|FG001|Overall Study|Death|1|||
154979138|NCT02938442|559347298|FG000|Overall Study|Lost to Follow-up|0|||
154979139|NCT02938442|559347299|FG001|Overall Study|Lost to Follow-up|1|||
154979140|NCT02938442|559347298|FG000|Overall Study|Physician Decision|0|||
154979141|NCT02938442|559347299|FG001|Overall Study|Physician Decision|1|||
154979142|NCT02938442|559347298|FG000|Overall Study|Withdrawal by Subject|2|||
154979143|NCT02938442|559347299|FG001|Overall Study|Withdrawal by Subject|0|||
154896641|NCT02431793|559042569|FG001|Overall Study|Lost to Follow-up|122|||
154896642|NCT02431793|559042570|FG002|Overall Study|Lost to Follow-up|104|||
154896643|NCT01563107|559042574|FG000|Overall Study|Physician Decision|0|||
154896644|NCT01563107|559042575|FG001|Overall Study|Physician Decision|1|||
154896645|NCT01563107|559042576|FG002|Overall Study|Physician Decision|1|||
154896646|NCT01563107|559042577|FG003|Overall Study|Physician Decision|3|||
154896647|NCT01563107|559042574|FG000|Overall Study|Withdrawal by Subject|1|||
154896648|NCT01563107|559042575|FG001|Overall Study|Withdrawal by Subject|2|||
154896649|NCT01563107|559042576|FG002|Overall Study|Withdrawal by Subject|1|||
154896650|NCT01563107|559042577|FG003|Overall Study|Withdrawal by Subject|2|||
154896651|NCT02707601|559042578|FG000|Overall Study|Death|0|||
154896652|NCT02707601|559042579|FG001|Overall Study|Death|1|||
154896653|NCT02707601|559042578|FG000|Overall Study|Lack of Efficacy|0|||
154896654|NCT02707601|559042579|FG001|Overall Study|Lack of Efficacy|1|||
154896655|NCT02707601|559042578|FG000|Overall Study|Investigator's Discretion|1|||
154896656|NCT02707601|559042579|FG001|Overall Study|Investigator's Discretion|0|||
154896657|NCT02707601|559042578|FG000|Overall Study|Withdrew Consent|0|||
154896658|NCT02707601|559042579|FG001|Overall Study|Withdrew Consent|1|||
154896659|NCT02707601|559042578|FG000|Overall Study|Lost to Follow-up|1|||
154896660|NCT02707601|559042579|FG001|Overall Study|Lost to Follow-up|1|||
154896661|NCT02707601|559042578|FG000|Overall Study|Participants Randomized but Not Treated|2|||
154896662|NCT02707601|559042579|FG001|Overall Study|Participants Randomized but Not Treated|0|||
154896663|NCT00063986|559042581|FG000|Overall Study|Withdrawal by Subject|1|||
154896664|NCT00063986|559042581|FG000|Overall Study|Ineligible|1|||
154896665|NCT00063986|559042581|FG000|Overall Study|Intra-operatively ineligible|4|||
154896666|NCT00247273|559042582|FG000|Overall Study|Adverse Event|85|||
154896667|NCT00247273|559042583|FG001|Overall Study|Adverse Event|80|||
154896668|NCT00247273|559042582|FG000|Overall Study|Physician Decision|6|||
154896669|NCT00247273|559042583|FG001|Overall Study|Physician Decision|3|||
154896670|NCT00247273|559042582|FG000|Overall Study|Lost to Follow-up|7|||
154896671|NCT00247273|559042583|FG001|Overall Study|Lost to Follow-up|7|||
154896672|NCT00247273|559042582|FG000|Overall Study|Withdrawal by Subject|46|||
154896673|NCT00247273|559042583|FG001|Overall Study|Withdrawal by Subject|47|||
154979144|NCT01115855|559347300|FG000|Overall Study|Adverse Event|16|||
154979145|NCT01115855|559347301|FG001|Overall Study|Adverse Event|18|||
154979146|NCT01115855|559347300|FG000|Overall Study|Death|6|||
154979147|NCT01115855|559347301|FG001|Overall Study|Death|5|||
154979148|NCT01115855|559347300|FG000|Overall Study|Lab Abnormality|1|||
155114183|NCT00778258|559846265|FG005|Overall Study|Adverse Event|1|||
154896674|NCT00247273|559042582|FG000|Overall Study|Did not take any study drug|2|||
154896675|NCT00247273|559042583|FG001|Overall Study|Did not take any study drug|0|||
155114184|NCT00778258|559846266|FG006|Overall Study|Adverse Event|0|||
154896676|NCT00607919|559042584|FG000|Acute Phase|Adverse Event|9|||
154896677|NCT00607919|559042585|FG001|Acute Phase|Adverse Event|2|||
154896678|NCT00607919|559042584|FG000|Acute Phase|Entry Criteria Not Met|1|||
154896679|NCT00607919|559042585|FG001|Acute Phase|Entry Criteria Not Met|1|||
154896680|NCT00607919|559042584|FG000|Acute Phase|Lack of Efficacy|1|||
154896681|NCT00607919|559042585|FG001|Acute Phase|Lack of Efficacy|2|||
154896682|NCT00607919|559042584|FG000|Acute Phase|Lost to Follow-up|9|||
154896683|NCT00607919|559042585|FG001|Acute Phase|Lost to Follow-up|3|||
155114185|NCT00778258|559846267|FG007|Overall Study|Adverse Event|0|||
155114186|NCT00778258|559846268|FG008|Overall Study|Adverse Event|0|||
154896684|NCT00607919|559042584|FG000|Acute Phase|Parent/Caregiver Decision|6|||
154979149|NCT01115855|559347301|FG001|Overall Study|Lab Abnormality|1|||
154979150|NCT01115855|559347300|FG000|Overall Study|Protocol Violation|0|||
154979151|NCT01115855|559347301|FG001|Overall Study|Protocol Violation|1|||
154979152|NCT01115855|559347300|FG000|Overall Study|Withdrawal by Subject|5|||
154979153|NCT01115855|559347301|FG001|Overall Study|Withdrawal by Subject|5|||
154979154|NCT01115855|559347300|FG000|Overall Study|Other|8|||
154979155|NCT01115855|559347301|FG001|Overall Study|Other|6|||
154979156|NCT00480324|559347302|FG000|Overall Study|Adverse Event|1|||
154979157|NCT00480324|559347303|FG001|Overall Study|Adverse Event|1|||
154979158|NCT00480324|559347302|FG000|Overall Study|Protocol Violation|0|||
154979159|NCT00480324|559347303|FG001|Overall Study|Protocol Violation|1|||
154979160|NCT00480324|559347302|FG000|Overall Study|Withdrawal by Subject|14|||
154979161|NCT00480324|559347303|FG001|Overall Study|Withdrawal by Subject|5|||
154979162|NCT00480324|559347302|FG000|Overall Study|Lost to Follow-up|17|||
154979163|NCT00480324|559347303|FG001|Overall Study|Lost to Follow-up|8|||
154979164|NCT00480324|559347302|FG000|Overall Study|Subject's mother pregnant|0|||
154979165|NCT00480324|559347303|FG001|Overall Study|Subject's mother pregnant|1|||
154979166|NCT01915940|559347304|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
154979167|NCT01915940|559347305|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
154979168|NCT01915940|559347306|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
154979169|NCT01915940|559347304|FG000|Treatment Period|Decision of Participant|0|||
154979170|NCT01915940|559347305|FG001|Treatment Period|Decision of Participant|1|||
154979171|NCT01915940|559347306|FG002|Treatment Period|Decision of Participant|3|||
154979172|NCT01915940|559347304|FG000|Treatment Period|Adverse Event|0|||
154979173|NCT01915940|559347305|FG001|Treatment Period|Adverse Event|9|||
154979174|NCT01915940|559347306|FG002|Treatment Period|Adverse Event|1|||
154979175|NCT01915940|559347304|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
154979176|NCT01915940|559347305|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
154979177|NCT01915940|559347306|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
154979178|NCT01546922|559347317|FG000|First Period of 10 Weeks|Protocol Violation|3|||
154979179|NCT01546922|559347318|FG001|First Period of 10 Weeks|Protocol Violation|1|||
154979180|NCT01546922|559347317|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
154979181|NCT01546922|559347318|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
154979182|NCT01546922|559347317|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
154979183|NCT01546922|559347318|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
154979184|NCT01546922|559347317|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
154979185|NCT01546922|559347318|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
154979186|NCT01546922|559347317|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
154979187|NCT01546922|559347318|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
154979188|NCT04086641|559347321|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
154979189|NCT04086641|559347322|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
154979190|NCT01005329|559347328|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
154979191|NCT00126126|559347333|FG000|Overall Study|Lost to Follow-up|0|||
154979192|NCT00126126|559347334|FG001|Overall Study|Lost to Follow-up|2|||
154979193|NCT01534078|559347335|FG000|Overall Study|Death|1|||
154979194|NCT01534078|559347335|FG000|Overall Study|Withdrawal by Subject|1|||
154979195|NCT00986570|559347339|FG000|Overall Study|Lost to Follow-up|6|||
154979196|NCT00986570|559347339|FG000|Overall Study|Potential bias for objective assessment|1|||
154979197|NCT02225665|559347340|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
154896685|NCT00607919|559042585|FG001|Acute Phase|Parent/Caregiver Decision|4|||
154896686|NCT00607919|559042584|FG000|Acute Phase|Protocol Violation|5|||
154896687|NCT00607919|559042585|FG001|Acute Phase|Protocol Violation|1|||
154896688|NCT00607919|559042584|FG000|Acute Phase|Withdrawal by Subject|3|||
154896689|NCT00607919|559042585|FG001|Acute Phase|Withdrawal by Subject|3|||
154896690|NCT00607919|559042584|FG000|Open-Label Phase|Adverse Event|1|||
154896691|NCT00607919|559042585|FG001|Open-Label Phase|Adverse Event|5|||
154896692|NCT00607919|559042584|FG000|Open-Label Phase|Lost to Follow-up|4|||
154896693|NCT00607919|559042585|FG001|Open-Label Phase|Lost to Follow-up|1|||
154896694|NCT00607919|559042584|FG000|Open-Label Phase|Protocol Violation|2|||
154896695|NCT00607919|559042585|FG001|Open-Label Phase|Protocol Violation|2|||
154979198|NCT02225665|559347341|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
154896696|NCT00607919|559042584|FG000|Open-Label Phase|Withdrawal by Subject|2|||
154896697|NCT00607919|559042585|FG001|Open-Label Phase|Withdrawal by Subject|2|||
154979199|NCT02225665|559347340|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
154896698|NCT00607919|559042584|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
154896699|NCT00607919|559042585|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
154979200|NCT02225665|559347341|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
154979201|NCT01311557|559347342|FG000|Overall Study|Serious adverse event|0|||
154979202|NCT01311557|559347343|FG001|Overall Study|Serious adverse event|1|||
154979203|NCT01311557|559347342|FG000|Overall Study|Protocol Violation|4|||
154979204|NCT01311557|559347343|FG001|Overall Study|Protocol Violation|2|||
155114187|NCT00778258|559846260|FG000|Overall Study|Lost to Follow-up|0|||
155114188|NCT00778258|559846261|FG001|Overall Study|Lost to Follow-up|0|||
155114189|NCT00778258|559846262|FG002|Overall Study|Lost to Follow-up|2|||
154896700|NCT02580240|559042586|FG000|Overall Study|Physician Decision|2|||
154979205|NCT01311557|559347342|FG000|Overall Study|Lost to Follow-up|0|||
154979206|NCT01311557|559347343|FG001|Overall Study|Lost to Follow-up|1|||
154979207|NCT01311557|559347342|FG000|Overall Study|Withdrawal by Subject|1|||
154979208|NCT01311557|559347343|FG001|Overall Study|Withdrawal by Subject|2|||
154979209|NCT00608517|559347344|FG000|Overall Study|Death|1|||
154979210|NCT00608517|559347345|FG001|Overall Study|Death|0|||
154979211|NCT00608517|559347346|FG002|Overall Study|Death|0|||
154979212|NCT00572039|559347347|FG000|Overall Study|Withdrawal by Subject|9|||
154979213|NCT00572039|559347348|FG001|Overall Study|Withdrawal by Subject|6|||
154979214|NCT00572039|559347347|FG000|Overall Study|Death|2|||
154979215|NCT00572039|559347348|FG001|Overall Study|Death|3|||
154979216|NCT00572039|559347347|FG000|Overall Study|Ill|5|||
154979217|NCT00572039|559347348|FG001|Overall Study|Ill|1|||
154979218|NCT01470417|559347351|FG000|Overall Study|Disease progression|0|||
154979219|NCT01470417|559347352|FG001|Overall Study|Disease progression|2|||
154979220|NCT02973321|559347355|FG000|Overall Study|Other than specified|0|||
154979221|NCT02973321|559347356|FG001|Overall Study|Other than specified|5|||
154979222|NCT02973321|559347357|FG002|Overall Study|Other than specified|3|||
154979223|NCT02973321|559347358|FG003|Overall Study|Other than specified|3|||
154979224|NCT02973321|559347359|FG004|Overall Study|Other than specified|1|||
154979225|NCT02973321|559347355|FG000|Overall Study|Lack of Efficacy|0|||
154979226|NCT02973321|559347356|FG001|Overall Study|Lack of Efficacy|0|||
154979227|NCT02973321|559347357|FG002|Overall Study|Lack of Efficacy|0|||
154979228|NCT02973321|559347358|FG003|Overall Study|Lack of Efficacy|0|||
154979229|NCT02973321|559347359|FG004|Overall Study|Lack of Efficacy|1|||
154979230|NCT02973321|559347355|FG000|Overall Study|Adverse Event|1|||
154979231|NCT02973321|559347356|FG001|Overall Study|Adverse Event|10|||
154979232|NCT02973321|559347357|FG002|Overall Study|Adverse Event|11|||
154979233|NCT02973321|559347358|FG003|Overall Study|Adverse Event|13|||
154979234|NCT02973321|559347359|FG004|Overall Study|Adverse Event|3|||
154979235|NCT01098110|559347364|FG000|Overall Study|Withdrawal by Subject|14|||
154979236|NCT01098110|559347365|FG001|Overall Study|Withdrawal by Subject|24|||
154979237|NCT01098110|559347366|FG002|Overall Study|Withdrawal by Subject|19|||
154979238|NCT01098110|559347364|FG000|Overall Study|Adverse Event|30|||
154979239|NCT01098110|559347365|FG001|Overall Study|Adverse Event|32|||
154979240|NCT01098110|559347366|FG002|Overall Study|Adverse Event|43|||
154979241|NCT01098110|559347364|FG000|Overall Study|Lack of Efficacy|13|||
154979242|NCT01098110|559347365|FG001|Overall Study|Lack of Efficacy|9|||
154979243|NCT01098110|559347366|FG002|Overall Study|Lack of Efficacy|27|||
154979244|NCT01098110|559347364|FG000|Overall Study|Other|4|||
154979245|NCT01098110|559347365|FG001|Overall Study|Other|7|||
154979246|NCT01098110|559347366|FG002|Overall Study|Other|5|||
154979247|NCT01098110|559347364|FG000|Overall Study|Untreated|1|||
154979248|NCT01098110|559347365|FG001|Overall Study|Untreated|1|||
154979249|NCT01098110|559347366|FG002|Overall Study|Untreated|0|||
154979250|NCT01355302|559347367|FG000|Phase 1b|Death|4|||
154979251|NCT01355302|559347368|FG001|Phase 1b|Death|0|||
154979252|NCT01355302|559347369|FG002|Phase 1b|Death|0|||
154979253|NCT01355302|559347367|FG000|Phase 1b|Study terminated by sponsor|2|||
154979254|NCT01355302|559347368|FG001|Phase 1b|Study terminated by sponsor|0|||
154979255|NCT01355302|559347369|FG002|Phase 1b|Study terminated by sponsor|0|||
154979256|NCT00263887|559347370|FG000|Overall Study|Withdrawal by Subject|1|||
154979257|NCT00263887|559347371|FG001|Overall Study|Withdrawal by Subject|1|||
154979258|NCT00263887|559347370|FG000|Overall Study|Lung transplantation|1|||
154979259|NCT00263887|559347371|FG001|Overall Study|Lung transplantation|2|||
154979260|NCT00263887|559347370|FG000|Overall Study|Too ill to attend visit|1|||
154979261|NCT00263887|559347371|FG001|Overall Study|Too ill to attend visit|0|||
154979262|NCT00263887|559347370|FG000|Overall Study|Adverse Event|0|||
154979263|NCT00263887|559347371|FG001|Overall Study|Adverse Event|2|||
154979264|NCT00263887|559347370|FG000|Overall Study|Disease progression|0|||
154979265|NCT00263887|559347371|FG001|Overall Study|Disease progression|1|||
154979266|NCT00263887|559347370|FG000|Overall Study|Lack of Efficacy|0|||
154979267|NCT00263887|559347371|FG001|Overall Study|Lack of Efficacy|1|||
154979268|NCT02274948|559347372|FG000|Overall Study|Lost to Follow-up|28|||
154979269|NCT02274948|559347373|FG001|Overall Study|Lost to Follow-up|25|||
154979270|NCT02274948|559347372|FG000|Overall Study|Withdrawal by Subject|64|||
154979271|NCT02274948|559347373|FG001|Overall Study|Withdrawal by Subject|58|||
154979272|NCT02274948|559347372|FG000|Overall Study|Stopped on family Practitioner advice|2|||
154979273|NCT02274948|559347373|FG001|Overall Study|Stopped on family Practitioner advice|5|||
154979274|NCT02274948|559347372|FG000|Overall Study|Left the area|4|||
154979275|NCT02274948|559347373|FG001|Overall Study|Left the area|3|||
154979276|NCT00865514|559347377|FG000|Overall Study|Infusion cost exceeded funding|2|||
154979277|NCT02865395|559347378|FG000|Overall Study|Physician Decision|6|||
154979278|NCT02865395|559347379|FG001|Overall Study|Physician Decision|10|||
154979279|NCT02865395|559347380|FG002|Overall Study|Physician Decision|7|||
154979280|NCT03920280|559347381|FG000|Overall Study|Adverse Event|2|||
154979281|NCT03920280|559347382|FG001|Overall Study|Adverse Event|3|||
154979282|NCT03920280|559347381|FG000|Overall Study|Lost to Follow-up|0|||
154979283|NCT03920280|559347382|FG001|Overall Study|Lost to Follow-up|1|||
154979284|NCT03920280|559347381|FG000|Overall Study|Withdrawal by Subject|1|||
154979285|NCT03920280|559347382|FG001|Overall Study|Withdrawal by Subject|1|||
154979286|NCT03920280|559347381|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
154979287|NCT03920280|559347382|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
154979288|NCT00985231|559347385|FG000|Overall Study|ineligible|1|||
154979289|NCT00985231|559347386|FG001|Overall Study|ineligible|0|||
154979290|NCT00985231|559347385|FG000|Overall Study|Protocol Violation|1|||
154979291|NCT00985231|559347386|FG001|Overall Study|Protocol Violation|0|||
154979292|NCT00985231|559347385|FG000|Overall Study|Withdrawal by Subject|1|||
154979293|NCT00985231|559347386|FG001|Overall Study|Withdrawal by Subject|0|||
154979294|NCT00985231|559347385|FG000|Overall Study|Lost to Follow-up|0|||
154979295|NCT00985231|559347386|FG001|Overall Study|Lost to Follow-up|1|||
154979296|NCT00985231|559347385|FG000|Overall Study|Study related symptoms & complaints|0|||
154979297|NCT00985231|559347386|FG001|Overall Study|Study related symptoms & complaints|2|||
154979298|NCT00983476|559347390|FG000|Overall Study|Did not receive intervention|17|||
154979299|NCT00983476|559347391|FG001|Overall Study|Did not receive intervention|22|||
154979300|NCT00983476|559347392|FG002|Overall Study|Did not receive intervention|0|||
154979301|NCT00575380|559347398|FG000|Overall Study|Withdrawal by Subject|1|||
154979302|NCT00575380|559347399|FG001|Overall Study|Withdrawal by Subject|0|||
154979303|NCT00575380|559347398|FG000|Overall Study|Adverse Event|0|||
154979304|NCT00575380|559347399|FG001|Overall Study|Adverse Event|1|||
154979305|NCT00575380|559347398|FG000|Overall Study|Various|0|||
154979306|NCT00575380|559347399|FG001|Overall Study|Various|2|||
154979307|NCT04019054|559347400|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
154979308|NCT04019054|559347401|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
154979309|NCT04019054|559347400|FG000|Overall Study|Withdrawal by Subject|3|||
154979310|NCT04019054|559347401|FG001|Overall Study|Withdrawal by Subject|1|||
154979311|NCT01040793|559347402|FG000|Overall Study|Adverse Event|5|||
154979312|NCT01040793|559347403|FG001|Overall Study|Adverse Event|3|||
154979313|NCT01040793|559347404|FG002|Overall Study|Adverse Event|0|||
154979314|NCT01040793|559347405|FG003|Overall Study|Adverse Event|2|||
154979315|NCT01040793|559347406|FG004|Overall Study|Adverse Event|2|||
154979316|NCT01040793|559347407|FG005|Overall Study|Adverse Event|1|||
154979317|NCT01040793|559347402|FG000|Overall Study|Protocol Violation|1|||
154979318|NCT01040793|559347403|FG001|Overall Study|Protocol Violation|1|||
154979319|NCT01040793|559347404|FG002|Overall Study|Protocol Violation|1|||
154979320|NCT01040793|559347405|FG003|Overall Study|Protocol Violation|0|||
154979321|NCT01040793|559347406|FG004|Overall Study|Protocol Violation|1|||
154979322|NCT01040793|559347407|FG005|Overall Study|Protocol Violation|0|||
154979323|NCT01040793|559347402|FG000|Overall Study|Lost to Follow-up|0|||
154979324|NCT01040793|559347403|FG001|Overall Study|Lost to Follow-up|1|||
154979325|NCT01040793|559347404|FG002|Overall Study|Lost to Follow-up|1|||
154979326|NCT01040793|559347405|FG003|Overall Study|Lost to Follow-up|0|||
154979327|NCT01040793|559347406|FG004|Overall Study|Lost to Follow-up|0|||
154979328|NCT01040793|559347407|FG005|Overall Study|Lost to Follow-up|0|||
154979329|NCT01040793|559347402|FG000|Overall Study|Withdrawal by Subject|0|||
154979330|NCT01040793|559347403|FG001|Overall Study|Withdrawal by Subject|0|||
154979331|NCT01040793|559347404|FG002|Overall Study|Withdrawal by Subject|0|||
154896701|NCT02580240|559042587|FG001|Overall Study|Physician Decision|0|||
154896702|NCT02911519|559042590|FG000|Overall Study|Lost to Follow-up|2|||
154896703|NCT02911519|559042591|FG001|Overall Study|Lost to Follow-up|2|||
154896704|NCT02911519|559042590|FG000|Overall Study|Death|0|||
154896705|NCT02911519|559042591|FG001|Overall Study|Death|2|||
154896706|NCT02001688|559042594|FG000|Overall Study|Withdrawal by Subject|0|||
154896707|NCT02001688|559042595|FG001|Overall Study|Withdrawal by Subject|0|||
154896708|NCT02001688|559042596|FG002|Overall Study|Withdrawal by Subject|1|||
154896709|NCT02001688|559042594|FG000|Overall Study|Adverse Event|0|||
154979332|NCT01040793|559347405|FG003|Overall Study|Withdrawal by Subject|2|||
154979333|NCT01040793|559347406|FG004|Overall Study|Withdrawal by Subject|0|||
154979334|NCT01040793|559347407|FG005|Overall Study|Withdrawal by Subject|0|||
154979335|NCT01040793|559347402|FG000|Overall Study|Other reasons not listed above|0|||
154979336|NCT01040793|559347403|FG001|Overall Study|Other reasons not listed above|0|||
154979337|NCT01040793|559347404|FG002|Overall Study|Other reasons not listed above|1|||
154979338|NCT01040793|559347405|FG003|Overall Study|Other reasons not listed above|0|||
154979339|NCT01040793|559347406|FG004|Overall Study|Other reasons not listed above|1|||
154979340|NCT01040793|559347407|FG005|Overall Study|Other reasons not listed above|0|||
154979341|NCT00003531|559347408|FG000|Overall Study|Not evaluable|10|||
154979342|NCT00346164|559347409|FG000|Overall Study|Adverse Event|0|||
155114190|NCT00778258|559846263|FG003|Overall Study|Lost to Follow-up|0|||
154896710|NCT02001688|559042595|FG001|Overall Study|Adverse Event|1|||
154896711|NCT02001688|559042596|FG002|Overall Study|Adverse Event|0|||
154979343|NCT00346164|559347410|FG001|Overall Study|Adverse Event|0|||
154979344|NCT00346164|559347411|FG002|Overall Study|Adverse Event|0|||
154979345|NCT00346164|559347412|FG003|Overall Study|Adverse Event|1|||
155114191|NCT00778258|559846264|FG004|Overall Study|Lost to Follow-up|0|||
154979346|NCT00346164|559347409|FG000|Overall Study|Lack of Efficacy|0|||
154979347|NCT00346164|559347410|FG001|Overall Study|Lack of Efficacy|1|||
154979348|NCT00346164|559347411|FG002|Overall Study|Lack of Efficacy|7|||
154896712|NCT00445341|559042598|FG000|Overall Study|refused further treatment|1|||
154896713|NCT00445341|559042598|FG000|Overall Study|taken off treatment too early|1|||
154896714|NCT03051217|559042599|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
154896715|NCT03051217|559042600|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
154896716|NCT03051217|559042601|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
154896717|NCT03051217|559042602|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
154896718|NCT03051217|559042603|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
154896719|NCT03051217|559042604|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
154896720|NCT03051217|559042605|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
154896721|NCT03051217|559042599|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
154896722|NCT03051217|559042600|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
154896723|NCT03051217|559042601|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
154896724|NCT03051217|559042602|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
154896725|NCT03051217|559042603|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
154896726|NCT03051217|559042604|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
154896727|NCT03051217|559042605|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
154896728|NCT03051217|559042599|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
154896729|NCT03051217|559042600|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
154896730|NCT03051217|559042601|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
154896731|NCT03051217|559042602|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
154896732|NCT03051217|559042603|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
154896733|NCT03051217|559042604|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
154896734|NCT03051217|559042605|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
154896735|NCT03051217|559042599|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
154896736|NCT03051217|559042600|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
154896737|NCT03051217|559042601|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
154896738|NCT03051217|559042602|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
154896739|NCT03051217|559042603|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
154896740|NCT03051217|559042604|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
154896741|NCT03051217|559042605|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
154896742|NCT03051217|559042599|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
154896743|NCT03051217|559042600|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
154896744|NCT03051217|559042601|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
154896745|NCT03051217|559042602|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
154896746|NCT03051217|559042603|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
154896747|NCT03051217|559042604|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
154896748|NCT03051217|559042605|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
154896749|NCT03051217|559042599|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
154896750|NCT03051217|559042600|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
154896751|NCT03051217|559042601|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
154896752|NCT03051217|559042602|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
154896753|NCT03051217|559042603|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
154896754|NCT03051217|559042604|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
154896755|NCT03051217|559042605|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
154896756|NCT03051217|559042599|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
154896757|NCT03051217|559042600|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
154896758|NCT03051217|559042601|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
154896759|NCT03051217|559042602|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
154896760|NCT03051217|559042603|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
154896761|NCT03051217|559042604|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
154896762|NCT03051217|559042605|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
154896763|NCT03051217|559042599|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
154896764|NCT03051217|559042600|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
154896765|NCT03051217|559042601|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
154896766|NCT03051217|559042602|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
154896767|NCT03051217|559042603|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
154896768|NCT03051217|559042604|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
154896769|NCT03051217|559042605|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
154896770|NCT01675141|559042606|FG000|Overall Study|Lenalidomide outside NIH|3|||
154896771|NCT01675141|559042606|FG000|Overall Study|Withdrawal by Subject|3|||
154896772|NCT01675141|559042606|FG000|Overall Study|Physician Decision|4|||
154896773|NCT01675141|559042606|FG000|Overall Study|No treatment, per protocol|1|||
154896774|NCT00109772|559042607|FG000|Double-blind Treatment|Adverse Event|14|||
154896775|NCT00109772|559042608|FG001|Double-blind Treatment|Adverse Event|5|||
154896776|NCT00109772|559042607|FG000|Double-blind Treatment|Lack of Efficacy|1|||
154979349|NCT00346164|559347412|FG003|Overall Study|Lack of Efficacy|25|||
154979350|NCT00346164|559347409|FG000|Overall Study|Physician Decision|0|||
154979351|NCT00346164|559347410|FG001|Overall Study|Physician Decision|1|||
154979352|NCT00346164|559347411|FG002|Overall Study|Physician Decision|2|||
154979353|NCT00346164|559347412|FG003|Overall Study|Physician Decision|27|||
154979354|NCT00346164|559347409|FG000|Overall Study|Protocol Violation|6|||
154979355|NCT00346164|559347410|FG001|Overall Study|Protocol Violation|2|||
154979356|NCT00346164|559347411|FG002|Overall Study|Protocol Violation|10|||
154979357|NCT00346164|559347412|FG003|Overall Study|Protocol Violation|4|||
154979358|NCT00346164|559347409|FG000|Overall Study|Withdrawal by Subject|0|||
154979359|NCT00346164|559347410|FG001|Overall Study|Withdrawal by Subject|0|||
154979360|NCT00346164|559347411|FG002|Overall Study|Withdrawal by Subject|2|||
154979361|NCT00346164|559347412|FG003|Overall Study|Withdrawal by Subject|0|||
154979362|NCT00346164|559347409|FG000|Overall Study|Ineligible|11|||
154979363|NCT00346164|559347410|FG001|Overall Study|Ineligible|2|||
154979364|NCT00346164|559347411|FG002|Overall Study|Ineligible|2|||
154979365|NCT00346164|559347412|FG003|Overall Study|Ineligible|23|||
154979366|NCT00346164|559347409|FG000|Overall Study|Refusal of further protocol therapy|0|||
154979367|NCT00346164|559347410|FG001|Overall Study|Refusal of further protocol therapy|1|||
154979368|NCT00346164|559347411|FG002|Overall Study|Refusal of further protocol therapy|3|||
154979369|NCT00346164|559347412|FG003|Overall Study|Refusal of further protocol therapy|15|||
154979370|NCT00346164|559347409|FG000|Overall Study|Inability to start week 16 tx on time|0|||
154979371|NCT00346164|559347410|FG001|Overall Study|Inability to start week 16 tx on time|0|||
154979372|NCT00346164|559347411|FG002|Overall Study|Inability to start week 16 tx on time|0|||
154979373|NCT00346164|559347412|FG003|Overall Study|Inability to start week 16 tx on time|11|||
154979374|NCT03139240|559347413|FG000|Overall Study|Lost to Follow-up|0|||
154979375|NCT03139240|559347414|FG001|Overall Study|Lost to Follow-up|1|||
154979376|NCT03139240|559347415|FG002|Overall Study|Lost to Follow-up|1|||
154979377|NCT03139240|559347416|FG003|Overall Study|Lost to Follow-up|0|||
154979378|NCT01955044|559347417|FG000|Overall Study|Death|1|||
154979379|NCT01955044|559347418|FG001|Overall Study|Death|1|||
154979380|NCT01955044|559347419|FG002|Overall Study|Death|0|||
154979381|NCT02260258|559347423|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
154979382|NCT02260258|559347424|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
154979383|NCT04232540|559347426|FG000|Overall Study|Lost to Follow-up|1|||
154979384|NCT04232540|559347427|FG001|Overall Study|Lost to Follow-up|0|||
154979385|NCT02105701|559347428|FG000|Overall Study|Lost to Follow-up|1|||
154979386|NCT02105701|559347429|FG001|Overall Study|Lost to Follow-up|0|||
154979387|NCT02105701|559347430|FG002|Overall Study|Lost to Follow-up|2|||
154979388|NCT02105701|559347431|FG003|Overall Study|Lost to Follow-up|1|||
154979389|NCT02105701|559347428|FG000|Overall Study|Protocol Violation|0|||
154979390|NCT02105701|559347429|FG001|Overall Study|Protocol Violation|0|||
154979391|NCT02105701|559347430|FG002|Overall Study|Protocol Violation|1|||
154979392|NCT02105701|559347431|FG003|Overall Study|Protocol Violation|0|||
154979393|NCT02105701|559347428|FG000|Overall Study|Withdrawal by Subject|2|||
154979394|NCT02105701|559347429|FG001|Overall Study|Withdrawal by Subject|1|||
154979395|NCT02105701|559347430|FG002|Overall Study|Withdrawal by Subject|0|||
154979396|NCT02105701|559347431|FG003|Overall Study|Withdrawal by Subject|1|||
154979397|NCT02105701|559347428|FG000|Overall Study|Death|1|||
154979398|NCT02105701|559347429|FG001|Overall Study|Death|0|||
154979399|NCT02105701|559347430|FG002|Overall Study|Death|0|||
155114192|NCT00778258|559846265|FG005|Overall Study|Lost to Follow-up|3|||
155114193|NCT00778258|559846266|FG006|Overall Study|Lost to Follow-up|2|||
155114194|NCT00778258|559846267|FG007|Overall Study|Lost to Follow-up|2|||
155114195|NCT00778258|559846268|FG008|Overall Study|Lost to Follow-up|0|||
155114196|NCT00778258|559846260|FG000|Overall Study|Withdrawal by Subject|6|||
155114197|NCT00778258|559846261|FG001|Overall Study|Withdrawal by Subject|2|||
155114198|NCT00778258|559846262|FG002|Overall Study|Withdrawal by Subject|8|||
155114199|NCT00778258|559846263|FG003|Overall Study|Withdrawal by Subject|2|||
154896777|NCT00109772|559042608|FG001|Double-blind Treatment|Lack of Efficacy|0|||
154896778|NCT00109772|559042607|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
154896779|NCT00109772|559042608|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
154896780|NCT00109772|559042607|FG000|Double-blind Treatment|Lost to Follow-up|2|||
154896781|NCT00109772|559042608|FG001|Double-blind Treatment|Lost to Follow-up|3|||
154896782|NCT00109772|559042607|FG000|Double-blind Treatment|Protocol Violation|0|||
154896783|NCT00109772|559042608|FG001|Double-blind Treatment|Protocol Violation|1|||
154896784|NCT00109772|559042607|FG000|Double-blind Treatment|Other|0|||
154896785|NCT00109772|559042608|FG001|Double-blind Treatment|Other|4|||
155114200|NCT00778258|559846264|FG004|Overall Study|Withdrawal by Subject|0|||
155114201|NCT00778258|559846265|FG005|Overall Study|Withdrawal by Subject|6|||
155114202|NCT00778258|559846266|FG006|Overall Study|Withdrawal by Subject|12|||
154979400|NCT02105701|559347431|FG003|Overall Study|Death|0|||
154979401|NCT03234608|559347432|FG000|Overall Study|Lost to Follow-up|23|||
154979402|NCT03234608|559347433|FG001|Overall Study|Lost to Follow-up|21|||
154979403|NCT03693950|559347434|FG000|Overall Study|Withdrawal by Subject|1|||
154979404|NCT03693950|559347435|FG001|Overall Study|Withdrawal by Subject|0|||
154979405|NCT01362296|559347436|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
154979406|NCT01362296|559347437|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
154979407|NCT01362296|559347438|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
154979408|NCT01362296|559347439|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
154979409|NCT01362296|559347436|FG000|Randomized Phase (RP)|Physician Decision|1|||
154979410|NCT01362296|559347437|FG001|Randomized Phase (RP)|Physician Decision|9|||
154979411|NCT01362296|559347438|FG002|Randomized Phase (RP)|Physician Decision|0|||
154979412|NCT01362296|559347439|FG003|Randomized Phase (RP)|Physician Decision|0|||
154979413|NCT01362296|559347436|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
154979414|NCT01362296|559347437|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
154979415|NCT01362296|559347438|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
154979416|NCT01362296|559347439|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
154979417|NCT01362296|559347436|FG000|Randomized Phase (RP)|Adverse Event|20|||
154979418|NCT01362296|559347437|FG001|Randomized Phase (RP)|Adverse Event|4|||
154979419|NCT01362296|559347438|FG002|Randomized Phase (RP)|Adverse Event|0|||
154979420|NCT01362296|559347439|FG003|Randomized Phase (RP)|Adverse Event|0|||
154979421|NCT01362296|559347436|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
154979422|NCT01362296|559347437|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
154979423|NCT01362296|559347438|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
154979424|NCT01362296|559347439|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
154979425|NCT01362296|559347436|FG000|Crossover Phase|PD including Death due to PD|0|||
154979426|NCT01362296|559347437|FG001|Crossover Phase|PD including Death due to PD|0|||
154979427|NCT01362296|559347438|FG002|Crossover Phase|PD including Death due to PD|16|||
154979428|NCT01362296|559347439|FG003|Crossover Phase|PD including Death due to PD|1|||
154979429|NCT01362296|559347436|FG000|Crossover Phase|Withdrawal by Subject|0|||
154979430|NCT01362296|559347437|FG001|Crossover Phase|Withdrawal by Subject|0|||
154979431|NCT01362296|559347438|FG002|Crossover Phase|Withdrawal by Subject|2|||
154979432|NCT01362296|559347439|FG003|Crossover Phase|Withdrawal by Subject|1|||
154979433|NCT01362296|559347436|FG000|Crossover Phase|Adverse Event|0|||
154979434|NCT01362296|559347437|FG001|Crossover Phase|Adverse Event|0|||
154979435|NCT01362296|559347438|FG002|Crossover Phase|Adverse Event|4|||
154979436|NCT01362296|559347439|FG003|Crossover Phase|Adverse Event|0|||
154979437|NCT01362296|559347436|FG000|Crossover Phase|Study Closed/Terminated|0|||
154979438|NCT01362296|559347437|FG001|Crossover Phase|Study Closed/Terminated|0|||
154979439|NCT01362296|559347438|FG002|Crossover Phase|Study Closed/Terminated|1|||
154979440|NCT01362296|559347439|FG003|Crossover Phase|Study Closed/Terminated|0|||
154979441|NCT04230876|559347441|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
154979442|NCT04230876|559347442|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
154979443|NCT01662362|559347443|FG000|Overall Study|Lost to Follow-up|38|||
154979444|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
154979445|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
154979446|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
154979447|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
154979448|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
154979449|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
154979450|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
154979451|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
154979452|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
154979453|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
154979454|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
154979455|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
154979456|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Death|0|||
155175651|NCT00869778|560080307|FG002|Overall Study|Adverse Event|0|||
155175652|NCT00869778|560080305|FG000|Overall Study|Withdrawal by Subject|3|||
154979457|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Death|1|||
154979458|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Death|0|||
154979459|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Death|0|||
154979460|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
154979461|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
154979462|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
154979463|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
154979464|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
154979465|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
154979466|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
154979467|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
154979468|NCT00545688|559347445|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
154979469|NCT00545688|559347446|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
154979470|NCT00545688|559347447|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
154979471|NCT00545688|559347448|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
154979472|NCT00545688|559347445|FG000|Adjuvant Treatment Period|Disease Progression|3|||
154979473|NCT00545688|559347446|FG001|Adjuvant Treatment Period|Disease Progression|3|||
154979474|NCT00545688|559347447|FG002|Adjuvant Treatment Period|Disease Progression|0|||
154979475|NCT00545688|559347448|FG003|Adjuvant Treatment Period|Disease Progression|7|||
154979476|NCT00545688|559347445|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
154979477|NCT00545688|559347446|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
154979478|NCT00545688|559347447|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
154979479|NCT00545688|559347448|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
154979480|NCT00545688|559347445|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
154979481|NCT00545688|559347446|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
154979482|NCT00545688|559347447|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
154979483|NCT00545688|559347448|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
154979484|NCT00545688|559347445|FG000|Adjuvant Treatment Period|Adverse Event|0|||
154979485|NCT00545688|559347446|FG001|Adjuvant Treatment Period|Adverse Event|3|||
154979486|NCT00545688|559347447|FG002|Adjuvant Treatment Period|Adverse Event|2|||
154979487|NCT00545688|559347448|FG003|Adjuvant Treatment Period|Adverse Event|2|||
154979488|NCT00545688|559347445|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
154979489|NCT00545688|559347446|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
154979490|NCT00545688|559347447|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
154979491|NCT00545688|559347448|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
154979492|NCT00545688|559347445|FG000|Follow-Up Period|Death|4|||
154979493|NCT00545688|559347446|FG001|Follow-Up Period|Death|2|||
154979494|NCT00545688|559347447|FG002|Follow-Up Period|Death|2|||
154979495|NCT00545688|559347448|FG003|Follow-Up Period|Death|6|||
154979496|NCT00545688|559347445|FG000|Follow-Up Period|Disease Progression|6|||
154979497|NCT00545688|559347446|FG001|Follow-Up Period|Disease Progression|5|||
154979498|NCT00545688|559347447|FG002|Follow-Up Period|Disease Progression|9|||
154979499|NCT00545688|559347448|FG003|Follow-Up Period|Disease Progression|9|||
154979500|NCT00545688|559347445|FG000|Follow-Up Period|Refused Treatment|6|||
154979501|NCT00545688|559347446|FG001|Follow-Up Period|Refused Treatment|2|||
154979502|NCT00545688|559347447|FG002|Follow-Up Period|Refused Treatment|0|||
154979503|NCT00545688|559347448|FG003|Follow-Up Period|Refused Treatment|2|||
154979504|NCT00545688|559347445|FG000|Follow-Up Period|Lost to Follow-up|3|||
154979505|NCT00545688|559347446|FG001|Follow-Up Period|Lost to Follow-up|3|||
154979506|NCT00545688|559347447|FG002|Follow-Up Period|Lost to Follow-up|3|||
154979507|NCT00545688|559347448|FG003|Follow-Up Period|Lost to Follow-up|1|||
154979508|NCT00545688|559347445|FG000|Follow-Up Period|Unspecified Reason|2|||
154979509|NCT00545688|559347446|FG001|Follow-Up Period|Unspecified Reason|5|||
154979510|NCT00545688|559347447|FG002|Follow-Up Period|Unspecified Reason|6|||
154979511|NCT00545688|559347448|FG003|Follow-Up Period|Unspecified Reason|8|||
154979512|NCT00545688|559347445|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
154979513|NCT00545688|559347446|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
154979514|NCT00545688|559347447|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
154979515|NCT00545688|559347448|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
154979516|NCT02339090|559347449|FG000|Overall Study|Adverse Event|1|||
154979517|NCT02339090|559347450|FG001|Overall Study|Adverse Event|0|||
154979518|NCT02339090|559347449|FG000|Overall Study|Lost to Follow-up|0|||
154979519|NCT02339090|559347450|FG001|Overall Study|Lost to Follow-up|1|||
154979520|NCT02339090|559347449|FG000|Overall Study|Non-compliance With Study Drug|0|||
154979521|NCT02339090|559347450|FG001|Overall Study|Non-compliance With Study Drug|1|||
154979522|NCT02339090|559347449|FG000|Overall Study|Withdrawal by Subject|2|||
154979523|NCT02339090|559347450|FG001|Overall Study|Withdrawal by Subject|1|||
154979524|NCT02339090|559347449|FG000|Overall Study|Poor Growth|3|||
154979525|NCT02339090|559347450|FG001|Overall Study|Poor Growth|0|||
154979526|NCT02339090|559347449|FG000|Overall Study|Randomized but not treated|0|||
154979527|NCT02339090|559347450|FG001|Overall Study|Randomized but not treated|2|||
154979528|NCT00248170|559347454|FG000|Overall Study|Withdrawal by Subject|71|||
154979529|NCT00248170|559347455|FG001|Overall Study|Withdrawal by Subject|79|||
154979530|NCT00248170|559347454|FG000|Overall Study|Protocol Violation|35|||
154979531|NCT00248170|559347455|FG001|Overall Study|Protocol Violation|30|||
154979532|NCT00248170|559347454|FG000|Overall Study|Lost to Follow-up|28|||
154979533|NCT00248170|559347455|FG001|Overall Study|Lost to Follow-up|35|||
154979534|NCT00248170|559347454|FG000|Overall Study|Disease progression|196|||
154979535|NCT00248170|559347455|FG001|Overall Study|Disease progression|216|||
154979536|NCT00248170|559347454|FG000|Overall Study|Death|28|||
154979537|NCT00248170|559347455|FG001|Overall Study|Death|47|||
154979538|NCT00248170|559347454|FG000|Overall Study|Adverse Event|311|||
154979539|NCT00248170|559347455|FG001|Overall Study|Adverse Event|296|||
154979540|NCT00248170|559347454|FG000|Overall Study|Administrative problems|22|||
154979541|NCT00248170|559347455|FG001|Overall Study|Administrative problems|25|||
154979542|NCT00248170|559347454|FG000|Overall Study|Abnormal test procedure(s) result|49|||
154979543|NCT00248170|559347455|FG001|Overall Study|Abnormal test procedure(s) result|61|||
154979544|NCT00248170|559347454|FG000|Overall Study|Abnormal laboratory values|4|||
154979545|NCT00248170|559347455|FG001|Overall Study|Abnormal laboratory values|0|||
154979546|NCT00248170|559347454|FG000|Overall Study|Protocol deviation|17|||
154979547|NCT00248170|559347455|FG001|Overall Study|Protocol deviation|19|||
154979548|NCT03581188|559349075|FG000|Overall Study|Inclusion criteria not met|3|||
154979549|NCT03581188|559349076|FG001|Overall Study|Inclusion criteria not met|2|||
154979550|NCT03581188|559349075|FG000|Overall Study|Lost to Follow-up|5|||
154896786|NCT00109772|559042607|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
154896787|NCT00109772|559042608|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
154896788|NCT00109772|559042607|FG000|Open-label Extension|Adverse Event|10|||
154896789|NCT00109772|559042608|FG001|Open-label Extension|Adverse Event|19|||
154896790|NCT00109772|559042607|FG000|Open-label Extension|Lack of Efficacy|19|||
154896791|NCT00109772|559042608|FG001|Open-label Extension|Lack of Efficacy|11|||
154896792|NCT00109772|559042607|FG000|Open-label Extension|Withdrawal by Subject|9|||
154896793|NCT00109772|559042608|FG001|Open-label Extension|Withdrawal by Subject|6|||
154896794|NCT00109772|559042607|FG000|Open-label Extension|Lost to Follow-up|1|||
154896795|NCT00109772|559042608|FG001|Open-label Extension|Lost to Follow-up|0|||
154896796|NCT00109772|559042607|FG000|Open-label Extension|Death|0|||
154896797|NCT00109772|559042608|FG001|Open-label Extension|Death|1|||
154896798|NCT00109772|559042607|FG000|Open-label Extension|Protocol Violation|2|||
154896799|NCT00109772|559042608|FG001|Open-label Extension|Protocol Violation|2|||
154896800|NCT00109772|559042607|FG000|Open-label Extension|Other|4|||
154896801|NCT00109772|559042608|FG001|Open-label Extension|Other|10|||
154896802|NCT01369225|559042610|FG000|Overall Study|Withdrawal by Subject|1|||
154896803|NCT01369225|559042611|FG001|Overall Study|Withdrawal by Subject|0|||
154896804|NCT01369225|559042612|FG002|Overall Study|Withdrawal by Subject|2|||
154896805|NCT01369225|559042613|FG003|Overall Study|Withdrawal by Subject|1|||
154896806|NCT01369225|559042614|FG004|Overall Study|Withdrawal by Subject|0|||
154896807|NCT01369225|559042615|FG005|Overall Study|Withdrawal by Subject|0|||
154896808|NCT01369225|559042610|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
154896809|NCT01369225|559042611|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
154896810|NCT01369225|559042612|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
154896811|NCT01369225|559042613|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
154896812|NCT01369225|559042614|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
154896813|NCT01369225|559042615|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
154896814|NCT01369225|559042610|FG000|Overall Study|Other|1|||
154896815|NCT01369225|559042611|FG001|Overall Study|Other|0|||
154896816|NCT01369225|559042612|FG002|Overall Study|Other|0|||
154896817|NCT01369225|559042613|FG003|Overall Study|Other|0|||
154896818|NCT01369225|559042614|FG004|Overall Study|Other|1|||
154896819|NCT01369225|559042615|FG005|Overall Study|Other|0|||
154896820|NCT01369225|559042610|FG000|Overall Study|Adverse Event|0|||
154896821|NCT01369225|559042611|FG001|Overall Study|Adverse Event|0|||
154896822|NCT01369225|559042612|FG002|Overall Study|Adverse Event|0|||
154896823|NCT01369225|559042613|FG003|Overall Study|Adverse Event|1|||
154896824|NCT01369225|559042614|FG004|Overall Study|Adverse Event|1|||
154896825|NCT01369225|559042615|FG005|Overall Study|Adverse Event|0|||
154896826|NCT00105183|559042619|FG000|Overall Study|Death|19|||
154896827|NCT00105183|559042620|FG001|Overall Study|Death|13|||
154896828|NCT00105183|559042621|FG002|Overall Study|Death|15|||
154896829|NCT00105183|559042619|FG000|Overall Study|Withdrawal by Subject|1|||
154896830|NCT00105183|559042620|FG001|Overall Study|Withdrawal by Subject|1|||
154896831|NCT00105183|559042621|FG002|Overall Study|Withdrawal by Subject|4|||
154896832|NCT00105183|559042619|FG000|Overall Study|Physician Decision|1|||
154896833|NCT00105183|559042620|FG001|Overall Study|Physician Decision|2|||
154896834|NCT00105183|559042621|FG002|Overall Study|Physician Decision|3|||
154896835|NCT00105183|559042619|FG000|Overall Study|Lost to Follow-up|0|||
154896836|NCT00105183|559042620|FG001|Overall Study|Lost to Follow-up|1|||
154896837|NCT00105183|559042621|FG002|Overall Study|Lost to Follow-up|1|||
154896838|NCT00105183|559042619|FG000|Overall Study|Other reason|1|||
154896839|NCT00105183|559042620|FG001|Overall Study|Other reason|2|||
154896840|NCT00105183|559042621|FG002|Overall Study|Other reason|0|||
154896841|NCT00792701|559042622|FG000|Overall Study|Adverse Event|0|||
154896842|NCT00792701|559042623|FG001|Overall Study|Adverse Event|22|||
154896843|NCT00792701|559042622|FG000|Overall Study|Ineligible|1|||
154896844|NCT00792701|559042623|FG001|Overall Study|Ineligible|3|||
154896845|NCT00792701|559042622|FG000|Overall Study|Withdrawal by Subject|1|||
154896846|NCT00792701|559042623|FG001|Overall Study|Withdrawal by Subject|19|||
154896847|NCT00792701|559042622|FG000|Overall Study|Not protocol specified|17|||
154896848|NCT00792701|559042623|FG001|Overall Study|Not protocol specified|0|||
155114203|NCT00778258|559846267|FG007|Overall Study|Withdrawal by Subject|12|||
155114204|NCT00778258|559846268|FG008|Overall Study|Withdrawal by Subject|4|||
155114205|NCT00778258|559846260|FG000|Overall Study|New Contraindication|0|||
154896849|NCT05507580|559042624|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
154896850|NCT05507580|559042625|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
154896851|NCT05507580|559042626|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
154896852|NCT05507580|559042627|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
154896853|NCT05507580|559042628|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
154896854|NCT05507580|559042629|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
154896855|NCT05507580|559042624|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
154896856|NCT05507580|559042625|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
154896857|NCT05507580|559042626|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154896858|NCT05507580|559042627|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154979551|NCT03581188|559349076|FG001|Overall Study|Lost to Follow-up|5|||
154979552|NCT03581188|559349075|FG000|Overall Study|Discontinued intervention|11|||
154896859|NCT05507580|559042628|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154896860|NCT05507580|559042629|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
154896861|NCT05507580|559042624|FG000|Double-Blind Treatment Period|Other, not specified|5|||
154896862|NCT05507580|559042625|FG001|Double-Blind Treatment Period|Other, not specified|4|||
154896863|NCT05507580|559042626|FG002|Double-Blind Treatment Period|Other, not specified|0|||
154896864|NCT05507580|559042627|FG003|Double-Blind Treatment Period|Other, not specified|0|||
154896865|NCT05507580|559042628|FG004|Double-Blind Treatment Period|Other, not specified|0|||
154896866|NCT05507580|559042629|FG005|Double-Blind Treatment Period|Other, not specified|0|||
154896867|NCT05507580|559042624|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
154896868|NCT05507580|559042625|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
154896869|NCT05507580|559042626|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
154896870|NCT05507580|559042627|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
154896871|NCT05507580|559042628|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
154896872|NCT05507580|559042629|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
154896873|NCT05507580|559042624|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
154896874|NCT05507580|559042625|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
154896875|NCT05507580|559042626|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
154896876|NCT05507580|559042627|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
154896877|NCT05507580|559042628|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
154896878|NCT05507580|559042629|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
154896879|NCT05507580|559042624|FG000|Single-Blind Treatment Period|Other, not specified|0|||
154896880|NCT05507580|559042625|FG001|Single-Blind Treatment Period|Other, not specified|0|||
154896881|NCT05507580|559042626|FG002|Single-Blind Treatment Period|Other, not specified|2|||
154896882|NCT05507580|559042627|FG003|Single-Blind Treatment Period|Other, not specified|7|||
154896883|NCT05507580|559042628|FG004|Single-Blind Treatment Period|Other, not specified|3|||
154896884|NCT05507580|559042629|FG005|Single-Blind Treatment Period|Other, not specified|5|||
154896885|NCT00615914|559042633|FG000|Overall Study|Adverse Event|274|||
154896886|NCT00615914|559042633|FG000|Overall Study|Death|20|||
154896887|NCT00615914|559042633|FG000|Overall Study|Lack of Efficacy|59|||
154896888|NCT00615914|559042633|FG000|Overall Study|Lost to Follow-up|187|||
154896889|NCT00615914|559042633|FG000|Overall Study|Withdrawal by Subject|16|||
154896890|NCT00615914|559042633|FG000|Overall Study|Physician Decision|4|||
154896891|NCT00615914|559042633|FG000|Overall Study|No data was collected.|65|||
154896892|NCT00615914|559042633|FG000|Overall Study|No treatment|2|||
154896893|NCT00615914|559042633|FG000|Overall Study|Irregularly enrolled patients|10|||
154896894|NCT03673956|559042634|FG000|Overall Study|Lost to Follow-up|1|||
154896895|NCT03673956|559042635|FG001|Overall Study|Lost to Follow-up|0|||
154896896|NCT03673956|559042636|FG002|Overall Study|Lost to Follow-up|0|||
154896897|NCT03673956|559042637|FG003|Overall Study|Lost to Follow-up|0|||
154896898|NCT03673956|559042634|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
154896899|NCT03673956|559042635|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
154896900|NCT03673956|559042636|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
154896901|NCT03673956|559042637|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
154896902|NCT01117012|559042643|FG000|Overall Study|Adverse Event|0|||
154896903|NCT01117012|559042644|FG001|Overall Study|Adverse Event|1|||
154896904|NCT01117012|559042643|FG000|Overall Study|Death|1|||
154896905|NCT01117012|559042644|FG001|Overall Study|Death|1|||
154896906|NCT01117012|559042643|FG000|Overall Study|Withdrawal by Subject|3|||
154896907|NCT01117012|559042644|FG001|Overall Study|Withdrawal by Subject|0|||
154896908|NCT01117012|559042643|FG000|Overall Study|Undefined|4|||
154896909|NCT01117012|559042644|FG001|Overall Study|Undefined|3|||
154896910|NCT00844285|559042645|FG000|Overall Study|Other|0|||
154896911|NCT00844285|559042646|FG001|Overall Study|Other|1|||
154896912|NCT00844285|559042647|FG002|Overall Study|Other|0|||
154896913|NCT00844285|559042645|FG000|Overall Study|Other than specified|95|||
154896914|NCT00844285|559042646|FG001|Overall Study|Other than specified|129|||
154896915|NCT00844285|559042647|FG002|Overall Study|Other than specified|12|||
154896916|NCT00844285|559042645|FG000|Overall Study|Site closure|256|||
154896917|NCT00844285|559042646|FG001|Overall Study|Site closure|450|||
154896918|NCT00844285|559042647|FG002|Overall Study|Site closure|50|||
154896919|NCT00844285|559042645|FG000|Overall Study|Follow-up < 8 years|16|||
154896920|NCT00844285|559042646|FG001|Overall Study|Follow-up < 8 years|23|||
154896921|NCT00844285|559042647|FG002|Overall Study|Follow-up < 8 years|4|||
154896922|NCT00844285|559042645|FG000|Overall Study|Protocol Violation|26|||
154896923|NCT00844285|559042646|FG001|Overall Study|Protocol Violation|28|||
154896924|NCT00844285|559042647|FG002|Overall Study|Protocol Violation|54|||
154979553|NCT03581188|559349076|FG001|Overall Study|Discontinued intervention|8|||
154979554|NCT01619579|559349079|FG000|Overall Study|Withdrawal by Subject|0|||
154979555|NCT01619579|559349080|FG001|Overall Study|Withdrawal by Subject|3|||
154979556|NCT01684215|559349082|FG000|Phase 1, Part 1|Adverse Event|1|||
154979557|NCT01684215|559349083|FG001|Phase 1, Part 1|Adverse Event|0|||
154979558|NCT01684215|559349084|FG002|Phase 1, Part 1|Adverse Event|0|||
154979559|NCT01684215|559349085|FG003|Phase 1, Part 1|Adverse Event|0|||
154979560|NCT01684215|559349082|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
155114206|NCT00778258|559846261|FG001|Overall Study|New Contraindication|0|||
155114207|NCT00778258|559846262|FG002|Overall Study|New Contraindication|0|||
155114208|NCT00778258|559846263|FG003|Overall Study|New Contraindication|0|||
154896925|NCT00844285|559042645|FG000|Overall Study|Death|22|||
154896926|NCT00844285|559042646|FG001|Overall Study|Death|21|||
154896927|NCT00844285|559042647|FG002|Overall Study|Death|8|||
154896928|NCT00844285|559042645|FG000|Overall Study|Withdrew Consent|344|||
154896929|NCT00844285|559042646|FG001|Overall Study|Withdrew Consent|466|||
154896930|NCT00844285|559042647|FG002|Overall Study|Withdrew Consent|70|||
154896931|NCT00844285|559042645|FG000|Overall Study|Lost to Follow-up|330|||
154896932|NCT00844285|559042646|FG001|Overall Study|Lost to Follow-up|486|||
154896933|NCT00844285|559042647|FG002|Overall Study|Lost to Follow-up|74|||
154896934|NCT05425719|559042648|FG000|Overall Study|Lost to Follow-up|4|||
154896935|NCT05425719|559042649|FG001|Overall Study|Lost to Follow-up|0|||
154896936|NCT05425719|559042648|FG000|Overall Study|Withdrew consent|1|||
154896937|NCT05425719|559042649|FG001|Overall Study|Withdrew consent|1|||
154896938|NCT01033487|559042652|FG000|Fourth Intervention Period|Adverse Event|0|||
154896939|NCT01033487|559042653|FG001|Fourth Intervention Period|Adverse Event|0|||
154896940|NCT01033487|559042654|FG002|Fourth Intervention Period|Adverse Event|0|||
154896941|NCT01033487|559042655|FG003|Fourth Intervention Period|Adverse Event|0|||
154896942|NCT01033487|559042656|FG004|Fourth Intervention Period|Adverse Event|0|||
154896943|NCT01033487|559042657|FG005|Fourth Intervention Period|Adverse Event|0|||
154896944|NCT01033487|559042658|FG006|Fourth Intervention Period|Adverse Event|0|||
154896945|NCT01033487|559042659|FG007|Fourth Intervention Period|Adverse Event|0|||
154896946|NCT01033487|559042660|FG008|Fourth Intervention Period|Adverse Event|1|||
154896947|NCT01033487|559042661|FG009|Fourth Intervention Period|Adverse Event|0|||
154896948|NCT02193828|559042662|FG000|Overall Study|Withdrawal by Subject|0|||
154896949|NCT02193828|559042663|FG001|Overall Study|Withdrawal by Subject|0|||
154896950|NCT02193828|559042664|FG002|Overall Study|Withdrawal by Subject|1|||
154896951|NCT02193828|559042665|FG003|Overall Study|Withdrawal by Subject|1|||
154896952|NCT00889681|559042666|FG000|Overall Study|Not meeting qualification Criteria|2|||
154896953|NCT00889681|559042666|FG000|Overall Study|Insurance disapproval|1|||
154896954|NCT01957787|559042667|FG000|Overall Study|Death|18|||
154896955|NCT01957787|559042667|FG000|Overall Study|Lost to Follow-up|3|||
154896956|NCT01957787|559042667|FG000|Overall Study|Withdrawal by Subject|3|||
154896957|NCT01957787|559042667|FG000|Overall Study|Entered Hospice or Similar Program|2|||
154896958|NCT01957787|559042667|FG000|Overall Study|Index Tumor(s) Resected|2|||
154896959|NCT01957787|559042667|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
154896960|NCT01957787|559042667|FG000|Overall Study|Local therapy, not cryoablation|6|||
154896961|NCT03954444|559042668|FG000|Overall Study|Withdrawal by Subject|5|||
154896962|NCT03954444|559042669|FG001|Overall Study|Withdrawal by Subject|5|||
154896963|NCT03954444|559042670|FG002|Overall Study|Withdrawal by Subject|5|||
154896964|NCT03954444|559042668|FG000|Overall Study|Adverse Event|1|||
154896965|NCT03954444|559042669|FG001|Overall Study|Adverse Event|3|||
154896966|NCT03954444|559042670|FG002|Overall Study|Adverse Event|2|||
154896967|NCT03954444|559042668|FG000|Overall Study|Protocol Violation|0|||
154896968|NCT03954444|559042669|FG001|Overall Study|Protocol Violation|3|||
154896969|NCT03954444|559042670|FG002|Overall Study|Protocol Violation|5|||
154896970|NCT03954444|559042668|FG000|Overall Study|Use of prohibited therapy|1|||
154896971|NCT03954444|559042669|FG001|Overall Study|Use of prohibited therapy|1|||
154896972|NCT03954444|559042670|FG002|Overall Study|Use of prohibited therapy|2|||
154896973|NCT03954444|559042668|FG000|Overall Study|Lost to Follow-up|1|||
154896974|NCT03954444|559042669|FG001|Overall Study|Lost to Follow-up|0|||
154896975|NCT03954444|559042670|FG002|Overall Study|Lost to Follow-up|1|||
154896976|NCT03954444|559042668|FG000|Overall Study|Non-compliant with study drug application|2|||
154896977|NCT03954444|559042669|FG001|Overall Study|Non-compliant with study drug application|2|||
155114209|NCT00778258|559846264|FG004|Overall Study|New Contraindication|0|||
154896978|NCT03954444|559042670|FG002|Overall Study|Non-compliant with study drug application|0|||
154896979|NCT03954444|559042668|FG000|Overall Study|Administrative reasons|0|||
154896980|NCT03954444|559042669|FG001|Overall Study|Administrative reasons|0|||
154896981|NCT03954444|559042670|FG002|Overall Study|Administrative reasons|1|||
154896982|NCT03954444|559042668|FG000|Overall Study|Miscellaneous|3|||
154896983|NCT03954444|559042669|FG001|Overall Study|Miscellaneous|2|||
154896984|NCT03954444|559042670|FG002|Overall Study|Miscellaneous|1|||
154896985|NCT03094832|559042673|FG000|Overall Study|Lost to Follow-up|0|||
154896986|NCT03094832|559042674|FG001|Overall Study|Lost to Follow-up|0|||
154896987|NCT03094832|559042675|FG002|Overall Study|Lost to Follow-up|0|||
154896988|NCT03094832|559042676|FG003|Overall Study|Lost to Follow-up|1|||
154896989|NCT03094832|559042677|FG004|Overall Study|Lost to Follow-up|1|||
154896990|NCT03094832|559042673|FG000|Overall Study|Death|1|||
154896991|NCT03094832|559042674|FG001|Overall Study|Death|0|||
155114210|NCT00778258|559846265|FG005|Overall Study|New Contraindication|0|||
155114211|NCT00778258|559846266|FG006|Overall Study|New Contraindication|0|||
155114212|NCT00778258|559846267|FG007|Overall Study|New Contraindication|1|||
154896992|NCT03094832|559042675|FG002|Overall Study|Death|0|||
155114213|NCT00778258|559846268|FG008|Overall Study|New Contraindication|0|||
155114214|NCT00778258|559846260|FG000|Overall Study|Non-compliance|0|||
155114215|NCT00778258|559846261|FG001|Overall Study|Non-compliance|0|||
155114216|NCT00778258|559846262|FG002|Overall Study|Non-compliance|0|||
155114217|NCT00778258|559846263|FG003|Overall Study|Non-compliance|1|||
155114218|NCT00778258|559846264|FG004|Overall Study|Non-compliance|0|||
155114219|NCT00778258|559846265|FG005|Overall Study|Non-compliance|0|||
155114220|NCT00778258|559846266|FG006|Overall Study|Non-compliance|0|||
155114221|NCT00778258|559846267|FG007|Overall Study|Non-compliance|0|||
155114222|NCT00778258|559846268|FG008|Overall Study|Non-compliance|0|||
155114223|NCT00778258|559846260|FG000|Overall Study|Other|0|||
155114224|NCT00778258|559846261|FG001|Overall Study|Other|0|||
154896993|NCT03094832|559042676|FG003|Overall Study|Death|0|||
154896994|NCT03094832|559042677|FG004|Overall Study|Death|0|||
154896995|NCT03094832|559042673|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
154896996|NCT03094832|559042674|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
154896997|NCT03094832|559042675|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
154896998|NCT03094832|559042676|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
154896999|NCT03094832|559042677|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
154897000|NCT03094832|559042673|FG000|Overall Study|Other|13|||
154897001|NCT03094832|559042674|FG001|Overall Study|Other|20|||
154897002|NCT03094832|559042675|FG002|Overall Study|Other|1|||
154897003|NCT03094832|559042676|FG003|Overall Study|Other|7|||
154897004|NCT03094832|559042677|FG004|Overall Study|Other|1|||
154897005|NCT00788697|559042684|FG000|Overall Study|No study drug administered|12|||
154897006|NCT00788697|559042684|FG000|Overall Study|Training Patients|74|||
154897007|NCT00788697|559042684|FG000|Overall Study|no truth standard procedure available|5|||
154897008|NCT00788697|559042684|FG000|Overall Study|Technically inadequate truth standard|1|||
154897009|NCT00788697|559042684|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
154897010|NCT00903370|559042685|FG000|Overall Study|Death|13|||
154897011|NCT00903370|559042686|FG001|Overall Study|Death|10|||
154897012|NCT00903370|559042685|FG000|Overall Study|Withdrawal by Subject|9|||
154897013|NCT00903370|559042686|FG001|Overall Study|Withdrawal by Subject|6|||
154897014|NCT00903370|559042685|FG000|Overall Study|Lost to Follow-up|6|||
154897015|NCT00903370|559042686|FG001|Overall Study|Lost to Follow-up|8|||
154897016|NCT00367432|559042687|FG000|First Period (16 Weeks)|Adverse Event|6|||
154897017|NCT00367432|559042688|FG001|First Period (16 Weeks)|Adverse Event|0|||
154897018|NCT00367432|559042687|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
154897019|NCT00367432|559042688|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
154897020|NCT00367432|559042687|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
154897021|NCT00367432|559042688|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
154897022|NCT00367432|559042687|FG000|First Period (16 Weeks)|Other Reason|2|||
154897023|NCT00367432|559042688|FG001|First Period (16 Weeks)|Other Reason|0|||
154897024|NCT00367432|559042687|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
154897025|NCT00367432|559042688|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
154897026|NCT00367432|559042687|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
154897027|NCT00367432|559042688|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
154897028|NCT00367432|559042687|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
154897029|NCT00367432|559042688|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
154897030|NCT00367432|559042687|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
154897031|NCT00367432|559042688|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
154897032|NCT00367432|559042687|FG000|Second Period (up to 54 Months)|Other Reason|6|||
154897033|NCT00367432|559042688|FG001|Second Period (up to 54 Months)|Other Reason|2|||
154897034|NCT00014911|559042689|FG000|Overall Study|Adverse Event|1|||
154897035|NCT00014911|559042689|FG000|Overall Study|Lost to Follow-up|1|||
154897036|NCT00014911|559042689|FG000|Overall Study|Withdrawal by Subject|6|||
154897037|NCT00014911|559042689|FG000|Overall Study|Unknown Reasons|2|||
154897038|NCT00014911|559042689|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
154979561|NCT01684215|559349083|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
155114225|NCT00778258|559846262|FG002|Overall Study|Other|0|||
155114226|NCT00778258|559846263|FG003|Overall Study|Other|0|||
154897039|NCT00345540|559042692|FG000|Overall Study|Withdrawal by Subject|1|||
154979562|NCT01684215|559349084|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
155114227|NCT00778258|559846264|FG004|Overall Study|Other|0|||
155114228|NCT00778258|559846265|FG005|Overall Study|Other|0|||
155114229|NCT00778258|559846266|FG006|Overall Study|Other|1|||
154897040|NCT04179786|559042693|FG000|Overall Study|Withdrawal by Subject|8|||
154897041|NCT01938001|559042694|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
154897042|NCT01938001|559042695|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
155114230|NCT00778258|559846267|FG007|Overall Study|Other|0|||
155114231|NCT00778258|559846268|FG008|Overall Study|Other|0|||
155114232|NCT00780143|559846269|FG000|Overall Study|Progressive disease|1|||
155114233|NCT00780143|559846269|FG000|Overall Study|Toxicity|1|||
155114234|NCT00780143|559846269|FG000|Overall Study|Adverse Event|1|||
155114235|NCT02644096|559846272|FG000|Overall Study|Withdrawal by Subject|28|||
154897043|NCT01938001|559042694|FG000|Pre-Treatment|Death|1|||
154897044|NCT01938001|559042695|FG001|Pre-Treatment|Death|0|||
154979563|NCT01684215|559349085|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
154979564|NCT01684215|559349082|FG000|Phase 1, Part 2|Adverse Event|0|||
154979565|NCT01684215|559349083|FG001|Phase 1, Part 2|Adverse Event|0|||
154979566|NCT01684215|559349084|FG002|Phase 1, Part 2|Adverse Event|1|||
154979567|NCT01684215|559349085|FG003|Phase 1, Part 2|Adverse Event|0|||
154979568|NCT01684215|559349082|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
154979569|NCT01684215|559349083|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
154979570|NCT01684215|559349084|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
154979571|NCT01684215|559349085|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
154979572|NCT01684215|559349082|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
154979573|NCT01684215|559349083|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
154979574|NCT01684215|559349084|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
154979575|NCT01684215|559349085|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
154979576|NCT01684215|559349082|FG000|Phase 2|Death|0|||
154979577|NCT01684215|559349083|FG001|Phase 2|Death|0|||
154979578|NCT01684215|559349084|FG002|Phase 2|Death|0|||
154979579|NCT01684215|559349085|FG003|Phase 2|Death|8|||
154979580|NCT01684215|559349082|FG000|Phase 2|Study terminated by sponsor|0|||
154979581|NCT01684215|559349083|FG001|Phase 2|Study terminated by sponsor|0|||
154979582|NCT01684215|559349084|FG002|Phase 2|Study terminated by sponsor|0|||
154979583|NCT01684215|559349085|FG003|Phase 2|Study terminated by sponsor|30|||
154979584|NCT01684215|559349082|FG000|Phase 2|Enrolled but not treated|0|||
154979585|NCT01684215|559349083|FG001|Phase 2|Enrolled but not treated|0|||
154979586|NCT01684215|559349084|FG002|Phase 2|Enrolled but not treated|0|||
154979587|NCT01684215|559349085|FG003|Phase 2|Enrolled but not treated|1|||
154979588|NCT01684215|559349082|FG000|Phase 2|Lost to Follow-up|0|||
154979589|NCT01684215|559349083|FG001|Phase 2|Lost to Follow-up|0|||
154979590|NCT01684215|559349084|FG002|Phase 2|Lost to Follow-up|0|||
154979591|NCT01684215|559349085|FG003|Phase 2|Lost to Follow-up|4|||
154979592|NCT04039919|559349089|FG000|Treatment Period 1|Withdrawal by Subject|1|||
154979593|NCT04039919|559349090|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155114236|NCT02644096|559846273|FG001|Overall Study|Withdrawal by Subject|25|||
155114237|NCT02461290|559846274|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
154979594|NCT04039919|559349091|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154979595|NCT04039919|559349092|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154979596|NCT04039919|559349093|FG004|Treatment Period 1|Withdrawal by Subject|0|||
154979597|NCT04039919|559349089|FG000|Treatment Period 1|Sponsor's decision|0|||
154979598|NCT04039919|559349090|FG001|Treatment Period 1|Sponsor's decision|0|||
154979599|NCT04039919|559349091|FG002|Treatment Period 1|Sponsor's decision|0|||
154979600|NCT04039919|559349092|FG003|Treatment Period 1|Sponsor's decision|0|||
154979601|NCT04039919|559349093|FG004|Treatment Period 1|Sponsor's decision|16|||
154979602|NCT04039919|559349089|FG000|Treatment Period 5|Withdrawal by Subject|1|||
154979603|NCT04039919|559349090|FG001|Treatment Period 5|Withdrawal by Subject|0|||
154979604|NCT04039919|559349091|FG002|Treatment Period 5|Withdrawal by Subject|0|||
154979605|NCT04039919|559349092|FG003|Treatment Period 5|Withdrawal by Subject|0|||
154979606|NCT04039919|559349093|FG004|Treatment Period 5|Withdrawal by Subject|0|||
154979607|NCT00983918|559349098|FG000|Overall Study|conversion to open cholecystectomy|0|||
154979608|NCT00983918|559349099|FG001|Overall Study|conversion to open cholecystectomy|2|||
154979609|NCT00983918|559349100|FG002|Overall Study|conversion to open cholecystectomy|2|||
154979610|NCT00983918|559349101|FG003|Overall Study|conversion to open cholecystectomy|2|||
154979611|NCT03250299|559349105|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
155114238|NCT02461290|559846274|FG000|Overall Study|Lost to Follow-up|3|||
155114239|NCT00322452|559846275|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155114240|NCT00322452|559846276|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155114241|NCT00322452|559846275|FG000|Overall Study|Lost to Follow-up|5|||
155114242|NCT00322452|559846276|FG001|Overall Study|Lost to Follow-up|2|||
155114243|NCT00322452|559846275|FG000|Overall Study|Withdrawal by Subject|19|||
155114244|NCT00322452|559846276|FG001|Overall Study|Withdrawal by Subject|46|||
154979612|NCT03250299|559349106|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
154979613|NCT03250299|559349107|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
154979614|NCT03250299|559349108|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
154979615|NCT03250299|559349109|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
154979616|NCT03250299|559349105|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
154979617|NCT03250299|559349106|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
154979618|NCT03250299|559349107|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
154979619|NCT03250299|559349108|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
154979620|NCT03250299|559349109|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
154979621|NCT03250299|559349105|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
154979622|NCT03250299|559349106|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
154979623|NCT03250299|559349107|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
154979624|NCT03250299|559349108|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
154979625|NCT03250299|559349109|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
154979626|NCT03250299|559349105|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
154979627|NCT03250299|559349106|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
154979628|NCT03250299|559349107|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
155114245|NCT00322452|559846275|FG000|Overall Study|Death|223|||
155175653|NCT00869778|560080306|FG001|Overall Study|Withdrawal by Subject|4|||
155175654|NCT00869778|560080307|FG002|Overall Study|Withdrawal by Subject|5|||
155175655|NCT00869778|560080305|FG000|Overall Study|Pregnancy|1|||
155175656|NCT00869778|560080306|FG001|Overall Study|Pregnancy|0|||
155175657|NCT00869778|560080307|FG002|Overall Study|Pregnancy|0|||
154897045|NCT01938001|559042694|FG000|Treatment|Death|2|||
154897046|NCT01938001|559042695|FG001|Treatment|Death|0|||
154897047|NCT01938001|559042694|FG000|Treatment|Adverse Event|14|||
154897048|NCT01938001|559042695|FG001|Treatment|Adverse Event|8|||
154897049|NCT01938001|559042694|FG000|Treatment|Progressive Disease|21|||
154897050|NCT01938001|559042695|FG001|Treatment|Progressive Disease|54|||
154897051|NCT01938001|559042694|FG000|Treatment|Withdrawal by Subject|13|||
154897052|NCT01938001|559042695|FG001|Treatment|Withdrawal by Subject|7|||
154897053|NCT01938001|559042694|FG000|Treatment|Other reasons|2|||
154897054|NCT01938001|559042695|FG001|Treatment|Other reasons|1|||
154897055|NCT03310580|559042696|FG000|Overall Study|Adverse Event|0|||
154897056|NCT03310580|559042697|FG001|Overall Study|Adverse Event|1|||
154897057|NCT03310580|559042698|FG002|Overall Study|Adverse Event|0|||
154897058|NCT03205982|559042705|FG000|Overall Study|Lost to Follow-up|20|||
154897059|NCT03205982|559042706|FG001|Overall Study|Lost to Follow-up|19|||
154897060|NCT03205982|559042705|FG000|Overall Study|Withdrawal by Subject|4|||
154897061|NCT03205982|559042706|FG001|Overall Study|Withdrawal by Subject|3|||
154897062|NCT03205982|559042705|FG000|Overall Study|Withdrawal by PI|0|||
154897063|NCT03205982|559042706|FG001|Overall Study|Withdrawal by PI|1|||
154897064|NCT02983799|559042709|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
154897065|NCT02983799|559042710|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
154897066|NCT02983799|559042711|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
154897067|NCT02983799|559042712|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
154897068|NCT02983799|559042713|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
154897069|NCT02983799|559042709|FG000|Overall Study|Death|20|||
154897070|NCT02983799|559042710|FG001|Overall Study|Death|5|||
154897071|NCT02983799|559042711|FG002|Overall Study|Death|23|||
154897072|NCT02983799|559042712|FG003|Overall Study|Death|47|||
154897073|NCT02983799|559042713|FG004|Overall Study|Death|7|||
154897074|NCT02983799|559042709|FG000|Overall Study|Withdrawal by Subject|1|||
154897075|NCT02983799|559042710|FG001|Overall Study|Withdrawal by Subject|0|||
154897076|NCT02983799|559042711|FG002|Overall Study|Withdrawal by Subject|3|||
154897077|NCT02983799|559042712|FG003|Overall Study|Withdrawal by Subject|4|||
154897078|NCT02983799|559042713|FG004|Overall Study|Withdrawal by Subject|1|||
154897079|NCT02983799|559042709|FG000|Overall Study|Protocol Violation|0|||
154897080|NCT02983799|559042710|FG001|Overall Study|Protocol Violation|1|||
154897081|NCT02983799|559042711|FG002|Overall Study|Protocol Violation|0|||
154897082|NCT02983799|559042712|FG003|Overall Study|Protocol Violation|0|||
154897083|NCT02983799|559042713|FG004|Overall Study|Protocol Violation|1|||
154897084|NCT02983799|559042709|FG000|Overall Study|Lost to Follow-up|1|||
154897085|NCT02983799|559042710|FG001|Overall Study|Lost to Follow-up|0|||
154897086|NCT02983799|559042711|FG002|Overall Study|Lost to Follow-up|1|||
154897087|NCT02983799|559042712|FG003|Overall Study|Lost to Follow-up|0|||
154897088|NCT02983799|559042713|FG004|Overall Study|Lost to Follow-up|0|||
154897089|NCT01626989|559042724|FG000|Screening Period|Screen Failure|15|||
154897090|NCT01626989|559042725|FG001|Screening Period|Screen Failure|0|||
154897091|NCT01626989|559042726|FG002|Screening Period|Screen Failure|0|||
154897092|NCT01626989|559042724|FG000|Screening Period|Withdrawal by Subject|2|||
154897093|NCT01626989|559042725|FG001|Screening Period|Withdrawal by Subject|0|||
154897094|NCT01626989|559042726|FG002|Screening Period|Withdrawal by Subject|0|||
154897095|NCT02293902|559042735|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
154897096|NCT02293902|559042736|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
154897097|NCT02293902|559042737|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
154897098|NCT02293902|559042738|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
154897099|NCT02293902|559042739|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
154897100|NCT02293902|559042735|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
154897101|NCT02293902|559042736|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
154897102|NCT02293902|559042737|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
154897103|NCT02293902|559042738|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
154897104|NCT02293902|559042739|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
154897105|NCT02293902|559042735|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
154897106|NCT02293902|559042736|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
154897107|NCT02293902|559042737|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
154897108|NCT02293902|559042738|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
154897109|NCT02293902|559042739|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
154897110|NCT02293902|559042735|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
154897111|NCT02293902|559042736|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
154897112|NCT02293902|559042737|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
154979629|NCT03250299|559349108|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
154979630|NCT03250299|559349109|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
154979631|NCT03346070|559349110|FG000|Overall Study|Death|0|||
154979632|NCT03346070|559349111|FG001|Overall Study|Death|0|||
154979633|NCT03346070|559349112|FG002|Overall Study|Death|0|||
154979634|NCT03346070|559349113|FG003|Overall Study|Death|0|||
154979635|NCT03346070|559349114|FG004|Overall Study|Death|1|||
154979636|NCT03346070|559349110|FG000|Overall Study|Lost to Follow-up|0|||
154979637|NCT03346070|559349111|FG001|Overall Study|Lost to Follow-up|1|||
154979638|NCT03346070|559349112|FG002|Overall Study|Lost to Follow-up|2|||
154979639|NCT03346070|559349113|FG003|Overall Study|Lost to Follow-up|0|||
154979640|NCT03346070|559349114|FG004|Overall Study|Lost to Follow-up|0|||
154979641|NCT03346070|559349110|FG000|Overall Study|Physician Decision|0|||
154979642|NCT03346070|559349111|FG001|Overall Study|Physician Decision|0|||
154979643|NCT03346070|559349112|FG002|Overall Study|Physician Decision|0|||
154979644|NCT03346070|559349113|FG003|Overall Study|Physician Decision|1|||
154979645|NCT03346070|559349114|FG004|Overall Study|Physician Decision|1|||
154979646|NCT03346070|559349110|FG000|Overall Study|Withdrawal by Subject|1|||
154979647|NCT03346070|559349111|FG001|Overall Study|Withdrawal by Subject|0|||
154979648|NCT03346070|559349112|FG002|Overall Study|Withdrawal by Subject|0|||
154979649|NCT03346070|559349113|FG003|Overall Study|Withdrawal by Subject|1|||
154979650|NCT03346070|559349114|FG004|Overall Study|Withdrawal by Subject|0|||
154979651|NCT03346070|559349110|FG000|Overall Study|Study medication not received as planned|2|||
154979652|NCT03346070|559349111|FG001|Overall Study|Study medication not received as planned|3|||
154979653|NCT03346070|559349112|FG002|Overall Study|Study medication not received as planned|2|||
154979654|NCT03346070|559349113|FG003|Overall Study|Study medication not received as planned|3|||
154979655|NCT03346070|559349114|FG004|Overall Study|Study medication not received as planned|2|||
154979656|NCT03346070|559349110|FG000|Overall Study|Screen Failure|0|||
154979657|NCT03346070|559349111|FG001|Overall Study|Screen Failure|0|||
154979658|NCT03346070|559349112|FG002|Overall Study|Screen Failure|0|||
154979659|NCT03346070|559349113|FG003|Overall Study|Screen Failure|1|||
154979660|NCT03346070|559349114|FG004|Overall Study|Screen Failure|1|||
154979661|NCT00977548|559349115|FG000|Overall Study|Ineligible|4|||
154979662|NCT00977548|559349115|FG000|Overall Study|Adverse Event|8|||
154979663|NCT00977548|559349115|FG000|Overall Study|Withdrawal by Subject|1|||
154979664|NCT02070757|559349118|FG000|Overall Study|Adverse Event|107|||
154979665|NCT02070757|559349119|FG001|Overall Study|Adverse Event|99|||
154979666|NCT02070757|559349118|FG000|Overall Study|Lost to Follow-up|7|||
154979667|NCT02070757|559349119|FG001|Overall Study|Lost to Follow-up|4|||
154979668|NCT02070757|559349118|FG000|Overall Study|Protocol Violation|0|||
154979669|NCT02070757|559349119|FG001|Overall Study|Protocol Violation|4|||
154979670|NCT02070757|559349118|FG000|Overall Study|Withdrawal by Subject|1|||
154979671|NCT02070757|559349119|FG001|Overall Study|Withdrawal by Subject|3|||
154979672|NCT02070757|559349118|FG000|Overall Study|Investigator Decision|0|||
154979673|NCT02070757|559349119|FG001|Overall Study|Investigator Decision|2|||
154979674|NCT02070757|559349118|FG000|Overall Study|Discharged from Study Hospital|2|||
154979675|NCT02070757|559349119|FG001|Overall Study|Discharged from Study Hospital|2|||
154979676|NCT01546142|559349120|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
154979677|NCT01546142|559349121|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
154979678|NCT01546142|559349120|FG000|Overall Study|Subject Noncompliance|1|||
154979679|NCT01546142|559349121|FG001|Overall Study|Subject Noncompliance|1|||
154979680|NCT01546142|559349120|FG000|Overall Study|Adverse Event|6|||
154979681|NCT01546142|559349121|FG001|Overall Study|Adverse Event|3|||
154979682|NCT01546142|559349120|FG000|Overall Study|Lost to Follow-up|20|||
154979683|NCT01546142|559349121|FG001|Overall Study|Lost to Follow-up|15|||
154979684|NCT01546142|559349120|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
154979685|NCT01546142|559349121|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
154979686|NCT01546142|559349120|FG000|Overall Study|Subject Randomized but Not Treated|1|||
154979687|NCT01546142|559349121|FG001|Overall Study|Subject Randomized but Not Treated|0|||
154979688|NCT01213836|559349122|FG000|Period 1, First Intervention|Adverse Event|2|||
154979689|NCT01213836|559349123|FG001|Period 1, First Intervention|Adverse Event|1|||
155114246|NCT00322452|559846276|FG001|Overall Study|Death|227|||
155114247|NCT00526656|559846277|FG000|Overall Study|Death|1|||
155114248|NCT00526656|559846277|FG000|Overall Study|Refused surgery|1|||
154979690|NCT01213836|559349122|FG000|Period 1, First Intervention|Protocol Violation|0|||
154979691|NCT01213836|559349123|FG001|Period 1, First Intervention|Protocol Violation|1|||
154979692|NCT01213836|559349122|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
154979693|NCT01213836|559349123|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
154979694|NCT00706095|559349129|FG000|Overall Study|Progressive Disease|4|||
154979695|NCT00706095|559349130|FG001|Overall Study|Progressive Disease|5|||
154979696|NCT00706095|559349131|FG002|Overall Study|Progressive Disease|3|||
154979697|NCT00706095|559349129|FG000|Overall Study|Clinical Progression|1|||
154979698|NCT00706095|559349130|FG001|Overall Study|Clinical Progression|2|||
154979699|NCT00706095|559349131|FG002|Overall Study|Clinical Progression|2|||
154979700|NCT00706095|559349129|FG000|Overall Study|Withdrawal by Subject|1|||
154979701|NCT00706095|559349130|FG001|Overall Study|Withdrawal by Subject|0|||
154979702|NCT00706095|559349131|FG002|Overall Study|Withdrawal by Subject|0|||
154979703|NCT00892281|559349139|FG000|Overall Study|Adverse Event|65|||
154979704|NCT00892281|559349140|FG001|Overall Study|Adverse Event|8|||
154979705|NCT00892281|559349139|FG000|Overall Study|Lost to Follow-up|81|||
154979706|NCT00892281|559349140|FG001|Overall Study|Lost to Follow-up|8|||
154979707|NCT00892281|559349139|FG000|Overall Study|Pregnancy|1|||
154979708|NCT00892281|559349140|FG001|Overall Study|Pregnancy|0|||
154979709|NCT00892281|559349139|FG000|Overall Study|Protocol Violation|7|||
154979710|NCT00892281|559349140|FG001|Overall Study|Protocol Violation|2|||
154979711|NCT00892281|559349139|FG000|Overall Study|Withdrawal by Subject|86|||
154979712|NCT00892281|559349140|FG001|Overall Study|Withdrawal by Subject|14|||
154979713|NCT00892281|559349139|FG000|Overall Study|Subject failed to return for final visit|2|||
154979714|NCT00892281|559349140|FG001|Overall Study|Subject failed to return for final visit|0|||
154979715|NCT00892281|559349139|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
154979716|NCT00892281|559349140|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
154979717|NCT00892281|559349139|FG000|Overall Study|Final visit completed 4 weeks late|0|||
154979718|NCT00892281|559349140|FG001|Overall Study|Final visit completed 4 weeks late|1|||
154979719|NCT00892281|559349139|FG000|Overall Study|Subject completed day after study closed|1|||
154979720|NCT00892281|559349140|FG001|Overall Study|Subject completed day after study closed|0|||
154979721|NCT00892281|559349139|FG000|Overall Study|Family emergency|1|||
154979722|NCT00892281|559349140|FG001|Overall Study|Family emergency|0|||
154979723|NCT00892281|559349139|FG000|Overall Study|Last visit not done - death in family|1|||
154979724|NCT00892281|559349140|FG001|Overall Study|Last visit not done - death in family|0|||
154979725|NCT00892281|559349139|FG000|Overall Study|Did not meet incl/excl criteria|1|||
154979726|NCT00892281|559349140|FG001|Overall Study|Did not meet incl/excl criteria|0|||
154979727|NCT00892281|559349139|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
154979728|NCT00892281|559349140|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
154979729|NCT00892281|559349139|FG000|Overall Study|Unable to redeem the drug voucher|1|||
154979730|NCT00892281|559349140|FG001|Overall Study|Unable to redeem the drug voucher|0|||
154979731|NCT00892281|559349139|FG000|Overall Study|Subject not good candidate for study|1|||
154979732|NCT00892281|559349140|FG001|Overall Study|Subject not good candidate for study|0|||
154979733|NCT00892281|559349139|FG000|Overall Study|Subject did not return for any visits|1|||
154979734|NCT00892281|559349140|FG001|Overall Study|Subject did not return for any visits|0|||
154979735|NCT00892281|559349139|FG000|Overall Study|Subject missed several visits/lost meds|1|||
154979736|NCT00892281|559349140|FG001|Overall Study|Subject missed several visits/lost meds|0|||
154979737|NCT00892281|559349139|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
154979738|NCT00892281|559349140|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
154979739|NCT00892281|559349139|FG000|Overall Study|Scheduled for knee replacement|0|||
154979740|NCT00892281|559349140|FG001|Overall Study|Scheduled for knee replacement|1|||
154979741|NCT00892281|559349139|FG000|Overall Study|PI complained of inadequate compensation|3|||
154979742|NCT00892281|559349140|FG001|Overall Study|PI complained of inadequate compensation|0|||
154979743|NCT00892281|559349139|FG000|Overall Study|Subject lost interest in program|0|||
154979744|NCT00892281|559349140|FG001|Overall Study|Subject lost interest in program|1|||
154979745|NCT00892281|559349139|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
154979746|NCT00892281|559349140|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
154979747|NCT00892281|559349139|FG000|Overall Study|Death in family|1|||
154979748|NCT00892281|559349140|FG001|Overall Study|Death in family|0|||
154979749|NCT00892281|559349139|FG000|Overall Study|Lack of efficacy of study product|2|||
154979750|NCT00892281|559349140|FG001|Overall Study|Lack of efficacy of study product|0|||
154979751|NCT00892281|559349139|FG000|Overall Study|Subject not seen by PI at final visit|1|||
154979752|NCT00892281|559349140|FG001|Overall Study|Subject not seen by PI at final visit|0|||
154979753|NCT00892281|559349139|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
154979754|NCT00892281|559349140|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
154979755|NCT00892281|559349139|FG000|Overall Study|Missed multiple visits|1|||
154979756|NCT00892281|559349140|FG001|Overall Study|Missed multiple visits|0|||
154979757|NCT00892281|559349139|FG000|Overall Study|Missed visits rescheduled out of window|1|||
154979758|NCT00892281|559349140|FG001|Overall Study|Missed visits rescheduled out of window|0|||
154979759|NCT00892281|559349139|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
154979760|NCT00892281|559349140|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
155114249|NCT02438384|559846278|FG000|Overall Study|Lost to Follow-up|8|||
155114250|NCT02438384|559846279|FG001|Overall Study|Lost to Follow-up|6|||
155114251|NCT02438384|559846280|FG002|Overall Study|Lost to Follow-up|4|||
155114252|NCT01795495|559846282|FG000|Overall Study|Protocol Violation|1|||
155114253|NCT01795495|559846283|FG001|Overall Study|Protocol Violation|0|||
154979761|NCT00892281|559349139|FG000|Overall Study|Subject had history of drug abuse|1|||
154979762|NCT00892281|559349140|FG001|Overall Study|Subject had history of drug abuse|0|||
154979763|NCT00892281|559349139|FG000|Overall Study|Rash on hand|1|||
154979764|NCT00892281|559349140|FG001|Overall Study|Rash on hand|0|||
154979765|NCT00892281|559349139|FG000|Overall Study|Visit 4 date out of window|1|||
154979766|NCT00892281|559349140|FG001|Overall Study|Visit 4 date out of window|0|||
154979767|NCT04220775|559349143|FG000|Overall Study|Adverse Event|1|||
155114254|NCT01795495|559846284|FG002|Overall Study|Protocol Violation|1|||
155114255|NCT01795495|559846282|FG000|Overall Study|Physician Decision|0|||
155114256|NCT01795495|559846283|FG001|Overall Study|Physician Decision|0|||
155114257|NCT01795495|559846284|FG002|Overall Study|Physician Decision|1|||
155114258|NCT04027049|559846285|FG000|Overall Study|Withdrawn by family|1|||
155114259|NCT04027049|559846286|FG001|Overall Study|Withdrawn by family|0|||
155114260|NCT04027049|559846285|FG000|Overall Study|Participant safety|1|||
155114261|NCT04027049|559846286|FG001|Overall Study|Participant safety|0|||
155114262|NCT02650128|559846287|FG000|Overall Study|Death|2|||
154897113|NCT02293902|559042738|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
154897114|NCT02293902|559042739|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
154897115|NCT02293902|559042735|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
154897116|NCT02293902|559042736|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
154897117|NCT02293902|559042737|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
154897118|NCT02293902|559042738|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
154897119|NCT02293902|559042739|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
154897120|NCT02947022|559042740|FG000|Overall Study|Study Stopped|1|||
154897121|NCT03077243|559044422|FG000|Overall Study|Death|1|||
155114263|NCT01740089|559848105|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
155175658|NCT00869778|560080305|FG000|Overall Study|Protocol Violation|5|||
154897122|NCT03077243|559044423|FG001|Overall Study|Death|2|||
154897123|NCT03077243|559044424|FG002|Overall Study|Death|0|||
154897124|NCT03077243|559044425|FG003|Overall Study|Death|0|||
154897125|NCT03077243|559044422|FG000|Overall Study|Withdrawal by Subject|1|||
154897126|NCT03077243|559044423|FG001|Overall Study|Withdrawal by Subject|3|||
154897127|NCT03077243|559044424|FG002|Overall Study|Withdrawal by Subject|0|||
154897128|NCT03077243|559044425|FG003|Overall Study|Withdrawal by Subject|0|||
154897129|NCT03077243|559044422|FG000|Overall Study|Physician Decision|1|||
154897130|NCT03077243|559044423|FG001|Overall Study|Physician Decision|0|||
154897131|NCT03077243|559044424|FG002|Overall Study|Physician Decision|0|||
154897132|NCT03077243|559044425|FG003|Overall Study|Physician Decision|0|||
154897133|NCT03077243|559044422|FG000|Overall Study|Research at two study sites terminated early|0|||
154897134|NCT03077243|559044423|FG001|Overall Study|Research at two study sites terminated early|0|||
154897135|NCT03077243|559044424|FG002|Overall Study|Research at two study sites terminated early|0|||
154897136|NCT03077243|559044425|FG003|Overall Study|Research at two study sites terminated early|69|||
154897137|NCT02574481|559044429|FG000|Overall Study|Withdrawal by Subject|29|||
154897138|NCT02574481|559044430|FG001|Overall Study|Withdrawal by Subject|15|||
154897139|NCT02574481|559044431|FG002|Overall Study|Withdrawal by Subject|4|||
154897140|NCT02574481|559044432|FG003|Overall Study|Withdrawal by Subject|1|||
154897141|NCT02574481|559044429|FG000|Overall Study|Adverse Event|5|||
154897142|NCT02574481|559044430|FG001|Overall Study|Adverse Event|1|||
154897143|NCT02574481|559044431|FG002|Overall Study|Adverse Event|1|||
154897144|NCT02574481|559044432|FG003|Overall Study|Adverse Event|0|||
154897145|NCT02574481|559044429|FG000|Overall Study|Visit Missed|15|||
154897146|NCT02574481|559044430|FG001|Overall Study|Visit Missed|7|||
154897147|NCT02574481|559044431|FG002|Overall Study|Visit Missed|5|||
154897148|NCT02574481|559044432|FG003|Overall Study|Visit Missed|0|||
154897149|NCT02574481|559044429|FG000|Overall Study|Other|7|||
154897150|NCT02574481|559044430|FG001|Overall Study|Other|2|||
154897151|NCT02574481|559044431|FG002|Overall Study|Other|0|||
154897152|NCT02574481|559044432|FG003|Overall Study|Other|0|||
154897153|NCT02574481|559044429|FG000|Overall Study|Death|48|||
154897154|NCT02574481|559044430|FG001|Overall Study|Death|26|||
154897155|NCT02574481|559044431|FG002|Overall Study|Death|12|||
154897156|NCT02574481|559044432|FG003|Overall Study|Death|4|||
154897157|NCT02574481|559044429|FG000|Overall Study|Physician Decision|5|||
154897158|NCT02574481|559044430|FG001|Overall Study|Physician Decision|2|||
154897159|NCT02574481|559044431|FG002|Overall Study|Physician Decision|0|||
154897160|NCT02574481|559044432|FG003|Overall Study|Physician Decision|0|||
154897161|NCT02574481|559044429|FG000|Overall Study|Lost to Follow-up|5|||
154897162|NCT02574481|559044430|FG001|Overall Study|Lost to Follow-up|1|||
154897163|NCT02574481|559044431|FG002|Overall Study|Lost to Follow-up|3|||
154897164|NCT02574481|559044432|FG003|Overall Study|Lost to Follow-up|0|||
154897165|NCT03984812|559044433|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897166|NCT03984812|559044434|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897167|NCT03984812|559044435|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
154897168|NCT03984812|559044436|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897169|NCT03984812|559044437|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897170|NCT03984812|559044438|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897171|NCT03984812|559044439|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897172|NCT03984812|559044440|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897173|NCT03984812|559044441|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897174|NCT03984812|559044442|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897175|NCT03984812|559044443|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
154897176|NCT01105936|559044444|FG000|Period 1|Adverse Event|0|||
155114264|NCT01740089|559848106|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
155114265|NCT01740089|559848107|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
155114266|NCT01740089|559848105|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
155114267|NCT01740089|559848106|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
155114268|NCT01740089|559848107|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
155114269|NCT01740089|559848105|FG000|After 12 Weeks|Lack of Efficacy|3|||
154979768|NCT04220775|559349144|FG001|Overall Study|Adverse Event|0|||
154979769|NCT04220775|559349143|FG000|Overall Study|Disease Progression|1|||
154979770|NCT04220775|559349144|FG001|Overall Study|Disease Progression|0|||
154979771|NCT00436917|559349145|FG000|Overall Study|Withdrawal by Subject|13|||
154979772|NCT00436917|559349145|FG000|Overall Study|Adverse Event|2|||
154979773|NCT00436917|559349145|FG000|Overall Study|Physician Decision|1|||
154979774|NCT00436917|559349145|FG000|Overall Study|Death|1|||
154979775|NCT00436917|559349145|FG000|Overall Study|Lost to Follow-up|1|||
154979776|NCT00436917|559349145|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
154979777|NCT00436917|559349145|FG000|Overall Study|Increased creatinine|1|||
154979778|NCT00436917|559349145|FG000|Overall Study|Personal conflicts of patient|1|||
154979779|NCT02169791|559349146|FG000|Overall Study|Death|6|||
154979780|NCT02169791|559349146|FG000|Overall Study|patient withdrew consent|1|||
154979781|NCT01009515|559349148|FG000|Overall Study|Withdrawal by Subject|3|||
154979782|NCT01501110|559349150|FG000|Overall Study|Death|0|||
154979783|NCT01501110|559349151|FG001|Overall Study|Death|1|||
154979784|NCT02075606|559349152|FG000|Overall Study|Adverse Event|5|||
154979785|NCT02075606|559349152|FG000|Overall Study|Withdrawal by Subject|1|||
154979786|NCT02075606|559349152|FG000|Overall Study|Death|1|||
155114270|NCT01740089|559848106|FG001|After 12 Weeks|Lack of Efficacy|1|||
155114271|NCT01740089|559848107|FG002|After 12 Weeks|Lack of Efficacy|4|||
155114272|NCT01740089|559848105|FG000|After 12 Weeks|Adverse Event|2|||
155114273|NCT01740089|559848106|FG001|After 12 Weeks|Adverse Event|0|||
154897177|NCT01105936|559044445|FG001|Period 1|Adverse Event|0|||
154897178|NCT01105936|559044446|FG002|Period 1|Adverse Event|0|||
154897179|NCT01105936|559044447|FG003|Period 1|Adverse Event|1|||
154897180|NCT01105936|559044444|FG000|Period 2|Adverse Event|1|||
154897181|NCT01105936|559044445|FG001|Period 2|Adverse Event|0|||
154897182|NCT01105936|559044446|FG002|Period 2|Adverse Event|0|||
154897183|NCT01105936|559044447|FG003|Period 2|Adverse Event|0|||
154897184|NCT01105936|559044444|FG000|Period 3|Protocol Violation|0|||
154897185|NCT01105936|559044445|FG001|Period 3|Protocol Violation|2|||
154897186|NCT01105936|559044446|FG002|Period 3|Protocol Violation|0|||
154897187|NCT01105936|559044447|FG003|Period 3|Protocol Violation|0|||
154897188|NCT02971007|559044449|FG000|Overall Study|Adverse Event|1|||
154897189|NCT02971007|559044450|FG001|Overall Study|Adverse Event|0|||
154897190|NCT02971007|559044451|FG002|Overall Study|Adverse Event|0|||
154897191|NCT02971007|559044449|FG000|Overall Study|Lost to Follow-up|0|||
154897192|NCT02971007|559044450|FG001|Overall Study|Lost to Follow-up|1|||
154897193|NCT02971007|559044451|FG002|Overall Study|Lost to Follow-up|1|||
154897194|NCT02971007|559044449|FG000|Overall Study|Withdrawal by Subject|0|||
154897195|NCT02971007|559044450|FG001|Overall Study|Withdrawal by Subject|1|||
154897196|NCT02971007|559044451|FG002|Overall Study|Withdrawal by Subject|0|||
154897197|NCT02971007|559044449|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
154897198|NCT02971007|559044450|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
154897199|NCT02971007|559044451|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
154897200|NCT02971007|559044449|FG000|Overall Study|Patient discontinued study drug|0|||
154897201|NCT02971007|559044450|FG001|Overall Study|Patient discontinued study drug|1|||
154897202|NCT02971007|559044451|FG002|Overall Study|Patient discontinued study drug|0|||
154897203|NCT03170258|559044456|FG000|Overall Study|Physician Decision|4|||
154897204|NCT03170258|559044457|FG001|Overall Study|Physician Decision|0|||
154897205|NCT03170258|559044456|FG000|Overall Study|Equipment issues|1|||
154897206|NCT03170258|559044457|FG001|Overall Study|Equipment issues|0|||
154897207|NCT03170258|559044456|FG000|Overall Study|Medication|1|||
154897208|NCT03170258|559044457|FG001|Overall Study|Medication|0|||
154897209|NCT03170258|559044456|FG000|Overall Study|Sleep issues|1|||
154979787|NCT02075606|559349152|FG000|Overall Study|Investigator's decision|1|||
154979788|NCT02075606|559349152|FG000|Overall Study|Symptom management|1|||
154979789|NCT02075606|559349152|FG000|Overall Study|Increasing Symptoms|1|||
154897210|NCT03170258|559044457|FG001|Overall Study|Sleep issues|0|||
154897211|NCT03276572|559044463|FG000|Overall Study|In follow-up|0|||
154897212|NCT03276572|559044464|FG001|Overall Study|In follow-up|0|||
154897213|NCT03276572|559044465|FG002|Overall Study|In follow-up|0|||
154897214|NCT03276572|559044466|FG003|Overall Study|In follow-up|0|||
154897215|NCT03276572|559044467|FG004|Overall Study|In follow-up|0|||
154979790|NCT01439724|559349154|FG000|Overall Study|missing consultation|9|||
154897216|NCT03276572|559044468|FG005|Overall Study|In follow-up|1|||
154979791|NCT01439724|559349155|FG001|Overall Study|missing consultation|8|||
154979792|NCT01857206|559349156|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
155114274|NCT01740089|559848107|FG002|After 12 Weeks|Adverse Event|5|||
155114275|NCT01740089|559848105|FG000|After 12 Weeks|Protocol Violation|1|||
154897217|NCT03276572|559044469|FG006|Overall Study|In follow-up|1|||
154979793|NCT01857206|559349157|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
155114276|NCT01740089|559848106|FG001|After 12 Weeks|Protocol Violation|1|||
155114277|NCT01740089|559848107|FG002|After 12 Weeks|Protocol Violation|1|||
155114278|NCT01740089|559848105|FG000|After 12 Weeks|Withdrawal by Subject|1|||
155114279|NCT01740089|559848106|FG001|After 12 Weeks|Withdrawal by Subject|1|||
155114280|NCT01740089|559848107|FG002|After 12 Weeks|Withdrawal by Subject|1|||
155114281|NCT02526524|559848114|FG000|Overall Study|Withdrawal by Subject|3|||
155114282|NCT02526524|559848115|FG001|Overall Study|Withdrawal by Subject|3|||
155114283|NCT02526524|559848116|FG002|Overall Study|Withdrawal by Subject|6|||
155114284|NCT02526524|559848117|FG003|Overall Study|Withdrawal by Subject|1|||
155114285|NCT02526524|559848118|FG004|Overall Study|Withdrawal by Subject|9|||
155114286|NCT02526524|559848119|FG005|Overall Study|Withdrawal by Subject|5|||
155114287|NCT02526524|559848114|FG000|Overall Study|Adverse Event|3|||
155114288|NCT02526524|559848115|FG001|Overall Study|Adverse Event|2|||
155114289|NCT02526524|559848116|FG002|Overall Study|Adverse Event|4|||
155114290|NCT02526524|559848117|FG003|Overall Study|Adverse Event|2|||
155114291|NCT02526524|559848118|FG004|Overall Study|Adverse Event|6|||
155114292|NCT02526524|559848119|FG005|Overall Study|Adverse Event|8|||
155114293|NCT02526524|559848114|FG000|Overall Study|Lost to Follow-up|2|||
155114294|NCT02526524|559848115|FG001|Overall Study|Lost to Follow-up|3|||
155114295|NCT02526524|559848116|FG002|Overall Study|Lost to Follow-up|8|||
155114296|NCT02526524|559848117|FG003|Overall Study|Lost to Follow-up|1|||
155114297|NCT02526524|559848118|FG004|Overall Study|Lost to Follow-up|2|||
155114298|NCT02526524|559848119|FG005|Overall Study|Lost to Follow-up|5|||
155114299|NCT02526524|559848114|FG000|Overall Study|Protocol Violation|3|||
155114300|NCT02526524|559848115|FG001|Overall Study|Protocol Violation|1|||
155114301|NCT02526524|559848116|FG002|Overall Study|Protocol Violation|5|||
155114302|NCT02526524|559848117|FG003|Overall Study|Protocol Violation|3|||
155114303|NCT02526524|559848118|FG004|Overall Study|Protocol Violation|4|||
155114304|NCT02526524|559848119|FG005|Overall Study|Protocol Violation|3|||
155114305|NCT02526524|559848114|FG000|Overall Study|Loss of Glucose Control|0|||
155114306|NCT02526524|559848115|FG001|Overall Study|Loss of Glucose Control|0|||
155114307|NCT02526524|559848116|FG002|Overall Study|Loss of Glucose Control|3|||
155114308|NCT02526524|559848117|FG003|Overall Study|Loss of Glucose Control|0|||
155114309|NCT02526524|559848118|FG004|Overall Study|Loss of Glucose Control|2|||
155114310|NCT02526524|559848119|FG005|Overall Study|Loss of Glucose Control|0|||
155114311|NCT02526524|559848114|FG000|Overall Study|Physician Decision|0|||
155114312|NCT02526524|559848115|FG001|Overall Study|Physician Decision|0|||
155114313|NCT02526524|559848116|FG002|Overall Study|Physician Decision|0|||
155114314|NCT02526524|559848117|FG003|Overall Study|Physician Decision|0|||
155114315|NCT02526524|559848118|FG004|Overall Study|Physician Decision|1|||
155114316|NCT02526524|559848119|FG005|Overall Study|Physician Decision|0|||
155114317|NCT02526524|559848114|FG000|Overall Study|Sponsor Decision|1|||
155114318|NCT02526524|559848115|FG001|Overall Study|Sponsor Decision|0|||
155114319|NCT02526524|559848116|FG002|Overall Study|Sponsor Decision|0|||
155114320|NCT02526524|559848117|FG003|Overall Study|Sponsor Decision|0|||
155114321|NCT02526524|559848118|FG004|Overall Study|Sponsor Decision|0|||
155114322|NCT02526524|559848119|FG005|Overall Study|Sponsor Decision|0|||
155114323|NCT00591149|559848123|FG000|Overall Study|Adverse Event|4|||
155114324|NCT00591149|559848123|FG000|Overall Study|Withdrawal by Subject|1|||
155175659|NCT00869778|560080306|FG001|Overall Study|Protocol Violation|3|||
155175660|NCT00869778|560080307|FG002|Overall Study|Protocol Violation|5|||
154897218|NCT03276572|559044463|FG000|Overall Study|Lost to Follow-up|0|||
154897219|NCT03276572|559044464|FG001|Overall Study|Lost to Follow-up|0|||
154897220|NCT03276572|559044465|FG002|Overall Study|Lost to Follow-up|0|||
154897221|NCT03276572|559044466|FG003|Overall Study|Lost to Follow-up|0|||
154897222|NCT03276572|559044467|FG004|Overall Study|Lost to Follow-up|0|||
154897223|NCT03276572|559044468|FG005|Overall Study|Lost to Follow-up|0|||
154897224|NCT03276572|559044469|FG006|Overall Study|Lost to Follow-up|1|||
154897225|NCT02954952|559044482|FG000|Overall Study|Withdrawal by Subject|1|||
154897226|NCT02954952|559044483|FG001|Overall Study|Withdrawal by Subject|0|||
154897227|NCT02954952|559044484|FG002|Overall Study|Withdrawal by Subject|0|||
154897228|NCT02954952|559044482|FG000|Overall Study|No data collected|0|||
154897229|NCT02954952|559044483|FG001|Overall Study|No data collected|1|||
154897230|NCT02954952|559044484|FG002|Overall Study|No data collected|0|||
154897231|NCT00724815|559044485|FG000|Overall Study|Randomized, not treated|31|||
154979794|NCT01857206|559349156|FG000|Overall Study|Lost to Follow-up|9|||
155114325|NCT00539513|559848124|FG000|Overall Study|Withdrawal by Subject|2|||
155114326|NCT00539513|559848125|FG001|Overall Study|Withdrawal by Subject|1|||
155114327|NCT00539513|559848124|FG000|Overall Study|Lost to Follow-up|0|||
155114328|NCT00539513|559848125|FG001|Overall Study|Lost to Follow-up|1|||
155114329|NCT03002818|559848126|FG000|Overall Study|Decision of the investigator|1|||
155114330|NCT01328041|559848127|FG000|Overall Study|Adverse Event|7|||
155114331|NCT01328041|559848127|FG000|Overall Study|Lack of Efficacy|27|||
155114332|NCT01328041|559848127|FG000|Overall Study|Protocol Violation|7|||
155114333|NCT01328041|559848127|FG000|Overall Study|Lost to Follow-up|7|||
155114334|NCT01328041|559848127|FG000|Overall Study|Physician Decision|2|||
155114335|NCT01328041|559848127|FG000|Overall Study|Withdrawal by Subject|7|||
155114336|NCT00711113|559848128|FG000|Overall Study|Lost to Follow-up|9|||
155114337|NCT00711113|559848128|FG000|Overall Study|Implant lost|2|||
154979795|NCT01857206|559349157|FG001|Overall Study|Lost to Follow-up|6|||
154979796|NCT01857206|559349156|FG000|Overall Study|Unclassified|3|||
154979797|NCT01857206|559349157|FG001|Overall Study|Unclassified|3|||
154979798|NCT01857206|559349156|FG000|Overall Study|Withdrawal by Subject|1|||
154979799|NCT01857206|559349157|FG001|Overall Study|Withdrawal by Subject|0|||
154979800|NCT01483625|559349160|FG000|Overall Study|Adverse Event|1|||
154979801|NCT01483625|559349161|FG001|Overall Study|Adverse Event|1|||
154979802|NCT01483625|559349160|FG000|Overall Study|Refused to continue medication|2|||
154979803|NCT01483625|559349161|FG001|Overall Study|Refused to continue medication|1|||
154979804|NCT01483625|559349160|FG000|Overall Study|Due to other reason|1|||
154979805|NCT01483625|559349161|FG001|Overall Study|Due to other reason|0|||
154979806|NCT00271024|559349166|FG000|Overall Study|Lost Interest|3|||
154979807|NCT00271024|559349167|FG001|Overall Study|Lost Interest|4|||
154979808|NCT00271024|559349168|FG002|Overall Study|Lost Interest|2|||
154979809|NCT00271024|559349169|FG003|Overall Study|Lost Interest|3|||
154979810|NCT00271024|559349166|FG000|Overall Study|Unknown/Unspecified|11|||
154979811|NCT00271024|559349167|FG001|Overall Study|Unknown/Unspecified|11|||
154979812|NCT00271024|559349168|FG002|Overall Study|Unknown/Unspecified|8|||
154979813|NCT00271024|559349169|FG003|Overall Study|Unknown/Unspecified|4|||
154979814|NCT00271024|559349166|FG000|Overall Study|Protocol Violation|1|||
154979815|NCT00271024|559349167|FG001|Overall Study|Protocol Violation|6|||
154979816|NCT00271024|559349168|FG002|Overall Study|Protocol Violation|5|||
154979817|NCT00271024|559349169|FG003|Overall Study|Protocol Violation|11|||
154979818|NCT00271024|559349166|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
154979819|NCT00271024|559349167|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
154979820|NCT00271024|559349168|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
154979821|NCT00271024|559349169|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
154979822|NCT00271024|559349166|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
154979823|NCT00271024|559349167|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
154979824|NCT00271024|559349168|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
154979825|NCT00271024|559349169|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
154979826|NCT01261624|559349170|FG000|Week 0 to Week 12|Disease Progression|1|||
154979827|NCT01261624|559349171|FG001|Week 0 to Week 12|Disease Progression|1|||
154979828|NCT01261624|559349170|FG000|Week 0 to Week 12|Insufficient Response|0|||
154979829|NCT01261624|559349171|FG001|Week 0 to Week 12|Insufficient Response|2|||
154979830|NCT01261624|559349170|FG000|Week 13 to Week 24|Insufficient Response|0|||
154979831|NCT01261624|559349171|FG001|Week 13 to Week 24|Insufficient Response|1|||
154979832|NCT02094261|559349175|FG000|Overall Study|Death|24|||
154979833|NCT02094261|559349175|FG000|Overall Study|Lost to Follow-up|1|||
154979834|NCT02094261|559349175|FG000|Overall Study|Withdrawal by Subject|4|||
154979835|NCT02094261|559349175|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
154979836|NCT01083680|559349185|FG000|Overall Study|Lost to Follow-up|2758|||
154979837|NCT01083680|559349185|FG000|Overall Study|Withdrawal by Subject|1086|||
154979838|NCT03877926|559349186|FG000|Overall Study|Adverse Event|1|||
154979839|NCT03877926|559349187|FG001|Overall Study|Adverse Event|0|||
154979840|NCT03877926|559349188|FG002|Overall Study|Adverse Event|0|||
154979841|NCT03877926|559349189|FG003|Overall Study|Adverse Event|0|||
154979842|NCT03877926|559349186|FG000|Overall Study|Death|2|||
154979843|NCT03877926|559349187|FG001|Overall Study|Death|2|||
154979844|NCT03877926|559349188|FG002|Overall Study|Death|2|||
154979845|NCT03877926|559349189|FG003|Overall Study|Death|0|||
154979846|NCT03877926|559349186|FG000|Overall Study|Lost to Follow-up|41|||
154979847|NCT03877926|559349187|FG001|Overall Study|Lost to Follow-up|52|||
154979848|NCT03877926|559349188|FG002|Overall Study|Lost to Follow-up|45|||
155114338|NCT02456636|559848129|FG000|Overall Study|Death|0|||
155114339|NCT02456636|559848130|FG001|Overall Study|Death|3|||
155114340|NCT02456636|559848131|FG002|Overall Study|Death|0|||
155114341|NCT02456636|559848129|FG000|Overall Study|Pregnancy|1|||
155114342|NCT02456636|559848130|FG001|Overall Study|Pregnancy|3|||
154979849|NCT03877926|559349189|FG003|Overall Study|Lost to Follow-up|17|||
154979850|NCT03877926|559349186|FG000|Overall Study|Physician Decision|2|||
154979851|NCT03877926|559349187|FG001|Overall Study|Physician Decision|0|||
155114343|NCT02456636|559848131|FG002|Overall Study|Pregnancy|5|||
155114344|NCT02456636|559848129|FG000|Overall Study|Physician Decision|4|||
155114345|NCT02456636|559848130|FG001|Overall Study|Physician Decision|5|||
154979852|NCT03877926|559349188|FG002|Overall Study|Physician Decision|2|||
154979853|NCT03877926|559349189|FG003|Overall Study|Physician Decision|0|||
154979854|NCT03877926|559349186|FG000|Overall Study|Withdrawal by Subject|18|||
154979855|NCT03877926|559349187|FG001|Overall Study|Withdrawal by Subject|21|||
154979856|NCT03877926|559349188|FG002|Overall Study|Withdrawal by Subject|12|||
154979857|NCT03877926|559349189|FG003|Overall Study|Withdrawal by Subject|4|||
154979858|NCT03877926|559349186|FG000|Overall Study|Other - Various|4|||
154979859|NCT03877926|559349187|FG001|Overall Study|Other - Various|1|||
155114346|NCT02456636|559848131|FG002|Overall Study|Physician Decision|4|||
155114347|NCT02456636|559848129|FG000|Overall Study|Withdrawal by Subject|13|||
154979860|NCT03877926|559349188|FG002|Overall Study|Other - Various|1|||
154979861|NCT03877926|559349189|FG003|Overall Study|Other - Various|0|||
154979862|NCT03877926|559349186|FG000|Overall Study|Not Treated|3|||
155114348|NCT02456636|559848130|FG001|Overall Study|Withdrawal by Subject|14|||
154897232|NCT00724815|559044486|FG001|Overall Study|Randomized, not treated|30|||
154897233|NCT00724815|559044485|FG000|Overall Study|Adverse Event|5|||
154897234|NCT00724815|559044486|FG001|Overall Study|Adverse Event|3|||
154897235|NCT00724815|559044485|FG000|Overall Study|Lost to Follow-up|4|||
154897236|NCT00724815|559044486|FG001|Overall Study|Lost to Follow-up|1|||
154897237|NCT00724815|559044485|FG000|Overall Study|Other Various|3|||
154897238|NCT00724815|559044486|FG001|Overall Study|Other Various|5|||
154897239|NCT00810043|559044487|FG000|Overall Study|Withdrawal by Subject|1|||
154897240|NCT00810043|559044488|FG001|Overall Study|Withdrawal by Subject|0|||
154897241|NCT00810043|559044489|FG002|Overall Study|Withdrawal by Subject|2|||
154897242|NCT00810043|559044487|FG000|Overall Study|Lost to Follow-up|1|||
154897243|NCT00810043|559044488|FG001|Overall Study|Lost to Follow-up|0|||
154897244|NCT00810043|559044489|FG002|Overall Study|Lost to Follow-up|0|||
154897245|NCT00810043|559044487|FG000|Overall Study|Physician Decision|0|||
154897246|NCT00810043|559044488|FG001|Overall Study|Physician Decision|0|||
154897247|NCT00810043|559044489|FG002|Overall Study|Physician Decision|2|||
154897248|NCT00810043|559044487|FG000|Overall Study|Death|2|||
154897249|NCT00810043|559044488|FG001|Overall Study|Death|0|||
154897250|NCT00810043|559044489|FG002|Overall Study|Death|0|||
154897251|NCT00810043|559044487|FG000|Overall Study|Unrelated medical problem|0|||
154897252|NCT00810043|559044488|FG001|Overall Study|Unrelated medical problem|1|||
154897253|NCT00810043|559044489|FG002|Overall Study|Unrelated medical problem|0|||
154897254|NCT00810043|559044487|FG000|Overall Study|Non-medical problem|0|||
154897255|NCT00810043|559044488|FG001|Overall Study|Non-medical problem|0|||
154897256|NCT00810043|559044489|FG002|Overall Study|Non-medical problem|1|||
154897257|NCT00810043|559044487|FG000|Overall Study|No longer met enrollment criteria|0|||
154897258|NCT00810043|559044488|FG001|Overall Study|No longer met enrollment criteria|0|||
154897259|NCT00810043|559044489|FG002|Overall Study|No longer met enrollment criteria|3|||
154897260|NCT00641706|559044495|FG000|Overall Study|Adverse Event|2|||
154897261|NCT00641706|559044496|FG001|Overall Study|Adverse Event|1|||
154897262|NCT00641706|559044495|FG000|Overall Study|Withdrawal by Subject|6|||
154897263|NCT00641706|559044496|FG001|Overall Study|Withdrawal by Subject|1|||
154897264|NCT00641706|559044495|FG000|Overall Study|Clinical Decline|1|||
154897265|NCT00641706|559044496|FG001|Overall Study|Clinical Decline|0|||
154897266|NCT00641706|559044495|FG000|Overall Study|Lead Investigator Decision|0|||
154897267|NCT00641706|559044496|FG001|Overall Study|Lead Investigator Decision|1|||
154897268|NCT01989754|559044497|FG000|Overall Study|Withdrawal by Subject|10|||
154897269|NCT01989754|559044498|FG001|Overall Study|Withdrawal by Subject|14|||
154897270|NCT01989754|559044497|FG000|Overall Study|Lost to Follow-up|28|||
154897271|NCT01989754|559044498|FG001|Overall Study|Lost to Follow-up|20|||
154897272|NCT01989754|559044497|FG000|Overall Study|Closed Site|1|||
154897273|NCT01989754|559044498|FG001|Overall Study|Closed Site|1|||
154897274|NCT01359046|559044499|FG000|Overall Study|Did not receive allocated intervention|6|||
154897275|NCT01359046|559044500|FG001|Overall Study|Did not receive allocated intervention|6|||
154897276|NCT01359046|559044499|FG000|Overall Study|Physician Decision|1|||
154897277|NCT01359046|559044500|FG001|Overall Study|Physician Decision|11|||
154897278|NCT03037307|559044503|FG000|Period 1|Did Not Meet Study Criteria|0|||
154897279|NCT03037307|559044504|FG001|Period 1|Did Not Meet Study Criteria|0|||
154897280|NCT03037307|559044505|FG002|Period 1|Did Not Meet Study Criteria|0|||
154897281|NCT03037307|559044506|FG003|Period 1|Did Not Meet Study Criteria|1|||
154897282|NCT03037307|559044507|FG004|Period 1|Did Not Meet Study Criteria|0|||
154897283|NCT03037307|559044508|FG005|Period 1|Did Not Meet Study Criteria|0|||
154897284|NCT00802867|559044509|FG000|Overall Study|Lost to Follow-up|6|||
154897285|NCT00802867|559044509|FG000|Overall Study|Protocol Violation|6|||
154897286|NCT00802867|559044509|FG000|Overall Study|Withdrawal by Subject|1|||
154897287|NCT03000686|559044516|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
154897288|NCT03000686|559044517|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
154897289|NCT03000686|559044518|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
154897290|NCT03000686|559044519|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
154897291|NCT02920450|559044520|FG000|Overall Study|Death|1|||
154897292|NCT02920450|559044521|FG001|Overall Study|Death|0|||
155114349|NCT02456636|559848131|FG002|Overall Study|Withdrawal by Subject|16|||
154897293|NCT02920450|559044522|FG002|Overall Study|Death|0|||
154897294|NCT02920450|559044523|FG003|Overall Study|Death|0|||
154897295|NCT02920450|559044520|FG000|Overall Study|Withdrawal by Subject|1|||
154897296|NCT02920450|559044521|FG001|Overall Study|Withdrawal by Subject|0|||
154897297|NCT02920450|559044522|FG002|Overall Study|Withdrawal by Subject|0|||
154897298|NCT02920450|559044523|FG003|Overall Study|Withdrawal by Subject|0|||
154897299|NCT00770224|559044530|FG000|Step 1: Induction|Adverse Event|3|||
154897300|NCT00770224|559044531|FG001|Step 1: Induction|Adverse Event|0|||
154897301|NCT00770224|559044530|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
154897302|NCT00770224|559044531|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
154897303|NCT00770224|559044530|FG000|Step 1: Induction|Other reason not protocol specified|2|||
154897304|NCT00770224|559044531|FG001|Step 1: Induction|Other reason not protocol specified|0|||
154897305|NCT00770224|559044530|FG000|Step 1: Induction|Ineligible|2|||
154897306|NCT00770224|559044531|FG001|Step 1: Induction|Ineligible|0|||
154897307|NCT00770224|559044530|FG000|Step 1: Induction|No protocol treatment given|1|||
154897308|NCT00770224|559044531|FG001|Step 1: Induction|No protocol treatment given|0|||
154897309|NCT00770224|559044530|FG000|Step 2: Maintenance|Adverse Event|0|||
154897310|NCT00770224|559044531|FG001|Step 2: Maintenance|Adverse Event|10|||
154897311|NCT00770224|559044530|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
154897312|NCT00770224|559044531|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
154897313|NCT00770224|559044530|FG000|Step 2: Maintenance|Progression/relapse|0|||
154897314|NCT00770224|559044531|FG001|Step 2: Maintenance|Progression/relapse|1|||
154897315|NCT00770224|559044530|FG000|Step 2: Maintenance|Death|0|||
154897316|NCT00770224|559044531|FG001|Step 2: Maintenance|Death|2|||
154897317|NCT00770224|559044530|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
154897318|NCT00770224|559044531|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
154897319|NCT00770224|559044530|FG000|Step 2: Maintenance|Ineligible|0|||
154897320|NCT00770224|559044531|FG001|Step 2: Maintenance|Ineligible|2|||
154897321|NCT04737759|559044532|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
154897322|NCT04737759|559044533|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
154897323|NCT04737759|559044532|FG000|Overall Study|Death|2|||
154897324|NCT04737759|559044533|FG001|Overall Study|Death|0|||
154897325|NCT04737759|559044532|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
154897326|NCT04737759|559044533|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
154897327|NCT04737759|559044532|FG000|Overall Study|Lost to Follow-up|4|||
154897328|NCT04737759|559044533|FG001|Overall Study|Lost to Follow-up|12|||
154897329|NCT01484561|559044534|FG000|Overall Study|Lack of Efficacy|3|||
154897330|NCT01484561|559044535|FG001|Overall Study|Lack of Efficacy|1|||
154897331|NCT01484561|559044534|FG000|Overall Study|Lost to Follow-up|1|||
154897332|NCT01484561|559044535|FG001|Overall Study|Lost to Follow-up|0|||
154897333|NCT01484561|559044534|FG000|Overall Study|Withdrawal by Subject|3|||
154897334|NCT01484561|559044535|FG001|Overall Study|Withdrawal by Subject|0|||
154897335|NCT01484561|559044534|FG000|Overall Study|Other|1|||
154897336|NCT01484561|559044535|FG001|Overall Study|Other|1|||
154897337|NCT01484561|559044534|FG000|Overall Study|Adverse Event|1|||
154897338|NCT01484561|559044535|FG001|Overall Study|Adverse Event|4|||
154897339|NCT01112982|559044536|FG000|Overall Study|Withdrawal by Subject|1|||
154897340|NCT01112982|559044536|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
154897341|NCT03371251|559044537|FG000|Overall Study|Withdrawal by Subject|1|||
154897342|NCT03371251|559044538|FG001|Overall Study|Withdrawal by Subject|0|||
154897343|NCT03371251|559044539|FG002|Overall Study|Withdrawal by Subject|1|||
154897344|NCT03371251|559044540|FG003|Overall Study|Withdrawal by Subject|0|||
154897345|NCT03371251|559044541|FG004|Overall Study|Withdrawal by Subject|2|||
154897346|NCT03371251|559044542|FG005|Overall Study|Withdrawal by Subject|2|||
154897347|NCT03371251|559044537|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
154897348|NCT03371251|559044538|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
154897349|NCT03371251|559044539|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
154897350|NCT03371251|559044540|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
154897351|NCT03371251|559044541|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
154897352|NCT03371251|559044542|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
154897353|NCT03371251|559044537|FG000|Overall Study|Adverse Event|0|||
154897354|NCT03371251|559044538|FG001|Overall Study|Adverse Event|0|||
154897355|NCT03371251|559044539|FG002|Overall Study|Adverse Event|0|||
154897356|NCT03371251|559044540|FG003|Overall Study|Adverse Event|0|||
154897357|NCT03371251|559044541|FG004|Overall Study|Adverse Event|1|||
154897358|NCT03371251|559044542|FG005|Overall Study|Adverse Event|0|||
154897359|NCT03371251|559044537|FG000|Overall Study|Decision by Sponsor|0|||
154897360|NCT03371251|559044538|FG001|Overall Study|Decision by Sponsor|0|||
154897361|NCT03371251|559044539|FG002|Overall Study|Decision by Sponsor|0|||
154897362|NCT03371251|559044540|FG003|Overall Study|Decision by Sponsor|0|||
154897363|NCT03371251|559044541|FG004|Overall Study|Decision by Sponsor|2|||
154897364|NCT03371251|559044542|FG005|Overall Study|Decision by Sponsor|0|||
154897365|NCT00294684|559044543|FG000|Overall Study|Lost to Follow-up|5|||
154897366|NCT00294684|559044544|FG001|Overall Study|Lost to Follow-up|8|||
154897367|NCT00126672|559044545|FG000|Overall Study|Adverse Event|4|||
154897368|NCT00126672|559044545|FG000|Overall Study|Lost to Follow-up|4|||
154897369|NCT01001234|559044546|FG000|Overall Study|Withdrawal by Subject|2|||
154897370|NCT01001234|559044547|FG001|Overall Study|Withdrawal by Subject|0|||
154897371|NCT01001234|559044548|FG002|Overall Study|Withdrawal by Subject|3|||
154897372|NCT01001234|559044549|FG003|Overall Study|Withdrawal by Subject|0|||
154897373|NCT01001234|559044550|FG004|Overall Study|Withdrawal by Subject|0|||
154897374|NCT01001234|559044546|FG000|Overall Study|Protocol Violation|34|||
154897375|NCT01001234|559044547|FG001|Overall Study|Protocol Violation|3|||
154897376|NCT01001234|559044548|FG002|Overall Study|Protocol Violation|19|||
154897377|NCT01001234|559044549|FG003|Overall Study|Protocol Violation|18|||
154897378|NCT01001234|559044550|FG004|Overall Study|Protocol Violation|0|||
154897379|NCT01001234|559044546|FG000|Overall Study|Lost to Follow-up|0|||
154897380|NCT01001234|559044547|FG001|Overall Study|Lost to Follow-up|0|||
154897381|NCT01001234|559044548|FG002|Overall Study|Lost to Follow-up|1|||
154979863|NCT03877926|559349187|FG001|Overall Study|Not Treated|1|||
154979864|NCT03877926|559349188|FG002|Overall Study|Not Treated|1|||
154979865|NCT03877926|559349189|FG003|Overall Study|Not Treated|0|||
154979866|NCT02400476|559349190|FG000|Overall Study|Adverse Event|57|||
154979867|NCT02400476|559349191|FG001|Overall Study|Adverse Event|10|||
154979868|NCT02400476|559349192|FG002|Overall Study|Adverse Event|22|||
154979869|NCT02400476|559349193|FG003|Overall Study|Adverse Event|19|||
154979870|NCT02400476|559349194|FG004|Overall Study|Adverse Event|5|||
154979871|NCT02400476|559349195|FG005|Overall Study|Adverse Event|8|||
154979872|NCT02400476|559349190|FG000|Overall Study|Withdrawal by Subject|4|||
154979873|NCT02400476|559349191|FG001|Overall Study|Withdrawal by Subject|1|||
154979874|NCT02400476|559349192|FG002|Overall Study|Withdrawal by Subject|12|||
154979875|NCT02400476|559349193|FG003|Overall Study|Withdrawal by Subject|7|||
154979876|NCT02400476|559349194|FG004|Overall Study|Withdrawal by Subject|5|||
154979877|NCT02400476|559349195|FG005|Overall Study|Withdrawal by Subject|5|||
154979878|NCT02400476|559349190|FG000|Overall Study|Lost to Follow-up|0|||
154979879|NCT02400476|559349191|FG001|Overall Study|Lost to Follow-up|0|||
154979880|NCT02400476|559349192|FG002|Overall Study|Lost to Follow-up|0|||
154979881|NCT02400476|559349193|FG003|Overall Study|Lost to Follow-up|1|||
154979882|NCT02400476|559349194|FG004|Overall Study|Lost to Follow-up|3|||
154979883|NCT02400476|559349195|FG005|Overall Study|Lost to Follow-up|1|||
154979884|NCT02400476|559349190|FG000|Overall Study|Physician Decision|0|||
154979885|NCT02400476|559349191|FG001|Overall Study|Physician Decision|0|||
154979886|NCT02400476|559349192|FG002|Overall Study|Physician Decision|1|||
154979887|NCT02400476|559349193|FG003|Overall Study|Physician Decision|1|||
154979888|NCT02400476|559349194|FG004|Overall Study|Physician Decision|0|||
154979889|NCT02400476|559349195|FG005|Overall Study|Physician Decision|1|||
154979890|NCT02400476|559349190|FG000|Overall Study|Other, Disease Progression|0|||
154979891|NCT02400476|559349191|FG001|Overall Study|Other, Disease Progression|1|||
154979892|NCT02400476|559349192|FG002|Overall Study|Other, Disease Progression|2|||
154979893|NCT02400476|559349193|FG003|Overall Study|Other, Disease Progression|1|||
154897382|NCT01001234|559044549|FG003|Overall Study|Lost to Follow-up|2|||
154897383|NCT01001234|559044550|FG004|Overall Study|Lost to Follow-up|0|||
154897384|NCT01001234|559044546|FG000|Overall Study|Physician Decision|1|||
154897385|NCT01001234|559044547|FG001|Overall Study|Physician Decision|0|||
154897386|NCT01001234|559044548|FG002|Overall Study|Physician Decision|0|||
154897387|NCT01001234|559044549|FG003|Overall Study|Physician Decision|0|||
154897388|NCT01001234|559044550|FG004|Overall Study|Physician Decision|0|||
154897389|NCT01001234|559044546|FG000|Overall Study|Not Treated: Adverse Event|1|||
154897390|NCT01001234|559044547|FG001|Overall Study|Not Treated: Adverse Event|0|||
154897391|NCT01001234|559044548|FG002|Overall Study|Not Treated: Adverse Event|0|||
154897392|NCT01001234|559044549|FG003|Overall Study|Not Treated: Adverse Event|0|||
154897393|NCT01001234|559044550|FG004|Overall Study|Not Treated: Adverse Event|0|||
154897394|NCT01001234|559044546|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
154897395|NCT01001234|559044547|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
154897396|NCT01001234|559044548|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
154897397|NCT01001234|559044549|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
154897398|NCT01001234|559044550|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
154897399|NCT01001234|559044546|FG000|Overall Study|Not Treated: Protocol Violation|3|||
154897400|NCT01001234|559044547|FG001|Overall Study|Not Treated: Protocol Violation|0|||
154897401|NCT01001234|559044548|FG002|Overall Study|Not Treated: Protocol Violation|0|||
154897402|NCT01001234|559044549|FG003|Overall Study|Not Treated: Protocol Violation|0|||
154897403|NCT01001234|559044550|FG004|Overall Study|Not Treated: Protocol Violation|0|||
154897404|NCT01001234|559044546|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
154979894|NCT02400476|559349194|FG004|Overall Study|Other, Disease Progression|2|||
154979895|NCT02400476|559349195|FG005|Overall Study|Other, Disease Progression|1|||
154979896|NCT02400476|559349190|FG000|Overall Study|Other, Decreased Quality of Life|0|||
154979897|NCT02400476|559349191|FG001|Overall Study|Other, Decreased Quality of Life|0|||
154979898|NCT02400476|559349192|FG002|Overall Study|Other, Decreased Quality of Life|2|||
154979899|NCT02400476|559349193|FG003|Overall Study|Other, Decreased Quality of Life|0|||
154979900|NCT02400476|559349194|FG004|Overall Study|Other, Decreased Quality of Life|0|||
154979901|NCT02400476|559349195|FG005|Overall Study|Other, Decreased Quality of Life|0|||
154979902|NCT02400476|559349190|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
154979903|NCT02400476|559349191|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
154979904|NCT02400476|559349192|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
154897405|NCT01001234|559044547|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
154897406|NCT01001234|559044548|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
154897407|NCT01001234|559044549|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
154979905|NCT02400476|559349193|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
154979906|NCT02400476|559349194|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
154979907|NCT02400476|559349195|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
154979908|NCT00588731|559349196|FG000|Overall Study|Withdrawal by Subject|3|||
154979909|NCT00588731|559349197|FG001|Overall Study|Withdrawal by Subject|2|||
154979910|NCT00467831|559349199|FG000|Overall Study|Death|2|||
154979911|NCT00467831|559349199|FG000|Overall Study|Withdrawal by Subject|1|||
154979912|NCT01832402|559349200|FG000|Overall Study|Lost to Follow-up|2|||
154979913|NCT01832402|559349201|FG001|Overall Study|Lost to Follow-up|0|||
154979914|NCT01832402|559349200|FG000|Overall Study|Withdrawal by Subject|3|||
154979915|NCT01832402|559349201|FG001|Overall Study|Withdrawal by Subject|3|||
154979916|NCT01832402|559349200|FG000|Overall Study|Declining Performance status|2|||
154979917|NCT01832402|559349201|FG001|Overall Study|Declining Performance status|1|||
154979918|NCT01198873|559349202|FG000|Overall Study|Adverse Event|4|||
154979919|NCT01198873|559349203|FG001|Overall Study|Adverse Event|7|||
154979920|NCT01198873|559349202|FG000|Overall Study|Study closure|29|||
154979921|NCT01198873|559349203|FG001|Overall Study|Study closure|23|||
154979922|NCT01198873|559349202|FG000|Overall Study|Other than above|4|||
154979923|NCT01198873|559349203|FG001|Overall Study|Other than above|2|||
154979924|NCT00860743|559349204|FG000|Overall Study|Withdrawal by Subject|3|||
154979925|NCT00860743|559349205|FG001|Overall Study|Withdrawal by Subject|0|||
154979926|NCT02776553|559349206|FG000|Overall Study|Lost to Follow-up|1|||
154979927|NCT02776553|559349207|FG001|Overall Study|Lost to Follow-up|0|||
154979928|NCT02776553|559349206|FG000|Overall Study|got liver transplant|1|||
154979929|NCT02776553|559349207|FG001|Overall Study|got liver transplant|2|||
154979930|NCT02776553|559349206|FG000|Overall Study|had other surgery|1|||
154979931|NCT02776553|559349207|FG001|Overall Study|had other surgery|0|||
154979932|NCT02776553|559349206|FG000|Overall Study|Protocol Violation|0|||
154979933|NCT02776553|559349207|FG001|Overall Study|Protocol Violation|1|||
154979934|NCT02927834|559349208|FG000|Overall Study|Lost to Follow-up|1|||
154979935|NCT02927834|559349209|FG001|Overall Study|Lost to Follow-up|2|||
154979936|NCT02927834|559349210|FG002|Overall Study|Lost to Follow-up|2|||
154979937|NCT00479388|559349211|FG000|Overall Study|Adverse Event|90|||
154979938|NCT00479388|559349212|FG001|Overall Study|Adverse Event|45|||
154979939|NCT00479388|559349211|FG000|Overall Study|Lost to Follow-up|0|||
154979940|NCT00479388|559349212|FG001|Overall Study|Lost to Follow-up|2|||
154979941|NCT00479388|559349211|FG000|Overall Study|Protocol Violation|10|||
154979942|NCT00479388|559349212|FG001|Overall Study|Protocol Violation|9|||
154979943|NCT00479388|559349211|FG000|Overall Study|Withdrawal by Subject|32|||
154979944|NCT00479388|559349212|FG001|Overall Study|Withdrawal by Subject|17|||
154979945|NCT01644149|559349213|FG000|Overall Study|Withdrawal by Subject|1|||
154979946|NCT01644149|559349214|FG001|Overall Study|Withdrawal by Subject|0|||
154979947|NCT01644149|559349213|FG000|Overall Study|Lost to Follow-up|3|||
154979948|NCT01644149|559349214|FG001|Overall Study|Lost to Follow-up|1|||
154979949|NCT00690482|559349217|FG000|Overall Study|Adverse Event|2|||
154979950|NCT00690482|559349218|FG001|Overall Study|Adverse Event|1|||
154979951|NCT00690482|559349217|FG000|Overall Study|Incorrect enrolment|0|||
154979952|NCT00690482|559349218|FG001|Overall Study|Incorrect enrolment|1|||
154979953|NCT00690482|559349217|FG000|Overall Study|Study-specific discontinuation criteria|1|||
154979954|NCT00690482|559349218|FG001|Overall Study|Study-specific discontinuation criteria|0|||
154979955|NCT00690482|559349217|FG000|Overall Study|Intake of prohibited medicine|1|||
154979956|NCT00690482|559349218|FG001|Overall Study|Intake of prohibited medicine|0|||
154897408|NCT01001234|559044550|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
154897409|NCT01001234|559044546|FG000|Overall Study|Not Treated: Pregnancy|3|||
154897410|NCT01001234|559044547|FG001|Overall Study|Not Treated: Pregnancy|0|||
154897411|NCT01001234|559044548|FG002|Overall Study|Not Treated: Pregnancy|0|||
154897412|NCT01001234|559044549|FG003|Overall Study|Not Treated: Pregnancy|0|||
154897413|NCT01001234|559044550|FG004|Overall Study|Not Treated: Pregnancy|0|||
154897414|NCT01001234|559044546|FG000|Overall Study|Not Treated: Physician Decision|37|||
154897415|NCT01001234|559044547|FG001|Overall Study|Not Treated: Physician Decision|4|||
154897416|NCT01001234|559044548|FG002|Overall Study|Not Treated: Physician Decision|0|||
154897417|NCT01001234|559044549|FG003|Overall Study|Not Treated: Physician Decision|0|||
154897418|NCT01001234|559044550|FG004|Overall Study|Not Treated: Physician Decision|0|||
154897419|NCT01001234|559044546|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
154897420|NCT01001234|559044547|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
154897421|NCT01001234|559044548|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
154897422|NCT01001234|559044549|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
154979957|NCT00690482|559349217|FG000|Overall Study|withdrew consent at rand.day|0|||
154897423|NCT01001234|559044550|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
154897424|NCT01851863|559044552|FG000|Overall Study|Did not receive study medication|2|||
154897425|NCT01851863|559044553|FG001|Overall Study|Did not receive study medication|5|||
154897426|NCT01851863|559044554|FG002|Overall Study|Did not receive study medication|3|||
154897427|NCT01851863|559044555|FG003|Overall Study|Did not receive study medication|0|||
154897428|NCT01851863|559044552|FG000|Overall Study|Lost to Follow-up|3|||
154979958|NCT00690482|559349218|FG001|Overall Study|withdrew consent at rand.day|1|||
154979959|NCT04798482|559349219|FG000|Overall Study|Physician Decision|1|||
154979960|NCT04798482|559349219|FG000|Overall Study|Lost eligibility|1|||
154979961|NCT00890552|559349220|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
154979962|NCT00890552|559349220|FG000|On-treatment|Early prog disease/ death|10|||
154979963|NCT04117945|559349224|FG000|Overall Study|Death|1|||
154979964|NCT04117945|559349225|FG001|Overall Study|Death|0|||
154979965|NCT04117945|559349224|FG000|Overall Study|Withdrawal by Subject|3|||
154897429|NCT01851863|559044553|FG001|Overall Study|Lost to Follow-up|4|||
154897430|NCT01851863|559044554|FG002|Overall Study|Lost to Follow-up|2|||
154897431|NCT01851863|559044555|FG003|Overall Study|Lost to Follow-up|3|||
154897432|NCT00753623|559044556|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
154897433|NCT00753623|559044557|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
154897434|NCT00753623|559044556|FG000|Phase I (14 Days)|Physician Decision|1|||
154897435|NCT00753623|559044557|FG001|Phase I (14 Days)|Physician Decision|2|||
154897436|NCT00753623|559044556|FG000|Phase I (14 Days)|Adverse Event|0|||
154897437|NCT00753623|559044557|FG001|Phase I (14 Days)|Adverse Event|1|||
154897438|NCT00753623|559044556|FG000|Washout (7 Days)|Physician Decision|1|||
154897439|NCT00753623|559044557|FG001|Washout (7 Days)|Physician Decision|0|||
154897440|NCT00753623|559044556|FG000|Phase II (14 Days)|Physician Decision|0|||
154897441|NCT00753623|559044557|FG001|Phase II (14 Days)|Physician Decision|1|||
154897442|NCT03332303|559044558|FG000|Overall Study|Participant did not dose|1|||
154897443|NCT03332303|559044559|FG001|Overall Study|Participant did not dose|2|||
154897444|NCT03332303|559044560|FG002|Overall Study|Participant did not dose|0|||
154897445|NCT03332303|559044558|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
154897446|NCT03332303|559044559|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
154897447|NCT03332303|559044560|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
154897448|NCT03332303|559044558|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
154897449|NCT03332303|559044559|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
154897450|NCT03332303|559044560|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
154897451|NCT03332303|559044558|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
154897452|NCT03332303|559044559|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
154897453|NCT03332303|559044560|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
154897454|NCT03332303|559044558|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
154897455|NCT03332303|559044559|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
154897456|NCT03332303|559044560|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
154897457|NCT03332303|559044558|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
154897458|NCT03332303|559044559|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
154897459|NCT03332303|559044560|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
154897460|NCT03332303|559044558|FG000|Overall Study|Participant had a significant protocol deviation|0|||
154897461|NCT03332303|559044559|FG001|Overall Study|Participant had a significant protocol deviation|1|||
154897462|NCT03332303|559044560|FG002|Overall Study|Participant had a significant protocol deviation|0|||
154897463|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
154897464|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
154897465|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
154897466|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
154897467|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
154897468|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
154897469|NCT00996593|559044561|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
154897470|NCT00996593|559044561|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
154897471|NCT00996593|559044561|FG000|Long-Term Follow-Up|Site Closed|1|||
154897472|NCT00871572|559044562|FG000|Overall Study|Adverse Event|0|||
154897473|NCT00871572|559044563|FG001|Overall Study|Adverse Event|2|||
154897474|NCT00871572|559044564|FG002|Overall Study|Adverse Event|0|||
154897475|NCT00871572|559044565|FG003|Overall Study|Adverse Event|3|||
154897476|NCT00871572|559044562|FG000|Overall Study|Investigator Decision|0|||
154897477|NCT00871572|559044563|FG001|Overall Study|Investigator Decision|1|||
154897478|NCT00871572|559044564|FG002|Overall Study|Investigator Decision|0|||
154897479|NCT00871572|559044565|FG003|Overall Study|Investigator Decision|1|||
154897480|NCT00871572|559044562|FG000|Overall Study|Lost to Follow-up|0|||
154897481|NCT00871572|559044563|FG001|Overall Study|Lost to Follow-up|1|||
154897482|NCT00871572|559044564|FG002|Overall Study|Lost to Follow-up|0|||
154897483|NCT00871572|559044565|FG003|Overall Study|Lost to Follow-up|1|||
154897484|NCT00871572|559044562|FG000|Overall Study|Protocol Violation|0|||
154897485|NCT00871572|559044563|FG001|Overall Study|Protocol Violation|0|||
154897486|NCT00871572|559044564|FG002|Overall Study|Protocol Violation|1|||
155114350|NCT02456636|559848129|FG000|Overall Study|Lost to Follow-up|50|||
155114351|NCT02456636|559848130|FG001|Overall Study|Lost to Follow-up|44|||
155114352|NCT02456636|559848131|FG002|Overall Study|Lost to Follow-up|50|||
155114353|NCT01606787|559848133|FG000|Overall Study|Withdrawal by Subject|4|||
155114354|NCT01606787|559848134|FG001|Overall Study|Withdrawal by Subject|5|||
154897487|NCT00871572|559044565|FG003|Overall Study|Protocol Violation|1|||
154897488|NCT00871572|559044562|FG000|Overall Study|Sponsor Decision|1|||
154897489|NCT00871572|559044563|FG001|Overall Study|Sponsor Decision|0|||
154897490|NCT00871572|559044564|FG002|Overall Study|Sponsor Decision|0|||
154897491|NCT00871572|559044565|FG003|Overall Study|Sponsor Decision|0|||
155114355|NCT01606787|559848133|FG000|Overall Study|Surgery canceled|0|||
155114356|NCT01606787|559848134|FG001|Overall Study|Surgery canceled|2|||
154897492|NCT00871572|559044562|FG000|Overall Study|Withdrawal by Subject|1|||
154897493|NCT00871572|559044563|FG001|Overall Study|Withdrawal by Subject|2|||
154897494|NCT00871572|559044564|FG002|Overall Study|Withdrawal by Subject|3|||
154897495|NCT00871572|559044565|FG003|Overall Study|Withdrawal by Subject|1|||
154897496|NCT00405652|559044570|FG000|Overall Study|Adverse Event|4|||
154897497|NCT00631540|559044573|FG000|Overall Study|Withdrawal by Subject|5|||
154897498|NCT00631540|559044573|FG000|Overall Study|Death|4|||
154897499|NCT00631540|559044573|FG000|Overall Study|Lost to Follow-up|2|||
154897500|NCT00631540|559044573|FG000|Overall Study|Core Lab Data Unavailable|3|||
154897501|NCT00795509|559044574|FG000|Overall Study|Protocol Violation|31|||
154897502|NCT00970268|559044575|FG000|Overall Study|Withdrawal by Subject|12|||
154897503|NCT00970268|559044576|FG001|Overall Study|Withdrawal by Subject|19|||
154897504|NCT00970268|559044575|FG000|Overall Study|Adverse Event|15|||
154897505|NCT00970268|559044576|FG001|Overall Study|Adverse Event|12|||
154897506|NCT00970268|559044575|FG000|Overall Study|Lack of Efficacy|3|||
154897507|NCT00970268|559044576|FG001|Overall Study|Lack of Efficacy|6|||
154897508|NCT00970268|559044575|FG000|Overall Study|Protocol Violation|4|||
154897509|NCT00970268|559044576|FG001|Overall Study|Protocol Violation|7|||
154897510|NCT00970268|559044575|FG000|Overall Study|Other Reason|3|||
154897511|NCT00970268|559044576|FG001|Overall Study|Other Reason|1|||
154897512|NCT00970268|559044575|FG000|Overall Study|COPD Exacerbation|4|||
154897513|NCT00970268|559044576|FG001|Overall Study|COPD Exacerbation|2|||
154897514|NCT00970268|559044575|FG000|Overall Study|Lost to Follow-up|1|||
154979966|NCT04117945|559349225|FG001|Overall Study|Withdrawal by Subject|1|||
154979967|NCT04117945|559349224|FG000|Overall Study|Disease Progression|0|||
154979968|NCT04117945|559349225|FG001|Overall Study|Disease Progression|2|||
154979969|NCT04117945|559349224|FG000|Overall Study|Ineligible|8|||
154979970|NCT04117945|559349225|FG001|Overall Study|Ineligible|7|||
154979971|NCT02737592|559349226|FG000|Overall Study|Withdrawal by Subject|1|||
154979972|NCT02792218|559349227|FG000|Overall Study|Patient/guardian decision|15|||
154979973|NCT02792218|559349228|FG001|Overall Study|Patient/guardian decision|42|||
154979974|NCT02792218|559349227|FG000|Overall Study|Adverse Event|15|||
154979975|NCT02792218|559349228|FG001|Overall Study|Adverse Event|14|||
154979976|NCT02792218|559349227|FG000|Overall Study|Lost to Follow-up|10|||
154979977|NCT02792218|559349228|FG001|Overall Study|Lost to Follow-up|5|||
154979978|NCT02792218|559349227|FG000|Overall Study|Lack of Efficacy|1|||
154979979|NCT02792218|559349228|FG001|Overall Study|Lack of Efficacy|12|||
154979980|NCT02792218|559349227|FG000|Overall Study|Physician Decision|4|||
154979981|NCT02792218|559349228|FG001|Overall Study|Physician Decision|4|||
154979982|NCT02792218|559349227|FG000|Overall Study|Protocol deviation|3|||
154979983|NCT02792218|559349228|FG001|Overall Study|Protocol deviation|2|||
154979984|NCT02792218|559349227|FG000|Overall Study|New therapy for study indication|0|||
154979985|NCT02792218|559349228|FG001|Overall Study|New therapy for study indication|1|||
154979986|NCT02792218|559349227|FG000|Overall Study|Non-compliance with study treatment|0|||
154979987|NCT02792218|559349228|FG001|Overall Study|Non-compliance with study treatment|1|||
154979988|NCT02792218|559349227|FG000|Overall Study|Pregnancy|1|||
154979989|NCT02792218|559349228|FG001|Overall Study|Pregnancy|0|||
154979990|NCT03123783|559349229|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
154979991|NCT03123783|559349230|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
154979992|NCT03123783|559349231|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
154979993|NCT03123783|559349232|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
154979994|NCT03123783|559349233|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
154979995|NCT03123783|559349234|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
154979996|NCT03123783|559349235|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
154979997|NCT03123783|559349229|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
154979998|NCT03123783|559349230|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
154979999|NCT03123783|559349231|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
154980000|NCT03123783|559349232|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
154980001|NCT03123783|559349233|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
154980002|NCT03123783|559349234|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
154980003|NCT03123783|559349235|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
154980004|NCT03123783|559349229|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
154980005|NCT03123783|559349230|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
154980006|NCT03123783|559349231|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
154980007|NCT03123783|559349232|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
154897515|NCT00970268|559044576|FG001|Overall Study|Lost to Follow-up|2|||
154897516|NCT00970268|559044575|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
154897517|NCT00970268|559044576|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
154897518|NCT01079195|559044577|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
154980008|NCT03123783|559349233|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
154980009|NCT03123783|559349234|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
155114357|NCT05312632|559848138|FG000|Overall Study|Adverse Event|12|||
155114358|NCT05312632|559848138|FG000|Overall Study|Withdrawal by Subject|10|||
155114359|NCT05312632|559848138|FG000|Overall Study|Lack of Efficacy|4|||
155114360|NCT05312632|559848138|FG000|Overall Study|Non-compliance with study procedures|9|||
155114361|NCT05312632|559848138|FG000|Overall Study|Other|4|||
155114362|NCT02379221|559848139|FG000|Overall Study|Lost to Follow-up|1|||
155114363|NCT02019108|559848140|FG000|Overall Study|Lost to Follow-up|5|||
155114364|NCT02019108|559848141|FG001|Overall Study|Lost to Follow-up|7|||
155114365|NCT00519376|559848144|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114366|NCT00519376|559848145|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114367|NCT00519376|559848146|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114368|NCT00519376|559848147|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114369|NCT00519376|559848148|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114370|NCT00519376|559848149|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114371|NCT00519376|559848150|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114372|NCT00519376|559848151|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114373|NCT00519376|559848152|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114374|NCT00519376|559848153|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114375|NCT00519376|559848154|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114376|NCT00519376|559848155|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114377|NCT00519376|559848156|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
155114378|NCT00519376|559848157|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114379|NCT00519376|559848158|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114380|NCT00519376|559848159|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
155114381|NCT00519376|559848144|FG000|Treatment Period 4|Lost to Follow-up|0|||
155114382|NCT00519376|559848145|FG001|Treatment Period 4|Lost to Follow-up|0|||
155114383|NCT00519376|559848146|FG002|Treatment Period 4|Lost to Follow-up|1|||
155114384|NCT00519376|559848147|FG003|Treatment Period 4|Lost to Follow-up|0|||
155114385|NCT00519376|559848148|FG004|Treatment Period 4|Lost to Follow-up|0|||
155114386|NCT00519376|559848149|FG005|Treatment Period 4|Lost to Follow-up|0|||
155114387|NCT00519376|559848150|FG006|Treatment Period 4|Lost to Follow-up|0|||
155114388|NCT00519376|559848151|FG007|Treatment Period 4|Lost to Follow-up|0|||
155114389|NCT00519376|559848152|FG008|Treatment Period 4|Lost to Follow-up|0|||
155114390|NCT00519376|559848153|FG009|Treatment Period 4|Lost to Follow-up|0|||
155114391|NCT00519376|559848154|FG010|Treatment Period 4|Lost to Follow-up|0|||
155114392|NCT00519376|559848155|FG011|Treatment Period 4|Lost to Follow-up|0|||
155114393|NCT00519376|559848156|FG012|Treatment Period 4|Lost to Follow-up|0|||
155114394|NCT00519376|559848157|FG013|Treatment Period 4|Lost to Follow-up|0|||
155114395|NCT00519376|559848158|FG014|Treatment Period 4|Lost to Follow-up|0|||
155114396|NCT00519376|559848159|FG015|Treatment Period 4|Lost to Follow-up|0|||
155114397|NCT02688088|559848162|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155114398|NCT02688088|559848163|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
155114399|NCT02688088|559848164|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155114400|NCT02688088|559848165|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155114401|NCT02688088|559848166|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
155114402|NCT02688088|559848162|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
154897519|NCT01079195|559044577|FG000|Overall Study|No Documentation Available|437|||
154897520|NCT01079195|559044577|FG000|Overall Study|Adverse Event|157|||
154897521|NCT01079195|559044577|FG000|Overall Study|Reason Unknown|39|||
154897522|NCT01079195|559044577|FG000|Overall Study|Withdrawal by Subject|18|||
154897523|NCT01079195|559044577|FG000|Overall Study|Financial Reasons|15|||
154897524|NCT01079195|559044577|FG000|Overall Study|Lack of Effectiveness|12|||
155114403|NCT02688088|559848163|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
155114404|NCT02688088|559848164|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155114405|NCT02688088|559848165|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155114406|NCT02688088|559848166|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
155114407|NCT02688088|559848162|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155114408|NCT02688088|559848163|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
155114409|NCT02688088|559848164|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155114410|NCT02688088|559848165|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155114411|NCT02688088|559848166|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
155114412|NCT02688088|559848162|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155114413|NCT02688088|559848163|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
155114414|NCT02688088|559848164|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155114415|NCT02688088|559848165|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155114416|NCT02688088|559848166|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
155114417|NCT02688088|559848162|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155114418|NCT02688088|559848163|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155114419|NCT02688088|559848164|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
155114420|NCT02688088|559848165|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
154897525|NCT01079195|559044577|FG000|Overall Study|Physician Decision|4|||
154897526|NCT01079195|559044577|FG000|Overall Study|Improved Status of Participant|4|||
154897527|NCT01079195|559044577|FG000|Overall Study|No Follow-up Documentation Available|4|||
154897528|NCT01079195|559044577|FG000|Overall Study|Non-compliance|2|||
154897529|NCT01999946|559044581|FG000|Overall Study|Participant not released from jail|2|||
154897530|NCT01999946|559044582|FG001|Overall Study|Participant not released from jail|2|||
154897531|NCT01999946|559044583|FG002|Overall Study|Participant not released from jail|0|||
154897532|NCT01999946|559044581|FG000|Overall Study|Not included in primary outcome analysis|0|||
154897533|NCT01999946|559044582|FG001|Overall Study|Not included in primary outcome analysis|0|||
154897534|NCT01999946|559044583|FG002|Overall Study|Not included in primary outcome analysis|79|||
154897535|NCT03366844|559046299|FG000|Overall Study|Physician Decision|1|||
154897536|NCT03366844|559046299|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
154897537|NCT02687711|559046302|FG000|Overall Study|Adverse Event|89|||
154897538|NCT02687711|559046302|FG000|Overall Study|Lack of Efficacy|70|||
154897539|NCT02687711|559046302|FG000|Overall Study|Lost to Follow-up|20|||
154897540|NCT02687711|559046302|FG000|Overall Study|Consent withdrawn|15|||
154897541|NCT02687711|559046302|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
154897542|NCT02687711|559046302|FG000|Overall Study|Too expensive|4|||
154897543|NCT02687711|559046302|FG000|Overall Study|Participant moved abroad|1|||
154897544|NCT02687711|559046302|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
154897545|NCT02687711|559046302|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
154897546|NCT02687711|559046302|FG000|Overall Study|Disliked taste|1|||
154897547|NCT02687711|559046302|FG000|Overall Study|Low mood|1|||
154897548|NCT02687711|559046302|FG000|Overall Study|Side effects|1|||
154897549|NCT02687711|559046302|FG000|Overall Study|Change of Hospital|1|||
154897550|NCT02687711|559046302|FG000|Overall Study|Liver Encephalopathy|1|||
154897551|NCT02687711|559046302|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
154897552|NCT02687711|559046302|FG000|Overall Study|Withdrawn due to intake interruption|1|||
154897553|NCT02687711|559046302|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
154897554|NCT02687711|559046302|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
154897555|NCT02687711|559046302|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
154897556|NCT02038790|559046307|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
154897557|NCT02038790|559046308|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
154897558|NCT02431702|559046309|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
154897559|NCT02431702|559046310|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
154897560|NCT02431702|559046311|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
154897561|NCT02431702|559046312|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
154897562|NCT02431702|559046313|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
154897563|NCT02431702|559046314|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
154897564|NCT02431702|559046315|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
154897565|NCT02431702|559046309|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
154897566|NCT02431702|559046310|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
154897567|NCT02431702|559046311|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
154897568|NCT02431702|559046312|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
154897569|NCT02431702|559046313|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
154897570|NCT02431702|559046314|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
154897571|NCT02431702|559046315|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
154897572|NCT02431702|559046309|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
154897573|NCT02431702|559046310|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
154897574|NCT02431702|559046311|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
154897575|NCT02431702|559046312|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
154897576|NCT02431702|559046313|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
154897577|NCT02431702|559046314|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
154897578|NCT02431702|559046315|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
154897579|NCT02431702|559046309|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
154897580|NCT02431702|559046310|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
154897581|NCT02431702|559046311|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
154897582|NCT02431702|559046312|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
154897583|NCT02431702|559046313|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
154897584|NCT02431702|559046314|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
154897585|NCT02431702|559046315|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
154897586|NCT02431702|559046309|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
154897587|NCT02431702|559046310|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
154897588|NCT02431702|559046311|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
154897589|NCT02431702|559046312|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
154897590|NCT02431702|559046313|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
154897591|NCT02431702|559046314|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
155175661|NCT00869778|560080305|FG000|Overall Study|Unblinding|1|||
154897592|NCT02431702|559046315|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
154897593|NCT02431702|559046309|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
154897594|NCT02431702|559046310|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
154897595|NCT02431702|559046311|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
154897596|NCT02431702|559046312|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
154897597|NCT02431702|559046313|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
154897598|NCT02431702|559046314|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
154897599|NCT02431702|559046315|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
154897600|NCT02431702|559046309|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
154897601|NCT02431702|559046310|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
154897602|NCT02431702|559046311|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
154897603|NCT02431702|559046312|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
154897604|NCT02431702|559046313|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
154897605|NCT02431702|559046314|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
154897606|NCT02431702|559046315|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
154897607|NCT02431702|559046309|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
154897608|NCT02431702|559046310|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
154897609|NCT02431702|559046311|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
154897610|NCT02431702|559046312|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
154897611|NCT02431702|559046313|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
154897612|NCT02431702|559046314|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
154897613|NCT02431702|559046315|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
154897614|NCT02431702|559046309|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
154897615|NCT02431702|559046310|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
154897616|NCT02431702|559046311|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
154897617|NCT02431702|559046312|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
154897618|NCT02431702|559046313|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
154897619|NCT02431702|559046314|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
154897620|NCT02431702|559046315|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
154897621|NCT02431702|559046309|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
154897622|NCT02431702|559046310|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
154897623|NCT02431702|559046311|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
154897624|NCT02431702|559046312|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
154897625|NCT02431702|559046313|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
154897626|NCT02431702|559046314|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
154897627|NCT02431702|559046315|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
154897628|NCT02431702|559046309|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
154897629|NCT02431702|559046310|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
154897630|NCT02431702|559046311|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
154897631|NCT02431702|559046312|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
154897632|NCT02431702|559046313|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
154897633|NCT02431702|559046314|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
154897634|NCT02431702|559046315|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
154897635|NCT02431702|559046309|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
154897636|NCT02431702|559046310|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
154897637|NCT02431702|559046311|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
154897638|NCT02431702|559046312|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
154897639|NCT02431702|559046313|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
154897640|NCT02431702|559046314|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
154897641|NCT02431702|559046315|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
154897642|NCT02431702|559046309|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
154897643|NCT02431702|559046310|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
154897644|NCT02431702|559046311|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
154897645|NCT02431702|559046312|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
154897646|NCT02431702|559046313|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
154897647|NCT02431702|559046314|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
154897648|NCT02431702|559046315|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
154897649|NCT02431702|559046309|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
154897650|NCT02431702|559046310|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
155114421|NCT02688088|559848166|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
155114422|NCT02688088|559848162|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
155114423|NCT02688088|559848163|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
155114424|NCT02688088|559848164|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
154897651|NCT02431702|559046311|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
154897652|NCT02431702|559046312|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
154897653|NCT02431702|559046313|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
154897654|NCT02431702|559046314|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
154897655|NCT02431702|559046315|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
154897656|NCT02431702|559046309|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
154897657|NCT02431702|559046310|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
154897658|NCT02431702|559046311|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
154897659|NCT02431702|559046312|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
154897660|NCT02431702|559046313|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
154897661|NCT02431702|559046314|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
154897662|NCT02431702|559046315|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
154897663|NCT03907969|559046316|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
154897664|NCT03907969|559046317|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
154897665|NCT03907969|559046318|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
154897666|NCT03907969|559046319|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
154897667|NCT03907969|559046320|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
154897668|NCT03907969|559046321|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
154897669|NCT03907969|559046322|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
154897670|NCT03907969|559046323|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
154897671|NCT03907969|559046324|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
154897672|NCT03907969|559046325|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
154897673|NCT03907969|559046326|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
154897674|NCT03907969|559046316|FG000|Monotherapy Part A|Progressive Disease|0|||
154897675|NCT03907969|559046317|FG001|Monotherapy Part A|Progressive Disease|1|||
154897676|NCT03907969|559046318|FG002|Monotherapy Part A|Progressive Disease|0|||
154897677|NCT03907969|559046319|FG003|Monotherapy Part A|Progressive Disease|0|||
154897678|NCT03907969|559046320|FG004|Monotherapy Part A|Progressive Disease|0|||
154897679|NCT03907969|559046321|FG005|Monotherapy Part A|Progressive Disease|1|||
154897680|NCT03907969|559046322|FG006|Monotherapy Part A|Progressive Disease|2|||
154897681|NCT03907969|559046323|FG007|Monotherapy Part A|Progressive Disease|0|||
154897682|NCT03907969|559046324|FG008|Monotherapy Part A|Progressive Disease|0|||
154897683|NCT03907969|559046325|FG009|Monotherapy Part A|Progressive Disease|0|||
154897684|NCT03907969|559046326|FG010|Monotherapy Part A|Progressive Disease|0|||
154897685|NCT03907969|559046316|FG000|Monotherapy Part A|Death|0|||
154897686|NCT03907969|559046317|FG001|Monotherapy Part A|Death|0|||
154897687|NCT03907969|559046318|FG002|Monotherapy Part A|Death|1|||
154897688|NCT03907969|559046319|FG003|Monotherapy Part A|Death|1|||
154897689|NCT03907969|559046320|FG004|Monotherapy Part A|Death|0|||
154897690|NCT03907969|559046321|FG005|Monotherapy Part A|Death|1|||
154897691|NCT03907969|559046322|FG006|Monotherapy Part A|Death|0|||
154897692|NCT03907969|559046323|FG007|Monotherapy Part A|Death|0|||
154897693|NCT03907969|559046324|FG008|Monotherapy Part A|Death|0|||
154897694|NCT03907969|559046325|FG009|Monotherapy Part A|Death|0|||
154897695|NCT03907969|559046326|FG010|Monotherapy Part A|Death|0|||
154897696|NCT03907969|559046316|FG000|Combination Therapy Part A|Adverse Event|0|||
154897697|NCT03907969|559046317|FG001|Combination Therapy Part A|Adverse Event|0|||
154897698|NCT03907969|559046318|FG002|Combination Therapy Part A|Adverse Event|0|||
154897699|NCT03907969|559046319|FG003|Combination Therapy Part A|Adverse Event|0|||
154897700|NCT03907969|559046320|FG004|Combination Therapy Part A|Adverse Event|0|||
154897701|NCT03907969|559046321|FG005|Combination Therapy Part A|Adverse Event|0|||
154897702|NCT03907969|559046322|FG006|Combination Therapy Part A|Adverse Event|0|||
154897703|NCT03907969|559046323|FG007|Combination Therapy Part A|Adverse Event|0|||
154897704|NCT03907969|559046324|FG008|Combination Therapy Part A|Adverse Event|0|||
154897705|NCT03907969|559046325|FG009|Combination Therapy Part A|Adverse Event|1|||
154897706|NCT03907969|559046326|FG010|Combination Therapy Part A|Adverse Event|1|||
154897707|NCT03907969|559046316|FG000|Combination Therapy Part A|Progressive disease|0|||
154897708|NCT03907969|559046317|FG001|Combination Therapy Part A|Progressive disease|0|||
154897709|NCT03907969|559046318|FG002|Combination Therapy Part A|Progressive disease|0|||
154897710|NCT03907969|559046319|FG003|Combination Therapy Part A|Progressive disease|0|||
154897711|NCT03907969|559046320|FG004|Combination Therapy Part A|Progressive disease|0|||
154897712|NCT03907969|559046321|FG005|Combination Therapy Part A|Progressive disease|0|||
154897713|NCT03907969|559046322|FG006|Combination Therapy Part A|Progressive disease|0|||
154897714|NCT03907969|559046323|FG007|Combination Therapy Part A|Progressive disease|1|||
154897715|NCT03907969|559046324|FG008|Combination Therapy Part A|Progressive disease|0|||
154897716|NCT03907969|559046325|FG009|Combination Therapy Part A|Progressive disease|2|||
154897717|NCT03907969|559046326|FG010|Combination Therapy Part A|Progressive disease|3|||
154897718|NCT03907969|559046316|FG000|Combination Therapy Part A|Death|0|||
154897719|NCT03907969|559046317|FG001|Combination Therapy Part A|Death|0|||
154897720|NCT03907969|559046318|FG002|Combination Therapy Part A|Death|0|||
154897721|NCT03907969|559046319|FG003|Combination Therapy Part A|Death|0|||
154897722|NCT03907969|559046320|FG004|Combination Therapy Part A|Death|0|||
154897723|NCT03907969|559046321|FG005|Combination Therapy Part A|Death|0|||
154897724|NCT03907969|559046322|FG006|Combination Therapy Part A|Death|0|||
154897725|NCT03907969|559046323|FG007|Combination Therapy Part A|Death|0|||
154897726|NCT03907969|559046324|FG008|Combination Therapy Part A|Death|1|||
154897727|NCT03907969|559046325|FG009|Combination Therapy Part A|Death|0|||
154897728|NCT03907969|559046326|FG010|Combination Therapy Part A|Death|1|||
154897729|NCT03907969|559046316|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
154897730|NCT03907969|559046317|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
154897731|NCT03907969|559046318|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
154897732|NCT03907969|559046319|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
154897733|NCT03907969|559046320|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
154897734|NCT03907969|559046321|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
154897735|NCT03907969|559046322|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
154897736|NCT03907969|559046323|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
154897737|NCT03907969|559046324|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
154897738|NCT03907969|559046325|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
154897739|NCT03907969|559046326|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
154897740|NCT03907969|559046316|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
154897741|NCT03907969|559046317|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
154897742|NCT03907969|559046318|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
154897743|NCT03907969|559046319|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
154897744|NCT03907969|559046320|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
154897745|NCT03907969|559046321|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
154897746|NCT03907969|559046322|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
154897747|NCT03907969|559046323|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
154897748|NCT03907969|559046324|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
154897749|NCT03907969|559046325|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
154897750|NCT03907969|559046326|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
154897751|NCT03907969|559046316|FG000|Combination Therapy Part A|Physician Decision|0|||
154897752|NCT03907969|559046317|FG001|Combination Therapy Part A|Physician Decision|0|||
154897753|NCT03907969|559046318|FG002|Combination Therapy Part A|Physician Decision|0|||
154897754|NCT03907969|559046319|FG003|Combination Therapy Part A|Physician Decision|0|||
154897755|NCT03907969|559046320|FG004|Combination Therapy Part A|Physician Decision|0|||
154897756|NCT03907969|559046321|FG005|Combination Therapy Part A|Physician Decision|0|||
154897757|NCT03907969|559046322|FG006|Combination Therapy Part A|Physician Decision|0|||
154897758|NCT03907969|559046323|FG007|Combination Therapy Part A|Physician Decision|1|||
154897759|NCT03907969|559046324|FG008|Combination Therapy Part A|Physician Decision|0|||
154897760|NCT03907969|559046325|FG009|Combination Therapy Part A|Physician Decision|0|||
154897761|NCT03907969|559046326|FG010|Combination Therapy Part A|Physician Decision|1|||
154897762|NCT04209530|559046328|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
154897763|NCT04209530|559046329|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
154897764|NCT04209530|559046328|FG000|Overall Study|Withdrawal by Subject|0|||
154897765|NCT04209530|559046329|FG001|Overall Study|Withdrawal by Subject|1|||
154897766|NCT00633893|559046330|FG000|Overall Study|Death|1|||
154897767|NCT00633893|559046331|FG001|Overall Study|Death|3|||
154897768|NCT00633893|559046332|FG002|Overall Study|Death|9|||
154897769|NCT00633893|559046330|FG000|Overall Study|Adverse Event|65|||
154897770|NCT00633893|559046331|FG001|Overall Study|Adverse Event|58|||
154897771|NCT00633893|559046332|FG002|Overall Study|Adverse Event|126|||
154897772|NCT00633893|559046330|FG000|Overall Study|Withdrawal by Subject|7|||
154897773|NCT00633893|559046331|FG001|Overall Study|Withdrawal by Subject|12|||
154897774|NCT00633893|559046332|FG002|Overall Study|Withdrawal by Subject|6|||
154897775|NCT00633893|559046330|FG000|Overall Study|Lost to Follow-up|2|||
154897776|NCT00633893|559046331|FG001|Overall Study|Lost to Follow-up|4|||
154897777|NCT00633893|559046332|FG002|Overall Study|Lost to Follow-up|8|||
154897778|NCT00633893|559046330|FG000|Overall Study|Poor/non-compliance|5|||
154897779|NCT00633893|559046331|FG001|Overall Study|Poor/non-compliance|12|||
154897780|NCT00633893|559046332|FG002|Overall Study|Poor/non-compliance|3|||
154897781|NCT00633893|559046330|FG000|Overall Study|Pregnancy|2|||
154897782|NCT00633893|559046331|FG001|Overall Study|Pregnancy|1|||
154897783|NCT00633893|559046332|FG002|Overall Study|Pregnancy|1|||
154897784|NCT00633893|559046330|FG000|Overall Study|Not meet/no longer meets criteria|4|||
154897785|NCT00633893|559046331|FG001|Overall Study|Not meet/no longer meets criteria|6|||
154897786|NCT00633893|559046332|FG002|Overall Study|Not meet/no longer meets criteria|4|||
154980010|NCT03123783|559349235|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
154980011|NCT03123783|559349229|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155114425|NCT02688088|559848165|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
154897787|NCT00633893|559046330|FG000|Overall Study|Other|28|||
154897788|NCT00633893|559046331|FG001|Overall Study|Other|33|||
154897789|NCT00633893|559046332|FG002|Overall Study|Other|31|||
154897790|NCT02044822|559046333|FG000|Overall Study|Study Terminated by Sponsor|77|||
154897791|NCT02044822|559046333|FG000|Overall Study|Investigator's Discretion|10|||
154897792|NCT02044822|559046333|FG000|Overall Study|Withdrew Consent|3|||
154897793|NCT02044822|559046333|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
154980012|NCT03123783|559349230|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
154980013|NCT03123783|559349231|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
155175662|NCT00869778|560080306|FG001|Overall Study|Unblinding|0|||
155175663|NCT00869778|560080307|FG002|Overall Study|Unblinding|0|||
155175664|NCT03339297|560080308|FG000|Overall Study|Relapse of Hematologic Disease|1|||
154897794|NCT02044822|559046333|FG000|Overall Study|Lost to Follow-up|1|||
154897795|NCT02025530|559046336|FG000|Overall Study|No longer met elligibility criteria|5|||
154897796|NCT02025530|559046337|FG001|Overall Study|No longer met elligibility criteria|1|||
154897797|NCT03551626|559046338|FG000|Overall Study|Adverse Event|88|||
154897798|NCT03551626|559046338|FG000|Overall Study|Disease relapse|18|||
154897799|NCT03551626|559046338|FG000|Overall Study|Withdrawal of informed consent|6|||
154897800|NCT03551626|559046338|FG000|Overall Study|Patient decision|5|||
154897801|NCT03551626|559046338|FG000|Overall Study|Physician Decision|4|||
154897802|NCT03551626|559046338|FG000|Overall Study|Lost to Follow-up|3|||
154897803|NCT03551626|559046338|FG000|Overall Study|Pregnancy|1|||
154897804|NCT03551626|559046338|FG000|Overall Study|Protocol deviation|1|||
154897805|NCT03551626|559046338|FG000|Overall Study|Technical problems|1|||
154897806|NCT00653328|559046339|FG000|Overall Study|Withdrawal by Subject|1|||
154897807|NCT00653328|559046339|FG000|Overall Study|Adverse Event|2|||
154897808|NCT00653328|559046339|FG000|Overall Study|Disease progression|10|||
154897809|NCT00653328|559046339|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
154897810|NCT01237223|559046346|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
154897811|NCT01237223|559046347|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
154897812|NCT01237223|559046348|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
154897813|NCT01237223|559046349|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
154897814|NCT01237223|559046350|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
154897815|NCT01237223|559046351|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
154897816|NCT01237223|559046346|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
154897817|NCT01237223|559046347|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
154897818|NCT01237223|559046348|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
154897819|NCT01237223|559046349|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
154897820|NCT01237223|559046350|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
154897821|NCT01237223|559046351|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
154897822|NCT01237223|559046346|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
154897823|NCT01237223|559046347|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
154897824|NCT01237223|559046348|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
154897825|NCT01237223|559046349|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
154897826|NCT01237223|559046350|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
154897827|NCT01237223|559046351|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
154897828|NCT01237223|559046346|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
154897829|NCT01237223|559046347|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
154897830|NCT01237223|559046348|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
154897831|NCT01237223|559046349|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
154897832|NCT01237223|559046350|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
154897833|NCT01237223|559046351|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
154897834|NCT01237223|559046346|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
154897835|NCT01237223|559046347|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
154897836|NCT01237223|559046348|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
154897837|NCT01237223|559046349|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
154897838|NCT01237223|559046350|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
154897839|NCT01237223|559046351|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
154897840|NCT01237223|559046346|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
154897841|NCT01237223|559046347|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
154897842|NCT01237223|559046348|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
154980014|NCT03123783|559349232|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
154980015|NCT03123783|559349233|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
154980016|NCT03123783|559349234|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
154980017|NCT03123783|559349235|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
154980018|NCT00955721|559349237|FG000|Overall Study|Physician Decision|1|||
154980019|NCT00955721|559349238|FG001|Overall Study|Physician Decision|0|||
154980020|NCT00955721|559349237|FG000|Overall Study|Death|1|||
154980021|NCT00955721|559349238|FG001|Overall Study|Death|0|||
155175665|NCT03339297|560080309|FG001|Overall Study|Relapse of Hematologic Disease|0|||
154897843|NCT01237223|559046349|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
155175666|NCT03339297|560080308|FG000|Overall Study|Death|10|||
155175667|NCT03339297|560080309|FG001|Overall Study|Death|7|||
154897844|NCT01237223|559046350|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
154897845|NCT01237223|559046351|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
154897846|NCT01237223|559046346|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
154897847|NCT01237223|559046347|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
154897848|NCT01237223|559046348|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
154897849|NCT01237223|559046349|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
154897850|NCT01237223|559046350|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
154897851|NCT01237223|559046351|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
154897852|NCT01237223|559046346|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
154897853|NCT01237223|559046347|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
154897854|NCT01237223|559046348|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
154897855|NCT01237223|559046349|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
154897856|NCT01237223|559046350|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
154897857|NCT01237223|559046351|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
154897858|NCT01237223|559046346|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
154897859|NCT01237223|559046347|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
154897860|NCT01237223|559046348|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
154897861|NCT01237223|559046349|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
154897862|NCT01237223|559046350|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
154897863|NCT01237223|559046351|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
154897864|NCT01237223|559046346|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
154897865|NCT01237223|559046347|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
154897866|NCT01237223|559046348|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
154897867|NCT01237223|559046349|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
154897868|NCT01237223|559046350|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
154897869|NCT01237223|559046351|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
154897870|NCT01017549|559046354|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
154897871|NCT01017549|559046354|FG000|One-year Follow-up|Lost to Follow-up|2|||
154897872|NCT01017549|559046354|FG000|One-year Follow-up|Withdrawal by Subject|5|||
154897873|NCT01017549|559046354|FG000|5 Year Follow-up|Lost to Follow-up|9|||
154897874|NCT01017549|559046354|FG000|5 Year Follow-up|Mastectomy|3|||
154897875|NCT00443846|559046356|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
154897876|NCT00443846|559046357|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
154897877|NCT00443846|559046356|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
154897878|NCT00443846|559046357|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
154897879|NCT00443846|559046356|FG000|Overall Study|Adverse Event|0|||
154897880|NCT00443846|559046357|FG001|Overall Study|Adverse Event|1|||
154897881|NCT00443846|559046356|FG000|Overall Study|Personal reason|8|||
154897882|NCT00443846|559046357|FG001|Overall Study|Personal reason|3|||
154897883|NCT00443846|559046356|FG000|Overall Study|Lost to Follow-up|1|||
154897884|NCT00443846|559046357|FG001|Overall Study|Lost to Follow-up|2|||
154897885|NCT00391807|559046366|FG000|Overall Study|Did not receive study medication|23|||
154897886|NCT00391807|559046366|FG000|Overall Study|Adverse Event|177|||
154897887|NCT00391807|559046366|FG000|Overall Study|Pregnancy|25|||
154897888|NCT00391807|559046366|FG000|Overall Study|Lost to Follow-up|227|||
154897889|NCT00391807|559046366|FG000|Overall Study|Withdrawal by Subject|147|||
154897890|NCT00391807|559046366|FG000|Overall Study|Protocol Violation|20|||
154897891|NCT00391807|559046366|FG000|Overall Study|Various|96|||
154897892|NCT05441540|559046369|FG000|Overall Study|Withdrawal by Subject|2|||
154897893|NCT00813917|559046370|FG000|Overall Study|Adverse Event|0|||
154897894|NCT00813917|559046371|FG001|Overall Study|Adverse Event|1|||
154897895|NCT00813917|559046370|FG000|Overall Study|Withdrawal by Subject|3|||
154897896|NCT00813917|559046371|FG001|Overall Study|Withdrawal by Subject|4|||
154897897|NCT00813917|559046370|FG000|Overall Study|Lost to Follow-up|3|||
154897898|NCT00813917|559046371|FG001|Overall Study|Lost to Follow-up|1|||
154897899|NCT04539262|559046374|FG000|Overall Study|Adverse Event|0|||
154897900|NCT04539262|559046375|FG001|Overall Study|Adverse Event|0|||
154897901|NCT04539262|559046376|FG002|Overall Study|Adverse Event|1|||
154897902|NCT04539262|559046377|FG003|Overall Study|Adverse Event|0|||
154897903|NCT04539262|559046378|FG004|Overall Study|Adverse Event|0|||
155114426|NCT02688088|559848166|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
154897904|NCT04539262|559046379|FG005|Overall Study|Adverse Event|0|||
155114427|NCT02688088|559848162|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
154897905|NCT04539262|559046380|FG006|Overall Study|Adverse Event|0|||
154897906|NCT04539262|559046381|FG007|Overall Study|Adverse Event|0|||
154897907|NCT04539262|559046374|FG000|Overall Study|Withdrew Consent|0|||
154897908|NCT04539262|559046375|FG001|Overall Study|Withdrew Consent|0|||
154897909|NCT04539262|559046376|FG002|Overall Study|Withdrew Consent|0|||
154897910|NCT04539262|559046377|FG003|Overall Study|Withdrew Consent|1|||
154897911|NCT04539262|559046378|FG004|Overall Study|Withdrew Consent|0|||
154897912|NCT04539262|559046379|FG005|Overall Study|Withdrew Consent|0|||
154897913|NCT04539262|559046380|FG006|Overall Study|Withdrew Consent|0|||
154897914|NCT04539262|559046381|FG007|Overall Study|Withdrew Consent|0|||
154897915|NCT04539262|559046374|FG000|Overall Study|Randomized, Not treated|0|||
154897916|NCT04539262|559046375|FG001|Overall Study|Randomized, Not treated|1|||
154897917|NCT04539262|559046376|FG002|Overall Study|Randomized, Not treated|0|||
154897918|NCT04539262|559046377|FG003|Overall Study|Randomized, Not treated|0|||
154897919|NCT04539262|559046378|FG004|Overall Study|Randomized, Not treated|0|||
154897920|NCT04539262|559046379|FG005|Overall Study|Randomized, Not treated|0|||
154897921|NCT04539262|559046380|FG006|Overall Study|Randomized, Not treated|1|||
154897922|NCT04539262|559046381|FG007|Overall Study|Randomized, Not treated|0|||
154897923|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
154897924|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
154897925|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
154897926|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
154897927|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
154897928|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
154897929|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
154897930|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
154897931|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
154897932|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
154897933|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
154897934|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
154897935|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
154897936|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
154897937|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
154897938|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
154897939|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
154897940|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
154897941|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
154897942|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
154897943|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
154897944|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
154897945|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
154897946|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
154897947|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
154897948|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Other|1|||
154897949|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Other|0|||
154897950|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Other|0|||
154897951|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Other|0|||
154897952|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Other|1|||
154897953|NCT02980692|559046384|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
154897954|NCT02980692|559046385|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
154897955|NCT02980692|559046386|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
154897956|NCT02980692|559046387|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
154897957|NCT02980692|559046388|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
154897958|NCT02980692|559046384|FG000|Double-blind Follow-up Period|Adverse Event|0|||
154897959|NCT02980692|559046385|FG001|Double-blind Follow-up Period|Adverse Event|0|||
154897960|NCT02980692|559046386|FG002|Double-blind Follow-up Period|Adverse Event|0|||
154897961|NCT02980692|559046387|FG003|Double-blind Follow-up Period|Adverse Event|1|||
154897962|NCT02980692|559046388|FG004|Double-blind Follow-up Period|Adverse Event|1|||
154897963|NCT02980692|559046384|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
154897964|NCT02980692|559046385|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
154897965|NCT02980692|559046386|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
154897966|NCT02980692|559046387|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
154897967|NCT02980692|559046388|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
154897968|NCT02980692|559046384|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
154897969|NCT02980692|559046385|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
154897970|NCT02980692|559046386|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
154897971|NCT02980692|559046387|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
154897972|NCT02980692|559046388|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
154897973|NCT02980692|559046384|FG000|Double-blind Follow-up Period|Pregnancy|0|||
154897974|NCT02980692|559046385|FG001|Double-blind Follow-up Period|Pregnancy|0|||
154897975|NCT02980692|559046386|FG002|Double-blind Follow-up Period|Pregnancy|1|||
154897976|NCT02980692|559046387|FG003|Double-blind Follow-up Period|Pregnancy|1|||
154980022|NCT00955721|559349237|FG000|Overall Study|Withdrawal by Subject|1|||
154980023|NCT00955721|559349238|FG001|Overall Study|Withdrawal by Subject|0|||
154980024|NCT01253317|559349250|FG000|Overall Study|Adverse Event|2|||
154980025|NCT00749411|559349252|FG000|Overall Study|Adverse Event|0|||
154980026|NCT00749411|559349253|FG001|Overall Study|Adverse Event|2|||
154980027|NCT00749411|559349252|FG000|Overall Study|Lack of Efficacy|0|||
154980028|NCT00749411|559349253|FG001|Overall Study|Lack of Efficacy|1|||
154980029|NCT00749411|559349252|FG000|Overall Study|Protocol Violation|1|||
154980030|NCT00749411|559349253|FG001|Overall Study|Protocol Violation|1|||
154980031|NCT00749411|559349252|FG000|Overall Study|Protocol-defined stopping criteria|0|||
154980032|NCT00749411|559349253|FG001|Overall Study|Protocol-defined stopping criteria|1|||
154980033|NCT03756883|559350489|FG000|Overall Study|Adverse Event|2|||
154980034|NCT03756883|559350490|FG001|Overall Study|Adverse Event|2|||
154980035|NCT03756883|559350491|FG002|Overall Study|Adverse Event|2|||
154980036|NCT03756883|559350489|FG000|Overall Study|Lack of Efficacy|0|||
154980037|NCT03756883|559350490|FG001|Overall Study|Lack of Efficacy|1|||
154980038|NCT03756883|559350491|FG002|Overall Study|Lack of Efficacy|2|||
154980039|NCT03756883|559350489|FG000|Overall Study|Lost to Follow-up|3|||
154980040|NCT03756883|559350490|FG001|Overall Study|Lost to Follow-up|3|||
154980041|NCT03756883|559350491|FG002|Overall Study|Lost to Follow-up|0|||
154980042|NCT03756883|559350489|FG000|Overall Study|Protocol Violation|2|||
154980043|NCT03756883|559350490|FG001|Overall Study|Protocol Violation|0|||
154980044|NCT03756883|559350491|FG002|Overall Study|Protocol Violation|1|||
154980045|NCT03756883|559350489|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
154980046|NCT03756883|559350490|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
154980047|NCT03756883|559350491|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
154980048|NCT03756883|559350489|FG000|Overall Study|Withdrawal by Subject|4|||
154980049|NCT03756883|559350490|FG001|Overall Study|Withdrawal by Subject|1|||
154980050|NCT03756883|559350491|FG002|Overall Study|Withdrawal by Subject|0|||
154980051|NCT03756883|559350489|FG000|Overall Study|Other Reasons|2|||
154980052|NCT03756883|559350490|FG001|Overall Study|Other Reasons|4|||
154980053|NCT03756883|559350491|FG002|Overall Study|Other Reasons|0|||
154980054|NCT00619359|559350492|FG000|Overall Study|Adverse Event|32|||
154980055|NCT00619359|559350493|FG001|Overall Study|Adverse Event|36|||
154980056|NCT00619359|559350492|FG000|Overall Study|Lost to Follow-up|12|||
154980057|NCT00619359|559350493|FG001|Overall Study|Lost to Follow-up|16|||
154980058|NCT00619359|559350492|FG000|Overall Study|Physician Decision|0|||
154980059|NCT00619359|559350493|FG001|Overall Study|Physician Decision|7|||
154980060|NCT00619359|559350492|FG000|Overall Study|Protocol Violation|1|||
154980061|NCT00619359|559350493|FG001|Overall Study|Protocol Violation|1|||
154980062|NCT00619359|559350492|FG000|Overall Study|Withdrawal by Subject|19|||
154980063|NCT00619359|559350493|FG001|Overall Study|Withdrawal by Subject|20|||
154980064|NCT00619359|559350492|FG000|Overall Study|Progressive Disease|3|||
154980065|NCT00619359|559350493|FG001|Overall Study|Progressive Disease|1|||
154980066|NCT05212883|559350497|FG000|Overall Study|Invalid test result|125|||
154980067|NCT02502734|559350498|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
154980068|NCT02502734|559350499|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
154980069|NCT02502734|559350498|FG000|Washout Period|Adverse Event|1|||
154980070|NCT02502734|559350499|FG001|Washout Period|Adverse Event|0|||
154980071|NCT03095118|559350505|FG000|Overall Study|Adverse Event|1|||
154980072|NCT03095118|559350505|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
154980073|NCT02363439|559350508|FG000|Overall Study|Lack of Efficacy|4|||
154980074|NCT03573817|559350513|FG000|Overall Study|Adverse Event|0|||
154980075|NCT03573817|559350514|FG001|Overall Study|Adverse Event|2|||
154980076|NCT03573817|559350513|FG000|Overall Study|Protocol Violation|0|||
154980077|NCT03573817|559350514|FG001|Overall Study|Protocol Violation|1|||
154980078|NCT03573817|559350513|FG000|Overall Study|Withdrawal by Subject|1|||
154980079|NCT03573817|559350514|FG001|Overall Study|Withdrawal by Subject|1|||
154980080|NCT00508027|559350517|FG000|Dose Level 1|Lost to Follow-up|4|||
154980081|NCT00508027|559350517|FG000|Dose Level 1|Withdrawal by Subject|2|||
154980082|NCT00508027|559350517|FG000|Dose Level 1|Physician Decision|2|||
154980083|NCT00508027|559350517|FG000|Dose Level 2|Lost to Follow-up|2|||
154980084|NCT00508027|559350517|FG000|Dose Level 2|Withdrawal by Subject|2|||
154980085|NCT01719562|559350518|FG000|Overall Study|Lost to Follow-up|1|||
154980086|NCT01719562|559350519|FG001|Overall Study|Lost to Follow-up|0|||
154980087|NCT01719562|559350518|FG000|Overall Study|Death|1|||
154980088|NCT01719562|559350519|FG001|Overall Study|Death|0|||
154980089|NCT01719562|559350518|FG000|Overall Study|New cancer diagnosis|1|||
154980090|NCT01719562|559350519|FG001|Overall Study|New cancer diagnosis|0|||
154980091|NCT02013531|559350522|FG000|Overall Study|Lost to Follow-up|3|||
154980092|NCT02013531|559350522|FG000|Overall Study|Met Withdrawal Criteria|1|||
154980093|NCT02013531|559350522|FG000|Overall Study|Withdrawal by Subject|1|||
154980094|NCT03554317|559350524|FG000|Overall Study|Withdrawal by Subject|1|||
154980095|NCT03554317|559350524|FG000|Overall Study|PSA Progression|3|||
154980096|NCT03554317|559350524|FG000|Overall Study|Radiographic Progression|4|||
154980097|NCT00939627|559350529|FG000|Overall Study|Disease Progression|16|||
154980098|NCT00939627|559350530|FG001|Overall Study|Disease Progression|12|||
154980099|NCT00939627|559350531|FG002|Overall Study|Disease Progression|0|||
154897977|NCT02980692|559046388|FG004|Double-blind Follow-up Period|Pregnancy|0|||
154897978|NCT02980692|559046384|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
154897979|NCT02980692|559046385|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
155114428|NCT02688088|559848163|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155114429|NCT02688088|559848164|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155114430|NCT02688088|559848165|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
155114431|NCT02688088|559848166|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
155114432|NCT02688088|559848162|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155114433|NCT02688088|559848163|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155114434|NCT02688088|559848164|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155114435|NCT02688088|559848165|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
155114436|NCT02688088|559848166|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
155114437|NCT02688088|559848162|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155114438|NCT02688088|559848163|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155114439|NCT02688088|559848164|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155114440|NCT02688088|559848165|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
155114441|NCT02688088|559848166|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
155114442|NCT01681069|559848180|FG000|Overall Study|Withdrawal by Subject|4|||
155114443|NCT01681069|559848181|FG001|Overall Study|Withdrawal by Subject|5|||
155114444|NCT01681069|559848180|FG000|Overall Study|Protocol Violation|1|||
155114445|NCT01681069|559848181|FG001|Overall Study|Protocol Violation|1|||
155114446|NCT01681069|559848180|FG000|Overall Study|Adverse Event|0|||
155114447|NCT01681069|559848181|FG001|Overall Study|Adverse Event|1|||
155114448|NCT03883165|559848182|FG000|Overall Study|Withdrawal by Subject|4|||
155114449|NCT03883165|559848183|FG001|Overall Study|Withdrawal by Subject|3|||
155114450|NCT00245050|559848184|FG000|Overall Study|Adverse Event|3|||
155114451|NCT00245050|559848185|FG001|Overall Study|Adverse Event|2|||
155114452|NCT00730041|559848186|FG000|Overall Study|Lost to Follow-up|0|||
155114453|NCT00730041|559848187|FG001|Overall Study|Lost to Follow-up|2|||
155114454|NCT02743949|559848188|FG000|Overall Study|Adverse Event|0|||
155114455|NCT02743949|559848189|FG001|Overall Study|Adverse Event|0|||
155114456|NCT02743949|559848190|FG002|Overall Study|Adverse Event|2|||
155114457|NCT02743949|559848188|FG000|Overall Study|Significant Protocol Deviation|2|||
155114458|NCT02743949|559848189|FG001|Overall Study|Significant Protocol Deviation|0|||
155114459|NCT02743949|559848190|FG002|Overall Study|Significant Protocol Deviation|1|||
155114460|NCT02743949|559848188|FG000|Overall Study|Voluntary Withdrawal|2|||
155114461|NCT02743949|559848189|FG001|Overall Study|Voluntary Withdrawal|1|||
155114462|NCT02743949|559848190|FG002|Overall Study|Voluntary Withdrawal|0|||
155114463|NCT01921218|559848191|FG000|Overall Study|Death|2|||
155114464|NCT01921218|559848192|FG001|Overall Study|Death|1|||
155114465|NCT01921218|559848191|FG000|Overall Study|Withdrawal by Subject|0|||
155114466|NCT01921218|559848192|FG001|Overall Study|Withdrawal by Subject|2|||
155114467|NCT01921218|559848191|FG000|Overall Study|Kidney transplant|1|||
155114468|NCT01921218|559848192|FG001|Overall Study|Kidney transplant|1|||
155114469|NCT01885208|559848193|FG000|Overall Study|Unclassified|32|||
155114470|NCT01885208|559848194|FG001|Overall Study|Unclassified|38|||
155114471|NCT00596154|559848198|FG000|Overall Study|Not Evaluable|2|||
155114472|NCT03888235|559848207|FG000|Overall Study|Lost to Follow-up|1|||
155114473|NCT03888235|559848208|FG001|Overall Study|Lost to Follow-up|1|||
155114474|NCT03888235|559848209|FG002|Overall Study|Lost to Follow-up|0|||
155114475|NCT01054560|559848210|FG000|Overall Study|Death|10|||
155114476|NCT01054560|559848211|FG001|Overall Study|Death|21|||
155114477|NCT01054560|559848210|FG000|Overall Study|Lost to Follow-up|2|||
155114478|NCT01054560|559848211|FG001|Overall Study|Lost to Follow-up|5|||
155114479|NCT01054560|559848210|FG000|Overall Study|Withdrawal by Subject|0|||
155114480|NCT01054560|559848211|FG001|Overall Study|Withdrawal by Subject|2|||
155114481|NCT01054560|559848210|FG000|Overall Study|Physician Decision|1|||
155114482|NCT01054560|559848211|FG001|Overall Study|Physician Decision|0|||
155114483|NCT02135029|559848215|FG000|Overall Study|Adverse Event|2|||
154897980|NCT02980692|559046386|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
155114484|NCT02135029|559848216|FG001|Overall Study|Adverse Event|2|||
155114485|NCT02135029|559848217|FG002|Overall Study|Adverse Event|2|||
155114486|NCT02135029|559848215|FG000|Overall Study|Lost to Follow-up|0|||
155114487|NCT02135029|559848216|FG001|Overall Study|Lost to Follow-up|1|||
155175668|NCT03339297|560080308|FG000|Overall Study|Hepatic Candidosis|1|||
155175669|NCT03339297|560080309|FG001|Overall Study|Hepatic Candidosis|0|||
155175670|NCT03339297|560080308|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
155175671|NCT03339297|560080309|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
154897981|NCT02980692|559046387|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
154897982|NCT02980692|559046388|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
155114488|NCT02135029|559848217|FG002|Overall Study|Lost to Follow-up|0|||
155114489|NCT02135029|559848215|FG000|Overall Study|Withdrawal by Subject|2|||
155114490|NCT02135029|559848216|FG001|Overall Study|Withdrawal by Subject|0|||
155114491|NCT02135029|559848217|FG002|Overall Study|Withdrawal by Subject|1|||
154980100|NCT00939627|559350529|FG000|Overall Study|Adverse Event|6|||
154980101|NCT00939627|559350530|FG001|Overall Study|Adverse Event|7|||
154980102|NCT00939627|559350531|FG002|Overall Study|Adverse Event|0|||
154980103|NCT00939627|559350529|FG000|Overall Study|Death|0|||
154980104|NCT00939627|559350530|FG001|Overall Study|Death|2|||
154980105|NCT00939627|559350531|FG002|Overall Study|Death|0|||
154980106|NCT00939627|559350529|FG000|Overall Study|Withdrawal by Subject|2|||
154980107|NCT00939627|559350530|FG001|Overall Study|Withdrawal by Subject|4|||
154980108|NCT00939627|559350531|FG002|Overall Study|Withdrawal by Subject|0|||
154980109|NCT00939627|559350529|FG000|Overall Study|Other complicating disease|1|||
154980110|NCT00939627|559350530|FG001|Overall Study|Other complicating disease|1|||
154980111|NCT00939627|559350531|FG002|Overall Study|Other complicating disease|0|||
154980112|NCT00939627|559350529|FG000|Overall Study|Not compliant|2|||
154980113|NCT00939627|559350530|FG001|Overall Study|Not compliant|0|||
154980114|NCT00939627|559350531|FG002|Overall Study|Not compliant|0|||
154980115|NCT00939627|559350529|FG000|Overall Study|No off-tx reason given|0|||
154980116|NCT00939627|559350530|FG001|Overall Study|No off-tx reason given|2|||
154980117|NCT00939627|559350531|FG002|Overall Study|No off-tx reason given|0|||
154980118|NCT00537199|559350536|FG000|Overall Study|Study Terminated|1|||
154980119|NCT00612677|559350541|FG000|Overall Study|study closed before treatment started|1|||
154980120|NCT03417830|559350543|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
154980121|NCT03417830|559350544|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
154980122|NCT00823199|559350545|FG000|Overall Study|Withdrawal by Subject|2|||
154980123|NCT00941720|559350549|FG000|Overall Study|Withdrawal by Subject|1|||
154980124|NCT00941720|559350549|FG000|Overall Study|Insurance denied participation|11|||
154980125|NCT00941720|559350549|FG000|Overall Study|ineligible|2|||
154980126|NCT01998243|559350552|FG000|Overall Study|Pregnancy|0|||
154980127|NCT01998243|559350553|FG001|Overall Study|Pregnancy|1|||
154980128|NCT01998243|559350552|FG000|Overall Study|Protocol Violation|5|||
154980129|NCT01998243|559350553|FG001|Overall Study|Protocol Violation|2|||
154980130|NCT01998243|559350552|FG000|Overall Study|Withdrawal by Subject|3|||
154980131|NCT01998243|559350553|FG001|Overall Study|Withdrawal by Subject|4|||
154980132|NCT00268892|559350557|FG000|Overall Study|Adverse Event|14|||
154980133|NCT00268892|559350558|FG001|Overall Study|Adverse Event|17|||
154980134|NCT00268892|559350559|FG002|Overall Study|Adverse Event|20|||
154980135|NCT00268892|559350557|FG000|Overall Study|Lack of Efficacy|1|||
154980136|NCT00268892|559350558|FG001|Overall Study|Lack of Efficacy|3|||
154980137|NCT00268892|559350559|FG002|Overall Study|Lack of Efficacy|0|||
154980138|NCT00268892|559350557|FG000|Overall Study|Withdrawal by Subject|14|||
154980139|NCT00268892|559350558|FG001|Overall Study|Withdrawal by Subject|15|||
154980140|NCT00268892|559350559|FG002|Overall Study|Withdrawal by Subject|13|||
154980141|NCT00268892|559350557|FG000|Overall Study|Physician Decision|0|||
154980142|NCT00268892|559350558|FG001|Overall Study|Physician Decision|1|||
154980143|NCT00268892|559350559|FG002|Overall Study|Physician Decision|0|||
154980144|NCT00268892|559350557|FG000|Overall Study|Lost to Follow-up|5|||
154980145|NCT00268892|559350558|FG001|Overall Study|Lost to Follow-up|2|||
154980146|NCT00268892|559350559|FG002|Overall Study|Lost to Follow-up|4|||
154980147|NCT00268892|559350557|FG000|Overall Study|Protocol Violation|0|||
154980148|NCT00268892|559350558|FG001|Overall Study|Protocol Violation|1|||
154980149|NCT00268892|559350559|FG002|Overall Study|Protocol Violation|0|||
154980150|NCT00268892|559350557|FG000|Overall Study|Disease Progression|1|||
154980151|NCT00268892|559350558|FG001|Overall Study|Disease Progression|1|||
154980152|NCT00268892|559350559|FG002|Overall Study|Disease Progression|0|||
154980153|NCT00268892|559350557|FG000|Overall Study|Trial Site Closed|4|||
154980154|NCT00268892|559350558|FG001|Overall Study|Trial Site Closed|2|||
154980155|NCT00268892|559350559|FG002|Overall Study|Trial Site Closed|2|||
154980156|NCT01640184|559350560|FG000|Overall Study|Death|1|||
154980157|NCT01640184|559350561|FG001|Overall Study|Death|0|||
154980158|NCT01640184|559350562|FG002|Overall Study|Death|0|||
154980159|NCT01640184|559350560|FG000|Overall Study|Lost to Follow-up|4|||
154980160|NCT01640184|559350561|FG001|Overall Study|Lost to Follow-up|1|||
154980161|NCT01640184|559350562|FG002|Overall Study|Lost to Follow-up|0|||
154980162|NCT01640184|559350560|FG000|Overall Study|Physician Decision|3|||
154980163|NCT01640184|559350561|FG001|Overall Study|Physician Decision|0|||
154980164|NCT01640184|559350562|FG002|Overall Study|Physician Decision|0|||
154980165|NCT01640184|559350560|FG000|Overall Study|Withdrawal by Subject|0|||
154980166|NCT01640184|559350561|FG001|Overall Study|Withdrawal by Subject|1|||
154980167|NCT01640184|559350562|FG002|Overall Study|Withdrawal by Subject|1|||
155114492|NCT02135029|559848215|FG000|Overall Study|Other|0|||
154980168|NCT01640184|559350560|FG000|Overall Study|Protocol Violation|0|||
154980169|NCT01640184|559350561|FG001|Overall Study|Protocol Violation|0|||
154980170|NCT01640184|559350562|FG002|Overall Study|Protocol Violation|1|||
154980171|NCT02087176|559350563|FG000|Overall Study|Withdrawal by Subject|1|||
154980172|NCT02087176|559350563|FG000|Overall Study|Death|10|||
154980173|NCT02087176|559350563|FG000|Overall Study|Censored|19|||
154980174|NCT02087176|559350563|FG000|Overall Study|Study Terminated by Sponsor|2|||
154980175|NCT02492841|559350564|FG000|Overall Study|Lost to Follow-up|34|||
154980176|NCT02492841|559350565|FG001|Overall Study|Lost to Follow-up|31|||
154980177|NCT02492841|559350566|FG002|Overall Study|Lost to Follow-up|35|||
154980178|NCT03812991|559350568|FG000|Overall Study|Lost to Follow-up|3|||
155114493|NCT02135029|559848216|FG001|Overall Study|Other|1|||
155114494|NCT02135029|559848217|FG002|Overall Study|Other|0|||
155114495|NCT02135029|559848215|FG000|Overall Study|Death|0|||
155114496|NCT02135029|559848216|FG001|Overall Study|Death|1|||
154897983|NCT02980692|559046384|FG000|Double-blind Follow-up Period|Other|0|||
154897984|NCT02980692|559046385|FG001|Double-blind Follow-up Period|Other|0|||
154897985|NCT02980692|559046386|FG002|Double-blind Follow-up Period|Other|1|||
154897986|NCT02980692|559046387|FG003|Double-blind Follow-up Period|Other|1|||
154897987|NCT02980692|559046388|FG004|Double-blind Follow-up Period|Other|3|||
154897988|NCT04702984|559046398|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
154897989|NCT03725293|559046399|FG000|Overall Study|Physician Decision|9|||
154897990|NCT03725293|559046400|FG001|Overall Study|Physician Decision|6|||
154897991|NCT03725293|559046399|FG000|Overall Study|alternative vascular access needs|1|||
154897992|NCT03725293|559046400|FG001|Overall Study|alternative vascular access needs|2|||
154897993|NCT03725293|559046399|FG000|Overall Study|venous anatomy screen failures|2|||
154897994|NCT03725293|559046400|FG001|Overall Study|venous anatomy screen failures|1|||
154897995|NCT03862495|559046401|FG000|Overall Study|Lost to Follow-up|37|||
154897996|NCT03862495|559046402|FG001|Overall Study|Lost to Follow-up|35|||
154897997|NCT00064077|559046403|FG000|Overall Study|Improper prior treatment|1|||
154897998|NCT00064077|559046404|FG001|Overall Study|Improper prior treatment|0|||
154897999|NCT00064077|559046405|FG002|Overall Study|Improper prior treatment|0|||
154898000|NCT00064077|559046406|FG003|Overall Study|Improper prior treatment|0|||
154898001|NCT00064077|559046403|FG000|Overall Study|Poor risk|2|||
154898002|NCT00064077|559046404|FG001|Overall Study|Poor risk|0|||
154898003|NCT00064077|559046405|FG002|Overall Study|Poor risk|1|||
154898004|NCT00064077|559046406|FG003|Overall Study|Poor risk|1|||
154898005|NCT00064077|559046403|FG000|Overall Study|Pathology|10|||
154898006|NCT00064077|559046404|FG001|Overall Study|Pathology|7|||
154898007|NCT00064077|559046405|FG002|Overall Study|Pathology|3|||
154898008|NCT00064077|559046406|FG003|Overall Study|Pathology|4|||
154898009|NCT00064077|559046403|FG000|Overall Study|No surgery|0|||
154898010|NCT00064077|559046404|FG001|Overall Study|No surgery|0|||
154898011|NCT00064077|559046405|FG002|Overall Study|No surgery|1|||
154898012|NCT00064077|559046406|FG003|Overall Study|No surgery|0|||
154898013|NCT00064077|559046403|FG000|Overall Study|No tumor|0|||
154898014|NCT00064077|559046404|FG001|Overall Study|No tumor|0|||
154898015|NCT00064077|559046405|FG002|Overall Study|No tumor|1|||
154898016|NCT00064077|559046406|FG003|Overall Study|No tumor|0|||
154898017|NCT00064077|559046403|FG000|Overall Study|Other reasons|2|||
154898018|NCT00064077|559046404|FG001|Overall Study|Other reasons|2|||
154898019|NCT00064077|559046405|FG002|Overall Study|Other reasons|1|||
154898020|NCT00064077|559046406|FG003|Overall Study|Other reasons|2|||
154898021|NCT01057862|559046407|FG000|Overall Study|Withdrawal by Subject|1|||
154898022|NCT01057862|559046408|FG001|Overall Study|Withdrawal by Subject|2|||
154898023|NCT03363165|559046409|FG000|3-month Follow-up|Death|0|||
154898024|NCT03363165|559046410|FG001|3-month Follow-up|Death|1|||
154898025|NCT03363165|559046409|FG000|6-month Follow-up|Death|0|||
154898026|NCT03363165|559046410|FG001|6-month Follow-up|Death|1|||
154898027|NCT03363165|559046409|FG000|6-month Follow-up|Withdrawal by Subject|1|||
154898028|NCT03363165|559046410|FG001|6-month Follow-up|Withdrawal by Subject|1|||
154898029|NCT03363165|559046409|FG000|12-month Follow-up|Death|1|||
154898030|NCT03363165|559046410|FG001|12-month Follow-up|Death|1|||
154898031|NCT03363165|559046409|FG000|12-month Follow-up|Withdrawal by Subject|1|||
154898032|NCT03363165|559046410|FG001|12-month Follow-up|Withdrawal by Subject|1|||
154898033|NCT02255760|559046411|FG000|Overall Study|Lost to Follow-up|0|||
154898034|NCT02255760|559046412|FG001|Overall Study|Lost to Follow-up|1|||
154898035|NCT02255760|559046413|FG002|Overall Study|Lost to Follow-up|0|||
154898036|NCT02255760|559046414|FG003|Overall Study|Lost to Follow-up|0|||
154980179|NCT03812991|559350569|FG001|Overall Study|Lost to Follow-up|1|||
154980180|NCT01876368|559350570|FG000|Overall Study|Adverse Event|2|||
154980181|NCT01876368|559350571|FG001|Overall Study|Adverse Event|5|||
154980182|NCT01876368|559350570|FG000|Overall Study|Lack of Efficacy|1|||
154980183|NCT01876368|559350571|FG001|Overall Study|Lack of Efficacy|0|||
154980184|NCT01876368|559350570|FG000|Overall Study|Lost to Follow-up|0|||
154980185|NCT01876368|559350571|FG001|Overall Study|Lost to Follow-up|1|||
154980186|NCT01876368|559350570|FG000|Overall Study|Non-compliance with study treatment|0|||
154980187|NCT01876368|559350571|FG001|Overall Study|Non-compliance with study treatment|1|||
154980188|NCT01876368|559350570|FG000|Overall Study|Physician Decision|0|||
154980189|NCT01876368|559350571|FG001|Overall Study|Physician Decision|2|||
154898037|NCT02255760|559046415|FG004|Overall Study|Lost to Follow-up|0|||
154898038|NCT00618813|559046416|FG000|Overall Study|Lack of Efficacy|1|||
154898039|NCT00618813|559046416|FG000|Overall Study|Physician Decision|2|||
154898040|NCT00618813|559046416|FG000|Overall Study|Withdrawal by Subject|1|||
154898041|NCT00003838|559046417|FG000|Overall Study|Death|0|||
154898042|NCT00003838|559046418|FG001|Overall Study|Death|12|||
154898043|NCT00003838|559046419|FG002|Overall Study|Death|7|||
154898044|NCT00003838|559046417|FG000|Overall Study|Lost to Follow-up|0|||
154980190|NCT01876368|559350570|FG000|Overall Study|Protocol deviation|3|||
154980191|NCT01876368|559350571|FG001|Overall Study|Protocol deviation|3|||
155114497|NCT02135029|559848217|FG002|Overall Study|Death|0|||
155114498|NCT02210689|559848218|FG000|Overall Study|Withdrawal by Subject|7|||
155114499|NCT02210689|559848219|FG001|Overall Study|Withdrawal by Subject|4|||
155114500|NCT02210689|559848220|FG002|Overall Study|Withdrawal by Subject|2|||
155114501|NCT02210689|559848218|FG000|Overall Study|Adverse Event|0|||
155114502|NCT02210689|559848219|FG001|Overall Study|Adverse Event|1|||
155114503|NCT02210689|559848220|FG002|Overall Study|Adverse Event|0|||
155114504|NCT02210689|559848218|FG000|Overall Study|Protocol Violation|1|||
154898045|NCT00003838|559046418|FG001|Overall Study|Lost to Follow-up|1|||
154898046|NCT00003838|559046419|FG002|Overall Study|Lost to Follow-up|1|||
154898047|NCT00003838|559046417|FG000|Overall Study|Disease Progression|0|||
154898048|NCT00003838|559046418|FG001|Overall Study|Disease Progression|12|||
154898049|NCT00003838|559046419|FG002|Overall Study|Disease Progression|0|||
154898050|NCT00268463|559046420|FG000|Overall Study|study terminated due to low accrual|10|||
154898051|NCT00268463|559046421|FG001|Overall Study|study terminated due to low accrual|12|||
154898052|NCT03495817|559046422|FG000|26 Week Open Label|Adverse Event|3|||
154898053|NCT03495817|559046422|FG000|26 Week Open Label|Withdrawal by Subject|4|||
154898054|NCT03495817|559046422|FG000|26 Week Open Label|Lost to Follow-up|1|||
154898055|NCT03495817|559046422|FG000|26 Week Extension|Lost to Follow-up|2|||
154898056|NCT01686958|559046423|FG000|Overall Study|Withdrawal by Subject|1|||
154898057|NCT02224638|559046433|FG000|Overall Study|Adverse Event|1|||
154898058|NCT02224638|559046434|FG001|Overall Study|Adverse Event|1|||
154898059|NCT01406652|559046435|FG000|Overall Study|Lost-to-follow-up|3|||
154898060|NCT01406652|559046436|FG001|Overall Study|Lost-to-follow-up|4|||
154898061|NCT01406652|559046435|FG000|Overall Study|Withdrawal by Subject|2|||
154898062|NCT01406652|559046436|FG001|Overall Study|Withdrawal by Subject|2|||
154898063|NCT01406652|559046435|FG000|Overall Study|Insufficient follow-up|5|||
154898064|NCT01406652|559046436|FG001|Overall Study|Insufficient follow-up|4|||
154898065|NCT01406652|559046435|FG000|Overall Study|Infection not sure|10|||
154898066|NCT01406652|559046436|FG001|Overall Study|Infection not sure|10|||
154898067|NCT00587301|559046443|FG000|Overall Study|Screen Failure|9|||
154898068|NCT00587301|559046443|FG000|Overall Study|Lost to Follow-up|22|||
154898069|NCT00587301|559046443|FG000|Overall Study|Withdrawal by Subject|7|||
154898070|NCT00587301|559046443|FG000|Overall Study|Protocol Violation|7|||
154898071|NCT01400139|559046444|FG000|HYD Core Study|Adverse Event|210|||
154898072|NCT01400139|559046444|FG000|HYD Core Study|Lack of Efficacy|59|||
154898073|NCT01400139|559046444|FG000|HYD Core Study|Withdrawal by Subject|114|||
154898074|NCT01400139|559046444|FG000|HYD Core Study|Lost to Follow-up|39|||
154898075|NCT01400139|559046444|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
154898076|NCT01400139|559046444|FG000|HYD Core Study|Administrative|56|||
154898077|NCT01400139|559046444|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
154898078|NCT01400139|559046444|FG000|HYD Extension Period|Adverse Event|8|||
154898079|NCT01400139|559046444|FG000|HYD Extension Period|Withdrawal by Subject|5|||
154898080|NCT01400139|559046444|FG000|HYD Extension Period|Administrative|10|||
154898081|NCT00418717|559046445|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
154898082|NCT00418717|559046445|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
154898083|NCT00994162|559046449|FG000|Overall Study|Withdrawal by Subject|1|||
154898084|NCT00994162|559046449|FG000|Overall Study|Lost to Follow-up|2|||
154898085|NCT00994162|559046449|FG000|Overall Study|Product Complaint|1|||
154898086|NCT00994162|559046449|FG000|Overall Study|Poor Compliance|5|||
154898087|NCT00994162|559046449|FG000|Overall Study|Lack of Response|3|||
154898088|NCT00994162|559046449|FG000|Overall Study|Discharged from Hospital|4|||
154898089|NCT00994162|559046449|FG000|Overall Study|Death|2|||
154898090|NCT00994162|559046449|FG000|Overall Study|Care Transferred to Another Physician|2|||
154898091|NCT00994162|559046449|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
154898092|NCT00994162|559046449|FG000|Overall Study|Physician Decision|2|||
154898093|NCT00994162|559046449|FG000|Overall Study|Surrounding Wound Erythematous|1|||
154898094|NCT00994162|559046449|FG000|Overall Study|Machine Losing Vaccum|1|||
154898095|NCT00994162|559046449|FG000|Overall Study|Patient Lived Too Far Away|1|||
154898096|NCT00994162|559046449|FG000|Overall Study|Above Knee Amputation|1|||
154898097|NCT00994162|559046449|FG000|Overall Study|Reason Not Reported By Site|1|||
154898098|NCT00719953|559046454|FG000|Overall Study|Adverse Event|4|||
154898099|NCT03175562|559046457|FG000|Overall Study|Adverse Event|1|||
154898100|NCT03175562|559046457|FG000|Overall Study|Lost to Follow-up|3|||
154898101|NCT03175562|559046457|FG000|Overall Study|Withdrawal by Subject|7|||
154898102|NCT03175562|559046457|FG000|Overall Study|Other (Not Specified)|5|||
154898103|NCT01230749|559046460|FG000|Overall Study|Adverse Event|0|||
154898104|NCT01230749|559046461|FG001|Overall Study|Adverse Event|0|||
154898105|NCT01230749|559046462|FG002|Overall Study|Adverse Event|0|||
154898106|NCT01230749|559046463|FG003|Overall Study|Adverse Event|1|||
154898107|NCT01230749|559046460|FG000|Overall Study|Physician Decision|0|||
154898108|NCT01230749|559046461|FG001|Overall Study|Physician Decision|0|||
154898109|NCT01230749|559046462|FG002|Overall Study|Physician Decision|1|||
154898110|NCT01230749|559046463|FG003|Overall Study|Physician Decision|0|||
154898111|NCT01230749|559046460|FG000|Overall Study|Withdrawal by Subject|0|||
154898112|NCT01230749|559046461|FG001|Overall Study|Withdrawal by Subject|1|||
154898113|NCT01230749|559046462|FG002|Overall Study|Withdrawal by Subject|0|||
154898114|NCT01230749|559046463|FG003|Overall Study|Withdrawal by Subject|0|||
155114505|NCT02210689|559848219|FG001|Overall Study|Protocol Violation|0|||
155114506|NCT02210689|559848220|FG002|Overall Study|Protocol Violation|0|||
155114507|NCT02210689|559848218|FG000|Overall Study|Lost to Follow-up|11|||
155114508|NCT02210689|559848219|FG001|Overall Study|Lost to Follow-up|9|||
155114509|NCT02210689|559848220|FG002|Overall Study|Lost to Follow-up|5|||
155114510|NCT02210689|559848218|FG000|Overall Study|Pregnancy|0|||
155114511|NCT02210689|559848219|FG001|Overall Study|Pregnancy|1|||
155114512|NCT02210689|559848220|FG002|Overall Study|Pregnancy|0|||
155114513|NCT02210689|559848218|FG000|Overall Study|Lack of Efficacy|0|||
155114514|NCT02210689|559848219|FG001|Overall Study|Lack of Efficacy|1|||
155114515|NCT02210689|559848220|FG002|Overall Study|Lack of Efficacy|5|||
155114516|NCT02210689|559848218|FG000|Overall Study|Prohibited medication|2|||
155114517|NCT02210689|559848219|FG001|Overall Study|Prohibited medication|8|||
155114518|NCT02210689|559848220|FG002|Overall Study|Prohibited medication|1|||
155114519|NCT02210689|559848218|FG000|Overall Study|Negative Nugent score at baseline|6|||
155114520|NCT02210689|559848219|FG001|Overall Study|Negative Nugent score at baseline|2|||
155114521|NCT02210689|559848220|FG002|Overall Study|Negative Nugent score at baseline|2|||
155114522|NCT02210689|559848218|FG000|Overall Study|Other|25|||
155114523|NCT02210689|559848219|FG001|Overall Study|Other|21|||
155114524|NCT02210689|559848220|FG002|Overall Study|Other|8|||
155114525|NCT00866047|559848221|FG000|Treatment Period|Progressive disease|13|||
155114526|NCT00866047|559848221|FG000|Treatment Period|Adverse Event|16|||
155114527|NCT00866047|559848221|FG000|Treatment Period|Physician Decision|14|||
155114528|NCT00866047|559848221|FG000|Treatment Period|Withdrawal by Subject|5|||
155114529|NCT00866047|559848221|FG000|Follow-up Period|Lost to Follow-up|5|||
155114530|NCT05427539|559848222|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
155114531|NCT05427539|559848223|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
155114532|NCT05427539|559848222|FG000|Period 1|Withdrawal by Subject|1|||
155114533|NCT05427539|559848223|FG001|Period 1|Withdrawal by Subject|0|||
155114534|NCT00223977|559848224|FG000|Overall Study|Adverse Event|7|||
155114535|NCT00223977|559848225|FG001|Overall Study|Adverse Event|10|||
155114536|NCT00223977|559848226|FG002|Overall Study|Adverse Event|0|||
155114537|NCT00223977|559848224|FG000|Overall Study|Protocol Violation|0|||
155114538|NCT00223977|559848225|FG001|Overall Study|Protocol Violation|0|||
155114539|NCT00223977|559848226|FG002|Overall Study|Protocol Violation|1|||
155114540|NCT00223977|559848224|FG000|Overall Study|Withdrawal by Subject|1|||
155114541|NCT00223977|559848225|FG001|Overall Study|Withdrawal by Subject|1|||
155114542|NCT00223977|559848226|FG002|Overall Study|Withdrawal by Subject|2|||
155114543|NCT00223977|559848224|FG000|Overall Study|Other|1|||
155114544|NCT00223977|559848225|FG001|Overall Study|Other|0|||
155114545|NCT00223977|559848226|FG002|Overall Study|Other|0|||
155114546|NCT04376684|559848231|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
155114547|NCT04376684|559848232|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
155114548|NCT04376684|559848233|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
155114549|NCT04376684|559848234|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
155114550|NCT04376684|559848231|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
155114551|NCT04376684|559848232|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
155114552|NCT04376684|559848233|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
155114553|NCT04376684|559848234|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
155114554|NCT04376684|559848231|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
155114555|NCT04376684|559848232|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
155114556|NCT04376684|559848233|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
155114557|NCT04376684|559848234|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
154898115|NCT01230749|559046460|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
155114558|NCT04376684|559848231|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
155114559|NCT04376684|559848232|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
155114560|NCT04376684|559848233|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
155114561|NCT04376684|559848234|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
155114562|NCT04376684|559848231|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
155114563|NCT04376684|559848232|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
155114564|NCT04376684|559848233|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
155114565|NCT04376684|559848234|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
155114566|NCT04376684|559848231|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
155114567|NCT04376684|559848232|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
155114568|NCT04376684|559848233|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
155114569|NCT04376684|559848234|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
155114570|NCT04376684|559848231|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
155114571|NCT04376684|559848232|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
154898116|NCT01230749|559046461|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
155114572|NCT04376684|559848233|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
155114573|NCT04376684|559848234|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
155114574|NCT04934800|559848236|FG000|Overall Study|Other|1|||
155114575|NCT04934800|559848236|FG000|Overall Study|Withdrawal by Subject|5|||
155114576|NCT04934800|559848236|FG000|Overall Study|Lack of Efficacy|1|||
155114577|NCT04934800|559848236|FG000|Overall Study|Adverse Event|9|||
155114578|NCT04934800|559848236|FG000|Overall Study|Lost to Follow-up|5|||
155114579|NCT04934800|559848236|FG000|Overall Study|Enrolled but not treated|1|||
155114580|NCT05596734|559848237|FG000|Substudy A|Withdrawal by Subject|1|||
154980192|NCT01876368|559350570|FG000|Overall Study|Subject/guardian decision|3|||
154980193|NCT01876368|559350571|FG001|Overall Study|Subject/guardian decision|1|||
154980194|NCT02563769|559350572|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
154980195|NCT02563769|559350573|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
154980196|NCT02563769|559350574|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
154980197|NCT01192399|559350578|FG000|Overall Study|Lack of Efficacy|2|||
154980198|NCT01930175|559350579|FG000|Core Study|Lost to Follow-up|0|||
154980199|NCT01930175|559350580|FG001|Core Study|Lost to Follow-up|1|||
154980200|NCT01930175|559350581|FG002|Core Study|Lost to Follow-up|0|||
154980201|NCT01930175|559350579|FG000|Core Study|Adverse Event|0|||
154980202|NCT01930175|559350580|FG001|Core Study|Adverse Event|0|||
154980203|NCT01930175|559350581|FG002|Core Study|Adverse Event|1|||
154980204|NCT02820740|559350582|FG000|Overall Study|Did not have procedure|2|||
154980205|NCT03903159|559350585|FG000|Overall Study|Discharged with Staff Approval|2|||
154980206|NCT03903159|559350585|FG000|Overall Study|Discharged at Staff Request|2|||
154980207|NCT03903159|559350585|FG000|Overall Study|Discharged Against Staff Advice|1|||
154980208|NCT00724373|559350586|FG000|Overall Study|Adverse Event|41|||
154980209|NCT00724373|559350586|FG000|Overall Study|Lack of Efficacy|82|||
154980210|NCT00724373|559350586|FG000|Overall Study|Lost to Follow-up|7|||
154980211|NCT00724373|559350586|FG000|Overall Study|Non-compliance|2|||
154980212|NCT00724373|559350586|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
154980213|NCT00724373|559350586|FG000|Overall Study|Participant moved away|1|||
154980214|NCT00724373|559350586|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
154980215|NCT00724373|559350586|FG000|Overall Study|Only to have 24 week regimen|1|||
154980216|NCT00724373|559350586|FG000|Overall Study|Viral Relapse|1|||
154980217|NCT00724373|559350586|FG000|Overall Study|Acute HCV infection|1|||
154980218|NCT00724373|559350586|FG000|Overall Study|Drug Relapse|1|||
154980219|NCT00724373|559350586|FG000|Overall Study|Tolerability|23|||
154980220|NCT02244424|559350588|FG000|Overall Study|Lost to Follow-up|20|||
154980221|NCT02244424|559350589|FG001|Overall Study|Lost to Follow-up|10|||
154980222|NCT00562120|559350593|FG000|First Intervention Period|Adverse Event|1|||
154980223|NCT00562120|559350594|FG001|First Intervention Period|Adverse Event|0|||
154980224|NCT00562120|559350595|FG002|First Intervention Period|Adverse Event|0|||
154980225|NCT00562120|559350596|FG003|First Intervention Period|Adverse Event|0|||
154980226|NCT00562120|559350593|FG000|First Intervention Period|Randomized but not Treated|1|||
154980227|NCT00562120|559350594|FG001|First Intervention Period|Randomized but not Treated|0|||
154980228|NCT00562120|559350595|FG002|First Intervention Period|Randomized but not Treated|0|||
154980229|NCT00562120|559350596|FG003|First Intervention Period|Randomized but not Treated|0|||
154980230|NCT02148445|559350597|FG000|Overall Study|Death|1|||
154980231|NCT02148445|559350598|FG001|Overall Study|Death|3|||
154980232|NCT03450629|559350599|FG000|Overall Study|Adverse Event|15|||
154980233|NCT03450629|559350600|FG001|Overall Study|Adverse Event|14|||
154980234|NCT03450629|559350599|FG000|Overall Study|Physician Decision|2|||
154980235|NCT03450629|559350600|FG001|Overall Study|Physician Decision|2|||
154980236|NCT03450629|559350599|FG000|Overall Study|Lack of Efficacy|2|||
154980237|NCT03450629|559350600|FG001|Overall Study|Lack of Efficacy|0|||
154980238|NCT03450629|559350599|FG000|Overall Study|Lost to Follow-up|4|||
154980239|NCT03450629|559350600|FG001|Overall Study|Lost to Follow-up|2|||
154980240|NCT03450629|559350599|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
154980241|NCT03450629|559350600|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
154980242|NCT03450629|559350599|FG000|Overall Study|Non-Compliance With Study Drug|2|||
154980243|NCT03450629|559350600|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154980244|NCT03450629|559350599|FG000|Overall Study|Protocol Violation|11|||
154980245|NCT03450629|559350600|FG001|Overall Study|Protocol Violation|8|||
154980246|NCT03450629|559350599|FG000|Overall Study|Withdrawal by Subject|12|||
154980247|NCT03450629|559350600|FG001|Overall Study|Withdrawal by Subject|6|||
154980248|NCT03366194|559350601|FG000|Overall Study|Lost to Follow-up|2|||
154980249|NCT02093923|559350602|FG000|Overall Study|Lost to Follow-up|0|||
154980250|NCT02093923|559350603|FG001|Overall Study|Lost to Follow-up|0|||
154980251|NCT02093923|559350604|FG002|Overall Study|Lost to Follow-up|0|||
154980252|NCT02093923|559350605|FG003|Overall Study|Lost to Follow-up|1|||
154980253|NCT02093923|559350606|FG004|Overall Study|Lost to Follow-up|0|||
154980254|NCT02093923|559350602|FG000|Overall Study|Screen failure after randomization|0|||
154980255|NCT02093923|559350603|FG001|Overall Study|Screen failure after randomization|0|||
154980256|NCT02093923|559350604|FG002|Overall Study|Screen failure after randomization|0|||
154980257|NCT02093923|559350605|FG003|Overall Study|Screen failure after randomization|1|||
154980258|NCT02093923|559350606|FG004|Overall Study|Screen failure after randomization|0|||
154980259|NCT03438006|559350607|FG000|Overall Study|Adverse Event|1|||
154980260|NCT03438006|559350607|FG000|Overall Study|Lost to Follow-up|67|||
154980261|NCT03438006|559350607|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
154980262|NCT03438006|559350607|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
154980263|NCT01181531|559350608|FG000|Overall Study|Other|17|||
154980264|NCT01181531|559350609|FG001|Overall Study|Other|12|||
154980265|NCT01181531|559350608|FG000|Overall Study|Partial consent by subject withdrawn|0|||
154980266|NCT01181531|559350609|FG001|Overall Study|Partial consent by subject withdrawn|1|||
154980267|NCT01181531|559350608|FG000|Overall Study|Physician Decision|3|||
154980268|NCT01181531|559350609|FG001|Overall Study|Physician Decision|1|||
154980269|NCT01181531|559350608|FG000|Overall Study|Noncompliance|2|||
154980270|NCT01181531|559350609|FG001|Overall Study|Noncompliance|2|||
154980271|NCT01181531|559350608|FG000|Overall Study|Ineligibility determined|1|||
154980272|NCT01181531|559350609|FG001|Overall Study|Ineligibility determined|2|||
154980273|NCT01181531|559350608|FG000|Overall Study|Protocol Specified Criteria|15|||
154980274|NCT01181531|559350609|FG001|Overall Study|Protocol Specified Criteria|8|||
154980275|NCT01181531|559350608|FG000|Overall Study|Pregnancy|0|||
154980276|NCT01181531|559350609|FG001|Overall Study|Pregnancy|1|||
154980277|NCT01181531|559350608|FG000|Overall Study|Withdrawal by Subject|8|||
154980278|NCT01181531|559350609|FG001|Overall Study|Withdrawal by Subject|7|||
154980279|NCT01181531|559350608|FG000|Overall Study|Protocol Violation|6|||
154980280|NCT01181531|559350609|FG001|Overall Study|Protocol Violation|6|||
154980281|NCT01181531|559350608|FG000|Overall Study|Death|9|||
154980282|NCT01181531|559350609|FG001|Overall Study|Death|12|||
154980283|NCT01181531|559350608|FG000|Overall Study|Adverse Event|0|||
154980284|NCT01181531|559350609|FG001|Overall Study|Adverse Event|1|||
154980285|NCT01507090|559350614|FG000|Overall Study|incomplete dataset|18|||
154980286|NCT04678817|559352157|FG000|Overall Study|Lost to Follow-up|28|||
154980287|NCT04678817|559352158|FG001|Overall Study|Lost to Follow-up|0|||
154980288|NCT04678817|559352159|FG002|Overall Study|Lost to Follow-up|0|||
154980289|NCT02124902|559352165|FG000|Overall Study|Adverse Event|7|||
154980290|NCT02124902|559352166|FG001|Overall Study|Adverse Event|2|||
154980291|NCT02124902|559352165|FG000|Overall Study|Went to alternative treatment|4|||
154980292|NCT02124902|559352166|FG001|Overall Study|Went to alternative treatment|0|||
154980293|NCT02124902|559352165|FG000|Overall Study|Withdrawal by Subject|2|||
154980294|NCT02124902|559352166|FG001|Overall Study|Withdrawal by Subject|1|||
154980295|NCT02124902|559352165|FG000|Overall Study|Physician Decision|2|||
154980296|NCT02124902|559352166|FG001|Overall Study|Physician Decision|0|||
154980297|NCT02124902|559352165|FG000|Overall Study|Not eligible|1|||
154980298|NCT02124902|559352166|FG001|Overall Study|Not eligible|0|||
154980299|NCT02124902|559352165|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
154980300|NCT02124902|559352166|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
154980301|NCT00546910|559352168|FG000|Overall Study|Adverse Event|2|||
154980302|NCT00546910|559352169|FG001|Overall Study|Adverse Event|3|||
154980303|NCT00546910|559352168|FG000|Overall Study|Lack of Efficacy|5|||
154980304|NCT00546910|559352169|FG001|Overall Study|Lack of Efficacy|7|||
154980305|NCT00546910|559352168|FG000|Overall Study|Physician Decision|0|||
154980306|NCT00546910|559352169|FG001|Overall Study|Physician Decision|1|||
154980307|NCT00546910|559352168|FG000|Overall Study|Withdrawal by Subject|2|||
154980308|NCT00546910|559352169|FG001|Overall Study|Withdrawal by Subject|0|||
154980309|NCT02284347|559352170|FG000|Overall Study|Lost to Follow-up|2|||
154980310|NCT02284347|559352170|FG000|Overall Study|Withdrawn prior to treatment|1|||
154980311|NCT01730040|559352172|FG000|Overall Study|Randomized but not treated|0|||
154980312|NCT01730040|559352173|FG001|Overall Study|Randomized but not treated|0|||
154980313|NCT01730040|559352174|FG002|Overall Study|Randomized but not treated|0|||
154980314|NCT01730040|559352175|FG003|Overall Study|Randomized but not treated|0|||
154980315|NCT01730040|559352176|FG004|Overall Study|Randomized but not treated|0|||
154980316|NCT01730040|559352177|FG005|Overall Study|Randomized but not treated|1|||
154980317|NCT01730040|559352178|FG006|Overall Study|Randomized but not treated|0|||
154980318|NCT01730040|559352172|FG000|Overall Study|Subject moved|0|||
154980319|NCT01730040|559352173|FG001|Overall Study|Subject moved|0|||
154980320|NCT01730040|559352174|FG002|Overall Study|Subject moved|1|||
154980321|NCT01730040|559352175|FG003|Overall Study|Subject moved|0|||
154980322|NCT01730040|559352176|FG004|Overall Study|Subject moved|0|||
154980323|NCT01730040|559352177|FG005|Overall Study|Subject moved|0|||
154980324|NCT01730040|559352178|FG006|Overall Study|Subject moved|1|||
154980325|NCT01730040|559352172|FG000|Overall Study|Physician Decision|0|||
154980326|NCT01730040|559352173|FG001|Overall Study|Physician Decision|0|||
154980327|NCT01730040|559352174|FG002|Overall Study|Physician Decision|0|||
154980328|NCT01730040|559352175|FG003|Overall Study|Physician Decision|0|||
154980329|NCT01730040|559352176|FG004|Overall Study|Physician Decision|0|||
154980330|NCT01730040|559352177|FG005|Overall Study|Physician Decision|1|||
154980331|NCT01730040|559352178|FG006|Overall Study|Physician Decision|1|||
154980332|NCT01730040|559352172|FG000|Overall Study|Other than specified|7|||
154980333|NCT01730040|559352173|FG001|Overall Study|Other than specified|8|||
154980334|NCT01730040|559352174|FG002|Overall Study|Other than specified|5|||
154980335|NCT01730040|559352175|FG003|Overall Study|Other than specified|5|||
154980336|NCT01730040|559352176|FG004|Overall Study|Other than specified|5|||
154980337|NCT01730040|559352177|FG005|Overall Study|Other than specified|4|||
154980338|NCT01730040|559352178|FG006|Overall Study|Other than specified|4|||
154980339|NCT01730040|559352172|FG000|Overall Study|Adverse Event|4|||
154980340|NCT01730040|559352173|FG001|Overall Study|Adverse Event|3|||
154980341|NCT01730040|559352174|FG002|Overall Study|Adverse Event|5|||
154980342|NCT01730040|559352175|FG003|Overall Study|Adverse Event|3|||
154980343|NCT01730040|559352176|FG004|Overall Study|Adverse Event|1|||
154980344|NCT01730040|559352177|FG005|Overall Study|Adverse Event|1|||
154980345|NCT01730040|559352178|FG006|Overall Study|Adverse Event|2|||
154898117|NCT01230749|559046462|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
154898118|NCT01230749|559046463|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
154898119|NCT02371980|559047845|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
154898120|NCT02371980|559047846|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
154898121|NCT02371980|559047847|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
154898122|NCT02371980|559047848|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
154898123|NCT02371980|559047849|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
154898124|NCT02371980|559047845|FG000|Open-label Period|Significant Protocol Deviation|19|||
154898125|NCT02371980|559047846|FG001|Open-label Period|Significant Protocol Deviation|0|||
154898126|NCT02371980|559047847|FG002|Open-label Period|Significant Protocol Deviation|0|||
154898127|NCT02371980|559047848|FG003|Open-label Period|Significant Protocol Deviation|0|||
154898128|NCT02371980|559047849|FG004|Open-label Period|Significant Protocol Deviation|0|||
154898129|NCT02371980|559047845|FG000|Open-label Period|Noncompliance with Study Drug|10|||
154898130|NCT02371980|559047846|FG001|Open-label Period|Noncompliance with Study Drug|0|||
154898131|NCT02371980|559047847|FG002|Open-label Period|Noncompliance with Study Drug|0|||
154898132|NCT02371980|559047848|FG003|Open-label Period|Noncompliance with Study Drug|0|||
154898133|NCT02371980|559047849|FG004|Open-label Period|Noncompliance with Study Drug|0|||
154898134|NCT02371980|559047845|FG000|Open-label Period|Lost to Follow-up|55|||
154898135|NCT02371980|559047846|FG001|Open-label Period|Lost to Follow-up|0|||
154898136|NCT02371980|559047847|FG002|Open-label Period|Lost to Follow-up|0|||
154898137|NCT02371980|559047848|FG003|Open-label Period|Lost to Follow-up|0|||
154898138|NCT02371980|559047849|FG004|Open-label Period|Lost to Follow-up|0|||
154898139|NCT02371980|559047845|FG000|Open-label Period|Voluntary Withdrawal|91|||
154898140|NCT02371980|559047846|FG001|Open-label Period|Voluntary Withdrawal|0|||
154898141|NCT02371980|559047847|FG002|Open-label Period|Voluntary Withdrawal|0|||
154898142|NCT02371980|559047848|FG003|Open-label Period|Voluntary Withdrawal|0|||
154898143|NCT02371980|559047849|FG004|Open-label Period|Voluntary Withdrawal|0|||
154898144|NCT02371980|559047845|FG000|Open-label Period|Pregnancy|1|||
154898145|NCT02371980|559047846|FG001|Open-label Period|Pregnancy|0|||
154898146|NCT02371980|559047847|FG002|Open-label Period|Pregnancy|0|||
154898147|NCT02371980|559047848|FG003|Open-label Period|Pregnancy|0|||
154898148|NCT02371980|559047849|FG004|Open-label Period|Pregnancy|0|||
154898149|NCT02371980|559047845|FG000|Open-label Period|Lack of Efficacy|116|||
154898150|NCT02371980|559047846|FG001|Open-label Period|Lack of Efficacy|0|||
154898151|NCT02371980|559047847|FG002|Open-label Period|Lack of Efficacy|0|||
154898152|NCT02371980|559047848|FG003|Open-label Period|Lack of Efficacy|0|||
154898153|NCT02371980|559047849|FG004|Open-label Period|Lack of Efficacy|0|||
154898154|NCT02371980|559047845|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
154898155|NCT02371980|559047846|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
154898156|NCT02371980|559047847|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
154898157|NCT02371980|559047848|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
154898158|NCT02371980|559047849|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
154898159|NCT02371980|559047845|FG000|Open-label Period|Reason not Specified|9|||
154898160|NCT02371980|559047846|FG001|Open-label Period|Reason not Specified|0|||
154898161|NCT02371980|559047847|FG002|Open-label Period|Reason not Specified|0|||
154898162|NCT02371980|559047848|FG003|Open-label Period|Reason not Specified|0|||
154898163|NCT02371980|559047849|FG004|Open-label Period|Reason not Specified|0|||
154898164|NCT02371980|559047845|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
154898165|NCT02371980|559047846|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
154898166|NCT02371980|559047847|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
154898167|NCT02371980|559047848|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
154898168|NCT02371980|559047849|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
154898169|NCT02371980|559047845|FG000|Double-blind Period|Significant Protocol Deviation|0|||
154898170|NCT02371980|559047846|FG001|Double-blind Period|Significant Protocol Deviation|2|||
154898171|NCT02371980|559047847|FG002|Double-blind Period|Significant Protocol Deviation|7|||
154898172|NCT02371980|559047848|FG003|Double-blind Period|Significant Protocol Deviation|3|||
154898173|NCT02371980|559047849|FG004|Double-blind Period|Significant Protocol Deviation|3|||
154898174|NCT02371980|559047845|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
154898175|NCT02371980|559047846|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
154898176|NCT02371980|559047847|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
154898177|NCT02371980|559047848|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
154980346|NCT01730040|559352172|FG000|Overall Study|Poor compliance to protocol|2|||
154980347|NCT01730040|559352173|FG001|Overall Study|Poor compliance to protocol|4|||
154898178|NCT02371980|559047849|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
154898179|NCT02371980|559047845|FG000|Double-blind Period|Lost to Follow-up|0|||
154898180|NCT02371980|559047846|FG001|Double-blind Period|Lost to Follow-up|8|||
154898181|NCT02371980|559047847|FG002|Double-blind Period|Lost to Follow-up|8|||
154898182|NCT02371980|559047848|FG003|Double-blind Period|Lost to Follow-up|6|||
154898183|NCT02371980|559047849|FG004|Double-blind Period|Lost to Follow-up|5|||
154980348|NCT01730040|559352174|FG002|Overall Study|Poor compliance to protocol|0|||
155114581|NCT05596734|559848238|FG001|Substudy A|Withdrawal by Subject|0|||
154898184|NCT02371980|559047845|FG000|Double-blind Period|Voluntary Withdrawal|0|||
154898185|NCT02371980|559047846|FG001|Double-blind Period|Voluntary Withdrawal|12|||
154898186|NCT02371980|559047847|FG002|Double-blind Period|Voluntary Withdrawal|8|||
154898187|NCT02371980|559047848|FG003|Double-blind Period|Voluntary Withdrawal|9|||
154898188|NCT02371980|559047849|FG004|Double-blind Period|Voluntary Withdrawal|11|||
154898189|NCT02371980|559047845|FG000|Double-blind Period|Relapse|0|||
154898190|NCT02371980|559047846|FG001|Double-blind Period|Relapse|50|||
154898191|NCT02371980|559047847|FG002|Double-blind Period|Relapse|25|||
154898192|NCT02371980|559047848|FG003|Double-blind Period|Relapse|25|||
154898193|NCT02371980|559047849|FG004|Double-blind Period|Relapse|26|||
154898194|NCT02371980|559047845|FG000|Double-blind Period|Reason not Specified|0|||
154898195|NCT02371980|559047846|FG001|Double-blind Period|Reason not Specified|3|||
154898196|NCT02371980|559047847|FG002|Double-blind Period|Reason not Specified|3|||
154898197|NCT02371980|559047848|FG003|Double-blind Period|Reason not Specified|2|||
154898198|NCT02371980|559047849|FG004|Double-blind Period|Reason not Specified|1|||
154898199|NCT02371980|559047845|FG000|Double-blind Period|Missing|0|||
154898200|NCT02371980|559047846|FG001|Double-blind Period|Missing|1|||
154898201|NCT02371980|559047847|FG002|Double-blind Period|Missing|0|||
154898202|NCT02371980|559047848|FG003|Double-blind Period|Missing|0|||
154898203|NCT02371980|559047849|FG004|Double-blind Period|Missing|0|||
154898204|NCT01280812|559047851|FG000|Overall Study|Withdrawal by Subject|2|||
154898205|NCT01280812|559047852|FG001|Overall Study|Withdrawal by Subject|1|||
154898206|NCT01280812|559047853|FG002|Overall Study|Withdrawal by Subject|0|||
154898207|NCT01280812|559047851|FG000|Overall Study|Lost to Follow-up|1|||
154898208|NCT01280812|559047852|FG001|Overall Study|Lost to Follow-up|1|||
154898209|NCT01280812|559047853|FG002|Overall Study|Lost to Follow-up|1|||
154898210|NCT00922974|559047856|FG000|Phase II Component|Protocol Violation|2|||
154898211|NCT00922974|559047857|FG001|Phase II Component|Protocol Violation|0|||
154898212|NCT00922974|559047856|FG000|Phase II Component|Not evaluable for treatment review|5|||
154898213|NCT00922974|559047857|FG001|Phase II Component|Not evaluable for treatment review|0|||
154898214|NCT00922974|559047856|FG000|Phase III Component|Protocol Violation|8|||
154898215|NCT00922974|559047857|FG001|Phase III Component|Protocol Violation|6|||
154898216|NCT03682055|559047858|FG000|Overall Study|Lack of Efficacy|1|||
154898217|NCT03682055|559047859|FG001|Overall Study|Lack of Efficacy|2|||
154898218|NCT03682055|559047860|FG002|Overall Study|Lack of Efficacy|1|||
154898219|NCT03682055|559047861|FG003|Overall Study|Lack of Efficacy|2|||
154898220|NCT03682055|559047862|FG004|Overall Study|Lack of Efficacy|1|||
154898221|NCT03682055|559047863|FG005|Overall Study|Lack of Efficacy|3|||
154898222|NCT03682055|559047858|FG000|Overall Study|Withdrawal by Subject|0|||
154898223|NCT03682055|559047859|FG001|Overall Study|Withdrawal by Subject|0|||
154898224|NCT03682055|559047860|FG002|Overall Study|Withdrawal by Subject|0|||
154898225|NCT03682055|559047861|FG003|Overall Study|Withdrawal by Subject|0|||
154898226|NCT03682055|559047862|FG004|Overall Study|Withdrawal by Subject|0|||
154898227|NCT03682055|559047863|FG005|Overall Study|Withdrawal by Subject|1|||
154898228|NCT03682055|559047858|FG000|Overall Study|Termination of Study by Sponsor|0|||
154898229|NCT03682055|559047859|FG001|Overall Study|Termination of Study by Sponsor|0|||
154898230|NCT03682055|559047860|FG002|Overall Study|Termination of Study by Sponsor|0|||
154898231|NCT03682055|559047861|FG003|Overall Study|Termination of Study by Sponsor|0|||
154898232|NCT03682055|559047862|FG004|Overall Study|Termination of Study by Sponsor|0|||
154898233|NCT03682055|559047863|FG005|Overall Study|Termination of Study by Sponsor|3|||
154898234|NCT00191386|559047864|FG000|Overall Study|Adverse Event|16|||
154898235|NCT00191386|559047864|FG000|Overall Study|Lost to Follow-up|1|||
154898236|NCT00191386|559047864|FG000|Overall Study|Entry Criteria Exclusion|3|||
154898237|NCT00191386|559047864|FG000|Overall Study|Protocol Violation|18|||
154898238|NCT00191386|559047864|FG000|Overall Study|Withdrawal by Subject|96|||
154898239|NCT00191386|559047864|FG000|Overall Study|Physician Decision|11|||
154898240|NCT00191386|559047864|FG000|Overall Study|Lack of Efficacy|15|||
154898241|NCT01826448|559047866|FG000|Overall Study|Adverse Event|1|||
154898242|NCT01826448|559047867|FG001|Overall Study|Adverse Event|3|||
154898243|NCT01826448|559047866|FG000|Overall Study|Disease progression|2|||
154898244|NCT01826448|559047867|FG001|Overall Study|Disease progression|4|||
154898245|NCT01826448|559047866|FG000|Overall Study|Withdrawal by Subject|1|||
154898246|NCT01826448|559047867|FG001|Overall Study|Withdrawal by Subject|0|||
154898247|NCT01826448|559047866|FG000|Overall Study|Physician Decision|0|||
154898248|NCT01826448|559047867|FG001|Overall Study|Physician Decision|1|||
154898249|NCT01826448|559047866|FG000|Overall Study|2 active cancers|0|||
154898250|NCT01826448|559047867|FG001|Overall Study|2 active cancers|1|||
154898251|NCT04038385|559047868|FG000|Overall Study|Completed baseline assessment only|7|||
154898252|NCT04038385|559047869|FG001|Overall Study|Completed baseline assessment only|4|||
154898253|NCT04038385|559047868|FG000|Overall Study|Moved out of area|4|||
154898254|NCT04038385|559047869|FG001|Overall Study|Moved out of area|2|||
154898255|NCT04038385|559047868|FG000|Overall Study|Discontinued study involvement|6|||
154898256|NCT04038385|559047869|FG001|Overall Study|Discontinued study involvement|1|||
154898257|NCT00402285|559047873|FG000|Overall Study|insufficient RNA quality|7|||
154898258|NCT00402285|559047874|FG001|Overall Study|insufficient RNA quality|6|||
154898259|NCT00402285|559047875|FG002|Overall Study|insufficient RNA quality|2|||
154898260|NCT00784459|559047876|FG000|Overall Study|Adverse Event|0|||
155114582|NCT05596734|559848239|FG002|Substudy A|Withdrawal by Subject|0|||
155114583|NCT05596734|559848240|FG003|Substudy A|Withdrawal by Subject|0|||
155114584|NCT05596734|559848241|FG004|Substudy A|Withdrawal by Subject|0|||
155114585|NCT05596734|559848242|FG005|Substudy A|Withdrawal by Subject|0|||
155114586|NCT05596734|559848243|FG006|Substudy A|Withdrawal by Subject|1|||
155114587|NCT05596734|559848244|FG007|Substudy A|Withdrawal by Subject|0|||
155114588|NCT05596734|559848245|FG008|Substudy A|Withdrawal by Subject|0|||
155114589|NCT05596734|559848246|FG009|Substudy A|Withdrawal by Subject|0|||
155114590|NCT05596734|559848247|FG010|Substudy A|Withdrawal by Subject|0|||
155114591|NCT05596734|559848248|FG011|Substudy A|Withdrawal by Subject|0|||
155114592|NCT05596734|559848249|FG012|Substudy A|Withdrawal by Subject|0|||
155114593|NCT05596734|559848250|FG013|Substudy A|Withdrawal by Subject|0|||
155114594|NCT05596734|559848251|FG014|Substudy A|Withdrawal by Subject|0|||
155114595|NCT05596734|559848252|FG015|Substudy A|Withdrawal by Subject|0|||
155114596|NCT05596734|559848253|FG016|Substudy A|Withdrawal by Subject|0|||
155114597|NCT05596734|559848254|FG017|Substudy A|Withdrawal by Subject|0|||
155114598|NCT05596734|559848255|FG018|Substudy A|Withdrawal by Subject|0|||
155114599|NCT05596734|559848256|FG019|Substudy A|Withdrawal by Subject|0|||
155114600|NCT05596734|559848257|FG020|Substudy A|Withdrawal by Subject|0|||
154898261|NCT00784459|559047877|FG001|Overall Study|Adverse Event|2|||
154898262|NCT02471586|559047883|FG000|Overall Study|Lost to Follow-up|3|||
154898263|NCT02471586|559047884|FG001|Overall Study|Lost to Follow-up|8|||
154898264|NCT02471586|559047885|FG002|Overall Study|Lost to Follow-up|4|||
154898265|NCT02471586|559047883|FG000|Overall Study|Death|2|||
154898266|NCT02471586|559047884|FG001|Overall Study|Death|2|||
155114601|NCT05596734|559848258|FG021|Substudy A|Withdrawal by Subject|0|||
154898267|NCT02471586|559047885|FG002|Overall Study|Death|0|||
154898268|NCT01419015|559047890|FG000|Overall Study|Death|2|||
154898269|NCT04839393|559047891|FG000|Overall Study|Adverse Event|0|||
154898270|NCT04839393|559047892|FG001|Overall Study|Adverse Event|0|||
154898271|NCT04839393|559047893|FG002|Overall Study|Adverse Event|2|||
154898272|NCT04839393|559047891|FG000|Overall Study|Withdrawal by participant|0|||
154898273|NCT04839393|559047892|FG001|Overall Study|Withdrawal by participant|0|||
154898274|NCT04839393|559047893|FG002|Overall Study|Withdrawal by participant|1|||
154898275|NCT01510028|559047894|FG000|Overall Study|Lack of Efficacy|1|||
154898276|NCT01510028|559047895|FG001|Overall Study|Lack of Efficacy|0|||
154898277|NCT01510028|559047896|FG002|Overall Study|Lack of Efficacy|0|||
154898278|NCT01510028|559047897|FG003|Overall Study|Lack of Efficacy|0|||
154898279|NCT02741310|559047898|FG000|Overall Study|Sponsor Decision|2|||
154898280|NCT02741310|559047899|FG001|Overall Study|Sponsor Decision|2|||
154898281|NCT05091918|559047900|FG000|Overall Study|Adverse Event|1|||
154898282|NCT05091918|559047900|FG000|Overall Study|Withdrawal by Subject|81|||
154898283|NCT01100658|559047902|FG000|Overall Study|Withdrawal by Subject|1|||
154898284|NCT01784211|559047906|FG000|Part A (Days 1-15)|Adverse Event|1|||
154898285|NCT01784211|559047907|FG001|Part A (Days 1-15)|Adverse Event|1|||
154898286|NCT01784211|559047908|FG002|Part A (Days 1-15)|Adverse Event|0|||
154898287|NCT01784211|559047909|FG003|Part A (Days 1-15)|Adverse Event|0|||
154898288|NCT01784211|559047910|FG004|Part A (Days 1-15)|Adverse Event|0|||
154898289|NCT01784211|559047911|FG005|Part A (Days 1-15)|Adverse Event|0|||
154898290|NCT01784211|559047906|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
154898291|NCT01784211|559047907|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
154898292|NCT01784211|559047908|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
154898293|NCT01784211|559047909|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
154898294|NCT01784211|559047910|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
154898295|NCT01784211|559047911|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
154898296|NCT00239356|559047914|FG000|Overall Study|Lack of Efficacy|1|||
154898297|NCT00239356|559047915|FG001|Overall Study|Lack of Efficacy|0|||
154898298|NCT00239356|559047914|FG000|Overall Study|Adverse Event|6|||
154898299|NCT00239356|559047915|FG001|Overall Study|Adverse Event|0|||
154898300|NCT00239356|559047914|FG000|Overall Study|Withdrawal by Subject|15|||
154898301|NCT00239356|559047915|FG001|Overall Study|Withdrawal by Subject|6|||
154898302|NCT00239356|559047914|FG000|Overall Study|Lost to Follow-up|3|||
154898303|NCT00239356|559047915|FG001|Overall Study|Lost to Follow-up|0|||
154898304|NCT00239356|559047914|FG000|Overall Study|poor/non-compliance|2|||
154898305|NCT00239356|559047915|FG001|Overall Study|poor/non-compliance|0|||
154898306|NCT00239356|559047914|FG000|Overall Study|Pregnancy|1|||
154898307|NCT00239356|559047915|FG001|Overall Study|Pregnancy|0|||
154898308|NCT00239356|559047914|FG000|Overall Study|Administrative reason|0|||
154898309|NCT00239356|559047915|FG001|Overall Study|Administrative reason|1|||
154898310|NCT00239356|559047914|FG000|Overall Study|Drug available on market|11|||
154898311|NCT00239356|559047915|FG001|Overall Study|Drug available on market|2|||
155114602|NCT05596734|559848259|FG022|Substudy A|Withdrawal by Subject|0|||
155114603|NCT05596734|559848260|FG023|Substudy A|Withdrawal by Subject|0|||
155114604|NCT05596734|559848237|FG000|Substudy A|Lost to Follow-up|1|||
155114605|NCT05596734|559848238|FG001|Substudy A|Lost to Follow-up|0|||
155114606|NCT05596734|559848239|FG002|Substudy A|Lost to Follow-up|1|||
154898312|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
154898313|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
155114607|NCT05596734|559848240|FG003|Substudy A|Lost to Follow-up|0|||
154898314|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
154898315|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
154898316|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
154898317|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
154898318|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
154898319|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
154898320|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
154898321|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
154898322|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
154898323|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
154898324|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
154898325|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
154898326|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
154898327|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
154898328|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
154898329|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
154898330|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
154898331|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
154898332|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
154898333|NCT01001572|559047916|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
154898334|NCT01001572|559047917|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
154898335|NCT01001572|559047918|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
154898336|NCT01001572|559047916|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
154898337|NCT01001572|559047917|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
154898338|NCT01001572|559047918|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
154898339|NCT01001572|559047916|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
154898340|NCT01001572|559047917|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
154898341|NCT01001572|559047918|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
154898342|NCT01001572|559047916|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
154898343|NCT01001572|559047917|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
154898344|NCT01001572|559047918|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
154898345|NCT01001572|559047916|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
154898346|NCT01001572|559047917|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
154898347|NCT01001572|559047918|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
154898348|NCT01001572|559047916|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
154898349|NCT01001572|559047917|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
154898350|NCT01001572|559047918|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
154898351|NCT01001572|559047916|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154898352|NCT01001572|559047917|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154898353|NCT01001572|559047918|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
154898354|NCT01094808|559047919|FG000|Overall Study|Withdrawal by Subject|1|||
154898355|NCT01094808|559047920|FG001|Overall Study|Withdrawal by Subject|1|||
154898356|NCT01094808|559047921|FG002|Overall Study|Withdrawal by Subject|0|||
154898357|NCT00369278|559047922|FG000|Overall Study|Adverse Event|14|||
154898358|NCT00369278|559047923|FG001|Overall Study|Adverse Event|11|||
154898359|NCT00369278|559047922|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154898360|NCT00369278|559047923|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
154898361|NCT00369278|559047922|FG000|Overall Study|Protocol Violation|2|||
154898362|NCT00369278|559047923|FG001|Overall Study|Protocol Violation|1|||
154898363|NCT00369278|559047922|FG000|Overall Study|Withdrawal by Subject|2|||
154898364|NCT00369278|559047923|FG001|Overall Study|Withdrawal by Subject|2|||
154898365|NCT00369278|559047922|FG000|Overall Study|Lost to Follow-up|1|||
154898366|NCT00369278|559047923|FG001|Overall Study|Lost to Follow-up|0|||
154898367|NCT00369278|559047922|FG000|Overall Study|Graft loss|1|||
154898368|NCT00369278|559047923|FG001|Overall Study|Graft loss|2|||
154898369|NCT02143141|559047930|FG000|Overall Study|pain scores at 24 hours not collected|1|||
154898370|NCT02143141|559047931|FG001|Overall Study|pain scores at 24 hours not collected|0|||
154898371|NCT04397796|559047934|FG000|Overall Study|Death|3|||
154898372|NCT04397796|559047935|FG001|Overall Study|Death|1|||
154980349|NCT01730040|559352175|FG003|Overall Study|Poor compliance to protocol|0|||
154980350|NCT01730040|559352176|FG004|Overall Study|Poor compliance to protocol|0|||
154980351|NCT01730040|559352177|FG005|Overall Study|Poor compliance to protocol|0|||
155114608|NCT05596734|559848241|FG004|Substudy A|Lost to Follow-up|0|||
154898373|NCT01809197|559047936|FG000|Overall Study|Lost to Follow-up|4|||
154898374|NCT01809197|559047937|FG001|Overall Study|Lost to Follow-up|2|||
154980352|NCT01730040|559352178|FG006|Overall Study|Poor compliance to protocol|1|||
154980353|NCT01301482|559352181|FG000|Overall Study|Withdrawal by Subject|1|||
154898375|NCT01809197|559047936|FG000|Overall Study|Adverse Event|2|||
154898376|NCT01809197|559047937|FG001|Overall Study|Adverse Event|3|||
154898377|NCT01809197|559047936|FG000|Overall Study|Failed slit lamp exam|1|||
155114609|NCT05596734|559848242|FG005|Substudy A|Lost to Follow-up|0|||
155114610|NCT05596734|559848243|FG006|Substudy A|Lost to Follow-up|0|||
155114611|NCT05596734|559848244|FG007|Substudy A|Lost to Follow-up|0|||
155114612|NCT05596734|559848245|FG008|Substudy A|Lost to Follow-up|0|||
155114613|NCT05596734|559848246|FG009|Substudy A|Lost to Follow-up|0|||
155114614|NCT05596734|559848247|FG010|Substudy A|Lost to Follow-up|0|||
155114615|NCT05596734|559848248|FG011|Substudy A|Lost to Follow-up|0|||
155114616|NCT05596734|559848249|FG012|Substudy A|Lost to Follow-up|0|||
155114617|NCT05596734|559848250|FG013|Substudy A|Lost to Follow-up|0|||
155114618|NCT05596734|559848251|FG014|Substudy A|Lost to Follow-up|0|||
155114619|NCT05596734|559848252|FG015|Substudy A|Lost to Follow-up|0|||
155114620|NCT05596734|559848253|FG016|Substudy A|Lost to Follow-up|0|||
155114621|NCT05596734|559848254|FG017|Substudy A|Lost to Follow-up|0|||
155114622|NCT05596734|559848255|FG018|Substudy A|Lost to Follow-up|0|||
155114623|NCT05596734|559848256|FG019|Substudy A|Lost to Follow-up|0|||
155114624|NCT05596734|559848257|FG020|Substudy A|Lost to Follow-up|0|||
155114625|NCT05596734|559848258|FG021|Substudy A|Lost to Follow-up|0|||
155114626|NCT05596734|559848259|FG022|Substudy A|Lost to Follow-up|0|||
155114627|NCT05596734|559848260|FG023|Substudy A|Lost to Follow-up|0|||
155114628|NCT05596734|559848237|FG000|Substudy B|Withdrawal by Subject|0|||
155114629|NCT05596734|559848238|FG001|Substudy B|Withdrawal by Subject|0|||
154898378|NCT01809197|559047937|FG001|Overall Study|Failed slit lamp exam|0|||
154898379|NCT01809197|559047936|FG000|Overall Study|Non-Compliance|1|||
154898380|NCT01809197|559047937|FG001|Overall Study|Non-Compliance|1|||
154898381|NCT01809197|559047936|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
154898382|NCT01809197|559047937|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
154898383|NCT01809197|559047936|FG000|Overall Study|Withdrawal by Subject|1|||
154898384|NCT01809197|559047937|FG001|Overall Study|Withdrawal by Subject|1|||
154898385|NCT01809197|559047936|FG000|Overall Study|Product not available|0|||
154898386|NCT01809197|559047937|FG001|Overall Study|Product not available|1|||
154898387|NCT00425113|559047938|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
154898388|NCT00425113|559047939|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
154898389|NCT00425113|559047938|FG000|Overall Study|diagnosis of abdominal TB|0|||
154898390|NCT00425113|559047939|FG001|Overall Study|diagnosis of abdominal TB|1|||
154898391|NCT00425113|559047938|FG000|Overall Study|missing study drug more than 14 days|0|||
154898392|NCT00425113|559047939|FG001|Overall Study|missing study drug more than 14 days|1|||
154898393|NCT00425113|559047938|FG000|Overall Study|Withdrawal by Subject|1|||
154898394|NCT00425113|559047939|FG001|Overall Study|Withdrawal by Subject|0|||
154898395|NCT04362813|559047940|FG000|Overall Study|Death|12|||
154898396|NCT04362813|559047941|FG001|Overall Study|Death|16|||
154898397|NCT04362813|559047940|FG000|Overall Study|Withdrawal by Subject|3|||
154898398|NCT04362813|559047941|FG001|Overall Study|Withdrawal by Subject|1|||
154898399|NCT04362813|559047940|FG000|Overall Study|Protocol Violation|0|||
154898400|NCT04362813|559047941|FG001|Overall Study|Protocol Violation|3|||
154898401|NCT04362813|559047940|FG000|Overall Study|Lost to Follow-up|1|||
154898402|NCT04362813|559047941|FG001|Overall Study|Lost to Follow-up|1|||
154898403|NCT04362813|559047940|FG000|Overall Study|Enrolled but did not receive treatment|2|||
154898404|NCT04362813|559047941|FG001|Overall Study|Enrolled but did not receive treatment|4|||
154898405|NCT02076334|559047948|FG000|Overall Study|Protocol Violation|1|||
154898406|NCT02076334|559047949|FG001|Overall Study|Protocol Violation|0|||
154898407|NCT02076334|559047950|FG002|Overall Study|Protocol Violation|0|||
154898408|NCT02076334|559047951|FG003|Overall Study|Protocol Violation|0|||
154898409|NCT02076334|559047948|FG000|Overall Study|Lost to Follow-up|0|||
154898410|NCT02076334|559047949|FG001|Overall Study|Lost to Follow-up|1|||
154898411|NCT02076334|559047950|FG002|Overall Study|Lost to Follow-up|1|||
154898412|NCT02076334|559047951|FG003|Overall Study|Lost to Follow-up|0|||
154898413|NCT02076334|559047948|FG000|Overall Study|muscle soreness|0|||
154898414|NCT02076334|559047949|FG001|Overall Study|muscle soreness|0|||
154898415|NCT02076334|559047950|FG002|Overall Study|muscle soreness|0|||
154898416|NCT02076334|559047951|FG003|Overall Study|muscle soreness|1|||
154898417|NCT03238352|559047952|FG000|Overall Study|Lost to Follow-up|0|||
154898418|NCT03238352|559047953|FG001|Overall Study|Lost to Follow-up|2|||
154898419|NCT03238352|559047954|FG002|Overall Study|Lost to Follow-up|1|||
154898420|NCT03238352|559047952|FG000|Overall Study|Withdrawal by Subject|0|||
154898421|NCT03238352|559047953|FG001|Overall Study|Withdrawal by Subject|1|||
154898422|NCT03238352|559047954|FG002|Overall Study|Withdrawal by Subject|0|||
155114630|NCT05596734|559848239|FG002|Substudy B|Withdrawal by Subject|0|||
155114631|NCT05596734|559848240|FG003|Substudy B|Withdrawal by Subject|0|||
155175672|NCT03339297|560080308|FG000|Overall Study|Consent Withdrawn by Participant|3|||
154898423|NCT01654523|559047956|FG000|Overall Study|Withdrawal by Subject|1|||
154898424|NCT04294095|559047957|FG000|Overall Study|Adverse Event|1|||
154898425|NCT04294095|559047958|FG001|Overall Study|Adverse Event|0|||
154898426|NCT01142193|559047959|FG000|Overall Study|Adverse Event|12|||
154898427|NCT01142193|559047960|FG001|Overall Study|Adverse Event|4|||
154898428|NCT01142193|559047959|FG000|Overall Study|Lack of Efficacy|2|||
155114632|NCT05596734|559848241|FG004|Substudy B|Withdrawal by Subject|0|||
155114633|NCT05596734|559848242|FG005|Substudy B|Withdrawal by Subject|0|||
154898429|NCT01142193|559047960|FG001|Overall Study|Lack of Efficacy|1|||
155114634|NCT05596734|559848243|FG006|Substudy B|Withdrawal by Subject|0|||
155114635|NCT05596734|559848244|FG007|Substudy B|Withdrawal by Subject|0|||
155114636|NCT05596734|559848245|FG008|Substudy B|Withdrawal by Subject|0|||
155114637|NCT05596734|559848246|FG009|Substudy B|Withdrawal by Subject|0|||
155114638|NCT05596734|559848247|FG010|Substudy B|Withdrawal by Subject|0|||
155114639|NCT05596734|559848248|FG011|Substudy B|Withdrawal by Subject|0|||
155114640|NCT05596734|559848249|FG012|Substudy B|Withdrawal by Subject|1|||
155114641|NCT05596734|559848250|FG013|Substudy B|Withdrawal by Subject|0|||
155114642|NCT05596734|559848251|FG014|Substudy B|Withdrawal by Subject|1|||
155114643|NCT05596734|559848252|FG015|Substudy B|Withdrawal by Subject|2|||
155114644|NCT05596734|559848253|FG016|Substudy B|Withdrawal by Subject|2|||
155114645|NCT05596734|559848254|FG017|Substudy B|Withdrawal by Subject|1|||
155114646|NCT05596734|559848255|FG018|Substudy B|Withdrawal by Subject|2|||
155114647|NCT05596734|559848256|FG019|Substudy B|Withdrawal by Subject|0|||
155114648|NCT05596734|559848257|FG020|Substudy B|Withdrawal by Subject|0|||
155114649|NCT05596734|559848258|FG021|Substudy B|Withdrawal by Subject|0|||
155114650|NCT05596734|559848259|FG022|Substudy B|Withdrawal by Subject|0|||
155114651|NCT05596734|559848260|FG023|Substudy B|Withdrawal by Subject|1|||
155114652|NCT05596734|559848237|FG000|Substudy B|Physician Decision|0|||
155114653|NCT05596734|559848238|FG001|Substudy B|Physician Decision|0|||
155114654|NCT05596734|559848239|FG002|Substudy B|Physician Decision|0|||
155114655|NCT05596734|559848240|FG003|Substudy B|Physician Decision|0|||
155114656|NCT05596734|559848241|FG004|Substudy B|Physician Decision|0|||
155114657|NCT05596734|559848242|FG005|Substudy B|Physician Decision|0|||
155114658|NCT05596734|559848243|FG006|Substudy B|Physician Decision|0|||
155114659|NCT05596734|559848244|FG007|Substudy B|Physician Decision|0|||
155114660|NCT05596734|559848245|FG008|Substudy B|Physician Decision|0|||
155114661|NCT05596734|559848246|FG009|Substudy B|Physician Decision|0|||
155114662|NCT05596734|559848247|FG010|Substudy B|Physician Decision|0|||
155114663|NCT05596734|559848248|FG011|Substudy B|Physician Decision|0|||
155114664|NCT05596734|559848249|FG012|Substudy B|Physician Decision|0|||
155114665|NCT05596734|559848250|FG013|Substudy B|Physician Decision|0|||
155114666|NCT05596734|559848251|FG014|Substudy B|Physician Decision|0|||
155114667|NCT05596734|559848252|FG015|Substudy B|Physician Decision|1|||
155114668|NCT05596734|559848253|FG016|Substudy B|Physician Decision|0|||
155114669|NCT05596734|559848254|FG017|Substudy B|Physician Decision|0|||
155114670|NCT05596734|559848255|FG018|Substudy B|Physician Decision|0|||
155114671|NCT05596734|559848256|FG019|Substudy B|Physician Decision|0|||
155114672|NCT05596734|559848257|FG020|Substudy B|Physician Decision|0|||
155114673|NCT05596734|559848258|FG021|Substudy B|Physician Decision|0|||
155114674|NCT05596734|559848259|FG022|Substudy B|Physician Decision|0|||
155114675|NCT05596734|559848260|FG023|Substudy B|Physician Decision|0|||
155114676|NCT05596734|559848237|FG000|Substudy B|Lost to Follow-up|0|||
155114677|NCT05596734|559848238|FG001|Substudy B|Lost to Follow-up|0|||
155114678|NCT05596734|559848239|FG002|Substudy B|Lost to Follow-up|0|||
155114679|NCT05596734|559848240|FG003|Substudy B|Lost to Follow-up|0|||
155114680|NCT05596734|559848241|FG004|Substudy B|Lost to Follow-up|0|||
155114681|NCT05596734|559848242|FG005|Substudy B|Lost to Follow-up|0|||
154898430|NCT01142193|559047959|FG000|Overall Study|Physician Decision|1|||
154898431|NCT01142193|559047960|FG001|Overall Study|Physician Decision|1|||
154898432|NCT01142193|559047959|FG000|Overall Study|Withdrawal by Subject|4|||
154898433|NCT01142193|559047960|FG001|Overall Study|Withdrawal by Subject|3|||
154898434|NCT01142193|559047959|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
154898435|NCT01142193|559047960|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
154898436|NCT01142193|559047959|FG000|Overall Study|Other|1|||
154898437|NCT01142193|559047960|FG001|Overall Study|Other|2|||
154898438|NCT02762708|559047961|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
154898439|NCT02762708|559047962|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
154898440|NCT02762708|559047963|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
155114682|NCT05596734|559848243|FG006|Substudy B|Lost to Follow-up|0|||
155114683|NCT05596734|559848244|FG007|Substudy B|Lost to Follow-up|0|||
155114684|NCT05596734|559848245|FG008|Substudy B|Lost to Follow-up|0|||
155114685|NCT05596734|559848246|FG009|Substudy B|Lost to Follow-up|0|||
155114686|NCT05596734|559848247|FG010|Substudy B|Lost to Follow-up|0|||
155114687|NCT05596734|559848248|FG011|Substudy B|Lost to Follow-up|0|||
155114688|NCT05596734|559848249|FG012|Substudy B|Lost to Follow-up|1|||
155114689|NCT05596734|559848250|FG013|Substudy B|Lost to Follow-up|0|||
155114690|NCT05596734|559848251|FG014|Substudy B|Lost to Follow-up|1|||
155114691|NCT05596734|559848252|FG015|Substudy B|Lost to Follow-up|1|||
155114692|NCT05596734|559848253|FG016|Substudy B|Lost to Follow-up|0|||
155114693|NCT05596734|559848254|FG017|Substudy B|Lost to Follow-up|0|||
155114694|NCT05596734|559848255|FG018|Substudy B|Lost to Follow-up|0|||
154898441|NCT02762708|559047964|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
154898442|NCT01468701|559047970|FG000|Overall Study|Not eligible|91|||
154980354|NCT00544817|559352184|FG000|Combined Modality|Lack of Efficacy|2|||
155114695|NCT05596734|559848256|FG019|Substudy B|Lost to Follow-up|0|||
155114696|NCT05596734|559848257|FG020|Substudy B|Lost to Follow-up|0|||
155114697|NCT05596734|559848258|FG021|Substudy B|Lost to Follow-up|0|||
155114698|NCT05596734|559848259|FG022|Substudy B|Lost to Follow-up|0|||
155114699|NCT05596734|559848260|FG023|Substudy B|Lost to Follow-up|0|||
155114700|NCT01974206|559848261|FG000|Overall Study|Did Not Take Study Drug|0|||
155114701|NCT01974206|559848262|FG001|Overall Study|Did Not Take Study Drug|1|||
155114702|NCT01974206|559848261|FG000|Overall Study|Physician Decision|1|||
155114703|NCT01974206|559848262|FG001|Overall Study|Physician Decision|0|||
155114704|NCT01974206|559848261|FG000|Overall Study|Withdrawal by Subject|3|||
155114705|NCT01974206|559848262|FG001|Overall Study|Withdrawal by Subject|0|||
154898443|NCT01468701|559047971|FG001|Overall Study|Not eligible|140|||
154898444|NCT01468701|559047972|FG002|Overall Study|Not eligible|29|||
154898445|NCT01468701|559047973|FG003|Overall Study|Not eligible|12|||
154898446|NCT01468701|559047974|FG004|Overall Study|Not eligible|22|||
154898447|NCT01468701|559047975|FG005|Overall Study|Not eligible|2|||
154898448|NCT01468701|559047976|FG006|Overall Study|Not eligible|39|||
154898449|NCT01468701|559047977|FG007|Overall Study|Not eligible|1|||
154898450|NCT01468701|559047978|FG008|Overall Study|Not eligible|40|||
154898451|NCT01468701|559047979|FG009|Overall Study|Not eligible|126|||
154898452|NCT01468701|559047980|FG010|Overall Study|Not eligible|39|||
154898453|NCT01468701|559047981|FG011|Overall Study|Not eligible|33|||
154898454|NCT01468701|559047982|FG012|Overall Study|Not eligible|1|||
154898455|NCT01468701|559047983|FG013|Overall Study|Not eligible|19|||
154898456|NCT01468701|559047984|FG014|Overall Study|Not eligible|1|||
154898457|NCT01468701|559047985|FG015|Overall Study|Not eligible|32|||
154898458|NCT01468701|559047986|FG016|Overall Study|Not eligible|0|||
154898459|NCT01468701|559047970|FG000|Overall Study|Lost to Follow-up|306|||
154898460|NCT01468701|559047971|FG001|Overall Study|Lost to Follow-up|0|||
154898461|NCT01468701|559047972|FG002|Overall Study|Lost to Follow-up|0|||
154898462|NCT01468701|559047973|FG003|Overall Study|Lost to Follow-up|0|||
154898463|NCT01468701|559047974|FG004|Overall Study|Lost to Follow-up|0|||
154898464|NCT01468701|559047975|FG005|Overall Study|Lost to Follow-up|0|||
154898465|NCT01468701|559047976|FG006|Overall Study|Lost to Follow-up|0|||
154898466|NCT01468701|559047977|FG007|Overall Study|Lost to Follow-up|0|||
154898467|NCT01468701|559047978|FG008|Overall Study|Lost to Follow-up|215|||
154898468|NCT01468701|559047979|FG009|Overall Study|Lost to Follow-up|309|||
154898469|NCT01468701|559047980|FG010|Overall Study|Lost to Follow-up|224|||
154898470|NCT01468701|559047981|FG011|Overall Study|Lost to Follow-up|212|||
154898471|NCT01468701|559047982|FG012|Overall Study|Lost to Follow-up|11|||
154898472|NCT01468701|559047983|FG013|Overall Study|Lost to Follow-up|164|||
154898473|NCT01468701|559047984|FG014|Overall Study|Lost to Follow-up|17|||
154898474|NCT01468701|559047985|FG015|Overall Study|Lost to Follow-up|127|||
154898475|NCT01468701|559047986|FG016|Overall Study|Lost to Follow-up|1|||
154898476|NCT01468701|559047970|FG000|Overall Study|Withdrawal by Subject|165|||
154898477|NCT01468701|559047971|FG001|Overall Study|Withdrawal by Subject|0|||
154898478|NCT01468701|559047972|FG002|Overall Study|Withdrawal by Subject|0|||
154898479|NCT01468701|559047973|FG003|Overall Study|Withdrawal by Subject|0|||
154898480|NCT01468701|559047974|FG004|Overall Study|Withdrawal by Subject|0|||
154898481|NCT01468701|559047975|FG005|Overall Study|Withdrawal by Subject|0|||
154898482|NCT01468701|559047976|FG006|Overall Study|Withdrawal by Subject|0|||
154898483|NCT01468701|559047977|FG007|Overall Study|Withdrawal by Subject|0|||
154898484|NCT01468701|559047978|FG008|Overall Study|Withdrawal by Subject|83|||
154898485|NCT01468701|559047979|FG009|Overall Study|Withdrawal by Subject|88|||
154898486|NCT01468701|559047980|FG010|Overall Study|Withdrawal by Subject|100|||
154898487|NCT01468701|559047981|FG011|Overall Study|Withdrawal by Subject|114|||
154898488|NCT01468701|559047982|FG012|Overall Study|Withdrawal by Subject|9|||
154898489|NCT01468701|559047983|FG013|Overall Study|Withdrawal by Subject|47|||
154898490|NCT01468701|559047984|FG014|Overall Study|Withdrawal by Subject|6|||
154898491|NCT01468701|559047985|FG015|Overall Study|Withdrawal by Subject|31|||
154898492|NCT01468701|559047986|FG016|Overall Study|Withdrawal by Subject|0|||
154898493|NCT01468701|559047970|FG000|Overall Study|Other reasons than listed|437|||
154898494|NCT01468701|559047971|FG001|Overall Study|Other reasons than listed|0|||
154898495|NCT01468701|559047972|FG002|Overall Study|Other reasons than listed|0|||
154898496|NCT01468701|559047973|FG003|Overall Study|Other reasons than listed|0|||
154898497|NCT01468701|559047974|FG004|Overall Study|Other reasons than listed|0|||
154898498|NCT01468701|559047975|FG005|Overall Study|Other reasons than listed|0|||
154898499|NCT01468701|559047976|FG006|Overall Study|Other reasons than listed|0|||
154898500|NCT01468701|559047977|FG007|Overall Study|Other reasons than listed|0|||
154898501|NCT01468701|559047978|FG008|Overall Study|Other reasons than listed|318|||
154898502|NCT01468701|559047979|FG009|Overall Study|Other reasons than listed|658|||
154898503|NCT01468701|559047980|FG010|Overall Study|Other reasons than listed|433|||
154898504|NCT01468701|559047981|FG011|Overall Study|Other reasons than listed|504|||
154898505|NCT01468701|559047982|FG012|Overall Study|Other reasons than listed|28|||
154898506|NCT01468701|559047983|FG013|Overall Study|Other reasons than listed|239|||
154898507|NCT01468701|559047984|FG014|Overall Study|Other reasons than listed|39|||
155114706|NCT01974206|559848261|FG000|Overall Study|Lost to Follow-up|1|||
154898508|NCT01468701|559047985|FG015|Overall Study|Other reasons than listed|172|||
154898509|NCT01468701|559047986|FG016|Overall Study|Other reasons than listed|0|||
154898510|NCT01468701|559047970|FG000|Overall Study|No end of study case report form|0|||
155114707|NCT01974206|559848262|FG001|Overall Study|Lost to Follow-up|0|||
155114708|NCT01974206|559848261|FG000|Overall Study|Death|1|||
154898511|NCT01468701|559047971|FG001|Overall Study|No end of study case report form|0|||
154980355|NCT00544817|559352184|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
154980356|NCT00544817|559352184|FG000|Combined Modality|Adverse Event|2|||
154980357|NCT00544817|559352184|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
154980358|NCT00544817|559352184|FG000|No Treatment Interval|Lack of Efficacy|8|||
154980359|NCT00544817|559352184|FG000|No Treatment Interval|Physician Decision|3|||
154980360|NCT00544817|559352184|FG000|No Treatment Interval|Adverse Event|1|||
154980361|NCT00544817|559352184|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
154980362|NCT00544817|559352184|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
154980363|NCT00544817|559352184|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
154980364|NCT01552369|559352185|FG000|Overall Study|Did not consent to extended follow up|8|||
154980365|NCT01552369|559352186|FG001|Overall Study|Did not consent to extended follow up|9|||
154980366|NCT00614926|559352187|FG000|Overall Study|Burden of travel|1|||
154898512|NCT01468701|559047972|FG002|Overall Study|No end of study case report form|0|||
154898513|NCT01468701|559047973|FG003|Overall Study|No end of study case report form|0|||
154898514|NCT01468701|559047974|FG004|Overall Study|No end of study case report form|0|||
154898515|NCT01468701|559047975|FG005|Overall Study|No end of study case report form|0|||
154898516|NCT01468701|559047976|FG006|Overall Study|No end of study case report form|0|||
154898517|NCT01468701|559047977|FG007|Overall Study|No end of study case report form|0|||
154898518|NCT01468701|559047978|FG008|Overall Study|No end of study case report form|4|||
154898519|NCT01468701|559047979|FG009|Overall Study|No end of study case report form|1|||
154898520|NCT01468701|559047980|FG010|Overall Study|No end of study case report form|2|||
154898521|NCT01468701|559047981|FG011|Overall Study|No end of study case report form|3|||
154898522|NCT01468701|559047982|FG012|Overall Study|No end of study case report form|0|||
154898523|NCT01468701|559047983|FG013|Overall Study|No end of study case report form|1|||
154898524|NCT01468701|559047984|FG014|Overall Study|No end of study case report form|0|||
154898525|NCT01468701|559047985|FG015|Overall Study|No end of study case report form|0|||
154898526|NCT01468701|559047986|FG016|Overall Study|No end of study case report form|0|||
154898527|NCT01468701|559047970|FG000|Overall Study|Not being followed up|0|||
154898528|NCT01468701|559047971|FG001|Overall Study|Not being followed up|4963|||
154898529|NCT01468701|559047972|FG002|Overall Study|Not being followed up|1755|||
154898530|NCT01468701|559047973|FG003|Overall Study|Not being followed up|703|||
154898531|NCT01468701|559047974|FG004|Overall Study|Not being followed up|1714|||
154898532|NCT01468701|559047975|FG005|Overall Study|Not being followed up|126|||
154898533|NCT01468701|559047976|FG006|Overall Study|Not being followed up|1170|||
154898534|NCT01468701|559047977|FG007|Overall Study|Not being followed up|4|||
154898535|NCT01468701|559047978|FG008|Overall Study|Not being followed up|0|||
154898536|NCT01468701|559047979|FG009|Overall Study|Not being followed up|0|||
154898537|NCT01468701|559047980|FG010|Overall Study|Not being followed up|0|||
154898538|NCT01468701|559047981|FG011|Overall Study|Not being followed up|0|||
154898539|NCT01468701|559047982|FG012|Overall Study|Not being followed up|0|||
154898540|NCT01468701|559047983|FG013|Overall Study|Not being followed up|0|||
154898541|NCT01468701|559047984|FG014|Overall Study|Not being followed up|0|||
154898542|NCT01468701|559047985|FG015|Overall Study|Not being followed up|0|||
154898543|NCT01468701|559047986|FG016|Overall Study|Not being followed up|0|||
154898544|NCT03136367|559047997|FG000|T1 Consultation|discontinued mistakenly included|2|||
154898545|NCT03136367|559047998|FG001|T1 Consultation|discontinued mistakenly included|6|||
154898546|NCT03136367|559047999|FG002|T1 Consultation|discontinued mistakenly included|1|||
154898547|NCT03136367|559047997|FG000|T1 Consultation|Discontinued other|0|||
154898548|NCT03136367|559047998|FG001|T1 Consultation|Discontinued other|1|||
154898549|NCT03136367|559047999|FG002|T1 Consultation|Discontinued other|0|||
154898550|NCT03136367|559047997|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
154898551|NCT03136367|559047998|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
154898552|NCT03136367|559047999|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
154898553|NCT03136367|559047997|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
154898554|NCT03136367|559047998|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
154898555|NCT03136367|559047999|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
154898556|NCT03136367|559047997|FG000|T2 Post-consultation|Discontinued other|0|||
154898557|NCT03136367|559047998|FG001|T2 Post-consultation|Discontinued other|2|||
154898558|NCT03136367|559047999|FG002|T2 Post-consultation|Discontinued other|6|||
154980367|NCT00614926|559352188|FG001|Overall Study|Burden of travel|0|||
154898559|NCT03136367|559047997|FG000|T2 Post-consultation|Discontinued transferred care|0|||
154898560|NCT03136367|559047998|FG001|T2 Post-consultation|Discontinued transferred care|0|||
154898561|NCT03136367|559047999|FG002|T2 Post-consultation|Discontinued transferred care|3|||
154898562|NCT03136367|559047997|FG000|T2 Post-consultation|Discontinued lost contact|0|||
154898563|NCT03136367|559047998|FG001|T2 Post-consultation|Discontinued lost contact|1|||
154898564|NCT03136367|559047999|FG002|T2 Post-consultation|Discontinued lost contact|0|||
154980368|NCT00614926|559352187|FG000|Overall Study|Adverse Event|3|||
154898565|NCT03136367|559047997|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
154898566|NCT03136367|559047998|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
154898567|NCT03136367|559047999|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
154980369|NCT00614926|559352188|FG001|Overall Study|Adverse Event|0|||
154980370|NCT02999984|559352198|FG000|Overall Study|Treatment Failure|1|||
154980371|NCT00754013|559352201|FG000|Overall Study|Lost to Follow-up|1|||
154980372|NCT00754013|559352202|FG001|Overall Study|Lost to Follow-up|1|||
154980373|NCT00754013|559352201|FG000|Overall Study|didn't return after study termed|3|||
154980374|NCT00754013|559352202|FG001|Overall Study|didn't return after study termed|4|||
154980375|NCT02310789|559352203|FG000|Overall Study|Adverse Event|1|||
154980376|NCT01197417|559352204|FG000|Overall Study|Physician Decision|3|||
154980377|NCT01197417|559352205|FG001|Overall Study|Physician Decision|2|||
154980378|NCT01197417|559352204|FG000|Overall Study|Withdrawal by Subject|2|||
154980379|NCT01197417|559352205|FG001|Overall Study|Withdrawal by Subject|4|||
154980380|NCT01197417|559352204|FG000|Overall Study|Site miscommunication|0|||
154980381|NCT01197417|559352205|FG001|Overall Study|Site miscommunication|1|||
154980382|NCT01197417|559352204|FG000|Overall Study|Subject transferred to intensive care|0|||
154980383|NCT01197417|559352205|FG001|Overall Study|Subject transferred to intensive care|1|||
154980384|NCT01197417|559352204|FG000|Overall Study|Not consented in time to receive drug|0|||
154980385|NCT01197417|559352205|FG001|Overall Study|Not consented in time to receive drug|1|||
154980386|NCT01197417|559352204|FG000|Overall Study|Hypotension|1|||
154980387|NCT01197417|559352205|FG001|Overall Study|Hypotension|2|||
154980388|NCT01197417|559352204|FG000|Overall Study|Found to be ineligible|2|||
154980389|NCT01197417|559352205|FG001|Overall Study|Found to be ineligible|5|||
154980390|NCT01197417|559352204|FG000|Overall Study|No 25-hour magnesium level|0|||
154980391|NCT01197417|559352205|FG001|Overall Study|No 25-hour magnesium level|2|||
154980392|NCT02813421|559352210|FG000|Overall Study|Withdrawal by Subject|1|||
154980393|NCT02813421|559352211|FG001|Overall Study|Withdrawal by Subject|2|||
154980394|NCT02813421|559352210|FG000|Overall Study|Lost to Follow-up|1|||
154980395|NCT02813421|559352211|FG001|Overall Study|Lost to Follow-up|1|||
154980396|NCT04213209|559352219|FG000|Overall Study|Protocol Violation|1|||
154980397|NCT04213209|559352220|FG001|Overall Study|Protocol Violation|0|||
154980398|NCT04213209|559352221|FG002|Overall Study|Protocol Violation|0|||
154980399|NCT04213209|559352222|FG003|Overall Study|Protocol Violation|0|||
154980400|NCT04213209|559352223|FG004|Overall Study|Protocol Violation|0|||
154980401|NCT04213209|559352224|FG005|Overall Study|Protocol Violation|0|||
154980402|NCT02129647|559352234|FG000|Overall Study|Adverse Event|2|||
154980403|NCT02129647|559352234|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
154980404|NCT01570283|559352236|FG000|Cohort 1: Dose Level 1|Death|0|||
154980405|NCT01570283|559352237|FG001|Cohort 1: Dose Level 1|Death|1|||
154980406|NCT01570283|559352238|FG002|Cohort 1: Dose Level 1|Death|0|||
154980407|NCT01570283|559352239|FG003|Cohort 1: Dose Level 1|Death|0|||
154980408|NCT01570283|559352240|FG004|Cohort 1: Dose Level 1|Death|0|||
154980409|NCT01570283|559352241|FG005|Cohort 1: Dose Level 1|Death|0|||
154980410|NCT01570283|559352236|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
154980411|NCT01570283|559352237|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
154980412|NCT01570283|559352238|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
154980413|NCT01570283|559352239|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
154980414|NCT01570283|559352240|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
154980415|NCT01570283|559352241|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
154980416|NCT01570283|559352236|FG000|Cohort 2: Dose Level 2|Death|0|||
154980417|NCT01570283|559352237|FG001|Cohort 2: Dose Level 2|Death|0|||
154980418|NCT01570283|559352238|FG002|Cohort 2: Dose Level 2|Death|1|||
154980419|NCT01570283|559352239|FG003|Cohort 2: Dose Level 2|Death|0|||
154980420|NCT01570283|559352240|FG004|Cohort 2: Dose Level 2|Death|0|||
154980421|NCT01570283|559352241|FG005|Cohort 2: Dose Level 2|Death|0|||
154980422|NCT01570283|559352236|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
154980423|NCT01570283|559352237|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
154980424|NCT01570283|559352238|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
154980425|NCT01570283|559352239|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
154980426|NCT01570283|559352240|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
154980427|NCT01570283|559352241|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
154980428|NCT01570283|559352236|FG000|Cohort 3: Dose Level 3|Death|0|||
154980429|NCT01570283|559352237|FG001|Cohort 3: Dose Level 3|Death|0|||
154980430|NCT01570283|559352238|FG002|Cohort 3: Dose Level 3|Death|0|||
154980431|NCT01570283|559352239|FG003|Cohort 3: Dose Level 3|Death|0|||
154980432|NCT01570283|559352240|FG004|Cohort 3: Dose Level 3|Death|0|||
154980433|NCT01570283|559352241|FG005|Cohort 3: Dose Level 3|Death|1|||
154980434|NCT01570283|559352236|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
154980435|NCT01570283|559352237|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
154980436|NCT01570283|559352238|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
154980437|NCT01570283|559352239|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
154980438|NCT01570283|559352240|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
155114709|NCT01974206|559848262|FG001|Overall Study|Death|0|||
155114710|NCT02059499|559848266|FG000|Upto Week 20|Lost to Follow-up|2|||
155114711|NCT02059499|559848267|FG001|Upto Week 20|Lost to Follow-up|6|||
155114712|NCT02059499|559848268|FG002|Upto Week 20|Lost to Follow-up|0|||
155114713|NCT02059499|559848266|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
154980439|NCT01570283|559352241|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
154980440|NCT00685802|559352244|FG000|Washout Period of 7 Days|Protocol Violation|2|||
154980441|NCT00685802|559352245|FG001|Washout Period of 7 Days|Protocol Violation|0|||
154980442|NCT00685802|559352244|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
154980443|NCT00685802|559352245|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
154980444|NCT01333072|559352246|FG000|Overall Study|Lost to Follow-up|3|||
154980445|NCT01333072|559352247|FG001|Overall Study|Lost to Follow-up|0|||
154980446|NCT01333072|559352246|FG000|Overall Study|Adverse Event|2|||
154980447|NCT01333072|559352247|FG001|Overall Study|Adverse Event|4|||
154980448|NCT01333072|559352246|FG000|Overall Study|Physician Decision|1|||
154980449|NCT01333072|559352247|FG001|Overall Study|Physician Decision|0|||
154980450|NCT00103038|559352250|FG000|Overall Study|Withdrawal by Subject|8|||
154980451|NCT00103038|559352250|FG000|Overall Study|Screen failure|3|||
154980452|NCT00103038|559352250|FG000|Overall Study|Death|1|||
154980453|NCT00103038|559352250|FG000|Overall Study|Physician Decision|1|||
154980454|NCT01463982|559352251|FG000|Overall Study|Withdrawal by Subject|0|||
154980455|NCT01463982|559352252|FG001|Overall Study|Withdrawal by Subject|1|||
154980456|NCT01463982|559352253|FG002|Overall Study|Withdrawal by Subject|1|||
154980457|NCT01463982|559352254|FG003|Overall Study|Withdrawal by Subject|0|||
154980458|NCT01463982|559352251|FG000|Overall Study|Treatment delay over 5 week|0|||
154980459|NCT01463982|559352252|FG001|Overall Study|Treatment delay over 5 week|0|||
154980460|NCT01463982|559352253|FG002|Overall Study|Treatment delay over 5 week|1|||
154980461|NCT01463982|559352254|FG003|Overall Study|Treatment delay over 5 week|0|||
154980462|NCT02462486|559352257|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
154980463|NCT02462486|559352258|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
154980464|NCT02462486|559352259|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
154980465|NCT02462486|559352257|FG000|Overall Study|Adverse Event|53|||
154980466|NCT02462486|559352258|FG001|Overall Study|Adverse Event|48|||
154980467|NCT02462486|559352259|FG002|Overall Study|Adverse Event|21|||
154980468|NCT02462486|559352257|FG000|Overall Study|Lack of Efficacy|6|||
154980469|NCT02462486|559352258|FG001|Overall Study|Lack of Efficacy|12|||
154980470|NCT02462486|559352259|FG002|Overall Study|Lack of Efficacy|3|||
154980471|NCT02462486|559352257|FG000|Overall Study|Lost to Follow-up|3|||
154980472|NCT02462486|559352258|FG001|Overall Study|Lost to Follow-up|4|||
154980473|NCT02462486|559352259|FG002|Overall Study|Lost to Follow-up|2|||
154980474|NCT02462486|559352257|FG000|Overall Study|Withdrawal by Subject|25|||
154980475|NCT02462486|559352258|FG001|Overall Study|Withdrawal by Subject|22|||
154980476|NCT02462486|559352259|FG002|Overall Study|Withdrawal by Subject|19|||
154980477|NCT02462486|559352257|FG000|Overall Study|Protocol Violation|3|||
154980478|NCT02462486|559352258|FG001|Overall Study|Protocol Violation|1|||
154980479|NCT02462486|559352259|FG002|Overall Study|Protocol Violation|1|||
154980480|NCT02462486|559352257|FG000|Overall Study|Reason not Specified|3|||
154980481|NCT02462486|559352258|FG001|Overall Study|Reason not Specified|4|||
154980482|NCT02462486|559352259|FG002|Overall Study|Reason not Specified|3|||
154980483|NCT01731886|559352261|FG000|Overall Study|Death|1|||
154980484|NCT01731886|559352262|FG001|Overall Study|Death|0|||
154980485|NCT01731886|559352261|FG000|Overall Study|Never started treatment|0|||
154980486|NCT01731886|559352262|FG001|Overall Study|Never started treatment|1|||
154898568|NCT03136367|559047997|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
154898569|NCT03136367|559047998|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
154898570|NCT03136367|559047999|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
154898571|NCT03136367|559047997|FG000|T3 1 Week After Surgery|other discontinued|2|||
154898572|NCT03136367|559047998|FG001|T3 1 Week After Surgery|other discontinued|4|||
154898573|NCT03136367|559047999|FG002|T3 1 Week After Surgery|other discontinued|3|||
154898574|NCT03136367|559047997|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
154898575|NCT03136367|559047998|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
154898576|NCT03136367|559047999|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
154898577|NCT03136367|559047997|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
154898578|NCT03136367|559047998|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
154898579|NCT03136367|559047999|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
154898580|NCT03136367|559047997|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
154898581|NCT03136367|559047998|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
154898582|NCT03136367|559047999|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
154898583|NCT03136367|559047997|FG000|T4 12 Weeks After Surgery|Death|0|||
154898584|NCT03136367|559047998|FG001|T4 12 Weeks After Surgery|Death|1|||
154980487|NCT01731886|559352261|FG000|Overall Study|Non-compliant|1|||
154980488|NCT01731886|559352262|FG001|Overall Study|Non-compliant|0|||
154898585|NCT03136367|559047999|FG002|T4 12 Weeks After Surgery|Death|3|||
154980489|NCT02280187|559352263|FG000|Overall Study|Lost to Follow-up|218|||
154980490|NCT04668274|559352264|FG000|Part 1 Study Period 1|Adverse Event|3|||
154980491|NCT04668274|559352265|FG001|Part 1 Study Period 1|Adverse Event|0|||
154980492|NCT04668274|559352266|FG002|Part 1 Study Period 1|Adverse Event|0|||
154980493|NCT04668274|559352267|FG003|Part 1 Study Period 1|Adverse Event|0|||
154980494|NCT04668274|559352264|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
154980495|NCT04668274|559352265|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
154980496|NCT04668274|559352266|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
154980497|NCT04668274|559352267|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
154980498|NCT04668274|559352264|FG000|Part 1 Study Period 2|Other|0|||
154980499|NCT04668274|559352265|FG001|Part 1 Study Period 2|Other|1|||
154980500|NCT04668274|559352266|FG002|Part 1 Study Period 2|Other|0|||
154980501|NCT04668274|559352267|FG003|Part 1 Study Period 2|Other|0|||
154980502|NCT04668274|559352264|FG000|Part 1 Study Period 3|Adverse Event|0|||
154980503|NCT04668274|559352265|FG001|Part 1 Study Period 3|Adverse Event|0|||
154980504|NCT04668274|559352266|FG002|Part 1 Study Period 3|Adverse Event|1|||
154980505|NCT04668274|559352267|FG003|Part 1 Study Period 3|Adverse Event|0|||
154980506|NCT04668274|559352264|FG000|Part 1 Study Period 3|Other|0|||
154980507|NCT04668274|559352265|FG001|Part 1 Study Period 3|Other|0|||
154980508|NCT04668274|559352266|FG002|Part 1 Study Period 3|Other|2|||
155114714|NCT02059499|559848267|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
155114715|NCT02059499|559848268|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
154898586|NCT03136367|559047997|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
154898587|NCT03136367|559047998|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
154898588|NCT03136367|559047999|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
154898589|NCT03136367|559047997|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
154898590|NCT03136367|559047998|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
154898591|NCT03136367|559047999|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
154898592|NCT03136367|559047997|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
154898593|NCT03136367|559047998|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
154898594|NCT03136367|559047999|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
154898595|NCT03136367|559047997|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
154898596|NCT03136367|559047998|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
154898597|NCT03136367|559047999|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
154898598|NCT03136367|559047997|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
154898599|NCT03136367|559047998|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
154898600|NCT03136367|559047999|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
154898601|NCT03136367|559047997|FG000|T5 1 Year After Surgery|Death|0|||
154898602|NCT03136367|559047998|FG001|T5 1 Year After Surgery|Death|0|||
154898603|NCT03136367|559047999|FG002|T5 1 Year After Surgery|Death|1|||
154898604|NCT03136367|559047997|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
154898605|NCT03136367|559047998|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
154898606|NCT03136367|559047999|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
154898607|NCT03136367|559047997|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
154898608|NCT03136367|559047998|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
154898609|NCT03136367|559047999|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
154898610|NCT03136367|559047997|FG000|T5 1 Year After Surgery|study ended before due|31|||
154898611|NCT03136367|559047998|FG001|T5 1 Year After Surgery|study ended before due|103|||
154898612|NCT03136367|559047999|FG002|T5 1 Year After Surgery|study ended before due|110|||
154898613|NCT03136367|559047997|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
154898614|NCT03136367|559047998|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
154898615|NCT03136367|559047999|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
154898616|NCT02146833|559048003|FG000|Overall Study|Death|10|||
154898617|NCT02146833|559048003|FG000|Overall Study|No longer consented to study treatment|1|||
154898618|NCT03726333|559048004|FG000|Overall Study|Progressive Disease|0|||
154898619|NCT03726333|559048005|FG001|Overall Study|Progressive Disease|0|||
154898620|NCT03726333|559048006|FG002|Overall Study|Progressive Disease|1|||
154898621|NCT03726333|559048007|FG003|Overall Study|Progressive Disease|0|||
154898622|NCT03726333|559048008|FG004|Overall Study|Progressive Disease|0|||
154898623|NCT03906136|559050227|FG000|Overall Study|Adverse Event|1|||
154898624|NCT03906136|559050228|FG001|Overall Study|Adverse Event|0|||
154898625|NCT03906136|559050227|FG000|Overall Study|Lost to Follow-up|7|||
154898626|NCT03906136|559050228|FG001|Overall Study|Lost to Follow-up|4|||
154898627|NCT03906136|559050227|FG000|Overall Study|Physician Decision|1|||
154898628|NCT03906136|559050228|FG001|Overall Study|Physician Decision|0|||
154898629|NCT03906136|559050227|FG000|Overall Study|Withdrawal by Subject|3|||
154898630|NCT03906136|559050228|FG001|Overall Study|Withdrawal by Subject|7|||
154898631|NCT00959894|559050240|FG000|Overall Study|Lost to Follow-up|10|||
154898632|NCT00959894|559050240|FG000|Overall Study|Adverse Event|3|||
154980509|NCT04668274|559352267|FG003|Part 1 Study Period 3|Other|0|||
154980510|NCT04668274|559352264|FG000|Part 2 Study Period 4|Other|0|||
154898633|NCT00959894|559050240|FG000|Overall Study|Withdrawal by Subject|1|||
154898634|NCT00959894|559050240|FG000|Overall Study|Need for contraindicated medication|1|||
154980511|NCT04668274|559352265|FG001|Part 2 Study Period 4|Other|0|||
154980512|NCT04668274|559352266|FG002|Part 2 Study Period 4|Other|0|||
154980513|NCT04668274|559352267|FG003|Part 2 Study Period 4|Other|1|||
154980514|NCT02039063|559352269|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
154980515|NCT02039063|559352270|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
155114716|NCT02059499|559848266|FG000|Upto Week 20|Withdrawal by Subject|1|||
154898635|NCT00959894|559050240|FG000|Overall Study|Subject moved out of town|1|||
154898636|NCT00405275|559050245|FG000|Overall Study|Death|1|||
154898637|NCT00405275|559050246|FG001|Overall Study|Death|0|||
154898638|NCT00405275|559050245|FG000|Overall Study|Lost to Follow-up|5|||
154898639|NCT00405275|559050246|FG001|Overall Study|Lost to Follow-up|1|||
154898640|NCT00405275|559050245|FG000|Overall Study|Withdrawal by Subject|7|||
154898641|NCT00405275|559050246|FG001|Overall Study|Withdrawal by Subject|9|||
154898642|NCT00405275|559050245|FG000|Overall Study|Unwilling to continue|10|||
154898643|NCT00405275|559050246|FG001|Overall Study|Unwilling to continue|9|||
154898644|NCT00088595|559050247|FG000|Overall Study|Adverse Event|11|||
154898645|NCT00088595|559050247|FG000|Overall Study|Withdrawal by Subject|8|||
154898646|NCT00088595|559050247|FG000|Overall Study|Ongoing (After Core)|7|||
154898647|NCT00088595|559050247|FG000|Overall Study|New Cancer Therapy|2|||
154898648|NCT01308853|559050252|FG000|Overall Study|Adverse Event|1|||
154898649|NCT01308853|559050252|FG000|Overall Study|Lost to Follow-up|2|||
154898650|NCT01308853|559050252|FG000|Overall Study|Insertion of permanent implants|1|||
154898651|NCT01376388|559050257|FG000|Overall Study|Adverse Event|13|||
154898652|NCT01376388|559050257|FG000|Overall Study|Lack of Efficacy|2|||
154898653|NCT01376388|559050257|FG000|Overall Study|Withdrawal by Subject|3|||
154898654|NCT02009930|559050265|FG000|Overall Study|withdrawn|5|||
154898655|NCT00666536|559050268|FG000|Overall Study|Adverse Event|9|||
154898656|NCT00666536|559050269|FG001|Overall Study|Adverse Event|19|||
154898657|NCT00666536|559050268|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
154898658|NCT00666536|559050269|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154898659|NCT00666536|559050268|FG000|Overall Study|Protocol deviation(s)|8|||
154898660|NCT00666536|559050269|FG001|Overall Study|Protocol deviation(s)|6|||
154898661|NCT00666536|559050268|FG000|Overall Study|Withdrawal by Subject|10|||
154898662|NCT00666536|559050269|FG001|Overall Study|Withdrawal by Subject|9|||
154898663|NCT00666536|559050268|FG000|Overall Study|Lost to Follow-up|4|||
154898664|NCT00666536|559050269|FG001|Overall Study|Lost to Follow-up|3|||
154898665|NCT02853123|559050273|FG000|Treatment Period 1|Adverse Event|0|||
154898666|NCT02853123|559050274|FG001|Treatment Period 1|Adverse Event|3|||
154898667|NCT02853123|559050273|FG000|Washout Period|Worsening of COPD|0|||
154898668|NCT02853123|559050274|FG001|Washout Period|Worsening of COPD|3|||
154898669|NCT02853123|559050273|FG000|Washout Period|Adverse Event|1|||
154898670|NCT02853123|559050274|FG001|Washout Period|Adverse Event|0|||
154898671|NCT03417505|559050277|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
154898672|NCT03417505|559050278|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
154898673|NCT03235726|559050283|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898674|NCT03235726|559050284|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898675|NCT03235726|559050285|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898676|NCT03235726|559050286|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898677|NCT03235726|559050287|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
154898678|NCT03235726|559050288|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898679|NCT03235726|559050289|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898680|NCT03235726|559050290|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898681|NCT03235726|559050291|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898682|NCT03235726|559050292|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
154898683|NCT03235726|559050283|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898684|NCT03235726|559050284|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898685|NCT03235726|559050285|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898686|NCT03235726|559050286|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898687|NCT03235726|559050287|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
154898688|NCT03235726|559050288|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898689|NCT03235726|559050289|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898690|NCT03235726|559050290|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898691|NCT03235726|559050291|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
154898692|NCT03235726|559050292|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
155114717|NCT02059499|559848267|FG001|Upto Week 20|Withdrawal by Subject|1|||
155114718|NCT02059499|559848268|FG002|Upto Week 20|Withdrawal by Subject|0|||
154898693|NCT00879437|559050293|FG000|Overall Study|Protocol Violation|0|||
154898694|NCT00879437|559050294|FG001|Overall Study|Protocol Violation|1|||
155114719|NCT02059499|559848266|FG000|Upto Week 20|No treatment per protocol criteria|0|||
155114720|NCT02059499|559848267|FG001|Upto Week 20|No treatment per protocol criteria|0|||
155114721|NCT02059499|559848268|FG002|Upto Week 20|No treatment per protocol criteria|5|||
154898695|NCT00879437|559050293|FG000|Overall Study|Death|1|||
154898696|NCT00879437|559050294|FG001|Overall Study|Death|0|||
154898697|NCT00291187|559050295|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
154898698|NCT00291187|559050296|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
154898699|NCT00291187|559050297|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
154898700|NCT00291187|559050298|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
155114722|NCT02059499|559848266|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
154898701|NCT01040845|559050299|FG000|Overall Study|Withdrawal by Subject|1|||
154898702|NCT01040845|559050300|FG001|Overall Study|Withdrawal by Subject|1|||
154898703|NCT01040845|559050299|FG000|Overall Study|Physician Decision|1|||
154898704|NCT01040845|559050300|FG001|Overall Study|Physician Decision|0|||
154898705|NCT01732107|559050301|FG000|Overall Study|Adverse Event|2|||
154898706|NCT01732107|559050301|FG000|Overall Study|Disease Progression|8|||
154898707|NCT01732107|559050301|FG000|Overall Study|Physician Decision|1|||
154898708|NCT01732107|559050301|FG000|Overall Study|Withdrawal by Subject|2|||
154898709|NCT04445688|559050303|FG000|Washout (One Week)|Adverse Event|2|||
154898710|NCT04445688|559050303|FG000|Washout (One Week)|Withdrawal by Subject|1|||
154898711|NCT02023268|559050304|FG000|Overall Study|Lack of Efficacy|0|||
154898712|NCT02023268|559050305|FG001|Overall Study|Lack of Efficacy|1|||
154898713|NCT02023268|559050304|FG000|Overall Study|Adverse Event|0|||
154898714|NCT02023268|559050305|FG001|Overall Study|Adverse Event|2|||
154898715|NCT02023268|559050304|FG000|Overall Study|Withdrawal by Subject|0|||
154898716|NCT02023268|559050305|FG001|Overall Study|Withdrawal by Subject|1|||
154898717|NCT00615459|559050306|FG000|Period I|Adverse Event|2|||
154898718|NCT00615459|559050307|FG001|Period I|Adverse Event|0|||
154898719|NCT00615459|559050308|FG002|Period I|Adverse Event|1|||
154898720|NCT00615459|559050309|FG003|Period I|Adverse Event|0|||
154898721|NCT00615459|559050306|FG000|Period I|Subject withdrew consent|1|||
154898722|NCT00615459|559050307|FG001|Period I|Subject withdrew consent|0|||
154898723|NCT00615459|559050308|FG002|Period I|Subject withdrew consent|0|||
154898724|NCT00615459|559050309|FG003|Period I|Subject withdrew consent|1|||
154898725|NCT00615459|559050306|FG000|Period I|Abnormal test procedure results|1|||
154898726|NCT00615459|559050307|FG001|Period I|Abnormal test procedure results|1|||
154898727|NCT00615459|559050308|FG002|Period I|Abnormal test procedure results|1|||
154898728|NCT00615459|559050309|FG003|Period I|Abnormal test procedure results|0|||
154898729|NCT00615459|559050306|FG000|Period II|Adverse Event|1|||
154898730|NCT00615459|559050307|FG001|Period II|Adverse Event|0|||
154898731|NCT00615459|559050308|FG002|Period II|Adverse Event|0|||
154898732|NCT00615459|559050309|FG003|Period II|Adverse Event|0|||
154898733|NCT00615459|559050306|FG000|Period II|Lost to Follow-up|0|||
154898734|NCT00615459|559050307|FG001|Period II|Lost to Follow-up|0|||
154898735|NCT00615459|559050308|FG002|Period II|Lost to Follow-up|0|||
154898736|NCT00615459|559050309|FG003|Period II|Lost to Follow-up|1|||
154898737|NCT00615459|559050306|FG000|Period III|Adverse Event|0|||
154898738|NCT00615459|559050307|FG001|Period III|Adverse Event|1|||
154898739|NCT00615459|559050308|FG002|Period III|Adverse Event|0|||
154898740|NCT00615459|559050309|FG003|Period III|Adverse Event|0|||
154898741|NCT00615459|559050306|FG000|Period III|Administrative problems|0|||
154898742|NCT00615459|559050307|FG001|Period III|Administrative problems|1|||
154898743|NCT00615459|559050308|FG002|Period III|Administrative problems|1|||
154898744|NCT00615459|559050309|FG003|Period III|Administrative problems|0|||
154898745|NCT00615459|559050306|FG000|Period III|Unsatisfactory therapeutic effect|0|||
154898746|NCT00615459|559050307|FG001|Period III|Unsatisfactory therapeutic effect|1|||
154898747|NCT00615459|559050308|FG002|Period III|Unsatisfactory therapeutic effect|0|||
154898748|NCT00615459|559050309|FG003|Period III|Unsatisfactory therapeutic effect|0|||
154898749|NCT00918346|559050319|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
154898750|NCT00918346|559050320|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
154898751|NCT03379376|559050321|FG000|Overall Study|Lost to Follow-up|2|||
154898752|NCT03379376|559050321|FG000|Overall Study|Did not wish to complete follow up|1|||
154898753|NCT03379376|559050321|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
154898754|NCT03379376|559050321|FG000|Overall Study|Death|1|||
154898755|NCT01611298|559050322|FG000|Overall Study|Relapsed|2|||
154898756|NCT04153929|559050323|FG000|Overall Study|Other than listed|2|||
154898757|NCT04153929|559050324|FG001|Overall Study|Other than listed|2|||
154898758|NCT04153929|559050325|FG002|Overall Study|Other than listed|0|||
154898759|NCT04153929|559050326|FG003|Overall Study|Other than listed|1|||
154898760|NCT04153929|559050327|FG004|Overall Study|Other than listed|0|||
154898761|NCT04153929|559050328|FG005|Overall Study|Other than listed|2|||
154898762|NCT04153929|559050329|FG006|Overall Study|Other than listed|2|||
154898763|NCT04153929|559050330|FG007|Overall Study|Other than listed|1|||
154898764|NCT04153929|559050323|FG000|Overall Study|Lost to Follow-up|2|||
154898765|NCT04153929|559050324|FG001|Overall Study|Lost to Follow-up|1|||
154898766|NCT04153929|559050325|FG002|Overall Study|Lost to Follow-up|0|||
154898767|NCT04153929|559050326|FG003|Overall Study|Lost to Follow-up|1|||
154980516|NCT02039063|559352271|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
154980517|NCT02039063|559352272|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
154980518|NCT02039063|559352269|FG000|Treatment Phase|Progression of disease|0|||
154898768|NCT04153929|559050327|FG004|Overall Study|Lost to Follow-up|1|||
154898769|NCT04153929|559050328|FG005|Overall Study|Lost to Follow-up|0|||
154898770|NCT04153929|559050329|FG006|Overall Study|Lost to Follow-up|0|||
154898771|NCT04153929|559050330|FG007|Overall Study|Lost to Follow-up|0|||
154898772|NCT04153929|559050323|FG000|Overall Study|Withdrawal by Subject|3|||
154898773|NCT04153929|559050324|FG001|Overall Study|Withdrawal by Subject|1|||
154898774|NCT04153929|559050325|FG002|Overall Study|Withdrawal by Subject|0|||
154898775|NCT04153929|559050326|FG003|Overall Study|Withdrawal by Subject|3|||
154898776|NCT04153929|559050327|FG004|Overall Study|Withdrawal by Subject|1|||
155114723|NCT02059499|559848267|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
155114724|NCT02059499|559848268|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
155114725|NCT02059499|559848266|FG000|Post-week 20|Lost to Follow-up|0|||
155114726|NCT02059499|559848267|FG001|Post-week 20|Lost to Follow-up|2|||
155114727|NCT02059499|559848268|FG002|Post-week 20|Lost to Follow-up|0|||
155114728|NCT02059499|559848266|FG000|Post-week 20|Withdrawal by Subject|0|||
154898777|NCT04153929|559050328|FG005|Overall Study|Withdrawal by Subject|0|||
154898778|NCT04153929|559050329|FG006|Overall Study|Withdrawal by Subject|1|||
154898779|NCT04153929|559050330|FG007|Overall Study|Withdrawal by Subject|0|||
154898780|NCT04153929|559050323|FG000|Overall Study|Protocol Violation|0|||
154898781|NCT04153929|559050324|FG001|Overall Study|Protocol Violation|0|||
154898782|NCT04153929|559050325|FG002|Overall Study|Protocol Violation|0|||
154898783|NCT04153929|559050326|FG003|Overall Study|Protocol Violation|0|||
154898784|NCT04153929|559050327|FG004|Overall Study|Protocol Violation|0|||
154898785|NCT04153929|559050328|FG005|Overall Study|Protocol Violation|0|||
154898786|NCT04153929|559050329|FG006|Overall Study|Protocol Violation|1|||
154898787|NCT04153929|559050330|FG007|Overall Study|Protocol Violation|2|||
154898788|NCT04153929|559050323|FG000|Overall Study|Adverse Event|3|||
154898789|NCT04153929|559050324|FG001|Overall Study|Adverse Event|5|||
154898790|NCT04153929|559050325|FG002|Overall Study|Adverse Event|5|||
154898791|NCT04153929|559050326|FG003|Overall Study|Adverse Event|11|||
154898792|NCT04153929|559050327|FG004|Overall Study|Adverse Event|15|||
154898793|NCT04153929|559050328|FG005|Overall Study|Adverse Event|4|||
154898794|NCT04153929|559050329|FG006|Overall Study|Adverse Event|8|||
154898795|NCT04153929|559050330|FG007|Overall Study|Adverse Event|2|||
154898796|NCT04153929|559050323|FG000|Overall Study|Not treated|1|||
154898797|NCT04153929|559050324|FG001|Overall Study|Not treated|0|||
154898798|NCT04153929|559050325|FG002|Overall Study|Not treated|0|||
154898799|NCT04153929|559050326|FG003|Overall Study|Not treated|0|||
154898800|NCT04153929|559050327|FG004|Overall Study|Not treated|0|||
154898801|NCT04153929|559050328|FG005|Overall Study|Not treated|0|||
154898802|NCT04153929|559050329|FG006|Overall Study|Not treated|1|||
154898803|NCT04153929|559050330|FG007|Overall Study|Not treated|0|||
154898804|NCT04083794|559050331|FG000|Overall Study|Lost to Follow-up|9|||
154898805|NCT01749800|559050334|FG000|Overall Study|not meeting inclusion criteria|3|||
154898806|NCT01749800|559050335|FG001|Overall Study|not meeting inclusion criteria|0|||
154898807|NCT01749800|559050336|FG002|Overall Study|not meeting inclusion criteria|0|||
154898808|NCT01749800|559050334|FG000|Overall Study|Withdrawal by Subject|0|||
154898809|NCT01749800|559050335|FG001|Overall Study|Withdrawal by Subject|1|||
154898810|NCT01749800|559050336|FG002|Overall Study|Withdrawal by Subject|0|||
154898811|NCT01975675|559050339|FG000|Overall Study|Death|0|||
154898812|NCT01975675|559050340|FG001|Overall Study|Death|1|||
154898813|NCT01975675|559050341|FG002|Overall Study|Death|0|||
154898814|NCT01975675|559050342|FG003|Overall Study|Death|0|||
154898815|NCT03639987|559050343|FG000|Overall Study|Study terminated by sponsor|26|||
154898816|NCT03639987|559050344|FG001|Overall Study|Study terminated by sponsor|25|||
154898817|NCT03639987|559050343|FG000|Overall Study|Lost to Follow-up|0|||
154898818|NCT03639987|559050344|FG001|Overall Study|Lost to Follow-up|1|||
154898819|NCT00224003|559050345|FG000|Overall Study|Adverse Event|1|||
154898820|NCT00224003|559050345|FG000|Overall Study|Protocol Violation|2|||
154898821|NCT00224003|559050345|FG000|Overall Study|Withdrawal by Subject|1|||
154898822|NCT00224003|559050345|FG000|Overall Study|unk|3|||
154898823|NCT00729326|559050352|FG000|Overall Study|Lost to Follow-up|2|||
154898824|NCT00729326|559050353|FG001|Overall Study|Lost to Follow-up|0|||
154898825|NCT00729326|559050352|FG000|Overall Study|Physician Decision|0|||
154898826|NCT00729326|559050353|FG001|Overall Study|Physician Decision|1|||
154898827|NCT00729326|559050352|FG000|Overall Study|Protocol Violation|3|||
154898828|NCT00729326|559050353|FG001|Overall Study|Protocol Violation|2|||
154898829|NCT00729326|559050352|FG000|Overall Study|Subject Decision|4|||
154898830|NCT00729326|559050353|FG001|Overall Study|Subject Decision|4|||
154898831|NCT00729326|559050352|FG000|Overall Study|Sponsor Decision|1|||
154898832|NCT00729326|559050353|FG001|Overall Study|Sponsor Decision|2|||
154898833|NCT01235728|559050355|FG000|Overall Study|Protocol Violation|0|||
154898834|NCT01235728|559050356|FG001|Overall Study|Protocol Violation|0|||
154898835|NCT01235728|559050357|FG002|Overall Study|Protocol Violation|0|||
154898836|NCT01235728|559050358|FG003|Overall Study|Protocol Violation|1|||
154898837|NCT01235728|559050359|FG004|Overall Study|Protocol Violation|0|||
154898838|NCT01235728|559050360|FG005|Overall Study|Protocol Violation|0|||
154898839|NCT01235728|559050361|FG006|Overall Study|Protocol Violation|0|||
154898840|NCT01235728|559050362|FG007|Overall Study|Protocol Violation|0|||
154898841|NCT01000025|559050363|FG000|Overall Study|Adverse Event|43|||
154898842|NCT01000025|559050364|FG001|Overall Study|Adverse Event|2|||
155114729|NCT02059499|559848267|FG001|Post-week 20|Withdrawal by Subject|1|||
155114730|NCT02059499|559848268|FG002|Post-week 20|Withdrawal by Subject|0|||
154898843|NCT01000025|559050363|FG000|Overall Study|Withdrawal by Subject|13|||
154898844|NCT01000025|559050364|FG001|Overall Study|Withdrawal by Subject|8|||
154898845|NCT01000025|559050363|FG000|Overall Study|Death|23|||
154898846|NCT01000025|559050364|FG001|Overall Study|Death|13|||
154898847|NCT01000025|559050363|FG000|Overall Study|Lack of Efficacy|363|||
155114731|NCT02059499|559848266|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
154898848|NCT01000025|559050364|FG001|Overall Study|Lack of Efficacy|208|||
154898849|NCT01000025|559050363|FG000|Overall Study|Intercurrent Illness|26|||
154898850|NCT01000025|559050364|FG001|Overall Study|Intercurrent Illness|7|||
154898851|NCT02738580|559050365|FG000|Overall Study|Adverse Event|1|||
154898852|NCT02738580|559050366|FG001|Overall Study|Adverse Event|0|||
154898853|NCT02738580|559050365|FG000|Overall Study|Lack of Efficacy|3|||
154898854|NCT02738580|559050366|FG001|Overall Study|Lack of Efficacy|2|||
154898855|NCT02738580|559050365|FG000|Overall Study|Withdrawal by Subject|0|||
154898856|NCT02738580|559050366|FG001|Overall Study|Withdrawal by Subject|1|||
154898857|NCT02738580|559050365|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
154898858|NCT02738580|559050366|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
154898859|NCT04354155|559050367|FG000|Overall Study|Withdrawal by Subject|1|||
154898860|NCT04354155|559050367|FG000|Overall Study|Did not meet criteria for study intervention|1|||
154898861|NCT01575899|559050372|FG000|Overall Study|Lost to Follow-up|3|||
154898862|NCT01575899|559050373|FG001|Overall Study|Lost to Follow-up|4|||
154898863|NCT01575899|559050374|FG002|Overall Study|Lost to Follow-up|2|||
154898864|NCT01575899|559050372|FG000|Overall Study|Protocol Violation|2|||
154898865|NCT01575899|559050373|FG001|Overall Study|Protocol Violation|1|||
154898866|NCT01575899|559050374|FG002|Overall Study|Protocol Violation|0|||
154898867|NCT02807844|559050375|FG000|Overall Study|Physician Decision|0|||
154898868|NCT02807844|559050376|FG001|Overall Study|Physician Decision|0|||
154898869|NCT02807844|559050377|FG002|Overall Study|Physician Decision|0|||
154898870|NCT02807844|559050378|FG003|Overall Study|Physician Decision|0|||
154898871|NCT02807844|559050379|FG004|Overall Study|Physician Decision|0|||
154898872|NCT02807844|559050380|FG005|Overall Study|Physician Decision|0|||
154898873|NCT02807844|559050381|FG006|Overall Study|Physician Decision|3|||
154898874|NCT02807844|559050382|FG007|Overall Study|Physician Decision|0|||
154898875|NCT02807844|559050383|FG008|Overall Study|Physician Decision|1|||
154898876|NCT02807844|559050384|FG009|Overall Study|Physician Decision|2|||
154898877|NCT02807844|559050375|FG000|Overall Study|Death|0|||
154898878|NCT02807844|559050376|FG001|Overall Study|Death|0|||
154898879|NCT02807844|559050377|FG002|Overall Study|Death|2|||
154898880|NCT02807844|559050378|FG003|Overall Study|Death|4|||
154898881|NCT02807844|559050379|FG004|Overall Study|Death|1|||
154898882|NCT02807844|559050380|FG005|Overall Study|Death|2|||
154898883|NCT02807844|559050381|FG006|Overall Study|Death|1|||
154898884|NCT02807844|559050382|FG007|Overall Study|Death|2|||
154898885|NCT02807844|559050383|FG008|Overall Study|Death|0|||
154898886|NCT02807844|559050384|FG009|Overall Study|Death|1|||
154898887|NCT02807844|559050375|FG000|Overall Study|Withdrawal by Subject|0|||
154898888|NCT02807844|559050376|FG001|Overall Study|Withdrawal by Subject|0|||
154898889|NCT02807844|559050377|FG002|Overall Study|Withdrawal by Subject|2|||
154898890|NCT02807844|559050378|FG003|Overall Study|Withdrawal by Subject|1|||
154898891|NCT02807844|559050379|FG004|Overall Study|Withdrawal by Subject|1|||
154898892|NCT02807844|559050380|FG005|Overall Study|Withdrawal by Subject|0|||
154898893|NCT02807844|559050381|FG006|Overall Study|Withdrawal by Subject|1|||
154898894|NCT02807844|559050382|FG007|Overall Study|Withdrawal by Subject|0|||
154898895|NCT02807844|559050383|FG008|Overall Study|Withdrawal by Subject|0|||
154898896|NCT02807844|559050384|FG009|Overall Study|Withdrawal by Subject|0|||
154898897|NCT02807844|559050375|FG000|Overall Study|Progressive disease|5|||
154898898|NCT02807844|559050376|FG001|Overall Study|Progressive disease|12|||
154898899|NCT02807844|559050377|FG002|Overall Study|Progressive disease|8|||
154898900|NCT02807844|559050378|FG003|Overall Study|Progressive disease|8|||
154898901|NCT02807844|559050379|FG004|Overall Study|Progressive disease|3|||
154898902|NCT02807844|559050380|FG005|Overall Study|Progressive disease|8|||
154898903|NCT02807844|559050381|FG006|Overall Study|Progressive disease|14|||
154898904|NCT02807844|559050382|FG007|Overall Study|Progressive disease|17|||
154898905|NCT02807844|559050383|FG008|Overall Study|Progressive disease|19|||
154898906|NCT02807844|559050384|FG009|Overall Study|Progressive disease|15|||
154898907|NCT02807844|559050375|FG000|Overall Study|Adverse Event|1|||
154898908|NCT02807844|559050376|FG001|Overall Study|Adverse Event|0|||
154898909|NCT02807844|559050377|FG002|Overall Study|Adverse Event|0|||
154898910|NCT02807844|559050378|FG003|Overall Study|Adverse Event|0|||
154898911|NCT02807844|559050379|FG004|Overall Study|Adverse Event|1|||
154898912|NCT02807844|559050380|FG005|Overall Study|Adverse Event|1|||
154898913|NCT02807844|559050381|FG006|Overall Study|Adverse Event|1|||
154898914|NCT02807844|559050382|FG007|Overall Study|Adverse Event|1|||
154898915|NCT02807844|559050383|FG008|Overall Study|Adverse Event|1|||
154898916|NCT02807844|559050384|FG009|Overall Study|Adverse Event|2|||
154898917|NCT03097029|559050385|FG000|Overall Study|Withdrawal by Subject|1|||
154898918|NCT00709124|559050386|FG000|Overall Study|Death|3|||
154898919|NCT00709124|559050387|FG001|Overall Study|Death|1|||
154898920|NCT00709124|559050386|FG000|Overall Study|encephalopathy; can't do assessment|1|||
154898921|NCT00709124|559050387|FG001|Overall Study|encephalopathy; can't do assessment|0|||
154898922|NCT00373490|559050388|FG000|Overall Study|Adverse Event|0|||
154898923|NCT00373490|559050389|FG001|Overall Study|Adverse Event|1|||
154898924|NCT00373490|559050388|FG000|Overall Study|Lack of Efficacy|9|||
154898925|NCT00373490|559050389|FG001|Overall Study|Lack of Efficacy|4|||
154898926|NCT00373490|559050388|FG000|Overall Study|Withdrawal by Subject|0|||
154898927|NCT00373490|559050389|FG001|Overall Study|Withdrawal by Subject|1|||
154898928|NCT00108953|559050396|FG000|Follow-up|Death|18|||
154898929|NCT00108953|559050397|FG001|Follow-up|Death|26|||
154898930|NCT00108953|559050396|FG000|Follow-up|Lost to Follow-up|1|||
154898931|NCT00108953|559050397|FG001|Follow-up|Lost to Follow-up|1|||
154898932|NCT00108953|559050396|FG000|Follow-up|Study terminated by sponsor|10|||
154898933|NCT00108953|559050397|FG001|Follow-up|Study terminated by sponsor|6|||
154898934|NCT00753688|559050398|FG000|Overall Study|Death|102|||
154898935|NCT00753688|559050399|FG001|Overall Study|Death|203|||
154898936|NCT00753688|559050398|FG000|Overall Study|Missing|4|||
154898937|NCT00753688|559050399|FG001|Overall Study|Missing|9|||
154898938|NCT00753688|559050398|FG000|Overall Study|Participant Withdrew Consent|2|||
154898939|NCT00753688|559050399|FG001|Overall Study|Participant Withdrew Consent|2|||
154898940|NCT00753688|559050398|FG000|Overall Study|Ongoing - in Follow-up|15|||
154898941|NCT00753688|559050399|FG001|Overall Study|Ongoing - in Follow-up|31|||
154898942|NCT00753688|559050398|FG000|Overall Study|Adverse Event|0|||
154898943|NCT00753688|559050399|FG001|Overall Study|Adverse Event|1|||
154898944|NCT02999100|559050400|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
154898945|NCT02999100|559050401|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
154898946|NCT02999100|559050402|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
154898947|NCT02999100|559050403|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
154898948|NCT02999100|559050404|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
154898949|NCT02999100|559050405|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
154898950|NCT02999100|559050400|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
154898951|NCT02999100|559050401|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
154898952|NCT02999100|559050402|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
154898953|NCT02999100|559050403|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
154898954|NCT02999100|559050404|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
154898955|NCT02999100|559050405|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
154898956|NCT02999100|559050400|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
154898957|NCT02999100|559050401|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
154898958|NCT02999100|559050402|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
154898959|NCT02999100|559050403|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
154898960|NCT02999100|559050404|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
154898961|NCT02999100|559050405|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
154898962|NCT03803202|559050406|FG000|Overall Study|Other|0|||
154898963|NCT03803202|559050407|FG001|Overall Study|Other|1|||
154898964|NCT03803202|559050408|FG002|Overall Study|Other|0|||
154898965|NCT03803202|559050409|FG003|Overall Study|Other|0|||
154898966|NCT03803202|559050410|FG004|Overall Study|Other|0|||
154898967|NCT03803202|559050411|FG005|Overall Study|Other|0|||
154898968|NCT03803202|559050412|FG006|Overall Study|Other|0|||
154898969|NCT03803202|559050413|FG007|Overall Study|Other|0|||
154898970|NCT03803202|559050414|FG008|Overall Study|Other|0|||
154898971|NCT03803202|559050406|FG000|Overall Study|Death|0|||
154898972|NCT03803202|559050407|FG001|Overall Study|Death|0|||
154898973|NCT03803202|559050408|FG002|Overall Study|Death|0|||
154898974|NCT03803202|559050409|FG003|Overall Study|Death|0|||
154898975|NCT03803202|559050410|FG004|Overall Study|Death|0|||
154898976|NCT03803202|559050411|FG005|Overall Study|Death|1|||
154898977|NCT03803202|559050412|FG006|Overall Study|Death|0|||
154898978|NCT03803202|559050413|FG007|Overall Study|Death|0|||
154898979|NCT03803202|559050414|FG008|Overall Study|Death|0|||
154898980|NCT03803202|559050406|FG000|Overall Study|Withdrawal by Subject|0|||
154898981|NCT03803202|559050407|FG001|Overall Study|Withdrawal by Subject|0|||
154898982|NCT03803202|559050408|FG002|Overall Study|Withdrawal by Subject|1|||
154898983|NCT03803202|559050409|FG003|Overall Study|Withdrawal by Subject|0|||
154898984|NCT03803202|559050410|FG004|Overall Study|Withdrawal by Subject|0|||
154898985|NCT03803202|559050411|FG005|Overall Study|Withdrawal by Subject|0|||
154898986|NCT03803202|559050412|FG006|Overall Study|Withdrawal by Subject|0|||
154898987|NCT03803202|559050413|FG007|Overall Study|Withdrawal by Subject|1|||
154898988|NCT03803202|559050414|FG008|Overall Study|Withdrawal by Subject|0|||
154898989|NCT03803202|559050406|FG000|Overall Study|Lost to Follow-up|0|||
154898990|NCT03803202|559050407|FG001|Overall Study|Lost to Follow-up|0|||
154898991|NCT03803202|559050408|FG002|Overall Study|Lost to Follow-up|0|||
154898992|NCT03803202|559050409|FG003|Overall Study|Lost to Follow-up|1|||
154898993|NCT03803202|559050410|FG004|Overall Study|Lost to Follow-up|1|||
154898994|NCT03803202|559050411|FG005|Overall Study|Lost to Follow-up|0|||
154898995|NCT03803202|559050412|FG006|Overall Study|Lost to Follow-up|1|||
154980519|NCT02039063|559352270|FG001|Treatment Phase|Progression of disease|0|||
154980520|NCT02039063|559352271|FG002|Treatment Phase|Progression of disease|1|||
154980521|NCT02039063|559352272|FG003|Treatment Phase|Progression of disease|1|||
154898996|NCT03803202|559050413|FG007|Overall Study|Lost to Follow-up|0|||
154898997|NCT03803202|559050414|FG008|Overall Study|Lost to Follow-up|0|||
154898998|NCT03595384|559050415|FG000|Overall Study|Other time commitments|8|||
154898999|NCT03595384|559050415|FG000|Overall Study|Changes to session time|7|||
154899000|NCT03595384|559050415|FG000|Overall Study|Relocation out of country|1|||
154899001|NCT01125293|559050416|FG000|Overall Study|Disease Progression|1|||
154899002|NCT01125293|559050417|FG001|Overall Study|Disease Progression|3|||
154899003|NCT01125293|559050418|FG002|Overall Study|Disease Progression|4|||
154899004|NCT01125293|559050419|FG003|Overall Study|Disease Progression|3|||
154899005|NCT01125293|559050420|FG004|Overall Study|Disease Progression|5|||
154899006|NCT01125293|559050421|FG005|Overall Study|Disease Progression|12|||
154899007|NCT01125293|559050416|FG000|Overall Study|Adverse Event|1|||
154899008|NCT01125293|559050417|FG001|Overall Study|Adverse Event|0|||
154899009|NCT01125293|559050418|FG002|Overall Study|Adverse Event|0|||
154899010|NCT01125293|559050419|FG003|Overall Study|Adverse Event|0|||
154899011|NCT01125293|559050420|FG004|Overall Study|Adverse Event|2|||
154899012|NCT01125293|559050421|FG005|Overall Study|Adverse Event|8|||
154899013|NCT01125293|559050416|FG000|Overall Study|Symptomatic Deterioration|1|||
154899014|NCT01125293|559050417|FG001|Overall Study|Symptomatic Deterioration|0|||
154899015|NCT01125293|559050418|FG002|Overall Study|Symptomatic Deterioration|0|||
154899016|NCT01125293|559050419|FG003|Overall Study|Symptomatic Deterioration|0|||
154899017|NCT01125293|559050420|FG004|Overall Study|Symptomatic Deterioration|0|||
154899018|NCT01125293|559050421|FG005|Overall Study|Symptomatic Deterioration|0|||
154899019|NCT01125293|559050416|FG000|Overall Study|Death|0|||
154899020|NCT01125293|559050417|FG001|Overall Study|Death|0|||
154899021|NCT01125293|559050418|FG002|Overall Study|Death|0|||
154899022|NCT01125293|559050419|FG003|Overall Study|Death|0|||
154899023|NCT01125293|559050420|FG004|Overall Study|Death|1|||
154899024|NCT01125293|559050421|FG005|Overall Study|Death|0|||
154899025|NCT01125293|559050416|FG000|Overall Study|Withdrawal by Subject|0|||
154899026|NCT01125293|559050417|FG001|Overall Study|Withdrawal by Subject|0|||
154899027|NCT01125293|559050418|FG002|Overall Study|Withdrawal by Subject|0|||
154899028|NCT01125293|559050419|FG003|Overall Study|Withdrawal by Subject|0|||
154899029|NCT01125293|559050420|FG004|Overall Study|Withdrawal by Subject|2|||
154899030|NCT01125293|559050421|FG005|Overall Study|Withdrawal by Subject|1|||
154899031|NCT01125293|559050416|FG000|Overall Study|Physician Decision|0|||
154899032|NCT01125293|559050417|FG001|Overall Study|Physician Decision|0|||
154899033|NCT01125293|559050418|FG002|Overall Study|Physician Decision|0|||
154899034|NCT01125293|559050419|FG003|Overall Study|Physician Decision|0|||
154899035|NCT01125293|559050420|FG004|Overall Study|Physician Decision|0|||
154899036|NCT01125293|559050421|FG005|Overall Study|Physician Decision|2|||
154899037|NCT00659126|559050424|FG000|Overall Study|Adverse Event|2|||
154899038|NCT00659126|559050425|FG001|Overall Study|Adverse Event|2|||
154899039|NCT00659126|559050424|FG000|Overall Study|Screen failure|1|||
154899040|NCT00659126|559050425|FG001|Overall Study|Screen failure|1|||
154899041|NCT00659126|559050424|FG000|Overall Study|Technical problems with MRI|0|||
154899042|NCT00659126|559050425|FG001|Overall Study|Technical problems with MRI|1|||
154899043|NCT02228564|559050429|FG000|Overall Study|Withdrawal by Subject|10|||
154899044|NCT02228564|559050429|FG000|Overall Study|Death|11|||
154899045|NCT02228564|559050429|FG000|Overall Study|Physician Decision|5|||
154899046|NCT02228564|559050429|FG000|Overall Study|Lost to Follow-up|17|||
154899047|NCT02228564|559050429|FG000|Overall Study|Other|6|||
154899048|NCT02633046|559050434|FG000|Overall Study|Adverse Event|8|||
154899049|NCT02633046|559050434|FG000|Overall Study|Physician Decision|7|||
154899050|NCT02633046|559050434|FG000|Overall Study|Withdrawal by Subject|8|||
154899051|NCT02633046|559050434|FG000|Overall Study|Increased proteinuria|2|||
154899052|NCT02633046|559050434|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
154899053|NCT02633046|559050434|FG000|Overall Study|Mutual decision patient and physician|1|||
154899054|NCT03700736|559050435|FG000|Overall Study|Pregnancy|1|||
154899055|NCT03700736|559050436|FG001|Overall Study|Pregnancy|1|||
154899056|NCT03700736|559050435|FG000|Overall Study|Withdrawal by Subject|2|||
154899057|NCT03700736|559050436|FG001|Overall Study|Withdrawal by Subject|6|||
154899058|NCT00446641|559052563|FG000|Overall Study|Withdrawal by Subject|8|||
154899059|NCT00446641|559052564|FG001|Overall Study|Withdrawal by Subject|3|||
154899060|NCT00446641|559052563|FG000|Overall Study|poor compliance|8|||
154899061|NCT00446641|559052564|FG001|Overall Study|poor compliance|6|||
154899062|NCT00446641|559052563|FG000|Overall Study|Lost to Follow-up|1|||
154899063|NCT00446641|559052564|FG001|Overall Study|Lost to Follow-up|1|||
154899064|NCT02959970|559052576|FG000|Overall Study|Adverse Event|1|||
154899065|NCT02959970|559052577|FG001|Overall Study|Adverse Event|0|||
154899066|NCT02959970|559052576|FG000|Overall Study|Withdrawal by Subject|0|||
154899067|NCT02959970|559052577|FG001|Overall Study|Withdrawal by Subject|2|||
154899068|NCT02959970|559052576|FG000|Overall Study|Lost to Follow-up|1|||
154899069|NCT02959970|559052577|FG001|Overall Study|Lost to Follow-up|5|||
154899070|NCT02475629|559052583|FG000|Overall Study|Adverse Event|1|||
154899071|NCT02475629|559052583|FG000|Overall Study|Death|4|||
154899072|NCT02475629|559052583|FG000|Overall Study|Physician Decision|1|||
154899073|NCT02475629|559052583|FG000|Overall Study|Withdrawal by Subject|1|||
154980522|NCT02039063|559352269|FG000|Extension Phase|Inadequate therapeutic effect|0|||
154899074|NCT02475629|559052583|FG000|Overall Study|Lost to Follow-up|1|||
154899075|NCT02475629|559052583|FG000|Overall Study|Subject non-compliance|1|||
154899076|NCT00928512|559052584|FG000|Overall Study|Adverse Event|4|||
154899077|NCT00928512|559052585|FG001|Overall Study|Adverse Event|3|||
154899078|NCT00928512|559052586|FG002|Overall Study|Adverse Event|2|||
154899079|NCT00928512|559052587|FG003|Overall Study|Adverse Event|8|||
154899080|NCT00928512|559052588|FG004|Overall Study|Adverse Event|6|||
154980523|NCT02039063|559352270|FG001|Extension Phase|Inadequate therapeutic effect|1|||
154980524|NCT02039063|559352271|FG002|Extension Phase|Inadequate therapeutic effect|2|||
154980525|NCT02039063|559352272|FG003|Extension Phase|Inadequate therapeutic effect|0|||
154980526|NCT02039063|559352269|FG000|Extension Phase|Progression of disease|0|||
154980527|NCT02039063|559352270|FG001|Extension Phase|Progression of disease|0|||
154980528|NCT02039063|559352271|FG002|Extension Phase|Progression of disease|0|||
154980529|NCT02039063|559352272|FG003|Extension Phase|Progression of disease|1|||
154980530|NCT02039063|559352269|FG000|Extension Phase|Adverse Event|0|||
154980531|NCT02039063|559352270|FG001|Extension Phase|Adverse Event|0|||
154980532|NCT02039063|559352271|FG002|Extension Phase|Adverse Event|1|||
154980533|NCT02039063|559352272|FG003|Extension Phase|Adverse Event|0|||
154980534|NCT03827018|559352273|FG000|Overall Study|Adverse Event|1|||
154980535|NCT03827018|559352274|FG001|Overall Study|Adverse Event|0|||
154980536|NCT03827018|559352273|FG000|Overall Study|Withdrawal by Subject|2|||
154980537|NCT03827018|559352274|FG001|Overall Study|Withdrawal by Subject|2|||
154980538|NCT03827018|559352273|FG000|Overall Study|Lack of Efficacy|0|||
154980539|NCT03827018|559352274|FG001|Overall Study|Lack of Efficacy|1|||
154980540|NCT00613730|559352279|FG000|Overall Study|Disease progression|2|||
154980541|NCT00613730|559352279|FG000|Overall Study|Administrative decision|1|||
154980542|NCT04965389|559352283|FG000|Overall Study|Other reasons|1|||
154980543|NCT04965389|559352284|FG001|Overall Study|Other reasons|0|||
154980544|NCT04965389|559352285|FG002|Overall Study|Other reasons|0|||
154980545|NCT04965389|559352286|FG003|Overall Study|Other reasons|0|||
154980546|NCT04965389|559352283|FG000|Overall Study|Participant withdrew consent|0|||
154980547|NCT04965389|559352284|FG001|Overall Study|Participant withdrew consent|1|||
154980548|NCT04965389|559352285|FG002|Overall Study|Participant withdrew consent|0|||
154980549|NCT04965389|559352286|FG003|Overall Study|Participant withdrew consent|0|||
154980550|NCT04965389|559352283|FG000|Overall Study|Poor/Non-compliance|0|||
154980551|NCT04965389|559352284|FG001|Overall Study|Poor/Non-compliance|1|||
154980552|NCT04965389|559352285|FG002|Overall Study|Poor/Non-compliance|0|||
154980553|NCT04965389|559352286|FG003|Overall Study|Poor/Non-compliance|0|||
154980554|NCT01436643|559352287|FG000|2-week Pre-treatment|Abnormal test result|0|||
154980555|NCT01436643|559352288|FG001|2-week Pre-treatment|Abnormal test result|0|||
154980556|NCT01436643|559352289|FG002|2-week Pre-treatment|Abnormal test result|0|||
154980557|NCT01436643|559352290|FG003|2-week Pre-treatment|Abnormal test result|1|||
154980558|NCT01436643|559352287|FG000|2-week Pre-treatment|Adverse Event|0|||
154980559|NCT01436643|559352288|FG001|2-week Pre-treatment|Adverse Event|0|||
154980560|NCT01436643|559352289|FG002|2-week Pre-treatment|Adverse Event|0|||
154980561|NCT01436643|559352290|FG003|2-week Pre-treatment|Adverse Event|5|||
154980562|NCT01436643|559352287|FG000|2-week Pre-treatment|Protocol Violation|0|||
154980563|NCT01436643|559352288|FG001|2-week Pre-treatment|Protocol Violation|0|||
154980564|NCT01436643|559352289|FG002|2-week Pre-treatment|Protocol Violation|0|||
154980565|NCT01436643|559352290|FG003|2-week Pre-treatment|Protocol Violation|4|||
154980566|NCT01436643|559352287|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
154980567|NCT01436643|559352288|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
154980568|NCT01436643|559352289|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
154980569|NCT01436643|559352290|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
154980570|NCT01436643|559352287|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
154980571|NCT01436643|559352288|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
154980572|NCT01436643|559352289|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
154980573|NCT01436643|559352290|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
154980574|NCT01436643|559352287|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
154980575|NCT01436643|559352288|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
154980576|NCT01436643|559352289|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
154980577|NCT01436643|559352290|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
154980578|NCT00842530|559352291|FG000|Overall Study|Serious adverse event|0|||
154980579|NCT00842530|559352292|FG001|Overall Study|Serious adverse event|6|||
154980580|NCT00842530|559352291|FG000|Overall Study|Other adverse event|6|||
154980581|NCT00842530|559352292|FG001|Overall Study|Other adverse event|1|||
154980582|NCT00842530|559352291|FG000|Overall Study|Protocol Violation|32|||
154980583|NCT00842530|559352292|FG001|Overall Study|Protocol Violation|14|||
154980584|NCT00842530|559352291|FG000|Overall Study|Lost to Follow-up|6|||
154980585|NCT00842530|559352292|FG001|Overall Study|Lost to Follow-up|8|||
154980586|NCT00842530|559352291|FG000|Overall Study|Withdrawal by Subject|73|||
155114732|NCT02059499|559848267|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
155114733|NCT02059499|559848268|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
155114734|NCT04210245|559848269|FG000|Overall Study|Adverse Event|0|||
154980587|NCT00842530|559352292|FG001|Overall Study|Withdrawal by Subject|28|||
154980588|NCT01382251|559352293|FG000|Overall Study|Surgeries cancelled or delayed|16|||
154980589|NCT01382251|559352294|FG001|Overall Study|Surgeries cancelled or delayed|16|||
154980590|NCT01382251|559352293|FG000|Overall Study|Lost to Follow-up|4|||
154980591|NCT01382251|559352294|FG001|Overall Study|Lost to Follow-up|4|||
154980592|NCT01382251|559352293|FG000|Overall Study|Contacted after study closed|1|||
154980593|NCT01382251|559352294|FG001|Overall Study|Contacted after study closed|1|||
154980594|NCT01117987|559352295|FG000|Overall Study|Protocol deviation|0|||
154980595|NCT01117987|559352296|FG001|Overall Study|Protocol deviation|1|||
154980596|NCT01117987|559352295|FG000|Overall Study|Subject no longer requires study drug|1|||
154980597|NCT01117987|559352296|FG001|Overall Study|Subject no longer requires study drug|0|||
154980598|NCT01117987|559352295|FG000|Overall Study|Lost to Follow-up|1|||
154980599|NCT01117987|559352296|FG001|Overall Study|Lost to Follow-up|1|||
154980600|NCT01117987|559352295|FG000|Overall Study|Abnormal test procedure result|2|||
154980601|NCT01117987|559352296|FG001|Overall Study|Abnormal test procedure result|0|||
154980602|NCT01117987|559352295|FG000|Overall Study|Lack of Efficacy|3|||
154980603|NCT01117987|559352296|FG001|Overall Study|Lack of Efficacy|4|||
154980604|NCT01117987|559352295|FG000|Overall Study|Death|5|||
154980605|NCT01117987|559352296|FG001|Overall Study|Death|10|||
155175673|NCT03339297|560080309|FG001|Overall Study|Consent Withdrawn by Participant|3|||
155175674|NCT03339297|560080308|FG000|Overall Study|Disease Relapse|2|||
155175675|NCT03339297|560080309|FG001|Overall Study|Disease Relapse|0|||
155175676|NCT03339297|560080308|FG000|Overall Study|Physician Decision|1|||
155175677|NCT03339297|560080309|FG001|Overall Study|Physician Decision|1|||
154899081|NCT00928512|559052584|FG000|Overall Study|Lack of Efficacy|2|||
154899082|NCT00928512|559052585|FG001|Overall Study|Lack of Efficacy|0|||
154980606|NCT01117987|559352295|FG000|Overall Study|Withdrawal by Subject|5|||
154980607|NCT01117987|559352296|FG001|Overall Study|Withdrawal by Subject|10|||
154980608|NCT01117987|559352295|FG000|Overall Study|Adverse Event|19|||
154980609|NCT01117987|559352296|FG001|Overall Study|Adverse Event|26|||
154980610|NCT01117987|559352295|FG000|Overall Study|Administrative problems|25|||
154980611|NCT01117987|559352296|FG001|Overall Study|Administrative problems|22|||
154980612|NCT02377063|559352297|FG000|Overall Study|Non-compliance|5|||
154980613|NCT01524913|559352298|FG000|Overall Study|Lost to Follow-up|4|||
154980614|NCT01524913|559352299|FG001|Overall Study|Lost to Follow-up|0|||
154899083|NCT00928512|559052586|FG002|Overall Study|Lack of Efficacy|4|||
154899084|NCT00928512|559052587|FG003|Overall Study|Lack of Efficacy|7|||
154899085|NCT00928512|559052588|FG004|Overall Study|Lack of Efficacy|3|||
154899086|NCT00928512|559052584|FG000|Overall Study|Protocol Violation|0|||
154899087|NCT00928512|559052585|FG001|Overall Study|Protocol Violation|1|||
154899088|NCT00928512|559052586|FG002|Overall Study|Protocol Violation|0|||
154899089|NCT00928512|559052587|FG003|Overall Study|Protocol Violation|1|||
154899090|NCT00928512|559052588|FG004|Overall Study|Protocol Violation|3|||
154899091|NCT00928512|559052584|FG000|Overall Study|Withdrawal by Subject|3|||
154899092|NCT00928512|559052585|FG001|Overall Study|Withdrawal by Subject|0|||
154899093|NCT00928512|559052586|FG002|Overall Study|Withdrawal by Subject|3|||
154899094|NCT00928512|559052587|FG003|Overall Study|Withdrawal by Subject|4|||
154899095|NCT00928512|559052588|FG004|Overall Study|Withdrawal by Subject|0|||
154899096|NCT00928512|559052584|FG000|Overall Study|Lost to Follow-up|1|||
154899097|NCT00928512|559052585|FG001|Overall Study|Lost to Follow-up|1|||
154899098|NCT00928512|559052586|FG002|Overall Study|Lost to Follow-up|2|||
154899099|NCT00928512|559052587|FG003|Overall Study|Lost to Follow-up|1|||
154899100|NCT00928512|559052588|FG004|Overall Study|Lost to Follow-up|3|||
154899101|NCT00928512|559052584|FG000|Overall Study|Administrative Problems|0|||
154899102|NCT00928512|559052585|FG001|Overall Study|Administrative Problems|1|||
154899103|NCT00928512|559052586|FG002|Overall Study|Administrative Problems|0|||
154899104|NCT00928512|559052587|FG003|Overall Study|Administrative Problems|0|||
154899105|NCT00928512|559052588|FG004|Overall Study|Administrative Problems|0|||
154899106|NCT01963780|559052589|FG000|Overall Study|Death|7|||
154899107|NCT03383614|559052590|FG000|Overall Study|Withdrawal by Subject|0|||
154899108|NCT03383614|559052591|FG001|Overall Study|Withdrawal by Subject|1|||
154899109|NCT03383614|559052592|FG002|Overall Study|Withdrawal by Subject|0|||
154899110|NCT03383614|559052593|FG003|Overall Study|Withdrawal by Subject|0|||
154899111|NCT01296698|559052594|FG000|Overall Study|Adverse Event|1|||
154899112|NCT01296698|559052595|FG001|Overall Study|Adverse Event|0|||
154899113|NCT01296698|559052594|FG000|Overall Study|Death|1|||
154899114|NCT01296698|559052595|FG001|Overall Study|Death|0|||
154980615|NCT01524913|559352300|FG002|Overall Study|Lost to Follow-up|0|||
154980616|NCT00702208|559352301|FG000|Overall Study|Lost to Follow-up|28|||
154980617|NCT00702208|559352301|FG000|Overall Study|Did not self-lavage|1|||
154980618|NCT00702208|559352301|FG000|Overall Study|Unsatisfactory colposcopy|2|||
154980619|NCT03183141|559352305|FG000|Overall Study|Withdrawal by Subject|2|||
155175678|NCT03339297|560080308|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
154899115|NCT01296698|559052594|FG000|Overall Study|Lost to Follow-up|19|||
154899116|NCT01296698|559052595|FG001|Overall Study|Lost to Follow-up|1|||
154899117|NCT01296698|559052594|FG000|Overall Study|Withdrawal by Subject|12|||
154899118|NCT01296698|559052595|FG001|Overall Study|Withdrawal by Subject|0|||
154899119|NCT01296698|559052594|FG000|Overall Study|Difficulty Contacting Subject|2|||
154980620|NCT03183141|559352306|FG001|Overall Study|Withdrawal by Subject|4|||
154980621|NCT03183141|559352305|FG000|Overall Study|Death|0|||
154980622|NCT03183141|559352306|FG001|Overall Study|Death|8|||
154980623|NCT02953678|559352309|FG000|Overall Study|Adverse Event|20|||
154980624|NCT02953678|559352309|FG000|Overall Study|Death|7|||
154980625|NCT02953678|559352309|FG000|Overall Study|Physician Decision|23|||
154899120|NCT01296698|559052595|FG001|Overall Study|Difficulty Contacting Subject|0|||
154899121|NCT01296698|559052594|FG000|Overall Study|Study Terminated by Sponsor|209|||
154899122|NCT01296698|559052595|FG001|Overall Study|Study Terminated by Sponsor|12|||
154980626|NCT02953678|559352309|FG000|Overall Study|Progressive Disease of GVHD|7|||
154980627|NCT02953678|559352309|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
154980628|NCT02953678|559352309|FG000|Overall Study|Withdrawal by participant|3|||
154899123|NCT03549429|559052600|FG000|Overall Study|Protocol Violation|5|||
154980629|NCT02953678|559352309|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
154980630|NCT02953678|559352309|FG000|Overall Study|Participants were transferred to commercial product.|3|||
154980631|NCT04034355|559352310|FG000|Overall Study|Study terminated by Sponsor|10|||
154980632|NCT04034355|559352311|FG001|Overall Study|Study terminated by Sponsor|17|||
154980633|NCT04034355|559352310|FG000|Overall Study|Withdrawal by Subject|12|||
154980634|NCT04034355|559352311|FG001|Overall Study|Withdrawal by Subject|11|||
154980635|NCT04034355|559352310|FG000|Overall Study|Site terminated by Sponsor|4|||
154980636|NCT04034355|559352311|FG001|Overall Study|Site terminated by Sponsor|5|||
154980637|NCT04034355|559352310|FG000|Overall Study|Adverse Event|2|||
154980638|NCT04034355|559352311|FG001|Overall Study|Adverse Event|0|||
154980639|NCT04034355|559352310|FG000|Overall Study|Death|1|||
154980640|NCT04034355|559352311|FG001|Overall Study|Death|1|||
154980641|NCT04034355|559352310|FG000|Overall Study|Not reported|2|||
154980642|NCT04034355|559352311|FG001|Overall Study|Not reported|0|||
154980643|NCT04034355|559352310|FG000|Overall Study|Lost to Follow-up|1|||
154980644|NCT04034355|559352311|FG001|Overall Study|Lost to Follow-up|0|||
154899124|NCT03549429|559052601|FG001|Overall Study|Protocol Violation|3|||
154899125|NCT04423757|559052604|FG000|Overall Study|Adverse Event|2|||
154899126|NCT04423757|559052605|FG001|Overall Study|Adverse Event|0|||
154899127|NCT04423757|559052604|FG000|Overall Study|Not treated|1|||
154899128|NCT04423757|559052605|FG001|Overall Study|Not treated|1|||
154899129|NCT01202760|559052606|FG000|Overall Study|Entry Criteria Not Met|0|||
154899130|NCT01202760|559052607|FG001|Overall Study|Entry Criteria Not Met|3|||
154899131|NCT01202760|559052608|FG002|Overall Study|Entry Criteria Not Met|1|||
154899132|NCT01202760|559052606|FG000|Overall Study|Adverse Event|11|||
154899133|NCT01202760|559052607|FG001|Overall Study|Adverse Event|9|||
154899134|NCT01202760|559052608|FG002|Overall Study|Adverse Event|10|||
154899135|NCT01202760|559052606|FG000|Overall Study|Death|2|||
154899136|NCT01202760|559052607|FG001|Overall Study|Death|1|||
154899137|NCT01202760|559052608|FG002|Overall Study|Death|0|||
154899138|NCT01202760|559052606|FG000|Overall Study|Lack of Efficacy|6|||
154899139|NCT01202760|559052607|FG001|Overall Study|Lack of Efficacy|8|||
154899140|NCT01202760|559052608|FG002|Overall Study|Lack of Efficacy|7|||
154899141|NCT01202760|559052606|FG000|Overall Study|Lost to Follow-up|0|||
154899142|NCT01202760|559052607|FG001|Overall Study|Lost to Follow-up|2|||
154899143|NCT01202760|559052608|FG002|Overall Study|Lost to Follow-up|1|||
154899144|NCT01202760|559052606|FG000|Overall Study|Parent / Caregiver Decision|0|||
154899145|NCT01202760|559052607|FG001|Overall Study|Parent / Caregiver Decision|1|||
154899146|NCT01202760|559052608|FG002|Overall Study|Parent / Caregiver Decision|0|||
154899147|NCT01202760|559052606|FG000|Overall Study|Withdrawal by Subject|17|||
154899148|NCT01202760|559052607|FG001|Overall Study|Withdrawal by Subject|18|||
154899149|NCT01202760|559052608|FG002|Overall Study|Withdrawal by Subject|14|||
154899150|NCT01202760|559052606|FG000|Overall Study|Physician Decision|0|||
154899151|NCT01202760|559052607|FG001|Overall Study|Physician Decision|1|||
154899152|NCT01202760|559052608|FG002|Overall Study|Physician Decision|0|||
154899153|NCT01202760|559052606|FG000|Overall Study|Protocol Violation|7|||
154899154|NCT01202760|559052607|FG001|Overall Study|Protocol Violation|5|||
154899155|NCT01202760|559052608|FG002|Overall Study|Protocol Violation|2|||
154899156|NCT01202760|559052606|FG000|Overall Study|Sponsor Decision|4|||
154899157|NCT01202760|559052607|FG001|Overall Study|Sponsor Decision|4|||
154899158|NCT01202760|559052608|FG002|Overall Study|Sponsor Decision|0|||
154899159|NCT02810951|559052609|FG000|Overall Study|Adverse Event|1|||
154980645|NCT04034355|559352310|FG000|Overall Study|Physician Decision|1|||
154980646|NCT04034355|559352311|FG001|Overall Study|Physician Decision|0|||
154980647|NCT04034355|559352310|FG000|Overall Study|Protocol Violation|0|||
154980648|NCT04034355|559352311|FG001|Overall Study|Protocol Violation|1|||
154980649|NCT04034355|559352310|FG000|Overall Study|Progressive disease|1|||
154980650|NCT04034355|559352311|FG001|Overall Study|Progressive disease|0|||
154980651|NCT01961687|559354019|FG000|Overall Study|Lost to Follow-up|19|||
154980652|NCT01961687|559354019|FG000|Overall Study|Re-operation|17|||
154899160|NCT03199638|559052610|FG000|Overall Study|inability to drink glutamine during regularly|0|||
154899161|NCT03199638|559052611|FG001|Overall Study|inability to drink glutamine during regularly|2|||
154980653|NCT01961687|559354019|FG000|Overall Study|Death|7|||
154980654|NCT01961687|559354019|FG000|Overall Study|Withdrawal by Subject|6|||
154980655|NCT01961687|559354019|FG000|Overall Study|Adverse Event|6|||
154980656|NCT01961687|559354019|FG000|Overall Study|Moved to area without study site|2|||
154899162|NCT00293241|559052612|FG000|Overall Study|Lost to Follow-up|9|||
154899163|NCT00293241|559052613|FG001|Overall Study|Lost to Follow-up|16|||
154899164|NCT00293241|559052612|FG000|Overall Study|Physician Decision|23|||
154899165|NCT00293241|559052613|FG001|Overall Study|Physician Decision|17|||
154899166|NCT00293241|559052612|FG000|Overall Study|Withdrawal by Subject|4|||
154980657|NCT01961687|559354019|FG000|Overall Study|Sponsor decision|2|||
154980658|NCT01961687|559354019|FG000|Overall Study|Physician Decision|1|||
154980659|NCT01961687|559354019|FG000|Overall Study|Unable to meet follow-up requirements|1|||
154899167|NCT00293241|559052613|FG001|Overall Study|Withdrawal by Subject|8|||
154899168|NCT01270958|559052617|FG000|Overall Study|Lost to Follow-up|2|||
154899169|NCT01270958|559052617|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
154899170|NCT00260429|559052618|FG000|Overall Study|failure to follow appointments|1|||
154899171|NCT00260429|559052619|FG001|Overall Study|failure to follow appointments|0|||
154899172|NCT00260429|559052618|FG000|Overall Study|scheduled hand surgery|1|||
154899173|NCT00260429|559052619|FG001|Overall Study|scheduled hand surgery|0|||
154899174|NCT02142504|559052621|FG000|Overall Study|Protocol Violation|2|||
154899175|NCT02142504|559052622|FG001|Overall Study|Protocol Violation|1|||
155114735|NCT04210245|559848270|FG001|Overall Study|Adverse Event|3|||
155114736|NCT04210245|559848271|FG002|Overall Study|Adverse Event|6|||
154899176|NCT02142504|559052623|FG002|Overall Study|Protocol Violation|2|||
154899177|NCT02142504|559052621|FG000|Overall Study|Adverse Event|2|||
154899178|NCT02142504|559052622|FG001|Overall Study|Adverse Event|3|||
154899179|NCT02142504|559052623|FG002|Overall Study|Adverse Event|4|||
154899180|NCT02142504|559052621|FG000|Overall Study|Lost to Follow-up|12|||
154899181|NCT02142504|559052622|FG001|Overall Study|Lost to Follow-up|19|||
154899182|NCT02142504|559052623|FG002|Overall Study|Lost to Follow-up|17|||
154899183|NCT02142504|559052621|FG000|Overall Study|Withdrawal by Subject|7|||
154899184|NCT02142504|559052622|FG001|Overall Study|Withdrawal by Subject|9|||
154899185|NCT02142504|559052623|FG002|Overall Study|Withdrawal by Subject|11|||
154899186|NCT02142504|559052621|FG000|Overall Study|Pregnancy|4|||
154899187|NCT02142504|559052622|FG001|Overall Study|Pregnancy|4|||
154899188|NCT02142504|559052623|FG002|Overall Study|Pregnancy|2|||
154899189|NCT02142504|559052621|FG000|Overall Study|Physician Decision|0|||
154899190|NCT02142504|559052622|FG001|Overall Study|Physician Decision|1|||
154899191|NCT02142504|559052623|FG002|Overall Study|Physician Decision|3|||
154899192|NCT02142504|559052621|FG000|Overall Study|Reason Not Specified|4|||
154899193|NCT02142504|559052622|FG001|Overall Study|Reason Not Specified|5|||
154899194|NCT02142504|559052623|FG002|Overall Study|Reason Not Specified|4|||
154899195|NCT01998399|559052624|FG000|Overall Study|Lost to Follow-up|1|||
154899196|NCT01998399|559052625|FG001|Overall Study|Lost to Follow-up|3|||
154899197|NCT01998399|559052624|FG000|Overall Study|Death|4|||
154899198|NCT01998399|559052625|FG001|Overall Study|Death|2|||
154899199|NCT01998399|559052624|FG000|Overall Study|Study stopped before dosing completed|3|||
154899200|NCT01998399|559052625|FG001|Overall Study|Study stopped before dosing completed|3|||
154899201|NCT01998399|559052624|FG000|Overall Study|Withdrawal by Subject|0|||
154899202|NCT01998399|559052625|FG001|Overall Study|Withdrawal by Subject|1|||
154899203|NCT00617591|559052632|FG000|Overall Study|Withdrew consent during Induction|4|||
154899204|NCT00617591|559052632|FG000|Overall Study|Withdrew consent during Maintenance|6|||
154899205|NCT04114539|559052633|FG000|Overall Study|Adverse Event|14|||
154899206|NCT04114539|559052633|FG000|Overall Study|Lost to Follow-up|2|||
154899207|NCT04114539|559052633|FG000|Overall Study|Non-compliance with Protocol|2|||
154899208|NCT04114539|559052633|FG000|Overall Study|Non-compliance with Study Drug|1|||
154899209|NCT04114539|559052633|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
154899210|NCT04114539|559052633|FG000|Overall Study|Withdrew consent|10|||
154899211|NCT04114539|559052633|FG000|Overall Study|Others not specified|5|||
154899212|NCT04114539|559052633|FG000|Overall Study|Investigator Decision|2|||
154899213|NCT00376246|559052635|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
154899214|NCT00376246|559052636|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
154899215|NCT00376246|559052635|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
154899216|NCT00376246|559052636|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
154899217|NCT00376246|559052635|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
154899218|NCT00376246|559052636|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
154899219|NCT00166517|559052641|FG000|Overall Study|Lost to Follow-up|1|||
154899220|NCT00166517|559052642|FG001|Overall Study|Lost to Follow-up|0|||
154899221|NCT00166517|559052641|FG000|Overall Study|Protocol Violation|4|||
154899222|NCT00166517|559052642|FG001|Overall Study|Protocol Violation|1|||
154899223|NCT00166517|559052641|FG000|Overall Study|Withdrawal by Subject|0|||
154899224|NCT00166517|559052642|FG001|Overall Study|Withdrawal by Subject|1|||
154899225|NCT01455415|559052643|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
154899226|NCT01455415|559052644|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
154899227|NCT01455415|559052643|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
154899228|NCT01455415|559052644|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
154899229|NCT01455415|559052643|FG000|Period 1|Drug Error not Associated to AE|0|||
154899230|NCT01455415|559052644|FG001|Period 1|Drug Error not Associated to AE|1|||
154899231|NCT01455415|559052643|FG000|Period 1|AE Not Related to Study Drug|2|||
154899232|NCT01455415|559052644|FG001|Period 1|AE Not Related to Study Drug|6|||
154899233|NCT01455415|559052643|FG000|Period 1|Withdrawal by Subject|4|||
154899234|NCT01455415|559052644|FG001|Period 1|Withdrawal by Subject|5|||
155114737|NCT04210245|559848272|FG003|Overall Study|Adverse Event|0|||
155114738|NCT04210245|559848269|FG000|Overall Study|Withdrawal by Subject|0|||
154899235|NCT01455415|559052643|FG000|Period 1|Unspecified Reason|1|||
154899236|NCT01455415|559052644|FG001|Period 1|Unspecified Reason|1|||
154899237|NCT01455415|559052643|FG000|Period 1|Protocol Violation|0|||
154899238|NCT01455415|559052644|FG001|Period 1|Protocol Violation|2|||
155114739|NCT04210245|559848270|FG001|Overall Study|Withdrawal by Subject|1|||
155114740|NCT04210245|559848271|FG002|Overall Study|Withdrawal by Subject|4|||
155114741|NCT04210245|559848272|FG003|Overall Study|Withdrawal by Subject|4|||
155114742|NCT04210245|559848269|FG000|Overall Study|Lost to Follow-up|0|||
155114743|NCT04210245|559848270|FG001|Overall Study|Lost to Follow-up|1|||
154899239|NCT01455415|559052643|FG000|Washout|AE Related to Study Drug|2|||
154899240|NCT01455415|559052644|FG001|Washout|AE Related to Study Drug|0|||
155114744|NCT04210245|559848271|FG002|Overall Study|Lost to Follow-up|1|||
155114745|NCT04210245|559848272|FG003|Overall Study|Lost to Follow-up|1|||
154899241|NCT01455415|559052643|FG000|Washout|Lost to Follow-up|1|||
154899242|NCT01455415|559052644|FG001|Washout|Lost to Follow-up|0|||
154899243|NCT01455415|559052643|FG000|Washout|Drug Error not Associated to AE|2|||
154899244|NCT01455415|559052644|FG001|Washout|Drug Error not Associated to AE|1|||
154899245|NCT01455415|559052643|FG000|Washout|AE Not Related to Study Drug|2|||
154899246|NCT01455415|559052644|FG001|Washout|AE Not Related to Study Drug|3|||
154899247|NCT01455415|559052643|FG000|Washout|Unspecified Reason|1|||
154899248|NCT01455415|559052644|FG001|Washout|Unspecified Reason|2|||
154899249|NCT01455415|559052643|FG000|Washout|Protocol Violation|0|||
154899250|NCT01455415|559052644|FG001|Washout|Protocol Violation|1|||
154899251|NCT01455415|559052643|FG000|Period 2|AE Related to Study Drug|1|||
154899252|NCT01455415|559052644|FG001|Period 2|AE Related to Study Drug|2|||
154899253|NCT01455415|559052643|FG000|Period 2|Lost to Follow-up|2|||
154899254|NCT01455415|559052644|FG001|Period 2|Lost to Follow-up|1|||
154899255|NCT01455415|559052643|FG000|Period 2|AE Not Related to Study Drug|2|||
154899256|NCT01455415|559052644|FG001|Period 2|AE Not Related to Study Drug|1|||
154899257|NCT01455415|559052643|FG000|Period 2|Lack of Efficacy|2|||
154899258|NCT01455415|559052644|FG001|Period 2|Lack of Efficacy|0|||
154899259|NCT01455415|559052643|FG000|Period 2|Withdrawal by Subject|2|||
154899260|NCT01455415|559052644|FG001|Period 2|Withdrawal by Subject|3|||
154899261|NCT01455415|559052643|FG000|Period 2|Unspecified Reason|2|||
154899262|NCT01455415|559052644|FG001|Period 2|Unspecified Reason|3|||
154899263|NCT01455415|559052643|FG000|Period 2|Protocol Violation|2|||
154899264|NCT01455415|559052644|FG001|Period 2|Protocol Violation|0|||
154899265|NCT01455415|559052643|FG000|Follow-up|AE Related to Study Drug|0|||
154899266|NCT01455415|559052644|FG001|Follow-up|AE Related to Study Drug|1|||
154899267|NCT01455415|559052643|FG000|Follow-up|Lack of Efficacy|0|||
154899268|NCT01455415|559052644|FG001|Follow-up|Lack of Efficacy|1|||
154899269|NCT01455415|559052643|FG000|Follow-up|Withdrawal by Subject|2|||
154899270|NCT01455415|559052644|FG001|Follow-up|Withdrawal by Subject|0|||
154899271|NCT01455415|559052643|FG000|Follow-up|Unspecified Reason|1|||
154899272|NCT01455415|559052644|FG001|Follow-up|Unspecified Reason|0|||
154899273|NCT03094611|559052648|FG000|Overall Study|Lack of Efficacy|1|||
154899274|NCT03094611|559052648|FG000|Overall Study|Stem Cell Transplant|1|||
154899275|NCT04285853|559052649|FG000|Overall Study|Withdrawal by Subject|1|||
154899276|NCT04285853|559052650|FG001|Overall Study|Withdrawal by Subject|0|||
154899277|NCT04285853|559052649|FG000|Overall Study|Lost to Follow-up|9|||
154899278|NCT04285853|559052650|FG001|Overall Study|Lost to Follow-up|5|||
154899279|NCT01496274|559052652|FG000|Overall Study|Protocol Violation|0|||
154899280|NCT01496274|559052653|FG001|Overall Study|Protocol Violation|1|||
154899281|NCT01496274|559052652|FG000|Overall Study|Adverse Event|1|||
154899282|NCT01496274|559052653|FG001|Overall Study|Adverse Event|1|||
154899283|NCT01496274|559052652|FG000|Overall Study|Withdrawal by Subject|2|||
154899284|NCT01496274|559052653|FG001|Overall Study|Withdrawal by Subject|0|||
154899285|NCT01496274|559052652|FG000|Overall Study|Lost to Follow-up|0|||
154899286|NCT01496274|559052653|FG001|Overall Study|Lost to Follow-up|3|||
154899287|NCT02758613|559052654|FG000|Treatment|Physician and Sponsor Decision|1|||
154899288|NCT02758613|559052655|FG001|Treatment|Physician and Sponsor Decision|0|||
154899289|NCT02758613|559052656|FG002|Treatment|Physician and Sponsor Decision|0|||
154899290|NCT02758613|559052657|FG003|Treatment|Physician and Sponsor Decision|0|||
154899291|NCT02758613|559052654|FG000|Treatment|Withdrawal by Subject|1|||
154899292|NCT02758613|559052655|FG001|Treatment|Withdrawal by Subject|0|||
154899293|NCT02758613|559052656|FG002|Treatment|Withdrawal by Subject|1|||
155114746|NCT04210245|559848269|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
155114747|NCT04210245|559848270|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
155114748|NCT04210245|559848271|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
154899294|NCT02758613|559052657|FG003|Treatment|Withdrawal by Subject|0|||
154899295|NCT00351819|559052659|FG000|Overall Study|Lost to Follow-up|4|||
154899296|NCT00351819|559052660|FG001|Overall Study|Lost to Follow-up|4|||
154899297|NCT00351819|559052659|FG000|Overall Study|Withdrawal by Subject|0|||
154899298|NCT00351819|559052660|FG001|Overall Study|Withdrawal by Subject|4|||
154899299|NCT00351819|559052659|FG000|Overall Study|Elevated PSA|1|||
154899300|NCT00351819|559052660|FG001|Overall Study|Elevated PSA|1|||
154899301|NCT00351819|559052659|FG000|Overall Study|Traumatic ankle fracture|1|||
154899302|NCT00351819|559052660|FG001|Overall Study|Traumatic ankle fracture|0|||
154899303|NCT00351819|559052659|FG000|Overall Study|Unprofessional behavior|1|||
154899304|NCT00351819|559052660|FG001|Overall Study|Unprofessional behavior|0|||
155150937|NCT00633477|559988127|FG001|Overall Study|Randomized but not treated|0|||
155175679|NCT03339297|560080309|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
155175680|NCT03339297|560080308|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
154899305|NCT00351819|559052659|FG000|Overall Study|Non-compliance|0|||
154899306|NCT00351819|559052660|FG001|Overall Study|Non-compliance|1|||
154899307|NCT00351819|559052659|FG000|Overall Study|Incarcerated|0|||
154899308|NCT00351819|559052660|FG001|Overall Study|Incarcerated|1|||
154899309|NCT00351819|559052659|FG000|Overall Study|Enrolled in another trial|0|||
154899310|NCT00351819|559052660|FG001|Overall Study|Enrolled in another trial|1|||
154899311|NCT00249795|559052662|FG000|Overall Study|Not treated|16|||
154899312|NCT00249795|559052663|FG001|Overall Study|Not treated|14|||
154899313|NCT00249795|559052662|FG000|Overall Study|Symptomatic hypotension|127|||
154899314|NCT00249795|559052663|FG001|Overall Study|Symptomatic hypotension|64|||
154899315|NCT00249795|559052662|FG000|Overall Study|Other Serious Adverse Event|84|||
154899316|NCT00249795|559052663|FG001|Overall Study|Other Serious Adverse Event|93|||
154899317|NCT00249795|559052662|FG000|Overall Study|Qualifying condition not present|26|||
154899318|NCT00249795|559052663|FG001|Overall Study|Qualifying condition not present|29|||
154899319|NCT00249795|559052662|FG000|Overall Study|Withdrawal by Subject|678|||
154899320|NCT00249795|559052663|FG001|Overall Study|Withdrawal by Subject|742|||
154899321|NCT00249795|559052662|FG000|Overall Study|Thromboembolic / outcome event|39|||
154899322|NCT00249795|559052663|FG001|Overall Study|Thromboembolic / outcome event|45|||
154899323|NCT00249795|559052662|FG000|Overall Study|Oral anticoagulant required|2|||
154899324|NCT00249795|559052663|FG001|Overall Study|Oral anticoagulant required|0|||
154899325|NCT00249795|559052662|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
154899326|NCT00249795|559052663|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
154899327|NCT00249795|559052662|FG000|Overall Study|Non-compliance|71|||
154899328|NCT00249795|559052663|FG001|Overall Study|Non-compliance|69|||
154899329|NCT00249795|559052662|FG000|Overall Study|Study drug intolerance|3|||
154899330|NCT00249795|559052663|FG001|Overall Study|Study drug intolerance|3|||
154899331|NCT00249795|559052662|FG000|Overall Study|Other adverse events (non-serious)|188|||
154899332|NCT00249795|559052663|FG001|Overall Study|Other adverse events (non-serious)|159|||
154899333|NCT00249795|559052662|FG000|Overall Study|Physician withdrew consent|71|||
154899334|NCT00249795|559052663|FG001|Overall Study|Physician withdrew consent|63|||
154899335|NCT00249795|559052662|FG000|Overall Study|Surgery / procedure|4|||
154899336|NCT00249795|559052663|FG001|Overall Study|Surgery / procedure|5|||
154899337|NCT00249795|559052662|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
154980660|NCT01467479|559354022|FG000|Overall Study|No Study Medication|1|||
154980661|NCT01467479|559354023|FG001|Overall Study|No Study Medication|0|||
154980662|NCT01467479|559354024|FG002|Overall Study|No Study Medication|2|||
154980663|NCT01467479|559354022|FG000|Overall Study|Adverse Event|1|||
154980664|NCT01467479|559354023|FG001|Overall Study|Adverse Event|2|||
154980665|NCT01467479|559354024|FG002|Overall Study|Adverse Event|0|||
154980666|NCT01467479|559354022|FG000|Overall Study|Death|0|||
154980667|NCT01467479|559354023|FG001|Overall Study|Death|0|||
154980668|NCT01467479|559354024|FG002|Overall Study|Death|1|||
154980669|NCT01467479|559354022|FG000|Overall Study|Lost to Follow-up|2|||
154980670|NCT01467479|559354023|FG001|Overall Study|Lost to Follow-up|5|||
154980671|NCT01467479|559354024|FG002|Overall Study|Lost to Follow-up|3|||
154980672|NCT01467479|559354022|FG000|Overall Study|Withdrawal of Consent|3|||
154980673|NCT01467479|559354023|FG001|Overall Study|Withdrawal of Consent|7|||
154980674|NCT01467479|559354024|FG002|Overall Study|Withdrawal of Consent|7|||
154980675|NCT01467479|559354022|FG000|Overall Study|Study Terminated by Sponsor|1|||
154980676|NCT01467479|559354023|FG001|Overall Study|Study Terminated by Sponsor|3|||
154980677|NCT01467479|559354024|FG002|Overall Study|Study Terminated by Sponsor|3|||
154980678|NCT01467479|559354022|FG000|Overall Study|Other|1|||
154980679|NCT01467479|559354023|FG001|Overall Study|Other|0|||
154980680|NCT01467479|559354024|FG002|Overall Study|Other|0|||
154980681|NCT02065713|559354034|FG000|Overall Study|Adverse Event|0|||
154980682|NCT02065713|559354035|FG001|Overall Study|Adverse Event|1|||
154980683|NCT02065713|559354034|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154980684|NCT02065713|559354035|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
154980685|NCT01833533|559354036|FG000|Overall Study|Adverse Event|0|||
154980686|NCT01833533|559354037|FG001|Overall Study|Adverse Event|1|||
154980687|NCT01833533|559354036|FG000|Overall Study|Lost to Follow-up|4|||
154980688|NCT01833533|559354037|FG001|Overall Study|Lost to Follow-up|9|||
154980689|NCT01833533|559354036|FG000|Overall Study|To Enter an Extension Study|0|||
154980690|NCT01833533|559354037|FG001|Overall Study|To Enter an Extension Study|4|||
154980691|NCT01833533|559354036|FG000|Overall Study|Other|2|||
154980692|NCT01833533|559354037|FG001|Overall Study|Other|7|||
154980693|NCT02017860|559354038|FG000|Overall Study|Adverse Event|1|||
154980694|NCT02017860|559354038|FG000|Overall Study|Withdrawal by Subject|1|||
154980695|NCT01048502|559354044|FG000|Overall Study|Lost to Follow-up|2|||
154980696|NCT01048502|559354045|FG001|Overall Study|Lost to Follow-up|0|||
154980697|NCT01048502|559354046|FG002|Overall Study|Lost to Follow-up|0|||
154980698|NCT01048502|559354047|FG003|Overall Study|Lost to Follow-up|0|||
154980699|NCT01048502|559354044|FG000|Overall Study|Adverse Event|1|||
154980700|NCT01048502|559354045|FG001|Overall Study|Adverse Event|0|||
154980701|NCT01048502|559354046|FG002|Overall Study|Adverse Event|0|||
154980702|NCT01048502|559354047|FG003|Overall Study|Adverse Event|0|||
155114749|NCT04210245|559848272|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
155114750|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
155114751|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155114752|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155114753|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155114754|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155114755|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
155114756|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
155114757|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
155114758|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155114759|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155114760|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155114761|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
155114762|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
155114763|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
155114764|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155114765|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155114766|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155114767|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
155114768|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
155114769|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
155114770|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155114771|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155114772|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155114773|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
155114774|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
155114775|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
155114776|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155114777|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155114778|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155114779|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
155114780|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
155114781|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155114782|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155114783|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155114784|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155114785|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
155114786|NCT03989349|559848275|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
155114787|NCT03989349|559848276|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
155114788|NCT03989349|559848277|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155114789|NCT03989349|559848278|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155114790|NCT03989349|559848279|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
154899338|NCT00249795|559052663|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
154899339|NCT00249795|559052662|FG000|Overall Study|Lightheadedness / dizziness|15|||
154899340|NCT00249795|559052663|FG001|Overall Study|Lightheadedness / dizziness|11|||
154899341|NCT00249795|559052662|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
154899342|NCT00249795|559052663|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
154899343|NCT00249795|559052662|FG000|Overall Study|Other contraindicated medication|1|||
154899344|NCT00249795|559052663|FG001|Overall Study|Other contraindicated medication|1|||
154899345|NCT00249795|559052662|FG000|Overall Study|Event related to cardiac condition|17|||
154899346|NCT00249795|559052663|FG001|Overall Study|Event related to cardiac condition|16|||
154899347|NCT00249795|559052662|FG000|Overall Study|Patient not wish to continue after May08|4|||
154899348|NCT00249795|559052663|FG001|Overall Study|Patient not wish to continue after May08|6|||
154980703|NCT01048502|559354044|FG000|Overall Study|Withdrawal by Subject|1|||
155114791|NCT03989349|559848280|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
155114792|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155114793|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
155114794|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
155114795|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
154899349|NCT00249795|559052662|FG000|Overall Study|Site not agree to continue after May08|1|||
154899350|NCT00249795|559052663|FG001|Overall Study|Site not agree to continue after May08|1|||
154980704|NCT01048502|559354045|FG001|Overall Study|Withdrawal by Subject|4|||
154980705|NCT01048502|559354046|FG002|Overall Study|Withdrawal by Subject|5|||
154980706|NCT01048502|559354047|FG003|Overall Study|Withdrawal by Subject|3|||
154980707|NCT01048502|559354044|FG000|Overall Study|Physician Decision|0|||
154980708|NCT01048502|559354045|FG001|Overall Study|Physician Decision|3|||
154980709|NCT01048502|559354046|FG002|Overall Study|Physician Decision|0|||
154980710|NCT01048502|559354047|FG003|Overall Study|Physician Decision|1|||
154980711|NCT03336242|559354048|FG000|Overall Study|Adverse Event|0|||
154980712|NCT03336242|559354049|FG001|Overall Study|Adverse Event|1|||
154980713|NCT02457611|559354051|FG000|Overall Study|Lost to Follow-up|3|||
154980714|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
154980715|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
154980716|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
154980717|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
154980718|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
154980719|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
154980720|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
154980721|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
154980722|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
154980723|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
154980724|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
154980725|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
154980726|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
154980727|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
154980728|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
154980729|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
154980730|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
154980731|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
154980732|NCT00384293|559354052|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
154980733|NCT00384293|559354053|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
154980734|NCT00384293|559354054|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
154980735|NCT00384293|559354052|FG000|Post-randomization Period|Adverse Event|0|||
154980736|NCT00384293|559354053|FG001|Post-randomization Period|Adverse Event|23|||
154980737|NCT00384293|559354054|FG002|Post-randomization Period|Adverse Event|7|||
154980738|NCT00384293|559354052|FG000|Post-randomization Period|Lost to Follow-up|0|||
154980739|NCT00384293|559354053|FG001|Post-randomization Period|Lost to Follow-up|2|||
154980740|NCT00384293|559354054|FG002|Post-randomization Period|Lost to Follow-up|1|||
154980741|NCT00384293|559354052|FG000|Post-randomization Period|Protocol Violation|0|||
155114796|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
155114797|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
155114798|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155114799|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
155114800|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
155114801|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
155114802|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
155114803|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
155114804|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155114805|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
155114806|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
155114807|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
155175681|NCT03339297|560080309|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
155175682|NCT03339297|560080308|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
155175683|NCT03339297|560080309|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
155175684|NCT03339297|560080308|FG000|Overall Study|Adverse Event, Non-fatal|1|||
155175685|NCT03339297|560080309|FG001|Overall Study|Adverse Event, Non-fatal|0|||
154980742|NCT00384293|559354053|FG001|Post-randomization Period|Protocol Violation|1|||
154980743|NCT00384293|559354054|FG002|Post-randomization Period|Protocol Violation|0|||
154980744|NCT00384293|559354052|FG000|Post-randomization Period|Withdrawal by Subject|0|||
155175686|NCT03339297|560080308|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
154980745|NCT00384293|559354053|FG001|Post-randomization Period|Withdrawal by Subject|8|||
154980746|NCT00384293|559354054|FG002|Post-randomization Period|Withdrawal by Subject|6|||
154980747|NCT00384293|559354052|FG000|Post-randomization Period|Trial Termination|0|||
155175687|NCT03339297|560080309|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
154980748|NCT00384293|559354053|FG001|Post-randomization Period|Trial Termination|180|||
154980749|NCT00384293|559354054|FG002|Post-randomization Period|Trial Termination|204|||
154980750|NCT00384293|559354052|FG000|Post-randomization Period|Patient Randomized in Error|0|||
154980751|NCT00384293|559354053|FG001|Post-randomization Period|Patient Randomized in Error|0|||
154980752|NCT00384293|559354054|FG002|Post-randomization Period|Patient Randomized in Error|1|||
154980753|NCT03005067|559354055|FG000|Overall Study|Withdrawal by Subject|3|||
154980754|NCT03005067|559354056|FG001|Overall Study|Withdrawal by Subject|2|||
154980755|NCT03005067|559354055|FG000|Overall Study|Adverse Event|4|||
154980756|NCT03005067|559354056|FG001|Overall Study|Adverse Event|3|||
154980757|NCT03005067|559354055|FG000|Overall Study|Other (reason not specified)|3|||
154980758|NCT03005067|559354056|FG001|Overall Study|Other (reason not specified)|1|||
154980759|NCT03005067|559354055|FG000|Overall Study|Protocol Violation|0|||
154980760|NCT03005067|559354056|FG001|Overall Study|Protocol Violation|1|||
154980761|NCT00296491|559354059|FG000|Overall Study|Low Pollen Counts|18|||
154980762|NCT00296491|559354060|FG001|Overall Study|Low Pollen Counts|26|||
154980763|NCT00296491|559354061|FG002|Overall Study|Low Pollen Counts|25|||
154980764|NCT00296491|559354062|FG003|Overall Study|Low Pollen Counts|16|||
154980765|NCT00296491|559354059|FG000|Overall Study|Protocol Violation|4|||
154980766|NCT00296491|559354060|FG001|Overall Study|Protocol Violation|6|||
154980767|NCT00296491|559354061|FG002|Overall Study|Protocol Violation|2|||
154980768|NCT00296491|559354062|FG003|Overall Study|Protocol Violation|3|||
154980769|NCT00296491|559354059|FG000|Overall Study|Adverse Event|1|||
154980770|NCT00296491|559354060|FG001|Overall Study|Adverse Event|3|||
154980771|NCT00296491|559354061|FG002|Overall Study|Adverse Event|1|||
154980772|NCT00296491|559354062|FG003|Overall Study|Adverse Event|4|||
154980773|NCT00296491|559354059|FG000|Overall Study|Withdrawn due to Asthma|0|||
154980774|NCT00296491|559354060|FG001|Overall Study|Withdrawn due to Asthma|0|||
154980775|NCT00296491|559354061|FG002|Overall Study|Withdrawn due to Asthma|0|||
154980776|NCT00296491|559354062|FG003|Overall Study|Withdrawn due to Asthma|4|||
154980777|NCT00296491|559354059|FG000|Overall Study|Withdrawal by Subject|7|||
154980778|NCT00296491|559354060|FG001|Overall Study|Withdrawal by Subject|3|||
154980779|NCT00296491|559354061|FG002|Overall Study|Withdrawal by Subject|3|||
154980780|NCT00296491|559354062|FG003|Overall Study|Withdrawal by Subject|2|||
154980781|NCT00296491|559354059|FG000|Overall Study|Non-Compliance|12|||
154980782|NCT00296491|559354060|FG001|Overall Study|Non-Compliance|13|||
154980783|NCT00296491|559354061|FG002|Overall Study|Non-Compliance|10|||
154980784|NCT00296491|559354062|FG003|Overall Study|Non-Compliance|14|||
154980785|NCT00296491|559354059|FG000|Overall Study|Lost to Follow-up|0|||
154980786|NCT00296491|559354060|FG001|Overall Study|Lost to Follow-up|2|||
154980787|NCT00296491|559354061|FG002|Overall Study|Lost to Follow-up|2|||
154980788|NCT00296491|559354062|FG003|Overall Study|Lost to Follow-up|0|||
154980789|NCT00493454|559354067|FG000|Overall Study|Withdrawal by Subject|1|||
154980790|NCT01740791|559354070|FG000|Overall Study|Randomized but never treated|5|||
154980791|NCT01740791|559354071|FG001|Overall Study|Randomized but never treated|3|||
154980792|NCT01740791|559354072|FG002|Overall Study|Randomized but never treated|2|||
154980793|NCT01740791|559354073|FG003|Overall Study|Randomized but never treated|2|||
154980794|NCT01740791|559354074|FG004|Overall Study|Randomized but never treated|1|||
154980795|NCT01740791|559354075|FG005|Overall Study|Randomized but never treated|3|||
154980796|NCT01740791|559354070|FG000|Overall Study|Lost to Follow-up|2|||
154980797|NCT01740791|559354071|FG001|Overall Study|Lost to Follow-up|0|||
154980798|NCT01740791|559354072|FG002|Overall Study|Lost to Follow-up|2|||
154980799|NCT01740791|559354073|FG003|Overall Study|Lost to Follow-up|3|||
154980800|NCT01740791|559354074|FG004|Overall Study|Lost to Follow-up|2|||
154980801|NCT01740791|559354075|FG005|Overall Study|Lost to Follow-up|3|||
154980802|NCT01740791|559354070|FG000|Overall Study|Withdrew Consent|4|||
154980803|NCT01740791|559354071|FG001|Overall Study|Withdrew Consent|0|||
154980804|NCT01740791|559354072|FG002|Overall Study|Withdrew Consent|1|||
154980805|NCT01740791|559354073|FG003|Overall Study|Withdrew Consent|2|||
154980806|NCT01740791|559354074|FG004|Overall Study|Withdrew Consent|0|||
154980807|NCT01740791|559354075|FG005|Overall Study|Withdrew Consent|3|||
154980808|NCT01740791|559354070|FG000|Overall Study|Investigator's discretion|1|||
154980809|NCT01740791|559354071|FG001|Overall Study|Investigator's discretion|0|||
154980810|NCT01740791|559354072|FG002|Overall Study|Investigator's discretion|1|||
154980811|NCT01740791|559354073|FG003|Overall Study|Investigator's discretion|0|||
154980812|NCT01740791|559354074|FG004|Overall Study|Investigator's discretion|0|||
154980813|NCT01740791|559354075|FG005|Overall Study|Investigator's discretion|1|||
154980814|NCT01740791|559354070|FG000|Overall Study|Adverse Event|0|||
154980815|NCT01740791|559354071|FG001|Overall Study|Adverse Event|0|||
154980816|NCT01740791|559354072|FG002|Overall Study|Adverse Event|0|||
154980817|NCT01740791|559354073|FG003|Overall Study|Adverse Event|0|||
154980818|NCT01740791|559354074|FG004|Overall Study|Adverse Event|0|||
154980819|NCT01740791|559354075|FG005|Overall Study|Adverse Event|1|||
154980820|NCT02310763|559354080|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
154980821|NCT02310763|559354081|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
154980822|NCT02310763|559354082|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
154980823|NCT02310763|559354080|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
154980824|NCT02310763|559354081|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
154980825|NCT02310763|559354082|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
154980826|NCT02310763|559354080|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
154980827|NCT02310763|559354081|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
155150938|NCT00770653|559988131|FG000|Overall Study|Adverse Event|13|||
154980828|NCT02310763|559354082|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
154980829|NCT02310763|559354080|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
154980830|NCT02310763|559354081|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
154980831|NCT02310763|559354082|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
154980832|NCT02310763|559354080|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
154980833|NCT02310763|559354081|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
154980834|NCT02310763|559354082|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
154980835|NCT02010255|559354083|FG000|Overall Study|Death|0|||
154980836|NCT02010255|559354084|FG001|Overall Study|Death|1|||
154980837|NCT02010255|559354085|FG002|Overall Study|Death|4|||
154980838|NCT02010255|559354086|FG003|Overall Study|Death|4|||
154980839|NCT02010255|559354087|FG004|Overall Study|Death|2|||
154980840|NCT02010255|559354088|FG005|Overall Study|Death|0|||
154980841|NCT02010255|559354089|FG006|Overall Study|Death|1|||
154980842|NCT02010255|559354090|FG007|Overall Study|Death|1|||
154980843|NCT02010255|559354091|FG008|Overall Study|Death|1|||
154980844|NCT02010255|559354092|FG009|Overall Study|Death|0|||
154980845|NCT02010255|559354093|FG010|Overall Study|Death|1|||
154980846|NCT02010255|559354094|FG011|Overall Study|Death|1|||
154980847|NCT02010255|559354095|FG012|Overall Study|Death|0|||
154980848|NCT02010255|559354096|FG013|Overall Study|Death|0|||
154980849|NCT02010255|559354083|FG000|Overall Study|Lack of Efficacy|4|||
154980850|NCT02010255|559354084|FG001|Overall Study|Lack of Efficacy|1|||
154980851|NCT02010255|559354085|FG002|Overall Study|Lack of Efficacy|2|||
154980852|NCT02010255|559354086|FG003|Overall Study|Lack of Efficacy|1|||
154980853|NCT02010255|559354087|FG004|Overall Study|Lack of Efficacy|1|||
154980854|NCT02010255|559354088|FG005|Overall Study|Lack of Efficacy|0|||
154980855|NCT02010255|559354089|FG006|Overall Study|Lack of Efficacy|0|||
154980856|NCT02010255|559354090|FG007|Overall Study|Lack of Efficacy|0|||
154980857|NCT02010255|559354091|FG008|Overall Study|Lack of Efficacy|0|||
154980858|NCT02010255|559354092|FG009|Overall Study|Lack of Efficacy|0|||
154980859|NCT02010255|559354093|FG010|Overall Study|Lack of Efficacy|1|||
154980860|NCT02010255|559354094|FG011|Overall Study|Lack of Efficacy|0|||
154980861|NCT02010255|559354095|FG012|Overall Study|Lack of Efficacy|0|||
154980862|NCT02010255|559354096|FG013|Overall Study|Lack of Efficacy|0|||
154980863|NCT02010255|559354083|FG000|Overall Study|Withdrew Consent|1|||
154980864|NCT02010255|559354084|FG001|Overall Study|Withdrew Consent|0|||
154980865|NCT02010255|559354085|FG002|Overall Study|Withdrew Consent|0|||
154980866|NCT02010255|559354086|FG003|Overall Study|Withdrew Consent|1|||
154980867|NCT02010255|559354087|FG004|Overall Study|Withdrew Consent|0|||
154980868|NCT02010255|559354088|FG005|Overall Study|Withdrew Consent|0|||
154980869|NCT02010255|559354089|FG006|Overall Study|Withdrew Consent|0|||
154980870|NCT02010255|559354090|FG007|Overall Study|Withdrew Consent|0|||
154980871|NCT02010255|559354091|FG008|Overall Study|Withdrew Consent|0|||
154980872|NCT02010255|559354092|FG009|Overall Study|Withdrew Consent|0|||
154980873|NCT02010255|559354093|FG010|Overall Study|Withdrew Consent|0|||
154980874|NCT02010255|559354094|FG011|Overall Study|Withdrew Consent|0|||
154980875|NCT02010255|559354095|FG012|Overall Study|Withdrew Consent|0|||
154980876|NCT02010255|559354096|FG013|Overall Study|Withdrew Consent|0|||
154980877|NCT02010255|559354083|FG000|Overall Study|Adverse Event|1|||
154980878|NCT02010255|559354084|FG001|Overall Study|Adverse Event|0|||
154980879|NCT02010255|559354085|FG002|Overall Study|Adverse Event|0|||
154980880|NCT02010255|559354086|FG003|Overall Study|Adverse Event|0|||
154980881|NCT02010255|559354087|FG004|Overall Study|Adverse Event|0|||
154980882|NCT02010255|559354088|FG005|Overall Study|Adverse Event|0|||
154980883|NCT02010255|559354089|FG006|Overall Study|Adverse Event|0|||
154980884|NCT02010255|559354090|FG007|Overall Study|Adverse Event|0|||
154980885|NCT02010255|559354091|FG008|Overall Study|Adverse Event|0|||
154980886|NCT02010255|559354092|FG009|Overall Study|Adverse Event|0|||
154980887|NCT02010255|559354093|FG010|Overall Study|Adverse Event|0|||
154980888|NCT02010255|559354094|FG011|Overall Study|Adverse Event|0|||
154980889|NCT02010255|559354095|FG012|Overall Study|Adverse Event|0|||
154980890|NCT02010255|559354096|FG013|Overall Study|Adverse Event|0|||
154980891|NCT02010255|559354083|FG000|Overall Study|Lost to Follow-up|0|||
154980892|NCT02010255|559354084|FG001|Overall Study|Lost to Follow-up|0|||
154980893|NCT02010255|559354085|FG002|Overall Study|Lost to Follow-up|1|||
154980894|NCT02010255|559354086|FG003|Overall Study|Lost to Follow-up|0|||
154980895|NCT02010255|559354087|FG004|Overall Study|Lost to Follow-up|1|||
154980896|NCT02010255|559354088|FG005|Overall Study|Lost to Follow-up|0|||
154980897|NCT02010255|559354089|FG006|Overall Study|Lost to Follow-up|0|||
154980898|NCT02010255|559354090|FG007|Overall Study|Lost to Follow-up|0|||
154980899|NCT02010255|559354091|FG008|Overall Study|Lost to Follow-up|0|||
154980900|NCT02010255|559354092|FG009|Overall Study|Lost to Follow-up|0|||
154980901|NCT02010255|559354093|FG010|Overall Study|Lost to Follow-up|0|||
154980902|NCT02010255|559354094|FG011|Overall Study|Lost to Follow-up|0|||
154980903|NCT02010255|559354095|FG012|Overall Study|Lost to Follow-up|0|||
154980904|NCT02010255|559354096|FG013|Overall Study|Lost to Follow-up|0|||
154980905|NCT02010255|559354083|FG000|Overall Study|Randomized but Not Treated|0|||
154980906|NCT02010255|559354084|FG001|Overall Study|Randomized but Not Treated|0|||
154980907|NCT02010255|559354085|FG002|Overall Study|Randomized but Not Treated|0|||
154980908|NCT02010255|559354086|FG003|Overall Study|Randomized but Not Treated|0|||
154899351|NCT00249795|559052662|FG000|Overall Study|Lost to Follow-up|0|||
154899352|NCT00249795|559052663|FG001|Overall Study|Lost to Follow-up|2|||
154899353|NCT00249795|559052662|FG000|Overall Study|Missing|0|||
154899354|NCT00249795|559052663|FG001|Overall Study|Missing|1|||
154899355|NCT00719537|559052665|FG000|Overall Study|Withdrawal by Subject|1|||
154899356|NCT00719537|559052666|FG001|Overall Study|Withdrawal by Subject|0|||
154899357|NCT00719537|559052665|FG000|Overall Study|Lost to Follow-up|0|||
154899358|NCT00719537|559052666|FG001|Overall Study|Lost to Follow-up|1|||
154899359|NCT02460978|559052667|FG000|Overall Study|Adverse Event|17|||
154899360|NCT02460978|559052668|FG001|Overall Study|Adverse Event|11|||
154899361|NCT02460978|559052669|FG002|Overall Study|Adverse Event|11|||
154899362|NCT02460978|559052667|FG000|Overall Study|Withdrawal by Subject|5|||
154899363|NCT02460978|559052668|FG001|Overall Study|Withdrawal by Subject|5|||
154899364|NCT02460978|559052669|FG002|Overall Study|Withdrawal by Subject|14|||
154899365|NCT02460978|559052667|FG000|Overall Study|Lost to Follow-up|2|||
154899366|NCT02460978|559052668|FG001|Overall Study|Lost to Follow-up|3|||
154899367|NCT02460978|559052669|FG002|Overall Study|Lost to Follow-up|1|||
154899368|NCT02460978|559052667|FG000|Overall Study|Protocol Violation|1|||
154899369|NCT02460978|559052668|FG001|Overall Study|Protocol Violation|1|||
154899370|NCT02460978|559052669|FG002|Overall Study|Protocol Violation|1|||
154899371|NCT02460978|559052667|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
154899372|NCT02460978|559052668|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
154899373|NCT02460978|559052669|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
154899374|NCT02460978|559052667|FG000|Overall Study|Pregnancy|0|||
154899375|NCT02460978|559052668|FG001|Overall Study|Pregnancy|0|||
154899376|NCT02460978|559052669|FG002|Overall Study|Pregnancy|2|||
154899377|NCT00588523|559052675|FG000|Overall Study|Not treated|3|||
154899378|NCT01459068|559052676|FG000|Overall Study|Withdrawal by Subject|8|||
154899379|NCT01459068|559052677|FG001|Overall Study|Withdrawal by Subject|18|||
154899380|NCT01459068|559052676|FG000|Overall Study|Lost to Follow-up|31|||
154899381|NCT01459068|559052677|FG001|Overall Study|Lost to Follow-up|15|||
154899382|NCT01459068|559052676|FG000|Overall Study|Death|0|||
154899383|NCT01459068|559052677|FG001|Overall Study|Death|1|||
154899384|NCT02023112|559052682|FG000|Overall Study|Withdrawal by Subject|2|||
154899385|NCT02023112|559052683|FG001|Overall Study|Withdrawal by Subject|1|||
154899386|NCT02910219|559052684|FG000|Overall Study|Withdrawal by Subject|1|||
154899387|NCT02910219|559052685|FG001|Overall Study|Withdrawal by Subject|1|||
154899388|NCT01425749|559052686|FG000|Overall Study|progression of melanoma|0|||
154899389|NCT01425749|559052687|FG001|Overall Study|progression of melanoma|1|||
154899390|NCT02096042|559052688|FG000|Overall Study|Disease Progression|1|||
154899391|NCT02096042|559052689|FG001|Overall Study|Disease Progression|0|||
154899392|NCT02096042|559052690|FG002|Overall Study|Disease Progression|0|||
154899393|NCT00701441|559052694|FG000|Overall Study|failure in cpap compliance|0|||
154899394|NCT00701441|559052695|FG001|Overall Study|failure in cpap compliance|4|||
154899395|NCT01068717|559052697|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
154899396|NCT01068717|559052698|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
154899397|NCT01068717|559052699|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
154899398|NCT01068717|559052700|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
154899399|NCT02679781|559052701|FG000|Overall Study|Lost to Follow-up|1|||
154899400|NCT02679781|559052702|FG001|Overall Study|Lost to Follow-up|2|||
154899401|NCT02679781|559052701|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
154899402|NCT02679781|559052702|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
154899403|NCT04209400|559052703|FG000|Overall Study|Withdrawal by Subject|0|||
154899404|NCT04209400|559052704|FG001|Overall Study|Withdrawal by Subject|1|||
154899405|NCT03404518|559052705|FG000|Overall Study|Lost to Follow-up|28|||
154899406|NCT03404518|559052706|FG001|Overall Study|Lost to Follow-up|30|||
154899407|NCT03404518|559052705|FG000|Overall Study|Protocol Violation|13|||
154899408|NCT03404518|559052706|FG001|Overall Study|Protocol Violation|6|||
154899409|NCT00651313|559052710|FG000|Overall Study|Adverse Event|0|||
154899410|NCT00651313|559052711|FG001|Overall Study|Adverse Event|1|||
154899411|NCT00651313|559052710|FG000|Overall Study|Withdrawal by Subject|3|||
154899412|NCT00651313|559052711|FG001|Overall Study|Withdrawal by Subject|1|||
154899413|NCT00651313|559052710|FG000|Overall Study|Lost to Follow-up|1|||
154899414|NCT00651313|559052711|FG001|Overall Study|Lost to Follow-up|1|||
154899415|NCT00651313|559052710|FG000|Overall Study|Adminstrative Discontinuation|2|||
154899416|NCT00651313|559052711|FG001|Overall Study|Adminstrative Discontinuation|3|||
154899417|NCT02853032|559052722|FG000|Overall Study|Adverse Event|4|||
154899418|NCT02853032|559052723|FG001|Overall Study|Adverse Event|0|||
154899419|NCT02853032|559052722|FG000|Overall Study|Withdrawal by Subject|3|||
154899420|NCT02853032|559052723|FG001|Overall Study|Withdrawal by Subject|1|||
154899421|NCT02853032|559052722|FG000|Overall Study|Requested to withdraw from all treatment|2|||
154899422|NCT02853032|559052723|FG001|Overall Study|Requested to withdraw from all treatment|2|||
154899423|NCT00676208|559052728|FG000|Overall Study|Lost to Follow-up|0|||
154899424|NCT00676208|559052729|FG001|Overall Study|Lost to Follow-up|2|||
154899425|NCT00676208|559052728|FG000|Overall Study|Incomplete data|2|||
154899426|NCT00676208|559052729|FG001|Overall Study|Incomplete data|4|||
155114808|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
155114809|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
155114810|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155114811|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155114812|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
155114813|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155114814|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
155114815|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
155114816|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155114817|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
155114818|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
154899427|NCT01410799|559052730|FG000|Overall Study|PI decision|13|||
154899428|NCT00617656|559052731|FG000|Overall Study|Inclusion error|4|||
154899429|NCT00617656|559052732|FG001|Overall Study|Inclusion error|4|||
154899430|NCT00617656|559052733|FG002|Overall Study|Inclusion error|0|||
154899431|NCT00617656|559052734|FG003|Overall Study|Inclusion error|0|||
154899432|NCT00617656|559052731|FG000|Overall Study|Missing data|44|||
154899433|NCT00617656|559052732|FG001|Overall Study|Missing data|30|||
154899434|NCT00617656|559052733|FG002|Overall Study|Missing data|13|||
154899435|NCT00617656|559052734|FG003|Overall Study|Missing data|6|||
155114819|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
155114820|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
154899436|NCT00617656|559052731|FG000|Overall Study|Withdrawal by Subject|0|||
154899437|NCT00617656|559052732|FG001|Overall Study|Withdrawal by Subject|2|||
154899438|NCT00617656|559052733|FG002|Overall Study|Withdrawal by Subject|0|||
154899439|NCT00617656|559052734|FG003|Overall Study|Withdrawal by Subject|0|||
154899440|NCT01696396|559054857|FG000|Overall Study|Withdrawal by Subject|19|||
154899441|NCT01696396|559054858|FG001|Overall Study|Withdrawal by Subject|5|||
154899442|NCT01696396|559054859|FG002|Overall Study|Withdrawal by Subject|19|||
154899443|NCT01696396|559054860|FG003|Overall Study|Withdrawal by Subject|11|||
154899444|NCT01696396|559054857|FG000|Overall Study|Decision by Sponsor|3|||
154899445|NCT01696396|559054858|FG001|Overall Study|Decision by Sponsor|1|||
154899446|NCT01696396|559054859|FG002|Overall Study|Decision by Sponsor|2|||
154899447|NCT01696396|559054860|FG003|Overall Study|Decision by Sponsor|2|||
154899448|NCT01696396|559054857|FG000|Overall Study|Lost to Follow-up|9|||
154899449|NCT01696396|559054858|FG001|Overall Study|Lost to Follow-up|1|||
154899450|NCT01696396|559054859|FG002|Overall Study|Lost to Follow-up|4|||
154899451|NCT01696396|559054860|FG003|Overall Study|Lost to Follow-up|1|||
154899452|NCT01696396|559054857|FG000|Overall Study|Death|0|||
154899453|NCT01696396|559054858|FG001|Overall Study|Death|0|||
154899454|NCT01696396|559054859|FG002|Overall Study|Death|1|||
154899455|NCT01696396|559054860|FG003|Overall Study|Death|0|||
154899456|NCT00323310|559054862|FG000|Overall Study|Withdrawal by Subject|1|||
154899457|NCT00323310|559054862|FG000|Overall Study|a parent refused blood draw|1|||
154899458|NCT00323310|559054862|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
154899459|NCT03565991|559054863|FG000|Overall Study|Other|11|||
154899460|NCT03565991|559054864|FG001|Overall Study|Other|0|||
154899461|NCT03565991|559054863|FG000|Overall Study|Global deterioration of health status|14|||
154899462|NCT03565991|559054864|FG001|Overall Study|Global deterioration of health status|4|||
154899463|NCT03565991|559054863|FG000|Overall Study|Withdrawal by Subject|2|||
154899464|NCT03565991|559054864|FG001|Overall Study|Withdrawal by Subject|6|||
154899465|NCT03565991|559054863|FG000|Overall Study|Progressive disease|121|||
154899466|NCT03565991|559054864|FG001|Overall Study|Progressive disease|29|||
154899467|NCT03565991|559054863|FG000|Overall Study|Death|3|||
154899468|NCT03565991|559054864|FG001|Overall Study|Death|0|||
155114821|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
155114822|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
155175688|NCT03339297|560080308|FG000|Overall Study|Patient Was Not Eligible|1|||
154899469|NCT03565991|559054863|FG000|Overall Study|Adverse Event|7|||
154899470|NCT03565991|559054864|FG001|Overall Study|Adverse Event|2|||
154899471|NCT00937326|559054866|FG000|Overall Study|Adverse Event|0|||
154899472|NCT00937326|559054867|FG001|Overall Study|Adverse Event|3|||
154899473|NCT00937326|559054868|FG002|Overall Study|Adverse Event|1|||
154899474|NCT00937326|559054869|FG003|Overall Study|Adverse Event|1|||
154899475|NCT00937326|559054870|FG004|Overall Study|Adverse Event|2|||
154899476|NCT00937326|559054866|FG000|Overall Study|Death|0|||
154899477|NCT00937326|559054867|FG001|Overall Study|Death|0|||
154899478|NCT00937326|559054868|FG002|Overall Study|Death|1|||
154899479|NCT00937326|559054869|FG003|Overall Study|Death|0|||
154899480|NCT00937326|559054870|FG004|Overall Study|Death|0|||
154899481|NCT00937326|559054866|FG000|Overall Study|Withdrawal by Subject|3|||
154899482|NCT00937326|559054867|FG001|Overall Study|Withdrawal by Subject|4|||
154899483|NCT00937326|559054868|FG002|Overall Study|Withdrawal by Subject|1|||
154899484|NCT00937326|559054869|FG003|Overall Study|Withdrawal by Subject|4|||
154899485|NCT00937326|559054870|FG004|Overall Study|Withdrawal by Subject|3|||
154899486|NCT00937326|559054866|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
154980909|NCT02010255|559354087|FG004|Overall Study|Randomized but Not Treated|0|||
154980910|NCT02010255|559354088|FG005|Overall Study|Randomized but Not Treated|0|||
154980911|NCT02010255|559354089|FG006|Overall Study|Randomized but Not Treated|0|||
154980912|NCT02010255|559354090|FG007|Overall Study|Randomized but Not Treated|0|||
154980913|NCT02010255|559354091|FG008|Overall Study|Randomized but Not Treated|0|||
154980914|NCT02010255|559354092|FG009|Overall Study|Randomized but Not Treated|0|||
154980915|NCT02010255|559354093|FG010|Overall Study|Randomized but Not Treated|0|||
154980916|NCT02010255|559354094|FG011|Overall Study|Randomized but Not Treated|0|||
154980917|NCT02010255|559354095|FG012|Overall Study|Randomized but Not Treated|0|||
155175689|NCT03339297|560080309|FG001|Overall Study|Patient Was Not Eligible|0|||
155175690|NCT01566214|560080316|FG000|Overall Study|Lost to Follow-up|3|||
155175691|NCT01566214|560080317|FG001|Overall Study|Lost to Follow-up|0|||
155175692|NCT03051620|560080318|FG000|Overall Study|Lost to Follow-up|6|||
155175693|NCT03051620|560080318|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
155175694|NCT00393510|560080319|FG000|Overall Study|Physician Decision|3|||
155175695|NCT00393510|560080320|FG001|Overall Study|Physician Decision|9|||
155175696|NCT00770146|560080324|FG000|Treatment Period|Withdrawal by Subject|6|||
155175697|NCT00770146|560080325|FG001|Treatment Period|Withdrawal by Subject|13|||
155175698|NCT00770146|560080324|FG000|Treatment Period|Adverse Event|2|||
155175699|NCT00770146|560080325|FG001|Treatment Period|Adverse Event|26|||
155175700|NCT00770146|560080324|FG000|Treatment Period|Other|1|||
155175701|NCT00770146|560080325|FG001|Treatment Period|Other|5|||
155175702|NCT00770146|560080324|FG000|Treatment Period|Protocol non-compliance|0|||
155175703|NCT00770146|560080325|FG001|Treatment Period|Protocol non-compliance|1|||
155175704|NCT00770146|560080324|FG000|Follow-up Period|Withdrawal by Subject|7|||
155175705|NCT00770146|560080325|FG001|Follow-up Period|Withdrawal by Subject|13|||
155175706|NCT00770146|560080324|FG000|Follow-up Period|Adverse Event|0|||
155175707|NCT00770146|560080325|FG001|Follow-up Period|Adverse Event|2|||
155175708|NCT00770146|560080324|FG000|Follow-up Period|Other|4|||
155175709|NCT00770146|560080325|FG001|Follow-up Period|Other|5|||
155175710|NCT04620798|560080326|FG000|Overall Study|Lost to Follow-up|126|||
155175711|NCT04620798|560080327|FG001|Overall Study|Lost to Follow-up|138|||
155175712|NCT03222492|560080334|FG000|Overall Study|Withdrawal by Subject|0|||
155175713|NCT03222492|560080335|FG001|Overall Study|Withdrawal by Subject|0|||
155175714|NCT03222492|560080336|FG002|Overall Study|Withdrawal by Subject|1|||
155175715|NCT03222492|560080337|FG003|Overall Study|Withdrawal by Subject|0|||
155175716|NCT03222492|560080334|FG000|Overall Study|COVID-19 related|0|||
155175717|NCT03222492|560080335|FG001|Overall Study|COVID-19 related|0|||
155175718|NCT03222492|560080336|FG002|Overall Study|COVID-19 related|1|||
154899487|NCT00937326|559054867|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
154899488|NCT00937326|559054868|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
154899489|NCT00937326|559054869|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
154899490|NCT00937326|559054870|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
154899491|NCT00790218|559054873|FG000|Overall Study|Death|1|||
154899492|NCT00790218|559054874|FG001|Overall Study|Death|0|||
154899493|NCT00790218|559054875|FG002|Overall Study|Death|0|||
154899494|NCT00086385|559054876|FG000|Overall Study|Death|2|||
154899495|NCT00086385|559054877|FG001|Overall Study|Death|2|||
154899496|NCT00086385|559054878|FG002|Overall Study|Death|1|||
154899497|NCT00086385|559054879|FG003|Overall Study|Death|1|||
154899498|NCT00880100|559054884|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
154899499|NCT00880100|559054884|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
154899500|NCT00880100|559054884|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
154899501|NCT03424044|559054886|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899502|NCT03424044|559054887|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899503|NCT03424044|559054888|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
154899504|NCT03424044|559054889|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899505|NCT03424044|559054890|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899506|NCT03424044|559054891|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899507|NCT03424044|559054892|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899508|NCT03424044|559054893|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154899509|NCT03424044|559054894|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
154980918|NCT02010255|559354096|FG013|Overall Study|Randomized but Not Treated|1|||
155175719|NCT03222492|560080337|FG003|Overall Study|COVID-19 related|0|||
155175720|NCT00674154|560080338|FG000|Overall Study|Withdrawal by Subject|3|||
155175721|NCT00674154|560080339|FG001|Overall Study|Withdrawal by Subject|1|||
154980919|NCT00171340|559354099|FG000|Overall Study|Adverse Event|46|||
154980920|NCT00171340|559354100|FG001|Overall Study|Adverse Event|42|||
154980921|NCT00171340|559354099|FG000|Overall Study|Lack of Efficacy|29|||
154980922|NCT00171340|559354100|FG001|Overall Study|Lack of Efficacy|41|||
154899510|NCT03424044|559054886|FG000|First Intervention (76 Hours)|Adverse Event|0|||
154899511|NCT03424044|559054887|FG001|First Intervention (76 Hours)|Adverse Event|0|||
154899512|NCT03424044|559054888|FG002|First Intervention (76 Hours)|Adverse Event|0|||
155175722|NCT00674154|560080338|FG000|Overall Study|Did not want parathyroidectomy|0|||
154899513|NCT03424044|559054889|FG003|First Intervention (76 Hours)|Adverse Event|0|||
155114823|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
155114824|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
155114825|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
155114826|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
155114827|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
155114828|NCT03989349|559848275|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
155114829|NCT03989349|559848276|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
155114830|NCT03989349|559848277|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
155114831|NCT03989349|559848278|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
155114832|NCT03989349|559848279|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
155114833|NCT03989349|559848280|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
155114834|NCT02684058|559848283|FG000|Treatment Period|Progressive disease|4|||
155114835|NCT02684058|559848284|FG001|Treatment Period|Progressive disease|10|||
155114836|NCT02684058|559848285|FG002|Treatment Period|Progressive disease|19|||
155114837|NCT02684058|559848283|FG000|Treatment Period|Adverse Event|3|||
155114838|NCT02684058|559848284|FG001|Treatment Period|Adverse Event|8|||
155114839|NCT02684058|559848285|FG002|Treatment Period|Adverse Event|1|||
155114840|NCT02684058|559848283|FG000|Treatment Period|Physician Decision|5|||
154899514|NCT03424044|559054890|FG004|First Intervention (76 Hours)|Adverse Event|1|||
154899515|NCT03424044|559054891|FG005|First Intervention (76 Hours)|Adverse Event|0|||
154899516|NCT03424044|559054892|FG006|First Intervention (76 Hours)|Adverse Event|0|||
154899517|NCT03424044|559054893|FG007|First Intervention (76 Hours)|Adverse Event|0|||
154899518|NCT03424044|559054894|FG008|First Intervention (76 Hours)|Adverse Event|0|||
154899519|NCT03424044|559054886|FG000|First Intervention (76 Hours)|device issues|0|||
154899520|NCT03424044|559054887|FG001|First Intervention (76 Hours)|device issues|0|||
154899521|NCT03424044|559054888|FG002|First Intervention (76 Hours)|device issues|0|||
154899522|NCT03424044|559054889|FG003|First Intervention (76 Hours)|device issues|0|||
154899523|NCT03424044|559054890|FG004|First Intervention (76 Hours)|device issues|0|||
154899524|NCT03424044|559054891|FG005|First Intervention (76 Hours)|device issues|0|||
154899525|NCT03424044|559054892|FG006|First Intervention (76 Hours)|device issues|1|||
154899526|NCT03424044|559054893|FG007|First Intervention (76 Hours)|device issues|1|||
154899527|NCT03424044|559054894|FG008|First Intervention (76 Hours)|device issues|1|||
154899528|NCT03424044|559054886|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
154899529|NCT03424044|559054887|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
154899530|NCT03424044|559054888|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
154899531|NCT03424044|559054889|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
154899532|NCT03424044|559054890|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
154899533|NCT03424044|559054891|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
154899534|NCT03424044|559054892|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
154899535|NCT03424044|559054893|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
154899536|NCT03424044|559054894|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
154899537|NCT03424044|559054886|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899538|NCT03424044|559054887|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899539|NCT03424044|559054888|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899540|NCT03424044|559054889|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
154899541|NCT03424044|559054890|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899542|NCT03424044|559054891|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899543|NCT03424044|559054892|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899544|NCT03424044|559054893|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899545|NCT03424044|559054894|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
154899546|NCT04402385|559054898|FG000|Overall Study|Withdrawal by Subject|4|||
154899547|NCT04402385|559054899|FG001|Overall Study|Withdrawal by Subject|4|||
154899548|NCT04402385|559054898|FG000|Overall Study|Lost to Follow-up|1|||
154899549|NCT04402385|559054899|FG001|Overall Study|Lost to Follow-up|1|||
154899550|NCT04402385|559054898|FG000|Overall Study|Physician Decision|0|||
154899551|NCT04402385|559054899|FG001|Overall Study|Physician Decision|1|||
154899552|NCT00731666|559054900|FG000|Overall Study|Adverse Event|2|||
154899553|NCT00731666|559054900|FG000|Overall Study|Lost to Follow-up|8|||
154899554|NCT00731666|559054900|FG000|Overall Study|Withdrawal by Subject|2|||
155114841|NCT02684058|559848284|FG001|Treatment Period|Physician Decision|1|||
155114842|NCT02684058|559848285|FG002|Treatment Period|Physician Decision|2|||
154899555|NCT00693420|559054901|FG000|Overall Study|Adverse Event|4|||
154899556|NCT00693420|559054902|FG001|Overall Study|Adverse Event|4|||
154899557|NCT00693420|559054901|FG000|Overall Study|Lost to Follow-up|0|||
154899558|NCT00693420|559054902|FG001|Overall Study|Lost to Follow-up|3|||
154899559|NCT00693420|559054901|FG000|Overall Study|Withdrawal by Subject|1|||
154899560|NCT00693420|559054902|FG001|Overall Study|Withdrawal by Subject|0|||
154899561|NCT00693420|559054901|FG000|Overall Study|Protocol Violation|0|||
154899562|NCT00693420|559054902|FG001|Overall Study|Protocol Violation|2|||
154899563|NCT00693420|559054901|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
154899564|NCT00693420|559054902|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
154899565|NCT00693420|559054901|FG000|Overall Study|Personal Reasons|1|||
154899566|NCT00693420|559054902|FG001|Overall Study|Personal Reasons|4|||
154899567|NCT01473355|559054903|FG000|Overall Study|Protocol Violation|2|||
154899568|NCT01473355|559054903|FG000|Overall Study|Adverse Event|2|||
154899569|NCT01473355|559054903|FG000|Overall Study|Lost to Follow-up|2|||
154899570|NCT00509028|559054904|FG000|Overall Study|Adverse Event|2|||
154899571|NCT00509028|559054905|FG001|Overall Study|Adverse Event|0|||
154899572|NCT00509028|559054904|FG000|Overall Study|Withdrawal by Subject|4|||
154899573|NCT00509028|559054905|FG001|Overall Study|Withdrawal by Subject|3|||
154899574|NCT00509028|559054904|FG000|Overall Study|Lost to Follow-up|0|||
154899575|NCT00509028|559054905|FG001|Overall Study|Lost to Follow-up|1|||
154899576|NCT00509028|559054904|FG000|Overall Study|Protocol Violation|4|||
154899577|NCT00509028|559054905|FG001|Overall Study|Protocol Violation|2|||
154899578|NCT00509028|559054904|FG000|Overall Study|Non-compliance|2|||
154899579|NCT00509028|559054905|FG001|Overall Study|Non-compliance|1|||
154899580|NCT05516134|559054914|FG000|Overall Study|Lost to Follow-up|1|||
154899581|NCT05516134|559054915|FG001|Overall Study|Lost to Follow-up|0|||
154899582|NCT05516134|559054916|FG002|Overall Study|Lost to Follow-up|0|||
154899583|NCT01831804|559054929|FG000|Overall Study|Adverse Event|0|||
154899584|NCT01831804|559054930|FG001|Overall Study|Adverse Event|0|||
154899585|NCT01831804|559054931|FG002|Overall Study|Adverse Event|0|||
154899586|NCT01831804|559054932|FG003|Overall Study|Adverse Event|0|||
154899587|NCT01831804|559054933|FG004|Overall Study|Adverse Event|0|||
154899588|NCT01831804|559054934|FG005|Overall Study|Adverse Event|0|||
154899589|NCT01831804|559054935|FG006|Overall Study|Adverse Event|1|||
154899590|NCT01831804|559054936|FG007|Overall Study|Adverse Event|0|||
154899591|NCT01831804|559054937|FG008|Overall Study|Adverse Event|1|||
154899592|NCT01831804|559054929|FG000|Overall Study|Protocol Violation|0|||
154899593|NCT01831804|559054930|FG001|Overall Study|Protocol Violation|0|||
154899594|NCT01831804|559054931|FG002|Overall Study|Protocol Violation|2|||
154899595|NCT01831804|559054932|FG003|Overall Study|Protocol Violation|0|||
154899596|NCT01831804|559054933|FG004|Overall Study|Protocol Violation|0|||
154899597|NCT01831804|559054934|FG005|Overall Study|Protocol Violation|0|||
154899598|NCT01831804|559054935|FG006|Overall Study|Protocol Violation|0|||
154899599|NCT01831804|559054936|FG007|Overall Study|Protocol Violation|0|||
154899600|NCT01831804|559054937|FG008|Overall Study|Protocol Violation|0|||
154899601|NCT01831804|559054929|FG000|Overall Study|Protocol defined stopping criteria|1|||
154899602|NCT01831804|559054930|FG001|Overall Study|Protocol defined stopping criteria|1|||
154899603|NCT01831804|559054931|FG002|Overall Study|Protocol defined stopping criteria|3|||
154899604|NCT01831804|559054932|FG003|Overall Study|Protocol defined stopping criteria|0|||
154899605|NCT01831804|559054933|FG004|Overall Study|Protocol defined stopping criteria|1|||
154899606|NCT01831804|559054934|FG005|Overall Study|Protocol defined stopping criteria|0|||
154899607|NCT01831804|559054935|FG006|Overall Study|Protocol defined stopping criteria|0|||
154899608|NCT01831804|559054936|FG007|Overall Study|Protocol defined stopping criteria|0|||
154899609|NCT01831804|559054937|FG008|Overall Study|Protocol defined stopping criteria|0|||
154899610|NCT01831804|559054929|FG000|Overall Study|Lost to Follow-up|0|||
154899611|NCT01831804|559054930|FG001|Overall Study|Lost to Follow-up|0|||
154980923|NCT00171340|559354099|FG000|Overall Study|Protocol Violation|7|||
154980924|NCT00171340|559354100|FG001|Overall Study|Protocol Violation|8|||
154980925|NCT00171340|559354099|FG000|Overall Study|Withdrawal by Subject|22|||
154980926|NCT00171340|559354100|FG001|Overall Study|Withdrawal by Subject|19|||
154980927|NCT00171340|559354099|FG000|Overall Study|Lost to Follow-up|0|||
154980928|NCT00171340|559354100|FG001|Overall Study|Lost to Follow-up|5|||
155114843|NCT02684058|559848283|FG000|Treatment Period|New therapy for study indication|1|||
154899612|NCT01831804|559054931|FG002|Overall Study|Lost to Follow-up|1|||
154899613|NCT01831804|559054932|FG003|Overall Study|Lost to Follow-up|0|||
154899614|NCT01831804|559054933|FG004|Overall Study|Lost to Follow-up|0|||
154899615|NCT01831804|559054934|FG005|Overall Study|Lost to Follow-up|0|||
154899616|NCT01831804|559054935|FG006|Overall Study|Lost to Follow-up|0|||
154899617|NCT01831804|559054936|FG007|Overall Study|Lost to Follow-up|0|||
154899618|NCT01831804|559054937|FG008|Overall Study|Lost to Follow-up|1|||
154899619|NCT01831804|559054929|FG000|Overall Study|Investigator discretion|0|||
154899620|NCT01831804|559054930|FG001|Overall Study|Investigator discretion|0|||
154899621|NCT01831804|559054931|FG002|Overall Study|Investigator discretion|0|||
154899622|NCT01831804|559054932|FG003|Overall Study|Investigator discretion|0|||
154899623|NCT01831804|559054933|FG004|Overall Study|Investigator discretion|1|||
154899624|NCT01831804|559054934|FG005|Overall Study|Investigator discretion|0|||
154899625|NCT01831804|559054935|FG006|Overall Study|Investigator discretion|0|||
154899626|NCT01831804|559054936|FG007|Overall Study|Investigator discretion|1|||
154899627|NCT01831804|559054937|FG008|Overall Study|Investigator discretion|0|||
154899628|NCT01831804|559054929|FG000|Overall Study|Withdrew Consent|0|||
154899629|NCT01831804|559054930|FG001|Overall Study|Withdrew Consent|1|||
154899630|NCT01831804|559054931|FG002|Overall Study|Withdrew Consent|0|||
154899631|NCT01831804|559054932|FG003|Overall Study|Withdrew Consent|0|||
154899632|NCT01831804|559054933|FG004|Overall Study|Withdrew Consent|0|||
154899633|NCT01831804|559054934|FG005|Overall Study|Withdrew Consent|0|||
154899634|NCT01831804|559054935|FG006|Overall Study|Withdrew Consent|0|||
154899635|NCT01831804|559054936|FG007|Overall Study|Withdrew Consent|2|||
154899636|NCT01831804|559054937|FG008|Overall Study|Withdrew Consent|0|||
154899637|NCT01819506|559054938|FG000|Overall Study|Physician Decision|5|||
154899638|NCT01819506|559054939|FG001|Overall Study|Physician Decision|2|||
154899639|NCT01819506|559054938|FG000|Overall Study|Withdrawal by Subject|3|||
154899640|NCT01819506|559054939|FG001|Overall Study|Withdrawal by Subject|3|||
154899641|NCT04685538|559054944|FG000|Overall Study|Adverse Event|0|||
154899642|NCT04685538|559054945|FG001|Overall Study|Adverse Event|1|||
154899643|NCT04685538|559054944|FG000|Overall Study|Lost to Follow-up|0|||
154899644|NCT04685538|559054945|FG001|Overall Study|Lost to Follow-up|2|||
154899645|NCT00114218|559054955|FG000|Overall Study|Wrong Cell Type|2|||
154899646|NCT00114218|559054955|FG000|Overall Study|Wrong Primary|1|||
154899647|NCT00114218|559054955|FG000|Overall Study|Never Treated|1|||
154899648|NCT01505114|559054956|FG000|Overall Study|Withdrawal by Subject|5|||
154899649|NCT01505114|559054957|FG001|Overall Study|Withdrawal by Subject|4|||
154899650|NCT01505114|559054958|FG002|Overall Study|Withdrawal by Subject|4|||
154899651|NCT01505114|559054959|FG003|Overall Study|Withdrawal by Subject|7|||
154899652|NCT01505114|559054956|FG000|Overall Study|Death|1|||
154899653|NCT01505114|559054957|FG001|Overall Study|Death|0|||
154899654|NCT01505114|559054958|FG002|Overall Study|Death|0|||
154899655|NCT01505114|559054959|FG003|Overall Study|Death|1|||
154899656|NCT01505114|559054956|FG000|Overall Study|unable to adhere to visit schedule|3|||
154899657|NCT01505114|559054957|FG001|Overall Study|unable to adhere to visit schedule|2|||
154899658|NCT01505114|559054958|FG002|Overall Study|unable to adhere to visit schedule|3|||
154899659|NCT01505114|559054959|FG003|Overall Study|unable to adhere to visit schedule|3|||
154899660|NCT01505114|559054956|FG000|Overall Study|Lost to Follow-up|11|||
154899661|NCT01505114|559054957|FG001|Overall Study|Lost to Follow-up|5|||
154899662|NCT01505114|559054958|FG002|Overall Study|Lost to Follow-up|8|||
154899663|NCT01505114|559054959|FG003|Overall Study|Lost to Follow-up|7|||
154899664|NCT01505114|559054956|FG000|Overall Study|relocated|4|||
154899665|NCT01505114|559054957|FG001|Overall Study|relocated|2|||
154899666|NCT01505114|559054958|FG002|Overall Study|relocated|2|||
154899667|NCT01505114|559054959|FG003|Overall Study|relocated|3|||
154899668|NCT01505114|559054956|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
154899669|NCT01505114|559054957|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
154899670|NCT01505114|559054958|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
154899671|NCT01505114|559054959|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
154899672|NCT01505114|559054956|FG000|Overall Study|staff safety concerns|0|||
154899673|NCT01505114|559054957|FG001|Overall Study|staff safety concerns|0|||
154899674|NCT01505114|559054958|FG002|Overall Study|staff safety concerns|0|||
154899675|NCT01505114|559054959|FG003|Overall Study|staff safety concerns|1|||
154899676|NCT01505114|559054956|FG000|Overall Study|investigator decision|1|||
154899677|NCT01505114|559054957|FG001|Overall Study|investigator decision|0|||
154899678|NCT01505114|559054958|FG002|Overall Study|investigator decision|1|||
154899679|NCT01505114|559054959|FG003|Overall Study|investigator decision|0|||
154899680|NCT03168555|559054960|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
154899681|NCT03168555|559054960|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
154899682|NCT03168555|559054960|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
154899683|NCT03168555|559054960|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
154899684|NCT01235507|559054962|FG000|Overall Study|Adverse Event|1|||
154899685|NCT01235507|559054962|FG000|Overall Study|Withdrawal by Subject|1|||
154899686|NCT02017704|559054965|FG000|Overall Study|Withdrawal by Subject|2|||
154899687|NCT02017704|559054966|FG001|Overall Study|Withdrawal by Subject|0|||
154899688|NCT01587274|559054967|FG000|Overall Study|Lost to Follow-up|4|||
154899689|NCT01587274|559054968|FG001|Overall Study|Lost to Follow-up|5|||
154899690|NCT01587274|559054969|FG002|Overall Study|Lost to Follow-up|3|||
154899691|NCT01421069|559054970|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
154899692|NCT01421069|559054970|FG000|Parent Study|Failed to return|3|||
154899693|NCT01421069|559054970|FG000|Parent Study|Withdrawal by Subject|1|||
154899694|NCT01421069|559054970|FG000|Parent Study|Lost to Follow-up|2|||
154899695|NCT01421069|559054970|FG000|Parent Study|Lack of Efficacy|1|||
154899696|NCT01421069|559054970|FG000|Overall Period for Extension Study|Other|2|||
154899697|NCT01421069|559054970|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
154899698|NCT01421069|559054970|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
154899699|NCT01421069|559054970|FG000|Overall Period for Extension Study|Pregnancy|1|||
154899700|NCT01421069|559054970|FG000|Overall Period for Extension Study|Adverse Event|1|||
155150939|NCT00770653|559988132|FG001|Overall Study|Adverse Event|5|||
154899701|NCT01421069|559054970|FG000|Overall Period for Extension Study|Protocol Violation|1|||
154899702|NCT01421069|559054970|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
154899703|NCT01421069|559054970|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
154899704|NCT01421069|559054970|FG000|Active Treatment Period|Other|1|||
154899705|NCT01421069|559054970|FG000|Active Treatment Period|No longer willing to participate in study|8|||
154899706|NCT01421069|559054970|FG000|Active Treatment Period|Insufficient clinical response|1|||
154899707|NCT01421069|559054970|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
154899708|NCT01421069|559054970|FG000|Active Treatment Period|Pregnancy|1|||
154899709|NCT01421069|559054970|FG000|Active Treatment Period|Adverse Event|1|||
154899710|NCT01421069|559054970|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
154899711|NCT01421069|559054970|FG000|Active Treatment Period|Enrolled in observational period|29|||
154899712|NCT01421069|559054970|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
154899713|NCT01421069|559054970|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
154899714|NCT01421069|559054970|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
154899715|NCT01421069|559054970|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
154899716|NCT01421069|559054970|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
154899717|NCT01421069|559054970|FG000|2b. Retreatment Period|Protocol Violation|1|||
154899718|NCT01421069|559054970|FG000|Observational Period|Other|1|||
154899719|NCT01421069|559054970|FG000|Observational Period|No longer willing to participate in study|4|||
154899720|NCT01421069|559054970|FG000|Observational Period|Lost to Follow-up|3|||
154899721|NCT01641081|559054971|FG000|Period 1|Sponsor request (potential unblinding)|0|||
154899722|NCT01641081|559054972|FG001|Period 1|Sponsor request (potential unblinding)|0|||
154899723|NCT01641081|559054973|FG002|Period 1|Sponsor request (potential unblinding)|0|||
154899724|NCT01641081|559054974|FG003|Period 1|Sponsor request (potential unblinding)|0|||
154899725|NCT01641081|559054975|FG004|Period 1|Sponsor request (potential unblinding)|0|||
154899726|NCT01641081|559054976|FG005|Period 1|Sponsor request (potential unblinding)|0|||
154899727|NCT01641081|559054977|FG006|Period 1|Sponsor request (potential unblinding)|1|||
154899728|NCT01641081|559054978|FG007|Period 1|Sponsor request (potential unblinding)|0|||
154899729|NCT01641081|559054979|FG008|Period 1|Sponsor request (potential unblinding)|0|||
154899730|NCT01641081|559054980|FG009|Period 1|Sponsor request (potential unblinding)|0|||
154899731|NCT01641081|559054971|FG000|Period 1|Protocol Violation|0|||
154899732|NCT01641081|559054972|FG001|Period 1|Protocol Violation|0|||
154899733|NCT01641081|559054973|FG002|Period 1|Protocol Violation|0|||
154980929|NCT00171340|559354099|FG000|Overall Study|Abnormal Laboratory Results|2|||
154980930|NCT00171340|559354100|FG001|Overall Study|Abnormal Laboratory Results|0|||
154980931|NCT00171340|559354099|FG000|Overall Study|Abnormal Test Procedure Results|6|||
154980932|NCT00171340|559354100|FG001|Overall Study|Abnormal Test Procedure Results|11|||
155175723|NCT00674154|560080339|FG001|Overall Study|Did not want parathyroidectomy|2|||
154980933|NCT00171340|559354099|FG000|Overall Study|No Longer Required Study Drug|1|||
154980934|NCT00171340|559354100|FG001|Overall Study|No Longer Required Study Drug|1|||
154980935|NCT00171340|559354099|FG000|Overall Study|Administrative Problems|5|||
154980936|NCT00171340|559354100|FG001|Overall Study|Administrative Problems|2|||
154980937|NCT00171340|559354099|FG000|Overall Study|Death|6|||
154980938|NCT00171340|559354100|FG001|Overall Study|Death|6|||
154980939|NCT00396331|559354106|FG000|Overall Study|Failed to mobilize - no transplant|8|||
154980940|NCT00396331|559354106|FG000|Overall Study|Did not go on to transplant|5|||
154980941|NCT00396331|559354106|FG000|Overall Study|Lost to Follow-up|3|||
154980942|NCT00396331|559354106|FG000|Overall Study|Death|16|||
154980943|NCT00680186|559354107|FG000|Overall Study|Adverse Event|47|||
154980944|NCT00680186|559354108|FG001|Overall Study|Adverse Event|44|||
154980945|NCT00680186|559354107|FG000|Overall Study|Protocol Violation|31|||
154980946|NCT00680186|559354108|FG001|Overall Study|Protocol Violation|26|||
154980947|NCT00680186|559354107|FG000|Overall Study|Lost to Follow-up|11|||
154980948|NCT00680186|559354108|FG001|Overall Study|Lost to Follow-up|6|||
154980949|NCT00680186|559354107|FG000|Overall Study|Withdrawal by Subject|32|||
154980950|NCT00680186|559354108|FG001|Overall Study|Withdrawal by Subject|39|||
154980951|NCT00680186|559354107|FG000|Overall Study|Other|4|||
154980952|NCT00680186|559354108|FG001|Overall Study|Other|1|||
154980953|NCT01351350|559354109|FG000|Overall Study|Disease Progression|5|||
154980954|NCT01351350|559354110|FG001|Overall Study|Disease Progression|13|||
154980955|NCT01351350|559354111|FG002|Overall Study|Disease Progression|6|||
154980956|NCT01351350|559354112|FG003|Overall Study|Disease Progression|8|||
154980957|NCT01351350|559354113|FG004|Overall Study|Disease Progression|5|||
154980958|NCT01351350|559354109|FG000|Overall Study|Adverse Event|1|||
154980959|NCT01351350|559354110|FG001|Overall Study|Adverse Event|10|||
154980960|NCT01351350|559354111|FG002|Overall Study|Adverse Event|1|||
154980961|NCT01351350|559354112|FG003|Overall Study|Adverse Event|2|||
154980962|NCT01351350|559354113|FG004|Overall Study|Adverse Event|0|||
154980963|NCT01351350|559354109|FG000|Overall Study|Participant Decision|2|||
154980964|NCT01351350|559354110|FG001|Overall Study|Participant Decision|6|||
154980965|NCT01351350|559354111|FG002|Overall Study|Participant Decision|3|||
154980966|NCT01351350|559354112|FG003|Overall Study|Participant Decision|3|||
154980967|NCT01351350|559354113|FG004|Overall Study|Participant Decision|2|||
154980968|NCT01351350|559354109|FG000|Overall Study|Enrolled but not Treated|0|||
154980969|NCT01351350|559354110|FG001|Overall Study|Enrolled but not Treated|0|||
154980970|NCT01351350|559354111|FG002|Overall Study|Enrolled but not Treated|1|||
154980971|NCT01351350|559354112|FG003|Overall Study|Enrolled but not Treated|0|||
154980972|NCT01351350|559354113|FG004|Overall Study|Enrolled but not Treated|0|||
154899734|NCT01641081|559054974|FG003|Period 1|Protocol Violation|0|||
154899735|NCT01641081|559054975|FG004|Period 1|Protocol Violation|1|||
154899736|NCT01641081|559054976|FG005|Period 1|Protocol Violation|0|||
154980973|NCT04647383|559354114|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
154980974|NCT04647383|559354115|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
155114844|NCT02684058|559848284|FG001|Treatment Period|New therapy for study indication|0|||
155114845|NCT02684058|559848285|FG002|Treatment Period|New therapy for study indication|0|||
155114846|NCT02684058|559848283|FG000|Treatment Period|Protocol deviation|0|||
155114847|NCT02684058|559848284|FG001|Treatment Period|Protocol deviation|1|||
155114848|NCT02684058|559848285|FG002|Treatment Period|Protocol deviation|0|||
155114849|NCT02684058|559848283|FG000|Treatment Period|Subject/guardian decision|4|||
155114850|NCT02684058|559848284|FG001|Treatment Period|Subject/guardian decision|3|||
155175724|NCT00816023|560080340|FG000|Overall Study|Lost to Follow-up|1|||
155175725|NCT00816023|560080341|FG001|Overall Study|Lost to Follow-up|1|||
154899737|NCT01641081|559054977|FG006|Period 1|Protocol Violation|0|||
154899738|NCT01641081|559054978|FG007|Period 1|Protocol Violation|1|||
154899739|NCT01641081|559054979|FG008|Period 1|Protocol Violation|0|||
154899740|NCT01641081|559054980|FG009|Period 1|Protocol Violation|0|||
154899741|NCT01641081|559054971|FG000|Period 1|Adverse Event|1|||
154899742|NCT01641081|559054972|FG001|Period 1|Adverse Event|0|||
154899743|NCT01641081|559054973|FG002|Period 1|Adverse Event|0|||
154899744|NCT01641081|559054974|FG003|Period 1|Adverse Event|0|||
154899745|NCT01641081|559054975|FG004|Period 1|Adverse Event|0|||
154899746|NCT01641081|559054976|FG005|Period 1|Adverse Event|0|||
154899747|NCT01641081|559054977|FG006|Period 1|Adverse Event|0|||
154899748|NCT01641081|559054978|FG007|Period 1|Adverse Event|2|||
154899749|NCT01641081|559054979|FG008|Period 1|Adverse Event|0|||
154899750|NCT01641081|559054980|FG009|Period 1|Adverse Event|0|||
154899751|NCT01641081|559054971|FG000|Period 2|Adverse Event|0|||
154899752|NCT01641081|559054972|FG001|Period 2|Adverse Event|0|||
154899753|NCT01641081|559054973|FG002|Period 2|Adverse Event|0|||
154899754|NCT01641081|559054974|FG003|Period 2|Adverse Event|0|||
154899755|NCT01641081|559054975|FG004|Period 2|Adverse Event|0|||
154899756|NCT01641081|559054976|FG005|Period 2|Adverse Event|1|||
154899757|NCT01641081|559054977|FG006|Period 2|Adverse Event|0|||
154899758|NCT01641081|559054978|FG007|Period 2|Adverse Event|0|||
154899759|NCT01641081|559054979|FG008|Period 2|Adverse Event|0|||
154899760|NCT01641081|559054980|FG009|Period 2|Adverse Event|0|||
154899761|NCT01641081|559054971|FG000|Period 2|Withdrawal by Subject|0|||
154899762|NCT01641081|559054972|FG001|Period 2|Withdrawal by Subject|0|||
154899763|NCT01641081|559054973|FG002|Period 2|Withdrawal by Subject|0|||
154899764|NCT01641081|559054974|FG003|Period 2|Withdrawal by Subject|1|||
154899765|NCT01641081|559054975|FG004|Period 2|Withdrawal by Subject|0|||
154899766|NCT01641081|559054976|FG005|Period 2|Withdrawal by Subject|0|||
154899767|NCT01641081|559054977|FG006|Period 2|Withdrawal by Subject|2|||
154899768|NCT01641081|559054978|FG007|Period 2|Withdrawal by Subject|0|||
154899769|NCT01641081|559054979|FG008|Period 2|Withdrawal by Subject|0|||
154899770|NCT01641081|559054980|FG009|Period 2|Withdrawal by Subject|0|||
154899771|NCT01641081|559054971|FG000|Period 2|Protocol Violation|1|||
154899772|NCT01641081|559054972|FG001|Period 2|Protocol Violation|0|||
154899773|NCT01641081|559054973|FG002|Period 2|Protocol Violation|0|||
154899774|NCT01641081|559054974|FG003|Period 2|Protocol Violation|0|||
154899775|NCT01641081|559054975|FG004|Period 2|Protocol Violation|0|||
154899776|NCT01641081|559054976|FG005|Period 2|Protocol Violation|0|||
154899777|NCT01641081|559054977|FG006|Period 2|Protocol Violation|0|||
154899778|NCT01641081|559054978|FG007|Period 2|Protocol Violation|0|||
154899779|NCT01641081|559054979|FG008|Period 2|Protocol Violation|0|||
154899780|NCT01641081|559054980|FG009|Period 2|Protocol Violation|0|||
154899781|NCT01641081|559054971|FG000|Period 3|Adverse Event|0|||
154899782|NCT01641081|559054972|FG001|Period 3|Adverse Event|0|||
154899783|NCT01641081|559054973|FG002|Period 3|Adverse Event|1|||
154899784|NCT01641081|559054974|FG003|Period 3|Adverse Event|0|||
154899785|NCT01641081|559054975|FG004|Period 3|Adverse Event|0|||
154899786|NCT01641081|559054976|FG005|Period 3|Adverse Event|0|||
154899787|NCT01641081|559054977|FG006|Period 3|Adverse Event|0|||
154899788|NCT01641081|559054978|FG007|Period 3|Adverse Event|0|||
155114851|NCT02684058|559848285|FG002|Treatment Period|Subject/guardian decision|0|||
155175726|NCT00816023|560080342|FG002|Overall Study|Lost to Follow-up|0|||
155175727|NCT00816023|560080343|FG003|Overall Study|Lost to Follow-up|0|||
155175728|NCT00816023|560080340|FG000|Overall Study|Withdrawal by Subject|1|||
155175729|NCT00816023|560080341|FG001|Overall Study|Withdrawal by Subject|0|||
155175730|NCT00816023|560080342|FG002|Overall Study|Withdrawal by Subject|0|||
155175731|NCT00816023|560080343|FG003|Overall Study|Withdrawal by Subject|0|||
154899789|NCT01641081|559054979|FG008|Period 3|Adverse Event|0|||
154899790|NCT01641081|559054980|FG009|Period 3|Adverse Event|0|||
154899791|NCT01641081|559054971|FG000|Period 3|Withdrawal by Subject|0|||
154899792|NCT01641081|559054972|FG001|Period 3|Withdrawal by Subject|0|||
154899793|NCT01641081|559054973|FG002|Period 3|Withdrawal by Subject|0|||
155114852|NCT02684058|559848283|FG000|Treatment Period|Death|0|||
154899794|NCT01641081|559054974|FG003|Period 3|Withdrawal by Subject|0|||
154899795|NCT01641081|559054975|FG004|Period 3|Withdrawal by Subject|0|||
154899796|NCT01641081|559054976|FG005|Period 3|Withdrawal by Subject|0|||
154899797|NCT01641081|559054977|FG006|Period 3|Withdrawal by Subject|0|||
154899798|NCT01641081|559054978|FG007|Period 3|Withdrawal by Subject|0|||
154899799|NCT01641081|559054979|FG008|Period 3|Withdrawal by Subject|1|||
154899800|NCT01641081|559054980|FG009|Period 3|Withdrawal by Subject|0|||
154899801|NCT01641081|559054971|FG000|Period 4|Adverse Event|0|||
154980975|NCT04647383|559354116|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
154980976|NCT04647383|559354117|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
154980977|NCT02470091|559354132|FG000|Overall Study|Withdrawal by Subject|1|||
154980978|NCT02470091|559354133|FG001|Overall Study|Withdrawal by Subject|0|||
154980979|NCT02470091|559354132|FG000|Overall Study|Ineligible|0|||
154980980|NCT02470091|559354133|FG001|Overall Study|Ineligible|2|||
154980981|NCT01298778|559354136|FG000|Overall Study|Lost to Follow-up|2|||
154980982|NCT01298778|559354137|FG001|Overall Study|Lost to Follow-up|3|||
154980983|NCT01298778|559354136|FG000|Overall Study|Incorrect use of VAS|1|||
154980984|NCT01298778|559354137|FG001|Overall Study|Incorrect use of VAS|0|||
154980985|NCT01298778|559354136|FG000|Overall Study|Withdrawal by Subject|0|||
154980986|NCT01298778|559354137|FG001|Overall Study|Withdrawal by Subject|1|||
154980987|NCT01298778|559354136|FG000|Overall Study|Protocol Violation|0|||
154980988|NCT01298778|559354137|FG001|Overall Study|Protocol Violation|1|||
154980989|NCT01298778|559354136|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
154980990|NCT01298778|559354137|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
154980991|NCT00536484|559354141|FG000|Overall Study|Adverse Event|21|||
154980992|NCT00536484|559354142|FG001|Overall Study|Adverse Event|34|||
154980993|NCT00536484|559354141|FG000|Overall Study|Withdrawal by Subject|11|||
154980994|NCT00536484|559354142|FG001|Overall Study|Withdrawal by Subject|11|||
154980995|NCT00536484|559354141|FG000|Overall Study|Lost to Follow-up|8|||
154980996|NCT00536484|559354142|FG001|Overall Study|Lost to Follow-up|6|||
154980997|NCT00536484|559354141|FG000|Overall Study|Lack of Efficacy|16|||
154980998|NCT00536484|559354142|FG001|Overall Study|Lack of Efficacy|5|||
154980999|NCT00536484|559354141|FG000|Overall Study|Other|4|||
154981000|NCT00536484|559354142|FG001|Overall Study|Other|0|||
154981001|NCT02549573|559354145|FG000|Overall Study|Withdrawal by Subject|0|||
154981002|NCT02549573|559354146|FG001|Overall Study|Withdrawal by Subject|2|||
154981003|NCT02549573|559354145|FG000|Overall Study|Protocol Violation|0|||
154981004|NCT02549573|559354146|FG001|Overall Study|Protocol Violation|1|||
154981005|NCT02083926|559354147|FG000|Overall Study|Withdrawal by Subject|1|||
154981006|NCT02083926|559354148|FG001|Overall Study|Withdrawal by Subject|0|||
154981007|NCT02939950|559354151|FG000|Overall Study|Lost to Follow-up|13|||
154981008|NCT02939950|559354152|FG001|Overall Study|Lost to Follow-up|16|||
154981009|NCT02939950|559354151|FG000|Overall Study|Positive slit lamp findings|0|||
154981010|NCT02939950|559354152|FG001|Overall Study|Positive slit lamp findings|1|||
154981011|NCT02939950|559354151|FG000|Overall Study|Chalazion upper lid|0|||
154981012|NCT02939950|559354152|FG001|Overall Study|Chalazion upper lid|1|||
154981013|NCT02939950|559354151|FG000|Overall Study|Lack of motivation|0|||
154981014|NCT02939950|559354152|FG001|Overall Study|Lack of motivation|2|||
154981015|NCT02939950|559354151|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
154981016|NCT02939950|559354152|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
154981017|NCT02939950|559354151|FG000|Overall Study|Military orders|1|||
154981018|NCT02939950|559354152|FG001|Overall Study|Military orders|0|||
154981019|NCT02939950|559354151|FG000|Overall Study|Participant Relocated|5|||
154981020|NCT02939950|559354152|FG001|Overall Study|Participant Relocated|3|||
154981021|NCT02939950|559354151|FG000|Overall Study|Study related symptoms|8|||
154981022|NCT02939950|559354152|FG001|Overall Study|Study related symptoms|8|||
154981023|NCT02939950|559354151|FG000|Overall Study|Unacceptable lens movement|2|||
154981024|NCT02939950|559354152|FG001|Overall Study|Unacceptable lens movement|0|||
154981025|NCT02939950|559354151|FG000|Overall Study|Protocol Violation|6|||
154981026|NCT02939950|559354152|FG001|Overall Study|Protocol Violation|3|||
154981027|NCT02939950|559354151|FG000|Overall Study|Physician Decision|2|||
154981028|NCT02939950|559354152|FG001|Overall Study|Physician Decision|0|||
154981029|NCT02939950|559354151|FG000|Overall Study|Pregnancy|6|||
154981030|NCT02939950|559354152|FG001|Overall Study|Pregnancy|7|||
154981031|NCT02939950|559354151|FG000|Overall Study|Withdrawal by Subject|12|||
154981032|NCT02939950|559354152|FG001|Overall Study|Withdrawal by Subject|28|||
154981033|NCT02939950|559354151|FG000|Overall Study|Adverse Event|7|||
154981034|NCT02939950|559354152|FG001|Overall Study|Adverse Event|3|||
154981035|NCT02939950|559354151|FG000|Overall Study|Randomized, not dispensed|1|||
154981036|NCT02939950|559354152|FG001|Overall Study|Randomized, not dispensed|0|||
154981037|NCT02939950|559354151|FG000|Overall Study|Ineligible at Baseline|2|||
154981038|NCT02939950|559354152|FG001|Overall Study|Ineligible at Baseline|8|||
154981039|NCT01937351|559355015|FG000|Overall Study|Withdrawal by Subject|4|||
154981040|NCT01937351|559355016|FG001|Overall Study|Withdrawal by Subject|2|||
154981041|NCT01937351|559355015|FG000|Overall Study|Death|1|||
154981042|NCT01937351|559355016|FG001|Overall Study|Death|0|||
154981043|NCT01937351|559355015|FG000|Overall Study|Not treated w device, per protocol fail|4|||
154981044|NCT01937351|559355016|FG001|Overall Study|Not treated w device, per protocol fail|0|||
154981045|NCT00655850|559355018|FG000|Overall Study|Death|2|||
154981046|NCT00655850|559355018|FG000|Overall Study|Withdrawal by Subject|1|||
154981047|NCT02459665|559355019|FG000|Overall Study|Withdrawal by Subject|0|||
155175732|NCT00816023|560080340|FG000|Overall Study|Physician Decision|0|||
154981048|NCT02459665|559355020|FG001|Overall Study|Withdrawal by Subject|1|||
154981049|NCT02459665|559355021|FG002|Overall Study|Withdrawal by Subject|1|||
154981050|NCT02459665|559355022|FG003|Overall Study|Withdrawal by Subject|2|||
154981051|NCT00865098|559355023|FG000|Overall Study|Progressive disease|1|||
154899802|NCT01641081|559054972|FG001|Period 4|Adverse Event|1|||
154899803|NCT01641081|559054973|FG002|Period 4|Adverse Event|0|||
154899804|NCT01641081|559054974|FG003|Period 4|Adverse Event|1|||
154899805|NCT01641081|559054975|FG004|Period 4|Adverse Event|0|||
154899806|NCT01641081|559054976|FG005|Period 4|Adverse Event|0|||
154899807|NCT01641081|559054977|FG006|Period 4|Adverse Event|0|||
154899808|NCT01641081|559054978|FG007|Period 4|Adverse Event|0|||
154899809|NCT01641081|559054979|FG008|Period 4|Adverse Event|0|||
154899810|NCT01641081|559054980|FG009|Period 4|Adverse Event|0|||
154899811|NCT01641081|559054971|FG000|Period 5|Adverse Event|0|||
154899812|NCT01641081|559054972|FG001|Period 5|Adverse Event|0|||
154899813|NCT01641081|559054973|FG002|Period 5|Adverse Event|2|||
154899814|NCT01641081|559054974|FG003|Period 5|Adverse Event|0|||
154899815|NCT01641081|559054975|FG004|Period 5|Adverse Event|0|||
154899816|NCT01641081|559054976|FG005|Period 5|Adverse Event|0|||
154899817|NCT01641081|559054977|FG006|Period 5|Adverse Event|0|||
154899818|NCT01641081|559054978|FG007|Period 5|Adverse Event|0|||
154899819|NCT01641081|559054979|FG008|Period 5|Adverse Event|0|||
154899820|NCT01641081|559054980|FG009|Period 5|Adverse Event|0|||
154899821|NCT01095666|559054984|FG000|Overall Study|Lack of Efficacy|0|||
154899822|NCT01095666|559054985|FG001|Overall Study|Lack of Efficacy|0|||
154899823|NCT01095666|559054986|FG002|Overall Study|Lack of Efficacy|1|||
154899824|NCT01095666|559054984|FG000|Overall Study|Adverse Event|2|||
154899825|NCT01095666|559054985|FG001|Overall Study|Adverse Event|1|||
154899826|NCT01095666|559054986|FG002|Overall Study|Adverse Event|3|||
154899827|NCT01095666|559054984|FG000|Overall Study|Lost to Follow-up|2|||
154899828|NCT01095666|559054985|FG001|Overall Study|Lost to Follow-up|2|||
154899829|NCT01095666|559054986|FG002|Overall Study|Lost to Follow-up|0|||
154899830|NCT01095666|559054984|FG000|Overall Study|Withdrawal by Subject|6|||
154899831|NCT01095666|559054985|FG001|Overall Study|Withdrawal by Subject|6|||
154899832|NCT01095666|559054986|FG002|Overall Study|Withdrawal by Subject|1|||
154899833|NCT01095666|559054984|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
154899834|NCT01095666|559054985|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
154899835|NCT01095666|559054986|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
154899836|NCT01250756|559054989|FG000|Infant Series|Withdrawal by Subject|4|||
154899837|NCT01250756|559054990|FG001|Infant Series|Withdrawal by Subject|5|||
154899838|NCT01250756|559054989|FG000|Infant Series|Randomized, Not Vaccinated|2|||
154899839|NCT01250756|559054990|FG001|Infant Series|Randomized, Not Vaccinated|2|||
154899840|NCT01250756|559054989|FG000|Infant Series|Other|22|||
154899841|NCT01250756|559054990|FG001|Infant Series|Other|0|||
154899842|NCT01250756|559054989|FG000|After Infant Series|Adverse Event|5|||
154899843|NCT01250756|559054990|FG001|After Infant Series|Adverse Event|2|||
154899844|NCT01250756|559054989|FG000|After Infant Series|Withdrawal by Subject|4|||
154899845|NCT01250756|559054990|FG001|After Infant Series|Withdrawal by Subject|1|||
154899846|NCT01250756|559054989|FG000|After Infant Series|Other|2|||
154899847|NCT01250756|559054990|FG001|After Infant Series|Other|1|||
154899848|NCT01250756|559054989|FG000|Toddler Dose|Adverse Event|0|||
154899849|NCT01250756|559054990|FG001|Toddler Dose|Adverse Event|1|||
154899850|NCT01250756|559054989|FG000|After Toddler Dose|Adverse Event|0|||
154899851|NCT01250756|559054990|FG001|After Toddler Dose|Adverse Event|1|||
154899852|NCT02925312|559054993|FG000|Overall Study|Lost to Follow-up|25|||
154899853|NCT02925312|559054994|FG001|Overall Study|Lost to Follow-up|0|||
154899854|NCT02925312|559054993|FG000|Overall Study|Adverse Event|2|||
154899855|NCT02925312|559054994|FG001|Overall Study|Adverse Event|0|||
154899856|NCT01225172|559054998|FG000|Overall Study|Subject decision to stop|1|||
154899857|NCT01225172|559054999|FG001|Overall Study|Subject decision to stop|0|||
154899858|NCT01225172|559054998|FG000|Overall Study|Subject request to discontinue treatment|3|||
154899859|NCT01225172|559054999|FG001|Overall Study|Subject request to discontinue treatment|1|||
154899860|NCT01225172|559054998|FG000|Overall Study|Subject no longer meets study criteria|1|||
154899861|NCT01225172|559054999|FG001|Overall Study|Subject no longer meets study criteria|0|||
154899862|NCT01225172|559054998|FG000|Overall Study|Withdrawal by Subject|1|||
154899863|NCT01225172|559054999|FG001|Overall Study|Withdrawal by Subject|0|||
154899864|NCT01822223|559055002|FG000|Overall Study|Death|0|||
154899865|NCT01822223|559055003|FG001|Overall Study|Death|1|||
154899866|NCT05041062|559055010|FG000|Overall Study|Adverse Event|2|||
154899867|NCT04018612|559055011|FG000|Overall Study|Withdrawal by Subject|1|||
154899868|NCT04018612|559055012|FG001|Overall Study|Withdrawal by Subject|0|||
154899869|NCT04018612|559055013|FG002|Overall Study|Withdrawal by Subject|1|||
154899870|NCT00361218|559055016|FG000|Overall Study|Lost to Follow-up|11|||
154899871|NCT00361218|559055016|FG000|Overall Study|Personal Reasons|7|||
155175733|NCT00816023|560080341|FG001|Overall Study|Physician Decision|0|||
154899872|NCT00361218|559055016|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
154899873|NCT03693404|559055017|FG000|Overall Study|Withdrawal by Subject|1|||
154899874|NCT03693404|559055018|FG001|Overall Study|Withdrawal by Subject|0|||
154899875|NCT03693404|559055017|FG000|Overall Study|Lost to Follow-up|0|||
154899876|NCT03693404|559055018|FG001|Overall Study|Lost to Follow-up|5|||
154899877|NCT03693404|559055017|FG000|Overall Study|Excluded from Analysis|0|||
154899878|NCT03693404|559055018|FG001|Overall Study|Excluded from Analysis|1|||
154899879|NCT01176240|559055019|FG000|Study 306A|Lack of Efficacy|2|||
154899880|NCT01176240|559055020|FG001|Study 306A|Lack of Efficacy|1|||
154899881|NCT01176240|559055019|FG000|Study 306A|Protocol Violation|0|||
154899882|NCT01176240|559055020|FG001|Study 306A|Protocol Violation|1|||
154899883|NCT01176240|559055019|FG000|Study 306A|Withdrawal by Subject|0|||
154899884|NCT01176240|559055020|FG001|Study 306A|Withdrawal by Subject|1|||
154899885|NCT01176240|559055019|FG000|Study 306A|Stop due to diverse problems|1|||
154899886|NCT01176240|559055020|FG001|Study 306A|Stop due to diverse problems|0|||
154899887|NCT01176240|559055019|FG000|Study 306B|Lack of Efficacy|5|||
154899888|NCT01176240|559055020|FG001|Study 306B|Lack of Efficacy|3|||
154899889|NCT01176240|559055019|FG000|Study 306B|Adverse Event|10|||
154899890|NCT01176240|559055020|FG001|Study 306B|Adverse Event|5|||
154899891|NCT01176240|559055019|FG000|Study 306B|Protocol Violation|2|||
154899892|NCT01176240|559055020|FG001|Study 306B|Protocol Violation|3|||
154899893|NCT01176240|559055019|FG000|Study 306B|Withdrawal by Subject|4|||
154899894|NCT01176240|559055020|FG001|Study 306B|Withdrawal by Subject|1|||
154899895|NCT01176240|559055019|FG000|Study 306B|Physician Decision|2|||
154899896|NCT01176240|559055020|FG001|Study 306B|Physician Decision|1|||
154899897|NCT01176240|559055019|FG000|Study 306B|Supine Hypertension|1|||
154899898|NCT01176240|559055020|FG001|Study 306B|Supine Hypertension|2|||
154899899|NCT01176240|559055019|FG000|Study 306B|Lost to Follow-up|0|||
154899900|NCT01176240|559055020|FG001|Study 306B|Lost to Follow-up|1|||
154899901|NCT01176240|559055019|FG000|Study 306B|withdrew prior to dosing|2|||
154899902|NCT01176240|559055020|FG001|Study 306B|withdrew prior to dosing|1|||
154899903|NCT05200455|559055021|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
154899904|NCT00807014|559055022|FG000|Overall Study|Participant Considered Disease Cured|13|||
154899905|NCT00807014|559055023|FG001|Overall Study|Participant Considered Disease Cured|2|||
154899906|NCT00807014|559055022|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
154899907|NCT00807014|559055023|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
154899908|NCT00807014|559055022|FG000|Overall Study|Protocol Violation|2|||
154899909|NCT00807014|559055023|FG001|Overall Study|Protocol Violation|8|||
154899910|NCT00807014|559055022|FG000|Overall Study|Adverse Event|0|||
154899911|NCT00807014|559055023|FG001|Overall Study|Adverse Event|2|||
154899912|NCT00807014|559055022|FG000|Overall Study|Lost to Follow-up|9|||
154899913|NCT00807014|559055023|FG001|Overall Study|Lost to Follow-up|7|||
154899914|NCT00807014|559055022|FG000|Overall Study|Recovery|1|||
154899915|NCT00807014|559055023|FG001|Overall Study|Recovery|0|||
154899916|NCT00807014|559055022|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
154899917|NCT00807014|559055023|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
154899918|NCT00892957|559055024|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
154899919|NCT00892957|559055025|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
154899920|NCT00892957|559055024|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
154899921|NCT00892957|559055025|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
154899922|NCT03307629|559055026|FG000|Overall Study|Withdrawal by Subject|0|||
154899923|NCT03307629|559055027|FG001|Overall Study|Withdrawal by Subject|0|||
154899924|NCT03307629|559055028|FG002|Overall Study|Withdrawal by Subject|0|||
154899925|NCT03307629|559055029|FG003|Overall Study|Withdrawal by Subject|2|||
154899926|NCT03307629|559055026|FG000|Overall Study|Disease Progression|0|||
154899927|NCT03307629|559055027|FG001|Overall Study|Disease Progression|0|||
154899928|NCT03307629|559055028|FG002|Overall Study|Disease Progression|0|||
154899929|NCT03307629|559055029|FG003|Overall Study|Disease Progression|3|||
154899930|NCT03307629|559055026|FG000|Overall Study|Death|0|||
154899931|NCT03307629|559055027|FG001|Overall Study|Death|3|||
154899932|NCT03307629|559055028|FG002|Overall Study|Death|0|||
154899933|NCT03307629|559055029|FG003|Overall Study|Death|1|||
154899934|NCT04876599|559055030|FG000|Overall Study|Missed|2|||
154899935|NCT04876599|559055031|FG001|Overall Study|Missed|0|||
154899936|NCT04876599|559055030|FG000|Overall Study|Declined|2|||
154899937|NCT04876599|559055031|FG001|Overall Study|Declined|3|||
154899938|NCT00669032|559055034|FG000|Overall Study|Lost to Follow-up|6|||
154899939|NCT00669032|559055035|FG001|Overall Study|Lost to Follow-up|5|||
154899940|NCT00669032|559055034|FG000|Overall Study|Lack of Efficacy|8|||
154899941|NCT00669032|559055035|FG001|Overall Study|Lack of Efficacy|19|||
154899942|NCT00669032|559055034|FG000|Overall Study|Withdrawal by Subject|12|||
154899943|NCT00669032|559055035|FG001|Overall Study|Withdrawal by Subject|13|||
154899944|NCT00669032|559055034|FG000|Overall Study|Adverse Event|12|||
155114853|NCT02684058|559848284|FG001|Treatment Period|Death|0|||
154899945|NCT00669032|559055035|FG001|Overall Study|Adverse Event|16|||
154899946|NCT00669032|559055034|FG000|Overall Study|Physician Decision|1|||
154899947|NCT00669032|559055035|FG001|Overall Study|Physician Decision|1|||
154899948|NCT00669032|559055034|FG000|Overall Study|No fulfilment of the selection criteria|5|||
154899949|NCT00669032|559055035|FG001|Overall Study|No fulfilment of the selection criteria|5|||
154899950|NCT00642018|559055038|FG000|Overall Study|Adverse Event|11|||
154899951|NCT00642018|559055039|FG001|Overall Study|Adverse Event|36|||
155114854|NCT02684058|559848285|FG002|Treatment Period|Death|2|||
154899952|NCT00642018|559055038|FG000|Overall Study|Withdrawal by Subject|4|||
154899953|NCT00642018|559055039|FG001|Overall Study|Withdrawal by Subject|10|||
154899954|NCT00642018|559055038|FG000|Overall Study|Progressive Disease|13|||
154899955|NCT00642018|559055039|FG001|Overall Study|Progressive Disease|18|||
154899956|NCT00642018|559055038|FG000|Overall Study|Physician Decision|0|||
154899957|NCT00642018|559055039|FG001|Overall Study|Physician Decision|10|||
154899958|NCT00642018|559055038|FG000|Overall Study|Protocol Violation|0|||
154899959|NCT00642018|559055039|FG001|Overall Study|Protocol Violation|1|||
154899960|NCT00642018|559055038|FG000|Overall Study|Death|0|||
154899961|NCT00642018|559055039|FG001|Overall Study|Death|3|||
154899962|NCT00642018|559055038|FG000|Overall Study|Entry Criteria Not Met|0|||
154899963|NCT00642018|559055039|FG001|Overall Study|Entry Criteria Not Met|1|||
154899964|NCT01607073|559055040|FG000|Overall Study|Adverse Event|1|||
154899965|NCT04126031|559055042|FG000|Part A|Withdrawal by Subject|0|||
154899966|NCT04126031|559055043|FG001|Part A|Withdrawal by Subject|0|||
154899967|NCT04126031|559055044|FG002|Part A|Withdrawal by Subject|1|||
154899968|NCT04126031|559055045|FG003|Part A|Withdrawal by Subject|0|||
154899969|NCT04126031|559055046|FG004|Part A|Withdrawal by Subject|0|||
154899970|NCT04126031|559055047|FG005|Part A|Withdrawal by Subject|0|||
154899971|NCT04126031|559055042|FG000|Part A|Other|1|||
154899972|NCT04126031|559055043|FG001|Part A|Other|0|||
154899973|NCT04126031|559055044|FG002|Part A|Other|0|||
154899974|NCT04126031|559055045|FG003|Part A|Other|0|||
154899975|NCT04126031|559055046|FG004|Part A|Other|0|||
154899976|NCT04126031|559055047|FG005|Part A|Other|0|||
154899977|NCT04126031|559055042|FG000|Part B|Adverse Event|0|||
154899978|NCT04126031|559055043|FG001|Part B|Adverse Event|0|||
154899979|NCT04126031|559055044|FG002|Part B|Adverse Event|0|||
154899980|NCT04126031|559055045|FG003|Part B|Adverse Event|0|||
154899981|NCT04126031|559055046|FG004|Part B|Adverse Event|0|||
154899982|NCT04126031|559055047|FG005|Part B|Adverse Event|2|||
154899983|NCT04126031|559055042|FG000|Part B|Pre-existing hypertransaminasemia|0|||
154899984|NCT04126031|559055043|FG001|Part B|Pre-existing hypertransaminasemia|0|||
154899985|NCT04126031|559055044|FG002|Part B|Pre-existing hypertransaminasemia|0|||
154899986|NCT04126031|559055045|FG003|Part B|Pre-existing hypertransaminasemia|0|||
154899987|NCT04126031|559055046|FG004|Part B|Pre-existing hypertransaminasemia|1|||
154899988|NCT04126031|559055047|FG005|Part B|Pre-existing hypertransaminasemia|0|||
154899989|NCT01946412|559055048|FG000|Overall Study|Adverse Event|1|||
154899990|NCT01946412|559055048|FG000|Overall Study|Non-Compliance|1|||
154899991|NCT01946412|559055048|FG000|Overall Study|Continued with commercial Kalydeco|2|||
154899992|NCT01946412|559055048|FG000|Overall Study|Difficulty in swallowing|1|||
154899993|NCT00131664|559055049|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
154899994|NCT00131664|559055050|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
154899995|NCT00131664|559055051|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
154899996|NCT00131664|559055052|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
154899997|NCT00131664|559055053|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
154899998|NCT00131664|559055054|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
154899999|NCT00131664|559055049|FG000|First Period (First 6 Months)|Death|0|||
154900000|NCT00131664|559055050|FG001|First Period (First 6 Months)|Death|1|||
154900001|NCT00131664|559055051|FG002|First Period (First 6 Months)|Death|0|||
154900002|NCT00131664|559055052|FG003|First Period (First 6 Months)|Death|0|||
154900003|NCT00131664|559055053|FG004|First Period (First 6 Months)|Death|0|||
154900004|NCT00131664|559055054|FG005|First Period (First 6 Months)|Death|0|||
154900005|NCT00131664|559055049|FG000|First Period (First 6 Months)|Protocol Violation|2|||
154900006|NCT00131664|559055050|FG001|First Period (First 6 Months)|Protocol Violation|2|||
154900007|NCT00131664|559055051|FG002|First Period (First 6 Months)|Protocol Violation|1|||
154900008|NCT00131664|559055052|FG003|First Period (First 6 Months)|Protocol Violation|0|||
154900009|NCT00131664|559055053|FG004|First Period (First 6 Months)|Protocol Violation|0|||
154900010|NCT00131664|559055054|FG005|First Period (First 6 Months)|Protocol Violation|0|||
154900011|NCT00131664|559055049|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
154900012|NCT00131664|559055050|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
154900013|NCT00131664|559055051|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
154900014|NCT00131664|559055052|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
154900015|NCT00131664|559055053|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
154900016|NCT00131664|559055054|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
154900017|NCT00131664|559055049|FG000|First Period (First 6 Months)|Adverse Event|9|||
154900018|NCT00131664|559055050|FG001|First Period (First 6 Months)|Adverse Event|4|||
155114855|NCT02684058|559848283|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155114856|NCT02684058|559848284|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
154900019|NCT00131664|559055051|FG002|First Period (First 6 Months)|Adverse Event|5|||
154900020|NCT00131664|559055052|FG003|First Period (First 6 Months)|Adverse Event|0|||
154900021|NCT00131664|559055053|FG004|First Period (First 6 Months)|Adverse Event|0|||
154900022|NCT00131664|559055054|FG005|First Period (First 6 Months)|Adverse Event|0|||
154900023|NCT00131664|559055049|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
155150940|NCT00770653|559988131|FG000|Overall Study|Protocol Violation|8|||
154900024|NCT00131664|559055050|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
154900025|NCT00131664|559055051|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
154900026|NCT00131664|559055052|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
154900027|NCT00131664|559055053|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
154924258|NCT01869959|559146443|FG001|Treatment Period|Withdrawal by Subject|1|||
154981052|NCT01715896|559355024|FG000|Overall Study|Lost to Follow-up|0|||
154981053|NCT01715896|559355025|FG001|Overall Study|Lost to Follow-up|2|||
154981054|NCT01715896|559355024|FG000|Overall Study|Withdrawal by Subject|1|||
154981055|NCT01715896|559355025|FG001|Overall Study|Withdrawal by Subject|4|||
154981056|NCT01715896|559355024|FG000|Overall Study|Other|2|||
154981057|NCT01715896|559355025|FG001|Overall Study|Other|5|||
154981058|NCT01117337|559355027|FG000|Overall Study|Lost to Follow-up|4|||
154981059|NCT01117337|559355028|FG001|Overall Study|Lost to Follow-up|0|||
154981060|NCT01045993|559355029|FG000|Overall Study|Treated-later found eligibility not met|0|||
154981061|NCT01045993|559355030|FG001|Overall Study|Treated-later found eligibility not met|1|||
154981062|NCT01045993|559355031|FG002|Overall Study|Treated-later found eligibility not met|0|||
154981063|NCT01045993|559355032|FG003|Overall Study|Treated-later found eligibility not met|0|||
154981064|NCT01659736|559355033|FG000|Treatment Period|Adverse Event|1|||
154981065|NCT01659736|559355034|FG001|Treatment Period|Adverse Event|1|||
154981066|NCT01659736|559355033|FG000|Treatment Period|Protocol Violation|3|||
154981067|NCT01659736|559355034|FG001|Treatment Period|Protocol Violation|1|||
154981068|NCT01659736|559355033|FG000|Treatment Period|Withdrawal by Subject|1|||
154981069|NCT01659736|559355034|FG001|Treatment Period|Withdrawal by Subject|0|||
154981070|NCT01659736|559355033|FG000|3-month Follow-up|Lost to Follow-up|0|||
154981071|NCT01659736|559355034|FG001|3-month Follow-up|Lost to Follow-up|1|||
154981072|NCT02791893|559355040|FG000|Blinded Phase|Lost to Follow-up|2|||
154981073|NCT02791893|559355041|FG001|Blinded Phase|Lost to Follow-up|2|||
154981074|NCT02791893|559355040|FG000|Blinded Phase|Withdrawal by Subject|1|||
154981075|NCT02791893|559355041|FG001|Blinded Phase|Withdrawal by Subject|2|||
154981076|NCT02791893|559355040|FG000|Open Label Phase|Lost to Follow-up|3|||
154981077|NCT02791893|559355041|FG001|Open Label Phase|Lost to Follow-up|0|||
155175734|NCT00816023|560080342|FG002|Overall Study|Physician Decision|1|||
155175735|NCT00816023|560080343|FG003|Overall Study|Physician Decision|0|||
155175736|NCT00816023|560080340|FG000|Overall Study|assessments complete prior to window|1|||
154900028|NCT00131664|559055054|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
154900029|NCT00131664|559055049|FG000|First Period (First 6 Months)|Administrative reasons|2|||
154900030|NCT00131664|559055050|FG001|First Period (First 6 Months)|Administrative reasons|0|||
154900031|NCT00131664|559055051|FG002|First Period (First 6 Months)|Administrative reasons|5|||
154900032|NCT00131664|559055052|FG003|First Period (First 6 Months)|Administrative reasons|0|||
154900033|NCT00131664|559055053|FG004|First Period (First 6 Months)|Administrative reasons|0|||
154900034|NCT00131664|559055054|FG005|First Period (First 6 Months)|Administrative reasons|0|||
154900035|NCT00131664|559055049|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
154900036|NCT00131664|559055050|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
154900037|NCT00131664|559055051|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
154900038|NCT00131664|559055052|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
154900039|NCT00131664|559055053|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
154900040|NCT00131664|559055054|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
154900041|NCT00131664|559055049|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
154900042|NCT00131664|559055050|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
154900043|NCT00131664|559055051|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
154900044|NCT00131664|559055052|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
154900045|NCT00131664|559055053|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
154900046|NCT00131664|559055054|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
154900047|NCT00131664|559055049|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
154900048|NCT00131664|559055050|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
154900049|NCT00131664|559055051|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
154900050|NCT00131664|559055052|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
154900051|NCT00131664|559055053|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
154900052|NCT00131664|559055054|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
154900053|NCT00131664|559055049|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
154900054|NCT00131664|559055050|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
154900055|NCT00131664|559055051|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
154900056|NCT00131664|559055052|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
154900057|NCT00131664|559055053|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
154900058|NCT00131664|559055054|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
154900059|NCT00131664|559055049|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
154900060|NCT00131664|559055050|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
154900061|NCT00131664|559055051|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
154981078|NCT02791893|559355040|FG000|Open Label Phase|Withdrawal by Subject|0|||
154981079|NCT02791893|559355041|FG001|Open Label Phase|Withdrawal by Subject|2|||
154981080|NCT02772562|559355045|FG000|Overall Study|Withdrawal by Subject|1|||
154981081|NCT02772562|559355045|FG000|Overall Study|Protocol Violation|1|||
154981082|NCT05575063|559355046|FG000|Overall Study|Withdrawal by Subject|1|||
154981083|NCT00775528|559355048|FG000|Overall Study|Protocol Violation|1|||
154900062|NCT00131664|559055052|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
154900063|NCT00131664|559055053|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
154900064|NCT00131664|559055054|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
154900065|NCT00131664|559055049|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
154900066|NCT00131664|559055050|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
154900067|NCT00131664|559055051|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
154900068|NCT00131664|559055052|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
154900069|NCT00131664|559055053|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
154900070|NCT00131664|559055054|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
154900071|NCT03250624|559057140|FG000|Overall Study|Lack of Efficacy|1|||
154900072|NCT03250624|559057141|FG001|Overall Study|Lack of Efficacy|4|||
154900073|NCT03250624|559057140|FG000|Overall Study|Adverse Event|0|||
154900074|NCT03250624|559057141|FG001|Overall Study|Adverse Event|1|||
154900075|NCT03250624|559057140|FG000|Overall Study|Other|1|||
154900076|NCT03250624|559057141|FG001|Overall Study|Other|2|||
154900077|NCT00106249|559057142|FG000|Overall Study|Lost to Follow-up|3|||
154900078|NCT00106249|559057143|FG001|Overall Study|Lost to Follow-up|2|||
154900079|NCT00948428|559057148|FG000|Overall Study|Withdrawal by Subject|6|||
154900080|NCT00948428|559057149|FG001|Overall Study|Withdrawal by Subject|12|||
154900081|NCT00948428|559057150|FG002|Overall Study|Withdrawal by Subject|7|||
154900082|NCT00948428|559057148|FG000|Overall Study|Adverse Event|6|||
154900083|NCT00948428|559057149|FG001|Overall Study|Adverse Event|3|||
154900084|NCT00948428|559057150|FG002|Overall Study|Adverse Event|0|||
154900085|NCT00948428|559057148|FG000|Overall Study|Lost to Follow-up|2|||
154900086|NCT00948428|559057149|FG001|Overall Study|Lost to Follow-up|1|||
154900087|NCT00948428|559057150|FG002|Overall Study|Lost to Follow-up|1|||
154900088|NCT00948428|559057148|FG000|Overall Study|Death|2|||
154900089|NCT00948428|559057149|FG001|Overall Study|Death|0|||
154900090|NCT00948428|559057150|FG002|Overall Study|Death|0|||
154900091|NCT00948428|559057148|FG000|Overall Study|Intercurrent Illness|1|||
154900092|NCT00948428|559057149|FG001|Overall Study|Intercurrent Illness|0|||
154900093|NCT00948428|559057150|FG002|Overall Study|Intercurrent Illness|0|||
154900094|NCT00948428|559057148|FG000|Overall Study|Non-compliance|1|||
154900095|NCT00948428|559057149|FG001|Overall Study|Non-compliance|2|||
154900096|NCT00948428|559057150|FG002|Overall Study|Non-compliance|0|||
154900097|NCT01843205|559057153|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
154900098|NCT01843205|559057154|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
154900099|NCT00606177|559057155|FG000|Overall Study|Adverse Event|9|||
154900100|NCT00606177|559057156|FG001|Overall Study|Adverse Event|5|||
154900101|NCT00606177|559057155|FG000|Overall Study|Lack of Efficacy|3|||
154900102|NCT00606177|559057156|FG001|Overall Study|Lack of Efficacy|7|||
154900103|NCT00606177|559057155|FG000|Overall Study|Physician Decision|1|||
154900104|NCT00606177|559057156|FG001|Overall Study|Physician Decision|0|||
154900105|NCT00606177|559057155|FG000|Overall Study|Protocol Violation|1|||
154900106|NCT00606177|559057156|FG001|Overall Study|Protocol Violation|4|||
154900107|NCT00606177|559057155|FG000|Overall Study|Withdrawal by Subject|5|||
154900108|NCT00606177|559057156|FG001|Overall Study|Withdrawal by Subject|6|||
154900109|NCT00606177|559057155|FG000|Overall Study|Progression to depressive phase|6|||
154900110|NCT00606177|559057156|FG001|Overall Study|Progression to depressive phase|1|||
154900111|NCT00606177|559057155|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
154900112|NCT00606177|559057156|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
154900113|NCT00606177|559057155|FG000|Overall Study|Change of residence or other commitments|1|||
154900114|NCT00606177|559057156|FG001|Overall Study|Change of residence or other commitments|1|||
154900115|NCT00136357|559057157|FG000|Overall Study|Withdrawal by Subject|3|||
154900116|NCT00136357|559057158|FG001|Overall Study|Withdrawal by Subject|2|||
154900117|NCT01355497|559057159|FG000|Overall Study|Death|19|||
154900118|NCT01355497|559057160|FG001|Overall Study|Death|18|||
154900119|NCT01355497|559057159|FG000|Overall Study|Lost to Follow-up|3|||
154900120|NCT01355497|559057160|FG001|Overall Study|Lost to Follow-up|0|||
155114857|NCT02684058|559848285|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155114858|NCT02684058|559848283|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
154900121|NCT01355497|559057159|FG000|Overall Study|Protocol Violation|0|||
154900122|NCT01355497|559057160|FG001|Overall Study|Protocol Violation|1|||
154900123|NCT01355497|559057159|FG000|Overall Study|other-not provided|9|||
154900124|NCT01355497|559057160|FG001|Overall Study|other-not provided|4|||
154900125|NCT01355497|559057159|FG000|Overall Study|Withdrawal by Subject|12|||
154900126|NCT01355497|559057160|FG001|Overall Study|Withdrawal by Subject|20|||
154900127|NCT01355497|559057159|FG000|Overall Study|noncompliance|1|||
154900128|NCT01355497|559057160|FG001|Overall Study|noncompliance|2|||
154900129|NCT01355497|559057159|FG000|Overall Study|progressive disease|11|||
154900130|NCT01355497|559057160|FG001|Overall Study|progressive disease|8|||
154900131|NCT01355497|559057159|FG000|Overall Study|Adverse Event|11|||
154900132|NCT01355497|559057160|FG001|Overall Study|Adverse Event|10|||
154900133|NCT01518309|559057161|FG000|Overall Study|Adverse Event|6|||
154900134|NCT01518309|559057161|FG000|Overall Study|Death|6|||
154900135|NCT01518309|559057161|FG000|Overall Study|Lack of Efficacy|7|||
154900136|NCT01518309|559057161|FG000|Overall Study|Withdrawal by Subject|6|||
154900137|NCT01518309|559057161|FG000|Overall Study|Physician Decision|3|||
154900138|NCT01518309|559057161|FG000|Overall Study|Sponsor Decision|2|||
154900139|NCT01518309|559057161|FG000|Overall Study|Not in Predefined Categories|9|||
154900140|NCT02603172|559057163|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
154900141|NCT02603172|559057164|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
154900142|NCT02603172|559057165|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
154900143|NCT02603172|559057166|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
154900144|NCT02603172|559057167|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
154900145|NCT02603172|559057168|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
154900146|NCT02603172|559057169|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
155114859|NCT02684058|559848284|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
154900147|NCT02603172|559057170|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
154900148|NCT00863317|559057171|FG000|Overall Study|Lost to Follow-up|8|||
154900149|NCT00863317|559057172|FG001|Overall Study|Lost to Follow-up|9|||
154900150|NCT00038142|559057175|FG000|Overall Study|Ineligible|1|||
154900151|NCT00038142|559057176|FG001|Overall Study|Ineligible|0|||
154900152|NCT00038142|559057175|FG000|Overall Study|Progressive Disease|11|||
154900153|NCT00038142|559057176|FG001|Overall Study|Progressive Disease|7|||
154900154|NCT00038142|559057175|FG000|Overall Study|Death|1|||
154900155|NCT00038142|559057176|FG001|Overall Study|Death|0|||
154900156|NCT00038142|559057175|FG000|Overall Study|Adverse Event|1|||
154900157|NCT00038142|559057176|FG001|Overall Study|Adverse Event|0|||
154900158|NCT00038142|559057175|FG000|Overall Study|Unknown Reason|8|||
154900159|NCT00038142|559057176|FG001|Overall Study|Unknown Reason|0|||
154900160|NCT00441727|559057177|FG000|Overall Study|Protocol Violation|19|||
154900161|NCT00441727|559057178|FG001|Overall Study|Protocol Violation|28|||
154900162|NCT00441727|559057179|FG002|Overall Study|Protocol Violation|32|||
154900163|NCT00441727|559057177|FG000|Overall Study|Adverse Event|26|||
154900164|NCT00441727|559057178|FG001|Overall Study|Adverse Event|33|||
154900165|NCT00441727|559057179|FG002|Overall Study|Adverse Event|28|||
154900166|NCT00441727|559057177|FG000|Overall Study|Lack of Efficacy|7|||
154900167|NCT00441727|559057178|FG001|Overall Study|Lack of Efficacy|8|||
154900168|NCT00441727|559057179|FG002|Overall Study|Lack of Efficacy|48|||
154900169|NCT00441727|559057177|FG000|Overall Study|Withdrawal by Subject|40|||
154900170|NCT00441727|559057178|FG001|Overall Study|Withdrawal by Subject|34|||
154900171|NCT00441727|559057179|FG002|Overall Study|Withdrawal by Subject|47|||
154900172|NCT00441727|559057177|FG000|Overall Study|Lost to Follow-up|5|||
154900173|NCT00441727|559057178|FG001|Overall Study|Lost to Follow-up|6|||
154900174|NCT00441727|559057179|FG002|Overall Study|Lost to Follow-up|5|||
154900175|NCT00441727|559057177|FG000|Overall Study|Safety Reasons|3|||
154900176|NCT00441727|559057178|FG001|Overall Study|Safety Reasons|1|||
154900177|NCT00441727|559057179|FG002|Overall Study|Safety Reasons|3|||
154900178|NCT00441727|559057177|FG000|Overall Study|Various reason specified|6|||
154900179|NCT00441727|559057178|FG001|Overall Study|Various reason specified|8|||
154900180|NCT00441727|559057179|FG002|Overall Study|Various reason specified|5|||
154900181|NCT02133001|559057184|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
154900182|NCT02133001|559057185|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
154900183|NCT02133001|559057184|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
154900184|NCT02133001|559057185|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
154900185|NCT02133001|559057184|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
154900186|NCT02133001|559057185|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
154900187|NCT02133001|559057184|FG000|Double Blind (Day 1-25)|Other|2|||
154900188|NCT02133001|559057185|FG001|Double Blind (Day 1-25)|Other|2|||
154900189|NCT02133001|559057184|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
154900190|NCT02133001|559057185|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
154900191|NCT02133001|559057184|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
154900192|NCT02133001|559057185|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
154900193|NCT02133001|559057184|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
154900194|NCT02133001|559057185|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
154900195|NCT02133001|559057184|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
154900196|NCT02133001|559057185|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
154900197|NCT04211961|559057186|FG000|Overall Study|Death|0|||
154900198|NCT04211961|559057187|FG001|Overall Study|Death|1|||
154900199|NCT04211961|559057186|FG000|Overall Study|Lost to Follow-up|0|||
154981084|NCT00873119|559355055|FG000|Overall Study|Patient request|4|||
154900200|NCT04211961|559057187|FG001|Overall Study|Lost to Follow-up|1|||
154900201|NCT04211961|559057186|FG000|Overall Study|Withdrawal by Subject|0|||
154900202|NCT04211961|559057187|FG001|Overall Study|Withdrawal by Subject|1|||
154900203|NCT00420342|559057188|FG000|Overall Study|Lost to Follow-up|1|||
154900204|NCT00420342|559057189|FG001|Overall Study|Lost to Follow-up|0|||
154900205|NCT00420342|559057190|FG002|Overall Study|Lost to Follow-up|1|||
154900206|NCT00420342|559057188|FG000|Overall Study|Withdrawal by Subject|0|||
155150941|NCT00770653|559988132|FG001|Overall Study|Protocol Violation|6|||
154900207|NCT00420342|559057189|FG001|Overall Study|Withdrawal by Subject|2|||
154900208|NCT00420342|559057190|FG002|Overall Study|Withdrawal by Subject|0|||
154900209|NCT03933215|559057191|FG000|Overall Study|Other|6|||
154900210|NCT03933215|559057191|FG000|Overall Study|Sponsor decision|5|||
154900211|NCT03933215|559057191|FG000|Overall Study|Protocol Violation|5|||
154900212|NCT03933215|559057191|FG000|Overall Study|Withdrawal by Subject|6|||
154900213|NCT03933215|559057191|FG000|Overall Study|Lost to Follow-up|6|||
154900214|NCT03933215|559057191|FG000|Overall Study|Enrolled but not treated|38|||
154900215|NCT05784129|559057194|FG000|Overall Study|Study terminated by sponsor|2|||
154900216|NCT05784129|559057195|FG001|Overall Study|Study terminated by sponsor|2|||
154900217|NCT00407550|559057196|FG000|Overall Study|Adverse Event|0|||
154900218|NCT00407550|559057197|FG001|Overall Study|Adverse Event|1|||
154900219|NCT00407550|559057196|FG000|Overall Study|Withdrawal by Subject|0|||
154900220|NCT00407550|559057197|FG001|Overall Study|Withdrawal by Subject|2|||
154900221|NCT00407550|559057196|FG000|Overall Study|Death|1|||
154900222|NCT00407550|559057197|FG001|Overall Study|Death|0|||
154900223|NCT00407550|559057196|FG000|Overall Study|Insurance or Other medical condition|2|||
154900224|NCT00407550|559057197|FG001|Overall Study|Insurance or Other medical condition|1|||
154900225|NCT01444898|559057198|FG000|Overall Study|Withdrawal by Subject|1|||
154900226|NCT02580591|559057200|FG000|Overall Study|Adverse Event|0|||
154900227|NCT02580591|559057201|FG001|Overall Study|Adverse Event|1|||
154900228|NCT02580591|559057202|FG002|Overall Study|Adverse Event|2|||
154900229|NCT02580591|559057203|FG003|Overall Study|Adverse Event|5|||
154900230|NCT02580591|559057200|FG000|Overall Study|Protocol Violation|3|||
154900231|NCT02580591|559057201|FG001|Overall Study|Protocol Violation|2|||
154900232|NCT02580591|559057202|FG002|Overall Study|Protocol Violation|1|||
154900233|NCT02580591|559057203|FG003|Overall Study|Protocol Violation|1|||
154900234|NCT02580591|559057200|FG000|Overall Study|Lost to Follow-up|5|||
154900235|NCT02580591|559057201|FG001|Overall Study|Lost to Follow-up|3|||
154900236|NCT02580591|559057202|FG002|Overall Study|Lost to Follow-up|3|||
154900237|NCT02580591|559057203|FG003|Overall Study|Lost to Follow-up|1|||
154900238|NCT02580591|559057200|FG000|Overall Study|Withdrawal by Subject|6|||
154900239|NCT02580591|559057201|FG001|Overall Study|Withdrawal by Subject|1|||
154900240|NCT02580591|559057202|FG002|Overall Study|Withdrawal by Subject|2|||
154900241|NCT02580591|559057203|FG003|Overall Study|Withdrawal by Subject|3|||
154900242|NCT02580591|559057200|FG000|Overall Study|Not treated|1|||
154900243|NCT02580591|559057201|FG001|Overall Study|Not treated|1|||
154900244|NCT02580591|559057202|FG002|Overall Study|Not treated|0|||
154900245|NCT02580591|559057203|FG003|Overall Study|Not treated|0|||
154900246|NCT02580591|559057200|FG000|Overall Study|Other than specified|3|||
154900247|NCT02580591|559057201|FG001|Overall Study|Other than specified|2|||
154900248|NCT02580591|559057202|FG002|Overall Study|Other than specified|5|||
154900249|NCT02580591|559057203|FG003|Overall Study|Other than specified|2|||
154900250|NCT01599806|559057205|FG000|Overall Study|Lost to Follow-up|20|||
154900251|NCT01599806|559057206|FG001|Overall Study|Lost to Follow-up|20|||
154900252|NCT01599806|559057205|FG000|Overall Study|Withdrawal by Subject|12|||
154900253|NCT01599806|559057206|FG001|Overall Study|Withdrawal by Subject|12|||
154900254|NCT01599806|559057205|FG000|Overall Study|Other Eligibility criteria|11|||
154900255|NCT01599806|559057206|FG001|Overall Study|Other Eligibility criteria|9|||
154900256|NCT00990249|559057212|FG000|Overall Study|Disease Progression|8|||
154900257|NCT00990249|559057212|FG000|Overall Study|Non-Compliance|1|||
154900258|NCT00990249|559057212|FG000|Overall Study|Death|2|||
154900259|NCT00990249|559057212|FG000|Overall Study|Not treated|2|||
154900260|NCT02873208|559057215|FG000|Overall Study|Withdrawal by Subject|36|||
154900261|NCT02873208|559057215|FG000|Overall Study|Lost to Follow-up|22|||
154900262|NCT02873208|559057215|FG000|Overall Study|Adverse Event|15|||
154900263|NCT02873208|559057215|FG000|Overall Study|Non-compliance with study drug|12|||
154900264|NCT02873208|559057215|FG000|Overall Study|Protocol Violation|8|||
154900265|NCT02873208|559057215|FG000|Overall Study|Pregnancy|2|||
154900266|NCT02873208|559057215|FG000|Overall Study|Incarceration|1|||
154900267|NCT02873208|559057215|FG000|Overall Study|Lack of Efficacy|1|||
154900268|NCT02873208|559057215|FG000|Overall Study|Physician Decision|1|||
154900269|NCT00415584|559057216|FG000|Overall Study|Withdrawal by Subject|1|||
154900270|NCT01061567|559057217|FG000|Overall Study|Adverse Event|32|||
154900271|NCT01061567|559057217|FG000|Overall Study|Death|2|||
154900272|NCT01061567|559057217|FG000|Overall Study|Lack of Efficacy|3|||
155175737|NCT00816023|560080341|FG001|Overall Study|assessments complete prior to window|1|||
155175738|NCT00816023|560080342|FG002|Overall Study|assessments complete prior to window|2|||
154900273|NCT01061567|559057217|FG000|Overall Study|Lost to Follow-up|24|||
155175739|NCT00816023|560080343|FG003|Overall Study|assessments complete prior to window|1|||
154900274|NCT01061567|559057217|FG000|Overall Study|Protocol Violation|1|||
154900275|NCT01061567|559057217|FG000|Overall Study|Withdrawal by Subject|11|||
154900276|NCT01061567|559057217|FG000|Overall Study|Other reason than stated above|3|||
154900277|NCT00563368|559057218|FG000|Overall Study|Lost to Follow-up|14|||
154900278|NCT00563368|559057219|FG001|Overall Study|Lost to Follow-up|14|||
154900279|NCT00563368|559057220|FG002|Overall Study|Lost to Follow-up|12|||
154900280|NCT00563368|559057221|FG003|Overall Study|Lost to Follow-up|6|||
154900281|NCT00563368|559057222|FG004|Overall Study|Lost to Follow-up|9|||
154900282|NCT00563368|559057223|FG005|Overall Study|Lost to Follow-up|8|||
154900283|NCT00563368|559057224|FG006|Overall Study|Lost to Follow-up|9|||
154900284|NCT00563368|559057218|FG000|Overall Study|Adverse Event|3|||
154900285|NCT00563368|559057219|FG001|Overall Study|Adverse Event|4|||
154900286|NCT00563368|559057220|FG002|Overall Study|Adverse Event|5|||
154900287|NCT00563368|559057221|FG003|Overall Study|Adverse Event|9|||
154900288|NCT00563368|559057222|FG004|Overall Study|Adverse Event|6|||
154900289|NCT00563368|559057223|FG005|Overall Study|Adverse Event|10|||
154900290|NCT00563368|559057224|FG006|Overall Study|Adverse Event|17|||
154900291|NCT00563368|559057218|FG000|Overall Study|Withdrawal by Subject|11|||
154900292|NCT00563368|559057219|FG001|Overall Study|Withdrawal by Subject|6|||
154900293|NCT00563368|559057220|FG002|Overall Study|Withdrawal by Subject|5|||
154900294|NCT00563368|559057221|FG003|Overall Study|Withdrawal by Subject|7|||
154900295|NCT00563368|559057222|FG004|Overall Study|Withdrawal by Subject|8|||
154900296|NCT00563368|559057223|FG005|Overall Study|Withdrawal by Subject|5|||
154900297|NCT00563368|559057224|FG006|Overall Study|Withdrawal by Subject|4|||
154900298|NCT00563368|559057218|FG000|Overall Study|protocol non-compliance|1|||
154900299|NCT00563368|559057219|FG001|Overall Study|protocol non-compliance|1|||
154900300|NCT00563368|559057220|FG002|Overall Study|protocol non-compliance|2|||
154900301|NCT00563368|559057221|FG003|Overall Study|protocol non-compliance|1|||
154900302|NCT00563368|559057222|FG004|Overall Study|protocol non-compliance|0|||
154900303|NCT00563368|559057223|FG005|Overall Study|protocol non-compliance|1|||
154900304|NCT00563368|559057224|FG006|Overall Study|protocol non-compliance|3|||
154900305|NCT00563368|559057218|FG000|Overall Study|Pregnancy|1|||
154900306|NCT00563368|559057219|FG001|Overall Study|Pregnancy|0|||
154900307|NCT00563368|559057220|FG002|Overall Study|Pregnancy|1|||
154900308|NCT00563368|559057221|FG003|Overall Study|Pregnancy|2|||
154900309|NCT00563368|559057222|FG004|Overall Study|Pregnancy|1|||
154900310|NCT00563368|559057223|FG005|Overall Study|Pregnancy|2|||
154900311|NCT00563368|559057224|FG006|Overall Study|Pregnancy|0|||
154900312|NCT00563368|559057218|FG000|Overall Study|requirement for restricted medication|0|||
154900313|NCT00563368|559057219|FG001|Overall Study|requirement for restricted medication|0|||
154900314|NCT00563368|559057220|FG002|Overall Study|requirement for restricted medication|2|||
154900315|NCT00563368|559057221|FG003|Overall Study|requirement for restricted medication|0|||
154900316|NCT00563368|559057222|FG004|Overall Study|requirement for restricted medication|0|||
154900317|NCT00563368|559057223|FG005|Overall Study|requirement for restricted medication|0|||
154900318|NCT00563368|559057224|FG006|Overall Study|requirement for restricted medication|0|||
154900319|NCT00563368|559057218|FG000|Overall Study|Other|5|||
154900320|NCT00563368|559057219|FG001|Overall Study|Other|5|||
154900321|NCT00563368|559057220|FG002|Overall Study|Other|3|||
154900322|NCT00563368|559057221|FG003|Overall Study|Other|4|||
154900323|NCT00563368|559057222|FG004|Overall Study|Other|4|||
154900324|NCT00563368|559057223|FG005|Overall Study|Other|4|||
154900325|NCT00563368|559057224|FG006|Overall Study|Other|0|||
154900326|NCT02640755|559057225|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
154900327|NCT02640755|559057226|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
154900328|NCT02640755|559057225|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
154900329|NCT02640755|559057226|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
154900330|NCT02640755|559057225|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
154900331|NCT02640755|559057226|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
154900332|NCT00841672|559057228|FG000|Overall Study|Adverse Event|7|||
154900333|NCT00841672|559057229|FG001|Overall Study|Adverse Event|16|||
154900334|NCT00841672|559057228|FG000|Overall Study|Abnormal test procedure result(s)|0|||
154900335|NCT00841672|559057229|FG001|Overall Study|Abnormal test procedure result(s)|1|||
154900336|NCT00841672|559057228|FG000|Overall Study|Subject withdrew consent|2|||
154900337|NCT00841672|559057229|FG001|Overall Study|Subject withdrew consent|4|||
154900338|NCT00841672|559057228|FG000|Overall Study|Lost to Follow-up|1|||
154900339|NCT00841672|559057229|FG001|Overall Study|Lost to Follow-up|1|||
154900340|NCT00841672|559057228|FG000|Overall Study|Administrative problems|9|||
154900341|NCT00841672|559057229|FG001|Overall Study|Administrative problems|9|||
154900342|NCT00841672|559057228|FG000|Overall Study|Misrandomized|1|||
154900343|NCT00841672|559057229|FG001|Overall Study|Misrandomized|0|||
154900344|NCT00841672|559057228|FG000|Overall Study|Protocol Deviation|0|||
154900345|NCT00841672|559057229|FG001|Overall Study|Protocol Deviation|1|||
155175740|NCT00816023|560080340|FG000|Overall Study|Randomized Not Treated|6|||
154900346|NCT00842361|559057232|FG000|Overall Study|Protocol Violation|1|||
154900347|NCT00842361|559057233|FG001|Overall Study|Protocol Violation|0|||
154900348|NCT00842361|559057232|FG000|Overall Study|Unclassified|0|||
154900349|NCT00842361|559057233|FG001|Overall Study|Unclassified|2|||
154900350|NCT02186561|559057234|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
154900351|NCT02186561|559057234|FG000|Enrollment|Enrollment Cap Reached|5|||
154900352|NCT02186561|559057234|FG000|Enrollment|Insurance Denial|2|||
154900353|NCT02186561|559057234|FG000|Enrollment|Withdrawal by Subject|2|||
155175741|NCT00816023|560080341|FG001|Overall Study|Randomized Not Treated|4|||
154900354|NCT02186561|559057234|FG000|Enrollment|Investigator Withdrew Consent|1|||
154900355|NCT02186561|559057234|FG000|30-Day Post Index Procedure Visit|Death|1|||
154900356|NCT02186561|559057234|FG000|1- Year Post Index Procedure Visit|Death|1|||
154900357|NCT02186561|559057234|FG000|1- Year Post Index Procedure Visit|Missed|1|||
154900358|NCT01072448|559057237|FG000|Overall Study|Adverse Event|9|||
154900359|NCT01072448|559057238|FG001|Overall Study|Adverse Event|10|||
154900360|NCT01072448|559057237|FG000|Overall Study|Subject withdrew consent|4|||
154900361|NCT01072448|559057238|FG001|Overall Study|Subject withdrew consent|9|||
154900362|NCT01072448|559057237|FG000|Overall Study|Protocol deviation|3|||
154900363|NCT01072448|559057238|FG001|Overall Study|Protocol deviation|4|||
154900364|NCT01072448|559057237|FG000|Overall Study|Abnormal test procedure result(s)|1|||
154900365|NCT01072448|559057238|FG001|Overall Study|Abnormal test procedure result(s)|0|||
154900366|NCT01072448|559057237|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154900367|NCT01072448|559057238|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
154900368|NCT01072448|559057237|FG000|Overall Study|Lost to Follow-up|1|||
154900369|NCT01072448|559057238|FG001|Overall Study|Lost to Follow-up|1|||
154900370|NCT01072448|559057237|FG000|Overall Study|Abnormal laboratory value(s)|0|||
154900371|NCT01072448|559057238|FG001|Overall Study|Abnormal laboratory value(s)|1|||
154900372|NCT01072448|559057237|FG000|Overall Study|Death|0|||
154900373|NCT01072448|559057238|FG001|Overall Study|Death|2|||
154900374|NCT00196196|559057243|FG000|Overall Study|Withdrawal by Subject|2|||
154981085|NCT00873119|559355056|FG001|Overall Study|Patient request|2|||
154981086|NCT00873119|559355055|FG000|Overall Study|Adverse Event|8|||
154981087|NCT00873119|559355056|FG001|Overall Study|Adverse Event|0|||
154981088|NCT00873119|559355055|FG000|Overall Study|Progressive disease|26|||
154981089|NCT00873119|559355056|FG001|Overall Study|Progressive disease|18|||
154981090|NCT00873119|559355055|FG000|Overall Study|Death|2|||
154981091|NCT00873119|559355056|FG001|Overall Study|Death|1|||
154981092|NCT00873119|559355055|FG000|Overall Study|Other|2|||
154981093|NCT00873119|559355056|FG001|Overall Study|Other|5|||
154981094|NCT00873119|559355055|FG000|Overall Study|Not treated|2|||
154900375|NCT00196196|559057243|FG000|Overall Study|Did not have required condition (hydroce|5|||
154900376|NCT01015820|559057246|FG000|Overall Study|Suboptimal measurements|1|||
154900377|NCT01015820|559057247|FG001|Overall Study|Suboptimal measurements|0|||
154900378|NCT03034057|559057248|FG000|Overall Study|Withdrawal by Subject|10|||
154900379|NCT03034057|559057248|FG000|Overall Study|Protocol Violation|1|||
154900380|NCT03034057|559057248|FG000|Overall Study|Not defined|2|||
154900381|NCT03034057|559057248|FG000|Overall Study|Lost to Follow-up|19|||
154900382|NCT03034057|559057248|FG000|Overall Study|Adverse Event|22|||
154900383|NCT03034057|559057248|FG000|Overall Study|Medication error without associated AE|1|||
154900384|NCT03339401|559057249|FG000|Overall Study|Death|2|||
154900385|NCT03339401|559057250|FG001|Overall Study|Death|1|||
154900386|NCT03339401|559057249|FG000|Overall Study|Withdrawal by Subject|2|||
154900387|NCT03339401|559057250|FG001|Overall Study|Withdrawal by Subject|0|||
154900388|NCT03339401|559057249|FG000|Overall Study|Study terminated|4|||
154900389|NCT03339401|559057250|FG001|Overall Study|Study terminated|3|||
154900390|NCT03339401|559057249|FG000|Overall Study|Investigator Decision|1|||
154900391|NCT03339401|559057250|FG001|Overall Study|Investigator Decision|0|||
154900392|NCT00718523|559057251|FG000|Overall Study|Withdrawal by Subject|5|||
154900393|NCT00718523|559057252|FG001|Overall Study|Withdrawal by Subject|7|||
154900394|NCT00718523|559057251|FG000|Overall Study|Death|13|||
154900395|NCT00718523|559057252|FG001|Overall Study|Death|17|||
154900396|NCT01313078|559057253|FG000|Overall Study|Death|1|||
154900397|NCT01313078|559057253|FG000|Overall Study|Discontinued study drug|1|||
154900398|NCT01313078|559057253|FG000|Overall Study|Withdrawal by Subject|1|||
154900399|NCT00910728|559057254|FG000|Overall Study|Lack of Efficacy|2|||
154900400|NCT00910728|559057255|FG001|Overall Study|Lack of Efficacy|3|||
154900401|NCT00910728|559057256|FG002|Overall Study|Lack of Efficacy|1|||
154900402|NCT00910728|559057257|FG003|Overall Study|Lack of Efficacy|2|||
154900403|NCT00910728|559057258|FG004|Overall Study|Lack of Efficacy|1|||
154900404|NCT00910728|559057259|FG005|Overall Study|Lack of Efficacy|0|||
154900405|NCT00910728|559057260|FG006|Overall Study|Lack of Efficacy|2|||
154900406|NCT00910728|559057261|FG007|Overall Study|Lack of Efficacy|2|||
154900407|NCT00910728|559057262|FG008|Overall Study|Lack of Efficacy|2|||
154981095|NCT00873119|559355056|FG001|Overall Study|Not treated|0|||
154981096|NCT03648879|559355057|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
154981097|NCT01884688|559355060|FG000|Overall Study|Screen Failure|2|||
154981098|NCT04099641|559355064|FG000|Overall Study|Death|46|||
154981099|NCT04099641|559355065|FG001|Overall Study|Death|12|||
154981100|NCT04099641|559355064|FG000|Overall Study|Lost to Follow-up|1|||
154900408|NCT00910728|559057254|FG000|Overall Study|Withdrawal by Subject|0|||
154900409|NCT00910728|559057255|FG001|Overall Study|Withdrawal by Subject|0|||
154900410|NCT00910728|559057256|FG002|Overall Study|Withdrawal by Subject|0|||
154900411|NCT00910728|559057257|FG003|Overall Study|Withdrawal by Subject|0|||
154900412|NCT00910728|559057258|FG004|Overall Study|Withdrawal by Subject|3|||
154981101|NCT04099641|559355065|FG001|Overall Study|Lost to Follow-up|0|||
154981102|NCT04099641|559355064|FG000|Overall Study|Withdrawal by Subject|2|||
154981103|NCT04099641|559355065|FG001|Overall Study|Withdrawal by Subject|0|||
154900413|NCT00910728|559057259|FG005|Overall Study|Withdrawal by Subject|1|||
154900414|NCT00910728|559057260|FG006|Overall Study|Withdrawal by Subject|2|||
154900415|NCT00910728|559057261|FG007|Overall Study|Withdrawal by Subject|0|||
154900416|NCT00910728|559057262|FG008|Overall Study|Withdrawal by Subject|0|||
154981104|NCT00895037|559355066|FG000|Overall Study|Death|0|||
154981105|NCT00895037|559355067|FG001|Overall Study|Death|2|||
154981106|NCT00895037|559355068|FG002|Overall Study|Death|1|||
154900417|NCT00910728|559057254|FG000|Overall Study|(not specified)|2|||
154900418|NCT00910728|559057255|FG001|Overall Study|(not specified)|0|||
154900419|NCT00910728|559057256|FG002|Overall Study|(not specified)|1|||
154900420|NCT00910728|559057257|FG003|Overall Study|(not specified)|0|||
154900421|NCT00910728|559057258|FG004|Overall Study|(not specified)|1|||
154900422|NCT00910728|559057259|FG005|Overall Study|(not specified)|0|||
154900423|NCT00910728|559057260|FG006|Overall Study|(not specified)|0|||
154900424|NCT00910728|559057261|FG007|Overall Study|(not specified)|0|||
154900425|NCT00910728|559057262|FG008|Overall Study|(not specified)|0|||
154900426|NCT00910728|559057254|FG000|Overall Study|Adverse Event|2|||
154900427|NCT00910728|559057255|FG001|Overall Study|Adverse Event|0|||
154900428|NCT00910728|559057256|FG002|Overall Study|Adverse Event|1|||
154900429|NCT00910728|559057257|FG003|Overall Study|Adverse Event|1|||
154900430|NCT00910728|559057258|FG004|Overall Study|Adverse Event|0|||
154900431|NCT00910728|559057259|FG005|Overall Study|Adverse Event|0|||
154900432|NCT00910728|559057260|FG006|Overall Study|Adverse Event|2|||
154900433|NCT00910728|559057261|FG007|Overall Study|Adverse Event|1|||
154900434|NCT00910728|559057262|FG008|Overall Study|Adverse Event|1|||
154900435|NCT01042938|559057263|FG000|Overall Study|Withdrawal by Subject|1|||
154900436|NCT01042938|559057264|FG001|Overall Study|Withdrawal by Subject|1|||
154900437|NCT01042938|559057263|FG000|Overall Study|Protocol Violation|1|||
154900438|NCT01042938|559057264|FG001|Overall Study|Protocol Violation|1|||
154900439|NCT01042938|559057263|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
154900440|NCT01042938|559057264|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
154900441|NCT03136484|559057265|FG000|Overall Study|Withdrawal by Subject|19|||
154900442|NCT03136484|559057266|FG001|Overall Study|Withdrawal by Subject|14|||
154900443|NCT03136484|559057265|FG000|Overall Study|Lost to Follow-up|7|||
154900444|NCT03136484|559057266|FG001|Overall Study|Lost to Follow-up|8|||
154900445|NCT03136484|559057265|FG000|Overall Study|Death|1|||
154900446|NCT03136484|559057266|FG001|Overall Study|Death|0|||
154900447|NCT01449955|559057269|FG000|Overall Study|Withdrawal by Subject|1|||
154900448|NCT01449955|559057270|FG001|Overall Study|Withdrawal by Subject|2|||
154900449|NCT01203787|559057271|FG000|Overall Study|Death|12|||
154900450|NCT01203787|559057272|FG001|Overall Study|Death|10|||
154900451|NCT01203787|559057271|FG000|Overall Study|Withdrawal by Subject|6|||
154900452|NCT01203787|559057272|FG001|Overall Study|Withdrawal by Subject|2|||
154900453|NCT01203787|559057271|FG000|Overall Study|Lost to Follow-up|2|||
154900454|NCT01203787|559057272|FG001|Overall Study|Lost to Follow-up|0|||
154900455|NCT01203787|559057271|FG000|Overall Study|Adverse Event|11|||
154900456|NCT01203787|559057272|FG001|Overall Study|Adverse Event|15|||
154900457|NCT01601470|559057273|FG000|Period 2 - LCZ696|Physician Decision|1|||
154900458|NCT03032510|559057274|FG000|Overall Study|Adverse Event|5|||
154900459|NCT03032510|559057275|FG001|Overall Study|Adverse Event|2|||
154900460|NCT03032510|559057274|FG000|Overall Study|Lost to Follow-up|8|||
154900461|NCT03032510|559057275|FG001|Overall Study|Lost to Follow-up|7|||
154900462|NCT03032510|559057274|FG000|Overall Study|Withdrawal by Subject|8|||
154900463|NCT03032510|559057275|FG001|Overall Study|Withdrawal by Subject|7|||
154900464|NCT03032510|559057274|FG000|Overall Study|Subject noncompliance|4|||
154900465|NCT03032510|559057275|FG001|Overall Study|Subject noncompliance|2|||
154900466|NCT03032510|559057274|FG000|Overall Study|Physician Decision|2|||
154900467|NCT03032510|559057275|FG001|Overall Study|Physician Decision|0|||
154900468|NCT00856986|559057276|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
154900469|NCT00856986|559057277|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
154900470|NCT00856986|559057278|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
154900471|NCT00856986|559057279|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
154900472|NCT00856986|559057280|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
154900473|NCT00856986|559057276|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
154900474|NCT00856986|559057277|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
154900475|NCT00856986|559057278|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
154900476|NCT00856986|559057279|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
154900477|NCT00856986|559057280|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
154900478|NCT00856986|559057276|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
154900479|NCT00856986|559057277|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
154900480|NCT00856986|559057278|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
154900481|NCT00856986|559057279|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
154900482|NCT00856986|559057280|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
154900483|NCT00856986|559057276|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
154900484|NCT00856986|559057277|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
154900485|NCT00856986|559057278|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
154900486|NCT00856986|559057279|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
154900487|NCT00856986|559057280|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
154900488|NCT00856986|559057276|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
154900489|NCT00856986|559057277|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
154900490|NCT00856986|559057278|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
154900491|NCT00856986|559057279|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
154900492|NCT00856986|559057280|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
154900493|NCT00856986|559057276|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
154900494|NCT00856986|559057277|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
154900495|NCT00856986|559057278|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
154900496|NCT00856986|559057279|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
154900497|NCT00856986|559057280|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
154900498|NCT00856986|559057276|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
154900499|NCT00856986|559057277|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
154900500|NCT00856986|559057278|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
154900501|NCT00856986|559057279|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
154900502|NCT00856986|559057280|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
154900503|NCT00856986|559057276|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
154900504|NCT00856986|559057277|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
154900505|NCT00856986|559057278|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
154900506|NCT00856986|559057279|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
154900507|NCT00856986|559057280|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
154900508|NCT00856986|559057276|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
154900509|NCT00856986|559057277|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
154900510|NCT00856986|559057278|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
154900511|NCT00856986|559057279|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
154900512|NCT00856986|559057280|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
154900513|NCT00856986|559057276|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
154900514|NCT00856986|559057277|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
154900515|NCT00856986|559057278|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
154900516|NCT00856986|559057279|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
154900517|NCT00856986|559057280|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
154900518|NCT00856986|559057276|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
154900519|NCT00856986|559057277|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
154900520|NCT00856986|559057278|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
154900521|NCT00856986|559057279|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
154900522|NCT00856986|559057280|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
154900523|NCT00856986|559057276|FG000|Main Period, Weeks 0-26|Unclassified|7|||
154900524|NCT00856986|559057277|FG001|Main Period, Weeks 0-26|Unclassified|6|||
154900525|NCT00856986|559057278|FG002|Main Period, Weeks 0-26|Unclassified|7|||
154900526|NCT00856986|559057279|FG003|Main Period, Weeks 0-26|Unclassified|0|||
154900527|NCT00856986|559057280|FG004|Main Period, Weeks 0-26|Unclassified|0|||
154900528|NCT00856986|559057276|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
154900529|NCT00856986|559057277|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
154900530|NCT00856986|559057278|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
154900531|NCT00856986|559057279|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
154900532|NCT00856986|559057280|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
154900533|NCT00856986|559057276|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
154900534|NCT00856986|559057277|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
154900535|NCT00856986|559057278|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
154900536|NCT00856986|559057279|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
154900537|NCT00856986|559057280|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
154900538|NCT00856986|559057276|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
154900539|NCT00856986|559057277|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
154900540|NCT00856986|559057278|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
154900541|NCT00856986|559057279|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
154900542|NCT00856986|559057280|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
154900543|NCT00856986|559057276|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
154900544|NCT00856986|559057277|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
154900545|NCT00856986|559057278|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
154900546|NCT00856986|559057279|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
154900547|NCT00856986|559057280|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
154900548|NCT00856986|559057276|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
154900549|NCT00856986|559057277|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
154900550|NCT00856986|559057278|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
154900551|NCT00856986|559057279|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
154900552|NCT00856986|559057280|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
154900553|NCT00856986|559057276|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
154900554|NCT00856986|559057277|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
154900555|NCT00856986|559057278|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
154900556|NCT00856986|559057279|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
154900557|NCT00856986|559057280|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
154900558|NCT01602549|559057283|FG000|Overall Study|Protocol Violation|0|||
154900559|NCT01602549|559057284|FG001|Overall Study|Protocol Violation|1|||
154900560|NCT01602549|559057283|FG000|Overall Study|Withdrawal by Subject|1|||
154900561|NCT01602549|559057284|FG001|Overall Study|Withdrawal by Subject|0|||
154900562|NCT01576406|559057285|FG000|Overall Study|Lost to Follow-up|1|||
154900563|NCT01576406|559057286|FG001|Overall Study|Lost to Follow-up|2|||
154900564|NCT01576406|559057287|FG002|Overall Study|Lost to Follow-up|0|||
154900565|NCT01576406|559057288|FG003|Overall Study|Lost to Follow-up|0|||
155114860|NCT02684058|559848285|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
155114861|NCT02684058|559848283|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155114862|NCT02684058|559848284|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
154900566|NCT01576406|559057289|FG004|Overall Study|Lost to Follow-up|0|||
154900567|NCT01576406|559057290|FG005|Overall Study|Lost to Follow-up|0|||
154900568|NCT01576406|559057285|FG000|Overall Study|Death|3|||
154900569|NCT01576406|559057286|FG001|Overall Study|Death|4|||
154900570|NCT01576406|559057287|FG002|Overall Study|Death|8|||
154900571|NCT01576406|559057288|FG003|Overall Study|Death|5|||
154900572|NCT01576406|559057289|FG004|Overall Study|Death|7|||
154900573|NCT01576406|559057290|FG005|Overall Study|Death|9|||
154900574|NCT01576406|559057285|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
154900575|NCT01576406|559057286|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
154900576|NCT01576406|559057287|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
154900577|NCT01576406|559057288|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
154900578|NCT01576406|559057289|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
154900579|NCT01576406|559057290|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
154900580|NCT01576406|559057285|FG000|Overall Study|Withdrawal the consent|2|||
154900581|NCT01576406|559057286|FG001|Overall Study|Withdrawal the consent|2|||
154900582|NCT01576406|559057287|FG002|Overall Study|Withdrawal the consent|5|||
154900583|NCT01576406|559057288|FG003|Overall Study|Withdrawal the consent|1|||
154900584|NCT01576406|559057289|FG004|Overall Study|Withdrawal the consent|1|||
154900585|NCT01576406|559057290|FG005|Overall Study|Withdrawal the consent|3|||
154900586|NCT01576406|559057285|FG000|Overall Study|Other|0|||
154900587|NCT01576406|559057286|FG001|Overall Study|Other|0|||
154900588|NCT01576406|559057287|FG002|Overall Study|Other|2|||
154900589|NCT01576406|559057288|FG003|Overall Study|Other|2|||
154900590|NCT01576406|559057289|FG004|Overall Study|Other|0|||
154900591|NCT01576406|559057290|FG005|Overall Study|Other|0|||
154900592|NCT02091921|559057291|FG000|Overall Study|Adverse Event|3|||
154900593|NCT02483078|559057292|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
154900594|NCT02483078|559057293|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
154900595|NCT02483078|559057292|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
154900596|NCT02483078|559057293|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
154900597|NCT02483078|559057292|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
154900598|NCT02483078|559057293|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
154900599|NCT02483078|559057292|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
154900600|NCT02483078|559057293|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
154900601|NCT02483078|559057292|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
154900602|NCT02483078|559057293|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
154900603|NCT02483078|559057292|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
154900604|NCT02483078|559057293|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
154900605|NCT01731990|559059008|FG000|Overall Study|Adverse Event|1|||
154900606|NCT01731990|559059009|FG001|Overall Study|Adverse Event|5|||
154900607|NCT01731990|559059008|FG000|Overall Study|Withdrawal by Subject|1|||
154900608|NCT01731990|559059009|FG001|Overall Study|Withdrawal by Subject|1|||
154900609|NCT01731990|559059008|FG000|Overall Study|Protocol deviation|1|||
154900610|NCT01731990|559059009|FG001|Overall Study|Protocol deviation|2|||
154900611|NCT01731990|559059008|FG000|Overall Study|Death|1|||
154900612|NCT01731990|559059009|FG001|Overall Study|Death|0|||
154900613|NCT01957215|559059016|FG000|Overall Study|Adverse Event|2|||
154900614|NCT01957215|559059017|FG001|Overall Study|Adverse Event|2|||
154900615|NCT01957215|559059016|FG000|Overall Study|Lost to Follow-up|3|||
154900616|NCT01957215|559059017|FG001|Overall Study|Lost to Follow-up|3|||
154900617|NCT01957215|559059016|FG000|Overall Study|Protocol Violation|1|||
154900618|NCT01957215|559059017|FG001|Overall Study|Protocol Violation|2|||
154900619|NCT01957215|559059016|FG000|Overall Study|Withdrawal by Subject|7|||
154900620|NCT01957215|559059017|FG001|Overall Study|Withdrawal by Subject|5|||
154900621|NCT03597503|559059021|FG000|Overall Study|Withdrawal by Subject|0|||
154900622|NCT03597503|559059022|FG001|Overall Study|Withdrawal by Subject|2|||
154900623|NCT03597503|559059021|FG000|Overall Study|Lost to Follow-up|1|||
154900624|NCT03597503|559059022|FG001|Overall Study|Lost to Follow-up|2|||
154900625|NCT03597503|559059021|FG000|Overall Study|Protocol Violation|1|||
154900626|NCT03597503|559059022|FG001|Overall Study|Protocol Violation|0|||
154900627|NCT02944513|559059023|FG000|Overall Study|Withdrawal by Subject|4|||
154900628|NCT02944513|559059024|FG001|Overall Study|Withdrawal by Subject|1|||
154900629|NCT02578992|559059027|FG000|Overall Study|equipment not available or malfunction|3|||
154900630|NCT02578992|559059028|FG001|Overall Study|equipment not available or malfunction|3|||
154900631|NCT01495689|559059033|FG000|Overall Study|Death|0|||
154900632|NCT01495689|559059034|FG001|Overall Study|Death|1|||
154900633|NCT01495689|559059033|FG000|Overall Study|Withdrawal by Subject|3|||
154900634|NCT01495689|559059034|FG001|Overall Study|Withdrawal by Subject|0|||
154900635|NCT01495689|559059033|FG000|Overall Study|Lost to Follow-up|7|||
154900636|NCT01495689|559059034|FG001|Overall Study|Lost to Follow-up|6|||
155114863|NCT02684058|559848285|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155114864|NCT02684058|559848283|FG000|Post-treatment Efficacy Follow-up|Death|0|||
155114865|NCT02684058|559848284|FG001|Post-treatment Efficacy Follow-up|Death|0|||
154900637|NCT03805971|559059035|FG000|Overall Study|Withdrawal by Subject|1|||
154900638|NCT03805971|559059035|FG000|Overall Study|Protocol Violation|2|||
154900639|NCT00517413|559059043|FG000|Overall Study|Adverse Event|7|||
154900640|NCT00517413|559059043|FG000|Overall Study|Death|13|||
154900641|NCT00517413|559059043|FG000|Overall Study|Protocol Violation|15|||
154900642|NCT00517413|559059043|FG000|Overall Study|Withdrawal by Subject|2|||
154900643|NCT00517413|559059043|FG000|Overall Study|Failure to return|1|||
154900644|NCT00517413|559059043|FG000|Overall Study|Other-Reasons|23|||
154900645|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Death|3|||
154900646|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Death|0|||
154900647|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Death|0|||
154900648|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Death|0|||
154900649|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Death|0|||
154900650|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
154900651|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
154900652|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
154900653|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
154900654|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
154900655|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
154900656|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
154900657|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
154900658|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
154900659|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
154900660|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Other|0|||
154900661|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Other|0|||
154900662|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Other|1|||
154900663|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Other|0|||
154900664|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Other|0|||
154900665|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
154900666|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
154900667|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
154900668|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
154900669|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
154900670|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
154900671|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
154900672|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
154900673|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
154900674|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
154900675|NCT01224106|559059044|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
154900676|NCT01224106|559059045|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154900677|NCT01224106|559059046|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
154900678|NCT01224106|559059047|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154900679|NCT01224106|559059048|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154900680|NCT01224106|559059044|FG000|Open-Label Extension (OLE) Phase|Death|0|||
154900681|NCT01224106|559059045|FG001|Open-Label Extension (OLE) Phase|Death|0|||
154900682|NCT01224106|559059046|FG002|Open-Label Extension (OLE) Phase|Death|0|||
154900683|NCT01224106|559059047|FG003|Open-Label Extension (OLE) Phase|Death|1|||
154900684|NCT01224106|559059048|FG004|Open-Label Extension (OLE) Phase|Death|3|||
154900685|NCT01224106|559059044|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
154900686|NCT01224106|559059045|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
154900687|NCT01224106|559059046|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
154900688|NCT01224106|559059047|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
154900689|NCT01224106|559059048|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
154900690|NCT01224106|559059044|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
154900691|NCT01224106|559059045|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
154900692|NCT01224106|559059046|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
154900693|NCT01224106|559059047|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
154900694|NCT01224106|559059048|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
154900695|NCT01224106|559059044|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
154900696|NCT01224106|559059045|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
155114866|NCT02684058|559848285|FG002|Post-treatment Efficacy Follow-up|Death|3|||
155114867|NCT02684058|559848283|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
155114868|NCT02684058|559848284|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
155114869|NCT02684058|559848285|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
155114870|NCT02684058|559848283|FG000|Post-treatment Survival Follow-up|Death|0|||
154900697|NCT01224106|559059046|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
154900698|NCT01224106|559059047|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
154900699|NCT01224106|559059048|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
155114871|NCT02684058|559848284|FG001|Post-treatment Survival Follow-up|Death|0|||
155114872|NCT02684058|559848285|FG002|Post-treatment Survival Follow-up|Death|7|||
155114873|NCT02684058|559848283|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
154900700|NCT01224106|559059044|FG000|Open-Label Extension (OLE) Phase|Other|0|||
154900701|NCT01224106|559059045|FG001|Open-Label Extension (OLE) Phase|Other|0|||
154900702|NCT01224106|559059046|FG002|Open-Label Extension (OLE) Phase|Other|0|||
154900703|NCT01224106|559059047|FG003|Open-Label Extension (OLE) Phase|Other|5|||
154900704|NCT01224106|559059048|FG004|Open-Label Extension (OLE) Phase|Other|3|||
154900705|NCT03210220|559059049|FG000|Overall Study|Physician Decision|1|||
154900706|NCT03210220|559059050|FG001|Overall Study|Physician Decision|0|||
154900707|NCT00839436|559059055|FG000|Overall Study|Developed exclusionary condition|1|||
154900708|NCT00839436|559059056|FG001|Overall Study|Developed exclusionary condition|0|||
154900709|NCT00839436|559059057|FG002|Overall Study|Developed exclusionary condition|0|||
154900710|NCT00839436|559059055|FG000|Overall Study|Withdrawal by Subject|0|||
154900711|NCT00839436|559059056|FG001|Overall Study|Withdrawal by Subject|1|||
154900712|NCT00839436|559059057|FG002|Overall Study|Withdrawal by Subject|0|||
154900713|NCT00839436|559059055|FG000|Overall Study|Study drug no longer available|0|||
154900714|NCT00839436|559059056|FG001|Overall Study|Study drug no longer available|0|||
154900715|NCT00839436|559059057|FG002|Overall Study|Study drug no longer available|1|||
154900716|NCT01440972|559059058|FG000|Overall Study|Withdrawal by Subject|3|||
154900717|NCT01440972|559059059|FG001|Overall Study|Withdrawal by Subject|2|||
154900718|NCT04072575|559059060|FG000|Overall Study|Physician Decision|1|||
154900719|NCT04072575|559059060|FG000|Overall Study|Adverse Event|7|||
154900720|NCT04072575|559059060|FG000|Overall Study|Withdrawal by Subject|14|||
154900721|NCT04072575|559059060|FG000|Overall Study|Other|2|||
154900722|NCT03006926|559059063|FG000|Overall Study|Adverse Event|0|||
154900723|NCT03006926|559059064|FG001|Overall Study|Adverse Event|27|||
154900724|NCT03006926|559059063|FG000|Overall Study|Withdrawal by Subject|0|||
154900725|NCT03006926|559059064|FG001|Overall Study|Withdrawal by Subject|1|||
154900726|NCT03006926|559059063|FG000|Overall Study|Radiological Disease Progression|0|||
154900727|NCT03006926|559059064|FG001|Overall Study|Radiological Disease Progression|52|||
154900728|NCT03006926|559059063|FG000|Overall Study|Clinical Disease Progression|0|||
154900729|NCT03006926|559059064|FG001|Overall Study|Clinical Disease Progression|10|||
154900730|NCT03006926|559059063|FG000|Overall Study|Other|0|||
154900731|NCT03006926|559059064|FG001|Overall Study|Other|8|||
154900732|NCT01838213|559059065|FG000|Overall Study|Ineligible|166|||
154900733|NCT01838213|559059066|FG001|Overall Study|Ineligible|191|||
154900734|NCT04882072|559059067|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
154900735|NCT04882072|559059068|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
154900736|NCT04882072|559059067|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
154900737|NCT04882072|559059068|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
154900738|NCT04882072|559059067|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
154900739|NCT04882072|559059068|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
154900740|NCT02918318|559059069|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
154900741|NCT02918318|559059070|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
154900742|NCT02918318|559059071|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
154900743|NCT02918318|559059072|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
154900744|NCT02918318|559059073|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
154900745|NCT02918318|559059069|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
154900746|NCT02918318|559059070|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
154900747|NCT02918318|559059071|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
154900748|NCT02918318|559059072|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
154900749|NCT02918318|559059073|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
154900750|NCT02918318|559059069|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
154981107|NCT01103479|559355070|FG000|Overall Study|Up to date with CRC screening|1|||
155114874|NCT02684058|559848284|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
155114875|NCT02684058|559848285|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
155114876|NCT02684058|559848283|FG000|Crossover Treatment Period|Progressive disease|0|||
154900751|NCT02918318|559059070|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
154900752|NCT02918318|559059071|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
154900753|NCT02918318|559059072|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
154900754|NCT02918318|559059073|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
154900755|NCT02918318|559059069|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
154900756|NCT02918318|559059070|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
154900757|NCT02918318|559059071|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
154900758|NCT02918318|559059072|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
154900759|NCT02918318|559059073|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
154900760|NCT02918318|559059069|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
154900761|NCT02918318|559059070|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
154981108|NCT01103479|559355071|FG001|Overall Study|Up to date with CRC screening|9|||
155114877|NCT02684058|559848284|FG001|Crossover Treatment Period|Progressive disease|1|||
154900762|NCT02918318|559059071|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
154900763|NCT02918318|559059072|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
154900764|NCT02918318|559059073|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
154900765|NCT02918318|559059069|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
155114878|NCT02684058|559848285|FG002|Crossover Treatment Period|Progressive disease|0|||
155114879|NCT03219034|559848286|FG000|Overall Study|Lost to Follow-up|9|||
155114880|NCT03219034|559848287|FG001|Overall Study|Lost to Follow-up|13|||
155114881|NCT03219034|559848286|FG000|Overall Study|Additional dental work needed|1|||
155114882|NCT03219034|559848287|FG001|Overall Study|Additional dental work needed|0|||
155114883|NCT03219034|559848286|FG000|Overall Study|UPPP Surgery|1|||
155114884|NCT03219034|559848287|FG001|Overall Study|UPPP Surgery|0|||
155114885|NCT03219034|559848286|FG000|Overall Study|Dental sensitivity|0|||
155114886|NCT03219034|559848287|FG001|Overall Study|Dental sensitivity|1|||
155114887|NCT03219034|559848286|FG000|Overall Study|Death in family|0|||
155114888|NCT03219034|559848287|FG001|Overall Study|Death in family|1|||
155114889|NCT01802580|559848288|FG000|Overall Study|Physician Decision|1|||
155114890|NCT01802580|559848289|FG001|Overall Study|Physician Decision|0|||
155114891|NCT01802580|559848288|FG000|Overall Study|Protocol Violation|2|||
155114892|NCT01802580|559848289|FG001|Overall Study|Protocol Violation|0|||
155114893|NCT01802580|559848288|FG000|Overall Study|Withdrawal by Subject|5|||
155114894|NCT01802580|559848289|FG001|Overall Study|Withdrawal by Subject|6|||
155114895|NCT01802580|559848288|FG000|Overall Study|Other|1|||
155114896|NCT01802580|559848289|FG001|Overall Study|Other|3|||
155114897|NCT01802580|559848288|FG000|Overall Study|Lack of Efficacy|0|||
155114898|NCT01802580|559848289|FG001|Overall Study|Lack of Efficacy|2|||
155114899|NCT01457014|559848291|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
155114900|NCT01457014|559848292|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
155114901|NCT01457014|559848293|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
155114902|NCT01457014|559848294|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
155114903|NCT01457014|559848291|FG000|First Night|Withdrawal by Subject|3|||
155114904|NCT01457014|559848292|FG001|First Night|Withdrawal by Subject|0|||
155114905|NCT01457014|559848293|FG002|First Night|Withdrawal by Subject|0|||
155114906|NCT01457014|559848294|FG003|First Night|Withdrawal by Subject|0|||
155114907|NCT03319953|559848295|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
155114908|NCT03319953|559848296|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
155114909|NCT03319953|559848297|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
155114910|NCT03319953|559848298|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
155114911|NCT03319953|559848295|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
155114912|NCT03319953|559848296|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
155114913|NCT03319953|559848297|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
155114914|NCT03319953|559848298|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
155114915|NCT03116828|559850375|FG000|Overall Study|Adverse Event|1|||
155114916|NCT03116828|559850376|FG001|Overall Study|Adverse Event|10|||
155114917|NCT03116828|559850375|FG000|Overall Study|Withdrawal by Subject|4|||
155114918|NCT03116828|559850376|FG001|Overall Study|Withdrawal by Subject|8|||
155114919|NCT03116828|559850375|FG000|Overall Study|OTHER|3|||
155114920|NCT03116828|559850376|FG001|Overall Study|OTHER|3|||
155114921|NCT00983515|559850377|FG000|Ritonavir Alone|liver panel out of range|6|||
155114922|NCT00983515|559850377|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
155114923|NCT05243745|559850378|FG000|Overall Study|Withdrawal by Subject|0|||
155114924|NCT05243745|559850379|FG001|Overall Study|Withdrawal by Subject|0|||
155114925|NCT05243745|559850380|FG002|Overall Study|Withdrawal by Subject|0|||
155114926|NCT05243745|559850381|FG003|Overall Study|Withdrawal by Subject|1|||
155114927|NCT05243745|559850378|FG000|Overall Study|Unable to Attend Visit 6|0|||
155114928|NCT05243745|559850379|FG001|Overall Study|Unable to Attend Visit 6|0|||
155114929|NCT05243745|559850380|FG002|Overall Study|Unable to Attend Visit 6|1|||
155114930|NCT05243745|559850381|FG003|Overall Study|Unable to Attend Visit 6|0|||
155114931|NCT02998203|559850382|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
155114932|NCT02998203|559850383|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
155114933|NCT02998203|559850382|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
155114934|NCT02998203|559850383|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
155114935|NCT04187144|559850386|FG000|Overall Study|Lost to Follow-up|12|||
155114936|NCT04187144|559850387|FG001|Overall Study|Lost to Follow-up|11|||
155114937|NCT04187144|559850386|FG000|Overall Study|Withdrawal by Subject|20|||
155114938|NCT04187144|559850387|FG001|Overall Study|Withdrawal by Subject|18|||
155114939|NCT04187144|559850386|FG000|Overall Study|Adverse Event|19|||
155114940|NCT04187144|559850387|FG001|Overall Study|Adverse Event|4|||
155114941|NCT04187144|559850386|FG000|Overall Study|Physician Decision|5|||
155114942|NCT04187144|559850387|FG001|Overall Study|Physician Decision|3|||
155114943|NCT04187144|559850386|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
155175742|NCT00816023|560080342|FG002|Overall Study|Randomized Not Treated|6|||
155114944|NCT04187144|559850387|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
155175743|NCT00816023|560080343|FG003|Overall Study|Randomized Not Treated|11|||
155114945|NCT04187144|559850386|FG000|Overall Study|Protocol Deviation|1|||
155114946|NCT04187144|559850387|FG001|Overall Study|Protocol Deviation|4|||
155114947|NCT01044745|559850388|FG000|Overall Study|Ineiligible|2|||
155175744|NCT00797966|560082131|FG000|Phase A|Lost to Follow-up|0|||
155175745|NCT00797966|560082132|FG001|Phase A|Lost to Follow-up|0|||
155175746|NCT00797966|560082133|FG002|Phase A|Lost to Follow-up|0|||
155175747|NCT00797966|560082134|FG003|Phase A|Lost to Follow-up|0|||
155175748|NCT00797966|560082135|FG004|Phase A|Lost to Follow-up|33|||
155175749|NCT00797966|560082136|FG005|Phase A|Lost to Follow-up|0|||
155175750|NCT00797966|560082131|FG000|Phase A|Adverse Event|0|||
155175751|NCT00797966|560082132|FG001|Phase A|Adverse Event|0|||
155175752|NCT00797966|560082133|FG002|Phase A|Adverse Event|0|||
155175753|NCT00797966|560082134|FG003|Phase A|Adverse Event|0|||
155175754|NCT00797966|560082135|FG004|Phase A|Adverse Event|46|||
155175755|NCT00797966|560082136|FG005|Phase A|Adverse Event|0|||
155175756|NCT00797966|560082131|FG000|Phase A|Met withdrawal criteria|0|||
155175757|NCT00797966|560082132|FG001|Phase A|Met withdrawal criteria|0|||
155175758|NCT00797966|560082133|FG002|Phase A|Met withdrawal criteria|0|||
155175759|NCT00797966|560082134|FG003|Phase A|Met withdrawal criteria|0|||
155175760|NCT00797966|560082135|FG004|Phase A|Met withdrawal criteria|4|||
155175761|NCT00797966|560082136|FG005|Phase A|Met withdrawal criteria|0|||
155175762|NCT00797966|560082131|FG000|Phase A|Physician Decision|0|||
155175763|NCT00797966|560082132|FG001|Phase A|Physician Decision|0|||
155175764|NCT00797966|560082133|FG002|Phase A|Physician Decision|0|||
155175765|NCT00797966|560082134|FG003|Phase A|Physician Decision|0|||
155175766|NCT00797966|560082135|FG004|Phase A|Physician Decision|13|||
155175767|NCT00797966|560082136|FG005|Phase A|Physician Decision|0|||
155175768|NCT00797966|560082131|FG000|Phase A|Withdrawal by Subject|0|||
155175769|NCT00797966|560082132|FG001|Phase A|Withdrawal by Subject|0|||
155175770|NCT00797966|560082133|FG002|Phase A|Withdrawal by Subject|0|||
155175771|NCT00797966|560082134|FG003|Phase A|Withdrawal by Subject|0|||
155175772|NCT00797966|560082135|FG004|Phase A|Withdrawal by Subject|33|||
155175773|NCT00797966|560082136|FG005|Phase A|Withdrawal by Subject|0|||
155175774|NCT00797966|560082131|FG000|Phase A|Protocol deviation|0|||
155175775|NCT00797966|560082132|FG001|Phase A|Protocol deviation|0|||
155175776|NCT00797966|560082133|FG002|Phase A|Protocol deviation|0|||
155175777|NCT00797966|560082134|FG003|Phase A|Protocol deviation|0|||
155175778|NCT00797966|560082135|FG004|Phase A|Protocol deviation|56|||
155175779|NCT00797966|560082136|FG005|Phase A|Protocol deviation|0|||
155175780|NCT00797966|560082131|FG000|Phase B|Lost to Follow-up|0|||
155175781|NCT00797966|560082132|FG001|Phase B|Lost to Follow-up|1|||
155175782|NCT00797966|560082133|FG002|Phase B|Lost to Follow-up|3|||
155175783|NCT00797966|560082134|FG003|Phase B|Lost to Follow-up|0|||
155175784|NCT00797966|560082135|FG004|Phase B|Lost to Follow-up|0|||
155175785|NCT00797966|560082136|FG005|Phase B|Lost to Follow-up|0|||
155175786|NCT00797966|560082131|FG000|Phase B|Adverse Event|2|||
155175787|NCT00797966|560082132|FG001|Phase B|Adverse Event|1|||
155175788|NCT00797966|560082133|FG002|Phase B|Adverse Event|3|||
155175789|NCT00797966|560082134|FG003|Phase B|Adverse Event|1|||
155175790|NCT00797966|560082135|FG004|Phase B|Adverse Event|0|||
155175791|NCT00797966|560082136|FG005|Phase B|Adverse Event|0|||
155175792|NCT00797966|560082131|FG000|Phase B|Met Withdrawal Criteria|3|||
155175793|NCT00797966|560082132|FG001|Phase B|Met Withdrawal Criteria|3|||
155175794|NCT00797966|560082133|FG002|Phase B|Met Withdrawal Criteria|6|||
155175795|NCT00797966|560082134|FG003|Phase B|Met Withdrawal Criteria|1|||
155175796|NCT00797966|560082135|FG004|Phase B|Met Withdrawal Criteria|0|||
155175797|NCT00797966|560082136|FG005|Phase B|Met Withdrawal Criteria|0|||
155114948|NCT03812185|559850396|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
155114949|NCT05526781|559850400|FG000|Overall Study|Lost to Follow-up|1|||
155114950|NCT04085458|559850401|FG000|Overall Study|Other|1|||
155114951|NCT04085458|559850401|FG000|Overall Study|Withdrawal by Subject|2|||
155114952|NCT04085458|559850401|FG000|Overall Study|Adverse Event|2|||
155114953|NCT00920218|559850402|FG000|Overall Study|Serious Adverse Event|2|||
155114954|NCT00920218|559850403|FG001|Overall Study|Serious Adverse Event|0|||
155175798|NCT00797966|560082131|FG000|Phase B|Physician Decision|1|||
155175799|NCT00797966|560082132|FG001|Phase B|Physician Decision|0|||
154900766|NCT02918318|559059070|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
155114955|NCT00920218|559850404|FG002|Overall Study|Serious Adverse Event|2|||
155175800|NCT00797966|560082133|FG002|Phase B|Physician Decision|3|||
155175801|NCT00797966|560082134|FG003|Phase B|Physician Decision|1|||
155175802|NCT00797966|560082135|FG004|Phase B|Physician Decision|0|||
155175803|NCT00797966|560082136|FG005|Phase B|Physician Decision|0|||
155175804|NCT00797966|560082131|FG000|Phase B|Withdrawal by Subject|1|||
155175805|NCT00797966|560082132|FG001|Phase B|Withdrawal by Subject|4|||
155175806|NCT00797966|560082133|FG002|Phase B|Withdrawal by Subject|3|||
155114956|NCT00920218|559850405|FG003|Overall Study|Serious Adverse Event|1|||
155114957|NCT00920218|559850402|FG000|Overall Study|Withdrawal by Subject|0|||
155175807|NCT00797966|560082134|FG003|Phase B|Withdrawal by Subject|3|||
155175808|NCT00797966|560082135|FG004|Phase B|Withdrawal by Subject|0|||
155175809|NCT00797966|560082136|FG005|Phase B|Withdrawal by Subject|0|||
155175810|NCT00797966|560082131|FG000|Phase B|Protocol Deviation|4|||
155175811|NCT00797966|560082132|FG001|Phase B|Protocol Deviation|8|||
155175812|NCT00797966|560082133|FG002|Phase B|Protocol Deviation|2|||
155175813|NCT00797966|560082134|FG003|Phase B|Protocol Deviation|6|||
155114958|NCT00920218|559850403|FG001|Overall Study|Withdrawal by Subject|3|||
155114959|NCT00920218|559850404|FG002|Overall Study|Withdrawal by Subject|2|||
155114960|NCT00920218|559850405|FG003|Overall Study|Withdrawal by Subject|0|||
155114961|NCT00920218|559850402|FG000|Overall Study|Migrated/moved from study area|0|||
154981109|NCT01103479|559355072|FG002|Overall Study|Up to date with CRC screening|12|||
155114962|NCT00920218|559850403|FG001|Overall Study|Migrated/moved from study area|0|||
155114963|NCT00920218|559850404|FG002|Overall Study|Migrated/moved from study area|1|||
155114964|NCT00920218|559850405|FG003|Overall Study|Migrated/moved from study area|0|||
155114965|NCT00920218|559850402|FG000|Overall Study|Lost to Follow-up|0|||
155114966|NCT00920218|559850403|FG001|Overall Study|Lost to Follow-up|1|||
155114967|NCT00920218|559850404|FG002|Overall Study|Lost to Follow-up|0|||
155114968|NCT00920218|559850405|FG003|Overall Study|Lost to Follow-up|3|||
155114969|NCT00920218|559850402|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
155114970|NCT00920218|559850403|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
155114971|NCT00920218|559850404|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
155114972|NCT00920218|559850405|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
155114973|NCT00920218|559850402|FG000|Overall Study|Other|0|||
155114974|NCT00920218|559850403|FG001|Overall Study|Other|0|||
155114975|NCT00920218|559850404|FG002|Overall Study|Other|1|||
155114976|NCT00920218|559850405|FG003|Overall Study|Other|0|||
155114977|NCT02449889|559850409|FG000|Overall Study|Adverse Event|1|||
155114978|NCT02449889|559850410|FG001|Overall Study|Adverse Event|2|||
155114979|NCT02449889|559850411|FG002|Overall Study|Adverse Event|0|||
155114980|NCT02449889|559850409|FG000|Overall Study|Protocol Violation|0|||
155114981|NCT02449889|559850410|FG001|Overall Study|Protocol Violation|4|||
155114982|NCT02449889|559850411|FG002|Overall Study|Protocol Violation|1|||
155114983|NCT01973387|559850412|FG000|Overall Study|Adverse Event|14|||
155114984|NCT01973387|559850413|FG001|Overall Study|Adverse Event|4|||
155114985|NCT01973387|559850412|FG000|Overall Study|Withdrawal by Subject|7|||
155114986|NCT01973387|559850413|FG001|Overall Study|Withdrawal by Subject|4|||
155114987|NCT01973387|559850412|FG000|Overall Study|Study terminated by sponsor|63|||
155114988|NCT01973387|559850413|FG001|Overall Study|Study terminated by sponsor|0|||
155114989|NCT01973387|559850412|FG000|Overall Study|Progressive disease or relapse|16|||
155114990|NCT01973387|559850413|FG001|Overall Study|Progressive disease or relapse|5|||
155114991|NCT01973387|559850412|FG000|Overall Study|Death|4|||
155114992|NCT01973387|559850413|FG001|Overall Study|Death|3|||
155114993|NCT01973387|559850412|FG000|Overall Study|Randomized, not treated|2|||
155114994|NCT01973387|559850413|FG001|Overall Study|Randomized, not treated|2|||
155114995|NCT01498575|559850414|FG000|Overall Sample|Withdrawal by Subject|60|||
155114996|NCT01498575|559850415|FG001|Overall Sample|Withdrawal by Subject|14|||
155114997|NCT01498575|559850414|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
155114998|NCT01498575|559850415|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
155114999|NCT01498575|559850414|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
155115000|NCT01498575|559850415|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
155115001|NCT00090142|559850417|FG000|Treatment Period I|Lost to Follow-up|1|||
155115002|NCT00090142|559850418|FG001|Treatment Period I|Lost to Follow-up|2|||
155115003|NCT00090142|559850417|FG000|Treatment Period I|Protocol Violation|2|||
155115004|NCT00090142|559850418|FG001|Treatment Period I|Protocol Violation|0|||
155115005|NCT00090142|559850417|FG000|Treatment Period I|Withdrawal by Subject|2|||
155115006|NCT00090142|559850418|FG001|Treatment Period I|Withdrawal by Subject|0|||
155115007|NCT00090142|559850417|FG000|Treatment Period I|Other|0|||
155115008|NCT00090142|559850418|FG001|Treatment Period I|Other|1|||
155115009|NCT00090142|559850417|FG000|Treatment Period II|Other|1|||
155115010|NCT00090142|559850418|FG001|Treatment Period II|Other|0|||
155115011|NCT02442310|559850419|FG000|Overall Study|Adverse Event|2|||
155115012|NCT02442310|559850419|FG000|Overall Study|Withdrawal by Subject|1|||
155115013|NCT01126437|559850420|FG000|Overall Study|Not treated|11|||
155115014|NCT01126437|559850421|FG001|Overall Study|Not treated|18|||
155115015|NCT01126437|559850422|FG002|Overall Study|Not treated|19|||
154981110|NCT01103479|559355070|FG000|Overall Study|Family history of CRC|1|||
155115016|NCT01126437|559850420|FG000|Overall Study|Sites with data irregularities/fraud|6|||
155115017|NCT01126437|559850421|FG001|Overall Study|Sites with data irregularities/fraud|6|||
155115018|NCT01126437|559850422|FG002|Overall Study|Sites with data irregularities/fraud|7|||
155115019|NCT01126437|559850420|FG000|Overall Study|Adverse Event|602|||
155115020|NCT01126437|559850421|FG001|Overall Study|Adverse Event|606|||
155115021|NCT01126437|559850422|FG002|Overall Study|Adverse Event|635|||
155115022|NCT01126437|559850420|FG000|Overall Study|Lack of Efficacy|65|||
155115023|NCT01126437|559850421|FG001|Overall Study|Lack of Efficacy|60|||
155115024|NCT01126437|559850422|FG002|Overall Study|Lack of Efficacy|59|||
155115025|NCT01126437|559850420|FG000|Overall Study|Protocol Violation|64|||
155115026|NCT01126437|559850421|FG001|Overall Study|Protocol Violation|66|||
155115027|NCT01126437|559850422|FG002|Overall Study|Protocol Violation|41|||
155115028|NCT01126437|559850420|FG000|Overall Study|Lost to Follow-up|52|||
155115029|NCT01126437|559850421|FG001|Overall Study|Lost to Follow-up|63|||
155115030|NCT01126437|559850422|FG002|Overall Study|Lost to Follow-up|55|||
155115031|NCT01126437|559850420|FG000|Overall Study|Withdrawal by Subject|331|||
155115032|NCT01126437|559850421|FG001|Overall Study|Withdrawal by Subject|335|||
155115033|NCT01126437|559850422|FG002|Overall Study|Withdrawal by Subject|319|||
155115034|NCT01126437|559850420|FG000|Overall Study|Other reason not specified|210|||
155115035|NCT01126437|559850421|FG001|Overall Study|Other reason not specified|176|||
155115036|NCT01126437|559850422|FG002|Overall Study|Other reason not specified|178|||
155115037|NCT00006046|559850434|FG000|Overall Study|Adverse Event|3|||
155115038|NCT00006046|559850435|FG001|Overall Study|Adverse Event|0|||
155115039|NCT00006046|559850436|FG002|Overall Study|Adverse Event|0|||
155115040|NCT00006046|559850437|FG003|Overall Study|Adverse Event|0|||
155115041|NCT00006046|559850438|FG004|Overall Study|Adverse Event|0|||
155115042|NCT00006046|559850434|FG000|Overall Study|Disease Progression|2|||
155115043|NCT00006046|559850435|FG001|Overall Study|Disease Progression|0|||
155115044|NCT00006046|559850436|FG002|Overall Study|Disease Progression|0|||
155115045|NCT00006046|559850437|FG003|Overall Study|Disease Progression|0|||
155115046|NCT00006046|559850438|FG004|Overall Study|Disease Progression|0|||
155115047|NCT03272828|559850439|FG000|Overall Study|Lost to Follow-up|7|||
155115048|NCT03272828|559850440|FG001|Overall Study|Lost to Follow-up|7|||
155115049|NCT03272828|559850439|FG000|Overall Study|Withdrawal by Subject|2|||
155175814|NCT00797966|560082135|FG004|Phase B|Protocol Deviation|0|||
155175815|NCT00797966|560082136|FG005|Phase B|Protocol Deviation|0|||
155175816|NCT00797966|560082131|FG000|Phase B|Lack of Efficacy|0|||
155175817|NCT00797966|560082132|FG001|Phase B|Lack of Efficacy|1|||
155175818|NCT00797966|560082133|FG002|Phase B|Lack of Efficacy|1|||
155175819|NCT00797966|560082134|FG003|Phase B|Lack of Efficacy|4|||
155175820|NCT00797966|560082135|FG004|Phase B|Lack of Efficacy|0|||
155175821|NCT00797966|560082136|FG005|Phase B|Lack of Efficacy|0|||
155175822|NCT00797966|560082131|FG000|Phase A+|Lost to Follow-up|0|||
155175823|NCT00797966|560082132|FG001|Phase A+|Lost to Follow-up|0|||
155175824|NCT00797966|560082133|FG002|Phase A+|Lost to Follow-up|0|||
155175825|NCT00797966|560082134|FG003|Phase A+|Lost to Follow-up|0|||
155175826|NCT00797966|560082135|FG004|Phase A+|Lost to Follow-up|0|||
155175827|NCT00797966|560082136|FG005|Phase A+|Lost to Follow-up|9|||
155175828|NCT00797966|560082131|FG000|Phase A+|Met withdrawal criteria|0|||
155175829|NCT00797966|560082132|FG001|Phase A+|Met withdrawal criteria|0|||
155175830|NCT00797966|560082133|FG002|Phase A+|Met withdrawal criteria|0|||
155175831|NCT00797966|560082134|FG003|Phase A+|Met withdrawal criteria|0|||
155175832|NCT00797966|560082135|FG004|Phase A+|Met withdrawal criteria|0|||
155175833|NCT00797966|560082136|FG005|Phase A+|Met withdrawal criteria|5|||
155175834|NCT00797966|560082131|FG000|Phase A+|Withdrawal by Subject|0|||
155175835|NCT00797966|560082132|FG001|Phase A+|Withdrawal by Subject|0|||
155175836|NCT00797966|560082133|FG002|Phase A+|Withdrawal by Subject|0|||
155175837|NCT00797966|560082134|FG003|Phase A+|Withdrawal by Subject|0|||
155175838|NCT00797966|560082135|FG004|Phase A+|Withdrawal by Subject|0|||
155175839|NCT00797966|560082136|FG005|Phase A+|Withdrawal by Subject|6|||
155175840|NCT00797966|560082131|FG000|Phase A+|Adverse Event|0|||
155175841|NCT00797966|560082132|FG001|Phase A+|Adverse Event|0|||
155175842|NCT00797966|560082133|FG002|Phase A+|Adverse Event|0|||
155175843|NCT00797966|560082134|FG003|Phase A+|Adverse Event|0|||
155175844|NCT00797966|560082135|FG004|Phase A+|Adverse Event|0|||
155175845|NCT00797966|560082136|FG005|Phase A+|Adverse Event|4|||
155175846|NCT00797966|560082131|FG000|Phase A+|Protocol deviation|0|||
155175847|NCT00797966|560082132|FG001|Phase A+|Protocol deviation|0|||
155175848|NCT00797966|560082133|FG002|Phase A+|Protocol deviation|0|||
155175849|NCT00797966|560082134|FG003|Phase A+|Protocol deviation|0|||
155175850|NCT00797966|560082135|FG004|Phase A+|Protocol deviation|0|||
155175851|NCT00797966|560082136|FG005|Phase A+|Protocol deviation|4|||
155175852|NCT01002820|560082139|FG000|Overall Study|Adverse Event|1|||
155175853|NCT01002820|560082139|FG000|Overall Study|Withdrawal by Subject|2|||
155175854|NCT01002820|560082139|FG000|Overall Study|Lack of Efficacy|1|||
155175855|NCT01430754|560082140|FG000|Run-In Phase|Circadian Period Ineligible|24|||
155175856|NCT01430754|560082141|FG001|Run-In Phase|Circadian Period Ineligible|0|||
155175857|NCT01430754|560082140|FG000|Run-In Phase|Protocol Violation|6|||
155175858|NCT01430754|560082141|FG001|Run-In Phase|Protocol Violation|0|||
155175859|NCT01430754|560082140|FG000|Run-In Phase|Adverse Event|2|||
155175860|NCT01430754|560082141|FG001|Run-In Phase|Adverse Event|0|||
155175861|NCT01430754|560082140|FG000|Run-In Phase|Other|2|||
155115050|NCT03272828|559850440|FG001|Overall Study|Withdrawal by Subject|0|||
155115051|NCT03272828|559850439|FG000|Overall Study|Deceased|1|||
155115052|NCT03272828|559850440|FG001|Overall Study|Deceased|1|||
155115053|NCT03272828|559850439|FG000|Overall Study|Failed implant|1|||
155115054|NCT03272828|559850440|FG001|Overall Study|Failed implant|2|||
155115055|NCT03176472|559850441|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
155115056|NCT03176472|559850442|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
155115057|NCT03176472|559850441|FG000|Double Blind Treatment Period|Adverse Event|0|||
155115058|NCT03176472|559850442|FG001|Double Blind Treatment Period|Adverse Event|5|||
155175862|NCT01430754|560082141|FG001|Run-In Phase|Other|0|||
155115059|NCT03176472|559850441|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
155115060|NCT03176472|559850442|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155115061|NCT03176472|559850441|FG000|Double Blind Treatment Period|Physician Decision|0|||
155175863|NCT01430754|560082140|FG000|Run-In Phase|Withdrawal by Subject|2|||
155175864|NCT01430754|560082141|FG001|Run-In Phase|Withdrawal by Subject|0|||
154981111|NCT01103479|559355071|FG001|Overall Study|Family history of CRC|0|||
154981112|NCT01103479|559355072|FG002|Overall Study|Family history of CRC|2|||
154981113|NCT01103479|559355070|FG000|Overall Study|Active cancer|1|||
154981114|NCT01103479|559355071|FG001|Overall Study|Active cancer|0|||
154981115|NCT01103479|559355072|FG002|Overall Study|Active cancer|0|||
154981116|NCT01103479|559355070|FG000|Overall Study|Saw non-study physician|2|||
154981117|NCT01103479|559355071|FG001|Overall Study|Saw non-study physician|0|||
154981118|NCT01103479|559355072|FG002|Overall Study|Saw non-study physician|0|||
155115062|NCT03176472|559850442|FG001|Double Blind Treatment Period|Physician Decision|1|||
155115063|NCT03176472|559850441|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155115064|NCT03176472|559850442|FG001|Double Blind Treatment Period|Protocol Violation|0|||
154981119|NCT00834899|559355073|FG000|Overall Study|Withdrawal by Subject|1|||
155115065|NCT03176472|559850441|FG000|Double Blind Treatment Period|Not Provided|1|||
155115066|NCT03176472|559850442|FG001|Double Blind Treatment Period|Not Provided|0|||
155115067|NCT03176472|559850441|FG000|Open Label Extension|Withdrawal by Subject|3|||
155115068|NCT03176472|559850442|FG001|Open Label Extension|Withdrawal by Subject|4|||
155115069|NCT03176472|559850441|FG000|Open Label Extension|Adverse Event|2|||
155115070|NCT03176472|559850442|FG001|Open Label Extension|Adverse Event|4|||
155115071|NCT03176472|559850441|FG000|Open Label Extension|Lost to Follow-up|1|||
155115072|NCT03176472|559850442|FG001|Open Label Extension|Lost to Follow-up|2|||
155115073|NCT03176472|559850441|FG000|Open Label Extension|Protocol Violation|0|||
155115074|NCT03176472|559850442|FG001|Open Label Extension|Protocol Violation|1|||
155115075|NCT03176472|559850441|FG000|Open Label Extension|Not Provided|2|||
155115076|NCT03176472|559850442|FG001|Open Label Extension|Not Provided|1|||
155115077|NCT00847665|559850448|FG000|Overall Study|Withdrawal by Subject|1|||
155115078|NCT00847665|559850449|FG001|Overall Study|Withdrawal by Subject|0|||
155115079|NCT04295681|559850456|FG000|Overall Study|Eligibility error|1|||
155115080|NCT04295681|559850457|FG001|Overall Study|Eligibility error|3|||
155115081|NCT00939029|559850458|FG000|Overall Study|Withdrawal by Subject|3|||
155115082|NCT00939029|559850459|FG001|Overall Study|Withdrawal by Subject|7|||
155115083|NCT00939029|559850458|FG000|Overall Study|Lost to Follow-up|3|||
155115084|NCT00939029|559850459|FG001|Overall Study|Lost to Follow-up|4|||
155115085|NCT00939029|559850458|FG000|Overall Study|Adverse Event|0|||
155115086|NCT00939029|559850459|FG001|Overall Study|Adverse Event|1|||
155115087|NCT04686084|559850461|FG000|Overall Study|Lost to Follow-up|1|||
155115088|NCT01535599|559850462|FG000|Overall Study|Adverse Event|6|||
155115089|NCT01535599|559850463|FG001|Overall Study|Adverse Event|15|||
155115090|NCT01535599|559850462|FG000|Overall Study|Lost to Follow-up|3|||
155115091|NCT01535599|559850463|FG001|Overall Study|Lost to Follow-up|4|||
155115092|NCT01535599|559850462|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
155115093|NCT01535599|559850463|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
155115094|NCT01535599|559850462|FG000|Overall Study|Treatment Failure|33|||
155115095|NCT01535599|559850463|FG001|Overall Study|Treatment Failure|66|||
155115096|NCT01535599|559850462|FG000|Overall Study|BL Culture + for Group A Strep|0|||
155115097|NCT01535599|559850463|FG001|Overall Study|BL Culture + for Group A Strep|1|||
155115098|NCT01535599|559850462|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
155115099|NCT01535599|559850463|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
155115100|NCT01535599|559850462|FG000|Overall Study|Randomized in Error|2|||
155115101|NCT01535599|559850463|FG001|Overall Study|Randomized in Error|4|||
155115102|NCT01535599|559850462|FG000|Overall Study|Did not use product|1|||
155115103|NCT01535599|559850463|FG001|Overall Study|Did not use product|0|||
155115104|NCT01535599|559850462|FG000|Overall Study|Other|1|||
155115105|NCT01535599|559850463|FG001|Overall Study|Other|0|||
155115106|NCT01535599|559850462|FG000|Overall Study|Stopped medication|0|||
155115107|NCT01535599|559850463|FG001|Overall Study|Stopped medication|1|||
155115108|NCT01535599|559850462|FG000|Overall Study|Noncompliance|0|||
155115109|NCT01535599|559850463|FG001|Overall Study|Noncompliance|1|||
155175865|NCT01430754|560082140|FG000|Run-In Phase|Lost to Follow-up|1|||
154981120|NCT00834899|559355074|FG001|Overall Study|Withdrawal by Subject|1|||
155115110|NCT02231892|559850472|FG000|Overall Study|Lost to Follow-up|1|||
155115111|NCT02231892|559850473|FG001|Overall Study|Lost to Follow-up|0|||
155115112|NCT02231892|559850474|FG002|Overall Study|Lost to Follow-up|3|||
155115113|NCT02231892|559850472|FG000|Overall Study|Withdrawal by Subject|4|||
155115114|NCT02231892|559850473|FG001|Overall Study|Withdrawal by Subject|3|||
155115115|NCT02231892|559850474|FG002|Overall Study|Withdrawal by Subject|15|||
155115116|NCT02231892|559850472|FG000|Overall Study|Physician Decision|0|||
155115117|NCT02231892|559850473|FG001|Overall Study|Physician Decision|2|||
155115118|NCT02231892|559850474|FG002|Overall Study|Physician Decision|4|||
155115119|NCT02231892|559850472|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
155115120|NCT02231892|559850473|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
155115121|NCT02231892|559850474|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
155115122|NCT02231892|559850472|FG000|Overall Study|Participant motor threshold was >83%|0|||
155115123|NCT02231892|559850473|FG001|Overall Study|Participant motor threshold was >83%|0|||
155115124|NCT02231892|559850474|FG002|Overall Study|Participant motor threshold was >83%|9|||
155115125|NCT02231892|559850472|FG000|Overall Study|Could not find motor threshold|2|||
154981121|NCT02610816|559355077|FG000|Phase 1|Withdrawal by Subject|2|||
154981122|NCT02610816|559355078|FG001|Phase 1|Withdrawal by Subject|6|||
154981123|NCT02610816|559355079|FG002|Phase 1|Withdrawal by Subject|0|||
154981124|NCT02610816|559355080|FG003|Phase 1|Withdrawal by Subject|0|||
154981125|NCT02610816|559355077|FG000|Phase 1|Lost to Follow-up|2|||
154981126|NCT02610816|559355078|FG001|Phase 1|Lost to Follow-up|1|||
154981127|NCT02610816|559355079|FG002|Phase 1|Lost to Follow-up|0|||
154981128|NCT02610816|559355080|FG003|Phase 1|Lost to Follow-up|0|||
154981129|NCT02610816|559355077|FG000|Phase 1|Physician Decision|0|||
154981130|NCT02610816|559355078|FG001|Phase 1|Physician Decision|1|||
154981131|NCT02610816|559355079|FG002|Phase 1|Physician Decision|0|||
154981132|NCT02610816|559355080|FG003|Phase 1|Physician Decision|0|||
154981133|NCT02610816|559355077|FG000|Phase 2|Withdrawal by Subject|0|||
154981134|NCT02610816|559355078|FG001|Phase 2|Withdrawal by Subject|0|||
154981135|NCT02610816|559355079|FG002|Phase 2|Withdrawal by Subject|9|||
154981136|NCT02610816|559355080|FG003|Phase 2|Withdrawal by Subject|3|||
154981137|NCT02610816|559355077|FG000|Phase 2|Lost to Follow-up|0|||
154981138|NCT02610816|559355078|FG001|Phase 2|Lost to Follow-up|0|||
154981139|NCT02610816|559355079|FG002|Phase 2|Lost to Follow-up|2|||
154981140|NCT02610816|559355080|FG003|Phase 2|Lost to Follow-up|0|||
154981141|NCT02610816|559355077|FG000|Phase 2|Physician Decision|0|||
154981142|NCT02610816|559355078|FG001|Phase 2|Physician Decision|0|||
154981143|NCT02610816|559355079|FG002|Phase 2|Physician Decision|0|||
154981144|NCT02610816|559355080|FG003|Phase 2|Physician Decision|2|||
154981145|NCT02610816|559355077|FG000|Phase 2|Pregnancy|0|||
154981146|NCT02610816|559355078|FG001|Phase 2|Pregnancy|0|||
154981147|NCT02610816|559355079|FG002|Phase 2|Pregnancy|0|||
154981148|NCT02610816|559355080|FG003|Phase 2|Pregnancy|1|||
154981149|NCT00384176|559355081|FG000|Overall Study|Death|239|||
154981150|NCT00384176|559355082|FG001|Overall Study|Death|247|||
154981151|NCT00384176|559355083|FG002|Overall Study|Death|105|||
154981152|NCT00384176|559355081|FG000|Overall Study|Withdrawal by Subject|52|||
154981153|NCT00384176|559355082|FG001|Overall Study|Withdrawal by Subject|48|||
154981154|NCT00384176|559355083|FG002|Overall Study|Withdrawal by Subject|22|||
154981155|NCT00384176|559355081|FG000|Overall Study|Lost to Follow-up|16|||
154981156|NCT00384176|559355082|FG001|Overall Study|Lost to Follow-up|18|||
154981157|NCT00384176|559355083|FG002|Overall Study|Lost to Follow-up|4|||
154981158|NCT00384176|559355081|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
154981159|NCT00384176|559355082|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
154981160|NCT00384176|559355083|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
154981161|NCT00384176|559355081|FG000|Overall Study|Longer QTC as Visit 1|1|||
154981162|NCT00384176|559355082|FG001|Overall Study|Longer QTC as Visit 1|0|||
154981163|NCT00384176|559355083|FG002|Overall Study|Longer QTC as Visit 1|0|||
154981164|NCT00384176|559355081|FG000|Overall Study|Toxicity of treatment|1|||
154981165|NCT00384176|559355082|FG001|Overall Study|Toxicity of treatment|0|||
155115126|NCT02231892|559850473|FG001|Overall Study|Could not find motor threshold|0|||
155115127|NCT02231892|559850474|FG002|Overall Study|Could not find motor threshold|1|||
155115128|NCT02231892|559850472|FG000|Overall Study|Could not find reliable motor hotspot|0|||
155115129|NCT02231892|559850473|FG001|Overall Study|Could not find reliable motor hotspot|0|||
155115130|NCT02231892|559850474|FG002|Overall Study|Could not find reliable motor hotspot|1|||
155115131|NCT03832322|559850475|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
155115132|NCT03832322|559850476|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
155115133|NCT01694121|559850485|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
155115134|NCT01694121|559850486|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
155115135|NCT00744978|559850489|FG000|Period 1|Lost to Follow-up|1|||
155115136|NCT00744978|559850490|FG001|Period 1|Lost to Follow-up|0|||
155115137|NCT00744978|559850489|FG000|Period 1|Withdrawal by Subject|0|||
155115138|NCT00744978|559850490|FG001|Period 1|Withdrawal by Subject|2|||
155115139|NCT00744978|559850489|FG000|Period 1|Other|0|||
154981166|NCT00384176|559355083|FG002|Overall Study|Toxicity of treatment|0|||
154981167|NCT00384176|559355081|FG000|Overall Study|Did not receive study treatment|0|||
154981168|NCT00384176|559355082|FG001|Overall Study|Did not receive study treatment|1|||
154981169|NCT00384176|559355083|FG002|Overall Study|Did not receive study treatment|1|||
154981170|NCT00384176|559355081|FG000|Overall Study|Physician Decision|0|||
154981171|NCT00384176|559355082|FG001|Overall Study|Physician Decision|2|||
154981172|NCT00384176|559355083|FG002|Overall Study|Physician Decision|0|||
154981173|NCT00384176|559355081|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
154981174|NCT00384176|559355082|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
155115140|NCT00744978|559850490|FG001|Period 1|Other|2|||
155115141|NCT00744978|559850489|FG000|Period 1|Adverse Event|4|||
155115142|NCT00744978|559850490|FG001|Period 1|Adverse Event|0|||
155115143|NCT00744978|559850489|FG000|Period 1|Randomized but not Treated|1|||
155115144|NCT00744978|559850490|FG001|Period 1|Randomized but not Treated|1|||
155115145|NCT00744978|559850489|FG000|Period 2|Adverse Event|0|||
155115146|NCT00744978|559850490|FG001|Period 2|Adverse Event|1|||
155115147|NCT03773133|559850491|FG000|Overall Study|Screen Failure|8|||
155115148|NCT02928029|559850492|FG000|Overall Study|Withdrawal by Subject|0|||
154981175|NCT00384176|559355083|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
154981176|NCT00402025|559355084|FG000|Overall Study|Adverse Event|0|||
154981177|NCT00402025|559355085|FG001|Overall Study|Adverse Event|0|||
155175866|NCT01430754|560082141|FG001|Run-In Phase|Lost to Follow-up|0|||
155175867|NCT02661178|560082149|FG000|Part 1|Protocol Violation|1|||
155175868|NCT02661178|560082150|FG001|Part 1|Protocol Violation|0|||
155175869|NCT02661178|560082151|FG002|Part 1|Protocol Violation|0|||
155175870|NCT02661178|560082152|FG003|Part 1|Protocol Violation|0|||
155175871|NCT02661178|560082153|FG004|Part 1|Protocol Violation|0|||
155175872|NCT02661178|560082154|FG005|Part 1|Protocol Violation|0|||
155175873|NCT02661178|560082155|FG006|Part 1|Protocol Violation|0|||
155175874|NCT02661178|560082156|FG007|Part 1|Protocol Violation|0|||
155175875|NCT02661178|560082157|FG008|Part 1|Protocol Violation|0|||
155175876|NCT02661178|560082158|FG009|Part 1|Protocol Violation|0|||
155175877|NCT02661178|560082159|FG010|Part 1|Protocol Violation|0|||
155175878|NCT02661178|560082160|FG011|Part 1|Protocol Violation|0|||
155175879|NCT02661178|560082161|FG012|Part 1|Protocol Violation|0|||
155175880|NCT02661178|560082162|FG013|Part 1|Protocol Violation|0|||
155175881|NCT02661178|560082163|FG014|Part 1|Protocol Violation|0|||
155175882|NCT05338671|560082164|FG000|Overall Study|Lost to Follow-up|2|||
155175883|NCT05338671|560082165|FG001|Overall Study|Lost to Follow-up|2|||
155175884|NCT05338671|560082164|FG000|Overall Study|Root canal completed in a single visit|1|||
155175885|NCT05338671|560082165|FG001|Overall Study|Root canal completed in a single visit|0|||
155175886|NCT02855541|560082168|FG000|Overall Study|Change in health status|2|||
155175887|NCT02855541|560082168|FG000|Overall Study|Withdrawal by Subject|2|||
155175888|NCT01242813|560082169|FG000|Overall Study|Lost to Follow-up|2|||
154900767|NCT02918318|559059071|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
154900768|NCT02918318|559059072|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
154900769|NCT02918318|559059073|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
154900770|NCT02918318|559059069|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
154900771|NCT02918318|559059070|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
154900772|NCT02918318|559059071|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
154900773|NCT02918318|559059072|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
154900774|NCT02918318|559059073|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
154900775|NCT02918318|559059069|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
154900776|NCT02918318|559059070|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
154900777|NCT02918318|559059071|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
154900778|NCT02918318|559059072|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
154900779|NCT02918318|559059073|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
154900780|NCT02918318|559059069|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
154900781|NCT02918318|559059070|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
154900782|NCT02918318|559059071|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
154900783|NCT02918318|559059072|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
154900784|NCT02918318|559059073|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
154900785|NCT02918318|559059069|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
154900786|NCT02918318|559059070|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
154900787|NCT02918318|559059071|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
154900788|NCT02918318|559059072|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
154900789|NCT02918318|559059073|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
154900790|NCT02918318|559059069|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
154900791|NCT02918318|559059070|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
154900792|NCT02918318|559059071|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
154900793|NCT02918318|559059072|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
154900794|NCT02918318|559059073|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
154900795|NCT02918318|559059069|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
154900796|NCT02918318|559059070|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
154900797|NCT02918318|559059071|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
154900798|NCT02918318|559059072|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
154900799|NCT02918318|559059073|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
154900800|NCT01548417|559059074|FG000|Overall Study|Withdrawal by Subject|0|||
154900801|NCT01548417|559059075|FG001|Overall Study|Withdrawal by Subject|2|||
154900802|NCT04583969|559059076|FG000|Overall Study|Death|31|||
154900803|NCT04583969|559059077|FG001|Overall Study|Death|38|||
154900804|NCT04583969|559059076|FG000|Overall Study|Lost to Follow-up|16|||
154900805|NCT04583969|559059077|FG001|Overall Study|Lost to Follow-up|13|||
154900806|NCT04583969|559059076|FG000|Overall Study|Protocol Violation|1|||
154900807|NCT04583969|559059077|FG001|Overall Study|Protocol Violation|0|||
154900808|NCT04583969|559059076|FG000|Overall Study|Withdrawal by Subject|3|||
154900809|NCT04583969|559059077|FG001|Overall Study|Withdrawal by Subject|3|||
154900810|NCT04583969|559059076|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
154900811|NCT04583969|559059077|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
155175889|NCT00701662|560082170|FG000|Overall Study|Lack of Efficacy|1|||
155175890|NCT02353143|560082177|FG000|Overall Study|Withdrawal by Subject|1|||
155175891|NCT02353143|560082178|FG001|Overall Study|Withdrawal by Subject|0|||
155175892|NCT02353143|560082179|FG002|Overall Study|Withdrawal by Subject|0|||
155175893|NCT02353143|560082180|FG003|Overall Study|Withdrawal by Subject|0|||
155175894|NCT02353143|560082181|FG004|Overall Study|Withdrawal by Subject|1|||
154981178|NCT00402025|559355086|FG002|Overall Study|Adverse Event|2|||
154981179|NCT00402025|559355084|FG000|Overall Study|Death|0|||
154981180|NCT00402025|559355085|FG001|Overall Study|Death|1|||
154981181|NCT00402025|559355086|FG002|Overall Study|Death|5|||
154981182|NCT00402025|559355084|FG000|Overall Study|Disease Progression|1|||
154981183|NCT00402025|559355085|FG001|Overall Study|Disease Progression|1|||
154981184|NCT00402025|559355086|FG002|Overall Study|Disease Progression|2|||
154981185|NCT00402025|559355084|FG000|Overall Study|Physician Decision|1|||
154981186|NCT00402025|559355085|FG001|Overall Study|Physician Decision|1|||
154981187|NCT00402025|559355086|FG002|Overall Study|Physician Decision|0|||
154981188|NCT00402025|559355084|FG000|Overall Study|Participant Decision|0|||
154981189|NCT00402025|559355085|FG001|Overall Study|Participant Decision|0|||
154981190|NCT00402025|559355086|FG002|Overall Study|Participant Decision|1|||
154981191|NCT03078478|559355094|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
154981192|NCT03078478|559355095|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
154981193|NCT03078478|559355094|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
155115149|NCT02928029|559850493|FG001|Overall Study|Withdrawal by Subject|1|||
155115150|NCT02928029|559850492|FG000|Overall Study|Radiological progression|1|||
154900812|NCT04583969|559059076|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
154900813|NCT04583969|559059077|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
154900814|NCT04583969|559059076|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
154900815|NCT04583969|559059077|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
154900816|NCT04583969|559059076|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
154900817|NCT04583969|559059077|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
154900818|NCT04583969|559059076|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
154900819|NCT04583969|559059077|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
154900820|NCT01192100|559059084|FG000|Overall Study|Withdrawal by Subject|0|||
154900821|NCT01192100|559059085|FG001|Overall Study|Withdrawal by Subject|0|||
154900822|NCT01192100|559059086|FG002|Overall Study|Withdrawal by Subject|0|||
154900823|NCT01192100|559059087|FG003|Overall Study|Withdrawal by Subject|0|||
154900824|NCT01192100|559059088|FG004|Overall Study|Withdrawal by Subject|1|||
154900825|NCT01192100|559059089|FG005|Overall Study|Withdrawal by Subject|0|||
154900826|NCT01192100|559059084|FG000|Overall Study|Protocol Violation|0|||
154900827|NCT01192100|559059085|FG001|Overall Study|Protocol Violation|0|||
154900828|NCT01192100|559059086|FG002|Overall Study|Protocol Violation|0|||
154900829|NCT01192100|559059087|FG003|Overall Study|Protocol Violation|1|||
154900830|NCT01192100|559059088|FG004|Overall Study|Protocol Violation|0|||
154900831|NCT01192100|559059089|FG005|Overall Study|Protocol Violation|0|||
154900832|NCT02057068|559059090|FG000|Overall Study|Withdrawal by Subject|2|||
154900833|NCT02057068|559059091|FG001|Overall Study|Withdrawal by Subject|2|||
154900834|NCT02057068|559059090|FG000|Overall Study|Caregiver (CG) Health|0|||
154900835|NCT02057068|559059091|FG001|Overall Study|Caregiver (CG) Health|2|||
154900836|NCT02057068|559059090|FG000|Overall Study|Carepartner (CP) Health|4|||
154900837|NCT02057068|559059091|FG001|Overall Study|Carepartner (CP) Health|2|||
154900838|NCT02057068|559059090|FG000|Overall Study|Lost to Follow-up|2|||
154900839|NCT02057068|559059091|FG001|Overall Study|Lost to Follow-up|2|||
154900840|NCT00865046|559059093|FG000|Overall Study|Lost to Follow-up|1|||
154900841|NCT00865046|559059094|FG001|Overall Study|Lost to Follow-up|4|||
154900842|NCT00865046|559059095|FG002|Overall Study|Lost to Follow-up|0|||
154900843|NCT00865046|559059093|FG000|Overall Study|Death|0|||
154900844|NCT00865046|559059094|FG001|Overall Study|Death|1|||
154900845|NCT00865046|559059095|FG002|Overall Study|Death|1|||
154900846|NCT00865046|559059093|FG000|Overall Study|Withdrawal by Subject|5|||
154900847|NCT00865046|559059094|FG001|Overall Study|Withdrawal by Subject|0|||
154981194|NCT03078478|559355095|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
154981195|NCT03078478|559355094|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
154981196|NCT03078478|559355095|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
154981197|NCT03078478|559355094|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
154981198|NCT03078478|559355095|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
154981199|NCT03078478|559355094|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
154981200|NCT03078478|559355095|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
154981201|NCT03078478|559355094|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
154981202|NCT03078478|559355095|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
154981203|NCT03078478|559355094|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
155115151|NCT02928029|559850493|FG001|Overall Study|Radiological progression|0|||
155115152|NCT02928029|559850492|FG000|Overall Study|Clinical progression|1|||
154981204|NCT03078478|559355095|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
154981205|NCT03078478|559355094|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
155115153|NCT02928029|559850493|FG001|Overall Study|Clinical progression|2|||
155115154|NCT02928029|559850492|FG000|Overall Study|AE not related to clinical progression|1|||
154900848|NCT00865046|559059095|FG002|Overall Study|Withdrawal by Subject|0|||
154900849|NCT01098032|559059101|FG000|Overall Study|Withdrawal by Subject|1|||
154900850|NCT01098032|559059102|FG001|Overall Study|Withdrawal by Subject|1|||
154900851|NCT02959190|559059103|FG000|Open Label|Adverse Event|5|||
154900852|NCT02959190|559059104|FG001|Open Label|Adverse Event|7|||
154900853|NCT02959190|559059105|FG002|Open Label|Adverse Event|3|||
154900854|NCT02959190|559059106|FG003|Open Label|Adverse Event|4|||
154900855|NCT02959190|559059103|FG000|Open Label|Pregnancy|0|||
154900856|NCT02959190|559059104|FG001|Open Label|Pregnancy|1|||
154900857|NCT02959190|559059105|FG002|Open Label|Pregnancy|0|||
154900858|NCT02959190|559059106|FG003|Open Label|Pregnancy|0|||
154900859|NCT02959190|559059103|FG000|Open Label|Withdrawal by Subject|2|||
154900860|NCT02959190|559059104|FG001|Open Label|Withdrawal by Subject|8|||
154900861|NCT02959190|559059105|FG002|Open Label|Withdrawal by Subject|0|||
154900862|NCT02959190|559059106|FG003|Open Label|Withdrawal by Subject|0|||
154900863|NCT02959190|559059103|FG000|Open Label|Physician Decision|0|||
154900864|NCT02959190|559059104|FG001|Open Label|Physician Decision|0|||
154900865|NCT02959190|559059105|FG002|Open Label|Physician Decision|1|||
154900866|NCT02959190|559059106|FG003|Open Label|Physician Decision|0|||
154900867|NCT02959190|559059103|FG000|Open Label|Protocol Violation|0|||
154900868|NCT02959190|559059104|FG001|Open Label|Protocol Violation|0|||
154900869|NCT02959190|559059105|FG002|Open Label|Protocol Violation|0|||
154900870|NCT02959190|559059106|FG003|Open Label|Protocol Violation|2|||
154900871|NCT02959190|559059103|FG000|Post Treatment Follow Up|Adverse Event|1|||
154900872|NCT02959190|559059104|FG001|Post Treatment Follow Up|Adverse Event|1|||
154900873|NCT02959190|559059105|FG002|Post Treatment Follow Up|Adverse Event|0|||
154900874|NCT02959190|559059106|FG003|Post Treatment Follow Up|Adverse Event|0|||
154900875|NCT02959190|559059103|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
154900876|NCT02959190|559059104|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
154900877|NCT02959190|559059105|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
154900878|NCT02959190|559059106|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
154900879|NCT02709109|559059108|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
154900880|NCT02709109|559059109|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
154900881|NCT02709109|559059110|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
154900882|NCT02709109|559059111|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
154900883|NCT02709109|559059108|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
154900884|NCT02709109|559059109|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
154900885|NCT02709109|559059110|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
154900886|NCT02709109|559059111|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
154900887|NCT02709109|559059108|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
154900888|NCT02709109|559059109|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
154900889|NCT02709109|559059110|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
154900890|NCT02709109|559059111|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
155115155|NCT02928029|559850493|FG001|Overall Study|AE not related to clinical progression|1|||
155115156|NCT00515294|559850494|FG000|Overall Study|Lost to Follow-up|3|||
155115157|NCT00515294|559850495|FG001|Overall Study|Lost to Follow-up|2|||
155115158|NCT00515294|559850496|FG002|Overall Study|Lost to Follow-up|3|||
155115159|NCT00515294|559850497|FG003|Overall Study|Lost to Follow-up|1|||
155115160|NCT00515294|559850494|FG000|Overall Study|Driver simulator problems|1|||
154900891|NCT02709109|559059108|FG000|Washout Period (28 Days)|Other|2|||
154900892|NCT02709109|559059109|FG001|Washout Period (28 Days)|Other|2|||
154900893|NCT02709109|559059110|FG002|Washout Period (28 Days)|Other|3|||
154900894|NCT02709109|559059111|FG003|Washout Period (28 Days)|Other|0|||
154900895|NCT02709109|559059108|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
154900896|NCT02709109|559059109|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
154900897|NCT02709109|559059110|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
154900898|NCT02709109|559059111|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
154900899|NCT02709109|559059108|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
154900900|NCT02709109|559059109|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
154900901|NCT02709109|559059110|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
154900902|NCT02709109|559059111|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
154900903|NCT02709109|559059108|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
154900904|NCT02709109|559059109|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
154900905|NCT02709109|559059110|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
154900906|NCT02709109|559059111|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
154900907|NCT02709109|559059108|FG000|Treatment Period 2 (28 Days)|Other|0|||
154900908|NCT02709109|559059109|FG001|Treatment Period 2 (28 Days)|Other|0|||
154900909|NCT02709109|559059110|FG002|Treatment Period 2 (28 Days)|Other|1|||
154900910|NCT02709109|559059111|FG003|Treatment Period 2 (28 Days)|Other|0|||
154900911|NCT01928082|559059113|FG000|Overall Study|Study terminated.|1|||
154900912|NCT01815580|559059116|FG000|Overall Study|Lost to Follow-up|4|||
154900913|NCT01815580|559059117|FG001|Overall Study|Lost to Follow-up|7|||
155115161|NCT00515294|559850495|FG001|Overall Study|Driver simulator problems|1|||
155115162|NCT00515294|559850496|FG002|Overall Study|Driver simulator problems|1|||
155115163|NCT00515294|559850497|FG003|Overall Study|Driver simulator problems|3|||
155115164|NCT00515294|559850494|FG000|Overall Study|Caffeine amount inaccurate|5|||
154900914|NCT01815580|559059116|FG000|Overall Study|Withdrawal by Subject|3|||
154900915|NCT01815580|559059117|FG001|Overall Study|Withdrawal by Subject|4|||
154981206|NCT03078478|559355095|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
154981207|NCT02756637|559355100|FG000|Overall Study|Not eligible for initial SWOG study|10|||
154981208|NCT02756637|559355101|FG001|Overall Study|Not eligible for initial SWOG study|10|||
154981209|NCT02756637|559355100|FG000|Overall Study|No available NLR value|44|||
154981210|NCT02756637|559355101|FG001|Overall Study|No available NLR value|44|||
154981211|NCT02756637|559355100|FG000|Overall Study|Did not complete curative therapy|33|||
154900916|NCT01815580|559059116|FG000|Overall Study|Excluded from analysis|5|||
154900917|NCT01815580|559059117|FG001|Overall Study|Excluded from analysis|4|||
154900918|NCT01814826|559059122|FG000|Overall Study|Other|3|||
154900919|NCT01814826|559059123|FG001|Overall Study|Other|5|||
154900920|NCT01814826|559059124|FG002|Overall Study|Other|0|||
154900921|NCT01814826|559059122|FG000|Overall Study|Death|29|||
154900922|NCT01814826|559059123|FG001|Overall Study|Death|24|||
154900923|NCT01814826|559059124|FG002|Overall Study|Death|3|||
154900924|NCT02917629|559059125|FG000|Overall Study|Withdrawal by Subject|0|||
154900925|NCT02917629|559059126|FG001|Overall Study|Withdrawal by Subject|1|||
154900926|NCT03271307|559059127|FG000|Overall Study|Lost to Follow-up|0|||
154900927|NCT03271307|559059128|FG001|Overall Study|Lost to Follow-up|0|||
154900928|NCT03271307|559059129|FG002|Overall Study|Lost to Follow-up|0|||
154900929|NCT03271307|559059130|FG003|Overall Study|Lost to Follow-up|28|||
154900930|NCT03271307|559059131|FG004|Overall Study|Lost to Follow-up|91|||
154900931|NCT03997760|559059132|FG000|Overall Study|Protocol Deviation|0|||
154900932|NCT03997760|559059133|FG001|Overall Study|Protocol Deviation|1|||
154900933|NCT03997760|559059134|FG002|Overall Study|Protocol Deviation|0|||
154900934|NCT03997760|559059135|FG003|Overall Study|Protocol Deviation|0|||
154900935|NCT02079519|559059141|FG000|Overall Study|Disease Progression|9|||
154900936|NCT02079519|559059141|FG000|Overall Study|Adverse Event|1|||
154900937|NCT01802515|559059142|FG000|Overall Study|Withdrawal by Subject|3|||
154900938|NCT01802515|559059143|FG001|Overall Study|Withdrawal by Subject|0|||
154900939|NCT01802515|559059144|FG002|Overall Study|Withdrawal by Subject|0|||
154900940|NCT02566109|559059145|FG000|Overall Study|Withdrawal by Subject|1|||
154900941|NCT01906476|559059146|FG000|Overall Study|Lost to Follow-up|17|||
154900942|NCT01906476|559059147|FG001|Overall Study|Lost to Follow-up|16|||
154900943|NCT01041404|559059150|FG000|Overall Study|Adverse Event|45|||
154900944|NCT01041404|559059151|FG001|Overall Study|Adverse Event|35|||
154900945|NCT01041404|559059150|FG000|Overall Study|Lack of Efficacy|200|||
154900946|NCT01041404|559059151|FG001|Overall Study|Lack of Efficacy|210|||
154900947|NCT01041404|559059150|FG000|Overall Study|Violation of Selection Criteria|0|||
154900948|NCT01041404|559059151|FG001|Overall Study|Violation of Selection Criteria|1|||
154900949|NCT01041404|559059150|FG000|Overall Study|Protocol Violation|4|||
154900950|NCT01041404|559059151|FG001|Overall Study|Protocol Violation|0|||
154900951|NCT01041404|559059150|FG000|Overall Study|Withdrawal by Subject|29|||
154900952|NCT01041404|559059151|FG001|Overall Study|Withdrawal by Subject|23|||
154900953|NCT01041404|559059150|FG000|Overall Study|Failure to Return|1|||
154900954|NCT01041404|559059151|FG001|Overall Study|Failure to Return|2|||
154900955|NCT01041404|559059150|FG000|Overall Study|Other|11|||
154900956|NCT01041404|559059151|FG001|Overall Study|Other|23|||
154900957|NCT00318370|559059154|FG000|Period 1|Lack of Efficacy|5|||
154900958|NCT00318370|559059155|FG001|Period 1|Lack of Efficacy|0|||
154900959|NCT00318370|559059156|FG002|Period 1|Lack of Efficacy|0|||
154900960|NCT00318370|559059154|FG000|Period 1|Physician Decision|1|||
154900961|NCT00318370|559059155|FG001|Period 1|Physician Decision|0|||
154900962|NCT00318370|559059156|FG002|Period 1|Physician Decision|0|||
154900963|NCT00318370|559059154|FG000|Period 1|Withdrawal by Subject|1|||
154900964|NCT00318370|559059155|FG001|Period 1|Withdrawal by Subject|0|||
154900965|NCT00318370|559059156|FG002|Period 1|Withdrawal by Subject|0|||
154900966|NCT00318370|559059154|FG000|Period 2|Adverse Event|0|||
154900967|NCT00318370|559059155|FG001|Period 2|Adverse Event|3|||
154900968|NCT00318370|559059156|FG002|Period 2|Adverse Event|0|||
154900969|NCT00318370|559059154|FG000|Period 2|Lack of Efficacy|0|||
154900970|NCT00318370|559059155|FG001|Period 2|Lack of Efficacy|5|||
154900971|NCT00318370|559059156|FG002|Period 2|Lack of Efficacy|0|||
154900972|NCT00318370|559059154|FG000|Period 2|Physician Decision|0|||
154900973|NCT00318370|559059155|FG001|Period 2|Physician Decision|1|||
154900974|NCT00318370|559059156|FG002|Period 2|Physician Decision|0|||
154981212|NCT02756637|559355101|FG001|Overall Study|Did not complete curative therapy|0|||
154900975|NCT00318370|559059154|FG000|Period 2|Withdrawal by Subject|0|||
154900976|NCT00318370|559059155|FG001|Period 2|Withdrawal by Subject|1|||
154900977|NCT00318370|559059156|FG002|Period 2|Withdrawal by Subject|0|||
155115165|NCT00515294|559850495|FG001|Overall Study|Caffeine amount inaccurate|0|||
154900978|NCT00318370|559059154|FG000|Period 2|Other|0|||
154900979|NCT00318370|559059155|FG001|Period 2|Other|1|||
154900980|NCT00318370|559059156|FG002|Period 2|Other|0|||
154900981|NCT00318370|559059154|FG000|Period 3|Adverse Event|0|||
154900982|NCT00318370|559059155|FG001|Period 3|Adverse Event|0|||
154900983|NCT00318370|559059156|FG002|Period 3|Adverse Event|1|||
154900984|NCT00318370|559059154|FG000|Period 3|Lack of Efficacy|0|||
154900985|NCT00318370|559059155|FG001|Period 3|Lack of Efficacy|0|||
154900986|NCT00318370|559059156|FG002|Period 3|Lack of Efficacy|24|||
154900987|NCT00318370|559059154|FG000|Period 3|Death|0|||
154981213|NCT03064438|559356792|FG000|Overall Study|Lost to Follow-up|1|||
154900988|NCT00318370|559059155|FG001|Period 3|Death|0|||
154900989|NCT00318370|559059156|FG002|Period 3|Death|1|||
154900990|NCT00318370|559059154|FG000|Period 3|Physician Decision|0|||
154900991|NCT00318370|559059155|FG001|Period 3|Physician Decision|0|||
154900992|NCT00318370|559059156|FG002|Period 3|Physician Decision|1|||
154900993|NCT00318370|559059154|FG000|Period 3|Withdrawal by Subject|0|||
154900994|NCT00318370|559059155|FG001|Period 3|Withdrawal by Subject|0|||
154900995|NCT00318370|559059156|FG002|Period 3|Withdrawal by Subject|3|||
154900996|NCT00318370|559059154|FG000|Period 3|Other|0|||
154900997|NCT00318370|559059155|FG001|Period 3|Other|0|||
154900998|NCT00318370|559059156|FG002|Period 3|Other|3|||
154900999|NCT03627494|559059161|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
154901000|NCT03627494|559059162|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901001|NCT03627494|559059163|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
154901002|NCT03627494|559059164|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901003|NCT03627494|559059165|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901004|NCT03627494|559059166|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901005|NCT03627494|559059167|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901006|NCT03627494|559059168|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901007|NCT03627494|559059169|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901008|NCT03627494|559059170|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901009|NCT03627494|559059171|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901010|NCT03627494|559059172|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
154901011|NCT03627494|559059161|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901012|NCT03627494|559059162|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901013|NCT03627494|559059163|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901014|NCT03627494|559059164|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901015|NCT03627494|559059165|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901016|NCT03627494|559059166|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901017|NCT03627494|559059167|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901018|NCT03627494|559059168|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901019|NCT03627494|559059169|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
154901020|NCT03627494|559059170|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901021|NCT03627494|559059171|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901022|NCT03627494|559059172|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
154901023|NCT03627494|559059161|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901024|NCT03627494|559059162|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901025|NCT03627494|559059163|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901026|NCT03627494|559059164|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901027|NCT03627494|559059165|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901028|NCT03627494|559059166|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901029|NCT03627494|559059167|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901030|NCT03627494|559059168|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901031|NCT03627494|559059169|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901032|NCT03627494|559059170|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
154901033|NCT03627494|559059171|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
154901034|NCT03627494|559059172|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
154901035|NCT01183104|559060875|FG000|Overall Study|Adverse Event|8|||
154901036|NCT01183104|559060876|FG001|Overall Study|Adverse Event|6|||
154901037|NCT01183104|559060875|FG000|Overall Study|Death|0|||
154901038|NCT01183104|559060876|FG001|Overall Study|Death|1|||
154901039|NCT01183104|559060875|FG000|Overall Study|Lost to Follow-up|14|||
154901040|NCT01183104|559060876|FG001|Overall Study|Lost to Follow-up|7|||
154901041|NCT01183104|559060875|FG000|Overall Study|Physician Decision|5|||
154901042|NCT01183104|559060876|FG001|Overall Study|Physician Decision|8|||
154901043|NCT01183104|559060875|FG000|Overall Study|Withdrawal by Subject|6|||
154901044|NCT01183104|559060876|FG001|Overall Study|Withdrawal by Subject|11|||
154901045|NCT01183104|559060875|FG000|Overall Study|Nonparticipation in Extension Study|39|||
154901046|NCT01183104|559060876|FG001|Overall Study|Nonparticipation in Extension Study|50|||
154901047|NCT01183104|559060875|FG000|Overall Study|Did not receive study drug|5|||
154901048|NCT01183104|559060876|FG001|Overall Study|Did not receive study drug|9|||
154901049|NCT01594749|559060877|FG000|Overall Study|Adverse Event|2|||
154901050|NCT01594749|559060878|FG001|Overall Study|Adverse Event|1|||
154901051|NCT01594749|559060877|FG000|Overall Study|Withdrawal by Subject|2|||
154981214|NCT03064438|559356793|FG001|Overall Study|Lost to Follow-up|0|||
154901052|NCT01594749|559060878|FG001|Overall Study|Withdrawal by Subject|2|||
154901053|NCT01594749|559060877|FG000|Overall Study|Protocol Violation|2|||
154981215|NCT03064438|559356792|FG000|Overall Study|Withdrawal by Subject|0|||
154901054|NCT01594749|559060878|FG001|Overall Study|Protocol Violation|0|||
154901055|NCT01594749|559060877|FG000|Overall Study|Physician Decision|1|||
154901056|NCT01594749|559060878|FG001|Overall Study|Physician Decision|1|||
154901057|NCT01594749|559060877|FG000|Overall Study|Non-compliance with Protocol|0|||
154901058|NCT01594749|559060878|FG001|Overall Study|Non-compliance with Protocol|1|||
154901059|NCT01594749|559060877|FG000|Overall Study|Lost to Follow-up|1|||
154901060|NCT01594749|559060878|FG001|Overall Study|Lost to Follow-up|0|||
154901061|NCT01594749|559060877|FG000|Overall Study|Death|9|||
154901062|NCT01594749|559060878|FG001|Overall Study|Death|3|||
154901063|NCT01594749|559060877|FG000|Overall Study|Not Treated|4|||
154981216|NCT03064438|559356793|FG001|Overall Study|Withdrawal by Subject|1|||
154901064|NCT01594749|559060878|FG001|Overall Study|Not Treated|10|||
154901065|NCT01594749|559060877|FG000|Overall Study|Lost Source Documentation|1|||
154901066|NCT01594749|559060878|FG001|Overall Study|Lost Source Documentation|0|||
154901067|NCT00688623|559060881|FG000|Overall Study|Adverse Event|22|||
154901068|NCT00688623|559060881|FG000|Overall Study|abnormal lab value|1|||
154901069|NCT00688623|559060881|FG000|Overall Study|Withdrawal by Subject|4|||
154901070|NCT00688623|559060881|FG000|Overall Study|Death|3|||
154981217|NCT01314118|559356794|FG000|Overall Study|Adverse Event|10|||
154981218|NCT01314118|559356794|FG000|Overall Study|Progressive disease|3|||
154981219|NCT01314118|559356794|FG000|Overall Study|Death|8|||
154981220|NCT01314118|559356794|FG000|Overall Study|Physician Decision|13|||
154901071|NCT00688623|559060881|FG000|Overall Study|disease progression|23|||
154901072|NCT00688623|559060881|FG000|Overall Study|Protocol Violation|2|||
154901073|NCT02443155|559060882|FG000|Overall Study|Adverse Event|3|||
154901074|NCT02443155|559060883|FG001|Overall Study|Adverse Event|4|||
154901075|NCT02443155|559060884|FG002|Overall Study|Adverse Event|1|||
154901076|NCT02443155|559060885|FG003|Overall Study|Adverse Event|2|||
154901077|NCT02443155|559060882|FG000|Overall Study|Unclassified|0|||
154901078|NCT02443155|559060883|FG001|Overall Study|Unclassified|0|||
154901079|NCT02443155|559060884|FG002|Overall Study|Unclassified|2|||
154901080|NCT02443155|559060885|FG003|Overall Study|Unclassified|1|||
154901081|NCT02443155|559060882|FG000|Overall Study|Withdrawal by Subject|4|||
154901082|NCT02443155|559060883|FG001|Overall Study|Withdrawal by Subject|7|||
154901083|NCT02443155|559060884|FG002|Overall Study|Withdrawal by Subject|3|||
154901084|NCT02443155|559060885|FG003|Overall Study|Withdrawal by Subject|9|||
154901085|NCT02443155|559060882|FG000|Overall Study|Pregnancy|3|||
154901086|NCT02443155|559060883|FG001|Overall Study|Pregnancy|1|||
154901087|NCT02443155|559060884|FG002|Overall Study|Pregnancy|1|||
154901088|NCT02443155|559060885|FG003|Overall Study|Pregnancy|2|||
154901089|NCT02443155|559060882|FG000|Overall Study|Lost to Follow-up|1|||
154901090|NCT02443155|559060883|FG001|Overall Study|Lost to Follow-up|2|||
154901091|NCT02443155|559060884|FG002|Overall Study|Lost to Follow-up|0|||
154901092|NCT02443155|559060885|FG003|Overall Study|Lost to Follow-up|1|||
154901093|NCT02443155|559060882|FG000|Overall Study|Protocol Violation|1|||
154901094|NCT02443155|559060883|FG001|Overall Study|Protocol Violation|0|||
154901095|NCT02443155|559060884|FG002|Overall Study|Protocol Violation|1|||
154901096|NCT02443155|559060885|FG003|Overall Study|Protocol Violation|1|||
154901097|NCT02443155|559060882|FG000|Overall Study|Death|0|||
154901098|NCT02443155|559060883|FG001|Overall Study|Death|0|||
154901099|NCT02443155|559060884|FG002|Overall Study|Death|1|||
154901100|NCT02443155|559060885|FG003|Overall Study|Death|0|||
154901101|NCT00608894|559060889|FG000|Overall Study|Withdrawal by Subject|0|||
154901102|NCT00608894|559060890|FG001|Overall Study|Withdrawal by Subject|2|||
154901103|NCT02809118|559060892|FG000|Overall Study|Withdrawal by Subject|0|||
154901104|NCT02809118|559060893|FG001|Overall Study|Withdrawal by Subject|1|||
154901105|NCT02809118|559060894|FG002|Overall Study|Withdrawal by Subject|1|||
154901106|NCT02828644|559060896|FG000|Overall Study|Lost to Follow-up|23|||
154901107|NCT02828644|559060897|FG001|Overall Study|Lost to Follow-up|22|||
154901108|NCT02408484|559060898|FG000|Overall Study|Withdrawal by Subject|3|||
154901109|NCT02408484|559060898|FG000|Overall Study|Not treated during study period|1|||
154901110|NCT02436915|559060899|FG000|Overall Study|Withdrawal by Subject|0|||
154901111|NCT02436915|559060900|FG001|Overall Study|Withdrawal by Subject|1|||
154901112|NCT01117181|559060902|FG000|Overall Study|Lost to Follow-up|1|||
154981221|NCT01314118|559356794|FG000|Overall Study|Sponsor Decision|1|||
154981222|NCT01314118|559356794|FG000|Overall Study|Protocol Violation|2|||
154981223|NCT01314118|559356794|FG000|Overall Study|Withdrawal by Subject|26|||
154981224|NCT01314118|559356794|FG000|Overall Study|Other|21|||
154981225|NCT04266301|559356795|FG000|Overall Study|Progressive Disease|111|||
154981226|NCT04266301|559356796|FG001|Overall Study|Progressive Disease|92|||
154901113|NCT01117181|559060903|FG001|Overall Study|Lost to Follow-up|0|||
154981227|NCT04266301|559356795|FG000|Overall Study|Adverse Event|41|||
154981228|NCT04266301|559356796|FG001|Overall Study|Adverse Event|43|||
154981229|NCT04266301|559356795|FG000|Overall Study|Death|26|||
155175895|NCT02353143|560082182|FG005|Overall Study|Withdrawal by Subject|0|||
154901114|NCT01117181|559060902|FG000|Overall Study|Withdrawal by Subject|0|||
154901115|NCT01117181|559060903|FG001|Overall Study|Withdrawal by Subject|2|||
154901116|NCT01119963|559060906|FG000|Overall Study|Lost to Follow-up|1|||
154901117|NCT01119963|559060907|FG001|Overall Study|Lost to Follow-up|1|||
154901118|NCT00254163|559060908|FG000|Overall Study|Adverse Event|29|||
154901119|NCT00254163|559060909|FG001|Overall Study|Adverse Event|26|||
154901120|NCT00254163|559060908|FG000|Overall Study|Patient request/withdrew consent|6|||
154901121|NCT00254163|559060909|FG001|Overall Study|Patient request/withdrew consent|4|||
154901122|NCT00254163|559060908|FG000|Overall Study|Investigator request|1|||
154901123|NCT00254163|559060909|FG001|Overall Study|Investigator request|3|||
154901124|NCT00254163|559060908|FG000|Overall Study|Failed entry|1|||
154901125|NCT00254163|559060909|FG001|Overall Study|Failed entry|3|||
154981230|NCT04266301|559356796|FG001|Overall Study|Death|35|||
154981231|NCT04266301|559356795|FG000|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
155175896|NCT02353143|560082183|FG006|Overall Study|Withdrawal by Subject|0|||
155115166|NCT00515294|559850496|FG002|Overall Study|Caffeine amount inaccurate|7|||
155115167|NCT00515294|559850497|FG003|Overall Study|Caffeine amount inaccurate|0|||
155115168|NCT02359045|559850501|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
154901126|NCT00254163|559060908|FG000|Overall Study|Progressive disease|0|||
155115169|NCT02359045|559850502|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155115170|NCT02359045|559850501|FG000|Overall Study|Lost to Follow-up|1|||
155115171|NCT02359045|559850502|FG001|Overall Study|Lost to Follow-up|1|||
155115172|NCT02359045|559850501|FG000|Overall Study|Adverse Event|0|||
155115173|NCT02359045|559850502|FG001|Overall Study|Adverse Event|1|||
155115174|NCT02979093|559850520|FG000|First Scan Session|Scanning data problems|1|||
155115175|NCT02979093|559850521|FG001|First Scan Session|Scanning data problems|2|||
155115176|NCT02979093|559850522|FG002|First Scan Session|Scanning data problems|2|||
155115177|NCT02979093|559850523|FG003|First Scan Session|Scanning data problems|0|||
155115178|NCT02979093|559850520|FG000|Second Scan Session|Scanning data problems|3|||
155115179|NCT02979093|559850521|FG001|Second Scan Session|Scanning data problems|0|||
155115180|NCT02979093|559850522|FG002|Second Scan Session|Scanning data problems|1|||
155115181|NCT02979093|559850523|FG003|Second Scan Session|Scanning data problems|3|||
155115182|NCT06107803|559850524|FG000|Overall Study|Adverse Event|1|||
155115183|NCT06107803|559850524|FG000|Overall Study|Withdrawal by Subject|2|||
155115184|NCT06107803|559850524|FG000|Overall Study|Protocol Violation|1|||
155115185|NCT03099174|559850525|FG000|Overall Study|Withdrawal by Subject|0|||
155115186|NCT03099174|559850526|FG001|Overall Study|Withdrawal by Subject|0|||
155115187|NCT03099174|559850527|FG002|Overall Study|Withdrawal by Subject|1|||
155115188|NCT03099174|559850528|FG003|Overall Study|Withdrawal by Subject|0|||
155115189|NCT03099174|559850529|FG004|Overall Study|Withdrawal by Subject|2|||
155115190|NCT03099174|559850530|FG005|Overall Study|Withdrawal by Subject|2|||
155115191|NCT03099174|559850531|FG006|Overall Study|Withdrawal by Subject|1|||
155115192|NCT03099174|559850532|FG007|Overall Study|Withdrawal by Subject|4|||
155115193|NCT03099174|559850525|FG000|Overall Study|Adverse Event|0|||
155115194|NCT03099174|559850526|FG001|Overall Study|Adverse Event|1|||
155115195|NCT03099174|559850527|FG002|Overall Study|Adverse Event|1|||
155115196|NCT03099174|559850528|FG003|Overall Study|Adverse Event|2|||
155115197|NCT03099174|559850529|FG004|Overall Study|Adverse Event|5|||
155115198|NCT03099174|559850530|FG005|Overall Study|Adverse Event|3|||
155115199|NCT03099174|559850531|FG006|Overall Study|Adverse Event|6|||
155115200|NCT03099174|559850532|FG007|Overall Study|Adverse Event|4|||
155115201|NCT03099174|559850525|FG000|Overall Study|Other than listed|6|||
155115202|NCT03099174|559850526|FG001|Overall Study|Other than listed|6|||
155115203|NCT03099174|559850527|FG002|Overall Study|Other than listed|5|||
154901127|NCT00254163|559060909|FG001|Overall Study|Progressive disease|1|||
154901128|NCT00254163|559060908|FG000|Overall Study|Death|0|||
154901129|NCT00254163|559060909|FG001|Overall Study|Death|1|||
154901130|NCT00254163|559060908|FG000|Overall Study|Other|8|||
154901131|NCT00254163|559060909|FG001|Overall Study|Other|8|||
154901132|NCT00216086|559060914|FG000|Overall Study|Protocol Violation|1|||
154901133|NCT00216086|559060914|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
154901134|NCT00216086|559060914|FG000|Overall Study|Social Reasons|2|||
154901135|NCT00809614|559060915|FG000|Overall Study|Lack of Efficacy|2|||
154901136|NCT00809614|559060916|FG001|Overall Study|Lack of Efficacy|3|||
154901137|NCT00809614|559060915|FG000|Overall Study|Withdrawal by Subject|1|||
154901138|NCT00809614|559060916|FG001|Overall Study|Withdrawal by Subject|1|||
154901139|NCT00364832|559060922|FG000|Core Period|Early Withdrawals|2|||
154901140|NCT00364832|559060923|FG001|Core Period|Early Withdrawals|2|||
154901141|NCT00364832|559060924|FG002|Core Period|Early Withdrawals|1|||
154901142|NCT00364832|559060925|FG003|Core Period|Early Withdrawals|1|||
154901143|NCT00364832|559060926|FG004|Core Period|Early Withdrawals|0|||
155115204|NCT03099174|559850528|FG003|Overall Study|Other than listed|6|||
154901144|NCT00364832|559060927|FG005|Core Period|Early Withdrawals|0|||
154901145|NCT00364832|559060928|FG006|Core Period|Early Withdrawals|4|||
155115205|NCT03099174|559850529|FG004|Overall Study|Other than listed|19|||
155115206|NCT03099174|559850530|FG005|Overall Study|Other than listed|10|||
155115207|NCT03099174|559850531|FG006|Overall Study|Other than listed|26|||
155115208|NCT03099174|559850532|FG007|Overall Study|Other than listed|23|||
155115209|NCT04730635|559850533|FG000|Overall Study|Lost to Follow-up|1|||
155115210|NCT04730635|559850534|FG001|Overall Study|Lost to Follow-up|0|||
155115211|NCT04730635|559850533|FG000|Overall Study|Withdrawal by Subject|0|||
155115212|NCT04730635|559850534|FG001|Overall Study|Withdrawal by Subject|1|||
155115213|NCT03070223|559850535|FG000|Overall Study|Lost to Follow-up|34|||
155115214|NCT03070223|559850536|FG001|Overall Study|Lost to Follow-up|27|||
155115215|NCT03070223|559850535|FG000|Overall Study|Withdrawal by Subject|12|||
155115216|NCT03070223|559850536|FG001|Overall Study|Withdrawal by Subject|22|||
155115217|NCT03070223|559850535|FG000|Overall Study|Protocol Violation|0|||
155115218|NCT03070223|559850536|FG001|Overall Study|Protocol Violation|1|||
155115219|NCT00516906|559850537|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
155115220|NCT00516906|559850538|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
155115221|NCT01327053|559850541|FG000|Overall Study|Adverse Event|23|||
155115222|NCT01327053|559850542|FG001|Overall Study|Adverse Event|57|||
154901146|NCT00364832|559060929|FG007|Core Period|Early Withdrawals|1|||
154981232|NCT04266301|559356796|FG001|Overall Study|Hematopoietic Stem-Cell Transplantation (HSCT) Planned|22|||
154981233|NCT04266301|559356795|FG000|Overall Study|Study Terminated by Sponsor|22|||
154981234|NCT04266301|559356796|FG001|Overall Study|Study Terminated by Sponsor|27|||
154981235|NCT04266301|559356795|FG000|Overall Study|Participant Decision|22|||
154901147|NCT00364832|559060930|FG008|Core Period|Early Withdrawals|0|||
154901148|NCT00364832|559060931|FG009|Core Period|Early Withdrawals|0|||
154981236|NCT04266301|559356796|FG001|Overall Study|Participant Decision|28|||
154981237|NCT04266301|559356795|FG000|Overall Study|Physician Decision|14|||
154981238|NCT04266301|559356796|FG001|Overall Study|Physician Decision|9|||
154981239|NCT04266301|559356795|FG000|Overall Study|New Therapy for Study Indication|2|||
154981240|NCT04266301|559356796|FG001|Overall Study|New Therapy for Study Indication|4|||
154981241|NCT04266301|559356795|FG000|Overall Study|Protocol Deviation|2|||
154981242|NCT04266301|559356796|FG001|Overall Study|Protocol Deviation|4|||
154981243|NCT04266301|559356795|FG000|Overall Study|Guardian Decision|1|||
154981244|NCT04266301|559356796|FG001|Overall Study|Guardian Decision|0|||
154981245|NCT04266301|559356795|FG000|Overall Study|Lost to Follow-up|1|||
154981246|NCT04266301|559356796|FG001|Overall Study|Lost to Follow-up|0|||
154981247|NCT04266301|559356795|FG000|Overall Study|Participants Not Treated|1|||
154981248|NCT04266301|559356796|FG001|Overall Study|Participants Not Treated|1|||
154981249|NCT04079712|559356797|FG000|Overall Study|Disease progression before starting treatment|1|||
154981250|NCT01432574|559356798|FG000|Overall Study|Moved|2|||
154981251|NCT01432574|559356798|FG000|Overall Study|Not interested|1|||
154981252|NCT04373551|559356799|FG000|Overall Study|Lost to Follow-up|15|||
154981253|NCT04373551|559356799|FG000|Overall Study|Did not collect 12-month data on participants enrolled in 2024 (at Site 2)|4|||
154981254|NCT01042535|559356800|FG000|Overall Study|disease progression prior to treatment|3|||
154981255|NCT01042535|559356800|FG000|Overall Study|disease progression during treatment|3|||
154981256|NCT01042535|559356800|FG000|Overall Study|complications from other disease|2|||
154901149|NCT00364832|559060932|FG010|Core Period|Early Withdrawals|0|||
154901150|NCT00364832|559060933|FG011|Core Period|Early Withdrawals|0|||
154901151|NCT00364832|559060922|FG000|Extension Year 1|Early Withdrawals|0|||
154901152|NCT00364832|559060923|FG001|Extension Year 1|Early Withdrawals|0|||
154901153|NCT00364832|559060924|FG002|Extension Year 1|Early Withdrawals|0|||
154901154|NCT00364832|559060925|FG003|Extension Year 1|Early Withdrawals|0|||
154901155|NCT00364832|559060926|FG004|Extension Year 1|Early Withdrawals|0|||
154901156|NCT00364832|559060927|FG005|Extension Year 1|Early Withdrawals|0|||
154901157|NCT00364832|559060928|FG006|Extension Year 1|Early Withdrawals|0|||
154901158|NCT00364832|559060929|FG007|Extension Year 1|Early Withdrawals|0|||
154901159|NCT00364832|559060930|FG008|Extension Year 1|Early Withdrawals|0|||
154901160|NCT00364832|559060931|FG009|Extension Year 1|Early Withdrawals|4|||
154901161|NCT00364832|559060932|FG010|Extension Year 1|Early Withdrawals|2|||
154901162|NCT00364832|559060933|FG011|Extension Year 1|Early Withdrawals|10|||
154901163|NCT00364832|559060922|FG000|Extension Year 2|Early Withdrawals|0|||
154901164|NCT00364832|559060923|FG001|Extension Year 2|Early Withdrawals|0|||
154901165|NCT00364832|559060924|FG002|Extension Year 2|Early Withdrawals|0|||
154901166|NCT00364832|559060925|FG003|Extension Year 2|Early Withdrawals|0|||
154901167|NCT00364832|559060926|FG004|Extension Year 2|Early Withdrawals|0|||
154901168|NCT00364832|559060927|FG005|Extension Year 2|Early Withdrawals|0|||
154901169|NCT00364832|559060928|FG006|Extension Year 2|Early Withdrawals|0|||
154901170|NCT00364832|559060929|FG007|Extension Year 2|Early Withdrawals|0|||
154901171|NCT00364832|559060930|FG008|Extension Year 2|Early Withdrawals|0|||
154901172|NCT00364832|559060931|FG009|Extension Year 2|Early Withdrawals|5|||
154901173|NCT00364832|559060932|FG010|Extension Year 2|Early Withdrawals|5|||
154901174|NCT00364832|559060933|FG011|Extension Year 2|Early Withdrawals|3|||
154901175|NCT01929018|559060949|FG000|Overall Study|Lost to Follow-up|1|||
154901176|NCT01929018|559060950|FG001|Overall Study|Lost to Follow-up|0|||
154901177|NCT01929018|559060949|FG000|Overall Study|Hospitalization|0|||
154901178|NCT01929018|559060950|FG001|Overall Study|Hospitalization|1|||
154901179|NCT00282568|559060951|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
154901180|NCT00282568|559060951|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
154901181|NCT00282568|559060951|FG000|Extended Treatment Period|Adverse Event|17|||
154901182|NCT00282568|559060951|FG000|Extended Treatment Period|Non-compliance|4|||
154901183|NCT00282568|559060951|FG000|Extended Treatment Period|Physician Decision|1|||
154981257|NCT00107042|559356803|FG000|Overall Study|Lost to Follow-up|9|||
154981258|NCT00107042|559356804|FG001|Overall Study|Lost to Follow-up|7|||
154901184|NCT00282568|559060951|FG000|Extended Treatment Period|Lost to Follow-up|2|||
154901185|NCT01266070|559060952|FG000|Overall Study|Adverse Event|3|||
154901186|NCT01266070|559060952|FG000|Overall Study|Protocol Violation|1|||
154901187|NCT02417064|559060953|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
154901188|NCT02417064|559060954|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
154901189|NCT02417064|559060955|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
154901190|NCT02417064|559060953|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
154981259|NCT00107042|559356803|FG000|Overall Study|Withdrawal by Subject|6|||
154981260|NCT00107042|559356804|FG001|Overall Study|Withdrawal by Subject|1|||
154981261|NCT00107042|559356803|FG000|Overall Study|Moved out of area|5|||
154901191|NCT02417064|559060954|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
154901192|NCT02417064|559060955|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
154901193|NCT02417064|559060953|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
154901194|NCT02417064|559060954|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
154901195|NCT02417064|559060955|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
154901196|NCT02417064|559060953|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
154901197|NCT02417064|559060954|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
154901198|NCT02417064|559060955|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
154901199|NCT02417064|559060953|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
154901200|NCT02417064|559060954|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
154901201|NCT02417064|559060955|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
154901202|NCT02417064|559060953|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
154901203|NCT02417064|559060954|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
154901204|NCT02417064|559060955|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
154901205|NCT02417064|559060953|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
154901206|NCT02417064|559060954|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
154901207|NCT02417064|559060955|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
154901208|NCT02417064|559060953|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
154901209|NCT02417064|559060954|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
154901210|NCT02417064|559060955|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
154901211|NCT02417064|559060953|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
154901212|NCT02417064|559060954|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
154901213|NCT02417064|559060955|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
154901214|NCT02417064|559060953|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
154901215|NCT02417064|559060954|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
154901216|NCT02417064|559060955|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
154901217|NCT02417064|559060953|FG000|Follow-up Phase (24 Weeks)|Other|2|||
154901218|NCT02417064|559060954|FG001|Follow-up Phase (24 Weeks)|Other|2|||
154901219|NCT02417064|559060955|FG002|Follow-up Phase (24 Weeks)|Other|3|||
154901220|NCT03185819|559060956|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
154901221|NCT03185819|559060957|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
154901222|NCT03185819|559060958|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
154901223|NCT03185819|559060959|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
154901224|NCT03185819|559060956|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
154901225|NCT03185819|559060957|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
154901226|NCT03185819|559060958|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
154901227|NCT03185819|559060959|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
154901228|NCT03185819|559060956|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
154901229|NCT03185819|559060957|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
154901230|NCT03185819|559060958|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
154901231|NCT03185819|559060959|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
154901232|NCT03185819|559060956|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
154901233|NCT03185819|559060957|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
154901234|NCT03185819|559060958|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
154901235|NCT03185819|559060959|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
154901236|NCT03185819|559060956|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
155115223|NCT01327053|559850541|FG000|Overall Study|Patient/guardian decision|11|||
155115224|NCT01327053|559850542|FG001|Overall Study|Patient/guardian decision|35|||
155115225|NCT01327053|559850541|FG000|Overall Study|Physician Decision|10|||
155115226|NCT01327053|559850542|FG001|Overall Study|Physician Decision|14|||
155115227|NCT01327053|559850541|FG000|Overall Study|Death|1|||
155115228|NCT01327053|559850542|FG001|Overall Study|Death|5|||
155115229|NCT01327053|559850541|FG000|Overall Study|Lost to Follow-up|2|||
155115230|NCT01327053|559850542|FG001|Overall Study|Lost to Follow-up|4|||
155115231|NCT01327053|559850541|FG000|Overall Study|Non-compliance with study treatment|0|||
155115232|NCT01327053|559850542|FG001|Overall Study|Non-compliance with study treatment|5|||
155115233|NCT01327053|559850541|FG000|Overall Study|Study terminated by Sponsor|1|||
155115234|NCT01327053|559850542|FG001|Overall Study|Study terminated by Sponsor|3|||
155115235|NCT01327053|559850541|FG000|Overall Study|Progressive disease|31|||
155115236|NCT01327053|559850542|FG001|Overall Study|Progressive disease|26|||
155115237|NCT01327053|559850541|FG000|Overall Study|Protocol Violation|0|||
154901237|NCT03185819|559060957|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
154901238|NCT03185819|559060958|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
154901239|NCT03185819|559060959|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
154901240|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
155115238|NCT01327053|559850542|FG001|Overall Study|Protocol Violation|1|||
155115239|NCT01327053|559850541|FG000|Overall Study|Untreated|0|||
155115240|NCT01327053|559850542|FG001|Overall Study|Untreated|1|||
155115241|NCT00721578|559850548|FG000|Overall Study|Death|1|||
155115242|NCT00721578|559850549|FG001|Overall Study|Death|1|||
154901241|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
154901242|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
154901243|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
154901244|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
154901245|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
154901246|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
154901247|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
154901248|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
154901249|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
154901250|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
154901251|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
154901252|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
154901253|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
154901254|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
154901255|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
154901256|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
154901257|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
154901258|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
154901259|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
154901260|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
154901261|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
154901262|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
154901263|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
154901264|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
154901265|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
154901266|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
154901267|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
154901268|NCT03185819|559060956|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
154901269|NCT03185819|559060957|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
154901270|NCT03185819|559060958|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
154901271|NCT03185819|559060959|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
154901272|NCT02939976|559060960|FG000|Overall Study|Lost to Follow-up|7|||
154901273|NCT02939976|559060961|FG001|Overall Study|Lost to Follow-up|1|||
154901274|NCT02939976|559060962|FG002|Overall Study|Lost to Follow-up|1|||
154901275|NCT02939976|559060963|FG003|Overall Study|Lost to Follow-up|2|||
154901276|NCT02939976|559060960|FG000|Overall Study|Withdrawal by Subject|4|||
154901277|NCT02939976|559060961|FG001|Overall Study|Withdrawal by Subject|0|||
154901278|NCT02939976|559060962|FG002|Overall Study|Withdrawal by Subject|2|||
154901279|NCT02939976|559060963|FG003|Overall Study|Withdrawal by Subject|4|||
154901280|NCT02939976|559060960|FG000|Overall Study|Due to early study closure|4|||
154901281|NCT02939976|559060961|FG001|Overall Study|Due to early study closure|3|||
154901282|NCT02939976|559060962|FG002|Overall Study|Due to early study closure|2|||
154901283|NCT02939976|559060963|FG003|Overall Study|Due to early study closure|3|||
154901284|NCT04080752|559060964|FG000|Overall Study|Adverse Event|2|||
154901285|NCT04080752|559060965|FG001|Overall Study|Adverse Event|3|||
154901286|NCT04080752|559060964|FG000|Overall Study|Lack of Efficacy|1|||
154901287|NCT04080752|559060965|FG001|Overall Study|Lack of Efficacy|0|||
154901288|NCT04080752|559060964|FG000|Overall Study|Lost to Follow-up|1|||
154901289|NCT04080752|559060965|FG001|Overall Study|Lost to Follow-up|0|||
154901290|NCT04080752|559060964|FG000|Overall Study|Pregnancy|0|||
154901291|NCT04080752|559060965|FG001|Overall Study|Pregnancy|1|||
154901292|NCT04080752|559060964|FG000|Overall Study|Withdrawal by Subject|7|||
154901293|NCT04080752|559060965|FG001|Overall Study|Withdrawal by Subject|0|||
154901294|NCT04080752|559060964|FG000|Overall Study|Non-Compliance with Study Drug|0|||
154901295|NCT04080752|559060965|FG001|Overall Study|Non-Compliance with Study Drug|1|||
154901296|NCT04080752|559060964|FG000|Overall Study|Other|2|||
154901297|NCT04080752|559060965|FG001|Overall Study|Other|1|||
154901298|NCT01585168|559060966|FG000|Overall Study|Lost to Follow-up|3|||
154901299|NCT01585168|559060967|FG001|Overall Study|Lost to Follow-up|1|||
154901300|NCT01585168|559060968|FG002|Overall Study|Lost to Follow-up|1|||
154901301|NCT01585168|559060969|FG003|Overall Study|Lost to Follow-up|1|||
154901302|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
154901303|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
154901304|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
154901305|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
155115243|NCT00721578|559850548|FG000|Overall Study|Withdrawal by Subject|1|||
155115244|NCT00721578|559850549|FG001|Overall Study|Withdrawal by Subject|1|||
155115245|NCT04621240|559850550|FG000|Overall Study|Withdrawal by Subject|36|||
155115246|NCT00211757|559850552|FG000|Overall Study|Withdrawal by Subject|1|||
155115247|NCT00211757|559850553|FG001|Overall Study|Withdrawal by Subject|1|||
155115248|NCT00211757|559850552|FG000|Overall Study|Lack of Efficacy|0|||
154901306|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
154901307|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
154901308|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
154901309|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
154901310|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
154901311|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
154901312|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
154901313|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
154901314|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
154901315|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
154901316|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
154901317|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
154901318|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
154901319|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
154901320|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
154901321|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
154901322|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
154901323|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
154901324|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
154901325|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
154901326|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Other|0|||
154901327|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Other|1|||
154901328|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Other|0|||
154901329|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Other|0|||
154901330|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
154901331|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
154901332|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
154901333|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
154901334|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
154901335|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
154901336|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
154901337|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
154901338|NCT01194414|559060970|FG000|24 Weeks Double Blind Period|Death|0|||
154901339|NCT01194414|559060971|FG001|24 Weeks Double Blind Period|Death|1|||
154901340|NCT01194414|559060972|FG002|24 Weeks Double Blind Period|Death|0|||
154901341|NCT01194414|559060973|FG003|24 Weeks Double Blind Period|Death|0|||
154901342|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
154901343|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
154901344|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
154901345|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
154901346|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
154901347|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
154901348|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
154901349|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
154901350|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
154901351|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
154981262|NCT00107042|559356804|FG001|Overall Study|Moved out of area|3|||
155115249|NCT00211757|559850553|FG001|Overall Study|Lack of Efficacy|1|||
155115250|NCT00789581|559852998|FG000|AC Therapy|Adverse Event|2|||
155115251|NCT00789581|559852999|FG001|AC Therapy|Adverse Event|3|||
155115252|NCT00789581|559852998|FG000|AC Therapy|Withdrawal by Subject|4|||
155115253|NCT00789581|559852999|FG001|AC Therapy|Withdrawal by Subject|7|||
155115254|NCT00789581|559852998|FG000|AC Therapy|Disease recurrence|3|||
155115255|NCT00789581|559852999|FG001|AC Therapy|Disease recurrence|1|||
155115256|NCT00789581|559852998|FG000|AC Therapy|Intercurrent Illness|1|||
155115257|NCT00789581|559852999|FG001|AC Therapy|Intercurrent Illness|0|||
155115258|NCT00789581|559852998|FG000|AC Therapy|Never Treated|1|||
155115259|NCT00789581|559852999|FG001|AC Therapy|Never Treated|4|||
155115260|NCT00789581|559852998|FG000|AC Therapy|Other|0|||
155115261|NCT00789581|559852999|FG001|AC Therapy|Other|2|||
155115262|NCT00789581|559852998|FG000|Adjuvant Therapy|Never treated|2|||
154901352|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
155115263|NCT00789581|559852999|FG001|Adjuvant Therapy|Never treated|2|||
155115264|NCT00789581|559852998|FG000|Adjuvant Therapy|Adverse Event|20|||
155115265|NCT00789581|559852999|FG001|Adjuvant Therapy|Adverse Event|44|||
155115266|NCT00789581|559852998|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
155115267|NCT00789581|559852999|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
155115268|NCT00789581|559852998|FG000|Adjuvant Therapy|Disease recurrence|2|||
155115269|NCT00789581|559852999|FG001|Adjuvant Therapy|Disease recurrence|1|||
155115270|NCT00789581|559852998|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
155115271|NCT00789581|559852999|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
155115272|NCT00789581|559852998|FG000|Adjuvant Therapy|Protocol Violation|1|||
155115273|NCT00789581|559852999|FG001|Adjuvant Therapy|Protocol Violation|1|||
155115274|NCT00789581|559852998|FG000|Adjuvant Therapy|Other|0|||
155115275|NCT00789581|559852999|FG001|Adjuvant Therapy|Other|1|||
154901353|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
154901354|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
154901355|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
154901356|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
154901357|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
154901358|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
154901359|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
154901360|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
154901361|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
154901362|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
154901363|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
154901364|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
154901365|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
154901366|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Other|2|||
154901367|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Other|1|||
154901368|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Other|0|||
154901369|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Other|0|||
154901370|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
154901371|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
154901372|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
154901373|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
154901374|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
154901375|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
154901376|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
154901377|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
154901378|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
154901379|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
154901380|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
154901381|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
154901382|NCT01194414|559060970|FG000|72 Weeks Open Label Extension|Death|1|||
154901383|NCT01194414|559060971|FG001|72 Weeks Open Label Extension|Death|2|||
154901384|NCT01194414|559060972|FG002|72 Weeks Open Label Extension|Death|0|||
154901385|NCT01194414|559060973|FG003|72 Weeks Open Label Extension|Death|2|||
154901386|NCT01782885|559060975|FG000|Overall Study|Lost to Follow-up|4|||
154901387|NCT01782885|559060976|FG001|Overall Study|Lost to Follow-up|6|||
154901388|NCT03447821|559060977|FG000|Overall Study|Withdrawal by Subject|1|||
154901389|NCT03447821|559060978|FG001|Overall Study|Withdrawal by Subject|1|||
154901390|NCT03447821|559060979|FG002|Overall Study|Withdrawal by Subject|0|||
154901391|NCT03447821|559060977|FG000|Overall Study|Lost to Follow-up|0|||
154901392|NCT03447821|559060978|FG001|Overall Study|Lost to Follow-up|0|||
154901393|NCT03447821|559060979|FG002|Overall Study|Lost to Follow-up|1|||
154901394|NCT00654420|559060980|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
154901395|NCT00654420|559060981|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
155115276|NCT03392883|559853004|FG000|Overall Study|Lost to Follow-up|122|||
155115277|NCT03392883|559853005|FG001|Overall Study|Lost to Follow-up|13|||
155115278|NCT03392883|559853006|FG002|Overall Study|Lost to Follow-up|9|||
155115279|NCT03392883|559853004|FG000|Overall Study|Death|4|||
155115280|NCT03392883|559853005|FG001|Overall Study|Death|0|||
155115281|NCT03392883|559853006|FG002|Overall Study|Death|0|||
155115282|NCT03392883|559853004|FG000|Overall Study|Lack of Efficacy|29|||
155115283|NCT03392883|559853005|FG001|Overall Study|Lack of Efficacy|0|||
154901396|NCT00654420|559060982|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
154901397|NCT00654420|559060983|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
154901398|NCT00654420|559060980|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
154901399|NCT00654420|559060981|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
154901400|NCT00654420|559060982|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
154901401|NCT00654420|559060983|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
154901402|NCT00654420|559060980|FG000|Phase II|Adverse Event|0|||
154901403|NCT00654420|559060981|FG001|Phase II|Adverse Event|0|||
154901404|NCT00654420|559060982|FG002|Phase II|Adverse Event|3|||
154901405|NCT00654420|559060983|FG003|Phase II|Adverse Event|3|||
154901406|NCT00654420|559060980|FG000|Phase II|Lost to Follow-up|0|||
155115284|NCT03392883|559853006|FG002|Overall Study|Lack of Efficacy|0|||
154901407|NCT00654420|559060981|FG001|Phase II|Lost to Follow-up|0|||
154901408|NCT00654420|559060982|FG002|Phase II|Lost to Follow-up|0|||
154901409|NCT00654420|559060983|FG003|Phase II|Lost to Follow-up|1|||
154981263|NCT00107042|559356803|FG000|Overall Study|Pregnancy|1|||
154901410|NCT00654420|559060980|FG000|Phase II|Physician Decision|0|||
154901411|NCT00654420|559060981|FG001|Phase II|Physician Decision|0|||
154901412|NCT00654420|559060982|FG002|Phase II|Physician Decision|0|||
154901413|NCT00654420|559060983|FG003|Phase II|Physician Decision|4|||
154901414|NCT00654420|559060980|FG000|Phase II|Progressive Disease|0|||
154901415|NCT00654420|559060981|FG001|Phase II|Progressive Disease|0|||
154901416|NCT00654420|559060982|FG002|Phase II|Progressive Disease|29|||
154901417|NCT00654420|559060983|FG003|Phase II|Progressive Disease|29|||
154901418|NCT00654420|559060980|FG000|Phase II|Withdrawal by Subject|0|||
154901419|NCT00654420|559060981|FG001|Phase II|Withdrawal by Subject|0|||
154901420|NCT00654420|559060982|FG002|Phase II|Withdrawal by Subject|4|||
154901421|NCT00654420|559060983|FG003|Phase II|Withdrawal by Subject|1|||
154901422|NCT00654420|559060980|FG000|Phase II|Missing Disposition Record|0|||
154901423|NCT00654420|559060981|FG001|Phase II|Missing Disposition Record|0|||
154901424|NCT00654420|559060982|FG002|Phase II|Missing Disposition Record|1|||
154901425|NCT00654420|559060983|FG003|Phase II|Missing Disposition Record|0|||
154901426|NCT00431496|559060993|FG000|Overall Study|Adverse Event|3|||
154901427|NCT00431496|559060993|FG000|Overall Study|Lost to Follow-up|1|||
154901428|NCT00431496|559060993|FG000|Overall Study|Withdrawal by Subject|2|||
154901429|NCT00431496|559060993|FG000|Overall Study|Protocol-specified criteria|5|||
154901430|NCT02343952|559060994|FG000|Study Treatment|Disease Progression|23|||
154901431|NCT02343952|559060994|FG000|Study Treatment|Death|3|||
154901432|NCT02343952|559060994|FG000|Study Treatment|Adverse Event|19|||
154901433|NCT02343952|559060994|FG000|Study Treatment|Withdrawal by Subject|7|||
154901434|NCT02343952|559060994|FG000|Study Treatment|other complicating Diseases|1|||
154901435|NCT02343952|559060994|FG000|Follow up|Withdrawal by Subject|3|||
154901436|NCT02343952|559060994|FG000|Follow up|Death|33|||
154901437|NCT02343952|559060994|FG000|Follow up|Patient does not meet eligibility for study.|1|||
154901438|NCT02343952|559060994|FG000|Follow up|Research department closed by the practice.|5|||
154901439|NCT02343952|559060994|FG000|Follow up|Patient went home to Russia|1|||
154901440|NCT02343952|559060994|FG000|Follow up|Disease Progression|1|||
154901441|NCT02343952|559060994|FG000|Follow up|study terminated|1|||
154901442|NCT02671760|559060996|FG000|Overall Study|Lost to Follow-up|0|||
154901443|NCT02671760|559060997|FG001|Overall Study|Lost to Follow-up|1|||
154901444|NCT02671760|559060998|FG002|Overall Study|Lost to Follow-up|0|||
154901445|NCT02999191|559060999|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
154901446|NCT02999191|559061000|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
154901447|NCT02999191|559061001|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
154901448|NCT01993667|559061009|FG000|Overall Study|Insufficient data to analyze|16|||
154901449|NCT01993667|559061010|FG001|Overall Study|Insufficient data to analyze|16|||
154901450|NCT01993667|559061009|FG000|Overall Study|Insufficient altitude reached|3|||
154901451|NCT01993667|559061010|FG001|Overall Study|Insufficient altitude reached|1|||
154901452|NCT01993667|559061009|FG000|Overall Study|Lost to Follow-up|2|||
154901453|NCT01993667|559061010|FG001|Overall Study|Lost to Follow-up|2|||
154901454|NCT01931150|559061011|FG000|Overall Study|Withdrawal by Subject|1|||
154901455|NCT01931150|559061012|FG001|Overall Study|Withdrawal by Subject|2|||
154901456|NCT04968353|559061015|FG000|Overall Study|Non-compliance|1|||
154901457|NCT04968353|559061016|FG001|Overall Study|Non-compliance|0|||
154901458|NCT04968353|559061017|FG002|Overall Study|Non-compliance|2|||
154901459|NCT04968353|559061018|FG003|Overall Study|Non-compliance|0|||
154901460|NCT00845845|559061019|FG000|Overall Study|Lost to Follow-up|0|||
154901461|NCT00845845|559061020|FG001|Overall Study|Lost to Follow-up|4|||
154901462|NCT01685203|559061021|FG000|Overall Study|Lost to Follow-up|3|||
154981264|NCT00107042|559356804|FG001|Overall Study|Pregnancy|1|||
155115285|NCT03392883|559853004|FG000|Overall Study|Withdrawal by Subject|180|||
155115286|NCT03392883|559853005|FG001|Overall Study|Withdrawal by Subject|0|||
155115287|NCT03392883|559853006|FG002|Overall Study|Withdrawal by Subject|0|||
155115288|NCT03392883|559853004|FG000|Overall Study|Adverse Event|1|||
155115289|NCT03392883|559853005|FG001|Overall Study|Adverse Event|0|||
155115290|NCT03392883|559853006|FG002|Overall Study|Adverse Event|0|||
155115291|NCT01345591|559853012|FG000|Overall Study|Lost to Follow-up|1|||
155115292|NCT00585546|559853013|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
154901463|NCT01685203|559061022|FG001|Overall Study|Lost to Follow-up|3|||
154901464|NCT01685203|559061023|FG002|Overall Study|Lost to Follow-up|0|||
154901465|NCT01685203|559061024|FG003|Overall Study|Lost to Follow-up|1|||
154901466|NCT01685203|559061025|FG004|Overall Study|Lost to Follow-up|0|||
154901467|NCT01685203|559061026|FG005|Overall Study|Lost to Follow-up|0|||
154901468|NCT01685203|559061027|FG006|Overall Study|Lost to Follow-up|0|||
154901469|NCT01685203|559061021|FG000|Overall Study|Adverse Event|0|||
154901470|NCT01685203|559061022|FG001|Overall Study|Adverse Event|0|||
154901471|NCT01685203|559061023|FG002|Overall Study|Adverse Event|0|||
154901472|NCT01685203|559061024|FG003|Overall Study|Adverse Event|0|||
154901473|NCT01685203|559061025|FG004|Overall Study|Adverse Event|0|||
154901474|NCT01685203|559061026|FG005|Overall Study|Adverse Event|2|||
154901475|NCT01685203|559061027|FG006|Overall Study|Adverse Event|0|||
154901476|NCT01685203|559061021|FG000|Overall Study|Adverse event and withdrew consent|1|||
154901477|NCT01685203|559061022|FG001|Overall Study|Adverse event and withdrew consent|0|||
154901478|NCT01685203|559061023|FG002|Overall Study|Adverse event and withdrew consent|0|||
154901479|NCT01685203|559061024|FG003|Overall Study|Adverse event and withdrew consent|0|||
154901480|NCT01685203|559061025|FG004|Overall Study|Adverse event and withdrew consent|0|||
154901481|NCT01685203|559061026|FG005|Overall Study|Adverse event and withdrew consent|0|||
154901482|NCT01685203|559061027|FG006|Overall Study|Adverse event and withdrew consent|0|||
154901483|NCT01685203|559061021|FG000|Overall Study|Patient's decision|0|||
154901484|NCT01685203|559061022|FG001|Overall Study|Patient's decision|0|||
154901485|NCT01685203|559061023|FG002|Overall Study|Patient's decision|0|||
154901486|NCT01685203|559061024|FG003|Overall Study|Patient's decision|0|||
154901487|NCT01685203|559061025|FG004|Overall Study|Patient's decision|0|||
154901488|NCT01685203|559061026|FG005|Overall Study|Patient's decision|1|||
154901489|NCT01685203|559061027|FG006|Overall Study|Patient's decision|0|||
154901490|NCT02896192|559061031|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
154901491|NCT02896192|559061031|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
154901492|NCT02896192|559061031|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
154901493|NCT01750840|559061032|FG000|Overall Study|Lost to Follow-up|4|||
154901494|NCT00479167|559061033|FG000|Overall Study|Withdrawal by Subject|1|||
154901495|NCT01570309|559061034|FG000|Overall Study|Withdrawal by Subject|3|||
154901496|NCT01570309|559061035|FG001|Overall Study|Withdrawal by Subject|3|||
154901497|NCT04095793|559061036|FG000|Overall Study|Adverse Event|3|||
154901498|NCT04095793|559061036|FG000|Overall Study|Study Terminated by Sponsor|103|||
154901499|NCT04095793|559061036|FG000|Overall Study|Withdrawal by Subject|4|||
154901500|NCT03619837|559061037|FG000|Screening|received organs from HCV-negative donors|47|||
154901501|NCT03619837|559061037|FG000|Screening|died on the wait-list|2|||
154901502|NCT03619837|559061037|FG000|Screening|remained on the wait list|40|||
154901503|NCT03619837|559061037|FG000|Screening|didn't meet eligibility criteria|3|||
154901504|NCT03619837|559061037|FG000|Screening|withdrew consent|2|||
154901505|NCT03619837|559061037|FG000|Screening|never listed for HCV-viremic donor|1|||
154901506|NCT03619837|559061037|FG000|Screening|developed exclusion criteria|2|||
154901507|NCT03619837|559061037|FG000|Screening|excluded by the investigator due to non-compliance|1|||
154901508|NCT01199198|559063478|FG000|Overall Study|Adverse Event|3|||
154901509|NCT01199198|559063479|FG001|Overall Study|Adverse Event|0|||
154901510|NCT01199198|559063478|FG000|Overall Study|Lost to Follow-up|1|||
154901511|NCT01199198|559063479|FG001|Overall Study|Lost to Follow-up|5|||
154901512|NCT01199198|559063478|FG000|Overall Study|Withdrawal by Subject|1|||
154901513|NCT01199198|559063479|FG001|Overall Study|Withdrawal by Subject|2|||
154901514|NCT01199198|559063478|FG000|Overall Study|ICU Transfer|1|||
154901515|NCT01199198|559063479|FG001|Overall Study|ICU Transfer|2|||
154901516|NCT01199198|559063478|FG000|Overall Study|Hospice-care transfer|1|||
154901517|NCT01199198|559063479|FG001|Overall Study|Hospice-care transfer|2|||
154901518|NCT04315298|559063480|FG000|Overall Study|Withdrawal by Subject|0|||
154901519|NCT04315298|559063481|FG001|Overall Study|Withdrawal by Subject|0|||
154981265|NCT00107042|559356803|FG000|Overall Study|Inadvertent enrollment|0|||
154981266|NCT00107042|559356804|FG001|Overall Study|Inadvertent enrollment|1|||
154981267|NCT00107042|559356803|FG000|Overall Study|vaccinated outside window|1|||
154981268|NCT00107042|559356804|FG001|Overall Study|vaccinated outside window|1|||
154981269|NCT00107042|559356803|FG000|Overall Study|Disallowed medications|0|||
154981270|NCT00107042|559356804|FG001|Overall Study|Disallowed medications|2|||
154981271|NCT03919448|559356805|FG000|Overall Study|Withdrawal by Subject|1|||
154981272|NCT03919448|559356806|FG001|Overall Study|Withdrawal by Subject|0|||
154981273|NCT03919448|559356807|FG002|Overall Study|Withdrawal by Subject|0|||
154981274|NCT01221090|559356809|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
154981275|NCT01221090|559356810|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
154981276|NCT01221090|559356811|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
154981277|NCT01221090|559356812|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
154981278|NCT01221090|559356809|FG000|Overall Study|Withdrawal by Subject|0|||
154981279|NCT01221090|559356810|FG001|Overall Study|Withdrawal by Subject|22|||
154901520|NCT04315298|559063482|FG002|Overall Study|Withdrawal by Subject|0|||
154981280|NCT01221090|559356811|FG002|Overall Study|Withdrawal by Subject|27|||
154981281|NCT01221090|559356812|FG003|Overall Study|Withdrawal by Subject|2|||
154981282|NCT03438539|559356813|FG000|Overall Study|Lost to Follow-up|8|||
154981283|NCT03438539|559356814|FG001|Overall Study|Lost to Follow-up|4|||
154901521|NCT04315298|559063483|FG003|Overall Study|Withdrawal by Subject|2|||
154901522|NCT04315298|559063484|FG004|Overall Study|Withdrawal by Subject|2|||
154981284|NCT03438539|559356815|FG002|Overall Study|Lost to Follow-up|10|||
154981285|NCT03438539|559356816|FG003|Overall Study|Lost to Follow-up|9|||
154901523|NCT04315298|559063485|FG005|Overall Study|Withdrawal by Subject|2|||
154901524|NCT04315298|559063486|FG006|Overall Study|Withdrawal by Subject|0|||
154901525|NCT04315298|559063487|FG007|Overall Study|Withdrawal by Subject|1|||
154901526|NCT04315298|559063488|FG008|Overall Study|Withdrawal by Subject|1|||
154901527|NCT04315298|559063489|FG009|Overall Study|Withdrawal by Subject|1|||
154901528|NCT04315298|559063490|FG010|Overall Study|Withdrawal by Subject|0|||
154901529|NCT04315298|559063491|FG011|Overall Study|Withdrawal by Subject|0|||
154901530|NCT04315298|559063492|FG012|Overall Study|Withdrawal by Subject|0|||
154901531|NCT04315298|559063493|FG013|Overall Study|Withdrawal by Subject|0|||
154981286|NCT03438539|559356817|FG004|Overall Study|Lost to Follow-up|3|||
154981287|NCT03438539|559356818|FG005|Overall Study|Lost to Follow-up|8|||
154981288|NCT04507126|559356819|FG000|Overall Study|Withdrawal by Subject|3|||
154981289|NCT04507126|559356819|FG000|Overall Study|Protocol Violation|4|||
154981290|NCT00440466|559356821|FG000|Overall Study|Death|3|||
154981291|NCT00440466|559356822|FG001|Overall Study|Death|2|||
154981292|NCT00440466|559356823|FG002|Overall Study|Death|9|||
154981293|NCT00440466|559356821|FG000|Overall Study|Adverse Event|3|||
154981294|NCT00440466|559356822|FG001|Overall Study|Adverse Event|4|||
154981295|NCT00440466|559356823|FG002|Overall Study|Adverse Event|11|||
154981296|NCT00440466|559356821|FG000|Overall Study|Lost to Follow-up|1|||
154981297|NCT00440466|559356822|FG001|Overall Study|Lost to Follow-up|0|||
154981298|NCT00440466|559356823|FG002|Overall Study|Lost to Follow-up|2|||
154981299|NCT00440466|559356821|FG000|Overall Study|Physician Decision|2|||
154981300|NCT00440466|559356822|FG001|Overall Study|Physician Decision|0|||
154981301|NCT00440466|559356823|FG002|Overall Study|Physician Decision|1|||
154981302|NCT00440466|559356821|FG000|Overall Study|Protocol Violation|2|||
154981303|NCT00440466|559356822|FG001|Overall Study|Protocol Violation|0|||
154981304|NCT00440466|559356823|FG002|Overall Study|Protocol Violation|4|||
154981305|NCT00440466|559356821|FG000|Overall Study|Withdrawal by Subject|2|||
154981306|NCT00440466|559356822|FG001|Overall Study|Withdrawal by Subject|5|||
154981307|NCT00440466|559356823|FG002|Overall Study|Withdrawal by Subject|9|||
154981308|NCT00440466|559356821|FG000|Overall Study|Began Dialysis|0|||
154981309|NCT00440466|559356822|FG001|Overall Study|Began Dialysis|0|||
154981310|NCT00440466|559356823|FG002|Overall Study|Began Dialysis|1|||
154981311|NCT00440466|559356821|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
154981312|NCT00440466|559356822|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
154981313|NCT00440466|559356823|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
154981314|NCT00140413|559356826|FG000|Overall Study|Lost to Follow-up|1|||
154981315|NCT00140413|559356827|FG001|Overall Study|Lost to Follow-up|0|||
154981316|NCT00140413|559356826|FG000|Overall Study|Withdrawal by Subject|2|||
154981317|NCT00140413|559356827|FG001|Overall Study|Withdrawal by Subject|0|||
154981318|NCT01223235|559356830|FG000|Overall Study|Withdrawal by Subject|1|||
154981319|NCT01014624|559356836|FG000|Overall Study|Adverse Event|0|||
154981320|NCT01014624|559356837|FG001|Overall Study|Adverse Event|1|||
154981321|NCT01014624|559356836|FG000|Overall Study|Protocol Violation|1|||
154981322|NCT01014624|559356837|FG001|Overall Study|Protocol Violation|0|||
154981323|NCT01014624|559356836|FG000|Overall Study|Withdrawal by Subject|1|||
154981324|NCT01014624|559356837|FG001|Overall Study|Withdrawal by Subject|0|||
154981325|NCT05444556|559356842|FG000|Overall Study|Withdrawal by Subject|0|||
154981326|NCT05444556|559356843|FG001|Overall Study|Withdrawal by Subject|0|||
154981327|NCT05444556|559356844|FG002|Overall Study|Withdrawal by Subject|2|||
154981328|NCT05444556|559356845|FG003|Overall Study|Withdrawal by Subject|1|||
154981329|NCT04976621|559356851|FG000|Overall Study|Lost to Follow-up|2|||
154981330|NCT04976621|559356852|FG001|Overall Study|Lost to Follow-up|2|||
154981331|NCT04976621|559356851|FG000|Overall Study|Withdrawal by Subject|1|||
154981332|NCT04976621|559356852|FG001|Overall Study|Withdrawal by Subject|1|||
154981333|NCT00949988|559356862|FG000|Overall Study|Withdrawal by Subject|3|||
154981334|NCT01929395|559356864|FG000|Overall Study|Did not complete - non-related toxicity|1|||
154981335|NCT01929395|559356865|FG001|Overall Study|Did not complete - non-related toxicity|0|||
154981336|NCT01929395|559356866|FG002|Overall Study|Did not complete - non-related toxicity|0|||
154981337|NCT01929395|559356864|FG000|Overall Study|Withdrawal by Subject|0|||
154901532|NCT04315298|559063494|FG014|Overall Study|Withdrawal by Subject|0|||
154901533|NCT04315298|559063495|FG015|Overall Study|Withdrawal by Subject|0|||
154901534|NCT04315298|559063496|FG016|Overall Study|Withdrawal by Subject|0|||
154901535|NCT04315298|559063497|FG017|Overall Study|Withdrawal by Subject|0|||
154901536|NCT04315298|559063498|FG018|Overall Study|Withdrawal by Subject|0|||
154901537|NCT04315298|559063480|FG000|Overall Study|Physician Decision|0|||
154901538|NCT04315298|559063481|FG001|Overall Study|Physician Decision|0|||
154901539|NCT04315298|559063482|FG002|Overall Study|Physician Decision|0|||
154901540|NCT04315298|559063483|FG003|Overall Study|Physician Decision|0|||
154901541|NCT04315298|559063484|FG004|Overall Study|Physician Decision|1|||
154901542|NCT04315298|559063485|FG005|Overall Study|Physician Decision|0|||
154901543|NCT04315298|559063486|FG006|Overall Study|Physician Decision|0|||
154901544|NCT04315298|559063487|FG007|Overall Study|Physician Decision|0|||
154981338|NCT01929395|559356865|FG001|Overall Study|Withdrawal by Subject|1|||
154981339|NCT01929395|559356866|FG002|Overall Study|Withdrawal by Subject|0|||
154981340|NCT01929395|559356864|FG000|Overall Study|Screen Fail|0|||
154981341|NCT01929395|559356865|FG001|Overall Study|Screen Fail|0|||
154981342|NCT01929395|559356866|FG002|Overall Study|Screen Fail|1|||
154981343|NCT00484419|559356867|FG000|Overall Study|Adverse Event|3|||
154901545|NCT04315298|559063488|FG008|Overall Study|Physician Decision|0|||
154901546|NCT04315298|559063489|FG009|Overall Study|Physician Decision|0|||
154981344|NCT00484419|559356868|FG001|Overall Study|Adverse Event|0|||
154981345|NCT00484419|559356869|FG002|Overall Study|Adverse Event|0|||
154981346|NCT00484419|559356867|FG000|Overall Study|Lost to Follow-up|1|||
154981347|NCT00484419|559356868|FG001|Overall Study|Lost to Follow-up|0|||
154981348|NCT00484419|559356869|FG002|Overall Study|Lost to Follow-up|2|||
154981349|NCT00484419|559356867|FG000|Overall Study|Withdrawal by Subject|3|||
154981350|NCT00484419|559356868|FG001|Overall Study|Withdrawal by Subject|1|||
154981351|NCT00484419|559356869|FG002|Overall Study|Withdrawal by Subject|1|||
154981352|NCT00484419|559356867|FG000|Overall Study|subject met discontinuation criteria|2|||
155115293|NCT00585546|559853013|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
155115294|NCT02851797|559853014|FG000|Overall Study|Withdrawal by Subject|4|||
154901547|NCT04315298|559063490|FG010|Overall Study|Physician Decision|0|||
154901548|NCT04315298|559063491|FG011|Overall Study|Physician Decision|0|||
154901549|NCT04315298|559063492|FG012|Overall Study|Physician Decision|0|||
154901550|NCT04315298|559063493|FG013|Overall Study|Physician Decision|0|||
154901551|NCT04315298|559063494|FG014|Overall Study|Physician Decision|0|||
154901552|NCT04315298|559063495|FG015|Overall Study|Physician Decision|0|||
154901553|NCT04315298|559063496|FG016|Overall Study|Physician Decision|0|||
154901554|NCT04315298|559063497|FG017|Overall Study|Physician Decision|0|||
154901555|NCT04315298|559063498|FG018|Overall Study|Physician Decision|0|||
154901556|NCT04315298|559063480|FG000|Overall Study|Lost to Follow-up|5|||
154901557|NCT04315298|559063481|FG001|Overall Study|Lost to Follow-up|10|||
154901558|NCT04315298|559063482|FG002|Overall Study|Lost to Follow-up|6|||
154901559|NCT04315298|559063483|FG003|Overall Study|Lost to Follow-up|8|||
154901560|NCT04315298|559063484|FG004|Overall Study|Lost to Follow-up|12|||
154901561|NCT04315298|559063485|FG005|Overall Study|Lost to Follow-up|13|||
154901562|NCT04315298|559063486|FG006|Overall Study|Lost to Follow-up|9|||
154901563|NCT04315298|559063487|FG007|Overall Study|Lost to Follow-up|16|||
154901564|NCT04315298|559063488|FG008|Overall Study|Lost to Follow-up|14|||
154901565|NCT04315298|559063489|FG009|Overall Study|Lost to Follow-up|0|||
154901566|NCT04315298|559063490|FG010|Overall Study|Lost to Follow-up|2|||
154901567|NCT04315298|559063491|FG011|Overall Study|Lost to Follow-up|1|||
154901568|NCT04315298|559063492|FG012|Overall Study|Lost to Follow-up|0|||
154901569|NCT04315298|559063493|FG013|Overall Study|Lost to Follow-up|0|||
154901570|NCT04315298|559063494|FG014|Overall Study|Lost to Follow-up|0|||
154901571|NCT04315298|559063495|FG015|Overall Study|Lost to Follow-up|2|||
154901572|NCT04315298|559063496|FG016|Overall Study|Lost to Follow-up|0|||
154901573|NCT04315298|559063497|FG017|Overall Study|Lost to Follow-up|0|||
154901574|NCT04315298|559063498|FG018|Overall Study|Lost to Follow-up|0|||
154901575|NCT04315298|559063480|FG000|Overall Study|Death|24|||
154901576|NCT04315298|559063481|FG001|Overall Study|Death|60|||
154901577|NCT04315298|559063482|FG002|Overall Study|Death|49|||
154901578|NCT04315298|559063483|FG003|Overall Study|Death|59|||
154901579|NCT04315298|559063484|FG004|Overall Study|Death|70|||
154901580|NCT04315298|559063485|FG005|Overall Study|Death|114|||
154901581|NCT04315298|559063486|FG006|Overall Study|Death|9|||
154901582|NCT04315298|559063487|FG007|Overall Study|Death|12|||
154901583|NCT04315298|559063488|FG008|Overall Study|Death|21|||
154901584|NCT04315298|559063489|FG009|Overall Study|Death|16|||
154901585|NCT04315298|559063490|FG010|Overall Study|Death|40|||
154901586|NCT04315298|559063491|FG011|Overall Study|Death|40|||
154901587|NCT04315298|559063492|FG012|Overall Study|Death|3|||
154901588|NCT04315298|559063493|FG013|Overall Study|Death|4|||
154901589|NCT04315298|559063494|FG014|Overall Study|Death|6|||
154901590|NCT04315298|559063495|FG015|Overall Study|Death|4|||
154901591|NCT04315298|559063496|FG016|Overall Study|Death|3|||
154901592|NCT04315298|559063497|FG017|Overall Study|Death|1|||
154901593|NCT04315298|559063498|FG018|Overall Study|Death|0|||
154901594|NCT03267511|559063499|FG000|Overall Study|Lost to Follow-up|0|||
154901595|NCT03267511|559063500|FG001|Overall Study|Lost to Follow-up|0|||
154901596|NCT03267511|559063501|FG002|Overall Study|Lost to Follow-up|0|||
154901597|NCT03267511|559063502|FG003|Overall Study|Lost to Follow-up|1|||
154901598|NCT02000219|559063504|FG000|14-Week Study Period|Physician Decision|1|||
154901599|NCT02000219|559063504|FG000|14-Week Study Period|Adverse Event|1|||
154981353|NCT00484419|559356868|FG001|Overall Study|subject met discontinuation criteria|2|||
155115295|NCT02851797|559853015|FG001|Overall Study|Withdrawal by Subject|2|||
155115296|NCT02851797|559853014|FG000|Overall Study|Adverse Event|3|||
154901600|NCT02000219|559063504|FG000|14-Week Study Period|Underwent transplantation|1|||
154901601|NCT02000219|559063504|FG000|Continuation Period|Withdrawal by Subject|1|||
154901602|NCT02000219|559063504|FG000|Continuation Period|Had liver transplant|2|||
154901603|NCT02000219|559063504|FG000|Continuation Period|Non-compliance with study drug|2|||
154901604|NCT02667236|559063505|FG000|Overall Study|Adverse Event|1|||
154901605|NCT02667236|559063506|FG001|Overall Study|Adverse Event|1|||
154901606|NCT02667236|559063505|FG000|Overall Study|Withdrawal by Subject|2|||
154901607|NCT02667236|559063506|FG001|Overall Study|Withdrawal by Subject|0|||
154901608|NCT00634751|559063508|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
154901609|NCT00634751|559063509|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
154901610|NCT00634751|559063510|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
154901611|NCT00634751|559063511|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
154901612|NCT00634751|559063508|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
154901613|NCT00634751|559063509|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
154901614|NCT00634751|559063510|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
154901615|NCT00634751|559063511|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
154901616|NCT00634751|559063508|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
154901617|NCT00634751|559063509|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
154901618|NCT00634751|559063510|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
154901619|NCT00634751|559063511|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
154901620|NCT01572844|559063512|FG000|Overall Study|Physician Decision|1|||
154901621|NCT01572844|559063513|FG001|Overall Study|Physician Decision|1|||
154901622|NCT03654560|559063522|FG000|Overall Study|Death|3|||
154901623|NCT03654560|559063523|FG001|Overall Study|Death|1|||
154901624|NCT03654560|559063522|FG000|Overall Study|Lost to Follow-up|1|||
154901625|NCT03654560|559063523|FG001|Overall Study|Lost to Follow-up|0|||
154901626|NCT00209092|559063524|FG000|Overall Study|Progression of disease|7|||
154901627|NCT00209092|559063525|FG001|Overall Study|Progression of disease|1|||
154901628|NCT00209092|559063524|FG000|Overall Study|Adverse Event|0|||
154901629|NCT00209092|559063525|FG001|Overall Study|Adverse Event|1|||
154901630|NCT00209092|559063524|FG000|Overall Study|Withdrawal by Subject|1|||
154901631|NCT00209092|559063525|FG001|Overall Study|Withdrawal by Subject|0|||
154901632|NCT01235338|559063526|FG000|Overall Study|Adverse Event|3|||
154901633|NCT01235338|559063527|FG001|Overall Study|Adverse Event|2|||
154901634|NCT01235338|559063526|FG000|Overall Study|Protocol Violation|1|||
154901635|NCT01235338|559063527|FG001|Overall Study|Protocol Violation|1|||
154901636|NCT01235338|559063526|FG000|Overall Study|Withdrawal by Subject|5|||
154901637|NCT01235338|559063527|FG001|Overall Study|Withdrawal by Subject|0|||
154901638|NCT01235338|559063526|FG000|Overall Study|Exclusion criteria violations|1|||
154901639|NCT01235338|559063527|FG001|Overall Study|Exclusion criteria violations|1|||
154901640|NCT01235338|559063526|FG000|Overall Study|Positive drug screen|0|||
154901641|NCT01235338|559063527|FG001|Overall Study|Positive drug screen|1|||
154901642|NCT01235338|559063526|FG000|Overall Study|Prohibited meds|1|||
154901643|NCT01235338|559063527|FG001|Overall Study|Prohibited meds|0|||
154901644|NCT05283499|559063528|FG000|Overall Study|Did not receive intervention|1|||
154901645|NCT05283499|559063529|FG001|Overall Study|Did not receive intervention|2|||
154901646|NCT02996110|559063530|FG000|Pre-Treatment|Other Reasons|0|||
154901647|NCT02996110|559063531|FG001|Pre-Treatment|Other Reasons|1|||
154901648|NCT02996110|559063532|FG002|Pre-Treatment|Other Reasons|0|||
154901649|NCT02996110|559063533|FG003|Pre-Treatment|Other Reasons|0|||
154901650|NCT02996110|559063534|FG004|Pre-Treatment|Other Reasons|1|||
154901651|NCT02996110|559063530|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
154901652|NCT02996110|559063531|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
154901653|NCT02996110|559063532|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
154901654|NCT02996110|559063533|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
154901655|NCT02996110|559063534|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
154901656|NCT02996110|559063530|FG000|Track 1|Disease Progression|15|||
154901657|NCT02996110|559063531|FG001|Track 1|Disease Progression|17|||
154901658|NCT02996110|559063532|FG002|Track 1|Disease Progression|0|||
154901659|NCT02996110|559063533|FG003|Track 1|Disease Progression|0|||
154901660|NCT02996110|559063534|FG004|Track 1|Disease Progression|0|||
154901661|NCT02996110|559063530|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
154901662|NCT02996110|559063531|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
154901663|NCT02996110|559063532|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
154901664|NCT02996110|559063533|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
154901665|NCT02996110|559063534|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
154901666|NCT02996110|559063530|FG000|Track 1|Study Drug Toxicity|5|||
154901667|NCT02996110|559063531|FG001|Track 1|Study Drug Toxicity|3|||
154901668|NCT02996110|559063532|FG002|Track 1|Study Drug Toxicity|0|||
154901669|NCT02996110|559063533|FG003|Track 1|Study Drug Toxicity|0|||
154901670|NCT02996110|559063534|FG004|Track 1|Study Drug Toxicity|0|||
154901671|NCT02996110|559063530|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
154901672|NCT02996110|559063531|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
154901673|NCT02996110|559063532|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
154901674|NCT02996110|559063533|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
154901675|NCT02996110|559063534|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
154901676|NCT02996110|559063530|FG000|Track 1|Administrative Reason by Sponsor|0|||
154901677|NCT02996110|559063531|FG001|Track 1|Administrative Reason by Sponsor|1|||
154901678|NCT02996110|559063532|FG002|Track 1|Administrative Reason by Sponsor|0|||
154901679|NCT02996110|559063533|FG003|Track 1|Administrative Reason by Sponsor|0|||
154901680|NCT02996110|559063534|FG004|Track 1|Administrative Reason by Sponsor|0|||
154901681|NCT02996110|559063530|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
154901682|NCT02996110|559063531|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
154901683|NCT02996110|559063532|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
154901684|NCT02996110|559063533|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
154901685|NCT02996110|559063534|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
154901686|NCT02996110|559063530|FG000|Track 2|Disease Progression|33|||
154901687|NCT02996110|559063531|FG001|Track 2|Disease Progression|26|||
154901688|NCT02996110|559063532|FG002|Track 2|Disease Progression|19|||
154901689|NCT02996110|559063533|FG003|Track 2|Disease Progression|16|||
154901690|NCT02996110|559063534|FG004|Track 2|Disease Progression|15|||
154901691|NCT02996110|559063530|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
154901692|NCT02996110|559063531|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
154901693|NCT02996110|559063532|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
154901694|NCT02996110|559063533|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
154901695|NCT02996110|559063534|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
154901696|NCT02996110|559063530|FG000|Track 2|Death|0|||
154901697|NCT02996110|559063531|FG001|Track 2|Death|0|||
154901698|NCT02996110|559063532|FG002|Track 2|Death|1|||
154901699|NCT02996110|559063533|FG003|Track 2|Death|0|||
154901700|NCT02996110|559063534|FG004|Track 2|Death|1|||
154901701|NCT02996110|559063530|FG000|Track 2|Study Drug Toxicity|4|||
154901702|NCT02996110|559063531|FG001|Track 2|Study Drug Toxicity|1|||
154901703|NCT02996110|559063532|FG002|Track 2|Study Drug Toxicity|4|||
154901704|NCT02996110|559063533|FG003|Track 2|Study Drug Toxicity|1|||
154901705|NCT02996110|559063534|FG004|Track 2|Study Drug Toxicity|0|||
154901706|NCT02996110|559063530|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
154901707|NCT02996110|559063531|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
154901708|NCT02996110|559063532|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
154901709|NCT02996110|559063533|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
154901710|NCT02996110|559063534|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
154901711|NCT02996110|559063530|FG000|Track 2|Participant Withdrew Consent|1|||
154901712|NCT02996110|559063531|FG001|Track 2|Participant Withdrew Consent|2|||
154901713|NCT02996110|559063532|FG002|Track 2|Participant Withdrew Consent|3|||
154901714|NCT02996110|559063533|FG003|Track 2|Participant Withdrew Consent|1|||
154901715|NCT02996110|559063534|FG004|Track 2|Participant Withdrew Consent|1|||
154901716|NCT02996110|559063530|FG000|Track 2|Other Reasons|0|||
154901717|NCT02996110|559063531|FG001|Track 2|Other Reasons|0|||
154901718|NCT02996110|559063532|FG002|Track 2|Other Reasons|1|||
154901719|NCT02996110|559063533|FG003|Track 2|Other Reasons|0|||
154901720|NCT02996110|559063534|FG004|Track 2|Other Reasons|1|||
154901721|NCT00524043|559063535|FG000|Overall Study|Lack of Efficacy|15|||
154901722|NCT00524043|559063536|FG001|Overall Study|Lack of Efficacy|13|||
154901723|NCT00524043|559063537|FG002|Overall Study|Lack of Efficacy|14|||
154901724|NCT00524043|559063535|FG000|Overall Study|Withdrawal by Subject|5|||
154901725|NCT00524043|559063536|FG001|Overall Study|Withdrawal by Subject|7|||
154901726|NCT00524043|559063537|FG002|Overall Study|Withdrawal by Subject|7|||
154901727|NCT00524043|559063535|FG000|Overall Study|Adverse Event|5|||
154901728|NCT00524043|559063536|FG001|Overall Study|Adverse Event|2|||
154901729|NCT00524043|559063537|FG002|Overall Study|Adverse Event|7|||
154901730|NCT00524043|559063535|FG000|Overall Study|Lost to Follow-up|3|||
154901731|NCT00524043|559063536|FG001|Overall Study|Lost to Follow-up|5|||
154901732|NCT00524043|559063537|FG002|Overall Study|Lost to Follow-up|3|||
154901733|NCT00524043|559063535|FG000|Overall Study|Various (eg, incarceration)|2|||
154901734|NCT00524043|559063536|FG001|Overall Study|Various (eg, incarceration)|1|||
154901735|NCT00524043|559063537|FG002|Overall Study|Various (eg, incarceration)|0|||
154901736|NCT03938636|559063538|FG000|Overall Study|Protocol Violation|0|||
154901737|NCT03938636|559063539|FG001|Overall Study|Protocol Violation|1|||
154901738|NCT03938636|559063540|FG002|Overall Study|Protocol Violation|1|||
154901739|NCT03938636|559063538|FG000|Overall Study|Subject withdrew due to death in family|0|||
154901740|NCT03938636|559063539|FG001|Overall Study|Subject withdrew due to death in family|1|||
154901741|NCT03938636|559063540|FG002|Overall Study|Subject withdrew due to death in family|0|||
154901742|NCT03938636|559063538|FG000|Overall Study|Missed visit|0|||
154901743|NCT03938636|559063539|FG001|Overall Study|Missed visit|1|||
154901744|NCT03938636|559063540|FG002|Overall Study|Missed visit|0|||
154901745|NCT03938636|559063538|FG000|Overall Study|Adverse Event|0|||
154901746|NCT03938636|559063539|FG001|Overall Study|Adverse Event|0|||
154901747|NCT03938636|559063540|FG002|Overall Study|Adverse Event|1|||
154901748|NCT03938636|559063538|FG000|Overall Study|Lost to Follow-up|0|||
154901749|NCT03938636|559063539|FG001|Overall Study|Lost to Follow-up|0|||
154901750|NCT03938636|559063540|FG002|Overall Study|Lost to Follow-up|1|||
154901751|NCT02579863|559063541|FG000|Overall Study|Final Disposition Unknown|2|||
154901752|NCT02579863|559063542|FG001|Overall Study|Final Disposition Unknown|1|||
154901753|NCT02579863|559063541|FG000|Overall Study|Adverse Event|18|||
154901754|NCT02579863|559063542|FG001|Overall Study|Adverse Event|11|||
154901755|NCT02579863|559063541|FG000|Overall Study|Death|31|||
154901756|NCT02579863|559063542|FG001|Overall Study|Death|29|||
154901757|NCT02579863|559063541|FG000|Overall Study|Lost to Follow-up|2|||
154901758|NCT02579863|559063542|FG001|Overall Study|Lost to Follow-up|1|||
154901759|NCT02579863|559063541|FG000|Overall Study|Physician Decision|1|||
154901760|NCT02579863|559063542|FG001|Overall Study|Physician Decision|2|||
154901761|NCT02579863|559063541|FG000|Overall Study|Screen Failure|0|||
154901762|NCT02579863|559063542|FG001|Overall Study|Screen Failure|2|||
154901763|NCT02579863|559063541|FG000|Overall Study|Study Terminated at Selected Sites|82|||
154901764|NCT02579863|559063542|FG001|Overall Study|Study Terminated at Selected Sites|88|||
154981354|NCT00484419|559356869|FG002|Overall Study|subject met discontinuation criteria|4|||
154901765|NCT02579863|559063541|FG000|Overall Study|Withdrawal by Subject|20|||
154901766|NCT02579863|559063542|FG001|Overall Study|Withdrawal by Subject|20|||
154901767|NCT01080625|559063543|FG000|Overall Study|Physician Decision|0|||
154901768|NCT01080625|559063544|FG001|Overall Study|Physician Decision|2|||
154901769|NCT01080625|559063545|FG002|Overall Study|Physician Decision|1|||
154901770|NCT00446797|559063546|FG000|Overall Study|Lack of Efficacy|0|||
154901771|NCT00446797|559063547|FG001|Overall Study|Lack of Efficacy|2|||
154901772|NCT00446797|559063546|FG000|Overall Study|Lost to Follow-up|5|||
154901773|NCT00446797|559063547|FG001|Overall Study|Lost to Follow-up|3|||
154901774|NCT00446797|559063546|FG000|Overall Study|Withdrawal by Subject|2|||
154901775|NCT00446797|559063547|FG001|Overall Study|Withdrawal by Subject|2|||
154901776|NCT00446797|559063546|FG000|Overall Study|Protocol Violation|1|||
154901777|NCT00446797|559063547|FG001|Overall Study|Protocol Violation|3|||
154901778|NCT00446797|559063546|FG000|Overall Study|subject entered at another site|0|||
154901779|NCT00446797|559063547|FG001|Overall Study|subject entered at another site|1|||
154901780|NCT00446797|559063546|FG000|Overall Study|did not meet entrance criteria|0|||
154901781|NCT00446797|559063547|FG001|Overall Study|did not meet entrance criteria|1|||
154901782|NCT03135262|559063548|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
154901783|NCT03135262|559063549|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
154901784|NCT03135262|559063550|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
154901785|NCT03135262|559063551|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
154901786|NCT03135262|559063552|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
154901787|NCT03135262|559063548|FG000|Overall Study|Progression of disease|0|||
154901788|NCT03135262|559063549|FG001|Overall Study|Progression of disease|0|||
154901789|NCT03135262|559063550|FG002|Overall Study|Progression of disease|0|||
154901790|NCT03135262|559063551|FG003|Overall Study|Progression of disease|1|||
154901791|NCT03135262|559063552|FG004|Overall Study|Progression of disease|0|||
154901792|NCT03135262|559063548|FG000|Overall Study|Death|6|||
154901793|NCT03135262|559063549|FG001|Overall Study|Death|2|||
154901794|NCT03135262|559063550|FG002|Overall Study|Death|2|||
154901795|NCT03135262|559063551|FG003|Overall Study|Death|2|||
154901796|NCT03135262|559063552|FG004|Overall Study|Death|0|||
154901797|NCT03135262|559063548|FG000|Overall Study|Withdrawal by Subject|0|||
154901798|NCT03135262|559063549|FG001|Overall Study|Withdrawal by Subject|0|||
154901799|NCT03135262|559063550|FG002|Overall Study|Withdrawal by Subject|1|||
154901800|NCT03135262|559063551|FG003|Overall Study|Withdrawal by Subject|0|||
154901801|NCT03135262|559063552|FG004|Overall Study|Withdrawal by Subject|1|||
154901802|NCT03135262|559063548|FG000|Overall Study|Study terminated by sponsor|2|||
154901803|NCT03135262|559063549|FG001|Overall Study|Study terminated by sponsor|4|||
154901804|NCT03135262|559063550|FG002|Overall Study|Study terminated by sponsor|4|||
154901805|NCT03135262|559063551|FG003|Overall Study|Study terminated by sponsor|3|||
154901806|NCT03135262|559063552|FG004|Overall Study|Study terminated by sponsor|0|||
154901807|NCT02728206|559063553|FG000|Overall Study|Death|1|||
154901808|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
154901809|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
154901810|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
154901811|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
154901812|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
154901813|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
154901814|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
154901815|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
154901816|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
154901817|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
154901818|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
154901819|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
154901820|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
154901821|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
154901822|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
154901823|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
154901824|NCT01291511|559063554|FG000|Cross-Titration and Stabilization Phase|Death|1|||
154901825|NCT01291511|559063555|FG001|Cross-Titration and Stabilization Phase|Death|0|||
154901826|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
154901827|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
154901828|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
154901829|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
154901830|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
154901831|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
154901832|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
155175897|NCT02353143|560082184|FG007|Overall Study|Withdrawal by Subject|1|||
155175898|NCT02353143|560082185|FG008|Overall Study|Withdrawal by Subject|1|||
154901833|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
154901834|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
154901835|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
154901836|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
154901837|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
154901838|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
154901839|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
154901840|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
154901841|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
154901842|NCT01291511|559063554|FG000|Double-blind Relapse Prevention Phase|Death|1|||
154901843|NCT01291511|559063555|FG001|Double-blind Relapse Prevention Phase|Death|0|||
154901844|NCT01366534|559063556|FG000|Overall Study|Lost to Follow-up|1|||
154901845|NCT01366534|559063557|FG001|Overall Study|Lost to Follow-up|0|||
154901846|NCT01366534|559063558|FG002|Overall Study|Lost to Follow-up|0|||
154901847|NCT01366534|559063556|FG000|Overall Study|Migrated|1|||
154901848|NCT01366534|559063557|FG001|Overall Study|Migrated|1|||
154901849|NCT01366534|559063558|FG002|Overall Study|Migrated|0|||
154901850|NCT01366534|559063556|FG000|Overall Study|Declined challenged|0|||
154901851|NCT01366534|559063557|FG001|Overall Study|Declined challenged|1|||
154901852|NCT01366534|559063558|FG002|Overall Study|Declined challenged|0|||
154901853|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
154901854|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
154901855|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
154901856|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
154901857|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
154901858|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
154901859|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
154901860|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
154901861|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
154901862|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
154901863|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
154901864|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
154901865|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
154901866|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
154901867|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
154901868|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
154901869|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
154901870|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
154901871|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
154901872|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
154901873|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
154901874|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
154901875|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
154901876|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
154901877|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
154901878|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
154901879|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
154901880|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
154901881|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
154901882|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
154901883|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
154901884|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
154901885|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
154901886|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
154901887|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
154901888|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
154901889|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
154901890|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
154901891|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
154901892|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
155115297|NCT02851797|559853015|FG001|Overall Study|Adverse Event|0|||
155115298|NCT03077438|559853016|FG000|Overall Study|Protocol Violation|3|||
155115299|NCT03077438|559853017|FG001|Overall Study|Protocol Violation|5|||
154901893|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
154901894|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
154901895|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
154901896|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
154901897|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
154901898|NCT03689972|559063561|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
154901899|NCT03689972|559063562|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
154901900|NCT03689972|559063563|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
154981355|NCT00484419|559356867|FG000|Overall Study|required restricted medication|1|||
154901901|NCT03689972|559063564|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
154901902|NCT03689972|559063565|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
154901903|NCT03689972|559063561|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
154901904|NCT03689972|559063562|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
154901905|NCT03689972|559063563|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
154901906|NCT03689972|559063564|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
154901907|NCT03689972|559063565|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
154901908|NCT03689972|559063561|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
154901909|NCT03689972|559063562|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
154901910|NCT03689972|559063563|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
154901911|NCT03689972|559063564|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
154901912|NCT03689972|559063565|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
154901913|NCT03689972|559063561|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
154901914|NCT03689972|559063562|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
154901915|NCT03689972|559063563|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
154901916|NCT03689972|559063564|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
154901917|NCT03689972|559063565|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
154901918|NCT03689972|559063561|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
154901919|NCT03689972|559063562|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
154901920|NCT03689972|559063563|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
154901921|NCT03689972|559063564|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
154901922|NCT03689972|559063565|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
154901923|NCT03689972|559063561|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
154901924|NCT03689972|559063562|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
154901925|NCT03689972|559063563|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
154901926|NCT03689972|559063564|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
154901927|NCT03689972|559063565|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
154901928|NCT03689972|559063561|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
154901929|NCT03689972|559063562|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
154901930|NCT03689972|559063563|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
154901931|NCT03689972|559063564|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
154901932|NCT03689972|559063565|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
154901933|NCT03689972|559063561|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
154901934|NCT03689972|559063562|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
154901935|NCT03689972|559063563|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
154901936|NCT03689972|559063564|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
154901937|NCT03689972|559063565|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
154901938|NCT03689972|559063561|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
154901939|NCT03689972|559063562|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
154901940|NCT03689972|559063563|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
154901941|NCT03689972|559063564|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
154901942|NCT03689972|559063565|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
154901943|NCT03689972|559063561|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
154901944|NCT03689972|559063562|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
154901945|NCT03689972|559063563|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
154901946|NCT03689972|559063564|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
154901947|NCT03689972|559063565|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
154901948|NCT00732641|559063566|FG000|Overall Study|Relapse or Progressive Disease|65|||
154901949|NCT00732641|559063567|FG001|Overall Study|Relapse or Progressive Disease|101|||
154901950|NCT00732641|559063566|FG000|Overall Study|Serious Adverse Events|12|||
154901951|NCT00732641|559063567|FG001|Overall Study|Serious Adverse Events|3|||
154901952|NCT00732641|559063566|FG000|Overall Study|Physician Decision|6|||
154901953|NCT00732641|559063567|FG001|Overall Study|Physician Decision|0|||
154901954|NCT00732641|559063566|FG000|Overall Study|Withdrawal by Subject|4|||
154901955|NCT00732641|559063567|FG001|Overall Study|Withdrawal by Subject|2|||
154901956|NCT00732641|559063566|FG000|Overall Study|Unable to Complete|1|||
154901957|NCT00732641|559063567|FG001|Overall Study|Unable to Complete|1|||
154901958|NCT00732641|559063566|FG000|Overall Study|Other|18|||
154901959|NCT00732641|559063567|FG001|Overall Study|Other|5|||
154901960|NCT00732238|559063568|FG000|Overall Study|Bacteremia|4|||
154901961|NCT00732238|559063569|FG001|Overall Study|Bacteremia|1|||
154901962|NCT00732238|559063568|FG000|Overall Study|Asymptomatic bacteriuria|1|||
154901963|NCT00732238|559063569|FG001|Overall Study|Asymptomatic bacteriuria|0|||
154901964|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
154901965|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
154901966|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
154901967|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
154901968|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
154901969|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
154901970|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
154901971|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
154901972|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
154901973|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
154901974|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
154901975|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
154901976|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
154901977|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
154901978|NCT03434041|559063570|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
154901979|NCT03434041|559063571|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
154901980|NCT03434041|559063570|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
154901981|NCT03434041|559063571|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
154901982|NCT03434041|559063570|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
154901983|NCT03434041|559063571|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
154901984|NCT03434041|559063570|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
154901985|NCT03434041|559063571|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
154901986|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
154901987|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
154901988|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
154901989|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
154901990|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
154901991|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
154901992|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
154901993|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
154901994|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
154901995|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
154901996|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
154901997|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
154901998|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
154901999|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
154902000|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
154902001|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
154902002|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
154902003|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
154902004|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
154902005|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
154902006|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
154902007|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
154902008|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
154902009|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
154902010|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
154902011|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
154902012|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
154902013|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
154902014|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
154902015|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
154902016|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
154902017|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
154902018|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
154902019|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
154902020|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
154902021|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
154902022|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
154902023|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
154902024|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
154981356|NCT00484419|559356868|FG001|Overall Study|required restricted medication|0|||
154981357|NCT00484419|559356869|FG002|Overall Study|required restricted medication|1|||
154981358|NCT00484419|559356867|FG000|Overall Study|Physician Decision|1|||
154981359|NCT00484419|559356868|FG001|Overall Study|Physician Decision|1|||
154981360|NCT00484419|559356869|FG002|Overall Study|Physician Decision|1|||
154981361|NCT00484419|559356867|FG000|Overall Study|subject unable to receive medication|1|||
155175899|NCT02353143|560082177|FG000|Overall Study|Lack of Efficacy|2|||
154902025|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
154902026|NCT03605836|559063572|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
154902027|NCT03605836|559063573|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
154902028|NCT03605836|559063574|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
154902029|NCT03605836|559063575|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
154902030|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
154902031|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
154902032|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
154902033|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
154902034|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
154902035|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
154902036|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
154902037|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
154902038|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
154902039|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
154902040|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
154902041|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
154902042|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
154902043|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
154902044|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
154902045|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
154902046|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
154902047|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
154902048|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
154902049|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
154902050|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
154902051|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
154902052|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
154902053|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
154902054|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
154902055|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
154902056|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
154902057|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
154902058|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
154902059|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
154902060|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
154902061|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
154902062|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
154902063|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
154902064|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
154902065|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
154902066|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
154902067|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
154902068|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
154902069|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
154902070|NCT03605836|559063572|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
154902071|NCT03605836|559063573|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
154902072|NCT03605836|559063574|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
154902073|NCT03605836|559063575|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
154902074|NCT02977507|559063576|FG000|Overall Study|Protocol Deviation|1|||
154902075|NCT02977507|559063577|FG001|Overall Study|Protocol Deviation|0|||
154902076|NCT02977507|559063576|FG000|Overall Study|Lost to Follow-up|1|||
154902077|NCT02977507|559063577|FG001|Overall Study|Lost to Follow-up|0|||
154902078|NCT00610207|559063580|FG000|Overall Study|Lost to Follow-up|3|||
154902079|NCT01594411|559063592|FG000|Overall Study|Lost to Follow-up|2|||
154902080|NCT01451398|559063596|FG000|Overall Study|Adverse Event|7|||
154902081|NCT01451398|559063597|FG001|Overall Study|Adverse Event|9|||
154902082|NCT01451398|559063596|FG000|Overall Study|Protocol Violation|1|||
154902083|NCT01451398|559063597|FG001|Overall Study|Protocol Violation|2|||
154902084|NCT01451398|559063596|FG000|Overall Study|Physician Decision|1|||
154902085|NCT01451398|559063597|FG001|Overall Study|Physician Decision|1|||
154902086|NCT01451398|559063596|FG000|Overall Study|Withdrawal by Subject|10|||
154902087|NCT01451398|559063597|FG001|Overall Study|Withdrawal by Subject|14|||
154902088|NCT01451398|559063596|FG000|Overall Study|Lost to Follow-up|6|||
155115300|NCT03077438|559853016|FG000|Overall Study|Withdrawal by Subject|3|||
154902089|NCT01451398|559063597|FG001|Overall Study|Lost to Follow-up|4|||
154902090|NCT01451398|559063596|FG000|Overall Study|Non-compliance with study drug|1|||
154902091|NCT01451398|559063597|FG001|Overall Study|Non-compliance with study drug|3|||
154902092|NCT01451398|559063596|FG000|Overall Study|Non-compliance with protocol|1|||
154902093|NCT01451398|559063597|FG001|Overall Study|Non-compliance with protocol|1|||
154902094|NCT01451398|559063596|FG000|Overall Study|Moved out of country|0|||
154902095|NCT01451398|559063597|FG001|Overall Study|Moved out of country|1|||
154902096|NCT01451398|559063596|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
154902097|NCT01451398|559063597|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
154902098|NCT01451398|559063596|FG000|Overall Study|Lack of Efficacy|0|||
154902099|NCT01451398|559063597|FG001|Overall Study|Lack of Efficacy|1|||
154902100|NCT00422669|559063601|FG000|Overall Study|The study was terminated early.|98|||
154902101|NCT00422669|559063602|FG001|Overall Study|The study was terminated early.|100|||
154902102|NCT00422669|559063603|FG002|Overall Study|The study was terminated early.|7|||
154902103|NCT00741260|559063605|FG000|Overall Study|Disease Progression|3|||
154902104|NCT00741260|559063606|FG001|Overall Study|Disease Progression|5|||
154902105|NCT00741260|559063607|FG002|Overall Study|Disease Progression|3|||
154902106|NCT00741260|559063608|FG003|Overall Study|Disease Progression|3|||
154902107|NCT00741260|559063609|FG004|Overall Study|Disease Progression|5|||
154902108|NCT00741260|559063610|FG005|Overall Study|Disease Progression|37|||
154902109|NCT00741260|559063611|FG006|Overall Study|Disease Progression|4|||
154902110|NCT00741260|559063605|FG000|Overall Study|Death|0|||
154902111|NCT00741260|559063606|FG001|Overall Study|Death|1|||
154902112|NCT00741260|559063607|FG002|Overall Study|Death|0|||
154902113|NCT00741260|559063608|FG003|Overall Study|Death|1|||
154902114|NCT00741260|559063609|FG004|Overall Study|Death|2|||
154902115|NCT00741260|559063610|FG005|Overall Study|Death|2|||
154902116|NCT00741260|559063611|FG006|Overall Study|Death|1|||
154902117|NCT00741260|559063605|FG000|Overall Study|Withdrawal by Subject|0|||
154902118|NCT00741260|559063606|FG001|Overall Study|Withdrawal by Subject|0|||
154902119|NCT00741260|559063607|FG002|Overall Study|Withdrawal by Subject|0|||
154902120|NCT00741260|559063608|FG003|Overall Study|Withdrawal by Subject|0|||
154902121|NCT00741260|559063609|FG004|Overall Study|Withdrawal by Subject|1|||
154902122|NCT00741260|559063610|FG005|Overall Study|Withdrawal by Subject|3|||
154902123|NCT00741260|559063611|FG006|Overall Study|Withdrawal by Subject|1|||
154902124|NCT00741260|559063605|FG000|Overall Study|Physician Decision|1|||
154902125|NCT00741260|559063606|FG001|Overall Study|Physician Decision|1|||
154902126|NCT00741260|559063607|FG002|Overall Study|Physician Decision|0|||
154902127|NCT00741260|559063608|FG003|Overall Study|Physician Decision|0|||
154902128|NCT00741260|559063609|FG004|Overall Study|Physician Decision|0|||
154902129|NCT00741260|559063610|FG005|Overall Study|Physician Decision|0|||
154902130|NCT00741260|559063611|FG006|Overall Study|Physician Decision|0|||
154902131|NCT00741260|559063605|FG000|Overall Study|Other|2|||
154902132|NCT00741260|559063606|FG001|Overall Study|Other|1|||
154902133|NCT00741260|559063607|FG002|Overall Study|Other|1|||
154902134|NCT00741260|559063608|FG003|Overall Study|Other|2|||
154902135|NCT00741260|559063609|FG004|Overall Study|Other|1|||
154902136|NCT00741260|559063610|FG005|Overall Study|Other|3|||
154902137|NCT00741260|559063611|FG006|Overall Study|Other|1|||
154902138|NCT02565615|559063612|FG000|Overall Study|Death|0|||
154902139|NCT02565615|559063613|FG001|Overall Study|Death|1|||
154902140|NCT02565615|559063614|FG002|Overall Study|Death|0|||
154902141|NCT02565615|559063615|FG003|Overall Study|Death|0|||
154902142|NCT02565615|559063616|FG004|Overall Study|Death|4|||
154902143|NCT02565615|559063612|FG000|Overall Study|Not willing to participate in study|2|||
154902144|NCT02565615|559063613|FG001|Overall Study|Not willing to participate in study|21|||
154902145|NCT02565615|559063614|FG002|Overall Study|Not willing to participate in study|0|||
154902146|NCT02565615|559063615|FG003|Overall Study|Not willing to participate in study|1|||
154902147|NCT02565615|559063616|FG004|Overall Study|Not willing to participate in study|169|||
154902148|NCT02565615|559063612|FG000|Overall Study|Lost to Follow-up|0|||
154902149|NCT02565615|559063613|FG001|Overall Study|Lost to Follow-up|4|||
154902150|NCT02565615|559063614|FG002|Overall Study|Lost to Follow-up|0|||
154902151|NCT02565615|559063615|FG003|Overall Study|Lost to Follow-up|1|||
154902152|NCT02565615|559063616|FG004|Overall Study|Lost to Follow-up|765|||
155115301|NCT03077438|559853017|FG001|Overall Study|Withdrawal by Subject|6|||
155115302|NCT03077438|559853016|FG000|Overall Study|Lost to Follow-up|6|||
154902153|NCT02565615|559063612|FG000|Overall Study|Not meeting eligibility criteria|0|||
154902154|NCT02565615|559063613|FG001|Overall Study|Not meeting eligibility criteria|7|||
154902155|NCT02565615|559063614|FG002|Overall Study|Not meeting eligibility criteria|0|||
154902156|NCT02565615|559063615|FG003|Overall Study|Not meeting eligibility criteria|0|||
154902157|NCT02565615|559063616|FG004|Overall Study|Not meeting eligibility criteria|25|||
154902158|NCT02565615|559063612|FG000|Overall Study|Reason not defined|0|||
154902159|NCT02565615|559063613|FG001|Overall Study|Reason not defined|2|||
154902160|NCT02565615|559063614|FG002|Overall Study|Reason not defined|0|||
154902161|NCT02565615|559063615|FG003|Overall Study|Reason not defined|1|||
154902162|NCT02565615|559063616|FG004|Overall Study|Reason not defined|62|||
154902163|NCT02565615|559063612|FG000|Overall Study|Adverse Event|1|||
154902164|NCT02565615|559063613|FG001|Overall Study|Adverse Event|1|||
155115303|NCT03077438|559853017|FG001|Overall Study|Lost to Follow-up|3|||
154902165|NCT02565615|559063614|FG002|Overall Study|Adverse Event|0|||
154902166|NCT02565615|559063615|FG003|Overall Study|Adverse Event|0|||
154902167|NCT02565615|559063616|FG004|Overall Study|Adverse Event|9|||
154902168|NCT02565615|559063612|FG000|Overall Study|Untreated|0|||
154902169|NCT02565615|559063613|FG001|Overall Study|Untreated|0|||
154902170|NCT02565615|559063614|FG002|Overall Study|Untreated|0|||
154902171|NCT02565615|559063615|FG003|Overall Study|Untreated|0|||
154902172|NCT02565615|559063616|FG004|Overall Study|Untreated|567|||
154902173|NCT05563714|559063621|FG000|Overall Study|Death|2|||
154902174|NCT05563714|559063622|FG001|Overall Study|Death|2|||
154902175|NCT05563714|559063623|FG002|Overall Study|Death|0|||
154902176|NCT05563714|559063624|FG003|Overall Study|Death|0|||
154902177|NCT05563714|559063621|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
154902178|NCT05563714|559063622|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
154902179|NCT05563714|559063623|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
154902180|NCT05563714|559063624|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
154902181|NCT05563714|559063621|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
154902182|NCT05563714|559063622|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
154902183|NCT05563714|559063623|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
154902184|NCT05563714|559063624|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
154902185|NCT05563714|559063621|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
154902186|NCT05563714|559063622|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
154902187|NCT05563714|559063623|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
154902188|NCT05563714|559063624|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
154902189|NCT05563714|559063621|FG000|Overall Study|Lost to Follow-up|22|||
154902190|NCT05563714|559063622|FG001|Overall Study|Lost to Follow-up|19|||
154902191|NCT05563714|559063623|FG002|Overall Study|Lost to Follow-up|0|||
154902192|NCT05563714|559063624|FG003|Overall Study|Lost to Follow-up|0|||
154902193|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
154902194|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
154902195|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
154902196|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
154902197|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
154902198|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
154902199|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
154902200|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
154902201|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
154902202|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
154902203|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
154902204|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
154902205|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
154902206|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
154902207|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
154902208|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
154902209|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
154902210|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
154902211|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
154902212|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
154902213|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
154902214|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
154902215|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
154902216|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
154902217|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
154902218|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
154902219|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
154902220|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
154902221|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
154902222|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
154902223|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
154902224|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
154981362|NCT00484419|559356868|FG001|Overall Study|subject unable to receive medication|0|||
154981363|NCT00484419|559356869|FG002|Overall Study|subject unable to receive medication|0|||
154981364|NCT00484419|559356867|FG000|Overall Study|subject relocated|0|||
154902225|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
154902226|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
154902227|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
154902228|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
154902229|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
154902230|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
154902231|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
154902232|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
154902233|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
154902234|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
154902235|NCT02120352|559063627|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
154902236|NCT02120352|559063628|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
154902237|NCT02120352|559063629|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
154902238|NCT02120352|559063630|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
154902239|NCT02120352|559063631|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
154902240|NCT02120352|559063632|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
154902241|NCT02120352|559063633|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
154902242|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
154902243|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
154902244|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
154902245|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
154902246|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
154902247|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
154902248|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
154902249|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
154902250|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
154902251|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
154902252|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
154902253|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
154902254|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
154902255|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
154902256|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
154902257|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
154902258|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
154902259|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
154902260|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
154902261|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
154902262|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
154902263|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
154902264|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
154902265|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
154902266|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
154902267|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
154902268|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
154902269|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
154902270|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
154902271|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
154902272|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
154902273|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
154902274|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
154902275|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
154902276|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
154902277|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
154902278|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
154902279|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
154902280|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
154902281|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
154902282|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
154902283|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
154902284|NCT02120352|559063627|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
154902285|NCT02120352|559063628|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
154902286|NCT02120352|559063629|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
154902287|NCT02120352|559063630|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
154902288|NCT02120352|559063631|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
154902289|NCT02120352|559063632|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
154902290|NCT02120352|559063633|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
154902291|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
155115304|NCT00813865|559853018|FG000|Overall Study|Failure to Respond|3|||
155115305|NCT00813865|559853018|FG000|Overall Study|Lost to Follow-up|3|||
155115306|NCT00813865|559853018|FG000|Overall Study|Withdrawal by Subject|1|||
154981365|NCT00484419|559356868|FG001|Overall Study|subject relocated|1|||
154981366|NCT00484419|559356869|FG002|Overall Study|subject relocated|0|||
154981367|NCT00484419|559356867|FG000|Overall Study|sponsor decision, randomized in error|0|||
154981368|NCT00484419|559356868|FG001|Overall Study|sponsor decision, randomized in error|0|||
154981369|NCT00484419|559356869|FG002|Overall Study|sponsor decision, randomized in error|2|||
154981370|NCT03604341|559356870|FG000|Overall Study|Withdrawal by Subject|1|||
154981371|NCT03604341|559356871|FG001|Overall Study|Withdrawal by Subject|1|||
154981372|NCT03604341|559356870|FG000|Overall Study|Adverse Event|1|||
154981373|NCT03604341|559356871|FG001|Overall Study|Adverse Event|0|||
154981374|NCT03604341|559356870|FG000|Overall Study|Protocol Violation|0|||
154981375|NCT03604341|559356871|FG001|Overall Study|Protocol Violation|1|||
154981376|NCT01829113|559356874|FG000|Overall Study|Disease Progression|37|||
154981377|NCT01829113|559356875|FG001|Overall Study|Disease Progression|48|||
154981378|NCT01829113|559356874|FG000|Overall Study|Adverse Event|14|||
154981379|NCT01829113|559356875|FG001|Overall Study|Adverse Event|10|||
154981380|NCT01829113|559356874|FG000|Overall Study|Withdrawal by Subject|17|||
154981381|NCT01829113|559356875|FG001|Overall Study|Withdrawal by Subject|10|||
154981382|NCT01829113|559356874|FG000|Overall Study|Death|4|||
154981383|NCT01829113|559356875|FG001|Overall Study|Death|6|||
155115307|NCT03172325|559853038|FG000|Overall Study|Adverse Event|2|||
155115308|NCT03172325|559853039|FG001|Overall Study|Adverse Event|3|||
155115309|NCT03172325|559853038|FG000|Overall Study|Positive PPD|1|||
155115310|NCT03172325|559853039|FG001|Overall Study|Positive PPD|0|||
155115311|NCT03172325|559853038|FG000|Overall Study|Poor Compliance|1|||
155115312|NCT03172325|559853039|FG001|Overall Study|Poor Compliance|1|||
155115313|NCT03622112|559853042|FG000|Overall Study|Withdrawal by Subject|6|||
155115314|NCT03622112|559853043|FG001|Overall Study|Withdrawal by Subject|2|||
155115315|NCT03622112|559853044|FG002|Overall Study|Withdrawal by Subject|4|||
155115316|NCT03622112|559853045|FG003|Overall Study|Withdrawal by Subject|2|||
155115317|NCT03622112|559853046|FG004|Overall Study|Withdrawal by Subject|1|||
155115318|NCT03622112|559853047|FG005|Overall Study|Withdrawal by Subject|2|||
155115319|NCT03622112|559853048|FG006|Overall Study|Withdrawal by Subject|2|||
155115320|NCT03622112|559853042|FG000|Overall Study|Death|0|||
155115321|NCT03622112|559853043|FG001|Overall Study|Death|0|||
155115322|NCT03622112|559853044|FG002|Overall Study|Death|0|||
155115323|NCT03622112|559853045|FG003|Overall Study|Death|1|||
155115324|NCT03622112|559853046|FG004|Overall Study|Death|0|||
155115325|NCT03622112|559853047|FG005|Overall Study|Death|0|||
155115326|NCT03622112|559853048|FG006|Overall Study|Death|0|||
155115327|NCT03622112|559853042|FG000|Overall Study|Lost to Follow-up|1|||
155115328|NCT03622112|559853043|FG001|Overall Study|Lost to Follow-up|1|||
155115329|NCT03622112|559853044|FG002|Overall Study|Lost to Follow-up|0|||
155115330|NCT03622112|559853045|FG003|Overall Study|Lost to Follow-up|0|||
155115331|NCT03622112|559853046|FG004|Overall Study|Lost to Follow-up|0|||
155115332|NCT03622112|559853047|FG005|Overall Study|Lost to Follow-up|0|||
155115333|NCT03622112|559853048|FG006|Overall Study|Lost to Follow-up|0|||
155115334|NCT03622112|559853042|FG000|Overall Study|Study-specific withdrawal criteria|10|||
155115335|NCT03622112|559853043|FG001|Overall Study|Study-specific withdrawal criteria|8|||
155115336|NCT03622112|559853044|FG002|Overall Study|Study-specific withdrawal criteria|7|||
155115337|NCT03622112|559853045|FG003|Overall Study|Study-specific withdrawal criteria|6|||
155115338|NCT03622112|559853046|FG004|Overall Study|Study-specific withdrawal criteria|4|||
155115339|NCT03622112|559853047|FG005|Overall Study|Study-specific withdrawal criteria|18|||
155115340|NCT03622112|559853048|FG006|Overall Study|Study-specific withdrawal criteria|4|||
155115341|NCT03622112|559853042|FG000|Overall Study|Protocol Violation|2|||
155115342|NCT03622112|559853043|FG001|Overall Study|Protocol Violation|0|||
154981384|NCT01829113|559356874|FG000|Overall Study|Sponsor Decision|1|||
154981385|NCT01829113|559356875|FG001|Overall Study|Sponsor Decision|1|||
154981386|NCT01829113|559356874|FG000|Overall Study|No Study Treatment Received|3|||
154981387|NCT01829113|559356875|FG001|Overall Study|No Study Treatment Received|2|||
154981388|NCT01829113|559356874|FG000|Overall Study|Physician Decision|1|||
155115343|NCT03622112|559853044|FG002|Overall Study|Protocol Violation|1|||
155115344|NCT03622112|559853045|FG003|Overall Study|Protocol Violation|1|||
154981389|NCT01829113|559356875|FG001|Overall Study|Physician Decision|1|||
154981390|NCT00355472|559356876|FG000|Overall Study|Physician Decision|1|||
154981391|NCT05445843|559356877|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
155115345|NCT03622112|559853046|FG004|Overall Study|Protocol Violation|0|||
155115346|NCT03622112|559853047|FG005|Overall Study|Protocol Violation|0|||
155115347|NCT03622112|559853048|FG006|Overall Study|Protocol Violation|0|||
155115348|NCT03622112|559853042|FG000|Overall Study|Adverse Event|6|||
155115349|NCT03622112|559853043|FG001|Overall Study|Adverse Event|8|||
155115350|NCT03622112|559853044|FG002|Overall Study|Adverse Event|4|||
155115351|NCT03622112|559853045|FG003|Overall Study|Adverse Event|11|||
155115352|NCT03622112|559853046|FG004|Overall Study|Adverse Event|4|||
155115353|NCT03622112|559853047|FG005|Overall Study|Adverse Event|20|||
154981392|NCT05445843|559356878|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
155115354|NCT03622112|559853048|FG006|Overall Study|Adverse Event|2|||
155115355|NCT03622112|559853042|FG000|Overall Study|Reason not specified|0|||
155115356|NCT03622112|559853043|FG001|Overall Study|Reason not specified|1|||
154902292|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
154902293|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
154902294|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
154902295|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
154902296|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
154902297|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
154902298|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
154902299|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
154902300|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
154902301|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
154902302|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
154902303|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
154902304|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
154902305|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
154902306|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
154902307|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
154902308|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
154902309|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
154902310|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
154902311|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
154902312|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
154902313|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
154902314|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
154902315|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
154902316|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
154902317|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
154902318|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
154902319|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
154902320|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
154902321|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
154902322|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
154902323|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
154902324|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
154902325|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
154902326|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
154902327|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
154902328|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
154902329|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
154902330|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
154902331|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
154902332|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
154902333|NCT02120352|559063627|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
154902334|NCT02120352|559063628|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
154902335|NCT02120352|559063629|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
154902336|NCT02120352|559063630|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
154902337|NCT02120352|559063631|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
154902338|NCT02120352|559063632|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
154902339|NCT02120352|559063633|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
154902340|NCT02120352|559063627|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
154902341|NCT02120352|559063628|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
154902342|NCT02120352|559063629|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
154902343|NCT02120352|559063630|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
154902344|NCT02120352|559063631|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
154902345|NCT02120352|559063632|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
155115357|NCT03622112|559853044|FG002|Overall Study|Reason not specified|0|||
154902346|NCT02120352|559063633|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
154902347|NCT02427100|559063634|FG000|Overall Study|Lost to Follow-up|0|||
154902348|NCT02427100|559063635|FG001|Overall Study|Lost to Follow-up|2|||
154902349|NCT01610206|559063638|FG000|Overall Study|Adverse Event|10|||
154902350|NCT01610206|559063639|FG001|Overall Study|Adverse Event|30|||
154902351|NCT00924729|559063640|FG000|Overall Study|insufficient volume for analysis|1|||
154902352|NCT00924729|559063641|FG001|Overall Study|insufficient volume for analysis|0|||
154902353|NCT00924729|559063640|FG000|Overall Study|Protocol Violation|1|||
155115358|NCT03622112|559853045|FG003|Overall Study|Reason not specified|1|||
155115359|NCT03622112|559853046|FG004|Overall Study|Reason not specified|1|||
155115360|NCT03622112|559853047|FG005|Overall Study|Reason not specified|2|||
154981393|NCT05445843|559356877|FG000|Overall Study|Progressive disease|17|||
154981394|NCT05445843|559356878|FG001|Overall Study|Progressive disease|9|||
154981395|NCT05445843|559356877|FG000|Overall Study|Physician Decision|16|||
154981396|NCT05445843|559356878|FG001|Overall Study|Physician Decision|4|||
154981397|NCT05445843|559356877|FG000|Overall Study|Death|6|||
154981398|NCT05445843|559356878|FG001|Overall Study|Death|3|||
154981399|NCT05445843|559356877|FG000|Overall Study|Subject decision|6|||
154981400|NCT05445843|559356878|FG001|Overall Study|Subject decision|2|||
154981401|NCT05445843|559356877|FG000|Overall Study|Adverse Event|2|||
154981402|NCT05445843|559356878|FG001|Overall Study|Adverse Event|0|||
154981403|NCT05307679|559356883|FG000|Overall Study|Study terminated by sponsor or physician decision|2|||
154981404|NCT05307679|559356884|FG001|Overall Study|Study terminated by sponsor or physician decision|5|||
154981405|NCT06279871|559356887|FG000|Overall Study|Death|0|||
154981406|NCT06279871|559356888|FG001|Overall Study|Death|0|||
154981407|NCT06279871|559356889|FG002|Overall Study|Death|0|||
154981408|NCT06279871|559356890|FG003|Overall Study|Death|0|||
154981409|NCT06279871|559356891|FG004|Overall Study|Death|0|||
154981410|NCT06279871|559356892|FG005|Overall Study|Death|1|||
154981411|NCT06279871|559356893|FG006|Overall Study|Death|0|||
154981412|NCT06279871|559356887|FG000|Overall Study|Other than Specified|1|||
154981413|NCT06279871|559356888|FG001|Overall Study|Other than Specified|0|||
154981414|NCT06279871|559356889|FG002|Overall Study|Other than Specified|4|||
154981415|NCT06279871|559356890|FG003|Overall Study|Other than Specified|0|||
154981416|NCT06279871|559356891|FG004|Overall Study|Other than Specified|0|||
154981417|NCT06279871|559356892|FG005|Overall Study|Other than Specified|0|||
154981418|NCT06279871|559356893|FG006|Overall Study|Other than Specified|0|||
154981419|NCT06279871|559356887|FG000|Overall Study|Withdrawal by Subject|4|||
154981420|NCT06279871|559356888|FG001|Overall Study|Withdrawal by Subject|8|||
154981421|NCT06279871|559356889|FG002|Overall Study|Withdrawal by Subject|4|||
154981422|NCT06279871|559356890|FG003|Overall Study|Withdrawal by Subject|2|||
154981423|NCT06279871|559356891|FG004|Overall Study|Withdrawal by Subject|0|||
154981424|NCT06279871|559356892|FG005|Overall Study|Withdrawal by Subject|0|||
154981425|NCT06279871|559356893|FG006|Overall Study|Withdrawal by Subject|0|||
154981426|NCT06279871|559356887|FG000|Overall Study|Lost to Follow-up|11|||
154981427|NCT06279871|559356888|FG001|Overall Study|Lost to Follow-up|10|||
154981428|NCT06279871|559356889|FG002|Overall Study|Lost to Follow-up|8|||
154981429|NCT06279871|559356890|FG003|Overall Study|Lost to Follow-up|0|||
154981430|NCT06279871|559356891|FG004|Overall Study|Lost to Follow-up|0|||
154981431|NCT06279871|559356892|FG005|Overall Study|Lost to Follow-up|0|||
154981432|NCT06279871|559356893|FG006|Overall Study|Lost to Follow-up|0|||
154981433|NCT06279871|559356887|FG000|Overall Study|Adverse Event|0|||
154981434|NCT06279871|559356888|FG001|Overall Study|Adverse Event|1|||
154981435|NCT06279871|559356889|FG002|Overall Study|Adverse Event|0|||
154981436|NCT06279871|559356890|FG003|Overall Study|Adverse Event|0|||
154981437|NCT06279871|559356891|FG004|Overall Study|Adverse Event|0|||
154981438|NCT06279871|559356892|FG005|Overall Study|Adverse Event|0|||
154981439|NCT06279871|559356893|FG006|Overall Study|Adverse Event|0|||
154981440|NCT00285584|559356898|FG000|Month 3|Lost to Follow-up|3|||
154981441|NCT00285584|559356899|FG001|Month 3|Lost to Follow-up|3|||
154981442|NCT00285584|559356898|FG000|Month 3|Withdrawal by Subject|1|||
154981443|NCT00285584|559356899|FG001|Month 3|Withdrawal by Subject|0|||
154981444|NCT00285584|559356898|FG000|Month 6|Lost to Follow-up|0|||
154981445|NCT00285584|559356899|FG001|Month 6|Lost to Follow-up|1|||
154981446|NCT00303667|559356906|FG000|Overall Study|Death|0|||
154981447|NCT00303667|559356907|FG001|Overall Study|Death|4|||
154981448|NCT01029392|559356908|FG000|Overall Study|Withdrawal by Subject|18|||
154981449|NCT01029392|559356909|FG001|Overall Study|Withdrawal by Subject|11|||
154981450|NCT01029392|559356908|FG000|Overall Study|Physician Decision|2|||
154981451|NCT01029392|559356909|FG001|Overall Study|Physician Decision|0|||
154981452|NCT01523587|559356910|FG000|Overall Study|Other than listed|5|||
154981453|NCT01523587|559356911|FG001|Overall Study|Other than listed|5|||
154981454|NCT01523587|559356910|FG000|Overall Study|Worsening of underlying cancer disease|19|||
154981455|NCT01523587|559356911|FG001|Overall Study|Worsening of underlying cancer disease|34|||
154981456|NCT01523587|559356910|FG000|Overall Study|Adverse Event|68|||
154981457|NCT01523587|559356911|FG001|Overall Study|Adverse Event|52|||
154981458|NCT01523587|559356910|FG000|Overall Study|Protocol Violation|5|||
154981459|NCT01523587|559356911|FG001|Overall Study|Protocol Violation|3|||
154981460|NCT01523587|559356910|FG000|Overall Study|Lost to Follow-up|2|||
154981461|NCT01523587|559356911|FG001|Overall Study|Lost to Follow-up|2|||
154981462|NCT01523587|559356910|FG000|Overall Study|Withdrawal by Subject|28|||
154981463|NCT01523587|559356911|FG001|Overall Study|Withdrawal by Subject|20|||
154981464|NCT01523587|559356910|FG000|Overall Study|Withdrew due to Progressive disease|265|||
154981465|NCT01523587|559356911|FG001|Overall Study|Withdrew due to Progressive disease|279|||
154981466|NCT01523587|559356910|FG000|Overall Study|Randomised but bot treated|6|||
154981467|NCT01523587|559356911|FG001|Overall Study|Randomised but bot treated|2|||
154981468|NCT02139124|559356912|FG000|Overall Study|Adverse Event|2|||
154981469|NCT02139124|559356913|FG001|Overall Study|Adverse Event|0|||
154981470|NCT02139124|559356914|FG002|Overall Study|Adverse Event|1|||
154981471|NCT02139124|559356915|FG003|Overall Study|Adverse Event|2|||
154902354|NCT00924729|559063641|FG001|Overall Study|Protocol Violation|0|||
154902355|NCT01929707|559063642|FG000|Intervention Period 1|Lost to Follow-up|0|||
154902356|NCT01929707|559063643|FG001|Intervention Period 1|Lost to Follow-up|0|||
154902357|NCT01929707|559063644|FG002|Intervention Period 1|Lost to Follow-up|0|||
154902358|NCT01929707|559063645|FG003|Intervention Period 1|Lost to Follow-up|1|||
154902359|NCT01929707|559063646|FG004|Intervention Period 1|Lost to Follow-up|0|||
154902360|NCT01929707|559063647|FG005|Intervention Period 1|Lost to Follow-up|0|||
154902361|NCT01929707|559063648|FG006|Intervention Period 1|Lost to Follow-up|0|||
154902362|NCT01929707|559063649|FG007|Intervention Period 1|Lost to Follow-up|0|||
154902363|NCT01929707|559063642|FG000|Intervention Period 1|Withdrawal by Subject|0|||
154902364|NCT01929707|559063643|FG001|Intervention Period 1|Withdrawal by Subject|0|||
154902365|NCT01929707|559063644|FG002|Intervention Period 1|Withdrawal by Subject|0|||
154902366|NCT01929707|559063645|FG003|Intervention Period 1|Withdrawal by Subject|2|||
154902367|NCT01929707|559063646|FG004|Intervention Period 1|Withdrawal by Subject|0|||
154902368|NCT01929707|559063647|FG005|Intervention Period 1|Withdrawal by Subject|0|||
154902369|NCT01929707|559063648|FG006|Intervention Period 1|Withdrawal by Subject|0|||
154902370|NCT01929707|559063649|FG007|Intervention Period 1|Withdrawal by Subject|0|||
154902371|NCT01929707|559063642|FG000|Intervention Period 2|Withdrawal by Subject|0|||
154902372|NCT01929707|559063643|FG001|Intervention Period 2|Withdrawal by Subject|0|||
154902373|NCT01929707|559063644|FG002|Intervention Period 2|Withdrawal by Subject|0|||
154902374|NCT01929707|559063645|FG003|Intervention Period 2|Withdrawal by Subject|0|||
154902375|NCT01929707|559063646|FG004|Intervention Period 2|Withdrawal by Subject|0|||
154902376|NCT01929707|559063647|FG005|Intervention Period 2|Withdrawal by Subject|2|||
154902377|NCT01929707|559063648|FG006|Intervention Period 2|Withdrawal by Subject|0|||
154902378|NCT01929707|559063649|FG007|Intervention Period 2|Withdrawal by Subject|0|||
154902379|NCT00023712|559063650|FG000|Overall Study|Not platinum sensitive|1|||
154902380|NCT00023712|559063651|FG001|Overall Study|Not platinum sensitive|0|||
154902381|NCT00023712|559063650|FG000|Overall Study|Never treated|1|||
154902382|NCT00023712|559063651|FG001|Overall Study|Never treated|1|||
154902383|NCT00437203|559063652|FG000|Overall Study|Death|0|||
154902384|NCT00437203|559063653|FG001|Overall Study|Death|0|||
154902385|NCT00437203|559063654|FG002|Overall Study|Death|1|||
154902386|NCT00437203|559063655|FG003|Overall Study|Death|0|||
154902387|NCT00437203|559063656|FG004|Overall Study|Death|0|||
154902388|NCT00437203|559063657|FG005|Overall Study|Death|0|||
154902389|NCT00437203|559063658|FG006|Overall Study|Death|0|||
154902390|NCT00437203|559063659|FG007|Overall Study|Death|1|||
154902391|NCT00437203|559063660|FG008|Overall Study|Death|0|||
154902392|NCT00437203|559063661|FG009|Overall Study|Death|1|||
154902393|NCT00437203|559063652|FG000|Overall Study|Adverse Event|1|||
154902394|NCT00437203|559063653|FG001|Overall Study|Adverse Event|1|||
154902395|NCT00437203|559063654|FG002|Overall Study|Adverse Event|0|||
154902396|NCT00437203|559063655|FG003|Overall Study|Adverse Event|0|||
154902397|NCT00437203|559063656|FG004|Overall Study|Adverse Event|0|||
154902398|NCT00437203|559063657|FG005|Overall Study|Adverse Event|0|||
154902399|NCT00437203|559063658|FG006|Overall Study|Adverse Event|0|||
154902400|NCT00437203|559063659|FG007|Overall Study|Adverse Event|1|||
154902401|NCT00437203|559063660|FG008|Overall Study|Adverse Event|0|||
154902402|NCT00437203|559063661|FG009|Overall Study|Adverse Event|1|||
154902403|NCT00437203|559063652|FG000|Overall Study|Study terminated by sponsor|0|||
154902404|NCT00437203|559063653|FG001|Overall Study|Study terminated by sponsor|0|||
154902405|NCT00437203|559063654|FG002|Overall Study|Study terminated by sponsor|0|||
154902406|NCT00437203|559063655|FG003|Overall Study|Study terminated by sponsor|0|||
154902407|NCT00437203|559063656|FG004|Overall Study|Study terminated by sponsor|0|||
154902408|NCT00437203|559063657|FG005|Overall Study|Study terminated by sponsor|0|||
154902409|NCT00437203|559063658|FG006|Overall Study|Study terminated by sponsor|0|||
154902410|NCT00437203|559063659|FG007|Overall Study|Study terminated by sponsor|0|||
154902411|NCT00437203|559063660|FG008|Overall Study|Study terminated by sponsor|1|||
154902412|NCT00437203|559063661|FG009|Overall Study|Study terminated by sponsor|0|||
154902413|NCT00437203|559063652|FG000|Overall Study|Objective progression or relapse|5|||
154902414|NCT00437203|559063653|FG001|Overall Study|Objective progression or relapse|6|||
154902415|NCT00437203|559063654|FG002|Overall Study|Objective progression or relapse|2|||
154981472|NCT02139124|559356916|FG004|Overall Study|Adverse Event|5|||
154902416|NCT00437203|559063655|FG003|Overall Study|Objective progression or relapse|3|||
154902417|NCT00437203|559063656|FG004|Overall Study|Objective progression or relapse|3|||
154902418|NCT00437203|559063657|FG005|Overall Study|Objective progression or relapse|3|||
154902419|NCT00437203|559063658|FG006|Overall Study|Objective progression or relapse|6|||
154902420|NCT00437203|559063659|FG007|Overall Study|Objective progression or relapse|1|||
154981473|NCT02139124|559356912|FG000|Overall Study|Withdrawal by Subject|2|||
154902421|NCT00437203|559063660|FG008|Overall Study|Objective progression or relapse|2|||
154902422|NCT00437203|559063661|FG009|Overall Study|Objective progression or relapse|2|||
154981474|NCT02139124|559356913|FG001|Overall Study|Withdrawal by Subject|2|||
154981475|NCT02139124|559356914|FG002|Overall Study|Withdrawal by Subject|2|||
154981476|NCT02139124|559356915|FG003|Overall Study|Withdrawal by Subject|2|||
154902423|NCT00437203|559063652|FG000|Overall Study|Other|0|||
154981477|NCT02139124|559356916|FG004|Overall Study|Withdrawal by Subject|3|||
154902424|NCT00437203|559063653|FG001|Overall Study|Other|1|||
154902425|NCT00437203|559063654|FG002|Overall Study|Other|0|||
154902426|NCT00437203|559063655|FG003|Overall Study|Other|0|||
154902427|NCT00437203|559063656|FG004|Overall Study|Other|0|||
154902428|NCT00437203|559063657|FG005|Overall Study|Other|0|||
154902429|NCT00437203|559063658|FG006|Overall Study|Other|1|||
154902430|NCT00437203|559063659|FG007|Overall Study|Other|0|||
154902431|NCT00437203|559063660|FG008|Overall Study|Other|0|||
154902432|NCT00437203|559063661|FG009|Overall Study|Other|0|||
154902433|NCT01915095|559063668|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
154902434|NCT01915095|559063669|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
154902435|NCT01915095|559063670|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
154902436|NCT01915095|559063671|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
154902437|NCT01915095|559063672|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
154902438|NCT02067533|559063673|FG000|Overall Study|Lost to Follow-up|4|||
154902439|NCT02067533|559063674|FG001|Overall Study|Lost to Follow-up|2|||
154902440|NCT00565812|559063675|FG000|Overall Study|Death|2|||
154902441|NCT00565812|559063676|FG001|Overall Study|Death|1|||
154902442|NCT00565812|559063677|FG002|Overall Study|Death|3|||
154902443|NCT00565812|559063675|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
154902444|NCT00565812|559063676|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
154902445|NCT00565812|559063677|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
154902446|NCT00565812|559063675|FG000|Overall Study|Lost to Follow-up|10|||
154902447|NCT00565812|559063676|FG001|Overall Study|Lost to Follow-up|8|||
154902448|NCT00565812|559063677|FG002|Overall Study|Lost to Follow-up|8|||
154902449|NCT00565812|559063675|FG000|Overall Study|Withdrawal by Subject|58|||
154902450|NCT00565812|559063676|FG001|Overall Study|Withdrawal by Subject|47|||
154902451|NCT00565812|559063677|FG002|Overall Study|Withdrawal by Subject|48|||
154902452|NCT00565812|559063675|FG000|Overall Study|Work Schedule|5|||
154902453|NCT00565812|559063676|FG001|Overall Study|Work Schedule|3|||
154902454|NCT00565812|559063677|FG002|Overall Study|Work Schedule|1|||
154902455|NCT00565812|559063675|FG000|Overall Study|Protocol Violation|2|||
154902456|NCT00565812|559063676|FG001|Overall Study|Protocol Violation|6|||
154902457|NCT00565812|559063677|FG002|Overall Study|Protocol Violation|4|||
154902458|NCT00565812|559063675|FG000|Overall Study|Adverse Event|41|||
154902459|NCT00565812|559063676|FG001|Overall Study|Adverse Event|54|||
154902460|NCT00565812|559063677|FG002|Overall Study|Adverse Event|40|||
154902461|NCT00565812|559063675|FG000|Overall Study|Jury Duty|1|||
154902462|NCT00565812|559063676|FG001|Overall Study|Jury Duty|0|||
154902463|NCT00565812|559063677|FG002|Overall Study|Jury Duty|0|||
154902464|NCT00565812|559063675|FG000|Overall Study|Relocated Out of Area|5|||
154902465|NCT00565812|559063676|FG001|Overall Study|Relocated Out of Area|8|||
154902466|NCT00565812|559063677|FG002|Overall Study|Relocated Out of Area|9|||
154902467|NCT00565812|559063675|FG000|Overall Study|Sponsor Decision|1|||
154902468|NCT00565812|559063676|FG001|Overall Study|Sponsor Decision|5|||
154902469|NCT00565812|559063677|FG002|Overall Study|Sponsor Decision|1|||
154902470|NCT00565812|559063675|FG000|Overall Study|Domestic Reasons|7|||
154902471|NCT00565812|559063676|FG001|Overall Study|Domestic Reasons|1|||
154902472|NCT00565812|559063677|FG002|Overall Study|Domestic Reasons|3|||
154902473|NCT00565812|559063675|FG000|Overall Study|Research Site Closure|6|||
154902474|NCT00565812|559063676|FG001|Overall Study|Research Site Closure|1|||
154902475|NCT00565812|559063677|FG002|Overall Study|Research Site Closure|8|||
154902476|NCT00565812|559063675|FG000|Overall Study|Surgical Intervention|0|||
154902477|NCT00565812|559063676|FG001|Overall Study|Surgical Intervention|1|||
154902478|NCT00565812|559063677|FG002|Overall Study|Surgical Intervention|2|||
154902479|NCT00565812|559063675|FG000|Overall Study|Low Compliance|1|||
154902480|NCT00565812|559063676|FG001|Overall Study|Low Compliance|0|||
154902481|NCT00565812|559063677|FG002|Overall Study|Low Compliance|1|||
154902482|NCT00565812|559063675|FG000|Overall Study|Follow-up Visit Not Completed|2|||
154902483|NCT00565812|559063676|FG001|Overall Study|Follow-up Visit Not Completed|0|||
154902484|NCT00565812|559063677|FG002|Overall Study|Follow-up Visit Not Completed|1|||
154902485|NCT00565812|559063675|FG000|Overall Study|Physician Decision|2|||
154902486|NCT00565812|559063676|FG001|Overall Study|Physician Decision|0|||
154902487|NCT00565812|559063677|FG002|Overall Study|Physician Decision|0|||
154902488|NCT00383708|559063678|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
154902489|NCT00383708|559063678|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
154902490|NCT00383708|559063678|FG000|Run-in Period|Protocol Violation|4|||
154902491|NCT00383708|559063678|FG000|Run-in Period|Adverse Event|2|||
154902492|NCT00383708|559063678|FG000|Run-in Period|Claustrophobia|1|||
154902493|NCT00383708|559063678|FG000|Co-administration Period|Adverse Event|5|||
154902494|NCT01997281|559063680|FG000|Overall Study|Withdrawal by Subject|1|||
154902495|NCT01997281|559063681|FG001|Overall Study|Withdrawal by Subject|0|||
154902496|NCT02384993|559063684|FG000|Overall Study|Adverse Event|0|||
154902497|NCT02384993|559063685|FG001|Overall Study|Adverse Event|1|||
154902498|NCT02650895|559063687|FG000|Overall Study|Withdrawal by Subject|0|||
154902499|NCT02650895|559063688|FG001|Overall Study|Withdrawal by Subject|1|||
154902500|NCT02650895|559063689|FG002|Overall Study|Withdrawal by Subject|0|||
154902501|NCT02650895|559063690|FG003|Overall Study|Withdrawal by Subject|0|||
154902502|NCT02650895|559063691|FG004|Overall Study|Withdrawal by Subject|0|||
154902503|NCT02650895|559063692|FG005|Overall Study|Withdrawal by Subject|0|||
154902504|NCT02859558|559065193|FG000|Step 1|Not Eligible|0|||
154902505|NCT02859558|559065194|FG001|Step 1|Not Eligible|0|||
154902506|NCT02859558|559065195|FG002|Step 1|Not Eligible|0|||
154902507|NCT02859558|559065196|FG003|Step 1|Not Eligible|0|||
154902508|NCT02859558|559065197|FG004|Step 1|Not Eligible|3|||
154902509|NCT02859558|559065193|FG000|Step 1|Lost to Follow-up|1|||
154902510|NCT02859558|559065194|FG001|Step 1|Lost to Follow-up|3|||
154902511|NCT02859558|559065195|FG002|Step 1|Lost to Follow-up|3|||
154902512|NCT02859558|559065196|FG003|Step 1|Lost to Follow-up|0|||
154902513|NCT02859558|559065197|FG004|Step 1|Lost to Follow-up|0|||
154902514|NCT02859558|559065193|FG000|Step 1|Did Not Return to Clinic|2|||
154902515|NCT02859558|559065194|FG001|Step 1|Did Not Return to Clinic|3|||
154902516|NCT02859558|559065195|FG002|Step 1|Did Not Return to Clinic|4|||
154902517|NCT02859558|559065196|FG003|Step 1|Did Not Return to Clinic|0|||
154902518|NCT02859558|559065197|FG004|Step 1|Did Not Return to Clinic|0|||
154902519|NCT02859558|559065193|FG000|Step 1|Moved|0|||
154902520|NCT02859558|559065194|FG001|Step 1|Moved|1|||
154902521|NCT02859558|559065195|FG002|Step 1|Moved|1|||
154902522|NCT02859558|559065196|FG003|Step 1|Moved|0|||
154902523|NCT02859558|559065197|FG004|Step 1|Moved|0|||
154902524|NCT02859558|559065193|FG000|Step 1|Withdrawal By Participant|1|||
154902525|NCT02859558|559065194|FG001|Step 1|Withdrawal By Participant|2|||
154902526|NCT02859558|559065195|FG002|Step 1|Withdrawal By Participant|1|||
154902527|NCT02859558|559065196|FG003|Step 1|Withdrawal By Participant|0|||
154902528|NCT02859558|559065197|FG004|Step 1|Withdrawal By Participant|0|||
154902529|NCT02859558|559065193|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
154902530|NCT02859558|559065194|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
154902531|NCT02859558|559065195|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
154902532|NCT02859558|559065196|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
154902533|NCT02859558|559065197|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
154902534|NCT02859558|559065193|FG000|Step 1|Incarceration|0|||
154902535|NCT02859558|559065194|FG001|Step 1|Incarceration|1|||
154902536|NCT02859558|559065195|FG002|Step 1|Incarceration|0|||
154902537|NCT02859558|559065196|FG003|Step 1|Incarceration|0|||
154902538|NCT02859558|559065197|FG004|Step 1|Incarceration|0|||
154902539|NCT02859558|559065193|FG000|Step 1|Non-Adherence to Study Drug|2|||
154902540|NCT02859558|559065194|FG001|Step 1|Non-Adherence to Study Drug|0|||
154902541|NCT02859558|559065195|FG002|Step 1|Non-Adherence to Study Drug|1|||
154902542|NCT02859558|559065196|FG003|Step 1|Non-Adherence to Study Drug|0|||
154902543|NCT02859558|559065197|FG004|Step 1|Non-Adherence to Study Drug|0|||
154902544|NCT02859558|559065193|FG000|Step 1|Non-Adherence to Study Requirements|3|||
154902545|NCT02859558|559065194|FG001|Step 1|Non-Adherence to Study Requirements|1|||
154902546|NCT02859558|559065195|FG002|Step 1|Non-Adherence to Study Requirements|0|||
154902547|NCT02859558|559065196|FG003|Step 1|Non-Adherence to Study Requirements|0|||
154902548|NCT02859558|559065197|FG004|Step 1|Non-Adherence to Study Requirements|0|||
154902549|NCT02859558|559065193|FG000|Step 1|Virologic Failure|2|||
154902550|NCT02859558|559065194|FG001|Step 1|Virologic Failure|1|||
154902551|NCT02859558|559065195|FG002|Step 1|Virologic Failure|1|||
154902552|NCT02859558|559065196|FG003|Step 1|Virologic Failure|0|||
154902553|NCT02859558|559065197|FG004|Step 1|Virologic Failure|0|||
154902554|NCT02859558|559065193|FG000|Step 2|Lost to Follow-up|3|||
154902555|NCT02859558|559065194|FG001|Step 2|Lost to Follow-up|3|||
154902556|NCT02859558|559065195|FG002|Step 2|Lost to Follow-up|1|||
154902557|NCT02859558|559065196|FG003|Step 2|Lost to Follow-up|0|||
154902558|NCT02859558|559065197|FG004|Step 2|Lost to Follow-up|0|||
154902559|NCT02859558|559065193|FG000|Step 2|Withdrawal by Subject|0|||
154902560|NCT02859558|559065194|FG001|Step 2|Withdrawal by Subject|1|||
154902561|NCT02859558|559065195|FG002|Step 2|Withdrawal by Subject|1|||
154902562|NCT02859558|559065196|FG003|Step 2|Withdrawal by Subject|0|||
154902563|NCT02859558|559065197|FG004|Step 2|Withdrawal by Subject|0|||
154902564|NCT02859558|559065193|FG000|Step 2|Unexpected Closure of Site|0|||
154902565|NCT02859558|559065194|FG001|Step 2|Unexpected Closure of Site|1|||
154902566|NCT02859558|559065195|FG002|Step 2|Unexpected Closure of Site|1|||
154902567|NCT02859558|559065196|FG003|Step 2|Unexpected Closure of Site|0|||
154902568|NCT02859558|559065197|FG004|Step 2|Unexpected Closure of Site|0|||
154902569|NCT02859558|559065193|FG000|Step 2|Death|1|||
154902570|NCT02859558|559065194|FG001|Step 2|Death|0|||
154902571|NCT02859558|559065195|FG002|Step 2|Death|0|||
154902572|NCT02859558|559065196|FG003|Step 2|Death|0|||
154902573|NCT02859558|559065197|FG004|Step 2|Death|0|||
154902574|NCT02859558|559065193|FG000|Step 2|Incarceration|0|||
154902575|NCT02859558|559065194|FG001|Step 2|Incarceration|0|||
154902576|NCT02859558|559065195|FG002|Step 2|Incarceration|1|||
154902577|NCT02859558|559065196|FG003|Step 2|Incarceration|0|||
154902578|NCT02859558|559065197|FG004|Step 2|Incarceration|0|||
154902579|NCT04507360|559065198|FG000|Week 1|Lost to Follow-up|0|||
154902580|NCT04507360|559065199|FG001|Week 1|Lost to Follow-up|0|||
154902581|NCT04507360|559065200|FG002|Week 1|Lost to Follow-up|0|||
154902582|NCT04507360|559065201|FG003|Week 1|Lost to Follow-up|0|||
154902583|NCT04507360|559065202|FG004|Week 1|Lost to Follow-up|0|||
154902584|NCT04507360|559065203|FG005|Week 1|Lost to Follow-up|0|||
154902585|NCT04507360|559065204|FG006|Week 1|Lost to Follow-up|0|||
154902586|NCT04507360|559065205|FG007|Week 1|Lost to Follow-up|0|||
154902587|NCT04507360|559065206|FG008|Week 1|Lost to Follow-up|72|||
154902588|NCT04507360|559065207|FG009|Week 1|Lost to Follow-up|22|||
154902589|NCT04507360|559065208|FG010|Week 1|Lost to Follow-up|10|||
154902590|NCT04507360|559065198|FG000|Week 2|Lost to Follow-up|0|||
154902591|NCT04507360|559065199|FG001|Week 2|Lost to Follow-up|0|||
154902592|NCT04507360|559065200|FG002|Week 2|Lost to Follow-up|0|||
154902593|NCT04507360|559065201|FG003|Week 2|Lost to Follow-up|0|||
154902594|NCT04507360|559065202|FG004|Week 2|Lost to Follow-up|0|||
154902595|NCT04507360|559065203|FG005|Week 2|Lost to Follow-up|0|||
154902596|NCT04507360|559065204|FG006|Week 2|Lost to Follow-up|0|||
154902597|NCT04507360|559065205|FG007|Week 2|Lost to Follow-up|0|||
154902598|NCT04507360|559065206|FG008|Week 2|Lost to Follow-up|121|||
154902599|NCT04507360|559065207|FG009|Week 2|Lost to Follow-up|85|||
154902600|NCT04507360|559065208|FG010|Week 2|Lost to Follow-up|82|||
154902601|NCT04507360|559065198|FG000|Week 3|Lost to Follow-up|0|||
154902602|NCT04507360|559065199|FG001|Week 3|Lost to Follow-up|0|||
154902603|NCT04507360|559065200|FG002|Week 3|Lost to Follow-up|0|||
154902604|NCT04507360|559065201|FG003|Week 3|Lost to Follow-up|0|||
154902605|NCT04507360|559065202|FG004|Week 3|Lost to Follow-up|0|||
154902606|NCT04507360|559065203|FG005|Week 3|Lost to Follow-up|0|||
154902607|NCT04507360|559065204|FG006|Week 3|Lost to Follow-up|0|||
154902608|NCT04507360|559065205|FG007|Week 3|Lost to Follow-up|0|||
154902609|NCT04507360|559065206|FG008|Week 3|Lost to Follow-up|123|||
154902610|NCT04507360|559065207|FG009|Week 3|Lost to Follow-up|92|||
154902611|NCT04507360|559065208|FG010|Week 3|Lost to Follow-up|84|||
154902612|NCT04507360|559065198|FG000|Week 4|Lost to Follow-up|0|||
154902613|NCT04507360|559065199|FG001|Week 4|Lost to Follow-up|0|||
154902614|NCT04507360|559065200|FG002|Week 4|Lost to Follow-up|0|||
154902615|NCT04507360|559065201|FG003|Week 4|Lost to Follow-up|0|||
154902616|NCT04507360|559065202|FG004|Week 4|Lost to Follow-up|0|||
154902617|NCT04507360|559065203|FG005|Week 4|Lost to Follow-up|0|||
154902618|NCT04507360|559065204|FG006|Week 4|Lost to Follow-up|0|||
154902619|NCT04507360|559065205|FG007|Week 4|Lost to Follow-up|0|||
154902620|NCT04507360|559065206|FG008|Week 4|Lost to Follow-up|131|||
154902621|NCT04507360|559065207|FG009|Week 4|Lost to Follow-up|115|||
154902622|NCT04507360|559065208|FG010|Week 4|Lost to Follow-up|102|||
154902623|NCT04507360|559065198|FG000|Week 5|Lost to Follow-up|0|||
154902624|NCT04507360|559065199|FG001|Week 5|Lost to Follow-up|0|||
154902625|NCT04507360|559065200|FG002|Week 5|Lost to Follow-up|0|||
154902626|NCT04507360|559065201|FG003|Week 5|Lost to Follow-up|0|||
154902627|NCT04507360|559065202|FG004|Week 5|Lost to Follow-up|0|||
154902628|NCT04507360|559065203|FG005|Week 5|Lost to Follow-up|0|||
154902629|NCT04507360|559065204|FG006|Week 5|Lost to Follow-up|0|||
154902630|NCT04507360|559065205|FG007|Week 5|Lost to Follow-up|0|||
154902631|NCT04507360|559065206|FG008|Week 5|Lost to Follow-up|103|||
154902632|NCT04507360|559065207|FG009|Week 5|Lost to Follow-up|135|||
154902633|NCT04507360|559065208|FG010|Week 5|Lost to Follow-up|143|||
154902634|NCT04507360|559065198|FG000|Week 8|Lost to Follow-up|0|||
154902635|NCT04507360|559065199|FG001|Week 8|Lost to Follow-up|0|||
154902636|NCT04507360|559065200|FG002|Week 8|Lost to Follow-up|0|||
154902637|NCT04507360|559065201|FG003|Week 8|Lost to Follow-up|0|||
154902638|NCT04507360|559065202|FG004|Week 8|Lost to Follow-up|0|||
154902639|NCT04507360|559065203|FG005|Week 8|Lost to Follow-up|0|||
154902640|NCT04507360|559065204|FG006|Week 8|Lost to Follow-up|0|||
154902641|NCT04507360|559065205|FG007|Week 8|Lost to Follow-up|0|||
154902642|NCT04507360|559065206|FG008|Week 8|Lost to Follow-up|139|||
154902643|NCT04507360|559065207|FG009|Week 8|Lost to Follow-up|145|||
154902644|NCT04507360|559065208|FG010|Week 8|Lost to Follow-up|152|||
154902645|NCT01432756|559065209|FG000|Overall Study|Lost to Follow-up|1|||
154902646|NCT01432756|559065210|FG001|Overall Study|Lost to Follow-up|0|||
154902647|NCT01432756|559065211|FG002|Overall Study|Lost to Follow-up|2|||
154902648|NCT01432756|559065212|FG003|Overall Study|Lost to Follow-up|1|||
154902649|NCT01004159|559065215|FG000|Overall Study|Adverse Event|2|||
154902650|NCT01004159|559065215|FG000|Overall Study|Disease Progression|18|||
154902651|NCT02712008|559065216|FG000|Baseline (Day 1) up to Week 12|Death|3|||
154902652|NCT02712008|559065217|FG001|Baseline (Day 1) up to Week 12|Death|0|||
154902653|NCT02712008|559065218|FG002|Baseline (Day 1) up to Week 12|Death|0|||
154902654|NCT02712008|559065219|FG003|Baseline (Day 1) up to Week 12|Death|0|||
154902655|NCT02712008|559065220|FG004|Baseline (Day 1) up to Week 12|Death|0|||
154902656|NCT02712008|559065221|FG005|Baseline (Day 1) up to Week 12|Death|0|||
154902657|NCT02712008|559065222|FG006|Baseline (Day 1) up to Week 12|Death|0|||
154981478|NCT02139124|559356912|FG000|Overall Study|Protocol Violation|0|||
154902658|NCT02712008|559065223|FG007|Baseline (Day 1) up to Week 12|Death|0|||
154902659|NCT02712008|559065216|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
154902660|NCT02712008|559065217|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
154902661|NCT02712008|559065218|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
154902662|NCT02712008|559065219|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
154902663|NCT02712008|559065220|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
154902664|NCT02712008|559065221|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
154902665|NCT02712008|559065222|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
154981479|NCT02139124|559356913|FG001|Overall Study|Protocol Violation|0|||
154902666|NCT02712008|559065223|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
154902667|NCT02712008|559065216|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
154902668|NCT02712008|559065217|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
154902669|NCT02712008|559065218|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
154902670|NCT02712008|559065219|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
154902671|NCT02712008|559065220|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
154902672|NCT02712008|559065221|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
154902673|NCT02712008|559065222|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
154902674|NCT02712008|559065223|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
154902675|NCT02712008|559065216|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902676|NCT02712008|559065217|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902677|NCT02712008|559065218|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
154902678|NCT02712008|559065219|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902679|NCT02712008|559065220|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902680|NCT02712008|559065221|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902681|NCT02712008|559065222|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902682|NCT02712008|559065223|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
154902683|NCT02712008|559065216|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902684|NCT02712008|559065217|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
154902685|NCT02712008|559065218|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902686|NCT02712008|559065219|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902687|NCT02712008|559065220|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902688|NCT02712008|559065221|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902689|NCT02712008|559065222|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902690|NCT02712008|559065223|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
154902691|NCT02712008|559065216|FG000|From Week 12 up to Week 36|Adverse Event|0|||
154902692|NCT02712008|559065217|FG001|From Week 12 up to Week 36|Adverse Event|0|||
154902693|NCT02712008|559065218|FG002|From Week 12 up to Week 36|Adverse Event|0|||
154902694|NCT02712008|559065219|FG003|From Week 12 up to Week 36|Adverse Event|0|||
154902695|NCT02712008|559065220|FG004|From Week 12 up to Week 36|Adverse Event|1|||
154902696|NCT02712008|559065221|FG005|From Week 12 up to Week 36|Adverse Event|0|||
154902697|NCT02712008|559065222|FG006|From Week 12 up to Week 36|Adverse Event|0|||
154902698|NCT02712008|559065223|FG007|From Week 12 up to Week 36|Adverse Event|2|||
154902699|NCT02712008|559065216|FG000|From Week 12 up to Week 36|Death|1|||
154902700|NCT02712008|559065217|FG001|From Week 12 up to Week 36|Death|0|||
154902701|NCT02712008|559065218|FG002|From Week 12 up to Week 36|Death|0|||
154902702|NCT02712008|559065219|FG003|From Week 12 up to Week 36|Death|0|||
154902703|NCT02712008|559065220|FG004|From Week 12 up to Week 36|Death|0|||
154902704|NCT02712008|559065221|FG005|From Week 12 up to Week 36|Death|0|||
154902705|NCT02712008|559065222|FG006|From Week 12 up to Week 36|Death|1|||
154902706|NCT02712008|559065223|FG007|From Week 12 up to Week 36|Death|0|||
154902707|NCT02712008|559065216|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
154902708|NCT02712008|559065217|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
154902709|NCT02712008|559065218|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
154902710|NCT02712008|559065219|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
154902711|NCT02712008|559065220|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
154902712|NCT02712008|559065221|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
154902713|NCT02712008|559065222|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
154902714|NCT02712008|559065223|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
154902715|NCT02712008|559065216|FG000|From Week 12 up to Week 36|Physician Decision|0|||
154902716|NCT02712008|559065217|FG001|From Week 12 up to Week 36|Physician Decision|0|||
154902717|NCT02712008|559065218|FG002|From Week 12 up to Week 36|Physician Decision|0|||
154902718|NCT02712008|559065219|FG003|From Week 12 up to Week 36|Physician Decision|1|||
155115361|NCT03622112|559853048|FG006|Overall Study|Reason not specified|1|||
154902719|NCT02712008|559065220|FG004|From Week 12 up to Week 36|Physician Decision|1|||
154902720|NCT02712008|559065221|FG005|From Week 12 up to Week 36|Physician Decision|0|||
154902721|NCT02712008|559065222|FG006|From Week 12 up to Week 36|Physician Decision|0|||
154902722|NCT02712008|559065223|FG007|From Week 12 up to Week 36|Physician Decision|0|||
154902723|NCT02712008|559065216|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
154902724|NCT02712008|559065217|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
154902725|NCT02712008|559065218|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
154902726|NCT02712008|559065219|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
154902727|NCT02712008|559065220|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
154902728|NCT02712008|559065221|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
154902729|NCT02712008|559065222|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
154902730|NCT02712008|559065223|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
154902731|NCT04483544|559065225|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
154902732|NCT04483544|559065225|FG000|Post-Treatment|Admitted to hospice|2|||
154902733|NCT04483544|559065225|FG000|Post-Treatment|Study terminated|3|||
154902734|NCT01131078|559065226|FG000|Overall Study|Adverse Event|22|||
154902735|NCT01131078|559065227|FG001|Overall Study|Adverse Event|12|||
154902736|NCT01131078|559065228|FG002|Overall Study|Adverse Event|17|||
154902737|NCT01131078|559065226|FG000|Overall Study|Progressive Disease|58|||
154902738|NCT01131078|559065227|FG001|Overall Study|Progressive Disease|77|||
154902739|NCT01131078|559065228|FG002|Overall Study|Progressive Disease|71|||
154902740|NCT01131078|559065226|FG000|Overall Study|Protocol Violation|1|||
154902741|NCT01131078|559065227|FG001|Overall Study|Protocol Violation|0|||
154902742|NCT01131078|559065228|FG002|Overall Study|Protocol Violation|0|||
154902743|NCT01131078|559065226|FG000|Overall Study|Lost to Follow-up|1|||
154902744|NCT01131078|559065227|FG001|Overall Study|Lost to Follow-up|1|||
154902745|NCT01131078|559065228|FG002|Overall Study|Lost to Follow-up|1|||
154902746|NCT01131078|559065226|FG000|Overall Study|Withdrawal by Subject|2|||
154902747|NCT01131078|559065227|FG001|Overall Study|Withdrawal by Subject|4|||
154902748|NCT01131078|559065228|FG002|Overall Study|Withdrawal by Subject|3|||
154902749|NCT01131078|559065226|FG000|Overall Study|Non-compliance|3|||
154902750|NCT01131078|559065227|FG001|Overall Study|Non-compliance|0|||
154902751|NCT01131078|559065228|FG002|Overall Study|Non-compliance|0|||
154902752|NCT01131078|559065226|FG000|Overall Study|Physician Decision|10|||
154902753|NCT01131078|559065227|FG001|Overall Study|Physician Decision|6|||
154902754|NCT01131078|559065228|FG002|Overall Study|Physician Decision|8|||
154902755|NCT01131078|559065226|FG000|Overall Study|Death|4|||
154902756|NCT01131078|559065227|FG001|Overall Study|Death|0|||
154902757|NCT01131078|559065228|FG002|Overall Study|Death|2|||
154902758|NCT01131078|559065226|FG000|Overall Study|Other|0|||
154902759|NCT01131078|559065227|FG001|Overall Study|Other|1|||
155115362|NCT03305419|559853052|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115363|NCT03305419|559853053|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
155115364|NCT03305419|559853054|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115365|NCT03305419|559853055|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115366|NCT03305419|559853056|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115367|NCT03305419|559853057|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115368|NCT03305419|559853058|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115369|NCT03305419|559853059|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
155115370|NCT03305419|559853052|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
155115371|NCT03305419|559853053|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115372|NCT03305419|559853054|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115373|NCT03305419|559853055|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115374|NCT03305419|559853056|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115375|NCT03305419|559853057|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115376|NCT03305419|559853058|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115377|NCT03305419|559853059|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
155115378|NCT03305419|559853052|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
155115379|NCT03305419|559853053|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155115380|NCT03305419|559853054|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155175900|NCT02353143|560082178|FG001|Overall Study|Lack of Efficacy|1|||
155175901|NCT02353143|560082179|FG002|Overall Study|Lack of Efficacy|2|||
154902760|NCT01131078|559065228|FG002|Overall Study|Other|0|||
154902761|NCT00736385|559065233|FG000|Overall Study|Withdrawal by Subject|2|||
154902762|NCT00736385|559065234|FG001|Overall Study|Withdrawal by Subject|2|||
154902763|NCT00736385|559065233|FG000|Overall Study|Adverse Event|0|||
154902764|NCT00736385|559065234|FG001|Overall Study|Adverse Event|1|||
154902765|NCT00098865|559065235|FG000|Overall Study|Progressive Disease|6|||
154902766|NCT00098865|559065235|FG000|Overall Study|Adverse Event|2|||
154902767|NCT00098865|559065235|FG000|Overall Study|Alternative Therapy|1|||
154902768|NCT00364351|559065236|FG000|Overall Study|Adverse Event|90|||
155115381|NCT03305419|559853055|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155175902|NCT02353143|560082180|FG003|Overall Study|Lack of Efficacy|4|||
155175903|NCT02353143|560082181|FG004|Overall Study|Lack of Efficacy|13|||
155175904|NCT02353143|560082182|FG005|Overall Study|Lack of Efficacy|2|||
155175905|NCT02353143|560082183|FG006|Overall Study|Lack of Efficacy|2|||
154902769|NCT00364351|559065237|FG001|Overall Study|Adverse Event|44|||
154902770|NCT00364351|559065236|FG000|Overall Study|Condition under investigation worsened|469|||
154902771|NCT00364351|559065237|FG001|Overall Study|Condition under investigation worsened|497|||
154902772|NCT00364351|559065236|FG000|Overall Study|Prohibited concomitant medication|0|||
154902773|NCT00364351|559065237|FG001|Overall Study|Prohibited concomitant medication|2|||
154902774|NCT00364351|559065236|FG000|Overall Study|Lost to Follow-up|1|||
154902775|NCT00364351|559065237|FG001|Overall Study|Lost to Follow-up|1|||
155115382|NCT03305419|559853056|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155115383|NCT03305419|559853057|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155115384|NCT03305419|559853058|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155115385|NCT03305419|559853059|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
155175906|NCT02353143|560082184|FG007|Overall Study|Lack of Efficacy|2|||
155175907|NCT02353143|560082185|FG008|Overall Study|Lack of Efficacy|1|||
154902776|NCT00364351|559065236|FG000|Overall Study|Withdrawal by Subject|30|||
154902777|NCT00364351|559065237|FG001|Overall Study|Withdrawal by Subject|29|||
154902778|NCT00364351|559065236|FG000|Overall Study|Incorrect enrollment|1|||
155175908|NCT02353143|560082177|FG000|Overall Study|reason not specified|1|||
155175909|NCT02353143|560082178|FG001|Overall Study|reason not specified|2|||
155175910|NCT02353143|560082179|FG002|Overall Study|reason not specified|0|||
155175911|NCT02353143|560082180|FG003|Overall Study|reason not specified|0|||
155175912|NCT02353143|560082181|FG004|Overall Study|reason not specified|6|||
155175913|NCT02353143|560082182|FG005|Overall Study|reason not specified|1|||
155175914|NCT02353143|560082183|FG006|Overall Study|reason not specified|0|||
155175915|NCT02353143|560082184|FG007|Overall Study|reason not specified|3|||
155175916|NCT02353143|560082185|FG008|Overall Study|reason not specified|1|||
155175917|NCT02353143|560082177|FG000|Overall Study|Physician Decision|0|||
155175918|NCT02353143|560082178|FG001|Overall Study|Physician Decision|4|||
155175919|NCT02353143|560082179|FG002|Overall Study|Physician Decision|2|||
155175920|NCT02353143|560082180|FG003|Overall Study|Physician Decision|3|||
155175921|NCT02353143|560082181|FG004|Overall Study|Physician Decision|4|||
155175922|NCT02353143|560082182|FG005|Overall Study|Physician Decision|0|||
155175923|NCT02353143|560082183|FG006|Overall Study|Physician Decision|1|||
155175924|NCT02353143|560082184|FG007|Overall Study|Physician Decision|2|||
155175925|NCT02353143|560082185|FG008|Overall Study|Physician Decision|0|||
155175926|NCT02353143|560082177|FG000|Overall Study|Adverse Event|0|||
155175927|NCT02353143|560082178|FG001|Overall Study|Adverse Event|0|||
155175928|NCT02353143|560082179|FG002|Overall Study|Adverse Event|1|||
155175929|NCT02353143|560082180|FG003|Overall Study|Adverse Event|0|||
155175930|NCT02353143|560082181|FG004|Overall Study|Adverse Event|1|||
155175931|NCT02353143|560082182|FG005|Overall Study|Adverse Event|1|||
155175932|NCT02353143|560082183|FG006|Overall Study|Adverse Event|0|||
155175933|NCT02353143|560082184|FG007|Overall Study|Adverse Event|0|||
155175934|NCT02353143|560082185|FG008|Overall Study|Adverse Event|0|||
155175935|NCT02353143|560082177|FG000|Overall Study|patient receiving other treatment for AML|0|||
155175936|NCT02353143|560082178|FG001|Overall Study|patient receiving other treatment for AML|0|||
155175937|NCT02353143|560082179|FG002|Overall Study|patient receiving other treatment for AML|1|||
155175938|NCT02353143|560082180|FG003|Overall Study|patient receiving other treatment for AML|0|||
155175939|NCT02353143|560082181|FG004|Overall Study|patient receiving other treatment for AML|0|||
154902779|NCT00364351|559065237|FG001|Overall Study|Incorrect enrollment|1|||
154902780|NCT00364351|559065236|FG000|Overall Study|Sponsor decision|1|||
154902781|NCT00364351|559065237|FG001|Overall Study|Sponsor decision|0|||
154902782|NCT00364351|559065236|FG000|Overall Study|Poor treatment compliance|0|||
154902783|NCT00364351|559065237|FG001|Overall Study|Poor treatment compliance|3|||
154902784|NCT00364351|559065236|FG000|Overall Study|Investigator error|0|||
154902785|NCT00364351|559065237|FG001|Overall Study|Investigator error|2|||
154902786|NCT00364351|559065236|FG000|Overall Study|Patient could not travel to site|0|||
154902787|NCT00364351|559065237|FG001|Overall Study|Patient could not travel to site|1|||
154902788|NCT00364351|559065236|FG000|Overall Study|Randomised treatment not started|0|||
154902789|NCT00364351|559065237|FG001|Overall Study|Randomised treatment not started|3|||
154902790|NCT00653068|559065238|FG000|Overall Study|Death|9|||
154902791|NCT00653068|559065238|FG000|Overall Study|Lack of Efficacy|34|||
154902792|NCT00653068|559065238|FG000|Overall Study|Physician Decision|4|||
154902793|NCT00653068|559065238|FG000|Overall Study|Withdrawal by Subject|1|||
154902794|NCT00653068|559065238|FG000|Overall Study|Ineligible|2|||
154902795|NCT02177786|559065239|FG000|Overall Study|Withdrew Consent|2|||
154902796|NCT02177786|559065240|FG001|Overall Study|Withdrew Consent|6|||
154902797|NCT02177786|559065241|FG002|Overall Study|Withdrew Consent|9|||
154902798|NCT02177786|559065242|FG003|Overall Study|Withdrew Consent|5|||
154902799|NCT02177786|559065239|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
154902800|NCT02177786|559065240|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
154902801|NCT02177786|559065241|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
154902802|NCT02177786|559065242|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
154902803|NCT02177786|559065239|FG000|Overall Study|Adverse Event|1|||
154902804|NCT02177786|559065240|FG001|Overall Study|Adverse Event|1|||
154981480|NCT02139124|559356914|FG002|Overall Study|Protocol Violation|0|||
154981481|NCT02139124|559356915|FG003|Overall Study|Protocol Violation|1|||
154981482|NCT02139124|559356916|FG004|Overall Study|Protocol Violation|1|||
154981483|NCT02139124|559356912|FG000|Overall Study|non-compliant|1|||
154981484|NCT02139124|559356913|FG001|Overall Study|non-compliant|0|||
154981485|NCT02139124|559356914|FG002|Overall Study|non-compliant|0|||
154981486|NCT02139124|559356915|FG003|Overall Study|non-compliant|2|||
154981487|NCT02139124|559356916|FG004|Overall Study|non-compliant|0|||
154981488|NCT02139124|559356912|FG000|Overall Study|incarceration|0|||
155175940|NCT02353143|560082182|FG005|Overall Study|patient receiving other treatment for AML|0|||
154902805|NCT02177786|559065241|FG002|Overall Study|Adverse Event|2|||
154902806|NCT02177786|559065242|FG003|Overall Study|Adverse Event|3|||
154902807|NCT02177786|559065239|FG000|Overall Study|Death|1|||
154981489|NCT02139124|559356913|FG001|Overall Study|incarceration|0|||
155175941|NCT02353143|560082183|FG006|Overall Study|patient receiving other treatment for AML|0|||
155175942|NCT02353143|560082184|FG007|Overall Study|patient receiving other treatment for AML|0|||
155175943|NCT02353143|560082185|FG008|Overall Study|patient receiving other treatment for AML|0|||
155175944|NCT02353143|560082177|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
154902808|NCT02177786|559065240|FG001|Overall Study|Death|1|||
154902809|NCT02177786|559065241|FG002|Overall Study|Death|1|||
154902810|NCT02177786|559065242|FG003|Overall Study|Death|1|||
154902811|NCT02177786|559065239|FG000|Overall Study|Lost to Follow-up|0|||
154902812|NCT02177786|559065240|FG001|Overall Study|Lost to Follow-up|0|||
154902813|NCT02177786|559065241|FG002|Overall Study|Lost to Follow-up|2|||
154902814|NCT02177786|559065242|FG003|Overall Study|Lost to Follow-up|2|||
154902815|NCT02177786|559065239|FG000|Overall Study|Non-Compliance with Study Drug|0|||
154902816|NCT02177786|559065240|FG001|Overall Study|Non-Compliance with Study Drug|1|||
154902817|NCT02177786|559065241|FG002|Overall Study|Non-Compliance with Study Drug|0|||
154902818|NCT02177786|559065242|FG003|Overall Study|Non-Compliance with Study Drug|1|||
154902819|NCT02177786|559065239|FG000|Overall Study|Protocol Violation|0|||
154902820|NCT02177786|559065240|FG001|Overall Study|Protocol Violation|0|||
154902821|NCT02177786|559065241|FG002|Overall Study|Protocol Violation|2|||
154902822|NCT02177786|559065242|FG003|Overall Study|Protocol Violation|0|||
154902823|NCT02177786|559065239|FG000|Overall Study|Progressive Disease|0|||
154902824|NCT02177786|559065240|FG001|Overall Study|Progressive Disease|1|||
154902825|NCT02177786|559065241|FG002|Overall Study|Progressive Disease|0|||
154902826|NCT02177786|559065242|FG003|Overall Study|Progressive Disease|0|||
154902827|NCT02177786|559065239|FG000|Overall Study|Missing study completion status|0|||
154902828|NCT02177786|559065240|FG001|Overall Study|Missing study completion status|1|||
154902829|NCT02177786|559065241|FG002|Overall Study|Missing study completion status|0|||
154902830|NCT02177786|559065242|FG003|Overall Study|Missing study completion status|0|||
154902831|NCT01305941|559065243|FG000|Overall Study|Adverse Event|6|||
154902832|NCT01305941|559065243|FG000|Overall Study|Clinical decline|2|||
154902833|NCT01305941|559065243|FG000|Overall Study|Withdrawal by Subject|1|||
154902834|NCT01305941|559065243|FG000|Overall Study|Death|1|||
154902835|NCT03950440|559065244|FG000|Overall Study|Death|8|||
154902836|NCT03950440|559065245|FG001|Overall Study|Death|2|||
154902837|NCT03950440|559065246|FG002|Overall Study|Death|1|||
154902838|NCT02892734|559065247|FG000|Treatment on Study|Progressive Disease|2|||
154902839|NCT02892734|559065247|FG000|Follow up for 2 Years|Death|2|||
154902840|NCT02892734|559065247|FG000|Follow up for 2 Years|Study closed early|1|||
154902841|NCT02043509|559065248|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
154902842|NCT02043509|559065249|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
154902843|NCT02043509|559065248|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
154902844|NCT02043509|559065249|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
154902845|NCT02043509|559065248|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
154902846|NCT02043509|559065249|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
154902847|NCT02043509|559065248|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
154902848|NCT02043509|559065249|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
154902849|NCT00608244|559065255|FG000|Overall Study|Adverse Event|1|||
154902850|NCT00608244|559065255|FG000|Overall Study|Low trough levels|1|||
154902851|NCT00430027|559065256|FG000|Overall Study|Study terminated|8|||
154902852|NCT01977040|559065261|FG000|Overall Study|Vasa previa not confirmed|2|||
154902853|NCT01685060|559065262|FG000|Overall Study|Rollover patients|16|||
154902854|NCT01685060|559065262|FG000|Overall Study|Adverse Event|12|||
154902855|NCT01685060|559065262|FG000|Overall Study|Progressive disease|69|||
154902856|NCT01685060|559065262|FG000|Overall Study|Physician Decision|14|||
154902857|NCT01685060|559065262|FG000|Overall Study|Subject/guardian decision|20|||
154902858|NCT01685060|559065262|FG000|Overall Study|Lost to Follow-up|1|||
154902859|NCT01685060|559065262|FG000|Overall Study|Death|8|||
154902860|NCT02158728|559065275|FG000|Overall Study|no procedure according to CIP done|3|||
154902861|NCT02158728|559065275|FG000|Overall Study|no qualified dataset|24|||
154902862|NCT01536418|559065283|FG000|Overall Study|Protocol Violation|2|||
154902863|NCT01536418|559065284|FG001|Overall Study|Protocol Violation|3|||
154902864|NCT01536418|559065283|FG000|Overall Study|Physician Decision|1|||
154902865|NCT01536418|559065284|FG001|Overall Study|Physician Decision|3|||
154902866|NCT01536418|559065283|FG000|Overall Study|Study closed/terminated|41|||
154902867|NCT01536418|559065284|FG001|Overall Study|Study closed/terminated|37|||
154902868|NCT01536418|559065283|FG000|Overall Study|Lack of Efficacy|10|||
154902869|NCT01536418|559065284|FG001|Overall Study|Lack of Efficacy|16|||
154902870|NCT01536418|559065283|FG000|Overall Study|Adverse Event|9|||
154902871|NCT01536418|559065284|FG001|Overall Study|Adverse Event|4|||
154981490|NCT02139124|559356914|FG002|Overall Study|incarceration|1|||
154981491|NCT02139124|559356915|FG003|Overall Study|incarceration|0|||
154902872|NCT01536418|559065283|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
154902873|NCT01536418|559065284|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
154902874|NCT01536418|559065283|FG000|Overall Study|Withdrawal by Subject|5|||
154902875|NCT01536418|559065284|FG001|Overall Study|Withdrawal by Subject|3|||
154902876|NCT02658149|559065289|FG000|Overall Study|Physician Decision|1|||
154902877|NCT02658149|559065290|FG001|Overall Study|Physician Decision|0|||
154902878|NCT00711412|559065291|FG000|Induction Treatment|Death|2|||
154902879|NCT00711412|559065291|FG000|Induction Treatment|Adverse Event|1|||
154902880|NCT00711412|559065291|FG000|Induction Treatment|Other|1|||
154902881|NCT00711412|559065291|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
154902882|NCT00711412|559065291|FG000|Evaluated for Combination Treatment|Death|1|||
154981492|NCT02139124|559356916|FG004|Overall Study|incarceration|0|||
155115386|NCT03305419|559853052|FG000|Part B (14 Days)|Adverse Event|0|||
155115387|NCT03305419|559853053|FG001|Part B (14 Days)|Adverse Event|0|||
155115388|NCT03305419|559853054|FG002|Part B (14 Days)|Adverse Event|0|||
155115389|NCT03305419|559853055|FG003|Part B (14 Days)|Adverse Event|0|||
155115390|NCT03305419|559853056|FG004|Part B (14 Days)|Adverse Event|1|||
154902883|NCT00711412|559065291|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
154902884|NCT00711412|559065291|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
154902885|NCT00711412|559065291|FG000|Combination Treatment|Progressive Disease|1|||
154902886|NCT00711412|559065291|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
154902887|NCT00711412|559065291|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
154902888|NCT00711412|559065291|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
154902889|NCT00711412|559065291|FG000|Evaluation for Response and Surgery|Death|1|||
154902890|NCT00711412|559065291|FG000|Survival Follow up Until Death|Other|12|||
154902891|NCT04097028|559065292|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
154902892|NCT04097028|559065292|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
154902893|NCT04097028|559065292|FG000|Overall Study|Disease Progression prior to Surgery|2|||
154902894|NCT04097028|559065292|FG000|Overall Study|Adverse Event prior to Surgery|1|||
154902895|NCT02473289|559065293|FG000|Overall Study|Adverse Event|2|||
154902896|NCT02473289|559065294|FG001|Overall Study|Adverse Event|3|||
154902897|NCT02473289|559065293|FG000|Overall Study|Lost to Follow-up|1|||
154902898|NCT02473289|559065294|FG001|Overall Study|Lost to Follow-up|1|||
154902899|NCT02473289|559065293|FG000|Overall Study|Protocol Violation|0|||
154902900|NCT02473289|559065294|FG001|Overall Study|Protocol Violation|1|||
154902901|NCT02473289|559065293|FG000|Overall Study|Withdrawal of consent|6|||
154902902|NCT02473289|559065294|FG001|Overall Study|Withdrawal of consent|7|||
154902903|NCT02473289|559065293|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
154902904|NCT02473289|559065294|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
154902905|NCT02473289|559065293|FG000|Overall Study|Other|2|||
154902906|NCT02473289|559065294|FG001|Overall Study|Other|0|||
154902907|NCT02244619|559065295|FG000|Overall Study|Did not receive study intervention|8|||
154902908|NCT02244619|559065296|FG001|Overall Study|Did not receive study intervention|21|||
154902909|NCT01156363|559065297|FG000|Overall Study|Adverse Event|6|||
154902910|NCT01156363|559065297|FG000|Overall Study|Insufficient Therapeutic Response|5|||
154902911|NCT01156363|559065297|FG000|Overall Study|Failure to Return|1|||
154902912|NCT01156363|559065297|FG000|Overall Study|Refused Treatment|4|||
154902913|NCT01156363|559065297|FG000|Overall Study|Other|6|||
154902914|NCT03285490|559065299|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
154902915|NCT03285490|559065300|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
154902916|NCT03285490|559065299|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
154902917|NCT03285490|559065300|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
154902918|NCT03745989|559065301|FG000|Overall Study|Death|3|||
154902919|NCT03745989|559065302|FG001|Overall Study|Death|7|||
154902920|NCT03745989|559065303|FG002|Overall Study|Death|4|||
154902921|NCT03745989|559065301|FG000|Overall Study|Lost to Follow-up|0|||
154902922|NCT03745989|559065302|FG001|Overall Study|Lost to Follow-up|2|||
154902923|NCT03745989|559065303|FG002|Overall Study|Lost to Follow-up|0|||
154902924|NCT03745989|559065301|FG000|Overall Study|Sponsor Decision|0|||
154902925|NCT03745989|559065302|FG001|Overall Study|Sponsor Decision|2|||
154902926|NCT03745989|559065303|FG002|Overall Study|Sponsor Decision|8|||
154902927|NCT03745989|559065301|FG000|Overall Study|Withdrawal by Subject|0|||
154902928|NCT03745989|559065302|FG001|Overall Study|Withdrawal by Subject|1|||
154902929|NCT03745989|559065303|FG002|Overall Study|Withdrawal by Subject|3|||
154902930|NCT00068822|559065304|FG000|First Randomized Intervention|Lost to Follow-up|1|||
154902931|NCT00068822|559065305|FG001|First Randomized Intervention|Lost to Follow-up|2|||
154902932|NCT00735072|559065311|FG000|Overall Study|interrupted study med during ARV change|1|||
154902933|NCT00735072|559065312|FG001|Overall Study|interrupted study med during ARV change|0|||
154902934|NCT00735072|559065311|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
154902935|NCT00735072|559065312|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
154902936|NCT00911144|559065313|FG000|Overall Study|Withdrawal by Subject|16|||
154902937|NCT00911144|559065314|FG001|Overall Study|Withdrawal by Subject|5|||
154902938|NCT00047008|559065316|FG000|Overall Study|Withdrawn consent|2|||
154902939|NCT00047008|559065317|FG001|Overall Study|Withdrawn consent|3|||
154902940|NCT00047008|559065316|FG000|Overall Study|Ineligible|9|||
154902941|NCT00047008|559065317|FG001|Overall Study|Ineligible|8|||
154902942|NCT00429572|559065318|FG000|Overall Study|Disease progression|1|||
155115391|NCT03305419|559853057|FG005|Part B (14 Days)|Adverse Event|2|||
155115392|NCT03305419|559853058|FG006|Part B (14 Days)|Adverse Event|4|||
154902943|NCT02773368|559065321|FG000|Overall Study|Lost to Follow-up|4|||
154902944|NCT02773368|559065322|FG001|Overall Study|Lost to Follow-up|1|||
154902945|NCT02773368|559065321|FG000|Overall Study|Withdrawal by Subject|5|||
154902946|NCT02773368|559065322|FG001|Overall Study|Withdrawal by Subject|1|||
154902947|NCT02773368|559065321|FG000|Overall Study|Unclassified|1|||
154902948|NCT02773368|559065322|FG001|Overall Study|Unclassified|1|||
154902949|NCT02773368|559065321|FG000|Overall Study|Missing|0|||
154902950|NCT02773368|559065322|FG001|Overall Study|Missing|1|||
154902951|NCT01047436|559065324|FG000|Overall Study|Protocol Violation|1|||
154902952|NCT01047436|559065325|FG001|Overall Study|Protocol Violation|0|||
154902953|NCT02635867|559065328|FG000|Overall Study|Lost to Follow-up|4|||
154902954|NCT02635867|559065329|FG001|Overall Study|Lost to Follow-up|3|||
154902955|NCT02635867|559065330|FG002|Overall Study|Lost to Follow-up|3|||
154902956|NCT02635867|559065331|FG003|Overall Study|Lost to Follow-up|4|||
154902957|NCT02635867|559065332|FG004|Overall Study|Lost to Follow-up|1|||
154902958|NCT02565576|559065335|FG000|Overall Study|abnormal lab value|2|||
154902959|NCT02565576|559065336|FG001|Overall Study|abnormal lab value|0|||
154902960|NCT02565576|559065335|FG000|Overall Study|subject / guardian decision|1|||
154902961|NCT02565576|559065336|FG001|Overall Study|subject / guardian decision|3|||
154902962|NCT02565576|559065335|FG000|Overall Study|Lost to Follow-up|1|||
154902963|NCT02565576|559065336|FG001|Overall Study|Lost to Follow-up|0|||
154902964|NCT02565576|559065335|FG000|Overall Study|Death|0|||
154902965|NCT02565576|559065336|FG001|Overall Study|Death|2|||
154902966|NCT02565576|559065335|FG000|Overall Study|Adverse Event|1|||
154902967|NCT02565576|559065336|FG001|Overall Study|Adverse Event|0|||
154902968|NCT00939341|559065337|FG000|Overall Study|Adverse Event|15|||
154902969|NCT00939341|559065337|FG000|Overall Study|Pregnancy|1|||
154902970|NCT00939341|559065337|FG000|Overall Study|Lost to Follow-up|23|||
154902971|NCT00939341|559065337|FG000|Overall Study|Withdrawal by Subject|13|||
154902972|NCT00939341|559065337|FG000|Overall Study|Protocol Violation|6|||
154902973|NCT00939341|559065337|FG000|Overall Study|Incorrect enrolment|8|||
154902974|NCT01408732|559065338|FG000|Overall Study|Withdrawal by Subject|2|||
154902975|NCT01408732|559065339|FG001|Overall Study|Withdrawal by Subject|2|||
154902976|NCT00424099|559065340|FG000|Overall Study|Adverse Event|0|||
154902977|NCT00424099|559065341|FG001|Overall Study|Adverse Event|1|||
154902978|NCT00424099|559065342|FG002|Overall Study|Adverse Event|1|||
154902979|NCT00424099|559065343|FG003|Overall Study|Adverse Event|0|||
154902980|NCT00424099|559065340|FG000|Overall Study|Death|0|||
154902981|NCT00424099|559065341|FG001|Overall Study|Death|1|||
154902982|NCT00424099|559065342|FG002|Overall Study|Death|0|||
154902983|NCT00424099|559065343|FG003|Overall Study|Death|0|||
154902984|NCT00424099|559065340|FG000|Overall Study|Illness|2|||
154902985|NCT00424099|559065341|FG001|Overall Study|Illness|0|||
154902986|NCT00424099|559065342|FG002|Overall Study|Illness|1|||
154902987|NCT00424099|559065343|FG003|Overall Study|Illness|4|||
154902988|NCT00424099|559065340|FG000|Overall Study|Lost to Follow-up|0|||
154902989|NCT00424099|559065341|FG001|Overall Study|Lost to Follow-up|0|||
154902990|NCT00424099|559065342|FG002|Overall Study|Lost to Follow-up|3|||
154902991|NCT00424099|559065343|FG003|Overall Study|Lost to Follow-up|0|||
154902992|NCT00424099|559065340|FG000|Overall Study|Hospitalized|1|||
154902993|NCT00424099|559065341|FG001|Overall Study|Hospitalized|2|||
154902994|NCT00424099|559065342|FG002|Overall Study|Hospitalized|1|||
154902995|NCT00424099|559065343|FG003|Overall Study|Hospitalized|3|||
154902996|NCT00424099|559065340|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
154902997|NCT00424099|559065341|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
154902998|NCT00424099|559065342|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
154902999|NCT00424099|559065343|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
154903000|NCT00424099|559065340|FG000|Overall Study|Withdrawal by Subject|1|||
154903001|NCT00424099|559065341|FG001|Overall Study|Withdrawal by Subject|9|||
154903002|NCT00424099|559065342|FG002|Overall Study|Withdrawal by Subject|4|||
154903003|NCT00424099|559065343|FG003|Overall Study|Withdrawal by Subject|6|||
154903004|NCT00424099|559065340|FG000|Overall Study|Physician Decision|0|||
154903005|NCT00424099|559065341|FG001|Overall Study|Physician Decision|0|||
154903006|NCT00424099|559065342|FG002|Overall Study|Physician Decision|1|||
154903007|NCT00424099|559065343|FG003|Overall Study|Physician Decision|0|||
154903008|NCT00424099|559065340|FG000|Overall Study|Missing|0|||
154903009|NCT00424099|559065341|FG001|Overall Study|Missing|0|||
154903010|NCT00424099|559065342|FG002|Overall Study|Missing|1|||
154903011|NCT00424099|559065343|FG003|Overall Study|Missing|0|||
154903012|NCT00764322|559065345|FG000|Overall Study|Withdrawal by Subject|11|||
154903013|NCT00764322|559065345|FG000|Overall Study|No CYP2D6 genotyping|9|||
154903014|NCT03097133|559065346|FG000|Overall Study|Lost to Follow-up|3|||
155115393|NCT03305419|559853059|FG007|Part B (14 Days)|Adverse Event|0|||
155115394|NCT03305419|559853052|FG000|Part B (14 Days)|Physician Decision|0|||
154903015|NCT03097133|559065347|FG001|Overall Study|Lost to Follow-up|2|||
154903016|NCT03097133|559065346|FG000|Overall Study|Withdrawal by Subject|2|||
154903017|NCT03097133|559065347|FG001|Overall Study|Withdrawal by Subject|5|||
154903018|NCT03097133|559065346|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
154903019|NCT03097133|559065347|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
154903020|NCT03097133|559065346|FG000|Overall Study|Other|3|||
154903021|NCT03097133|559065347|FG001|Overall Study|Other|2|||
154903022|NCT03097133|559065346|FG000|Overall Study|Adverse Event|1|||
154903023|NCT03097133|559065347|FG001|Overall Study|Adverse Event|0|||
155115395|NCT03305419|559853053|FG001|Part B (14 Days)|Physician Decision|0|||
154903024|NCT02910089|559065350|FG000|Overall Study|Lost insurance eligibility|22|||
154903025|NCT02910089|559065351|FG001|Overall Study|Lost insurance eligibility|16|||
154903026|NCT00633360|559065352|FG000|Overall Study|Lost to Follow-up|1|||
154903027|NCT00633360|559065353|FG001|Overall Study|Lost to Follow-up|1|||
154903028|NCT00633360|559065352|FG000|Overall Study|Adverse Event|3|||
154903029|NCT00633360|559065353|FG001|Overall Study|Adverse Event|1|||
154903030|NCT00633360|559065352|FG000|Overall Study|Protocol Violation|0|||
154903031|NCT00633360|559065353|FG001|Overall Study|Protocol Violation|1|||
154903032|NCT00329784|559065354|FG000|Overall Study|Lost to Follow-up|0|||
154903033|NCT00329784|559065355|FG001|Overall Study|Lost to Follow-up|1|||
154903034|NCT00329784|559065356|FG002|Overall Study|Lost to Follow-up|0|||
154903035|NCT00329784|559065357|FG003|Overall Study|Lost to Follow-up|0|||
154903036|NCT00329784|559065354|FG000|Overall Study|Withdrawal by Subject|4|||
154903037|NCT00329784|559065355|FG001|Overall Study|Withdrawal by Subject|2|||
154903038|NCT00329784|559065356|FG002|Overall Study|Withdrawal by Subject|0|||
154903039|NCT00329784|559065357|FG003|Overall Study|Withdrawal by Subject|0|||
154903040|NCT00329784|559065354|FG000|Overall Study|Other|1|||
154903041|NCT00329784|559065355|FG001|Overall Study|Other|2|||
154903042|NCT00329784|559065356|FG002|Overall Study|Other|0|||
154903043|NCT00329784|559065357|FG003|Overall Study|Other|0|||
154903044|NCT03695471|559067192|FG000|Overall Study|Cancellation|1|||
154903045|NCT03050307|559067194|FG000|Overall Study|Adverse Event|4|||
154903046|NCT03050307|559067195|FG001|Overall Study|Adverse Event|2|||
154903047|NCT03050307|559067194|FG000|Overall Study|Significant Protocol Deviation|0|||
154903048|NCT03050307|559067195|FG001|Overall Study|Significant Protocol Deviation|1|||
154903049|NCT03050307|559067194|FG000|Overall Study|Lost to Follow-up|0|||
154903050|NCT03050307|559067195|FG001|Overall Study|Lost to Follow-up|1|||
154903051|NCT03050307|559067194|FG000|Overall Study|Voluntary Withdrawal|3|||
154903052|NCT03050307|559067195|FG001|Overall Study|Voluntary Withdrawal|4|||
154903053|NCT03050307|559067194|FG000|Overall Study|Reason not Specified|1|||
154903054|NCT03050307|559067195|FG001|Overall Study|Reason not Specified|1|||
154903055|NCT00439309|559067196|FG000|Follow-Up|Death|1|||
154903056|NCT00439309|559067197|FG001|Follow-Up|Death|0|||
154903057|NCT00439309|559067196|FG000|Follow-Up|Lost to Follow-up|2|||
154903058|NCT00439309|559067197|FG001|Follow-Up|Lost to Follow-up|0|||
154903059|NCT00439309|559067196|FG000|Follow-Up|Withdrawal by Subject|0|||
154903060|NCT00439309|559067197|FG001|Follow-Up|Withdrawal by Subject|1|||
154903061|NCT00439309|559067196|FG000|Follow-Up|Late response by subject|0|||
154903062|NCT00439309|559067197|FG001|Follow-Up|Late response by subject|1|||
154903063|NCT00464620|559067198|FG000|Overall Study|Physician Decision|1|||
154903064|NCT00464620|559067199|FG001|Overall Study|Physician Decision|0|||
154903065|NCT00464620|559067200|FG002|Overall Study|Physician Decision|0|||
154903066|NCT00464620|559067198|FG000|Overall Study|Withdrawal by Subject|1|||
154903067|NCT00464620|559067199|FG001|Overall Study|Withdrawal by Subject|0|||
154903068|NCT00464620|559067200|FG002|Overall Study|Withdrawal by Subject|3|||
154903069|NCT00464620|559067198|FG000|Overall Study|Ineligible sarcoma subtype|0|||
154903070|NCT00464620|559067199|FG001|Overall Study|Ineligible sarcoma subtype|2|||
154903071|NCT00464620|559067200|FG002|Overall Study|Ineligible sarcoma subtype|2|||
154903072|NCT00464620|559067198|FG000|Overall Study|Use of prohibited concomitant medication|0|||
154903073|NCT00464620|559067199|FG001|Overall Study|Use of prohibited concomitant medication|0|||
154903074|NCT00464620|559067200|FG002|Overall Study|Use of prohibited concomitant medication|2|||
154903075|NCT01998906|559067201|FG000|Overall Study|Participants ongoing in follow-up|77|||
154903076|NCT01998906|559067202|FG001|Overall Study|Participants ongoing in follow-up|60|||
154903077|NCT01998906|559067203|FG002|Overall Study|Participants ongoing in follow-up|58|||
154903078|NCT01998906|559067201|FG000|Overall Study|Death|21|||
154903079|NCT01998906|559067202|FG001|Overall Study|Death|30|||
154903080|NCT01998906|559067203|FG002|Overall Study|Death|17|||
154903081|NCT01998906|559067201|FG000|Overall Study|Lack of Efficacy|10|||
154903082|NCT01998906|559067202|FG001|Overall Study|Lack of Efficacy|9|||
154903083|NCT01998906|559067203|FG002|Overall Study|Lack of Efficacy|8|||
154903084|NCT01998906|559067201|FG000|Overall Study|Failure to return|0|||
154903085|NCT01998906|559067202|FG001|Overall Study|Failure to return|2|||
154903086|NCT01998906|559067203|FG002|Overall Study|Failure to return|4|||
154903087|NCT01998906|559067201|FG000|Overall Study|Violation of Selection Criteria|0|||
154903088|NCT01998906|559067202|FG001|Overall Study|Violation of Selection Criteria|0|||
154903089|NCT01998906|559067203|FG002|Overall Study|Violation of Selection Criteria|1|||
154903090|NCT01998906|559067201|FG000|Overall Study|Withdrawal by Subject|1|||
154903091|NCT01998906|559067202|FG001|Overall Study|Withdrawal by Subject|4|||
154903092|NCT01998906|559067203|FG002|Overall Study|Withdrawal by Subject|3|||
154903093|NCT01998906|559067201|FG000|Overall Study|Administrative/Other|2|||
154903094|NCT01998906|559067202|FG001|Overall Study|Administrative/Other|1|||
154903095|NCT01998906|559067203|FG002|Overall Study|Administrative/Other|3|||
154903096|NCT01998906|559067201|FG000|Overall Study|Other|3|||
154903097|NCT01998906|559067202|FG001|Overall Study|Other|8|||
154903098|NCT01998906|559067203|FG002|Overall Study|Other|4|||
154903099|NCT06048809|559067205|FG000|Overall Study|Adverse Event|2|||
154903100|NCT06048809|559067206|FG001|Overall Study|Adverse Event|0|||
154903101|NCT06048809|559067205|FG000|Overall Study|Withdrawal by Subject|1|||
154903102|NCT06048809|559067206|FG001|Overall Study|Withdrawal by Subject|1|||
154903103|NCT02234050|559067225|FG000|Overall Study|Lack of Efficacy|38|||
154903104|NCT02234050|559067226|FG001|Overall Study|Lack of Efficacy|22|||
155115396|NCT03305419|559853054|FG002|Part B (14 Days)|Physician Decision|0|||
155115397|NCT03305419|559853055|FG003|Part B (14 Days)|Physician Decision|0|||
155115398|NCT03305419|559853056|FG004|Part B (14 Days)|Physician Decision|2|||
155115399|NCT03305419|559853057|FG005|Part B (14 Days)|Physician Decision|8|||
155115400|NCT03305419|559853058|FG006|Part B (14 Days)|Physician Decision|1|||
155115401|NCT03305419|559853059|FG007|Part B (14 Days)|Physician Decision|0|||
155115402|NCT01155466|559853060|FG000|Overall Study|Adverse Event|13|||
155115403|NCT01155466|559853061|FG001|Overall Study|Adverse Event|15|||
155115404|NCT01155466|559853062|FG002|Overall Study|Adverse Event|6|||
155115405|NCT01155466|559853063|FG003|Overall Study|Adverse Event|17|||
155115406|NCT01155466|559853064|FG004|Overall Study|Adverse Event|18|||
155115407|NCT01155466|559853060|FG000|Overall Study|Lost to Follow-up|0|||
155115408|NCT01155466|559853061|FG001|Overall Study|Lost to Follow-up|0|||
155115409|NCT01155466|559853062|FG002|Overall Study|Lost to Follow-up|0|||
155115410|NCT01155466|559853063|FG003|Overall Study|Lost to Follow-up|0|||
155115411|NCT01155466|559853064|FG004|Overall Study|Lost to Follow-up|2|||
155115412|NCT01155466|559853060|FG000|Overall Study|Withdrawal by Subject|7|||
155115413|NCT01155466|559853061|FG001|Overall Study|Withdrawal by Subject|5|||
155115414|NCT01155466|559853062|FG002|Overall Study|Withdrawal by Subject|9|||
155115415|NCT01155466|559853063|FG003|Overall Study|Withdrawal by Subject|4|||
155115416|NCT01155466|559853064|FG004|Overall Study|Withdrawal by Subject|4|||
155115417|NCT01155466|559853060|FG000|Overall Study|Protocol Violation|0|||
155115418|NCT01155466|559853061|FG001|Overall Study|Protocol Violation|0|||
155115419|NCT01155466|559853062|FG002|Overall Study|Protocol Violation|2|||
154903105|NCT02234050|559067225|FG000|Overall Study|Adverse Event|13|||
154903106|NCT02234050|559067226|FG001|Overall Study|Adverse Event|1|||
154903107|NCT02234050|559067225|FG000|Overall Study|Withdrawal by Subject|4|||
154903108|NCT02234050|559067226|FG001|Overall Study|Withdrawal by Subject|2|||
154903109|NCT02234050|559067225|FG000|Overall Study|Sponsor's decision|6|||
154903110|NCT02234050|559067226|FG001|Overall Study|Sponsor's decision|0|||
154903111|NCT01680991|559067233|FG000|Overall Study|Adverse Event|1|||
154903112|NCT01680991|559067234|FG001|Overall Study|Adverse Event|0|||
154903113|NCT01680991|559067235|FG002|Overall Study|Adverse Event|0|||
154903114|NCT01680991|559067233|FG000|Overall Study|Death|1|||
154903115|NCT01680991|559067234|FG001|Overall Study|Death|0|||
154903116|NCT01680991|559067235|FG002|Overall Study|Death|1|||
154903117|NCT01680991|559067233|FG000|Overall Study|Protocol Violation|0|||
154903118|NCT01680991|559067234|FG001|Overall Study|Protocol Violation|1|||
154903119|NCT01680991|559067235|FG002|Overall Study|Protocol Violation|0|||
154903120|NCT01680991|559067233|FG000|Overall Study|Withdrawal by Subject|5|||
154903121|NCT01680991|559067234|FG001|Overall Study|Withdrawal by Subject|1|||
154903122|NCT01680991|559067235|FG002|Overall Study|Withdrawal by Subject|0|||
154903123|NCT01680991|559067233|FG000|Overall Study|Progressive disease (PD)|0|||
154903124|NCT01680991|559067234|FG001|Overall Study|Progressive disease (PD)|10|||
154903125|NCT01680991|559067235|FG002|Overall Study|Progressive disease (PD)|0|||
154903126|NCT01680991|559067233|FG000|Overall Study|Physician Decision|0|||
154903127|NCT01680991|559067234|FG001|Overall Study|Physician Decision|7|||
154903128|NCT01680991|559067235|FG002|Overall Study|Physician Decision|2|||
154903129|NCT01680991|559067233|FG000|Overall Study|Bad physical condition|0|||
154903130|NCT01680991|559067234|FG001|Overall Study|Bad physical condition|0|||
154903131|NCT01680991|559067235|FG002|Overall Study|Bad physical condition|1|||
154903132|NCT01680991|559067233|FG000|Overall Study|PD confirmed in other hospital|1|||
154903133|NCT01680991|559067234|FG001|Overall Study|PD confirmed in other hospital|0|||
154903134|NCT01680991|559067235|FG002|Overall Study|PD confirmed in other hospital|0|||
154903135|NCT06073054|559067236|FG000|Overall Study|Withdrawal by Subject|2|||
154903136|NCT00796003|559067237|FG000|Overall Study|Disease Progression|2|||
154903137|NCT00796003|559067238|FG001|Overall Study|Disease Progression|13|||
154903138|NCT00796003|559067237|FG000|Overall Study|Adverse Event|1|||
154903139|NCT00796003|559067238|FG001|Overall Study|Adverse Event|7|||
154903140|NCT00796003|559067237|FG000|Overall Study|Specified organ function not met|0|||
154903141|NCT00796003|559067238|FG001|Overall Study|Specified organ function not met|1|||
154903142|NCT00796003|559067237|FG000|Overall Study|Physician Decision|0|||
154903143|NCT00796003|559067238|FG001|Overall Study|Physician Decision|4|||
154903144|NCT00796003|559067237|FG000|Overall Study|Withdrawal by Subject|0|||
154903145|NCT00796003|559067238|FG001|Overall Study|Withdrawal by Subject|1|||
155115420|NCT01155466|559853063|FG003|Overall Study|Protocol Violation|0|||
155115421|NCT01155466|559853064|FG004|Overall Study|Protocol Violation|1|||
155115422|NCT01155466|559853060|FG000|Overall Study|Administrative|0|||
155115423|NCT01155466|559853061|FG001|Overall Study|Administrative|3|||
155115424|NCT01155466|559853062|FG002|Overall Study|Administrative|0|||
155115425|NCT01155466|559853063|FG003|Overall Study|Administrative|0|||
155115426|NCT01155466|559853064|FG004|Overall Study|Administrative|0|||
155115427|NCT01155466|559853060|FG000|Overall Study|Randomized not treated|2|||
155115428|NCT01155466|559853061|FG001|Overall Study|Randomized not treated|2|||
155115429|NCT01155466|559853062|FG002|Overall Study|Randomized not treated|3|||
155115430|NCT01155466|559853063|FG003|Overall Study|Randomized not treated|0|||
154903146|NCT00796003|559067237|FG000|Overall Study|Other|0|||
154903147|NCT00796003|559067238|FG001|Overall Study|Other|1|||
154981493|NCT02139124|559356912|FG000|Overall Study|subject moved|1|||
154981494|NCT02139124|559356913|FG001|Overall Study|subject moved|0|||
154981495|NCT02139124|559356914|FG002|Overall Study|subject moved|0|||
154981496|NCT02139124|559356915|FG003|Overall Study|subject moved|0|||
154981497|NCT02139124|559356916|FG004|Overall Study|subject moved|0|||
154981498|NCT02139124|559356912|FG000|Overall Study|Lost to Follow-up|3|||
154981499|NCT02139124|559356913|FG001|Overall Study|Lost to Follow-up|2|||
154981500|NCT02139124|559356914|FG002|Overall Study|Lost to Follow-up|0|||
154981501|NCT02139124|559356915|FG003|Overall Study|Lost to Follow-up|5|||
154981502|NCT02139124|559356916|FG004|Overall Study|Lost to Follow-up|4|||
154981503|NCT02691741|559356917|FG000|Overall Study|Adverse Event|0|||
154981504|NCT02691741|559356918|FG001|Overall Study|Adverse Event|2|||
154981505|NCT02691741|559356917|FG000|Overall Study|Lost to Follow-up|1|||
154981506|NCT02691741|559356918|FG001|Overall Study|Lost to Follow-up|0|||
154981507|NCT02691741|559356917|FG000|Overall Study|Physician Decision|0|||
154981508|NCT02691741|559356918|FG001|Overall Study|Physician Decision|1|||
154981509|NCT02691741|559356917|FG000|Overall Study|Withdrawal by Subject|0|||
154981510|NCT02691741|559356918|FG001|Overall Study|Withdrawal by Subject|4|||
154981511|NCT02697773|559356919|FG000|Overall Study|Adverse Event|2|||
154981512|NCT02697773|559356920|FG001|Overall Study|Adverse Event|1|||
154981513|NCT02697773|559356921|FG002|Overall Study|Adverse Event|2|||
154981514|NCT02697773|559356919|FG000|Overall Study|Death|0|||
154981515|NCT02697773|559356920|FG001|Overall Study|Death|0|||
154981516|NCT02697773|559356921|FG002|Overall Study|Death|2|||
154981517|NCT02697773|559356919|FG000|Overall Study|Lack of Efficacy|4|||
154981518|NCT02697773|559356920|FG001|Overall Study|Lack of Efficacy|6|||
154981519|NCT02697773|559356921|FG002|Overall Study|Lack of Efficacy|6|||
154981520|NCT02697773|559356919|FG000|Overall Study|Lost to Follow-up|5|||
154981521|NCT02697773|559356920|FG001|Overall Study|Lost to Follow-up|5|||
154981522|NCT02697773|559356921|FG002|Overall Study|Lost to Follow-up|7|||
154981523|NCT02697773|559356919|FG000|Overall Study|Other|15|||
154981524|NCT02697773|559356920|FG001|Overall Study|Other|11|||
154981525|NCT02697773|559356921|FG002|Overall Study|Other|10|||
154981526|NCT02697773|559356919|FG000|Overall Study|Protocol Violation|1|||
154981527|NCT02697773|559356920|FG001|Overall Study|Protocol Violation|1|||
154981528|NCT02697773|559356921|FG002|Overall Study|Protocol Violation|0|||
154981529|NCT02697773|559356919|FG000|Overall Study|Withdrawal by Subject|10|||
154981530|NCT02697773|559356920|FG001|Overall Study|Withdrawal by Subject|13|||
154981531|NCT02697773|559356921|FG002|Overall Study|Withdrawal by Subject|13|||
154981532|NCT02697773|559356919|FG000|Overall Study|Randomized but not treated|1|||
154981533|NCT02697773|559356920|FG001|Overall Study|Randomized but not treated|1|||
154981534|NCT02697773|559356921|FG002|Overall Study|Randomized but not treated|0|||
154981535|NCT02243293|559356922|FG000|Overall Study|Adverse Event|1|||
154981536|NCT02243293|559356923|FG001|Overall Study|Adverse Event|0|||
154981537|NCT02243293|559356924|FG002|Overall Study|Adverse Event|0|||
154981538|NCT02243293|559356925|FG003|Overall Study|Adverse Event|0|||
154981539|NCT02243293|559356926|FG004|Overall Study|Adverse Event|0|||
154981540|NCT02243293|559356927|FG005|Overall Study|Adverse Event|0|||
154981541|NCT02243293|559356928|FG006|Overall Study|Adverse Event|0|||
154981542|NCT02243293|559356929|FG007|Overall Study|Adverse Event|0|||
154981543|NCT02243293|559356930|FG008|Overall Study|Adverse Event|0|||
154981544|NCT02243293|559356931|FG009|Overall Study|Adverse Event|0|||
154981545|NCT02243293|559356932|FG010|Overall Study|Adverse Event|0|||
155115431|NCT01155466|559853064|FG004|Overall Study|Randomized not treated|2|||
155115432|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
155115433|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
154981546|NCT02243293|559356933|FG011|Overall Study|Adverse Event|0|||
154981547|NCT02243293|559356934|FG012|Overall Study|Adverse Event|0|||
154981548|NCT02243293|559356935|FG013|Overall Study|Adverse Event|0|||
154981549|NCT02243293|559356936|FG014|Overall Study|Adverse Event|0|||
154981550|NCT02243293|559356937|FG015|Overall Study|Adverse Event|1|||
154981551|NCT02243293|559356938|FG016|Overall Study|Adverse Event|0|||
154981552|NCT02243293|559356939|FG017|Overall Study|Adverse Event|0|||
154981553|NCT02243293|559356940|FG018|Overall Study|Adverse Event|0|||
154981554|NCT02243293|559356941|FG019|Overall Study|Adverse Event|0|||
154981555|NCT02243293|559356942|FG020|Overall Study|Adverse Event|1|||
154981556|NCT02243293|559356943|FG021|Overall Study|Adverse Event|0|||
154981557|NCT02243293|559356922|FG000|Overall Study|Withdrawal by Subject|1|||
154981558|NCT02243293|559356923|FG001|Overall Study|Withdrawal by Subject|0|||
154981559|NCT02243293|559356924|FG002|Overall Study|Withdrawal by Subject|0|||
154981560|NCT02243293|559356925|FG003|Overall Study|Withdrawal by Subject|0|||
154981561|NCT02243293|559356926|FG004|Overall Study|Withdrawal by Subject|0|||
154981562|NCT02243293|559356927|FG005|Overall Study|Withdrawal by Subject|0|||
155115434|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
155115435|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
155115436|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
154981563|NCT02243293|559356928|FG006|Overall Study|Withdrawal by Subject|0|||
154981564|NCT02243293|559356929|FG007|Overall Study|Withdrawal by Subject|0|||
154981565|NCT02243293|559356930|FG008|Overall Study|Withdrawal by Subject|0|||
155115437|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
154903148|NCT00796003|559067237|FG000|Overall Study|Participants Not treated|0|||
154903149|NCT00796003|559067238|FG001|Overall Study|Participants Not treated|2|||
154903150|NCT01131130|559067240|FG000|Period 1 - Baseline|Pregnancy|1|||
154903151|NCT01131130|559067240|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
154903152|NCT03345342|559067241|FG000|Open-Label Phase|Adverse Event|30|||
154903153|NCT03345342|559067242|FG001|Open-Label Phase|Adverse Event|0|||
154903154|NCT03345342|559067243|FG002|Open-Label Phase|Adverse Event|0|||
154903155|NCT03345342|559067244|FG003|Open-Label Phase|Adverse Event|0|||
154903156|NCT03345342|559067245|FG004|Open-Label Phase|Adverse Event|0|||
154903157|NCT03345342|559067241|FG000|Open-Label Phase|Death|1|||
154903158|NCT03345342|559067242|FG001|Open-Label Phase|Death|0|||
154903159|NCT03345342|559067243|FG002|Open-Label Phase|Death|0|||
154903160|NCT03345342|559067244|FG003|Open-Label Phase|Death|0|||
154903161|NCT03345342|559067245|FG004|Open-Label Phase|Death|0|||
154903162|NCT03345342|559067241|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
154903163|NCT03345342|559067242|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
154903164|NCT03345342|559067243|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
154903165|NCT03345342|559067244|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
154903166|NCT03345342|559067245|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
154903167|NCT03345342|559067241|FG000|Open-Label Phase|Lack of Efficacy|6|||
154903168|NCT03345342|559067242|FG001|Open-Label Phase|Lack of Efficacy|0|||
154903169|NCT03345342|559067243|FG002|Open-Label Phase|Lack of Efficacy|0|||
154903170|NCT03345342|559067244|FG003|Open-Label Phase|Lack of Efficacy|0|||
154903171|NCT03345342|559067245|FG004|Open-Label Phase|Lack of Efficacy|0|||
154903172|NCT03345342|559067241|FG000|Open-Label Phase|Lost to Follow-up|9|||
154903173|NCT03345342|559067242|FG001|Open-Label Phase|Lost to Follow-up|0|||
154903174|NCT03345342|559067243|FG002|Open-Label Phase|Lost to Follow-up|0|||
154903175|NCT03345342|559067244|FG003|Open-Label Phase|Lost to Follow-up|0|||
154903176|NCT03345342|559067245|FG004|Open-Label Phase|Lost to Follow-up|0|||
154903177|NCT03345342|559067241|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
154903178|NCT03345342|559067242|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
154903179|NCT03345342|559067243|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
154903180|NCT03345342|559067244|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
154903181|NCT03345342|559067245|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
154903182|NCT03345342|559067241|FG000|Open-Label Phase|Physician Decision|4|||
154903183|NCT03345342|559067242|FG001|Open-Label Phase|Physician Decision|0|||
154903184|NCT03345342|559067243|FG002|Open-Label Phase|Physician Decision|0|||
154903185|NCT03345342|559067244|FG003|Open-Label Phase|Physician Decision|0|||
154903186|NCT03345342|559067245|FG004|Open-Label Phase|Physician Decision|0|||
154903187|NCT03345342|559067241|FG000|Open-Label Phase|Protocol Violation|8|||
154903188|NCT03345342|559067242|FG001|Open-Label Phase|Protocol Violation|0|||
154903189|NCT03345342|559067243|FG002|Open-Label Phase|Protocol Violation|0|||
154903190|NCT03345342|559067244|FG003|Open-Label Phase|Protocol Violation|0|||
154903191|NCT03345342|559067245|FG004|Open-Label Phase|Protocol Violation|0|||
154903192|NCT03345342|559067241|FG000|Open-Label Phase|Withdrawal by Subject|57|||
154903193|NCT03345342|559067242|FG001|Open-Label Phase|Withdrawal by Subject|0|||
154903194|NCT03345342|559067243|FG002|Open-Label Phase|Withdrawal by Subject|0|||
154903195|NCT03345342|559067244|FG003|Open-Label Phase|Withdrawal by Subject|0|||
154903196|NCT03345342|559067245|FG004|Open-Label Phase|Withdrawal by Subject|0|||
154903197|NCT03345342|559067241|FG000|Open-Label Phase|Other|15|||
154903198|NCT03345342|559067242|FG001|Open-Label Phase|Other|0|||
154903199|NCT03345342|559067243|FG002|Open-Label Phase|Other|0|||
154903200|NCT03345342|559067244|FG003|Open-Label Phase|Other|0|||
154903201|NCT03345342|559067245|FG004|Open-Label Phase|Other|0|||
154903202|NCT03345342|559067241|FG000|Double-Blind Phase|Adverse Event|0|||
154903203|NCT03345342|559067242|FG001|Double-Blind Phase|Adverse Event|1|||
154903204|NCT03345342|559067243|FG002|Double-Blind Phase|Adverse Event|6|||
154903205|NCT03345342|559067244|FG003|Double-Blind Phase|Adverse Event|0|||
154903206|NCT03345342|559067245|FG004|Double-Blind Phase|Adverse Event|0|||
154903207|NCT03345342|559067241|FG000|Double-Blind Phase|Death|0|||
154903208|NCT03345342|559067242|FG001|Double-Blind Phase|Death|2|||
155115438|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
154903209|NCT03345342|559067243|FG002|Double-Blind Phase|Death|1|||
154903210|NCT03345342|559067244|FG003|Double-Blind Phase|Death|0|||
154903211|NCT03345342|559067245|FG004|Double-Blind Phase|Death|0|||
154903212|NCT03345342|559067241|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
154903213|NCT03345342|559067242|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
154903214|NCT03345342|559067243|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
154903215|NCT03345342|559067244|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
154903216|NCT03345342|559067245|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
154903217|NCT03345342|559067241|FG000|Double-Blind Phase|Lost to Follow-up|0|||
154903218|NCT03345342|559067242|FG001|Double-Blind Phase|Lost to Follow-up|1|||
155115439|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
154903219|NCT03345342|559067243|FG002|Double-Blind Phase|Lost to Follow-up|7|||
154903220|NCT03345342|559067244|FG003|Double-Blind Phase|Lost to Follow-up|0|||
154903221|NCT03345342|559067245|FG004|Double-Blind Phase|Lost to Follow-up|0|||
154903222|NCT03345342|559067241|FG000|Double-Blind Phase|Physician Decision|0|||
154903223|NCT03345342|559067242|FG001|Double-Blind Phase|Physician Decision|1|||
154903224|NCT03345342|559067243|FG002|Double-Blind Phase|Physician Decision|4|||
154903225|NCT03345342|559067244|FG003|Double-Blind Phase|Physician Decision|0|||
154903226|NCT03345342|559067245|FG004|Double-Blind Phase|Physician Decision|0|||
154903227|NCT03345342|559067241|FG000|Double-Blind Phase|Protocol Violation|0|||
154903228|NCT03345342|559067242|FG001|Double-Blind Phase|Protocol Violation|0|||
154903229|NCT03345342|559067243|FG002|Double-Blind Phase|Protocol Violation|1|||
154903230|NCT03345342|559067244|FG003|Double-Blind Phase|Protocol Violation|0|||
154903231|NCT03345342|559067245|FG004|Double-Blind Phase|Protocol Violation|0|||
154903232|NCT03345342|559067241|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
154903233|NCT03345342|559067242|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
154903234|NCT03345342|559067243|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
154903235|NCT03345342|559067244|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
154903236|NCT03345342|559067245|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
154903237|NCT03345342|559067241|FG000|Double-Blind Phase|Other|0|||
154903238|NCT03345342|559067242|FG001|Double-Blind Phase|Other|1|||
154903239|NCT03345342|559067243|FG002|Double-Blind Phase|Other|3|||
154903240|NCT03345342|559067244|FG003|Double-Blind Phase|Other|0|||
154903241|NCT03345342|559067245|FG004|Double-Blind Phase|Other|0|||
154903242|NCT03345342|559067241|FG000|Follow-Up Phase|Adverse Event|0|||
154903243|NCT03345342|559067242|FG001|Follow-Up Phase|Adverse Event|0|||
154903244|NCT03345342|559067243|FG002|Follow-Up Phase|Adverse Event|0|||
154903245|NCT03345342|559067244|FG003|Follow-Up Phase|Adverse Event|0|||
154903246|NCT03345342|559067245|FG004|Follow-Up Phase|Adverse Event|4|||
154903247|NCT03345342|559067241|FG000|Follow-Up Phase|Lost to Follow-up|0|||
154903248|NCT03345342|559067242|FG001|Follow-Up Phase|Lost to Follow-up|0|||
154903249|NCT03345342|559067243|FG002|Follow-Up Phase|Lost to Follow-up|0|||
154903250|NCT03345342|559067244|FG003|Follow-Up Phase|Lost to Follow-up|0|||
154903251|NCT03345342|559067245|FG004|Follow-Up Phase|Lost to Follow-up|6|||
154903252|NCT03345342|559067241|FG000|Follow-Up Phase|Physician Decision|0|||
154903253|NCT03345342|559067242|FG001|Follow-Up Phase|Physician Decision|0|||
154903254|NCT03345342|559067243|FG002|Follow-Up Phase|Physician Decision|0|||
154903255|NCT03345342|559067244|FG003|Follow-Up Phase|Physician Decision|0|||
154903256|NCT03345342|559067245|FG004|Follow-Up Phase|Physician Decision|5|||
154903257|NCT03345342|559067241|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
154903258|NCT03345342|559067242|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
154903259|NCT03345342|559067243|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
154903260|NCT03345342|559067244|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
154903261|NCT03345342|559067245|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
154903262|NCT03345342|559067241|FG000|Follow-Up Phase|Other|0|||
154903263|NCT03345342|559067242|FG001|Follow-Up Phase|Other|0|||
154903264|NCT03345342|559067243|FG002|Follow-Up Phase|Other|0|||
154903265|NCT03345342|559067244|FG003|Follow-Up Phase|Other|3|||
154903266|NCT03345342|559067245|FG004|Follow-Up Phase|Other|1|||
154903267|NCT02437162|559067246|FG000|Overall Study|Protocol Violation|0|||
154903268|NCT02437162|559067247|FG001|Overall Study|Protocol Violation|1|||
154903269|NCT02437162|559067248|FG002|Overall Study|Protocol Violation|0|||
155115440|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
154903270|NCT02437162|559067246|FG000|Overall Study|Randomized but not treated|0|||
154903271|NCT02437162|559067247|FG001|Overall Study|Randomized but not treated|0|||
154903272|NCT02437162|559067248|FG002|Overall Study|Randomized but not treated|1|||
154903273|NCT02437162|559067246|FG000|Overall Study|Study discontinued by Sponsor|93|||
154903274|NCT02437162|559067247|FG001|Overall Study|Study discontinued by Sponsor|98|||
154903275|NCT02437162|559067248|FG002|Overall Study|Study discontinued by Sponsor|97|||
154903276|NCT02437162|559067246|FG000|Overall Study|Withdrawal by Subject|13|||
154903277|NCT02437162|559067247|FG001|Overall Study|Withdrawal by Subject|7|||
154981566|NCT02243293|559356931|FG009|Overall Study|Withdrawal by Subject|1|||
154981567|NCT02243293|559356932|FG010|Overall Study|Withdrawal by Subject|0|||
154981568|NCT02243293|559356933|FG011|Overall Study|Withdrawal by Subject|1|||
154981569|NCT02243293|559356934|FG012|Overall Study|Withdrawal by Subject|0|||
154981570|NCT02243293|559356935|FG013|Overall Study|Withdrawal by Subject|0|||
154981571|NCT02243293|559356936|FG014|Overall Study|Withdrawal by Subject|0|||
154981572|NCT02243293|559356937|FG015|Overall Study|Withdrawal by Subject|0|||
154981573|NCT02243293|559356938|FG016|Overall Study|Withdrawal by Subject|0|||
154981574|NCT02243293|559356939|FG017|Overall Study|Withdrawal by Subject|0|||
154981575|NCT02243293|559356940|FG018|Overall Study|Withdrawal by Subject|0|||
154981576|NCT02243293|559356941|FG019|Overall Study|Withdrawal by Subject|0|||
154981577|NCT02243293|559356942|FG020|Overall Study|Withdrawal by Subject|0|||
154981578|NCT02243293|559356943|FG021|Overall Study|Withdrawal by Subject|1|||
154903278|NCT02437162|559067248|FG002|Overall Study|Withdrawal by Subject|9|||
154903279|NCT02437162|559067246|FG000|Overall Study|Adverse Event|0|||
154903280|NCT02437162|559067247|FG001|Overall Study|Adverse Event|1|||
154981579|NCT02243293|559356922|FG000|Overall Study|Lost to Follow-up|0|||
154903281|NCT02437162|559067248|FG002|Overall Study|Adverse Event|0|||
154903282|NCT02437162|559067246|FG000|Overall Study|Lost to Follow-up|1|||
154981580|NCT02243293|559356923|FG001|Overall Study|Lost to Follow-up|1|||
155115441|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
155115442|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Other|1|||
155115443|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Other|1|||
155115444|NCT02075047|559853065|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
155115445|NCT02075047|559853066|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
155115446|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
155115447|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
155115448|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
155115449|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
155115450|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
155115451|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
155115452|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
155115453|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
155115454|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
155115455|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
155115456|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Other|1|||
155115457|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Other|2|||
155115458|NCT02075047|559853065|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
155115459|NCT02075047|559853066|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
155115460|NCT01229254|559853071|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
155115461|NCT01229254|559853072|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
155115462|NCT01229254|559853073|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
155115463|NCT01229254|559853071|FG000|Overall Study|Adverse Event|4|||
155115464|NCT01229254|559853072|FG001|Overall Study|Adverse Event|5|||
155115465|NCT01229254|559853073|FG002|Overall Study|Adverse Event|3|||
155115466|NCT01229254|559853071|FG000|Overall Study|Lost to Follow-up|3|||
155115467|NCT01229254|559853072|FG001|Overall Study|Lost to Follow-up|0|||
155115468|NCT01229254|559853073|FG002|Overall Study|Lost to Follow-up|1|||
155115469|NCT01229254|559853071|FG000|Overall Study|Physician Decision|0|||
155115470|NCT01229254|559853072|FG001|Overall Study|Physician Decision|3|||
155115471|NCT01229254|559853073|FG002|Overall Study|Physician Decision|0|||
155115472|NCT01229254|559853071|FG000|Overall Study|Protocol Violation|4|||
155115473|NCT01229254|559853072|FG001|Overall Study|Protocol Violation|6|||
155115474|NCT01229254|559853073|FG002|Overall Study|Protocol Violation|5|||
155115475|NCT01229254|559853071|FG000|Overall Study|Withdrawal by Subject|1|||
155115476|NCT01229254|559853072|FG001|Overall Study|Withdrawal by Subject|0|||
155115477|NCT01229254|559853073|FG002|Overall Study|Withdrawal by Subject|1|||
155115478|NCT01229254|559853071|FG000|Overall Study|Non-compliance with Study Drug|0|||
155115479|NCT01229254|559853072|FG001|Overall Study|Non-compliance with Study Drug|1|||
155115480|NCT01229254|559853073|FG002|Overall Study|Non-compliance with Study Drug|1|||
155115481|NCT02186652|559853078|FG000|Overall Study|Lost to Follow-up|2|||
155115482|NCT02186652|559853079|FG001|Overall Study|Lost to Follow-up|0|||
155115483|NCT03770728|559853083|FG000|Overall Study|Adverse Event|1|||
155115484|NCT03770728|559853084|FG001|Overall Study|Adverse Event|0|||
155115485|NCT03770728|559853085|FG002|Overall Study|Adverse Event|1|||
154903283|NCT02437162|559067247|FG001|Overall Study|Lost to Follow-up|0|||
154903284|NCT02437162|559067248|FG002|Overall Study|Lost to Follow-up|1|||
154903285|NCT02437162|559067246|FG000|Overall Study|Death|0|||
154903286|NCT02437162|559067247|FG001|Overall Study|Death|1|||
154903287|NCT02437162|559067248|FG002|Overall Study|Death|0|||
154903288|NCT02437162|559067246|FG000|Overall Study|Other|0|||
154903289|NCT02437162|559067247|FG001|Overall Study|Other|0|||
154903290|NCT02437162|559067248|FG002|Overall Study|Other|1|||
154903291|NCT03981744|559067253|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
154903292|NCT03981744|559067254|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
154903293|NCT03981744|559067255|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
154903294|NCT03981744|559067256|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
154903295|NCT03981744|559067253|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
154903296|NCT03981744|559067254|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
154903297|NCT03981744|559067255|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
154981581|NCT02243293|559356924|FG002|Overall Study|Lost to Follow-up|1|||
155115486|NCT03770728|559853086|FG003|Overall Study|Adverse Event|0|||
155115487|NCT03770728|559853083|FG000|Overall Study|Poor compliance to protocol|0|||
155115488|NCT03770728|559853084|FG001|Overall Study|Poor compliance to protocol|0|||
155115489|NCT03770728|559853085|FG002|Overall Study|Poor compliance to protocol|1|||
154981582|NCT02243293|559356925|FG003|Overall Study|Lost to Follow-up|1|||
155115490|NCT03770728|559853086|FG003|Overall Study|Poor compliance to protocol|0|||
154903298|NCT03981744|559067256|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
154903299|NCT03981744|559067253|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
155115491|NCT03770728|559853083|FG000|Overall Study|Withdrawal by Subject|13|||
154981583|NCT02243293|559356926|FG004|Overall Study|Lost to Follow-up|0|||
154903300|NCT03981744|559067254|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
155115492|NCT03770728|559853084|FG001|Overall Study|Withdrawal by Subject|8|||
155115493|NCT03770728|559853085|FG002|Overall Study|Withdrawal by Subject|9|||
154903301|NCT03981744|559067255|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
155115494|NCT03770728|559853086|FG003|Overall Study|Withdrawal by Subject|13|||
155115495|NCT03770728|559853083|FG000|Overall Study|Other than specified|24|||
155115496|NCT03770728|559853084|FG001|Overall Study|Other than specified|23|||
155115497|NCT03770728|559853085|FG002|Overall Study|Other than specified|21|||
154903302|NCT03981744|559067256|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
154903303|NCT04338321|559067257|FG000|Overall Study|Adverse Event|4|||
154903304|NCT04338321|559067258|FG001|Overall Study|Adverse Event|10|||
154903305|NCT04338321|559067257|FG000|Overall Study|Death|1|||
154903306|NCT04338321|559067258|FG001|Overall Study|Death|1|||
154903307|NCT04338321|559067257|FG000|Overall Study|Lost to Follow-up|4|||
154903308|NCT04338321|559067258|FG001|Overall Study|Lost to Follow-up|9|||
154903309|NCT04338321|559067257|FG000|Overall Study|Withdrawal by Subject|45|||
154903310|NCT04338321|559067258|FG001|Overall Study|Withdrawal by Subject|69|||
154903311|NCT04338321|559067257|FG000|Overall Study|Physician Decision|5|||
154903312|NCT04338321|559067258|FG001|Overall Study|Physician Decision|9|||
154903313|NCT04338321|559067257|FG000|Overall Study|Other|3|||
154903314|NCT04338321|559067258|FG001|Overall Study|Other|10|||
154903315|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
154903316|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
154903317|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
154903318|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
154903319|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
154903320|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
154903321|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
154903322|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
154903323|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
154903324|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
154903325|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
154903326|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
154903327|NCT03321526|559067259|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
154903328|NCT03321526|559067260|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
154903329|NCT03321526|559067259|FG000|Follow-up Phase (2 Weeks)|Other|24|||
154903330|NCT03321526|559067260|FG001|Follow-up Phase (2 Weeks)|Other|24|||
154903331|NCT01989572|559067261|FG000|Overall Study|Lack of Efficacy|35|||
154903332|NCT01989572|559067262|FG001|Overall Study|Lack of Efficacy|48|||
154903333|NCT01989572|559067263|FG002|Overall Study|Lack of Efficacy|48|||
154903334|NCT01989572|559067264|FG003|Overall Study|Lack of Efficacy|43|||
154903335|NCT01989572|559067265|FG004|Overall Study|Lack of Efficacy|71|||
154903336|NCT01989572|559067266|FG005|Overall Study|Lack of Efficacy|79|||
154903337|NCT01989572|559067261|FG000|Overall Study|Adverse Event|2|||
154903338|NCT01989572|559067262|FG001|Overall Study|Adverse Event|1|||
154903339|NCT01989572|559067263|FG002|Overall Study|Adverse Event|3|||
154903340|NCT01989572|559067264|FG003|Overall Study|Adverse Event|0|||
154903341|NCT01989572|559067265|FG004|Overall Study|Adverse Event|3|||
154903342|NCT01989572|559067266|FG005|Overall Study|Adverse Event|0|||
154903343|NCT01989572|559067261|FG000|Overall Study|Death|0|||
154903344|NCT01989572|559067262|FG001|Overall Study|Death|0|||
154903345|NCT01989572|559067263|FG002|Overall Study|Death|0|||
154903346|NCT01989572|559067264|FG003|Overall Study|Death|0|||
154903347|NCT01989572|559067265|FG004|Overall Study|Death|1|||
154903348|NCT01989572|559067266|FG005|Overall Study|Death|0|||
154903349|NCT01989572|559067261|FG000|Overall Study|Withdrawal by Subject|4|||
154903350|NCT01989572|559067262|FG001|Overall Study|Withdrawal by Subject|1|||
154903351|NCT01989572|559067263|FG002|Overall Study|Withdrawal by Subject|5|||
154903352|NCT01989572|559067264|FG003|Overall Study|Withdrawal by Subject|1|||
154903353|NCT01989572|559067265|FG004|Overall Study|Withdrawal by Subject|12|||
154903354|NCT01989572|559067266|FG005|Overall Study|Withdrawal by Subject|4|||
154903355|NCT01989572|559067261|FG000|Overall Study|complicating disease|1|||
154903356|NCT01989572|559067262|FG001|Overall Study|complicating disease|1|||
154903357|NCT01989572|559067263|FG002|Overall Study|complicating disease|2|||
154903358|NCT01989572|559067264|FG003|Overall Study|complicating disease|0|||
154903359|NCT01989572|559067265|FG004|Overall Study|complicating disease|1|||
154903360|NCT01989572|559067266|FG005|Overall Study|complicating disease|0|||
154903361|NCT01989572|559067261|FG000|Overall Study|error|2|||
154903362|NCT01989572|559067262|FG001|Overall Study|error|1|||
154903363|NCT01989572|559067263|FG002|Overall Study|error|1|||
154903364|NCT01989572|559067264|FG003|Overall Study|error|1|||
154903365|NCT01989572|559067265|FG004|Overall Study|error|1|||
154903366|NCT01989572|559067266|FG005|Overall Study|error|1|||
154903367|NCT01989572|559067261|FG000|Overall Study|maximum dose reached|0|||
154903368|NCT01989572|559067262|FG001|Overall Study|maximum dose reached|1|||
154903369|NCT01989572|559067263|FG002|Overall Study|maximum dose reached|0|||
154903370|NCT01989572|559067264|FG003|Overall Study|maximum dose reached|0|||
154903371|NCT01989572|559067265|FG004|Overall Study|maximum dose reached|1|||
155115498|NCT03770728|559853086|FG003|Overall Study|Other than specified|22|||
154903372|NCT01989572|559067266|FG005|Overall Study|maximum dose reached|0|||
154903373|NCT01989572|559067261|FG000|Overall Study|unknown/not specify|3|||
154903374|NCT01989572|559067262|FG001|Overall Study|unknown/not specify|4|||
154903375|NCT01989572|559067263|FG002|Overall Study|unknown/not specify|1|||
154903376|NCT01989572|559067264|FG003|Overall Study|unknown/not specify|3|||
154903377|NCT01989572|559067265|FG004|Overall Study|unknown/not specify|3|||
154903378|NCT01989572|559067266|FG005|Overall Study|unknown/not specify|5|||
154903379|NCT01989572|559067261|FG000|Overall Study|not start protocol therapy|5|||
154903380|NCT01989572|559067262|FG001|Overall Study|not start protocol therapy|1|||
154903381|NCT01989572|559067263|FG002|Overall Study|not start protocol therapy|2|||
154903382|NCT01989572|559067264|FG003|Overall Study|not start protocol therapy|3|||
154903383|NCT01989572|559067265|FG004|Overall Study|not start protocol therapy|4|||
154903384|NCT01989572|559067266|FG005|Overall Study|not start protocol therapy|18|||
154903385|NCT01989572|559067261|FG000|Overall Study|alternative therapy|3|||
154903386|NCT01989572|559067262|FG001|Overall Study|alternative therapy|0|||
154903387|NCT01989572|559067263|FG002|Overall Study|alternative therapy|0|||
154903388|NCT01989572|559067264|FG003|Overall Study|alternative therapy|0|||
154903389|NCT01989572|559067265|FG004|Overall Study|alternative therapy|1|||
154903390|NCT01989572|559067266|FG005|Overall Study|alternative therapy|3|||
154903391|NCT02280096|559067271|FG000|Overall Study|Pregnancy|1|||
154903392|NCT02280096|559067272|FG001|Overall Study|Pregnancy|0|||
154903393|NCT02280096|559067271|FG000|Overall Study|Functional neurological disorder|1|||
154903394|NCT02280096|559067272|FG001|Overall Study|Functional neurological disorder|0|||
154903395|NCT02280096|559067271|FG000|Overall Study|Lack of attachment|0|||
154903396|NCT02280096|559067272|FG001|Overall Study|Lack of attachment|1|||
154903397|NCT00246376|559067277|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
154903398|NCT00246376|559067278|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
154903399|NCT00246376|559067279|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
154903400|NCT00246376|559067280|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
154903401|NCT00246376|559067281|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
154903402|NCT00246376|559067277|FG000|Overall Study|Adverse Event|2|||
154903403|NCT00246376|559067278|FG001|Overall Study|Adverse Event|3|||
154903404|NCT00246376|559067279|FG002|Overall Study|Adverse Event|1|||
154903405|NCT00246376|559067280|FG003|Overall Study|Adverse Event|3|||
154903406|NCT00246376|559067281|FG004|Overall Study|Adverse Event|1|||
154903407|NCT00246376|559067277|FG000|Overall Study|Lost to Follow-up|2|||
154903408|NCT00246376|559067278|FG001|Overall Study|Lost to Follow-up|11|||
154903409|NCT00246376|559067279|FG002|Overall Study|Lost to Follow-up|11|||
154903410|NCT00246376|559067280|FG003|Overall Study|Lost to Follow-up|16|||
154903411|NCT00246376|559067281|FG004|Overall Study|Lost to Follow-up|13|||
154903412|NCT01849562|559067290|FG000|Overall Study|Lost to Follow-up|1|||
154903413|NCT01849562|559067291|FG001|Overall Study|Lost to Follow-up|0|||
154903414|NCT01849562|559067292|FG002|Overall Study|Lost to Follow-up|0|||
154903415|NCT01849562|559067290|FG000|Overall Study|Non-compliance with Study Drug|1|||
154903416|NCT01849562|559067291|FG001|Overall Study|Non-compliance with Study Drug|0|||
154903417|NCT01849562|559067292|FG002|Overall Study|Non-compliance with Study Drug|0|||
154903418|NCT00481988|559067293|FG000|Overall Study|Withdrawal by Subject|1|||
154903419|NCT00481988|559067294|FG001|Overall Study|Withdrawal by Subject|1|||
154903420|NCT04599972|559067303|FG000|Overall Study|Withdrawal by Subject|6|||
154903421|NCT04599972|559067304|FG001|Overall Study|Withdrawal by Subject|1|||
154903422|NCT04599972|559067303|FG000|Overall Study|Adverse Event|1|||
154903423|NCT04599972|559067304|FG001|Overall Study|Adverse Event|1|||
154903424|NCT04599972|559067303|FG000|Overall Study|Lost to Follow-up|1|||
154903425|NCT04599972|559067304|FG001|Overall Study|Lost to Follow-up|6|||
154903426|NCT04599972|559067303|FG000|Overall Study|Protocol Violation|1|||
154903427|NCT04599972|559067304|FG001|Overall Study|Protocol Violation|0|||
154903428|NCT04599972|559067303|FG000|Overall Study|Other reason|1|||
154903429|NCT04599972|559067304|FG001|Overall Study|Other reason|0|||
154903430|NCT01347073|559067307|FG000|Overall Study|Adverse Event|1|||
154903431|NCT01347073|559067307|FG000|Overall Study|Liver Transplant|1|||
154903432|NCT03236506|559067308|FG000|Overall Study|Death|1|||
154903433|NCT03236506|559067309|FG001|Overall Study|Death|1|||
154903434|NCT03236506|559067310|FG002|Overall Study|Death|1|||
154903435|NCT03236506|559067308|FG000|Overall Study|Withdrawal by Subject|3|||
154903436|NCT03236506|559067309|FG001|Overall Study|Withdrawal by Subject|3|||
154903437|NCT03236506|559067310|FG002|Overall Study|Withdrawal by Subject|4|||
154903438|NCT03236506|559067308|FG000|Overall Study|Did not initiate treatment|2|||
154903439|NCT03236506|559067309|FG001|Overall Study|Did not initiate treatment|1|||
154903440|NCT03236506|559067310|FG002|Overall Study|Did not initiate treatment|2|||
154903441|NCT00621244|559067315|FG000|Overall Study|Withdrawal by Subject|7|||
154903442|NCT00621244|559067316|FG001|Overall Study|Withdrawal by Subject|3|||
154903443|NCT00621244|559067317|FG002|Overall Study|Withdrawal by Subject|3|||
154903444|NCT00621244|559067318|FG003|Overall Study|Withdrawal by Subject|3|||
154903445|NCT00621244|559067315|FG000|Overall Study|Disease progression|44|||
154903446|NCT00621244|559067316|FG001|Overall Study|Disease progression|20|||
154903447|NCT00621244|559067317|FG002|Overall Study|Disease progression|20|||
154903448|NCT00621244|559067318|FG003|Overall Study|Disease progression|15|||
154903449|NCT00621244|559067315|FG000|Overall Study|Death|3|||
155115499|NCT00503776|559853087|FG000|Overall Study|Withdrawal by Subject|1|||
154903450|NCT00621244|559067316|FG001|Overall Study|Death|3|||
154903451|NCT00621244|559067317|FG002|Overall Study|Death|1|||
154903452|NCT00621244|559067318|FG003|Overall Study|Death|1|||
154903453|NCT00621244|559067315|FG000|Overall Study|Adverse Event|27|||
154903454|NCT00621244|559067316|FG001|Overall Study|Adverse Event|7|||
154903455|NCT00621244|559067317|FG002|Overall Study|Adverse Event|9|||
154903456|NCT00621244|559067318|FG003|Overall Study|Adverse Event|2|||
154903457|NCT00621244|559067315|FG000|Overall Study|Administrative problems|5|||
154903458|NCT00621244|559067316|FG001|Overall Study|Administrative problems|1|||
154903459|NCT00621244|559067317|FG002|Overall Study|Administrative problems|0|||
154903460|NCT00621244|559067318|FG003|Overall Study|Administrative problems|2|||
154903461|NCT01690988|559067321|FG000|Overall Study|Withdrawal by Subject|2|||
154903462|NCT01690988|559067322|FG001|Overall Study|Withdrawal by Subject|2|||
154903463|NCT01690988|559067323|FG002|Overall Study|Withdrawal by Subject|3|||
154903464|NCT01690988|559067321|FG000|Overall Study|Physician Decision|0|||
154903465|NCT01690988|559067322|FG001|Overall Study|Physician Decision|0|||
154903466|NCT01690988|559067323|FG002|Overall Study|Physician Decision|1|||
154903467|NCT01690988|559067321|FG000|Overall Study|Operation Cancelled|1|||
154903468|NCT01690988|559067322|FG001|Overall Study|Operation Cancelled|1|||
154903469|NCT01690988|559067323|FG002|Overall Study|Operation Cancelled|0|||
154903470|NCT01690988|559067321|FG000|Overall Study|Determined ineligible|1|||
154903471|NCT01690988|559067322|FG001|Overall Study|Determined ineligible|0|||
154903472|NCT01690988|559067323|FG002|Overall Study|Determined ineligible|0|||
154903473|NCT01690988|559067321|FG000|Overall Study|Death|1|||
154903474|NCT01690988|559067322|FG001|Overall Study|Death|1|||
154903475|NCT01690988|559067323|FG002|Overall Study|Death|1|||
154903476|NCT01690988|559067321|FG000|Overall Study|Sedated|1|||
154903477|NCT01690988|559067322|FG001|Overall Study|Sedated|1|||
154903478|NCT01690988|559067323|FG002|Overall Study|Sedated|2|||
154903479|NCT03696576|559067333|FG000|Overall Study|Soreness of throat after therapy|1|||
154903480|NCT03696576|559067334|FG001|Overall Study|Soreness of throat after therapy|1|||
154903481|NCT03696576|559067333|FG000|Overall Study|Lost to Follow-up|2|||
154903482|NCT03696576|559067334|FG001|Overall Study|Lost to Follow-up|4|||
154903483|NCT00312728|559067335|FG000|Overall Study|Progressive disease|53|||
154903484|NCT00312728|559067335|FG000|Overall Study|Adverse Event|32|||
154903485|NCT00312728|559067335|FG000|Overall Study|Withdrawal by Subject|10|||
154903486|NCT00312728|559067335|FG000|Overall Study|Required non-protocol cancer treatment|2|||
154903487|NCT00312728|559067335|FG000|Overall Study|Protocol Violation|2|||
154903488|NCT00312728|559067335|FG000|Overall Study|Other|10|||
154903489|NCT00312728|559067335|FG000|Overall Study|Other|1|||
154903490|NCT00179517|559067339|FG000|Overall Study|Withdrawal by Subject|2|||
154903491|NCT00179517|559067340|FG001|Overall Study|Withdrawal by Subject|1|||
154903492|NCT04857892|559067342|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
154903493|NCT04857892|559067343|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
154903494|NCT04857892|559067344|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
154903495|NCT04857892|559067345|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
154903496|NCT04857892|559067346|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
154903497|NCT04857892|559067342|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
154903498|NCT04857892|559067343|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
154903499|NCT04857892|559067344|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
154903500|NCT04857892|559067345|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
154903501|NCT04857892|559067346|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
154903502|NCT04857892|559067342|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
154903503|NCT04857892|559067343|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
154903504|NCT04857892|559067344|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
154903505|NCT04857892|559067345|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
154903506|NCT04857892|559067346|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
154903507|NCT00880607|559067350|FG000|Overall Study|Physician Decision|2|||
154903508|NCT00880607|559067351|FG001|Overall Study|Physician Decision|2|||
154903509|NCT00880607|559067350|FG000|Overall Study|Protocol Violation|2|||
155115500|NCT00503776|559853088|FG001|Overall Study|Withdrawal by Subject|0|||
155115501|NCT00503776|559853089|FG002|Overall Study|Withdrawal by Subject|1|||
154903510|NCT00880607|559067351|FG001|Overall Study|Protocol Violation|1|||
154903511|NCT00880607|559067350|FG000|Overall Study|surgery did not extend past L1 level|3|||
154903512|NCT00880607|559067351|FG001|Overall Study|surgery did not extend past L1 level|0|||
154903513|NCT01627782|559067354|FG000|Overall Study|Adverse Event|1|||
154903514|NCT01627782|559067355|FG001|Overall Study|Adverse Event|2|||
154903515|NCT01627782|559067356|FG002|Overall Study|Adverse Event|0|||
154903516|NCT01627782|559067357|FG003|Overall Study|Adverse Event|1|||
154903517|NCT01627782|559067354|FG000|Overall Study|Lack of Efficacy|11|||
154903518|NCT01627782|559067355|FG001|Overall Study|Lack of Efficacy|1|||
154903519|NCT01627782|559067356|FG002|Overall Study|Lack of Efficacy|15|||
154903520|NCT01627782|559067357|FG003|Overall Study|Lack of Efficacy|2|||
155115502|NCT00503776|559853090|FG003|Overall Study|Withdrawal by Subject|1|||
155115503|NCT00503776|559853087|FG000|Overall Study|Physician Decision|0|||
154981584|NCT02243293|559356927|FG005|Overall Study|Lost to Follow-up|0|||
154981585|NCT02243293|559356928|FG006|Overall Study|Lost to Follow-up|3|||
154981586|NCT02243293|559356929|FG007|Overall Study|Lost to Follow-up|0|||
154981587|NCT02243293|559356930|FG008|Overall Study|Lost to Follow-up|0|||
154981588|NCT02243293|559356931|FG009|Overall Study|Lost to Follow-up|0|||
154981589|NCT02243293|559356932|FG010|Overall Study|Lost to Follow-up|0|||
154981590|NCT02243293|559356933|FG011|Overall Study|Lost to Follow-up|2|||
154981591|NCT02243293|559356934|FG012|Overall Study|Lost to Follow-up|0|||
154981592|NCT02243293|559356935|FG013|Overall Study|Lost to Follow-up|0|||
154981593|NCT02243293|559356936|FG014|Overall Study|Lost to Follow-up|0|||
154981594|NCT02243293|559356937|FG015|Overall Study|Lost to Follow-up|0|||
154981595|NCT02243293|559356938|FG016|Overall Study|Lost to Follow-up|3|||
154981596|NCT02243293|559356939|FG017|Overall Study|Lost to Follow-up|1|||
154981597|NCT02243293|559356940|FG018|Overall Study|Lost to Follow-up|0|||
154981598|NCT02243293|559356941|FG019|Overall Study|Lost to Follow-up|0|||
154981599|NCT02243293|559356942|FG020|Overall Study|Lost to Follow-up|1|||
154981600|NCT02243293|559356943|FG021|Overall Study|Lost to Follow-up|2|||
154981601|NCT02243293|559356922|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
154981602|NCT02243293|559356923|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
154981603|NCT02243293|559356924|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
154981604|NCT02243293|559356925|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
154981605|NCT02243293|559356926|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
154981606|NCT02243293|559356927|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
154981607|NCT02243293|559356928|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
154981608|NCT02243293|559356929|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
154981609|NCT02243293|559356930|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
154981610|NCT02243293|559356931|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
154981611|NCT02243293|559356932|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
154981612|NCT02243293|559356933|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
154981613|NCT02243293|559356934|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
154981614|NCT02243293|559356935|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
154981615|NCT02243293|559356936|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
154981616|NCT02243293|559356937|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
154981617|NCT02243293|559356938|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
154903521|NCT01627782|559067354|FG000|Overall Study|Protocol Violation|1|||
154903522|NCT01627782|559067355|FG001|Overall Study|Protocol Violation|0|||
154903523|NCT01627782|559067356|FG002|Overall Study|Protocol Violation|0|||
154903524|NCT01627782|559067357|FG003|Overall Study|Protocol Violation|0|||
154903525|NCT01627782|559067354|FG000|Overall Study|Withdrawal by Subject|2|||
154903526|NCT01627782|559067355|FG001|Overall Study|Withdrawal by Subject|1|||
154903527|NCT01627782|559067356|FG002|Overall Study|Withdrawal by Subject|0|||
154903528|NCT01627782|559067357|FG003|Overall Study|Withdrawal by Subject|0|||
154903529|NCT01627782|559067354|FG000|Overall Study|Other|0|||
155115504|NCT00503776|559853088|FG001|Overall Study|Physician Decision|0|||
155115505|NCT00503776|559853089|FG002|Overall Study|Physician Decision|1|||
154903530|NCT01627782|559067355|FG001|Overall Study|Other|2|||
154903531|NCT01627782|559067356|FG002|Overall Study|Other|0|||
154903532|NCT01627782|559067357|FG003|Overall Study|Other|3|||
154903533|NCT01627782|559067354|FG000|Overall Study|Randomized But Not Treated|1|||
154903534|NCT01627782|559067355|FG001|Overall Study|Randomized But Not Treated|0|||
154903535|NCT01627782|559067356|FG002|Overall Study|Randomized But Not Treated|0|||
154903536|NCT01627782|559067357|FG003|Overall Study|Randomized But Not Treated|0|||
154903537|NCT00643448|559067358|FG000|Overall Study|Lack of Efficacy|2|||
154903538|NCT00643448|559067359|FG001|Overall Study|Lack of Efficacy|0|||
154903539|NCT00643448|559067360|FG002|Overall Study|Lack of Efficacy|4|||
154981618|NCT02243293|559356939|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
154981619|NCT02243293|559356940|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
155115506|NCT00503776|559853090|FG003|Overall Study|Physician Decision|1|||
154903540|NCT00643448|559067358|FG000|Overall Study|Adverse Event|2|||
154903541|NCT00643448|559067359|FG001|Overall Study|Adverse Event|2|||
154903542|NCT00643448|559067360|FG002|Overall Study|Adverse Event|2|||
154903543|NCT00643448|559067358|FG000|Overall Study|QTcF>550 ms|0|||
154903544|NCT00643448|559067359|FG001|Overall Study|QTcF>550 ms|3|||
154981620|NCT02243293|559356941|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
154903545|NCT00643448|559067360|FG002|Overall Study|QTcF>550 ms|0|||
154903546|NCT00981682|559067361|FG000|Overall Study|Adverse Event|48|||
154981621|NCT02243293|559356942|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
154981622|NCT02243293|559356943|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
154981623|NCT02243293|559356922|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
154981624|NCT02243293|559356923|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
154981625|NCT02243293|559356924|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
154981626|NCT02243293|559356925|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
154903547|NCT00981682|559067361|FG000|Overall Study|Withdrawal by Subject|52|||
154903548|NCT00981682|559067361|FG000|Overall Study|Lost to Follow-up|14|||
154903549|NCT00981682|559067361|FG000|Overall Study|Lack of Efficacy|13|||
154903550|NCT00981682|559067361|FG000|Overall Study|Protocol Violation|6|||
154903551|NCT00981682|559067361|FG000|Overall Study|administrative|9|||
154903552|NCT00400946|559069652|FG000|Overall Study|Ineligible|0|||
154903553|NCT00400946|559069653|FG001|Overall Study|Ineligible|0|||
154903554|NCT00400946|559069654|FG002|Overall Study|Ineligible|0|||
154903555|NCT00400946|559069655|FG003|Overall Study|Ineligible|5|||
154903556|NCT00400946|559069656|FG004|Overall Study|Ineligible|1|||
154903557|NCT00400946|559069652|FG000|Overall Study|Induction Failure|0|||
154903558|NCT00400946|559069653|FG001|Overall Study|Induction Failure|0|||
154903559|NCT00400946|559069654|FG002|Overall Study|Induction Failure|0|||
154903560|NCT00400946|559069655|FG003|Overall Study|Induction Failure|11|||
154903561|NCT00400946|559069656|FG004|Overall Study|Induction Failure|8|||
154903562|NCT00400946|559069652|FG000|Overall Study|Induction Death|0|||
154903563|NCT00400946|559069653|FG001|Overall Study|Induction Death|0|||
154903564|NCT00400946|559069654|FG002|Overall Study|Induction Death|0|||
154903565|NCT00400946|559069655|FG003|Overall Study|Induction Death|13|||
154903566|NCT00400946|559069656|FG004|Overall Study|Induction Death|3|||
154903567|NCT00400946|559069652|FG000|Overall Study|Lost to Follow-up|1|||
154903568|NCT00400946|559069653|FG001|Overall Study|Lost to Follow-up|1|||
154903569|NCT00400946|559069654|FG002|Overall Study|Lost to Follow-up|0|||
154903570|NCT00400946|559069655|FG003|Overall Study|Lost to Follow-up|0|||
154903571|NCT00400946|559069656|FG004|Overall Study|Lost to Follow-up|1|||
154903572|NCT00400946|559069652|FG000|Overall Study|Remission Death|1|||
154903573|NCT00400946|559069653|FG001|Overall Study|Remission Death|1|||
154903574|NCT00400946|559069654|FG002|Overall Study|Remission Death|0|||
154903575|NCT00400946|559069655|FG003|Overall Study|Remission Death|0|||
154903576|NCT00400946|559069656|FG004|Overall Study|Remission Death|1|||
154903577|NCT00400946|559069652|FG000|Overall Study|Relapse|9|||
154903578|NCT00400946|559069653|FG001|Overall Study|Relapse|2|||
154903579|NCT00400946|559069654|FG002|Overall Study|Relapse|1|||
154903580|NCT00400946|559069655|FG003|Overall Study|Relapse|1|||
154903581|NCT00400946|559069656|FG004|Overall Study|Relapse|5|||
154903582|NCT00400946|559069652|FG000|Overall Study|Transplant in CR1|0|||
154903583|NCT00400946|559069653|FG001|Overall Study|Transplant in CR1|0|||
154903584|NCT00400946|559069654|FG002|Overall Study|Transplant in CR1|0|||
154903585|NCT00400946|559069655|FG003|Overall Study|Transplant in CR1|10|||
154903586|NCT00400946|559069656|FG004|Overall Study|Transplant in CR1|1|||
154903587|NCT00400946|559069652|FG000|Overall Study|Withdrawal by Subject|2|||
154903588|NCT00400946|559069653|FG001|Overall Study|Withdrawal by Subject|5|||
154903589|NCT00400946|559069654|FG002|Overall Study|Withdrawal by Subject|1|||
154903590|NCT00400946|559069655|FG003|Overall Study|Withdrawal by Subject|5|||
154903591|NCT00400946|559069656|FG004|Overall Study|Withdrawal by Subject|8|||
154903592|NCT00400946|559069652|FG000|Overall Study|Clinical|1|||
154903593|NCT00400946|559069653|FG001|Overall Study|Clinical|2|||
154903594|NCT00400946|559069654|FG002|Overall Study|Clinical|0|||
154903595|NCT00400946|559069655|FG003|Overall Study|Clinical|2|||
154903596|NCT00400946|559069656|FG004|Overall Study|Clinical|9|||
154903597|NCT00400946|559069652|FG000|Overall Study|Other|0|||
154903598|NCT00400946|559069653|FG001|Overall Study|Other|0|||
154903599|NCT00400946|559069654|FG002|Overall Study|Other|0|||
154903600|NCT00400946|559069655|FG003|Overall Study|Other|0|||
154903601|NCT00400946|559069656|FG004|Overall Study|Other|1|||
154903602|NCT02204410|559069657|FG000|Overall Study|Lost to Follow-up|5|||
154903603|NCT02204410|559069657|FG000|Overall Study|Physician Decision|2|||
154903604|NCT02204410|559069657|FG000|Overall Study|Protocol Violation|1|||
154903605|NCT02204410|559069657|FG000|Overall Study|Withdrawal by Subject|3|||
154903606|NCT02782104|559069665|FG000|Overall Study|Other|215|||
154903607|NCT02782104|559069665|FG000|Overall Study|Induction Day 28 Non Responder|9|||
154903608|NCT02782104|559069665|FG000|Overall Study|Non-Compliance with Study Drug|2|||
154903609|NCT02782104|559069665|FG000|Overall Study|Death|8|||
154903610|NCT02782104|559069665|FG000|Overall Study|Pregnancy|6|||
154903611|NCT02782104|559069665|FG000|Overall Study|Withdrawal by Subject|63|||
154903612|NCT02782104|559069665|FG000|Overall Study|Protocol Violation|7|||
154903613|NCT02782104|559069665|FG000|Overall Study|Lack of Efficacy|61|||
154903614|NCT02782104|559069665|FG000|Overall Study|Lost to Follow-up|23|||
154903615|NCT02782104|559069665|FG000|Overall Study|Adverse Event|74|||
154903616|NCT03464136|559069666|FG000|Overall Study|Lost to Follow-up|5|||
154903617|NCT03464136|559069667|FG001|Overall Study|Lost to Follow-up|8|||
154903618|NCT03464136|559069666|FG000|Overall Study|Withdrawal by Subject|16|||
154903619|NCT03464136|559069667|FG001|Overall Study|Withdrawal by Subject|13|||
154903620|NCT03464136|559069666|FG000|Overall Study|Death|1|||
154903621|NCT03464136|559069667|FG001|Overall Study|Death|0|||
154903622|NCT03464136|559069666|FG000|Overall Study|Other|8|||
154903623|NCT03464136|559069667|FG001|Overall Study|Other|4|||
154903624|NCT02438787|559069668|FG000|Overall Study|Adverse Event|1|||
154903625|NCT02438787|559069669|FG001|Overall Study|Adverse Event|0|||
154903626|NCT02438787|559069670|FG002|Overall Study|Adverse Event|2|||
154903627|NCT02438787|559069668|FG000|Overall Study|Lack of Efficacy|1|||
154903628|NCT02438787|559069669|FG001|Overall Study|Lack of Efficacy|2|||
154903629|NCT02438787|559069670|FG002|Overall Study|Lack of Efficacy|0|||
154903630|NCT02438787|559069668|FG000|Overall Study|Lost to Follow-up|0|||
154903631|NCT02438787|559069669|FG001|Overall Study|Lost to Follow-up|1|||
154903632|NCT02438787|559069670|FG002|Overall Study|Lost to Follow-up|0|||
155115507|NCT02778555|559853091|FG000|Overall Study|Withdrawal by Subject|55|||
155115508|NCT02778555|559853092|FG001|Overall Study|Withdrawal by Subject|32|||
155115509|NCT02778555|559853093|FG002|Overall Study|Withdrawal by Subject|107|||
155115510|NCT00107315|559853094|FG000|Overall Study|Disease Progression|9|||
155115511|NCT00107315|559853094|FG000|Overall Study|Adverse Event|4|||
155115512|NCT00107315|559853094|FG000|Overall Study|Withdrawal by Subject|2|||
155115513|NCT02509039|559853097|FG000|Overall Study|Adverse Event|0|||
155115514|NCT02509039|559853098|FG001|Overall Study|Adverse Event|1|||
155115515|NCT02509039|559853099|FG002|Overall Study|Adverse Event|1|||
154903633|NCT02438787|559069668|FG000|Overall Study|Protocol Violation|0|||
154903634|NCT02438787|559069669|FG001|Overall Study|Protocol Violation|0|||
154903635|NCT02438787|559069670|FG002|Overall Study|Protocol Violation|1|||
154903636|NCT02438787|559069668|FG000|Overall Study|Withdrawal by Subject|15|||
154903637|NCT02438787|559069669|FG001|Overall Study|Withdrawal by Subject|7|||
154903638|NCT02438787|559069670|FG002|Overall Study|Withdrawal by Subject|10|||
154903639|NCT02438787|559069668|FG000|Overall Study|Study discontinued by sponsor|64|||
154903640|NCT02438787|559069669|FG001|Overall Study|Study discontinued by sponsor|72|||
154903641|NCT02438787|559069670|FG002|Overall Study|Study discontinued by sponsor|69|||
154903642|NCT02438787|559069668|FG000|Overall Study|Other|0|||
154903643|NCT02438787|559069669|FG001|Overall Study|Other|1|||
154903644|NCT02438787|559069670|FG002|Overall Study|Other|0|||
154903645|NCT02438787|559069668|FG000|Overall Study|Site terminated by sponsor|0|||
154903646|NCT02438787|559069669|FG001|Overall Study|Site terminated by sponsor|0|||
154903647|NCT02438787|559069670|FG002|Overall Study|Site terminated by sponsor|1|||
154903648|NCT03412565|559069671|FG000|Overall Study|Lost to Follow-up|0|||
154903649|NCT03412565|559069672|FG001|Overall Study|Lost to Follow-up|0|||
154903650|NCT03412565|559069673|FG002|Overall Study|Lost to Follow-up|1|||
154903651|NCT03412565|559069674|FG003|Overall Study|Lost to Follow-up|0|||
154903652|NCT03412565|559069671|FG000|Overall Study|Physician Decision|0|||
154903653|NCT03412565|559069672|FG001|Overall Study|Physician Decision|0|||
154903654|NCT03412565|559069673|FG002|Overall Study|Physician Decision|0|||
154903655|NCT03412565|559069674|FG003|Overall Study|Physician Decision|1|||
154903656|NCT03412565|559069671|FG000|Overall Study|Withdrawal by Subject|0|||
154903657|NCT03412565|559069672|FG001|Overall Study|Withdrawal by Subject|4|||
154903658|NCT03412565|559069673|FG002|Overall Study|Withdrawal by Subject|5|||
154903659|NCT03412565|559069674|FG003|Overall Study|Withdrawal by Subject|5|||
154903660|NCT03412565|559069671|FG000|Overall Study|Death|1|||
154903661|NCT03412565|559069672|FG001|Overall Study|Death|3|||
154903662|NCT03412565|559069673|FG002|Overall Study|Death|4|||
154903663|NCT03412565|559069674|FG003|Overall Study|Death|5|||
154903664|NCT03412565|559069671|FG000|Overall Study|Data collection ended|0|||
154903665|NCT03412565|559069672|FG001|Overall Study|Data collection ended|41|||
154903666|NCT03412565|559069673|FG002|Overall Study|Data collection ended|41|||
154903667|NCT03412565|559069674|FG003|Overall Study|Data collection ended|40|||
154903668|NCT03277105|559069675|FG000|Overall Study|Death|129|||
154903669|NCT03277105|559069676|FG001|Overall Study|Death|124|||
154903670|NCT03277105|559069675|FG000|Overall Study|Lost to Follow-up|2|||
154903671|NCT03277105|559069676|FG001|Overall Study|Lost to Follow-up|4|||
154903672|NCT03277105|559069675|FG000|Overall Study|Withdrawal by Subject|10|||
154903673|NCT03277105|559069676|FG001|Overall Study|Withdrawal by Subject|10|||
154903674|NCT03277105|559069675|FG000|Overall Study|Other|118|||
154903675|NCT03277105|559069676|FG001|Overall Study|Other|125|||
154903676|NCT02418585|559069680|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
154903677|NCT02418585|559069681|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
154903678|NCT02418585|559069680|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
154903679|NCT02418585|559069681|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
154903680|NCT02418585|559069680|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
154903681|NCT02418585|559069681|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
154903682|NCT02418585|559069680|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
154903683|NCT02418585|559069681|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
154903684|NCT02418585|559069680|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
154903685|NCT02418585|559069681|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
154903686|NCT02418585|559069680|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
154903687|NCT02418585|559069681|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
154903688|NCT02418585|559069680|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
154903689|NCT02418585|559069681|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
154903690|NCT02418585|559069680|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
154903691|NCT02418585|559069681|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
154903692|NCT02418585|559069680|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
154903693|NCT02418585|559069681|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
154903694|NCT02418585|559069680|FG000|Follow-up Phase (24 Weeks)|Other|3|||
154903695|NCT02418585|559069681|FG001|Follow-up Phase (24 Weeks)|Other|2|||
154903696|NCT04159701|559069682|FG000|Period 1: Treatment Period|Pregnancy|1|||
154903697|NCT04159701|559069683|FG001|Period 1: Treatment Period|Pregnancy|0|||
154903698|NCT04159701|559069682|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
155115516|NCT02509039|559853100|FG003|Overall Study|Adverse Event|1|||
154903699|NCT04159701|559069683|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
154903700|NCT04159701|559069682|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
154903701|NCT04159701|559069683|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
154903702|NCT04159701|559069682|FG000|Washout Period|site terminated by sponsor|0|||
154903703|NCT04159701|559069683|FG001|Washout Period|site terminated by sponsor|1|||
154903704|NCT04159701|559069682|FG000|Washout Period|study terminated by sponsor|10|||
154903705|NCT04159701|559069683|FG001|Washout Period|study terminated by sponsor|3|||
154903706|NCT04159701|559069682|FG000|Washout Period|Withdrawal by Subject|1|||
154903707|NCT04159701|559069683|FG001|Washout Period|Withdrawal by Subject|0|||
154903708|NCT04159701|559069682|FG000|Washout Period|Inadvertent Enrollment|1|||
154903709|NCT04159701|559069683|FG001|Washout Period|Inadvertent Enrollment|0|||
154903710|NCT04159701|559069682|FG000|Washout Period|Miscellaneous|1|||
154903711|NCT04159701|559069683|FG001|Washout Period|Miscellaneous|0|||
154903712|NCT04159701|559069682|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
154903713|NCT04159701|559069683|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
154903714|NCT04159701|559069682|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
154903715|NCT04159701|559069683|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
154903716|NCT04159701|559069682|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
154903717|NCT04159701|559069683|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
154903718|NCT04159701|559069682|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
154903719|NCT04159701|559069683|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
154903720|NCT04159701|559069682|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
154903721|NCT04159701|559069683|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
154903722|NCT00638690|559069686|FG000|Overall Study|Death|655|||
154903723|NCT00638690|559069687|FG001|Overall Study|Death|335|||
154903724|NCT00638690|559069686|FG000|Overall Study|Withdrawal by Subject|22|||
154903725|NCT00638690|559069687|FG001|Overall Study|Withdrawal by Subject|5|||
154903726|NCT00638690|559069686|FG000|Overall Study|Lost to Follow-up|4|||
154903727|NCT00638690|559069687|FG001|Overall Study|Lost to Follow-up|2|||
154903728|NCT02348840|559069695|FG000|Overall Study|Withdrawal by Subject|2|||
154903729|NCT02348840|559069696|FG001|Overall Study|Withdrawal by Subject|1|||
154903730|NCT02348840|559069697|FG002|Overall Study|Withdrawal by Subject|0|||
154903731|NCT02348840|559069698|FG003|Overall Study|Withdrawal by Subject|0|||
154903732|NCT00373880|559069699|FG000|Overall Study|Physician Decision|3|||
154903733|NCT00373880|559069699|FG000|Overall Study|Arrested|1|||
154903734|NCT00373880|559069699|FG000|Overall Study|Protocol Violation|14|||
154903735|NCT02865928|559069707|FG000|Overall Study|Withdrawal by Subject|1|||
154903736|NCT02865928|559069708|FG001|Overall Study|Withdrawal by Subject|0|||
154903737|NCT02865928|559069707|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
154903738|NCT02865928|559069708|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
154903739|NCT02865928|559069707|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
154903740|NCT02865928|559069708|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
154903741|NCT03152110|559069709|FG000|Overall Study|Withdrawal by Subject|3|||
154903742|NCT00552344|559069714|FG000|Overall Study|Lack of Efficacy|55|||
154903743|NCT00552344|559069714|FG000|Overall Study|Loss of efficacy|75|||
154903744|NCT00552344|559069714|FG000|Overall Study|Lost to Follow-up|8|||
154903745|NCT00552344|559069714|FG000|Overall Study|Withdrawal by Subject|48|||
154903746|NCT00552344|559069714|FG000|Overall Study|SAE, non-fatal|6|||
154903747|NCT00552344|559069714|FG000|Overall Study|AE, non-serious non-fatal|38|||
154903748|NCT00552344|559069714|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
154903749|NCT00552344|559069714|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
154903750|NCT00552344|559069714|FG000|Overall Study|Other Reason|22|||
154903751|NCT01634100|559069715|FG000|Overall Study|Withdrawal by Subject|1|||
154903752|NCT01634100|559069716|FG001|Overall Study|Withdrawal by Subject|0|||
154903753|NCT01634100|559069717|FG002|Overall Study|Withdrawal by Subject|1|||
154903754|NCT01634100|559069718|FG003|Overall Study|Withdrawal by Subject|0|||
154903755|NCT01634100|559069719|FG004|Overall Study|Withdrawal by Subject|0|||
154903756|NCT01634100|559069720|FG005|Overall Study|Withdrawal by Subject|0|||
154903757|NCT00471276|559069721|FG000|Overall Study|Death|2|||
154903758|NCT00471276|559069721|FG000|Overall Study|Adverse Event|16|||
154903759|NCT00471276|559069721|FG000|Overall Study|Protocol Violation|1|||
154903760|NCT00471276|559069721|FG000|Overall Study|Objective progression or relapse|54|||
154903761|NCT00471276|559069721|FG000|Overall Study|Global deterioration of health status|1|||
154903762|NCT00471276|559069721|FG000|Overall Study|Other|3|||
154903763|NCT00471276|559069721|FG000|Overall Study|Refused treatment|6|||
154903764|NCT00338806|559069722|FG000|Acute Phase|Withdrawal by Subject|0|||
154903765|NCT00338806|559069723|FG001|Acute Phase|Withdrawal by Subject|1|||
154903766|NCT00338806|559069722|FG000|Follow-up|Lost to Follow-up|1|||
154981627|NCT02243293|559356926|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
154981628|NCT02243293|559356927|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
154981629|NCT02243293|559356928|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
155115517|NCT02509039|559853097|FG000|Overall Study|Withdrawal by Subject|0|||
155115518|NCT02509039|559853098|FG001|Overall Study|Withdrawal by Subject|0|||
155115519|NCT02509039|559853099|FG002|Overall Study|Withdrawal by Subject|1|||
155115520|NCT02509039|559853100|FG003|Overall Study|Withdrawal by Subject|0|||
155115521|NCT02509039|559853097|FG000|Overall Study|Progressive disease|2|||
155115522|NCT02509039|559853098|FG001|Overall Study|Progressive disease|2|||
155115523|NCT02509039|559853099|FG002|Overall Study|Progressive disease|1|||
155115524|NCT02509039|559853100|FG003|Overall Study|Progressive disease|5|||
155115525|NCT02509039|559853097|FG000|Overall Study|Study terminated by Sponsor|1|||
155115526|NCT02509039|559853098|FG001|Overall Study|Study terminated by Sponsor|0|||
155115527|NCT02509039|559853099|FG002|Overall Study|Study terminated by Sponsor|0|||
155115528|NCT02509039|559853100|FG003|Overall Study|Study terminated by Sponsor|0|||
155115529|NCT03943550|559853103|FG000|Overall Study|Adverse Event|0|||
155115530|NCT03943550|559853104|FG001|Overall Study|Adverse Event|0|||
155115531|NCT03943550|559853105|FG002|Overall Study|Adverse Event|1|||
155115532|NCT03943550|559853103|FG000|Overall Study|Lost to Follow-up|0|||
155115533|NCT03943550|559853104|FG001|Overall Study|Lost to Follow-up|0|||
155115534|NCT03943550|559853105|FG002|Overall Study|Lost to Follow-up|1|||
155115535|NCT03943550|559853103|FG000|Overall Study|Progressive Disease|0|||
155115536|NCT03943550|559853104|FG001|Overall Study|Progressive Disease|0|||
155115537|NCT03943550|559853105|FG002|Overall Study|Progressive Disease|2|||
155115538|NCT03943550|559853103|FG000|Overall Study|Participant Moved Out of the Country|0|||
155115539|NCT03943550|559853104|FG001|Overall Study|Participant Moved Out of the Country|1|||
155115540|NCT03943550|559853105|FG002|Overall Study|Participant Moved Out of the Country|0|||
155115541|NCT04659174|559853114|FG000|Overall Study|Sponsor decision to discontinue study|0|||
155115542|NCT04659174|559853115|FG001|Overall Study|Sponsor decision to discontinue study|2|||
155115543|NCT04659174|559853114|FG000|Overall Study|Lost to Follow-up|9|||
155115544|NCT04659174|559853115|FG001|Overall Study|Lost to Follow-up|11|||
155115545|NCT04659174|559853114|FG000|Overall Study|Adverse Event|8|||
155115546|NCT04659174|559853115|FG001|Overall Study|Adverse Event|5|||
155115547|NCT04659174|559853114|FG000|Overall Study|Withdrawal by Subject|17|||
155115548|NCT04659174|559853115|FG001|Overall Study|Withdrawal by Subject|33|||
155115549|NCT04659174|559853114|FG000|Overall Study|Progressive disease|0|||
155115550|NCT04659174|559853115|FG001|Overall Study|Progressive disease|2|||
155115551|NCT04659174|559853114|FG000|Overall Study|Other reasons|0|||
155115552|NCT04659174|559853115|FG001|Overall Study|Other reasons|2|||
155115553|NCT04659174|559853114|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
154903767|NCT00338806|559069723|FG001|Follow-up|Lost to Follow-up|3|||
154903768|NCT00744991|559069726|FG000|Overall Study|Progressive Disease|11|||
154903769|NCT00744991|559069726|FG000|Overall Study|Withdrawal by Subject|8|||
154903770|NCT00744991|559069726|FG000|Overall Study|Physician Decision|3|||
154903771|NCT00744991|559069726|FG000|Overall Study|Adverse Event|2|||
154903772|NCT00744991|559069726|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
154903773|NCT01662986|559069727|FG000|Overall Study|Adverse Event|5|||
154903774|NCT01662986|559069728|FG001|Overall Study|Adverse Event|4|||
154903775|NCT01662986|559069727|FG000|Overall Study|Protocol Violation|2|||
154903776|NCT01662986|559069728|FG001|Overall Study|Protocol Violation|3|||
154903777|NCT01662986|559069727|FG000|Overall Study|Lost to Follow-up|5|||
154903778|NCT01662986|559069728|FG001|Overall Study|Lost to Follow-up|4|||
154903779|NCT01662986|559069727|FG000|Overall Study|Withdrawal by Subject|2|||
154903780|NCT01662986|559069728|FG001|Overall Study|Withdrawal by Subject|2|||
154903781|NCT01662986|559069727|FG000|Overall Study|Not Treated|1|||
154903782|NCT01662986|559069728|FG001|Overall Study|Not Treated|0|||
154903783|NCT01662986|559069727|FG000|Overall Study|Other than stated above|3|||
154903784|NCT01662986|559069728|FG001|Overall Study|Other than stated above|0|||
154903785|NCT01975376|559069731|FG000|Overall Study|Adverse Event|5|||
154903786|NCT01975376|559069732|FG001|Overall Study|Adverse Event|5|||
154903787|NCT01975376|559069731|FG000|Overall Study|Death|65|||
154903788|NCT01975376|559069732|FG001|Overall Study|Death|72|||
154903789|NCT01975376|559069731|FG000|Overall Study|Lost to Follow-up|70|||
154903790|NCT01975376|559069732|FG001|Overall Study|Lost to Follow-up|66|||
154903791|NCT01975376|559069731|FG000|Overall Study|Withdrew consent|68|||
154903792|NCT01975376|559069732|FG001|Overall Study|Withdrew consent|62|||
154903793|NCT01975376|559069731|FG000|Overall Study|Other|2|||
154903794|NCT01975376|559069732|FG001|Overall Study|Other|4|||
154903795|NCT01975376|559069731|FG000|Overall Study|Randomized, Not Treated|16|||
154903796|NCT01975376|559069732|FG001|Overall Study|Randomized, Not Treated|8|||
154903797|NCT01448707|559069738|FG000|Overall Study|Adverse Event|3|||
154903798|NCT01448707|559069739|FG001|Overall Study|Adverse Event|1|||
154903799|NCT01448707|559069738|FG000|Overall Study|Lost to Follow-up|2|||
154903800|NCT01448707|559069739|FG001|Overall Study|Lost to Follow-up|6|||
154903801|NCT01448707|559069738|FG000|Overall Study|Withdrawal by Subject|6|||
154903802|NCT01448707|559069739|FG001|Overall Study|Withdrawal by Subject|7|||
154903803|NCT01448707|559069738|FG000|Overall Study|Other|7|||
154903804|NCT01448707|559069739|FG001|Overall Study|Other|4|||
154903805|NCT02033850|559069745|FG000|Overall Study|Death|1|||
154903806|NCT02033850|559069746|FG001|Overall Study|Death|0|||
154903807|NCT02033850|559069745|FG000|Overall Study|unrelated medical reason|1|||
154903808|NCT02033850|559069746|FG001|Overall Study|unrelated medical reason|1|||
154903809|NCT02820038|559069750|FG000|Overall Study|Lost to Follow-up|7|||
154903810|NCT02820038|559069751|FG001|Overall Study|Lost to Follow-up|11|||
154903811|NCT02820038|559069752|FG002|Overall Study|Lost to Follow-up|2|||
154903812|NCT02820038|559069753|FG003|Overall Study|Lost to Follow-up|9|||
154903813|NCT02820038|559069750|FG000|Overall Study|Withdrawal by Subject|3|||
154903814|NCT02820038|559069751|FG001|Overall Study|Withdrawal by Subject|14|||
154903815|NCT02820038|559069752|FG002|Overall Study|Withdrawal by Subject|3|||
154903816|NCT02820038|559069753|FG003|Overall Study|Withdrawal by Subject|13|||
154903817|NCT03215667|559069754|FG000|Overall Study|Physician Decision|4|||
154903818|NCT00560794|559069755|FG000|Overall Study|Adverse Event|2|||
154903819|NCT00560794|559069755|FG000|Overall Study|Patient was not Compliant|1|||
154903820|NCT00560794|559069755|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
154903821|NCT00560794|559069755|FG000|Overall Study|Hematological Relapse|1|||
154903822|NCT00560794|559069755|FG000|Overall Study|Received Bone Marrow Transplant|6|||
154903823|NCT00614991|559069756|FG000|Overall Study|Adverse Event|3|||
154903824|NCT00614991|559069757|FG001|Overall Study|Adverse Event|3|||
154903825|NCT00614991|559069758|FG002|Overall Study|Adverse Event|0|||
154903826|NCT00614991|559069759|FG003|Overall Study|Adverse Event|0|||
154903827|NCT00614991|559069760|FG004|Overall Study|Adverse Event|1|||
154903828|NCT00614991|559069761|FG005|Overall Study|Adverse Event|0|||
154903829|NCT00368472|559069765|FG000|Overall Study|Adverse Event|22|||
154903830|NCT00368472|559069765|FG000|Overall Study|Medication non-compliance|4|||
154903831|NCT00368472|559069765|FG000|Overall Study|Protocol Violation|2|||
154903832|NCT00368472|559069765|FG000|Overall Study|Request of Investigator or Sponsor|3|||
154903833|NCT00368472|559069765|FG000|Overall Study|Withdrawal by Subject|40|||
154903834|NCT00368472|559069765|FG000|Overall Study|Diary non-compliance|1|||
154903835|NCT00368472|559069765|FG000|Overall Study|Other|32|||
154903836|NCT00368472|559069765|FG000|Overall Study|Missing Final Disposition Date|1|||
154903837|NCT01922739|559069769|FG000|Titration/Adjustment Period|Adverse Event|3|||
154903838|NCT01922739|559069769|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
154903839|NCT01922739|559069769|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
154903840|NCT01922739|559069769|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
154903841|NCT01922739|559069769|FG000|Open-label Treatment Period|Adverse Event|6|||
154903842|NCT01922739|559069769|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
154903843|NCT01922739|559069769|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
154903844|NCT01922739|559069769|FG000|Open-label Treatment Period|Protocol Violation|5|||
154903845|NCT01922739|559069769|FG000|Open-label Treatment Period|Pregnancy|1|||
154981630|NCT02243293|559356929|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
154981631|NCT02243293|559356930|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
154981632|NCT02243293|559356931|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
154981633|NCT02243293|559356932|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
154981634|NCT02243293|559356933|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
154981635|NCT02243293|559356934|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
154981636|NCT02243293|559356935|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
154981637|NCT02243293|559356936|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
154981638|NCT02243293|559356937|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
154981639|NCT02243293|559356938|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
154981640|NCT02243293|559356939|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
154981641|NCT02243293|559356940|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
154981642|NCT02243293|559356941|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
154981643|NCT02243293|559356942|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
154981644|NCT02243293|559356943|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
154981645|NCT03069417|559356944|FG000|Overall Study|Lost to Follow-up|2|||
154981646|NCT03069417|559356945|FG001|Overall Study|Lost to Follow-up|0|||
154981647|NCT03069417|559356944|FG000|Overall Study|Reason Unknown|4|||
154981648|NCT03069417|559356945|FG001|Overall Study|Reason Unknown|7|||
154981649|NCT00440115|559356946|FG000|Overall Study|Death|7|||
154981650|NCT00440115|559356947|FG001|Overall Study|Death|9|||
154981651|NCT00440115|559356948|FG002|Overall Study|Death|5|||
154981652|NCT00440115|559356946|FG000|Overall Study|Incarceration|0|||
154981653|NCT00440115|559356947|FG001|Overall Study|Incarceration|2|||
154981654|NCT00440115|559356948|FG002|Overall Study|Incarceration|1|||
154981655|NCT01172821|559356952|FG000|Overall Study|Adverse Event|5|||
154981656|NCT01172821|559356953|FG001|Overall Study|Adverse Event|2|||
154981657|NCT01172821|559356954|FG002|Overall Study|Adverse Event|2|||
154981658|NCT01172821|559356955|FG003|Overall Study|Adverse Event|7|||
154981659|NCT01172821|559356952|FG000|Overall Study|Protocol Violation|0|||
154903846|NCT01922739|559069769|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
154903847|NCT01922739|559069769|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
154903848|NCT01922739|559069769|FG000|Open-label Treatment Period|Physician Decision|1|||
154981660|NCT01172821|559356953|FG001|Overall Study|Protocol Violation|2|||
154981661|NCT01172821|559356954|FG002|Overall Study|Protocol Violation|1|||
154981662|NCT01172821|559356955|FG003|Overall Study|Protocol Violation|2|||
154903849|NCT01922739|559069769|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
155115554|NCT04659174|559853115|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
155115555|NCT04659174|559853114|FG000|Overall Study|Alcohol or illegal drug use|0|||
155115556|NCT04659174|559853115|FG001|Overall Study|Alcohol or illegal drug use|3|||
155115557|NCT04659174|559853114|FG000|Overall Study|Violation of entry criteria|1|||
155115558|NCT04659174|559853115|FG001|Overall Study|Violation of entry criteria|0|||
155115559|NCT04659174|559853114|FG000|Overall Study|Death|0|||
155115560|NCT04659174|559853115|FG001|Overall Study|Death|1|||
155115561|NCT03276026|559853118|FG000|Overall Study|Protocol Violation|1|||
155115562|NCT03276026|559853119|FG001|Overall Study|Protocol Violation|0|||
155115563|NCT03650803|559853121|FG000|Overall Study|Lost to Follow-up|6|||
155115564|NCT01534260|559853122|FG000|Overall Study|Adverse Event|1|||
155115565|NCT01534260|559853123|FG001|Overall Study|Adverse Event|8|||
155115566|NCT01534260|559853122|FG000|Overall Study|Death|2|||
155115567|NCT01534260|559853123|FG001|Overall Study|Death|0|||
154903850|NCT00044213|559069770|FG000|Overall Study|Withdrawal by Subject|50|||
154903851|NCT00044213|559069771|FG001|Overall Study|Withdrawal by Subject|65|||
154903852|NCT00044213|559069772|FG002|Overall Study|Withdrawal by Subject|91|||
154903853|NCT00044213|559069773|FG003|Overall Study|Withdrawal by Subject|83|||
154903854|NCT00044213|559069770|FG000|Overall Study|Death|42|||
154903855|NCT00044213|559069771|FG001|Overall Study|Death|42|||
154903856|NCT00044213|559069772|FG002|Overall Study|Death|42|||
154903857|NCT00044213|559069773|FG003|Overall Study|Death|49|||
154903858|NCT00044213|559069770|FG000|Overall Study|Lost to Follow-up|8|||
154903859|NCT00044213|559069771|FG001|Overall Study|Lost to Follow-up|5|||
154903860|NCT00044213|559069772|FG002|Overall Study|Lost to Follow-up|5|||
154903861|NCT00044213|559069773|FG003|Overall Study|Lost to Follow-up|4|||
154903862|NCT00422240|559069774|FG000|Overall Study|Lack of Efficacy|1|||
154903863|NCT00422240|559069775|FG001|Overall Study|Lack of Efficacy|2|||
154903864|NCT00422240|559069776|FG002|Overall Study|Lack of Efficacy|0|||
154903865|NCT00422240|559069777|FG003|Overall Study|Lack of Efficacy|1|||
154903866|NCT00422240|559069774|FG000|Overall Study|Adverse Event|11|||
154903867|NCT00422240|559069775|FG001|Overall Study|Adverse Event|4|||
154903868|NCT00422240|559069776|FG002|Overall Study|Adverse Event|5|||
154903869|NCT00422240|559069777|FG003|Overall Study|Adverse Event|2|||
154903870|NCT00422240|559069774|FG000|Overall Study|Subject request|21|||
154903871|NCT00422240|559069775|FG001|Overall Study|Subject request|17|||
154903872|NCT00422240|559069776|FG002|Overall Study|Subject request|18|||
154903873|NCT00422240|559069777|FG003|Overall Study|Subject request|30|||
154903874|NCT00422240|559069774|FG000|Overall Study|Protocol Violation|0|||
154903875|NCT00422240|559069775|FG001|Overall Study|Protocol Violation|1|||
154903876|NCT00422240|559069776|FG002|Overall Study|Protocol Violation|0|||
154903877|NCT00422240|559069777|FG003|Overall Study|Protocol Violation|1|||
154903878|NCT00422240|559069774|FG000|Overall Study|Lost to Follow-up|31|||
154903879|NCT00422240|559069775|FG001|Overall Study|Lost to Follow-up|32|||
154903880|NCT00422240|559069776|FG002|Overall Study|Lost to Follow-up|19|||
154903881|NCT00422240|559069777|FG003|Overall Study|Lost to Follow-up|34|||
154903882|NCT00422240|559069774|FG000|Overall Study|Other|1|||
154903883|NCT00422240|559069775|FG001|Overall Study|Other|0|||
154903884|NCT00422240|559069776|FG002|Overall Study|Other|0|||
154903885|NCT00422240|559069777|FG003|Overall Study|Other|1|||
154903886|NCT00422240|559069774|FG000|Overall Study|Pregnancy|3|||
154903887|NCT00422240|559069775|FG001|Overall Study|Pregnancy|1|||
154903888|NCT00422240|559069776|FG002|Overall Study|Pregnancy|1|||
154903889|NCT00422240|559069777|FG003|Overall Study|Pregnancy|2|||
154903890|NCT01927068|559069781|FG000|Overall Study|Death|37|||
154903891|NCT01927068|559069782|FG001|Overall Study|Death|3|||
154903892|NCT01927068|559069781|FG000|Overall Study|Withdrawal by Subject|50|||
154903893|NCT01927068|559069782|FG001|Overall Study|Withdrawal by Subject|3|||
154903894|NCT01927068|559069781|FG000|Overall Study|Lost to Follow-up|10|||
154903895|NCT01927068|559069782|FG001|Overall Study|Lost to Follow-up|2|||
154903896|NCT01927068|559069781|FG000|Overall Study|Physician Decision|9|||
154903897|NCT01927068|559069782|FG001|Overall Study|Physician Decision|0|||
155115568|NCT01534260|559853122|FG000|Overall Study|Lack of Efficacy|1|||
155115569|NCT01534260|559853123|FG001|Overall Study|Lack of Efficacy|1|||
155115570|NCT01534260|559853122|FG000|Overall Study|Withdrawal by Subject|1|||
155115571|NCT01534260|559853123|FG001|Overall Study|Withdrawal by Subject|3|||
155115572|NCT01534260|559853122|FG000|Overall Study|Disease Progression|8|||
154903898|NCT01927068|559069781|FG000|Overall Study|Missed last follow-up visit|2|||
154903899|NCT01927068|559069782|FG001|Overall Study|Missed last follow-up visit|0|||
154903900|NCT05104749|559069783|FG000|Overall Study|Lost to Follow-up|2|||
154903901|NCT05104749|559069784|FG001|Overall Study|Lost to Follow-up|3|||
154903902|NCT03964493|559069785|FG000|Overall Study|Withdrawal by Subject|4|||
154903903|NCT03964493|559069786|FG001|Overall Study|Withdrawal by Subject|1|||
154903904|NCT03964493|559069785|FG000|Overall Study|Lost to Follow-up|13|||
154903905|NCT03964493|559069786|FG001|Overall Study|Lost to Follow-up|4|||
154903906|NCT02963766|559069787|FG000|Double-Blind Period|Adverse Event|1|||
154903907|NCT02963766|559069788|FG001|Double-Blind Period|Adverse Event|0|||
155115573|NCT01534260|559853123|FG001|Overall Study|Disease Progression|6|||
154903908|NCT02963766|559069789|FG002|Double-Blind Period|Adverse Event|1|||
155115574|NCT01534260|559853122|FG000|Overall Study|Physician Decision|3|||
154981663|NCT01172821|559356952|FG000|Overall Study|Lost to Follow-up|4|||
154981664|NCT01172821|559356953|FG001|Overall Study|Lost to Follow-up|1|||
154981665|NCT01172821|559356954|FG002|Overall Study|Lost to Follow-up|2|||
154981666|NCT01172821|559356955|FG003|Overall Study|Lost to Follow-up|2|||
154981667|NCT01172821|559356952|FG000|Overall Study|Withdrawal by Subject|2|||
154981668|NCT01172821|559356953|FG001|Overall Study|Withdrawal by Subject|3|||
154981669|NCT01172821|559356954|FG002|Overall Study|Withdrawal by Subject|3|||
154981670|NCT01172821|559356955|FG003|Overall Study|Withdrawal by Subject|3|||
154981671|NCT01172821|559356952|FG000|Overall Study|Other|3|||
154981672|NCT01172821|559356953|FG001|Overall Study|Other|4|||
154981673|NCT01172821|559356954|FG002|Overall Study|Other|5|||
154981674|NCT01172821|559356955|FG003|Overall Study|Other|3|||
154981675|NCT02985879|559356956|FG000|Overall Study|Adverse Event|7|||
154981676|NCT02985879|559356957|FG001|Overall Study|Adverse Event|9|||
154981677|NCT02985879|559356958|FG002|Overall Study|Adverse Event|7|||
154981678|NCT02985879|559356956|FG000|Overall Study|Withdrew consent|6|||
154981679|NCT02985879|559356957|FG001|Overall Study|Withdrew consent|8|||
154981680|NCT02985879|559356958|FG002|Overall Study|Withdrew consent|10|||
154981681|NCT02985879|559356956|FG000|Overall Study|Lost to Follow-up|1|||
154981682|NCT02985879|559356957|FG001|Overall Study|Lost to Follow-up|0|||
154981683|NCT02985879|559356958|FG002|Overall Study|Lost to Follow-up|2|||
154981684|NCT02985879|559356956|FG000|Overall Study|Other, not specified|62|||
154981685|NCT02985879|559356957|FG001|Overall Study|Other, not specified|58|||
154981686|NCT02985879|559356958|FG002|Overall Study|Other, not specified|58|||
155115575|NCT01534260|559853123|FG001|Overall Study|Physician Decision|1|||
155115576|NCT01534260|559853122|FG000|Overall Study|No treatment, per protocol|0|||
155115577|NCT01534260|559853123|FG001|Overall Study|No treatment, per protocol|1|||
155115578|NCT00503581|559853130|FG000|Overall Study|Study closed|3|||
155115579|NCT00503581|559853131|FG001|Overall Study|Study closed|4|||
155115580|NCT00503581|559853132|FG002|Overall Study|Study closed|2|||
155115581|NCT01301066|559853134|FG000|Overall Study|Lost to Follow-up|5|||
155115582|NCT01301066|559853135|FG001|Overall Study|Lost to Follow-up|11|||
155115583|NCT01301066|559853134|FG000|Overall Study|Protocol Violation|8|||
155115584|NCT01301066|559853135|FG001|Overall Study|Protocol Violation|7|||
155115585|NCT01301066|559853134|FG000|Overall Study|Withdrawal by Subject|4|||
155115586|NCT01301066|559853135|FG001|Overall Study|Withdrawal by Subject|9|||
155115587|NCT01301066|559853134|FG000|Overall Study|Adverse Event|6|||
155115588|NCT01301066|559853135|FG001|Overall Study|Adverse Event|6|||
155115589|NCT01301066|559853134|FG000|Overall Study|Sponsor Decision|2|||
155115590|NCT01301066|559853135|FG001|Overall Study|Sponsor Decision|1|||
155115591|NCT01301066|559853134|FG000|Overall Study|Physician Decision|0|||
155115592|NCT01301066|559853135|FG001|Overall Study|Physician Decision|1|||
155115593|NCT01301066|559853134|FG000|Overall Study|Other|2|||
155115594|NCT01301066|559853135|FG001|Overall Study|Other|0|||
155115595|NCT02118766|559853140|FG000|Overall Study|Adverse Event|7|||
155115596|NCT02118766|559853141|FG001|Overall Study|Adverse Event|2|||
155115597|NCT02118766|559853140|FG000|Overall Study|Withdrawal by Subject|3|||
155115598|NCT02118766|559853141|FG001|Overall Study|Withdrawal by Subject|6|||
155115599|NCT02118766|559853140|FG000|Overall Study|Lost to Follow-up|5|||
155115600|NCT02118766|559853141|FG001|Overall Study|Lost to Follow-up|4|||
155115601|NCT02118766|559853140|FG000|Overall Study|Withdrawal by parent/guardian|12|||
155115602|NCT02118766|559853141|FG001|Overall Study|Withdrawal by parent/guardian|18|||
155115603|NCT02118766|559853140|FG000|Overall Study|Other|3|||
155115604|NCT02118766|559853141|FG001|Overall Study|Other|1|||
155115605|NCT02248649|559853144|FG000|Overall Study|Death|7|||
155115606|NCT02248649|559853145|FG001|Overall Study|Death|11|||
155115607|NCT02248649|559853144|FG000|Overall Study|Lost to Follow-up|14|||
155115608|NCT02248649|559853145|FG001|Overall Study|Lost to Follow-up|10|||
155115609|NCT02438683|559853146|FG000|Overall Study|Adverse Event|1|||
155115610|NCT02438683|559853147|FG001|Overall Study|Adverse Event|0|||
155115611|NCT02438683|559853148|FG002|Overall Study|Adverse Event|0|||
155115612|NCT02438683|559853149|FG003|Overall Study|Adverse Event|0|||
155115613|NCT02438683|559853150|FG004|Overall Study|Adverse Event|0|||
155115614|NCT02438683|559853151|FG005|Overall Study|Adverse Event|0|||
155115615|NCT01202188|559853165|FG000|Overall Study|Protocol deviation|14|||
155115616|NCT01202188|559853166|FG001|Overall Study|Protocol deviation|8|||
155115617|NCT01202188|559853167|FG002|Overall Study|Protocol deviation|12|||
155115618|NCT01202188|559853168|FG003|Overall Study|Protocol deviation|10|||
155115619|NCT01202188|559853169|FG004|Overall Study|Protocol deviation|11|||
155115620|NCT01202188|559853165|FG000|Overall Study|Subject withdrew consent|12|||
155115621|NCT01202188|559853166|FG001|Overall Study|Subject withdrew consent|13|||
155115622|NCT01202188|559853167|FG002|Overall Study|Subject withdrew consent|22|||
155115623|NCT01202188|559853168|FG003|Overall Study|Subject withdrew consent|11|||
155115624|NCT01202188|559853169|FG004|Overall Study|Subject withdrew consent|13|||
155115625|NCT01202188|559853165|FG000|Overall Study|Adverse Event|5|||
155115626|NCT01202188|559853166|FG001|Overall Study|Adverse Event|23|||
155115627|NCT01202188|559853167|FG002|Overall Study|Adverse Event|13|||
155115628|NCT01202188|559853168|FG003|Overall Study|Adverse Event|10|||
155115629|NCT01202188|559853169|FG004|Overall Study|Adverse Event|10|||
155115630|NCT01202188|559853165|FG000|Overall Study|Administrative problems|3|||
154903909|NCT02963766|559069787|FG000|Double-Blind Period|Physician Decision|1|||
154903910|NCT02963766|559069788|FG001|Double-Blind Period|Physician Decision|0|||
154903911|NCT02963766|559069789|FG002|Double-Blind Period|Physician Decision|0|||
154903912|NCT02963766|559069787|FG000|Double-Blind Period|Withdrawal by Subject|1|||
154903913|NCT02963766|559069788|FG001|Double-Blind Period|Withdrawal by Subject|1|||
154903914|NCT02963766|559069789|FG002|Double-Blind Period|Withdrawal by Subject|0|||
154903915|NCT02963766|559069787|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
154903916|NCT02963766|559069788|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
154903917|NCT02963766|559069789|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
154903918|NCT02963766|559069787|FG000|Double-Blind Period|Protocol Violation|1|||
154903919|NCT02963766|559069788|FG001|Double-Blind Period|Protocol Violation|0|||
154903920|NCT02963766|559069789|FG002|Double-Blind Period|Protocol Violation|0|||
154903921|NCT02963766|559069787|FG000|Double-Blind Period|Lost to Follow-up|0|||
154903922|NCT02963766|559069788|FG001|Double-Blind Period|Lost to Follow-up|1|||
155115631|NCT01202188|559853166|FG001|Overall Study|Administrative problems|2|||
155115632|NCT01202188|559853167|FG002|Overall Study|Administrative problems|1|||
155115633|NCT01202188|559853168|FG003|Overall Study|Administrative problems|1|||
155115634|NCT01202188|559853169|FG004|Overall Study|Administrative problems|2|||
155115635|NCT01202188|559853165|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155115636|NCT01202188|559853166|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155115637|NCT01202188|559853167|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155115638|NCT01202188|559853168|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
155115639|NCT01202188|559853169|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
155115640|NCT01202188|559853165|FG000|Overall Study|Lost to Follow-up|1|||
155115641|NCT01202188|559853166|FG001|Overall Study|Lost to Follow-up|1|||
155115642|NCT01202188|559853167|FG002|Overall Study|Lost to Follow-up|0|||
155115643|NCT01202188|559853168|FG003|Overall Study|Lost to Follow-up|4|||
155115644|NCT01202188|559853169|FG004|Overall Study|Lost to Follow-up|1|||
155115645|NCT01202188|559853165|FG000|Overall Study|Death|1|||
155115646|NCT01202188|559853166|FG001|Overall Study|Death|1|||
155115647|NCT01202188|559853167|FG002|Overall Study|Death|1|||
155115648|NCT01202188|559853168|FG003|Overall Study|Death|1|||
155115649|NCT01202188|559853169|FG004|Overall Study|Death|0|||
155115650|NCT01202188|559853165|FG000|Overall Study|Abnormal test procedure result (s)|0|||
155115651|NCT01202188|559853166|FG001|Overall Study|Abnormal test procedure result (s)|0|||
155115652|NCT01202188|559853167|FG002|Overall Study|Abnormal test procedure result (s)|2|||
155115653|NCT01202188|559853168|FG003|Overall Study|Abnormal test procedure result (s)|0|||
155115654|NCT01202188|559853169|FG004|Overall Study|Abnormal test procedure result (s)|0|||
155115655|NCT05032690|559853170|FG000|Period 1|Adverse Event|0|||
155115656|NCT05032690|559853171|FG001|Period 1|Adverse Event|1|||
155115657|NCT05032690|559853172|FG002|Period 1|Adverse Event|0|||
155115658|NCT05032690|559853173|FG003|Period 1|Adverse Event|0|||
155115659|NCT05032690|559853170|FG000|Period 1|Withdrawal by Subject|1|||
155115660|NCT05032690|559853171|FG001|Period 1|Withdrawal by Subject|0|||
155115661|NCT05032690|559853172|FG002|Period 1|Withdrawal by Subject|0|||
155115662|NCT05032690|559853173|FG003|Period 1|Withdrawal by Subject|0|||
155115663|NCT05032690|559853170|FG000|Period 1|No longer meets eligibility criteria|0|||
155115664|NCT05032690|559853171|FG001|Period 1|No longer meets eligibility criteria|1|||
155115665|NCT05032690|559853172|FG002|Period 1|No longer meets eligibility criteria|0|||
154903923|NCT02963766|559069789|FG002|Double-Blind Period|Lost to Follow-up|0|||
154903924|NCT02963766|559069787|FG000|Open Label Extension (OLE)|Physician Decision|1|||
154903925|NCT02963766|559069788|FG001|Open Label Extension (OLE)|Physician Decision|2|||
154903926|NCT02963766|559069789|FG002|Open Label Extension (OLE)|Physician Decision|2|||
154903927|NCT02963766|559069787|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
154903928|NCT02963766|559069788|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
154903929|NCT02963766|559069789|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
154903930|NCT02224274|559069793|FG000|Overall Study|Death|1|||
154903931|NCT02224274|559069794|FG001|Overall Study|Death|0|||
154903932|NCT00499460|559069795|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
154903933|NCT00499460|559069796|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
154903934|NCT00499460|559069795|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
154903935|NCT00499460|559069796|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
155115666|NCT05032690|559853173|FG003|Period 1|No longer meets eligibility criteria|0|||
155115667|NCT05032690|559853170|FG000|Period 2|Adverse Event|1|||
155115668|NCT05032690|559853171|FG001|Period 2|Adverse Event|0|||
155115669|NCT05032690|559853172|FG002|Period 2|Adverse Event|0|||
155175945|NCT02353143|560082178|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
154903936|NCT00499460|559069795|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
154903937|NCT00499460|559069796|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
154903938|NCT00887068|559069797|FG000|Overall Study|Withdrawal by Subject|2|||
154903939|NCT00887068|559069798|FG001|Overall Study|Withdrawal by Subject|0|||
155115670|NCT05032690|559853173|FG003|Period 2|Adverse Event|0|||
155115671|NCT05032690|559853170|FG000|Period 2|Withdrawal by Subject|0|||
155115672|NCT05032690|559853171|FG001|Period 2|Withdrawal by Subject|1|||
155115673|NCT05032690|559853172|FG002|Period 2|Withdrawal by Subject|0|||
155115674|NCT05032690|559853173|FG003|Period 2|Withdrawal by Subject|0|||
155115675|NCT05032690|559853170|FG000|Period 2|No longer meets eligibility criteria|0|||
155115676|NCT05032690|559853171|FG001|Period 2|No longer meets eligibility criteria|1|||
154903940|NCT00887068|559069797|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
154903941|NCT00887068|559069798|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
154903942|NCT03073200|559069807|FG000|Double Blind Treatment Period|Protocol Violation|1|||
154903943|NCT03073200|559069808|FG001|Double Blind Treatment Period|Protocol Violation|0|||
154903944|NCT03073200|559069809|FG002|Double Blind Treatment Period|Protocol Violation|0|||
154903945|NCT03073200|559069810|FG003|Double Blind Treatment Period|Protocol Violation|0|||
154903946|NCT03073200|559069811|FG004|Double Blind Treatment Period|Protocol Violation|0|||
154903947|NCT03073200|559069812|FG005|Double Blind Treatment Period|Protocol Violation|0|||
154903948|NCT03073200|559069813|FG006|Double Blind Treatment Period|Protocol Violation|0|||
154903949|NCT03073200|559069814|FG007|Double Blind Treatment Period|Protocol Violation|0|||
154903950|NCT03073200|559069815|FG008|Double Blind Treatment Period|Protocol Violation|0|||
154903951|NCT03073200|559069816|FG009|Double Blind Treatment Period|Protocol Violation|0|||
154903952|NCT03073200|559069817|FG010|Double Blind Treatment Period|Protocol Violation|0|||
154903953|NCT03073200|559069818|FG011|Double Blind Treatment Period|Protocol Violation|0|||
154903954|NCT03073200|559069819|FG012|Double Blind Treatment Period|Protocol Violation|0|||
154903955|NCT03073200|559069820|FG013|Double Blind Treatment Period|Protocol Violation|0|||
154903956|NCT03073200|559069821|FG014|Double Blind Treatment Period|Protocol Violation|0|||
154903957|NCT03073200|559069807|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903958|NCT03073200|559069808|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
154903959|NCT03073200|559069809|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903960|NCT03073200|559069810|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903961|NCT03073200|559069811|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903962|NCT03073200|559069812|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903963|NCT03073200|559069813|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903964|NCT03073200|559069814|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
155115677|NCT05032690|559853172|FG002|Period 2|No longer meets eligibility criteria|0|||
154903965|NCT03073200|559069815|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903966|NCT03073200|559069816|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903967|NCT03073200|559069817|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903968|NCT03073200|559069818|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903969|NCT03073200|559069819|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903970|NCT03073200|559069820|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903971|NCT03073200|559069821|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
154903972|NCT03073200|559069807|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
154903973|NCT03073200|559069808|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903974|NCT03073200|559069809|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903975|NCT03073200|559069810|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903976|NCT03073200|559069811|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903977|NCT03073200|559069812|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903978|NCT03073200|559069813|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903979|NCT03073200|559069814|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903980|NCT03073200|559069815|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903981|NCT03073200|559069816|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903982|NCT03073200|559069817|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903983|NCT03073200|559069818|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903984|NCT03073200|559069819|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903985|NCT03073200|559069820|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903986|NCT03073200|559069821|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
154903987|NCT03073200|559069807|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903988|NCT03073200|559069808|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903989|NCT03073200|559069809|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903990|NCT03073200|559069810|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
154903991|NCT03073200|559069811|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
154903992|NCT03073200|559069812|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903993|NCT03073200|559069813|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903994|NCT03073200|559069814|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903995|NCT03073200|559069815|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903996|NCT03073200|559069816|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903997|NCT03073200|559069817|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
154903998|NCT03073200|559069818|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
155115678|NCT05032690|559853173|FG003|Period 2|No longer meets eligibility criteria|0|||
155115679|NCT05032690|559853170|FG000|Period 3|Adverse Event|0|||
154903999|NCT03073200|559069819|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
154904000|NCT03073200|559069820|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
154981687|NCT02723773|559359121|FG000|Overall Study|Adverse Event|934|||
154981688|NCT02723773|559359122|FG001|Overall Study|Adverse Event|3|||
155115680|NCT05032690|559853171|FG001|Period 3|Adverse Event|1|||
155115681|NCT05032690|559853172|FG002|Period 3|Adverse Event|0|||
154904001|NCT03073200|559069821|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
154904002|NCT03073200|559069807|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
154904003|NCT03073200|559069808|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
154904004|NCT03073200|559069809|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
154904005|NCT03073200|559069810|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
154904006|NCT03073200|559069811|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
154904007|NCT03073200|559069812|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
154904008|NCT03073200|559069813|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
154904009|NCT03073200|559069814|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
154904010|NCT03073200|559069815|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
154904011|NCT03073200|559069816|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
154904012|NCT03073200|559069817|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
154904013|NCT03073200|559069818|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
154904014|NCT03073200|559069819|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
154904015|NCT03073200|559069820|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
154904016|NCT03073200|559069821|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
154904017|NCT03073200|559069807|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904018|NCT03073200|559069808|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904019|NCT03073200|559069809|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904020|NCT03073200|559069810|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904021|NCT03073200|559069811|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
154904022|NCT03073200|559069812|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904023|NCT03073200|559069813|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904024|NCT03073200|559069814|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904025|NCT03073200|559069815|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904026|NCT03073200|559069816|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904027|NCT03073200|559069817|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904028|NCT03073200|559069818|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904029|NCT03073200|559069819|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904030|NCT03073200|559069820|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904031|NCT03073200|559069821|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
154904032|NCT03073200|559069807|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904033|NCT03073200|559069808|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904034|NCT03073200|559069809|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904035|NCT03073200|559069810|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
154904036|NCT03073200|559069811|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
154904037|NCT03073200|559069812|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904038|NCT03073200|559069813|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904039|NCT03073200|559069814|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904040|NCT03073200|559069815|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904041|NCT03073200|559069816|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904042|NCT03073200|559069817|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904043|NCT03073200|559069818|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904044|NCT03073200|559069819|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904045|NCT03073200|559069820|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904046|NCT03073200|559069821|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
154904047|NCT03073200|559069807|FG000|Extension Period|Lost to Follow-up|0|||
154904048|NCT03073200|559069808|FG001|Extension Period|Lost to Follow-up|0|||
154904049|NCT03073200|559069809|FG002|Extension Period|Lost to Follow-up|0|||
154904050|NCT03073200|559069810|FG003|Extension Period|Lost to Follow-up|0|||
154904051|NCT03073200|559069811|FG004|Extension Period|Lost to Follow-up|0|||
154904052|NCT03073200|559069812|FG005|Extension Period|Lost to Follow-up|0|||
154904053|NCT03073200|559069813|FG006|Extension Period|Lost to Follow-up|1|||
154904054|NCT03073200|559069814|FG007|Extension Period|Lost to Follow-up|1|||
154904055|NCT03073200|559069815|FG008|Extension Period|Lost to Follow-up|0|||
154904056|NCT03073200|559069816|FG009|Extension Period|Lost to Follow-up|0|||
154904057|NCT03073200|559069817|FG010|Extension Period|Lost to Follow-up|0|||
154904058|NCT03073200|559069818|FG011|Extension Period|Lost to Follow-up|0|||
154904059|NCT03073200|559069819|FG012|Extension Period|Lost to Follow-up|0|||
154981689|NCT02723773|559359123|FG002|Overall Study|Adverse Event|1|||
155115682|NCT05032690|559853173|FG003|Period 3|Adverse Event|0|||
155115683|NCT00487942|559853174|FG000|Overall Study|Adverse Event|1|||
155115684|NCT00487942|559853175|FG001|Overall Study|Adverse Event|1|||
154904060|NCT03073200|559069820|FG013|Extension Period|Lost to Follow-up|0|||
154904061|NCT03073200|559069821|FG014|Extension Period|Lost to Follow-up|0|||
154981690|NCT02723773|559359124|FG003|Overall Study|Adverse Event|9|||
154904062|NCT03073200|559069807|FG000|Extension Period|Sponsor Decision|0|||
154904063|NCT03073200|559069808|FG001|Extension Period|Sponsor Decision|0|||
154904064|NCT03073200|559069809|FG002|Extension Period|Sponsor Decision|0|||
155115685|NCT00487942|559853176|FG002|Overall Study|Adverse Event|1|||
155115686|NCT00487942|559853177|FG003|Overall Study|Adverse Event|1|||
155115687|NCT00487942|559853174|FG000|Overall Study|Lost to Follow-up|1|||
155115688|NCT00487942|559853175|FG001|Overall Study|Lost to Follow-up|0|||
155115689|NCT00487942|559853176|FG002|Overall Study|Lost to Follow-up|0|||
154904065|NCT03073200|559069810|FG003|Extension Period|Sponsor Decision|0|||
154904066|NCT03073200|559069811|FG004|Extension Period|Sponsor Decision|0|||
154904067|NCT03073200|559069812|FG005|Extension Period|Sponsor Decision|0|||
154904068|NCT03073200|559069813|FG006|Extension Period|Sponsor Decision|0|||
154904069|NCT03073200|559069814|FG007|Extension Period|Sponsor Decision|0|||
154904070|NCT03073200|559069815|FG008|Extension Period|Sponsor Decision|1|||
154904071|NCT03073200|559069816|FG009|Extension Period|Sponsor Decision|0|||
154904072|NCT03073200|559069817|FG010|Extension Period|Sponsor Decision|0|||
154904073|NCT03073200|559069818|FG011|Extension Period|Sponsor Decision|0|||
154904074|NCT03073200|559069819|FG012|Extension Period|Sponsor Decision|0|||
154904075|NCT03073200|559069820|FG013|Extension Period|Sponsor Decision|0|||
154904076|NCT03073200|559069821|FG014|Extension Period|Sponsor Decision|0|||
154904077|NCT03073200|559069807|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
154904078|NCT03073200|559069808|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
154904079|NCT03073200|559069809|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
154904080|NCT03073200|559069810|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
154904081|NCT03073200|559069811|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
154904082|NCT03073200|559069812|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
154904083|NCT03073200|559069813|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
154904084|NCT03073200|559069814|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
154904085|NCT03073200|559069815|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
154904086|NCT03073200|559069816|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
154904087|NCT03073200|559069817|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
154904088|NCT03073200|559069818|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
154904089|NCT03073200|559069819|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
154904090|NCT03073200|559069820|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
154904091|NCT03073200|559069821|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
154904092|NCT03073200|559069807|FG000|Extension Period|Withdrawal by Subject|0|||
154904093|NCT03073200|559069808|FG001|Extension Period|Withdrawal by Subject|0|||
154904094|NCT03073200|559069809|FG002|Extension Period|Withdrawal by Subject|0|||
154904095|NCT03073200|559069810|FG003|Extension Period|Withdrawal by Subject|0|||
154904096|NCT03073200|559069811|FG004|Extension Period|Withdrawal by Subject|0|||
154904097|NCT03073200|559069812|FG005|Extension Period|Withdrawal by Subject|0|||
154904098|NCT03073200|559069813|FG006|Extension Period|Withdrawal by Subject|1|||
154904099|NCT03073200|559069814|FG007|Extension Period|Withdrawal by Subject|2|||
154904100|NCT03073200|559069815|FG008|Extension Period|Withdrawal by Subject|0|||
154904101|NCT03073200|559069816|FG009|Extension Period|Withdrawal by Subject|0|||
154904102|NCT03073200|559069817|FG010|Extension Period|Withdrawal by Subject|0|||
154904103|NCT03073200|559069818|FG011|Extension Period|Withdrawal by Subject|0|||
154904104|NCT03073200|559069819|FG012|Extension Period|Withdrawal by Subject|0|||
154904105|NCT03073200|559069820|FG013|Extension Period|Withdrawal by Subject|0|||
154904106|NCT03073200|559069821|FG014|Extension Period|Withdrawal by Subject|0|||
154904107|NCT03073200|559069807|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904108|NCT03073200|559069808|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904109|NCT03073200|559069809|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904110|NCT03073200|559069810|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904111|NCT03073200|559069811|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904112|NCT03073200|559069812|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904113|NCT03073200|559069813|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904114|NCT03073200|559069814|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904115|NCT03073200|559069815|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
155115690|NCT00487942|559853177|FG003|Overall Study|Lost to Follow-up|1|||
155115691|NCT00487942|559853174|FG000|Overall Study|Protocol Violation|1|||
155115692|NCT00487942|559853175|FG001|Overall Study|Protocol Violation|1|||
155115693|NCT00487942|559853176|FG002|Overall Study|Protocol Violation|0|||
154904116|NCT03073200|559069816|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904117|NCT03073200|559069817|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904118|NCT03073200|559069818|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
154904119|NCT03073200|559069819|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904120|NCT03073200|559069820|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904121|NCT03073200|559069821|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
154904122|NCT03073200|559069807|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904123|NCT03073200|559069808|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904124|NCT03073200|559069809|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904125|NCT03073200|559069810|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
155115694|NCT00487942|559853177|FG003|Overall Study|Protocol Violation|0|||
155175946|NCT02353143|560082179|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
155175947|NCT02353143|560082180|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
155175948|NCT02353143|560082181|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
154904126|NCT03073200|559069811|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904127|NCT03073200|559069812|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904128|NCT03073200|559069813|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904129|NCT03073200|559069814|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904130|NCT03073200|559069815|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904131|NCT03073200|559069816|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904132|NCT03073200|559069817|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904133|NCT03073200|559069818|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
154904134|NCT03073200|559069819|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904135|NCT03073200|559069820|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904136|NCT03073200|559069821|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
154904137|NCT03073200|559069807|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904138|NCT03073200|559069808|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904139|NCT03073200|559069809|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904140|NCT03073200|559069810|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904141|NCT03073200|559069811|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904142|NCT03073200|559069812|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904143|NCT03073200|559069813|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904144|NCT03073200|559069814|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904145|NCT03073200|559069815|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904146|NCT03073200|559069816|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904147|NCT03073200|559069817|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
154904148|NCT03073200|559069818|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
154904149|NCT03073200|559069819|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904150|NCT03073200|559069820|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904151|NCT03073200|559069821|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
154904152|NCT03073200|559069807|FG000|Randomized Withdrawal Period|Adverse Event|0|||
154904153|NCT03073200|559069808|FG001|Randomized Withdrawal Period|Adverse Event|0|||
154904154|NCT03073200|559069809|FG002|Randomized Withdrawal Period|Adverse Event|0|||
154904155|NCT03073200|559069810|FG003|Randomized Withdrawal Period|Adverse Event|0|||
154904156|NCT03073200|559069811|FG004|Randomized Withdrawal Period|Adverse Event|0|||
154904157|NCT03073200|559069812|FG005|Randomized Withdrawal Period|Adverse Event|0|||
154904158|NCT03073200|559069813|FG006|Randomized Withdrawal Period|Adverse Event|0|||
154904159|NCT03073200|559069814|FG007|Randomized Withdrawal Period|Adverse Event|0|||
154904160|NCT03073200|559069815|FG008|Randomized Withdrawal Period|Adverse Event|0|||
154904161|NCT03073200|559069816|FG009|Randomized Withdrawal Period|Adverse Event|0|||
154904162|NCT03073200|559069817|FG010|Randomized Withdrawal Period|Adverse Event|1|||
154904163|NCT03073200|559069818|FG011|Randomized Withdrawal Period|Adverse Event|0|||
154904164|NCT03073200|559069819|FG012|Randomized Withdrawal Period|Adverse Event|0|||
154904165|NCT03073200|559069820|FG013|Randomized Withdrawal Period|Adverse Event|0|||
154904166|NCT03073200|559069821|FG014|Randomized Withdrawal Period|Adverse Event|0|||
154904167|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904168|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904169|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904170|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904171|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904172|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904173|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904174|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904175|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904176|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904177|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904178|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904179|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904180|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
154904181|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
154904182|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904183|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904184|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904185|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904186|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904187|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904188|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904189|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154981691|NCT02723773|559359121|FG000|Overall Study|Protocol Violation|1|||
154981692|NCT02723773|559359122|FG001|Overall Study|Protocol Violation|0|||
154981693|NCT02723773|559359123|FG002|Overall Study|Protocol Violation|0|||
154981694|NCT02723773|559359124|FG003|Overall Study|Protocol Violation|0|||
154981695|NCT02723773|559359121|FG000|Overall Study|Withdrawal by Subject|360|||
154981696|NCT02723773|559359122|FG001|Overall Study|Withdrawal by Subject|5|||
154981697|NCT02723773|559359123|FG002|Overall Study|Withdrawal by Subject|6|||
154981698|NCT02723773|559359124|FG003|Overall Study|Withdrawal by Subject|10|||
154981699|NCT02723773|559359121|FG000|Overall Study|Migrated/moved from study area|37|||
154981700|NCT02723773|559359122|FG001|Overall Study|Migrated/moved from study area|0|||
154981701|NCT02723773|559359123|FG002|Overall Study|Migrated/moved from study area|0|||
154981702|NCT02723773|559359124|FG003|Overall Study|Migrated/moved from study area|1|||
154981703|NCT02723773|559359121|FG000|Overall Study|Lost to Follow-up|198|||
154981704|NCT02723773|559359122|FG001|Overall Study|Lost to Follow-up|0|||
154981705|NCT02723773|559359123|FG002|Overall Study|Lost to Follow-up|0|||
154981706|NCT02723773|559359124|FG003|Overall Study|Lost to Follow-up|0|||
154981707|NCT02723773|559359121|FG000|Overall Study|Other|189|||
154981708|NCT02723773|559359122|FG001|Overall Study|Other|1|||
154981709|NCT02723773|559359123|FG002|Overall Study|Other|2|||
154981710|NCT02723773|559359124|FG003|Overall Study|Other|2|||
154981711|NCT05168774|559359125|FG000|Overall Study|Lack of Efficacy|1|||
154981712|NCT05168774|559359126|FG001|Overall Study|Lack of Efficacy|2|||
154981713|NCT05168774|559359125|FG000|Overall Study|Withdrawal by Subject|1|||
154981714|NCT05168774|559359126|FG001|Overall Study|Withdrawal by Subject|2|||
154981715|NCT05168774|559359125|FG000|Overall Study|Adverse Event|2|||
154981716|NCT05168774|559359126|FG001|Overall Study|Adverse Event|0|||
154981717|NCT03940703|559359127|FG000|Overall Study|Still under treatment|31|||
154981718|NCT03940703|559359128|FG001|Overall Study|Still under treatment|0|||
154981719|NCT03310957|559359129|FG000|Overall Study|Withdrawal by Subject|1|||
154981720|NCT03310957|559359130|FG001|Overall Study|Withdrawal by Subject|1|||
154981721|NCT03310957|559359131|FG002|Overall Study|Withdrawal by Subject|1|||
154981722|NCT03310957|559359132|FG003|Overall Study|Withdrawal by Subject|5|||
154981723|NCT03310957|559359133|FG004|Overall Study|Withdrawal by Subject|0|||
154981724|NCT03310957|559359134|FG005|Overall Study|Withdrawal by Subject|4|||
154981725|NCT03310957|559359135|FG006|Overall Study|Withdrawal by Subject|3|||
154981726|NCT03310957|559359129|FG000|Overall Study|Site Terminated|0|||
154981727|NCT03310957|559359130|FG001|Overall Study|Site Terminated|1|||
154981728|NCT03310957|559359131|FG002|Overall Study|Site Terminated|1|||
154981729|NCT03310957|559359132|FG003|Overall Study|Site Terminated|1|||
154981730|NCT03310957|559359133|FG004|Overall Study|Site Terminated|0|||
154981731|NCT03310957|559359134|FG005|Overall Study|Site Terminated|2|||
154981732|NCT03310957|559359135|FG006|Overall Study|Site Terminated|8|||
154981733|NCT03310957|559359129|FG000|Overall Study|Lost to Follow-up|1|||
154981734|NCT03310957|559359130|FG001|Overall Study|Lost to Follow-up|1|||
154981735|NCT03310957|559359131|FG002|Overall Study|Lost to Follow-up|1|||
154981736|NCT03310957|559359132|FG003|Overall Study|Lost to Follow-up|4|||
154981737|NCT03310957|559359133|FG004|Overall Study|Lost to Follow-up|0|||
154981738|NCT03310957|559359134|FG005|Overall Study|Lost to Follow-up|4|||
154981739|NCT03310957|559359135|FG006|Overall Study|Lost to Follow-up|2|||
154981740|NCT03310957|559359129|FG000|Overall Study|Death|5|||
154981741|NCT03310957|559359130|FG001|Overall Study|Death|8|||
154981742|NCT03310957|559359131|FG002|Overall Study|Death|18|||
154981743|NCT03310957|559359132|FG003|Overall Study|Death|31|||
155115695|NCT00487942|559853174|FG000|Overall Study|Withdrawal by Subject|0|||
155115696|NCT00487942|559853175|FG001|Overall Study|Withdrawal by Subject|1|||
155115697|NCT00487942|559853176|FG002|Overall Study|Withdrawal by Subject|2|||
155115698|NCT00487942|559853177|FG003|Overall Study|Withdrawal by Subject|0|||
155115699|NCT05151445|559853178|FG000|Overall Study|Withdrawal by Subject|3|||
155115700|NCT02298179|559853182|FG000|Overall Study|Lost to Follow-up|0|||
155115701|NCT02298179|559853183|FG001|Overall Study|Lost to Follow-up|0|||
155115702|NCT02298179|559853184|FG002|Overall Study|Lost to Follow-up|1|||
155115703|NCT02298179|559853185|FG003|Overall Study|Lost to Follow-up|0|||
154981744|NCT03310957|559359133|FG004|Overall Study|Death|1|||
154981745|NCT03310957|559359134|FG005|Overall Study|Death|29|||
154981746|NCT03310957|559359135|FG006|Overall Study|Death|7|||
154981747|NCT03310957|559359129|FG000|Overall Study|Discontinuation per sponsor|0|||
154981748|NCT03310957|559359130|FG001|Overall Study|Discontinuation per sponsor|1|||
155115704|NCT02298179|559853186|FG004|Overall Study|Lost to Follow-up|0|||
154981749|NCT03310957|559359131|FG002|Overall Study|Discontinuation per sponsor|2|||
154981750|NCT03310957|559359132|FG003|Overall Study|Discontinuation per sponsor|4|||
154981751|NCT03310957|559359133|FG004|Overall Study|Discontinuation per sponsor|1|||
154981752|NCT03310957|559359134|FG005|Overall Study|Discontinuation per sponsor|9|||
154981753|NCT03310957|559359135|FG006|Overall Study|Discontinuation per sponsor|12|||
154981754|NCT03310957|559359129|FG000|Overall Study|Discontinuation per protocol amendment 11|0|||
154981755|NCT03310957|559359130|FG001|Overall Study|Discontinuation per protocol amendment 11|0|||
154981756|NCT03310957|559359131|FG002|Overall Study|Discontinuation per protocol amendment 11|0|||
154981757|NCT03310957|559359132|FG003|Overall Study|Discontinuation per protocol amendment 11|1|||
155115705|NCT02298179|559853187|FG005|Overall Study|Lost to Follow-up|0|||
155115706|NCT02298179|559853188|FG006|Overall Study|Lost to Follow-up|0|||
155115707|NCT02298179|559853189|FG007|Overall Study|Lost to Follow-up|1|||
155115708|NCT02298179|559853190|FG008|Overall Study|Lost to Follow-up|0|||
155115709|NCT02298179|559853191|FG009|Overall Study|Lost to Follow-up|0|||
155115710|NCT02298179|559853192|FG010|Overall Study|Lost to Follow-up|0|||
155115711|NCT02298179|559853193|FG011|Overall Study|Lost to Follow-up|0|||
155115712|NCT00082368|559853196|FG000|Overall Study|Not treated-pt had poor IV access|1|||
155115713|NCT03559517|559853197|FG000|Overall Study|Withdrawal by Subject|1|||
155115714|NCT03559517|559853198|FG001|Overall Study|Withdrawal by Subject|0|||
155115715|NCT03559517|559853199|FG002|Overall Study|Withdrawal by Subject|0|||
155115716|NCT01846299|559853200|FG000|Overall Study|Physician Decision|4|||
154904190|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904191|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904192|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904193|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904194|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904195|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
154904196|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
154904197|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904198|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904199|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904200|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904201|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904202|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904203|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904204|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904205|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904206|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904207|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904208|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904209|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904210|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
154904211|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
154904212|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904213|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904214|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904215|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904216|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904217|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904218|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904219|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904220|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904221|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904222|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904223|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904224|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904225|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
154904226|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
154904227|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904228|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904229|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904230|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904231|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904232|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904233|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904234|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904235|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904236|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904237|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904238|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904239|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904240|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
154904241|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
155115717|NCT01846299|559853201|FG001|Overall Study|Physician Decision|2|||
155115718|NCT01846299|559853200|FG000|Overall Study|Protocol deviation|1|||
155115719|NCT01846299|559853201|FG001|Overall Study|Protocol deviation|0|||
155115720|NCT01846299|559853200|FG000|Overall Study|Death|1|||
154904242|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904243|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904244|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904245|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904246|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904247|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904248|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904249|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904250|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904251|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904252|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904253|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904254|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904255|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
154904256|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
154904257|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904258|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904259|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904260|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904261|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904262|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904263|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904264|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904265|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904266|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904267|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904268|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904269|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904270|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
154904271|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
154904272|NCT03073200|559069807|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904273|NCT03073200|559069808|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904274|NCT03073200|559069809|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904275|NCT03073200|559069810|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904276|NCT03073200|559069811|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904277|NCT03073200|559069812|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904278|NCT03073200|559069813|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904279|NCT03073200|559069814|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904280|NCT03073200|559069815|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904281|NCT03073200|559069816|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904282|NCT03073200|559069817|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904283|NCT03073200|559069818|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904284|NCT03073200|559069819|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904285|NCT03073200|559069820|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
154904286|NCT03073200|559069821|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
154904287|NCT01474889|559069822|FG000|Overall Study|Physician Decision|1|||
154904288|NCT01474889|559069823|FG001|Overall Study|Physician Decision|0|||
154904289|NCT01474889|559069824|FG002|Overall Study|Physician Decision|0|||
154904290|NCT01474889|559069822|FG000|Overall Study|Did not meet inclusion|1|||
154904291|NCT01474889|559069823|FG001|Overall Study|Did not meet inclusion|0|||
154904292|NCT01474889|559069824|FG002|Overall Study|Did not meet inclusion|0|||
154904293|NCT01474889|559069822|FG000|Overall Study|Withdrawal by Subject|0|||
154904294|NCT01474889|559069823|FG001|Overall Study|Withdrawal by Subject|1|||
154904295|NCT01474889|559069824|FG002|Overall Study|Withdrawal by Subject|0|||
154904296|NCT00901394|559069825|FG000|Overall Study|Physician Decision|1|||
154904297|NCT00901394|559069826|FG001|Overall Study|Physician Decision|1|||
154904298|NCT00901394|559069827|FG002|Overall Study|Physician Decision|2|||
154904299|NCT02290340|559069830|FG000|Overall Study|Lost to Follow-up|0|||
154904300|NCT02290340|559069831|FG001|Overall Study|Lost to Follow-up|0|||
154904301|NCT02290340|559069832|FG002|Overall Study|Lost to Follow-up|0|||
154904302|NCT02290340|559069833|FG003|Overall Study|Lost to Follow-up|1|||
154904303|NCT02290340|559069830|FG000|Overall Study|Withdrawal by Subject|1|||
154904304|NCT02290340|559069831|FG001|Overall Study|Withdrawal by Subject|0|||
154904305|NCT02290340|559069832|FG002|Overall Study|Withdrawal by Subject|0|||
154981758|NCT03310957|559359133|FG004|Overall Study|Discontinuation per protocol amendment 11|0|||
155115721|NCT01846299|559853201|FG001|Overall Study|Death|2|||
154904306|NCT02290340|559069833|FG003|Overall Study|Withdrawal by Subject|0|||
154981759|NCT03310957|559359134|FG005|Overall Study|Discontinuation per protocol amendment 11|3|||
154981760|NCT03310957|559359135|FG006|Overall Study|Discontinuation per protocol amendment 11|5|||
154981761|NCT03310957|559359129|FG000|Overall Study|Treatment landscape|0|||
154981762|NCT03310957|559359130|FG001|Overall Study|Treatment landscape|0|||
154981763|NCT03310957|559359131|FG002|Overall Study|Treatment landscape|1|||
154981764|NCT03310957|559359132|FG003|Overall Study|Treatment landscape|1|||
154981765|NCT03310957|559359133|FG004|Overall Study|Treatment landscape|0|||
154981766|NCT03310957|559359134|FG005|Overall Study|Treatment landscape|1|||
154981767|NCT03310957|559359135|FG006|Overall Study|Treatment landscape|0|||
154981768|NCT03310957|559359129|FG000|Overall Study|Alanine aminotransferase (ALT) increased|0|||
154981769|NCT03310957|559359130|FG001|Overall Study|Alanine aminotransferase (ALT) increased|0|||
154981770|NCT03310957|559359131|FG002|Overall Study|Alanine aminotransferase (ALT) increased|0|||
154981771|NCT03310957|559359132|FG003|Overall Study|Alanine aminotransferase (ALT) increased|0|||
154981772|NCT03310957|559359133|FG004|Overall Study|Alanine aminotransferase (ALT) increased|1|||
154981773|NCT03310957|559359134|FG005|Overall Study|Alanine aminotransferase (ALT) increased|0|||
154981774|NCT03310957|559359135|FG006|Overall Study|Alanine aminotransferase (ALT) increased|0|||
154981775|NCT03310957|559359129|FG000|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
154981776|NCT03310957|559359130|FG001|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
154981777|NCT03310957|559359131|FG002|Overall Study|Elevated Aspartate aminotransferase (AST)|1|||
154981778|NCT03310957|559359132|FG003|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
154981779|NCT03310957|559359133|FG004|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
154981780|NCT03310957|559359134|FG005|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
154981781|NCT03310957|559359135|FG006|Overall Study|Elevated Aspartate aminotransferase (AST)|0|||
154981782|NCT03310957|559359129|FG000|Overall Study|Hospice|0|||
154981783|NCT03310957|559359130|FG001|Overall Study|Hospice|0|||
154981784|NCT03310957|559359131|FG002|Overall Study|Hospice|0|||
154981785|NCT03310957|559359132|FG003|Overall Study|Hospice|0|||
154981786|NCT03310957|559359133|FG004|Overall Study|Hospice|0|||
154981787|NCT03310957|559359134|FG005|Overall Study|Hospice|1|||
154981788|NCT03310957|559359135|FG006|Overall Study|Hospice|0|||
154981789|NCT03310957|559359129|FG000|Overall Study|Progressive|0|||
154981790|NCT03310957|559359130|FG001|Overall Study|Progressive|0|||
154981791|NCT03310957|559359131|FG002|Overall Study|Progressive|1|||
154981792|NCT03310957|559359132|FG003|Overall Study|Progressive|0|||
154981793|NCT03310957|559359133|FG004|Overall Study|Progressive|0|||
154981794|NCT03310957|559359134|FG005|Overall Study|Progressive|0|||
154981795|NCT03310957|559359135|FG006|Overall Study|Progressive|0|||
154981796|NCT03768726|559359142|FG000|Treatment Phase|Adverse Event|2|||
154981797|NCT03768726|559359143|FG001|Treatment Phase|Adverse Event|2|||
154981798|NCT03768726|559359142|FG000|Treatment Phase|Lost to Follow-up|1|||
154981799|NCT03768726|559359143|FG001|Treatment Phase|Lost to Follow-up|0|||
154981800|NCT03768726|559359142|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
154981801|NCT03768726|559359143|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
154981802|NCT03768726|559359142|FG000|Treatment Phase|Withdrawal by Subject|3|||
154981803|NCT03768726|559359143|FG001|Treatment Phase|Withdrawal by Subject|1|||
154981804|NCT03768726|559359142|FG000|Follow-Up|Adverse Event|2|||
154981805|NCT03768726|559359143|FG001|Follow-Up|Adverse Event|2|||
154981806|NCT03768726|559359142|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
154981807|NCT03768726|559359143|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
154981808|NCT03768726|559359142|FG000|Follow-Up|Withdrawal by Subject|2|||
154981809|NCT03768726|559359143|FG001|Follow-Up|Withdrawal by Subject|0|||
154981810|NCT03768726|559359142|FG000|Follow-Up|Other|1|||
154981811|NCT03768726|559359143|FG001|Follow-Up|Other|0|||
154981812|NCT01286558|559359144|FG000|Overall Study|Adverse Event|1|||
154981813|NCT01286558|559359145|FG001|Overall Study|Adverse Event|1|||
154981814|NCT01286558|559359144|FG000|Overall Study|Withdrawal by Subject|0|||
154981815|NCT01286558|559359145|FG001|Overall Study|Withdrawal by Subject|1|||
154981816|NCT01787279|559359147|FG000|Overall Study|Lost to Follow-up|2|||
154981817|NCT01787279|559359147|FG000|Overall Study|Lack of Efficacy|1|||
154981818|NCT01567826|559359149|FG000|Overall Study|Lost to Follow-up|3|||
155115722|NCT01846299|559853200|FG000|Overall Study|Lost to Follow-up|3|||
155115723|NCT01846299|559853201|FG001|Overall Study|Lost to Follow-up|0|||
155115724|NCT01846299|559853200|FG000|Overall Study|Withdrawal by Subject|1|||
155115725|NCT01846299|559853201|FG001|Overall Study|Withdrawal by Subject|6|||
155115726|NCT01846299|559853200|FG000|Overall Study|Adverse Event|2|||
154981819|NCT01567826|559359150|FG001|Overall Study|Lost to Follow-up|2|||
154981820|NCT01360866|559359153|FG000|Overall Study|Lost to Follow-up|11|||
154981821|NCT01360866|559359154|FG001|Overall Study|Lost to Follow-up|28|||
154981822|NCT01360866|559359155|FG002|Overall Study|Lost to Follow-up|41|||
154981823|NCT01360866|559359156|FG003|Overall Study|Lost to Follow-up|0|||
154981824|NCT01360866|559359153|FG000|Overall Study|Adverse Event|56|||
154981825|NCT01360866|559359154|FG001|Overall Study|Adverse Event|61|||
154981826|NCT01360866|559359155|FG002|Overall Study|Adverse Event|134|||
154981827|NCT01360866|559359156|FG003|Overall Study|Adverse Event|6|||
154981828|NCT01360866|559359153|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
154981829|NCT01360866|559359154|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
154981830|NCT01360866|559359155|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
155115727|NCT01846299|559853201|FG001|Overall Study|Adverse Event|0|||
154981831|NCT01360866|559359156|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
154981832|NCT01360866|559359153|FG000|Overall Study|Withdrawn by Investigator|9|||
154981833|NCT01360866|559359154|FG001|Overall Study|Withdrawn by Investigator|8|||
154981834|NCT01360866|559359155|FG002|Overall Study|Withdrawn by Investigator|31|||
154981835|NCT01360866|559359156|FG003|Overall Study|Withdrawn by Investigator|2|||
154981836|NCT01360866|559359153|FG000|Overall Study|Withdrawal by participant|79|||
154981837|NCT01360866|559359154|FG001|Overall Study|Withdrawal by participant|89|||
154981838|NCT01360866|559359155|FG002|Overall Study|Withdrawal by participant|168|||
154981839|NCT01360866|559359156|FG003|Overall Study|Withdrawal by participant|8|||
154981840|NCT01360866|559359153|FG000|Overall Study|Protocol Deviation|25|||
154981841|NCT01360866|559359154|FG001|Overall Study|Protocol Deviation|33|||
154981842|NCT01360866|559359155|FG002|Overall Study|Protocol Deviation|61|||
154981843|NCT01360866|559359156|FG003|Overall Study|Protocol Deviation|2|||
154981844|NCT01360866|559359153|FG000|Overall Study|Lack of Efficacy|30|||
154981845|NCT01360866|559359154|FG001|Overall Study|Lack of Efficacy|40|||
154981846|NCT01360866|559359155|FG002|Overall Study|Lack of Efficacy|30|||
154981847|NCT01360866|559359156|FG003|Overall Study|Lack of Efficacy|4|||
154981848|NCT00918463|559359158|FG000|Overall Study|Death|1|||
154981849|NCT00918463|559359158|FG000|Overall Study|Lack of Efficacy|1|||
154981850|NCT04319159|559359168|FG000|Overall Study|Screening failure|13|||
154981851|NCT04319159|559359168|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
154981852|NCT04319159|559359168|FG000|Overall Study|Withdrawal by Subject|1|||
154981853|NCT05560763|559359172|FG000|Overall Study|Withdrawal by Subject|4|||
154981854|NCT06972251|559359173|FG000|Overall Study|Withdrawal by Subject|1|||
154981855|NCT06972251|559359174|FG001|Overall Study|Withdrawal by Subject|0|||
154981856|NCT06972251|559359173|FG000|Overall Study|Lost to Follow-up|10|||
154981857|NCT06972251|559359174|FG001|Overall Study|Lost to Follow-up|2|||
154981858|NCT05224544|559359175|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
154981859|NCT05224544|559359176|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
154981860|NCT02674386|559359177|FG000|Overall Study|Lost to Follow-up|0|||
154981861|NCT02674386|559359178|FG001|Overall Study|Lost to Follow-up|1|||
154981862|NCT02674386|559359179|FG002|Overall Study|Lost to Follow-up|1|||
154981863|NCT02674386|559359177|FG000|Overall Study|Withdrawal by Subject|0|||
154981864|NCT02674386|559359178|FG001|Overall Study|Withdrawal by Subject|4|||
154981865|NCT02674386|559359179|FG002|Overall Study|Withdrawal by Subject|0|||
154981866|NCT02674386|559359177|FG000|Overall Study|Other|0|||
154981867|NCT02674386|559359178|FG001|Overall Study|Other|1|||
154981868|NCT02674386|559359179|FG002|Overall Study|Other|0|||
154981869|NCT02674386|559359177|FG000|Overall Study|Enrolled but not evaluated|0|||
154981870|NCT02674386|559359178|FG001|Overall Study|Enrolled but not evaluated|4|||
154981871|NCT02674386|559359179|FG002|Overall Study|Enrolled but not evaluated|0|||
154981872|NCT04706507|559359180|FG000|Overall Study|Death|45|||
154981873|NCT04706507|559359181|FG001|Overall Study|Death|22|||
154981874|NCT04706507|559359180|FG000|Overall Study|Unable to adhere|0|||
154981875|NCT04706507|559359181|FG001|Overall Study|Unable to adhere|2|||
154981876|NCT04706507|559359180|FG000|Overall Study|Lost to Follow-up|13|||
154981877|NCT04706507|559359181|FG001|Overall Study|Lost to Follow-up|12|||
154981878|NCT04706507|559359180|FG000|Overall Study|Withdrawal of consent|1|||
154981879|NCT04706507|559359181|FG001|Overall Study|Withdrawal of consent|1|||
154981880|NCT04706507|559359180|FG000|Overall Study|Patient or LAR refuses further participation|0|||
154981881|NCT04706507|559359181|FG001|Overall Study|Patient or LAR refuses further participation|3|||
154981882|NCT00351351|559359187|FG000|Overall Study|surgical access pbs; device issues|9|||
154981883|NCT00351351|559359188|FG001|Overall Study|surgical access pbs; device issues|4|||
154981884|NCT03891329|559359190|FG000|Overall Study|Death|5|||
154981885|NCT03891329|559359190|FG000|Overall Study|Lost to Follow-up|4|||
154981886|NCT03891329|559359190|FG000|Overall Study|Physician Decision|4|||
154981887|NCT03891329|559359190|FG000|Overall Study|Device explanted|3|||
154981888|NCT03891329|559359190|FG000|Overall Study|No study device implanted|3|||
154981889|NCT03176784|559359191|FG000|Overall Study|Lost to Follow-up|77|||
154981890|NCT03176784|559359192|FG001|Overall Study|Lost to Follow-up|79|||
154981891|NCT03176784|559359193|FG002|Overall Study|Lost to Follow-up|79|||
154981892|NCT03176784|559359194|FG003|Overall Study|Lost to Follow-up|49|||
154981893|NCT03176784|559359191|FG000|Overall Study|Withdrawal by Subject|28|||
154981894|NCT03176784|559359192|FG001|Overall Study|Withdrawal by Subject|34|||
154981895|NCT03176784|559359193|FG002|Overall Study|Withdrawal by Subject|34|||
154981896|NCT03176784|559359194|FG003|Overall Study|Withdrawal by Subject|21|||
154981897|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
154981898|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
154981899|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
154981900|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
155115728|NCT01330628|559853202|FG000|Overall Study|Death|2|||
154981901|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
154981902|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
154981903|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
154981904|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
154981905|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
154981906|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
155115729|NCT01330628|559853203|FG001|Overall Study|Death|3|||
154904307|NCT02290340|559069830|FG000|Overall Study|Other|1|||
154904308|NCT02290340|559069831|FG001|Overall Study|Other|0|||
154904309|NCT02290340|559069832|FG002|Overall Study|Other|0|||
154904310|NCT02290340|559069833|FG003|Overall Study|Other|1|||
154904311|NCT04964557|559069836|FG000|Overall Study|Withdrawal by Subject|3|||
154904312|NCT04964557|559069837|FG001|Overall Study|Withdrawal by Subject|2|||
154904313|NCT04964557|559069836|FG000|Overall Study|Lost to Follow-up|1|||
154904314|NCT04964557|559069837|FG001|Overall Study|Lost to Follow-up|2|||
154904315|NCT04964557|559069836|FG000|Overall Study|Physician Decision|2|||
154904316|NCT04964557|559069837|FG001|Overall Study|Physician Decision|0|||
154904317|NCT04964557|559069836|FG000|Overall Study|Death|3|||
154904318|NCT04964557|559069837|FG001|Overall Study|Death|0|||
154904319|NCT04964557|559069836|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
154904320|NCT04964557|559069837|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
154904321|NCT03209362|559069839|FG000|Overall Study|Adverse Event|0|||
154904322|NCT03209362|559069840|FG001|Overall Study|Adverse Event|1|||
154904323|NCT03209362|559069839|FG000|Overall Study|Lost to Follow-up|0|||
154904324|NCT03209362|559069840|FG001|Overall Study|Lost to Follow-up|1|||
154904325|NCT03209362|559069839|FG000|Overall Study|Withdrawal by Subject|2|||
154904326|NCT03209362|559069840|FG001|Overall Study|Withdrawal by Subject|0|||
154904327|NCT03209362|559069839|FG000|Overall Study|Other|0|||
154904328|NCT03209362|559069840|FG001|Overall Study|Other|1|||
154904329|NCT00251589|559069841|FG000|Overall Study|Adverse Event|5|||
154904330|NCT00251589|559069842|FG001|Overall Study|Adverse Event|1|||
154904331|NCT00251589|559069843|FG002|Overall Study|Adverse Event|2|||
154904332|NCT00251589|559069844|FG003|Overall Study|Adverse Event|1|||
154904333|NCT00251589|559069841|FG000|Overall Study|Withdrawal by Subject|1|||
154904334|NCT00251589|559069842|FG001|Overall Study|Withdrawal by Subject|1|||
154904335|NCT00251589|559069843|FG002|Overall Study|Withdrawal by Subject|0|||
154904336|NCT00251589|559069844|FG003|Overall Study|Withdrawal by Subject|0|||
154904337|NCT00251589|559069841|FG000|Overall Study|Discontinued due to progressive disease|9|||
154904338|NCT00251589|559069842|FG001|Overall Study|Discontinued due to progressive disease|1|||
154904339|NCT00251589|559069843|FG002|Overall Study|Discontinued due to progressive disease|0|||
154904340|NCT00251589|559069844|FG003|Overall Study|Discontinued due to progressive disease|1|||
154904341|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Adverse Event|22|||
154904342|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Adverse Event|0|||
154904343|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
154904344|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
154904345|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
154904346|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
154904347|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
154904348|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
154904349|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
154904350|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
154904351|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
154904352|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
154904353|NCT02493868|559069847|FG000|Induction Phase: DE Participants|Other|8|||
154904354|NCT02493868|559069848|FG001|Induction Phase: DE Participants|Other|0|||
154904355|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
154904356|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
154904357|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
154904358|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
154904359|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
154904360|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
154904361|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
154904362|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
154904363|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
154904364|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
154904365|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
154904366|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
154904367|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
154904368|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
154904369|NCT02493868|559069847|FG000|Optimization Phase: DE+TE Participants|Other|10|||
154904370|NCT02493868|559069848|FG001|Optimization Phase: DE+TE Participants|Other|2|||
154904371|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
154904372|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
154904373|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
154904374|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
154904375|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
154981907|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
154981908|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
154981909|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
154981910|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
154981911|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
154981912|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
154981913|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
154981914|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
154981915|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
154981916|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
154981917|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
154981918|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
154981919|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
154981920|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
154981921|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
154981922|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
154981923|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
154981924|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
154981925|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Death|0|||
154981926|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Death|1|||
154981927|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Death|0|||
154981928|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Death|0|||
154981929|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
154981930|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
154981931|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
154981932|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
154981933|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
154981934|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
154981935|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
154981936|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
154981937|NCT02990806|559359195|FG000|Stage 1 (22 Weeks)|Other|1|||
154981938|NCT02990806|559359196|FG001|Stage 1 (22 Weeks)|Other|3|||
154981939|NCT02990806|559359197|FG002|Stage 1 (22 Weeks)|Other|0|||
154981940|NCT02990806|559359198|FG003|Stage 1 (22 Weeks)|Other|0|||
154981941|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
154981942|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
154981943|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
154981944|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
154981945|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Death|1|||
154981946|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Death|0|||
154981947|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Death|0|||
154981948|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Death|0|||
154981949|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
154981950|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
154981951|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
154981952|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
154981953|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
154981954|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
154981955|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
154981956|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
154981957|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
154981958|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
154981959|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
154981960|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
154981961|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
154981962|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
154981963|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
154981964|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
154981965|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
154981966|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
154981967|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
154981968|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
154981969|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
154981970|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
154981971|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
154981972|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
154981973|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
154981974|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
154981975|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
154981976|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
154981977|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
155115730|NCT01330628|559853202|FG000|Overall Study|Lost to Follow-up|5|||
155115731|NCT01330628|559853203|FG001|Overall Study|Lost to Follow-up|6|||
155115732|NCT01330628|559853202|FG000|Overall Study|Adverse Event|44|||
155115733|NCT01330628|559853203|FG001|Overall Study|Adverse Event|25|||
155115734|NCT01330628|559853202|FG000|Overall Study|Withdrawn|18|||
154904376|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
154904377|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
154904378|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
154904379|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
154904380|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
154904381|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
154904382|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
154904383|NCT02493868|559069847|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
154904384|NCT02493868|559069848|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
154904385|NCT02493868|559069847|FG000|Follow-up Phase|Lost to Follow-up|1|||
154904386|NCT02493868|559069848|FG001|Follow-up Phase|Lost to Follow-up|0|||
154904387|NCT02493868|559069847|FG000|Follow-up Phase|Withdrawal by Subject|3|||
154904388|NCT02493868|559069848|FG001|Follow-up Phase|Withdrawal by Subject|0|||
154904389|NCT02493868|559069847|FG000|Follow-up Phase|Investigator Decision|5|||
154904390|NCT02493868|559069848|FG001|Follow-up Phase|Investigator Decision|1|||
154904391|NCT02493868|559069847|FG000|Follow-up Phase|Other|2|||
154904392|NCT02493868|559069848|FG001|Follow-up Phase|Other|1|||
154904393|NCT02407236|559069849|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
154904394|NCT02407236|559069850|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
154904395|NCT02407236|559069851|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
154904396|NCT02407236|559069852|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
154904397|NCT02407236|559069853|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
154904398|NCT02407236|559069854|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
154904399|NCT02407236|559069855|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
154904400|NCT02407236|559069856|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
154904401|NCT02407236|559069857|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
154904402|NCT02407236|559069858|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
154904403|NCT02407236|559069859|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
154904404|NCT02407236|559069860|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
154904405|NCT02407236|559069861|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
154904406|NCT02407236|559069849|FG000|Induction Study (8 Weeks)|Death|0|||
154904407|NCT02407236|559069850|FG001|Induction Study (8 Weeks)|Death|0|||
154904408|NCT02407236|559069851|FG002|Induction Study (8 Weeks)|Death|1|||
154904409|NCT02407236|559069852|FG003|Induction Study (8 Weeks)|Death|0|||
154904410|NCT02407236|559069853|FG004|Induction Study (8 Weeks)|Death|0|||
154904411|NCT02407236|559069854|FG005|Induction Study (8 Weeks)|Death|0|||
154904412|NCT02407236|559069855|FG006|Induction Study (8 Weeks)|Death|0|||
154904413|NCT02407236|559069856|FG007|Induction Study (8 Weeks)|Death|0|||
154904414|NCT02407236|559069857|FG008|Induction Study (8 Weeks)|Death|0|||
154904415|NCT02407236|559069858|FG009|Induction Study (8 Weeks)|Death|0|||
154904416|NCT02407236|559069859|FG010|Induction Study (8 Weeks)|Death|0|||
154904417|NCT02407236|559069860|FG011|Induction Study (8 Weeks)|Death|0|||
154904418|NCT02407236|559069861|FG012|Induction Study (8 Weeks)|Death|0|||
154904419|NCT02407236|559069849|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
154904420|NCT02407236|559069850|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
154904421|NCT02407236|559069851|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
154904422|NCT02407236|559069852|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904423|NCT02407236|559069853|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904424|NCT02407236|559069854|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904425|NCT02407236|559069855|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904426|NCT02407236|559069856|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904427|NCT02407236|559069857|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904428|NCT02407236|559069858|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904429|NCT02407236|559069859|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904430|NCT02407236|559069860|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904431|NCT02407236|559069861|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
154904432|NCT02407236|559069849|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155115735|NCT01330628|559853203|FG001|Overall Study|Withdrawn|6|||
154904433|NCT02407236|559069850|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904434|NCT02407236|559069851|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
154904435|NCT02407236|559069852|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904436|NCT02407236|559069853|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904437|NCT02407236|559069854|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904438|NCT02407236|559069855|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904439|NCT02407236|559069856|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904440|NCT02407236|559069857|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904441|NCT02407236|559069858|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904442|NCT02407236|559069859|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
155115736|NCT01330628|559853202|FG000|Overall Study|Didn't receive study treatment|1|||
155115737|NCT01330628|559853203|FG001|Overall Study|Didn't receive study treatment|0|||
155115738|NCT02226198|559855066|FG000|Lead-in Phase|Protocol Violation|1|||
155115739|NCT02226198|559855067|FG001|Lead-in Phase|Protocol Violation|0|||
155115740|NCT02226198|559855068|FG002|Lead-in Phase|Protocol Violation|0|||
155115741|NCT02226198|559855066|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
155115742|NCT02226198|559855067|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
155115743|NCT02226198|559855068|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
155175949|NCT02353143|560082182|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
155175950|NCT02353143|560082183|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
154904443|NCT02407236|559069860|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904444|NCT02407236|559069861|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
154904445|NCT02407236|559069849|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
154904446|NCT02407236|559069850|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
154904447|NCT02407236|559069851|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
154904448|NCT02407236|559069852|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
154904449|NCT02407236|559069853|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
154904450|NCT02407236|559069854|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
154904451|NCT02407236|559069855|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
154904452|NCT02407236|559069856|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
154904453|NCT02407236|559069857|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
154904454|NCT02407236|559069858|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
154904455|NCT02407236|559069859|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
154904456|NCT02407236|559069860|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
154904457|NCT02407236|559069861|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
154904458|NCT02407236|559069849|FG000|Induction Study (8 Weeks)|Other|2|||
154904459|NCT02407236|559069850|FG001|Induction Study (8 Weeks)|Other|1|||
154904460|NCT02407236|559069851|FG002|Induction Study (8 Weeks)|Other|5|||
154904461|NCT02407236|559069852|FG003|Induction Study (8 Weeks)|Other|0|||
154904462|NCT02407236|559069853|FG004|Induction Study (8 Weeks)|Other|0|||
154904463|NCT02407236|559069854|FG005|Induction Study (8 Weeks)|Other|0|||
154904464|NCT02407236|559069855|FG006|Induction Study (8 Weeks)|Other|0|||
154904465|NCT02407236|559069856|FG007|Induction Study (8 Weeks)|Other|0|||
154904466|NCT02407236|559069857|FG008|Induction Study (8 Weeks)|Other|0|||
154904467|NCT02407236|559069858|FG009|Induction Study (8 Weeks)|Other|0|||
154904468|NCT02407236|559069859|FG010|Induction Study (8 Weeks)|Other|0|||
154904469|NCT02407236|559069860|FG011|Induction Study (8 Weeks)|Other|0|||
154904470|NCT02407236|559069861|FG012|Induction Study (8 Weeks)|Other|0|||
154904471|NCT02407236|559069849|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904472|NCT02407236|559069850|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904473|NCT02407236|559069851|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904474|NCT02407236|559069852|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
154904475|NCT02407236|559069853|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
154904476|NCT02407236|559069854|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
154904477|NCT02407236|559069855|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
154904478|NCT02407236|559069856|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
154904479|NCT02407236|559069857|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904480|NCT02407236|559069858|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904481|NCT02407236|559069859|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904482|NCT02407236|559069860|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904483|NCT02407236|559069861|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
154904484|NCT02407236|559069849|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904485|NCT02407236|559069850|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904486|NCT02407236|559069851|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904487|NCT02407236|559069852|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
154904488|NCT02407236|559069853|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
154904489|NCT02407236|559069854|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
154904490|NCT02407236|559069855|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
154904491|NCT02407236|559069856|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
154904492|NCT02407236|559069857|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904493|NCT02407236|559069858|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904494|NCT02407236|559069859|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904495|NCT02407236|559069860|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904496|NCT02407236|559069861|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
154904497|NCT02407236|559069849|FG000|Maintenance Study (44 Weeks)|Other|0|||
154904498|NCT02407236|559069850|FG001|Maintenance Study (44 Weeks)|Other|0|||
154904499|NCT02407236|559069851|FG002|Maintenance Study (44 Weeks)|Other|0|||
154904500|NCT02407236|559069852|FG003|Maintenance Study (44 Weeks)|Other|5|||
154904501|NCT02407236|559069853|FG004|Maintenance Study (44 Weeks)|Other|7|||
154904502|NCT02407236|559069854|FG005|Maintenance Study (44 Weeks)|Other|8|||
154904503|NCT02407236|559069855|FG006|Maintenance Study (44 Weeks)|Other|4|||
155115744|NCT01440517|559855072|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
155115745|NCT01288612|559855073|FG000|Overall Study|Unable to contact|11|||
154981978|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
154981979|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
154981980|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
154981981|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
154981982|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
154981983|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
154981984|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
154981985|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Other|3|||
154981986|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Other|0|||
154981987|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Other|4|||
154981988|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Other|1|||
154981989|NCT02990806|559359195|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
154981990|NCT02990806|559359196|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
155115746|NCT01288612|559855074|FG001|Overall Study|Unable to contact|16|||
155115747|NCT01288612|559855075|FG002|Overall Study|Unable to contact|20|||
155115748|NCT01288612|559855073|FG000|Overall Study|Declined|78|||
155115749|NCT01288612|559855074|FG001|Overall Study|Declined|63|||
155115750|NCT01288612|559855075|FG002|Overall Study|Declined|62|||
155115751|NCT01288612|559855073|FG000|Overall Study|Unable to intubate|0|||
154981991|NCT02990806|559359197|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
154981992|NCT02990806|559359198|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
154981993|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
154981994|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
154981995|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
154981996|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
154981997|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
154981998|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
154981999|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
154982000|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
154982001|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
154982002|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
154982003|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
154982004|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
154982005|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
154982006|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
154982007|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
154982008|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
154982009|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
154982010|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
154982011|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
154982012|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
154982013|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
154982014|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
154982015|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
154982016|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
154982017|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
154982018|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
154982019|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
154982020|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
154982021|NCT02990806|559359195|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
154982022|NCT02990806|559359196|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
154982023|NCT02990806|559359197|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
154982024|NCT02990806|559359198|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
154982025|NCT02654587|559359199|FG000|Overall Study|patient alive at end of study|22|||
154982026|NCT02654587|559359200|FG001|Overall Study|patient alive at end of study|8|||
154982027|NCT02654587|559359199|FG000|Overall Study|Withdrawal by Subject|1|||
154982028|NCT02654587|559359200|FG001|Overall Study|Withdrawal by Subject|7|||
154982029|NCT01825837|559359201|FG000|PART I|Withdrawal by Subject|0|||
154982030|NCT01825837|559359202|FG001|PART I|Withdrawal by Subject|0|||
154982031|NCT01825837|559359203|FG002|PART I|Withdrawal by Subject|0|||
154982032|NCT01825837|559359204|FG003|PART I|Withdrawal by Subject|6|||
154982033|NCT01825837|559359201|FG000|PART I|Patient non-compliance|0|||
154982034|NCT01825837|559359202|FG001|PART I|Patient non-compliance|0|||
155115752|NCT01288612|559855074|FG001|Overall Study|Unable to intubate|3|||
155115753|NCT01288612|559855075|FG002|Overall Study|Unable to intubate|0|||
155115754|NCT00871923|559855076|FG000|Overall Study|Death|1|||
155115755|NCT00871923|559855076|FG000|Overall Study|Withdrawal by Subject|1|||
155115756|NCT01263015|559855081|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
155115757|NCT01263015|559855082|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
154982035|NCT01825837|559359203|FG002|PART I|Patient non-compliance|0|||
154982036|NCT01825837|559359204|FG003|PART I|Patient non-compliance|1|||
154982037|NCT01825837|559359201|FG000|PART I|Treatment failure|0|||
154982038|NCT01825837|559359202|FG001|PART I|Treatment failure|0|||
154982039|NCT01825837|559359203|FG002|PART I|Treatment failure|0|||
154982040|NCT01825837|559359204|FG003|PART I|Treatment failure|7|||
154982041|NCT01825837|559359201|FG000|PART I|reason unspecified|0|||
154982042|NCT01825837|559359202|FG001|PART I|reason unspecified|0|||
154982043|NCT01825837|559359203|FG002|PART I|reason unspecified|0|||
154982044|NCT01825837|559359204|FG003|PART I|reason unspecified|3|||
154982045|NCT01825837|559359201|FG000|PART II|Withdrawal by Subject|3|||
154982046|NCT01825837|559359202|FG001|PART II|Withdrawal by Subject|3|||
154982047|NCT01825837|559359203|FG002|PART II|Withdrawal by Subject|7|||
154982048|NCT01825837|559359204|FG003|PART II|Withdrawal by Subject|0|||
155115758|NCT01263015|559855081|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
155115759|NCT01263015|559855082|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
155115760|NCT01263015|559855081|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
155115761|NCT01263015|559855082|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
155115762|NCT01263015|559855081|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
155115763|NCT01263015|559855082|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
155115764|NCT01263015|559855081|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
154982049|NCT01825837|559359201|FG000|PART II|Patient non-compliance|5|||
154982050|NCT01825837|559359202|FG001|PART II|Patient non-compliance|2|||
154982051|NCT01825837|559359203|FG002|PART II|Patient non-compliance|4|||
154982052|NCT01825837|559359204|FG003|PART II|Patient non-compliance|0|||
154982053|NCT01825837|559359201|FG000|PART II|Adverse Event|3|||
154982054|NCT01825837|559359202|FG001|PART II|Adverse Event|3|||
154982055|NCT01825837|559359203|FG002|PART II|Adverse Event|1|||
154982056|NCT01825837|559359204|FG003|PART II|Adverse Event|0|||
154982057|NCT01825837|559359201|FG000|PART II|Treatment failure|6|||
154982058|NCT01825837|559359202|FG001|PART II|Treatment failure|4|||
154982059|NCT01825837|559359203|FG002|PART II|Treatment failure|5|||
154982060|NCT01825837|559359204|FG003|PART II|Treatment failure|0|||
154982061|NCT01825837|559359201|FG000|PART II|reason unspecified|2|||
154982062|NCT01825837|559359202|FG001|PART II|reason unspecified|2|||
154982063|NCT01825837|559359203|FG002|PART II|reason unspecified|2|||
154982064|NCT01825837|559359204|FG003|PART II|reason unspecified|0|||
154982065|NCT00904748|559359207|FG000|Overall Study|Withdrawal by Subject|1|||
154982066|NCT00904748|559359208|FG001|Overall Study|Withdrawal by Subject|1|||
154982067|NCT00904748|559359209|FG002|Overall Study|Withdrawal by Subject|1|||
154982068|NCT00904748|559359210|FG003|Overall Study|Withdrawal by Subject|2|||
154982069|NCT00904748|559359211|FG004|Overall Study|Withdrawal by Subject|0|||
154982070|NCT00904748|559359212|FG005|Overall Study|Withdrawal by Subject|0|||
154982071|NCT00904748|559359207|FG000|Overall Study|Adverse Event|0|||
154982072|NCT00904748|559359208|FG001|Overall Study|Adverse Event|0|||
154982073|NCT00904748|559359209|FG002|Overall Study|Adverse Event|0|||
154982074|NCT00904748|559359210|FG003|Overall Study|Adverse Event|0|||
154982075|NCT00904748|559359211|FG004|Overall Study|Adverse Event|1|||
154982076|NCT00904748|559359212|FG005|Overall Study|Adverse Event|0|||
154982077|NCT01682148|559359213|FG000|Overall Study|Withdrawal by Subject|2|||
154982078|NCT01682148|559359214|FG001|Overall Study|Withdrawal by Subject|0|||
154982079|NCT01682148|559359213|FG000|Overall Study|Lost to Follow-up|1|||
154982080|NCT01682148|559359214|FG001|Overall Study|Lost to Follow-up|2|||
154982081|NCT01682148|559359213|FG000|Overall Study|Protocol Violation|1|||
154982082|NCT01682148|559359214|FG001|Overall Study|Protocol Violation|1|||
154982083|NCT01803269|559359215|FG000|Overall Study|Withdrawal by Subject|3|||
154982084|NCT01803269|559359216|FG001|Overall Study|Withdrawal by Subject|0|||
154982085|NCT01803269|559359217|FG002|Overall Study|Withdrawal by Subject|0|||
154982086|NCT01202877|559359218|FG000|Overall Study|Disease Progression|0|||
154982087|NCT01202877|559359219|FG001|Overall Study|Disease Progression|1|||
154982088|NCT01202877|559359220|FG002|Overall Study|Disease Progression|2|||
154982089|NCT01202877|559359218|FG000|Overall Study|Adverse Event|0|||
154982090|NCT01202877|559359219|FG001|Overall Study|Adverse Event|0|||
155115765|NCT01263015|559855082|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
155115766|NCT01263015|559855081|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
155115767|NCT01263015|559855082|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
155175951|NCT02353143|560082184|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
154982091|NCT01202877|559359220|FG002|Overall Study|Adverse Event|2|||
154982092|NCT01202877|559359218|FG000|Overall Study|Withdrawal by Subject|0|||
154982093|NCT01202877|559359219|FG001|Overall Study|Withdrawal by Subject|0|||
154982094|NCT01202877|559359220|FG002|Overall Study|Withdrawal by Subject|1|||
154982095|NCT01202877|559359218|FG000|Overall Study|Death|0|||
154982096|NCT01202877|559359219|FG001|Overall Study|Death|0|||
154982097|NCT01202877|559359220|FG002|Overall Study|Death|1|||
154982098|NCT04403763|559359221|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
154982099|NCT04403763|559359222|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
154982100|NCT04403763|559359223|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
154982101|NCT04403763|559359224|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
154904504|NCT02407236|559069856|FG007|Maintenance Study (44 Weeks)|Other|6|||
154904505|NCT02407236|559069857|FG008|Maintenance Study (44 Weeks)|Other|0|||
154904506|NCT02407236|559069858|FG009|Maintenance Study (44 Weeks)|Other|0|||
154904507|NCT02407236|559069859|FG010|Maintenance Study (44 Weeks)|Other|0|||
154904508|NCT02407236|559069860|FG011|Maintenance Study (44 Weeks)|Other|0|||
154904509|NCT02407236|559069861|FG012|Maintenance Study (44 Weeks)|Other|0|||
154904510|NCT02407236|559069849|FG000|Maintenance Study (44 Weeks)|Death|0|||
154904511|NCT02407236|559069850|FG001|Maintenance Study (44 Weeks)|Death|0|||
154904512|NCT02407236|559069851|FG002|Maintenance Study (44 Weeks)|Death|0|||
154904513|NCT02407236|559069852|FG003|Maintenance Study (44 Weeks)|Death|0|||
154904514|NCT02407236|559069853|FG004|Maintenance Study (44 Weeks)|Death|0|||
154904515|NCT02407236|559069854|FG005|Maintenance Study (44 Weeks)|Death|0|||
154904516|NCT02407236|559069855|FG006|Maintenance Study (44 Weeks)|Death|0|||
154904517|NCT02407236|559069856|FG007|Maintenance Study (44 Weeks)|Death|1|||
154904518|NCT02407236|559069857|FG008|Maintenance Study (44 Weeks)|Death|0|||
154904519|NCT02407236|559069858|FG009|Maintenance Study (44 Weeks)|Death|0|||
154904520|NCT02407236|559069859|FG010|Maintenance Study (44 Weeks)|Death|0|||
154904521|NCT02407236|559069860|FG011|Maintenance Study (44 Weeks)|Death|0|||
154904522|NCT02407236|559069861|FG012|Maintenance Study (44 Weeks)|Death|0|||
154904523|NCT02407236|559069849|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904524|NCT02407236|559069850|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904525|NCT02407236|559069851|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904526|NCT02407236|559069852|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904527|NCT02407236|559069853|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904528|NCT02407236|559069854|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904529|NCT02407236|559069855|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904530|NCT02407236|559069856|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
154904531|NCT02407236|559069857|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
154904532|NCT02407236|559069858|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
154904533|NCT02407236|559069859|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
154904534|NCT02407236|559069860|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
154904535|NCT02407236|559069861|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
154904536|NCT02407236|559069849|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904537|NCT02407236|559069850|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904538|NCT02407236|559069851|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904539|NCT02407236|559069852|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904540|NCT02407236|559069853|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904541|NCT02407236|559069854|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904542|NCT02407236|559069855|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904543|NCT02407236|559069856|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904544|NCT02407236|559069857|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904545|NCT02407236|559069858|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904546|NCT02407236|559069859|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
154904547|NCT02407236|559069860|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904548|NCT02407236|559069861|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
154904549|NCT02407236|559069849|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904550|NCT02407236|559069850|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904551|NCT02407236|559069851|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904552|NCT02407236|559069852|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904553|NCT02407236|559069853|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904554|NCT02407236|559069854|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904555|NCT02407236|559069855|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904556|NCT02407236|559069856|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
154904557|NCT02407236|559069857|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
154904558|NCT02407236|559069858|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
154904559|NCT02407236|559069859|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
154904560|NCT02407236|559069860|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
154904561|NCT02407236|559069861|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
154904562|NCT02407236|559069849|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
154904563|NCT02407236|559069850|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
154904564|NCT02407236|559069851|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
154904565|NCT02407236|559069852|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
154904566|NCT02407236|559069853|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
154904567|NCT02407236|559069854|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
154904568|NCT02407236|559069855|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
154904569|NCT02407236|559069856|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
154904570|NCT02407236|559069857|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
154904571|NCT02407236|559069858|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
154904572|NCT02407236|559069859|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
154982102|NCT04403763|559359225|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
154982103|NCT04403763|559359226|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
154982104|NCT04403763|559359227|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
154982105|NCT04403763|559359221|FG000|Stage 1|Early termination due to PK tube failure|0|||
154982106|NCT04403763|559359222|FG001|Stage 1|Early termination due to PK tube failure|0|||
154982107|NCT04403763|559359223|FG002|Stage 1|Early termination due to PK tube failure|1|||
154982108|NCT04403763|559359224|FG003|Stage 1|Early termination due to PK tube failure|0|||
154982109|NCT04403763|559359225|FG004|Stage 1|Early termination due to PK tube failure|0|||
154982110|NCT04403763|559359226|FG005|Stage 1|Early termination due to PK tube failure|0|||
154982111|NCT04403763|559359227|FG006|Stage 1|Early termination due to PK tube failure|0|||
154982112|NCT04403763|559359221|FG000|Stage 2A|Adverse Event|0|||
154982113|NCT04403763|559359222|FG001|Stage 2A|Adverse Event|0|||
154982114|NCT04403763|559359223|FG002|Stage 2A|Adverse Event|0|||
154982115|NCT04403763|559359224|FG003|Stage 2A|Adverse Event|0|||
154982116|NCT04403763|559359225|FG004|Stage 2A|Adverse Event|0|||
154982117|NCT04403763|559359226|FG005|Stage 2A|Adverse Event|0|||
154982118|NCT04403763|559359227|FG006|Stage 2A|Adverse Event|1|||
154982119|NCT01376310|559359228|FG000|Overall Study|Study closed/terminated|1|||
154982120|NCT01376310|559359229|FG001|Overall Study|Study closed/terminated|2|||
154982121|NCT01376310|559359228|FG000|Overall Study|Withdrawal by Subject|8|||
154982122|NCT01376310|559359229|FG001|Overall Study|Withdrawal by Subject|2|||
154982123|NCT01376310|559359228|FG000|Overall Study|Physician Decision|26|||
154982124|NCT01376310|559359229|FG001|Overall Study|Physician Decision|7|||
154982125|NCT01376310|559359228|FG000|Overall Study|Lost to Follow-up|1|||
154982126|NCT01376310|559359229|FG001|Overall Study|Lost to Follow-up|0|||
154982127|NCT02339740|559359232|FG000|Overall Study|Death|1|||
154982128|NCT02339740|559359233|FG001|Overall Study|Death|0|||
154982129|NCT02339740|559359232|FG000|Overall Study|Physician Decision|0|||
154982130|NCT02339740|559359233|FG001|Overall Study|Physician Decision|2|||
154982131|NCT02339740|559359232|FG000|Overall Study|Withdrawal by Subject|5|||
154982132|NCT02339740|559359233|FG001|Overall Study|Withdrawal by Subject|1|||
154982133|NCT02339740|559359232|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
154982134|NCT02339740|559359233|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
154982135|NCT01807117|559359234|FG000|Overall Study|Physician Decision|2|||
154982136|NCT01807117|559359234|FG000|Overall Study|Disease diagnosis not a study disease|1|||
154982137|NCT01534637|559359235|FG000|Overall Study|Physician Decision|3|||
154982138|NCT01534637|559359235|FG000|Overall Study|Lack of Efficacy|3|||
154982139|NCT01534637|559359235|FG000|Overall Study|Withdrawal by Subject|1|||
154982140|NCT01534637|559359235|FG000|Overall Study|Adverse Event|1|||
154982141|NCT01534637|559359235|FG000|Overall Study|Liver Mets before treatment|1|||
154982142|NCT02709486|559359238|FG000|Overall Study|Adverse Event|2|||
154982143|NCT02709486|559359239|FG001|Overall Study|Adverse Event|5|||
154982144|NCT02709486|559359240|FG002|Overall Study|Adverse Event|3|||
154982145|NCT02709486|559359238|FG000|Overall Study|Death|0|||
154982146|NCT02709486|559359239|FG001|Overall Study|Death|0|||
154982147|NCT02709486|559359240|FG002|Overall Study|Death|2|||
154982148|NCT02709486|559359238|FG000|Overall Study|Insufficient clinical response|7|||
154982149|NCT02709486|559359239|FG001|Overall Study|Insufficient clinical response|3|||
154982150|NCT02709486|559359240|FG002|Overall Study|Insufficient clinical response|3|||
154982151|NCT02709486|559359238|FG000|Overall Study|Lost to Follow-up|3|||
154982152|NCT02709486|559359239|FG001|Overall Study|Lost to Follow-up|2|||
154982153|NCT02709486|559359240|FG002|Overall Study|Lost to Follow-up|2|||
154982154|NCT02709486|559359238|FG000|Overall Study|Other|0|||
154982155|NCT02709486|559359239|FG001|Overall Study|Other|2|||
154982156|NCT02709486|559359240|FG002|Overall Study|Other|3|||
154982157|NCT02709486|559359238|FG000|Overall Study|Withdrawal by Subject|32|||
154982158|NCT02709486|559359239|FG001|Overall Study|Withdrawal by Subject|22|||
154982159|NCT02709486|559359240|FG002|Overall Study|Withdrawal by Subject|32|||
154982160|NCT00606502|559359243|FG000|Randomization|Randomized but not treated|3|||
154982161|NCT00606502|559359244|FG001|Randomization|Randomized but not treated|0|||
154982162|NCT00606502|559359243|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
154982163|NCT00606502|559359244|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
155175952|NCT02353143|560082185|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
154982164|NCT02443545|559359249|FG000|Overall Study|Adverse Event|1|||
154982165|NCT02443545|559359250|FG001|Overall Study|Adverse Event|1|||
154982166|NCT02443545|559359249|FG000|Overall Study|Lost to Follow-up|0|||
154982167|NCT02443545|559359250|FG001|Overall Study|Lost to Follow-up|2|||
154982168|NCT02443545|559359249|FG000|Overall Study|Physician Decision|3|||
154982169|NCT02443545|559359250|FG001|Overall Study|Physician Decision|0|||
154982170|NCT02443545|559359249|FG000|Overall Study|Protocol Violation|8|||
154982171|NCT02443545|559359250|FG001|Overall Study|Protocol Violation|1|||
154982172|NCT02443545|559359249|FG000|Overall Study|Pregnancy|1|||
154982173|NCT02443545|559359250|FG001|Overall Study|Pregnancy|1|||
154982174|NCT02443545|559359249|FG000|Overall Study|Withdrawal by Subject|6|||
154982175|NCT02443545|559359250|FG001|Overall Study|Withdrawal by Subject|3|||
154982176|NCT02443545|559359249|FG000|Overall Study|Termination of study|20|||
154982177|NCT02443545|559359250|FG001|Overall Study|Termination of study|11|||
155175953|NCT04905498|560082191|FG000|Overall Study|Lost to Follow-up|0|||
154982178|NCT00706355|559359251|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
154982179|NCT00706355|559359252|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
154982180|NCT00706355|559359253|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
154982181|NCT00706355|559359254|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
154982182|NCT00706355|559359251|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
154982183|NCT00706355|559359252|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
154982184|NCT00706355|559359253|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
154982185|NCT00706355|559359254|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
154982186|NCT00706355|559359251|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
154982187|NCT00706355|559359252|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
154982188|NCT00706355|559359253|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
154982189|NCT00706355|559359254|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
154982190|NCT00706355|559359251|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
154982191|NCT00706355|559359252|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
154982192|NCT00706355|559359253|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
154982193|NCT00706355|559359254|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
154982194|NCT00706355|559359251|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
154982195|NCT00706355|559359252|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
154982196|NCT00706355|559359253|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
154982197|NCT00706355|559359254|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
154982198|NCT00706355|559359251|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
154982199|NCT00706355|559359252|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
154982200|NCT00706355|559359253|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
154982201|NCT00706355|559359254|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
154982202|NCT00706355|559359251|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
154982203|NCT00706355|559359252|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
154982204|NCT00706355|559359253|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
154982205|NCT00706355|559359254|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
154982206|NCT00706355|559359251|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
154982207|NCT00706355|559359252|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
154982208|NCT00706355|559359253|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
154982209|NCT00706355|559359254|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
154982210|NCT00706355|559359251|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
154982211|NCT00706355|559359252|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
154982212|NCT00706355|559359253|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
154982213|NCT00706355|559359254|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
154982214|NCT04179019|559359257|FG000|Overall Study|Lost to Follow-up|2|||
154982215|NCT04179019|559359257|FG000|Overall Study|Physician Decision|2|||
154982216|NCT04179019|559359257|FG000|Overall Study|Withdrawal by Subject|5|||
154982217|NCT04179019|559359257|FG000|Overall Study|Adverse Event|4|||
154982218|NCT01855048|559359258|FG000|Overall Study|Withdrawal by Subject|0|||
154982219|NCT01855048|559359259|FG001|Overall Study|Withdrawal by Subject|1|||
154982220|NCT01855048|559359260|FG002|Overall Study|Withdrawal by Subject|0|||
154982221|NCT01855048|559359261|FG003|Overall Study|Withdrawal by Subject|0|||
154982222|NCT01855048|559359262|FG004|Overall Study|Withdrawal by Subject|1|||
154982223|NCT01855048|559359263|FG005|Overall Study|Withdrawal by Subject|0|||
154982224|NCT03465436|559359264|FG000|Period 1|Protocol Violation|0|||
154982225|NCT03465436|559359265|FG001|Period 1|Protocol Violation|0|||
154982226|NCT03465436|559359266|FG002|Period 1|Protocol Violation|1|||
154982227|NCT03465436|559359267|FG003|Period 1|Protocol Violation|0|||
154982228|NCT03465436|559359264|FG000|Period 2|Protocol Violation|0|||
154982229|NCT03465436|559359265|FG001|Period 2|Protocol Violation|1|||
154982230|NCT03465436|559359266|FG002|Period 2|Protocol Violation|0|||
154982231|NCT03465436|559359267|FG003|Period 2|Protocol Violation|0|||
154982232|NCT03465436|559359264|FG000|Period 3|Protocol Violation|1|||
154982233|NCT03465436|559359265|FG001|Period 3|Protocol Violation|1|||
154982234|NCT03465436|559359266|FG002|Period 3|Protocol Violation|0|||
154982235|NCT03465436|559359267|FG003|Period 3|Protocol Violation|0|||
154982236|NCT03465436|559359264|FG000|Period 4|Protocol Violation|0|||
154982237|NCT03465436|559359265|FG001|Period 4|Protocol Violation|0|||
154982238|NCT03465436|559359266|FG002|Period 4|Protocol Violation|1|||
154982239|NCT03465436|559359267|FG003|Period 4|Protocol Violation|0|||
154982240|NCT01813071|559359268|FG000|Overall Study|Protocol Violation|0|||
154982241|NCT01813071|559359269|FG001|Overall Study|Protocol Violation|0|||
154982242|NCT01813071|559359270|FG002|Overall Study|Protocol Violation|0|||
154982243|NCT01813071|559359271|FG003|Overall Study|Protocol Violation|0|||
154982244|NCT01813071|559359272|FG004|Overall Study|Protocol Violation|1|||
154982245|NCT01813071|559359273|FG005|Overall Study|Protocol Violation|4|||
154982246|NCT01813071|559359274|FG006|Overall Study|Protocol Violation|2|||
154982247|NCT01813071|559359275|FG007|Overall Study|Protocol Violation|4|||
154982248|NCT01813071|559359276|FG008|Overall Study|Protocol Violation|2|||
154982249|NCT01813071|559359268|FG000|Overall Study|Withdrawal by Subject|0|||
154982250|NCT01813071|559359269|FG001|Overall Study|Withdrawal by Subject|0|||
154982251|NCT01813071|559359270|FG002|Overall Study|Withdrawal by Subject|0|||
154982252|NCT01813071|559359271|FG003|Overall Study|Withdrawal by Subject|0|||
154982253|NCT01813071|559359272|FG004|Overall Study|Withdrawal by Subject|0|||
154982254|NCT01813071|559359273|FG005|Overall Study|Withdrawal by Subject|1|||
154982255|NCT01813071|559359274|FG006|Overall Study|Withdrawal by Subject|0|||
154982256|NCT01813071|559359275|FG007|Overall Study|Withdrawal by Subject|0|||
154982257|NCT01813071|559359276|FG008|Overall Study|Withdrawal by Subject|0|||
154982258|NCT01813071|559359268|FG000|Overall Study|Adverse Event|0|||
154982259|NCT01813071|559359269|FG001|Overall Study|Adverse Event|0|||
154982260|NCT01813071|559359270|FG002|Overall Study|Adverse Event|0|||
154982261|NCT01813071|559359271|FG003|Overall Study|Adverse Event|0|||
154982262|NCT01813071|559359272|FG004|Overall Study|Adverse Event|0|||
154982263|NCT01813071|559359273|FG005|Overall Study|Adverse Event|1|||
154982264|NCT01813071|559359274|FG006|Overall Study|Adverse Event|0|||
154982265|NCT01813071|559359275|FG007|Overall Study|Adverse Event|0|||
154982266|NCT01813071|559359276|FG008|Overall Study|Adverse Event|0|||
154982267|NCT01813071|559359268|FG000|Overall Study|Physician Decision|0|||
154982268|NCT01813071|559359269|FG001|Overall Study|Physician Decision|0|||
154982269|NCT01813071|559359270|FG002|Overall Study|Physician Decision|0|||
154982270|NCT01813071|559359271|FG003|Overall Study|Physician Decision|0|||
154982271|NCT01813071|559359272|FG004|Overall Study|Physician Decision|0|||
154982272|NCT01813071|559359273|FG005|Overall Study|Physician Decision|0|||
154982273|NCT01813071|559359274|FG006|Overall Study|Physician Decision|1|||
154982274|NCT01813071|559359275|FG007|Overall Study|Physician Decision|0|||
154982275|NCT01813071|559359276|FG008|Overall Study|Physician Decision|0|||
154982276|NCT01813071|559359268|FG000|Overall Study|Met inc/exc criteria|0|||
154982277|NCT01813071|559359269|FG001|Overall Study|Met inc/exc criteria|0|||
154982278|NCT01813071|559359270|FG002|Overall Study|Met inc/exc criteria|0|||
154982279|NCT01813071|559359271|FG003|Overall Study|Met inc/exc criteria|0|||
154982280|NCT01813071|559359272|FG004|Overall Study|Met inc/exc criteria|0|||
154982281|NCT01813071|559359273|FG005|Overall Study|Met inc/exc criteria|1|||
154982282|NCT01813071|559359274|FG006|Overall Study|Met inc/exc criteria|0|||
154982283|NCT01813071|559359275|FG007|Overall Study|Met inc/exc criteria|1|||
154982284|NCT01813071|559359276|FG008|Overall Study|Met inc/exc criteria|1|||
154982285|NCT05486065|559359277|FG000|Overall Study|Withdrawal by Subject|1|||
154982286|NCT05486065|559359278|FG001|Overall Study|Withdrawal by Subject|5|||
154982287|NCT05486065|559359279|FG002|Overall Study|Withdrawal by Subject|4|||
154982288|NCT05486065|559359280|FG003|Overall Study|Withdrawal by Subject|3|||
154982289|NCT05486065|559359277|FG000|Overall Study|Lost to Follow-up|4|||
154982290|NCT05486065|559359278|FG001|Overall Study|Lost to Follow-up|2|||
154982291|NCT05486065|559359279|FG002|Overall Study|Lost to Follow-up|2|||
154982292|NCT05486065|559359280|FG003|Overall Study|Lost to Follow-up|2|||
154982293|NCT05486065|559359277|FG000|Overall Study|Physician Decision|0|||
154982294|NCT05486065|559359278|FG001|Overall Study|Physician Decision|1|||
154982295|NCT05486065|559359279|FG002|Overall Study|Physician Decision|1|||
154982296|NCT05486065|559359280|FG003|Overall Study|Physician Decision|0|||
154982297|NCT05486065|559359277|FG000|Overall Study|Failure to meet randomization criteria|0|||
154982298|NCT05486065|559359278|FG001|Overall Study|Failure to meet randomization criteria|0|||
154982299|NCT05486065|559359279|FG002|Overall Study|Failure to meet randomization criteria|0|||
154982300|NCT05486065|559359280|FG003|Overall Study|Failure to meet randomization criteria|1|||
154982301|NCT01425528|559359281|FG000|Overall Study|Withdrawal by Subject|1|||
154982302|NCT01425528|559359282|FG001|Overall Study|Withdrawal by Subject|1|||
154982303|NCT00307931|559359283|FG000|Overall Study|Adverse Event|1|||
154982304|NCT00613834|559359286|FG000|Overall Study|Withdrawal by Subject|0|||
154982305|NCT00613834|559359287|FG001|Overall Study|Withdrawal by Subject|3|||
154982306|NCT02658487|559360549|FG000|Overall Study|Death|2|||
154982307|NCT02658487|559360549|FG000|Overall Study|Disease progression|10|||
154982308|NCT02658487|559360549|FG000|Overall Study|Alternative therapy|1|||
154982309|NCT02658487|559360549|FG000|Overall Study|Adverse Event|1|||
154982310|NCT02658487|559360549|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
154982311|NCT02658487|559360549|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
154982312|NCT02516410|559360561|FG000|Overall Study|Adverse Event|0|||
155115768|NCT01263015|559855081|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
155115769|NCT01263015|559855082|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
155115770|NCT01263015|559855081|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
155115771|NCT01263015|559855082|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
154982313|NCT02516410|559360562|FG001|Overall Study|Adverse Event|1|||
154982314|NCT02516410|559360561|FG000|Overall Study|Withdrawal by Subject|0|||
154982315|NCT02516410|559360562|FG001|Overall Study|Withdrawal by Subject|1|||
154982316|NCT01475253|559360567|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
154982317|NCT01475253|559360568|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
154982318|NCT01475253|559360569|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
154982319|NCT01475253|559360570|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
154982320|NCT01475253|559360567|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
154982321|NCT01475253|559360568|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
154982322|NCT01475253|559360569|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
154982323|NCT01475253|559360570|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
154982324|NCT03135899|559360571|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982325|NCT03135899|559360572|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982326|NCT03135899|559360573|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982327|NCT03135899|559360574|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982328|NCT03135899|559360575|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982329|NCT03135899|559360576|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982330|NCT03135899|559360577|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
154982331|NCT03135899|559360578|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
154982332|NCT03135899|559360571|FG000|Overall Study|Withdrawal by Subject|0|||
154982333|NCT03135899|559360572|FG001|Overall Study|Withdrawal by Subject|0|||
154982334|NCT03135899|559360573|FG002|Overall Study|Withdrawal by Subject|0|||
154982335|NCT03135899|559360574|FG003|Overall Study|Withdrawal by Subject|0|||
154982336|NCT03135899|559360575|FG004|Overall Study|Withdrawal by Subject|0|||
154982337|NCT03135899|559360576|FG005|Overall Study|Withdrawal by Subject|2|||
154982338|NCT03135899|559360577|FG006|Overall Study|Withdrawal by Subject|0|||
154982339|NCT03135899|559360578|FG007|Overall Study|Withdrawal by Subject|0|||
154982340|NCT04146363|559360579|FG000|Induction Period|Adverse Event|1|||
154982341|NCT04146363|559360580|FG001|Induction Period|Adverse Event|2|||
154982342|NCT04146363|559360581|FG002|Induction Period|Adverse Event|0|||
154982343|NCT04146363|559360582|FG003|Induction Period|Adverse Event|0|||
154982344|NCT04146363|559360583|FG004|Induction Period|Adverse Event|0|||
154982345|NCT04146363|559360584|FG005|Induction Period|Adverse Event|0|||
154982346|NCT04146363|559360585|FG006|Induction Period|Adverse Event|0|||
154982347|NCT04146363|559360586|FG007|Induction Period|Adverse Event|0|||
154982348|NCT04146363|559360587|FG008|Induction Period|Adverse Event|0|||
154982349|NCT04146363|559360588|FG009|Induction Period|Adverse Event|0|||
154982350|NCT04146363|559360589|FG010|Induction Period|Adverse Event|0|||
154982351|NCT04146363|559360579|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
154982352|NCT04146363|559360580|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
154982353|NCT04146363|559360581|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
154982354|NCT04146363|559360582|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
154982355|NCT04146363|559360583|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
154982356|NCT04146363|559360584|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
154982357|NCT04146363|559360585|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
154982358|NCT04146363|559360586|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
154982359|NCT04146363|559360587|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
154982360|NCT04146363|559360588|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
154982361|NCT04146363|559360589|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
154982362|NCT04146363|559360579|FG000|Induction Period|Lack of Efficacy|7|||
154982363|NCT04146363|559360580|FG001|Induction Period|Lack of Efficacy|2|||
154982364|NCT04146363|559360581|FG002|Induction Period|Lack of Efficacy|0|||
154982365|NCT04146363|559360582|FG003|Induction Period|Lack of Efficacy|0|||
154982366|NCT04146363|559360583|FG004|Induction Period|Lack of Efficacy|0|||
154982367|NCT04146363|559360584|FG005|Induction Period|Lack of Efficacy|0|||
154982368|NCT04146363|559360585|FG006|Induction Period|Lack of Efficacy|0|||
154982369|NCT04146363|559360586|FG007|Induction Period|Lack of Efficacy|0|||
154982370|NCT04146363|559360587|FG008|Induction Period|Lack of Efficacy|0|||
154982371|NCT04146363|559360588|FG009|Induction Period|Lack of Efficacy|0|||
154982372|NCT04146363|559360589|FG010|Induction Period|Lack of Efficacy|0|||
154982373|NCT04146363|559360579|FG000|Induction Period|Lost to Follow-up|1|||
154982374|NCT04146363|559360580|FG001|Induction Period|Lost to Follow-up|4|||
154982375|NCT04146363|559360581|FG002|Induction Period|Lost to Follow-up|0|||
154982376|NCT04146363|559360582|FG003|Induction Period|Lost to Follow-up|0|||
154982377|NCT04146363|559360583|FG004|Induction Period|Lost to Follow-up|0|||
154982378|NCT04146363|559360584|FG005|Induction Period|Lost to Follow-up|0|||
154982379|NCT04146363|559360585|FG006|Induction Period|Lost to Follow-up|0|||
154982380|NCT04146363|559360586|FG007|Induction Period|Lost to Follow-up|0|||
154982381|NCT04146363|559360587|FG008|Induction Period|Lost to Follow-up|0|||
154982382|NCT04146363|559360588|FG009|Induction Period|Lost to Follow-up|0|||
154982383|NCT04146363|559360589|FG010|Induction Period|Lost to Follow-up|0|||
154982384|NCT04146363|559360579|FG000|Induction Period|Positive quantiferon test|0|||
154982385|NCT04146363|559360580|FG001|Induction Period|Positive quantiferon test|1|||
154982386|NCT04146363|559360581|FG002|Induction Period|Positive quantiferon test|0|||
154982387|NCT04146363|559360582|FG003|Induction Period|Positive quantiferon test|0|||
154982388|NCT04146363|559360583|FG004|Induction Period|Positive quantiferon test|0|||
154982389|NCT04146363|559360584|FG005|Induction Period|Positive quantiferon test|0|||
154982390|NCT04146363|559360585|FG006|Induction Period|Positive quantiferon test|0|||
154982391|NCT04146363|559360586|FG007|Induction Period|Positive quantiferon test|0|||
154982392|NCT04146363|559360587|FG008|Induction Period|Positive quantiferon test|0|||
154982393|NCT04146363|559360588|FG009|Induction Period|Positive quantiferon test|0|||
154982394|NCT04146363|559360589|FG010|Induction Period|Positive quantiferon test|0|||
154982395|NCT04146363|559360579|FG000|Induction Period|Protocol Deviation|5|||
154982396|NCT04146363|559360580|FG001|Induction Period|Protocol Deviation|6|||
154982397|NCT04146363|559360581|FG002|Induction Period|Protocol Deviation|0|||
154982398|NCT04146363|559360582|FG003|Induction Period|Protocol Deviation|0|||
154982399|NCT04146363|559360583|FG004|Induction Period|Protocol Deviation|0|||
154982400|NCT04146363|559360584|FG005|Induction Period|Protocol Deviation|0|||
154982401|NCT04146363|559360585|FG006|Induction Period|Protocol Deviation|0|||
154982402|NCT04146363|559360586|FG007|Induction Period|Protocol Deviation|0|||
154982403|NCT04146363|559360587|FG008|Induction Period|Protocol Deviation|0|||
154982404|NCT04146363|559360588|FG009|Induction Period|Protocol Deviation|0|||
154982405|NCT04146363|559360589|FG010|Induction Period|Protocol Deviation|0|||
154982406|NCT04146363|559360579|FG000|Induction Period|Withdrawal by Subject|6|||
154982407|NCT04146363|559360580|FG001|Induction Period|Withdrawal by Subject|3|||
154982408|NCT04146363|559360581|FG002|Induction Period|Withdrawal by Subject|0|||
154982409|NCT04146363|559360582|FG003|Induction Period|Withdrawal by Subject|0|||
154982410|NCT04146363|559360583|FG004|Induction Period|Withdrawal by Subject|0|||
154982411|NCT04146363|559360584|FG005|Induction Period|Withdrawal by Subject|0|||
154982412|NCT04146363|559360585|FG006|Induction Period|Withdrawal by Subject|0|||
154982413|NCT04146363|559360586|FG007|Induction Period|Withdrawal by Subject|0|||
154982414|NCT04146363|559360587|FG008|Induction Period|Withdrawal by Subject|0|||
154982415|NCT04146363|559360588|FG009|Induction Period|Withdrawal by Subject|0|||
154982416|NCT04146363|559360589|FG010|Induction Period|Withdrawal by Subject|0|||
154982417|NCT04146363|559360579|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982418|NCT04146363|559360580|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982419|NCT04146363|559360581|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982420|NCT04146363|559360582|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982421|NCT04146363|559360583|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982422|NCT04146363|559360584|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982423|NCT04146363|559360585|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
154982424|NCT04146363|559360586|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
154982425|NCT04146363|559360587|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982426|NCT04146363|559360588|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982427|NCT04146363|559360589|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
154982428|NCT04146363|559360579|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982429|NCT04146363|559360580|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982430|NCT04146363|559360581|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
155115772|NCT01263015|559855081|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
154982431|NCT04146363|559360582|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982432|NCT04146363|559360583|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982433|NCT04146363|559360584|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982434|NCT04146363|559360585|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982435|NCT04146363|559360586|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
154982436|NCT04146363|559360587|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982437|NCT04146363|559360588|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982438|NCT04146363|559360589|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
154982439|NCT04146363|559360579|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982440|NCT04146363|559360580|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982441|NCT04146363|559360581|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982442|NCT04146363|559360582|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982443|NCT04146363|559360583|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982444|NCT04146363|559360584|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982445|NCT04146363|559360585|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
154982446|NCT04146363|559360586|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
154982447|NCT04146363|559360587|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982448|NCT04146363|559360588|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982449|NCT04146363|559360589|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
154982450|NCT04146363|559360579|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982451|NCT04146363|559360580|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982452|NCT04146363|559360581|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
154982453|NCT04146363|559360582|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982454|NCT04146363|559360583|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982455|NCT04146363|559360584|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
154982456|NCT04146363|559360585|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
155115773|NCT01263015|559855082|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
155115774|NCT01263015|559855081|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
154982457|NCT04146363|559360586|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982458|NCT04146363|559360587|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982459|NCT04146363|559360588|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
155115775|NCT01263015|559855082|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
154982460|NCT04146363|559360589|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
154982461|NCT04146363|559360579|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982462|NCT04146363|559360580|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982463|NCT04146363|559360581|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982464|NCT04146363|559360582|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982465|NCT04146363|559360583|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
154982466|NCT04146363|559360584|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
154982467|NCT04146363|559360585|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
154982468|NCT04146363|559360586|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
154982469|NCT04146363|559360587|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982470|NCT04146363|559360588|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982471|NCT04146363|559360589|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
154982472|NCT04146363|559360579|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982473|NCT04146363|559360580|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982474|NCT04146363|559360581|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
154982475|NCT04146363|559360582|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982476|NCT04146363|559360583|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982477|NCT04146363|559360584|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
154982478|NCT04146363|559360585|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
154982479|NCT04146363|559360586|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
154982480|NCT04146363|559360587|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982481|NCT04146363|559360588|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982482|NCT04146363|559360589|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
154982483|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982484|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982485|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982486|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982487|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982488|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982489|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982490|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982491|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
154982492|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
154982493|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
154982494|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982495|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982496|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982497|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982498|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982499|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982500|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982501|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
154982502|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
154982503|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
154982504|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
154982505|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982506|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982507|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982508|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982509|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982510|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982511|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982512|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982513|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
154982514|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
154982515|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
154982516|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982517|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982518|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982519|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982520|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982521|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982522|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982523|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
155175954|NCT04905498|560082192|FG001|Overall Study|Lost to Follow-up|2|||
155175955|NCT04905498|560082191|FG000|Overall Study|COVID lockdown|1|||
154982524|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
154982525|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
154982526|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
154982527|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982528|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982529|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982530|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982531|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982532|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982533|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982534|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
154982535|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
154982536|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
154982537|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
154982538|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982539|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982540|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982541|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982542|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982543|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982544|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982545|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982546|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982547|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
154982548|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
154982549|NCT04146363|559360579|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982550|NCT04146363|559360580|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982551|NCT04146363|559360581|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982552|NCT04146363|559360582|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982553|NCT04146363|559360583|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982554|NCT04146363|559360584|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982555|NCT04146363|559360585|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
155115776|NCT01263015|559855081|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
155115777|NCT01263015|559855082|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
155115778|NCT01263015|559855081|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
155115779|NCT01263015|559855082|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
155115780|NCT05599451|559855083|FG000|Overall Study|Not randomized|11|||
155115781|NCT05599451|559855084|FG001|Overall Study|Not randomized|0|||
155115782|NCT05599451|559855085|FG002|Overall Study|Not randomized|0|||
155115783|NCT05599451|559855086|FG003|Overall Study|Not randomized|0|||
155115784|NCT05599451|559855087|FG004|Overall Study|Not randomized|0|||
155115785|NCT05599451|559855083|FG000|Overall Study|Physician Decision|0|||
155115786|NCT05599451|559855084|FG001|Overall Study|Physician Decision|0|||
155115787|NCT05599451|559855085|FG002|Overall Study|Physician Decision|0|||
155115788|NCT05599451|559855086|FG003|Overall Study|Physician Decision|1|||
155115789|NCT05599451|559855087|FG004|Overall Study|Physician Decision|0|||
155115790|NCT02723006|559855088|FG000|Overall Study|Withdrawal by Subject|0|||
155115791|NCT02723006|559855089|FG001|Overall Study|Withdrawal by Subject|1|||
155115792|NCT02723006|559855090|FG002|Overall Study|Withdrawal by Subject|1|||
155115793|NCT02723006|559855088|FG000|Overall Study|Study Terminated by Sponsor|1|||
155115794|NCT02723006|559855089|FG001|Overall Study|Study Terminated by Sponsor|6|||
155115795|NCT02723006|559855090|FG002|Overall Study|Study Terminated by Sponsor|6|||
155115796|NCT00303446|559855091|FG000|Overall Study|Withdrawal by Subject|2|||
155115797|NCT00303446|559855092|FG001|Overall Study|Withdrawal by Subject|2|||
155115798|NCT00303446|559855091|FG000|Overall Study|Death|0|||
155115799|NCT00303446|559855092|FG001|Overall Study|Death|1|||
155115800|NCT00303446|559855091|FG000|Overall Study|Physician Decision|0|||
155115801|NCT00303446|559855092|FG001|Overall Study|Physician Decision|1|||
155115802|NCT03285958|559855093|FG000|Overall Study|Lost to Follow-up|1|||
155115803|NCT03285958|559855094|FG001|Overall Study|Lost to Follow-up|1|||
155115804|NCT03285958|559855093|FG000|Overall Study|Withdrawal by Subject|1|||
155115805|NCT03285958|559855094|FG001|Overall Study|Withdrawal by Subject|0|||
155115806|NCT03285958|559855093|FG000|Overall Study|Not able to attend required orientation|3|||
155115807|NCT03285958|559855094|FG001|Overall Study|Not able to attend required orientation|0|||
155115808|NCT03842969|559855107|FG000|Overall Study|Participant declined follow-up visit|0|||
155115809|NCT03842969|559855108|FG001|Overall Study|Participant declined follow-up visit|1|||
155115810|NCT03842969|559855109|FG002|Overall Study|Participant declined follow-up visit|0|||
155115811|NCT03842969|559855107|FG000|Overall Study|Sponsor's decision|12|||
155115812|NCT03842969|559855108|FG001|Overall Study|Sponsor's decision|99|||
155115813|NCT03842969|559855109|FG002|Overall Study|Sponsor's decision|61|||
155115814|NCT03842969|559855107|FG000|Overall Study|Pregnancy|0|||
155115815|NCT03842969|559855108|FG001|Overall Study|Pregnancy|0|||
154982556|NCT04146363|559360586|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982557|NCT04146363|559360587|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982558|NCT04146363|559360588|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
154982559|NCT04146363|559360589|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
154982560|NCT02914236|559360594|FG000|Overall Study|Lost to Follow-up|1|||
154982561|NCT00380692|559360595|FG000|Study Period II - Double Blind|Adverse Event|1|||
154982562|NCT00380692|559360596|FG001|Study Period II - Double Blind|Adverse Event|0|||
154982563|NCT00380692|559360595|FG000|Study Period II - Double Blind|Protocol Violation|2|||
154982564|NCT00380692|559360596|FG001|Study Period II - Double Blind|Protocol Violation|2|||
154982565|NCT00380692|559360595|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
154982566|NCT00380692|559360596|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
154982567|NCT00380692|559360595|FG000|Study Period II - Double Blind|Physician Decision|0|||
154982568|NCT00380692|559360596|FG001|Study Period II - Double Blind|Physician Decision|1|||
154982569|NCT00380692|559360595|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
154982570|NCT00380692|559360596|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
154982571|NCT00380692|559360595|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
154982572|NCT00380692|559360596|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
154982573|NCT00380692|559360595|FG000|Study Period III - Open Label|Adverse Event|5|||
154982574|NCT00380692|559360596|FG001|Study Period III - Open Label|Adverse Event|3|||
154982575|NCT00380692|559360595|FG000|Study Period III - Open Label|Protocol Violation|0|||
154982576|NCT00380692|559360596|FG001|Study Period III - Open Label|Protocol Violation|0|||
154982577|NCT00380692|559360595|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
154982578|NCT00380692|559360596|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
154982579|NCT00380692|559360595|FG000|Study Period III - Open Label|Physician Decision|0|||
154982580|NCT00380692|559360596|FG001|Study Period III - Open Label|Physician Decision|3|||
154982581|NCT00380692|559360595|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
154982582|NCT00380692|559360596|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
154982583|NCT00380692|559360595|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
154982584|NCT00380692|559360596|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
154982585|NCT02676284|559360597|FG000|Overall Study|Withdrawal by Subject|1|||
154982586|NCT00708708|559360599|FG000|Overall Study|Another therapy instead of Enbrel|141|||
154982587|NCT00708708|559360599|FG000|Overall Study|Lost to Follow-up|52|||
154982588|NCT00708708|559360599|FG000|Overall Study|Withdrawal by Subject|51|||
154982589|NCT00708708|559360599|FG000|Overall Study|Intolerance|42|||
154982590|NCT00708708|559360599|FG000|Overall Study|Another therapy along with Enbrel|15|||
154982591|NCT00708708|559360599|FG000|Overall Study|Other unspecified|11|||
154982592|NCT00708708|559360599|FG000|Overall Study|Good effectiveness|9|||
154982593|NCT00708708|559360599|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
154982594|NCT00708708|559360599|FG000|Overall Study|Administrative reasons|7|||
154982595|NCT00708708|559360599|FG000|Overall Study|Lack of effectiveness|4|||
154982596|NCT00708708|559360599|FG000|Overall Study|Lack of compliance|3|||
154982597|NCT00708708|559360599|FG000|Overall Study|Pregnancy|3|||
154982598|NCT00708708|559360599|FG000|Overall Study|Adverse Event|3|||
154982599|NCT00708708|559360599|FG000|Overall Study|Missing values|392|||
154982600|NCT04776746|559360600|FG000|Overall Study|Study terminated by sponsor|61|||
154982601|NCT04776746|559360600|FG000|Overall Study|Adverse Event|5|||
154982602|NCT04776746|559360600|FG000|Overall Study|Death|4|||
154982603|NCT04776746|559360600|FG000|Overall Study|Lack of Efficacy|3|||
154982604|NCT04776746|559360600|FG000|Overall Study|Noncompliance with study drug|2|||
154982605|NCT04776746|559360600|FG000|Overall Study|Not related to COVID-19|2|||
154982606|NCT00856830|559360603|FG000|Irinotecan & Bendamustine|Death|0|||
154982607|NCT00856830|559360604|FG001|Irinotecan & Bendamustine|Death|0|||
154982608|NCT00856830|559360605|FG002|Irinotecan & Bendamustine|Death|0|||
154982609|NCT00856830|559360606|FG003|Irinotecan & Bendamustine|Death|2|||
154982610|NCT00856830|559360603|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
154982611|NCT00856830|559360604|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
154982612|NCT00856830|559360605|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
155115816|NCT03842969|559855109|FG002|Overall Study|Pregnancy|1|||
155115817|NCT03842969|559855107|FG000|Overall Study|Death|1|||
154982613|NCT00856830|559360606|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
154982614|NCT02148913|559360607|FG000|Overall Study|Death|0|||
154982615|NCT02148913|559360608|FG001|Overall Study|Death|1|||
154982616|NCT02148913|559360609|FG002|Overall Study|Death|0|||
155115818|NCT03842969|559855108|FG001|Overall Study|Death|0|||
155115819|NCT03842969|559855109|FG002|Overall Study|Death|1|||
154982617|NCT02148913|559360610|FG003|Overall Study|Death|0|||
154982618|NCT01287039|559360612|FG000|Overall Study|Noncompliance with study procedures|0|||
154982619|NCT01287039|559360613|FG001|Overall Study|Noncompliance with study procedures|1|||
154982620|NCT01287039|559360612|FG000|Overall Study|Change of location/residence|0|||
154982621|NCT01287039|559360613|FG001|Overall Study|Change of location/residence|3|||
154982622|NCT01287039|559360612|FG000|Overall Study|Elective surgery|0|||
154982623|NCT01287039|559360613|FG001|Overall Study|Elective surgery|1|||
155115820|NCT03842969|559855107|FG000|Overall Study|Withdrawal by Subject|3|||
155115821|NCT03842969|559855108|FG001|Overall Study|Withdrawal by Subject|30|||
154982624|NCT01287039|559360612|FG000|Overall Study|Protocol Violation|2|||
154982625|NCT01287039|559360613|FG001|Overall Study|Protocol Violation|3|||
154982626|NCT01287039|559360612|FG000|Overall Study|Excluded medication taken|1|||
154982627|NCT01287039|559360613|FG001|Overall Study|Excluded medication taken|0|||
154982628|NCT01287039|559360612|FG000|Overall Study|Noncompliance with study medication|0|||
154982629|NCT01287039|559360613|FG001|Overall Study|Noncompliance with study medication|1|||
154982630|NCT01287039|559360612|FG000|Overall Study|Problem with travel|0|||
154982631|NCT01287039|559360613|FG001|Overall Study|Problem with travel|1|||
154982632|NCT01287039|559360612|FG000|Overall Study|Death|1|||
154982633|NCT01287039|559360613|FG001|Overall Study|Death|0|||
154982634|NCT01287039|559360612|FG000|Overall Study|Change of residence|1|||
154982635|NCT01287039|559360613|FG001|Overall Study|Change of residence|0|||
154982636|NCT01287039|559360612|FG000|Overall Study|Adverse Event|7|||
154982637|NCT01287039|559360613|FG001|Overall Study|Adverse Event|4|||
154982638|NCT01287039|559360612|FG000|Overall Study|Withdrawal by Subject|14|||
154982639|NCT01287039|559360613|FG001|Overall Study|Withdrawal by Subject|11|||
154982640|NCT01287039|559360612|FG000|Overall Study|Lost to Follow-up|3|||
154982641|NCT01287039|559360613|FG001|Overall Study|Lost to Follow-up|2|||
154982642|NCT02694549|559360614|FG000|Overall Study|screen failures|2|||
154982643|NCT03265288|559360619|FG000|Overall Study|Adverse Event|0|||
154982644|NCT03265288|559360620|FG001|Overall Study|Adverse Event|1|||
154982645|NCT03265288|559360619|FG000|Overall Study|Withdrawal by Subject|13|||
154982646|NCT03265288|559360620|FG001|Overall Study|Withdrawal by Subject|5|||
154982647|NCT03265288|559360619|FG000|Overall Study|Drug Withdrawn|3|||
154982648|NCT03265288|559360620|FG001|Overall Study|Drug Withdrawn|3|||
154982649|NCT03265288|559360619|FG000|Overall Study|Any Other Reason|7|||
154982650|NCT03265288|559360620|FG001|Overall Study|Any Other Reason|3|||
154982651|NCT00099268|559360624|FG000|Overall Study|Withdrawal by Subject|46|||
154982652|NCT00099268|559360625|FG001|Overall Study|Withdrawal by Subject|28|||
154982653|NCT00099268|559360624|FG000|Overall Study|Adverse Event|19|||
154982654|NCT00099268|559360625|FG001|Overall Study|Adverse Event|19|||
154982655|NCT00099268|559360624|FG000|Overall Study|Protocol Violation|9|||
154982656|NCT00099268|559360625|FG001|Overall Study|Protocol Violation|8|||
154982657|NCT00099268|559360624|FG000|Overall Study|Lost to Follow-up|6|||
154982658|NCT00099268|559360625|FG001|Overall Study|Lost to Follow-up|4|||
154982659|NCT00099268|559360624|FG000|Overall Study|Lack of Efficacy|5|||
154982660|NCT00099268|559360625|FG001|Overall Study|Lack of Efficacy|18|||
154982661|NCT00099268|559360624|FG000|Overall Study|Administrative problems|4|||
154982662|NCT00099268|559360625|FG001|Overall Study|Administrative problems|4|||
154982663|NCT00099268|559360624|FG000|Overall Study|Death|3|||
154982664|NCT00099268|559360625|FG001|Overall Study|Death|1|||
154982665|NCT03702049|559360626|FG000|Overall Study|Lost to Follow-up|4|||
154982666|NCT03702049|559360626|FG000|Overall Study|Physician Decision|1|||
154982667|NCT05016622|559360627|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
154982668|NCT05016622|559360627|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
154982669|NCT00171301|559360635|FG000|Overall Study|Death|1|||
154982670|NCT00171301|559360636|FG001|Overall Study|Death|2|||
154982671|NCT00171301|559360635|FG000|Overall Study|Adverse Event|1|||
154982672|NCT00171301|559360636|FG001|Overall Study|Adverse Event|2|||
154982673|NCT00171301|559360635|FG000|Overall Study|Lost to Follow-up|6|||
154982674|NCT00171301|559360636|FG001|Overall Study|Lost to Follow-up|2|||
154982675|NCT00171301|559360635|FG000|Overall Study|Protocol Violation|0|||
154982676|NCT00171301|559360636|FG001|Overall Study|Protocol Violation|2|||
154982677|NCT00171301|559360635|FG000|Overall Study|Withdrawal by Subject|0|||
154982678|NCT00171301|559360636|FG001|Overall Study|Withdrawal by Subject|1|||
154982679|NCT02370914|559360641|FG000|Overall Study|Protocol Violation|2|||
154982680|NCT01557842|559360643|FG000|Overall Study|Lost to Follow-up|0|||
154982681|NCT01557842|559360644|FG001|Overall Study|Lost to Follow-up|1|||
154982682|NCT01557842|559360643|FG000|Overall Study|Death|1|||
154982683|NCT01557842|559360644|FG001|Overall Study|Death|0|||
154982684|NCT01557842|559360643|FG000|Overall Study|Lack of Efficacy|0|||
154982685|NCT01557842|559360644|FG001|Overall Study|Lack of Efficacy|1|||
154982686|NCT01557842|559360643|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
154982687|NCT01557842|559360644|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
154982688|NCT01557842|559360643|FG000|Overall Study|Study Terminated by Sponsor|3|||
154982689|NCT01557842|559360644|FG001|Overall Study|Study Terminated by Sponsor|4|||
154982690|NCT01557842|559360643|FG000|Overall Study|Not Ablated|2|||
154982691|NCT01557842|559360644|FG001|Overall Study|Not Ablated|0|||
154982692|NCT00754442|559360645|FG000|Overall Study|Withdrawal by Subject|5|||
154982693|NCT00754442|559360646|FG001|Overall Study|Withdrawal by Subject|3|||
154982694|NCT01341587|559360648|FG000|Overall Study|Lost to Follow-up|2|||
154982695|NCT01341587|559360649|FG001|Overall Study|Lost to Follow-up|0|||
154982696|NCT01341587|559360648|FG000|Overall Study|stopped using the meters|2|||
154982697|NCT01341587|559360649|FG001|Overall Study|stopped using the meters|10|||
154982698|NCT01056640|559360650|FG000|Overall Study|Withdrawal by Subject|11|||
154982699|NCT01056640|559360651|FG001|Overall Study|Withdrawal by Subject|8|||
154982700|NCT01056640|559360650|FG000|Overall Study|Death|15|||
154982701|NCT01056640|559360651|FG001|Overall Study|Death|4|||
154982702|NCT00466726|559360654|FG000|Overall Study|Not evaluable for response|14|||
154982703|NCT00350402|559360655|FG000|Overall Study|Lost to Follow-up|1|||
154982704|NCT00350402|559360656|FG001|Overall Study|Lost to Follow-up|1|||
154982705|NCT00645944|559360657|FG000|Randomized|Withdrawal by Subject|1|||
154982706|NCT00645944|559360658|FG001|Randomized|Withdrawal by Subject|2|||
154982707|NCT00645944|559360657|FG000|Received Medication|Adverse Event|2|||
154982708|NCT00645944|559360658|FG001|Received Medication|Adverse Event|1|||
154982709|NCT00645944|559360657|FG000|Received Medication|Withdrawal by Subject|1|||
154982710|NCT00645944|559360658|FG001|Received Medication|Withdrawal by Subject|1|||
154982711|NCT00645944|559360657|FG000|Received Medication|Lost to Follow-up|1|||
154982712|NCT00645944|559360658|FG001|Received Medication|Lost to Follow-up|0|||
154982713|NCT00645944|559360657|FG000|Received Medication|Protocol Violation|2|||
154982714|NCT00645944|559360658|FG001|Received Medication|Protocol Violation|1|||
154982715|NCT02377921|559360664|FG000|Overall Study|Subject non-compliance|1|||
154982716|NCT02377921|559360665|FG001|Overall Study|Subject non-compliance|1|||
154982717|NCT00560937|559360672|FG000|Overall Study|Withdrawal by Subject|0|||
154982718|NCT00560937|559360673|FG001|Overall Study|Withdrawal by Subject|1|||
154982719|NCT00560937|559360672|FG000|Overall Study|Physician Decision|1|||
154982720|NCT00560937|559360673|FG001|Overall Study|Physician Decision|1|||
154982721|NCT03919162|559360674|FG000|Overall Study|Adverse Event|3|||
154982722|NCT03919162|559360675|FG001|Overall Study|Adverse Event|2|||
154982723|NCT03919162|559360674|FG000|Overall Study|Death|2|||
154982724|NCT03919162|559360675|FG001|Overall Study|Death|0|||
154982725|NCT03919162|559360674|FG000|Overall Study|Lost to Follow-up|1|||
154982726|NCT03919162|559360675|FG001|Overall Study|Lost to Follow-up|0|||
154982727|NCT03919162|559360674|FG000|Overall Study|Withdrawal by Subject|12|||
154982728|NCT03919162|559360675|FG001|Overall Study|Withdrawal by Subject|12|||
154982729|NCT03919162|559360674|FG000|Overall Study|Study terminated by Sponsor|20|||
154982730|NCT03919162|559360675|FG001|Overall Study|Study terminated by Sponsor|24|||
154982731|NCT03919162|559360674|FG000|Overall Study|Screen failure|1|||
154982732|NCT03919162|559360675|FG001|Overall Study|Screen failure|0|||
154982733|NCT03919162|559360674|FG000|Overall Study|Missing|1|||
154982734|NCT03919162|559360675|FG001|Overall Study|Missing|1|||
154982735|NCT01688726|559360677|FG000|Overall Study|Adverse Event|1|||
154982736|NCT01688726|559360678|FG001|Overall Study|Adverse Event|0|||
154982737|NCT01688726|559360677|FG000|Overall Study|Relocated abroad|0|||
154982738|NCT01688726|559360678|FG001|Overall Study|Relocated abroad|1|||
154982739|NCT01885182|559361954|FG000|Overall Study|Adverse Event|11|||
154982740|NCT01885182|559361955|FG001|Overall Study|Adverse Event|13|||
154982741|NCT01885182|559361954|FG000|Overall Study|Withdrawal by Subject|13|||
154982742|NCT01885182|559361955|FG001|Overall Study|Withdrawal by Subject|6|||
154982743|NCT01885182|559361954|FG000|Overall Study|Lost to Follow-up|2|||
154982744|NCT01885182|559361955|FG001|Overall Study|Lost to Follow-up|2|||
154982745|NCT01885182|559361954|FG000|Overall Study|Lack of Efficacy|8|||
154982746|NCT01885182|559361955|FG001|Overall Study|Lack of Efficacy|1|||
154982747|NCT03575871|559361960|FG000|Overall Study|Adverse Event|5|||
154982748|NCT03575871|559361961|FG001|Overall Study|Adverse Event|5|||
154982749|NCT03575871|559361962|FG002|Overall Study|Adverse Event|8|||
154982750|NCT03575871|559361960|FG000|Overall Study|Death|1|||
154982751|NCT03575871|559361961|FG001|Overall Study|Death|0|||
154982752|NCT03575871|559361962|FG002|Overall Study|Death|0|||
154982753|NCT03575871|559361960|FG000|Overall Study|Lack of Efficacy|5|||
154982754|NCT03575871|559361961|FG001|Overall Study|Lack of Efficacy|4|||
154982755|NCT03575871|559361962|FG002|Overall Study|Lack of Efficacy|7|||
154982756|NCT03575871|559361960|FG000|Overall Study|Lost to Follow-up|1|||
154982757|NCT03575871|559361961|FG001|Overall Study|Lost to Follow-up|1|||
154982758|NCT03575871|559361962|FG002|Overall Study|Lost to Follow-up|1|||
154982759|NCT03575871|559361960|FG000|Overall Study|Protocol Deviation|1|||
154982760|NCT03575871|559361961|FG001|Overall Study|Protocol Deviation|1|||
154982761|NCT03575871|559361962|FG002|Overall Study|Protocol Deviation|1|||
154982762|NCT03575871|559361960|FG000|Overall Study|Withdrawal by Subject|6|||
154982763|NCT03575871|559361961|FG001|Overall Study|Withdrawal by Subject|1|||
154982764|NCT03575871|559361962|FG002|Overall Study|Withdrawal by Subject|9|||
155115822|NCT03842969|559855109|FG002|Overall Study|Withdrawal by Subject|18|||
154982765|NCT03575871|559361960|FG000|Overall Study|Other than specified|2|||
154982766|NCT03575871|559361961|FG001|Overall Study|Other than specified|2|||
154982767|NCT03575871|559361962|FG002|Overall Study|Other than specified|0|||
154982768|NCT05506358|559361963|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
154982769|NCT05506358|559361964|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
154982770|NCT05506358|559361965|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
155115823|NCT03842969|559855107|FG000|Overall Study|Protocol Violation|1|||
154982771|NCT05506358|559361966|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
154982772|NCT05506358|559361967|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
154982773|NCT05506358|559361963|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
154982774|NCT05506358|559361964|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
155115824|NCT03842969|559855108|FG001|Overall Study|Protocol Violation|1|||
155115825|NCT03842969|559855109|FG002|Overall Study|Protocol Violation|0|||
155115826|NCT03842969|559855107|FG000|Overall Study|Physician Decision|0|||
155115827|NCT03842969|559855108|FG001|Overall Study|Physician Decision|3|||
155115828|NCT03842969|559855109|FG002|Overall Study|Physician Decision|0|||
155115829|NCT03842969|559855107|FG000|Overall Study|Lost to Follow-up|0|||
155115830|NCT03842969|559855108|FG001|Overall Study|Lost to Follow-up|2|||
155115831|NCT03842969|559855109|FG002|Overall Study|Lost to Follow-up|0|||
155115832|NCT03842969|559855107|FG000|Overall Study|Adverse Event|0|||
155115833|NCT03842969|559855108|FG001|Overall Study|Adverse Event|2|||
155115834|NCT03842969|559855109|FG002|Overall Study|Adverse Event|0|||
155115835|NCT02264665|559855112|FG000|Overall Study|Other|0|||
155115836|NCT02264665|559855113|FG001|Overall Study|Other|0|||
155115837|NCT02264665|559855114|FG002|Overall Study|Other|3|||
155115838|NCT02264665|559855115|FG003|Overall Study|Other|0|||
154904573|NCT02407236|559069860|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
154904574|NCT02407236|559069861|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
154982775|NCT05506358|559361965|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
154982776|NCT05506358|559361966|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
154982777|NCT05506358|559361967|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
154982778|NCT05506358|559361963|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
154982779|NCT05506358|559361964|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
154982780|NCT05506358|559361965|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
154982781|NCT05506358|559361966|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
154982782|NCT05506358|559361967|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
154982783|NCT05506358|559361963|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
154982784|NCT05506358|559361964|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
154982785|NCT05506358|559361965|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
154982786|NCT05506358|559361966|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
154982787|NCT05506358|559361967|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
154982788|NCT05506358|559361963|FG000|Overall Study|HbE trait|0|||
155115839|NCT02264665|559855116|FG004|Overall Study|Other|0|||
155115840|NCT02264665|559855117|FG005|Overall Study|Other|0|||
154904575|NCT02177812|559069867|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
154904576|NCT02177812|559069868|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
154904577|NCT02177812|559069869|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
154904578|NCT02177812|559069870|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
154904579|NCT02177812|559069871|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
154904580|NCT02177812|559069872|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
154904581|NCT02177812|559069873|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
154904582|NCT02177812|559069874|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
154904583|NCT02177812|559069875|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
154904584|NCT02177812|559069867|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904585|NCT02177812|559069868|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904586|NCT02177812|559069869|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904587|NCT02177812|559069870|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904588|NCT02177812|559069871|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904589|NCT02177812|559069872|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
154904590|NCT02177812|559069873|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
154904591|NCT02177812|559069874|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904592|NCT02177812|559069875|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
154904593|NCT02177812|559069867|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
154904594|NCT02177812|559069868|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
154904595|NCT02177812|559069869|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
154904596|NCT02177812|559069870|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
154904597|NCT02177812|559069871|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
154904598|NCT02177812|559069872|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
154904599|NCT02177812|559069873|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
154904600|NCT02177812|559069874|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
154904601|NCT02177812|559069875|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
154904602|NCT04888507|559072075|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
154904603|NCT00636155|559072076|FG000|Overall Study|Adverse Event|8|||
154904604|NCT00636155|559072076|FG000|Overall Study|Lack of Efficacy|1|||
154904605|NCT00636155|559072076|FG000|Overall Study|Withdrawal by Subject|3|||
154904606|NCT00636155|559072076|FG000|Overall Study|Stem cell transplant|1|||
155115841|NCT02264665|559855118|FG006|Overall Study|Other|0|||
155115842|NCT02264665|559855112|FG000|Overall Study|Death|9|||
155115843|NCT02264665|559855113|FG001|Overall Study|Death|8|||
155175956|NCT04905498|560082192|FG001|Overall Study|COVID lockdown|0|||
154904607|NCT00636155|559072076|FG000|Overall Study|Physician Decision|5|||
155175957|NCT01525901|560082196|FG000|Period 2: 12 Weeks|Adverse Event|0|||
154904608|NCT00766142|559072077|FG000|Overall Study|Protocol Violation|4|||
154904609|NCT05643170|559072083|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
154904610|NCT05643170|559072083|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
154904611|NCT02358863|559072084|FG000|Overall Study|Physician Decision|3|||
154982789|NCT05506358|559361964|FG001|Overall Study|HbE trait|0|||
154982790|NCT05506358|559361965|FG002|Overall Study|HbE trait|0|||
154982791|NCT05506358|559361966|FG003|Overall Study|HbE trait|1|||
154982792|NCT05506358|559361967|FG004|Overall Study|HbE trait|0|||
154982793|NCT01173471|559361972|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
154982794|NCT01173471|559361973|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
154982795|NCT01173471|559361974|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
154982796|NCT01173471|559361975|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
154982797|NCT01173471|559361972|FG000|Overall Study|Condition under investigation worsened|2|||
154982798|NCT01173471|559361973|FG001|Overall Study|Condition under investigation worsened|0|||
154982799|NCT01173471|559361974|FG002|Overall Study|Condition under investigation worsened|0|||
154982800|NCT01173471|559361975|FG003|Overall Study|Condition under investigation worsened|0|||
154982801|NCT01173471|559361972|FG000|Overall Study|Lost to Follow-up|0|||
154982802|NCT01173471|559361973|FG001|Overall Study|Lost to Follow-up|0|||
155115844|NCT02264665|559855114|FG002|Overall Study|Death|13|||
155115845|NCT02264665|559855115|FG003|Overall Study|Death|5|||
155115846|NCT02264665|559855116|FG004|Overall Study|Death|0|||
155115847|NCT02264665|559855117|FG005|Overall Study|Death|0|||
155115848|NCT02264665|559855118|FG006|Overall Study|Death|1|||
155115849|NCT02264665|559855112|FG000|Overall Study|Lost to Follow-up|1|||
155115850|NCT02264665|559855113|FG001|Overall Study|Lost to Follow-up|0|||
155115851|NCT02264665|559855114|FG002|Overall Study|Lost to Follow-up|2|||
155115852|NCT02264665|559855115|FG003|Overall Study|Lost to Follow-up|1|||
155115853|NCT02264665|559855116|FG004|Overall Study|Lost to Follow-up|0|||
155115854|NCT02264665|559855117|FG005|Overall Study|Lost to Follow-up|0|||
155115855|NCT02264665|559855118|FG006|Overall Study|Lost to Follow-up|0|||
155115856|NCT02264665|559855112|FG000|Overall Study|Participant decision|0|||
155115857|NCT02264665|559855113|FG001|Overall Study|Participant decision|0|||
155115858|NCT02264665|559855114|FG002|Overall Study|Participant decision|0|||
155115859|NCT02264665|559855115|FG003|Overall Study|Participant decision|1|||
155115860|NCT02264665|559855116|FG004|Overall Study|Participant decision|0|||
155115861|NCT02264665|559855117|FG005|Overall Study|Participant decision|0|||
155115862|NCT02264665|559855118|FG006|Overall Study|Participant decision|0|||
155115863|NCT02264665|559855112|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
155115864|NCT02264665|559855113|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
155115865|NCT02264665|559855114|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
155115866|NCT02264665|559855115|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
155115867|NCT02264665|559855116|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
155115868|NCT02264665|559855117|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
155115869|NCT02264665|559855118|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
155115870|NCT02264665|559855112|FG000|Overall Study|Data Missing|0|||
155115871|NCT02264665|559855113|FG001|Overall Study|Data Missing|0|||
154982803|NCT01173471|559361974|FG002|Overall Study|Lost to Follow-up|1|||
154982804|NCT01173471|559361975|FG003|Overall Study|Lost to Follow-up|0|||
155115872|NCT02264665|559855114|FG002|Overall Study|Data Missing|1|||
155115873|NCT02264665|559855115|FG003|Overall Study|Data Missing|0|||
155115874|NCT02264665|559855116|FG004|Overall Study|Data Missing|0|||
154904612|NCT02632344|559072101|FG000|Overall Study|Adverse Event|3|||
154904613|NCT02632344|559072101|FG000|Overall Study|Lack of Efficacy|3|||
154904614|NCT02632344|559072101|FG000|Overall Study|Withdrawal by Subject|2|||
154904615|NCT00777257|559072102|FG000|Overall Study|Adverse Event|3|||
154904616|NCT00777257|559072103|FG001|Overall Study|Adverse Event|1|||
154904617|NCT00777257|559072104|FG002|Overall Study|Adverse Event|0|||
154904618|NCT00777257|559072102|FG000|Overall Study|Lost to Follow-up|3|||
154904619|NCT00777257|559072103|FG001|Overall Study|Lost to Follow-up|3|||
154904620|NCT00777257|559072104|FG002|Overall Study|Lost to Follow-up|2|||
154904621|NCT00777257|559072102|FG000|Overall Study|Protocol Violation|2|||
154904622|NCT00777257|559072103|FG001|Overall Study|Protocol Violation|2|||
154904623|NCT00777257|559072104|FG002|Overall Study|Protocol Violation|2|||
154904624|NCT00777257|559072102|FG000|Overall Study|Withdrawal by Subject|3|||
154904625|NCT00777257|559072103|FG001|Overall Study|Withdrawal by Subject|6|||
154904626|NCT00777257|559072104|FG002|Overall Study|Withdrawal by Subject|5|||
154904627|NCT05426460|559072105|FG000|Overall Study|Protocol Violation|1|||
154904628|NCT05426460|559072106|FG001|Overall Study|Protocol Violation|1|||
154904629|NCT05426460|559072107|FG002|Overall Study|Protocol Violation|1|||
154904630|NCT05426460|559072108|FG003|Overall Study|Protocol Violation|0|||
154982805|NCT01173471|559361972|FG000|Overall Study|Reason given as Other|0|||
154982806|NCT01173471|559361973|FG001|Overall Study|Reason given as Other|0|||
155115875|NCT02264665|559855117|FG005|Overall Study|Data Missing|0|||
155115876|NCT02264665|559855118|FG006|Overall Study|Data Missing|0|||
155115877|NCT01468207|559855119|FG000|Treatment Period 1|Adverse Event|1|||
155115878|NCT01468207|559855120|FG001|Treatment Period 1|Adverse Event|0|||
154904631|NCT02973997|559072112|FG000|Overall Study|Withdrawal by Subject|4|||
154904632|NCT02973997|559072113|FG001|Overall Study|Withdrawal by Subject|0|||
154904633|NCT02973997|559072112|FG000|Overall Study|Adverse Event|4|||
154982807|NCT01173471|559361974|FG002|Overall Study|Reason given as Other|1|||
154982808|NCT01173471|559361975|FG003|Overall Study|Reason given as Other|0|||
155115879|NCT01468207|559855121|FG002|Treatment Period 1|Adverse Event|0|||
155115880|NCT01468207|559855122|FG003|Treatment Period 1|Adverse Event|0|||
155115881|NCT01468207|559855123|FG004|Treatment Period 1|Adverse Event|0|||
155115882|NCT01468207|559855124|FG005|Treatment Period 1|Adverse Event|0|||
155115883|NCT01468207|559855119|FG000|Treatment Period 1|Protocol Violation|1|||
155115884|NCT01468207|559855120|FG001|Treatment Period 1|Protocol Violation|1|||
155115885|NCT01468207|559855121|FG002|Treatment Period 1|Protocol Violation|0|||
155115886|NCT01468207|559855122|FG003|Treatment Period 1|Protocol Violation|0|||
155115887|NCT01468207|559855123|FG004|Treatment Period 1|Protocol Violation|0|||
155115888|NCT01468207|559855124|FG005|Treatment Period 1|Protocol Violation|0|||
155115889|NCT01468207|559855119|FG000|Treatment Period 1|Withdrawal by Subject|5|||
155115890|NCT01468207|559855120|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155115891|NCT01468207|559855121|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155115892|NCT01468207|559855122|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155115893|NCT01468207|559855123|FG004|Treatment Period 1|Withdrawal by Subject|0|||
154904634|NCT02973997|559072113|FG001|Overall Study|Adverse Event|1|||
154904635|NCT02973997|559072112|FG000|Overall Study|Disease Progression|11|||
154904636|NCT02973997|559072113|FG001|Overall Study|Disease Progression|20|||
154904637|NCT02973997|559072112|FG000|Overall Study|Alternative Therapy|3|||
154904638|NCT02973997|559072113|FG001|Overall Study|Alternative Therapy|0|||
154904639|NCT02973997|559072112|FG000|Overall Study|Other complicating disease|0|||
155115894|NCT01468207|559855124|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155115895|NCT01468207|559855119|FG000|Treatment Period 1|Lost to Follow-up|2|||
155175958|NCT01525901|560082197|FG001|Period 2: 12 Weeks|Adverse Event|1|||
154904640|NCT02973997|559072113|FG001|Overall Study|Other complicating disease|1|||
154904641|NCT02973997|559072112|FG000|Overall Study|Death|0|||
154904642|NCT02973997|559072113|FG001|Overall Study|Death|1|||
154904643|NCT01431521|559072114|FG000|Overall Study|Withdrawal by Subject|0|||
154904644|NCT01431521|559072115|FG001|Overall Study|Withdrawal by Subject|0|||
154904645|NCT01431521|559072116|FG002|Overall Study|Withdrawal by Subject|1|||
154904646|NCT01431521|559072117|FG003|Overall Study|Withdrawal by Subject|0|||
154904647|NCT00444951|559072118|FG000|Overall Study|Lost to Follow-up|1|||
154904648|NCT00444951|559072119|FG001|Overall Study|Lost to Follow-up|1|||
154904649|NCT00444951|559072120|FG002|Overall Study|Lost to Follow-up|0|||
154904650|NCT00444951|559072118|FG000|Overall Study|Withdrawal by Subject|4|||
154904651|NCT00444951|559072119|FG001|Overall Study|Withdrawal by Subject|5|||
154904652|NCT00444951|559072120|FG002|Overall Study|Withdrawal by Subject|3|||
154904653|NCT00366444|559072121|FG000|Overall Study|Withdrawal by Subject|1|||
154904654|NCT00366444|559072122|FG001|Overall Study|Withdrawal by Subject|1|||
154904655|NCT00366444|559072121|FG000|Overall Study|Lack of Efficacy|0|||
154904656|NCT00366444|559072122|FG001|Overall Study|Lack of Efficacy|1|||
154904657|NCT04984876|559072123|FG000|Overall Study|Subject decision|2|||
154904658|NCT04984876|559072124|FG001|Overall Study|Subject decision|10|||
154904659|NCT04984876|559072125|FG002|Overall Study|Subject decision|3|||
154904660|NCT04984876|559072126|FG003|Overall Study|Subject decision|3|||
154904661|NCT04984876|559072127|FG004|Overall Study|Subject decision|3|||
154904662|NCT04984876|559072128|FG005|Overall Study|Subject decision|0|||
154904663|NCT04984876|559072123|FG000|Overall Study|Guardian decision|0|||
154904664|NCT04984876|559072124|FG001|Overall Study|Guardian decision|1|||
154904665|NCT04984876|559072125|FG002|Overall Study|Guardian decision|0|||
154904666|NCT04984876|559072126|FG003|Overall Study|Guardian decision|2|||
154904667|NCT04984876|559072127|FG004|Overall Study|Guardian decision|0|||
154904668|NCT04984876|559072128|FG005|Overall Study|Guardian decision|1|||
154904669|NCT04984876|559072123|FG000|Overall Study|Lost to Follow-up|0|||
154904670|NCT04984876|559072124|FG001|Overall Study|Lost to Follow-up|0|||
154904671|NCT04984876|559072125|FG002|Overall Study|Lost to Follow-up|1|||
154904672|NCT04984876|559072126|FG003|Overall Study|Lost to Follow-up|1|||
154904673|NCT04984876|559072127|FG004|Overall Study|Lost to Follow-up|0|||
155175959|NCT01525901|560082198|FG002|Period 2: 12 Weeks|Adverse Event|0|||
155175960|NCT01525901|560082199|FG003|Period 2: 12 Weeks|Adverse Event|0|||
155175961|NCT04449029|560082200|FG000|Overall Study|Adverse Event|0|||
154982809|NCT04132336|559361976|FG000|Overall Study|Investigator Decision|0|||
155115896|NCT01468207|559855120|FG001|Treatment Period 1|Lost to Follow-up|1|||
155115897|NCT01468207|559855121|FG002|Treatment Period 1|Lost to Follow-up|0|||
155115898|NCT01468207|559855122|FG003|Treatment Period 1|Lost to Follow-up|0|||
155115899|NCT01468207|559855123|FG004|Treatment Period 1|Lost to Follow-up|0|||
155115900|NCT01468207|559855124|FG005|Treatment Period 1|Lost to Follow-up|0|||
155115901|NCT01468207|559855119|FG000|Treatment Period 1|Other|0|||
155115902|NCT01468207|559855120|FG001|Treatment Period 1|Other|2|||
155115903|NCT01468207|559855121|FG002|Treatment Period 1|Other|0|||
155175962|NCT04449029|560082201|FG001|Overall Study|Adverse Event|1|||
155115904|NCT01468207|559855122|FG003|Treatment Period 1|Other|0|||
154904674|NCT04984876|559072128|FG005|Overall Study|Lost to Follow-up|0|||
154904675|NCT04984876|559072123|FG000|Overall Study|Physician Decision|1|||
154904676|NCT04984876|559072124|FG001|Overall Study|Physician Decision|0|||
154904677|NCT04984876|559072125|FG002|Overall Study|Physician Decision|0|||
154904678|NCT04984876|559072126|FG003|Overall Study|Physician Decision|1|||
154904679|NCT04984876|559072127|FG004|Overall Study|Physician Decision|0|||
155175963|NCT04449029|560082202|FG002|Overall Study|Adverse Event|1|||
155115905|NCT01468207|559855123|FG004|Treatment Period 1|Other|0|||
155115906|NCT01468207|559855124|FG005|Treatment Period 1|Other|0|||
155115907|NCT01468207|559855119|FG000|Treatment Period 2|Adverse Event|0|||
155115908|NCT01468207|559855120|FG001|Treatment Period 2|Adverse Event|0|||
155115909|NCT01468207|559855121|FG002|Treatment Period 2|Adverse Event|6|||
155115910|NCT01468207|559855122|FG003|Treatment Period 2|Adverse Event|1|||
155115911|NCT01468207|559855123|FG004|Treatment Period 2|Adverse Event|2|||
155115912|NCT01468207|559855124|FG005|Treatment Period 2|Adverse Event|1|||
155115913|NCT01468207|559855119|FG000|Treatment Period 2|Lack of Efficacy|0|||
155115914|NCT01468207|559855120|FG001|Treatment Period 2|Lack of Efficacy|0|||
155115915|NCT01468207|559855121|FG002|Treatment Period 2|Lack of Efficacy|1|||
155115916|NCT01468207|559855122|FG003|Treatment Period 2|Lack of Efficacy|1|||
155115917|NCT01468207|559855123|FG004|Treatment Period 2|Lack of Efficacy|0|||
155115918|NCT01468207|559855124|FG005|Treatment Period 2|Lack of Efficacy|2|||
155115919|NCT01468207|559855119|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155115920|NCT01468207|559855120|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155115921|NCT01468207|559855121|FG002|Treatment Period 2|Withdrawal by Subject|5|||
155115922|NCT01468207|559855122|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155115923|NCT01468207|559855123|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155115924|NCT01468207|559855124|FG005|Treatment Period 2|Withdrawal by Subject|2|||
155115925|NCT01468207|559855119|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
155115926|NCT01468207|559855120|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
155115927|NCT01468207|559855121|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
155115928|NCT01468207|559855122|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
155115929|NCT01468207|559855123|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
155115930|NCT01468207|559855124|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
155115931|NCT01468207|559855119|FG000|Treatment Period 2|Lost to Follow-up|0|||
155115932|NCT01468207|559855120|FG001|Treatment Period 2|Lost to Follow-up|0|||
155115933|NCT01468207|559855121|FG002|Treatment Period 2|Lost to Follow-up|5|||
155115934|NCT01468207|559855122|FG003|Treatment Period 2|Lost to Follow-up|1|||
155115935|NCT01468207|559855123|FG004|Treatment Period 2|Lost to Follow-up|0|||
155115936|NCT01468207|559855124|FG005|Treatment Period 2|Lost to Follow-up|0|||
155115937|NCT01468207|559855119|FG000|Treatment Period 2|Other|0|||
155115938|NCT01468207|559855120|FG001|Treatment Period 2|Other|0|||
155115939|NCT01468207|559855121|FG002|Treatment Period 2|Other|5|||
155115940|NCT01468207|559855122|FG003|Treatment Period 2|Other|1|||
155115941|NCT01468207|559855123|FG004|Treatment Period 2|Other|1|||
155115942|NCT01468207|559855124|FG005|Treatment Period 2|Other|2|||
155115943|NCT00413894|559855129|FG000|Overall Study|Withdrawal by Subject|10|||
155115944|NCT00413894|559855129|FG000|Overall Study|Administrative Reasons|1|||
155115945|NCT00413894|559855129|FG000|Overall Study|Hb <10 grams/deciliter|12|||
155115946|NCT00413894|559855129|FG000|Overall Study|Adverse Event|28|||
155115947|NCT00413894|559855129|FG000|Overall Study|Protocol Violation|11|||
155115948|NCT00413894|559855129|FG000|Overall Study|Other|18|||
155115949|NCT04225676|559855130|FG000|Overall Study|Physician Decision|1|||
155115950|NCT04225676|559855130|FG000|Overall Study|Lack of Efficacy|1|||
155115951|NCT04225676|559855130|FG000|Overall Study|Study terminated by sponsor|3|||
155115952|NCT01942161|559855131|FG000|Overall Study|Adverse Event|1|||
154982810|NCT04132336|559361977|FG001|Overall Study|Investigator Decision|1|||
154982811|NCT04132336|559361978|FG002|Overall Study|Investigator Decision|0|||
154982812|NCT04132336|559361979|FG003|Overall Study|Investigator Decision|0|||
154982813|NCT04132336|559361980|FG004|Overall Study|Investigator Decision|0|||
154982814|NCT04132336|559361981|FG005|Overall Study|Investigator Decision|0|||
154982815|NCT04132336|559361982|FG006|Overall Study|Investigator Decision|0|||
154982816|NCT00584844|559361983|FG000|Overall Study|Withdrawal by Subject|59|||
154982817|NCT00584844|559361983|FG000|Overall Study|Screen Failure|20|||
154982818|NCT06005597|559361986|FG000|Overall Study|Lost to Follow-up|1|||
154982819|NCT06005597|559361987|FG001|Overall Study|Lost to Follow-up|2|||
154982820|NCT06005597|559361988|FG002|Overall Study|Lost to Follow-up|1|||
155115953|NCT01942161|559855132|FG001|Overall Study|Adverse Event|2|||
155115954|NCT01942161|559855133|FG002|Overall Study|Adverse Event|5|||
155115955|NCT01942161|559855131|FG000|Overall Study|Physician Decision|3|||
155115956|NCT01942161|559855132|FG001|Overall Study|Physician Decision|1|||
155115957|NCT01942161|559855133|FG002|Overall Study|Physician Decision|0|||
155115958|NCT01942161|559855131|FG000|Overall Study|Protocol Violation|1|||
155115959|NCT01942161|559855132|FG001|Overall Study|Protocol Violation|0|||
155115960|NCT01942161|559855133|FG002|Overall Study|Protocol Violation|0|||
154982821|NCT06005597|559361989|FG003|Overall Study|Lost to Follow-up|2|||
154982822|NCT06005597|559361986|FG000|Overall Study|Death|1|||
155115961|NCT01942161|559855131|FG000|Overall Study|Withdrawal by Subject|3|||
155115962|NCT01942161|559855132|FG001|Overall Study|Withdrawal by Subject|3|||
155115963|NCT01942161|559855133|FG002|Overall Study|Withdrawal by Subject|1|||
155115964|NCT05289271|559855138|FG000|Overall Study|Mistakenly allocated, untreated|1|||
155115965|NCT05289271|559855139|FG001|Overall Study|Mistakenly allocated, untreated|0|||
155115966|NCT01257568|559855140|FG000|Overall Study|Lost to Follow-up|2|||
155115967|NCT01257568|559855140|FG000|Overall Study|Withdrawal by Subject|6|||
155175964|NCT04449029|560082203|FG003|Overall Study|Adverse Event|0|||
154982823|NCT06005597|559361987|FG001|Overall Study|Death|1|||
154982824|NCT06005597|559361988|FG002|Overall Study|Death|1|||
154982825|NCT06005597|559361989|FG003|Overall Study|Death|0|||
154982826|NCT02100319|559361990|FG000|Overall Study|Case Report Forms Uncollected|11|||
154982827|NCT02100319|559361990|FG000|Overall Study|Protocol Deviation|5|||
154982828|NCT00252174|559361991|FG000|Overall Study|Withdrawal by Subject|0|||
154982829|NCT00252174|559361992|FG001|Overall Study|Withdrawal by Subject|1|||
154982830|NCT00252174|559361993|FG002|Overall Study|Withdrawal by Subject|0|||
154982831|NCT02224573|559361994|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
154982832|NCT02224573|559361995|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
154982833|NCT02224573|559361994|FG000|Treatment Phase|Started on Other IMP|1|||
154982834|NCT02224573|559361995|FG001|Treatment Phase|Started on Other IMP|0|||
154982835|NCT02224573|559361994|FG000|Treatment Phase|Participant Discontinued IMP|0|||
154982836|NCT02224573|559361995|FG001|Treatment Phase|Participant Discontinued IMP|1|||
154982837|NCT02224573|559361994|FG000|Treatment Phase|Lack of Efficacy|15|||
154982838|NCT02224573|559361995|FG001|Treatment Phase|Lack of Efficacy|8|||
154982839|NCT02224573|559361994|FG000|Treatment Phase|Began Commercial Product|1|||
154982840|NCT02224573|559361995|FG001|Treatment Phase|Began Commercial Product|0|||
154982841|NCT02224573|559361994|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
154982842|NCT02224573|559361995|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
154982843|NCT02224573|559361994|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
154982844|NCT02224573|559361995|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
154982845|NCT02224573|559361994|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
154982846|NCT02224573|559361995|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
154982847|NCT02224573|559361994|FG000|Treatment Phase|Continued Compassionate Use|1|||
154982848|NCT02224573|559361995|FG001|Treatment Phase|Continued Compassionate Use|0|||
154982849|NCT02224573|559361994|FG000|Treatment Phase|Lack of Efficiency|2|||
154982850|NCT02224573|559361995|FG001|Treatment Phase|Lack of Efficiency|1|||
154982851|NCT02224573|559361994|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
154982852|NCT02224573|559361995|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
154982853|NCT02224573|559361994|FG000|Treatment Phase|Participant Moved|2|||
154982854|NCT02224573|559361995|FG001|Treatment Phase|Participant Moved|0|||
154982855|NCT02224573|559361994|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
154982856|NCT02224573|559361995|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
154982857|NCT02224573|559361994|FG000|Treatment Phase|Refused Medication|1|||
154982858|NCT02224573|559361995|FG001|Treatment Phase|Refused Medication|1|||
154982859|NCT02224573|559361994|FG000|Treatment Phase|Adverse Event|26|||
154982860|NCT02224573|559361995|FG001|Treatment Phase|Adverse Event|38|||
154982861|NCT02224573|559361994|FG000|Treatment Phase|Placed in Group Home|0|||
154982862|NCT02224573|559361995|FG001|Treatment Phase|Placed in Group Home|1|||
154982863|NCT02224573|559361994|FG000|Treatment Phase|Pursued Other Trials|1|||
154982864|NCT02224573|559361995|FG001|Treatment Phase|Pursued Other Trials|0|||
154982865|NCT02224573|559361994|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
154982866|NCT02224573|559361995|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
154982867|NCT02224573|559361994|FG000|Treatment Phase|Lost to Follow-up|2|||
154982868|NCT02224573|559361995|FG001|Treatment Phase|Lost to Follow-up|1|||
154982869|NCT02224573|559361994|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
154982870|NCT02224573|559361995|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
154982871|NCT02224573|559361994|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
154982872|NCT02224573|559361995|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
154982873|NCT02224573|559361994|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
154982874|NCT02224573|559361995|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
154982875|NCT02224573|559361994|FG000|Taper Phase|Adverse Event|1|||
154982876|NCT02224573|559361995|FG001|Taper Phase|Adverse Event|1|||
154982877|NCT02546362|559361996|FG000|4-week Treatment Period|Lost to Follow-up|1|||
154982878|NCT02546362|559361996|FG000|4-week Treatment Period|Change in medication|2|||
154982879|NCT02546362|559361996|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
154982880|NCT02546362|559361996|FG000|12-week Treatment Period|Lost to Follow-up|2|||
155115968|NCT01257568|559855140|FG000|Overall Study|Terminated|1|||
155115969|NCT01257568|559855140|FG000|Overall Study|Component Revision|24|||
155115970|NCT00132691|559855148|FG000|Overall Study|Lost to Follow-up|5|||
155115971|NCT00132691|559855149|FG001|Overall Study|Lost to Follow-up|8|||
155115972|NCT00132691|559855148|FG000|Overall Study|Missed 2-year visit|4|||
155115973|NCT00132691|559855149|FG001|Overall Study|Missed 2-year visit|4|||
155115974|NCT00132691|559855148|FG000|Overall Study|Death|2|||
154982881|NCT02546362|559361996|FG000|12-week Treatment Period|Change in medication|1|||
154982882|NCT01138826|559361997|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
154982883|NCT01138826|559361998|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
154982884|NCT01138826|559361999|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
154982885|NCT01138826|559362000|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
155115975|NCT00132691|559855149|FG001|Overall Study|Death|0|||
155115976|NCT03356977|559855150|FG000|Overall Study|Lost to Follow-up|3|||
155115977|NCT03356977|559855150|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155115978|NCT00908115|559855157|FG000|Overall Study|Other|14|||
155115979|NCT01728077|559855158|FG000|Overall Study|Lack of Efficacy|3|||
155115980|NCT01728077|559855159|FG001|Overall Study|Lack of Efficacy|1|||
155115981|NCT01728077|559855158|FG000|Overall Study|Lost to Follow-up|1|||
155115982|NCT01728077|559855159|FG001|Overall Study|Lost to Follow-up|0|||
155115983|NCT01728077|559855158|FG000|Overall Study|Subject choice|2|||
155115984|NCT01728077|559855159|FG001|Overall Study|Subject choice|3|||
155115985|NCT01728077|559855158|FG000|Overall Study|Death|0|||
155175965|NCT04449029|560082204|FG004|Overall Study|Adverse Event|1|||
154904680|NCT04984876|559072128|FG005|Overall Study|Physician Decision|0|||
154904681|NCT04984876|559072123|FG000|Overall Study|Adverse Event|0|||
154904682|NCT04984876|559072124|FG001|Overall Study|Adverse Event|0|||
154904683|NCT04984876|559072125|FG002|Overall Study|Adverse Event|1|||
154904684|NCT04984876|559072126|FG003|Overall Study|Adverse Event|0|||
154904685|NCT04984876|559072127|FG004|Overall Study|Adverse Event|0|||
154904686|NCT04984876|559072128|FG005|Overall Study|Adverse Event|0|||
154904687|NCT02000622|559072129|FG000|Overall Study|Withdrawal by Subject|5|||
154904688|NCT02000622|559072130|FG001|Overall Study|Withdrawal by Subject|7|||
154904689|NCT02000622|559072129|FG000|Overall Study|Lost to Follow-up|4|||
154904690|NCT02000622|559072130|FG001|Overall Study|Lost to Follow-up|0|||
154904691|NCT02000622|559072129|FG000|Overall Study|Death|159|||
154904692|NCT02000622|559072130|FG001|Overall Study|Death|73|||
154904693|NCT02000622|559072129|FG000|Overall Study|Withdrawn due to site closure|1|||
154904694|NCT02000622|559072130|FG001|Overall Study|Withdrawn due to site closure|0|||
154904695|NCT01405027|559072131|FG000|Overall Study|Withdrawn consent|3|||
154904696|NCT01405027|559072132|FG001|Overall Study|Withdrawn consent|0|||
154904697|NCT01405027|559072131|FG000|Overall Study|Lost to Follow-up|16|||
154904698|NCT01405027|559072132|FG001|Overall Study|Lost to Follow-up|24|||
154904699|NCT01405027|559072131|FG000|Overall Study|Investigator judgement|0|||
154904700|NCT01405027|559072132|FG001|Overall Study|Investigator judgement|2|||
154904701|NCT01405027|559072131|FG000|Overall Study|Death|1|||
154904702|NCT01405027|559072132|FG001|Overall Study|Death|0|||
154904703|NCT01405027|559072131|FG000|Overall Study|Other or Unknown|12|||
154904704|NCT01405027|559072132|FG001|Overall Study|Other or Unknown|25|||
154904705|NCT01938391|559072136|FG000|6 Month Follow up|Withdrawal by Subject|1|||
154904706|NCT01938391|559072136|FG000|12 Month Follow up|Physician Decision|1|||
154904707|NCT01938391|559072136|FG000|12 Month Follow up|Withdrawal by Subject|1|||
154904708|NCT01077193|559072137|FG000|Overall Study|Lost to Follow-up|1|||
154904709|NCT01077193|559072137|FG000|Overall Study|Withdrawal by Subject|2|||
154904710|NCT01077193|559072137|FG000|Overall Study|Lack of Efficacy|1|||
154904711|NCT01077193|559072137|FG000|Overall Study|Study Terminated by Sponsor|40|||
154904712|NCT04924114|559072141|FG000|Overall Study|Withdrawal by Subject|0|||
154904713|NCT04924114|559072142|FG001|Overall Study|Withdrawal by Subject|2|||
154904714|NCT04924114|559072143|FG002|Overall Study|Withdrawal by Subject|2|||
154904715|NCT04924114|559072144|FG003|Overall Study|Withdrawal by Subject|0|||
154904716|NCT04924114|559072145|FG004|Overall Study|Withdrawal by Subject|2|||
154904717|NCT04960202|559072146|FG000|Overall Study|Other|5|||
154904718|NCT04960202|559072147|FG001|Overall Study|Other|0|||
154904719|NCT04960202|559072146|FG000|Overall Study|Withdrawal by Subject|37|||
154904720|NCT04960202|559072147|FG001|Overall Study|Withdrawal by Subject|43|||
154904721|NCT04960202|559072146|FG000|Overall Study|Lost to Follow-up|20|||
154904722|NCT04960202|559072147|FG001|Overall Study|Lost to Follow-up|16|||
154904723|NCT04960202|559072146|FG000|Overall Study|Death|0|||
154904724|NCT04960202|559072147|FG001|Overall Study|Death|15|||
154904725|NCT03774875|559072149|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
154904726|NCT03774875|559072150|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
154904727|NCT03774875|559072149|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
154904728|NCT03774875|559072150|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
154904729|NCT03774875|559072149|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
154904730|NCT03774875|559072150|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
154904731|NCT03774875|559072149|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
154904732|NCT03774875|559072150|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
154904733|NCT03774875|559072149|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
154904734|NCT03774875|559072150|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
154904735|NCT03774875|559072149|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
154904736|NCT03774875|559072150|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
154904737|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
154904738|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
154904739|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
154904740|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
154904741|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
154904742|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
154904743|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
155115986|NCT01728077|559855159|FG001|Overall Study|Death|1|||
155115987|NCT01728077|559855158|FG000|Overall Study|Patient moving|1|||
155115988|NCT01728077|559855159|FG001|Overall Study|Patient moving|0|||
155115989|NCT01728077|559855158|FG000|Overall Study|Non compliance|1|||
155115990|NCT01728077|559855159|FG001|Overall Study|Non compliance|0|||
155115991|NCT00378599|559855160|FG000|Overall Study|Adverse Event|38|||
155115992|NCT00378599|559855160|FG000|Overall Study|Protocol Violation|2|||
155115993|NCT00378599|559855160|FG000|Overall Study|Treatment failure|7|||
155115994|NCT00378599|559855160|FG000|Overall Study|Withdrawal by Subject|5|||
155115995|NCT00642369|559855161|FG000|Overall Study|Adverse Event|2|||
155115996|NCT00642369|559855162|FG001|Overall Study|Adverse Event|3|||
155115997|NCT00642369|559855161|FG000|Overall Study|Withdrawal by Subject|1|||
155115998|NCT00642369|559855162|FG001|Overall Study|Withdrawal by Subject|0|||
155175966|NCT04449029|560082205|FG005|Overall Study|Adverse Event|0|||
155175967|NCT04449029|560082206|FG006|Overall Study|Adverse Event|1|||
154904744|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
154904745|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
154904746|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
154904747|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
154904748|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
154904749|NCT03774875|559072149|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
154904750|NCT03774875|559072150|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
154904751|NCT02498392|559072151|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
154904752|NCT02498392|559072152|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
154904753|NCT02498392|559072151|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
154904754|NCT02498392|559072152|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
154904755|NCT02498392|559072151|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
154904756|NCT02498392|559072152|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
154904757|NCT02498392|559072151|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
154904758|NCT02498392|559072152|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
154904759|NCT02498392|559072151|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
154904760|NCT02498392|559072152|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
154904761|NCT02498392|559072151|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
154904762|NCT02498392|559072152|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
154904763|NCT02352090|559072153|FG000|Overall Study|general malaise|1|||
154904764|NCT02352090|559072154|FG001|Overall Study|general malaise|0|||
154904765|NCT02352090|559072155|FG002|Overall Study|general malaise|0|||
154904766|NCT02352090|559072153|FG000|Overall Study|non-specified mild side-effects|0|||
154904767|NCT02352090|559072154|FG001|Overall Study|non-specified mild side-effects|0|||
154904768|NCT02352090|559072155|FG002|Overall Study|non-specified mild side-effects|2|||
154904769|NCT03687827|559072156|FG000|Treatment Period 1|Death|0|||
154904770|NCT03687827|559072157|FG001|Treatment Period 1|Death|1|||
154904771|NCT03687827|559072156|FG000|Treatment Period 1|Lost to Follow-up|2|||
154904772|NCT03687827|559072157|FG001|Treatment Period 1|Lost to Follow-up|2|||
154904773|NCT03687827|559072156|FG000|Treatment Period 1|Physician Decision|5|||
154904774|NCT03687827|559072157|FG001|Treatment Period 1|Physician Decision|2|||
154904775|NCT03687827|559072156|FG000|Treatment Period 1|Withdrawal by Subject|7|||
154904776|NCT03687827|559072157|FG001|Treatment Period 1|Withdrawal by Subject|3|||
154904777|NCT03687827|559072156|FG000|Treatment Period 2|Physician Decision|4|||
154904778|NCT03687827|559072157|FG001|Treatment Period 2|Physician Decision|1|||
154904779|NCT03687827|559072156|FG000|Treatment Period 2|Withdrawal by Subject|1|||
154904780|NCT03687827|559072157|FG001|Treatment Period 2|Withdrawal by Subject|2|||
154904781|NCT01678313|559072163|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
154904782|NCT01678313|559072164|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
154904783|NCT01678313|559072163|FG000|Completed the 3-month Therapy|Physician Decision|3|||
154904784|NCT01678313|559072164|FG001|Completed the 3-month Therapy|Physician Decision|4|||
154904785|NCT01678313|559072163|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
154904786|NCT01678313|559072164|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
154904787|NCT01678313|559072163|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
154904788|NCT01678313|559072164|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
154904789|NCT00981292|559072165|FG000|Day 1|Protocol Violation|1|||
154904790|NCT00981292|559072166|FG001|Day 1|Protocol Violation|0|||
154904791|NCT00981292|559072167|FG002|Day 1|Protocol Violation|0|||
154904792|NCT00981292|559072168|FG003|Day 1|Protocol Violation|0|||
154904793|NCT00981292|559072169|FG004|Day 1|Protocol Violation|0|||
154904794|NCT00981292|559072170|FG005|Day 1|Protocol Violation|2|||
154904795|NCT00981292|559072165|FG000|Day 2|Protocol Violation|2|||
154904796|NCT00981292|559072166|FG001|Day 2|Protocol Violation|0|||
154904797|NCT00981292|559072167|FG002|Day 2|Protocol Violation|0|||
154904798|NCT00981292|559072168|FG003|Day 2|Protocol Violation|0|||
154904799|NCT00981292|559072169|FG004|Day 2|Protocol Violation|0|||
154904800|NCT00981292|559072170|FG005|Day 2|Protocol Violation|0|||
154904801|NCT00981292|559072165|FG000|Day 3|Protocol Violation|0|||
154904802|NCT00981292|559072166|FG001|Day 3|Protocol Violation|0|||
155115999|NCT00642369|559855161|FG000|Overall Study|misdiagnosis|0|||
155116000|NCT00642369|559855162|FG001|Overall Study|misdiagnosis|1|||
155116001|NCT00642369|559855161|FG000|Overall Study|Lack of Efficacy|2|||
155116002|NCT00642369|559855162|FG001|Overall Study|Lack of Efficacy|2|||
155116003|NCT04035564|559855163|FG000|Overall Study|Protocol Violation|1|||
155116004|NCT04035564|559855164|FG001|Overall Study|Protocol Violation|2|||
154982886|NCT01138826|559362001|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
154982887|NCT01138826|559362002|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
154982888|NCT02566993|559362003|FG000|Overall Study|Randomized but not treated|5|||
154982889|NCT02566993|559362004|FG001|Overall Study|Randomized but not treated|16|||
154982890|NCT02566993|559362003|FG000|Overall Study|Progressive disease|213|||
154982891|NCT02566993|559362004|FG001|Overall Study|Progressive disease|152|||
154982892|NCT02566993|559362003|FG000|Overall Study|Withdrawal by Subject|12|||
154982893|NCT02566993|559362004|FG001|Overall Study|Withdrawal by Subject|28|||
154982894|NCT02566993|559362003|FG000|Overall Study|Death|17|||
154982895|NCT02566993|559362004|FG001|Overall Study|Death|23|||
154982896|NCT02566993|559362003|FG000|Overall Study|Physician Decision|10|||
154982897|NCT02566993|559362004|FG001|Overall Study|Physician Decision|17|||
154982898|NCT02566993|559362003|FG000|Overall Study|Study drug-related adverse event|20|||
154982899|NCT02566993|559362004|FG001|Overall Study|Study drug-related adverse event|41|||
154982900|NCT02566993|559362003|FG000|Overall Study|Non study drug-related adverse event|9|||
154982901|NCT02566993|559362004|FG001|Overall Study|Non study drug-related adverse event|9|||
154982902|NCT02566993|559362003|FG000|Overall Study|Symptomatic deterioration|9|||
154982903|NCT02566993|559362004|FG001|Overall Study|Symptomatic deterioration|16|||
154982904|NCT02566993|559362003|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
154982905|NCT02566993|559362004|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
154982906|NCT02566993|559362003|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
154982907|NCT02566993|559362004|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
154982908|NCT02566993|559362003|FG000|Overall Study|Screening failure|2|||
154982909|NCT02566993|559362004|FG001|Overall Study|Screening failure|0|||
154982910|NCT02566993|559362003|FG000|Overall Study|Lost to Follow-up|0|||
154982911|NCT02566993|559362004|FG001|Overall Study|Lost to Follow-up|1|||
155116005|NCT04035564|559855163|FG000|Overall Study|No laboratory available|2|||
155116006|NCT04035564|559855164|FG001|Overall Study|No laboratory available|2|||
155116007|NCT04035564|559855163|FG000|Overall Study|Guardian declined consent|1|||
155116008|NCT04035564|559855164|FG001|Overall Study|Guardian declined consent|2|||
155116009|NCT00624585|559855169|FG000|Overall Study|Death|3|||
154904803|NCT00981292|559072167|FG002|Day 3|Protocol Violation|0|||
154904804|NCT00981292|559072168|FG003|Day 3|Protocol Violation|0|||
154904805|NCT00981292|559072169|FG004|Day 3|Protocol Violation|0|||
154904806|NCT00981292|559072170|FG005|Day 3|Protocol Violation|1|||
154904807|NCT03377452|559072171|FG000|Overall Study|Refused assessment|0|||
154904808|NCT03377452|559072172|FG001|Overall Study|Refused assessment|2|||
154904809|NCT03377452|559072171|FG000|Overall Study|Lost to Follow-up|5|||
154904810|NCT03377452|559072172|FG001|Overall Study|Lost to Follow-up|4|||
154904811|NCT05179057|559072173|FG000|Overall Study|Adverse Event|3|||
154904812|NCT05179057|559072174|FG001|Overall Study|Adverse Event|2|||
154904813|NCT05179057|559072173|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
154904814|NCT05179057|559072174|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
154904815|NCT05179057|559072173|FG000|Overall Study|Study terminated|13|||
154904816|NCT05179057|559072174|FG001|Overall Study|Study terminated|7|||
154904817|NCT05179057|559072173|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
154904818|NCT05179057|559072174|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
154904819|NCT05179057|559072173|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
154904820|NCT05179057|559072174|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
154904821|NCT03375203|559072175|FG000|Overall Study|Protocol Violation|0|||
154904822|NCT03375203|559072176|FG001|Overall Study|Protocol Violation|0|||
154904823|NCT03375203|559072177|FG002|Overall Study|Protocol Violation|1|||
154904824|NCT03375203|559072178|FG003|Overall Study|Protocol Violation|0|||
154904825|NCT03375203|559072179|FG004|Overall Study|Protocol Violation|0|||
154904826|NCT03375203|559072175|FG000|Overall Study|Adverse Event|2|||
154904827|NCT03375203|559072176|FG001|Overall Study|Adverse Event|3|||
154904828|NCT03375203|559072177|FG002|Overall Study|Adverse Event|0|||
154904829|NCT03375203|559072178|FG003|Overall Study|Adverse Event|2|||
154904830|NCT03375203|559072179|FG004|Overall Study|Adverse Event|2|||
154904831|NCT03375203|559072175|FG000|Overall Study|Withdrawal by Subject|3|||
154904832|NCT03375203|559072176|FG001|Overall Study|Withdrawal by Subject|0|||
154904833|NCT03375203|559072177|FG002|Overall Study|Withdrawal by Subject|1|||
154904834|NCT03375203|559072178|FG003|Overall Study|Withdrawal by Subject|0|||
154904835|NCT03375203|559072179|FG004|Overall Study|Withdrawal by Subject|2|||
154904836|NCT03375203|559072175|FG000|Overall Study|Non-compliance with study drug|1|||
154904837|NCT03375203|559072176|FG001|Overall Study|Non-compliance with study drug|0|||
154904838|NCT03375203|559072177|FG002|Overall Study|Non-compliance with study drug|0|||
154982912|NCT02566993|559362003|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
155116010|NCT00624585|559855169|FG000|Overall Study|Disease Progression|6|||
155116011|NCT00624585|559855169|FG000|Overall Study|Adverse Event|3|||
155116012|NCT04154345|559855174|FG000|Overall Study|Covid-19 pandemic|4|||
155116013|NCT00676520|559855176|FG000|Overall Study|Withdrawal by Subject|163|||
155116014|NCT00676520|559855176|FG000|Overall Study|Lost to Follow-up|162|||
155116015|NCT00676520|559855176|FG000|Overall Study|Death|159|||
155116016|NCT00676520|559855176|FG000|Overall Study|Physician Decision|20|||
155116017|NCT00676520|559855176|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
155116018|NCT00676520|559855176|FG000|Overall Study|Other Reason|18|||
155116019|NCT01425359|559855177|FG000|Overall Study|Randomized but Not Treated|2|||
155116020|NCT01425359|559855178|FG001|Overall Study|Randomized but Not Treated|3|||
155116021|NCT01425359|559855177|FG000|Overall Study|Adverse Event|9|||
155116022|NCT01425359|559855178|FG001|Overall Study|Adverse Event|8|||
155116023|NCT01425359|559855177|FG000|Overall Study|Revascularization|0|||
155116024|NCT01425359|559855178|FG001|Overall Study|Revascularization|1|||
155116025|NCT01425359|559855177|FG000|Overall Study|Death|0|||
155116026|NCT01425359|559855178|FG001|Overall Study|Death|1|||
155116027|NCT01425359|559855177|FG000|Overall Study|Unsatisfactory Response|1|||
155116028|NCT01425359|559855178|FG001|Overall Study|Unsatisfactory Response|0|||
155116029|NCT01425359|559855177|FG000|Overall Study|Protocol Violation|1|||
155116030|NCT01425359|559855178|FG001|Overall Study|Protocol Violation|2|||
155116031|NCT01425359|559855177|FG000|Overall Study|Subject Withdrew Consent|1|||
155116032|NCT01425359|559855178|FG001|Overall Study|Subject Withdrew Consent|2|||
155116033|NCT01425359|559855177|FG000|Overall Study|Investigator's Discretion|2|||
155116034|NCT01425359|559855178|FG001|Overall Study|Investigator's Discretion|0|||
155116035|NCT01425359|559855177|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
155116036|NCT01425359|559855178|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
155116037|NCT04043234|559855183|FG000|Overall Study|Lost to Follow-up|1|||
155116038|NCT04043234|559855183|FG000|Overall Study|Withdrawal by Subject|1|||
155116039|NCT01165320|559855184|FG000|Overall Study|Clinical adverse experience|2|||
155116040|NCT01165320|559855185|FG001|Overall Study|Clinical adverse experience|1|||
155116041|NCT01165320|559855186|FG002|Overall Study|Clinical adverse experience|0|||
155116042|NCT01165320|559855184|FG000|Overall Study|Laboratory adverse experience|1|||
155116043|NCT01165320|559855185|FG001|Overall Study|Laboratory adverse experience|0|||
155116044|NCT01165320|559855186|FG002|Overall Study|Laboratory adverse experience|0|||
154982913|NCT02566993|559362004|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
154982914|NCT05206448|559362005|FG000|Overall Study|Lost to Follow-up|2|||
154982915|NCT05206448|559362006|FG001|Overall Study|Lost to Follow-up|2|||
154982916|NCT05206448|559362005|FG000|Overall Study|Withdrawal by Subject|2|||
154982917|NCT05206448|559362006|FG001|Overall Study|Withdrawal by Subject|0|||
154982918|NCT05206448|559362005|FG000|Overall Study|found ineligible after randomization|1|||
154982919|NCT05206448|559362006|FG001|Overall Study|found ineligible after randomization|1|||
154982920|NCT05206448|559362005|FG000|Overall Study|unable to complete study due to personal constraints|1|||
154982921|NCT05206448|559362006|FG001|Overall Study|unable to complete study due to personal constraints|0|||
154982922|NCT05206448|559362005|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
154982923|NCT05206448|559362006|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
154982924|NCT02589522|559362008|FG000|Overall Study|Physician Decision|1|||
154982925|NCT02589522|559362009|FG001|Overall Study|Physician Decision|2|||
154982926|NCT02589522|559362010|FG002|Overall Study|Physician Decision|0|||
154982927|NCT02589522|559362008|FG000|Overall Study|Did not start treatment|1|||
154982928|NCT02589522|559362009|FG001|Overall Study|Did not start treatment|0|||
154982929|NCT02589522|559362010|FG002|Overall Study|Did not start treatment|0|||
154982930|NCT05611996|559362011|FG000|Overall Study|Ineligible|1|||
154982931|NCT05611996|559362011|FG000|Overall Study|Withdrawal by Subject|9|||
154982932|NCT04479475|559362012|FG000|Overall Study|Withdrawal by Subject|7|||
154982933|NCT03451006|559362013|FG000|Overall Study|Withdrawal by Subject|2|||
154982934|NCT03451006|559362014|FG001|Overall Study|Withdrawal by Subject|2|||
154982935|NCT02278718|559362019|FG000|Overall Study|Adverse Event|1|||
154982936|NCT02278718|559362020|FG001|Overall Study|Adverse Event|0|||
154982937|NCT02278718|559362019|FG000|Overall Study|Lost to Follow-up|2|||
154982938|NCT02278718|559362020|FG001|Overall Study|Lost to Follow-up|4|||
154982939|NCT02278718|559362019|FG000|Overall Study|Withdrawal by Subject|1|||
154982940|NCT02278718|559362020|FG001|Overall Study|Withdrawal by Subject|4|||
154982941|NCT02278718|559362019|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
154982942|NCT02278718|559362020|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
154982943|NCT02278718|559362019|FG000|Overall Study|Missing|0|||
154982944|NCT02278718|559362020|FG001|Overall Study|Missing|1|||
154982945|NCT04440449|559362021|FG000|Overall Study|Lost to Follow-up|2|||
154982946|NCT04440449|559362022|FG001|Overall Study|Lost to Follow-up|0|||
154982947|NCT02547766|559362023|FG000|Overall Study|Withdrawal by Subject|1|||
154982948|NCT03253744|559362030|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
155116045|NCT01165320|559855184|FG000|Overall Study|Lack of Efficacy|0|||
155116046|NCT01165320|559855185|FG001|Overall Study|Lack of Efficacy|2|||
155116047|NCT01165320|559855186|FG002|Overall Study|Lack of Efficacy|0|||
155116048|NCT01165320|559855184|FG000|Overall Study|Reason unknown|0|||
155116049|NCT01165320|559855185|FG001|Overall Study|Reason unknown|1|||
154982949|NCT03253744|559362031|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
154982950|NCT03253744|559362032|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
154982951|NCT03253744|559362033|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
154982952|NCT03847194|559362034|FG000|Overall Study|Lost to Follow-up|2|||
154982953|NCT03847194|559362035|FG001|Overall Study|Lost to Follow-up|5|||
154982954|NCT03847194|559362034|FG000|Overall Study|Withdrawal by Subject|1|||
154982955|NCT03847194|559362035|FG001|Overall Study|Withdrawal by Subject|2|||
154982956|NCT03847194|559362034|FG000|Overall Study|Death|0|||
154982957|NCT03847194|559362035|FG001|Overall Study|Death|1|||
154982958|NCT01134627|559362036|FG000|Overall Study|Adverse Event|47|||
154982959|NCT01134627|559362037|FG001|Overall Study|Adverse Event|31|||
154982960|NCT01134627|559362036|FG000|Overall Study|Lost to Follow-up|1|||
154982961|NCT01134627|559362037|FG001|Overall Study|Lost to Follow-up|2|||
154982962|NCT01134627|559362036|FG000|Overall Study|Protocol Violation|3|||
154982963|NCT01134627|559362037|FG001|Overall Study|Protocol Violation|5|||
154982964|NCT01134627|559362036|FG000|Overall Study|Lack of Efficacy|2|||
154982965|NCT01134627|559362037|FG001|Overall Study|Lack of Efficacy|12|||
154982966|NCT01134627|559362036|FG000|Overall Study|Withdrawal by Subject|4|||
154982967|NCT01134627|559362037|FG001|Overall Study|Withdrawal by Subject|3|||
154982968|NCT01134627|559362036|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
154982969|NCT01134627|559362037|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
154982970|NCT01134627|559362036|FG000|Overall Study|Other|11|||
154982971|NCT01134627|559362037|FG001|Overall Study|Other|14|||
154982972|NCT01010750|559362038|FG000|Second Intervention|Adverse Event|0|||
154982973|NCT01010750|559362039|FG001|Second Intervention|Adverse Event|1|||
154982974|NCT01010750|559362040|FG002|Second Intervention|Adverse Event|0|||
154982975|NCT01010750|559362041|FG003|Second Intervention|Adverse Event|0|||
154982976|NCT01010750|559362042|FG004|Second Intervention|Adverse Event|0|||
154982977|NCT01010750|559362043|FG005|Second Intervention|Adverse Event|0|||
154982978|NCT02442271|559362046|FG000|Overall Study|Adverse Event|1|||
154982979|NCT02442271|559362046|FG000|Overall Study|Withdrew Consent|1|||
154982980|NCT02442271|559362046|FG000|Overall Study|Lost to Follow-up|1|||
154982981|NCT02442271|559362046|FG000|Overall Study|Other|1|||
154982982|NCT01560507|559362047|FG000|Overall Study|Lost to Follow-up|3|||
154982983|NCT01560507|559362048|FG001|Overall Study|Lost to Follow-up|1|||
154982984|NCT01560507|559362049|FG002|Overall Study|Lost to Follow-up|2|||
154982985|NCT01560507|559362047|FG000|Overall Study|Withdrawal by Subject|1|||
154982986|NCT01560507|559362048|FG001|Overall Study|Withdrawal by Subject|1|||
154982987|NCT01560507|559362049|FG002|Overall Study|Withdrawal by Subject|0|||
154982988|NCT03545191|559362050|FG000|Overall Study|Death|1|||
154982989|NCT03545191|559362051|FG001|Overall Study|Death|0|||
154982990|NCT03545191|559362052|FG002|Overall Study|Death|0|||
154982991|NCT03545191|559362050|FG000|Overall Study|Adverse Event|4|||
154982992|NCT03545191|559362051|FG001|Overall Study|Adverse Event|2|||
154982993|NCT03545191|559362052|FG002|Overall Study|Adverse Event|7|||
154982994|NCT03545191|559362050|FG000|Overall Study|Other reasons|3|||
154982995|NCT03545191|559362051|FG001|Overall Study|Other reasons|11|||
154982996|NCT03545191|559362052|FG002|Overall Study|Other reasons|8|||
154982997|NCT03545191|559362050|FG000|Overall Study|Withdrawal by Subject|13|||
154982998|NCT03545191|559362051|FG001|Overall Study|Withdrawal by Subject|10|||
154982999|NCT03545191|559362052|FG002|Overall Study|Withdrawal by Subject|12|||
154983000|NCT03545191|559362050|FG000|Overall Study|Lost to Follow-up|1|||
154983001|NCT03545191|559362051|FG001|Overall Study|Lost to Follow-up|2|||
154983002|NCT03545191|559362052|FG002|Overall Study|Lost to Follow-up|3|||
154983003|NCT02746627|559362057|FG000|Overall Study|Withdrawal by Subject|1|||
154983004|NCT02746627|559362058|FG001|Overall Study|Withdrawal by Subject|1|||
154983005|NCT02746627|559362059|FG002|Overall Study|Withdrawal by Subject|1|||
154983006|NCT02858726|559362060|FG000|Overall Study|Adverse Event|4|||
154983007|NCT02858726|559362061|FG001|Overall Study|Adverse Event|4|||
154983008|NCT02858726|559362062|FG002|Overall Study|Adverse Event|9|||
154983009|NCT02858726|559362063|FG003|Overall Study|Adverse Event|1|||
154983010|NCT02858726|559362060|FG000|Overall Study|Physician Decision|0|||
154983011|NCT02858726|559362061|FG001|Overall Study|Physician Decision|0|||
154983012|NCT02858726|559362062|FG002|Overall Study|Physician Decision|1|||
154983013|NCT02858726|559362063|FG003|Overall Study|Physician Decision|0|||
155116050|NCT01165320|559855186|FG002|Overall Study|Reason unknown|0|||
155116051|NCT00385944|559855188|FG000|1st Maintenance Dose Period|Physician Decision|1|||
154983014|NCT02858726|559362060|FG000|Overall Study|Protocol Violation|0|||
154983015|NCT02858726|559362061|FG001|Overall Study|Protocol Violation|0|||
154983016|NCT02858726|559362062|FG002|Overall Study|Protocol Violation|0|||
154983017|NCT02858726|559362063|FG003|Overall Study|Protocol Violation|1|||
154983018|NCT02858726|559362060|FG000|Overall Study|Study Terminated by Sponsor|0|||
154983019|NCT02858726|559362061|FG001|Overall Study|Study Terminated by Sponsor|0|||
154983020|NCT02858726|559362062|FG002|Overall Study|Study Terminated by Sponsor|0|||
154983021|NCT02858726|559362063|FG003|Overall Study|Study Terminated by Sponsor|1|||
154983022|NCT02858726|559362060|FG000|Overall Study|Withdrawal by Subject|1|||
155116052|NCT00385944|559855189|FG001|1st Maintenance Dose Period|Physician Decision|0|||
154983023|NCT02858726|559362061|FG001|Overall Study|Withdrawal by Subject|2|||
154983024|NCT02858726|559362062|FG002|Overall Study|Withdrawal by Subject|1|||
155116053|NCT00385944|559855190|FG002|1st Maintenance Dose Period|Physician Decision|0|||
155175968|NCT04449029|560082207|FG007|Overall Study|Adverse Event|0|||
154904839|NCT03375203|559072178|FG003|Overall Study|Non-compliance with study drug|0|||
154904840|NCT03375203|559072179|FG004|Overall Study|Non-compliance with study drug|0|||
154904841|NCT03375203|559072175|FG000|Overall Study|Randomized, not treated.|0|||
154904842|NCT03375203|559072176|FG001|Overall Study|Randomized, not treated.|1|||
154904843|NCT03375203|559072177|FG002|Overall Study|Randomized, not treated.|0|||
154904844|NCT03375203|559072178|FG003|Overall Study|Randomized, not treated.|0|||
154904845|NCT03375203|559072179|FG004|Overall Study|Randomized, not treated.|0|||
154904846|NCT03107793|559072180|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
154904847|NCT03107793|559072181|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
154904848|NCT03107793|559072182|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
154904849|NCT03107793|559072183|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
154904850|NCT03107793|559072184|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
154904851|NCT03107793|559072180|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
154904852|NCT03107793|559072181|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
154904853|NCT03107793|559072182|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
154904854|NCT03107793|559072183|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
154904855|NCT03107793|559072184|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
154904856|NCT03107793|559072180|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
154904857|NCT03107793|559072181|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
154904858|NCT03107793|559072182|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
154904859|NCT03107793|559072183|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
154904860|NCT03107793|559072184|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
154904861|NCT03107793|559072180|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
154904862|NCT03107793|559072181|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
154904863|NCT03107793|559072182|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
154904864|NCT03107793|559072183|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
154904865|NCT03107793|559072184|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
154904866|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
154904867|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
154904868|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
154904869|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
154904870|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
154904871|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
154904872|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
154904873|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
154904874|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
154904875|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
154904876|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
154904877|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
154904878|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
154904879|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
154904880|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
154904881|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
154904882|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
154904883|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
154904884|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
154904885|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
154904886|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
154904887|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
154904888|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
154904889|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
154904890|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
154904891|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
154904892|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
154904893|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
154904894|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
154904895|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
154904896|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154904897|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
154904898|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154904899|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154904900|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
154904901|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
154904902|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
154904903|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
154904904|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
154904905|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
154983025|NCT02858726|559362063|FG003|Overall Study|Withdrawal by Subject|0|||
154983026|NCT02858726|559362060|FG000|Overall Study|Noncompliance|0|||
154983027|NCT02858726|559362061|FG001|Overall Study|Noncompliance|1|||
154983028|NCT02858726|559362062|FG002|Overall Study|Noncompliance|0|||
154983029|NCT02858726|559362063|FG003|Overall Study|Noncompliance|0|||
154983030|NCT00233987|559362068|FG000|Overall Study|Withdrawal by Subject|1|||
154983031|NCT00233987|559362068|FG000|Overall Study|Lack of Efficacy|2|||
154983032|NCT00233987|559362068|FG000|Overall Study|Reason Under Review|1|||
154983033|NCT00233987|559362068|FG000|Overall Study|Other - Not Protocol Specified|5|||
154983034|NCT00233987|559362068|FG000|Overall Study|Eligible but No Treatment Received|2|||
154983035|NCT00233987|559362068|FG000|Overall Study|Ineligible|4|||
154983036|NCT04553913|559362071|FG000|Overall Study|patient's block resolved prior to PACU|1|||
154983037|NCT04553913|559362071|FG000|Overall Study|did not use the device properly|5|||
154983038|NCT01481324|559362073|FG000|Overall Study|Missing Data|0|||
154983039|NCT01481324|559362074|FG001|Overall Study|Missing Data|2|||
154983040|NCT01481324|559362075|FG002|Overall Study|Missing Data|2|||
154983041|NCT00710749|559362078|FG000|First Intervention|Withdrawal by Subject|1|||
154983042|NCT00710749|559362079|FG001|First Intervention|Withdrawal by Subject|0|||
154983043|NCT05478252|559362080|FG000|Overall Study|Withdrawal by Subject|2|||
154983044|NCT05478252|559362081|FG001|Overall Study|Withdrawal by Subject|3|||
154983045|NCT05478252|559362080|FG000|Overall Study|Lost to Follow-up|4|||
154983046|NCT05478252|559362081|FG001|Overall Study|Lost to Follow-up|2|||
154983047|NCT05478252|559362080|FG000|Overall Study|Physician Decision|1|||
154983048|NCT05478252|559362081|FG001|Overall Study|Physician Decision|1|||
154983049|NCT05478252|559362080|FG000|Overall Study|Death|1|||
154983050|NCT05478252|559362081|FG001|Overall Study|Death|0|||
154983051|NCT04846881|559362082|FG000|Overall Study|Adverse Event|14|||
154983052|NCT04846881|559362083|FG001|Overall Study|Adverse Event|15|||
154983053|NCT04846881|559362082|FG000|Overall Study|Burden of study procedures|7|||
154983054|NCT04846881|559362083|FG001|Overall Study|Burden of study procedures|3|||
154983055|NCT04846881|559362082|FG000|Overall Study|Protocol deviation|6|||
154983056|NCT04846881|559362083|FG001|Overall Study|Protocol deviation|4|||
154983057|NCT04846881|559362082|FG000|Overall Study|Perceived lack of efficacy|5|||
154983058|NCT04846881|559362083|FG001|Overall Study|Perceived lack of efficacy|2|||
154983059|NCT04846881|559362082|FG000|Overall Study|Change of residence|2|||
154983060|NCT04846881|559362083|FG001|Overall Study|Change of residence|0|||
154983061|NCT04846881|559362082|FG000|Overall Study|Technical problems|0|||
154983062|NCT04846881|559362083|FG001|Overall Study|Technical problems|1|||
154983063|NCT04846881|559362082|FG000|Overall Study|Other than listed|3|||
154983064|NCT04846881|559362083|FG001|Overall Study|Other than listed|10|||
154983065|NCT04846881|559362082|FG000|Overall Study|No reason available|1|||
154983066|NCT04846881|559362083|FG001|Overall Study|No reason available|3|||
154983067|NCT04846881|559362082|FG000|Overall Study|Patient randomised in error|1|||
154983068|NCT04846881|559362083|FG001|Overall Study|Patient randomised in error|0|||
154983069|NCT04560998|559362084|FG000|Overall Study|Withdrawal by Subject|18|||
154983070|NCT04560998|559362085|FG001|Overall Study|Withdrawal by Subject|12|||
154983071|NCT04560998|559362084|FG000|Overall Study|Lost to Follow-up|8|||
154983072|NCT04560998|559362085|FG001|Overall Study|Lost to Follow-up|5|||
154983073|NCT04560998|559362084|FG000|Overall Study|Physician Decision|4|||
154983074|NCT04560998|559362085|FG001|Overall Study|Physician Decision|0|||
154983075|NCT03821272|559364345|FG000|Overall Study|Death|1|||
154983076|NCT03821272|559364346|FG001|Overall Study|Death|0|||
154983077|NCT03821272|559364345|FG000|Overall Study|Physician Decision|1|||
154983078|NCT03821272|559364346|FG001|Overall Study|Physician Decision|0|||
154983079|NCT03821272|559364345|FG000|Overall Study|Withdrawal by Subject|1|||
154983080|NCT03821272|559364346|FG001|Overall Study|Withdrawal by Subject|0|||
154983081|NCT03959527|559364356|FG000|Overall Study|Withdrawal by Subject|8|||
154983082|NCT03959527|559364357|FG001|Overall Study|Withdrawal by Subject|3|||
154983083|NCT03959527|559364356|FG000|Overall Study|Lost to Follow-up|31|||
154983084|NCT03959527|559364357|FG001|Overall Study|Lost to Follow-up|15|||
154983085|NCT03959527|559364356|FG000|Overall Study|Did not meet eligibility criteria|1|||
154983086|NCT03959527|559364357|FG001|Overall Study|Did not meet eligibility criteria|1|||
154983087|NCT03959527|559364356|FG000|Overall Study|Protocol Violation|10|||
154983088|NCT03959527|559364357|FG001|Overall Study|Protocol Violation|5|||
154983089|NCT01688466|559364358|FG000|Overall Study|Withdrawal by Subject|2|||
155116054|NCT00385944|559855188|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
155116055|NCT00385944|559855189|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
155116056|NCT00385944|559855190|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
154983090|NCT01688466|559364359|FG001|Overall Study|Withdrawal by Subject|1|||
155116057|NCT00385944|559855188|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
154983091|NCT01688466|559364358|FG000|Overall Study|Death|0|||
154983092|NCT01688466|559364359|FG001|Overall Study|Death|1|||
154983093|NCT01688466|559364358|FG000|Overall Study|Adverse Event|0|||
154983094|NCT01688466|559364359|FG001|Overall Study|Adverse Event|4|||
154983095|NCT01688466|559364358|FG000|Overall Study|Not evaluable|0|||
154983096|NCT01688466|559364359|FG001|Overall Study|Not evaluable|1|||
154983097|NCT01000610|559364364|FG000|Overall Study|Adverse Event|1|||
154983098|NCT01000610|559364364|FG000|Overall Study|Lost to Follow-up|4|||
154983099|NCT01000610|559364364|FG000|Overall Study|Treatment failure|1|||
154983100|NCT01010126|559364365|FG000|Overall Study|Withdrawal by Subject|1|||
154983101|NCT01010126|559364366|FG001|Overall Study|Withdrawal by Subject|0|||
154983102|NCT01010126|559364367|FG002|Overall Study|Withdrawal by Subject|1|||
154983103|NCT01010126|559364368|FG003|Overall Study|Withdrawal by Subject|0|||
154983104|NCT01010126|559364369|FG004|Overall Study|Withdrawal by Subject|3|||
154983105|NCT01010126|559364370|FG005|Overall Study|Withdrawal by Subject|0|||
154983106|NCT00493246|559364373|FG000|Overall Study|Withdrawal by Subject|0|||
154983107|NCT00493246|559364374|FG001|Overall Study|Withdrawal by Subject|0|||
154983108|NCT00493246|559364375|FG002|Overall Study|Withdrawal by Subject|0|||
154983109|NCT00493246|559364376|FG003|Overall Study|Withdrawal by Subject|0|||
154983110|NCT00493246|559364377|FG004|Overall Study|Withdrawal by Subject|1|||
154983111|NCT00493246|559364378|FG005|Overall Study|Withdrawal by Subject|0|||
154983112|NCT00493246|559364379|FG006|Overall Study|Withdrawal by Subject|0|||
154983113|NCT00493246|559364380|FG007|Overall Study|Withdrawal by Subject|0|||
154983114|NCT00493246|559364373|FG000|Overall Study|No access to draw blood|0|||
154983115|NCT00493246|559364374|FG001|Overall Study|No access to draw blood|0|||
154983116|NCT00493246|559364375|FG002|Overall Study|No access to draw blood|0|||
154983117|NCT00493246|559364376|FG003|Overall Study|No access to draw blood|0|||
154983118|NCT00493246|559364377|FG004|Overall Study|No access to draw blood|0|||
154983119|NCT00493246|559364378|FG005|Overall Study|No access to draw blood|1|||
154983120|NCT00493246|559364379|FG006|Overall Study|No access to draw blood|0|||
154983121|NCT00493246|559364380|FG007|Overall Study|No access to draw blood|0|||
154983122|NCT00493246|559364373|FG000|Overall Study|Lost to Follow-up|0|||
154983123|NCT00493246|559364374|FG001|Overall Study|Lost to Follow-up|0|||
154983124|NCT00493246|559364375|FG002|Overall Study|Lost to Follow-up|0|||
154983125|NCT00493246|559364376|FG003|Overall Study|Lost to Follow-up|0|||
154983126|NCT00493246|559364377|FG004|Overall Study|Lost to Follow-up|0|||
154983127|NCT00493246|559364378|FG005|Overall Study|Lost to Follow-up|0|||
154983128|NCT00493246|559364379|FG006|Overall Study|Lost to Follow-up|1|||
154983129|NCT00493246|559364380|FG007|Overall Study|Lost to Follow-up|0|||
154983130|NCT00595335|559364385|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
154983131|NCT00595335|559364386|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
154983132|NCT00595335|559364385|FG000|Baseline to Six Months|Disease Progression|1|||
154983133|NCT00595335|559364386|FG001|Baseline to Six Months|Disease Progression|1|||
154983134|NCT00595335|559364385|FG000|Baseline to Six Months|Adverse Event|1|||
154983135|NCT00595335|559364386|FG001|Baseline to Six Months|Adverse Event|0|||
154983136|NCT00595335|559364385|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
154983137|NCT00595335|559364386|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
154983138|NCT00595335|559364385|FG000|Six Months to Twelve Months|Disease Progression|1|||
154983139|NCT00595335|559364386|FG001|Six Months to Twelve Months|Disease Progression|0|||
154983140|NCT00493779|559364394|FG000|Overall Study|Logistical issue at site|1|||
154983141|NCT01647958|559364395|FG000|Initial Study|Lost to Follow-up|2|||
154983142|NCT01647958|559364396|FG001|Initial Study|Lost to Follow-up|3|||
154983143|NCT01647958|559364395|FG000|Continuation Phase|treatment received during Overall Study|39|||
154983144|NCT01647958|559364396|FG001|Continuation Phase|treatment received during Overall Study|0|||
154983145|NCT01647958|559364395|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
154983146|NCT01647958|559364396|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
154983147|NCT01207440|559364404|FG000|Overall Study|Adverse Event|46|||
154983148|NCT01207440|559364405|FG001|Overall Study|Adverse Event|11|||
154983149|NCT01207440|559364406|FG002|Overall Study|Adverse Event|7|||
154983150|NCT01207440|559364407|FG003|Overall Study|Adverse Event|2|||
154983151|NCT01207440|559364408|FG004|Overall Study|Adverse Event|6|||
154983152|NCT01207440|559364409|FG005|Overall Study|Adverse Event|6|||
154983153|NCT01207440|559364410|FG006|Overall Study|Adverse Event|2|||
154983154|NCT01207440|559364404|FG000|Overall Study|Death|6|||
154983155|NCT01207440|559364405|FG001|Overall Study|Death|3|||
154983156|NCT01207440|559364406|FG002|Overall Study|Death|2|||
154983157|NCT01207440|559364407|FG003|Overall Study|Death|2|||
154983158|NCT01207440|559364408|FG004|Overall Study|Death|7|||
154904906|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
154904907|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
154904908|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
154904909|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
154904910|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
154904911|NCT03107793|559072180|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
154904912|NCT03107793|559072181|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
154904913|NCT03107793|559072182|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
154904914|NCT03107793|559072183|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
154983159|NCT01207440|559364409|FG005|Overall Study|Death|5|||
154983160|NCT01207440|559364410|FG006|Overall Study|Death|1|||
154983161|NCT01207440|559364404|FG000|Overall Study|Lack of Efficacy|13|||
154983162|NCT01207440|559364405|FG001|Overall Study|Lack of Efficacy|2|||
154983163|NCT01207440|559364406|FG002|Overall Study|Lack of Efficacy|5|||
154983164|NCT01207440|559364407|FG003|Overall Study|Lack of Efficacy|1|||
154983165|NCT01207440|559364408|FG004|Overall Study|Lack of Efficacy|2|||
154983166|NCT01207440|559364409|FG005|Overall Study|Lack of Efficacy|3|||
154983167|NCT01207440|559364410|FG006|Overall Study|Lack of Efficacy|0|||
154983168|NCT01207440|559364404|FG000|Overall Study|Lost to Follow-up|0|||
154983169|NCT01207440|559364405|FG001|Overall Study|Lost to Follow-up|0|||
154983170|NCT01207440|559364406|FG002|Overall Study|Lost to Follow-up|2|||
154983171|NCT01207440|559364407|FG003|Overall Study|Lost to Follow-up|1|||
154983172|NCT01207440|559364408|FG004|Overall Study|Lost to Follow-up|0|||
154983173|NCT01207440|559364409|FG005|Overall Study|Lost to Follow-up|0|||
154983174|NCT01207440|559364410|FG006|Overall Study|Lost to Follow-up|0|||
154983175|NCT01207440|559364404|FG000|Overall Study|Non-compliance with Study Drug|3|||
154983176|NCT01207440|559364405|FG001|Overall Study|Non-compliance with Study Drug|0|||
154983177|NCT01207440|559364406|FG002|Overall Study|Non-compliance with Study Drug|1|||
154983178|NCT01207440|559364407|FG003|Overall Study|Non-compliance with Study Drug|0|||
154983179|NCT01207440|559364408|FG004|Overall Study|Non-compliance with Study Drug|0|||
154983180|NCT01207440|559364409|FG005|Overall Study|Non-compliance with Study Drug|0|||
154983181|NCT01207440|559364410|FG006|Overall Study|Non-compliance with Study Drug|0|||
154983182|NCT01207440|559364404|FG000|Overall Study|Physician Decision|6|||
154983183|NCT01207440|559364405|FG001|Overall Study|Physician Decision|5|||
154983184|NCT01207440|559364406|FG002|Overall Study|Physician Decision|5|||
154983185|NCT01207440|559364407|FG003|Overall Study|Physician Decision|0|||
154983186|NCT01207440|559364408|FG004|Overall Study|Physician Decision|1|||
154983187|NCT01207440|559364409|FG005|Overall Study|Physician Decision|0|||
154983188|NCT01207440|559364410|FG006|Overall Study|Physician Decision|0|||
154983189|NCT01207440|559364404|FG000|Overall Study|Progressive Disease|19|||
154983190|NCT01207440|559364405|FG001|Overall Study|Progressive Disease|10|||
154983191|NCT01207440|559364406|FG002|Overall Study|Progressive Disease|19|||
154983192|NCT01207440|559364407|FG003|Overall Study|Progressive Disease|7|||
154983193|NCT01207440|559364408|FG004|Overall Study|Progressive Disease|23|||
154983194|NCT01207440|559364409|FG005|Overall Study|Progressive Disease|27|||
154983195|NCT01207440|559364410|FG006|Overall Study|Progressive Disease|0|||
154983196|NCT01207440|559364404|FG000|Overall Study|Protocol Violation|2|||
154983197|NCT01207440|559364405|FG001|Overall Study|Protocol Violation|0|||
154983198|NCT01207440|559364406|FG002|Overall Study|Protocol Violation|0|||
154983199|NCT01207440|559364407|FG003|Overall Study|Protocol Violation|0|||
154983200|NCT01207440|559364408|FG004|Overall Study|Protocol Violation|0|||
154983201|NCT01207440|559364409|FG005|Overall Study|Protocol Violation|0|||
154983202|NCT01207440|559364410|FG006|Overall Study|Protocol Violation|0|||
154983203|NCT01207440|559364404|FG000|Overall Study|Site Terminated by Sponsor|69|||
154983204|NCT01207440|559364405|FG001|Overall Study|Site Terminated by Sponsor|19|||
154983205|NCT01207440|559364406|FG002|Overall Study|Site Terminated by Sponsor|12|||
154983206|NCT01207440|559364407|FG003|Overall Study|Site Terminated by Sponsor|2|||
154983207|NCT01207440|559364408|FG004|Overall Study|Site Terminated by Sponsor|3|||
154983208|NCT01207440|559364409|FG005|Overall Study|Site Terminated by Sponsor|0|||
154983209|NCT01207440|559364410|FG006|Overall Study|Site Terminated by Sponsor|2|||
154983210|NCT01207440|559364404|FG000|Overall Study|Withdrawal by Subject|29|||
154983211|NCT01207440|559364405|FG001|Overall Study|Withdrawal by Subject|4|||
154983212|NCT01207440|559364406|FG002|Overall Study|Withdrawal by Subject|5|||
154983213|NCT01207440|559364407|FG003|Overall Study|Withdrawal by Subject|3|||
154983214|NCT01207440|559364408|FG004|Overall Study|Withdrawal by Subject|2|||
154983215|NCT01207440|559364409|FG005|Overall Study|Withdrawal by Subject|2|||
154983216|NCT01207440|559364410|FG006|Overall Study|Withdrawal by Subject|0|||
154983217|NCT01207440|559364404|FG000|Overall Study|Reason Not Specified|10|||
154983218|NCT01207440|559364405|FG001|Overall Study|Reason Not Specified|10|||
154983219|NCT01207440|559364406|FG002|Overall Study|Reason Not Specified|7|||
154983220|NCT01207440|559364407|FG003|Overall Study|Reason Not Specified|0|||
154983221|NCT01207440|559364408|FG004|Overall Study|Reason Not Specified|4|||
154983222|NCT01207440|559364409|FG005|Overall Study|Reason Not Specified|3|||
155116058|NCT00385944|559855189|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
155116059|NCT00385944|559855190|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
154983223|NCT01207440|559364410|FG006|Overall Study|Reason Not Specified|0|||
154983224|NCT02698865|559364411|FG000|Overall Study|Other|11|||
154983225|NCT02698865|559364412|FG001|Overall Study|Other|11|||
154983226|NCT02698865|559364411|FG000|Overall Study|Withdrawal by Subject|20|||
154983227|NCT02698865|559364412|FG001|Overall Study|Withdrawal by Subject|16|||
154983228|NCT02698865|559364411|FG000|Overall Study|Physician Decision|0|||
154983229|NCT02698865|559364412|FG001|Overall Study|Physician Decision|4|||
155116060|NCT00385944|559855188|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
155175969|NCT04449029|560082200|FG000|Overall Study|Lost to Follow-up|0|||
154983230|NCT02698865|559364411|FG000|Overall Study|Lost to Follow-up|4|||
154983231|NCT02698865|559364412|FG001|Overall Study|Lost to Follow-up|2|||
154983232|NCT03861481|559364413|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
154983233|NCT03861481|559364414|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
154983234|NCT03861481|559364413|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
154983235|NCT03861481|559364414|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
154983236|NCT03861481|559364413|FG000|Overall Study|Relapse|1|||
155116061|NCT00385944|559855189|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
154904915|NCT03107793|559072184|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
154904916|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
154904917|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
154904918|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
154904919|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
154904920|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
154904921|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
154904922|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
154904923|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
154904924|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
154904925|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
154904926|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
154904927|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
154904928|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
154904929|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
154904930|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
154904931|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Death|0|||
154904932|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Death|0|||
154904933|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Death|0|||
154904934|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Death|0|||
154904935|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Death|1|||
154904936|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
154904937|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
154904938|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
154904939|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
154904940|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
154904941|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
154904942|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
154904943|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
154904944|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
154904945|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
154904946|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
154904947|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
154904948|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
154904949|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
154904950|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
154904951|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
154904952|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
154904953|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
154904954|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
154904955|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
154904956|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
154904957|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
154904958|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
154904959|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
154904960|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
154904961|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Other|0|||
154904962|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Other|0|||
154904963|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Other|0|||
154904964|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Other|1|||
154904965|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Other|3|||
154904966|NCT03107793|559072180|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
154904967|NCT03107793|559072181|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
154904968|NCT03107793|559072182|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
154904969|NCT03107793|559072183|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
154904970|NCT03107793|559072184|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
154904971|NCT01872897|559072192|FG000|Overall Study|Withdrawal by Subject|1|||
154904972|NCT01872897|559072193|FG001|Overall Study|Withdrawal by Subject|0|||
154904973|NCT02040857|559072194|FG000|Overall Study|Adverse Event|14|||
154904974|NCT02040857|559072194|FG000|Overall Study|Physician Decision|5|||
154983237|NCT03861481|559364414|FG001|Overall Study|Relapse|0|||
155116062|NCT00385944|559855190|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
154904975|NCT02040857|559072194|FG000|Overall Study|Withdrawal by Subject|31|||
154904976|NCT02040857|559072194|FG000|Overall Study|patient non-compliance|3|||
155116063|NCT00590824|559855191|FG000|Overall Study|Disease could not be resected|0|||
154983238|NCT03861481|559364413|FG000|Overall Study|Withdrawal by Subject|0|||
154983239|NCT03861481|559364414|FG001|Overall Study|Withdrawal by Subject|1|||
154983240|NCT03861481|559364413|FG000|Overall Study|Lack of Efficacy|4|||
154983241|NCT03861481|559364414|FG001|Overall Study|Lack of Efficacy|5|||
154983242|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
154983243|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
154983244|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
154983245|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
154983246|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
154983247|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
154983248|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
154983249|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
154983250|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
154983251|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
154983252|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
154983253|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
154983254|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
154983255|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
154983256|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
154983257|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
154983258|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
154983259|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
154904977|NCT02040857|559072194|FG000|Overall Study|Lost to Follow-up|2|||
154904978|NCT02040857|559072194|FG000|Overall Study|recurrence|4|||
154904979|NCT02040857|559072194|FG000|Overall Study|ineligible|1|||
154904980|NCT03146403|559072200|FG000|Overall Study|Withdrawal by Subject|0|||
154904981|NCT03146403|559072201|FG001|Overall Study|Withdrawal by Subject|3|||
154904982|NCT03146403|559072200|FG000|Overall Study|Lost to Follow-up|2|||
154904983|NCT03146403|559072201|FG001|Overall Study|Lost to Follow-up|0|||
154904984|NCT01024920|559072202|FG000|Overall Study|Progressive disease|47|||
154983260|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
154983261|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
154983262|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
154983263|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
154983264|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
154983265|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
154983266|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
154983267|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
154983268|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
154983269|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
154983270|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
154983271|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
154983272|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
154983273|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
154983274|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
154983275|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
154983276|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
154983277|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
154983278|NCT00773734|559364415|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
154983279|NCT00773734|559364416|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
154983280|NCT00773734|559364417|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
154983281|NCT00773734|559364418|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
154983282|NCT00773734|559364419|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
154983283|NCT00773734|559364420|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
154983284|NCT00773734|559364415|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
154983285|NCT00773734|559364416|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
154983286|NCT00773734|559364417|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
154904985|NCT01024920|559072203|FG001|Overall Study|Progressive disease|25|||
154904986|NCT01024920|559072202|FG000|Overall Study|Adverse Event|8|||
154904987|NCT01024920|559072203|FG001|Overall Study|Adverse Event|4|||
154983287|NCT00773734|559364418|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
154983288|NCT00773734|559364419|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
154983289|NCT00773734|559364420|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
154983290|NCT00773734|559364415|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
154983291|NCT00773734|559364416|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
154904988|NCT01024920|559072202|FG000|Overall Study|Lost to Follow-up|0|||
154904989|NCT01024920|559072203|FG001|Overall Study|Lost to Follow-up|1|||
154904990|NCT01024920|559072202|FG000|Overall Study|Patient refusal to continue|4|||
154983292|NCT00773734|559364417|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
154983293|NCT00773734|559364418|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
154983294|NCT00773734|559364419|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
154983295|NCT00773734|559364420|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
154983296|NCT00773734|559364415|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
154983297|NCT00773734|559364416|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
154983298|NCT00773734|559364417|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
154983299|NCT00773734|559364418|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
154983300|NCT00773734|559364419|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
154983301|NCT00773734|559364420|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
154983302|NCT00773734|559364415|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
154983303|NCT00773734|559364416|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
154983304|NCT00773734|559364417|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
154983305|NCT00773734|559364418|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
154983306|NCT00773734|559364419|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
154983307|NCT00773734|559364420|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
154983308|NCT00773734|559364415|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
154983309|NCT00773734|559364416|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
154983310|NCT00773734|559364417|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
154983311|NCT00773734|559364418|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
154983312|NCT00773734|559364419|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
154983313|NCT00773734|559364420|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
154983314|NCT00773734|559364415|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
154983315|NCT00773734|559364416|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
154983316|NCT00773734|559364417|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
154983317|NCT00773734|559364418|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
155175970|NCT04449029|560082201|FG001|Overall Study|Lost to Follow-up|1|||
155175971|NCT04449029|560082202|FG002|Overall Study|Lost to Follow-up|0|||
155175972|NCT04449029|560082203|FG003|Overall Study|Lost to Follow-up|0|||
155175973|NCT04449029|560082204|FG004|Overall Study|Lost to Follow-up|0|||
155175974|NCT04449029|560082205|FG005|Overall Study|Lost to Follow-up|0|||
155175975|NCT04449029|560082206|FG006|Overall Study|Lost to Follow-up|0|||
155175976|NCT04449029|560082207|FG007|Overall Study|Lost to Follow-up|0|||
155175977|NCT04449029|560082200|FG000|Overall Study|Protocol Violation|0|||
155175978|NCT04449029|560082201|FG001|Overall Study|Protocol Violation|1|||
155175979|NCT04449029|560082202|FG002|Overall Study|Protocol Violation|0|||
155175980|NCT04449029|560082203|FG003|Overall Study|Protocol Violation|0|||
155175981|NCT04449029|560082204|FG004|Overall Study|Protocol Violation|0|||
155175982|NCT04449029|560082205|FG005|Overall Study|Protocol Violation|0|||
155175983|NCT04449029|560082206|FG006|Overall Study|Protocol Violation|0|||
155175984|NCT04449029|560082207|FG007|Overall Study|Protocol Violation|0|||
155175985|NCT04449029|560082200|FG000|Overall Study|Physician Decision|0|||
155175986|NCT04449029|560082201|FG001|Overall Study|Physician Decision|0|||
155175987|NCT04449029|560082202|FG002|Overall Study|Physician Decision|0|||
155175988|NCT04449029|560082203|FG003|Overall Study|Physician Decision|0|||
155175989|NCT04449029|560082204|FG004|Overall Study|Physician Decision|0|||
155175990|NCT04449029|560082205|FG005|Overall Study|Physician Decision|1|||
155175991|NCT04449029|560082206|FG006|Overall Study|Physician Decision|0|||
155175992|NCT04449029|560082207|FG007|Overall Study|Physician Decision|0|||
155175993|NCT04449029|560082200|FG000|Overall Study|Withdrawal by Subject|3|||
155175994|NCT04449029|560082201|FG001|Overall Study|Withdrawal by Subject|0|||
155175995|NCT04449029|560082202|FG002|Overall Study|Withdrawal by Subject|1|||
154904991|NCT01024920|559072203|FG001|Overall Study|Patient refusal to continue|0|||
154904992|NCT01024920|559072202|FG000|Overall Study|Other than listed|5|||
154904993|NCT01024920|559072203|FG001|Overall Study|Other than listed|1|||
154904994|NCT01024920|559072202|FG000|Overall Study|Not treated|3|||
154904995|NCT01024920|559072203|FG001|Overall Study|Not treated|0|||
154904996|NCT01024920|559072202|FG000|Overall Study|Protocol Violation|0|||
154904997|NCT01024920|559072203|FG001|Overall Study|Protocol Violation|1|||
154904998|NCT02182999|559072205|FG000|Overall Study|Adverse Event|4|||
154904999|NCT02182999|559072206|FG001|Overall Study|Adverse Event|3|||
154905000|NCT02182999|559072205|FG000|Overall Study|Physician Decision|1|||
154905001|NCT02182999|559072206|FG001|Overall Study|Physician Decision|0|||
154905002|NCT02252588|559072207|FG000|Overall Study|Withdrawal by Subject|4|||
154905003|NCT02252588|559072208|FG001|Overall Study|Withdrawal by Subject|0|||
154905004|NCT02972593|559072210|FG000|Overall Study|Lost to Follow-up|19|||
154905005|NCT02972593|559072211|FG001|Overall Study|Lost to Follow-up|15|||
154905006|NCT02972593|559072210|FG000|Overall Study|Protocol Violation|1|||
154905007|NCT02972593|559072211|FG001|Overall Study|Protocol Violation|0|||
154905008|NCT00693693|559072212|FG000|Overall Study|Lost to Follow-up|1|||
154905009|NCT00693693|559072213|FG001|Overall Study|Lost to Follow-up|1|||
154905010|NCT00693693|559072214|FG002|Overall Study|Lost to Follow-up|2|||
155175996|NCT04449029|560082203|FG003|Overall Study|Withdrawal by Subject|1|||
155175997|NCT04449029|560082204|FG004|Overall Study|Withdrawal by Subject|5|||
154983318|NCT00773734|559364419|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
154983319|NCT00773734|559364420|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
154983320|NCT00773734|559364415|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
154983321|NCT00773734|559364416|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
154983322|NCT00773734|559364417|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
154983323|NCT00773734|559364418|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
154983324|NCT00773734|559364419|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
154983325|NCT00773734|559364420|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
154983326|NCT00773734|559364415|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
154983327|NCT00773734|559364416|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
154983328|NCT00773734|559364417|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
154983329|NCT00773734|559364418|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
154983330|NCT00773734|559364419|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
154983331|NCT00773734|559364420|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
154983332|NCT00773734|559364415|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
154983333|NCT00773734|559364416|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
154983334|NCT00773734|559364417|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
154983335|NCT00773734|559364418|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
154983336|NCT00773734|559364419|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
154983337|NCT00773734|559364420|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
154983338|NCT00773734|559364415|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
154983339|NCT00773734|559364416|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
154983340|NCT00773734|559364417|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
154983341|NCT00773734|559364418|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
154983342|NCT00773734|559364419|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
154983343|NCT00773734|559364420|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
154983344|NCT00773734|559364415|FG000|Extension: Active Treatment Week 24-52|Other|0|||
154983345|NCT00773734|559364416|FG001|Extension: Active Treatment Week 24-52|Other|0|||
154983346|NCT00773734|559364417|FG002|Extension: Active Treatment Week 24-52|Other|1|||
154983347|NCT00773734|559364418|FG003|Extension: Active Treatment Week 24-52|Other|2|||
154983348|NCT00773734|559364419|FG004|Extension: Active Treatment Week 24-52|Other|0|||
154983349|NCT00773734|559364420|FG005|Extension: Active Treatment Week 24-52|Other|1|||
154983350|NCT00773734|559364415|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
154983351|NCT00773734|559364416|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
154983352|NCT00773734|559364417|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
154983353|NCT00773734|559364418|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
154983354|NCT00773734|559364419|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
155116064|NCT00590824|559855192|FG001|Overall Study|Disease could not be resected|2|||
155116065|NCT00590824|559855193|FG002|Overall Study|Disease could not be resected|1|||
155116066|NCT00590824|559855194|FG003|Overall Study|Disease could not be resected|0|||
155116067|NCT00590824|559855191|FG000|Overall Study|Adverse Event|0|||
155116068|NCT00590824|559855192|FG001|Overall Study|Adverse Event|0|||
155116069|NCT00590824|559855193|FG002|Overall Study|Adverse Event|0|||
155116070|NCT00590824|559855194|FG003|Overall Study|Adverse Event|1|||
155116071|NCT01778049|559855196|FG000|Open Label Treatment Period|Adverse Event|5|||
155116072|NCT01778049|559855197|FG001|Open Label Treatment Period|Adverse Event|15|||
155116073|NCT01778049|559855198|FG002|Open Label Treatment Period|Adverse Event|0|||
155116074|NCT01778049|559855199|FG003|Open Label Treatment Period|Adverse Event|0|||
155116075|NCT01778049|559855200|FG004|Open Label Treatment Period|Adverse Event|0|||
155116076|NCT01778049|559855201|FG005|Open Label Treatment Period|Adverse Event|0|||
155116077|NCT01778049|559855196|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
155116078|NCT01778049|559855197|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
155116079|NCT01778049|559855198|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
155116080|NCT01778049|559855199|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
155116081|NCT01778049|559855200|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
155116082|NCT01778049|559855201|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
155116083|NCT01778049|559855196|FG000|Open Label Treatment Period|Protocol Violation|5|||
155116084|NCT01778049|559855197|FG001|Open Label Treatment Period|Protocol Violation|5|||
155116085|NCT01778049|559855198|FG002|Open Label Treatment Period|Protocol Violation|0|||
155116086|NCT01778049|559855199|FG003|Open Label Treatment Period|Protocol Violation|0|||
155116087|NCT01778049|559855200|FG004|Open Label Treatment Period|Protocol Violation|0|||
155116088|NCT01778049|559855201|FG005|Open Label Treatment Period|Protocol Violation|0|||
155116089|NCT01778049|559855196|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
155116090|NCT01778049|559855197|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
155116091|NCT01778049|559855198|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
155116092|NCT01778049|559855199|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
155116093|NCT01778049|559855200|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
155116094|NCT01778049|559855201|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
155116095|NCT01778049|559855196|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
155116096|NCT01778049|559855197|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
155116097|NCT01778049|559855198|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
155116098|NCT01778049|559855199|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
155116099|NCT01778049|559855200|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
154905011|NCT00285649|559072215|FG000|Overall Study|Lost to Follow-up|6|||
154905012|NCT00285649|559072216|FG001|Overall Study|Lost to Follow-up|4|||
154905013|NCT00285649|559072217|FG002|Overall Study|Lost to Follow-up|4|||
154905014|NCT00285649|559072215|FG000|Overall Study|Withdrawal by Subject|3|||
154905015|NCT00285649|559072216|FG001|Overall Study|Withdrawal by Subject|2|||
154905016|NCT00285649|559072217|FG002|Overall Study|Withdrawal by Subject|2|||
154905017|NCT02203916|559072218|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
154905018|NCT02203916|559072219|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
154905019|NCT02203916|559072220|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
154905020|NCT02203916|559072218|FG000|Overall Study|Major Protocol Deviation|1|||
154905021|NCT02203916|559072219|FG001|Overall Study|Major Protocol Deviation|1|||
154905022|NCT02203916|559072220|FG002|Overall Study|Major Protocol Deviation|0|||
154905023|NCT02203916|559072218|FG000|Overall Study|Lost to Follow-up|0|||
154905024|NCT02203916|559072219|FG001|Overall Study|Lost to Follow-up|1|||
154905025|NCT02203916|559072220|FG002|Overall Study|Lost to Follow-up|0|||
154905026|NCT02203916|559072218|FG000|Overall Study|Voluntary Withdrawal|3|||
154905027|NCT02203916|559072219|FG001|Overall Study|Voluntary Withdrawal|3|||
154905028|NCT02203916|559072220|FG002|Overall Study|Voluntary Withdrawal|8|||
154905029|NCT02203916|559072218|FG000|Overall Study|Lack of Efficacy|3|||
154905030|NCT02203916|559072219|FG001|Overall Study|Lack of Efficacy|0|||
154905031|NCT02203916|559072220|FG002|Overall Study|Lack of Efficacy|0|||
154905032|NCT02203916|559072218|FG000|Overall Study|Reason Not Specified|0|||
154905033|NCT02203916|559072219|FG001|Overall Study|Reason Not Specified|2|||
154905034|NCT02203916|559072220|FG002|Overall Study|Reason Not Specified|1|||
154905035|NCT01466062|559072221|FG000|Overall Study|Adverse Event|1|||
154905036|NCT01466062|559072221|FG000|Overall Study|Withdrawal by Subject|1|||
154905037|NCT01925014|559072222|FG000|Overall Study|Inappropriate enrollment|4|||
154905038|NCT01925014|559072223|FG001|Overall Study|Inappropriate enrollment|6|||
154905039|NCT01925014|559072222|FG000|Overall Study|Withdrawal by Subject|5|||
154905040|NCT01925014|559072223|FG001|Overall Study|Withdrawal by Subject|13|||
154905041|NCT03077711|559072224|FG000|Overall Study|Lost to Follow-up|2|||
154905042|NCT03077711|559072225|FG001|Overall Study|Lost to Follow-up|2|||
154905043|NCT03077711|559072224|FG000|Overall Study|noncompliant taking medication|2|||
154905044|NCT03077711|559072225|FG001|Overall Study|noncompliant taking medication|0|||
154905045|NCT01819194|559072226|FG000|Overall Study|Loss of study articles|2|||
154905046|NCT00045630|559072227|FG000|Overall Study|Adverse Event|1|||
154905047|NCT00045630|559072227|FG000|Overall Study|Refusal unrelated to adverse event|1|||
154905048|NCT00045630|559072227|FG000|Overall Study|Progression/relapse|1|||
154905049|NCT00045630|559072227|FG000|Overall Study|Death|1|||
154905050|NCT00045630|559072227|FG000|Overall Study|Ineligible|2|||
154905051|NCT04449276|559072228|FG000|Overall Study|Adverse Event|1|||
154905052|NCT04449276|559072229|FG001|Overall Study|Adverse Event|2|||
154905053|NCT04449276|559072230|FG002|Overall Study|Adverse Event|0|||
154905054|NCT04449276|559072231|FG003|Overall Study|Adverse Event|0|||
154905055|NCT04449276|559072232|FG004|Overall Study|Adverse Event|2|||
154905056|NCT04449276|559072233|FG005|Overall Study|Adverse Event|0|||
154905057|NCT04449276|559072234|FG006|Overall Study|Adverse Event|0|||
154905058|NCT04449276|559072235|FG007|Overall Study|Adverse Event|1|||
154905059|NCT04449276|559072228|FG000|Overall Study|Withdrawal by Subject|2|||
154905060|NCT04449276|559072229|FG001|Overall Study|Withdrawal by Subject|0|||
154905061|NCT04449276|559072230|FG002|Overall Study|Withdrawal by Subject|0|||
154905062|NCT04449276|559072231|FG003|Overall Study|Withdrawal by Subject|1|||
154905063|NCT04449276|559072232|FG004|Overall Study|Withdrawal by Subject|0|||
154905064|NCT04449276|559072233|FG005|Overall Study|Withdrawal by Subject|0|||
154905065|NCT04449276|559072234|FG006|Overall Study|Withdrawal by Subject|0|||
154905066|NCT04449276|559072235|FG007|Overall Study|Withdrawal by Subject|0|||
154905067|NCT04449276|559072228|FG000|Overall Study|Other|0|||
154905068|NCT04449276|559072229|FG001|Overall Study|Other|2|||
154905069|NCT04449276|559072230|FG002|Overall Study|Other|3|||
154905070|NCT04449276|559072231|FG003|Overall Study|Other|2|||
154905071|NCT04449276|559072232|FG004|Overall Study|Other|0|||
154905072|NCT04449276|559072233|FG005|Overall Study|Other|0|||
154905073|NCT04449276|559072234|FG006|Overall Study|Other|0|||
154905074|NCT04449276|559072235|FG007|Overall Study|Other|1|||
154905075|NCT01614795|559072236|FG000|Overall Study|Adverse Event|0|||
154905076|NCT01614795|559072237|FG001|Overall Study|Adverse Event|0|||
154905077|NCT01614795|559072238|FG002|Overall Study|Adverse Event|1|||
154905078|NCT01614795|559072239|FG003|Overall Study|Adverse Event|1|||
154905079|NCT01614795|559072236|FG000|Overall Study|Lack of Efficacy|10|||
154905080|NCT01614795|559072237|FG001|Overall Study|Lack of Efficacy|10|||
154905081|NCT01614795|559072238|FG002|Overall Study|Lack of Efficacy|9|||
154905082|NCT01614795|559072239|FG003|Overall Study|Lack of Efficacy|8|||
154905083|NCT01614795|559072236|FG000|Overall Study|Physician Decision|1|||
154905084|NCT01614795|559072237|FG001|Overall Study|Physician Decision|0|||
155116100|NCT01778049|559855201|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
155116101|NCT01778049|559855196|FG000|Open Label Treatment Period|Not treated|2|||
155116102|NCT01778049|559855197|FG001|Open Label Treatment Period|Not treated|1|||
155116103|NCT01778049|559855198|FG002|Open Label Treatment Period|Not treated|0|||
155116104|NCT01778049|559855199|FG003|Open Label Treatment Period|Not treated|0|||
155116105|NCT01778049|559855200|FG004|Open Label Treatment Period|Not treated|0|||
155116106|NCT01778049|559855201|FG005|Open Label Treatment Period|Not treated|0|||
155116107|NCT01778049|559855196|FG000|Open Label Treatment Period|Other reason not defined above|77|||
155116108|NCT01778049|559855197|FG001|Open Label Treatment Period|Other reason not defined above|94|||
155116109|NCT01778049|559855198|FG002|Open Label Treatment Period|Other reason not defined above|0|||
155116110|NCT01778049|559855199|FG003|Open Label Treatment Period|Other reason not defined above|0|||
155116111|NCT01778049|559855200|FG004|Open Label Treatment Period|Other reason not defined above|0|||
155116112|NCT01778049|559855201|FG005|Open Label Treatment Period|Other reason not defined above|0|||
155116113|NCT01778049|559855196|FG000|Double Blind Treatment Period|Adverse Event|0|||
155116114|NCT01778049|559855197|FG001|Double Blind Treatment Period|Adverse Event|0|||
155116115|NCT01778049|559855198|FG002|Double Blind Treatment Period|Adverse Event|4|||
155116116|NCT01778049|559855199|FG003|Double Blind Treatment Period|Adverse Event|5|||
155116117|NCT01778049|559855200|FG004|Double Blind Treatment Period|Adverse Event|3|||
155116118|NCT01778049|559855201|FG005|Double Blind Treatment Period|Adverse Event|2|||
155116119|NCT01778049|559855196|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
155116120|NCT01778049|559855197|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155116121|NCT01778049|559855198|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155116122|NCT01778049|559855199|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
155116123|NCT01778049|559855200|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
155116124|NCT01778049|559855201|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
155116125|NCT01778049|559855196|FG000|Double Blind Treatment Period|Protocol Violation|0|||
155116126|NCT01778049|559855197|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155116127|NCT01778049|559855198|FG002|Double Blind Treatment Period|Protocol Violation|2|||
155116128|NCT01778049|559855199|FG003|Double Blind Treatment Period|Protocol Violation|0|||
155116129|NCT01778049|559855200|FG004|Double Blind Treatment Period|Protocol Violation|0|||
155116130|NCT01778049|559855201|FG005|Double Blind Treatment Period|Protocol Violation|0|||
155116131|NCT01778049|559855196|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155116132|NCT01778049|559855197|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155116133|NCT01778049|559855198|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
155116134|NCT01778049|559855199|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
155116135|NCT01778049|559855200|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
155116136|NCT01778049|559855201|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
155116137|NCT01778049|559855196|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
155116138|NCT01778049|559855197|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
155116139|NCT01778049|559855198|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
155116140|NCT01778049|559855199|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
155116141|NCT01778049|559855200|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
155116142|NCT01778049|559855201|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
155116143|NCT01778049|559855196|FG000|Double Blind Treatment Period|Not treated|0|||
155116144|NCT01778049|559855197|FG001|Double Blind Treatment Period|Not treated|0|||
155116145|NCT01778049|559855198|FG002|Double Blind Treatment Period|Not treated|0|||
155116146|NCT01778049|559855199|FG003|Double Blind Treatment Period|Not treated|2|||
155116147|NCT01778049|559855200|FG004|Double Blind Treatment Period|Not treated|2|||
155116148|NCT01778049|559855201|FG005|Double Blind Treatment Period|Not treated|0|||
155116149|NCT01778049|559855196|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
155116150|NCT01778049|559855197|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
155116151|NCT01778049|559855198|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
155116152|NCT01778049|559855199|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
155116153|NCT01778049|559855200|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
155116154|NCT01778049|559855201|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
155116155|NCT02379988|559855203|FG000|Overall Study|Not eligible|1|||
155116156|NCT03359785|559855208|FG000|Overall Study|Protocol Violation|0|||
155116157|NCT03359785|559855209|FG001|Overall Study|Protocol Violation|1|||
155116158|NCT03359785|559855210|FG002|Overall Study|Protocol Violation|0|||
155116159|NCT03359785|559855211|FG003|Overall Study|Protocol Violation|0|||
155116160|NCT03359785|559855208|FG000|Overall Study|Early study termination due to study pause|0|||
155116161|NCT03359785|559855209|FG001|Overall Study|Early study termination due to study pause|0|||
155116162|NCT03359785|559855210|FG002|Overall Study|Early study termination due to study pause|2|||
155116163|NCT03359785|559855211|FG003|Overall Study|Early study termination due to study pause|0|||
154905085|NCT01614795|559072238|FG002|Overall Study|Physician Decision|1|||
154905086|NCT01614795|559072239|FG003|Overall Study|Physician Decision|1|||
154905087|NCT01614795|559072236|FG000|Overall Study|Withdrawal by Subject|0|||
154905088|NCT01614795|559072237|FG001|Overall Study|Withdrawal by Subject|1|||
154905089|NCT01614795|559072238|FG002|Overall Study|Withdrawal by Subject|0|||
155116164|NCT03359785|559855208|FG000|Overall Study|Withdrawal by Subject|2|||
155116165|NCT03359785|559855209|FG001|Overall Study|Withdrawal by Subject|2|||
155116166|NCT03359785|559855210|FG002|Overall Study|Withdrawal by Subject|0|||
155116167|NCT03359785|559855211|FG003|Overall Study|Withdrawal by Subject|0|||
155116168|NCT01895543|559855212|FG000|Overall Study|Withdrawal by Subject|43|||
155116169|NCT01895543|559855212|FG000|Overall Study|Lost to Follow-up|25|||
155116170|NCT01895543|559855212|FG000|Overall Study|Adverse Event|28|||
155116171|NCT01895543|559855212|FG000|Overall Study|Subject's substantial non-compliance|6|||
155116172|NCT01895543|559855212|FG000|Overall Study|Protocol Violation|1|||
155116173|NCT01895543|559855212|FG000|Overall Study|Physician Decision|2|||
155116174|NCT01895543|559855212|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
155116175|NCT00367744|559855213|FG000|Overall Study|Lost to Follow-up|4|||
155116176|NCT00367744|559855214|FG001|Overall Study|Lost to Follow-up|5|||
155116177|NCT04262882|559855216|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
155116178|NCT04262882|559855217|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
155116179|NCT04262882|559855216|FG000|Overall Study|Lost to Follow-up|1|||
155116180|NCT04262882|559855217|FG001|Overall Study|Lost to Follow-up|0|||
154905090|NCT01614795|559072239|FG003|Overall Study|Withdrawal by Subject|2|||
154905091|NCT01614795|559072236|FG000|Overall Study|Ineligible|0|||
154905092|NCT01614795|559072237|FG001|Overall Study|Ineligible|1|||
154905093|NCT01614795|559072238|FG002|Overall Study|Ineligible|0|||
154905094|NCT01614795|559072239|FG003|Overall Study|Ineligible|0|||
154905095|NCT00701103|559072240|FG000|Overall Study|Adverse Event|0|||
154905096|NCT00701103|559072241|FG001|Overall Study|Adverse Event|0|||
154905097|NCT00701103|559072242|FG002|Overall Study|Adverse Event|1|||
154905098|NCT00701103|559072243|FG003|Overall Study|Adverse Event|1|||
155116181|NCT02825420|559855220|FG000|Overall Study|Death|30|||
155116182|NCT02825420|559855221|FG001|Overall Study|Death|12|||
155116183|NCT02825420|559855220|FG000|Overall Study|Progressive disease|6|||
155116184|NCT02825420|559855221|FG001|Overall Study|Progressive disease|1|||
155116185|NCT02825420|559855220|FG000|Overall Study|Lost to Follow-up|2|||
154905099|NCT00701103|559072244|FG004|Overall Study|Adverse Event|0|||
154905100|NCT00701103|559072245|FG005|Overall Study|Adverse Event|1|||
154905101|NCT00701103|559072246|FG006|Overall Study|Adverse Event|1|||
154905102|NCT00701103|559072247|FG007|Overall Study|Adverse Event|0|||
154905103|NCT00701103|559072248|FG008|Overall Study|Adverse Event|0|||
154905104|NCT00701103|559072249|FG009|Overall Study|Adverse Event|2|||
154905105|NCT00701103|559072250|FG010|Overall Study|Adverse Event|0|||
154905106|NCT00701103|559072240|FG000|Overall Study|Progressive Disease|5|||
154905107|NCT00701103|559072241|FG001|Overall Study|Progressive Disease|2|||
154905108|NCT00701103|559072242|FG002|Overall Study|Progressive Disease|6|||
154905109|NCT00701103|559072243|FG003|Overall Study|Progressive Disease|5|||
154905110|NCT00701103|559072244|FG004|Overall Study|Progressive Disease|6|||
154905111|NCT00701103|559072245|FG005|Overall Study|Progressive Disease|5|||
154905112|NCT00701103|559072246|FG006|Overall Study|Progressive Disease|7|||
154905113|NCT00701103|559072247|FG007|Overall Study|Progressive Disease|7|||
155116186|NCT02825420|559855221|FG001|Overall Study|Lost to Follow-up|2|||
155116187|NCT02825420|559855220|FG000|Overall Study|Withdrawal by Subject|1|||
155116188|NCT02825420|559855221|FG001|Overall Study|Withdrawal by Subject|1|||
155116189|NCT02825420|559855220|FG000|Overall Study|Protocol amendment not signed|1|||
154905114|NCT00701103|559072248|FG008|Overall Study|Progressive Disease|8|||
154905115|NCT00701103|559072249|FG009|Overall Study|Progressive Disease|8|||
154905116|NCT00701103|559072250|FG010|Overall Study|Progressive Disease|11|||
154905117|NCT00701103|559072240|FG000|Overall Study|Withdrawal by Subject|0|||
154905118|NCT00701103|559072241|FG001|Overall Study|Withdrawal by Subject|1|||
154905119|NCT00701103|559072242|FG002|Overall Study|Withdrawal by Subject|1|||
155116190|NCT02825420|559855221|FG001|Overall Study|Protocol amendment not signed|1|||
155116191|NCT02825420|559855220|FG000|Overall Study|Physician Decision|1|||
154905120|NCT00701103|559072243|FG003|Overall Study|Withdrawal by Subject|0|||
154905121|NCT00701103|559072244|FG004|Overall Study|Withdrawal by Subject|0|||
154905122|NCT00701103|559072245|FG005|Overall Study|Withdrawal by Subject|0|||
154905123|NCT00701103|559072246|FG006|Overall Study|Withdrawal by Subject|0|||
154905124|NCT00701103|559072247|FG007|Overall Study|Withdrawal by Subject|0|||
154905125|NCT00701103|559072248|FG008|Overall Study|Withdrawal by Subject|0|||
155116192|NCT02825420|559855221|FG001|Overall Study|Physician Decision|0|||
155116193|NCT02825420|559855220|FG000|Overall Study|Did not receive PLD|2|||
155116194|NCT02825420|559855221|FG001|Overall Study|Did not receive PLD|0|||
155116195|NCT04258995|559856778|FG000|Overall Study|Lost to Follow-up|1|||
155116196|NCT04258995|559856779|FG001|Overall Study|Lost to Follow-up|1|||
154905126|NCT00701103|559072249|FG009|Overall Study|Withdrawal by Subject|0|||
154905127|NCT00701103|559072250|FG010|Overall Study|Withdrawal by Subject|0|||
154905128|NCT00701103|559072240|FG000|Overall Study|Other|0|||
154905129|NCT00701103|559072241|FG001|Overall Study|Other|0|||
154905130|NCT00701103|559072242|FG002|Overall Study|Other|0|||
154905131|NCT00701103|559072243|FG003|Overall Study|Other|0|||
154905132|NCT00701103|559072244|FG004|Overall Study|Other|0|||
154905133|NCT00701103|559072245|FG005|Overall Study|Other|0|||
154905134|NCT00701103|559072246|FG006|Overall Study|Other|0|||
154905135|NCT00701103|559072247|FG007|Overall Study|Other|0|||
154905136|NCT00701103|559072248|FG008|Overall Study|Other|1|||
154905137|NCT00701103|559072249|FG009|Overall Study|Other|1|||
154905138|NCT00701103|559072250|FG010|Overall Study|Other|0|||
154905139|NCT00089999|559072254|FG000|Overall Study|Adverse Event|4|||
154905140|NCT00089999|559072255|FG001|Overall Study|Adverse Event|7|||
154905141|NCT00089999|559072254|FG000|Overall Study|Withdrawal by Subject|0|||
154905142|NCT00089999|559072255|FG001|Overall Study|Withdrawal by Subject|4|||
154905143|NCT00089999|559072254|FG000|Overall Study|Lost to Follow-up|2|||
154905144|NCT00089999|559072255|FG001|Overall Study|Lost to Follow-up|1|||
154905145|NCT00089999|559072254|FG000|Overall Study|Radiological Progression of Cancer|52|||
154905146|NCT00089999|559072255|FG001|Overall Study|Radiological Progression of Cancer|44|||
154905147|NCT00089999|559072254|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
154905148|NCT00089999|559072255|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
154905149|NCT00089999|559072254|FG000|Overall Study|Death|3|||
154905150|NCT00089999|559072255|FG001|Overall Study|Death|3|||
154905151|NCT00089999|559072254|FG000|Overall Study|Poor General Condition|1|||
154905152|NCT00089999|559072255|FG001|Overall Study|Poor General Condition|0|||
154905153|NCT00089999|559072254|FG000|Overall Study|Clinical Progression|1|||
154905154|NCT00089999|559072255|FG001|Overall Study|Clinical Progression|2|||
154905155|NCT00089999|559072254|FG000|Overall Study|Physician Decision|2|||
154905156|NCT00089999|559072255|FG001|Overall Study|Physician Decision|2|||
154905157|NCT00089999|559072254|FG000|Overall Study|Patient Underwent Surgery|2|||
154905158|NCT00089999|559072255|FG001|Overall Study|Patient Underwent Surgery|0|||
154905159|NCT00089999|559072254|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
154905160|NCT00089999|559072255|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
154905161|NCT03039569|559072256|FG000|Overall Study|Lost to Follow-up|5|||
154905162|NCT03039569|559072257|FG001|Overall Study|Lost to Follow-up|4|||
154905163|NCT01167153|559072258|FG000|Overall Study|Non-effective therapy|1|||
154905164|NCT01167153|559072259|FG001|Overall Study|Non-effective therapy|4|||
154905165|NCT01167153|559072258|FG000|Overall Study|AE including clinical laboratory AE|2|||
154905166|NCT01167153|559072259|FG001|Overall Study|AE including clinical laboratory AE|8|||
154905167|NCT01167153|559072258|FG000|Overall Study|Hypotension|1|||
154905168|NCT01167153|559072259|FG001|Overall Study|Hypotension|0|||
154905169|NCT01167153|559072258|FG000|Overall Study|Lost to Follow-up|7|||
154905170|NCT01167153|559072259|FG001|Overall Study|Lost to Follow-up|9|||
154905171|NCT01167153|559072258|FG000|Overall Study|Non-compliance to concomitant medication|0|||
154905172|NCT01167153|559072259|FG001|Overall Study|Non-compliance to concomitant medication|2|||
154905173|NCT01167153|559072258|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
154905174|NCT01167153|559072259|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
154905175|NCT01167153|559072258|FG000|Overall Study|Withdrawal consent|1|||
154905176|NCT01167153|559072259|FG001|Overall Study|Withdrawal consent|1|||
154905177|NCT01167153|559072258|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
154905178|NCT01167153|559072259|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
154905179|NCT01462045|559073489|FG000|Overall Study|Family matter|0|||
154905180|NCT01462045|559073490|FG001|Overall Study|Family matter|1|||
154905181|NCT01462045|559073491|FG002|Overall Study|Family matter|0|||
154905182|NCT03558828|559073492|FG000|Overall Study|Lost to Follow-up|4|||
154905183|NCT03558828|559073493|FG001|Overall Study|Lost to Follow-up|3|||
154905184|NCT03558828|559073494|FG002|Overall Study|Lost to Follow-up|3|||
154905185|NCT03558828|559073495|FG003|Overall Study|Lost to Follow-up|5|||
154905186|NCT03558828|559073496|FG004|Overall Study|Lost to Follow-up|2|||
154905187|NCT03558828|559073497|FG005|Overall Study|Lost to Follow-up|3|||
154905188|NCT03558828|559073492|FG000|Overall Study|dropped before the intervention|1|||
154905189|NCT03558828|559073493|FG001|Overall Study|dropped before the intervention|1|||
154905190|NCT03558828|559073494|FG002|Overall Study|dropped before the intervention|0|||
154905191|NCT03558828|559073495|FG003|Overall Study|dropped before the intervention|0|||
154905192|NCT03558828|559073496|FG004|Overall Study|dropped before the intervention|0|||
154905193|NCT03558828|559073497|FG005|Overall Study|dropped before the intervention|0|||
154905194|NCT03671148|559073498|FG000|Overall Study|Adverse Event|3|||
154905195|NCT03671148|559073499|FG001|Overall Study|Adverse Event|2|||
154905196|NCT03671148|559073498|FG000|Overall Study|Withdrawal by Subject|8|||
154905197|NCT03671148|559073499|FG001|Overall Study|Withdrawal by Subject|2|||
154905198|NCT03671148|559073498|FG000|Overall Study|Lost to Follow-up|1|||
154905199|NCT03671148|559073499|FG001|Overall Study|Lost to Follow-up|2|||
154905200|NCT03671148|559073498|FG000|Overall Study|Lack of Efficacy|7|||
154905201|NCT03671148|559073499|FG001|Overall Study|Lack of Efficacy|2|||
154905202|NCT03671148|559073498|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
154905203|NCT03671148|559073499|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
154905204|NCT03671148|559073498|FG000|Overall Study|Other|1|||
155116197|NCT01962987|559856781|FG000|Overall Study|Adverse Event|4|||
154905205|NCT03671148|559073499|FG001|Overall Study|Other|0|||
154905206|NCT03671148|559073498|FG000|Overall Study|Incomplete Randomization Visit|1|||
154905207|NCT03671148|559073499|FG001|Overall Study|Incomplete Randomization Visit|0|||
154905208|NCT00673816|559073502|FG000|Overall Study|Adverse Event|1|||
154905209|NCT00673816|559073502|FG000|Overall Study|Withdrawal by Subject|1|||
154905210|NCT01804842|559073503|FG000|Overall Study|Adverse Event|1|||
154905211|NCT01804842|559073504|FG001|Overall Study|Adverse Event|1|||
154905212|NCT01804842|559073505|FG002|Overall Study|Adverse Event|0|||
154905213|NCT01804842|559073503|FG000|Overall Study|Lost to Follow-up|1|||
154905214|NCT01804842|559073504|FG001|Overall Study|Lost to Follow-up|0|||
154905215|NCT01804842|559073505|FG002|Overall Study|Lost to Follow-up|0|||
154905216|NCT01804842|559073503|FG000|Overall Study|Non-Compliance|1|||
154905217|NCT01804842|559073504|FG001|Overall Study|Non-Compliance|1|||
154905218|NCT01804842|559073505|FG002|Overall Study|Non-Compliance|0|||
154905219|NCT01804842|559073503|FG000|Overall Study|Personal Reason|0|||
154905220|NCT01804842|559073504|FG001|Overall Study|Personal Reason|0|||
154905221|NCT01804842|559073505|FG002|Overall Study|Personal Reason|1|||
154905222|NCT00413777|559073506|FG000|Fixed-dose Period|Lost to Follow-up|1|||
154905223|NCT00413777|559073507|FG001|Fixed-dose Period|Lost to Follow-up|1|||
154905224|NCT00413777|559073506|FG000|Fixed-dose Period|Adverse Event|2|||
154905225|NCT00413777|559073507|FG001|Fixed-dose Period|Adverse Event|1|||
154905226|NCT00413777|559073506|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
154905227|NCT00413777|559073507|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
154905228|NCT00413777|559073506|FG000|Fixed-dose Period|Withdrew Consent|0|||
154905229|NCT00413777|559073507|FG001|Fixed-dose Period|Withdrew Consent|1|||
154905230|NCT05180721|559073510|FG000|Overall Study|Lost to Follow-up|4|||
154905231|NCT02736929|559073523|FG000|Main Study|Lost to Follow-up|7|||
154905232|NCT02736929|559073524|FG001|Main Study|Lost to Follow-up|1|||
154905233|NCT02736929|559073525|FG002|Main Study|Lost to Follow-up|0|||
154905234|NCT02736929|559073523|FG000|Main Study|Withdrawal by Subject|1|||
154905235|NCT02736929|559073524|FG001|Main Study|Withdrawal by Subject|1|||
154905236|NCT02736929|559073525|FG002|Main Study|Withdrawal by Subject|0|||
154905237|NCT02736929|559073523|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
154905238|NCT02736929|559073524|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
154905239|NCT02736929|559073525|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
154905240|NCT02465489|559073528|FG000|Overall Study|Adverse Event|5|||
154905241|NCT01855425|559073535|FG000|Overall Study|Physician Decision|20|||
154905242|NCT00414973|559073543|FG000|Overall Study|Withdrawal by Subject|14|||
154905243|NCT00414973|559073544|FG001|Overall Study|Withdrawal by Subject|4|||
154905244|NCT00414973|559073545|FG002|Overall Study|Withdrawal by Subject|1|||
154905245|NCT00414973|559073546|FG003|Overall Study|Withdrawal by Subject|0|||
154905246|NCT00414973|559073543|FG000|Overall Study|Adverse Event|10|||
154905247|NCT00414973|559073544|FG001|Overall Study|Adverse Event|0|||
154905248|NCT00414973|559073545|FG002|Overall Study|Adverse Event|1|||
154905249|NCT00414973|559073546|FG003|Overall Study|Adverse Event|0|||
154905250|NCT00414973|559073543|FG000|Overall Study|Protocol Violation|3|||
154905251|NCT00414973|559073544|FG001|Overall Study|Protocol Violation|4|||
154905252|NCT00414973|559073545|FG002|Overall Study|Protocol Violation|0|||
154905253|NCT00414973|559073546|FG003|Overall Study|Protocol Violation|0|||
154905254|NCT00414973|559073543|FG000|Overall Study|Lost to Follow-up|0|||
154905255|NCT00414973|559073544|FG001|Overall Study|Lost to Follow-up|2|||
154905256|NCT00414973|559073545|FG002|Overall Study|Lost to Follow-up|0|||
154905257|NCT00414973|559073546|FG003|Overall Study|Lost to Follow-up|0|||
154905258|NCT00414973|559073543|FG000|Overall Study|Sponsor Decision|1|||
154905259|NCT00414973|559073544|FG001|Overall Study|Sponsor Decision|0|||
154905260|NCT00414973|559073545|FG002|Overall Study|Sponsor Decision|0|||
154905261|NCT00414973|559073546|FG003|Overall Study|Sponsor Decision|0|||
154905262|NCT00414973|559073543|FG000|Overall Study|Death|0|||
154905263|NCT00414973|559073544|FG001|Overall Study|Death|0|||
154905264|NCT00414973|559073545|FG002|Overall Study|Death|1|||
154905265|NCT00414973|559073546|FG003|Overall Study|Death|0|||
154905266|NCT01196091|559073550|FG000|Overall Study|Adverse Event|22|||
154905267|NCT01196091|559073551|FG001|Overall Study|Adverse Event|27|||
154905268|NCT01196091|559073552|FG002|Overall Study|Adverse Event|26|||
154905269|NCT01196091|559073550|FG000|Overall Study|Death|3|||
154905270|NCT01196091|559073551|FG001|Overall Study|Death|2|||
154905271|NCT01196091|559073552|FG002|Overall Study|Death|2|||
154905272|NCT01196091|559073550|FG000|Overall Study|Entry Criteria Not Met|11|||
154905273|NCT01196091|559073551|FG001|Overall Study|Entry Criteria Not Met|11|||
154905274|NCT01196091|559073552|FG002|Overall Study|Entry Criteria Not Met|10|||
154905275|NCT01196091|559073550|FG000|Overall Study|Lack of Efficacy|15|||
154905276|NCT01196091|559073551|FG001|Overall Study|Lack of Efficacy|12|||
154905277|NCT01196091|559073552|FG002|Overall Study|Lack of Efficacy|17|||
154905278|NCT01196091|559073550|FG000|Overall Study|Lost to Follow-up|5|||
154905279|NCT01196091|559073551|FG001|Overall Study|Lost to Follow-up|5|||
154905280|NCT01196091|559073552|FG002|Overall Study|Lost to Follow-up|6|||
154905281|NCT01196091|559073550|FG000|Overall Study|Parent/Caregiver Decision|0|||
154905282|NCT01196091|559073551|FG001|Overall Study|Parent/Caregiver Decision|0|||
154905283|NCT01196091|559073552|FG002|Overall Study|Parent/Caregiver Decision|1|||
154905284|NCT01196091|559073550|FG000|Overall Study|Withdrawal by Subject|16|||
154905285|NCT01196091|559073551|FG001|Overall Study|Withdrawal by Subject|19|||
154905286|NCT01196091|559073552|FG002|Overall Study|Withdrawal by Subject|22|||
154905287|NCT01196091|559073550|FG000|Overall Study|Physician Decision|3|||
154905288|NCT01196091|559073551|FG001|Overall Study|Physician Decision|3|||
154905289|NCT01196091|559073552|FG002|Overall Study|Physician Decision|4|||
154905290|NCT01196091|559073550|FG000|Overall Study|Protocol Violation|1|||
154905291|NCT01196091|559073551|FG001|Overall Study|Protocol Violation|3|||
154905292|NCT01196091|559073552|FG002|Overall Study|Protocol Violation|3|||
154905293|NCT01196091|559073550|FG000|Overall Study|Sponsor Decision|6|||
154905294|NCT01196091|559073551|FG001|Overall Study|Sponsor Decision|5|||
154905295|NCT01196091|559073552|FG002|Overall Study|Sponsor Decision|4|||
154905296|NCT01196091|559073550|FG000|Overall Study|Excluded Site|5|||
154905297|NCT01196091|559073551|FG001|Overall Study|Excluded Site|11|||
154905298|NCT01196091|559073552|FG002|Overall Study|Excluded Site|8|||
154905299|NCT01196091|559073550|FG000|Overall Study|Randomized, No Study Drug Received|1|||
154905300|NCT01196091|559073551|FG001|Overall Study|Randomized, No Study Drug Received|0|||
154905301|NCT01196091|559073552|FG002|Overall Study|Randomized, No Study Drug Received|1|||
154905302|NCT01487863|559073556|FG000|Overall Study|Death|19|||
154905303|NCT01487863|559073557|FG001|Overall Study|Death|19|||
154905304|NCT04247828|559073558|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
154905305|NCT02324049|559073562|FG000|Part C|Study terminated|11|||
154905306|NCT03198728|559073563|FG000|Overall Study|Adverse Event|10|||
154905307|NCT03198728|559073564|FG001|Overall Study|Adverse Event|5|||
154905308|NCT03198728|559073563|FG000|Overall Study|Lost to Follow-up|21|||
154905309|NCT03198728|559073564|FG001|Overall Study|Lost to Follow-up|7|||
154905310|NCT03198728|559073563|FG000|Overall Study|Physician Decision|7|||
154905311|NCT03198728|559073564|FG001|Overall Study|Physician Decision|2|||
154905312|NCT03198728|559073563|FG000|Overall Study|Withdrawal by Subject|14|||
154905313|NCT03198728|559073564|FG001|Overall Study|Withdrawal by Subject|10|||
154905314|NCT03083470|559073565|FG000|Overall Study|Lost to Follow-up|0|||
154905315|NCT03083470|559073566|FG001|Overall Study|Lost to Follow-up|0|||
154905316|NCT03083470|559073567|FG002|Overall Study|Lost to Follow-up|0|||
154905317|NCT03083470|559073568|FG003|Overall Study|Lost to Follow-up|0|||
154905318|NCT03083470|559073569|FG004|Overall Study|Lost to Follow-up|1|||
154905319|NCT03083470|559073565|FG000|Overall Study|Withdrawal by Subject|0|||
154905320|NCT03083470|559073566|FG001|Overall Study|Withdrawal by Subject|0|||
154905321|NCT03083470|559073567|FG002|Overall Study|Withdrawal by Subject|0|||
154905322|NCT03083470|559073568|FG003|Overall Study|Withdrawal by Subject|0|||
154905323|NCT03083470|559073569|FG004|Overall Study|Withdrawal by Subject|1|||
154905324|NCT01512693|559073570|FG000|Overall Study|Withdrawal by Subject|0|||
154905325|NCT01512693|559073571|FG001|Overall Study|Withdrawal by Subject|1|||
154905326|NCT00736450|559073578|FG000|Overall Study|Not ABC gene eligible|19|||
154905327|NCT00736450|559073578|FG000|Overall Study|Withdrawal by Subject|5|||
154905328|NCT00736450|559073578|FG000|Overall Study|Physician Decision|1|||
154905329|NCT00981747|559073595|FG000|Losartan|Withdrawal by Subject|1|||
154905330|NCT00981747|559073595|FG000|Losartan|Death|1|||
154905331|NCT00981747|559073595|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
154905332|NCT01437267|559073601|FG000|Overall Study|Withdrawal by Subject|0|||
154905333|NCT01437267|559073602|FG001|Overall Study|Withdrawal by Subject|0|||
154905334|NCT01437267|559073603|FG002|Overall Study|Withdrawal by Subject|0|||
154905335|NCT01437267|559073604|FG003|Overall Study|Withdrawal by Subject|1|||
154905336|NCT01437267|559073605|FG004|Overall Study|Withdrawal by Subject|0|||
154905337|NCT01437267|559073606|FG005|Overall Study|Withdrawal by Subject|0|||
154905338|NCT01437267|559073601|FG000|Overall Study|Protocol Violation|0|||
154905339|NCT01437267|559073602|FG001|Overall Study|Protocol Violation|1|||
154905340|NCT01437267|559073603|FG002|Overall Study|Protocol Violation|0|||
154905341|NCT01437267|559073604|FG003|Overall Study|Protocol Violation|0|||
154905342|NCT01437267|559073605|FG004|Overall Study|Protocol Violation|0|||
154905343|NCT01437267|559073606|FG005|Overall Study|Protocol Violation|0|||
154905344|NCT03934203|559073607|FG000|Overall Study|Adverse Event|0|||
154905345|NCT03934203|559073608|FG001|Overall Study|Adverse Event|0|||
155116198|NCT01962987|559856782|FG001|Overall Study|Adverse Event|4|||
155116199|NCT01962987|559856783|FG002|Overall Study|Adverse Event|0|||
154905346|NCT03934203|559073609|FG002|Overall Study|Adverse Event|1|||
155116200|NCT01962987|559856781|FG000|Overall Study|Lost to Follow-up|0|||
155116201|NCT01962987|559856782|FG001|Overall Study|Lost to Follow-up|0|||
155116202|NCT01962987|559856783|FG002|Overall Study|Lost to Follow-up|1|||
155116203|NCT01962987|559856781|FG000|Overall Study|Non compliance with dosing requirements|4|||
155116204|NCT01962987|559856782|FG001|Overall Study|Non compliance with dosing requirements|2|||
155116205|NCT01962987|559856783|FG002|Overall Study|Non compliance with dosing requirements|0|||
155116206|NCT01962987|559856781|FG000|Overall Study|Miscellaneous|1|||
155116207|NCT01962987|559856782|FG001|Overall Study|Miscellaneous|9|||
154905347|NCT03934203|559073610|FG003|Overall Study|Adverse Event|0|||
154905348|NCT03934203|559073611|FG004|Overall Study|Adverse Event|1|||
154905349|NCT03934203|559073612|FG005|Overall Study|Adverse Event|0|||
154905350|NCT03934203|559073613|FG006|Overall Study|Adverse Event|2|||
154905351|NCT03934203|559073614|FG007|Overall Study|Adverse Event|0|||
154905352|NCT03934203|559073615|FG008|Overall Study|Adverse Event|0|||
154905353|NCT03934203|559073616|FG009|Overall Study|Adverse Event|0|||
154905354|NCT03934203|559073617|FG010|Overall Study|Adverse Event|0|||
154905355|NCT03934203|559073618|FG011|Overall Study|Adverse Event|0|||
154905356|NCT03934203|559073619|FG012|Overall Study|Adverse Event|0|||
154905357|NCT03934203|559073620|FG013|Overall Study|Adverse Event|1|||
155116208|NCT01962987|559856783|FG002|Overall Study|Miscellaneous|2|||
154905358|NCT03934203|559073621|FG014|Overall Study|Adverse Event|0|||
154905359|NCT00333970|559073624|FG000|Overall Study|Withdrawal by Subject|13|||
154905360|NCT00333970|559073625|FG001|Overall Study|Withdrawal by Subject|7|||
154905361|NCT00441480|559073626|FG000|Overall Study|Protocol Violation|1|||
154905362|NCT00441480|559073627|FG001|Overall Study|Protocol Violation|1|||
154905363|NCT00441480|559073626|FG000|Overall Study|Withdrawal by Subject|2|||
154905364|NCT00441480|559073627|FG001|Overall Study|Withdrawal by Subject|3|||
154905365|NCT00899678|559073628|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
154905366|NCT00899678|559073629|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
154905367|NCT00899678|559073630|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
154905368|NCT00899678|559073628|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
154905369|NCT00899678|559073629|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
154905370|NCT00899678|559073630|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
154905371|NCT00899678|559073628|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
154905372|NCT00899678|559073629|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
154905373|NCT00899678|559073630|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
154905374|NCT00899678|559073628|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
154905375|NCT00899678|559073629|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
154905376|NCT00899678|559073630|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
154905377|NCT00899678|559073628|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
154905378|NCT00899678|559073629|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
154905379|NCT00899678|559073630|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
154905380|NCT00899678|559073628|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
154905381|NCT00899678|559073629|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
154905382|NCT00899678|559073630|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
154905383|NCT00899678|559073628|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
154905384|NCT00899678|559073629|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
154905385|NCT00899678|559073630|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
154905386|NCT00899678|559073628|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
154905387|NCT00899678|559073629|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
154905388|NCT00899678|559073630|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
154905389|NCT00899678|559073628|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
154905390|NCT00899678|559073629|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
154905391|NCT00899678|559073630|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
154905392|NCT02092324|559073631|FG000|Overall Study|Adverse Event|1|||
154905393|NCT02092324|559073631|FG000|Overall Study|Lack of Efficacy|6|||
154905394|NCT02092324|559073631|FG000|Overall Study|Proceed to Transplant|3|||
154905395|NCT02092324|559073631|FG000|Overall Study|Physician Decision|7|||
154905396|NCT02092324|559073631|FG000|Overall Study|Misdiagnosis|2|||
154905397|NCT01624467|559073632|FG000|Overall Study|Withdrawal by Subject|2|||
154905398|NCT01624467|559073632|FG000|Overall Study|Lost to Follow-up|1|||
154905399|NCT01624467|559073632|FG000|Overall Study|Adverse Event|7|||
154905400|NCT01624467|559073632|FG000|Overall Study|Progressive Disease|19|||
154905401|NCT01624467|559073632|FG000|Overall Study|Per Sponsor Requirement|1|||
154905402|NCT01624467|559073632|FG000|Overall Study|Subject Withdrew from Treatment|1|||
154905403|NCT00398138|559073633|FG000|Overall Study|Adverse Event|2|||
154905404|NCT03954704|559073639|FG000|Overall Study|Death|1|||
154905405|NCT03954704|559073640|FG001|Overall Study|Death|1|||
154905406|NCT03954704|559073641|FG002|Overall Study|Death|1|||
154905407|NCT03954704|559073642|FG003|Overall Study|Death|3|||
154905408|NCT03954704|559073643|FG004|Overall Study|Death|2|||
154905409|NCT03954704|559073644|FG005|Overall Study|Death|2|||
154905410|NCT03954704|559073645|FG006|Overall Study|Death|0|||
154905411|NCT03954704|559073639|FG000|Overall Study|Withdrew Consent|0|||
154905412|NCT03954704|559073640|FG001|Overall Study|Withdrew Consent|0|||
154905413|NCT03954704|559073641|FG002|Overall Study|Withdrew Consent|1|||
154905414|NCT03954704|559073642|FG003|Overall Study|Withdrew Consent|0|||
154905415|NCT03954704|559073643|FG004|Overall Study|Withdrew Consent|0|||
154905416|NCT03954704|559073644|FG005|Overall Study|Withdrew Consent|1|||
154905417|NCT03954704|559073645|FG006|Overall Study|Withdrew Consent|0|||
154905418|NCT03954704|559073639|FG000|Overall Study|Lost to Follow-up|0|||
154905419|NCT03954704|559073640|FG001|Overall Study|Lost to Follow-up|0|||
154905420|NCT03954704|559073641|FG002|Overall Study|Lost to Follow-up|0|||
154905421|NCT03954704|559073642|FG003|Overall Study|Lost to Follow-up|0|||
154905422|NCT03954704|559073643|FG004|Overall Study|Lost to Follow-up|0|||
154905423|NCT03954704|559073644|FG005|Overall Study|Lost to Follow-up|0|||
154905424|NCT03954704|559073645|FG006|Overall Study|Lost to Follow-up|1|||
154905425|NCT03954704|559073639|FG000|Overall Study|Study Terminated by Sponsor|0|||
154905426|NCT03954704|559073640|FG001|Overall Study|Study Terminated by Sponsor|0|||
154905427|NCT03954704|559073641|FG002|Overall Study|Study Terminated by Sponsor|1|||
154905428|NCT03954704|559073642|FG003|Overall Study|Study Terminated by Sponsor|0|||
154905429|NCT03954704|559073643|FG004|Overall Study|Study Terminated by Sponsor|1|||
154905430|NCT03954704|559073644|FG005|Overall Study|Study Terminated by Sponsor|4|||
155116209|NCT01962987|559856781|FG000|Overall Study|Restricted medication|5|||
155116210|NCT01962987|559856782|FG001|Overall Study|Restricted medication|1|||
155116211|NCT01962987|559856783|FG002|Overall Study|Restricted medication|1|||
155116212|NCT01962987|559856781|FG000|Overall Study|Serious Adverse Event|1|||
155116213|NCT01962987|559856782|FG001|Overall Study|Serious Adverse Event|0|||
155116214|NCT01962987|559856783|FG002|Overall Study|Serious Adverse Event|0|||
155116215|NCT01962987|559856781|FG000|Overall Study|Withdrawal by Subject|11|||
155116216|NCT01962987|559856782|FG001|Overall Study|Withdrawal by Subject|10|||
155116217|NCT01962987|559856783|FG002|Overall Study|Withdrawal by Subject|6|||
155116218|NCT01962987|559856781|FG000|Overall Study|Randomized in Error|4|||
155116219|NCT01962987|559856782|FG001|Overall Study|Randomized in Error|2|||
155116220|NCT01962987|559856783|FG002|Overall Study|Randomized in Error|2|||
155116221|NCT00316693|559856784|FG000|Overall Study|Adverse Event|6|||
155116222|NCT00316693|559856785|FG001|Overall Study|Adverse Event|1|||
155116223|NCT00316693|559856784|FG000|Overall Study|Protocol Violation|1|||
155116224|NCT00316693|559856785|FG001|Overall Study|Protocol Violation|0|||
155116225|NCT00316693|559856784|FG000|Overall Study|Withdrawal by Subject|6|||
155116226|NCT00316693|559856785|FG001|Overall Study|Withdrawal by Subject|6|||
155116227|NCT00316693|559856784|FG000|Overall Study|Lost to Follow-up|26|||
155116228|NCT00316693|559856785|FG001|Overall Study|Lost to Follow-up|34|||
155116229|NCT00316693|559856784|FG000|Overall Study|Other|38|||
155116230|NCT00316693|559856785|FG001|Overall Study|Other|44|||
155116231|NCT01967823|559856786|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
154905431|NCT03954704|559073645|FG006|Overall Study|Study Terminated by Sponsor|2|||
154905432|NCT03954704|559073639|FG000|Overall Study|Enrolled but not Treated|0|||
154905433|NCT03954704|559073640|FG001|Overall Study|Enrolled but not Treated|0|||
154905434|NCT03954704|559073641|FG002|Overall Study|Enrolled but not Treated|0|||
154905435|NCT03954704|559073642|FG003|Overall Study|Enrolled but not Treated|0|||
154905436|NCT03954704|559073643|FG004|Overall Study|Enrolled but not Treated|0|||
154905437|NCT03954704|559073644|FG005|Overall Study|Enrolled but not Treated|1|||
154905438|NCT03954704|559073645|FG006|Overall Study|Enrolled but not Treated|0|||
154905439|NCT02571972|559073648|FG000|Overall Study|Protocol Violation|2|||
154905440|NCT02571972|559073648|FG000|Overall Study|Withdrawal by Subject|2|||
154905441|NCT03287830|559076092|FG000|Overall Study|Withdrawal by Subject|1|||
154905442|NCT03287830|559076093|FG001|Overall Study|Withdrawal by Subject|1|||
154905443|NCT03287830|559076092|FG000|Overall Study|not meeting inclusion criteria|5|||
154905444|NCT03287830|559076093|FG001|Overall Study|not meeting inclusion criteria|12|||
154905445|NCT00608842|559076094|FG000|Overall Study|Participant's Request|0|||
154905446|NCT00608842|559076095|FG001|Overall Study|Participant's Request|1|||
154905447|NCT00608842|559076096|FG002|Overall Study|Participant's Request|2|||
154905448|NCT00608842|559076097|FG003|Overall Study|Participant's Request|1|||
154905449|NCT00608842|559076094|FG000|Overall Study|Lost to Follow-up|1|||
154905450|NCT00608842|559076095|FG001|Overall Study|Lost to Follow-up|0|||
154905451|NCT00608842|559076096|FG002|Overall Study|Lost to Follow-up|0|||
154905452|NCT00608842|559076097|FG003|Overall Study|Lost to Follow-up|0|||
154905453|NCT01688999|559076098|FG000|Overall Study|Withdrawal by Subject|5|||
154905454|NCT01688999|559076099|FG001|Overall Study|Withdrawal by Subject|1|||
154905455|NCT01688999|559076100|FG002|Overall Study|Withdrawal by Subject|1|||
154905456|NCT01688999|559076098|FG000|Overall Study|Adverse Event|2|||
154905457|NCT01688999|559076099|FG001|Overall Study|Adverse Event|0|||
154905458|NCT01688999|559076100|FG002|Overall Study|Adverse Event|2|||
154905459|NCT01688999|559076098|FG000|Overall Study|Ineligible/Not treated|1|||
154905460|NCT01688999|559076099|FG001|Overall Study|Ineligible/Not treated|0|||
154905461|NCT01688999|559076100|FG002|Overall Study|Ineligible/Not treated|0|||
154905462|NCT02768103|559076101|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
154905463|NCT03039790|559076118|FG000|Overall Study|Lost to Follow-up|2|||
154905464|NCT03039790|559076119|FG001|Overall Study|Lost to Follow-up|0|||
154905465|NCT03039790|559076120|FG002|Overall Study|Lost to Follow-up|1|||
154905466|NCT03039790|559076121|FG003|Overall Study|Lost to Follow-up|1|||
154905467|NCT03039790|559076122|FG004|Overall Study|Lost to Follow-up|0|||
155116232|NCT00416715|559856792|FG000|Overall Study|Not evaluable for joint aches|7|||
155116233|NCT00416715|559856792|FG000|Overall Study|Vitamin D levels not evaluable|8|||
155116234|NCT03224507|559856802|FG000|Overall Study|Death|3|||
155116235|NCT03224507|559856803|FG001|Overall Study|Death|0|||
154905468|NCT03039790|559076123|FG005|Overall Study|Lost to Follow-up|1|||
154905469|NCT03039790|559076124|FG006|Overall Study|Lost to Follow-up|1|||
154905470|NCT03039790|559076125|FG007|Overall Study|Lost to Follow-up|1|||
154905471|NCT03039790|559076126|FG008|Overall Study|Lost to Follow-up|0|||
154905472|NCT03039790|559076127|FG009|Overall Study|Lost to Follow-up|1|||
154905473|NCT03039790|559076128|FG010|Overall Study|Lost to Follow-up|1|||
154905474|NCT03039790|559076129|FG011|Overall Study|Lost to Follow-up|0|||
154905475|NCT03039790|559076130|FG012|Overall Study|Lost to Follow-up|1|||
154905476|NCT03039790|559076131|FG013|Overall Study|Lost to Follow-up|0|||
154905477|NCT03039790|559076132|FG014|Overall Study|Lost to Follow-up|3|||
154905478|NCT03039790|559076133|FG015|Overall Study|Lost to Follow-up|1|||
155116236|NCT03224507|559856802|FG000|Overall Study|Lack of Efficacy|6|||
155116237|NCT03224507|559856803|FG001|Overall Study|Lack of Efficacy|0|||
155116238|NCT03224507|559856802|FG000|Overall Study|Withdrawal by Subject|6|||
155116239|NCT03224507|559856803|FG001|Overall Study|Withdrawal by Subject|0|||
155116240|NCT01007435|559856804|FG000|Overall Study|Adverse Event|16|||
154905479|NCT03039790|559076134|FG016|Overall Study|Lost to Follow-up|2|||
154905480|NCT03039790|559076135|FG017|Overall Study|Lost to Follow-up|2|||
154905481|NCT03039790|559076136|FG018|Overall Study|Lost to Follow-up|1|||
154905482|NCT03039790|559076137|FG019|Overall Study|Lost to Follow-up|3|||
154905483|NCT03039790|559076118|FG000|Overall Study|Withdrawal of Consent|1|||
154905484|NCT03039790|559076119|FG001|Overall Study|Withdrawal of Consent|0|||
154905485|NCT03039790|559076120|FG002|Overall Study|Withdrawal of Consent|0|||
154905486|NCT03039790|559076121|FG003|Overall Study|Withdrawal of Consent|1|||
154905487|NCT03039790|559076122|FG004|Overall Study|Withdrawal of Consent|0|||
154905488|NCT03039790|559076123|FG005|Overall Study|Withdrawal of Consent|0|||
154905489|NCT03039790|559076124|FG006|Overall Study|Withdrawal of Consent|0|||
154905490|NCT03039790|559076125|FG007|Overall Study|Withdrawal of Consent|0|||
154905491|NCT03039790|559076126|FG008|Overall Study|Withdrawal of Consent|0|||
154905492|NCT03039790|559076127|FG009|Overall Study|Withdrawal of Consent|1|||
154905493|NCT03039790|559076128|FG010|Overall Study|Withdrawal of Consent|0|||
154905494|NCT03039790|559076129|FG011|Overall Study|Withdrawal of Consent|0|||
154905495|NCT03039790|559076130|FG012|Overall Study|Withdrawal of Consent|2|||
154905496|NCT03039790|559076131|FG013|Overall Study|Withdrawal of Consent|0|||
154905497|NCT03039790|559076132|FG014|Overall Study|Withdrawal of Consent|1|||
154905498|NCT03039790|559076133|FG015|Overall Study|Withdrawal of Consent|5|||
154905499|NCT03039790|559076134|FG016|Overall Study|Withdrawal of Consent|3|||
154905500|NCT03039790|559076135|FG017|Overall Study|Withdrawal of Consent|0|||
154905501|NCT03039790|559076136|FG018|Overall Study|Withdrawal of Consent|2|||
154905502|NCT03039790|559076137|FG019|Overall Study|Withdrawal of Consent|5|||
154905503|NCT03039790|559076118|FG000|Overall Study|Death|0|||
154905504|NCT03039790|559076119|FG001|Overall Study|Death|0|||
154905505|NCT03039790|559076120|FG002|Overall Study|Death|0|||
154905506|NCT03039790|559076121|FG003|Overall Study|Death|0|||
154905507|NCT03039790|559076122|FG004|Overall Study|Death|0|||
154905508|NCT03039790|559076123|FG005|Overall Study|Death|0|||
154905509|NCT03039790|559076124|FG006|Overall Study|Death|0|||
154905510|NCT03039790|559076125|FG007|Overall Study|Death|0|||
154905511|NCT03039790|559076126|FG008|Overall Study|Death|0|||
154905512|NCT03039790|559076127|FG009|Overall Study|Death|0|||
154905513|NCT03039790|559076128|FG010|Overall Study|Death|0|||
154905514|NCT03039790|559076129|FG011|Overall Study|Death|0|||
154905515|NCT03039790|559076130|FG012|Overall Study|Death|0|||
154905516|NCT03039790|559076131|FG013|Overall Study|Death|0|||
154905517|NCT03039790|559076132|FG014|Overall Study|Death|0|||
154905518|NCT03039790|559076133|FG015|Overall Study|Death|1|||
154905519|NCT03039790|559076134|FG016|Overall Study|Death|3|||
154905520|NCT03039790|559076135|FG017|Overall Study|Death|0|||
154905521|NCT03039790|559076136|FG018|Overall Study|Death|2|||
154905522|NCT03039790|559076137|FG019|Overall Study|Death|0|||
154905523|NCT03039790|559076118|FG000|Overall Study|Reason, not Specified|1|||
154905524|NCT03039790|559076119|FG001|Overall Study|Reason, not Specified|0|||
154905525|NCT03039790|559076120|FG002|Overall Study|Reason, not Specified|0|||
154905526|NCT03039790|559076121|FG003|Overall Study|Reason, not Specified|0|||
154905527|NCT03039790|559076122|FG004|Overall Study|Reason, not Specified|0|||
154905528|NCT03039790|559076123|FG005|Overall Study|Reason, not Specified|0|||
154905529|NCT03039790|559076124|FG006|Overall Study|Reason, not Specified|0|||
154905530|NCT03039790|559076125|FG007|Overall Study|Reason, not Specified|0|||
154905531|NCT03039790|559076126|FG008|Overall Study|Reason, not Specified|0|||
154905532|NCT03039790|559076127|FG009|Overall Study|Reason, not Specified|0|||
154905533|NCT03039790|559076128|FG010|Overall Study|Reason, not Specified|0|||
154905534|NCT03039790|559076129|FG011|Overall Study|Reason, not Specified|0|||
154905535|NCT03039790|559076130|FG012|Overall Study|Reason, not Specified|0|||
154905536|NCT03039790|559076131|FG013|Overall Study|Reason, not Specified|0|||
154905537|NCT03039790|559076132|FG014|Overall Study|Reason, not Specified|0|||
154905538|NCT03039790|559076133|FG015|Overall Study|Reason, not Specified|0|||
154905539|NCT03039790|559076134|FG016|Overall Study|Reason, not Specified|2|||
154905540|NCT03039790|559076135|FG017|Overall Study|Reason, not Specified|0|||
154905541|NCT03039790|559076136|FG018|Overall Study|Reason, not Specified|1|||
154905542|NCT03039790|559076137|FG019|Overall Study|Reason, not Specified|0|||
154905543|NCT00498368|559076140|FG000|Overall Study|Withdrawal by Subject|3|||
154905544|NCT00498368|559076141|FG001|Overall Study|Withdrawal by Subject|2|||
154905545|NCT02266004|559076142|FG000|Overall Study|unrelated adverse event|1|||
154905546|NCT02266004|559076142|FG000|Overall Study|Physician Decision|1|||
154905547|NCT01025232|559076149|FG000|Overall Study|Study drug no longer available|3|||
154905548|NCT01025232|559076150|FG001|Overall Study|Study drug no longer available|6|||
154905549|NCT03748420|559076151|FG000|Overall Study|No 12 month medication adherence data available|0|||
154905550|NCT03748420|559076152|FG001|Overall Study|No 12 month medication adherence data available|1|||
154905551|NCT03748420|559076151|FG000|Overall Study|Death|24|||
154905552|NCT03748420|559076152|FG001|Overall Study|Death|28|||
154905553|NCT03748420|559076151|FG000|Overall Study|Lost to Follow-up|231|||
154905554|NCT03748420|559076152|FG001|Overall Study|Lost to Follow-up|230|||
154905555|NCT01764022|559076153|FG000|Overall Study|Death|3|||
154905556|NCT01764022|559076154|FG001|Overall Study|Death|5|||
154905557|NCT01764022|559076153|FG000|Overall Study|Withdrawal by Subject|2|||
154905558|NCT01764022|559076154|FG001|Overall Study|Withdrawal by Subject|6|||
154905559|NCT01764022|559076153|FG000|Overall Study|Lack of Efficacy|0|||
154905560|NCT01764022|559076154|FG001|Overall Study|Lack of Efficacy|1|||
154905561|NCT01764022|559076153|FG000|Overall Study|Physician Decision|0|||
154905562|NCT01764022|559076154|FG001|Overall Study|Physician Decision|2|||
154905563|NCT01764022|559076153|FG000|Overall Study|Lost to Follow-up|2|||
154905564|NCT01764022|559076154|FG001|Overall Study|Lost to Follow-up|0|||
154905565|NCT01764022|559076153|FG000|Overall Study|Protocol Violation|1|||
154905566|NCT01764022|559076154|FG001|Overall Study|Protocol Violation|0|||
154905567|NCT01899768|559076155|FG000|Part A|Adverse Event|2|||
154905568|NCT01899768|559076155|FG000|Part A|Withdrawal by Subject|1|||
154905569|NCT01899768|559076155|FG000|Part B|Adverse Event|1|||
154905570|NCT01899768|559076155|FG000|Part B|Withdrawal by Subject|1|||
154905571|NCT04476108|559076156|FG000|Overall Study|Adverse Event|4|||
154905572|NCT04476108|559076157|FG001|Overall Study|Adverse Event|1|||
154905573|NCT04476108|559076156|FG000|Overall Study|Lost to Follow-up|1|||
154905574|NCT04476108|559076157|FG001|Overall Study|Lost to Follow-up|0|||
154905575|NCT04476108|559076156|FG000|Overall Study|Inadvertent Enrollment|1|||
154905576|NCT04476108|559076157|FG001|Overall Study|Inadvertent Enrollment|0|||
154905577|NCT04476108|559076156|FG000|Overall Study|Protocol Violation|1|||
154905578|NCT04476108|559076157|FG001|Overall Study|Protocol Violation|1|||
154905579|NCT04476108|559076156|FG000|Overall Study|Withdrawal by Subject|1|||
154905580|NCT04476108|559076157|FG001|Overall Study|Withdrawal by Subject|1|||
154905581|NCT00850135|559076158|FG000|Overall Study|Physician Decision|1|||
154905582|NCT02253992|559076159|FG000|Overall Study|Study drug toxicity|1|||
154905583|NCT02253992|559076160|FG001|Overall Study|Study drug toxicity|0|||
154905584|NCT02253992|559076161|FG002|Overall Study|Study drug toxicity|10|||
154905585|NCT02253992|559076159|FG000|Overall Study|Disease progression|4|||
154905586|NCT02253992|559076160|FG001|Overall Study|Disease progression|3|||
154905587|NCT02253992|559076161|FG002|Overall Study|Disease progression|98|||
154905588|NCT02253992|559076159|FG000|Overall Study|Withdrawal by Subject|0|||
154905589|NCT02253992|559076160|FG001|Overall Study|Withdrawal by Subject|0|||
154905590|NCT02253992|559076161|FG002|Overall Study|Withdrawal by Subject|3|||
154905591|NCT02253992|559076159|FG000|Overall Study|Adverse Event|0|||
154905592|NCT02253992|559076160|FG001|Overall Study|Adverse Event|0|||
154905593|NCT02253992|559076161|FG002|Overall Study|Adverse Event|8|||
154905594|NCT02253992|559076159|FG000|Overall Study|Death|0|||
154905595|NCT02253992|559076160|FG001|Overall Study|Death|0|||
154905596|NCT02253992|559076161|FG002|Overall Study|Death|1|||
154905597|NCT02253992|559076159|FG000|Overall Study|Subject discontinued study drug|1|||
154905598|NCT02253992|559076160|FG001|Overall Study|Subject discontinued study drug|0|||
154905599|NCT02253992|559076161|FG002|Overall Study|Subject discontinued study drug|1|||
154905600|NCT02253992|559076159|FG000|Overall Study|Completed treatment as per protocol|0|||
154905601|NCT02253992|559076160|FG001|Overall Study|Completed treatment as per protocol|1|||
154905602|NCT02253992|559076161|FG002|Overall Study|Completed treatment as per protocol|22|||
154905603|NCT02253992|559076159|FG000|Overall Study|Other|0|||
154905604|NCT02253992|559076160|FG001|Overall Study|Other|0|||
154905605|NCT02253992|559076161|FG002|Overall Study|Other|1|||
154905606|NCT02159365|559076162|FG000|Overall Study|Disease Progression|23|||
154905607|NCT02159365|559076162|FG000|Overall Study|Other reasons|11|||
154905608|NCT02159365|559076162|FG000|Overall Study|Administrative reason by Sponsor|9|||
154905609|NCT02159365|559076162|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
154905610|NCT02159365|559076162|FG000|Overall Study|Study drug toxicity|7|||
154905611|NCT02159365|559076162|FG000|Overall Study|Maximum clinical benefit|3|||
154905612|NCT02159365|559076162|FG000|Overall Study|Subject request to discontinue treatment|3|||
154905613|NCT02159365|559076162|FG000|Overall Study|Subject withdrew consent|3|||
154905614|NCT02159365|559076162|FG000|Overall Study|Death|1|||
154905615|NCT02159365|559076162|FG000|Overall Study|Lost to Follow-up|1|||
155116241|NCT01007435|559856805|FG001|Overall Study|Adverse Event|25|||
155116242|NCT01007435|559856806|FG002|Overall Study|Adverse Event|47|||
155116243|NCT01007435|559856807|FG003|Overall Study|Adverse Event|31|||
155116244|NCT01007435|559856804|FG000|Overall Study|Death|2|||
155116245|NCT01007435|559856805|FG001|Overall Study|Death|4|||
155116246|NCT01007435|559856806|FG002|Overall Study|Death|2|||
155116247|NCT01007435|559856807|FG003|Overall Study|Death|1|||
154983355|NCT00773734|559364420|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
154905616|NCT04051944|559076163|FG000|Overall Study|Study ending|1|||
154905617|NCT04051944|559076164|FG001|Overall Study|Study ending|1|||
154905618|NCT04051944|559076163|FG000|Overall Study|Early study termination by participant|1|||
154905619|NCT04051944|559076164|FG001|Overall Study|Early study termination by participant|0|||
154905620|NCT04051944|559076163|FG000|Overall Study|Withdrawal by Subject|2|||
154905621|NCT04051944|559076164|FG001|Overall Study|Withdrawal by Subject|2|||
154905622|NCT04051944|559076163|FG000|Overall Study|Lack of Efficacy|3|||
154905623|NCT04051944|559076164|FG001|Overall Study|Lack of Efficacy|0|||
154905624|NCT04051944|559076163|FG000|Overall Study|Adverse event, non- fatal|1|||
154905625|NCT04051944|559076164|FG001|Overall Study|Adverse event, non- fatal|1|||
155116248|NCT01007435|559856804|FG000|Overall Study|Insufficient Therapeutic Response|21|||
155116249|NCT01007435|559856805|FG001|Overall Study|Insufficient Therapeutic Response|7|||
155116250|NCT01007435|559856806|FG002|Overall Study|Insufficient Therapeutic Response|2|||
155116251|NCT01007435|559856807|FG003|Overall Study|Insufficient Therapeutic Response|9|||
155116252|NCT01007435|559856804|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
155116253|NCT01007435|559856805|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
155116254|NCT01007435|559856806|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
155116255|NCT01007435|559856807|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
155116256|NCT01007435|559856804|FG000|Overall Study|Other Protocol Violation|2|||
155116257|NCT01007435|559856805|FG001|Overall Study|Other Protocol Violation|0|||
155116258|NCT01007435|559856806|FG002|Overall Study|Other Protocol Violation|1|||
155116259|NCT01007435|559856807|FG003|Overall Study|Other Protocol Violation|0|||
155116260|NCT01007435|559856804|FG000|Overall Study|Refused Treatment|13|||
155116261|NCT01007435|559856805|FG001|Overall Study|Refused Treatment|13|||
155116262|NCT01007435|559856806|FG002|Overall Study|Refused Treatment|5|||
155116263|NCT01007435|559856807|FG003|Overall Study|Refused Treatment|8|||
155116264|NCT01007435|559856804|FG000|Overall Study|Failure to Return|5|||
155116265|NCT01007435|559856805|FG001|Overall Study|Failure to Return|4|||
155116266|NCT01007435|559856806|FG002|Overall Study|Failure to Return|3|||
155116267|NCT01007435|559856807|FG003|Overall Study|Failure to Return|6|||
155116268|NCT01007435|559856804|FG000|Overall Study|Reason not Specified|1|||
155116269|NCT01007435|559856805|FG001|Overall Study|Reason not Specified|1|||
155116270|NCT01007435|559856806|FG002|Overall Study|Reason not Specified|2|||
155116271|NCT01007435|559856807|FG003|Overall Study|Reason not Specified|1|||
155116272|NCT01032291|559856808|FG000|Safety Lead-in|Adverse Event|1|||
155116273|NCT01032291|559856809|FG001|Safety Lead-in|Adverse Event|0|||
155116274|NCT01032291|559856810|FG002|Safety Lead-in|Adverse Event|0|||
155116275|NCT01032291|559856808|FG000|Safety Lead-in|Death|1|||
155116276|NCT01032291|559856809|FG001|Safety Lead-in|Death|0|||
155116277|NCT01032291|559856810|FG002|Safety Lead-in|Death|0|||
155116278|NCT01032291|559856808|FG000|Proof of Concept|Adverse Event|0|||
155116279|NCT01032291|559856809|FG001|Proof of Concept|Adverse Event|5|||
155116280|NCT01032291|559856810|FG002|Proof of Concept|Adverse Event|1|||
155116281|NCT01032291|559856808|FG000|Proof of Concept|Death|0|||
155116282|NCT01032291|559856809|FG001|Proof of Concept|Death|1|||
155116283|NCT01032291|559856810|FG002|Proof of Concept|Death|2|||
155116284|NCT01032291|559856808|FG000|Proof of Concept|Lack of Efficacy|0|||
155116285|NCT01032291|559856809|FG001|Proof of Concept|Lack of Efficacy|1|||
155116286|NCT01032291|559856810|FG002|Proof of Concept|Lack of Efficacy|0|||
155116287|NCT01032291|559856808|FG000|Proof of Concept|Never Received Study Drug|0|||
155116288|NCT01032291|559856809|FG001|Proof of Concept|Never Received Study Drug|1|||
155116289|NCT01032291|559856810|FG002|Proof of Concept|Never Received Study Drug|0|||
155116290|NCT02576535|559856811|FG000|Overall Study|Withdrawal by Subject|2|||
155116291|NCT02545517|559856812|FG000|Overall Study|Death|2|||
155116292|NCT02545517|559856813|FG001|Overall Study|Death|2|||
155116293|NCT02545517|559856814|FG002|Overall Study|Death|1|||
155116294|NCT02545517|559856812|FG000|Overall Study|Lost to Follow-up|14|||
155116295|NCT02545517|559856813|FG001|Overall Study|Lost to Follow-up|13|||
155116296|NCT02545517|559856814|FG002|Overall Study|Lost to Follow-up|17|||
155116297|NCT02545517|559856812|FG000|Overall Study|Protocol Violation|0|||
155116298|NCT02545517|559856813|FG001|Overall Study|Protocol Violation|1|||
155116299|NCT02545517|559856814|FG002|Overall Study|Protocol Violation|1|||
155116300|NCT02545517|559856812|FG000|Overall Study|Withdrawal by Subject|5|||
155116301|NCT02545517|559856813|FG001|Overall Study|Withdrawal by Subject|8|||
155116302|NCT02545517|559856814|FG002|Overall Study|Withdrawal by Subject|9|||
155116303|NCT02545517|559856812|FG000|Overall Study|Administrative reason|5|||
154905626|NCT01526928|559076165|FG000|Overall Study|Progressive Disease|35|||
154905627|NCT01526928|559076166|FG001|Overall Study|Progressive Disease|17|||
154905628|NCT01526928|559076167|FG002|Overall Study|Progressive Disease|150|||
154905629|NCT01526928|559076168|FG003|Overall Study|Progressive Disease|182|||
155116304|NCT02545517|559856813|FG001|Overall Study|Administrative reason|6|||
155116305|NCT02545517|559856814|FG002|Overall Study|Administrative reason|10|||
155116306|NCT02545517|559856812|FG000|Overall Study|Other|2|||
155116307|NCT02545517|559856813|FG001|Overall Study|Other|4|||
155116308|NCT02545517|559856814|FG002|Overall Study|Other|3|||
155116309|NCT03327220|559856816|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
155116310|NCT03327220|559856817|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
154905630|NCT01526928|559076169|FG004|Overall Study|Progressive Disease|76|||
155116311|NCT03327220|559856816|FG000|Overall Study|Investigator Decision|2|||
155116312|NCT03327220|559856817|FG001|Overall Study|Investigator Decision|0|||
155116313|NCT03327220|559856816|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
155116314|NCT03327220|559856817|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
155116315|NCT03327220|559856816|FG000|Overall Study|Fungal infection|1|||
155116316|NCT03327220|559856817|FG001|Overall Study|Fungal infection|0|||
155116317|NCT03327220|559856816|FG000|Overall Study|Discharged to Rehabilitation|0|||
155116318|NCT03327220|559856817|FG001|Overall Study|Discharged to Rehabilitation|1|||
154905631|NCT01526928|559076170|FG005|Overall Study|Progressive Disease|4|||
155116319|NCT03327220|559856816|FG000|Overall Study|Missing|1|||
155116320|NCT03327220|559856817|FG001|Overall Study|Missing|0|||
154905632|NCT01526928|559076165|FG000|Overall Study|Adverse Event|2|||
154905633|NCT01526928|559076166|FG001|Overall Study|Adverse Event|1|||
154905634|NCT01526928|559076167|FG002|Overall Study|Adverse Event|29|||
154905635|NCT01526928|559076168|FG003|Overall Study|Adverse Event|40|||
154905636|NCT01526928|559076169|FG004|Overall Study|Adverse Event|13|||
154905637|NCT01526928|559076170|FG005|Overall Study|Adverse Event|2|||
154905638|NCT01526928|559076165|FG000|Overall Study|Death|0|||
154905639|NCT01526928|559076166|FG001|Overall Study|Death|0|||
154905640|NCT01526928|559076167|FG002|Overall Study|Death|3|||
154905641|NCT01526928|559076168|FG003|Overall Study|Death|0|||
154905642|NCT01526928|559076169|FG004|Overall Study|Death|0|||
154905643|NCT01526928|559076170|FG005|Overall Study|Death|0|||
154905644|NCT01526928|559076165|FG000|Overall Study|Withdrawal by Subject|1|||
154905645|NCT01526928|559076166|FG001|Overall Study|Withdrawal by Subject|0|||
154905646|NCT01526928|559076167|FG002|Overall Study|Withdrawal by Subject|13|||
154905647|NCT01526928|559076168|FG003|Overall Study|Withdrawal by Subject|11|||
154905648|NCT01526928|559076169|FG004|Overall Study|Withdrawal by Subject|3|||
154905649|NCT01526928|559076170|FG005|Overall Study|Withdrawal by Subject|0|||
154905650|NCT01526928|559076165|FG000|Overall Study|Physician Decision|0|||
154905651|NCT01526928|559076166|FG001|Overall Study|Physician Decision|0|||
154905652|NCT01526928|559076167|FG002|Overall Study|Physician Decision|2|||
154905653|NCT01526928|559076168|FG003|Overall Study|Physician Decision|5|||
154905654|NCT01526928|559076169|FG004|Overall Study|Physician Decision|0|||
154905655|NCT01526928|559076170|FG005|Overall Study|Physician Decision|0|||
154905656|NCT01526928|559076165|FG000|Overall Study|Other Reason|0|||
154905657|NCT01526928|559076166|FG001|Overall Study|Other Reason|1|||
154905658|NCT01526928|559076167|FG002|Overall Study|Other Reason|11|||
154905659|NCT01526928|559076168|FG003|Overall Study|Other Reason|4|||
154905660|NCT01526928|559076169|FG004|Overall Study|Other Reason|1|||
154905661|NCT01526928|559076170|FG005|Overall Study|Other Reason|0|||
154905662|NCT01526928|559076165|FG000|Overall Study|Lost to Follow-up|0|||
154905663|NCT01526928|559076166|FG001|Overall Study|Lost to Follow-up|0|||
154905664|NCT01526928|559076167|FG002|Overall Study|Lost to Follow-up|0|||
154905665|NCT01526928|559076168|FG003|Overall Study|Lost to Follow-up|1|||
154905666|NCT01526928|559076169|FG004|Overall Study|Lost to Follow-up|0|||
154905667|NCT01526928|559076170|FG005|Overall Study|Lost to Follow-up|0|||
154905668|NCT01526928|559076165|FG000|Overall Study|Protocol Deviation|0|||
154905669|NCT01526928|559076166|FG001|Overall Study|Protocol Deviation|0|||
154905670|NCT01526928|559076167|FG002|Overall Study|Protocol Deviation|0|||
154905671|NCT01526928|559076168|FG003|Overall Study|Protocol Deviation|2|||
154905672|NCT01526928|559076169|FG004|Overall Study|Protocol Deviation|0|||
154905673|NCT01526928|559076170|FG005|Overall Study|Protocol Deviation|0|||
154905674|NCT01526928|559076165|FG000|Overall Study|Missing|0|||
154905675|NCT01526928|559076166|FG001|Overall Study|Missing|0|||
154905676|NCT01526928|559076167|FG002|Overall Study|Missing|1|||
154905677|NCT01526928|559076168|FG003|Overall Study|Missing|0|||
154905678|NCT01526928|559076169|FG004|Overall Study|Missing|2|||
154905679|NCT01526928|559076170|FG005|Overall Study|Missing|0|||
154905680|NCT04157751|559076171|FG000|Overall Study|Withdrawal by Subject|12|||
154905681|NCT04157751|559076172|FG001|Overall Study|Withdrawal by Subject|17|||
154905682|NCT04157751|559076171|FG000|Overall Study|Lost to Follow-up|6|||
154905683|NCT04157751|559076172|FG001|Overall Study|Lost to Follow-up|2|||
154905684|NCT04157751|559076171|FG000|Overall Study|Adverse Event|34|||
154905685|NCT04157751|559076172|FG001|Overall Study|Adverse Event|23|||
154905686|NCT04157751|559076171|FG000|Overall Study|Not treated|1|||
154905687|NCT04157751|559076172|FG001|Overall Study|Not treated|5|||
154905688|NCT04157751|559076171|FG000|Overall Study|Other reason not stated above|10|||
154905689|NCT04157751|559076172|FG001|Overall Study|Other reason not stated above|10|||
154905690|NCT04731922|559076173|FG000|Overall Study|Adverse Event|0|||
154905691|NCT04731922|559076174|FG001|Overall Study|Adverse Event|0|||
154905692|NCT04731922|559076175|FG002|Overall Study|Adverse Event|0|||
154905693|NCT04731922|559076176|FG003|Overall Study|Adverse Event|0|||
154905694|NCT04731922|559076177|FG004|Overall Study|Adverse Event|0|||
154905695|NCT04731922|559076178|FG005|Overall Study|Adverse Event|0|||
154905696|NCT04731922|559076179|FG006|Overall Study|Adverse Event|0|||
154905697|NCT04731922|559076180|FG007|Overall Study|Adverse Event|0|||
154905698|NCT04731922|559076181|FG008|Overall Study|Adverse Event|0|||
154905699|NCT04731922|559076182|FG009|Overall Study|Adverse Event|0|||
154905700|NCT04731922|559076183|FG010|Overall Study|Adverse Event|1|||
154905701|NCT04731922|559076184|FG011|Overall Study|Adverse Event|0|||
154905702|NCT04731922|559076185|FG012|Overall Study|Adverse Event|0|||
154905703|NCT04731922|559076186|FG013|Overall Study|Adverse Event|0|||
154905704|NCT04731922|559076187|FG014|Overall Study|Adverse Event|0|||
154905705|NCT04731922|559076188|FG015|Overall Study|Adverse Event|0|||
154905706|NCT04731922|559076189|FG016|Overall Study|Adverse Event|0|||
154905707|NCT04731922|559076173|FG000|Overall Study|Lost to Follow-up|0|||
154905708|NCT04731922|559076174|FG001|Overall Study|Lost to Follow-up|0|||
154905709|NCT04731922|559076175|FG002|Overall Study|Lost to Follow-up|0|||
154905710|NCT04731922|559076176|FG003|Overall Study|Lost to Follow-up|1|||
154905711|NCT04731922|559076177|FG004|Overall Study|Lost to Follow-up|0|||
154905712|NCT04731922|559076178|FG005|Overall Study|Lost to Follow-up|1|||
155116321|NCT00523705|559856818|FG000|Overall Study|No time for study.|0|||
155116322|NCT00523705|559856819|FG001|Overall Study|No time for study.|1|||
155116323|NCT00543803|559856822|FG000|Overall Study|Adverse Event|14|||
155116324|NCT00543803|559856822|FG000|Overall Study|Lack of Efficacy|22|||
155116325|NCT00543803|559856822|FG000|Overall Study|Lost to Follow-up|20|||
155116326|NCT00543803|559856822|FG000|Overall Study|Other|86|||
155116327|NCT01639339|559856827|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
154905713|NCT04731922|559076179|FG006|Overall Study|Lost to Follow-up|0|||
154905714|NCT04731922|559076180|FG007|Overall Study|Lost to Follow-up|0|||
154905715|NCT04731922|559076181|FG008|Overall Study|Lost to Follow-up|0|||
154905716|NCT04731922|559076182|FG009|Overall Study|Lost to Follow-up|0|||
154905717|NCT04731922|559076183|FG010|Overall Study|Lost to Follow-up|0|||
154905718|NCT04731922|559076184|FG011|Overall Study|Lost to Follow-up|0|||
154905719|NCT04731922|559076185|FG012|Overall Study|Lost to Follow-up|0|||
154905720|NCT04731922|559076186|FG013|Overall Study|Lost to Follow-up|0|||
154905721|NCT04731922|559076187|FG014|Overall Study|Lost to Follow-up|0|||
154905722|NCT04731922|559076188|FG015|Overall Study|Lost to Follow-up|0|||
154905723|NCT04731922|559076189|FG016|Overall Study|Lost to Follow-up|0|||
155116328|NCT01639339|559856828|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
155116329|NCT01639339|559856827|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
154905724|NCT04731922|559076173|FG000|Overall Study|Withdrawal by Subject|1|||
154905725|NCT04731922|559076174|FG001|Overall Study|Withdrawal by Subject|0|||
154905726|NCT04731922|559076175|FG002|Overall Study|Withdrawal by Subject|0|||
154905727|NCT04731922|559076176|FG003|Overall Study|Withdrawal by Subject|0|||
154905728|NCT04731922|559076177|FG004|Overall Study|Withdrawal by Subject|1|||
154905729|NCT04731922|559076178|FG005|Overall Study|Withdrawal by Subject|0|||
154905730|NCT04731922|559076179|FG006|Overall Study|Withdrawal by Subject|1|||
154905731|NCT04731922|559076180|FG007|Overall Study|Withdrawal by Subject|0|||
154905732|NCT04731922|559076181|FG008|Overall Study|Withdrawal by Subject|0|||
154905733|NCT04731922|559076182|FG009|Overall Study|Withdrawal by Subject|0|||
154905734|NCT04731922|559076183|FG010|Overall Study|Withdrawal by Subject|0|||
154905735|NCT04731922|559076184|FG011|Overall Study|Withdrawal by Subject|0|||
154905736|NCT04731922|559076185|FG012|Overall Study|Withdrawal by Subject|0|||
154905737|NCT04731922|559076186|FG013|Overall Study|Withdrawal by Subject|1|||
154905738|NCT04731922|559076187|FG014|Overall Study|Withdrawal by Subject|0|||
154905739|NCT04731922|559076188|FG015|Overall Study|Withdrawal by Subject|0|||
154905740|NCT04731922|559076189|FG016|Overall Study|Withdrawal by Subject|0|||
154905741|NCT04731922|559076173|FG000|Overall Study|Other|0|||
154905742|NCT04731922|559076174|FG001|Overall Study|Other|0|||
154905743|NCT04731922|559076175|FG002|Overall Study|Other|0|||
154905744|NCT04731922|559076176|FG003|Overall Study|Other|0|||
154905745|NCT04731922|559076177|FG004|Overall Study|Other|0|||
154905746|NCT04731922|559076178|FG005|Overall Study|Other|0|||
154905747|NCT04731922|559076179|FG006|Overall Study|Other|1|||
154905748|NCT04731922|559076180|FG007|Overall Study|Other|0|||
154905749|NCT04731922|559076181|FG008|Overall Study|Other|0|||
154905750|NCT04731922|559076182|FG009|Overall Study|Other|0|||
154905751|NCT04731922|559076183|FG010|Overall Study|Other|0|||
154905752|NCT04731922|559076184|FG011|Overall Study|Other|0|||
154905753|NCT04731922|559076185|FG012|Overall Study|Other|0|||
154905754|NCT04731922|559076186|FG013|Overall Study|Other|0|||
154905755|NCT04731922|559076187|FG014|Overall Study|Other|0|||
154905756|NCT04731922|559076188|FG015|Overall Study|Other|0|||
154905757|NCT04731922|559076189|FG016|Overall Study|Other|0|||
154905758|NCT00422903|559076192|FG000|Overall Study|Disease Progression|3|||
154905759|NCT00422903|559076193|FG001|Overall Study|Disease Progression|1|||
154905760|NCT00422903|559076192|FG000|Overall Study|Adverse Event|0|||
154905761|NCT00422903|559076193|FG001|Overall Study|Adverse Event|2|||
154905762|NCT00422903|559076192|FG000|Overall Study|Informed Consent Withdrawn|1|||
154905763|NCT00422903|559076193|FG001|Overall Study|Informed Consent Withdrawn|2|||
154905764|NCT03446612|559076198|FG000|Overall Study|Protocol defined stopping criteria|0|||
154905765|NCT03446612|559076199|FG001|Overall Study|Protocol defined stopping criteria|1|||
155116330|NCT01639339|559856828|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
155116331|NCT01639339|559856827|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
154905766|NCT01810380|559076205|FG000|Overall Study|Randomised not treated|2|||
155116332|NCT01639339|559856828|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
154905767|NCT01810380|559076206|FG001|Overall Study|Randomised not treated|1|||
154905768|NCT01810380|559076207|FG002|Overall Study|Randomised not treated|1|||
154905769|NCT01810380|559076205|FG000|Overall Study|Adverse Event|11|||
154905770|NCT01810380|559076206|FG001|Overall Study|Adverse Event|14|||
154905771|NCT01810380|559076207|FG002|Overall Study|Adverse Event|4|||
154905772|NCT01810380|559076205|FG000|Overall Study|Lack of Efficacy|24|||
154905773|NCT01810380|559076206|FG001|Overall Study|Lack of Efficacy|10|||
154905774|NCT01810380|559076207|FG002|Overall Study|Lack of Efficacy|11|||
154905775|NCT01810380|559076205|FG000|Overall Study|Protocol Violation|1|||
154905776|NCT01810380|559076206|FG001|Overall Study|Protocol Violation|0|||
154905777|NCT01810380|559076207|FG002|Overall Study|Protocol Violation|1|||
154905778|NCT01810380|559076205|FG000|Overall Study|Withdrawal by Subject|6|||
155116333|NCT01639339|559856827|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
154905779|NCT01810380|559076206|FG001|Overall Study|Withdrawal by Subject|0|||
154905780|NCT01810380|559076207|FG002|Overall Study|Withdrawal by Subject|6|||
154905781|NCT01810380|559076205|FG000|Overall Study|Administrative or other reasons|11|||
154905782|NCT01810380|559076206|FG001|Overall Study|Administrative or other reasons|13|||
154905783|NCT01810380|559076207|FG002|Overall Study|Administrative or other reasons|9|||
154905784|NCT02829775|559076208|FG000|Overall Study|Death|1|||
154905785|NCT02829775|559076208|FG000|Overall Study|Withdrawal by Subject|3|||
154905786|NCT02829775|559076208|FG000|Overall Study|Disease remission|1|||
154905787|NCT00033371|559076209|FG000|Overall Study|Adverse Event|1|||
154905788|NCT00033371|559076210|FG001|Overall Study|Adverse Event|5|||
154905789|NCT00033371|559076209|FG000|Overall Study|Lost to Follow-up|2|||
154905790|NCT00033371|559076210|FG001|Overall Study|Lost to Follow-up|1|||
154905791|NCT00033371|559076209|FG000|Overall Study|Withdrawal by Subject|3|||
154905792|NCT00033371|559076210|FG001|Overall Study|Withdrawal by Subject|3|||
154905793|NCT00033371|559076209|FG000|Overall Study|Disease Progression|0|||
154905794|NCT00033371|559076210|FG001|Overall Study|Disease Progression|1|||
154905795|NCT02699125|559076213|FG000|Placebo|Lost to Follow-up|2|||
154905796|NCT02699125|559076214|FG001|Placebo|Lost to Follow-up|0|||
154905797|NCT02699125|559076213|FG000|Placebo|Protocol Violation|1|||
154905798|NCT02699125|559076214|FG001|Placebo|Protocol Violation|0|||
154905799|NCT02699125|559076213|FG000|Placebo|Withdrawal by Subject|0|||
154905800|NCT02699125|559076214|FG001|Placebo|Withdrawal by Subject|4|||
154905801|NCT02699125|559076213|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
154905802|NCT02699125|559076214|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
154905803|NCT01390038|559076217|FG000|Overall Study|Death|1|||
154905804|NCT01390038|559076217|FG000|Overall Study|Lost to Follow-up|1|||
154905805|NCT01390038|559076217|FG000|Overall Study|Withdrawal by Subject|4|||
154905806|NCT01390038|559076217|FG000|Overall Study|Simpliciti System Removal|2|||
154905807|NCT03799627|559076218|FG000|Overall Study|Adverse Event|1|||
154905808|NCT03799627|559076219|FG001|Overall Study|Adverse Event|2|||
154905809|NCT03799627|559076220|FG002|Overall Study|Adverse Event|0|||
154905810|NCT03799627|559076221|FG003|Overall Study|Adverse Event|0|||
154905811|NCT03799627|559076222|FG004|Overall Study|Adverse Event|2|||
154905812|NCT03799627|559076223|FG005|Overall Study|Adverse Event|5|||
154905813|NCT03799627|559076224|FG006|Overall Study|Adverse Event|0|||
154905814|NCT03799627|559076225|FG007|Overall Study|Adverse Event|2|||
154905815|NCT03799627|559076226|FG008|Overall Study|Adverse Event|0|||
154905816|NCT03799627|559076218|FG000|Overall Study|Physician Decision|2|||
154905817|NCT03799627|559076219|FG001|Overall Study|Physician Decision|2|||
154905818|NCT03799627|559076220|FG002|Overall Study|Physician Decision|0|||
154905819|NCT03799627|559076221|FG003|Overall Study|Physician Decision|0|||
154905820|NCT03799627|559076222|FG004|Overall Study|Physician Decision|2|||
154905821|NCT03799627|559076223|FG005|Overall Study|Physician Decision|2|||
154905822|NCT03799627|559076224|FG006|Overall Study|Physician Decision|0|||
154905823|NCT03799627|559076225|FG007|Overall Study|Physician Decision|0|||
154905824|NCT03799627|559076226|FG008|Overall Study|Physician Decision|0|||
154905825|NCT03799627|559076218|FG000|Overall Study|Withdrawal by Subject|1|||
154905826|NCT03799627|559076219|FG001|Overall Study|Withdrawal by Subject|1|||
154905827|NCT03799627|559076220|FG002|Overall Study|Withdrawal by Subject|0|||
154905828|NCT03799627|559076221|FG003|Overall Study|Withdrawal by Subject|2|||
154905829|NCT03799627|559076222|FG004|Overall Study|Withdrawal by Subject|0|||
154905830|NCT03799627|559076223|FG005|Overall Study|Withdrawal by Subject|3|||
154905831|NCT03799627|559076224|FG006|Overall Study|Withdrawal by Subject|0|||
154905832|NCT03799627|559076225|FG007|Overall Study|Withdrawal by Subject|0|||
154905833|NCT03799627|559076226|FG008|Overall Study|Withdrawal by Subject|0|||
154905834|NCT03799627|559076218|FG000|Overall Study|Lack of Efficacy|0|||
154905835|NCT03799627|559076219|FG001|Overall Study|Lack of Efficacy|0|||
154905836|NCT03799627|559076220|FG002|Overall Study|Lack of Efficacy|0|||
154905837|NCT03799627|559076221|FG003|Overall Study|Lack of Efficacy|1|||
154905838|NCT03799627|559076222|FG004|Overall Study|Lack of Efficacy|0|||
154905839|NCT03799627|559076223|FG005|Overall Study|Lack of Efficacy|0|||
154905840|NCT03799627|559076224|FG006|Overall Study|Lack of Efficacy|0|||
155116334|NCT01639339|559856828|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
154905841|NCT03799627|559076225|FG007|Overall Study|Lack of Efficacy|0|||
154905842|NCT03799627|559076226|FG008|Overall Study|Lack of Efficacy|0|||
154905843|NCT03799627|559076218|FG000|Overall Study|Lost to Follow-up|0|||
154905844|NCT03799627|559076219|FG001|Overall Study|Lost to Follow-up|0|||
154905845|NCT03799627|559076220|FG002|Overall Study|Lost to Follow-up|0|||
154905846|NCT03799627|559076221|FG003|Overall Study|Lost to Follow-up|0|||
154905847|NCT03799627|559076222|FG004|Overall Study|Lost to Follow-up|0|||
154905848|NCT03799627|559076223|FG005|Overall Study|Lost to Follow-up|0|||
154905849|NCT03799627|559076224|FG006|Overall Study|Lost to Follow-up|1|||
154905850|NCT03799627|559076225|FG007|Overall Study|Lost to Follow-up|0|||
154905851|NCT03799627|559076226|FG008|Overall Study|Lost to Follow-up|1|||
154905852|NCT03799627|559076218|FG000|Overall Study|Death|0|||
154905853|NCT03799627|559076219|FG001|Overall Study|Death|0|||
154905854|NCT03799627|559076220|FG002|Overall Study|Death|0|||
155116335|NCT01639339|559856827|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
154905855|NCT03799627|559076221|FG003|Overall Study|Death|1|||
154905856|NCT03799627|559076222|FG004|Overall Study|Death|0|||
154905857|NCT03799627|559076223|FG005|Overall Study|Death|0|||
154905858|NCT03799627|559076224|FG006|Overall Study|Death|0|||
154905859|NCT03799627|559076225|FG007|Overall Study|Death|0|||
154905860|NCT03799627|559076226|FG008|Overall Study|Death|0|||
154905861|NCT03799627|559076218|FG000|Overall Study|Study Drug Put on Hold|1|||
154905862|NCT03799627|559076219|FG001|Overall Study|Study Drug Put on Hold|0|||
154905863|NCT03799627|559076220|FG002|Overall Study|Study Drug Put on Hold|0|||
154905864|NCT03799627|559076221|FG003|Overall Study|Study Drug Put on Hold|0|||
154905865|NCT03799627|559076222|FG004|Overall Study|Study Drug Put on Hold|0|||
154905866|NCT03799627|559076223|FG005|Overall Study|Study Drug Put on Hold|0|||
154905867|NCT03799627|559076224|FG006|Overall Study|Study Drug Put on Hold|0|||
154905868|NCT03799627|559076225|FG007|Overall Study|Study Drug Put on Hold|0|||
154905869|NCT03799627|559076226|FG008|Overall Study|Study Drug Put on Hold|0|||
154905870|NCT03799627|559076218|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
154905871|NCT03799627|559076219|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
154905872|NCT03799627|559076220|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
154905873|NCT03799627|559076221|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
154905874|NCT03799627|559076222|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
154905875|NCT03799627|559076223|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
154905876|NCT03799627|559076224|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
154905877|NCT03799627|559076225|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
154905878|NCT03799627|559076226|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
154905879|NCT03799627|559076218|FG000|Overall Study|Kidney Transplantation|1|||
154905880|NCT03799627|559076219|FG001|Overall Study|Kidney Transplantation|0|||
154905881|NCT03799627|559076220|FG002|Overall Study|Kidney Transplantation|0|||
154905882|NCT03799627|559076221|FG003|Overall Study|Kidney Transplantation|1|||
154905883|NCT03799627|559076222|FG004|Overall Study|Kidney Transplantation|1|||
154905884|NCT03799627|559076223|FG005|Overall Study|Kidney Transplantation|0|||
154905885|NCT03799627|559076224|FG006|Overall Study|Kidney Transplantation|0|||
154905886|NCT03799627|559076225|FG007|Overall Study|Kidney Transplantation|0|||
154905887|NCT03799627|559076226|FG008|Overall Study|Kidney Transplantation|0|||
154905888|NCT03799627|559076218|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
154905889|NCT03799627|559076219|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
154905890|NCT03799627|559076220|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
154905891|NCT03799627|559076221|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
154905892|NCT03799627|559076222|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
154905893|NCT03799627|559076223|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
154905894|NCT03799627|559076224|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
154905895|NCT03799627|559076225|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
154905896|NCT03799627|559076226|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
154905897|NCT03799627|559076218|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905898|NCT03799627|559076219|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
154905899|NCT03799627|559076220|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905900|NCT03799627|559076221|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905901|NCT03799627|559076222|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905902|NCT03799627|559076223|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905903|NCT03799627|559076224|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905904|NCT03799627|559076225|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905905|NCT03799627|559076226|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
154905906|NCT03799627|559076218|FG000|Overall Study|Met Exclusion Criteria|0|||
154905907|NCT03799627|559076219|FG001|Overall Study|Met Exclusion Criteria|0|||
154905908|NCT03799627|559076220|FG002|Overall Study|Met Exclusion Criteria|0|||
154905909|NCT03799627|559076221|FG003|Overall Study|Met Exclusion Criteria|1|||
154905910|NCT03799627|559076222|FG004|Overall Study|Met Exclusion Criteria|0|||
154905911|NCT03799627|559076223|FG005|Overall Study|Met Exclusion Criteria|0|||
154905912|NCT03799627|559076224|FG006|Overall Study|Met Exclusion Criteria|0|||
154905913|NCT03799627|559076225|FG007|Overall Study|Met Exclusion Criteria|0|||
154905914|NCT03799627|559076226|FG008|Overall Study|Met Exclusion Criteria|0|||
154905915|NCT03799627|559076218|FG000|Overall Study|Investigational Product Noncompliance|0|||
154905916|NCT03799627|559076219|FG001|Overall Study|Investigational Product Noncompliance|0|||
154905917|NCT03799627|559076220|FG002|Overall Study|Investigational Product Noncompliance|0|||
154905918|NCT03799627|559076221|FG003|Overall Study|Investigational Product Noncompliance|1|||
154905919|NCT03799627|559076222|FG004|Overall Study|Investigational Product Noncompliance|0|||
154905920|NCT03799627|559076223|FG005|Overall Study|Investigational Product Noncompliance|0|||
154905921|NCT03799627|559076224|FG006|Overall Study|Investigational Product Noncompliance|0|||
154905922|NCT03799627|559076225|FG007|Overall Study|Investigational Product Noncompliance|0|||
154905923|NCT03799627|559076226|FG008|Overall Study|Investigational Product Noncompliance|0|||
154905924|NCT03799627|559076218|FG000|Overall Study|Participant Relocation|0|||
154905925|NCT03799627|559076219|FG001|Overall Study|Participant Relocation|0|||
154905926|NCT03799627|559076220|FG002|Overall Study|Participant Relocation|0|||
155116336|NCT01639339|559856828|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
155116337|NCT01639339|559856827|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
155116338|NCT01639339|559856828|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
155116339|NCT01639339|559856827|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
155116340|NCT01639339|559856828|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
155116341|NCT01639339|559856827|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
155116342|NCT01639339|559856828|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
155116343|NCT01639339|559856827|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
155116344|NCT01639339|559856828|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
154905927|NCT03799627|559076221|FG003|Overall Study|Participant Relocation|1|||
154905928|NCT03799627|559076222|FG004|Overall Study|Participant Relocation|0|||
154905929|NCT03799627|559076223|FG005|Overall Study|Participant Relocation|1|||
154905930|NCT03799627|559076224|FG006|Overall Study|Participant Relocation|0|||
154905931|NCT03799627|559076225|FG007|Overall Study|Participant Relocation|0|||
154905932|NCT03799627|559076226|FG008|Overall Study|Participant Relocation|0|||
154905933|NCT03799627|559076218|FG000|Overall Study|Eurofin Issue|0|||
154905934|NCT03799627|559076219|FG001|Overall Study|Eurofin Issue|0|||
154905935|NCT03799627|559076220|FG002|Overall Study|Eurofin Issue|0|||
154905936|NCT03799627|559076221|FG003|Overall Study|Eurofin Issue|0|||
154905937|NCT03799627|559076222|FG004|Overall Study|Eurofin Issue|1|||
154905938|NCT03799627|559076223|FG005|Overall Study|Eurofin Issue|0|||
154905939|NCT03799627|559076224|FG006|Overall Study|Eurofin Issue|0|||
154905940|NCT03799627|559076225|FG007|Overall Study|Eurofin Issue|0|||
154905941|NCT03799627|559076226|FG008|Overall Study|Eurofin Issue|0|||
154905942|NCT03799627|559076218|FG000|Overall Study|Noncompliance with Site Instructions|0|||
154905943|NCT03799627|559076219|FG001|Overall Study|Noncompliance with Site Instructions|0|||
154905944|NCT03799627|559076220|FG002|Overall Study|Noncompliance with Site Instructions|0|||
154905945|NCT03799627|559076221|FG003|Overall Study|Noncompliance with Site Instructions|0|||
154905946|NCT03799627|559076222|FG004|Overall Study|Noncompliance with Site Instructions|1|||
154905947|NCT03799627|559076223|FG005|Overall Study|Noncompliance with Site Instructions|0|||
154905948|NCT03799627|559076224|FG006|Overall Study|Noncompliance with Site Instructions|0|||
154905949|NCT03799627|559076225|FG007|Overall Study|Noncompliance with Site Instructions|0|||
154905950|NCT03799627|559076226|FG008|Overall Study|Noncompliance with Site Instructions|0|||
154905951|NCT03799627|559076218|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905952|NCT03799627|559076219|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905953|NCT03799627|559076220|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905954|NCT03799627|559076221|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905955|NCT03799627|559076222|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
154905956|NCT03799627|559076223|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905957|NCT03799627|559076224|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905958|NCT03799627|559076225|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905959|NCT03799627|559076226|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
154905960|NCT03799627|559076218|FG000|Overall Study|Changes In Hemoglobin Values|1|||
154905961|NCT03799627|559076219|FG001|Overall Study|Changes In Hemoglobin Values|2|||
154905962|NCT03799627|559076220|FG002|Overall Study|Changes In Hemoglobin Values|1|||
154905963|NCT03799627|559076221|FG003|Overall Study|Changes In Hemoglobin Values|0|||
154905964|NCT03799627|559076222|FG004|Overall Study|Changes In Hemoglobin Values|0|||
154905965|NCT03799627|559076223|FG005|Overall Study|Changes In Hemoglobin Values|2|||
154905966|NCT03799627|559076224|FG006|Overall Study|Changes In Hemoglobin Values|1|||
154905967|NCT03799627|559076225|FG007|Overall Study|Changes In Hemoglobin Values|0|||
154905968|NCT03799627|559076226|FG008|Overall Study|Changes In Hemoglobin Values|1|||
154905969|NCT03148795|559076239|FG000|Overall Study|Progressive Disease|1|||
154905970|NCT00441012|559076240|FG000|Overall Study|Adverse Event|0|||
154905971|NCT00441012|559076241|FG001|Overall Study|Adverse Event|1|||
154905972|NCT00441012|559076240|FG000|Overall Study|Lost to Follow-up|3|||
154905973|NCT00441012|559076241|FG001|Overall Study|Lost to Follow-up|3|||
154905974|NCT00441012|559076240|FG000|Overall Study|Protocol Violation|10|||
154905975|NCT00441012|559076241|FG001|Overall Study|Protocol Violation|9|||
154905976|NCT00441012|559076240|FG000|Overall Study|Withdrawal by Subject|4|||
154905977|NCT00441012|559076241|FG001|Overall Study|Withdrawal by Subject|0|||
154905978|NCT00441012|559076240|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
155116345|NCT01639339|559856827|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
155116346|NCT01639339|559856828|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
154905979|NCT00441012|559076241|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
154905980|NCT04489940|559076242|FG000|Overall Study|Other|2|||
154905981|NCT04489940|559076242|FG000|Overall Study|Withdrawal by Subject|2|||
154905982|NCT04489940|559076242|FG000|Overall Study|Death|5|||
154905983|NCT04489940|559076242|FG000|Overall Study|Lost to Follow-up|1|||
154905984|NCT02725268|559076243|FG000|Overall Study|Death|58|||
154905985|NCT02725268|559076244|FG001|Overall Study|Death|59|||
154905986|NCT02725268|559076245|FG002|Overall Study|Death|30|||
155116347|NCT02649218|559856829|FG000|Overall Study|Adverse Event|8|||
154905987|NCT02725268|559076246|FG003|Overall Study|Death|16|||
154905988|NCT02725268|559076243|FG000|Overall Study|Lost to Follow-up|4|||
154905989|NCT02725268|559076244|FG001|Overall Study|Lost to Follow-up|3|||
154905990|NCT02725268|559076245|FG002|Overall Study|Lost to Follow-up|0|||
154905991|NCT02725268|559076246|FG003|Overall Study|Lost to Follow-up|1|||
154905992|NCT02725268|559076243|FG000|Overall Study|Site Terminated by Sponsor|0|||
154905993|NCT02725268|559076244|FG001|Overall Study|Site Terminated by Sponsor|1|||
154905994|NCT02725268|559076245|FG002|Overall Study|Site Terminated by Sponsor|0|||
154905995|NCT02725268|559076246|FG003|Overall Study|Site Terminated by Sponsor|0|||
154905996|NCT02725268|559076243|FG000|Overall Study|Withdrawal by Subject|8|||
154905997|NCT02725268|559076244|FG001|Overall Study|Withdrawal by Subject|6|||
154905998|NCT02725268|559076245|FG002|Overall Study|Withdrawal by Subject|8|||
154905999|NCT02725268|559076246|FG003|Overall Study|Withdrawal by Subject|1|||
154906000|NCT02725268|559076243|FG000|Overall Study|Reason not Specified|2|||
154906001|NCT02725268|559076244|FG001|Overall Study|Reason not Specified|1|||
154906002|NCT02725268|559076245|FG002|Overall Study|Reason not Specified|0|||
154906003|NCT02725268|559076246|FG003|Overall Study|Reason not Specified|0|||
154906004|NCT04498468|559076247|FG000|Overall Study|Lost to Follow-up|3|||
154906005|NCT00262314|559076253|FG000|Overall Study|Changing physicians|38|||
154906006|NCT00262314|559076253|FG000|Overall Study|Death|12|||
154906007|NCT00262314|559076253|FG000|Overall Study|Patient's decision|92|||
154906008|NCT00262314|559076253|FG000|Overall Study|Other|95|||
154906009|NCT00262314|559076253|FG000|Overall Study|Lost to Follow-up|70|||
154906010|NCT00262314|559076253|FG000|Overall Study|Administrative withdrawal|30|||
154906011|NCT04973085|559076258|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
154906012|NCT04973085|559076259|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
154906013|NCT00654368|559076262|FG000|Overall Study|Ineligibility determined|6|||
154906014|NCT00654368|559076263|FG001|Overall Study|Ineligibility determined|0|||
154906015|NCT00654368|559076264|FG002|Overall Study|Ineligibility determined|0|||
154906016|NCT00654368|559076262|FG000|Overall Study|Protocol deviation|3|||
154906017|NCT00654368|559076263|FG001|Overall Study|Protocol deviation|2|||
154906018|NCT00654368|559076264|FG002|Overall Study|Protocol deviation|1|||
154906019|NCT00654368|559076262|FG000|Overall Study|Non-compliance|2|||
154906020|NCT00654368|559076263|FG001|Overall Study|Non-compliance|1|||
154906021|NCT00654368|559076264|FG002|Overall Study|Non-compliance|2|||
154906022|NCT00654368|559076262|FG000|Overall Study|Withdrawal by Subject|5|||
154906023|NCT00654368|559076263|FG001|Overall Study|Withdrawal by Subject|2|||
154906024|NCT00654368|559076264|FG002|Overall Study|Withdrawal by Subject|2|||
154906025|NCT00654368|559076262|FG000|Overall Study|Disease progression|21|||
154906026|NCT00654368|559076263|FG001|Overall Study|Disease progression|31|||
154906027|NCT00654368|559076264|FG002|Overall Study|Disease progression|13|||
154906028|NCT00654368|559076262|FG000|Overall Study|Requirement for alternative therapy|1|||
154906029|NCT00654368|559076263|FG001|Overall Study|Requirement for alternative therapy|1|||
154906030|NCT00654368|559076264|FG002|Overall Study|Requirement for alternative therapy|1|||
154906031|NCT00654368|559076262|FG000|Overall Study|Physician Decision|0|||
154906032|NCT00654368|559076263|FG001|Overall Study|Physician Decision|0|||
154906033|NCT00654368|559076264|FG002|Overall Study|Physician Decision|2|||
154906034|NCT00654368|559076262|FG000|Overall Study|Death|1|||
154906035|NCT00654368|559076263|FG001|Overall Study|Death|0|||
154906036|NCT00654368|559076264|FG002|Overall Study|Death|0|||
154906037|NCT00654368|559076262|FG000|Overall Study|Pregnancy|0|||
154906038|NCT00654368|559076263|FG001|Overall Study|Pregnancy|0|||
154906039|NCT00654368|559076264|FG002|Overall Study|Pregnancy|2|||
154906040|NCT00654368|559076262|FG000|Overall Study|Other|0|||
155116348|NCT02649218|559856829|FG000|Overall Study|Lack of Efficacy|8|||
155116349|NCT02649218|559856829|FG000|Overall Study|Pregnancy|3|||
154906041|NCT00654368|559076263|FG001|Overall Study|Other|2|||
154906042|NCT00654368|559076264|FG002|Overall Study|Other|3|||
154906043|NCT00654368|559076262|FG000|Overall Study|Adverse Event|14|||
154906044|NCT00654368|559076263|FG001|Overall Study|Adverse Event|9|||
154906045|NCT00654368|559076264|FG002|Overall Study|Adverse Event|6|||
154906046|NCT03418376|559076269|FG000|Overall Study|Musculoskeletal injury|1|||
154906047|NCT03418376|559076270|FG001|Overall Study|Musculoskeletal injury|2|||
154906048|NCT03418376|559076271|FG002|Overall Study|Musculoskeletal injury|1|||
154906049|NCT03418376|559076272|FG003|Overall Study|Musculoskeletal injury|0|||
154906050|NCT03418376|559076269|FG000|Overall Study|Personal reasons|0|||
154906051|NCT03418376|559076270|FG001|Overall Study|Personal reasons|2|||
154906052|NCT03418376|559076271|FG002|Overall Study|Personal reasons|2|||
154906053|NCT03418376|559076272|FG003|Overall Study|Personal reasons|1|||
154906054|NCT03418376|559076269|FG000|Overall Study|Exacerbation|0|||
154906055|NCT03418376|559076270|FG001|Overall Study|Exacerbation|1|||
154906056|NCT03418376|559076271|FG002|Overall Study|Exacerbation|0|||
154906057|NCT03418376|559076272|FG003|Overall Study|Exacerbation|0|||
154983356|NCT00773734|559364415|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
154983357|NCT00773734|559364416|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
154906058|NCT00814307|559076273|FG000|Overall Study|Randomized but not treated|1|||
154906059|NCT00814307|559076274|FG001|Overall Study|Randomized but not treated|0|||
155116350|NCT02649218|559856829|FG000|Overall Study|Protocol Violation|3|||
155116351|NCT02649218|559856829|FG000|Overall Study|Physician Decision|1|||
155116352|NCT02649218|559856829|FG000|Overall Study|Withdrawal by Subject|2|||
155116353|NCT04003207|559856834|FG000|Overall Study|Protocol Violation|1|||
155116354|NCT03894969|559856836|FG000|Overall Study|Adverse Event|0|||
155116355|NCT03894969|559856837|FG001|Overall Study|Adverse Event|2|||
155116356|NCT03894969|559856838|FG002|Overall Study|Adverse Event|0|||
155116357|NCT03894969|559856839|FG003|Overall Study|Adverse Event|1|||
155175998|NCT04449029|560082205|FG005|Overall Study|Withdrawal by Subject|1|||
155175999|NCT04449029|560082206|FG006|Overall Study|Withdrawal by Subject|4|||
155176000|NCT04449029|560082207|FG007|Overall Study|Withdrawal by Subject|0|||
155176001|NCT02486627|560082208|FG000|Overall Study|Death|1|||
155176002|NCT02486627|560082209|FG001|Overall Study|Death|0|||
155176003|NCT02486627|560082208|FG000|Overall Study|Other Unspecified|0|||
155176004|NCT02486627|560082209|FG001|Overall Study|Other Unspecified|2|||
155176005|NCT02486627|560082208|FG000|Overall Study|Consent Withdrawn by Participant|4|||
155176006|NCT02486627|560082209|FG001|Overall Study|Consent Withdrawn by Participant|3|||
155176007|NCT02486627|560082208|FG000|Overall Study|Significant Participant Noncompliance|1|||
155176008|NCT02486627|560082209|FG001|Overall Study|Significant Participant Noncompliance|1|||
155176009|NCT02486627|560082208|FG000|Overall Study|Lost to Follow-up|1|||
155176010|NCT02486627|560082209|FG001|Overall Study|Lost to Follow-up|3|||
155176011|NCT02112045|560082212|FG000|Overall Study|Withdrawal by Subject|1|||
155176012|NCT02112045|560082213|FG001|Overall Study|Withdrawal by Subject|0|||
155176013|NCT01073462|560082214|FG000|Overall Study|Death|14|||
155176014|NCT01073462|560082214|FG000|Overall Study|Kidney transplant|10|||
155176015|NCT01073462|560082214|FG000|Overall Study|Low parathyroid hormone levels|8|||
155176016|NCT01073462|560082214|FG000|Overall Study|Serious adverse event|2|||
155176017|NCT01073462|560082214|FG000|Overall Study|Lost to Follow-up|7|||
155176018|NCT00247611|560082219|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
155176019|NCT00247611|560082220|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
155176020|NCT00247611|560082219|FG000|Baselined|Completed baseline only|9|||
155176021|NCT00247611|560082220|FG001|Baselined|Completed baseline only|8|||
155176022|NCT05395091|560082221|FG000|Baseline to Month 12|Adverse Event|7|||
155176023|NCT05395091|560082222|FG001|Baseline to Month 12|Adverse Event|2|||
155176024|NCT05395091|560082223|FG002|Baseline to Month 12|Adverse Event|0|||
155176025|NCT05395091|560082221|FG000|Baseline to Month 12|Death|3|||
155176026|NCT05395091|560082222|FG001|Baseline to Month 12|Death|1|||
155176027|NCT05395091|560082223|FG002|Baseline to Month 12|Death|0|||
155176028|NCT05395091|560082221|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
155176029|NCT05395091|560082222|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
155176030|NCT05395091|560082223|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
155176031|NCT05395091|560082221|FG000|Baseline to Month 12|Protocol Violation|2|||
155176032|NCT05395091|560082222|FG001|Baseline to Month 12|Protocol Violation|3|||
155176033|NCT05395091|560082223|FG002|Baseline to Month 12|Protocol Violation|0|||
155176034|NCT05395091|560082221|FG000|Baseline to Month 12|Physician Decision|1|||
155176035|NCT05395091|560082222|FG001|Baseline to Month 12|Physician Decision|0|||
155176036|NCT05395091|560082223|FG002|Baseline to Month 12|Physician Decision|0|||
155176037|NCT05395091|560082221|FG000|Month 12 to Month 18|Death|1|||
155176038|NCT05395091|560082222|FG001|Month 12 to Month 18|Death|0|||
155176039|NCT05395091|560082223|FG002|Month 12 to Month 18|Death|0|||
155176040|NCT05395091|560082221|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
155176041|NCT05395091|560082222|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
155176042|NCT05395091|560082223|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
155176043|NCT05395091|560082221|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
155176044|NCT05395091|560082222|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
155176045|NCT05395091|560082223|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
155176046|NCT05395091|560082221|FG000|Month 12 to Month 18|Other reasons|0|||
155176047|NCT05395091|560082222|FG001|Month 12 to Month 18|Other reasons|0|||
155176048|NCT05395091|560082223|FG002|Month 12 to Month 18|Other reasons|1|||
155176049|NCT01509053|560082225|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
155176050|NCT01509053|560082225|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
155176051|NCT01509053|560082225|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
155176052|NCT01509053|560082225|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
155176053|NCT01509053|560082225|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
155176054|NCT01509053|560082225|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
155176055|NCT01915303|560082230|FG000|Core Phase|Adverse Event|7|||
155176056|NCT01915303|560082230|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
155176057|NCT01915303|560082230|FG000|Core Phase|Death|2|||
154906060|NCT00814307|559076275|FG002|Overall Study|Randomized but not treated|0|||
154906061|NCT00814307|559076276|FG003|Overall Study|Randomized but not treated|0|||
154906062|NCT00814307|559076273|FG000|Overall Study|Adverse Event|3|||
155116358|NCT03894969|559856840|FG004|Overall Study|Adverse Event|2|||
155116359|NCT03894969|559856836|FG000|Overall Study|Lost to Follow-up|3|||
154906063|NCT00814307|559076274|FG001|Overall Study|Adverse Event|9|||
155116360|NCT03894969|559856837|FG001|Overall Study|Lost to Follow-up|1|||
155116361|NCT03894969|559856838|FG002|Overall Study|Lost to Follow-up|1|||
154906064|NCT00814307|559076275|FG002|Overall Study|Adverse Event|3|||
154906065|NCT00814307|559076276|FG003|Overall Study|Adverse Event|2|||
154906066|NCT00814307|559076273|FG000|Overall Study|Lack of Efficacy|1|||
154906067|NCT00814307|559076274|FG001|Overall Study|Lack of Efficacy|1|||
154906068|NCT00814307|559076275|FG002|Overall Study|Lack of Efficacy|3|||
154906069|NCT00814307|559076276|FG003|Overall Study|Lack of Efficacy|4|||
154906070|NCT00814307|559076273|FG000|Overall Study|Other|1|||
154906071|NCT00814307|559076274|FG001|Overall Study|Other|2|||
154906072|NCT00814307|559076275|FG002|Overall Study|Other|0|||
154906073|NCT00814307|559076276|FG003|Overall Study|Other|1|||
154906074|NCT00814307|559076273|FG000|Overall Study|Protocol Violation|2|||
154906075|NCT00814307|559076274|FG001|Overall Study|Protocol Violation|8|||
154906076|NCT00814307|559076275|FG002|Overall Study|Protocol Violation|1|||
154906077|NCT00814307|559076276|FG003|Overall Study|Protocol Violation|1|||
154906078|NCT00814307|559076273|FG000|Overall Study|Withdrawal by Subject|4|||
154906079|NCT00814307|559076274|FG001|Overall Study|Withdrawal by Subject|6|||
154906080|NCT00814307|559076275|FG002|Overall Study|Withdrawal by Subject|0|||
154906081|NCT00814307|559076276|FG003|Overall Study|Withdrawal by Subject|2|||
154906082|NCT00814307|559076273|FG000|Overall Study|Death|0|||
154906083|NCT00814307|559076274|FG001|Overall Study|Death|1|||
154906084|NCT00814307|559076275|FG002|Overall Study|Death|0|||
154906085|NCT00814307|559076276|FG003|Overall Study|Death|0|||
154906086|NCT00149890|559076280|FG000|Overall Study|Adverse Event|1|||
154906087|NCT00149890|559076281|FG001|Overall Study|Adverse Event|8|||
154906088|NCT00149890|559076280|FG000|Overall Study|Lack of Efficacy|8|||
154906089|NCT00149890|559076281|FG001|Overall Study|Lack of Efficacy|9|||
154906090|NCT00149890|559076280|FG000|Overall Study|Protocol Violation|1|||
154906091|NCT00149890|559076281|FG001|Overall Study|Protocol Violation|0|||
154906092|NCT00149890|559076280|FG000|Overall Study|Lost to Follow-up|1|||
154906093|NCT00149890|559076281|FG001|Overall Study|Lost to Follow-up|0|||
154906094|NCT00149890|559076280|FG000|Overall Study|Graft Loss|2|||
154906095|NCT00149890|559076281|FG001|Overall Study|Graft Loss|1|||
154906096|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
154906097|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
154906098|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
154906099|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
154906100|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
154906101|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
154906102|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
154906103|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
154906104|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
154906105|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
154906106|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
154906107|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
154906108|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
154906109|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
154906110|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
154906111|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
154906112|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
154906113|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
154906114|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
154906115|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
154906116|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
154906117|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
154906118|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
154906119|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
154906120|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
154906121|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
154906122|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
154906123|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
154906124|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
154906125|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
154906126|NCT04757376|559076284|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
154906127|NCT04757376|559076285|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
154906128|NCT04757376|559076286|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
154906129|NCT04757376|559076287|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
154906130|NCT04757376|559076288|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
154906131|NCT04757376|559076284|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
155116362|NCT03894969|559856839|FG003|Overall Study|Lost to Follow-up|0|||
155116363|NCT03894969|559856840|FG004|Overall Study|Lost to Follow-up|0|||
155116364|NCT03894969|559856836|FG000|Overall Study|Withdrawal by Subject|2|||
155116365|NCT03894969|559856837|FG001|Overall Study|Withdrawal by Subject|1|||
155116366|NCT03894969|559856838|FG002|Overall Study|Withdrawal by Subject|3|||
155116367|NCT03894969|559856839|FG003|Overall Study|Withdrawal by Subject|4|||
155116368|NCT03894969|559856840|FG004|Overall Study|Withdrawal by Subject|8|||
155116369|NCT03894969|559856836|FG000|Overall Study|Other|0|||
155116370|NCT03894969|559856837|FG001|Overall Study|Other|0|||
155116371|NCT03894969|559856838|FG002|Overall Study|Other|0|||
155116372|NCT03894969|559856839|FG003|Overall Study|Other|0|||
155116373|NCT03894969|559856840|FG004|Overall Study|Other|3|||
155116374|NCT03894969|559856836|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
155116375|NCT03894969|559856837|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
155116376|NCT03894969|559856838|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
155116377|NCT03894969|559856839|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
155116378|NCT03894969|559856840|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
155116379|NCT03894969|559856836|FG000|Overall Study|Solicited Adverse Event|0|||
155116380|NCT03894969|559856837|FG001|Overall Study|Solicited Adverse Event|1|||
155116381|NCT03894969|559856838|FG002|Overall Study|Solicited Adverse Event|0|||
155116382|NCT03894969|559856839|FG003|Overall Study|Solicited Adverse Event|0|||
155116383|NCT03894969|559856840|FG004|Overall Study|Solicited Adverse Event|0|||
155116384|NCT00468676|559856841|FG000|Overall Study|Lost to Follow-up|14|||
155116385|NCT00468676|559856842|FG001|Overall Study|Lost to Follow-up|11|||
155116386|NCT00468676|559856841|FG000|Overall Study|Death|2|||
155116387|NCT00468676|559856842|FG001|Overall Study|Death|1|||
155116388|NCT02378298|559856845|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
155116389|NCT02378298|559856846|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
155116390|NCT02378298|559856847|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
155116391|NCT02378298|559856845|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
155116392|NCT02378298|559856846|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
155116393|NCT02378298|559856847|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
155116394|NCT02378298|559856845|FG000|Surveillance (19-68 Weeks)|Death|1|||
155116395|NCT02378298|559856846|FG001|Surveillance (19-68 Weeks)|Death|0|||
155116396|NCT02378298|559856847|FG002|Surveillance (19-68 Weeks)|Death|0|||
155116397|NCT04173260|559856848|FG000|Overall Study|Early termination|4|||
155116398|NCT02308163|559856851|FG000|Overall Study|Not fulfill eligible criteria|1|||
155116399|NCT02308163|559856852|FG001|Overall Study|Not fulfill eligible criteria|2|||
155116400|NCT02308163|559856853|FG002|Overall Study|Not fulfill eligible criteria|0|||
155116401|NCT02308163|559856854|FG003|Overall Study|Not fulfill eligible criteria|1|||
155116402|NCT02308163|559856855|FG004|Overall Study|Not fulfill eligible criteria|1|||
155116403|NCT02308163|559856851|FG000|Overall Study|Adverse Event|9|||
155116404|NCT02308163|559856852|FG001|Overall Study|Adverse Event|5|||
155116405|NCT02308163|559856853|FG002|Overall Study|Adverse Event|2|||
155116406|NCT02308163|559856854|FG003|Overall Study|Adverse Event|2|||
155116407|NCT02308163|559856855|FG004|Overall Study|Adverse Event|11|||
155116408|NCT02308163|559856851|FG000|Overall Study|Lack of Efficacy|11|||
155116409|NCT02308163|559856852|FG001|Overall Study|Lack of Efficacy|3|||
155116410|NCT02308163|559856853|FG002|Overall Study|Lack of Efficacy|8|||
155116411|NCT02308163|559856854|FG003|Overall Study|Lack of Efficacy|4|||
155116412|NCT02308163|559856855|FG004|Overall Study|Lack of Efficacy|6|||
155116413|NCT02308163|559856851|FG000|Overall Study|Withdrawal of consent|2|||
155116414|NCT02308163|559856852|FG001|Overall Study|Withdrawal of consent|3|||
155116415|NCT02308163|559856853|FG002|Overall Study|Withdrawal of consent|0|||
155116416|NCT02308163|559856854|FG003|Overall Study|Withdrawal of consent|2|||
155116417|NCT02308163|559856855|FG004|Overall Study|Withdrawal of consent|6|||
155116418|NCT02308163|559856851|FG000|Overall Study|Protocol Violation|3|||
155116419|NCT02308163|559856852|FG001|Overall Study|Protocol Violation|3|||
155116420|NCT02308163|559856853|FG002|Overall Study|Protocol Violation|3|||
155116421|NCT02308163|559856854|FG003|Overall Study|Protocol Violation|2|||
155116422|NCT02308163|559856855|FG004|Overall Study|Protocol Violation|5|||
155116423|NCT02308163|559856851|FG000|Overall Study|Lab data met discontinuation criteria|3|||
155116424|NCT02308163|559856852|FG001|Overall Study|Lab data met discontinuation criteria|0|||
155116425|NCT02308163|559856853|FG002|Overall Study|Lab data met discontinuation criteria|0|||
154906132|NCT04757376|559076285|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
154924259|NCT01869959|559146444|FG002|Treatment Period|Withdrawal by Subject|0|||
155116426|NCT02308163|559856854|FG003|Overall Study|Lab data met discontinuation criteria|2|||
155116427|NCT02308163|559856855|FG004|Overall Study|Lab data met discontinuation criteria|0|||
155116428|NCT02308163|559856851|FG000|Overall Study|Miscellaneous|2|||
155116429|NCT02308163|559856852|FG001|Overall Study|Miscellaneous|2|||
155116430|NCT02308163|559856853|FG002|Overall Study|Miscellaneous|1|||
155116431|NCT02308163|559856854|FG003|Overall Study|Miscellaneous|0|||
155116432|NCT02308163|559856855|FG004|Overall Study|Miscellaneous|5|||
155116433|NCT00443053|559856863|FG000|Overall Study|Adverse Event|2|||
155116434|NCT00443053|559856864|FG001|Overall Study|Adverse Event|1|||
155116435|NCT00443053|559856863|FG000|Overall Study|Withdrawal by Subject|9|||
155116436|NCT00443053|559856864|FG001|Overall Study|Withdrawal by Subject|18|||
155116437|NCT00443053|559856863|FG000|Overall Study|Lost to Follow-up|4|||
155116438|NCT00443053|559856864|FG001|Overall Study|Lost to Follow-up|5|||
155116439|NCT00443053|559856863|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
155116440|NCT00443053|559856864|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155116441|NCT00443053|559856863|FG000|Overall Study|Noncompliance|2|||
155116442|NCT00443053|559856864|FG001|Overall Study|Noncompliance|1|||
155116443|NCT00443053|559856863|FG000|Overall Study|Other|3|||
155116444|NCT00443053|559856864|FG001|Overall Study|Other|4|||
155116445|NCT00443053|559856863|FG000|Overall Study|Physician Decision|0|||
155116446|NCT00443053|559856864|FG001|Overall Study|Physician Decision|4|||
155116447|NCT00541866|559856865|FG000|Overall Study|Adverse Event|3|||
155116448|NCT00541866|559856866|FG001|Overall Study|Adverse Event|0|||
155116449|NCT00541866|559856867|FG002|Overall Study|Adverse Event|0|||
154906133|NCT04757376|559076286|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
154906134|NCT04757376|559076287|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
154906135|NCT04757376|559076288|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
154906136|NCT01307046|559076289|FG000|Overall Study|Adverse Event|3|||
154906137|NCT01307046|559076290|FG001|Overall Study|Adverse Event|3|||
154906138|NCT01307046|559076289|FG000|Overall Study|Lack of Efficacy|0|||
154906139|NCT01307046|559076290|FG001|Overall Study|Lack of Efficacy|2|||
154906140|NCT01307046|559076289|FG000|Overall Study|Physician Decision|2|||
154906141|NCT01307046|559076290|FG001|Overall Study|Physician Decision|0|||
154906142|NCT01307046|559076289|FG000|Overall Study|Withdrawal by Subject|1|||
154906143|NCT01307046|559076290|FG001|Overall Study|Withdrawal by Subject|1|||
154906144|NCT01307046|559076289|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
154906145|NCT01307046|559076290|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
154906146|NCT01307046|559076289|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
154906147|NCT01307046|559076290|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
154906148|NCT03898323|559076291|FG000|Overall Study|Physician Decision|1|||
154906149|NCT02569398|559076297|FG000|Overall Study|Adverse Event|0|||
154906150|NCT02569398|559076298|FG001|Overall Study|Adverse Event|1|||
154906151|NCT02569398|559076299|FG002|Overall Study|Adverse Event|6|||
154906152|NCT02569398|559076297|FG000|Overall Study|Withdrawal by Subject|43|||
154906153|NCT02569398|559076298|FG001|Overall Study|Withdrawal by Subject|43|||
154906154|NCT02569398|559076299|FG002|Overall Study|Withdrawal by Subject|30|||
154906155|NCT02569398|559076297|FG000|Overall Study|Study terminated by sponsor|130|||
154906156|NCT02569398|559076298|FG001|Overall Study|Study terminated by sponsor|131|||
154906157|NCT02569398|559076299|FG002|Overall Study|Study terminated by sponsor|134|||
154906158|NCT02569398|559076297|FG000|Overall Study|Other|12|||
154906159|NCT02569398|559076298|FG001|Overall Study|Other|14|||
154906160|NCT02569398|559076299|FG002|Overall Study|Other|13|||
154906161|NCT03039192|559076302|FG000|Overall Study|Lost to Follow-up|4|||
154906162|NCT03039192|559076303|FG001|Overall Study|Lost to Follow-up|4|||
154906163|NCT03039192|559076302|FG000|Overall Study|Adverse event, serious fatal|0|||
154906164|NCT03039192|559076303|FG001|Overall Study|Adverse event, serious fatal|1|||
154906165|NCT03039192|559076302|FG000|Overall Study|Adverse event, non-fatal|0|||
154906166|NCT03039192|559076303|FG001|Overall Study|Adverse event, non-fatal|2|||
154906167|NCT03039192|559076302|FG000|Overall Study|Withdrawal by Subject|6|||
154906168|NCT03039192|559076303|FG001|Overall Study|Withdrawal by Subject|9|||
154906169|NCT03039192|559076302|FG000|Overall Study|Discontinued from treatment phase|19|||
154906170|NCT03039192|559076303|FG001|Overall Study|Discontinued from treatment phase|12|||
154906171|NCT03039192|559076302|FG000|Overall Study|Other|3|||
154906172|NCT03039192|559076303|FG001|Overall Study|Other|2|||
154906173|NCT03559192|559076304|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
154906174|NCT03559192|559076305|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
154906175|NCT03559192|559076306|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
155116450|NCT00541866|559856868|FG003|Overall Study|Adverse Event|0|||
154906176|NCT03559192|559076304|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
155116451|NCT00541866|559856869|FG004|Overall Study|Adverse Event|0|||
155116452|NCT00541866|559856865|FG000|Overall Study|Death|1|||
154906177|NCT03559192|559076305|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
154906178|NCT03559192|559076306|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
154906179|NCT03559192|559076304|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
154906180|NCT03559192|559076305|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
154906181|NCT03559192|559076306|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
154906182|NCT03559192|559076304|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
155116453|NCT00541866|559856866|FG001|Overall Study|Death|0|||
155116454|NCT00541866|559856867|FG002|Overall Study|Death|0|||
155116455|NCT00541866|559856868|FG003|Overall Study|Death|0|||
155116456|NCT00541866|559856869|FG004|Overall Study|Death|0|||
155116457|NCT00541866|559856865|FG000|Overall Study|Lack of Efficacy|19|||
155116458|NCT00541866|559856866|FG001|Overall Study|Lack of Efficacy|15|||
155116459|NCT00541866|559856867|FG002|Overall Study|Lack of Efficacy|10|||
155116460|NCT00541866|559856868|FG003|Overall Study|Lack of Efficacy|12|||
155116461|NCT00541866|559856869|FG004|Overall Study|Lack of Efficacy|14|||
155116462|NCT00541866|559856865|FG000|Overall Study|Not Reported or Other|11|||
155116463|NCT00541866|559856866|FG001|Overall Study|Not Reported or Other|3|||
155116464|NCT00541866|559856867|FG002|Overall Study|Not Reported or Other|3|||
155116465|NCT00541866|559856868|FG003|Overall Study|Not Reported or Other|3|||
155116466|NCT00541866|559856869|FG004|Overall Study|Not Reported or Other|1|||
155116467|NCT00541866|559856865|FG000|Overall Study|Physician Decision|0|||
155116468|NCT00541866|559856866|FG001|Overall Study|Physician Decision|0|||
155116469|NCT00541866|559856867|FG002|Overall Study|Physician Decision|2|||
155116470|NCT00541866|559856868|FG003|Overall Study|Physician Decision|1|||
155116471|NCT00541866|559856869|FG004|Overall Study|Physician Decision|0|||
155116472|NCT00522418|559856870|FG000|Overall Study|Local IRB Consent Violation|5|||
155116473|NCT00522418|559856871|FG001|Overall Study|Local IRB Consent Violation|5|||
154906183|NCT03559192|559076305|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
154906184|NCT03559192|559076306|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
154906185|NCT03559192|559076304|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
154906186|NCT03559192|559076305|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
154906187|NCT03559192|559076306|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
154906188|NCT03559192|559076304|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
154906189|NCT03559192|559076305|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
154906190|NCT03559192|559076306|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
154906191|NCT03559192|559076304|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
154906192|NCT03559192|559076305|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
154906193|NCT03559192|559076306|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
154906194|NCT03559192|559076304|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
154906195|NCT03559192|559076305|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
154906196|NCT03559192|559076306|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
154906197|NCT03559192|559076304|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
154906198|NCT03559192|559076305|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
154906199|NCT03559192|559076306|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
154906200|NCT03277794|559076309|FG000|Overall Study|Lost to Follow-up|2|||
154906201|NCT03277794|559076310|FG001|Overall Study|Lost to Follow-up|4|||
154906202|NCT03277794|559076309|FG000|Overall Study|Withdrew due to high acuity|1|||
154906203|NCT03277794|559076310|FG001|Overall Study|Withdrew due to high acuity|0|||
154906204|NCT05166603|559076316|FG000|Overall Study|Withdrawal by Subject|68|||
154906205|NCT05166603|559076317|FG001|Overall Study|Withdrawal by Subject|0|||
154906206|NCT01673373|559078224|FG000|Overall Study|Death|2|||
154906207|NCT02710422|559078225|FG000|Overall Study|Termination of study|9|||
154906208|NCT02710422|559078226|FG001|Overall Study|Termination of study|9|||
154906209|NCT01370499|559078227|FG000|Overall Study|Adverse Event|38|||
154906210|NCT01370499|559078228|FG001|Overall Study|Adverse Event|12|||
154906211|NCT01370499|559078227|FG000|Overall Study|Lack of Efficacy|4|||
154906212|NCT01370499|559078228|FG001|Overall Study|Lack of Efficacy|2|||
154906213|NCT01370499|559078227|FG000|Overall Study|Lost to Follow-up|2|||
154906214|NCT01370499|559078228|FG001|Overall Study|Lost to Follow-up|1|||
154906215|NCT01370499|559078227|FG000|Overall Study|Physician Decision|3|||
154906216|NCT01370499|559078228|FG001|Overall Study|Physician Decision|3|||
154906217|NCT01370499|559078227|FG000|Overall Study|Protocol Violation|5|||
154906218|NCT01370499|559078228|FG001|Overall Study|Protocol Violation|4|||
154906219|NCT01370499|559078227|FG000|Overall Study|Withdrawal by Subject|18|||
154906220|NCT01370499|559078228|FG001|Overall Study|Withdrawal by Subject|7|||
154906221|NCT01370499|559078227|FG000|Overall Study|Sponsor Decision|41|||
154906222|NCT01370499|559078228|FG001|Overall Study|Sponsor Decision|15|||
154906223|NCT02045979|559078232|FG000|Overall Study|Informed Consent Withdrawn|2|||
154906224|NCT02045979|559078233|FG001|Overall Study|Informed Consent Withdrawn|0|||
154906225|NCT02045979|559078234|FG002|Overall Study|Informed Consent Withdrawn|1|||
154906226|NCT02045979|559078232|FG000|Overall Study|not specified above|0|||
154906227|NCT02045979|559078233|FG001|Overall Study|not specified above|1|||
154906228|NCT02045979|559078234|FG002|Overall Study|not specified above|0|||
154906229|NCT00378534|559078242|FG000|Overall Study|Participants did not receive transplant|3|||
154906230|NCT00378534|559078243|FG001|Overall Study|Participants did not receive transplant|0|||
154906231|NCT04969900|559078244|FG000|Overall Study|Physician Decision|1|||
154906232|NCT04969900|559078245|FG001|Overall Study|Physician Decision|1|||
154906233|NCT04969900|559078244|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
155116474|NCT00522418|559856870|FG000|Overall Study|Early Study Termination|46|||
155116475|NCT00522418|559856871|FG001|Overall Study|Early Study Termination|47|||
154906234|NCT04969900|559078245|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
154906235|NCT03261037|559078249|FG000|Overall Study|Withdrawal by Subject|2|||
154906236|NCT03261037|559078250|FG001|Overall Study|Withdrawal by Subject|13|||
154906237|NCT03261037|559078251|FG002|Overall Study|Withdrawal by Subject|0|||
155116476|NCT00522418|559856870|FG000|Overall Study|Noncompliance|2|||
155116477|NCT00522418|559856871|FG001|Overall Study|Noncompliance|2|||
155116478|NCT00522418|559856870|FG000|Overall Study|Reason Not Specified|3|||
155116479|NCT00522418|559856871|FG001|Overall Study|Reason Not Specified|1|||
155116480|NCT00522418|559856870|FG000|Overall Study|Consent Withdraw|1|||
155116481|NCT00522418|559856871|FG001|Overall Study|Consent Withdraw|2|||
155116482|NCT00522418|559856870|FG000|Overall Study|Lack of Efficacy|0|||
155116483|NCT00522418|559856871|FG001|Overall Study|Lack of Efficacy|1|||
155116484|NCT00578877|559856872|FG000|Overall Study|Lost to Follow-up|8|||
155116485|NCT00578877|559856873|FG001|Overall Study|Lost to Follow-up|10|||
155116486|NCT00578877|559856872|FG000|Overall Study|early discontinue|61|||
155116487|NCT00578877|559856873|FG001|Overall Study|early discontinue|101|||
155116488|NCT00578877|559856872|FG000|Overall Study|did not provide follow-up data|12|||
155116489|NCT00578877|559856873|FG001|Overall Study|did not provide follow-up data|17|||
155116490|NCT02256384|559856879|FG000|Overall Study|Withdrawal by Subject|12|||
155116491|NCT02256384|559856879|FG000|Overall Study|Equipment not capturing data|2|||
155116492|NCT02136680|559856880|FG000|Overall Study|No Longer Interested|1|||
155116493|NCT02136680|559856881|FG001|Overall Study|No Longer Interested|1|||
155116494|NCT02136680|559856880|FG000|Overall Study|No longer receiving care at clinic|3|||
155116495|NCT02136680|559856881|FG001|Overall Study|No longer receiving care at clinic|5|||
155116496|NCT02136680|559856880|FG000|Overall Study|Moved away|5|||
155116497|NCT02136680|559856881|FG001|Overall Study|Moved away|4|||
155116498|NCT02136680|559856880|FG000|Overall Study|Unable to schedule|17|||
155116499|NCT02136680|559856881|FG001|Overall Study|Unable to schedule|16|||
155116500|NCT02136680|559856880|FG000|Overall Study|Study ended before interview due|6|||
155116501|NCT02136680|559856881|FG001|Overall Study|Study ended before interview due|3|||
155116502|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
155116503|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
155116504|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
155116505|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
155116506|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
155116507|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
155116508|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
155116509|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
155116510|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
155116511|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
155116512|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
155116513|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
155116514|NCT01632241|559856882|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
155116515|NCT01632241|559856883|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
155116516|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
155116517|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
155116518|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
155116519|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
155116520|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
155116521|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
155116522|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
155116523|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
154906238|NCT03261037|559078252|FG003|Overall Study|Withdrawal by Subject|18|||
154906239|NCT03261037|559078249|FG000|Overall Study|Non-compliance with study procedures|0|||
154906240|NCT03261037|559078250|FG001|Overall Study|Non-compliance with study procedures|2|||
154906241|NCT03261037|559078251|FG002|Overall Study|Non-compliance with study procedures|0|||
154906242|NCT03261037|559078252|FG003|Overall Study|Non-compliance with study procedures|6|||
154906243|NCT03261037|559078249|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
154906244|NCT03261037|559078250|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
154906245|NCT03261037|559078251|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
154906246|NCT03261037|559078252|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
155116524|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
155116525|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
155116526|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
155116527|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
155116528|NCT01632241|559856882|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
155116529|NCT01632241|559856883|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
155116530|NCT01638013|559856884|FG000|Overall Study|Adverse Event|36|||
155116531|NCT01638013|559856885|FG001|Overall Study|Adverse Event|29|||
155116532|NCT01638013|559856886|FG002|Overall Study|Adverse Event|48|||
155116533|NCT01638013|559856884|FG000|Overall Study|Lack of Efficacy|39|||
155116534|NCT01638013|559856885|FG001|Overall Study|Lack of Efficacy|11|||
155116535|NCT01638013|559856886|FG002|Overall Study|Lack of Efficacy|14|||
155116536|NCT01638013|559856884|FG000|Overall Study|Protocol Violation|10|||
155176058|NCT01915303|560082230|FG000|Core Phase|Protocol Violation|2|||
155176059|NCT01915303|560082230|FG000|Core Phase|Abnormal lab value|1|||
155116537|NCT01638013|559856885|FG001|Overall Study|Protocol Violation|7|||
155116538|NCT01638013|559856886|FG002|Overall Study|Protocol Violation|11|||
155116539|NCT01638013|559856884|FG000|Overall Study|Met discontinuation criteria|4|||
155116540|NCT01638013|559856885|FG001|Overall Study|Met discontinuation criteria|0|||
155116541|NCT01638013|559856886|FG002|Overall Study|Met discontinuation criteria|7|||
155116542|NCT01638013|559856884|FG000|Overall Study|Subject Lost to Follow up|1|||
155116543|NCT01638013|559856885|FG001|Overall Study|Subject Lost to Follow up|0|||
155116544|NCT01638013|559856886|FG002|Overall Study|Subject Lost to Follow up|1|||
155116545|NCT01638013|559856884|FG000|Overall Study|Miscellaneous|25|||
155116546|NCT01638013|559856885|FG001|Overall Study|Miscellaneous|19|||
155116547|NCT01638013|559856886|FG002|Overall Study|Miscellaneous|23|||
154906247|NCT03261037|559078249|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
154906248|NCT03261037|559078250|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
154906249|NCT03261037|559078251|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
154906250|NCT03261037|559078252|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
154906251|NCT03261037|559078249|FG000|Overall Study|Diagnosed but protocol deviation|1|||
154906252|NCT03261037|559078250|FG001|Overall Study|Diagnosed but protocol deviation|0|||
154906253|NCT03261037|559078251|FG002|Overall Study|Diagnosed but protocol deviation|0|||
154906254|NCT03261037|559078252|FG003|Overall Study|Diagnosed but protocol deviation|0|||
154906255|NCT03261037|559078249|FG000|Overall Study|Participant did not want to continue the study|0|||
154906256|NCT03261037|559078250|FG001|Overall Study|Participant did not want to continue the study|1|||
154906257|NCT03261037|559078251|FG002|Overall Study|Participant did not want to continue the study|0|||
154906258|NCT03261037|559078252|FG003|Overall Study|Participant did not want to continue the study|0|||
154906259|NCT03261037|559078249|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
154906260|NCT03261037|559078250|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
154906261|NCT03261037|559078251|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
154906262|NCT03261037|559078252|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
154906263|NCT03261037|559078249|FG000|Overall Study|Participant presented clinical improvement|0|||
154906264|NCT03261037|559078250|FG001|Overall Study|Participant presented clinical improvement|2|||
154906265|NCT03261037|559078251|FG002|Overall Study|Participant presented clinical improvement|0|||
154906266|NCT03261037|559078252|FG003|Overall Study|Participant presented clinical improvement|0|||
154906267|NCT03261037|559078249|FG000|Overall Study|Technical difficulties|0|||
154906268|NCT03261037|559078250|FG001|Overall Study|Technical difficulties|0|||
154906269|NCT03261037|559078251|FG002|Overall Study|Technical difficulties|0|||
154906270|NCT03261037|559078252|FG003|Overall Study|Technical difficulties|1|||
154906271|NCT03261037|559078249|FG000|Overall Study|Equipment failed to work|0|||
154906272|NCT03261037|559078250|FG001|Overall Study|Equipment failed to work|0|||
154906273|NCT03261037|559078251|FG002|Overall Study|Equipment failed to work|0|||
154906274|NCT03261037|559078252|FG003|Overall Study|Equipment failed to work|1|||
154906275|NCT03261037|559078249|FG000|Overall Study|End of study for participant and no follow up|0|||
154906276|NCT03261037|559078250|FG001|Overall Study|End of study for participant and no follow up|0|||
154906277|NCT03261037|559078251|FG002|Overall Study|End of study for participant and no follow up|0|||
154906278|NCT03261037|559078252|FG003|Overall Study|End of study for participant and no follow up|1|||
154906279|NCT03261037|559078249|FG000|Overall Study|Participant was too weak to continue in study|1|||
154906280|NCT03261037|559078250|FG001|Overall Study|Participant was too weak to continue in study|0|||
154906281|NCT03261037|559078251|FG002|Overall Study|Participant was too weak to continue in study|0|||
154906282|NCT03261037|559078252|FG003|Overall Study|Participant was too weak to continue in study|0|||
154906283|NCT00425945|559078253|FG000|Overall Study|Concern about Supplement|2|||
154906284|NCT00425945|559078254|FG001|Overall Study|Concern about Supplement|0|||
154906285|NCT00425945|559078253|FG000|Overall Study|Inconvenience|0|||
154906286|NCT00425945|559078254|FG001|Overall Study|Inconvenience|2|||
154906287|NCT00425945|559078253|FG000|Overall Study|Lost to Follow-up|0|||
154906288|NCT00425945|559078254|FG001|Overall Study|Lost to Follow-up|2|||
154906289|NCT00425945|559078253|FG000|Overall Study|Began hypertension medication|1|||
154906290|NCT00425945|559078254|FG001|Overall Study|Began hypertension medication|0|||
154906291|NCT00425945|559078253|FG000|Overall Study|Began cancer treatments|1|||
154906292|NCT00425945|559078254|FG001|Overall Study|Began cancer treatments|0|||
154906293|NCT00425945|559078253|FG000|Overall Study|Moved from area|0|||
154906294|NCT00425945|559078254|FG001|Overall Study|Moved from area|1|||
154906295|NCT03878160|559078258|FG000|Overall Study|Lost to Follow-up|1|||
154906296|NCT03878160|559078259|FG001|Overall Study|Lost to Follow-up|1|||
154906297|NCT03878160|559078260|FG002|Overall Study|Lost to Follow-up|1|||
154906298|NCT03878160|559078258|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
154906299|NCT03878160|559078259|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
155116548|NCT01638013|559856884|FG000|Overall Study|Withdrawal of Consent|16|||
155116549|NCT01638013|559856885|FG001|Overall Study|Withdrawal of Consent|12|||
155116550|NCT01638013|559856886|FG002|Overall Study|Withdrawal of Consent|16|||
155116551|NCT01638013|559856884|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
155176060|NCT01915303|560082230|FG000|Core Phase|Withdrawal by Subject|1|||
155116552|NCT01638013|559856885|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
155116553|NCT01638013|559856886|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
155116554|NCT00496483|559859022|FG000|Overall Study|Not dosed|9|||
155116555|NCT00496483|559859022|FG000|Overall Study|Adverse Event|2|||
155116556|NCT00496483|559859022|FG000|Overall Study|Lack of Efficacy|1|||
155116557|NCT03245736|559859024|FG000|Overall Study|Adverse Event|1|||
155116558|NCT03245736|559859024|FG000|Overall Study|Progressive Disease|4|||
155116559|NCT01739933|559859025|FG000|Overall Study|Death|89|||
155116560|NCT01739933|559859026|FG001|Overall Study|Death|86|||
155116561|NCT01739933|559859025|FG000|Overall Study|Withdrawal by Subject|10|||
155116562|NCT01739933|559859026|FG001|Overall Study|Withdrawal by Subject|8|||
155116563|NCT01739933|559859025|FG000|Overall Study|Lost to Follow-up|3|||
155116564|NCT01739933|559859026|FG001|Overall Study|Lost to Follow-up|10|||
155116565|NCT01739933|559859025|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
155116566|NCT01739933|559859026|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
155116567|NCT00347438|559859030|FG000|Overall Study|Withdrawal by Subject|1|||
155116568|NCT00347438|559859030|FG000|Overall Study|Physician Decision|1|||
154906300|NCT03878160|559078260|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
154906301|NCT02881151|559078263|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
154906302|NCT00589602|559078268|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
154906303|NCT05618808|559078269|FG000|Overall Study|Withdrawal by Subject|3|||
154906304|NCT05618808|559078270|FG001|Overall Study|Withdrawal by Subject|1|||
154906305|NCT05618808|559078271|FG002|Overall Study|Withdrawal by Subject|3|||
154906306|NCT03887052|559078272|FG000|Overall Study|Adverse Event|2|||
154906307|NCT03887052|559078272|FG000|Overall Study|Physician Decision|2|||
154906308|NCT03887052|559078272|FG000|Overall Study|Withdrawal by Subject|3|||
154906309|NCT03887052|559078272|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
154906310|NCT03887052|559078272|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
154906311|NCT02365506|559078273|FG000|Overall Study|Investigator's Discretion|0|||
154906312|NCT02365506|559078274|FG001|Overall Study|Investigator's Discretion|0|||
154906313|NCT02365506|559078275|FG002|Overall Study|Investigator's Discretion|1|||
154906314|NCT02155712|559078280|FG000|Overall Study|Death|12|||
154906315|NCT02155712|559078281|FG001|Overall Study|Death|0|||
154906316|NCT02155712|559078280|FG000|Overall Study|Lost to Follow-up|37|||
154906317|NCT02155712|559078281|FG001|Overall Study|Lost to Follow-up|22|||
154906318|NCT02155712|559078280|FG000|Overall Study|Revision of device|4|||
154906319|NCT02155712|559078281|FG001|Overall Study|Revision of device|3|||
154906320|NCT02155712|559078280|FG000|Overall Study|Withdrawal by Subject|39|||
154906321|NCT02155712|559078281|FG001|Overall Study|Withdrawal by Subject|21|||
154906322|NCT02155712|559078280|FG000|Overall Study|Site termination|77|||
154906323|NCT02155712|559078281|FG001|Overall Study|Site termination|19|||
154906324|NCT02155712|559078280|FG000|Overall Study|Sponsor terminated study early|150|||
154906325|NCT02155712|559078281|FG001|Overall Study|Sponsor terminated study early|0|||
154906326|NCT02155712|559078280|FG000|Overall Study|Missed final 5-year protocol visit|0|||
154906327|NCT02155712|559078281|FG001|Overall Study|Missed final 5-year protocol visit|32|||
154906328|NCT02155712|559078280|FG000|Overall Study|Censored because surgery cancelled|6|||
154906329|NCT02155712|559078281|FG001|Overall Study|Censored because surgery cancelled|10|||
154906330|NCT02155712|559078280|FG000|Overall Study|Censored because study device was not implanted|61|||
154906331|NCT02155712|559078281|FG001|Overall Study|Censored because study device was not implanted|66|||
154906332|NCT02155712|559078280|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
154906333|NCT02155712|559078281|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
154906334|NCT04288089|559078282|FG000|Overall Study|Ongoing Treatment|2|||
154906335|NCT04288089|559078283|FG001|Overall Study|Ongoing Treatment|1|||
154906336|NCT04288089|559078284|FG002|Overall Study|Ongoing Treatment|1|||
154906337|NCT04288089|559078285|FG003|Overall Study|Ongoing Treatment|4|||
154906338|NCT00976963|559078286|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
154906339|NCT00976963|559078287|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
154906340|NCT00976963|559078286|FG000|Overall Study|administrative error|1|||
154906341|NCT00976963|559078287|FG001|Overall Study|administrative error|0|||
154906342|NCT00976963|559078286|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
154906343|NCT00976963|559078287|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
154906344|NCT00537771|559078290|FG000|Overall Study|Withdrawal by Subject|6|||
154906345|NCT00537771|559078291|FG001|Overall Study|Withdrawal by Subject|23|||
155116569|NCT01529515|559859031|FG000|TRANSITION PHASE|Adverse Event|16|||
155116570|NCT01529515|559859032|FG001|TRANSITION PHASE|Adverse Event|0|||
155176061|NCT01915303|560082230|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
154906346|NCT00537771|559078290|FG000|Overall Study|Adverse Event|8|||
154906347|NCT00537771|559078291|FG001|Overall Study|Adverse Event|15|||
154906348|NCT00537771|559078290|FG000|Overall Study|Lost to Follow-up|9|||
154906349|NCT00537771|559078291|FG001|Overall Study|Lost to Follow-up|15|||
155116571|NCT01529515|559859033|FG002|TRANSITION PHASE|Adverse Event|0|||
155116572|NCT01529515|559859034|FG003|TRANSITION PHASE|Adverse Event|0|||
155116573|NCT01529515|559859031|FG000|TRANSITION PHASE|Death|1|||
154906350|NCT00537771|559078290|FG000|Overall Study|Protocol Violation|2|||
154906351|NCT00537771|559078291|FG001|Overall Study|Protocol Violation|6|||
154906352|NCT00537771|559078290|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
154906353|NCT00537771|559078291|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
154906354|NCT02148952|559078292|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
154906355|NCT02148952|559078293|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
154906356|NCT02148952|559078292|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
154906357|NCT02148952|559078293|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
154906358|NCT02148952|559078292|FG000|Follow-Up|Lost to Follow-up|219|||
154906359|NCT02148952|559078293|FG001|Follow-Up|Lost to Follow-up|231|||
154906360|NCT02148952|559078292|FG000|Follow-Up|Withdrawal by Subject|46|||
154906361|NCT02148952|559078293|FG001|Follow-Up|Withdrawal by Subject|48|||
154906362|NCT01600105|559078294|FG000|Total Participants|Withdrawal by Subject|1|||
154906363|NCT01600105|559078295|FG001|Total Participants|Withdrawal by Subject|0|||
154906364|NCT01600105|559078294|FG000|Total Participants|No images in PACS|10|||
154906365|NCT01600105|559078295|FG001|Total Participants|No images in PACS|0|||
154906366|NCT01600105|559078294|FG000|Total Participants|Insufficient image quality|30|||
154906367|NCT01600105|559078295|FG001|Total Participants|Insufficient image quality|10|||
154906368|NCT01600105|559078294|FG000|Sub Study I|Insufficient image quality|0|||
154906369|NCT01600105|559078295|FG001|Sub Study I|Insufficient image quality|10|||
154906370|NCT01600105|559078294|FG000|Sub Study II|Withdrawal by Subject|1|||
154906371|NCT01600105|559078295|FG001|Sub Study II|Withdrawal by Subject|0|||
154906372|NCT01600105|559078294|FG000|Sub Study II|No images in PACS|1|||
154906373|NCT01600105|559078295|FG001|Sub Study II|No images in PACS|0|||
154906374|NCT01600105|559078294|FG000|Sub Study II|Insufficient image quality|3|||
154906375|NCT01600105|559078295|FG001|Sub Study II|Insufficient image quality|0|||
154906376|NCT01600105|559078294|FG000|Sub Study III|Insufficient image quality|5|||
154906377|NCT01600105|559078295|FG001|Sub Study III|Insufficient image quality|0|||
154906378|NCT01600105|559078294|FG000|Sub Study V|Poor Image Quality|2|||
154906379|NCT01600105|559078295|FG001|Sub Study V|Poor Image Quality|0|||
154906380|NCT01263444|559078296|FG000|Overall Study|Adverse Event|8|||
154906381|NCT01263444|559078296|FG000|Overall Study|Withdrawal by Subject|1|||
154906382|NCT01263444|559078296|FG000|Overall Study|Protocol Violation|1|||
154906383|NCT04007367|559078297|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
154906384|NCT04007367|559078298|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
154906385|NCT04007367|559078299|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
154906386|NCT04007367|559078297|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
154906387|NCT04007367|559078298|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
154906388|NCT04007367|559078299|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
154906389|NCT04007367|559078297|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
154906390|NCT04007367|559078298|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
154906391|NCT04007367|559078299|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
154906392|NCT04007367|559078297|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
154906393|NCT04007367|559078298|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
154906394|NCT04007367|559078299|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
154906395|NCT04007367|559078297|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
154906396|NCT04007367|559078298|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
154906397|NCT04007367|559078299|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
154906398|NCT04043416|559078300|FG000|Washout|Change in health condition|0|||
154906399|NCT04043416|559078301|FG001|Washout|Change in health condition|1|||
154906400|NCT00623766|559078309|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
154906401|NCT00623766|559078310|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
154906402|NCT00623766|559078309|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
154906403|NCT00623766|559078310|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
154906404|NCT00623766|559078309|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
154906405|NCT00623766|559078310|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
154906406|NCT00623766|559078309|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
154906407|NCT00623766|559078310|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
154906408|NCT00623766|559078309|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
154906409|NCT00623766|559078310|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
154906410|NCT00893763|559078311|FG000|Overall Study|extubated|110|||
154906411|NCT00893763|559078312|FG001|Overall Study|extubated|110|||
154906412|NCT00796549|559078313|FG000|Overall Study|Adverse Event|11|||
154906413|NCT00796549|559078313|FG000|Overall Study|not entered|149|||
154906414|NCT00796549|559078313|FG000|Overall Study|Other|2|||
154906415|NCT00796549|559078313|FG000|Overall Study|Progressive disease|56|||
154906416|NCT03523715|559078315|FG000|Overall Study|Lost to Follow-up|11|||
154906417|NCT03523715|559078316|FG001|Overall Study|Lost to Follow-up|14|||
154906418|NCT03523715|559078315|FG000|Overall Study|Did not meet inclusion criteria|1|||
154906419|NCT03523715|559078316|FG001|Overall Study|Did not meet inclusion criteria|0|||
154906420|NCT03523715|559078315|FG000|Overall Study|Internally inconsistent reporting|0|||
155176062|NCT01915303|560082230|FG000|Extension Phase|Withdrawal by Subject|4|||
155116574|NCT01529515|559859032|FG001|TRANSITION PHASE|Death|0|||
155116575|NCT01529515|559859033|FG002|TRANSITION PHASE|Death|0|||
155116576|NCT01529515|559859034|FG003|TRANSITION PHASE|Death|0|||
155116577|NCT01529515|559859031|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
155116578|NCT01529515|559859032|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
155116579|NCT01529515|559859033|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
154906421|NCT03523715|559078316|FG001|Overall Study|Internally inconsistent reporting|2|||
154906422|NCT00606229|559078317|FG000|Overall Study|Adverse Event|11|||
154906423|NCT00606229|559078317|FG000|Overall Study|Lack of Efficacy|1|||
154906424|NCT00606229|559078317|FG000|Overall Study|Withdrawal by Subject|4|||
154906425|NCT00606229|559078317|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
154906426|NCT00606229|559078317|FG000|Overall Study|change of residence or other commitments|2|||
154906427|NCT02139280|559078318|FG000|Overall Study|No longer eligible|2|||
155116580|NCT01529515|559859034|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
155116581|NCT01529515|559859031|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
155116582|NCT01529515|559859032|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
155116583|NCT01529515|559859033|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
155116584|NCT01529515|559859034|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
155116585|NCT01529515|559859031|FG000|TRANSITION PHASE|Protocol Violation|4|||
155116586|NCT01529515|559859032|FG001|TRANSITION PHASE|Protocol Violation|0|||
155116587|NCT01529515|559859033|FG002|TRANSITION PHASE|Protocol Violation|0|||
155116588|NCT01529515|559859034|FG003|TRANSITION PHASE|Protocol Violation|0|||
155116589|NCT01529515|559859031|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
154906428|NCT02139280|559078319|FG001|Overall Study|No longer eligible|0|||
154906429|NCT01302691|559078322|FG000|Overall Study|Adverse Event|2|||
154906430|NCT01302691|559078323|FG001|Overall Study|Adverse Event|0|||
154906431|NCT01302691|559078322|FG000|Overall Study|Death|0|||
154906432|NCT01302691|559078323|FG001|Overall Study|Death|1|||
154906433|NCT01302691|559078322|FG000|Overall Study|Lost to Follow-up|1|||
154906434|NCT01302691|559078323|FG001|Overall Study|Lost to Follow-up|0|||
154906435|NCT01302691|559078322|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
154906436|NCT01302691|559078323|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
154906437|NCT01302691|559078322|FG000|Overall Study|Physician Decision|0|||
154906438|NCT01302691|559078323|FG001|Overall Study|Physician Decision|1|||
154906439|NCT01302691|559078322|FG000|Overall Study|Protocol Violation|1|||
154906440|NCT01302691|559078323|FG001|Overall Study|Protocol Violation|0|||
154906441|NCT01039428|559078332|FG000|Overall Study|Protocol Violation|1|||
154906442|NCT01039428|559078333|FG001|Overall Study|Protocol Violation|0|||
154906443|NCT01039428|559078332|FG000|Overall Study|Withdrawal by Subject|1|||
154906444|NCT01039428|559078333|FG001|Overall Study|Withdrawal by Subject|0|||
154906445|NCT01313039|559078334|FG000|Overall Study|Physician Decision|1|||
154906446|NCT01313039|559078334|FG000|Overall Study|Adverse Event|1|||
154906447|NCT00117572|559078335|FG000|Overall Study|Site withdrew before starting treatment|2|||
154906448|NCT00117572|559078336|FG001|Overall Study|Site withdrew before starting treatment|3|||
154906449|NCT00117572|559078335|FG000|Overall Study|Withdrawal by Subject|3|||
154906450|NCT00117572|559078336|FG001|Overall Study|Withdrawal by Subject|3|||
154906451|NCT00117572|559078335|FG000|Overall Study|Protocol Violation|1|||
154906452|NCT00117572|559078336|FG001|Overall Study|Protocol Violation|0|||
154906453|NCT00090766|559078337|FG000|Overall Study|Nephrectomy Planned|0|||
154906454|NCT00090766|559078338|FG001|Overall Study|Nephrectomy Planned|0|||
154906455|NCT00090766|559078339|FG002|Overall Study|Nephrectomy Planned|1|||
154906456|NCT00090766|559078337|FG000|Overall Study|Death|1|||
154906457|NCT00090766|559078338|FG001|Overall Study|Death|0|||
154906458|NCT00090766|559078339|FG002|Overall Study|Death|0|||
154906459|NCT00090766|559078337|FG000|Overall Study|Admin|0|||
154906460|NCT00090766|559078338|FG001|Overall Study|Admin|2|||
154906461|NCT00090766|559078339|FG002|Overall Study|Admin|0|||
154906462|NCT00090766|559078337|FG000|Overall Study|Lost to Follow-up|2|||
154906463|NCT00090766|559078338|FG001|Overall Study|Lost to Follow-up|0|||
154906464|NCT00090766|559078339|FG002|Overall Study|Lost to Follow-up|2|||
154906465|NCT00804986|559078340|FG000|Overall Study|Adverse Event|0|||
154906466|NCT00804986|559078341|FG001|Overall Study|Adverse Event|1|||
154906467|NCT00804986|559078342|FG002|Overall Study|Adverse Event|2|||
154906468|NCT00804986|559078343|FG003|Overall Study|Adverse Event|1|||
154906469|NCT00804986|559078344|FG004|Overall Study|Adverse Event|3|||
154906470|NCT00804986|559078345|FG005|Overall Study|Adverse Event|0|||
154906471|NCT00804986|559078340|FG000|Overall Study|Lack of Efficacy|0|||
154906472|NCT00804986|559078341|FG001|Overall Study|Lack of Efficacy|0|||
154906473|NCT00804986|559078342|FG002|Overall Study|Lack of Efficacy|0|||
155116590|NCT01529515|559859032|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
155116591|NCT01529515|559859033|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
155116592|NCT01529515|559859034|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
154906474|NCT00804986|559078343|FG003|Overall Study|Lack of Efficacy|1|||
154906475|NCT00804986|559078344|FG004|Overall Study|Lack of Efficacy|0|||
154906476|NCT00804986|559078345|FG005|Overall Study|Lack of Efficacy|3|||
154906477|NCT00804986|559078340|FG000|Overall Study|Lost to Follow-up|0|||
155116593|NCT01529515|559859031|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
155116594|NCT01529515|559859032|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
155176063|NCT01915303|560082230|FG000|Extension Phase|Adverse Event|3|||
155116595|NCT01529515|559859033|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
154906478|NCT00804986|559078341|FG001|Overall Study|Lost to Follow-up|0|||
154906479|NCT00804986|559078342|FG002|Overall Study|Lost to Follow-up|0|||
154906480|NCT00804986|559078343|FG003|Overall Study|Lost to Follow-up|1|||
154906481|NCT00804986|559078344|FG004|Overall Study|Lost to Follow-up|1|||
154906482|NCT00804986|559078345|FG005|Overall Study|Lost to Follow-up|3|||
154906483|NCT00804986|559078340|FG000|Overall Study|Protocol Violation|0|||
154906484|NCT00804986|559078341|FG001|Overall Study|Protocol Violation|1|||
154906485|NCT00804986|559078342|FG002|Overall Study|Protocol Violation|0|||
154906486|NCT00804986|559078343|FG003|Overall Study|Protocol Violation|1|||
154906487|NCT00804986|559078344|FG004|Overall Study|Protocol Violation|0|||
154906488|NCT00804986|559078345|FG005|Overall Study|Protocol Violation|0|||
154906489|NCT00804986|559078340|FG000|Overall Study|Withdrawal by Subject|0|||
154906490|NCT00804986|559078341|FG001|Overall Study|Withdrawal by Subject|3|||
154906491|NCT00804986|559078342|FG002|Overall Study|Withdrawal by Subject|0|||
154906492|NCT00804986|559078343|FG003|Overall Study|Withdrawal by Subject|3|||
154906493|NCT00804986|559078344|FG004|Overall Study|Withdrawal by Subject|5|||
154906494|NCT00804986|559078345|FG005|Overall Study|Withdrawal by Subject|3|||
154906495|NCT00804986|559078340|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
154906496|NCT00804986|559078341|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
154906497|NCT00804986|559078342|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
154906498|NCT00804986|559078343|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
154906499|NCT00804986|559078344|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
154906500|NCT00804986|559078345|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
154906501|NCT00804986|559078340|FG000|Overall Study|Sponsor Decision|0|||
154906502|NCT00804986|559078341|FG001|Overall Study|Sponsor Decision|1|||
154906503|NCT00804986|559078342|FG002|Overall Study|Sponsor Decision|0|||
154906504|NCT00804986|559078343|FG003|Overall Study|Sponsor Decision|0|||
154906505|NCT00804986|559078344|FG004|Overall Study|Sponsor Decision|0|||
154906506|NCT00804986|559078345|FG005|Overall Study|Sponsor Decision|0|||
154906507|NCT00804986|559078340|FG000|Overall Study|Physician Decision|1|||
154906508|NCT00804986|559078341|FG001|Overall Study|Physician Decision|0|||
154906509|NCT00804986|559078342|FG002|Overall Study|Physician Decision|0|||
154906510|NCT00804986|559078343|FG003|Overall Study|Physician Decision|0|||
154906511|NCT00804986|559078344|FG004|Overall Study|Physician Decision|0|||
154906512|NCT00804986|559078345|FG005|Overall Study|Physician Decision|0|||
154906513|NCT02774291|559078346|FG000|Overall Study|Lost to Follow-up|1|||
154906514|NCT01387594|559078347|FG000|Overall Study|Withdrawal by Subject|0|||
154906515|NCT01387594|559078348|FG001|Overall Study|Withdrawal by Subject|2|||
154906516|NCT01387594|559078347|FG000|Overall Study|Lost to Follow-up|0|||
154906517|NCT01387594|559078348|FG001|Overall Study|Lost to Follow-up|1|||
154906518|NCT00397891|559078357|FG000|Overall Study|Withdrawal by Subject|1|||
154906519|NCT00397891|559078358|FG001|Overall Study|Withdrawal by Subject|0|||
154906520|NCT00397891|559078359|FG002|Overall Study|Withdrawal by Subject|0|||
154906521|NCT00397891|559078360|FG003|Overall Study|Withdrawal by Subject|0|||
154906522|NCT00397891|559078361|FG004|Overall Study|Withdrawal by Subject|1|||
154906523|NCT00412113|559078362|FG000|Overall Study|Adverse Event|11|||
154906524|NCT00412113|559078363|FG001|Overall Study|Adverse Event|15|||
154906525|NCT00412113|559078362|FG000|Overall Study|did not receive treatment|1|||
154906526|NCT00412113|559078363|FG001|Overall Study|did not receive treatment|0|||
154906527|NCT00796224|559078364|FG000|Overall Study|Adverse Event|1|||
154906528|NCT00796224|559078365|FG001|Overall Study|Adverse Event|0|||
154906529|NCT00796224|559078364|FG000|Overall Study|Protocol Violation|0|||
154906530|NCT00796224|559078365|FG001|Overall Study|Protocol Violation|1|||
154906531|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
154906532|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
154906533|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
154906534|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
154906535|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
154906536|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
154906537|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
155116596|NCT01529515|559859034|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
155116597|NCT01529515|559859031|FG000|TRANSITION PHASE|Other|9|||
155116598|NCT01529515|559859032|FG001|TRANSITION PHASE|Other|0|||
155116599|NCT01529515|559859033|FG002|TRANSITION PHASE|Other|0|||
155116600|NCT01529515|559859034|FG003|TRANSITION PHASE|Other|0|||
155116601|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Adverse Event|0|||
155116602|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Adverse Event|10|||
155116603|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Adverse Event|0|||
154906538|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
154906539|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
154906540|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
154906541|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
154906542|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
154906543|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
154906544|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
154906545|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
155116604|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Adverse Event|0|||
155116605|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
155116606|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
155116607|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
155116608|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
155116609|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
155116610|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
155116611|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
155116612|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
155116613|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
155116614|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
155116615|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
155116616|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
155176064|NCT01915303|560082230|FG000|Extension Phase|Death|1|||
155176065|NCT01915303|560082230|FG000|Extension Phase|Protocol Violation|1|||
155176066|NCT02509117|560082232|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176067|NCT02509117|560082233|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
155176068|NCT02509117|560082234|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176069|NCT02509117|560082235|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176070|NCT02509117|560082236|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176071|NCT02509117|560082237|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176072|NCT02509117|560082238|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176073|NCT02509117|560082239|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176074|NCT02509117|560082240|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176075|NCT02509117|560082241|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
155176076|NCT02509117|560082232|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176077|NCT02509117|560082233|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176078|NCT02509117|560082234|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176079|NCT02509117|560082235|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176080|NCT02509117|560082236|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176081|NCT02509117|560082237|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176082|NCT02509117|560082238|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155176083|NCT02509117|560082239|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
154906546|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
154906547|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
154906548|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
154906549|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
154906550|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
154906551|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
154906552|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
154906553|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
154906554|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
154906555|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
154906556|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
154906557|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
154906558|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
154906559|NCT03227224|559078366|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
154906560|NCT03227224|559078367|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
154906561|NCT03227224|559078368|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
154906562|NCT03227224|559078369|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
154906563|NCT03227224|559078366|FG000|Follow-up Phase (2 Weeks)|Other|4|||
154906564|NCT03227224|559078367|FG001|Follow-up Phase (2 Weeks)|Other|4|||
154906565|NCT03227224|559078368|FG002|Follow-up Phase (2 Weeks)|Other|6|||
154906566|NCT03227224|559078369|FG003|Follow-up Phase (2 Weeks)|Other|3|||
154906567|NCT04195750|559078370|FG000|Overall Study|Death|245|||
154906568|NCT04195750|559078371|FG001|Overall Study|Death|253|||
154906569|NCT04195750|559078372|FG002|Overall Study|Death|5|||
155116617|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
155116618|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
155116619|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
155116620|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
155116621|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
155176084|NCT02509117|560082240|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
155116622|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
155116623|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
154906570|NCT04195750|559078370|FG000|Overall Study|Physician Decision|0|||
154906571|NCT04195750|559078371|FG001|Overall Study|Physician Decision|1|||
154906572|NCT04195750|559078372|FG002|Overall Study|Physician Decision|0|||
154906573|NCT04195750|559078370|FG000|Overall Study|Withdrawal by Subject|9|||
154906574|NCT04195750|559078371|FG001|Overall Study|Withdrawal by Subject|8|||
154906575|NCT04195750|559078372|FG002|Overall Study|Withdrawal by Subject|0|||
154906576|NCT04195750|559078370|FG000|Overall Study|Ongoing|120|||
154906577|NCT04195750|559078371|FG001|Overall Study|Ongoing|110|||
154906578|NCT04195750|559078372|FG002|Overall Study|Ongoing|4|||
154906579|NCT02406027|559078373|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
154906580|NCT02406027|559078374|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
154906581|NCT02406027|559078375|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
154906582|NCT02406027|559078376|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
154906583|NCT02406027|559078377|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
154906584|NCT02406027|559078378|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
154906585|NCT02406027|559078379|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
154906586|NCT02406027|559078373|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
154906587|NCT02406027|559078374|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
154906588|NCT02406027|559078375|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
154906589|NCT02406027|559078376|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
154906590|NCT02406027|559078377|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
154906591|NCT02406027|559078378|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
154906592|NCT02406027|559078379|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
154906593|NCT02406027|559078373|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
154906594|NCT02406027|559078374|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
154906595|NCT02406027|559078375|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
154906596|NCT02406027|559078376|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
154906597|NCT02406027|559078377|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
154906598|NCT02406027|559078378|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
154906599|NCT02406027|559078379|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
154906600|NCT02406027|559078373|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
154906601|NCT02406027|559078374|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
154906602|NCT02406027|559078375|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
154906603|NCT02406027|559078376|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
154906604|NCT02406027|559078377|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
154906605|NCT02406027|559078378|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
154906606|NCT02406027|559078379|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
154906607|NCT02406027|559078373|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
154906608|NCT02406027|559078374|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
154906609|NCT02406027|559078375|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
154906610|NCT02406027|559078376|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
154906611|NCT02406027|559078377|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
154906612|NCT02406027|559078378|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
154906613|NCT02406027|559078379|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
154906614|NCT02406027|559078373|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
154906615|NCT02406027|559078374|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
154906616|NCT02406027|559078375|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
154906617|NCT02406027|559078376|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
154906618|NCT02406027|559078377|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
154906619|NCT02406027|559078378|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
154906620|NCT02406027|559078379|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
154906621|NCT02406027|559078373|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
154906622|NCT02406027|559078374|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
154906623|NCT02406027|559078375|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
154906624|NCT02406027|559078376|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
154906625|NCT02406027|559078377|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
154906626|NCT02406027|559078378|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
154906627|NCT02406027|559078379|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
154906628|NCT02406027|559078373|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
154906629|NCT02406027|559078374|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
154906630|NCT02406027|559078375|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
154906631|NCT02406027|559078376|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
154906632|NCT02406027|559078377|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
154906633|NCT02406027|559078378|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
154906634|NCT02406027|559078379|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
154906635|NCT02406027|559078373|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
155116624|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
155116625|NCT01529515|559859031|FG000|MAINTENANCE PHASE|Other|0|||
155116626|NCT01529515|559859032|FG001|MAINTENANCE PHASE|Other|10|||
155116627|NCT01529515|559859033|FG002|MAINTENANCE PHASE|Other|0|||
155116628|NCT01529515|559859034|FG003|MAINTENANCE PHASE|Other|0|||
155116629|NCT01529515|559859031|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
155116630|NCT01529515|559859032|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
155116631|NCT01529515|559859033|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
155116632|NCT01529515|559859034|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
155116633|NCT01529515|559859031|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
155116634|NCT01529515|559859032|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
155116635|NCT01529515|559859033|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
155116636|NCT01529515|559859034|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
155116637|NCT01529515|559859031|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
155116638|NCT01529515|559859032|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
155116639|NCT01529515|559859033|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
155116640|NCT01529515|559859034|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
155116641|NCT01529515|559859031|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
155116642|NCT01529515|559859032|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
155116643|NCT01529515|559859033|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
154906636|NCT02406027|559078374|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
154906637|NCT02406027|559078375|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
154906638|NCT02406027|559078376|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
154906639|NCT02406027|559078377|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
154906640|NCT02406027|559078378|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
154906641|NCT02406027|559078379|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
154906642|NCT02406027|559078373|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
154906643|NCT02406027|559078374|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
154906644|NCT02406027|559078375|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
154906645|NCT02406027|559078376|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
154906646|NCT02406027|559078377|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
154906647|NCT02406027|559078378|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
154906648|NCT02406027|559078379|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
154906649|NCT02254304|559078382|FG000|Overall Study|Adverse Event|2|||
154906650|NCT02254304|559078383|FG001|Overall Study|Adverse Event|1|||
154906651|NCT02254304|559078382|FG000|Overall Study|Lost to Follow-up|2|||
154906652|NCT02254304|559078383|FG001|Overall Study|Lost to Follow-up|2|||
154906653|NCT02254304|559078382|FG000|Overall Study|Protocol Violation|1|||
154906654|NCT02254304|559078383|FG001|Overall Study|Protocol Violation|0|||
154906655|NCT02254304|559078382|FG000|Overall Study|Withdrawal by Subject|3|||
154906656|NCT02254304|559078383|FG001|Overall Study|Withdrawal by Subject|0|||
154906657|NCT02254304|559078382|FG000|Overall Study|Injection site pain and Injection fear|1|||
154906658|NCT02254304|559078383|FG001|Overall Study|Injection site pain and Injection fear|0|||
154906659|NCT02254304|559078382|FG000|Overall Study|Personal causes|4|||
154906660|NCT02254304|559078383|FG001|Overall Study|Personal causes|1|||
154906661|NCT02254304|559078382|FG000|Overall Study|Personal decision|1|||
154906662|NCT02254304|559078383|FG001|Overall Study|Personal decision|0|||
154906663|NCT00887822|559080558|FG000|Overall Study|Insufficient therapeutic response|53|||
154906664|NCT00887822|559080559|FG001|Overall Study|Insufficient therapeutic response|55|||
154906665|NCT00887822|559080558|FG000|Overall Study|Adverse Event|14|||
154906666|NCT00887822|559080559|FG001|Overall Study|Adverse Event|17|||
154906667|NCT00887822|559080558|FG000|Overall Study|Failure to return|11|||
154906668|NCT00887822|559080559|FG001|Overall Study|Failure to return|11|||
154906669|NCT00887822|559080558|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
154906670|NCT00887822|559080559|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
154906671|NCT00887822|559080558|FG000|Overall Study|Administrative/Other than specified|5|||
154906672|NCT00887822|559080559|FG001|Overall Study|Administrative/Other than specified|4|||
154906673|NCT00887822|559080558|FG000|Overall Study|Death|2|||
154906674|NCT00887822|559080559|FG001|Overall Study|Death|3|||
154906675|NCT00887822|559080558|FG000|Overall Study|Protocol Violation|0|||
154906676|NCT00887822|559080559|FG001|Overall Study|Protocol Violation|1|||
154906677|NCT00887822|559080558|FG000|Overall Study|Randomized but not treated|0|||
154906678|NCT00887822|559080559|FG001|Overall Study|Randomized but not treated|1|||
155116644|NCT01529515|559859034|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
155116645|NCT01529515|559859031|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
154906679|NCT04284787|559080562|FG000|Overall Study|Disease Progression|9|||
154906680|NCT04284787|559080563|FG001|Overall Study|Disease Progression|12|||
154906681|NCT04284787|559080562|FG000|Overall Study|Physician Decision|12|||
154906682|NCT04284787|559080563|FG001|Overall Study|Physician Decision|7|||
154906683|NCT04284787|559080562|FG000|Overall Study|Transplant|5|||
155116646|NCT01529515|559859032|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
155116647|NCT01529515|559859033|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
155116648|NCT01529515|559859034|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
155116649|NCT01529515|559859031|FG000|DOUBLE BLIND PHASE|Other|0|||
155116650|NCT01529515|559859032|FG001|DOUBLE BLIND PHASE|Other|0|||
155116651|NCT01529515|559859033|FG002|DOUBLE BLIND PHASE|Other|9|||
154906684|NCT04284787|559080563|FG001|Overall Study|Transplant|4|||
154906685|NCT04284787|559080562|FG000|Overall Study|Death|1|||
154906686|NCT04284787|559080563|FG001|Overall Study|Death|2|||
154906687|NCT04284787|559080562|FG000|Overall Study|Adverse Event|0|||
154906688|NCT04284787|559080563|FG001|Overall Study|Adverse Event|4|||
154906689|NCT04284787|559080562|FG000|Overall Study|Non-adherence|2|||
154906690|NCT04284787|559080563|FG001|Overall Study|Non-adherence|0|||
154906691|NCT04284787|559080562|FG000|Overall Study|Lack of Efficacy|2|||
154906692|NCT04284787|559080563|FG001|Overall Study|Lack of Efficacy|0|||
154906693|NCT01874353|559080564|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
154906694|NCT01874353|559080565|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
154906695|NCT01874353|559080566|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
154906696|NCT01874353|559080567|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
154906697|NCT01874353|559080564|FG000|Overall Study|Lost to Follow-up|2|||
154906698|NCT01874353|559080565|FG001|Overall Study|Lost to Follow-up|2|||
154906699|NCT01874353|559080566|FG002|Overall Study|Lost to Follow-up|2|||
154906700|NCT01874353|559080567|FG003|Overall Study|Lost to Follow-up|0|||
154906701|NCT01874353|559080564|FG000|Overall Study|Death|110|||
154906702|NCT01874353|559080565|FG001|Overall Study|Death|60|||
154906703|NCT01874353|559080566|FG002|Overall Study|Death|13|||
154906704|NCT01874353|559080567|FG003|Overall Study|Death|7|||
154906705|NCT01874353|559080564|FG000|Overall Study|Withdrawal by Subject|13|||
154906706|NCT01874353|559080565|FG001|Overall Study|Withdrawal by Subject|11|||
154906707|NCT01874353|559080566|FG002|Overall Study|Withdrawal by Subject|0|||
154906708|NCT01874353|559080567|FG003|Overall Study|Withdrawal by Subject|0|||
154906709|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
154906710|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
154906711|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Death|1|||
154906712|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Death|1|||
154906713|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
154906714|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
154906715|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
154906716|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
154906717|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
154906718|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
154906719|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
154906720|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
154906721|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
154906722|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
154906723|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
154906724|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
154906725|NCT03728881|559080568|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
154906726|NCT03728881|559080569|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
154906727|NCT03728881|559080568|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
154906728|NCT03728881|559080569|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
154906729|NCT03728881|559080568|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
154906730|NCT03728881|559080569|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
154906731|NCT04517253|559080572|FG000|Primary Treatment Period|Adverse Event|1|||
154906732|NCT04517253|559080573|FG001|Primary Treatment Period|Adverse Event|0|||
154906733|NCT04517253|559080574|FG002|Primary Treatment Period|Adverse Event|0|||
154906734|NCT04517253|559080572|FG000|Primary Treatment Period|Death|0|||
154906735|NCT04517253|559080573|FG001|Primary Treatment Period|Death|1|||
154906736|NCT04517253|559080574|FG002|Primary Treatment Period|Death|0|||
154906737|NCT04517253|559080572|FG000|Maintenance Period|Withdrawal by Subject|1|||
154906738|NCT04517253|559080573|FG001|Maintenance Period|Withdrawal by Subject|0|||
154906739|NCT04517253|559080574|FG002|Maintenance Period|Withdrawal by Subject|0|||
154906740|NCT04517253|559080572|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
154906741|NCT04517253|559080573|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
154906742|NCT04517253|559080574|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
154906743|NCT06048367|559080575|FG000|Overall Study|Withdrawal by Subject|0|||
154906744|NCT06048367|559080576|FG001|Overall Study|Withdrawal by Subject|1|||
154906745|NCT06048367|559080577|FG002|Overall Study|Withdrawal by Subject|0|||
155116652|NCT01529515|559859034|FG003|DOUBLE BLIND PHASE|Other|2|||
155116653|NCT03334851|559859035|FG000|Overall Study|Other|0|||
155116654|NCT03334851|559859036|FG001|Overall Study|Other|0|||
155116655|NCT03334851|559859037|FG002|Overall Study|Other|0|||
154906746|NCT06048367|559080578|FG003|Overall Study|Withdrawal by Subject|0|||
155116656|NCT03334851|559859038|FG003|Overall Study|Other|0|||
155116657|NCT03334851|559859039|FG004|Overall Study|Other|0|||
155116658|NCT03334851|559859040|FG005|Overall Study|Other|0|||
155116659|NCT03334851|559859041|FG006|Overall Study|Other|0|||
155116660|NCT03334851|559859042|FG007|Overall Study|Other|1|||
155116661|NCT03334851|559859043|FG008|Overall Study|Other|0|||
155116662|NCT03334851|559859044|FG009|Overall Study|Other|0|||
155116663|NCT03334851|559859045|FG010|Overall Study|Other|0|||
155116664|NCT03334851|559859046|FG011|Overall Study|Other|0|||
155116665|NCT03334851|559859047|FG012|Overall Study|Other|0|||
155116666|NCT03334851|559859035|FG000|Overall Study|Adverse Event|0|||
154906747|NCT06048367|559080579|FG004|Overall Study|Withdrawal by Subject|0|||
154906748|NCT06048367|559080575|FG000|Overall Study|Withdrawal by Subject|0|||
154906749|NCT06048367|559080576|FG001|Overall Study|Withdrawal by Subject|0|||
154906750|NCT06048367|559080577|FG002|Overall Study|Withdrawal by Subject|1|||
154906751|NCT06048367|559080578|FG003|Overall Study|Withdrawal by Subject|0|||
154906752|NCT06048367|559080579|FG004|Overall Study|Withdrawal by Subject|0|||
154906753|NCT06048367|559080575|FG000|Overall Study|Withdrawal by Subject|0|||
154906754|NCT06048367|559080576|FG001|Overall Study|Withdrawal by Subject|0|||
154906755|NCT06048367|559080577|FG002|Overall Study|Withdrawal by Subject|0|||
154906756|NCT06048367|559080578|FG003|Overall Study|Withdrawal by Subject|1|||
154906757|NCT06048367|559080579|FG004|Overall Study|Withdrawal by Subject|0|||
154906758|NCT06048367|559080575|FG000|Overall Study|Withdrawal by Subject|0|||
154906759|NCT06048367|559080576|FG001|Overall Study|Withdrawal by Subject|0|||
154906760|NCT06048367|559080577|FG002|Overall Study|Withdrawal by Subject|0|||
154906761|NCT06048367|559080578|FG003|Overall Study|Withdrawal by Subject|1|||
154906762|NCT06048367|559080579|FG004|Overall Study|Withdrawal by Subject|0|||
154906763|NCT05505734|559080580|FG000|Overall Study|Withdrawal by Subject|51|||
154906764|NCT05505734|559080581|FG001|Overall Study|Withdrawal by Subject|64|||
154906765|NCT05505734|559080580|FG000|Overall Study|Adverse Event|6|||
154906766|NCT05505734|559080581|FG001|Overall Study|Adverse Event|20|||
154906767|NCT05505734|559080580|FG000|Overall Study|Protocol Violation|8|||
154906768|NCT05505734|559080581|FG001|Overall Study|Protocol Violation|15|||
154906769|NCT05505734|559080580|FG000|Overall Study|Lack of therapeutic response|0|||
154906770|NCT05505734|559080581|FG001|Overall Study|Lack of therapeutic response|1|||
154906771|NCT05505734|559080580|FG000|Overall Study|Lost to Follow-up|247|||
154906772|NCT05505734|559080581|FG001|Overall Study|Lost to Follow-up|237|||
154906773|NCT05505734|559080580|FG000|Overall Study|Physician Decision|22|||
154906774|NCT05505734|559080581|FG001|Overall Study|Physician Decision|13|||
154906775|NCT05505734|559080580|FG000|Overall Study|Death|2|||
154906776|NCT05505734|559080581|FG001|Overall Study|Death|1|||
154906777|NCT05505734|559080580|FG000|Overall Study|Withdrawal by parent/guardian|0|||
154906778|NCT05505734|559080581|FG001|Overall Study|Withdrawal by parent/guardian|1|||
154906779|NCT05505734|559080580|FG000|Overall Study|Pregnancy|1|||
154906780|NCT05505734|559080581|FG001|Overall Study|Pregnancy|0|||
154906781|NCT05505734|559080580|FG000|Overall Study|Other|17|||
154906782|NCT05505734|559080581|FG001|Overall Study|Other|13|||
154906783|NCT01266876|559080585|FG000|Overall Study|Adverse Event|0|||
154906784|NCT01266876|559080586|FG001|Overall Study|Adverse Event|0|||
154906785|NCT01266876|559080587|FG002|Overall Study|Adverse Event|0|||
154906786|NCT01266876|559080588|FG003|Overall Study|Adverse Event|1|||
154906787|NCT01266876|559080589|FG004|Overall Study|Adverse Event|0|||
154906788|NCT05016037|559080591|FG000|Overall Study|Lost to Follow-up|2|||
154906789|NCT03575351|559080592|FG000|Overall Study|Adverse Event|1|||
154906790|NCT03575351|559080593|FG001|Overall Study|Adverse Event|0|||
154906791|NCT03575351|559080592|FG000|Overall Study|Death|2|||
154906792|NCT03575351|559080593|FG001|Overall Study|Death|2|||
154906793|NCT03575351|559080592|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
154906794|NCT03575351|559080593|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
154906795|NCT03575351|559080592|FG000|Overall Study|Lack of Efficacy|28|||
154906796|NCT03575351|559080593|FG001|Overall Study|Lack of Efficacy|0|||
154906797|NCT03575351|559080592|FG000|Overall Study|Withdrawal by Subject|1|||
154906798|NCT03575351|559080593|FG001|Overall Study|Withdrawal by Subject|1|||
154906799|NCT03575351|559080592|FG000|Overall Study|Physician Decision|3|||
154906800|NCT03575351|559080593|FG001|Overall Study|Physician Decision|0|||
154906801|NCT03575351|559080592|FG000|Overall Study|Disease relapse|15|||
154906802|NCT03575351|559080593|FG001|Overall Study|Disease relapse|6|||
154906803|NCT03575351|559080592|FG000|Overall Study|Study drug manufacturing failure|0|||
154906804|NCT03575351|559080593|FG001|Overall Study|Study drug manufacturing failure|1|||
154906805|NCT03575351|559080592|FG000|Overall Study|other reasons|5|||
154906806|NCT03575351|559080593|FG001|Overall Study|other reasons|0|||
154906807|NCT03715205|559080594|FG000|Overall Study|Death|13|||
155116667|NCT03334851|559859036|FG001|Overall Study|Adverse Event|0|||
154906808|NCT03715205|559080594|FG000|Overall Study|Lost to Follow-up|2|||
154906809|NCT03715205|559080594|FG000|Overall Study|Physician Decision|93|||
154906810|NCT03715205|559080594|FG000|Overall Study|Withdrawal by Subject|26|||
154906811|NCT02623699|559080595|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906812|NCT02623699|559080596|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
154906813|NCT02623699|559080597|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155116668|NCT03334851|559859037|FG002|Overall Study|Adverse Event|0|||
154906814|NCT02623699|559080598|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906815|NCT02623699|559080599|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906816|NCT02623699|559080600|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
155116669|NCT03334851|559859038|FG003|Overall Study|Adverse Event|0|||
154906817|NCT02623699|559080601|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906818|NCT02623699|559080602|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906819|NCT02623699|559080603|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906820|NCT02623699|559080604|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906821|NCT02623699|559080605|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906822|NCT02623699|559080606|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
154906823|NCT02623699|559080595|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906824|NCT02623699|559080596|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906825|NCT02623699|559080597|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906826|NCT02623699|559080598|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906827|NCT02623699|559080599|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906828|NCT02623699|559080600|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906829|NCT02623699|559080601|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
154906830|NCT02623699|559080602|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
155116670|NCT03334851|559859039|FG004|Overall Study|Adverse Event|0|||
154906831|NCT02623699|559080603|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906832|NCT02623699|559080604|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906833|NCT02623699|559080605|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906834|NCT02623699|559080606|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
154906835|NCT02623699|559080595|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906836|NCT02623699|559080596|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906837|NCT02623699|559080597|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906838|NCT02623699|559080598|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906839|NCT02623699|559080599|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906840|NCT02623699|559080600|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
154906841|NCT02623699|559080601|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906842|NCT02623699|559080602|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906843|NCT02623699|559080603|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906844|NCT02623699|559080604|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
155116671|NCT03334851|559859040|FG005|Overall Study|Adverse Event|0|||
155116672|NCT03334851|559859041|FG006|Overall Study|Adverse Event|0|||
155116673|NCT03334851|559859042|FG007|Overall Study|Adverse Event|1|||
155116674|NCT03334851|559859043|FG008|Overall Study|Adverse Event|0|||
155116675|NCT03334851|559859044|FG009|Overall Study|Adverse Event|0|||
155116676|NCT03334851|559859045|FG010|Overall Study|Adverse Event|0|||
155116677|NCT03334851|559859046|FG011|Overall Study|Adverse Event|0|||
155116678|NCT03334851|559859047|FG012|Overall Study|Adverse Event|0|||
155116679|NCT03334851|559859035|FG000|Overall Study|Withdrawal by Subject|0|||
155116680|NCT03334851|559859036|FG001|Overall Study|Withdrawal by Subject|0|||
155116681|NCT03334851|559859037|FG002|Overall Study|Withdrawal by Subject|0|||
155116682|NCT03334851|559859038|FG003|Overall Study|Withdrawal by Subject|0|||
155116683|NCT03334851|559859039|FG004|Overall Study|Withdrawal by Subject|0|||
155116684|NCT03334851|559859040|FG005|Overall Study|Withdrawal by Subject|0|||
155116685|NCT03334851|559859041|FG006|Overall Study|Withdrawal by Subject|0|||
155116686|NCT03334851|559859042|FG007|Overall Study|Withdrawal by Subject|0|||
155116687|NCT03334851|559859043|FG008|Overall Study|Withdrawal by Subject|0|||
155116688|NCT03334851|559859044|FG009|Overall Study|Withdrawal by Subject|0|||
155116689|NCT03334851|559859045|FG010|Overall Study|Withdrawal by Subject|1|||
155116690|NCT03334851|559859046|FG011|Overall Study|Withdrawal by Subject|0|||
155116691|NCT03334851|559859047|FG012|Overall Study|Withdrawal by Subject|1|||
155116692|NCT03334851|559859035|FG000|Overall Study|Lost to Follow-up|0|||
155116693|NCT03334851|559859036|FG001|Overall Study|Lost to Follow-up|0|||
155116694|NCT03334851|559859037|FG002|Overall Study|Lost to Follow-up|0|||
155116695|NCT03334851|559859038|FG003|Overall Study|Lost to Follow-up|0|||
155116696|NCT03334851|559859039|FG004|Overall Study|Lost to Follow-up|0|||
155116697|NCT03334851|559859040|FG005|Overall Study|Lost to Follow-up|0|||
154906845|NCT02623699|559080605|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906846|NCT02623699|559080606|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
154906847|NCT02623699|559080595|FG000|Part B (Up to 289 Days)|Death|0|||
155116698|NCT03334851|559859041|FG006|Overall Study|Lost to Follow-up|0|||
155116699|NCT03334851|559859042|FG007|Overall Study|Lost to Follow-up|0|||
154906848|NCT02623699|559080596|FG001|Part B (Up to 289 Days)|Death|0|||
154906849|NCT02623699|559080597|FG002|Part B (Up to 289 Days)|Death|0|||
154906850|NCT02623699|559080598|FG003|Part B (Up to 289 Days)|Death|0|||
154906851|NCT02623699|559080599|FG004|Part B (Up to 289 Days)|Death|0|||
155116700|NCT03334851|559859043|FG008|Overall Study|Lost to Follow-up|0|||
154906852|NCT02623699|559080600|FG005|Part B (Up to 289 Days)|Death|1|||
154906853|NCT02623699|559080601|FG006|Part B (Up to 289 Days)|Death|1|||
155116701|NCT03334851|559859044|FG009|Overall Study|Lost to Follow-up|0|||
155116702|NCT03334851|559859045|FG010|Overall Study|Lost to Follow-up|2|||
155116703|NCT03334851|559859046|FG011|Overall Study|Lost to Follow-up|1|||
155116704|NCT03334851|559859047|FG012|Overall Study|Lost to Follow-up|0|||
154906854|NCT02623699|559080602|FG007|Part B (Up to 289 Days)|Death|0|||
154906855|NCT02623699|559080603|FG008|Part B (Up to 289 Days)|Death|1|||
154906856|NCT02623699|559080604|FG009|Part B (Up to 289 Days)|Death|0|||
154906857|NCT02623699|559080605|FG010|Part B (Up to 289 Days)|Death|0|||
155116705|NCT00693017|559859048|FG000|Overall Study|Sponsor Decision|2|||
155116706|NCT00693017|559859049|FG001|Overall Study|Sponsor Decision|1|||
154906858|NCT02623699|559080606|FG011|Part B (Up to 289 Days)|Death|0|||
154906859|NCT02623699|559080595|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
154906860|NCT02623699|559080596|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
154906861|NCT02623699|559080597|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
154906862|NCT02623699|559080598|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
154906863|NCT02623699|559080599|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
154906864|NCT02623699|559080600|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
154906865|NCT02623699|559080601|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
154906866|NCT02623699|559080602|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
154906867|NCT02623699|559080603|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
154906868|NCT02623699|559080604|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
154906869|NCT02623699|559080605|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
154906870|NCT02623699|559080606|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
154906871|NCT02623699|559080595|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906872|NCT02623699|559080596|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906873|NCT02623699|559080597|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906874|NCT02623699|559080598|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906875|NCT02623699|559080599|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906876|NCT02623699|559080600|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906877|NCT02623699|559080601|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906878|NCT02623699|559080602|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906879|NCT02623699|559080603|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906880|NCT02623699|559080604|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
154906881|NCT02623699|559080605|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
154906882|NCT02623699|559080606|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
154906883|NCT02623699|559080595|FG000|Part C (Up to 236 Days)|Death|0|||
154906884|NCT02623699|559080596|FG001|Part C (Up to 236 Days)|Death|0|||
154906885|NCT02623699|559080597|FG002|Part C (Up to 236 Days)|Death|0|||
154906886|NCT02623699|559080598|FG003|Part C (Up to 236 Days)|Death|0|||
154906887|NCT02623699|559080599|FG004|Part C (Up to 236 Days)|Death|0|||
154906888|NCT02623699|559080600|FG005|Part C (Up to 236 Days)|Death|0|||
154906889|NCT02623699|559080601|FG006|Part C (Up to 236 Days)|Death|0|||
154906890|NCT02623699|559080602|FG007|Part C (Up to 236 Days)|Death|0|||
154906891|NCT02623699|559080603|FG008|Part C (Up to 236 Days)|Death|0|||
154906892|NCT02623699|559080604|FG009|Part C (Up to 236 Days)|Death|0|||
154906893|NCT02623699|559080605|FG010|Part C (Up to 236 Days)|Death|0|||
154906894|NCT02623699|559080606|FG011|Part C (Up to 236 Days)|Death|1|||
154906895|NCT02623699|559080595|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
154906896|NCT02623699|559080596|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
154906897|NCT02623699|559080597|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
154906898|NCT02623699|559080598|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
154906899|NCT02623699|559080599|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
154906900|NCT02623699|559080600|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
154906901|NCT02623699|559080601|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
154906902|NCT02623699|559080602|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
154906903|NCT02623699|559080603|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
154906904|NCT02623699|559080604|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
154906905|NCT02623699|559080605|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
154906906|NCT02623699|559080606|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
154906907|NCT00557323|559080607|FG000|Overall Study|Death|3|||
154906908|NCT00557323|559080607|FG000|Overall Study|Withdrawal by Subject|2|||
154906909|NCT00557323|559080607|FG000|Overall Study|Administrative change|2|||
154906910|NCT00592072|559080608|FG000|Wash Out Period|Lost to Follow-up|1|||
154906911|NCT00592072|559080609|FG001|Wash Out Period|Lost to Follow-up|1|||
154906912|NCT03369704|559080610|FG000|Treatment Epoch|technical problems|1|||
154906913|NCT03369704|559080611|FG001|Treatment Epoch|technical problems|0|||
154906914|NCT03369704|559080610|FG000|Treatment Epoch|Protocol Violation|1|||
154906915|NCT03369704|559080611|FG001|Treatment Epoch|Protocol Violation|0|||
154906916|NCT03369704|559080610|FG000|Treatment Epoch|Lost to Follow-up|0|||
154906917|NCT03369704|559080611|FG001|Treatment Epoch|Lost to Follow-up|1|||
154906918|NCT03369704|559080610|FG000|Treatment Epoch|Lack of Efficacy|0|||
154906919|NCT03369704|559080611|FG001|Treatment Epoch|Lack of Efficacy|2|||
154906920|NCT03369704|559080610|FG000|Treatment Epoch|Adverse Event|2|||
154906921|NCT03369704|559080611|FG001|Treatment Epoch|Adverse Event|0|||
154906922|NCT03369704|559080610|FG000|Follow-up Epoch|Lost to Follow-up|1|||
154906923|NCT03369704|559080611|FG001|Follow-up Epoch|Lost to Follow-up|0|||
154906924|NCT02010567|559080615|FG000|Overall Study|Adverse Event|0|||
154906925|NCT02010567|559080616|FG001|Overall Study|Adverse Event|0|||
154906926|NCT02010567|559080617|FG002|Overall Study|Adverse Event|1|||
154906927|NCT02010567|559080618|FG003|Overall Study|Adverse Event|0|||
154906928|NCT02010567|559080619|FG004|Overall Study|Adverse Event|1|||
154906929|NCT00118040|559080620|FG000|Overall Study|Adverse Event|0|||
154906930|NCT00118040|559080621|FG001|Overall Study|Adverse Event|1|||
154906931|NCT00118040|559080622|FG002|Overall Study|Adverse Event|0|||
154906932|NCT00118040|559080620|FG000|Overall Study|Withdrawal by Subject|0|||
154906933|NCT00118040|559080621|FG001|Overall Study|Withdrawal by Subject|0|||
154906934|NCT00118040|559080622|FG002|Overall Study|Withdrawal by Subject|2|||
155116707|NCT00693017|559859048|FG000|Overall Study|Death|0|||
155116708|NCT00693017|559859049|FG001|Overall Study|Death|1|||
155116709|NCT01691885|559859051|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
155116710|NCT01691885|559859052|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
155116711|NCT01691885|559859051|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
155116712|NCT01691885|559859052|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
155116713|NCT00688324|559859054|FG000|Overall Study|Withdrawal by Subject|2|||
155116714|NCT00688324|559859054|FG000|Overall Study|Physician Decision|5|||
155116715|NCT00688324|559859054|FG000|Overall Study|Lost to Follow-up|1|||
155116716|NCT01562314|559859056|FG000|Overall Study|Adverse Event|10|||
155116717|NCT01562314|559859057|FG001|Overall Study|Adverse Event|5|||
155116718|NCT01562314|559859056|FG000|Overall Study|Met Withdrawal Criteria|3|||
155116719|NCT01562314|559859057|FG001|Overall Study|Met Withdrawal Criteria|2|||
155116720|NCT01562314|559859056|FG000|Overall Study|Withdrawal by Subject|0|||
155116721|NCT01562314|559859057|FG001|Overall Study|Withdrawal by Subject|1|||
155116722|NCT01190475|559859058|FG000|Overall Study|Withdrawal by Subject|0|||
155116723|NCT01190475|559859059|FG001|Overall Study|Withdrawal by Subject|0|||
155116724|NCT01190475|559859060|FG002|Overall Study|Withdrawal by Subject|1|||
155116725|NCT00996281|559859061|FG000|Overall Study|Adverse Event|75|||
155116726|NCT00996281|559859062|FG001|Overall Study|Adverse Event|37|||
155116727|NCT00996281|559859061|FG000|Overall Study|Major Protocol Deviation|6|||
155116728|NCT00996281|559859062|FG001|Overall Study|Major Protocol Deviation|7|||
155116729|NCT00996281|559859061|FG000|Overall Study|Lost to Follow-up|14|||
155116730|NCT00996281|559859062|FG001|Overall Study|Lost to Follow-up|16|||
155116731|NCT00996281|559859061|FG000|Overall Study|Withdrawal by Subject|31|||
155116732|NCT00996281|559859062|FG001|Overall Study|Withdrawal by Subject|20|||
155116733|NCT00996281|559859061|FG000|Overall Study|Lack of Efficacy|0|||
155116734|NCT00996281|559859062|FG001|Overall Study|Lack of Efficacy|2|||
155116735|NCT00996281|559859061|FG000|Overall Study|Other|5|||
155116736|NCT00996281|559859062|FG001|Overall Study|Other|7|||
154906935|NCT00118040|559080620|FG000|Overall Study|Medical Contraindication|0|||
154906936|NCT00118040|559080621|FG001|Overall Study|Medical Contraindication|0|||
155116737|NCT03505788|559859065|FG000|Overall Study|Lost to Follow-up|2|||
155116738|NCT03505788|559859066|FG001|Overall Study|Lost to Follow-up|1|||
155116739|NCT03505788|559859065|FG000|Overall Study|Withdrawal by Subject|1|||
155116740|NCT03505788|559859066|FG001|Overall Study|Withdrawal by Subject|3|||
155116741|NCT03505788|559859065|FG000|Overall Study|Physician Decision|0|||
155116742|NCT03505788|559859066|FG001|Overall Study|Physician Decision|1|||
155116743|NCT03575065|559859067|FG000|Overall Study|Death|31|||
155116744|NCT03575065|559859068|FG001|Overall Study|Death|12|||
155116745|NCT03575065|559859067|FG000|Overall Study|Sponsor's Decision|28|||
155116746|NCT03575065|559859068|FG001|Overall Study|Sponsor's Decision|13|||
155116747|NCT03575065|559859067|FG000|Overall Study|Withdrawal by Subject|2|||
155116748|NCT03575065|559859068|FG001|Overall Study|Withdrawal by Subject|1|||
155116749|NCT03575065|559859067|FG000|Overall Study|Lost to Follow-up|1|||
155116750|NCT03575065|559859068|FG001|Overall Study|Lost to Follow-up|0|||
155116751|NCT02323126|559859073|FG000|Overall Study|Patient / guardian decision|0|||
155116752|NCT02323126|559859074|FG001|Overall Study|Patient / guardian decision|1|||
155116753|NCT02323126|559859075|FG002|Overall Study|Patient / guardian decision|2|||
155116754|NCT02323126|559859073|FG000|Overall Study|Progressive disease|14|||
155116755|NCT02323126|559859074|FG001|Overall Study|Progressive disease|8|||
155116756|NCT02323126|559859075|FG002|Overall Study|Progressive disease|14|||
155116757|NCT02323126|559859073|FG000|Overall Study|Physician Decision|0|||
155116758|NCT02323126|559859074|FG001|Overall Study|Physician Decision|1|||
155116759|NCT02323126|559859075|FG002|Overall Study|Physician Decision|3|||
154906937|NCT00118040|559080622|FG002|Overall Study|Medical Contraindication|1|||
154906938|NCT00118040|559080620|FG000|Overall Study|Non-Compliant Participant|1|||
154906939|NCT00118040|559080621|FG001|Overall Study|Non-Compliant Participant|1|||
154906940|NCT00118040|559080622|FG002|Overall Study|Non-Compliant Participant|2|||
154906941|NCT00118040|559080620|FG000|Overall Study|Other|0|||
154906942|NCT00118040|559080621|FG001|Overall Study|Other|0|||
154906943|NCT00118040|559080622|FG002|Overall Study|Other|1|||
154906944|NCT03733249|559080623|FG000|Overall Study|Death|7|||
155116760|NCT02323126|559859073|FG000|Overall Study|Death|1|||
154906945|NCT03733249|559080623|FG000|Overall Study|Disease relapse|16|||
154906946|NCT03733249|559080623|FG000|Overall Study|Lost to Follow-up|4|||
155116761|NCT02323126|559859074|FG001|Overall Study|Death|1|||
154906947|NCT03733249|559080623|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
154906948|NCT03733249|559080623|FG000|Overall Study|Withdrawal by Subject|1|||
154906949|NCT00772889|559080625|FG000|Overall Study|Adverse Event|7|||
155116762|NCT02323126|559859075|FG002|Overall Study|Death|4|||
155116763|NCT02323126|559859073|FG000|Overall Study|Adverse Event|3|||
155116764|NCT02323126|559859074|FG001|Overall Study|Adverse Event|5|||
155116765|NCT02323126|559859075|FG002|Overall Study|Adverse Event|7|||
155116766|NCT00396136|559859076|FG000|Overall Study|Death|43|||
155116767|NCT00396136|559859076|FG000|Overall Study|Withdrawal by Subject|59|||
155116768|NCT00396136|559859076|FG000|Overall Study|Lost to Follow-up|15|||
155116769|NCT00396136|559859076|FG000|Overall Study|Study device explanted|8|||
155116770|NCT01779856|559859077|FG000|Overall Study|Withdrawal by Subject|15|||
155116771|NCT01779856|559859077|FG000|Overall Study|Death|3|||
155116772|NCT01779856|559859077|FG000|Overall Study|Physician Decision|1|||
155116773|NCT01779856|559859077|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
155116774|NCT01779856|559859077|FG000|Overall Study|Delays in scheduling implant|1|||
155116775|NCT01779856|559859077|FG000|Overall Study|Subject ineligible for Implant|2|||
155116776|NCT03960580|559859078|FG000|Overall Study|Adverse Event|2|||
155116777|NCT03960580|559859079|FG001|Overall Study|Adverse Event|1|||
155116778|NCT03960580|559859080|FG002|Overall Study|Adverse Event|1|||
155116779|NCT03960580|559859078|FG000|Overall Study|Lost to Follow-up|1|||
155116780|NCT03960580|559859079|FG001|Overall Study|Lost to Follow-up|0|||
155116781|NCT03960580|559859080|FG002|Overall Study|Lost to Follow-up|0|||
155116782|NCT03960580|559859078|FG000|Overall Study|Lack of Efficacy|2|||
155116783|NCT03960580|559859079|FG001|Overall Study|Lack of Efficacy|1|||
155116784|NCT03960580|559859080|FG002|Overall Study|Lack of Efficacy|0|||
155116785|NCT03960580|559859078|FG000|Overall Study|Protocol Violation|0|||
155116786|NCT03960580|559859079|FG001|Overall Study|Protocol Violation|0|||
155116787|NCT03960580|559859080|FG002|Overall Study|Protocol Violation|1|||
155116788|NCT03960580|559859078|FG000|Overall Study|Withdrawal by Subject|1|||
155116789|NCT03960580|559859079|FG001|Overall Study|Withdrawal by Subject|1|||
155116790|NCT03960580|559859080|FG002|Overall Study|Withdrawal by Subject|1|||
155116791|NCT03960580|559859078|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
155116792|NCT03960580|559859079|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
155116793|NCT03960580|559859080|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
155116794|NCT01774097|559859085|FG000|Overall Study|Withdrawal by Subject|1|||
155116795|NCT01774097|559859086|FG001|Overall Study|Withdrawal by Subject|1|||
155116796|NCT01774097|559859085|FG000|Overall Study|Adverse Event|1|||
155116797|NCT01774097|559859086|FG001|Overall Study|Adverse Event|1|||
155116798|NCT03447314|559859087|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
155116799|NCT03447314|559859088|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
155116800|NCT03447314|559859089|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
155116801|NCT03447314|559859090|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
155116802|NCT03447314|559859091|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
155116803|NCT03447314|559859092|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
155116804|NCT03447314|559859093|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
155116805|NCT03447314|559859094|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116806|NCT03447314|559859095|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116807|NCT03447314|559859096|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116808|NCT03447314|559859097|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
155116809|NCT03447314|559859098|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
155116810|NCT03447314|559859099|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116811|NCT03447314|559859100|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116812|NCT03447314|559859101|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116813|NCT03447314|559859102|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116814|NCT03447314|559859103|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116815|NCT03447314|559859104|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
155116816|NCT03447314|559859087|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155116817|NCT03447314|559859088|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
154906950|NCT00772889|559080626|FG001|Overall Study|Adverse Event|4|||
154906951|NCT00772889|559080627|FG002|Overall Study|Adverse Event|0|||
154906952|NCT00772889|559080625|FG000|Overall Study|Withdrawal by Subject|9|||
154906953|NCT00772889|559080626|FG001|Overall Study|Withdrawal by Subject|8|||
154906954|NCT00772889|559080627|FG002|Overall Study|Withdrawal by Subject|9|||
154906955|NCT00772889|559080625|FG000|Overall Study|Lost to Follow-up|6|||
154906956|NCT00772889|559080626|FG001|Overall Study|Lost to Follow-up|6|||
154906957|NCT00772889|559080627|FG002|Overall Study|Lost to Follow-up|7|||
154906958|NCT03323086|559080628|FG000|Overall Study|Lost to Follow-up|3|||
154906959|NCT03323086|559080629|FG001|Overall Study|Lost to Follow-up|2|||
155116818|NCT03447314|559859089|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155116819|NCT03447314|559859090|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
154906960|NCT00355615|559080630|FG000|Randomized Double Blind Period|Adverse Event|1|||
154906961|NCT00355615|559080631|FG001|Randomized Double Blind Period|Adverse Event|0|||
154906962|NCT00355615|559080632|FG002|Randomized Double Blind Period|Adverse Event|0|||
154906963|NCT00355615|559080633|FG003|Randomized Double Blind Period|Adverse Event|0|||
155116820|NCT03447314|559859091|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116821|NCT03447314|559859092|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
155116822|NCT03447314|559859093|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
154906964|NCT00355615|559080634|FG004|Randomized Double Blind Period|Adverse Event|0|||
154906965|NCT00355615|559080630|FG000|Randomized Double Blind Period|Protocol Violation|0|||
154906966|NCT00355615|559080631|FG001|Randomized Double Blind Period|Protocol Violation|0|||
155116823|NCT03447314|559859094|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116824|NCT03447314|559859095|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116825|NCT03447314|559859096|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
154906967|NCT00355615|559080632|FG002|Randomized Double Blind Period|Protocol Violation|1|||
154906968|NCT00355615|559080633|FG003|Randomized Double Blind Period|Protocol Violation|1|||
154906969|NCT00355615|559080634|FG004|Randomized Double Blind Period|Protocol Violation|0|||
154906970|NCT00355615|559080630|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
154906971|NCT00355615|559080631|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
154906972|NCT00355615|559080632|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
154906973|NCT00355615|559080633|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
154906974|NCT00355615|559080634|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
154906975|NCT00355615|559080630|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
154906976|NCT00355615|559080631|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
154906977|NCT00355615|559080632|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
154906978|NCT00355615|559080633|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
154906979|NCT00355615|559080634|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
154906980|NCT00355615|559080630|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
154906981|NCT00355615|559080631|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
154906982|NCT00355615|559080632|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
154906983|NCT00355615|559080633|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
154906984|NCT00355615|559080634|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
154906985|NCT00355615|559080630|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
154906986|NCT00355615|559080631|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
154906987|NCT00355615|559080632|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
154906988|NCT00355615|559080633|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
154906989|NCT00355615|559080634|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
154906990|NCT04259346|559080635|FG000|Overall Study|Lost to Follow-up|1|||
154906991|NCT04259346|559080636|FG001|Overall Study|Lost to Follow-up|3|||
154906992|NCT04259346|559080635|FG000|Overall Study|Protocol Violation|1|||
154906993|NCT04259346|559080636|FG001|Overall Study|Protocol Violation|0|||
154906994|NCT04259346|559080635|FG000|Overall Study|Withdrawal by Subject|1|||
154906995|NCT04259346|559080636|FG001|Overall Study|Withdrawal by Subject|0|||
154906996|NCT04259346|559080635|FG000|Overall Study|Adverse Event|1|||
154906997|NCT04259346|559080636|FG001|Overall Study|Adverse Event|1|||
154906998|NCT00085644|559080639|FG000|Double-Blind Period|Adverse Event|5|||
154906999|NCT00085644|559080640|FG001|Double-Blind Period|Adverse Event|2|||
154907000|NCT00085644|559080641|FG002|Double-Blind Period|Adverse Event|0|||
154907001|NCT00085644|559080639|FG000|Double-Blind Period|Withdrawal by Subject|3|||
154907002|NCT00085644|559080640|FG001|Double-Blind Period|Withdrawal by Subject|0|||
154907003|NCT00085644|559080641|FG002|Double-Blind Period|Withdrawal by Subject|0|||
154907004|NCT00085644|559080639|FG000|Double-Blind Period|Lost to Follow-up|2|||
154907005|NCT00085644|559080640|FG001|Double-Blind Period|Lost to Follow-up|1|||
154907006|NCT00085644|559080641|FG002|Double-Blind Period|Lost to Follow-up|0|||
154907007|NCT00085644|559080639|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
154907008|NCT00085644|559080640|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
154907009|NCT00085644|559080641|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
154907010|NCT00085644|559080639|FG000|Double-Blind Period|Contemplating pregnancy|1|||
154907011|NCT00085644|559080640|FG001|Double-Blind Period|Contemplating pregnancy|0|||
154907012|NCT00085644|559080641|FG002|Double-Blind Period|Contemplating pregnancy|0|||
154907013|NCT00085644|559080639|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
154907014|NCT00085644|559080640|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
154907015|NCT00085644|559080641|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
154907016|NCT00085644|559080639|FG000|Open-Label Period|Adverse Event|0|||
154907017|NCT00085644|559080640|FG001|Open-Label Period|Adverse Event|0|||
154907018|NCT00085644|559080641|FG002|Open-Label Period|Adverse Event|38|||
154907019|NCT00085644|559080639|FG000|Open-Label Period|Withdrawal by Subject|0|||
154907020|NCT00085644|559080640|FG001|Open-Label Period|Withdrawal by Subject|0|||
154907021|NCT00085644|559080641|FG002|Open-Label Period|Withdrawal by Subject|29|||
154907022|NCT00085644|559080639|FG000|Open-Label Period|Lost to Follow-up|0|||
154907023|NCT00085644|559080640|FG001|Open-Label Period|Lost to Follow-up|0|||
154907024|NCT00085644|559080641|FG002|Open-Label Period|Lost to Follow-up|13|||
154907025|NCT00085644|559080639|FG000|Open-Label Period|Lack of Efficacy|0|||
154907026|NCT00085644|559080640|FG001|Open-Label Period|Lack of Efficacy|0|||
155116826|NCT03447314|559859097|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116827|NCT03447314|559859098|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
154907027|NCT00085644|559080641|FG002|Open-Label Period|Lack of Efficacy|15|||
154907028|NCT00085644|559080639|FG000|Open-Label Period|Pregnancy|0|||
154907029|NCT00085644|559080640|FG001|Open-Label Period|Pregnancy|0|||
155116828|NCT03447314|559859099|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
154907030|NCT00085644|559080641|FG002|Open-Label Period|Pregnancy|3|||
154907031|NCT00085644|559080639|FG000|Open-Label Period|Contemplating pregnancy|0|||
154907032|NCT00085644|559080640|FG001|Open-Label Period|Contemplating pregnancy|0|||
154907033|NCT00085644|559080641|FG002|Open-Label Period|Contemplating pregnancy|3|||
154907034|NCT00085644|559080639|FG000|Open-Label Period|Protocol Violation|0|||
155116829|NCT03447314|559859100|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116830|NCT03447314|559859101|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116831|NCT03447314|559859102|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116832|NCT03447314|559859103|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116833|NCT03447314|559859104|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
155116834|NCT03447314|559859087|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116835|NCT03447314|559859088|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116836|NCT03447314|559859089|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
155116837|NCT03447314|559859090|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116838|NCT03447314|559859091|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116839|NCT03447314|559859092|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116840|NCT03447314|559859093|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116841|NCT03447314|559859094|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116842|NCT03447314|559859095|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116843|NCT03447314|559859096|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116844|NCT03447314|559859097|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116845|NCT03447314|559859098|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116846|NCT03447314|559859099|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116847|NCT03447314|559859100|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116848|NCT03447314|559859101|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116849|NCT03447314|559859102|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116850|NCT03447314|559859103|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116851|NCT03447314|559859104|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
155116852|NCT03447314|559859087|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116853|NCT03447314|559859088|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116854|NCT03447314|559859089|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
155116855|NCT03447314|559859090|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116856|NCT03447314|559859091|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116857|NCT03447314|559859092|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116858|NCT03447314|559859093|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116859|NCT03447314|559859094|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116860|NCT03447314|559859095|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116861|NCT03447314|559859096|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116862|NCT03447314|559859097|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116863|NCT03447314|559859098|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116864|NCT03447314|559859099|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116865|NCT03447314|559859100|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116866|NCT03447314|559859101|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116867|NCT03447314|559859102|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116868|NCT03447314|559859103|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116869|NCT03447314|559859104|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
155116870|NCT03447314|559859087|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116871|NCT03447314|559859088|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116872|NCT03447314|559859089|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116873|NCT03447314|559859090|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116874|NCT03447314|559859091|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116875|NCT03447314|559859092|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116876|NCT03447314|559859093|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116877|NCT03447314|559859094|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116878|NCT03447314|559859095|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116879|NCT03447314|559859096|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116880|NCT03447314|559859097|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
155116881|NCT03447314|559859098|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116882|NCT03447314|559859099|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116883|NCT03447314|559859100|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116884|NCT03447314|559859101|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116885|NCT03447314|559859102|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155150942|NCT00770653|559988131|FG000|Overall Study|Withdrawal by Subject|4|||
154907035|NCT00085644|559080640|FG001|Open-Label Period|Protocol Violation|0|||
155116886|NCT03447314|559859103|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
154907036|NCT00085644|559080641|FG002|Open-Label Period|Protocol Violation|4|||
154907037|NCT00085644|559080639|FG000|Open-Label Period|Personal reason|0|||
154907038|NCT00085644|559080640|FG001|Open-Label Period|Personal reason|0|||
155116887|NCT03447314|559859104|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
155116888|NCT03447314|559859087|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116889|NCT03447314|559859088|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116890|NCT03447314|559859089|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116891|NCT03447314|559859090|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
155116892|NCT03447314|559859091|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116893|NCT03447314|559859092|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
155116894|NCT03447314|559859093|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116895|NCT03447314|559859094|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116896|NCT03447314|559859095|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116897|NCT03447314|559859096|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116898|NCT03447314|559859097|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116899|NCT03447314|559859098|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116900|NCT03447314|559859099|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116901|NCT03447314|559859100|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116902|NCT03447314|559859101|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116903|NCT03447314|559859102|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116904|NCT03447314|559859103|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116905|NCT03447314|559859104|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
155116906|NCT01920568|559859105|FG000|Overall Study|Adverse Event|27|||
155116907|NCT01920568|559859106|FG001|Overall Study|Adverse Event|8|||
155116908|NCT01920568|559859105|FG000|Overall Study|Protocol Violation|5|||
155116909|NCT01920568|559859106|FG001|Overall Study|Protocol Violation|3|||
155116910|NCT01920568|559859105|FG000|Overall Study|Lost to Follow-up|2|||
155116911|NCT01920568|559859106|FG001|Overall Study|Lost to Follow-up|2|||
155116912|NCT01920568|559859105|FG000|Overall Study|Physician Decision|13|||
155116913|NCT01920568|559859106|FG001|Overall Study|Physician Decision|4|||
155116914|NCT01920568|559859105|FG000|Overall Study|Withdrawal by Subject|79|||
155116915|NCT01920568|559859106|FG001|Overall Study|Withdrawal by Subject|55|||
155116916|NCT01920568|559859105|FG000|Overall Study|Death due to disease progression|25|||
155116917|NCT01920568|559859106|FG001|Overall Study|Death due to disease progression|12|||
155116918|NCT01703208|559859108|FG000|Overall Study|Death|61|||
155116919|NCT01703208|559859109|FG001|Overall Study|Death|48|||
155116920|NCT01703208|559859108|FG000|Overall Study|Lack of Efficacy|1|||
155116921|NCT01703208|559859109|FG001|Overall Study|Lack of Efficacy|2|||
155116922|NCT01703208|559859108|FG000|Overall Study|Lost to Follow-up|68|||
155116923|NCT01703208|559859109|FG001|Overall Study|Lost to Follow-up|62|||
155116924|NCT01703208|559859108|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155116925|NCT01703208|559859109|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155116926|NCT01703208|559859108|FG000|Overall Study|Excluded Medication|1|||
155116927|NCT01703208|559859109|FG001|Overall Study|Excluded Medication|2|||
155116928|NCT01703208|559859108|FG000|Overall Study|Site Discontinued Study Participation|23|||
155116929|NCT01703208|559859109|FG001|Overall Study|Site Discontinued Study Participation|27|||
155116930|NCT01703208|559859108|FG000|Overall Study|Physician Decision|11|||
155116931|NCT01703208|559859109|FG001|Overall Study|Physician Decision|13|||
155116932|NCT01703208|559859108|FG000|Overall Study|Progressive disease|2|||
155116933|NCT01703208|559859109|FG001|Overall Study|Progressive disease|2|||
155116934|NCT01703208|559859108|FG000|Overall Study|Protocol Violation|1|||
155116935|NCT01703208|559859109|FG001|Overall Study|Protocol Violation|1|||
155116936|NCT01703208|559859108|FG000|Overall Study|Study Terminated by Sponsor|1710|||
155116937|NCT01703208|559859109|FG001|Overall Study|Study Terminated by Sponsor|1716|||
155116938|NCT01703208|559859108|FG000|Overall Study|Withdrawal by Subject|205|||
155116939|NCT01703208|559859109|FG001|Overall Study|Withdrawal by Subject|209|||
155116940|NCT01703208|559859108|FG000|Overall Study|Adverse Event|14|||
155116941|NCT01703208|559859109|FG001|Overall Study|Adverse Event|19|||
155116942|NCT01703208|559859108|FG000|Overall Study|Technical Problems|0|||
155116943|NCT01703208|559859109|FG001|Overall Study|Technical Problems|1|||
155116944|NCT01703208|559859108|FG000|Overall Study|Protocol Deviation|2|||
155116945|NCT01703208|559859109|FG001|Overall Study|Protocol Deviation|0|||
155116946|NCT00252694|559859110|FG000|Overall Study|Withdrawal by Subject|83|||
155116947|NCT00252694|559859111|FG001|Overall Study|Withdrawal by Subject|91|||
155116948|NCT00252694|559859110|FG000|Overall Study|Death|36|||
155116949|NCT00252694|559859111|FG001|Overall Study|Death|34|||
155116950|NCT00252694|559859110|FG000|Overall Study|Mostly Lost to Follow Up|8|||
155116951|NCT00252694|559859111|FG001|Overall Study|Mostly Lost to Follow Up|13|||
155116952|NCT00252694|559859110|FG000|Overall Study|Patient Moving|17|||
155116953|NCT00252694|559859111|FG001|Overall Study|Patient Moving|16|||
154907039|NCT00085644|559080641|FG002|Open-Label Period|Personal reason|4|||
155116954|NCT01271712|559859117|FG000|Double Blind Treatment|Death|2|||
155116955|NCT01271712|559859118|FG001|Double Blind Treatment|Death|0|||
155116956|NCT01271712|559859117|FG000|Double Blind Treatment|Lack of Efficacy|1|||
155116957|NCT01271712|559859118|FG001|Double Blind Treatment|Lack of Efficacy|0|||
155116958|NCT01271712|559859117|FG000|Double Blind Treatment|Adverse Event|9|||
155116959|NCT01271712|559859118|FG001|Double Blind Treatment|Adverse Event|4|||
155116960|NCT01271712|559859117|FG000|Double Blind Treatment|Progressive disease|23|||
155116961|NCT01271712|559859118|FG001|Double Blind Treatment|Progressive disease|3|||
155116962|NCT01271712|559859117|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
155116963|NCT01271712|559859118|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
155116964|NCT01271712|559859117|FG000|Double Blind Treatment|Non compliance with study drug|2|||
155116965|NCT01271712|559859118|FG001|Double Blind Treatment|Non compliance with study drug|0|||
155116966|NCT01271712|559859117|FG000|Double Blind Treatment|receive no study drug|1|||
155116967|NCT01271712|559859118|FG001|Double Blind Treatment|receive no study drug|0|||
155116968|NCT01271712|559859117|FG000|Open Label Treatment|Death|6|||
155116969|NCT01271712|559859118|FG001|Open Label Treatment|Death|5|||
155116970|NCT01271712|559859117|FG000|Open Label Treatment|Withdrawal by Subject|6|||
155116971|NCT01271712|559859118|FG001|Open Label Treatment|Withdrawal by Subject|11|||
155116972|NCT01271712|559859117|FG000|Open Label Treatment|Physician Decision|2|||
154907040|NCT03330106|559080642|FG000|Part A|Withdrawal by Subject|1|||
154907041|NCT03330106|559080643|FG001|Part A|Withdrawal by Subject|1|||
154907042|NCT03330106|559080644|FG002|Part A|Withdrawal by Subject|0|||
155116973|NCT01271712|559859118|FG001|Open Label Treatment|Physician Decision|0|||
154907043|NCT03330106|559080645|FG003|Part A|Withdrawal by Subject|0|||
154907044|NCT03330106|559080642|FG000|Part A|Death|2|||
154907045|NCT03330106|559080643|FG001|Part A|Death|1|||
154907046|NCT03330106|559080644|FG002|Part A|Death|0|||
154907047|NCT03330106|559080645|FG003|Part A|Death|0|||
154907048|NCT03330106|559080642|FG000|Part A|Adverse Event|0|||
154907049|NCT03330106|559080643|FG001|Part A|Adverse Event|1|||
154907050|NCT03330106|559080644|FG002|Part A|Adverse Event|0|||
154907051|NCT03330106|559080645|FG003|Part A|Adverse Event|0|||
154907052|NCT03330106|559080642|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
154907053|NCT03330106|559080643|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
154907054|NCT03330106|559080644|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
154907055|NCT03330106|559080645|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
154907056|NCT03330106|559080642|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
154907057|NCT03330106|559080643|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
154907058|NCT03330106|559080644|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
154907059|NCT03330106|559080645|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
154907060|NCT03330106|559080642|FG000|Part A|Progressive Disease|0|||
154907061|NCT03330106|559080643|FG001|Part A|Progressive Disease|1|||
154907062|NCT03330106|559080644|FG002|Part A|Progressive Disease|0|||
154907063|NCT03330106|559080645|FG003|Part A|Progressive Disease|0|||
154907064|NCT03330106|559080642|FG000|Part B|Lost to Follow-up|0|||
154907065|NCT03330106|559080643|FG001|Part B|Lost to Follow-up|0|||
154907066|NCT03330106|559080644|FG002|Part B|Lost to Follow-up|0|||
154907067|NCT03330106|559080645|FG003|Part B|Lost to Follow-up|1|||
154907068|NCT03330106|559080642|FG000|Part B|Withdrawal by Subject|0|||
154907069|NCT03330106|559080643|FG001|Part B|Withdrawal by Subject|0|||
154907070|NCT03330106|559080644|FG002|Part B|Withdrawal by Subject|4|||
154907071|NCT03330106|559080645|FG003|Part B|Withdrawal by Subject|0|||
154907072|NCT03330106|559080642|FG000|Part B|Death|0|||
154907073|NCT03330106|559080643|FG001|Part B|Death|0|||
154907074|NCT03330106|559080644|FG002|Part B|Death|2|||
154907075|NCT03330106|559080645|FG003|Part B|Death|0|||
154907076|NCT03330106|559080642|FG000|Part B|Clinical Progression|0|||
154907077|NCT03330106|559080643|FG001|Part B|Clinical Progression|0|||
154907078|NCT03330106|559080644|FG002|Part B|Clinical Progression|1|||
154907079|NCT03330106|559080645|FG003|Part B|Clinical Progression|1|||
154907080|NCT03330106|559080642|FG000|Part B|Symptomatic Deterioration|0|||
154907081|NCT03330106|559080643|FG001|Part B|Symptomatic Deterioration|0|||
154907082|NCT03330106|559080644|FG002|Part B|Symptomatic Deterioration|0|||
155116974|NCT01271712|559859117|FG000|Open Label Treatment|Adverse Event|14|||
155116975|NCT01271712|559859118|FG001|Open Label Treatment|Adverse Event|8|||
155116976|NCT01271712|559859117|FG000|Open Label Treatment|Progressive disease|59|||
155116977|NCT01271712|559859118|FG001|Open Label Treatment|Progressive disease|32|||
154907083|NCT03330106|559080645|FG003|Part B|Symptomatic Deterioration|1|||
154907084|NCT03330106|559080642|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
154907085|NCT03330106|559080643|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
154907086|NCT03330106|559080644|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
154907087|NCT03330106|559080645|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
154907088|NCT03330106|559080642|FG000|Part B|Progressive Disease|0|||
154907089|NCT03330106|559080643|FG001|Part B|Progressive Disease|0|||
154907090|NCT03330106|559080644|FG002|Part B|Progressive Disease|11|||
155116978|NCT01271712|559859117|FG000|Open Label Treatment|transferred to rollover study|1|||
154907091|NCT03330106|559080645|FG003|Part B|Progressive Disease|4|||
154907092|NCT00486889|559080647|FG000|Overall Study|Death|3|||
154907093|NCT00486889|559080647|FG000|Overall Study|Non-compliant|2|||
154907094|NCT00486889|559080647|FG000|Overall Study|Withdrawal by Subject|6|||
154907095|NCT01738594|559080649|FG000|Registration and Treatment Start|Adverse Event|0|||
154907096|NCT01738594|559080650|FG001|Registration and Treatment Start|Adverse Event|1|||
154907097|NCT01738594|559080651|FG002|Registration and Treatment Start|Adverse Event|0|||
154907098|NCT01738594|559080652|FG003|Registration and Treatment Start|Adverse Event|0|||
154907099|NCT01738594|559080653|FG004|Registration and Treatment Start|Adverse Event|0|||
154907100|NCT01738594|559080654|FG005|Registration and Treatment Start|Adverse Event|0|||
154907101|NCT01738594|559080655|FG006|Registration and Treatment Start|Adverse Event|0|||
154907102|NCT01738594|559080656|FG007|Registration and Treatment Start|Adverse Event|0|||
154907103|NCT01738594|559080649|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907104|NCT01738594|559080650|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907105|NCT01738594|559080651|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907106|NCT01738594|559080652|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907107|NCT01738594|559080653|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907108|NCT01738594|559080654|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
154907109|NCT01738594|559080655|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907110|NCT01738594|559080656|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
154907111|NCT01738594|559080649|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907112|NCT01738594|559080650|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
154907113|NCT01738594|559080651|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907114|NCT01738594|559080652|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907115|NCT01738594|559080653|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907116|NCT01738594|559080654|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907117|NCT01738594|559080655|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907118|NCT01738594|559080656|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
154907119|NCT01738594|559080649|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907120|NCT01738594|559080650|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907121|NCT01738594|559080651|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907122|NCT01738594|559080652|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907123|NCT01738594|559080653|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907124|NCT01738594|559080654|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
154907125|NCT01738594|559080655|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907126|NCT01738594|559080656|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
154907127|NCT01738594|559080649|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907128|NCT01738594|559080650|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907129|NCT01738594|559080651|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907130|NCT01738594|559080652|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907131|NCT01738594|559080653|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907132|NCT01738594|559080654|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
154907133|NCT01738594|559080655|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907134|NCT01738594|559080656|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
154907135|NCT01738594|559080649|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907136|NCT01738594|559080650|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907137|NCT01738594|559080651|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907138|NCT01738594|559080652|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907139|NCT01738594|559080653|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
154907140|NCT01738594|559080654|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907141|NCT01738594|559080655|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907142|NCT01738594|559080656|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
154907143|NCT01738594|559080649|FG000|Follow up for 1 Year|Death|0|||
154907144|NCT01738594|559080650|FG001|Follow up for 1 Year|Death|0|||
154907145|NCT01738594|559080651|FG002|Follow up for 1 Year|Death|0|||
154907146|NCT01738594|559080652|FG003|Follow up for 1 Year|Death|0|||
154907147|NCT01738594|559080653|FG004|Follow up for 1 Year|Death|0|||
154907148|NCT01738594|559080654|FG005|Follow up for 1 Year|Death|1|||
154907149|NCT01738594|559080655|FG006|Follow up for 1 Year|Death|0|||
154907150|NCT01738594|559080656|FG007|Follow up for 1 Year|Death|0|||
154907151|NCT01738594|559080649|FG000|Follow up for 1 Year|Other|0|||
154907152|NCT01738594|559080650|FG001|Follow up for 1 Year|Other|0|||
154907153|NCT01738594|559080651|FG002|Follow up for 1 Year|Other|0|||
154907154|NCT01738594|559080652|FG003|Follow up for 1 Year|Other|0|||
154907155|NCT01738594|559080653|FG004|Follow up for 1 Year|Other|0|||
154907156|NCT01738594|559080654|FG005|Follow up for 1 Year|Other|2|||
154907157|NCT01738594|559080655|FG006|Follow up for 1 Year|Other|0|||
154907158|NCT01738594|559080656|FG007|Follow up for 1 Year|Other|0|||
154907159|NCT00376675|559080659|FG000|Overall Study|Withdrawal by Subject|9|||
154907160|NCT00376675|559080660|FG001|Overall Study|Withdrawal by Subject|2|||
154907161|NCT00376675|559080659|FG000|Overall Study|Adverse Event|10|||
154907162|NCT00376675|559080660|FG001|Overall Study|Adverse Event|5|||
154907163|NCT00376675|559080659|FG000|Overall Study|Other Reason|1|||
154907164|NCT00376675|559080660|FG001|Overall Study|Other Reason|7|||
154907165|NCT00942422|559080663|FG000|Overall Study|Withdrawal by Subject|1|||
154907166|NCT00942422|559080663|FG000|Overall Study|Death|1|||
154907167|NCT00942422|559080663|FG000|Overall Study|Progressive diease|1|||
154907168|NCT01332851|559080664|FG000|Overall Study|Withdrawal by Subject|4|||
154907169|NCT01332851|559080665|FG001|Overall Study|Withdrawal by Subject|2|||
154907170|NCT01332851|559080664|FG000|Overall Study|Lost to Follow-up|7|||
154907171|NCT01332851|559080665|FG001|Overall Study|Lost to Follow-up|11|||
154907172|NCT01947894|559080666|FG000|Overall Study|Other|3|||
154907173|NCT01947894|559080667|FG001|Overall Study|Other|4|||
154907174|NCT01947894|559080668|FG002|Overall Study|Other|3|||
154907175|NCT01947894|559080666|FG000|Overall Study|Withdrawal by Subject|12|||
154907176|NCT01947894|559080667|FG001|Overall Study|Withdrawal by Subject|4|||
154907177|NCT01947894|559080668|FG002|Overall Study|Withdrawal by Subject|1|||
154907178|NCT01947894|559080666|FG000|Overall Study|Death|12|||
154907179|NCT01947894|559080667|FG001|Overall Study|Death|1|||
154907180|NCT01947894|559080668|FG002|Overall Study|Death|0|||
154907181|NCT01947894|559080666|FG000|Overall Study|Physician Decision|2|||
154907182|NCT01947894|559080667|FG001|Overall Study|Physician Decision|0|||
154907183|NCT01947894|559080668|FG002|Overall Study|Physician Decision|0|||
154907184|NCT01947894|559080666|FG000|Overall Study|Adverse Event|5|||
154907185|NCT01947894|559080667|FG001|Overall Study|Adverse Event|1|||
154907186|NCT01947894|559080668|FG002|Overall Study|Adverse Event|0|||
154907187|NCT01947894|559080666|FG000|Overall Study|Switched to other growth hormone brand|53|||
154907188|NCT01947894|559080667|FG001|Overall Study|Switched to other growth hormone brand|8|||
154907189|NCT01947894|559080668|FG002|Overall Study|Switched to other growth hormone brand|23|||
154907190|NCT03796195|559080669|FG000|Overall Study|Study closed early|1|||
154907191|NCT04445051|559080670|FG000|Overall Study|Adverse Event|0|||
154907192|NCT04445051|559080671|FG001|Overall Study|Adverse Event|0|||
155116979|NCT01271712|559859118|FG001|Open Label Treatment|transferred to rollover study|0|||
155116980|NCT01271712|559859117|FG000|Open Label Treatment|Non-compliance with study drug|1|||
155116981|NCT01271712|559859118|FG001|Open Label Treatment|Non-compliance with study drug|0|||
155116982|NCT01271712|559859117|FG000|Open Label Treatment|Protocol Violation|0|||
155116983|NCT01271712|559859118|FG001|Open Label Treatment|Protocol Violation|1|||
155116984|NCT01271712|559859117|FG000|Open Label Treatment|Switching to other therapy|2|||
155116985|NCT01271712|559859118|FG001|Open Label Treatment|Switching to other therapy|1|||
155116986|NCT01271712|559859117|FG000|Safety Follow-up|Death|11|||
155116987|NCT01271712|559859118|FG001|Safety Follow-up|Death|7|||
154907193|NCT04445051|559080672|FG002|Overall Study|Adverse Event|1|||
154907194|NCT04445051|559080673|FG003|Overall Study|Adverse Event|0|||
154907195|NCT04445051|559080674|FG004|Overall Study|Adverse Event|0|||
154907196|NCT04445051|559080675|FG005|Overall Study|Adverse Event|0|||
154907197|NCT02201472|559080676|FG000|Overall Study|Lack of Efficacy|2|||
154907198|NCT01300767|559080677|FG000|Overall Study|Discomfort|2|||
154907199|NCT01300767|559080677|FG000|Overall Study|Biomicroscopy|1|||
154907200|NCT01300767|559080677|FG000|Overall Study|Unacceptable fit|1|||
154907201|NCT01188811|559080682|FG000|Overall Study|Withdrawal by Subject|0|||
154907202|NCT01188811|559080683|FG001|Overall Study|Withdrawal by Subject|2|||
154907203|NCT01188811|559080682|FG000|Overall Study|Adverse Event|6|||
154907204|NCT01188811|559080683|FG001|Overall Study|Adverse Event|0|||
154907205|NCT01602744|559080684|FG000|Overall Study|Death|17|||
154907206|NCT01602744|559080685|FG001|Overall Study|Death|15|||
154907207|NCT01602744|559080684|FG000|Overall Study|Lost to Follow-up|13|||
154907208|NCT01602744|559080685|FG001|Overall Study|Lost to Follow-up|8|||
154907209|NCT01316380|559080688|FG000|Overall Study|Adverse Event|0|||
154907210|NCT01316380|559080689|FG001|Overall Study|Adverse Event|2|||
154907211|NCT01316380|559080690|FG002|Overall Study|Adverse Event|1|||
154907212|NCT01316380|559080688|FG000|Overall Study|Protocol Violation|0|||
154907213|NCT01316380|559080689|FG001|Overall Study|Protocol Violation|0|||
154907214|NCT01316380|559080690|FG002|Overall Study|Protocol Violation|1|||
154907215|NCT01316380|559080688|FG000|Overall Study|Withdrawal by Subject|1|||
154907216|NCT01316380|559080689|FG001|Overall Study|Withdrawal by Subject|2|||
154907217|NCT01316380|559080690|FG002|Overall Study|Withdrawal by Subject|0|||
155116988|NCT01271712|559859117|FG000|Safety Follow-up|Withdrawal by Subject|4|||
155116989|NCT01271712|559859118|FG001|Safety Follow-up|Withdrawal by Subject|2|||
155116990|NCT01271712|559859117|FG000|Safety Follow-up|Protocol Violation|1|||
154907218|NCT01316380|559080688|FG000|Overall Study|Other|0|||
154907219|NCT01316380|559080689|FG001|Overall Study|Other|1|||
154907220|NCT01316380|559080690|FG002|Overall Study|Other|1|||
154907221|NCT01316380|559080688|FG000|Overall Study|Not treated|1|||
154907222|NCT01316380|559080689|FG001|Overall Study|Not treated|0|||
154907223|NCT01316380|559080690|FG002|Overall Study|Not treated|0|||
154907224|NCT00609167|559080694|FG000|Overall Study|Withdrawal by Subject|1|||
154907225|NCT00609167|559080695|FG001|Overall Study|Withdrawal by Subject|0|||
154907226|NCT00609167|559080694|FG000|Overall Study|Lack of Efficacy|1|||
154907227|NCT00609167|559080695|FG001|Overall Study|Lack of Efficacy|0|||
154907228|NCT00609167|559080694|FG000|Overall Study|Adverse Event|5|||
154907229|NCT00609167|559080695|FG001|Overall Study|Adverse Event|1|||
154907230|NCT00609167|559080694|FG000|Overall Study|Disease Progression|1|||
154907231|NCT00609167|559080695|FG001|Overall Study|Disease Progression|0|||
154907232|NCT00609167|559080694|FG000|Overall Study|Stem Cell Transplant|0|||
154907233|NCT00609167|559080695|FG001|Overall Study|Stem Cell Transplant|6|||
154907234|NCT00712270|559080696|FG000|Overall Study|Withdrawal by Subject|11|||
154907235|NCT00712270|559080696|FG000|Overall Study|Screen Failure|3|||
154907236|NCT02574520|559080697|FG000|Overall Study|Not dosed|2|||
154907237|NCT02574520|559080698|FG001|Overall Study|Not dosed|0|||
154907238|NCT02574520|559080699|FG002|Overall Study|Not dosed|5|||
154907239|NCT02574520|559080700|FG003|Overall Study|Not dosed|4|||
154907240|NCT02574520|559080697|FG000|Overall Study|Adverse Event|0|||
154907241|NCT02574520|559080698|FG001|Overall Study|Adverse Event|0|||
154907242|NCT02574520|559080699|FG002|Overall Study|Adverse Event|0|||
154907243|NCT02574520|559080700|FG003|Overall Study|Adverse Event|1|||
154907244|NCT02574520|559080697|FG000|Overall Study|Withdrawal by Subject|0|||
154907245|NCT02574520|559080698|FG001|Overall Study|Withdrawal by Subject|0|||
154907246|NCT02574520|559080699|FG002|Overall Study|Withdrawal by Subject|0|||
154907247|NCT02574520|559080700|FG003|Overall Study|Withdrawal by Subject|1|||
154907248|NCT02574520|559080697|FG000|Overall Study|Other|0|||
154907249|NCT02574520|559080698|FG001|Overall Study|Other|0|||
154907250|NCT02574520|559080699|FG002|Overall Study|Other|0|||
154907251|NCT02574520|559080700|FG003|Overall Study|Other|2|||
154907252|NCT03935594|559080709|FG000|Overall Study|Physician Decision|3|||
154907253|NCT01435122|559080710|FG000|Overall Study|Early withdrawal due to toxicity|8|||
154907254|NCT04412668|559080711|FG000|Overall Study|Death - multiple comorbidities|2|||
154907255|NCT04412668|559080712|FG001|Overall Study|Death - multiple comorbidities|0|||
154907256|NCT04412668|559080713|FG002|Overall Study|Death - multiple comorbidities|0|||
154907257|NCT04412668|559080711|FG000|Overall Study|Withdrawal by Subject|3|||
154907258|NCT04412668|559080712|FG001|Overall Study|Withdrawal by Subject|0|||
154907259|NCT04412668|559080713|FG002|Overall Study|Withdrawal by Subject|0|||
155116991|NCT01271712|559859118|FG001|Safety Follow-up|Protocol Violation|1|||
155116992|NCT01271712|559859117|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
155116993|NCT01271712|559859118|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
155116994|NCT01271712|559859117|FG000|Safety Follow-up|No follow-up|1|||
155116995|NCT01271712|559859118|FG001|Safety Follow-up|No follow-up|1|||
155116996|NCT01271712|559859117|FG000|Safety Follow-up|Progressive disease|1|||
155116997|NCT01271712|559859118|FG001|Safety Follow-up|Progressive disease|0|||
155116998|NCT01271712|559859117|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
155116999|NCT01271712|559859118|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
155117000|NCT00096226|559859121|FG000|Overall Study|Ineligible|2|||
155117001|NCT00096226|559859121|FG000|Overall Study|Protocol treatment not started|1|||
155117002|NCT03941964|559859123|FG000|Overall Study|Adverse Event|1|||
155117003|NCT03941964|559859124|FG001|Overall Study|Adverse Event|8|||
155117004|NCT03941964|559859123|FG000|Overall Study|Progressive disease|7|||
155117005|NCT03941964|559859124|FG001|Overall Study|Progressive disease|3|||
155117006|NCT03941964|559859123|FG000|Overall Study|Lack of Efficacy|0|||
155117007|NCT03941964|559859124|FG001|Overall Study|Lack of Efficacy|1|||
155117008|NCT03941964|559859123|FG000|Overall Study|Death|3|||
155117009|NCT03941964|559859124|FG001|Overall Study|Death|1|||
154907260|NCT04412668|559080711|FG000|Overall Study|Other than Specified|2|||
154907261|NCT04412668|559080712|FG001|Overall Study|Other than Specified|0|||
154907262|NCT04412668|559080713|FG002|Overall Study|Other than Specified|0|||
154907263|NCT03864627|559080715|FG000|Overall Study|Adverse Event|0|||
154907264|NCT03864627|559080716|FG001|Overall Study|Adverse Event|1|||
154907265|NCT03864627|559080715|FG000|Overall Study|Lack of Efficacy|0|||
154907266|NCT03864627|559080716|FG001|Overall Study|Lack of Efficacy|1|||
155117010|NCT03941964|559859123|FG000|Overall Study|Withdrew consent|1|||
155117011|NCT03941964|559859124|FG001|Overall Study|Withdrew consent|3|||
154907267|NCT03864627|559080715|FG000|Overall Study|Lost to Follow-up|0|||
154907268|NCT03864627|559080716|FG001|Overall Study|Lost to Follow-up|1|||
154907269|NCT03864627|559080715|FG000|Overall Study|Withdrawal by Subject|4|||
154907270|NCT03864627|559080716|FG001|Overall Study|Withdrawal by Subject|8|||
154907271|NCT03864627|559080715|FG000|Overall Study|Study terminated by sponsor|0|||
154907272|NCT03864627|559080716|FG001|Overall Study|Study terminated by sponsor|1|||
155117012|NCT03941964|559859123|FG000|Overall Study|Physician Decision|9|||
155117013|NCT03941964|559859124|FG001|Overall Study|Physician Decision|2|||
155117014|NCT03941964|559859123|FG000|Overall Study|Other, not specified|2|||
155117015|NCT03941964|559859124|FG001|Overall Study|Other, not specified|1|||
154907273|NCT01388491|559080717|FG000|Overall Study|Adverse Event|10|||
154907274|NCT01388491|559080718|FG001|Overall Study|Adverse Event|9|||
154907275|NCT01388491|559080717|FG000|Overall Study|Sponsor Request|9|||
155117016|NCT00118846|559859125|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
155117017|NCT00118846|559859126|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
154907276|NCT01388491|559080718|FG001|Overall Study|Sponsor Request|7|||
154907277|NCT01388491|559080717|FG000|Overall Study|Withdrawal by Subject|6|||
154907278|NCT01388491|559080718|FG001|Overall Study|Withdrawal by Subject|10|||
154907279|NCT01388491|559080717|FG000|Overall Study|Lost to Follow-up|4|||
154907280|NCT01388491|559080718|FG001|Overall Study|Lost to Follow-up|3|||
154907281|NCT01388491|559080717|FG000|Overall Study|Protocol Violation|2|||
154907282|NCT01388491|559080718|FG001|Overall Study|Protocol Violation|0|||
154907283|NCT01388491|559080717|FG000|Overall Study|Noncompliance|2|||
154907284|NCT01388491|559080718|FG001|Overall Study|Noncompliance|0|||
154907285|NCT01388491|559080717|FG000|Overall Study|Pregnancy|1|||
154907286|NCT01388491|559080718|FG001|Overall Study|Pregnancy|0|||
154907287|NCT04035473|559080720|FG000|Screening/Baseline|Death|0|||
154907288|NCT04035473|559080721|FG001|Screening/Baseline|Death|1|||
154907289|NCT04035473|559080720|FG000|Screening/Baseline|Adverse Event|0|||
154907290|NCT04035473|559080721|FG001|Screening/Baseline|Adverse Event|1|||
154907291|NCT04035473|559080720|FG000|Follow-up Period|Adverse Event|2|||
154907292|NCT04035473|559080721|FG001|Follow-up Period|Adverse Event|0|||
154907293|NCT00112840|559080722|FG000|Overall Study|Physician Decision|1|||
154907294|NCT00112840|559080723|FG001|Overall Study|Physician Decision|0|||
154907295|NCT00112840|559080724|FG002|Overall Study|Physician Decision|0|||
154907296|NCT00112840|559080722|FG000|Overall Study|Withdrawal by Subject|1|||
154907297|NCT00112840|559080723|FG001|Overall Study|Withdrawal by Subject|0|||
154907298|NCT00112840|559080724|FG002|Overall Study|Withdrawal by Subject|1|||
154907299|NCT00112840|559080722|FG000|Overall Study|Protocol Violation|0|||
154907300|NCT00112840|559080723|FG001|Overall Study|Protocol Violation|0|||
154907301|NCT00112840|559080724|FG002|Overall Study|Protocol Violation|5|||
154907302|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
154907303|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
154907304|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
154907305|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
154907306|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Other|13|||
154907307|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
154907308|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
154907309|NCT02497287|559080727|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
154907310|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
154907311|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
154907312|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
154907313|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
154907314|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
154907315|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
154907316|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
154907317|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
154907318|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
154907319|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
154907320|NCT02497287|559080727|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
154907321|NCT02497287|559080727|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
154907322|NCT02497287|559080727|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
154907323|NCT02497287|559080727|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
154907324|NCT02497287|559080727|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
154907325|NCT02497287|559080727|FG000|Follow-up Phase (4 Week)|Other|1|||
154907326|NCT03782376|559080728|FG000|Overall Study|Lost to Follow-up|2|||
154907327|NCT03782376|559080729|FG001|Overall Study|Lost to Follow-up|2|||
154907328|NCT03782376|559080728|FG000|Overall Study|Withdrawal by Subject|7|||
154907329|NCT03782376|559080729|FG001|Overall Study|Withdrawal by Subject|11|||
154907330|NCT03782376|559080728|FG000|Overall Study|Death|1|||
154907331|NCT03782376|559080729|FG001|Overall Study|Death|0|||
154907332|NCT03782376|559080728|FG000|Overall Study|Other|16|||
154907333|NCT03782376|559080729|FG001|Overall Study|Other|17|||
154907334|NCT02659098|559080730|FG000|Overall Study|Withdrawal by Subject|7|||
154907335|NCT04363944|559080731|FG000|Overall Study|Withdrawal by Subject|2|||
154907336|NCT04363944|559080732|FG001|Overall Study|Withdrawal by Subject|0|||
154907337|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
154907338|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
155117018|NCT00118846|559859125|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
155117019|NCT00118846|559859126|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
154907339|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Death|0|||
154907340|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Death|4|||
154907341|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
155117020|NCT00118846|559859125|FG000|Overall Study|Physician Decision|1|||
155117021|NCT00118846|559859126|FG001|Overall Study|Physician Decision|0|||
154907342|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
154907343|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
154907344|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
154907345|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
154907346|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
155117022|NCT00118846|559859125|FG000|Overall Study|Medical condition|2|||
154907347|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
154907348|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
154907349|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
154907350|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
154907351|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Other|4|||
154907352|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Other|3|||
154907353|NCT03517722|559080733|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
154907354|NCT03517722|559080734|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
154907355|NCT03517722|559080733|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
154907356|NCT03517722|559080734|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
154907357|NCT03517722|559080733|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
154907358|NCT03517722|559080734|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
155117023|NCT00118846|559859126|FG001|Overall Study|Medical condition|2|||
154907359|NCT03517722|559080733|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
154907360|NCT03517722|559080734|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
154907361|NCT03517722|559080733|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
154907362|NCT03517722|559080734|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
154907363|NCT03573804|559080736|FG000|Overall Study|claustrophobia or MRI table problems|10|||
154907364|NCT00952419|559080737|FG000|Overall Study|Adverse Event|2|||
154907365|NCT00952419|559080738|FG001|Overall Study|Adverse Event|0|||
154907366|NCT00952419|559080739|FG002|Overall Study|Adverse Event|0|||
154907367|NCT00952419|559080737|FG000|Overall Study|Protocol Violation|3|||
154907368|NCT00952419|559080738|FG001|Overall Study|Protocol Violation|7|||
154907369|NCT00952419|559080739|FG002|Overall Study|Protocol Violation|0|||
154907370|NCT00952419|559080737|FG000|Overall Study|Withdrawal by Subject|1|||
154907371|NCT00952419|559080738|FG001|Overall Study|Withdrawal by Subject|3|||
154907372|NCT00952419|559080739|FG002|Overall Study|Withdrawal by Subject|0|||
154907373|NCT01654224|559082203|FG000|Overall Study|Lost to Follow-up|2|||
154907374|NCT01654224|559082204|FG001|Overall Study|Lost to Follow-up|2|||
154907375|NCT01654224|559082203|FG000|Overall Study|Did not receive allocation|1|||
154907376|NCT01654224|559082204|FG001|Overall Study|Did not receive allocation|8|||
154907377|NCT01654224|559082203|FG000|Overall Study|Insufficient blood sample|3|||
154907378|NCT01654224|559082204|FG001|Overall Study|Insufficient blood sample|2|||
154907379|NCT03763942|559082206|FG000|Overall Study|Lost to Follow-up|114|||
154907380|NCT03763942|559082207|FG001|Overall Study|Lost to Follow-up|54|||
154907381|NCT03763942|559082206|FG000|Overall Study|Protocol Violation|1|||
154907382|NCT03763942|559082207|FG001|Overall Study|Protocol Violation|0|||
154907383|NCT03763942|559082206|FG000|Overall Study|Withdrawal by Subject|2|||
154907384|NCT03763942|559082207|FG001|Overall Study|Withdrawal by Subject|0|||
154907385|NCT03763942|559082206|FG000|Overall Study|Other|2|||
154907386|NCT03763942|559082207|FG001|Overall Study|Other|3|||
154907387|NCT00166504|559082208|FG000|Overall Study|Adverse Event|3|||
154907388|NCT00166504|559082209|FG001|Overall Study|Adverse Event|3|||
154907389|NCT00166504|559082208|FG000|Overall Study|Lost to Follow-up|1|||
154907390|NCT00166504|559082209|FG001|Overall Study|Lost to Follow-up|1|||
154907391|NCT00166504|559082208|FG000|Overall Study|Withdrawal by Subject|1|||
154907392|NCT00166504|559082209|FG001|Overall Study|Withdrawal by Subject|0|||
154907393|NCT02200510|559082210|FG000|Overall Study|Death|1|||
154907394|NCT02200510|559082211|FG001|Overall Study|Death|1|||
154907395|NCT02200510|559082210|FG000|Overall Study|Protocol Violation|0|||
154907396|NCT02200510|559082211|FG001|Overall Study|Protocol Violation|1|||
154907397|NCT02200510|559082210|FG000|Overall Study|Lost to Follow-up|7|||
154907398|NCT02200510|559082211|FG001|Overall Study|Lost to Follow-up|1|||
154907399|NCT02200510|559082210|FG000|Overall Study|potential COI - joined study team|1|||
154907400|NCT02200510|559082211|FG001|Overall Study|potential COI - joined study team|0|||
154907401|NCT04423718|559082216|FG000|Main Study|Adverse Event|9|||
154907402|NCT04423718|559082217|FG001|Main Study|Adverse Event|5|||
154907403|NCT04423718|559082218|FG002|Main Study|Adverse Event|8|||
154907404|NCT04423718|559082216|FG000|Main Study|Physician Decision|3|||
154907405|NCT04423718|559082217|FG001|Main Study|Physician Decision|3|||
154907406|NCT04423718|559082218|FG002|Main Study|Physician Decision|2|||
154907407|NCT04423718|559082216|FG000|Main Study|Protocol Violation|0|||
154907408|NCT04423718|559082217|FG001|Main Study|Protocol Violation|0|||
154907409|NCT04423718|559082218|FG002|Main Study|Protocol Violation|1|||
155117024|NCT00118846|559859125|FG000|Overall Study|Lost to Follow-up|0|||
154907410|NCT04423718|559082216|FG000|Main Study|Lost to Follow-up|3|||
154907411|NCT04423718|559082217|FG001|Main Study|Lost to Follow-up|3|||
154907412|NCT04423718|559082218|FG002|Main Study|Lost to Follow-up|4|||
154907413|NCT04423718|559082216|FG000|Main Study|Lack of Efficacy|2|||
154907414|NCT04423718|559082217|FG001|Main Study|Lack of Efficacy|1|||
154907415|NCT04423718|559082218|FG002|Main Study|Lack of Efficacy|0|||
154907416|NCT04423718|559082216|FG000|Main Study|Withdrawal by Subject|14|||
154907417|NCT04423718|559082217|FG001|Main Study|Withdrawal by Subject|20|||
154907418|NCT04423718|559082218|FG002|Main Study|Withdrawal by Subject|20|||
154907419|NCT04423718|559082216|FG000|Main Study|Death|10|||
154907420|NCT04423718|559082217|FG001|Main Study|Death|7|||
154907421|NCT04423718|559082218|FG002|Main Study|Death|7|||
154907422|NCT04423718|559082216|FG000|Main Study|COVID-19 pandemic|2|||
154907423|NCT04423718|559082217|FG001|Main Study|COVID-19 pandemic|2|||
154907424|NCT04423718|559082218|FG002|Main Study|COVID-19 pandemic|2|||
154907425|NCT04423718|559082216|FG000|Main Study|Other|7|||
154907426|NCT04423718|559082217|FG001|Main Study|Other|3|||
154907427|NCT04423718|559082218|FG002|Main Study|Other|2|||
154907428|NCT04423718|559082216|FG000|Extension Phase|Other|1|||
154907429|NCT04423718|559082217|FG001|Extension Phase|Other|0|||
154907430|NCT04423718|559082218|FG002|Extension Phase|Other|0|||
154907431|NCT04423718|559082216|FG000|Extension Phase|Logistical problems|0|||
154907432|NCT04423718|559082217|FG001|Extension Phase|Logistical problems|1|||
154907433|NCT04423718|559082218|FG002|Extension Phase|Logistical problems|1|||
154907434|NCT04423718|559082216|FG000|Extension Phase|Physician Decision|1|||
154907435|NCT04423718|559082217|FG001|Extension Phase|Physician Decision|0|||
154907436|NCT04423718|559082218|FG002|Extension Phase|Physician Decision|1|||
154907437|NCT04423718|559082216|FG000|Extension Phase|Lack of Efficacy|2|||
154907438|NCT04423718|559082217|FG001|Extension Phase|Lack of Efficacy|0|||
154907439|NCT04423718|559082218|FG002|Extension Phase|Lack of Efficacy|1|||
154907440|NCT04423718|559082216|FG000|Extension Phase|Lost to Follow-up|0|||
154907441|NCT04423718|559082217|FG001|Extension Phase|Lost to Follow-up|2|||
154907442|NCT04423718|559082218|FG002|Extension Phase|Lost to Follow-up|3|||
154907443|NCT04423718|559082216|FG000|Extension Phase|Adverse Event|2|||
154907444|NCT04423718|559082217|FG001|Extension Phase|Adverse Event|3|||
154907445|NCT04423718|559082218|FG002|Extension Phase|Adverse Event|1|||
154907446|NCT04423718|559082216|FG000|Extension Phase|Death|4|||
154907447|NCT04423718|559082217|FG001|Extension Phase|Death|7|||
154907448|NCT04423718|559082218|FG002|Extension Phase|Death|2|||
154907449|NCT04423718|559082216|FG000|Extension Phase|Withdrawal by Subject|11|||
154907450|NCT04423718|559082217|FG001|Extension Phase|Withdrawal by Subject|11|||
154907451|NCT04423718|559082218|FG002|Extension Phase|Withdrawal by Subject|7|||
154907452|NCT05298774|559082223|FG000|Overall Study|Physician Decision|3|||
154907453|NCT05298774|559082223|FG000|Overall Study|Withdrawal by Subject|2|||
154907454|NCT05298774|559082223|FG000|Overall Study|Lost to Follow-up|3|||
154907455|NCT05298774|559082223|FG000|Overall Study|Screen failure|1|||
154907456|NCT04992507|559082224|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
154907457|NCT04992507|559082225|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
154907458|NCT04992507|559082224|FG000|Overall Study|Death|0|||
154907459|NCT04992507|559082225|FG001|Overall Study|Death|1|||
154907460|NCT04651777|559082227|FG000|Overall Study|Adverse Event|1|||
154907461|NCT04651777|559082227|FG000|Overall Study|Withdrawal by Subject|2|||
154907462|NCT04088331|559082228|FG000|Overall Study|Lost to Follow-up|3|||
154907463|NCT04088331|559082228|FG000|Overall Study|Withdrawal by Subject|7|||
154907464|NCT04088331|559082228|FG000|Overall Study|Adverse Event|4|||
154907465|NCT03598140|559082229|FG000|Overall Study|enrolled but didn't start|1|||
154907466|NCT03598140|559082230|FG001|Overall Study|enrolled but didn't start|0|||
154907467|NCT03070119|559082232|FG000|Overall Study|Adverse Event|0|||
154907468|NCT03070119|559082233|FG001|Overall Study|Adverse Event|0|||
154907469|NCT03070119|559082234|FG002|Overall Study|Adverse Event|1|||
154907470|NCT03070119|559082232|FG000|Overall Study|Lost to Follow-up|0|||
154907471|NCT03070119|559082233|FG001|Overall Study|Lost to Follow-up|1|||
154907472|NCT03070119|559082234|FG002|Overall Study|Lost to Follow-up|0|||
154907473|NCT03070119|559082232|FG000|Overall Study|Consent Withdrawn|6|||
154907474|NCT03070119|559082233|FG001|Overall Study|Consent Withdrawn|5|||
154907475|NCT03070119|559082234|FG002|Overall Study|Consent Withdrawn|3|||
154907476|NCT03070119|559082232|FG000|Overall Study|Investigator Decision|0|||
154907477|NCT03070119|559082233|FG001|Overall Study|Investigator Decision|0|||
154907478|NCT03070119|559082234|FG002|Overall Study|Investigator Decision|1|||
155117025|NCT00118846|559859126|FG001|Overall Study|Lost to Follow-up|2|||
155117026|NCT00118846|559859125|FG000|Overall Study|Personal reason|4|||
155117027|NCT00118846|559859126|FG001|Overall Study|Personal reason|5|||
155117028|NCT01468233|559859127|FG000|Treatment Period 1|Adverse Event|5|||
154907479|NCT03070119|559082232|FG000|Overall Study|Death|7|||
154907480|NCT03070119|559082233|FG001|Overall Study|Death|14|||
154907481|NCT03070119|559082234|FG002|Overall Study|Death|5|||
155117029|NCT01468233|559859128|FG001|Treatment Period 1|Adverse Event|3|||
154907482|NCT03070119|559082232|FG000|Overall Study|Disease Progression|5|||
154907483|NCT03070119|559082233|FG001|Overall Study|Disease Progression|7|||
154907484|NCT03070119|559082234|FG002|Overall Study|Disease Progression|7|||
154907485|NCT03070119|559082232|FG000|Overall Study|Reason not Specified|2|||
154907486|NCT03070119|559082233|FG001|Overall Study|Reason not Specified|2|||
154907487|NCT03070119|559082234|FG002|Overall Study|Reason not Specified|1|||
154907488|NCT01023516|559082235|FG000|Overall Study|Voluntary discontinuation|7|||
154907489|NCT01023516|559082236|FG001|Overall Study|Voluntary discontinuation|5|||
154907490|NCT01023516|559082235|FG000|Overall Study|Adverse Event|9|||
154907491|NCT01023516|559082236|FG001|Overall Study|Adverse Event|6|||
154907492|NCT01023516|559082235|FG000|Overall Study|Safety reason|0|||
154907493|NCT01023516|559082236|FG001|Overall Study|Safety reason|3|||
154907494|NCT01023516|559082235|FG000|Overall Study|Study-specific criteria|4|||
154907495|NCT01023516|559082236|FG001|Overall Study|Study-specific criteria|2|||
154907496|NCT01023516|559082235|FG000|Overall Study|Incorrect enrolment|4|||
154907497|NCT01023516|559082236|FG001|Overall Study|Incorrect enrolment|2|||
155117030|NCT01468233|559859129|FG002|Treatment Period 1|Adverse Event|0|||
155117031|NCT01468233|559859130|FG003|Treatment Period 1|Adverse Event|0|||
155117032|NCT01468233|559859131|FG004|Treatment Period 1|Adverse Event|0|||
155117033|NCT01468233|559859132|FG005|Treatment Period 1|Adverse Event|0|||
155117034|NCT01468233|559859127|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155117035|NCT01468233|559859128|FG001|Treatment Period 1|Withdrawal by Subject|4|||
155117036|NCT01468233|559859129|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155117037|NCT01468233|559859130|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155117038|NCT01468233|559859131|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155117039|NCT01468233|559859132|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155117040|NCT01468233|559859127|FG000|Treatment Period 1|Lost to Follow-up|3|||
155117041|NCT01468233|559859128|FG001|Treatment Period 1|Lost to Follow-up|0|||
155117042|NCT01468233|559859129|FG002|Treatment Period 1|Lost to Follow-up|0|||
155117043|NCT01468233|559859130|FG003|Treatment Period 1|Lost to Follow-up|0|||
155117044|NCT01468233|559859131|FG004|Treatment Period 1|Lost to Follow-up|0|||
155117045|NCT01468233|559859132|FG005|Treatment Period 1|Lost to Follow-up|0|||
155176085|NCT02509117|560082241|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
155176086|NCT02509117|560082232|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
154907498|NCT02060903|559082237|FG000|Overall Study|Lost to Follow-up|4|||
154907499|NCT02060903|559082238|FG001|Overall Study|Lost to Follow-up|0|||
154907500|NCT02060903|559082237|FG000|Overall Study|Withdrawal by Subject|0|||
154907501|NCT02060903|559082238|FG001|Overall Study|Withdrawal by Subject|7|||
154907502|NCT01058395|559082239|FG000|Overall Study|Death|2|||
154907503|NCT01058395|559082240|FG001|Overall Study|Death|1|||
154907504|NCT01058395|559082239|FG000|Overall Study|Lost to Follow-up|1|||
154907505|NCT01058395|559082240|FG001|Overall Study|Lost to Follow-up|0|||
154907506|NCT01996865|559082241|FG000|Induction Period|Protocol Violation|1|||
154907507|NCT01996865|559082242|FG001|Induction Period|Protocol Violation|0|||
154907508|NCT01996865|559082243|FG002|Induction Period|Protocol Violation|0|||
154907509|NCT01996865|559082241|FG000|Induction Period|Progressive Disease|4|||
154907510|NCT01996865|559082242|FG001|Induction Period|Progressive Disease|0|||
154907511|NCT01996865|559082243|FG002|Induction Period|Progressive Disease|0|||
154907512|NCT01996865|559082241|FG000|Induction Period|Lost to Follow-up|10|||
154907513|NCT01996865|559082242|FG001|Induction Period|Lost to Follow-up|0|||
154907514|NCT01996865|559082243|FG002|Induction Period|Lost to Follow-up|0|||
154907515|NCT01996865|559082241|FG000|Induction Period|Other Reasons|13|||
154907516|NCT01996865|559082242|FG001|Induction Period|Other Reasons|0|||
154907517|NCT01996865|559082243|FG002|Induction Period|Other Reasons|0|||
154907518|NCT01996865|559082241|FG000|Induction Period|Adverse Event|20|||
154907519|NCT01996865|559082242|FG001|Induction Period|Adverse Event|0|||
154907520|NCT01996865|559082243|FG002|Induction Period|Adverse Event|0|||
154907521|NCT01996865|559082241|FG000|Induction Period|Withdrawal by Subject|60|||
154907522|NCT01996865|559082242|FG001|Induction Period|Withdrawal by Subject|0|||
154907523|NCT01996865|559082243|FG002|Induction Period|Withdrawal by Subject|0|||
154907524|NCT01996865|559082241|FG000|Induction Period|Death|111|||
154907525|NCT01996865|559082242|FG001|Induction Period|Death|0|||
154907526|NCT01996865|559082243|FG002|Induction Period|Death|0|||
154907527|NCT01996865|559082241|FG000|Maintenance Period|Protocol Violation|0|||
154907528|NCT01996865|559082242|FG001|Maintenance Period|Protocol Violation|1|||
154907529|NCT01996865|559082243|FG002|Maintenance Period|Protocol Violation|1|||
154907530|NCT01996865|559082241|FG000|Maintenance Period|Other reasons|0|||
154907531|NCT01996865|559082242|FG001|Maintenance Period|Other reasons|8|||
154907532|NCT01996865|559082243|FG002|Maintenance Period|Other reasons|5|||
154907533|NCT01996865|559082241|FG000|Maintenance Period|Progressive Disease|0|||
154907534|NCT01996865|559082242|FG001|Maintenance Period|Progressive Disease|6|||
154907535|NCT01996865|559082243|FG002|Maintenance Period|Progressive Disease|23|||
154907536|NCT01996865|559082241|FG000|Maintenance Period|Withdrawal by Subject|0|||
154907537|NCT01996865|559082242|FG001|Maintenance Period|Withdrawal by Subject|18|||
154907538|NCT01996865|559082243|FG002|Maintenance Period|Withdrawal by Subject|4|||
154907539|NCT01996865|559082241|FG000|Maintenance Period|Adverse Event|0|||
154907540|NCT01996865|559082242|FG001|Maintenance Period|Adverse Event|7|||
154907541|NCT01996865|559082243|FG002|Maintenance Period|Adverse Event|7|||
154907542|NCT01996865|559082241|FG000|Maintenance Period|Death|0|||
155117046|NCT01468233|559859127|FG000|Treatment Period 1|Other|1|||
154907543|NCT01996865|559082242|FG001|Maintenance Period|Death|15|||
154907544|NCT01996865|559082243|FG002|Maintenance Period|Death|3|||
154907545|NCT01996865|559082241|FG000|Maintenance Period|Lost to Follow-up|0|||
154907546|NCT01996865|559082242|FG001|Maintenance Period|Lost to Follow-up|2|||
154907547|NCT01996865|559082243|FG002|Maintenance Period|Lost to Follow-up|0|||
154907548|NCT05304611|559082244|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907549|NCT05304611|559082245|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907550|NCT05304611|559082246|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907551|NCT05304611|559082247|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
155117047|NCT01468233|559859128|FG001|Treatment Period 1|Other|1|||
155117048|NCT01468233|559859129|FG002|Treatment Period 1|Other|0|||
154907552|NCT05304611|559082248|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907553|NCT05304611|559082249|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907554|NCT05304611|559082250|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
154907555|NCT05304611|559082251|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907556|NCT05304611|559082252|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
154907557|NCT05304611|559082253|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907558|NCT05304611|559082254|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907559|NCT05304611|559082255|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
154907560|NCT05304611|559082244|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
154907561|NCT05304611|559082245|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
154907562|NCT05304611|559082246|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
154907563|NCT05304611|559082247|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
154907564|NCT05304611|559082248|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
154907565|NCT05304611|559082249|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
154907566|NCT05304611|559082250|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
154907567|NCT05304611|559082251|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
154907568|NCT05304611|559082252|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
154907569|NCT05304611|559082253|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
154907570|NCT05304611|559082254|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
154907571|NCT05304611|559082255|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
154907572|NCT05304611|559082244|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
154907573|NCT05304611|559082245|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
154907574|NCT05304611|559082246|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
154907575|NCT05304611|559082247|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
154907576|NCT05304611|559082248|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
154907577|NCT05304611|559082249|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
154907578|NCT05304611|559082250|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
154907579|NCT05304611|559082251|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
154907580|NCT05304611|559082252|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
154907581|NCT05304611|559082253|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
154907582|NCT05304611|559082254|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
154907583|NCT05304611|559082255|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
154907584|NCT02354690|559082256|FG000|Overall Study|Physician Decision|1|||
154907585|NCT00515099|559082257|FG000|Overall Study|Lost to Follow-up|0|||
154907586|NCT00515099|559082258|FG001|Overall Study|Lost to Follow-up|4|||
154907587|NCT00515099|559082257|FG000|Overall Study|Withdrawal by Subject|2|||
154907588|NCT00515099|559082258|FG001|Overall Study|Withdrawal by Subject|0|||
154907589|NCT00515099|559082257|FG000|Overall Study|IRB Recommendation|1|||
154907590|NCT00515099|559082258|FG001|Overall Study|IRB Recommendation|0|||
154907591|NCT03342404|559082259|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
154907592|NCT03342404|559082260|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
154907593|NCT03342404|559082259|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
154907594|NCT03342404|559082260|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
154907595|NCT03342404|559082259|FG000|Blinded Treatment Phase|Adverse Event|5|||
154907596|NCT03342404|559082260|FG001|Blinded Treatment Phase|Adverse Event|4|||
154907597|NCT03342404|559082259|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
154907598|NCT03342404|559082260|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
154907599|NCT03342404|559082259|FG000|Blinded Treatment Phase|Other reasons|1|||
154907600|NCT03342404|559082260|FG001|Blinded Treatment Phase|Other reasons|0|||
154907601|NCT03342404|559082259|FG000|Blinded Treatment Phase|Physician Decision|1|||
154907602|NCT03342404|559082260|FG001|Blinded Treatment Phase|Physician Decision|0|||
154907603|NCT03342404|559082259|FG000|Blinded Treatment Phase|Death|1|||
154907604|NCT03342404|559082260|FG001|Blinded Treatment Phase|Death|0|||
154907605|NCT03342404|559082259|FG000|Open-Label Phase|Lost to Follow-up|0|||
154907606|NCT03342404|559082260|FG001|Open-Label Phase|Lost to Follow-up|1|||
154907607|NCT03342404|559082259|FG000|Open-Label Phase|Other reasons|0|||
154907608|NCT03342404|559082260|FG001|Open-Label Phase|Other reasons|1|||
154907609|NCT03342404|559082259|FG000|Open-Label Phase|Adverse Event|0|||
154907610|NCT03342404|559082260|FG001|Open-Label Phase|Adverse Event|3|||
155117049|NCT01468233|559859130|FG003|Treatment Period 1|Other|0|||
154907611|NCT03342404|559082259|FG000|Open-Label Phase|Withdrawal by Subject|0|||
154907612|NCT03342404|559082260|FG001|Open-Label Phase|Withdrawal by Subject|6|||
155117050|NCT01468233|559859131|FG004|Treatment Period 1|Other|0|||
155117051|NCT01468233|559859132|FG005|Treatment Period 1|Other|0|||
155117052|NCT01468233|559859127|FG000|Treatment Period 2|Adverse Event|0|||
154907613|NCT05333289|559082261|FG000|Overall Study|Other|1|||
154907614|NCT05333289|559082262|FG001|Overall Study|Other|0|||
154907615|NCT05333289|559082263|FG002|Overall Study|Other|0|||
154907616|NCT05333289|559082264|FG003|Overall Study|Other|1|||
154907617|NCT05333289|559082265|FG004|Overall Study|Other|1|||
154907618|NCT05333289|559082266|FG005|Overall Study|Other|2|||
154907619|NCT05333289|559082267|FG006|Overall Study|Other|2|||
154907620|NCT05333289|559082268|FG007|Overall Study|Other|0|||
154907621|NCT05333289|559082261|FG000|Overall Study|Withdrawal by Subject|1|||
155117053|NCT01468233|559859128|FG001|Treatment Period 2|Adverse Event|0|||
155117054|NCT01468233|559859129|FG002|Treatment Period 2|Adverse Event|3|||
154907622|NCT05333289|559082262|FG001|Overall Study|Withdrawal by Subject|2|||
154907623|NCT05333289|559082263|FG002|Overall Study|Withdrawal by Subject|2|||
154907624|NCT05333289|559082264|FG003|Overall Study|Withdrawal by Subject|1|||
154907625|NCT05333289|559082265|FG004|Overall Study|Withdrawal by Subject|1|||
154907626|NCT05333289|559082266|FG005|Overall Study|Withdrawal by Subject|2|||
154907627|NCT05333289|559082267|FG006|Overall Study|Withdrawal by Subject|1|||
154907628|NCT05333289|559082268|FG007|Overall Study|Withdrawal by Subject|3|||
154907629|NCT05333289|559082261|FG000|Overall Study|Protocol Violation|1|||
154907630|NCT05333289|559082262|FG001|Overall Study|Protocol Violation|0|||
154907631|NCT05333289|559082263|FG002|Overall Study|Protocol Violation|0|||
154907632|NCT05333289|559082264|FG003|Overall Study|Protocol Violation|0|||
154907633|NCT05333289|559082265|FG004|Overall Study|Protocol Violation|0|||
154907634|NCT05333289|559082266|FG005|Overall Study|Protocol Violation|0|||
154907635|NCT05333289|559082267|FG006|Overall Study|Protocol Violation|0|||
154907636|NCT05333289|559082268|FG007|Overall Study|Protocol Violation|0|||
154907637|NCT05333289|559082261|FG000|Overall Study|Physician Decision|0|||
154907638|NCT05333289|559082262|FG001|Overall Study|Physician Decision|0|||
154907639|NCT05333289|559082263|FG002|Overall Study|Physician Decision|1|||
154907640|NCT05333289|559082264|FG003|Overall Study|Physician Decision|0|||
154907641|NCT05333289|559082265|FG004|Overall Study|Physician Decision|0|||
154907642|NCT05333289|559082266|FG005|Overall Study|Physician Decision|2|||
154907643|NCT05333289|559082267|FG006|Overall Study|Physician Decision|0|||
154907644|NCT05333289|559082268|FG007|Overall Study|Physician Decision|0|||
154907645|NCT05333289|559082261|FG000|Overall Study|Lost to Follow-up|6|||
154907646|NCT05333289|559082262|FG001|Overall Study|Lost to Follow-up|0|||
154907647|NCT05333289|559082263|FG002|Overall Study|Lost to Follow-up|1|||
154907648|NCT05333289|559082264|FG003|Overall Study|Lost to Follow-up|6|||
154907649|NCT05333289|559082265|FG004|Overall Study|Lost to Follow-up|3|||
154907650|NCT05333289|559082266|FG005|Overall Study|Lost to Follow-up|3|||
154907651|NCT05333289|559082267|FG006|Overall Study|Lost to Follow-up|2|||
154907652|NCT05333289|559082268|FG007|Overall Study|Lost to Follow-up|1|||
154907653|NCT05333289|559082261|FG000|Overall Study|Death|1|||
154907654|NCT05333289|559082262|FG001|Overall Study|Death|0|||
154907655|NCT05333289|559082263|FG002|Overall Study|Death|0|||
154907656|NCT05333289|559082264|FG003|Overall Study|Death|0|||
154907657|NCT05333289|559082265|FG004|Overall Study|Death|0|||
154907658|NCT05333289|559082266|FG005|Overall Study|Death|0|||
154907659|NCT05333289|559082267|FG006|Overall Study|Death|0|||
154907660|NCT05333289|559082268|FG007|Overall Study|Death|0|||
154907661|NCT00372489|559082271|FG000|Overall Study|Adverse Event|18|||
154907662|NCT00372489|559082271|FG000|Overall Study|Lack of Efficacy|1|||
154907663|NCT00372489|559082271|FG000|Overall Study|Lost to Follow-up|3|||
154907664|NCT00372489|559082271|FG000|Overall Study|Physician Decision|3|||
154907665|NCT00372489|559082271|FG000|Overall Study|Withdrawal by Subject|5|||
154907666|NCT00372489|559082271|FG000|Overall Study|Patient Relocation|2|||
154907667|NCT00372489|559082271|FG000|Overall Study|Renal transplant|6|||
154907668|NCT00372489|559082271|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
154907669|NCT04430036|559082279|FG000|Safety Run in Phase|Progression of disease|2|||
154907670|NCT05559203|559082280|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
154907671|NCT01249157|559082281|FG000|Overall Study|Withdrawal by Subject|1|||
154907672|NCT02392468|559082282|FG000|Overall Study|Adverse Event|0|||
154907673|NCT02392468|559082283|FG001|Overall Study|Adverse Event|1|||
154907674|NCT02392468|559082284|FG002|Overall Study|Adverse Event|0|||
154907675|NCT02392468|559082285|FG003|Overall Study|Adverse Event|0|||
154907676|NCT02392468|559082286|FG004|Overall Study|Adverse Event|0|||
154907677|NCT02392468|559082287|FG005|Overall Study|Adverse Event|1|||
154907678|NCT03630016|559082288|FG000|Overall Study|Poor Sensor Placement|1|||
154907679|NCT05083949|559082289|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
154907680|NCT05083949|559082290|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
154907681|NCT05083949|559082289|FG000|Period 1|Adverse Event|1|||
154907682|NCT05083949|559082290|FG001|Period 1|Adverse Event|1|||
154907683|NCT05083949|559082289|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
154907684|NCT05083949|559082290|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
154907685|NCT05083949|559082289|FG000|Period 2|Adverse Event|0|||
154907686|NCT05083949|559082290|FG001|Period 2|Adverse Event|2|||
154907687|NCT01678560|559082293|FG000|Overall Study|Physician Decision|4|||
154907688|NCT01678560|559082294|FG001|Overall Study|Physician Decision|4|||
154907689|NCT01678560|559082293|FG000|Overall Study|Death|0|||
154907690|NCT01678560|559082294|FG001|Overall Study|Death|1|||
154907691|NCT01678560|559082293|FG000|Overall Study|Withdrawal by Subject|0|||
154907692|NCT01678560|559082294|FG001|Overall Study|Withdrawal by Subject|1|||
154907693|NCT00959699|559082295|FG000|Treatment Period|Adverse Event|3|||
154907694|NCT00959699|559082296|FG001|Treatment Period|Adverse Event|13|||
155117055|NCT01468233|559859130|FG003|Treatment Period 2|Adverse Event|0|||
154907695|NCT00959699|559082295|FG000|Treatment Period|Lack of Efficacy|15|||
154907696|NCT00959699|559082296|FG001|Treatment Period|Lack of Efficacy|6|||
154907697|NCT00959699|559082295|FG000|Treatment Period|Lost to Follow-up|0|||
154907698|NCT00959699|559082296|FG001|Treatment Period|Lost to Follow-up|1|||
154907699|NCT00959699|559082295|FG000|Treatment Period|Withdrawal by Subject|1|||
154907700|NCT00959699|559082296|FG001|Treatment Period|Withdrawal by Subject|3|||
154907701|NCT00959699|559082295|FG000|Treatment Period|Non-Compliance with Protocol|0|||
154907702|NCT00959699|559082296|FG001|Treatment Period|Non-Compliance with Protocol|1|||
154907703|NCT00959699|559082295|FG000|Treatment Period|Did not receive treatment|0|||
154907704|NCT00959699|559082296|FG001|Treatment Period|Did not receive treatment|1|||
154907705|NCT00959699|559082295|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
154907706|NCT00959699|559082296|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
154907707|NCT00959699|559082295|FG000|Follow-up Period|Lost to Follow-up|3|||
154907708|NCT00959699|559082296|FG001|Follow-up Period|Lost to Follow-up|2|||
154907709|NCT00959699|559082295|FG000|Follow-up Period|Withdrawal by Subject|3|||
154907710|NCT00959699|559082296|FG001|Follow-up Period|Withdrawal by Subject|4|||
154907711|NCT04228445|559082297|FG000|Overall Study|Lost to Follow-up|1|||
154907712|NCT04228445|559082298|FG001|Overall Study|Lost to Follow-up|1|||
154907713|NCT04228445|559082297|FG000|Overall Study|Physician Decision|1|||
154907714|NCT04228445|559082298|FG001|Overall Study|Physician Decision|2|||
154907715|NCT04228445|559082297|FG000|Overall Study|Withdrawal by Subject|0|||
154907716|NCT04228445|559082298|FG001|Overall Study|Withdrawal by Subject|1|||
154907717|NCT04228445|559082297|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
154907718|NCT04228445|559082298|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
154907719|NCT00606294|559082301|FG000|Overall Study|Withdrawal by Subject|36|||
154907720|NCT00606294|559082302|FG001|Overall Study|Withdrawal by Subject|0|||
154907721|NCT03924427|559082303|FG000|Overall Study|Adverse Event|4|||
154907722|NCT03924427|559082303|FG000|Overall Study|Lack of Efficacy|1|||
154907723|NCT03924427|559082303|FG000|Overall Study|Withdrawal by Subject|1|||
154907724|NCT00471315|559082309|FG000|Overall Study|Adverse Event|7|||
154907725|NCT00471315|559082309|FG000|Overall Study|Withdrawal by Subject|1|||
154907726|NCT01365091|559082310|FG000|Period 1|Adverse Event|1|||
154907727|NCT01365091|559082311|FG001|Period 1|Adverse Event|0|||
154907728|NCT01365091|559082312|FG002|Period 1|Adverse Event|2|||
154907729|NCT01365091|559082313|FG003|Period 1|Adverse Event|3|||
154907730|NCT01365091|559082310|FG000|Period 1|Positive test result for drugs of abuse|1|||
154907731|NCT01365091|559082311|FG001|Period 1|Positive test result for drugs of abuse|0|||
154907732|NCT01365091|559082312|FG002|Period 1|Positive test result for drugs of abuse|0|||
154907733|NCT01365091|559082313|FG003|Period 1|Positive test result for drugs of abuse|0|||
154907734|NCT01365091|559082310|FG000|Period 1|No longer met study criteria|0|||
154907735|NCT01365091|559082311|FG001|Period 1|No longer met study criteria|1|||
154907736|NCT01365091|559082312|FG002|Period 1|No longer met study criteria|0|||
154907737|NCT01365091|559082313|FG003|Period 1|No longer met study criteria|0|||
154907738|NCT01365091|559082310|FG000|Period 1|Withdrawal by Subject|0|||
154907739|NCT01365091|559082311|FG001|Period 1|Withdrawal by Subject|1|||
154907740|NCT01365091|559082312|FG002|Period 1|Withdrawal by Subject|0|||
154907741|NCT01365091|559082313|FG003|Period 1|Withdrawal by Subject|0|||
154907742|NCT01365091|559082310|FG000|Period 1|Personal reasons|0|||
154907743|NCT01365091|559082311|FG001|Period 1|Personal reasons|0|||
154907744|NCT01365091|559082312|FG002|Period 1|Personal reasons|1|||
154907745|NCT01365091|559082313|FG003|Period 1|Personal reasons|0|||
154907746|NCT01365091|559082310|FG000|Period 2|Withdrawal by Subject|1|||
154907747|NCT01365091|559082311|FG001|Period 2|Withdrawal by Subject|0|||
154907748|NCT01365091|559082312|FG002|Period 2|Withdrawal by Subject|0|||
154907749|NCT01365091|559082313|FG003|Period 2|Withdrawal by Subject|0|||
154907750|NCT01365091|559082310|FG000|Period 2|Adverse Event|0|||
154907751|NCT01365091|559082311|FG001|Period 2|Adverse Event|0|||
154907752|NCT01365091|559082312|FG002|Period 2|Adverse Event|1|||
154907753|NCT01365091|559082313|FG003|Period 2|Adverse Event|0|||
154907754|NCT05307523|559082315|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
154907755|NCT05307523|559082316|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
154907756|NCT05307523|559082315|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
154907757|NCT05307523|559082316|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
154907758|NCT05116683|559082317|FG000|Overall Study|Physician Decision|4|||
154907759|NCT00683774|559082322|FG000|Overall Study|Withdrawal by Subject|0|||
154907760|NCT00683774|559082323|FG001|Overall Study|Withdrawal by Subject|1|||
154907761|NCT00683774|559082322|FG000|Overall Study|Physician Decision|3|||
154907762|NCT00683774|559082323|FG001|Overall Study|Physician Decision|0|||
154907763|NCT02875366|559082324|FG000|Overall Study|Adverse Event|0|||
154907764|NCT02875366|559082325|FG001|Overall Study|Adverse Event|2|||
154907765|NCT02875366|559082324|FG000|Overall Study|Noncompliance|0|||
154907766|NCT02875366|559082325|FG001|Overall Study|Noncompliance|1|||
154907767|NCT03595176|559082326|FG000|Overall Study|Death|0|||
154907768|NCT03595176|559082327|FG001|Overall Study|Death|2|||
154907769|NCT03595176|559082326|FG000|Overall Study|Lost to Follow-up|0|||
154907770|NCT03595176|559082327|FG001|Overall Study|Lost to Follow-up|1|||
154907771|NCT02735044|559082329|FG000|Overall Study|Adverse Event|3|||
154907772|NCT02735044|559082330|FG001|Overall Study|Adverse Event|3|||
154907773|NCT02735044|559082329|FG000|Overall Study|Lack of Efficacy|1|||
154907774|NCT02735044|559082330|FG001|Overall Study|Lack of Efficacy|0|||
154907775|NCT02735044|559082329|FG000|Overall Study|Poor compliance to protocol|7|||
154907776|NCT02735044|559082330|FG001|Overall Study|Poor compliance to protocol|7|||
154907777|NCT02735044|559082329|FG000|Overall Study|Randomized and not treated|0|||
154907778|NCT02735044|559082330|FG001|Overall Study|Randomized and not treated|2|||
154907779|NCT02735044|559082329|FG000|Overall Study|Other, not specified above|5|||
154907780|NCT02735044|559082330|FG001|Overall Study|Other, not specified above|11|||
154907781|NCT01682759|559082331|FG000|Overall Study|Death|2|||
154907782|NCT01682759|559082332|FG001|Overall Study|Death|1|||
154907783|NCT01682759|559082331|FG000|Overall Study|Lost to Follow-up|10|||
154907784|NCT01682759|559082332|FG001|Overall Study|Lost to Follow-up|13|||
154907785|NCT01682759|559082331|FG000|Overall Study|Physician Decision|1|||
154907786|NCT01682759|559082332|FG001|Overall Study|Physician Decision|1|||
154907787|NCT01682759|559082331|FG000|Overall Study|Withdrawal by Subject|56|||
154907788|NCT01682759|559082332|FG001|Overall Study|Withdrawal by Subject|55|||
154907789|NCT01201967|559082336|FG000|Overall Study|Lost to Follow-up|6|||
154907790|NCT01201967|559082337|FG001|Overall Study|Lost to Follow-up|5|||
154907791|NCT02116361|559082340|FG000|Overall Study|Pregnancy|0|||
154907792|NCT02116361|559082341|FG001|Overall Study|Pregnancy|0|||
154907793|NCT02116361|559082342|FG002|Overall Study|Pregnancy|0|||
154907794|NCT02116361|559082343|FG003|Overall Study|Pregnancy|1|||
154907795|NCT02116361|559082340|FG000|Overall Study|Protocol Violation|1|||
154907796|NCT02116361|559082341|FG001|Overall Study|Protocol Violation|0|||
154907797|NCT02116361|559082342|FG002|Overall Study|Protocol Violation|0|||
154907798|NCT02116361|559082343|FG003|Overall Study|Protocol Violation|2|||
154907799|NCT02116361|559082340|FG000|Overall Study|Physician Decision|2|||
154907800|NCT02116361|559082341|FG001|Overall Study|Physician Decision|3|||
154907801|NCT02116361|559082342|FG002|Overall Study|Physician Decision|0|||
154907802|NCT02116361|559082343|FG003|Overall Study|Physician Decision|0|||
154907803|NCT02116361|559082340|FG000|Overall Study|Adverse Event|1|||
154907804|NCT02116361|559082341|FG001|Overall Study|Adverse Event|0|||
154907805|NCT02116361|559082342|FG002|Overall Study|Adverse Event|0|||
154907806|NCT02116361|559082343|FG003|Overall Study|Adverse Event|3|||
154907807|NCT02116361|559082340|FG000|Overall Study|Other Reasons|3|||
154907808|NCT02116361|559082341|FG001|Overall Study|Other Reasons|3|||
154907809|NCT02116361|559082342|FG002|Overall Study|Other Reasons|3|||
154907810|NCT02116361|559082343|FG003|Overall Study|Other Reasons|3|||
154907811|NCT02116361|559082340|FG000|Overall Study|Lack of Efficacy|5|||
154907812|NCT02116361|559082341|FG001|Overall Study|Lack of Efficacy|7|||
154907813|NCT02116361|559082342|FG002|Overall Study|Lack of Efficacy|4|||
154907814|NCT02116361|559082343|FG003|Overall Study|Lack of Efficacy|3|||
154907815|NCT02116361|559082340|FG000|Overall Study|Lost to Follow-up|4|||
154907816|NCT02116361|559082341|FG001|Overall Study|Lost to Follow-up|5|||
154907817|NCT02116361|559082342|FG002|Overall Study|Lost to Follow-up|7|||
154907818|NCT02116361|559082343|FG003|Overall Study|Lost to Follow-up|5|||
154907819|NCT02116361|559082340|FG000|Overall Study|Personal Reasons|6|||
155117056|NCT01468233|559859131|FG004|Treatment Period 2|Adverse Event|2|||
155117057|NCT01468233|559859132|FG005|Treatment Period 2|Adverse Event|1|||
155117058|NCT01468233|559859127|FG000|Treatment Period 2|Lack of Efficacy|0|||
154907820|NCT02116361|559082341|FG001|Overall Study|Personal Reasons|6|||
154907821|NCT02116361|559082342|FG002|Overall Study|Personal Reasons|4|||
154907822|NCT02116361|559082343|FG003|Overall Study|Personal Reasons|9|||
154907823|NCT02116361|559082340|FG000|Overall Study|Investigator Decision - Relapse|9|||
154907824|NCT02116361|559082341|FG001|Overall Study|Investigator Decision - Relapse|7|||
154907825|NCT02116361|559082342|FG002|Overall Study|Investigator Decision - Relapse|8|||
154907826|NCT02116361|559082343|FG003|Overall Study|Investigator Decision - Relapse|5|||
154907827|NCT01592773|559084354|FG000|Overall Study|Study Terminated by Sponsor|582|||
154907828|NCT01592773|559084354|FG000|Overall Study|Withdrawal by Subject|35|||
154907829|NCT01592773|559084354|FG000|Overall Study|Lost to Follow-up|19|||
154907830|NCT01592773|559084354|FG000|Overall Study|Adverse Event|17|||
154907831|NCT01592773|559084354|FG000|Overall Study|Lack of Efficacy|9|||
154907832|NCT01592773|559084354|FG000|Overall Study|Protocol Violation|2|||
154907833|NCT01592773|559084354|FG000|Overall Study|Inclusion/exclusion not meet|1|||
154907834|NCT01592773|559084354|FG000|Overall Study|Other Reason|1|||
155117059|NCT01468233|559859128|FG001|Treatment Period 2|Lack of Efficacy|0|||
155117060|NCT01468233|559859129|FG002|Treatment Period 2|Lack of Efficacy|9|||
155117061|NCT01468233|559859130|FG003|Treatment Period 2|Lack of Efficacy|2|||
154907835|NCT04418427|559084355|FG000|Overall Study|Death|0|||
154907836|NCT04418427|559084356|FG001|Overall Study|Death|1|||
154907837|NCT04418427|559084357|FG002|Overall Study|Death|0|||
154907838|NCT04418427|559084355|FG000|Overall Study|Lost to Follow-up|0|||
154907839|NCT04418427|559084356|FG001|Overall Study|Lost to Follow-up|2|||
154907840|NCT04418427|559084357|FG002|Overall Study|Lost to Follow-up|2|||
154907841|NCT04418427|559084355|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
154907842|NCT04418427|559084356|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
154907843|NCT04418427|559084357|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
154907844|NCT04418427|559084355|FG000|Overall Study|Pre-existing medical condition|0|||
154907845|NCT04418427|559084356|FG001|Overall Study|Pre-existing medical condition|1|||
154907846|NCT04418427|559084357|FG002|Overall Study|Pre-existing medical condition|0|||
154907847|NCT00121485|559084358|FG000|Overall Study|Not implanted|1|||
154907848|NCT00121485|559084359|FG001|Overall Study|Not implanted|5|||
154907849|NCT00121485|559084358|FG000|Overall Study|Crossover|0|||
154907850|NCT00121485|559084359|FG001|Overall Study|Crossover|2|||
154907851|NCT04076579|559084360|FG000|Overall Study|Adverse Event|2|||
154907852|NCT04076579|559084361|FG001|Overall Study|Adverse Event|0|||
154907853|NCT04076579|559084360|FG000|Overall Study|discontinued due to toxicity|1|||
154907854|NCT04076579|559084361|FG001|Overall Study|discontinued due to toxicity|0|||
154907855|NCT04076579|559084360|FG000|Overall Study|Physician Decision|1|||
154907856|NCT04076579|559084361|FG001|Overall Study|Physician Decision|0|||
154907857|NCT04076579|559084360|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
154907858|NCT04076579|559084361|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
154907859|NCT04076579|559084360|FG000|Overall Study|Noncompliance|0|||
154907860|NCT04076579|559084361|FG001|Overall Study|Noncompliance|1|||
154907861|NCT04076579|559084360|FG000|Overall Study|Withdrawal by Subject|0|||
154907862|NCT04076579|559084361|FG001|Overall Study|Withdrawal by Subject|2|||
154907863|NCT01997892|559084364|FG000|Overall Study|Physician Decision|2|||
154907864|NCT01997892|559084364|FG000|Overall Study|Lost to Follow-up|6|||
154907865|NCT01997892|559084364|FG000|Overall Study|Death|14|||
154907866|NCT01997892|559084364|FG000|Overall Study|Renal transplant|8|||
155117062|NCT01468233|559859131|FG004|Treatment Period 2|Lack of Efficacy|0|||
155117063|NCT01468233|559859132|FG005|Treatment Period 2|Lack of Efficacy|1|||
155117064|NCT01468233|559859127|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155117065|NCT01468233|559859128|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155117066|NCT01468233|559859129|FG002|Treatment Period 2|Withdrawal by Subject|9|||
155117067|NCT01468233|559859130|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155117068|NCT01468233|559859131|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155117069|NCT01468233|559859132|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155117070|NCT01468233|559859127|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
155117071|NCT01468233|559859128|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
155117072|NCT01468233|559859129|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
155117073|NCT01468233|559859130|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
155117074|NCT01468233|559859131|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
155117075|NCT01468233|559859132|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
155117076|NCT01468233|559859127|FG000|Treatment Period 2|Lost to Follow-up|0|||
155117077|NCT01468233|559859128|FG001|Treatment Period 2|Lost to Follow-up|0|||
155117078|NCT01468233|559859129|FG002|Treatment Period 2|Lost to Follow-up|3|||
155117079|NCT01468233|559859130|FG003|Treatment Period 2|Lost to Follow-up|0|||
155117080|NCT01468233|559859131|FG004|Treatment Period 2|Lost to Follow-up|2|||
155117081|NCT01468233|559859132|FG005|Treatment Period 2|Lost to Follow-up|0|||
154907867|NCT01997892|559084364|FG000|Overall Study|Other|3|||
155117082|NCT01468233|559859127|FG000|Treatment Period 2|Other|0|||
155117083|NCT01468233|559859128|FG001|Treatment Period 2|Other|0|||
155117084|NCT01468233|559859129|FG002|Treatment Period 2|Other|3|||
155117085|NCT01468233|559859130|FG003|Treatment Period 2|Other|0|||
155117086|NCT01468233|559859131|FG004|Treatment Period 2|Other|1|||
155117087|NCT01468233|559859132|FG005|Treatment Period 2|Other|0|||
155117088|NCT01574157|559859136|FG000|Overall Study|Withdrawal by Subject|4|||
155117089|NCT01574157|559859137|FG001|Overall Study|Withdrawal by Subject|5|||
155117090|NCT01574157|559859136|FG000|Overall Study|Lost to Follow-up|0|||
155117091|NCT01574157|559859137|FG001|Overall Study|Lost to Follow-up|3|||
155117092|NCT01944098|559859144|FG000|Overall Study|Physician Decision|1|||
155117093|NCT01944098|559859145|FG001|Overall Study|Physician Decision|0|||
155117094|NCT00855933|559859146|FG000|Overall Study|Withdrawal by Subject|0|||
155117095|NCT00855933|559859147|FG001|Overall Study|Withdrawal by Subject|1|||
155117096|NCT00951080|559859148|FG000|Overall Study|Adverse Event|3|||
155117097|NCT00951080|559859149|FG001|Overall Study|Adverse Event|3|||
155117098|NCT00951080|559859148|FG000|Overall Study|Lost to Follow-up|0|||
155117099|NCT00951080|559859149|FG001|Overall Study|Lost to Follow-up|1|||
155117100|NCT00951080|559859148|FG000|Overall Study|Physician Decision|4|||
155117101|NCT00951080|559859149|FG001|Overall Study|Physician Decision|1|||
155117102|NCT00951080|559859148|FG000|Overall Study|Other|19|||
155117103|NCT00951080|559859149|FG001|Overall Study|Other|22|||
155117104|NCT05463744|559859150|FG000|Treatment Period|Withdrawal by Subject|19|||
155117105|NCT05463744|559859151|FG001|Treatment Period|Withdrawal by Subject|16|||
155117106|NCT05463744|559859150|FG000|Treatment Period|Adverse Event|4|||
155117107|NCT05463744|559859151|FG001|Treatment Period|Adverse Event|4|||
155117108|NCT05463744|559859150|FG000|Treatment Period|Pregnancy|0|||
155117109|NCT05463744|559859151|FG001|Treatment Period|Pregnancy|3|||
155117110|NCT05463744|559859150|FG000|Treatment Period|Lost to Follow-up|1|||
155117111|NCT05463744|559859151|FG001|Treatment Period|Lost to Follow-up|3|||
155117112|NCT05463744|559859150|FG000|Treatment Period|Inadvertent enrollment|2|||
155117113|NCT05463744|559859151|FG001|Treatment Period|Inadvertent enrollment|1|||
155117114|NCT05463744|559859150|FG000|Treatment Period|Death|0|||
155117115|NCT05463744|559859151|FG001|Treatment Period|Death|1|||
155117116|NCT05463744|559859150|FG000|Treatment Period|Non-compliance with Study Drug|1|||
155117117|NCT05463744|559859151|FG001|Treatment Period|Non-compliance with Study Drug|0|||
155117118|NCT05463744|559859150|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
155117119|NCT05463744|559859151|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
155117120|NCT05463744|559859150|FG000|Treatment Period|Physician Decision|0|||
155117121|NCT05463744|559859151|FG001|Treatment Period|Physician Decision|1|||
155117122|NCT05463744|559859150|FG000|Follow-Up Period|Withdrawal by Subject|3|||
155117123|NCT05463744|559859151|FG001|Follow-Up Period|Withdrawal by Subject|1|||
155117124|NCT05463744|559859150|FG000|Follow-Up Period|Lost to Follow-up|1|||
155117125|NCT05463744|559859151|FG001|Follow-Up Period|Lost to Follow-up|1|||
154907868|NCT01997892|559084364|FG000|Overall Study|Study completion data not recorded|35|||
154907869|NCT02531633|559084365|FG000|Part A (52 Weeks)|Sponsor request|24|||
154907870|NCT02531633|559084366|FG001|Part A (52 Weeks)|Sponsor request|24|||
154907871|NCT02531633|559084367|FG002|Part A (52 Weeks)|Sponsor request|18|||
154907872|NCT02531633|559084368|FG003|Part A (52 Weeks)|Sponsor request|18|||
154907873|NCT02531633|559084369|FG004|Part A (52 Weeks)|Sponsor request|19|||
154907874|NCT02531633|559084370|FG005|Part A (52 Weeks)|Sponsor request|0|||
154907875|NCT02531633|559084371|FG006|Part A (52 Weeks)|Sponsor request|0|||
154907876|NCT02531633|559084372|FG007|Part A (52 Weeks)|Sponsor request|0|||
154907877|NCT02531633|559084373|FG008|Part A (52 Weeks)|Sponsor request|0|||
154907878|NCT02531633|559084374|FG009|Part A (52 Weeks)|Sponsor request|0|||
154907879|NCT02531633|559084365|FG000|Part A (52 Weeks)|Protocol Violation|1|||
154907880|NCT02531633|559084366|FG001|Part A (52 Weeks)|Protocol Violation|0|||
154907881|NCT02531633|559084367|FG002|Part A (52 Weeks)|Protocol Violation|0|||
154907882|NCT02531633|559084368|FG003|Part A (52 Weeks)|Protocol Violation|0|||
154907883|NCT02531633|559084369|FG004|Part A (52 Weeks)|Protocol Violation|0|||
154907884|NCT02531633|559084370|FG005|Part A (52 Weeks)|Protocol Violation|0|||
154907885|NCT02531633|559084371|FG006|Part A (52 Weeks)|Protocol Violation|0|||
154907886|NCT02531633|559084372|FG007|Part A (52 Weeks)|Protocol Violation|0|||
154907887|NCT02531633|559084373|FG008|Part A (52 Weeks)|Protocol Violation|0|||
154907888|NCT02531633|559084374|FG009|Part A (52 Weeks)|Protocol Violation|0|||
154907889|NCT02531633|559084365|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
154907890|NCT02531633|559084366|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
154907891|NCT02531633|559084367|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
154907892|NCT02531633|559084368|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
154907893|NCT02531633|559084369|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
154907894|NCT02531633|559084370|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
154907895|NCT02531633|559084371|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
154907896|NCT02531633|559084372|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
154907897|NCT02531633|559084373|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
154907898|NCT02531633|559084374|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
154907899|NCT02531633|559084365|FG000|Part A (52 Weeks)|Physician Decision|1|||
154907900|NCT02531633|559084366|FG001|Part A (52 Weeks)|Physician Decision|4|||
154907901|NCT02531633|559084367|FG002|Part A (52 Weeks)|Physician Decision|3|||
154907902|NCT02531633|559084368|FG003|Part A (52 Weeks)|Physician Decision|1|||
154907903|NCT02531633|559084369|FG004|Part A (52 Weeks)|Physician Decision|0|||
154907904|NCT02531633|559084370|FG005|Part A (52 Weeks)|Physician Decision|0|||
154907905|NCT02531633|559084371|FG006|Part A (52 Weeks)|Physician Decision|0|||
154907906|NCT02531633|559084372|FG007|Part A (52 Weeks)|Physician Decision|0|||
154907907|NCT02531633|559084373|FG008|Part A (52 Weeks)|Physician Decision|0|||
154907908|NCT02531633|559084374|FG009|Part A (52 Weeks)|Physician Decision|0|||
154907909|NCT02531633|559084365|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
154907910|NCT02531633|559084366|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
154907911|NCT02531633|559084367|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
154907912|NCT02531633|559084368|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
154907913|NCT02531633|559084369|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
154907914|NCT02531633|559084370|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
154907915|NCT02531633|559084371|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
154907916|NCT02531633|559084372|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
154907917|NCT02531633|559084373|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
154907918|NCT02531633|559084374|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
154907919|NCT02531633|559084365|FG000|Part A (52 Weeks)|Other|2|||
154907920|NCT02531633|559084366|FG001|Part A (52 Weeks)|Other|0|||
154907921|NCT02531633|559084367|FG002|Part A (52 Weeks)|Other|0|||
154907922|NCT02531633|559084368|FG003|Part A (52 Weeks)|Other|0|||
154907923|NCT02531633|559084369|FG004|Part A (52 Weeks)|Other|0|||
154907924|NCT02531633|559084370|FG005|Part A (52 Weeks)|Other|0|||
154907925|NCT02531633|559084371|FG006|Part A (52 Weeks)|Other|0|||
154907926|NCT02531633|559084372|FG007|Part A (52 Weeks)|Other|0|||
154907927|NCT02531633|559084373|FG008|Part A (52 Weeks)|Other|0|||
154907928|NCT02531633|559084374|FG009|Part A (52 Weeks)|Other|0|||
154907929|NCT02531633|559084365|FG000|Part B (104 Weeks)|Sponsor request|0|||
154907930|NCT02531633|559084366|FG001|Part B (104 Weeks)|Sponsor request|0|||
154907931|NCT02531633|559084367|FG002|Part B (104 Weeks)|Sponsor request|0|||
154907932|NCT02531633|559084368|FG003|Part B (104 Weeks)|Sponsor request|0|||
154907933|NCT02531633|559084369|FG004|Part B (104 Weeks)|Sponsor request|0|||
154907934|NCT02531633|559084370|FG005|Part B (104 Weeks)|Sponsor request|8|||
154907935|NCT02531633|559084371|FG006|Part B (104 Weeks)|Sponsor request|5|||
155117126|NCT01960998|559859152|FG000|Overall Study|Lost to Follow-up|3|||
155117127|NCT01960998|559859153|FG001|Overall Study|Lost to Follow-up|7|||
155117128|NCT01960998|559859152|FG000|Overall Study|Death|0|||
155117129|NCT01960998|559859153|FG001|Overall Study|Death|1|||
155117130|NCT01960998|559859152|FG000|Overall Study|Withdrawal by Subject|8|||
155117131|NCT01960998|559859153|FG001|Overall Study|Withdrawal by Subject|2|||
155117132|NCT01960998|559859152|FG000|Overall Study|lost computer access|0|||
155117133|NCT01960998|559859153|FG001|Overall Study|lost computer access|1|||
155117134|NCT03761394|559859154|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
155117135|NCT03761394|559859155|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
155117136|NCT03761394|559859156|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
155117137|NCT03761394|559859157|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
155117138|NCT03761394|559859154|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
155117139|NCT03761394|559859155|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
155117140|NCT03761394|559859156|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
155117141|NCT03761394|559859157|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
155117142|NCT03761394|559859154|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
155117143|NCT03761394|559859155|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
155117144|NCT03761394|559859156|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
155117145|NCT03761394|559859157|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
155117146|NCT03761394|559859154|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
155117147|NCT03761394|559859155|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
155117148|NCT03761394|559859156|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
154907936|NCT02531633|559084372|FG007|Part B (104 Weeks)|Sponsor request|3|||
154907937|NCT02531633|559084373|FG008|Part B (104 Weeks)|Sponsor request|5|||
154907938|NCT02531633|559084374|FG009|Part B (104 Weeks)|Sponsor request|4|||
154907939|NCT02531633|559084365|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
154907940|NCT02531633|559084366|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
154907941|NCT02531633|559084367|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
154907942|NCT02531633|559084368|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
154907943|NCT02531633|559084369|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
154907944|NCT02531633|559084370|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
154907945|NCT02531633|559084371|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
154907946|NCT02531633|559084372|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
154907947|NCT02531633|559084373|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
154907948|NCT02531633|559084374|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
154907949|NCT04097925|559084375|FG000|Overall Study|Withdrawal by Subject|1|||
154907950|NCT02608099|559084376|FG000|Overall Study|Ablation procedure not initiated|3|||
154907951|NCT02608099|559084377|FG001|Overall Study|Ablation procedure not initiated|2|||
154907952|NCT01952041|559084378|FG000|Overall Study|Lost to Follow-up|9|||
154907953|NCT01952041|559084379|FG001|Overall Study|Lost to Follow-up|16|||
154907954|NCT01952041|559084378|FG000|Overall Study|Withdrawal by Subject|7|||
154907955|NCT01952041|559084379|FG001|Overall Study|Withdrawal by Subject|5|||
154907956|NCT01952041|559084378|FG000|Overall Study|Death|1|||
154907957|NCT01952041|559084379|FG001|Overall Study|Death|0|||
154907958|NCT01736176|559084380|FG000|Overall Study|Adverse Event|3|||
154907959|NCT01736176|559084380|FG000|Overall Study|Withdrawal by Subject|4|||
154907960|NCT01736176|559084380|FG000|Overall Study|Lack of Efficacy|3|||
154907961|NCT01736176|559084380|FG000|Overall Study|Unable to Complete PEG Placement|1|||
154907962|NCT00186121|559084381|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
154907963|NCT00186121|559084381|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
154907964|NCT00186121|559084381|FG000|Overall Study|Not eligible (no treatment)|1|||
154907965|NCT03650387|559084382|FG000|Overall Study|Withdrawal by Subject|13|||
154907966|NCT03650387|559084382|FG000|Overall Study|Lost to Follow-up|12|||
154907967|NCT03650387|559084382|FG000|Overall Study|Adverse Event (Not related)|1|||
154907968|NCT03650387|559084382|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
154907969|NCT00417248|559084383|FG000|Overall Study|Study Terminated|6|||
154907970|NCT00417248|559084383|FG000|Overall Study|Death|1|||
154907971|NCT00417248|559084383|FG000|Overall Study|Lack of Efficacy|1|||
154907972|NCT01569568|559084384|FG000|Overall Study|Physician Decision|0|||
154907973|NCT01569568|559084385|FG001|Overall Study|Physician Decision|2|||
154907974|NCT05815758|559084386|FG000|Overall Study|Adverse Event|6|||
154907975|NCT05815758|559084387|FG001|Overall Study|Adverse Event|2|||
154907976|NCT05815758|559084386|FG000|Overall Study|Lost to Follow-up|14|||
154907977|NCT05815758|559084387|FG001|Overall Study|Lost to Follow-up|1|||
154907978|NCT05815758|559084386|FG000|Overall Study|Withdrawal by Subject|6|||
154907979|NCT05815758|559084387|FG001|Overall Study|Withdrawal by Subject|6|||
154907980|NCT05815758|559084386|FG000|Overall Study|Protocol Violation|1|||
154907981|NCT05815758|559084387|FG001|Overall Study|Protocol Violation|1|||
154907982|NCT05815758|559084386|FG000|Overall Study|Discontinued|4|||
154907983|NCT05815758|559084387|FG001|Overall Study|Discontinued|4|||
154907984|NCT03661983|559084388|FG000|Open Label Stabilization Phase|Adverse Event|5|||
154907985|NCT03661983|559084389|FG001|Open Label Stabilization Phase|Adverse Event|0|||
154907986|NCT03661983|559084390|FG002|Open Label Stabilization Phase|Adverse Event|0|||
154907987|NCT03661983|559084391|FG003|Open Label Stabilization Phase|Adverse Event|0|||
154907988|NCT03661983|559084388|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
154907989|NCT03661983|559084389|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
154907990|NCT03661983|559084390|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
154907991|NCT03661983|559084391|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
154907992|NCT03661983|559084388|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
154907993|NCT03661983|559084389|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
154907994|NCT03661983|559084390|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
154907995|NCT03661983|559084391|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
154907996|NCT03661983|559084388|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
154907997|NCT03661983|559084389|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
154907998|NCT03661983|559084390|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
154907999|NCT03661983|559084391|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
154908000|NCT03661983|559084388|FG000|Double-blind Randomized Phase|Adverse Event|0|||
154908001|NCT03661983|559084389|FG001|Double-blind Randomized Phase|Adverse Event|1|||
154908002|NCT03661983|559084390|FG002|Double-blind Randomized Phase|Adverse Event|0|||
154908003|NCT03661983|559084391|FG003|Double-blind Randomized Phase|Adverse Event|0|||
154908004|NCT03661983|559084388|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
154908005|NCT03661983|559084389|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
154908006|NCT03661983|559084390|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
154908007|NCT03661983|559084391|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
154908008|NCT03661983|559084388|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
154908009|NCT03661983|559084389|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
154908010|NCT03661983|559084390|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
154908011|NCT03661983|559084391|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
154908012|NCT03661983|559084388|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
154908013|NCT03661983|559084389|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
154908014|NCT03661983|559084390|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
154908015|NCT03661983|559084391|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
154908016|NCT02903966|559084392|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
154908017|NCT02903966|559084393|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
154908018|NCT02903966|559084392|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
154908019|NCT02903966|559084393|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
154908020|NCT02903966|559084392|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
154908021|NCT02903966|559084393|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
154908022|NCT00934791|559084394|FG000|Overall Study|Withdrawal by Subject|1|||
154908023|NCT00934791|559084395|FG001|Overall Study|Withdrawal by Subject|0|||
154908024|NCT01320033|559084397|FG000|Overall Study|Lack of Efficacy|0|||
154908025|NCT01320033|559084398|FG001|Overall Study|Lack of Efficacy|0|||
154908026|NCT01320033|559084399|FG002|Overall Study|Lack of Efficacy|1|||
154908027|NCT01320033|559084397|FG000|Overall Study|Adverse Event|9|||
154908028|NCT01320033|559084398|FG001|Overall Study|Adverse Event|7|||
154908029|NCT01320033|559084399|FG002|Overall Study|Adverse Event|8|||
154908030|NCT01320033|559084397|FG000|Overall Study|Withdrawal by Subject|22|||
154908031|NCT01320033|559084398|FG001|Overall Study|Withdrawal by Subject|23|||
154908032|NCT01320033|559084399|FG002|Overall Study|Withdrawal by Subject|23|||
154908033|NCT01320033|559084397|FG000|Overall Study|Protocol Violation|3|||
154908034|NCT01320033|559084398|FG001|Overall Study|Protocol Violation|5|||
154908035|NCT01320033|559084399|FG002|Overall Study|Protocol Violation|3|||
154908036|NCT01320033|559084397|FG000|Overall Study|Lost to Follow-up|22|||
154908037|NCT01320033|559084398|FG001|Overall Study|Lost to Follow-up|26|||
154908038|NCT01320033|559084399|FG002|Overall Study|Lost to Follow-up|17|||
154908039|NCT01320033|559084397|FG000|Overall Study|Other|2|||
154908040|NCT01320033|559084398|FG001|Overall Study|Other|3|||
154908041|NCT01320033|559084399|FG002|Overall Study|Other|1|||
154908042|NCT02425891|559084400|FG000|Overall Study|Death|333|||
154908043|NCT02425891|559084401|FG001|Overall Study|Death|314|||
154908044|NCT02425891|559084400|FG000|Overall Study|Lost to Follow-up|4|||
154908045|NCT02425891|559084401|FG001|Overall Study|Lost to Follow-up|6|||
154908046|NCT02425891|559084400|FG000|Overall Study|Non-Compliance|1|||
154908047|NCT02425891|559084401|FG001|Overall Study|Non-Compliance|1|||
154908048|NCT02425891|559084400|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
155117149|NCT03761394|559859157|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
155117150|NCT02910401|559859158|FG000|Overall Study|Study closure Study closure|0|||
155117151|NCT02910401|559859159|FG001|Overall Study|Study closure Study closure|0|||
155117152|NCT02910401|559859160|FG002|Overall Study|Study closure Study closure|2|||
155117153|NCT02910401|559859158|FG000|Overall Study|Physician Decision|1|||
154908049|NCT02425891|559084401|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
154908050|NCT02425891|559084400|FG000|Overall Study|Physician Decision|0|||
154908051|NCT02425891|559084401|FG001|Overall Study|Physician Decision|1|||
154908052|NCT02425891|559084400|FG000|Overall Study|Protocol Violation|1|||
154908053|NCT02425891|559084401|FG001|Overall Study|Protocol Violation|1|||
154908054|NCT02425891|559084400|FG000|Overall Study|Study Terminated By Sponsor|85|||
154908055|NCT02425891|559084401|FG001|Overall Study|Study Terminated By Sponsor|95|||
154908056|NCT02425891|559084400|FG000|Overall Study|Withdrawal by Subject|27|||
154908057|NCT02425891|559084401|FG001|Overall Study|Withdrawal by Subject|32|||
155117154|NCT02910401|559859159|FG001|Overall Study|Physician Decision|0|||
155117155|NCT02910401|559859160|FG002|Overall Study|Physician Decision|0|||
155117156|NCT00098748|559859163|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
154908058|NCT00963469|559084402|FG000|Overall Study|Adverse Event|15|||
154908059|NCT00963469|559084403|FG001|Overall Study|Adverse Event|11|||
154908060|NCT00963469|559084404|FG002|Overall Study|Adverse Event|1|||
154908061|NCT00963469|559084402|FG000|Overall Study|Lack of Efficacy|10|||
154908062|NCT00963469|559084403|FG001|Overall Study|Lack of Efficacy|7|||
154908063|NCT00963469|559084404|FG002|Overall Study|Lack of Efficacy|2|||
154908064|NCT00963469|559084402|FG000|Overall Study|Lost to Follow-up|1|||
154908065|NCT00963469|559084403|FG001|Overall Study|Lost to Follow-up|1|||
154908066|NCT00963469|559084404|FG002|Overall Study|Lost to Follow-up|0|||
154908067|NCT00963469|559084402|FG000|Overall Study|Protocol Violation|5|||
154908068|NCT00963469|559084403|FG001|Overall Study|Protocol Violation|5|||
154908069|NCT00963469|559084404|FG002|Overall Study|Protocol Violation|3|||
154908070|NCT00963469|559084402|FG000|Overall Study|Withdrawal by Subject|4|||
154908071|NCT00963469|559084403|FG001|Overall Study|Withdrawal by Subject|1|||
154908072|NCT00963469|559084404|FG002|Overall Study|Withdrawal by Subject|1|||
154908073|NCT00963469|559084402|FG000|Overall Study|Pre-randomization Adverse Event|1|||
154908074|NCT00963469|559084403|FG001|Overall Study|Pre-randomization Adverse Event|2|||
154908075|NCT00963469|559084404|FG002|Overall Study|Pre-randomization Adverse Event|0|||
154908076|NCT00963469|559084402|FG000|Overall Study|Moved|1|||
154908077|NCT00963469|559084403|FG001|Overall Study|Moved|0|||
154908078|NCT00963469|559084404|FG002|Overall Study|Moved|0|||
154908079|NCT00963469|559084402|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
154908080|NCT00963469|559084403|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
154908081|NCT00963469|559084404|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
154908082|NCT04124952|559084407|FG000|Overall Study|Lost to Follow-up|1|||
154908083|NCT02943577|559084408|FG000|Overall Study|Protocol Violation|0|||
154908084|NCT02943577|559084409|FG001|Overall Study|Protocol Violation|1|||
154908085|NCT02943577|559084408|FG000|Overall Study|Adverse Event|3|||
154908086|NCT02943577|559084409|FG001|Overall Study|Adverse Event|2|||
154908087|NCT02943577|559084408|FG000|Overall Study|Lost to Follow-up|0|||
154908088|NCT02943577|559084409|FG001|Overall Study|Lost to Follow-up|1|||
154908089|NCT02943577|559084408|FG000|Overall Study|Withdrawal by Subject|1|||
154908090|NCT02943577|559084409|FG001|Overall Study|Withdrawal by Subject|1|||
154908091|NCT02943577|559084408|FG000|Overall Study|Pregnancy|1|||
154908092|NCT02943577|559084409|FG001|Overall Study|Pregnancy|0|||
154908093|NCT00808028|559084414|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
154908094|NCT00808028|559084415|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
154908095|NCT00808028|559084416|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
154908096|NCT00808028|559084417|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
154908097|NCT00808028|559084414|FG000|Stage 1 (6 Months)|Other|1|||
154908098|NCT00808028|559084415|FG001|Stage 1 (6 Months)|Other|0|||
154908099|NCT00808028|559084416|FG002|Stage 1 (6 Months)|Other|2|||
154908100|NCT00808028|559084417|FG003|Stage 1 (6 Months)|Other|4|||
154908101|NCT00808028|559084414|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
154908102|NCT00808028|559084415|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
154908103|NCT00808028|559084416|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
154908104|NCT00808028|559084417|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
154908105|NCT00808028|559084414|FG000|Stage 1 (6 Months)|Adverse Event|0|||
154908106|NCT00808028|559084415|FG001|Stage 1 (6 Months)|Adverse Event|0|||
154908107|NCT00808028|559084416|FG002|Stage 1 (6 Months)|Adverse Event|1|||
154908108|NCT00808028|559084417|FG003|Stage 1 (6 Months)|Adverse Event|2|||
154908109|NCT00808028|559084414|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
154908110|NCT00808028|559084415|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
154908111|NCT00808028|559084416|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
154908112|NCT00808028|559084417|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
154908113|NCT00808028|559084414|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
154908114|NCT00808028|559084415|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
154908115|NCT00808028|559084416|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
154908116|NCT00808028|559084417|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
154908117|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
154908118|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
154908119|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
154908120|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
155117157|NCT00098748|559859164|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
154908121|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
154908122|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
154908123|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
155117158|NCT00098748|559859165|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
154908124|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
154908125|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
154908126|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
154908127|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
154908128|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
154908129|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
154908130|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
154908131|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
154908132|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
154908133|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
154908134|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
154908135|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
154908136|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
154908137|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
154908138|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
154908139|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
154908140|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
154908141|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
154908142|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
154908143|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
154908144|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
154908145|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
154908146|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
154908147|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
154908148|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
154908149|NCT00808028|559084414|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
154908150|NCT00808028|559084415|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
154908151|NCT00808028|559084416|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
154908152|NCT00808028|559084417|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
154908153|NCT01222767|559084418|FG000|Overall Study|Progressive disease|13|||
154908154|NCT01222767|559084418|FG000|Overall Study|Adverse Event|2|||
154908155|NCT01222767|559084418|FG000|Overall Study|Surgical resection|1|||
154908156|NCT01222767|559084418|FG000|Overall Study|Never treated|1|||
154908157|NCT00081263|559084423|FG000|Overall Study|clerical error|1|||
154908158|NCT00081263|559084424|FG001|Overall Study|clerical error|0|||
154908159|NCT00081263|559084423|FG000|Overall Study|wrong cell type|7|||
154908160|NCT00081263|559084424|FG001|Overall Study|wrong cell type|5|||
154908161|NCT00081263|559084423|FG000|Overall Study|improper pre-protocol therapy|0|||
154908162|NCT00081263|559084424|FG001|Overall Study|improper pre-protocol therapy|1|||
154908163|NCT00081263|559084423|FG000|Overall Study|Inadequate pathology|0|||
154908164|NCT00081263|559084424|FG001|Overall Study|Inadequate pathology|1|||
154908165|NCT00081263|559084423|FG000|Overall Study|Never treated|4|||
154908166|NCT00081263|559084424|FG001|Overall Study|Never treated|5|||
154908167|NCT00081263|559084423|FG000|Overall Study|Inadequate data|5|||
154908168|NCT00081263|559084424|FG001|Overall Study|Inadequate data|10|||
154908169|NCT01852591|559084425|FG000|Overall Study|Withdrawal by Subject|2|||
154908170|NCT01852591|559084425|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
154908171|NCT01267955|559084428|FG000|Stage 1 (6 Months)|Death|3|||
154908172|NCT01267955|559084428|FG000|Stage 2 (6 Months)|Death|5|||
154908173|NCT01267955|559084428|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
154908174|NCT00729560|559084429|FG000|Overall Study|Withdrawal by Subject|3|||
154908175|NCT03233308|559084430|FG000|Overall Study|Adverse Event|1|||
154908176|NCT03233308|559084430|FG000|Overall Study|Protocol Violation|1|||
154908177|NCT03662789|559084431|FG000|Overall Study|Lost to Follow-up|1|||
154908178|NCT03662789|559084432|FG001|Overall Study|Lost to Follow-up|2|||
154908179|NCT03662789|559084431|FG000|Overall Study|Could not perform treadmill test|4|||
154908180|NCT03662789|559084432|FG001|Overall Study|Could not perform treadmill test|4|||
154908181|NCT03662789|559084431|FG000|Overall Study|Death|0|||
154908182|NCT03662789|559084432|FG001|Overall Study|Death|1|||
154908183|NCT02136134|559084433|FG000|Overall Study|Death|170|||
154908184|NCT02136134|559084434|FG001|Overall Study|Death|148|||
154908185|NCT02136134|559084433|FG000|Overall Study|Withdrawal by Subject|19|||
154908186|NCT02136134|559084434|FG001|Overall Study|Withdrawal by Subject|10|||
154908187|NCT02136134|559084433|FG000|Overall Study|Lost to Follow-up|3|||
154908188|NCT02136134|559084434|FG001|Overall Study|Lost to Follow-up|3|||
154908189|NCT02136134|559084433|FG000|Overall Study|Uspecified|55|||
154908190|NCT02136134|559084434|FG001|Overall Study|Uspecified|90|||
154908191|NCT02974621|559084435|FG000|Overall Study|Didn't receive study treatment|1|||
154908192|NCT02974621|559084436|FG001|Overall Study|Didn't receive study treatment|10|||
154908193|NCT00732472|559084437|FG000|Overall Study|Adverse Event|0|||
154908194|NCT00732472|559084438|FG001|Overall Study|Adverse Event|1|||
154908195|NCT00732472|559084439|FG002|Overall Study|Adverse Event|1|||
154908196|NCT00732472|559084440|FG003|Overall Study|Adverse Event|1|||
154908197|NCT00732472|559084437|FG000|Overall Study|Protocol Violation|0|||
154908198|NCT00732472|559084438|FG001|Overall Study|Protocol Violation|0|||
154908199|NCT00732472|559084439|FG002|Overall Study|Protocol Violation|0|||
154908200|NCT00732472|559084440|FG003|Overall Study|Protocol Violation|1|||
154908201|NCT00732472|559084437|FG000|Overall Study|Withdrawal by Subject|0|||
154908202|NCT00732472|559084438|FG001|Overall Study|Withdrawal by Subject|2|||
154908203|NCT00732472|559084439|FG002|Overall Study|Withdrawal by Subject|0|||
154908204|NCT00732472|559084440|FG003|Overall Study|Withdrawal by Subject|1|||
154908205|NCT02559115|559084443|FG000|Overall Study|Withdrawal by Subject|3|||
154908206|NCT00963820|559084450|FG000|Dose Escalation Phase|Progressive Disease|3|||
154908207|NCT00963820|559084451|FG001|Dose Escalation Phase|Progressive Disease|3|||
155117159|NCT00098748|559859163|FG000|Received Study Treatment|Death|2|||
155117160|NCT00098748|559859164|FG001|Received Study Treatment|Death|1|||
155117161|NCT00098748|559859165|FG002|Received Study Treatment|Death|2|||
155117162|NCT00098748|559859163|FG000|Received Study Treatment|Adverse Event|1|||
155117163|NCT00098748|559859164|FG001|Received Study Treatment|Adverse Event|2|||
155117164|NCT00098748|559859165|FG002|Received Study Treatment|Adverse Event|5|||
155117165|NCT00098748|559859163|FG000|Received Study Treatment|Lack of Efficacy|40|||
155117166|NCT00098748|559859164|FG001|Received Study Treatment|Lack of Efficacy|27|||
155117167|NCT00098748|559859165|FG002|Received Study Treatment|Lack of Efficacy|27|||
155117168|NCT00098748|559859163|FG000|Received Study Treatment|Other|2|||
155117169|NCT00098748|559859164|FG001|Received Study Treatment|Other|2|||
155117170|NCT00098748|559859165|FG002|Received Study Treatment|Other|6|||
155117171|NCT00098748|559859163|FG000|Received Study Treatment|Subject defaulted|3|||
155117172|NCT00098748|559859164|FG001|Received Study Treatment|Subject defaulted|4|||
155117173|NCT00098748|559859165|FG002|Received Study Treatment|Subject defaulted|4|||
155117174|NCT00098748|559859163|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
155117175|NCT00098748|559859164|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
155117176|NCT00098748|559859165|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
155117177|NCT00098748|559859163|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
155117178|NCT00098748|559859164|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
155117179|NCT00098748|559859165|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
155117180|NCT00098748|559859163|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
155117181|NCT00098748|559859164|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
155117182|NCT00098748|559859165|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
155117183|NCT00098748|559859163|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
155117184|NCT00098748|559859164|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
154908208|NCT00963820|559084452|FG002|Dose Escalation Phase|Progressive Disease|3|||
154908209|NCT00963820|559084453|FG003|Dose Escalation Phase|Progressive Disease|3|||
154908210|NCT00963820|559084454|FG004|Dose Escalation Phase|Progressive Disease|4|||
154908211|NCT00963820|559084455|FG005|Dose Escalation Phase|Progressive Disease|3|||
154908212|NCT00963820|559084456|FG006|Dose Escalation Phase|Progressive Disease|3|||
154908213|NCT00963820|559084457|FG007|Dose Escalation Phase|Progressive Disease|2|||
154908214|NCT00963820|559084458|FG008|Dose Escalation Phase|Progressive Disease|0|||
154908215|NCT00963820|559084459|FG009|Dose Escalation Phase|Progressive Disease|0|||
154908216|NCT00963820|559084460|FG010|Dose Escalation Phase|Progressive Disease|0|||
154908217|NCT00963820|559084461|FG011|Dose Escalation Phase|Progressive Disease|0|||
154908218|NCT00963820|559084450|FG000|Dose Escalation Phase|Adverse Event|0|||
154908219|NCT00963820|559084451|FG001|Dose Escalation Phase|Adverse Event|0|||
154908220|NCT00963820|559084452|FG002|Dose Escalation Phase|Adverse Event|0|||
154908221|NCT00963820|559084453|FG003|Dose Escalation Phase|Adverse Event|0|||
154908222|NCT00963820|559084454|FG004|Dose Escalation Phase|Adverse Event|0|||
154908223|NCT00963820|559084455|FG005|Dose Escalation Phase|Adverse Event|0|||
154908224|NCT00963820|559084456|FG006|Dose Escalation Phase|Adverse Event|3|||
154908225|NCT00963820|559084457|FG007|Dose Escalation Phase|Adverse Event|1|||
154908226|NCT00963820|559084458|FG008|Dose Escalation Phase|Adverse Event|0|||
154908227|NCT00963820|559084459|FG009|Dose Escalation Phase|Adverse Event|0|||
154908228|NCT00963820|559084460|FG010|Dose Escalation Phase|Adverse Event|0|||
154908229|NCT00963820|559084461|FG011|Dose Escalation Phase|Adverse Event|0|||
154908230|NCT00963820|559084450|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
154908231|NCT00963820|559084451|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
154908232|NCT00963820|559084452|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
154908233|NCT00963820|559084453|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
154908234|NCT00963820|559084454|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
154908235|NCT00963820|559084455|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
155117185|NCT00098748|559859165|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
155117186|NCT00098748|559859163|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
155117187|NCT00098748|559859164|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
155117188|NCT00098748|559859165|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
155117189|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
155176087|NCT02509117|560082233|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
154908236|NCT00963820|559084456|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
154908237|NCT00963820|559084457|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
154908238|NCT00963820|559084458|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
154908239|NCT00963820|559084459|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
154908240|NCT00963820|559084460|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
154908241|NCT00963820|559084461|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
155117190|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
155117191|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Death|0|||
155117192|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Death|0|||
155117193|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
155117194|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
155117195|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
155117196|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
155117197|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
155117198|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
155117199|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
155117200|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
155117201|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
155117202|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
155117203|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
155117204|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
155117205|NCT00433160|559859168|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
155117206|NCT00433160|559859169|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
155117207|NCT00433160|559859168|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
155117208|NCT00433160|559859169|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
155117209|NCT00433160|559859168|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
155117210|NCT00433160|559859169|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
155117211|NCT00433160|559859168|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
155117212|NCT00433160|559859169|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
155117213|NCT00433160|559859168|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
155117214|NCT00433160|559859169|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
155117215|NCT00433160|559859168|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
155117216|NCT00433160|559859169|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
155117217|NCT00433160|559859168|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
155117218|NCT00433160|559859169|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
155117219|NCT00433160|559859168|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
155117220|NCT00433160|559859169|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
155117221|NCT01774253|559859170|FG000|Overall Study|Lack of Efficacy|4|||
155117222|NCT01774253|559859170|FG000|Overall Study|Physician Decision|2|||
155117223|NCT01774253|559859170|FG000|Overall Study|Withdrawal by Subject|2|||
155117224|NCT01774253|559859170|FG000|Overall Study|Death|1|||
155117225|NCT02240368|559859171|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
155117226|NCT02240368|559859172|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
155117227|NCT02240368|559859173|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
155117228|NCT02240368|559859171|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
155117229|NCT02240368|559859172|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
155117230|NCT02240368|559859173|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
155117231|NCT02080481|559859182|FG000|Overall Study|Never received a block.|1|||
155117232|NCT02080481|559859183|FG001|Overall Study|Never received a block.|0|||
155117233|NCT04508751|559859186|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
155117234|NCT04508751|559859187|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
155117235|NCT04508751|559859188|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
155117236|NCT03551665|559859191|FG000|Overall Study|Lost to Follow-up|11|||
155117237|NCT03551665|559859192|FG001|Overall Study|Lost to Follow-up|2|||
155117238|NCT00642174|559860648|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
154908242|NCT00963820|559084450|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908243|NCT00963820|559084451|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908244|NCT00963820|559084452|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908245|NCT00963820|559084453|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908246|NCT00963820|559084454|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908247|NCT00963820|559084455|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908248|NCT00963820|559084456|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
154908249|NCT00963820|559084457|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908250|NCT00963820|559084458|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908251|NCT00963820|559084459|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154983358|NCT00773734|559364417|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
155117239|NCT00642174|559860649|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
155117240|NCT01730339|559860650|FG000|Overall Study|Withdrawal by Subject|3|||
155117241|NCT01730339|559860651|FG001|Overall Study|Withdrawal by Subject|2|||
155117242|NCT01730339|559860650|FG000|Overall Study|Lost to Follow-up|1|||
155117243|NCT01730339|559860651|FG001|Overall Study|Lost to Follow-up|1|||
155117244|NCT01730339|559860650|FG000|Overall Study|Un-specified|1|||
155117245|NCT01730339|559860651|FG001|Overall Study|Un-specified|0|||
155117246|NCT00896363|559860652|FG000|Overall Study|Adverse Event|3|||
155117247|NCT00896363|559860653|FG001|Overall Study|Adverse Event|4|||
154908252|NCT00963820|559084460|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908253|NCT00963820|559084461|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
154908254|NCT00963820|559084450|FG000|Expansion Phase|Progressive Disease|0|||
154908255|NCT00963820|559084451|FG001|Expansion Phase|Progressive Disease|0|||
154908256|NCT00963820|559084452|FG002|Expansion Phase|Progressive Disease|0|||
154908257|NCT00963820|559084453|FG003|Expansion Phase|Progressive Disease|0|||
154908258|NCT00963820|559084454|FG004|Expansion Phase|Progressive Disease|0|||
154908259|NCT00963820|559084455|FG005|Expansion Phase|Progressive Disease|0|||
154908260|NCT00963820|559084456|FG006|Expansion Phase|Progressive Disease|0|||
154908261|NCT00963820|559084457|FG007|Expansion Phase|Progressive Disease|0|||
154908262|NCT00963820|559084458|FG008|Expansion Phase|Progressive Disease|8|||
154908263|NCT00963820|559084459|FG009|Expansion Phase|Progressive Disease|6|||
154908264|NCT00963820|559084460|FG010|Expansion Phase|Progressive Disease|4|||
154908265|NCT00963820|559084461|FG011|Expansion Phase|Progressive Disease|2|||
154908266|NCT00963820|559084450|FG000|Expansion Phase|Adverse Event|0|||
154908267|NCT00963820|559084451|FG001|Expansion Phase|Adverse Event|0|||
154908268|NCT00963820|559084452|FG002|Expansion Phase|Adverse Event|0|||
154908269|NCT00963820|559084453|FG003|Expansion Phase|Adverse Event|0|||
154908270|NCT00963820|559084454|FG004|Expansion Phase|Adverse Event|0|||
154908271|NCT00963820|559084455|FG005|Expansion Phase|Adverse Event|0|||
154908272|NCT00963820|559084456|FG006|Expansion Phase|Adverse Event|0|||
154908273|NCT00963820|559084457|FG007|Expansion Phase|Adverse Event|0|||
154908274|NCT00963820|559084458|FG008|Expansion Phase|Adverse Event|1|||
154908275|NCT00963820|559084459|FG009|Expansion Phase|Adverse Event|3|||
154908276|NCT00963820|559084460|FG010|Expansion Phase|Adverse Event|0|||
154908277|NCT00963820|559084461|FG011|Expansion Phase|Adverse Event|0|||
154908278|NCT00963820|559084450|FG000|Expansion Phase|Withdrawal by Subject|0|||
154908279|NCT00963820|559084451|FG001|Expansion Phase|Withdrawal by Subject|0|||
154908280|NCT00963820|559084452|FG002|Expansion Phase|Withdrawal by Subject|0|||
154908281|NCT00963820|559084453|FG003|Expansion Phase|Withdrawal by Subject|0|||
154908282|NCT00963820|559084454|FG004|Expansion Phase|Withdrawal by Subject|0|||
154908283|NCT00963820|559084455|FG005|Expansion Phase|Withdrawal by Subject|0|||
154908284|NCT00963820|559084456|FG006|Expansion Phase|Withdrawal by Subject|0|||
154908285|NCT00963820|559084457|FG007|Expansion Phase|Withdrawal by Subject|0|||
154908286|NCT00963820|559084458|FG008|Expansion Phase|Withdrawal by Subject|1|||
154908287|NCT00963820|559084459|FG009|Expansion Phase|Withdrawal by Subject|0|||
154908288|NCT00963820|559084460|FG010|Expansion Phase|Withdrawal by Subject|1|||
154908289|NCT00963820|559084461|FG011|Expansion Phase|Withdrawal by Subject|1|||
154908290|NCT00963820|559084450|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908291|NCT00963820|559084451|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908292|NCT00963820|559084452|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908293|NCT00963820|559084453|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908294|NCT00963820|559084454|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908295|NCT00963820|559084455|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908296|NCT00963820|559084456|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908297|NCT00963820|559084457|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908298|NCT00963820|559084458|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908299|NCT00963820|559084459|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908300|NCT00963820|559084460|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
154908301|NCT00963820|559084461|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
154908302|NCT04556175|559084466|FG000|Overall Study|Study terminated due to COVID-19|8|||
154908303|NCT04556175|559084467|FG001|Overall Study|Study terminated due to COVID-19|8|||
154908304|NCT05549505|559084468|FG000|Overall Study|Lost to Follow-up|2|||
154908305|NCT05549505|559084469|FG001|Overall Study|Lost to Follow-up|0|||
154908306|NCT05549505|559084468|FG000|Overall Study|Withdrawal by Subject|3|||
154908307|NCT05549505|559084469|FG001|Overall Study|Withdrawal by Subject|3|||
154908308|NCT05549505|559084468|FG000|Overall Study|Other: Miscellaneous|3|||
154908309|NCT05549505|559084469|FG001|Overall Study|Other: Miscellaneous|6|||
154908310|NCT02756845|559084472|FG000|Overall Study|Death|12|||
154908311|NCT02756845|559084473|FG001|Overall Study|Death|2|||
155117248|NCT00896363|559860654|FG002|Overall Study|Adverse Event|2|||
155117249|NCT00896363|559860652|FG000|Overall Study|Lack of Efficacy|0|||
154908312|NCT02756845|559084472|FG000|Overall Study|Withdrawal by Subject|1|||
155117250|NCT00896363|559860653|FG001|Overall Study|Lack of Efficacy|2|||
154908313|NCT02756845|559084473|FG001|Overall Study|Withdrawal by Subject|0|||
154908314|NCT01878175|559084474|FG000|Overall Study|Developed contraindicated health problem|2|||
154908315|NCT01842334|559084475|FG000|Overall Study|Withdrawal by Subject|3|||
154908316|NCT01842334|559084476|FG001|Overall Study|Withdrawal by Subject|3|||
154908317|NCT01842334|559084475|FG000|Overall Study|Moved away mid-study|0|||
154908318|NCT01842334|559084476|FG001|Overall Study|Moved away mid-study|1|||
154908319|NCT03299166|559084477|FG000|Overall Study|Adverse Event|9|||
154908320|NCT03299166|559084478|FG001|Overall Study|Adverse Event|4|||
154908321|NCT03299166|559084477|FG000|Overall Study|Withdrawal by Subject|6|||
155117251|NCT00896363|559860654|FG002|Overall Study|Lack of Efficacy|1|||
155117252|NCT00896363|559860652|FG000|Overall Study|Withdrawal by Subject|3|||
154908322|NCT03299166|559084478|FG001|Overall Study|Withdrawal by Subject|5|||
154908323|NCT03299166|559084477|FG000|Overall Study|Physician Decision|1|||
154908324|NCT03299166|559084478|FG001|Overall Study|Physician Decision|1|||
154908325|NCT03299166|559084477|FG000|Overall Study|Sponsor Decision|3|||
154908326|NCT03299166|559084478|FG001|Overall Study|Sponsor Decision|0|||
154908327|NCT03299166|559084477|FG000|Overall Study|Lost to Follow-up|2|||
154908328|NCT03299166|559084478|FG001|Overall Study|Lost to Follow-up|4|||
154908329|NCT03299166|559084477|FG000|Overall Study|Randomization Error|0|||
154908330|NCT03299166|559084478|FG001|Overall Study|Randomization Error|1|||
154908331|NCT03299166|559084477|FG000|Overall Study|Subject unable to return due to COVID|1|||
154908332|NCT03299166|559084478|FG001|Overall Study|Subject unable to return due to COVID|0|||
154908333|NCT03299166|559084477|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
154908334|NCT03299166|559084478|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
154908335|NCT00423592|559084480|FG000|Overall Study|Adverse Event (through Week 12)|2|||
154908336|NCT00423592|559084480|FG000|Overall Study|Adverse Event (post Week 12)|5|||
154908337|NCT00062647|559084481|FG000|Overall Study|Death|2|||
154908338|NCT00062647|559084482|FG001|Overall Study|Death|2|||
154908339|NCT00062647|559084481|FG000|Overall Study|Adverse Event|1|||
154908340|NCT00062647|559084482|FG001|Overall Study|Adverse Event|1|||
154908341|NCT00062647|559084481|FG000|Overall Study|Withdrawal by Subject|2|||
154908342|NCT00062647|559084482|FG001|Overall Study|Withdrawal by Subject|1|||
154908343|NCT00062647|559084481|FG000|Overall Study|Protocol Violation|1|||
154908344|NCT00062647|559084482|FG001|Overall Study|Protocol Violation|0|||
155117253|NCT00896363|559860653|FG001|Overall Study|Withdrawal by Subject|5|||
155117254|NCT00896363|559860654|FG002|Overall Study|Withdrawal by Subject|5|||
155117255|NCT01145352|559860659|FG000|Overall Study|Found to have been registered twice|6|||
155117256|NCT01145352|559860659|FG000|Overall Study|Treated before marketing approval|4|||
154908345|NCT00062647|559084481|FG000|Overall Study|Lost to Follow-up|1|||
154908346|NCT00062647|559084482|FG001|Overall Study|Lost to Follow-up|2|||
154908347|NCT00062647|559084481|FG000|Overall Study|Failed continuation criteria|4|||
154908348|NCT00062647|559084482|FG001|Overall Study|Failed continuation criteria|2|||
154908349|NCT00062647|559084481|FG000|Overall Study|Other|4|||
154908350|NCT00062647|559084482|FG001|Overall Study|Other|4|||
154908351|NCT00062647|559084481|FG000|Overall Study|Never received study treatment|1|||
154908352|NCT00062647|559084482|FG001|Overall Study|Never received study treatment|1|||
154908353|NCT00255008|559084487|FG000|Overall Study|Adverse Event|1|||
154908354|NCT00255008|559084488|FG001|Overall Study|Adverse Event|1|||
154908355|NCT00255008|559084489|FG002|Overall Study|Adverse Event|2|||
154908356|NCT00255008|559084490|FG003|Overall Study|Adverse Event|0|||
154908357|NCT00255008|559084487|FG000|Overall Study|Lost to Follow-up|1|||
154908358|NCT00255008|559084488|FG001|Overall Study|Lost to Follow-up|0|||
154908359|NCT00255008|559084489|FG002|Overall Study|Lost to Follow-up|1|||
154908360|NCT00255008|559084490|FG003|Overall Study|Lost to Follow-up|2|||
154908361|NCT00255008|559084487|FG000|Overall Study|Did not meet viral reduction criteria|4|||
154908362|NCT00255008|559084488|FG001|Overall Study|Did not meet viral reduction criteria|5|||
154908363|NCT00255008|559084489|FG002|Overall Study|Did not meet viral reduction criteria|0|||
154908364|NCT00255008|559084490|FG003|Overall Study|Did not meet viral reduction criteria|1|||
154908365|NCT00255008|559084487|FG000|Overall Study|Withdrew consent|0|||
154908366|NCT00255008|559084488|FG001|Overall Study|Withdrew consent|0|||
154908367|NCT00255008|559084489|FG002|Overall Study|Withdrew consent|2|||
154908368|NCT00255008|559084490|FG003|Overall Study|Withdrew consent|0|||
154908369|NCT00255008|559084487|FG000|Overall Study|Sponsor request|18|||
154908370|NCT00255008|559084488|FG001|Overall Study|Sponsor request|3|||
154908371|NCT00255008|559084489|FG002|Overall Study|Sponsor request|8|||
154908372|NCT00255008|559084490|FG003|Overall Study|Sponsor request|17|||
154908373|NCT00255008|559084487|FG000|Overall Study|Adverse lab experience|1|||
154908374|NCT00255008|559084488|FG001|Overall Study|Adverse lab experience|0|||
154908375|NCT00255008|559084489|FG002|Overall Study|Adverse lab experience|0|||
154908376|NCT00255008|559084490|FG003|Overall Study|Adverse lab experience|0|||
154908377|NCT00255008|559084487|FG000|Overall Study|Other|7|||
154908378|NCT00255008|559084488|FG001|Overall Study|Other|0|||
154908379|NCT00255008|559084489|FG002|Overall Study|Other|3|||
154908380|NCT00255008|559084490|FG003|Overall Study|Other|2|||
154908381|NCT02470429|559084491|FG000|Overall Study|Adverse Event|1|||
154908382|NCT02470429|559084492|FG001|Overall Study|Adverse Event|0|||
154908383|NCT02470429|559084491|FG000|Overall Study|Withdrawal by Subject|1|||
154908384|NCT02470429|559084492|FG001|Overall Study|Withdrawal by Subject|0|||
154908385|NCT00322387|559084493|FG000|Treatment Period|Adverse Event|0|||
154908386|NCT00322387|559084494|FG001|Treatment Period|Adverse Event|1|||
154908387|NCT00322387|559084493|FG000|Follow-up Period|Final assessment not done|1|||
154908388|NCT00322387|559084494|FG001|Follow-up Period|Final assessment not done|3|||
154908389|NCT00322387|559084493|FG000|Follow-up Period|Death|1|||
154908390|NCT00322387|559084494|FG001|Follow-up Period|Death|0|||
154908391|NCT00707486|559084497|FG000|Overall Study|Withdrawal by Subject|1|||
154908392|NCT01976624|559084498|FG000|Overall Study|Participants contraindicated|2|||
154908393|NCT01976624|559084498|FG000|Overall Study|Participants age less than 19 years|12|||
154908394|NCT00691054|559084501|FG000|Overall Study|Withdrawal by Subject|1|||
155117257|NCT01145352|559860659|FG000|Overall Study|Syringe formulation was used|1|||
155117258|NCT03095027|559860660|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
155117259|NCT03095027|559860661|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
155117260|NCT02982018|559860662|FG000|Overall Study|Incorrect Lens Dispensed|1|||
155117261|NCT02982018|559860663|FG001|Overall Study|Incorrect Lens Dispensed|0|||
155117262|NCT02982018|559860662|FG000|Overall Study|Protocol Violation|1|||
155117263|NCT02982018|559860663|FG001|Overall Study|Protocol Violation|1|||
155117264|NCT02982018|559860662|FG000|Overall Study|Adverse Event|1|||
155117265|NCT02982018|559860663|FG001|Overall Study|Adverse Event|1|||
155117266|NCT02982018|559860662|FG000|Overall Study|Lens Discomfort|2|||
155117267|NCT02982018|559860663|FG001|Overall Study|Lens Discomfort|0|||
155117268|NCT02982018|559860662|FG000|Overall Study|Withdrawal by Subject|0|||
155117269|NCT02982018|559860663|FG001|Overall Study|Withdrawal by Subject|1|||
155117270|NCT04098367|559860665|FG000|Overall Study|Adverse Event|0|||
155117271|NCT04098367|559860666|FG001|Overall Study|Adverse Event|0|||
155117272|NCT04098367|559860667|FG002|Overall Study|Adverse Event|1|||
155117273|NCT04098367|559860665|FG000|Overall Study|Lost to Follow-up|1|||
155117274|NCT04098367|559860666|FG001|Overall Study|Lost to Follow-up|5|||
155117275|NCT04098367|559860667|FG002|Overall Study|Lost to Follow-up|2|||
155117276|NCT04098367|559860665|FG000|Overall Study|Withdrawal by Subject|0|||
155117277|NCT04098367|559860666|FG001|Overall Study|Withdrawal by Subject|0|||
155117278|NCT04098367|559860667|FG002|Overall Study|Withdrawal by Subject|1|||
155117279|NCT04098367|559860665|FG000|Overall Study|Sick . Could not attend visit|1|||
154908395|NCT01226472|559084504|FG000|Overall Study|Progressive Disease|1|||
154908396|NCT00740116|559085835|FG000|Overall Study|Withdrawal by Subject|1|||
154908397|NCT00740116|559085836|FG001|Overall Study|Withdrawal by Subject|1|||
154908398|NCT00740116|559085835|FG000|Overall Study|Protocol Violation|1|||
154908399|NCT00740116|559085836|FG001|Overall Study|Protocol Violation|4|||
154908400|NCT02499172|559085837|FG000|Overall Study|Financial reason|0|||
154908401|NCT02499172|559085838|FG001|Overall Study|Financial reason|0|||
154908402|NCT02499172|559085839|FG002|Overall Study|Financial reason|523|||
154908403|NCT02499172|559085840|FG003|Overall Study|Financial reason|436|||
154908404|NCT02499172|559085837|FG000|Overall Study|Lost to Follow-up|65|||
154908405|NCT02499172|559085838|FG001|Overall Study|Lost to Follow-up|64|||
154908406|NCT02499172|559085839|FG002|Overall Study|Lost to Follow-up|0|||
154908407|NCT02499172|559085840|FG003|Overall Study|Lost to Follow-up|0|||
154908408|NCT01293123|559085841|FG000|Overall Study|Lost to Follow-up|0|||
154908409|NCT01293123|559085842|FG001|Overall Study|Lost to Follow-up|1|||
154908410|NCT01888965|559085852|FG000|Overall Study|Adverse Event|5|||
154908411|NCT01888965|559085852|FG000|Overall Study|Lack of Efficacy|4|||
154908412|NCT03793010|559085853|FG000|Overall Study|Withdrawal by Subject|5|||
154908413|NCT03793010|559085854|FG001|Overall Study|Withdrawal by Subject|7|||
154908414|NCT03793010|559085853|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
154908415|NCT03793010|559085854|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
154908416|NCT03793010|559085853|FG000|Overall Study|Lost to Follow-up|1|||
154908417|NCT03793010|559085854|FG001|Overall Study|Lost to Follow-up|2|||
154908418|NCT03793010|559085853|FG000|Overall Study|Patient couldn't sit still for injection|1|||
154908419|NCT03793010|559085854|FG001|Overall Study|Patient couldn't sit still for injection|0|||
154908420|NCT03793010|559085853|FG000|Overall Study|Withdrew to pursue other treatment|1|||
154908421|NCT03793010|559085854|FG001|Overall Study|Withdrew to pursue other treatment|0|||
154908422|NCT03793010|559085853|FG000|Overall Study|Did not meet eligibility criteria|1|||
154908423|NCT03793010|559085854|FG001|Overall Study|Did not meet eligibility criteria|0|||
154908424|NCT02145429|559085895|FG000|Overall Study|Death|4|||
154908425|NCT02145429|559085896|FG001|Overall Study|Death|5|||
154908426|NCT02145429|559085895|FG000|Overall Study|Lost to Follow-up|4|||
154908427|NCT02145429|559085896|FG001|Overall Study|Lost to Follow-up|3|||
154908428|NCT02145429|559085895|FG000|Overall Study|Withdrawal by Subject|8|||
154908429|NCT02145429|559085896|FG001|Overall Study|Withdrawal by Subject|3|||
154908430|NCT01944462|559085899|FG000|PPPP Educational Program|Lost to Follow-up|60|||
154908431|NCT02274311|559085902|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
154908432|NCT00508001|559085903|FG000|Overall Study|Adverse Event|2|||
154908433|NCT00508001|559085904|FG001|Overall Study|Adverse Event|0|||
154908434|NCT00508001|559085905|FG002|Overall Study|Adverse Event|4|||
154908435|NCT00508001|559085903|FG000|Overall Study|condition under investigation worsened|13|||
154908436|NCT00508001|559085904|FG001|Overall Study|condition under investigation worsened|7|||
154908437|NCT00508001|559085905|FG002|Overall Study|condition under investigation worsened|1|||
154908438|NCT00508001|559085903|FG000|Overall Study|Death|0|||
154908439|NCT00508001|559085904|FG001|Overall Study|Death|1|||
154908440|NCT00508001|559085905|FG002|Overall Study|Death|1|||
154908441|NCT00508001|559085903|FG000|Overall Study|Withdrawal by Subject|4|||
154908442|NCT00508001|559085904|FG001|Overall Study|Withdrawal by Subject|4|||
154908443|NCT00508001|559085905|FG002|Overall Study|Withdrawal by Subject|1|||
154908444|NCT04437511|559085906|FG000|Overall Study|Adverse Event|50|||
154908445|NCT04437511|559085907|FG001|Overall Study|Adverse Event|21|||
154908446|NCT04437511|559085906|FG000|Overall Study|Death|15|||
154908447|NCT04437511|559085907|FG001|Overall Study|Death|10|||
154908448|NCT04437511|559085906|FG000|Overall Study|Lost to Follow-up|11|||
154908449|NCT04437511|559085907|FG001|Overall Study|Lost to Follow-up|11|||
154908450|NCT04437511|559085906|FG000|Overall Study|Physician Decision|19|||
154908451|NCT04437511|559085907|FG001|Overall Study|Physician Decision|10|||
154908452|NCT04437511|559085906|FG000|Overall Study|Progressive Disease|4|||
154908453|NCT04437511|559085907|FG001|Overall Study|Progressive Disease|7|||
154908454|NCT04437511|559085906|FG000|Overall Study|Withdrawal by Subject|111|||
154908455|NCT04437511|559085907|FG001|Overall Study|Withdrawal by Subject|94|||
154908456|NCT04437511|559085906|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
154908457|NCT04437511|559085907|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
154908458|NCT04437511|559085906|FG000|Overall Study|Continuing Study|7|||
154908459|NCT04437511|559085907|FG001|Overall Study|Continuing Study|5|||
154908460|NCT03093350|559085912|FG000|Overall Study|Death|1|||
154908461|NCT03093350|559085912|FG000|Overall Study|Signed consent, never began treartment|1|||
154908462|NCT02750501|559085927|FG000|Overall Study|Adverse Event|4|||
154908463|NCT02750501|559085927|FG000|Overall Study|Physician Decision|1|||
154908464|NCT02750501|559085927|FG000|Overall Study|Protocol Violation|1|||
154908465|NCT02750501|559085927|FG000|Overall Study|G-tube came out|1|||
154908466|NCT02750501|559085927|FG000|Overall Study|Non-compliant use of PERT|1|||
154908467|NCT03797144|559085928|FG000|Enrollment|Protocol Violation|4|||
154908468|NCT03797144|559085929|FG001|Enrollment|Protocol Violation|1|||
154908469|NCT03797144|559085928|FG000|Surgery|Protocol Violation|1|||
154908470|NCT03797144|559085929|FG001|Surgery|Protocol Violation|0|||
154908471|NCT03797144|559085928|FG000|3 Month|Early termination cut-off date|2|||
154908472|NCT03797144|559085929|FG001|3 Month|Early termination cut-off date|0|||
154908473|NCT03797144|559085928|FG000|12 Month|Early termination cut-off date|8|||
154908474|NCT03797144|559085929|FG001|12 Month|Early termination cut-off date|9|||
154908475|NCT03797144|559085928|FG000|24 Month|Early termination cut-off date|1|||
154908476|NCT03797144|559085929|FG001|24 Month|Early termination cut-off date|1|||
154908477|NCT00403390|559085930|FG000|Overall Study|Withdrawal by Subject|1|||
154908478|NCT00403390|559085931|FG001|Overall Study|Withdrawal by Subject|0|||
154908479|NCT00403390|559085930|FG000|Overall Study|samples lost|1|||
154908480|NCT00403390|559085931|FG001|Overall Study|samples lost|0|||
154908481|NCT00403390|559085930|FG000|Overall Study|non-compliant|1|||
154908482|NCT00403390|559085931|FG001|Overall Study|non-compliant|0|||
154908483|NCT01796106|559085932|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
154908484|NCT01796106|559085933|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
154908485|NCT04107935|559085934|FG000|Overall Study|Death|1|||
154908486|NCT04107935|559085935|FG001|Overall Study|Death|0|||
154908487|NCT00002981|559085939|FG000|Overall Study|Inevaluable|6|||
154908488|NCT01833806|559085943|FG000|Overall Study|Alternative treatment|2|||
154908489|NCT01833806|559085943|FG000|Overall Study|Death|5|||
154908490|NCT01833806|559085943|FG000|Overall Study|Physician Decision|1|||
154908491|NCT01833806|559085943|FG000|Overall Study|Lost to Follow-up|1|||
154908492|NCT01885104|559085957|FG000|Overall Study|Withdrawal of Consent|1|||
154908493|NCT01885104|559085958|FG001|Overall Study|Withdrawal of Consent|0|||
154908494|NCT01885104|559085957|FG000|Overall Study|Lost to Follow-up|0|||
154908495|NCT01885104|559085958|FG001|Overall Study|Lost to Follow-up|1|||
154908496|NCT01885104|559085957|FG000|Overall Study|Physician Decision|1|||
154908497|NCT01885104|559085958|FG001|Overall Study|Physician Decision|0|||
154908498|NCT00126425|559085960|FG000|Overall Study|Withdrawal by Subject|17|||
154908499|NCT00126425|559085961|FG001|Overall Study|Withdrawal by Subject|1|||
154908500|NCT00126425|559085960|FG000|Overall Study|Lost to Follow-up|8|||
154908501|NCT00126425|559085961|FG001|Overall Study|Lost to Follow-up|4|||
154908502|NCT00126425|559085960|FG000|Overall Study|Protocol Violation|9|||
154908503|NCT00126425|559085961|FG001|Overall Study|Protocol Violation|6|||
154908504|NCT00126425|559085960|FG000|Overall Study|Adverse Event|1|||
154908505|NCT00126425|559085961|FG001|Overall Study|Adverse Event|0|||
154908506|NCT00126425|559085960|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
154908507|NCT00126425|559085961|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
154908508|NCT00126425|559085960|FG000|Overall Study|Other|5|||
154908509|NCT00126425|559085961|FG001|Overall Study|Other|0|||
154908510|NCT01894776|559085962|FG000|Overall Study|Withdrawal by Subject|1|||
154908511|NCT02415595|559085963|FG000|Overall Study|Administrative reason by sponsor|39|||
154908512|NCT02415595|559085964|FG001|Overall Study|Administrative reason by sponsor|40|||
154908513|NCT02415595|559085965|FG002|Overall Study|Administrative reason by sponsor|41|||
154908514|NCT02415595|559085966|FG003|Overall Study|Administrative reason by sponsor|39|||
154908515|NCT02415595|559085963|FG000|Overall Study|Adverse Event|1|||
154908516|NCT02415595|559085964|FG001|Overall Study|Adverse Event|3|||
154908517|NCT02415595|559085965|FG002|Overall Study|Adverse Event|5|||
154908518|NCT02415595|559085966|FG003|Overall Study|Adverse Event|10|||
154908519|NCT02415595|559085963|FG000|Overall Study|Lack of Efficacy|4|||
154908520|NCT02415595|559085964|FG001|Overall Study|Lack of Efficacy|4|||
154908521|NCT02415595|559085965|FG002|Overall Study|Lack of Efficacy|0|||
154908522|NCT02415595|559085966|FG003|Overall Study|Lack of Efficacy|0|||
154908523|NCT02415595|559085963|FG000|Overall Study|Lost to Follow-up|1|||
155117280|NCT04098367|559860666|FG001|Overall Study|Sick . Could not attend visit|0|||
155117281|NCT04098367|559860667|FG002|Overall Study|Sick . Could not attend visit|0|||
155117282|NCT02251717|559860668|FG000|Overall Study|Adverse Event|0|||
155117283|NCT02251717|559860669|FG001|Overall Study|Adverse Event|1|||
155117284|NCT02251717|559860668|FG000|Overall Study|Withdrew Consent|1|||
155117285|NCT02251717|559860669|FG001|Overall Study|Withdrew Consent|0|||
155117286|NCT00322023|559860670|FG000|Overall Study|various|0|||
155117287|NCT00322023|559860671|FG001|Overall Study|various|2|||
155117288|NCT00322023|559860672|FG002|Overall Study|various|6|||
155176088|NCT02509117|560082234|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176089|NCT02509117|560082235|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176090|NCT02509117|560082236|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176091|NCT02509117|560082237|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176092|NCT02509117|560082238|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176093|NCT02509117|560082239|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176094|NCT02509117|560082240|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
155176095|NCT02509117|560082241|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
155176096|NCT00832624|560082242|FG000|Overall Study|Study Terminated|10|||
155176097|NCT00548184|560082245|FG000|Overall Study|Adverse Event|3|||
155176098|NCT00548184|560082245|FG000|Overall Study|took other drug|1|||
155176099|NCT00548184|560082245|FG000|Overall Study|Found Her2 negative|1|||
155176100|NCT00280748|560082249|FG000|Overall Study|Decline in performance|3|||
155176101|NCT00280748|560082249|FG000|Overall Study|Extra-cranial disease progression|1|||
155176102|NCT01433250|560082250|FG000|Overall Study|Protocol Violation|0|||
155176103|NCT01433250|560082251|FG001|Overall Study|Protocol Violation|1|||
155176104|NCT01433250|560082250|FG000|Overall Study|Withdrawal by Subject|3|||
155176105|NCT01433250|560082251|FG001|Overall Study|Withdrawal by Subject|2|||
155176106|NCT03148691|560082252|FG000|Overall Study|Protocol Violation|1|||
155176107|NCT03148691|560082253|FG001|Overall Study|Protocol Violation|2|||
155176108|NCT03148691|560082254|FG002|Overall Study|Protocol Violation|7|||
155176109|NCT03148691|560082252|FG000|Overall Study|Lost to Follow-up|0|||
155176110|NCT03148691|560082253|FG001|Overall Study|Lost to Follow-up|0|||
155176111|NCT03148691|560082254|FG002|Overall Study|Lost to Follow-up|1|||
155176112|NCT03148691|560082252|FG000|Overall Study|Other|1|||
155176113|NCT03148691|560082253|FG001|Overall Study|Other|0|||
155176114|NCT03148691|560082254|FG002|Overall Study|Other|0|||
155176115|NCT03148691|560082252|FG000|Overall Study|Withdrawal by Subject|1|||
155176116|NCT03148691|560082253|FG001|Overall Study|Withdrawal by Subject|0|||
155176117|NCT03148691|560082254|FG002|Overall Study|Withdrawal by Subject|0|||
155176118|NCT00321646|560082261|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
155176119|NCT00321646|560082261|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
155176120|NCT00321646|560082261|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
155176121|NCT00392379|560082265|FG000|Overall Study|Withdrawal by Subject|17|||
155176122|NCT00392379|560082266|FG001|Overall Study|Withdrawal by Subject|28|||
155176123|NCT00392379|560082265|FG000|Overall Study|Lost to Follow-up|4|||
155176124|NCT00392379|560082266|FG001|Overall Study|Lost to Follow-up|9|||
155176125|NCT00392379|560082265|FG000|Overall Study|Adverse Event|1|||
155176126|NCT00392379|560082266|FG001|Overall Study|Adverse Event|1|||
155176127|NCT01700387|560082267|FG000|Overall Study|Withdrawal by Subject|1|||
155176128|NCT01700387|560082268|FG001|Overall Study|Withdrawal by Subject|2|||
155176129|NCT01700387|560082267|FG000|Overall Study|Adverse Event|1|||
155176130|NCT01700387|560082268|FG001|Overall Study|Adverse Event|1|||
155176131|NCT01700387|560082267|FG000|Overall Study|Lost to Follow-up|2|||
155176132|NCT01700387|560082268|FG001|Overall Study|Lost to Follow-up|1|||
155176133|NCT00934843|560082276|FG000|Overall Study|Protocol Violation|0|||
155176134|NCT00934843|560082277|FG001|Overall Study|Protocol Violation|1|||
155176135|NCT01375075|560082285|FG000|Overall Study|Adverse Event|0|||
155176136|NCT01375075|560082286|FG001|Overall Study|Adverse Event|0|||
155176137|NCT01375075|560082287|FG002|Overall Study|Adverse Event|3|||
154908524|NCT02415595|559085964|FG001|Overall Study|Lost to Follow-up|3|||
154908525|NCT02415595|559085965|FG002|Overall Study|Lost to Follow-up|1|||
154908526|NCT02415595|559085966|FG003|Overall Study|Lost to Follow-up|1|||
154908527|NCT02415595|559085963|FG000|Overall Study|Poor/Non-compliance|1|||
154908528|NCT02415595|559085964|FG001|Overall Study|Poor/Non-compliance|0|||
154908529|NCT02415595|559085965|FG002|Overall Study|Poor/Non-compliance|1|||
154908530|NCT02415595|559085966|FG003|Overall Study|Poor/Non-compliance|0|||
155117289|NCT03920293|559860673|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
155117290|NCT03920293|559860674|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
155176138|NCT01375075|560082288|FG003|Overall Study|Adverse Event|1|||
155176139|NCT01375075|560082289|FG004|Overall Study|Adverse Event|0|||
155176140|NCT01375075|560082290|FG005|Overall Study|Adverse Event|1|||
155176141|NCT01375075|560082285|FG000|Overall Study|Entry Criterion Not Met|1|||
155176142|NCT01375075|560082286|FG001|Overall Study|Entry Criterion Not Met|0|||
155117291|NCT03920293|559860673|FG000|Randomized-Controlled Period|Physician Decision|1|||
155176143|NCT01375075|560082287|FG002|Overall Study|Entry Criterion Not Met|0|||
155176144|NCT01375075|560082288|FG003|Overall Study|Entry Criterion Not Met|0|||
155117292|NCT03920293|559860674|FG001|Randomized-Controlled Period|Physician Decision|2|||
155117293|NCT03920293|559860673|FG000|Randomized-Controlled Period|Adverse Event|0|||
155117294|NCT03920293|559860674|FG001|Randomized-Controlled Period|Adverse Event|2|||
155117295|NCT03920293|559860673|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
155117296|NCT03920293|559860674|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
155117297|NCT03920293|559860673|FG000|Randomized-Controlled Period|Death|2|||
155117298|NCT03920293|559860674|FG001|Randomized-Controlled Period|Death|0|||
155117299|NCT03920293|559860673|FG000|Randomized-Controlled Period|Protocol Violation|1|||
155117300|NCT03920293|559860674|FG001|Randomized-Controlled Period|Protocol Violation|0|||
155117301|NCT03920293|559860673|FG000|Randomized-Controlled Period|Noncompliance|1|||
154908531|NCT02415595|559085963|FG000|Overall Study|Reached stopping criteria|0|||
154908532|NCT02415595|559085964|FG001|Overall Study|Reached stopping criteria|1|||
154908533|NCT02415595|559085965|FG002|Overall Study|Reached stopping criteria|1|||
154908534|NCT02415595|559085966|FG003|Overall Study|Reached stopping criteria|0|||
154908535|NCT02415595|559085963|FG000|Overall Study|Withdrawal by Subject|4|||
154908536|NCT02415595|559085964|FG001|Overall Study|Withdrawal by Subject|0|||
154908537|NCT02415595|559085965|FG002|Overall Study|Withdrawal by Subject|1|||
154908538|NCT02415595|559085966|FG003|Overall Study|Withdrawal by Subject|3|||
154908539|NCT02415595|559085963|FG000|Overall Study|Other|0|||
154908540|NCT02415595|559085964|FG001|Overall Study|Other|1|||
154908541|NCT02415595|559085965|FG002|Overall Study|Other|1|||
154908542|NCT02415595|559085966|FG003|Overall Study|Other|0|||
154908543|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
154908544|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
154908545|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
154908546|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
154908547|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
154908548|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
154908549|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
154908550|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
154908551|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
154908552|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
154908553|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
154908554|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
154908555|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
154908556|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
154908557|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
154908558|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
154908559|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
154908560|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
154908561|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
154908562|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
154908563|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
154908564|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
154908565|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
154908566|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
154908567|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Screen failure|0|||
154908568|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Screen failure|1|||
154908569|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Screen failure|2|||
154908570|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Screen failure|0|||
154908571|NCT02614261|559085967|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
154908572|NCT02614261|559085968|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
154908573|NCT02614261|559085969|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
154908574|NCT02614261|559085970|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
154908575|NCT02614261|559085967|FG000|Open-Label Extension Phase|Adverse Event|23|||
154908576|NCT02614261|559085968|FG001|Open-Label Extension Phase|Adverse Event|12|||
154908577|NCT02614261|559085969|FG002|Open-Label Extension Phase|Adverse Event|11|||
154908578|NCT02614261|559085970|FG003|Open-Label Extension Phase|Adverse Event|0|||
154908579|NCT02614261|559085967|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
154908580|NCT02614261|559085968|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
154908581|NCT02614261|559085969|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
154908582|NCT02614261|559085970|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
154908583|NCT02614261|559085967|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
154908584|NCT02614261|559085968|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
154908585|NCT02614261|559085969|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
154908586|NCT02614261|559085970|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
154908587|NCT02614261|559085967|FG000|Open-Label Extension Phase|Physician Decision|2|||
154908588|NCT02614261|559085968|FG001|Open-Label Extension Phase|Physician Decision|0|||
154908589|NCT02614261|559085969|FG002|Open-Label Extension Phase|Physician Decision|0|||
154908590|NCT02614261|559085970|FG003|Open-Label Extension Phase|Physician Decision|0|||
154983359|NCT00773734|559364418|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
154983360|NCT00773734|559364419|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
155117302|NCT03920293|559860674|FG001|Randomized-Controlled Period|Noncompliance|0|||
155117303|NCT03920293|559860673|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
154908591|NCT02614261|559085967|FG000|Open-Label Extension Phase|Pregnancy|1|||
154908592|NCT02614261|559085968|FG001|Open-Label Extension Phase|Pregnancy|2|||
154908593|NCT02614261|559085969|FG002|Open-Label Extension Phase|Pregnancy|1|||
154908594|NCT02614261|559085970|FG003|Open-Label Extension Phase|Pregnancy|0|||
154908595|NCT02614261|559085967|FG000|Open-Label Extension Phase|Protocol Violation|3|||
154908596|NCT02614261|559085968|FG001|Open-Label Extension Phase|Protocol Violation|4|||
154908597|NCT02614261|559085969|FG002|Open-Label Extension Phase|Protocol Violation|1|||
154908598|NCT02614261|559085970|FG003|Open-Label Extension Phase|Protocol Violation|0|||
154908599|NCT02614261|559085967|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
154908600|NCT02614261|559085968|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
154908601|NCT02614261|559085969|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
154908602|NCT02614261|559085970|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
154908603|NCT02614261|559085967|FG000|Follow-up Phase|Adverse Event|2|||
154908604|NCT02614261|559085968|FG001|Follow-up Phase|Adverse Event|0|||
154908605|NCT02614261|559085969|FG002|Follow-up Phase|Adverse Event|1|||
154908606|NCT02614261|559085970|FG003|Follow-up Phase|Adverse Event|0|||
154908607|NCT02614261|559085967|FG000|Follow-up Phase|Lost to Follow-up|12|||
154908608|NCT02614261|559085968|FG001|Follow-up Phase|Lost to Follow-up|5|||
154908609|NCT02614261|559085969|FG002|Follow-up Phase|Lost to Follow-up|2|||
154908610|NCT02614261|559085970|FG003|Follow-up Phase|Lost to Follow-up|0|||
154908611|NCT02614261|559085967|FG000|Follow-up Phase|Physician Decision|5|||
154908612|NCT02614261|559085968|FG001|Follow-up Phase|Physician Decision|1|||
154908613|NCT02614261|559085969|FG002|Follow-up Phase|Physician Decision|0|||
154908614|NCT02614261|559085970|FG003|Follow-up Phase|Physician Decision|0|||
154908615|NCT02614261|559085967|FG000|Follow-up Phase|Pregnancy|0|||
154908616|NCT02614261|559085968|FG001|Follow-up Phase|Pregnancy|1|||
154908617|NCT02614261|559085969|FG002|Follow-up Phase|Pregnancy|0|||
154908618|NCT02614261|559085970|FG003|Follow-up Phase|Pregnancy|0|||
154908619|NCT02614261|559085967|FG000|Follow-up Phase|Protocol Violation|1|||
154908620|NCT02614261|559085968|FG001|Follow-up Phase|Protocol Violation|0|||
154908621|NCT02614261|559085969|FG002|Follow-up Phase|Protocol Violation|0|||
154908622|NCT02614261|559085970|FG003|Follow-up Phase|Protocol Violation|0|||
154908623|NCT02614261|559085967|FG000|Follow-up Phase|Withdrawal by Subject|12|||
154908624|NCT02614261|559085968|FG001|Follow-up Phase|Withdrawal by Subject|4|||
154908625|NCT02614261|559085969|FG002|Follow-up Phase|Withdrawal by Subject|11|||
154908626|NCT02614261|559085970|FG003|Follow-up Phase|Withdrawal by Subject|0|||
154908627|NCT02614261|559085967|FG000|Israel Addendum|Withdrawal by Subject|0|||
154908628|NCT02614261|559085968|FG001|Israel Addendum|Withdrawal by Subject|0|||
154908629|NCT02614261|559085969|FG002|Israel Addendum|Withdrawal by Subject|0|||
154908630|NCT02614261|559085970|FG003|Israel Addendum|Withdrawal by Subject|4|||
154908631|NCT04350372|559085973|FG000|Overall Study|Death|1|||
154908632|NCT03512275|559085975|FG000|Overall Study|Withdrawal by Subject|1|||
154908633|NCT03512275|559085976|FG001|Overall Study|Withdrawal by Subject|3|||
154908634|NCT03512275|559085975|FG000|Overall Study|Physician Decision|0|||
154908635|NCT03512275|559085976|FG001|Overall Study|Physician Decision|1|||
154908636|NCT03512275|559085975|FG000|Overall Study|Lost to Follow-up|0|||
154908637|NCT03512275|559085976|FG001|Overall Study|Lost to Follow-up|3|||
154908638|NCT03512275|559085975|FG000|Overall Study|Other|1|||
154908639|NCT03512275|559085976|FG001|Overall Study|Other|0|||
154908640|NCT00113555|559085977|FG000|Overall Study|Baseline Failure|59|||
154908641|NCT00113555|559085977|FG000|Overall Study|Permanently Explanted|7|||
154908642|NCT00113555|559085977|FG000|Overall Study|Death|1|||
154908643|NCT00113555|559085977|FG000|Overall Study|Missed Followup|4|||
154908644|NCT00113555|559085977|FG000|Overall Study|Lost to Follow-up|8|||
154908645|NCT03858686|559085978|FG000|Period 1|Adverse Event|1|||
154908646|NCT03858686|559085979|FG001|Period 1|Adverse Event|1|||
154908647|NCT03858686|559085978|FG000|Period 1|Lack of compliance|0|||
154983361|NCT00773734|559364420|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
154983362|NCT00773734|559364415|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
154983363|NCT00773734|559364416|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
154983364|NCT00773734|559364417|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
154983365|NCT00773734|559364418|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
154983366|NCT00773734|559364419|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
154983367|NCT00773734|559364420|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
154983368|NCT00773734|559364415|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
154983369|NCT00773734|559364416|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
154908648|NCT03858686|559085979|FG001|Period 1|Lack of compliance|1|||
154908649|NCT03858686|559085978|FG000|Period 1|Adverse Event|0|||
154908650|NCT03858686|559085979|FG001|Period 1|Adverse Event|1|||
154908651|NCT03858686|559085978|FG000|Period 2|Adverse Event|0|||
154908652|NCT03858686|559085979|FG001|Period 2|Adverse Event|1|||
154908653|NCT00102804|559085980|FG000|Overall Study|Progressive Disease (PD)|307|||
154908654|NCT00102804|559085981|FG001|Overall Study|Progressive Disease (PD)|196|||
154908655|NCT00102804|559085980|FG000|Overall Study|Withdrawal by Subject|46|||
154908656|NCT00102804|559085981|FG001|Overall Study|Withdrawal by Subject|7|||
154908657|NCT00102804|559085980|FG000|Overall Study|Adverse Event|37|||
154908658|NCT00102804|559085981|FG001|Overall Study|Adverse Event|3|||
154908659|NCT00102804|559085980|FG000|Overall Study|Physician Decision|24|||
154908660|NCT00102804|559085981|FG001|Overall Study|Physician Decision|6|||
154908661|NCT00102804|559085980|FG000|Overall Study|Death|5|||
154908662|NCT00102804|559085981|FG001|Overall Study|Death|6|||
154908663|NCT00102804|559085980|FG000|Overall Study|Enrollment Criteria Not Met|6|||
154908664|NCT00102804|559085981|FG001|Overall Study|Enrollment Criteria Not Met|0|||
154908665|NCT00102804|559085980|FG000|Overall Study|Lost to Follow-up|4|||
154908666|NCT00102804|559085981|FG001|Overall Study|Lost to Follow-up|1|||
154908667|NCT00102804|559085980|FG000|Overall Study|Protocol Violation|2|||
154908668|NCT00102804|559085981|FG001|Overall Study|Protocol Violation|1|||
154908669|NCT00102804|559085980|FG000|Overall Study|Satisfactory Response|2|||
154908670|NCT00102804|559085981|FG001|Overall Study|Satisfactory Response|0|||
154908671|NCT00102804|559085980|FG000|Overall Study|Sponsor Decision|1|||
154908672|NCT00102804|559085981|FG001|Overall Study|Sponsor Decision|0|||
154908673|NCT00102804|559085980|FG000|Overall Study|Alive, Receiving Treatment|7|||
154908674|NCT00102804|559085981|FG001|Overall Study|Alive, Receiving Treatment|2|||
154908675|NCT02299206|559085984|FG000|Overall Study|Lost to Follow-up|1|||
154908676|NCT02299206|559085984|FG000|Overall Study|Withdrawal by Subject|1|||
154908677|NCT03128307|559085987|FG000|Overall Study|Lost to Follow-up|29|||
154908678|NCT03128307|559085987|FG000|Overall Study|Withdrawal by Subject|5|||
154908679|NCT03455530|559087689|FG000|Overall Study|Withdrawal by Subject|9|||
154908680|NCT03455530|559087690|FG001|Overall Study|Withdrawal by Subject|1|||
154908681|NCT03455530|559087691|FG002|Overall Study|Withdrawal by Subject|3|||
154908682|NCT03455530|559087692|FG003|Overall Study|Withdrawal by Subject|3|||
154908683|NCT03037489|559087694|FG000|Overall Study|Adverse Event|4|||
154908684|NCT03037489|559087695|FG001|Overall Study|Adverse Event|0|||
154908685|NCT03037489|559087694|FG000|Overall Study|Withdrawal by Subject|3|||
154908686|NCT03037489|559087695|FG001|Overall Study|Withdrawal by Subject|0|||
154908687|NCT04167514|559087696|FG000|Overall Study|Adverse event, not serious|0|||
154908688|NCT04167514|559087697|FG001|Overall Study|Adverse event, not serious|1|||
154908689|NCT04167514|559087696|FG000|Overall Study|Lost to Follow-up|1|||
154908690|NCT04167514|559087697|FG001|Overall Study|Lost to Follow-up|0|||
154908691|NCT04167514|559087696|FG000|Overall Study|Participant Decision|2|||
154908692|NCT04167514|559087697|FG001|Overall Study|Participant Decision|4|||
154908693|NCT04167514|559087696|FG000|Overall Study|Physician Decision|3|||
154908694|NCT04167514|559087697|FG001|Overall Study|Physician Decision|2|||
154908695|NCT04167514|559087696|FG000|Overall Study|Death|14|||
154908696|NCT04167514|559087697|FG001|Overall Study|Death|18|||
154908697|NCT04167514|559087696|FG000|Overall Study|Enrolled but treatment not administered|2|||
154908698|NCT04167514|559087697|FG001|Overall Study|Enrolled but treatment not administered|0|||
154908699|NCT04167514|559087696|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
154908700|NCT04167514|559087697|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
154908701|NCT04167514|559087696|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
154908702|NCT04167514|559087697|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
154908703|NCT00939055|559087698|FG000|Overall Study|Discontinuation prior to procedure|4|||
154908704|NCT00939055|559087699|FG001|Overall Study|Discontinuation prior to procedure|0|||
154908705|NCT00584987|559087700|FG000|Overall Study|Protocol Violation|1|||
154908706|NCT00584987|559087701|FG001|Overall Study|Protocol Violation|1|||
154908707|NCT00584987|559087702|FG002|Overall Study|Protocol Violation|1|||
154908708|NCT00584987|559087703|FG003|Overall Study|Protocol Violation|0|||
154908709|NCT00584987|559087700|FG000|Overall Study|Adverse Event|0|||
154908710|NCT00584987|559087701|FG001|Overall Study|Adverse Event|0|||
154908711|NCT00584987|559087702|FG002|Overall Study|Adverse Event|0|||
154908712|NCT00584987|559087703|FG003|Overall Study|Adverse Event|1|||
154908713|NCT02773849|559087710|FG000|Overall Study|Lost to Follow-up|11|||
154908714|NCT02773849|559087710|FG000|Overall Study|Death|26|||
154908715|NCT02773849|559087710|FG000|Overall Study|Withdrawal by Subject|5|||
154908716|NCT02773849|559087710|FG000|Overall Study|Withdrawal of Consent|9|||
154908717|NCT02773849|559087710|FG000|Overall Study|Other: not due to lack of tolerability|11|||
154908718|NCT00723489|559087711|FG000|Overall Study|Physician Decision|0|||
154908719|NCT00723489|559087712|FG001|Overall Study|Physician Decision|1|||
154908720|NCT00723489|559087713|FG002|Overall Study|Physician Decision|0|||
154908721|NCT00723489|559087714|FG003|Overall Study|Physician Decision|0|||
154908722|NCT00723489|559087711|FG000|Overall Study|Pregnancy|0|||
154908723|NCT00723489|559087712|FG001|Overall Study|Pregnancy|0|||
154908724|NCT00723489|559087713|FG002|Overall Study|Pregnancy|0|||
154908725|NCT00723489|559087714|FG003|Overall Study|Pregnancy|1|||
154908726|NCT00723489|559087711|FG000|Overall Study|Withdrawal by Subject|0|||
154908727|NCT00723489|559087712|FG001|Overall Study|Withdrawal by Subject|0|||
154908728|NCT00723489|559087713|FG002|Overall Study|Withdrawal by Subject|0|||
154908729|NCT00723489|559087714|FG003|Overall Study|Withdrawal by Subject|1|||
154908730|NCT00723489|559087711|FG000|Overall Study|Seropositive at baseline|1|||
154908731|NCT00723489|559087712|FG001|Overall Study|Seropositive at baseline|0|||
154908732|NCT00723489|559087713|FG002|Overall Study|Seropositive at baseline|0|||
154908733|NCT00723489|559087714|FG003|Overall Study|Seropositive at baseline|0|||
154908734|NCT00723489|559087711|FG000|Overall Study|Prohibited Medication|0|||
154908735|NCT00723489|559087712|FG001|Overall Study|Prohibited Medication|0|||
154908736|NCT00723489|559087713|FG002|Overall Study|Prohibited Medication|0|||
154908737|NCT00723489|559087714|FG003|Overall Study|Prohibited Medication|1|||
154908738|NCT00723489|559087711|FG000|Overall Study|Samples Collected Out of Window|0|||
154908739|NCT00723489|559087712|FG001|Overall Study|Samples Collected Out of Window|3|||
154908740|NCT00723489|559087713|FG002|Overall Study|Samples Collected Out of Window|0|||
154908741|NCT00723489|559087714|FG003|Overall Study|Samples Collected Out of Window|0|||
154908742|NCT01599585|559087715|FG000|Overall Study|Withdrawal by Subject|16|||
154908743|NCT01599585|559087716|FG001|Overall Study|Withdrawal by Subject|9|||
154908744|NCT01599585|559087715|FG000|Overall Study|Lost to Follow-up|3|||
154908745|NCT01599585|559087716|FG001|Overall Study|Lost to Follow-up|5|||
154908746|NCT01599585|559087715|FG000|Overall Study|randomized did not start treatment|3|||
154908747|NCT01599585|559087716|FG001|Overall Study|randomized did not start treatment|3|||
154908748|NCT03657576|559087717|FG000|Overall Study|Death|0|||
154908749|NCT03657576|559087718|FG001|Overall Study|Death|1|||
154908750|NCT03657576|559087719|FG002|Overall Study|Death|1|||
154908751|NCT03657576|559087720|FG003|Overall Study|Death|0|||
154908752|NCT03657576|559087721|FG004|Overall Study|Death|0|||
154908753|NCT03657576|559087722|FG005|Overall Study|Death|0|||
154908754|NCT03657576|559087717|FG000|Overall Study|Withdrawal by Subject|0|||
154908755|NCT03657576|559087718|FG001|Overall Study|Withdrawal by Subject|0|||
154908756|NCT03657576|559087719|FG002|Overall Study|Withdrawal by Subject|0|||
154908757|NCT03657576|559087720|FG003|Overall Study|Withdrawal by Subject|1|||
154908758|NCT03657576|559087721|FG004|Overall Study|Withdrawal by Subject|0|||
154908759|NCT03657576|559087722|FG005|Overall Study|Withdrawal by Subject|0|||
154908760|NCT03657576|559087717|FG000|Overall Study|Screen Fail|0|||
154908761|NCT03657576|559087718|FG001|Overall Study|Screen Fail|0|||
154908762|NCT03657576|559087719|FG002|Overall Study|Screen Fail|0|||
154908763|NCT03657576|559087720|FG003|Overall Study|Screen Fail|0|||
154908764|NCT03657576|559087721|FG004|Overall Study|Screen Fail|0|||
154908765|NCT03657576|559087722|FG005|Overall Study|Screen Fail|5|||
154908766|NCT03657576|559087717|FG000|Overall Study|Disease Progression|1|||
154908767|NCT03657576|559087718|FG001|Overall Study|Disease Progression|1|||
154908768|NCT03657576|559087719|FG002|Overall Study|Disease Progression|0|||
154908769|NCT03657576|559087720|FG003|Overall Study|Disease Progression|5|||
154908770|NCT03657576|559087721|FG004|Overall Study|Disease Progression|0|||
154908771|NCT03657576|559087722|FG005|Overall Study|Disease Progression|0|||
154908772|NCT03657576|559087717|FG000|Overall Study|Insurance Coverage|0|||
154908773|NCT03657576|559087718|FG001|Overall Study|Insurance Coverage|0|||
154908774|NCT03657576|559087719|FG002|Overall Study|Insurance Coverage|0|||
154908775|NCT03657576|559087720|FG003|Overall Study|Insurance Coverage|1|||
154908776|NCT03657576|559087721|FG004|Overall Study|Insurance Coverage|0|||
154908777|NCT03657576|559087722|FG005|Overall Study|Insurance Coverage|0|||
154908778|NCT01263470|559087725|FG000|Overall Study|Adverse Event|2|||
154908779|NCT01263470|559087726|FG001|Overall Study|Adverse Event|2|||
154908780|NCT01263470|559087727|FG002|Overall Study|Adverse Event|1|||
154908781|NCT01263470|559087728|FG003|Overall Study|Adverse Event|1|||
154908782|NCT01263470|559087729|FG004|Overall Study|Adverse Event|2|||
154908783|NCT01263470|559087730|FG005|Overall Study|Adverse Event|2|||
154908784|NCT01263470|559087725|FG000|Overall Study|Protocol Violation|0|||
154908785|NCT01263470|559087726|FG001|Overall Study|Protocol Violation|1|||
154908786|NCT01263470|559087727|FG002|Overall Study|Protocol Violation|0|||
154908787|NCT01263470|559087728|FG003|Overall Study|Protocol Violation|0|||
154908788|NCT01263470|559087729|FG004|Overall Study|Protocol Violation|0|||
154908789|NCT01263470|559087730|FG005|Overall Study|Protocol Violation|1|||
154908790|NCT01263470|559087725|FG000|Overall Study|Withdrawal by Subject|0|||
154908791|NCT01263470|559087726|FG001|Overall Study|Withdrawal by Subject|1|||
154908792|NCT01263470|559087727|FG002|Overall Study|Withdrawal by Subject|1|||
154908793|NCT01263470|559087728|FG003|Overall Study|Withdrawal by Subject|2|||
154908794|NCT01263470|559087729|FG004|Overall Study|Withdrawal by Subject|0|||
154908795|NCT01263470|559087730|FG005|Overall Study|Withdrawal by Subject|2|||
154908796|NCT01263470|559087725|FG000|Overall Study|Lack of Efficacy|0|||
154908797|NCT01263470|559087726|FG001|Overall Study|Lack of Efficacy|0|||
154908798|NCT01263470|559087727|FG002|Overall Study|Lack of Efficacy|2|||
154908799|NCT01263470|559087728|FG003|Overall Study|Lack of Efficacy|0|||
154908800|NCT01263470|559087729|FG004|Overall Study|Lack of Efficacy|0|||
154908801|NCT01263470|559087730|FG005|Overall Study|Lack of Efficacy|0|||
154908802|NCT01263470|559087725|FG000|Overall Study|Participant Unavailability|0|||
154908803|NCT01263470|559087726|FG001|Overall Study|Participant Unavailability|1|||
154908804|NCT01263470|559087727|FG002|Overall Study|Participant Unavailability|0|||
154908805|NCT01263470|559087728|FG003|Overall Study|Participant Unavailability|0|||
154908806|NCT01263470|559087729|FG004|Overall Study|Participant Unavailability|0|||
154908807|NCT01263470|559087730|FG005|Overall Study|Participant Unavailability|0|||
154908808|NCT01263470|559087725|FG000|Overall Study|Study Drug Non-compliance|0|||
154908809|NCT01263470|559087726|FG001|Overall Study|Study Drug Non-compliance|0|||
154983370|NCT00773734|559364417|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
154983371|NCT00773734|559364418|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
154983372|NCT00773734|559364419|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
154983373|NCT00773734|559364420|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
154983374|NCT01220297|559364427|FG000|Overall Study|Death|2|||
154983375|NCT01220297|559364427|FG000|Overall Study|Lost to Follow-up|1|||
154983376|NCT02119286|559364429|FG000|Overall Study|Adverse Event|9|||
154983377|NCT02119286|559364430|FG001|Overall Study|Adverse Event|7|||
154983378|NCT02119286|559364431|FG002|Overall Study|Adverse Event|2|||
154983379|NCT02119286|559364429|FG000|Overall Study|Lack of Efficacy|11|||
154983380|NCT02119286|559364430|FG001|Overall Study|Lack of Efficacy|3|||
154983381|NCT02119286|559364431|FG002|Overall Study|Lack of Efficacy|4|||
154983382|NCT02119286|559364429|FG000|Overall Study|Lost to Follow-up|2|||
154983383|NCT02119286|559364430|FG001|Overall Study|Lost to Follow-up|0|||
154983384|NCT02119286|559364431|FG002|Overall Study|Lost to Follow-up|1|||
154983385|NCT02119286|559364429|FG000|Overall Study|Withdrawal by Subject|4|||
154983386|NCT02119286|559364430|FG001|Overall Study|Withdrawal by Subject|1|||
154983387|NCT02119286|559364431|FG002|Overall Study|Withdrawal by Subject|0|||
154983388|NCT04109313|559364432|FG000|Overall Study|Pregnancy|1|||
154983389|NCT04109313|559364432|FG000|Overall Study|Adverse Event|11|||
154983390|NCT04109313|559364432|FG000|Overall Study|Lack of Efficacy|11|||
154983391|NCT04109313|559364432|FG000|Overall Study|Lost to Follow-up|1|||
154983392|NCT04109313|559364432|FG000|Overall Study|Physician Decision|2|||
154983393|NCT04109313|559364432|FG000|Overall Study|Subject Decision|13|||
154983394|NCT04109313|559364432|FG000|Overall Study|Covid-19 situation|2|||
154983395|NCT01272921|559364433|FG000|Overall Study|Protocol Violation|2|||
154983396|NCT01272921|559364434|FG001|Overall Study|Protocol Violation|1|||
154983397|NCT01132664|559364435|FG000|Phase lb|Adverse Event|0|||
154983398|NCT01132664|559364436|FG001|Phase lb|Adverse Event|1|||
154983399|NCT01132664|559364437|FG002|Phase lb|Adverse Event|0|||
154983400|NCT01132664|559364438|FG003|Phase lb|Adverse Event|0|||
154983401|NCT01132664|559364439|FG004|Phase lb|Adverse Event|0|||
154983402|NCT01132664|559364435|FG000|Phase lb|Withdrawal by Subject|1|||
154983403|NCT01132664|559364436|FG001|Phase lb|Withdrawal by Subject|2|||
154983404|NCT01132664|559364437|FG002|Phase lb|Withdrawal by Subject|0|||
154983405|NCT01132664|559364438|FG003|Phase lb|Withdrawal by Subject|0|||
154983406|NCT01132664|559364439|FG004|Phase lb|Withdrawal by Subject|0|||
154983407|NCT01132664|559364435|FG000|Phase lb|Disease Progression|4|||
154983408|NCT01132664|559364436|FG001|Phase lb|Disease Progression|9|||
154983409|NCT01132664|559364437|FG002|Phase lb|Disease Progression|0|||
154983410|NCT01132664|559364438|FG003|Phase lb|Disease Progression|0|||
154983411|NCT01132664|559364439|FG004|Phase lb|Disease Progression|0|||
154983412|NCT01132664|559364435|FG000|Phase ll|Death|0|||
154983413|NCT01132664|559364436|FG001|Phase ll|Death|0|||
154983414|NCT01132664|559364437|FG002|Phase ll|Death|2|||
154983415|NCT01132664|559364438|FG003|Phase ll|Death|0|||
154983416|NCT01132664|559364439|FG004|Phase ll|Death|0|||
154983417|NCT01132664|559364435|FG000|Phase ll|Adverse Event|0|||
154983418|NCT01132664|559364436|FG001|Phase ll|Adverse Event|0|||
154983419|NCT01132664|559364437|FG002|Phase ll|Adverse Event|10|||
154983420|NCT01132664|559364438|FG003|Phase ll|Adverse Event|0|||
154983421|NCT01132664|559364439|FG004|Phase ll|Adverse Event|0|||
154983422|NCT01132664|559364435|FG000|Phase ll|Withdrawal by Subject|0|||
154983423|NCT01132664|559364436|FG001|Phase ll|Withdrawal by Subject|0|||
154983424|NCT01132664|559364437|FG002|Phase ll|Withdrawal by Subject|3|||
154983425|NCT01132664|559364438|FG003|Phase ll|Withdrawal by Subject|0|||
154983426|NCT01132664|559364439|FG004|Phase ll|Withdrawal by Subject|0|||
154983427|NCT01132664|559364435|FG000|Phase ll|Disease progression|0|||
154983428|NCT01132664|559364436|FG001|Phase ll|Disease progression|0|||
154983429|NCT01132664|559364437|FG002|Phase ll|Disease progression|35|||
154983430|NCT01132664|559364438|FG003|Phase ll|Disease progression|0|||
154983431|NCT01132664|559364439|FG004|Phase ll|Disease progression|0|||
154983432|NCT01132664|559364435|FG000|BM Cohort|Disease progression|0|||
154983433|NCT01132664|559364436|FG001|BM Cohort|Disease progression|0|||
154983434|NCT01132664|559364437|FG002|BM Cohort|Disease progression|0|||
154983435|NCT01132664|559364438|FG003|BM Cohort|Disease progression|3|||
154983436|NCT01132664|559364439|FG004|BM Cohort|Disease progression|4|||
154983437|NCT01132664|559364435|FG000|BM Cohort|Adverse Event|0|||
154983438|NCT01132664|559364436|FG001|BM Cohort|Adverse Event|0|||
154983439|NCT01132664|559364437|FG002|BM Cohort|Adverse Event|0|||
154983440|NCT01132664|559364438|FG003|BM Cohort|Adverse Event|0|||
154983441|NCT01132664|559364439|FG004|BM Cohort|Adverse Event|1|||
154983442|NCT01132664|559364435|FG000|BM Cohort|Withdrawal by Subject|0|||
154983443|NCT01132664|559364436|FG001|BM Cohort|Withdrawal by Subject|0|||
154983444|NCT01132664|559364437|FG002|BM Cohort|Withdrawal by Subject|0|||
154983445|NCT01132664|559364438|FG003|BM Cohort|Withdrawal by Subject|0|||
154983446|NCT01132664|559364439|FG004|BM Cohort|Withdrawal by Subject|1|||
154983447|NCT01996332|559364441|FG000|Overall Study|Adverse Event|117|||
154983448|NCT01996332|559364441|FG000|Overall Study|Lack of Efficacy|1245|||
154983449|NCT01996332|559364441|FG000|Overall Study|Death|264|||
154983450|NCT01996332|559364441|FG000|Overall Study|Protocol Violation|9|||
154983451|NCT01996332|559364441|FG000|Overall Study|Withdrawal by Subject|71|||
154983452|NCT01996332|559364441|FG000|Overall Study|Other|20|||
154908810|NCT01263470|559087727|FG002|Overall Study|Study Drug Non-compliance|0|||
154908811|NCT01263470|559087728|FG003|Overall Study|Study Drug Non-compliance|0|||
154908812|NCT01263470|559087729|FG004|Overall Study|Study Drug Non-compliance|1|||
154908813|NCT01263470|559087730|FG005|Overall Study|Study Drug Non-compliance|0|||
154908814|NCT00610714|559087731|FG000|Overall Study|Adverse Event|3|||
154908815|NCT00610714|559087732|FG001|Overall Study|Adverse Event|1|||
154908816|NCT00610714|559087731|FG000|Overall Study|Death|12|||
154908817|NCT00610714|559087732|FG001|Overall Study|Death|18|||
154908818|NCT00610714|559087731|FG000|Overall Study|Withdrawal by Subject|9|||
154908819|NCT00610714|559087732|FG001|Overall Study|Withdrawal by Subject|3|||
154908820|NCT00610714|559087731|FG000|Overall Study|Study completion at 120 PFS events|2|||
154908821|NCT00610714|559087732|FG001|Overall Study|Study completion at 120 PFS events|2|||
154908822|NCT01327573|559087733|FG000|Overall Study|Physician Decision|3|||
154908823|NCT01327573|559087734|FG001|Overall Study|Physician Decision|1|||
154908824|NCT01108263|559087735|FG000|Overall Study|Adverse Event|0|||
154908825|NCT01108263|559087736|FG001|Overall Study|Adverse Event|1|||
154908826|NCT00638989|559087737|FG000|Overall Study|Lost to Follow-up|0|||
154908827|NCT00638989|559087738|FG001|Overall Study|Lost to Follow-up|0|||
154908828|NCT00638989|559087739|FG002|Overall Study|Lost to Follow-up|1|||
154908829|NCT05245071|559087740|FG000|Overall Study|Progressive disease|18|||
154908830|NCT05245071|559087740|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
154908831|NCT05245071|559087740|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
154908832|NCT01602822|559087741|FG000|Overall Study|Adverse Event|11|||
154908833|NCT00853112|559087744|FG000|Overall Study|Randomized but not treated|0|||
154908834|NCT00853112|559087745|FG001|Overall Study|Randomized but not treated|1|||
154908835|NCT00853112|559087746|FG002|Overall Study|Randomized but not treated|0|||
154908836|NCT00853112|559087747|FG003|Overall Study|Randomized but not treated|2|||
154908837|NCT00853112|559087748|FG004|Overall Study|Randomized but not treated|0|||
154908838|NCT00853112|559087749|FG005|Overall Study|Randomized but not treated|0|||
154908839|NCT00853112|559087750|FG006|Overall Study|Randomized but not treated|1|||
154908840|NCT01553591|559087751|FG000|Overall Study|Voluntarily withdrew|94|||
154908841|NCT01553591|559087752|FG001|Overall Study|Voluntarily withdrew|79|||
154908842|NCT01553591|559087753|FG002|Overall Study|Voluntarily withdrew|96|||
154908843|NCT01553591|559087751|FG000|Overall Study|Adverse Event|36|||
154908844|NCT01553591|559087752|FG001|Overall Study|Adverse Event|45|||
154908845|NCT01553591|559087753|FG002|Overall Study|Adverse Event|16|||
154908846|NCT01553591|559087751|FG000|Overall Study|Lost to Follow-up|25|||
154908847|NCT01553591|559087752|FG001|Overall Study|Lost to Follow-up|23|||
154908848|NCT01553591|559087753|FG002|Overall Study|Lost to Follow-up|16|||
154908849|NCT01553591|559087751|FG000|Overall Study|Physician decision: other|11|||
154908850|NCT01553591|559087752|FG001|Overall Study|Physician decision: other|14|||
154908851|NCT01553591|559087753|FG002|Overall Study|Physician decision: other|16|||
154908852|NCT01553591|559087751|FG000|Overall Study|Physician decision: lack of efficacy|2|||
154908853|NCT01553591|559087752|FG001|Overall Study|Physician decision: lack of efficacy|3|||
154908854|NCT01553591|559087753|FG002|Overall Study|Physician decision: lack of efficacy|7|||
154908855|NCT01553591|559087751|FG000|Overall Study|Protocol Violation|3|||
154908856|NCT01553591|559087752|FG001|Overall Study|Protocol Violation|4|||
154908857|NCT01553591|559087753|FG002|Overall Study|Protocol Violation|4|||
154908858|NCT01553591|559087751|FG000|Overall Study|Sponsor decision|1|||
154908859|NCT01553591|559087752|FG001|Overall Study|Sponsor decision|0|||
154908860|NCT01553591|559087753|FG002|Overall Study|Sponsor decision|3|||
154908861|NCT01553591|559087751|FG000|Overall Study|Randomized and never dispensed drug|0|||
154908862|NCT01553591|559087752|FG001|Overall Study|Randomized and never dispensed drug|1|||
154908863|NCT01553591|559087753|FG002|Overall Study|Randomized and never dispensed drug|0|||
154908864|NCT02477800|559087754|FG000|Placebo-Controlled Period|Adverse Event|16|||
154908865|NCT02477800|559087755|FG001|Placebo-Controlled Period|Adverse Event|25|||
154908866|NCT02477800|559087756|FG002|Placebo-Controlled Period|Adverse Event|28|||
154908867|NCT02477800|559087757|FG003|Placebo-Controlled Period|Adverse Event|0|||
154908868|NCT02477800|559087758|FG004|Placebo-Controlled Period|Adverse Event|0|||
154908869|NCT02477800|559087759|FG005|Placebo-Controlled Period|Adverse Event|0|||
154908870|NCT02477800|559087760|FG006|Placebo-Controlled Period|Adverse Event|0|||
154908871|NCT02477800|559087754|FG000|Placebo-Controlled Period|Change of Treatment|1|||
154908872|NCT02477800|559087755|FG001|Placebo-Controlled Period|Change of Treatment|2|||
154908873|NCT02477800|559087756|FG002|Placebo-Controlled Period|Change of Treatment|1|||
154908874|NCT02477800|559087757|FG003|Placebo-Controlled Period|Change of Treatment|0|||
154908875|NCT02477800|559087758|FG004|Placebo-Controlled Period|Change of Treatment|0|||
154908876|NCT02477800|559087759|FG005|Placebo-Controlled Period|Change of Treatment|0|||
154908877|NCT02477800|559087760|FG006|Placebo-Controlled Period|Change of Treatment|0|||
154908878|NCT02477800|559087754|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
154908879|NCT02477800|559087755|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
154908880|NCT02477800|559087756|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
154908881|NCT02477800|559087757|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
154908882|NCT02477800|559087758|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
154908883|NCT02477800|559087759|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
154908884|NCT02477800|559087760|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
154908885|NCT02477800|559087754|FG000|Placebo-Controlled Period|Death|0|||
154908886|NCT02477800|559087755|FG001|Placebo-Controlled Period|Death|3|||
154908887|NCT02477800|559087756|FG002|Placebo-Controlled Period|Death|2|||
154908888|NCT02477800|559087757|FG003|Placebo-Controlled Period|Death|0|||
154908889|NCT02477800|559087758|FG004|Placebo-Controlled Period|Death|0|||
154908890|NCT02477800|559087759|FG005|Placebo-Controlled Period|Death|0|||
154908891|NCT02477800|559087760|FG006|Placebo-Controlled Period|Death|0|||
154908892|NCT02477800|559087754|FG000|Placebo-Controlled Period|Disease Progression|1|||
154908893|NCT02477800|559087755|FG001|Placebo-Controlled Period|Disease Progression|0|||
154908894|NCT02477800|559087756|FG002|Placebo-Controlled Period|Disease Progression|1|||
154908895|NCT02477800|559087757|FG003|Placebo-Controlled Period|Disease Progression|0|||
154908896|NCT02477800|559087758|FG004|Placebo-Controlled Period|Disease Progression|0|||
154908897|NCT02477800|559087759|FG005|Placebo-Controlled Period|Disease Progression|0|||
154908898|NCT02477800|559087760|FG006|Placebo-Controlled Period|Disease Progression|0|||
154908899|NCT02477800|559087754|FG000|Placebo-Controlled Period|Investigator Decision|3|||
154908900|NCT02477800|559087755|FG001|Placebo-Controlled Period|Investigator Decision|2|||
154908901|NCT02477800|559087756|FG002|Placebo-Controlled Period|Investigator Decision|1|||
154908902|NCT02477800|559087757|FG003|Placebo-Controlled Period|Investigator Decision|0|||
154908903|NCT02477800|559087758|FG004|Placebo-Controlled Period|Investigator Decision|0|||
154908904|NCT02477800|559087759|FG005|Placebo-Controlled Period|Investigator Decision|0|||
154908905|NCT02477800|559087760|FG006|Placebo-Controlled Period|Investigator Decision|0|||
154908906|NCT02477800|559087754|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
154908907|NCT02477800|559087755|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
154908908|NCT02477800|559087756|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
154908909|NCT02477800|559087757|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
154908910|NCT02477800|559087758|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
154908911|NCT02477800|559087759|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
154908912|NCT02477800|559087760|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
154908913|NCT02477800|559087754|FG000|Placebo-Controlled Period|Relocation|2|||
154908914|NCT02477800|559087755|FG001|Placebo-Controlled Period|Relocation|0|||
154908915|NCT02477800|559087756|FG002|Placebo-Controlled Period|Relocation|0|||
154908916|NCT02477800|559087757|FG003|Placebo-Controlled Period|Relocation|0|||
154908917|NCT02477800|559087758|FG004|Placebo-Controlled Period|Relocation|0|||
154908918|NCT02477800|559087759|FG005|Placebo-Controlled Period|Relocation|0|||
154908919|NCT02477800|559087760|FG006|Placebo-Controlled Period|Relocation|0|||
154908920|NCT02477800|559087754|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
154908921|NCT02477800|559087755|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
154908922|NCT02477800|559087756|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
154908923|NCT02477800|559087757|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
154908924|NCT02477800|559087758|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
154908925|NCT02477800|559087759|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
154908926|NCT02477800|559087760|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
154908927|NCT02477800|559087754|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
154908928|NCT02477800|559087755|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
154908929|NCT02477800|559087756|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
154908930|NCT02477800|559087757|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
154908931|NCT02477800|559087758|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
154908932|NCT02477800|559087759|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
154908933|NCT02477800|559087760|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
154908934|NCT02477800|559087754|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
154908935|NCT02477800|559087755|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
154908936|NCT02477800|559087756|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
154908937|NCT02477800|559087757|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
154908938|NCT02477800|559087758|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
154908939|NCT02477800|559087759|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
154908940|NCT02477800|559087760|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
154908941|NCT02477800|559087754|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
154908942|NCT02477800|559087755|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
154908943|NCT02477800|559087756|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
154908944|NCT02477800|559087757|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
154908945|NCT02477800|559087758|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
154908946|NCT02477800|559087759|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
154908947|NCT02477800|559087760|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
154908948|NCT02477800|559087754|FG000|Placebo-Controlled Period|Reason not Specified|161|||
154908949|NCT02477800|559087755|FG001|Placebo-Controlled Period|Reason not Specified|161|||
154908950|NCT02477800|559087756|FG002|Placebo-Controlled Period|Reason not Specified|189|||
154908951|NCT02477800|559087757|FG003|Placebo-Controlled Period|Reason not Specified|0|||
154908952|NCT02477800|559087758|FG004|Placebo-Controlled Period|Reason not Specified|0|||
154908953|NCT02477800|559087759|FG005|Placebo-Controlled Period|Reason not Specified|0|||
154983453|NCT01996332|559364441|FG000|Overall Study|Clinical Deterioration|28|||
154983454|NCT01996332|559364441|FG000|Overall Study|Physician Decision|17|||
154983455|NCT01996332|559364441|FG000|Overall Study|Lost to Follow-up|34|||
154983456|NCT02113189|559364442|FG000|Overall Study|Lost to follow up|2|||
154983457|NCT02113189|559364443|FG001|Overall Study|Lost to follow up|1|||
154983458|NCT02113189|559364444|FG002|Overall Study|Lost to follow up|3|||
154983459|NCT02954159|559364445|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
154983460|NCT02954159|559364446|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
154983461|NCT02954159|559364445|FG000|Overall Study|Withdrawal by Subject|0|||
154983462|NCT02954159|559364446|FG001|Overall Study|Withdrawal by Subject|1|||
154983463|NCT03438396|559364447|FG000|Overall Study|Reason Not Specified|9|||
154983464|NCT03438396|559364447|FG000|Overall Study|Withdrawal by Subject|5|||
154983465|NCT03438396|559364447|FG000|Overall Study|Lost to Follow-up|2|||
154983466|NCT03438396|559364447|FG000|Overall Study|Death|85|||
154983467|NCT03438396|559364447|FG000|Overall Study|Not treated|1|||
154983468|NCT00262041|559364448|FG000|Overall Study|Withdrawal by Subject|0|||
154983469|NCT00262041|559364449|FG001|Overall Study|Withdrawal by Subject|3|||
154983470|NCT00262041|559364450|FG002|Overall Study|Withdrawal by Subject|1|||
154983471|NCT00262041|559364448|FG000|Overall Study|Lost to Follow-up|1|||
154983472|NCT00262041|559364449|FG001|Overall Study|Lost to Follow-up|1|||
154983473|NCT00262041|559364450|FG002|Overall Study|Lost to Follow-up|5|||
154908954|NCT02477800|559087760|FG006|Placebo-Controlled Period|Reason not Specified|0|||
154908955|NCT02477800|559087754|FG000|Long Term Extension Period|Adverse Event|0|||
154908956|NCT02477800|559087755|FG001|Long Term Extension Period|Adverse Event|0|||
154908957|NCT02477800|559087756|FG002|Long Term Extension Period|Adverse Event|0|||
154908958|NCT02477800|559087757|FG003|Long Term Extension Period|Adverse Event|6|||
154908959|NCT02477800|559087758|FG004|Long Term Extension Period|Adverse Event|2|||
154908960|NCT02477800|559087759|FG005|Long Term Extension Period|Adverse Event|4|||
154908961|NCT02477800|559087760|FG006|Long Term Extension Period|Adverse Event|3|||
154908962|NCT02477800|559087754|FG000|Long Term Extension Period|Death|0|||
154908963|NCT02477800|559087755|FG001|Long Term Extension Period|Death|0|||
154908964|NCT02477800|559087756|FG002|Long Term Extension Period|Death|0|||
154908965|NCT02477800|559087757|FG003|Long Term Extension Period|Death|1|||
154908966|NCT02477800|559087758|FG004|Long Term Extension Period|Death|1|||
154908967|NCT02477800|559087759|FG005|Long Term Extension Period|Death|1|||
154908968|NCT02477800|559087760|FG006|Long Term Extension Period|Death|2|||
154908969|NCT02477800|559087754|FG000|Long Term Extension Period|Consent Withdrawn|0|||
154908970|NCT02477800|559087755|FG001|Long Term Extension Period|Consent Withdrawn|0|||
154908971|NCT02477800|559087756|FG002|Long Term Extension Period|Consent Withdrawn|0|||
154908972|NCT02477800|559087757|FG003|Long Term Extension Period|Consent Withdrawn|10|||
154908973|NCT02477800|559087758|FG004|Long Term Extension Period|Consent Withdrawn|4|||
154908974|NCT02477800|559087759|FG005|Long Term Extension Period|Consent Withdrawn|13|||
154908975|NCT02477800|559087760|FG006|Long Term Extension Period|Consent Withdrawn|16|||
154908976|NCT02477800|559087754|FG000|Long Term Extension Period|Disease Progression|0|||
154908977|NCT02477800|559087755|FG001|Long Term Extension Period|Disease Progression|0|||
154908978|NCT02477800|559087756|FG002|Long Term Extension Period|Disease Progression|0|||
154908979|NCT02477800|559087757|FG003|Long Term Extension Period|Disease Progression|3|||
154908980|NCT02477800|559087758|FG004|Long Term Extension Period|Disease Progression|1|||
154908981|NCT02477800|559087759|FG005|Long Term Extension Period|Disease Progression|1|||
154908982|NCT02477800|559087760|FG006|Long Term Extension Period|Disease Progression|0|||
154908983|NCT02477800|559087754|FG000|Long Term Extension Period|Investigator Decision|0|||
154908984|NCT02477800|559087755|FG001|Long Term Extension Period|Investigator Decision|0|||
154908985|NCT02477800|559087756|FG002|Long Term Extension Period|Investigator Decision|0|||
154908986|NCT02477800|559087757|FG003|Long Term Extension Period|Investigator Decision|0|||
154908987|NCT02477800|559087758|FG004|Long Term Extension Period|Investigator Decision|0|||
154908988|NCT02477800|559087759|FG005|Long Term Extension Period|Investigator Decision|0|||
154908989|NCT02477800|559087760|FG006|Long Term Extension Period|Investigator Decision|2|||
154908990|NCT02477800|559087754|FG000|Long Term Extension Period|Lost to Follow-up|0|||
154908991|NCT02477800|559087755|FG001|Long Term Extension Period|Lost to Follow-up|0|||
154908992|NCT02477800|559087756|FG002|Long Term Extension Period|Lost to Follow-up|0|||
154908993|NCT02477800|559087757|FG003|Long Term Extension Period|Lost to Follow-up|0|||
154908994|NCT02477800|559087758|FG004|Long Term Extension Period|Lost to Follow-up|1|||
154908995|NCT02477800|559087759|FG005|Long Term Extension Period|Lost to Follow-up|3|||
154908996|NCT02477800|559087760|FG006|Long Term Extension Period|Lost to Follow-up|0|||
154908997|NCT02477800|559087754|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
154908998|NCT02477800|559087755|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
154908999|NCT02477800|559087756|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
154909000|NCT02477800|559087757|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
154909001|NCT02477800|559087758|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
154983474|NCT00262041|559364448|FG000|Overall Study|Unable to classify|1|||
154909002|NCT02477800|559087759|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
154983475|NCT00262041|559364449|FG001|Overall Study|Unable to classify|0|||
154983476|NCT00262041|559364450|FG002|Overall Study|Unable to classify|0|||
154983477|NCT03578237|559364451|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
154983478|NCT03578237|559364452|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
154983479|NCT02488330|559364453|FG000|Overall Study|Adverse Event|1|||
154983480|NCT02488330|559364453|FG000|Overall Study|Physician Decision|2|||
154983481|NCT02488330|559364453|FG000|Overall Study|Death|2|||
154983482|NCT02488330|559364453|FG000|Overall Study|Disease Progression|3|||
154983483|NCT02488330|559364453|FG000|Overall Study|Study Termination by Sponsor|4|||
154983484|NCT02384941|559364456|FG000|Overall Study|Adverse Event|11|||
154983485|NCT02384941|559364457|FG001|Overall Study|Adverse Event|13|||
154983486|NCT02384941|559364458|FG002|Overall Study|Adverse Event|17|||
154983487|NCT02384941|559364456|FG000|Overall Study|Lost to Follow-up|3|||
154983488|NCT02384941|559364457|FG001|Overall Study|Lost to Follow-up|2|||
154983489|NCT02384941|559364458|FG002|Overall Study|Lost to Follow-up|1|||
154983490|NCT02384941|559364456|FG000|Overall Study|Non-Compliance With Study Drug|2|||
154983491|NCT02384941|559364457|FG001|Overall Study|Non-Compliance With Study Drug|0|||
154983492|NCT02384941|559364458|FG002|Overall Study|Non-Compliance With Study Drug|1|||
154983493|NCT02384941|559364456|FG000|Overall Study|Physician Decision|1|||
154983494|NCT02384941|559364457|FG001|Overall Study|Physician Decision|1|||
154983495|NCT02384941|559364458|FG002|Overall Study|Physician Decision|0|||
154983496|NCT02384941|559364456|FG000|Overall Study|Protocol Violation|3|||
154983497|NCT02384941|559364457|FG001|Overall Study|Protocol Violation|0|||
154983498|NCT02384941|559364458|FG002|Overall Study|Protocol Violation|0|||
154983499|NCT02384941|559364456|FG000|Overall Study|Withdrawal by Subject|26|||
154983500|NCT02384941|559364457|FG001|Overall Study|Withdrawal by Subject|19|||
154983501|NCT02384941|559364458|FG002|Overall Study|Withdrawal by Subject|20|||
154983502|NCT02384941|559364456|FG000|Overall Study|Pregnancy|0|||
154983503|NCT02384941|559364457|FG001|Overall Study|Pregnancy|0|||
154983504|NCT02384941|559364458|FG002|Overall Study|Pregnancy|1|||
154983505|NCT02384941|559364456|FG000|Overall Study|Other than specified above|4|||
154983506|NCT02384941|559364457|FG001|Overall Study|Other than specified above|0|||
154983507|NCT02384941|559364458|FG002|Overall Study|Other than specified above|1|||
154983508|NCT02493777|559364459|FG000|Overall Study|Lost to Follow-up|0|||
154983509|NCT02493777|559364460|FG001|Overall Study|Lost to Follow-up|1|||
154983510|NCT00468728|559364461|FG000|Treatment|criteria for mITT population|4|||
154983511|NCT00468728|559364462|FG001|Treatment|criteria for mITT population|11|||
154983512|NCT00468728|559364461|FG000|Follow-up|mITT failure|34|||
154983513|NCT00468728|559364462|FG001|Follow-up|mITT failure|31|||
154983514|NCT01642914|559364463|FG000|Overall Study|Adverse Event|11|||
155117304|NCT03920293|559860674|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
155117305|NCT03920293|559860673|FG000|Open- Label Extension Period|Death|3|||
155117306|NCT03920293|559860674|FG001|Open- Label Extension Period|Death|3|||
155117307|NCT03920293|559860673|FG000|Open- Label Extension Period|Physician Decision|5|||
154983515|NCT01642914|559364464|FG001|Overall Study|Adverse Event|7|||
154983516|NCT01642914|559364465|FG002|Overall Study|Adverse Event|15|||
154983517|NCT01642914|559364463|FG000|Overall Study|Lack of Efficacy|9|||
154983518|NCT01642914|559364464|FG001|Overall Study|Lack of Efficacy|4|||
155117308|NCT03920293|559860674|FG001|Open- Label Extension Period|Physician Decision|3|||
155117309|NCT03920293|559860673|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
155117310|NCT03920293|559860674|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
155117311|NCT01972308|559860677|FG000|Overall Study|Withdrawal by Subject|0|||
155117312|NCT01972308|559860678|FG001|Overall Study|Withdrawal by Subject|1|||
155117313|NCT01972308|559860677|FG000|Overall Study|Lost to Follow-up|4|||
155117314|NCT01972308|559860678|FG001|Overall Study|Lost to Follow-up|6|||
155117315|NCT01972308|559860677|FG000|Overall Study|Death|4|||
155117316|NCT01972308|559860678|FG001|Overall Study|Death|1|||
155117317|NCT00666588|559860679|FG000|Overall Study|ineligible|2|||
155117318|NCT00666588|559860680|FG001|Overall Study|ineligible|0|||
155117319|NCT00666588|559860681|FG002|Overall Study|ineligible|0|||
155117320|NCT00666588|559860682|FG003|Overall Study|ineligible|2|||
155117321|NCT00666588|559860679|FG000|Overall Study|inevaluable|2|||
155117322|NCT00666588|559860680|FG001|Overall Study|inevaluable|0|||
155117323|NCT00666588|559860681|FG002|Overall Study|inevaluable|0|||
155117324|NCT00666588|559860682|FG003|Overall Study|inevaluable|0|||
155117325|NCT00521599|559860683|FG000|Overall Study|Adverse Event|5|||
155117326|NCT00521599|559860684|FG001|Overall Study|Adverse Event|7|||
154983519|NCT01642914|559364465|FG002|Overall Study|Lack of Efficacy|2|||
154983520|NCT01642914|559364463|FG000|Overall Study|Protocol Violation|15|||
154983521|NCT01642914|559364464|FG001|Overall Study|Protocol Violation|13|||
154983522|NCT01642914|559364465|FG002|Overall Study|Protocol Violation|6|||
155117327|NCT00521599|559860685|FG002|Overall Study|Adverse Event|6|||
154983523|NCT01642914|559364463|FG000|Overall Study|Withdrawal by Subject|5|||
154983524|NCT01642914|559364464|FG001|Overall Study|Withdrawal by Subject|5|||
154983525|NCT01642914|559364465|FG002|Overall Study|Withdrawal by Subject|10|||
154983526|NCT01642914|559364463|FG000|Overall Study|Lost to Follow-up|5|||
155117328|NCT00521599|559860683|FG000|Overall Study|Treatment Failure|8|||
154983527|NCT01642914|559364464|FG001|Overall Study|Lost to Follow-up|3|||
154983528|NCT01642914|559364465|FG002|Overall Study|Lost to Follow-up|7|||
154983529|NCT01642914|559364463|FG000|Overall Study|Other Reason|1|||
155117329|NCT00521599|559860684|FG001|Overall Study|Treatment Failure|9|||
155117330|NCT00521599|559860685|FG002|Overall Study|Treatment Failure|22|||
155117331|NCT00521599|559860683|FG000|Overall Study|Lost to Follow-up|2|||
154909003|NCT02477800|559087760|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
154909004|NCT02477800|559087754|FG000|Long Term Extension Period|Study Visit Burden|0|||
154909005|NCT02477800|559087755|FG001|Long Term Extension Period|Study Visit Burden|0|||
154909006|NCT02477800|559087756|FG002|Long Term Extension Period|Study Visit Burden|0|||
154909007|NCT02477800|559087757|FG003|Long Term Extension Period|Study Visit Burden|3|||
154909008|NCT02477800|559087758|FG004|Long Term Extension Period|Study Visit Burden|0|||
154909009|NCT02477800|559087759|FG005|Long Term Extension Period|Study Visit Burden|2|||
154909010|NCT02477800|559087760|FG006|Long Term Extension Period|Study Visit Burden|2|||
154909011|NCT02477800|559087754|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
154909012|NCT02477800|559087755|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
154909013|NCT02477800|559087756|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
154909014|NCT02477800|559087757|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
154909015|NCT02477800|559087758|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
154909016|NCT02477800|559087759|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
154909017|NCT02477800|559087760|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
154909018|NCT02477800|559087754|FG000|Long Term Extension Period|Reason not Specified|0|||
154909019|NCT02477800|559087755|FG001|Long Term Extension Period|Reason not Specified|0|||
154909020|NCT02477800|559087756|FG002|Long Term Extension Period|Reason not Specified|0|||
154909021|NCT02477800|559087757|FG003|Long Term Extension Period|Reason not Specified|126|||
154909022|NCT02477800|559087758|FG004|Long Term Extension Period|Reason not Specified|140|||
154909023|NCT02477800|559087759|FG005|Long Term Extension Period|Reason not Specified|270|||
154909024|NCT02477800|559087760|FG006|Long Term Extension Period|Reason not Specified|224|||
154909025|NCT02871791|559087761|FG000|Phase 1b|Death|0|||
154909026|NCT02871791|559087762|FG001|Phase 1b|Death|1|||
154909027|NCT02871791|559087761|FG000|Phase 1b|progressive disease|6|||
154909028|NCT02871791|559087762|FG001|Phase 1b|progressive disease|2|||
154909029|NCT02871791|559087761|FG000|Phase 2|Death|1|||
154909030|NCT02871791|559087762|FG001|Phase 2|Death|0|||
154909031|NCT02871791|559087761|FG000|Phase 2|Lost to Follow-up|2|||
154909032|NCT02871791|559087762|FG001|Phase 2|Lost to Follow-up|0|||
154909033|NCT01426009|559087766|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
154909034|NCT01426009|559087766|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
154909035|NCT01426009|559087766|FG000|Washout 1|Withdrawal by Subject|1|||
154909036|NCT01426009|559087766|FG000|Washout 1|Personal Reasons|1|||
154909037|NCT01426009|559087766|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
154909038|NCT01426009|559087766|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
154909039|NCT01426009|559087766|FG000|Washout 2|electrive surgery|1|||
154909040|NCT01426009|559087766|FG000|Washout 3|personal reasons|1|||
154909041|NCT01426009|559087766|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
154909042|NCT01426009|559087766|FG000|Washout 4|Lost to Follow-up|1|||
154909043|NCT02005211|559087775|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
154909044|NCT02005211|559087776|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
154909045|NCT02005211|559087777|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
154909046|NCT02005211|559087778|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
154909047|NCT02005211|559087779|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
154909048|NCT02005211|559087780|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
154909049|NCT02005211|559087781|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
154909050|NCT00397631|559087784|FG000|Overall Study|Adverse Event|5|||
154909051|NCT00397631|559087785|FG001|Overall Study|Adverse Event|6|||
154909052|NCT00397631|559087784|FG000|Overall Study|Lack of Efficacy|7|||
154909053|NCT00397631|559087785|FG001|Overall Study|Lack of Efficacy|10|||
154909054|NCT00397631|559087784|FG000|Overall Study|Lost to Follow-up|8|||
154909055|NCT00397631|559087785|FG001|Overall Study|Lost to Follow-up|9|||
154909056|NCT00397631|559087784|FG000|Overall Study|Physician Decision|2|||
154909057|NCT00397631|559087785|FG001|Overall Study|Physician Decision|0|||
154909058|NCT00397631|559087784|FG000|Overall Study|Protocol Violation|0|||
154909059|NCT00397631|559087785|FG001|Overall Study|Protocol Violation|1|||
154909060|NCT00397631|559087784|FG000|Overall Study|Withdrawal by Subject|7|||
154909061|NCT00397631|559087785|FG001|Overall Study|Withdrawal by Subject|14|||
154909062|NCT00397631|559087784|FG000|Overall Study|protocol discontinuation criteria|1|||
154909063|NCT00397631|559087785|FG001|Overall Study|protocol discontinuation criteria|4|||
154909064|NCT02202161|559087786|FG000|Overall Study|Adverse Event|1|||
154909065|NCT02202161|559087787|FG001|Overall Study|Adverse Event|1|||
154909066|NCT02202161|559087788|FG002|Overall Study|Adverse Event|0|||
154909067|NCT02202161|559087789|FG003|Overall Study|Adverse Event|0|||
154909068|NCT02202161|559087790|FG004|Overall Study|Adverse Event|0|||
154909069|NCT02202161|559087791|FG005|Overall Study|Adverse Event|1|||
154909070|NCT02202161|559087792|FG006|Overall Study|Adverse Event|0|||
154909071|NCT02202161|559087793|FG007|Overall Study|Adverse Event|0|||
154909072|NCT02202161|559087786|FG000|Overall Study|Did not meet continuation criteria|0|||
154909073|NCT02202161|559087787|FG001|Overall Study|Did not meet continuation criteria|0|||
155117332|NCT00521599|559860684|FG001|Overall Study|Lost to Follow-up|1|||
154983530|NCT01642914|559364464|FG001|Overall Study|Other Reason|0|||
154983531|NCT01642914|559364465|FG002|Overall Study|Other Reason|0|||
154983532|NCT01705236|559364466|FG000|Overall Study|Lost to Follow-up|1|||
154983533|NCT01705236|559364466|FG000|Overall Study|Administrative problems|2|||
154983534|NCT01705236|559364466|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
154983535|NCT01705236|559364466|FG000|Overall Study|Protocol Violation|3|||
154983536|NCT01705236|559364466|FG000|Overall Study|Abnormal test procedure result(s)|4|||
154983537|NCT01705236|559364466|FG000|Overall Study|Abnormal laboratory value(s)|4|||
154983538|NCT01705236|559364466|FG000|Overall Study|Withdrawal by Subject|5|||
154983539|NCT01705236|559364466|FG000|Overall Study|Adverse Event|5|||
154983540|NCT03028740|559364467|FG000|Overall Study|Did not Receive Study Drug|4|||
154983541|NCT03028740|559364468|FG001|Overall Study|Did not Receive Study Drug|5|||
154983542|NCT03028740|559364467|FG000|Overall Study|Adverse Event|8|||
154983543|NCT03028740|559364468|FG001|Overall Study|Adverse Event|26|||
154983544|NCT03028740|559364467|FG000|Overall Study|Lack of Efficacy|0|||
154983545|NCT03028740|559364468|FG001|Overall Study|Lack of Efficacy|1|||
154983546|NCT03028740|559364467|FG000|Overall Study|Withdrawal by Subject|48|||
154983547|NCT03028740|559364468|FG001|Overall Study|Withdrawal by Subject|101|||
154983548|NCT03028740|559364467|FG000|Overall Study|Lost to Follow-up|30|||
154983549|NCT03028740|559364468|FG001|Overall Study|Lost to Follow-up|54|||
154983550|NCT03028740|559364467|FG000|Overall Study|Physician Decision|4|||
154983551|NCT03028740|559364468|FG001|Overall Study|Physician Decision|11|||
154983552|NCT03028740|559364467|FG000|Overall Study|Protocol Violation|4|||
154983553|NCT03028740|559364468|FG001|Overall Study|Protocol Violation|8|||
154983554|NCT03028740|559364467|FG000|Overall Study|Non-compliance with Study Drug|0|||
154983555|NCT03028740|559364468|FG001|Overall Study|Non-compliance with Study Drug|2|||
154983556|NCT03028740|559364467|FG000|Overall Study|Study Terminated by Sponsor|467|||
154983557|NCT03028740|559364468|FG001|Overall Study|Study Terminated by Sponsor|917|||
154983558|NCT03028740|559364467|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
154983559|NCT03028740|559364468|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
154983560|NCT03028740|559364467|FG000|Overall Study|Reason not Specified|1|||
154983561|NCT03028740|559364468|FG001|Overall Study|Reason not Specified|5|||
154983562|NCT01478828|559364472|FG000|Overall Study|Adverse Event|1|||
154983563|NCT02025010|559364476|FG000|Overall Study|Symptomatic or radiographic progression|36|||
154983564|NCT02025010|559364476|FG000|Overall Study|Adverse Event|6|||
154983565|NCT02025010|559364476|FG000|Overall Study|Physician Decision|7|||
154983566|NCT02025010|559364476|FG000|Overall Study|Withdrawal by Subject|3|||
154983567|NCT02025010|559364476|FG000|Overall Study|Intercurrent illness|3|||
154983568|NCT02025010|559364476|FG000|Overall Study|Patients still on treatment|3|||
154983569|NCT02025010|559364476|FG000|Overall Study|Never initiate the treatment|2|||
154983570|NCT04572243|559364478|FG000|Core Study: 14 Weeks|Adverse Event|1|||
154983571|NCT04572243|559364479|FG001|Core Study: 14 Weeks|Adverse Event|2|||
154983572|NCT04572243|559364480|FG002|Core Study: 14 Weeks|Adverse Event|0|||
154983573|NCT04572243|559364481|FG003|Core Study: 14 Weeks|Adverse Event|0|||
154983574|NCT04572243|559364478|FG000|Core Study: 14 Weeks|Subject choice|0|||
154983575|NCT04572243|559364479|FG001|Core Study: 14 Weeks|Subject choice|2|||
154983576|NCT04572243|559364480|FG002|Core Study: 14 Weeks|Subject choice|0|||
154983577|NCT04572243|559364481|FG003|Core Study: 14 Weeks|Subject choice|0|||
154983578|NCT04572243|559364478|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
154983579|NCT04572243|559364479|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
154983580|NCT04572243|559364480|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
154983581|NCT04572243|559364481|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
154983582|NCT04572243|559364478|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
154983583|NCT04572243|559364479|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
154983584|NCT04572243|559364480|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
154983585|NCT04572243|559364481|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
154983586|NCT01661881|559364482|FG000|Overall Study|Disease Progression|1|||
154983587|NCT01231373|559364483|FG000|Overall Study|Withdrew consent prior to randomization|2|||
154983588|NCT01231373|559364484|FG001|Overall Study|Withdrew consent prior to randomization|1|||
154983589|NCT01231373|559364485|FG002|Overall Study|Withdrew consent prior to randomization|0|||
154983590|NCT01231373|559364486|FG003|Overall Study|Withdrew consent prior to randomization|0|||
154983591|NCT01231373|559364483|FG000|Overall Study|Lost to Follow-up|0|||
154983592|NCT01231373|559364484|FG001|Overall Study|Lost to Follow-up|0|||
154983593|NCT01231373|559364485|FG002|Overall Study|Lost to Follow-up|0|||
154983594|NCT01231373|559364486|FG003|Overall Study|Lost to Follow-up|1|||
154983595|NCT01231373|559364483|FG000|Overall Study|Withdrew Consent|1|||
154983596|NCT01231373|559364484|FG001|Overall Study|Withdrew Consent|0|||
154983597|NCT01231373|559364485|FG002|Overall Study|Withdrew Consent|0|||
154983598|NCT01231373|559364486|FG003|Overall Study|Withdrew Consent|0|||
154983599|NCT01790113|559364487|FG000|Overall Study|Adverse Event|2|||
154983600|NCT01790113|559364488|FG001|Overall Study|Adverse Event|7|||
154983601|NCT01790113|559364487|FG000|Overall Study|Study ended due to FDA clearance|1|||
154983602|NCT01790113|559364488|FG001|Overall Study|Study ended due to FDA clearance|68|||
154983603|NCT00775606|559364489|FG000|Overall Study|Study sponsor terminated funding|3|||
154983604|NCT00775606|559364490|FG001|Overall Study|Study sponsor terminated funding|0|||
154983605|NCT01144403|559364492|FG000|Overall Study|Lost to Follow-up|3|||
154983606|NCT01144403|559364492|FG000|Overall Study|Death|1|||
154983607|NCT01144403|559364492|FG000|Overall Study|Adverse Event|1|||
155176145|NCT01375075|560082289|FG004|Overall Study|Entry Criterion Not Met|0|||
155176146|NCT01375075|560082290|FG005|Overall Study|Entry Criterion Not Met|1|||
155176147|NCT01375075|560082285|FG000|Overall Study|Withdrawal by Subject|0|||
154983608|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
154983609|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
154983610|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
154983611|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
154983612|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
154983613|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
154983614|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
154983615|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
154983616|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
154983617|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
154983618|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
154983619|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
154983620|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
154983621|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
154983622|NCT04740931|559364494|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
154983623|NCT04740931|559364495|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
154983624|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
154983625|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
154983626|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
154983627|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
154983628|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
154983629|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
154983630|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
154983631|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
154983632|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
154983633|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
154983634|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
154983635|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
154983636|NCT04740931|559364494|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
154983637|NCT04740931|559364495|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
154983638|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
154983639|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
154983640|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
154983641|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
154983642|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
154983643|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
154983644|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
154983645|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
154983646|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
154983647|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
154983648|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
154983649|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
154983650|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
154983651|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
154983652|NCT02510014|559364498|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
154983653|NCT02510014|559364499|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
154983654|NCT02510014|559364498|FG000|Treatment Period|Adverse Event|11|||
154983655|NCT02510014|559364499|FG001|Treatment Period|Adverse Event|4|||
154983656|NCT02510014|559364498|FG000|Treatment Period|Withdrawal symptoms|3|||
154983657|NCT02510014|559364499|FG001|Treatment Period|Withdrawal symptoms|0|||
154983658|NCT02510014|559364498|FG000|Treatment Period|Lost to Follow-up|80|||
154983659|NCT02510014|559364499|FG001|Treatment Period|Lost to Follow-up|19|||
154983660|NCT02510014|559364498|FG000|Treatment Period|Physician Decision|5|||
154983661|NCT02510014|559364499|FG001|Treatment Period|Physician Decision|0|||
154983662|NCT02510014|559364498|FG000|Treatment Period|Withdrawal by Subject|67|||
154983663|NCT02510014|559364499|FG001|Treatment Period|Withdrawal by Subject|24|||
154983664|NCT02510014|559364498|FG000|Treatment Period|Withdrawn by the investigator|7|||
154983665|NCT02510014|559364499|FG001|Treatment Period|Withdrawn by the investigator|1|||
154983666|NCT02510014|559364498|FG000|Treatment Period|Protocol Violation|4|||
154983667|NCT02510014|559364499|FG001|Treatment Period|Protocol Violation|4|||
154983668|NCT02510014|559364498|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
154983669|NCT02510014|559364499|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
154983670|NCT01020799|559364503|FG000|Overall Study|Adverse Event|4|||
154983671|NCT01020799|559364504|FG001|Overall Study|Adverse Event|3|||
155176148|NCT01375075|560082286|FG001|Overall Study|Withdrawal by Subject|1|||
154983672|NCT01020799|559364505|FG002|Overall Study|Adverse Event|2|||
154983673|NCT01020799|559364503|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
154983674|NCT01020799|559364504|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
154983675|NCT01020799|559364505|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
154983676|NCT01020799|559364503|FG000|Overall Study|Protocol Violation|3|||
154983677|NCT01020799|559364504|FG001|Overall Study|Protocol Violation|2|||
154983678|NCT01020799|559364505|FG002|Overall Study|Protocol Violation|0|||
154983679|NCT01020799|559364503|FG000|Overall Study|Withdrawal by Subject|2|||
154983680|NCT01020799|559364504|FG001|Overall Study|Withdrawal by Subject|2|||
154983681|NCT01020799|559364505|FG002|Overall Study|Withdrawal by Subject|3|||
154983682|NCT01020799|559364503|FG000|Overall Study|Lost to Follow-up|6|||
154983683|NCT01020799|559364504|FG001|Overall Study|Lost to Follow-up|4|||
154983684|NCT01020799|559364505|FG002|Overall Study|Lost to Follow-up|2|||
154983685|NCT02972502|559364506|FG000|Overall Study|Lost to Follow-up|3|||
154983686|NCT02972502|559364507|FG001|Overall Study|Lost to Follow-up|1|||
154983687|NCT02972502|559364506|FG000|Overall Study|Withdrawal by Subject|1|||
154983688|NCT02972502|559364507|FG001|Overall Study|Withdrawal by Subject|1|||
154983689|NCT03832738|559364508|FG000|Overall Study|Withdrawal by Subject|6|||
154983690|NCT03832738|559364509|FG001|Overall Study|Withdrawal by Subject|7|||
154983691|NCT03832738|559364510|FG002|Overall Study|Withdrawal by Subject|16|||
154983692|NCT03832738|559364508|FG000|Overall Study|Physician Decision|0|||
154983693|NCT03832738|559364509|FG001|Overall Study|Physician Decision|1|||
154983694|NCT03832738|559364510|FG002|Overall Study|Physician Decision|2|||
154983695|NCT03832738|559364508|FG000|Overall Study|Adverse Event|2|||
154983696|NCT03832738|559364509|FG001|Overall Study|Adverse Event|3|||
154983697|NCT03832738|559364510|FG002|Overall Study|Adverse Event|1|||
154983698|NCT03832738|559364508|FG000|Overall Study|Pregnancy|0|||
154983699|NCT03832738|559364509|FG001|Overall Study|Pregnancy|1|||
154983700|NCT03832738|559364510|FG002|Overall Study|Pregnancy|0|||
154983701|NCT03852459|559364511|FG000|Overall Study|Adverse Event|2|||
154983702|NCT03852459|559364512|FG001|Overall Study|Adverse Event|2|||
154983703|NCT03852459|559364511|FG000|Overall Study|Withdrawal by Subject|1|||
154983704|NCT03852459|559364512|FG001|Overall Study|Withdrawal by Subject|1|||
154983705|NCT00049842|559364513|FG000|Treatment Phase|Adverse Event|47|||
154983706|NCT00049842|559364514|FG001|Treatment Phase|Adverse Event|12|||
154983707|NCT00049842|559364513|FG000|Treatment Phase|Withdrawal by Subject|35|||
154983708|NCT00049842|559364514|FG001|Treatment Phase|Withdrawal by Subject|46|||
154983709|NCT00049842|559364513|FG000|Treatment Phase|Non-compliance with protocol|7|||
154983710|NCT00049842|559364514|FG001|Treatment Phase|Non-compliance with protocol|8|||
154983711|NCT00049842|559364513|FG000|Treatment Phase|Lost to Follow-up|4|||
154983712|NCT00049842|559364514|FG001|Treatment Phase|Lost to Follow-up|8|||
154983713|NCT00049842|559364513|FG000|Treatment Phase|Administrative|0|||
154983714|NCT00049842|559364514|FG001|Treatment Phase|Administrative|3|||
154983715|NCT00049842|559364513|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
154983716|NCT00049842|559364514|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
154983717|NCT00049842|559364513|FG000|Follow-up Phase|Adverse Event|6|||
154983718|NCT00049842|559364514|FG001|Follow-up Phase|Adverse Event|1|||
154983719|NCT00049842|559364513|FG000|Follow-up Phase|Other|1|||
154983720|NCT00049842|559364514|FG001|Follow-up Phase|Other|4|||
154983721|NCT00831623|559364515|FG000|Overall Study|Withdrawal by Subject|9|||
154983722|NCT00831623|559364515|FG000|Overall Study|Lost to Follow-up|1|||
154983723|NCT00831623|559364515|FG000|Overall Study|Not 2 years post-treatment|12|||
154983724|NCT02080832|559364521|FG000|Overall Study|Excluded from analysis by MRI|9|||
154983725|NCT02080832|559364522|FG001|Overall Study|Excluded from analysis by MRI|10|||
154983726|NCT02080832|559364523|FG002|Overall Study|Excluded from analysis by MRI|14|||
154983727|NCT02080832|559364521|FG000|Overall Study|Lost to Follow-up|0|||
154983728|NCT02080832|559364522|FG001|Overall Study|Lost to Follow-up|2|||
154983729|NCT02080832|559364523|FG002|Overall Study|Lost to Follow-up|2|||
154983730|NCT01138111|559364527|FG000|Overall Study|Withdrawal by Subject|5|||
154983731|NCT01138111|559364527|FG000|Overall Study|Adverse Event|1|||
154983732|NCT01138111|559364527|FG000|Overall Study|Death|1|||
154983733|NCT01138111|559364527|FG000|Overall Study|Lost to Follow-up|2|||
154983734|NCT01118117|559364528|FG000|Overall Study|Death|8|||
154983735|NCT01118117|559364529|FG001|Overall Study|Death|0|||
154983736|NCT01118117|559364528|FG000|Overall Study|Lost to Follow-up|6|||
154983737|NCT01118117|559364529|FG001|Overall Study|Lost to Follow-up|0|||
154983738|NCT01118117|559364528|FG000|Overall Study|Missed 12 Month Visit|7|||
154983739|NCT01118117|559364529|FG001|Overall Study|Missed 12 Month Visit|0|||
154983740|NCT01660022|559364530|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
154983741|NCT01660022|559364531|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
154983742|NCT01660022|559364532|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
154983743|NCT01660022|559364533|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
154983744|NCT01660022|559364534|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
154983745|NCT01660022|559364535|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
154983746|NCT01660022|559364530|FG000|First Sequence (7 Days)|Adverse Event|0|||
154983747|NCT01660022|559364531|FG001|First Sequence (7 Days)|Adverse Event|0|||
155117333|NCT00521599|559860685|FG002|Overall Study|Lost to Follow-up|2|||
154983748|NCT01660022|559364532|FG002|First Sequence (7 Days)|Adverse Event|0|||
154983749|NCT01660022|559364533|FG003|First Sequence (7 Days)|Adverse Event|0|||
154983750|NCT01660022|559364534|FG004|First Sequence (7 Days)|Adverse Event|1|||
154983751|NCT01660022|559364535|FG005|First Sequence (7 Days)|Adverse Event|3|||
154983752|NCT01660022|559364530|FG000|First Sequence (7 Days)|Protocol Violation|0|||
154983753|NCT01660022|559364531|FG001|First Sequence (7 Days)|Protocol Violation|0|||
154983754|NCT01660022|559364532|FG002|First Sequence (7 Days)|Protocol Violation|0|||
154983755|NCT01660022|559364533|FG003|First Sequence (7 Days)|Protocol Violation|0|||
154983756|NCT01660022|559364534|FG004|First Sequence (7 Days)|Protocol Violation|0|||
154983757|NCT01660022|559364535|FG005|First Sequence (7 Days)|Protocol Violation|1|||
154983758|NCT01277718|559364539|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
154983759|NCT01277718|559364540|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
154983760|NCT01277718|559364539|FG000|Period 2 - Second Intervention|Physician Decision|0|||
154983761|NCT01277718|559364540|FG001|Period 2 - Second Intervention|Physician Decision|2|||
154983762|NCT00653991|559364541|FG000|3 Month Follow-up|Participant would not respond|150|||
154983763|NCT00653991|559364542|FG001|3 Month Follow-up|Participant would not respond|157|||
154983764|NCT00653991|559364541|FG000|6 Month Follow-up|Participant would not respond|133|||
154983765|NCT00653991|559364542|FG001|6 Month Follow-up|Participant would not respond|141|||
154983766|NCT02149121|559364543|FG000|Main Study Period|Lack of Efficacy|2|||
154983767|NCT02149121|559364544|FG001|Main Study Period|Lack of Efficacy|2|||
154983768|NCT02149121|559364545|FG002|Main Study Period|Lack of Efficacy|1|||
154983769|NCT02149121|559364546|FG003|Main Study Period|Lack of Efficacy|0|||
154983770|NCT02149121|559364547|FG004|Main Study Period|Lack of Efficacy|0|||
154983771|NCT02149121|559364548|FG005|Main Study Period|Lack of Efficacy|0|||
154983772|NCT02149121|559364549|FG006|Main Study Period|Lack of Efficacy|0|||
154983773|NCT02149121|559364543|FG000|Main Study Period|Withdrawal by Subject|9|||
154983774|NCT02149121|559364544|FG001|Main Study Period|Withdrawal by Subject|5|||
154983775|NCT02149121|559364545|FG002|Main Study Period|Withdrawal by Subject|1|||
154983776|NCT02149121|559364546|FG003|Main Study Period|Withdrawal by Subject|0|||
154983777|NCT02149121|559364547|FG004|Main Study Period|Withdrawal by Subject|0|||
154983778|NCT02149121|559364548|FG005|Main Study Period|Withdrawal by Subject|0|||
154983779|NCT02149121|559364549|FG006|Main Study Period|Withdrawal by Subject|0|||
154983780|NCT02149121|559364543|FG000|Main Study Period|Adverse Event|2|||
154983781|NCT02149121|559364544|FG001|Main Study Period|Adverse Event|5|||
154983782|NCT02149121|559364545|FG002|Main Study Period|Adverse Event|1|||
154983783|NCT02149121|559364546|FG003|Main Study Period|Adverse Event|0|||
154983784|NCT02149121|559364547|FG004|Main Study Period|Adverse Event|0|||
154983785|NCT02149121|559364548|FG005|Main Study Period|Adverse Event|0|||
154983786|NCT02149121|559364549|FG006|Main Study Period|Adverse Event|0|||
154983787|NCT02149121|559364543|FG000|Main Study Period|Protocol Violation|2|||
154983788|NCT02149121|559364544|FG001|Main Study Period|Protocol Violation|0|||
154983789|NCT02149121|559364545|FG002|Main Study Period|Protocol Violation|0|||
154983790|NCT02149121|559364546|FG003|Main Study Period|Protocol Violation|0|||
154983791|NCT02149121|559364547|FG004|Main Study Period|Protocol Violation|0|||
154983792|NCT02149121|559364548|FG005|Main Study Period|Protocol Violation|0|||
154983793|NCT02149121|559364549|FG006|Main Study Period|Protocol Violation|0|||
154983794|NCT02149121|559364543|FG000|Main Study Period|Lost to Follow-up|2|||
154983795|NCT02149121|559364544|FG001|Main Study Period|Lost to Follow-up|1|||
154983796|NCT02149121|559364545|FG002|Main Study Period|Lost to Follow-up|0|||
154983797|NCT02149121|559364546|FG003|Main Study Period|Lost to Follow-up|0|||
154983798|NCT02149121|559364547|FG004|Main Study Period|Lost to Follow-up|0|||
154983799|NCT02149121|559364548|FG005|Main Study Period|Lost to Follow-up|0|||
154983800|NCT02149121|559364549|FG006|Main Study Period|Lost to Follow-up|0|||
154983801|NCT02149121|559364543|FG000|Main Study Period|Death|1|||
154983802|NCT02149121|559364544|FG001|Main Study Period|Death|0|||
154983803|NCT02149121|559364545|FG002|Main Study Period|Death|0|||
154983804|NCT02149121|559364546|FG003|Main Study Period|Death|0|||
154983805|NCT02149121|559364547|FG004|Main Study Period|Death|0|||
154983806|NCT02149121|559364548|FG005|Main Study Period|Death|0|||
154983807|NCT02149121|559364549|FG006|Main Study Period|Death|0|||
154983808|NCT02149121|559364543|FG000|Main Study Period|Physician Decision|1|||
154983809|NCT02149121|559364544|FG001|Main Study Period|Physician Decision|0|||
154983810|NCT02149121|559364545|FG002|Main Study Period|Physician Decision|0|||
154983811|NCT02149121|559364546|FG003|Main Study Period|Physician Decision|0|||
154983812|NCT02149121|559364547|FG004|Main Study Period|Physician Decision|0|||
154983813|NCT02149121|559364548|FG005|Main Study Period|Physician Decision|0|||
154983814|NCT02149121|559364549|FG006|Main Study Period|Physician Decision|0|||
154983815|NCT02149121|559364543|FG000|Main Study Period|Developed any malignancy|0|||
154983816|NCT02149121|559364544|FG001|Main Study Period|Developed any malignancy|1|||
154983817|NCT02149121|559364545|FG002|Main Study Period|Developed any malignancy|1|||
154983818|NCT02149121|559364546|FG003|Main Study Period|Developed any malignancy|0|||
154983819|NCT02149121|559364547|FG004|Main Study Period|Developed any malignancy|0|||
154983820|NCT02149121|559364548|FG005|Main Study Period|Developed any malignancy|0|||
154983821|NCT02149121|559364549|FG006|Main Study Period|Developed any malignancy|0|||
154983822|NCT02149121|559364543|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
155117334|NCT00521599|559860683|FG000|Overall Study|Withdrawal by Subject|3|||
155117335|NCT00521599|559860684|FG001|Overall Study|Withdrawal by Subject|5|||
155117336|NCT00521599|559860685|FG002|Overall Study|Withdrawal by Subject|1|||
155117337|NCT00521599|559860683|FG000|Overall Study|Withdrawal by subject treatment related|3|||
155117338|NCT00521599|559860684|FG001|Overall Study|Withdrawal by subject treatment related|1|||
155117339|NCT00521599|559860685|FG002|Overall Study|Withdrawal by subject treatment related|2|||
154983823|NCT02149121|559364544|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
154983824|NCT02149121|559364545|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
154983825|NCT02149121|559364546|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
154983826|NCT02149121|559364547|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
154983827|NCT02149121|559364548|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
154983828|NCT02149121|559364549|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
154983829|NCT02149121|559364543|FG000|Main Study Period|Disease progression|0|||
154983830|NCT02149121|559364544|FG001|Main Study Period|Disease progression|1|||
154983831|NCT02149121|559364545|FG002|Main Study Period|Disease progression|0|||
154983832|NCT02149121|559364546|FG003|Main Study Period|Disease progression|0|||
154983833|NCT02149121|559364547|FG004|Main Study Period|Disease progression|0|||
154983834|NCT02149121|559364548|FG005|Main Study Period|Disease progression|0|||
154983835|NCT02149121|559364549|FG006|Main Study Period|Disease progression|0|||
154983836|NCT02149121|559364543|FG000|Extension Study Period|Withdrawal by Subject|0|||
154983837|NCT02149121|559364544|FG001|Extension Study Period|Withdrawal by Subject|0|||
154983838|NCT02149121|559364545|FG002|Extension Study Period|Withdrawal by Subject|0|||
154983839|NCT02149121|559364546|FG003|Extension Study Period|Withdrawal by Subject|1|||
154983840|NCT02149121|559364547|FG004|Extension Study Period|Withdrawal by Subject|0|||
154983841|NCT02149121|559364548|FG005|Extension Study Period|Withdrawal by Subject|2|||
154983842|NCT02149121|559364549|FG006|Extension Study Period|Withdrawal by Subject|0|||
154983843|NCT00515034|559364550|FG000|Overall Study|Adverse Event|2|||
154983844|NCT00515034|559364551|FG001|Overall Study|Adverse Event|0|||
154983845|NCT00515034|559364552|FG002|Overall Study|Adverse Event|1|||
154983846|NCT00515034|559364553|FG003|Overall Study|Adverse Event|0|||
154983847|NCT00515034|559364550|FG000|Overall Study|Death|4|||
154983848|NCT00515034|559364551|FG001|Overall Study|Death|2|||
154983849|NCT00515034|559364552|FG002|Overall Study|Death|1|||
154983850|NCT00515034|559364553|FG003|Overall Study|Death|3|||
154983851|NCT00515034|559364550|FG000|Overall Study|Withdrawal by Subject|1|||
154983852|NCT00515034|559364551|FG001|Overall Study|Withdrawal by Subject|0|||
154983853|NCT00515034|559364552|FG002|Overall Study|Withdrawal by Subject|3|||
154983854|NCT00515034|559364553|FG003|Overall Study|Withdrawal by Subject|0|||
154983855|NCT00515034|559364550|FG000|Overall Study|Physician Decision|0|||
154983856|NCT00515034|559364551|FG001|Overall Study|Physician Decision|0|||
154983857|NCT00515034|559364552|FG002|Overall Study|Physician Decision|1|||
154983858|NCT00515034|559364553|FG003|Overall Study|Physician Decision|1|||
154983859|NCT00515034|559364550|FG000|Overall Study|Other|1|||
154983860|NCT00515034|559364551|FG001|Overall Study|Other|0|||
154983861|NCT00515034|559364552|FG002|Overall Study|Other|2|||
154983862|NCT00515034|559364553|FG003|Overall Study|Other|1|||
154983863|NCT02655016|559364554|FG000|Overall Study|Disease progression|6|||
154983864|NCT02655016|559364555|FG001|Overall Study|Disease progression|4|||
154983865|NCT02655016|559364554|FG000|Overall Study|Site closed|0|||
154983866|NCT02655016|559364555|FG001|Overall Study|Site closed|1|||
154983867|NCT02655016|559364554|FG000|Overall Study|Death|30|||
154983868|NCT02655016|559364555|FG001|Overall Study|Death|48|||
154983869|NCT02655016|559364554|FG000|Overall Study|Lost to Follow-up|1|||
154983870|NCT02655016|559364555|FG001|Overall Study|Lost to Follow-up|1|||
154983871|NCT02655016|559364554|FG000|Overall Study|Withdrawal by Subject|18|||
154983872|NCT02655016|559364555|FG001|Overall Study|Withdrawal by Subject|36|||
154983873|NCT05904769|559366234|FG000|Overall Study|Physician Decision|0|||
155117340|NCT00521599|559860683|FG000|Overall Study|Protocol Violation|2|||
155117341|NCT00521599|559860684|FG001|Overall Study|Protocol Violation|4|||
155117342|NCT00521599|559860685|FG002|Overall Study|Protocol Violation|2|||
155117343|NCT00521599|559860683|FG000|Overall Study|Did not meet protocol eligibility|2|||
155117344|NCT00521599|559860684|FG001|Overall Study|Did not meet protocol eligibility|2|||
155117345|NCT00521599|559860685|FG002|Overall Study|Did not meet protocol eligibility|1|||
155117346|NCT00791479|559860686|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155117347|NCT00791479|559860687|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155117348|NCT00791479|559860688|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155117349|NCT00791479|559860689|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
154983874|NCT05904769|559366235|FG001|Overall Study|Physician Decision|6|||
154983875|NCT05626803|559366238|FG000|Overall Study|Lost to Follow-up|0|||
154983876|NCT05626803|559366239|FG001|Overall Study|Lost to Follow-up|1|||
154983877|NCT05626803|559366240|FG002|Overall Study|Lost to Follow-up|0|||
154983878|NCT05626803|559366241|FG003|Overall Study|Lost to Follow-up|0|||
154983879|NCT04974619|559366243|FG000|Overall Study|Lost to Follow-up|0|||
154983880|NCT04974619|559366244|FG001|Overall Study|Lost to Follow-up|0|||
154983881|NCT04974619|559366245|FG002|Overall Study|Lost to Follow-up|1|||
155117350|NCT00791479|559860690|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
154909074|NCT02202161|559087788|FG002|Overall Study|Did not meet continuation criteria|0|||
154909075|NCT02202161|559087789|FG003|Overall Study|Did not meet continuation criteria|0|||
154909076|NCT02202161|559087790|FG004|Overall Study|Did not meet continuation criteria|0|||
154909077|NCT02202161|559087791|FG005|Overall Study|Did not meet continuation criteria|0|||
154909078|NCT02202161|559087792|FG006|Overall Study|Did not meet continuation criteria|0|||
154909079|NCT02202161|559087793|FG007|Overall Study|Did not meet continuation criteria|3|||
154909080|NCT02202161|559087786|FG000|Overall Study|Physician Decision|0|||
154909081|NCT02202161|559087787|FG001|Overall Study|Physician Decision|0|||
154909082|NCT02202161|559087788|FG002|Overall Study|Physician Decision|0|||
154909083|NCT02202161|559087789|FG003|Overall Study|Physician Decision|0|||
154909084|NCT02202161|559087790|FG004|Overall Study|Physician Decision|0|||
154909085|NCT02202161|559087791|FG005|Overall Study|Physician Decision|0|||
154909086|NCT02202161|559087792|FG006|Overall Study|Physician Decision|0|||
154909087|NCT02202161|559087793|FG007|Overall Study|Physician Decision|3|||
154909088|NCT02202161|559087786|FG000|Overall Study|Withdrawal by Subject|0|||
154909089|NCT02202161|559087787|FG001|Overall Study|Withdrawal by Subject|0|||
154909090|NCT02202161|559087788|FG002|Overall Study|Withdrawal by Subject|0|||
154909091|NCT02202161|559087789|FG003|Overall Study|Withdrawal by Subject|0|||
154909092|NCT02202161|559087790|FG004|Overall Study|Withdrawal by Subject|1|||
154909093|NCT02202161|559087791|FG005|Overall Study|Withdrawal by Subject|0|||
154909094|NCT02202161|559087792|FG006|Overall Study|Withdrawal by Subject|0|||
154909095|NCT02202161|559087793|FG007|Overall Study|Withdrawal by Subject|0|||
154909096|NCT03685643|559087796|FG000|Overall Study|Lost to Follow-up|14|||
154909097|NCT03685643|559087797|FG001|Overall Study|Lost to Follow-up|22|||
154909098|NCT02943668|559087799|FG000|Overall Study|Disease Progression|1|||
154909099|NCT01828567|559087808|FG000|Overall Study|Lost to Follow-up|27|||
154909100|NCT01828567|559087809|FG001|Overall Study|Lost to Follow-up|9|||
154909101|NCT01828567|559087808|FG000|Overall Study|Excluded - did not meet criteria|4|||
154909102|NCT01828567|559087809|FG001|Overall Study|Excluded - did not meet criteria|1|||
154909103|NCT02332876|559087814|FG000|Overall Study|Lost to Follow-up|1|||
154909104|NCT02332876|559087815|FG001|Overall Study|Lost to Follow-up|1|||
154909105|NCT03325010|559087816|FG000|Overall Study|Adverse Event|3|||
154909106|NCT03325010|559087817|FG001|Overall Study|Adverse Event|8|||
154909107|NCT03325010|559087816|FG000|Overall Study|Protocol Violation|1|||
154909108|NCT03325010|559087817|FG001|Overall Study|Protocol Violation|8|||
154909109|NCT03325010|559087816|FG000|Overall Study|Withdrawal by Subject|1|||
154909110|NCT03325010|559087817|FG001|Overall Study|Withdrawal by Subject|3|||
154909111|NCT03325010|559087816|FG000|Overall Study|Lost to Follow-up|1|||
154909112|NCT03325010|559087817|FG001|Overall Study|Lost to Follow-up|0|||
154909113|NCT03325010|559087816|FG000|Overall Study|Physician Decision|1|||
154909114|NCT03325010|559087817|FG001|Overall Study|Physician Decision|1|||
154909115|NCT03325010|559087816|FG000|Overall Study|Lack of Efficacy|2|||
154909116|NCT03325010|559087817|FG001|Overall Study|Lack of Efficacy|0|||
154909117|NCT04474366|559087822|FG000|Overall Study|Lost to Follow-up|2|||
154909118|NCT04474366|559087823|FG001|Overall Study|Lost to Follow-up|5|||
154909119|NCT04063865|559087824|FG000|Overall Study|Physician Decision|1|||
154909120|NCT04063865|559087825|FG001|Overall Study|Physician Decision|3|||
154909121|NCT04063865|559087824|FG000|Overall Study|Study Closed Prior to Completion|4|||
154909122|NCT04063865|559087825|FG001|Overall Study|Study Closed Prior to Completion|4|||
154909123|NCT04063865|559087824|FG000|Overall Study|Withdrawal by Subject|1|||
154909124|NCT04063865|559087825|FG001|Overall Study|Withdrawal by Subject|1|||
154909125|NCT00320190|559087826|FG000|First 12 Months|Completed but did not enter extension|5|||
154909126|NCT00320190|559087827|FG001|First 12 Months|Completed but did not enter extension|3|||
154909127|NCT00320190|559087826|FG000|First 12 Months|Sponsor terminated study|2|||
154909128|NCT00320190|559087827|FG001|First 12 Months|Sponsor terminated study|2|||
154909129|NCT00320190|559087826|FG000|First 12 Months|Lost to Follow-up|0|||
154909130|NCT00320190|559087827|FG001|First 12 Months|Lost to Follow-up|1|||
154909131|NCT00320190|559087826|FG000|First 12 Months|Enrollment failure|0|||
154909132|NCT00320190|559087827|FG001|First 12 Months|Enrollment failure|1|||
154909133|NCT00320190|559087826|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
154909134|NCT00320190|559087827|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
154909135|NCT00320190|559087826|FG000|First 12 Months|Investigator request|0|||
154909136|NCT00320190|559087827|FG001|First 12 Months|Investigator request|1|||
154909137|NCT00320190|559087826|FG000|First 12 Months|Study drug toxicity|0|||
154909138|NCT00320190|559087827|FG001|First 12 Months|Study drug toxicity|1|||
154909139|NCT00320190|559087826|FG000|First 12 Months|Withdrawal by Subject|0|||
154909140|NCT00320190|559087827|FG001|First 12 Months|Withdrawal by Subject|1|||
154909141|NCT00320190|559087826|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
154909142|NCT00320190|559087827|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
154909143|NCT00320190|559087826|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
154909144|NCT00320190|559087827|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
154909145|NCT00320190|559087826|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
154909146|NCT00320190|559087827|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
154909147|NCT01700140|559087828|FG000|Overall Study|Use of rescue drugs|3|||
154909148|NCT01700140|559087829|FG001|Overall Study|Use of rescue drugs|3|||
155117351|NCT00791479|559860691|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
155117352|NCT00791479|559860686|FG000|Overall Study|Adverse Event|0|||
155117353|NCT00791479|559860687|FG001|Overall Study|Adverse Event|1|||
155117354|NCT00791479|559860688|FG002|Overall Study|Adverse Event|0|||
155117355|NCT00791479|559860689|FG003|Overall Study|Adverse Event|2|||
155117356|NCT00791479|559860690|FG004|Overall Study|Adverse Event|0|||
155117357|NCT00791479|559860691|FG005|Overall Study|Adverse Event|1|||
155117358|NCT00791479|559860686|FG000|Overall Study|Lost to Follow-up|0|||
155117359|NCT00791479|559860687|FG001|Overall Study|Lost to Follow-up|1|||
155117360|NCT00791479|559860688|FG002|Overall Study|Lost to Follow-up|0|||
155117361|NCT00791479|559860689|FG003|Overall Study|Lost to Follow-up|0|||
155117362|NCT00791479|559860690|FG004|Overall Study|Lost to Follow-up|0|||
155117363|NCT00791479|559860691|FG005|Overall Study|Lost to Follow-up|1|||
155117364|NCT00791479|559860686|FG000|Overall Study|Protocol Violation|2|||
155117365|NCT00791479|559860687|FG001|Overall Study|Protocol Violation|1|||
155117366|NCT00791479|559860688|FG002|Overall Study|Protocol Violation|0|||
155117367|NCT00791479|559860689|FG003|Overall Study|Protocol Violation|1|||
155117368|NCT00791479|559860690|FG004|Overall Study|Protocol Violation|0|||
155117369|NCT00791479|559860691|FG005|Overall Study|Protocol Violation|0|||
155117370|NCT00791479|559860686|FG000|Overall Study|Withdrawal by Subject|0|||
155117371|NCT00791479|559860687|FG001|Overall Study|Withdrawal by Subject|0|||
155117372|NCT00791479|559860688|FG002|Overall Study|Withdrawal by Subject|0|||
155117373|NCT00791479|559860689|FG003|Overall Study|Withdrawal by Subject|1|||
155117374|NCT00791479|559860690|FG004|Overall Study|Withdrawal by Subject|0|||
155117375|NCT00791479|559860691|FG005|Overall Study|Withdrawal by Subject|1|||
155117376|NCT01610713|559860692|FG000|Overall Study|Adverse Event|3|||
155117377|NCT01610713|559860693|FG001|Overall Study|Adverse Event|0|||
155117378|NCT01610713|559860692|FG000|Overall Study|Lack of Efficacy|1|||
155117379|NCT01610713|559860693|FG001|Overall Study|Lack of Efficacy|0|||
155117380|NCT01610713|559860692|FG000|Overall Study|low mood and poor motivation|1|||
155117381|NCT01610713|559860693|FG001|Overall Study|low mood and poor motivation|0|||
155117382|NCT01610713|559860692|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
155117383|NCT01610713|559860693|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
155117384|NCT01610713|559860692|FG000|Overall Study|Lost to Follow-up|0|||
155117385|NCT01610713|559860693|FG001|Overall Study|Lost to Follow-up|1|||
155117386|NCT01342965|559860694|FG000|Overall Study|Death|58|||
155117387|NCT01342965|559860695|FG001|Overall Study|Death|57|||
155117388|NCT01342965|559860694|FG000|Overall Study|Lost to Follow-up|5|||
155117389|NCT01342965|559860695|FG001|Overall Study|Lost to Follow-up|3|||
155117390|NCT01342965|559860694|FG000|Overall Study|Other Reasons- Unspecified|44|||
155117391|NCT01342965|559860695|FG001|Overall Study|Other Reasons- Unspecified|38|||
155117392|NCT01342965|559860694|FG000|Overall Study|Withdrawal by Subject|2|||
155117393|NCT01342965|559860695|FG001|Overall Study|Withdrawal by Subject|9|||
155117394|NCT00856206|559860696|FG000|Overall Study|Protocol Violation|6|||
155117395|NCT00856206|559860697|FG001|Overall Study|Protocol Violation|18|||
155117396|NCT00856206|559860696|FG000|Overall Study|Adverse Event|10|||
155117397|NCT00856206|559860697|FG001|Overall Study|Adverse Event|46|||
155117398|NCT00856206|559860696|FG000|Overall Study|Lack of Efficacy|1|||
155117399|NCT00856206|559860697|FG001|Overall Study|Lack of Efficacy|2|||
155117400|NCT00856206|559860696|FG000|Overall Study|Withdrawal by Subject|15|||
155117401|NCT00856206|559860697|FG001|Overall Study|Withdrawal by Subject|36|||
155117402|NCT00856206|559860696|FG000|Overall Study|Lost to Follow-up|13|||
155117403|NCT00856206|559860697|FG001|Overall Study|Lost to Follow-up|39|||
155117404|NCT00856206|559860696|FG000|Overall Study|Death|2|||
155117405|NCT00856206|559860697|FG001|Overall Study|Death|2|||
155117406|NCT00856206|559860696|FG000|Overall Study|Decision by the Sponsor|4|||
155117407|NCT00856206|559860697|FG001|Overall Study|Decision by the Sponsor|8|||
155117408|NCT00856206|559860696|FG000|Overall Study|Other than specified above|3|||
155117409|NCT00856206|559860697|FG001|Overall Study|Other than specified above|10|||
155117410|NCT01170598|559860700|FG000|Overall Study|Withdrawal by Subject|1|||
155117411|NCT01170598|559860700|FG000|Overall Study|Death|3|||
155176149|NCT01375075|560082287|FG002|Overall Study|Withdrawal by Subject|0|||
155176150|NCT01375075|560082288|FG003|Overall Study|Withdrawal by Subject|0|||
154909149|NCT01700140|559087830|FG002|Overall Study|Use of rescue drugs|1|||
154909150|NCT01700140|559087828|FG000|Overall Study|Discontinuation of radiotherapy|1|||
154909151|NCT01700140|559087829|FG001|Overall Study|Discontinuation of radiotherapy|0|||
154909152|NCT01700140|559087830|FG002|Overall Study|Discontinuation of radiotherapy|0|||
154909153|NCT01700140|559087828|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
154909154|NCT01700140|559087829|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
154909155|NCT01700140|559087830|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
155117412|NCT01170598|559860700|FG000|Overall Study|Lost to Follow-up|1|||
155117413|NCT01170598|559860700|FG000|Overall Study|Refused|1|||
155117414|NCT04584346|559860701|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
155117415|NCT04584346|559860702|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
155117416|NCT02780856|559860703|FG000|Overall Study|Lost to Follow-up|1|||
155117417|NCT03006458|559860709|FG000|First Intervention|Unsatisfied Vision|0|||
155117418|NCT03006458|559860710|FG001|First Intervention|Unsatisfied Vision|3|||
154983882|NCT04974619|559366243|FG000|Overall Study|Withdrawal by Subject|0|||
154983883|NCT04974619|559366244|FG001|Overall Study|Withdrawal by Subject|0|||
154983884|NCT04974619|559366245|FG002|Overall Study|Withdrawal by Subject|1|||
154983885|NCT04974619|559366243|FG000|Overall Study|Protocol Violation|0|||
154983886|NCT04974619|559366244|FG001|Overall Study|Protocol Violation|1|||
154983887|NCT04974619|559366245|FG002|Overall Study|Protocol Violation|0|||
154983888|NCT01131299|559366250|FG000|Overall Study|Withdrawal by Subject|4|||
154983889|NCT01131299|559366251|FG001|Overall Study|Withdrawal by Subject|7|||
154983890|NCT03341000|559366252|FG000|Overall Study|Adverse Event|1|||
154983891|NCT01592721|559366253|FG000|Long-term Follow-up|Death|1|||
154983892|NCT00821873|559366254|FG000|Overall Study|Lost to Follow-up|4|||
154983893|NCT01304693|559366260|FG000|Overall Study|Adverse Event|0|||
154983894|NCT01304693|559366261|FG001|Overall Study|Adverse Event|0|||
154983895|NCT01304693|559366262|FG002|Overall Study|Adverse Event|0|||
154983896|NCT01304693|559366263|FG003|Overall Study|Adverse Event|0|||
154983897|NCT01304693|559366264|FG004|Overall Study|Adverse Event|1|||
155117419|NCT02437409|559860712|FG000|Overall Study|Withdrawal by Subject|3|||
155117420|NCT02437409|559860712|FG000|Overall Study|Screening failure|12|||
155117421|NCT04669262|559860722|FG000|Overall Study|Withdrawal by Subject|0|||
154983898|NCT01304693|559366260|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
154983899|NCT01304693|559366261|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
154983900|NCT01304693|559366262|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
154983901|NCT01304693|559366263|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
154983902|NCT01304693|559366264|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
154983903|NCT02581163|559366266|FG000|Overall Study|Failure to return|15|||
154983904|NCT02581163|559366266|FG000|Overall Study|Insufficient virological response|3|||
154983905|NCT02581163|559366266|FG000|Overall Study|Withdrew consent|1|||
154983906|NCT02581163|559366266|FG000|Overall Study|Death|1|||
154983907|NCT02581163|559366266|FG000|Overall Study|Other, not specified|9|||
154983908|NCT01744093|559366270|FG000|Overall Study|Withdrawal by Subject|6|||
154983909|NCT01744093|559366271|FG001|Overall Study|Withdrawal by Subject|1|||
154983910|NCT02006628|559366272|FG000|Overall Study|Adverse Event|1|||
154983911|NCT02006628|559366273|FG001|Overall Study|Adverse Event|1|||
154983912|NCT02006628|559366272|FG000|Overall Study|Withdrawal by Subject|2|||
154983913|NCT02006628|559366273|FG001|Overall Study|Withdrawal by Subject|1|||
154983914|NCT01206816|559366276|FG000|Overall Study|Protocol Violation|0|||
154983915|NCT01206816|559366277|FG001|Overall Study|Protocol Violation|0|||
154983916|NCT01206816|559366278|FG002|Overall Study|Protocol Violation|1|||
154983917|NCT01206816|559366279|FG003|Overall Study|Protocol Violation|0|||
154983918|NCT01206816|559366280|FG004|Overall Study|Protocol Violation|0|||
154983919|NCT01206816|559366281|FG005|Overall Study|Protocol Violation|0|||
154983920|NCT01206816|559366282|FG006|Overall Study|Protocol Violation|0|||
154983921|NCT01206816|559366276|FG000|Overall Study|Withdrawal by Subject|0|||
154983922|NCT01206816|559366277|FG001|Overall Study|Withdrawal by Subject|0|||
154983923|NCT01206816|559366278|FG002|Overall Study|Withdrawal by Subject|1|||
154983924|NCT01206816|559366279|FG003|Overall Study|Withdrawal by Subject|0|||
154983925|NCT01206816|559366280|FG004|Overall Study|Withdrawal by Subject|0|||
154983926|NCT01206816|559366281|FG005|Overall Study|Withdrawal by Subject|0|||
154983927|NCT01206816|559366282|FG006|Overall Study|Withdrawal by Subject|0|||
154983928|NCT01206816|559366276|FG000|Overall Study|Progressive disease|3|||
154983929|NCT01206816|559366277|FG001|Overall Study|Progressive disease|3|||
154983930|NCT01206816|559366278|FG002|Overall Study|Progressive disease|13|||
154983931|NCT01206816|559366279|FG003|Overall Study|Progressive disease|3|||
154983932|NCT01206816|559366280|FG004|Overall Study|Progressive disease|3|||
154983933|NCT01206816|559366281|FG005|Overall Study|Progressive disease|16|||
154983934|NCT01206816|559366282|FG006|Overall Study|Progressive disease|3|||
154983935|NCT01206816|559366276|FG000|Overall Study|Other AE|0|||
154983936|NCT01206816|559366277|FG001|Overall Study|Other AE|0|||
155117422|NCT04669262|559860723|FG001|Overall Study|Withdrawal by Subject|0|||
155117423|NCT04669262|559860724|FG002|Overall Study|Withdrawal by Subject|0|||
155117424|NCT04669262|559860725|FG003|Overall Study|Withdrawal by Subject|1|||
155117425|NCT04669262|559860722|FG000|Overall Study|Randomized but Not Treated|0|||
154983937|NCT01206816|559366278|FG002|Overall Study|Other AE|4|||
154983938|NCT01206816|559366279|FG003|Overall Study|Other AE|0|||
154983939|NCT01206816|559366280|FG004|Overall Study|Other AE|0|||
154983940|NCT01206816|559366281|FG005|Overall Study|Other AE|3|||
154983941|NCT01206816|559366282|FG006|Overall Study|Other AE|2|||
154983942|NCT01206816|559366276|FG000|Overall Study|other than stated above|0|||
154983943|NCT01206816|559366277|FG001|Overall Study|other than stated above|0|||
154983944|NCT01206816|559366278|FG002|Overall Study|other than stated above|1|||
154983945|NCT01206816|559366279|FG003|Overall Study|other than stated above|0|||
154983946|NCT01206816|559366280|FG004|Overall Study|other than stated above|0|||
154983947|NCT01206816|559366281|FG005|Overall Study|other than stated above|0|||
154983948|NCT01206816|559366282|FG006|Overall Study|other than stated above|1|||
154983949|NCT01939496|559366283|FG000|Overall Study|Adverse Event|2|||
154983950|NCT01939496|559366284|FG001|Overall Study|Adverse Event|0|||
155117426|NCT04669262|559860723|FG001|Overall Study|Randomized but Not Treated|1|||
155117427|NCT04669262|559860724|FG002|Overall Study|Randomized but Not Treated|0|||
154983951|NCT01939496|559366285|FG002|Overall Study|Adverse Event|0|||
154983952|NCT01939496|559366283|FG000|Overall Study|Lost to Follow-up|1|||
154983953|NCT01939496|559366284|FG001|Overall Study|Lost to Follow-up|1|||
154983954|NCT01939496|559366285|FG002|Overall Study|Lost to Follow-up|0|||
154983955|NCT01939496|559366283|FG000|Overall Study|Physician Decision|1|||
154983956|NCT01939496|559366284|FG001|Overall Study|Physician Decision|0|||
154983957|NCT01939496|559366285|FG002|Overall Study|Physician Decision|0|||
154983958|NCT01939496|559366283|FG000|Overall Study|Protocol Violation|3|||
154983959|NCT01939496|559366284|FG001|Overall Study|Protocol Violation|0|||
154983960|NCT01939496|559366285|FG002|Overall Study|Protocol Violation|0|||
154983961|NCT01939496|559366283|FG000|Overall Study|Withdrawal by Subject|0|||
154983962|NCT01939496|559366284|FG001|Overall Study|Withdrawal by Subject|1|||
154983963|NCT01939496|559366285|FG002|Overall Study|Withdrawal by Subject|1|||
154983964|NCT01939496|559366283|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
154983965|NCT01939496|559366284|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
154983966|NCT01939496|559366285|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
154983967|NCT01939496|559366283|FG000|Overall Study|Other|2|||
154983968|NCT01939496|559366284|FG001|Overall Study|Other|0|||
154983969|NCT01939496|559366285|FG002|Overall Study|Other|1|||
154983970|NCT01300052|559366287|FG000|Overall Study|Adverse Event|3|||
154983971|NCT01300052|559366288|FG001|Overall Study|Adverse Event|0|||
154983972|NCT01300052|559366287|FG000|Overall Study|Withdrawal by Subject|2|||
154983973|NCT01300052|559366288|FG001|Overall Study|Withdrawal by Subject|2|||
154983974|NCT01300052|559366287|FG000|Overall Study|Protocol Violation|1|||
154983975|NCT01300052|559366288|FG001|Overall Study|Protocol Violation|1|||
154983976|NCT03212794|559366289|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
155117428|NCT04669262|559860725|FG003|Overall Study|Randomized but Not Treated|0|||
155117429|NCT03549871|559860728|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
155117430|NCT03549871|559860729|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
155117431|NCT03549871|559860728|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
155117432|NCT03549871|559860729|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
155117433|NCT03549871|559860728|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
155117434|NCT03549871|559860729|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
155117435|NCT03549871|559860728|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
155117436|NCT03549871|559860729|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
155117437|NCT03549871|559860728|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
155117438|NCT03549871|559860729|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
155117439|NCT03549871|559860728|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
155117440|NCT03549871|559860729|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
155117441|NCT03549871|559860728|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
155117442|NCT03549871|559860729|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
155117443|NCT03549871|559860728|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
155117444|NCT03549871|559860729|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
155117445|NCT03549871|559860728|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
155117446|NCT03549871|559860729|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
155117447|NCT03549871|559860728|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
155117448|NCT03549871|559860729|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
155117449|NCT03549871|559860728|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
155117450|NCT03549871|559860729|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
155117451|NCT00737568|559860730|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
155117452|NCT00737568|559860731|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
155117453|NCT00737568|559860730|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
155117454|NCT00737568|559860731|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
155117455|NCT00737568|559860730|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
155117456|NCT00737568|559860731|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
155117457|NCT00737568|559860730|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
155117458|NCT00737568|559860731|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
155117459|NCT00737568|559860730|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
155117460|NCT00737568|559860731|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
155117461|NCT00737568|559860730|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
155117462|NCT00737568|559860731|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
155117463|NCT00737568|559860730|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
154983977|NCT03212794|559366290|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
154983978|NCT03212794|559366289|FG000|Overall Study|Lost to Follow-up|5|||
154983979|NCT03212794|559366290|FG001|Overall Study|Lost to Follow-up|6|||
154983980|NCT03212794|559366289|FG000|Overall Study|Incarcerated; unable to participate|2|||
155117464|NCT00737568|559860731|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
155117465|NCT00737568|559860730|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
155117466|NCT00737568|559860731|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
155117467|NCT00737568|559860730|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
155117468|NCT00737568|559860731|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
155117469|NCT01133626|559860732|FG000|Overall Study|Adverse Event|0|||
154909156|NCT01700140|559087828|FG000|Overall Study|Aggravation of symptoms|1|||
154909157|NCT01700140|559087829|FG001|Overall Study|Aggravation of symptoms|0|||
154909158|NCT01700140|559087830|FG002|Overall Study|Aggravation of symptoms|0|||
154909159|NCT01700140|559087828|FG000|Overall Study|Adverse Event|0|||
154909160|NCT01700140|559087829|FG001|Overall Study|Adverse Event|1|||
154909161|NCT01700140|559087830|FG002|Overall Study|Adverse Event|0|||
154909162|NCT01700140|559087828|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
154909163|NCT01700140|559087829|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
154909164|NCT01700140|559087830|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
154909165|NCT01060124|559087831|FG000|Overall Study|Other|16|||
154909166|NCT01060124|559087831|FG000|Overall Study|Adverse Event|14|||
154909167|NCT01060124|559087831|FG000|Overall Study|Withdrawal by Subject|7|||
154909168|NCT00518336|559087837|FG000|Year 7|Lost to Follow-up|2|||
154909169|NCT00518336|559087838|FG001|Year 7|Lost to Follow-up|0|||
154909170|NCT00518336|559087837|FG000|Year 7|Could not attend in time|0|||
154909171|NCT00518336|559087838|FG001|Year 7|Could not attend in time|3|||
154909172|NCT00518336|559087837|FG000|Year 8|Lost to Follow-up|1|||
154909173|NCT00518336|559087838|FG001|Year 8|Lost to Follow-up|1|||
154909174|NCT00518336|559087837|FG000|Year 8|Could not attend in time|0|||
154909175|NCT00518336|559087838|FG001|Year 8|Could not attend in time|1|||
154909176|NCT00518336|559087837|FG000|Year 9|Migrated/moved from study area|1|||
154909177|NCT00518336|559087838|FG001|Year 9|Migrated/moved from study area|1|||
154909178|NCT00518336|559087837|FG000|Year 9|Lost to Follow-up|3|||
154909179|NCT00518336|559087838|FG001|Year 9|Lost to Follow-up|0|||
154909180|NCT00518336|559087837|FG000|Year 9|Personal reasons|1|||
154909181|NCT00518336|559087838|FG001|Year 9|Personal reasons|0|||
154909182|NCT03399786|559087839|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
154909183|NCT03399786|559087840|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
154909184|NCT03399786|559087841|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
154909185|NCT03399786|559087842|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
154909186|NCT03399786|559087839|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
154909187|NCT03399786|559087840|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
154909188|NCT03399786|559087841|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
154909189|NCT03399786|559087842|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
154909190|NCT03399786|559087839|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
154909191|NCT03399786|559087840|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
154909192|NCT03399786|559087841|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
154909193|NCT03399786|559087842|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
154909194|NCT01855919|559089487|FG000|Overall Study|Adverse Event|16|||
154909195|NCT01855919|559089488|FG001|Overall Study|Adverse Event|8|||
154909196|NCT01855919|559089487|FG000|Overall Study|Lack of Efficacy|1|||
154909197|NCT01855919|559089488|FG001|Overall Study|Lack of Efficacy|3|||
154909198|NCT01855919|559089487|FG000|Overall Study|Withdrawal by Subject|4|||
154909199|NCT01855919|559089488|FG001|Overall Study|Withdrawal by Subject|10|||
154909200|NCT01855919|559089487|FG000|Overall Study|Entry Criteria Not Met|1|||
154909201|NCT01855919|559089488|FG001|Overall Study|Entry Criteria Not Met|1|||
154909202|NCT01855919|559089487|FG000|Overall Study|Protocol Violation|1|||
154909203|NCT01855919|559089488|FG001|Overall Study|Protocol Violation|4|||
154909204|NCT02972658|559089495|FG000|Overall Study|Adverse Event|0|||
154909205|NCT02972658|559089496|FG001|Overall Study|Adverse Event|3|||
154909206|NCT02972658|559089497|FG002|Overall Study|Adverse Event|0|||
154909207|NCT02972658|559089498|FG003|Overall Study|Adverse Event|2|||
154909208|NCT02972658|559089495|FG000|Overall Study|Other-determined by Investigator|1|||
154909209|NCT02972658|559089496|FG001|Overall Study|Other-determined by Investigator|1|||
154909210|NCT02972658|559089497|FG002|Overall Study|Other-determined by Investigator|0|||
154909211|NCT02972658|559089498|FG003|Overall Study|Other-determined by Investigator|0|||
154909212|NCT02972658|559089495|FG000|Overall Study|Death|0|||
154909213|NCT02972658|559089496|FG001|Overall Study|Death|0|||
154909214|NCT02972658|559089497|FG002|Overall Study|Death|0|||
154909215|NCT02972658|559089498|FG003|Overall Study|Death|1|||
155117470|NCT01133626|559860733|FG001|Overall Study|Adverse Event|1|||
154909216|NCT02972658|559089495|FG000|Overall Study|Lost to Follow-up|0|||
154909217|NCT02972658|559089496|FG001|Overall Study|Lost to Follow-up|1|||
154909218|NCT02972658|559089497|FG002|Overall Study|Lost to Follow-up|1|||
154909219|NCT02972658|559089498|FG003|Overall Study|Lost to Follow-up|2|||
154983981|NCT03212794|559366290|FG001|Overall Study|Incarcerated; unable to participate|0|||
154909220|NCT02972658|559089495|FG000|Overall Study|Progressive Disease|0|||
154909221|NCT02972658|559089496|FG001|Overall Study|Progressive Disease|1|||
154909222|NCT02972658|559089497|FG002|Overall Study|Progressive Disease|0|||
155117471|NCT01133626|559860734|FG002|Overall Study|Adverse Event|0|||
155117472|NCT01133626|559860732|FG000|Overall Study|Withdrawal by Subject|1|||
155117473|NCT01133626|559860733|FG001|Overall Study|Withdrawal by Subject|2|||
155117474|NCT01133626|559860734|FG002|Overall Study|Withdrawal by Subject|2|||
155117475|NCT01133626|559860732|FG000|Overall Study|Other|0|||
155117476|NCT01133626|559860733|FG001|Overall Study|Other|2|||
155117477|NCT01133626|559860734|FG002|Overall Study|Other|0|||
155117478|NCT00835640|559860743|FG000|Second Intervention|Protocol Violation|1|||
155117479|NCT00835640|559860744|FG001|Second Intervention|Protocol Violation|0|||
155117480|NCT01357161|559860745|FG000|Part 1 (Open Label Run-in)|Death|5|||
155117481|NCT01357161|559860746|FG001|Part 1 (Open Label Run-in)|Death|0|||
155117482|NCT01357161|559860747|FG002|Part 1 (Open Label Run-in)|Death|0|||
155117483|NCT01357161|559860745|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
155117484|NCT01357161|559860746|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
155117485|NCT01357161|559860747|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
155117486|NCT01357161|559860745|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
155117487|NCT01357161|559860746|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
155117488|NCT01357161|559860747|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
155117489|NCT01357161|559860745|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
155117490|NCT01357161|559860746|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
155117491|NCT01357161|559860747|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
155117492|NCT01357161|559860745|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
155117493|NCT01357161|559860746|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
155117494|NCT01357161|559860747|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
155117495|NCT01357161|559860745|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
155117496|NCT01357161|559860746|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
155117497|NCT01357161|559860747|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
155117498|NCT01357161|559860745|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
155117499|NCT01357161|559860746|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
155117500|NCT01357161|559860747|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
155117501|NCT01357161|559860745|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
155117502|NCT01357161|559860746|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
155117503|NCT01357161|559860747|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
155117504|NCT01357161|559860745|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
155117505|NCT01357161|559860746|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
155117506|NCT01357161|559860747|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
155117507|NCT01357161|559860745|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
155117508|NCT01357161|559860746|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
155117509|NCT01357161|559860747|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
155117510|NCT01357161|559860745|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
155117511|NCT01357161|559860746|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
155117512|NCT01357161|559860747|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
155117513|NCT00068250|559860748|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
155117514|NCT00068250|559860749|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
155117515|NCT00068250|559860750|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
155117516|NCT00068250|559860751|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
155117517|NCT01824823|559860752|FG000|Overall Study|Lack of Efficacy|1|||
155117518|NCT01824823|559860753|FG001|Overall Study|Lack of Efficacy|1|||
155117519|NCT01824823|559860752|FG000|Overall Study|Off-treatment reason not submitted|1|||
155117520|NCT01824823|559860753|FG001|Overall Study|Off-treatment reason not submitted|0|||
155117521|NCT01939002|559860760|FG000|Overall Study|Adverse Event|13|||
155117522|NCT01939002|559860761|FG001|Overall Study|Adverse Event|13|||
155117523|NCT01939002|559860760|FG000|Overall Study|Withdrawal by Subject|5|||
155117524|NCT01939002|559860761|FG001|Overall Study|Withdrawal by Subject|3|||
155117525|NCT01939002|559860760|FG000|Overall Study|Other|1|||
155117526|NCT01939002|559860761|FG001|Overall Study|Other|2|||
155117527|NCT00871117|559860766|FG000|Overall Study|Lost to Follow-up|5|||
155117528|NCT00871117|559860767|FG001|Overall Study|Lost to Follow-up|6|||
155117529|NCT00871117|559860766|FG000|Overall Study|Other|0|||
155117530|NCT00871117|559860767|FG001|Overall Study|Other|4|||
155176151|NCT01375075|560082289|FG004|Overall Study|Withdrawal by Subject|0|||
154909223|NCT02972658|559089498|FG003|Overall Study|Progressive Disease|1|||
154909224|NCT02972658|559089495|FG000|Overall Study|Withdrawal by Subject|4|||
155117531|NCT03222973|559860768|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
155117532|NCT03222973|559860769|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
155117533|NCT03222973|559860770|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
155117534|NCT03222973|559860771|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
155117535|NCT03222973|559860768|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
155117536|NCT03222973|559860769|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
155117537|NCT03222973|559860770|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
155117538|NCT03222973|559860771|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
154909225|NCT02972658|559089496|FG001|Overall Study|Withdrawal by Subject|4|||
154909226|NCT02972658|559089497|FG002|Overall Study|Withdrawal by Subject|1|||
154909227|NCT02972658|559089498|FG003|Overall Study|Withdrawal by Subject|6|||
154909228|NCT02972658|559089495|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
154909229|NCT02972658|559089496|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
154909230|NCT02972658|559089497|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
154909231|NCT02972658|559089498|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
154909232|NCT02972658|559089495|FG000|Overall Study|Sponsor Decision|70|||
154909233|NCT02972658|559089496|FG001|Overall Study|Sponsor Decision|127|||
154909234|NCT02972658|559089497|FG002|Overall Study|Sponsor Decision|72|||
154909235|NCT02972658|559089498|FG003|Overall Study|Sponsor Decision|119|||
154909236|NCT03958149|559089502|FG000|Overall Study|Withdrawal by Subject|0|||
154909237|NCT03958149|559089503|FG001|Overall Study|Withdrawal by Subject|1|||
154983982|NCT03212794|559366289|FG000|Overall Study|Withdrawal by Subject|1|||
154983983|NCT03212794|559366290|FG001|Overall Study|Withdrawal by Subject|0|||
154983984|NCT03212794|559366289|FG000|Overall Study|Death|0|||
154983985|NCT03212794|559366290|FG001|Overall Study|Death|1|||
154983986|NCT03212794|559366289|FG000|Overall Study|Found to be ineligible after allocation|0|||
155117539|NCT03222973|559860768|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
155117540|NCT03222973|559860769|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
155117541|NCT03222973|559860770|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
155117542|NCT03222973|559860771|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
155117543|NCT03222973|559860768|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
155117544|NCT03222973|559860769|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
155117545|NCT03222973|559860770|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
155117546|NCT03222973|559860771|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
155117547|NCT03222973|559860768|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
155117548|NCT03222973|559860769|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
155117549|NCT03222973|559860770|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
155117550|NCT03222973|559860771|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
155117551|NCT03222973|559860768|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
155117552|NCT03222973|559860769|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
155117553|NCT03222973|559860770|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
155117554|NCT03222973|559860771|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
155117555|NCT03222973|559860768|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
155117556|NCT03222973|559860769|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
155117557|NCT03222973|559860770|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
155117558|NCT03222973|559860771|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
155117559|NCT03222973|559860768|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
155117560|NCT03222973|559860769|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
155117561|NCT03222973|559860770|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
155117562|NCT03222973|559860771|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
155117563|NCT03222973|559860768|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
155117564|NCT03222973|559860769|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
155117565|NCT03222973|559860770|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
155117566|NCT03222973|559860771|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
155117567|NCT03222973|559860768|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
155117568|NCT03222973|559860769|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
155117569|NCT03222973|559860770|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
155117570|NCT03222973|559860771|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
155117571|NCT03222973|559860768|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
155117572|NCT03222973|559860769|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
155117573|NCT03222973|559860770|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
155117574|NCT03222973|559860771|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
155117575|NCT03222973|559860768|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
155117576|NCT03222973|559860769|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
155117577|NCT03222973|559860770|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
155117578|NCT03222973|559860771|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
155117579|NCT02439450|559860773|FG000|Overall Study|Adverse Event|4|||
155117580|NCT02439450|559860774|FG001|Overall Study|Adverse Event|1|||
155117581|NCT02439450|559860775|FG002|Overall Study|Adverse Event|0|||
155117582|NCT02439450|559860776|FG003|Overall Study|Adverse Event|0|||
155117583|NCT02439450|559860773|FG000|Overall Study|Withdrawal by Subject|1|||
155117584|NCT02439450|559860774|FG001|Overall Study|Withdrawal by Subject|2|||
155117585|NCT02439450|559860775|FG002|Overall Study|Withdrawal by Subject|0|||
155117586|NCT02439450|559860776|FG003|Overall Study|Withdrawal by Subject|0|||
155117587|NCT02439450|559860773|FG000|Overall Study|Death|3|||
155117588|NCT02439450|559860774|FG001|Overall Study|Death|0|||
155117589|NCT02439450|559860775|FG002|Overall Study|Death|0|||
155117590|NCT02439450|559860776|FG003|Overall Study|Death|1|||
154909238|NCT02785588|559089504|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
154909239|NCT02785588|559089504|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
155117591|NCT02439450|559860773|FG000|Overall Study|Progressive Disease|18|||
155117592|NCT02439450|559860774|FG001|Overall Study|Progressive Disease|41|||
155117593|NCT02439450|559860775|FG002|Overall Study|Progressive Disease|2|||
155117594|NCT02439450|559860776|FG003|Overall Study|Progressive Disease|3|||
154983987|NCT03212794|559366290|FG001|Overall Study|Found to be ineligible after allocation|1|||
154983988|NCT03212794|559366289|FG000|Overall Study|Relocated out of area|2|||
154983989|NCT03212794|559366290|FG001|Overall Study|Relocated out of area|0|||
154983990|NCT01763918|559366294|FG000|Overall Study|Withdrawal by Subject|2|||
154983991|NCT01763918|559366295|FG001|Overall Study|Withdrawal by Subject|1|||
154983992|NCT01763918|559366296|FG002|Overall Study|Withdrawal by Subject|1|||
154983993|NCT01763918|559366297|FG003|Overall Study|Withdrawal by Subject|2|||
154983994|NCT01763918|559366294|FG000|Overall Study|Sponsor Decision|4|||
154983995|NCT01763918|559366295|FG001|Overall Study|Sponsor Decision|0|||
154983996|NCT01763918|559366296|FG002|Overall Study|Sponsor Decision|9|||
154983997|NCT01763918|559366297|FG003|Overall Study|Sponsor Decision|0|||
154983998|NCT00897949|559366298|FG000|Overall Study|Adverse Event|1|||
154983999|NCT00897949|559366299|FG001|Overall Study|Adverse Event|1|||
154984000|NCT00897949|559366300|FG002|Overall Study|Adverse Event|0|||
154984001|NCT00897949|559366298|FG000|Overall Study|Lost to Follow-up|0|||
154984002|NCT00897949|559366299|FG001|Overall Study|Lost to Follow-up|2|||
154984003|NCT00897949|559366300|FG002|Overall Study|Lost to Follow-up|1|||
154984004|NCT00897949|559366298|FG000|Overall Study|Protocol Violation|6|||
154984005|NCT00897949|559366299|FG001|Overall Study|Protocol Violation|3|||
154984006|NCT00897949|559366300|FG002|Overall Study|Protocol Violation|1|||
154984007|NCT00897949|559366298|FG000|Overall Study|Withdrawal by Subject|1|||
154984008|NCT00897949|559366299|FG001|Overall Study|Withdrawal by Subject|2|||
154984009|NCT00897949|559366300|FG002|Overall Study|Withdrawal by Subject|0|||
154984010|NCT00897949|559366298|FG000|Overall Study|Patient Uncoorperative|0|||
154984011|NCT00897949|559366299|FG001|Overall Study|Patient Uncoorperative|2|||
154984012|NCT00897949|559366300|FG002|Overall Study|Patient Uncoorperative|1|||
154984013|NCT00897949|559366298|FG000|Overall Study|Lost to Follow-up|30|||
154984014|NCT00897949|559366299|FG001|Overall Study|Lost to Follow-up|23|||
154984015|NCT00897949|559366300|FG002|Overall Study|Lost to Follow-up|17|||
154984016|NCT00897949|559366298|FG000|Overall Study|Withdrawal by Subject|24|||
154984017|NCT00897949|559366299|FG001|Overall Study|Withdrawal by Subject|31|||
154984018|NCT00897949|559366300|FG002|Overall Study|Withdrawal by Subject|17|||
154984019|NCT00897949|559366298|FG000|Overall Study|Abnormal Prestudy Labs|2|||
154984020|NCT00897949|559366299|FG001|Overall Study|Abnormal Prestudy Labs|3|||
154984021|NCT00897949|559366300|FG002|Overall Study|Abnormal Prestudy Labs|4|||
154984022|NCT00897949|559366298|FG000|Overall Study|Abnormal Baseline ECG|2|||
154984023|NCT00897949|559366299|FG001|Overall Study|Abnormal Baseline ECG|2|||
154984024|NCT00897949|559366300|FG002|Overall Study|Abnormal Baseline ECG|4|||
154984025|NCT00897949|559366298|FG000|Overall Study|Need for Concom. Med.|0|||
154984026|NCT00897949|559366299|FG001|Overall Study|Need for Concom. Med.|1|||
154984027|NCT00897949|559366300|FG002|Overall Study|Need for Concom. Med.|1|||
154984028|NCT00897949|559366298|FG000|Overall Study|Lack of Migraine Attack|29|||
154984029|NCT00897949|559366299|FG001|Overall Study|Lack of Migraine Attack|30|||
154984030|NCT00897949|559366300|FG002|Overall Study|Lack of Migraine Attack|19|||
154984031|NCT00897949|559366298|FG000|Overall Study|Did not take study drug|9|||
154984032|NCT00897949|559366299|FG001|Overall Study|Did not take study drug|3|||
154984033|NCT00897949|559366300|FG002|Overall Study|Did not take study drug|4|||
154984034|NCT05444543|559366302|FG000|Overall Study|Withdrawal by Subject|1|||
154984035|NCT05444543|559366303|FG001|Overall Study|Withdrawal by Subject|0|||
154984036|NCT05444543|559366302|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
154984037|NCT05444543|559366303|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
154984038|NCT05444543|559366302|FG000|Overall Study|Adverse Event|0|||
154984039|NCT05444543|559366303|FG001|Overall Study|Adverse Event|1|||
154984040|NCT05444543|559366302|FG000|Overall Study|Family relocating at a distance from study site|0|||
154984041|NCT05444543|559366303|FG001|Overall Study|Family relocating at a distance from study site|1|||
154984042|NCT02408120|559366304|FG000|Overall Study|Withdrawal by Subject|0|||
154984043|NCT02408120|559366305|FG001|Overall Study|Withdrawal by Subject|1|||
154984044|NCT02408120|559366304|FG000|Overall Study|Treatment Refusal|1|||
154984045|NCT02408120|559366305|FG001|Overall Study|Treatment Refusal|0|||
154984046|NCT02408120|559366304|FG000|Overall Study|Received Steroids|1|||
154984047|NCT02408120|559366305|FG001|Overall Study|Received Steroids|1|||
154984048|NCT02408120|559366304|FG000|Overall Study|Discharged same day|1|||
154984049|NCT02408120|559366305|FG001|Overall Study|Discharged same day|1|||
154984050|NCT02408120|559366304|FG000|Overall Study|Did not receive insulin|1|||
154984051|NCT02408120|559366305|FG001|Overall Study|Did not receive insulin|2|||
154984052|NCT00977431|559366309|FG000|Overall Study|Other than listed|1|||
154984053|NCT00977431|559366310|FG001|Overall Study|Other than listed|0|||
154984054|NCT00977431|559366311|FG002|Overall Study|Other than listed|0|||
154984055|NCT00977431|559366312|FG003|Overall Study|Other than listed|0|||
154984056|NCT00977431|559366313|FG004|Overall Study|Other than listed|2|||
154984057|NCT00977431|559366309|FG000|Overall Study|Protocol Violation|0|||
154984058|NCT00977431|559366310|FG001|Overall Study|Protocol Violation|0|||
154984059|NCT00977431|559366311|FG002|Overall Study|Protocol Violation|1|||
154984060|NCT00977431|559366312|FG003|Overall Study|Protocol Violation|0|||
154984061|NCT00977431|559366313|FG004|Overall Study|Protocol Violation|0|||
154984062|NCT00977431|559366309|FG000|Overall Study|Adverse Event|3|||
154909240|NCT00621764|559089506|FG000|Overall Study|Protocol Violation|0|||
154909241|NCT00621764|559089507|FG001|Overall Study|Protocol Violation|0|||
154909242|NCT00621764|559089508|FG002|Overall Study|Protocol Violation|0|||
154909243|NCT00621764|559089509|FG003|Overall Study|Protocol Violation|1|||
154909244|NCT00724243|559089514|FG000|Overall Study|Lack of Efficacy|10|||
154909245|NCT00724243|559089514|FG000|Overall Study|Adverse Event|5|||
154909246|NCT03031327|559089515|FG000|Overall Study|Withdrawal by Subject|0|||
154909247|NCT03031327|559089516|FG001|Overall Study|Withdrawal by Subject|1|||
154909248|NCT03031327|559089517|FG002|Overall Study|Withdrawal by Subject|1|||
154909249|NCT00669240|559089518|FG000|Overall Study|Lack of Efficacy|33|||
154909250|NCT00669240|559089518|FG000|Overall Study|Withdrawal by Subject|42|||
154909251|NCT00669240|559089518|FG000|Overall Study|Lost to Follow-up|34|||
154909252|NCT00669240|559089518|FG000|Overall Study|Adverse Event|21|||
154909253|NCT00669240|559089518|FG000|Overall Study|Other|19|||
154909254|NCT00669240|559089518|FG000|Overall Study|Enrolled but not treated|15|||
154909255|NCT00669240|559089518|FG000|Overall Study|Enrolled but no dosing record|1|||
154909256|NCT00686699|559089519|FG000|Treatment Period 1|Adverse Event|0|||
154909257|NCT00686699|559089520|FG001|Treatment Period 1|Adverse Event|2|||
154909258|NCT00908895|559089521|FG000|Overall Study|Lost to Follow-up|1|||
154909259|NCT00908895|559089522|FG001|Overall Study|Lost to Follow-up|3|||
154909260|NCT00908895|559089521|FG000|Overall Study|algodystrophy|2|||
154909261|NCT00908895|559089522|FG001|Overall Study|algodystrophy|2|||
154909262|NCT00908895|559089521|FG000|Overall Study|Adverse Event|1|||
154909263|NCT00908895|559089522|FG001|Overall Study|Adverse Event|1|||
154909264|NCT00364611|559089523|FG000|Overall Study|Did not receive study medication|0|||
154909265|NCT00364611|559089524|FG001|Overall Study|Did not receive study medication|1|||
154909266|NCT00364611|559089523|FG000|Overall Study|Adverse Event|7|||
154909267|NCT00364611|559089524|FG001|Overall Study|Adverse Event|4|||
154909268|NCT00364611|559089523|FG000|Overall Study|Participant's Request|3|||
154909269|NCT00364611|559089524|FG001|Overall Study|Participant's Request|4|||
154909270|NCT00364611|559089523|FG000|Overall Study|Disease Progression|38|||
154909271|NCT00364611|559089524|FG001|Overall Study|Disease Progression|8|||
154909272|NCT00364611|559089523|FG000|Overall Study|Investigator decision|2|||
154909273|NCT00364611|559089524|FG001|Overall Study|Investigator decision|2|||
154909274|NCT00364611|559089523|FG000|Overall Study|Found Ineligible|1|||
154909275|NCT00364611|559089524|FG001|Overall Study|Found Ineligible|0|||
154909276|NCT00364611|559089523|FG000|Overall Study|Presumed CR on Study|0|||
154909277|NCT00364611|559089524|FG001|Overall Study|Presumed CR on Study|1|||
154909278|NCT00364611|559089523|FG000|Overall Study|Receiving Liver Ablation|0|||
154909279|NCT00364611|559089524|FG001|Overall Study|Receiving Liver Ablation|1|||
154909280|NCT02059174|559089525|FG000|Period 1|Withdrawal by Subject|0|||
154909281|NCT02059174|559089526|FG001|Period 1|Withdrawal by Subject|2|||
154909282|NCT02059174|559089525|FG000|Period 2|Withdrawal by Subject|0|||
154909283|NCT02059174|559089526|FG001|Period 2|Withdrawal by Subject|2|||
154909284|NCT02059174|559089525|FG000|Period 2|Protocol Violation|1|||
154909285|NCT02059174|559089526|FG001|Period 2|Protocol Violation|0|||
154909286|NCT02059174|559089525|FG000|Period 3|Physician Decision|1|||
154909287|NCT02059174|559089526|FG001|Period 3|Physician Decision|0|||
154909288|NCT00087594|559089527|FG000|Overall Study|Adverse Event|2|||
154909289|NCT00087594|559089528|FG001|Overall Study|Adverse Event|3|||
154909290|NCT00087594|559089527|FG000|Overall Study|Lost to Follow-up|0|||
154909291|NCT00087594|559089528|FG001|Overall Study|Lost to Follow-up|2|||
154909292|NCT00087594|559089527|FG000|Overall Study|Withdrawal by Subject|4|||
154909293|NCT00087594|559089528|FG001|Overall Study|Withdrawal by Subject|2|||
154909294|NCT00087594|559089527|FG000|Overall Study|Lack of Efficacy|2|||
154909295|NCT00087594|559089528|FG001|Overall Study|Lack of Efficacy|5|||
154909296|NCT00768040|559089529|FG000|Overall Study|Adverse Event|3|||
154909297|NCT00768040|559089530|FG001|Overall Study|Adverse Event|2|||
154909298|NCT00768040|559089529|FG000|Overall Study|Abnormal laboratory value|1|||
154909299|NCT00768040|559089530|FG001|Overall Study|Abnormal laboratory value|1|||
154909300|NCT02094612|559089535|FG000|Overall Study|Lost to Follow-up|47|||
154909301|NCT02094612|559089536|FG001|Overall Study|Lost to Follow-up|47|||
154909302|NCT02094612|559089535|FG000|Overall Study|Never started ADHD medication|32|||
154909303|NCT02094612|559089536|FG001|Overall Study|Never started ADHD medication|23|||
154909304|NCT00290355|559089537|FG000|Overall Study|Serious adverse event|7|||
154909305|NCT00290355|559089538|FG001|Overall Study|Serious adverse event|4|||
154909306|NCT00290355|559089537|FG000|Overall Study|Study product reactogenicity|1|||
154909307|NCT00290355|559089538|FG001|Overall Study|Study product reactogenicity|0|||
154909308|NCT00290355|559089537|FG000|Overall Study|Protocol Violation|1|||
154909309|NCT00290355|559089538|FG001|Overall Study|Protocol Violation|0|||
154909310|NCT00290355|559089537|FG000|Overall Study|Withdrawal by Subject|2|||
154909311|NCT00290355|559089538|FG001|Overall Study|Withdrawal by Subject|0|||
154909312|NCT00290355|559089537|FG000|Overall Study|Migrated / moved from the study area|1|||
154909313|NCT00290355|559089538|FG001|Overall Study|Migrated / moved from the study area|0|||
154909314|NCT00290355|559089537|FG000|Overall Study|Lost to Follow-up|3|||
154984063|NCT00977431|559366310|FG001|Overall Study|Adverse Event|0|||
154909315|NCT00290355|559089538|FG001|Overall Study|Lost to Follow-up|1|||
154909316|NCT00290355|559089537|FG000|Overall Study|Other|2|||
154909317|NCT00290355|559089538|FG001|Overall Study|Other|0|||
154909318|NCT03345849|559089539|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
154909319|NCT03345849|559089540|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
154909320|NCT03345849|559089541|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
154909321|NCT03345849|559089542|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
154909322|NCT03345849|559089539|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
154909323|NCT03345849|559089540|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
154909324|NCT03345849|559089541|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
154909325|NCT03345849|559089542|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
154909326|NCT03345849|559089539|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
154909327|NCT03345849|559089540|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
154909328|NCT03345849|559089541|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
154909329|NCT03345849|559089542|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
154909330|NCT03345849|559089539|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
154909331|NCT03345849|559089540|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
154909332|NCT03345849|559089541|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
154909333|NCT03345849|559089542|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
154909334|NCT03345849|559089539|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
154909335|NCT03345849|559089540|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
154909336|NCT03345849|559089541|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
154909337|NCT03345849|559089542|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
154909338|NCT03345849|559089539|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
154909339|NCT03345849|559089540|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
154909340|NCT03345849|559089541|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
154909341|NCT03345849|559089542|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
154909342|NCT03345849|559089539|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
154909343|NCT03345849|559089540|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
154909344|NCT03345849|559089541|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
154909345|NCT03345849|559089542|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
154909346|NCT03345849|559089539|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
154909347|NCT03345849|559089540|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
154909348|NCT03345849|559089541|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
154909349|NCT03345849|559089542|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
154909350|NCT03345849|559089539|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
154909351|NCT03345849|559089540|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
154909352|NCT03345849|559089541|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
154909353|NCT03345849|559089542|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
154909354|NCT03345849|559089539|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
154909355|NCT03345849|559089540|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
154909356|NCT03345849|559089541|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
154909357|NCT03345849|559089542|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
154909358|NCT03345849|559089539|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
154909359|NCT03345849|559089540|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
154909360|NCT03345849|559089541|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
154909361|NCT03345849|559089542|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
154909362|NCT03991936|559089543|FG000|Overall Study|Lost to Follow-up|1|||
154909363|NCT03991936|559089544|FG001|Overall Study|Lost to Follow-up|1|||
154909364|NCT03991936|559089545|FG002|Overall Study|Lost to Follow-up|1|||
154909365|NCT03991936|559089546|FG003|Overall Study|Lost to Follow-up|1|||
154909366|NCT03991936|559089547|FG004|Overall Study|Lost to Follow-up|1|||
154909367|NCT00777036|559089554|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
154909368|NCT00777036|559089555|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
154909369|NCT00777036|559089556|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
154909370|NCT00777036|559089557|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
154909371|NCT00777036|559089554|FG000|On Treatment|Administrative Reason By Sponsor|1|||
154909372|NCT00777036|559089555|FG001|On Treatment|Administrative Reason By Sponsor|0|||
154909373|NCT00777036|559089556|FG002|On Treatment|Administrative Reason By Sponsor|9|||
154909374|NCT00777036|559089557|FG003|On Treatment|Administrative Reason By Sponsor|0|||
154909375|NCT00777036|559089554|FG000|On Treatment|Failure to Meet Study Criteria|0|||
154909376|NCT00777036|559089555|FG001|On Treatment|Failure to Meet Study Criteria|1|||
154909377|NCT00777036|559089556|FG002|On Treatment|Failure to Meet Study Criteria|4|||
154909378|NCT00777036|559089557|FG003|On Treatment|Failure to Meet Study Criteria|0|||
154909379|NCT00777036|559089554|FG000|On Treatment|Pregnancy|1|||
154909380|NCT00777036|559089555|FG001|On Treatment|Pregnancy|0|||
154984064|NCT00977431|559366311|FG002|Overall Study|Adverse Event|4|||
155176152|NCT01375075|560082290|FG005|Overall Study|Withdrawal by Subject|1|||
154984065|NCT00977431|559366312|FG003|Overall Study|Adverse Event|0|||
154984066|NCT00977431|559366313|FG004|Overall Study|Adverse Event|6|||
154984067|NCT00977431|559366309|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
154984068|NCT00977431|559366310|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
154984069|NCT00977431|559366311|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
154984070|NCT00977431|559366312|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
154984071|NCT00977431|559366313|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
154984072|NCT00977431|559366309|FG000|Overall Study|Progressive disease|2|||
154984073|NCT00977431|559366310|FG001|Overall Study|Progressive disease|6|||
154984074|NCT00977431|559366311|FG002|Overall Study|Progressive disease|1|||
154984075|NCT00977431|559366312|FG003|Overall Study|Progressive disease|3|||
154984076|NCT00977431|559366313|FG004|Overall Study|Progressive disease|5|||
154984077|NCT03739138|559366320|FG000|Overall Study|Death|0|||
154984078|NCT03739138|559366321|FG001|Overall Study|Death|7|||
154984079|NCT03739138|559366322|FG002|Overall Study|Death|4|||
154984080|NCT03739138|559366323|FG003|Overall Study|Death|13|||
154984081|NCT03739138|559366324|FG004|Overall Study|Death|0|||
154984082|NCT03739138|559366320|FG000|Overall Study|Lost to Follow-up|0|||
154984083|NCT03739138|559366321|FG001|Overall Study|Lost to Follow-up|0|||
154984084|NCT03739138|559366322|FG002|Overall Study|Lost to Follow-up|1|||
154984085|NCT03739138|559366323|FG003|Overall Study|Lost to Follow-up|0|||
154984086|NCT03739138|559366324|FG004|Overall Study|Lost to Follow-up|0|||
154984087|NCT03739138|559366320|FG000|Overall Study|Study Terminated By Sponsor|0|||
154984088|NCT03739138|559366321|FG001|Overall Study|Study Terminated By Sponsor|0|||
154984089|NCT03739138|559366322|FG002|Overall Study|Study Terminated By Sponsor|0|||
154984090|NCT03739138|559366323|FG003|Overall Study|Study Terminated By Sponsor|4|||
154984091|NCT03739138|559366324|FG004|Overall Study|Study Terminated By Sponsor|0|||
154984092|NCT03739138|559366320|FG000|Overall Study|Withdrawal by Subject|0|||
154984093|NCT03739138|559366321|FG001|Overall Study|Withdrawal by Subject|0|||
154984094|NCT03739138|559366322|FG002|Overall Study|Withdrawal by Subject|0|||
154984095|NCT03739138|559366323|FG003|Overall Study|Withdrawal by Subject|1|||
154984096|NCT03739138|559366324|FG004|Overall Study|Withdrawal by Subject|0|||
154984097|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
154984098|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
154984099|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
154984100|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
154984101|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
154984102|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
154984103|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
154984104|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
154984105|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
154984106|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
154984107|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Subject decision|1|||
154984108|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Subject decision|1|||
154984109|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
154984110|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
154984111|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
154984112|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
154984113|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
154984114|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
154984115|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
154984116|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
154984117|NCT00518882|559366327|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
154984118|NCT00518882|559366328|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
154984119|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
154984120|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
154984121|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
154984122|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
155117595|NCT03730961|559860779|FG000|Overall Study|Adverse Event|0|||
155117596|NCT03730961|559860780|FG001|Overall Study|Adverse Event|1|||
155117597|NCT04143217|559861965|FG000|Overall Study|Withdrawal by Subject|42|||
155117598|NCT04143217|559861965|FG000|Overall Study|Adverse Event|29|||
155117599|NCT04143217|559861965|FG000|Overall Study|Lost to Follow-up|29|||
155117600|NCT04143217|559861965|FG000|Overall Study|Lack of Efficacy|15|||
155117601|NCT04143217|559861965|FG000|Overall Study|Physician Decision|1|||
155117602|NCT04143217|559861965|FG000|Overall Study|Non-Compliance With Study Drug|6|||
155117603|NCT04143217|559861965|FG000|Overall Study|Other, Multiple Categories|11|||
154984123|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
155117604|NCT03555981|559861970|FG000|Overall Study|Lost to Follow-up|0|||
154984124|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
154984125|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
154984126|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
154984127|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
155117605|NCT03555981|559861971|FG001|Overall Study|Lost to Follow-up|2|||
155117606|NCT00354107|559861972|FG000|Overall Study|Adverse Event|2|||
155117607|NCT00354107|559861972|FG000|Overall Study|Physician Decision|2|||
155117608|NCT00354107|559861972|FG000|Overall Study|Withdrawal by Subject|1|||
155117609|NCT03361189|559861978|FG000|Overall Study|Received heart transplant|1|||
155117610|NCT03361189|559861979|FG001|Overall Study|Received heart transplant|0|||
155117611|NCT03361189|559861978|FG000|Overall Study|Pacemake replacement|0|||
155117612|NCT03361189|559861979|FG001|Overall Study|Pacemake replacement|1|||
154909381|NCT00777036|559089556|FG002|On Treatment|Pregnancy|1|||
154909382|NCT00777036|559089557|FG003|On Treatment|Pregnancy|0|||
154909383|NCT00777036|559089554|FG000|On Treatment|Non-compliance with Study Drug|1|||
154909384|NCT00777036|559089555|FG001|On Treatment|Non-compliance with Study Drug|0|||
154909385|NCT00777036|559089556|FG002|On Treatment|Non-compliance with Study Drug|1|||
154909386|NCT00777036|559089557|FG003|On Treatment|Non-compliance with Study Drug|0|||
154909387|NCT00777036|559089554|FG000|On Treatment|Maximum Clinical Benefit|2|||
154909388|NCT00777036|559089555|FG001|On Treatment|Maximum Clinical Benefit|0|||
154909389|NCT00777036|559089556|FG002|On Treatment|Maximum Clinical Benefit|5|||
154909390|NCT00777036|559089557|FG003|On Treatment|Maximum Clinical Benefit|0|||
154909391|NCT00777036|559089554|FG000|On Treatment|Withdrawal by Subject|0|||
154909392|NCT00777036|559089555|FG001|On Treatment|Withdrawal by Subject|2|||
154909393|NCT00777036|559089556|FG002|On Treatment|Withdrawal by Subject|2|||
154909394|NCT00777036|559089557|FG003|On Treatment|Withdrawal by Subject|0|||
154909395|NCT00777036|559089554|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
154909396|NCT00777036|559089555|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
154909397|NCT00777036|559089556|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
154909398|NCT00777036|559089557|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
154909399|NCT00777036|559089554|FG000|On Treatment|Death|0|||
154909400|NCT00777036|559089555|FG001|On Treatment|Death|2|||
154909401|NCT00777036|559089556|FG002|On Treatment|Death|0|||
154909402|NCT00777036|559089557|FG003|On Treatment|Death|0|||
154909403|NCT00777036|559089554|FG000|On Treatment|Study Drug Toxicity|1|||
154909404|NCT00777036|559089555|FG001|On Treatment|Study Drug Toxicity|0|||
154909405|NCT00777036|559089556|FG002|On Treatment|Study Drug Toxicity|4|||
154909406|NCT00777036|559089557|FG003|On Treatment|Study Drug Toxicity|0|||
154909407|NCT00777036|559089554|FG000|On Treatment|Progressive Disease|6|||
154909408|NCT00777036|559089555|FG001|On Treatment|Progressive Disease|4|||
154909409|NCT00777036|559089556|FG002|On Treatment|Progressive Disease|7|||
154909410|NCT00777036|559089557|FG003|On Treatment|Progressive Disease|0|||
154909411|NCT00777036|559089554|FG000|On Treatment|Not Reported|0|||
154909412|NCT00777036|559089555|FG001|On Treatment|Not Reported|0|||
154909413|NCT00777036|559089556|FG002|On Treatment|Not Reported|2|||
154909414|NCT00777036|559089557|FG003|On Treatment|Not Reported|0|||
154909415|NCT00777036|559089554|FG000|On Treatment|Site Closed|0|||
154909416|NCT00777036|559089555|FG001|On Treatment|Site Closed|1|||
154909417|NCT00777036|559089556|FG002|On Treatment|Site Closed|1|||
154909418|NCT00777036|559089557|FG003|On Treatment|Site Closed|0|||
154909419|NCT00777036|559089554|FG000|Follow-Up|Withdrawal by Subject|0|||
154909420|NCT00777036|559089555|FG001|Follow-Up|Withdrawal by Subject|0|||
154909421|NCT00777036|559089556|FG002|Follow-Up|Withdrawal by Subject|5|||
154909422|NCT00777036|559089557|FG003|Follow-Up|Withdrawal by Subject|0|||
154909423|NCT00777036|559089554|FG000|Follow-Up|Death|1|||
154909424|NCT00777036|559089555|FG001|Follow-Up|Death|9|||
154909425|NCT00777036|559089556|FG002|Follow-Up|Death|0|||
154909426|NCT00777036|559089557|FG003|Follow-Up|Death|0|||
154909427|NCT00777036|559089554|FG000|Follow-Up|Lost to Follow-up|3|||
154909428|NCT00777036|559089555|FG001|Follow-Up|Lost to Follow-up|0|||
154909429|NCT00777036|559089556|FG002|Follow-Up|Lost to Follow-up|0|||
154909430|NCT00777036|559089557|FG003|Follow-Up|Lost to Follow-up|0|||
154909431|NCT00777036|559089554|FG000|Follow-Up|Reason Not Specified|4|||
154909432|NCT00777036|559089555|FG001|Follow-Up|Reason Not Specified|0|||
154909433|NCT00777036|559089556|FG002|Follow-Up|Reason Not Specified|13|||
154909434|NCT00777036|559089557|FG003|Follow-Up|Reason Not Specified|0|||
154909435|NCT00777036|559089554|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
154909436|NCT00777036|559089555|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
154909437|NCT00777036|559089556|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
154909438|NCT00777036|559089557|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
154909439|NCT05564039|559089558|FG000|Overall Study|Adverse Event|1|||
154909440|NCT05564039|559089559|FG001|Overall Study|Adverse Event|0|||
154909441|NCT05564039|559089558|FG000|Overall Study|Death|1|||
154909442|NCT05564039|559089559|FG001|Overall Study|Death|1|||
154909443|NCT05564039|559089558|FG000|Overall Study|Lost to Follow-up|3|||
154909444|NCT05564039|559089559|FG001|Overall Study|Lost to Follow-up|2|||
154909445|NCT05564039|559089558|FG000|Overall Study|Withdrawal by Subject|2|||
154909446|NCT05564039|559089559|FG001|Overall Study|Withdrawal by Subject|0|||
154909447|NCT05564039|559089558|FG000|Overall Study|Inadvertent enrollment|3|||
154909448|NCT05564039|559089559|FG001|Overall Study|Inadvertent enrollment|6|||
154909449|NCT01685372|559089560|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
154909450|NCT01685372|559089561|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
154909451|NCT00829010|559089564|FG000|Overall Study|Adverse Event|1|||
154909452|NCT00829010|559089565|FG001|Overall Study|Adverse Event|0|||
154909453|NCT00829010|559089566|FG002|Overall Study|Adverse Event|0|||
154909454|NCT00829010|559089567|FG003|Overall Study|Adverse Event|0|||
154909455|NCT00829010|559089568|FG004|Overall Study|Adverse Event|0|||
154909456|NCT00829010|559089564|FG000|Overall Study|Withdrawal by Subject|0|||
154909457|NCT00829010|559089565|FG001|Overall Study|Withdrawal by Subject|1|||
154909458|NCT00829010|559089566|FG002|Overall Study|Withdrawal by Subject|1|||
154909459|NCT00829010|559089567|FG003|Overall Study|Withdrawal by Subject|0|||
154909460|NCT00829010|559089568|FG004|Overall Study|Withdrawal by Subject|2|||
154909461|NCT00829010|559089564|FG000|Overall Study|Lost to Follow-up|1|||
154909462|NCT00829010|559089565|FG001|Overall Study|Lost to Follow-up|0|||
154909463|NCT00829010|559089566|FG002|Overall Study|Lost to Follow-up|2|||
154909464|NCT00829010|559089567|FG003|Overall Study|Lost to Follow-up|0|||
154909465|NCT00829010|559089568|FG004|Overall Study|Lost to Follow-up|0|||
154909466|NCT00829010|559089564|FG000|Overall Study|Fatality|5|||
154909467|NCT00829010|559089565|FG001|Overall Study|Fatality|4|||
154909468|NCT00829010|559089566|FG002|Overall Study|Fatality|0|||
154909469|NCT00829010|559089567|FG003|Overall Study|Fatality|3|||
154909470|NCT00829010|559089568|FG004|Overall Study|Fatality|0|||
154909471|NCT00829010|559089564|FG000|Overall Study|Migrated/Moved from study area|3|||
154909472|NCT00829010|559089565|FG001|Overall Study|Migrated/Moved from study area|4|||
154909473|NCT00829010|559089566|FG002|Overall Study|Migrated/Moved from study area|0|||
154909474|NCT00829010|559089567|FG003|Overall Study|Migrated/Moved from study area|5|||
154909475|NCT00829010|559089568|FG004|Overall Study|Migrated/Moved from study area|0|||
154909476|NCT01029691|559089569|FG000|Continued APAP to Delivery|Death|0|||
154909477|NCT01029691|559089570|FG001|Continued APAP to Delivery|Death|0|||
154909478|NCT01029691|559089571|FG002|Continued APAP to Delivery|Death|1|||
154909479|NCT00137267|559089574|FG000|Overall Study|Lost to Follow-up|15|||
154909480|NCT00137267|559089575|FG001|Overall Study|Lost to Follow-up|21|||
154909481|NCT05492877|559089577|FG000|Overall Study|Adverse Event|11|||
154909482|NCT05492877|559089578|FG001|Overall Study|Adverse Event|7|||
154909483|NCT05492877|559089577|FG000|Overall Study|Death|1|||
154909484|NCT05492877|559089578|FG001|Overall Study|Death|0|||
154909485|NCT05492877|559089577|FG000|Overall Study|Lost to Follow-up|1|||
154909486|NCT05492877|559089578|FG001|Overall Study|Lost to Follow-up|1|||
154909487|NCT05492877|559089577|FG000|Overall Study|Physician Decision|1|||
154909488|NCT05492877|559089578|FG001|Overall Study|Physician Decision|2|||
154909489|NCT05492877|559089577|FG000|Overall Study|Protocol Violation|1|||
154909490|NCT05492877|559089578|FG001|Overall Study|Protocol Violation|1|||
154909491|NCT05492877|559089577|FG000|Overall Study|Withdrawal by Subject|3|||
154909492|NCT05492877|559089578|FG001|Overall Study|Withdrawal by Subject|7|||
154909493|NCT05492877|559089577|FG000|Overall Study|Reason not specified|6|||
154909494|NCT05492877|559089578|FG001|Overall Study|Reason not specified|4|||
154909495|NCT00129376|559089579|FG000|Overall Study|Adverse Event|1|||
154909496|NCT00129376|559089579|FG000|Overall Study|Lack of Efficacy|1|||
154909497|NCT00528840|559089588|FG000|Overall Study|Lost to Follow-up|10|||
154909498|NCT00528840|559089588|FG000|Overall Study|Adverse Event|1|||
154909499|NCT00528840|559089588|FG000|Overall Study|Withdrawal by Subject|17|||
154909500|NCT00528840|559089588|FG000|Overall Study|Death|2|||
154909501|NCT00528840|559089588|FG000|Overall Study|Administrative Reasons|1|||
154909502|NCT00528840|559089588|FG000|Overall Study|Other|2|||
154909503|NCT01603628|559089589|FG000|Overall Study|Personal Reasons|1|||
154909504|NCT01603628|559089590|FG001|Overall Study|Personal Reasons|1|||
154909505|NCT01603628|559089591|FG002|Overall Study|Personal Reasons|2|||
154909506|NCT01603628|559089589|FG000|Overall Study|Protocol Violation|1|||
154909507|NCT01603628|559089590|FG001|Overall Study|Protocol Violation|1|||
154909508|NCT01603628|559089591|FG002|Overall Study|Protocol Violation|0|||
154909509|NCT01603628|559089589|FG000|Overall Study|Lost to Follow-up|0|||
154909510|NCT01603628|559089590|FG001|Overall Study|Lost to Follow-up|1|||
154909511|NCT01603628|559089591|FG002|Overall Study|Lost to Follow-up|0|||
154909512|NCT01603628|559089589|FG000|Overall Study|Other Miscellaneous Reason|1|||
154909513|NCT01603628|559089590|FG001|Overall Study|Other Miscellaneous Reason|0|||
154909514|NCT01603628|559089591|FG002|Overall Study|Other Miscellaneous Reason|0|||
154909515|NCT01969565|559089592|FG000|Overall Study|Withdrawal by Subject|1|||
154909516|NCT00832091|559089593|FG000|Overall Study|Adverse Event|1|||
154909517|NCT00832091|559089594|FG001|Overall Study|Adverse Event|1|||
154909518|NCT00832091|559089593|FG000|Overall Study|Protocol Violation|1|||
154909519|NCT00832091|559089594|FG001|Overall Study|Protocol Violation|0|||
154909520|NCT00832091|559089593|FG000|Overall Study|Withdrawal by Subject|2|||
154909521|NCT00832091|559089594|FG001|Overall Study|Withdrawal by Subject|1|||
154909522|NCT00832091|559089593|FG000|Overall Study|Prohibited Medication|1|||
154909523|NCT00832091|559089594|FG001|Overall Study|Prohibited Medication|0|||
154909524|NCT00952588|559089595|FG000|Overall Study|Death|28|||
154909525|NCT00952588|559089596|FG001|Overall Study|Death|13|||
154909526|NCT00952588|559089595|FG000|Overall Study|Withdrawal by Subject|2|||
154909527|NCT00952588|559089596|FG001|Overall Study|Withdrawal by Subject|5|||
154909528|NCT00952588|559089595|FG000|Overall Study|Adverse Event|2|||
154909529|NCT00952588|559089596|FG001|Overall Study|Adverse Event|3|||
154909530|NCT00952588|559089595|FG000|Overall Study|Lost to Follow-up|2|||
154909531|NCT00952588|559089596|FG001|Overall Study|Lost to Follow-up|0|||
154909532|NCT00952588|559089595|FG000|Overall Study|Physician Decision|0|||
154909533|NCT00952588|559089596|FG001|Overall Study|Physician Decision|1|||
154909534|NCT00952588|559089595|FG000|Overall Study|Lack of Efficacy|2|||
154909535|NCT00952588|559089596|FG001|Overall Study|Lack of Efficacy|2|||
154909536|NCT00398086|559089597|FG000|Overall Study|Unacceptable Toxicity|2|||
154909537|NCT00398086|559089598|FG001|Overall Study|Unacceptable Toxicity|8|||
154909538|NCT00398086|559089599|FG002|Overall Study|Unacceptable Toxicity|2|||
154909539|NCT00398086|559089597|FG000|Overall Study|Adverse Event|1|||
154909540|NCT00398086|559089598|FG001|Overall Study|Adverse Event|4|||
154909541|NCT00398086|559089599|FG002|Overall Study|Adverse Event|0|||
154909542|NCT00398086|559089597|FG000|Overall Study|Physician Decision|1|||
154909543|NCT00398086|559089598|FG001|Overall Study|Physician Decision|4|||
154909544|NCT00398086|559089599|FG002|Overall Study|Physician Decision|0|||
154909545|NCT00398086|559089597|FG000|Overall Study|Withdrawal by Subject|5|||
154909546|NCT00398086|559089598|FG001|Overall Study|Withdrawal by Subject|7|||
154909547|NCT00398086|559089599|FG002|Overall Study|Withdrawal by Subject|0|||
154909548|NCT02087241|559089606|FG000|Overall Study|Death|2|||
154909549|NCT02087241|559089607|FG001|Overall Study|Death|1|||
154909550|NCT02087241|559089608|FG002|Overall Study|Death|1|||
154909551|NCT02087241|559089609|FG003|Overall Study|Death|1|||
154909552|NCT02087241|559089606|FG000|Overall Study|Withdrawal by Subject|1|||
154909553|NCT02087241|559089607|FG001|Overall Study|Withdrawal by Subject|0|||
154909554|NCT02087241|559089608|FG002|Overall Study|Withdrawal by Subject|0|||
154909555|NCT02087241|559089609|FG003|Overall Study|Withdrawal by Subject|1|||
154909556|NCT02087241|559089606|FG000|Overall Study|Progressive Disease|0|||
154909557|NCT02087241|559089607|FG001|Overall Study|Progressive Disease|0|||
154909558|NCT02087241|559089608|FG002|Overall Study|Progressive Disease|0|||
154909559|NCT02087241|559089609|FG003|Overall Study|Progressive Disease|1|||
154909560|NCT02087241|559089606|FG000|Overall Study|Study Terminated by Sponsor|0|||
154909561|NCT02087241|559089607|FG001|Overall Study|Study Terminated by Sponsor|2|||
154909562|NCT02087241|559089608|FG002|Overall Study|Study Terminated by Sponsor|0|||
154909563|NCT02087241|559089609|FG003|Overall Study|Study Terminated by Sponsor|4|||
154909564|NCT01955005|559089610|FG000|Overall Study|Withdrawal by Subject|3|||
154909565|NCT01955005|559089611|FG001|Overall Study|Withdrawal by Subject|5|||
154909566|NCT02201251|559089612|FG000|Overall Study|Adverse Event|1|||
154909567|NCT02201251|559089613|FG001|Overall Study|Adverse Event|1|||
154909568|NCT02201251|559089612|FG000|Overall Study|Protocol Violation|1|||
154909569|NCT02201251|559089613|FG001|Overall Study|Protocol Violation|0|||
154909570|NCT02201251|559089612|FG000|Overall Study|Noncompliance with Study Drug|0|||
154909571|NCT02201251|559089613|FG001|Overall Study|Noncompliance with Study Drug|1|||
154909572|NCT02201251|559089612|FG000|Overall Study|Withdrawal by Subject|2|||
154909573|NCT02201251|559089613|FG001|Overall Study|Withdrawal by Subject|1|||
154909574|NCT00572728|559089618|FG000|Overall Study|Withdrawal by Subject|10|||
154909575|NCT00572728|559089618|FG000|Overall Study|Ineligible|3|||
154909576|NCT00572728|559089618|FG000|Overall Study|Enrolled under Amendment 4|5|||
154909577|NCT00572728|559089618|FG000|Overall Study|Offstudy due to complicating disease|1|||
154909578|NCT00572728|559089618|FG000|Overall Study|FLT1 not completed|4|||
154909579|NCT00572728|559089618|FG000|Overall Study|First Chemotherapy not initiated|2|||
154909580|NCT00572728|559089618|FG000|Overall Study|FLT2 not completed|5|||
154909581|NCT00572728|559089618|FG000|Overall Study|Second chemotherapy not initiated|1|||
154909582|NCT00572728|559089618|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
154909583|NCT00572728|559089618|FG000|Overall Study|Pathology missing|1|||
154909584|NCT02724111|559089623|FG000|Overall Study|Protocol Violation|2|||
154909585|NCT02724111|559089624|FG001|Overall Study|Protocol Violation|5|||
154909586|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
154909587|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154909588|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154909589|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154909590|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154909591|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
154909592|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
154909593|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154909594|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154909595|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154909596|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154909597|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
154909598|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
154909599|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154909600|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154909601|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154909602|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154909603|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
154909604|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Other|14|||
154909605|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Other|0|||
154909606|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Other|0|||
154909607|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Other|0|||
154909608|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Other|0|||
154909609|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Other|0|||
154909610|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
154909611|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
154909612|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
154909613|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
154909614|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
154909615|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
154909616|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
154909617|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154909618|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154909619|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154909620|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154909621|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
154909622|NCT02141854|559089628|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
154909623|NCT02141854|559089629|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154909624|NCT02141854|559089630|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154909625|NCT02141854|559089631|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154909626|NCT02141854|559089632|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154909627|NCT02141854|559089633|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
154909628|NCT02141854|559089628|FG000|Treatment Period|Protocol Violation|0|||
154909629|NCT02141854|559089629|FG001|Treatment Period|Protocol Violation|1|||
154909630|NCT02141854|559089630|FG002|Treatment Period|Protocol Violation|0|||
154909631|NCT02141854|559089631|FG003|Treatment Period|Protocol Violation|2|||
154909632|NCT02141854|559089632|FG004|Treatment Period|Protocol Violation|2|||
154909633|NCT02141854|559089633|FG005|Treatment Period|Protocol Violation|1|||
154909634|NCT02141854|559089628|FG000|Treatment Period|Noncompliance|0|||
154909635|NCT02141854|559089629|FG001|Treatment Period|Noncompliance|0|||
154909636|NCT02141854|559089630|FG002|Treatment Period|Noncompliance|0|||
154909637|NCT02141854|559089631|FG003|Treatment Period|Noncompliance|1|||
154909638|NCT02141854|559089632|FG004|Treatment Period|Noncompliance|0|||
154909639|NCT02141854|559089633|FG005|Treatment Period|Noncompliance|0|||
154909640|NCT02141854|559089628|FG000|Treatment Period|Lack of Efficacy|0|||
154909641|NCT02141854|559089629|FG001|Treatment Period|Lack of Efficacy|0|||
154909642|NCT02141854|559089630|FG002|Treatment Period|Lack of Efficacy|0|||
154909643|NCT02141854|559089631|FG003|Treatment Period|Lack of Efficacy|1|||
154909644|NCT02141854|559089632|FG004|Treatment Period|Lack of Efficacy|1|||
154909645|NCT02141854|559089633|FG005|Treatment Period|Lack of Efficacy|7|||
154909646|NCT02141854|559089628|FG000|Treatment Period|Pregnancy|0|||
154909647|NCT02141854|559089629|FG001|Treatment Period|Pregnancy|1|||
154909648|NCT02141854|559089630|FG002|Treatment Period|Pregnancy|0|||
154909649|NCT02141854|559089631|FG003|Treatment Period|Pregnancy|0|||
154909650|NCT02141854|559089632|FG004|Treatment Period|Pregnancy|0|||
154909651|NCT02141854|559089633|FG005|Treatment Period|Pregnancy|0|||
154909652|NCT02141854|559089628|FG000|Treatment Period|Other|0|||
154909653|NCT02141854|559089629|FG001|Treatment Period|Other|1|||
154909654|NCT02141854|559089630|FG002|Treatment Period|Other|2|||
154909655|NCT02141854|559089631|FG003|Treatment Period|Other|0|||
154909656|NCT02141854|559089632|FG004|Treatment Period|Other|1|||
154909657|NCT02141854|559089633|FG005|Treatment Period|Other|2|||
154909658|NCT02141854|559089628|FG000|Treatment Period|Adverse Event|0|||
154909659|NCT02141854|559089629|FG001|Treatment Period|Adverse Event|2|||
154909660|NCT02141854|559089630|FG002|Treatment Period|Adverse Event|2|||
154909661|NCT02141854|559089631|FG003|Treatment Period|Adverse Event|0|||
154909662|NCT02141854|559089632|FG004|Treatment Period|Adverse Event|2|||
154909663|NCT02141854|559089633|FG005|Treatment Period|Adverse Event|2|||
154909664|NCT02141854|559089628|FG000|Treatment Period|Withdrawal by Subject|0|||
154909665|NCT02141854|559089629|FG001|Treatment Period|Withdrawal by Subject|2|||
154909666|NCT02141854|559089630|FG002|Treatment Period|Withdrawal by Subject|3|||
154909667|NCT02141854|559089631|FG003|Treatment Period|Withdrawal by Subject|3|||
154909668|NCT02141854|559089632|FG004|Treatment Period|Withdrawal by Subject|4|||
154909669|NCT02141854|559089633|FG005|Treatment Period|Withdrawal by Subject|7|||
154909670|NCT02141854|559089628|FG000|Treatment Period|Disease progression|0|||
154909671|NCT02141854|559089629|FG001|Treatment Period|Disease progression|2|||
154909672|NCT02141854|559089630|FG002|Treatment Period|Disease progression|1|||
154909673|NCT02141854|559089631|FG003|Treatment Period|Disease progression|3|||
154909674|NCT02141854|559089632|FG004|Treatment Period|Disease progression|0|||
154909675|NCT02141854|559089633|FG005|Treatment Period|Disease progression|18|||
154909676|NCT02141854|559089628|FG000|Treatment Period|Lost to Follow-up|0|||
154909677|NCT02141854|559089629|FG001|Treatment Period|Lost to Follow-up|1|||
154909678|NCT02141854|559089630|FG002|Treatment Period|Lost to Follow-up|1|||
154909679|NCT02141854|559089631|FG003|Treatment Period|Lost to Follow-up|1|||
154909680|NCT02141854|559089632|FG004|Treatment Period|Lost to Follow-up|0|||
154909681|NCT02141854|559089633|FG005|Treatment Period|Lost to Follow-up|1|||
154909682|NCT01868594|559089634|FG000|Overall Study|Do not meet inclusion criteria|4|||
155117613|NCT03344549|559861980|FG000|Overall Study|Withdrawal by Subject|3|||
155117614|NCT03344549|559861981|FG001|Overall Study|Withdrawal by Subject|2|||
155117615|NCT03344549|559861980|FG000|Overall Study|Dialysis|2|||
155117616|NCT03344549|559861981|FG001|Overall Study|Dialysis|0|||
155117617|NCT03344549|559861980|FG000|Overall Study|Cancer|1|||
155117618|NCT03344549|559861981|FG001|Overall Study|Cancer|0|||
155117619|NCT03344549|559861980|FG000|Overall Study|Lack of electronic device|1|||
155117620|NCT03344549|559861981|FG001|Overall Study|Lack of electronic device|0|||
154909683|NCT01868594|559089635|FG001|Overall Study|Do not meet inclusion criteria|3|||
154909684|NCT01190020|559089638|FG000|Overall Study|Adverse Event|2|||
154909685|NCT01190020|559089639|FG001|Overall Study|Adverse Event|0|||
154909686|NCT01190020|559089638|FG000|Overall Study|Lost to Follow-up|2|||
154909687|NCT01190020|559089639|FG001|Overall Study|Lost to Follow-up|0|||
154909688|NCT01190020|559089638|FG000|Overall Study|Withdrawal by Subject|3|||
154909689|NCT01190020|559089639|FG001|Overall Study|Withdrawal by Subject|0|||
154909690|NCT02422186|559089642|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
154909691|NCT02422186|559089643|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
154909692|NCT02422186|559089642|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
154909693|NCT02422186|559089643|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
154909694|NCT02422186|559089642|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
154909695|NCT02422186|559089643|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
154909696|NCT02422186|559089642|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
154909697|NCT02422186|559089643|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
154909698|NCT02422186|559089642|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
154909699|NCT02422186|559089643|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
154909700|NCT02422186|559089642|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
154909701|NCT02422186|559089643|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
154909702|NCT02422186|559089642|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
154909703|NCT02422186|559089643|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
154909704|NCT02422186|559089642|FG000|Follow-up Phase (2 Weeks)|Other|3|||
154909705|NCT02422186|559089643|FG001|Follow-up Phase (2 Weeks)|Other|0|||
154909706|NCT03074318|559089644|FG000|Overall Study|Adverse Event|0|||
154909707|NCT03074318|559089645|FG001|Overall Study|Adverse Event|1|||
154909708|NCT03074318|559089646|FG002|Overall Study|Adverse Event|1|||
154909709|NCT03074318|559089647|FG003|Overall Study|Adverse Event|1|||
154909710|NCT03074318|559089644|FG000|Overall Study|Death|1|||
154909711|NCT03074318|559089645|FG001|Overall Study|Death|0|||
154909712|NCT03074318|559089646|FG002|Overall Study|Death|0|||
154909713|NCT03074318|559089647|FG003|Overall Study|Death|0|||
154909714|NCT03074318|559089644|FG000|Overall Study|Withdrawal by Subject|1|||
154909715|NCT03074318|559089645|FG001|Overall Study|Withdrawal by Subject|2|||
154909716|NCT03074318|559089646|FG002|Overall Study|Withdrawal by Subject|2|||
154909717|NCT03074318|559089647|FG003|Overall Study|Withdrawal by Subject|4|||
154909718|NCT03074318|559089644|FG000|Overall Study|Trial Closure|2|||
154909719|NCT03074318|559089645|FG001|Overall Study|Trial Closure|2|||
154909720|NCT03074318|559089646|FG002|Overall Study|Trial Closure|3|||
154909721|NCT03074318|559089647|FG003|Overall Study|Trial Closure|11|||
154909722|NCT02583399|559091971|FG000|Overall Study|Able to be discharged|3|||
154909723|NCT02583399|559091971|FG000|Overall Study|Wanted to use a restricted medication|3|||
154909724|NCT02759939|559091972|FG000|Overall Study|Missing data on first outcome assessed|11|||
154909725|NCT02759939|559091973|FG001|Overall Study|Missing data on first outcome assessed|2|||
154909726|NCT02759939|559091974|FG002|Overall Study|Missing data on first outcome assessed|5|||
154909727|NCT02759939|559091975|FG003|Overall Study|Missing data on first outcome assessed|2|||
154909728|NCT02759939|559091972|FG000|Overall Study|Ineligible for T2 and T3|310|||
154909729|NCT02759939|559091973|FG001|Overall Study|Ineligible for T2 and T3|179|||
154909730|NCT02759939|559091974|FG002|Overall Study|Ineligible for T2 and T3|366|||
154909731|NCT02759939|559091975|FG003|Overall Study|Ineligible for T2 and T3|391|||
154909732|NCT02759939|559091972|FG000|Overall Study|Lost to Follow-up|735|||
154909733|NCT02759939|559091973|FG001|Overall Study|Lost to Follow-up|791|||
154909734|NCT02759939|559091974|FG002|Overall Study|Lost to Follow-up|783|||
154909735|NCT02759939|559091975|FG003|Overall Study|Lost to Follow-up|650|||
154909736|NCT04397757|559091976|FG000|Overall Study|Death|3|||
154909737|NCT04397757|559091977|FG001|Overall Study|Death|11|||
154909738|NCT04397757|559091976|FG000|Overall Study|Withdrawal by Subject|2|||
155117621|NCT03344549|559861980|FG000|Overall Study|Transportation difficulty|0|||
154909739|NCT04397757|559091977|FG001|Overall Study|Withdrawal by Subject|0|||
154909740|NCT04397757|559091976|FG000|Overall Study|Lost to Follow-up|4|||
154909741|NCT04397757|559091977|FG001|Overall Study|Lost to Follow-up|3|||
154909742|NCT02306148|559091978|FG000|Overall Study|Adverse Event|12|||
154909743|NCT02306148|559091979|FG001|Overall Study|Adverse Event|6|||
154909744|NCT02306148|559091978|FG000|Overall Study|Lost to Follow-up|1|||
154909745|NCT02306148|559091979|FG001|Overall Study|Lost to Follow-up|4|||
155117622|NCT03344549|559861981|FG001|Overall Study|Transportation difficulty|13|||
155117623|NCT03333252|559861982|FG000|Overall Study|Adverse Event|10|||
155117624|NCT03333252|559861983|FG001|Overall Study|Adverse Event|6|||
155117625|NCT03333252|559861984|FG002|Overall Study|Adverse Event|5|||
155117626|NCT03333252|559861985|FG003|Overall Study|Adverse Event|2|||
155117627|NCT03333252|559861982|FG000|Overall Study|Death|1|||
155117628|NCT03333252|559861983|FG001|Overall Study|Death|3|||
155117629|NCT03333252|559861984|FG002|Overall Study|Death|0|||
155117630|NCT03333252|559861985|FG003|Overall Study|Death|0|||
155117631|NCT03333252|559861982|FG000|Overall Study|Lack of Efficacy|8|||
155117632|NCT03333252|559861983|FG001|Overall Study|Lack of Efficacy|4|||
155117633|NCT03333252|559861984|FG002|Overall Study|Lack of Efficacy|0|||
155117634|NCT03333252|559861985|FG003|Overall Study|Lack of Efficacy|7|||
155117635|NCT03333252|559861982|FG000|Overall Study|Lost to Follow-up|0|||
155117636|NCT03333252|559861983|FG001|Overall Study|Lost to Follow-up|5|||
155117637|NCT03333252|559861984|FG002|Overall Study|Lost to Follow-up|9|||
155117638|NCT03333252|559861985|FG003|Overall Study|Lost to Follow-up|3|||
155117639|NCT03333252|559861982|FG000|Overall Study|Withdrawal by Subject|14|||
155117640|NCT03333252|559861983|FG001|Overall Study|Withdrawal by Subject|24|||
155117641|NCT03333252|559861984|FG002|Overall Study|Withdrawal by Subject|11|||
155117642|NCT03333252|559861985|FG003|Overall Study|Withdrawal by Subject|17|||
155117643|NCT01685801|559861991|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
155117644|NCT01685801|559861992|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
155117645|NCT01685801|559861993|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
155117646|NCT01685801|559861994|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
155117647|NCT01685801|559861991|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
155117648|NCT01685801|559861992|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
155117649|NCT01685801|559861993|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
155117650|NCT01685801|559861994|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
155117651|NCT00113399|559861995|FG000|Overall Study|Death|1|||
155117652|NCT00113399|559861996|FG001|Overall Study|Death|1|||
155117653|NCT00113399|559861995|FG000|Overall Study|Withdrawal by Subject|1|||
155117654|NCT00113399|559861996|FG001|Overall Study|Withdrawal by Subject|2|||
155117655|NCT00113399|559861995|FG000|Overall Study|Complete Response|0|||
155117656|NCT00113399|559861996|FG001|Overall Study|Complete Response|1|||
155117657|NCT00113399|559861995|FG000|Overall Study|Other|0|||
155117658|NCT00113399|559861996|FG001|Overall Study|Other|1|||
155117659|NCT00496197|559862000|FG000|Overall Study|Discontinued study due to death|43|||
155117660|NCT00496197|559862000|FG000|Overall Study|Adverse Event|13|||
155117661|NCT00496197|559862000|FG000|Overall Study|Does not meet entrance criteria|5|||
155117662|NCT00496197|559862000|FG000|Overall Study|Insufficient clinical response|3|||
155117663|NCT00496197|559862000|FG000|Overall Study|Insufficient bacteriological response|10|||
155117664|NCT00496197|559862000|FG000|Overall Study|Lost to Follow-up|11|||
155117665|NCT00496197|559862000|FG000|Overall Study|Withdrawal by Subject|11|||
155117666|NCT00496197|559862000|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
155117667|NCT00496197|559862000|FG000|Overall Study|Other|14|||
155117668|NCT00496197|559862000|FG000|Overall Study|Protocol Violation|8|||
155117669|NCT00149994|559862001|FG000|Overall Study|Administrative problems:|1|||
155117670|NCT00149994|559862002|FG001|Overall Study|Administrative problems:|0|||
155117671|NCT00149994|559862001|FG000|Overall Study|Protocol Violation|0|||
155117672|NCT00149994|559862002|FG001|Overall Study|Protocol Violation|1|||
155117673|NCT00557310|559862007|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
155117674|NCT00557310|559862007|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
155117675|NCT00557310|559862007|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
155117676|NCT00557310|559862007|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
155117677|NCT00557310|559862007|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
155117678|NCT00557310|559862007|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
155117679|NCT02781792|559862009|FG000|Overall Study|Adverse Event|1|||
155117680|NCT02781792|559862010|FG001|Overall Study|Adverse Event|2|||
155117681|NCT02781792|559862009|FG000|Overall Study|Withdrawal by Subject|3|||
155117682|NCT02781792|559862010|FG001|Overall Study|Withdrawal by Subject|1|||
155117683|NCT02781792|559862009|FG000|Overall Study|Lack of Efficacy|1|||
155117684|NCT02781792|559862010|FG001|Overall Study|Lack of Efficacy|1|||
155117685|NCT02781792|559862009|FG000|Overall Study|Hospice|0|||
155117686|NCT02781792|559862010|FG001|Overall Study|Hospice|1|||
155117687|NCT04049266|559862016|FG000|Overall Study|Adverse Event|16|||
155117688|NCT04049266|559862017|FG001|Overall Study|Adverse Event|9|||
155117689|NCT04049266|559862016|FG000|Overall Study|Non-compliance with study drug|0|||
155117690|NCT04049266|559862017|FG001|Overall Study|Non-compliance with study drug|3|||
154984128|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
155117691|NCT04049266|559862016|FG000|Overall Study|Withdrawal by Subject|6|||
155117692|NCT04049266|559862017|FG001|Overall Study|Withdrawal by Subject|10|||
155117693|NCT04049266|559862016|FG000|Overall Study|Lost to Follow-up|2|||
155117694|NCT04049266|559862017|FG001|Overall Study|Lost to Follow-up|2|||
155117695|NCT04049266|559862016|FG000|Overall Study|Progressive disease|11|||
155117696|NCT04049266|559862017|FG001|Overall Study|Progressive disease|2|||
155117697|NCT04049266|559862016|FG000|Overall Study|Physician Decision|1|||
155117698|NCT04049266|559862017|FG001|Overall Study|Physician Decision|0|||
155117699|NCT04049266|559862016|FG000|Overall Study|Patient moved out of state|1|||
155117700|NCT04049266|559862017|FG001|Overall Study|Patient moved out of state|0|||
155117701|NCT04600076|559862020|FG000|Overall Study|Lost to Follow-up|3|||
154909746|NCT02646891|559091986|FG000|Overall Study|Adverse Event|0|||
154909747|NCT02646891|559091987|FG001|Overall Study|Adverse Event|1|||
154909748|NCT02646891|559091988|FG002|Overall Study|Adverse Event|0|||
154909749|NCT02646891|559091989|FG003|Overall Study|Adverse Event|0|||
154909750|NCT02646891|559091990|FG004|Overall Study|Adverse Event|0|||
154909751|NCT02646891|559091991|FG005|Overall Study|Adverse Event|0|||
154909752|NCT02646891|559091992|FG006|Overall Study|Adverse Event|0|||
154909753|NCT02646891|559091993|FG007|Overall Study|Adverse Event|0|||
154909754|NCT02646891|559091994|FG008|Overall Study|Adverse Event|0|||
154909755|NCT02646891|559091995|FG009|Overall Study|Adverse Event|0|||
154909756|NCT02646891|559091986|FG000|Overall Study|Lost to Follow-up|0|||
154909757|NCT02646891|559091987|FG001|Overall Study|Lost to Follow-up|0|||
154909758|NCT02646891|559091988|FG002|Overall Study|Lost to Follow-up|0|||
154909759|NCT02646891|559091989|FG003|Overall Study|Lost to Follow-up|0|||
154909760|NCT02646891|559091990|FG004|Overall Study|Lost to Follow-up|0|||
154909761|NCT02646891|559091991|FG005|Overall Study|Lost to Follow-up|0|||
154909762|NCT02646891|559091992|FG006|Overall Study|Lost to Follow-up|2|||
154909763|NCT02646891|559091993|FG007|Overall Study|Lost to Follow-up|2|||
154909764|NCT02646891|559091994|FG008|Overall Study|Lost to Follow-up|2|||
154909765|NCT02646891|559091995|FG009|Overall Study|Lost to Follow-up|2|||
154909766|NCT02646891|559091986|FG000|Overall Study|Protocol Violation|0|||
154909767|NCT02646891|559091987|FG001|Overall Study|Protocol Violation|0|||
154909768|NCT02646891|559091988|FG002|Overall Study|Protocol Violation|0|||
154909769|NCT02646891|559091989|FG003|Overall Study|Protocol Violation|0|||
154909770|NCT02646891|559091990|FG004|Overall Study|Protocol Violation|0|||
154909771|NCT02646891|559091991|FG005|Overall Study|Protocol Violation|0|||
154909772|NCT02646891|559091992|FG006|Overall Study|Protocol Violation|1|||
154909773|NCT02646891|559091993|FG007|Overall Study|Protocol Violation|1|||
154909774|NCT02646891|559091994|FG008|Overall Study|Protocol Violation|0|||
154909775|NCT02646891|559091995|FG009|Overall Study|Protocol Violation|0|||
154909776|NCT02646891|559091986|FG000|Overall Study|Withdrawal by Subject|2|||
154909777|NCT02646891|559091987|FG001|Overall Study|Withdrawal by Subject|0|||
154909778|NCT02646891|559091988|FG002|Overall Study|Withdrawal by Subject|1|||
154909779|NCT02646891|559091989|FG003|Overall Study|Withdrawal by Subject|0|||
154909780|NCT02646891|559091990|FG004|Overall Study|Withdrawal by Subject|0|||
154909781|NCT02646891|559091991|FG005|Overall Study|Withdrawal by Subject|0|||
154909782|NCT02646891|559091992|FG006|Overall Study|Withdrawal by Subject|5|||
154909783|NCT02646891|559091993|FG007|Overall Study|Withdrawal by Subject|9|||
154909784|NCT02646891|559091994|FG008|Overall Study|Withdrawal by Subject|7|||
154909785|NCT02646891|559091995|FG009|Overall Study|Withdrawal by Subject|3|||
154909786|NCT02646891|559091986|FG000|Overall Study|Death|0|||
154909787|NCT02646891|559091987|FG001|Overall Study|Death|0|||
154909788|NCT02646891|559091988|FG002|Overall Study|Death|0|||
154909789|NCT02646891|559091989|FG003|Overall Study|Death|0|||
154909790|NCT02646891|559091990|FG004|Overall Study|Death|0|||
154909791|NCT02646891|559091991|FG005|Overall Study|Death|0|||
154909792|NCT02646891|559091992|FG006|Overall Study|Death|1|||
154909793|NCT02646891|559091993|FG007|Overall Study|Death|1|||
154909794|NCT02646891|559091994|FG008|Overall Study|Death|1|||
154909795|NCT02646891|559091995|FG009|Overall Study|Death|0|||
154909796|NCT01542632|559091996|FG000|Overall Study|Withdrawal of Consent|0|||
154909797|NCT01542632|559091997|FG001|Overall Study|Withdrawal of Consent|0|||
154909798|NCT01542632|559091998|FG002|Overall Study|Withdrawal of Consent|0|||
154909799|NCT01542632|559091999|FG003|Overall Study|Withdrawal of Consent|2|||
154909800|NCT01542632|559092000|FG004|Overall Study|Withdrawal of Consent|3|||
154909801|NCT01542632|559092001|FG005|Overall Study|Withdrawal of Consent|0|||
154909802|NCT01542632|559091996|FG000|Overall Study|Adverse Event|0|||
154909803|NCT01542632|559091997|FG001|Overall Study|Adverse Event|0|||
154909804|NCT01542632|559091998|FG002|Overall Study|Adverse Event|1|||
154909805|NCT01542632|559091999|FG003|Overall Study|Adverse Event|0|||
154909806|NCT01542632|559092000|FG004|Overall Study|Adverse Event|0|||
154909807|NCT01542632|559092001|FG005|Overall Study|Adverse Event|0|||
154909808|NCT01542632|559091996|FG000|Overall Study|Lost to Follow-up|0|||
154909809|NCT01542632|559091997|FG001|Overall Study|Lost to Follow-up|1|||
154909810|NCT01542632|559091998|FG002|Overall Study|Lost to Follow-up|0|||
154909811|NCT01542632|559091999|FG003|Overall Study|Lost to Follow-up|0|||
155117702|NCT03664674|559862021|FG000|Overall Study|Adverse Event|1|||
155117703|NCT03664674|559862022|FG001|Overall Study|Adverse Event|1|||
155117704|NCT03664674|559862021|FG000|Overall Study|Physician Decision|0|||
154984129|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
155117705|NCT03664674|559862022|FG001|Overall Study|Physician Decision|1|||
155117706|NCT03664674|559862021|FG000|Overall Study|Withdrawal by Subject|2|||
154909812|NCT01542632|559092000|FG004|Overall Study|Lost to Follow-up|0|||
154909813|NCT01542632|559092001|FG005|Overall Study|Lost to Follow-up|0|||
154909814|NCT01542632|559091996|FG000|Overall Study|Sponsor/Investigator Decision|0|||
154909815|NCT01542632|559091997|FG001|Overall Study|Sponsor/Investigator Decision|0|||
154909816|NCT01542632|559091998|FG002|Overall Study|Sponsor/Investigator Decision|0|||
154909817|NCT01542632|559091999|FG003|Overall Study|Sponsor/Investigator Decision|0|||
154909818|NCT01542632|559092000|FG004|Overall Study|Sponsor/Investigator Decision|1|||
155117707|NCT03664674|559862022|FG001|Overall Study|Withdrawal by Subject|0|||
154909819|NCT01542632|559092001|FG005|Overall Study|Sponsor/Investigator Decision|0|||
154909820|NCT00033514|559092002|FG000|Overall Study|Lost to Follow-up|1|||
154909821|NCT00033514|559092003|FG001|Overall Study|Lost to Follow-up|1|||
154909822|NCT00033514|559092002|FG000|Overall Study|Withdrawal by Subject|0|||
154909823|NCT00033514|559092003|FG001|Overall Study|Withdrawal by Subject|3|||
154909824|NCT03225833|559092004|FG000|Overall Study|Adverse Event|0|||
154909825|NCT03225833|559092005|FG001|Overall Study|Adverse Event|1|||
154909826|NCT03225833|559092006|FG002|Overall Study|Adverse Event|2|||
154909827|NCT03225833|559092007|FG003|Overall Study|Adverse Event|0|||
154909828|NCT03225833|559092008|FG004|Overall Study|Adverse Event|0|||
154909829|NCT03225833|559092009|FG005|Overall Study|Adverse Event|2|||
154909830|NCT03225833|559092004|FG000|Overall Study|Withdrawal by Subject|1|||
154909831|NCT03225833|559092005|FG001|Overall Study|Withdrawal by Subject|0|||
154909832|NCT03225833|559092006|FG002|Overall Study|Withdrawal by Subject|0|||
154909833|NCT03225833|559092007|FG003|Overall Study|Withdrawal by Subject|0|||
154909834|NCT03225833|559092008|FG004|Overall Study|Withdrawal by Subject|1|||
154909835|NCT03225833|559092009|FG005|Overall Study|Withdrawal by Subject|0|||
154909836|NCT03225833|559092004|FG000|Overall Study|Termination of Study by Sponsor|4|||
154909837|NCT03225833|559092005|FG001|Overall Study|Termination of Study by Sponsor|0|||
154909838|NCT03225833|559092006|FG002|Overall Study|Termination of Study by Sponsor|0|||
154909839|NCT03225833|559092007|FG003|Overall Study|Termination of Study by Sponsor|0|||
154909840|NCT03225833|559092008|FG004|Overall Study|Termination of Study by Sponsor|0|||
154909841|NCT03225833|559092009|FG005|Overall Study|Termination of Study by Sponsor|7|||
154909842|NCT03225833|559092004|FG000|Overall Study|Sponsor Decision|0|||
154909843|NCT03225833|559092005|FG001|Overall Study|Sponsor Decision|0|||
154909844|NCT03225833|559092006|FG002|Overall Study|Sponsor Decision|0|||
154909845|NCT03225833|559092007|FG003|Overall Study|Sponsor Decision|0|||
154909846|NCT03225833|559092008|FG004|Overall Study|Sponsor Decision|0|||
154909847|NCT03225833|559092009|FG005|Overall Study|Sponsor Decision|1|||
154909848|NCT04564027|559092021|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
154909849|NCT04564027|559092022|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
154909850|NCT04564027|559092023|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
154909851|NCT04564027|559092024|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
154909852|NCT05827978|559092025|FG000|Overall Study|Adverse Event|1|||
154909853|NCT05827978|559092026|FG001|Overall Study|Adverse Event|0|||
154909854|NCT05827978|559092027|FG002|Overall Study|Adverse Event|0|||
154909855|NCT05827978|559092028|FG003|Overall Study|Adverse Event|1|||
154909856|NCT05827978|559092029|FG004|Overall Study|Adverse Event|0|||
154909857|NCT05827978|559092030|FG005|Overall Study|Adverse Event|0|||
154909858|NCT05827978|559092025|FG000|Overall Study|Death|1|||
154909859|NCT05827978|559092026|FG001|Overall Study|Death|5|||
154909860|NCT05827978|559092027|FG002|Overall Study|Death|2|||
154909861|NCT05827978|559092028|FG003|Overall Study|Death|3|||
154909862|NCT05827978|559092029|FG004|Overall Study|Death|1|||
154909863|NCT05827978|559092030|FG005|Overall Study|Death|3|||
154909864|NCT05827978|559092025|FG000|Overall Study|Lost to Follow-up|57|||
154909865|NCT05827978|559092026|FG001|Overall Study|Lost to Follow-up|88|||
154909866|NCT05827978|559092027|FG002|Overall Study|Lost to Follow-up|54|||
154909867|NCT05827978|559092028|FG003|Overall Study|Lost to Follow-up|47|||
154909868|NCT05827978|559092029|FG004|Overall Study|Lost to Follow-up|25|||
154909869|NCT05827978|559092030|FG005|Overall Study|Lost to Follow-up|10|||
154909870|NCT05827978|559092025|FG000|Overall Study|Noncompliance with Study Procedures|0|||
154909871|NCT05827978|559092026|FG001|Overall Study|Noncompliance with Study Procedures|1|||
154909872|NCT05827978|559092027|FG002|Overall Study|Noncompliance with Study Procedures|1|||
154909873|NCT05827978|559092028|FG003|Overall Study|Noncompliance with Study Procedures|1|||
154909874|NCT05827978|559092029|FG004|Overall Study|Noncompliance with Study Procedures|1|||
154909875|NCT05827978|559092030|FG005|Overall Study|Noncompliance with Study Procedures|0|||
154909876|NCT05827978|559092025|FG000|Overall Study|Physician Decision|2|||
154909877|NCT05827978|559092026|FG001|Overall Study|Physician Decision|0|||
154909878|NCT05827978|559092027|FG002|Overall Study|Physician Decision|1|||
155176153|NCT01576159|560082291|FG000|Overall Study|Withdrawal by Subject|0|||
155176154|NCT01576159|560082292|FG001|Overall Study|Withdrawal by Subject|1|||
155176155|NCT01576159|560082293|FG002|Overall Study|Withdrawal by Subject|0|||
155176156|NCT01576159|560082294|FG003|Overall Study|Withdrawal by Subject|0|||
154909879|NCT05827978|559092028|FG003|Overall Study|Physician Decision|2|||
154909880|NCT05827978|559092029|FG004|Overall Study|Physician Decision|1|||
154909881|NCT05827978|559092030|FG005|Overall Study|Physician Decision|1|||
154909882|NCT05827978|559092025|FG000|Overall Study|Protocol Violation|5|||
154909883|NCT05827978|559092026|FG001|Overall Study|Protocol Violation|2|||
154909884|NCT05827978|559092027|FG002|Overall Study|Protocol Violation|0|||
154909885|NCT05827978|559092028|FG003|Overall Study|Protocol Violation|0|||
154909886|NCT05827978|559092029|FG004|Overall Study|Protocol Violation|0|||
154984130|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
154984131|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
154909887|NCT05827978|559092030|FG005|Overall Study|Protocol Violation|0|||
154909888|NCT05827978|559092025|FG000|Overall Study|Withdrawal by Subject|17|||
154909889|NCT05827978|559092026|FG001|Overall Study|Withdrawal by Subject|16|||
155117708|NCT00794365|559862023|FG000|Overall Study|Lost to Follow-up|38|||
155117709|NCT00794365|559862023|FG000|Overall Study|Other|17|||
155117710|NCT00794365|559862023|FG000|Overall Study|Poor Compliance|11|||
155117711|NCT00794365|559862023|FG000|Overall Study|Adverse Event|10|||
155117712|NCT00794365|559862023|FG000|Overall Study|Lack of Efficacy|3|||
155117713|NCT03538444|559862027|FG000|Overall Study|opioid withdrawal|1|||
155117714|NCT03538444|559862028|FG001|Overall Study|opioid withdrawal|0|||
155117715|NCT03022097|559862031|FG000|Overall Study|Adverse Event|3|||
155117716|NCT03022097|559862032|FG001|Overall Study|Adverse Event|4|||
155117717|NCT03022097|559862033|FG002|Overall Study|Adverse Event|1|||
155117718|NCT03022097|559862034|FG003|Overall Study|Adverse Event|3|||
155117719|NCT03022097|559862031|FG000|Overall Study|Progressive Disease|2|||
155117720|NCT03022097|559862032|FG001|Overall Study|Progressive Disease|0|||
155117721|NCT03022097|559862033|FG002|Overall Study|Progressive Disease|5|||
155117722|NCT03022097|559862034|FG003|Overall Study|Progressive Disease|2|||
155117723|NCT03022097|559862031|FG000|Overall Study|Lack of Efficacy|0|||
155117724|NCT03022097|559862032|FG001|Overall Study|Lack of Efficacy|0|||
155117725|NCT03022097|559862033|FG002|Overall Study|Lack of Efficacy|3|||
155117726|NCT03022097|559862034|FG003|Overall Study|Lack of Efficacy|3|||
155117727|NCT03022097|559862031|FG000|Overall Study|Protocol Violation|1|||
155117728|NCT03022097|559862032|FG001|Overall Study|Protocol Violation|0|||
155117729|NCT03022097|559862033|FG002|Overall Study|Protocol Violation|1|||
155117730|NCT03022097|559862034|FG003|Overall Study|Protocol Violation|0|||
155117731|NCT03022097|559862031|FG000|Overall Study|Withdrawal by Subject|11|||
155117732|NCT03022097|559862032|FG001|Overall Study|Withdrawal by Subject|13|||
155117733|NCT03022097|559862033|FG002|Overall Study|Withdrawal by Subject|15|||
155117734|NCT03022097|559862034|FG003|Overall Study|Withdrawal by Subject|21|||
155176157|NCT01576159|560082291|FG000|Overall Study|Physician Decision|0|||
155176158|NCT01576159|560082292|FG001|Overall Study|Physician Decision|0|||
155117735|NCT03022097|559862031|FG000|Overall Study|Lost to Follow-up|0|||
155117736|NCT03022097|559862032|FG001|Overall Study|Lost to Follow-up|0|||
155117737|NCT03022097|559862033|FG002|Overall Study|Lost to Follow-up|1|||
155117738|NCT03022097|559862034|FG003|Overall Study|Lost to Follow-up|1|||
155117739|NCT03022097|559862031|FG000|Overall Study|Other|4|||
155117740|NCT03022097|559862032|FG001|Overall Study|Other|1|||
155117741|NCT03022097|559862033|FG002|Overall Study|Other|6|||
155117742|NCT03022097|559862034|FG003|Overall Study|Other|4|||
155117743|NCT03022097|559862031|FG000|Overall Study|Due to COVID-19 pandemic|0|||
155117744|NCT03022097|559862032|FG001|Overall Study|Due to COVID-19 pandemic|1|||
155117745|NCT03022097|559862033|FG002|Overall Study|Due to COVID-19 pandemic|0|||
155117746|NCT03022097|559862034|FG003|Overall Study|Due to COVID-19 pandemic|0|||
155117747|NCT00457821|559862039|FG000|Part 2|Withdrawal by Subject|0|||
155117748|NCT00457821|559862040|FG001|Part 2|Withdrawal by Subject|0|||
155117749|NCT00457821|559862041|FG002|Part 2|Withdrawal by Subject|0|||
155117750|NCT00457821|559862042|FG003|Part 2|Withdrawal by Subject|0|||
155117751|NCT00457821|559862043|FG004|Part 2|Withdrawal by Subject|0|||
155117752|NCT00457821|559862044|FG005|Part 2|Withdrawal by Subject|0|||
155117753|NCT00457821|559862045|FG006|Part 2|Withdrawal by Subject|0|||
155117754|NCT00457821|559862046|FG007|Part 2|Withdrawal by Subject|1|||
155117755|NCT00790647|559862049|FG000|Overall Study|Adverse Event|1|||
155117756|NCT00027378|559862050|FG000|Overall Study|Physician Decision|0|||
155117757|NCT00027378|559862051|FG001|Overall Study|Physician Decision|3|||
155117758|NCT02851407|559862057|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155117759|NCT02851407|559862058|FG001|Overall Study|Withdrawal by parent/guardian|7|||
155117760|NCT02851407|559862057|FG000|Overall Study|Protocol deviation|0|||
155117761|NCT02851407|559862058|FG001|Overall Study|Protocol deviation|1|||
155117762|NCT02851407|559862057|FG000|Overall Study|Transferred to another hospital to continue|1|||
155117763|NCT02851407|559862058|FG001|Overall Study|Transferred to another hospital to continue|0|||
155117764|NCT02851407|559862057|FG000|Overall Study|Other Death|30|||
155117765|NCT02851407|559862058|FG001|Overall Study|Other Death|20|||
155176159|NCT01576159|560082293|FG002|Overall Study|Physician Decision|1|||
154909890|NCT05827978|559092027|FG002|Overall Study|Withdrawal by Subject|10|||
154909891|NCT05827978|559092028|FG003|Overall Study|Withdrawal by Subject|12|||
155117766|NCT02851407|559862057|FG000|Overall Study|Adverse event, serious fatal|6|||
155117767|NCT02851407|559862058|FG001|Overall Study|Adverse event, serious fatal|8|||
155117768|NCT02851407|559862057|FG000|Overall Study|Consent withdrawn by participant|5|||
155117769|NCT02851407|559862058|FG001|Overall Study|Consent withdrawn by participant|3|||
155117770|NCT02851407|559862057|FG000|Overall Study|Screen failure|2|||
155117771|NCT02851407|559862058|FG001|Overall Study|Screen failure|1|||
155176160|NCT01576159|560082294|FG003|Overall Study|Physician Decision|0|||
155176161|NCT01576159|560082291|FG000|Overall Study|Lost to Follow-up|0|||
154909892|NCT05827978|559092029|FG004|Overall Study|Withdrawal by Subject|10|||
155117772|NCT02851407|559862057|FG000|Overall Study|Disease relapse|9|||
155117773|NCT02851407|559862058|FG001|Overall Study|Disease relapse|6|||
155117774|NCT02851407|559862057|FG000|Overall Study|Physician Decision|7|||
155117775|NCT02851407|559862058|FG001|Overall Study|Physician Decision|6|||
155117776|NCT02851407|559862057|FG000|Overall Study|Transferred to hospital closer to home|0|||
155117777|NCT02851407|559862058|FG001|Overall Study|Transferred to hospital closer to home|1|||
155117778|NCT02851407|559862057|FG000|Overall Study|Enrolled in an investigational study|0|||
154909893|NCT05827978|559092030|FG005|Overall Study|Withdrawal by Subject|9|||
154909894|NCT05827978|559092025|FG000|Overall Study|Other Than Specified|0|||
154909895|NCT05827978|559092026|FG001|Overall Study|Other Than Specified|0|||
154909896|NCT05827978|559092027|FG002|Overall Study|Other Than Specified|1|||
154909897|NCT05827978|559092028|FG003|Overall Study|Other Than Specified|0|||
154909898|NCT05827978|559092029|FG004|Overall Study|Other Than Specified|2|||
154909899|NCT05827978|559092030|FG005|Overall Study|Other Than Specified|0|||
154909900|NCT04785144|559092031|FG000|Overall Study|Withdrawal by Subject|4|||
154909901|NCT04785144|559092032|FG001|Overall Study|Withdrawal by Subject|1|||
154909902|NCT04785144|559092033|FG002|Overall Study|Withdrawal by Subject|0|||
154909903|NCT04785144|559092034|FG003|Overall Study|Withdrawal by Subject|0|||
154909904|NCT04785144|559092035|FG004|Overall Study|Withdrawal by Subject|0|||
154909905|NCT04785144|559092036|FG005|Overall Study|Withdrawal by Subject|2|||
154909906|NCT04785144|559092037|FG006|Overall Study|Withdrawal by Subject|2|||
154909907|NCT04785144|559092038|FG007|Overall Study|Withdrawal by Subject|0|||
154909908|NCT04785144|559092039|FG008|Overall Study|Withdrawal by Subject|1|||
154909909|NCT04785144|559092040|FG009|Overall Study|Withdrawal by Subject|0|||
154909910|NCT04785144|559092031|FG000|Overall Study|Lost to Follow-up|1|||
154909911|NCT04785144|559092032|FG001|Overall Study|Lost to Follow-up|0|||
154909912|NCT04785144|559092033|FG002|Overall Study|Lost to Follow-up|0|||
154909913|NCT04785144|559092034|FG003|Overall Study|Lost to Follow-up|0|||
154909914|NCT04785144|559092035|FG004|Overall Study|Lost to Follow-up|1|||
154909915|NCT04785144|559092036|FG005|Overall Study|Lost to Follow-up|2|||
154909916|NCT04785144|559092037|FG006|Overall Study|Lost to Follow-up|1|||
154909917|NCT04785144|559092038|FG007|Overall Study|Lost to Follow-up|2|||
154909918|NCT04785144|559092039|FG008|Overall Study|Lost to Follow-up|4|||
154909919|NCT04785144|559092040|FG009|Overall Study|Lost to Follow-up|1|||
154909920|NCT04785144|559092031|FG000|Overall Study|Protocol Violation|0|||
155117779|NCT02851407|559862058|FG001|Overall Study|Enrolled in an investigational study|1|||
155117780|NCT02851407|559862057|FG000|Overall Study|Early recovery|1|||
155117781|NCT02851407|559862058|FG001|Overall Study|Early recovery|0|||
155117782|NCT02851407|559862057|FG000|Overall Study|Adverse event, non-fatal|7|||
155117783|NCT02851407|559862058|FG001|Overall Study|Adverse event, non-fatal|5|||
155117784|NCT02851407|559862057|FG000|Overall Study|Lost to Follow-up|0|||
155117785|NCT02851407|559862058|FG001|Overall Study|Lost to Follow-up|2|||
155117786|NCT01713283|559862059|FG000|Overall Study|Lack of Efficacy|10|||
155117787|NCT01713283|559862060|FG001|Overall Study|Lack of Efficacy|2|||
155117788|NCT01713283|559862059|FG000|Overall Study|Lost to Follow-up|1|||
155117789|NCT01713283|559862060|FG001|Overall Study|Lost to Follow-up|1|||
155117790|NCT02585830|559862061|FG000|Overall Study|Withdrawal by Subject|3|||
155117791|NCT00350272|559862062|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
155117792|NCT00350272|559862063|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
155117793|NCT00350272|559862062|FG000|Blinded 12-Week Treatment|Death|1|||
155117794|NCT00350272|559862063|FG001|Blinded 12-Week Treatment|Death|0|||
154909921|NCT04785144|559092032|FG001|Overall Study|Protocol Violation|0|||
154909922|NCT04785144|559092033|FG002|Overall Study|Protocol Violation|0|||
154909923|NCT04785144|559092034|FG003|Overall Study|Protocol Violation|0|||
154909924|NCT04785144|559092035|FG004|Overall Study|Protocol Violation|0|||
154909925|NCT04785144|559092036|FG005|Overall Study|Protocol Violation|0|||
154909926|NCT04785144|559092037|FG006|Overall Study|Protocol Violation|1|||
154909927|NCT04785144|559092038|FG007|Overall Study|Protocol Violation|0|||
154909928|NCT04785144|559092039|FG008|Overall Study|Protocol Violation|0|||
154909929|NCT04785144|559092040|FG009|Overall Study|Protocol Violation|0|||
154909930|NCT04785144|559092031|FG000|Overall Study|Physician Decision|0|||
154909931|NCT04785144|559092032|FG001|Overall Study|Physician Decision|0|||
154909932|NCT04785144|559092033|FG002|Overall Study|Physician Decision|0|||
154909933|NCT04785144|559092034|FG003|Overall Study|Physician Decision|0|||
154909934|NCT04785144|559092035|FG004|Overall Study|Physician Decision|0|||
154909935|NCT04785144|559092036|FG005|Overall Study|Physician Decision|0|||
154909936|NCT04785144|559092037|FG006|Overall Study|Physician Decision|0|||
154909937|NCT04785144|559092038|FG007|Overall Study|Physician Decision|0|||
154909938|NCT04785144|559092039|FG008|Overall Study|Physician Decision|0|||
154909939|NCT04785144|559092040|FG009|Overall Study|Physician Decision|1|||
154909940|NCT04785144|559092031|FG000|Overall Study|Unable to continue due to work schedule|0|||
154909941|NCT04785144|559092032|FG001|Overall Study|Unable to continue due to work schedule|0|||
154909942|NCT04785144|559092033|FG002|Overall Study|Unable to continue due to work schedule|0|||
154909943|NCT04785144|559092034|FG003|Overall Study|Unable to continue due to work schedule|0|||
154909944|NCT04785144|559092035|FG004|Overall Study|Unable to continue due to work schedule|0|||
154909945|NCT04785144|559092036|FG005|Overall Study|Unable to continue due to work schedule|0|||
154909946|NCT04785144|559092037|FG006|Overall Study|Unable to continue due to work schedule|0|||
154909947|NCT04785144|559092038|FG007|Overall Study|Unable to continue due to work schedule|0|||
154909948|NCT04785144|559092039|FG008|Overall Study|Unable to continue due to work schedule|0|||
154984132|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
155117795|NCT00350272|559862062|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
155117796|NCT00350272|559862063|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
155117797|NCT00350272|559862062|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
154909949|NCT04785144|559092040|FG009|Overall Study|Unable to continue due to work schedule|1|||
154909950|NCT00712712|559092043|FG000|Overall Study|Protocol Violation|11|||
154909951|NCT00712712|559092043|FG000|Overall Study|Radiofrequency not done|3|||
154909952|NCT00712712|559092043|FG000|Overall Study|Death|8|||
154909953|NCT00712712|559092043|FG000|Overall Study|Withdrawal by Subject|1|||
154909954|NCT02289833|559092049|FG000|Overall Study|Study discontinuation|0|||
154909955|NCT02289833|559092050|FG001|Overall Study|Study discontinuation|1|||
154909956|NCT02289833|559092049|FG000|Overall Study|Lost to Follow-up|4|||
154909957|NCT02289833|559092050|FG001|Overall Study|Lost to Follow-up|0|||
154909958|NCT02289833|559092049|FG000|Overall Study|Death|23|||
154909959|NCT02289833|559092050|FG001|Overall Study|Death|16|||
154909960|NCT01756833|559092062|FG000|Overall Study|Withdrawal by Subject|4|||
154909961|NCT01756833|559092063|FG001|Overall Study|Withdrawal by Subject|3|||
154909962|NCT04554394|559092064|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
154909963|NCT04554394|559092065|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
154909964|NCT04554394|559092064|FG000|Overall Study|Withdrawal by Subject|2|||
154909965|NCT04554394|559092065|FG001|Overall Study|Withdrawal by Subject|2|||
154909966|NCT04554394|559092064|FG000|Overall Study|Lost to Follow-up|2|||
154909967|NCT04554394|559092065|FG001|Overall Study|Lost to Follow-up|2|||
154909968|NCT04554394|559092064|FG000|Overall Study|Physician Decision|1|||
154909969|NCT04554394|559092065|FG001|Overall Study|Physician Decision|1|||
154909970|NCT01766401|559092066|FG000|Overall Study|Adverse Event|7|||
154909971|NCT01766401|559092067|FG001|Overall Study|Adverse Event|22|||
154909972|NCT01766401|559092066|FG000|Overall Study|Lack of Efficacy|1|||
154909973|NCT01766401|559092067|FG001|Overall Study|Lack of Efficacy|2|||
154909974|NCT01766401|559092066|FG000|Overall Study|Protocol Violation|3|||
154909975|NCT01766401|559092067|FG001|Overall Study|Protocol Violation|8|||
154909976|NCT01766401|559092066|FG000|Overall Study|Withdrawal by Subject|15|||
154909977|NCT01766401|559092067|FG001|Overall Study|Withdrawal by Subject|12|||
154984133|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
154984134|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
154984135|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
154984136|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
154984137|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
154984138|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
154984139|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
154984140|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
154984141|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
154984142|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
154984143|NCT00518882|559366327|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
154984144|NCT00518882|559366328|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
154984145|NCT02696031|559366329|FG000|Up to Week 24|Adverse Event|2|||
154984146|NCT02696031|559366330|FG001|Up to Week 24|Adverse Event|4|||
154984147|NCT02696031|559366331|FG002|Up to Week 24|Adverse Event|2|||
154984148|NCT02696031|559366332|FG003|Up to Week 24|Adverse Event|0|||
154984149|NCT02696031|559366333|FG004|Up to Week 24|Adverse Event|0|||
154984150|NCT02696031|559366334|FG005|Up to Week 24|Adverse Event|0|||
154984151|NCT02696031|559366329|FG000|Up to Week 24|Lack of Efficacy|2|||
154984152|NCT02696031|559366330|FG001|Up to Week 24|Lack of Efficacy|1|||
154984153|NCT02696031|559366331|FG002|Up to Week 24|Lack of Efficacy|2|||
154984154|NCT02696031|559366332|FG003|Up to Week 24|Lack of Efficacy|0|||
154984155|NCT02696031|559366333|FG004|Up to Week 24|Lack of Efficacy|0|||
154984156|NCT02696031|559366334|FG005|Up to Week 24|Lack of Efficacy|0|||
154984157|NCT02696031|559366329|FG000|Up to Week 24|Lost to Follow-up|0|||
154984158|NCT02696031|559366330|FG001|Up to Week 24|Lost to Follow-up|1|||
154984159|NCT02696031|559366331|FG002|Up to Week 24|Lost to Follow-up|1|||
154984160|NCT02696031|559366332|FG003|Up to Week 24|Lost to Follow-up|0|||
154984161|NCT02696031|559366333|FG004|Up to Week 24|Lost to Follow-up|0|||
154984162|NCT02696031|559366334|FG005|Up to Week 24|Lost to Follow-up|0|||
154984163|NCT02696031|559366329|FG000|Up to Week 24|Physician Decision|1|||
154984164|NCT02696031|559366330|FG001|Up to Week 24|Physician Decision|0|||
154984165|NCT02696031|559366331|FG002|Up to Week 24|Physician Decision|1|||
155117798|NCT00350272|559862063|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
155117799|NCT00350272|559862062|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
154984166|NCT02696031|559366332|FG003|Up to Week 24|Physician Decision|0|||
154984167|NCT02696031|559366333|FG004|Up to Week 24|Physician Decision|0|||
154984168|NCT02696031|559366334|FG005|Up to Week 24|Physician Decision|0|||
154984169|NCT02696031|559366329|FG000|Up to Week 24|Protocol Violation|1|||
154909978|NCT01766401|559092066|FG000|Overall Study|Lost to Follow-up|10|||
154984170|NCT02696031|559366330|FG001|Up to Week 24|Protocol Violation|0|||
154984171|NCT02696031|559366331|FG002|Up to Week 24|Protocol Violation|0|||
154984172|NCT02696031|559366332|FG003|Up to Week 24|Protocol Violation|0|||
154909979|NCT01766401|559092067|FG001|Overall Study|Lost to Follow-up|11|||
154909980|NCT01766401|559092066|FG000|Overall Study|Pregnancy|1|||
154909981|NCT01766401|559092067|FG001|Overall Study|Pregnancy|1|||
154909982|NCT00886587|559092068|FG000|Overall Study|Adverse Event|2|||
155117800|NCT00350272|559862063|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
155117801|NCT00350272|559862062|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
155117802|NCT00350272|559862063|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
155117803|NCT00350272|559862062|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
155117804|NCT00350272|559862063|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
155117805|NCT00350272|559862062|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
155117806|NCT00350272|559862063|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
155117807|NCT00350272|559862062|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
155117808|NCT00350272|559862063|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
155117809|NCT00350272|559862062|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
155117810|NCT00350272|559862063|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
155117811|NCT00350272|559862062|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
155117812|NCT00350272|559862063|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
155117813|NCT00235391|559862064|FG000|Overall Study|Adverse Event|4|||
155117814|NCT00235391|559862065|FG001|Overall Study|Adverse Event|5|||
155117815|NCT00235391|559862066|FG002|Overall Study|Adverse Event|10|||
155117816|NCT00235391|559862067|FG003|Overall Study|Adverse Event|72|||
155117817|NCT00235391|559862068|FG004|Overall Study|Adverse Event|5|||
155117818|NCT00235391|559862069|FG005|Overall Study|Adverse Event|2|||
155117819|NCT00235391|559862064|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155117820|NCT00235391|559862065|FG001|Overall Study|Abnormal laboratory value(s)|5|||
155117821|NCT00235391|559862066|FG002|Overall Study|Abnormal laboratory value(s)|4|||
155117822|NCT00235391|559862067|FG003|Overall Study|Abnormal laboratory value(s)|27|||
155117823|NCT00235391|559862068|FG004|Overall Study|Abnormal laboratory value(s)|1|||
155117824|NCT00235391|559862069|FG005|Overall Study|Abnormal laboratory value(s)|2|||
155117825|NCT00235391|559862064|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155117826|NCT00235391|559862065|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155117827|NCT00235391|559862066|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155117828|NCT00235391|559862067|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
155117829|NCT00235391|559862068|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
155117830|NCT00235391|559862069|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
155117831|NCT00235391|559862064|FG000|Overall Study|Condition no longer requires treatment|3|||
155117832|NCT00235391|559862065|FG001|Overall Study|Condition no longer requires treatment|0|||
155117833|NCT00235391|559862066|FG002|Overall Study|Condition no longer requires treatment|0|||
155117834|NCT00235391|559862067|FG003|Overall Study|Condition no longer requires treatment|11|||
155117835|NCT00235391|559862068|FG004|Overall Study|Condition no longer requires treatment|1|||
155117836|NCT00235391|559862069|FG005|Overall Study|Condition no longer requires treatment|0|||
155117837|NCT00235391|559862064|FG000|Overall Study|Protocol deviation|0|||
155117838|NCT00235391|559862065|FG001|Overall Study|Protocol deviation|0|||
155117839|NCT00235391|559862066|FG002|Overall Study|Protocol deviation|1|||
155117840|NCT00235391|559862067|FG003|Overall Study|Protocol deviation|11|||
155117841|NCT00235391|559862068|FG004|Overall Study|Protocol deviation|0|||
155117842|NCT00235391|559862069|FG005|Overall Study|Protocol deviation|0|||
155117843|NCT00235391|559862064|FG000|Overall Study|Withdrawal by Subject|2|||
155117844|NCT00235391|559862065|FG001|Overall Study|Withdrawal by Subject|3|||
155117845|NCT00235391|559862066|FG002|Overall Study|Withdrawal by Subject|3|||
155117846|NCT00235391|559862067|FG003|Overall Study|Withdrawal by Subject|61|||
155117847|NCT00235391|559862068|FG004|Overall Study|Withdrawal by Subject|5|||
155117848|NCT00235391|559862069|FG005|Overall Study|Withdrawal by Subject|0|||
155117849|NCT00235391|559862064|FG000|Overall Study|Lost to Follow-up|0|||
155117850|NCT00235391|559862065|FG001|Overall Study|Lost to Follow-up|3|||
155117851|NCT00235391|559862066|FG002|Overall Study|Lost to Follow-up|3|||
155117852|NCT00235391|559862067|FG003|Overall Study|Lost to Follow-up|16|||
155117853|NCT00235391|559862068|FG004|Overall Study|Lost to Follow-up|0|||
155117854|NCT00235391|559862069|FG005|Overall Study|Lost to Follow-up|0|||
155117855|NCT00235391|559862064|FG000|Overall Study|Administrative problems|0|||
155117856|NCT00235391|559862065|FG001|Overall Study|Administrative problems|0|||
155117857|NCT00235391|559862066|FG002|Overall Study|Administrative problems|0|||
155117858|NCT00235391|559862067|FG003|Overall Study|Administrative problems|1|||
155117859|NCT00235391|559862068|FG004|Overall Study|Administrative problems|0|||
155117860|NCT00235391|559862069|FG005|Overall Study|Administrative problems|0|||
155117861|NCT00235391|559862064|FG000|Overall Study|Death|0|||
155117862|NCT00235391|559862065|FG001|Overall Study|Death|0|||
155117863|NCT00235391|559862066|FG002|Overall Study|Death|1|||
155117864|NCT00235391|559862067|FG003|Overall Study|Death|4|||
155117865|NCT00235391|559862068|FG004|Overall Study|Death|0|||
155117866|NCT00235391|559862069|FG005|Overall Study|Death|0|||
155117867|NCT03349645|559862070|FG000|Overall Study|Sponsor Terminated Study|75|||
155117868|NCT03349645|559862070|FG000|Overall Study|Withdrawal by Subject|4|||
155117869|NCT03349645|559862070|FG000|Overall Study|Protocol Violation|1|||
155117870|NCT03349645|559862070|FG000|Overall Study|Other|2|||
155117871|NCT02927925|559862073|FG000|Overall Study|Death|16|||
155117872|NCT02927925|559862073|FG000|Overall Study|Physician Decision|1|||
155117873|NCT02927925|559862073|FG000|Overall Study|Withdrawal by Subject|11|||
155117874|NCT02927925|559862073|FG000|Overall Study|Other|3|||
155117875|NCT02927925|559862073|FG000|Overall Study|Disease progression at clinical cutoff|1|||
155117876|NCT01080768|559862081|FG000|Overall Study|Protocol Deviation|2|||
155117877|NCT01080768|559862082|FG001|Overall Study|Protocol Deviation|1|||
155117878|NCT03510468|559862083|FG000|Overall Study|Lost to Follow-up|1|||
155117879|NCT03510468|559862083|FG000|Overall Study|Adverse Event|5|||
155117880|NCT03510468|559862083|FG000|Overall Study|Physician Decision|1|||
155117881|NCT03510468|559862083|FG000|Overall Study|non-compliant with treatment|2|||
155117882|NCT03510468|559862083|FG000|Overall Study|Missed visit|1|||
155117883|NCT01300819|559862088|FG000|Overall Study|Adverse Event|9|||
155117884|NCT01300819|559862089|FG001|Overall Study|Adverse Event|27|||
155117885|NCT01300819|559862088|FG000|Overall Study|Lack of Efficacy|2|||
155117886|NCT01300819|559862089|FG001|Overall Study|Lack of Efficacy|1|||
155117887|NCT01300819|559862088|FG000|Overall Study|Withdrawal by Subject|10|||
155176162|NCT01576159|560082292|FG001|Overall Study|Lost to Follow-up|0|||
155176163|NCT01576159|560082293|FG002|Overall Study|Lost to Follow-up|0|||
154909983|NCT00886587|559092069|FG001|Overall Study|Adverse Event|1|||
154909984|NCT00886587|559092068|FG000|Overall Study|Protocol Violation|2|||
154909985|NCT00886587|559092069|FG001|Overall Study|Protocol Violation|0|||
154909986|NCT00886587|559092068|FG000|Overall Study|Withdrawal by Subject|0|||
154909987|NCT00886587|559092069|FG001|Overall Study|Withdrawal by Subject|1|||
154909988|NCT00808132|559092073|FG000|Overall Study|Adverse Event|34|||
154909989|NCT00808132|559092074|FG001|Overall Study|Adverse Event|33|||
154909990|NCT00808132|559092075|FG002|Overall Study|Adverse Event|16|||
154909991|NCT00808132|559092076|FG003|Overall Study|Adverse Event|31|||
154909992|NCT00808132|559092077|FG004|Overall Study|Adverse Event|33|||
154909993|NCT00808132|559092073|FG000|Overall Study|Death|0|||
154909994|NCT00808132|559092074|FG001|Overall Study|Death|0|||
154909995|NCT00808132|559092075|FG002|Overall Study|Death|0|||
154909996|NCT00808132|559092076|FG003|Overall Study|Death|0|||
154909997|NCT00808132|559092077|FG004|Overall Study|Death|1|||
154909998|NCT00808132|559092073|FG000|Overall Study|Physician Decision|0|||
154909999|NCT00808132|559092074|FG001|Overall Study|Physician Decision|1|||
154910000|NCT00808132|559092075|FG002|Overall Study|Physician Decision|0|||
154910001|NCT00808132|559092076|FG003|Overall Study|Physician Decision|0|||
154910002|NCT00808132|559092077|FG004|Overall Study|Physician Decision|0|||
154910003|NCT00808132|559092073|FG000|Overall Study|Lost to Follow-up|8|||
154910004|NCT00808132|559092074|FG001|Overall Study|Lost to Follow-up|10|||
154910005|NCT00808132|559092075|FG002|Overall Study|Lost to Follow-up|11|||
154910006|NCT00808132|559092076|FG003|Overall Study|Lost to Follow-up|8|||
154910007|NCT00808132|559092077|FG004|Overall Study|Lost to Follow-up|9|||
154910008|NCT00808132|559092073|FG000|Overall Study|Protocol Violation|8|||
154910009|NCT00808132|559092074|FG001|Overall Study|Protocol Violation|9|||
154910010|NCT00808132|559092075|FG002|Overall Study|Protocol Violation|4|||
154910011|NCT00808132|559092076|FG003|Overall Study|Protocol Violation|9|||
154910012|NCT00808132|559092077|FG004|Overall Study|Protocol Violation|5|||
154910013|NCT00808132|559092073|FG000|Overall Study|Withdrawal by Subject|27|||
154910014|NCT00808132|559092074|FG001|Overall Study|Withdrawal by Subject|18|||
154910015|NCT00808132|559092075|FG002|Overall Study|Withdrawal by Subject|2|||
154910016|NCT00808132|559092076|FG003|Overall Study|Withdrawal by Subject|7|||
154910017|NCT00808132|559092077|FG004|Overall Study|Withdrawal by Subject|16|||
154910018|NCT00808132|559092073|FG000|Overall Study|Other|6|||
154910019|NCT00808132|559092074|FG001|Overall Study|Other|4|||
154910020|NCT00808132|559092075|FG002|Overall Study|Other|6|||
154910021|NCT00808132|559092076|FG003|Overall Study|Other|2|||
154910022|NCT00808132|559092077|FG004|Overall Study|Other|15|||
154910023|NCT00808132|559092073|FG000|Overall Study|Randomized, but not treated|10|||
154910024|NCT00808132|559092074|FG001|Overall Study|Randomized, but not treated|7|||
154910025|NCT00808132|559092075|FG002|Overall Study|Randomized, but not treated|9|||
154910026|NCT00808132|559092076|FG003|Overall Study|Randomized, but not treated|8|||
154910027|NCT00808132|559092077|FG004|Overall Study|Randomized, but not treated|9|||
154910028|NCT00808132|559092073|FG000|Overall Study|Unsatisfactory response|5|||
154910029|NCT00808132|559092074|FG001|Overall Study|Unsatisfactory response|6|||
154910030|NCT00808132|559092075|FG002|Overall Study|Unsatisfactory response|6|||
154910031|NCT00808132|559092076|FG003|Overall Study|Unsatisfactory response|4|||
155117888|NCT01300819|559862089|FG001|Overall Study|Withdrawal by Subject|12|||
155117889|NCT01300819|559862088|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
155117890|NCT01300819|559862089|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
155117891|NCT01300819|559862088|FG000|Overall Study|Refusal to down titrate study drug|0|||
154910032|NCT00808132|559092077|FG004|Overall Study|Unsatisfactory response|12|||
155117892|NCT01300819|559862089|FG001|Overall Study|Refusal to down titrate study drug|1|||
155176164|NCT01576159|560082294|FG003|Overall Study|Lost to Follow-up|1|||
154910033|NCT02795182|559092078|FG000|Overall Study|Death|5|||
154910034|NCT02795182|559092079|FG001|Overall Study|Death|4|||
154910035|NCT02795182|559092080|FG002|Overall Study|Death|4|||
154910036|NCT02795182|559092081|FG003|Overall Study|Death|18|||
154910037|NCT02795182|559092078|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
154910038|NCT02795182|559092079|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
154910039|NCT02795182|559092080|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
154984173|NCT02696031|559366333|FG004|Up to Week 24|Protocol Violation|0|||
154984174|NCT02696031|559366334|FG005|Up to Week 24|Protocol Violation|0|||
154984175|NCT02696031|559366329|FG000|Up to Week 24|Withdrawal by Subject|4|||
154984176|NCT02696031|559366330|FG001|Up to Week 24|Withdrawal by Subject|1|||
154984177|NCT02696031|559366331|FG002|Up to Week 24|Withdrawal by Subject|5|||
154984178|NCT02696031|559366332|FG003|Up to Week 24|Withdrawal by Subject|0|||
154984179|NCT02696031|559366333|FG004|Up to Week 24|Withdrawal by Subject|0|||
154984180|NCT02696031|559366334|FG005|Up to Week 24|Withdrawal by Subject|0|||
154984181|NCT02696031|559366329|FG000|Up to Week 52|Adverse Event|4|||
154984182|NCT02696031|559366330|FG001|Up to Week 52|Adverse Event|5|||
154984183|NCT02696031|559366331|FG002|Up to Week 52|Adverse Event|3|||
154984184|NCT02696031|559366332|FG003|Up to Week 52|Adverse Event|0|||
154984185|NCT02696031|559366333|FG004|Up to Week 52|Adverse Event|0|||
154984186|NCT02696031|559366334|FG005|Up to Week 52|Adverse Event|0|||
154984187|NCT02696031|559366329|FG000|Up to Week 52|Lack of Efficacy|10|||
154984188|NCT02696031|559366330|FG001|Up to Week 52|Lack of Efficacy|7|||
154984189|NCT02696031|559366331|FG002|Up to Week 52|Lack of Efficacy|11|||
154984190|NCT02696031|559366332|FG003|Up to Week 52|Lack of Efficacy|0|||
154984191|NCT02696031|559366333|FG004|Up to Week 52|Lack of Efficacy|0|||
154984192|NCT02696031|559366334|FG005|Up to Week 52|Lack of Efficacy|0|||
154984193|NCT02696031|559366329|FG000|Up to Week 52|Lost to Follow-up|1|||
154984194|NCT02696031|559366330|FG001|Up to Week 52|Lost to Follow-up|1|||
154984195|NCT02696031|559366331|FG002|Up to Week 52|Lost to Follow-up|1|||
154984196|NCT02696031|559366332|FG003|Up to Week 52|Lost to Follow-up|0|||
154984197|NCT02696031|559366333|FG004|Up to Week 52|Lost to Follow-up|0|||
154984198|NCT02696031|559366334|FG005|Up to Week 52|Lost to Follow-up|0|||
154984199|NCT02696031|559366329|FG000|Up to Week 52|Physician Decision|1|||
154984200|NCT02696031|559366330|FG001|Up to Week 52|Physician Decision|1|||
154984201|NCT02696031|559366331|FG002|Up to Week 52|Physician Decision|2|||
154984202|NCT02696031|559366332|FG003|Up to Week 52|Physician Decision|0|||
154984203|NCT02696031|559366333|FG004|Up to Week 52|Physician Decision|0|||
154984204|NCT02696031|559366334|FG005|Up to Week 52|Physician Decision|0|||
154984205|NCT02696031|559366329|FG000|Up to Week 52|Pregnancy|0|||
154984206|NCT02696031|559366330|FG001|Up to Week 52|Pregnancy|2|||
154984207|NCT02696031|559366331|FG002|Up to Week 52|Pregnancy|0|||
154984208|NCT02696031|559366332|FG003|Up to Week 52|Pregnancy|0|||
154984209|NCT02696031|559366333|FG004|Up to Week 52|Pregnancy|0|||
154984210|NCT02696031|559366334|FG005|Up to Week 52|Pregnancy|0|||
154984211|NCT02696031|559366329|FG000|Up to Week 52|Protocol Violation|1|||
154984212|NCT02696031|559366330|FG001|Up to Week 52|Protocol Violation|0|||
154984213|NCT02696031|559366331|FG002|Up to Week 52|Protocol Violation|0|||
154984214|NCT02696031|559366332|FG003|Up to Week 52|Protocol Violation|0|||
154984215|NCT02696031|559366333|FG004|Up to Week 52|Protocol Violation|0|||
154984216|NCT02696031|559366334|FG005|Up to Week 52|Protocol Violation|0|||
154984217|NCT02696031|559366329|FG000|Up to Week 52|Withdrawal by Subject|12|||
154984218|NCT02696031|559366330|FG001|Up to Week 52|Withdrawal by Subject|3|||
154984219|NCT02696031|559366331|FG002|Up to Week 52|Withdrawal by Subject|9|||
154984220|NCT02696031|559366332|FG003|Up to Week 52|Withdrawal by Subject|0|||
154984221|NCT02696031|559366333|FG004|Up to Week 52|Withdrawal by Subject|0|||
154984222|NCT02696031|559366334|FG005|Up to Week 52|Withdrawal by Subject|0|||
154984223|NCT02696031|559366329|FG000|Up to Week 104|Pregnancy|0|||
154984224|NCT02696031|559366330|FG001|Up to Week 104|Pregnancy|2|||
154984225|NCT02696031|559366331|FG002|Up to Week 104|Pregnancy|1|||
154984226|NCT02696031|559366332|FG003|Up to Week 104|Pregnancy|0|||
154984227|NCT02696031|559366333|FG004|Up to Week 104|Pregnancy|0|||
154984228|NCT02696031|559366334|FG005|Up to Week 104|Pregnancy|0|||
154984229|NCT02696031|559366329|FG000|Up to Week 104|Withdrawal by Subject|15|||
154984230|NCT02696031|559366330|FG001|Up to Week 104|Withdrawal by Subject|10|||
154984231|NCT02696031|559366331|FG002|Up to Week 104|Withdrawal by Subject|16|||
155117893|NCT01300819|559862088|FG000|Overall Study|Administrative reason|0|||
155117894|NCT01300819|559862089|FG001|Overall Study|Administrative reason|1|||
155117895|NCT01300819|559862088|FG000|Overall Study|Safety follow up not done by mistake|0|||
154984232|NCT02696031|559366332|FG003|Up to Week 104|Withdrawal by Subject|0|||
154984233|NCT02696031|559366333|FG004|Up to Week 104|Withdrawal by Subject|0|||
154984234|NCT02696031|559366334|FG005|Up to Week 104|Withdrawal by Subject|0|||
154984235|NCT02696031|559366329|FG000|Up to Week 104|Protocol Violation|1|||
154984236|NCT02696031|559366330|FG001|Up to Week 104|Protocol Violation|0|||
154984237|NCT02696031|559366331|FG002|Up to Week 104|Protocol Violation|0|||
155117896|NCT01300819|559862089|FG001|Overall Study|Safety follow up not done by mistake|1|||
154984238|NCT02696031|559366332|FG003|Up to Week 104|Protocol Violation|0|||
154984239|NCT02696031|559366333|FG004|Up to Week 104|Protocol Violation|0|||
154984240|NCT02696031|559366334|FG005|Up to Week 104|Protocol Violation|0|||
154984241|NCT02696031|559366329|FG000|Up to Week 104|Physician Decision|1|||
154984242|NCT02696031|559366330|FG001|Up to Week 104|Physician Decision|2|||
154984243|NCT02696031|559366331|FG002|Up to Week 104|Physician Decision|3|||
154984244|NCT02696031|559366332|FG003|Up to Week 104|Physician Decision|0|||
154984245|NCT02696031|559366333|FG004|Up to Week 104|Physician Decision|0|||
154984246|NCT02696031|559366334|FG005|Up to Week 104|Physician Decision|0|||
154984247|NCT02696031|559366329|FG000|Up to Week 104|Lost to Follow-up|2|||
154984248|NCT02696031|559366330|FG001|Up to Week 104|Lost to Follow-up|3|||
154910040|NCT02795182|559092081|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
154910041|NCT02795182|559092078|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
154910042|NCT02795182|559092079|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
154910043|NCT02795182|559092080|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
154910044|NCT02795182|559092081|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
154910045|NCT02795182|559092078|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
154910046|NCT02795182|559092079|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
154910047|NCT02795182|559092080|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
154910048|NCT02795182|559092081|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
154910049|NCT02795182|559092078|FG000|Overall Study|Withdrawal by Subject|4|||
154910050|NCT02795182|559092079|FG001|Overall Study|Withdrawal by Subject|0|||
154910051|NCT02795182|559092080|FG002|Overall Study|Withdrawal by Subject|0|||
154910052|NCT02795182|559092081|FG003|Overall Study|Withdrawal by Subject|3|||
154910053|NCT02795182|559092078|FG000|Overall Study|Lost to Follow-up|0|||
154910054|NCT02795182|559092079|FG001|Overall Study|Lost to Follow-up|0|||
154910055|NCT02795182|559092080|FG002|Overall Study|Lost to Follow-up|1|||
154910056|NCT02795182|559092081|FG003|Overall Study|Lost to Follow-up|1|||
154910057|NCT02795182|559092078|FG000|Overall Study|Roll Over to Long Term Extension|3|||
154910058|NCT02795182|559092079|FG001|Overall Study|Roll Over to Long Term Extension|3|||
154910059|NCT02795182|559092080|FG002|Overall Study|Roll Over to Long Term Extension|2|||
154910060|NCT02795182|559092081|FG003|Overall Study|Roll Over to Long Term Extension|5|||
154910061|NCT02795182|559092078|FG000|Overall Study|Progressive Disease|0|||
154910062|NCT02795182|559092079|FG001|Overall Study|Progressive Disease|1|||
154910063|NCT02795182|559092080|FG002|Overall Study|Progressive Disease|0|||
154910064|NCT02795182|559092081|FG003|Overall Study|Progressive Disease|4|||
154910065|NCT02795182|559092078|FG000|Overall Study|Physician Decision|0|||
154910066|NCT02795182|559092079|FG001|Overall Study|Physician Decision|0|||
154910067|NCT02795182|559092080|FG002|Overall Study|Physician Decision|0|||
154910068|NCT02795182|559092081|FG003|Overall Study|Physician Decision|1|||
154910069|NCT01108068|559092082|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
154910070|NCT01108068|559092083|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
154910071|NCT00696774|559092084|FG000|Period II|Adverse Event|0|||
154910072|NCT00696774|559092085|FG001|Period II|Adverse Event|0|||
154910073|NCT00696774|559092086|FG002|Period II|Adverse Event|15|||
154910074|NCT00696774|559092084|FG000|Period II|Lost to Follow-up|0|||
154910075|NCT00696774|559092085|FG001|Period II|Lost to Follow-up|0|||
154910076|NCT00696774|559092086|FG002|Period II|Lost to Follow-up|4|||
154910077|NCT00696774|559092084|FG000|Period II|Protocol Violation|0|||
154910078|NCT00696774|559092085|FG001|Period II|Protocol Violation|0|||
154910079|NCT00696774|559092086|FG002|Period II|Protocol Violation|11|||
154910080|NCT00696774|559092084|FG000|Period II|Withdrawal by Subject|0|||
154910081|NCT00696774|559092085|FG001|Period II|Withdrawal by Subject|0|||
154910082|NCT00696774|559092086|FG002|Period II|Withdrawal by Subject|4|||
154910083|NCT00696774|559092084|FG000|Period II|Sponsor Decision|0|||
154910084|NCT00696774|559092085|FG001|Period II|Sponsor Decision|0|||
154910085|NCT00696774|559092086|FG002|Period II|Sponsor Decision|0|||
154910086|NCT00696774|559092084|FG000|Period II|Lack of Efficacy|0|||
154910087|NCT00696774|559092085|FG001|Period II|Lack of Efficacy|0|||
154910088|NCT00696774|559092086|FG002|Period II|Lack of Efficacy|2|||
154910089|NCT00696774|559092084|FG000|Period III|Adverse Event|1|||
154910090|NCT00696774|559092085|FG001|Period III|Adverse Event|1|||
154910091|NCT00696774|559092086|FG002|Period III|Adverse Event|0|||
154910092|NCT00696774|559092084|FG000|Period III|Lost to Follow-up|2|||
154910093|NCT00696774|559092085|FG001|Period III|Lost to Follow-up|1|||
154910094|NCT00696774|559092086|FG002|Period III|Lost to Follow-up|0|||
154910095|NCT00696774|559092084|FG000|Period III|Protocol Violation|1|||
154910096|NCT00696774|559092085|FG001|Period III|Protocol Violation|1|||
154910097|NCT00696774|559092086|FG002|Period III|Protocol Violation|0|||
154910098|NCT00696774|559092084|FG000|Period III|Withdrawal by Subject|1|||
154910099|NCT00696774|559092085|FG001|Period III|Withdrawal by Subject|2|||
154910100|NCT00696774|559092086|FG002|Period III|Withdrawal by Subject|0|||
154910101|NCT00696774|559092084|FG000|Period III|Sponsor Decision|2|||
154910102|NCT00696774|559092085|FG001|Period III|Sponsor Decision|0|||
154910103|NCT00696774|559092086|FG002|Period III|Sponsor Decision|0|||
154910104|NCT00696774|559092084|FG000|Period III|Lack of Efficacy|0|||
154910105|NCT00696774|559092085|FG001|Period III|Lack of Efficacy|2|||
154910106|NCT00696774|559092086|FG002|Period III|Lack of Efficacy|0|||
154910107|NCT01021553|559092087|FG000|Overall Study|Adverse Event|1|||
154910108|NCT01021553|559092088|FG001|Overall Study|Adverse Event|0|||
154910109|NCT01021553|559092089|FG002|Overall Study|Adverse Event|0|||
154910110|NCT01021553|559092087|FG000|Overall Study|Lack of Efficacy|2|||
154910111|NCT01021553|559092088|FG001|Overall Study|Lack of Efficacy|2|||
154910112|NCT01021553|559092089|FG002|Overall Study|Lack of Efficacy|0|||
155176165|NCT01576159|560082291|FG000|Overall Study|Protocol Violation|1|||
154910113|NCT01021553|559092087|FG000|Overall Study|Protocol Violation|0|||
154910114|NCT01021553|559092088|FG001|Overall Study|Protocol Violation|2|||
155117897|NCT01300819|559862088|FG000|Overall Study|Follow up call was not done|1|||
155117898|NCT01300819|559862089|FG001|Overall Study|Follow up call was not done|0|||
155117899|NCT01444027|559862090|FG000|Overall Study|Withdrawal by Subject|4|||
155117900|NCT01444027|559862091|FG001|Overall Study|Withdrawal by Subject|10|||
155117901|NCT01444027|559862092|FG002|Overall Study|Withdrawal by Subject|24|||
155117902|NCT01444027|559862090|FG000|Overall Study|Lost to Follow-up|26|||
155117903|NCT01444027|559862091|FG001|Overall Study|Lost to Follow-up|20|||
154910115|NCT01021553|559092089|FG002|Overall Study|Protocol Violation|2|||
154910116|NCT01021553|559092087|FG000|Overall Study|Lost to Follow-up|0|||
154910117|NCT01021553|559092088|FG001|Overall Study|Lost to Follow-up|0|||
154910118|NCT01021553|559092089|FG002|Overall Study|Lost to Follow-up|1|||
154910119|NCT01021553|559092087|FG000|Overall Study|Withdrawal by Subject|1|||
154910120|NCT01021553|559092088|FG001|Overall Study|Withdrawal by Subject|1|||
154910121|NCT01021553|559092089|FG002|Overall Study|Withdrawal by Subject|0|||
154910122|NCT01950364|559092090|FG000|Overall Study|Adverse Event|3|||
154910123|NCT01950364|559092091|FG001|Overall Study|Adverse Event|0|||
154910124|NCT01950364|559092090|FG000|Overall Study|Stem Cell Transplant|2|||
154910125|NCT01950364|559092091|FG001|Overall Study|Stem Cell Transplant|6|||
154910126|NCT01950364|559092090|FG000|Overall Study|Disease Progression|5|||
154910127|NCT01950364|559092091|FG001|Overall Study|Disease Progression|2|||
154910128|NCT01950364|559092090|FG000|Overall Study|Withdrawal by Subject|0|||
154910129|NCT01950364|559092091|FG001|Overall Study|Withdrawal by Subject|1|||
154910130|NCT01950364|559092090|FG000|Overall Study|Protocol Violation|0|||
154910131|NCT01950364|559092091|FG001|Overall Study|Protocol Violation|1|||
154910132|NCT00033293|559092092|FG000|Overall Study|Death|0|||
154910133|NCT00033293|559092093|FG001|Overall Study|Death|1|||
154910134|NCT00033293|559092092|FG000|Overall Study|Lack of Efficacy|5|||
154910135|NCT00033293|559092093|FG001|Overall Study|Lack of Efficacy|8|||
154910136|NCT00033293|559092092|FG000|Overall Study|Lost to Follow-up|0|||
154910137|NCT00033293|559092093|FG001|Overall Study|Lost to Follow-up|1|||
154910138|NCT00033293|559092092|FG000|Overall Study|Physician Decision|3|||
154910139|NCT00033293|559092093|FG001|Overall Study|Physician Decision|1|||
154910140|NCT00033293|559092092|FG000|Overall Study|Withdrawal by Subject|1|||
154910141|NCT00033293|559092093|FG001|Overall Study|Withdrawal by Subject|0|||
154910142|NCT00033293|559092092|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
154910143|NCT00033293|559092093|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
154910144|NCT00033293|559092092|FG000|Overall Study|Treatment refused|0|||
154910145|NCT00033293|559092093|FG001|Overall Study|Treatment refused|6|||
154910146|NCT00935701|559092094|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
154910147|NCT00836953|559092095|FG000|Overall Study|Withdrawal by Subject|1|||
154910148|NCT00836953|559092095|FG000|Overall Study|Lost to Follow-up|1|||
154910149|NCT01200758|559092096|FG000|Stage I|Death|0|||
154910150|NCT01200758|559092097|FG001|Stage I|Death|1|||
154910151|NCT01200758|559092098|FG002|Stage I|Death|0|||
154910152|NCT01200758|559092099|FG003|Stage I|Death|0|||
154910153|NCT01200758|559092096|FG000|Stage I|Physician Decision|1|||
154910154|NCT01200758|559092097|FG001|Stage I|Physician Decision|1|||
154910155|NCT01200758|559092098|FG002|Stage I|Physician Decision|0|||
154910156|NCT01200758|559092099|FG003|Stage I|Physician Decision|0|||
154910157|NCT01200758|559092096|FG000|Stage I|Lack of Efficacy|2|||
154910158|NCT01200758|559092097|FG001|Stage I|Lack of Efficacy|1|||
154910159|NCT01200758|559092098|FG002|Stage I|Lack of Efficacy|0|||
154910160|NCT01200758|559092099|FG003|Stage I|Lack of Efficacy|0|||
154910161|NCT01200758|559092096|FG000|Stage I|Adverse Event|5|||
154910162|NCT01200758|559092097|FG001|Stage I|Adverse Event|5|||
154910163|NCT01200758|559092098|FG002|Stage I|Adverse Event|0|||
154910164|NCT01200758|559092099|FG003|Stage I|Adverse Event|0|||
154910165|NCT01200758|559092096|FG000|Stage I|Withdrawal by Subject|1|||
154910166|NCT01200758|559092097|FG001|Stage I|Withdrawal by Subject|2|||
154910167|NCT01200758|559092098|FG002|Stage I|Withdrawal by Subject|0|||
154910168|NCT01200758|559092099|FG003|Stage I|Withdrawal by Subject|0|||
154910169|NCT01200758|559092096|FG000|Stage I|Disease Progression|9|||
154910170|NCT01200758|559092097|FG001|Stage I|Disease Progression|7|||
154910171|NCT01200758|559092098|FG002|Stage I|Disease Progression|0|||
154910172|NCT01200758|559092099|FG003|Stage I|Disease Progression|0|||
154910173|NCT01200758|559092096|FG000|Stage 2|Disease Progression|0|||
154910174|NCT01200758|559092097|FG001|Stage 2|Disease Progression|0|||
154910175|NCT01200758|559092098|FG002|Stage 2|Disease Progression|16|||
154910176|NCT01200758|559092099|FG003|Stage 2|Disease Progression|21|||
154910177|NCT01200758|559092096|FG000|Stage 2|Lack of Efficacy|0|||
154910178|NCT01200758|559092097|FG001|Stage 2|Lack of Efficacy|0|||
154910179|NCT01200758|559092098|FG002|Stage 2|Lack of Efficacy|4|||
155117904|NCT01444027|559862092|FG002|Overall Study|Lost to Follow-up|14|||
155117905|NCT00840060|559863722|FG000|Overall Study|Withdrawal by Subject|1|||
154910180|NCT01200758|559092099|FG003|Stage 2|Lack of Efficacy|2|||
154910181|NCT01200758|559092096|FG000|Stage 2|Physician Decision|0|||
154910182|NCT01200758|559092097|FG001|Stage 2|Physician Decision|0|||
154910183|NCT01200758|559092098|FG002|Stage 2|Physician Decision|5|||
154910184|NCT01200758|559092099|FG003|Stage 2|Physician Decision|7|||
154910185|NCT01200758|559092096|FG000|Stage 2|Adverse Event|0|||
154910186|NCT01200758|559092097|FG001|Stage 2|Adverse Event|0|||
154910187|NCT01200758|559092098|FG002|Stage 2|Adverse Event|5|||
154910188|NCT01200758|559092099|FG003|Stage 2|Adverse Event|9|||
154910189|NCT01200758|559092096|FG000|Stage 2|Withdrawal by Subject|0|||
154910190|NCT01200758|559092097|FG001|Stage 2|Withdrawal by Subject|0|||
154910191|NCT01200758|559092098|FG002|Stage 2|Withdrawal by Subject|4|||
154910192|NCT01200758|559092099|FG003|Stage 2|Withdrawal by Subject|1|||
154910193|NCT01200758|559092096|FG000|Stage 2|Lost to Follow-up|0|||
154910194|NCT01200758|559092097|FG001|Stage 2|Lost to Follow-up|0|||
154910195|NCT01200758|559092098|FG002|Stage 2|Lost to Follow-up|3|||
154910196|NCT01200758|559092099|FG003|Stage 2|Lost to Follow-up|1|||
154910197|NCT01200758|559092096|FG000|Stage 2|Protocol Violation|0|||
154910198|NCT01200758|559092097|FG001|Stage 2|Protocol Violation|0|||
154910199|NCT01200758|559092098|FG002|Stage 2|Protocol Violation|1|||
154910200|NCT01200758|559092099|FG003|Stage 2|Protocol Violation|4|||
154910201|NCT01200758|559092096|FG000|Stage 2|Death|0|||
154910202|NCT01200758|559092097|FG001|Stage 2|Death|0|||
154910203|NCT01200758|559092098|FG002|Stage 2|Death|3|||
154910204|NCT01200758|559092099|FG003|Stage 2|Death|5|||
154910205|NCT02711553|559092100|FG000|Overall Study|Withdrawal by Subject|2|||
154910206|NCT02711553|559092101|FG001|Overall Study|Withdrawal by Subject|1|||
154910207|NCT02711553|559092102|FG002|Overall Study|Withdrawal by Subject|1|||
154910208|NCT02711553|559092103|FG003|Overall Study|Withdrawal by Subject|0|||
154910209|NCT02711553|559092100|FG000|Overall Study|Lost to Follow-up|3|||
154910210|NCT02711553|559092101|FG001|Overall Study|Lost to Follow-up|3|||
154910211|NCT02711553|559092102|FG002|Overall Study|Lost to Follow-up|6|||
154910212|NCT02711553|559092103|FG003|Overall Study|Lost to Follow-up|3|||
154910213|NCT02711553|559092100|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
154910214|NCT02711553|559092101|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
154910215|NCT02711553|559092102|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
154910216|NCT02711553|559092103|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
154910217|NCT04048876|559092106|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
154910218|NCT04048876|559092107|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
154910219|NCT04048876|559092108|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
154910220|NCT04048876|559092109|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
154910221|NCT04048876|559092106|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
154910222|NCT04048876|559092107|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
154910223|NCT04048876|559092108|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
154910224|NCT04048876|559092109|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
154910225|NCT04048876|559092106|FG000|Placebo Controlled Phase|Adverse Event|0|||
154910226|NCT04048876|559092107|FG001|Placebo Controlled Phase|Adverse Event|1|||
154910227|NCT04048876|559092108|FG002|Placebo Controlled Phase|Adverse Event|0|||
154910228|NCT04048876|559092109|FG003|Placebo Controlled Phase|Adverse Event|0|||
154910229|NCT04048876|559092106|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
154910230|NCT04048876|559092107|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
154910231|NCT04048876|559092108|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
154910232|NCT04048876|559092109|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
154910233|NCT01197794|559092110|FG000|Overall Study|Adverse Event|3|||
154910234|NCT01197794|559092111|FG001|Overall Study|Adverse Event|2|||
154910235|NCT01197794|559092112|FG002|Overall Study|Adverse Event|4|||
154910236|NCT01197794|559092113|FG003|Overall Study|Adverse Event|4|||
154910237|NCT01197794|559092114|FG004|Overall Study|Adverse Event|4|||
154910238|NCT01197794|559092115|FG005|Overall Study|Adverse Event|2|||
154910239|NCT01197794|559092116|FG006|Overall Study|Adverse Event|3|||
154910240|NCT01197794|559092110|FG000|Overall Study|Protocol Violation|0|||
154910241|NCT01197794|559092111|FG001|Overall Study|Protocol Violation|0|||
154910242|NCT01197794|559092112|FG002|Overall Study|Protocol Violation|0|||
154910243|NCT01197794|559092113|FG003|Overall Study|Protocol Violation|0|||
154910244|NCT01197794|559092114|FG004|Overall Study|Protocol Violation|2|||
154910245|NCT01197794|559092115|FG005|Overall Study|Protocol Violation|0|||
154910246|NCT01197794|559092116|FG006|Overall Study|Protocol Violation|1|||
154910247|NCT01197794|559092110|FG000|Overall Study|Development of study withdrawal criteria|3|||
154910248|NCT01197794|559092111|FG001|Overall Study|Development of study withdrawal criteria|0|||
154910249|NCT01197794|559092112|FG002|Overall Study|Development of study withdrawal criteria|0|||
154910250|NCT01197794|559092113|FG003|Overall Study|Development of study withdrawal criteria|1|||
154910251|NCT01197794|559092114|FG004|Overall Study|Development of study withdrawal criteria|0|||
154910252|NCT01197794|559092115|FG005|Overall Study|Development of study withdrawal criteria|0|||
154910253|NCT01197794|559092116|FG006|Overall Study|Development of study withdrawal criteria|1|||
154910254|NCT01197794|559092110|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
154910255|NCT01197794|559092111|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
154910256|NCT01197794|559092112|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
154910257|NCT01197794|559092113|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
154910258|NCT01197794|559092114|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
154910259|NCT01197794|559092115|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
154910260|NCT01197794|559092116|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
154910261|NCT01197794|559092110|FG000|Overall Study|Withdrawal by Subject|3|||
154910262|NCT01197794|559092111|FG001|Overall Study|Withdrawal by Subject|3|||
154910263|NCT01197794|559092112|FG002|Overall Study|Withdrawal by Subject|4|||
154910264|NCT01197794|559092113|FG003|Overall Study|Withdrawal by Subject|1|||
154910265|NCT01197794|559092114|FG004|Overall Study|Withdrawal by Subject|1|||
154910266|NCT01197794|559092115|FG005|Overall Study|Withdrawal by Subject|5|||
154910267|NCT01197794|559092116|FG006|Overall Study|Withdrawal by Subject|6|||
154910268|NCT01197794|559092110|FG000|Overall Study|Lost to Follow-up|1|||
154910269|NCT01197794|559092111|FG001|Overall Study|Lost to Follow-up|1|||
154910270|NCT01197794|559092112|FG002|Overall Study|Lost to Follow-up|0|||
154910271|NCT01197794|559092113|FG003|Overall Study|Lost to Follow-up|1|||
154910272|NCT01197794|559092114|FG004|Overall Study|Lost to Follow-up|0|||
154910273|NCT01197794|559092115|FG005|Overall Study|Lost to Follow-up|1|||
154910274|NCT01197794|559092116|FG006|Overall Study|Lost to Follow-up|0|||
154910275|NCT01197794|559092110|FG000|Overall Study|Other|1|||
154910276|NCT01197794|559092111|FG001|Overall Study|Other|1|||
154910277|NCT01197794|559092112|FG002|Overall Study|Other|3|||
154910278|NCT01197794|559092113|FG003|Overall Study|Other|0|||
154910279|NCT01197794|559092114|FG004|Overall Study|Other|2|||
154910280|NCT01197794|559092115|FG005|Overall Study|Other|2|||
154910281|NCT01197794|559092116|FG006|Overall Study|Other|4|||
154910282|NCT04055844|559092117|FG000|Overall Study|Adverse Event|12|||
154984249|NCT02696031|559366331|FG002|Up to Week 104|Lost to Follow-up|1|||
154984250|NCT02696031|559366332|FG003|Up to Week 104|Lost to Follow-up|0|||
154984251|NCT02696031|559366333|FG004|Up to Week 104|Lost to Follow-up|0|||
154984252|NCT02696031|559366334|FG005|Up to Week 104|Lost to Follow-up|0|||
155117906|NCT00840060|559863723|FG001|Overall Study|Withdrawal by Subject|0|||
155117907|NCT00840060|559863722|FG000|Overall Study|Change in emotional/behavioral status|0|||
155117908|NCT00840060|559863723|FG001|Overall Study|Change in emotional/behavioral status|1|||
155117909|NCT00428220|559863724|FG000|Overall Study|Participant died|8|||
155117910|NCT00428220|559863724|FG000|Overall Study|Global deterioration of health status|7|||
155117911|NCT00428220|559863724|FG000|Overall Study|Lost to Follow-up|4|||
155117912|NCT00428220|559863724|FG000|Overall Study|Objective progression or relapse|123|||
155117913|NCT00428220|559863724|FG000|Overall Study|Participant refused continued treatment|7|||
155117914|NCT00428220|559863724|FG000|Overall Study|Adverse Event|51|||
155117915|NCT00428220|559863724|FG000|Overall Study|Other|23|||
155117916|NCT00509093|559863725|FG000|Overall Study|Adverse Event|10|||
155117917|NCT00509093|559863725|FG000|Overall Study|Disease Progression|9|||
155117918|NCT00509093|559863725|FG000|Overall Study|Transformed into MDS|1|||
155117919|NCT00509093|559863725|FG000|Overall Study|Withdrawal by Subject|3|||
155117920|NCT00509093|559863725|FG000|Overall Study|Physician Decision|1|||
155117921|NCT01103063|559863726|FG000|Overall Study|Adverse Event|3|||
155117922|NCT01103063|559863727|FG001|Overall Study|Adverse Event|1|||
155117923|NCT01103063|559863726|FG000|Overall Study|Lost to Follow-up|68|||
155117924|NCT01103063|559863727|FG001|Overall Study|Lost to Follow-up|51|||
155117925|NCT01103063|559863726|FG000|Overall Study|Withdrawal by Subject|60|||
155117926|NCT01103063|559863727|FG001|Overall Study|Withdrawal by Subject|15|||
155117927|NCT01103063|559863726|FG000|Overall Study|Other|16|||
155117928|NCT01103063|559863727|FG001|Overall Study|Other|11|||
155117929|NCT01103063|559863726|FG000|Overall Study|Protocol Violation|1|||
155117930|NCT01103063|559863727|FG001|Overall Study|Protocol Violation|0|||
155117931|NCT01103063|559863726|FG000|Overall Study|Study terminated by Sponsor|326|||
155117932|NCT01103063|559863727|FG001|Overall Study|Study terminated by Sponsor|342|||
155117933|NCT01103063|559863726|FG000|Overall Study|Death|3|||
155117934|NCT01103063|559863727|FG001|Overall Study|Death|1|||
155117935|NCT02210832|559863736|FG000|Overall Study|Pregnancy termination .|3|||
155117936|NCT02210832|559863737|FG001|Overall Study|Pregnancy termination .|4|||
155117937|NCT02210832|559863738|FG002|Overall Study|Pregnancy termination .|1|||
155117938|NCT02210832|559863736|FG000|Overall Study|Lost to Follow-up|26|||
155117939|NCT02210832|559863737|FG001|Overall Study|Lost to Follow-up|32|||
155117940|NCT02210832|559863738|FG002|Overall Study|Lost to Follow-up|17|||
155117941|NCT00445939|559863741|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
155117942|NCT00445939|559863742|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
155117943|NCT00445939|559863743|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
155117944|NCT00445939|559863744|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
155117945|NCT00445939|559863741|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
155117946|NCT00445939|559863742|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
154984253|NCT02696031|559366329|FG000|Up to Week 104|Lack of Efficacy|13|||
155117947|NCT00445939|559863743|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
155117948|NCT00445939|559863744|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
155117949|NCT00919867|559863748|FG000|First Intervention|Withdrawal by Subject|0|||
155117950|NCT00919867|559863749|FG001|First Intervention|Withdrawal by Subject|0|||
155176166|NCT01576159|560082292|FG001|Overall Study|Protocol Violation|0|||
154910283|NCT04055844|559092117|FG000|Overall Study|Poor Performance|1|||
154910284|NCT04055844|559092117|FG000|Overall Study|Death|1|||
154984254|NCT02696031|559366330|FG001|Up to Week 104|Lack of Efficacy|12|||
155117951|NCT00919867|559863750|FG002|First Intervention|Withdrawal by Subject|1|||
155117952|NCT00919867|559863751|FG003|First Intervention|Withdrawal by Subject|0|||
155117953|NCT00919867|559863752|FG004|First Intervention|Withdrawal by Subject|0|||
155117954|NCT00919867|559863753|FG005|First Intervention|Withdrawal by Subject|0|||
155117955|NCT00919867|559863748|FG000|First Intervention|Physician Decision|0|||
155117956|NCT00919867|559863749|FG001|First Intervention|Physician Decision|0|||
155117957|NCT00919867|559863750|FG002|First Intervention|Physician Decision|0|||
155117958|NCT00919867|559863751|FG003|First Intervention|Physician Decision|0|||
155117959|NCT00919867|559863752|FG004|First Intervention|Physician Decision|0|||
155117960|NCT00919867|559863753|FG005|First Intervention|Physician Decision|1|||
155117961|NCT01069861|559863758|FG000|Overall Study|Death|1|||
155117962|NCT01069861|559863758|FG000|Overall Study|Adverse Event|1|||
155117963|NCT01069861|559863758|FG000|Overall Study|Did not meet entrance criteria|1|||
155117964|NCT03350256|559863759|FG000|Overall Study|Inclusion/exclusion violation|4|||
155117965|NCT03350256|559863759|FG000|Overall Study|Recommended for other therapies|2|||
155117966|NCT03350256|559863759|FG000|Overall Study|Protocol Violation|3|||
155117967|NCT03350256|559863759|FG000|Overall Study|Non compliance|2|||
155117968|NCT03350256|559863759|FG000|Overall Study|Denial by insurance|1|||
155117969|NCT03350256|559863759|FG000|Overall Study|Adverse Event|2|||
155117970|NCT03350256|559863759|FG000|Overall Study|Trial failure|12|||
155117971|NCT03350256|559863759|FG000|Overall Study|Did not proceed to permanent implant|3|||
155117972|NCT03350256|559863759|FG000|Overall Study|Withdrawal by Subject|3|||
155117973|NCT03350256|559863759|FG000|Overall Study|Subject moving out of state|1|||
155117974|NCT03350256|559863759|FG000|Overall Study|Lost to Follow-up|1|||
155117975|NCT03350256|559863759|FG000|Overall Study|Lack of Efficacy|2|||
155117976|NCT02680041|559863760|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
155117977|NCT02680041|559863760|FG000|Overall Study|Lost to Follow-up|2|||
155117978|NCT04979897|559863765|FG000|Overall Study|Death|1|||
155117979|NCT04979897|559863766|FG001|Overall Study|Death|8|||
155117980|NCT04979897|559863765|FG000|Overall Study|Lost to Follow-up|111|||
155117981|NCT04979897|559863766|FG001|Overall Study|Lost to Follow-up|56|||
155117982|NCT04979897|559863765|FG000|Overall Study|Withdrawal by Subject|7|||
155117983|NCT04979897|559863766|FG001|Overall Study|Withdrawal by Subject|2|||
155176167|NCT01576159|560082293|FG002|Overall Study|Protocol Violation|0|||
154984255|NCT02696031|559366331|FG002|Up to Week 104|Lack of Efficacy|11|||
154984256|NCT02696031|559366332|FG003|Up to Week 104|Lack of Efficacy|0|||
154984257|NCT02696031|559366333|FG004|Up to Week 104|Lack of Efficacy|0|||
154984258|NCT02696031|559366334|FG005|Up to Week 104|Lack of Efficacy|0|||
154984259|NCT02696031|559366329|FG000|Up to Week 104|Adverse Event|7|||
154984260|NCT02696031|559366330|FG001|Up to Week 104|Adverse Event|11|||
154984261|NCT02696031|559366331|FG002|Up to Week 104|Adverse Event|5|||
154984262|NCT02696031|559366332|FG003|Up to Week 104|Adverse Event|0|||
154984263|NCT02696031|559366333|FG004|Up to Week 104|Adverse Event|0|||
154984264|NCT02696031|559366334|FG005|Up to Week 104|Adverse Event|0|||
154984265|NCT02696031|559366329|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
154984266|NCT02696031|559366330|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
154984267|NCT02696031|559366331|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
154984268|NCT02696031|559366332|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
154984269|NCT02696031|559366333|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
154984270|NCT02696031|559366334|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
154984271|NCT02696031|559366329|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
154984272|NCT02696031|559366330|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
154984273|NCT02696031|559366331|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
154984274|NCT02696031|559366332|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
154984275|NCT02696031|559366333|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
154984276|NCT02696031|559366334|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
154984277|NCT02696031|559366329|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
154984278|NCT02696031|559366330|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
154984279|NCT02696031|559366331|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
154984280|NCT02696031|559366332|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
154984281|NCT02696031|559366333|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
154984282|NCT02696031|559366334|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
154984283|NCT02696031|559366329|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
154984284|NCT02696031|559366330|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
154984285|NCT02696031|559366331|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
154984286|NCT02696031|559366332|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
154984287|NCT02696031|559366333|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
154984288|NCT02696031|559366334|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
155117984|NCT03405935|559863767|FG000|Overall Study|Adverse Event|3|||
155117985|NCT03405935|559863767|FG000|Overall Study|Death|2|||
155117986|NCT03405935|559863767|FG000|Overall Study|Withdrawal by Subject|1|||
155117987|NCT03405935|559863767|FG000|Overall Study|Lost to Follow-up|2|||
155117988|NCT04195438|559863773|FG000|Overall Study|Withdrawal by Subject|1|||
155117989|NCT03136497|559863774|FG000|Overall Study|Screen Failure|1|||
155176168|NCT01576159|560082294|FG003|Overall Study|Protocol Violation|0|||
155176169|NCT00311584|560082295|FG000|Overall Study|Death|1|||
155117990|NCT03136497|559863775|FG001|Overall Study|Screen Failure|0|||
155117991|NCT03136497|559863776|FG002|Overall Study|Screen Failure|0|||
155117992|NCT00934947|559863777|FG000|Overall Study|Adverse Event|0|||
155117993|NCT00934947|559863778|FG001|Overall Study|Adverse Event|2|||
155117994|NCT01451931|559863794|FG000|Overall Study|Lost to Follow-up|17|||
155117995|NCT01451931|559863795|FG001|Overall Study|Lost to Follow-up|36|||
155117996|NCT01451931|559863796|FG002|Overall Study|Lost to Follow-up|21|||
155117997|NCT01451931|559863794|FG000|Overall Study|Withdrawal by Subject|16|||
155117998|NCT01451931|559863795|FG001|Overall Study|Withdrawal by Subject|22|||
154910285|NCT03457636|559092124|FG000|Overall Study|Lost to Follow-up|2|||
154910286|NCT02996500|559092125|FG000|Overall Study|Adverse Event|1|||
154910287|NCT02996500|559092126|FG001|Overall Study|Adverse Event|1|||
154910288|NCT02996500|559092127|FG002|Overall Study|Adverse Event|4|||
154910289|NCT02996500|559092128|FG003|Overall Study|Adverse Event|3|||
154910290|NCT02996500|559092129|FG004|Overall Study|Adverse Event|1|||
154910291|NCT02996500|559092130|FG005|Overall Study|Adverse Event|2|||
154910292|NCT02996500|559092125|FG000|Overall Study|Lack of Efficacy|0|||
154910293|NCT02996500|559092126|FG001|Overall Study|Lack of Efficacy|0|||
154910294|NCT02996500|559092127|FG002|Overall Study|Lack of Efficacy|0|||
154910295|NCT02996500|559092128|FG003|Overall Study|Lack of Efficacy|0|||
154910296|NCT02996500|559092129|FG004|Overall Study|Lack of Efficacy|2|||
154910297|NCT02996500|559092130|FG005|Overall Study|Lack of Efficacy|0|||
154910298|NCT02996500|559092125|FG000|Overall Study|Lost to Follow-up|1|||
154910299|NCT02996500|559092126|FG001|Overall Study|Lost to Follow-up|0|||
154910300|NCT02996500|559092127|FG002|Overall Study|Lost to Follow-up|0|||
154910301|NCT02996500|559092128|FG003|Overall Study|Lost to Follow-up|0|||
154910302|NCT02996500|559092129|FG004|Overall Study|Lost to Follow-up|0|||
154910303|NCT02996500|559092130|FG005|Overall Study|Lost to Follow-up|1|||
154910304|NCT02996500|559092125|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
154910305|NCT02996500|559092126|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
154910306|NCT02996500|559092127|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
154910307|NCT02996500|559092128|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
154910308|NCT02996500|559092129|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
154910309|NCT02996500|559092130|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
154910310|NCT02996500|559092125|FG000|Overall Study|Non-Compliance With Study Drug|0|||
154910311|NCT02996500|559092126|FG001|Overall Study|Non-Compliance With Study Drug|0|||
154910312|NCT02996500|559092127|FG002|Overall Study|Non-Compliance With Study Drug|0|||
154910313|NCT02996500|559092128|FG003|Overall Study|Non-Compliance With Study Drug|0|||
154910314|NCT02996500|559092129|FG004|Overall Study|Non-Compliance With Study Drug|0|||
154910315|NCT02996500|559092130|FG005|Overall Study|Non-Compliance With Study Drug|1|||
154910316|NCT02996500|559092125|FG000|Overall Study|Progressive Disease|1|||
154910317|NCT02996500|559092126|FG001|Overall Study|Progressive Disease|0|||
154910318|NCT02996500|559092127|FG002|Overall Study|Progressive Disease|0|||
154910319|NCT02996500|559092128|FG003|Overall Study|Progressive Disease|0|||
154910320|NCT02996500|559092129|FG004|Overall Study|Progressive Disease|0|||
154910321|NCT02996500|559092130|FG005|Overall Study|Progressive Disease|0|||
154910322|NCT02996500|559092125|FG000|Overall Study|Other|2|||
154910323|NCT02996500|559092126|FG001|Overall Study|Other|0|||
154910324|NCT02996500|559092127|FG002|Overall Study|Other|2|||
154910325|NCT02996500|559092128|FG003|Overall Study|Other|0|||
154910326|NCT02996500|559092129|FG004|Overall Study|Other|0|||
154910327|NCT02996500|559092130|FG005|Overall Study|Other|0|||
154910328|NCT02996500|559092125|FG000|Overall Study|Protocol Violation|0|||
154910329|NCT02996500|559092126|FG001|Overall Study|Protocol Violation|0|||
154910330|NCT02996500|559092127|FG002|Overall Study|Protocol Violation|0|||
154910331|NCT02996500|559092128|FG003|Overall Study|Protocol Violation|1|||
154910332|NCT02996500|559092129|FG004|Overall Study|Protocol Violation|0|||
154910333|NCT02996500|559092130|FG005|Overall Study|Protocol Violation|0|||
154910334|NCT02996500|559092125|FG000|Overall Study|Withdrawal by Subject|3|||
154910335|NCT02996500|559092126|FG001|Overall Study|Withdrawal by Subject|0|||
154910336|NCT02996500|559092127|FG002|Overall Study|Withdrawal by Subject|3|||
154910337|NCT02996500|559092128|FG003|Overall Study|Withdrawal by Subject|0|||
154910338|NCT02996500|559092129|FG004|Overall Study|Withdrawal by Subject|2|||
154910339|NCT02996500|559092130|FG005|Overall Study|Withdrawal by Subject|0|||
155117999|NCT01451931|559863796|FG002|Overall Study|Withdrawal by Subject|22|||
155118000|NCT00230282|559863801|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
154910340|NCT02187224|559092131|FG000|Overall Study|Did not show up for test day|1|||
154910341|NCT02187224|559092132|FG001|Overall Study|Did not show up for test day|0|||
154910342|NCT01347840|559092135|FG000|Overall Study|Withdrawal by Subject|1|||
154910343|NCT01010776|559092136|FG000|Main Phase|Withdrawal by Subject|14|||
154910344|NCT01010776|559092136|FG000|Main Phase|Lack of Efficacy|8|||
154910345|NCT01010776|559092136|FG000|Main Phase|Adverse Event|7|||
154910346|NCT01010776|559092136|FG000|Main Phase|Lost to Follow-up|6|||
154910347|NCT01010776|559092136|FG000|Main Phase|Non-compliance to study medication|5|||
154910348|NCT01010776|559092136|FG000|Main Phase|Selection failure|2|||
154910349|NCT01010776|559092136|FG000|Main Phase|Inform consent withdrawal|1|||
154910350|NCT01010776|559092136|FG000|Main Phase|Other|1|||
154910351|NCT01010776|559092136|FG000|Main Phase|Did not received study medication|5|||
154984289|NCT02696031|559366329|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
154984290|NCT02696031|559366330|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
154984291|NCT02696031|559366331|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
154984292|NCT02696031|559366332|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
154984293|NCT02696031|559366333|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
154984294|NCT02696031|559366334|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
154984295|NCT02696031|559366329|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
154984296|NCT02696031|559366330|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
154984297|NCT02696031|559366331|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
154984298|NCT02696031|559366332|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
154984299|NCT02696031|559366333|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
154984300|NCT02696031|559366334|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
154984301|NCT02696031|559366329|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
154984302|NCT02696031|559366330|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
154984303|NCT02696031|559366331|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
154984304|NCT02696031|559366332|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
154984305|NCT02696031|559366333|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
154984306|NCT02696031|559366334|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
154984307|NCT00597116|559366335|FG000|Overall Study|Adverse Event|2|||
154984308|NCT00597116|559366336|FG001|Overall Study|Adverse Event|1|||
154984309|NCT00597116|559366335|FG000|Overall Study|Withdrawal by Subject|0|||
154984310|NCT00597116|559366336|FG001|Overall Study|Withdrawal by Subject|2|||
154984311|NCT00597116|559366335|FG000|Overall Study|Physician Decision|0|||
154984312|NCT00597116|559366336|FG001|Overall Study|Physician Decision|1|||
154984313|NCT00597116|559366335|FG000|Overall Study|Death|0|||
154984314|NCT00597116|559366336|FG001|Overall Study|Death|1|||
154984315|NCT00597116|559366335|FG000|Overall Study|Lost to Follow-up|1|||
154984316|NCT00597116|559366336|FG001|Overall Study|Lost to Follow-up|0|||
154984317|NCT00597116|559366335|FG000|Overall Study|Progressive disease|11|||
154984318|NCT00597116|559366336|FG001|Overall Study|Progressive disease|6|||
154984319|NCT02096588|559366337|FG000|Overall Study|Lack of Efficacy|2|||
154984320|NCT02096588|559366338|FG001|Overall Study|Lack of Efficacy|0|||
154984321|NCT02096588|559366337|FG000|Overall Study|Withdrawal by Subject|0|||
154984322|NCT02096588|559366338|FG001|Overall Study|Withdrawal by Subject|1|||
154984323|NCT01258101|559366339|FG000|Overall Study|Adverse Event|5|||
154984324|NCT01258101|559366340|FG001|Overall Study|Adverse Event|6|||
154984325|NCT01258101|559366341|FG002|Overall Study|Adverse Event|0|||
154984326|NCT01258101|559366342|FG003|Overall Study|Adverse Event|0|||
154984327|NCT01258101|559366339|FG000|Overall Study|Extra exclusion criterion amended|2|||
154984328|NCT01258101|559366340|FG001|Overall Study|Extra exclusion criterion amended|1|||
154984329|NCT01258101|559366341|FG002|Overall Study|Extra exclusion criterion amended|1|||
154984330|NCT01258101|559366342|FG003|Overall Study|Extra exclusion criterion amended|1|||
154984331|NCT01258101|559366339|FG000|Overall Study|Informed consent has been withdrawn|2|||
154984332|NCT01258101|559366340|FG001|Overall Study|Informed consent has been withdrawn|2|||
154984333|NCT01258101|559366341|FG002|Overall Study|Informed consent has been withdrawn|1|||
154984334|NCT01258101|559366342|FG003|Overall Study|Informed consent has been withdrawn|1|||
154984335|NCT01258101|559366339|FG000|Overall Study|Patient is not able to attend visits|8|||
154984336|NCT01258101|559366340|FG001|Overall Study|Patient is not able to attend visits|9|||
154984337|NCT01258101|559366341|FG002|Overall Study|Patient is not able to attend visits|7|||
154984338|NCT01258101|559366342|FG003|Overall Study|Patient is not able to attend visits|6|||
155118001|NCT00230282|559863801|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
154984339|NCT01258101|559366339|FG000|Overall Study|Patient´s compliance|4|||
154984340|NCT01258101|559366340|FG001|Overall Study|Patient´s compliance|3|||
154984341|NCT01258101|559366341|FG002|Overall Study|Patient´s compliance|1|||
155118002|NCT00230282|559863801|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
155118003|NCT00230282|559863801|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
155118004|NCT01369680|559863803|FG000|Overall Study|Lost to Follow-up|0|||
155118005|NCT01369680|559863804|FG001|Overall Study|Lost to Follow-up|0|||
155118006|NCT01369680|559863805|FG002|Overall Study|Lost to Follow-up|1|||
155118007|NCT01369680|559863806|FG003|Overall Study|Lost to Follow-up|2|||
155118008|NCT01904149|559863808|FG000|Overall Study|Adverse Event|3|||
155118009|NCT01904149|559863809|FG001|Overall Study|Adverse Event|4|||
154984342|NCT01258101|559366342|FG003|Overall Study|Patient´s compliance|2|||
155118010|NCT01904149|559863810|FG002|Overall Study|Adverse Event|0|||
155118011|NCT01904149|559863811|FG003|Overall Study|Adverse Event|1|||
155118012|NCT01904149|559863812|FG004|Overall Study|Adverse Event|1|||
155118013|NCT01904149|559863813|FG005|Overall Study|Adverse Event|2|||
154984343|NCT01258101|559366339|FG000|Overall Study|Lost to Follow-up|5|||
154984344|NCT01258101|559366340|FG001|Overall Study|Lost to Follow-up|5|||
154984345|NCT01258101|559366341|FG002|Overall Study|Lost to Follow-up|0|||
154984346|NCT01258101|559366342|FG003|Overall Study|Lost to Follow-up|6|||
154984347|NCT01258101|559366339|FG000|Overall Study|PCR positive at week 24|0|||
154984348|NCT01258101|559366340|FG001|Overall Study|PCR positive at week 24|0|||
154984349|NCT01258101|559366341|FG002|Overall Study|PCR positive at week 24|0|||
154984350|NCT01258101|559366342|FG003|Overall Study|PCR positive at week 24|1|||
154984351|NCT01258101|559366339|FG000|Overall Study|Other reason|7|||
154984352|NCT01258101|559366340|FG001|Overall Study|Other reason|8|||
154984353|NCT01258101|559366341|FG002|Overall Study|Other reason|1|||
154984354|NCT01258101|559366342|FG003|Overall Study|Other reason|8|||
154984355|NCT02903238|559366343|FG000|Overall Study|Lost to Follow-up|4|||
154984356|NCT01949116|559366349|FG000|Overall Study|Death|2|||
154984357|NCT01949116|559366350|FG001|Overall Study|Death|0|||
154984358|NCT01949116|559366349|FG000|Overall Study|Lost to Follow-up|1|||
154984359|NCT01949116|559366350|FG001|Overall Study|Lost to Follow-up|3|||
154984360|NCT01949116|559366349|FG000|Overall Study|Withdrawal by Subject|5|||
154984361|NCT01949116|559366350|FG001|Overall Study|Withdrawal by Subject|3|||
154984362|NCT02556307|559366355|FG000|Overall Study|Premature treatment interruption|11|||
154910352|NCT01010776|559092136|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
154910353|NCT01010776|559092136|FG000|Extension Phase|Other|3|||
154910354|NCT03258762|559092152|FG000|Overall Study|Lost to Follow-up|0|||
154910355|NCT03258762|559092153|FG001|Overall Study|Lost to Follow-up|1|||
154910356|NCT02545049|559092154|FG000|Overall Study|Withdrawal by Subject|1|||
154910357|NCT02545049|559092155|FG001|Overall Study|Withdrawal by Subject|7|||
154910358|NCT02545049|559092154|FG000|Overall Study|Lost to Follow-up|4|||
154910359|NCT02545049|559092155|FG001|Overall Study|Lost to Follow-up|6|||
154910360|NCT02545049|559092154|FG000|Overall Study|GCP violations|37|||
154910361|NCT02545049|559092155|FG001|Overall Study|GCP violations|48|||
154910362|NCT04223778|559092160|FG000|Overall Study|Death|1|||
154910363|NCT04223778|559092161|FG001|Overall Study|Death|1|||
154910364|NCT04223778|559092160|FG000|Overall Study|Lost to Follow-up|4|||
154910365|NCT04223778|559092161|FG001|Overall Study|Lost to Follow-up|5|||
154910366|NCT04223778|559092160|FG000|Overall Study|Physician Decision|10|||
154910367|NCT04223778|559092161|FG001|Overall Study|Physician Decision|6|||
154910368|NCT04223778|559092160|FG000|Overall Study|Withdrawal by Subject|35|||
154910369|NCT04223778|559092161|FG001|Overall Study|Withdrawal by Subject|17|||
154910370|NCT04223778|559092160|FG000|Overall Study|Not Reported|7|||
154910371|NCT04223778|559092161|FG001|Overall Study|Not Reported|8|||
154910372|NCT03053180|559094378|FG000|Overall Study|Failure to Return|1|||
154910373|NCT01465958|559094382|FG000|Run-in Phase|Protocol Violation|1|||
154910374|NCT01465958|559094383|FG001|Run-in Phase|Protocol Violation|0|||
154910375|NCT01465958|559094382|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
154910376|NCT01465958|559094383|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
154910377|NCT00211536|559094386|FG000|Overall Study|Withdrawal by Subject|2|||
154910378|NCT00211536|559094387|FG001|Overall Study|Withdrawal by Subject|2|||
154910379|NCT00211536|559094386|FG000|Overall Study|Physician Decision|0|||
154910380|NCT00211536|559094387|FG001|Overall Study|Physician Decision|5|||
154910381|NCT00211536|559094386|FG000|Overall Study|Adverse Event|2|||
154910382|NCT00211536|559094387|FG001|Overall Study|Adverse Event|0|||
154910383|NCT01004861|559094388|FG000|Overall Study|Disease progression|3|||
154910384|NCT01004861|559094389|FG001|Overall Study|Disease progression|4|||
154910385|NCT01004861|559094390|FG002|Overall Study|Disease progression|5|||
154910386|NCT01004861|559094391|FG003|Overall Study|Disease progression|4|||
154910387|NCT01004861|559094392|FG004|Overall Study|Disease progression|4|||
154910388|NCT01004861|559094393|FG005|Overall Study|Disease progression|4|||
154910389|NCT01004861|559094394|FG006|Overall Study|Disease progression|5|||
154910390|NCT01004861|559094395|FG007|Overall Study|Disease progression|1|||
154910391|NCT01004861|559094396|FG008|Overall Study|Disease progression|4|||
154910392|NCT01004861|559094397|FG009|Overall Study|Disease progression|7|||
154910393|NCT01004861|559094398|FG010|Overall Study|Disease progression|6|||
154910394|NCT01004861|559094399|FG011|Overall Study|Disease progression|3|||
154910395|NCT01004861|559094400|FG012|Overall Study|Disease progression|8|||
154910396|NCT01004861|559094388|FG000|Overall Study|Physician Decision|0|||
154910397|NCT01004861|559094389|FG001|Overall Study|Physician Decision|2|||
154910398|NCT01004861|559094390|FG002|Overall Study|Physician Decision|1|||
154910399|NCT01004861|559094391|FG003|Overall Study|Physician Decision|1|||
154910400|NCT01004861|559094392|FG004|Overall Study|Physician Decision|1|||
154910401|NCT01004861|559094393|FG005|Overall Study|Physician Decision|0|||
154910402|NCT01004861|559094394|FG006|Overall Study|Physician Decision|0|||
154910403|NCT01004861|559094395|FG007|Overall Study|Physician Decision|1|||
154910404|NCT01004861|559094396|FG008|Overall Study|Physician Decision|0|||
154910405|NCT01004861|559094397|FG009|Overall Study|Physician Decision|0|||
154910406|NCT01004861|559094398|FG010|Overall Study|Physician Decision|0|||
154910407|NCT01004861|559094399|FG011|Overall Study|Physician Decision|0|||
154984363|NCT02556307|559366355|FG000|Overall Study|Lost to Follow-up|36|||
154910408|NCT01004861|559094400|FG012|Overall Study|Physician Decision|3|||
154910409|NCT01004861|559094388|FG000|Overall Study|Adverse Event|0|||
154910410|NCT01004861|559094389|FG001|Overall Study|Adverse Event|0|||
154910411|NCT01004861|559094390|FG002|Overall Study|Adverse Event|0|||
154910412|NCT01004861|559094391|FG003|Overall Study|Adverse Event|1|||
154910413|NCT01004861|559094392|FG004|Overall Study|Adverse Event|0|||
154910414|NCT01004861|559094393|FG005|Overall Study|Adverse Event|2|||
154910415|NCT01004861|559094394|FG006|Overall Study|Adverse Event|1|||
154984364|NCT02556307|559366355|FG000|Overall Study|Change to triple therapy|4|||
154984365|NCT02556307|559366355|FG000|Overall Study|Enrolled but not treated|2|||
154984366|NCT03438227|559366359|FG000|Overall Study|Withdrawal by Subject|10|||
154984367|NCT03438227|559366360|FG001|Overall Study|Withdrawal by Subject|5|||
154984368|NCT00706992|559366370|FG000|Overall Study|Study termination|5|||
154984369|NCT00706992|559366371|FG001|Overall Study|Study termination|5|||
154984370|NCT00706992|559366372|FG002|Overall Study|Study termination|6|||
154984371|NCT00706992|559366373|FG003|Overall Study|Study termination|2|||
154984372|NCT00706992|559366374|FG004|Overall Study|Study termination|3|||
154984373|NCT00706992|559366375|FG005|Overall Study|Study termination|2|||
154984374|NCT00706992|559366376|FG006|Overall Study|Study termination|3|||
154984375|NCT00706992|559366370|FG000|Overall Study|Disease progression before treatment|0|||
154984376|NCT00706992|559366371|FG001|Overall Study|Disease progression before treatment|0|||
155118014|NCT01904149|559863808|FG000|Overall Study|Lack of Efficacy|0|||
154984377|NCT00706992|559366372|FG002|Overall Study|Disease progression before treatment|0|||
154984378|NCT00706992|559366373|FG003|Overall Study|Disease progression before treatment|0|||
154984379|NCT00706992|559366374|FG004|Overall Study|Disease progression before treatment|1|||
154984380|NCT00706992|559366375|FG005|Overall Study|Disease progression before treatment|0|||
154984381|NCT00706992|559366376|FG006|Overall Study|Disease progression before treatment|0|||
154984382|NCT01244061|559366385|FG000|Overall Study|Death|1|||
154984383|NCT01244061|559366386|FG001|Overall Study|Death|0|||
154984384|NCT01244061|559366385|FG000|Overall Study|Did not meet entrance criteria|1|||
154984385|NCT01244061|559366386|FG001|Overall Study|Did not meet entrance criteria|0|||
154984386|NCT01244061|559366385|FG000|Overall Study|Lack of Efficacy|1|||
154984387|NCT01244061|559366386|FG001|Overall Study|Lack of Efficacy|3|||
154984388|NCT01244061|559366385|FG000|Overall Study|Lost to Follow-up|34|||
154984389|NCT01244061|559366386|FG001|Overall Study|Lost to Follow-up|30|||
154984390|NCT01244061|559366385|FG000|Overall Study|Withdrawal by Subject|29|||
154984391|NCT01244061|559366386|FG001|Overall Study|Withdrawal by Subject|46|||
154984392|NCT01244061|559366385|FG000|Overall Study|Other|8|||
154984393|NCT01244061|559366386|FG001|Overall Study|Other|19|||
154984394|NCT01244061|559366385|FG000|Overall Study|Protocol Violation|1|||
154984395|NCT01244061|559366386|FG001|Overall Study|Protocol Violation|1|||
154984396|NCT01244061|559366385|FG000|Overall Study|Adverse Event|5|||
154984397|NCT01244061|559366386|FG001|Overall Study|Adverse Event|2|||
154984398|NCT01244061|559366385|FG000|Overall Study|Randomized but not treated|2|||
154984399|NCT01244061|559366386|FG001|Overall Study|Randomized but not treated|2|||
154984400|NCT03166124|559366387|FG000|Treatment Period 1|Adverse Event|0|||
154984401|NCT03166124|559366388|FG001|Treatment Period 1|Adverse Event|0|||
154984402|NCT03166124|559366389|FG002|Treatment Period 1|Adverse Event|1|||
154984403|NCT03166124|559366390|FG003|Treatment Period 1|Adverse Event|0|||
154984404|NCT03166124|559366387|FG000|Wash-out Period|Withdrawal by Subject|0|||
154984405|NCT03166124|559366388|FG001|Wash-out Period|Withdrawal by Subject|1|||
154984406|NCT03166124|559366389|FG002|Wash-out Period|Withdrawal by Subject|0|||
154984407|NCT03166124|559366390|FG003|Wash-out Period|Withdrawal by Subject|1|||
154984408|NCT03166124|559366387|FG000|Wash-out Period|Adverse Event|0|||
154984409|NCT03166124|559366388|FG001|Wash-out Period|Adverse Event|1|||
154984410|NCT03166124|559366389|FG002|Wash-out Period|Adverse Event|1|||
154984411|NCT03166124|559366390|FG003|Wash-out Period|Adverse Event|0|||
154984412|NCT03487848|559366395|FG000|Overall Study|Lost to Follow-up|1|||
154984413|NCT06029959|559368820|FG000|Overall Study|Physician Decision|6|||
154984414|NCT04495283|559368821|FG000|Overall Study|Physician Decision|0|||
154984415|NCT04495283|559368822|FG001|Overall Study|Physician Decision|0|||
154984416|NCT04495283|559368823|FG002|Overall Study|Physician Decision|1|||
154984417|NCT04495283|559368821|FG000|Overall Study|Withdrawal by Subject|0|||
154984418|NCT04495283|559368822|FG001|Overall Study|Withdrawal by Subject|1|||
154984419|NCT04495283|559368823|FG002|Overall Study|Withdrawal by Subject|1|||
154984420|NCT04495283|559368821|FG000|Overall Study|Other|1|||
154984421|NCT04495283|559368822|FG001|Overall Study|Other|0|||
155118015|NCT01904149|559863809|FG001|Overall Study|Lack of Efficacy|3|||
155118016|NCT01904149|559863810|FG002|Overall Study|Lack of Efficacy|1|||
155118017|NCT01904149|559863811|FG003|Overall Study|Lack of Efficacy|3|||
155118018|NCT01904149|559863812|FG004|Overall Study|Lack of Efficacy|3|||
154984422|NCT04495283|559368823|FG002|Overall Study|Other|1|||
154984423|NCT04718194|559368828|FG000|Overall Study|Withdrawal by Subject|3|||
154984424|NCT04718194|559368829|FG001|Overall Study|Withdrawal by Subject|0|||
154984425|NCT04718194|559368828|FG000|Overall Study|Lost to Follow-up|3|||
154984426|NCT04718194|559368829|FG001|Overall Study|Lost to Follow-up|0|||
154984427|NCT01215513|559368830|FG000|Overall Study|Not completed CS42|9|||
154984428|NCT01215513|559368830|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
154984429|NCT01215513|559368830|FG000|Overall Study|Adverse event (CS42A)|2|||
154984430|NCT01215513|559368830|FG000|Overall Study|Physician decision (CS42A)|6|||
154984431|NCT01215513|559368830|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
154984432|NCT01215513|559368830|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
154984433|NCT00158756|559368831|FG000|Overall Study|Withdrawal by Subject|5|||
154984434|NCT00158756|559368832|FG001|Overall Study|Withdrawal by Subject|0|||
154984435|NCT00158756|559368833|FG002|Overall Study|Withdrawal by Subject|6|||
154984436|NCT00158756|559368834|FG003|Overall Study|Withdrawal by Subject|1|||
155118019|NCT01904149|559863813|FG005|Overall Study|Lack of Efficacy|1|||
154984437|NCT00158756|559368835|FG004|Overall Study|Withdrawal by Subject|3|||
154984438|NCT00158756|559368831|FG000|Overall Study|Adverse Event|0|||
154984439|NCT00158756|559368832|FG001|Overall Study|Adverse Event|0|||
154984440|NCT00158756|559368833|FG002|Overall Study|Adverse Event|1|||
154984441|NCT00158756|559368834|FG003|Overall Study|Adverse Event|0|||
154984442|NCT00158756|559368835|FG004|Overall Study|Adverse Event|0|||
154984443|NCT00158756|559368831|FG000|Overall Study|Serious adverse event|0|||
154984444|NCT00158756|559368832|FG001|Overall Study|Serious adverse event|0|||
154984445|NCT00158756|559368833|FG002|Overall Study|Serious adverse event|1|||
154984446|NCT00158756|559368834|FG003|Overall Study|Serious adverse event|0|||
154984447|NCT00158756|559368835|FG004|Overall Study|Serious adverse event|0|||
154984448|NCT01553747|559368837|FG000|Overall Study|Protocol Violation|0|||
154984449|NCT01553747|559368838|FG001|Overall Study|Protocol Violation|2|||
154984450|NCT01553747|559368839|FG002|Overall Study|Protocol Violation|0|||
154984451|NCT01553747|559368837|FG000|Overall Study|Voluntarily withdrew|70|||
154984452|NCT01553747|559368838|FG001|Overall Study|Voluntarily withdrew|66|||
154984453|NCT01553747|559368839|FG002|Overall Study|Voluntarily withdrew|74|||
154984454|NCT01553747|559368837|FG000|Overall Study|Adverse event or SAE|32|||
154984455|NCT01553747|559368838|FG001|Overall Study|Adverse event or SAE|28|||
154984456|NCT01553747|559368839|FG002|Overall Study|Adverse event or SAE|19|||
154984457|NCT01553747|559368837|FG000|Overall Study|Physician decision: other|10|||
154984458|NCT01553747|559368838|FG001|Overall Study|Physician decision: other|8|||
154984459|NCT01553747|559368839|FG002|Overall Study|Physician decision: other|7|||
154984460|NCT01553747|559368837|FG000|Overall Study|Lost to Follow-up|11|||
154984461|NCT01553747|559368838|FG001|Overall Study|Lost to Follow-up|5|||
154984462|NCT01553747|559368839|FG002|Overall Study|Lost to Follow-up|6|||
154984463|NCT01553747|559368837|FG000|Overall Study|Sponsor decision, specify|7|||
154984464|NCT01553747|559368838|FG001|Overall Study|Sponsor decision, specify|5|||
154984465|NCT01553747|559368839|FG002|Overall Study|Sponsor decision, specify|0|||
154984466|NCT01553747|559368837|FG000|Overall Study|Physician decision: lack of efficacy|1|||
154984467|NCT01553747|559368838|FG001|Overall Study|Physician decision: lack of efficacy|5|||
154984468|NCT01553747|559368839|FG002|Overall Study|Physician decision: lack of efficacy|3|||
154984469|NCT00102687|559368840|FG000|Initial Period|Withdrawal by Subject|6|||
154984470|NCT00102687|559368841|FG001|Initial Period|Withdrawal by Subject|3|||
154984471|NCT00102687|559368842|FG002|Initial Period|Withdrawal by Subject|5|||
154984472|NCT00102687|559368843|FG003|Initial Period|Withdrawal by Subject|0|||
154984473|NCT00102687|559368844|FG004|Initial Period|Withdrawal by Subject|0|||
154984474|NCT00102687|559368840|FG000|Initial Period|Adverse Event|4|||
154984475|NCT00102687|559368841|FG001|Initial Period|Adverse Event|7|||
154984476|NCT00102687|559368842|FG002|Initial Period|Adverse Event|9|||
154984477|NCT00102687|559368843|FG003|Initial Period|Adverse Event|0|||
154984478|NCT00102687|559368844|FG004|Initial Period|Adverse Event|0|||
154984479|NCT00102687|559368840|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
154984480|NCT00102687|559368841|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
154984481|NCT00102687|559368842|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
154984482|NCT00102687|559368843|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
154984483|NCT00102687|559368844|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
154984484|NCT00102687|559368840|FG000|Initial Period|Protocol Violation|0|||
154984485|NCT00102687|559368841|FG001|Initial Period|Protocol Violation|0|||
154984486|NCT00102687|559368842|FG002|Initial Period|Protocol Violation|2|||
154984487|NCT00102687|559368843|FG003|Initial Period|Protocol Violation|0|||
154984488|NCT00102687|559368844|FG004|Initial Period|Protocol Violation|0|||
154984489|NCT00102687|559368840|FG000|Initial Period|Physician Decision|2|||
154984490|NCT00102687|559368841|FG001|Initial Period|Physician Decision|9|||
154984491|NCT00102687|559368842|FG002|Initial Period|Physician Decision|6|||
154984492|NCT00102687|559368843|FG003|Initial Period|Physician Decision|0|||
154984493|NCT00102687|559368844|FG004|Initial Period|Physician Decision|0|||
154984494|NCT00102687|559368840|FG000|Initial Period|Sponsor's decision|0|||
154984495|NCT00102687|559368841|FG001|Initial Period|Sponsor's decision|1|||
154984496|NCT00102687|559368842|FG002|Initial Period|Sponsor's decision|1|||
154984497|NCT00102687|559368843|FG003|Initial Period|Sponsor's decision|0|||
154984498|NCT00102687|559368844|FG004|Initial Period|Sponsor's decision|0|||
154984499|NCT00102687|559368840|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
154984500|NCT00102687|559368841|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
154984501|NCT00102687|559368842|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
154984502|NCT00102687|559368843|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
154984503|NCT00102687|559368844|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
154984504|NCT00102687|559368840|FG000|Initial Period|Death|1|||
155118020|NCT01904149|559863808|FG000|Overall Study|Withdrawal by Subject|1|||
155118021|NCT01904149|559863809|FG001|Overall Study|Withdrawal by Subject|3|||
154984505|NCT00102687|559368841|FG001|Initial Period|Death|1|||
154984506|NCT00102687|559368842|FG002|Initial Period|Death|1|||
154984507|NCT00102687|559368843|FG003|Initial Period|Death|0|||
154984508|NCT00102687|559368844|FG004|Initial Period|Death|0|||
154984509|NCT00102687|559368840|FG000|Maintenance Period|Withdrawal by Subject|4|||
154984510|NCT00102687|559368841|FG001|Maintenance Period|Withdrawal by Subject|0|||
154910416|NCT01004861|559094395|FG007|Overall Study|Adverse Event|1|||
154910417|NCT01004861|559094396|FG008|Overall Study|Adverse Event|13|||
154910418|NCT01004861|559094397|FG009|Overall Study|Adverse Event|1|||
154910419|NCT01004861|559094398|FG010|Overall Study|Adverse Event|1|||
154910420|NCT01004861|559094399|FG011|Overall Study|Adverse Event|0|||
154910421|NCT01004861|559094400|FG012|Overall Study|Adverse Event|2|||
154910422|NCT01004861|559094388|FG000|Overall Study|Protocol Violation|0|||
154910423|NCT01004861|559094389|FG001|Overall Study|Protocol Violation|0|||
154910424|NCT01004861|559094390|FG002|Overall Study|Protocol Violation|0|||
154910425|NCT01004861|559094391|FG003|Overall Study|Protocol Violation|0|||
154910426|NCT01004861|559094392|FG004|Overall Study|Protocol Violation|1|||
154910427|NCT01004861|559094393|FG005|Overall Study|Protocol Violation|0|||
154910428|NCT01004861|559094394|FG006|Overall Study|Protocol Violation|0|||
154910429|NCT01004861|559094395|FG007|Overall Study|Protocol Violation|0|||
154910430|NCT01004861|559094396|FG008|Overall Study|Protocol Violation|0|||
154910431|NCT01004861|559094397|FG009|Overall Study|Protocol Violation|0|||
154910432|NCT01004861|559094398|FG010|Overall Study|Protocol Violation|0|||
154910433|NCT01004861|559094399|FG011|Overall Study|Protocol Violation|0|||
154910434|NCT01004861|559094400|FG012|Overall Study|Protocol Violation|0|||
154910435|NCT01004861|559094388|FG000|Overall Study|Lost to Follow-up|0|||
154910436|NCT01004861|559094389|FG001|Overall Study|Lost to Follow-up|0|||
154910437|NCT01004861|559094390|FG002|Overall Study|Lost to Follow-up|0|||
154910438|NCT01004861|559094391|FG003|Overall Study|Lost to Follow-up|0|||
154910439|NCT01004861|559094392|FG004|Overall Study|Lost to Follow-up|0|||
154910440|NCT01004861|559094393|FG005|Overall Study|Lost to Follow-up|0|||
154910441|NCT01004861|559094394|FG006|Overall Study|Lost to Follow-up|0|||
154910442|NCT01004861|559094395|FG007|Overall Study|Lost to Follow-up|1|||
154910443|NCT01004861|559094396|FG008|Overall Study|Lost to Follow-up|3|||
154910444|NCT01004861|559094397|FG009|Overall Study|Lost to Follow-up|0|||
154910445|NCT01004861|559094398|FG010|Overall Study|Lost to Follow-up|0|||
154910446|NCT01004861|559094399|FG011|Overall Study|Lost to Follow-up|1|||
154910447|NCT01004861|559094400|FG012|Overall Study|Lost to Follow-up|0|||
154910448|NCT01004861|559094388|FG000|Overall Study|Non-compliance|0|||
154910449|NCT01004861|559094389|FG001|Overall Study|Non-compliance|0|||
154910450|NCT01004861|559094390|FG002|Overall Study|Non-compliance|0|||
154910451|NCT01004861|559094391|FG003|Overall Study|Non-compliance|0|||
154910452|NCT01004861|559094392|FG004|Overall Study|Non-compliance|0|||
154910453|NCT01004861|559094393|FG005|Overall Study|Non-compliance|0|||
154910454|NCT01004861|559094394|FG006|Overall Study|Non-compliance|0|||
154910455|NCT01004861|559094395|FG007|Overall Study|Non-compliance|0|||
154910456|NCT01004861|559094396|FG008|Overall Study|Non-compliance|5|||
154910457|NCT01004861|559094397|FG009|Overall Study|Non-compliance|0|||
154910458|NCT01004861|559094398|FG010|Overall Study|Non-compliance|0|||
154910459|NCT01004861|559094399|FG011|Overall Study|Non-compliance|0|||
154910460|NCT01004861|559094400|FG012|Overall Study|Non-compliance|1|||
154910461|NCT01004861|559094388|FG000|Overall Study|Other|0|||
154910462|NCT01004861|559094389|FG001|Overall Study|Other|0|||
154910463|NCT01004861|559094390|FG002|Overall Study|Other|0|||
154910464|NCT01004861|559094391|FG003|Overall Study|Other|0|||
154910465|NCT01004861|559094392|FG004|Overall Study|Other|0|||
154910466|NCT01004861|559094393|FG005|Overall Study|Other|0|||
154910467|NCT01004861|559094394|FG006|Overall Study|Other|0|||
154910468|NCT01004861|559094395|FG007|Overall Study|Other|0|||
154910469|NCT01004861|559094396|FG008|Overall Study|Other|0|||
154910470|NCT01004861|559094397|FG009|Overall Study|Other|2|||
154910471|NCT01004861|559094398|FG010|Overall Study|Other|1|||
154910472|NCT01004861|559094399|FG011|Overall Study|Other|2|||
154910473|NCT01004861|559094400|FG012|Overall Study|Other|3|||
154910474|NCT01004861|559094388|FG000|Overall Study|Patient decision|0|||
154910475|NCT01004861|559094389|FG001|Overall Study|Patient decision|0|||
154910476|NCT01004861|559094390|FG002|Overall Study|Patient decision|0|||
154910477|NCT01004861|559094391|FG003|Overall Study|Patient decision|0|||
154910478|NCT01004861|559094392|FG004|Overall Study|Patient decision|1|||
154910479|NCT01004861|559094393|FG005|Overall Study|Patient decision|0|||
154910480|NCT01004861|559094394|FG006|Overall Study|Patient decision|1|||
154910481|NCT01004861|559094395|FG007|Overall Study|Patient decision|0|||
154910482|NCT01004861|559094396|FG008|Overall Study|Patient decision|7|||
154910483|NCT01004861|559094397|FG009|Overall Study|Patient decision|1|||
154910484|NCT01004861|559094398|FG010|Overall Study|Patient decision|1|||
154910485|NCT01004861|559094399|FG011|Overall Study|Patient decision|2|||
154910486|NCT01004861|559094400|FG012|Overall Study|Patient decision|3|||
154910487|NCT01004861|559094388|FG000|Overall Study|Transitioned to Phase 4 study|0|||
154910488|NCT01004861|559094389|FG001|Overall Study|Transitioned to Phase 4 study|0|||
154910489|NCT01004861|559094390|FG002|Overall Study|Transitioned to Phase 4 study|0|||
154910490|NCT01004861|559094391|FG003|Overall Study|Transitioned to Phase 4 study|0|||
154910491|NCT01004861|559094392|FG004|Overall Study|Transitioned to Phase 4 study|0|||
154910492|NCT01004861|559094393|FG005|Overall Study|Transitioned to Phase 4 study|0|||
154910493|NCT01004861|559094394|FG006|Overall Study|Transitioned to Phase 4 study|0|||
154910494|NCT01004861|559094395|FG007|Overall Study|Transitioned to Phase 4 study|0|||
154910495|NCT01004861|559094396|FG008|Overall Study|Transitioned to Phase 4 study|2|||
154910496|NCT01004861|559094397|FG009|Overall Study|Transitioned to Phase 4 study|0|||
155118022|NCT01904149|559863810|FG002|Overall Study|Withdrawal by Subject|1|||
154910497|NCT01004861|559094398|FG010|Overall Study|Transitioned to Phase 4 study|0|||
154910498|NCT01004861|559094399|FG011|Overall Study|Transitioned to Phase 4 study|0|||
154910499|NCT01004861|559094400|FG012|Overall Study|Transitioned to Phase 4 study|0|||
154910500|NCT01004861|559094388|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910501|NCT01004861|559094389|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910502|NCT01004861|559094390|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910503|NCT01004861|559094391|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910504|NCT01004861|559094392|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910505|NCT01004861|559094393|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910506|NCT01004861|559094394|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910507|NCT01004861|559094395|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910508|NCT01004861|559094396|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
154910509|NCT01004861|559094397|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910510|NCT01004861|559094398|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910511|NCT01004861|559094399|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910512|NCT01004861|559094400|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
154910513|NCT01004861|559094388|FG000|Overall Study|Patient withdrew|0|||
154910514|NCT01004861|559094389|FG001|Overall Study|Patient withdrew|0|||
154910515|NCT01004861|559094390|FG002|Overall Study|Patient withdrew|0|||
154910516|NCT01004861|559094391|FG003|Overall Study|Patient withdrew|0|||
154910517|NCT01004861|559094392|FG004|Overall Study|Patient withdrew|0|||
154910518|NCT01004861|559094393|FG005|Overall Study|Patient withdrew|0|||
154910519|NCT01004861|559094394|FG006|Overall Study|Patient withdrew|0|||
154910520|NCT01004861|559094395|FG007|Overall Study|Patient withdrew|0|||
154910521|NCT01004861|559094396|FG008|Overall Study|Patient withdrew|1|||
154910522|NCT01004861|559094397|FG009|Overall Study|Patient withdrew|0|||
154910523|NCT01004861|559094398|FG010|Overall Study|Patient withdrew|0|||
154910524|NCT01004861|559094399|FG011|Overall Study|Patient withdrew|0|||
154910525|NCT01004861|559094400|FG012|Overall Study|Patient withdrew|0|||
154910526|NCT01004861|559094388|FG000|Overall Study|Surgical resection|0|||
154910527|NCT01004861|559094389|FG001|Overall Study|Surgical resection|0|||
154910528|NCT01004861|559094390|FG002|Overall Study|Surgical resection|0|||
154910529|NCT01004861|559094391|FG003|Overall Study|Surgical resection|0|||
154910530|NCT01004861|559094392|FG004|Overall Study|Surgical resection|0|||
154910531|NCT01004861|559094393|FG005|Overall Study|Surgical resection|0|||
154910532|NCT01004861|559094394|FG006|Overall Study|Surgical resection|0|||
154910533|NCT01004861|559094395|FG007|Overall Study|Surgical resection|0|||
154910534|NCT01004861|559094396|FG008|Overall Study|Surgical resection|1|||
154910535|NCT01004861|559094397|FG009|Overall Study|Surgical resection|0|||
154910536|NCT01004861|559094398|FG010|Overall Study|Surgical resection|0|||
154910537|NCT01004861|559094399|FG011|Overall Study|Surgical resection|0|||
154910538|NCT01004861|559094400|FG012|Overall Study|Surgical resection|0|||
154910539|NCT01004861|559094388|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910540|NCT01004861|559094389|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910541|NCT01004861|559094390|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910542|NCT01004861|559094391|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910543|NCT01004861|559094392|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910544|NCT01004861|559094393|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910545|NCT01004861|559094394|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910546|NCT01004861|559094395|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910547|NCT01004861|559094396|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
154910548|NCT01004861|559094397|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910549|NCT01004861|559094398|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910550|NCT01004861|559094399|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910551|NCT01004861|559094400|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
154910552|NCT01004861|559094388|FG000|Overall Study|Study termination by Sponsor|0|||
154910553|NCT01004861|559094389|FG001|Overall Study|Study termination by Sponsor|0|||
154910554|NCT01004861|559094390|FG002|Overall Study|Study termination by Sponsor|0|||
154910555|NCT01004861|559094391|FG003|Overall Study|Study termination by Sponsor|0|||
154910556|NCT01004861|559094392|FG004|Overall Study|Study termination by Sponsor|0|||
154984511|NCT00102687|559368842|FG002|Maintenance Period|Withdrawal by Subject|2|||
154984512|NCT00102687|559368843|FG003|Maintenance Period|Withdrawal by Subject|3|||
155118023|NCT01904149|559863811|FG003|Overall Study|Withdrawal by Subject|0|||
154984513|NCT00102687|559368844|FG004|Maintenance Period|Withdrawal by Subject|1|||
154984514|NCT00102687|559368840|FG000|Maintenance Period|Adverse Event|1|||
154984515|NCT00102687|559368841|FG001|Maintenance Period|Adverse Event|0|||
154984516|NCT00102687|559368842|FG002|Maintenance Period|Adverse Event|0|||
154984517|NCT00102687|559368843|FG003|Maintenance Period|Adverse Event|1|||
154984518|NCT00102687|559368844|FG004|Maintenance Period|Adverse Event|3|||
154984519|NCT00102687|559368840|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
154984520|NCT00102687|559368841|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
154984521|NCT00102687|559368842|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
154984522|NCT00102687|559368843|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
154984523|NCT00102687|559368844|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
154984524|NCT00102687|559368840|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
154984525|NCT00102687|559368841|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
154984526|NCT00102687|559368842|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
154984527|NCT00102687|559368843|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
154984528|NCT00102687|559368844|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
154984529|NCT00102687|559368840|FG000|Maintenance Period|Death|0|||
154984530|NCT00102687|559368841|FG001|Maintenance Period|Death|0|||
154984531|NCT00102687|559368842|FG002|Maintenance Period|Death|0|||
154984532|NCT00102687|559368843|FG003|Maintenance Period|Death|1|||
154984533|NCT00102687|559368844|FG004|Maintenance Period|Death|1|||
154984534|NCT00102687|559368840|FG000|Maintenance Period|Physician Decision|1|||
154984535|NCT00102687|559368841|FG001|Maintenance Period|Physician Decision|2|||
154984536|NCT00102687|559368842|FG002|Maintenance Period|Physician Decision|3|||
154984537|NCT00102687|559368843|FG003|Maintenance Period|Physician Decision|0|||
154984538|NCT00102687|559368844|FG004|Maintenance Period|Physician Decision|4|||
154984539|NCT00063882|559368848|FG000|Overall Study|Protocol Violation|3|||
154984540|NCT00063882|559368849|FG001|Overall Study|Protocol Violation|3|||
154984541|NCT00063882|559368848|FG000|Overall Study|Withdrawal by Subject|2|||
154984542|NCT00063882|559368849|FG001|Overall Study|Withdrawal by Subject|1|||
154984543|NCT00700817|559368850|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
154984544|NCT00700817|559368851|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
154984545|NCT00700817|559368852|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
154984546|NCT00700817|559368853|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
154984547|NCT00700817|559368854|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
154984548|NCT00700817|559368850|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
154984549|NCT00700817|559368851|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
154984550|NCT00700817|559368852|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
154984551|NCT00700817|559368853|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
154984552|NCT00700817|559368854|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
154984553|NCT00700817|559368850|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
154984554|NCT00700817|559368851|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
154984555|NCT00700817|559368852|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
154984556|NCT00700817|559368853|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
154984557|NCT00700817|559368854|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
154984558|NCT00700817|559368850|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
154984559|NCT00700817|559368851|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
154984560|NCT00700817|559368852|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
154984561|NCT00700817|559368853|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
154984562|NCT00700817|559368854|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
154984563|NCT00700817|559368850|FG000|Week 0-26 (Main Period)|Unclassified|14|||
154984564|NCT00700817|559368851|FG001|Week 0-26 (Main Period)|Unclassified|4|||
154984565|NCT00700817|559368852|FG002|Week 0-26 (Main Period)|Unclassified|8|||
154984566|NCT00700817|559368853|FG003|Week 0-26 (Main Period)|Unclassified|0|||
154984567|NCT00700817|559368854|FG004|Week 0-26 (Main Period)|Unclassified|0|||
155118024|NCT01904149|559863812|FG004|Overall Study|Withdrawal by Subject|1|||
155118025|NCT01904149|559863813|FG005|Overall Study|Withdrawal by Subject|0|||
155118026|NCT01904149|559863808|FG000|Overall Study|Protocol Violation|0|||
155118027|NCT01904149|559863809|FG001|Overall Study|Protocol Violation|1|||
155118028|NCT01904149|559863810|FG002|Overall Study|Protocol Violation|0|||
155118029|NCT01904149|559863811|FG003|Overall Study|Protocol Violation|0|||
155118030|NCT01904149|559863812|FG004|Overall Study|Protocol Violation|0|||
155118031|NCT01904149|559863813|FG005|Overall Study|Protocol Violation|0|||
155118032|NCT01904149|559863808|FG000|Overall Study|non compliance with study drug|1|||
155118033|NCT01904149|559863809|FG001|Overall Study|non compliance with study drug|0|||
155118034|NCT01904149|559863810|FG002|Overall Study|non compliance with study drug|0|||
155118035|NCT01904149|559863811|FG003|Overall Study|non compliance with study drug|0|||
154984568|NCT00700817|559368850|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
154984569|NCT00700817|559368851|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
154984570|NCT00700817|559368852|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
154984571|NCT00700817|559368853|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
154984572|NCT00700817|559368854|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
154984573|NCT00700817|559368850|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
154984574|NCT00700817|559368851|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
155118036|NCT01904149|559863812|FG004|Overall Study|non compliance with study drug|0|||
155118037|NCT01904149|559863813|FG005|Overall Study|non compliance with study drug|0|||
155118038|NCT00812006|559863814|FG000|Overall Study|Lost to Follow-up|0|||
155118039|NCT00812006|559863815|FG001|Overall Study|Lost to Follow-up|0|||
155118040|NCT00812006|559863816|FG002|Overall Study|Lost to Follow-up|2|||
155118041|NCT00812006|559863814|FG000|Overall Study|Physician Decision|0|||
155118042|NCT00812006|559863815|FG001|Overall Study|Physician Decision|0|||
155118043|NCT00812006|559863816|FG002|Overall Study|Physician Decision|1|||
155118044|NCT00812006|559863814|FG000|Overall Study|Withdrawal by Subject|2|||
155118045|NCT00812006|559863815|FG001|Overall Study|Withdrawal by Subject|1|||
155118046|NCT00812006|559863816|FG002|Overall Study|Withdrawal by Subject|1|||
155118047|NCT00812006|559863814|FG000|Overall Study|Lack of Qualifying Event|4|||
155118048|NCT00812006|559863815|FG001|Overall Study|Lack of Qualifying Event|2|||
154910557|NCT01004861|559094393|FG005|Overall Study|Study termination by Sponsor|0|||
154910558|NCT01004861|559094394|FG006|Overall Study|Study termination by Sponsor|0|||
154910559|NCT01004861|559094395|FG007|Overall Study|Study termination by Sponsor|0|||
154910560|NCT01004861|559094396|FG008|Overall Study|Study termination by Sponsor|1|||
154910561|NCT01004861|559094397|FG009|Overall Study|Study termination by Sponsor|0|||
154910562|NCT01004861|559094398|FG010|Overall Study|Study termination by Sponsor|0|||
154910563|NCT01004861|559094399|FG011|Overall Study|Study termination by Sponsor|0|||
154910564|NCT01004861|559094400|FG012|Overall Study|Study termination by Sponsor|0|||
154910565|NCT04610827|559094402|FG000|Overall Study|Withdrawal by Subject|1|||
154910566|NCT04610827|559094403|FG001|Overall Study|Withdrawal by Subject|1|||
154910567|NCT04610827|559094404|FG002|Overall Study|Withdrawal by Subject|0|||
154910568|NCT01693562|559094405|FG000|Escalation Phase|Withdrawal by Subject|0|||
154910569|NCT01693562|559094406|FG001|Escalation Phase|Withdrawal by Subject|1|||
154910570|NCT01693562|559094407|FG002|Escalation Phase|Withdrawal by Subject|0|||
154910571|NCT01693562|559094408|FG003|Escalation Phase|Withdrawal by Subject|0|||
154910572|NCT01693562|559094409|FG004|Escalation Phase|Withdrawal by Subject|0|||
154910573|NCT01693562|559094410|FG005|Escalation Phase|Withdrawal by Subject|2|||
154910574|NCT01693562|559094411|FG006|Escalation Phase|Withdrawal by Subject|0|||
154910575|NCT01693562|559094412|FG007|Escalation Phase|Withdrawal by Subject|0|||
154910576|NCT01693562|559094413|FG008|Escalation Phase|Withdrawal by Subject|0|||
154910577|NCT01693562|559094414|FG009|Escalation Phase|Withdrawal by Subject|0|||
154910578|NCT01693562|559094415|FG010|Escalation Phase|Withdrawal by Subject|0|||
154910579|NCT01693562|559094416|FG011|Escalation Phase|Withdrawal by Subject|0|||
154910580|NCT01693562|559094417|FG012|Escalation Phase|Withdrawal by Subject|0|||
154910581|NCT01693562|559094418|FG013|Escalation Phase|Withdrawal by Subject|0|||
154910582|NCT01693562|559094419|FG014|Escalation Phase|Withdrawal by Subject|0|||
154910583|NCT01693562|559094420|FG015|Escalation Phase|Withdrawal by Subject|0|||
154910584|NCT01693562|559094421|FG016|Escalation Phase|Withdrawal by Subject|0|||
154910585|NCT01693562|559094422|FG017|Escalation Phase|Withdrawal by Subject|0|||
154910586|NCT01693562|559094423|FG018|Escalation Phase|Withdrawal by Subject|0|||
154910587|NCT01693562|559094424|FG019|Escalation Phase|Withdrawal by Subject|0|||
154910588|NCT01693562|559094425|FG020|Escalation Phase|Withdrawal by Subject|0|||
154910589|NCT01693562|559094426|FG021|Escalation Phase|Withdrawal by Subject|0|||
154910590|NCT01693562|559094427|FG022|Escalation Phase|Withdrawal by Subject|0|||
154910591|NCT01693562|559094405|FG000|Escalation Phase|Death|4|||
154910592|NCT01693562|559094406|FG001|Escalation Phase|Death|2|||
154910593|NCT01693562|559094407|FG002|Escalation Phase|Death|0|||
154910594|NCT01693562|559094408|FG003|Escalation Phase|Death|3|||
154910595|NCT01693562|559094409|FG004|Escalation Phase|Death|6|||
154910596|NCT01693562|559094410|FG005|Escalation Phase|Death|4|||
154910597|NCT01693562|559094411|FG006|Escalation Phase|Death|0|||
154910598|NCT01693562|559094412|FG007|Escalation Phase|Death|0|||
154910599|NCT01693562|559094413|FG008|Escalation Phase|Death|0|||
154910600|NCT01693562|559094414|FG009|Escalation Phase|Death|0|||
154910601|NCT01693562|559094415|FG010|Escalation Phase|Death|0|||
154910602|NCT01693562|559094416|FG011|Escalation Phase|Death|0|||
154910603|NCT01693562|559094417|FG012|Escalation Phase|Death|0|||
154910604|NCT01693562|559094418|FG013|Escalation Phase|Death|0|||
154910605|NCT01693562|559094419|FG014|Escalation Phase|Death|0|||
154910606|NCT01693562|559094420|FG015|Escalation Phase|Death|0|||
154910607|NCT01693562|559094421|FG016|Escalation Phase|Death|0|||
154910608|NCT01693562|559094422|FG017|Escalation Phase|Death|0|||
154910609|NCT01693562|559094423|FG018|Escalation Phase|Death|0|||
154910610|NCT01693562|559094424|FG019|Escalation Phase|Death|0|||
154910611|NCT01693562|559094425|FG020|Escalation Phase|Death|0|||
154910612|NCT01693562|559094426|FG021|Escalation Phase|Death|0|||
154910613|NCT01693562|559094427|FG022|Escalation Phase|Death|0|||
154910614|NCT01693562|559094405|FG000|Escalation Phase|Lost to Follow-up|0|||
154910615|NCT01693562|559094406|FG001|Escalation Phase|Lost to Follow-up|1|||
154910616|NCT01693562|559094407|FG002|Escalation Phase|Lost to Follow-up|1|||
154910617|NCT01693562|559094408|FG003|Escalation Phase|Lost to Follow-up|0|||
154910618|NCT01693562|559094409|FG004|Escalation Phase|Lost to Follow-up|0|||
154910619|NCT01693562|559094410|FG005|Escalation Phase|Lost to Follow-up|0|||
155118049|NCT00812006|559863816|FG002|Overall Study|Lack of Qualifying Event|2|||
155118050|NCT00580034|559863821|FG000|Overall Study|Toxicity|10|||
155118051|NCT00580034|559863822|FG001|Overall Study|Toxicity|0|||
154984575|NCT00700817|559368852|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
154984576|NCT00700817|559368853|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
154984577|NCT00700817|559368854|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
154984578|NCT00700817|559368850|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
154984579|NCT00700817|559368851|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
154984580|NCT00700817|559368852|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
154984581|NCT00700817|559368853|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
154984582|NCT00700817|559368854|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
154984583|NCT00700817|559368850|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
154984584|NCT00700817|559368851|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
154984585|NCT00700817|559368852|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
154984586|NCT00700817|559368853|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
154984587|NCT00700817|559368854|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
154984588|NCT00700817|559368850|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
154984589|NCT00700817|559368851|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
154984590|NCT00700817|559368852|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
154984591|NCT00700817|559368853|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
154984592|NCT00700817|559368854|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
154984593|NCT00700817|559368850|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
154984594|NCT00700817|559368851|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
154984595|NCT00700817|559368852|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
154984596|NCT00700817|559368853|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
154984597|NCT00700817|559368854|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
154984598|NCT00700817|559368850|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
154984599|NCT00700817|559368851|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
154984600|NCT00700817|559368852|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
154984601|NCT00700817|559368853|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
154984602|NCT00700817|559368854|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
154984603|NCT00700817|559368850|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
154984604|NCT00700817|559368851|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
154984605|NCT00700817|559368852|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
154984606|NCT00700817|559368853|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
154984607|NCT00700817|559368854|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
154984608|NCT00700817|559368850|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
154984609|NCT00700817|559368851|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
154984610|NCT00700817|559368852|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
154984611|NCT00700817|559368853|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
154984612|NCT00700817|559368854|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
154984613|NCT00700817|559368850|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
154984614|NCT00700817|559368851|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
154984615|NCT00700817|559368852|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
154984616|NCT00700817|559368853|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
154984617|NCT00700817|559368854|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
154984618|NCT00767520|559368855|FG000|Overall Study|Participants still on treatment|11|||
154984619|NCT00767520|559368856|FG001|Overall Study|Participants still on treatment|15|||
154984620|NCT00767520|559368855|FG000|Overall Study|Randomized in error and Never treated|0|||
154984621|NCT00767520|559368856|FG001|Overall Study|Randomized in error and Never treated|2|||
154984622|NCT02777918|559368857|FG000|Overall Study|Medical reasons|1|||
154984623|NCT02777918|559368858|FG001|Overall Study|Medical reasons|2|||
154984624|NCT02777918|559368857|FG000|Overall Study|Too busy / stressed|1|||
154984625|NCT02777918|559368858|FG001|Overall Study|Too busy / stressed|1|||
154984626|NCT02777918|559368857|FG000|Overall Study|Withdrawal by Subject|1|||
154984627|NCT02777918|559368858|FG001|Overall Study|Withdrawal by Subject|1|||
154984628|NCT00058214|559368860|FG000|Overall Study|Adverse Event|1|||
154984629|NCT00958126|559368870|FG000|Overall Study|Serious Adverse Event|0|||
154984630|NCT00958126|559368871|FG001|Overall Study|Serious Adverse Event|2|||
154984631|NCT00958126|559368872|FG002|Overall Study|Serious Adverse Event|0|||
154984632|NCT00958126|559368873|FG003|Overall Study|Serious Adverse Event|0|||
154984633|NCT00958126|559368874|FG004|Overall Study|Serious Adverse Event|0|||
154910620|NCT01693562|559094411|FG006|Escalation Phase|Lost to Follow-up|0|||
154910621|NCT01693562|559094412|FG007|Escalation Phase|Lost to Follow-up|0|||
154910622|NCT01693562|559094413|FG008|Escalation Phase|Lost to Follow-up|0|||
154910623|NCT01693562|559094414|FG009|Escalation Phase|Lost to Follow-up|0|||
154910624|NCT01693562|559094415|FG010|Escalation Phase|Lost to Follow-up|0|||
154910625|NCT01693562|559094416|FG011|Escalation Phase|Lost to Follow-up|0|||
154910626|NCT01693562|559094417|FG012|Escalation Phase|Lost to Follow-up|0|||
154910627|NCT01693562|559094418|FG013|Escalation Phase|Lost to Follow-up|0|||
154910628|NCT01693562|559094419|FG014|Escalation Phase|Lost to Follow-up|0|||
154910629|NCT01693562|559094420|FG015|Escalation Phase|Lost to Follow-up|0|||
154910630|NCT01693562|559094421|FG016|Escalation Phase|Lost to Follow-up|0|||
154984634|NCT00958126|559368875|FG005|Overall Study|Serious Adverse Event|0|||
154984635|NCT00958126|559368876|FG006|Overall Study|Serious Adverse Event|1|||
154984636|NCT00958126|559368877|FG007|Overall Study|Serious Adverse Event|0|||
154984637|NCT00958126|559368870|FG000|Overall Study|Withdrawal by Subject|0|||
154984638|NCT00958126|559368871|FG001|Overall Study|Withdrawal by Subject|2|||
154984639|NCT00958126|559368872|FG002|Overall Study|Withdrawal by Subject|0|||
154984640|NCT00958126|559368873|FG003|Overall Study|Withdrawal by Subject|0|||
154984641|NCT00958126|559368874|FG004|Overall Study|Withdrawal by Subject|0|||
154984642|NCT00958126|559368875|FG005|Overall Study|Withdrawal by Subject|0|||
154984643|NCT00958126|559368876|FG006|Overall Study|Withdrawal by Subject|0|||
154984644|NCT00958126|559368877|FG007|Overall Study|Withdrawal by Subject|0|||
154984645|NCT00958126|559368870|FG000|Overall Study|Moved away from study area|0|||
154984646|NCT00958126|559368871|FG001|Overall Study|Moved away from study area|0|||
154984647|NCT00958126|559368872|FG002|Overall Study|Moved away from study area|1|||
154984648|NCT00958126|559368873|FG003|Overall Study|Moved away from study area|1|||
154984649|NCT00958126|559368874|FG004|Overall Study|Moved away from study area|0|||
154984650|NCT00958126|559368875|FG005|Overall Study|Moved away from study area|0|||
154984651|NCT00958126|559368876|FG006|Overall Study|Moved away from study area|0|||
154984652|NCT00958126|559368877|FG007|Overall Study|Moved away from study area|0|||
154984653|NCT00958126|559368870|FG000|Overall Study|Lost to Follow-up|1|||
154984654|NCT00958126|559368871|FG001|Overall Study|Lost to Follow-up|5|||
154984655|NCT00958126|559368872|FG002|Overall Study|Lost to Follow-up|9|||
154984656|NCT00958126|559368873|FG003|Overall Study|Lost to Follow-up|8|||
154984657|NCT00958126|559368874|FG004|Overall Study|Lost to Follow-up|0|||
154984658|NCT00958126|559368875|FG005|Overall Study|Lost to Follow-up|0|||
154984659|NCT00958126|559368876|FG006|Overall Study|Lost to Follow-up|0|||
154984660|NCT00958126|559368877|FG007|Overall Study|Lost to Follow-up|0|||
154984661|NCT00958126|559368870|FG000|Overall Study|Sponsor/Investigator decision|0|||
154984662|NCT00958126|559368871|FG001|Overall Study|Sponsor/Investigator decision|0|||
154984663|NCT00958126|559368872|FG002|Overall Study|Sponsor/Investigator decision|0|||
154984664|NCT00958126|559368873|FG003|Overall Study|Sponsor/Investigator decision|1|||
154984665|NCT00958126|559368874|FG004|Overall Study|Sponsor/Investigator decision|0|||
154984666|NCT00958126|559368875|FG005|Overall Study|Sponsor/Investigator decision|0|||
154984667|NCT00958126|559368876|FG006|Overall Study|Sponsor/Investigator decision|0|||
154984668|NCT00958126|559368877|FG007|Overall Study|Sponsor/Investigator decision|0|||
154984669|NCT00958126|559368870|FG000|Overall Study|Other Reason|0|||
154984670|NCT00958126|559368871|FG001|Overall Study|Other Reason|0|||
154984671|NCT00958126|559368872|FG002|Overall Study|Other Reason|0|||
154984672|NCT00958126|559368873|FG003|Overall Study|Other Reason|1|||
154984673|NCT00958126|559368874|FG004|Overall Study|Other Reason|0|||
154984674|NCT00958126|559368875|FG005|Overall Study|Other Reason|1|||
154984675|NCT00958126|559368876|FG006|Overall Study|Other Reason|0|||
154984676|NCT00958126|559368877|FG007|Overall Study|Other Reason|0|||
154984677|NCT00720226|559368878|FG000|Overall Study|Withdrawal by Subject|7|||
154984678|NCT00720226|559368879|FG001|Overall Study|Withdrawal by Subject|4|||
154984679|NCT03401073|559368880|FG000|Overall Study|Lost to Follow-up|1|||
154984680|NCT03401073|559368881|FG001|Overall Study|Lost to Follow-up|2|||
154984681|NCT00733369|559368882|FG000|Overall Study|Lost to Follow-up|2|||
154984682|NCT00733369|559368883|FG001|Overall Study|Lost to Follow-up|1|||
154984683|NCT00733369|559368882|FG000|Overall Study|Adverse Event|4|||
154984684|NCT00733369|559368883|FG001|Overall Study|Adverse Event|4|||
154984685|NCT00733369|559368882|FG000|Overall Study|Protocol Violation|4|||
154984686|NCT00733369|559368883|FG001|Overall Study|Protocol Violation|4|||
154984687|NCT01470612|559368884|FG000|Overall Study|Adverse Event|20|||
154984688|NCT01470612|559368885|FG001|Overall Study|Adverse Event|80|||
154984689|NCT01470612|559368884|FG000|Overall Study|Death|0|||
154984690|NCT01470612|559368885|FG001|Overall Study|Death|1|||
154984691|NCT01470612|559368884|FG000|Overall Study|Lack of Efficacy|20|||
154984692|NCT01470612|559368885|FG001|Overall Study|Lack of Efficacy|326|||
154984693|NCT01470612|559368884|FG000|Overall Study|Lost to Follow-up|2|||
154984694|NCT01470612|559368885|FG001|Overall Study|Lost to Follow-up|5|||
154984695|NCT01470612|559368884|FG000|Overall Study|Did not meet entrance criteria|0|||
154984696|NCT01470612|559368885|FG001|Overall Study|Did not meet entrance criteria|1|||
154984697|NCT01470612|559368884|FG000|Overall Study|Pregnancy|2|||
154984698|NCT01470612|559368885|FG001|Overall Study|Pregnancy|10|||
155118052|NCT00772369|559863824|FG000|Overall Study|Did not return record release form|1|||
155118053|NCT03372460|559863825|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
155118054|NCT03372460|559863826|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
155118055|NCT02499900|559863827|FG000|Core Study Period|Other|1|||
154984699|NCT01470612|559368884|FG000|Overall Study|Protocol Violation|2|||
154984700|NCT01470612|559368885|FG001|Overall Study|Protocol Violation|7|||
154984701|NCT01470612|559368884|FG000|Overall Study|Withdrawal by Subject|24|||
154984702|NCT01470612|559368885|FG001|Overall Study|Withdrawal by Subject|79|||
154984703|NCT01470612|559368884|FG000|Overall Study|Other|14|||
154984704|NCT01470612|559368885|FG001|Overall Study|Other|156|||
154984705|NCT02039414|559368886|FG000|Overall Study|Delivered|1|||
154984706|NCT02039414|559368887|FG001|Overall Study|Delivered|1|||
154984707|NCT02039414|559368886|FG000|Overall Study|Lost to Follow-up|2|||
154984708|NCT02039414|559368887|FG001|Overall Study|Lost to Follow-up|0|||
155118056|NCT02499900|559863828|FG001|Core Study Period|Other|4|||
155118057|NCT02499900|559863827|FG000|Core Study Period|Lost to Follow-up|1|||
155118058|NCT02499900|559863828|FG001|Core Study Period|Lost to Follow-up|2|||
155118059|NCT02499900|559863827|FG000|Core Study Period|Per sponsor request|0|||
155118060|NCT02499900|559863828|FG001|Core Study Period|Per sponsor request|1|||
155118061|NCT02499900|559863827|FG000|Core Study Period|Pregnancy|1|||
155118062|NCT02499900|559863828|FG001|Core Study Period|Pregnancy|0|||
155118063|NCT02499900|559863827|FG000|Core Study Period|Protocol Violation|3|||
155118064|NCT02499900|559863828|FG001|Core Study Period|Protocol Violation|0|||
155118065|NCT02499900|559863827|FG000|Core Study Period|Withdrawal by Subject|11|||
154910631|NCT01693562|559094422|FG017|Escalation Phase|Lost to Follow-up|0|||
154910632|NCT01693562|559094423|FG018|Escalation Phase|Lost to Follow-up|0|||
154910633|NCT01693562|559094424|FG019|Escalation Phase|Lost to Follow-up|0|||
154910634|NCT01693562|559094425|FG020|Escalation Phase|Lost to Follow-up|0|||
154910635|NCT01693562|559094426|FG021|Escalation Phase|Lost to Follow-up|0|||
154910636|NCT01693562|559094427|FG022|Escalation Phase|Lost to Follow-up|0|||
154910637|NCT01693562|559094405|FG000|Escalation Phase|Other|0|||
154910638|NCT01693562|559094406|FG001|Escalation Phase|Other|0|||
154910639|NCT01693562|559094407|FG002|Escalation Phase|Other|2|||
154910640|NCT01693562|559094408|FG003|Escalation Phase|Other|0|||
154910641|NCT01693562|559094409|FG004|Escalation Phase|Other|0|||
154910642|NCT01693562|559094410|FG005|Escalation Phase|Other|1|||
154910643|NCT01693562|559094411|FG006|Escalation Phase|Other|0|||
154910644|NCT01693562|559094412|FG007|Escalation Phase|Other|0|||
154910645|NCT01693562|559094413|FG008|Escalation Phase|Other|0|||
154910646|NCT01693562|559094414|FG009|Escalation Phase|Other|0|||
154910647|NCT01693562|559094415|FG010|Escalation Phase|Other|0|||
154910648|NCT01693562|559094416|FG011|Escalation Phase|Other|0|||
154910649|NCT01693562|559094417|FG012|Escalation Phase|Other|0|||
154910650|NCT01693562|559094418|FG013|Escalation Phase|Other|0|||
154910651|NCT01693562|559094419|FG014|Escalation Phase|Other|0|||
154910652|NCT01693562|559094420|FG015|Escalation Phase|Other|0|||
154910653|NCT01693562|559094421|FG016|Escalation Phase|Other|0|||
154910654|NCT01693562|559094422|FG017|Escalation Phase|Other|0|||
154910655|NCT01693562|559094423|FG018|Escalation Phase|Other|0|||
154910656|NCT01693562|559094424|FG019|Escalation Phase|Other|0|||
154910657|NCT01693562|559094425|FG020|Escalation Phase|Other|0|||
154910658|NCT01693562|559094426|FG021|Escalation Phase|Other|0|||
154910659|NCT01693562|559094427|FG022|Escalation Phase|Other|0|||
154910660|NCT01693562|559094405|FG000|Exploration Phase|Withdrawal by Subject|0|||
154910661|NCT01693562|559094406|FG001|Exploration Phase|Withdrawal by Subject|0|||
154910662|NCT01693562|559094407|FG002|Exploration Phase|Withdrawal by Subject|0|||
154910663|NCT01693562|559094408|FG003|Exploration Phase|Withdrawal by Subject|0|||
154910664|NCT01693562|559094409|FG004|Exploration Phase|Withdrawal by Subject|0|||
154910665|NCT01693562|559094410|FG005|Exploration Phase|Withdrawal by Subject|0|||
154910666|NCT01693562|559094411|FG006|Exploration Phase|Withdrawal by Subject|2|||
154910667|NCT01693562|559094412|FG007|Exploration Phase|Withdrawal by Subject|0|||
154910668|NCT01693562|559094413|FG008|Exploration Phase|Withdrawal by Subject|0|||
154910669|NCT01693562|559094414|FG009|Exploration Phase|Withdrawal by Subject|0|||
154910670|NCT01693562|559094415|FG010|Exploration Phase|Withdrawal by Subject|0|||
154910671|NCT01693562|559094416|FG011|Exploration Phase|Withdrawal by Subject|0|||
154910672|NCT01693562|559094417|FG012|Exploration Phase|Withdrawal by Subject|0|||
154910673|NCT01693562|559094418|FG013|Exploration Phase|Withdrawal by Subject|0|||
154910674|NCT01693562|559094419|FG014|Exploration Phase|Withdrawal by Subject|0|||
154910675|NCT01693562|559094420|FG015|Exploration Phase|Withdrawal by Subject|0|||
154910676|NCT01693562|559094421|FG016|Exploration Phase|Withdrawal by Subject|0|||
154910677|NCT01693562|559094422|FG017|Exploration Phase|Withdrawal by Subject|0|||
154910678|NCT01693562|559094423|FG018|Exploration Phase|Withdrawal by Subject|0|||
154910679|NCT01693562|559094424|FG019|Exploration Phase|Withdrawal by Subject|0|||
154910680|NCT01693562|559094425|FG020|Exploration Phase|Withdrawal by Subject|0|||
154910681|NCT01693562|559094426|FG021|Exploration Phase|Withdrawal by Subject|0|||
154910682|NCT01693562|559094427|FG022|Exploration Phase|Withdrawal by Subject|0|||
154910683|NCT01693562|559094405|FG000|Exploration Phase|Death|0|||
154910684|NCT01693562|559094406|FG001|Exploration Phase|Death|0|||
154910685|NCT01693562|559094407|FG002|Exploration Phase|Death|0|||
154910686|NCT01693562|559094408|FG003|Exploration Phase|Death|0|||
154910687|NCT01693562|559094409|FG004|Exploration Phase|Death|0|||
155118066|NCT02499900|559863828|FG001|Core Study Period|Withdrawal by Subject|10|||
154910688|NCT01693562|559094410|FG005|Exploration Phase|Death|0|||
154910689|NCT01693562|559094411|FG006|Exploration Phase|Death|17|||
154910690|NCT01693562|559094412|FG007|Exploration Phase|Death|0|||
154910691|NCT01693562|559094413|FG008|Exploration Phase|Death|0|||
154910692|NCT01693562|559094414|FG009|Exploration Phase|Death|0|||
154910693|NCT01693562|559094415|FG010|Exploration Phase|Death|0|||
154910694|NCT01693562|559094416|FG011|Exploration Phase|Death|0|||
154910695|NCT01693562|559094417|FG012|Exploration Phase|Death|0|||
154910696|NCT01693562|559094418|FG013|Exploration Phase|Death|0|||
154910697|NCT01693562|559094419|FG014|Exploration Phase|Death|0|||
154910698|NCT01693562|559094420|FG015|Exploration Phase|Death|0|||
154910699|NCT01693562|559094421|FG016|Exploration Phase|Death|0|||
154910700|NCT01693562|559094422|FG017|Exploration Phase|Death|0|||
154910701|NCT01693562|559094423|FG018|Exploration Phase|Death|0|||
155118067|NCT02499900|559863827|FG000|Core Study Period|Adverse Event|18|||
155118068|NCT02499900|559863828|FG001|Core Study Period|Adverse Event|14|||
155118069|NCT02499900|559863827|FG000|Core Study Period|Death|0|||
155118070|NCT02499900|559863828|FG001|Core Study Period|Death|1|||
155118071|NCT02499900|559863827|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
155118072|NCT02499900|559863828|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
155118073|NCT02499900|559863827|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
155118074|NCT02499900|559863828|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
155118075|NCT02499900|559863827|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
155118076|NCT02499900|559863828|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
155118077|NCT02499900|559863827|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
155118078|NCT02499900|559863828|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
155118079|NCT02499900|559863827|FG000|Extension Study Period|Adverse Event|2|||
155118080|NCT02499900|559863828|FG001|Extension Study Period|Adverse Event|4|||
155118081|NCT02499900|559863827|FG000|Extension Study Period|Withdrawal by Subject|5|||
155118082|NCT02499900|559863828|FG001|Extension Study Period|Withdrawal by Subject|2|||
155118083|NCT02499900|559863827|FG000|Extension Study Period|Physician Decision|2|||
155118084|NCT02499900|559863828|FG001|Extension Study Period|Physician Decision|5|||
155118085|NCT02499900|559863827|FG000|Extension Study Period|Pregnancy|1|||
155118086|NCT02499900|559863828|FG001|Extension Study Period|Pregnancy|2|||
155118087|NCT02499900|559863827|FG000|Extension Study Period|Lost to Follow-up|2|||
155118088|NCT02499900|559863828|FG001|Extension Study Period|Lost to Follow-up|5|||
155118089|NCT02499900|559863827|FG000|Extension Study Period|Other|0|||
155118090|NCT02499900|559863828|FG001|Extension Study Period|Other|2|||
155118091|NCT00916058|559863829|FG000|Phase 1|Screen Failure|0|||
155118092|NCT00916058|559863830|FG001|Phase 1|Screen Failure|0|||
155118093|NCT00916058|559863831|FG002|Phase 1|Screen Failure|0|||
155118094|NCT00916058|559863832|FG003|Phase 1|Screen Failure|0|||
155118095|NCT00916058|559863833|FG004|Phase 1|Screen Failure|0|||
155118096|NCT00916058|559863834|FG005|Phase 1|Screen Failure|1|||
155118097|NCT00916058|559863835|FG006|Phase 1|Screen Failure|0|||
155118098|NCT00916058|559863829|FG000|Phase 2|Screen Failure|0|||
155118099|NCT00916058|559863830|FG001|Phase 2|Screen Failure|0|||
155118100|NCT00916058|559863831|FG002|Phase 2|Screen Failure|0|||
155118101|NCT00916058|559863832|FG003|Phase 2|Screen Failure|0|||
155118102|NCT00916058|559863833|FG004|Phase 2|Screen Failure|0|||
155118103|NCT00916058|559863834|FG005|Phase 2|Screen Failure|0|||
155118104|NCT00916058|559863835|FG006|Phase 2|Screen Failure|3|||
155118105|NCT03385265|559863836|FG000|Overall Study|Withdrawal by Subject|5|||
155118106|NCT03385265|559863837|FG001|Overall Study|Withdrawal by Subject|2|||
155118107|NCT03385265|559863838|FG002|Overall Study|Withdrawal by Subject|5|||
155118108|NCT03385265|559863839|FG003|Overall Study|Withdrawal by Subject|2|||
155118109|NCT01170065|559863859|FG000|Overall Study|Adverse Event|17|||
155118110|NCT01170065|559863860|FG001|Overall Study|Adverse Event|50|||
154910702|NCT01693562|559094424|FG019|Exploration Phase|Death|0|||
154910703|NCT01693562|559094425|FG020|Exploration Phase|Death|0|||
154910704|NCT01693562|559094426|FG021|Exploration Phase|Death|0|||
154910705|NCT01693562|559094427|FG022|Exploration Phase|Death|0|||
154910706|NCT01693562|559094405|FG000|Exploration Phase|Other|0|||
154910707|NCT01693562|559094406|FG001|Exploration Phase|Other|0|||
154910708|NCT01693562|559094407|FG002|Exploration Phase|Other|0|||
154910709|NCT01693562|559094408|FG003|Exploration Phase|Other|0|||
154910710|NCT01693562|559094409|FG004|Exploration Phase|Other|0|||
154910711|NCT01693562|559094410|FG005|Exploration Phase|Other|0|||
154910712|NCT01693562|559094411|FG006|Exploration Phase|Other|2|||
154910713|NCT01693562|559094412|FG007|Exploration Phase|Other|0|||
154910714|NCT01693562|559094413|FG008|Exploration Phase|Other|0|||
154910715|NCT01693562|559094414|FG009|Exploration Phase|Other|0|||
154910716|NCT01693562|559094415|FG010|Exploration Phase|Other|0|||
154910717|NCT01693562|559094416|FG011|Exploration Phase|Other|0|||
154910718|NCT01693562|559094417|FG012|Exploration Phase|Other|0|||
154910719|NCT01693562|559094418|FG013|Exploration Phase|Other|0|||
154910720|NCT01693562|559094419|FG014|Exploration Phase|Other|0|||
154910721|NCT01693562|559094420|FG015|Exploration Phase|Other|0|||
154910722|NCT01693562|559094421|FG016|Exploration Phase|Other|0|||
154910723|NCT01693562|559094422|FG017|Exploration Phase|Other|0|||
154910724|NCT01693562|559094423|FG018|Exploration Phase|Other|0|||
155118111|NCT01170065|559863861|FG002|Overall Study|Adverse Event|10|||
155118112|NCT01170065|559863859|FG000|Overall Study|Lost to Follow-up|1|||
155118113|NCT01170065|559863860|FG001|Overall Study|Lost to Follow-up|4|||
154910725|NCT01693562|559094424|FG019|Exploration Phase|Other|0|||
154910726|NCT01693562|559094425|FG020|Exploration Phase|Other|0|||
154910727|NCT01693562|559094426|FG021|Exploration Phase|Other|0|||
154910728|NCT01693562|559094427|FG022|Exploration Phase|Other|0|||
155118114|NCT01170065|559863861|FG002|Overall Study|Lost to Follow-up|1|||
155118115|NCT01170065|559863859|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
154910729|NCT01693562|559094405|FG000|Expansion Phase|Withdrawal by Subject|0|||
154910730|NCT01693562|559094406|FG001|Expansion Phase|Withdrawal by Subject|0|||
154910731|NCT01693562|559094407|FG002|Expansion Phase|Withdrawal by Subject|0|||
154910732|NCT01693562|559094408|FG003|Expansion Phase|Withdrawal by Subject|0|||
154984709|NCT02039414|559368886|FG000|Overall Study|Protocol Violation|3|||
154984710|NCT02039414|559368887|FG001|Overall Study|Protocol Violation|1|||
155118116|NCT01170065|559863860|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
155118117|NCT01170065|559863861|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
155118118|NCT01170065|559863859|FG000|Overall Study|Reason other than specified|3|||
155118119|NCT01170065|559863860|FG001|Overall Study|Reason other than specified|8|||
155118120|NCT01170065|559863861|FG002|Overall Study|Reason other than specified|3|||
155118121|NCT01170065|559863859|FG000|Overall Study|Ongoing after planned observation time|5|||
155118122|NCT01170065|559863860|FG001|Overall Study|Ongoing after planned observation time|26|||
155118123|NCT01170065|559863861|FG002|Overall Study|Ongoing after planned observation time|10|||
155118124|NCT02434354|559863862|FG000|Overall Study|screen fail|3|||
155118125|NCT01071200|559863863|FG000|Overall Study|Lack of ovarian response|1|||
155118126|NCT01071200|559863864|FG001|Overall Study|Lack of ovarian response|1|||
155118127|NCT01071200|559863863|FG000|Overall Study|No fertilization|4|||
155118128|NCT01071200|559863864|FG001|Overall Study|No fertilization|0|||
155118129|NCT01071200|559863863|FG000|Overall Study|No oocytes retrieved|1|||
155118130|NCT01071200|559863864|FG001|Overall Study|No oocytes retrieved|1|||
155118131|NCT01071200|559863863|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
155118132|NCT01071200|559863864|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
155118133|NCT01071200|559863863|FG000|Overall Study|No viable embryos|0|||
155118134|NCT01071200|559863864|FG001|Overall Study|No viable embryos|1|||
155118135|NCT01920893|559863865|FG000|Overall Study|Adverse Event|5|||
155118136|NCT01920893|559863866|FG001|Overall Study|Adverse Event|2|||
155118137|NCT01920893|559863865|FG000|Overall Study|Lack of Efficacy|2|||
155118138|NCT01920893|559863866|FG001|Overall Study|Lack of Efficacy|0|||
155118139|NCT01767493|559863868|FG000|Overall Study|screen failures|3|||
155118140|NCT00724854|559863871|FG000|Overall Study|Lack of Efficacy|187|||
155118141|NCT00724854|559863872|FG001|Overall Study|Lack of Efficacy|13|||
155118142|NCT00724854|559863871|FG000|Overall Study|Lost to Follow-up|87|||
155118143|NCT00724854|559863872|FG001|Overall Study|Lost to Follow-up|10|||
155118144|NCT00724854|559863871|FG000|Overall Study|Adverse Event|62|||
155118145|NCT00724854|559863872|FG001|Overall Study|Adverse Event|4|||
155118146|NCT00724854|559863871|FG000|Overall Study|Other|42|||
155118147|NCT00724854|559863872|FG001|Overall Study|Other|3|||
155118148|NCT00724854|559863871|FG000|Overall Study|Death|11|||
155118149|NCT00724854|559863872|FG001|Overall Study|Death|0|||
155118150|NCT00724854|559863871|FG000|Overall Study|Change of treatment|7|||
155118151|NCT00724854|559863872|FG001|Overall Study|Change of treatment|0|||
155118152|NCT00724854|559863871|FG000|Overall Study|Withdrawal by Subject|5|||
155118153|NCT00724854|559863872|FG001|Overall Study|Withdrawal by Subject|0|||
155118154|NCT00724854|559863871|FG000|Overall Study|Adverse event + lack of efficacy|2|||
155118155|NCT00724854|559863872|FG001|Overall Study|Adverse event + lack of efficacy|1|||
155118156|NCT01819129|559863873|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
154984711|NCT01347866|559368888|FG000|Overall Study|Death|0|||
154984712|NCT01347866|559368889|FG001|Overall Study|Death|0|||
154984713|NCT01347866|559368890|FG002|Overall Study|Death|0|||
154984714|NCT01347866|559368891|FG003|Overall Study|Death|1|||
154984715|NCT01347866|559368892|FG004|Overall Study|Death|2|||
154984716|NCT01347866|559368893|FG005|Overall Study|Death|2|||
154984717|NCT01347866|559368894|FG006|Overall Study|Death|1|||
154984718|NCT01347866|559368895|FG007|Overall Study|Death|0|||
154984719|NCT01347866|559368896|FG008|Overall Study|Death|4|||
154984720|NCT01347866|559368897|FG009|Overall Study|Death|1|||
154984721|NCT01347866|559368898|FG010|Overall Study|Death|3|||
154984722|NCT01347866|559368899|FG011|Overall Study|Death|1|||
154984723|NCT01347866|559368900|FG012|Overall Study|Death|2|||
154984724|NCT01347866|559368901|FG013|Overall Study|Death|0|||
155118157|NCT01819129|559863874|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
155118158|NCT01819129|559863873|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
155118159|NCT01819129|559863874|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
154984725|NCT01347866|559368902|FG014|Overall Study|Death|0|||
154984726|NCT01347866|559368903|FG015|Overall Study|Death|1|||
154984727|NCT01347866|559368904|FG016|Overall Study|Death|0|||
155118160|NCT01819129|559863873|FG000|Overall Study|Other, Subject moved out of the country|0|||
155118161|NCT01819129|559863874|FG001|Overall Study|Other, Subject moved out of the country|1|||
155118162|NCT01819129|559863873|FG000|Overall Study|Withdrawal by Subject|15|||
155118163|NCT01819129|559863874|FG001|Overall Study|Withdrawal by Subject|15|||
155118164|NCT01819129|559863873|FG000|Overall Study|Lost to Follow-up|5|||
155118165|NCT01819129|559863874|FG001|Overall Study|Lost to Follow-up|2|||
154984728|NCT01347866|559368888|FG000|Overall Study|Lost to Follow-up|0|||
154984729|NCT01347866|559368889|FG001|Overall Study|Lost to Follow-up|0|||
154984730|NCT01347866|559368890|FG002|Overall Study|Lost to Follow-up|0|||
154984731|NCT01347866|559368891|FG003|Overall Study|Lost to Follow-up|0|||
154984732|NCT01347866|559368892|FG004|Overall Study|Lost to Follow-up|0|||
154984733|NCT01347866|559368893|FG005|Overall Study|Lost to Follow-up|0|||
154984734|NCT01347866|559368894|FG006|Overall Study|Lost to Follow-up|0|||
154984735|NCT01347866|559368895|FG007|Overall Study|Lost to Follow-up|1|||
154984736|NCT01347866|559368896|FG008|Overall Study|Lost to Follow-up|1|||
154984737|NCT01347866|559368897|FG009|Overall Study|Lost to Follow-up|0|||
154910733|NCT01693562|559094409|FG004|Expansion Phase|Withdrawal by Subject|0|||
154910734|NCT01693562|559094410|FG005|Expansion Phase|Withdrawal by Subject|0|||
154910735|NCT01693562|559094411|FG006|Expansion Phase|Withdrawal by Subject|0|||
154910736|NCT01693562|559094412|FG007|Expansion Phase|Withdrawal by Subject|16|||
154910737|NCT01693562|559094413|FG008|Expansion Phase|Withdrawal by Subject|2|||
154910738|NCT01693562|559094414|FG009|Expansion Phase|Withdrawal by Subject|54|||
154910739|NCT01693562|559094415|FG010|Expansion Phase|Withdrawal by Subject|2|||
154910740|NCT01693562|559094416|FG011|Expansion Phase|Withdrawal by Subject|2|||
154910741|NCT01693562|559094417|FG012|Expansion Phase|Withdrawal by Subject|3|||
154910742|NCT01693562|559094418|FG013|Expansion Phase|Withdrawal by Subject|5|||
154910743|NCT01693562|559094419|FG014|Expansion Phase|Withdrawal by Subject|16|||
154910744|NCT01693562|559094420|FG015|Expansion Phase|Withdrawal by Subject|7|||
154910745|NCT01693562|559094421|FG016|Expansion Phase|Withdrawal by Subject|40|||
154910746|NCT01693562|559094422|FG017|Expansion Phase|Withdrawal by Subject|4|||
154910747|NCT01693562|559094423|FG018|Expansion Phase|Withdrawal by Subject|8|||
154910748|NCT01693562|559094424|FG019|Expansion Phase|Withdrawal by Subject|3|||
154910749|NCT01693562|559094425|FG020|Expansion Phase|Withdrawal by Subject|1|||
154910750|NCT01693562|559094426|FG021|Expansion Phase|Withdrawal by Subject|8|||
154910751|NCT01693562|559094427|FG022|Expansion Phase|Withdrawal by Subject|1|||
154910752|NCT01693562|559094405|FG000|Expansion Phase|Death|0|||
154910753|NCT01693562|559094406|FG001|Expansion Phase|Death|0|||
154910754|NCT01693562|559094407|FG002|Expansion Phase|Death|0|||
154910755|NCT01693562|559094408|FG003|Expansion Phase|Death|0|||
154910756|NCT01693562|559094409|FG004|Expansion Phase|Death|0|||
154910757|NCT01693562|559094410|FG005|Expansion Phase|Death|0|||
154910758|NCT01693562|559094411|FG006|Expansion Phase|Death|0|||
154910759|NCT01693562|559094412|FG007|Expansion Phase|Death|42|||
154910760|NCT01693562|559094413|FG008|Expansion Phase|Death|17|||
154910761|NCT01693562|559094414|FG009|Expansion Phase|Death|208|||
154910762|NCT01693562|559094415|FG010|Expansion Phase|Death|30|||
154910763|NCT01693562|559094416|FG011|Expansion Phase|Death|8|||
154910764|NCT01693562|559094417|FG012|Expansion Phase|Death|19|||
154910765|NCT01693562|559094418|FG013|Expansion Phase|Death|42|||
154910766|NCT01693562|559094419|FG014|Expansion Phase|Death|23|||
154910767|NCT01693562|559094420|FG015|Expansion Phase|Death|23|||
154910768|NCT01693562|559094421|FG016|Expansion Phase|Death|128|||
154910769|NCT01693562|559094422|FG017|Expansion Phase|Death|16|||
154910770|NCT01693562|559094423|FG018|Expansion Phase|Death|36|||
154910771|NCT01693562|559094424|FG019|Expansion Phase|Death|16|||
154910772|NCT01693562|559094425|FG020|Expansion Phase|Death|17|||
154910773|NCT01693562|559094426|FG021|Expansion Phase|Death|35|||
154910774|NCT01693562|559094427|FG022|Expansion Phase|Death|7|||
154910775|NCT01693562|559094405|FG000|Expansion Phase|Lost to Follow-up|0|||
154910776|NCT01693562|559094406|FG001|Expansion Phase|Lost to Follow-up|0|||
154910777|NCT01693562|559094407|FG002|Expansion Phase|Lost to Follow-up|0|||
154910778|NCT01693562|559094408|FG003|Expansion Phase|Lost to Follow-up|0|||
154910779|NCT01693562|559094409|FG004|Expansion Phase|Lost to Follow-up|0|||
154910780|NCT01693562|559094410|FG005|Expansion Phase|Lost to Follow-up|0|||
154910781|NCT01693562|559094411|FG006|Expansion Phase|Lost to Follow-up|0|||
154910782|NCT01693562|559094412|FG007|Expansion Phase|Lost to Follow-up|1|||
154910783|NCT01693562|559094413|FG008|Expansion Phase|Lost to Follow-up|2|||
154910784|NCT01693562|559094414|FG009|Expansion Phase|Lost to Follow-up|10|||
154910785|NCT01693562|559094415|FG010|Expansion Phase|Lost to Follow-up|4|||
154910786|NCT01693562|559094416|FG011|Expansion Phase|Lost to Follow-up|4|||
154910787|NCT01693562|559094417|FG012|Expansion Phase|Lost to Follow-up|1|||
154910788|NCT01693562|559094418|FG013|Expansion Phase|Lost to Follow-up|3|||
154910789|NCT01693562|559094419|FG014|Expansion Phase|Lost to Follow-up|0|||
154910790|NCT01693562|559094420|FG015|Expansion Phase|Lost to Follow-up|1|||
154910791|NCT01693562|559094421|FG016|Expansion Phase|Lost to Follow-up|1|||
154910792|NCT01693562|559094422|FG017|Expansion Phase|Lost to Follow-up|0|||
154910793|NCT01693562|559094423|FG018|Expansion Phase|Lost to Follow-up|2|||
154910794|NCT01693562|559094424|FG019|Expansion Phase|Lost to Follow-up|1|||
154910795|NCT01693562|559094425|FG020|Expansion Phase|Lost to Follow-up|2|||
154910796|NCT01693562|559094426|FG021|Expansion Phase|Lost to Follow-up|2|||
154910797|NCT01693562|559094427|FG022|Expansion Phase|Lost to Follow-up|1|||
154910798|NCT01693562|559094405|FG000|Expansion Phase|Other|0|||
154910799|NCT01693562|559094406|FG001|Expansion Phase|Other|0|||
154910800|NCT01693562|559094407|FG002|Expansion Phase|Other|0|||
154910801|NCT01693562|559094408|FG003|Expansion Phase|Other|0|||
154910802|NCT01693562|559094409|FG004|Expansion Phase|Other|0|||
154910803|NCT01693562|559094410|FG005|Expansion Phase|Other|0|||
154910804|NCT01693562|559094411|FG006|Expansion Phase|Other|0|||
154910805|NCT01693562|559094412|FG007|Expansion Phase|Other|3|||
155176170|NCT00311584|560082296|FG001|Overall Study|Death|0|||
154910806|NCT01693562|559094413|FG008|Expansion Phase|Other|1|||
154910807|NCT01693562|559094414|FG009|Expansion Phase|Other|28|||
154910808|NCT01693562|559094415|FG010|Expansion Phase|Other|4|||
154910809|NCT01693562|559094416|FG011|Expansion Phase|Other|7|||
154910810|NCT01693562|559094417|FG012|Expansion Phase|Other|0|||
154910811|NCT01693562|559094418|FG013|Expansion Phase|Other|1|||
154910812|NCT01693562|559094419|FG014|Expansion Phase|Other|1|||
154910813|NCT01693562|559094420|FG015|Expansion Phase|Other|0|||
154910814|NCT01693562|559094421|FG016|Expansion Phase|Other|28|||
154910815|NCT01693562|559094422|FG017|Expansion Phase|Other|0|||
154910816|NCT01693562|559094423|FG018|Expansion Phase|Other|1|||
154910817|NCT01693562|559094424|FG019|Expansion Phase|Other|0|||
154910818|NCT01693562|559094425|FG020|Expansion Phase|Other|1|||
154910819|NCT01693562|559094426|FG021|Expansion Phase|Other|17|||
154910820|NCT01693562|559094427|FG022|Expansion Phase|Other|1|||
154910821|NCT04735432|559094428|FG000|Overall Study|Other - due to personal reason|1|||
155118166|NCT01819129|559863873|FG000|Overall Study|Lack of Efficacy|0|||
155118167|NCT01819129|559863874|FG001|Overall Study|Lack of Efficacy|1|||
155118168|NCT01819129|559863873|FG000|Overall Study|Adverse Event|1|||
155118169|NCT01819129|559863874|FG001|Overall Study|Adverse Event|4|||
155118170|NCT01819129|559863873|FG000|Overall Study|Death|1|||
155118171|NCT01819129|559863874|FG001|Overall Study|Death|1|||
155118172|NCT01819129|559863873|FG000|Overall Study|Withdrawal Criteria|20|||
155118173|NCT01819129|559863874|FG001|Overall Study|Withdrawal Criteria|15|||
155118174|NCT02752958|559863877|FG000|Overall Study|Adverse Event|3|||
155118175|NCT02752958|559863877|FG000|Overall Study|Lost to Follow-up|1|||
155118176|NCT02752958|559863877|FG000|Overall Study|Protocol Violation|1|||
155118177|NCT02752958|559863877|FG000|Overall Study|Withdrawal by Subject|2|||
155118178|NCT02752958|559863877|FG000|Overall Study|Other (Reason not specified)|2|||
155118179|NCT02836873|559863880|FG000|Overall Study|Protocol Violation|0|||
155118180|NCT02836873|559863881|FG001|Overall Study|Protocol Violation|1|||
155118181|NCT02836873|559863880|FG000|Overall Study|Adverse Event|1|||
155118182|NCT02836873|559863881|FG001|Overall Study|Adverse Event|4|||
155118183|NCT02836873|559863880|FG000|Overall Study|Withdrawal by Subject|2|||
155118184|NCT02836873|559863881|FG001|Overall Study|Withdrawal by Subject|2|||
155118185|NCT02836873|559863880|FG000|Overall Study|Lost to Follow-up|1|||
155118186|NCT02836873|559863881|FG001|Overall Study|Lost to Follow-up|3|||
155118187|NCT02836873|559863880|FG000|Overall Study|Physician Decision|0|||
155118188|NCT02836873|559863881|FG001|Overall Study|Physician Decision|1|||
155118189|NCT02836873|559863880|FG000|Overall Study|Other|1|||
155118190|NCT02836873|559863881|FG001|Overall Study|Other|0|||
155118191|NCT00853125|559863888|FG000|Overall Study|Study participant's donor was CMV +|1|||
155118192|NCT01646645|559863896|FG000|Overall Study|No Treated|1|||
155118193|NCT01646645|559863896|FG000|Overall Study|Inevaluable Donor|29|||
155118194|NCT00884039|559863897|FG000|Overall Study|Withdrawal by Subject|0|||
155118195|NCT00884039|559863898|FG001|Overall Study|Withdrawal by Subject|1|||
155118196|NCT00884039|559863897|FG000|Overall Study|Lack of Efficacy|2|||
155118197|NCT00884039|559863898|FG001|Overall Study|Lack of Efficacy|0|||
155118198|NCT00717522|559863899|FG000|Overall Study|Disease Progression|5|||
155118199|NCT00717522|559863899|FG000|Overall Study|Adverse Event|1|||
155118200|NCT00717522|559863899|FG000|Overall Study|Death|1|||
155118201|NCT01799239|559863900|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
155118202|NCT01799239|559863901|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
155118203|NCT01799239|559863900|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
155118204|NCT01799239|559863901|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
155118205|NCT01799239|559863900|FG000|Period 1 (7 Days)|Protocol Violation|0|||
155118206|NCT01799239|559863901|FG001|Period 1 (7 Days)|Protocol Violation|1|||
155118207|NCT01799239|559863900|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
155118208|NCT01799239|559863901|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
155118209|NCT01799239|559863900|FG000|Period 2 (7 Days)|Protocol Violation|1|||
155118210|NCT01799239|559863901|FG001|Period 2 (7 Days)|Protocol Violation|0|||
155118211|NCT03966885|559865791|FG000|Overall Study|Death|1|||
155118212|NCT03966885|559865792|FG001|Overall Study|Death|0|||
155118213|NCT03966885|559865791|FG000|Overall Study|Lost to Follow-up|1|||
155118214|NCT03966885|559865792|FG001|Overall Study|Lost to Follow-up|2|||
155118215|NCT03966885|559865791|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
155118216|NCT03966885|559865792|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
155118217|NCT03966885|559865791|FG000|Overall Study|Moved from study area.|0|||
155118218|NCT03966885|559865792|FG001|Overall Study|Moved from study area.|2|||
155118219|NCT01514240|559865793|FG000|Overall Study|Adverse Event|4|||
155118220|NCT01514240|559865794|FG001|Overall Study|Adverse Event|4|||
155118221|NCT01514240|559865793|FG000|Overall Study|Subject Decision|2|||
155118222|NCT01514240|559865794|FG001|Overall Study|Subject Decision|7|||
155118223|NCT05013424|559865795|FG000|Overall Study|Lost to Follow-up|1|||
155118224|NCT05013424|559865796|FG001|Overall Study|Lost to Follow-up|1|||
155118225|NCT05013424|559865797|FG002|Overall Study|Lost to Follow-up|1|||
155118226|NCT05013424|559865795|FG000|Overall Study|Withdrawal by Subject|0|||
155118227|NCT05013424|559865796|FG001|Overall Study|Withdrawal by Subject|1|||
155118228|NCT05013424|559865797|FG002|Overall Study|Withdrawal by Subject|0|||
155118229|NCT04411420|559865798|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
154910822|NCT04735432|559094429|FG001|Overall Study|Other - due to personal reason|0|||
154910823|NCT04735432|559094428|FG000|Overall Study|Adverse Event|2|||
155118230|NCT04411420|559865799|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
155118231|NCT04411420|559865798|FG000|Survey Subset|Lost to Follow-up|134|||
155118232|NCT04411420|559865799|FG001|Survey Subset|Lost to Follow-up|120|||
155118233|NCT00549900|559865800|FG000|Overall Study|Adverse Event|1|||
155118234|NCT03899064|559865804|FG000|Overall Study|Lost to Follow-up|1|||
155118235|NCT03899064|559865804|FG000|Overall Study|Protocol Violation|2|||
155118236|NCT03899064|559865804|FG000|Overall Study|Withdrawal by Subject|2|||
155118237|NCT03899064|559865804|FG000|Overall Study|Other|2|||
155118238|NCT03283098|559865805|FG000|Overall Study|Withdrawal by Subject|0|||
155118239|NCT03283098|559865806|FG001|Overall Study|Withdrawal by Subject|1|||
155118240|NCT00798317|559865811|FG000|Overall Study|Physician Decision|0|||
155118241|NCT00798317|559865812|FG001|Overall Study|Physician Decision|1|||
155118242|NCT00798317|559865811|FG000|Overall Study|Withdrawal by Subject|5|||
155118243|NCT00798317|559865812|FG001|Overall Study|Withdrawal by Subject|4|||
155118244|NCT00798317|559865811|FG000|Overall Study|Lost to Follow-up|2|||
155118245|NCT00798317|559865812|FG001|Overall Study|Lost to Follow-up|2|||
155118246|NCT00798317|559865811|FG000|Overall Study|Adverse Event|2|||
155118247|NCT00798317|559865812|FG001|Overall Study|Adverse Event|0|||
155118248|NCT00798317|559865811|FG000|Overall Study|Death|1|||
155118249|NCT00798317|559865812|FG001|Overall Study|Death|0|||
155118250|NCT01278407|559865813|FG000|Confirmatory Phase|Adverse Event|5|||
155118251|NCT01278407|559865814|FG001|Confirmatory Phase|Adverse Event|10|||
155118252|NCT01278407|559865815|FG002|Confirmatory Phase|Adverse Event|1|||
155118253|NCT01278407|559865816|FG003|Confirmatory Phase|Adverse Event|0|||
155118254|NCT01278407|559865817|FG004|Confirmatory Phase|Adverse Event|0|||
155118255|NCT01278407|559865813|FG000|Confirmatory Phase|Participant's Choice|3|||
155118256|NCT01278407|559865814|FG001|Confirmatory Phase|Participant's Choice|5|||
155118257|NCT01278407|559865815|FG002|Confirmatory Phase|Participant's Choice|3|||
155118258|NCT01278407|559865816|FG003|Confirmatory Phase|Participant's Choice|0|||
155118259|NCT01278407|559865817|FG004|Confirmatory Phase|Participant's Choice|0|||
155118260|NCT01278407|559865813|FG000|Confirmatory Phase|Other|1|||
155118261|NCT01278407|559865814|FG001|Confirmatory Phase|Other|1|||
155118262|NCT01278407|559865815|FG002|Confirmatory Phase|Other|2|||
155118263|NCT01278407|559865816|FG003|Confirmatory Phase|Other|0|||
155118264|NCT01278407|559865817|FG004|Confirmatory Phase|Other|0|||
155118265|NCT01278407|559865813|FG000|Extension Phase|Adverse Event|0|||
155118266|NCT01278407|559865814|FG001|Extension Phase|Adverse Event|0|||
155118267|NCT01278407|559865815|FG002|Extension Phase|Adverse Event|0|||
155118268|NCT01278407|559865816|FG003|Extension Phase|Adverse Event|7|||
155118269|NCT01278407|559865817|FG004|Extension Phase|Adverse Event|16|||
155118270|NCT01278407|559865813|FG000|Extension Phase|Participant's Choice|0|||
155118271|NCT01278407|559865814|FG001|Extension Phase|Participant's Choice|0|||
155118272|NCT01278407|559865815|FG002|Extension Phase|Participant's Choice|0|||
155118273|NCT01278407|559865816|FG003|Extension Phase|Participant's Choice|4|||
155118274|NCT01278407|559865817|FG004|Extension Phase|Participant's Choice|11|||
155118275|NCT01278407|559865813|FG000|Extension Phase|Other|0|||
155118276|NCT01278407|559865814|FG001|Extension Phase|Other|0|||
155118277|NCT01278407|559865815|FG002|Extension Phase|Other|0|||
155118278|NCT01278407|559865816|FG003|Extension Phase|Other|1|||
155118279|NCT01278407|559865817|FG004|Extension Phase|Other|3|||
155118280|NCT02534935|559865818|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
155118281|NCT02534935|559865819|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
155118282|NCT02534935|559865820|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
155118283|NCT02534935|559865818|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
155118284|NCT02534935|559865819|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
155118285|NCT02534935|559865820|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
155118286|NCT02534935|559865818|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
155118287|NCT02534935|559865819|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
155118288|NCT02534935|559865820|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
155118289|NCT02534935|559865818|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
155118290|NCT02534935|559865819|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
155118291|NCT02534935|559865820|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
155118292|NCT02534935|559865818|FG000|Stage 1: 24 Months|Adverse Event|0|||
155118293|NCT02534935|559865819|FG001|Stage 1: 24 Months|Adverse Event|2|||
155118294|NCT02534935|559865820|FG002|Stage 1: 24 Months|Adverse Event|0|||
155118295|NCT02534935|559865818|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
155118296|NCT02534935|559865819|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
155118297|NCT02534935|559865820|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
155118298|NCT02534935|559865818|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
155118299|NCT02534935|559865819|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
155118300|NCT02534935|559865820|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
155118301|NCT01596335|559865821|FG000|Overall Study|exacerbation of primary disease|5|||
155118302|NCT01596335|559865822|FG001|Overall Study|exacerbation of primary disease|9|||
155118303|NCT01460719|559865823|FG000|Overall Study|Adverse Event|1|||
155176171|NCT00311584|560082295|FG000|Overall Study|Lack of Efficacy|12|||
154910824|NCT04735432|559094429|FG001|Overall Study|Adverse Event|0|||
155118304|NCT01460719|559865823|FG000|Overall Study|Withdrawal by Subject|1|||
155118305|NCT04431713|559865824|FG000|Overall Study|Withdrawal by Subject|2|||
155118306|NCT04431713|559865825|FG001|Overall Study|Withdrawal by Subject|0|||
155118307|NCT04431713|559865824|FG000|Overall Study|Death|2|||
155118308|NCT04431713|559865825|FG001|Overall Study|Death|2|||
155118309|NCT01344538|559865826|FG000|Overall Study|Adverse Event|1|||
155176172|NCT00311584|560082296|FG001|Overall Study|Lack of Efficacy|15|||
155118310|NCT01344538|559865827|FG001|Overall Study|Adverse Event|1|||
155118311|NCT01344538|559865826|FG000|Overall Study|Lost to Follow-up|1|||
155118312|NCT01344538|559865827|FG001|Overall Study|Lost to Follow-up|0|||
155118313|NCT01655381|559865830|FG000|Overall Study|Investigator Decision|1|||
155118314|NCT01655381|559865830|FG000|Overall Study|Moved to Another City|1|||
155118315|NCT01655381|559865830|FG000|Overall Study|Insufficient Treatment Response|1|||
155118316|NCT02324205|559865831|FG000|Overall Study|Withdrawal by Subject|37|||
155118317|NCT00613925|559865839|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
155118318|NCT00613925|559865840|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
155118319|NCT00543296|559865841|FG000|Overall Study|Physician Decision|7|||
155118320|NCT02891681|559865846|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
155118321|NCT02891681|559865847|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
155118322|NCT02891681|559865848|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
155118323|NCT02891681|559865846|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
155118324|NCT02891681|559865847|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
155118325|NCT02891681|559865848|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
155118326|NCT02891681|559865846|FG000|Overall Study|Taken off study after first imaging appointment|1|||
155118327|NCT02891681|559865847|FG001|Overall Study|Taken off study after first imaging appointment|0|||
155118328|NCT02891681|559865848|FG002|Overall Study|Taken off study after first imaging appointment|0|||
155118329|NCT01224821|559865849|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
155118330|NCT01224821|559865849|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
155118331|NCT01224821|559865849|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
155118332|NCT01224821|559865849|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
155118333|NCT01224821|559865849|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
155118334|NCT01224821|559865849|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
155118335|NCT01224821|559865849|FG000|Long-Term Follow-Up|Death|2|||
155118336|NCT01224821|559865849|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
155118337|NCT00683917|559865850|FG000|Overall Study|Study prematurely terminated|10|||
155118338|NCT02174523|559865851|FG000|Overall Study|Withdrawal by Subject|1|||
155118339|NCT02174523|559865852|FG001|Overall Study|Withdrawal by Subject|0|||
155118340|NCT03640052|559865853|FG000|Overall Study|Lost to Follow-up|0|||
155118341|NCT03640052|559865854|FG001|Overall Study|Lost to Follow-up|1|||
155118342|NCT03640052|559865855|FG002|Overall Study|Lost to Follow-up|0|||
155118343|NCT03640052|559865856|FG003|Overall Study|Lost to Follow-up|0|||
155118344|NCT03640052|559865857|FG004|Overall Study|Lost to Follow-up|0|||
155118345|NCT04422561|559865858|FG000|Overall Study|Lost to Follow-up|25|||
155118346|NCT04422561|559865859|FG001|Overall Study|Lost to Follow-up|11|||
155118347|NCT00623545|559865860|FG000|Overall Study|Adverse Event|6|||
155118348|NCT00623545|559865860|FG000|Overall Study|Withdrawal by Subject|4|||
155118349|NCT04239222|559865861|FG000|Baseline|Withdrawal by Subject|0|||
155118350|NCT04239222|559865862|FG001|Baseline|Withdrawal by Subject|0|||
155118351|NCT04239222|559865863|FG002|Baseline|Withdrawal by Subject|1|||
155118352|NCT04239222|559865864|FG003|Baseline|Withdrawal by Subject|1|||
155118353|NCT04239222|559865861|FG000|First Foot Assignment|Withdrawal by Subject|0|||
155118354|NCT04239222|559865862|FG001|First Foot Assignment|Withdrawal by Subject|0|||
155118355|NCT04239222|559865863|FG002|First Foot Assignment|Withdrawal by Subject|1|||
155118356|NCT04239222|559865864|FG003|First Foot Assignment|Withdrawal by Subject|0|||
155118357|NCT04239222|559865861|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
155118358|NCT04239222|559865862|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
155118359|NCT04239222|559865863|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
155118360|NCT04239222|559865864|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
155118361|NCT02685748|559865868|FG000|Overall Study|Withdrawal by Subject|3|||
155118362|NCT02685748|559865869|FG001|Overall Study|Withdrawal by Subject|2|||
155118363|NCT05479097|559865870|FG000|Overall Study|Withdrawal by Subject|2|||
155118364|NCT00937404|559865871|FG000|Overall Study|Protocol Violation|1|||
155118365|NCT00937404|559865871|FG000|Overall Study|Withdrawal by Subject|1|||
155118366|NCT01482169|559865878|FG000|Overall Study|Physician Decision|2|||
155118367|NCT00445848|559865879|FG000|Overall Study|Adverse Event|14|||
155118368|NCT00445848|559865879|FG000|Overall Study|Withdrawal by Subject|4|||
155118369|NCT00445848|559865879|FG000|Overall Study|Progression|62|||
155118370|NCT00445848|559865879|FG000|Overall Study|Other-Not protocol specified|5|||
155118371|NCT01185964|559865887|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
155118372|NCT01185964|559865888|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
155118373|NCT01185964|559865889|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
155118374|NCT01185964|559865890|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
155118375|NCT01185964|559865887|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
155118376|NCT01185964|559865888|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
155118377|NCT01185964|559865889|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
155118378|NCT01185964|559865890|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
155118379|NCT01185964|559865887|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
155118380|NCT01185964|559865888|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
154984738|NCT01347866|559368898|FG010|Overall Study|Lost to Follow-up|0|||
154984739|NCT01347866|559368899|FG011|Overall Study|Lost to Follow-up|0|||
154984740|NCT01347866|559368900|FG012|Overall Study|Lost to Follow-up|0|||
154984741|NCT01347866|559368901|FG013|Overall Study|Lost to Follow-up|0|||
154984742|NCT01347866|559368902|FG014|Overall Study|Lost to Follow-up|0|||
154984743|NCT01347866|559368903|FG015|Overall Study|Lost to Follow-up|0|||
154984744|NCT01347866|559368904|FG016|Overall Study|Lost to Follow-up|0|||
154984745|NCT01347866|559368888|FG000|Overall Study|Other|3|||
154984746|NCT01347866|559368889|FG001|Overall Study|Other|1|||
154984747|NCT01347866|559368890|FG002|Overall Study|Other|1|||
154984748|NCT01347866|559368891|FG003|Overall Study|Other|4|||
154984749|NCT01347866|559368892|FG004|Overall Study|Other|5|||
154984750|NCT01347866|559368893|FG005|Overall Study|Other|0|||
154984751|NCT01347866|559368894|FG006|Overall Study|Other|5|||
154984752|NCT01347866|559368895|FG007|Overall Study|Other|3|||
154984753|NCT01347866|559368896|FG008|Overall Study|Other|22|||
154984754|NCT01347866|559368897|FG009|Overall Study|Other|5|||
154984755|NCT01347866|559368898|FG010|Overall Study|Other|0|||
154984756|NCT01347866|559368899|FG011|Overall Study|Other|3|||
154984757|NCT01347866|559368900|FG012|Overall Study|Other|4|||
154984758|NCT01347866|559368901|FG013|Overall Study|Other|4|||
154984759|NCT01347866|559368902|FG014|Overall Study|Other|2|||
154984760|NCT01347866|559368903|FG015|Overall Study|Other|3|||
154984761|NCT01347866|559368904|FG016|Overall Study|Other|0|||
154984762|NCT01347866|559368888|FG000|Overall Study|Subject refused further follow-up|2|||
154984763|NCT01347866|559368889|FG001|Overall Study|Subject refused further follow-up|0|||
154984764|NCT01347866|559368890|FG002|Overall Study|Subject refused further follow-up|0|||
154984765|NCT01347866|559368891|FG003|Overall Study|Subject refused further follow-up|2|||
154984766|NCT01347866|559368892|FG004|Overall Study|Subject refused further follow-up|0|||
154984767|NCT01347866|559368893|FG005|Overall Study|Subject refused further follow-up|1|||
154984768|NCT01347866|559368894|FG006|Overall Study|Subject refused further follow-up|0|||
154984769|NCT01347866|559368895|FG007|Overall Study|Subject refused further follow-up|0|||
154984770|NCT01347866|559368896|FG008|Overall Study|Subject refused further follow-up|4|||
154984771|NCT01347866|559368897|FG009|Overall Study|Subject refused further follow-up|1|||
154984772|NCT01347866|559368898|FG010|Overall Study|Subject refused further follow-up|0|||
154984773|NCT01347866|559368899|FG011|Overall Study|Subject refused further follow-up|0|||
154984774|NCT01347866|559368900|FG012|Overall Study|Subject refused further follow-up|1|||
154984775|NCT01347866|559368901|FG013|Overall Study|Subject refused further follow-up|3|||
154984776|NCT01347866|559368902|FG014|Overall Study|Subject refused further follow-up|1|||
154984777|NCT01347866|559368903|FG015|Overall Study|Subject refused further follow-up|0|||
154984778|NCT01347866|559368904|FG016|Overall Study|Subject refused further follow-up|2|||
154984779|NCT00430950|559368905|FG000|Overall Study|Adverse Event|7|||
154984780|NCT00430950|559368906|FG001|Overall Study|Adverse Event|6|||
154984781|NCT00430950|559368905|FG000|Overall Study|Withdrawal by Subject|1|||
154984782|NCT00430950|559368906|FG001|Overall Study|Withdrawal by Subject|0|||
154984783|NCT00430950|559368905|FG000|Overall Study|concomitant medication,etc.|5|||
154984784|NCT00430950|559368906|FG001|Overall Study|concomitant medication,etc.|7|||
154984785|NCT02429934|559368909|FG000|Overall Study|Withdrawal by Subject|0|||
154984786|NCT02429934|559368910|FG001|Overall Study|Withdrawal by Subject|2|||
154984787|NCT02429934|559368909|FG000|Overall Study|Adverse Event|2|||
154984788|NCT02429934|559368910|FG001|Overall Study|Adverse Event|0|||
154984789|NCT02429934|559368909|FG000|Overall Study|Lost to Follow-up|1|||
154984790|NCT02429934|559368910|FG001|Overall Study|Lost to Follow-up|1|||
154984791|NCT02429934|559368909|FG000|Overall Study|Physician Decision|1|||
154984792|NCT02429934|559368910|FG001|Overall Study|Physician Decision|0|||
154984793|NCT00869024|559368911|FG000|Overall Study|Death|2|||
154984794|NCT00869024|559368912|FG001|Overall Study|Death|3|||
154984795|NCT00869024|559368911|FG000|Overall Study|Lost to Follow-up|0|||
154984796|NCT00869024|559368912|FG001|Overall Study|Lost to Follow-up|1|||
154984797|NCT00869024|559368911|FG000|Overall Study|Protocol Violation|0|||
154984798|NCT00869024|559368912|FG001|Overall Study|Protocol Violation|1|||
155118381|NCT01185964|559865889|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
155118382|NCT01185964|559865890|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
155118383|NCT01185964|559865887|FG000|Phase 1b and Phase 2|Adverse Event|1|||
155118384|NCT01185964|559865888|FG001|Phase 1b and Phase 2|Adverse Event|0|||
154984799|NCT00293202|559368913|FG000|Overall Study|Withdrawal by Subject|1|||
154984800|NCT00293202|559368914|FG001|Overall Study|Withdrawal by Subject|2|||
154984801|NCT00293202|559368913|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
155118385|NCT01185964|559865889|FG002|Phase 1b and Phase 2|Adverse Event|2|||
154984802|NCT00293202|559368914|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
154984803|NCT00293202|559368913|FG000|Overall Study|on-hold due to fistula maturation time|1|||
154984804|NCT00293202|559368914|FG001|Overall Study|on-hold due to fistula maturation time|0|||
154984805|NCT01564459|559368916|FG000|Run-In|Adverse Event|7|||
154984806|NCT01564459|559368917|FG001|Run-In|Adverse Event|0|||
154984807|NCT01564459|559368918|FG002|Run-In|Adverse Event|0|||
154984808|NCT01564459|559368916|FG000|Run-In|Lost to Follow-up|1|||
154984809|NCT01564459|559368917|FG001|Run-In|Lost to Follow-up|0|||
154984810|NCT01564459|559368918|FG002|Run-In|Lost to Follow-up|0|||
154984811|NCT01564459|559368916|FG000|Run-In|Non-compliance with study drug|2|||
154984812|NCT01564459|559368917|FG001|Run-In|Non-compliance with study drug|0|||
154984813|NCT01564459|559368918|FG002|Run-In|Non-compliance with study drug|0|||
154984814|NCT01564459|559368916|FG000|Run-In|Protocol Violation|1|||
154984815|NCT01564459|559368917|FG001|Run-In|Protocol Violation|0|||
154984816|NCT01564459|559368918|FG002|Run-In|Protocol Violation|0|||
154984817|NCT01564459|559368916|FG000|Run-In|Withdrawal by Subject|1|||
155118386|NCT01185964|559865890|FG003|Phase 1b and Phase 2|Adverse Event|0|||
155118387|NCT01185964|559865887|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
155118388|NCT01185964|559865888|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
155118389|NCT01185964|559865889|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
155118390|NCT01185964|559865890|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
155118391|NCT01185964|559865887|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
155176173|NCT00311584|560082295|FG000|Overall Study|Physician Decision|4|||
154910825|NCT04657003|559094430|FG000|Overall Study|Adverse Event|5|||
154910826|NCT04657003|559094431|FG001|Overall Study|Adverse Event|1|||
154910827|NCT04657003|559094432|FG002|Overall Study|Adverse Event|5|||
154910828|NCT04657003|559094430|FG000|Overall Study|Death|0|||
154910829|NCT04657003|559094431|FG001|Overall Study|Death|2|||
154910830|NCT04657003|559094432|FG002|Overall Study|Death|0|||
154910831|NCT04657003|559094430|FG000|Overall Study|Lost to Follow-up|8|||
154910832|NCT04657003|559094431|FG001|Overall Study|Lost to Follow-up|4|||
154910833|NCT04657003|559094432|FG002|Overall Study|Lost to Follow-up|10|||
154910834|NCT04657003|559094430|FG000|Overall Study|Other - As Reported by Investigator|3|||
154910835|NCT04657003|559094431|FG001|Overall Study|Other - As Reported by Investigator|2|||
154910836|NCT04657003|559094432|FG002|Overall Study|Other - As Reported by Investigator|2|||
154910837|NCT04657003|559094430|FG000|Overall Study|Pregnancy|2|||
154910838|NCT04657003|559094431|FG001|Overall Study|Pregnancy|0|||
154910839|NCT04657003|559094432|FG002|Overall Study|Pregnancy|2|||
154910840|NCT04657003|559094430|FG000|Overall Study|Withdrawal by Subject|16|||
154910841|NCT04657003|559094431|FG001|Overall Study|Withdrawal by Subject|7|||
154910842|NCT04657003|559094432|FG002|Overall Study|Withdrawal by Subject|10|||
154910843|NCT01823991|559094435|FG000|Overall Study|Withdrawal by Subject|8|||
154910844|NCT01823991|559094436|FG001|Overall Study|Withdrawal by Subject|5|||
154910845|NCT05158244|559094437|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
154910846|NCT05158244|559094438|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
154910847|NCT05158244|559094439|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
154910848|NCT05158244|559094440|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
154910849|NCT05158244|559094441|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
154910850|NCT05158244|559094437|FG000|Overall Study|Withdrawal by Subject|0|||
154910851|NCT05158244|559094438|FG001|Overall Study|Withdrawal by Subject|0|||
154910852|NCT05158244|559094439|FG002|Overall Study|Withdrawal by Subject|1|||
154910853|NCT05158244|559094440|FG003|Overall Study|Withdrawal by Subject|0|||
154910854|NCT05158244|559094441|FG004|Overall Study|Withdrawal by Subject|0|||
154910855|NCT02408016|559094443|FG000|Overall Study|Death|6|||
154910856|NCT02408016|559094444|FG001|Overall Study|Death|1|||
154910857|NCT02408016|559094445|FG002|Overall Study|Death|0|||
154910858|NCT02408016|559094443|FG000|Overall Study|Physician Decision|0|||
154910859|NCT02408016|559094444|FG001|Overall Study|Physician Decision|2|||
154910860|NCT02408016|559094445|FG002|Overall Study|Physician Decision|0|||
154910861|NCT00805194|559094446|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
154910862|NCT00805194|559094447|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
154910863|NCT00805194|559094446|FG000|Overall Study|Worsening or AE of underlying disease|64|||
154910864|NCT00805194|559094447|FG001|Overall Study|Worsening or AE of underlying disease|70|||
154910865|NCT00805194|559094446|FG000|Overall Study|Other AE|84|||
154910866|NCT00805194|559094447|FG001|Overall Study|Other AE|73|||
154910867|NCT00805194|559094446|FG000|Overall Study|Protocol Violation|9|||
154910868|NCT00805194|559094447|FG001|Overall Study|Protocol Violation|9|||
154910869|NCT00805194|559094446|FG000|Overall Study|Lost to Follow-up|5|||
154910870|NCT00805194|559094447|FG001|Overall Study|Lost to Follow-up|5|||
154910871|NCT00805194|559094446|FG000|Overall Study|Withdrawal by Subject|60|||
154910872|NCT00805194|559094447|FG001|Overall Study|Withdrawal by Subject|42|||
154910873|NCT00805194|559094446|FG000|Overall Study|Not treated|3|||
154910874|NCT00805194|559094447|FG001|Overall Study|Not treated|4|||
154910875|NCT00805194|559094446|FG000|Overall Study|Reasons other than stated above|20|||
154910876|NCT00805194|559094447|FG001|Overall Study|Reasons other than stated above|16|||
154910877|NCT02185040|559094451|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
154910878|NCT02185040|559094452|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
154910879|NCT02185040|559094453|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
154910880|NCT02185040|559094454|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
154910881|NCT02185040|559094455|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
154910882|NCT02185040|559094456|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
154910883|NCT02185040|559094457|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
154984818|NCT01564459|559368917|FG001|Run-In|Withdrawal by Subject|0|||
154984819|NCT01564459|559368918|FG002|Run-In|Withdrawal by Subject|0|||
154984820|NCT01564459|559368916|FG000|Double-blind Treatment|Adverse Event|0|||
154984821|NCT01564459|559368917|FG001|Double-blind Treatment|Adverse Event|0|||
154984822|NCT01564459|559368918|FG002|Double-blind Treatment|Adverse Event|1|||
154984823|NCT02025751|559368926|FG000|Overall Study|Lost to Follow-up|1|||
154984824|NCT02025751|559368927|FG001|Overall Study|Lost to Follow-up|0|||
154984825|NCT02025751|559368926|FG000|Overall Study|Adverse Event|0|||
154984826|NCT02025751|559368927|FG001|Overall Study|Adverse Event|1|||
154984827|NCT02025751|559368926|FG000|Overall Study|Physician Decision|0|||
154984828|NCT02025751|559368927|FG001|Overall Study|Physician Decision|1|||
154984829|NCT02025751|559368926|FG000|Overall Study|Withdrawal by Subject|0|||
154984830|NCT02025751|559368927|FG001|Overall Study|Withdrawal by Subject|1|||
154984831|NCT02181296|559368928|FG000|Overall Study|Lost to Follow-up|7|||
154984832|NCT02181296|559368929|FG001|Overall Study|Lost to Follow-up|6|||
154984833|NCT03864042|559368930|FG000|DDI Phase|Adverse Event|2|||
154984834|NCT03864042|559368931|FG001|DDI Phase|Adverse Event|0|||
154984835|NCT03864042|559368932|FG002|DDI Phase|Adverse Event|0|||
154984836|NCT03864042|559368930|FG000|DDI Phase|Physician Decision|1|||
154984837|NCT03864042|559368931|FG001|DDI Phase|Physician Decision|0|||
154984838|NCT03864042|559368932|FG002|DDI Phase|Physician Decision|0|||
154984839|NCT03864042|559368930|FG000|DDI Phase|Progressive Disease|1|||
154984840|NCT03864042|559368931|FG001|DDI Phase|Progressive Disease|0|||
154984841|NCT03864042|559368932|FG002|DDI Phase|Progressive Disease|0|||
154984842|NCT03864042|559368930|FG000|Post-DDI Phase|Adverse Event|5|||
154984843|NCT03864042|559368931|FG001|Post-DDI Phase|Adverse Event|3|||
154984844|NCT03864042|559368932|FG002|Post-DDI Phase|Adverse Event|2|||
154984845|NCT03864042|559368930|FG000|Post-DDI Phase|Progressive Disease|11|||
154984846|NCT03864042|559368931|FG001|Post-DDI Phase|Progressive Disease|6|||
154984847|NCT03864042|559368932|FG002|Post-DDI Phase|Progressive Disease|13|||
154984848|NCT03864042|559368930|FG000|Post-DDI Phase|Discretion of investigator|1|||
154984849|NCT03864042|559368931|FG001|Post-DDI Phase|Discretion of investigator|1|||
154984850|NCT03864042|559368932|FG002|Post-DDI Phase|Discretion of investigator|0|||
154984851|NCT03864042|559368930|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
154984852|NCT03864042|559368931|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
154984853|NCT03864042|559368932|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
154984854|NCT03864042|559368930|FG000|Post-DDI Phase|Withdrawal of consent|1|||
154984855|NCT03864042|559368931|FG001|Post-DDI Phase|Withdrawal of consent|2|||
154984856|NCT03864042|559368932|FG002|Post-DDI Phase|Withdrawal of consent|0|||
154984857|NCT00766831|559368935|FG000|Overall Study|Withdrawal by Subject|4|||
154984858|NCT00766831|559368935|FG000|Overall Study|Lost to Follow-up|3|||
154984859|NCT00766831|559368935|FG000|Overall Study|Adverse Event|20|||
154984860|NCT00766831|559368935|FG000|Overall Study|Protocol Violation|15|||
154984861|NCT00766831|559368935|FG000|Overall Study|Physician Decision|5|||
154984862|NCT00766831|559368935|FG000|Overall Study|Withdrawal of consent|26|||
154984863|NCT00766831|559368935|FG000|Overall Study|Non cooperation by participants|14|||
154984864|NCT00766831|559368935|FG000|Overall Study|Other|28|||
154984865|NCT00788593|559368938|FG000|Placebo Run-in Phase|Adverse Event|2|||
154984866|NCT00788593|559368939|FG001|Placebo Run-in Phase|Adverse Event|0|||
154984867|NCT00788593|559368940|FG002|Placebo Run-in Phase|Adverse Event|0|||
154984868|NCT00788593|559368938|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
154984869|NCT00788593|559368939|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
154984870|NCT00788593|559368940|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
154984871|NCT00788593|559368938|FG000|Placebo Run-in Phase|Protocol Violation|2|||
154984872|NCT00788593|559368939|FG001|Placebo Run-in Phase|Protocol Violation|0|||
154984873|NCT00788593|559368940|FG002|Placebo Run-in Phase|Protocol Violation|0|||
154910884|NCT02185040|559094451|FG000|Part 1 Treatment Phase|Adverse Event|1|||
154910885|NCT02185040|559094452|FG001|Part 1 Treatment Phase|Adverse Event|0|||
154910886|NCT02185040|559094453|FG002|Part 1 Treatment Phase|Adverse Event|0|||
154910887|NCT02185040|559094454|FG003|Part 1 Treatment Phase|Adverse Event|2|||
154910888|NCT02185040|559094455|FG004|Part 1 Treatment Phase|Adverse Event|3|||
154910889|NCT02185040|559094456|FG005|Part 1 Treatment Phase|Adverse Event|0|||
154910890|NCT02185040|559094457|FG006|Part 1 Treatment Phase|Adverse Event|0|||
154910891|NCT02185040|559094451|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
154910892|NCT02185040|559094452|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
154910893|NCT02185040|559094453|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
154910894|NCT02185040|559094454|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
154984874|NCT00788593|559368938|FG000|First Intervention Period|Adverse Event|0|||
154984875|NCT00788593|559368939|FG001|First Intervention Period|Adverse Event|1|||
154984876|NCT00788593|559368940|FG002|First Intervention Period|Adverse Event|0|||
154984877|NCT00788593|559368938|FG000|Second Intervention Period|Lost to Follow-up|0|||
154984878|NCT00788593|559368939|FG001|Second Intervention Period|Lost to Follow-up|1|||
154910895|NCT02185040|559094455|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
154910896|NCT02185040|559094456|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
154910897|NCT02185040|559094457|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
154984879|NCT00788593|559368940|FG002|Second Intervention Period|Lost to Follow-up|0|||
155118392|NCT01185964|559865888|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
155118393|NCT01185964|559865889|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
155118394|NCT01185964|559865890|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
155118395|NCT01185964|559865887|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
155118396|NCT01185964|559865888|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
155118397|NCT01185964|559865889|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
155118398|NCT01185964|559865890|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
155118399|NCT01185964|559865887|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
155118400|NCT01185964|559865888|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
155118401|NCT01185964|559865889|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
155118402|NCT01185964|559865890|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
155118403|NCT04465877|559865891|FG000|Overall Study|Noncompliant with study requirements|0|||
155118404|NCT04465877|559865892|FG001|Overall Study|Noncompliant with study requirements|0|||
155118405|NCT04465877|559865893|FG002|Overall Study|Noncompliant with study requirements|1|||
155118406|NCT04465877|559865894|FG003|Overall Study|Noncompliant with study requirements|0|||
155118407|NCT02323204|559865897|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
155118408|NCT02323204|559865898|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
155118409|NCT02323204|559865899|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
155118410|NCT02323204|559865900|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
155118411|NCT02323204|559865897|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
155118412|NCT02323204|559865898|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
155118413|NCT02323204|559865899|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
155118414|NCT02323204|559865900|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
155118415|NCT02323204|559865897|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
155118416|NCT02323204|559865898|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
155118417|NCT02323204|559865899|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
155118418|NCT02323204|559865900|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
155118419|NCT02323204|559865897|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
155118420|NCT02323204|559865898|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
155118421|NCT02323204|559865899|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
155118422|NCT02323204|559865900|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
155118423|NCT02323204|559865897|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
155118424|NCT02323204|559865898|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
155118425|NCT02323204|559865899|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
155118426|NCT02323204|559865900|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
155118427|NCT02323204|559865897|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
155118428|NCT02323204|559865898|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
155118429|NCT02323204|559865899|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
155118430|NCT02323204|559865900|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
155118431|NCT02323204|559865897|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155118432|NCT02323204|559865898|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
155118433|NCT02323204|559865899|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155118434|NCT02323204|559865900|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
155118435|NCT02323204|559865897|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
155118436|NCT02323204|559865898|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
155118437|NCT02323204|559865899|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
155118438|NCT02323204|559865900|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
155118439|NCT02323204|559865897|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155118440|NCT02323204|559865898|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
155118441|NCT02323204|559865899|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
155118442|NCT02323204|559865900|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
155118443|NCT03440918|559865906|FG000|Overall Study|Protocol Violation|0|||
155118444|NCT03440918|559865907|FG001|Overall Study|Protocol Violation|16|||
155118445|NCT01396265|559865919|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
155118446|NCT04962230|559865920|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
155118447|NCT04962230|559865920|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
155118448|NCT03444766|559865921|FG000|Overall Study|Other Reasons|2|||
155118449|NCT03444766|559865921|FG000|Overall Study|Participant Withdrew Consent|5|||
155118450|NCT03444766|559865921|FG000|Overall Study|Lost to Follow-up|2|||
155118451|NCT03444766|559865921|FG000|Overall Study|Death|2|||
154910898|NCT02185040|559094451|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
154910899|NCT02185040|559094452|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
154910900|NCT02185040|559094453|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
154910901|NCT02185040|559094454|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
154910902|NCT02185040|559094455|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
154910903|NCT02185040|559094456|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
154910904|NCT02185040|559094457|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
154910905|NCT02185040|559094451|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
154910906|NCT02185040|559094452|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
154910907|NCT02185040|559094453|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
154910908|NCT02185040|559094454|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
154910909|NCT02185040|559094455|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
154910910|NCT02185040|559094456|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
154910911|NCT02185040|559094457|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
154910912|NCT02185040|559094451|FG000|Active Treatment Extension Phase|Adverse Event|0|||
154910913|NCT02185040|559094452|FG001|Active Treatment Extension Phase|Adverse Event|0|||
154910914|NCT02185040|559094453|FG002|Active Treatment Extension Phase|Adverse Event|0|||
154910915|NCT02185040|559094454|FG003|Active Treatment Extension Phase|Adverse Event|0|||
154910916|NCT02185040|559094455|FG004|Active Treatment Extension Phase|Adverse Event|0|||
154910917|NCT02185040|559094456|FG005|Active Treatment Extension Phase|Adverse Event|1|||
154910918|NCT02185040|559094457|FG006|Active Treatment Extension Phase|Adverse Event|4|||
154910919|NCT02185040|559094451|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
154910920|NCT02185040|559094452|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
154910921|NCT02185040|559094453|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
154910922|NCT02185040|559094454|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
154910923|NCT02185040|559094455|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
154910924|NCT02185040|559094456|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
154910925|NCT02185040|559094457|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
154910926|NCT02185040|559094451|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
154910927|NCT02185040|559094452|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
154910928|NCT02185040|559094453|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
154910929|NCT02185040|559094454|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
154910930|NCT02185040|559094455|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
154910931|NCT02185040|559094456|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
154910932|NCT02185040|559094457|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
154910933|NCT03557801|559094460|FG000|Overall Study|Protocol Violation|1|||
154910934|NCT03557801|559094461|FG001|Overall Study|Protocol Violation|0|||
154910935|NCT03557801|559094462|FG002|Overall Study|Protocol Violation|0|||
154910936|NCT03557801|559094460|FG000|Overall Study|Withdrawal by Subject|1|||
154910937|NCT03557801|559094461|FG001|Overall Study|Withdrawal by Subject|0|||
154910938|NCT03557801|559094462|FG002|Overall Study|Withdrawal by Subject|3|||
154910939|NCT03557801|559094460|FG000|Overall Study|Lost to Follow-up|0|||
154910940|NCT03557801|559094461|FG001|Overall Study|Lost to Follow-up|1|||
154910941|NCT03557801|559094462|FG002|Overall Study|Lost to Follow-up|0|||
154910942|NCT00535236|559094463|FG000|Overall Study|Adverse Event|1|||
154910943|NCT00535236|559094464|FG001|Overall Study|Adverse Event|0|||
154910944|NCT00535236|559094465|FG002|Overall Study|Adverse Event|9|||
154910945|NCT00535236|559094466|FG003|Overall Study|Adverse Event|3|||
154910946|NCT00535236|559094467|FG004|Overall Study|Adverse Event|3|||
154910947|NCT00535236|559094468|FG005|Overall Study|Adverse Event|0|||
154910948|NCT00535236|559094469|FG006|Overall Study|Adverse Event|5|||
154910949|NCT00535236|559094470|FG007|Overall Study|Adverse Event|1|||
154910950|NCT00535236|559094471|FG008|Overall Study|Adverse Event|2|||
154910951|NCT00535236|559094472|FG009|Overall Study|Adverse Event|1|||
154910952|NCT00535236|559094463|FG000|Overall Study|Lost to Follow-up|1|||
154910953|NCT00535236|559094464|FG001|Overall Study|Lost to Follow-up|2|||
154910954|NCT00535236|559094465|FG002|Overall Study|Lost to Follow-up|0|||
154910955|NCT00535236|559094466|FG003|Overall Study|Lost to Follow-up|0|||
154910956|NCT00535236|559094467|FG004|Overall Study|Lost to Follow-up|2|||
154910957|NCT00535236|559094468|FG005|Overall Study|Lost to Follow-up|0|||
154910958|NCT00535236|559094469|FG006|Overall Study|Lost to Follow-up|0|||
154910959|NCT00535236|559094470|FG007|Overall Study|Lost to Follow-up|0|||
154910960|NCT00535236|559094471|FG008|Overall Study|Lost to Follow-up|6|||
154910961|NCT00535236|559094472|FG009|Overall Study|Lost to Follow-up|1|||
154910962|NCT00535236|559094463|FG000|Overall Study|Physician Decision|0|||
154910963|NCT00535236|559094464|FG001|Overall Study|Physician Decision|0|||
154910964|NCT00535236|559094465|FG002|Overall Study|Physician Decision|0|||
154910965|NCT00535236|559094466|FG003|Overall Study|Physician Decision|0|||
154910966|NCT00535236|559094467|FG004|Overall Study|Physician Decision|1|||
154910967|NCT00535236|559094468|FG005|Overall Study|Physician Decision|0|||
155118452|NCT03444766|559865921|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
155118453|NCT03444766|559865921|FG000|Overall Study|Disease Progression|49|||
155118454|NCT01598753|559865922|FG000|Overall Study|Adverse Event|1|||
155118455|NCT01598753|559865923|FG001|Overall Study|Adverse Event|9|||
154910968|NCT00535236|559094469|FG006|Overall Study|Physician Decision|1|||
154910969|NCT00535236|559094470|FG007|Overall Study|Physician Decision|0|||
154910970|NCT00535236|559094471|FG008|Overall Study|Physician Decision|0|||
154910971|NCT00535236|559094472|FG009|Overall Study|Physician Decision|0|||
154910972|NCT00535236|559094463|FG000|Overall Study|Protocol Violation|2|||
154910973|NCT00535236|559094464|FG001|Overall Study|Protocol Violation|0|||
154910974|NCT00535236|559094465|FG002|Overall Study|Protocol Violation|1|||
155118456|NCT01598753|559865924|FG002|Overall Study|Adverse Event|1|||
154984880|NCT00788593|559368938|FG000|Second Intervention Period|Other|0|||
154984881|NCT00788593|559368939|FG001|Second Intervention Period|Other|0|||
154984882|NCT00788593|559368940|FG002|Second Intervention Period|Other|1|||
154984883|NCT01392326|559368941|FG000|Overall Study|Death|2|||
154984884|NCT01392326|559368942|FG001|Overall Study|Death|0|||
154984885|NCT01392326|559368943|FG002|Overall Study|Death|0|||
154984886|NCT01392326|559368941|FG000|Overall Study|Withdrawal by Subject|12|||
154984887|NCT01392326|559368942|FG001|Overall Study|Withdrawal by Subject|11|||
154984888|NCT01392326|559368943|FG002|Overall Study|Withdrawal by Subject|15|||
154984889|NCT01392326|559368941|FG000|Overall Study|Protocol Violation|2|||
154984890|NCT01392326|559368942|FG001|Overall Study|Protocol Violation|0|||
154984891|NCT01392326|559368943|FG002|Overall Study|Protocol Violation|0|||
154984892|NCT01392326|559368941|FG000|Overall Study|Pregnancy|0|||
154984893|NCT01392326|559368942|FG001|Overall Study|Pregnancy|0|||
154984894|NCT01392326|559368943|FG002|Overall Study|Pregnancy|1|||
154984895|NCT01392326|559368941|FG000|Overall Study|Physician Decision|7|||
154984896|NCT01392326|559368942|FG001|Overall Study|Physician Decision|5|||
154984897|NCT01392326|559368943|FG002|Overall Study|Physician Decision|2|||
154984898|NCT01392326|559368941|FG000|Overall Study|Lost to Follow-up|1|||
154984899|NCT01392326|559368942|FG001|Overall Study|Lost to Follow-up|3|||
154984900|NCT01392326|559368943|FG002|Overall Study|Lost to Follow-up|4|||
154984901|NCT01392326|559368941|FG000|Overall Study|Lack of Efficacy|14|||
154984902|NCT01392326|559368942|FG001|Overall Study|Lack of Efficacy|10|||
154984903|NCT01392326|559368943|FG002|Overall Study|Lack of Efficacy|15|||
154984904|NCT01392326|559368941|FG000|Overall Study|Adverse Event|9|||
154984905|NCT01392326|559368942|FG001|Overall Study|Adverse Event|6|||
154984906|NCT01392326|559368943|FG002|Overall Study|Adverse Event|11|||
154984907|NCT00518622|559368944|FG000|Overall Study|Lost to Follow-up|0|||
154984908|NCT00518622|559368945|FG001|Overall Study|Lost to Follow-up|0|||
154984909|NCT00518622|559368946|FG002|Overall Study|Lost to Follow-up|1|||
154984910|NCT00518622|559368947|FG003|Overall Study|Lost to Follow-up|0|||
154984911|NCT00518622|559368948|FG004|Overall Study|Lost to Follow-up|0|||
154984912|NCT00518622|559368949|FG005|Overall Study|Lost to Follow-up|0|||
154984913|NCT00518622|559368950|FG006|Overall Study|Lost to Follow-up|0|||
154984914|NCT00518622|559368951|FG007|Overall Study|Lost to Follow-up|0|||
154984915|NCT00518622|559368944|FG000|Overall Study|Study medication taken incorrectly|0|||
154984916|NCT00518622|559368945|FG001|Overall Study|Study medication taken incorrectly|1|||
154984917|NCT00518622|559368946|FG002|Overall Study|Study medication taken incorrectly|0|||
154984918|NCT00518622|559368947|FG003|Overall Study|Study medication taken incorrectly|0|||
154984919|NCT00518622|559368948|FG004|Overall Study|Study medication taken incorrectly|0|||
154984920|NCT00518622|559368949|FG005|Overall Study|Study medication taken incorrectly|0|||
154984921|NCT00518622|559368950|FG006|Overall Study|Study medication taken incorrectly|0|||
154984922|NCT00518622|559368951|FG007|Overall Study|Study medication taken incorrectly|0|||
154984923|NCT03499119|559368952|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
154984924|NCT03499119|559368953|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
154984925|NCT03499119|559368954|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
154984926|NCT03499119|559368955|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
154984927|NCT03499119|559368952|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
154984928|NCT03499119|559368953|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
154984929|NCT03499119|559368954|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
154984930|NCT03499119|559368955|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
154984931|NCT03499119|559368952|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
154984932|NCT03499119|559368953|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
154984933|NCT03499119|559368954|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
154984934|NCT03499119|559368955|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
154984935|NCT03499119|559368952|FG000|Optional Extension Phase|Lost to Follow-up|0|||
154984936|NCT03499119|559368953|FG001|Optional Extension Phase|Lost to Follow-up|0|||
154984937|NCT03499119|559368954|FG002|Optional Extension Phase|Lost to Follow-up|0|||
154984938|NCT03499119|559368955|FG003|Optional Extension Phase|Lost to Follow-up|1|||
154984939|NCT03499119|559368952|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
154984940|NCT03499119|559368953|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
154984941|NCT03499119|559368954|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
154984942|NCT03499119|559368955|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
154984943|NCT03499119|559368952|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
154984944|NCT03499119|559368953|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
154984945|NCT03499119|559368954|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
154984946|NCT03499119|559368955|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
154984947|NCT02333487|559368956|FG000|Overall Study|Adverse Event|0|||
154984948|NCT02333487|559368957|FG001|Overall Study|Adverse Event|2|||
154984949|NCT02333487|559368958|FG002|Overall Study|Adverse Event|0|||
154984950|NCT00123955|559368959|FG000|Overall Study|Adverse Event|1|||
154984951|NCT00123955|559368960|FG001|Overall Study|Adverse Event|0|||
154984952|NCT00123955|559368959|FG000|Overall Study|Withdrawal by Subject|4|||
154984953|NCT00123955|559368960|FG001|Overall Study|Withdrawal by Subject|3|||
154984954|NCT00123955|559368959|FG000|Overall Study|Death|0|||
154984955|NCT00123955|559368960|FG001|Overall Study|Death|1|||
155118457|NCT01598753|559865925|FG003|Overall Study|Adverse Event|7|||
155118458|NCT01598753|559865922|FG000|Overall Study|Lost to Follow-up|4|||
155118459|NCT01598753|559865923|FG001|Overall Study|Lost to Follow-up|3|||
155118460|NCT01598753|559865924|FG002|Overall Study|Lost to Follow-up|7|||
155118461|NCT01598753|559865925|FG003|Overall Study|Lost to Follow-up|5|||
155118462|NCT01598753|559865922|FG000|Overall Study|Physician Decision|0|||
155118463|NCT01598753|559865923|FG001|Overall Study|Physician Decision|1|||
155118464|NCT01598753|559865924|FG002|Overall Study|Physician Decision|0|||
155118465|NCT01598753|559865925|FG003|Overall Study|Physician Decision|2|||
155118466|NCT01598753|559865922|FG000|Overall Study|Withdrawal by Subject|7|||
155118467|NCT01598753|559865923|FG001|Overall Study|Withdrawal by Subject|2|||
155118468|NCT01598753|559865924|FG002|Overall Study|Withdrawal by Subject|0|||
155118469|NCT01598753|559865925|FG003|Overall Study|Withdrawal by Subject|1|||
155118470|NCT04346108|559865926|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
155118471|NCT04346108|559865927|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
155118472|NCT04346108|559865928|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
155118473|NCT04346108|559865926|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
155118474|NCT04346108|559865927|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
155118475|NCT04346108|559865928|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
155118476|NCT01081301|559865929|FG000|Overall Study|Bereaved|3|||
155118477|NCT01081301|559865929|FG000|Overall Study|Too busy|5|||
155118478|NCT01081301|559865929|FG000|Overall Study|Patient too ill|2|||
155118479|NCT01081301|559865929|FG000|Overall Study|Lost to Follow-up|4|||
155118480|NCT02046226|559865930|FG000|Overall Study|Lost to Follow-up|7|||
155118481|NCT01095653|559865931|FG000|Overall Study|Lack of Efficacy|3|||
155118482|NCT01095653|559865932|FG001|Overall Study|Lack of Efficacy|0|||
155118483|NCT01095653|559865933|FG002|Overall Study|Lack of Efficacy|0|||
155118484|NCT01095653|559865931|FG000|Overall Study|Adverse Event|1|||
155118485|NCT01095653|559865932|FG001|Overall Study|Adverse Event|4|||
155118486|NCT01095653|559865933|FG002|Overall Study|Adverse Event|4|||
155118487|NCT01095653|559865931|FG000|Overall Study|Lost to Follow-up|1|||
155118488|NCT01095653|559865932|FG001|Overall Study|Lost to Follow-up|0|||
155118489|NCT01095653|559865933|FG002|Overall Study|Lost to Follow-up|4|||
155118490|NCT01095653|559865931|FG000|Overall Study|Withdrawal by Subject|4|||
155118491|NCT01095653|559865932|FG001|Overall Study|Withdrawal by Subject|5|||
155118492|NCT01095653|559865933|FG002|Overall Study|Withdrawal by Subject|3|||
155118493|NCT01095653|559865931|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
155118494|NCT01095653|559865932|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
155118495|NCT01095653|559865933|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
155118496|NCT00171925|559865934|FG000|Overall Study|Adverse Event|10|||
155118497|NCT00171925|559865935|FG001|Overall Study|Adverse Event|6|||
155118498|NCT00171925|559865934|FG000|Overall Study|Protocol Violation|1|||
155118499|NCT00171925|559865935|FG001|Overall Study|Protocol Violation|1|||
155118500|NCT00171925|559865934|FG000|Overall Study|Withdrawal by Subject|6|||
155118501|NCT00171925|559865935|FG001|Overall Study|Withdrawal by Subject|9|||
155118502|NCT00171925|559865934|FG000|Overall Study|Lost to Follow-up|2|||
155118503|NCT00171925|559865935|FG001|Overall Study|Lost to Follow-up|2|||
155118504|NCT00171925|559865934|FG000|Overall Study|Administrative problems|10|||
155118505|NCT00171925|559865935|FG001|Overall Study|Administrative problems|11|||
155118506|NCT00171925|559865934|FG000|Overall Study|Death|1|||
155118507|NCT00171925|559865935|FG001|Overall Study|Death|2|||
155118508|NCT02692040|559865936|FG000|Overall Study|Protocol Violation|0|||
155118509|NCT02692040|559865937|FG001|Overall Study|Protocol Violation|0|||
155118510|NCT02692040|559865938|FG002|Overall Study|Protocol Violation|0|||
155118511|NCT02692040|559865939|FG003|Overall Study|Protocol Violation|0|||
155118512|NCT02692040|559865940|FG004|Overall Study|Protocol Violation|0|||
155118513|NCT02692040|559865941|FG005|Overall Study|Protocol Violation|0|||
155118514|NCT02692040|559865942|FG006|Overall Study|Protocol Violation|0|||
155118515|NCT02692040|559865943|FG007|Overall Study|Protocol Violation|0|||
155118516|NCT02692040|559865944|FG008|Overall Study|Protocol Violation|0|||
155118517|NCT02692040|559865945|FG009|Overall Study|Protocol Violation|0|||
155118518|NCT02692040|559865946|FG010|Overall Study|Protocol Violation|0|||
155118519|NCT02692040|559865947|FG011|Overall Study|Protocol Violation|0|||
155176174|NCT00311584|560082296|FG001|Overall Study|Physician Decision|5|||
155176175|NCT00311584|560082295|FG000|Overall Study|Withdrawal by Subject|1|||
155118520|NCT02692040|559865948|FG012|Overall Study|Protocol Violation|1|||
155118521|NCT02692040|559865949|FG013|Overall Study|Protocol Violation|0|||
155118522|NCT02692040|559865950|FG014|Overall Study|Protocol Violation|0|||
155176176|NCT00311584|560082296|FG001|Overall Study|Withdrawal by Subject|1|||
155176177|NCT00311584|560082295|FG000|Overall Study|ineligible|2|||
155176178|NCT00311584|560082296|FG001|Overall Study|ineligible|2|||
155118523|NCT02692040|559865951|FG015|Overall Study|Protocol Violation|0|||
155118524|NCT02692040|559865952|FG016|Overall Study|Protocol Violation|0|||
155118525|NCT02692040|559865936|FG000|Overall Study|Adverse Event|0|||
155118526|NCT02692040|559865937|FG001|Overall Study|Adverse Event|0|||
155118527|NCT02692040|559865938|FG002|Overall Study|Adverse Event|0|||
155118528|NCT02692040|559865939|FG003|Overall Study|Adverse Event|0|||
155176179|NCT01454778|560082297|FG000|Overall Study|Lost to Follow-up|2|||
154910975|NCT00535236|559094466|FG003|Overall Study|Protocol Violation|0|||
154910976|NCT00535236|559094467|FG004|Overall Study|Protocol Violation|0|||
154910977|NCT00535236|559094468|FG005|Overall Study|Protocol Violation|0|||
154910978|NCT00535236|559094469|FG006|Overall Study|Protocol Violation|0|||
154910979|NCT00535236|559094470|FG007|Overall Study|Protocol Violation|0|||
154910980|NCT00535236|559094471|FG008|Overall Study|Protocol Violation|1|||
154910981|NCT00535236|559094472|FG009|Overall Study|Protocol Violation|0|||
154910982|NCT00535236|559094463|FG000|Overall Study|Withdrawal by Subject|3|||
154910983|NCT00535236|559094464|FG001|Overall Study|Withdrawal by Subject|0|||
154910984|NCT00535236|559094465|FG002|Overall Study|Withdrawal by Subject|2|||
154910985|NCT00535236|559094466|FG003|Overall Study|Withdrawal by Subject|1|||
154910986|NCT00535236|559094467|FG004|Overall Study|Withdrawal by Subject|6|||
154910987|NCT00535236|559094468|FG005|Overall Study|Withdrawal by Subject|1|||
154910988|NCT00535236|559094469|FG006|Overall Study|Withdrawal by Subject|5|||
154910989|NCT00535236|559094470|FG007|Overall Study|Withdrawal by Subject|0|||
154910990|NCT00535236|559094471|FG008|Overall Study|Withdrawal by Subject|4|||
154910991|NCT00535236|559094472|FG009|Overall Study|Withdrawal by Subject|2|||
154910992|NCT00141297|559094474|FG000|Overall Study|Adverse Event|0|||
154910993|NCT00141297|559094475|FG001|Overall Study|Adverse Event|0|||
154910994|NCT00141297|559094476|FG002|Overall Study|Adverse Event|1|||
154910995|NCT00141297|559094477|FG003|Overall Study|Adverse Event|0|||
154910996|NCT00141297|559094478|FG004|Overall Study|Adverse Event|1|||
154910997|NCT00141297|559094479|FG005|Overall Study|Adverse Event|1|||
154910998|NCT00141297|559094480|FG006|Overall Study|Adverse Event|0|||
154910999|NCT00141297|559094481|FG007|Overall Study|Adverse Event|1|||
154911000|NCT00141297|559094482|FG008|Overall Study|Adverse Event|1|||
154911001|NCT00141297|559094483|FG009|Overall Study|Adverse Event|0|||
154911002|NCT00141297|559094474|FG000|Overall Study|Death|1|||
154911003|NCT00141297|559094475|FG001|Overall Study|Death|0|||
154911004|NCT00141297|559094476|FG002|Overall Study|Death|0|||
154911005|NCT00141297|559094477|FG003|Overall Study|Death|0|||
154911006|NCT00141297|559094478|FG004|Overall Study|Death|0|||
154911007|NCT00141297|559094479|FG005|Overall Study|Death|0|||
154911008|NCT00141297|559094480|FG006|Overall Study|Death|0|||
154911009|NCT00141297|559094481|FG007|Overall Study|Death|0|||
154911010|NCT00141297|559094482|FG008|Overall Study|Death|1|||
154911011|NCT00141297|559094483|FG009|Overall Study|Death|0|||
154911012|NCT00141297|559094474|FG000|Overall Study|Withdrawal by Subject|0|||
154911013|NCT00141297|559094475|FG001|Overall Study|Withdrawal by Subject|0|||
154911014|NCT00141297|559094476|FG002|Overall Study|Withdrawal by Subject|0|||
154911015|NCT00141297|559094477|FG003|Overall Study|Withdrawal by Subject|0|||
154911016|NCT00141297|559094478|FG004|Overall Study|Withdrawal by Subject|0|||
154911017|NCT00141297|559094479|FG005|Overall Study|Withdrawal by Subject|0|||
154911018|NCT00141297|559094480|FG006|Overall Study|Withdrawal by Subject|0|||
154911019|NCT00141297|559094481|FG007|Overall Study|Withdrawal by Subject|0|||
154911020|NCT00141297|559094482|FG008|Overall Study|Withdrawal by Subject|1|||
154911021|NCT00141297|559094483|FG009|Overall Study|Withdrawal by Subject|0|||
154911022|NCT00141297|559094474|FG000|Overall Study|Other|0|||
154911023|NCT00141297|559094475|FG001|Overall Study|Other|0|||
154911024|NCT00141297|559094476|FG002|Overall Study|Other|0|||
154911025|NCT00141297|559094477|FG003|Overall Study|Other|1|||
154911026|NCT00141297|559094478|FG004|Overall Study|Other|5|||
154911027|NCT00141297|559094479|FG005|Overall Study|Other|0|||
154911028|NCT00141297|559094480|FG006|Overall Study|Other|0|||
154911029|NCT00141297|559094481|FG007|Overall Study|Other|0|||
154911030|NCT00141297|559094482|FG008|Overall Study|Other|2|||
154911031|NCT00141297|559094483|FG009|Overall Study|Other|0|||
154911032|NCT00141297|559094474|FG000|Overall Study|Progressive Disease|2|||
154911033|NCT00141297|559094475|FG001|Overall Study|Progressive Disease|3|||
154911034|NCT00141297|559094476|FG002|Overall Study|Progressive Disease|6|||
154911035|NCT00141297|559094477|FG003|Overall Study|Progressive Disease|2|||
154911036|NCT00141297|559094478|FG004|Overall Study|Progressive Disease|15|||
154911037|NCT00141297|559094479|FG005|Overall Study|Progressive Disease|2|||
154911038|NCT00141297|559094480|FG006|Overall Study|Progressive Disease|3|||
154911039|NCT00141297|559094481|FG007|Overall Study|Progressive Disease|3|||
154911040|NCT00141297|559094482|FG008|Overall Study|Progressive Disease|15|||
154911041|NCT00141297|559094483|FG009|Overall Study|Progressive Disease|6|||
154911042|NCT00141297|559094474|FG000|Overall Study|Transitioned|0|||
154911043|NCT00141297|559094475|FG001|Overall Study|Transitioned|0|||
154911044|NCT00141297|559094476|FG002|Overall Study|Transitioned|0|||
154911045|NCT00141297|559094477|FG003|Overall Study|Transitioned|0|||
154911046|NCT00141297|559094478|FG004|Overall Study|Transitioned|1|||
154911047|NCT00141297|559094479|FG005|Overall Study|Transitioned|0|||
154911048|NCT00141297|559094480|FG006|Overall Study|Transitioned|0|||
154911049|NCT00141297|559094481|FG007|Overall Study|Transitioned|0|||
154911050|NCT00141297|559094482|FG008|Overall Study|Transitioned|0|||
154911051|NCT00141297|559094483|FG009|Overall Study|Transitioned|0|||
154911052|NCT02987205|559094485|FG000|Overall Study|Adverse Event|1|||
154911053|NCT02987205|559094485|FG000|Overall Study|Withdrawal by Subject|3|||
154911054|NCT03558503|559094486|FG000|Overall Study|Adverse Event|1|||
154911055|NCT03558503|559094486|FG000|Overall Study|Death|1|||
155118529|NCT02692040|559865940|FG004|Overall Study|Adverse Event|0|||
155118530|NCT02692040|559865941|FG005|Overall Study|Adverse Event|0|||
155118531|NCT02692040|559865942|FG006|Overall Study|Adverse Event|0|||
155118532|NCT02692040|559865943|FG007|Overall Study|Adverse Event|0|||
155118533|NCT02692040|559865944|FG008|Overall Study|Adverse Event|0|||
155118534|NCT02692040|559865945|FG009|Overall Study|Adverse Event|0|||
155118535|NCT02692040|559865946|FG010|Overall Study|Adverse Event|0|||
155118536|NCT02692040|559865947|FG011|Overall Study|Adverse Event|0|||
155118537|NCT02692040|559865948|FG012|Overall Study|Adverse Event|0|||
155118538|NCT02692040|559865949|FG013|Overall Study|Adverse Event|3|||
155118539|NCT02692040|559865950|FG014|Overall Study|Adverse Event|1|||
155118540|NCT02692040|559865951|FG015|Overall Study|Adverse Event|1|||
155118541|NCT02692040|559865952|FG016|Overall Study|Adverse Event|0|||
155118542|NCT03746600|559865959|FG000|Overall Study|Withdrawal by Subject|3|||
155118543|NCT03746600|559865960|FG001|Overall Study|Withdrawal by Subject|3|||
155118544|NCT03746600|559865959|FG000|Overall Study|dismissed from study|1|||
155118545|NCT03746600|559865960|FG001|Overall Study|dismissed from study|0|||
155118546|NCT03746600|559865959|FG000|Overall Study|Lost to Follow-up|1|||
155118547|NCT03746600|559865960|FG001|Overall Study|Lost to Follow-up|0|||
155118548|NCT00072293|559865963|FG000|Overall Study|Lost to Follow-up|1|||
155118549|NCT00072293|559865964|FG001|Overall Study|Lost to Follow-up|1|||
155118550|NCT00072293|559865963|FG000|Overall Study|Withdrawal by Subject|0|||
155118551|NCT00072293|559865964|FG001|Overall Study|Withdrawal by Subject|1|||
154911056|NCT03558503|559094486|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
154984956|NCT01558297|559368961|FG000|Overall Study|Withdrawal by Subject|2|||
154984957|NCT01558297|559368962|FG001|Overall Study|Withdrawal by Subject|2|||
154911057|NCT04566445|559094491|FG000|Overall Study|Death|4|||
154911058|NCT04566445|559094492|FG001|Overall Study|Death|1|||
154911059|NCT04566445|559094493|FG002|Overall Study|Death|1|||
154911060|NCT04566445|559094491|FG000|Overall Study|Lost to Follow-up|3|||
154911061|NCT04566445|559094492|FG001|Overall Study|Lost to Follow-up|1|||
154911062|NCT04566445|559094493|FG002|Overall Study|Lost to Follow-up|1|||
154911063|NCT04566445|559094491|FG000|Overall Study|Study terminated by sponsor|11|||
154911064|NCT04566445|559094492|FG001|Overall Study|Study terminated by sponsor|17|||
154911065|NCT04566445|559094493|FG002|Overall Study|Study terminated by sponsor|32|||
154911066|NCT04566445|559094491|FG000|Overall Study|Withdrawal by Subject|12|||
154984958|NCT01558297|559368963|FG002|Overall Study|Withdrawal by Subject|1|||
154984959|NCT00094094|559368964|FG000|Overall Study|Death|2|||
154984960|NCT00094094|559368964|FG000|Overall Study|Lack of Efficacy|23|||
154984961|NCT00094094|559368964|FG000|Overall Study|Adverse Event|7|||
154984962|NCT04459715|559368969|FG000|Overall Study|Adverse Event|3|||
154984963|NCT04459715|559368970|FG001|Overall Study|Adverse Event|3|||
154984964|NCT04459715|559368969|FG000|Overall Study|Death|111|||
154984965|NCT04459715|559368970|FG001|Overall Study|Death|93|||
154984966|NCT04459715|559368969|FG000|Overall Study|Lost to Follow-up|10|||
154984967|NCT04459715|559368970|FG001|Overall Study|Lost to Follow-up|9|||
154984968|NCT04459715|559368969|FG000|Overall Study|Other Reasons|4|||
154984969|NCT04459715|559368970|FG001|Overall Study|Other Reasons|5|||
154984970|NCT04459715|559368969|FG000|Overall Study|PROTOCOL DEVIATION|0|||
154984971|NCT04459715|559368970|FG001|Overall Study|PROTOCOL DEVIATION|1|||
154984972|NCT04459715|559368969|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
154984973|NCT04459715|559368970|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
154984974|NCT04459715|559368969|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
154984975|NCT04459715|559368970|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
154984976|NCT04459715|559368969|FG000|Overall Study|Withdrawal by Subject|22|||
154984977|NCT04459715|559368970|FG001|Overall Study|Withdrawal by Subject|22|||
154984978|NCT02427984|559368971|FG000|Overall Study|Lost to Follow-up|13|||
154984979|NCT02427984|559368972|FG001|Overall Study|Lost to Follow-up|5|||
154984980|NCT02427984|559368973|FG002|Overall Study|Lost to Follow-up|18|||
154984981|NCT02631876|559370163|FG000|Overall Study|Death|96|||
154984982|NCT02631876|559370164|FG001|Overall Study|Death|50|||
154984983|NCT02631876|559370163|FG000|Overall Study|Investigator's discretion|1|||
154984984|NCT02631876|559370164|FG001|Overall Study|Investigator's discretion|0|||
154984985|NCT02631876|559370163|FG000|Overall Study|Lost to Follow-up|2|||
154984986|NCT02631876|559370164|FG001|Overall Study|Lost to Follow-up|0|||
154984987|NCT02631876|559370163|FG000|Overall Study|Withdrawal by Subject|16|||
154984988|NCT02631876|559370164|FG001|Overall Study|Withdrawal by Subject|9|||
154984989|NCT02631876|559370163|FG000|Overall Study|Other than specified|4|||
154984990|NCT02631876|559370164|FG001|Overall Study|Other than specified|4|||
154984991|NCT04285567|559370165|FG000|Overall Study|Death|3|||
154911067|NCT04566445|559094492|FG001|Overall Study|Withdrawal by Subject|14|||
155118552|NCT04209114|559865965|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
154984992|NCT04285567|559370166|FG001|Overall Study|Death|3|||
154984993|NCT04285567|559370165|FG000|Overall Study|Lost to Follow-up|1|||
154984994|NCT04285567|559370166|FG001|Overall Study|Lost to Follow-up|1|||
154984995|NCT04285567|559370165|FG000|Overall Study|Reason Not Specified|1|||
155118553|NCT04209114|559865966|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
155118554|NCT04209114|559865967|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
155118555|NCT04209114|559865965|FG000|Pre-Treatment Phase|Other reasons|0|||
154911068|NCT04566445|559094493|FG002|Overall Study|Withdrawal by Subject|13|||
154911069|NCT04566445|559094491|FG000|Overall Study|Randomized but not treated due to AE|2|||
154911070|NCT04566445|559094492|FG001|Overall Study|Randomized but not treated due to AE|1|||
154911071|NCT04566445|559094493|FG002|Overall Study|Randomized but not treated due to AE|0|||
154911072|NCT04566445|559094491|FG000|Overall Study|Adverse Event|1|||
154911073|NCT04566445|559094492|FG001|Overall Study|Adverse Event|1|||
154911074|NCT04566445|559094493|FG002|Overall Study|Adverse Event|0|||
154911075|NCT02061540|559094494|FG000|Overall Study|Adverse Event|2|||
154911076|NCT02061540|559094494|FG000|Overall Study|Withdrawal by Subject|2|||
154911077|NCT04005755|559094497|FG000|Overall Study|Adverse Event|6|||
154911078|NCT04005755|559094497|FG000|Overall Study|Physician Decision|3|||
154911079|NCT04005755|559094497|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
154911080|NCT04005755|559094497|FG000|Overall Study|Withdrawal by Subject|3|||
154911081|NCT04005755|559094497|FG000|Overall Study|Lost to Follow-up|1|||
154911082|NCT02561273|559094504|FG000|Overall Study|Protocol Violation|1|||
154911083|NCT02561273|559094505|FG001|Overall Study|Protocol Violation|0|||
154911084|NCT02723019|559094506|FG000|Overall Study|Death|17|||
154911085|NCT02723019|559094507|FG001|Overall Study|Death|13|||
154911086|NCT02723019|559094506|FG000|Overall Study|Withdrawal by Subject|11|||
154911087|NCT02723019|559094507|FG001|Overall Study|Withdrawal by Subject|7|||
154911088|NCT02723019|559094506|FG000|Overall Study|Lost to Follow-up|57|||
154911089|NCT02723019|559094507|FG001|Overall Study|Lost to Follow-up|70|||
154911090|NCT00958191|559094509|FG000|Overall Study|Death|4|||
154911091|NCT00958191|559094509|FG000|Overall Study|Lost to Follow-up|5|||
154911092|NCT00958191|559094509|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
154911093|NCT00958191|559094509|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
154911094|NCT00958191|559094509|FG000|Overall Study|Revision of study device|4|||
154911095|NCT00958191|559094509|FG000|Overall Study|Site termination|11|||
154911096|NCT00958191|559094509|FG000|Overall Study|No 5 yr x-rays|56|||
154911097|NCT00611767|559094510|FG000|Overall Study|Withdrawal by Subject|4|||
154911098|NCT00611767|559094511|FG001|Overall Study|Withdrawal by Subject|1|||
154911099|NCT00611767|559094510|FG000|Overall Study|Thiopental not available|3|||
154911100|NCT00611767|559094511|FG001|Overall Study|Thiopental not available|0|||
154911101|NCT00611767|559094510|FG000|Overall Study|didn't like the medication|1|||
154911102|NCT00611767|559094511|FG001|Overall Study|didn't like the medication|1|||
154911103|NCT00611767|559094510|FG000|Overall Study|Physician Decision|1|||
154911104|NCT00611767|559094511|FG001|Overall Study|Physician Decision|0|||
154911105|NCT01642004|559094512|FG000|Randomization|Adverse Event unrelated to study drug|1|||
154911106|NCT01642004|559094513|FG001|Randomization|Adverse Event unrelated to study drug|0|||
154911107|NCT01642004|559094512|FG000|Randomization|Participant withdrew consent|1|||
154911108|NCT01642004|559094513|FG001|Randomization|Participant withdrew consent|6|||
154911109|NCT01642004|559094512|FG000|Randomization|No longer meets study criteria|2|||
154911110|NCT01642004|559094513|FG001|Randomization|No longer meets study criteria|2|||
154911111|NCT01642004|559094512|FG000|Treatment|Disease progression|95|||
154911112|NCT01642004|559094513|FG001|Treatment|Disease progression|79|||
154911113|NCT01642004|559094512|FG000|Treatment|Study drug toxicity|10|||
154911114|NCT01642004|559094513|FG001|Treatment|Study drug toxicity|13|||
154911115|NCT01642004|559094512|FG000|Treatment|Death|1|||
154911116|NCT01642004|559094513|FG001|Treatment|Death|1|||
154911117|NCT01642004|559094512|FG000|Treatment|Adverse event unrelated to study drug|9|||
154911118|NCT01642004|559094513|FG001|Treatment|Adverse event unrelated to study drug|13|||
154911119|NCT01642004|559094512|FG000|Treatment|Maximum clinical benefit|1|||
154911120|NCT01642004|559094513|FG001|Treatment|Maximum clinical benefit|9|||
154911121|NCT01642004|559094512|FG000|Treatment|Poor/non-compliance|1|||
154911122|NCT01642004|559094513|FG001|Treatment|Poor/non-compliance|0|||
154911123|NCT01642004|559094512|FG000|Treatment|No longer meets study criteria|1|||
154911124|NCT01642004|559094513|FG001|Treatment|No longer meets study criteria|2|||
154911125|NCT01642004|559094512|FG000|Treatment|Other reasons|2|||
154911126|NCT01642004|559094513|FG001|Treatment|Other reasons|0|||
154911127|NCT01642004|559094512|FG000|Treatment|Not reported|0|||
154911128|NCT01642004|559094513|FG001|Treatment|Not reported|3|||
154911129|NCT01642004|559094512|FG000|Treatment|Participant request to discontinue study treatment|6|||
154911130|NCT01642004|559094513|FG001|Treatment|Participant request to discontinue study treatment|4|||
154911131|NCT01642004|559094512|FG000|Treatment|Participant withdrew consent|5|||
154984996|NCT04285567|559370166|FG001|Overall Study|Reason Not Specified|1|||
154984997|NCT04285567|559370165|FG000|Overall Study|Physician Decision|2|||
154911132|NCT01642004|559094513|FG001|Treatment|Participant withdrew consent|5|||
154911133|NCT02718625|559094514|FG000|Overall Study|Adverse Event|0|||
154911134|NCT02718625|559094515|FG001|Overall Study|Adverse Event|1|||
154911135|NCT02718625|559094514|FG000|Overall Study|Termination of Study by Sponsor|0|||
154911136|NCT02718625|559094515|FG001|Overall Study|Termination of Study by Sponsor|1|||
154911137|NCT01818765|559094518|FG000|Overall Study|Death|2|||
154984998|NCT04285567|559370166|FG001|Overall Study|Physician Decision|1|||
154911138|NCT01562327|559094519|FG000|Overall Study|Adverse Event|2|||
154911139|NCT01562327|559094519|FG000|Overall Study|Lack of Efficacy|1|||
154911140|NCT01562327|559094519|FG000|Overall Study|Participant drop-out|1|||
155118556|NCT04209114|559865966|FG001|Pre-Treatment Phase|Other reasons|0|||
154911141|NCT01562327|559094519|FG000|Overall Study|Infusion not received at 6 month window|4|||
154911142|NCT01947127|559094520|FG000|Overall Study|Protocol Violation|18|||
154911143|NCT01947127|559094521|FG001|Overall Study|Protocol Violation|38|||
154911144|NCT01947127|559094520|FG000|Overall Study|Withdrawal by Subject|1|||
154911145|NCT01947127|559094521|FG001|Overall Study|Withdrawal by Subject|1|||
154911146|NCT01947127|559094520|FG000|Overall Study|Data loss|4|||
154911147|NCT01947127|559094521|FG001|Overall Study|Data loss|4|||
154911148|NCT00170846|559094522|FG000|Overall Study|Subject withdrew Informed Consent|5|||
154911149|NCT00170846|559094523|FG001|Overall Study|Subject withdrew Informed Consent|12|||
154911150|NCT00170846|559094524|FG002|Overall Study|Subject withdrew Informed Consent|8|||
154911151|NCT00170846|559094522|FG000|Overall Study|Lost to Follow-up|6|||
154911152|NCT00170846|559094523|FG001|Overall Study|Lost to Follow-up|3|||
154911153|NCT00170846|559094524|FG002|Overall Study|Lost to Follow-up|2|||
154911154|NCT00170846|559094522|FG000|Overall Study|Death|0|||
154911155|NCT00170846|559094523|FG001|Overall Study|Death|3|||
154911156|NCT00170846|559094524|FG002|Overall Study|Death|3|||
154911157|NCT00170846|559094522|FG000|Overall Study|Reason Missing|0|||
154911158|NCT00170846|559094523|FG001|Overall Study|Reason Missing|1|||
154911159|NCT00170846|559094524|FG002|Overall Study|Reason Missing|0|||
154911160|NCT00887913|559094529|FG000|Overall Study|Withdrawal by Subject|6|||
154911161|NCT01708915|559094532|FG000|Overall Study|Adverse Event|1|||
154911162|NCT01708915|559094533|FG001|Overall Study|Adverse Event|0|||
154911163|NCT01708915|559094534|FG002|Overall Study|Adverse Event|9|||
154911164|NCT01708915|559094535|FG003|Overall Study|Adverse Event|13|||
154911165|NCT01708915|559094532|FG000|Overall Study|Lack of Efficacy|84|||
154911166|NCT01708915|559094533|FG001|Overall Study|Lack of Efficacy|60|||
154911167|NCT01708915|559094534|FG002|Overall Study|Lack of Efficacy|35|||
154911168|NCT01708915|559094535|FG003|Overall Study|Lack of Efficacy|15|||
154911169|NCT01708915|559094532|FG000|Overall Study|Protocol Violation|0|||
154911170|NCT01708915|559094533|FG001|Overall Study|Protocol Violation|0|||
154911171|NCT01708915|559094534|FG002|Overall Study|Protocol Violation|0|||
154911172|NCT01708915|559094535|FG003|Overall Study|Protocol Violation|1|||
154911173|NCT01708915|559094532|FG000|Overall Study|Withdrawal by Subject|0|||
154911174|NCT01708915|559094533|FG001|Overall Study|Withdrawal by Subject|1|||
154911175|NCT01708915|559094534|FG002|Overall Study|Withdrawal by Subject|2|||
154911176|NCT01708915|559094535|FG003|Overall Study|Withdrawal by Subject|2|||
154911177|NCT01708915|559094532|FG000|Overall Study|Other reasons than stated above|1|||
154911178|NCT01708915|559094533|FG001|Overall Study|Other reasons than stated above|1|||
154911179|NCT01708915|559094534|FG002|Overall Study|Other reasons than stated above|0|||
154911180|NCT01708915|559094535|FG003|Overall Study|Other reasons than stated above|2|||
154911181|NCT01369069|559094536|FG000|Overall Study|Lost to Follow-up|8|||
154911182|NCT01369069|559094537|FG001|Overall Study|Lost to Follow-up|9|||
154911183|NCT01369069|559094536|FG000|Overall Study|Withdrawal by Subject|9|||
154911184|NCT01369069|559094537|FG001|Overall Study|Withdrawal by Subject|7|||
154911185|NCT02573012|559094540|FG000|Overall Study|Adverse Event|5|||
154911186|NCT02573012|559094541|FG001|Overall Study|Adverse Event|5|||
154911187|NCT02573012|559094540|FG000|Overall Study|Lack of Efficacy|5|||
154911188|NCT02573012|559094541|FG001|Overall Study|Lack of Efficacy|4|||
154911189|NCT02573012|559094540|FG000|Overall Study|Non-compliance|1|||
154911190|NCT02573012|559094541|FG001|Overall Study|Non-compliance|2|||
154911191|NCT02573012|559094540|FG000|Overall Study|Withdrawal by Subject|2|||
154911192|NCT02573012|559094541|FG001|Overall Study|Withdrawal by Subject|2|||
154911193|NCT02573012|559094540|FG000|Overall Study|Study Ended per Protocol|1|||
154911194|NCT02573012|559094541|FG001|Overall Study|Study Ended per Protocol|0|||
154911195|NCT02573012|559094540|FG000|Overall Study|Physician Decision|1|||
154911196|NCT02573012|559094541|FG001|Overall Study|Physician Decision|2|||
154911197|NCT01846208|559094542|FG000|Overall Study|Withdrew prior to treatment|1|||
154911198|NCT01846208|559094543|FG001|Overall Study|Withdrew prior to treatment|1|||
154911199|NCT01846208|559094544|FG002|Overall Study|Withdrew prior to treatment|1|||
154911200|NCT01846208|559094542|FG000|Overall Study|Dosing Symptoms|1|||
154911201|NCT01846208|559094543|FG001|Overall Study|Dosing Symptoms|2|||
154911202|NCT01846208|559094544|FG002|Overall Study|Dosing Symptoms|6|||
154911203|NCT01846208|559094542|FG000|Overall Study|Withdrawal by Subject|5|||
154911204|NCT01846208|559094543|FG001|Overall Study|Withdrawal by Subject|0|||
154911205|NCT01846208|559094544|FG002|Overall Study|Withdrawal by Subject|0|||
154911206|NCT01846208|559094542|FG000|Overall Study|Non-compliance|1|||
154911207|NCT01846208|559094543|FG001|Overall Study|Non-compliance|1|||
154911208|NCT01846208|559094544|FG002|Overall Study|Non-compliance|0|||
154911209|NCT01846208|559094542|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
154911210|NCT01846208|559094543|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
155118557|NCT04209114|559865967|FG002|Pre-Treatment Phase|Other reasons|1|||
155118558|NCT04209114|559865965|FG000|Pre-Treatment Phase|Death|0|||
155118559|NCT04209114|559865966|FG001|Pre-Treatment Phase|Death|0|||
155118560|NCT04209114|559865967|FG002|Pre-Treatment Phase|Death|1|||
155118561|NCT04209114|559865965|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
155118562|NCT04209114|559865966|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
155118563|NCT04209114|559865967|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
155118564|NCT04209114|559865965|FG000|Treatment Phase|Other reasons|5|||
154984999|NCT04285567|559370165|FG000|Overall Study|Withdrawal by Subject|2|||
154985000|NCT04285567|559370166|FG001|Overall Study|Withdrawal by Subject|6|||
154985001|NCT04285567|559370165|FG000|Overall Study|Adverse Event|1|||
154985002|NCT04285567|559370166|FG001|Overall Study|Adverse Event|0|||
154985003|NCT04285567|559370165|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
154985004|NCT04285567|559370166|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
154985005|NCT01408563|559370167|FG000|Overall Study|Ineligible after consent/ registration|2|||
154985006|NCT02246439|559370168|FG000|Overall Study|Adverse Event|3|||
154985007|NCT02246439|559370169|FG001|Overall Study|Adverse Event|0|||
154985008|NCT02246439|559370168|FG000|Overall Study|Lost to Follow-up|7|||
154985009|NCT02246439|559370169|FG001|Overall Study|Lost to Follow-up|5|||
154985010|NCT02246439|559370168|FG000|Overall Study|Protocol Violation|0|||
154985011|NCT02246439|559370169|FG001|Overall Study|Protocol Violation|2|||
154985012|NCT02246439|559370168|FG000|Overall Study|Physician Decision|0|||
154985013|NCT02246439|559370169|FG001|Overall Study|Physician Decision|1|||
154985014|NCT02246439|559370168|FG000|Overall Study|Unkonwn|1|||
154985015|NCT02246439|559370169|FG001|Overall Study|Unkonwn|3|||
154985016|NCT02246439|559370168|FG000|Overall Study|Withdrawal by Subject|1|||
154985017|NCT02246439|559370169|FG001|Overall Study|Withdrawal by Subject|0|||
154985018|NCT03439852|559370172|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
154985019|NCT03439852|559370173|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
154911211|NCT01846208|559094544|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
154911212|NCT01846208|559094542|FG000|Overall Study|Refused SU OFC|0|||
154911213|NCT01846208|559094543|FG001|Overall Study|Refused SU OFC|0|||
154911214|NCT01846208|559094544|FG002|Overall Study|Refused SU OFC|1|||
154911215|NCT01424306|559094545|FG000|Overall Study|Protocol Violation|0|||
154911216|NCT01424306|559094546|FG001|Overall Study|Protocol Violation|0|||
154911217|NCT01424306|559094547|FG002|Overall Study|Protocol Violation|0|||
154911218|NCT01424306|559094548|FG003|Overall Study|Protocol Violation|0|||
154911219|NCT01424306|559094549|FG004|Overall Study|Protocol Violation|1|||
154911220|NCT01424306|559094550|FG005|Overall Study|Protocol Violation|0|||
154911221|NCT03231228|559094551|FG000|Overall Study|Lost to Follow-up|2|||
154911222|NCT03231228|559094552|FG001|Overall Study|Lost to Follow-up|0|||
154911223|NCT03231228|559094551|FG000|Overall Study|Physician Decision|1|||
154911224|NCT03231228|559094552|FG001|Overall Study|Physician Decision|0|||
154911225|NCT01875874|559094556|FG000|Overall Study|Death|3|||
154911226|NCT02096471|559094559|FG000|Overall Study|Adverse Event|1|||
154911227|NCT02096471|559094559|FG000|Overall Study|Lack of Efficacy|7|||
154911228|NCT02096471|559094559|FG000|Overall Study|Withdrawal by Subject|3|||
154911229|NCT02096471|559094559|FG000|Overall Study|Non-Compliant|2|||
154911230|NCT00374127|559094560|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
154911231|NCT00374127|559094560|FG000|Overall Study|Blood could not be drawn.|2|||
154911232|NCT00374127|559094560|FG000|Overall Study|Protocol Violation|5|||
154911233|NCT00374127|559094560|FG000|Overall Study|Pregnancy|1|||
154911234|NCT03344562|559094561|FG000|Overall Study|Withdrawal by Subject|2|||
154911235|NCT03344562|559094562|FG001|Overall Study|Withdrawal by Subject|0|||
154911236|NCT02463331|559094568|FG000|Overall Study|Adverse Event|4|||
154911237|NCT02463331|559094569|FG001|Overall Study|Adverse Event|2|||
154911238|NCT02463331|559094568|FG000|Overall Study|Lost to Follow-up|1|||
154911239|NCT02463331|559094569|FG001|Overall Study|Lost to Follow-up|1|||
154911240|NCT02463331|559094568|FG000|Overall Study|Pregnancy|2|||
154911241|NCT02463331|559094569|FG001|Overall Study|Pregnancy|3|||
154911242|NCT02463331|559094568|FG000|Overall Study|Lack of Efficacy|6|||
154911243|NCT02463331|559094569|FG001|Overall Study|Lack of Efficacy|0|||
154911244|NCT02463331|559094568|FG000|Overall Study|Physician Decision|3|||
154911245|NCT02463331|559094569|FG001|Overall Study|Physician Decision|0|||
154911246|NCT02382276|559094570|FG000|Overall Study|Withdrawal by Subject|4|||
154911247|NCT02382276|559094571|FG001|Overall Study|Withdrawal by Subject|8|||
154911248|NCT02382276|559094572|FG002|Overall Study|Withdrawal by Subject|5|||
154911249|NCT02382276|559094570|FG000|Overall Study|Adverse Event|7|||
154911250|NCT02382276|559094571|FG001|Overall Study|Adverse Event|2|||
154911251|NCT02382276|559094572|FG002|Overall Study|Adverse Event|32|||
154911252|NCT02382276|559094570|FG000|Overall Study|Physician Decision|0|||
154911253|NCT02382276|559094571|FG001|Overall Study|Physician Decision|0|||
154911254|NCT02382276|559094572|FG002|Overall Study|Physician Decision|2|||
154911255|NCT01222416|559094573|FG000|Overall Study|ineligible;metastasis|3|||
154911256|NCT01222416|559094574|FG001|Overall Study|ineligible;metastasis|0|||
154911257|NCT01222416|559094573|FG000|Overall Study|Adverse Event|4|||
154911258|NCT01222416|559094574|FG001|Overall Study|Adverse Event|0|||
154911259|NCT01222416|559094573|FG000|Overall Study|Withdrawal by Subject|5|||
154911260|NCT01222416|559094574|FG001|Overall Study|Withdrawal by Subject|0|||
154911261|NCT01222416|559094573|FG000|Overall Study|scheduling|6|||
154985020|NCT03439852|559370172|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
154985021|NCT03439852|559370173|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
154911262|NCT01222416|559094574|FG001|Overall Study|scheduling|0|||
154911263|NCT01222416|559094573|FG000|Overall Study|missed view/scan|1|||
154911264|NCT01222416|559094574|FG001|Overall Study|missed view/scan|0|||
154985022|NCT03439852|559370172|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
155176180|NCT01454778|560082297|FG000|Overall Study|Death|1|||
155176181|NCT02907892|560083879|FG000|Overall Study|Lost to Follow-up|27|||
155176182|NCT02907892|560083880|FG001|Overall Study|Lost to Follow-up|40|||
155176183|NCT04531462|560083881|FG000|Overall Study|Withdrawal by Subject|3|||
155176184|NCT04531462|560083882|FG001|Overall Study|Withdrawal by Subject|1|||
155176185|NCT04531462|560083881|FG000|Overall Study|Adverse Event|3|||
155176186|NCT04531462|560083882|FG001|Overall Study|Adverse Event|3|||
155176187|NCT00348933|560083885|FG000|Overall Study|Withdrawal by Subject|10|||
155176188|NCT00348933|560083885|FG000|Overall Study|Lost to Follow-up|6|||
155176189|NCT00348933|560083885|FG000|Overall Study|Protocol Violation|2|||
155176190|NCT00348933|560083885|FG000|Overall Study|Adverse Event|7|||
155176191|NCT01489111|560083886|FG000|Overall Study|Withdrawal criterion|1|||
155176192|NCT01727700|560083887|FG000|Overall Study|Adverse Event|0|||
155176193|NCT01727700|560083888|FG001|Overall Study|Adverse Event|7|||
155176194|NCT01727700|560083889|FG002|Overall Study|Adverse Event|1|||
155176195|NCT01727700|560083887|FG000|Overall Study|Particpant withdrew consent|0|||
155176196|NCT01727700|560083888|FG001|Overall Study|Particpant withdrew consent|3|||
155176197|NCT01727700|560083889|FG002|Overall Study|Particpant withdrew consent|1|||
155176198|NCT01727700|560083887|FG000|Overall Study|Protocol Violation|2|||
155176199|NCT01727700|560083888|FG001|Overall Study|Protocol Violation|0|||
155176200|NCT01727700|560083889|FG002|Overall Study|Protocol Violation|0|||
155176201|NCT01757691|560083892|FG000|Overall Study|Administrative problems|2|||
155176202|NCT01757691|560083893|FG001|Overall Study|Administrative problems|0|||
155176203|NCT03699475|560083894|FG000|Overall Study|Death|1|||
155176204|NCT01713933|560083895|FG000|Overall Study|Lost to Follow-up|2|||
155176205|NCT01713933|560083895|FG000|Overall Study|Withdrawal by Subject|3|||
155176206|NCT01713933|560083895|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
154911265|NCT01222416|559094573|FG000|Overall Study|Death|1|||
154911266|NCT01222416|559094574|FG001|Overall Study|Death|0|||
154911267|NCT03049852|559094581|FG000|Overall Study|Lost to Follow-up|0|||
154911268|NCT03049852|559094582|FG001|Overall Study|Lost to Follow-up|1|||
154911269|NCT03049852|559094583|FG002|Overall Study|Lost to Follow-up|0|||
154911270|NCT02709889|559094584|FG000|Overall Study|Withdrawal by Subject|11|||
154911271|NCT02709889|559094585|FG001|Overall Study|Withdrawal by Subject|10|||
154911272|NCT02709889|559094586|FG002|Overall Study|Withdrawal by Subject|2|||
154911273|NCT02709889|559094587|FG003|Overall Study|Withdrawal by Subject|12|||
154911274|NCT02709889|559094584|FG000|Overall Study|Death|25|||
154911275|NCT02709889|559094585|FG001|Overall Study|Death|38|||
154911276|NCT02709889|559094586|FG002|Overall Study|Death|4|||
154911277|NCT02709889|559094587|FG003|Overall Study|Death|44|||
154911278|NCT02709889|559094584|FG000|Overall Study|Physician Decision|1|||
154911279|NCT02709889|559094585|FG001|Overall Study|Physician Decision|2|||
154911280|NCT02709889|559094586|FG002|Overall Study|Physician Decision|3|||
154911281|NCT02709889|559094587|FG003|Overall Study|Physician Decision|5|||
154911282|NCT02709889|559094584|FG000|Overall Study|Lost to Follow-up|2|||
154911283|NCT02709889|559094585|FG001|Overall Study|Lost to Follow-up|0|||
154911284|NCT02709889|559094586|FG002|Overall Study|Lost to Follow-up|0|||
154911285|NCT02709889|559094587|FG003|Overall Study|Lost to Follow-up|4|||
154911286|NCT02709889|559094584|FG000|Overall Study|Study Terminated by Sponsor|4|||
154911287|NCT02709889|559094585|FG001|Overall Study|Study Terminated by Sponsor|6|||
154911288|NCT02709889|559094586|FG002|Overall Study|Study Terminated by Sponsor|2|||
154911289|NCT02709889|559094587|FG003|Overall Study|Study Terminated by Sponsor|17|||
154911290|NCT02709889|559094584|FG000|Overall Study|Other, Not Specified|0|||
154911291|NCT02709889|559094585|FG001|Overall Study|Other, Not Specified|1|||
154911292|NCT02709889|559094586|FG002|Overall Study|Other, Not Specified|1|||
154911293|NCT02709889|559094587|FG003|Overall Study|Other, Not Specified|6|||
154911294|NCT00656799|559094588|FG000|Overall Study|Death|2|||
154911295|NCT03347279|559096119|FG000|Overall Study|Withdrawal by Subject|8|||
154911296|NCT03347279|559096120|FG001|Overall Study|Withdrawal by Subject|15|||
154911297|NCT03347279|559096119|FG000|Overall Study|Death|0|||
154911298|NCT03347279|559096120|FG001|Overall Study|Death|2|||
154911299|NCT03347279|559096119|FG000|Overall Study|Lost to Follow-up|5|||
154911300|NCT03347279|559096120|FG001|Overall Study|Lost to Follow-up|2|||
154911301|NCT03347279|559096119|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
154911302|NCT03347279|559096120|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
154911303|NCT03818399|559096124|FG000|Overall Study|Lost to Follow-up|11|||
154911304|NCT03818399|559096124|FG000|Overall Study|Withdrawal by Subject|1|||
154911305|NCT03818399|559096124|FG000|Overall Study|Protocol Violation|2|||
154911306|NCT00718887|559096125|FG000|Overall Study|Withdrawal by Subject|3|||
154911307|NCT00718887|559096126|FG001|Overall Study|Withdrawal by Subject|2|||
154911308|NCT00718887|559096125|FG000|Overall Study|Not identified|2|||
154911309|NCT00718887|559096126|FG001|Overall Study|Not identified|7|||
154911310|NCT00775138|559096127|FG000|Overall Study|Withdrawal by Subject|0|||
154911311|NCT00775138|559096128|FG001|Overall Study|Withdrawal by Subject|0|||
154911312|NCT00775138|559096129|FG002|Overall Study|Withdrawal by Subject|2|||
154911313|NCT00775138|559096130|FG003|Overall Study|Withdrawal by Subject|2|||
154911314|NCT00775138|559096127|FG000|Overall Study|Adverse Event|0|||
154985023|NCT03439852|559370173|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
154985024|NCT04271735|559370174|FG000|Overall Study|Physician Decision|2|||
154985025|NCT04271735|559370175|FG001|Overall Study|Physician Decision|0|||
154985026|NCT00922272|559370176|FG000|Open-label Phase|Adverse Event|5|||
154985027|NCT00922272|559370177|FG001|Open-label Phase|Adverse Event|0|||
154985028|NCT00922272|559370176|FG000|Open-label Phase|Protocol Violation|1|||
154985029|NCT00922272|559370177|FG001|Open-label Phase|Protocol Violation|0|||
154985030|NCT00922272|559370176|FG000|Open-label Phase|Withdrawal by Subject|11|||
154985031|NCT00922272|559370177|FG001|Open-label Phase|Withdrawal by Subject|0|||
154985032|NCT00922272|559370176|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
154985033|NCT00922272|559370177|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
154985034|NCT00922272|559370176|FG000|Open-label Phase|Withdrawal criteria met|5|||
154985035|NCT00922272|559370177|FG001|Open-label Phase|Withdrawal criteria met|0|||
154985036|NCT00922272|559370176|FG000|Double-blind Phase|Adverse Event|1|||
154985037|NCT00922272|559370177|FG001|Double-blind Phase|Adverse Event|1|||
154985038|NCT00922272|559370176|FG000|Double-blind Phase|Withdrawal by Subject|1|||
154985039|NCT00922272|559370177|FG001|Double-blind Phase|Withdrawal by Subject|1|||
154985040|NCT00922272|559370176|FG000|Double-blind Phase|Lost to Follow-up|2|||
155118565|NCT04209114|559865966|FG001|Treatment Phase|Other reasons|3|||
155118566|NCT04209114|559865967|FG002|Treatment Phase|Other reasons|0|||
155118567|NCT04209114|559865965|FG000|Treatment Phase|Lost to Follow-up|1|||
155118568|NCT04209114|559865966|FG001|Treatment Phase|Lost to Follow-up|0|||
155118569|NCT04209114|559865967|FG002|Treatment Phase|Lost to Follow-up|0|||
155118570|NCT04209114|559865965|FG000|Treatment Phase|Participant withdrew consent|1|||
155118571|NCT04209114|559865966|FG001|Treatment Phase|Participant withdrew consent|0|||
155118572|NCT04209114|559865967|FG002|Treatment Phase|Participant withdrew consent|0|||
155118573|NCT04209114|559865965|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
155118574|NCT04209114|559865966|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
155118575|NCT04209114|559865967|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
155118576|NCT04209114|559865965|FG000|Treatment Phase|Death|4|||
155118577|NCT04209114|559865966|FG001|Treatment Phase|Death|1|||
155118578|NCT04209114|559865967|FG002|Treatment Phase|Death|0|||
155118579|NCT04209114|559865965|FG000|Treatment Phase|Study drug toxicity|4|||
155118580|NCT04209114|559865966|FG001|Treatment Phase|Study drug toxicity|6|||
155118581|NCT04209114|559865967|FG002|Treatment Phase|Study drug toxicity|0|||
155118582|NCT04209114|559865965|FG000|Treatment Phase|Disease progression|6|||
155118583|NCT04209114|559865966|FG001|Treatment Phase|Disease progression|9|||
155118584|NCT04209114|559865967|FG002|Treatment Phase|Disease progression|0|||
155118585|NCT02826421|559865975|FG000|Overall Study|Adverse Event|1|||
155118586|NCT02826421|559865976|FG001|Overall Study|Adverse Event|0|||
155118587|NCT02826421|559865977|FG002|Overall Study|Adverse Event|0|||
155118588|NCT02826421|559865978|FG003|Overall Study|Adverse Event|1|||
155118589|NCT02826421|559865975|FG000|Overall Study|Withdrawal by Subject|1|||
155118590|NCT02826421|559865976|FG001|Overall Study|Withdrawal by Subject|3|||
155118591|NCT02826421|559865977|FG002|Overall Study|Withdrawal by Subject|1|||
155118592|NCT02826421|559865978|FG003|Overall Study|Withdrawal by Subject|1|||
155118593|NCT02826421|559865975|FG000|Overall Study|Reason not given|1|||
155118594|NCT02826421|559865976|FG001|Overall Study|Reason not given|0|||
155118595|NCT02826421|559865977|FG002|Overall Study|Reason not given|1|||
155118596|NCT02826421|559865978|FG003|Overall Study|Reason not given|0|||
155118597|NCT02210221|559865983|FG000|Overall Study|Lack of Efficacy|7|||
155118598|NCT02210221|559865983|FG000|Overall Study|Withdrawal by Subject|43|||
155118599|NCT00405964|559865984|FG000|Overall Study|Treatment Failure|17|||
155118600|NCT00405964|559865985|FG001|Overall Study|Treatment Failure|45|||
155118601|NCT00405964|559865984|FG000|Overall Study|Adverse Event|7|||
155118602|NCT00405964|559865985|FG001|Overall Study|Adverse Event|16|||
155118603|NCT00405964|559865984|FG000|Overall Study|Lost to Follow-up|5|||
155118604|NCT00405964|559865985|FG001|Overall Study|Lost to Follow-up|5|||
155118605|NCT00405964|559865984|FG000|Overall Study|Withdrawal by Subject|19|||
155118606|NCT00405964|559865985|FG001|Overall Study|Withdrawal by Subject|23|||
155118607|NCT00405964|559865984|FG000|Overall Study|Protocol Violation|11|||
155118608|NCT00405964|559865985|FG001|Overall Study|Protocol Violation|6|||
155118609|NCT04030247|559868346|FG000|Overall Study|Withdrawal by Subject|4|||
155118610|NCT04030247|559868346|FG000|Overall Study|Lost to Follow-up|13|||
155176207|NCT00528970|560083898|FG000|Overall Study|Adverse Event|6|||
155176208|NCT00528970|560083899|FG001|Overall Study|Adverse Event|8|||
154985041|NCT00922272|559370177|FG001|Double-blind Phase|Lost to Follow-up|1|||
154985042|NCT00922272|559370176|FG000|Double-blind Phase|Withdrawal criteria met|1|||
155118611|NCT05320393|559868347|FG000|Overall Study|Withdrawal by Subject|1|||
154985043|NCT00922272|559370177|FG001|Double-blind Phase|Withdrawal criteria met|1|||
155118612|NCT05320393|559868348|FG001|Overall Study|Withdrawal by Subject|0|||
155118613|NCT05320393|559868349|FG002|Overall Study|Withdrawal by Subject|2|||
155118614|NCT05320393|559868347|FG000|Overall Study|Lost to Follow-up|1|||
155118615|NCT05320393|559868348|FG001|Overall Study|Lost to Follow-up|2|||
155118616|NCT05320393|559868349|FG002|Overall Study|Lost to Follow-up|1|||
155118617|NCT05320393|559868347|FG000|Overall Study|Moved; too much driving|0|||
155118618|NCT05320393|559868348|FG001|Overall Study|Moved; too much driving|0|||
155176209|NCT00528970|560083900|FG002|Overall Study|Adverse Event|5|||
155176210|NCT00528970|560083898|FG000|Overall Study|Lost to Follow-up|0|||
154911315|NCT00775138|559096128|FG001|Overall Study|Adverse Event|0|||
154911316|NCT00775138|559096129|FG002|Overall Study|Adverse Event|1|||
154911317|NCT00775138|559096130|FG003|Overall Study|Adverse Event|0|||
154911318|NCT00103207|559096131|FG000|Overall Study|Adverse Event|3|||
154911319|NCT00103207|559096131|FG000|Overall Study|Death|1|||
154911320|NCT00103207|559096131|FG000|Overall Study|Withdrawal by Subject|2|||
154911321|NCT00103207|559096131|FG000|Overall Study|Other complicating disease|1|||
154911322|NCT00103207|559096131|FG000|Overall Study|Ineligible|4|||
154911323|NCT00103207|559096131|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
154911324|NCT00811395|559096132|FG000|Extension Treatment|Adverse Event|1|||
154911325|NCT00811395|559096133|FG001|Extension Treatment|Adverse Event|2|||
154911326|NCT00811395|559096134|FG002|Extension Treatment|Adverse Event|2|||
154911327|NCT00811395|559096135|FG003|Extension Treatment|Adverse Event|2|||
154911328|NCT00811395|559096136|FG004|Extension Treatment|Adverse Event|0|||
154911329|NCT00811395|559096137|FG005|Extension Treatment|Adverse Event|1|||
154911330|NCT00811395|559096132|FG000|Extension Treatment|Progressive disease|1|||
154911331|NCT00811395|559096133|FG001|Extension Treatment|Progressive disease|1|||
154911332|NCT00811395|559096134|FG002|Extension Treatment|Progressive disease|0|||
154911333|NCT00811395|559096135|FG003|Extension Treatment|Progressive disease|0|||
154911334|NCT00811395|559096136|FG004|Extension Treatment|Progressive disease|0|||
154911335|NCT00811395|559096137|FG005|Extension Treatment|Progressive disease|0|||
154911336|NCT00811395|559096132|FG000|Extension Treatment|Participant did not wish to continue|0|||
154911337|NCT00811395|559096133|FG001|Extension Treatment|Participant did not wish to continue|3|||
154911338|NCT00811395|559096134|FG002|Extension Treatment|Participant did not wish to continue|0|||
154911339|NCT00811395|559096135|FG003|Extension Treatment|Participant did not wish to continue|1|||
154911340|NCT00811395|559096136|FG004|Extension Treatment|Participant did not wish to continue|0|||
154911341|NCT00811395|559096137|FG005|Extension Treatment|Participant did not wish to continue|1|||
154911342|NCT00811395|559096132|FG000|Extension Treatment|Other than above|0|||
154911343|NCT00811395|559096133|FG001|Extension Treatment|Other than above|0|||
154911344|NCT00811395|559096134|FG002|Extension Treatment|Other than above|1|||
154911345|NCT00811395|559096135|FG003|Extension Treatment|Other than above|0|||
154911346|NCT00811395|559096136|FG004|Extension Treatment|Other than above|0|||
154911347|NCT00811395|559096137|FG005|Extension Treatment|Other than above|0|||
154911348|NCT00890201|559096144|FG000|Overall Study|Protocol Violation|5|||
154911349|NCT00890201|559096145|FG001|Overall Study|Protocol Violation|56|||
154911350|NCT02181504|559096146|FG000|Overall Study|Adverse Event|1|||
154911351|NCT02181504|559096147|FG001|Overall Study|Adverse Event|1|||
154911352|NCT02181504|559096148|FG002|Overall Study|Adverse Event|1|||
154911353|NCT01469637|559096149|FG000|First Intervention|Unacceptable behavior|0|||
154911354|NCT01469637|559096150|FG001|First Intervention|Unacceptable behavior|1|||
154911355|NCT01469637|559096149|FG000|Second Intervention|Incarcerated|1|||
154911356|NCT01469637|559096150|FG001|Second Intervention|Incarcerated|0|||
154911357|NCT01371721|559096153|FG000|Overall Study|Adverse Event|5|||
154911358|NCT01371721|559096154|FG001|Overall Study|Adverse Event|4|||
154911359|NCT01371721|559096155|FG002|Overall Study|Adverse Event|5|||
154911360|NCT01371721|559096153|FG000|Overall Study|Protocol Violation|6|||
154911361|NCT01371721|559096154|FG001|Overall Study|Protocol Violation|4|||
154911362|NCT01371721|559096155|FG002|Overall Study|Protocol Violation|5|||
154911363|NCT01371721|559096153|FG000|Overall Study|Lost to Follow-up|8|||
154911364|NCT01371721|559096154|FG001|Overall Study|Lost to Follow-up|2|||
154911365|NCT01371721|559096155|FG002|Overall Study|Lost to Follow-up|6|||
154911366|NCT01371721|559096153|FG000|Overall Study|Withdrawal by Subject|5|||
154911367|NCT01371721|559096154|FG001|Overall Study|Withdrawal by Subject|7|||
154911368|NCT01371721|559096155|FG002|Overall Study|Withdrawal by Subject|11|||
154911369|NCT01371721|559096153|FG000|Overall Study|Other|2|||
154911370|NCT01371721|559096154|FG001|Overall Study|Other|3|||
154911371|NCT01371721|559096155|FG002|Overall Study|Other|0|||
154911372|NCT01371721|559096153|FG000|Overall Study|Lack of Efficacy|2|||
154911373|NCT01371721|559096154|FG001|Overall Study|Lack of Efficacy|4|||
154911374|NCT01371721|559096155|FG002|Overall Study|Lack of Efficacy|3|||
154911375|NCT01371721|559096153|FG000|Overall Study|Randomized but not treated|1|||
154911376|NCT01371721|559096154|FG001|Overall Study|Randomized but not treated|0|||
154911377|NCT01371721|559096155|FG002|Overall Study|Randomized but not treated|0|||
154911378|NCT02877134|559096158|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911379|NCT02877134|559096159|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
154911380|NCT02877134|559096160|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911381|NCT02877134|559096161|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911382|NCT02877134|559096162|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
155176211|NCT00528970|560083899|FG001|Overall Study|Lost to Follow-up|0|||
154911383|NCT02877134|559096163|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
154911384|NCT02877134|559096164|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911385|NCT02877134|559096165|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911386|NCT02877134|559096166|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911387|NCT02877134|559096167|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
154985044|NCT00922272|559370176|FG000|Double-blind Phase|Noncompliance|1|||
154985045|NCT00922272|559370177|FG001|Double-blind Phase|Noncompliance|1|||
154985046|NCT00922272|559370176|FG000|Double-blind Phase|Positive urine drug screen|1|||
154985047|NCT00922272|559370177|FG001|Double-blind Phase|Positive urine drug screen|1|||
154985048|NCT03197558|559370178|FG000|Overall Study|Tubes not placed|1|||
154985049|NCT00931268|559370187|FG000|Overall Study|Lost to Follow-up|6|||
154985050|NCT02072148|559370188|FG000|Overall Study|withdrew prior to surgery|23|||
154985051|NCT02072148|559370189|FG001|Overall Study|withdrew prior to surgery|0|||
154985052|NCT02072148|559370190|FG002|Overall Study|withdrew prior to surgery|0|||
154985053|NCT02072148|559370188|FG000|Overall Study|Death|0|||
154985054|NCT02072148|559370189|FG001|Overall Study|Death|0|||
154985055|NCT02072148|559370190|FG002|Overall Study|Death|1|||
154985056|NCT02072148|559370188|FG000|Overall Study|Withdrawal by Subject|0|||
154985057|NCT02072148|559370189|FG001|Overall Study|Withdrawal by Subject|13|||
154985058|NCT02072148|559370190|FG002|Overall Study|Withdrawal by Subject|12|||
154985059|NCT00430495|559370192|FG000|Overall Study|Adverse Event|2|||
154985060|NCT00430495|559370193|FG001|Overall Study|Adverse Event|3|||
154985061|NCT00430495|559370194|FG002|Overall Study|Adverse Event|2|||
154985062|NCT00430495|559370195|FG003|Overall Study|Adverse Event|0|||
154985063|NCT00430495|559370192|FG000|Overall Study|Death|0|||
154985064|NCT00430495|559370193|FG001|Overall Study|Death|0|||
154985065|NCT00430495|559370194|FG002|Overall Study|Death|1|||
154985066|NCT00430495|559370195|FG003|Overall Study|Death|0|||
154985067|NCT00430495|559370192|FG000|Overall Study|Lost to Follow-up|0|||
154985068|NCT00430495|559370193|FG001|Overall Study|Lost to Follow-up|1|||
154985069|NCT00430495|559370194|FG002|Overall Study|Lost to Follow-up|4|||
154985070|NCT00430495|559370195|FG003|Overall Study|Lost to Follow-up|0|||
154985071|NCT00430495|559370192|FG000|Overall Study|Protocol Violation|1|||
154985072|NCT00430495|559370193|FG001|Overall Study|Protocol Violation|0|||
154985073|NCT00430495|559370194|FG002|Overall Study|Protocol Violation|1|||
154985074|NCT00430495|559370195|FG003|Overall Study|Protocol Violation|0|||
154985075|NCT00430495|559370192|FG000|Overall Study|Disease Progression|1|||
154985076|NCT00430495|559370193|FG001|Overall Study|Disease Progression|1|||
154985077|NCT00430495|559370194|FG002|Overall Study|Disease Progression|0|||
154985078|NCT00430495|559370195|FG003|Overall Study|Disease Progression|0|||
154985079|NCT00430495|559370192|FG000|Overall Study|Other|8|||
154985080|NCT00430495|559370193|FG001|Overall Study|Other|2|||
154985081|NCT00430495|559370194|FG002|Overall Study|Other|5|||
154985082|NCT00430495|559370195|FG003|Overall Study|Other|4|||
154985083|NCT00430495|559370192|FG000|Overall Study|Randomized but not Treated|2|||
154985084|NCT00430495|559370193|FG001|Overall Study|Randomized but not Treated|0|||
154985085|NCT00430495|559370194|FG002|Overall Study|Randomized but not Treated|0|||
154985086|NCT00430495|559370195|FG003|Overall Study|Randomized but not Treated|0|||
154985087|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
154985088|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
154985089|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
154985090|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
154985091|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
154985092|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
154985093|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
155118619|NCT05320393|559868349|FG002|Overall Study|Moved; too much driving|2|||
155118620|NCT05320393|559868347|FG000|Overall Study|Did not receive treatment|0|||
155118621|NCT05320393|559868348|FG001|Overall Study|Did not receive treatment|0|||
155118622|NCT05320393|559868349|FG002|Overall Study|Did not receive treatment|1|||
155118623|NCT03187834|559868350|FG000|Overall Study|Lost to Follow-up|0|||
155118624|NCT03187834|559868351|FG001|Overall Study|Lost to Follow-up|1|||
155118625|NCT03187834|559868352|FG002|Overall Study|Lost to Follow-up|2|||
155118626|NCT03187834|559868353|FG003|Overall Study|Lost to Follow-up|2|||
155118627|NCT03187834|559868350|FG000|Overall Study|Had invalid anthropometric measurements|5|||
155118628|NCT03187834|559868351|FG001|Overall Study|Had invalid anthropometric measurements|3|||
155118629|NCT03187834|559868352|FG002|Overall Study|Had invalid anthropometric measurements|4|||
155118630|NCT03187834|559868353|FG003|Overall Study|Had invalid anthropometric measurements|2|||
155118631|NCT03559699|559868354|FG000|Overall Study|Withdrawal by Subject|6|||
155118632|NCT03559699|559868354|FG000|Overall Study|Lost to Follow-up|1|||
155118633|NCT00031460|559868355|FG000|Overall Study|Lost to Follow-up|0|||
155118634|NCT00031460|559868356|FG001|Overall Study|Lost to Follow-up|1|||
155118635|NCT00031460|559868355|FG000|Overall Study|Withdrawal by Subject|1|||
155118636|NCT00031460|559868356|FG001|Overall Study|Withdrawal by Subject|1|||
154985094|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
154985095|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
154985096|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
154985097|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
154985098|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
154985099|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
154985100|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
154985101|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
155118637|NCT00031460|559868355|FG000|Overall Study|Non-Compliant|1|||
155118638|NCT00031460|559868356|FG001|Overall Study|Non-Compliant|1|||
154985102|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
154985103|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
154985104|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
154985105|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
154985106|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
154985107|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
154985108|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
154985109|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
154985110|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
154985111|NCT01421342|559370196|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
154985112|NCT01421342|559370197|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
154985113|NCT01421342|559370198|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
154985114|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
154985115|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
154985116|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
154985117|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
154985118|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
154985119|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
154985120|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
154985121|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
154985122|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
154985123|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
154985124|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
154985125|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
154985126|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
154985127|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
154985128|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
154985129|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
154985130|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
154985131|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
154985132|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
154985133|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
154985134|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
154985135|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
154985136|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
154985137|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
154985138|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
154985139|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
154985140|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
155118639|NCT00031460|559868355|FG000|Overall Study|Death|0|||
155118640|NCT00031460|559868356|FG001|Overall Study|Death|1|||
155118641|NCT00031460|559868355|FG000|Overall Study|Reactivation of Disease|5|||
155118642|NCT00031460|559868356|FG001|Overall Study|Reactivation of Disease|9|||
155118643|NCT00031460|559868355|FG000|Overall Study|Disruption of blinded drug supply|2|||
155118644|NCT00031460|559868356|FG001|Overall Study|Disruption of blinded drug supply|0|||
155118645|NCT00031460|559868355|FG000|Overall Study|Confirmed unevaluable|0|||
155118646|NCT00031460|559868356|FG001|Overall Study|Confirmed unevaluable|1|||
155118647|NCT00471887|559868359|FG000|Overall Study|Adverse Event|9|||
155118648|NCT03710876|559868360|FG000|Overall Study|Death|0|||
155118649|NCT03710876|559868361|FG001|Overall Study|Death|2|||
155118650|NCT03710876|559868360|FG000|Overall Study|Withdrawal by Subject|0|||
155118651|NCT03710876|559868361|FG001|Overall Study|Withdrawal by Subject|2|||
155118652|NCT01176565|559868369|FG000|Overall Study|Lost to Follow-up|12|||
155118653|NCT01176565|559868370|FG001|Overall Study|Lost to Follow-up|16|||
155118654|NCT01176565|559868369|FG000|Overall Study|Withdrawal by Subject|7|||
155118655|NCT01176565|559868370|FG001|Overall Study|Withdrawal by Subject|1|||
155118656|NCT01176565|559868369|FG000|Overall Study|Not Analyzed (any other reason)|1|||
155118657|NCT01176565|559868370|FG001|Overall Study|Not Analyzed (any other reason)|2|||
155118658|NCT03602885|559868372|FG000|Overall Study|Lost to Follow-up|3|||
155118659|NCT03602885|559868373|FG001|Overall Study|Lost to Follow-up|0|||
155118660|NCT02754141|559868374|FG000|Overall Study|Disease progression|11|||
155118661|NCT02754141|559868375|FG001|Overall Study|Disease progression|7|||
155118662|NCT02754141|559868376|FG002|Overall Study|Disease progression|8|||
155118663|NCT02754141|559868377|FG003|Overall Study|Disease progression|5|||
155118664|NCT02754141|559868378|FG004|Overall Study|Disease progression|7|||
155118665|NCT02754141|559868379|FG005|Overall Study|Disease progression|7|||
155118666|NCT02754141|559868380|FG006|Overall Study|Disease progression|7|||
155118667|NCT02754141|559868381|FG007|Overall Study|Disease progression|6|||
155176212|NCT00528970|560083900|FG002|Overall Study|Lost to Follow-up|1|||
155118668|NCT02754141|559868382|FG008|Overall Study|Disease progression|11|||
154985141|NCT01421342|559370196|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
154985142|NCT01421342|559370197|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
154985143|NCT01421342|559370198|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
154985144|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
154985145|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
154985146|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
154985147|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
154985148|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
154985149|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
154985150|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
154985151|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
154985152|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
154985153|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
154985154|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
154985155|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
154985156|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
154985157|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
154985158|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
154985159|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
154985160|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
154985161|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
154985162|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
154985163|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
154985164|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
154985165|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
154985166|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
154985167|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
154985168|NCT01421342|559370196|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
154985169|NCT01421342|559370197|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
154985170|NCT01421342|559370198|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
154985171|NCT03656874|559370201|FG000|Overall Study|Lost to Follow-up|3|||
154985172|NCT03656874|559370202|FG001|Overall Study|Lost to Follow-up|17|||
154985173|NCT02528123|559370203|FG000|Overall Study|Lost to Follow-up|1|||
154985174|NCT05420012|559370206|FG000|Overall Study|Lost to Follow-up|0|||
154985175|NCT05420012|559370207|FG001|Overall Study|Lost to Follow-up|1|||
154985176|NCT00942331|559370212|FG000|Overall Study|Did not start treatment|15|||
154985177|NCT00942331|559370213|FG001|Overall Study|Did not start treatment|22|||
154985178|NCT00567476|559370217|FG000|Overall Study|Adverse Event|2|||
154985179|NCT00567476|559370218|FG001|Overall Study|Adverse Event|0|||
154985180|NCT00567476|559370217|FG000|Overall Study|Pregnancy|1|||
154985181|NCT00567476|559370218|FG001|Overall Study|Pregnancy|0|||
154985182|NCT00567476|559370217|FG000|Overall Study|Protocol Violation|4|||
154985183|NCT00567476|559370218|FG001|Overall Study|Protocol Violation|1|||
154985184|NCT00567476|559370217|FG000|Overall Study|Lost to Follow-up|0|||
154985185|NCT00567476|559370218|FG001|Overall Study|Lost to Follow-up|1|||
154985186|NCT00567476|559370217|FG000|Overall Study|Administrative issues|1|||
154985187|NCT00567476|559370218|FG001|Overall Study|Administrative issues|0|||
154985188|NCT00567476|559370217|FG000|Overall Study|Medical Decision|0|||
154985189|NCT00567476|559370218|FG001|Overall Study|Medical Decision|1|||
154985190|NCT00567476|559370217|FG000|Overall Study|Non-adherence to protocol|0|||
154985191|NCT00567476|559370218|FG001|Overall Study|Non-adherence to protocol|1|||
154911388|NCT02877134|559096168|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911389|NCT02877134|559096169|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
154911390|NCT02877134|559096158|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911391|NCT02877134|559096159|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
154911392|NCT02877134|559096160|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911393|NCT02877134|559096161|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
154911394|NCT02877134|559096162|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911395|NCT02877134|559096163|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911396|NCT02877134|559096164|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
154911397|NCT02877134|559096165|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911398|NCT02877134|559096166|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911399|NCT02877134|559096167|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911400|NCT02877134|559096168|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911401|NCT02877134|559096169|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
154911402|NCT02877134|559096158|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
154985192|NCT01338987|559370224|FG000|Overall Study|enrolled on new protocol|0|||
154911403|NCT02877134|559096159|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
155118669|NCT02754141|559868383|FG009|Overall Study|Disease progression|16|||
155118670|NCT02754141|559868384|FG010|Overall Study|Disease progression|18|||
155118671|NCT02754141|559868385|FG011|Overall Study|Disease progression|13|||
155118672|NCT02754141|559868386|FG012|Overall Study|Disease progression|10|||
155118673|NCT02754141|559868387|FG013|Overall Study|Disease progression|12|||
155118674|NCT02754141|559868388|FG014|Overall Study|Disease progression|12|||
155118675|NCT02754141|559868389|FG015|Overall Study|Disease progression|14|||
155118676|NCT02754141|559868390|FG016|Overall Study|Disease progression|0|||
155118677|NCT02754141|559868391|FG017|Overall Study|Disease progression|1|||
155118678|NCT02754141|559868374|FG000|Overall Study|Study drug toxicity|1|||
155118679|NCT02754141|559868375|FG001|Overall Study|Study drug toxicity|1|||
155118680|NCT02754141|559868376|FG002|Overall Study|Study drug toxicity|0|||
155118681|NCT02754141|559868377|FG003|Overall Study|Study drug toxicity|0|||
155118682|NCT02754141|559868378|FG004|Overall Study|Study drug toxicity|0|||
155118683|NCT02754141|559868379|FG005|Overall Study|Study drug toxicity|0|||
155118684|NCT02754141|559868380|FG006|Overall Study|Study drug toxicity|0|||
155118685|NCT02754141|559868381|FG007|Overall Study|Study drug toxicity|0|||
155118686|NCT02754141|559868382|FG008|Overall Study|Study drug toxicity|0|||
155118687|NCT02754141|559868383|FG009|Overall Study|Study drug toxicity|0|||
155118688|NCT02754141|559868384|FG010|Overall Study|Study drug toxicity|2|||
155118689|NCT02754141|559868385|FG011|Overall Study|Study drug toxicity|1|||
155118690|NCT02754141|559868386|FG012|Overall Study|Study drug toxicity|1|||
155118691|NCT02754141|559868387|FG013|Overall Study|Study drug toxicity|0|||
155118692|NCT02754141|559868388|FG014|Overall Study|Study drug toxicity|0|||
155118693|NCT02754141|559868389|FG015|Overall Study|Study drug toxicity|0|||
155118694|NCT02754141|559868390|FG016|Overall Study|Study drug toxicity|0|||
155118695|NCT02754141|559868391|FG017|Overall Study|Study drug toxicity|0|||
155118696|NCT02754141|559868374|FG000|Overall Study|AE unrelated to study drug|1|||
155118697|NCT02754141|559868375|FG001|Overall Study|AE unrelated to study drug|1|||
155118698|NCT02754141|559868376|FG002|Overall Study|AE unrelated to study drug|0|||
155118699|NCT02754141|559868377|FG003|Overall Study|AE unrelated to study drug|1|||
155118700|NCT02754141|559868378|FG004|Overall Study|AE unrelated to study drug|3|||
155118701|NCT02754141|559868379|FG005|Overall Study|AE unrelated to study drug|2|||
155118702|NCT02754141|559868380|FG006|Overall Study|AE unrelated to study drug|1|||
155118703|NCT02754141|559868381|FG007|Overall Study|AE unrelated to study drug|0|||
155118704|NCT02754141|559868382|FG008|Overall Study|AE unrelated to study drug|0|||
155118705|NCT02754141|559868383|FG009|Overall Study|AE unrelated to study drug|0|||
155118706|NCT02754141|559868384|FG010|Overall Study|AE unrelated to study drug|0|||
155118707|NCT02754141|559868385|FG011|Overall Study|AE unrelated to study drug|0|||
155118708|NCT02754141|559868386|FG012|Overall Study|AE unrelated to study drug|0|||
155118709|NCT02754141|559868387|FG013|Overall Study|AE unrelated to study drug|0|||
155118710|NCT02754141|559868388|FG014|Overall Study|AE unrelated to study drug|0|||
155118711|NCT02754141|559868389|FG015|Overall Study|AE unrelated to study drug|0|||
155118712|NCT02754141|559868390|FG016|Overall Study|AE unrelated to study drug|0|||
155118713|NCT02754141|559868391|FG017|Overall Study|AE unrelated to study drug|0|||
155118714|NCT02754141|559868374|FG000|Overall Study|Request to discontinue|0|||
155118715|NCT02754141|559868375|FG001|Overall Study|Request to discontinue|0|||
155118716|NCT02754141|559868376|FG002|Overall Study|Request to discontinue|0|||
155118717|NCT02754141|559868377|FG003|Overall Study|Request to discontinue|0|||
155118718|NCT02754141|559868378|FG004|Overall Study|Request to discontinue|0|||
155118719|NCT02754141|559868379|FG005|Overall Study|Request to discontinue|0|||
155118720|NCT02754141|559868380|FG006|Overall Study|Request to discontinue|0|||
155118721|NCT02754141|559868381|FG007|Overall Study|Request to discontinue|0|||
155118722|NCT02754141|559868382|FG008|Overall Study|Request to discontinue|1|||
155118723|NCT02754141|559868383|FG009|Overall Study|Request to discontinue|0|||
155118724|NCT02754141|559868384|FG010|Overall Study|Request to discontinue|0|||
155118725|NCT02754141|559868385|FG011|Overall Study|Request to discontinue|0|||
155118726|NCT02754141|559868386|FG012|Overall Study|Request to discontinue|0|||
155118727|NCT02754141|559868387|FG013|Overall Study|Request to discontinue|1|||
155118728|NCT02754141|559868388|FG014|Overall Study|Request to discontinue|1|||
155118729|NCT02754141|559868389|FG015|Overall Study|Request to discontinue|0|||
155118730|NCT02754141|559868390|FG016|Overall Study|Request to discontinue|0|||
155118731|NCT02754141|559868391|FG017|Overall Study|Request to discontinue|0|||
155118732|NCT02754141|559868374|FG000|Overall Study|Withdrew consent|0|||
155118733|NCT02754141|559868375|FG001|Overall Study|Withdrew consent|0|||
155118734|NCT02754141|559868376|FG002|Overall Study|Withdrew consent|0|||
155118735|NCT02754141|559868377|FG003|Overall Study|Withdrew consent|0|||
155118736|NCT02754141|559868378|FG004|Overall Study|Withdrew consent|0|||
155118737|NCT02754141|559868379|FG005|Overall Study|Withdrew consent|0|||
155118738|NCT02754141|559868380|FG006|Overall Study|Withdrew consent|0|||
155118739|NCT02754141|559868381|FG007|Overall Study|Withdrew consent|0|||
155118740|NCT02754141|559868382|FG008|Overall Study|Withdrew consent|0|||
155118741|NCT02754141|559868383|FG009|Overall Study|Withdrew consent|1|||
155118742|NCT02754141|559868384|FG010|Overall Study|Withdrew consent|0|||
155118743|NCT02754141|559868385|FG011|Overall Study|Withdrew consent|0|||
154985193|NCT01338987|559370225|FG001|Overall Study|enrolled on new protocol|0|||
154985194|NCT01338987|559370226|FG002|Overall Study|enrolled on new protocol|1|||
154985195|NCT01338987|559370227|FG003|Overall Study|enrolled on new protocol|0|||
154985196|NCT01338987|559370228|FG004|Overall Study|enrolled on new protocol|0|||
154985197|NCT01338987|559370224|FG000|Overall Study|Disease progression on study|2|||
154985198|NCT01338987|559370225|FG001|Overall Study|Disease progression on study|1|||
154985199|NCT01338987|559370226|FG002|Overall Study|Disease progression on study|1|||
154985200|NCT01338987|559370227|FG003|Overall Study|Disease progression on study|0|||
154985201|NCT01338987|559370228|FG004|Overall Study|Disease progression on study|0|||
154985202|NCT00757848|559370229|FG000|Overall Study|Voluntary discontinuation|1|||
154985203|NCT00757848|559370230|FG001|Overall Study|Voluntary discontinuation|0|||
154985204|NCT00757848|559370229|FG000|Overall Study|Adverse Event|1|||
154985205|NCT00757848|559370230|FG001|Overall Study|Adverse Event|2|||
154985206|NCT00757848|559370229|FG000|Overall Study|Incorrect enrolment|1|||
154985207|NCT00757848|559370230|FG001|Overall Study|Incorrect enrolment|0|||
154985208|NCT03856593|559370234|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
154985209|NCT03856593|559370235|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
154985210|NCT03078582|559370237|FG000|Overall Study|Adverse Event|0|||
154985211|NCT03078582|559370238|FG001|Overall Study|Adverse Event|8|||
154985212|NCT03977701|559370243|FG000|Overall Study|COVID-19 pandemic|0|||
154985213|NCT03977701|559370244|FG001|Overall Study|COVID-19 pandemic|0|||
154985214|NCT03977701|559370245|FG002|Overall Study|COVID-19 pandemic|0|||
154985215|NCT03977701|559370246|FG003|Overall Study|COVID-19 pandemic|0|||
154985216|NCT03977701|559370247|FG004|Overall Study|COVID-19 pandemic|0|||
154985217|NCT03977701|559370248|FG005|Overall Study|COVID-19 pandemic|1|||
154985218|NCT03977701|559370249|FG006|Overall Study|COVID-19 pandemic|0|||
154985219|NCT03977701|559370250|FG007|Overall Study|COVID-19 pandemic|1|||
154985220|NCT03977701|559370251|FG008|Overall Study|COVID-19 pandemic|0|||
154985221|NCT03977701|559370252|FG009|Overall Study|COVID-19 pandemic|0|||
154985222|NCT02939014|559370259|FG000|Overall Study|Lost to Follow-up|1|||
154985223|NCT02939014|559370260|FG001|Overall Study|Lost to Follow-up|0|||
154985224|NCT02939014|559370259|FG000|Overall Study|Death|4|||
154985225|NCT02939014|559370260|FG001|Overall Study|Death|3|||
154985226|NCT01568866|559370261|FG000|Overall Study|Disease Progression|208|||
154985227|NCT01568866|559370262|FG001|Overall Study|Disease Progression|183|||
154985228|NCT01568866|559370261|FG000|Overall Study|Adverse Event|94|||
154985229|NCT01568866|559370262|FG001|Overall Study|Adverse Event|96|||
154985230|NCT01568866|559370261|FG000|Overall Study|Patient Request|55|||
154985231|NCT01568866|559370262|FG001|Overall Study|Patient Request|71|||
154985232|NCT01568866|559370261|FG000|Overall Study|Physician Decision|40|||
154985233|NCT01568866|559370262|FG001|Overall Study|Physician Decision|32|||
154985234|NCT01568866|559370261|FG000|Overall Study|Withdrawal by Subject|19|||
154985235|NCT01568866|559370262|FG001|Overall Study|Withdrawal by Subject|11|||
154985236|NCT01568866|559370261|FG000|Overall Study|Death|10|||
154985237|NCT01568866|559370262|FG001|Overall Study|Death|18|||
154985238|NCT01568866|559370261|FG000|Overall Study|Protocol Non-compliance|2|||
154985239|NCT01568866|559370262|FG001|Overall Study|Protocol Non-compliance|4|||
154985240|NCT01568866|559370261|FG000|Overall Study|Lost to Follow-up|1|||
154985241|NCT01568866|559370262|FG001|Overall Study|Lost to Follow-up|0|||
154985242|NCT01568866|559370261|FG000|Overall Study|Randomized but Not Dosed|9|||
154985243|NCT01568866|559370262|FG001|Overall Study|Randomized but Not Dosed|1|||
154985244|NCT01698775|559370263|FG000|Phase A|Adverse Event|2|||
154985245|NCT01698775|559370264|FG001|Phase A|Adverse Event|1|||
154985246|NCT01698775|559370263|FG000|Phase A|Death|1|||
154985247|NCT01698775|559370264|FG001|Phase A|Death|1|||
154985248|NCT01698775|559370263|FG000|Phase A|Lack of Efficacy|1|||
154985249|NCT01698775|559370264|FG001|Phase A|Lack of Efficacy|0|||
154985250|NCT01698775|559370263|FG000|Phase A|Lost to Follow-up|1|||
154985251|NCT01698775|559370264|FG001|Phase A|Lost to Follow-up|2|||
154985252|NCT01698775|559370263|FG000|Phase A|Protocol Violation|1|||
154985253|NCT01698775|559370264|FG001|Phase A|Protocol Violation|0|||
154985254|NCT01698775|559370263|FG000|Phase A|Withdrawal by Subject|3|||
154985255|NCT01698775|559370264|FG001|Phase A|Withdrawal by Subject|4|||
154985256|NCT01698775|559370263|FG000|Phase A|Kidney [transplant]|0|||
155118744|NCT02754141|559868386|FG012|Overall Study|Withdrew consent|0|||
155118745|NCT02754141|559868387|FG013|Overall Study|Withdrew consent|0|||
155118746|NCT02754141|559868388|FG014|Overall Study|Withdrew consent|0|||
154985257|NCT01698775|559370264|FG001|Phase A|Kidney [transplant]|1|||
154985258|NCT01698775|559370263|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
154985259|NCT01698775|559370264|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
154985260|NCT01698775|559370263|FG000|Phase B|Adverse Event|6|||
154985261|NCT01698775|559370264|FG001|Phase B|Adverse Event|3|||
154985262|NCT01698775|559370263|FG000|Phase B|Death|0|||
154985263|NCT01698775|559370264|FG001|Phase B|Death|1|||
154985264|NCT01698775|559370263|FG000|Phase B|Lack of Efficacy|0|||
154985265|NCT01698775|559370264|FG001|Phase B|Lack of Efficacy|1|||
155118747|NCT02754141|559868389|FG015|Overall Study|Withdrew consent|0|||
154985266|NCT01698775|559370263|FG000|Phase B|Lost to Follow-up|0|||
154985267|NCT01698775|559370264|FG001|Phase B|Lost to Follow-up|1|||
155118748|NCT02754141|559868390|FG016|Overall Study|Withdrew consent|0|||
155118749|NCT02754141|559868391|FG017|Overall Study|Withdrew consent|0|||
155118750|NCT02754141|559868374|FG000|Overall Study|Maximum clinical benefit|0|||
155118751|NCT02754141|559868375|FG001|Overall Study|Maximum clinical benefit|0|||
155118752|NCT02754141|559868376|FG002|Overall Study|Maximum clinical benefit|0|||
155118753|NCT02754141|559868377|FG003|Overall Study|Maximum clinical benefit|1|||
155118754|NCT02754141|559868378|FG004|Overall Study|Maximum clinical benefit|0|||
155118755|NCT02754141|559868379|FG005|Overall Study|Maximum clinical benefit|0|||
155118756|NCT02754141|559868380|FG006|Overall Study|Maximum clinical benefit|0|||
155118757|NCT02754141|559868381|FG007|Overall Study|Maximum clinical benefit|0|||
155118758|NCT02754141|559868382|FG008|Overall Study|Maximum clinical benefit|0|||
155118759|NCT02754141|559868383|FG009|Overall Study|Maximum clinical benefit|0|||
155118760|NCT02754141|559868384|FG010|Overall Study|Maximum clinical benefit|0|||
154985268|NCT01698775|559370263|FG000|Phase B|Physician Decision|1|||
154985269|NCT01698775|559370264|FG001|Phase B|Physician Decision|1|||
154985270|NCT01698775|559370263|FG000|Phase B|Protocol Violation|1|||
154985271|NCT01698775|559370264|FG001|Phase B|Protocol Violation|1|||
154985272|NCT01698775|559370263|FG000|Phase B|Withdrawal by Subject|6|||
154985273|NCT01698775|559370264|FG001|Phase B|Withdrawal by Subject|2|||
154985274|NCT02340221|559370269|FG000|Overall Study|Death|100|||
154985275|NCT02340221|559370270|FG001|Overall Study|Death|197|||
154985276|NCT02340221|559370269|FG000|Overall Study|Withdrawal by Participant|24|||
154985277|NCT02340221|559370270|FG001|Overall Study|Withdrawal by Participant|37|||
154985278|NCT02340221|559370269|FG000|Overall Study|Lost to Follow-up|4|||
154985279|NCT02340221|559370270|FG001|Overall Study|Lost to Follow-up|15|||
154985280|NCT02340221|559370269|FG000|Overall Study|Reason Not Specified|85|||
154985281|NCT02340221|559370270|FG001|Overall Study|Reason Not Specified|165|||
154985282|NCT02340221|559370269|FG000|Overall Study|Study Terminated by Sponsor|1|||
154985283|NCT02340221|559370270|FG001|Overall Study|Study Terminated by Sponsor|3|||
154985284|NCT01583218|559370271|FG000|Overall Study|Withdrawal by Subject|43|||
154985285|NCT01583218|559370272|FG001|Overall Study|Withdrawal by Subject|29|||
154985286|NCT01583218|559370271|FG000|Overall Study|Death|206|||
154985287|NCT01583218|559370272|FG001|Overall Study|Death|211|||
154985288|NCT01583218|559370271|FG000|Overall Study|Lost to Follow-up|11|||
154985289|NCT01583218|559370272|FG001|Overall Study|Lost to Follow-up|17|||
154985290|NCT01583218|559370271|FG000|Overall Study|Adverse event or serious adverse event|3|||
154985291|NCT01583218|559370272|FG001|Overall Study|Adverse event or serious adverse event|3|||
154985292|NCT01583218|559370271|FG000|Overall Study|Patient /Family decision|3|||
154985293|NCT01583218|559370272|FG001|Overall Study|Patient /Family decision|0|||
154985294|NCT01583218|559370271|FG000|Overall Study|Cannot contact patient directly|1|||
154985295|NCT01583218|559370272|FG001|Overall Study|Cannot contact patient directly|2|||
154985296|NCT01583218|559370271|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
154985297|NCT01583218|559370272|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
154985298|NCT01583218|559370271|FG000|Overall Study|Patient did not wish to attend visits|0|||
154985299|NCT01583218|559370272|FG001|Overall Study|Patient did not wish to attend visits|1|||
154985300|NCT01583218|559370271|FG000|Overall Study|Patient randomized but not dosed|17|||
154985301|NCT01583218|559370272|FG001|Overall Study|Patient randomized but not dosed|16|||
154985302|NCT01583218|559370271|FG000|Overall Study|Patient was assessed via phone in person|1|||
154985303|NCT01583218|559370272|FG001|Overall Study|Patient was assessed via phone in person|0|||
154985304|NCT01583218|559370271|FG000|Overall Study|Patient deemed ineligible after random|2|||
154985305|NCT01583218|559370272|FG001|Overall Study|Patient deemed ineligible after random|0|||
154985306|NCT01583218|559370271|FG000|Overall Study|Patient was early terminated from study|0|||
154985307|NCT01583218|559370272|FG001|Overall Study|Patient was early terminated from study|1|||
154985308|NCT01583218|559370271|FG000|Overall Study|Patient was randomized due to mistake|1|||
154985309|NCT01583218|559370272|FG001|Overall Study|Patient was randomized due to mistake|0|||
154985310|NCT01583218|559370271|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
154985311|NCT01583218|559370272|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
154985312|NCT01583218|559370271|FG000|Overall Study|Withdraw of consent on day of random|1|||
154985313|NCT01583218|559370272|FG001|Overall Study|Withdraw of consent on day of random|0|||
154985314|NCT00952276|559370275|FG000|Overall Study|Withdrawal by Subject|1|||
154985315|NCT00952276|559370276|FG001|Overall Study|Withdrawal by Subject|0|||
154985316|NCT00952276|559370277|FG002|Overall Study|Withdrawal by Subject|0|||
154985317|NCT00952276|559370278|FG003|Overall Study|Withdrawal by Subject|1|||
154985318|NCT00952276|559370279|FG004|Overall Study|Withdrawal by Subject|0|||
155118761|NCT02754141|559868385|FG011|Overall Study|Maximum clinical benefit|0|||
154985319|NCT01013649|559371992|FG000|First Step|Withdrawal by Subject|36|||
155118762|NCT02754141|559868386|FG012|Overall Study|Maximum clinical benefit|0|||
155118763|NCT02754141|559868387|FG013|Overall Study|Maximum clinical benefit|0|||
155118764|NCT02754141|559868388|FG014|Overall Study|Maximum clinical benefit|0|||
155118765|NCT02754141|559868389|FG015|Overall Study|Maximum clinical benefit|0|||
155118766|NCT02754141|559868390|FG016|Overall Study|Maximum clinical benefit|0|||
155118767|NCT02754141|559868391|FG017|Overall Study|Maximum clinical benefit|0|||
155118768|NCT02754141|559868374|FG000|Overall Study|No longer meets study criteria|0|||
155118769|NCT02754141|559868375|FG001|Overall Study|No longer meets study criteria|0|||
154985320|NCT01013649|559371993|FG001|First Step|Withdrawal by Subject|19|||
154985321|NCT01013649|559371994|FG002|First Step|Withdrawal by Subject|0|||
154985322|NCT01013649|559371995|FG003|First Step|Withdrawal by Subject|0|||
154985323|NCT01013649|559371992|FG000|First Step|Progression|58|||
154985324|NCT01013649|559371993|FG001|First Step|Progression|23|||
154985325|NCT01013649|559371994|FG002|First Step|Progression|0|||
154985326|NCT01013649|559371995|FG003|First Step|Progression|0|||
154985327|NCT01013649|559371992|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
154985328|NCT01013649|559371993|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
154985329|NCT01013649|559371994|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
154985330|NCT01013649|559371995|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
154985331|NCT01013649|559371992|FG000|First Step|Death|3|||
154985332|NCT01013649|559371993|FG001|First Step|Death|4|||
154985333|NCT01013649|559371994|FG002|First Step|Death|0|||
154985334|NCT01013649|559371995|FG003|First Step|Death|0|||
154985335|NCT01013649|559371992|FG000|First Step|Adverse Event|9|||
154985336|NCT01013649|559371993|FG001|First Step|Adverse Event|5|||
154985337|NCT01013649|559371994|FG002|First Step|Adverse Event|0|||
154985338|NCT01013649|559371995|FG003|First Step|Adverse Event|0|||
154985339|NCT01013649|559371992|FG000|First Step|Other|4|||
154985340|NCT01013649|559371993|FG001|First Step|Other|6|||
154985341|NCT01013649|559371994|FG002|First Step|Other|0|||
154985342|NCT01013649|559371995|FG003|First Step|Other|0|||
154985343|NCT02091141|559371999|FG000|Overall Study|Death|280|||
154985344|NCT02091141|559372000|FG001|Overall Study|Death|118|||
154985345|NCT02091141|559372001|FG002|Overall Study|Death|46|||
154985346|NCT02091141|559372002|FG003|Overall Study|Death|13|||
154985347|NCT02091141|559372003|FG004|Overall Study|Death|31|||
154985348|NCT02091141|559372004|FG005|Overall Study|Death|16|||
154985349|NCT02091141|559372005|FG006|Overall Study|Death|12|||
154985350|NCT02091141|559371999|FG000|Overall Study|Withdrawal by Subject|21|||
154985351|NCT02091141|559372000|FG001|Overall Study|Withdrawal by Subject|13|||
154985352|NCT02091141|559372001|FG002|Overall Study|Withdrawal by Subject|3|||
154985353|NCT02091141|559372002|FG003|Overall Study|Withdrawal by Subject|2|||
154985354|NCT02091141|559372003|FG004|Overall Study|Withdrawal by Subject|2|||
154985355|NCT02091141|559372004|FG005|Overall Study|Withdrawal by Subject|3|||
154985356|NCT02091141|559372005|FG006|Overall Study|Withdrawal by Subject|0|||
154985357|NCT02091141|559371999|FG000|Overall Study|Lost to Follow-up|21|||
154985358|NCT02091141|559372000|FG001|Overall Study|Lost to Follow-up|5|||
154985359|NCT02091141|559372001|FG002|Overall Study|Lost to Follow-up|1|||
154985360|NCT02091141|559372002|FG003|Overall Study|Lost to Follow-up|0|||
154985361|NCT02091141|559372003|FG004|Overall Study|Lost to Follow-up|1|||
154985362|NCT02091141|559372004|FG005|Overall Study|Lost to Follow-up|2|||
154985363|NCT02091141|559372005|FG006|Overall Study|Lost to Follow-up|0|||
154985364|NCT02091141|559371999|FG000|Overall Study|Reason Not Specified|6|||
154985365|NCT02091141|559372000|FG001|Overall Study|Reason Not Specified|5|||
154985366|NCT02091141|559372001|FG002|Overall Study|Reason Not Specified|2|||
154985367|NCT02091141|559372002|FG003|Overall Study|Reason Not Specified|0|||
154985368|NCT02091141|559372003|FG004|Overall Study|Reason Not Specified|0|||
154985369|NCT02091141|559372004|FG005|Overall Study|Reason Not Specified|0|||
154985370|NCT02091141|559372005|FG006|Overall Study|Reason Not Specified|1|||
154985371|NCT02091141|559371999|FG000|Overall Study|Study Ended by Sponsor|1|||
154985372|NCT02091141|559372000|FG001|Overall Study|Study Ended by Sponsor|9|||
154985373|NCT02091141|559372001|FG002|Overall Study|Study Ended by Sponsor|0|||
154985374|NCT02091141|559372002|FG003|Overall Study|Study Ended by Sponsor|0|||
154985375|NCT02091141|559372003|FG004|Overall Study|Study Ended by Sponsor|0|||
154985376|NCT02091141|559372004|FG005|Overall Study|Study Ended by Sponsor|0|||
154985377|NCT02091141|559372005|FG006|Overall Study|Study Ended by Sponsor|0|||
154985378|NCT02091141|559371999|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
154985379|NCT02091141|559372000|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
154985380|NCT02091141|559372001|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
155118770|NCT02754141|559868376|FG002|Overall Study|No longer meets study criteria|0|||
155118771|NCT02754141|559868377|FG003|Overall Study|No longer meets study criteria|1|||
155118772|NCT02754141|559868378|FG004|Overall Study|No longer meets study criteria|0|||
155118773|NCT02754141|559868379|FG005|Overall Study|No longer meets study criteria|0|||
154985381|NCT02091141|559372002|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
154985382|NCT02091141|559372003|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
154985383|NCT02091141|559372004|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
154985384|NCT02091141|559372005|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
155118774|NCT02754141|559868380|FG006|Overall Study|No longer meets study criteria|0|||
155118775|NCT02754141|559868381|FG007|Overall Study|No longer meets study criteria|0|||
154985385|NCT04551911|559372006|FG000|Overall Study|Lost to Follow-up|2|||
154985386|NCT04551911|559372007|FG001|Overall Study|Lost to Follow-up|1|||
154985387|NCT04551911|559372006|FG000|Overall Study|Withdrawal by Subject|10|||
154985388|NCT04551911|559372007|FG001|Overall Study|Withdrawal by Subject|10|||
154985389|NCT04551911|559372006|FG000|Overall Study|Did not receive the study drug|3|||
155118776|NCT02754141|559868382|FG008|Overall Study|No longer meets study criteria|0|||
155118777|NCT02754141|559868383|FG009|Overall Study|No longer meets study criteria|0|||
155118778|NCT02754141|559868384|FG010|Overall Study|No longer meets study criteria|0|||
155118779|NCT02754141|559868385|FG011|Overall Study|No longer meets study criteria|0|||
154911404|NCT02877134|559096160|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
154911405|NCT02877134|559096161|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
154911406|NCT02877134|559096162|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
154911407|NCT02877134|559096163|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
154911408|NCT02877134|559096164|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
154911409|NCT02877134|559096165|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
155118780|NCT02754141|559868386|FG012|Overall Study|No longer meets study criteria|0|||
155118781|NCT02754141|559868387|FG013|Overall Study|No longer meets study criteria|0|||
154911410|NCT02877134|559096166|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
154911411|NCT02877134|559096167|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
154911412|NCT02877134|559096168|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
154911413|NCT02877134|559096169|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
154911414|NCT02877134|559096158|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
154911415|NCT02877134|559096159|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
154911416|NCT02877134|559096160|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
154911417|NCT02877134|559096161|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
154911418|NCT02877134|559096162|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
154911419|NCT02877134|559096163|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
154911420|NCT02877134|559096164|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
154911421|NCT02877134|559096165|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
154911422|NCT02877134|559096166|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
154911423|NCT02877134|559096167|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
154911424|NCT02877134|559096168|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
154911425|NCT02877134|559096169|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
154911426|NCT02877134|559096158|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911427|NCT02877134|559096159|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911428|NCT02877134|559096160|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911429|NCT02877134|559096161|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911430|NCT02877134|559096162|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911431|NCT02877134|559096163|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911432|NCT02877134|559096164|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911433|NCT02877134|559096165|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911434|NCT02877134|559096166|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
154911435|NCT02877134|559096167|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911436|NCT02877134|559096168|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911437|NCT02877134|559096169|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
154911438|NCT02877134|559096158|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911439|NCT02877134|559096159|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911440|NCT02877134|559096160|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911441|NCT02877134|559096161|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911442|NCT02877134|559096162|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911443|NCT02877134|559096163|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911444|NCT02877134|559096164|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
154911445|NCT02877134|559096165|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
154911446|NCT02877134|559096166|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
154911447|NCT02877134|559096167|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
154911448|NCT02877134|559096168|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
154911449|NCT02877134|559096169|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
154911450|NCT02877134|559096158|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911451|NCT02877134|559096159|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911452|NCT02877134|559096160|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911453|NCT02877134|559096161|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911454|NCT02877134|559096162|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911455|NCT02877134|559096163|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911456|NCT02877134|559096164|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911457|NCT02877134|559096165|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
154911458|NCT02877134|559096166|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
154911459|NCT02877134|559096167|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
154911460|NCT02877134|559096168|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911461|NCT02877134|559096169|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
154911462|NCT02877134|559096158|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
154911463|NCT02877134|559096159|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
154911464|NCT02877134|559096160|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
154911465|NCT02877134|559096161|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
154911466|NCT02877134|559096162|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
154911467|NCT02877134|559096163|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
154911468|NCT02877134|559096164|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
154911469|NCT02877134|559096165|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
154911470|NCT02877134|559096166|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
154911471|NCT02877134|559096167|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
154911472|NCT02877134|559096168|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
154911473|NCT02877134|559096169|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
154911474|NCT01055457|559096170|FG000|Overall Study|Lost to Follow-up|0|||
154911475|NCT01055457|559096171|FG001|Overall Study|Lost to Follow-up|1|||
154911476|NCT01055457|559096172|FG002|Overall Study|Lost to Follow-up|0|||
154911477|NCT01055457|559096173|FG003|Overall Study|Lost to Follow-up|0|||
154911478|NCT01055457|559096174|FG004|Overall Study|Lost to Follow-up|0|||
154911479|NCT01055457|559096175|FG005|Overall Study|Lost to Follow-up|1|||
154911480|NCT01055457|559096176|FG006|Overall Study|Lost to Follow-up|0|||
154911481|NCT01055457|559096177|FG007|Overall Study|Lost to Follow-up|0|||
154911482|NCT01055457|559096178|FG008|Overall Study|Lost to Follow-up|0|||
154911483|NCT01055457|559096179|FG009|Overall Study|Lost to Follow-up|0|||
154911484|NCT01055457|559096170|FG000|Overall Study|Protocol Violation|0|||
154911485|NCT01055457|559096171|FG001|Overall Study|Protocol Violation|0|||
154911486|NCT01055457|559096172|FG002|Overall Study|Protocol Violation|1|||
154911487|NCT01055457|559096173|FG003|Overall Study|Protocol Violation|1|||
154911488|NCT01055457|559096174|FG004|Overall Study|Protocol Violation|1|||
154911489|NCT01055457|559096175|FG005|Overall Study|Protocol Violation|2|||
154911490|NCT01055457|559096176|FG006|Overall Study|Protocol Violation|1|||
154911491|NCT01055457|559096177|FG007|Overall Study|Protocol Violation|0|||
154911492|NCT01055457|559096178|FG008|Overall Study|Protocol Violation|0|||
154911493|NCT01055457|559096179|FG009|Overall Study|Protocol Violation|1|||
154911494|NCT01055457|559096170|FG000|Overall Study|Subject Disinterest|0|||
154911495|NCT01055457|559096171|FG001|Overall Study|Subject Disinterest|0|||
154911496|NCT01055457|559096172|FG002|Overall Study|Subject Disinterest|0|||
154911497|NCT01055457|559096173|FG003|Overall Study|Subject Disinterest|0|||
154911498|NCT01055457|559096174|FG004|Overall Study|Subject Disinterest|0|||
154911499|NCT01055457|559096175|FG005|Overall Study|Subject Disinterest|0|||
154911500|NCT01055457|559096176|FG006|Overall Study|Subject Disinterest|0|||
154911501|NCT01055457|559096177|FG007|Overall Study|Subject Disinterest|1|||
154911502|NCT01055457|559096178|FG008|Overall Study|Subject Disinterest|0|||
154911503|NCT01055457|559096179|FG009|Overall Study|Subject Disinterest|0|||
154911504|NCT01055457|559096170|FG000|Overall Study|Subject Ineligible|1|||
154911505|NCT01055457|559096171|FG001|Overall Study|Subject Ineligible|0|||
154911506|NCT01055457|559096172|FG002|Overall Study|Subject Ineligible|1|||
154911507|NCT01055457|559096173|FG003|Overall Study|Subject Ineligible|0|||
155118782|NCT02754141|559868388|FG014|Overall Study|No longer meets study criteria|0|||
155118783|NCT02754141|559868389|FG015|Overall Study|No longer meets study criteria|0|||
155118784|NCT02754141|559868390|FG016|Overall Study|No longer meets study criteria|0|||
155118785|NCT02754141|559868391|FG017|Overall Study|No longer meets study criteria|0|||
155118786|NCT02754141|559868374|FG000|Overall Study|Other reasons|0|||
155118787|NCT02754141|559868375|FG001|Overall Study|Other reasons|0|||
155118788|NCT02754141|559868376|FG002|Overall Study|Other reasons|0|||
155118789|NCT02754141|559868377|FG003|Overall Study|Other reasons|0|||
155118790|NCT02754141|559868378|FG004|Overall Study|Other reasons|0|||
155118791|NCT02754141|559868379|FG005|Overall Study|Other reasons|0|||
155118792|NCT02754141|559868380|FG006|Overall Study|Other reasons|0|||
155118793|NCT02754141|559868381|FG007|Overall Study|Other reasons|1|||
155118794|NCT02754141|559868382|FG008|Overall Study|Other reasons|0|||
155118795|NCT02754141|559868383|FG009|Overall Study|Other reasons|0|||
155118796|NCT02754141|559868384|FG010|Overall Study|Other reasons|0|||
155118797|NCT02754141|559868385|FG011|Overall Study|Other reasons|0|||
155118798|NCT02754141|559868386|FG012|Overall Study|Other reasons|2|||
155118799|NCT02754141|559868387|FG013|Overall Study|Other reasons|0|||
155118800|NCT02754141|559868388|FG014|Overall Study|Other reasons|0|||
155118801|NCT02754141|559868389|FG015|Overall Study|Other reasons|0|||
155118802|NCT02754141|559868390|FG016|Overall Study|Other reasons|0|||
155118803|NCT02754141|559868391|FG017|Overall Study|Other reasons|0|||
155118804|NCT02754141|559868374|FG000|Overall Study|Completed treatment as per protocol|0|||
155118805|NCT02754141|559868375|FG001|Overall Study|Completed treatment as per protocol|1|||
155118806|NCT02754141|559868376|FG002|Overall Study|Completed treatment as per protocol|0|||
154911508|NCT01055457|559096174|FG004|Overall Study|Subject Ineligible|1|||
154911509|NCT01055457|559096175|FG005|Overall Study|Subject Ineligible|0|||
154911510|NCT01055457|559096176|FG006|Overall Study|Subject Ineligible|0|||
154911511|NCT01055457|559096177|FG007|Overall Study|Subject Ineligible|0|||
154911512|NCT01055457|559096178|FG008|Overall Study|Subject Ineligible|0|||
154911513|NCT01055457|559096179|FG009|Overall Study|Subject Ineligible|0|||
154911514|NCT01055457|559096170|FG000|Overall Study|Discomfort|0|||
155118807|NCT02754141|559868377|FG003|Overall Study|Completed treatment as per protocol|0|||
155118808|NCT02754141|559868378|FG004|Overall Study|Completed treatment as per protocol|0|||
154911515|NCT01055457|559096171|FG001|Overall Study|Discomfort|0|||
154911516|NCT01055457|559096172|FG002|Overall Study|Discomfort|0|||
154911517|NCT01055457|559096173|FG003|Overall Study|Discomfort|0|||
154911518|NCT01055457|559096174|FG004|Overall Study|Discomfort|1|||
154911519|NCT01055457|559096175|FG005|Overall Study|Discomfort|0|||
154911520|NCT01055457|559096176|FG006|Overall Study|Discomfort|0|||
154911521|NCT01055457|559096177|FG007|Overall Study|Discomfort|0|||
154911522|NCT01055457|559096178|FG008|Overall Study|Discomfort|0|||
154911523|NCT01055457|559096179|FG009|Overall Study|Discomfort|0|||
154911524|NCT01055457|559096170|FG000|Overall Study|Pregnancy|0|||
154911525|NCT01055457|559096171|FG001|Overall Study|Pregnancy|0|||
154911526|NCT01055457|559096172|FG002|Overall Study|Pregnancy|0|||
154911527|NCT01055457|559096173|FG003|Overall Study|Pregnancy|1|||
154911528|NCT01055457|559096174|FG004|Overall Study|Pregnancy|0|||
154911529|NCT01055457|559096175|FG005|Overall Study|Pregnancy|0|||
154911530|NCT01055457|559096176|FG006|Overall Study|Pregnancy|0|||
154911531|NCT01055457|559096177|FG007|Overall Study|Pregnancy|0|||
154911532|NCT01055457|559096178|FG008|Overall Study|Pregnancy|0|||
154911533|NCT01055457|559096179|FG009|Overall Study|Pregnancy|0|||
154911534|NCT01055457|559096170|FG000|Overall Study|Adverse Event|0|||
154911535|NCT01055457|559096171|FG001|Overall Study|Adverse Event|0|||
154911536|NCT01055457|559096172|FG002|Overall Study|Adverse Event|0|||
154911537|NCT01055457|559096173|FG003|Overall Study|Adverse Event|1|||
154911538|NCT01055457|559096174|FG004|Overall Study|Adverse Event|0|||
154911539|NCT01055457|559096175|FG005|Overall Study|Adverse Event|0|||
154911540|NCT01055457|559096176|FG006|Overall Study|Adverse Event|0|||
154911541|NCT01055457|559096177|FG007|Overall Study|Adverse Event|0|||
154911542|NCT01055457|559096178|FG008|Overall Study|Adverse Event|0|||
154911543|NCT01055457|559096179|FG009|Overall Study|Adverse Event|0|||
154911544|NCT03267576|559096187|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
154911545|NCT03267576|559096188|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
154911546|NCT03267576|559096187|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
154911547|NCT03267576|559096188|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
154911548|NCT00882362|559096189|FG000|Overall Study|Adverse Event|13|||
154911549|NCT00882362|559096190|FG001|Overall Study|Adverse Event|10|||
154911550|NCT00882362|559096189|FG000|Overall Study|Withdrawal by Subject|13|||
154911551|NCT00882362|559096190|FG001|Overall Study|Withdrawal by Subject|10|||
154911552|NCT00882362|559096189|FG000|Overall Study|Lack of Efficacy|3|||
154911553|NCT00882362|559096190|FG001|Overall Study|Lack of Efficacy|0|||
154911554|NCT00882362|559096189|FG000|Overall Study|Protocol Violation|7|||
154911555|NCT00882362|559096190|FG001|Overall Study|Protocol Violation|2|||
154911556|NCT00882362|559096189|FG000|Overall Study|Pregnancy|1|||
154911557|NCT00882362|559096190|FG001|Overall Study|Pregnancy|0|||
154911558|NCT00882362|559096189|FG000|Overall Study|Physician Decision|5|||
154911559|NCT00882362|559096190|FG001|Overall Study|Physician Decision|1|||
154911560|NCT00882362|559096189|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
154911561|NCT00882362|559096190|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
154911562|NCT00882362|559096189|FG000|Overall Study|change of residence or other commitments|5|||
154911563|NCT00882362|559096190|FG001|Overall Study|change of residence or other commitments|0|||
154911564|NCT01268514|559096191|FG000|Overall Study|Adverse Event|20|||
154911565|NCT01268514|559096191|FG000|Overall Study|Death|8|||
154911566|NCT01268514|559096191|FG000|Overall Study|Lost to Follow-up|5|||
154911567|NCT01268514|559096191|FG000|Overall Study|Withdrawal by Subject|3|||
154911568|NCT01268514|559096191|FG000|Overall Study|Withdrawal by Surgeon|5|||
154911569|NCT01432938|559096192|FG000|First Intervention|Protocol Violation|1|||
154911570|NCT01432938|559096193|FG001|First Intervention|Protocol Violation|0|||
154911571|NCT01432938|559096192|FG000|First Intervention|Physician Decision|1|||
154911572|NCT01432938|559096193|FG001|First Intervention|Physician Decision|0|||
154911573|NCT01432938|559096192|FG000|Second Intervention|Adverse Event|1|||
154911574|NCT01432938|559096193|FG001|Second Intervention|Adverse Event|0|||
154911575|NCT01601873|559096194|FG000|Overall Study|Lost to Follow-up|2|||
154911576|NCT01601873|559096195|FG001|Overall Study|Lost to Follow-up|3|||
154911577|NCT02736474|559096197|FG000|Overall Study|Lost to Follow-up|0|||
154911578|NCT02736474|559096198|FG001|Overall Study|Lost to Follow-up|1|||
154911579|NCT01024946|559096199|FG000|Overall Study|Screen Failure|3|||
154911580|NCT01024946|559096199|FG000|Overall Study|Withdrawal by Subject|1|||
154911581|NCT01024946|559096199|FG000|Overall Study|Adverse Event|1|||
154911582|NCT03147495|559096200|FG000|Overall Study|Physician Decision|0|||
155118809|NCT02754141|559868379|FG005|Overall Study|Completed treatment as per protocol|0|||
155118810|NCT02754141|559868380|FG006|Overall Study|Completed treatment as per protocol|0|||
154911583|NCT03147495|559096201|FG001|Overall Study|Physician Decision|6|||
154911584|NCT02483611|559096202|FG000|Overall Study|Protocol Violation|0|||
154911585|NCT02483611|559096203|FG001|Overall Study|Protocol Violation|0|||
154911586|NCT02483611|559096204|FG002|Overall Study|Protocol Violation|1|||
154911587|NCT02608892|559096205|FG000|Overall Study|Lost to Follow-up|1|||
154911588|NCT02608892|559096206|FG001|Overall Study|Lost to Follow-up|0|||
154911589|NCT00877890|559096209|FG000|Overall Study|Adverse Event|6|||
154911590|NCT00877890|559096210|FG001|Overall Study|Adverse Event|6|||
154911591|NCT00877890|559096209|FG000|Overall Study|Lost to Follow-up|5|||
154911592|NCT00877890|559096210|FG001|Overall Study|Lost to Follow-up|5|||
154985390|NCT04551911|559372007|FG001|Overall Study|Did not receive the study drug|4|||
154985391|NCT02177136|559372012|FG000|DB Phase|Withdrawal by Subject|2|||
154985392|NCT02177136|559372013|FG001|DB Phase|Withdrawal by Subject|0|||
154985393|NCT02177136|559372014|FG002|DB Phase|Withdrawal by Subject|0|||
154985394|NCT02177136|559372015|FG003|DB Phase|Withdrawal by Subject|0|||
154985395|NCT02177136|559372012|FG000|DB Phase|Discontinued Due to Pruritus|1|||
154985396|NCT02177136|559372013|FG001|DB Phase|Discontinued Due to Pruritus|3|||
154985397|NCT02177136|559372014|FG002|DB Phase|Discontinued Due to Pruritus|0|||
154985398|NCT02177136|559372015|FG003|DB Phase|Discontinued Due to Pruritus|0|||
154985399|NCT02177136|559372012|FG000|DB Phase|Adverse Event|3|||
154985400|NCT02177136|559372013|FG001|DB Phase|Adverse Event|2|||
155118811|NCT02754141|559868381|FG007|Overall Study|Completed treatment as per protocol|0|||
155118812|NCT02754141|559868382|FG008|Overall Study|Completed treatment as per protocol|0|||
155118813|NCT02754141|559868383|FG009|Overall Study|Completed treatment as per protocol|0|||
155118814|NCT02754141|559868384|FG010|Overall Study|Completed treatment as per protocol|0|||
155118815|NCT02754141|559868385|FG011|Overall Study|Completed treatment as per protocol|0|||
155118816|NCT02754141|559868386|FG012|Overall Study|Completed treatment as per protocol|1|||
155118817|NCT02754141|559868387|FG013|Overall Study|Completed treatment as per protocol|0|||
155118818|NCT02754141|559868388|FG014|Overall Study|Completed treatment as per protocol|0|||
155118819|NCT02754141|559868389|FG015|Overall Study|Completed treatment as per protocol|0|||
155118820|NCT02754141|559868390|FG016|Overall Study|Completed treatment as per protocol|0|||
155118821|NCT02754141|559868391|FG017|Overall Study|Completed treatment as per protocol|0|||
155118822|NCT02754141|559868374|FG000|Overall Study|Not completing monotherapy|0|||
155118823|NCT02754141|559868375|FG001|Overall Study|Not completing monotherapy|0|||
155118824|NCT02754141|559868376|FG002|Overall Study|Not completing monotherapy|0|||
155118825|NCT02754141|559868377|FG003|Overall Study|Not completing monotherapy|0|||
155118826|NCT02754141|559868378|FG004|Overall Study|Not completing monotherapy|0|||
155118827|NCT02754141|559868379|FG005|Overall Study|Not completing monotherapy|0|||
155118828|NCT02754141|559868380|FG006|Overall Study|Not completing monotherapy|0|||
155118829|NCT02754141|559868381|FG007|Overall Study|Not completing monotherapy|0|||
155118830|NCT02754141|559868382|FG008|Overall Study|Not completing monotherapy|0|||
155118831|NCT02754141|559868383|FG009|Overall Study|Not completing monotherapy|0|||
155118832|NCT02754141|559868384|FG010|Overall Study|Not completing monotherapy|0|||
155118833|NCT02754141|559868385|FG011|Overall Study|Not completing monotherapy|0|||
155118834|NCT02754141|559868386|FG012|Overall Study|Not completing monotherapy|0|||
155118835|NCT02754141|559868387|FG013|Overall Study|Not completing monotherapy|1|||
155118836|NCT02754141|559868388|FG014|Overall Study|Not completing monotherapy|0|||
155118837|NCT02754141|559868389|FG015|Overall Study|Not completing monotherapy|0|||
155118838|NCT02754141|559868390|FG016|Overall Study|Not completing monotherapy|0|||
155118839|NCT02754141|559868391|FG017|Overall Study|Not completing monotherapy|0|||
155118840|NCT01187446|559868395|FG000|Overall Study|Patient started non-protocol therapy|0|||
155118841|NCT01187446|559868396|FG001|Overall Study|Patient started non-protocol therapy|1|||
155118842|NCT01007123|559868401|FG000|Overall Study|Adverse Event|3|||
155118843|NCT01007123|559868402|FG001|Overall Study|Adverse Event|4|||
155118844|NCT01007123|559868403|FG002|Overall Study|Adverse Event|7|||
155118845|NCT01007123|559868404|FG003|Overall Study|Adverse Event|1|||
155118846|NCT01007123|559868401|FG000|Overall Study|Lack of Efficacy|1|||
155118847|NCT01007123|559868402|FG001|Overall Study|Lack of Efficacy|0|||
155118848|NCT01007123|559868403|FG002|Overall Study|Lack of Efficacy|1|||
155118849|NCT01007123|559868404|FG003|Overall Study|Lack of Efficacy|4|||
155118850|NCT01007123|559868401|FG000|Overall Study|Protocol Violation|1|||
155118851|NCT01007123|559868402|FG001|Overall Study|Protocol Violation|1|||
155118852|NCT01007123|559868403|FG002|Overall Study|Protocol Violation|2|||
155118853|NCT01007123|559868404|FG003|Overall Study|Protocol Violation|1|||
154985401|NCT02177136|559372014|FG002|DB Phase|Adverse Event|3|||
154985402|NCT02177136|559372015|FG003|DB Phase|Adverse Event|0|||
154985403|NCT02177136|559372012|FG000|DB Phase|Protocol Violation|0|||
154985404|NCT02177136|559372013|FG001|DB Phase|Protocol Violation|0|||
154985405|NCT02177136|559372014|FG002|DB Phase|Protocol Violation|1|||
154985406|NCT02177136|559372015|FG003|DB Phase|Protocol Violation|0|||
154985407|NCT02177136|559372012|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
154985408|NCT02177136|559372013|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
155118854|NCT01007123|559868401|FG000|Overall Study|Withdrawal by Subject|1|||
155118855|NCT01007123|559868402|FG001|Overall Study|Withdrawal by Subject|0|||
154985409|NCT02177136|559372014|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
154985410|NCT02177136|559372015|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
155118856|NCT01007123|559868403|FG002|Overall Study|Withdrawal by Subject|1|||
155118857|NCT01007123|559868404|FG003|Overall Study|Withdrawal by Subject|0|||
155118858|NCT01007123|559868401|FG000|Overall Study|Lost to Follow-up|0|||
155118859|NCT01007123|559868402|FG001|Overall Study|Lost to Follow-up|1|||
155118860|NCT01007123|559868403|FG002|Overall Study|Lost to Follow-up|0|||
155118861|NCT01007123|559868404|FG003|Overall Study|Lost to Follow-up|0|||
155118862|NCT00823212|559868405|FG000|Overall Study|Death|8|||
154985411|NCT02177136|559372012|FG000|LTSE Phase|Withdrawal by Subject|0|||
154985412|NCT02177136|559372013|FG001|LTSE Phase|Withdrawal by Subject|0|||
154985413|NCT02177136|559372014|FG002|LTSE Phase|Withdrawal by Subject|0|||
155118863|NCT00823212|559868406|FG001|Overall Study|Death|10|||
154985414|NCT02177136|559372015|FG003|LTSE Phase|Withdrawal by Subject|6|||
154985415|NCT02177136|559372012|FG000|LTSE Phase|Adverse Event|0|||
154985416|NCT02177136|559372013|FG001|LTSE Phase|Adverse Event|0|||
154985417|NCT02177136|559372014|FG002|LTSE Phase|Adverse Event|0|||
154985418|NCT02177136|559372015|FG003|LTSE Phase|Adverse Event|10|||
154985419|NCT02177136|559372012|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
154985420|NCT02177136|559372013|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
154985421|NCT02177136|559372014|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
154985422|NCT02177136|559372015|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
154985423|NCT02177136|559372012|FG000|LTSE Phase|Physician Decision|0|||
154985424|NCT02177136|559372013|FG001|LTSE Phase|Physician Decision|0|||
154985425|NCT02177136|559372014|FG002|LTSE Phase|Physician Decision|0|||
154985426|NCT02177136|559372015|FG003|LTSE Phase|Physician Decision|2|||
154985427|NCT02177136|559372012|FG000|LTSE Phase|Lost to Follow-up|0|||
154985428|NCT02177136|559372013|FG001|LTSE Phase|Lost to Follow-up|0|||
154985429|NCT02177136|559372014|FG002|LTSE Phase|Lost to Follow-up|0|||
154985430|NCT02177136|559372015|FG003|LTSE Phase|Lost to Follow-up|1|||
154985431|NCT02177136|559372012|FG000|LTSE Phase|Participant Moved|0|||
154985432|NCT02177136|559372013|FG001|LTSE Phase|Participant Moved|0|||
154985433|NCT02177136|559372014|FG002|LTSE Phase|Participant Moved|0|||
154985434|NCT02177136|559372015|FG003|LTSE Phase|Participant Moved|1|||
154985435|NCT02054130|559372016|FG000|Overall Study|Withdrawal by Subject|4|||
154985436|NCT02054130|559372017|FG001|Overall Study|Withdrawal by Subject|4|||
154985437|NCT02054130|559372018|FG002|Overall Study|Withdrawal by Subject|7|||
154985438|NCT02054130|559372019|FG003|Overall Study|Withdrawal by Subject|10|||
154985439|NCT02054130|559372016|FG000|Overall Study|Death|0|||
154985440|NCT02054130|559372017|FG001|Overall Study|Death|1|||
154985441|NCT02054130|559372018|FG002|Overall Study|Death|0|||
154985442|NCT02054130|559372019|FG003|Overall Study|Death|0|||
154985443|NCT02054130|559372016|FG000|Overall Study|Lost to Follow-up|0|||
154985444|NCT02054130|559372017|FG001|Overall Study|Lost to Follow-up|0|||
154985445|NCT02054130|559372018|FG002|Overall Study|Lost to Follow-up|1|||
154985446|NCT02054130|559372019|FG003|Overall Study|Lost to Follow-up|2|||
154985447|NCT02054130|559372016|FG000|Overall Study|Missed dose|4|||
154985448|NCT02054130|559372017|FG001|Overall Study|Missed dose|6|||
154985449|NCT02054130|559372018|FG002|Overall Study|Missed dose|7|||
154985450|NCT02054130|559372019|FG003|Overall Study|Missed dose|10|||
154985451|NCT01386684|559372020|FG000|Overall Study|Lost to Follow-up|51|||
154985452|NCT01386684|559372020|FG000|Overall Study|Other|51|||
154985453|NCT01386684|559372020|FG000|Overall Study|Death|47|||
154985454|NCT01386684|559372020|FG000|Overall Study|Withdrawal of Consent|44|||
154985455|NCT01386684|559372020|FG000|Overall Study|Alternative Therapy Required|37|||
154985456|NCT01386684|559372020|FG000|Overall Study|Disease Progression|28|||
154985457|NCT01386684|559372020|FG000|Overall Study|Adverse Event|20|||
154985458|NCT01386684|559372020|FG000|Overall Study|Noncompliance|8|||
154985459|NCT01386684|559372020|FG000|Overall Study|Protocol Violation|4|||
154985460|NCT01386684|559372020|FG000|Overall Study|Missing|3|||
154985461|NCT00094458|559372023|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
154985462|NCT00094458|559372024|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
154985463|NCT00094458|559372025|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
154985464|NCT00094458|559372026|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
154985465|NCT00094458|559372027|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
154985466|NCT00094458|559372028|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
154985467|NCT00094458|559372023|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
154985468|NCT00094458|559372024|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
154985469|NCT00094458|559372025|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
154985470|NCT00094458|559372026|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
154985471|NCT00094458|559372027|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
154985472|NCT00094458|559372028|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
154985473|NCT00094458|559372023|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
154985474|NCT00094458|559372024|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
154985475|NCT00094458|559372025|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
154985476|NCT00094458|559372026|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
154985477|NCT00094458|559372027|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
155118864|NCT00823212|559868405|FG000|Overall Study|Withdrawal by Subject|6|||
154985478|NCT00094458|559372028|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
154985479|NCT00094458|559372023|FG000|Main Study: Through Week 30|Adverse Event|38|||
154985480|NCT00094458|559372024|FG001|Main Study: Through Week 30|Adverse Event|20|||
154985481|NCT00094458|559372025|FG002|Main Study: Through Week 30|Adverse Event|28|||
154985482|NCT00094458|559372026|FG003|Main Study: Through Week 30|Adverse Event|0|||
154985483|NCT00094458|559372027|FG004|Main Study: Through Week 30|Adverse Event|0|||
154985484|NCT00094458|559372028|FG005|Main Study: Through Week 30|Adverse Event|0|||
154985485|NCT00094458|559372023|FG000|Main Study: Through Week 30|Death|1|||
154985486|NCT00094458|559372024|FG001|Main Study: Through Week 30|Death|0|||
154985487|NCT00094458|559372025|FG002|Main Study: Through Week 30|Death|0|||
154985488|NCT00094458|559372026|FG003|Main Study: Through Week 30|Death|0|||
154985489|NCT00094458|559372027|FG004|Main Study: Through Week 30|Death|0|||
155118865|NCT00823212|559868406|FG001|Overall Study|Withdrawal by Subject|1|||
155118866|NCT00823212|559868405|FG000|Overall Study|Incarcerated|0|||
155118867|NCT00823212|559868406|FG001|Overall Study|Incarcerated|1|||
155118868|NCT00823212|559868405|FG000|Overall Study|Missed 12-month visit|21|||
155118869|NCT00823212|559868406|FG001|Overall Study|Missed 12-month visit|21|||
154911593|NCT00877890|559096209|FG000|Overall Study|Protocol Violation|0|||
154911594|NCT00877890|559096210|FG001|Overall Study|Protocol Violation|1|||
154911595|NCT00877890|559096209|FG000|Overall Study|Withdrawal of Consent|6|||
154911596|NCT00877890|559096210|FG001|Overall Study|Withdrawal of Consent|12|||
154911597|NCT00877890|559096209|FG000|Overall Study|Investigator Decision|0|||
154911598|NCT00877890|559096210|FG001|Overall Study|Investigator Decision|2|||
154911599|NCT00877890|559096209|FG000|Overall Study|Loss of Glucose Control|3|||
154911600|NCT00877890|559096210|FG001|Overall Study|Loss of Glucose Control|4|||
154911601|NCT00984009|559096211|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
154911602|NCT00281528|559096212|FG000|Overall Study|Progressive Disease|28|||
154911603|NCT00281528|559096213|FG001|Overall Study|Progressive Disease|18|||
154911604|NCT00281528|559096214|FG002|Overall Study|Progressive Disease|27|||
154911605|NCT00281528|559096212|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
154911606|NCT00281528|559096213|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
154911607|NCT00281528|559096214|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
154911608|NCT00281528|559096212|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
154911609|NCT00281528|559096213|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
154911610|NCT00281528|559096214|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
154911611|NCT00281528|559096212|FG000|Overall Study|Physician Decision|11|||
154911612|NCT00281528|559096213|FG001|Overall Study|Physician Decision|4|||
154911613|NCT00281528|559096214|FG002|Overall Study|Physician Decision|5|||
154911614|NCT00281528|559096212|FG000|Overall Study|Protocol Violation|1|||
154911615|NCT00281528|559096213|FG001|Overall Study|Protocol Violation|0|||
154911616|NCT00281528|559096214|FG002|Overall Study|Protocol Violation|1|||
154911617|NCT00281528|559096212|FG000|Overall Study|Withdrawal by Subject|5|||
154911618|NCT00281528|559096213|FG001|Overall Study|Withdrawal by Subject|5|||
154911619|NCT00281528|559096214|FG002|Overall Study|Withdrawal by Subject|7|||
154911620|NCT00281528|559096212|FG000|Overall Study|Other|6|||
154911621|NCT00281528|559096213|FG001|Overall Study|Other|3|||
154911622|NCT00281528|559096214|FG002|Overall Study|Other|5|||
154911623|NCT01987609|559096223|FG000|Overall Study|Adverse Event|1|||
154911624|NCT01066546|559096224|FG000|Overall Study|Study terminated by sponsor|5|||
154911625|NCT03452397|559096229|FG000|Overall Study|Adverse Event|1|||
154911626|NCT03452397|559096230|FG001|Overall Study|Adverse Event|0|||
154911627|NCT03452397|559096231|FG002|Overall Study|Adverse Event|0|||
154911628|NCT03452397|559096232|FG003|Overall Study|Adverse Event|0|||
154911629|NCT03452397|559096229|FG000|Overall Study|Administrative reason|0|||
154911630|NCT03452397|559096230|FG001|Overall Study|Administrative reason|0|||
154911631|NCT03452397|559096231|FG002|Overall Study|Administrative reason|1|||
154911632|NCT03452397|559096232|FG003|Overall Study|Administrative reason|1|||
154911633|NCT03452397|559096229|FG000|Overall Study|Withdrawal by Subject|0|||
154911634|NCT03452397|559096230|FG001|Overall Study|Withdrawal by Subject|0|||
154911635|NCT03452397|559096231|FG002|Overall Study|Withdrawal by Subject|1|||
154911636|NCT03452397|559096232|FG003|Overall Study|Withdrawal by Subject|0|||
154911637|NCT00125268|559096233|FG000|Overall Study|Withdrawal by Subject|1|||
154911638|NCT00125268|559096234|FG001|Overall Study|Withdrawal by Subject|1|||
154911639|NCT00925522|559096235|FG000|Overall Study|study closed -- business decision|20|||
154911640|NCT02561572|559096236|FG000|Overall Study|Inadequate time before surgery|2|||
154911641|NCT02561572|559096237|FG001|Overall Study|Inadequate time before surgery|1|||
154911642|NCT02561572|559096236|FG000|Overall Study|Protocol Violation|0|||
154911643|NCT02561572|559096237|FG001|Overall Study|Protocol Violation|1|||
154911644|NCT02691468|559096238|FG000|Overall Study|Bronchial blocker use|2|||
154911645|NCT02691468|559096239|FG001|Overall Study|Bronchial blocker use|1|||
154911646|NCT02691468|559096238|FG000|Overall Study|Lost to Follow-up|2|||
154911647|NCT02691468|559096239|FG001|Overall Study|Lost to Follow-up|1|||
154911648|NCT02691468|559096238|FG000|Overall Study|Failure to advance FOB|2|||
154911649|NCT02691468|559096239|FG001|Overall Study|Failure to advance FOB|0|||
154911650|NCT01436357|559096242|FG000|Overall Study|Death|5|||
154911651|NCT01436357|559096243|FG001|Overall Study|Death|1|||
154911652|NCT01436357|559096242|FG000|Overall Study|Enrolled but not vaccinated|1|||
154911653|NCT01436357|559096243|FG001|Overall Study|Enrolled but not vaccinated|1|||
154911654|NCT01436357|559096242|FG000|Overall Study|Incarceration|18|||
154911655|NCT01436357|559096243|FG001|Overall Study|Incarceration|20|||
154911656|NCT01436357|559096242|FG000|Overall Study|Lost to Follow-up|67|||
154911657|NCT01436357|559096243|FG001|Overall Study|Lost to Follow-up|61|||
154911658|NCT01436357|559096242|FG000|Overall Study|Protocol Violation|1|||
154911659|NCT01436357|559096243|FG001|Overall Study|Protocol Violation|0|||
154911660|NCT01436357|559096242|FG000|Overall Study|Withdrawal by Subject|26|||
154911661|NCT01436357|559096243|FG001|Overall Study|Withdrawal by Subject|38|||
154911662|NCT01436357|559096242|FG000|Overall Study|Physician Decision|3|||
154911663|NCT01436357|559096243|FG001|Overall Study|Physician Decision|4|||
154911664|NCT01436357|559096242|FG000|Overall Study|Moved out of area|1|||
154985490|NCT00094458|559372028|FG005|Main Study: Through Week 30|Death|0|||
154985491|NCT00094458|559372023|FG000|Main Study: Through Week 30|Other|19|||
154985492|NCT00094458|559372024|FG001|Main Study: Through Week 30|Other|16|||
154985493|NCT00094458|559372025|FG002|Main Study: Through Week 30|Other|9|||
154985494|NCT00094458|559372026|FG003|Main Study: Through Week 30|Other|0|||
154985495|NCT00094458|559372027|FG004|Main Study: Through Week 30|Other|0|||
154985496|NCT00094458|559372028|FG005|Main Study: Through Week 30|Other|0|||
154985497|NCT00094458|559372023|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
154985498|NCT00094458|559372024|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
154985499|NCT00094458|559372025|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
154985500|NCT00094458|559372026|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
154985501|NCT00094458|559372027|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
154985502|NCT00094458|559372028|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
154985503|NCT00094458|559372023|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
154985504|NCT00094458|559372024|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
154985505|NCT00094458|559372025|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
154985506|NCT00094458|559372026|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
154985507|NCT00094458|559372027|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
154985508|NCT00094458|559372028|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
154985509|NCT00094458|559372023|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
154985510|NCT00094458|559372024|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
154985511|NCT00094458|559372025|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
154985512|NCT00094458|559372026|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
154985513|NCT00094458|559372027|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
154985514|NCT00094458|559372028|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
154985515|NCT00094458|559372023|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
154985516|NCT00094458|559372024|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
154985517|NCT00094458|559372025|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
154985518|NCT00094458|559372026|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
154985519|NCT00094458|559372027|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
154985520|NCT00094458|559372028|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
154985521|NCT00094458|559372023|FG000|OLE: Open-Label Extension|Adverse Event|0|||
154985522|NCT00094458|559372024|FG001|OLE: Open-Label Extension|Adverse Event|0|||
154985523|NCT00094458|559372025|FG002|OLE: Open-Label Extension|Adverse Event|0|||
154985524|NCT00094458|559372026|FG003|OLE: Open-Label Extension|Adverse Event|0|||
154985525|NCT00094458|559372027|FG004|OLE: Open-Label Extension|Adverse Event|3|||
154985526|NCT00094458|559372028|FG005|OLE: Open-Label Extension|Adverse Event|4|||
154985527|NCT00094458|559372023|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
154985528|NCT00094458|559372024|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
154985529|NCT00094458|559372025|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
155118870|NCT00320255|559868407|FG000|Overall Study|Lack of Efficacy|1|||
155118871|NCT00320255|559868408|FG001|Overall Study|Lack of Efficacy|0|||
154911665|NCT01436357|559096243|FG001|Overall Study|Moved out of area|2|||
154911666|NCT01436357|559096242|FG000|Overall Study|Subject in rehab|0|||
154911667|NCT01436357|559096243|FG001|Overall Study|Subject in rehab|1|||
154911668|NCT05281094|559096245|FG000|Overall Study|Adverse Event|1|||
154911669|NCT05281094|559096246|FG001|Overall Study|Adverse Event|0|||
154911670|NCT05281094|559096245|FG000|Overall Study|Lost to Follow-up|29|||
154911671|NCT05281094|559096246|FG001|Overall Study|Lost to Follow-up|22|||
154911672|NCT05281094|559096245|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
154911673|NCT05281094|559096246|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
154911674|NCT05281094|559096245|FG000|Overall Study|Death|1|||
154911675|NCT05281094|559096246|FG001|Overall Study|Death|2|||
154911676|NCT05281094|559096245|FG000|Overall Study|Not pre-specified reason|8|||
154911677|NCT05281094|559096246|FG001|Overall Study|Not pre-specified reason|5|||
154911678|NCT04191096|559096256|FG000|Overall Study|Death|102|||
154911679|NCT04191096|559096257|FG001|Overall Study|Death|89|||
154911680|NCT04191096|559096256|FG000|Overall Study|Lost to Follow-up|1|||
154911681|NCT04191096|559096257|FG001|Overall Study|Lost to Follow-up|1|||
154911682|NCT04191096|559096256|FG000|Overall Study|Withdrawal by Subject|5|||
154911683|NCT04191096|559096257|FG001|Overall Study|Withdrawal by Subject|5|||
154911684|NCT04191096|559096256|FG000|Overall Study|Participants Ongoing|518|||
154911685|NCT04191096|559096257|FG001|Overall Study|Participants Ongoing|530|||
154911686|NCT02683668|559096260|FG000|Period 2|Withdrawal by Subject|0|||
154911687|NCT02683668|559096261|FG001|Period 2|Withdrawal by Subject|1|||
154911688|NCT02683668|559096262|FG002|Period 2|Withdrawal by Subject|0|||
154911689|NCT00631969|559096263|FG000|Overall Study|Adverse Event|3|||
154911690|NCT00631969|559096264|FG001|Overall Study|Adverse Event|1|||
154911691|NCT00631969|559096263|FG000|Overall Study|Lack of Efficacy|2|||
154911692|NCT00631969|559096264|FG001|Overall Study|Lack of Efficacy|8|||
154911693|NCT00631969|559096263|FG000|Overall Study|Lost to Follow-up|2|||
154911694|NCT00631969|559096264|FG001|Overall Study|Lost to Follow-up|1|||
154985530|NCT00094458|559372026|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
154911695|NCT00631969|559096263|FG000|Overall Study|Protocol Violation|1|||
154911696|NCT00631969|559096264|FG001|Overall Study|Protocol Violation|1|||
154911697|NCT00631969|559096263|FG000|Overall Study|Consent Withdrawn|5|||
154911698|NCT00631969|559096264|FG001|Overall Study|Consent Withdrawn|7|||
154911699|NCT00631969|559096263|FG000|Overall Study|Noncompliant With Study Medication|0|||
154911700|NCT00631969|559096264|FG001|Overall Study|Noncompliant With Study Medication|1|||
154911701|NCT00631969|559096263|FG000|Overall Study|No Drug Exposure|2|||
154911702|NCT00631969|559096264|FG001|Overall Study|No Drug Exposure|2|||
154911703|NCT03893630|559096265|FG000|Overall Study|Lost to Follow-up|5|||
154911704|NCT03893630|559096266|FG001|Overall Study|Lost to Follow-up|4|||
154911705|NCT03893630|559096267|FG002|Overall Study|Lost to Follow-up|2|||
154911706|NCT03893630|559096265|FG000|Overall Study|Withdrawal by Subject|3|||
154911707|NCT03893630|559096266|FG001|Overall Study|Withdrawal by Subject|6|||
154911708|NCT03893630|559096267|FG002|Overall Study|Withdrawal by Subject|3|||
154911709|NCT03893630|559096265|FG000|Overall Study|Discontinued Intervention|0|||
154911710|NCT03893630|559096266|FG001|Overall Study|Discontinued Intervention|4|||
154911711|NCT03893630|559096267|FG002|Overall Study|Discontinued Intervention|2|||
154911712|NCT00027027|559097822|FG000|Overall Study|Adverse Event|0|||
154911713|NCT00027027|559097823|FG001|Overall Study|Adverse Event|0|||
154911714|NCT00027027|559097824|FG002|Overall Study|Adverse Event|1|||
154911715|NCT00027027|559097825|FG003|Overall Study|Adverse Event|0|||
154911716|NCT00027027|559097826|FG004|Overall Study|Adverse Event|1|||
154911717|NCT00027027|559097822|FG000|Overall Study|Admitted for Signs of PD|0|||
154911718|NCT00027027|559097823|FG001|Overall Study|Admitted for Signs of PD|0|||
154911719|NCT00027027|559097824|FG002|Overall Study|Admitted for Signs of PD|0|||
154911720|NCT00027027|559097825|FG003|Overall Study|Admitted for Signs of PD|0|||
154911721|NCT00027027|559097826|FG004|Overall Study|Admitted for Signs of PD|1|||
154911722|NCT00027027|559097822|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
154911723|NCT00027027|559097823|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
154911724|NCT00027027|559097824|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
154911725|NCT00027027|559097825|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
154911726|NCT00027027|559097826|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
154911727|NCT00027027|559097822|FG000|Overall Study|PD Requiring Surgery|0|||
154911728|NCT00027027|559097823|FG001|Overall Study|PD Requiring Surgery|0|||
154911729|NCT00027027|559097824|FG002|Overall Study|PD Requiring Surgery|1|||
154911730|NCT00027027|559097825|FG003|Overall Study|PD Requiring Surgery|0|||
154911731|NCT00027027|559097826|FG004|Overall Study|PD Requiring Surgery|0|||
154911732|NCT00027027|559097822|FG000|Overall Study|Physician Decision Due To PD|2|||
154911733|NCT00027027|559097823|FG001|Overall Study|Physician Decision Due To PD|3|||
154911734|NCT00027027|559097824|FG002|Overall Study|Physician Decision Due To PD|2|||
154911735|NCT00027027|559097825|FG003|Overall Study|Physician Decision Due To PD|3|||
154911736|NCT00027027|559097826|FG004|Overall Study|Physician Decision Due To PD|5|||
154911737|NCT00027027|559097822|FG000|Overall Study|Withdrawal by Subject|0|||
154911738|NCT00027027|559097823|FG001|Overall Study|Withdrawal by Subject|0|||
154911739|NCT00027027|559097824|FG002|Overall Study|Withdrawal by Subject|0|||
154911740|NCT00027027|559097825|FG003|Overall Study|Withdrawal by Subject|0|||
154911741|NCT00027027|559097826|FG004|Overall Study|Withdrawal by Subject|1|||
154911742|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
154911743|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
154911744|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
154911745|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
154911746|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
154911747|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
154911748|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
154911749|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
154911750|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Death|0|||
154911751|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Death|0|||
154911752|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Death|0|||
154911753|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Death|1|||
154911754|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Death|1|||
154911755|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Death|0|||
154911756|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Death|2|||
154911757|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Death|0|||
154911758|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911759|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911760|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911761|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
154911762|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911763|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911764|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911765|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
154911766|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911767|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911768|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911769|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
154985531|NCT00094458|559372027|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
154985532|NCT00094458|559372028|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
154985533|NCT00094458|559372023|FG000|OLE: Open-Label Extension|Patient decision|0|||
154985534|NCT00094458|559372024|FG001|OLE: Open-Label Extension|Patient decision|0|||
154985535|NCT00094458|559372025|FG002|OLE: Open-Label Extension|Patient decision|0|||
154985536|NCT00094458|559372026|FG003|OLE: Open-Label Extension|Patient decision|0|||
154985537|NCT00094458|559372027|FG004|OLE: Open-Label Extension|Patient decision|1|||
154985538|NCT00094458|559372028|FG005|OLE: Open-Label Extension|Patient decision|0|||
154985539|NCT01995266|559372036|FG000|Overall Study|Death|1|||
154985540|NCT01995266|559372036|FG000|Overall Study|Lack of Efficacy|6|||
154985541|NCT01995266|559372036|FG000|Overall Study|Adverse Event|2|||
154985542|NCT03247517|559372037|FG000|Overall Study|Adverse Event|0|||
154985543|NCT03247517|559372038|FG001|Overall Study|Adverse Event|4|||
154985544|NCT03247517|559372039|FG002|Overall Study|Adverse Event|2|||
154985545|NCT03247517|559372037|FG000|Overall Study|Lost to Follow-up|2|||
154985546|NCT03247517|559372038|FG001|Overall Study|Lost to Follow-up|6|||
154985547|NCT03247517|559372039|FG002|Overall Study|Lost to Follow-up|4|||
154985548|NCT03247517|559372037|FG000|Overall Study|Consent withdrawn by caregiver|1|||
154985549|NCT03247517|559372038|FG001|Overall Study|Consent withdrawn by caregiver|4|||
154985550|NCT03247517|559372039|FG002|Overall Study|Consent withdrawn by caregiver|7|||
154985551|NCT03247517|559372037|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
154985552|NCT03247517|559372038|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
154985553|NCT03247517|559372039|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
154985554|NCT03247517|559372037|FG000|Overall Study|Protocol Violation|0|||
154985555|NCT03247517|559372038|FG001|Overall Study|Protocol Violation|2|||
154985556|NCT03247517|559372039|FG002|Overall Study|Protocol Violation|0|||
154985557|NCT03247517|559372037|FG000|Overall Study|Multiple reasons|3|||
154985558|NCT03247517|559372038|FG001|Overall Study|Multiple reasons|1|||
154985559|NCT03247517|559372039|FG002|Overall Study|Multiple reasons|0|||
154985560|NCT00619112|559372040|FG000|Overall Study|Adverse Event|1|||
154985561|NCT00619112|559372041|FG001|Overall Study|Adverse Event|2|||
154985562|NCT00729248|559372042|FG000|Overall Study|Physician Decision|2|||
154985563|NCT03573505|559372045|FG000|Overall Study|Adverse Event|1|||
154985564|NCT03573505|559372046|FG001|Overall Study|Adverse Event|1|||
154985565|NCT03573505|559372045|FG000|Overall Study|Consent withdrawn|0|||
154985566|NCT03573505|559372046|FG001|Overall Study|Consent withdrawn|1|||
154985567|NCT03573505|559372045|FG000|Overall Study|Disease progression|0|||
154985568|NCT03573505|559372046|FG001|Overall Study|Disease progression|1|||
154985569|NCT03573505|559372045|FG000|Overall Study|Site Terminated by Sponsor|1|||
154985570|NCT03573505|559372046|FG001|Overall Study|Site Terminated by Sponsor|1|||
154985571|NCT03573505|559372045|FG000|Overall Study|Study terminated by sponsor|50|||
154985572|NCT03573505|559372046|FG001|Overall Study|Study terminated by sponsor|45|||
154985573|NCT03573505|559372045|FG000|Overall Study|Reason not specified|0|||
154985574|NCT03573505|559372046|FG001|Overall Study|Reason not specified|1|||
154985575|NCT03573505|559372045|FG000|Overall Study|Death|0|||
154985576|NCT03573505|559372046|FG001|Overall Study|Death|4|||
154985577|NCT04268316|559372047|FG000|Overall Study|Withdrawal by Subject|2|||
154985578|NCT04268316|559372048|FG001|Overall Study|Withdrawal by Subject|1|||
154985579|NCT04268316|559372049|FG002|Overall Study|Withdrawal by Subject|0|||
154985580|NCT02040779|559372051|FG000|Overall Study|Adverse Event|1|||
154985581|NCT02040779|559372052|FG001|Overall Study|Adverse Event|0|||
154985582|NCT02040779|559372053|FG002|Overall Study|Adverse Event|0|||
154985583|NCT02040779|559372051|FG000|Overall Study|Withdrawal by Subject|4|||
154985584|NCT02040779|559372052|FG001|Overall Study|Withdrawal by Subject|1|||
154985585|NCT02040779|559372053|FG002|Overall Study|Withdrawal by Subject|3|||
154985586|NCT02040779|559372051|FG000|Overall Study|Non-compliance|0|||
154985587|NCT02040779|559372052|FG001|Overall Study|Non-compliance|1|||
154985588|NCT02040779|559372053|FG002|Overall Study|Non-compliance|0|||
154985589|NCT02040779|559372051|FG000|Overall Study|Protocol Violation|2|||
154985590|NCT02040779|559372052|FG001|Overall Study|Protocol Violation|1|||
154985591|NCT02040779|559372053|FG002|Overall Study|Protocol Violation|0|||
154985592|NCT02040779|559372051|FG000|Overall Study|Lost to Follow-up|1|||
154985593|NCT02040779|559372052|FG001|Overall Study|Lost to Follow-up|2|||
154985594|NCT02040779|559372053|FG002|Overall Study|Lost to Follow-up|1|||
154985595|NCT02040779|559372051|FG000|Overall Study|Lack of Efficacy|4|||
154985596|NCT02040779|559372052|FG001|Overall Study|Lack of Efficacy|2|||
154985597|NCT02040779|559372053|FG002|Overall Study|Lack of Efficacy|0|||
154985598|NCT02132637|559372054|FG000|Study Period 1|Withdrawal by Subject|0|||
154985599|NCT02132637|559372055|FG001|Study Period 1|Withdrawal by Subject|4|||
154985600|NCT02132637|559372054|FG000|Study Period 1|Physician Decision|1|||
154985601|NCT02132637|559372055|FG001|Study Period 1|Physician Decision|0|||
154985602|NCT02132637|559372054|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
154985603|NCT02132637|559372055|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
154985604|NCT02132637|559372054|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
154985605|NCT02132637|559372055|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
154985606|NCT00866658|559372064|FG000|Overall Study|Adverse Event|5|||
154985607|NCT00866658|559372065|FG001|Overall Study|Adverse Event|14|||
155118872|NCT00320255|559868409|FG002|Overall Study|Lack of Efficacy|0|||
155118873|NCT00320255|559868410|FG003|Overall Study|Lack of Efficacy|0|||
155118874|NCT00320255|559868411|FG004|Overall Study|Lack of Efficacy|0|||
154911770|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911771|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911772|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911773|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
154911774|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
154911775|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
154911776|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
154911777|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
154911778|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
154911779|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
154911780|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
154911781|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
154911782|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
154911783|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
154911784|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
154985608|NCT00866658|559372064|FG000|Overall Study|Lack of Efficacy|2|||
154985609|NCT00866658|559372065|FG001|Overall Study|Lack of Efficacy|1|||
154985610|NCT00866658|559372064|FG000|Overall Study|Withdrawal by Subject|1|||
154985611|NCT00866658|559372065|FG001|Overall Study|Withdrawal by Subject|0|||
154985612|NCT00866658|559372064|FG000|Overall Study|Protocol Violation|1|||
154985613|NCT00866658|559372065|FG001|Overall Study|Protocol Violation|1|||
154985614|NCT00866658|559372064|FG000|Overall Study|Familial and Personal Reasons|4|||
154985615|NCT00866658|559372065|FG001|Overall Study|Familial and Personal Reasons|5|||
154985616|NCT00652028|559372068|FG000|Overall Study|Adverse Event|1|||
154985617|NCT00652028|559372069|FG001|Overall Study|Adverse Event|0|||
154985618|NCT00652028|559372070|FG002|Overall Study|Adverse Event|0|||
154985619|NCT00652028|559372071|FG003|Overall Study|Adverse Event|0|||
154985620|NCT00652028|559372068|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
154985621|NCT00652028|559372069|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
154985622|NCT00652028|559372070|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
154985623|NCT00652028|559372071|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
154985624|NCT00652028|559372068|FG000|Overall Study|Physician Decision|0|||
154985625|NCT00652028|559372069|FG001|Overall Study|Physician Decision|0|||
154985626|NCT00652028|559372070|FG002|Overall Study|Physician Decision|1|||
154985627|NCT00652028|559372071|FG003|Overall Study|Physician Decision|0|||
154985628|NCT02751359|559372073|FG000|Overall Study|Lost to Follow-up|1|||
154985629|NCT02400671|559372074|FG000|Overall Study|Death|5|||
154985630|NCT02400671|559372075|FG001|Overall Study|Death|3|||
154985631|NCT02400671|559372076|FG002|Overall Study|Death|4|||
154985632|NCT02400671|559372074|FG000|Overall Study|Lost to Follow-up|20|||
154985633|NCT02400671|559372075|FG001|Overall Study|Lost to Follow-up|27|||
154985634|NCT02400671|559372076|FG002|Overall Study|Lost to Follow-up|24|||
154985635|NCT02400671|559372074|FG000|Overall Study|Withdrawal by Subject|2|||
154985636|NCT02400671|559372075|FG001|Overall Study|Withdrawal by Subject|2|||
154985637|NCT02400671|559372076|FG002|Overall Study|Withdrawal by Subject|0|||
154985638|NCT02145026|559372080|FG000|Overall Study|Adverse Event|2|||
154985639|NCT02145026|559372080|FG000|Overall Study|Death|4|||
154985640|NCT02145026|559372080|FG000|Overall Study|Withdrawal by Subject|2|||
154985641|NCT02145026|559372080|FG000|Overall Study|Physician Decision|4|||
154985642|NCT00127036|559372081|FG000|Overall Study|Insufficient Data for Analysis|6|||
154985643|NCT00127036|559372082|FG001|Overall Study|Insufficient Data for Analysis|11|||
154985644|NCT00127036|559372081|FG000|Overall Study|Screen Failure|2|||
154985645|NCT00127036|559372082|FG001|Overall Study|Screen Failure|0|||
154985646|NCT01797835|559372089|FG000|Overall Study|Lost to Follow-up|31|||
154985647|NCT01797835|559372090|FG001|Overall Study|Lost to Follow-up|27|||
154985648|NCT01403064|559372091|FG000|Overall Study|Death|0|||
154985649|NCT01403064|559372092|FG001|Overall Study|Death|0|||
154985650|NCT01403064|559372093|FG002|Overall Study|Death|1|||
154985651|NCT01403064|559372094|FG003|Overall Study|Death|1|||
154985652|NCT01403064|559372091|FG000|Overall Study|Withdrawal by Subject|0|||
154985653|NCT01403064|559372092|FG001|Overall Study|Withdrawal by Subject|0|||
154985654|NCT01403064|559372093|FG002|Overall Study|Withdrawal by Subject|1|||
154985655|NCT01403064|559372094|FG003|Overall Study|Withdrawal by Subject|1|||
154985656|NCT01403064|559372091|FG000|Overall Study|Other|1|||
154985657|NCT01403064|559372092|FG001|Overall Study|Other|0|||
155118875|NCT00320255|559868412|FG005|Overall Study|Lack of Efficacy|0|||
154985658|NCT01403064|559372093|FG002|Overall Study|Other|2|||
154985659|NCT01403064|559372094|FG003|Overall Study|Other|1|||
154985660|NCT00973765|559372095|FG000|Overall Study|Lost to Follow-up|8|||
154985661|NCT00973765|559372096|FG001|Overall Study|Lost to Follow-up|14|||
154985662|NCT04920916|559372097|FG000|Phase IIa 60 Day Study|Death|2|||
154985663|NCT04920916|559372098|FG001|Phase IIa 60 Day Study|Death|5|||
154985664|NCT04920916|559372097|FG000|1 Year Follow up (Phone Call)|Death|1|||
154985665|NCT04920916|559372098|FG001|1 Year Follow up (Phone Call)|Death|3|||
154985666|NCT04920916|559372097|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
154985667|NCT04920916|559372098|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
154985668|NCT02011113|559372099|FG000|Overall Study|Adverse Event|4|||
154985669|NCT02011113|559372099|FG000|Overall Study|Disease Progression (DP)|16|||
154985670|NCT02011113|559372099|FG000|Overall Study|Death|1|||
154985671|NCT02011113|559372099|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
154985672|NCT02011113|559372099|FG000|Overall Study|Investigator's judgement- DP|3|||
154985673|NCT02011113|559372099|FG000|Overall Study|Study terminated by sponsor|11|||
154985674|NCT02669940|559372102|FG000|Overall Study|Failure to return|0|||
154985675|NCT02669940|559372103|FG001|Overall Study|Failure to return|3|||
154985676|NCT02669940|559372102|FG000|Overall Study|Insufficient follow-up data|1|||
154985677|NCT02669940|559372103|FG001|Overall Study|Insufficient follow-up data|0|||
154985678|NCT01892657|559372104|FG000|Overall Study|Withdrawal by Subject|6|||
154985679|NCT01892657|559372104|FG000|Overall Study|Protocol Violation|12|||
154985680|NCT05065983|559372105|FG000|Overall Study|Lost to Follow-up|2|||
154985681|NCT00986180|559372106|FG000|Overall Study|Adverse Event|21|||
154985682|NCT00986180|559372107|FG001|Overall Study|Adverse Event|23|||
154985683|NCT00986180|559372106|FG000|Overall Study|Lack of Efficacy|4|||
154985684|NCT00986180|559372107|FG001|Overall Study|Lack of Efficacy|3|||
154985685|NCT00986180|559372106|FG000|Overall Study|Lost to Follow-up|5|||
154985686|NCT00986180|559372107|FG001|Overall Study|Lost to Follow-up|7|||
154985687|NCT00986180|559372106|FG000|Overall Study|Physician Decision|1|||
154985688|NCT00986180|559372107|FG001|Overall Study|Physician Decision|3|||
154985689|NCT00986180|559372106|FG000|Overall Study|Protocol Violation|2|||
154985690|NCT00986180|559372107|FG001|Overall Study|Protocol Violation|0|||
154985691|NCT00986180|559372106|FG000|Overall Study|Withdrawal by Subject|1|||
154985692|NCT00986180|559372107|FG001|Overall Study|Withdrawal by Subject|9|||
154985693|NCT00986180|559372106|FG000|Overall Study|Miscellanies|10|||
154985694|NCT00986180|559372107|FG001|Overall Study|Miscellanies|11|||
154985695|NCT03251963|559372110|FG000|Overall Study|inappropriate Xa level timing|6|||
154985696|NCT03251963|559372111|FG001|Overall Study|inappropriate Xa level timing|3|||
154985697|NCT03251963|559372110|FG000|Overall Study|no peak Xa level drawn|2|||
154985698|NCT03251963|559372111|FG001|Overall Study|no peak Xa level drawn|0|||
154985699|NCT03251963|559372110|FG000|Overall Study|bled prior to Xa level|1|||
154985700|NCT03251963|559372111|FG001|Overall Study|bled prior to Xa level|2|||
154985701|NCT04505293|559372112|FG000|Overall Study|Lost to Follow-up|2|||
154985702|NCT04505293|559372112|FG000|Overall Study|Withdrawal by Subject|6|||
154985703|NCT04505293|559372112|FG000|Overall Study|CT scan unreadable|277|||
154985704|NCT00506129|559372113|FG000|Overall Study|Disease Progression/Relapse|15|||
154985705|NCT00506129|559372113|FG000|Overall Study|Death|7|||
154985706|NCT04295135|559372114|FG000|Overall Study|Withdrawal by Subject|2|||
154985707|NCT04295135|559372115|FG001|Overall Study|Withdrawal by Subject|1|||
154985708|NCT04295135|559372114|FG000|Overall Study|Subject left organization|8|||
154985709|NCT04295135|559372115|FG001|Overall Study|Subject left organization|4|||
154985710|NCT02923674|559372116|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
154985711|NCT02923674|559372117|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
154985712|NCT02923674|559372118|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
154985713|NCT02923674|559372116|FG000|Overall Study|Lost to Follow-up|7|||
154985714|NCT02923674|559372117|FG001|Overall Study|Lost to Follow-up|12|||
154985715|NCT02923674|559372118|FG002|Overall Study|Lost to Follow-up|7|||
154985716|NCT02923674|559372116|FG000|Overall Study|Problem with intervention|2|||
154985717|NCT02923674|559372117|FG001|Overall Study|Problem with intervention|2|||
154985718|NCT02923674|559372118|FG002|Overall Study|Problem with intervention|1|||
154985719|NCT02923674|559372116|FG000|Overall Study|Adverse Event|3|||
154985720|NCT02923674|559372117|FG001|Overall Study|Adverse Event|1|||
154985721|NCT02923674|559372118|FG002|Overall Study|Adverse Event|1|||
155118876|NCT00320255|559868407|FG000|Overall Study|Adverse Event|5|||
154985722|NCT02923674|559372116|FG000|Overall Study|Withdrawal by Subject|2|||
154985723|NCT02923674|559372117|FG001|Overall Study|Withdrawal by Subject|2|||
154985724|NCT02923674|559372118|FG002|Overall Study|Withdrawal by Subject|2|||
154985725|NCT02712333|559372121|FG000|First Period|Withdrawal by Subject|3|||
154985726|NCT02712333|559372122|FG001|First Period|Withdrawal by Subject|2|||
154985727|NCT03463993|559372123|FG000|Overall Study|Lost to Follow-up|7|||
155118877|NCT00320255|559868408|FG001|Overall Study|Adverse Event|2|||
155118878|NCT00320255|559868409|FG002|Overall Study|Adverse Event|3|||
155118879|NCT00320255|559868410|FG003|Overall Study|Adverse Event|2|||
154985728|NCT03463993|559372124|FG001|Overall Study|Lost to Follow-up|8|||
154985729|NCT03463993|559372123|FG000|Overall Study|Withdrawal by Subject|2|||
154985730|NCT03463993|559372124|FG001|Overall Study|Withdrawal by Subject|0|||
154985731|NCT03463993|559372123|FG000|Overall Study|Protocol Violation|4|||
154985732|NCT03463993|559372124|FG001|Overall Study|Protocol Violation|1|||
154985733|NCT03463993|559372123|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
154985734|NCT03463993|559372124|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
154985735|NCT03463993|559372123|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
155118880|NCT00320255|559868411|FG004|Overall Study|Adverse Event|0|||
154911785|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
154911786|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
154911787|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
154911788|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
154911789|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
154911790|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
154911791|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
154911792|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
154911793|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
154911794|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
154911795|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
154911796|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
154911797|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
154911798|NCT02442765|559097830|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
154911799|NCT02442765|559097831|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
154911800|NCT02442765|559097832|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
154911801|NCT02442765|559097833|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
154911802|NCT02442765|559097834|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
154911803|NCT02442765|559097835|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
154911804|NCT02442765|559097836|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
154911805|NCT02442765|559097837|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
154911806|NCT00003389|559097838|FG000|Overall Study|Disease progression|6|||
154911807|NCT00003389|559097839|FG001|Overall Study|Disease progression|1|||
154911808|NCT00003389|559097838|FG000|Overall Study|Adverse Event|13|||
154911809|NCT00003389|559097839|FG001|Overall Study|Adverse Event|2|||
154911810|NCT00003389|559097838|FG000|Overall Study|Death|0|||
154911811|NCT00003389|559097839|FG001|Overall Study|Death|3|||
154911812|NCT00003389|559097838|FG000|Overall Study|Withdrawal by Subject|12|||
154911813|NCT00003389|559097839|FG001|Overall Study|Withdrawal by Subject|5|||
154911814|NCT00003389|559097838|FG000|Overall Study|Alternative therapy|2|||
154911815|NCT00003389|559097839|FG001|Overall Study|Alternative therapy|1|||
154911816|NCT00003389|559097838|FG000|Overall Study|Complicating disease|1|||
154911817|NCT00003389|559097839|FG001|Overall Study|Complicating disease|0|||
154911818|NCT00003389|559097838|FG000|Overall Study|Off-treatment reason missing|31|||
154911819|NCT00003389|559097839|FG001|Overall Study|Off-treatment reason missing|21|||
154911820|NCT00003389|559097838|FG000|Overall Study|Ineligible|33|||
154911821|NCT00003389|559097839|FG001|Overall Study|Ineligible|27|||
154911822|NCT04880642|559097840|FG000|Randomization|Withdrawal by Subject|2|||
154911823|NCT04880642|559097841|FG001|Randomization|Withdrawal by Subject|3|||
154911824|NCT04880642|559097840|FG000|Treatment Period|Adverse Event|0|||
154911825|NCT04880642|559097841|FG001|Treatment Period|Adverse Event|1|||
154911826|NCT04880642|559097840|FG000|Treatment Period|Death|6|||
154911827|NCT04880642|559097841|FG001|Treatment Period|Death|6|||
154911828|NCT04880642|559097840|FG000|Treatment Period|Lost to Follow-up|1|||
154911829|NCT04880642|559097841|FG001|Treatment Period|Lost to Follow-up|0|||
154911830|NCT04880642|559097840|FG000|Treatment Period|Protocol Violation|0|||
154911831|NCT04880642|559097841|FG001|Treatment Period|Protocol Violation|1|||
154911832|NCT04880642|559097840|FG000|Treatment Period|Withdrawal by Subject|5|||
154911833|NCT04880642|559097841|FG001|Treatment Period|Withdrawal by Subject|3|||
154911834|NCT04880642|559097840|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
154911835|NCT04880642|559097841|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
154911836|NCT04880642|559097840|FG000|Follow-up|Death|4|||
154911837|NCT04880642|559097841|FG001|Follow-up|Death|3|||
154911838|NCT04880642|559097840|FG000|Follow-up|Withdrawal by Subject|1|||
154911839|NCT04880642|559097841|FG001|Follow-up|Withdrawal by Subject|0|||
154911840|NCT00561795|559097842|FG000|Overall Study|Adverse Event|3|||
154911841|NCT00561795|559097843|FG001|Overall Study|Adverse Event|3|||
154911842|NCT00561795|559097844|FG002|Overall Study|Adverse Event|0|||
154911843|NCT00561795|559097845|FG003|Overall Study|Adverse Event|0|||
154911844|NCT00561795|559097842|FG000|Overall Study|Study Closed/Terminated|0|||
154911845|NCT00561795|559097843|FG001|Overall Study|Study Closed/Terminated|3|||
154911846|NCT00561795|559097844|FG002|Overall Study|Study Closed/Terminated|0|||
154911847|NCT00561795|559097845|FG003|Overall Study|Study Closed/Terminated|0|||
154911848|NCT00561795|559097842|FG000|Overall Study|Physician Decision|1|||
154911849|NCT00561795|559097843|FG001|Overall Study|Physician Decision|0|||
154911850|NCT00561795|559097844|FG002|Overall Study|Physician Decision|0|||
154911851|NCT00561795|559097845|FG003|Overall Study|Physician Decision|0|||
154911852|NCT02807376|559097846|FG000|Overall Study|Intra-operative exclusion criteria|3|||
154911853|NCT02807376|559097847|FG001|Overall Study|Intra-operative exclusion criteria|0|||
154911854|NCT02807376|559097846|FG000|Overall Study|Lost to Follow-up|0|||
154911855|NCT02807376|559097847|FG001|Overall Study|Lost to Follow-up|1|||
154911856|NCT00948389|559097850|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
154911857|NCT00948389|559097851|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
154911858|NCT00948389|559097852|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
154911859|NCT00948389|559097853|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
154911860|NCT00948389|559097854|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
154911861|NCT00948389|559097850|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
154911862|NCT00948389|559097851|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
154911863|NCT00948389|559097852|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
154911864|NCT00948389|559097853|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
154911865|NCT00948389|559097854|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
154911866|NCT00948389|559097850|FG000|Overall Study|Both Progression and Toxicity|1|||
154911867|NCT00948389|559097851|FG001|Overall Study|Both Progression and Toxicity|0|||
154911868|NCT00948389|559097852|FG002|Overall Study|Both Progression and Toxicity|0|||
154911869|NCT00948389|559097853|FG003|Overall Study|Both Progression and Toxicity|0|||
154911870|NCT00948389|559097854|FG004|Overall Study|Both Progression and Toxicity|0|||
154911871|NCT01611558|559097861|FG000|Induction Phase|Study drug toxicity|15|||
154911872|NCT01611558|559097861|FG000|Induction Phase|Disease progression|18|||
154911873|NCT01611558|559097861|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
154911874|NCT01611558|559097861|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
154911875|NCT01611558|559097861|FG000|Induction Phase|Death|1|||
154911876|NCT01611558|559097861|FG000|Maintenance Phase|Withdrawal by Subject|1|||
154911877|NCT01611558|559097861|FG000|Maintenance Phase|Elevated Uric acid|1|||
154911878|NCT03798366|559097871|FG000|Overall Study|Lost to Follow-up|0|||
154911879|NCT03798366|559097872|FG001|Overall Study|Lost to Follow-up|1|||
154911880|NCT01412333|559097876|FG000|Overall Study|Adverse Event|40|||
154911881|NCT01412333|559097877|FG001|Overall Study|Adverse Event|42|||
154911882|NCT01412333|559097876|FG000|Overall Study|Death|5|||
154911883|NCT01412333|559097877|FG001|Overall Study|Death|6|||
154911884|NCT01412333|559097876|FG000|Overall Study|Lack of Efficacy|22|||
154911885|NCT01412333|559097877|FG001|Overall Study|Lack of Efficacy|10|||
154911886|NCT01412333|559097876|FG000|Overall Study|Lost to Follow-up|15|||
154911887|NCT01412333|559097877|FG001|Overall Study|Lost to Follow-up|12|||
154911888|NCT01412333|559097876|FG000|Overall Study|Non-Compliance|3|||
154911889|NCT01412333|559097877|FG001|Overall Study|Non-Compliance|7|||
154911890|NCT01412333|559097876|FG000|Overall Study|Non-Compliance With Study Drug|1|||
154911891|NCT01412333|559097877|FG001|Overall Study|Non-Compliance With Study Drug|1|||
154911892|NCT01412333|559097876|FG000|Overall Study|Other|30|||
154911893|NCT01412333|559097877|FG001|Overall Study|Other|33|||
154911894|NCT01412333|559097876|FG000|Overall Study|Physician Decision|11|||
154911895|NCT01412333|559097877|FG001|Overall Study|Physician Decision|16|||
154911896|NCT01412333|559097876|FG000|Overall Study|Pregnancy|6|||
154911897|NCT01412333|559097877|FG001|Overall Study|Pregnancy|4|||
154911898|NCT01412333|559097876|FG000|Overall Study|Protocol Violation|1|||
154911899|NCT01412333|559097877|FG001|Overall Study|Protocol Violation|2|||
154911900|NCT01412333|559097876|FG000|Overall Study|Study Terminated By Sponsor|3|||
154911901|NCT01412333|559097877|FG001|Overall Study|Study Terminated By Sponsor|2|||
154911902|NCT01412333|559097876|FG000|Overall Study|Withdrawal by Subject|51|||
154911903|NCT01412333|559097877|FG001|Overall Study|Withdrawal by Subject|54|||
154911904|NCT01412333|559097876|FG000|Overall Study|Missing|1|||
154911905|NCT01412333|559097877|FG001|Overall Study|Missing|3|||
154911906|NCT04005885|559097879|FG000|First Intervention|Withdrawal by Subject|1|||
154911907|NCT04005885|559097880|FG001|First Intervention|Withdrawal by Subject|1|||
154911908|NCT04005885|559097879|FG000|Second Intervention|Withdrawal by Subject|0|||
154911909|NCT04005885|559097880|FG001|Second Intervention|Withdrawal by Subject|2|||
154911910|NCT00750867|559097883|FG000|Overall Study|Adverse Event|2|||
154911911|NCT00394654|559097884|FG000|Overall Study|Lost to Follow-up|1|||
154911912|NCT00394654|559097885|FG001|Overall Study|Lost to Follow-up|0|||
154911913|NCT00394654|559097884|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
154911914|NCT00394654|559097885|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
154911915|NCT00474539|559097886|FG000|Infant Series|Withdrawal by Subject|3|||
154911916|NCT00474539|559097887|FG001|Infant Series|Withdrawal by Subject|4|||
154911917|NCT00474539|559097886|FG000|Infant Series|Randomization error|5|||
154911918|NCT00474539|559097887|FG001|Infant Series|Randomization error|0|||
154911919|NCT00474539|559097886|FG000|Infant Series|Lost to Follow-up|2|||
154911920|NCT00474539|559097887|FG001|Infant Series|Lost to Follow-up|1|||
154911921|NCT00474539|559097886|FG000|Infant Series|Protocol Violation|0|||
154911922|NCT00474539|559097887|FG001|Infant Series|Protocol Violation|1|||
154911923|NCT00474539|559097886|FG000|After Infant Series|Lost to Follow-up|3|||
154911924|NCT00474539|559097887|FG001|After Infant Series|Lost to Follow-up|0|||
154911925|NCT00474539|559097886|FG000|After Infant Series|Withdrawal by Subject|1|||
154911926|NCT00474539|559097887|FG001|After Infant Series|Withdrawal by Subject|0|||
154911927|NCT00474539|559097886|FG000|Toddler Dose|Protocol Violation|1|||
154911928|NCT00474539|559097887|FG001|Toddler Dose|Protocol Violation|0|||
154911929|NCT03442595|559097888|FG000|Overall Study|Lost to Follow-up|94|||
154911930|NCT03442595|559097889|FG001|Overall Study|Lost to Follow-up|0|||
154911931|NCT03018340|559097892|FG000|Overall Study|Adverse Event|1|||
154911932|NCT03018340|559097893|FG001|Overall Study|Adverse Event|2|||
154911933|NCT03018340|559097892|FG000|Overall Study|Withdrawal by Subject|0|||
154911934|NCT03018340|559097893|FG001|Overall Study|Withdrawal by Subject|8|||
154911935|NCT03018340|559097892|FG000|Overall Study|Lack of Efficacy|0|||
154911936|NCT03018340|559097893|FG001|Overall Study|Lack of Efficacy|1|||
154911937|NCT03018340|559097892|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
154911938|NCT03018340|559097893|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
155118881|NCT00320255|559868412|FG005|Overall Study|Adverse Event|0|||
155118882|NCT00320255|559868407|FG000|Overall Study|Withdrawal by Subject|1|||
155118883|NCT00320255|559868408|FG001|Overall Study|Withdrawal by Subject|2|||
155118884|NCT00320255|559868409|FG002|Overall Study|Withdrawal by Subject|2|||
155118885|NCT00320255|559868410|FG003|Overall Study|Withdrawal by Subject|4|||
155118886|NCT00320255|559868411|FG004|Overall Study|Withdrawal by Subject|0|||
155118887|NCT00320255|559868412|FG005|Overall Study|Withdrawal by Subject|0|||
155118888|NCT00320255|559868407|FG000|Overall Study|Poor compliance/noncompliance|1|||
155118889|NCT00320255|559868408|FG001|Overall Study|Poor compliance/noncompliance|1|||
155118890|NCT00320255|559868409|FG002|Overall Study|Poor compliance/noncompliance|0|||
155118891|NCT00320255|559868410|FG003|Overall Study|Poor compliance/noncompliance|1|||
155118892|NCT00320255|559868411|FG004|Overall Study|Poor compliance/noncompliance|0|||
155118893|NCT00320255|559868412|FG005|Overall Study|Poor compliance/noncompliance|0|||
155118894|NCT00320255|559868407|FG000|Overall Study|No longer meets study criteria|0|||
155118895|NCT00320255|559868408|FG001|Overall Study|No longer meets study criteria|0|||
155118896|NCT00320255|559868409|FG002|Overall Study|No longer meets study criteria|0|||
155118897|NCT00320255|559868410|FG003|Overall Study|No longer meets study criteria|1|||
155118898|NCT00320255|559868411|FG004|Overall Study|No longer meets study criteria|0|||
155118899|NCT00320255|559868412|FG005|Overall Study|No longer meets study criteria|0|||
155118900|NCT00320255|559868407|FG000|Overall Study|Other|3|||
155118901|NCT00320255|559868408|FG001|Overall Study|Other|2|||
155118902|NCT00320255|559868409|FG002|Overall Study|Other|1|||
155118903|NCT00320255|559868410|FG003|Overall Study|Other|0|||
155118904|NCT00320255|559868411|FG004|Overall Study|Other|0|||
155118905|NCT00320255|559868412|FG005|Overall Study|Other|0|||
155118906|NCT00090233|559868414|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
155118907|NCT00090233|559868415|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
155118908|NCT00090233|559868414|FG000|Overall Study|Adverse Event|214|||
155118909|NCT00090233|559868415|FG001|Overall Study|Adverse Event|198|||
155118910|NCT00090233|559868414|FG000|Overall Study|Lost to Follow-up|68|||
155118911|NCT00090233|559868415|FG001|Overall Study|Lost to Follow-up|95|||
155118912|NCT00090233|559868414|FG000|Overall Study|Protocol Violation|960|||
155118913|NCT00090233|559868415|FG001|Overall Study|Protocol Violation|1022|||
155118914|NCT00090233|559868414|FG000|Overall Study|Withdrawal by Subject|182|||
155118915|NCT00090233|559868415|FG001|Overall Study|Withdrawal by Subject|211|||
155118916|NCT00090233|559868414|FG000|Overall Study|Moved|203|||
155118917|NCT00090233|559868415|FG001|Overall Study|Moved|189|||
155118918|NCT00090233|559868414|FG000|Overall Study|Other|1211|||
155118919|NCT00090233|559868415|FG001|Overall Study|Other|1160|||
155118920|NCT00090233|559868414|FG000|Overall Study|Data not available at data cut-off point|1552|||
155118921|NCT00090233|559868415|FG001|Overall Study|Data not available at data cut-off point|1563|||
155118922|NCT04863248|559868416|FG000|Overall Study|Sponsor Terminated|4|||
155118923|NCT04863248|559868417|FG001|Overall Study|Sponsor Terminated|1|||
155118924|NCT04863248|559868416|FG000|Overall Study|Death|0|||
155118925|NCT04863248|559868417|FG001|Overall Study|Death|1|||
155118926|NCT04863248|559868416|FG000|Overall Study|Withdrawal by Subject|0|||
155118927|NCT04863248|559868417|FG001|Overall Study|Withdrawal by Subject|1|||
155118928|NCT01779869|559868418|FG000|Overall Study|Physician Decision|2|||
154985736|NCT03463993|559372124|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
154985737|NCT01546649|559372129|FG000|Overall Study|Adverse Event|4|||
154985738|NCT01546649|559372130|FG001|Overall Study|Adverse Event|5|||
154985739|NCT01546649|559372129|FG000|Overall Study|Protocol Violation|1|||
154985740|NCT01546649|559372130|FG001|Overall Study|Protocol Violation|0|||
154985741|NCT01546649|559372129|FG000|Overall Study|Lack of Efficacy|1|||
154985742|NCT01546649|559372130|FG001|Overall Study|Lack of Efficacy|0|||
154985743|NCT01546649|559372129|FG000|Overall Study|Recurrence|1|||
154985744|NCT01546649|559372130|FG001|Overall Study|Recurrence|1|||
154985745|NCT01546649|559372129|FG000|Overall Study|Discovery of secondary cancer|0|||
154985746|NCT01546649|559372130|FG001|Overall Study|Discovery of secondary cancer|1|||
154985747|NCT01546649|559372129|FG000|Overall Study|Withdrawal by Subject|1|||
154985748|NCT01546649|559372130|FG001|Overall Study|Withdrawal by Subject|2|||
154985749|NCT01621191|559372132|FG000|Overall Study|Adverse Event|9|||
155118929|NCT01691105|559868423|FG000|1 Month Follow-up|Lost to Follow-up|41|||
155118930|NCT01691105|559868424|FG001|1 Month Follow-up|Lost to Follow-up|38|||
155118931|NCT01691105|559868423|FG000|1 Month Follow-up|Death|2|||
155118932|NCT01691105|559868424|FG001|1 Month Follow-up|Death|3|||
155118933|NCT01691105|559868423|FG000|6 Month Follow-up|Lost to Follow-up|39|||
155118934|NCT01691105|559868424|FG001|6 Month Follow-up|Lost to Follow-up|58|||
155118935|NCT01691105|559868423|FG000|6 Month Follow-up|Death|13|||
155118936|NCT01691105|559868424|FG001|6 Month Follow-up|Death|13|||
155118937|NCT01691105|559868423|FG000|12 Month Follow-up|Lost to Follow-up|50|||
155118938|NCT01691105|559868424|FG001|12 Month Follow-up|Lost to Follow-up|71|||
155118939|NCT01691105|559868423|FG000|12 Month Follow-up|Death|22|||
155118940|NCT01691105|559868424|FG001|12 Month Follow-up|Death|30|||
154985750|NCT01621191|559372132|FG000|Overall Study|Withdrawal by Subject|8|||
154985751|NCT01621191|559372132|FG000|Overall Study|Lack of Efficacy|6|||
154985752|NCT01621191|559372132|FG000|Overall Study|Lost to Follow-up|1|||
154911939|NCT03018340|559097892|FG000|Overall Study|Lost to Follow-up|1|||
154911940|NCT03018340|559097893|FG001|Overall Study|Lost to Follow-up|7|||
154911941|NCT03018340|559097892|FG000|Overall Study|Protocol Violation|3|||
154911942|NCT03018340|559097893|FG001|Overall Study|Protocol Violation|7|||
154911943|NCT03018340|559097892|FG000|Overall Study|Not further specified|0|||
154911944|NCT03018340|559097893|FG001|Overall Study|Not further specified|1|||
154911945|NCT00381706|559097894|FG000|Overall Study|Never treated|7|||
154911946|NCT00381706|559097895|FG001|Overall Study|Never treated|2|||
154911947|NCT00381706|559097896|FG002|Overall Study|Never treated|1|||
154911948|NCT02364999|559097897|FG000|Overall Study|Death|136|||
154911949|NCT02364999|559097898|FG001|Overall Study|Death|138|||
154911950|NCT02364999|559097897|FG000|Overall Study|Lost to Follow-up|10|||
154911951|NCT02364999|559097898|FG001|Overall Study|Lost to Follow-up|15|||
154911952|NCT02364999|559097897|FG000|Overall Study|Protocol Violation|3|||
154911953|NCT02364999|559097898|FG001|Overall Study|Protocol Violation|2|||
154911954|NCT02364999|559097897|FG000|Overall Study|Withdrawal by Subject|14|||
154911955|NCT02364999|559097898|FG001|Overall Study|Withdrawal by Subject|14|||
154911956|NCT02364999|559097897|FG000|Overall Study|Other|0|||
154911957|NCT02364999|559097898|FG001|Overall Study|Other|1|||
154911958|NCT02364999|559097897|FG000|Overall Study|Randomized but did not receive treatment|2|||
154911959|NCT02364999|559097898|FG001|Overall Study|Randomized but did not receive treatment|3|||
154911960|NCT00550615|559097899|FG000|Overall Study|Withdrawal by Subject|0|||
154911961|NCT00550615|559097900|FG001|Overall Study|Withdrawal by Subject|0|||
154911962|NCT00550615|559097901|FG002|Overall Study|Withdrawal by Subject|2|||
154911963|NCT00550615|559097902|FG003|Overall Study|Withdrawal by Subject|3|||
154911964|NCT00550615|559097899|FG000|Overall Study|Not evaluable|0|||
154911965|NCT00550615|559097900|FG001|Overall Study|Not evaluable|0|||
154911966|NCT00550615|559097901|FG002|Overall Study|Not evaluable|2|||
154911967|NCT00550615|559097902|FG003|Overall Study|Not evaluable|7|||
154911968|NCT00598585|559097903|FG000|Overall Study|Lost to Follow-up|1|||
154911969|NCT00598585|559097904|FG001|Overall Study|Lost to Follow-up|0|||
154911970|NCT00545584|559097905|FG000|Overall Study|Only one reason for discontinuation|62|||
154911971|NCT00545584|559097906|FG001|Overall Study|Only one reason for discontinuation|61|||
154911972|NCT00545584|559097907|FG002|Overall Study|Only one reason for discontinuation|48|||
154911973|NCT00545584|559097905|FG000|Overall Study|Two or more reasons for discontinuation|17|||
154911974|NCT00545584|559097906|FG001|Overall Study|Two or more reasons for discontinuation|19|||
154911975|NCT00545584|559097907|FG002|Overall Study|Two or more reasons for discontinuation|8|||
154911976|NCT00461552|559097911|FG000|Overall Study|Drug Dispensing error|0|||
154911977|NCT00461552|559097912|FG001|Overall Study|Drug Dispensing error|2|||
154911978|NCT00523744|559097913|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
154911979|NCT00523744|559097913|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
154911980|NCT00523744|559097913|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
154911981|NCT00523744|559097913|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
154911982|NCT00523744|559097913|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
154911983|NCT00523744|559097913|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
154911984|NCT01289028|559097914|FG000|Overall Study|Progressive Disease|49|||
154911985|NCT01289028|559097914|FG000|Overall Study|Adverse Event|14|||
154911986|NCT01289028|559097914|FG000|Overall Study|Withdrawal by Subject|6|||
154911987|NCT01289028|559097914|FG000|Overall Study|Death|4|||
154911988|NCT01289028|559097914|FG000|Overall Study|Lack of Efficacy|2|||
154911989|NCT01289028|559097914|FG000|Overall Study|No longer required|2|||
154911990|NCT01289028|559097914|FG000|Overall Study|Lost to Follow-up|2|||
154911991|NCT01289028|559097914|FG000|Overall Study|New Cancer Therapy|2|||
154911992|NCT01289028|559097914|FG000|Overall Study|Abnormal Lab Value|1|||
154911993|NCT01289028|559097914|FG000|Overall Study|Missing reason for discon|1|||
154911994|NCT00998985|559097917|FG000|Overall Study|Withdrawal by Subject|0|||
154911995|NCT00998985|559097918|FG001|Overall Study|Withdrawal by Subject|0|||
154911996|NCT00998985|559097919|FG002|Overall Study|Withdrawal by Subject|0|||
154911997|NCT00998985|559097920|FG003|Overall Study|Withdrawal by Subject|0|||
154911998|NCT00998985|559097921|FG004|Overall Study|Withdrawal by Subject|0|||
154911999|NCT00998985|559097922|FG005|Overall Study|Withdrawal by Subject|0|||
154912000|NCT00998985|559097923|FG006|Overall Study|Withdrawal by Subject|0|||
154912001|NCT00998985|559097924|FG007|Overall Study|Withdrawal by Subject|0|||
154912002|NCT00998985|559097925|FG008|Overall Study|Withdrawal by Subject|1|||
154912003|NCT00998985|559097926|FG009|Overall Study|Withdrawal by Subject|0|||
154912004|NCT00998985|559097927|FG010|Overall Study|Withdrawal by Subject|0|||
154912005|NCT00998985|559097928|FG011|Overall Study|Withdrawal by Subject|0|||
154912006|NCT00998985|559097929|FG012|Overall Study|Withdrawal by Subject|0|||
154912007|NCT00998985|559097930|FG013|Overall Study|Withdrawal by Subject|0|||
154912008|NCT00998985|559097917|FG000|Overall Study|Protocol Violation|0|||
154912009|NCT00998985|559097918|FG001|Overall Study|Protocol Violation|0|||
154912010|NCT00998985|559097919|FG002|Overall Study|Protocol Violation|0|||
154912011|NCT00998985|559097920|FG003|Overall Study|Protocol Violation|0|||
154912012|NCT00998985|559097921|FG004|Overall Study|Protocol Violation|0|||
154912013|NCT00998985|559097922|FG005|Overall Study|Protocol Violation|1|||
154912014|NCT00998985|559097923|FG006|Overall Study|Protocol Violation|0|||
154912015|NCT00998985|559097924|FG007|Overall Study|Protocol Violation|0|||
154912016|NCT00998985|559097925|FG008|Overall Study|Protocol Violation|0|||
154912017|NCT00998985|559097926|FG009|Overall Study|Protocol Violation|0|||
154912018|NCT00998985|559097927|FG010|Overall Study|Protocol Violation|0|||
154912019|NCT00998985|559097928|FG011|Overall Study|Protocol Violation|0|||
154912020|NCT00998985|559097929|FG012|Overall Study|Protocol Violation|0|||
154912021|NCT00998985|559097930|FG013|Overall Study|Protocol Violation|0|||
154912022|NCT00415623|559097933|FG000|Overall Study|Adverse Event|3|||
154912023|NCT00415623|559097934|FG001|Overall Study|Adverse Event|4|||
154912024|NCT00415623|559097933|FG000|Overall Study|Death|1|||
154912025|NCT00415623|559097934|FG001|Overall Study|Death|0|||
154912026|NCT00415623|559097933|FG000|Overall Study|Withdrawal by Subject|1|||
154912027|NCT00415623|559097934|FG001|Overall Study|Withdrawal by Subject|1|||
154912028|NCT02520141|559097940|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
154912029|NCT02036476|559097943|FG000|Overall Study|Withdrawal by Subject|2|||
154912030|NCT02036476|559097943|FG000|Overall Study|Progressive Disease|4|||
154912031|NCT02036476|559097943|FG000|Overall Study|Unacceptable Toxicity|2|||
154912032|NCT00703781|559097944|FG000|Overall Study|Withdrawal by Subject|1|||
154912033|NCT00703781|559097945|FG001|Overall Study|Withdrawal by Subject|2|||
154912034|NCT00703781|559097944|FG000|Overall Study|Cancelled surgery|1|||
154912035|NCT00703781|559097945|FG001|Overall Study|Cancelled surgery|0|||
154912036|NCT02168816|559097946|FG000|Overall Study|Lost to Follow-up|2|||
154912037|NCT02168816|559097947|FG001|Overall Study|Lost to Follow-up|2|||
154912038|NCT01225211|559097950|FG000|Overall Study|Adverse Event|0|||
154912039|NCT01225211|559097951|FG001|Overall Study|Adverse Event|0|||
154912040|NCT01225211|559097952|FG002|Overall Study|Adverse Event|1|||
154912041|NCT01225211|559097953|FG003|Overall Study|Adverse Event|0|||
154912042|NCT01225211|559097954|FG004|Overall Study|Adverse Event|0|||
154912043|NCT01225211|559097955|FG005|Overall Study|Adverse Event|0|||
154912044|NCT01225211|559097956|FG006|Overall Study|Adverse Event|0|||
154912045|NCT01225211|559097957|FG007|Overall Study|Adverse Event|0|||
154912046|NCT01225211|559097958|FG008|Overall Study|Adverse Event|0|||
154912047|NCT01225211|559097959|FG009|Overall Study|Adverse Event|1|||
154912048|NCT01225211|559097950|FG000|Overall Study|Withdrawal by Subject|0|||
154912049|NCT01225211|559097951|FG001|Overall Study|Withdrawal by Subject|0|||
154912050|NCT01225211|559097952|FG002|Overall Study|Withdrawal by Subject|0|||
154912051|NCT01225211|559097953|FG003|Overall Study|Withdrawal by Subject|0|||
154912052|NCT01225211|559097954|FG004|Overall Study|Withdrawal by Subject|0|||
154912053|NCT01225211|559097955|FG005|Overall Study|Withdrawal by Subject|0|||
154912054|NCT01225211|559097956|FG006|Overall Study|Withdrawal by Subject|1|||
154912055|NCT01225211|559097957|FG007|Overall Study|Withdrawal by Subject|0|||
154912056|NCT01225211|559097958|FG008|Overall Study|Withdrawal by Subject|1|||
154912057|NCT01225211|559097959|FG009|Overall Study|Withdrawal by Subject|3|||
154912058|NCT01225211|559097950|FG000|Overall Study|Other|0|||
154912059|NCT01225211|559097951|FG001|Overall Study|Other|0|||
154912060|NCT01225211|559097952|FG002|Overall Study|Other|0|||
154912061|NCT01225211|559097953|FG003|Overall Study|Other|0|||
154912062|NCT01225211|559097954|FG004|Overall Study|Other|0|||
154912063|NCT01225211|559097955|FG005|Overall Study|Other|0|||
154912064|NCT01225211|559097956|FG006|Overall Study|Other|0|||
154912065|NCT01225211|559097957|FG007|Overall Study|Other|0|||
154912066|NCT01225211|559097958|FG008|Overall Study|Other|0|||
154912067|NCT01225211|559097959|FG009|Overall Study|Other|1|||
154912068|NCT00537810|559097966|FG000|Overall Study|Withdrawal by Subject|4|||
154912069|NCT00537810|559097967|FG001|Overall Study|Withdrawal by Subject|11|||
154912070|NCT00537810|559097968|FG002|Overall Study|Withdrawal by Subject|4|||
154912071|NCT00537810|559097969|FG003|Overall Study|Withdrawal by Subject|3|||
154912072|NCT00537810|559097966|FG000|Overall Study|Medically withdrawn|2|||
154912073|NCT00537810|559097967|FG001|Overall Study|Medically withdrawn|2|||
154912074|NCT00537810|559097968|FG002|Overall Study|Medically withdrawn|0|||
154912075|NCT00537810|559097969|FG003|Overall Study|Medically withdrawn|1|||
155118941|NCT01691105|559868423|FG000|12 Month Biochemical Verification|Death|22|||
155118942|NCT01691105|559868424|FG001|12 Month Biochemical Verification|Death|30|||
155118943|NCT01691105|559868423|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
154912076|NCT00410514|559097974|FG000|Overall Study|Adverse Event|2|||
154912077|NCT00410514|559097975|FG001|Overall Study|Adverse Event|2|||
154912078|NCT00410514|559097976|FG002|Overall Study|Adverse Event|2|||
155118944|NCT01691105|559868424|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
154912079|NCT00410514|559097974|FG000|Overall Study|Protocol Violation|0|||
154912080|NCT00410514|559097975|FG001|Overall Study|Protocol Violation|1|||
154912081|NCT00410514|559097976|FG002|Overall Study|Protocol Violation|1|||
154912082|NCT00410514|559097974|FG000|Overall Study|Lost to Follow-up|0|||
154912083|NCT00410514|559097975|FG001|Overall Study|Lost to Follow-up|0|||
154912084|NCT00410514|559097976|FG002|Overall Study|Lost to Follow-up|2|||
154912085|NCT00410514|559097974|FG000|Overall Study|Non-compliant with study procedures|0|||
154912086|NCT00410514|559097975|FG001|Overall Study|Non-compliant with study procedures|0|||
154912087|NCT00410514|559097976|FG002|Overall Study|Non-compliant with study procedures|2|||
154912088|NCT02985684|559097979|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
154985753|NCT01621191|559372132|FG000|Overall Study|Site Removed From Study|1|||
154985754|NCT00706381|559372135|FG000|Overall Study|Lost to Follow-up|0|||
154985755|NCT00706381|559372136|FG001|Overall Study|Lost to Follow-up|1|||
154985756|NCT00706381|559372137|FG002|Overall Study|Lost to Follow-up|1|||
154985757|NCT00706381|559372138|FG003|Overall Study|Lost to Follow-up|0|||
154985758|NCT04355663|559372139|FG000|Overall Study|Physician Decision|2|||
154985759|NCT04355663|559372140|FG001|Overall Study|Physician Decision|7|||
154985760|NCT04355663|559372141|FG002|Overall Study|Physician Decision|0|||
154985761|NCT04355663|559372139|FG000|Overall Study|Adverse Event|0|||
154985762|NCT04355663|559372140|FG001|Overall Study|Adverse Event|0|||
154985763|NCT04355663|559372141|FG002|Overall Study|Adverse Event|1|||
154985764|NCT04355663|559372139|FG000|Overall Study|Withdrawal by Subject|0|||
154985765|NCT04355663|559372140|FG001|Overall Study|Withdrawal by Subject|8|||
154985766|NCT04355663|559372141|FG002|Overall Study|Withdrawal by Subject|3|||
154985767|NCT01901874|559372144|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
154985768|NCT01901874|559372144|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
154985769|NCT01901874|559372144|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
154985770|NCT01901874|559372144|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
154985771|NCT01901874|559372144|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
154985772|NCT01901874|559372144|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
154985773|NCT02687360|559372160|FG000|Overall Study|Withdrawal by Subject|3|||
154985774|NCT02687360|559372161|FG001|Overall Study|Withdrawal by Subject|0|||
154985775|NCT02143583|559372164|FG000|Overall Study|Withdrawal by Subject|1|||
154985776|NCT02143583|559372165|FG001|Overall Study|Withdrawal by Subject|0|||
154985777|NCT02143583|559372166|FG002|Overall Study|Withdrawal by Subject|1|||
154985778|NCT02143583|559372164|FG000|Overall Study|husband illness|0|||
154985779|NCT02143583|559372165|FG001|Overall Study|husband illness|0|||
154985780|NCT02143583|559372166|FG002|Overall Study|husband illness|1|||
154985781|NCT04189445|559373578|FG000|Overall Study|Withdrawal of consent|8|||
154985782|NCT04189445|559373579|FG001|Overall Study|Withdrawal of consent|1|||
154985783|NCT04189445|559373580|FG002|Overall Study|Withdrawal of consent|0|||
154985784|NCT04189445|559373578|FG000|Overall Study|Study Terminated by Sponsor|25|||
154985785|NCT04189445|559373579|FG001|Overall Study|Study Terminated by Sponsor|3|||
154985786|NCT04189445|559373580|FG002|Overall Study|Study Terminated by Sponsor|0|||
154985787|NCT04189445|559373578|FG000|Overall Study|Death|54|||
154985788|NCT04189445|559373579|FG001|Overall Study|Death|24|||
154985789|NCT04189445|559373580|FG002|Overall Study|Death|0|||
154985790|NCT00003138|559373581|FG000|Step 1|Reasons off treatment not documented|60|||
154985791|NCT00003138|559373582|FG001|Step 1|Reasons off treatment not documented|57|||
154985792|NCT00003138|559373581|FG000|Step 1|Never started treatment|1|||
154985793|NCT00003138|559373582|FG001|Step 1|Never started treatment|0|||
154985794|NCT00003138|559373581|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
154985795|NCT00003138|559373582|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
154985796|NCT00003138|559373581|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
154985797|NCT00003138|559373582|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
154985798|NCT00003138|559373581|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
154985799|NCT00003138|559373582|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
154985800|NCT00003138|559373581|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
154985801|NCT00003138|559373582|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
154985802|NCT02960893|559373584|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
154985803|NCT02960893|559373585|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
154985804|NCT02960893|559373586|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
154985805|NCT02960893|559373587|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
154985806|NCT02960893|559373584|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
154985807|NCT02960893|559373585|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
154985808|NCT02960893|559373586|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
154985809|NCT02960893|559373587|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
154985810|NCT02960893|559373584|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
154985811|NCT02960893|559373585|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
154985812|NCT02960893|559373586|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
154985813|NCT02960893|559373587|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
154985814|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
154985815|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
154985816|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
154985817|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
154985818|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
154985819|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
154985820|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
154985821|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
154985822|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
154985823|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
154985824|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
154985825|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
154985826|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
154985827|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
154985828|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
154985829|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
154985830|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
154985831|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
154985832|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
154985833|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
154985834|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
154985835|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
154985836|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
154985837|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
154985838|NCT02960893|559373584|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
154985839|NCT02960893|559373585|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
154985840|NCT02960893|559373586|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
154985841|NCT02960893|559373587|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
154985842|NCT01045421|559373588|FG000|Phase 1|Progressive Disease|0|||
154985843|NCT01045421|559373589|FG001|Phase 1|Progressive Disease|0|||
154985844|NCT01045421|559373590|FG002|Phase 1|Progressive Disease|0|||
154985845|NCT01045421|559373591|FG003|Phase 1|Progressive Disease|0|||
154985846|NCT01045421|559373592|FG004|Phase 1|Progressive Disease|1|||
154985847|NCT01045421|559373593|FG005|Phase 1|Progressive Disease|0|||
154985848|NCT01045421|559373594|FG006|Phase 1|Progressive Disease|0|||
154985849|NCT01045421|559373595|FG007|Phase 1|Progressive Disease|0|||
154985850|NCT01045421|559373596|FG008|Phase 1|Progressive Disease|0|||
154985851|NCT01045421|559373597|FG009|Phase 1|Progressive Disease|0|||
154985852|NCT01045421|559373598|FG010|Phase 1|Progressive Disease|0|||
154985853|NCT01045421|559373588|FG000|Phase 1|Withdrawal by Subject|0|||
154985854|NCT01045421|559373589|FG001|Phase 1|Withdrawal by Subject|0|||
154985855|NCT01045421|559373590|FG002|Phase 1|Withdrawal by Subject|0|||
154985856|NCT01045421|559373591|FG003|Phase 1|Withdrawal by Subject|1|||
154985857|NCT01045421|559373592|FG004|Phase 1|Withdrawal by Subject|0|||
154985858|NCT01045421|559373593|FG005|Phase 1|Withdrawal by Subject|0|||
154985859|NCT01045421|559373594|FG006|Phase 1|Withdrawal by Subject|0|||
154985860|NCT01045421|559373595|FG007|Phase 1|Withdrawal by Subject|0|||
154985861|NCT01045421|559373596|FG008|Phase 1|Withdrawal by Subject|0|||
154985862|NCT01045421|559373597|FG009|Phase 1|Withdrawal by Subject|0|||
154985863|NCT01045421|559373598|FG010|Phase 1|Withdrawal by Subject|0|||
154985864|NCT01045421|559373588|FG000|Phase 2|Progressive Disease|0|||
154985865|NCT01045421|559373589|FG001|Phase 2|Progressive Disease|0|||
154985866|NCT01045421|559373590|FG002|Phase 2|Progressive Disease|0|||
154985867|NCT01045421|559373591|FG003|Phase 2|Progressive Disease|0|||
154985868|NCT01045421|559373592|FG004|Phase 2|Progressive Disease|0|||
154985869|NCT01045421|559373593|FG005|Phase 2|Progressive Disease|0|||
154985870|NCT01045421|559373594|FG006|Phase 2|Progressive Disease|0|||
154985871|NCT01045421|559373595|FG007|Phase 2|Progressive Disease|1|||
154985872|NCT01045421|559373596|FG008|Phase 2|Progressive Disease|1|||
154985873|NCT01045421|559373597|FG009|Phase 2|Progressive Disease|1|||
154985874|NCT01045421|559373598|FG010|Phase 2|Progressive Disease|1|||
154985875|NCT01045421|559373588|FG000|Phase 2|Death|0|||
154985876|NCT01045421|559373589|FG001|Phase 2|Death|0|||
154985877|NCT01045421|559373590|FG002|Phase 2|Death|0|||
154985878|NCT01045421|559373591|FG003|Phase 2|Death|0|||
154985879|NCT01045421|559373592|FG004|Phase 2|Death|0|||
154985880|NCT01045421|559373593|FG005|Phase 2|Death|0|||
154985881|NCT01045421|559373594|FG006|Phase 2|Death|0|||
154985882|NCT01045421|559373595|FG007|Phase 2|Death|1|||
154985883|NCT01045421|559373596|FG008|Phase 2|Death|1|||
154985884|NCT01045421|559373597|FG009|Phase 2|Death|2|||
154985885|NCT01045421|559373598|FG010|Phase 2|Death|0|||
154985886|NCT01045421|559373588|FG000|Phase 2|Other|0|||
154985887|NCT01045421|559373589|FG001|Phase 2|Other|0|||
154985888|NCT01045421|559373590|FG002|Phase 2|Other|0|||
154985889|NCT01045421|559373591|FG003|Phase 2|Other|0|||
154985890|NCT01045421|559373592|FG004|Phase 2|Other|0|||
154985891|NCT01045421|559373593|FG005|Phase 2|Other|0|||
154985892|NCT01045421|559373594|FG006|Phase 2|Other|0|||
154985893|NCT01045421|559373595|FG007|Phase 2|Other|3|||
154985894|NCT01045421|559373596|FG008|Phase 2|Other|0|||
154985895|NCT01045421|559373597|FG009|Phase 2|Other|0|||
154985896|NCT01045421|559373598|FG010|Phase 2|Other|1|||
154985897|NCT04556552|559373599|FG000|Overall Study|Lost to Follow-up|1|||
154985898|NCT04556552|559373600|FG001|Overall Study|Lost to Follow-up|0|||
154985899|NCT04556552|559373599|FG000|Overall Study|Claustrophobia|0|||
154985900|NCT04556552|559373600|FG001|Overall Study|Claustrophobia|1|||
154985901|NCT04556552|559373599|FG000|Overall Study|Inability to continue|0|||
154985902|NCT04556552|559373600|FG001|Overall Study|Inability to continue|1|||
154985903|NCT01553279|559373601|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
154985904|NCT01553279|559373602|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
154985905|NCT01553279|559373601|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
154985906|NCT01553279|559373602|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
154985907|NCT01553279|559373601|FG000|Interim Period|Withdrawal by Subject|2|||
154985908|NCT01553279|559373602|FG001|Interim Period|Withdrawal by Subject|2|||
154985909|NCT01553279|559373601|FG000|Interim Period|Lost to Follow-up|1|||
154985910|NCT01553279|559373602|FG001|Interim Period|Lost to Follow-up|0|||
154985911|NCT01553279|559373601|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
155118945|NCT01691105|559868423|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
154985912|NCT01553279|559373602|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
154985913|NCT01553279|559373601|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
154985914|NCT01553279|559373602|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
154985915|NCT00605865|559373603|FG000|Overall Study|Protocol Violation|115|||
154985916|NCT03955471|559373604|FG000|Overall Study|Death|22|||
154985917|NCT03955471|559373604|FG000|Overall Study|Lost to Follow-up|1|||
154985918|NCT03955471|559373604|FG000|Overall Study|Withdrawal by Subject|6|||
154985919|NCT03955471|559373604|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
154985920|NCT01030341|559373607|FG000|Overall Study|Withdrawal by Subject|1|||
154985921|NCT01030341|559373607|FG000|Overall Study|Lost to Follow-up|2|||
154985922|NCT01884311|559373610|FG000|Overall Study|Withdrawal by Subject|3|||
154985923|NCT01884311|559373610|FG000|Overall Study|withdrew consent due to AEs|1|||
154985924|NCT01884311|559373610|FG000|Overall Study|Precautionary measure|1|||
154985925|NCT03310411|559373613|FG000|Period 1|Adverse Event|0|||
154985926|NCT03310411|559373614|FG001|Period 1|Adverse Event|0|||
154985927|NCT03310411|559373615|FG002|Period 1|Adverse Event|0|||
154985928|NCT03310411|559373616|FG003|Period 1|Adverse Event|1|||
154985929|NCT03623386|559373619|FG000|Overall Study|Protocol Violation|3|||
154985930|NCT03623386|559373620|FG001|Overall Study|Protocol Violation|2|||
154985931|NCT03623386|559373621|FG002|Overall Study|Protocol Violation|0|||
154985932|NCT03623386|559373619|FG000|Overall Study|Physician Decision|1|||
154985933|NCT03623386|559373620|FG001|Overall Study|Physician Decision|1|||
154985934|NCT03623386|559373621|FG002|Overall Study|Physician Decision|0|||
154985935|NCT03623386|559373619|FG000|Overall Study|Lost to Follow-up|0|||
154985936|NCT03623386|559373620|FG001|Overall Study|Lost to Follow-up|2|||
154985937|NCT03623386|559373621|FG002|Overall Study|Lost to Follow-up|0|||
154985938|NCT03623386|559373619|FG000|Overall Study|COVID-19|0|||
154985939|NCT03623386|559373620|FG001|Overall Study|COVID-19|1|||
154985940|NCT03623386|559373621|FG002|Overall Study|COVID-19|0|||
154985941|NCT03052322|559373622|FG000|Overall Study|Other un-specified|1|||
154985942|NCT03052322|559373623|FG001|Overall Study|Other un-specified|2|||
154985943|NCT03052322|559373622|FG000|Overall Study|Withdrawal by Subject|10|||
154985944|NCT03052322|559373623|FG001|Overall Study|Withdrawal by Subject|9|||
154985945|NCT03052322|559373622|FG000|Overall Study|Death|0|||
154985946|NCT03052322|559373623|FG001|Overall Study|Death|2|||
154985947|NCT03052322|559373622|FG000|Overall Study|Lack of Efficacy|1|||
154985948|NCT03052322|559373623|FG001|Overall Study|Lack of Efficacy|2|||
154985949|NCT03052322|559373622|FG000|Overall Study|Protocol Violation|1|||
154985950|NCT03052322|559373623|FG001|Overall Study|Protocol Violation|0|||
154985951|NCT03052322|559373622|FG000|Overall Study|Lost to Follow-up|2|||
154985952|NCT03052322|559373623|FG001|Overall Study|Lost to Follow-up|4|||
154985953|NCT03052322|559373622|FG000|Overall Study|Adverse Event|6|||
154985954|NCT03052322|559373623|FG001|Overall Study|Adverse Event|13|||
154985955|NCT00003875|559373634|FG000|Overall Study|Screen Failed|1|||
154985956|NCT03835325|559373637|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
154985957|NCT03835325|559373637|FG000|Overall Study|Selection failure|1|||
154985958|NCT01370213|559373638|FG000|Overall Study|Early Death|1|||
154985959|NCT01370213|559373639|FG001|Overall Study|Early Death|0|||
155118946|NCT01691105|559868424|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
155118947|NCT00957944|559868425|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
155118948|NCT00957944|559868426|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
155118949|NCT01777542|559868429|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
155118950|NCT01777542|559868430|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
155118951|NCT05605691|559868433|FG000|Overall Study|Lost to Follow-up|1|||
155118952|NCT02279719|559868434|FG000|Overall Study|Patients randomized but never treated|0|||
155118953|NCT02279719|559868435|FG001|Overall Study|Patients randomized but never treated|0|||
155118954|NCT02279719|559868436|FG002|Overall Study|Patients randomized but never treated|0|||
155118955|NCT02279719|559868437|FG003|Overall Study|Patients randomized but never treated|0|||
155118956|NCT02279719|559868438|FG004|Overall Study|Patients randomized but never treated|3|||
154985960|NCT01370213|559373640|FG002|Overall Study|Early Death|0|||
154985961|NCT01370213|559373638|FG000|Overall Study|Not evaluable|0|||
154985962|NCT01370213|559373639|FG001|Overall Study|Not evaluable|2|||
154985963|NCT01370213|559373640|FG002|Overall Study|Not evaluable|0|||
154985964|NCT01550744|559373646|FG000|Open-Label|Lost to Follow-up|7|||
154985965|NCT01550744|559373647|FG001|Open-Label|Lost to Follow-up|0|||
154985966|NCT01550744|559373648|FG002|Open-Label|Lost to Follow-up|0|||
154985967|NCT01550744|559373646|FG000|Open-Label|Withdrawal by Subject|13|||
154985968|NCT01550744|559373647|FG001|Open-Label|Withdrawal by Subject|0|||
154985969|NCT01550744|559373648|FG002|Open-Label|Withdrawal by Subject|0|||
154985970|NCT01550744|559373646|FG000|Open-Label|Adverse Event|11|||
154985971|NCT01550744|559373647|FG001|Open-Label|Adverse Event|0|||
154985972|NCT01550744|559373648|FG002|Open-Label|Adverse Event|0|||
154985973|NCT01550744|559373646|FG000|Open-Label|Lack of Efficacy|4|||
154985974|NCT01550744|559373647|FG001|Open-Label|Lack of Efficacy|0|||
154985975|NCT01550744|559373648|FG002|Open-Label|Lack of Efficacy|0|||
154985976|NCT01550744|559373646|FG000|Open-Label|Protocol Violation|4|||
154985977|NCT01550744|559373647|FG001|Open-Label|Protocol Violation|0|||
154985978|NCT01550744|559373648|FG002|Open-Label|Protocol Violation|0|||
154985979|NCT01550744|559373646|FG000|Open-Label|Not all 3 study drug injections received|2|||
154985980|NCT01550744|559373647|FG001|Open-Label|Not all 3 study drug injections received|0|||
154985981|NCT01550744|559373648|FG002|Open-Label|Not all 3 study drug injections received|0|||
154985982|NCT01550744|559373646|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
154985983|NCT01550744|559373647|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
154985984|NCT01550744|559373648|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
154985985|NCT01550744|559373646|FG000|Open-Label|Other|1|||
154985986|NCT01550744|559373647|FG001|Open-Label|Other|0|||
154985987|NCT01550744|559373648|FG002|Open-Label|Other|0|||
154985988|NCT01550744|559373646|FG000|Double-Blind|Lost to Follow-up|0|||
154985989|NCT01550744|559373647|FG001|Double-Blind|Lost to Follow-up|6|||
154985990|NCT01550744|559373648|FG002|Double-Blind|Lost to Follow-up|12|||
154985991|NCT01550744|559373646|FG000|Double-Blind|Withdrawal by Subject|0|||
154985992|NCT01550744|559373647|FG001|Double-Blind|Withdrawal by Subject|2|||
154985993|NCT01550744|559373648|FG002|Double-Blind|Withdrawal by Subject|15|||
154985994|NCT01550744|559373646|FG000|Double-Blind|Adverse Event|0|||
154985995|NCT01550744|559373647|FG001|Double-Blind|Adverse Event|4|||
154985996|NCT01550744|559373648|FG002|Double-Blind|Adverse Event|15|||
154985997|NCT01550744|559373646|FG000|Double-Blind|Death|0|||
154985998|NCT01550744|559373647|FG001|Double-Blind|Death|1|||
154985999|NCT01550744|559373648|FG002|Double-Blind|Death|0|||
154986000|NCT01550744|559373646|FG000|Double-Blind|Lack of Efficacy|0|||
154986001|NCT01550744|559373647|FG001|Double-Blind|Lack of Efficacy|2|||
154986002|NCT01550744|559373648|FG002|Double-Blind|Lack of Efficacy|8|||
154986003|NCT01550744|559373646|FG000|Double-Blind|Protocol Violation|0|||
154986004|NCT01550744|559373647|FG001|Double-Blind|Protocol Violation|0|||
154986005|NCT01550744|559373648|FG002|Double-Blind|Protocol Violation|4|||
154986006|NCT01550744|559373646|FG000|Double-Blind|Pregnancy|0|||
154986007|NCT01550744|559373647|FG001|Double-Blind|Pregnancy|0|||
154986008|NCT01550744|559373648|FG002|Double-Blind|Pregnancy|3|||
154986009|NCT01550744|559373646|FG000|Double-Blind|Other|0|||
154986010|NCT01550744|559373647|FG001|Double-Blind|Other|2|||
154986011|NCT01550744|559373648|FG002|Double-Blind|Other|10|||
154986012|NCT01782482|559373656|FG000|Overall Study|Adverse Event|2|||
154986013|NCT01782482|559373657|FG001|Overall Study|Adverse Event|1|||
154986014|NCT01782482|559373656|FG000|Overall Study|Lost to Follow-up|2|||
154986015|NCT01782482|559373657|FG001|Overall Study|Lost to Follow-up|3|||
154986016|NCT01782482|559373656|FG000|Overall Study|Physician Decision|1|||
154986017|NCT01782482|559373657|FG001|Overall Study|Physician Decision|0|||
154986018|NCT01782482|559373656|FG000|Overall Study|Protocol Violation|1|||
154986019|NCT01782482|559373657|FG001|Overall Study|Protocol Violation|0|||
154986020|NCT01782482|559373656|FG000|Overall Study|Withdrawal by Subject|2|||
154986021|NCT01782482|559373657|FG001|Overall Study|Withdrawal by Subject|3|||
154986022|NCT01782482|559373656|FG000|Overall Study|Randomized in Error|2|||
154986023|NCT01782482|559373657|FG001|Overall Study|Randomized in Error|2|||
154986024|NCT01782482|559373656|FG000|Overall Study|Habitually wearing toric lens OS|0|||
154986025|NCT01782482|559373657|FG001|Overall Study|Habitually wearing toric lens OS|1|||
154986026|NCT03395639|559373661|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
154986027|NCT03395639|559373662|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
154986028|NCT03395639|559373663|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
154986029|NCT03395639|559373661|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
154986030|NCT03395639|559373662|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
154986031|NCT03395639|559373663|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
154986032|NCT03395639|559373661|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
154986033|NCT03395639|559373662|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
155118957|NCT02279719|559868439|FG005|Overall Study|Patients randomized but never treated|0|||
154986034|NCT03395639|559373663|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
154986035|NCT03395639|559373661|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
154986036|NCT03395639|559373662|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
154986037|NCT03395639|559373663|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
154986038|NCT03395639|559373661|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
154986039|NCT03395639|559373662|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
154986040|NCT03395639|559373663|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
154986041|NCT02595008|559373668|FG000|Overall Study|Enrolled In Error|1|||
154912089|NCT02985684|559097979|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
154912090|NCT02985684|559097979|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
154912091|NCT02390167|559099249|FG000|Overall Study|Lost to Follow-up|1|||
154912092|NCT01265719|559099251|FG000|Overall Study|Does not meet entrance criteria|0|||
154912093|NCT01265719|559099252|FG001|Overall Study|Does not meet entrance criteria|3|||
154912094|NCT01265719|559099251|FG000|Overall Study|Other reasons|2|||
154912095|NCT01265719|559099252|FG001|Overall Study|Other reasons|0|||
154912096|NCT01265719|559099251|FG000|Overall Study|Withdrawal by Subject|8|||
154912097|NCT01265719|559099252|FG001|Overall Study|Withdrawal by Subject|3|||
154912098|NCT01265719|559099251|FG000|Overall Study|Lost to Follow-up|2|||
154912099|NCT01265719|559099252|FG001|Overall Study|Lost to Follow-up|7|||
154912100|NCT01265719|559099251|FG000|Overall Study|Adverse Event|2|||
154912101|NCT01265719|559099252|FG001|Overall Study|Adverse Event|0|||
154912102|NCT02554721|559099253|FG000|Overall Study|Adverse Event|1|||
154912103|NCT02554721|559099254|FG001|Overall Study|Adverse Event|0|||
154912104|NCT02554721|559099255|FG002|Overall Study|Adverse Event|0|||
154912105|NCT02554721|559099256|FG003|Overall Study|Adverse Event|0|||
154912106|NCT02554721|559099257|FG004|Overall Study|Adverse Event|1|||
154912107|NCT02554721|559099253|FG000|Overall Study|Noncompliance|0|||
154912108|NCT02554721|559099254|FG001|Overall Study|Noncompliance|0|||
154912109|NCT02554721|559099255|FG002|Overall Study|Noncompliance|0|||
154912110|NCT02554721|559099256|FG003|Overall Study|Noncompliance|0|||
154912111|NCT02554721|559099257|FG004|Overall Study|Noncompliance|1|||
154912112|NCT05466240|559099262|FG000|Overall Study|Adverse Event|1|||
154912113|NCT05466240|559099263|FG001|Overall Study|Adverse Event|0|||
154912114|NCT05466240|559099262|FG000|Overall Study|Withdrawal by Subject|1|||
154912115|NCT05466240|559099263|FG001|Overall Study|Withdrawal by Subject|0|||
154912116|NCT00945945|559099266|FG000|Overall Study|Adverse Event|15|||
154912117|NCT00945945|559099267|FG001|Overall Study|Adverse Event|35|||
154912118|NCT00945945|559099266|FG000|Overall Study|Withdrawal by Subject|7|||
154912119|NCT00945945|559099267|FG001|Overall Study|Withdrawal by Subject|10|||
154912120|NCT00945945|559099266|FG000|Overall Study|Lost to Follow-up|4|||
154912121|NCT00945945|559099267|FG001|Overall Study|Lost to Follow-up|5|||
154912122|NCT00945945|559099266|FG000|Overall Study|Lack of Efficacy|6|||
154912123|NCT00945945|559099267|FG001|Overall Study|Lack of Efficacy|2|||
154912124|NCT00945945|559099266|FG000|Overall Study|Protocol Violation|4|||
154912125|NCT00945945|559099267|FG001|Overall Study|Protocol Violation|2|||
154912126|NCT00945945|559099266|FG000|Overall Study|Entry Criteria Not Met|0|||
154912127|NCT00945945|559099267|FG001|Overall Study|Entry Criteria Not Met|1|||
154912128|NCT02967562|559099270|FG000|Overall Study|Consent not obtained|1|||
154912129|NCT02967562|559099271|FG001|Overall Study|Consent not obtained|0|||
154912130|NCT02967562|559099270|FG000|Overall Study|High leak precluding analysis|1|||
154912131|NCT02967562|559099271|FG001|Overall Study|High leak precluding analysis|1|||
154912132|NCT00286156|559099275|FG000|Overall Study|Missed 12 month visit|0|||
154912133|NCT00286156|559099276|FG001|Overall Study|Missed 12 month visit|0|||
154912134|NCT00286156|559099277|FG002|Overall Study|Missed 12 month visit|1|||
154912135|NCT00286156|559099275|FG000|Overall Study|AE: pulmonary embolus|0|||
154912136|NCT00286156|559099276|FG001|Overall Study|AE: pulmonary embolus|1|||
154912137|NCT00286156|559099277|FG002|Overall Study|AE: pulmonary embolus|0|||
154912138|NCT00286156|559099275|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
154912139|NCT00286156|559099276|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
154912140|NCT00286156|559099277|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
154912141|NCT00286156|559099275|FG000|Overall Study|AE: pneumonia|1|||
154912142|NCT00286156|559099276|FG001|Overall Study|AE: pneumonia|0|||
154912143|NCT00286156|559099277|FG002|Overall Study|AE: pneumonia|0|||
154912144|NCT01072500|559099280|FG000|Overall Study|Death|2|||
154912145|NCT01072500|559099281|FG001|Overall Study|Death|2|||
154912146|NCT01072500|559099280|FG000|Overall Study|Lost to Follow-up|5|||
154912147|NCT01072500|559099281|FG001|Overall Study|Lost to Follow-up|2|||
154912148|NCT01072500|559099280|FG000|Overall Study|Withdrawal by Subject|17|||
154912149|NCT01072500|559099281|FG001|Overall Study|Withdrawal by Subject|10|||
154912150|NCT01836549|559099282|FG000|Overall Study|Did not receive study drug|0|||
154912151|NCT01836549|559099283|FG001|Overall Study|Did not receive study drug|0|||
154912152|NCT01836549|559099284|FG002|Overall Study|Did not receive study drug|1|||
154912153|NCT01836549|559099285|FG003|Overall Study|Did not receive study drug|0|||
154912154|NCT01836549|559099286|FG004|Overall Study|Did not receive study drug|0|||
154912155|NCT01836549|559099287|FG005|Overall Study|Did not receive study drug|0|||
154912156|NCT01836549|559099288|FG006|Overall Study|Did not receive study drug|0|||
154912157|NCT01836549|559099282|FG000|Overall Study|Patient declared ineligible|0|||
154912158|NCT01836549|559099283|FG001|Overall Study|Patient declared ineligible|0|||
154912159|NCT01836549|559099284|FG002|Overall Study|Patient declared ineligible|0|||
154912160|NCT01836549|559099285|FG003|Overall Study|Patient declared ineligible|1|||
154912161|NCT01836549|559099286|FG004|Overall Study|Patient declared ineligible|0|||
154912162|NCT01836549|559099287|FG005|Overall Study|Patient declared ineligible|0|||
154912163|NCT01836549|559099288|FG006|Overall Study|Patient declared ineligible|0|||
154912164|NCT01836549|559099282|FG000|Overall Study|Patient inevaluable to start therapy|0|||
154912165|NCT01836549|559099283|FG001|Overall Study|Patient inevaluable to start therapy|0|||
154912166|NCT01836549|559099284|FG002|Overall Study|Patient inevaluable to start therapy|0|||
154912167|NCT01836549|559099285|FG003|Overall Study|Patient inevaluable to start therapy|0|||
154912168|NCT01836549|559099286|FG004|Overall Study|Patient inevaluable to start therapy|0|||
154912169|NCT01836549|559099287|FG005|Overall Study|Patient inevaluable to start therapy|0|||
154912170|NCT01836549|559099288|FG006|Overall Study|Patient inevaluable to start therapy|1|||
154912171|NCT04652102|559099289|FG000|Overall Study|Adverse Event|14|||
154912172|NCT04652102|559099290|FG001|Overall Study|Adverse Event|13|||
154912173|NCT04652102|559099289|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
154912174|NCT04652102|559099290|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
154912175|NCT04652102|559099289|FG000|Overall Study|Physician Decision|78|||
154912176|NCT04652102|559099290|FG001|Overall Study|Physician Decision|40|||
154912177|NCT04652102|559099289|FG000|Overall Study|Study Ended by Sponsor|64|||
154912178|NCT04652102|559099290|FG001|Overall Study|Study Ended by Sponsor|17|||
154912179|NCT04652102|559099289|FG000|Overall Study|Withdrawal by Subject|4625|||
154912180|NCT04652102|559099290|FG001|Overall Study|Withdrawal by Subject|5594|||
154912181|NCT04652102|559099289|FG000|Overall Study|Lost to Follow-up|2019|||
154912182|NCT04652102|559099290|FG001|Overall Study|Lost to Follow-up|1082|||
154912183|NCT04652102|559099289|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
154912184|NCT04652102|559099290|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
154912185|NCT04652102|559099289|FG000|Overall Study|Miscellaneous|80|||
154912186|NCT04652102|559099290|FG001|Overall Study|Miscellaneous|64|||
154912187|NCT02192190|559099293|FG000|Overall Study|Adverse Event|1|||
154912188|NCT02192190|559099294|FG001|Overall Study|Adverse Event|1|||
154912189|NCT02192190|559099295|FG002|Overall Study|Adverse Event|0|||
154912190|NCT02192190|559099296|FG003|Overall Study|Adverse Event|0|||
154912191|NCT02192190|559099297|FG004|Overall Study|Adverse Event|0|||
154912192|NCT02192190|559099298|FG005|Overall Study|Adverse Event|0|||
154912193|NCT02192190|559099293|FG000|Overall Study|Lost to Follow-up|3|||
154912194|NCT02192190|559099294|FG001|Overall Study|Lost to Follow-up|3|||
154912195|NCT02192190|559099295|FG002|Overall Study|Lost to Follow-up|2|||
154912196|NCT02192190|559099296|FG003|Overall Study|Lost to Follow-up|1|||
154912197|NCT02192190|559099297|FG004|Overall Study|Lost to Follow-up|4|||
154912198|NCT02192190|559099298|FG005|Overall Study|Lost to Follow-up|3|||
154912199|NCT02192190|559099293|FG000|Overall Study|Physician Decision|2|||
154912200|NCT02192190|559099294|FG001|Overall Study|Physician Decision|0|||
154912201|NCT02192190|559099295|FG002|Overall Study|Physician Decision|0|||
154912202|NCT02192190|559099296|FG003|Overall Study|Physician Decision|0|||
154912203|NCT02192190|559099297|FG004|Overall Study|Physician Decision|0|||
154912204|NCT02192190|559099298|FG005|Overall Study|Physician Decision|0|||
154912205|NCT02192190|559099293|FG000|Overall Study|Terminated by Sponsor|43|||
154912206|NCT02192190|559099294|FG001|Overall Study|Terminated by Sponsor|23|||
154912207|NCT02192190|559099295|FG002|Overall Study|Terminated by Sponsor|20|||
154912208|NCT02192190|559099296|FG003|Overall Study|Terminated by Sponsor|23|||
154912209|NCT02192190|559099297|FG004|Overall Study|Terminated by Sponsor|21|||
154912210|NCT02192190|559099298|FG005|Overall Study|Terminated by Sponsor|23|||
154912211|NCT02192190|559099293|FG000|Overall Study|Withdrawal by Subject|4|||
154912212|NCT02192190|559099294|FG001|Overall Study|Withdrawal by Subject|1|||
154912213|NCT02192190|559099295|FG002|Overall Study|Withdrawal by Subject|2|||
154912214|NCT02192190|559099296|FG003|Overall Study|Withdrawal by Subject|1|||
154912215|NCT02192190|559099297|FG004|Overall Study|Withdrawal by Subject|5|||
154912216|NCT02192190|559099298|FG005|Overall Study|Withdrawal by Subject|3|||
154912217|NCT02192190|559099293|FG000|Overall Study|Could not Keep Visit Schedule|1|||
154912218|NCT02192190|559099294|FG001|Overall Study|Could not Keep Visit Schedule|0|||
154912219|NCT02192190|559099295|FG002|Overall Study|Could not Keep Visit Schedule|0|||
154912220|NCT02192190|559099296|FG003|Overall Study|Could not Keep Visit Schedule|0|||
154912221|NCT02192190|559099297|FG004|Overall Study|Could not Keep Visit Schedule|0|||
154912222|NCT02192190|559099298|FG005|Overall Study|Could not Keep Visit Schedule|0|||
154912223|NCT02192190|559099293|FG000|Overall Study|Positive Drug Screen|0|||
154912224|NCT02192190|559099294|FG001|Overall Study|Positive Drug Screen|0|||
154912225|NCT02192190|559099295|FG002|Overall Study|Positive Drug Screen|0|||
155118958|NCT02279719|559868440|FG006|Overall Study|Patients randomized but never treated|3|||
155118959|NCT04706273|559868441|FG000|Overall Study|Withdrawal by Subject|27|||
154912226|NCT02192190|559099296|FG003|Overall Study|Positive Drug Screen|1|||
154912227|NCT02192190|559099297|FG004|Overall Study|Positive Drug Screen|0|||
154912228|NCT02192190|559099298|FG005|Overall Study|Positive Drug Screen|0|||
154912229|NCT02192190|559099293|FG000|Overall Study|Inadequate Pain Relief|0|||
154912230|NCT02192190|559099294|FG001|Overall Study|Inadequate Pain Relief|1|||
154912231|NCT02192190|559099295|FG002|Overall Study|Inadequate Pain Relief|1|||
154912232|NCT02192190|559099296|FG003|Overall Study|Inadequate Pain Relief|0|||
154912233|NCT02192190|559099297|FG004|Overall Study|Inadequate Pain Relief|0|||
154912234|NCT02192190|559099298|FG005|Overall Study|Inadequate Pain Relief|0|||
154912235|NCT02447952|559099299|FG000|Overall Study|Adverse Event|2|||
154912236|NCT02447952|559099299|FG000|Overall Study|Physician Decision|1|||
154912237|NCT02447952|559099299|FG000|Overall Study|Withdrawal by Subject|4|||
154912238|NCT01657253|559099300|FG000|Overall Study|Lost to Follow-up|6|||
154912239|NCT01657253|559099301|FG001|Overall Study|Lost to Follow-up|5|||
154912240|NCT01657253|559099300|FG000|Overall Study|Withdrawal by Subject|11|||
154912241|NCT01657253|559099301|FG001|Overall Study|Withdrawal by Subject|12|||
154912242|NCT01657253|559099300|FG000|Overall Study|Adverse Event|0|||
154912243|NCT01657253|559099301|FG001|Overall Study|Adverse Event|1|||
154912244|NCT00579527|559099302|FG000|Overall Study|Death|4|||
154912245|NCT00203294|559099303|FG000|Overall Study|Withdrawal by Subject|8|||
154912246|NCT00203294|559099304|FG001|Overall Study|Withdrawal by Subject|13|||
154912247|NCT02405091|559099306|FG000|Overall Study|Adverse Event|16|||
154912248|NCT02405091|559099307|FG001|Overall Study|Adverse Event|10|||
154912249|NCT02405091|559099308|FG002|Overall Study|Adverse Event|0|||
154912250|NCT02405091|559099306|FG000|Overall Study|Protocol Violation|1|||
154912251|NCT02405091|559099307|FG001|Overall Study|Protocol Violation|0|||
154912252|NCT02405091|559099308|FG002|Overall Study|Protocol Violation|0|||
154912253|NCT02405091|559099306|FG000|Overall Study|Noncompliance|1|||
154912254|NCT02405091|559099307|FG001|Overall Study|Noncompliance|6|||
154912255|NCT02405091|559099308|FG002|Overall Study|Noncompliance|2|||
154912256|NCT02405091|559099306|FG000|Overall Study|Withdrawal by Subject|4|||
154912257|NCT02405091|559099307|FG001|Overall Study|Withdrawal by Subject|8|||
154912258|NCT02405091|559099308|FG002|Overall Study|Withdrawal by Subject|0|||
154912259|NCT02405091|559099306|FG000|Overall Study|Death|0|||
154912260|NCT02405091|559099307|FG001|Overall Study|Death|1|||
154912261|NCT02405091|559099308|FG002|Overall Study|Death|0|||
154912262|NCT02405091|559099306|FG000|Overall Study|Lost to Follow-up|5|||
154912263|NCT02405091|559099307|FG001|Overall Study|Lost to Follow-up|6|||
154912264|NCT02405091|559099308|FG002|Overall Study|Lost to Follow-up|0|||
154912265|NCT02405091|559099306|FG000|Overall Study|Physician Decision|2|||
154912266|NCT02405091|559099307|FG001|Overall Study|Physician Decision|2|||
154912267|NCT02405091|559099308|FG002|Overall Study|Physician Decision|0|||
154912268|NCT01948791|559099315|FG000|Overall Study|Adverse Event|12|||
154912269|NCT01948791|559099315|FG000|Overall Study|Lack of Efficacy|3|||
154912270|NCT01948791|559099315|FG000|Overall Study|Protocol Violation|2|||
154912271|NCT01948791|559099315|FG000|Overall Study|Withdrawal by Subject|5|||
154912272|NCT01948791|559099315|FG000|Overall Study|Lost to Follow-up|6|||
154912273|NCT01948791|559099315|FG000|Overall Study|Management issues|1|||
154912274|NCT01948791|559099315|FG000|Overall Study|Others|7|||
154912275|NCT01948791|559099315|FG000|Overall Study|Screening failure|35|||
154912276|NCT00135694|559099321|FG000|Overall Study|Adverse Event|17|||
154912277|NCT00135694|559099322|FG001|Overall Study|Adverse Event|4|||
154912278|NCT00135694|559099323|FG002|Overall Study|Adverse Event|0|||
154912279|NCT00135694|559099321|FG000|Overall Study|Death|14|||
154912280|NCT00135694|559099322|FG001|Overall Study|Death|1|||
154912281|NCT00135694|559099323|FG002|Overall Study|Death|2|||
154912282|NCT00135694|559099321|FG000|Overall Study|Lost to Follow-up|8|||
154912283|NCT00135694|559099322|FG001|Overall Study|Lost to Follow-up|7|||
154912284|NCT00135694|559099323|FG002|Overall Study|Lost to Follow-up|1|||
154912285|NCT00135694|559099321|FG000|Overall Study|Withdrawal by Subject|41|||
154912286|NCT00135694|559099322|FG001|Overall Study|Withdrawal by Subject|7|||
154912287|NCT00135694|559099323|FG002|Overall Study|Withdrawal by Subject|4|||
154912288|NCT00135694|559099321|FG000|Overall Study|Protocol Violation|19|||
154912289|NCT00135694|559099322|FG001|Overall Study|Protocol Violation|1|||
154912290|NCT00135694|559099323|FG002|Overall Study|Protocol Violation|0|||
154912291|NCT00135694|559099321|FG000|Overall Study|Hepatitis C related reasons|39|||
154912292|NCT00135694|559099322|FG001|Overall Study|Hepatitis C related reasons|1|||
154912293|NCT00135694|559099323|FG002|Overall Study|Hepatitis C related reasons|0|||
154912294|NCT00135694|559099321|FG000|Overall Study|Ineligible for Random assignment|42|||
154912295|NCT00135694|559099322|FG001|Overall Study|Ineligible for Random assignment|0|||
154912296|NCT00135694|559099323|FG002|Overall Study|Ineligible for Random assignment|0|||
154912297|NCT02584660|559099324|FG000|Overall Study|Adverse Event|4|||
155118960|NCT04706273|559868441|FG000|Overall Study|Physician Decision|1|||
155118961|NCT04706273|559868441|FG000|Overall Study|Lost to Follow-up|42|||
155118962|NCT04706273|559868441|FG000|Overall Study|Death|85|||
155118963|NCT04706273|559868441|FG000|Overall Study|Amputation that removes study device|2|||
155118964|NCT04706273|559868441|FG000|Overall Study|Surgical bypass|3|||
154912298|NCT02584660|559099325|FG001|Overall Study|Adverse Event|0|||
154912299|NCT02584660|559099324|FG000|Overall Study|Lost to Follow-up|3|||
154912300|NCT02584660|559099325|FG001|Overall Study|Lost to Follow-up|4|||
154912301|NCT02584660|559099324|FG000|Overall Study|Protocol Violation|0|||
154912302|NCT02584660|559099325|FG001|Overall Study|Protocol Violation|1|||
154912303|NCT02584660|559099324|FG000|Overall Study|Withdrawal by Subject|0|||
154912304|NCT02584660|559099325|FG001|Overall Study|Withdrawal by Subject|2|||
154912305|NCT02584660|559099324|FG000|Overall Study|Other|0|||
154912306|NCT02584660|559099325|FG001|Overall Study|Other|1|||
154912307|NCT00660816|559099326|FG000|Overall Study|Adverse Event|1|||
154912308|NCT00660816|559099327|FG001|Overall Study|Adverse Event|2|||
154912309|NCT00660816|559099326|FG000|Overall Study|Withdrawal by Subject|1|||
154912310|NCT00660816|559099327|FG001|Overall Study|Withdrawal by Subject|0|||
154912311|NCT00660816|559099326|FG000|Overall Study|Death|0|||
154912312|NCT00660816|559099327|FG001|Overall Study|Death|2|||
154912313|NCT00660816|559099326|FG000|Overall Study|Lack of Efficacy|1|||
155118965|NCT04706273|559868441|FG000|Overall Study|Changing hospital|23|||
155118966|NCT04706273|559868441|FG000|Overall Study|Unable to attend hospital|2|||
154912314|NCT00660816|559099327|FG001|Overall Study|Lack of Efficacy|0|||
154912315|NCT00660816|559099326|FG000|Overall Study|Physician Decision|0|||
154912316|NCT00660816|559099327|FG001|Overall Study|Physician Decision|2|||
154912317|NCT00660816|559099326|FG000|Overall Study|Protocol Violation|1|||
154912318|NCT00660816|559099327|FG001|Overall Study|Protocol Violation|0|||
154912319|NCT00660816|559099326|FG000|Overall Study|Disease Progression|16|||
154912320|NCT00660816|559099327|FG001|Overall Study|Disease Progression|12|||
154912321|NCT00660816|559099326|FG000|Overall Study|Complicating Disease|0|||
154912322|NCT00660816|559099327|FG001|Overall Study|Complicating Disease|1|||
154912323|NCT00374452|559099328|FG000|Overall Study|Left clinic before intervention started|4|||
154912324|NCT00374452|559099329|FG001|Overall Study|Left clinic before intervention started|1|||
154912325|NCT00374452|559099328|FG000|Overall Study|Change in job role before intervention|0|||
154912326|NCT00374452|559099329|FG001|Overall Study|Change in job role before intervention|1|||
154912327|NCT00374452|559099328|FG000|Overall Study|Left clinic after intervention started|1|||
154912328|NCT00374452|559099329|FG001|Overall Study|Left clinic after intervention started|1|||
154912329|NCT00374452|559099328|FG000|Overall Study|Withdrawal by Subject|0|||
154912330|NCT00374452|559099329|FG001|Overall Study|Withdrawal by Subject|2|||
154912331|NCT02583711|559099332|FG000|Overall Study|Withdrawal by Subject|0|||
154912332|NCT02583711|559099333|FG001|Overall Study|Withdrawal by Subject|10|||
154912333|NCT02583711|559099334|FG002|Overall Study|Withdrawal by Subject|0|||
154912334|NCT01012037|559099335|FG000|Overall Study|Adverse Event|0|||
154912335|NCT01012037|559099336|FG001|Overall Study|Adverse Event|8|||
154912336|NCT01012037|559099337|FG002|Overall Study|Adverse Event|3|||
154912337|NCT01012037|559099335|FG000|Overall Study|Protocol Violation|0|||
154912338|NCT01012037|559099336|FG001|Overall Study|Protocol Violation|3|||
154912339|NCT01012037|559099337|FG002|Overall Study|Protocol Violation|5|||
154912340|NCT01012037|559099335|FG000|Overall Study|Withdrawal by Subject|0|||
154912341|NCT01012037|559099336|FG001|Overall Study|Withdrawal by Subject|4|||
154912342|NCT01012037|559099337|FG002|Overall Study|Withdrawal by Subject|1|||
154912343|NCT01012037|559099335|FG000|Overall Study|Other reason (not specified)|1|||
154912344|NCT01012037|559099336|FG001|Overall Study|Other reason (not specified)|1|||
154912345|NCT01012037|559099337|FG002|Overall Study|Other reason (not specified)|1|||
154912346|NCT00542425|559099343|FG000|Initial 24 Weeks|Administrative reasons|0|||
154912347|NCT00542425|559099344|FG001|Initial 24 Weeks|Administrative reasons|0|||
154912348|NCT00542425|559099345|FG002|Initial 24 Weeks|Administrative reasons|1|||
154912349|NCT00542425|559099346|FG003|Initial 24 Weeks|Administrative reasons|1|||
154912350|NCT00542425|559099347|FG004|Initial 24 Weeks|Administrative reasons|0|||
154912351|NCT00542425|559099343|FG000|Initial 24 Weeks|Adverse Event|0|||
154912352|NCT00542425|559099344|FG001|Initial 24 Weeks|Adverse Event|1|||
154912353|NCT00542425|559099345|FG002|Initial 24 Weeks|Adverse Event|1|||
154912354|NCT00542425|559099346|FG003|Initial 24 Weeks|Adverse Event|3|||
154912355|NCT00542425|559099347|FG004|Initial 24 Weeks|Adverse Event|2|||
154912356|NCT00542425|559099343|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
154912357|NCT00542425|559099344|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
154912358|NCT00542425|559099345|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
154912359|NCT00542425|559099346|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
154912360|NCT00542425|559099347|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
154912361|NCT00542425|559099343|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
154912362|NCT00542425|559099344|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
154912363|NCT00542425|559099345|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
154912364|NCT00542425|559099346|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
154912365|NCT00542425|559099347|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
154912366|NCT00542425|559099343|FG000|Initial 24 Weeks|Non-compliance|0|||
154912367|NCT00542425|559099344|FG001|Initial 24 Weeks|Non-compliance|0|||
154912368|NCT00542425|559099345|FG002|Initial 24 Weeks|Non-compliance|0|||
154912369|NCT00542425|559099346|FG003|Initial 24 Weeks|Non-compliance|1|||
154912370|NCT00542425|559099347|FG004|Initial 24 Weeks|Non-compliance|1|||
154912371|NCT00542425|559099343|FG000|Initial 24 Weeks|Protocol Violation|0|||
154912372|NCT00542425|559099344|FG001|Initial 24 Weeks|Protocol Violation|0|||
154912373|NCT00542425|559099345|FG002|Initial 24 Weeks|Protocol Violation|0|||
154912374|NCT00542425|559099346|FG003|Initial 24 Weeks|Protocol Violation|1|||
155118967|NCT03541187|559868444|FG000|Overall Study|Lost to Follow-up|2|||
154912375|NCT00542425|559099347|FG004|Initial 24 Weeks|Protocol Violation|0|||
154912376|NCT00542425|559099343|FG000|Initial 24 Weeks|Refusal of treatment|2|||
154912377|NCT00542425|559099344|FG001|Initial 24 Weeks|Refusal of treatment|2|||
154912378|NCT00542425|559099345|FG002|Initial 24 Weeks|Refusal of treatment|1|||
154912379|NCT00542425|559099346|FG003|Initial 24 Weeks|Refusal of treatment|4|||
154912380|NCT00542425|559099347|FG004|Initial 24 Weeks|Refusal of treatment|1|||
154912381|NCT00542425|559099343|FG000|Initial 24 Weeks|Other|0|||
154912382|NCT00542425|559099344|FG001|Initial 24 Weeks|Other|2|||
154912383|NCT00542425|559099345|FG002|Initial 24 Weeks|Other|1|||
154912384|NCT00542425|559099346|FG003|Initial 24 Weeks|Other|0|||
154912385|NCT00542425|559099347|FG004|Initial 24 Weeks|Other|0|||
154912386|NCT00542425|559099343|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
154912387|NCT00542425|559099344|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
154912388|NCT00542425|559099345|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
154912389|NCT00542425|559099346|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
154912390|NCT00542425|559099347|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
154912391|NCT00542425|559099343|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
154912392|NCT00542425|559099344|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
154912393|NCT00542425|559099345|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
154912394|NCT00542425|559099346|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
154912395|NCT00542425|559099347|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
154912396|NCT00542425|559099343|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
154912397|NCT00542425|559099344|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
154912398|NCT00542425|559099345|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
154912399|NCT00542425|559099346|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
154912400|NCT00542425|559099347|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
154912401|NCT00542425|559099343|FG000|Extended 24 Weeks of Treatment|Other|1|||
154912402|NCT00542425|559099344|FG001|Extended 24 Weeks of Treatment|Other|1|||
154912403|NCT00542425|559099345|FG002|Extended 24 Weeks of Treatment|Other|0|||
154912404|NCT00542425|559099346|FG003|Extended 24 Weeks of Treatment|Other|0|||
154912405|NCT00542425|559099347|FG004|Extended 24 Weeks of Treatment|Other|1|||
154912406|NCT00472043|559099348|FG000|Overall Study|Withdrawal by Subject|1|||
154912407|NCT00472043|559099349|FG001|Overall Study|Withdrawal by Subject|0|||
154912408|NCT00472043|559099348|FG000|Overall Study|Death|1|||
154912409|NCT00472043|559099349|FG001|Overall Study|Death|0|||
154912410|NCT03032523|559099352|FG000|Overall Study|Withdrawal by Subject|2|||
154912411|NCT03032523|559099353|FG001|Overall Study|Withdrawal by Subject|2|||
154912412|NCT03032523|559099352|FG000|Overall Study|Physician Decision|1|||
154912413|NCT03032523|559099353|FG001|Overall Study|Physician Decision|0|||
154912414|NCT02590406|559099354|FG000|Overall Study|Adverse Event|1|||
154912415|NCT02590406|559099355|FG001|Overall Study|Adverse Event|0|||
154912416|NCT02590406|559099354|FG000|Overall Study|Saturometer malfunction|0|||
154912417|NCT02590406|559099355|FG001|Overall Study|Saturometer malfunction|1|||
154912418|NCT05375838|559099356|FG000|Overall Study|Other|0|||
154912419|NCT05375838|559099357|FG001|Overall Study|Other|0|||
154912420|NCT05375838|559099358|FG002|Overall Study|Other|0|||
154912421|NCT05375838|559099359|FG003|Overall Study|Other|1|||
154912422|NCT05375838|559099360|FG004|Overall Study|Other|1|||
154912423|NCT05375838|559099361|FG005|Overall Study|Other|0|||
154912424|NCT05375838|559099356|FG000|Overall Study|Withdrawal by Subject|2|||
154912425|NCT05375838|559099357|FG001|Overall Study|Withdrawal by Subject|1|||
154912426|NCT05375838|559099358|FG002|Overall Study|Withdrawal by Subject|3|||
154912427|NCT05375838|559099359|FG003|Overall Study|Withdrawal by Subject|2|||
154912428|NCT05375838|559099360|FG004|Overall Study|Withdrawal by Subject|2|||
154912429|NCT05375838|559099361|FG005|Overall Study|Withdrawal by Subject|0|||
155118968|NCT03541187|559868445|FG001|Overall Study|Lost to Follow-up|6|||
155118969|NCT03541187|559868444|FG000|Overall Study|Pregnancy|0|||
154912430|NCT05375838|559099356|FG000|Overall Study|Protocol Violation|0|||
154912431|NCT05375838|559099357|FG001|Overall Study|Protocol Violation|0|||
154912432|NCT05375838|559099358|FG002|Overall Study|Protocol Violation|0|||
154912433|NCT05375838|559099359|FG003|Overall Study|Protocol Violation|0|||
154912434|NCT05375838|559099360|FG004|Overall Study|Protocol Violation|1|||
154912435|NCT05375838|559099361|FG005|Overall Study|Protocol Violation|0|||
154912436|NCT05375838|559099356|FG000|Overall Study|Physician Decision|0|||
154912437|NCT05375838|559099357|FG001|Overall Study|Physician Decision|1|||
154912438|NCT05375838|559099358|FG002|Overall Study|Physician Decision|0|||
154912439|NCT05375838|559099359|FG003|Overall Study|Physician Decision|0|||
154912440|NCT05375838|559099360|FG004|Overall Study|Physician Decision|0|||
154912441|NCT05375838|559099361|FG005|Overall Study|Physician Decision|1|||
154912442|NCT05375838|559099356|FG000|Overall Study|Lost to Follow-up|2|||
154912443|NCT05375838|559099357|FG001|Overall Study|Lost to Follow-up|7|||
154912444|NCT05375838|559099358|FG002|Overall Study|Lost to Follow-up|0|||
154912445|NCT05375838|559099359|FG003|Overall Study|Lost to Follow-up|4|||
154912446|NCT05375838|559099360|FG004|Overall Study|Lost to Follow-up|2|||
154912447|NCT05375838|559099361|FG005|Overall Study|Lost to Follow-up|3|||
154912448|NCT00957723|559099362|FG000|Overall Study|Death|3|||
154912449|NCT00957723|559099362|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
154912450|NCT00957723|559099362|FG000|Overall Study|Lost to Follow-up|8|||
154912451|NCT00957723|559099362|FG000|Overall Study|Withdrawal by Subject|24|||
154912452|NCT00957723|559099362|FG000|Overall Study|Investigative Site Terminated|61|||
154912453|NCT00957723|559099362|FG000|Overall Study|Intercurrent Illness|2|||
154912454|NCT00957723|559099362|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
154912455|NCT02178592|559099363|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
154912456|NCT02178592|559099364|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
154912457|NCT02178592|559099363|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
154912458|NCT02178592|559099364|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
154912459|NCT02178592|559099363|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
154912460|NCT02178592|559099364|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
154912461|NCT02178592|559099363|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
154912462|NCT02178592|559099364|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
154912463|NCT02178592|559099363|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
154912464|NCT02178592|559099364|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
154912465|NCT02178592|559099363|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
154912466|NCT02178592|559099364|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
154912467|NCT02178592|559099363|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
154912468|NCT02178592|559099364|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
154912469|NCT02178592|559099363|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
154912470|NCT02178592|559099364|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
154912471|NCT02178592|559099363|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
154912472|NCT02178592|559099364|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
154912473|NCT02178592|559099363|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
154912474|NCT02178592|559099364|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
154912475|NCT02178592|559099363|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
154912476|NCT02178592|559099364|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
154912477|NCT02178592|559099363|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
154912478|NCT02178592|559099364|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
154912479|NCT02975206|559099365|FG000|Overall Study|Withdrawal by Subject|14|||
154912480|NCT02975206|559099366|FG001|Overall Study|Withdrawal by Subject|11|||
154912481|NCT02975206|559099367|FG002|Overall Study|Withdrawal by Subject|11|||
154912482|NCT02975206|559099365|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
154912483|NCT02975206|559099366|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
154912484|NCT02975206|559099367|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
154912485|NCT01984294|559099370|FG000|Overall Study|Randomized but Never Treated|0|||
154912486|NCT01984294|559099371|FG001|Overall Study|Randomized but Never Treated|0|||
154912487|NCT01984294|559099372|FG002|Overall Study|Randomized but Never Treated|1|||
154912488|NCT01984294|559099370|FG000|Overall Study|Lack of Efficacy|4|||
154912489|NCT01984294|559099371|FG001|Overall Study|Lack of Efficacy|2|||
154912490|NCT01984294|559099372|FG002|Overall Study|Lack of Efficacy|6|||
154912491|NCT01984294|559099370|FG000|Overall Study|Adverse Event|0|||
154912492|NCT01984294|559099371|FG001|Overall Study|Adverse Event|1|||
154912493|NCT01984294|559099372|FG002|Overall Study|Adverse Event|0|||
154912494|NCT00392210|559099374|FG000|First Voiding Trial|Physician Decision|2|||
154912495|NCT00392210|559099375|FG001|First Voiding Trial|Physician Decision|2|||
154912496|NCT02067104|559099376|FG000|Overall Study|Study termination due to low accrual|4|||
154912497|NCT02067104|559099377|FG001|Overall Study|Study termination due to low accrual|5|||
154912498|NCT02610231|559099378|FG000|Overall Study|Withdrawal by Subject|27|||
154912499|NCT02610231|559099378|FG000|Overall Study|Adverse Event|20|||
154912500|NCT02610231|559099378|FG000|Overall Study|Death|5|||
154912501|NCT02610231|559099378|FG000|Overall Study|Surgery|2|||
154912502|NCT02610231|559099378|FG000|Overall Study|Physician Decision|1|||
154912503|NCT02610231|559099378|FG000|Overall Study|Non Compliance|2|||
154912504|NCT02610231|559099378|FG000|Overall Study|Other|3|||
154912505|NCT01279954|559099386|FG000|Overall Study|Lack of Efficacy|3|||
154912506|NCT01279954|559099387|FG001|Overall Study|Lack of Efficacy|4|||
154912507|NCT02140762|559099388|FG000|Overall Study|Adverse Event|1|||
154912508|NCT02140762|559099389|FG001|Overall Study|Adverse Event|1|||
154912509|NCT02140762|559099388|FG000|Overall Study|Lost to Follow-up|9|||
154912510|NCT02140762|559099389|FG001|Overall Study|Lost to Follow-up|5|||
154912511|NCT02140762|559099388|FG000|Overall Study|Protocol Violation|1|||
154912512|NCT02140762|559099389|FG001|Overall Study|Protocol Violation|1|||
154912513|NCT02140762|559099388|FG000|Overall Study|Withdrawal by Subject|6|||
154912514|NCT02140762|559099389|FG001|Overall Study|Withdrawal by Subject|4|||
154912515|NCT02140762|559099388|FG000|Overall Study|Other|0|||
154912516|NCT02140762|559099389|FG001|Overall Study|Other|1|||
154912517|NCT01711359|559099391|FG000|Treatment Period|Withdrawal by Subject|18|||
154912518|NCT01711359|559099392|FG001|Treatment Period|Withdrawal by Subject|7|||
154912519|NCT01711359|559099393|FG002|Treatment Period|Withdrawal by Subject|13|||
154912520|NCT01711359|559099391|FG000|Treatment Period|Lack of Efficacy|13|||
154912521|NCT01711359|559099392|FG001|Treatment Period|Lack of Efficacy|2|||
154912522|NCT01711359|559099393|FG002|Treatment Period|Lack of Efficacy|2|||
154912523|NCT01711359|559099391|FG000|Treatment Period|Adverse Event|8|||
154912524|NCT01711359|559099392|FG001|Treatment Period|Adverse Event|10|||
154912525|NCT01711359|559099393|FG002|Treatment Period|Adverse Event|24|||
154912526|NCT01711359|559099391|FG000|Treatment Period|Physician Decision|4|||
155118970|NCT03541187|559868445|FG001|Overall Study|Pregnancy|1|||
155118971|NCT03541187|559868444|FG000|Overall Study|Withdrawal by Subject|6|||
154912527|NCT01711359|559099392|FG001|Treatment Period|Physician Decision|3|||
155118972|NCT03541187|559868445|FG001|Overall Study|Withdrawal by Subject|2|||
155118973|NCT03541187|559868444|FG000|Overall Study|Moved out of town|1|||
154912528|NCT01711359|559099393|FG002|Treatment Period|Physician Decision|2|||
154912529|NCT01711359|559099391|FG000|Treatment Period|Death|3|||
154912530|NCT01711359|559099392|FG001|Treatment Period|Death|0|||
154912531|NCT01711359|559099393|FG002|Treatment Period|Death|0|||
154912532|NCT01711359|559099391|FG000|Treatment Period|Entry Criteria Not Met|1|||
154912533|NCT01711359|559099392|FG001|Treatment Period|Entry Criteria Not Met|0|||
154912534|NCT01711359|559099393|FG002|Treatment Period|Entry Criteria Not Met|0|||
154912535|NCT01711359|559099391|FG000|Treatment Period|Sponsor Decision|1|||
154912536|NCT01711359|559099392|FG001|Treatment Period|Sponsor Decision|0|||
154912537|NCT01711359|559099393|FG002|Treatment Period|Sponsor Decision|0|||
155118974|NCT03541187|559868445|FG001|Overall Study|Moved out of town|0|||
155118975|NCT03541187|559868444|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
155118976|NCT03541187|559868445|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
154912538|NCT01711359|559099391|FG000|Treatment Period|Lost to Follow-up|1|||
154912539|NCT01711359|559099392|FG001|Treatment Period|Lost to Follow-up|1|||
154912540|NCT01711359|559099393|FG002|Treatment Period|Lost to Follow-up|1|||
154912541|NCT01711359|559099391|FG000|Treatment Period|Randomized, Not Treated|3|||
154912542|NCT01711359|559099392|FG001|Treatment Period|Randomized, Not Treated|1|||
154912543|NCT01711359|559099393|FG002|Treatment Period|Randomized, Not Treated|0|||
154912544|NCT01385098|559099396|FG000|Overall Study|Adverse Event|10|||
154912545|NCT01385098|559099396|FG000|Overall Study|Lost to Follow-up|4|||
154912546|NCT02698176|559099397|FG000|Overall Study|Progressive disease|4|||
154912547|NCT02698176|559099398|FG001|Overall Study|Progressive disease|3|||
154912548|NCT02698176|559099399|FG002|Overall Study|Progressive disease|1|||
154912549|NCT02698176|559099400|FG003|Overall Study|Progressive disease|0|||
154912550|NCT02698176|559099397|FG000|Overall Study|Adverse Event|2|||
154912551|NCT02698176|559099398|FG001|Overall Study|Adverse Event|0|||
154912552|NCT02698176|559099399|FG002|Overall Study|Adverse Event|0|||
154912553|NCT02698176|559099400|FG003|Overall Study|Adverse Event|0|||
154912554|NCT02698176|559099397|FG000|Overall Study|Clinical progression|3|||
154912555|NCT02698176|559099398|FG001|Overall Study|Clinical progression|0|||
154912556|NCT02698176|559099399|FG002|Overall Study|Clinical progression|0|||
154912557|NCT02698176|559099400|FG003|Overall Study|Clinical progression|0|||
154912558|NCT02449915|559099401|FG000|Overall Study|Exclusion criteria - drug use|1|||
154912559|NCT02449915|559099402|FG001|Overall Study|Exclusion criteria - drug use|0|||
154912560|NCT02449915|559099401|FG000|Overall Study|Withdrawal by Subject|0|||
154912561|NCT02449915|559099402|FG001|Overall Study|Withdrawal by Subject|2|||
154912562|NCT02449915|559099401|FG000|Overall Study|Intraoperative surgical findings|1|||
154912563|NCT02449915|559099402|FG001|Overall Study|Intraoperative surgical findings|1|||
154912564|NCT02449915|559099401|FG000|Overall Study|Abnormal preop lab|0|||
154912565|NCT02449915|559099402|FG001|Overall Study|Abnormal preop lab|1|||
154912566|NCT01021293|559099404|FG000|Overall Study|Serious Adverse Event|2|||
154912567|NCT01021293|559099405|FG001|Overall Study|Serious Adverse Event|1|||
154912568|NCT01021293|559099404|FG000|Overall Study|Adverse Event|2|||
154912569|NCT01021293|559099405|FG001|Overall Study|Adverse Event|1|||
154912570|NCT01021293|559099404|FG000|Overall Study|Withdrawal by Subject|1|||
154912571|NCT01021293|559099405|FG001|Overall Study|Withdrawal by Subject|3|||
154912572|NCT01021293|559099404|FG000|Overall Study|Migrated/moved from study area|6|||
154912573|NCT01021293|559099405|FG001|Overall Study|Migrated/moved from study area|18|||
154912574|NCT01021293|559099404|FG000|Overall Study|Lost to Follow-up|1|||
154912575|NCT01021293|559099405|FG001|Overall Study|Lost to Follow-up|1|||
154912576|NCT01451203|559101009|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
154912577|NCT01451203|559101010|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
154912578|NCT01451203|559101009|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
154912579|NCT01451203|559101010|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
154912580|NCT01451203|559101009|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
154912581|NCT01451203|559101010|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
154912582|NCT01451203|559101009|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
154912583|NCT01451203|559101010|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
154912584|NCT01451203|559101009|FG000|Double-blind Treatment Period|Adverse Event|6|||
154912585|NCT01451203|559101010|FG001|Double-blind Treatment Period|Adverse Event|9|||
154912586|NCT01451203|559101009|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
154912587|NCT01451203|559101010|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
154912588|NCT01451203|559101009|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
154912589|NCT01451203|559101010|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
155118977|NCT03541187|559868444|FG000|Overall Study|Did not meet randomization criteria|1|||
155118978|NCT03541187|559868445|FG001|Overall Study|Did not meet randomization criteria|1|||
154912590|NCT01451203|559101009|FG000|Double-blind Treatment Period|Investigator decision|2|||
154912591|NCT01451203|559101010|FG001|Double-blind Treatment Period|Investigator decision|0|||
154912592|NCT01451203|559101009|FG000|Post-treatment Period|Consent withdrawn|2|||
154912593|NCT01451203|559101010|FG001|Post-treatment Period|Consent withdrawn|4|||
154912594|NCT01451203|559101009|FG000|Post-treatment Period|Lack of Efficacy|12|||
154912595|NCT01451203|559101010|FG001|Post-treatment Period|Lack of Efficacy|28|||
154912596|NCT01451203|559101009|FG000|Post-treatment Period|Adverse Event|0|||
154912597|NCT01451203|559101010|FG001|Post-treatment Period|Adverse Event|1|||
154912598|NCT01451203|559101009|FG000|Post-treatment Period|Investigator decision|0|||
154912599|NCT01451203|559101010|FG001|Post-treatment Period|Investigator decision|1|||
154912600|NCT00626327|559101011|FG000|Overall Study|Withdrawal by Subject|21|||
154912601|NCT00626327|559101012|FG001|Overall Study|Withdrawal by Subject|29|||
154912602|NCT00626327|559101013|FG002|Overall Study|Withdrawal by Subject|30|||
154912603|NCT00626327|559101011|FG000|Overall Study|Adverse Event|1|||
154912604|NCT00626327|559101012|FG001|Overall Study|Adverse Event|0|||
154912605|NCT00626327|559101013|FG002|Overall Study|Adverse Event|0|||
154912606|NCT00626327|559101011|FG000|Overall Study|Lost to Follow-up|24|||
154912607|NCT00626327|559101012|FG001|Overall Study|Lost to Follow-up|21|||
154912608|NCT00626327|559101013|FG002|Overall Study|Lost to Follow-up|23|||
154912609|NCT00626327|559101011|FG000|Overall Study|Inappropriate enrollment|4|||
154912610|NCT00626327|559101012|FG001|Overall Study|Inappropriate enrollment|5|||
154912611|NCT00626327|559101013|FG002|Overall Study|Inappropriate enrollment|3|||
154912612|NCT00626327|559101011|FG000|Overall Study|Administrative Reason|2|||
154912613|NCT00626327|559101012|FG001|Overall Study|Administrative Reason|0|||
154912614|NCT00626327|559101013|FG002|Overall Study|Administrative Reason|6|||
154912615|NCT00626327|559101011|FG000|Overall Study|Protocol Violation|26|||
154912616|NCT00626327|559101012|FG001|Overall Study|Protocol Violation|4|||
154912617|NCT00626327|559101013|FG002|Overall Study|Protocol Violation|26|||
154912618|NCT04235959|559101016|FG000|Overall Study|Protocol Violation|0|||
154912619|NCT04235959|559101017|FG001|Overall Study|Protocol Violation|1|||
154912620|NCT04235959|559101018|FG002|Overall Study|Protocol Violation|0|||
154912621|NCT04235959|559101016|FG000|Overall Study|Adverse Event|1|||
154912622|NCT04235959|559101017|FG001|Overall Study|Adverse Event|0|||
154912623|NCT04235959|559101018|FG002|Overall Study|Adverse Event|0|||
154912624|NCT00125138|559101019|FG000|Overall Study|Adverse Event|1|||
154912625|NCT00125138|559101020|FG001|Overall Study|Adverse Event|0|||
154912626|NCT00125138|559101021|FG002|Overall Study|Adverse Event|3|||
154912627|NCT00125138|559101022|FG003|Overall Study|Adverse Event|2|||
154912628|NCT00125138|559101019|FG000|Overall Study|Withdrawal by Subject|2|||
154912629|NCT00125138|559101020|FG001|Overall Study|Withdrawal by Subject|3|||
154912630|NCT00125138|559101021|FG002|Overall Study|Withdrawal by Subject|1|||
154912631|NCT00125138|559101022|FG003|Overall Study|Withdrawal by Subject|1|||
154912632|NCT00125138|559101019|FG000|Overall Study|Lack of Efficacy|0|||
154912633|NCT00125138|559101020|FG001|Overall Study|Lack of Efficacy|0|||
154912634|NCT00125138|559101021|FG002|Overall Study|Lack of Efficacy|0|||
154912635|NCT00125138|559101022|FG003|Overall Study|Lack of Efficacy|1|||
154912636|NCT00125138|559101019|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
154912637|NCT00125138|559101020|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
154912638|NCT00125138|559101021|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
154912639|NCT00125138|559101022|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
154912640|NCT03228836|559101027|FG000|Overall Study|Adverse Event|3|||
154912641|NCT03228836|559101027|FG000|Overall Study|Withdrawal by Subject|1|||
154912642|NCT03228836|559101027|FG000|Overall Study|Death|1|||
154912643|NCT03228836|559101027|FG000|Overall Study|Physician Decision|1|||
154912644|NCT03228836|559101027|FG000|Overall Study|Disease Progression|7|||
154986042|NCT02595008|559373669|FG001|Overall Study|Enrolled In Error|0|||
154986043|NCT03407118|559373670|FG000|Period 2|Withdrawal by Subject|1|||
154986044|NCT03407118|559373671|FG001|Period 2|Withdrawal by Subject|0|||
154986045|NCT01641133|559373672|FG000|Overall Study|Protocol Violation|0|||
154986046|NCT01641133|559373673|FG001|Overall Study|Protocol Violation|1|||
154986047|NCT01641133|559373674|FG002|Overall Study|Protocol Violation|1|||
154986048|NCT01641133|559373672|FG000|Overall Study|Migrated/moved from study area|5|||
154986049|NCT01641133|559373673|FG001|Overall Study|Migrated/moved from study area|3|||
154986050|NCT01641133|559373674|FG002|Overall Study|Migrated/moved from study area|1|||
154986051|NCT01641133|559373672|FG000|Overall Study|Adverse Event|0|||
154912645|NCT03228836|559101027|FG000|Overall Study|Other|4|||
154912646|NCT00405756|559101029|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
154912647|NCT00405756|559101030|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
154912648|NCT00405756|559101031|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
154912649|NCT00405756|559101029|FG000|Double-blind Treatment|Adverse Event|31|||
154912650|NCT00405756|559101030|FG001|Double-blind Treatment|Adverse Event|27|||
154912651|NCT00405756|559101031|FG002|Double-blind Treatment|Adverse Event|12|||
154912652|NCT00405756|559101029|FG000|Double-blind Treatment|Disease Progression|47|||
154912653|NCT00405756|559101030|FG001|Double-blind Treatment|Disease Progression|81|||
154912654|NCT00405756|559101031|FG002|Double-blind Treatment|Disease Progression|102|||
154912655|NCT00405756|559101029|FG000|Double-blind Treatment|Lack of Efficacy|1|||
154912656|NCT00405756|559101030|FG001|Double-blind Treatment|Lack of Efficacy|4|||
154912657|NCT00405756|559101031|FG002|Double-blind Treatment|Lack of Efficacy|2|||
154912658|NCT00405756|559101029|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
154986052|NCT01641133|559373673|FG001|Overall Study|Adverse Event|0|||
154986053|NCT01641133|559373674|FG002|Overall Study|Adverse Event|1|||
154986054|NCT01641133|559373672|FG000|Overall Study|Withdrawal by Subject|5|||
154912659|NCT00405756|559101030|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
154912660|NCT00405756|559101031|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
154986055|NCT01641133|559373673|FG001|Overall Study|Withdrawal by Subject|3|||
154912661|NCT00405756|559101029|FG000|Double-blind Treatment|Lost to Follow-up|1|||
154912662|NCT00405756|559101030|FG001|Double-blind Treatment|Lost to Follow-up|0|||
154912663|NCT00405756|559101031|FG002|Double-blind Treatment|Lost to Follow-up|0|||
154912664|NCT00405756|559101029|FG000|Double-blind Treatment|Death|4|||
154912665|NCT00405756|559101030|FG001|Double-blind Treatment|Death|4|||
154912666|NCT00405756|559101031|FG002|Double-blind Treatment|Death|4|||
154912667|NCT00405756|559101029|FG000|Double-blind Treatment|Protocol Violation|1|||
154912668|NCT00405756|559101030|FG001|Double-blind Treatment|Protocol Violation|0|||
154912669|NCT00405756|559101031|FG002|Double-blind Treatment|Protocol Violation|2|||
154912670|NCT00405756|559101029|FG000|Double-blind Treatment|Other|7|||
154912671|NCT00405756|559101030|FG001|Double-blind Treatment|Other|4|||
154912672|NCT00405756|559101031|FG002|Double-blind Treatment|Other|4|||
154912673|NCT00405756|559101029|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
154912674|NCT00405756|559101030|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
154912675|NCT00405756|559101031|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
154912676|NCT00405756|559101029|FG000|Open-label Extension|Adverse Event|1|||
154912677|NCT00405756|559101030|FG001|Open-label Extension|Adverse Event|3|||
154912678|NCT00405756|559101031|FG002|Open-label Extension|Adverse Event|7|||
154912679|NCT00405756|559101029|FG000|Open-label Extension|Disease Progression|8|||
154986056|NCT01641133|559373674|FG002|Overall Study|Withdrawal by Subject|3|||
154986057|NCT01641133|559373672|FG000|Overall Study|Lost to Follow-up|0|||
154986058|NCT01641133|559373673|FG001|Overall Study|Lost to Follow-up|2|||
154986059|NCT01641133|559373674|FG002|Overall Study|Lost to Follow-up|2|||
154986060|NCT02220725|559373675|FG000|Overall Study|Lost to Follow-up|0|||
154986061|NCT02220725|559373676|FG001|Overall Study|Lost to Follow-up|0|||
154986062|NCT02220725|559373677|FG002|Overall Study|Lost to Follow-up|0|||
154986063|NCT02220725|559373678|FG003|Overall Study|Lost to Follow-up|1|||
154986064|NCT02220725|559373675|FG000|Overall Study|Withdrawal by Subject|0|||
154986065|NCT02220725|559373676|FG001|Overall Study|Withdrawal by Subject|0|||
154986066|NCT02220725|559373677|FG002|Overall Study|Withdrawal by Subject|0|||
154986067|NCT02220725|559373678|FG003|Overall Study|Withdrawal by Subject|1|||
154986068|NCT03351231|559373679|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
154986069|NCT03351231|559373679|FG000|Combination Therapy Period|Disease progression|2|||
154986070|NCT03351231|559373679|FG000|Combination Therapy Period|Study drug toxicity|1|||
154986071|NCT03351231|559373679|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
154986072|NCT03351231|559373679|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
154986073|NCT03351231|559373679|FG000|Safety Follow-Up Period|Other reason|2|||
154986074|NCT01673698|559373682|FG000|Overall Study|Lost to Follow-up|51|||
154986075|NCT01673698|559373683|FG001|Overall Study|Lost to Follow-up|13|||
154986076|NCT01297322|559373684|FG000|Overall Study|Lost to Follow-up|1|||
154986077|NCT01297322|559373685|FG001|Overall Study|Lost to Follow-up|0|||
154986078|NCT01297322|559373684|FG000|Overall Study|Withdrawal by Subject|0|||
154986079|NCT01297322|559373685|FG001|Overall Study|Withdrawal by Subject|1|||
154986080|NCT01297322|559373684|FG000|Overall Study|Protocol Violation|0|||
154986081|NCT01297322|559373685|FG001|Overall Study|Protocol Violation|3|||
154986082|NCT01111019|559373686|FG000|Overall Study|Withdrew Prematurely|2|||
154986083|NCT01111019|559373686|FG000|Overall Study|Other|1|||
154986084|NCT02013375|559373687|FG000|Overall Study|Did not engraft|1|||
154986085|NCT02013375|559373687|FG000|Overall Study|Did not engraft|1|||
154986086|NCT00712985|559373688|FG000|Overall Study|1 withdrew prior to start of drug|1|||
154986087|NCT00712985|559373688|FG000|Overall Study|1 patient moved out of state|1|||
154986088|NCT00712985|559373688|FG000|Overall Study|Lack of Efficacy|3|||
154986089|NCT02674061|559373689|FG000|Overall Study|Death|229|||
155176213|NCT00528970|560083898|FG000|Overall Study|Other than specified|2|||
154912680|NCT00405756|559101030|FG001|Open-label Extension|Disease Progression|23|||
154986090|NCT02674061|559373690|FG001|Overall Study|Death|77|||
154986091|NCT02674061|559373689|FG000|Overall Study|Lost to Follow-up|3|||
154986092|NCT02674061|559373690|FG001|Overall Study|Lost to Follow-up|3|||
154986093|NCT02674061|559373689|FG000|Overall Study|Withdrawal by Subject|9|||
154986094|NCT02674061|559373690|FG001|Overall Study|Withdrawal by Subject|1|||
154986095|NCT02674061|559373689|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
154986096|NCT02674061|559373690|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
154986097|NCT03334721|559373693|FG000|Overall Study|Withdrawal by Subject|1|||
154986098|NCT03334721|559373694|FG001|Overall Study|Withdrawal by Subject|0|||
154986099|NCT03334721|559373693|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
155176214|NCT00528970|560083899|FG001|Overall Study|Other than specified|3|||
154912681|NCT00405756|559101031|FG002|Open-label Extension|Disease Progression|26|||
154912682|NCT00405756|559101029|FG000|Open-label Extension|Withdrawal by Subject|2|||
154912683|NCT00405756|559101030|FG001|Open-label Extension|Withdrawal by Subject|3|||
154912684|NCT00405756|559101031|FG002|Open-label Extension|Withdrawal by Subject|3|||
154986100|NCT03334721|559373694|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
154986101|NCT01663727|559373695|FG000|Overall Study|Death|161|||
154986102|NCT01663727|559373696|FG001|Overall Study|Death|155|||
154986103|NCT01663727|559373695|FG000|Overall Study|Lost to Follow-up|10|||
154986104|NCT01663727|559373696|FG001|Overall Study|Lost to Follow-up|8|||
154986105|NCT01663727|559373695|FG000|Overall Study|Withdrawal by Subject|18|||
154986106|NCT01663727|559373696|FG001|Overall Study|Withdrawal by Subject|25|||
154986107|NCT01663727|559373695|FG000|Overall Study|Study Terminated|51|||
154986108|NCT01663727|559373696|FG001|Overall Study|Study Terminated|50|||
154986109|NCT01663727|559373695|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
154986110|NCT01663727|559373696|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
154986111|NCT01663727|559373695|FG000|Overall Study|Withdrawal prior to dosing.|1|||
154986112|NCT01663727|559373696|FG001|Overall Study|Withdrawal prior to dosing.|0|||
154986113|NCT01902628|559373697|FG000|Overall Study|Withdrawal of participant's consent|7|||
154986114|NCT01902628|559373697|FG000|Overall Study|Adverse Event|41|||
154986115|NCT01902628|559373697|FG000|Overall Study|Lost to Follow-up|35|||
154986116|NCT01232491|559373698|FG000|Overall Study|Adverse Event|13|||
154986117|NCT01232491|559373699|FG001|Overall Study|Adverse Event|8|||
154986118|NCT01232491|559373698|FG000|Overall Study|Lack of Efficacy|1|||
154986119|NCT01232491|559373699|FG001|Overall Study|Lack of Efficacy|5|||
154986120|NCT01232491|559373698|FG000|Overall Study|Protocol Violation|13|||
154986121|NCT01232491|559373699|FG001|Overall Study|Protocol Violation|11|||
154986122|NCT01232491|559373698|FG000|Overall Study|Withdrawal Criteria|12|||
154986123|NCT01232491|559373699|FG001|Overall Study|Withdrawal Criteria|21|||
154986124|NCT01232491|559373698|FG000|Overall Study|Other|21|||
154986125|NCT01232491|559373699|FG001|Overall Study|Other|18|||
154986126|NCT02932228|559373702|FG000|Overall Study|Death|8|||
154986127|NCT02932228|559373703|FG001|Overall Study|Death|23|||
155118979|NCT03541187|559868444|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
155118980|NCT03541187|559868445|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
155118981|NCT03541187|559868444|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
155118982|NCT03541187|559868445|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
155118983|NCT02701777|559868446|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
155118984|NCT02701777|559868447|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
155118985|NCT02701777|559868448|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
155118986|NCT02701777|559868449|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
155118987|NCT02701777|559868446|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
155118988|NCT02701777|559868447|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
154912685|NCT00405756|559101029|FG000|Open-label Extension|Death|1|||
154912686|NCT00405756|559101030|FG001|Open-label Extension|Death|2|||
154912687|NCT00405756|559101031|FG002|Open-label Extension|Death|4|||
154912688|NCT00405756|559101029|FG000|Open-label Extension|Other|0|||
154912689|NCT00405756|559101030|FG001|Open-label Extension|Other|1|||
154912690|NCT00405756|559101031|FG002|Open-label Extension|Other|7|||
154912691|NCT00405756|559101029|FG000|Follow-up|Ongoing in Follow-up Period|52|||
154912692|NCT00405756|559101030|FG001|Follow-up|Ongoing in Follow-up Period|51|||
154912693|NCT00405756|559101031|FG002|Follow-up|Ongoing in Follow-up Period|60|||
154912694|NCT00405756|559101029|FG000|Follow-up|Death|21|||
154912695|NCT00405756|559101030|FG001|Follow-up|Death|31|||
154912696|NCT00405756|559101031|FG002|Follow-up|Death|24|||
154912697|NCT00405756|559101029|FG000|Follow-up|Lost to Follow-up|2|||
154912698|NCT00405756|559101030|FG001|Follow-up|Lost to Follow-up|8|||
154912699|NCT00405756|559101031|FG002|Follow-up|Lost to Follow-up|4|||
154912700|NCT02870348|559101034|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
154912701|NCT00672139|559101035|FG000|Overall Study|Death|14|||
154912702|NCT00672139|559101036|FG001|Overall Study|Death|23|||
154912703|NCT00672139|559101035|FG000|Overall Study|Withdrawal by Subject|2|||
154912704|NCT00672139|559101036|FG001|Overall Study|Withdrawal by Subject|11|||
154912705|NCT00672139|559101035|FG000|Overall Study|Adverse Event|4|||
154912706|NCT00672139|559101036|FG001|Overall Study|Adverse Event|7|||
154912707|NCT00672139|559101035|FG000|Overall Study|Physician Decision|2|||
154912708|NCT00672139|559101036|FG001|Overall Study|Physician Decision|0|||
154912709|NCT00672139|559101035|FG000|Overall Study|Lack of Efficacy|4|||
154912710|NCT00672139|559101036|FG001|Overall Study|Lack of Efficacy|1|||
154912711|NCT00672139|559101035|FG000|Overall Study|Protocol Violation|1|||
154912712|NCT00672139|559101036|FG001|Overall Study|Protocol Violation|1|||
154912713|NCT00672139|559101035|FG000|Overall Study|hospice discharge, caregiver requests|3|||
154912714|NCT00672139|559101036|FG001|Overall Study|hospice discharge, caregiver requests|2|||
154912715|NCT01051856|559101037|FG000|Overall Study|Withdrawal by Subject|1|||
154912716|NCT01051856|559101038|FG001|Overall Study|Withdrawal by Subject|0|||
154912717|NCT02381795|559101039|FG000|Overall Study|Withdrawal by Subject|1|||
154912718|NCT02381795|559101039|FG000|Overall Study|Study Terminated|2|||
154912719|NCT02176226|559101040|FG000|Overall Study|Lost to Follow-up|3|||
154912720|NCT02176226|559101040|FG000|Overall Study|Withdrew prior to treatment|6|||
154912721|NCT01488994|559101043|FG000|Overall Study|Withdrawal by Subject|0|||
154986128|NCT02932228|559373702|FG000|Overall Study|not eligible upon chart review|2|||
154912722|NCT01488994|559101044|FG001|Overall Study|Withdrawal by Subject|1|||
154986129|NCT02932228|559373703|FG001|Overall Study|not eligible upon chart review|5|||
154912723|NCT02908841|559101045|FG000|Overall Study|Physician Decision|4|||
154912724|NCT02908841|559101046|FG001|Overall Study|Physician Decision|0|||
154986130|NCT02522403|559375166|FG000|Overall Study|Lost to Follow-up|2|||
154986131|NCT02522403|559375167|FG001|Overall Study|Lost to Follow-up|2|||
154986132|NCT02522403|559375166|FG000|Overall Study|Withdrawal by Subject|2|||
154986133|NCT02522403|559375167|FG001|Overall Study|Withdrawal by Subject|4|||
154986134|NCT05142566|559375168|FG000|Overall Study|Protocol Violation|1|||
154986135|NCT00856973|559375169|FG000|Overall Study|Adverse Event|5|||
154986136|NCT00856973|559375170|FG001|Overall Study|Adverse Event|5|||
154986137|NCT00856973|559375171|FG002|Overall Study|Adverse Event|3|||
154986138|NCT00856973|559375169|FG000|Overall Study|Lost to Follow-up|6|||
154986139|NCT00856973|559375170|FG001|Overall Study|Lost to Follow-up|3|||
154986140|NCT00856973|559375171|FG002|Overall Study|Lost to Follow-up|5|||
154986141|NCT00856973|559375169|FG000|Overall Study|Physician Decision|0|||
154986142|NCT00856973|559375170|FG001|Overall Study|Physician Decision|3|||
154986143|NCT00856973|559375171|FG002|Overall Study|Physician Decision|1|||
154986144|NCT00856973|559375169|FG000|Overall Study|Protocol Violation|1|||
154986145|NCT00856973|559375170|FG001|Overall Study|Protocol Violation|2|||
154986146|NCT00856973|559375171|FG002|Overall Study|Protocol Violation|1|||
154986147|NCT00856973|559375169|FG000|Overall Study|Withdrawal by Subject|13|||
154986148|NCT00856973|559375170|FG001|Overall Study|Withdrawal by Subject|16|||
154986149|NCT00856973|559375171|FG002|Overall Study|Withdrawal by Subject|15|||
154986150|NCT00856973|559375169|FG000|Overall Study|Other|11|||
154986151|NCT00856973|559375170|FG001|Overall Study|Other|12|||
154986152|NCT00856973|559375171|FG002|Overall Study|Other|13|||
154986153|NCT00515541|559375174|FG000|Overall Study|Physician Decision|0|||
154986154|NCT00515541|559375175|FG001|Overall Study|Physician Decision|2|||
154986155|NCT00515541|559375176|FG002|Overall Study|Physician Decision|0|||
154986156|NCT00515541|559375177|FG003|Overall Study|Physician Decision|1|||
154986157|NCT00515541|559375174|FG000|Overall Study|No show for appointments|0|||
154986158|NCT00515541|559375175|FG001|Overall Study|No show for appointments|1|||
154986159|NCT00515541|559375176|FG002|Overall Study|No show for appointments|0|||
154986160|NCT00515541|559375177|FG003|Overall Study|No show for appointments|2|||
154986161|NCT00515541|559375174|FG000|Overall Study|Withdrawal by Subject|0|||
154986162|NCT00515541|559375175|FG001|Overall Study|Withdrawal by Subject|2|||
154986163|NCT00515541|559375176|FG002|Overall Study|Withdrawal by Subject|0|||
154986164|NCT00515541|559375177|FG003|Overall Study|Withdrawal by Subject|2|||
154986165|NCT02588950|559375178|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
154986166|NCT02588950|559375179|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
154986167|NCT02588950|559375180|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
154986168|NCT02588950|559375181|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
154986169|NCT02588950|559375178|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
154986170|NCT02588950|559375179|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
154986171|NCT02588950|559375180|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
154986172|NCT02588950|559375181|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
154912725|NCT01117428|559101049|FG000|Overall Study|Lack of Efficacy|1|||
154912726|NCT01117428|559101050|FG001|Overall Study|Lack of Efficacy|0|||
154912727|NCT01117428|559101051|FG002|Overall Study|Lack of Efficacy|0|||
154912728|NCT01117428|559101052|FG003|Overall Study|Lack of Efficacy|0|||
154912729|NCT01117428|559101053|FG004|Overall Study|Lack of Efficacy|0|||
154912730|NCT01117428|559101054|FG005|Overall Study|Lack of Efficacy|0|||
154912731|NCT01117428|559101049|FG000|Overall Study|Adverse Event|4|||
154912732|NCT01117428|559101050|FG001|Overall Study|Adverse Event|0|||
154912733|NCT01117428|559101051|FG002|Overall Study|Adverse Event|0|||
154912734|NCT01117428|559101052|FG003|Overall Study|Adverse Event|0|||
154912735|NCT01117428|559101053|FG004|Overall Study|Adverse Event|1|||
154912736|NCT01117428|559101054|FG005|Overall Study|Adverse Event|2|||
154912737|NCT01117428|559101049|FG000|Overall Study|Death|0|||
154912738|NCT01117428|559101050|FG001|Overall Study|Death|1|||
154912739|NCT01117428|559101051|FG002|Overall Study|Death|2|||
154912740|NCT01117428|559101052|FG003|Overall Study|Death|0|||
154912741|NCT01117428|559101053|FG004|Overall Study|Death|0|||
154912742|NCT01117428|559101054|FG005|Overall Study|Death|1|||
154986173|NCT02072824|559375182|FG000|Overall Study|Insufficient clinical response|1|||
154986174|NCT02072824|559375183|FG001|Overall Study|Insufficient clinical response|0|||
154986175|NCT02072824|559375184|FG002|Overall Study|Insufficient clinical response|1|||
154986176|NCT02072824|559375182|FG000|Overall Study|No longer willing to participate|1|||
154986177|NCT02072824|559375183|FG001|Overall Study|No longer willing to participate|0|||
154912743|NCT01117428|559101049|FG000|Overall Study|Physician Decision|0|||
154912744|NCT01117428|559101050|FG001|Overall Study|Physician Decision|1|||
154912745|NCT01117428|559101051|FG002|Overall Study|Physician Decision|0|||
155118989|NCT02701777|559868448|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
155118990|NCT02701777|559868449|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
155118991|NCT00869050|559868450|FG000|Overall Study|Screen Failure|3|||
154912746|NCT01117428|559101052|FG003|Overall Study|Physician Decision|0|||
154912747|NCT01117428|559101053|FG004|Overall Study|Physician Decision|0|||
154912748|NCT01117428|559101054|FG005|Overall Study|Physician Decision|0|||
154986178|NCT02072824|559375184|FG002|Overall Study|No longer willing to participate|1|||
154986179|NCT02072824|559375182|FG000|Overall Study|Medication error|0|||
154986180|NCT02072824|559375183|FG001|Overall Study|Medication error|1|||
154986181|NCT02072824|559375184|FG002|Overall Study|Medication error|0|||
154986182|NCT02072824|559375182|FG000|Overall Study|Adverse Event|0|||
155176215|NCT00528970|560083900|FG002|Overall Study|Other than specified|3|||
155176216|NCT00528970|560083898|FG000|Overall Study|Protocol Violation|2|||
155176217|NCT00528970|560083899|FG001|Overall Study|Protocol Violation|1|||
155176218|NCT00528970|560083900|FG002|Overall Study|Protocol Violation|4|||
155176219|NCT00528970|560083898|FG000|Overall Study|Lack of Efficacy|0|||
155176220|NCT00528970|560083899|FG001|Overall Study|Lack of Efficacy|0|||
155176221|NCT00528970|560083900|FG002|Overall Study|Lack of Efficacy|1|||
155176222|NCT00528970|560083898|FG000|Overall Study|Withdrawal by Subject|4|||
155176223|NCT00528970|560083899|FG001|Overall Study|Withdrawal by Subject|3|||
155176224|NCT00528970|560083900|FG002|Overall Study|Withdrawal by Subject|5|||
155176225|NCT00528970|560083898|FG000|Overall Study|Randomized but not treated|0|||
155176226|NCT00528970|560083899|FG001|Overall Study|Randomized but not treated|0|||
155176227|NCT00528970|560083900|FG002|Overall Study|Randomized but not treated|1|||
155176228|NCT01009840|560083901|FG000|Overall Study|Lost to Follow-up|1|||
155176229|NCT01009840|560083901|FG000|Overall Study|Adverse Event|4|||
155176230|NCT01009840|560083901|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
155176231|NCT01009840|560083901|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
155176232|NCT01009840|560083901|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
155176233|NCT01011478|560083909|FG000|Overall Study|No follow up data|12|||
155176234|NCT01011478|560083910|FG001|Overall Study|No follow up data|7|||
155176235|NCT04461600|560083911|FG000|Overall Study|Death|6|||
155176236|NCT04461600|560083912|FG001|Overall Study|Death|5|||
155176237|NCT04461600|560083911|FG000|Overall Study|Withdrawal by Subject|0|||
154912749|NCT01117428|559101049|FG000|Overall Study|Withdrawal by Subject|0|||
154912750|NCT01117428|559101050|FG001|Overall Study|Withdrawal by Subject|0|||
154912751|NCT01117428|559101051|FG002|Overall Study|Withdrawal by Subject|1|||
154912752|NCT01117428|559101052|FG003|Overall Study|Withdrawal by Subject|0|||
154912753|NCT01117428|559101053|FG004|Overall Study|Withdrawal by Subject|0|||
154912754|NCT01117428|559101054|FG005|Overall Study|Withdrawal by Subject|0|||
154912755|NCT01117428|559101049|FG000|Overall Study|Progressive disease|15|||
154912756|NCT01117428|559101050|FG001|Overall Study|Progressive disease|27|||
154912757|NCT01117428|559101051|FG002|Overall Study|Progressive disease|10|||
154912758|NCT01117428|559101052|FG003|Overall Study|Progressive disease|12|||
154912759|NCT01117428|559101053|FG004|Overall Study|Progressive disease|16|||
154912760|NCT01117428|559101054|FG005|Overall Study|Progressive disease|17|||
154912761|NCT01038635|559101056|FG000|Overall Study|Disease Progression|2|||
154912762|NCT01038635|559101057|FG001|Overall Study|Disease Progression|0|||
154912763|NCT01038635|559101058|FG002|Overall Study|Disease Progression|0|||
154912764|NCT01038635|559101059|FG003|Overall Study|Disease Progression|0|||
154912765|NCT01038635|559101060|FG004|Overall Study|Disease Progression|0|||
154912766|NCT01038635|559101061|FG005|Overall Study|Disease Progression|0|||
154912767|NCT01038635|559101062|FG006|Overall Study|Disease Progression|1|||
154912768|NCT01038635|559101063|FG007|Overall Study|Disease Progression|4|||
154912769|NCT01038635|559101064|FG008|Overall Study|Disease Progression|0|||
154912770|NCT01038635|559101056|FG000|Overall Study|Death|0|||
154912771|NCT01038635|559101057|FG001|Overall Study|Death|0|||
154912772|NCT01038635|559101058|FG002|Overall Study|Death|0|||
154912773|NCT01038635|559101059|FG003|Overall Study|Death|0|||
154912774|NCT01038635|559101060|FG004|Overall Study|Death|1|||
154912775|NCT01038635|559101061|FG005|Overall Study|Death|0|||
154912776|NCT01038635|559101062|FG006|Overall Study|Death|1|||
154912777|NCT01038635|559101063|FG007|Overall Study|Death|1|||
154912778|NCT01038635|559101064|FG008|Overall Study|Death|2|||
154912779|NCT01227252|559101065|FG000|Overall Study|Sponsor Decision|0|||
154912780|NCT01227252|559101066|FG001|Overall Study|Sponsor Decision|1|||
154912781|NCT01227252|559101067|FG002|Overall Study|Sponsor Decision|0|||
154912782|NCT01227252|559101068|FG003|Overall Study|Sponsor Decision|0|||
154912783|NCT01227252|559101065|FG000|Overall Study|Lost to Follow-up|0|||
154912784|NCT01227252|559101066|FG001|Overall Study|Lost to Follow-up|1|||
154912785|NCT01227252|559101067|FG002|Overall Study|Lost to Follow-up|0|||
154912786|NCT01227252|559101068|FG003|Overall Study|Lost to Follow-up|0|||
154912787|NCT01227252|559101065|FG000|Overall Study|Withdrawal by Subject|0|||
154912788|NCT01227252|559101066|FG001|Overall Study|Withdrawal by Subject|1|||
154912789|NCT01227252|559101067|FG002|Overall Study|Withdrawal by Subject|0|||
154912790|NCT01227252|559101068|FG003|Overall Study|Withdrawal by Subject|0|||
154912791|NCT01034709|559101072|FG000|Overall Study|Protocol Violation|9|||
154912792|NCT01034709|559101073|FG001|Overall Study|Protocol Violation|16|||
154912793|NCT01060150|559101074|FG000|Overall Study|Adverse Event|6|||
154912794|NCT01060150|559101074|FG000|Overall Study|Lost to Follow-up|1|||
154912795|NCT01060150|559101074|FG000|Overall Study|Protocol Violation|6|||
154986183|NCT02072824|559375183|FG001|Overall Study|Adverse Event|0|||
155176238|NCT04461600|560083912|FG001|Overall Study|Withdrawal by Subject|1|||
154912796|NCT01060150|559101074|FG000|Overall Study|Withdrawal by Subject|8|||
154912797|NCT01060150|559101074|FG000|Overall Study|Enrolled, but not treated|2|||
154912798|NCT01970540|559101075|FG000|Overall Study|Non-treatment-related AE|0|||
155176239|NCT02278471|560083916|FG000|Overall Study|Lost to Follow-up|6|||
154912799|NCT01970540|559101076|FG001|Overall Study|Non-treatment-related AE|0|||
154912800|NCT01970540|559101077|FG002|Overall Study|Non-treatment-related AE|1|||
154912801|NCT01970540|559101075|FG000|Overall Study|Progressive disease|55|||
155176240|NCT02278471|560083917|FG001|Overall Study|Lost to Follow-up|15|||
154912802|NCT01970540|559101076|FG001|Overall Study|Progressive disease|23|||
154912803|NCT01970540|559101077|FG002|Overall Study|Progressive disease|10|||
154912804|NCT01970540|559101075|FG000|Overall Study|Treatment delay over protocol|0|||
154912805|NCT01970540|559101076|FG001|Overall Study|Treatment delay over protocol|0|||
154912806|NCT01970540|559101077|FG002|Overall Study|Treatment delay over protocol|1|||
154912807|NCT01970540|559101075|FG000|Overall Study|Physician Decision|7|||
154912808|NCT01970540|559101076|FG001|Overall Study|Physician Decision|2|||
154912809|NCT01970540|559101077|FG002|Overall Study|Physician Decision|0|||
154912810|NCT01970540|559101075|FG000|Overall Study|Clinical progression|0|||
154912811|NCT01970540|559101076|FG001|Overall Study|Clinical progression|1|||
154912812|NCT01970540|559101077|FG002|Overall Study|Clinical progression|1|||
154912813|NCT01970540|559101075|FG000|Overall Study|End of study|2|||
154912814|NCT01970540|559101076|FG001|Overall Study|End of study|0|||
154912815|NCT01970540|559101077|FG002|Overall Study|End of study|2|||
154912816|NCT01970540|559101075|FG000|Overall Study|Adverse Event|0|||
154912817|NCT01970540|559101076|FG001|Overall Study|Adverse Event|2|||
154912818|NCT01970540|559101077|FG002|Overall Study|Adverse Event|1|||
154912819|NCT01970540|559101075|FG000|Overall Study|Treatment-related AE|4|||
154912820|NCT01970540|559101076|FG001|Overall Study|Treatment-related AE|0|||
154912821|NCT01970540|559101077|FG002|Overall Study|Treatment-related AE|2|||
154912822|NCT01970540|559101075|FG000|Overall Study|Withdrawal by Subject|4|||
154912823|NCT01970540|559101076|FG001|Overall Study|Withdrawal by Subject|0|||
154912824|NCT01970540|559101077|FG002|Overall Study|Withdrawal by Subject|1|||
154912825|NCT01970540|559101075|FG000|Overall Study|Clinical deterioration|1|||
154912826|NCT01970540|559101076|FG001|Overall Study|Clinical deterioration|0|||
154912827|NCT01970540|559101077|FG002|Overall Study|Clinical deterioration|0|||
154912828|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Adverse Event|30|||
154912829|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Adverse Event|25|||
154912830|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Adverse Event|23|||
154912831|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Adverse Event|14|||
154912832|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Death|0|||
154912833|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Death|0|||
154912834|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Death|1|||
154912835|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Death|0|||
154912836|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Physician Decision|0|||
155118992|NCT00759356|559868453|FG000|Overall Study|Adverse Event|0|||
155118993|NCT00759356|559868454|FG001|Overall Study|Adverse Event|1|||
155118994|NCT00759356|559868453|FG000|Overall Study|Withdrawal by Subject|0|||
155118995|NCT00759356|559868454|FG001|Overall Study|Withdrawal by Subject|2|||
155118996|NCT00759356|559868453|FG000|Overall Study|Subject was unable to return|1|||
155118997|NCT00759356|559868454|FG001|Overall Study|Subject was unable to return|0|||
155118998|NCT03199053|559868455|FG000|ST Period|Withdrawal by Subject|2|||
155118999|NCT03199053|559868456|FG001|ST Period|Withdrawal by Subject|4|||
155119000|NCT03199053|559868457|FG002|ST Period|Withdrawal by Subject|6|||
155119001|NCT03199053|559868455|FG000|ST Period|Withdrawal by parent/guardian|1|||
155119002|NCT03199053|559868456|FG001|ST Period|Withdrawal by parent/guardian|1|||
155119003|NCT03199053|559868457|FG002|ST Period|Withdrawal by parent/guardian|1|||
155119004|NCT03199053|559868455|FG000|ST Period|Lost to Follow-up|2|||
155119005|NCT03199053|559868456|FG001|ST Period|Lost to Follow-up|0|||
154912837|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Physician Decision|1|||
154912838|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Physician Decision|0|||
154912839|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Physician Decision|1|||
154912840|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
154912841|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
154912842|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
154912843|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
154912844|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Other|6|||
154912845|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Other|1|||
154912846|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Other|0|||
154912847|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Other|2|||
154912848|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
154912849|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
154912850|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
154912851|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
154912852|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
154912853|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
154912854|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
154912855|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
154912856|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
154912857|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
154912858|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
155119006|NCT03199053|559868457|FG002|ST Period|Lost to Follow-up|1|||
155119007|NCT03199053|559868455|FG000|LT Period|Withdrawal by Subject|1|||
155176241|NCT02278471|560083916|FG000|Overall Study|Death|2|||
155176242|NCT02278471|560083917|FG001|Overall Study|Death|2|||
154912859|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
154986184|NCT02072824|559375184|FG002|Overall Study|Adverse Event|1|||
155176243|NCT02278471|560083916|FG000|Overall Study|Withdrawal by Subject|0|||
155176244|NCT02278471|560083917|FG001|Overall Study|Withdrawal by Subject|3|||
154986185|NCT01196078|559375191|FG000|Overall Study|Withdrawal by Subject|3|||
154986186|NCT01196078|559375192|FG001|Overall Study|Withdrawal by Subject|5|||
154986187|NCT01196078|559375191|FG000|Overall Study|Adverse Event|4|||
154986188|NCT01196078|559375192|FG001|Overall Study|Adverse Event|4|||
154986189|NCT01196078|559375191|FG000|Overall Study|Protocol Violation|2|||
154986190|NCT01196078|559375192|FG001|Overall Study|Protocol Violation|1|||
154912860|NCT00242710|559101079|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
154912861|NCT00242710|559101080|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
154912862|NCT00242710|559101081|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
154912863|NCT00242710|559101082|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
154912864|NCT00242710|559101079|FG000|Period Between Core Study and Extension|Adverse Event|2|||
154912865|NCT00242710|559101080|FG001|Period Between Core Study and Extension|Adverse Event|3|||
154912866|NCT00242710|559101081|FG002|Period Between Core Study and Extension|Adverse Event|5|||
154912867|NCT00242710|559101082|FG003|Period Between Core Study and Extension|Adverse Event|2|||
154912868|NCT00242710|559101079|FG000|Period Between Core Study and Extension|Physician Decision|1|||
154912869|NCT00242710|559101080|FG001|Period Between Core Study and Extension|Physician Decision|1|||
154986191|NCT01196078|559375191|FG000|Overall Study|Lack of Efficacy|17|||
154986192|NCT01196078|559375192|FG001|Overall Study|Lack of Efficacy|23|||
154986193|NCT01196078|559375191|FG000|Overall Study|Lost to Follow-up|1|||
154986194|NCT01196078|559375192|FG001|Overall Study|Lost to Follow-up|0|||
154912870|NCT00242710|559101081|FG002|Period Between Core Study and Extension|Physician Decision|0|||
154912871|NCT00242710|559101082|FG003|Period Between Core Study and Extension|Physician Decision|0|||
155119008|NCT03199053|559868456|FG001|LT Period|Withdrawal by Subject|3|||
155119009|NCT03199053|559868457|FG002|LT Period|Withdrawal by Subject|3|||
155119010|NCT03199053|559868455|FG000|LT Period|Withdrawal by parent/guardian|0|||
155119011|NCT03199053|559868456|FG001|LT Period|Withdrawal by parent/guardian|0|||
155119012|NCT03199053|559868457|FG002|LT Period|Withdrawal by parent/guardian|1|||
155119013|NCT03199053|559868455|FG000|LT Period|Lost to Follow-up|0|||
155119014|NCT03199053|559868456|FG001|LT Period|Lost to Follow-up|1|||
155119015|NCT03199053|559868457|FG002|LT Period|Lost to Follow-up|1|||
155119016|NCT03199053|559868455|FG000|LT Period|Miscellaneous|0|||
155119017|NCT03199053|559868456|FG001|LT Period|Miscellaneous|0|||
155119018|NCT03199053|559868457|FG002|LT Period|Miscellaneous|2|||
155119019|NCT03199053|559868455|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
155119020|NCT03199053|559868456|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
155119021|NCT03199053|559868457|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
155119022|NCT03199053|559868455|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
155119023|NCT03199053|559868456|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
155119024|NCT03199053|559868457|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
155119025|NCT03199053|559868455|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
155119026|NCT03199053|559868456|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
155119027|NCT03199053|559868457|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
155119028|NCT03199053|559868455|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
155119029|NCT03199053|559868456|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
155119030|NCT03199053|559868457|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
155119031|NCT02509052|559868467|FG000|Overall Study|Non compliance|0|||
155119032|NCT02509052|559868468|FG001|Overall Study|Non compliance|0|||
155119033|NCT02509052|559868469|FG002|Overall Study|Non compliance|1|||
155119034|NCT01323270|559868470|FG000|Overall Study|Withdrawal by Subject|19|||
155119035|NCT01323270|559868471|FG001|Overall Study|Withdrawal by Subject|10|||
155119036|NCT01323270|559868470|FG000|Overall Study|Protocol Violation|9|||
154912872|NCT00242710|559101079|FG000|Period Between Core Study and Extension|Other|24|||
154912873|NCT00242710|559101080|FG001|Period Between Core Study and Extension|Other|24|||
154986195|NCT01196078|559375191|FG000|Overall Study|Death|6|||
154986196|NCT01196078|559375192|FG001|Overall Study|Death|4|||
155119037|NCT01323270|559868471|FG001|Overall Study|Protocol Violation|7|||
155119038|NCT01323270|559868470|FG000|Overall Study|Lost to Follow-up|4|||
155119039|NCT01323270|559868471|FG001|Overall Study|Lost to Follow-up|6|||
155119040|NCT01323270|559868470|FG000|Overall Study|Adverse Event|8|||
155119041|NCT01323270|559868471|FG001|Overall Study|Adverse Event|0|||
155176245|NCT01437995|560083920|FG000|Overall Study|Lost to Follow-up|11|||
154986197|NCT02667288|559375193|FG000|Overall Study|Protocol Violation|5|||
155119042|NCT01323270|559868470|FG000|Overall Study|Other|0|||
155119043|NCT01323270|559868471|FG001|Overall Study|Other|3|||
155119044|NCT01323270|559868470|FG000|Overall Study|Physician Decision|0|||
155119045|NCT01323270|559868471|FG001|Overall Study|Physician Decision|2|||
154986198|NCT02667288|559375193|FG000|Overall Study|Lost to Follow-up|3|||
155119046|NCT01323270|559868470|FG000|Overall Study|Not eligible|1|||
155176246|NCT01437995|560083921|FG001|Overall Study|Lost to Follow-up|18|||
154986199|NCT02667288|559375193|FG000|Overall Study|Withdrawal by Subject|5|||
154986200|NCT03921151|559375194|FG000|Overall Study|Withdrawal by Subject|11|||
155119047|NCT01323270|559868471|FG001|Overall Study|Not eligible|1|||
154912874|NCT00242710|559101081|FG002|Period Between Core Study and Extension|Other|9|||
154912875|NCT00242710|559101082|FG003|Period Between Core Study and Extension|Other|11|||
154912876|NCT00242710|559101079|FG000|Period Between Core Study and Extension|Extension not Available|17|||
154912877|NCT00242710|559101080|FG001|Period Between Core Study and Extension|Extension not Available|21|||
154912878|NCT00242710|559101081|FG002|Period Between Core Study and Extension|Extension not Available|8|||
154912879|NCT00242710|559101082|FG003|Period Between Core Study and Extension|Extension not Available|7|||
154912880|NCT00242710|559101079|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
154912881|NCT00242710|559101080|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
154912882|NCT00242710|559101081|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
154912883|NCT00242710|559101082|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
154912884|NCT00242710|559101079|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
154912885|NCT00242710|559101080|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
154912886|NCT00242710|559101081|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
154912887|NCT00242710|559101082|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
154912888|NCT00242710|559101079|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
154986201|NCT03921151|559375195|FG001|Overall Study|Withdrawal by Subject|16|||
154986202|NCT00857792|559375197|FG000|Overall Study|inadequate image quality for analysis|12|||
154986203|NCT03001219|559375201|FG000|Proof of Concept|Study Termination by Sponsor|0|||
154986204|NCT03001219|559375202|FG001|Proof of Concept|Study Termination by Sponsor|1|||
154986205|NCT03001219|559375201|FG000|Proof of Concept|Withdrawal by Subject|0|||
154986206|NCT03001219|559375202|FG001|Proof of Concept|Withdrawal by Subject|4|||
154986207|NCT03001219|559375201|FG000|Proof of Concept|Protocol Deviation|0|||
154986208|NCT03001219|559375202|FG001|Proof of Concept|Protocol Deviation|1|||
154986209|NCT03001219|559375201|FG000|Proof of Concept|Adverse Event|1|||
154986210|NCT03001219|559375202|FG001|Proof of Concept|Adverse Event|1|||
154986211|NCT03001219|559375201|FG000|Proof of Concept|Physician Decision|1|||
154986212|NCT03001219|559375202|FG001|Proof of Concept|Physician Decision|0|||
154986213|NCT03001219|559375201|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
154986214|NCT03001219|559375202|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
154986215|NCT03001219|559375201|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
154986216|NCT03001219|559375202|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
154986217|NCT03001219|559375201|FG000|Extension Period Analysis|Physician Decision|0|||
154986218|NCT03001219|559375202|FG001|Extension Period Analysis|Physician Decision|1|||
155176247|NCT01437995|560083922|FG002|Overall Study|Lost to Follow-up|20|||
155176248|NCT04618770|560083923|FG000|Overall Study|Censored from Analysis|12|||
155176249|NCT04618770|560083923|FG000|Overall Study|Early Termination|25|||
155176250|NCT04391049|560083924|FG000|Overall Study|Protocol Violation|1|||
155176251|NCT03874429|560083925|FG000|Overall Study|Adverse Event|2|||
155176252|NCT03874429|560083926|FG001|Overall Study|Adverse Event|2|||
155176253|NCT03874429|560083925|FG000|Overall Study|Lack of Efficacy|0|||
155176254|NCT03874429|560083926|FG001|Overall Study|Lack of Efficacy|1|||
155176255|NCT03874429|560083925|FG000|Overall Study|Covid-19 pandemic|4|||
155176256|NCT03874429|560083926|FG001|Overall Study|Covid-19 pandemic|2|||
155176257|NCT03337490|560083927|FG000|Overall Study|Withdrawal by Subject|1|||
155176258|NCT03337490|560083928|FG001|Overall Study|Withdrawal by Subject|0|||
155176259|NCT03337490|560083929|FG002|Overall Study|Withdrawal by Subject|0|||
155176260|NCT03337490|560083927|FG000|Overall Study|Lack of Efficacy|10|||
155176261|NCT03337490|560083928|FG001|Overall Study|Lack of Efficacy|12|||
155176262|NCT03337490|560083929|FG002|Overall Study|Lack of Efficacy|35|||
155176263|NCT03337490|560083927|FG000|Overall Study|Physician Decision|0|||
155176264|NCT03337490|560083928|FG001|Overall Study|Physician Decision|1|||
155176265|NCT03337490|560083929|FG002|Overall Study|Physician Decision|0|||
155176266|NCT03337490|560083927|FG000|Overall Study|Lost to Follow-up|0|||
155176267|NCT03337490|560083928|FG001|Overall Study|Lost to Follow-up|1|||
155176268|NCT03337490|560083929|FG002|Overall Study|Lost to Follow-up|0|||
155176269|NCT01689532|560083930|FG000|Overall Study|Adverse Event|9|||
155176270|NCT01689532|560083931|FG001|Overall Study|Adverse Event|5|||
155176271|NCT01689532|560083930|FG000|Overall Study|Lack of Efficacy|2|||
155176272|NCT01689532|560083931|FG001|Overall Study|Lack of Efficacy|2|||
155176273|NCT01689532|560083930|FG000|Overall Study|Withdrawal by Subject|1|||
155176274|NCT01689532|560083931|FG001|Overall Study|Withdrawal by Subject|2|||
154912889|NCT00242710|559101080|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
154912890|NCT00242710|559101081|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
154986219|NCT03001219|559375201|FG000|Extension Period Analysis|Adverse Event|1|||
154986220|NCT03001219|559375202|FG001|Extension Period Analysis|Adverse Event|1|||
155176275|NCT01689532|560083930|FG000|Overall Study|Physician Decision|2|||
155176276|NCT01689532|560083931|FG001|Overall Study|Physician Decision|0|||
155176277|NCT01363349|560083932|FG000|Overall Study|Adverse Event|6|||
155176278|NCT01363349|560083933|FG001|Overall Study|Adverse Event|7|||
155176279|NCT01363349|560083932|FG000|Overall Study|Lack of Efficacy|3|||
155176280|NCT01363349|560083933|FG001|Overall Study|Lack of Efficacy|10|||
155176281|NCT01363349|560083932|FG000|Overall Study|Non compliance/Protocol deviations|2|||
155176282|NCT01363349|560083933|FG001|Overall Study|Non compliance/Protocol deviations|2|||
154986221|NCT03001219|559375201|FG000|Extension Period Analysis|Protocol Deviation|0|||
154986222|NCT03001219|559375202|FG001|Extension Period Analysis|Protocol Deviation|1|||
154986223|NCT03001219|559375201|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
154986224|NCT03001219|559375202|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
154986225|NCT03733210|559375203|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
154986226|NCT03733210|559375204|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
154986227|NCT03760250|559375205|FG000|Overall Study|Withdrawal by Subject|1|||
154986228|NCT03760250|559375205|FG000|Overall Study|Physician Decision|1|||
154986229|NCT04421586|559375215|FG000|Overall Study|Death|0|||
154986230|NCT04421586|559375216|FG001|Overall Study|Death|1|||
154986231|NCT04421586|559375215|FG000|Overall Study|Lost to Follow-up|2|||
154986232|NCT04421586|559375216|FG001|Overall Study|Lost to Follow-up|2|||
154986233|NCT04421586|559375215|FG000|Overall Study|Withdrawn by PI|1|||
154986234|NCT04421586|559375216|FG001|Overall Study|Withdrawn by PI|0|||
154986235|NCT04421586|559375215|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
154912891|NCT00242710|559101082|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
154912892|NCT00242710|559101079|FG000|Study Extension (up to Year 2)|Death|0|||
154986236|NCT04421586|559375216|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
154986237|NCT02963441|559375217|FG000|Overall Study|Protocol violation or withdrawn|8|||
154986238|NCT02963441|559375217|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
154986239|NCT02963441|559375217|FG000|Overall Study|IDx-DR insufficient quality|33|||
154986240|NCT04688931|559375218|FG000|Overall Study|Adverse Event|4|||
154986241|NCT04688931|559375219|FG001|Overall Study|Adverse Event|1|||
154986242|NCT04688931|559375218|FG000|Overall Study|Withdrawal by Subject|5|||
155119048|NCT01323270|559868470|FG000|Overall Study|Death|1|||
154912893|NCT00242710|559101080|FG001|Study Extension (up to Year 2)|Death|0|||
154912894|NCT00242710|559101081|FG002|Study Extension (up to Year 2)|Death|0|||
154912895|NCT00242710|559101082|FG003|Study Extension (up to Year 2)|Death|1|||
154912896|NCT00242710|559101079|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
154912897|NCT00242710|559101080|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
154912898|NCT00242710|559101081|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
154912899|NCT00242710|559101082|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
154912900|NCT00242710|559101079|FG000|Study Extension (up to Year 2)|Other|3|||
154912901|NCT00242710|559101080|FG001|Study Extension (up to Year 2)|Other|5|||
154912902|NCT00242710|559101081|FG002|Study Extension (up to Year 2)|Other|4|||
154912903|NCT00242710|559101082|FG003|Study Extension (up to Year 2)|Other|3|||
154912904|NCT00242710|559101079|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
154912905|NCT00242710|559101080|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
154912906|NCT00242710|559101081|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
154912907|NCT00242710|559101082|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
154912908|NCT00242710|559101079|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
154912909|NCT00242710|559101080|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
154912910|NCT00242710|559101081|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
154912911|NCT00242710|559101082|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
155119049|NCT01323270|559868471|FG001|Overall Study|Death|0|||
155119050|NCT01323270|559868470|FG000|Overall Study|Randomized, but not vaccinated|1|||
155119051|NCT01323270|559868471|FG001|Overall Study|Randomized, but not vaccinated|0|||
155119052|NCT01571284|559868472|FG000|Overall Study|Participant's decision|84|||
155119053|NCT01571284|559868472|FG000|Overall Study|Lost to Follow-up|3|||
155119054|NCT01571284|559868472|FG000|Overall Study|Enrolled but not treated|2|||
155119055|NCT01571284|559868472|FG000|Overall Study|Other than specified above|80|||
155119056|NCT00075725|559868473|FG000|Overall Study|Adverse Event|6|||
155119057|NCT00075725|559868474|FG001|Overall Study|Adverse Event|6|||
155119058|NCT00075725|559868475|FG002|Overall Study|Adverse Event|20|||
155119059|NCT00075725|559868476|FG003|Overall Study|Adverse Event|8|||
155119060|NCT00075725|559868477|FG004|Overall Study|Adverse Event|4|||
155119061|NCT00075725|559868478|FG005|Overall Study|Adverse Event|38|||
155119062|NCT00075725|559868479|FG006|Overall Study|Adverse Event|3|||
155119063|NCT00075725|559868480|FG007|Overall Study|Adverse Event|51|||
155119064|NCT00075725|559868481|FG008|Overall Study|Adverse Event|15|||
155119065|NCT00075725|559868482|FG009|Overall Study|Adverse Event|4|||
155119066|NCT00075725|559868483|FG010|Overall Study|Adverse Event|2|||
154912912|NCT01683058|559101083|FG000|Overall Study|Lost to Follow-up|9|||
154912913|NCT01683058|559101083|FG000|Overall Study|Adverse Event|6|||
154912914|NCT01683058|559101083|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
155119067|NCT00075725|559868484|FG011|Overall Study|Adverse Event|2|||
155119068|NCT00075725|559868473|FG000|Overall Study|Death|3|||
154912915|NCT01683058|559101083|FG000|Overall Study|Withdrawal by Subject|7|||
154912916|NCT01683058|559101083|FG000|Overall Study|Lack of Efficacy|2|||
154986243|NCT04688931|559375219|FG001|Overall Study|Withdrawal by Subject|16|||
155119069|NCT00075725|559868474|FG001|Overall Study|Death|5|||
155119070|NCT00075725|559868475|FG002|Overall Study|Death|10|||
154986244|NCT04688931|559375218|FG000|Overall Study|Physician Decision|3|||
154986245|NCT04688931|559375219|FG001|Overall Study|Physician Decision|5|||
155119071|NCT00075725|559868476|FG003|Overall Study|Death|2|||
155119072|NCT00075725|559868477|FG004|Overall Study|Death|3|||
154986246|NCT04688931|559375218|FG000|Overall Study|Noncompliance|0|||
154986247|NCT04688931|559375219|FG001|Overall Study|Noncompliance|1|||
154986248|NCT04688931|559375218|FG000|Overall Study|Lost to Follow-up|1|||
154986249|NCT04688931|559375219|FG001|Overall Study|Lost to Follow-up|3|||
154986250|NCT04688931|559375218|FG000|Overall Study|Randomization Error|3|||
154986251|NCT04688931|559375219|FG001|Overall Study|Randomization Error|0|||
154986252|NCT04688931|559375218|FG000|Overall Study|Not Eligible|1|||
154986253|NCT04688931|559375219|FG001|Overall Study|Not Eligible|3|||
154986254|NCT04688931|559375218|FG000|Overall Study|Disease Progression|0|||
154986255|NCT04688931|559375219|FG001|Overall Study|Disease Progression|2|||
154986256|NCT04688931|559375218|FG000|Overall Study|Sponsor Requirement|1|||
154986257|NCT04688931|559375219|FG001|Overall Study|Sponsor Requirement|1|||
154986258|NCT04688931|559375218|FG000|Overall Study|Other Reason|1|||
154986259|NCT04688931|559375219|FG001|Overall Study|Other Reason|2|||
154986260|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Adverse Event|9|||
154986261|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Adverse Event|4|||
154986262|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Adverse Event|5|||
154986263|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Adverse Event|9|||
154986264|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Adverse Event|8|||
154986265|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Adverse Event|0|||
154986266|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Adverse Event|0|||
154986267|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
154986268|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
154986269|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
154986270|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
154986271|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
154986272|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
154986273|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
154986274|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Death|1|||
154986275|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Death|1|||
154986276|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Death|1|||
154986277|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Death|1|||
154986278|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Death|0|||
154986279|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Death|0|||
154986280|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Death|0|||
154986281|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
154986282|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
154986283|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
154986284|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
154986285|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
154986286|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
154986287|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
154986288|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
154986289|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
154986290|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
154986291|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
154986292|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
154986293|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
154986294|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
154986295|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
154986296|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
154986297|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
154986298|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
154986299|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
154986300|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
154986301|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
154986302|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Other|2|||
154986303|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Other|9|||
154986304|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Other|9|||
154986305|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Other|3|||
155176283|NCT01363349|560083932|FG000|Overall Study|Withdrawal by Subject|14|||
154986306|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Other|2|||
154986307|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Other|0|||
154986308|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Other|0|||
154986309|NCT00361335|559375220|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
154986310|NCT00361335|559375221|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
154986311|NCT00361335|559375222|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
154986312|NCT00361335|559375223|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
154986313|NCT00361335|559375224|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
154986314|NCT00361335|559375225|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
154986315|NCT00361335|559375226|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
154986316|NCT00361335|559375220|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
154986317|NCT00361335|559375221|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
154986318|NCT00361335|559375222|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
154986319|NCT00361335|559375223|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
154986320|NCT00361335|559375224|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
154986321|NCT00361335|559375225|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
154986322|NCT00361335|559375226|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
154986323|NCT00361335|559375220|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
154986324|NCT00361335|559375221|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
154912917|NCT01057394|559101084|FG000|Overall Study|Not eligible|0|||
154912918|NCT01057394|559101085|FG001|Overall Study|Not eligible|2|||
154986325|NCT00361335|559375222|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
154986326|NCT00361335|559375223|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
154986327|NCT00361335|559375224|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
154986328|NCT00361335|559375225|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
154986329|NCT00361335|559375226|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
154986330|NCT00361335|559375220|FG000|SC Period: Week E0 to Week E24|Death|0|||
154986331|NCT00361335|559375221|FG001|SC Period: Week E0 to Week E24|Death|0|||
154986332|NCT00361335|559375222|FG002|SC Period: Week E0 to Week E24|Death|0|||
154986333|NCT00361335|559375223|FG003|SC Period: Week E0 to Week E24|Death|0|||
154986334|NCT00361335|559375224|FG004|SC Period: Week E0 to Week E24|Death|0|||
154986335|NCT00361335|559375225|FG005|SC Period: Week E0 to Week E24|Death|0|||
154986336|NCT00361335|559375226|FG006|SC Period: Week E0 to Week E24|Death|1|||
154986337|NCT00361335|559375220|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
154986338|NCT00361335|559375221|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
154986339|NCT00361335|559375222|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
154986340|NCT00361335|559375223|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
154986341|NCT00361335|559375224|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
154986342|NCT00361335|559375225|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
154986343|NCT00361335|559375226|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
154986344|NCT00361335|559375220|FG000|SC Period: Week E0 to Week E24|Other|1|||
154986345|NCT00361335|559375221|FG001|SC Period: Week E0 to Week E24|Other|0|||
154986346|NCT00361335|559375222|FG002|SC Period: Week E0 to Week E24|Other|0|||
154986347|NCT00361335|559375223|FG003|SC Period: Week E0 to Week E24|Other|1|||
154986348|NCT00361335|559375224|FG004|SC Period: Week E0 to Week E24|Other|0|||
154986349|NCT00361335|559375225|FG005|SC Period: Week E0 to Week E24|Other|1|||
154986350|NCT00361335|559375226|FG006|SC Period: Week E0 to Week E24|Other|2|||
154986351|NCT00361335|559375220|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
154986352|NCT00361335|559375221|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
154986353|NCT00361335|559375222|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
154986354|NCT00361335|559375223|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
154912919|NCT01195636|559101086|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
154912920|NCT01195636|559101087|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
154912921|NCT01195636|559101086|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
154912922|NCT01195636|559101087|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
154912923|NCT01195636|559101086|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
154912924|NCT01195636|559101087|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
154912925|NCT01195636|559101086|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
154912926|NCT01195636|559101087|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
154912927|NCT01195636|559101086|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
154912928|NCT01195636|559101087|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
154912929|NCT01195636|559101086|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
154912930|NCT01195636|559101087|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
154912931|NCT01195636|559101086|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
154912932|NCT01195636|559101087|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
154912933|NCT01195636|559101086|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
154912934|NCT01195636|559101087|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
154912935|NCT01566981|559101097|FG000|Overall Study|Lost to Follow-up|5|||
154986355|NCT00361335|559375224|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
154986356|NCT00361335|559375225|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
154986357|NCT00361335|559375226|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
154986358|NCT01765582|559375227|FG000|Overall Study|Other|3|||
154986359|NCT01765582|559375228|FG001|Overall Study|Other|6|||
154986360|NCT01765582|559375229|FG002|Overall Study|Other|9|||
154986361|NCT01765582|559375227|FG000|Overall Study|Lost to Follow-up|2|||
154986362|NCT01765582|559375228|FG001|Overall Study|Lost to Follow-up|2|||
154986363|NCT01765582|559375229|FG002|Overall Study|Lost to Follow-up|1|||
154986364|NCT01765582|559375227|FG000|Overall Study|Death|31|||
154986365|NCT01765582|559375228|FG001|Overall Study|Death|36|||
154986366|NCT01765582|559375229|FG002|Overall Study|Death|33|||
154986367|NCT01765582|559375227|FG000|Overall Study|Sponsor Decision|46|||
154986368|NCT01765582|559375228|FG001|Overall Study|Sponsor Decision|42|||
154986369|NCT01765582|559375229|FG002|Overall Study|Sponsor Decision|42|||
154986370|NCT01765582|559375227|FG000|Overall Study|Withdrawal of Consent|11|||
154986371|NCT01765582|559375228|FG001|Overall Study|Withdrawal of Consent|6|||
154986372|NCT01765582|559375229|FG002|Overall Study|Withdrawal of Consent|10|||
154986373|NCT00616941|559375232|FG000|Overall Study|Progressive Disease|1|||
154912936|NCT01566981|559101098|FG001|Overall Study|Lost to Follow-up|8|||
154912937|NCT02177942|559101099|FG000|Overall Study|Adverse Event|1|||
154912938|NCT02177942|559101100|FG001|Overall Study|Adverse Event|0|||
154912939|NCT02177942|559101099|FG000|Overall Study|Lost to Follow-up|1|||
154912940|NCT02177942|559101100|FG001|Overall Study|Lost to Follow-up|1|||
154912941|NCT02177942|559101099|FG000|Overall Study|Protocol Violation|4|||
154912942|NCT02177942|559101100|FG001|Overall Study|Protocol Violation|6|||
154912943|NCT02177942|559101099|FG000|Overall Study|Withdrawal by Subject|71|||
154912944|NCT02177942|559101100|FG001|Overall Study|Withdrawal by Subject|81|||
154912945|NCT01234337|559101106|FG000|Overall Study|Adverse Event|58|||
154912946|NCT01234337|559101107|FG001|Overall Study|Adverse Event|21|||
154912947|NCT01234337|559101106|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
154912948|NCT01234337|559101107|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
154912949|NCT01234337|559101106|FG000|Overall Study|Investi. decision not protocol driven|5|||
154912950|NCT01234337|559101107|FG001|Overall Study|Investi. decision not protocol driven|6|||
154912951|NCT01234337|559101106|FG000|Overall Study|Non-compliant with study medication|3|||
154912952|NCT01234337|559101107|FG001|Overall Study|Non-compliant with study medication|2|||
154912953|NCT01234337|559101106|FG000|Overall Study|Randomized but not treated|6|||
154912954|NCT01234337|559101107|FG001|Overall Study|Randomized but not treated|4|||
154912955|NCT01234337|559101106|FG000|Overall Study|Lost to Follow-up|0|||
154912956|NCT01234337|559101107|FG001|Overall Study|Lost to Follow-up|1|||
154912957|NCT01234337|559101106|FG000|Overall Study|Protocol Violation|2|||
154912958|NCT01234337|559101107|FG001|Overall Study|Protocol Violation|3|||
154912959|NCT01234337|559101106|FG000|Overall Study|Withdrawal by Subject|11|||
154912960|NCT01234337|559101107|FG001|Overall Study|Withdrawal by Subject|9|||
154912961|NCT01234337|559101106|FG000|Overall Study|Death|0|||
154912962|NCT01234337|559101107|FG001|Overall Study|Death|1|||
154912963|NCT01234337|559101106|FG000|Overall Study|Switch to commercial drug|0|||
154912964|NCT01234337|559101107|FG001|Overall Study|Switch to commercial drug|1|||
154912965|NCT00247962|559101114|FG000|Overall Study|Adverse Event|15|||
154912966|NCT00247962|559101115|FG001|Overall Study|Adverse Event|12|||
154912967|NCT00247962|559101114|FG000|Overall Study|Lost to Follow-up|3|||
154912968|NCT00247962|559101115|FG001|Overall Study|Lost to Follow-up|1|||
154912969|NCT00247962|559101114|FG000|Overall Study|Physician Decision|0|||
154912970|NCT00247962|559101115|FG001|Overall Study|Physician Decision|1|||
154912971|NCT00247962|559101114|FG000|Overall Study|Protocol Violation|1|||
154912972|NCT00247962|559101115|FG001|Overall Study|Protocol Violation|1|||
154912973|NCT00247962|559101114|FG000|Overall Study|Withdrawal by Subject|3|||
154912974|NCT00247962|559101115|FG001|Overall Study|Withdrawal by Subject|2|||
154912975|NCT00247962|559101114|FG000|Overall Study|Lack of Efficacy|4|||
154912976|NCT00247962|559101115|FG001|Overall Study|Lack of Efficacy|2|||
154912977|NCT02555722|559101116|FG000|Week 2|Adverse Event|0|||
154912978|NCT02555722|559101117|FG001|Week 2|Adverse Event|1|||
154912979|NCT02555722|559101116|FG000|Week 2|Withdrawal by Subject|1|||
154912980|NCT02555722|559101117|FG001|Week 2|Withdrawal by Subject|0|||
154912981|NCT02555722|559101116|FG000|Month 1|Lens Discomfort|1|||
154912982|NCT02555722|559101117|FG001|Month 1|Lens Discomfort|0|||
154912983|NCT02555722|559101116|FG000|Month 2|Withdrawal by Subject|3|||
154912984|NCT02555722|559101117|FG001|Month 2|Withdrawal by Subject|0|||
154912985|NCT02555722|559101116|FG000|Month 2|Lost to Follow-up|1|||
154912986|NCT02555722|559101117|FG001|Month 2|Lost to Follow-up|0|||
154912987|NCT00702949|559101118|FG000|Overall Study|Refusal|3|||
154912988|NCT00702949|559101119|FG001|Overall Study|Refusal|2|||
154912989|NCT00702949|559101120|FG002|Overall Study|Refusal|2|||
154912990|NCT00702949|559101118|FG000|Overall Study|Adverse Event|1|||
154912991|NCT00702949|559101119|FG001|Overall Study|Adverse Event|6|||
154912992|NCT00702949|559101120|FG002|Overall Study|Adverse Event|3|||
154912993|NCT00702949|559101118|FG000|Overall Study|Other Medical Reason/unknown|1|||
154912994|NCT00702949|559101119|FG001|Overall Study|Other Medical Reason/unknown|1|||
154912995|NCT00702949|559101120|FG002|Overall Study|Other Medical Reason/unknown|3|||
154912996|NCT03525613|559101125|FG000|Overall Study|Adverse Event|11|||
154912997|NCT03525613|559101126|FG001|Overall Study|Adverse Event|8|||
154912998|NCT03525613|559101127|FG002|Overall Study|Adverse Event|3|||
154912999|NCT03525613|559101128|FG003|Overall Study|Adverse Event|3|||
154913000|NCT03525613|559101125|FG000|Overall Study|Lost to Follow-up|4|||
154913001|NCT03525613|559101126|FG001|Overall Study|Lost to Follow-up|5|||
154913002|NCT03525613|559101127|FG002|Overall Study|Lost to Follow-up|3|||
154913003|NCT03525613|559101128|FG003|Overall Study|Lost to Follow-up|2|||
154913004|NCT03525613|559101125|FG000|Overall Study|Physician Decision|0|||
154913005|NCT03525613|559101126|FG001|Overall Study|Physician Decision|1|||
154913006|NCT03525613|559101127|FG002|Overall Study|Physician Decision|0|||
154913007|NCT03525613|559101128|FG003|Overall Study|Physician Decision|1|||
154913008|NCT03525613|559101125|FG000|Overall Study|Consent Withdrawal|25|||
154913009|NCT03525613|559101126|FG001|Overall Study|Consent Withdrawal|16|||
154913010|NCT03525613|559101127|FG002|Overall Study|Consent Withdrawal|12|||
154913011|NCT03525613|559101128|FG003|Overall Study|Consent Withdrawal|9|||
154913012|NCT03525613|559101125|FG000|Overall Study|Death|20|||
154913013|NCT03525613|559101126|FG001|Overall Study|Death|9|||
154913014|NCT03525613|559101127|FG002|Overall Study|Death|7|||
154913015|NCT03525613|559101128|FG003|Overall Study|Death|1|||
154913016|NCT03525613|559101125|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
154913017|NCT03525613|559101126|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
154913018|NCT03525613|559101127|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
154913019|NCT03525613|559101128|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
154913020|NCT03480360|559101129|FG000|Overall Study|Death|2|||
154913021|NCT02120469|559101134|FG000|Overall Study|HER-2/neu-amplified|1|||
154913022|NCT02120469|559101135|FG001|Overall Study|HER-2/neu-amplified|0|||
154913023|NCT02120469|559101136|FG002|Overall Study|HER-2/neu-amplified|1|||
154913024|NCT01040728|559101137|FG000|Overall Study|Adverse Event|4|||
154913025|NCT01040728|559101138|FG001|Overall Study|Adverse Event|8|||
154913026|NCT01040728|559101139|FG002|Overall Study|Adverse Event|0|||
154913027|NCT01040728|559101140|FG003|Overall Study|Adverse Event|4|||
154913028|NCT01040728|559101137|FG000|Overall Study|Withdrawal by Subject|0|||
154913029|NCT01040728|559101138|FG001|Overall Study|Withdrawal by Subject|1|||
154913030|NCT01040728|559101139|FG002|Overall Study|Withdrawal by Subject|1|||
154913031|NCT01040728|559101140|FG003|Overall Study|Withdrawal by Subject|0|||
154913032|NCT01040728|559101137|FG000|Overall Study|Protocol Violation|0|||
154913033|NCT01040728|559101138|FG001|Overall Study|Protocol Violation|0|||
154913034|NCT01040728|559101139|FG002|Overall Study|Protocol Violation|0|||
154913035|NCT01040728|559101140|FG003|Overall Study|Protocol Violation|1|||
154913036|NCT01040728|559101137|FG000|Overall Study|Lack of Efficacy|0|||
154913037|NCT01040728|559101138|FG001|Overall Study|Lack of Efficacy|1|||
154913038|NCT01040728|559101139|FG002|Overall Study|Lack of Efficacy|0|||
154913039|NCT01040728|559101140|FG003|Overall Study|Lack of Efficacy|1|||
154913040|NCT01040728|559101137|FG000|Overall Study|Other reasons not listed above|0|||
154913041|NCT01040728|559101138|FG001|Overall Study|Other reasons not listed above|1|||
154913042|NCT01040728|559101139|FG002|Overall Study|Other reasons not listed above|0|||
154913043|NCT01040728|559101140|FG003|Overall Study|Other reasons not listed above|0|||
154913044|NCT00590031|559101142|FG000|Overall Study|Adverse Event|3|||
154913045|NCT00590031|559101142|FG000|Overall Study|Withdrawal by Subject|1|||
154913046|NCT00590031|559101142|FG000|Overall Study|Metastatic Disease|1|||
154913047|NCT00590031|559101142|FG000|Overall Study|Admin Hold|1|||
154913048|NCT03196973|559101143|FG000|Overall Study|Adverse Event|1|||
154913049|NCT03196973|559101144|FG001|Overall Study|Adverse Event|1|||
154913050|NCT03196973|559101145|FG002|Overall Study|Adverse Event|2|||
154913051|NCT03196973|559101143|FG000|Overall Study|Lack of Efficacy|2|||
154913052|NCT03196973|559101144|FG001|Overall Study|Lack of Efficacy|6|||
154913053|NCT03196973|559101145|FG002|Overall Study|Lack of Efficacy|1|||
154913054|NCT03196973|559101143|FG000|Overall Study|Lost to Follow-up|4|||
154913055|NCT03196973|559101144|FG001|Overall Study|Lost to Follow-up|3|||
154913056|NCT03196973|559101145|FG002|Overall Study|Lost to Follow-up|2|||
154913057|NCT03196973|559101143|FG000|Overall Study|Consent withdrawn|2|||
154913058|NCT03196973|559101144|FG001|Overall Study|Consent withdrawn|1|||
154913059|NCT03196973|559101145|FG002|Overall Study|Consent withdrawn|0|||
154913060|NCT03196973|559101143|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
154913061|NCT03196973|559101144|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
154913062|NCT03196973|559101145|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
154913063|NCT01809327|559101146|FG000|Overall Study|Lost to Follow-up|5|||
154913064|NCT01809327|559101147|FG001|Overall Study|Lost to Follow-up|2|||
154913065|NCT01809327|559101148|FG002|Overall Study|Lost to Follow-up|4|||
154913066|NCT01809327|559101149|FG003|Overall Study|Lost to Follow-up|2|||
154913067|NCT01809327|559101150|FG004|Overall Study|Lost to Follow-up|3|||
154913068|NCT01809327|559101146|FG000|Overall Study|Withdrawal by Subject|6|||
154913069|NCT01809327|559101147|FG001|Overall Study|Withdrawal by Subject|4|||
154913070|NCT01809327|559101148|FG002|Overall Study|Withdrawal by Subject|4|||
154913071|NCT01809327|559101149|FG003|Overall Study|Withdrawal by Subject|2|||
154913072|NCT01809327|559101150|FG004|Overall Study|Withdrawal by Subject|5|||
154913073|NCT01809327|559101146|FG000|Overall Study|Adverse Event|4|||
154913074|NCT01809327|559101147|FG001|Overall Study|Adverse Event|3|||
154913075|NCT01809327|559101148|FG002|Overall Study|Adverse Event|7|||
154913076|NCT01809327|559101149|FG003|Overall Study|Adverse Event|4|||
154913077|NCT01809327|559101150|FG004|Overall Study|Adverse Event|8|||
154913078|NCT01809327|559101146|FG000|Overall Study|Death|1|||
154913079|NCT01809327|559101147|FG001|Overall Study|Death|0|||
154913080|NCT01809327|559101148|FG002|Overall Study|Death|0|||
154913081|NCT01809327|559101149|FG003|Overall Study|Death|0|||
154913082|NCT01809327|559101150|FG004|Overall Study|Death|0|||
154913083|NCT01809327|559101146|FG000|Overall Study|Protocol Violation|0|||
154913084|NCT01809327|559101147|FG001|Overall Study|Protocol Violation|1|||
154913085|NCT01809327|559101148|FG002|Overall Study|Protocol Violation|0|||
154913086|NCT01809327|559101149|FG003|Overall Study|Protocol Violation|0|||
154986374|NCT00616941|559375233|FG001|Overall Study|Progressive Disease|2|||
154986375|NCT00616941|559375234|FG002|Overall Study|Progressive Disease|1|||
154913087|NCT01809327|559101150|FG004|Overall Study|Protocol Violation|0|||
154913088|NCT01809327|559101146|FG000|Overall Study|Physician Decision|1|||
154913089|NCT01809327|559101147|FG001|Overall Study|Physician Decision|1|||
154913090|NCT01809327|559101148|FG002|Overall Study|Physician Decision|0|||
154913091|NCT01809327|559101149|FG003|Overall Study|Physician Decision|0|||
154913092|NCT01809327|559101150|FG004|Overall Study|Physician Decision|0|||
154913093|NCT01809327|559101146|FG000|Overall Study|Pregnancy|1|||
154913094|NCT01809327|559101147|FG001|Overall Study|Pregnancy|0|||
154913095|NCT01809327|559101148|FG002|Overall Study|Pregnancy|0|||
154913096|NCT01809327|559101149|FG003|Overall Study|Pregnancy|0|||
154913097|NCT01809327|559101150|FG004|Overall Study|Pregnancy|0|||
154913098|NCT01809327|559101146|FG000|Overall Study|Other|14|||
154913099|NCT01809327|559101147|FG001|Overall Study|Other|15|||
154913100|NCT01809327|559101148|FG002|Overall Study|Other|7|||
154913101|NCT01809327|559101149|FG003|Overall Study|Other|4|||
154913102|NCT01809327|559101150|FG004|Overall Study|Other|9|||
154913103|NCT01610414|559101151|FG000|Study Start - Month 13|Serious Adverse Event|65|||
154913104|NCT01610414|559101152|FG001|Study Start - Month 13|Serious Adverse Event|67|||
154913105|NCT01610414|559101151|FG000|Study Start - Month 13|Adverse Event|14|||
154913106|NCT01610414|559101152|FG001|Study Start - Month 13|Adverse Event|14|||
154913107|NCT01610414|559101151|FG000|Study Start - Month 13|Protocol Violation|3|||
154913108|NCT01610414|559101152|FG001|Study Start - Month 13|Protocol Violation|1|||
154913109|NCT01610414|559101151|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
154913110|NCT01610414|559101152|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
154913111|NCT01610414|559101151|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
154913112|NCT01610414|559101152|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
154913113|NCT01610414|559101151|FG000|Study Start - Month 13|Lost to Follow-up|4|||
154913114|NCT01610414|559101152|FG001|Study Start - Month 13|Lost to Follow-up|6|||
154913115|NCT01610414|559101151|FG000|Study Start - Month 13|Suspected HZ episode|1|||
154913116|NCT01610414|559101152|FG001|Study Start - Month 13|Suspected HZ episode|3|||
154913117|NCT01610414|559101151|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
154913118|NCT01610414|559101152|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
154913119|NCT01610414|559101151|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
154913120|NCT01610414|559101152|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
154913121|NCT01610414|559101151|FG000|Month 13 - Month 25|Adverse Event|8|||
154913122|NCT01610414|559101152|FG001|Month 13 - Month 25|Adverse Event|4|||
154913123|NCT01610414|559101151|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
154913124|NCT01610414|559101152|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
154913125|NCT01610414|559101151|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
154913126|NCT01610414|559101152|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
154913127|NCT01610414|559101151|FG000|Month 13 - Month 25|Protocol Violation|0|||
154913128|NCT01610414|559101152|FG001|Month 13 - Month 25|Protocol Violation|2|||
154913129|NCT01610414|559101151|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
154913130|NCT01610414|559101152|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
154913131|NCT01610414|559101151|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
154913132|NCT01610414|559101152|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
154913133|NCT01610414|559101151|FG000|After Month 25|Study end not reached|48|||
154913134|NCT01610414|559101152|FG001|After Month 25|Study end not reached|53|||
154913135|NCT00826540|559101157|FG000|Overall Study|ineligible|3|||
154913136|NCT00826540|559101157|FG000|Overall Study|Withdrawal by Subject|1|||
154913137|NCT01166386|559101158|FG000|Overall Study|Withdrawal by Subject|3|||
154913138|NCT01166386|559101159|FG001|Overall Study|Withdrawal by Subject|5|||
154913139|NCT02802735|559101160|FG000|Overall Study|Withdrawal by Subject|0|||
154913140|NCT02802735|559101161|FG001|Overall Study|Withdrawal by Subject|1|||
154913141|NCT02802735|559101162|FG002|Overall Study|Withdrawal by Subject|0|||
154913142|NCT02802735|559101163|FG003|Overall Study|Withdrawal by Subject|0|||
154913143|NCT02802735|559101164|FG004|Overall Study|Withdrawal by Subject|0|||
154913144|NCT03922711|559101167|FG000|Overall Study|Adverse Event|3|||
154913145|NCT03922711|559101168|FG001|Overall Study|Adverse Event|2|||
154913146|NCT03922711|559101169|FG002|Overall Study|Adverse Event|2|||
154913147|NCT03922711|559101167|FG000|Overall Study|Protocol Violation|1|||
154913148|NCT03922711|559101168|FG001|Overall Study|Protocol Violation|0|||
154913149|NCT03922711|559101169|FG002|Overall Study|Protocol Violation|0|||
154913150|NCT03922711|559101167|FG000|Overall Study|Withdrawal by Subject|0|||
154913151|NCT03922711|559101168|FG001|Overall Study|Withdrawal by Subject|3|||
154913152|NCT03922711|559101169|FG002|Overall Study|Withdrawal by Subject|1|||
154913153|NCT03922711|559101167|FG000|Overall Study|Not further specified|0|||
155119073|NCT00075725|559868478|FG005|Overall Study|Death|25|||
155119074|NCT00075725|559868479|FG006|Overall Study|Death|4|||
155119075|NCT00075725|559868480|FG007|Overall Study|Death|22|||
155119076|NCT00075725|559868481|FG008|Overall Study|Death|14|||
155119077|NCT00075725|559868482|FG009|Overall Study|Death|4|||
154913154|NCT03922711|559101168|FG001|Overall Study|Not further specified|0|||
154913155|NCT03922711|559101169|FG002|Overall Study|Not further specified|1|||
154913156|NCT02390362|559101172|FG000|Overall Study|Withdrawal by Subject|0|||
154913157|NCT02390362|559101173|FG001|Overall Study|Withdrawal by Subject|1|||
154913158|NCT04009824|559101174|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
154913159|NCT04009824|559101175|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
154913160|NCT04009824|559101176|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
154913161|NCT04009824|559101177|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
154913162|NCT04009824|559101178|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
154913163|NCT00554840|559101179|FG000|Overall Study|Physician Decision|0|||
154913164|NCT00554840|559101180|FG001|Overall Study|Physician Decision|1|||
154913165|NCT04335929|559103589|FG000|Overall Study|Lost to Follow-up|10|||
154913166|NCT02534324|559103595|FG000|Overall Study|Protocol Violation|4|||
154913167|NCT02534324|559103596|FG001|Overall Study|Protocol Violation|1|||
154913168|NCT02534324|559103595|FG000|Overall Study|Lost to Follow-up|20|||
154913169|NCT02534324|559103596|FG001|Overall Study|Lost to Follow-up|7|||
154913170|NCT02534324|559103595|FG000|Overall Study|Adverse Event|1|||
154913171|NCT02534324|559103596|FG001|Overall Study|Adverse Event|0|||
154913172|NCT05604781|559103599|FG000|Overall Study|Lost to Follow-up|3|||
154913173|NCT05604781|559103599|FG000|Overall Study|Adverse Event|1|||
154913174|NCT00303602|559103600|FG000|Overall Study|Adverse Event|2|||
154913175|NCT00303602|559103601|FG001|Overall Study|Adverse Event|2|||
154913176|NCT00303602|559103600|FG000|Overall Study|Withdrawal by Subject|5|||
154913177|NCT00303602|559103601|FG001|Overall Study|Withdrawal by Subject|6|||
154913178|NCT00303602|559103600|FG000|Overall Study|Lost to Follow-up|5|||
154913179|NCT00303602|559103601|FG001|Overall Study|Lost to Follow-up|2|||
154913180|NCT00303602|559103600|FG000|Overall Study|Protocol entry criteria not met|2|||
154913181|NCT00303602|559103601|FG001|Overall Study|Protocol entry criteria not met|2|||
154913182|NCT00303602|559103600|FG000|Overall Study|Physician Decision|2|||
154913183|NCT00303602|559103601|FG001|Overall Study|Physician Decision|1|||
154913184|NCT00303602|559103600|FG000|Overall Study|Noncompliance|2|||
154913185|NCT00303602|559103601|FG001|Overall Study|Noncompliance|2|||
154913186|NCT00303602|559103600|FG000|Overall Study|Protocol Violation|1|||
154913187|NCT00303602|559103601|FG001|Overall Study|Protocol Violation|0|||
154913188|NCT02889861|559103612|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
154913189|NCT02551874|559103619|FG000|Overall Study|Lost to Follow-up|0|||
154913190|NCT02551874|559103620|FG001|Overall Study|Lost to Follow-up|2|||
154913191|NCT02551874|559103619|FG000|Overall Study|Pregnancy|0|||
154913192|NCT02551874|559103620|FG001|Overall Study|Pregnancy|1|||
154913193|NCT02551874|559103619|FG000|Overall Study|Reason not reported|10|||
154913194|NCT02551874|559103620|FG001|Overall Study|Reason not reported|4|||
154913195|NCT02551874|559103619|FG000|Overall Study|Did not receive randomized treatment|0|||
154913196|NCT02551874|559103620|FG001|Overall Study|Did not receive randomized treatment|7|||
154913197|NCT02551874|559103619|FG000|Overall Study|Did not enter long-term study|18|||
154913198|NCT02551874|559103620|FG001|Overall Study|Did not enter long-term study|25|||
154913199|NCT00313716|559103621|FG000|Overall Study|Death|3|||
154913200|NCT00313716|559103622|FG001|Overall Study|Death|2|||
154913201|NCT00313716|559103623|FG002|Overall Study|Death|9|||
154913202|NCT00313716|559103624|FG003|Overall Study|Death|3|||
154913203|NCT00313716|559103625|FG004|Overall Study|Death|5|||
154913204|NCT00313716|559103626|FG005|Overall Study|Death|9|||
154913205|NCT00313716|559103621|FG000|Overall Study|Lost to Follow-up|2|||
154913206|NCT00313716|559103622|FG001|Overall Study|Lost to Follow-up|5|||
154913207|NCT00313716|559103623|FG002|Overall Study|Lost to Follow-up|2|||
154913208|NCT00313716|559103624|FG003|Overall Study|Lost to Follow-up|1|||
154913209|NCT00313716|559103625|FG004|Overall Study|Lost to Follow-up|0|||
154913210|NCT00313716|559103626|FG005|Overall Study|Lost to Follow-up|4|||
154913211|NCT00313716|559103621|FG000|Overall Study|Withdrawal by Subject|0|||
154913212|NCT00313716|559103622|FG001|Overall Study|Withdrawal by Subject|1|||
154913213|NCT00313716|559103623|FG002|Overall Study|Withdrawal by Subject|1|||
154913214|NCT00313716|559103624|FG003|Overall Study|Withdrawal by Subject|0|||
154986376|NCT00616941|559375232|FG000|Overall Study|Adverse Event|0|||
154986377|NCT00616941|559375233|FG001|Overall Study|Adverse Event|1|||
154986378|NCT00616941|559375234|FG002|Overall Study|Adverse Event|1|||
154986379|NCT00616941|559375232|FG000|Overall Study|Subject Non-compliance|0|||
154986380|NCT00616941|559375233|FG001|Overall Study|Subject Non-compliance|0|||
154913215|NCT00313716|559103625|FG004|Overall Study|Withdrawal by Subject|1|||
154913216|NCT00313716|559103626|FG005|Overall Study|Withdrawal by Subject|0|||
154913217|NCT02491463|559103627|FG000|Overall Study|Withdrawal by Subject|1|||
154913218|NCT02491463|559103628|FG001|Overall Study|Withdrawal by Subject|2|||
154913219|NCT02491463|559103629|FG002|Overall Study|Withdrawal by Subject|0|||
154913220|NCT02491463|559103630|FG003|Overall Study|Withdrawal by Subject|0|||
154913221|NCT02491463|559103627|FG000|Overall Study|Migrated/moved from study area|1|||
154913222|NCT02491463|559103628|FG001|Overall Study|Migrated/moved from study area|5|||
154913223|NCT02491463|559103629|FG002|Overall Study|Migrated/moved from study area|1|||
154913224|NCT02491463|559103630|FG003|Overall Study|Migrated/moved from study area|1|||
154986381|NCT00616941|559375234|FG002|Overall Study|Subject Non-compliance|1|||
154986382|NCT00616941|559375232|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
154913225|NCT02491463|559103627|FG000|Overall Study|Lost to Follow-up|0|||
154913226|NCT02491463|559103628|FG001|Overall Study|Lost to Follow-up|3|||
154986383|NCT00616941|559375233|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
154913227|NCT02491463|559103629|FG002|Overall Study|Lost to Follow-up|3|||
154913228|NCT02491463|559103630|FG003|Overall Study|Lost to Follow-up|0|||
154913229|NCT01491802|559103631|FG000|Overall Study|Adverse Event|1|||
154913230|NCT01491802|559103632|FG001|Overall Study|Adverse Event|1|||
154913231|NCT01491802|559103631|FG000|Overall Study|Withdrawal by Subject|0|||
154913232|NCT01491802|559103632|FG001|Overall Study|Withdrawal by Subject|1|||
155119078|NCT00075725|559868483|FG010|Overall Study|Death|3|||
155119079|NCT00075725|559868484|FG011|Overall Study|Death|0|||
155119080|NCT00075725|559868473|FG000|Overall Study|Lost to Follow-up|1|||
155119081|NCT00075725|559868474|FG001|Overall Study|Lost to Follow-up|1|||
155119082|NCT00075725|559868475|FG002|Overall Study|Lost to Follow-up|4|||
155119083|NCT00075725|559868476|FG003|Overall Study|Lost to Follow-up|1|||
155119084|NCT00075725|559868477|FG004|Overall Study|Lost to Follow-up|0|||
155119085|NCT00075725|559868478|FG005|Overall Study|Lost to Follow-up|13|||
155119086|NCT00075725|559868479|FG006|Overall Study|Lost to Follow-up|2|||
155119087|NCT00075725|559868480|FG007|Overall Study|Lost to Follow-up|4|||
155119088|NCT00075725|559868481|FG008|Overall Study|Lost to Follow-up|1|||
155119089|NCT00075725|559868482|FG009|Overall Study|Lost to Follow-up|0|||
155119090|NCT00075725|559868483|FG010|Overall Study|Lost to Follow-up|0|||
155119091|NCT00075725|559868484|FG011|Overall Study|Lost to Follow-up|0|||
155119092|NCT00075725|559868473|FG000|Overall Study|Physician Decision|2|||
155119093|NCT00075725|559868474|FG001|Overall Study|Physician Decision|6|||
155119094|NCT00075725|559868475|FG002|Overall Study|Physician Decision|5|||
155119095|NCT00075725|559868476|FG003|Overall Study|Physician Decision|8|||
155119096|NCT00075725|559868477|FG004|Overall Study|Physician Decision|4|||
155119097|NCT00075725|559868478|FG005|Overall Study|Physician Decision|19|||
155119098|NCT00075725|559868479|FG006|Overall Study|Physician Decision|3|||
155119099|NCT00075725|559868480|FG007|Overall Study|Physician Decision|17|||
155119100|NCT00075725|559868481|FG008|Overall Study|Physician Decision|5|||
155119101|NCT00075725|559868482|FG009|Overall Study|Physician Decision|0|||
155119102|NCT00075725|559868483|FG010|Overall Study|Physician Decision|1|||
155119103|NCT00075725|559868484|FG011|Overall Study|Physician Decision|0|||
155119104|NCT00075725|559868473|FG000|Overall Study|Pregnancy|0|||
155119105|NCT00075725|559868474|FG001|Overall Study|Pregnancy|0|||
155119106|NCT00075725|559868475|FG002|Overall Study|Pregnancy|0|||
155119107|NCT00075725|559868476|FG003|Overall Study|Pregnancy|0|||
155119108|NCT00075725|559868477|FG004|Overall Study|Pregnancy|0|||
155119109|NCT00075725|559868478|FG005|Overall Study|Pregnancy|1|||
155119110|NCT00075725|559868479|FG006|Overall Study|Pregnancy|0|||
155119111|NCT00075725|559868480|FG007|Overall Study|Pregnancy|1|||
155119112|NCT00075725|559868481|FG008|Overall Study|Pregnancy|0|||
155119113|NCT00075725|559868482|FG009|Overall Study|Pregnancy|0|||
154913233|NCT01864746|559103635|FG000|Overall Study|Disease recurrence|25|||
154913234|NCT01864746|559103636|FG001|Overall Study|Disease recurrence|40|||
154913235|NCT01864746|559103635|FG000|Overall Study|Second primary invasive nonbreast|2|||
154913236|NCT01864746|559103636|FG001|Overall Study|Second primary invasive nonbreast|3|||
154913237|NCT01864746|559103635|FG000|Overall Study|Death|2|||
154913238|NCT01864746|559103636|FG001|Overall Study|Death|1|||
154913239|NCT01864746|559103635|FG000|Overall Study|Adverse Event|33|||
154913240|NCT01864746|559103636|FG001|Overall Study|Adverse Event|5|||
154913241|NCT01864746|559103635|FG000|Overall Study|Withdrawal by Subject|56|||
154913242|NCT01864746|559103636|FG001|Overall Study|Withdrawal by Subject|41|||
154913243|NCT01864746|559103635|FG000|Overall Study|Physician Decision|5|||
154913244|NCT01864746|559103636|FG001|Overall Study|Physician Decision|6|||
154913245|NCT00663208|559103637|FG000|Treatment Period|Lost to Follow-up|0|||
154913246|NCT00663208|559103638|FG001|Treatment Period|Lost to Follow-up|1|||
154913247|NCT00663208|559103639|FG002|Treatment Period|Lost to Follow-up|0|||
154913248|NCT00663208|559103640|FG003|Treatment Period|Lost to Follow-up|0|||
154913249|NCT00663208|559103641|FG004|Treatment Period|Lost to Follow-up|0|||
154913250|NCT00663208|559103642|FG005|Treatment Period|Lost to Follow-up|0|||
154913251|NCT00663208|559103643|FG006|Treatment Period|Lost to Follow-up|0|||
154913252|NCT00663208|559103637|FG000|Follow-up Period|Lost to Follow-up|2|||
154913253|NCT00663208|559103638|FG001|Follow-up Period|Lost to Follow-up|0|||
154913254|NCT00663208|559103639|FG002|Follow-up Period|Lost to Follow-up|3|||
154913255|NCT00663208|559103640|FG003|Follow-up Period|Lost to Follow-up|2|||
154913256|NCT00663208|559103641|FG004|Follow-up Period|Lost to Follow-up|0|||
154913257|NCT00663208|559103642|FG005|Follow-up Period|Lost to Follow-up|0|||
154913258|NCT00663208|559103643|FG006|Follow-up Period|Lost to Follow-up|0|||
154913259|NCT00663208|559103637|FG000|Follow-up Period|Other reason|1|||
154913260|NCT00663208|559103638|FG001|Follow-up Period|Other reason|0|||
154913261|NCT00663208|559103639|FG002|Follow-up Period|Other reason|0|||
154913262|NCT00663208|559103640|FG003|Follow-up Period|Other reason|0|||
154913263|NCT00663208|559103641|FG004|Follow-up Period|Other reason|0|||
154913264|NCT00663208|559103642|FG005|Follow-up Period|Other reason|0|||
154913265|NCT00663208|559103643|FG006|Follow-up Period|Other reason|1|||
154913266|NCT01005966|559103644|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
154913267|NCT01005966|559103645|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
154913268|NCT01005966|559103646|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
154913269|NCT01005966|559103647|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
154913270|NCT01005966|559103648|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
154913271|NCT01005966|559103644|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
154913272|NCT01005966|559103645|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
154913273|NCT01005966|559103646|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
154913274|NCT01005966|559103647|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
154986384|NCT00616941|559375234|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
154986385|NCT00616941|559375232|FG000|Overall Study|Vaccination Suspended|0|||
154986386|NCT00616941|559375233|FG001|Overall Study|Vaccination Suspended|0|||
154986387|NCT00616941|559375234|FG002|Overall Study|Vaccination Suspended|3|||
154986388|NCT00714493|559375242|FG000|Overall Study|Adverse Event|11|||
154986389|NCT00714493|559375242|FG000|Overall Study|Death|3|||
154986390|NCT00714493|559375242|FG000|Overall Study|Lack of Efficacy|10|||
154986391|NCT00714493|559375242|FG000|Overall Study|Lost to Follow-up|3|||
154986392|NCT00714493|559375242|FG000|Overall Study|Protocol Violation|12|||
154986393|NCT00714493|559375242|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
154986394|NCT00714493|559375242|FG000|Overall Study|OTHER|2|||
154986395|NCT00251719|559375243|FG000|Overall Study|Adverse Event|14|||
154986396|NCT00251719|559375244|FG001|Overall Study|Adverse Event|8|||
154986397|NCT00251719|559375245|FG002|Overall Study|Adverse Event|7|||
154986398|NCT00251719|559375243|FG000|Overall Study|Protocol Violation|1|||
154986399|NCT00251719|559375244|FG001|Overall Study|Protocol Violation|1|||
154986400|NCT00251719|559375245|FG002|Overall Study|Protocol Violation|1|||
154986401|NCT00251719|559375243|FG000|Overall Study|Lost to Follow-up|5|||
154986402|NCT00251719|559375244|FG001|Overall Study|Lost to Follow-up|11|||
154986403|NCT00251719|559375245|FG002|Overall Study|Lost to Follow-up|8|||
154986404|NCT00251719|559375243|FG000|Overall Study|Withdrawal by Subject|14|||
154986405|NCT00251719|559375244|FG001|Overall Study|Withdrawal by Subject|12|||
154986406|NCT00251719|559375245|FG002|Overall Study|Withdrawal by Subject|11|||
154986407|NCT00251719|559375243|FG000|Overall Study|Lack of Efficacy|2|||
154986408|NCT00251719|559375244|FG001|Overall Study|Lack of Efficacy|1|||
154986409|NCT00251719|559375245|FG002|Overall Study|Lack of Efficacy|0|||
154986410|NCT00251719|559375243|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
154986411|NCT00251719|559375244|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
154986412|NCT00251719|559375245|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
154986413|NCT00251719|559375243|FG000|Overall Study|Investigator decision|1|||
154986414|NCT00251719|559375244|FG001|Overall Study|Investigator decision|1|||
154986415|NCT00251719|559375245|FG002|Overall Study|Investigator decision|0|||
154986416|NCT00251719|559375243|FG000|Overall Study|Noncompliance|2|||
154986417|NCT00251719|559375244|FG001|Overall Study|Noncompliance|3|||
154986418|NCT00251719|559375245|FG002|Overall Study|Noncompliance|1|||
154986419|NCT00251719|559375243|FG000|Overall Study|Barrett's esophagus|2|||
154986420|NCT00251719|559375244|FG001|Overall Study|Barrett's esophagus|2|||
154986421|NCT00251719|559375245|FG002|Overall Study|Barrett's esophagus|0|||
154986422|NCT00557076|559375247|FG000|Overall Study|Unblinding|0|||
154986423|NCT00557076|559375248|FG001|Overall Study|Unblinding|1|||
154986424|NCT02792959|559375249|FG000|Overall Study|Protocol Violation|1|||
154986425|NCT03484117|559375250|FG000|Overall Study|Lost to Follow-up|1|||
154986426|NCT03484117|559375251|FG001|Overall Study|Lost to Follow-up|3|||
154986427|NCT03484117|559375250|FG000|Overall Study|Declined participation in exit assess|1|||
154986428|NCT03484117|559375251|FG001|Overall Study|Declined participation in exit assess|1|||
154986429|NCT01780987|559375255|FG000|Overall Study|Adverse Event|0|||
154986430|NCT01780987|559375256|FG001|Overall Study|Adverse Event|4|||
154986431|NCT01780987|559375255|FG000|Overall Study|Withdrawal by Subject|2|||
154986432|NCT01780987|559375256|FG001|Overall Study|Withdrawal by Subject|0|||
154986433|NCT01780987|559375255|FG000|Overall Study|Request of Changing Hospital|0|||
154986434|NCT01780987|559375256|FG001|Overall Study|Request of Changing Hospital|1|||
154986435|NCT01780987|559375255|FG000|Overall Study|Changing Residence|1|||
154986436|NCT01780987|559375256|FG001|Overall Study|Changing Residence|0|||
154986437|NCT01780987|559375255|FG000|Overall Study|Not Receiving any Study Medication|0|||
154986438|NCT01780987|559375256|FG001|Overall Study|Not Receiving any Study Medication|1|||
154986439|NCT02303041|559375257|FG000|Overall Study|Adverse Event|1|||
154986440|NCT02303041|559375258|FG001|Overall Study|Adverse Event|2|||
154986441|NCT00886288|559375259|FG000|Overall Study|no respect of the 12 weeks period|657|||
154986442|NCT00886288|559375260|FG001|Overall Study|no respect of the 12 weeks period|227|||
154986443|NCT00886288|559375259|FG000|Overall Study|Lost to Follow-up|86|||
154986444|NCT00886288|559375260|FG001|Overall Study|Lost to Follow-up|0|||
154986445|NCT02335983|559375261|FG000|Overall Study|Sponsor Decision|0|||
154986446|NCT02335983|559375262|FG001|Overall Study|Sponsor Decision|0|||
154986447|NCT02335983|559375263|FG002|Overall Study|Sponsor Decision|1|||
154986448|NCT02335983|559375264|FG003|Overall Study|Sponsor Decision|1|||
154986449|NCT02335983|559375265|FG004|Overall Study|Sponsor Decision|0|||
154986450|NCT02335983|559375266|FG005|Overall Study|Sponsor Decision|1|||
154986451|NCT02335983|559375261|FG000|Overall Study|Withdrawal by Subject|3|||
154986452|NCT02335983|559375262|FG001|Overall Study|Withdrawal by Subject|2|||
154986453|NCT02335983|559375263|FG002|Overall Study|Withdrawal by Subject|2|||
154986454|NCT02335983|559375264|FG003|Overall Study|Withdrawal by Subject|1|||
154986455|NCT02335983|559375265|FG004|Overall Study|Withdrawal by Subject|3|||
154986456|NCT02335983|559375266|FG005|Overall Study|Withdrawal by Subject|9|||
154986457|NCT02335983|559375261|FG000|Overall Study|Death|0|||
154986458|NCT02335983|559375262|FG001|Overall Study|Death|0|||
154986459|NCT02335983|559375263|FG002|Overall Study|Death|2|||
154986460|NCT02335983|559375264|FG003|Overall Study|Death|0|||
154986461|NCT02335983|559375265|FG004|Overall Study|Death|0|||
154913275|NCT01005966|559103648|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
154913276|NCT01005966|559103644|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
154913277|NCT01005966|559103645|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
154913278|NCT01005966|559103646|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
154913279|NCT01005966|559103647|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
154913280|NCT01005966|559103648|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
154913281|NCT01005966|559103644|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
154913282|NCT01005966|559103645|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
154913283|NCT01005966|559103646|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
154913284|NCT01005966|559103647|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
154913285|NCT01005966|559103648|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
154913286|NCT01005966|559103644|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
154913287|NCT01005966|559103645|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
154913288|NCT01005966|559103646|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
154913289|NCT01005966|559103647|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
154913290|NCT01005966|559103648|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
154913291|NCT01005966|559103644|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
154913292|NCT01005966|559103645|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
154913293|NCT01005966|559103646|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
154913294|NCT01005966|559103647|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
154913295|NCT01005966|559103648|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
154913296|NCT01005966|559103644|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
154913297|NCT01005966|559103645|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
154913298|NCT01005966|559103646|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
154913299|NCT01005966|559103647|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
154913300|NCT01005966|559103648|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
154913301|NCT01005966|559103644|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
154913302|NCT01005966|559103645|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
154913303|NCT01005966|559103646|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
154913304|NCT01005966|559103647|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
154913305|NCT01005966|559103648|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
154913306|NCT01005966|559103644|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
154913307|NCT01005966|559103645|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
154913308|NCT01005966|559103646|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
154913309|NCT01005966|559103647|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
154913310|NCT01005966|559103648|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
154913311|NCT00039377|559103651|FG000|Initial Registration|Adverse Event|2|||
154913312|NCT00039377|559103652|FG001|Initial Registration|Adverse Event|0|||
154913313|NCT00039377|559103653|FG002|Initial Registration|Adverse Event|0|||
154913314|NCT00039377|559103654|FG003|Initial Registration|Adverse Event|0|||
154913315|NCT00039377|559103651|FG000|Initial Registration|Relapsed|6|||
154913316|NCT00039377|559103652|FG001|Initial Registration|Relapsed|0|||
154913317|NCT00039377|559103653|FG002|Initial Registration|Relapsed|0|||
154913318|NCT00039377|559103654|FG003|Initial Registration|Relapsed|0|||
154913319|NCT00039377|559103651|FG000|Initial Registration|Received non-protocol therapy|11|||
154913320|NCT00039377|559103652|FG001|Initial Registration|Received non-protocol therapy|0|||
154913321|NCT00039377|559103653|FG002|Initial Registration|Received non-protocol therapy|0|||
154913322|NCT00039377|559103654|FG003|Initial Registration|Received non-protocol therapy|0|||
154913323|NCT00039377|559103651|FG000|Initial Registration|Withdrawal by Subject|3|||
154913324|NCT00039377|559103652|FG001|Initial Registration|Withdrawal by Subject|0|||
154913325|NCT00039377|559103653|FG002|Initial Registration|Withdrawal by Subject|0|||
154913326|NCT00039377|559103654|FG003|Initial Registration|Withdrawal by Subject|0|||
154913327|NCT04067310|559103658|FG000|Overall Study|Physician Decision|2|||
154913328|NCT04067310|559103659|FG001|Overall Study|Physician Decision|6|||
154913329|NCT04067310|559103658|FG000|Overall Study|Lost to Follow-up|0|||
154913330|NCT04067310|559103659|FG001|Overall Study|Lost to Follow-up|1|||
154913331|NCT04067310|559103658|FG000|Overall Study|Withdrawal by Subject|3|||
154913332|NCT04067310|559103659|FG001|Overall Study|Withdrawal by Subject|0|||
154913333|NCT01041027|559103660|FG000|Overall Study|Withdrawal by Subject|2|||
154913334|NCT01041027|559103660|FG000|Overall Study|Protocol Violation|1|||
154913335|NCT01041027|559103660|FG000|Overall Study|Delayed Radiation Therapy|1|||
154913336|NCT01041027|559103660|FG000|Overall Study|Adverse Event|4|||
154913337|NCT01347931|559103661|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
154913338|NCT01249404|559103662|FG000|Overall Study|Study treatment not received|0|||
154913339|NCT01249404|559103663|FG001|Overall Study|Study treatment not received|1|||
154913340|NCT01249404|559103664|FG002|Overall Study|Study treatment not received|2|||
154913341|NCT01249404|559103662|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
154913342|NCT01249404|559103663|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
154913343|NCT01249404|559103664|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
154913344|NCT01249404|559103662|FG000|Overall Study|Adverse Event|2|||
154913345|NCT01249404|559103663|FG001|Overall Study|Adverse Event|2|||
154913346|NCT01249404|559103664|FG002|Overall Study|Adverse Event|2|||
154913347|NCT01249404|559103662|FG000|Overall Study|Withdrawal by Subject|2|||
154913348|NCT01249404|559103663|FG001|Overall Study|Withdrawal by Subject|2|||
154913349|NCT01249404|559103664|FG002|Overall Study|Withdrawal by Subject|0|||
154913350|NCT01249404|559103662|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
154913351|NCT01249404|559103663|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
154913352|NCT01249404|559103664|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
154913353|NCT01249404|559103662|FG000|Overall Study|Non compliance to visit schedule|0|||
154913354|NCT01249404|559103663|FG001|Overall Study|Non compliance to visit schedule|1|||
154913355|NCT01249404|559103664|FG002|Overall Study|Non compliance to visit schedule|0|||
154913356|NCT03890731|559103665|FG000|Overall Study|Progressive disease|1|||
154913357|NCT03890731|559103665|FG000|Overall Study|Patient's decision|1|||
154913358|NCT03890731|559103665|FG000|Overall Study|Adverse Event|4|||
154913359|NCT04144140|559103666|FG000|Overall Study|Other|0|||
154913360|NCT04144140|559103667|FG001|Overall Study|Other|0|||
154913361|NCT04144140|559103668|FG002|Overall Study|Other|0|||
154913362|NCT04144140|559103669|FG003|Overall Study|Other|0|||
154913363|NCT04144140|559103670|FG004|Overall Study|Other|0|||
154913364|NCT04144140|559103671|FG005|Overall Study|Other|1|||
154913365|NCT04144140|559103672|FG006|Overall Study|Other|0|||
154913366|NCT01640353|559103673|FG000|Overall Study|Withdrew prior to treatment|10|||
154913367|NCT01640353|559103673|FG000|Overall Study|Withdrawn from analysis at term site|12|||
154913368|NCT01640353|559103673|FG000|Overall Study|Withdrawal by Subject|5|||
154913369|NCT01640353|559103673|FG000|Overall Study|Death|2|||
154913370|NCT01640353|559103673|FG000|Overall Study|Early site termination|3|||
154913371|NCT01640353|559103673|FG000|Overall Study|Lost to Follow-up|12|||
154913372|NCT01640353|559103673|FG000|Overall Study|Physician Decision|1|||
154913373|NCT02679222|559103675|FG000|Overall Study|No time for project|1|||
154913374|NCT04354870|559103676|FG000|Overall Study|Lost to Follow-up|32|||
154913375|NCT04354870|559103677|FG001|Overall Study|Lost to Follow-up|12|||
154913376|NCT04354870|559103676|FG000|Overall Study|Withdrawal by Subject|10|||
154913377|NCT04354870|559103677|FG001|Overall Study|Withdrawal by Subject|16|||
154913378|NCT04354870|559103676|FG000|Overall Study|Did not complete all study visits|6|||
154913379|NCT04354870|559103677|FG001|Overall Study|Did not complete all study visits|5|||
154913380|NCT04450394|559103678|FG000|Overall Study|Adverse Event|2|||
154913381|NCT04450394|559103679|FG001|Overall Study|Adverse Event|0|||
154913382|NCT04450394|559103680|FG002|Overall Study|Adverse Event|0|||
154913383|NCT04450394|559103678|FG000|Overall Study|Death|0|||
154913384|NCT04450394|559103679|FG001|Overall Study|Death|1|||
154913385|NCT04450394|559103680|FG002|Overall Study|Death|0|||
154913386|NCT04450394|559103678|FG000|Overall Study|Lost to Follow-up|0|||
154913387|NCT04450394|559103679|FG001|Overall Study|Lost to Follow-up|3|||
154913388|NCT04450394|559103680|FG002|Overall Study|Lost to Follow-up|0|||
154913389|NCT04450394|559103678|FG000|Overall Study|Physician Decision|0|||
154913390|NCT04450394|559103679|FG001|Overall Study|Physician Decision|1|||
154913391|NCT04450394|559103680|FG002|Overall Study|Physician Decision|0|||
154913392|NCT04450394|559103678|FG000|Overall Study|Protocol Violation|2|||
154913393|NCT04450394|559103679|FG001|Overall Study|Protocol Violation|0|||
154913394|NCT04450394|559103680|FG002|Overall Study|Protocol Violation|0|||
154913395|NCT04450394|559103678|FG000|Overall Study|Withdrawal by Subject|6|||
154913396|NCT04450394|559103679|FG001|Overall Study|Withdrawal by Subject|9|||
154913397|NCT04450394|559103680|FG002|Overall Study|Withdrawal by Subject|0|||
154913398|NCT01066819|559103681|FG000|Overall Study|Adverse Event|18|||
154913399|NCT01066819|559103682|FG001|Overall Study|Adverse Event|1|||
154913400|NCT01066819|559103683|FG002|Overall Study|Adverse Event|6|||
154913401|NCT01066819|559103684|FG003|Overall Study|Adverse Event|0|||
154913402|NCT01066819|559103685|FG004|Overall Study|Adverse Event|0|||
154913403|NCT01066819|559103686|FG005|Overall Study|Adverse Event|0|||
154913404|NCT01066819|559103681|FG000|Overall Study|Death|5|||
154913405|NCT01066819|559103682|FG001|Overall Study|Death|0|||
154913406|NCT01066819|559103683|FG002|Overall Study|Death|1|||
154913407|NCT01066819|559103684|FG003|Overall Study|Death|0|||
154913408|NCT01066819|559103685|FG004|Overall Study|Death|0|||
154913409|NCT01066819|559103686|FG005|Overall Study|Death|0|||
154913410|NCT01066819|559103681|FG000|Overall Study|Lack of Efficacy|22|||
154913411|NCT01066819|559103682|FG001|Overall Study|Lack of Efficacy|1|||
154913412|NCT01066819|559103683|FG002|Overall Study|Lack of Efficacy|2|||
154913413|NCT01066819|559103684|FG003|Overall Study|Lack of Efficacy|1|||
154913414|NCT01066819|559103685|FG004|Overall Study|Lack of Efficacy|0|||
154913415|NCT01066819|559103686|FG005|Overall Study|Lack of Efficacy|0|||
154913416|NCT01066819|559103681|FG000|Overall Study|Physician Decision|6|||
154913417|NCT01066819|559103682|FG001|Overall Study|Physician Decision|2|||
154913418|NCT01066819|559103683|FG002|Overall Study|Physician Decision|3|||
154913419|NCT01066819|559103684|FG003|Overall Study|Physician Decision|0|||
154913420|NCT01066819|559103685|FG004|Overall Study|Physician Decision|0|||
154913421|NCT01066819|559103686|FG005|Overall Study|Physician Decision|0|||
154913422|NCT01066819|559103681|FG000|Overall Study|Protocol Violation|12|||
154913423|NCT01066819|559103682|FG001|Overall Study|Protocol Violation|6|||
154913424|NCT01066819|559103683|FG002|Overall Study|Protocol Violation|0|||
154913425|NCT01066819|559103684|FG003|Overall Study|Protocol Violation|0|||
154913426|NCT01066819|559103685|FG004|Overall Study|Protocol Violation|0|||
154913427|NCT01066819|559103686|FG005|Overall Study|Protocol Violation|0|||
154913428|NCT01066819|559103681|FG000|Overall Study|Withdrawal by Subject|29|||
154913429|NCT01066819|559103682|FG001|Overall Study|Withdrawal by Subject|11|||
154913430|NCT01066819|559103683|FG002|Overall Study|Withdrawal by Subject|6|||
154913431|NCT01066819|559103684|FG003|Overall Study|Withdrawal by Subject|0|||
154913432|NCT01066819|559103685|FG004|Overall Study|Withdrawal by Subject|0|||
154913433|NCT01066819|559103686|FG005|Overall Study|Withdrawal by Subject|0|||
154913434|NCT01066819|559103681|FG000|Overall Study|Administrative|6|||
154913435|NCT01066819|559103682|FG001|Overall Study|Administrative|4|||
154913436|NCT01066819|559103683|FG002|Overall Study|Administrative|2|||
154913437|NCT01066819|559103684|FG003|Overall Study|Administrative|0|||
154913438|NCT01066819|559103685|FG004|Overall Study|Administrative|0|||
154913439|NCT01066819|559103686|FG005|Overall Study|Administrative|0|||
154913440|NCT01066819|559103681|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
154913441|NCT01066819|559103682|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
154913442|NCT01066819|559103683|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
154913443|NCT01066819|559103684|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
154913444|NCT01066819|559103685|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
154913445|NCT01066819|559103686|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
154913446|NCT01066819|559103681|FG000|Overall Study|Early termination|2|||
154913447|NCT01066819|559103682|FG001|Overall Study|Early termination|0|||
154913448|NCT01066819|559103683|FG002|Overall Study|Early termination|0|||
154913449|NCT01066819|559103684|FG003|Overall Study|Early termination|0|||
154913450|NCT01066819|559103685|FG004|Overall Study|Early termination|0|||
154913451|NCT01066819|559103686|FG005|Overall Study|Early termination|0|||
154913452|NCT01066819|559103681|FG000|Overall Study|Failed to return|298|||
154913453|NCT01066819|559103682|FG001|Overall Study|Failed to return|107|||
154913454|NCT01066819|559103683|FG002|Overall Study|Failed to return|68|||
154913455|NCT01066819|559103684|FG003|Overall Study|Failed to return|7|||
154913456|NCT01066819|559103685|FG004|Overall Study|Failed to return|2|||
154913457|NCT01066819|559103686|FG005|Overall Study|Failed to return|3|||
154913458|NCT01066819|559103681|FG000|Overall Study|Lab test not done|9|||
154913459|NCT01066819|559103682|FG001|Overall Study|Lab test not done|0|||
154913460|NCT01066819|559103683|FG002|Overall Study|Lab test not done|2|||
154913461|NCT01066819|559103684|FG003|Overall Study|Lab test not done|1|||
154913462|NCT01066819|559103685|FG004|Overall Study|Lab test not done|0|||
154913463|NCT01066819|559103686|FG005|Overall Study|Lab test not done|0|||
154913464|NCT01066819|559103681|FG000|Overall Study|Miscellaneous|28|||
154913465|NCT01066819|559103682|FG001|Overall Study|Miscellaneous|10|||
154913466|NCT01066819|559103683|FG002|Overall Study|Miscellaneous|18|||
154913467|NCT01066819|559103684|FG003|Overall Study|Miscellaneous|1|||
154913468|NCT01066819|559103685|FG004|Overall Study|Miscellaneous|0|||
154913469|NCT01066819|559103686|FG005|Overall Study|Miscellaneous|0|||
154913470|NCT01066819|559103681|FG000|Overall Study|Non responders|123|||
154913471|NCT01066819|559103682|FG001|Overall Study|Non responders|2|||
154913472|NCT01066819|559103683|FG002|Overall Study|Non responders|7|||
154913473|NCT01066819|559103684|FG003|Overall Study|Non responders|2|||
154913474|NCT01066819|559103685|FG004|Overall Study|Non responders|0|||
154913475|NCT01066819|559103686|FG005|Overall Study|Non responders|1|||
154913476|NCT01066819|559103681|FG000|Overall Study|Not categorised|9|||
154913477|NCT01066819|559103682|FG001|Overall Study|Not categorised|2|||
154913478|NCT01066819|559103683|FG002|Overall Study|Not categorised|6|||
154913479|NCT01066819|559103684|FG003|Overall Study|Not categorised|1|||
154913480|NCT01066819|559103685|FG004|Overall Study|Not categorised|0|||
154913481|NCT01066819|559103686|FG005|Overall Study|Not categorised|0|||
154913482|NCT01066819|559103681|FG000|Overall Study|Relapse|16|||
154913483|NCT01066819|559103682|FG001|Overall Study|Relapse|4|||
154913484|NCT01066819|559103683|FG002|Overall Study|Relapse|3|||
154913485|NCT01066819|559103684|FG003|Overall Study|Relapse|0|||
154913486|NCT01066819|559103685|FG004|Overall Study|Relapse|0|||
154913487|NCT01066819|559103686|FG005|Overall Study|Relapse|0|||
154913488|NCT01066819|559103681|FG000|Overall Study|Results not available|1|||
154913489|NCT01066819|559103682|FG001|Overall Study|Results not available|0|||
154913490|NCT01066819|559103683|FG002|Overall Study|Results not available|0|||
154913491|NCT01066819|559103684|FG003|Overall Study|Results not available|0|||
154986462|NCT02335983|559375266|FG005|Overall Study|Death|0|||
154986463|NCT02335983|559375261|FG000|Overall Study|Lost to Follow-up|0|||
154986464|NCT02335983|559375262|FG001|Overall Study|Lost to Follow-up|0|||
154913492|NCT01066819|559103685|FG004|Overall Study|Results not available|0|||
154913493|NCT01066819|559103686|FG005|Overall Study|Results not available|0|||
154986465|NCT02335983|559375263|FG002|Overall Study|Lost to Follow-up|0|||
155176284|NCT01363349|560083933|FG001|Overall Study|Withdrawal by Subject|6|||
154913494|NCT01066819|559103681|FG000|Overall Study|Screen failure|1|||
154913495|NCT01066819|559103682|FG001|Overall Study|Screen failure|0|||
154913496|NCT01066819|559103683|FG002|Overall Study|Screen failure|0|||
154913497|NCT01066819|559103684|FG003|Overall Study|Screen failure|0|||
154913498|NCT01066819|559103685|FG004|Overall Study|Screen failure|0|||
154913499|NCT01066819|559103686|FG005|Overall Study|Screen failure|0|||
154913500|NCT01066819|559103681|FG000|Overall Study|Spontaneous cure|1|||
154913501|NCT01066819|559103682|FG001|Overall Study|Spontaneous cure|0|||
154913502|NCT01066819|559103683|FG002|Overall Study|Spontaneous cure|0|||
154913503|NCT01066819|559103684|FG003|Overall Study|Spontaneous cure|0|||
154913504|NCT01066819|559103685|FG004|Overall Study|Spontaneous cure|0|||
154913505|NCT01066819|559103686|FG005|Overall Study|Spontaneous cure|0|||
154913506|NCT01066819|559103681|FG000|Overall Study|Treatment never started|85|||
154913507|NCT01066819|559103682|FG001|Overall Study|Treatment never started|19|||
154913508|NCT01066819|559103683|FG002|Overall Study|Treatment never started|19|||
154913509|NCT01066819|559103684|FG003|Overall Study|Treatment never started|3|||
154913510|NCT01066819|559103685|FG004|Overall Study|Treatment never started|2|||
154913511|NCT01066819|559103686|FG005|Overall Study|Treatment never started|2|||
154913512|NCT01066819|559103681|FG000|Overall Study|Treatment stopped|12|||
154913513|NCT01066819|559103682|FG001|Overall Study|Treatment stopped|1|||
154913514|NCT01066819|559103683|FG002|Overall Study|Treatment stopped|2|||
154913515|NCT01066819|559103684|FG003|Overall Study|Treatment stopped|1|||
154913516|NCT01066819|559103685|FG004|Overall Study|Treatment stopped|0|||
154913517|NCT01066819|559103686|FG005|Overall Study|Treatment stopped|0|||
154913518|NCT01066819|559103681|FG000|Overall Study|Other|5|||
154913519|NCT01066819|559103682|FG001|Overall Study|Other|1|||
154913520|NCT01066819|559103683|FG002|Overall Study|Other|1|||
154913521|NCT01066819|559103684|FG003|Overall Study|Other|0|||
154913522|NCT01066819|559103685|FG004|Overall Study|Other|0|||
154913523|NCT01066819|559103686|FG005|Overall Study|Other|0|||
154913524|NCT00303719|559103689|FG000|Overall Study|Not evaluable, prior therapies|0|||
154913525|NCT00303719|559103690|FG001|Overall Study|Not evaluable, prior therapies|30|||
154913526|NCT00303719|559103689|FG000|Overall Study|Lost to Follow-up|0|||
154913527|NCT00303719|559103690|FG001|Overall Study|Lost to Follow-up|7|||
154913528|NCT01641952|559103691|FG000|Overall Study|Lost to Follow-up|28|||
154913529|NCT01641952|559103691|FG000|Overall Study|Adverse Event|6|||
154913530|NCT03633461|559103703|FG000|Overall Study|Lost to Follow-up|0|||
154986466|NCT02335983|559375264|FG003|Overall Study|Lost to Follow-up|0|||
154986467|NCT02335983|559375265|FG004|Overall Study|Lost to Follow-up|0|||
154986468|NCT02335983|559375266|FG005|Overall Study|Lost to Follow-up|1|||
154986469|NCT02335983|559375261|FG000|Overall Study|Protocol Specified Criteria|5|||
154986470|NCT02335983|559375262|FG001|Overall Study|Protocol Specified Criteria|7|||
154986471|NCT02335983|559375263|FG002|Overall Study|Protocol Specified Criteria|27|||
154986472|NCT02335983|559375264|FG003|Overall Study|Protocol Specified Criteria|7|||
154986473|NCT02335983|559375265|FG004|Overall Study|Protocol Specified Criteria|5|||
154986474|NCT02335983|559375266|FG005|Overall Study|Protocol Specified Criteria|21|||
154986475|NCT01070771|559375267|FG000|Overall Study|Adverse Event|2|||
154986476|NCT01070771|559375267|FG000|Overall Study|Protocol Violation|1|||
154986477|NCT00289874|559375268|FG000|Overall Study|Adverse Event|1|||
154986478|NCT00289874|559375269|FG001|Overall Study|Adverse Event|5|||
154986479|NCT00289874|559375268|FG000|Overall Study|Lost to Follow-up|1|||
154986480|NCT00289874|559375269|FG001|Overall Study|Lost to Follow-up|1|||
154986481|NCT00289874|559375268|FG000|Overall Study|Protocol Violation|3|||
154986482|NCT00289874|559375269|FG001|Overall Study|Protocol Violation|2|||
154986483|NCT00289874|559375268|FG000|Overall Study|Did not meet eligibility|1|||
154986484|NCT00289874|559375269|FG001|Overall Study|Did not meet eligibility|0|||
154986485|NCT03127644|559375270|FG000|Overall Study|Study-specific withdrawal criteria|0|||
154986486|NCT03127644|559375271|FG001|Overall Study|Study-specific withdrawal criteria|0|||
154986487|NCT03127644|559375272|FG002|Overall Study|Study-specific withdrawal criteria|2|||
154986488|NCT05070546|559375275|FG000|Overall Study|Death|0|||
154986489|NCT05070546|559375276|FG001|Overall Study|Death|0|||
154986490|NCT05070546|559375277|FG002|Overall Study|Death|0|||
154986491|NCT05070546|559375278|FG003|Overall Study|Death|0|||
154986492|NCT05070546|559375279|FG004|Overall Study|Death|0|||
154986493|NCT05070546|559375280|FG005|Overall Study|Death|1|||
154986494|NCT05070546|559375275|FG000|Overall Study|Lost to Follow-up|8|||
154986495|NCT05070546|559375276|FG001|Overall Study|Lost to Follow-up|2|||
154986496|NCT05070546|559375277|FG002|Overall Study|Lost to Follow-up|7|||
154986497|NCT05070546|559375278|FG003|Overall Study|Lost to Follow-up|1|||
154913531|NCT03633461|559103704|FG001|Overall Study|Lost to Follow-up|1|||
154986498|NCT05070546|559375279|FG004|Overall Study|Lost to Follow-up|2|||
154986499|NCT05070546|559375280|FG005|Overall Study|Lost to Follow-up|0|||
154986500|NCT05070546|559375275|FG000|Overall Study|Withdrawal by Subject|1|||
155119114|NCT00075725|559868483|FG010|Overall Study|Pregnancy|0|||
154986501|NCT05070546|559375276|FG001|Overall Study|Withdrawal by Subject|1|||
154986502|NCT05070546|559375277|FG002|Overall Study|Withdrawal by Subject|3|||
154986503|NCT05070546|559375278|FG003|Overall Study|Withdrawal by Subject|0|||
154986504|NCT05070546|559375279|FG004|Overall Study|Withdrawal by Subject|0|||
154913532|NCT02516605|559103711|FG000|Overall Study|Protocol Violation|0|||
154913533|NCT02516605|559103712|FG001|Overall Study|Protocol Violation|0|||
154913534|NCT02516605|559103713|FG002|Overall Study|Protocol Violation|0|||
154913535|NCT02516605|559103714|FG003|Overall Study|Protocol Violation|0|||
154913536|NCT02516605|559103715|FG004|Overall Study|Protocol Violation|1|||
154913537|NCT02516605|559103711|FG000|Overall Study|Withdrawal by Subject|0|||
154986505|NCT05070546|559375280|FG005|Overall Study|Withdrawal by Subject|0|||
154986506|NCT05070546|559375275|FG000|Overall Study|Other|0|||
154986507|NCT05070546|559375276|FG001|Overall Study|Other|0|||
154913538|NCT02516605|559103712|FG001|Overall Study|Withdrawal by Subject|0|||
154913539|NCT02516605|559103713|FG002|Overall Study|Withdrawal by Subject|0|||
154913540|NCT02516605|559103714|FG003|Overall Study|Withdrawal by Subject|1|||
154913541|NCT02516605|559103715|FG004|Overall Study|Withdrawal by Subject|0|||
155119115|NCT00075725|559868484|FG011|Overall Study|Pregnancy|0|||
155119116|NCT00075725|559868473|FG000|Overall Study|Protocol Violation|1|||
154913542|NCT02643420|559103716|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
154913543|NCT02643420|559103717|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
154913544|NCT02643420|559103716|FG000|Overall Study|Withdrawal by Subject|25|||
154913545|NCT02643420|559103717|FG001|Overall Study|Withdrawal by Subject|19|||
154913546|NCT02643420|559103716|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
154913547|NCT02643420|559103717|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
154913548|NCT02643420|559103716|FG000|Overall Study|Lost to Follow-up|6|||
154913549|NCT02643420|559103717|FG001|Overall Study|Lost to Follow-up|10|||
154913550|NCT02643420|559103716|FG000|Overall Study|Investigator Decision|2|||
154913551|NCT02643420|559103717|FG001|Overall Study|Investigator Decision|4|||
154913552|NCT02643420|559103716|FG000|Overall Study|Sponsor decision|1|||
155119117|NCT00075725|559868474|FG001|Overall Study|Protocol Violation|1|||
155119118|NCT00075725|559868475|FG002|Overall Study|Protocol Violation|0|||
154913553|NCT02643420|559103717|FG001|Overall Study|Sponsor decision|1|||
154913554|NCT02643420|559103716|FG000|Overall Study|Death|0|||
154913555|NCT02643420|559103717|FG001|Overall Study|Death|2|||
154913556|NCT02643420|559103716|FG000|Overall Study|Reason not Specified|8|||
154913557|NCT02643420|559103717|FG001|Overall Study|Reason not Specified|7|||
154913558|NCT01710709|559103718|FG000|Overall Study|Lost to Follow-up|29|||
154913559|NCT01710709|559103718|FG000|Overall Study|Adverse Event|48|||
154913560|NCT01710709|559103718|FG000|Overall Study|Participant met withdrawal criteria|33|||
154913561|NCT01710709|559103718|FG000|Overall Study|Participant withdrawn by investigator|2|||
154913562|NCT01710709|559103718|FG000|Overall Study|Withdrawal by Subject|53|||
154913563|NCT01710709|559103718|FG000|Overall Study|Protocol Violation|5|||
154913564|NCT01710709|559103718|FG000|Overall Study|Lack of Efficacy|3|||
154913565|NCT01716585|559103722|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
154913566|NCT01716585|559103723|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
154913567|NCT01716585|559103722|FG000|Double-blind Treatment|Adverse Event|2|||
154913568|NCT01716585|559103723|FG001|Double-blind Treatment|Adverse Event|1|||
154913569|NCT01716585|559103722|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
154913570|NCT01716585|559103723|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
154913571|NCT01716585|559103722|FG000|Double-blind Treatment|Lost to Follow-up|2|||
154913572|NCT01716585|559103723|FG001|Double-blind Treatment|Lost to Follow-up|0|||
154913573|NCT01716585|559103722|FG000|Double-blind Treatment|Subject Noncompliant|1|||
154913574|NCT01716585|559103723|FG001|Double-blind Treatment|Subject Noncompliant|0|||
154913575|NCT01716585|559103722|FG000|Double-blind Treatment|Other|1|||
154986508|NCT05070546|559375277|FG002|Overall Study|Other|0|||
154986509|NCT05070546|559375278|FG003|Overall Study|Other|0|||
154986510|NCT05070546|559375279|FG004|Overall Study|Other|3|||
154986511|NCT05070546|559375280|FG005|Overall Study|Other|0|||
154986512|NCT05070546|559375275|FG000|Overall Study|Randomized but not vaccinated|1|||
154986513|NCT05070546|559375276|FG001|Overall Study|Randomized but not vaccinated|0|||
154986514|NCT05070546|559375277|FG002|Overall Study|Randomized but not vaccinated|1|||
154986515|NCT05070546|559375278|FG003|Overall Study|Randomized but not vaccinated|1|||
154986516|NCT05070546|559375279|FG004|Overall Study|Randomized but not vaccinated|3|||
154986517|NCT05070546|559375280|FG005|Overall Study|Randomized but not vaccinated|0|||
154986518|NCT00136318|559375281|FG000|Overall Study|Adverse Event|5|||
154986519|NCT00136318|559375282|FG001|Overall Study|Adverse Event|5|||
154986520|NCT00136318|559375281|FG000|Overall Study|Withdrawal by Subject|2|||
154986521|NCT00136318|559375282|FG001|Overall Study|Withdrawal by Subject|2|||
154986522|NCT02787408|559375286|FG000|Overall Study|Death|16|||
154986523|NCT02787408|559375286|FG000|Overall Study|Withdrawal by Subject|1|||
154986524|NCT02787408|559375286|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
154986525|NCT00038649|559375288|FG000|Overall Study|Adverse Event|9|||
154986526|NCT00995085|559375289|FG000|Overall Study|Withdrawal by Subject|5|||
154986527|NCT01194973|559375290|FG000|Screening Period|Screen Failure|3|||
154986528|NCT01194973|559375290|FG000|26 Week Treatment Period|Adverse Event|1|||
154986529|NCT01194973|559375290|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
154986530|NCT01194973|559375290|FG000|26 Week Treatment Period|Pregnancy|1|||
154986531|NCT01491035|559375299|FG000|Overall Study|Lost to Follow-up|0|||
154986532|NCT01491035|559375300|FG001|Overall Study|Lost to Follow-up|0|||
154986533|NCT01491035|559375301|FG002|Overall Study|Lost to Follow-up|0|||
154986534|NCT01491035|559375302|FG003|Overall Study|Lost to Follow-up|0|||
154986535|NCT01491035|559375303|FG004|Overall Study|Lost to Follow-up|1|||
154986536|NCT01491035|559375304|FG005|Overall Study|Lost to Follow-up|0|||
154986537|NCT01491035|559375305|FG006|Overall Study|Lost to Follow-up|0|||
154986538|NCT01491035|559375306|FG007|Overall Study|Lost to Follow-up|0|||
154986539|NCT02999477|559375307|FG000|Overall Study|found ineligible after first dose|0|||
155119119|NCT00075725|559868476|FG003|Overall Study|Protocol Violation|3|||
154913576|NCT01716585|559103723|FG001|Double-blind Treatment|Other|0|||
154913577|NCT01716585|559103722|FG000|Open-label Treatment|Adverse Event|0|||
154913578|NCT01716585|559103723|FG001|Open-label Treatment|Adverse Event|2|||
154913579|NCT01716585|559103722|FG000|Open-label Treatment|Virologic Failure|0|||
154913580|NCT01716585|559103723|FG001|Open-label Treatment|Virologic Failure|2|||
154913581|NCT01716585|559103722|FG000|Open-label Treatment|Withdrawal by Subject|0|||
154913582|NCT01716585|559103723|FG001|Open-label Treatment|Withdrawal by Subject|3|||
154913583|NCT02275052|559103724|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
154913584|NCT02275052|559103725|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
154913585|NCT02275052|559103726|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
154913586|NCT02275052|559103727|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
154913587|NCT02275052|559103724|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
154913588|NCT02275052|559103725|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
154913589|NCT02275052|559103726|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
154913590|NCT02275052|559103727|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
154913591|NCT02275052|559103724|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
154913592|NCT02275052|559103725|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
154913593|NCT02275052|559103726|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
154913594|NCT02275052|559103727|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
154913595|NCT02275052|559103724|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
154913596|NCT02275052|559103725|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
154913597|NCT02275052|559103726|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
154913598|NCT02275052|559103727|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
154913599|NCT02275052|559103724|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
154913600|NCT02275052|559103725|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
154913601|NCT02275052|559103726|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
154913602|NCT02275052|559103727|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
154913603|NCT02275052|559103724|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
154913604|NCT02275052|559103725|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
154913605|NCT02275052|559103726|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
154913606|NCT02275052|559103727|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
154913607|NCT02275052|559103724|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
154913608|NCT02275052|559103725|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
154913609|NCT02275052|559103726|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
154913610|NCT02275052|559103727|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
154913611|NCT02275052|559103724|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
154913612|NCT02275052|559103725|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
154913613|NCT02275052|559103726|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
154913614|NCT02275052|559103727|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
154913615|NCT02275052|559103724|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
154913616|NCT02275052|559103725|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
154913617|NCT02275052|559103726|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
154913618|NCT02275052|559103727|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
154913619|NCT02275052|559103724|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
154913620|NCT02275052|559103725|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
154913621|NCT02275052|559103726|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
154913622|NCT02275052|559103727|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
154913623|NCT02275052|559103724|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
154913624|NCT02275052|559103725|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
154913625|NCT02275052|559103726|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
154913626|NCT02275052|559103727|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
154913627|NCT05102734|559103728|FG000|Overall Study|Did not require vasopressors|1|||
154913628|NCT05102734|559103729|FG001|Overall Study|Did not require vasopressors|0|||
154913629|NCT05102734|559103728|FG000|Overall Study|Did not have functioning PA catheter|1|||
154913630|NCT05102734|559103729|FG001|Overall Study|Did not have functioning PA catheter|0|||
154913631|NCT05102734|559103728|FG000|Overall Study|Inadequate video quality|2|||
154913632|NCT05102734|559103729|FG001|Overall Study|Inadequate video quality|0|||
154913633|NCT03055806|559103735|FG000|Overall Study|Adverse Event|0|||
154913634|NCT03055806|559103736|FG001|Overall Study|Adverse Event|0|||
154913635|NCT03055806|559103737|FG002|Overall Study|Adverse Event|1|||
155119120|NCT00075725|559868477|FG004|Overall Study|Protocol Violation|3|||
155119121|NCT00075725|559868478|FG005|Overall Study|Protocol Violation|2|||
154913636|NCT03055806|559103738|FG003|Overall Study|Adverse Event|1|||
154913637|NCT03055806|559103735|FG000|Overall Study|Lost to Follow-up|0|||
154913638|NCT03055806|559103736|FG001|Overall Study|Lost to Follow-up|3|||
154913639|NCT03055806|559103737|FG002|Overall Study|Lost to Follow-up|6|||
155119122|NCT00075725|559868479|FG006|Overall Study|Protocol Violation|1|||
154913640|NCT03055806|559103738|FG003|Overall Study|Lost to Follow-up|7|||
154913641|NCT03055806|559103735|FG000|Overall Study|Physician Decision|1|||
154913642|NCT03055806|559103736|FG001|Overall Study|Physician Decision|0|||
154913643|NCT03055806|559103737|FG002|Overall Study|Physician Decision|0|||
154913644|NCT03055806|559103738|FG003|Overall Study|Physician Decision|1|||
154913645|NCT03055806|559103735|FG000|Overall Study|Protocol Violation|1|||
154913646|NCT03055806|559103736|FG001|Overall Study|Protocol Violation|0|||
154913647|NCT03055806|559103737|FG002|Overall Study|Protocol Violation|0|||
154913648|NCT03055806|559103738|FG003|Overall Study|Protocol Violation|0|||
154913649|NCT03055806|559103735|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
154913650|NCT03055806|559103736|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
154913651|NCT03055806|559103737|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
154913652|NCT03055806|559103738|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
154913653|NCT03055806|559103735|FG000|Overall Study|Withdrawal of consent to continue study|2|||
154913654|NCT03055806|559103736|FG001|Overall Study|Withdrawal of consent to continue study|3|||
154913655|NCT03055806|559103737|FG002|Overall Study|Withdrawal of consent to continue study|4|||
154913656|NCT03055806|559103738|FG003|Overall Study|Withdrawal of consent to continue study|6|||
154913657|NCT03055806|559103735|FG000|Overall Study|Partner not willing to try intercourse|1|||
154913658|NCT03055806|559103736|FG001|Overall Study|Partner not willing to try intercourse|0|||
154913659|NCT03055806|559103737|FG002|Overall Study|Partner not willing to try intercourse|0|||
154913660|NCT03055806|559103738|FG003|Overall Study|Partner not willing to try intercourse|0|||
154913661|NCT04601194|559103739|FG000|Overall Study|Lost to Follow-up|7|||
154913662|NCT02630459|559103740|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
154913663|NCT02630459|559103741|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
154913664|NCT02630459|559103742|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
154913665|NCT02630459|559103743|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
154913666|NCT02630459|559103744|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
154913667|NCT02630459|559103745|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
154913668|NCT02630459|559103746|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
154913669|NCT02630459|559103747|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
154913670|NCT02630459|559103740|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913671|NCT02630459|559103741|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913672|NCT02630459|559103742|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
154913673|NCT02630459|559103743|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913674|NCT02630459|559103744|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913675|NCT02630459|559103745|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913676|NCT02630459|559103746|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913677|NCT02630459|559103747|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
154913678|NCT02630459|559103740|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
154913679|NCT02630459|559103741|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
154913680|NCT02630459|559103742|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
154913681|NCT02630459|559103743|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
154913682|NCT02630459|559103744|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
154913683|NCT02630459|559103745|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
154913684|NCT02630459|559103746|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
154913685|NCT02630459|559103747|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
154913686|NCT02630459|559103740|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
154913687|NCT02630459|559103741|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913688|NCT02630459|559103742|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913689|NCT02630459|559103743|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913690|NCT02630459|559103744|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913691|NCT02630459|559103745|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913692|NCT02630459|559103746|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913693|NCT02630459|559103747|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
154913694|NCT02630459|559103740|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
154913695|NCT02630459|559103741|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
154913696|NCT02630459|559103742|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
154913697|NCT02630459|559103743|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
154913698|NCT02630459|559103744|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
154913699|NCT02630459|559103745|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
154913700|NCT02630459|559103746|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
154913701|NCT02630459|559103747|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
154913702|NCT02630459|559103740|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
154913703|NCT02630459|559103741|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
154913704|NCT02630459|559103742|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
155176285|NCT01363349|560083932|FG000|Overall Study|Lost to Follow-up|5|||
154913705|NCT02630459|559103743|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
154913706|NCT02630459|559103744|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
154913707|NCT02630459|559103745|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
154913708|NCT02630459|559103746|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
154913709|NCT02630459|559103747|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
154913710|NCT02630459|559103740|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913711|NCT02630459|559103741|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913712|NCT02630459|559103742|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913713|NCT02630459|559103743|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913714|NCT02630459|559103744|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
154913715|NCT02630459|559103745|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913716|NCT02630459|559103746|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913717|NCT02630459|559103747|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
154913718|NCT00846027|559103748|FG000|Overall Study|Death|3|||
154913719|NCT00846027|559103748|FG000|Overall Study|Disease Progression|30|||
154913720|NCT00846027|559103748|FG000|Overall Study|Toxicity|12|||
154913721|NCT00846027|559103748|FG000|Overall Study|Patient Decision|7|||
154913722|NCT00846027|559103748|FG000|Overall Study|Investigator Discretion|29|||
154913723|NCT00846027|559103748|FG000|Overall Study|Protocol Violation|2|||
154913724|NCT00846027|559103748|FG000|Overall Study|Subject Not Treated|7|||
154913725|NCT04905563|559103751|FG000|Overall Study|Withdrawal by Subject|1|||
154913726|NCT04905563|559103752|FG001|Overall Study|Withdrawal by Subject|0|||
154913727|NCT04905563|559103751|FG000|Overall Study|Standard of care orders entered by resident|1|||
154913728|NCT04905563|559103752|FG001|Overall Study|Standard of care orders entered by resident|0|||
154913729|NCT04905563|559103751|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
154913730|NCT04905563|559103752|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
154913731|NCT04905563|559103751|FG000|Overall Study|Withdrawal by Subject|0|||
154913732|NCT04905563|559103752|FG001|Overall Study|Withdrawal by Subject|1|||
154913733|NCT01797302|559103753|FG000|Overall Study|Lost to Follow-up|16|||
154913734|NCT01797302|559103754|FG001|Overall Study|Lost to Follow-up|23|||
154913735|NCT01797302|559103755|FG002|Overall Study|Lost to Follow-up|22|||
154913736|NCT01797302|559103753|FG000|Overall Study|Withdrawal by Subject|1|||
154913737|NCT01797302|559103754|FG001|Overall Study|Withdrawal by Subject|3|||
154913738|NCT01797302|559103755|FG002|Overall Study|Withdrawal by Subject|4|||
154913739|NCT00689611|559103758|FG000|Overall Study|Death|6|||
154913740|NCT00689611|559103759|FG001|Overall Study|Death|9|||
154913741|NCT00689611|559103758|FG000|Overall Study|Withdrawal by Subject|8|||
154913742|NCT00689611|559103759|FG001|Overall Study|Withdrawal by Subject|9|||
154913743|NCT00689611|559103758|FG000|Overall Study|Lost to Follow-up|27|||
154913744|NCT00689611|559103759|FG001|Overall Study|Lost to Follow-up|28|||
154913745|NCT00568399|559103760|FG000|Overall Study|Death|2|||
154913746|NCT00568399|559103760|FG000|Overall Study|Adverse Event|5|||
154913747|NCT00568399|559103760|FG000|Overall Study|Withdrawal by Subject|8|||
154913748|NCT00106626|559103761|FG000|Overall Study|Adverse Event|5|||
154913749|NCT00106626|559103762|FG001|Overall Study|Adverse Event|4|||
154913750|NCT00106626|559103763|FG002|Overall Study|Adverse Event|3|||
154913751|NCT00106626|559103764|FG003|Overall Study|Adverse Event|3|||
154913752|NCT00106626|559103761|FG000|Overall Study|Progressive Disease|4|||
154913753|NCT00106626|559103762|FG001|Overall Study|Progressive Disease|1|||
154913754|NCT00106626|559103763|FG002|Overall Study|Progressive Disease|9|||
154913755|NCT00106626|559103764|FG003|Overall Study|Progressive Disease|10|||
154913756|NCT00106626|559103761|FG000|Overall Study|Received radiation on new therapy|1|||
154913757|NCT00106626|559103762|FG001|Overall Study|Received radiation on new therapy|0|||
154913758|NCT00106626|559103763|FG002|Overall Study|Received radiation on new therapy|0|||
154913759|NCT00106626|559103764|FG003|Overall Study|Received radiation on new therapy|0|||
154913760|NCT00106626|559103761|FG000|Overall Study|> 14 day delay in therapy start|0|||
154913761|NCT00106626|559103762|FG001|Overall Study|> 14 day delay in therapy start|1|||
154913762|NCT00106626|559103763|FG002|Overall Study|> 14 day delay in therapy start|0|||
154913763|NCT00106626|559103764|FG003|Overall Study|> 14 day delay in therapy start|0|||
154913764|NCT02519777|559103765|FG000|Overall Study|Death|1|||
154913765|NCT02519777|559103766|FG001|Overall Study|Death|0|||
154913766|NCT02519777|559103767|FG002|Overall Study|Death|0|||
154913767|NCT02519777|559103765|FG000|Overall Study|Lost to Follow-up|0|||
154913768|NCT02519777|559103766|FG001|Overall Study|Lost to Follow-up|4|||
154913769|NCT02519777|559103767|FG002|Overall Study|Lost to Follow-up|2|||
154913770|NCT02519777|559103765|FG000|Overall Study|Withdrawal by Subject|3|||
154913771|NCT02519777|559103766|FG001|Overall Study|Withdrawal by Subject|1|||
154913772|NCT02519777|559103767|FG002|Overall Study|Withdrawal by Subject|0|||
154913773|NCT02519777|559103765|FG000|Overall Study|Severe Debilitation|1|||
154913774|NCT02519777|559103766|FG001|Overall Study|Severe Debilitation|1|||
154913775|NCT02519777|559103767|FG002|Overall Study|Severe Debilitation|1|||
154913776|NCT02519777|559103765|FG000|Overall Study|Not able to get to clinic|1|||
154913777|NCT02519777|559103766|FG001|Overall Study|Not able to get to clinic|2|||
154913778|NCT02519777|559103767|FG002|Overall Study|Not able to get to clinic|1|||
154913779|NCT02607865|559103770|FG000|Overall Study|Lost to Follow-up|9|||
154913780|NCT02607865|559103771|FG001|Overall Study|Lost to Follow-up|7|||
154913781|NCT02607865|559103772|FG002|Overall Study|Lost to Follow-up|7|||
154913782|NCT02607865|559103773|FG003|Overall Study|Lost to Follow-up|5|||
154913783|NCT02607865|559103770|FG000|Overall Study|Withdrawal by Subject|18|||
154913784|NCT02607865|559103771|FG001|Overall Study|Withdrawal by Subject|18|||
154913785|NCT02607865|559103772|FG002|Overall Study|Withdrawal by Subject|17|||
154913786|NCT02607865|559103773|FG003|Overall Study|Withdrawal by Subject|8|||
154913787|NCT02607865|559103770|FG000|Overall Study|Death|5|||
154913788|NCT02607865|559103771|FG001|Overall Study|Death|4|||
154913789|NCT02607865|559103772|FG002|Overall Study|Death|1|||
154913790|NCT02607865|559103773|FG003|Overall Study|Death|3|||
154913791|NCT02607865|559103770|FG000|Overall Study|Unclassified|1|||
154913792|NCT02607865|559103771|FG001|Overall Study|Unclassified|1|||
154913793|NCT02607865|559103772|FG002|Overall Study|Unclassified|2|||
154913794|NCT02607865|559103773|FG003|Overall Study|Unclassified|0|||
154913795|NCT00994890|559103774|FG000|Overall Study|Adverse Event|13|||
154913796|NCT00994890|559103775|FG001|Overall Study|Adverse Event|9|||
154913797|NCT00994890|559103776|FG002|Overall Study|Adverse Event|11|||
154913798|NCT00994890|559103774|FG000|Overall Study|Lack of Efficacy|0|||
154913799|NCT00994890|559103775|FG001|Overall Study|Lack of Efficacy|0|||
154913800|NCT00994890|559103776|FG002|Overall Study|Lack of Efficacy|1|||
154913801|NCT00994890|559103774|FG000|Overall Study|Lost to Follow-up|6|||
154913802|NCT00994890|559103775|FG001|Overall Study|Lost to Follow-up|1|||
154913803|NCT00994890|559103776|FG002|Overall Study|Lost to Follow-up|3|||
154913804|NCT00994890|559103774|FG000|Overall Study|No longer willing to participate|8|||
154913805|NCT00994890|559103775|FG001|Overall Study|No longer willing to participate|5|||
154913806|NCT00994890|559103776|FG002|Overall Study|No longer willing to participate|13|||
154913807|NCT00994890|559103774|FG000|Overall Study|Protocol Violation|2|||
154913808|NCT00994890|559103775|FG001|Overall Study|Protocol Violation|4|||
154913809|NCT00994890|559103776|FG002|Overall Study|Protocol Violation|0|||
154913810|NCT00994890|559103774|FG000|Overall Study|Study terminated by sponsor|199|||
154913811|NCT00994890|559103775|FG001|Overall Study|Study terminated by sponsor|201|||
154913812|NCT00994890|559103776|FG002|Overall Study|Study terminated by sponsor|197|||
154913813|NCT00994890|559103774|FG000|Overall Study|Randomized, but not treated|1|||
154913814|NCT00994890|559103775|FG001|Overall Study|Randomized, but not treated|0|||
154913815|NCT00994890|559103776|FG002|Overall Study|Randomized, but not treated|0|||
154913816|NCT00994890|559103774|FG000|Overall Study|Other|2|||
154913817|NCT00994890|559103775|FG001|Overall Study|Other|2|||
154913818|NCT00994890|559103776|FG002|Overall Study|Other|1|||
154913819|NCT01899729|559103779|FG000|Overall Study|Adverse Event|1|||
154913820|NCT01899729|559103780|FG001|Overall Study|Adverse Event|0|||
154913821|NCT01899729|559103781|FG002|Overall Study|Adverse Event|0|||
154913822|NCT01899729|559103782|FG003|Overall Study|Adverse Event|0|||
154913823|NCT01899729|559103783|FG004|Overall Study|Adverse Event|1|||
154913824|NCT01899729|559103779|FG000|Overall Study|Withdrawal by Subject|1|||
154913825|NCT01899729|559103780|FG001|Overall Study|Withdrawal by Subject|2|||
154913826|NCT01899729|559103781|FG002|Overall Study|Withdrawal by Subject|0|||
154913827|NCT01899729|559103782|FG003|Overall Study|Withdrawal by Subject|0|||
154913828|NCT01899729|559103783|FG004|Overall Study|Withdrawal by Subject|0|||
154913829|NCT01899729|559103779|FG000|Overall Study|Lack of Efficacy|0|||
154913830|NCT01899729|559103780|FG001|Overall Study|Lack of Efficacy|0|||
154913831|NCT01899729|559103781|FG002|Overall Study|Lack of Efficacy|2|||
154913832|NCT01899729|559103782|FG003|Overall Study|Lack of Efficacy|0|||
154913833|NCT01899729|559103783|FG004|Overall Study|Lack of Efficacy|1|||
154913834|NCT00795717|559103790|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
154913835|NCT00795717|559103791|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
154913836|NCT00795717|559103790|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
154913837|NCT00795717|559103791|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
154913838|NCT00795717|559103790|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
154913839|NCT00795717|559103791|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
154913840|NCT00795717|559103790|FG000|Phase II|too busy|0|||
154913841|NCT00795717|559103791|FG001|Phase II|too busy|1|||
154913842|NCT01021423|559103794|FG000|Overall Study|Study terminated|4|||
154913843|NCT01021423|559103795|FG001|Overall Study|Study terminated|5|||
154913844|NCT00122317|559103796|FG000|Overall Study|Death|3|||
154913845|NCT00122317|559103796|FG000|Overall Study|Adverse Event|4|||
154913846|NCT00122317|559103796|FG000|Overall Study|Physician Decision|2|||
154913847|NCT00122317|559103796|FG000|Overall Study|patient non-compliance|1|||
154913848|NCT00122317|559103796|FG000|Overall Study|Withdrawal by Subject|1|||
154913849|NCT03756285|559103797|FG000|Overall Study|Lost to Follow-up|0|||
154913850|NCT03756285|559103798|FG001|Overall Study|Lost to Follow-up|1|||
154913851|NCT03756285|559103797|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
154913852|NCT03756285|559103798|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
154913853|NCT03756285|559103797|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
154913854|NCT03756285|559103798|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
154913855|NCT04728815|559103799|FG000|Overall Study|Lost to Follow-up|3|||
154913856|NCT04728815|559103800|FG001|Overall Study|Lost to Follow-up|0|||
154913857|NCT04728815|559103801|FG002|Overall Study|Lost to Follow-up|0|||
154913858|NCT04728815|559103802|FG003|Overall Study|Lost to Follow-up|1|||
154913859|NCT04728815|559103803|FG004|Overall Study|Lost to Follow-up|1|||
154913860|NCT04728815|559103804|FG005|Overall Study|Lost to Follow-up|0|||
154913861|NCT04728815|559103805|FG006|Overall Study|Lost to Follow-up|2|||
154913862|NCT04728815|559103806|FG007|Overall Study|Lost to Follow-up|0|||
154913863|NCT04728815|559103799|FG000|Overall Study|Physician Decision|0|||
154913864|NCT04728815|559103800|FG001|Overall Study|Physician Decision|0|||
154913865|NCT04728815|559103801|FG002|Overall Study|Physician Decision|1|||
154913866|NCT04728815|559103802|FG003|Overall Study|Physician Decision|0|||
154913867|NCT04728815|559103803|FG004|Overall Study|Physician Decision|0|||
154913868|NCT04728815|559103804|FG005|Overall Study|Physician Decision|0|||
154913869|NCT04728815|559103805|FG006|Overall Study|Physician Decision|0|||
154913870|NCT04728815|559103806|FG007|Overall Study|Physician Decision|0|||
154913871|NCT04728815|559103799|FG000|Overall Study|Treatment drop|0|||
154913872|NCT04728815|559103800|FG001|Overall Study|Treatment drop|2|||
154913873|NCT04728815|559103801|FG002|Overall Study|Treatment drop|1|||
154913874|NCT04728815|559103802|FG003|Overall Study|Treatment drop|0|||
154913875|NCT04728815|559103803|FG004|Overall Study|Treatment drop|3|||
154913876|NCT04728815|559103804|FG005|Overall Study|Treatment drop|1|||
154913877|NCT04728815|559103805|FG006|Overall Study|Treatment drop|3|||
154913878|NCT04728815|559103806|FG007|Overall Study|Treatment drop|0|||
154913879|NCT04728815|559103799|FG000|Overall Study|Study drop|0|||
154913880|NCT04728815|559103800|FG001|Overall Study|Study drop|3|||
154913881|NCT04728815|559103801|FG002|Overall Study|Study drop|3|||
154913882|NCT04728815|559103802|FG003|Overall Study|Study drop|0|||
154913883|NCT04728815|559103803|FG004|Overall Study|Study drop|0|||
154913884|NCT04728815|559103804|FG005|Overall Study|Study drop|0|||
154913885|NCT04728815|559103805|FG006|Overall Study|Study drop|7|||
154913886|NCT04728815|559103806|FG007|Overall Study|Study drop|0|||
154913887|NCT00957034|559103807|FG000|Overall Study|Adverse Event|0|||
154913888|NCT00957034|559103808|FG001|Overall Study|Adverse Event|1|||
154913889|NCT00957034|559103809|FG002|Overall Study|Adverse Event|1|||
154913890|NCT00957034|559103807|FG000|Overall Study|Sponsor Terminated Study|6|||
154913891|NCT00957034|559103808|FG001|Overall Study|Sponsor Terminated Study|1|||
154913892|NCT00957034|559103809|FG002|Overall Study|Sponsor Terminated Study|5|||
154913893|NCT00957034|559103807|FG000|Overall Study|Withdrawal by Subject|0|||
154913894|NCT00957034|559103808|FG001|Overall Study|Withdrawal by Subject|2|||
154913895|NCT00957034|559103809|FG002|Overall Study|Withdrawal by Subject|0|||
154913896|NCT05315297|559103810|FG000|Overall Study|Lost to Follow-up|6|||
154913897|NCT05315297|559103811|FG001|Overall Study|Lost to Follow-up|4|||
154913898|NCT05315297|559103810|FG000|Overall Study|Withdrawal by Subject|0|||
154913899|NCT05315297|559103811|FG001|Overall Study|Withdrawal by Subject|1|||
154913900|NCT01084096|559105881|FG000|Overall Study|Lost to Follow-up|1501|||
154913901|NCT01084096|559105882|FG001|Overall Study|Lost to Follow-up|1833|||
154913902|NCT01084096|559105881|FG000|Overall Study|Withdrawal by Subject|3|||
154913903|NCT01084096|559105882|FG001|Overall Study|Withdrawal by Subject|0|||
154913904|NCT01084096|559105881|FG000|Overall Study|Woman had a miscarriage|21|||
154913905|NCT01084096|559105882|FG001|Overall Study|Woman had a miscarriage|17|||
154913906|NCT00027846|559105883|FG000|Overall Study|Lost to Follow-up|0|||
154913907|NCT00027846|559105884|FG001|Overall Study|Lost to Follow-up|41|||
154913908|NCT00027846|559105885|FG002|Overall Study|Lost to Follow-up|9|||
154913909|NCT00027846|559105883|FG000|Overall Study|Withdrawal by Subject|0|||
154913910|NCT00027846|559105884|FG001|Overall Study|Withdrawal by Subject|14|||
154913911|NCT00027846|559105885|FG002|Overall Study|Withdrawal by Subject|7|||
154913912|NCT00027846|559105883|FG000|Overall Study|Ineligible for study|2|||
154913913|NCT00027846|559105884|FG001|Overall Study|Ineligible for study|6|||
154913914|NCT00027846|559105885|FG002|Overall Study|Ineligible for study|14|||
154913915|NCT00027846|559105883|FG000|Overall Study|Entry into another COG therapeutic study|0|||
154913916|NCT00027846|559105884|FG001|Overall Study|Entry into another COG therapeutic study|5|||
154913917|NCT00027846|559105885|FG002|Overall Study|Entry into another COG therapeutic study|2|||
154913918|NCT00027846|559105883|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
154913919|NCT00027846|559105884|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
154913920|NCT00027846|559105885|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
154913921|NCT02033369|559105886|FG000|Overall Study|Physician Decision|1|||
154913922|NCT02033369|559105887|FG001|Overall Study|Physician Decision|2|||
154913923|NCT02033369|559105886|FG000|Overall Study|Not a good demographic match|0|||
154986540|NCT02999477|559375308|FG001|Overall Study|found ineligible after first dose|1|||
154913924|NCT02033369|559105887|FG001|Overall Study|Not a good demographic match|2|||
154913925|NCT02033369|559105886|FG000|Overall Study|Withdrawal by Subject|1|||
154913926|NCT02033369|559105887|FG001|Overall Study|Withdrawal by Subject|1|||
154913927|NCT02033369|559105886|FG000|Overall Study|Lost to Follow-up|1|||
154913928|NCT02033369|559105887|FG001|Overall Study|Lost to Follow-up|0|||
154913929|NCT02033369|559105886|FG000|Overall Study|Protocol Violation|2|||
154913930|NCT02033369|559105887|FG001|Overall Study|Protocol Violation|0|||
154913931|NCT01503229|559105888|FG000|Overall Study|Withdrew consent|1|||
154913932|NCT01354964|559105889|FG000|Overall Study|Lost to Follow-up|2|||
154913933|NCT01354964|559105890|FG001|Overall Study|Lost to Follow-up|0|||
154913934|NCT01354964|559105889|FG000|Overall Study|IV access issues|1|||
155119123|NCT00075725|559868480|FG007|Overall Study|Protocol Violation|2|||
155119124|NCT00075725|559868481|FG008|Overall Study|Protocol Violation|3|||
155119125|NCT00075725|559868482|FG009|Overall Study|Protocol Violation|0|||
155119126|NCT00075725|559868483|FG010|Overall Study|Protocol Violation|0|||
155119127|NCT00075725|559868484|FG011|Overall Study|Protocol Violation|1|||
154913935|NCT01354964|559105890|FG001|Overall Study|IV access issues|1|||
155119128|NCT00075725|559868473|FG000|Overall Study|Withdrawal by Subject|12|||
155119129|NCT00075725|559868474|FG001|Overall Study|Withdrawal by Subject|3|||
154913936|NCT01354964|559105889|FG000|Overall Study|Physician Decision|1|||
154913937|NCT01354964|559105890|FG001|Overall Study|Physician Decision|0|||
154913938|NCT00711009|559105891|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
154913939|NCT00711009|559105892|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
154913940|NCT00711009|559105891|FG000|Overall Study|Withdrawal by Subject|4|||
154913941|NCT00711009|559105892|FG001|Overall Study|Withdrawal by Subject|2|||
154913942|NCT00711009|559105891|FG000|Overall Study|Lost to Follow-up|3|||
154913943|NCT00711009|559105892|FG001|Overall Study|Lost to Follow-up|9|||
154913944|NCT00711009|559105891|FG000|Overall Study|Participant Noncompliant|0|||
154913945|NCT00711009|559105892|FG001|Overall Study|Participant Noncompliant|1|||
154913946|NCT00711009|559105891|FG000|Overall Study|Virologic Failure|2|||
154913947|NCT00711009|559105892|FG001|Overall Study|Virologic Failure|1|||
154913948|NCT00711009|559105891|FG000|Overall Study|Pregnancy|1|||
154913949|NCT00711009|559105892|FG001|Overall Study|Pregnancy|0|||
154913950|NCT00711009|559105891|FG000|Overall Study|Site closing|0|||
154913951|NCT00711009|559105892|FG001|Overall Study|Site closing|1|||
154913952|NCT00711009|559105891|FG000|Overall Study|Dose adjustment|1|||
154913953|NCT00711009|559105892|FG001|Overall Study|Dose adjustment|0|||
154913954|NCT01459016|559105894|FG000|Overall Study|Withdrawal by Subject|11|||
154913955|NCT01459016|559105894|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
154913956|NCT03922945|559105898|FG000|Overall Study|Adverse Event|1|||
154913957|NCT03922945|559105899|FG001|Overall Study|Adverse Event|1|||
154913958|NCT03922945|559105900|FG002|Overall Study|Adverse Event|2|||
154913959|NCT03922945|559105898|FG000|Overall Study|Lost to Follow-up|13|||
154913960|NCT03922945|559105899|FG001|Overall Study|Lost to Follow-up|9|||
154913961|NCT03922945|559105900|FG002|Overall Study|Lost to Follow-up|20|||
154913962|NCT03922945|559105898|FG000|Overall Study|Lack of Efficacy|2|||
154913963|NCT03922945|559105899|FG001|Overall Study|Lack of Efficacy|0|||
154913964|NCT03922945|559105900|FG002|Overall Study|Lack of Efficacy|1|||
154913965|NCT03922945|559105898|FG000|Overall Study|Protocol Non-Compliance|0|||
154913966|NCT03922945|559105899|FG001|Overall Study|Protocol Non-Compliance|0|||
154913967|NCT03922945|559105900|FG002|Overall Study|Protocol Non-Compliance|1|||
154913968|NCT03922945|559105898|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
154913969|NCT03922945|559105899|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
154913970|NCT03922945|559105900|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
154913971|NCT03922945|559105898|FG000|Overall Study|All Other Personal Reasons|1|||
154913972|NCT03922945|559105899|FG001|Overall Study|All Other Personal Reasons|1|||
154913973|NCT03922945|559105900|FG002|Overall Study|All Other Personal Reasons|2|||
154913974|NCT02493712|559105901|FG000|Overall Study|Withdrawal by Subject|1|||
154913975|NCT02493712|559105902|FG001|Overall Study|Withdrawal by Subject|0|||
154913976|NCT02493712|559105903|FG002|Overall Study|Withdrawal by Subject|2|||
154913977|NCT02493712|559105901|FG000|Overall Study|Protocol Violation|0|||
154913978|NCT02493712|559105902|FG001|Overall Study|Protocol Violation|0|||
154913979|NCT02493712|559105903|FG002|Overall Study|Protocol Violation|1|||
154913980|NCT02493712|559105901|FG000|Overall Study|Lost to Follow-up|1|||
154913981|NCT02493712|559105902|FG001|Overall Study|Lost to Follow-up|0|||
154913982|NCT02493712|559105903|FG002|Overall Study|Lost to Follow-up|0|||
154913983|NCT02493712|559105901|FG000|Overall Study|Physician Decision|0|||
154913984|NCT02493712|559105902|FG001|Overall Study|Physician Decision|1|||
154913985|NCT02493712|559105903|FG002|Overall Study|Physician Decision|0|||
154913986|NCT02493712|559105901|FG000|Overall Study|Lack of Efficacy|0|||
154913987|NCT02493712|559105902|FG001|Overall Study|Lack of Efficacy|5|||
154913988|NCT02493712|559105903|FG002|Overall Study|Lack of Efficacy|3|||
154913989|NCT02528643|559105904|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
154913990|NCT02528643|559105905|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
154913991|NCT02528643|559105904|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
154913992|NCT02528643|559105905|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
154913993|NCT02528643|559105904|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
154913994|NCT02528643|559105905|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
154913995|NCT02528643|559105904|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
154913996|NCT02528643|559105905|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
154913997|NCT02528643|559105904|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
154913998|NCT02528643|559105905|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
154913999|NCT02528643|559105904|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
155119130|NCT00075725|559868475|FG002|Overall Study|Withdrawal by Subject|6|||
155119131|NCT00075725|559868476|FG003|Overall Study|Withdrawal by Subject|10|||
154986541|NCT02999477|559375307|FG000|Overall Study|Withdrawal by Subject|1|||
154986542|NCT02999477|559375308|FG001|Overall Study|Withdrawal by Subject|1|||
155176286|NCT01363349|560083933|FG001|Overall Study|Lost to Follow-up|6|||
155176287|NCT01363349|560083932|FG000|Overall Study|Not reported|36|||
154914000|NCT02528643|559105905|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
154914001|NCT02528643|559105904|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
154914002|NCT02528643|559105905|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
154914003|NCT02058940|559105906|FG000|Overall Study|Discharged from Critical Care Unit|1|||
154914004|NCT02039687|559105912|FG000|Overall Study|Adverse Event|0|||
154914005|NCT02039687|559105913|FG001|Overall Study|Adverse Event|0|||
154914006|NCT02039687|559105914|FG002|Overall Study|Adverse Event|1|||
154914007|NCT02039687|559105915|FG003|Overall Study|Adverse Event|0|||
154914008|NCT02039687|559105912|FG000|Overall Study|Withdrawal by Subject|0|||
154914009|NCT02039687|559105913|FG001|Overall Study|Withdrawal by Subject|1|||
154914010|NCT02039687|559105914|FG002|Overall Study|Withdrawal by Subject|0|||
154914011|NCT02039687|559105915|FG003|Overall Study|Withdrawal by Subject|0|||
154914012|NCT02039687|559105912|FG000|Overall Study|treatment assignment could not be confir|0|||
154914013|NCT02039687|559105913|FG001|Overall Study|treatment assignment could not be confir|0|||
154914014|NCT02039687|559105914|FG002|Overall Study|treatment assignment could not be confir|2|||
154914015|NCT02039687|559105915|FG003|Overall Study|treatment assignment could not be confir|0|||
154914016|NCT01524900|559105929|FG000|Overall Study|Lost to Follow-up|3|||
154914017|NCT01524900|559105930|FG001|Overall Study|Lost to Follow-up|12|||
154914018|NCT01524900|559105931|FG002|Overall Study|Lost to Follow-up|1|||
154914019|NCT01524900|559105932|FG003|Overall Study|Lost to Follow-up|0|||
154914020|NCT01524900|559105933|FG004|Overall Study|Lost to Follow-up|0|||
154914021|NCT01524900|559105929|FG000|Overall Study|Other reason than stated above|1|||
154914022|NCT01524900|559105930|FG001|Overall Study|Other reason than stated above|1|||
154914023|NCT01524900|559105931|FG002|Overall Study|Other reason than stated above|0|||
154914024|NCT01524900|559105932|FG003|Overall Study|Other reason than stated above|0|||
154914025|NCT01524900|559105933|FG004|Overall Study|Other reason than stated above|0|||
154914026|NCT01524900|559105929|FG000|Overall Study|No reason documented|2|||
154914027|NCT01524900|559105930|FG001|Overall Study|No reason documented|1|||
154914028|NCT01524900|559105931|FG002|Overall Study|No reason documented|0|||
154914029|NCT01524900|559105932|FG003|Overall Study|No reason documented|1|||
154914030|NCT01524900|559105933|FG004|Overall Study|No reason documented|0|||
154914031|NCT03758612|559105934|FG000|Washout Period|Withdrawal by Subject|0|||
154914032|NCT03758612|559105935|FG001|Washout Period|Withdrawal by Subject|0|||
154914033|NCT03758612|559105936|FG002|Washout Period|Withdrawal by Subject|2|||
154914034|NCT03758612|559105937|FG003|Washout Period|Withdrawal by Subject|0|||
154914035|NCT03758612|559105938|FG004|Washout Period|Withdrawal by Subject|0|||
154914036|NCT03758612|559105939|FG005|Washout Period|Withdrawal by Subject|0|||
154914037|NCT03758612|559105940|FG006|Washout Period|Withdrawal by Subject|0|||
154914038|NCT03758612|559105941|FG007|Washout Period|Withdrawal by Subject|0|||
154914039|NCT03758612|559105942|FG008|Washout Period|Withdrawal by Subject|0|||
154914040|NCT03758612|559105943|FG009|Washout Period|Withdrawal by Subject|0|||
154914041|NCT03758612|559105944|FG010|Washout Period|Withdrawal by Subject|0|||
154914042|NCT03758612|559105945|FG011|Washout Period|Withdrawal by Subject|0|||
154914043|NCT03758612|559105934|FG000|Period 2|Protocol Violation|0|||
154914044|NCT03758612|559105935|FG001|Period 2|Protocol Violation|0|||
154914045|NCT03758612|559105936|FG002|Period 2|Protocol Violation|0|||
154914046|NCT03758612|559105937|FG003|Period 2|Protocol Violation|0|||
154914047|NCT03758612|559105938|FG004|Period 2|Protocol Violation|1|||
154914048|NCT03758612|559105939|FG005|Period 2|Protocol Violation|0|||
154914049|NCT03758612|559105940|FG006|Period 2|Protocol Violation|0|||
154914050|NCT03758612|559105941|FG007|Period 2|Protocol Violation|0|||
154914051|NCT03758612|559105942|FG008|Period 2|Protocol Violation|0|||
154914052|NCT03758612|559105943|FG009|Period 2|Protocol Violation|0|||
154914053|NCT03758612|559105944|FG010|Period 2|Protocol Violation|0|||
154914054|NCT03758612|559105945|FG011|Period 2|Protocol Violation|0|||
154914055|NCT00959192|559105946|FG000|Overall Study|Adverse Event|1|||
154914056|NCT00959192|559105947|FG001|Overall Study|Adverse Event|1|||
154914057|NCT00959192|559105948|FG002|Overall Study|Adverse Event|1|||
154914058|NCT00959192|559105949|FG003|Overall Study|Adverse Event|0|||
154914059|NCT00959192|559105946|FG000|Overall Study|Investigator Request|1|||
154914060|NCT00959192|559105947|FG001|Overall Study|Investigator Request|0|||
154914061|NCT00959192|559105948|FG002|Overall Study|Investigator Request|0|||
154986543|NCT03303625|559377294|FG000|Overall Study|Withdrawal by Subject|2|||
155176288|NCT01363349|560083933|FG001|Overall Study|Not reported|37|||
155176289|NCT01363349|560083932|FG000|Overall Study|missing|1|||
155176290|NCT01363349|560083933|FG001|Overall Study|missing|2|||
155176291|NCT01958489|560083934|FG000|Period 2|Adverse Event|0|||
154914062|NCT00959192|559105949|FG003|Overall Study|Investigator Request|0|||
154914063|NCT00959192|559105946|FG000|Overall Study|Caregiver Request|0|||
154914064|NCT00959192|559105947|FG001|Overall Study|Caregiver Request|0|||
154914065|NCT00959192|559105948|FG002|Overall Study|Caregiver Request|2|||
154914066|NCT00959192|559105949|FG003|Overall Study|Caregiver Request|1|||
155119132|NCT00075725|559868477|FG004|Overall Study|Withdrawal by Subject|6|||
154914067|NCT00532441|559105950|FG000|Overall Study|Death|1|||
154914068|NCT00532441|559105951|FG001|Overall Study|Death|0|||
154914069|NCT01967134|559105952|FG000|Overall Study|Lost to Follow-up|0|||
154914070|NCT01967134|559105953|FG001|Overall Study|Lost to Follow-up|1|||
154914071|NCT01967134|559105954|FG002|Overall Study|Lost to Follow-up|0|||
154914072|NCT00443534|559105955|FG000|Overall Study|Lack of Efficacy|67|||
154914073|NCT00443534|559105955|FG000|Overall Study|Adverse Event|16|||
154914074|NCT00443534|559105955|FG000|Overall Study|Death|9|||
154914075|NCT00443534|559105955|FG000|Overall Study|Withdrawal by Subject|8|||
154914076|NCT00443534|559105955|FG000|Overall Study|Study Terminated by Sponsor|12|||
154914077|NCT00443534|559105955|FG000|Overall Study|Other|10|||
154914078|NCT00443534|559105955|FG000|Overall Study|Enrolled, Not Treated|1|||
154914079|NCT01603615|559105956|FG000|Overall Study|Did not Receive Treatment|7|||
154914080|NCT01603615|559105956|FG000|Overall Study|Lost to Follow-up|9|||
154914081|NCT01603615|559105956|FG000|Overall Study|Personal Reasons|17|||
154914082|NCT01603615|559105956|FG000|Overall Study|Other Miscellaneous|1|||
154914083|NCT00305773|559105957|FG000|Overall Study|Death|3|||
154914084|NCT00305773|559105958|FG001|Overall Study|Death|2|||
154914085|NCT00305773|559105957|FG000|Overall Study|Adverse Event|1|||
154914086|NCT00305773|559105958|FG001|Overall Study|Adverse Event|2|||
154914087|NCT00305773|559105957|FG000|Overall Study|Alternative Treatment|4|||
154914088|NCT00305773|559105958|FG001|Overall Study|Alternative Treatment|4|||
154914089|NCT00305773|559105957|FG000|Overall Study|Physician Decision|1|||
154914090|NCT00305773|559105958|FG001|Overall Study|Physician Decision|1|||
154914091|NCT00305773|559105957|FG000|Overall Study|Withdrawal by Subject|1|||
154914092|NCT00305773|559105958|FG001|Overall Study|Withdrawal by Subject|4|||
154914093|NCT00305773|559105957|FG000|Overall Study|Disease Progression|1|||
154914094|NCT00305773|559105958|FG001|Overall Study|Disease Progression|3|||
154914095|NCT00305773|559105957|FG000|Overall Study|All other reasons|3|||
154914096|NCT00305773|559105958|FG001|Overall Study|All other reasons|2|||
154914097|NCT03419741|559105959|FG000|Overall Study|Adverse Event|1|||
154914098|NCT03419741|559105960|FG001|Overall Study|Adverse Event|0|||
154914099|NCT03419741|559105959|FG000|Overall Study|Withdrawal by Subject|1|||
154914100|NCT03419741|559105960|FG001|Overall Study|Withdrawal by Subject|2|||
154914101|NCT00303329|559105961|FG000|Overall Study|Adverse Event|7|||
154914102|NCT00303329|559105962|FG001|Overall Study|Adverse Event|14|||
154914103|NCT00303329|559105961|FG000|Overall Study|Abnormal Laboratory Values|0|||
154914104|NCT00303329|559105962|FG001|Overall Study|Abnormal Laboratory Values|1|||
154914105|NCT00303329|559105961|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
154914106|NCT00303329|559105962|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
154914107|NCT00303329|559105961|FG000|Overall Study|Condition no longer requires study drug|0|||
154914108|NCT00303329|559105962|FG001|Overall Study|Condition no longer requires study drug|8|||
154914109|NCT00303329|559105961|FG000|Overall Study|Protocol Violation|3|||
154914110|NCT00303329|559105962|FG001|Overall Study|Protocol Violation|0|||
154914111|NCT00303329|559105961|FG000|Overall Study|Withdrawal by Subject|9|||
154914112|NCT00303329|559105962|FG001|Overall Study|Withdrawal by Subject|15|||
154914113|NCT00303329|559105961|FG000|Overall Study|Lost to Follow-up|0|||
154914114|NCT00303329|559105962|FG001|Overall Study|Lost to Follow-up|1|||
154914115|NCT00303329|559105961|FG000|Overall Study|Administrative problems|1|||
154914116|NCT00303329|559105962|FG001|Overall Study|Administrative problems|0|||
154914117|NCT00303329|559105961|FG000|Overall Study|Death|2|||
154914118|NCT00303329|559105962|FG001|Overall Study|Death|12|||
154914119|NCT00303329|559105961|FG000|Overall Study|Stopped at end of core|3|||
154914120|NCT00303329|559105962|FG001|Overall Study|Stopped at end of core|9|||
154914121|NCT00303329|559105961|FG000|Overall Study|Stopped at end of extension 1|1|||
154914122|NCT00303329|559105962|FG001|Overall Study|Stopped at end of extension 1|0|||
154914123|NCT03384316|559105965|FG000|Overall Study|Screen failure|0|||
154914124|NCT03384316|559105966|FG001|Overall Study|Screen failure|1|||
154914125|NCT00413231|559105967|FG000|0 to 30-day Post Treatment|Death|5|||
154914126|NCT00413231|559105967|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
154914127|NCT00413231|559105967|FG000|30-day to 365-day Post Treatment|Death|13|||
154914128|NCT00413231|559105967|FG000|365-day to 60-month Post Treatment|Death|36|||
154914129|NCT00413231|559105967|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
154914130|NCT00413231|559105967|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
154914131|NCT00413231|559105967|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
154914132|NCT01539720|559105975|FG000|Overall Study|Screen Fail|15|||
155119133|NCT00075725|559868478|FG005|Overall Study|Withdrawal by Subject|27|||
154914133|NCT01539720|559105976|FG001|Overall Study|Screen Fail|3|||
154914134|NCT01539720|559105975|FG000|Overall Study|Lost to Follow-up|14|||
154914135|NCT01539720|559105976|FG001|Overall Study|Lost to Follow-up|7|||
154914136|NCT00298766|559105977|FG000|Overall Study|Adverse Event|18|||
154914137|NCT00298766|559105977|FG000|Overall Study|Death|2|||
154914138|NCT00298766|559105977|FG000|Overall Study|Withdrawal by Subject|9|||
154914139|NCT00298766|559105977|FG000|Overall Study|Treatment ongoing|4|||
154914140|NCT00298766|559105977|FG000|Overall Study|Progression of amyloid markers|4|||
155119134|NCT00075725|559868479|FG006|Overall Study|Withdrawal by Subject|7|||
155119135|NCT00075725|559868480|FG007|Overall Study|Withdrawal by Subject|31|||
154914141|NCT00298766|559105977|FG000|Overall Study|Deterioration in KPS and organ function|1|||
154914142|NCT00298766|559105977|FG000|Overall Study|Subjects overall condition deterioration|4|||
154914143|NCT00298766|559105977|FG000|Overall Study|Other|4|||
154914144|NCT03812224|559105984|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
154914145|NCT03812224|559105985|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
154914146|NCT03812224|559105984|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
154914147|NCT03812224|559105985|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
154914148|NCT03812224|559105984|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
154914149|NCT03812224|559105985|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
154914150|NCT03812224|559105984|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
154914151|NCT03812224|559105985|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
154914152|NCT01731951|559105986|FG000|Overall Study|Documented Disease Progression|1|||
154914153|NCT01731951|559105987|FG001|Overall Study|Documented Disease Progression|0|||
154914154|NCT01731951|559105988|FG002|Overall Study|Documented Disease Progression|0|||
154914155|NCT01731951|559105989|FG003|Overall Study|Documented Disease Progression|0|||
154914156|NCT01731951|559105990|FG004|Overall Study|Documented Disease Progression|0|||
154914157|NCT01731951|559105991|FG005|Overall Study|Documented Disease Progression|0|||
154914158|NCT01731951|559105986|FG000|Overall Study|Lost to Follow-up|2|||
154914159|NCT01731951|559105987|FG001|Overall Study|Lost to Follow-up|0|||
154914160|NCT01731951|559105988|FG002|Overall Study|Lost to Follow-up|0|||
154914161|NCT01731951|559105989|FG003|Overall Study|Lost to Follow-up|1|||
154914162|NCT01731951|559105990|FG004|Overall Study|Lost to Follow-up|3|||
154914163|NCT01731951|559105991|FG005|Overall Study|Lost to Follow-up|1|||
154914164|NCT01731951|559105986|FG000|Overall Study|Withdrawal of Consent|1|||
154914165|NCT01731951|559105987|FG001|Overall Study|Withdrawal of Consent|0|||
154914166|NCT01731951|559105988|FG002|Overall Study|Withdrawal of Consent|0|||
154914167|NCT01731951|559105989|FG003|Overall Study|Withdrawal of Consent|0|||
154914168|NCT01731951|559105990|FG004|Overall Study|Withdrawal of Consent|0|||
154914169|NCT01731951|559105991|FG005|Overall Study|Withdrawal of Consent|2|||
154914170|NCT01731951|559105986|FG000|Overall Study|Death|13|||
154914171|NCT01731951|559105987|FG001|Overall Study|Death|15|||
154914172|NCT01731951|559105988|FG002|Overall Study|Death|9|||
154914173|NCT01731951|559105989|FG003|Overall Study|Death|8|||
154914174|NCT01731951|559105990|FG004|Overall Study|Death|9|||
154914175|NCT01731951|559105991|FG005|Overall Study|Death|6|||
154914176|NCT00348686|559105992|FG000|Overall Study|Withdrawal by Subject|45|||
154914177|NCT00348686|559105992|FG000|Overall Study|Adverse Event|5|||
154914178|NCT00348686|559105992|FG000|Overall Study|Protocol Violation|6|||
154914179|NCT00348686|559105992|FG000|Overall Study|Lost to Follow-up|2|||
154914180|NCT00348686|559105992|FG000|Overall Study|Multiple Reasons|8|||
154914181|NCT01258738|559105993|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
154914182|NCT01258738|559105994|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
154914183|NCT01258738|559105993|FG000|Double-blind Period|Withdrawal by Subject|2|||
154914184|NCT01258738|559105994|FG001|Double-blind Period|Withdrawal by Subject|2|||
154914185|NCT01258738|559105993|FG000|Double-blind Period|Protocol Violation|1|||
154914186|NCT01258738|559105994|FG001|Double-blind Period|Protocol Violation|1|||
154914187|NCT01258738|559105993|FG000|Double-blind Period|Adverse Event|3|||
154914188|NCT01258738|559105994|FG001|Double-blind Period|Adverse Event|1|||
154914189|NCT01258738|559105993|FG000|Open-label Period|Did not meet inclusion criteria|0|||
154914190|NCT01258738|559105994|FG001|Open-label Period|Did not meet inclusion criteria|1|||
154914191|NCT01258738|559105993|FG000|Open-label Period|Insufficient clinical response|5|||
154914192|NCT01258738|559105994|FG001|Open-label Period|Insufficient clinical response|3|||
154914193|NCT01258738|559105993|FG000|Open-label Period|Lost to Follow-up|0|||
154914194|NCT01258738|559105994|FG001|Open-label Period|Lost to Follow-up|2|||
154914195|NCT01258738|559105993|FG000|Open-label Period|Withdrawal by Subject|5|||
154914196|NCT01258738|559105994|FG001|Open-label Period|Withdrawal by Subject|6|||
154914197|NCT01258738|559105993|FG000|Open-label Period|Protocol Violation|2|||
154914198|NCT01258738|559105994|FG001|Open-label Period|Protocol Violation|2|||
154914199|NCT01258738|559105993|FG000|Open-label Period|Adverse Event|4|||
154914200|NCT01258738|559105994|FG001|Open-label Period|Adverse Event|5|||
154914201|NCT01258738|559105993|FG000|Open-label Period|Other Reasons|0|||
155119136|NCT00075725|559868481|FG008|Overall Study|Withdrawal by Subject|10|||
155119137|NCT00075725|559868482|FG009|Overall Study|Withdrawal by Subject|2|||
155119138|NCT00075725|559868483|FG010|Overall Study|Withdrawal by Subject|0|||
155119139|NCT00075725|559868484|FG011|Overall Study|Withdrawal by Subject|0|||
154914202|NCT01258738|559105994|FG001|Open-label Period|Other Reasons|1|||
154914203|NCT01258738|559105993|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
154914204|NCT01258738|559105994|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
154914205|NCT02418000|559105995|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
154914206|NCT02418000|559105996|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914207|NCT02418000|559105997|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914208|NCT02418000|559105998|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914209|NCT02418000|559105999|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
155119140|NCT00075725|559868473|FG000|Overall Study|Disease Progression, all other reasons|17|||
154914210|NCT02418000|559105995|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
154914211|NCT02418000|559105996|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
154914212|NCT02418000|559105997|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
154914213|NCT02418000|559105998|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
154914214|NCT02418000|559105999|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
154914215|NCT02418000|559105995|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
154914216|NCT02418000|559105996|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
154914217|NCT02418000|559105997|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
154914218|NCT02418000|559105998|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
154914219|NCT02418000|559105999|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
154914220|NCT02418000|559105995|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914221|NCT02418000|559105996|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
154914222|NCT02418000|559105997|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914223|NCT02418000|559105998|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914224|NCT02418000|559105999|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
154914225|NCT02418000|559105995|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
154914226|NCT02418000|559105996|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
154914227|NCT02418000|559105997|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
154914228|NCT02418000|559105998|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
154914229|NCT02418000|559105999|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
154914230|NCT02418000|559105995|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914231|NCT02418000|559105996|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914232|NCT02418000|559105997|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
154914233|NCT02418000|559105998|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914234|NCT02418000|559105999|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914235|NCT02418000|559105995|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914236|NCT02418000|559105996|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154986544|NCT03303625|559377295|FG001|Overall Study|Withdrawal by Subject|0|||
154986545|NCT03303625|559377296|FG002|Overall Study|Withdrawal by Subject|0|||
154914237|NCT02418000|559105997|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154986546|NCT03303625|559377297|FG003|Overall Study|Withdrawal by Subject|0|||
154986547|NCT03340064|559377299|FG000|First Period|Adverse Event, non-fatal|2|||
154986548|NCT03340064|559377300|FG001|First Period|Adverse Event, non-fatal|0|||
154986549|NCT03340064|559377299|FG000|First Period|Lack of Efficacy|3|||
154986550|NCT03340064|559377300|FG001|First Period|Lack of Efficacy|0|||
154986551|NCT03340064|559377299|FG000|Second Period|Adverse Event, non-fatal|1|||
154986552|NCT03340064|559377300|FG001|Second Period|Adverse Event, non-fatal|1|||
154986553|NCT03340064|559377299|FG000|Second Period|Lack of Efficacy|11|||
154986554|NCT03340064|559377300|FG001|Second Period|Lack of Efficacy|0|||
154986555|NCT03340064|559377299|FG000|Second Period|Physician Decision|3|||
154986556|NCT03340064|559377300|FG001|Second Period|Physician Decision|0|||
154986557|NCT03340064|559377299|FG000|Second Period|Withdrawal by Subject|2|||
154986558|NCT03340064|559377300|FG001|Second Period|Withdrawal by Subject|1|||
154986559|NCT03340064|559377299|FG000|Second Period|Approved Drug Available For Indication|1|||
154986560|NCT03340064|559377300|FG001|Second Period|Approved Drug Available For Indication|0|||
154986561|NCT03340064|559377299|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
154986562|NCT03340064|559377300|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
154986563|NCT02221037|559377301|FG000|Overall Study|Physician Decision|0|||
154986564|NCT02221037|559377302|FG001|Overall Study|Physician Decision|0|||
155119141|NCT00075725|559868474|FG001|Overall Study|Disease Progression, all other reasons|5|||
155119142|NCT00075725|559868475|FG002|Overall Study|Disease Progression, all other reasons|33|||
155119143|NCT00075725|559868476|FG003|Overall Study|Disease Progression, all other reasons|6|||
154914238|NCT02418000|559105998|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
154914239|NCT02418000|559105999|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914240|NCT02418000|559105995|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
154914241|NCT02418000|559105996|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
154914242|NCT02418000|559105997|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
154914243|NCT02418000|559105998|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
155119144|NCT00075725|559868477|FG004|Overall Study|Disease Progression, all other reasons|21|||
155119145|NCT00075725|559868478|FG005|Overall Study|Disease Progression, all other reasons|59|||
155119146|NCT00075725|559868479|FG006|Overall Study|Disease Progression, all other reasons|20|||
155119147|NCT00075725|559868480|FG007|Overall Study|Disease Progression, all other reasons|46|||
155119148|NCT00075725|559868481|FG008|Overall Study|Disease Progression, all other reasons|21|||
154914244|NCT02418000|559105999|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
154914245|NCT02418000|559105995|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914246|NCT02418000|559105996|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154986565|NCT02221037|559377303|FG002|Overall Study|Physician Decision|1|||
154986566|NCT02221037|559377304|FG003|Overall Study|Physician Decision|0|||
154986567|NCT02307266|559377305|FG000|Overall Study|Adverse Event|3|||
154914247|NCT02418000|559105997|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914248|NCT02418000|559105998|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
154914249|NCT02418000|559105999|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
154914250|NCT00490815|559106004|FG000|Overall Study|Adverse Event|2|||
154914251|NCT00490815|559106005|FG001|Overall Study|Adverse Event|3|||
154914252|NCT00490815|559106004|FG000|Overall Study|Withdrawal by Subject|4|||
154914253|NCT00490815|559106005|FG001|Overall Study|Withdrawal by Subject|0|||
154914254|NCT00490815|559106004|FG000|Overall Study|Lost to Follow-up|1|||
154914255|NCT00490815|559106005|FG001|Overall Study|Lost to Follow-up|3|||
154914256|NCT00490815|559106004|FG000|Overall Study|Death|1|||
154914257|NCT00490815|559106005|FG001|Overall Study|Death|3|||
154914258|NCT02195531|559106010|FG000|Overall Study|Withdrawal by Subject|1|||
154914259|NCT02195531|559106011|FG001|Overall Study|Withdrawal by Subject|1|||
154914260|NCT02195531|559106012|FG002|Overall Study|Withdrawal by Subject|1|||
154914261|NCT01284127|559106013|FG000|Overall Study|Adverse Event|2|||
154914262|NCT01284127|559106013|FG000|Overall Study|Withdrawal by Subject|4|||
154914263|NCT01284127|559106013|FG000|Overall Study|Physician Decision|1|||
154914264|NCT02516306|559106014|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
154914265|NCT02516306|559106015|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
154914266|NCT03227692|559106017|FG000|Overall Study|Protocol Violation|1|||
154914267|NCT03227692|559106018|FG001|Overall Study|Protocol Violation|1|||
154914268|NCT03227692|559106017|FG000|Overall Study|Lost to Follow-up|4|||
154914269|NCT03227692|559106018|FG001|Overall Study|Lost to Follow-up|2|||
154914270|NCT03227692|559106017|FG000|Overall Study|Adverse Event|0|||
154914271|NCT03227692|559106018|FG001|Overall Study|Adverse Event|2|||
154914272|NCT00256204|559106019|FG000|Overall Study|Adverse Event|10|||
154914273|NCT00256204|559106020|FG001|Overall Study|Adverse Event|14|||
154914274|NCT00256204|559106021|FG002|Overall Study|Adverse Event|16|||
154914275|NCT00256204|559106022|FG003|Overall Study|Adverse Event|14|||
154914276|NCT00256204|559106019|FG000|Overall Study|Death|0|||
154914277|NCT00256204|559106020|FG001|Overall Study|Death|1|||
154914278|NCT00256204|559106021|FG002|Overall Study|Death|0|||
154914279|NCT00256204|559106022|FG003|Overall Study|Death|0|||
154914280|NCT00256204|559106019|FG000|Overall Study|Lost to Follow-up|1|||
154914281|NCT00256204|559106020|FG001|Overall Study|Lost to Follow-up|1|||
154914282|NCT00256204|559106021|FG002|Overall Study|Lost to Follow-up|1|||
154914283|NCT00256204|559106022|FG003|Overall Study|Lost to Follow-up|2|||
154914284|NCT00256204|559106019|FG000|Overall Study|Protocol Violation|1|||
154914285|NCT00256204|559106020|FG001|Overall Study|Protocol Violation|0|||
154914286|NCT00256204|559106021|FG002|Overall Study|Protocol Violation|2|||
154914287|NCT00256204|559106022|FG003|Overall Study|Protocol Violation|1|||
154914288|NCT00256204|559106019|FG000|Overall Study|Physician Decision|0|||
154914289|NCT00256204|559106020|FG001|Overall Study|Physician Decision|0|||
154914290|NCT00256204|559106021|FG002|Overall Study|Physician Decision|1|||
154914291|NCT00256204|559106022|FG003|Overall Study|Physician Decision|2|||
154914292|NCT00256204|559106019|FG000|Overall Study|Withdrawal by Subject|17|||
154914293|NCT00256204|559106020|FG001|Overall Study|Withdrawal by Subject|6|||
154914294|NCT00256204|559106021|FG002|Overall Study|Withdrawal by Subject|7|||
154914295|NCT00256204|559106022|FG003|Overall Study|Withdrawal by Subject|5|||
154914296|NCT00256204|559106019|FG000|Overall Study|Need for additional prohibited treatment|38|||
154914297|NCT00256204|559106020|FG001|Overall Study|Need for additional prohibited treatment|28|||
154914298|NCT00256204|559106021|FG002|Overall Study|Need for additional prohibited treatment|27|||
154914299|NCT00256204|559106022|FG003|Overall Study|Need for additional prohibited treatment|25|||
154914300|NCT01351415|559106023|FG000|Overall Study|Withdrawal by Subject|15|||
154914301|NCT01351415|559106024|FG001|Overall Study|Withdrawal by Subject|17|||
154914302|NCT01351415|559106023|FG000|Overall Study|Trial termination by the Sponsor|28|||
154914303|NCT01351415|559106024|FG001|Overall Study|Trial termination by the Sponsor|19|||
154914304|NCT01351415|559106023|FG000|Overall Study|Lost to Follow-up|5|||
154914305|NCT01351415|559106024|FG001|Overall Study|Lost to Follow-up|7|||
154914306|NCT01351415|559106023|FG000|Overall Study|Death|190|||
154914307|NCT01351415|559106024|FG001|Overall Study|Death|187|||
154914308|NCT01351415|559106023|FG000|Overall Study|Physician Decision|2|||
154914309|NCT01351415|559106024|FG001|Overall Study|Physician Decision|3|||
154914310|NCT01351415|559106023|FG000|Overall Study|Reason unknown|0|||
154914311|NCT01351415|559106024|FG001|Overall Study|Reason unknown|2|||
154914312|NCT01351415|559106023|FG000|Overall Study|Never Started|5|||
154914313|NCT01351415|559106024|FG001|Overall Study|Never Started|5|||
154914314|NCT00699582|559106032|FG000|Overall Study|Adverse Event|4|||
154914315|NCT00699582|559106033|FG001|Overall Study|Adverse Event|11|||
154914316|NCT00699582|559106034|FG002|Overall Study|Adverse Event|23|||
154914317|NCT00699582|559106032|FG000|Overall Study|Withdrawal by Subject|6|||
154914318|NCT00699582|559106033|FG001|Overall Study|Withdrawal by Subject|7|||
154914319|NCT00699582|559106034|FG002|Overall Study|Withdrawal by Subject|4|||
154914320|NCT00699582|559106032|FG000|Overall Study|Lack of Efficacy|1|||
154914321|NCT00699582|559106033|FG001|Overall Study|Lack of Efficacy|0|||
154914322|NCT00699582|559106034|FG002|Overall Study|Lack of Efficacy|1|||
154914323|NCT00699582|559106032|FG000|Overall Study|Progressive Disease|1|||
154914324|NCT00699582|559106033|FG001|Overall Study|Progressive Disease|0|||
154914325|NCT00699582|559106034|FG002|Overall Study|Progressive Disease|0|||
154914326|NCT00699582|559106032|FG000|Overall Study|Administrative/Other|4|||
154914327|NCT00699582|559106033|FG001|Overall Study|Administrative/Other|3|||
154914328|NCT00699582|559106034|FG002|Overall Study|Administrative/Other|0|||
154914329|NCT00699582|559106032|FG000|Overall Study|Randomized, Not Treated|2|||
154914330|NCT00699582|559106033|FG001|Overall Study|Randomized, Not Treated|1|||
154914331|NCT00699582|559106034|FG002|Overall Study|Randomized, Not Treated|0|||
154914332|NCT03117309|559106037|FG000|Overall Study|Not meeting inclusion criteria|0|||
154914333|NCT03117309|559106038|FG001|Overall Study|Not meeting inclusion criteria|1|||
154914334|NCT01142791|559106057|FG000|Overall Study|Alternative Treatment|1|||
154914335|NCT01142791|559106058|FG001|Overall Study|Alternative Treatment|0|||
154914336|NCT01142791|559106057|FG000|Overall Study|Lost to Follow-up|1|||
154914337|NCT01142791|559106058|FG001|Overall Study|Lost to Follow-up|0|||
154914338|NCT01142791|559106057|FG000|Overall Study|Withdrawal by Subject|5|||
154914339|NCT01142791|559106058|FG001|Overall Study|Withdrawal by Subject|0|||
154914340|NCT01142791|559106057|FG000|Overall Study|Received only 1 sonication|0|||
154914341|NCT01142791|559106058|FG001|Overall Study|Received only 1 sonication|6|||
154914342|NCT01981096|559106060|FG000|Overall Study|Parent illness|1|||
154914343|NCT01981096|559106061|FG001|Overall Study|Parent illness|0|||
154914344|NCT01981096|559106060|FG000|Overall Study|Withdrawal by Subject|0|||
154914345|NCT01981096|559106061|FG001|Overall Study|Withdrawal by Subject|1|||
154914346|NCT01981096|559106060|FG000|Overall Study|Lost to Follow-up|2|||
154914347|NCT01981096|559106061|FG001|Overall Study|Lost to Follow-up|0|||
154914348|NCT01454531|559106062|FG000|Overall Study|Adverse Event|14|||
154914349|NCT01454531|559106062|FG000|Overall Study|Withdrawal by Subject|5|||
154914350|NCT01454531|559106062|FG000|Overall Study|Lost to Follow-up|1|||
154914351|NCT01454531|559106062|FG000|Overall Study|Physician Decision|1|||
154914352|NCT01454531|559106062|FG000|Overall Study|Delay in IMP administration|1|||
154914353|NCT01454531|559106062|FG000|Overall Study|Other|1|||
154914354|NCT01277666|559106063|FG000|Overall Study|Adverse Event|26|||
154914355|NCT01277666|559106064|FG001|Overall Study|Adverse Event|25|||
154914356|NCT01277666|559106065|FG002|Overall Study|Adverse Event|20|||
154914357|NCT01277666|559106063|FG000|Overall Study|Lack of Efficacy|8|||
154914358|NCT01277666|559106064|FG001|Overall Study|Lack of Efficacy|20|||
154914359|NCT01277666|559106065|FG002|Overall Study|Lack of Efficacy|12|||
154914360|NCT01277666|559106063|FG000|Overall Study|Protocol Violation|2|||
154914361|NCT01277666|559106064|FG001|Overall Study|Protocol Violation|3|||
154914362|NCT01277666|559106065|FG002|Overall Study|Protocol Violation|2|||
154914363|NCT01277666|559106063|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
154914364|NCT01277666|559106064|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
154914365|NCT01277666|559106065|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
154914366|NCT01277666|559106063|FG000|Overall Study|Lost to Follow-up|1|||
154914367|NCT01277666|559106064|FG001|Overall Study|Lost to Follow-up|1|||
154914368|NCT01277666|559106065|FG002|Overall Study|Lost to Follow-up|2|||
154914369|NCT01277666|559106063|FG000|Overall Study|Withdrawal by Subject|7|||
154914370|NCT01277666|559106064|FG001|Overall Study|Withdrawal by Subject|8|||
154914371|NCT01277666|559106065|FG002|Overall Study|Withdrawal by Subject|6|||
154914372|NCT01277666|559106063|FG000|Overall Study|Death|0|||
154914373|NCT01277666|559106064|FG001|Overall Study|Death|0|||
154914374|NCT01277666|559106065|FG002|Overall Study|Death|1|||
154914375|NCT02886338|559106066|FG000|Overall Study|Withdrawal by Subject|1|||
154914376|NCT06334055|559106068|FG000|Overall Study|Adverse Event|4|||
154914377|NCT06334055|559106068|FG000|Overall Study|Disqualified|72|||
154914378|NCT02146274|559107942|FG000|Overall Study|Protocol Violation|73|||
154914379|NCT02500901|559107956|FG000|Overall Study|Disease ProgressionDD|2|||
154914380|NCT00656136|559107957|FG000|Overall Study|Progressive disease|177|||
154914381|NCT00656136|559107958|FG001|Overall Study|Progressive disease|322|||
154914382|NCT00656136|559107957|FG000|Overall Study|Other Adverse Event|5|||
154914383|NCT00656136|559107958|FG001|Overall Study|Other Adverse Event|51|||
154914384|NCT00656136|559107957|FG000|Overall Study|Protocol Violation|2|||
154914385|NCT00656136|559107958|FG001|Overall Study|Protocol Violation|3|||
154914386|NCT00656136|559107957|FG000|Overall Study|Patient refused to take study medication|7|||
154914387|NCT00656136|559107958|FG001|Overall Study|Patient refused to take study medication|10|||
154914388|NCT00656136|559107957|FG000|Overall Study|Unknown and others|4|||
154914389|NCT00656136|559107958|FG001|Overall Study|Unknown and others|4|||
154914390|NCT03938857|559107966|FG000|Overall Study|Physician Decision|1|||
154914391|NCT03938857|559107967|FG001|Overall Study|Physician Decision|0|||
154914392|NCT03938857|559107968|FG002|Overall Study|Physician Decision|0|||
154914393|NCT03938857|559107969|FG003|Overall Study|Physician Decision|0|||
154914394|NCT02127970|559107970|FG000|Overall Study|Adverse Event|2|||
154914395|NCT02127970|559107971|FG001|Overall Study|Adverse Event|1|||
154914396|NCT02127970|559107970|FG000|Overall Study|Death|1|||
154914397|NCT02127970|559107971|FG001|Overall Study|Death|1|||
154914398|NCT02127970|559107970|FG000|Overall Study|Lost to Follow-up|14|||
154914399|NCT02127970|559107971|FG001|Overall Study|Lost to Follow-up|14|||
154914400|NCT02127970|559107970|FG000|Overall Study|Reason not Specified|4|||
154914401|NCT02127970|559107971|FG001|Overall Study|Reason not Specified|7|||
154914402|NCT02127970|559107970|FG000|Overall Study|Pregnancy|0|||
154914403|NCT02127970|559107971|FG001|Overall Study|Pregnancy|1|||
154914404|NCT02127970|559107970|FG000|Overall Study|Subject Withdrew Consent|5|||
154914405|NCT02127970|559107971|FG001|Overall Study|Subject Withdrew Consent|3|||
154914406|NCT01398176|559107972|FG000|Overall Study|Lost to Follow-up|1|||
154914407|NCT01398176|559107973|FG001|Overall Study|Lost to Follow-up|3|||
154914408|NCT01398176|559107972|FG000|Overall Study|Physician Decision|2|||
154914409|NCT01398176|559107973|FG001|Overall Study|Physician Decision|3|||
154914410|NCT00542321|559107974|FG000|Overall Study|Death|0|||
154914411|NCT00542321|559107975|FG001|Overall Study|Death|1|||
154914412|NCT01871870|559107979|FG000|Overall Study|Hardware issues|7|||
154914413|NCT01871870|559107979|FG000|Overall Study|hyperglycemia|2|||
154914414|NCT02988115|559107985|FG000|Overall Study|Adverse Event|6|||
154914415|NCT02988115|559107986|FG001|Overall Study|Adverse Event|1|||
154914416|NCT02988115|559107985|FG000|Overall Study|Sponsor Decision|5|||
154914417|NCT02988115|559107986|FG001|Overall Study|Sponsor Decision|2|||
154914418|NCT02988115|559107985|FG000|Overall Study|Withdrawal by Subject|1|||
154914419|NCT02988115|559107986|FG001|Overall Study|Withdrawal by Subject|1|||
154914420|NCT02988115|559107985|FG000|Overall Study|Withdrawn by Mistake|1|||
154914421|NCT02988115|559107986|FG001|Overall Study|Withdrawn by Mistake|0|||
154914422|NCT02988115|559107985|FG000|Overall Study|Lost to Follow-up|1|||
154914423|NCT02988115|559107986|FG001|Overall Study|Lost to Follow-up|0|||
154914424|NCT00253747|559107987|FG000|Overall Study|Lost to Follow-up|13|||
154914425|NCT00253747|559107988|FG001|Overall Study|Lost to Follow-up|14|||
154914426|NCT00253747|559107987|FG000|Overall Study|Withdrawal by Subject|10|||
154914427|NCT00253747|559107988|FG001|Overall Study|Withdrawal by Subject|11|||
154914428|NCT00253747|559107987|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
154914429|NCT00253747|559107988|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
154914430|NCT00104299|559107990|FG000|Overall Study|Adverse Event|3|||
154914431|NCT00104299|559107991|FG001|Overall Study|Adverse Event|1|||
154914432|NCT00104299|559107990|FG000|Overall Study|Death|2|||
154914433|NCT00104299|559107991|FG001|Overall Study|Death|2|||
154914434|NCT00104299|559107990|FG000|Overall Study|Withdrawal by Subject|2|||
154914435|NCT00104299|559107991|FG001|Overall Study|Withdrawal by Subject|6|||
154914436|NCT00104299|559107990|FG000|Overall Study|Physician Decision|1|||
154914437|NCT00104299|559107991|FG001|Overall Study|Physician Decision|1|||
154914438|NCT00104299|559107990|FG000|Overall Study|To have renal transplant|1|||
154914439|NCT00104299|559107991|FG001|Overall Study|To have renal transplant|0|||
154914440|NCT02452034|559107992|FG000|Overall Study|Adverse Event|0|||
154914441|NCT02452034|559107993|FG001|Overall Study|Adverse Event|0|||
154914442|NCT02452034|559107994|FG002|Overall Study|Adverse Event|0|||
154914443|NCT02452034|559107995|FG003|Overall Study|Adverse Event|0|||
154914444|NCT02452034|559107996|FG004|Overall Study|Adverse Event|0|||
154914445|NCT02452034|559107997|FG005|Overall Study|Adverse Event|1|||
154914446|NCT02452034|559107992|FG000|Overall Study|Death|0|||
154914447|NCT02452034|559107993|FG001|Overall Study|Death|0|||
154914448|NCT02452034|559107994|FG002|Overall Study|Death|0|||
154914449|NCT02452034|559107995|FG003|Overall Study|Death|0|||
154914450|NCT02452034|559107996|FG004|Overall Study|Death|1|||
154914451|NCT02452034|559107997|FG005|Overall Study|Death|1|||
154914452|NCT02452034|559107992|FG000|Overall Study|Physician Decision|0|||
154914453|NCT02452034|559107993|FG001|Overall Study|Physician Decision|1|||
154914454|NCT02452034|559107994|FG002|Overall Study|Physician Decision|1|||
154914455|NCT02452034|559107995|FG003|Overall Study|Physician Decision|0|||
154914456|NCT02452034|559107996|FG004|Overall Study|Physician Decision|0|||
154914457|NCT02452034|559107997|FG005|Overall Study|Physician Decision|0|||
154914458|NCT02452034|559107992|FG000|Overall Study|Protocol Violation|0|||
154914459|NCT02452034|559107993|FG001|Overall Study|Protocol Violation|0|||
154914460|NCT02452034|559107994|FG002|Overall Study|Protocol Violation|0|||
154914461|NCT02452034|559107995|FG003|Overall Study|Protocol Violation|0|||
154914462|NCT02452034|559107996|FG004|Overall Study|Protocol Violation|0|||
154914463|NCT02452034|559107997|FG005|Overall Study|Protocol Violation|1|||
154914464|NCT02452034|559107992|FG000|Overall Study|Screen Failure|1|||
154914465|NCT02452034|559107993|FG001|Overall Study|Screen Failure|0|||
154914466|NCT02452034|559107994|FG002|Overall Study|Screen Failure|0|||
154914467|NCT02452034|559107995|FG003|Overall Study|Screen Failure|1|||
154914468|NCT02452034|559107996|FG004|Overall Study|Screen Failure|0|||
154914469|NCT02452034|559107997|FG005|Overall Study|Screen Failure|0|||
154914470|NCT02452034|559107992|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
154914471|NCT02452034|559107993|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
154914472|NCT02452034|559107994|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
154914473|NCT02452034|559107995|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
154914474|NCT02452034|559107996|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
154914475|NCT02452034|559107997|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
154914476|NCT03288987|559107999|FG000|Overall Study|Protocol Violation|10|||
154914477|NCT03288987|559108000|FG001|Overall Study|Protocol Violation|4|||
154914478|NCT01904760|559108002|FG000|Overall Study|Protocol Violation|1|||
154914479|NCT01904760|559108003|FG001|Overall Study|Protocol Violation|0|||
154914480|NCT00732199|559108008|FG000|Overall Study|Withdrawal by Subject|25|||
154914481|NCT00732199|559108009|FG001|Overall Study|Withdrawal by Subject|18|||
154914482|NCT00732199|559108008|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
154914483|NCT00732199|559108009|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
154914484|NCT02242305|559108018|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
154914485|NCT02242305|559108019|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
154914486|NCT02242305|559108018|FG000|Overall Study|Adverse Event|1|||
154914487|NCT02242305|559108019|FG001|Overall Study|Adverse Event|0|||
154914488|NCT02242305|559108018|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
154914489|NCT02242305|559108019|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
154914490|NCT02242305|559108018|FG000|Overall Study|Subject withdraws inform consent|0|||
154914491|NCT02242305|559108019|FG001|Overall Study|Subject withdraws inform consent|4|||
154914492|NCT02242305|559108018|FG000|Overall Study|Lost to Follow-up|2|||
154914493|NCT02242305|559108019|FG001|Overall Study|Lost to Follow-up|0|||
154914494|NCT03018028|559108022|FG000|Overall Study|Withdrawal by Subject|3|||
154914495|NCT03018028|559108023|FG001|Overall Study|Withdrawal by Subject|0|||
154914496|NCT03018028|559108024|FG002|Overall Study|Withdrawal by Subject|1|||
154914497|NCT03018028|559108025|FG003|Overall Study|Withdrawal by Subject|2|||
154914498|NCT03018028|559108026|FG004|Overall Study|Withdrawal by Subject|0|||
154914499|NCT02543801|559108030|FG000|Overall Study|Protocol Violation|1|||
154914500|NCT02543801|559108031|FG001|Overall Study|Protocol Violation|2|||
154914501|NCT02543801|559108032|FG002|Overall Study|Protocol Violation|0|||
154914502|NCT02543801|559108033|FG003|Overall Study|Protocol Violation|0|||
154914503|NCT01756846|559108034|FG000|Overall Study|Lost to Follow-up|5|||
154914504|NCT01756846|559108035|FG001|Overall Study|Lost to Follow-up|10|||
154914505|NCT01756846|559108034|FG000|Overall Study|Withdrawal by Subject|1|||
154914506|NCT01756846|559108035|FG001|Overall Study|Withdrawal by Subject|2|||
154914507|NCT03490734|559108043|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
154914508|NCT03490734|559108044|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
154914509|NCT03490734|559108045|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
154914510|NCT03490734|559108046|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
154914511|NCT03490734|559108043|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
154914512|NCT03490734|559108044|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
154914513|NCT03490734|559108045|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
154914514|NCT03490734|559108046|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
154914515|NCT03490734|559108043|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
154914516|NCT03490734|559108044|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
154914517|NCT03490734|559108045|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
154914518|NCT03490734|559108046|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
154914519|NCT03490734|559108043|FG000|Post-intervention Scan Visit|Adverse Event|2|||
154914520|NCT03490734|559108044|FG001|Post-intervention Scan Visit|Adverse Event|0|||
154914521|NCT03490734|559108045|FG002|Post-intervention Scan Visit|Adverse Event|0|||
154914522|NCT03490734|559108046|FG003|Post-intervention Scan Visit|Adverse Event|0|||
154914523|NCT03490734|559108043|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
154914524|NCT03490734|559108044|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
154914525|NCT03490734|559108045|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
154914526|NCT03490734|559108046|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
154914527|NCT03490734|559108043|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
154914528|NCT03490734|559108044|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
154914529|NCT03490734|559108045|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
154914530|NCT03490734|559108046|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
154914531|NCT02692560|559108052|FG000|Overall Study|Withdrawal by Subject|0|||
154914532|NCT02692560|559108053|FG001|Overall Study|Withdrawal by Subject|6|||
154914533|NCT00715949|559108056|FG000|Overall Study|could not finish first test|4|||
154914534|NCT00420212|559108057|FG000|Overall Study|Adverse Event|22|||
154914535|NCT00420212|559108058|FG001|Overall Study|Adverse Event|40|||
154914536|NCT00420212|559108059|FG002|Overall Study|Adverse Event|36|||
154914537|NCT00420212|559108057|FG000|Overall Study|Lost to Follow-up|9|||
154914538|NCT00420212|559108058|FG001|Overall Study|Lost to Follow-up|11|||
154914539|NCT00420212|559108059|FG002|Overall Study|Lost to Follow-up|11|||
154914540|NCT00420212|559108057|FG000|Overall Study|Withdrawal by Subject|31|||
154914541|NCT00420212|559108058|FG001|Overall Study|Withdrawal by Subject|22|||
154914542|NCT00420212|559108059|FG002|Overall Study|Withdrawal by Subject|19|||
154914543|NCT00420212|559108057|FG000|Overall Study|Physician Decision|4|||
154914544|NCT00420212|559108058|FG001|Overall Study|Physician Decision|4|||
154914545|NCT00420212|559108059|FG002|Overall Study|Physician Decision|3|||
154914546|NCT00420212|559108057|FG000|Overall Study|Protocol Violation|4|||
155176292|NCT01958489|560083935|FG001|Period 2|Adverse Event|1|||
154914547|NCT00420212|559108058|FG001|Overall Study|Protocol Violation|4|||
154914548|NCT00420212|559108059|FG002|Overall Study|Protocol Violation|8|||
154914549|NCT00420212|559108057|FG000|Overall Study|Death|0|||
154914550|NCT00420212|559108058|FG001|Overall Study|Death|0|||
154914551|NCT00420212|559108059|FG002|Overall Study|Death|1|||
154914552|NCT00420212|559108057|FG000|Overall Study|Other-Unspecified|21|||
154914553|NCT00420212|559108058|FG001|Overall Study|Other-Unspecified|14|||
154914554|NCT00420212|559108059|FG002|Overall Study|Other-Unspecified|18|||
155176293|NCT00917644|560083936|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
154914555|NCT01326910|559108060|FG000|Overall Study|Withdrawal by Subject|3|||
154914556|NCT01326910|559108061|FG001|Overall Study|Withdrawal by Subject|2|||
154914557|NCT01326910|559108060|FG000|Overall Study|Protocol Violation|1|||
154914558|NCT01326910|559108061|FG001|Overall Study|Protocol Violation|1|||
154914559|NCT02274766|559108064|FG000|Overall Study|Withdrawal by Subject|3|||
154914560|NCT02274766|559108065|FG001|Overall Study|Withdrawal by Subject|6|||
154914561|NCT02274766|559108064|FG000|Overall Study|Did Not Receive Study Drug|1|||
154914562|NCT02274766|559108065|FG001|Overall Study|Did Not Receive Study Drug|1|||
154914563|NCT02274766|559108064|FG000|Overall Study|Subject Unwilling to Proceed|0|||
154914564|NCT02274766|559108065|FG001|Overall Study|Subject Unwilling to Proceed|1|||
154914565|NCT02274766|559108064|FG000|Overall Study|Adverse Event|0|||
154914566|NCT02274766|559108065|FG001|Overall Study|Adverse Event|1|||
154914567|NCT02394028|559108068|FG000|Induction Phase|Adverse Event|2|||
154914568|NCT02394028|559108069|FG001|Induction Phase|Adverse Event|4|||
154914569|NCT02394028|559108070|FG002|Induction Phase|Adverse Event|1|||
154914570|NCT02394028|559108071|FG003|Induction Phase|Adverse Event|2|||
154914571|NCT02394028|559108072|FG004|Induction Phase|Adverse Event|5|||
154914572|NCT02394028|559108073|FG005|Induction Phase|Adverse Event|2|||
154914573|NCT02394028|559108074|FG006|Induction Phase|Adverse Event|0|||
154914574|NCT02394028|559108075|FG007|Induction Phase|Adverse Event|0|||
154914575|NCT02394028|559108076|FG008|Induction Phase|Adverse Event|0|||
154914576|NCT02394028|559108077|FG009|Induction Phase|Adverse Event|0|||
154914577|NCT02394028|559108078|FG010|Induction Phase|Adverse Event|0|||
154914578|NCT02394028|559108068|FG000|Induction Phase|Lack of Efficacy|3|||
154914579|NCT02394028|559108069|FG001|Induction Phase|Lack of Efficacy|6|||
154914580|NCT02394028|559108070|FG002|Induction Phase|Lack of Efficacy|2|||
154914581|NCT02394028|559108071|FG003|Induction Phase|Lack of Efficacy|17|||
154914582|NCT02394028|559108072|FG004|Induction Phase|Lack of Efficacy|14|||
154914583|NCT02394028|559108073|FG005|Induction Phase|Lack of Efficacy|8|||
154914584|NCT02394028|559108074|FG006|Induction Phase|Lack of Efficacy|17|||
154914585|NCT02394028|559108075|FG007|Induction Phase|Lack of Efficacy|23|||
154914586|NCT02394028|559108076|FG008|Induction Phase|Lack of Efficacy|0|||
154914587|NCT02394028|559108077|FG009|Induction Phase|Lack of Efficacy|0|||
154914588|NCT02394028|559108078|FG010|Induction Phase|Lack of Efficacy|0|||
154914589|NCT02394028|559108068|FG000|Induction Phase|Lost to Follow-up|1|||
154914590|NCT02394028|559108069|FG001|Induction Phase|Lost to Follow-up|0|||
154914591|NCT02394028|559108070|FG002|Induction Phase|Lost to Follow-up|0|||
154914592|NCT02394028|559108071|FG003|Induction Phase|Lost to Follow-up|1|||
154914593|NCT02394028|559108072|FG004|Induction Phase|Lost to Follow-up|0|||
154914594|NCT02394028|559108073|FG005|Induction Phase|Lost to Follow-up|0|||
154914595|NCT02394028|559108074|FG006|Induction Phase|Lost to Follow-up|1|||
154914596|NCT02394028|559108075|FG007|Induction Phase|Lost to Follow-up|0|||
154914597|NCT02394028|559108076|FG008|Induction Phase|Lost to Follow-up|0|||
154914598|NCT02394028|559108077|FG009|Induction Phase|Lost to Follow-up|0|||
154914599|NCT02394028|559108078|FG010|Induction Phase|Lost to Follow-up|0|||
154914600|NCT02394028|559108068|FG000|Induction Phase|Non-compliance|0|||
154914601|NCT02394028|559108069|FG001|Induction Phase|Non-compliance|1|||
154914602|NCT02394028|559108070|FG002|Induction Phase|Non-compliance|3|||
154914603|NCT02394028|559108071|FG003|Induction Phase|Non-compliance|1|||
154914604|NCT02394028|559108072|FG004|Induction Phase|Non-compliance|3|||
154914605|NCT02394028|559108073|FG005|Induction Phase|Non-compliance|0|||
154914606|NCT02394028|559108074|FG006|Induction Phase|Non-compliance|1|||
154914607|NCT02394028|559108075|FG007|Induction Phase|Non-compliance|1|||
154914608|NCT02394028|559108076|FG008|Induction Phase|Non-compliance|0|||
154914609|NCT02394028|559108077|FG009|Induction Phase|Non-compliance|0|||
154914610|NCT02394028|559108078|FG010|Induction Phase|Non-compliance|0|||
154914611|NCT02394028|559108068|FG000|Induction Phase|Physician Decision|0|||
154914612|NCT02394028|559108069|FG001|Induction Phase|Physician Decision|0|||
154914613|NCT02394028|559108070|FG002|Induction Phase|Physician Decision|1|||
154914614|NCT02394028|559108071|FG003|Induction Phase|Physician Decision|4|||
154914615|NCT02394028|559108072|FG004|Induction Phase|Physician Decision|0|||
154914616|NCT02394028|559108073|FG005|Induction Phase|Physician Decision|2|||
154914617|NCT02394028|559108074|FG006|Induction Phase|Physician Decision|1|||
154914618|NCT02394028|559108075|FG007|Induction Phase|Physician Decision|0|||
154914619|NCT02394028|559108076|FG008|Induction Phase|Physician Decision|0|||
154986568|NCT02307266|559377306|FG001|Overall Study|Adverse Event|1|||
154914620|NCT02394028|559108077|FG009|Induction Phase|Physician Decision|0|||
154914621|NCT02394028|559108078|FG010|Induction Phase|Physician Decision|0|||
154914622|NCT02394028|559108068|FG000|Induction Phase|Protocol Violation|0|||
154986569|NCT02307266|559377307|FG002|Overall Study|Adverse Event|5|||
154986570|NCT02307266|559377305|FG000|Overall Study|Withdrawal by Subject|2|||
154914623|NCT02394028|559108069|FG001|Induction Phase|Protocol Violation|2|||
154914624|NCT02394028|559108070|FG002|Induction Phase|Protocol Violation|0|||
154914625|NCT02394028|559108071|FG003|Induction Phase|Protocol Violation|3|||
154914626|NCT02394028|559108072|FG004|Induction Phase|Protocol Violation|0|||
154914627|NCT02394028|559108073|FG005|Induction Phase|Protocol Violation|1|||
154914628|NCT02394028|559108074|FG006|Induction Phase|Protocol Violation|1|||
154914629|NCT02394028|559108075|FG007|Induction Phase|Protocol Violation|0|||
154986571|NCT02307266|559377306|FG001|Overall Study|Withdrawal by Subject|0|||
155119149|NCT00075725|559868482|FG009|Overall Study|Disease Progression, all other reasons|4|||
155119150|NCT00075725|559868483|FG010|Overall Study|Disease Progression, all other reasons|0|||
155119151|NCT00075725|559868484|FG011|Overall Study|Disease Progression, all other reasons|5|||
155119152|NCT00075725|559868473|FG000|Overall Study|Patient off treatment|0|||
155119153|NCT00075725|559868474|FG001|Overall Study|Patient off treatment|0|||
155119154|NCT00075725|559868475|FG002|Overall Study|Patient off treatment|1|||
155119155|NCT00075725|559868476|FG003|Overall Study|Patient off treatment|2|||
155119156|NCT00075725|559868477|FG004|Overall Study|Patient off treatment|1|||
155119157|NCT00075725|559868478|FG005|Overall Study|Patient off treatment|0|||
155119158|NCT00075725|559868479|FG006|Overall Study|Patient off treatment|0|||
155119159|NCT00075725|559868480|FG007|Overall Study|Patient off treatment|2|||
155119160|NCT00075725|559868481|FG008|Overall Study|Patient off treatment|1|||
155119161|NCT00075725|559868482|FG009|Overall Study|Patient off treatment|0|||
155119162|NCT00075725|559868483|FG010|Overall Study|Patient off treatment|0|||
155119163|NCT00075725|559868484|FG011|Overall Study|Patient off treatment|0|||
155119164|NCT00075725|559868473|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
155119165|NCT00075725|559868474|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
155119166|NCT00075725|559868475|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
155119167|NCT00075725|559868476|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
155119168|NCT00075725|559868477|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
155119169|NCT00075725|559868478|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
155119170|NCT00075725|559868479|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
155119171|NCT00075725|559868480|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
155119172|NCT00075725|559868481|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
155119173|NCT00075725|559868482|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
155119174|NCT00075725|559868483|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
155119175|NCT00075725|559868484|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
155119176|NCT00075725|559868473|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
155119177|NCT00075725|559868474|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
155119178|NCT00075725|559868475|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
155119179|NCT00075725|559868476|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
155119180|NCT00075725|559868477|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
155119181|NCT00075725|559868478|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
155119182|NCT00075725|559868479|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
155119183|NCT00075725|559868480|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
155119184|NCT00075725|559868481|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
155119185|NCT00075725|559868482|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
155119186|NCT00075725|559868483|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
155119187|NCT00075725|559868484|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
155119188|NCT00075725|559868473|FG000|Overall Study|Pt non compliant with therapy|2|||
155119189|NCT00075725|559868474|FG001|Overall Study|Pt non compliant with therapy|1|||
155119190|NCT00075725|559868475|FG002|Overall Study|Pt non compliant with therapy|1|||
155119191|NCT00075725|559868476|FG003|Overall Study|Pt non compliant with therapy|0|||
155119192|NCT00075725|559868477|FG004|Overall Study|Pt non compliant with therapy|2|||
155119193|NCT00075725|559868478|FG005|Overall Study|Pt non compliant with therapy|14|||
155119194|NCT00075725|559868479|FG006|Overall Study|Pt non compliant with therapy|2|||
155119195|NCT00075725|559868480|FG007|Overall Study|Pt non compliant with therapy|5|||
155119196|NCT00075725|559868481|FG008|Overall Study|Pt non compliant with therapy|3|||
155119197|NCT00075725|559868482|FG009|Overall Study|Pt non compliant with therapy|0|||
155119198|NCT00075725|559868483|FG010|Overall Study|Pt non compliant with therapy|0|||
155119199|NCT00075725|559868484|FG011|Overall Study|Pt non compliant with therapy|0|||
155119200|NCT00075725|559868473|FG000|Overall Study|Pt age out of range for treatment|0|||
155119201|NCT00075725|559868474|FG001|Overall Study|Pt age out of range for treatment|1|||
155119202|NCT00075725|559868475|FG002|Overall Study|Pt age out of range for treatment|0|||
155119203|NCT00075725|559868476|FG003|Overall Study|Pt age out of range for treatment|0|||
155119204|NCT00075725|559868477|FG004|Overall Study|Pt age out of range for treatment|0|||
155119205|NCT00075725|559868478|FG005|Overall Study|Pt age out of range for treatment|1|||
155119206|NCT00075725|559868479|FG006|Overall Study|Pt age out of range for treatment|0|||
155119207|NCT00075725|559868480|FG007|Overall Study|Pt age out of range for treatment|1|||
155119208|NCT00075725|559868481|FG008|Overall Study|Pt age out of range for treatment|0|||
155119209|NCT00075725|559868482|FG009|Overall Study|Pt age out of range for treatment|0|||
155119210|NCT00075725|559868483|FG010|Overall Study|Pt age out of range for treatment|0|||
155119211|NCT00075725|559868484|FG011|Overall Study|Pt age out of range for treatment|0|||
155119212|NCT00075725|559868473|FG000|Overall Study|Insurance issues|0|||
155119213|NCT00075725|559868474|FG001|Overall Study|Insurance issues|1|||
155119214|NCT00075725|559868475|FG002|Overall Study|Insurance issues|0|||
155119215|NCT00075725|559868476|FG003|Overall Study|Insurance issues|1|||
155119216|NCT00075725|559868477|FG004|Overall Study|Insurance issues|1|||
155176294|NCT00917644|560083937|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
155176295|NCT00917644|560083936|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
155176296|NCT00917644|560083937|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
154914630|NCT02394028|559108076|FG008|Induction Phase|Protocol Violation|0|||
155119217|NCT00075725|559868478|FG005|Overall Study|Insurance issues|1|||
154914631|NCT02394028|559108077|FG009|Induction Phase|Protocol Violation|0|||
154914632|NCT02394028|559108078|FG010|Induction Phase|Protocol Violation|0|||
154914633|NCT02394028|559108068|FG000|Induction Phase|Withdrawal by Subject|1|||
154914634|NCT02394028|559108069|FG001|Induction Phase|Withdrawal by Subject|2|||
154914635|NCT02394028|559108070|FG002|Induction Phase|Withdrawal by Subject|4|||
154914636|NCT02394028|559108071|FG003|Induction Phase|Withdrawal by Subject|6|||
154914637|NCT02394028|559108072|FG004|Induction Phase|Withdrawal by Subject|7|||
154914638|NCT02394028|559108073|FG005|Induction Phase|Withdrawal by Subject|4|||
154914639|NCT02394028|559108074|FG006|Induction Phase|Withdrawal by Subject|3|||
154914640|NCT02394028|559108075|FG007|Induction Phase|Withdrawal by Subject|6|||
154914641|NCT02394028|559108076|FG008|Induction Phase|Withdrawal by Subject|0|||
154914642|NCT02394028|559108077|FG009|Induction Phase|Withdrawal by Subject|0|||
154914643|NCT02394028|559108078|FG010|Induction Phase|Withdrawal by Subject|0|||
154914644|NCT02394028|559108068|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914645|NCT02394028|559108069|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914646|NCT02394028|559108070|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914647|NCT02394028|559108071|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914648|NCT02394028|559108072|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914649|NCT02394028|559108073|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914650|NCT02394028|559108074|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
154914651|NCT02394028|559108075|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914652|NCT02394028|559108076|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914653|NCT02394028|559108077|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914654|NCT02394028|559108078|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
154914655|NCT02394028|559108068|FG000|Induction Phase|Sponsor decision|0|||
154914656|NCT02394028|559108069|FG001|Induction Phase|Sponsor decision|1|||
154914657|NCT02394028|559108070|FG002|Induction Phase|Sponsor decision|2|||
154914658|NCT02394028|559108071|FG003|Induction Phase|Sponsor decision|0|||
154914659|NCT02394028|559108072|FG004|Induction Phase|Sponsor decision|0|||
154914660|NCT02394028|559108073|FG005|Induction Phase|Sponsor decision|0|||
154914661|NCT02394028|559108074|FG006|Induction Phase|Sponsor decision|0|||
154914662|NCT02394028|559108075|FG007|Induction Phase|Sponsor decision|0|||
154914663|NCT02394028|559108076|FG008|Induction Phase|Sponsor decision|0|||
154914664|NCT02394028|559108077|FG009|Induction Phase|Sponsor decision|0|||
154914665|NCT02394028|559108078|FG010|Induction Phase|Sponsor decision|0|||
154914666|NCT02394028|559108068|FG000|Induction Phase|Technical reason|0|||
154914667|NCT02394028|559108069|FG001|Induction Phase|Technical reason|0|||
154914668|NCT02394028|559108070|FG002|Induction Phase|Technical reason|0|||
154914669|NCT02394028|559108071|FG003|Induction Phase|Technical reason|1|||
154914670|NCT02394028|559108072|FG004|Induction Phase|Technical reason|0|||
154914671|NCT02394028|559108073|FG005|Induction Phase|Technical reason|0|||
154914672|NCT02394028|559108074|FG006|Induction Phase|Technical reason|0|||
154914673|NCT02394028|559108075|FG007|Induction Phase|Technical reason|0|||
154914674|NCT02394028|559108076|FG008|Induction Phase|Technical reason|0|||
154914675|NCT02394028|559108077|FG009|Induction Phase|Technical reason|0|||
154914676|NCT02394028|559108078|FG010|Induction Phase|Technical reason|0|||
154914677|NCT02394028|559108068|FG000|Induction Phase|:ack of calculation|0|||
154914678|NCT02394028|559108069|FG001|Induction Phase|:ack of calculation|0|||
154914679|NCT02394028|559108070|FG002|Induction Phase|:ack of calculation|0|||
154914680|NCT02394028|559108071|FG003|Induction Phase|:ack of calculation|0|||
154914681|NCT02394028|559108072|FG004|Induction Phase|:ack of calculation|0|||
154914682|NCT02394028|559108073|FG005|Induction Phase|:ack of calculation|0|||
154914683|NCT02394028|559108074|FG006|Induction Phase|:ack of calculation|0|||
154914684|NCT02394028|559108075|FG007|Induction Phase|:ack of calculation|1|||
154914685|NCT02394028|559108076|FG008|Induction Phase|:ack of calculation|0|||
154914686|NCT02394028|559108077|FG009|Induction Phase|:ack of calculation|0|||
154914687|NCT02394028|559108078|FG010|Induction Phase|:ack of calculation|0|||
154914688|NCT02394028|559108068|FG000|Maintenance Phase|Protocol Violation|0|||
154914689|NCT02394028|559108069|FG001|Maintenance Phase|Protocol Violation|0|||
154914690|NCT02394028|559108070|FG002|Maintenance Phase|Protocol Violation|0|||
154914691|NCT02394028|559108071|FG003|Maintenance Phase|Protocol Violation|0|||
154914692|NCT02394028|559108072|FG004|Maintenance Phase|Protocol Violation|0|||
154914693|NCT02394028|559108073|FG005|Maintenance Phase|Protocol Violation|0|||
154914694|NCT02394028|559108074|FG006|Maintenance Phase|Protocol Violation|0|||
154914695|NCT02394028|559108075|FG007|Maintenance Phase|Protocol Violation|0|||
154914696|NCT02394028|559108076|FG008|Maintenance Phase|Protocol Violation|0|||
154914697|NCT02394028|559108077|FG009|Maintenance Phase|Protocol Violation|0|||
154914698|NCT02394028|559108078|FG010|Maintenance Phase|Protocol Violation|1|||
154914699|NCT02394028|559108068|FG000|Maintenance Phase|Physician Decision|0|||
155119218|NCT00075725|559868479|FG006|Overall Study|Insurance issues|0|||
155119219|NCT00075725|559868480|FG007|Overall Study|Insurance issues|1|||
155119220|NCT00075725|559868481|FG008|Overall Study|Insurance issues|0|||
154986572|NCT02307266|559377307|FG002|Overall Study|Withdrawal by Subject|1|||
154986573|NCT02307266|559377305|FG000|Overall Study|Lost to Follow-up|3|||
154986574|NCT02307266|559377306|FG001|Overall Study|Lost to Follow-up|0|||
154986575|NCT02307266|559377307|FG002|Overall Study|Lost to Follow-up|0|||
154986576|NCT02856880|559377309|FG000|Overall Study|Withdrawal of consent|1|||
154986577|NCT00793780|559377310|FG000|Overall Study|Withdrawal by Subject|2|||
154986578|NCT00793780|559377311|FG001|Overall Study|Withdrawal by Subject|1|||
154986579|NCT02858492|559377312|FG000|Overall Study|Withdrawal by Subject|0|||
154986580|NCT02858492|559377313|FG001|Overall Study|Withdrawal by Subject|1|||
154986581|NCT02858492|559377314|FG002|Overall Study|Withdrawal by Subject|0|||
154986582|NCT02858492|559377315|FG003|Overall Study|Withdrawal by Subject|1|||
154986583|NCT02858492|559377312|FG000|Overall Study|Adverse Event|0|||
154986584|NCT02858492|559377313|FG001|Overall Study|Adverse Event|0|||
154986585|NCT02858492|559377314|FG002|Overall Study|Adverse Event|0|||
154986586|NCT02858492|559377315|FG003|Overall Study|Adverse Event|3|||
154986587|NCT02858492|559377312|FG000|Overall Study|Lack of Efficacy|0|||
154986588|NCT02858492|559377313|FG001|Overall Study|Lack of Efficacy|0|||
154986589|NCT02858492|559377314|FG002|Overall Study|Lack of Efficacy|0|||
154986590|NCT02858492|559377315|FG003|Overall Study|Lack of Efficacy|1|||
154986591|NCT02858492|559377312|FG000|Overall Study|Protocol defined stopping criteria|0|||
154986592|NCT02858492|559377313|FG001|Overall Study|Protocol defined stopping criteria|0|||
154986593|NCT02858492|559377314|FG002|Overall Study|Protocol defined stopping criteria|0|||
154986594|NCT02858492|559377315|FG003|Overall Study|Protocol defined stopping criteria|1|||
154986595|NCT02944383|559377316|FG000|Overall Study|Lost to Follow-up|0|||
154986596|NCT02944383|559377317|FG001|Overall Study|Lost to Follow-up|0|||
154986597|NCT02944383|559377318|FG002|Overall Study|Lost to Follow-up|1|||
154986598|NCT02944383|559377316|FG000|Overall Study|Withdrawal by Subject|1|||
154986599|NCT02944383|559377317|FG001|Overall Study|Withdrawal by Subject|0|||
154986600|NCT02944383|559377318|FG002|Overall Study|Withdrawal by Subject|0|||
154986601|NCT01032018|559377321|FG000|Overall Study|Lost to Follow-up|6|||
154986602|NCT01032018|559377322|FG001|Overall Study|Lost to Follow-up|5|||
154986603|NCT01032018|559377321|FG000|Overall Study|Death|0|||
154986604|NCT01032018|559377322|FG001|Overall Study|Death|1|||
154986605|NCT00858143|559377326|FG000|Overall Study|Adverse Event|16|||
154986606|NCT00858143|559377326|FG000|Overall Study|Lack of Efficacy|4|||
154986607|NCT00858143|559377326|FG000|Overall Study|Death|7|||
154986608|NCT00858143|559377326|FG000|Overall Study|Other|23|||
154986609|NCT03853148|559377330|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
154986610|NCT03853148|559377331|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
154986611|NCT03853148|559377332|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
154986612|NCT03853148|559377333|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
154986613|NCT01293539|559377339|FG000|Overall Study|Physician Decision|1|||
154986614|NCT01248013|559377343|FG000|Overall Study|Withdrawal by Subject|14|||
154986615|NCT00841906|559377344|FG000|Overall Study|Withdrawal by Subject|2|||
154986616|NCT00841906|559377345|FG001|Overall Study|Withdrawal by Subject|0|||
154986617|NCT00076804|559377346|FG000|Overall Study|Death|9|||
154914700|NCT02394028|559108069|FG001|Maintenance Phase|Physician Decision|0|||
154914701|NCT02394028|559108070|FG002|Maintenance Phase|Physician Decision|0|||
154914702|NCT02394028|559108071|FG003|Maintenance Phase|Physician Decision|0|||
154914703|NCT02394028|559108072|FG004|Maintenance Phase|Physician Decision|0|||
154914704|NCT02394028|559108073|FG005|Maintenance Phase|Physician Decision|0|||
154914705|NCT02394028|559108074|FG006|Maintenance Phase|Physician Decision|0|||
154914706|NCT02394028|559108075|FG007|Maintenance Phase|Physician Decision|0|||
154914707|NCT02394028|559108076|FG008|Maintenance Phase|Physician Decision|1|||
154914708|NCT02394028|559108077|FG009|Maintenance Phase|Physician Decision|3|||
154914709|NCT02394028|559108078|FG010|Maintenance Phase|Physician Decision|2|||
154914710|NCT02394028|559108068|FG000|Maintenance Phase|Lack of Efficacy|0|||
154914711|NCT02394028|559108069|FG001|Maintenance Phase|Lack of Efficacy|0|||
154914712|NCT02394028|559108070|FG002|Maintenance Phase|Lack of Efficacy|0|||
154914713|NCT02394028|559108071|FG003|Maintenance Phase|Lack of Efficacy|0|||
154914714|NCT02394028|559108072|FG004|Maintenance Phase|Lack of Efficacy|0|||
154914715|NCT02394028|559108073|FG005|Maintenance Phase|Lack of Efficacy|0|||
154914716|NCT02394028|559108074|FG006|Maintenance Phase|Lack of Efficacy|0|||
154914717|NCT02394028|559108075|FG007|Maintenance Phase|Lack of Efficacy|0|||
154986618|NCT00076804|559377347|FG001|Overall Study|Death|20|||
154986619|NCT00076804|559377346|FG000|Overall Study|Lost to Follow-up|9|||
155119221|NCT00075725|559868482|FG009|Overall Study|Insurance issues|0|||
154914718|NCT02394028|559108076|FG008|Maintenance Phase|Lack of Efficacy|7|||
154914719|NCT02394028|559108077|FG009|Maintenance Phase|Lack of Efficacy|25|||
154914720|NCT02394028|559108078|FG010|Maintenance Phase|Lack of Efficacy|33|||
154914721|NCT02394028|559108068|FG000|Maintenance Phase|Death|0|||
154986620|NCT00076804|559377347|FG001|Overall Study|Lost to Follow-up|9|||
154986621|NCT00076804|559377346|FG000|Overall Study|Withdrawal by Subject|10|||
154986622|NCT00076804|559377347|FG001|Overall Study|Withdrawal by Subject|8|||
155119222|NCT00075725|559868483|FG010|Overall Study|Insurance issues|0|||
155176297|NCT00917644|560083936|FG000|Period 2: Second Intervention|family emergency|1|||
155176298|NCT00917644|560083937|FG001|Period 2: Second Intervention|family emergency|0|||
155176299|NCT01101308|560083938|FG000|Period 1|Adverse Event|2|||
155176300|NCT01101308|560083939|FG001|Period 1|Adverse Event|1|||
155176301|NCT01101308|560083938|FG000|Period 1|Positive for cotinine|1|||
155176302|NCT01101308|560083939|FG001|Period 1|Positive for cotinine|0|||
155176303|NCT02282345|560083941|FG000|Overall Study|Progression|0|||
155176304|NCT02282345|560083942|FG001|Overall Study|Progression|1|||
155176305|NCT00711516|560083943|FG000|Overall Study|Adverse Event|1|||
155176306|NCT00711516|560083944|FG001|Overall Study|Adverse Event|1|||
155176307|NCT00711516|560083943|FG000|Overall Study|Withdrawal by Subject|0|||
155176308|NCT00711516|560083944|FG001|Overall Study|Withdrawal by Subject|1|||
155176309|NCT00711516|560083943|FG000|Overall Study|Protocol Violation|0|||
155176310|NCT00711516|560083944|FG001|Overall Study|Protocol Violation|1|||
155176311|NCT01029405|560083946|FG000|Overall Study|Withdrawal by Subject|0|||
155176312|NCT01029405|560083947|FG001|Overall Study|Withdrawal by Subject|1|||
155176313|NCT01029405|560083948|FG002|Overall Study|Withdrawal by Subject|2|||
155176314|NCT01029405|560083949|FG003|Overall Study|Withdrawal by Subject|0|||
155176315|NCT01029405|560083946|FG000|Overall Study|Protocol Violation|0|||
155176316|NCT01029405|560083947|FG001|Overall Study|Protocol Violation|0|||
155176317|NCT01029405|560083948|FG002|Overall Study|Protocol Violation|0|||
155176318|NCT01029405|560083949|FG003|Overall Study|Protocol Violation|1|||
155176319|NCT01029405|560083946|FG000|Overall Study|Adverse Event|0|||
155176320|NCT01029405|560083947|FG001|Overall Study|Adverse Event|0|||
155176321|NCT01029405|560083948|FG002|Overall Study|Adverse Event|1|||
155176322|NCT01029405|560083949|FG003|Overall Study|Adverse Event|1|||
155176323|NCT01029405|560083946|FG000|Overall Study|Lost to Follow-up|2|||
155176324|NCT01029405|560083947|FG001|Overall Study|Lost to Follow-up|1|||
155176325|NCT01029405|560083948|FG002|Overall Study|Lost to Follow-up|1|||
155176326|NCT01029405|560083949|FG003|Overall Study|Lost to Follow-up|2|||
155176327|NCT01029405|560083946|FG000|Overall Study|Other|0|||
155176328|NCT01029405|560083947|FG001|Overall Study|Other|1|||
155176329|NCT01029405|560083948|FG002|Overall Study|Other|0|||
155176330|NCT01029405|560083949|FG003|Overall Study|Other|1|||
155176331|NCT00409175|560083950|FG000|Overall Study|Adverse Event|4|||
155176332|NCT00409175|560083951|FG001|Overall Study|Adverse Event|3|||
155176333|NCT00409175|560083950|FG000|Overall Study|Withdrawal by Subject|1|||
155176334|NCT00409175|560083951|FG001|Overall Study|Withdrawal by Subject|2|||
155176335|NCT00409175|560083950|FG000|Overall Study|Negative genotype|0|||
155176336|NCT00409175|560083951|FG001|Overall Study|Negative genotype|1|||
155176337|NCT00409175|560083950|FG000|Overall Study|Liver transplantation|13|||
155119223|NCT00075725|559868484|FG011|Overall Study|Insurance issues|0|||
155119224|NCT00075725|559868473|FG000|Overall Study|MRD positive after extended ind|0|||
155119225|NCT00075725|559868474|FG001|Overall Study|MRD positive after extended ind|1|||
155119226|NCT00075725|559868475|FG002|Overall Study|MRD positive after extended ind|1|||
155119227|NCT00075725|559868476|FG003|Overall Study|MRD positive after extended ind|0|||
155119228|NCT00075725|559868477|FG004|Overall Study|MRD positive after extended ind|1|||
155119229|NCT00075725|559868478|FG005|Overall Study|MRD positive after extended ind|2|||
155119230|NCT00075725|559868479|FG006|Overall Study|MRD positive after extended ind|0|||
155119231|NCT00075725|559868480|FG007|Overall Study|MRD positive after extended ind|1|||
155119232|NCT00075725|559868481|FG008|Overall Study|MRD positive after extended ind|0|||
155119233|NCT00075725|559868482|FG009|Overall Study|MRD positive after extended ind|0|||
155119234|NCT00075725|559868483|FG010|Overall Study|MRD positive after extended ind|0|||
155119235|NCT00075725|559868484|FG011|Overall Study|MRD positive after extended ind|0|||
155119236|NCT00075725|559868473|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
155119237|NCT00075725|559868474|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
155119238|NCT00075725|559868475|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
155119239|NCT00075725|559868476|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
155119240|NCT00075725|559868477|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
155176338|NCT00409175|560083951|FG001|Overall Study|Liver transplantation|13|||
155176339|NCT03316911|560083954|FG000|Overall Study|Lost to Follow-up|33|||
155176340|NCT03316911|560083955|FG001|Overall Study|Lost to Follow-up|29|||
155176341|NCT01119937|560083956|FG000|Overall Study|Adverse Event|11|||
155176342|NCT01119937|560083957|FG001|Overall Study|Adverse Event|5|||
155176343|NCT01119937|560083956|FG000|Overall Study|Protocol deviation|3|||
155176344|NCT01119937|560083957|FG001|Overall Study|Protocol deviation|1|||
155176345|NCT01119937|560083956|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
155176346|NCT01119937|560083957|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155176347|NCT01119937|560083956|FG000|Overall Study|Withdrawal by Subject|2|||
155176348|NCT01119937|560083957|FG001|Overall Study|Withdrawal by Subject|1|||
155176349|NCT01270802|560083958|FG000|Overall Study|Withdrawal by Subject|1|||
155176350|NCT01270802|560083959|FG001|Overall Study|Withdrawal by Subject|0|||
155119241|NCT00075725|559868478|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
155176351|NCT01270802|560083958|FG000|Overall Study|Adverse Event|1|||
155176352|NCT01270802|560083959|FG001|Overall Study|Adverse Event|0|||
155176353|NCT01270802|560083958|FG000|Overall Study|Lost to Follow-up|0|||
155176354|NCT01270802|560083959|FG001|Overall Study|Lost to Follow-up|1|||
154986623|NCT00076804|559377346|FG000|Overall Study|Early study Closure|32|||
154986624|NCT00076804|559377347|FG001|Overall Study|Early study Closure|32|||
154986625|NCT00354341|559377348|FG000|Overall Study|Adverse Event|1|||
154986626|NCT00354341|559377349|FG001|Overall Study|Adverse Event|0|||
154986627|NCT00354341|559377348|FG000|Overall Study|Death|0|||
154986628|NCT00354341|559377349|FG001|Overall Study|Death|2|||
154986629|NCT00354341|559377348|FG000|Overall Study|Refused treatment|1|||
154986630|NCT00354341|559377349|FG001|Overall Study|Refused treatment|2|||
154986631|NCT00354341|559377348|FG000|Overall Study|Failure to return|0|||
154986632|NCT00354341|559377349|FG001|Overall Study|Failure to return|1|||
154986633|NCT00354341|559377348|FG000|Overall Study|Other|1|||
154986634|NCT00354341|559377349|FG001|Overall Study|Other|2|||
154986635|NCT01732874|559377350|FG000|Overall Study|Withdrawal by Subject|5|||
154986636|NCT01732874|559377351|FG001|Overall Study|Withdrawal by Subject|1|||
154986637|NCT01732874|559377350|FG000|Overall Study|Death of Infant|3|||
154986638|NCT01732874|559377351|FG001|Overall Study|Death of Infant|2|||
154986639|NCT00688376|559377352|FG000|Double-Blind Phase|Adverse Event|4|||
154986640|NCT00688376|559377353|FG001|Double-Blind Phase|Adverse Event|4|||
154986641|NCT00688376|559377352|FG000|Double-Blind Phase|Protocol Violation|1|||
154986642|NCT00688376|559377353|FG001|Double-Blind Phase|Protocol Violation|2|||
154986643|NCT00688376|559377352|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
154986644|NCT00688376|559377353|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
154986645|NCT00688376|559377352|FG000|Double-Blind Phase|Not treated|0|||
154986646|NCT00688376|559377353|FG001|Double-Blind Phase|Not treated|1|||
154986647|NCT00688376|559377352|FG000|Blinded Extension Phase|Adverse Event|3|||
154986648|NCT00688376|559377353|FG001|Blinded Extension Phase|Adverse Event|4|||
154986649|NCT00688376|559377352|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
154986650|NCT00688376|559377353|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
154986651|NCT00688376|559377352|FG000|Blinded Extension Phase|Physician Decision|1|||
154986652|NCT00688376|559377353|FG001|Blinded Extension Phase|Physician Decision|0|||
154986653|NCT00688376|559377352|FG000|Blinded Extension Phase|Other|1|||
154986654|NCT00688376|559377353|FG001|Blinded Extension Phase|Other|0|||
154986655|NCT03096847|559377360|FG000|Overall Study|Other|2|||
154986656|NCT03096847|559377361|FG001|Overall Study|Other|1|||
154986657|NCT03096847|559377362|FG002|Overall Study|Other|2|||
154986658|NCT03096847|559377360|FG000|Overall Study|Lost to Follow-up|1|||
154986659|NCT03096847|559377361|FG001|Overall Study|Lost to Follow-up|0|||
154986660|NCT03096847|559377362|FG002|Overall Study|Lost to Follow-up|1|||
154986661|NCT03096847|559377360|FG000|Overall Study|Death|6|||
154986662|NCT03096847|559377361|FG001|Overall Study|Death|0|||
154986663|NCT03096847|559377362|FG002|Overall Study|Death|2|||
154986664|NCT03096847|559377360|FG000|Overall Study|Protocol Violation|3|||
154986665|NCT03096847|559377361|FG001|Overall Study|Protocol Violation|0|||
154986666|NCT03096847|559377362|FG002|Overall Study|Protocol Violation|6|||
154986667|NCT03096847|559377360|FG000|Overall Study|Physician Decision|12|||
154986668|NCT03096847|559377361|FG001|Overall Study|Physician Decision|2|||
154986669|NCT03096847|559377362|FG002|Overall Study|Physician Decision|8|||
154986670|NCT03096847|559377360|FG000|Overall Study|Withdrawal by Subject|24|||
154986671|NCT03096847|559377361|FG001|Overall Study|Withdrawal by Subject|1|||
155119242|NCT00075725|559868479|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
155119243|NCT00075725|559868480|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
154914722|NCT02394028|559108069|FG001|Maintenance Phase|Death|0|||
154914723|NCT02394028|559108070|FG002|Maintenance Phase|Death|0|||
154914724|NCT02394028|559108071|FG003|Maintenance Phase|Death|0|||
154914725|NCT02394028|559108072|FG004|Maintenance Phase|Death|0|||
154914726|NCT02394028|559108073|FG005|Maintenance Phase|Death|0|||
154914727|NCT02394028|559108074|FG006|Maintenance Phase|Death|0|||
154914728|NCT02394028|559108075|FG007|Maintenance Phase|Death|0|||
154914729|NCT02394028|559108076|FG008|Maintenance Phase|Death|0|||
154914730|NCT02394028|559108077|FG009|Maintenance Phase|Death|0|||
154914731|NCT02394028|559108078|FG010|Maintenance Phase|Death|1|||
154914732|NCT02394028|559108068|FG000|Maintenance Phase|Adverse Event|0|||
154914733|NCT02394028|559108069|FG001|Maintenance Phase|Adverse Event|0|||
154986672|NCT03096847|559377362|FG002|Overall Study|Withdrawal by Subject|12|||
154986673|NCT03096847|559377360|FG000|Overall Study|Adverse Event|72|||
154986674|NCT03096847|559377361|FG001|Overall Study|Adverse Event|6|||
154986675|NCT03096847|559377362|FG002|Overall Study|Adverse Event|28|||
154986676|NCT03096847|559377360|FG000|Overall Study|Progressive disease|97|||
154986677|NCT03096847|559377361|FG001|Overall Study|Progressive disease|10|||
154986678|NCT03096847|559377362|FG002|Overall Study|Progressive disease|78|||
154986679|NCT03096847|559377360|FG000|Overall Study|Non-compliance with study medication|1|||
154986680|NCT03096847|559377361|FG001|Overall Study|Non-compliance with study medication|0|||
154986681|NCT03096847|559377362|FG002|Overall Study|Non-compliance with study medication|0|||
154986682|NCT03096847|559377360|FG000|Overall Study|New therapy for study indication|1|||
154914734|NCT02394028|559108070|FG002|Maintenance Phase|Adverse Event|0|||
154986683|NCT03096847|559377361|FG001|Overall Study|New therapy for study indication|0|||
154986684|NCT03096847|559377362|FG002|Overall Study|New therapy for study indication|1|||
154986685|NCT00359632|559377363|FG000|Overall Study|Death|2|||
154914735|NCT02394028|559108071|FG003|Maintenance Phase|Adverse Event|0|||
154914736|NCT02394028|559108072|FG004|Maintenance Phase|Adverse Event|0|||
154914737|NCT02394028|559108073|FG005|Maintenance Phase|Adverse Event|0|||
154914738|NCT02394028|559108074|FG006|Maintenance Phase|Adverse Event|0|||
154914739|NCT02394028|559108075|FG007|Maintenance Phase|Adverse Event|0|||
154914740|NCT02394028|559108076|FG008|Maintenance Phase|Adverse Event|1|||
154914741|NCT02394028|559108077|FG009|Maintenance Phase|Adverse Event|1|||
154914742|NCT02394028|559108078|FG010|Maintenance Phase|Adverse Event|3|||
154914743|NCT02394028|559108068|FG000|Maintenance Phase|Site closure|0|||
154914744|NCT02394028|559108069|FG001|Maintenance Phase|Site closure|0|||
154914745|NCT02394028|559108070|FG002|Maintenance Phase|Site closure|0|||
154914746|NCT02394028|559108071|FG003|Maintenance Phase|Site closure|0|||
154914747|NCT02394028|559108072|FG004|Maintenance Phase|Site closure|0|||
154914748|NCT02394028|559108073|FG005|Maintenance Phase|Site closure|0|||
154914749|NCT02394028|559108074|FG006|Maintenance Phase|Site closure|0|||
154914750|NCT02394028|559108075|FG007|Maintenance Phase|Site closure|0|||
154914751|NCT02394028|559108076|FG008|Maintenance Phase|Site closure|0|||
154914752|NCT02394028|559108077|FG009|Maintenance Phase|Site closure|1|||
154914753|NCT02394028|559108078|FG010|Maintenance Phase|Site closure|0|||
154914754|NCT02394028|559108068|FG000|Maintenance Phase|Withdrawal by Subject|0|||
154914755|NCT02394028|559108069|FG001|Maintenance Phase|Withdrawal by Subject|0|||
154914756|NCT02394028|559108070|FG002|Maintenance Phase|Withdrawal by Subject|0|||
154914757|NCT02394028|559108071|FG003|Maintenance Phase|Withdrawal by Subject|0|||
154914758|NCT02394028|559108072|FG004|Maintenance Phase|Withdrawal by Subject|0|||
154914759|NCT02394028|559108073|FG005|Maintenance Phase|Withdrawal by Subject|0|||
154914760|NCT02394028|559108074|FG006|Maintenance Phase|Withdrawal by Subject|0|||
154914761|NCT02394028|559108075|FG007|Maintenance Phase|Withdrawal by Subject|0|||
154914762|NCT02394028|559108076|FG008|Maintenance Phase|Withdrawal by Subject|3|||
154914763|NCT02394028|559108077|FG009|Maintenance Phase|Withdrawal by Subject|12|||
154914764|NCT02394028|559108078|FG010|Maintenance Phase|Withdrawal by Subject|12|||
154914765|NCT00866606|559108080|FG000|Overall Study|Lost to Follow-up|3|||
154914766|NCT00866606|559108080|FG000|Overall Study|Adverse Event|1|||
154914767|NCT04129242|559108082|FG000|Overall Study|Physician Decision|1|||
154914768|NCT04129242|559108083|FG001|Overall Study|Physician Decision|1|||
154914769|NCT04129242|559108082|FG000|Overall Study|Protocol Violation|0|||
154914770|NCT04129242|559108083|FG001|Overall Study|Protocol Violation|1|||
154914771|NCT00806494|559108087|FG000|Overall Study|Adverse Event|29|||
154914772|NCT00806494|559108087|FG000|Overall Study|Lack of Efficacy|6|||
154914773|NCT00806494|559108087|FG000|Overall Study|Lost to Follow-up|10|||
154914774|NCT00806494|559108087|FG000|Overall Study|Other|30|||
154914775|NCT00806494|559108087|FG000|Overall Study|Withdrawal by Subject|5|||
154914776|NCT01230827|559108090|FG000|Overall Study|Lost to Follow-up|0|||
154914777|NCT01230827|559108091|FG001|Overall Study|Lost to Follow-up|0|||
154914778|NCT01230827|559108092|FG002|Overall Study|Lost to Follow-up|1|||
154914779|NCT01230827|559108093|FG003|Overall Study|Lost to Follow-up|3|||
154914780|NCT01230827|559108090|FG000|Overall Study|Withdrawal by Subject|1|||
154914781|NCT01230827|559108091|FG001|Overall Study|Withdrawal by Subject|0|||
154914782|NCT01230827|559108092|FG002|Overall Study|Withdrawal by Subject|3|||
154914783|NCT01230827|559108093|FG003|Overall Study|Withdrawal by Subject|2|||
154914784|NCT01230827|559108090|FG000|Overall Study|Lack of Efficacy|14|||
154914785|NCT01230827|559108091|FG001|Overall Study|Lack of Efficacy|1|||
154914786|NCT01230827|559108092|FG002|Overall Study|Lack of Efficacy|2|||
154914787|NCT01230827|559108093|FG003|Overall Study|Lack of Efficacy|3|||
154914788|NCT01230827|559108090|FG000|Overall Study|Adverse Event|4|||
154914789|NCT01230827|559108091|FG001|Overall Study|Adverse Event|2|||
154914790|NCT01230827|559108092|FG002|Overall Study|Adverse Event|3|||
154914791|NCT01230827|559108093|FG003|Overall Study|Adverse Event|7|||
154914792|NCT01230827|559108090|FG000|Overall Study|Recovery|0|||
154914793|NCT01230827|559108091|FG001|Overall Study|Recovery|6|||
154914794|NCT01230827|559108092|FG002|Overall Study|Recovery|0|||
154914795|NCT01230827|559108093|FG003|Overall Study|Recovery|0|||
154914796|NCT01230827|559108090|FG000|Overall Study|Study terminated by Sponsor|0|||
154914797|NCT01230827|559108091|FG001|Overall Study|Study terminated by Sponsor|2|||
154914798|NCT01230827|559108092|FG002|Overall Study|Study terminated by Sponsor|56|||
154914799|NCT01230827|559108093|FG003|Overall Study|Study terminated by Sponsor|63|||
154914800|NCT00805142|559108094|FG000|Titration Period|Adverse Event|3|||
154914801|NCT00805142|559108095|FG001|Titration Period|Adverse Event|3|||
154914802|NCT00805142|559108094|FG000|Titration Period|Lack of Efficacy|1|||
154914803|NCT00805142|559108095|FG001|Titration Period|Lack of Efficacy|1|||
154914804|NCT00805142|559108094|FG000|Titration Period|Lost to Follow-up|0|||
154914805|NCT00805142|559108095|FG001|Titration Period|Lost to Follow-up|1|||
154914806|NCT00805142|559108094|FG000|Titration Period|Disease Progression|2|||
154914807|NCT00805142|559108095|FG001|Titration Period|Disease Progression|1|||
154914808|NCT00805142|559108094|FG000|Titration Period|Withdrawal of consent|0|||
154914809|NCT00805142|559108095|FG001|Titration Period|Withdrawal of consent|1|||
154914810|NCT00805142|559108094|FG000|Titration Period|Other|0|||
154914811|NCT00805142|559108095|FG001|Titration Period|Other|3|||
154914812|NCT00805142|559108094|FG000|Maintenance Period|Adverse Event|0|||
154914813|NCT00805142|559108095|FG001|Maintenance Period|Adverse Event|1|||
154914814|NCT00805142|559108094|FG000|Maintenance Period|Other|0|||
154914815|NCT00805142|559108095|FG001|Maintenance Period|Other|1|||
154914816|NCT00424463|559108096|FG000|Overall Study|Adverse Event|2|||
154914817|NCT00424463|559108097|FG001|Overall Study|Adverse Event|3|||
154914818|NCT00424463|559108098|FG002|Overall Study|Adverse Event|2|||
154914819|NCT00424463|559108096|FG000|Overall Study|Physician Decision|0|||
154914820|NCT00424463|559108097|FG001|Overall Study|Physician Decision|2|||
154914821|NCT00424463|559108098|FG002|Overall Study|Physician Decision|2|||
154914822|NCT00424463|559108096|FG000|Overall Study|Withdrawal by Subject|4|||
154914823|NCT00424463|559108097|FG001|Overall Study|Withdrawal by Subject|2|||
154914824|NCT00424463|559108098|FG002|Overall Study|Withdrawal by Subject|5|||
154914825|NCT00424463|559108096|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
154914826|NCT00424463|559108097|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
154914827|NCT00424463|559108098|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
154914828|NCT00424463|559108096|FG000|Overall Study|Patient's convenience|0|||
154914829|NCT00424463|559108097|FG001|Overall Study|Patient's convenience|0|||
154914830|NCT00424463|559108098|FG002|Overall Study|Patient's convenience|1|||
154914831|NCT02927990|559110131|FG000|Overall Study|Protocol Violation|4|||
154914832|NCT02927990|559110131|FG000|Overall Study|Physician Decision|9|||
154914833|NCT02927990|559110131|FG000|Overall Study|Room switched and therefore no study device available|15|||
154914834|NCT02927990|559110131|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
154914835|NCT00960323|559110132|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
154914836|NCT00772031|559110136|FG000|Overall Study|Early termination of trial|12|||
154914837|NCT00772031|559110137|FG001|Overall Study|Early termination of trial|10|||
154914838|NCT00772031|559110136|FG000|Overall Study|Lost to Follow-up|20|||
154914839|NCT00772031|559110137|FG001|Overall Study|Lost to Follow-up|33|||
154914840|NCT02194699|559110142|FG000|Randomised|Did not receive treatment|1|||
154914841|NCT02194699|559110143|FG001|Randomised|Did not receive treatment|5|||
154914842|NCT02194699|559110142|FG000|Randomised|Without potential for 52 weeks of IP|5|||
154914843|NCT02194699|559110143|FG001|Randomised|Without potential for 52 weeks of IP|5|||
154914844|NCT02194699|559110142|FG000|Randomised|Duplicate patient|2|||
154914845|NCT02194699|559110143|FG001|Randomised|Duplicate patient|1|||
154914846|NCT02194699|559110142|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
154914847|NCT02194699|559110143|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
154914848|NCT02194699|559110142|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
154914849|NCT02194699|559110143|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
154914850|NCT02194699|559110142|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
154914851|NCT02194699|559110143|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
154914852|NCT02194699|559110142|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
154914853|NCT02194699|559110143|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
154914854|NCT02194699|559110142|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
154914855|NCT02194699|559110143|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
154914856|NCT02194699|559110142|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
154914857|NCT02194699|559110143|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
154914858|NCT02719028|559110144|FG000|Overall Study|Adverse Event|2|||
154914859|NCT02719028|559110145|FG001|Overall Study|Adverse Event|1|||
154914860|NCT02719028|559110146|FG002|Overall Study|Adverse Event|4|||
154914861|NCT02719028|559110147|FG003|Overall Study|Adverse Event|8|||
154914862|NCT02719028|559110144|FG000|Overall Study|Physician Decision|0|||
154914863|NCT02719028|559110145|FG001|Overall Study|Physician Decision|1|||
154914864|NCT02719028|559110146|FG002|Overall Study|Physician Decision|1|||
154914865|NCT02719028|559110147|FG003|Overall Study|Physician Decision|1|||
154914866|NCT02719028|559110144|FG000|Overall Study|Use of prohibited medication|0|||
154914867|NCT02719028|559110145|FG001|Overall Study|Use of prohibited medication|0|||
154914868|NCT02719028|559110146|FG002|Overall Study|Use of prohibited medication|1|||
154914869|NCT02719028|559110147|FG003|Overall Study|Use of prohibited medication|0|||
154914870|NCT02719028|559110144|FG000|Overall Study|Protocol Violation|0|||
154914871|NCT02719028|559110145|FG001|Overall Study|Protocol Violation|0|||
154914872|NCT02719028|559110146|FG002|Overall Study|Protocol Violation|0|||
154914873|NCT02719028|559110147|FG003|Overall Study|Protocol Violation|1|||
154914874|NCT03287960|559110148|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
154914875|NCT03287960|559110148|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
154914876|NCT01191190|559110149|FG000|Overall Study|Withdrawal by Subject|1|||
154914877|NCT01667731|559110151|FG000|Overall Study|Enrolled but not treated|0|||
154914878|NCT01667731|559110152|FG001|Overall Study|Enrolled but not treated|0|||
154914879|NCT01667731|559110153|FG002|Overall Study|Enrolled but not treated|0|||
154914880|NCT01667731|559110154|FG003|Overall Study|Enrolled but not treated|0|||
154914881|NCT01667731|559110155|FG004|Overall Study|Enrolled but not treated|1|||
154914882|NCT01667731|559110151|FG000|Overall Study|Efficacy Failure|1|||
154914883|NCT01667731|559110152|FG001|Overall Study|Efficacy Failure|12|||
154914884|NCT01667731|559110153|FG002|Overall Study|Efficacy Failure|0|||
154914885|NCT01667731|559110154|FG003|Overall Study|Efficacy Failure|1|||
154914886|NCT01667731|559110155|FG004|Overall Study|Efficacy Failure|24|||
154914887|NCT01667731|559110151|FG000|Overall Study|Lost to Follow-up|2|||
154914888|NCT01667731|559110152|FG001|Overall Study|Lost to Follow-up|3|||
154914889|NCT01667731|559110153|FG002|Overall Study|Lost to Follow-up|1|||
155119244|NCT00075725|559868481|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
154914890|NCT01667731|559110154|FG003|Overall Study|Lost to Follow-up|1|||
154914891|NCT01667731|559110155|FG004|Overall Study|Lost to Follow-up|2|||
154914892|NCT01667731|559110151|FG000|Overall Study|Subject Withdrew Consent|2|||
154914893|NCT01667731|559110152|FG001|Overall Study|Subject Withdrew Consent|0|||
154914894|NCT01667731|559110153|FG002|Overall Study|Subject Withdrew Consent|1|||
154914895|NCT01667731|559110154|FG003|Overall Study|Subject Withdrew Consent|0|||
154914896|NCT01667731|559110155|FG004|Overall Study|Subject Withdrew Consent|1|||
154914897|NCT01667731|559110151|FG000|Overall Study|Death|0|||
154914898|NCT01667731|559110152|FG001|Overall Study|Death|1|||
154914899|NCT01667731|559110153|FG002|Overall Study|Death|0|||
154914900|NCT01667731|559110154|FG003|Overall Study|Death|0|||
154914901|NCT01667731|559110155|FG004|Overall Study|Death|0|||
154914902|NCT00561912|559110156|FG000|Overall Study|ineligible|1|||
154914903|NCT01977651|559110157|FG000|4 Month Treatment Period|Adverse Event|34|||
154914904|NCT01977651|559110157|FG000|4 Month Treatment Period|Death|3|||
154914905|NCT01977651|559110157|FG000|4 Month Treatment Period|Progressive Disease|43|||
154914906|NCT01977651|559110157|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
154914907|NCT01977651|559110157|FG000|4 Month Treatment Period|Physician Decision|4|||
154914908|NCT01977651|559110157|FG000|1 Year Extension Period|Adverse Event|14|||
154914909|NCT01977651|559110157|FG000|1 Year Extension Period|Death|10|||
154914910|NCT01977651|559110157|FG000|1 Year Extension Period|Lost to Follow-up|2|||
154914911|NCT01977651|559110157|FG000|1 Year Extension Period|Progressive Disease|86|||
154914912|NCT01977651|559110157|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
154914913|NCT01977651|559110157|FG000|1 Year Extension Period|Physician Decision|6|||
154914914|NCT01977651|559110157|FG000|1 Year Extension Period|Miscellaneous|1|||
154914915|NCT01977651|559110157|FG000|Post 1 Year Extension Period|Adverse Event|5|||
154914916|NCT01977651|559110157|FG000|Post 1 Year Extension Period|Death|13|||
154914917|NCT01977651|559110157|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
154914918|NCT01977651|559110157|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
154914919|NCT01977651|559110157|FG000|Post 1 Year Extension Period|Physician Decision|4|||
154914920|NCT01977651|559110157|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
154914921|NCT03287089|559110162|FG000|Overall Study|Lost to Follow-up|0|||
154914922|NCT03287089|559110163|FG001|Overall Study|Lost to Follow-up|2|||
154914923|NCT03287089|559110162|FG000|Overall Study|Physician Decision|0|||
154914924|NCT03287089|559110163|FG001|Overall Study|Physician Decision|2|||
154914925|NCT03287089|559110162|FG000|Overall Study|Withdrawal by Subject|0|||
154914926|NCT03287089|559110163|FG001|Overall Study|Withdrawal by Subject|2|||
154914927|NCT01729559|559110164|FG000|Overall Study|Protocol Violation|31|||
154914928|NCT01729559|559110165|FG001|Overall Study|Protocol Violation|28|||
154914929|NCT03672006|559110172|FG000|Overall Study|exclusion criteria met|0|||
154914930|NCT03672006|559110173|FG001|Overall Study|exclusion criteria met|1|||
154914931|NCT02764229|559110175|FG000|Overall Study|Withdrawal by Subject|15|||
154914932|NCT02764229|559110175|FG000|Overall Study|Adverse Event|9|||
154914933|NCT02764229|559110175|FG000|Overall Study|Physician Decision|5|||
154914934|NCT02764229|559110175|FG000|Overall Study|Lost to Follow-up|3|||
154914935|NCT02764229|559110175|FG000|Overall Study|Lack of Efficacy|1|||
154914936|NCT02764229|559110175|FG000|Overall Study|Study Stopped by Sponsor|69|||
154914937|NCT04249076|559110191|FG000|Overall Study|Adverse Event|1|||
154914938|NCT04249076|559110192|FG001|Overall Study|Adverse Event|1|||
154914939|NCT04249076|559110191|FG000|Overall Study|Protocol Violation|1|||
154914940|NCT04249076|559110192|FG001|Overall Study|Protocol Violation|2|||
154914941|NCT04249076|559110191|FG000|Overall Study|Lack of Efficacy|0|||
154914942|NCT04249076|559110192|FG001|Overall Study|Lack of Efficacy|1|||
154914943|NCT04249076|559110191|FG000|Overall Study|Withdrawal by Subject|0|||
154914944|NCT04249076|559110192|FG001|Overall Study|Withdrawal by Subject|1|||
154914945|NCT00783263|559110193|FG000|Overall Study|Adverse Event|3|||
154914946|NCT00783263|559110194|FG001|Overall Study|Adverse Event|0|||
154914947|NCT00783263|559110195|FG002|Overall Study|Adverse Event|2|||
154914948|NCT00783263|559110196|FG003|Overall Study|Adverse Event|1|||
154914949|NCT00783263|559110193|FG000|Overall Study|Lost to Follow-up|1|||
154914950|NCT00783263|559110194|FG001|Overall Study|Lost to Follow-up|1|||
154914951|NCT00783263|559110195|FG002|Overall Study|Lost to Follow-up|0|||
154914952|NCT00783263|559110196|FG003|Overall Study|Lost to Follow-up|0|||
154914953|NCT00783263|559110193|FG000|Overall Study|Withdrawal by Subject|0|||
154914954|NCT00783263|559110194|FG001|Overall Study|Withdrawal by Subject|1|||
154914955|NCT00783263|559110195|FG002|Overall Study|Withdrawal by Subject|1|||
154914956|NCT00783263|559110196|FG003|Overall Study|Withdrawal by Subject|2|||
154914957|NCT00265382|559110200|FG000|Overall Study|Adverse Event|21|||
154914958|NCT00265382|559110200|FG000|Overall Study|Laboratory Abnormality|1|||
154914959|NCT00265382|559110200|FG000|Overall Study|Lost to Follow-up|3|||
154914960|NCT00265382|559110200|FG000|Overall Study|Lack of Efficacy|6|||
154914961|NCT00265382|559110200|FG000|Overall Study|Miscellaneous|6|||
154914962|NCT00265382|559110200|FG000|Overall Study|Withdrawal by Subject|13|||
154914963|NCT00265382|559110200|FG000|Overall Study|Study terminated by sponsor|94|||
154914964|NCT00265382|559110200|FG000|Overall Study|Death|1|||
154914965|NCT00082628|559110208|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
154914966|NCT00082628|559110209|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
155119245|NCT00075725|559868482|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
155119246|NCT00075725|559868483|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
155119247|NCT00075725|559868484|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
155119248|NCT00075725|559868473|FG000|Overall Study|Inevaluable|1|||
155119249|NCT00075725|559868474|FG001|Overall Study|Inevaluable|1|||
155119250|NCT00075725|559868475|FG002|Overall Study|Inevaluable|4|||
154914967|NCT00082628|559110210|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
154914968|NCT00082628|559110211|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
154914969|NCT00082628|559110212|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
154914970|NCT00082628|559110208|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
154914971|NCT00082628|559110209|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
154914972|NCT00082628|559110210|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
154914973|NCT00082628|559110211|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
154914974|NCT00082628|559110212|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
154914975|NCT00082628|559110208|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
154914976|NCT00082628|559110209|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
154914977|NCT00082628|559110210|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
154914978|NCT00082628|559110211|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
154914979|NCT00082628|559110212|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
154914980|NCT00082628|559110208|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
154914981|NCT00082628|559110209|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
154914982|NCT00082628|559110210|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
154914983|NCT00082628|559110211|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
154914984|NCT00082628|559110212|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
154914985|NCT00082628|559110208|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
154914986|NCT00082628|559110209|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
154914987|NCT00082628|559110210|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
154914988|NCT00082628|559110211|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
154914989|NCT00082628|559110212|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
154914990|NCT00082628|559110208|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
154914991|NCT00082628|559110209|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
154914992|NCT00082628|559110210|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
154914993|NCT00082628|559110211|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
154914994|NCT00082628|559110212|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
154914995|NCT00082628|559110208|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
154914996|NCT00082628|559110209|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
154914997|NCT00082628|559110210|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
154914998|NCT00082628|559110211|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
154914999|NCT00082628|559110212|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
154915000|NCT03481634|559110217|FG000|Overall Study|Withdrawal by Subject|16|||
154915001|NCT03481634|559110218|FG001|Overall Study|Withdrawal by Subject|19|||
154915002|NCT03481634|559110219|FG002|Overall Study|Withdrawal by Subject|14|||
154915003|NCT03481634|559110217|FG000|Overall Study|Protocol Violation|1|||
154915004|NCT03481634|559110218|FG001|Overall Study|Protocol Violation|0|||
154915005|NCT03481634|559110219|FG002|Overall Study|Protocol Violation|1|||
154915006|NCT03481634|559110217|FG000|Overall Study|Progressive disease|0|||
154915007|NCT03481634|559110218|FG001|Overall Study|Progressive disease|1|||
154915008|NCT03481634|559110219|FG002|Overall Study|Progressive disease|0|||
154915009|NCT03481634|559110217|FG000|Overall Study|Physician Decision|3|||
154915010|NCT03481634|559110218|FG001|Overall Study|Physician Decision|0|||
154915011|NCT03481634|559110219|FG002|Overall Study|Physician Decision|1|||
154915012|NCT03481634|559110217|FG000|Overall Study|Lost to Follow-up|3|||
154915013|NCT03481634|559110218|FG001|Overall Study|Lost to Follow-up|4|||
154915014|NCT03481634|559110219|FG002|Overall Study|Lost to Follow-up|4|||
154915015|NCT03481634|559110217|FG000|Overall Study|Death|4|||
154915016|NCT03481634|559110218|FG001|Overall Study|Death|8|||
154915017|NCT03481634|559110219|FG002|Overall Study|Death|7|||
154915018|NCT03481634|559110217|FG000|Overall Study|Adverse Event|6|||
154915019|NCT03481634|559110218|FG001|Overall Study|Adverse Event|3|||
154915020|NCT03481634|559110219|FG002|Overall Study|Adverse Event|7|||
154915021|NCT01849289|559110225|FG000|Overall Study|Adverse Event|3|||
154915022|NCT01849289|559110226|FG001|Overall Study|Adverse Event|3|||
154915023|NCT01849289|559110225|FG000|Overall Study|Protocol Violation|3|||
154915024|NCT01849289|559110226|FG001|Overall Study|Protocol Violation|3|||
154915025|NCT01849289|559110225|FG000|Overall Study|Withdrawal criteria|1|||
155119251|NCT00075725|559868476|FG003|Overall Study|Inevaluable|2|||
155119252|NCT00075725|559868477|FG004|Overall Study|Inevaluable|2|||
155119253|NCT00075725|559868478|FG005|Overall Study|Inevaluable|9|||
154986686|NCT00359632|559377364|FG001|Overall Study|Death|0|||
154986687|NCT00359632|559377363|FG000|Overall Study|Adverse Event|1|||
154986688|NCT00359632|559377364|FG001|Overall Study|Adverse Event|0|||
154986689|NCT00359632|559377363|FG000|Overall Study|Non-compliance with visit schedule|1|||
154986690|NCT00359632|559377364|FG001|Overall Study|Non-compliance with visit schedule|0|||
154986691|NCT03978091|559377365|FG000|Overall Study|Lost to Follow-up|0|||
154986692|NCT03978091|559377366|FG001|Overall Study|Lost to Follow-up|0|||
154915026|NCT01849289|559110226|FG001|Overall Study|Withdrawal criteria|0|||
154915027|NCT01849289|559110225|FG000|Overall Study|Unclassified|25|||
154915028|NCT01849289|559110226|FG001|Overall Study|Unclassified|18|||
154915029|NCT00352027|559110227|FG000|Overall Study|Progressive disease|3|||
154915030|NCT04491591|559110228|FG000|Overall Study|Accidently randomized|3|||
154915031|NCT04491591|559110229|FG001|Overall Study|Accidently randomized|1|||
154915032|NCT04491591|559110230|FG002|Overall Study|Accidently randomized|0|||
154986693|NCT03978091|559377367|FG002|Overall Study|Lost to Follow-up|1|||
154986694|NCT03978091|559377368|FG003|Overall Study|Lost to Follow-up|0|||
154986695|NCT03978091|559377369|FG004|Overall Study|Lost to Follow-up|0|||
154986696|NCT03978091|559377370|FG005|Overall Study|Lost to Follow-up|0|||
154986697|NCT03978091|559377365|FG000|Overall Study|Withdrawal by Subject|0|||
154986698|NCT03978091|559377366|FG001|Overall Study|Withdrawal by Subject|0|||
154986699|NCT03978091|559377367|FG002|Overall Study|Withdrawal by Subject|0|||
154986700|NCT03978091|559377368|FG003|Overall Study|Withdrawal by Subject|1|||
154986701|NCT03978091|559377369|FG004|Overall Study|Withdrawal by Subject|1|||
154986702|NCT03978091|559377370|FG005|Overall Study|Withdrawal by Subject|0|||
154986703|NCT04700280|559377378|FG000|Overall Study|Adverse Event|4|||
154986704|NCT04700280|559377379|FG001|Overall Study|Adverse Event|0|||
154986705|NCT04700280|559377378|FG000|Overall Study|Lack of Efficacy|1|||
154986706|NCT04700280|559377379|FG001|Overall Study|Lack of Efficacy|0|||
154986707|NCT04700280|559377378|FG000|Overall Study|Study terminated by sponsor|5|||
154986708|NCT04700280|559377379|FG001|Overall Study|Study terminated by sponsor|3|||
154986709|NCT04700280|559377378|FG000|Overall Study|Other than specified|1|||
154986710|NCT04700280|559377379|FG001|Overall Study|Other than specified|0|||
154986711|NCT01843348|559377380|FG000|Overall Study|Withdrawal by Subject|4|||
154986712|NCT01843348|559377381|FG001|Overall Study|Withdrawal by Subject|16|||
154986713|NCT01843348|559377382|FG002|Overall Study|Withdrawal by Subject|18|||
154986714|NCT01843348|559377380|FG000|Overall Study|Lost to Follow-up|5|||
154986715|NCT01843348|559377381|FG001|Overall Study|Lost to Follow-up|4|||
154986716|NCT01843348|559377382|FG002|Overall Study|Lost to Follow-up|2|||
154986717|NCT01843348|559377380|FG000|Overall Study|Death|5|||
154986718|NCT01843348|559377381|FG001|Overall Study|Death|3|||
154986719|NCT01843348|559377382|FG002|Overall Study|Death|4|||
154986720|NCT01843348|559377380|FG000|Overall Study|Graft loss/retransplantation|5|||
154986721|NCT01843348|559377381|FG001|Overall Study|Graft loss/retransplantation|8|||
154986722|NCT01843348|559377382|FG002|Overall Study|Graft loss/retransplantation|11|||
154986723|NCT01843348|559377380|FG000|Overall Study|Various reasons|4|||
154986724|NCT01843348|559377381|FG001|Overall Study|Various reasons|9|||
154986725|NCT01843348|559377382|FG002|Overall Study|Various reasons|6|||
154986726|NCT00251641|559377383|FG000|Overall Study|Adverse Event|80|||
154986727|NCT00251641|559377384|FG001|Overall Study|Adverse Event|8|||
154986728|NCT00251641|559377383|FG000|Overall Study|Lack of Efficacy|2|||
154986729|NCT00251641|559377384|FG001|Overall Study|Lack of Efficacy|1|||
154986730|NCT00251641|559377383|FG000|Overall Study|Progression of Disease|0|||
154986731|NCT00251641|559377384|FG001|Overall Study|Progression of Disease|2|||
154986732|NCT00251641|559377383|FG000|Overall Study|Lost to Follow-up|3|||
154986733|NCT00251641|559377384|FG001|Overall Study|Lost to Follow-up|3|||
154986734|NCT00251641|559377383|FG000|Overall Study|Withdrawal by Subject|6|||
154986735|NCT00251641|559377384|FG001|Overall Study|Withdrawal by Subject|8|||
154986736|NCT00251641|559377383|FG000|Overall Study|Protocol Violation|10|||
154986737|NCT00251641|559377384|FG001|Overall Study|Protocol Violation|2|||
154986738|NCT00251641|559377383|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
154986739|NCT00251641|559377384|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
154986740|NCT00251641|559377383|FG000|Overall Study|Switched Treatment|9|||
154915033|NCT04491591|559110228|FG000|Overall Study|Did not complete survey|28|||
154915034|NCT04491591|559110229|FG001|Overall Study|Did not complete survey|20|||
154915035|NCT04491591|559110230|FG002|Overall Study|Did not complete survey|3|||
154915036|NCT03099304|559110231|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
154986741|NCT00251641|559377384|FG001|Overall Study|Switched Treatment|63|||
154986742|NCT02093221|559377385|FG000|Overall Study|Adverse Event|1|||
154986743|NCT02093221|559377386|FG001|Overall Study|Adverse Event|0|||
154986744|NCT02093221|559377387|FG002|Overall Study|Adverse Event|0|||
154986745|NCT02093221|559377388|FG003|Overall Study|Adverse Event|0|||
154986746|NCT02093221|559377389|FG004|Overall Study|Adverse Event|0|||
154986747|NCT02093221|559377385|FG000|Overall Study|Withdrawal by Subject|1|||
154986748|NCT02093221|559377386|FG001|Overall Study|Withdrawal by Subject|1|||
154986749|NCT02093221|559377387|FG002|Overall Study|Withdrawal by Subject|4|||
154986750|NCT02093221|559377388|FG003|Overall Study|Withdrawal by Subject|1|||
154986751|NCT02093221|559377389|FG004|Overall Study|Withdrawal by Subject|1|||
154986752|NCT02093221|559377385|FG000|Overall Study|Lost to Follow-up|2|||
154915037|NCT03099304|559110232|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
154915038|NCT03099304|559110233|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
154915039|NCT03099304|559110234|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
154915040|NCT03099304|559110235|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
154915041|NCT03099304|559110236|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
154915042|NCT03099304|559110231|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
154915043|NCT03099304|559110232|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
154915044|NCT03099304|559110233|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
154915045|NCT03099304|559110234|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
154915046|NCT03099304|559110235|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
154915047|NCT03099304|559110236|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
154915048|NCT03099304|559110231|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
154915049|NCT03099304|559110232|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
154915050|NCT03099304|559110233|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
154915051|NCT03099304|559110234|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
154915052|NCT03099304|559110235|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
154915053|NCT03099304|559110236|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
154915054|NCT03099304|559110231|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
154915055|NCT03099304|559110232|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
154915056|NCT03099304|559110233|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
154915057|NCT03099304|559110234|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
154915058|NCT03099304|559110235|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
154915059|NCT03099304|559110236|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
154915060|NCT03099304|559110231|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
154915061|NCT03099304|559110232|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
154915062|NCT03099304|559110233|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
154915063|NCT03099304|559110234|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
154915064|NCT03099304|559110235|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
154915065|NCT03099304|559110236|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
154915066|NCT03099304|559110231|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
154915067|NCT03099304|559110232|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
154915068|NCT03099304|559110233|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
154915069|NCT03099304|559110234|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
154915070|NCT03099304|559110235|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
154915071|NCT03099304|559110236|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
154915072|NCT03099304|559110231|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
154915073|NCT03099304|559110232|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
154915074|NCT03099304|559110233|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
154915075|NCT03099304|559110234|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
154915076|NCT03099304|559110235|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
154915077|NCT03099304|559110236|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
154915078|NCT03099304|559110231|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
154915079|NCT03099304|559110232|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
154915080|NCT03099304|559110233|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
154915081|NCT03099304|559110234|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
154915082|NCT03099304|559110235|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
154915083|NCT03099304|559110236|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
154915084|NCT03099304|559110231|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
154915085|NCT03099304|559110232|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
154915086|NCT03099304|559110233|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
154915087|NCT03099304|559110234|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
154915088|NCT03099304|559110235|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
154915089|NCT03099304|559110236|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
154915090|NCT03099304|559110231|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
154915091|NCT03099304|559110232|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
154915092|NCT03099304|559110233|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
154915093|NCT03099304|559110234|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
154915094|NCT03099304|559110235|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
154915095|NCT03099304|559110236|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
154915096|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
154915097|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
154915098|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
154915099|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
154915100|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
155119254|NCT00075725|559868479|FG006|Overall Study|Inevaluable|1|||
155119255|NCT00075725|559868480|FG007|Overall Study|Inevaluable|11|||
155119256|NCT00075725|559868481|FG008|Overall Study|Inevaluable|2|||
155119257|NCT00075725|559868482|FG009|Overall Study|Inevaluable|0|||
155119258|NCT00075725|559868483|FG010|Overall Study|Inevaluable|1|||
155119259|NCT00075725|559868484|FG011|Overall Study|Inevaluable|0|||
155119260|NCT00075725|559868473|FG000|Overall Study|Other|4|||
155119261|NCT00075725|559868474|FG001|Overall Study|Other|2|||
154915101|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
154915102|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
154915103|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
154915104|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
154915105|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
154915106|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
154915107|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
154915108|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
154915109|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
154915110|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
154915111|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
154915112|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
154915113|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
154915114|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
154915115|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
154915116|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
154915117|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
154915118|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
154915119|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
154915120|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
154915121|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
154915122|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
154915123|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
154915124|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
154915125|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
154915126|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
154915127|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
154915128|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
154915129|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
154915130|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
154915131|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
154915132|NCT03099304|559110231|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
154915133|NCT03099304|559110232|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
154915134|NCT03099304|559110233|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
154915135|NCT03099304|559110234|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
154915136|NCT03099304|559110235|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
154915137|NCT03099304|559110236|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
154915138|NCT01058356|559110237|FG000|Overall Study|Adverse Event|5|||
154915139|NCT01058356|559110237|FG000|Overall Study|Administration of contraindicated drugs|12|||
154915140|NCT01058356|559110237|FG000|Overall Study|Withdrawal by Subject|21|||
154915141|NCT01058356|559110237|FG000|Overall Study|Lost to Follow-up|4|||
154915142|NCT02993783|559110238|FG000|Overall Study|Reason not Specified|6|||
154915143|NCT02993783|559110239|FG001|Overall Study|Reason not Specified|9|||
154915144|NCT00606021|559110242|FG000|Induction Phase|Death|73|||
154915145|NCT00606021|559110243|FG001|Induction Phase|Death|0|||
154915146|NCT00606021|559110244|FG002|Induction Phase|Death|0|||
154915147|NCT00606021|559110242|FG000|Induction Phase|Physician Decision|2|||
154915148|NCT00606021|559110243|FG001|Induction Phase|Physician Decision|0|||
154915149|NCT00606021|559110244|FG002|Induction Phase|Physician Decision|0|||
154915150|NCT00606021|559110242|FG000|Induction Phase|Withdrawal by Subject|2|||
154915151|NCT00606021|559110243|FG001|Induction Phase|Withdrawal by Subject|0|||
154915152|NCT00606021|559110244|FG002|Induction Phase|Withdrawal by Subject|0|||
154915153|NCT00606021|559110242|FG000|Induction Phase|Lost to Follow-up|10|||
154915154|NCT00606021|559110243|FG001|Induction Phase|Lost to Follow-up|0|||
154915155|NCT00606021|559110244|FG002|Induction Phase|Lost to Follow-up|0|||
154915156|NCT00606021|559110242|FG000|Maintenance Phase|Death|0|||
154915157|NCT00606021|559110243|FG001|Maintenance Phase|Death|17|||
154915158|NCT00606021|559110244|FG002|Maintenance Phase|Death|15|||
154915159|NCT00606021|559110242|FG000|Maintenance Phase|Physician Decision|0|||
154915160|NCT00606021|559110243|FG001|Maintenance Phase|Physician Decision|1|||
154915161|NCT00606021|559110244|FG002|Maintenance Phase|Physician Decision|0|||
154915162|NCT00606021|559110242|FG000|Maintenance Phase|Lost to Follow-up|0|||
154915163|NCT00606021|559110243|FG001|Maintenance Phase|Lost to Follow-up|5|||
154915164|NCT00606021|559110244|FG002|Maintenance Phase|Lost to Follow-up|2|||
154915165|NCT03480841|559110245|FG000|Overall Study|Lost to Follow-up|2|||
154915166|NCT01362049|559110246|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
154915167|NCT01362049|559110247|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
154915168|NCT01362049|559110248|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
154915169|NCT01362049|559110249|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
154915170|NCT01362049|559110246|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
155176355|NCT02025556|560083972|FG000|Overall Study|Adverse Event|0|||
155176356|NCT02025556|560083973|FG001|Overall Study|Adverse Event|4|||
155176357|NCT02025556|560083974|FG002|Overall Study|Adverse Event|2|||
155176358|NCT02025556|560083972|FG000|Overall Study|Lack of Efficacy|2|||
155176359|NCT02025556|560083973|FG001|Overall Study|Lack of Efficacy|1|||
154915171|NCT01362049|559110247|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
154915172|NCT01362049|559110248|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
154915173|NCT01362049|559110249|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
154915174|NCT02417935|559110252|FG000|Treatment Period|Adverse Event|12|||
154915175|NCT02417935|559110253|FG001|Treatment Period|Adverse Event|10|||
154915176|NCT02417935|559110252|FG000|Treatment Period|Lost to Follow-up|1|||
154915177|NCT02417935|559110253|FG001|Treatment Period|Lost to Follow-up|0|||
154915178|NCT02417935|559110252|FG000|Treatment Period|Entry Criteria not met|0|||
154915179|NCT02417935|559110253|FG001|Treatment Period|Entry Criteria not met|1|||
154915180|NCT02417935|559110252|FG000|Treatment Period|Protocol Violation|2|||
154915181|NCT02417935|559110253|FG001|Treatment Period|Protocol Violation|1|||
154915182|NCT02417935|559110252|FG000|Treatment Period|Withdrawal by Subject|3|||
154915183|NCT02417935|559110253|FG001|Treatment Period|Withdrawal by Subject|3|||
154915184|NCT02417935|559110252|FG000|Treatment Period|Physician Decision|3|||
154915185|NCT02417935|559110253|FG001|Treatment Period|Physician Decision|1|||
154915186|NCT02850276|559110256|FG000|Overall Study|screen failure|43|||
154915187|NCT02850276|559110256|FG000|Overall Study|Withdrawal by Subject|14|||
154915188|NCT02850276|559110256|FG000|Overall Study|Physician Decision|2|||
154915189|NCT02850276|559110256|FG000|Overall Study|Lost to Follow-up|2|||
154915190|NCT00989664|559110258|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
154915191|NCT00989664|559110258|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
154915192|NCT00989664|559110258|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
154915193|NCT00989664|559110258|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
154915194|NCT00989664|559110258|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
154915195|NCT00989664|559110258|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
154915196|NCT00989664|559110258|FG000|Long-Term Follow-Up|Death|3|||
154915197|NCT00095836|559110259|FG000|Overall Study|Lost to Follow-up|1|||
154915198|NCT00095836|559110259|FG000|Overall Study|Adverse Event|1|||
154915199|NCT00095836|559110259|FG000|Overall Study|Death|2|||
154915200|NCT00962780|559110262|FG000|Overall Study|Death|0|||
154915201|NCT00962780|559110263|FG001|Overall Study|Death|1|||
154915202|NCT00962780|559110262|FG000|Overall Study|Protocol Violation|9|||
154915203|NCT00962780|559110263|FG001|Overall Study|Protocol Violation|4|||
154915204|NCT00962780|559110262|FG000|Overall Study|Withdrawal by Subject|1|||
154915205|NCT00962780|559110263|FG001|Overall Study|Withdrawal by Subject|8|||
154915206|NCT00962780|559110262|FG000|Overall Study|Other|0|||
154915207|NCT00962780|559110263|FG001|Overall Study|Other|1|||
154915208|NCT02504424|559110267|FG000|Overall Study|Withdrawal by Subject|2|||
154915209|NCT00426842|559110268|FG000|Overall Study|Lost to Follow-up|1|||
154915210|NCT00982111|559110269|FG000|Overall Study|Adverse Event|1|||
154915211|NCT00982111|559110270|FG001|Overall Study|Adverse Event|1|||
154915212|NCT00982111|559110269|FG000|Overall Study|Progressive Disease|46|||
154915213|NCT00982111|559110270|FG001|Overall Study|Progressive Disease|39|||
154915214|NCT00982111|559110269|FG000|Overall Study|Lost to Follow-up|9|||
154915215|NCT00982111|559110270|FG001|Overall Study|Lost to Follow-up|6|||
154915216|NCT00982111|559110269|FG000|Overall Study|New Anti-Cancer Therapy|5|||
154915217|NCT00982111|559110270|FG001|Overall Study|New Anti-Cancer Therapy|5|||
154915218|NCT00982111|559110269|FG000|Overall Study|Medical Decision|1|||
154915219|NCT00982111|559110270|FG001|Overall Study|Medical Decision|0|||
154915220|NCT00982111|559110269|FG000|Overall Study|Withdrawal by Subject|17|||
154915221|NCT00982111|559110270|FG001|Overall Study|Withdrawal by Subject|19|||
154915222|NCT00982111|559110269|FG000|Overall Study|Global Study End|0|||
154915223|NCT00982111|559110270|FG001|Overall Study|Global Study End|1|||
154915224|NCT00982111|559110269|FG000|Overall Study|Sponsor's Decision|0|||
154915225|NCT00982111|559110270|FG001|Overall Study|Sponsor's Decision|1|||
154915226|NCT00422942|559110272|FG000|Overall Study|Study terminated by Sponsor|3|||
154915227|NCT02828982|559110275|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
154915228|NCT02828982|559110276|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
154915229|NCT02312934|559110277|FG000|Overall Study|Lost to Follow-up|1|||
154915230|NCT02312934|559110278|FG001|Overall Study|Lost to Follow-up|0|||
155176360|NCT02025556|560083974|FG002|Overall Study|Lack of Efficacy|0|||
154915231|NCT02312934|559110277|FG000|Overall Study|Physician Decision|1|||
154915232|NCT02312934|559110278|FG001|Overall Study|Physician Decision|0|||
154915233|NCT03395704|559110279|FG000|Overall Study|Adverse Event|2|||
154915234|NCT03395704|559110280|FG001|Overall Study|Adverse Event|1|||
154915235|NCT03395704|559110279|FG000|Overall Study|Withdrawal by Subject|2|||
154915236|NCT03395704|559110280|FG001|Overall Study|Withdrawal by Subject|1|||
155176361|NCT02025556|560083972|FG000|Overall Study|Protocol Violation|2|||
154915237|NCT03395704|559110279|FG000|Overall Study|Physician Decision|0|||
154915238|NCT03395704|559110280|FG001|Overall Study|Physician Decision|1|||
154915239|NCT01156012|559110281|FG000|Overall Study|Adverse Event|3|||
155176362|NCT02025556|560083973|FG001|Overall Study|Protocol Violation|1|||
154986753|NCT02093221|559377386|FG001|Overall Study|Lost to Follow-up|0|||
154986754|NCT02093221|559377387|FG002|Overall Study|Lost to Follow-up|1|||
154986755|NCT02093221|559377388|FG003|Overall Study|Lost to Follow-up|1|||
154986756|NCT02093221|559377389|FG004|Overall Study|Lost to Follow-up|0|||
154986757|NCT02093221|559377385|FG000|Overall Study|Death|0|||
154986758|NCT02093221|559377386|FG001|Overall Study|Death|1|||
154986759|NCT02093221|559377387|FG002|Overall Study|Death|0|||
154986760|NCT02093221|559377388|FG003|Overall Study|Death|0|||
154986761|NCT02093221|559377389|FG004|Overall Study|Death|0|||
154986762|NCT02093221|559377385|FG000|Overall Study|Protocol Violation|0|||
154986763|NCT02093221|559377386|FG001|Overall Study|Protocol Violation|1|||
154986764|NCT02093221|559377387|FG002|Overall Study|Protocol Violation|0|||
154986765|NCT02093221|559377388|FG003|Overall Study|Protocol Violation|0|||
154986766|NCT02093221|559377389|FG004|Overall Study|Protocol Violation|0|||
154986767|NCT02093221|559377385|FG000|Overall Study|Study termination|6|||
154986768|NCT02093221|559377386|FG001|Overall Study|Study termination|5|||
154986769|NCT02093221|559377387|FG002|Overall Study|Study termination|4|||
154986770|NCT02093221|559377388|FG003|Overall Study|Study termination|6|||
154986771|NCT02093221|559377389|FG004|Overall Study|Study termination|7|||
154986772|NCT01846273|559377392|FG000|Overall Study|Adverse Event|9|||
154986773|NCT01846273|559377393|FG001|Overall Study|Adverse Event|7|||
154986774|NCT01846273|559377394|FG002|Overall Study|Adverse Event|0|||
154986775|NCT01846273|559377392|FG000|Overall Study|Subject withdrew consent|5|||
154986776|NCT01846273|559377393|FG001|Overall Study|Subject withdrew consent|8|||
154986777|NCT01846273|559377394|FG002|Overall Study|Subject withdrew consent|0|||
154986778|NCT01846273|559377392|FG000|Overall Study|Lost to Follow-up|2|||
154986779|NCT01846273|559377393|FG001|Overall Study|Lost to Follow-up|1|||
154986780|NCT01846273|559377394|FG002|Overall Study|Lost to Follow-up|0|||
154986781|NCT01846273|559377392|FG000|Overall Study|Administrative problems|1|||
154986782|NCT01846273|559377393|FG001|Overall Study|Administrative problems|0|||
154986783|NCT01846273|559377394|FG002|Overall Study|Administrative problems|0|||
154986784|NCT01846273|559377392|FG000|Overall Study|Death|2|||
154986785|NCT01846273|559377393|FG001|Overall Study|Death|1|||
154986786|NCT01846273|559377394|FG002|Overall Study|Death|0|||
154986787|NCT01846273|559377392|FG000|Overall Study|Disease Progression|0|||
154986788|NCT01846273|559377393|FG001|Overall Study|Disease Progression|4|||
154986789|NCT01846273|559377394|FG002|Overall Study|Disease Progression|0|||
154986790|NCT01846273|559377392|FG000|Overall Study|Protocol Deviation|2|||
154986791|NCT01846273|559377393|FG001|Overall Study|Protocol Deviation|3|||
154986792|NCT01846273|559377394|FG002|Overall Study|Protocol Deviation|0|||
154986793|NCT01846273|559377392|FG000|Overall Study|Physician Decision|1|||
154986794|NCT01846273|559377393|FG001|Overall Study|Physician Decision|2|||
154986795|NCT01846273|559377394|FG002|Overall Study|Physician Decision|0|||
154986796|NCT00891839|559377395|FG000|Overall Study|Adverse Event|2|||
154986797|NCT00891839|559377395|FG000|Overall Study|Withdrawal by Subject|2|||
154986798|NCT00891839|559377395|FG000|Overall Study|Disease progression|3|||
154986799|NCT00851643|559377398|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
154915240|NCT01156012|559110282|FG001|Overall Study|Adverse Event|1|||
154915241|NCT01156012|559110281|FG000|Overall Study|Lost to Follow-up|1|||
154915242|NCT01156012|559110282|FG001|Overall Study|Lost to Follow-up|0|||
154915243|NCT01156012|559110281|FG000|Overall Study|Withdrawal by Subject|1|||
154915244|NCT01156012|559110282|FG001|Overall Study|Withdrawal by Subject|0|||
154915245|NCT01156012|559110281|FG000|Overall Study|use of commercial drug instead of study|0|||
154915246|NCT01156012|559110282|FG001|Overall Study|use of commercial drug instead of study|1|||
154915247|NCT01156012|559110281|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
154915248|NCT01156012|559110282|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
154915249|NCT03458234|559110283|FG000|Overall Study|Withdrawal by Subject|1|||
154915250|NCT00577382|559112164|FG000|Overall Study|Adverse Event|0|||
154915251|NCT00577382|559112165|FG001|Overall Study|Adverse Event|6|||
154915252|NCT00577382|559112164|FG000|Overall Study|Withdrawal by Subject|0|||
154915253|NCT00577382|559112165|FG001|Overall Study|Withdrawal by Subject|1|||
154915254|NCT00577382|559112164|FG000|Overall Study|Progressive Disease|17|||
154915255|NCT00577382|559112165|FG001|Overall Study|Progressive Disease|19|||
154915256|NCT00577382|559112164|FG000|Overall Study|Intercurrent Illness|1|||
154915257|NCT00577382|559112165|FG001|Overall Study|Intercurrent Illness|2|||
154915258|NCT00577382|559112164|FG000|Overall Study|Death|1|||
154986800|NCT00851643|559377399|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
154986801|NCT00851643|559377400|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
154986802|NCT00851643|559377401|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
154986803|NCT00851643|559377402|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
154986804|NCT00851643|559377403|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
154986805|NCT00851643|559377398|FG000|Base Study (Up to 12 Months)|Other|0|||
154986806|NCT00851643|559377399|FG001|Base Study (Up to 12 Months)|Other|0|||
154986807|NCT00851643|559377400|FG002|Base Study (Up to 12 Months)|Other|0|||
154986808|NCT00851643|559377401|FG003|Base Study (Up to 12 Months)|Other|0|||
154986809|NCT00851643|559377402|FG004|Base Study (Up to 12 Months)|Other|0|||
154986810|NCT00851643|559377403|FG005|Base Study (Up to 12 Months)|Other|1|||
154986811|NCT00851643|559377398|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
154915259|NCT00577382|559112165|FG001|Overall Study|Death|1|||
154915260|NCT00577382|559112164|FG000|Overall Study|Lost to Follow-up|2|||
154915261|NCT00577382|559112165|FG001|Overall Study|Lost to Follow-up|2|||
154915262|NCT01345162|559112166|FG000|Overall Study|Protocol Violation|2|||
154915263|NCT01345162|559112167|FG001|Overall Study|Protocol Violation|4|||
154915264|NCT03007472|559112169|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
154915265|NCT03007472|559112169|FG000|Overall Study|Death|2|||
154915266|NCT03007472|559112169|FG000|Overall Study|Loss to Follow Up|1|||
154915267|NCT00649220|559112170|FG000|Overall Study|Adverse Event|2|||
154915268|NCT00649220|559112170|FG000|Overall Study|Withdrawal by Subject|1|||
154915269|NCT00525499|559112171|FG000|Overall Study|Lost to Follow-up|2|||
154915270|NCT00525499|559112172|FG001|Overall Study|Lost to Follow-up|4|||
154915271|NCT00525499|559112173|FG002|Overall Study|Lost to Follow-up|1|||
154915272|NCT00525499|559112174|FG003|Overall Study|Lost to Follow-up|4|||
154915273|NCT00525499|559112171|FG000|Overall Study|Adverse Event|0|||
154915274|NCT00525499|559112172|FG001|Overall Study|Adverse Event|1|||
154915275|NCT00525499|559112173|FG002|Overall Study|Adverse Event|0|||
154915276|NCT00525499|559112174|FG003|Overall Study|Adverse Event|1|||
154915277|NCT00525499|559112171|FG000|Overall Study|Withdrawal by Subject|5|||
154915278|NCT00525499|559112172|FG001|Overall Study|Withdrawal by Subject|1|||
154915279|NCT00525499|559112173|FG002|Overall Study|Withdrawal by Subject|5|||
154915280|NCT00525499|559112174|FG003|Overall Study|Withdrawal by Subject|2|||
154915281|NCT00525499|559112171|FG000|Overall Study|Protocol Violation|0|||
154915282|NCT00525499|559112172|FG001|Overall Study|Protocol Violation|1|||
154915283|NCT00525499|559112173|FG002|Overall Study|Protocol Violation|1|||
154915284|NCT00525499|559112174|FG003|Overall Study|Protocol Violation|0|||
154915285|NCT02906644|559112175|FG000|First 2 Weeks|Withdrawal by Subject|0|||
154915286|NCT02906644|559112176|FG001|First 2 Weeks|Withdrawal by Subject|2|||
154915287|NCT02906644|559112175|FG000|First 2 Weeks|Physician Decision|1|||
154915288|NCT02906644|559112176|FG001|First 2 Weeks|Physician Decision|1|||
154915289|NCT02906644|559112175|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
154915290|NCT02906644|559112176|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
154915291|NCT02906644|559112175|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
154915292|NCT02906644|559112176|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
154915293|NCT00608426|559112177|FG000|Overall Study|Death|32|||
154915294|NCT00608426|559112178|FG001|Overall Study|Death|36|||
154915295|NCT00608426|559112177|FG000|Overall Study|Lost to Follow-up|485|||
154915296|NCT00608426|559112178|FG001|Overall Study|Lost to Follow-up|521|||
154915297|NCT00608426|559112177|FG000|Overall Study|refused, health issues, wrong address|319|||
154915298|NCT00608426|559112178|FG001|Overall Study|refused, health issues, wrong address|348|||
154915299|NCT00761891|559112179|FG000|Overall Study|Withdrawal by Subject|10|||
154915300|NCT01453439|559112183|FG000|Treatment Phase|Withdrawal by Subject|13|||
154915301|NCT01453439|559112184|FG001|Treatment Phase|Withdrawal by Subject|10|||
154915302|NCT01453439|559112183|FG000|Treatment Phase|Suicidal Ideation|2|||
154915303|NCT01453439|559112184|FG001|Treatment Phase|Suicidal Ideation|0|||
154915304|NCT01453439|559112183|FG000|Treatment Phase|Need for higher level of care|1|||
154915305|NCT01453439|559112184|FG001|Treatment Phase|Need for higher level of care|1|||
154915306|NCT01453439|559112183|FG000|Treatment Phase|Therapist conflict of interest|1|||
154915307|NCT01453439|559112184|FG001|Treatment Phase|Therapist conflict of interest|0|||
154915308|NCT01453439|559112183|FG000|Follow-up|Withdrawal by Subject|0|||
154915309|NCT01453439|559112184|FG001|Follow-up|Withdrawal by Subject|1|||
154915310|NCT01453439|559112183|FG000|Follow-up|Lost to Follow-up|5|||
154915311|NCT01453439|559112184|FG001|Follow-up|Lost to Follow-up|10|||
154915312|NCT01014442|559112185|FG000|Overall Study|Adverse Event|0|||
154915313|NCT01014442|559112186|FG001|Overall Study|Adverse Event|8|||
154915314|NCT01014442|559112185|FG000|Overall Study|Withdrawal by Subject|4|||
154915315|NCT01014442|559112186|FG001|Overall Study|Withdrawal by Subject|4|||
154915316|NCT01014442|559112185|FG000|Overall Study|Protocol Violation|2|||
154915317|NCT01014442|559112186|FG001|Overall Study|Protocol Violation|5|||
154915318|NCT01014442|559112185|FG000|Overall Study|Lack of Compliance|0|||
154915319|NCT01014442|559112186|FG001|Overall Study|Lack of Compliance|1|||
154915320|NCT01014442|559112185|FG000|Overall Study|Unspecified Reason|1|||
154915321|NCT01014442|559112186|FG001|Overall Study|Unspecified Reason|1|||
154915322|NCT02074059|559112187|FG000|Overall Study|Death|0|||
155119262|NCT00075725|559868475|FG002|Overall Study|Other|1|||
155119263|NCT00075725|559868476|FG003|Overall Study|Other|1|||
154915323|NCT02074059|559112188|FG001|Overall Study|Death|0|||
154915324|NCT02074059|559112189|FG002|Overall Study|Death|0|||
154915325|NCT02074059|559112190|FG003|Overall Study|Death|0|||
154915326|NCT02074059|559112191|FG004|Overall Study|Death|1|||
154915327|NCT02074059|559112192|FG005|Overall Study|Death|1|||
154915328|NCT00672490|559112196|FG000|Overall Study|Withdrawal by Subject|8|||
154915329|NCT00672490|559112197|FG001|Overall Study|Withdrawal by Subject|8|||
154915330|NCT00672490|559112196|FG000|Overall Study|Lack of Compliance|2|||
154915331|NCT00672490|559112197|FG001|Overall Study|Lack of Compliance|7|||
154915332|NCT00672490|559112196|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
154915333|NCT00672490|559112197|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
154915334|NCT00672490|559112196|FG000|Overall Study|Adverse Event|5|||
154915335|NCT00672490|559112197|FG001|Overall Study|Adverse Event|8|||
154915336|NCT00672490|559112196|FG000|Overall Study|Violation of Concomitant Medicine|1|||
154915337|NCT00672490|559112197|FG001|Overall Study|Violation of Concomitant Medicine|0|||
154915338|NCT00672490|559112196|FG000|Overall Study|Intolerance|0|||
154915339|NCT00672490|559112197|FG001|Overall Study|Intolerance|2|||
154915340|NCT00672490|559112196|FG000|Overall Study|Lost to Follow-up|1|||
154915341|NCT00672490|559112197|FG001|Overall Study|Lost to Follow-up|5|||
154915342|NCT00672490|559112196|FG000|Overall Study|No reason was provided|6|||
154915343|NCT00672490|559112197|FG001|Overall Study|No reason was provided|2|||
154915344|NCT02030067|559112200|FG000|Overall Study|Disease Progression|1|||
154915345|NCT02030067|559112201|FG001|Overall Study|Disease Progression|1|||
154915346|NCT02030067|559112202|FG002|Overall Study|Disease Progression|2|||
154915347|NCT02030067|559112203|FG003|Overall Study|Disease Progression|2|||
154915348|NCT02030067|559112204|FG004|Overall Study|Disease Progression|3|||
154915349|NCT02030067|559112205|FG005|Overall Study|Disease Progression|2|||
154915350|NCT02030067|559112206|FG006|Overall Study|Disease Progression|3|||
154915351|NCT02030067|559112207|FG007|Overall Study|Disease Progression|3|||
154915352|NCT02030067|559112208|FG008|Overall Study|Disease Progression|4|||
154915353|NCT02030067|559112209|FG009|Overall Study|Disease Progression|3|||
154915354|NCT02030067|559112210|FG010|Overall Study|Disease Progression|7|||
154915355|NCT02030067|559112211|FG011|Overall Study|Disease Progression|2|||
154915356|NCT02030067|559112212|FG012|Overall Study|Disease Progression|59|||
154915357|NCT02030067|559112200|FG000|Overall Study|Withdrawal by Subject|0|||
154915358|NCT02030067|559112201|FG001|Overall Study|Withdrawal by Subject|0|||
154915359|NCT02030067|559112202|FG002|Overall Study|Withdrawal by Subject|0|||
154915360|NCT02030067|559112203|FG003|Overall Study|Withdrawal by Subject|1|||
154915361|NCT02030067|559112204|FG004|Overall Study|Withdrawal by Subject|0|||
154915362|NCT02030067|559112205|FG005|Overall Study|Withdrawal by Subject|0|||
154915363|NCT02030067|559112206|FG006|Overall Study|Withdrawal by Subject|0|||
154915364|NCT02030067|559112207|FG007|Overall Study|Withdrawal by Subject|1|||
154915365|NCT02030067|559112208|FG008|Overall Study|Withdrawal by Subject|0|||
154915366|NCT02030067|559112209|FG009|Overall Study|Withdrawal by Subject|0|||
154915367|NCT02030067|559112210|FG010|Overall Study|Withdrawal by Subject|3|||
154915368|NCT02030067|559112211|FG011|Overall Study|Withdrawal by Subject|0|||
154915369|NCT02030067|559112212|FG012|Overall Study|Withdrawal by Subject|6|||
154915370|NCT02030067|559112200|FG000|Overall Study|Physician Decision|0|||
154915371|NCT02030067|559112201|FG001|Overall Study|Physician Decision|0|||
154915372|NCT02030067|559112202|FG002|Overall Study|Physician Decision|0|||
154915373|NCT02030067|559112203|FG003|Overall Study|Physician Decision|0|||
154915374|NCT02030067|559112204|FG004|Overall Study|Physician Decision|0|||
154915375|NCT02030067|559112205|FG005|Overall Study|Physician Decision|0|||
154915376|NCT02030067|559112206|FG006|Overall Study|Physician Decision|0|||
154915377|NCT02030067|559112207|FG007|Overall Study|Physician Decision|0|||
154915378|NCT02030067|559112208|FG008|Overall Study|Physician Decision|0|||
154915379|NCT02030067|559112209|FG009|Overall Study|Physician Decision|0|||
154915380|NCT02030067|559112210|FG010|Overall Study|Physician Decision|1|||
154915381|NCT02030067|559112211|FG011|Overall Study|Physician Decision|0|||
154915382|NCT02030067|559112212|FG012|Overall Study|Physician Decision|3|||
154915383|NCT02030067|559112200|FG000|Overall Study|other reasons|0|||
154915384|NCT02030067|559112201|FG001|Overall Study|other reasons|0|||
154915385|NCT02030067|559112202|FG002|Overall Study|other reasons|0|||
154915386|NCT02030067|559112203|FG003|Overall Study|other reasons|0|||
154915387|NCT02030067|559112204|FG004|Overall Study|other reasons|0|||
154915388|NCT02030067|559112205|FG005|Overall Study|other reasons|1|||
154915389|NCT02030067|559112206|FG006|Overall Study|other reasons|0|||
154915390|NCT02030067|559112207|FG007|Overall Study|other reasons|0|||
154915391|NCT02030067|559112208|FG008|Overall Study|other reasons|2|||
154915392|NCT02030067|559112209|FG009|Overall Study|other reasons|0|||
154915393|NCT02030067|559112210|FG010|Overall Study|other reasons|0|||
154915394|NCT02030067|559112211|FG011|Overall Study|other reasons|0|||
154915395|NCT02030067|559112212|FG012|Overall Study|other reasons|4|||
154915396|NCT02030067|559112200|FG000|Overall Study|Adverse Event|0|||
154915397|NCT02030067|559112201|FG001|Overall Study|Adverse Event|0|||
154915398|NCT02030067|559112202|FG002|Overall Study|Adverse Event|0|||
154915399|NCT02030067|559112203|FG003|Overall Study|Adverse Event|0|||
154915400|NCT02030067|559112204|FG004|Overall Study|Adverse Event|0|||
154915401|NCT02030067|559112205|FG005|Overall Study|Adverse Event|0|||
154915402|NCT02030067|559112206|FG006|Overall Study|Adverse Event|0|||
154915403|NCT02030067|559112207|FG007|Overall Study|Adverse Event|0|||
154915404|NCT02030067|559112208|FG008|Overall Study|Adverse Event|0|||
155119264|NCT00075725|559868477|FG004|Overall Study|Other|1|||
154915405|NCT02030067|559112209|FG009|Overall Study|Adverse Event|0|||
154915406|NCT02030067|559112210|FG010|Overall Study|Adverse Event|0|||
154915407|NCT02030067|559112211|FG011|Overall Study|Adverse Event|1|||
154915408|NCT02030067|559112212|FG012|Overall Study|Adverse Event|8|||
154915409|NCT00545740|559112218|FG000|Overall Study|Lack of Efficacy|34|||
154915410|NCT00545740|559112219|FG001|Overall Study|Lack of Efficacy|35|||
154915411|NCT00545740|559112220|FG002|Overall Study|Lack of Efficacy|47|||
154915412|NCT00545740|559112221|FG003|Overall Study|Lack of Efficacy|36|||
154915413|NCT00545740|559112218|FG000|Overall Study|Withdrawal by Subject|17|||
155119265|NCT00075725|559868478|FG005|Overall Study|Other|4|||
154915414|NCT00545740|559112219|FG001|Overall Study|Withdrawal by Subject|15|||
154915415|NCT00545740|559112220|FG002|Overall Study|Withdrawal by Subject|16|||
154915416|NCT00545740|559112221|FG003|Overall Study|Withdrawal by Subject|18|||
154915417|NCT00545740|559112218|FG000|Overall Study|Adverse Event|10|||
154915418|NCT00545740|559112219|FG001|Overall Study|Adverse Event|18|||
154915419|NCT00545740|559112220|FG002|Overall Study|Adverse Event|19|||
154915420|NCT00545740|559112221|FG003|Overall Study|Adverse Event|9|||
154915421|NCT00545740|559112218|FG000|Overall Study|Lost to Follow-up|7|||
154915422|NCT00545740|559112219|FG001|Overall Study|Lost to Follow-up|5|||
154915423|NCT00545740|559112220|FG002|Overall Study|Lost to Follow-up|5|||
154915424|NCT00545740|559112221|FG003|Overall Study|Lost to Follow-up|6|||
154915425|NCT00545740|559112218|FG000|Overall Study|Protocol Violation|1|||
154915426|NCT00545740|559112219|FG001|Overall Study|Protocol Violation|3|||
154915427|NCT00545740|559112220|FG002|Overall Study|Protocol Violation|1|||
154915428|NCT00545740|559112221|FG003|Overall Study|Protocol Violation|0|||
154915429|NCT00545740|559112218|FG000|Overall Study|Non-compliance|0|||
154915430|NCT00545740|559112219|FG001|Overall Study|Non-compliance|2|||
154915431|NCT00545740|559112220|FG002|Overall Study|Non-compliance|1|||
154915432|NCT00545740|559112221|FG003|Overall Study|Non-compliance|0|||
154915433|NCT00545740|559112218|FG000|Overall Study|Moved|2|||
154915434|NCT00545740|559112219|FG001|Overall Study|Moved|0|||
154915435|NCT00545740|559112220|FG002|Overall Study|Moved|1|||
154915436|NCT00545740|559112221|FG003|Overall Study|Moved|0|||
154915437|NCT00545740|559112218|FG000|Overall Study|Diverticulitis attack|0|||
154915438|NCT00545740|559112219|FG001|Overall Study|Diverticulitis attack|0|||
154915439|NCT00545740|559112220|FG002|Overall Study|Diverticulitis attack|1|||
154915440|NCT00545740|559112221|FG003|Overall Study|Diverticulitis attack|1|||
154915441|NCT00545740|559112218|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
154915442|NCT00545740|559112219|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
154915443|NCT00545740|559112220|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
154915444|NCT00545740|559112221|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
154915445|NCT00545740|559112218|FG000|Overall Study|Site closure|1|||
154915446|NCT00545740|559112219|FG001|Overall Study|Site closure|0|||
154915447|NCT00545740|559112220|FG002|Overall Study|Site closure|0|||
154915448|NCT00545740|559112221|FG003|Overall Study|Site closure|0|||
154915449|NCT00545740|559112218|FG000|Overall Study|Missed visit|1|||
154915450|NCT00545740|559112219|FG001|Overall Study|Missed visit|0|||
154915451|NCT00545740|559112220|FG002|Overall Study|Missed visit|0|||
154915452|NCT00545740|559112221|FG003|Overall Study|Missed visit|0|||
154915453|NCT00545740|559112218|FG000|Overall Study|Physician Decision|0|||
154915454|NCT00545740|559112219|FG001|Overall Study|Physician Decision|0|||
154915455|NCT00545740|559112220|FG002|Overall Study|Physician Decision|3|||
154915456|NCT00545740|559112221|FG003|Overall Study|Physician Decision|0|||
154915457|NCT00545740|559112218|FG000|Overall Study|Accepted only monthly telephone calls|1|||
154915458|NCT00545740|559112219|FG001|Overall Study|Accepted only monthly telephone calls|0|||
154915459|NCT00545740|559112220|FG002|Overall Study|Accepted only monthly telephone calls|0|||
154915460|NCT00545740|559112221|FG003|Overall Study|Accepted only monthly telephone calls|0|||
154915461|NCT00545740|559112218|FG000|Overall Study|Sponsor decision|0|||
154915462|NCT00545740|559112219|FG001|Overall Study|Sponsor decision|1|||
154915463|NCT00545740|559112220|FG002|Overall Study|Sponsor decision|0|||
154915464|NCT00545740|559112221|FG003|Overall Study|Sponsor decision|0|||
154915465|NCT00545740|559112218|FG000|Overall Study|Lack of time|0|||
154915466|NCT00545740|559112219|FG001|Overall Study|Lack of time|1|||
154915467|NCT00545740|559112220|FG002|Overall Study|Lack of time|0|||
154915468|NCT00545740|559112221|FG003|Overall Study|Lack of time|0|||
154915469|NCT00545740|559112218|FG000|Overall Study|Non-adherence to visits|0|||
154915470|NCT00545740|559112219|FG001|Overall Study|Non-adherence to visits|1|||
154915471|NCT00545740|559112220|FG002|Overall Study|Non-adherence to visits|0|||
154915472|NCT00545740|559112221|FG003|Overall Study|Non-adherence to visits|0|||
154915473|NCT00545740|559112218|FG000|Overall Study|Patient difficulties|0|||
154915474|NCT00545740|559112219|FG001|Overall Study|Patient difficulties|1|||
154915475|NCT00545740|559112220|FG002|Overall Study|Patient difficulties|0|||
154915476|NCT00545740|559112221|FG003|Overall Study|Patient difficulties|0|||
154915477|NCT00545740|559112218|FG000|Overall Study|Husband against study|0|||
154915478|NCT00545740|559112219|FG001|Overall Study|Husband against study|0|||
154915479|NCT00545740|559112220|FG002|Overall Study|Husband against study|1|||
154915480|NCT00545740|559112221|FG003|Overall Study|Husband against study|0|||
154915481|NCT02117024|559112222|FG000|Overall Study|Progressive Disease|26|||
154915482|NCT02117024|559112223|FG001|Overall Study|Progressive Disease|9|||
154915483|NCT02117024|559112222|FG000|Overall Study|Significant Clinical Progression|7|||
154915484|NCT02117024|559112223|FG001|Overall Study|Significant Clinical Progression|4|||
154915485|NCT02117024|559112222|FG000|Overall Study|Death|5|||
154915486|NCT02117024|559112223|FG001|Overall Study|Death|0|||
154915487|NCT02117024|559112222|FG000|Overall Study|Withdrawal by Subject|3|||
154915488|NCT02117024|559112223|FG001|Overall Study|Withdrawal by Subject|1|||
154915489|NCT02117024|559112222|FG000|Overall Study|Protocol Violation|1|||
154915490|NCT02117024|559112223|FG001|Overall Study|Protocol Violation|0|||
154915491|NCT02117024|559112222|FG000|Overall Study|Adverse Event|1|||
154986812|NCT00851643|559377399|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
154986813|NCT00851643|559377400|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
154986814|NCT00851643|559377401|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
154986815|NCT00851643|559377402|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
154986816|NCT00851643|559377403|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
154986817|NCT00851643|559377398|FG000|Extension Study (Up to 36 Months)|Moved|0|||
154986818|NCT00851643|559377399|FG001|Extension Study (Up to 36 Months)|Moved|2|||
154986819|NCT00851643|559377400|FG002|Extension Study (Up to 36 Months)|Moved|1|||
154986820|NCT00851643|559377401|FG003|Extension Study (Up to 36 Months)|Moved|1|||
154986821|NCT00851643|559377402|FG004|Extension Study (Up to 36 Months)|Moved|0|||
154986822|NCT00851643|559377403|FG005|Extension Study (Up to 36 Months)|Moved|1|||
154986823|NCT00359788|559377404|FG000|Overall Study|Adverse Event|11|||
154986824|NCT00359788|559377405|FG001|Overall Study|Adverse Event|10|||
154986825|NCT00359788|559377404|FG000|Overall Study|Lack of Efficacy|1|||
154986826|NCT00359788|559377405|FG001|Overall Study|Lack of Efficacy|2|||
154986827|NCT00359788|559377404|FG000|Overall Study|Lost to Follow-up|3|||
154986828|NCT00359788|559377405|FG001|Overall Study|Lost to Follow-up|2|||
154986829|NCT00359788|559377404|FG000|Overall Study|Withdrawal by Subject|4|||
154986830|NCT00359788|559377405|FG001|Overall Study|Withdrawal by Subject|1|||
154986831|NCT00359788|559377404|FG000|Overall Study|Protocol Violation|4|||
154986832|NCT00359788|559377405|FG001|Overall Study|Protocol Violation|2|||
154986833|NCT00673933|559377406|FG000|Overall Study|Withdrawal by Subject|2|||
154986834|NCT00673933|559377406|FG000|Overall Study|Lost to Follow-up|1|||
154986835|NCT04932941|559377407|FG000|Overall Study|Lost to Follow-up|3|||
154915492|NCT02117024|559112223|FG001|Overall Study|Adverse Event|2|||
154915493|NCT02117024|559112222|FG000|Overall Study|Randomized in Error|1|||
154915494|NCT02117024|559112223|FG001|Overall Study|Randomized in Error|0|||
154915495|NCT02117024|559112222|FG000|Overall Study|Patient returned to primary oncologist|0|||
154915496|NCT02117024|559112223|FG001|Overall Study|Patient returned to primary oncologist|1|||
154915497|NCT02117024|559112222|FG000|Overall Study|Patient took treatment break|0|||
154915498|NCT02117024|559112223|FG001|Overall Study|Patient took treatment break|1|||
154915499|NCT02117024|559112222|FG000|Overall Study|Physician Decision|0|||
154915500|NCT02117024|559112223|FG001|Overall Study|Physician Decision|2|||
154915501|NCT00565721|559112224|FG000|Overall Study|Screen Failure|2|||
154915502|NCT00565721|559112224|FG000|Overall Study|Lost to Follow-up|6|||
154915503|NCT00565721|559112224|FG000|Overall Study|Technical Problems|1|||
154915504|NCT00565721|559112224|FG000|Overall Study|Physician Decision|2|||
154915505|NCT00565721|559112224|FG000|Overall Study|Other reasons|6|||
154915506|NCT04062240|559112227|FG000|Overall Study|equipment malfunction|1|||
154915507|NCT03323385|559112235|FG000|Overall Study|Withdrawal by Subject|1|||
154915508|NCT03323385|559112236|FG001|Overall Study|Withdrawal by Subject|2|||
154915509|NCT03323385|559112235|FG000|Overall Study|Noncompliance|0|||
154915510|NCT03323385|559112236|FG001|Overall Study|Noncompliance|1|||
154915511|NCT04118127|559112238|FG000|Overall Study|Trial terminated by sponsor|0|||
154915512|NCT04118127|559112239|FG001|Overall Study|Trial terminated by sponsor|12|||
154915513|NCT04118127|559112238|FG000|Overall Study|Adverse Event|1|||
154915514|NCT04118127|559112239|FG001|Overall Study|Adverse Event|2|||
154915515|NCT04118127|559112238|FG000|Overall Study|Physician Decision|0|||
154915516|NCT04118127|559112239|FG001|Overall Study|Physician Decision|1|||
154915517|NCT04118127|559112238|FG000|Overall Study|Withdrawal by Subject|2|||
154915518|NCT04118127|559112239|FG001|Overall Study|Withdrawal by Subject|1|||
154915519|NCT01681836|559112245|FG000|Second Intervention|Withdrawal by Subject|0|||
154915520|NCT01681836|559112246|FG001|Second Intervention|Withdrawal by Subject|1|||
154915521|NCT02142712|559112247|FG000|Overall Study|Lost to Follow-up|1|||
154915522|NCT02142712|559112248|FG001|Overall Study|Lost to Follow-up|1|||
154915523|NCT02142712|559112249|FG002|Overall Study|Lost to Follow-up|1|||
154915524|NCT02142712|559112250|FG003|Overall Study|Lost to Follow-up|0|||
154915525|NCT04815291|559112268|FG000|Overall Study|Lost to Follow-up|1|||
154915526|NCT04815291|559112268|FG000|Overall Study|Physician Decision|4|||
154915527|NCT04815291|559112268|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
154915528|NCT02646332|559112269|FG000|Overall Study|Lost to Follow-up|0|||
154915529|NCT02646332|559112270|FG001|Overall Study|Lost to Follow-up|3|||
154915530|NCT02363322|559112273|FG000|Overall Study|Lost to Follow-up|1|||
154915531|NCT02363322|559112274|FG001|Overall Study|Lost to Follow-up|0|||
154915532|NCT02269709|559112275|FG000|Time of Enrollment|Withdrawal by Subject|3|||
154915533|NCT02269709|559112275|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
154915534|NCT02269709|559112275|FG000|Six Month Follow-up|Lost to Follow-up|12|||
154915535|NCT02909504|559112276|FG000|Overall Study|Adverse Event|2|||
154915536|NCT02909504|559112276|FG000|Overall Study|Lack of Efficacy|3|||
154915537|NCT02909504|559112276|FG000|Overall Study|Withdrawal by Subject|4|||
154915538|NCT02909504|559112276|FG000|Overall Study|Pregnancy|1|||
154915539|NCT02909504|559112276|FG000|Overall Study|Subject moved|1|||
154915540|NCT02909504|559112276|FG000|Overall Study|Lost to Follow-up|1|||
154915541|NCT02055976|559112277|FG000|Overall Study|Other|0|||
154915542|NCT02055976|559112278|FG001|Overall Study|Other|0|||
154915543|NCT02055976|559112279|FG002|Overall Study|Other|1|||
154986836|NCT04932941|559377408|FG001|Overall Study|Lost to Follow-up|1|||
154986837|NCT04932941|559377407|FG000|Overall Study|Withdrawal by Subject|7|||
154986838|NCT04932941|559377408|FG001|Overall Study|Withdrawal by Subject|4|||
154986839|NCT04932941|559377407|FG000|Overall Study|Other|4|||
154986840|NCT04932941|559377408|FG001|Overall Study|Other|2|||
154986841|NCT05069155|559377409|FG000|Overall Study|Withdrawal by Subject|1|||
154986842|NCT05069155|559377410|FG001|Overall Study|Withdrawal by Subject|3|||
154986843|NCT02206620|559377411|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
154986844|NCT02206620|559377412|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
154986845|NCT02206620|559377411|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
154986846|NCT02206620|559377412|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
154986847|NCT01929031|559377413|FG000|Overall Study|Adverse Event|3|||
154986848|NCT01929031|559377414|FG001|Overall Study|Adverse Event|1|||
154986849|NCT01929031|559377415|FG002|Overall Study|Adverse Event|1|||
154986850|NCT01929031|559377416|FG003|Overall Study|Adverse Event|0|||
154986851|NCT01929031|559377417|FG004|Overall Study|Adverse Event|0|||
154986852|NCT01929031|559377418|FG005|Overall Study|Adverse Event|0|||
154986853|NCT01929031|559377413|FG000|Overall Study|Protocol Violation|1|||
154986854|NCT01929031|559377414|FG001|Overall Study|Protocol Violation|0|||
154986855|NCT01929031|559377415|FG002|Overall Study|Protocol Violation|0|||
154986856|NCT01929031|559377416|FG003|Overall Study|Protocol Violation|0|||
154986857|NCT01929031|559377417|FG004|Overall Study|Protocol Violation|0|||
154986858|NCT01929031|559377418|FG005|Overall Study|Protocol Violation|1|||
154986859|NCT01929031|559377413|FG000|Overall Study|Reason other than specified above|0|||
154986860|NCT01929031|559377414|FG001|Overall Study|Reason other than specified above|1|||
154986861|NCT01929031|559377415|FG002|Overall Study|Reason other than specified above|0|||
154986862|NCT01929031|559377416|FG003|Overall Study|Reason other than specified above|0|||
154986863|NCT01929031|559377417|FG004|Overall Study|Reason other than specified above|1|||
154986864|NCT01929031|559377418|FG005|Overall Study|Reason other than specified above|0|||
154986865|NCT01366443|559377419|FG000|Overall Study|Lost to Follow-up|2|||
154986866|NCT01366443|559377419|FG000|Overall Study|Under 18 yo|1|||
154986867|NCT05816200|559377420|FG000|Overall Study|Lost to Follow-up|2|||
154986868|NCT05816200|559377421|FG001|Overall Study|Lost to Follow-up|1|||
154986869|NCT02394730|559377422|FG000|Overall Study|Lost to Follow-up|1|||
154986870|NCT02394730|559377423|FG001|Overall Study|Lost to Follow-up|0|||
154986871|NCT02394730|559377422|FG000|Overall Study|Withdrawal by Subject|0|||
154986872|NCT02394730|559377423|FG001|Overall Study|Withdrawal by Subject|1|||
154986873|NCT00731549|559377424|FG000|Overall Study|Lost to Follow-up|19|||
154986874|NCT00731549|559377424|FG000|Overall Study|Met withdrawal criteria|24|||
154986875|NCT00731549|559377424|FG000|Overall Study|Physician Decision|16|||
154986876|NCT00731549|559377424|FG000|Overall Study|Withdrawal by Subject|89|||
154986877|NCT00731549|559377424|FG000|Overall Study|Protocol deviation|1|||
154986878|NCT00731549|559377424|FG000|Overall Study|Adverse Event|31|||
154986879|NCT00731549|559377424|FG000|Overall Study|Lack of efficacy with AE|37|||
154986880|NCT00731549|559377424|FG000|Overall Study|Lack of efficacy without AE|6|||
154986881|NCT00588640|559377425|FG000|Overall Study|Physician Decision|1|||
154986882|NCT00588640|559377425|FG000|Overall Study|Ineligible Patient|1|||
154986883|NCT01393730|559377426|FG000|Overall Study|Withdrawal by Subject|3|||
154986884|NCT01393730|559377426|FG000|Overall Study|Other|2|||
154986885|NCT01393730|559377426|FG000|Overall Study|Adverse Event|1|||
154986886|NCT00103402|559377427|FG000|Overall Study|Adverse Event|3|||
154986887|NCT00103402|559377428|FG001|Overall Study|Adverse Event|4|||
154986888|NCT00103402|559377427|FG000|Overall Study|Lost to Follow-up|8|||
154986889|NCT00103402|559377428|FG001|Overall Study|Lost to Follow-up|7|||
154986890|NCT00103402|559377427|FG000|Overall Study|Dissatisfied/No longer interested|6|||
154986891|NCT00103402|559377428|FG001|Overall Study|Dissatisfied/No longer interested|6|||
154986892|NCT00103402|559377427|FG000|Overall Study|Personal constraints/Other|5|||
154986893|NCT00103402|559377428|FG001|Overall Study|Personal constraints/Other|0|||
154986894|NCT00507546|559377429|FG000|Overall Study|Withdrawal by Subject|1|||
154986895|NCT00507546|559377430|FG001|Overall Study|Withdrawal by Subject|0|||
154986896|NCT00507546|559377429|FG000|Overall Study|Protocol Violation|1|||
154986897|NCT00507546|559377430|FG001|Overall Study|Protocol Violation|0|||
154986898|NCT00507546|559377429|FG000|Overall Study|Physician Decision|0|||
154986899|NCT00507546|559377430|FG001|Overall Study|Physician Decision|1|||
154986900|NCT02384850|559377431|FG000|Overall Study|Withdrawal by Subject|2|||
154986901|NCT02384850|559377432|FG001|Overall Study|Withdrawal by Subject|2|||
154986902|NCT03510182|559377438|FG000|Overall Study|Withdrawal by Subject|2|||
154986903|NCT00375492|559377440|FG000|Overall Study|Adverse Event|4|||
154986904|NCT00375492|559377441|FG001|Overall Study|Adverse Event|5|||
154986905|NCT00375492|559377440|FG000|Overall Study|Entry Criteria Not Met|0|||
154986906|NCT00375492|559377441|FG001|Overall Study|Entry Criteria Not Met|1|||
154986907|NCT00375492|559377440|FG000|Overall Study|Loss of Glucose Control|0|||
154986908|NCT00375492|559377441|FG001|Overall Study|Loss of Glucose Control|1|||
154986909|NCT00375492|559377440|FG000|Overall Study|Lost to Follow-up|10|||
154986910|NCT00375492|559377441|FG001|Overall Study|Lost to Follow-up|5|||
154986911|NCT00375492|559377440|FG000|Overall Study|Physician Decision|0|||
154986912|NCT00375492|559377441|FG001|Overall Study|Physician Decision|4|||
154986913|NCT00375492|559377440|FG000|Overall Study|Protocol Violation|6|||
155176363|NCT02025556|560083974|FG002|Overall Study|Protocol Violation|0|||
155176364|NCT02025556|560083972|FG000|Overall Study|Withdrawal by Subject|0|||
154915544|NCT02055976|559112280|FG003|Overall Study|Other|0|||
154915545|NCT02055976|559112281|FG004|Overall Study|Other|0|||
154915546|NCT02055976|559112282|FG005|Overall Study|Other|0|||
154915547|NCT02055976|559112283|FG006|Overall Study|Other|0|||
154915548|NCT02055976|559112284|FG007|Overall Study|Other|0|||
154915549|NCT02055976|559112285|FG008|Overall Study|Other|0|||
154915550|NCT02055976|559112277|FG000|Overall Study|Adverse Event|0|||
154915551|NCT02055976|559112278|FG001|Overall Study|Adverse Event|0|||
154915552|NCT02055976|559112279|FG002|Overall Study|Adverse Event|0|||
154915553|NCT02055976|559112280|FG003|Overall Study|Adverse Event|0|||
154915554|NCT02055976|559112281|FG004|Overall Study|Adverse Event|0|||
154915555|NCT02055976|559112282|FG005|Overall Study|Adverse Event|1|||
154915556|NCT02055976|559112283|FG006|Overall Study|Adverse Event|1|||
154915557|NCT02055976|559112284|FG007|Overall Study|Adverse Event|0|||
154915558|NCT02055976|559112285|FG008|Overall Study|Adverse Event|0|||
154915559|NCT02055976|559112277|FG000|Overall Study|Does not meet entrance criteria|0|||
154915560|NCT02055976|559112278|FG001|Overall Study|Does not meet entrance criteria|0|||
154915561|NCT02055976|559112279|FG002|Overall Study|Does not meet entrance criteria|0|||
154915562|NCT02055976|559112280|FG003|Overall Study|Does not meet entrance criteria|0|||
154915563|NCT02055976|559112281|FG004|Overall Study|Does not meet entrance criteria|0|||
154915564|NCT02055976|559112282|FG005|Overall Study|Does not meet entrance criteria|0|||
154915565|NCT02055976|559112283|FG006|Overall Study|Does not meet entrance criteria|1|||
154915566|NCT02055976|559112284|FG007|Overall Study|Does not meet entrance criteria|0|||
154915567|NCT02055976|559112285|FG008|Overall Study|Does not meet entrance criteria|0|||
154915568|NCT02055976|559112277|FG000|Overall Study|Lost to Follow-up|0|||
154915569|NCT02055976|559112278|FG001|Overall Study|Lost to Follow-up|0|||
154915570|NCT02055976|559112279|FG002|Overall Study|Lost to Follow-up|0|||
154915571|NCT02055976|559112280|FG003|Overall Study|Lost to Follow-up|1|||
154915572|NCT02055976|559112281|FG004|Overall Study|Lost to Follow-up|0|||
154915573|NCT02055976|559112282|FG005|Overall Study|Lost to Follow-up|0|||
154915574|NCT02055976|559112283|FG006|Overall Study|Lost to Follow-up|0|||
154915575|NCT02055976|559112284|FG007|Overall Study|Lost to Follow-up|0|||
154915576|NCT02055976|559112285|FG008|Overall Study|Lost to Follow-up|0|||
154915577|NCT03769753|559112290|FG000|Overall Study|Not Treated|6|||
154915578|NCT03769753|559112290|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
154915579|NCT01070381|559112291|FG000|Period 2, 1 Week of Wear|Handling|0|||
154915580|NCT01070381|559112292|FG001|Period 2, 1 Week of Wear|Handling|1|||
154915581|NCT01070381|559112291|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
154915582|NCT01070381|559112292|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
154915583|NCT01657903|559112294|FG000|Overall Study|Lost to Follow-up|1|||
154915584|NCT01657903|559112294|FG000|Overall Study|Withdrawal by Subject|1|||
154915585|NCT00620815|559112295|FG000|Overall Study|Adverse Event|1|||
154915586|NCT00620815|559112296|FG001|Overall Study|Adverse Event|1|||
154915587|NCT00620815|559112297|FG002|Overall Study|Adverse Event|2|||
154915588|NCT00620815|559112295|FG000|Overall Study|Withdrawal by Subject|1|||
154915589|NCT00620815|559112296|FG001|Overall Study|Withdrawal by Subject|2|||
154915590|NCT00620815|559112297|FG002|Overall Study|Withdrawal by Subject|0|||
154915591|NCT00620815|559112295|FG000|Overall Study|Lost to Follow-up|1|||
154915592|NCT00620815|559112296|FG001|Overall Study|Lost to Follow-up|6|||
154915593|NCT00620815|559112297|FG002|Overall Study|Lost to Follow-up|3|||
154915594|NCT00620815|559112295|FG000|Overall Study|Inappropriate enrolment|0|||
154915595|NCT00620815|559112296|FG001|Overall Study|Inappropriate enrolment|0|||
154915596|NCT00620815|559112297|FG002|Overall Study|Inappropriate enrolment|1|||
154915597|NCT00620815|559112295|FG000|Overall Study|Protocol Violation|1|||
154915598|NCT00620815|559112296|FG001|Overall Study|Protocol Violation|2|||
154915599|NCT00620815|559112297|FG002|Overall Study|Protocol Violation|1|||
154915600|NCT00983827|559112298|FG000|Overall Study|Withdrawal by Subject|1|||
154915601|NCT01888367|559112301|FG000|Overall Study|Physician Decision|3|||
154915602|NCT01888367|559112302|FG001|Overall Study|Physician Decision|4|||
154915603|NCT01888367|559112303|FG002|Overall Study|Physician Decision|2|||
154915604|NCT01888367|559112301|FG000|Overall Study|Death|2|||
154915605|NCT01888367|559112302|FG001|Overall Study|Death|0|||
154915606|NCT01888367|559112303|FG002|Overall Study|Death|1|||
154915607|NCT01888367|559112301|FG000|Overall Study|Withdrawal by Subject|1|||
154915608|NCT01888367|559112302|FG001|Overall Study|Withdrawal by Subject|0|||
154915609|NCT01888367|559112303|FG002|Overall Study|Withdrawal by Subject|1|||
154915610|NCT01888367|559112301|FG000|Overall Study|Lost to Follow-up|1|||
154915611|NCT01888367|559112302|FG001|Overall Study|Lost to Follow-up|1|||
154986914|NCT00375492|559377441|FG001|Overall Study|Protocol Violation|3|||
154915612|NCT01888367|559112303|FG002|Overall Study|Lost to Follow-up|0|||
154915613|NCT01888367|559112301|FG000|Overall Study|Protocol Violation|0|||
154915614|NCT01888367|559112302|FG001|Overall Study|Protocol Violation|0|||
154915615|NCT01888367|559112303|FG002|Overall Study|Protocol Violation|1|||
154915616|NCT01888367|559112301|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
154915617|NCT01888367|559112302|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
154915618|NCT01888367|559112303|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
155119266|NCT00075725|559868479|FG006|Overall Study|Other|2|||
155119267|NCT00075725|559868480|FG007|Overall Study|Other|9|||
155119268|NCT00075725|559868481|FG008|Overall Study|Other|2|||
155119269|NCT00075725|559868482|FG009|Overall Study|Other|1|||
155119270|NCT00075725|559868483|FG010|Overall Study|Other|0|||
154915619|NCT01854918|559112304|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
154915620|NCT01854918|559112305|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
154915621|NCT01854918|559112304|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
154915622|NCT01854918|559112305|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
154915623|NCT01854918|559112304|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
154915624|NCT01854918|559112305|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
154915625|NCT01854918|559112304|FG000|SOC-controlled Period (Year 1)|Death|5|||
154915626|NCT01854918|559112305|FG001|SOC-controlled Period (Year 1)|Death|5|||
154915627|NCT01854918|559112304|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
154915628|NCT01854918|559112305|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
154915629|NCT01854918|559112304|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
154915630|NCT01854918|559112305|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
154915631|NCT01854918|559112304|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
154915632|NCT01854918|559112305|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
154915633|NCT01854918|559112304|FG000|All-IP Period (Years 2 and 3)|Death|5|||
154915634|NCT01854918|559112305|FG001|All-IP Period (Years 2 and 3)|Death|16|||
154915635|NCT02146352|559112311|FG000|Overall Study|Death|1|||
154915636|NCT02146352|559112311|FG000|Overall Study|Patient entered hospice care|1|||
154915637|NCT02918006|559112312|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
154915638|NCT02918006|559112313|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
154915639|NCT02918006|559112314|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
154915640|NCT02918006|559112312|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
154915641|NCT02918006|559112313|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
154915642|NCT02918006|559112314|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
154915643|NCT02918006|559112312|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
154915644|NCT02918006|559112313|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
154915645|NCT02918006|559112314|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
154915646|NCT02918006|559112312|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
154915647|NCT02918006|559112313|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
154915648|NCT02918006|559112314|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
154915649|NCT02918006|559112312|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
154915650|NCT02918006|559112313|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
154915651|NCT02918006|559112314|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
154915652|NCT02918006|559112312|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
154915653|NCT02918006|559112313|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
154915654|NCT02918006|559112314|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
154915655|NCT02918006|559112312|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
154915656|NCT02918006|559112313|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
154915657|NCT02918006|559112314|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
154915658|NCT02918006|559112312|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
154915659|NCT02918006|559112313|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
154915660|NCT02918006|559112314|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
154915661|NCT02918006|559112312|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
154915662|NCT02918006|559112313|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
154915663|NCT02918006|559112314|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
154915664|NCT03091920|559112318|FG000|Overall Study|Adverse Event|0|||
154915665|NCT03091920|559112319|FG001|Overall Study|Adverse Event|1|||
154915666|NCT03091920|559112320|FG002|Overall Study|Adverse Event|0|||
154915667|NCT00453349|559112321|FG000|Randomized|Adverse Event|12|||
154915668|NCT00453349|559112322|FG001|Randomized|Adverse Event|11|||
154915669|NCT00453349|559112321|FG000|Randomized|Lack of Efficacy|2|||
154915670|NCT00453349|559112322|FG001|Randomized|Lack of Efficacy|1|||
154915671|NCT00453349|559112321|FG000|Randomized|Lost to Follow-up|7|||
154915672|NCT00453349|559112322|FG001|Randomized|Lost to Follow-up|5|||
154915673|NCT00453349|559112321|FG000|Randomized|Protocol Violation|1|||
154915674|NCT00453349|559112322|FG001|Randomized|Protocol Violation|1|||
155119271|NCT00075725|559868484|FG011|Overall Study|Other|3|||
155119272|NCT00075725|559868473|FG000|Overall Study|Pt trying to find a BM donor|0|||
155119273|NCT00075725|559868474|FG001|Overall Study|Pt trying to find a BM donor|1|||
155119274|NCT00075725|559868475|FG002|Overall Study|Pt trying to find a BM donor|0|||
154915675|NCT00453349|559112321|FG000|Randomized|Withdrawal by Subject|3|||
154915676|NCT00453349|559112322|FG001|Randomized|Withdrawal by Subject|5|||
154915677|NCT00453349|559112321|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
154915678|NCT00453349|559112322|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
154915679|NCT00453349|559112321|FG000|Completed Study|Adverse Event|12|||
154915680|NCT00453349|559112322|FG001|Completed Study|Adverse Event|11|||
155119275|NCT00075725|559868476|FG003|Overall Study|Pt trying to find a BM donor|0|||
155176365|NCT02025556|560083973|FG001|Overall Study|Withdrawal by Subject|3|||
155176366|NCT02025556|560083974|FG002|Overall Study|Withdrawal by Subject|6|||
155176367|NCT02025556|560083972|FG000|Overall Study|Lost to Follow-up|2|||
155176368|NCT02025556|560083973|FG001|Overall Study|Lost to Follow-up|4|||
155176369|NCT02025556|560083974|FG002|Overall Study|Lost to Follow-up|0|||
155176370|NCT02025556|560083972|FG000|Overall Study|Reason not reported|0|||
155176371|NCT02025556|560083973|FG001|Overall Study|Reason not reported|0|||
155176372|NCT02025556|560083974|FG002|Overall Study|Reason not reported|1|||
155176373|NCT00627445|560083976|FG000|Overall Study|Adverse Event|3|||
155176374|NCT00627445|560083977|FG001|Overall Study|Adverse Event|3|||
155176375|NCT00627445|560083976|FG000|Overall Study|Lack of Efficacy|0|||
155176376|NCT00627445|560083977|FG001|Overall Study|Lack of Efficacy|1|||
155176377|NCT00627445|560083976|FG000|Overall Study|Other|6|||
155176378|NCT00627445|560083977|FG001|Overall Study|Other|8|||
155176379|NCT01238588|560083978|FG000|Overall Study|Withdrawal by Subject|1|||
155176380|NCT01238588|560083978|FG000|Overall Study|Physician Decision|2|||
155176381|NCT00796991|560083983|FG000|Overall Study|Adverse Event|0|||
155176382|NCT00796991|560083984|FG001|Overall Study|Adverse Event|0|||
155176383|NCT00796991|560083985|FG002|Overall Study|Adverse Event|1|||
155176384|NCT00796991|560083983|FG000|Overall Study|Death|2|||
155176385|NCT00796991|560083984|FG001|Overall Study|Death|0|||
155176386|NCT00796991|560083985|FG002|Overall Study|Death|0|||
155176387|NCT00796991|560083983|FG000|Overall Study|Disease Progression|10|||
155176388|NCT00796991|560083984|FG001|Overall Study|Disease Progression|9|||
155176389|NCT00796991|560083985|FG002|Overall Study|Disease Progression|7|||
155176390|NCT00796991|560083983|FG000|Overall Study|Study Drug Toxicity|3|||
155176391|NCT00796991|560083984|FG001|Overall Study|Study Drug Toxicity|3|||
155176392|NCT00796991|560083985|FG002|Overall Study|Study Drug Toxicity|5|||
155176393|NCT00796991|560083983|FG000|Overall Study|Withdrawal by Subject|0|||
155176394|NCT00796991|560083984|FG001|Overall Study|Withdrawal by Subject|0|||
155176395|NCT00796991|560083985|FG002|Overall Study|Withdrawal by Subject|1|||
155176396|NCT00834080|560083988|FG000|Overall Study|Adverse Event|7|||
155176397|NCT00834080|560083988|FG000|Overall Study|Lost to Follow-up|7|||
155176398|NCT00834080|560083988|FG000|Overall Study|Withdrawal by Subject|5|||
155176399|NCT00834080|560083988|FG000|Overall Study|Other - Pregnancy|1|||
155176400|NCT00834080|560083988|FG000|Overall Study|Other - False positive tests of the UDS|1|||
155176401|NCT00834080|560083988|FG000|Overall Study|Physician Decision|1|||
155176402|NCT00834080|560083988|FG000|Overall Study|Subject Relocated|1|||
155176403|NCT04345367|560083990|FG000|Overall Study|Other|3|||
155119276|NCT00075725|559868477|FG004|Overall Study|Pt trying to find a BM donor|0|||
155119277|NCT00075725|559868478|FG005|Overall Study|Pt trying to find a BM donor|0|||
155119278|NCT00075725|559868479|FG006|Overall Study|Pt trying to find a BM donor|0|||
155119279|NCT00075725|559868480|FG007|Overall Study|Pt trying to find a BM donor|0|||
155119280|NCT00075725|559868481|FG008|Overall Study|Pt trying to find a BM donor|0|||
155119281|NCT00075725|559868482|FG009|Overall Study|Pt trying to find a BM donor|0|||
155119282|NCT00075725|559868483|FG010|Overall Study|Pt trying to find a BM donor|0|||
155119283|NCT00075725|559868484|FG011|Overall Study|Pt trying to find a BM donor|0|||
155119284|NCT00075725|559868473|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
155119285|NCT00075725|559868474|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
155176404|NCT04345367|560083991|FG001|Overall Study|Other|4|||
155176405|NCT04345367|560083990|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
155176406|NCT04345367|560083991|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
155176407|NCT04345367|560083990|FG000|Overall Study|Withdrawal by Subject|11|||
155176408|NCT04345367|560083991|FG001|Overall Study|Withdrawal by Subject|11|||
155176409|NCT04345367|560083990|FG000|Overall Study|Protocol Violation|4|||
155119286|NCT00075725|559868475|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
155119287|NCT00075725|559868476|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
155119288|NCT00075725|559868477|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
155176410|NCT04345367|560083991|FG001|Overall Study|Protocol Violation|3|||
155176411|NCT04345367|560083990|FG000|Overall Study|Lost to Follow-up|2|||
155176412|NCT04345367|560083991|FG001|Overall Study|Lost to Follow-up|4|||
155176413|NCT04345367|560083990|FG000|Overall Study|Lack of Efficacy|2|||
155176414|NCT04345367|560083991|FG001|Overall Study|Lack of Efficacy|0|||
155176415|NCT04345367|560083990|FG000|Overall Study|Death|2|||
155176416|NCT04345367|560083991|FG001|Overall Study|Death|0|||
155176417|NCT04345367|560083990|FG000|Overall Study|Adverse Event|10|||
155176418|NCT04345367|560083991|FG001|Overall Study|Adverse Event|9|||
155176419|NCT02431260|560083992|FG000|Overall Study|Subject Decision|0|||
155176420|NCT02431260|560083993|FG001|Overall Study|Subject Decision|1|||
155176421|NCT02431260|560083994|FG002|Overall Study|Subject Decision|1|||
155176422|NCT02431260|560083995|FG003|Overall Study|Subject Decision|0|||
155176423|NCT02431260|560083996|FG004|Overall Study|Subject Decision|0|||
155176424|NCT02431260|560083997|FG005|Overall Study|Subject Decision|0|||
155176425|NCT02431260|560083998|FG006|Overall Study|Subject Decision|0|||
155176426|NCT02431260|560083999|FG007|Overall Study|Subject Decision|0|||
155176427|NCT02431260|560084000|FG008|Overall Study|Subject Decision|1|||
155176428|NCT02431260|560084001|FG009|Overall Study|Subject Decision|1|||
155176429|NCT02431260|560084002|FG010|Overall Study|Subject Decision|0|||
154915681|NCT00453349|559112321|FG000|Completed Study|Lack of Efficacy|2|||
154915682|NCT00453349|559112322|FG001|Completed Study|Lack of Efficacy|1|||
154915683|NCT00453349|559112321|FG000|Completed Study|Lost to Follow-up|7|||
154915684|NCT00453349|559112322|FG001|Completed Study|Lost to Follow-up|5|||
154915685|NCT00453349|559112321|FG000|Completed Study|Protocol Violation|1|||
154915686|NCT00453349|559112322|FG001|Completed Study|Protocol Violation|1|||
154915687|NCT00453349|559112321|FG000|Completed Study|Withdrawal by Subject|3|||
154915688|NCT00453349|559112322|FG001|Completed Study|Withdrawal by Subject|5|||
154915689|NCT00453349|559112321|FG000|Completed Study|Lost to follow up after study treatment|2|||
154915690|NCT00453349|559112322|FG001|Completed Study|Lost to follow up after study treatment|11|||
154915691|NCT01513460|559112325|FG000|Overall Study|Death|0|||
154915692|NCT01513460|559112326|FG001|Overall Study|Death|0|||
154915693|NCT01513460|559112327|FG002|Overall Study|Death|1|||
154915694|NCT01513460|559112325|FG000|Overall Study|Lost to Follow-up|0|||
154915695|NCT01513460|559112326|FG001|Overall Study|Lost to Follow-up|0|||
154915696|NCT01513460|559112327|FG002|Overall Study|Lost to Follow-up|2|||
154915697|NCT01513460|559112325|FG000|Overall Study|Abnormal laboratory value|1|||
154915698|NCT01513460|559112326|FG001|Overall Study|Abnormal laboratory value|0|||
154915699|NCT01513460|559112327|FG002|Overall Study|Abnormal laboratory value|1|||
154915700|NCT01513460|559112325|FG000|Overall Study|Lack of Efficacy|1|||
154915701|NCT01513460|559112326|FG001|Overall Study|Lack of Efficacy|2|||
154915702|NCT01513460|559112327|FG002|Overall Study|Lack of Efficacy|5|||
154915703|NCT01513460|559112325|FG000|Overall Study|Protocol deviations|3|||
154915704|NCT01513460|559112326|FG001|Overall Study|Protocol deviations|4|||
154915705|NCT01513460|559112327|FG002|Overall Study|Protocol deviations|3|||
154915706|NCT01513460|559112325|FG000|Overall Study|Withdrawal by Subject|7|||
154915707|NCT01513460|559112326|FG001|Overall Study|Withdrawal by Subject|8|||
154915708|NCT01513460|559112327|FG002|Overall Study|Withdrawal by Subject|21|||
154915709|NCT01513460|559112325|FG000|Overall Study|Adverse Event|16|||
154915710|NCT01513460|559112326|FG001|Overall Study|Adverse Event|18|||
154915711|NCT01513460|559112327|FG002|Overall Study|Adverse Event|23|||
154915712|NCT01513460|559112325|FG000|Overall Study|Abnormal test procedure|1|||
154915713|NCT01513460|559112326|FG001|Overall Study|Abnormal test procedure|0|||
154915714|NCT01513460|559112327|FG002|Overall Study|Abnormal test procedure|0|||
154986915|NCT00375492|559377440|FG000|Overall Study|Sponsor Decision|0|||
154986916|NCT00375492|559377441|FG001|Overall Study|Sponsor Decision|1|||
154986917|NCT00375492|559377440|FG000|Overall Study|Withdrawal by Subject|6|||
154986918|NCT00375492|559377441|FG001|Overall Study|Withdrawal by Subject|6|||
154986919|NCT04062448|559379135|FG000|Overall Study|Lost to Follow-up|1|||
154986920|NCT04062448|559379135|FG000|Overall Study|Withdrawal by Subject|2|||
154986921|NCT04385277|559379136|FG000|Overall Study|Physician Decision|2|||
154986922|NCT04385277|559379136|FG000|Overall Study|Ineligible|1|||
154986923|NCT04385277|559379136|FG000|Overall Study|Patient/Parent Refusal|2|||
154986924|NCT04905290|559379137|FG000|Overall Study|Adverse Event|4|||
154986925|NCT04905290|559379137|FG000|Overall Study|Death|2|||
154986926|NCT04905290|559379137|FG000|Overall Study|Withdrawal by Subject|4|||
154986927|NCT04905290|559379137|FG000|Overall Study|Physician Decision|2|||
154986928|NCT04905290|559379137|FG000|Overall Study|Lost to Follow-up|2|||
154986929|NCT04905290|559379137|FG000|Overall Study|Screen Failure|2|||
154986930|NCT04905290|559379137|FG000|Overall Study|Unsuccessful Procedure|2|||
154986931|NCT03295318|559379138|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
154986932|NCT03295318|559379139|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
154986933|NCT03295318|559379140|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
154986934|NCT03295318|559379138|FG000|Overall Study|Death|1|||
154986935|NCT03295318|559379139|FG001|Overall Study|Death|1|||
154986936|NCT03295318|559379140|FG002|Overall Study|Death|1|||
154986937|NCT03295318|559379138|FG000|Overall Study|Protocol Violation|4|||
154986938|NCT03295318|559379139|FG001|Overall Study|Protocol Violation|3|||
155119289|NCT00075725|559868478|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
155119290|NCT00075725|559868479|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
155119291|NCT00075725|559868480|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
155119292|NCT00075725|559868481|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
155119293|NCT00075725|559868482|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
154915715|NCT00489216|559112331|FG000|Overall Study|Adverse Event|1|||
154986939|NCT03295318|559379140|FG002|Overall Study|Protocol Violation|3|||
154986940|NCT03295318|559379138|FG000|Overall Study|Withdrawal by Subject|0|||
154986941|NCT03295318|559379139|FG001|Overall Study|Withdrawal by Subject|0|||
154986942|NCT03295318|559379140|FG002|Overall Study|Withdrawal by Subject|1|||
155119294|NCT00075725|559868483|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
155119295|NCT00075725|559868484|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
154915716|NCT02475564|559112334|FG000|Overall Study|Withdrawal by Subject|1|||
154915717|NCT02475564|559112335|FG001|Overall Study|Withdrawal by Subject|0|||
154915718|NCT02475564|559112334|FG000|Overall Study|Lost to Follow-up|2|||
154915719|NCT02475564|559112335|FG001|Overall Study|Lost to Follow-up|1|||
154915720|NCT02475564|559112334|FG000|Overall Study|Intense Menstrual bleeding|1|||
154915721|NCT02475564|559112335|FG001|Overall Study|Intense Menstrual bleeding|0|||
154915722|NCT02705755|559112336|FG000|Part A (6 Days)|Adverse Event|1|||
155176430|NCT02431260|560084003|FG011|Overall Study|Subject Decision|1|||
155176431|NCT02431260|560084004|FG012|Overall Study|Subject Decision|0|||
155176432|NCT02431260|560084005|FG013|Overall Study|Subject Decision|0|||
155176433|NCT02431260|560083992|FG000|Overall Study|Death|4|||
155176434|NCT02431260|560083993|FG001|Overall Study|Death|4|||
155176435|NCT02431260|560083994|FG002|Overall Study|Death|3|||
155176436|NCT02431260|560083995|FG003|Overall Study|Death|4|||
155176437|NCT02431260|560083996|FG004|Overall Study|Death|2|||
155176438|NCT02431260|560083997|FG005|Overall Study|Death|2|||
155176439|NCT02431260|560083998|FG006|Overall Study|Death|3|||
155176440|NCT02431260|560083999|FG007|Overall Study|Death|1|||
155176441|NCT02431260|560084000|FG008|Overall Study|Death|6|||
155176442|NCT02431260|560084001|FG009|Overall Study|Death|6|||
155176443|NCT02431260|560084002|FG010|Overall Study|Death|3|||
155176444|NCT02431260|560084003|FG011|Overall Study|Death|2|||
155176445|NCT02431260|560084004|FG012|Overall Study|Death|5|||
155176446|NCT02431260|560084005|FG013|Overall Study|Death|1|||
155176447|NCT02431260|560083992|FG000|Overall Study|Lost to Follow-up|0|||
155176448|NCT02431260|560083993|FG001|Overall Study|Lost to Follow-up|0|||
155176449|NCT02431260|560083994|FG002|Overall Study|Lost to Follow-up|0|||
155176450|NCT02431260|560083995|FG003|Overall Study|Lost to Follow-up|0|||
155176451|NCT02431260|560083996|FG004|Overall Study|Lost to Follow-up|0|||
155176452|NCT02431260|560083997|FG005|Overall Study|Lost to Follow-up|1|||
155176453|NCT02431260|560083998|FG006|Overall Study|Lost to Follow-up|0|||
155176454|NCT02431260|560083999|FG007|Overall Study|Lost to Follow-up|0|||
155176455|NCT02431260|560084000|FG008|Overall Study|Lost to Follow-up|0|||
155176456|NCT02431260|560084001|FG009|Overall Study|Lost to Follow-up|0|||
155176457|NCT02431260|560084002|FG010|Overall Study|Lost to Follow-up|0|||
155176458|NCT02431260|560084003|FG011|Overall Study|Lost to Follow-up|0|||
155176459|NCT02431260|560084004|FG012|Overall Study|Lost to Follow-up|0|||
155176460|NCT02431260|560084005|FG013|Overall Study|Lost to Follow-up|0|||
155176461|NCT02431260|560083992|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155176462|NCT02431260|560083993|FG001|Overall Study|Study Terminated by the Sponsor|0|||
155176463|NCT02431260|560083994|FG002|Overall Study|Study Terminated by the Sponsor|2|||
155176464|NCT02431260|560083995|FG003|Overall Study|Study Terminated by the Sponsor|1|||
155176465|NCT02431260|560083996|FG004|Overall Study|Study Terminated by the Sponsor|1|||
155176466|NCT02431260|560083997|FG005|Overall Study|Study Terminated by the Sponsor|0|||
155176467|NCT02431260|560083998|FG006|Overall Study|Study Terminated by the Sponsor|1|||
155176468|NCT02431260|560083999|FG007|Overall Study|Study Terminated by the Sponsor|2|||
155176469|NCT02431260|560084000|FG008|Overall Study|Study Terminated by the Sponsor|1|||
155176470|NCT02431260|560084001|FG009|Overall Study|Study Terminated by the Sponsor|1|||
155176471|NCT02431260|560084002|FG010|Overall Study|Study Terminated by the Sponsor|1|||
155176472|NCT02431260|560084003|FG011|Overall Study|Study Terminated by the Sponsor|0|||
155176473|NCT02431260|560084004|FG012|Overall Study|Study Terminated by the Sponsor|4|||
155176474|NCT02431260|560084005|FG013|Overall Study|Study Terminated by the Sponsor|0|||
155176475|NCT02431260|560083992|FG000|Overall Study|Physician Decision|0|||
155176476|NCT02431260|560083993|FG001|Overall Study|Physician Decision|0|||
155176477|NCT02431260|560083994|FG002|Overall Study|Physician Decision|0|||
155176478|NCT02431260|560083995|FG003|Overall Study|Physician Decision|0|||
155176479|NCT02431260|560083996|FG004|Overall Study|Physician Decision|0|||
155176480|NCT02431260|560083997|FG005|Overall Study|Physician Decision|1|||
155176481|NCT02431260|560083998|FG006|Overall Study|Physician Decision|0|||
155176482|NCT02431260|560083999|FG007|Overall Study|Physician Decision|0|||
155176483|NCT02431260|560084000|FG008|Overall Study|Physician Decision|0|||
155176484|NCT02431260|560084001|FG009|Overall Study|Physician Decision|0|||
155176485|NCT02431260|560084002|FG010|Overall Study|Physician Decision|0|||
155176486|NCT02431260|560084003|FG011|Overall Study|Physician Decision|0|||
155176487|NCT02431260|560084004|FG012|Overall Study|Physician Decision|0|||
155176488|NCT02431260|560084005|FG013|Overall Study|Physician Decision|0|||
155176489|NCT02431260|560083992|FG000|Overall Study|Other Unspecified|0|||
155176490|NCT02431260|560083993|FG001|Overall Study|Other Unspecified|0|||
155176491|NCT02431260|560083994|FG002|Overall Study|Other Unspecified|0|||
155176492|NCT02431260|560083995|FG003|Overall Study|Other Unspecified|0|||
155176493|NCT02431260|560083996|FG004|Overall Study|Other Unspecified|0|||
155176494|NCT02431260|560083997|FG005|Overall Study|Other Unspecified|0|||
155176495|NCT02431260|560083998|FG006|Overall Study|Other Unspecified|0|||
155176496|NCT02431260|560083999|FG007|Overall Study|Other Unspecified|0|||
155176497|NCT02431260|560084000|FG008|Overall Study|Other Unspecified|0|||
155176498|NCT02431260|560084001|FG009|Overall Study|Other Unspecified|0|||
155176499|NCT02431260|560084002|FG010|Overall Study|Other Unspecified|0|||
155176500|NCT02431260|560084003|FG011|Overall Study|Other Unspecified|1|||
155176501|NCT02431260|560084004|FG012|Overall Study|Other Unspecified|1|||
155176502|NCT02431260|560084005|FG013|Overall Study|Other Unspecified|0|||
155176503|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
155176504|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
155176505|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
155176506|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
155176507|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
155176508|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
155119296|NCT00075725|559868473|FG000|Overall Study|Unsuccessful institutional transfer|0|||
155119297|NCT00075725|559868474|FG001|Overall Study|Unsuccessful institutional transfer|0|||
155119298|NCT00075725|559868475|FG002|Overall Study|Unsuccessful institutional transfer|2|||
155119299|NCT00075725|559868476|FG003|Overall Study|Unsuccessful institutional transfer|0|||
155119300|NCT00075725|559868477|FG004|Overall Study|Unsuccessful institutional transfer|0|||
154915723|NCT02705755|559112337|FG001|Part A (6 Days)|Adverse Event|0|||
154915724|NCT02705755|559112338|FG002|Part A (6 Days)|Adverse Event|0|||
154915725|NCT02705755|559112339|FG003|Part A (6 Days)|Adverse Event|0|||
154915726|NCT02705755|559112336|FG000|Part A (6 Days)|Physician Decision|3|||
154915727|NCT02705755|559112337|FG001|Part A (6 Days)|Physician Decision|0|||
154915728|NCT02705755|559112338|FG002|Part A (6 Days)|Physician Decision|0|||
154915729|NCT02705755|559112339|FG003|Part A (6 Days)|Physician Decision|0|||
154915730|NCT02705755|559112336|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
154915731|NCT02705755|559112337|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
154915732|NCT02705755|559112338|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
154915733|NCT02705755|559112339|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
154915734|NCT02705755|559112336|FG000|Part C (20 Weeks)|Physician Decision|0|||
154915735|NCT02705755|559112337|FG001|Part C (20 Weeks)|Physician Decision|0|||
154915736|NCT02705755|559112338|FG002|Part C (20 Weeks)|Physician Decision|0|||
154915737|NCT02705755|559112339|FG003|Part C (20 Weeks)|Physician Decision|2|||
154915738|NCT02705755|559112336|FG000|Part C (20 Weeks)|Adverse Event|0|||
154915739|NCT02705755|559112337|FG001|Part C (20 Weeks)|Adverse Event|0|||
154915740|NCT02705755|559112338|FG002|Part C (20 Weeks)|Adverse Event|0|||
154915741|NCT02705755|559112339|FG003|Part C (20 Weeks)|Adverse Event|6|||
154915742|NCT02705755|559112336|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
154915743|NCT02705755|559112337|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
154915744|NCT02705755|559112338|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
154915745|NCT02705755|559112339|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
154915746|NCT01906489|559112340|FG000|Overall Study|Adverse Event|10|||
154915747|NCT01906489|559112341|FG001|Overall Study|Adverse Event|3|||
154915748|NCT01906489|559112340|FG000|Overall Study|Worsening of CKD|6|||
154915749|NCT01906489|559112341|FG001|Overall Study|Worsening of CKD|4|||
154915750|NCT01906489|559112340|FG000|Overall Study|Withdrawal by Subject|5|||
154915751|NCT01906489|559112341|FG001|Overall Study|Withdrawal by Subject|0|||
154915752|NCT01906489|559112340|FG000|Overall Study|Worsening of Anemia|1|||
154915753|NCT01906489|559112341|FG001|Overall Study|Worsening of Anemia|0|||
154915754|NCT01906489|559112340|FG000|Overall Study|Protocol Violation|0|||
154915755|NCT01906489|559112341|FG001|Overall Study|Protocol Violation|1|||
154915756|NCT01906489|559112340|FG000|Overall Study|Non- Compliance|1|||
154915757|NCT01906489|559112341|FG001|Overall Study|Non- Compliance|0|||
154915758|NCT01906489|559112340|FG000|Overall Study|Sponsor Decision|1|||
154915759|NCT01906489|559112341|FG001|Overall Study|Sponsor Decision|0|||
154915760|NCT01906489|559112340|FG000|Overall Study|Lost to Follow-up|1|||
154915761|NCT01906489|559112341|FG001|Overall Study|Lost to Follow-up|1|||
154915762|NCT01906489|559112340|FG000|Overall Study|Other|1|||
154915763|NCT01906489|559112341|FG001|Overall Study|Other|0|||
154915764|NCT04524663|559114061|FG000|Overall Study|Withdrawal by Subject|0|||
154915765|NCT04524663|559114062|FG001|Overall Study|Withdrawal by Subject|2|||
154915766|NCT01519700|559114063|FG000|Overall Study|Death|1|||
154915767|NCT01519700|559114064|FG001|Overall Study|Death|0|||
154915768|NCT01519700|559114065|FG002|Overall Study|Death|0|||
154915769|NCT01519700|559114066|FG003|Overall Study|Death|0|||
154915770|NCT01519700|559114063|FG000|Overall Study|Lost to Follow-up|0|||
154915771|NCT01519700|559114064|FG001|Overall Study|Lost to Follow-up|0|||
154915772|NCT01519700|559114065|FG002|Overall Study|Lost to Follow-up|1|||
154915773|NCT01519700|559114066|FG003|Overall Study|Lost to Follow-up|1|||
154915774|NCT01519700|559114063|FG000|Overall Study|Physician Decision|1|||
154915775|NCT01519700|559114064|FG001|Overall Study|Physician Decision|1|||
154915776|NCT01519700|559114065|FG002|Overall Study|Physician Decision|3|||
155119301|NCT00075725|559868478|FG005|Overall Study|Unsuccessful institutional transfer|0|||
154915777|NCT01519700|559114066|FG003|Overall Study|Physician Decision|0|||
154915778|NCT01519700|559114063|FG000|Overall Study|Withdrawal by Subject|5|||
154915779|NCT01519700|559114064|FG001|Overall Study|Withdrawal by Subject|3|||
154915780|NCT01519700|559114065|FG002|Overall Study|Withdrawal by Subject|3|||
154915781|NCT01519700|559114066|FG003|Overall Study|Withdrawal by Subject|2|||
154915782|NCT01519700|559114063|FG000|Overall Study|Other Reason|2|||
154915783|NCT01519700|559114064|FG001|Overall Study|Other Reason|2|||
154915784|NCT01519700|559114065|FG002|Overall Study|Other Reason|0|||
154915785|NCT01519700|559114066|FG003|Overall Study|Other Reason|4|||
154915786|NCT05111548|559114067|FG000|Overall Study|Withdrawal by Subject|2|||
154915787|NCT05111548|559114068|FG001|Overall Study|Withdrawal by Subject|1|||
154915788|NCT05111548|559114067|FG000|Overall Study|Adverse Event|1|||
154915789|NCT05111548|559114068|FG001|Overall Study|Adverse Event|0|||
154915790|NCT00386152|559114072|FG000|Overall Study|Adverse Event|6|||
154915791|NCT00386152|559114073|FG001|Overall Study|Adverse Event|5|||
154915792|NCT00386152|559114074|FG002|Overall Study|Adverse Event|4|||
154915793|NCT00386152|559114072|FG000|Overall Study|Chang from original chemo stratification|4|||
154915794|NCT00386152|559114073|FG001|Overall Study|Chang from original chemo stratification|5|||
154986943|NCT03295318|559379138|FG000|Overall Study|Subject discontinued due to travel|0|||
154986944|NCT03295318|559379139|FG001|Overall Study|Subject discontinued due to travel|1|||
155119302|NCT00075725|559868479|FG006|Overall Study|Unsuccessful institutional transfer|0|||
155119303|NCT00075725|559868480|FG007|Overall Study|Unsuccessful institutional transfer|0|||
155119304|NCT00075725|559868481|FG008|Overall Study|Unsuccessful institutional transfer|0|||
155119305|NCT00075725|559868482|FG009|Overall Study|Unsuccessful institutional transfer|1|||
155119306|NCT00075725|559868483|FG010|Overall Study|Unsuccessful institutional transfer|0|||
155119307|NCT00075725|559868484|FG011|Overall Study|Unsuccessful institutional transfer|0|||
155119308|NCT00075725|559868473|FG000|Overall Study|specimen(s) not submitted|0|||
155119309|NCT00075725|559868474|FG001|Overall Study|specimen(s) not submitted|0|||
155119310|NCT00075725|559868475|FG002|Overall Study|specimen(s) not submitted|2|||
155119311|NCT00075725|559868476|FG003|Overall Study|specimen(s) not submitted|0|||
155119312|NCT00075725|559868477|FG004|Overall Study|specimen(s) not submitted|0|||
155119313|NCT00075725|559868478|FG005|Overall Study|specimen(s) not submitted|0|||
155119314|NCT00075725|559868479|FG006|Overall Study|specimen(s) not submitted|0|||
155119315|NCT00075725|559868480|FG007|Overall Study|specimen(s) not submitted|0|||
155119316|NCT00075725|559868481|FG008|Overall Study|specimen(s) not submitted|0|||
155119317|NCT00075725|559868482|FG009|Overall Study|specimen(s) not submitted|0|||
155119318|NCT00075725|559868483|FG010|Overall Study|specimen(s) not submitted|0|||
155119319|NCT00075725|559868484|FG011|Overall Study|specimen(s) not submitted|0|||
155119320|NCT00075725|559868473|FG000|Overall Study|Pt went to transplant|0|||
155119321|NCT00075725|559868474|FG001|Overall Study|Pt went to transplant|0|||
155119322|NCT00075725|559868475|FG002|Overall Study|Pt went to transplant|0|||
155119323|NCT00075725|559868476|FG003|Overall Study|Pt went to transplant|1|||
155119324|NCT00075725|559868477|FG004|Overall Study|Pt went to transplant|0|||
155119325|NCT00075725|559868478|FG005|Overall Study|Pt went to transplant|1|||
155119326|NCT00075725|559868479|FG006|Overall Study|Pt went to transplant|0|||
155119327|NCT00075725|559868480|FG007|Overall Study|Pt went to transplant|0|||
155119328|NCT00075725|559868481|FG008|Overall Study|Pt went to transplant|0|||
155119329|NCT00075725|559868482|FG009|Overall Study|Pt went to transplant|0|||
155119330|NCT00075725|559868483|FG010|Overall Study|Pt went to transplant|0|||
155119331|NCT00075725|559868484|FG011|Overall Study|Pt went to transplant|0|||
155119332|NCT00075725|559868473|FG000|Overall Study|Pt received additional steroids|0|||
155119333|NCT00075725|559868474|FG001|Overall Study|Pt received additional steroids|0|||
155119334|NCT00075725|559868475|FG002|Overall Study|Pt received additional steroids|0|||
155119335|NCT00075725|559868476|FG003|Overall Study|Pt received additional steroids|1|||
155119336|NCT00075725|559868477|FG004|Overall Study|Pt received additional steroids|0|||
155119337|NCT00075725|559868478|FG005|Overall Study|Pt received additional steroids|0|||
155119338|NCT00075725|559868479|FG006|Overall Study|Pt received additional steroids|0|||
155119339|NCT00075725|559868480|FG007|Overall Study|Pt received additional steroids|0|||
155119340|NCT00075725|559868481|FG008|Overall Study|Pt received additional steroids|0|||
155119341|NCT00075725|559868482|FG009|Overall Study|Pt received additional steroids|0|||
155119342|NCT00075725|559868483|FG010|Overall Study|Pt received additional steroids|0|||
155119343|NCT00075725|559868484|FG011|Overall Study|Pt received additional steroids|0|||
155119344|NCT00075725|559868473|FG000|Overall Study|Pt relocated|0|||
155119345|NCT00075725|559868474|FG001|Overall Study|Pt relocated|0|||
155119346|NCT00075725|559868475|FG002|Overall Study|Pt relocated|0|||
155119347|NCT00075725|559868476|FG003|Overall Study|Pt relocated|2|||
155119348|NCT00075725|559868477|FG004|Overall Study|Pt relocated|0|||
155119349|NCT00075725|559868478|FG005|Overall Study|Pt relocated|1|||
155119350|NCT00075725|559868479|FG006|Overall Study|Pt relocated|1|||
155119351|NCT00075725|559868480|FG007|Overall Study|Pt relocated|2|||
155119352|NCT00075725|559868481|FG008|Overall Study|Pt relocated|1|||
155119353|NCT00075725|559868482|FG009|Overall Study|Pt relocated|0|||
155119354|NCT00075725|559868483|FG010|Overall Study|Pt relocated|0|||
155119355|NCT00075725|559868484|FG011|Overall Study|Pt relocated|0|||
155119356|NCT00075725|559868473|FG000|Overall Study|Institution Terminated|0|||
155119357|NCT00075725|559868474|FG001|Overall Study|Institution Terminated|0|||
155119358|NCT00075725|559868475|FG002|Overall Study|Institution Terminated|0|||
155119359|NCT00075725|559868476|FG003|Overall Study|Institution Terminated|0|||
155119360|NCT00075725|559868477|FG004|Overall Study|Institution Terminated|1|||
155119361|NCT00075725|559868478|FG005|Overall Study|Institution Terminated|0|||
155119362|NCT00075725|559868479|FG006|Overall Study|Institution Terminated|0|||
154986945|NCT03295318|559379140|FG002|Overall Study|Subject discontinued due to travel|0|||
155119363|NCT00075725|559868480|FG007|Overall Study|Institution Terminated|3|||
155119364|NCT00075725|559868481|FG008|Overall Study|Institution Terminated|0|||
154986946|NCT03747601|559379141|FG000|Overall Study|COVID halt to visits|4|||
154986947|NCT04319718|559379145|FG000|Overall Study|Adverse Event|0|||
155119365|NCT00075725|559868482|FG009|Overall Study|Institution Terminated|0|||
155119366|NCT00075725|559868483|FG010|Overall Study|Institution Terminated|0|||
155119367|NCT00075725|559868484|FG011|Overall Study|Institution Terminated|0|||
155119368|NCT00075725|559868473|FG000|Overall Study|Study Closure|1|||
155119369|NCT00075725|559868474|FG001|Overall Study|Study Closure|0|||
155119370|NCT00075725|559868475|FG002|Overall Study|Study Closure|0|||
155119371|NCT00075725|559868476|FG003|Overall Study|Study Closure|0|||
154915795|NCT00386152|559114074|FG002|Overall Study|Chang from original chemo stratification|6|||
154915796|NCT00386152|559114072|FG000|Overall Study|Death|3|||
154915797|NCT00386152|559114073|FG001|Overall Study|Death|0|||
154915798|NCT00386152|559114074|FG002|Overall Study|Death|1|||
154915799|NCT00386152|559114072|FG000|Overall Study|Disease progression|7|||
154915800|NCT00386152|559114073|FG001|Overall Study|Disease progression|4|||
154915801|NCT00386152|559114074|FG002|Overall Study|Disease progression|5|||
154915802|NCT00386152|559114072|FG000|Overall Study|Physician Decision|13|||
154915803|NCT00386152|559114073|FG001|Overall Study|Physician Decision|10|||
154915804|NCT00386152|559114074|FG002|Overall Study|Physician Decision|4|||
154915805|NCT00386152|559114072|FG000|Overall Study|Lost to Follow-up|1|||
154915806|NCT00386152|559114073|FG001|Overall Study|Lost to Follow-up|0|||
154915807|NCT00386152|559114074|FG002|Overall Study|Lost to Follow-up|0|||
154915808|NCT00386152|559114072|FG000|Overall Study|Completed chemotherapy|4|||
154915809|NCT00386152|559114073|FG001|Overall Study|Completed chemotherapy|5|||
154915810|NCT00386152|559114074|FG002|Overall Study|Completed chemotherapy|1|||
154915811|NCT00386152|559114072|FG000|Overall Study|Protocol Violation|3|||
154915812|NCT00386152|559114073|FG001|Overall Study|Protocol Violation|5|||
154915813|NCT00386152|559114074|FG002|Overall Study|Protocol Violation|2|||
154915814|NCT00386152|559114072|FG000|Overall Study|Withdrawal by Subject|3|||
154915815|NCT00386152|559114073|FG001|Overall Study|Withdrawal by Subject|6|||
154915816|NCT00386152|559114074|FG002|Overall Study|Withdrawal by Subject|10|||
154915817|NCT01101321|559114075|FG000|Period 1|Withdrawal by Subject|1|||
154915818|NCT01101321|559114076|FG001|Period 1|Withdrawal by Subject|1|||
154915819|NCT01101321|559114075|FG000|Period 1|Adverse Event|3|||
154915820|NCT01101321|559114076|FG001|Period 1|Adverse Event|3|||
154915821|NCT02577107|559114080|FG000|Overall Study|Protocol deviation|0|||
154915822|NCT02577107|559114081|FG001|Overall Study|Protocol deviation|1|||
154915823|NCT01856920|559114082|FG000|Overall Study|Disease Progression On Study|3|||
154915824|NCT01856920|559114083|FG001|Overall Study|Disease Progression On Study|4|||
154915825|NCT01856920|559114082|FG000|Overall Study|Disease Progression before Treatment|1|||
154915826|NCT01856920|559114083|FG001|Overall Study|Disease Progression before Treatment|0|||
154915827|NCT01856920|559114082|FG000|Overall Study|Ineligible|0|||
154915828|NCT01856920|559114083|FG001|Overall Study|Ineligible|1|||
154915829|NCT01856920|559114082|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
154915830|NCT01856920|559114083|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
154915831|NCT01856920|559114082|FG000|Overall Study|Refused further Treatment|5|||
154915832|NCT01856920|559114083|FG001|Overall Study|Refused further Treatment|1|||
154915833|NCT01856920|559114082|FG000|Overall Study|Other Reasons|0|||
154915834|NCT01856920|559114083|FG001|Overall Study|Other Reasons|1|||
154915835|NCT01856920|559114082|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
154915836|NCT01856920|559114083|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
154915837|NCT01980056|559114092|FG000|Overall Study|Death|1|||
154915838|NCT01980056|559114093|FG001|Overall Study|Death|1|||
154915839|NCT01980056|559114094|FG002|Overall Study|Death|0|||
154915840|NCT02135848|559114100|FG000|Overall Study|Adverse Event|2|||
154915841|NCT02135848|559114101|FG001|Overall Study|Adverse Event|0|||
154915842|NCT02135848|559114100|FG000|Overall Study|Withdrawal by Subject|1|||
154915843|NCT02135848|559114101|FG001|Overall Study|Withdrawal by Subject|1|||
154915844|NCT00083616|559114102|FG000|Overall Study|Disease Progression|16|||
154915845|NCT00083616|559114102|FG000|Overall Study|Lost to Follow-up|1|||
154915846|NCT00083616|559114102|FG000|Overall Study|Physician Decision|2|||
154915847|NCT00083616|559114102|FG000|Overall Study|Withdrawal by Subject|3|||
154915848|NCT00083616|559114102|FG000|Overall Study|Ineligibility determined|2|||
154915849|NCT00083616|559114102|FG000|Overall Study|Non-compliance|1|||
154915850|NCT00083616|559114102|FG000|Overall Study|Other|6|||
154915851|NCT01474993|559114103|FG000|Overall Study|Lost to Follow-up|1|||
154915852|NCT01474993|559114104|FG001|Overall Study|Lost to Follow-up|2|||
154915853|NCT01474993|559114103|FG000|Overall Study|Adverse Event|0|||
154915854|NCT01474993|559114104|FG001|Overall Study|Adverse Event|1|||
154915855|NCT03258710|559114105|FG000|Overall Study|Adverse Event|1|||
154915856|NCT03258710|559114105|FG000|Overall Study|Protocol-defined stopping criteria|1|||
154915857|NCT03258710|559114105|FG000|Overall Study|Physician Decision|1|||
154915858|NCT03451630|559114106|FG000|Overall Study|Death|15|||
154915859|NCT03451630|559114107|FG001|Overall Study|Death|16|||
154915860|NCT03451630|559114108|FG002|Overall Study|Death|11|||
154915861|NCT03451630|559114106|FG000|Overall Study|Lost to Follow-up|9|||
154915862|NCT03451630|559114107|FG001|Overall Study|Lost to Follow-up|0|||
154915863|NCT03451630|559114108|FG002|Overall Study|Lost to Follow-up|4|||
154915864|NCT03451630|559114106|FG000|Overall Study|Withdrawal by Subject|0|||
154915865|NCT03451630|559114107|FG001|Overall Study|Withdrawal by Subject|3|||
154915866|NCT03451630|559114108|FG002|Overall Study|Withdrawal by Subject|0|||
154915867|NCT03451630|559114106|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
154915868|NCT03451630|559114107|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
154915869|NCT03451630|559114108|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
154986948|NCT04319718|559379146|FG001|Overall Study|Adverse Event|2|||
154986949|NCT04319718|559379145|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
154986950|NCT04319718|559379146|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
154986951|NCT00321828|559379147|FG000|Overall Study|Ineligible|3|||
154986952|NCT00321828|559379147|FG000|Overall Study|No follow up data|1|||
154986953|NCT00573157|559379148|FG000|Overall Study|Adverse Event|3|||
154986954|NCT00573157|559379149|FG001|Overall Study|Adverse Event|1|||
154986955|NCT00573157|559379148|FG000|Overall Study|Other|1|||
154986956|NCT00573157|559379149|FG001|Overall Study|Other|1|||
154986957|NCT00090610|559379150|FG000|Overall Study|Withdrawal by Subject|1|||
154986958|NCT00090610|559379151|FG001|Overall Study|Withdrawal by Subject|1|||
154986959|NCT00599521|559379152|FG000|Overall Study|Lack of Efficacy|4|||
154986960|NCT00599521|559379153|FG001|Overall Study|Lack of Efficacy|8|||
154986961|NCT00599521|559379152|FG000|Overall Study|Adverse Event|4|||
154986962|NCT00599521|559379153|FG001|Overall Study|Adverse Event|1|||
154986963|NCT00599521|559379152|FG000|Overall Study|Withdrawal by Subject|28|||
154986964|NCT00599521|559379153|FG001|Overall Study|Withdrawal by Subject|34|||
154986965|NCT00599521|559379152|FG000|Overall Study|Protocol Violation|1|||
154986966|NCT00599521|559379153|FG001|Overall Study|Protocol Violation|1|||
154986967|NCT00599521|559379152|FG000|Overall Study|Lost to Follow-up|23|||
154986968|NCT00599521|559379153|FG001|Overall Study|Lost to Follow-up|23|||
154986969|NCT00599521|559379152|FG000|Overall Study|Pregnancy|0|||
154986970|NCT00599521|559379153|FG001|Overall Study|Pregnancy|2|||
154986971|NCT00609518|559379154|FG000|Overall Study|Death from Study Disease|32|||
154986972|NCT00609518|559379155|FG001|Overall Study|Death from Study Disease|32|||
154986973|NCT00609518|559379154|FG000|Overall Study|Withdrawal by Subject|5|||
154986974|NCT00609518|559379155|FG001|Overall Study|Withdrawal by Subject|3|||
154986975|NCT00609518|559379154|FG000|Overall Study|Lost to Follow-up|3|||
154986976|NCT00609518|559379155|FG001|Overall Study|Lost to Follow-up|0|||
154986977|NCT00609518|559379154|FG000|Overall Study|Physician Decision|1|||
154986978|NCT00609518|559379155|FG001|Overall Study|Physician Decision|3|||
154986979|NCT00609518|559379154|FG000|Overall Study|Death from Adverse Event|2|||
154986980|NCT00609518|559379155|FG001|Overall Study|Death from Adverse Event|2|||
154986981|NCT05855616|559379156|FG000|Overall Study|Lost to Follow-up|1|||
154986982|NCT05855616|559379157|FG001|Overall Study|Lost to Follow-up|2|||
154986983|NCT01388166|559379158|FG000|Overall Study|Adverse Event|16|||
154986984|NCT01388166|559379158|FG000|Overall Study|Lost to Follow-up|30|||
154986985|NCT01388166|559379158|FG000|Overall Study|Others than specified above|13|||
154986986|NCT04397445|559379159|FG000|Overall Study|Withdrawal by Subject|1|||
154986987|NCT04397445|559379160|FG001|Overall Study|Withdrawal by Subject|0|||
154986988|NCT04397445|559379161|FG002|Overall Study|Withdrawal by Subject|0|||
154986989|NCT04397445|559379162|FG003|Overall Study|Withdrawal by Subject|0|||
154986990|NCT01429051|559379163|FG000|Titration Phase|Death|1|||
154986991|NCT01429051|559379163|FG000|Titration Phase|Withdrawal by Subject|7|||
154986992|NCT01429051|559379163|FG000|Titration Phase|Physician Decision|1|||
154986993|NCT01429051|559379163|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
154986994|NCT01429051|559379163|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
154986995|NCT01429051|559379163|FG000|Efficacy Phase|Adverse Event|1|||
154986996|NCT01429051|559379163|FG000|Efficacy Phase|Death|1|||
154986997|NCT01429051|559379163|FG000|Tolerability Phase|Death|5|||
154986998|NCT01429051|559379163|FG000|Tolerability Phase|Adverse Event|2|||
154986999|NCT01429051|559379163|FG000|Tolerability Phase|Withdrawal by Subject|5|||
154987000|NCT01429051|559379163|FG000|Tolerability Phase|Physician Decision|1|||
154987001|NCT01429051|559379163|FG000|Tolerability Phase|Other|2|||
154987002|NCT00891371|559379164|FG000|Pre-assignment|Inclusion/exclusion|5|||
154987003|NCT00891371|559379164|FG000|Pre-assignment|Consent withdrawal|1|||
154987004|NCT00891371|559379164|FG000|Treatment|Lack of Efficacy|5|||
154987005|NCT00891371|559379164|FG000|Treatment|Adverse Event|2|||
154987006|NCT00891371|559379164|FG000|Treatment|Death|1|||
154987007|NCT00891371|559379164|FG000|Treatment|Lost to Follow-up|1|||
154987008|NCT00307034|559379165|FG000|Overall Study|Adverse Event|1|||
154987009|NCT00307034|559379166|FG001|Overall Study|Adverse Event|2|||
154987010|NCT00307034|559379165|FG000|Overall Study|Withdrawal by Subject|1|||
154987011|NCT00307034|559379166|FG001|Overall Study|Withdrawal by Subject|2|||
155176509|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
154987012|NCT00307034|559379165|FG000|Overall Study|Lost to Follow-up|0|||
154987013|NCT00307034|559379166|FG001|Overall Study|Lost to Follow-up|3|||
154987014|NCT02034058|559379167|FG000|Overall Study|Death|3|||
154987015|NCT01449279|559379180|FG000|Overall Study|Lack of Efficacy|5|||
154987016|NCT01449279|559379180|FG000|Overall Study|Toxicity|2|||
154987017|NCT03709823|559379181|FG000|Overall Study|Adverse Event|0|||
154987018|NCT03709823|559379182|FG001|Overall Study|Adverse Event|0|||
154987019|NCT03709823|559379183|FG002|Overall Study|Adverse Event|1|||
154987020|NCT03709823|559379184|FG003|Overall Study|Adverse Event|0|||
155176510|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
155176511|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
154987021|NCT03709823|559379185|FG004|Overall Study|Adverse Event|0|||
154987022|NCT03709823|559379186|FG005|Overall Study|Adverse Event|0|||
155119372|NCT00075725|559868477|FG004|Overall Study|Study Closure|1|||
155119373|NCT00075725|559868478|FG005|Overall Study|Study Closure|3|||
155119374|NCT00075725|559868479|FG006|Overall Study|Study Closure|0|||
155119375|NCT00075725|559868480|FG007|Overall Study|Study Closure|1|||
155119376|NCT00075725|559868481|FG008|Overall Study|Study Closure|0|||
155119377|NCT00075725|559868482|FG009|Overall Study|Study Closure|0|||
155119378|NCT00075725|559868483|FG010|Overall Study|Study Closure|0|||
155119379|NCT00075725|559868484|FG011|Overall Study|Study Closure|0|||
155119380|NCT00075725|559868473|FG000|Overall Study|Other complications|0|||
155119381|NCT00075725|559868474|FG001|Overall Study|Other complications|0|||
155119382|NCT00075725|559868475|FG002|Overall Study|Other complications|0|||
155119383|NCT00075725|559868476|FG003|Overall Study|Other complications|0|||
155119384|NCT00075725|559868477|FG004|Overall Study|Other complications|0|||
155119385|NCT00075725|559868478|FG005|Overall Study|Other complications|1|||
155119386|NCT00075725|559868479|FG006|Overall Study|Other complications|0|||
155119387|NCT00075725|559868480|FG007|Overall Study|Other complications|0|||
155119388|NCT00075725|559868481|FG008|Overall Study|Other complications|0|||
155119389|NCT00075725|559868482|FG009|Overall Study|Other complications|0|||
155119390|NCT00075725|559868483|FG010|Overall Study|Other complications|0|||
155119391|NCT00075725|559868484|FG011|Overall Study|Other complications|0|||
155119392|NCT00075725|559868473|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
155119393|NCT00075725|559868474|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
155119394|NCT00075725|559868475|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
155119395|NCT00075725|559868476|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
155119396|NCT00075725|559868477|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
155119397|NCT00075725|559868478|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
155119398|NCT00075725|559868479|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
155119399|NCT00075725|559868480|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
155119400|NCT00075725|559868481|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
155119401|NCT00075725|559868482|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
155119402|NCT00075725|559868483|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
155119403|NCT00075725|559868484|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
155119404|NCT00075725|559868473|FG000|Overall Study|Pt incarcerated|0|||
155119405|NCT00075725|559868474|FG001|Overall Study|Pt incarcerated|0|||
155119406|NCT00075725|559868475|FG002|Overall Study|Pt incarcerated|0|||
155119407|NCT00075725|559868476|FG003|Overall Study|Pt incarcerated|0|||
154915870|NCT02041533|559114109|FG000|Pre-Treatment Period|Disease Progression|1|||
154915871|NCT02041533|559114110|FG001|Pre-Treatment Period|Disease Progression|1|||
154915872|NCT02041533|559114109|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
154915873|NCT02041533|559114110|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
154915874|NCT02041533|559114109|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
154915875|NCT02041533|559114110|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
154915876|NCT02041533|559114109|FG000|Treatment Period|Disease progression|189|||
154915877|NCT02041533|559114110|FG001|Treatment Period|Disease progression|146|||
154915878|NCT02041533|559114109|FG000|Treatment Period|Study drug toxicity|30|||
154915879|NCT02041533|559114110|FG001|Treatment Period|Study drug toxicity|34|||
154915880|NCT02041533|559114109|FG000|Treatment Period|Death|1|||
154915881|NCT02041533|559114110|FG001|Treatment Period|Death|0|||
154915882|NCT02041533|559114109|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
154915883|NCT02041533|559114110|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
154915884|NCT02041533|559114109|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
154915885|NCT02041533|559114110|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
154915886|NCT02041533|559114109|FG000|Treatment Period|Participant withdrew consent|2|||
154915887|NCT02041533|559114110|FG001|Treatment Period|Participant withdrew consent|2|||
154915888|NCT02041533|559114109|FG000|Treatment Period|Maximum clinical benefit|0|||
154915889|NCT02041533|559114110|FG001|Treatment Period|Maximum clinical benefit|18|||
154915890|NCT02041533|559114109|FG000|Treatment Period|Poor/Non-compliance|1|||
154915891|NCT02041533|559114110|FG001|Treatment Period|Poor/Non-compliance|0|||
154915892|NCT02041533|559114109|FG000|Treatment Period|Administrative reason by sponsor|1|||
154915893|NCT02041533|559114110|FG001|Treatment Period|Administrative reason by sponsor|0|||
154915894|NCT02041533|559114109|FG000|Treatment Period|Other reasons|9|||
154915895|NCT02041533|559114110|FG001|Treatment Period|Other reasons|2|||
154915896|NCT02041533|559114109|FG000|Treatment Period|Not Reported|0|||
154915897|NCT02041533|559114110|FG001|Treatment Period|Not Reported|1|||
154915898|NCT02813681|559114111|FG000|Overall Study|Physician Decision|5|||
154915899|NCT02813681|559114112|FG001|Overall Study|Physician Decision|5|||
154915900|NCT02813681|559114113|FG002|Overall Study|Physician Decision|0|||
154915901|NCT02813681|559114111|FG000|Overall Study|Lost to Follow-up|0|||
154915902|NCT02813681|559114112|FG001|Overall Study|Lost to Follow-up|1|||
154915903|NCT02813681|559114113|FG002|Overall Study|Lost to Follow-up|0|||
154915904|NCT01957111|559114116|FG000|Overall Study|Withdrawal by Subject|1|||
154915905|NCT01957111|559114117|FG001|Overall Study|Withdrawal by Subject|1|||
154915906|NCT03961529|559114118|FG000|Overall Study|Adverse Event|13|||
155119408|NCT00075725|559868477|FG004|Overall Study|Pt incarcerated|0|||
154915907|NCT03961529|559114119|FG001|Overall Study|Adverse Event|5|||
154987023|NCT03709823|559379181|FG000|Overall Study|Lost to Follow-up|2|||
154987024|NCT03709823|559379182|FG001|Overall Study|Lost to Follow-up|2|||
154987025|NCT03709823|559379183|FG002|Overall Study|Lost to Follow-up|2|||
154987026|NCT03709823|559379184|FG003|Overall Study|Lost to Follow-up|1|||
154987027|NCT03709823|559379185|FG004|Overall Study|Lost to Follow-up|1|||
154987028|NCT03709823|559379186|FG005|Overall Study|Lost to Follow-up|0|||
154987029|NCT03709823|559379181|FG000|Overall Study|Withdrawal by Subject|1|||
154987030|NCT03709823|559379182|FG001|Overall Study|Withdrawal by Subject|3|||
154987031|NCT03709823|559379183|FG002|Overall Study|Withdrawal by Subject|0|||
154987032|NCT03709823|559379184|FG003|Overall Study|Withdrawal by Subject|0|||
154987033|NCT03709823|559379185|FG004|Overall Study|Withdrawal by Subject|0|||
154987034|NCT03709823|559379186|FG005|Overall Study|Withdrawal by Subject|0|||
154987035|NCT03709823|559379181|FG000|Overall Study|Other, Not Specified|0|||
154987036|NCT03709823|559379182|FG001|Overall Study|Other, Not Specified|0|||
154987037|NCT03709823|559379183|FG002|Overall Study|Other, Not Specified|0|||
154987038|NCT03709823|559379184|FG003|Overall Study|Other, Not Specified|1|||
154987039|NCT03709823|559379185|FG004|Overall Study|Other, Not Specified|0|||
154987040|NCT03709823|559379186|FG005|Overall Study|Other, Not Specified|0|||
154987041|NCT00846521|559379189|FG000|Overall Study|Withdrawal by Subject|5|||
154987042|NCT00846521|559379189|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
154987043|NCT00846521|559379189|FG000|Overall Study|Protocol Violation|1|||
154987044|NCT04392583|559379190|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
154987045|NCT03201250|559379191|FG000|Overall Study|screen failures|3|||
154987046|NCT03201250|559379192|FG001|Overall Study|screen failures|0|||
154987047|NCT03201250|559379193|FG002|Overall Study|screen failures|0|||
154987048|NCT02397408|559379194|FG000|Overall Study|Physician Decision|4|||
154987049|NCT02397408|559379194|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
154987050|NCT03551496|559379195|FG000|Overall Study|Death|11|||
154987051|NCT03551496|559379196|FG001|Overall Study|Death|7|||
154987052|NCT03551496|559379195|FG000|Overall Study|Withdrawal by Subject|4|||
154987053|NCT03551496|559379196|FG001|Overall Study|Withdrawal by Subject|3|||
154987054|NCT03551496|559379195|FG000|Overall Study|Other Reasons|1|||
154987055|NCT03551496|559379196|FG001|Overall Study|Other Reasons|0|||
154987056|NCT00140426|559379201|FG000|Overall Study|Withdrawal by Subject|0|||
154987057|NCT00140426|559379202|FG001|Overall Study|Withdrawal by Subject|3|||
154987058|NCT00950963|559379203|FG000|Overall Study|Lost to Follow-up|29|||
154987059|NCT00950963|559379204|FG001|Overall Study|Lost to Follow-up|24|||
154987060|NCT04168190|559379205|FG000|Overall Study|Lost to Follow-up|0|||
154987061|NCT04168190|559379206|FG001|Overall Study|Lost to Follow-up|1|||
154987062|NCT04168190|559379207|FG002|Overall Study|Lost to Follow-up|0|||
154987063|NCT04168190|559379208|FG003|Overall Study|Lost to Follow-up|7|||
154987064|NCT04168190|559379209|FG004|Overall Study|Lost to Follow-up|5|||
154987065|NCT04168190|559379205|FG000|Overall Study|Withdrawal by Subject|1|||
154987066|NCT04168190|559379206|FG001|Overall Study|Withdrawal by Subject|0|||
154987067|NCT04168190|559379207|FG002|Overall Study|Withdrawal by Subject|0|||
154987068|NCT04168190|559379208|FG003|Overall Study|Withdrawal by Subject|2|||
154987069|NCT04168190|559379209|FG004|Overall Study|Withdrawal by Subject|4|||
154987070|NCT04168190|559379205|FG000|Overall Study|Death|0|||
154987071|NCT04168190|559379206|FG001|Overall Study|Death|0|||
154987072|NCT04168190|559379207|FG002|Overall Study|Death|0|||
154987073|NCT04168190|559379208|FG003|Overall Study|Death|1|||
154987074|NCT04168190|559379209|FG004|Overall Study|Death|0|||
154987075|NCT01675661|559379210|FG000|Overall Study|Lost to Follow-up|22|||
154987076|NCT01675661|559379211|FG001|Overall Study|Lost to Follow-up|23|||
154987077|NCT01675661|559379210|FG000|Overall Study|Practical problems|9|||
154987078|NCT01675661|559379211|FG001|Overall Study|Practical problems|5|||
154987079|NCT01675661|559379210|FG000|Overall Study|Moved away|5|||
154987080|NCT01675661|559379211|FG001|Overall Study|Moved away|6|||
154987081|NCT01675661|559379210|FG000|Overall Study|Withdrawal by Subject|3|||
154987082|NCT01675661|559379211|FG001|Overall Study|Withdrawal by Subject|7|||
154987083|NCT01675661|559379210|FG000|Overall Study|Physician Decision|0|||
154987084|NCT01675661|559379211|FG001|Overall Study|Physician Decision|2|||
154987085|NCT01675661|559379210|FG000|Overall Study|Death|0|||
154987086|NCT01675661|559379211|FG001|Overall Study|Death|1|||
154987087|NCT01675661|559379210|FG000|Overall Study|Other reason|1|||
154987088|NCT01675661|559379211|FG001|Overall Study|Other reason|2|||
154987089|NCT04765384|559379212|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
155119409|NCT00075725|559868478|FG005|Overall Study|Pt incarcerated|0|||
154987090|NCT04765384|559379213|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
154987091|NCT04765384|559379214|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
154987092|NCT04765384|559379215|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
154987093|NCT04765384|559379216|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
154987094|NCT04765384|559379217|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
155119410|NCT00075725|559868479|FG006|Overall Study|Pt incarcerated|0|||
155119411|NCT00075725|559868480|FG007|Overall Study|Pt incarcerated|1|||
154987095|NCT04765384|559379212|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
154987096|NCT04765384|559379213|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
155119412|NCT00075725|559868481|FG008|Overall Study|Pt incarcerated|0|||
155176512|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
155176513|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
155176514|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
155176515|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
155176516|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
155176517|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
155176518|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
155176519|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
155176520|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
155176521|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
155176522|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
155176523|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
155176524|NCT01227824|560084008|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
155176525|NCT01227824|560084009|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
155176526|NCT01227824|560084010|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
155176527|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
155176528|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
155176529|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
155176530|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
155176531|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
155176532|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
155176533|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
155176534|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
155176535|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
155176536|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
155176537|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
155176538|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
155176539|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
155176540|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
155176541|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
155176542|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
155176543|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
155176544|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
155176545|NCT01227824|560084008|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
155176546|NCT01227824|560084009|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
155176547|NCT01227824|560084010|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
155176548|NCT02730793|560084011|FG000|Overall Study|Physician Decision|0|||
155176549|NCT02730793|560084012|FG001|Overall Study|Physician Decision|1|||
155176550|NCT02730793|560084011|FG000|Overall Study|Withdrawal by Subject|0|||
155176551|NCT02730793|560084012|FG001|Overall Study|Withdrawal by Subject|1|||
155176552|NCT02365233|560084013|FG000|Overall Study|IRB withheld the data|1|||
155176553|NCT02365233|560084014|FG001|Overall Study|IRB withheld the data|2|||
155176554|NCT02365233|560084015|FG002|Overall Study|IRB withheld the data|2|||
155176555|NCT00995566|560084016|FG000|Overall Study|Adverse Event|2|||
155176556|NCT00995566|560084016|FG000|Overall Study|Early study termination|52|||
155176557|NCT00384111|560084021|FG000|Overall Study|Disease Progression|3|||
155176558|NCT00384111|560084021|FG000|Overall Study|Adverse Event|1|||
155176559|NCT00384111|560084021|FG000|Overall Study|Investigator Decision|3|||
155176560|NCT00384111|560084021|FG000|Overall Study|Study Terminated by the Sponsor|19|||
155176561|NCT01227629|560084023|FG000|Overall Study|Adverse Event|2|||
155176562|NCT01227629|560084024|FG001|Overall Study|Adverse Event|2|||
155176563|NCT01227629|560084025|FG002|Overall Study|Adverse Event|1|||
155176564|NCT01227629|560084026|FG003|Overall Study|Adverse Event|6|||
155176565|NCT01227629|560084027|FG004|Overall Study|Adverse Event|1|||
155176566|NCT01227629|560084028|FG005|Overall Study|Adverse Event|1|||
155176567|NCT01227629|560084029|FG006|Overall Study|Adverse Event|6|||
155176568|NCT01227629|560084030|FG007|Overall Study|Adverse Event|6|||
155176569|NCT01227629|560084031|FG008|Overall Study|Adverse Event|4|||
155176570|NCT01227629|560084032|FG009|Overall Study|Adverse Event|0|||
155176571|NCT01227629|560084023|FG000|Overall Study|Protocol Violation|0|||
155176572|NCT01227629|560084024|FG001|Overall Study|Protocol Violation|0|||
154915908|NCT03961529|559114120|FG002|Overall Study|Adverse Event|2|||
154915909|NCT03961529|559114118|FG000|Overall Study|Withdrawal by Subject|17|||
154915910|NCT03961529|559114119|FG001|Overall Study|Withdrawal by Subject|2|||
154915911|NCT03961529|559114120|FG002|Overall Study|Withdrawal by Subject|1|||
154915912|NCT03961529|559114118|FG000|Overall Study|Withdrawal by parent/guardian|0|||
154915913|NCT03961529|559114119|FG001|Overall Study|Withdrawal by parent/guardian|7|||
154915914|NCT03961529|559114120|FG002|Overall Study|Withdrawal by parent/guardian|0|||
154915915|NCT03961529|559114118|FG000|Overall Study|Physician Decision|2|||
154915916|NCT03961529|559114119|FG001|Overall Study|Physician Decision|1|||
154915917|NCT03961529|559114120|FG002|Overall Study|Physician Decision|1|||
154915918|NCT03961529|559114118|FG000|Overall Study|Lost to Follow-up|2|||
154915919|NCT03961529|559114119|FG001|Overall Study|Lost to Follow-up|1|||
154915920|NCT03961529|559114120|FG002|Overall Study|Lost to Follow-up|0|||
154915921|NCT03961529|559114118|FG000|Overall Study|Lack of Efficacy|2|||
154915922|NCT03961529|559114119|FG001|Overall Study|Lack of Efficacy|0|||
154915923|NCT03961529|559114120|FG002|Overall Study|Lack of Efficacy|1|||
154915924|NCT03961529|559114118|FG000|Overall Study|Other|6|||
154915925|NCT03961529|559114119|FG001|Overall Study|Other|1|||
154915926|NCT03961529|559114120|FG002|Overall Study|Other|0|||
154915927|NCT03644173|559114121|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
154915928|NCT03644173|559114121|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
154915929|NCT03644173|559114121|FG000|Participants at the 1-month Follow up|Death|2|||
154915930|NCT03644173|559114121|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
154915931|NCT03500419|559114122|FG000|Overall Study|Withdrawal by Subject|2|||
154915932|NCT03500419|559114123|FG001|Overall Study|Withdrawal by Subject|25|||
154915933|NCT01497899|559114124|FG000|Double-Blind Phase|Randomized but not Treated|1|||
154915934|NCT01497899|559114125|FG001|Double-Blind Phase|Randomized but not Treated|0|||
154915935|NCT01497899|559114126|FG002|Double-Blind Phase|Randomized but not Treated|0|||
154915936|NCT01497899|559114127|FG003|Double-Blind Phase|Randomized but not Treated|0|||
154915937|NCT01497899|559114124|FG000|Double-Blind Phase|Adverse Event|1|||
154915938|NCT01497899|559114125|FG001|Double-Blind Phase|Adverse Event|0|||
154915939|NCT01497899|559114126|FG002|Double-Blind Phase|Adverse Event|0|||
154915940|NCT01497899|559114127|FG003|Double-Blind Phase|Adverse Event|0|||
154915941|NCT01497899|559114124|FG000|Double-Blind Phase|Lack of Efficacy|0|||
154915942|NCT01497899|559114125|FG001|Double-Blind Phase|Lack of Efficacy|1|||
154915943|NCT01497899|559114126|FG002|Double-Blind Phase|Lack of Efficacy|0|||
154915944|NCT01497899|559114127|FG003|Double-Blind Phase|Lack of Efficacy|0|||
154915945|NCT01497899|559114124|FG000|Double-Blind Phase|Investigator's Discretion|1|||
154915946|NCT01497899|559114125|FG001|Double-Blind Phase|Investigator's Discretion|0|||
154915947|NCT01497899|559114126|FG002|Double-Blind Phase|Investigator's Discretion|0|||
154915948|NCT01497899|559114127|FG003|Double-Blind Phase|Investigator's Discretion|0|||
154915949|NCT01497899|559114124|FG000|Double-Blind Phase|Withdrew Consent|0|||
154915950|NCT01497899|559114125|FG001|Double-Blind Phase|Withdrew Consent|1|||
154915951|NCT01497899|559114126|FG002|Double-Blind Phase|Withdrew Consent|0|||
154915952|NCT01497899|559114127|FG003|Double-Blind Phase|Withdrew Consent|0|||
154915953|NCT01497899|559114124|FG000|Double-Blind Phase|Lost to Follow-up|3|||
154915954|NCT01497899|559114125|FG001|Double-Blind Phase|Lost to Follow-up|2|||
154915955|NCT01497899|559114126|FG002|Double-Blind Phase|Lost to Follow-up|0|||
154915956|NCT01497899|559114127|FG003|Double-Blind Phase|Lost to Follow-up|0|||
154915957|NCT01497899|559114124|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
154915958|NCT01497899|559114125|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
154915959|NCT01497899|559114126|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
154915960|NCT01497899|559114127|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
154915961|NCT01497899|559114124|FG000|Open-Label Extension Phase|Adverse Event|1|||
154915962|NCT01497899|559114125|FG001|Open-Label Extension Phase|Adverse Event|0|||
154915963|NCT01497899|559114126|FG002|Open-Label Extension Phase|Adverse Event|0|||
154915964|NCT01497899|559114127|FG003|Open-Label Extension Phase|Adverse Event|0|||
154915965|NCT01497899|559114124|FG000|Open-Label Extension Phase|Death|1|||
154915966|NCT01497899|559114125|FG001|Open-Label Extension Phase|Death|0|||
154915967|NCT01497899|559114126|FG002|Open-Label Extension Phase|Death|0|||
154915968|NCT01497899|559114127|FG003|Open-Label Extension Phase|Death|0|||
154915969|NCT01497899|559114124|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
154915970|NCT01497899|559114125|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
154915971|NCT01497899|559114126|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
154915972|NCT01497899|559114127|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
154915973|NCT01497899|559114124|FG000|Open-Label Extension Phase|Pregnancy|0|||
154915974|NCT01497899|559114125|FG001|Open-Label Extension Phase|Pregnancy|1|||
154987097|NCT04765384|559379214|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
154987098|NCT04765384|559379215|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
154915975|NCT01497899|559114126|FG002|Open-Label Extension Phase|Pregnancy|1|||
154915976|NCT01497899|559114127|FG003|Open-Label Extension Phase|Pregnancy|0|||
154915977|NCT01497899|559114124|FG000|Open-Label Extension Phase|Protocol Violation|0|||
154915978|NCT01497899|559114125|FG001|Open-Label Extension Phase|Protocol Violation|0|||
154915979|NCT01497899|559114126|FG002|Open-Label Extension Phase|Protocol Violation|1|||
154915980|NCT01497899|559114127|FG003|Open-Label Extension Phase|Protocol Violation|0|||
154915981|NCT01497899|559114124|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
154915982|NCT01497899|559114125|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
154915983|NCT01497899|559114126|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
154915984|NCT01497899|559114127|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
154915985|NCT01874288|559114131|FG000|Overall Study|Withdrawal by Subject|1|||
154915986|NCT01874288|559114132|FG001|Overall Study|Withdrawal by Subject|0|||
154915987|NCT01874288|559114133|FG002|Overall Study|Withdrawal by Subject|2|||
154915988|NCT01874288|559114134|FG003|Overall Study|Withdrawal by Subject|1|||
154987099|NCT04765384|559379216|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
154987100|NCT04765384|559379217|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
154987101|NCT04765384|559379212|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
154987102|NCT04765384|559379213|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
154987103|NCT04765384|559379214|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
154987104|NCT04765384|559379215|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
154987105|NCT04765384|559379216|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
154987106|NCT04765384|559379217|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
154987107|NCT04765384|559379212|FG000|Post-natal: Neonates and Infants|Death|0|||
154987108|NCT04765384|559379213|FG001|Post-natal: Neonates and Infants|Death|0|||
154987109|NCT04765384|559379214|FG002|Post-natal: Neonates and Infants|Death|0|||
154987110|NCT04765384|559379215|FG003|Post-natal: Neonates and Infants|Death|1|||
154987111|NCT04765384|559379216|FG004|Post-natal: Neonates and Infants|Death|0|||
154987112|NCT04765384|559379217|FG005|Post-natal: Neonates and Infants|Death|0|||
154987113|NCT04765384|559379212|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
154987114|NCT04765384|559379213|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
154987115|NCT04765384|559379214|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
154987116|NCT04765384|559379215|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
154987117|NCT04765384|559379216|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
154987118|NCT04765384|559379217|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
154987119|NCT02992418|559379218|FG000|Overall Study|Withdrawal by Subject|11|||
154987120|NCT02992418|559379219|FG001|Overall Study|Withdrawal by Subject|12|||
154987121|NCT02992418|559379218|FG000|Overall Study|Non-compliance with the protocol|308|||
154987122|NCT02992418|559379219|FG001|Overall Study|Non-compliance with the protocol|308|||
154987123|NCT02992418|559379218|FG000|Overall Study|Lost to Follow-up|27|||
154987124|NCT02992418|559379219|FG001|Overall Study|Lost to Follow-up|22|||
154987125|NCT00629265|559379220|FG000|Overall Study|Lost to Follow-up|4|||
154987126|NCT00629265|559379221|FG001|Overall Study|Lost to Follow-up|5|||
154987127|NCT00629265|559379220|FG000|Overall Study|Withdrawal by Subject|11|||
154987128|NCT00629265|559379221|FG001|Overall Study|Withdrawal by Subject|8|||
154987129|NCT00629265|559379220|FG000|Overall Study|Death|1|||
154987130|NCT00629265|559379221|FG001|Overall Study|Death|0|||
154987131|NCT00629265|559379220|FG000|Overall Study|Adverse Event|2|||
154987132|NCT00629265|559379221|FG001|Overall Study|Adverse Event|0|||
154987133|NCT00629265|559379220|FG000|Overall Study|HNC Recurrence|4|||
154987134|NCT00629265|559379221|FG001|Overall Study|HNC Recurrence|0|||
154987135|NCT00629265|559379220|FG000|Overall Study|Other CA Requiring Treatment|1|||
154987136|NCT00629265|559379221|FG001|Overall Study|Other CA Requiring Treatment|3|||
154987137|NCT00629265|559379220|FG000|Overall Study|Needed Esophageal Dilation|4|||
154987138|NCT00629265|559379221|FG001|Overall Study|Needed Esophageal Dilation|1|||
154987139|NCT00629265|559379220|FG000|Overall Study|Unrelated Medical Complications|3|||
154987140|NCT00629265|559379221|FG001|Overall Study|Unrelated Medical Complications|1|||
154987141|NCT00629265|559379220|FG000|Overall Study|Unknown Reason|2|||
154987142|NCT00629265|559379221|FG001|Overall Study|Unknown Reason|2|||
154987143|NCT01006135|559379222|FG000|Overall Study|Adverse Event|22|||
154987144|NCT01006135|559379222|FG000|Overall Study|Protocol Violation|14|||
154987145|NCT01006135|559379222|FG000|Overall Study|Lost to Follow-up|32|||
154987146|NCT01006135|559379222|FG000|Overall Study|Other|72|||
154987147|NCT01732484|559379223|FG000|Overall Study|Death|7|||
154987148|NCT01732484|559379223|FG000|Overall Study|Lost to Follow-up|14|||
154987149|NCT01732484|559379223|FG000|Overall Study|chronical illness|5|||
154987150|NCT01087489|559379224|FG000|Overall Study|enrolled in another VA study|0|||
154987151|NCT01087489|559379225|FG001|Overall Study|enrolled in another VA study|1|||
154987152|NCT01087489|559379224|FG000|Overall Study|Death|0|||
154987153|NCT01087489|559379225|FG001|Overall Study|Death|1|||
154987154|NCT01087489|559379224|FG000|Overall Study|unable to survey by telephone|0|||
154987155|NCT01087489|559379225|FG001|Overall Study|unable to survey by telephone|1|||
154987156|NCT02032706|559379233|FG000|Overall Study|Did not qualify|5|||
154987157|NCT02032706|559379233|FG000|Overall Study|Protocol Violation|1|||
154987158|NCT00893737|559379234|FG000|Overall Study|Adverse Event|4|||
154987159|NCT00893737|559379234|FG000|Overall Study|Withdrawal by Subject|2|||
154987160|NCT00893737|559379234|FG000|Overall Study|Lost to Follow-up|6|||
154987161|NCT00928707|559379235|FG000|Overall Study|Protocol Violation|1|||
154987162|NCT00928707|559379236|FG001|Overall Study|Protocol Violation|0|||
154987163|NCT00132028|559379237|FG000|Overall Study|Adverse Event|7|||
154987164|NCT00132028|559379237|FG000|Overall Study|Death|2|||
154987165|NCT00132028|559379237|FG000|Overall Study|Lack of Efficacy|11|||
155119413|NCT00075725|559868482|FG009|Overall Study|Pt incarcerated|0|||
154987166|NCT00132028|559379237|FG000|Overall Study|Withdrawal by Subject|2|||
154987167|NCT00132028|559379237|FG000|Overall Study|not eligible|2|||
154987168|NCT00132028|559379237|FG000|Overall Study|Physician Decision|3|||
155119414|NCT00075725|559868483|FG010|Overall Study|Pt incarcerated|0|||
154987169|NCT02140411|559379238|FG000|Overall Study|Adverse Event|1|||
154987170|NCT03981419|559379241|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
154987171|NCT03981419|559379242|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
155176573|NCT01227629|560084025|FG002|Overall Study|Protocol Violation|0|||
155176574|NCT01227629|560084026|FG003|Overall Study|Protocol Violation|1|||
154915989|NCT01874288|559114135|FG004|Overall Study|Withdrawal by Subject|1|||
154915990|NCT01874288|559114131|FG000|Overall Study|Physician Decision|0|||
154915991|NCT01874288|559114132|FG001|Overall Study|Physician Decision|0|||
154915992|NCT01874288|559114133|FG002|Overall Study|Physician Decision|0|||
154915993|NCT01874288|559114134|FG003|Overall Study|Physician Decision|1|||
154915994|NCT01874288|559114135|FG004|Overall Study|Physician Decision|0|||
154915995|NCT01874288|559114131|FG000|Overall Study|Progressive disease|2|||
154915996|NCT01874288|559114132|FG001|Overall Study|Progressive disease|0|||
154915997|NCT01874288|559114133|FG002|Overall Study|Progressive disease|3|||
154915998|NCT01874288|559114134|FG003|Overall Study|Progressive disease|5|||
154915999|NCT01874288|559114135|FG004|Overall Study|Progressive disease|1|||
154916000|NCT04212221|559114136|FG000|Overall Study|Remained on Treatment|0|||
154916001|NCT04212221|559114137|FG001|Overall Study|Remained on Treatment|0|||
154916002|NCT04212221|559114138|FG002|Overall Study|Remained on Treatment|0|||
154916003|NCT04212221|559114139|FG003|Overall Study|Remained on Treatment|1|||
154916004|NCT04212221|559114140|FG004|Overall Study|Remained on Treatment|0|||
154916005|NCT04212221|559114141|FG005|Overall Study|Remained on Treatment|0|||
154916006|NCT04212221|559114142|FG006|Overall Study|Remained on Treatment|3|||
154916007|NCT04212221|559114143|FG007|Overall Study|Remained on Treatment|9|||
154916008|NCT04212221|559114136|FG000|Overall Study|Adverse Event|0|||
154916009|NCT04212221|559114137|FG001|Overall Study|Adverse Event|0|||
154916010|NCT04212221|559114138|FG002|Overall Study|Adverse Event|0|||
154916011|NCT04212221|559114139|FG003|Overall Study|Adverse Event|0|||
154916012|NCT04212221|559114140|FG004|Overall Study|Adverse Event|0|||
154916013|NCT04212221|559114141|FG005|Overall Study|Adverse Event|0|||
154916014|NCT04212221|559114142|FG006|Overall Study|Adverse Event|2|||
154916015|NCT04212221|559114143|FG007|Overall Study|Adverse Event|3|||
154916016|NCT04212221|559114136|FG000|Overall Study|Death|0|||
154916017|NCT04212221|559114137|FG001|Overall Study|Death|0|||
154916018|NCT04212221|559114138|FG002|Overall Study|Death|0|||
154916019|NCT04212221|559114139|FG003|Overall Study|Death|0|||
154916020|NCT04212221|559114140|FG004|Overall Study|Death|0|||
154916021|NCT04212221|559114141|FG005|Overall Study|Death|0|||
154916022|NCT04212221|559114142|FG006|Overall Study|Death|0|||
154916023|NCT04212221|559114143|FG007|Overall Study|Death|2|||
154916024|NCT04212221|559114136|FG000|Overall Study|Disease progression according to irRECIST|1|||
154916025|NCT04212221|559114137|FG001|Overall Study|Disease progression according to irRECIST|2|||
154916026|NCT04212221|559114138|FG002|Overall Study|Disease progression according to irRECIST|3|||
154916027|NCT04212221|559114139|FG003|Overall Study|Disease progression according to irRECIST|3|||
154916028|NCT04212221|559114140|FG004|Overall Study|Disease progression according to irRECIST|2|||
154916029|NCT04212221|559114141|FG005|Overall Study|Disease progression according to irRECIST|2|||
154916030|NCT04212221|559114142|FG006|Overall Study|Disease progression according to irRECIST|21|||
154916031|NCT04212221|559114143|FG007|Overall Study|Disease progression according to irRECIST|17|||
154916032|NCT04212221|559114136|FG000|Overall Study|Global Deterioration of Health Status|0|||
154916033|NCT04212221|559114137|FG001|Overall Study|Global Deterioration of Health Status|0|||
154916034|NCT04212221|559114138|FG002|Overall Study|Global Deterioration of Health Status|0|||
154916035|NCT04212221|559114139|FG003|Overall Study|Global Deterioration of Health Status|0|||
154916036|NCT04212221|559114140|FG004|Overall Study|Global Deterioration of Health Status|0|||
154916037|NCT04212221|559114141|FG005|Overall Study|Global Deterioration of Health Status|0|||
154916038|NCT04212221|559114142|FG006|Overall Study|Global Deterioration of Health Status|0|||
154916039|NCT04212221|559114143|FG007|Overall Study|Global Deterioration of Health Status|2|||
154916040|NCT04212221|559114136|FG000|Overall Study|Investigator's Decision|0|||
154916041|NCT04212221|559114137|FG001|Overall Study|Investigator's Decision|0|||
154916042|NCT04212221|559114138|FG002|Overall Study|Investigator's Decision|0|||
154916043|NCT04212221|559114139|FG003|Overall Study|Investigator's Decision|1|||
154916044|NCT04212221|559114140|FG004|Overall Study|Investigator's Decision|0|||
154916045|NCT04212221|559114141|FG005|Overall Study|Investigator's Decision|0|||
154916046|NCT04212221|559114142|FG006|Overall Study|Investigator's Decision|3|||
154916047|NCT04212221|559114143|FG007|Overall Study|Investigator's Decision|0|||
154916048|NCT04212221|559114136|FG000|Overall Study|Participant refused to continue treatment|0|||
154916049|NCT04212221|559114137|FG001|Overall Study|Participant refused to continue treatment|1|||
154916050|NCT04212221|559114138|FG002|Overall Study|Participant refused to continue treatment|0|||
154916051|NCT04212221|559114139|FG003|Overall Study|Participant refused to continue treatment|1|||
154916052|NCT04212221|559114140|FG004|Overall Study|Participant refused to continue treatment|1|||
154916053|NCT04212221|559114141|FG005|Overall Study|Participant refused to continue treatment|2|||
154916054|NCT04212221|559114142|FG006|Overall Study|Participant refused to continue treatment|4|||
154916055|NCT04212221|559114143|FG007|Overall Study|Participant refused to continue treatment|2|||
154916056|NCT04212221|559114136|FG000|Overall Study|Protocol Violation|0|||
154916057|NCT04212221|559114137|FG001|Overall Study|Protocol Violation|0|||
154916058|NCT04212221|559114138|FG002|Overall Study|Protocol Violation|0|||
155176575|NCT01227629|560084027|FG004|Overall Study|Protocol Violation|0|||
154916059|NCT04212221|559114139|FG003|Overall Study|Protocol Violation|0|||
154916060|NCT04212221|559114140|FG004|Overall Study|Protocol Violation|0|||
155119415|NCT00075725|559868484|FG011|Overall Study|Pt incarcerated|0|||
155119416|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Death|1|||
155119417|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Death|1|||
155119418|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Death|0|||
155119419|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Death|0|||
155119420|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Death|1|||
155119421|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Death|0|||
155119422|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Death|0|||
155119423|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Death|0|||
155119424|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Death|0|||
155119425|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Death|0|||
155119426|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
155119427|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
155119428|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
155119429|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
155119430|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
155119431|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
155119432|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
155119433|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
155119434|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
155119435|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
155119436|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119437|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119438|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119439|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119440|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
155119441|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119442|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119443|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119444|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119445|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
155119446|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
155119447|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119448|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119449|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119450|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119451|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119452|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119453|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119454|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119455|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
155119456|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
155119457|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155119458|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155119459|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
154916061|NCT04212221|559114141|FG005|Overall Study|Protocol Violation|0|||
154916062|NCT04212221|559114142|FG006|Overall Study|Protocol Violation|0|||
154916063|NCT04212221|559114143|FG007|Overall Study|Protocol Violation|1|||
154916064|NCT00636506|559114144|FG000|Overall Study|Lost to Follow-up|8|||
154916065|NCT00636506|559114144|FG000|Overall Study|Explanted|1|||
154916066|NCT00636506|559114144|FG000|Overall Study|Withdrawal by Subject|6|||
154916067|NCT00636506|559114144|FG000|Overall Study|Procedure aborted|1|||
154916068|NCT01624974|559114145|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
154916069|NCT01624974|559114146|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
154916070|NCT01624974|559114145|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
154916071|NCT01624974|559114146|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
154916072|NCT01624974|559114145|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
154916073|NCT01624974|559114146|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
154916074|NCT01624974|559114145|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
154916075|NCT01624974|559114146|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
154916076|NCT01624974|559114145|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
154916077|NCT01624974|559114146|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
154916078|NCT01624974|559114145|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
154916079|NCT01624974|559114146|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
154916080|NCT01624974|559114145|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
154916081|NCT01624974|559114146|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
154916082|NCT01624974|559114145|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
154916083|NCT01624974|559114146|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
155119460|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
154916084|NCT01624974|559114145|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
155119461|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155176576|NCT01227629|560084028|FG005|Overall Study|Protocol Violation|0|||
154987172|NCT01330459|559379243|FG000|Overall Study|Physician Decision|0|||
154987173|NCT01330459|559379244|FG001|Overall Study|Physician Decision|2|||
154987174|NCT02005887|559379250|FG000|Overall Study|Protocol Violation|0|||
154987175|NCT02005887|559379251|FG001|Overall Study|Protocol Violation|2|||
154987176|NCT01615263|559379260|FG000|Overall Study|Post-randomization exclusion|0|||
154987177|NCT01615263|559379261|FG001|Overall Study|Post-randomization exclusion|2|||
154987178|NCT00160641|559379262|FG000|Overall Study|Adverse Event|102|||
154987179|NCT00160641|559379262|FG000|Overall Study|Withdrawal by Subject|87|||
154987180|NCT00160641|559379262|FG000|Overall Study|Lost to Follow-up|8|||
154987181|NCT00160641|559379262|FG000|Overall Study|Lack of Efficacy|12|||
154987182|NCT00160641|559379262|FG000|Overall Study|Protocol Violation|3|||
154987183|NCT00160641|559379262|FG000|Overall Study|Other|9|||
154987184|NCT01321008|559379265|FG000|Overall Study|Early Study Termination|1|||
154987185|NCT00770692|559379266|FG000|Overall Study|Withdrawal by Subject|7|||
154987186|NCT00770692|559379267|FG001|Overall Study|Withdrawal by Subject|9|||
154987187|NCT00770692|559379268|FG002|Overall Study|Withdrawal by Subject|9|||
154987188|NCT00770692|559379269|FG003|Overall Study|Withdrawal by Subject|6|||
154987189|NCT00770692|559379266|FG000|Overall Study|Adverse Event|3|||
154987190|NCT00770692|559379267|FG001|Overall Study|Adverse Event|0|||
154987191|NCT00770692|559379268|FG002|Overall Study|Adverse Event|4|||
154987192|NCT00770692|559379269|FG003|Overall Study|Adverse Event|4|||
154987193|NCT00770692|559379266|FG000|Overall Study|Investigator judgment|2|||
154987194|NCT00770692|559379267|FG001|Overall Study|Investigator judgment|0|||
154987195|NCT00770692|559379268|FG002|Overall Study|Investigator judgment|1|||
154987196|NCT00770692|559379269|FG003|Overall Study|Investigator judgment|1|||
154987197|NCT01230892|559379270|FG000|Overall Study|Withdrawal by Subject|1|||
154987198|NCT01230892|559379271|FG001|Overall Study|Withdrawal by Subject|1|||
154987199|NCT01230892|559379270|FG000|Overall Study|Lost to Follow-up|2|||
154987200|NCT01230892|559379271|FG001|Overall Study|Lost to Follow-up|0|||
154987201|NCT00679913|559379272|FG000|Overall Study|Protocol Violation|18|||
154987202|NCT00679913|559379273|FG001|Overall Study|Protocol Violation|13|||
154987203|NCT00725621|559379274|FG000|Overall Study|Adverse Event|25|||
154987204|NCT00725621|559379274|FG000|Overall Study|Lack of Efficacy|46|||
154987205|NCT00725621|559379274|FG000|Overall Study|Withdrawal by Subject|57|||
154987206|NCT00725621|559379274|FG000|Overall Study|Physician Decision|19|||
154987207|NCT00725621|559379274|FG000|Overall Study|Lost to Follow-up|52|||
154987208|NCT00725621|559379274|FG000|Overall Study|Non-compliance|8|||
155119462|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155119463|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155119464|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155119465|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
155119466|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
155119467|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155119468|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155176577|NCT01227629|560084029|FG006|Overall Study|Protocol Violation|0|||
154916085|NCT01624974|559114146|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
154987209|NCT00725621|559379274|FG000|Overall Study|Continued treatment by other physician|6|||
155119469|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
155119470|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155119471|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
154916086|NCT01624974|559114145|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
154916087|NCT01624974|559114146|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
154916088|NCT01624974|559114145|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
154916089|NCT01624974|559114146|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
154916090|NCT01624974|559114145|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
154916091|NCT01624974|559114146|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
154916092|NCT02607735|559114147|FG000|Primary Study|Randomized but Never Treated|1|||
154916093|NCT02607735|559114148|FG001|Primary Study|Randomized but Never Treated|0|||
154916094|NCT02607735|559114149|FG002|Primary Study|Randomized but Never Treated|0|||
154916095|NCT02607735|559114147|FG000|Primary Study|Lost to Follow-up|4|||
154916096|NCT02607735|559114148|FG001|Primary Study|Lost to Follow-up|0|||
154916097|NCT02607735|559114149|FG002|Primary Study|Lost to Follow-up|0|||
154916098|NCT02607735|559114147|FG000|Primary Study|Withdrew Consent|2|||
154987210|NCT00725621|559379274|FG000|Overall Study|Switched to other study|1|||
155119472|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155119473|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155119474|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
155119475|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
154987211|NCT00725621|559379274|FG000|Overall Study|Switched to other drug|1|||
154987212|NCT00725621|559379274|FG000|Overall Study|Prepared for elective surgery|1|||
154987213|NCT00725621|559379274|FG000|Overall Study|Reason not specified|55|||
154987214|NCT01189500|559379275|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
154987215|NCT01189500|559379275|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
154987216|NCT00062751|559379276|FG000|Overall Study|Disease progression|24|||
155176578|NCT01227629|560084030|FG007|Overall Study|Protocol Violation|0|||
154987217|NCT00062751|559379277|FG001|Overall Study|Disease progression|17|||
154987218|NCT00062751|559379278|FG002|Overall Study|Disease progression|24|||
154987219|NCT00062751|559379279|FG003|Overall Study|Disease progression|2|||
154987220|NCT00062751|559379280|FG004|Overall Study|Disease progression|2|||
154987221|NCT00062751|559379276|FG000|Overall Study|Adverse Event|4|||
154987222|NCT00062751|559379277|FG001|Overall Study|Adverse Event|7|||
154987223|NCT00062751|559379278|FG002|Overall Study|Adverse Event|2|||
154987224|NCT00062751|559379279|FG003|Overall Study|Adverse Event|2|||
154987225|NCT00062751|559379280|FG004|Overall Study|Adverse Event|2|||
154987226|NCT00062751|559379276|FG000|Overall Study|Other|2|||
154987227|NCT00062751|559379277|FG001|Overall Study|Other|3|||
154987228|NCT00062751|559379278|FG002|Overall Study|Other|1|||
154987229|NCT00062751|559379279|FG003|Overall Study|Other|0|||
154987230|NCT00062751|559379280|FG004|Overall Study|Other|1|||
154987231|NCT00062751|559379276|FG000|Overall Study|Withdrawal by Subject|1|||
154987232|NCT00062751|559379277|FG001|Overall Study|Withdrawal by Subject|2|||
154987233|NCT00062751|559379278|FG002|Overall Study|Withdrawal by Subject|2|||
154987234|NCT00062751|559379279|FG003|Overall Study|Withdrawal by Subject|1|||
154987235|NCT00062751|559379280|FG004|Overall Study|Withdrawal by Subject|0|||
154987236|NCT00062751|559379276|FG000|Overall Study|Symptomatic deterioration|1|||
154987237|NCT00062751|559379277|FG001|Overall Study|Symptomatic deterioration|1|||
154987238|NCT00062751|559379278|FG002|Overall Study|Symptomatic deterioration|0|||
154987239|NCT00062751|559379279|FG003|Overall Study|Symptomatic deterioration|0|||
154987240|NCT00062751|559379280|FG004|Overall Study|Symptomatic deterioration|1|||
154987241|NCT00062751|559379276|FG000|Overall Study|Death|1|||
154987242|NCT00062751|559379277|FG001|Overall Study|Death|0|||
154987243|NCT00062751|559379278|FG002|Overall Study|Death|1|||
154987244|NCT00062751|559379279|FG003|Overall Study|Death|0|||
154987245|NCT00062751|559379280|FG004|Overall Study|Death|0|||
154987246|NCT01000493|559379281|FG000|Overall Study|Adverse Event|3|||
154987247|NCT01000493|559379282|FG001|Overall Study|Adverse Event|6|||
154987248|NCT01000493|559379281|FG000|Overall Study|Lack of Efficacy|1|||
154987249|NCT01000493|559379282|FG001|Overall Study|Lack of Efficacy|1|||
154987250|NCT01000493|559379281|FG000|Overall Study|Protocol Violation|1|||
154987251|NCT01000493|559379282|FG001|Overall Study|Protocol Violation|8|||
154987252|NCT01000493|559379281|FG000|Overall Study|Study closed/terminated|25|||
154987253|NCT01000493|559379282|FG001|Overall Study|Study closed/terminated|23|||
154987254|NCT01000493|559379281|FG000|Overall Study|Lost to Follow-up|5|||
154987255|NCT01000493|559379282|FG001|Overall Study|Lost to Follow-up|9|||
154987256|NCT01000493|559379281|FG000|Overall Study|Physician Decision|1|||
154987257|NCT01000493|559379282|FG001|Overall Study|Physician Decision|1|||
154987258|NCT01000493|559379281|FG000|Overall Study|Withdrawal by Subject|3|||
154987259|NCT01000493|559379282|FG001|Overall Study|Withdrawal by Subject|7|||
154987260|NCT03629028|559379283|FG000|Overall Study|Lost to Follow-up|26|||
154987261|NCT03629028|559379284|FG001|Overall Study|Lost to Follow-up|23|||
154987262|NCT03629028|559379283|FG000|Overall Study|Pregnancy|4|||
154987263|NCT03629028|559379284|FG001|Overall Study|Pregnancy|2|||
154987264|NCT03629028|559379283|FG000|Overall Study|intolerance to examination|2|||
154987265|NCT03629028|559379284|FG001|Overall Study|intolerance to examination|0|||
154987266|NCT03097588|559379288|FG000|Overall Study|Adverse Event|1|||
154987267|NCT01144364|559379289|FG000|Induction Phase|Disease progression|14|||
154987268|NCT01144364|559379290|FG001|Induction Phase|Disease progression|0|||
154987269|NCT01144364|559379291|FG002|Induction Phase|Disease progression|0|||
154987270|NCT01144364|559379289|FG000|Induction Phase|Adverse Event|9|||
154987271|NCT01144364|559379290|FG001|Induction Phase|Adverse Event|0|||
154987272|NCT01144364|559379291|FG002|Induction Phase|Adverse Event|0|||
154987273|NCT01144364|559379289|FG000|Induction Phase|Death|1|||
154987274|NCT01144364|559379290|FG001|Induction Phase|Death|0|||
154987275|NCT01144364|559379291|FG002|Induction Phase|Death|0|||
154987276|NCT01144364|559379289|FG000|Induction Phase|Withdrawal by Subject|1|||
154987277|NCT01144364|559379290|FG001|Induction Phase|Withdrawal by Subject|0|||
154987278|NCT01144364|559379291|FG002|Induction Phase|Withdrawal by Subject|0|||
154987279|NCT01144364|559379289|FG000|Induction Phase|Lost to Follow-up|2|||
154987280|NCT01144364|559379290|FG001|Induction Phase|Lost to Follow-up|0|||
154987281|NCT01144364|559379291|FG002|Induction Phase|Lost to Follow-up|0|||
154987282|NCT01144364|559379289|FG000|Induction Phase|Physician Decision|1|||
154987283|NCT01144364|559379290|FG001|Induction Phase|Physician Decision|0|||
154987284|NCT01144364|559379291|FG002|Induction Phase|Physician Decision|0|||
154987285|NCT01144364|559379289|FG000|Induction Phase|Stable disease|2|||
154987286|NCT01144364|559379290|FG001|Induction Phase|Stable disease|0|||
154987287|NCT01144364|559379291|FG002|Induction Phase|Stable disease|0|||
154987288|NCT01144364|559379289|FG000|Induction Phase|Secondary neoplasia|1|||
154987289|NCT01144364|559379290|FG001|Induction Phase|Secondary neoplasia|0|||
154987290|NCT01144364|559379291|FG002|Induction Phase|Secondary neoplasia|0|||
154987291|NCT01144364|559379289|FG000|Induction Phase|Protocol Violation|1|||
154987292|NCT01144364|559379290|FG001|Induction Phase|Protocol Violation|0|||
154987293|NCT01144364|559379291|FG002|Induction Phase|Protocol Violation|0|||
154987294|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
154987295|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
155176579|NCT01227629|560084031|FG008|Overall Study|Protocol Violation|0|||
154987296|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
155119476|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
154916099|NCT02607735|559114148|FG001|Primary Study|Withdrew Consent|0|||
154916100|NCT02607735|559114149|FG002|Primary Study|Withdrew Consent|0|||
154916101|NCT02607735|559114147|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
154916102|NCT02607735|559114148|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
154916103|NCT02607735|559114149|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
154916104|NCT02607735|559114147|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
154916105|NCT02607735|559114148|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
154916106|NCT02607735|559114149|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
154916107|NCT01646255|559114150|FG000|Overall Study|Adverse Event|7|||
154916108|NCT01646255|559114151|FG001|Overall Study|Adverse Event|8|||
154916109|NCT01646255|559114150|FG000|Overall Study|Lack of Efficacy|2|||
154916110|NCT01646255|559114151|FG001|Overall Study|Lack of Efficacy|0|||
154916111|NCT01646255|559114150|FG000|Overall Study|Withdrawal by Subject|10|||
154916112|NCT01646255|559114151|FG001|Overall Study|Withdrawal by Subject|6|||
154916113|NCT01646255|559114150|FG000|Overall Study|Compliance is not well|1|||
154916114|NCT01646255|559114151|FG001|Overall Study|Compliance is not well|0|||
154916115|NCT01646255|559114150|FG000|Overall Study|Inclusion Criteria Deviation|1|||
154916116|NCT01646255|559114151|FG001|Overall Study|Inclusion Criteria Deviation|0|||
154916117|NCT01376908|559114152|FG000|Overall Study|Protocol Violation|1|||
154916118|NCT01376908|559114153|FG001|Overall Study|Protocol Violation|1|||
154916119|NCT01376908|559114152|FG000|Overall Study|Withdrawal by Subject|1|||
154916120|NCT01376908|559114153|FG001|Overall Study|Withdrawal by Subject|2|||
154916121|NCT00742391|559114156|FG000|Overall Study|Adverse Event|2|||
154916122|NCT00742391|559114157|FG001|Overall Study|Adverse Event|1|||
154916123|NCT00742391|559114156|FG000|Overall Study|Lost to Follow-up|1|||
154916124|NCT00742391|559114157|FG001|Overall Study|Lost to Follow-up|0|||
154916125|NCT00742391|559114156|FG000|Overall Study|Protocol Violation|1|||
154916126|NCT00742391|559114157|FG001|Overall Study|Protocol Violation|0|||
154916127|NCT01241318|559114160|FG000|Overall Study|Woman: false pregnancies|27|||
154916128|NCT01241318|559114161|FG001|Overall Study|Woman: false pregnancies|15|||
154916129|NCT01241318|559114160|FG000|Overall Study|Woman: miscarriage/abortion|46|||
154916130|NCT01241318|559114161|FG001|Overall Study|Woman: miscarriage/abortion|38|||
154916131|NCT01241318|559114160|FG000|Overall Study|Withdrawal by Subject|175|||
154987297|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
154987298|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
154987299|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
154987300|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Death|0|||
154987301|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Death|2|||
154987302|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Death|0|||
154987303|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
154987304|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
154987305|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
154987306|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
154987307|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
154987308|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
154987309|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
154987310|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
154987311|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
154987312|NCT01144364|559379289|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
154987313|NCT01144364|559379290|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
154987314|NCT01144364|559379291|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
154987315|NCT03828448|559379292|FG000|Overall Study|Sponsor's Discretion|34|||
154987316|NCT02037165|559379293|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
154987317|NCT02037165|559379294|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
154987318|NCT02037165|559379295|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
154987319|NCT02037165|559379296|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
154987320|NCT02037165|559379297|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
154987321|NCT02192164|559379301|FG000|Overall Study|Other|8|||
154987322|NCT02192164|559379301|FG000|Overall Study|Withdrawal by Subject|1|||
154916132|NCT01241318|559114161|FG001|Overall Study|Withdrawal by Subject|46|||
154916133|NCT01241318|559114160|FG000|Overall Study|Lost to Follow-up|740|||
154987323|NCT02192164|559379301|FG000|Overall Study|Physician Decision|4|||
154916134|NCT01241318|559114161|FG001|Overall Study|Lost to Follow-up|455|||
154916135|NCT01241318|559114160|FG000|Overall Study|Death|2|||
154916136|NCT01241318|559114161|FG001|Overall Study|Death|4|||
154987324|NCT02192164|559379301|FG000|Overall Study|Did not meet the exclusion criteria|1|||
154916137|NCT01241318|559114160|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
154916138|NCT01241318|559114161|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
154916139|NCT01241318|559114160|FG000|Overall Study|Woman: Stillborn infant|129|||
154916140|NCT01241318|559114161|FG001|Overall Study|Woman: Stillborn infant|146|||
154987325|NCT00609466|559379311|FG000|Overall Study|Withdrawal by Subject|0|||
154987326|NCT00609466|559379312|FG001|Overall Study|Withdrawal by Subject|1|||
154987327|NCT00609466|559379313|FG002|Overall Study|Withdrawal by Subject|1|||
154987328|NCT00609466|559379311|FG000|Overall Study|Adverse Event|2|||
154987329|NCT00609466|559379312|FG001|Overall Study|Adverse Event|3|||
154987330|NCT00609466|559379313|FG002|Overall Study|Adverse Event|1|||
154987331|NCT00609466|559379311|FG000|Overall Study|Lack of Efficacy|0|||
154987332|NCT00609466|559379312|FG001|Overall Study|Lack of Efficacy|2|||
154987333|NCT00609466|559379313|FG002|Overall Study|Lack of Efficacy|2|||
154987334|NCT03512262|559379314|FG000|Overall Study|Adverse Event|8|||
154987335|NCT03512262|559379315|FG001|Overall Study|Adverse Event|3|||
154987336|NCT03512262|559379314|FG000|Overall Study|Death (non-treatment emergent)|1|||
154987337|NCT03512262|559379315|FG001|Overall Study|Death (non-treatment emergent)|0|||
154987338|NCT03512262|559379314|FG000|Overall Study|Withdrawal by Subject|17|||
154987339|NCT03512262|559379315|FG001|Overall Study|Withdrawal by Subject|9|||
154987340|NCT03512262|559379314|FG000|Overall Study|Lost to Follow-up|7|||
155119477|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
155119478|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
155119479|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
155119480|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
155119481|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155119482|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155119483|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155119484|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155119485|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
155119486|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
155119487|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
155119488|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
155119489|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119490|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
155119491|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119492|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119493|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119494|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119495|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119496|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
155119497|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119498|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119499|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
155119500|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
155119501|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119502|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119503|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119504|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119505|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
155119506|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155119507|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155119508|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119509|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155119510|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155119511|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119512|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119513|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119514|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119515|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119516|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155176580|NCT01227629|560084032|FG009|Overall Study|Protocol Violation|0|||
154987341|NCT03512262|559379315|FG001|Overall Study|Lost to Follow-up|1|||
154987342|NCT03512262|559379314|FG000|Overall Study|Other than Specified|2|||
154987343|NCT03512262|559379315|FG001|Overall Study|Other than Specified|2|||
154987344|NCT01299805|559379316|FG000|Overall Study|Adverse Event|2|||
154987345|NCT01299805|559379317|FG001|Overall Study|Adverse Event|0|||
154987346|NCT04032158|559380462|FG000|Overall Study|Study Termination|2|||
154987347|NCT04032158|559380463|FG001|Overall Study|Study Termination|1|||
154987348|NCT00059787|559380464|FG000|Overall Study|Adverse Event|13|||
154987349|NCT00059787|559380464|FG000|Overall Study|disease progression|2|||
154987350|NCT00059787|559380464|FG000|Overall Study|ineligible|1|||
154987351|NCT00059787|559380464|FG000|Overall Study|Other|4|||
154987352|NCT01859130|559380465|FG000|Overall Study|Death|4|||
154987353|NCT01859130|559380465|FG000|Overall Study|Lost to Follow-up|16|||
154987354|NCT01859130|559380465|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
154987355|NCT01859130|559380465|FG000|Overall Study|Physician Decision|6|||
154987356|NCT01859130|559380465|FG000|Overall Study|Withdrawal by Subject|17|||
154987357|NCT01859130|559380465|FG000|Overall Study|Adverse Event|11|||
154987358|NCT04325204|559380466|FG000|Overall Study|Death|0|||
154987359|NCT04325204|559380467|FG001|Overall Study|Death|1|||
154987360|NCT04325204|559380466|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
154987361|NCT04325204|559380467|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
154987362|NCT04325204|559380466|FG000|Overall Study|Lost to Follow-up|8|||
154987363|NCT04325204|559380467|FG001|Overall Study|Lost to Follow-up|8|||
154987364|NCT04325204|559380466|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
154987365|NCT04325204|559380467|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
154987366|NCT04710979|559380471|FG000|Overall Study|Lost to Follow-up|2|||
154987367|NCT04710979|559380472|FG001|Overall Study|Lost to Follow-up|4|||
154987368|NCT04710979|559380471|FG000|Overall Study|Withdrawal by Subject|1|||
154987369|NCT04710979|559380472|FG001|Overall Study|Withdrawal by Subject|0|||
154987370|NCT00103311|559380478|FG000|Overall Study|Lost to Follow-up|1|||
154987371|NCT00103311|559380479|FG001|Overall Study|Lost to Follow-up|0|||
154987372|NCT00103311|559380478|FG000|Overall Study|Withdrawal by Subject|2|||
154987373|NCT00103311|559380479|FG001|Overall Study|Withdrawal by Subject|1|||
154987374|NCT00103311|559380478|FG000|Overall Study|Adverse Event|1|||
154987375|NCT00103311|559380479|FG001|Overall Study|Adverse Event|0|||
155119517|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119518|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
155119519|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119520|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
154916141|NCT02355665|559114162|FG000|Overall Study|Adverse Event|16|||
154916142|NCT02355665|559114163|FG001|Overall Study|Adverse Event|24|||
154916143|NCT02355665|559114162|FG000|Overall Study|Protocol Violation|2|||
154916144|NCT02355665|559114163|FG001|Overall Study|Protocol Violation|0|||
154916145|NCT02355665|559114162|FG000|Overall Study|Withdrawal by Subject|90|||
154916146|NCT02355665|559114163|FG001|Overall Study|Withdrawal by Subject|100|||
154916147|NCT02355665|559114162|FG000|Overall Study|Lost to Follow-up|131|||
154916148|NCT02355665|559114163|FG001|Overall Study|Lost to Follow-up|103|||
154916149|NCT02355665|559114162|FG000|Overall Study|Death|4|||
155119521|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119522|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119523|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119524|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119525|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119526|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
154916150|NCT02355665|559114163|FG001|Overall Study|Death|2|||
154916151|NCT02355665|559114162|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
154916152|NCT02355665|559114163|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
154916153|NCT02380703|559114164|FG000|Overall Study|Withdrawal by Subject|12|||
154916154|NCT02380703|559114165|FG001|Overall Study|Withdrawal by Subject|9|||
154916155|NCT02380703|559114164|FG000|Overall Study|Lost to Follow-up|12|||
154916156|NCT02380703|559114165|FG001|Overall Study|Lost to Follow-up|12|||
154916157|NCT02380703|559114164|FG000|Overall Study|Caregiver death|1|||
154916158|NCT02380703|559114165|FG001|Overall Study|Caregiver death|0|||
154916159|NCT02380703|559114164|FG000|Overall Study|Person with dementia (PWD) death|7|||
154916160|NCT02380703|559114165|FG001|Overall Study|Person with dementia (PWD) death|8|||
154916161|NCT02380703|559114164|FG000|Overall Study|Entered Long-term Care|4|||
154916162|NCT02380703|559114165|FG001|Overall Study|Entered Long-term Care|7|||
154987376|NCT00912093|559380480|FG000|The Controlled Phase|Death|0|||
154987377|NCT00912093|559380481|FG001|The Controlled Phase|Death|1|||
154987378|NCT00912093|559380482|FG002|The Controlled Phase|Death|0|||
154987379|NCT00912093|559380483|FG003|The Controlled Phase|Death|0|||
154987380|NCT00912093|559380484|FG004|The Controlled Phase|Death|0|||
154987381|NCT00912093|559380480|FG000|The Controlled Phase|Medical Condition|0|||
154916163|NCT03607994|559114166|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
154916164|NCT03607994|559114167|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
154916165|NCT01882439|559114176|FG000|Overall Study|Adverse event related to study drug|3|||
154916166|NCT01882439|559114177|FG001|Overall Study|Adverse event related to study drug|8|||
154916167|NCT01882439|559114178|FG002|Overall Study|Adverse event related to study drug|1|||
154916168|NCT01882439|559114179|FG003|Overall Study|Adverse event related to study drug|2|||
154916169|NCT01882439|559114176|FG000|Overall Study|Pregnancy|0|||
154916170|NCT01882439|559114177|FG001|Overall Study|Pregnancy|1|||
154916171|NCT01882439|559114178|FG002|Overall Study|Pregnancy|0|||
154916172|NCT01882439|559114179|FG003|Overall Study|Pregnancy|0|||
154916173|NCT01882439|559114176|FG000|Overall Study|Protocol Violation|2|||
154916174|NCT01882439|559114177|FG001|Overall Study|Protocol Violation|2|||
154916175|NCT01882439|559114178|FG002|Overall Study|Protocol Violation|0|||
154916176|NCT01882439|559114179|FG003|Overall Study|Protocol Violation|1|||
154916177|NCT01882439|559114176|FG000|Overall Study|No longer willing to participate|1|||
154916178|NCT01882439|559114177|FG001|Overall Study|No longer willing to participate|4|||
154916179|NCT01882439|559114178|FG002|Overall Study|No longer willing to participate|2|||
154916180|NCT01882439|559114179|FG003|Overall Study|No longer willing to participate|3|||
154916181|NCT01882439|559114176|FG000|Overall Study|Medication error with no associated AE|0|||
154916182|NCT01882439|559114177|FG001|Overall Study|Medication error with no associated AE|0|||
154916183|NCT01882439|559114178|FG002|Overall Study|Medication error with no associated AE|2|||
154916184|NCT01882439|559114179|FG003|Overall Study|Medication error with no associated AE|0|||
154916185|NCT01882439|559114176|FG000|Overall Study|Insufficient clinical response|1|||
154916186|NCT01882439|559114177|FG001|Overall Study|Insufficient clinical response|4|||
154916187|NCT01882439|559114178|FG002|Overall Study|Insufficient clinical response|4|||
154916188|NCT01882439|559114179|FG003|Overall Study|Insufficient clinical response|2|||
154916189|NCT01882439|559114176|FG000|Overall Study|Adverse event unrelated to study drug|2|||
154916190|NCT01882439|559114177|FG001|Overall Study|Adverse event unrelated to study drug|2|||
154916191|NCT01882439|559114178|FG002|Overall Study|Adverse event unrelated to study drug|1|||
154916192|NCT01882439|559114179|FG003|Overall Study|Adverse event unrelated to study drug|1|||
154916193|NCT01775995|559114180|FG000|Overall Study|Lost to Follow-up|1|||
154916194|NCT01775995|559114181|FG001|Overall Study|Lost to Follow-up|1|||
154916195|NCT01997333|559114182|FG000|Randomization and Treatment|Disease Progression|70|||
154916196|NCT01997333|559114183|FG001|Randomization and Treatment|Disease Progression|159|||
154916197|NCT01997333|559114182|FG000|Randomization and Treatment|Adverse Event|10|||
154916198|NCT01997333|559114183|FG001|Randomization and Treatment|Adverse Event|32|||
154916199|NCT01997333|559114182|FG000|Randomization and Treatment|Physician Decision|0|||
154916200|NCT01997333|559114183|FG001|Randomization and Treatment|Physician Decision|4|||
154916201|NCT01997333|559114182|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
154916202|NCT01997333|559114183|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
154916203|NCT01997333|559114182|FG000|Randomization and Treatment|Did not receive treatment|17|||
154916204|NCT01997333|559114183|FG001|Randomization and Treatment|Did not receive treatment|5|||
154916205|NCT01997333|559114182|FG000|Survival Follow up|Withdrawal by Subject|15|||
154916206|NCT01997333|559114183|FG001|Survival Follow up|Withdrawal by Subject|6|||
154916207|NCT01997333|559114182|FG000|Survival Follow up|Lost to Follow-up|0|||
154916208|NCT01997333|559114183|FG001|Survival Follow up|Lost to Follow-up|6|||
154916209|NCT01997333|559114182|FG000|Survival Follow up|Various|1|||
154916210|NCT01997333|559114183|FG001|Survival Follow up|Various|2|||
154916211|NCT02198040|559116436|FG000|Overall Study|Work reasons|0|||
154916212|NCT02198040|559116437|FG001|Overall Study|Work reasons|1|||
154916213|NCT02198040|559116438|FG002|Overall Study|Work reasons|0|||
154916214|NCT02198040|559116436|FG000|Overall Study|Withdrawal by Subject|0|||
154916215|NCT02198040|559116437|FG001|Overall Study|Withdrawal by Subject|0|||
154916216|NCT02198040|559116438|FG002|Overall Study|Withdrawal by Subject|1|||
154916217|NCT03359811|559116439|FG000|Overall Study|Protocol Violation|2|||
154916218|NCT03359811|559116440|FG001|Overall Study|Protocol Violation|0|||
154916219|NCT01189201|559116447|FG000|Overall Study|Adverse Event|1|||
154916220|NCT01682876|559116448|FG000|Overall Study|Administrative reason|4|||
154916221|NCT01682876|559116449|FG001|Overall Study|Administrative reason|4|||
154916222|NCT01682876|559116450|FG002|Overall Study|Administrative reason|0|||
154916223|NCT01682876|559116451|FG003|Overall Study|Administrative reason|3|||
154916224|NCT01682876|559116448|FG000|Overall Study|Adverse Event|0|||
154916225|NCT01682876|559116449|FG001|Overall Study|Adverse Event|0|||
154916226|NCT01682876|559116450|FG002|Overall Study|Adverse Event|0|||
154916227|NCT01682876|559116451|FG003|Overall Study|Adverse Event|1|||
154916228|NCT01682876|559116448|FG000|Overall Study|Lost to Follow-up|11|||
154916229|NCT01682876|559116449|FG001|Overall Study|Lost to Follow-up|15|||
154916230|NCT01682876|559116450|FG002|Overall Study|Lost to Follow-up|9|||
154916231|NCT01682876|559116451|FG003|Overall Study|Lost to Follow-up|11|||
154916232|NCT01682876|559116448|FG000|Overall Study|Protocol Violation|1|||
154916233|NCT01682876|559116449|FG001|Overall Study|Protocol Violation|1|||
154916234|NCT01682876|559116450|FG002|Overall Study|Protocol Violation|1|||
154916235|NCT01682876|559116451|FG003|Overall Study|Protocol Violation|1|||
154916236|NCT01682876|559116448|FG000|Overall Study|Withdrawal by Subject|4|||
154987382|NCT00912093|559380481|FG001|The Controlled Phase|Medical Condition|1|||
154987383|NCT00912093|559380482|FG002|The Controlled Phase|Medical Condition|0|||
154987384|NCT00912093|559380483|FG003|The Controlled Phase|Medical Condition|0|||
154987385|NCT00912093|559380484|FG004|The Controlled Phase|Medical Condition|0|||
154987386|NCT00912093|559380480|FG000|The Controlled Phase|Lost to Follow-up|0|||
154987387|NCT00912093|559380481|FG001|The Controlled Phase|Lost to Follow-up|0|||
154987388|NCT00912093|559380482|FG002|The Controlled Phase|Lost to Follow-up|0|||
154987389|NCT00912093|559380483|FG003|The Controlled Phase|Lost to Follow-up|0|||
154987390|NCT00912093|559380484|FG004|The Controlled Phase|Lost to Follow-up|1|||
154987391|NCT03827564|559380489|FG000|Overall Study|Discontinued due to Study Termination|1|||
154987392|NCT03827564|559380490|FG001|Overall Study|Discontinued due to Study Termination|0|||
154987393|NCT02621034|559380494|FG000|Overall Study|Lost to Follow-up|3|||
154987394|NCT02621034|559380495|FG001|Overall Study|Lost to Follow-up|2|||
154987395|NCT02621034|559380496|FG002|Overall Study|Lost to Follow-up|5|||
154987396|NCT02372071|559380500|FG000|Overall Study|Protocol Violation|18|||
154987397|NCT01968694|559380501|FG000|Washout (1 Month)|Lost to Follow-up|0|||
154987398|NCT01968694|559380502|FG001|Washout (1 Month)|Lost to Follow-up|1|||
154987399|NCT02836496|559380503|FG000|Overall Study|Adverse Event|2|||
154987400|NCT02836496|559380504|FG001|Overall Study|Adverse Event|1|||
154987401|NCT02836496|559380503|FG000|Overall Study|Withdrawal by Subject|0|||
154987402|NCT02836496|559380504|FG001|Overall Study|Withdrawal by Subject|1|||
154987403|NCT01400919|559380505|FG000|Overall Study|Withdrawal by Subject|4|||
154987404|NCT01400919|559380505|FG000|Overall Study|Lost to Follow-up|2|||
154987405|NCT01400919|559380505|FG000|Overall Study|Missed visit|2|||
154987406|NCT03347422|559380506|FG000|Part A (26 Weeks)|Adverse Event|3|||
154987407|NCT03347422|559380507|FG001|Part A (26 Weeks)|Adverse Event|0|||
154987408|NCT03347422|559380506|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
154987409|NCT03347422|559380507|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
154987410|NCT03347422|559380506|FG000|Part B (149 Weeks)|Adverse Event|0|||
154987411|NCT03347422|559380507|FG001|Part B (149 Weeks)|Adverse Event|1|||
154987412|NCT03347422|559380506|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
154916237|NCT01682876|559116449|FG001|Overall Study|Withdrawal by Subject|0|||
154916238|NCT01682876|559116450|FG002|Overall Study|Withdrawal by Subject|0|||
154916239|NCT01682876|559116451|FG003|Overall Study|Withdrawal by Subject|2|||
154916240|NCT01682876|559116448|FG000|Overall Study|Other|1|||
154916241|NCT01682876|559116449|FG001|Overall Study|Other|0|||
154916242|NCT01682876|559116450|FG002|Overall Study|Other|1|||
154916243|NCT01682876|559116451|FG003|Overall Study|Other|1|||
154916244|NCT00911508|559116455|FG000|Overall Study|Lost to Follow-up|27|||
154916245|NCT00911508|559116456|FG001|Overall Study|Lost to Follow-up|18|||
154916246|NCT00911508|559116455|FG000|Overall Study|Withdrawal by Subject|79|||
154916247|NCT00911508|559116456|FG001|Overall Study|Withdrawal by Subject|112|||
154916248|NCT00240331|559116459|FG000|Overall Study|Withdrawal by Subject|125|||
154916249|NCT00240331|559116460|FG001|Overall Study|Withdrawal by Subject|132|||
154916250|NCT00240331|559116459|FG000|Overall Study|Option selected by investigator|1|||
154916251|NCT00240331|559116460|FG001|Overall Study|Option selected by investigator|2|||
154916252|NCT01409382|559116461|FG000|Overall Study|Lost to Follow-up|1|||
154916253|NCT01409382|559116462|FG001|Overall Study|Lost to Follow-up|1|||
154916254|NCT01409382|559116461|FG000|Overall Study|Protocol Violation|0|||
154916255|NCT01409382|559116462|FG001|Overall Study|Protocol Violation|3|||
154916256|NCT01409382|559116461|FG000|Overall Study|Multiple pregnancy|2|||
154916257|NCT01409382|559116462|FG001|Overall Study|Multiple pregnancy|4|||
154916258|NCT01409382|559116461|FG000|Overall Study|Still pregnant when study ended|13|||
154916259|NCT01409382|559116462|FG001|Overall Study|Still pregnant when study ended|2|||
154916260|NCT01409382|559116461|FG000|Overall Study|Did not manage to get pregnant|64|||
154916261|NCT01409382|559116462|FG001|Overall Study|Did not manage to get pregnant|70|||
154916262|NCT01409382|559116461|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
154916263|NCT01409382|559116462|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
154987413|NCT03347422|559380507|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
154987414|NCT03347422|559380506|FG000|Part B (149 Weeks)|Other|1|||
154987415|NCT03347422|559380507|FG001|Part B (149 Weeks)|Other|0|||
154987416|NCT01246011|559380509|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
154987417|NCT01246011|559380510|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
154987418|NCT01246011|559380511|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
155119527|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
155119528|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
155176581|NCT01227629|560084023|FG000|Overall Study|Lost to Follow-up|0|||
154916264|NCT01233076|559116463|FG000|Period 2, One Week|Lost to Follow-up|1|||
154916265|NCT01233076|559116464|FG001|Period 2, One Week|Lost to Follow-up|0|||
154916266|NCT04308668|559116465|FG000|Overall Study|Lost to Follow-up|32|||
154916267|NCT04308668|559116466|FG001|Overall Study|Lost to Follow-up|38|||
154916268|NCT04308668|559116465|FG000|Overall Study|Withdrawal by Subject|4|||
154916269|NCT04308668|559116466|FG001|Overall Study|Withdrawal by Subject|4|||
154987419|NCT01246011|559380509|FG000|Overall Study|Withdrawal by Subject|0|||
154987420|NCT01246011|559380510|FG001|Overall Study|Withdrawal by Subject|0|||
154987421|NCT01246011|559380511|FG002|Overall Study|Withdrawal by Subject|1|||
154916270|NCT01266967|559116467|FG000|Overall Study|Death|69|||
154916271|NCT01266967|559116468|FG001|Overall Study|Death|61|||
154916272|NCT01266967|559116467|FG000|Overall Study|Study Closed/Terminated|15|||
154916273|NCT01266967|559116468|FG001|Overall Study|Study Closed/Terminated|17|||
154916274|NCT01266967|559116467|FG000|Overall Study|Lost to Follow-up|2|||
154916275|NCT01266967|559116468|FG001|Overall Study|Lost to Follow-up|1|||
154916276|NCT01266967|559116467|FG000|Overall Study|Physician Decision|0|||
154916277|NCT01266967|559116468|FG001|Overall Study|Physician Decision|1|||
154916278|NCT01266967|559116467|FG000|Overall Study|Withdrawal by Subject|3|||
154916279|NCT01266967|559116468|FG001|Overall Study|Withdrawal by Subject|3|||
154916280|NCT04563845|559116469|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916281|NCT04563845|559116470|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916282|NCT04563845|559116471|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916283|NCT04563845|559116472|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916284|NCT04563845|559116473|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916285|NCT04563845|559116474|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916286|NCT04563845|559116475|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916287|NCT04563845|559116476|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
154916288|NCT04563845|559116477|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916289|NCT04563845|559116478|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916290|NCT04563845|559116479|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916291|NCT04563845|559116480|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916292|NCT04563845|559116481|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916293|NCT04563845|559116482|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
154916294|NCT04563845|559116469|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916295|NCT04563845|559116470|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916296|NCT04563845|559116471|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916297|NCT04563845|559116472|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916298|NCT04563845|559116473|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
154916299|NCT04563845|559116474|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916300|NCT04563845|559116475|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916301|NCT04563845|559116476|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916302|NCT04563845|559116477|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916303|NCT04563845|559116478|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916304|NCT04563845|559116479|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916305|NCT04563845|559116480|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916306|NCT04563845|559116481|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916307|NCT04563845|559116482|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
154916308|NCT01020812|559116483|FG000|Overall Study|Physician Decision|1|||
154916309|NCT01020812|559116483|FG000|Overall Study|Withdrawal by Subject|1|||
154916310|NCT01020812|559116483|FG000|Overall Study|Protocol Violation|1|||
154916311|NCT00883896|559116497|FG000|Overall Study|Lost to Follow-up|0|||
154916312|NCT00883896|559116498|FG001|Overall Study|Lost to Follow-up|0|||
154916313|NCT00883896|559116499|FG002|Overall Study|Lost to Follow-up|0|||
154916314|NCT00883896|559116500|FG003|Overall Study|Lost to Follow-up|2|||
154916315|NCT00883896|559116497|FG000|Overall Study|Withdrawal by Subject|5|||
154916316|NCT00883896|559116498|FG001|Overall Study|Withdrawal by Subject|0|||
154916317|NCT00883896|559116499|FG002|Overall Study|Withdrawal by Subject|1|||
154916318|NCT00883896|559116500|FG003|Overall Study|Withdrawal by Subject|3|||
154916319|NCT00883896|559116497|FG000|Overall Study|Lack of Efficacy|0|||
154916320|NCT00883896|559116498|FG001|Overall Study|Lack of Efficacy|0|||
154916321|NCT00883896|559116499|FG002|Overall Study|Lack of Efficacy|0|||
154916322|NCT00883896|559116500|FG003|Overall Study|Lack of Efficacy|2|||
154916323|NCT00883896|559116497|FG000|Overall Study|Other|1|||
154916324|NCT00883896|559116498|FG001|Overall Study|Other|0|||
154916325|NCT00883896|559116499|FG002|Overall Study|Other|0|||
154916326|NCT00883896|559116500|FG003|Overall Study|Other|0|||
154916327|NCT02546193|559116501|FG000|Overall Study|Withdrawal by Subject|2|||
154916328|NCT02546193|559116502|FG001|Overall Study|Withdrawal by Subject|0|||
154916329|NCT02546193|559116503|FG002|Overall Study|Withdrawal by Subject|1|||
154916330|NCT02546193|559116504|FG003|Overall Study|Withdrawal by Subject|0|||
154916331|NCT02546193|559116501|FG000|Overall Study|Not eligible at time of induction|4|||
154916332|NCT02546193|559116502|FG001|Overall Study|Not eligible at time of induction|6|||
154916333|NCT02546193|559116503|FG002|Overall Study|Not eligible at time of induction|1|||
154916334|NCT02546193|559116504|FG003|Overall Study|Not eligible at time of induction|0|||
154916335|NCT03339999|559116514|FG000|Overall Study|Adverse Event|1|||
154916336|NCT03339999|559116515|FG001|Overall Study|Adverse Event|2|||
154916337|NCT03339999|559116516|FG002|Overall Study|Adverse Event|2|||
154916338|NCT03339999|559116517|FG003|Overall Study|Adverse Event|1|||
154916339|NCT03339999|559116514|FG000|Overall Study|Lack of Efficacy|0|||
154916340|NCT03339999|559116515|FG001|Overall Study|Lack of Efficacy|1|||
154916341|NCT03339999|559116516|FG002|Overall Study|Lack of Efficacy|0|||
154916342|NCT03339999|559116517|FG003|Overall Study|Lack of Efficacy|0|||
154916343|NCT03339999|559116514|FG000|Overall Study|Lost to Follow-up|0|||
154916344|NCT03339999|559116515|FG001|Overall Study|Lost to Follow-up|0|||
154916345|NCT03339999|559116516|FG002|Overall Study|Lost to Follow-up|0|||
154916346|NCT03339999|559116517|FG003|Overall Study|Lost to Follow-up|1|||
154916347|NCT03339999|559116514|FG000|Overall Study|Study Terminated by Sponsor|6|||
154916348|NCT03339999|559116515|FG001|Overall Study|Study Terminated by Sponsor|3|||
154916349|NCT03339999|559116516|FG002|Overall Study|Study Terminated by Sponsor|4|||
154916350|NCT03339999|559116517|FG003|Overall Study|Study Terminated by Sponsor|3|||
154916351|NCT03380091|559116519|FG000|Overall Study|Withdrawal by Subject|2|||
154916352|NCT03380091|559116520|FG001|Overall Study|Withdrawal by Subject|1|||
154916353|NCT03802331|559116521|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
154916354|NCT03802331|559116522|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
154916355|NCT00368069|559116524|FG000|Overall Study|Adverse Event|5|||
154916356|NCT00368069|559116525|FG001|Overall Study|Adverse Event|2|||
154916357|NCT00368069|559116524|FG000|Overall Study|Lack of Efficacy|0|||
154916358|NCT00368069|559116525|FG001|Overall Study|Lack of Efficacy|1|||
154916359|NCT00368069|559116524|FG000|Overall Study|Lost to Follow-up|1|||
154916360|NCT00368069|559116525|FG001|Overall Study|Lost to Follow-up|0|||
154916361|NCT00368069|559116524|FG000|Overall Study|Protocol Violation|0|||
154916362|NCT00368069|559116525|FG001|Overall Study|Protocol Violation|2|||
154916363|NCT00368069|559116524|FG000|Overall Study|Withdrawal of Consent|2|||
154916364|NCT00368069|559116525|FG001|Overall Study|Withdrawal of Consent|1|||
154916365|NCT00368069|559116524|FG000|Overall Study|no blood sampling possible|0|||
154916366|NCT00368069|559116525|FG001|Overall Study|no blood sampling possible|1|||
154916367|NCT03432819|559116526|FG000|Overall Study|Lost to Follow-up|2|||
154916368|NCT03432819|559116527|FG001|Overall Study|Lost to Follow-up|2|||
154916369|NCT03432819|559116526|FG000|Overall Study|Withdrawal by Subject|5|||
154987422|NCT03914950|559380520|FG000|Overall Study|Physician Decision|54|||
154987423|NCT02575911|559380529|FG000|Overall Study|Lost to Follow-up|1|||
154987424|NCT01249365|559380530|FG000|Overall Study|Lost to Follow-up|1|||
154987425|NCT03579966|559380531|FG000|Overall Study|Adverse Event|6|||
154987426|NCT03579966|559380531|FG000|Overall Study|Lost to Follow-up|4|||
154987427|NCT03579966|559380531|FG000|Overall Study|Physician Decision|10|||
154987428|NCT03579966|559380531|FG000|Overall Study|Pregnancy|1|||
154987429|NCT03579966|559380531|FG000|Overall Study|Withdrawal by Subject|16|||
154987430|NCT03579966|559380531|FG000|Overall Study|Study terminated by Sponsor|22|||
154987431|NCT03579966|559380531|FG000|Overall Study|Protocol Violation|1|||
154987432|NCT02408068|559380534|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
154987433|NCT02408068|559380535|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
154987434|NCT02408068|559380536|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
154987435|NCT02408068|559380537|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
154987436|NCT02408068|559380538|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
154987437|NCT02408068|559380539|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
154987438|NCT01340768|559380540|FG000|Overall Study|Lost to Follow-up|10|||
154987439|NCT01340768|559380541|FG001|Overall Study|Lost to Follow-up|4|||
154987440|NCT01340768|559380540|FG000|Overall Study|Withdrawal by Subject|5|||
154987441|NCT01340768|559380541|FG001|Overall Study|Withdrawal by Subject|1|||
154987442|NCT01340768|559380540|FG000|Overall Study|Other|2|||
154987443|NCT01340768|559380541|FG001|Overall Study|Other|0|||
154987444|NCT03052959|559380544|FG000|Overall Study|Lost to Follow-up|4|||
154987445|NCT03052959|559380545|FG001|Overall Study|Lost to Follow-up|5|||
154987446|NCT01524679|559380546|FG000|Overall Study|Lost to Follow-up|1|||
154987447|NCT01524679|559380547|FG001|Overall Study|Lost to Follow-up|4|||
154987448|NCT01524679|559380546|FG000|Overall Study|Withdrawal by Subject|4|||
154987449|NCT01524679|559380547|FG001|Overall Study|Withdrawal by Subject|4|||
154987450|NCT01524679|559380546|FG000|Overall Study|Adverse Event|9|||
154987451|NCT01524679|559380547|FG001|Overall Study|Adverse Event|0|||
154987452|NCT01524679|559380546|FG000|Overall Study|Protocol Violation|1|||
154987453|NCT01524679|559380547|FG001|Overall Study|Protocol Violation|0|||
154987454|NCT01524679|559380546|FG000|Overall Study|Lack of Efficacy|2|||
154987455|NCT01524679|559380547|FG001|Overall Study|Lack of Efficacy|0|||
154916370|NCT03432819|559116527|FG001|Overall Study|Withdrawal by Subject|3|||
154916371|NCT00760994|559116528|FG000|Overall Study|Lost to Follow-up|4|||
154916372|NCT00760994|559116529|FG001|Overall Study|Lost to Follow-up|4|||
154916373|NCT00760994|559116530|FG002|Overall Study|Lost to Follow-up|3|||
154987456|NCT01524679|559380546|FG000|Overall Study|e.g.wish for children, relocation|6|||
154916374|NCT02500706|559116533|FG000|Overall Study|Adverse Event|0|||
154987457|NCT01524679|559380547|FG001|Overall Study|e.g.wish for children, relocation|1|||
154987458|NCT03321630|559380550|FG000|Overall Study|Adverse Event|1|||
154987459|NCT03321630|559380550|FG000|Overall Study|Investigator Discretion|2|||
154916375|NCT02500706|559116534|FG001|Overall Study|Adverse Event|0|||
154916376|NCT02500706|559116535|FG002|Overall Study|Adverse Event|1|||
154916377|NCT02500706|559116533|FG000|Overall Study|Lost to Follow-up|0|||
154916378|NCT02500706|559116534|FG001|Overall Study|Lost to Follow-up|1|||
154987460|NCT03321630|559380550|FG000|Overall Study|Withdrawal by Subject|1|||
154987461|NCT02149108|559380551|FG000|Overall Study|Not treated|1|||
154987462|NCT02149108|559380552|FG001|Overall Study|Not treated|2|||
154987463|NCT02149108|559380551|FG000|Overall Study|Progressive Disease (PD)|324|||
154987464|NCT02149108|559380552|FG001|Overall Study|Progressive Disease (PD)|318|||
154987465|NCT02149108|559380551|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
154987466|NCT02149108|559380552|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
154987467|NCT02149108|559380551|FG000|Overall Study|Other Adverse Event (AE)|8|||
154987468|NCT02149108|559380552|FG001|Overall Study|Other Adverse Event (AE)|18|||
154987469|NCT02149108|559380551|FG000|Overall Study|Other not defined above|0|||
154987470|NCT02149108|559380552|FG001|Overall Study|Other not defined above|2|||
154987471|NCT02149108|559380551|FG000|Overall Study|Refusal to continue trial medication|15|||
154987472|NCT02149108|559380552|FG001|Overall Study|Refusal to continue trial medication|11|||
154987473|NCT02149108|559380551|FG000|Overall Study|Lost to Follow-up|1|||
154987474|NCT02149108|559380552|FG001|Overall Study|Lost to Follow-up|0|||
154987475|NCT02325518|559380553|FG000|Overall Study|Adverse Event|4|||
154987476|NCT02325518|559380554|FG001|Overall Study|Adverse Event|1|||
154987477|NCT02325518|559380553|FG000|Overall Study|Physician Decision|0|||
154987478|NCT02325518|559380554|FG001|Overall Study|Physician Decision|1|||
154987479|NCT02325518|559380553|FG000|Overall Study|Withdrawal by Subject|0|||
154987480|NCT02325518|559380554|FG001|Overall Study|Withdrawal by Subject|1|||
154987481|NCT00987389|559380555|FG000|Overall Study|Ineligible|0|||
154987482|NCT00987389|559380556|FG001|Overall Study|Ineligible|3|||
154987483|NCT00987389|559380557|FG002|Overall Study|Ineligible|0|||
154987484|NCT00987389|559380558|FG003|Overall Study|Ineligible|0|||
154987485|NCT00987389|559380555|FG000|Overall Study|Lost to Follow-up|4|||
154987486|NCT00987389|559380556|FG001|Overall Study|Lost to Follow-up|1|||
154987487|NCT00987389|559380557|FG002|Overall Study|Lost to Follow-up|3|||
154987488|NCT00987389|559380558|FG003|Overall Study|Lost to Follow-up|1|||
154987489|NCT00987389|559380555|FG000|Overall Study|Withdrawal by Subject|4|||
154987490|NCT00987389|559380556|FG001|Overall Study|Withdrawal by Subject|3|||
154987491|NCT00987389|559380557|FG002|Overall Study|Withdrawal by Subject|2|||
154987492|NCT00987389|559380558|FG003|Overall Study|Withdrawal by Subject|1|||
154987493|NCT00987389|559380555|FG000|Overall Study|Withdrawn from Treatment|0|||
154987494|NCT00987389|559380556|FG001|Overall Study|Withdrawn from Treatment|1|||
154987495|NCT00987389|559380557|FG002|Overall Study|Withdrawn from Treatment|0|||
154987496|NCT00987389|559380558|FG003|Overall Study|Withdrawn from Treatment|0|||
154987497|NCT00987389|559380555|FG000|Overall Study|Multiple different reasons|1|||
154987498|NCT00987389|559380556|FG001|Overall Study|Multiple different reasons|0|||
154987499|NCT00987389|559380557|FG002|Overall Study|Multiple different reasons|3|||
154987500|NCT00987389|559380558|FG003|Overall Study|Multiple different reasons|1|||
154987501|NCT00289536|559380561|FG000|Period 3|Lost to Follow-up|0|||
154987502|NCT00289536|559380562|FG001|Period 3|Lost to Follow-up|0|||
154987503|NCT00289536|559380563|FG002|Period 3|Lost to Follow-up|1|||
154987504|NCT03246126|559380568|FG000|Overall Study|Withdrawal by Subject|0|||
154987505|NCT03246126|559380569|FG001|Overall Study|Withdrawal by Subject|1|||
154987506|NCT04465630|559380572|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
154987507|NCT04465630|559380572|FG000|Overall Study|Screen failure|8|||
154987508|NCT04465630|559380572|FG000|Overall Study|Baseline failure|16|||
154987509|NCT05297578|559380576|FG000|Overall Study|Lost to Follow-up|1|||
154987510|NCT05297578|559380577|FG001|Overall Study|Lost to Follow-up|1|||
154987511|NCT05297578|559380578|FG002|Overall Study|Lost to Follow-up|2|||
154987512|NCT05297578|559380579|FG003|Overall Study|Lost to Follow-up|1|||
154987513|NCT05297578|559380576|FG000|Overall Study|Death|0|||
154987514|NCT05297578|559380577|FG001|Overall Study|Death|1|||
154987515|NCT05297578|559380578|FG002|Overall Study|Death|0|||
154987516|NCT05297578|559380579|FG003|Overall Study|Death|0|||
155119529|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
155119530|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
155119531|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155119532|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155119533|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155119534|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
155119535|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
154987517|NCT05297578|559380576|FG000|Overall Study|Withdrawal by Subject|0|||
154987518|NCT05297578|559380577|FG001|Overall Study|Withdrawal by Subject|0|||
155119536|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119537|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119538|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119539|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
154987519|NCT05297578|559380578|FG002|Overall Study|Withdrawal by Subject|1|||
154987520|NCT05297578|559380579|FG003|Overall Study|Withdrawal by Subject|0|||
154987521|NCT01169532|559380583|FG000|Overall Study|Withdrawal by Subject|1|||
154987522|NCT01156142|559380584|FG000|Overall Study|Withdrawal by Subject|8|||
154987523|NCT01156142|559380585|FG001|Overall Study|Withdrawal by Subject|6|||
154987524|NCT01156142|559380584|FG000|Overall Study|Ineligible|0|||
154987525|NCT01156142|559380585|FG001|Overall Study|Ineligible|1|||
154987526|NCT01437943|559380586|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
154987527|NCT01437943|559380587|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
154987528|NCT01437943|559380586|FG000|Overall Study|Subject expressed pregnancy plans|1|||
154987529|NCT01437943|559380587|FG001|Overall Study|Subject expressed pregnancy plans|0|||
154987530|NCT01437943|559380586|FG000|Overall Study|Adverse Event|2|||
154987531|NCT01437943|559380587|FG001|Overall Study|Adverse Event|0|||
154987532|NCT00985712|559380589|FG000|Overall Study|Adverse Event|0|||
154987533|NCT00985712|559380590|FG001|Overall Study|Adverse Event|1|||
154987534|NCT00985712|559380589|FG000|Overall Study|Lost to Follow-up|2|||
154987535|NCT00985712|559380590|FG001|Overall Study|Lost to Follow-up|2|||
154987536|NCT00985712|559380589|FG000|Overall Study|Protocol Violation|0|||
154987537|NCT00985712|559380590|FG001|Overall Study|Protocol Violation|1|||
154987538|NCT00985712|559380589|FG000|Overall Study|Withdrawal by Subject|4|||
154987539|NCT00985712|559380590|FG001|Overall Study|Withdrawal by Subject|1|||
154987540|NCT00985712|559380589|FG000|Overall Study|Sponsor decision|0|||
154987541|NCT00985712|559380590|FG001|Overall Study|Sponsor decision|2|||
154987542|NCT01875471|559380591|FG000|Overall Study|Adverse Event|0|||
154987543|NCT01875471|559380592|FG001|Overall Study|Adverse Event|1|||
154987544|NCT01875471|559380591|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
154987545|NCT01875471|559380592|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
154987546|NCT00257920|559380593|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
154987547|NCT00257920|559380594|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
154987548|NCT00257920|559380593|FG000|Period: Second Intervention|Other|2|||
154987549|NCT00257920|559380594|FG001|Period: Second Intervention|Other|1|||
154987550|NCT01346774|559380597|FG000|Overall Study|Did not take a single dose|6|||
154987551|NCT01346774|559380598|FG001|Overall Study|Did not take a single dose|4|||
154987552|NCT01346774|559380597|FG000|Overall Study|Lost to Follow-up|3|||
154987553|NCT01346774|559380598|FG001|Overall Study|Lost to Follow-up|4|||
154987554|NCT01346774|559380597|FG000|Overall Study|Withdrawal by Subject|1|||
154987555|NCT01346774|559380598|FG001|Overall Study|Withdrawal by Subject|4|||
154987556|NCT01346774|559380597|FG000|Overall Study|Protocol Violation|2|||
154987557|NCT01346774|559380598|FG001|Overall Study|Protocol Violation|3|||
154987558|NCT01346774|559380597|FG000|Overall Study|Adverse Event|1|||
154987559|NCT01346774|559380598|FG001|Overall Study|Adverse Event|2|||
154987560|NCT00448136|559380601|FG000|Overall Study|Death|3|||
154987561|NCT00448136|559380602|FG001|Overall Study|Death|8|||
154987562|NCT00448136|559380601|FG000|Overall Study|Investigator's decision (progression)|1|||
154987563|NCT00448136|559380602|FG001|Overall Study|Investigator's decision (progression)|0|||
154987564|NCT00922987|559380605|FG000|Overall Study|Insufficient clinical response|1|||
154987565|NCT00922987|559380605|FG000|Overall Study|Protocol Violation|2|||
154987566|NCT00922987|559380605|FG000|Overall Study|Adverse Event|1|||
154987567|NCT01334710|559380606|FG000|Overall Study|Trial was terminated|3|||
154987568|NCT02935686|559382687|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
154987569|NCT02935686|559382688|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
154987570|NCT02935686|559382689|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
154987571|NCT02935686|559382690|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
154987572|NCT02935686|559382691|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
154987573|NCT02935686|559382687|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
154987574|NCT02935686|559382688|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
154987575|NCT02935686|559382689|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
154987576|NCT02935686|559382690|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
154987577|NCT02935686|559382691|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
154987578|NCT02935686|559382687|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
154987579|NCT02935686|559382688|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
154987580|NCT02935686|559382689|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
154987581|NCT02935686|559382690|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
154987582|NCT02935686|559382691|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
155119540|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
155119541|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119542|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119543|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119544|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
154987583|NCT02935686|559382687|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
154987584|NCT02935686|559382688|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
154987585|NCT02935686|559382689|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
155119545|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
154987586|NCT02935686|559382690|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
154987587|NCT02935686|559382691|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
155119546|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
154987588|NCT02935686|559382687|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
154987589|NCT02935686|559382688|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
154987590|NCT02935686|559382689|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
154987591|NCT02935686|559382690|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
155176582|NCT01227629|560084024|FG001|Overall Study|Lost to Follow-up|0|||
155176583|NCT01227629|560084025|FG002|Overall Study|Lost to Follow-up|0|||
155176584|NCT01227629|560084026|FG003|Overall Study|Lost to Follow-up|0|||
155176585|NCT01227629|560084027|FG004|Overall Study|Lost to Follow-up|1|||
155176586|NCT01227629|560084028|FG005|Overall Study|Lost to Follow-up|0|||
155176587|NCT01227629|560084029|FG006|Overall Study|Lost to Follow-up|0|||
155176588|NCT01227629|560084030|FG007|Overall Study|Lost to Follow-up|0|||
155176589|NCT01227629|560084031|FG008|Overall Study|Lost to Follow-up|0|||
155176590|NCT01227629|560084032|FG009|Overall Study|Lost to Follow-up|0|||
155176591|NCT01227629|560084023|FG000|Overall Study|Withdrawal by Subject|0|||
155176592|NCT01227629|560084024|FG001|Overall Study|Withdrawal by Subject|0|||
155176593|NCT01227629|560084025|FG002|Overall Study|Withdrawal by Subject|0|||
155176594|NCT01227629|560084026|FG003|Overall Study|Withdrawal by Subject|0|||
155176595|NCT01227629|560084027|FG004|Overall Study|Withdrawal by Subject|0|||
155176596|NCT01227629|560084028|FG005|Overall Study|Withdrawal by Subject|0|||
155176597|NCT01227629|560084029|FG006|Overall Study|Withdrawal by Subject|2|||
155176598|NCT01227629|560084030|FG007|Overall Study|Withdrawal by Subject|0|||
155176599|NCT01227629|560084031|FG008|Overall Study|Withdrawal by Subject|0|||
155176600|NCT01227629|560084032|FG009|Overall Study|Withdrawal by Subject|1|||
155176601|NCT01227629|560084023|FG000|Overall Study|Other|0|||
155176602|NCT01227629|560084024|FG001|Overall Study|Other|0|||
155176603|NCT01227629|560084025|FG002|Overall Study|Other|0|||
155176604|NCT01227629|560084026|FG003|Overall Study|Other|1|||
155176605|NCT01227629|560084027|FG004|Overall Study|Other|0|||
155176606|NCT01227629|560084028|FG005|Overall Study|Other|0|||
155176607|NCT01227629|560084029|FG006|Overall Study|Other|0|||
155176608|NCT01227629|560084030|FG007|Overall Study|Other|0|||
155176609|NCT01227629|560084031|FG008|Overall Study|Other|2|||
155176610|NCT01227629|560084032|FG009|Overall Study|Other|1|||
155176611|NCT02055365|560086358|FG000|Overall Study|Prematurely Withdrawn|1|||
155176612|NCT01258998|560086361|FG000|Overall Study|Ineligible|1|||
155176613|NCT03224598|560086362|FG000|Overall Study|Lost to Follow-up|0|||
155176614|NCT03224598|560086363|FG001|Overall Study|Lost to Follow-up|2|||
155176615|NCT03224598|560086364|FG002|Overall Study|Lost to Follow-up|0|||
155176616|NCT03224598|560086362|FG000|Overall Study|Other|0|||
155176617|NCT03224598|560086363|FG001|Overall Study|Other|1|||
155176618|NCT03224598|560086364|FG002|Overall Study|Other|0|||
155176619|NCT01264081|560086374|FG000|Participants Screened|Screening failures|30|||
155176620|NCT01264081|560086374|FG000|Started Treatment|Withdrawal by Subject|1|||
155176621|NCT01264081|560086374|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
155176622|NCT02716896|560086375|FG000|Overall Study|Physician Decision|0|||
155176623|NCT02716896|560086376|FG001|Overall Study|Physician Decision|1|||
155176624|NCT02054481|560086382|FG000|Overall Study|Adverse Event|1|||
155176625|NCT02054481|560086383|FG001|Overall Study|Adverse Event|1|||
155176626|NCT02054481|560086384|FG002|Overall Study|Adverse Event|0|||
155176627|NCT02054481|560086385|FG003|Overall Study|Adverse Event|1|||
155176628|NCT02054481|560086382|FG000|Overall Study|Lost to Follow-up|1|||
155176629|NCT02054481|560086383|FG001|Overall Study|Lost to Follow-up|0|||
155176630|NCT02054481|560086384|FG002|Overall Study|Lost to Follow-up|0|||
154987592|NCT02935686|559382691|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
154987593|NCT02935686|559382687|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
154987594|NCT02935686|559382688|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
154987595|NCT02935686|559382689|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
154987596|NCT02935686|559382690|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
154987597|NCT02935686|559382691|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
154987598|NCT02935686|559382687|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
154987599|NCT02935686|559382688|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
154987600|NCT02935686|559382689|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
154987601|NCT02935686|559382690|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
154987602|NCT02935686|559382691|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
154987603|NCT02935686|559382687|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
154987604|NCT02935686|559382688|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
154987605|NCT02935686|559382689|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
154987606|NCT02935686|559382690|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
154987607|NCT02935686|559382691|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
154987608|NCT02935686|559382687|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
154987609|NCT02935686|559382688|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
154987610|NCT02935686|559382689|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
154987611|NCT02935686|559382690|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
154987612|NCT02935686|559382691|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
155176631|NCT02054481|560086385|FG003|Overall Study|Lost to Follow-up|0|||
155176632|NCT02054481|560086382|FG000|Overall Study|Other reason|2|||
155176633|NCT02054481|560086383|FG001|Overall Study|Other reason|1|||
155176634|NCT02054481|560086384|FG002|Overall Study|Other reason|2|||
155176635|NCT02054481|560086385|FG003|Overall Study|Other reason|0|||
155176636|NCT02320903|560086386|FG000|Overall Study|Withdrawal by Subject|0|||
155119547|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119548|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155119549|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155119550|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155119551|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119552|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119553|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119554|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119555|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119556|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
155119557|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119558|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119559|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119560|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
155119561|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119562|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119563|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119564|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119565|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
155119566|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119567|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
154987613|NCT02935686|559382687|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
154987614|NCT02935686|559382688|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
154987615|NCT02935686|559382689|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
154987616|NCT02935686|559382690|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
154987617|NCT02935686|559382691|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
154987618|NCT02935686|559382687|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
154987619|NCT02935686|559382688|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
154987620|NCT02935686|559382689|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
154987621|NCT02935686|559382690|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
154987622|NCT02935686|559382691|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
154987623|NCT01183221|559382692|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
154987624|NCT01183221|559382693|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
154987625|NCT00678041|559382703|FG000|Overall Study|Physician Decision|5|||
154987626|NCT00678041|559382704|FG001|Overall Study|Physician Decision|5|||
154987627|NCT02358343|559382705|FG000|Screening Intervention|Death|0|||
154987628|NCT02358343|559382706|FG001|Screening Intervention|Death|2|||
154987629|NCT02358343|559382707|FG002|Screening Intervention|Death|0|||
154987630|NCT02358343|559382708|FG003|Screening Intervention|Death|0|||
154987631|NCT02358343|559382709|FG004|Screening Intervention|Death|0|||
154987632|NCT02358343|559382705|FG000|Screening Intervention|Withdrawal by Subject|1|||
154987633|NCT02358343|559382706|FG001|Screening Intervention|Withdrawal by Subject|0|||
154987634|NCT02358343|559382707|FG002|Screening Intervention|Withdrawal by Subject|0|||
154987635|NCT02358343|559382708|FG003|Screening Intervention|Withdrawal by Subject|0|||
154987636|NCT02358343|559382709|FG004|Screening Intervention|Withdrawal by Subject|0|||
154987637|NCT02358343|559382705|FG000|Screening Intervention|Determined Ineligible|5|||
154987638|NCT02358343|559382706|FG001|Screening Intervention|Determined Ineligible|6|||
154987639|NCT02358343|559382707|FG002|Screening Intervention|Determined Ineligible|0|||
154987640|NCT02358343|559382708|FG003|Screening Intervention|Determined Ineligible|0|||
154987641|NCT02358343|559382709|FG004|Screening Intervention|Determined Ineligible|0|||
154987642|NCT02358343|559382705|FG000|Comparative Efficacy Trial / Observation|Death|0|||
154987643|NCT02358343|559382706|FG001|Comparative Efficacy Trial / Observation|Death|0|||
154987644|NCT02358343|559382707|FG002|Comparative Efficacy Trial / Observation|Death|2|||
154987645|NCT02358343|559382708|FG003|Comparative Efficacy Trial / Observation|Death|0|||
154987646|NCT02358343|559382709|FG004|Comparative Efficacy Trial / Observation|Death|0|||
154987647|NCT02358343|559382705|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
154987648|NCT02358343|559382706|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
154987649|NCT02358343|559382707|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
154987650|NCT02358343|559382708|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
154987651|NCT02358343|559382709|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
154987652|NCT02358343|559382705|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
154987653|NCT02358343|559382706|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
154987654|NCT02358343|559382707|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
154987655|NCT02358343|559382708|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
154987656|NCT02358343|559382709|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
154987657|NCT00577395|559382710|FG000|Overall Study|Study was terminated early by Sponsor|7|||
154987658|NCT00577395|559382711|FG001|Overall Study|Study was terminated early by Sponsor|6|||
154987659|NCT01700049|559382718|FG000|Overall Study|Withdrawal by Subject|1|||
154987660|NCT03084367|559382721|FG000|Overall Study|Lost to Follow-up|32|||
154987661|NCT03084367|559382721|FG000|Overall Study|Withdrawal by Subject|4|||
154987662|NCT03084367|559382721|FG000|Overall Study|Other|1|||
154987663|NCT01206101|559382722|FG000|Overall Study|Adverse Event|1|||
154987664|NCT01206101|559382723|FG001|Overall Study|Adverse Event|0|||
154987665|NCT01206101|559382722|FG000|Overall Study|Physician Decision|0|||
154987666|NCT01206101|559382723|FG001|Overall Study|Physician Decision|1|||
154987667|NCT01206101|559382722|FG000|Overall Study|Unclassified|1|||
154987668|NCT01206101|559382723|FG001|Overall Study|Unclassified|0|||
154987669|NCT00450619|559382734|FG000|Overall Study|refused treatment after randomization|2|||
154987670|NCT00450619|559382735|FG001|Overall Study|refused treatment after randomization|0|||
154987671|NCT00450619|559382734|FG000|Overall Study|did not progress; refused further trmt|1|||
154987672|NCT00450619|559382735|FG001|Overall Study|did not progress; refused further trmt|1|||
154987673|NCT00450619|559382734|FG000|Overall Study|Adverse Event|1|||
154987674|NCT00450619|559382735|FG001|Overall Study|Adverse Event|0|||
154987675|NCT03254602|559382736|FG000|Overall Study|Lost to Follow-up|4|||
154987676|NCT02963311|559382739|FG000|Overall Study|Withdrawal by Subject|1|||
154987677|NCT02963311|559382739|FG000|Overall Study|Screen Failure|4|||
154987678|NCT01691820|559382740|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
154987679|NCT01691820|559382741|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
154987680|NCT01691820|559382740|FG000|Overall Study|Migrated/moved from study area|7|||
154987681|NCT01691820|559382741|FG001|Overall Study|Migrated/moved from study area|4|||
154987682|NCT01691820|559382740|FG000|Overall Study|Lost to Follow-up|6|||
154987683|NCT01691820|559382741|FG001|Overall Study|Lost to Follow-up|17|||
154987684|NCT01691820|559382740|FG000|Overall Study|Other (unspecified)|4|||
154987685|NCT01691820|559382741|FG001|Overall Study|Other (unspecified)|1|||
154987686|NCT04442490|559382743|FG000|Overall Study|Withdrawal by Subject|18|||
154987687|NCT04442490|559382744|FG001|Overall Study|Withdrawal by Subject|10|||
154987688|NCT04442490|559382743|FG000|Overall Study|Lost to Follow-up|7|||
154987689|NCT04442490|559382744|FG001|Overall Study|Lost to Follow-up|7|||
154987690|NCT04442490|559382743|FG000|Overall Study|Adverse Event|2|||
154987691|NCT04442490|559382744|FG001|Overall Study|Adverse Event|6|||
154987692|NCT04442490|559382743|FG000|Overall Study|Noncompliance|3|||
154987693|NCT04442490|559382744|FG001|Overall Study|Noncompliance|1|||
154987694|NCT04442490|559382743|FG000|Overall Study|Physician Decision|2|||
154987695|NCT04442490|559382744|FG001|Overall Study|Physician Decision|1|||
154987696|NCT04442490|559382743|FG000|Overall Study|Reason not Specified|2|||
154987697|NCT04442490|559382744|FG001|Overall Study|Reason not Specified|1|||
154987698|NCT04442490|559382743|FG000|Overall Study|Randomized but not Treated|3|||
154987699|NCT04442490|559382744|FG001|Overall Study|Randomized but not Treated|3|||
154987700|NCT02038907|559382750|FG000|Overall Study|Protocol Violation|0|||
154987701|NCT02038907|559382751|FG001|Overall Study|Protocol Violation|0|||
154987702|NCT02038907|559382752|FG002|Overall Study|Protocol Violation|0|||
154987703|NCT02038907|559382753|FG003|Overall Study|Protocol Violation|0|||
154987704|NCT02038907|559382754|FG004|Overall Study|Protocol Violation|0|||
154987705|NCT02038907|559382755|FG005|Overall Study|Protocol Violation|0|||
154987706|NCT02038907|559382756|FG006|Overall Study|Protocol Violation|0|||
154987707|NCT02038907|559382757|FG007|Overall Study|Protocol Violation|0|||
154987708|NCT02038907|559382758|FG008|Overall Study|Protocol Violation|0|||
154987709|NCT02038907|559382759|FG009|Overall Study|Protocol Violation|0|||
154987710|NCT02038907|559382760|FG010|Overall Study|Protocol Violation|1|||
154987711|NCT02038907|559382761|FG011|Overall Study|Protocol Violation|0|||
154987712|NCT02038907|559382762|FG012|Overall Study|Protocol Violation|0|||
155119568|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119569|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119570|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
154987713|NCT02038907|559382763|FG013|Overall Study|Protocol Violation|0|||
154987714|NCT02038907|559382750|FG000|Overall Study|Withdrawal by Subject|0|||
154987715|NCT02038907|559382751|FG001|Overall Study|Withdrawal by Subject|0|||
154987716|NCT02038907|559382752|FG002|Overall Study|Withdrawal by Subject|0|||
154987717|NCT02038907|559382753|FG003|Overall Study|Withdrawal by Subject|0|||
154987718|NCT02038907|559382754|FG004|Overall Study|Withdrawal by Subject|0|||
154987719|NCT02038907|559382755|FG005|Overall Study|Withdrawal by Subject|0|||
154987720|NCT02038907|559382756|FG006|Overall Study|Withdrawal by Subject|0|||
154987721|NCT02038907|559382757|FG007|Overall Study|Withdrawal by Subject|0|||
154987722|NCT02038907|559382758|FG008|Overall Study|Withdrawal by Subject|0|||
154987723|NCT02038907|559382759|FG009|Overall Study|Withdrawal by Subject|0|||
154987724|NCT02038907|559382760|FG010|Overall Study|Withdrawal by Subject|1|||
155119571|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119572|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119573|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119574|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119575|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119576|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119577|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
155119578|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119579|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119580|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
155119581|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119582|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119583|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119584|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119585|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
155119586|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
155119587|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119588|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119589|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119590|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
155119591|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119592|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119593|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119594|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119595|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
155119596|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
155119597|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119598|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
155119599|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119600|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
155119601|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119602|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119603|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119604|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119605|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
155119606|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Other|5|||
155119607|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Other|1|||
155119608|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Other|0|||
155119609|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Other|3|||
155119610|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Other|0|||
155119611|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Other|0|||
155119612|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Other|0|||
155119613|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Other|0|||
155119614|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Other|0|||
155119615|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Other|0|||
155119616|NCT03352557|559868485|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119617|NCT03352557|559868486|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119618|NCT03352557|559868487|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119619|NCT03352557|559868488|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119620|NCT03352557|559868489|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
155119621|NCT03352557|559868490|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119622|NCT03352557|559868491|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119623|NCT03352557|559868492|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
154987725|NCT02038907|559382761|FG011|Overall Study|Withdrawal by Subject|0|||
154987726|NCT02038907|559382762|FG012|Overall Study|Withdrawal by Subject|0|||
154987727|NCT02038907|559382763|FG013|Overall Study|Withdrawal by Subject|0|||
154987728|NCT02618408|559382764|FG000|Overall Study|Withdrawal by Subject|1|||
154987729|NCT02618408|559382765|FG001|Overall Study|Withdrawal by Subject|0|||
154987730|NCT02618408|559382766|FG002|Overall Study|Withdrawal by Subject|4|||
154987731|NCT02618408|559382764|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
154987732|NCT02618408|559382765|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
154987733|NCT02618408|559382766|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
154987734|NCT02618408|559382764|FG000|Overall Study|Lost to Follow-up|4|||
154987735|NCT02618408|559382765|FG001|Overall Study|Lost to Follow-up|2|||
154987736|NCT02618408|559382766|FG002|Overall Study|Lost to Follow-up|6|||
155119624|NCT03352557|559868493|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
155119625|NCT03352557|559868494|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
154987737|NCT02618408|559382764|FG000|Overall Study|Adverse Event|4|||
155119626|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Death|0|||
154987738|NCT02618408|559382765|FG001|Overall Study|Adverse Event|0|||
154987739|NCT02618408|559382766|FG002|Overall Study|Adverse Event|10|||
154987740|NCT02618408|559382764|FG000|Overall Study|Physician Decision|1|||
155119627|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Death|0|||
155119628|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Death|0|||
155119629|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Death|0|||
155119630|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Death|0|||
155119631|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Death|1|||
155119632|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Death|0|||
155119633|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Death|1|||
155119634|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Death|1|||
155119635|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Death|1|||
155119636|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119637|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119638|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119639|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119640|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119641|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
155119642|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119643|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119644|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119645|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
155119646|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119647|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119648|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119649|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119650|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119651|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119652|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119653|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119654|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
155119655|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
155119656|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155119657|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155119658|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155119659|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155119660|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
155119661|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
155119662|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
155119663|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
155119664|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
155119665|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
155119666|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119667|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119668|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119669|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119670|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119671|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
155119672|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
155119673|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
155119674|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
155119675|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
155119676|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119677|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119678|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119679|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119680|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119681|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155150943|NCT00770653|559988132|FG001|Overall Study|Withdrawal by Subject|7|||
155150944|NCT00770653|559988131|FG000|Overall Study|Lack of Compliance|1|||
154987741|NCT02618408|559382765|FG001|Overall Study|Physician Decision|1|||
154987742|NCT02618408|559382766|FG002|Overall Study|Physician Decision|2|||
155119682|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119683|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155119684|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
155119685|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
155119686|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155119687|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
154987743|NCT02618408|559382764|FG000|Overall Study|Protocol Violation|1|||
154987744|NCT02618408|559382765|FG001|Overall Study|Protocol Violation|1|||
154987745|NCT02618408|559382766|FG002|Overall Study|Protocol Violation|2|||
154987746|NCT02618408|559382764|FG000|Overall Study|Other, Multiple Categories|0|||
154987747|NCT02618408|559382765|FG001|Overall Study|Other, Multiple Categories|0|||
154987748|NCT02618408|559382766|FG002|Overall Study|Other, Multiple Categories|4|||
154987749|NCT01155024|559382767|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
154987750|NCT01155024|559382768|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
154987751|NCT01155024|559382767|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
154987752|NCT01155024|559382768|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
154987753|NCT01155024|559382767|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
154987754|NCT01155024|559382768|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
154987755|NCT00801099|559382769|FG000|Overall Study|Lost to Follow-up|101|||
154987756|NCT04078126|559382770|FG000|Washout|Study put on hold due to COVID-19|0|||
154987757|NCT04078126|559382771|FG001|Washout|Study put on hold due to COVID-19|2|||
154987758|NCT04078126|559382770|FG000|Period 2|Study put on hold due to COVID-19|1|||
154987759|NCT04078126|559382771|FG001|Period 2|Study put on hold due to COVID-19|1|||
154987760|NCT02981303|559382772|FG000|Overall Study|Progressive Disease|17|||
154987761|NCT02981303|559382773|FG001|Overall Study|Progressive Disease|37|||
154987762|NCT02981303|559382772|FG000|Overall Study|Adverse Event|1|||
154987763|NCT02981303|559382773|FG001|Overall Study|Adverse Event|4|||
154987764|NCT02981303|559382772|FG000|Overall Study|Withdrawal by Subject|0|||
154987765|NCT02981303|559382773|FG001|Overall Study|Withdrawal by Subject|1|||
154987766|NCT00706511|559382776|FG000|Overall Study|Withdrawal by Subject|1|||
154987767|NCT00706511|559382777|FG001|Overall Study|Withdrawal by Subject|0|||
154987768|NCT00706511|559382778|FG002|Overall Study|Withdrawal by Subject|0|||
154987769|NCT00706511|559382779|FG003|Overall Study|Withdrawal by Subject|0|||
154987770|NCT02272634|559382786|FG000|Overall Study|Adverse Event|1|||
154987771|NCT02272634|559382787|FG001|Overall Study|Adverse Event|0|||
154987772|NCT02272634|559382788|FG002|Overall Study|Adverse Event|0|||
154987773|NCT02272634|559382786|FG000|Overall Study|Protocol Violation|0|||
154987774|NCT02272634|559382787|FG001|Overall Study|Protocol Violation|0|||
154987775|NCT02272634|559382788|FG002|Overall Study|Protocol Violation|1|||
154987776|NCT02272634|559382786|FG000|Overall Study|Withdrawal by Subject|0|||
154987777|NCT02272634|559382787|FG001|Overall Study|Withdrawal by Subject|1|||
154987778|NCT02272634|559382788|FG002|Overall Study|Withdrawal by Subject|0|||
154987779|NCT04620135|559382790|FG000|Study Completion|Adverse Event|2|||
154987780|NCT04620135|559382791|FG001|Study Completion|Adverse Event|3|||
154987781|NCT04620135|559382790|FG000|Study Completion|Withdrawal by Subject|2|||
154987782|NCT04620135|559382791|FG001|Study Completion|Withdrawal by Subject|0|||
154987783|NCT04647721|559382792|FG000|Overall Study|Withdrawal by Subject|0|||
154987784|NCT04647721|559382793|FG001|Overall Study|Withdrawal by Subject|2|||
154987785|NCT04647721|559382792|FG000|Overall Study|Lost to Follow-up|2|||
154987786|NCT04647721|559382793|FG001|Overall Study|Lost to Follow-up|0|||
154987787|NCT02643355|559382794|FG000|Overall Study|Withdrawal by Subject|1|||
154987788|NCT02643355|559382795|FG001|Overall Study|Withdrawal by Subject|3|||
154987789|NCT02643355|559382794|FG000|Overall Study|Protocol Violation|0|||
154987790|NCT02643355|559382795|FG001|Overall Study|Protocol Violation|2|||
154987791|NCT01974440|559382798|FG000|Overall Study|Lost to Follow-up|7|||
154987792|NCT01974440|559382799|FG001|Overall Study|Lost to Follow-up|7|||
154987793|NCT01974440|559382798|FG000|Overall Study|Withdrawal by Subject|24|||
154987794|NCT01974440|559382799|FG001|Overall Study|Withdrawal by Subject|20|||
154987795|NCT01974440|559382798|FG000|Overall Study|Sponsor decision|109|||
154987796|NCT01974440|559382799|FG001|Overall Study|Sponsor decision|110|||
154987797|NCT00762437|559382800|FG000|Overall Study|Lost to Follow-up|7|||
154987798|NCT00762437|559382800|FG000|Overall Study|Missed final study visit|11|||
154987799|NCT00762437|559382800|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
154987800|NCT04771403|559382804|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
154987801|NCT04771403|559382805|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
154987802|NCT04771403|559382804|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
154987803|NCT04771403|559382805|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
154987804|NCT04771403|559382804|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
155119688|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155119689|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155119690|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155119691|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
155119692|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
155119693|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
155119694|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
155119695|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
155119696|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119697|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119698|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119699|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119700|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119701|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119702|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119703|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
155119704|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
155119705|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
155119706|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119707|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119708|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119709|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119710|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119711|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119712|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119713|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
155119714|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119715|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
155119716|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119717|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119718|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119719|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119720|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119721|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119722|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119723|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
155119724|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119725|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
155119726|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119727|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119728|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119729|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119730|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119731|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119732|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119733|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
155119734|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
155119735|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
155119736|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119737|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119738|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119739|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155176637|NCT02320903|560086387|FG001|Overall Study|Withdrawal by Subject|9|||
155176638|NCT02320903|560086388|FG002|Overall Study|Withdrawal by Subject|9|||
155176639|NCT02320903|560086386|FG000|Overall Study|Exited therapy; no longer eligible|8|||
155176640|NCT02320903|560086387|FG001|Overall Study|Exited therapy; no longer eligible|2|||
155176641|NCT02320903|560086388|FG002|Overall Study|Exited therapy; no longer eligible|2|||
155176642|NCT02320903|560086386|FG000|Overall Study|Lost to Follow-up|0|||
155176643|NCT02320903|560086387|FG001|Overall Study|Lost to Follow-up|5|||
154987805|NCT04771403|559382805|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
154987806|NCT04771403|559382804|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
154987807|NCT04771403|559382805|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
154987808|NCT04771403|559382804|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
154987809|NCT04771403|559382805|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
154987810|NCT04771403|559382804|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
154987811|NCT04771403|559382805|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
154987812|NCT04771403|559382804|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
154987813|NCT04771403|559382805|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
154987814|NCT04771403|559382804|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
154987815|NCT04771403|559382805|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
154987816|NCT00857259|559382806|FG000|Overall Study|Protocol Violation|1|||
154987817|NCT00857259|559382807|FG001|Overall Study|Protocol Violation|0|||
154987818|NCT00857259|559382808|FG002|Overall Study|Protocol Violation|1|||
154987819|NCT02701413|559382809|FG000|Overall Study|Withdrawal by Subject|7|||
154987820|NCT02701413|559382810|FG001|Overall Study|Withdrawal by Subject|11|||
154987821|NCT01660334|559382815|FG000|Overall Study|Lost to Follow-up|1|||
154987822|NCT00988065|559382816|FG000|Overall Study|Adverse Event|4|||
154987823|NCT00988065|559382817|FG001|Overall Study|Adverse Event|10|||
154987824|NCT00988065|559382818|FG002|Overall Study|Adverse Event|2|||
154987825|NCT00988065|559382816|FG000|Overall Study|Lost to Follow-up|1|||
154987826|NCT00988065|559382817|FG001|Overall Study|Lost to Follow-up|2|||
154987827|NCT00988065|559382818|FG002|Overall Study|Lost to Follow-up|2|||
154987828|NCT00988065|559382816|FG000|Overall Study|Subject withdrew consent|3|||
154987829|NCT00988065|559382817|FG001|Overall Study|Subject withdrew consent|5|||
154987830|NCT00988065|559382818|FG002|Overall Study|Subject withdrew consent|2|||
154987831|NCT00988065|559382816|FG000|Overall Study|Noncompliance with protocol|5|||
154987832|NCT00988065|559382817|FG001|Overall Study|Noncompliance with protocol|6|||
154987833|NCT00988065|559382818|FG002|Overall Study|Noncompliance with protocol|9|||
154987834|NCT01640873|559382819|FG000|Overall Study|Protocol Violation|2|||
154987835|NCT01640873|559382820|FG001|Overall Study|Protocol Violation|1|||
154987836|NCT02749292|559382821|FG000|Overall Study|Physician Decision|1|||
154987837|NCT02749292|559382822|FG001|Overall Study|Physician Decision|0|||
154987838|NCT02749292|559382821|FG000|Overall Study|Withdrawal by Subject|5|||
154987839|NCT02749292|559382822|FG001|Overall Study|Withdrawal by Subject|7|||
154987840|NCT02749292|559382821|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
154987841|NCT02749292|559382822|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
154987842|NCT02749292|559382821|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
154987843|NCT02749292|559382822|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
154987844|NCT02749292|559382821|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
154987845|NCT02749292|559382822|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
154987846|NCT02749292|559382821|FG000|Overall Study|Adverse Event|4|||
154987847|NCT02749292|559382822|FG001|Overall Study|Adverse Event|1|||
154987848|NCT02749292|559382821|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
154987849|NCT02749292|559382822|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
154987850|NCT02749292|559382821|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
154987851|NCT02749292|559382822|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
154987852|NCT02749292|559382821|FG000|Overall Study|Requiring glucocorticoids|0|||
154987853|NCT02749292|559382822|FG001|Overall Study|Requiring glucocorticoids|3|||
154987854|NCT02749292|559382821|FG000|Overall Study|Cancer|1|||
154987855|NCT02749292|559382822|FG001|Overall Study|Cancer|0|||
154987856|NCT02458092|559382823|FG000|Overall Study|Withdrawal by Subject|1|||
154987857|NCT02458092|559382824|FG001|Overall Study|Withdrawal by Subject|0|||
154987858|NCT00876018|559382825|FG000|Overall Study|Lost to Follow-up|0|||
154987859|NCT00876018|559382826|FG001|Overall Study|Lost to Follow-up|1|||
154987860|NCT00876018|559382827|FG002|Overall Study|Lost to Follow-up|1|||
154987861|NCT00876018|559382825|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
154987862|NCT00876018|559382826|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
154987863|NCT00876018|559382827|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
154987864|NCT00456495|559382837|FG000|Overall Study|Physician Decision|2|||
154987865|NCT01301508|559382838|FG000|Overall Study|Withdrawal by Subject|1|||
154987866|NCT01301508|559382839|FG001|Overall Study|Withdrawal by Subject|2|||
154987867|NCT01301508|559382838|FG000|Overall Study|Lost to Follow-up|0|||
155176644|NCT02320903|560086388|FG002|Overall Study|Lost to Follow-up|5|||
154987868|NCT01301508|559382839|FG001|Overall Study|Lost to Follow-up|1|||
154987869|NCT01300923|559382840|FG000|Overall Study|Physician Decision|0|||
154987870|NCT01300923|559382841|FG001|Overall Study|Physician Decision|2|||
154987871|NCT02707861|559382844|FG000|Overall Study|Went onto commercial drug|30|||
154987872|NCT02707861|559382845|FG001|Overall Study|Went onto commercial drug|23|||
154987873|NCT02707861|559382844|FG000|Overall Study|Adverse Event|2|||
154987874|NCT02707861|559382845|FG001|Overall Study|Adverse Event|3|||
154987875|NCT02707861|559382844|FG000|Overall Study|Death|5|||
154987876|NCT02707861|559382845|FG001|Overall Study|Death|2|||
154987877|NCT02707861|559382844|FG000|Overall Study|Lack of Efficacy|0|||
154987878|NCT02707861|559382845|FG001|Overall Study|Lack of Efficacy|2|||
154987879|NCT02707861|559382844|FG000|Overall Study|Physician Decision|1|||
154987880|NCT02707861|559382845|FG001|Overall Study|Physician Decision|4|||
154987881|NCT02707861|559382844|FG000|Overall Study|Withdrawal by Subject|2|||
154987882|NCT02707861|559382845|FG001|Overall Study|Withdrawal by Subject|1|||
154987883|NCT02707861|559382844|FG000|Overall Study|Lost to Follow-up|1|||
154987884|NCT02707861|559382845|FG001|Overall Study|Lost to Follow-up|3|||
154987885|NCT01940497|559382846|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
154987886|NCT01940497|559382847|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
154987887|NCT01940497|559382846|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
154987888|NCT01940497|559382847|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
154987889|NCT01940497|559382846|FG000|Overall Study|Violation of Entry Criteria|1|||
154987890|NCT01940497|559382847|FG001|Overall Study|Violation of Entry Criteria|1|||
154987891|NCT01940497|559382846|FG000|Overall Study|Refused Treatment|1|||
154987892|NCT01940497|559382847|FG001|Overall Study|Refused Treatment|3|||
154987893|NCT01940497|559382846|FG000|Overall Study|Withdrew Consent|6|||
154987894|NCT01940497|559382847|FG001|Overall Study|Withdrew Consent|2|||
154987895|NCT01940497|559382846|FG000|Overall Study|Administrative/Other|1|||
154987896|NCT01940497|559382847|FG001|Overall Study|Administrative/Other|1|||
154987897|NCT03123861|559382848|FG000|Overall Study|Protocol Violation|1|||
154987898|NCT03123861|559382849|FG001|Overall Study|Protocol Violation|1|||
154987899|NCT03123861|559382848|FG000|Overall Study|Withdrawal by Subject|2|||
154987900|NCT03123861|559382849|FG001|Overall Study|Withdrawal by Subject|2|||
154987901|NCT00369382|559382852|FG000|Overall Study|Death|0|||
154987902|NCT00369382|559382853|FG001|Overall Study|Death|2|||
154987903|NCT00369382|559382852|FG000|Overall Study|Physician Decision|2|||
154987904|NCT00369382|559382853|FG001|Overall Study|Physician Decision|1|||
154987905|NCT00369382|559382852|FG000|Overall Study|Withdrawal by Subject|5|||
154987906|NCT00369382|559382853|FG001|Overall Study|Withdrawal by Subject|0|||
154987907|NCT00369382|559382852|FG000|Overall Study|Randomized, not treated|2|||
154987908|NCT00369382|559382853|FG001|Overall Study|Randomized, not treated|0|||
154987909|NCT00369382|559382852|FG000|Overall Study|Other|1|||
154987910|NCT00369382|559382853|FG001|Overall Study|Other|0|||
154987911|NCT03407430|559382857|FG000|Washout|Protocol Violation|1|||
154987912|NCT03407430|559382858|FG001|Washout|Protocol Violation|0|||
154987913|NCT04221789|559385144|FG000|Overall Study|deviation from protoco|22|||
154987914|NCT04221789|559385145|FG001|Overall Study|deviation from protoco|8|||
154987915|NCT06218823|559385156|FG000|Overall Study|Death|3|||
154987916|NCT06218823|559385157|FG001|Overall Study|Death|0|||
154987917|NCT06218823|559385156|FG000|Overall Study|Lost to Follow-up|0|||
154987918|NCT06218823|559385157|FG001|Overall Study|Lost to Follow-up|2|||
154987919|NCT06077487|559385158|FG000|Overall Study|Withdrawal by Subject|0|||
154987920|NCT06077487|559385159|FG001|Overall Study|Withdrawal by Subject|1|||
154987921|NCT05101486|559385160|FG000|Overall Study|Death|1|||
154987922|NCT05101486|559385161|FG001|Overall Study|Death|0|||
154987923|NCT05101486|559385162|FG002|Overall Study|Death|1|||
154987924|NCT05101486|559385160|FG000|Overall Study|Lost to Follow-up|12|||
154987925|NCT05101486|559385161|FG001|Overall Study|Lost to Follow-up|8|||
154987926|NCT05101486|559385162|FG002|Overall Study|Lost to Follow-up|17|||
154987927|NCT05101486|559385160|FG000|Overall Study|Physician Decision|1|||
154987928|NCT05101486|559385161|FG001|Overall Study|Physician Decision|0|||
154987929|NCT05101486|559385162|FG002|Overall Study|Physician Decision|0|||
154987930|NCT05101486|559385160|FG000|Overall Study|Protocol Violation|0|||
154987931|NCT05101486|559385161|FG001|Overall Study|Protocol Violation|0|||
155119740|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119741|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
154987932|NCT05101486|559385162|FG002|Overall Study|Protocol Violation|1|||
154987933|NCT05101486|559385160|FG000|Overall Study|Withdrawal by Subject|5|||
154987934|NCT05101486|559385161|FG001|Overall Study|Withdrawal by Subject|2|||
154987935|NCT05101486|559385162|FG002|Overall Study|Withdrawal by Subject|4|||
154987936|NCT05101486|559385160|FG000|Overall Study|Randomized but not vaccinated|1|||
154987937|NCT05101486|559385161|FG001|Overall Study|Randomized but not vaccinated|1|||
154987938|NCT05101486|559385162|FG002|Overall Study|Randomized but not vaccinated|1|||
154987939|NCT02788045|559385163|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
154987940|NCT02788045|559385164|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
154987941|NCT02788045|559385165|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
154987942|NCT02788045|559385163|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
154987943|NCT02788045|559385164|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
155119742|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119743|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119744|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
155119745|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
155119746|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119747|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119748|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155176645|NCT03811093|560086403|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
155176646|NCT03811093|560086404|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
155176647|NCT03811093|560086403|FG000|Overall Study|Unable to measure body fat percentage|2|||
154916379|NCT02500706|559116535|FG002|Overall Study|Lost to Follow-up|1|||
154916380|NCT02500706|559116533|FG000|Overall Study|Withdrawal by Subject|4|||
154916381|NCT02500706|559116534|FG001|Overall Study|Withdrawal by Subject|6|||
154916382|NCT02500706|559116535|FG002|Overall Study|Withdrawal by Subject|4|||
154916383|NCT02500706|559116533|FG000|Overall Study|Unclassified|0|||
154916384|NCT02500706|559116534|FG001|Overall Study|Unclassified|0|||
154916385|NCT02500706|559116535|FG002|Overall Study|Unclassified|1|||
154916386|NCT00529152|559116536|FG000|Overall Study|Adverse Event|2|||
154916387|NCT00529152|559116536|FG000|Overall Study|Withdrawal by Subject|2|||
154916388|NCT00529152|559116536|FG000|Overall Study|Lost to Follow-up|1|||
154916389|NCT01000311|559116544|FG000|Overall Study|Adverse Event|2|||
154916390|NCT01000311|559116545|FG001|Overall Study|Adverse Event|5|||
154916391|NCT01000311|559116544|FG000|Overall Study|Withdrawal by Subject|16|||
154916392|NCT01000311|559116545|FG001|Overall Study|Withdrawal by Subject|24|||
154916393|NCT01000311|559116544|FG000|Overall Study|Lost to Follow-up|15|||
154916394|NCT01000311|559116545|FG001|Overall Study|Lost to Follow-up|24|||
154916395|NCT01000311|559116544|FG000|Overall Study|Protocol Violation|1|||
154916396|NCT01000311|559116545|FG001|Overall Study|Protocol Violation|2|||
154916397|NCT01000311|559116544|FG000|Overall Study|Inappropriate enrollment|2|||
154916398|NCT01000311|559116545|FG001|Overall Study|Inappropriate enrollment|0|||
154916399|NCT01000311|559116544|FG000|Overall Study|Administrative reason|9|||
154916400|NCT01000311|559116545|FG001|Overall Study|Administrative reason|15|||
154916401|NCT04411472|559116549|FG000|Overall Study|Adverse Event|5|||
154916402|NCT04411472|559116550|FG001|Overall Study|Adverse Event|10|||
154916403|NCT04411472|559116551|FG002|Overall Study|Adverse Event|1|||
154916404|NCT04411472|559116552|FG003|Overall Study|Adverse Event|0|||
154916405|NCT04411472|559116553|FG004|Overall Study|Adverse Event|0|||
154916406|NCT04411472|559116554|FG005|Overall Study|Adverse Event|0|||
154916407|NCT04411472|559116549|FG000|Overall Study|Protocol Violation|1|||
154916408|NCT04411472|559116550|FG001|Overall Study|Protocol Violation|0|||
154916409|NCT04411472|559116551|FG002|Overall Study|Protocol Violation|0|||
154916410|NCT04411472|559116552|FG003|Overall Study|Protocol Violation|0|||
154916411|NCT04411472|559116553|FG004|Overall Study|Protocol Violation|0|||
154916412|NCT04411472|559116554|FG005|Overall Study|Protocol Violation|0|||
154916413|NCT04411472|559116549|FG000|Overall Study|Withdrawal by Subject|0|||
154916414|NCT04411472|559116550|FG001|Overall Study|Withdrawal by Subject|1|||
154916415|NCT04411472|559116551|FG002|Overall Study|Withdrawal by Subject|0|||
154916416|NCT04411472|559116552|FG003|Overall Study|Withdrawal by Subject|1|||
154916417|NCT04411472|559116553|FG004|Overall Study|Withdrawal by Subject|0|||
154916418|NCT04411472|559116554|FG005|Overall Study|Withdrawal by Subject|0|||
154916419|NCT04411472|559116549|FG000|Overall Study|Physician Decision|1|||
154916420|NCT04411472|559116550|FG001|Overall Study|Physician Decision|0|||
154916421|NCT04411472|559116551|FG002|Overall Study|Physician Decision|0|||
154916422|NCT04411472|559116552|FG003|Overall Study|Physician Decision|0|||
154916423|NCT04411472|559116553|FG004|Overall Study|Physician Decision|0|||
154916424|NCT04411472|559116554|FG005|Overall Study|Physician Decision|0|||
155119749|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155176648|NCT03811093|560086404|FG001|Overall Study|Unable to measure body fat percentage|0|||
155176649|NCT01095094|560086406|FG000|Overall Study|Withdrawal by Subject|1|||
155176650|NCT01095094|560086406|FG000|Overall Study|Death|1|||
155176651|NCT01095094|560086406|FG000|Overall Study|Physician Decision|1|||
155176652|NCT01475071|560086416|FG000|Overall Study|Physician Decision|1|||
155119750|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119751|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119752|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119753|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119754|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
155119755|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
155119756|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119757|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155176653|NCT01475071|560086416|FG000|Overall Study|Withdrawal by Subject|6|||
155176654|NCT01475071|560086416|FG000|Overall Study|Lost to Follow-up|1|||
154916425|NCT04411472|559116549|FG000|Overall Study|Study terminated by sponsor|17|||
154916426|NCT04411472|559116550|FG001|Overall Study|Study terminated by sponsor|20|||
154916427|NCT04411472|559116551|FG002|Overall Study|Study terminated by sponsor|3|||
155119758|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119759|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119760|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119761|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119762|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119763|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
155119764|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
155119765|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
154916428|NCT04411472|559116552|FG003|Overall Study|Study terminated by sponsor|0|||
154916429|NCT04411472|559116553|FG004|Overall Study|Study terminated by sponsor|0|||
154916430|NCT04411472|559116554|FG005|Overall Study|Study terminated by sponsor|0|||
154916431|NCT05060003|559116555|FG000|Overall Study|ctDNA negative|7|||
154916432|NCT01747655|559116558|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
154916433|NCT01747655|559116559|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
154916434|NCT01747655|559116558|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
154916435|NCT01747655|559116559|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
154916436|NCT01747655|559116558|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
154916437|NCT01747655|559116559|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
154916438|NCT01373294|559116562|FG000|Overall Study|Adverse Event|1|||
154916439|NCT01373294|559116563|FG001|Overall Study|Adverse Event|0|||
154916440|NCT00684073|559116564|FG000|Selection|Selection/non-selection criteria|3|||
154916441|NCT00684073|559116564|FG000|Selection|Death|1|||
154916442|NCT00684073|559116564|FG000|Selection|noncompliance|1|||
154916443|NCT00684073|559116564|FG000|Selection|Lost to Follow-up|1|||
154916444|NCT00684073|559116564|FG000|Selection|request of the sponsor|1|||
154916445|NCT00684073|559116564|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
154916446|NCT01259388|559116566|FG000|Overall Study|Adverse Event|3|||
154916447|NCT01259388|559116567|FG001|Overall Study|Adverse Event|0|||
154916448|NCT01259388|559116566|FG000|Overall Study|Withdrawal by Subject|1|||
154916449|NCT01259388|559116567|FG001|Overall Study|Withdrawal by Subject|1|||
154916450|NCT01259388|559116566|FG000|Overall Study|Physician Decision|1|||
154916451|NCT01259388|559116567|FG001|Overall Study|Physician Decision|0|||
154916452|NCT02728804|559116573|FG000|Overall Study|Ineligible|3|||
154916453|NCT02728804|559116573|FG000|Overall Study|Did not complete baseline questionnaire|9|||
154916454|NCT02728804|559116573|FG000|Overall Study|Death|99|||
154916455|NCT00591786|559116574|FG000|Overall Study|Withdrawal of Informed Consent|0|||
154916456|NCT00591786|559116575|FG001|Overall Study|Withdrawal of Informed Consent|0|||
154916457|NCT00591786|559116576|FG002|Overall Study|Withdrawal of Informed Consent|1|||
154916458|NCT00591786|559116577|FG003|Overall Study|Withdrawal of Informed Consent|0|||
154916459|NCT00591786|559116578|FG004|Overall Study|Withdrawal of Informed Consent|0|||
154916460|NCT00591786|559116579|FG005|Overall Study|Withdrawal of Informed Consent|0|||
154916461|NCT00591786|559116580|FG006|Overall Study|Withdrawal of Informed Consent|0|||
154916462|NCT00591786|559116581|FG007|Overall Study|Withdrawal of Informed Consent|0|||
154916463|NCT00591786|559116582|FG008|Overall Study|Withdrawal of Informed Consent|0|||
154916464|NCT00591786|559116583|FG009|Overall Study|Withdrawal of Informed Consent|0|||
154916465|NCT01920061|559116585|FG000|Overall Study|Death|1|||
154916466|NCT01920061|559116586|FG001|Overall Study|Death|1|||
154916467|NCT01920061|559116587|FG002|Overall Study|Death|0|||
154916468|NCT01920061|559116588|FG003|Overall Study|Death|1|||
154916469|NCT01920061|559116589|FG004|Overall Study|Death|1|||
154916470|NCT01920061|559116590|FG005|Overall Study|Death|0|||
154916471|NCT01920061|559116591|FG006|Overall Study|Death|0|||
154916472|NCT01920061|559116592|FG007|Overall Study|Death|1|||
154916473|NCT01920061|559116593|FG008|Overall Study|Death|0|||
154916474|NCT01920061|559116594|FG009|Overall Study|Death|1|||
154916475|NCT01920061|559116595|FG010|Overall Study|Death|0|||
154916476|NCT01920061|559116596|FG011|Overall Study|Death|1|||
154916477|NCT01920061|559116597|FG012|Overall Study|Death|0|||
154916478|NCT01920061|559116598|FG013|Overall Study|Death|2|||
154916479|NCT01920061|559116599|FG014|Overall Study|Death|0|||
154916480|NCT01920061|559116600|FG015|Overall Study|Death|0|||
154916481|NCT01920061|559116601|FG016|Overall Study|Death|0|||
154916482|NCT01920061|559116602|FG017|Overall Study|Death|0|||
154916483|NCT01920061|559116603|FG018|Overall Study|Death|1|||
154916484|NCT01920061|559116604|FG019|Overall Study|Death|0|||
154916485|NCT01920061|559116585|FG000|Overall Study|Lost to Follow-up|0|||
154916486|NCT01920061|559116586|FG001|Overall Study|Lost to Follow-up|2|||
154916487|NCT01920061|559116587|FG002|Overall Study|Lost to Follow-up|0|||
154916488|NCT01920061|559116588|FG003|Overall Study|Lost to Follow-up|0|||
155119766|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
154916489|NCT01920061|559116589|FG004|Overall Study|Lost to Follow-up|0|||
154916490|NCT01920061|559116590|FG005|Overall Study|Lost to Follow-up|0|||
155119767|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
154916491|NCT01920061|559116591|FG006|Overall Study|Lost to Follow-up|1|||
154916492|NCT01920061|559116592|FG007|Overall Study|Lost to Follow-up|0|||
154916493|NCT01920061|559116593|FG008|Overall Study|Lost to Follow-up|0|||
154916494|NCT01920061|559116594|FG009|Overall Study|Lost to Follow-up|0|||
154987944|NCT02788045|559385165|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
154987945|NCT02788045|559385163|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
154987946|NCT02788045|559385164|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
154987947|NCT02788045|559385165|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
154987948|NCT02788045|559385163|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
154987949|NCT02788045|559385164|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
154987950|NCT02788045|559385165|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
154987951|NCT02788045|559385163|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
154987952|NCT02788045|559385164|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
154987953|NCT02788045|559385165|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
154987954|NCT02788045|559385163|FG000|Main Study (Up to Week 72)|Other|3|||
154987955|NCT02788045|559385164|FG001|Main Study (Up to Week 72)|Other|0|||
154987956|NCT02788045|559385165|FG002|Main Study (Up to Week 72)|Other|0|||
154987957|NCT02788045|559385163|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
154987958|NCT02788045|559385164|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
154987959|NCT02788045|559385165|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
154987960|NCT02788045|559385163|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
154987961|NCT02788045|559385164|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
154987962|NCT02788045|559385165|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
154987963|NCT02788045|559385163|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
154987964|NCT02788045|559385164|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
154987965|NCT02788045|559385165|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
154987966|NCT04394351|559385166|FG000|Part A (16 Weeks)|Adverse Event|1|||
154987967|NCT04394351|559385167|FG001|Part A (16 Weeks)|Adverse Event|0|||
154987968|NCT04394351|559385168|FG002|Part A (16 Weeks)|Adverse Event|0|||
154987969|NCT04394351|559385169|FG003|Part A (16 Weeks)|Adverse Event|0|||
154987970|NCT04394351|559385170|FG004|Part A (16 Weeks)|Adverse Event|0|||
154987971|NCT04394351|559385171|FG005|Part A (16 Weeks)|Adverse Event|0|||
154987972|NCT04394351|559385172|FG006|Part A (16 Weeks)|Adverse Event|0|||
154987973|NCT04394351|559385173|FG007|Part A (16 Weeks)|Adverse Event|0|||
154987974|NCT04394351|559385166|FG000|Part A (16 Weeks)|Physician Decision|0|||
154987975|NCT04394351|559385167|FG001|Part A (16 Weeks)|Physician Decision|1|||
154987976|NCT04394351|559385168|FG002|Part A (16 Weeks)|Physician Decision|0|||
154987977|NCT04394351|559385169|FG003|Part A (16 Weeks)|Physician Decision|0|||
154987978|NCT04394351|559385170|FG004|Part A (16 Weeks)|Physician Decision|0|||
154987979|NCT04394351|559385171|FG005|Part A (16 Weeks)|Physician Decision|0|||
154987980|NCT04394351|559385172|FG006|Part A (16 Weeks)|Physician Decision|0|||
154987981|NCT04394351|559385173|FG007|Part A (16 Weeks)|Physician Decision|0|||
154987982|NCT04394351|559385166|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987983|NCT04394351|559385167|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
154987984|NCT04394351|559385168|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987985|NCT04394351|559385169|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987986|NCT04394351|559385170|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987987|NCT04394351|559385171|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987988|NCT04394351|559385172|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987989|NCT04394351|559385173|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
154987990|NCT04394351|559385166|FG000|Part B (36 Weeks)|Adverse Event|0|||
154987991|NCT04394351|559385167|FG001|Part B (36 Weeks)|Adverse Event|0|||
154987992|NCT04394351|559385168|FG002|Part B (36 Weeks)|Adverse Event|0|||
154987993|NCT04394351|559385169|FG003|Part B (36 Weeks)|Adverse Event|0|||
154987994|NCT04394351|559385170|FG004|Part B (36 Weeks)|Adverse Event|0|||
154987995|NCT04394351|559385171|FG005|Part B (36 Weeks)|Adverse Event|0|||
154987996|NCT04394351|559385172|FG006|Part B (36 Weeks)|Adverse Event|1|||
154987997|NCT04394351|559385173|FG007|Part B (36 Weeks)|Adverse Event|0|||
154987998|NCT04394351|559385166|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154987999|NCT04394351|559385167|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154988000|NCT04394351|559385168|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154988001|NCT04394351|559385169|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154988002|NCT04394351|559385170|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154988003|NCT04394351|559385171|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154988004|NCT04394351|559385172|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
154988005|NCT04394351|559385173|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
154988006|NCT04394351|559385166|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988007|NCT04394351|559385167|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988008|NCT04394351|559385168|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988009|NCT04394351|559385169|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988010|NCT04394351|559385170|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988011|NCT04394351|559385171|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988012|NCT04394351|559385172|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
154988013|NCT04394351|559385173|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
154988014|NCT04394351|559385166|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
155150945|NCT00770653|559988132|FG001|Overall Study|Lack of Compliance|4|||
154988015|NCT04394351|559385167|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
154988016|NCT04394351|559385168|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
154988017|NCT04394351|559385169|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
154988018|NCT04394351|559385170|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
154988019|NCT04394351|559385171|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
154988020|NCT04394351|559385172|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
154988021|NCT04394351|559385173|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
154988022|NCT04394351|559385166|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988023|NCT04394351|559385167|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988024|NCT04394351|559385168|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988025|NCT04394351|559385169|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988026|NCT04394351|559385170|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988027|NCT04394351|559385171|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988028|NCT04394351|559385172|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
154988029|NCT04394351|559385173|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
154988030|NCT00144781|559385174|FG000|Overall Study|Adverse Event|0|||
154988031|NCT00144781|559385175|FG001|Overall Study|Adverse Event|1|||
154988032|NCT00144781|559385176|FG002|Overall Study|Adverse Event|0|||
154988033|NCT00144781|559385177|FG003|Overall Study|Adverse Event|0|||
154988034|NCT00144781|559385174|FG000|Overall Study|Non-compliant|0|||
154988035|NCT00144781|559385175|FG001|Overall Study|Non-compliant|1|||
154988036|NCT00144781|559385176|FG002|Overall Study|Non-compliant|0|||
154988037|NCT00144781|559385177|FG003|Overall Study|Non-compliant|0|||
154988038|NCT02068092|559385178|FG000|Overall Study|Physician Decision|2|||
154988039|NCT02068092|559385178|FG000|Overall Study|Adverse Event|2|||
154988040|NCT02068092|559385178|FG000|Overall Study|Lost to Follow-up|4|||
154988041|NCT02068092|559385178|FG000|Overall Study|Withdrawal by Subject|2|||
154988042|NCT03696953|559385179|FG000|Overall Study|Withdrawal by Subject|6|||
154988043|NCT03696953|559385180|FG001|Overall Study|Withdrawal by Subject|1|||
154988044|NCT03696953|559385179|FG000|Overall Study|missed GBS swabs|2|||
154988045|NCT03696953|559385180|FG001|Overall Study|missed GBS swabs|2|||
154988046|NCT03696953|559385179|FG000|Overall Study|lost study bottle containing capsules|2|||
154988047|NCT03696953|559385180|FG001|Overall Study|lost study bottle containing capsules|0|||
154988048|NCT03696953|559385179|FG000|Overall Study|Premature birth|1|||
154988049|NCT03696953|559385180|FG001|Overall Study|Premature birth|4|||
154988050|NCT03696953|559385179|FG000|Overall Study|Gestational hypertension|1|||
154988051|NCT03696953|559385180|FG001|Overall Study|Gestational hypertension|1|||
154988052|NCT03696953|559385179|FG000|Overall Study|Gestational diabetes|2|||
154988053|NCT03696953|559385180|FG001|Overall Study|Gestational diabetes|1|||
154988054|NCT03696953|559385179|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
154988055|NCT03696953|559385180|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
154988056|NCT03696953|559385179|FG000|Overall Study|Changed prenatal provider|1|||
154988057|NCT03696953|559385180|FG001|Overall Study|Changed prenatal provider|1|||
154988058|NCT03502707|559385181|FG000|Overall Study|Adverse Event|0|||
154988059|NCT03502707|559385182|FG001|Overall Study|Adverse Event|0|||
154988060|NCT03502707|559385183|FG002|Overall Study|Adverse Event|0|||
154988061|NCT03502707|559385184|FG003|Overall Study|Adverse Event|0|||
154988062|NCT03502707|559385185|FG004|Overall Study|Adverse Event|0|||
154988063|NCT03502707|559385186|FG005|Overall Study|Adverse Event|0|||
154988064|NCT03502707|559385187|FG006|Overall Study|Adverse Event|0|||
154988065|NCT03502707|559385188|FG007|Overall Study|Adverse Event|0|||
154988066|NCT03502707|559385189|FG008|Overall Study|Adverse Event|0|||
154988067|NCT03502707|559385190|FG009|Overall Study|Adverse Event|0|||
154988068|NCT03502707|559385191|FG010|Overall Study|Adverse Event|0|||
154988069|NCT03502707|559385192|FG011|Overall Study|Adverse Event|0|||
154988070|NCT03502707|559385193|FG012|Overall Study|Adverse Event|0|||
154988071|NCT03502707|559385194|FG013|Overall Study|Adverse Event|0|||
154988072|NCT03502707|559385195|FG014|Overall Study|Adverse Event|0|||
154988073|NCT03502707|559385196|FG015|Overall Study|Adverse Event|1|||
154988074|NCT03502707|559385197|FG016|Overall Study|Adverse Event|5|||
154988075|NCT03502707|559385198|FG017|Overall Study|Adverse Event|0|||
154988076|NCT03502707|559385181|FG000|Overall Study|Death|0|||
154988077|NCT03502707|559385182|FG001|Overall Study|Death|0|||
154988078|NCT03502707|559385183|FG002|Overall Study|Death|0|||
154988079|NCT03502707|559385184|FG003|Overall Study|Death|1|||
154988080|NCT03502707|559385185|FG004|Overall Study|Death|0|||
154988081|NCT03502707|559385186|FG005|Overall Study|Death|0|||
154988082|NCT03502707|559385187|FG006|Overall Study|Death|0|||
154988083|NCT03502707|559385188|FG007|Overall Study|Death|0|||
154988084|NCT03502707|559385189|FG008|Overall Study|Death|1|||
154988085|NCT03502707|559385190|FG009|Overall Study|Death|1|||
154988086|NCT03502707|559385191|FG010|Overall Study|Death|0|||
154988087|NCT03502707|559385192|FG011|Overall Study|Death|0|||
155119768|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
154988088|NCT03502707|559385193|FG012|Overall Study|Death|1|||
154988089|NCT03502707|559385194|FG013|Overall Study|Death|0|||
154988090|NCT03502707|559385195|FG014|Overall Study|Death|0|||
154988091|NCT03502707|559385196|FG015|Overall Study|Death|1|||
154988092|NCT03502707|559385197|FG016|Overall Study|Death|0|||
154988093|NCT03502707|559385198|FG017|Overall Study|Death|0|||
154988094|NCT03502707|559385181|FG000|Overall Study|Lost to Follow-up|0|||
154988095|NCT03502707|559385182|FG001|Overall Study|Lost to Follow-up|0|||
154988096|NCT03502707|559385183|FG002|Overall Study|Lost to Follow-up|0|||
154988097|NCT03502707|559385184|FG003|Overall Study|Lost to Follow-up|0|||
154988098|NCT03502707|559385185|FG004|Overall Study|Lost to Follow-up|0|||
154988099|NCT03502707|559385186|FG005|Overall Study|Lost to Follow-up|0|||
154988100|NCT03502707|559385187|FG006|Overall Study|Lost to Follow-up|0|||
154988101|NCT03502707|559385188|FG007|Overall Study|Lost to Follow-up|5|||
154988102|NCT03502707|559385189|FG008|Overall Study|Lost to Follow-up|0|||
154988103|NCT03502707|559385190|FG009|Overall Study|Lost to Follow-up|2|||
154988104|NCT03502707|559385191|FG010|Overall Study|Lost to Follow-up|1|||
154988105|NCT03502707|559385192|FG011|Overall Study|Lost to Follow-up|2|||
154988106|NCT03502707|559385193|FG012|Overall Study|Lost to Follow-up|1|||
154988107|NCT03502707|559385194|FG013|Overall Study|Lost to Follow-up|1|||
154988108|NCT03502707|559385195|FG014|Overall Study|Lost to Follow-up|0|||
154988109|NCT03502707|559385196|FG015|Overall Study|Lost to Follow-up|4|||
154988110|NCT03502707|559385197|FG016|Overall Study|Lost to Follow-up|9|||
154988111|NCT03502707|559385198|FG017|Overall Study|Lost to Follow-up|2|||
154988112|NCT03502707|559385181|FG000|Overall Study|Physician Decision|0|||
154988113|NCT03502707|559385182|FG001|Overall Study|Physician Decision|0|||
154988114|NCT03502707|559385183|FG002|Overall Study|Physician Decision|0|||
154988115|NCT03502707|559385184|FG003|Overall Study|Physician Decision|0|||
154988116|NCT03502707|559385185|FG004|Overall Study|Physician Decision|0|||
154988117|NCT03502707|559385186|FG005|Overall Study|Physician Decision|0|||
154988118|NCT03502707|559385187|FG006|Overall Study|Physician Decision|0|||
154988119|NCT03502707|559385188|FG007|Overall Study|Physician Decision|0|||
154988120|NCT03502707|559385189|FG008|Overall Study|Physician Decision|2|||
154988121|NCT03502707|559385190|FG009|Overall Study|Physician Decision|1|||
154988122|NCT03502707|559385191|FG010|Overall Study|Physician Decision|0|||
154988123|NCT03502707|559385192|FG011|Overall Study|Physician Decision|0|||
154988124|NCT03502707|559385193|FG012|Overall Study|Physician Decision|0|||
154988125|NCT03502707|559385194|FG013|Overall Study|Physician Decision|0|||
154988126|NCT03502707|559385195|FG014|Overall Study|Physician Decision|1|||
154988127|NCT03502707|559385196|FG015|Overall Study|Physician Decision|3|||
154988128|NCT03502707|559385197|FG016|Overall Study|Physician Decision|0|||
154988129|NCT03502707|559385198|FG017|Overall Study|Physician Decision|0|||
154988130|NCT03502707|559385181|FG000|Overall Study|Protocol Violation|0|||
154988131|NCT03502707|559385182|FG001|Overall Study|Protocol Violation|0|||
154988132|NCT03502707|559385183|FG002|Overall Study|Protocol Violation|0|||
154988133|NCT03502707|559385184|FG003|Overall Study|Protocol Violation|0|||
154988134|NCT03502707|559385185|FG004|Overall Study|Protocol Violation|0|||
154988135|NCT03502707|559385186|FG005|Overall Study|Protocol Violation|0|||
154988136|NCT03502707|559385187|FG006|Overall Study|Protocol Violation|0|||
154988137|NCT03502707|559385188|FG007|Overall Study|Protocol Violation|0|||
154988138|NCT03502707|559385189|FG008|Overall Study|Protocol Violation|0|||
154988139|NCT03502707|559385190|FG009|Overall Study|Protocol Violation|0|||
154988140|NCT03502707|559385191|FG010|Overall Study|Protocol Violation|0|||
154988141|NCT03502707|559385192|FG011|Overall Study|Protocol Violation|0|||
154988142|NCT03502707|559385193|FG012|Overall Study|Protocol Violation|0|||
154988143|NCT03502707|559385194|FG013|Overall Study|Protocol Violation|0|||
154988144|NCT03502707|559385195|FG014|Overall Study|Protocol Violation|0|||
154988145|NCT03502707|559385196|FG015|Overall Study|Protocol Violation|1|||
155176655|NCT04456673|560086417|FG000|Overall Study|Adverse Event|7|||
155176656|NCT04456673|560086418|FG001|Overall Study|Adverse Event|14|||
155176657|NCT04456673|560086417|FG000|Overall Study|Poor compliance to protocol|1|||
155176658|NCT04456673|560086418|FG001|Overall Study|Poor compliance to protocol|0|||
154988146|NCT03502707|559385197|FG016|Overall Study|Protocol Violation|0|||
154988147|NCT03502707|559385198|FG017|Overall Study|Protocol Violation|0|||
154988148|NCT03502707|559385181|FG000|Overall Study|Withdrawal by Subject|1|||
154988149|NCT03502707|559385182|FG001|Overall Study|Withdrawal by Subject|1|||
154988150|NCT03502707|559385183|FG002|Overall Study|Withdrawal by Subject|0|||
154988151|NCT03502707|559385184|FG003|Overall Study|Withdrawal by Subject|0|||
154988152|NCT03502707|559385185|FG004|Overall Study|Withdrawal by Subject|0|||
154988153|NCT03502707|559385186|FG005|Overall Study|Withdrawal by Subject|2|||
154988154|NCT03502707|559385187|FG006|Overall Study|Withdrawal by Subject|0|||
154988155|NCT03502707|559385188|FG007|Overall Study|Withdrawal by Subject|3|||
154988156|NCT03502707|559385189|FG008|Overall Study|Withdrawal by Subject|1|||
154988157|NCT03502707|559385190|FG009|Overall Study|Withdrawal by Subject|2|||
154988158|NCT03502707|559385191|FG010|Overall Study|Withdrawal by Subject|12|||
154988159|NCT03502707|559385192|FG011|Overall Study|Withdrawal by Subject|23|||
154988160|NCT03502707|559385193|FG012|Overall Study|Withdrawal by Subject|5|||
154988161|NCT03502707|559385194|FG013|Overall Study|Withdrawal by Subject|3|||
154988162|NCT03502707|559385195|FG014|Overall Study|Withdrawal by Subject|3|||
154988163|NCT03502707|559385196|FG015|Overall Study|Withdrawal by Subject|43|||
154988164|NCT03502707|559385197|FG016|Overall Study|Withdrawal by Subject|44|||
154988165|NCT03502707|559385198|FG017|Overall Study|Withdrawal by Subject|18|||
154988166|NCT03502707|559385181|FG000|Overall Study|Sponsor's Decision|1|||
154988167|NCT03502707|559385182|FG001|Overall Study|Sponsor's Decision|0|||
155119769|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155119770|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155119771|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155119772|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155119773|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
155119774|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
155119775|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
155119776|NCT03352557|559868485|FG000|LTE Period: Week 80 to Week 173|Other|0|||
155119777|NCT03352557|559868486|FG001|LTE Period: Week 80 to Week 173|Other|0|||
155119778|NCT03352557|559868487|FG002|LTE Period: Week 80 to Week 173|Other|0|||
155119779|NCT03352557|559868488|FG003|LTE Period: Week 80 to Week 173|Other|0|||
155119780|NCT03352557|559868489|FG004|LTE Period: Week 80 to Week 173|Other|0|||
155119781|NCT03352557|559868490|FG005|LTE Period: Week 80 to Week 173|Other|0|||
155119782|NCT03352557|559868491|FG006|LTE Period: Week 80 to Week 173|Other|0|||
155119783|NCT03352557|559868492|FG007|LTE Period: Week 80 to Week 173|Other|1|||
155119784|NCT03352557|559868493|FG008|LTE Period: Week 80 to Week 173|Other|0|||
155119785|NCT03352557|559868494|FG009|LTE Period: Week 80 to Week 173|Other|0|||
155119786|NCT04677660|559868495|FG000|Overall Study|Lost to Follow-up|0|||
155119787|NCT04677660|559868496|FG001|Overall Study|Lost to Follow-up|2|||
155119788|NCT04677660|559868495|FG000|Overall Study|Withdrawal by Subject|0|||
155119789|NCT04677660|559868496|FG001|Overall Study|Withdrawal by Subject|1|||
155119790|NCT04677660|559868495|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
155119791|NCT04677660|559868496|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
155119792|NCT03242772|559868497|FG000|Overall Study|Lost to Follow-up|2|||
155119793|NCT03242772|559868498|FG001|Overall Study|Lost to Follow-up|0|||
155119794|NCT03242772|559868497|FG000|Overall Study|Physician Decision|0|||
155119795|NCT03242772|559868498|FG001|Overall Study|Physician Decision|1|||
155119796|NCT03242772|559868497|FG000|Overall Study|Withdrawal by Subject|1|||
155119797|NCT03242772|559868498|FG001|Overall Study|Withdrawal by Subject|0|||
155119798|NCT01560637|559868502|FG000|Overall Study|Adverse Event|63|||
155119799|NCT01560637|559868502|FG000|Overall Study|Death|69|||
155119800|NCT01560637|559868502|FG000|Overall Study|Lost to Follow-up|8|||
155119801|NCT01560637|559868502|FG000|Overall Study|Protocol Violation|8|||
155119802|NCT01560637|559868502|FG000|Overall Study|Withdrawal by Subject|24|||
155119803|NCT01560637|559868502|FG000|Overall Study|Progressive Disease|20|||
155119804|NCT01560637|559868502|FG000|Overall Study|Other Reason Not Specified|6|||
155119805|NCT01089023|559868503|FG000|Overall Study|Lost to Follow-up|3|||
155119806|NCT01089023|559868503|FG000|Overall Study|Adverse Event|1|||
155119807|NCT01089023|559868503|FG000|Overall Study|Withdrawal by Subject|1|||
155119808|NCT01089023|559868503|FG000|Overall Study|Protocol Violation|1|||
155119809|NCT01089023|559868503|FG000|Overall Study|Lack of Efficacy|1|||
155119810|NCT03220581|559868506|FG000|Overall Study|Withdrawal by Subject|0|||
155119811|NCT03220581|559868507|FG001|Overall Study|Withdrawal by Subject|1|||
155119812|NCT03220581|559868506|FG000|Overall Study|Lost to Follow-up|3|||
155119813|NCT03220581|559868507|FG001|Overall Study|Lost to Follow-up|6|||
155119814|NCT03576755|559868511|FG000|Overall Study|Withdrawal by Subject|1|||
155119815|NCT03576755|559868512|FG001|Overall Study|Withdrawal by Subject|0|||
155119816|NCT03576755|559868513|FG002|Overall Study|Withdrawal by Subject|0|||
155119817|NCT03576755|559868514|FG003|Overall Study|Withdrawal by Subject|0|||
155119818|NCT02275117|559868515|FG000|Overall Study|Adverse Event|0|||
155119819|NCT02275117|559868516|FG001|Overall Study|Adverse Event|0|||
155119820|NCT02275117|559868517|FG002|Overall Study|Adverse Event|0|||
155119821|NCT02275117|559868518|FG003|Overall Study|Adverse Event|0|||
155119822|NCT02275117|559868519|FG004|Overall Study|Adverse Event|1|||
155119823|NCT02275117|559868515|FG000|Overall Study|Lack of Efficacy|6|||
155119824|NCT02275117|559868516|FG001|Overall Study|Lack of Efficacy|7|||
155119825|NCT02275117|559868517|FG002|Overall Study|Lack of Efficacy|5|||
155119826|NCT02275117|559868518|FG003|Overall Study|Lack of Efficacy|2|||
155119827|NCT02275117|559868519|FG004|Overall Study|Lack of Efficacy|10|||
155119828|NCT02275117|559868515|FG000|Overall Study|Lost to Follow-up|11|||
155119829|NCT02275117|559868516|FG001|Overall Study|Lost to Follow-up|16|||
155119830|NCT02275117|559868517|FG002|Overall Study|Lost to Follow-up|15|||
155119831|NCT02275117|559868518|FG003|Overall Study|Lost to Follow-up|16|||
155119832|NCT02275117|559868519|FG004|Overall Study|Lost to Follow-up|8|||
155176659|NCT04456673|560086417|FG000|Overall Study|Withdrawal by Subject|31|||
155119833|NCT02275117|559868515|FG000|Overall Study|Physician Decision|0|||
155119834|NCT02275117|559868516|FG001|Overall Study|Physician Decision|1|||
155119835|NCT02275117|559868517|FG002|Overall Study|Physician Decision|1|||
155119836|NCT02275117|559868518|FG003|Overall Study|Physician Decision|0|||
155119837|NCT02275117|559868519|FG004|Overall Study|Physician Decision|1|||
155119838|NCT02275117|559868515|FG000|Overall Study|Protocol Violation|1|||
155119839|NCT02275117|559868516|FG001|Overall Study|Protocol Violation|0|||
155119840|NCT02275117|559868517|FG002|Overall Study|Protocol Violation|1|||
155119841|NCT02275117|559868518|FG003|Overall Study|Protocol Violation|1|||
155119842|NCT02275117|559868519|FG004|Overall Study|Protocol Violation|0|||
155119843|NCT02275117|559868515|FG000|Overall Study|Withdrawal by Subject|6|||
155119844|NCT02275117|559868516|FG001|Overall Study|Withdrawal by Subject|4|||
154988168|NCT03502707|559385183|FG002|Overall Study|Sponsor's Decision|0|||
154988169|NCT03502707|559385184|FG003|Overall Study|Sponsor's Decision|0|||
154988170|NCT03502707|559385185|FG004|Overall Study|Sponsor's Decision|0|||
154988171|NCT03502707|559385186|FG005|Overall Study|Sponsor's Decision|0|||
154988172|NCT03502707|559385187|FG006|Overall Study|Sponsor's Decision|0|||
154988173|NCT03502707|559385188|FG007|Overall Study|Sponsor's Decision|0|||
154988174|NCT03502707|559385189|FG008|Overall Study|Sponsor's Decision|0|||
154988175|NCT03502707|559385190|FG009|Overall Study|Sponsor's Decision|1|||
154988176|NCT03502707|559385191|FG010|Overall Study|Sponsor's Decision|0|||
155119845|NCT02275117|559868517|FG002|Overall Study|Withdrawal by Subject|7|||
155119846|NCT02275117|559868518|FG003|Overall Study|Withdrawal by Subject|3|||
155119847|NCT02275117|559868519|FG004|Overall Study|Withdrawal by Subject|3|||
155119848|NCT02275117|559868515|FG000|Overall Study|Terminated by Sponsor|4|||
155119849|NCT02275117|559868516|FG001|Overall Study|Terminated by Sponsor|4|||
155119850|NCT02275117|559868517|FG002|Overall Study|Terminated by Sponsor|4|||
155119851|NCT02275117|559868518|FG003|Overall Study|Terminated by Sponsor|6|||
155119852|NCT02275117|559868519|FG004|Overall Study|Terminated by Sponsor|4|||
155119853|NCT02275117|559868515|FG000|Overall Study|Worsening of Study Indication|0|||
155119854|NCT02275117|559868516|FG001|Overall Study|Worsening of Study Indication|1|||
155119855|NCT02275117|559868517|FG002|Overall Study|Worsening of Study Indication|2|||
155119856|NCT02275117|559868518|FG003|Overall Study|Worsening of Study Indication|0|||
155119857|NCT02275117|559868519|FG004|Overall Study|Worsening of Study Indication|0|||
155119858|NCT02275117|559868515|FG000|Overall Study|Study Burden|5|||
155119859|NCT02275117|559868516|FG001|Overall Study|Study Burden|4|||
155119860|NCT02275117|559868517|FG002|Overall Study|Study Burden|7|||
155119861|NCT02275117|559868518|FG003|Overall Study|Study Burden|5|||
155119862|NCT02275117|559868519|FG004|Overall Study|Study Burden|7|||
155119863|NCT02275117|559868515|FG000|Overall Study|Other|1|||
155119864|NCT02275117|559868516|FG001|Overall Study|Other|0|||
155119865|NCT02275117|559868517|FG002|Overall Study|Other|0|||
154916495|NCT01920061|559116595|FG010|Overall Study|Lost to Follow-up|3|||
154916496|NCT01920061|559116596|FG011|Overall Study|Lost to Follow-up|0|||
154916497|NCT01920061|559116597|FG012|Overall Study|Lost to Follow-up|0|||
154916498|NCT01920061|559116598|FG013|Overall Study|Lost to Follow-up|0|||
154916499|NCT01920061|559116599|FG014|Overall Study|Lost to Follow-up|0|||
154916500|NCT01920061|559116600|FG015|Overall Study|Lost to Follow-up|0|||
154916501|NCT01920061|559116601|FG016|Overall Study|Lost to Follow-up|0|||
154916502|NCT01920061|559116602|FG017|Overall Study|Lost to Follow-up|1|||
154916503|NCT01920061|559116603|FG018|Overall Study|Lost to Follow-up|4|||
154916504|NCT01920061|559116604|FG019|Overall Study|Lost to Follow-up|3|||
154916505|NCT01920061|559116585|FG000|Overall Study|Other|1|||
154916506|NCT01920061|559116586|FG001|Overall Study|Other|1|||
154916507|NCT01920061|559116587|FG002|Overall Study|Other|2|||
154916508|NCT01920061|559116588|FG003|Overall Study|Other|1|||
154916509|NCT01920061|559116589|FG004|Overall Study|Other|0|||
154916510|NCT01920061|559116590|FG005|Overall Study|Other|1|||
154916511|NCT01920061|559116591|FG006|Overall Study|Other|0|||
154916512|NCT01920061|559116592|FG007|Overall Study|Other|0|||
154916513|NCT01920061|559116593|FG008|Overall Study|Other|0|||
154916514|NCT01920061|559116594|FG009|Overall Study|Other|1|||
154916515|NCT01920061|559116595|FG010|Overall Study|Other|1|||
154916516|NCT01920061|559116596|FG011|Overall Study|Other|2|||
154916517|NCT01920061|559116597|FG012|Overall Study|Other|1|||
154916518|NCT01920061|559116598|FG013|Overall Study|Other|4|||
154916519|NCT01920061|559116599|FG014|Overall Study|Other|0|||
154916520|NCT01920061|559116600|FG015|Overall Study|Other|1|||
154916521|NCT01920061|559116601|FG016|Overall Study|Other|1|||
154916522|NCT01920061|559116602|FG017|Overall Study|Other|0|||
154916523|NCT01920061|559116603|FG018|Overall Study|Other|1|||
154916524|NCT01920061|559116604|FG019|Overall Study|Other|1|||
154916525|NCT01920061|559116585|FG000|Overall Study|Participant refused further follow-up|0|||
154988177|NCT03502707|559385192|FG011|Overall Study|Sponsor's Decision|0|||
154988178|NCT03502707|559385193|FG012|Overall Study|Sponsor's Decision|0|||
154988179|NCT03502707|559385194|FG013|Overall Study|Sponsor's Decision|0|||
155119866|NCT02275117|559868518|FG003|Overall Study|Other|0|||
155119867|NCT02275117|559868519|FG004|Overall Study|Other|2|||
155119868|NCT02014480|559868522|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155119869|NCT02014480|559868523|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155119870|NCT02014480|559868524|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
155119871|NCT02014480|559868525|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155119872|NCT02014480|559868526|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
154916526|NCT01920061|559116586|FG001|Overall Study|Participant refused further follow-up|0|||
154916527|NCT01920061|559116587|FG002|Overall Study|Participant refused further follow-up|0|||
154916528|NCT01920061|559116588|FG003|Overall Study|Participant refused further follow-up|0|||
154916529|NCT01920061|559116589|FG004|Overall Study|Participant refused further follow-up|1|||
154916530|NCT01920061|559116590|FG005|Overall Study|Participant refused further follow-up|1|||
154916531|NCT01920061|559116591|FG006|Overall Study|Participant refused further follow-up|0|||
154916532|NCT01920061|559116592|FG007|Overall Study|Participant refused further follow-up|0|||
154988180|NCT03502707|559385195|FG014|Overall Study|Sponsor's Decision|0|||
155176660|NCT04456673|560086418|FG001|Overall Study|Withdrawal by Subject|23|||
155176661|NCT04456673|560086417|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
155176662|NCT04456673|560086418|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
155176663|NCT04575597|560086422|FG000|Overall Study|Death|0|||
155176664|NCT04575597|560086423|FG001|Overall Study|Death|0|||
155176665|NCT04575597|560086424|FG002|Overall Study|Death|0|||
155176666|NCT04575597|560086425|FG003|Overall Study|Death|1|||
155176667|NCT04575597|560086426|FG004|Overall Study|Death|3|||
155176668|NCT04575597|560086427|FG005|Overall Study|Death|14|||
155176669|NCT04575597|560086422|FG000|Overall Study|Lost to Follow-up|2|||
155176670|NCT04575597|560086423|FG001|Overall Study|Lost to Follow-up|1|||
155176671|NCT04575597|560086424|FG002|Overall Study|Lost to Follow-up|1|||
155176672|NCT04575597|560086425|FG003|Overall Study|Lost to Follow-up|2|||
155119873|NCT02014480|559868527|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155119874|NCT02014480|559868522|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155119875|NCT02014480|559868523|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155119876|NCT02014480|559868524|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155119877|NCT02014480|559868525|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
155119878|NCT02014480|559868526|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155119879|NCT02014480|559868527|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155119880|NCT02014480|559868522|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155119881|NCT02014480|559868523|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155119882|NCT02014480|559868524|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
155119883|NCT02014480|559868525|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155119884|NCT02014480|559868526|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155119885|NCT02014480|559868527|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155119886|NCT02014480|559868522|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155119887|NCT02014480|559868523|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155119888|NCT02014480|559868524|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
155119889|NCT02014480|559868525|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155119890|NCT02014480|559868526|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155119891|NCT02014480|559868527|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155119892|NCT02014480|559868522|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155119893|NCT02014480|559868523|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
155119894|NCT02014480|559868524|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155119895|NCT02014480|559868525|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155119896|NCT02014480|559868526|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155119897|NCT02014480|559868527|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155119898|NCT02014480|559868522|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
155119899|NCT02014480|559868523|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
155119900|NCT02014480|559868524|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
155119901|NCT02014480|559868525|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
155119902|NCT02014480|559868526|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
155119903|NCT02014480|559868527|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
155119904|NCT02014480|559868522|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155119905|NCT02014480|559868523|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155119906|NCT02014480|559868524|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155119907|NCT02014480|559868525|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155119908|NCT02014480|559868526|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155119909|NCT02014480|559868527|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
155119910|NCT01338610|559868528|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
155119911|NCT01338610|559868529|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
155119912|NCT01338610|559868530|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
155119913|NCT01338610|559868528|FG000|Overall Study|Protocol Violation|1|||
155176673|NCT04575597|560086426|FG004|Overall Study|Lost to Follow-up|10|||
155176674|NCT04575597|560086427|FG005|Overall Study|Lost to Follow-up|8|||
155176675|NCT04575597|560086422|FG000|Overall Study|Withdrawal by Subject|2|||
155176676|NCT04575597|560086423|FG001|Overall Study|Withdrawal by Subject|2|||
155176677|NCT04575597|560086424|FG002|Overall Study|Withdrawal by Subject|4|||
155176678|NCT04575597|560086425|FG003|Overall Study|Withdrawal by Subject|2|||
154916533|NCT01920061|559116593|FG008|Overall Study|Participant refused further follow-up|1|||
154916534|NCT01920061|559116594|FG009|Overall Study|Participant refused further follow-up|0|||
154916535|NCT01920061|559116595|FG010|Overall Study|Participant refused further follow-up|1|||
154916536|NCT01920061|559116596|FG011|Overall Study|Participant refused further follow-up|0|||
155176679|NCT04575597|560086426|FG004|Overall Study|Withdrawal by Subject|25|||
155176680|NCT04575597|560086427|FG005|Overall Study|Withdrawal by Subject|28|||
154916537|NCT01920061|559116597|FG012|Overall Study|Participant refused further follow-up|1|||
155119914|NCT01338610|559868529|FG001|Overall Study|Protocol Violation|0|||
155119915|NCT01338610|559868530|FG002|Overall Study|Protocol Violation|1|||
155119916|NCT01338610|559868528|FG000|Overall Study|Adverse Event|3|||
155176681|NCT04575597|560086422|FG000|Overall Study|Not Recorded|0|||
155176682|NCT04575597|560086423|FG001|Overall Study|Not Recorded|0|||
154916538|NCT01920061|559116598|FG013|Overall Study|Participant refused further follow-up|0|||
154916539|NCT01920061|559116599|FG014|Overall Study|Participant refused further follow-up|1|||
154916540|NCT01920061|559116600|FG015|Overall Study|Participant refused further follow-up|2|||
154916541|NCT01920061|559116601|FG016|Overall Study|Participant refused further follow-up|1|||
154916542|NCT01920061|559116602|FG017|Overall Study|Participant refused further follow-up|1|||
154916543|NCT01920061|559116603|FG018|Overall Study|Participant refused further follow-up|0|||
154916544|NCT01920061|559116604|FG019|Overall Study|Participant refused further follow-up|0|||
154916545|NCT00554229|559116605|FG000|Overall Study|Lost to Follow-up|3|||
154916546|NCT00554229|559116606|FG001|Overall Study|Lost to Follow-up|6|||
154916547|NCT00554229|559116605|FG000|Overall Study|Withdrawal by Subject|29|||
154916548|NCT00554229|559116606|FG001|Overall Study|Withdrawal by Subject|37|||
154916549|NCT00554229|559116605|FG000|Overall Study|Adverse Event|71|||
154916550|NCT00554229|559116606|FG001|Overall Study|Adverse Event|39|||
154916551|NCT00554229|559116605|FG000|Overall Study|Protocol Violation|3|||
154916552|NCT00554229|559116606|FG001|Overall Study|Protocol Violation|3|||
154916553|NCT00554229|559116605|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
154916554|NCT00554229|559116606|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
154916555|NCT00554229|559116605|FG000|Overall Study|Randomised but no treatment received|1|||
154916556|NCT00554229|559116606|FG001|Overall Study|Randomised but no treatment received|0|||
154916557|NCT03969589|559116607|FG000|Overall Study|Lost to Follow-up|3|||
154916558|NCT03969589|559116608|FG001|Overall Study|Lost to Follow-up|2|||
154916559|NCT03969589|559116607|FG000|Overall Study|Declined Follow-Up|0|||
154916560|NCT03969589|559116608|FG001|Overall Study|Declined Follow-Up|1|||
154916561|NCT03143855|559116609|FG000|Overall Study|Withdrawal by Subject|4|||
154916562|NCT03143855|559116610|FG001|Overall Study|Withdrawal by Subject|3|||
154916563|NCT03143855|559116609|FG000|Overall Study|Protocol Violation|1|||
154916564|NCT03143855|559116610|FG001|Overall Study|Protocol Violation|0|||
154916565|NCT03143855|559116609|FG000|Overall Study|Participant experienced withdrawal|0|||
154916566|NCT03143855|559116610|FG001|Overall Study|Participant experienced withdrawal|1|||
154916567|NCT03691831|559118432|FG000|Overall Study|Lost to Follow-up|16|||
154916568|NCT03691831|559118433|FG001|Overall Study|Lost to Follow-up|12|||
154916569|NCT03691831|559118432|FG000|Overall Study|Withdrawal by Subject|9|||
154916570|NCT03691831|559118433|FG001|Overall Study|Withdrawal by Subject|17|||
154916571|NCT03691831|559118432|FG000|Overall Study|Investigator Decision|2|||
154916572|NCT03691831|559118433|FG001|Overall Study|Investigator Decision|2|||
154916573|NCT00337935|559118434|FG000|Overall Study|Adverse Event|2|||
154916574|NCT00337935|559118435|FG001|Overall Study|Adverse Event|5|||
154916575|NCT00337935|559118434|FG000|Overall Study|Death|2|||
154916576|NCT00337935|559118435|FG001|Overall Study|Death|8|||
154916577|NCT00337935|559118434|FG000|Overall Study|Physician Decision|1|||
154916578|NCT00337935|559118435|FG001|Overall Study|Physician Decision|1|||
154916579|NCT00337935|559118434|FG000|Overall Study|Lost to Follow-up|0|||
154916580|NCT00337935|559118435|FG001|Overall Study|Lost to Follow-up|1|||
154916581|NCT00337935|559118434|FG000|Overall Study|Protocol Violation|4|||
154916582|NCT00337935|559118435|FG001|Overall Study|Protocol Violation|3|||
154916583|NCT00337935|559118434|FG000|Overall Study|Withdrawal by Subject|1|||
154916584|NCT00337935|559118435|FG001|Overall Study|Withdrawal by Subject|7|||
154916585|NCT00337935|559118434|FG000|Overall Study|Other|0|||
154916586|NCT00337935|559118435|FG001|Overall Study|Other|1|||
154916587|NCT00337935|559118434|FG000|Overall Study|Lack of Efficacy|0|||
154916588|NCT00337935|559118435|FG001|Overall Study|Lack of Efficacy|1|||
154916589|NCT04120116|559118439|FG000|Overall Study|Lost to Follow-up|0|||
154916590|NCT04120116|559118440|FG001|Overall Study|Lost to Follow-up|1|||
154916591|NCT04120116|559118441|FG002|Overall Study|Lost to Follow-up|0|||
154916592|NCT04120116|559118442|FG003|Overall Study|Lost to Follow-up|2|||
154916593|NCT04120116|559118439|FG000|Overall Study|Withdrawal by Subject|1|||
154916594|NCT04120116|559118440|FG001|Overall Study|Withdrawal by Subject|0|||
154916595|NCT04120116|559118441|FG002|Overall Study|Withdrawal by Subject|1|||
154916596|NCT04120116|559118442|FG003|Overall Study|Withdrawal by Subject|1|||
154916597|NCT04120116|559118439|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
154916598|NCT04120116|559118440|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
154916599|NCT04120116|559118441|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
154916600|NCT04120116|559118442|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
154916601|NCT01846039|559118443|FG000|Overall Study|Protocol Violation|1|||
154916602|NCT01846039|559118443|FG000|Overall Study|Subject Withdrew Consent|1|||
154916603|NCT03824704|559118463|FG000|Overall Study|Study Terminated by Sponsor|1|||
154916604|NCT02155660|559118466|FG000|Overall Study|Other Reason|8|||
154916605|NCT02155660|559118467|FG001|Overall Study|Other Reason|6|||
154916606|NCT02155660|559118468|FG002|Overall Study|Other Reason|10|||
154916607|NCT02155660|559118469|FG003|Overall Study|Other Reason|10|||
154916608|NCT02155660|559118466|FG000|Overall Study|Study-specific withdrawal criteria|0|||
154916609|NCT02155660|559118467|FG001|Overall Study|Study-specific withdrawal criteria|1|||
154988181|NCT03502707|559385196|FG015|Overall Study|Sponsor's Decision|2|||
154988182|NCT03502707|559385197|FG016|Overall Study|Sponsor's Decision|1|||
154988183|NCT03502707|559385198|FG017|Overall Study|Sponsor's Decision|0|||
154988184|NCT03502707|559385181|FG000|Overall Study|Initiated Prohibited Medication|0|||
154988185|NCT03502707|559385182|FG001|Overall Study|Initiated Prohibited Medication|0|||
154988186|NCT03502707|559385183|FG002|Overall Study|Initiated Prohibited Medication|0|||
154988187|NCT03502707|559385184|FG003|Overall Study|Initiated Prohibited Medication|0|||
154988188|NCT03502707|559385185|FG004|Overall Study|Initiated Prohibited Medication|0|||
154988189|NCT03502707|559385186|FG005|Overall Study|Initiated Prohibited Medication|0|||
154988190|NCT03502707|559385187|FG006|Overall Study|Initiated Prohibited Medication|0|||
154988191|NCT03502707|559385188|FG007|Overall Study|Initiated Prohibited Medication|0|||
154988192|NCT03502707|559385189|FG008|Overall Study|Initiated Prohibited Medication|0|||
154988193|NCT03502707|559385190|FG009|Overall Study|Initiated Prohibited Medication|0|||
154988194|NCT03502707|559385191|FG010|Overall Study|Initiated Prohibited Medication|0|||
154988195|NCT03502707|559385192|FG011|Overall Study|Initiated Prohibited Medication|0|||
154988196|NCT03502707|559385193|FG012|Overall Study|Initiated Prohibited Medication|0|||
154988197|NCT03502707|559385194|FG013|Overall Study|Initiated Prohibited Medication|0|||
154988198|NCT03502707|559385195|FG014|Overall Study|Initiated Prohibited Medication|0|||
154988199|NCT03502707|559385196|FG015|Overall Study|Initiated Prohibited Medication|0|||
154988200|NCT03502707|559385197|FG016|Overall Study|Initiated Prohibited Medication|1|||
154988201|NCT03502707|559385198|FG017|Overall Study|Initiated Prohibited Medication|0|||
154988202|NCT03502707|559385181|FG000|Overall Study|Other|0|||
154988203|NCT03502707|559385182|FG001|Overall Study|Other|0|||
154988204|NCT03502707|559385183|FG002|Overall Study|Other|0|||
154988205|NCT03502707|559385184|FG003|Overall Study|Other|0|||
154988206|NCT03502707|559385185|FG004|Overall Study|Other|0|||
154988207|NCT03502707|559385186|FG005|Overall Study|Other|0|||
154988208|NCT03502707|559385187|FG006|Overall Study|Other|0|||
154988209|NCT03502707|559385188|FG007|Overall Study|Other|0|||
154988210|NCT03502707|559385189|FG008|Overall Study|Other|1|||
154988211|NCT03502707|559385190|FG009|Overall Study|Other|1|||
154988212|NCT03502707|559385191|FG010|Overall Study|Other|2|||
154988213|NCT03502707|559385192|FG011|Overall Study|Other|0|||
154988214|NCT03502707|559385193|FG012|Overall Study|Other|0|||
154988215|NCT03502707|559385194|FG013|Overall Study|Other|0|||
154988216|NCT03502707|559385195|FG014|Overall Study|Other|0|||
154988217|NCT03502707|559385196|FG015|Overall Study|Other|4|||
154988218|NCT03502707|559385197|FG016|Overall Study|Other|1|||
154988219|NCT03502707|559385198|FG017|Overall Study|Other|0|||
154988220|NCT03502707|559385181|FG000|Overall Study|Randomized but not vaccinated|0|||
154988221|NCT03502707|559385182|FG001|Overall Study|Randomized but not vaccinated|0|||
154988222|NCT03502707|559385183|FG002|Overall Study|Randomized but not vaccinated|0|||
154988223|NCT03502707|559385184|FG003|Overall Study|Randomized but not vaccinated|0|||
154988224|NCT03502707|559385185|FG004|Overall Study|Randomized but not vaccinated|0|||
154988225|NCT03502707|559385186|FG005|Overall Study|Randomized but not vaccinated|0|||
154988226|NCT03502707|559385187|FG006|Overall Study|Randomized but not vaccinated|0|||
154988227|NCT03502707|559385188|FG007|Overall Study|Randomized but not vaccinated|0|||
154988228|NCT03502707|559385189|FG008|Overall Study|Randomized but not vaccinated|0|||
154988229|NCT03502707|559385190|FG009|Overall Study|Randomized but not vaccinated|0|||
154988230|NCT03502707|559385191|FG010|Overall Study|Randomized but not vaccinated|0|||
154988231|NCT03502707|559385192|FG011|Overall Study|Randomized but not vaccinated|1|||
154988232|NCT03502707|559385193|FG012|Overall Study|Randomized but not vaccinated|0|||
154988233|NCT03502707|559385194|FG013|Overall Study|Randomized but not vaccinated|0|||
154988234|NCT03502707|559385195|FG014|Overall Study|Randomized but not vaccinated|0|||
154988235|NCT03502707|559385196|FG015|Overall Study|Randomized but not vaccinated|0|||
154988236|NCT03502707|559385197|FG016|Overall Study|Randomized but not vaccinated|0|||
154988237|NCT03502707|559385198|FG017|Overall Study|Randomized but not vaccinated|1|||
154988238|NCT00461253|559385199|FG000|Overall Study|Death|985|||
154988239|NCT00461253|559385200|FG001|Overall Study|Death|0|||
154988240|NCT00461253|559385199|FG000|Overall Study|Protocol Violation|613|||
154988241|NCT00461253|559385200|FG001|Overall Study|Protocol Violation|236|||
154988242|NCT00461253|559385199|FG000|Overall Study|no response|2609|||
154988243|NCT00461253|559385200|FG001|Overall Study|no response|11789|||
154988244|NCT00461253|559385199|FG000|Overall Study|administrative|773|||
154988245|NCT00461253|559385200|FG001|Overall Study|administrative|7773|||
154988246|NCT01933113|559385201|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
154988247|NCT02297438|559385202|FG000|Overall Study|Death|79|||
154988248|NCT02297438|559385203|FG001|Overall Study|Death|86|||
154988249|NCT02297438|559385202|FG000|Overall Study|Lost to Follow-up|9|||
154988250|NCT02297438|559385203|FG001|Overall Study|Lost to Follow-up|7|||
155176683|NCT04575597|560086424|FG002|Overall Study|Not Recorded|0|||
154988251|NCT02297438|559385202|FG000|Overall Study|Withdrawal by Subject|7|||
154988252|NCT02297438|559385203|FG001|Overall Study|Withdrawal by Subject|0|||
154988253|NCT02297438|559385202|FG000|Overall Study|Other|9|||
154988254|NCT02297438|559385203|FG001|Overall Study|Other|5|||
154988255|NCT02297438|559385202|FG000|Overall Study|Ongoing|65|||
154988256|NCT02297438|559385203|FG001|Overall Study|Ongoing|73|||
155119917|NCT01338610|559868529|FG001|Overall Study|Adverse Event|0|||
155119918|NCT01338610|559868530|FG002|Overall Study|Adverse Event|0|||
154916610|NCT02155660|559118468|FG002|Overall Study|Study-specific withdrawal criteria|1|||
154916611|NCT02155660|559118469|FG003|Overall Study|Study-specific withdrawal criteria|1|||
154916612|NCT02155660|559118466|FG000|Overall Study|Severe non-compliance|0|||
154916613|NCT02155660|559118467|FG001|Overall Study|Severe non-compliance|4|||
154916614|NCT02155660|559118468|FG002|Overall Study|Severe non-compliance|0|||
154916615|NCT02155660|559118469|FG003|Overall Study|Severe non-compliance|1|||
154916616|NCT02155660|559118466|FG000|Overall Study|Adverse Event|2|||
154916617|NCT02155660|559118467|FG001|Overall Study|Adverse Event|6|||
154916618|NCT02155660|559118468|FG002|Overall Study|Adverse Event|3|||
154916619|NCT02155660|559118469|FG003|Overall Study|Adverse Event|1|||
154916620|NCT02155660|559118466|FG000|Overall Study|Lost to Follow-up|3|||
154916621|NCT02155660|559118467|FG001|Overall Study|Lost to Follow-up|6|||
154916622|NCT02155660|559118468|FG002|Overall Study|Lost to Follow-up|5|||
154916623|NCT02155660|559118469|FG003|Overall Study|Lost to Follow-up|8|||
154916624|NCT02155660|559118466|FG000|Overall Study|Death|17|||
154916625|NCT02155660|559118467|FG001|Overall Study|Death|19|||
154916626|NCT02155660|559118468|FG002|Overall Study|Death|17|||
154916627|NCT02155660|559118469|FG003|Overall Study|Death|19|||
154916628|NCT02155660|559118466|FG000|Overall Study|Withdrawal by Subject|28|||
154916629|NCT02155660|559118467|FG001|Overall Study|Withdrawal by Subject|31|||
154916630|NCT02155660|559118468|FG002|Overall Study|Withdrawal by Subject|24|||
154916631|NCT02155660|559118469|FG003|Overall Study|Withdrawal by Subject|21|||
154916632|NCT03730987|559118470|FG000|Overall Study|Lost to Follow-up|2|||
154916633|NCT03730987|559118471|FG001|Overall Study|Lost to Follow-up|0|||
154916634|NCT03730987|559118472|FG002|Overall Study|Lost to Follow-up|2|||
154916635|NCT03730987|559118473|FG003|Overall Study|Lost to Follow-up|0|||
154916636|NCT02505945|559118474|FG000|Overall Study|Withdrawal by Subject|13|||
154916637|NCT02505945|559118475|FG001|Overall Study|Withdrawal by Subject|2|||
154916638|NCT02505945|559118474|FG000|Overall Study|Adverse Event|1|||
154916639|NCT02505945|559118475|FG001|Overall Study|Adverse Event|0|||
154916640|NCT02505945|559118474|FG000|Overall Study|Physician Decision|2|||
154916641|NCT02505945|559118475|FG001|Overall Study|Physician Decision|1|||
154916642|NCT02505945|559118474|FG000|Overall Study|Lost to Follow-up|6|||
154916643|NCT02505945|559118475|FG001|Overall Study|Lost to Follow-up|1|||
154916644|NCT02406586|559118476|FG000|Overall Study|Lost to Follow-up|0|||
154916645|NCT02406586|559118477|FG001|Overall Study|Lost to Follow-up|4|||
154916646|NCT02406586|559118478|FG002|Overall Study|Lost to Follow-up|2|||
154916647|NCT02406586|559118476|FG000|Overall Study|Withdrawal by Subject|1|||
154916648|NCT02406586|559118477|FG001|Overall Study|Withdrawal by Subject|0|||
154916649|NCT02406586|559118478|FG002|Overall Study|Withdrawal by Subject|0|||
154916650|NCT01072175|559118479|FG000|Part A (Drug-Drug Interaction)|Death|1|||
154916651|NCT01072175|559118480|FG001|Part A (Drug-Drug Interaction)|Death|0|||
154916652|NCT01072175|559118481|FG002|Part A (Drug-Drug Interaction)|Death|0|||
154916653|NCT01072175|559118482|FG003|Part A (Drug-Drug Interaction)|Death|0|||
154916654|NCT01072175|559118483|FG004|Part A (Drug-Drug Interaction)|Death|0|||
154916655|NCT01072175|559118484|FG005|Part A (Drug-Drug Interaction)|Death|0|||
154916656|NCT01072175|559118485|FG006|Part A (Drug-Drug Interaction)|Death|0|||
154916657|NCT01072175|559118486|FG007|Part A (Drug-Drug Interaction)|Death|0|||
154916658|NCT01072175|559118487|FG008|Part A (Drug-Drug Interaction)|Death|0|||
154916659|NCT01072175|559118488|FG009|Part A (Drug-Drug Interaction)|Death|0|||
154916660|NCT01072175|559118489|FG010|Part A (Drug-Drug Interaction)|Death|0|||
154916661|NCT01072175|559118490|FG011|Part A (Drug-Drug Interaction)|Death|0|||
154916662|NCT01072175|559118491|FG012|Part A (Drug-Drug Interaction)|Death|0|||
154916663|NCT01072175|559118479|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
154916664|NCT01072175|559118480|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916665|NCT01072175|559118481|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916666|NCT01072175|559118482|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916667|NCT01072175|559118483|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916668|NCT01072175|559118484|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916669|NCT01072175|559118485|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916670|NCT01072175|559118486|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916671|NCT01072175|559118487|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916672|NCT01072175|559118488|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916673|NCT01072175|559118489|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916674|NCT01072175|559118490|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916675|NCT01072175|559118491|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
154916676|NCT01072175|559118479|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
154916677|NCT01072175|559118480|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916678|NCT01072175|559118481|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916679|NCT01072175|559118482|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916680|NCT01072175|559118483|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
155119919|NCT01865812|559868531|FG000|Primary Treatment Phase|Adverse Event|2|||
155119920|NCT01865812|559868532|FG001|Primary Treatment Phase|Adverse Event|0|||
155176684|NCT04575597|560086425|FG003|Overall Study|Not Recorded|0|||
155176685|NCT04575597|560086426|FG004|Overall Study|Not Recorded|0|||
155176686|NCT04575597|560086427|FG005|Overall Study|Not Recorded|2|||
155176687|NCT04575597|560086422|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155176688|NCT04575597|560086423|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155176689|NCT04575597|560086424|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155176690|NCT04575597|560086425|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155176691|NCT04575597|560086426|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
155176692|NCT04575597|560086427|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
155176693|NCT02095132|560086429|FG000|Overall Study|Adverse Event|0|||
155176694|NCT02095132|560086430|FG001|Overall Study|Adverse Event|0|||
155176695|NCT02095132|560086431|FG002|Overall Study|Adverse Event|0|||
155176696|NCT02095132|560086432|FG003|Overall Study|Adverse Event|0|||
155176697|NCT02095132|560086433|FG004|Overall Study|Adverse Event|1|||
155176698|NCT02095132|560086434|FG005|Overall Study|Adverse Event|0|||
155176699|NCT02095132|560086435|FG006|Overall Study|Adverse Event|1|||
154988257|NCT03107026|559385204|FG000|Overall Study|Adverse Event|2|||
155176700|NCT02095132|560086436|FG007|Overall Study|Adverse Event|0|||
155176701|NCT02095132|560086437|FG008|Overall Study|Adverse Event|0|||
155176702|NCT02095132|560086429|FG000|Overall Study|Death|0|||
155176703|NCT02095132|560086430|FG001|Overall Study|Death|0|||
155176704|NCT02095132|560086431|FG002|Overall Study|Death|0|||
155176705|NCT02095132|560086432|FG003|Overall Study|Death|0|||
155176706|NCT02095132|560086433|FG004|Overall Study|Death|0|||
155176707|NCT02095132|560086434|FG005|Overall Study|Death|0|||
155176708|NCT02095132|560086435|FG006|Overall Study|Death|1|||
155176709|NCT02095132|560086436|FG007|Overall Study|Death|0|||
155176710|NCT02095132|560086437|FG008|Overall Study|Death|0|||
155176711|NCT02095132|560086429|FG000|Overall Study|Lack of Efficacy|3|||
155176712|NCT02095132|560086430|FG001|Overall Study|Lack of Efficacy|5|||
155176713|NCT02095132|560086431|FG002|Overall Study|Lack of Efficacy|2|||
155176714|NCT02095132|560086432|FG003|Overall Study|Lack of Efficacy|8|||
155176715|NCT02095132|560086433|FG004|Overall Study|Lack of Efficacy|3|||
155176716|NCT02095132|560086434|FG005|Overall Study|Lack of Efficacy|6|||
155176717|NCT02095132|560086435|FG006|Overall Study|Lack of Efficacy|10|||
155176718|NCT02095132|560086436|FG007|Overall Study|Lack of Efficacy|9|||
155176719|NCT02095132|560086437|FG008|Overall Study|Lack of Efficacy|8|||
155176720|NCT02095132|560086429|FG000|Overall Study|Physician Decision|1|||
155176721|NCT02095132|560086430|FG001|Overall Study|Physician Decision|0|||
155176722|NCT02095132|560086431|FG002|Overall Study|Physician Decision|0|||
155176723|NCT02095132|560086432|FG003|Overall Study|Physician Decision|0|||
155176724|NCT02095132|560086433|FG004|Overall Study|Physician Decision|0|||
155176725|NCT02095132|560086434|FG005|Overall Study|Physician Decision|0|||
155176726|NCT02095132|560086435|FG006|Overall Study|Physician Decision|1|||
155176727|NCT02095132|560086436|FG007|Overall Study|Physician Decision|0|||
155176728|NCT02095132|560086437|FG008|Overall Study|Physician Decision|2|||
155176729|NCT02095132|560086429|FG000|Overall Study|Withdrawal by Subject|0|||
155176730|NCT02095132|560086430|FG001|Overall Study|Withdrawal by Subject|0|||
155176731|NCT02095132|560086431|FG002|Overall Study|Withdrawal by Subject|2|||
155176732|NCT02095132|560086432|FG003|Overall Study|Withdrawal by Subject|2|||
155176733|NCT02095132|560086433|FG004|Overall Study|Withdrawal by Subject|3|||
155176734|NCT02095132|560086434|FG005|Overall Study|Withdrawal by Subject|0|||
155176735|NCT02095132|560086435|FG006|Overall Study|Withdrawal by Subject|5|||
155176736|NCT02095132|560086436|FG007|Overall Study|Withdrawal by Subject|0|||
155176737|NCT02095132|560086437|FG008|Overall Study|Withdrawal by Subject|0|||
155176738|NCT02108262|560086440|FG000|Overall Study|Non-compliance|0|||
155176739|NCT02108262|560086441|FG001|Overall Study|Non-compliance|2|||
154988258|NCT03107026|559385205|FG001|Overall Study|Adverse Event|14|||
154988259|NCT03107026|559385206|FG002|Overall Study|Adverse Event|23|||
154988260|NCT03107026|559385204|FG000|Overall Study|Lost to Follow-up|12|||
154988261|NCT03107026|559385205|FG001|Overall Study|Lost to Follow-up|12|||
154988262|NCT03107026|559385206|FG002|Overall Study|Lost to Follow-up|13|||
154988263|NCT03107026|559385204|FG000|Overall Study|Protocol Violation|1|||
154988264|NCT03107026|559385205|FG001|Overall Study|Protocol Violation|2|||
154988265|NCT03107026|559385206|FG002|Overall Study|Protocol Violation|0|||
154988266|NCT03107026|559385204|FG000|Overall Study|Pregnancy|1|||
154988267|NCT03107026|559385205|FG001|Overall Study|Pregnancy|0|||
155176740|NCT02108262|560086442|FG002|Overall Study|Non-compliance|1|||
155176741|NCT02108262|560086443|FG003|Overall Study|Non-compliance|1|||
154988268|NCT03107026|559385206|FG002|Overall Study|Pregnancy|0|||
154988269|NCT03107026|559385204|FG000|Overall Study|Withdrawal by Subject|13|||
154988270|NCT03107026|559385205|FG001|Overall Study|Withdrawal by Subject|5|||
155176742|NCT02108262|560086440|FG000|Overall Study|Randomized by error/screen failure|0|||
155176743|NCT02108262|560086441|FG001|Overall Study|Randomized by error/screen failure|0|||
155176744|NCT02108262|560086442|FG002|Overall Study|Randomized by error/screen failure|1|||
155176745|NCT02108262|560086443|FG003|Overall Study|Randomized by error/screen failure|0|||
155176746|NCT02108262|560086440|FG000|Overall Study|Distance to center|0|||
155176747|NCT02108262|560086441|FG001|Overall Study|Distance to center|1|||
155176748|NCT02108262|560086442|FG002|Overall Study|Distance to center|1|||
155176749|NCT02108262|560086443|FG003|Overall Study|Distance to center|0|||
154988271|NCT03107026|559385206|FG002|Overall Study|Withdrawal by Subject|17|||
154988272|NCT03107026|559385204|FG000|Overall Study|non compliance with study visits|1|||
154988273|NCT03107026|559385205|FG001|Overall Study|non compliance with study visits|2|||
154988274|NCT03107026|559385206|FG002|Overall Study|non compliance with study visits|0|||
154988275|NCT03107026|559385204|FG000|Overall Study|non-compliance with study drug|2|||
154988276|NCT03107026|559385205|FG001|Overall Study|non-compliance with study drug|2|||
154988277|NCT03107026|559385206|FG002|Overall Study|non-compliance with study drug|3|||
154988278|NCT03107026|559385204|FG000|Overall Study|Physician Decision|0|||
154988279|NCT03107026|559385205|FG001|Overall Study|Physician Decision|1|||
154988280|NCT03107026|559385206|FG002|Overall Study|Physician Decision|0|||
155119921|NCT01865812|559868531|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
155119922|NCT01865812|559868532|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
155119923|NCT01865812|559868531|FG000|Long-term Safety Extension Phase|Pruritus|0|||
155119924|NCT01865812|559868532|FG001|Long-term Safety Extension Phase|Pruritus|3|||
155119925|NCT01865812|559868531|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
155119926|NCT01865812|559868532|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
154988281|NCT00062010|559385207|FG000|Overall Study|Ineligible|3|||
154988282|NCT00852969|559385208|FG000|Overall Study|Adverse Event|0|||
154988283|NCT00852969|559385209|FG001|Overall Study|Adverse Event|1|||
154988284|NCT00852969|559385208|FG000|Overall Study|Lost to Follow-up|0|||
154988285|NCT00852969|559385209|FG001|Overall Study|Lost to Follow-up|1|||
154988286|NCT00807248|559385210|FG000|Overall Study|Adverse Event|1|||
154988287|NCT00807248|559385211|FG001|Overall Study|Adverse Event|2|||
154988288|NCT00807248|559385212|FG002|Overall Study|Adverse Event|2|||
154988289|NCT00807248|559385213|FG003|Overall Study|Adverse Event|6|||
154988290|NCT00807248|559385210|FG000|Overall Study|Lack of Efficacy|14|||
154988291|NCT00807248|559385211|FG001|Overall Study|Lack of Efficacy|4|||
154988292|NCT00807248|559385212|FG002|Overall Study|Lack of Efficacy|8|||
154988293|NCT00807248|559385213|FG003|Overall Study|Lack of Efficacy|3|||
154988294|NCT00807248|559385210|FG000|Overall Study|Protocol Violation|0|||
154988295|NCT00807248|559385211|FG001|Overall Study|Protocol Violation|1|||
154988296|NCT00807248|559385212|FG002|Overall Study|Protocol Violation|1|||
154988297|NCT00807248|559385213|FG003|Overall Study|Protocol Violation|0|||
154988298|NCT00807248|559385210|FG000|Overall Study|Withdrawal of Consent|5|||
154988299|NCT00807248|559385211|FG001|Overall Study|Withdrawal of Consent|5|||
154988300|NCT00807248|559385212|FG002|Overall Study|Withdrawal of Consent|5|||
154988301|NCT00807248|559385213|FG003|Overall Study|Withdrawal of Consent|5|||
154988302|NCT00807248|559385210|FG000|Overall Study|Lost to Follow-up|1|||
154988303|NCT00807248|559385211|FG001|Overall Study|Lost to Follow-up|0|||
154988304|NCT00807248|559385212|FG002|Overall Study|Lost to Follow-up|0|||
154988305|NCT00807248|559385213|FG003|Overall Study|Lost to Follow-up|0|||
154988306|NCT00807248|559385210|FG000|Overall Study|Other Reason|0|||
154988307|NCT00807248|559385211|FG001|Overall Study|Other Reason|0|||
154988308|NCT00807248|559385212|FG002|Overall Study|Other Reason|2|||
154988309|NCT00807248|559385213|FG003|Overall Study|Other Reason|0|||
154988310|NCT02518919|559385214|FG000|Overall Study|Protocol Violation|1|||
154988311|NCT02518919|559385215|FG001|Overall Study|Protocol Violation|1|||
154988312|NCT02518919|559385216|FG002|Overall Study|Protocol Violation|2|||
154988313|NCT04498403|559385217|FG000|Overall Study|Adverse Event|1|||
154988314|NCT04498403|559385218|FG001|Overall Study|Adverse Event|0|||
155119927|NCT01865812|559868531|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
155119928|NCT01865812|559868532|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
155119929|NCT00054691|559868533|FG000|Overall Study|Unmeasurable Disease|2|||
155119930|NCT00054691|559868533|FG000|Overall Study|Noncompliant|1|||
155119931|NCT02914548|559868536|FG000|Overall Study|Adverse Event|15|||
155119932|NCT02914548|559868537|FG001|Overall Study|Adverse Event|7|||
155119933|NCT02914548|559868538|FG002|Overall Study|Adverse Event|15|||
155119934|NCT02914548|559868536|FG000|Overall Study|Physician Decision|2|||
155119935|NCT02914548|559868537|FG001|Overall Study|Physician Decision|2|||
155119936|NCT02914548|559868538|FG002|Overall Study|Physician Decision|0|||
155119937|NCT02914548|559868536|FG000|Overall Study|Protocol Violation|1|||
154988315|NCT04498403|559385217|FG000|Overall Study|Study Terminated By Sponsor|29|||
154988316|NCT04498403|559385218|FG001|Overall Study|Study Terminated By Sponsor|10|||
154988317|NCT01951885|559385219|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
154988318|NCT01951885|559385220|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
155176750|NCT02108262|560086440|FG000|Overall Study|Adverse Event|0|||
155176751|NCT02108262|560086441|FG001|Overall Study|Adverse Event|11|||
154988319|NCT01951885|559385219|FG000|Overall Study|Adverse Event|1|||
155119938|NCT02914548|559868537|FG001|Overall Study|Protocol Violation|0|||
155119939|NCT02914548|559868538|FG002|Overall Study|Protocol Violation|0|||
155119940|NCT02914548|559868536|FG000|Overall Study|Withdrawal by Subject|3|||
154988320|NCT01951885|559385220|FG001|Overall Study|Adverse Event|0|||
154988321|NCT01951885|559385219|FG000|Overall Study|Withdrawal by Subject|0|||
154988322|NCT01951885|559385220|FG001|Overall Study|Withdrawal by Subject|1|||
154988323|NCT01951885|559385219|FG000|Overall Study|ineligible due to a change in donor|0|||
154988324|NCT01951885|559385220|FG001|Overall Study|ineligible due to a change in donor|1|||
155119941|NCT02914548|559868537|FG001|Overall Study|Withdrawal by Subject|4|||
155119942|NCT02914548|559868538|FG002|Overall Study|Withdrawal by Subject|4|||
155119943|NCT02914548|559868536|FG000|Overall Study|>40% of body surface area|0|||
155119944|NCT02914548|559868537|FG001|Overall Study|>40% of body surface area|1|||
155119945|NCT02914548|559868538|FG002|Overall Study|>40% of body surface area|1|||
155119946|NCT03023826|559868543|FG000|Period 1|Withdrawal by Subject|0|||
154916681|NCT01072175|559118484|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916682|NCT01072175|559118485|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916683|NCT01072175|559118486|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916684|NCT01072175|559118487|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916685|NCT01072175|559118488|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916686|NCT01072175|559118489|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916687|NCT01072175|559118490|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916688|NCT01072175|559118491|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
154916689|NCT01072175|559118479|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
154916690|NCT01072175|559118480|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
154916691|NCT01072175|559118481|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
154916692|NCT01072175|559118482|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
154916693|NCT01072175|559118483|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
154916694|NCT01072175|559118484|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
154916695|NCT01072175|559118485|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
154916696|NCT01072175|559118486|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
154916697|NCT01072175|559118487|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
154916698|NCT01072175|559118488|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
154916699|NCT01072175|559118489|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
154916700|NCT01072175|559118490|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
154916701|NCT01072175|559118491|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
154916702|NCT01072175|559118479|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916703|NCT01072175|559118480|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916704|NCT01072175|559118481|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
154916705|NCT01072175|559118482|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916706|NCT01072175|559118483|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
154916707|NCT01072175|559118484|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916708|NCT01072175|559118485|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916709|NCT01072175|559118486|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916710|NCT01072175|559118487|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916711|NCT01072175|559118488|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916712|NCT01072175|559118489|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916713|NCT01072175|559118490|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916714|NCT01072175|559118491|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
154916715|NCT01072175|559118479|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916716|NCT01072175|559118480|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
154916717|NCT01072175|559118481|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916718|NCT01072175|559118482|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
154916719|NCT01072175|559118483|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
154916720|NCT01072175|559118484|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916721|NCT01072175|559118485|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916722|NCT01072175|559118486|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916723|NCT01072175|559118487|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916724|NCT01072175|559118488|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916725|NCT01072175|559118489|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916726|NCT01072175|559118490|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916727|NCT01072175|559118491|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
154916728|NCT01072175|559118479|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916729|NCT01072175|559118480|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916730|NCT01072175|559118481|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
154916731|NCT01072175|559118482|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
154916732|NCT01072175|559118483|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
154916733|NCT01072175|559118484|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916734|NCT01072175|559118485|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916735|NCT01072175|559118486|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916736|NCT01072175|559118487|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916737|NCT01072175|559118488|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916738|NCT01072175|559118489|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916739|NCT01072175|559118490|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154916740|NCT01072175|559118491|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
154988325|NCT01951885|559385219|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
154988326|NCT01951885|559385220|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
154988327|NCT03188718|559385222|FG000|Overall Study|Participant noncompliance|4|||
154988328|NCT03188718|559385222|FG000|Overall Study|Withdrawal by Subject|1|||
154988329|NCT03188718|559385222|FG000|Overall Study|Device failure|3|||
154988330|NCT04322149|559385223|FG000|Overall Study|Adverse Event|1|||
154988331|NCT04322149|559385224|FG001|Overall Study|Adverse Event|1|||
154988332|NCT04322149|559385225|FG002|Overall Study|Adverse Event|0|||
154988333|NCT04322149|559385226|FG003|Overall Study|Adverse Event|0|||
154988334|NCT04322149|559385223|FG000|Overall Study|Withdrawal by Subject|0|||
154988335|NCT04322149|559385224|FG001|Overall Study|Withdrawal by Subject|0|||
154988336|NCT04322149|559385225|FG002|Overall Study|Withdrawal by Subject|0|||
154988337|NCT04322149|559385226|FG003|Overall Study|Withdrawal by Subject|2|||
154988338|NCT04322149|559385223|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
154988339|NCT04322149|559385224|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
154988340|NCT04322149|559385225|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
154988341|NCT04322149|559385226|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
154988342|NCT00368979|559385228|FG000|Overall Study|Adverse Event|9|||
154988343|NCT00368979|559385229|FG001|Overall Study|Adverse Event|16|||
154988344|NCT00368979|559385228|FG000|Overall Study|Lack of Efficacy|5|||
154988345|NCT00368979|559385229|FG001|Overall Study|Lack of Efficacy|3|||
154988346|NCT00368979|559385228|FG000|Overall Study|Other|3|||
154988347|NCT00368979|559385229|FG001|Overall Study|Other|1|||
154988348|NCT00368979|559385228|FG000|Overall Study|Lost to Follow-up|1|||
154988349|NCT00368979|559385229|FG001|Overall Study|Lost to Follow-up|0|||
154988350|NCT00368979|559385228|FG000|Overall Study|Protocol Violation|2|||
154988351|NCT00368979|559385229|FG001|Overall Study|Protocol Violation|1|||
154988352|NCT00368979|559385228|FG000|Overall Study|Withdrawal by Subject|5|||
154988353|NCT00368979|559385229|FG001|Overall Study|Withdrawal by Subject|9|||
154988354|NCT00394524|559385230|FG000|Overall Study|Protocol Violation|2|||
154988355|NCT00394524|559385231|FG001|Overall Study|Protocol Violation|3|||
154988356|NCT00394524|559385230|FG000|Overall Study|Death|1|||
154988357|NCT00394524|559385231|FG001|Overall Study|Death|0|||
154988358|NCT00394524|559385230|FG000|Overall Study|Withdrawal by Subject|0|||
154988359|NCT00394524|559385231|FG001|Overall Study|Withdrawal by Subject|1|||
154988360|NCT01462318|559385232|FG000|Main Study / TP-DI Study|Other|2|||
154988361|NCT01462318|559385233|FG001|Main Study / TP-DI Study|Other|0|||
154988362|NCT01462318|559385234|FG002|Main Study / TP-DI Study|Other|0|||
154988363|NCT01462318|559385232|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
154988364|NCT01462318|559385233|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
154988365|NCT01462318|559385234|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
154988366|NCT01462318|559385232|FG000|Main Study / TP-DI Study|Adverse Event|4|||
154988367|NCT01462318|559385233|FG001|Main Study / TP-DI Study|Adverse Event|0|||
154988368|NCT01462318|559385234|FG002|Main Study / TP-DI Study|Adverse Event|0|||
154988369|NCT01462318|559385232|FG000|Extension Phase|Lost to Follow-up|0|||
154988370|NCT01462318|559385233|FG001|Extension Phase|Lost to Follow-up|0|||
154988371|NCT01462318|559385234|FG002|Extension Phase|Lost to Follow-up|1|||
154988372|NCT01462318|559385232|FG000|Extension Phase|Other|0|||
154988373|NCT01462318|559385233|FG001|Extension Phase|Other|0|||
154988374|NCT01462318|559385234|FG002|Extension Phase|Other|1|||
154988375|NCT01462318|559385232|FG000|Extension Phase|Disease Progression|0|||
154988376|NCT01462318|559385233|FG001|Extension Phase|Disease Progression|0|||
154988377|NCT01462318|559385234|FG002|Extension Phase|Disease Progression|1|||
154988378|NCT01462318|559385232|FG000|Extension Phase|Withdrawal by Subject|0|||
154988379|NCT01462318|559385233|FG001|Extension Phase|Withdrawal by Subject|0|||
154988380|NCT01462318|559385234|FG002|Extension Phase|Withdrawal by Subject|15|||
154988381|NCT01462318|559385232|FG000|Extension Phase|Investigator Decision|0|||
154988382|NCT01462318|559385233|FG001|Extension Phase|Investigator Decision|0|||
154988383|NCT01462318|559385234|FG002|Extension Phase|Investigator Decision|5|||
154988384|NCT01462318|559385232|FG000|Extension Phase|Adverse Event|0|||
154988385|NCT01462318|559385233|FG001|Extension Phase|Adverse Event|0|||
154988386|NCT01462318|559385234|FG002|Extension Phase|Adverse Event|22|||
154988387|NCT02238626|559385235|FG000|Overall Study|Adverse Event|3|||
154988388|NCT02238626|559385236|FG001|Overall Study|Adverse Event|5|||
154988389|NCT02238626|559385237|FG002|Overall Study|Adverse Event|0|||
154988390|NCT02238626|559385238|FG003|Overall Study|Adverse Event|3|||
154988391|NCT02238626|559385235|FG000|Overall Study|Lost to Follow-up|2|||
154988392|NCT02238626|559385236|FG001|Overall Study|Lost to Follow-up|4|||
154988393|NCT02238626|559385237|FG002|Overall Study|Lost to Follow-up|2|||
154988394|NCT02238626|559385238|FG003|Overall Study|Lost to Follow-up|2|||
154988395|NCT02238626|559385235|FG000|Overall Study|Withdrawal by Subject|0|||
154988396|NCT02238626|559385236|FG001|Overall Study|Withdrawal by Subject|3|||
154988397|NCT02238626|559385237|FG002|Overall Study|Withdrawal by Subject|0|||
154988398|NCT02238626|559385238|FG003|Overall Study|Withdrawal by Subject|1|||
154988399|NCT02238626|559385235|FG000|Overall Study|Death|0|||
154988400|NCT02238626|559385236|FG001|Overall Study|Death|0|||
155119947|NCT03023826|559868544|FG001|Period 1|Withdrawal by Subject|0|||
155119948|NCT03023826|559868545|FG002|Period 1|Withdrawal by Subject|0|||
155119949|NCT03023826|559868546|FG003|Period 1|Withdrawal by Subject|0|||
155119950|NCT03023826|559868547|FG004|Period 1|Withdrawal by Subject|1|||
155119951|NCT03023826|559868548|FG005|Period 1|Withdrawal by Subject|0|||
155119952|NCT01371643|559868550|FG000|Overall Study|Withdrawal by Subject|3|||
155119953|NCT01371643|559868551|FG001|Overall Study|Withdrawal by Subject|0|||
155119954|NCT02374814|559868552|FG000|Overall Study|Lost to Follow-up|1|||
155119955|NCT02374814|559868553|FG001|Overall Study|Lost to Follow-up|1|||
155119956|NCT02374814|559868554|FG002|Overall Study|Lost to Follow-up|0|||
155119957|NCT02374814|559868555|FG003|Overall Study|Lost to Follow-up|1|||
155119958|NCT02374814|559868556|FG004|Overall Study|Lost to Follow-up|0|||
155119959|NCT02374814|559868557|FG005|Overall Study|Lost to Follow-up|0|||
155119960|NCT02374814|559868552|FG000|Overall Study|Withdrawal by Subject|0|||
154916741|NCT01072175|559118479|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
155119961|NCT02374814|559868553|FG001|Overall Study|Withdrawal by Subject|0|||
154916742|NCT01072175|559118480|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
154916743|NCT01072175|559118481|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916744|NCT01072175|559118482|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
154916745|NCT01072175|559118483|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
154916746|NCT01072175|559118484|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916747|NCT01072175|559118485|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916748|NCT01072175|559118486|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916749|NCT01072175|559118487|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916750|NCT01072175|559118488|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916751|NCT01072175|559118489|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916752|NCT01072175|559118490|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916753|NCT01072175|559118491|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
154916754|NCT01072175|559118479|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
154916755|NCT01072175|559118480|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
154916756|NCT01072175|559118481|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
154916757|NCT01072175|559118482|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
154916758|NCT01072175|559118483|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
154916759|NCT01072175|559118484|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
154916760|NCT01072175|559118485|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
154916761|NCT01072175|559118486|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
154916762|NCT01072175|559118487|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
154916763|NCT01072175|559118488|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
154916764|NCT01072175|559118489|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
154916765|NCT01072175|559118490|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
154916766|NCT01072175|559118491|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
154916767|NCT01072175|559118479|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916768|NCT01072175|559118480|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916769|NCT01072175|559118481|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916770|NCT01072175|559118482|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916771|NCT01072175|559118483|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916772|NCT01072175|559118484|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
154916773|NCT01072175|559118485|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
154916774|NCT01072175|559118486|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
154916775|NCT01072175|559118487|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916776|NCT01072175|559118488|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916777|NCT01072175|559118489|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916778|NCT01072175|559118490|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916779|NCT01072175|559118491|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
154916780|NCT01072175|559118479|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916781|NCT01072175|559118480|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916782|NCT01072175|559118481|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916783|NCT01072175|559118482|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916784|NCT01072175|559118483|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916785|NCT01072175|559118484|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916786|NCT01072175|559118485|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
154916787|NCT01072175|559118486|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
154916788|NCT01072175|559118487|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916789|NCT01072175|559118488|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916790|NCT01072175|559118489|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916791|NCT01072175|559118490|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916792|NCT01072175|559118491|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
154916793|NCT01072175|559118479|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
155119962|NCT02374814|559868554|FG002|Overall Study|Withdrawal by Subject|1|||
154988401|NCT02238626|559385237|FG002|Overall Study|Death|1|||
154988402|NCT02238626|559385238|FG003|Overall Study|Death|1|||
154988403|NCT02238626|559385235|FG000|Overall Study|Other|0|||
154988404|NCT02238626|559385236|FG001|Overall Study|Other|2|||
154988405|NCT02238626|559385237|FG002|Overall Study|Other|0|||
154988406|NCT02238626|559385238|FG003|Overall Study|Other|0|||
154988407|NCT00270257|559385239|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
154988408|NCT00270257|559385240|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
154988409|NCT01195103|559385243|FG000|Overall Study|Withdrawal by Subject|1|||
154988410|NCT01195103|559385244|FG001|Overall Study|Withdrawal by Subject|0|||
154988411|NCT01195103|559385245|FG002|Overall Study|Withdrawal by Subject|0|||
154988412|NCT00974974|559385251|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
154988413|NCT00974974|559385252|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
154988414|NCT00974974|559385251|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
154988415|NCT00974974|559385252|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
154988416|NCT00974974|559385251|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
154988417|NCT00974974|559385252|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
154988418|NCT00974974|559385251|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
154988419|NCT00974974|559385252|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
154988420|NCT00974974|559385251|FG000|IR CD-LD Dose Adjustment|Various|0|||
154988421|NCT00974974|559385252|FG001|IR CD-LD Dose Adjustment|Various|9|||
154988422|NCT00974974|559385251|FG000|IPX066 Dose Conversion|Adverse Event|23|||
154988423|NCT00974974|559385252|FG001|IPX066 Dose Conversion|Adverse Event|0|||
154988424|NCT00974974|559385251|FG000|IPX066 Dose Conversion|Death|2|||
154988425|NCT00974974|559385252|FG001|IPX066 Dose Conversion|Death|0|||
154988426|NCT00974974|559385251|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
154988427|NCT00974974|559385252|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
154988428|NCT00974974|559385251|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
154988429|NCT00974974|559385252|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
154988430|NCT00974974|559385251|FG000|IPX066 Dose Conversion|Various|3|||
154988431|NCT00974974|559385252|FG001|IPX066 Dose Conversion|Various|0|||
154988432|NCT00974974|559385251|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
154988433|NCT00974974|559385252|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
154988434|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
154988435|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
154988436|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
154988437|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
154988438|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
154988439|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
154988440|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
154988441|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
154988442|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
154988443|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
154988444|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
154988445|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
154988446|NCT00974974|559385251|FG000|Maintenance - Double Blind Treatment|Various|4|||
154988447|NCT00974974|559385252|FG001|Maintenance - Double Blind Treatment|Various|0|||
154988448|NCT01959035|559385253|FG000|Overall Study|Adverse Event|5|||
154988449|NCT01959035|559385253|FG000|Overall Study|Withdrawal by Subject|4|||
154988450|NCT01959035|559385253|FG000|Overall Study|Lost to Follow-up|1|||
154988451|NCT01959035|559385253|FG000|Overall Study|Other (no primary reason given)|1|||
154988452|NCT02227147|559385256|FG000|Controlled Treatment Period|Adverse Event|4|||
154988453|NCT02227147|559385257|FG001|Controlled Treatment Period|Adverse Event|3|||
154988454|NCT02227147|559385256|FG000|Controlled Treatment Period|Other|2|||
154988455|NCT02227147|559385257|FG001|Controlled Treatment Period|Other|0|||
154988456|NCT02227147|559385256|FG000|Follow-up Period|Other|3|||
154988457|NCT02227147|559385257|FG001|Follow-up Period|Other|5|||
154988458|NCT00158600|559385258|FG000|Overall Study|unable to commit time to study|0|||
155176752|NCT02108262|560086442|FG002|Overall Study|Adverse Event|6|||
155176753|NCT02108262|560086443|FG003|Overall Study|Adverse Event|12|||
155176754|NCT02108262|560086440|FG000|Overall Study|Death|0|||
155176755|NCT02108262|560086441|FG001|Overall Study|Death|2|||
155176756|NCT02108262|560086442|FG002|Overall Study|Death|2|||
155176757|NCT02108262|560086443|FG003|Overall Study|Death|1|||
155176758|NCT02108262|560086440|FG000|Overall Study|Lost to Follow-up|0|||
154988459|NCT00158600|559385259|FG001|Overall Study|unable to commit time to study|1|||
154988460|NCT00158600|559385258|FG000|Overall Study|Adverse Event|2|||
154988461|NCT00158600|559385259|FG001|Overall Study|Adverse Event|1|||
155176759|NCT02108262|560086441|FG001|Overall Study|Lost to Follow-up|0|||
155176760|NCT02108262|560086442|FG002|Overall Study|Lost to Follow-up|1|||
155176761|NCT02108262|560086443|FG003|Overall Study|Lost to Follow-up|0|||
155176762|NCT02108262|560086440|FG000|Overall Study|Physician Decision|0|||
155176763|NCT02108262|560086441|FG001|Overall Study|Physician Decision|0|||
155176764|NCT02108262|560086442|FG002|Overall Study|Physician Decision|2|||
155176765|NCT02108262|560086443|FG003|Overall Study|Physician Decision|0|||
155176766|NCT02108262|560086440|FG000|Overall Study|Withdrawal by Subject|0|||
155176767|NCT02108262|560086441|FG001|Overall Study|Withdrawal by Subject|7|||
155176768|NCT02108262|560086442|FG002|Overall Study|Withdrawal by Subject|3|||
155176769|NCT02108262|560086443|FG003|Overall Study|Withdrawal by Subject|4|||
155176770|NCT02108262|560086440|FG000|Overall Study|Due to key hepatic values|0|||
155176771|NCT02108262|560086441|FG001|Overall Study|Due to key hepatic values|1|||
155176772|NCT02108262|560086442|FG002|Overall Study|Due to key hepatic values|0|||
155176773|NCT02108262|560086443|FG003|Overall Study|Due to key hepatic values|0|||
155176774|NCT02108262|560086440|FG000|Overall Study|Unable to contact patient|0|||
155176775|NCT02108262|560086441|FG001|Overall Study|Unable to contact patient|3|||
155176776|NCT02108262|560086442|FG002|Overall Study|Unable to contact patient|1|||
155176777|NCT02108262|560086443|FG003|Overall Study|Unable to contact patient|2|||
155176778|NCT02108262|560086440|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
155176779|NCT02108262|560086441|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
154988462|NCT00158600|559385258|FG000|Overall Study|Death|1|||
154988463|NCT00158600|559385259|FG001|Overall Study|Death|0|||
154988464|NCT00158600|559385258|FG000|Overall Study|Withdrawal by Subject|2|||
154988465|NCT00158600|559385259|FG001|Overall Study|Withdrawal by Subject|2|||
154988466|NCT05183217|559385264|FG000|Overall Study|Withdrawal by Subject|1|||
154988467|NCT05183217|559385265|FG001|Overall Study|Withdrawal by Subject|1|||
154988468|NCT01593696|559385266|FG000|Dose Escalation|Progressive Disease|2|||
154988469|NCT01593696|559385267|FG001|Dose Escalation|Progressive Disease|0|||
154988470|NCT01593696|559385268|FG002|Dose Escalation|Progressive Disease|0|||
154988471|NCT01593696|559385269|FG003|Dose Escalation|Progressive Disease|0|||
154988472|NCT01593696|559385266|FG000|Dose Expansion|Fungal infection|0|||
154988473|NCT01593696|559385267|FG001|Dose Expansion|Fungal infection|0|||
154988474|NCT01593696|559385268|FG002|Dose Expansion|Fungal infection|1|||
154988475|NCT01593696|559385269|FG003|Dose Expansion|Fungal infection|0|||
154988476|NCT01936623|559385274|FG000|Overall Study|Lost to Follow-up|0|||
154988477|NCT01936623|559385275|FG001|Overall Study|Lost to Follow-up|5|||
154988478|NCT00415194|559385280|FG000|Overall Study|Adverse Event|37|||
154988479|NCT00415194|559385281|FG001|Overall Study|Adverse Event|32|||
154988480|NCT00415194|559385280|FG000|Overall Study|Entry Criteria Not Met|4|||
154988481|NCT00415194|559385281|FG001|Overall Study|Entry Criteria Not Met|8|||
154988482|NCT00415194|559385280|FG000|Overall Study|Lost to Follow-up|1|||
154988483|NCT00415194|559385281|FG001|Overall Study|Lost to Follow-up|0|||
154988484|NCT00415194|559385280|FG000|Overall Study|Physician Decision|10|||
154988485|NCT00415194|559385281|FG001|Overall Study|Physician Decision|16|||
154988486|NCT00415194|559385280|FG000|Overall Study|Progressive Disease|180|||
154988487|NCT00415194|559385281|FG001|Overall Study|Progressive Disease|217|||
154988488|NCT00415194|559385280|FG000|Overall Study|Protocol Violation|4|||
154988489|NCT00415194|559385281|FG001|Overall Study|Protocol Violation|2|||
154988490|NCT00415194|559385280|FG000|Overall Study|Withdrawal by Subject|28|||
154988491|NCT00415194|559385281|FG001|Overall Study|Withdrawal by Subject|21|||
154988492|NCT00415194|559385280|FG000|Overall Study|Death Due to Study Disease|26|||
154988493|NCT00415194|559385281|FG001|Overall Study|Death Due to Study Disease|29|||
154988494|NCT00415194|559385280|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
154988495|NCT00415194|559385281|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
154988496|NCT00415194|559385280|FG000|Overall Study|Death Due to Procedural Related AE|0|||
154988497|NCT00415194|559385281|FG001|Overall Study|Death Due to Procedural Related AE|1|||
154988498|NCT00415194|559385280|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
154988499|NCT00415194|559385281|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
154988500|NCT01297465|559385282|FG000|Overall Study|Lack of Ovarian Response|1|||
154988501|NCT01297465|559385283|FG001|Overall Study|Lack of Ovarian Response|1|||
154988502|NCT01297465|559385282|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
154988503|NCT01297465|559385283|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
154988504|NCT01297465|559385282|FG000|Overall Study|No Oocytes Retrieved|1|||
154988505|NCT01297465|559385283|FG001|Overall Study|No Oocytes Retrieved|1|||
154988506|NCT01297465|559385282|FG000|Overall Study|Poor oocyte quality|0|||
154988507|NCT01297465|559385283|FG001|Overall Study|Poor oocyte quality|1|||
154988508|NCT01297465|559385282|FG000|Overall Study|No Fertilization|6|||
154988509|NCT01297465|559385283|FG001|Overall Study|No Fertilization|4|||
154988510|NCT01297465|559385282|FG000|Overall Study|All Embryos Discarded|0|||
154988511|NCT01297465|559385283|FG001|Overall Study|All Embryos Discarded|1|||
154988512|NCT01297465|559385282|FG000|Overall Study|Intention to Freeze all Embryos|0|||
154988513|NCT01297465|559385283|FG001|Overall Study|Intention to Freeze all Embryos|1|||
154988514|NCT00969540|559385284|FG000|Overall Study|Lost to Follow-up|1|||
154988515|NCT00969540|559385285|FG001|Overall Study|Lost to Follow-up|1|||
154988516|NCT00369655|559385286|FG000|Overall Study|Refusal of further treatment|2|||
154988517|NCT01683838|559385287|FG000|Overall Study|Adverse Event|12|||
154988518|NCT01683838|559385288|FG001|Overall Study|Adverse Event|2|||
154988519|NCT01683838|559385287|FG000|Overall Study|Protocol Violation|3|||
154988520|NCT01683838|559385288|FG001|Overall Study|Protocol Violation|1|||
155176780|NCT02108262|560086442|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
155176781|NCT02108262|560086443|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
155176782|NCT02108262|560086440|FG000|Overall Study|Patient did not want another infusion|0|||
154988521|NCT01683838|559385287|FG000|Overall Study|Withdrawal by Subject|6|||
154988522|NCT01683838|559385288|FG001|Overall Study|Withdrawal by Subject|5|||
154988523|NCT01683838|559385287|FG000|Overall Study|Lost to Follow-up|1|||
154988524|NCT01683838|559385288|FG001|Overall Study|Lost to Follow-up|1|||
154988525|NCT01683838|559385287|FG000|Overall Study|Other|4|||
154988526|NCT01683838|559385288|FG001|Overall Study|Other|3|||
154988527|NCT01646138|559385289|FG000|Overall Study|Lost to Follow-up|0|||
154988528|NCT01646138|559385290|FG001|Overall Study|Lost to Follow-up|0|||
154988529|NCT01646138|559385291|FG002|Overall Study|Lost to Follow-up|0|||
154988530|NCT01646138|559385292|FG003|Overall Study|Lost to Follow-up|0|||
154988531|NCT01646138|559385293|FG004|Overall Study|Lost to Follow-up|2|||
154988532|NCT04049617|559385294|FG000|Overall Study|Adverse Event|0|||
154988533|NCT04049617|559385295|FG001|Overall Study|Adverse Event|0|||
154988534|NCT04049617|559385296|FG002|Overall Study|Adverse Event|0|||
154988535|NCT04049617|559385297|FG003|Overall Study|Adverse Event|1|||
154988536|NCT04049617|559385298|FG004|Overall Study|Adverse Event|0|||
154988537|NCT04049617|559385299|FG005|Overall Study|Adverse Event|0|||
154988538|NCT04049617|559385294|FG000|Overall Study|Death|0|||
154988539|NCT04049617|559385295|FG001|Overall Study|Death|0|||
154988540|NCT04049617|559385296|FG002|Overall Study|Death|0|||
154988541|NCT04049617|559385297|FG003|Overall Study|Death|0|||
154988542|NCT04049617|559385298|FG004|Overall Study|Death|0|||
154988543|NCT04049617|559385299|FG005|Overall Study|Death|1|||
154988544|NCT04049617|559385294|FG000|Overall Study|Lost to Follow-up|0|||
154988545|NCT04049617|559385295|FG001|Overall Study|Lost to Follow-up|0|||
154988546|NCT04049617|559385296|FG002|Overall Study|Lost to Follow-up|0|||
154988547|NCT04049617|559385297|FG003|Overall Study|Lost to Follow-up|1|||
154988548|NCT04049617|559385298|FG004|Overall Study|Lost to Follow-up|0|||
154988549|NCT04049617|559385299|FG005|Overall Study|Lost to Follow-up|0|||
154988550|NCT04049617|559385294|FG000|Overall Study|Withdrew consent|0|||
154988551|NCT04049617|559385295|FG001|Overall Study|Withdrew consent|0|||
154988552|NCT04049617|559385296|FG002|Overall Study|Withdrew consent|1|||
154988553|NCT04049617|559385297|FG003|Overall Study|Withdrew consent|0|||
154988554|NCT04049617|559385298|FG004|Overall Study|Withdrew consent|0|||
154988555|NCT04049617|559385299|FG005|Overall Study|Withdrew consent|0|||
154988556|NCT02669758|559385300|FG000|Overall Study|Withdrawal by Subject|43|||
154988557|NCT02669758|559385300|FG000|Overall Study|Lost to Follow-up|19|||
154988558|NCT02669758|559385300|FG000|Overall Study|Adverse Event|16|||
154988559|NCT02669758|559385300|FG000|Overall Study|Non-Compliance with Study Drug|8|||
154988560|NCT02669758|559385300|FG000|Overall Study|Lack of Efficacy|5|||
154988561|NCT02669758|559385300|FG000|Overall Study|Pregnancy|1|||
154988562|NCT02669758|559385300|FG000|Overall Study|Study noncompliance|1|||
154988563|NCT02669758|559385300|FG000|Overall Study|Protocol Violation|1|||
154988564|NCT02455050|559385301|FG000|Treatment Period 1|Lost to Follow-up|1|||
154988565|NCT02455050|559385302|FG001|Treatment Period 1|Lost to Follow-up|1|||
154988566|NCT02455050|559385303|FG002|Treatment Period 1|Lost to Follow-up|1|||
154988567|NCT02455050|559385304|FG003|Treatment Period 1|Lost to Follow-up|2|||
154988568|NCT02455050|559385301|FG000|Treatment Period 2|Lost to Follow-up|1|||
154988569|NCT02455050|559385302|FG001|Treatment Period 2|Lost to Follow-up|0|||
154988570|NCT02455050|559385303|FG002|Treatment Period 2|Lost to Follow-up|2|||
154988571|NCT02455050|559385304|FG003|Treatment Period 2|Lost to Follow-up|1|||
154988572|NCT03402750|559385305|FG000|Overall Study|Lost to Follow-up|2|||
154988573|NCT03402750|559385306|FG001|Overall Study|Lost to Follow-up|1|||
154988574|NCT01831765|559385309|FG000|Overall Study|Lack of Efficacy|1|||
154988575|NCT01831765|559385310|FG001|Overall Study|Lack of Efficacy|0|||
154988576|NCT01831765|559385311|FG002|Overall Study|Lack of Efficacy|0|||
154988577|NCT01831765|559385309|FG000|Overall Study|Other, sponsor withdrew subject|0|||
154988578|NCT01831765|559385310|FG001|Overall Study|Other, sponsor withdrew subject|1|||
154988579|NCT01831765|559385311|FG002|Overall Study|Other, sponsor withdrew subject|0|||
154988580|NCT01831765|559385309|FG000|Overall Study|Pregnancy|1|||
154988581|NCT01831765|559385310|FG001|Overall Study|Pregnancy|1|||
154988582|NCT01831765|559385311|FG002|Overall Study|Pregnancy|2|||
154988583|NCT01831765|559385309|FG000|Overall Study|Death|0|||
154988584|NCT01831765|559385310|FG001|Overall Study|Death|1|||
154988585|NCT01831765|559385311|FG002|Overall Study|Death|1|||
154988586|NCT01831765|559385309|FG000|Overall Study|Other, site closed|1|||
154988587|NCT01831765|559385310|FG001|Overall Study|Other, site closed|1|||
154988588|NCT01831765|559385311|FG002|Overall Study|Other, site closed|0|||
154988589|NCT01831765|559385309|FG000|Overall Study|Adverse Event|5|||
154988590|NCT01831765|559385310|FG001|Overall Study|Adverse Event|3|||
154988591|NCT01831765|559385311|FG002|Overall Study|Adverse Event|3|||
154988592|NCT01831765|559385309|FG000|Overall Study|Withdrawal by Subject|22|||
154988593|NCT01831765|559385310|FG001|Overall Study|Withdrawal by Subject|7|||
154988594|NCT01831765|559385311|FG002|Overall Study|Withdrawal by Subject|17|||
154988595|NCT01831765|559385309|FG000|Overall Study|Withdrawal criteria|12|||
154988596|NCT01831765|559385310|FG001|Overall Study|Withdrawal criteria|10|||
154988597|NCT01831765|559385311|FG002|Overall Study|Withdrawal criteria|16|||
154988598|NCT01831765|559385309|FG000|Overall Study|Lost to Follow-up|2|||
154988599|NCT01831765|559385310|FG001|Overall Study|Lost to Follow-up|3|||
154988600|NCT01831765|559385311|FG002|Overall Study|Lost to Follow-up|3|||
154988601|NCT00080938|559385316|FG000|Overall Study|Adverse Event|3|||
154988602|NCT00080938|559385316|FG000|Overall Study|Withdrawal by Subject|6|||
155119963|NCT02374814|559868555|FG003|Overall Study|Withdrawal by Subject|1|||
155119964|NCT02374814|559868556|FG004|Overall Study|Withdrawal by Subject|0|||
155119965|NCT02374814|559868557|FG005|Overall Study|Withdrawal by Subject|0|||
155119966|NCT02182440|559868559|FG000|Overall Study|Adverse Event|0|||
155119967|NCT02182440|559868560|FG001|Overall Study|Adverse Event|1|||
155119968|NCT02182440|559868561|FG002|Overall Study|Adverse Event|0|||
155119969|NCT02182440|559868562|FG003|Overall Study|Adverse Event|0|||
155119970|NCT02182440|559868559|FG000|Overall Study|Death|31|||
155119971|NCT02182440|559868560|FG001|Overall Study|Death|8|||
155119972|NCT02182440|559868561|FG002|Overall Study|Death|5|||
155119973|NCT02182440|559868562|FG003|Overall Study|Death|16|||
155119974|NCT02182440|559868559|FG000|Overall Study|Protocol Violation|0|||
155119975|NCT02182440|559868560|FG001|Overall Study|Protocol Violation|1|||
155119976|NCT02182440|559868561|FG002|Overall Study|Protocol Violation|0|||
155119977|NCT02182440|559868562|FG003|Overall Study|Protocol Violation|0|||
154988603|NCT00080938|559385316|FG000|Overall Study|Death|2|||
154988604|NCT00080938|559385316|FG000|Overall Study|Lack of Efficacy|7|||
154988605|NCT00080938|559385316|FG000|Overall Study|other disease|1|||
154988606|NCT00080938|559385316|FG000|Overall Study|Not started protocol therapy|1|||
154988607|NCT00080938|559385316|FG000|Overall Study|Ineligible|4|||
154988608|NCT02116608|559385319|FG000|Overall Study|Lost to Follow-up|0|||
154988609|NCT02116608|559385320|FG001|Overall Study|Lost to Follow-up|0|||
154988610|NCT02116608|559385321|FG002|Overall Study|Lost to Follow-up|1|||
154988611|NCT02116608|559385319|FG000|Overall Study|Physician Decision|0|||
154988612|NCT02116608|559385320|FG001|Overall Study|Physician Decision|1|||
154988613|NCT02116608|559385321|FG002|Overall Study|Physician Decision|0|||
154988614|NCT02116608|559385319|FG000|Overall Study|Death|0|||
154988615|NCT02116608|559385320|FG001|Overall Study|Death|1|||
154988616|NCT02116608|559385321|FG002|Overall Study|Death|0|||
154988617|NCT00988442|559385322|FG000|Overall Study|Death|1|||
154988618|NCT00988442|559385323|FG001|Overall Study|Death|2|||
154988619|NCT00988442|559385322|FG000|Overall Study|Lost to Follow-up|0|||
154988620|NCT00988442|559385323|FG001|Overall Study|Lost to Follow-up|1|||
154988621|NCT00988442|559385322|FG000|Overall Study|Early Study Closure|29|||
154988622|NCT00988442|559385323|FG001|Overall Study|Early Study Closure|25|||
154988623|NCT00117325|559385324|FG000|Overall Study|Adverse Event|3|||
154988624|NCT00117325|559385325|FG001|Overall Study|Adverse Event|3|||
154988625|NCT00117325|559385324|FG000|Overall Study|Lost to Follow-up|1|||
154988626|NCT00117325|559385325|FG001|Overall Study|Lost to Follow-up|1|||
154988627|NCT00117325|559385324|FG000|Overall Study|Protocol Violation|2|||
154988628|NCT00117325|559385325|FG001|Overall Study|Protocol Violation|3|||
154988629|NCT00117325|559385324|FG000|Overall Study|Withdrawal by Subject|3|||
154988630|NCT00117325|559385325|FG001|Overall Study|Withdrawal by Subject|2|||
154988631|NCT00117325|559385324|FG000|Overall Study|Lack of Efficacy|1|||
154988632|NCT00117325|559385325|FG001|Overall Study|Lack of Efficacy|0|||
154988633|NCT00117325|559385324|FG000|Overall Study|Use of prohibited medicine|1|||
154988634|NCT00117325|559385325|FG001|Overall Study|Use of prohibited medicine|2|||
154988635|NCT00117325|559385324|FG000|Overall Study|Early termination|1|||
154988636|NCT00117325|559385325|FG001|Overall Study|Early termination|1|||
154988637|NCT00117325|559385324|FG000|Overall Study|Admisnitrative|1|||
154988638|NCT00117325|559385325|FG001|Overall Study|Admisnitrative|0|||
154988639|NCT02138136|559385326|FG000|Overall Study|Protocol Violation|4|||
154988640|NCT02138136|559385326|FG000|Overall Study|Physician Decision|7|||
154988641|NCT02138136|559385326|FG000|Overall Study|Lack of Efficacy|35|||
154988642|NCT02138136|559385326|FG000|Overall Study|Pregnancy|2|||
154988643|NCT02138136|559385326|FG000|Overall Study|Adverse Event|18|||
154988644|NCT02138136|559385326|FG000|Overall Study|Withdrawal by Subject|36|||
154988645|NCT02138136|559385326|FG000|Overall Study|Lost to Follow-up|32|||
154988646|NCT02138136|559385326|FG000|Overall Study|Withdrawn by Sponsor|5|||
154988647|NCT01359644|559385327|FG000|Treatment Period|Lack of Efficacy|0|||
154988648|NCT01359644|559385328|FG001|Treatment Period|Lack of Efficacy|1|||
154988649|NCT01359644|559385329|FG002|Treatment Period|Lack of Efficacy|0|||
154988650|NCT01359644|559385330|FG003|Treatment Period|Lack of Efficacy|0|||
154988651|NCT01359644|559385331|FG004|Treatment Period|Lack of Efficacy|0|||
154988652|NCT01359644|559385332|FG005|Treatment Period|Lack of Efficacy|0|||
154988653|NCT01359644|559385333|FG006|Treatment Period|Lack of Efficacy|0|||
154988654|NCT01359644|559385334|FG007|Treatment Period|Lack of Efficacy|0|||
154988655|NCT01359644|559385335|FG008|Treatment Period|Lack of Efficacy|0|||
154988656|NCT01359644|559385336|FG009|Treatment Period|Lack of Efficacy|0|||
154988657|NCT01359644|559385327|FG000|Treatment Period|Adverse Event|0|||
154988658|NCT01359644|559385328|FG001|Treatment Period|Adverse Event|0|||
154988659|NCT01359644|559385329|FG002|Treatment Period|Adverse Event|1|||
154988660|NCT01359644|559385330|FG003|Treatment Period|Adverse Event|0|||
155119978|NCT02182440|559868559|FG000|Overall Study|Physician Decision|1|||
154988661|NCT01359644|559385331|FG004|Treatment Period|Adverse Event|0|||
154988662|NCT01359644|559385332|FG005|Treatment Period|Adverse Event|1|||
154988663|NCT01359644|559385333|FG006|Treatment Period|Adverse Event|0|||
154988664|NCT01359644|559385334|FG007|Treatment Period|Adverse Event|0|||
154988665|NCT01359644|559385335|FG008|Treatment Period|Adverse Event|0|||
155119979|NCT02182440|559868560|FG001|Overall Study|Physician Decision|0|||
154988666|NCT01359644|559385336|FG009|Treatment Period|Adverse Event|0|||
154988667|NCT01359644|559385327|FG000|Treatment Period|Lost to Follow-up|0|||
154988668|NCT01359644|559385328|FG001|Treatment Period|Lost to Follow-up|0|||
154988669|NCT01359644|559385329|FG002|Treatment Period|Lost to Follow-up|0|||
154988670|NCT01359644|559385330|FG003|Treatment Period|Lost to Follow-up|0|||
154988671|NCT01359644|559385331|FG004|Treatment Period|Lost to Follow-up|0|||
154988672|NCT01359644|559385332|FG005|Treatment Period|Lost to Follow-up|1|||
154988673|NCT01359644|559385333|FG006|Treatment Period|Lost to Follow-up|0|||
154988674|NCT01359644|559385334|FG007|Treatment Period|Lost to Follow-up|0|||
154988675|NCT01359644|559385335|FG008|Treatment Period|Lost to Follow-up|0|||
154988676|NCT01359644|559385336|FG009|Treatment Period|Lost to Follow-up|0|||
154988677|NCT01359644|559385327|FG000|Follow-up Period|Withdrawal by Subject|0|||
154988678|NCT01359644|559385328|FG001|Follow-up Period|Withdrawal by Subject|0|||
154988679|NCT01359644|559385329|FG002|Follow-up Period|Withdrawal by Subject|0|||
154988680|NCT01359644|559385330|FG003|Follow-up Period|Withdrawal by Subject|0|||
154988681|NCT01359644|559385331|FG004|Follow-up Period|Withdrawal by Subject|0|||
154988682|NCT01359644|559385332|FG005|Follow-up Period|Withdrawal by Subject|1|||
154988683|NCT01359644|559385333|FG006|Follow-up Period|Withdrawal by Subject|0|||
154988684|NCT01359644|559385334|FG007|Follow-up Period|Withdrawal by Subject|0|||
154988685|NCT01359644|559385335|FG008|Follow-up Period|Withdrawal by Subject|0|||
154988686|NCT01359644|559385336|FG009|Follow-up Period|Withdrawal by Subject|0|||
154988687|NCT01359644|559385327|FG000|Follow-up Period|Lost to Follow-up|0|||
154988688|NCT01359644|559385328|FG001|Follow-up Period|Lost to Follow-up|0|||
154988689|NCT01359644|559385329|FG002|Follow-up Period|Lost to Follow-up|0|||
154988690|NCT01359644|559385330|FG003|Follow-up Period|Lost to Follow-up|0|||
154988691|NCT01359644|559385331|FG004|Follow-up Period|Lost to Follow-up|0|||
154988692|NCT01359644|559385332|FG005|Follow-up Period|Lost to Follow-up|0|||
154988693|NCT01359644|559385333|FG006|Follow-up Period|Lost to Follow-up|1|||
154988694|NCT01359644|559385334|FG007|Follow-up Period|Lost to Follow-up|2|||
154988695|NCT01359644|559385335|FG008|Follow-up Period|Lost to Follow-up|0|||
154988696|NCT01359644|559385336|FG009|Follow-up Period|Lost to Follow-up|0|||
154988697|NCT00311311|559385338|FG000|Overall Study|Adverse Event|3|||
154988698|NCT00311311|559385339|FG001|Overall Study|Adverse Event|2|||
154988699|NCT00311311|559385338|FG000|Overall Study|Withdrawal by Subject|1|||
154988700|NCT00311311|559385339|FG001|Overall Study|Withdrawal by Subject|1|||
154988701|NCT00311311|559385338|FG000|Overall Study|Noncompliance|0|||
154988702|NCT00311311|559385339|FG001|Overall Study|Noncompliance|1|||
154988703|NCT00311311|559385338|FG000|Overall Study|Study Termination by Sponsor|3|||
154988704|NCT00311311|559385339|FG001|Overall Study|Study Termination by Sponsor|4|||
154988705|NCT00311311|559385338|FG000|Overall Study|Death|1|||
154988706|NCT00311311|559385339|FG001|Overall Study|Death|0|||
154988707|NCT00311311|559385338|FG000|Overall Study|Lack of ancillary assistance|0|||
154988708|NCT00311311|559385339|FG001|Overall Study|Lack of ancillary assistance|1|||
154988709|NCT00546572|559385340|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
154988710|NCT00546572|559385341|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
154988711|NCT00546572|559385340|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
154988712|NCT00546572|559385341|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
154988713|NCT00546572|559385340|FG000|Vax 1 / Year 0|Protocol Violation|3|||
154988714|NCT00546572|559385341|FG001|Vax 1 / Year 0|Protocol Violation|4|||
154988715|NCT00546572|559385340|FG000|Vax 1 / Year 0|Death|2|||
154988716|NCT00546572|559385341|FG001|Vax 1 / Year 0|Death|2|||
154988717|NCT00546572|559385340|FG000|Vax 1 / Year 0|Adverse Event|0|||
154988718|NCT00546572|559385341|FG001|Vax 1 / Year 0|Adverse Event|1|||
154988719|NCT00546572|559385340|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
154988720|NCT00546572|559385341|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
154988721|NCT00546572|559385340|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
154988722|NCT00546572|559385341|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
154988723|NCT00546572|559385340|FG000|Vax 2 / Year 1|Other|1|||
154988724|NCT00546572|559385341|FG001|Vax 2 / Year 1|Other|1|||
154988725|NCT00546572|559385340|FG000|Vax 2 / Year 1|Adverse Event|1|||
154988726|NCT00546572|559385341|FG001|Vax 2 / Year 1|Adverse Event|0|||
154988727|NCT00546572|559385340|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
154988728|NCT00546572|559385341|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
154988729|NCT03979820|559385342|FG000|Overall Study|Protocol Violation|1|||
154988730|NCT03979820|559385343|FG001|Overall Study|Protocol Violation|0|||
154988731|NCT03979820|559385344|FG002|Overall Study|Protocol Violation|0|||
154988732|NCT03979820|559385345|FG003|Overall Study|Protocol Violation|0|||
154988733|NCT03979820|559385342|FG000|Overall Study|Withdrawal by Subject|0|||
154988734|NCT03979820|559385343|FG001|Overall Study|Withdrawal by Subject|0|||
154988735|NCT03979820|559385344|FG002|Overall Study|Withdrawal by Subject|1|||
154988736|NCT03979820|559385345|FG003|Overall Study|Withdrawal by Subject|0|||
154988737|NCT03979820|559385342|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
154988738|NCT03979820|559385343|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
154988739|NCT03979820|559385344|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
154988740|NCT03979820|559385345|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
155119980|NCT02182440|559868561|FG002|Overall Study|Physician Decision|0|||
155119981|NCT02182440|559868562|FG003|Overall Study|Physician Decision|0|||
155119982|NCT02182440|559868559|FG000|Overall Study|Withdrawal by Subject|1|||
155119983|NCT02182440|559868560|FG001|Overall Study|Withdrawal by Subject|1|||
155119984|NCT02182440|559868561|FG002|Overall Study|Withdrawal by Subject|3|||
155119985|NCT02182440|559868562|FG003|Overall Study|Withdrawal by Subject|4|||
155119986|NCT02182440|559868559|FG000|Overall Study|different, e.g adm other hospital|12|||
155119987|NCT02182440|559868560|FG001|Overall Study|different, e.g adm other hospital|3|||
155119988|NCT02182440|559868561|FG002|Overall Study|different, e.g adm other hospital|3|||
155119989|NCT02182440|559868562|FG003|Overall Study|different, e.g adm other hospital|10|||
155119990|NCT03754582|559868563|FG000|Treatment Phase|Adverse Event|0|||
155119991|NCT03754582|559868564|FG001|Treatment Phase|Adverse Event|1|||
155119992|NCT03754582|559868565|FG002|Treatment Phase|Adverse Event|0|||
155119993|NCT03754582|559868563|FG000|Follow-up Phase|Other|0|||
155119994|NCT03754582|559868564|FG001|Follow-up Phase|Other|0|||
155119995|NCT03754582|559868565|FG002|Follow-up Phase|Other|1|||
155119996|NCT01561755|559868568|FG000|Overall Study|Lost to Follow-up|0|||
155119997|NCT01561755|559868569|FG001|Overall Study|Lost to Follow-up|1|||
155119998|NCT02981407|559868570|FG000|Overall Study|Withdrawal by Subject|2|||
155119999|NCT02981407|559868571|FG001|Overall Study|Withdrawal by Subject|0|||
155120000|NCT02818036|559868579|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
155120001|NCT02818036|559868580|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
155120002|NCT02818036|559868579|FG000|Overall Study|Withdrawal by Subject|1|||
155120003|NCT02818036|559868580|FG001|Overall Study|Withdrawal by Subject|0|||
155120004|NCT01319721|559868581|FG000|Overall Study|Lost to Follow-up|1|||
155120005|NCT01319721|559868582|FG001|Overall Study|Lost to Follow-up|6|||
155120006|NCT00468845|559868583|FG000|Overall Study|Adverse Event|9|||
155120007|NCT00468845|559868584|FG001|Overall Study|Adverse Event|14|||
155120008|NCT00468845|559868585|FG002|Overall Study|Adverse Event|11|||
155120009|NCT00468845|559868583|FG000|Overall Study|Lost to Follow-up|2|||
155120010|NCT00468845|559868584|FG001|Overall Study|Lost to Follow-up|1|||
155120011|NCT00468845|559868585|FG002|Overall Study|Lost to Follow-up|2|||
155120012|NCT00468845|559868583|FG000|Overall Study|Other|4|||
155120013|NCT00468845|559868584|FG001|Overall Study|Other|9|||
155120014|NCT00468845|559868585|FG002|Overall Study|Other|5|||
155120015|NCT00468845|559868583|FG000|Overall Study|No longer willing to participate|5|||
155120016|NCT00468845|559868584|FG001|Overall Study|No longer willing to participate|6|||
155120017|NCT00468845|559868585|FG002|Overall Study|No longer willing to participate|10|||
155120018|NCT00468845|559868583|FG000|Overall Study|Randomized, not treated|1|||
155120019|NCT00468845|559868584|FG001|Overall Study|Randomized, not treated|4|||
155120020|NCT00468845|559868585|FG002|Overall Study|Randomized, not treated|2|||
155120021|NCT01930890|559870872|FG000|Overall Study|Study Termination|14|||
155120022|NCT01930890|559870873|FG001|Overall Study|Study Termination|28|||
155120023|NCT01930890|559870874|FG002|Overall Study|Study Termination|13|||
155120024|NCT01930890|559870875|FG003|Overall Study|Study Termination|25|||
155120025|NCT01930890|559870872|FG000|Overall Study|Death|0|||
155120026|NCT01930890|559870873|FG001|Overall Study|Death|0|||
155120027|NCT01930890|559870874|FG002|Overall Study|Death|0|||
155120028|NCT01930890|559870875|FG003|Overall Study|Death|1|||
155120029|NCT01930890|559870872|FG000|Overall Study|Investigator Decision|0|||
155120030|NCT01930890|559870873|FG001|Overall Study|Investigator Decision|1|||
155120031|NCT01930890|559870874|FG002|Overall Study|Investigator Decision|0|||
155120032|NCT01930890|559870875|FG003|Overall Study|Investigator Decision|0|||
155120033|NCT01930890|559870872|FG000|Overall Study|Consent Withdrawn|0|||
155120034|NCT01930890|559870873|FG001|Overall Study|Consent Withdrawn|3|||
155120035|NCT01930890|559870874|FG002|Overall Study|Consent Withdrawn|0|||
155120036|NCT01930890|559870875|FG003|Overall Study|Consent Withdrawn|1|||
155120037|NCT01930890|559870872|FG000|Overall Study|Adverse Event|0|||
155120038|NCT01930890|559870873|FG001|Overall Study|Adverse Event|1|||
155120039|NCT01930890|559870874|FG002|Overall Study|Adverse Event|0|||
155120040|NCT01930890|559870875|FG003|Overall Study|Adverse Event|0|||
155120041|NCT02838901|559870876|FG000|Overall Study|Withdrawal by Subject|1|||
155120042|NCT02838901|559870877|FG001|Overall Study|Withdrawal by Subject|1|||
155120043|NCT02838901|559870876|FG000|Overall Study|Lost to Follow-up|1|||
155120044|NCT02838901|559870877|FG001|Overall Study|Lost to Follow-up|1|||
155120045|NCT02285114|559870879|FG000|Main Phase|Investigator's Discretion|0|||
155120046|NCT02285114|559870880|FG001|Main Phase|Investigator's Discretion|2|||
155120047|NCT02285114|559870881|FG002|Main Phase|Investigator's Discretion|0|||
155120048|NCT02285114|559870882|FG003|Main Phase|Investigator's Discretion|0|||
155120049|NCT02285114|559870883|FG004|Main Phase|Investigator's Discretion|0|||
154988741|NCT00536263|559385346|FG000|Overall Study|Adverse Event|5|||
155120050|NCT02285114|559870884|FG005|Main Phase|Investigator's Discretion|0|||
155120051|NCT02285114|559870879|FG000|Main Phase|Enrolled but Never Treated|1|||
155120052|NCT02285114|559870880|FG001|Main Phase|Enrolled but Never Treated|0|||
155120053|NCT02285114|559870881|FG002|Main Phase|Enrolled but Never Treated|0|||
155120054|NCT02285114|559870882|FG003|Main Phase|Enrolled but Never Treated|0|||
155120055|NCT02285114|559870883|FG004|Main Phase|Enrolled but Never Treated|0|||
155120056|NCT02285114|559870884|FG005|Main Phase|Enrolled but Never Treated|0|||
155120057|NCT02285114|559870879|FG000|Main Phase|Withdrew Consent|0|||
155120058|NCT02285114|559870880|FG001|Main Phase|Withdrew Consent|0|||
155120059|NCT02285114|559870881|FG002|Main Phase|Withdrew Consent|1|||
155120060|NCT02285114|559870882|FG003|Main Phase|Withdrew Consent|0|||
155120061|NCT02285114|559870883|FG004|Main Phase|Withdrew Consent|0|||
155120062|NCT02285114|559870884|FG005|Main Phase|Withdrew Consent|0|||
155120063|NCT02285114|559870879|FG000|Extension Phase|Investigator's Discretion|0|||
155120064|NCT02285114|559870880|FG001|Extension Phase|Investigator's Discretion|0|||
155120065|NCT02285114|559870881|FG002|Extension Phase|Investigator's Discretion|0|||
155120066|NCT02285114|559870882|FG003|Extension Phase|Investigator's Discretion|14|||
155120067|NCT02285114|559870883|FG004|Extension Phase|Investigator's Discretion|1|||
155120068|NCT02285114|559870884|FG005|Extension Phase|Investigator's Discretion|0|||
155120069|NCT02285114|559870879|FG000|Extension Phase|Lost to Follow-up|0|||
155120070|NCT02285114|559870880|FG001|Extension Phase|Lost to Follow-up|0|||
155120071|NCT02285114|559870881|FG002|Extension Phase|Lost to Follow-up|0|||
155120072|NCT02285114|559870882|FG003|Extension Phase|Lost to Follow-up|1|||
155120073|NCT02285114|559870883|FG004|Extension Phase|Lost to Follow-up|1|||
155120074|NCT02285114|559870884|FG005|Extension Phase|Lost to Follow-up|0|||
155120075|NCT02285114|559870879|FG000|Extension Phase|Non-compliance with Study Drug|0|||
155120076|NCT02285114|559870880|FG001|Extension Phase|Non-compliance with Study Drug|0|||
155120077|NCT02285114|559870881|FG002|Extension Phase|Non-compliance with Study Drug|0|||
155120078|NCT02285114|559870882|FG003|Extension Phase|Non-compliance with Study Drug|2|||
155120079|NCT02285114|559870883|FG004|Extension Phase|Non-compliance with Study Drug|0|||
155120080|NCT02285114|559870884|FG005|Extension Phase|Non-compliance with Study Drug|0|||
155120081|NCT02285114|559870879|FG000|Extension Phase|Pregnancy|0|||
155120082|NCT02285114|559870880|FG001|Extension Phase|Pregnancy|0|||
155120083|NCT02285114|559870881|FG002|Extension Phase|Pregnancy|0|||
155120084|NCT02285114|559870882|FG003|Extension Phase|Pregnancy|1|||
155120085|NCT02285114|559870883|FG004|Extension Phase|Pregnancy|0|||
155120086|NCT02285114|559870884|FG005|Extension Phase|Pregnancy|0|||
155120087|NCT01156389|559870885|FG000|Overall Study|Elevated liver enzymes|4|||
155120088|NCT01156389|559870886|FG001|Overall Study|Elevated liver enzymes|0|||
155120089|NCT01156389|559870885|FG000|Overall Study|Vomiting|0|||
155120090|NCT01156389|559870886|FG001|Overall Study|Vomiting|1|||
155120091|NCT02351349|559870887|FG000|Overall Study|Withdrawal by Subject|2|||
155120092|NCT02351349|559870888|FG001|Overall Study|Withdrawal by Subject|3|||
155120093|NCT00350623|559870889|FG000|Overall Study|Lost to Follow-up|8|||
155120094|NCT00350623|559870890|FG001|Overall Study|Lost to Follow-up|3|||
155120095|NCT00350623|559870891|FG002|Overall Study|Lost to Follow-up|4|||
155120096|NCT00350623|559870889|FG000|Overall Study|Withdrawal by Subject|0|||
155120097|NCT00350623|559870890|FG001|Overall Study|Withdrawal by Subject|1|||
155120098|NCT00350623|559870891|FG002|Overall Study|Withdrawal by Subject|1|||
155120099|NCT00350623|559870889|FG000|Overall Study|patient traveling outside the country|0|||
155120100|NCT00350623|559870890|FG001|Overall Study|patient traveling outside the country|0|||
155120101|NCT00350623|559870891|FG002|Overall Study|patient traveling outside the country|1|||
155120102|NCT04126564|559870895|FG000|Overall Study|Withdrawal by Subject|0|||
155120103|NCT04126564|559870896|FG001|Overall Study|Withdrawal by Subject|2|||
155120104|NCT04126564|559870895|FG000|Overall Study|Lost to Follow-up|0|||
155120105|NCT04126564|559870896|FG001|Overall Study|Lost to Follow-up|1|||
155120106|NCT02536300|559870902|FG000|Overall Study|Investigator's Discretion|17|||
155120107|NCT02536300|559870903|FG001|Overall Study|Investigator's Discretion|11|||
155120108|NCT02536300|559870904|FG002|Overall Study|Investigator's Discretion|2|||
155120109|NCT02536300|559870902|FG000|Overall Study|Progressive Disease|11|||
155120110|NCT02536300|559870903|FG001|Overall Study|Progressive Disease|7|||
155120111|NCT02536300|559870904|FG002|Overall Study|Progressive Disease|6|||
155120112|NCT02536300|559870902|FG000|Overall Study|Study Terminated by Sponsor|6|||
155120113|NCT02536300|559870903|FG001|Overall Study|Study Terminated by Sponsor|4|||
155120114|NCT02536300|559870904|FG002|Overall Study|Study Terminated by Sponsor|7|||
155120115|NCT02536300|559870902|FG000|Overall Study|Death|7|||
155120116|NCT02536300|559870903|FG001|Overall Study|Death|0|||
155120117|NCT02536300|559870904|FG002|Overall Study|Death|5|||
155120118|NCT02536300|559870902|FG000|Overall Study|Withdrew Consent|4|||
155120119|NCT02536300|559870903|FG001|Overall Study|Withdrew Consent|2|||
155120120|NCT02536300|559870904|FG002|Overall Study|Withdrew Consent|0|||
155120121|NCT02536300|559870902|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
155120122|NCT02536300|559870903|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
154988742|NCT00536263|559385347|FG001|Overall Study|Adverse Event|5|||
155120123|NCT02536300|559870904|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
155120124|NCT02536300|559870902|FG000|Overall Study|Enrolled but Never Treated|0|||
155120125|NCT02536300|559870903|FG001|Overall Study|Enrolled but Never Treated|0|||
155120126|NCT02536300|559870904|FG002|Overall Study|Enrolled but Never Treated|1|||
155120127|NCT02536300|559870902|FG000|Overall Study|Non-compliance With Study Drug|1|||
155120128|NCT02536300|559870903|FG001|Overall Study|Non-compliance With Study Drug|0|||
155120129|NCT02536300|559870904|FG002|Overall Study|Non-compliance With Study Drug|0|||
155120130|NCT02536300|559870902|FG000|Overall Study|Protocol Violation|0|||
155120131|NCT02536300|559870903|FG001|Overall Study|Protocol Violation|1|||
154988743|NCT00536263|559385348|FG002|Overall Study|Adverse Event|7|||
155120132|NCT02536300|559870904|FG002|Overall Study|Protocol Violation|0|||
155120133|NCT03298984|559870910|FG000|Overall Study|Physician Decision|1|||
155120134|NCT03298984|559870911|FG001|Overall Study|Physician Decision|0|||
154916794|NCT01072175|559118480|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916795|NCT01072175|559118481|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916796|NCT01072175|559118482|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916797|NCT01072175|559118483|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916798|NCT01072175|559118484|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
154916799|NCT01072175|559118485|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
154916800|NCT01072175|559118486|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
154916801|NCT01072175|559118487|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916802|NCT01072175|559118488|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916803|NCT01072175|559118489|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916804|NCT01072175|559118490|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916805|NCT01072175|559118491|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
154916806|NCT01072175|559118479|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916807|NCT01072175|559118480|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916808|NCT01072175|559118481|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916809|NCT01072175|559118482|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916810|NCT01072175|559118483|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916811|NCT01072175|559118484|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
154916812|NCT01072175|559118485|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
154916813|NCT01072175|559118486|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916814|NCT01072175|559118487|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916815|NCT01072175|559118488|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916816|NCT01072175|559118489|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916817|NCT01072175|559118490|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916818|NCT01072175|559118491|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
154916819|NCT01072175|559118479|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916820|NCT01072175|559118480|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916821|NCT01072175|559118481|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916822|NCT01072175|559118482|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916823|NCT01072175|559118483|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916824|NCT01072175|559118484|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916825|NCT01072175|559118485|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916826|NCT01072175|559118486|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916827|NCT01072175|559118487|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
154916828|NCT01072175|559118488|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916829|NCT01072175|559118489|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916830|NCT01072175|559118490|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916831|NCT01072175|559118491|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
154916832|NCT01072175|559118479|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916833|NCT01072175|559118480|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916834|NCT01072175|559118481|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916835|NCT01072175|559118482|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916836|NCT01072175|559118483|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916837|NCT01072175|559118484|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916838|NCT01072175|559118485|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916839|NCT01072175|559118486|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916840|NCT01072175|559118487|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
154916841|NCT01072175|559118488|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916842|NCT01072175|559118489|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916843|NCT01072175|559118490|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916844|NCT01072175|559118491|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
154916845|NCT01072175|559118479|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916846|NCT01072175|559118480|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916847|NCT01072175|559118481|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916848|NCT01072175|559118482|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916849|NCT01072175|559118483|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916850|NCT01072175|559118484|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916851|NCT01072175|559118485|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916852|NCT01072175|559118486|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154988744|NCT00536263|559385346|FG000|Overall Study|Lost to Follow-up|3|||
155120135|NCT03298984|559870912|FG002|Overall Study|Physician Decision|0|||
155176783|NCT02108262|560086441|FG001|Overall Study|Patient did not want another infusion|3|||
155176784|NCT02108262|560086442|FG002|Overall Study|Patient did not want another infusion|3|||
155176785|NCT02108262|560086443|FG003|Overall Study|Patient did not want another infusion|2|||
155176786|NCT02108262|560086440|FG000|Overall Study|Vacation|0|||
155176787|NCT02108262|560086441|FG001|Overall Study|Vacation|1|||
155176788|NCT02108262|560086442|FG002|Overall Study|Vacation|0|||
155176789|NCT02108262|560086443|FG003|Overall Study|Vacation|0|||
155176790|NCT02108262|560086440|FG000|Overall Study|Patient decision|0|||
155176791|NCT02108262|560086441|FG001|Overall Study|Patient decision|7|||
155176792|NCT02108262|560086442|FG002|Overall Study|Patient decision|9|||
155176793|NCT02108262|560086443|FG003|Overall Study|Patient decision|14|||
155176794|NCT02108262|560086440|FG000|Overall Study|Missed IV due to pharmacy error|0|||
155176795|NCT02108262|560086441|FG001|Overall Study|Missed IV due to pharmacy error|0|||
155176796|NCT02108262|560086442|FG002|Overall Study|Missed IV due to pharmacy error|1|||
155176797|NCT02108262|560086443|FG003|Overall Study|Missed IV due to pharmacy error|0|||
155176798|NCT05027971|560086444|FG000|Overall Study|Physician Decision|7|||
155176799|NCT05027971|560086445|FG001|Overall Study|Physician Decision|3|||
155176800|NCT05027971|560086444|FG000|Overall Study|Lost to Follow-up|1|||
155176801|NCT05027971|560086445|FG001|Overall Study|Lost to Follow-up|1|||
155176802|NCT05027971|560086444|FG000|Overall Study|Withdrawal by Subject|0|||
155176803|NCT05027971|560086445|FG001|Overall Study|Withdrawal by Subject|2|||
155176804|NCT05027971|560086444|FG000|Overall Study|Non-study fiber used.|0|||
155176805|NCT05027971|560086445|FG001|Overall Study|Non-study fiber used.|1|||
155176806|NCT05027971|560086444|FG000|Overall Study|Protocol Violation|0|||
155176807|NCT05027971|560086445|FG001|Overall Study|Protocol Violation|2|||
155176808|NCT00796523|560086446|FG000|Overall Study|Lost to Follow-up|9|||
155176809|NCT00796523|560086447|FG001|Overall Study|Lost to Follow-up|7|||
155176810|NCT00439738|560086449|FG000|Overall Study|Withdrawal by Subject|16|||
155176811|NCT00439738|560086450|FG001|Overall Study|Withdrawal by Subject|13|||
155176812|NCT00439738|560086449|FG000|Overall Study|Adverse Event|6|||
155176813|NCT00439738|560086450|FG001|Overall Study|Adverse Event|4|||
155176814|NCT00439738|560086449|FG000|Overall Study|Lost to Follow-up|5|||
155176815|NCT00439738|560086450|FG001|Overall Study|Lost to Follow-up|6|||
155176816|NCT00439738|560086449|FG000|Overall Study|Protocol Violation|6|||
155176817|NCT00439738|560086450|FG001|Overall Study|Protocol Violation|3|||
155176818|NCT00439738|560086449|FG000|Overall Study|Lack of Efficacy|2|||
155176819|NCT00439738|560086450|FG001|Overall Study|Lack of Efficacy|2|||
155176820|NCT00439738|560086449|FG000|Overall Study|Abnormal Lab Values|1|||
155176821|NCT00439738|560086450|FG001|Overall Study|Abnormal Lab Values|0|||
155176822|NCT02576145|560086451|FG000|Overall Study|Adverse Event|1|||
155176823|NCT02576145|560086452|FG001|Overall Study|Adverse Event|0|||
155176824|NCT02576145|560086451|FG000|Overall Study|Withdrawal by Subject|1|||
155176825|NCT02576145|560086452|FG001|Overall Study|Withdrawal by Subject|0|||
155176826|NCT02576145|560086451|FG000|Overall Study|Acute rejection|1|||
155176827|NCT02576145|560086452|FG001|Overall Study|Acute rejection|0|||
155176828|NCT02576145|560086451|FG000|Overall Study|Tetanus Titers Decreased|0|||
155176829|NCT02576145|560086452|FG001|Overall Study|Tetanus Titers Decreased|1|||
155176830|NCT00781885|560086453|FG000|Overall Study|Physician Decision|1|||
155176831|NCT01755026|560086454|FG000|Overall Study|Adverse Event|1|||
155176832|NCT01755026|560086455|FG001|Overall Study|Adverse Event|0|||
155176833|NCT01755026|560086454|FG000|Overall Study|Withdrawal by Subject|1|||
155176834|NCT01755026|560086455|FG001|Overall Study|Withdrawal by Subject|1|||
155176835|NCT02395302|560086458|FG000|Overall Study|Screen Failure|3|||
155176836|NCT02395302|560086458|FG000|Overall Study|Run In Failure|7|||
155176837|NCT02395302|560086458|FG000|Overall Study|Withdrawal by Subject|2|||
155176838|NCT02395302|560086458|FG000|Overall Study|Physician Decision|2|||
155176839|NCT00160667|560086459|FG000|Overall Study|Adverse Event|3|||
155176840|NCT00160667|560086460|FG001|Overall Study|Adverse Event|1|||
155176841|NCT00160667|560086461|FG002|Overall Study|Adverse Event|4|||
155176842|NCT00160667|560086459|FG000|Overall Study|Withdrawal by Subject|2|||
155176843|NCT00160667|560086460|FG001|Overall Study|Withdrawal by Subject|0|||
155176844|NCT00160667|560086461|FG002|Overall Study|Withdrawal by Subject|1|||
155176845|NCT00160667|560086459|FG000|Overall Study|Lack of Efficacy|0|||
155176846|NCT00160667|560086460|FG001|Overall Study|Lack of Efficacy|1|||
155176847|NCT00160667|560086461|FG002|Overall Study|Lack of Efficacy|0|||
155176848|NCT00160667|560086459|FG000|Overall Study|Protocol Violation|0|||
155176849|NCT00160667|560086460|FG001|Overall Study|Protocol Violation|1|||
155176850|NCT00160667|560086461|FG002|Overall Study|Protocol Violation|0|||
155176851|NCT00160667|560086459|FG000|Overall Study|Patient decision|0|||
155176852|NCT00160667|560086460|FG001|Overall Study|Patient decision|0|||
155176853|NCT00160667|560086461|FG002|Overall Study|Patient decision|1|||
155176854|NCT01806662|560086464|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
155176855|NCT01806662|560086465|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
155176856|NCT01806662|560086464|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
155176857|NCT01806662|560086465|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
155176858|NCT01806662|560086464|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
155176859|NCT01806662|560086465|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
155176860|NCT01806662|560086464|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
155176861|NCT01806662|560086465|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
155176862|NCT00043550|560086466|FG000|Overall Study|Withdrawal by Subject|22|||
155176863|NCT00043550|560086467|FG001|Overall Study|Withdrawal by Subject|12|||
155176864|NCT00043550|560086468|FG002|Overall Study|Withdrawal by Subject|20|||
155176865|NCT02285062|560086471|FG000|Pre-Treatment Period|Protocol Violation|0|||
155176866|NCT02285062|560086472|FG001|Pre-Treatment Period|Protocol Violation|2|||
155176867|NCT02285062|560086471|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
155176868|NCT02285062|560086472|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155176869|NCT00545129|560086478|FG000|Overall Study|Lack of Efficacy|2|||
155176870|NCT00545129|560086479|FG001|Overall Study|Lack of Efficacy|5|||
155176871|NCT00545129|560086478|FG000|Overall Study|Death|2|||
155176872|NCT00545129|560086479|FG001|Overall Study|Death|1|||
155176873|NCT00545129|560086478|FG000|Overall Study|Adverse Event|1|||
155176874|NCT00545129|560086479|FG001|Overall Study|Adverse Event|1|||
155176875|NCT00545129|560086478|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
155176876|NCT00545129|560086479|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
155176877|NCT00545129|560086478|FG000|Overall Study|Other|3|||
155176878|NCT00545129|560086479|FG001|Overall Study|Other|3|||
155176879|NCT00821509|560086480|FG000|Overall Study|Withdrawal by Subject|12|||
155176880|NCT00821509|560086481|FG001|Overall Study|Withdrawal by Subject|11|||
155176881|NCT00821509|560086482|FG002|Overall Study|Withdrawal by Subject|34|||
155176882|NCT00807573|560086484|FG000|Overall Study|Withdrawal by Subject|1|||
155176883|NCT00807573|560086484|FG000|Overall Study|Adverse Event|1|||
155176884|NCT01551420|560086485|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
155176885|NCT01551420|560086486|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
155120136|NCT03298984|559870913|FG003|Overall Study|Physician Decision|6|||
155120137|NCT03298984|559870910|FG000|Overall Study|Lack of Efficacy|0|||
155120138|NCT03298984|559870911|FG001|Overall Study|Lack of Efficacy|1|||
155120139|NCT03298984|559870912|FG002|Overall Study|Lack of Efficacy|1|||
155120140|NCT03298984|559870913|FG003|Overall Study|Lack of Efficacy|4|||
155120141|NCT03298984|559870910|FG000|Overall Study|Relapsed disease (following remission)|0|||
155120142|NCT03298984|559870911|FG001|Overall Study|Relapsed disease (following remission)|0|||
155120143|NCT03298984|559870912|FG002|Overall Study|Relapsed disease (following remission)|1|||
155120144|NCT03298984|559870913|FG003|Overall Study|Relapsed disease (following remission)|1|||
155120145|NCT03298984|559870910|FG000|Overall Study|Adverse Event|0|||
155120146|NCT03298984|559870911|FG001|Overall Study|Adverse Event|0|||
155120147|NCT03298984|559870912|FG002|Overall Study|Adverse Event|0|||
155120148|NCT03298984|559870913|FG003|Overall Study|Adverse Event|1|||
155120149|NCT03298984|559870910|FG000|Overall Study|Death|0|||
155120150|NCT03298984|559870911|FG001|Overall Study|Death|0|||
155120151|NCT03298984|559870912|FG002|Overall Study|Death|0|||
155120152|NCT03298984|559870913|FG003|Overall Study|Death|2|||
155120153|NCT03298984|559870910|FG000|Overall Study|Insurance Company Decision|0|||
155120154|NCT03298984|559870911|FG001|Overall Study|Insurance Company Decision|0|||
155120155|NCT03298984|559870912|FG002|Overall Study|Insurance Company Decision|0|||
155120156|NCT03298984|559870913|FG003|Overall Study|Insurance Company Decision|1|||
155120157|NCT00585221|559870916|FG000|Overall Study|Protocol Violation|8|||
155120158|NCT03263923|559870918|FG000|Overall Study|Withdrawal by Subject|10|||
155120159|NCT03263923|559870919|FG001|Overall Study|Withdrawal by Subject|8|||
155120160|NCT03263923|559870918|FG000|Overall Study|Lost to Follow-up|15|||
155120161|NCT03263923|559870919|FG001|Overall Study|Lost to Follow-up|13|||
155120162|NCT02229214|559870924|FG000|Overall Study|Adverse Event|2|||
155120163|NCT02229214|559870925|FG001|Overall Study|Adverse Event|0|||
155120164|NCT02229214|559870924|FG000|Overall Study|Withdrawal by Subject|4|||
155120165|NCT02229214|559870925|FG001|Overall Study|Withdrawal by Subject|0|||
155120166|NCT00246025|559870932|FG000|Overall Study|Adverse Event|7|||
155120167|NCT00246025|559870933|FG001|Overall Study|Adverse Event|9|||
155120168|NCT00246025|559870934|FG002|Overall Study|Adverse Event|9|||
155120169|NCT00246025|559870935|FG003|Overall Study|Adverse Event|10|||
155120170|NCT00246025|559870932|FG000|Overall Study|Withdrawal by Subject|3|||
155120171|NCT00246025|559870933|FG001|Overall Study|Withdrawal by Subject|0|||
155176886|NCT01551420|560086485|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
155176887|NCT01551420|560086486|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
155176888|NCT01551420|560086485|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
155176889|NCT01551420|560086486|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
155120172|NCT00246025|559870934|FG002|Overall Study|Withdrawal by Subject|1|||
155120173|NCT00246025|559870935|FG003|Overall Study|Withdrawal by Subject|2|||
155120174|NCT00246025|559870932|FG000|Overall Study|unsuitable medical history was found|0|||
155120175|NCT00246025|559870933|FG001|Overall Study|unsuitable medical history was found|0|||
155120176|NCT00246025|559870934|FG002|Overall Study|unsuitable medical history was found|0|||
155120177|NCT00246025|559870935|FG003|Overall Study|unsuitable medical history was found|1|||
155120178|NCT01643850|559870936|FG000|Overall Study|Withdrawal by Subject|0|||
155120179|NCT01643850|559870937|FG001|Overall Study|Withdrawal by Subject|0|||
155176890|NCT01551420|560086485|FG000|Screened for Part B Eligibility|Declined participation|8|||
155176891|NCT01551420|560086486|FG001|Screened for Part B Eligibility|Declined participation|1|||
155176892|NCT01551420|560086485|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
155176893|NCT01551420|560086486|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
155176894|NCT01551420|560086485|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
155176895|NCT01551420|560086486|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
155176896|NCT01551420|560086485|FG000|Home Use (Part B)|Withdrawal by staff|0|||
155176897|NCT01551420|560086486|FG001|Home Use (Part B)|Withdrawal by staff|1|||
155176898|NCT00169442|560086487|FG000|Overall Study|Withdrawal by Subject|0|||
155176899|NCT00169442|560086488|FG001|Overall Study|Withdrawal by Subject|0|||
155176900|NCT00169442|560086489|FG002|Overall Study|Withdrawal by Subject|1|||
155176901|NCT00169442|560086490|FG003|Overall Study|Withdrawal by Subject|0|||
155176902|NCT00169442|560086491|FG004|Overall Study|Withdrawal by Subject|0|||
155176903|NCT00169442|560086492|FG005|Overall Study|Withdrawal by Subject|0|||
155176904|NCT00169442|560086487|FG000|Overall Study|Migrated/moved from study area|0|||
155176905|NCT00169442|560086488|FG001|Overall Study|Migrated/moved from study area|0|||
155176906|NCT00169442|560086489|FG002|Overall Study|Migrated/moved from study area|0|||
155176907|NCT00169442|560086490|FG003|Overall Study|Migrated/moved from study area|0|||
155176908|NCT00169442|560086491|FG004|Overall Study|Migrated/moved from study area|0|||
155176909|NCT00169442|560086492|FG005|Overall Study|Migrated/moved from study area|2|||
155176910|NCT00169442|560086487|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155176911|NCT00169442|560086488|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155176912|NCT00169442|560086489|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155176913|NCT00169442|560086490|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155176914|NCT00169442|560086491|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
155176915|NCT00169442|560086492|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
155176916|NCT00169442|560086487|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155176917|NCT00169442|560086488|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
155176918|NCT00169442|560086489|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155176919|NCT00169442|560086490|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155176920|NCT00169442|560086491|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155176921|NCT00169442|560086492|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
155176922|NCT01426789|560086493|FG000|Part 1|Protocol deviation|0|||
155176923|NCT01426789|560086494|FG001|Part 1|Protocol deviation|1|||
155176924|NCT01426789|560086495|FG002|Part 1|Protocol deviation|0|||
155176925|NCT01426789|560086496|FG003|Part 1|Protocol deviation|0|||
155176926|NCT01426789|560086497|FG004|Part 1|Protocol deviation|0|||
155176927|NCT01426789|560086498|FG005|Part 1|Protocol deviation|0|||
155176928|NCT01426789|560086493|FG000|Part 1|Lost to Follow-up|1|||
155176929|NCT01426789|560086494|FG001|Part 1|Lost to Follow-up|2|||
155176930|NCT01426789|560086495|FG002|Part 1|Lost to Follow-up|0|||
155176931|NCT01426789|560086496|FG003|Part 1|Lost to Follow-up|0|||
155176932|NCT01426789|560086497|FG004|Part 1|Lost to Follow-up|0|||
155176933|NCT01426789|560086498|FG005|Part 1|Lost to Follow-up|0|||
155176934|NCT01426789|560086493|FG000|Part 1|Lack of Efficacy|2|||
155176935|NCT01426789|560086494|FG001|Part 1|Lack of Efficacy|1|||
155176936|NCT01426789|560086495|FG002|Part 1|Lack of Efficacy|0|||
155176937|NCT01426789|560086496|FG003|Part 1|Lack of Efficacy|0|||
155176938|NCT01426789|560086497|FG004|Part 1|Lack of Efficacy|0|||
154916853|NCT01072175|559118487|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
154916854|NCT01072175|559118488|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916855|NCT01072175|559118489|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916856|NCT01072175|559118490|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916857|NCT01072175|559118491|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
154916858|NCT01072175|559118479|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916859|NCT01072175|559118480|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916860|NCT01072175|559118481|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916861|NCT01072175|559118482|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916862|NCT01072175|559118483|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916863|NCT01072175|559118484|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916864|NCT01072175|559118485|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916865|NCT01072175|559118486|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916866|NCT01072175|559118487|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
154916867|NCT01072175|559118488|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916868|NCT01072175|559118489|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154988745|NCT00536263|559385347|FG001|Overall Study|Lost to Follow-up|4|||
155176939|NCT01426789|560086498|FG005|Part 1|Lack of Efficacy|0|||
155176940|NCT01426789|560086493|FG000|Part 1|Adverse Event|3|||
155176941|NCT01426789|560086494|FG001|Part 1|Adverse Event|0|||
155176942|NCT01426789|560086495|FG002|Part 1|Adverse Event|0|||
155176943|NCT01426789|560086496|FG003|Part 1|Adverse Event|0|||
155176944|NCT01426789|560086497|FG004|Part 1|Adverse Event|0|||
155176945|NCT01426789|560086498|FG005|Part 1|Adverse Event|0|||
155176946|NCT01426789|560086493|FG000|Part 2|Protocol deviation|0|||
155176947|NCT01426789|560086494|FG001|Part 2|Protocol deviation|0|||
154988746|NCT00536263|559385348|FG002|Overall Study|Lost to Follow-up|4|||
154988747|NCT00536263|559385346|FG000|Overall Study|Subject withdrew - not treatment related|2|||
154988748|NCT00536263|559385347|FG001|Overall Study|Subject withdrew - not treatment related|0|||
154988749|NCT00536263|559385348|FG002|Overall Study|Subject withdrew - not treatment related|5|||
154988750|NCT00536263|559385346|FG000|Overall Study|Subject withdrew - treatment related|0|||
155176948|NCT01426789|560086495|FG002|Part 2|Protocol deviation|1|||
155176949|NCT01426789|560086496|FG003|Part 2|Protocol deviation|0|||
155176950|NCT01426789|560086497|FG004|Part 2|Protocol deviation|0|||
155176951|NCT01426789|560086498|FG005|Part 2|Protocol deviation|0|||
155176952|NCT01426789|560086493|FG000|Part 2|Death|0|||
155176953|NCT01426789|560086494|FG001|Part 2|Death|0|||
155176954|NCT01426789|560086495|FG002|Part 2|Death|1|||
155176955|NCT01426789|560086496|FG003|Part 2|Death|0|||
155176956|NCT01426789|560086497|FG004|Part 2|Death|1|||
155176957|NCT01426789|560086498|FG005|Part 2|Death|0|||
155176958|NCT01426789|560086493|FG000|Part 2|Administrative problems|0|||
155176959|NCT01426789|560086494|FG001|Part 2|Administrative problems|0|||
155176960|NCT01426789|560086495|FG002|Part 2|Administrative problems|2|||
155176961|NCT01426789|560086496|FG003|Part 2|Administrative problems|0|||
155176962|NCT01426789|560086497|FG004|Part 2|Administrative problems|1|||
155176963|NCT01426789|560086498|FG005|Part 2|Administrative problems|0|||
155176964|NCT01426789|560086493|FG000|Part 2|Lost to Follow-up|0|||
155176965|NCT01426789|560086494|FG001|Part 2|Lost to Follow-up|0|||
155176966|NCT01426789|560086495|FG002|Part 2|Lost to Follow-up|4|||
155176967|NCT01426789|560086496|FG003|Part 2|Lost to Follow-up|0|||
154988751|NCT00536263|559385347|FG001|Overall Study|Subject withdrew - treatment related|3|||
154988752|NCT00536263|559385348|FG002|Overall Study|Subject withdrew - treatment related|2|||
154988753|NCT00536263|559385346|FG000|Overall Study|Noncompliance with protocol|0|||
154988754|NCT00536263|559385347|FG001|Overall Study|Noncompliance with protocol|0|||
154988755|NCT00536263|559385348|FG002|Overall Study|Noncompliance with protocol|1|||
154988756|NCT00536263|559385346|FG000|Overall Study|Did not meet protocol eligibility|1|||
154988757|NCT00536263|559385347|FG001|Overall Study|Did not meet protocol eligibility|2|||
154988758|NCT00536263|559385348|FG002|Overall Study|Did not meet protocol eligibility|2|||
154988759|NCT02989168|559385369|FG000|Overall Study|Withdrawal by Subject|2|||
154988760|NCT02989168|559385370|FG001|Overall Study|Withdrawal by Subject|0|||
154988761|NCT02989168|559385369|FG000|Overall Study|Physician Decision|0|||
154988762|NCT02989168|559385370|FG001|Overall Study|Physician Decision|1|||
154988763|NCT02989168|559385369|FG000|Overall Study|Adverse Event|1|||
154988764|NCT02989168|559385370|FG001|Overall Study|Adverse Event|2|||
154988765|NCT02989168|559385369|FG000|Overall Study|Sponsor stopped study.|1|||
154988766|NCT02989168|559385370|FG001|Overall Study|Sponsor stopped study.|0|||
154988767|NCT03456960|559385371|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
154988768|NCT03456960|559385372|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155120180|NCT01643850|559870938|FG002|Overall Study|Withdrawal by Subject|0|||
155120181|NCT01643850|559870939|FG003|Overall Study|Withdrawal by Subject|0|||
155120182|NCT01643850|559870940|FG004|Overall Study|Withdrawal by Subject|1|||
154988769|NCT03456960|559385373|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
154988770|NCT03456960|559385374|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
154988771|NCT03456960|559385375|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
154988772|NCT03456960|559385376|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
154988773|NCT03456960|559385371|FG000|Period 2 (1 Day)|Adverse Event|1|||
154988774|NCT03456960|559385372|FG001|Period 2 (1 Day)|Adverse Event|0|||
154988775|NCT03456960|559385373|FG002|Period 2 (1 Day)|Adverse Event|0|||
155120183|NCT01643850|559870941|FG005|Overall Study|Withdrawal by Subject|0|||
155120184|NCT01643850|559870942|FG006|Overall Study|Withdrawal by Subject|0|||
155120185|NCT01643850|559870943|FG007|Overall Study|Withdrawal by Subject|0|||
155120186|NCT01643850|559870944|FG008|Overall Study|Withdrawal by Subject|0|||
155120187|NCT01643850|559870936|FG000|Overall Study|Lost to Follow-up|0|||
155120188|NCT01643850|559870937|FG001|Overall Study|Lost to Follow-up|0|||
155120189|NCT01643850|559870938|FG002|Overall Study|Lost to Follow-up|0|||
155120190|NCT01643850|559870939|FG003|Overall Study|Lost to Follow-up|0|||
155120191|NCT01643850|559870940|FG004|Overall Study|Lost to Follow-up|0|||
154988776|NCT03456960|559385374|FG003|Period 2 (1 Day)|Adverse Event|1|||
154988777|NCT03456960|559385375|FG004|Period 2 (1 Day)|Adverse Event|0|||
154988778|NCT03456960|559385376|FG005|Period 2 (1 Day)|Adverse Event|0|||
154988779|NCT00532935|559385377|FG000|Overall Study|Adverse Event|11|||
154988780|NCT00532935|559385378|FG001|Overall Study|Adverse Event|12|||
155120192|NCT01643850|559870941|FG005|Overall Study|Lost to Follow-up|0|||
155176968|NCT01426789|560086497|FG004|Part 2|Lost to Follow-up|1|||
154988781|NCT00532935|559385377|FG000|Overall Study|Lack of Efficacy|0|||
155120193|NCT01643850|559870942|FG006|Overall Study|Lost to Follow-up|1|||
155120194|NCT01643850|559870943|FG007|Overall Study|Lost to Follow-up|0|||
155176969|NCT01426789|560086498|FG005|Part 2|Lost to Follow-up|0|||
155176970|NCT01426789|560086493|FG000|Part 2|Withdrawal by Subject|0|||
155176971|NCT01426789|560086494|FG001|Part 2|Withdrawal by Subject|0|||
155176972|NCT01426789|560086495|FG002|Part 2|Withdrawal by Subject|0|||
155176973|NCT01426789|560086496|FG003|Part 2|Withdrawal by Subject|1|||
155176974|NCT01426789|560086497|FG004|Part 2|Withdrawal by Subject|2|||
154988782|NCT00532935|559385378|FG001|Overall Study|Lack of Efficacy|3|||
154988783|NCT00532935|559385377|FG000|Overall Study|Lost to Follow-up|10|||
154988784|NCT00532935|559385378|FG001|Overall Study|Lost to Follow-up|6|||
154988785|NCT00532935|559385377|FG000|Overall Study|Physician Decision|4|||
154988786|NCT00532935|559385378|FG001|Overall Study|Physician Decision|5|||
154988787|NCT00532935|559385377|FG000|Overall Study|Pregnancy|1|||
154988788|NCT00532935|559385378|FG001|Overall Study|Pregnancy|0|||
154988789|NCT00532935|559385377|FG000|Overall Study|Protocol Violation|4|||
154988790|NCT00532935|559385378|FG001|Overall Study|Protocol Violation|2|||
154988791|NCT00532935|559385377|FG000|Overall Study|Withdrawal by Subject|10|||
154988792|NCT00532935|559385378|FG001|Overall Study|Withdrawal by Subject|9|||
154988793|NCT00532935|559385377|FG000|Overall Study|Protocol Specific Criteria|11|||
154988794|NCT00532935|559385378|FG001|Overall Study|Protocol Specific Criteria|15|||
154988795|NCT00502801|559385379|FG000|Treatment Period|Withdrawal by Subject|3|||
154988796|NCT00502801|559385379|FG000|Treatment Period|Adverse Event|7|||
154988797|NCT00502801|559385379|FG000|Treatment Period|Death|14|||
154988798|NCT00502801|559385379|FG000|Treatment Period|OTHER|30|||
154988799|NCT00502801|559385379|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
154988800|NCT00502801|559385379|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
154988801|NCT00502801|559385379|FG000|End of Therapy to Test of Cure|Death|3|||
154988802|NCT00502801|559385379|FG000|End of Therapy to Test of Cure|OTHER|2|||
154988803|NCT01288053|559387040|FG000|Overall Study|Death|1|||
154988804|NCT03188666|559387041|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
154988805|NCT03188666|559387042|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
154988806|NCT03188666|559387043|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
154988807|NCT03188666|559387044|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
154988808|NCT03188666|559387041|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
154988809|NCT03188666|559387042|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
154988810|NCT03188666|559387043|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
154988811|NCT03188666|559387044|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
154988812|NCT03188666|559387041|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
154988813|NCT03188666|559387042|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
154988814|NCT03188666|559387043|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
154988815|NCT03188666|559387044|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
154988816|NCT03188666|559387041|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
154988817|NCT03188666|559387042|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
154988818|NCT03188666|559387043|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
154988819|NCT03188666|559387044|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
154988820|NCT04092894|559387045|FG000|Overall Study|Withdrawal by Subject|2|||
154988821|NCT04092894|559387046|FG001|Overall Study|Withdrawal by Subject|4|||
154988822|NCT04092894|559387045|FG000|Overall Study|Discontinued EEG after randomization|10|||
154988823|NCT04092894|559387046|FG001|Overall Study|Discontinued EEG after randomization|6|||
154988824|NCT01106014|559387047|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
154988825|NCT01106014|559387048|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
154988826|NCT01106014|559387047|FG000|Overall Study|Adverse Event|78|||
154988827|NCT01106014|559387048|FG001|Overall Study|Adverse Event|42|||
154988828|NCT01106014|559387047|FG000|Overall Study|Withdrawal by Subject|43|||
154988829|NCT01106014|559387048|FG001|Overall Study|Withdrawal by Subject|37|||
154988830|NCT01106014|559387047|FG000|Overall Study|Administrative reason|7|||
154988831|NCT01106014|559387048|FG001|Overall Study|Administrative reason|6|||
154988832|NCT01106014|559387047|FG000|Overall Study|Lost to Follow-up|2|||
154988833|NCT01106014|559387048|FG001|Overall Study|Lost to Follow-up|3|||
154988834|NCT05071313|559387049|FG000|Overall Study|Lost to Follow-up|17|||
154988835|NCT05071313|559387050|FG001|Overall Study|Lost to Follow-up|10|||
154988836|NCT05071313|559387049|FG000|Overall Study|Physician Decision|1|||
154988837|NCT05071313|559387050|FG001|Overall Study|Physician Decision|6|||
154988838|NCT05071313|559387049|FG000|Overall Study|Death|1|||
154988839|NCT05071313|559387050|FG001|Overall Study|Death|0|||
154988840|NCT05071313|559387049|FG000|Overall Study|Withdrawal by Subject|10|||
154988841|NCT05071313|559387050|FG001|Overall Study|Withdrawal by Subject|15|||
155120195|NCT01643850|559870944|FG008|Overall Study|Lost to Follow-up|1|||
155120196|NCT01643850|559870936|FG000|Overall Study|Adverse Event|0|||
155120197|NCT01643850|559870937|FG001|Overall Study|Adverse Event|0|||
154988842|NCT05071313|559387049|FG000|Overall Study|Other|1|||
154988843|NCT05071313|559387050|FG001|Overall Study|Other|0|||
154988844|NCT05071313|559387049|FG000|Overall Study|Randomized but not vaccinated|4|||
154988845|NCT05071313|559387050|FG001|Overall Study|Randomized but not vaccinated|2|||
154988846|NCT03596151|559387051|FG000|Overall Study|Withdrawal by Subject|1|||
154988847|NCT02444793|559387053|FG000|Overall Study|Lost to Follow-up|2|||
155120198|NCT01643850|559870938|FG002|Overall Study|Adverse Event|0|||
154988848|NCT02444793|559387054|FG001|Overall Study|Lost to Follow-up|2|||
154988849|NCT02444793|559387055|FG002|Overall Study|Lost to Follow-up|0|||
154988850|NCT02444793|559387056|FG003|Overall Study|Lost to Follow-up|0|||
154988851|NCT02444793|559387053|FG000|Overall Study|Death|0|||
154988852|NCT02444793|559387054|FG001|Overall Study|Death|3|||
154988853|NCT02444793|559387055|FG002|Overall Study|Death|0|||
154988854|NCT02444793|559387056|FG003|Overall Study|Death|0|||
154988855|NCT02444793|559387053|FG000|Overall Study|Other|0|||
154988856|NCT02444793|559387054|FG001|Overall Study|Other|0|||
154988857|NCT02444793|559387055|FG002|Overall Study|Other|2|||
154988858|NCT02444793|559387056|FG003|Overall Study|Other|0|||
154988859|NCT02444793|559387053|FG000|Overall Study|Objective progression or relapse|9|||
154988860|NCT02444793|559387054|FG001|Overall Study|Objective progression or relapse|1|||
154988861|NCT02444793|559387055|FG002|Overall Study|Objective progression or relapse|2|||
154988862|NCT02444793|559387056|FG003|Overall Study|Objective progression or relapse|3|||
154988863|NCT02504671|559387062|FG000|Overall Study|Withdrawal by Subject|1|||
154988864|NCT02504671|559387063|FG001|Overall Study|Withdrawal by Subject|5|||
154988865|NCT02504671|559387064|FG002|Overall Study|Withdrawal by Subject|4|||
154988866|NCT02504671|559387065|FG003|Overall Study|Withdrawal by Subject|4|||
154988867|NCT02504671|559387066|FG004|Overall Study|Withdrawal by Subject|5|||
154916869|NCT01072175|559118490|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916870|NCT01072175|559118491|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
154916871|NCT01072175|559118479|FG000|Part D (HPMC Capsules)|Death|0|||
154916872|NCT01072175|559118480|FG001|Part D (HPMC Capsules)|Death|0|||
154916873|NCT01072175|559118481|FG002|Part D (HPMC Capsules)|Death|0|||
154916874|NCT01072175|559118482|FG003|Part D (HPMC Capsules)|Death|0|||
154916875|NCT01072175|559118483|FG004|Part D (HPMC Capsules)|Death|0|||
154988868|NCT02504671|559387067|FG005|Overall Study|Withdrawal by Subject|3|||
154988869|NCT02504671|559387062|FG000|Overall Study|Lack of Efficacy|1|||
154988870|NCT02504671|559387063|FG001|Overall Study|Lack of Efficacy|3|||
154988871|NCT02504671|559387064|FG002|Overall Study|Lack of Efficacy|1|||
154988872|NCT02504671|559387065|FG003|Overall Study|Lack of Efficacy|0|||
154988873|NCT02504671|559387066|FG004|Overall Study|Lack of Efficacy|4|||
154988874|NCT02504671|559387067|FG005|Overall Study|Lack of Efficacy|4|||
154988875|NCT02504671|559387062|FG000|Overall Study|Adverse Event|1|||
154988876|NCT02504671|559387063|FG001|Overall Study|Adverse Event|1|||
154988877|NCT02504671|559387064|FG002|Overall Study|Adverse Event|0|||
154988878|NCT02504671|559387065|FG003|Overall Study|Adverse Event|1|||
154988879|NCT02504671|559387066|FG004|Overall Study|Adverse Event|0|||
154988880|NCT02504671|559387067|FG005|Overall Study|Adverse Event|2|||
154988881|NCT02504671|559387062|FG000|Overall Study|Protocol Violation|2|||
154988882|NCT02504671|559387063|FG001|Overall Study|Protocol Violation|1|||
154988883|NCT02504671|559387064|FG002|Overall Study|Protocol Violation|0|||
154988884|NCT02504671|559387065|FG003|Overall Study|Protocol Violation|0|||
154988885|NCT02504671|559387066|FG004|Overall Study|Protocol Violation|0|||
154988886|NCT02504671|559387067|FG005|Overall Study|Protocol Violation|1|||
154988887|NCT02504671|559387062|FG000|Overall Study|Lost to Follow-up|0|||
154988888|NCT02504671|559387063|FG001|Overall Study|Lost to Follow-up|0|||
154988889|NCT02504671|559387064|FG002|Overall Study|Lost to Follow-up|2|||
154988890|NCT02504671|559387065|FG003|Overall Study|Lost to Follow-up|0|||
154988891|NCT02504671|559387066|FG004|Overall Study|Lost to Follow-up|0|||
154988892|NCT02504671|559387067|FG005|Overall Study|Lost to Follow-up|1|||
154988893|NCT02504671|559387062|FG000|Overall Study|Protocol defined stopping criteria|7|||
154988894|NCT02504671|559387063|FG001|Overall Study|Protocol defined stopping criteria|4|||
154988895|NCT02504671|559387064|FG002|Overall Study|Protocol defined stopping criteria|3|||
154988896|NCT02504671|559387065|FG003|Overall Study|Protocol defined stopping criteria|5|||
154988897|NCT02504671|559387066|FG004|Overall Study|Protocol defined stopping criteria|3|||
154988898|NCT02504671|559387067|FG005|Overall Study|Protocol defined stopping criteria|3|||
154988899|NCT00210249|559387068|FG000|Overall Study|Lost to Follow-up|5|||
154988900|NCT00210249|559387068|FG000|Overall Study|Protocol Violation|11|||
154988901|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
154988902|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
154988903|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
154988904|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
154988905|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
154988906|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
154988907|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
154988908|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
154988909|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
154988910|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
154988911|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
154988912|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
154988913|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
154988914|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
154916876|NCT01072175|559118484|FG005|Part D (HPMC Capsules)|Death|0|||
154916877|NCT01072175|559118485|FG006|Part D (HPMC Capsules)|Death|0|||
154988915|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
154988916|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
154988917|NCT03182244|559387073|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
154988918|NCT03182244|559387074|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
154988919|NCT03182244|559387073|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
154916878|NCT01072175|559118486|FG007|Part D (HPMC Capsules)|Death|0|||
155120199|NCT01643850|559870939|FG003|Overall Study|Adverse Event|0|||
155120200|NCT01643850|559870940|FG004|Overall Study|Adverse Event|1|||
155120201|NCT01643850|559870941|FG005|Overall Study|Adverse Event|0|||
155120202|NCT01643850|559870942|FG006|Overall Study|Adverse Event|0|||
155120203|NCT01643850|559870943|FG007|Overall Study|Adverse Event|0|||
155120204|NCT01643850|559870944|FG008|Overall Study|Adverse Event|0|||
155120205|NCT01643850|559870936|FG000|Overall Study|Administrative Problems|0|||
155120206|NCT01643850|559870937|FG001|Overall Study|Administrative Problems|0|||
155120207|NCT01643850|559870938|FG002|Overall Study|Administrative Problems|1|||
155120208|NCT01643850|559870939|FG003|Overall Study|Administrative Problems|0|||
155120209|NCT01643850|559870940|FG004|Overall Study|Administrative Problems|1|||
155120210|NCT01643850|559870941|FG005|Overall Study|Administrative Problems|0|||
155120211|NCT01643850|559870942|FG006|Overall Study|Administrative Problems|0|||
155120212|NCT01643850|559870943|FG007|Overall Study|Administrative Problems|0|||
155120213|NCT01643850|559870944|FG008|Overall Study|Administrative Problems|0|||
155120214|NCT00931723|559870945|FG000|Overall Study|Withdrawal by Subject|11|||
155120215|NCT00931723|559870946|FG001|Overall Study|Withdrawal by Subject|13|||
155120216|NCT00931723|559870945|FG000|Overall Study|Adverse Event|6|||
155120217|NCT00931723|559870946|FG001|Overall Study|Adverse Event|13|||
155120218|NCT00931723|559870945|FG000|Overall Study|Lithium found in blood|0|||
155120219|NCT00931723|559870946|FG001|Overall Study|Lithium found in blood|1|||
155120220|NCT00931723|559870945|FG000|Overall Study|Condition under investigation worsened|1|||
155120221|NCT00931723|559870946|FG001|Overall Study|Condition under investigation worsened|2|||
155120222|NCT00931723|559870945|FG000|Overall Study|Lost to Follow-up|1|||
155120223|NCT00931723|559870946|FG001|Overall Study|Lost to Follow-up|2|||
155120224|NCT00931723|559870945|FG000|Overall Study|Study-specific discontinuation criteria|1|||
155120225|NCT00931723|559870946|FG001|Overall Study|Study-specific discontinuation criteria|1|||
155120226|NCT00931723|559870945|FG000|Overall Study|Severe non-compliance to protocol|2|||
155120227|NCT00931723|559870946|FG001|Overall Study|Severe non-compliance to protocol|0|||
155120228|NCT00931723|559870945|FG000|Overall Study|Safety reasons|0|||
155120229|NCT00931723|559870946|FG001|Overall Study|Safety reasons|1|||
155120230|NCT00931723|559870945|FG000|Overall Study|Took prohibited concomitant medication|0|||
155120231|NCT00931723|559870946|FG001|Overall Study|Took prohibited concomitant medication|1|||
155120232|NCT00931723|559870945|FG000|Overall Study|Lack or insufficient theraputic response|2|||
155120233|NCT00931723|559870946|FG001|Overall Study|Lack or insufficient theraputic response|5|||
155120234|NCT00931723|559870945|FG000|Overall Study|Sponsor decision|1|||
155120235|NCT00931723|559870946|FG001|Overall Study|Sponsor decision|0|||
155120236|NCT00931723|559870945|FG000|Overall Study|Late hospital discharge|1|||
155120237|NCT00931723|559870946|FG001|Overall Study|Late hospital discharge|0|||
155120238|NCT03054350|559870947|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
155120239|NCT03054350|559870948|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
155120240|NCT03054350|559870949|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
155120241|NCT03054350|559870950|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
155120242|NCT03054350|559870951|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
155120243|NCT03054350|559870952|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
155120244|NCT03054350|559870947|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155120245|NCT03054350|559870948|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155120246|NCT03054350|559870949|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
155120247|NCT03054350|559870950|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155120248|NCT03054350|559870951|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155120249|NCT03054350|559870952|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
155120250|NCT03054350|559870947|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
155120251|NCT03054350|559870948|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155120252|NCT03054350|559870949|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155120253|NCT03054350|559870950|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
155120254|NCT03054350|559870951|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155120255|NCT03054350|559870952|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
155120256|NCT03054350|559870947|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155120257|NCT03054350|559870948|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155120258|NCT03054350|559870949|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
155120259|NCT03054350|559870950|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155120260|NCT03054350|559870951|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155120261|NCT03054350|559870952|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
155120262|NCT03305081|559870961|FG000|Overall Study|Lost to Follow-up|10|||
155120263|NCT03305081|559870962|FG001|Overall Study|Lost to Follow-up|15|||
155120264|NCT04065074|559870963|FG000|Overall Study|Adverse Event|1|||
155120265|NCT04065074|559870963|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
155120266|NCT01218100|559870964|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
155120267|NCT01218100|559870965|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
154988920|NCT03182244|559387074|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
154988921|NCT03182244|559387073|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
154988922|NCT03182244|559387074|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
154988923|NCT03182244|559387073|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
154988924|NCT03182244|559387074|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
154988925|NCT03182244|559387073|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
154988926|NCT03182244|559387074|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
154988927|NCT01687478|559387075|FG000|Overall Study|Adverse Event|3|||
154988928|NCT01687478|559387076|FG001|Overall Study|Adverse Event|10|||
154988929|NCT01687478|559387075|FG000|Overall Study|Lost to Follow-up|1|||
154988930|NCT01687478|559387076|FG001|Overall Study|Lost to Follow-up|3|||
154988931|NCT01687478|559387075|FG000|Overall Study|Protocol Violation|0|||
154988932|NCT01687478|559387076|FG001|Overall Study|Protocol Violation|2|||
154988933|NCT01687478|559387075|FG000|Overall Study|Withdrawal by Subject|21|||
154988934|NCT01687478|559387076|FG001|Overall Study|Withdrawal by Subject|19|||
154988935|NCT01687478|559387075|FG000|Overall Study|Physician Decision|1|||
154988936|NCT01687478|559387076|FG001|Overall Study|Physician Decision|3|||
154988937|NCT01687478|559387075|FG000|Overall Study|Entry Criteria Not Met|6|||
154988938|NCT01687478|559387076|FG001|Overall Study|Entry Criteria Not Met|2|||
154988939|NCT02049450|559387077|FG000|Overall Study|Adverse Event|2|||
154988940|NCT02049450|559387077|FG000|Overall Study|Withdrawal by Subject|1|||
154988941|NCT02049450|559387077|FG000|Overall Study|Patients/guardian decision|1|||
154988942|NCT02492880|559387078|FG000|Overall Study|Lost to Follow-up|1|||
154988943|NCT02492880|559387078|FG000|Overall Study|Protocol Violation|1|||
154988944|NCT00292188|559387082|FG000|Single-Blind|Adverse Event|14|||
154988945|NCT00292188|559387083|FG001|Single-Blind|Adverse Event|0|||
154988946|NCT00292188|559387084|FG002|Single-Blind|Adverse Event|0|||
154988947|NCT00292188|559387082|FG000|Single-Blind|Lack of Efficacy|2|||
154988948|NCT00292188|559387083|FG001|Single-Blind|Lack of Efficacy|0|||
154988949|NCT00292188|559387084|FG002|Single-Blind|Lack of Efficacy|0|||
154988950|NCT00292188|559387082|FG000|Single-Blind|Laboratory Abnormality|5|||
154988951|NCT00292188|559387083|FG001|Single-Blind|Laboratory Abnormality|0|||
154988952|NCT00292188|559387084|FG002|Single-Blind|Laboratory Abnormality|0|||
154988953|NCT00292188|559387082|FG000|Single-Blind|Lost to Follow-up|3|||
154988954|NCT00292188|559387083|FG001|Single-Blind|Lost to Follow-up|0|||
154988955|NCT00292188|559387084|FG002|Single-Blind|Lost to Follow-up|0|||
154988956|NCT00292188|559387082|FG000|Single-Blind|Other|77|||
154988957|NCT00292188|559387083|FG001|Single-Blind|Other|0|||
154988958|NCT00292188|559387084|FG002|Single-Blind|Other|0|||
154988959|NCT00292188|559387082|FG000|Single-Blind|Withdrawal by Subject|12|||
154988960|NCT00292188|559387083|FG001|Single-Blind|Withdrawal by Subject|0|||
154988961|NCT00292188|559387084|FG002|Single-Blind|Withdrawal by Subject|0|||
154988962|NCT00292188|559387082|FG000|Single-Blind|Did not receive treatment|1|||
154988963|NCT00292188|559387083|FG001|Single-Blind|Did not receive treatment|0|||
154988964|NCT00292188|559387084|FG002|Single-Blind|Did not receive treatment|0|||
154988965|NCT00292188|559387082|FG000|Double-Blind|Adverse Event|0|||
154988966|NCT00292188|559387083|FG001|Double-Blind|Adverse Event|25|||
154988967|NCT00292188|559387084|FG002|Double-Blind|Adverse Event|9|||
154988968|NCT00292188|559387082|FG000|Double-Blind|Lack of Efficacy|0|||
154988969|NCT00292188|559387083|FG001|Double-Blind|Lack of Efficacy|2|||
154988970|NCT00292188|559387084|FG002|Double-Blind|Lack of Efficacy|12|||
154988971|NCT00292188|559387082|FG000|Double-Blind|Lost to Follow-up|0|||
154988972|NCT00292188|559387083|FG001|Double-Blind|Lost to Follow-up|1|||
155120268|NCT01218100|559870966|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
155120269|NCT01218100|559870967|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
155120270|NCT01218100|559870964|FG000|Overall Study|Adverse Event|4|||
155120271|NCT01218100|559870965|FG001|Overall Study|Adverse Event|6|||
155120272|NCT01218100|559870966|FG002|Overall Study|Adverse Event|6|||
155120273|NCT01218100|559870967|FG003|Overall Study|Adverse Event|7|||
155120274|NCT01218100|559870964|FG000|Overall Study|Lack of Efficacy|9|||
155120275|NCT01218100|559870965|FG001|Overall Study|Lack of Efficacy|6|||
155120276|NCT01218100|559870966|FG002|Overall Study|Lack of Efficacy|5|||
155120277|NCT01218100|559870967|FG003|Overall Study|Lack of Efficacy|12|||
155120278|NCT01218100|559870964|FG000|Overall Study|Protocol Violation|0|||
155120279|NCT01218100|559870965|FG001|Overall Study|Protocol Violation|0|||
155120280|NCT01218100|559870966|FG002|Overall Study|Protocol Violation|1|||
155120281|NCT01218100|559870967|FG003|Overall Study|Protocol Violation|1|||
155120282|NCT01218100|559870964|FG000|Overall Study|Withdrawal by Subject|5|||
154988973|NCT00292188|559387084|FG002|Double-Blind|Lost to Follow-up|0|||
154988974|NCT00292188|559387082|FG000|Double-Blind|Other|0|||
154988975|NCT00292188|559387083|FG001|Double-Blind|Other|3|||
154988976|NCT00292188|559387084|FG002|Double-Blind|Other|4|||
154988977|NCT00292188|559387082|FG000|Double-Blind|Withdrawal by Subject|0|||
154988978|NCT00292188|559387083|FG001|Double-Blind|Withdrawal by Subject|0|||
155120283|NCT01218100|559870965|FG001|Overall Study|Withdrawal by Subject|2|||
155120284|NCT01218100|559870966|FG002|Overall Study|Withdrawal by Subject|6|||
155120285|NCT01218100|559870967|FG003|Overall Study|Withdrawal by Subject|7|||
154988979|NCT00292188|559387084|FG002|Double-Blind|Withdrawal by Subject|3|||
154988980|NCT00292188|559387082|FG000|Double-Blind|Laboratory Abnormality|0|||
155120286|NCT01218100|559870964|FG000|Overall Study|Lost to Follow-up|3|||
155120287|NCT01218100|559870965|FG001|Overall Study|Lost to Follow-up|8|||
155120288|NCT01218100|559870966|FG002|Overall Study|Lost to Follow-up|2|||
155120289|NCT01218100|559870967|FG003|Overall Study|Lost to Follow-up|1|||
155120290|NCT01218100|559870964|FG000|Overall Study|Other Reason|2|||
155120291|NCT01218100|559870965|FG001|Overall Study|Other Reason|2|||
155120292|NCT01218100|559870966|FG002|Overall Study|Other Reason|6|||
155120293|NCT01218100|559870967|FG003|Overall Study|Other Reason|4|||
155120294|NCT02437305|559870968|FG000|Overall Study|Lost to Follow-up|18|||
155120295|NCT02437305|559870969|FG001|Overall Study|Lost to Follow-up|12|||
155120296|NCT03883113|559870971|FG000|Overall Study|Physician Decision|4|||
155120297|NCT03883113|559870972|FG001|Overall Study|Physician Decision|2|||
155120298|NCT03883113|559870971|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
155120299|NCT03883113|559870972|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
155120300|NCT03883113|559870971|FG000|Overall Study|Pregnancy|1|||
155120301|NCT03883113|559870972|FG001|Overall Study|Pregnancy|0|||
155120302|NCT03883113|559870971|FG000|Overall Study|Adverse Event|0|||
155120303|NCT03883113|559870972|FG001|Overall Study|Adverse Event|1|||
155120304|NCT03883113|559870971|FG000|Overall Study|Withdrawal by Subject|1|||
155120305|NCT03883113|559870972|FG001|Overall Study|Withdrawal by Subject|2|||
155120306|NCT03883113|559870971|FG000|Overall Study|Lost to Follow-up|1|||
155120307|NCT03883113|559870972|FG001|Overall Study|Lost to Follow-up|0|||
155120308|NCT02446418|559870978|FG000|Overall Study|Adverse Event|4|||
154988981|NCT00292188|559387083|FG001|Double-Blind|Laboratory Abnormality|0|||
154988982|NCT00292188|559387084|FG002|Double-Blind|Laboratory Abnormality|1|||
154988983|NCT00824616|559387085|FG000|Overall Study|Adverse Event|2|||
154988984|NCT00824616|559387086|FG001|Overall Study|Adverse Event|1|||
154988985|NCT00824616|559387085|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
154988986|NCT00824616|559387086|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
154988987|NCT00824616|559387085|FG000|Overall Study|Hyperglycemia|1|||
154988988|NCT00824616|559387086|FG001|Overall Study|Hyperglycemia|1|||
154988989|NCT00824616|559387085|FG000|Overall Study|Lack of Efficacy|2|||
154988990|NCT00824616|559387086|FG001|Overall Study|Lack of Efficacy|1|||
154988991|NCT00824616|559387085|FG000|Overall Study|Lost to Follow-up|0|||
154988992|NCT00824616|559387086|FG001|Overall Study|Lost to Follow-up|1|||
154988993|NCT00824616|559387085|FG000|Overall Study|Withdrawal by Subject|1|||
154988994|NCT00824616|559387086|FG001|Overall Study|Withdrawal by Subject|1|||
154988995|NCT01200992|559387087|FG000|Overall Study|Study terminated early|35|||
154988996|NCT01200992|559387088|FG001|Overall Study|Study terminated early|41|||
155120309|NCT02446418|559870979|FG001|Overall Study|Adverse Event|8|||
155120310|NCT02446418|559870978|FG000|Overall Study|Physician Decision|5|||
155120311|NCT02446418|559870979|FG001|Overall Study|Physician Decision|1|||
155120312|NCT02446418|559870978|FG000|Overall Study|Withdrawal by Subject|3|||
155120313|NCT02446418|559870979|FG001|Overall Study|Withdrawal by Subject|3|||
155120314|NCT02446418|559870978|FG000|Overall Study|Lost to Follow-up|2|||
155120315|NCT02446418|559870979|FG001|Overall Study|Lost to Follow-up|2|||
155120316|NCT02446418|559870978|FG000|Overall Study|Protocol Violation|1|||
155120317|NCT02446418|559870979|FG001|Overall Study|Protocol Violation|2|||
155120318|NCT02446418|559870978|FG000|Overall Study|Lack of Efficacy|2|||
155120319|NCT02446418|559870979|FG001|Overall Study|Lack of Efficacy|0|||
155120320|NCT02446418|559870978|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
155120321|NCT02446418|559870979|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
155120322|NCT03421743|559870982|FG000|Overall Study|Lack of Efficacy|1|||
155120323|NCT03421743|559870983|FG001|Overall Study|Lack of Efficacy|0|||
155120324|NCT03421743|559870982|FG000|Overall Study|Adverse Event|2|||
155120325|NCT03421743|559870983|FG001|Overall Study|Adverse Event|1|||
155120326|NCT03421743|559870982|FG000|Overall Study|Withdrawal by Subject|0|||
155120327|NCT03421743|559870983|FG001|Overall Study|Withdrawal by Subject|1|||
155120328|NCT00435162|559870984|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
154988997|NCT01200992|559387087|FG000|Overall Study|Randomized but not treated|2|||
154988998|NCT01200992|559387088|FG001|Overall Study|Randomized but not treated|0|||
154988999|NCT00792935|559387089|FG000|Overall Study|Adverse Event|2|||
155176975|NCT01426789|560086498|FG005|Part 2|Withdrawal by Subject|0|||
154989000|NCT00792935|559387090|FG001|Overall Study|Adverse Event|1|||
155120329|NCT00435162|559870985|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
155120330|NCT00435162|559870986|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
155120331|NCT00435162|559870987|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
155120332|NCT00435162|559870988|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
154989001|NCT00792935|559387089|FG000|Overall Study|Lost to Follow-up|0|||
155120333|NCT00435162|559870989|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
154989002|NCT00792935|559387090|FG001|Overall Study|Lost to Follow-up|1|||
154989003|NCT00792935|559387089|FG000|Overall Study|Protocol Violation|2|||
155120334|NCT00694096|559870990|FG000|Overall Study|Withdrawal by Subject|5|||
155120335|NCT00977938|559870995|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
155120336|NCT00977938|559870996|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
155120337|NCT00977938|559870997|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
155176976|NCT01426789|560086493|FG000|Part 2|Lack of Efficacy|0|||
155176977|NCT01426789|560086494|FG001|Part 2|Lack of Efficacy|0|||
155176978|NCT01426789|560086495|FG002|Part 2|Lack of Efficacy|5|||
155176979|NCT01426789|560086496|FG003|Part 2|Lack of Efficacy|0|||
155176980|NCT01426789|560086497|FG004|Part 2|Lack of Efficacy|2|||
155176981|NCT01426789|560086498|FG005|Part 2|Lack of Efficacy|0|||
155176982|NCT01426789|560086493|FG000|Part 2|Adverse Event|0|||
155176983|NCT01426789|560086494|FG001|Part 2|Adverse Event|0|||
155176984|NCT01426789|560086495|FG002|Part 2|Adverse Event|2|||
155176985|NCT01426789|560086496|FG003|Part 2|Adverse Event|0|||
155176986|NCT01426789|560086497|FG004|Part 2|Adverse Event|1|||
155176987|NCT01426789|560086498|FG005|Part 2|Adverse Event|0|||
155176988|NCT04054947|560086499|FG000|Overall Study|Withdrawal by Subject|1|||
155176989|NCT04054947|560086500|FG001|Overall Study|Withdrawal by Subject|0|||
155176990|NCT04054947|560086499|FG000|Overall Study|Lost to Follow-up|2|||
155176991|NCT04054947|560086500|FG001|Overall Study|Lost to Follow-up|5|||
155176992|NCT04463069|560086503|FG000|Overall Study|Withdrawal by Subject|2|||
155176993|NCT04463069|560086504|FG001|Overall Study|Withdrawal by Subject|10|||
155176994|NCT04463069|560086503|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
155176995|NCT04463069|560086504|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
155176996|NCT03073733|560086511|FG000|Overall Study|Lost to Follow-up|1|||
155176997|NCT03073733|560086512|FG001|Overall Study|Lost to Follow-up|0|||
155176998|NCT03073733|560086513|FG002|Overall Study|Lost to Follow-up|0|||
155176999|NCT03073733|560086511|FG000|Overall Study|Physician Decision|0|||
155177000|NCT03073733|560086512|FG001|Overall Study|Physician Decision|1|||
155177001|NCT03073733|560086513|FG002|Overall Study|Physician Decision|0|||
155177002|NCT03073733|560086511|FG000|Overall Study|Withdrawal by Subject|0|||
155177003|NCT03073733|560086512|FG001|Overall Study|Withdrawal by Subject|0|||
155177004|NCT03073733|560086513|FG002|Overall Study|Withdrawal by Subject|1|||
155177005|NCT00835731|560086514|FG000|Overall Study|Withdrawal by Subject|1|||
155177006|NCT00835731|560086515|FG001|Overall Study|Withdrawal by Subject|0|||
155177007|NCT00835731|560086514|FG000|Overall Study|Physician Decision|1|||
155177008|NCT00835731|560086515|FG001|Overall Study|Physician Decision|1|||
155177009|NCT00348881|560086516|FG000|Overall Study|Lost to Follow-up|12|||
155177010|NCT00348881|560086517|FG001|Overall Study|Lost to Follow-up|6|||
155177011|NCT00348881|560086516|FG000|Overall Study|Withdrawal by Subject|3|||
155177012|NCT00348881|560086517|FG001|Overall Study|Withdrawal by Subject|4|||
155177013|NCT00348881|560086516|FG000|Overall Study|Adverse Event|2|||
155177014|NCT00348881|560086517|FG001|Overall Study|Adverse Event|0|||
155177015|NCT00348881|560086516|FG000|Overall Study|Serious Adverse Event|0|||
155177016|NCT00348881|560086517|FG001|Overall Study|Serious Adverse Event|2|||
155177017|NCT00129311|560086518|FG000|Overall Study|Withdrawal by Subject|12|||
155177018|NCT00129311|560086519|FG001|Overall Study|Withdrawal by Subject|19|||
155177019|NCT00881868|560086522|FG000|Overall Study|Adverse Event|0|||
155177020|NCT00881868|560086523|FG001|Overall Study|Adverse Event|1|||
155177021|NCT00881868|560086522|FG000|Overall Study|Lost to Follow-up|2|||
155177022|NCT00881868|560086523|FG001|Overall Study|Lost to Follow-up|1|||
155177023|NCT00881868|560086522|FG000|Overall Study|Physician Decision|4|||
155177024|NCT00881868|560086523|FG001|Overall Study|Physician Decision|0|||
155177025|NCT00881868|560086522|FG000|Overall Study|Protocol Violation|2|||
155177026|NCT00881868|560086523|FG001|Overall Study|Protocol Violation|0|||
155177027|NCT01981551|560086524|FG000|Overall Study|Refused further treatment|8|||
155177028|NCT01981551|560086524|FG000|Overall Study|Adverse Event|1|||
155177029|NCT02880956|560086525|FG000|Overall Study|Adverse Event|3|||
155177030|NCT02880956|560086526|FG001|Overall Study|Adverse Event|6|||
155177031|NCT02880956|560086527|FG002|Overall Study|Adverse Event|5|||
155177032|NCT02880956|560086528|FG003|Overall Study|Adverse Event|4|||
155177033|NCT02880956|560086525|FG000|Overall Study|Withdrawal by Subject|9|||
155177034|NCT02880956|560086526|FG001|Overall Study|Withdrawal by Subject|4|||
155177035|NCT02880956|560086527|FG002|Overall Study|Withdrawal by Subject|6|||
155177036|NCT02880956|560086528|FG003|Overall Study|Withdrawal by Subject|11|||
155177037|NCT02880956|560086525|FG000|Overall Study|Lost to Follow-up|0|||
155177038|NCT02880956|560086526|FG001|Overall Study|Lost to Follow-up|1|||
155177039|NCT02880956|560086527|FG002|Overall Study|Lost to Follow-up|0|||
155177040|NCT02880956|560086528|FG003|Overall Study|Lost to Follow-up|0|||
155177041|NCT02880956|560086525|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155177042|NCT02880956|560086526|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
155177043|NCT02880956|560086527|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
155177044|NCT02880956|560086528|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
155177045|NCT02880956|560086525|FG000|Overall Study|Other, Not Specified|4|||
155177046|NCT02880956|560086526|FG001|Overall Study|Other, Not Specified|2|||
155177047|NCT02880956|560086527|FG002|Overall Study|Other, Not Specified|0|||
155177048|NCT02880956|560086528|FG003|Overall Study|Other, Not Specified|3|||
155177049|NCT02081859|560086529|FG000|Overall Study|No fertilization|2|||
155177050|NCT02081859|560086530|FG001|Overall Study|No fertilization|2|||
155177051|NCT02081859|560086529|FG000|Overall Study|No sperm|1|||
155177052|NCT02081859|560086530|FG001|Overall Study|No sperm|0|||
155177053|NCT02081859|560086529|FG000|Overall Study|Unanticipated freeze all cycle|2|||
155177054|NCT02081859|560086530|FG001|Overall Study|Unanticipated freeze all cycle|6|||
154989004|NCT00792935|559387090|FG001|Overall Study|Protocol Violation|0|||
154989005|NCT00792935|559387089|FG000|Overall Study|Withdrawal by Subject|0|||
154989006|NCT00792935|559387090|FG001|Overall Study|Withdrawal by Subject|1|||
154989007|NCT03186781|559387091|FG000|Overall Study|Lost to Follow-up|0|||
154989008|NCT03186781|559387092|FG001|Overall Study|Lost to Follow-up|0|||
154989009|NCT03186781|559387093|FG002|Overall Study|Lost to Follow-up|1|||
154989010|NCT03186781|559387094|FG003|Overall Study|Lost to Follow-up|0|||
154989011|NCT03186781|559387095|FG004|Overall Study|Lost to Follow-up|1|||
154989012|NCT03186781|559387096|FG005|Overall Study|Lost to Follow-up|0|||
154989013|NCT03186781|559387091|FG000|Overall Study|Moved from Area|0|||
154989014|NCT03186781|559387092|FG001|Overall Study|Moved from Area|0|||
154989015|NCT03186781|559387093|FG002|Overall Study|Moved from Area|0|||
154989016|NCT03186781|559387094|FG003|Overall Study|Moved from Area|0|||
154989017|NCT03186781|559387095|FG004|Overall Study|Moved from Area|1|||
154989018|NCT03186781|559387096|FG005|Overall Study|Moved from Area|0|||
154989019|NCT03186781|559387091|FG000|Overall Study|Withdrawal by Subject|0|||
154989020|NCT03186781|559387092|FG001|Overall Study|Withdrawal by Subject|0|||
154989021|NCT03186781|559387093|FG002|Overall Study|Withdrawal by Subject|0|||
154989022|NCT03186781|559387094|FG003|Overall Study|Withdrawal by Subject|0|||
154989023|NCT03186781|559387095|FG004|Overall Study|Withdrawal by Subject|1|||
154989024|NCT03186781|559387096|FG005|Overall Study|Withdrawal by Subject|0|||
154989025|NCT04709835|559387098|FG000|Overall Study|Withdrawal by Subject|0|||
154989026|NCT04709835|559387099|FG001|Overall Study|Withdrawal by Subject|1|||
154989027|NCT04709835|559387100|FG002|Overall Study|Withdrawal by Subject|0|||
154989028|NCT00622466|559387103|FG000|Overall Study|Death|1|||
154989029|NCT00622466|559387103|FG000|Overall Study|Adverse Event|1|||
154989030|NCT00622466|559387103|FG000|Overall Study|Withdrawal by Subject|2|||
154989031|NCT03397771|559387107|FG000|Overall Study|2 erroneously randomized, never treated|3|||
154989032|NCT03397771|559387108|FG001|Overall Study|2 erroneously randomized, never treated|1|||
154989033|NCT03397771|559387107|FG000|Overall Study|Withdrawal by Subject|1|||
154989034|NCT03397771|559387108|FG001|Overall Study|Withdrawal by Subject|3|||
154989035|NCT03397771|559387107|FG000|Overall Study|Protocol Violation|2|||
154989036|NCT03397771|559387108|FG001|Overall Study|Protocol Violation|2|||
154989037|NCT03397771|559387107|FG000|Overall Study|Adverse Event|2|||
154989038|NCT03397771|559387108|FG001|Overall Study|Adverse Event|1|||
154989039|NCT03393806|559387109|FG000|Overall Study|Physician Decision|1|||
154989040|NCT03393806|559387110|FG001|Overall Study|Physician Decision|0|||
154989041|NCT02534844|559387111|FG000|Part B|Withdrawal by Subject|0|||
154989042|NCT02534844|559387112|FG001|Part B|Withdrawal by Subject|0|||
154989043|NCT02534844|559387113|FG002|Part B|Withdrawal by Subject|0|||
154989044|NCT02534844|559387114|FG003|Part B|Withdrawal by Subject|0|||
154989045|NCT02534844|559387115|FG004|Part B|Withdrawal by Subject|2|||
154989046|NCT02534844|559387116|FG005|Part B|Withdrawal by Subject|1|||
154989047|NCT00507130|559387117|FG000|Overall Study|Lost to Follow-up|0|||
154989048|NCT00507130|559387118|FG001|Overall Study|Lost to Follow-up|0|||
154989049|NCT00507130|559387119|FG002|Overall Study|Lost to Follow-up|1|||
154989050|NCT00507130|559387120|FG003|Overall Study|Lost to Follow-up|1|||
154989051|NCT00507130|559387117|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
154989052|NCT00507130|559387118|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
154989053|NCT00507130|559387119|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
154989054|NCT00507130|559387120|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
154989055|NCT02605993|559387121|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
154989056|NCT02605993|559387122|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
154989057|NCT02605993|559387123|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
155120338|NCT00977938|559870998|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
155120339|NCT00977938|559870995|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
155120340|NCT00977938|559870996|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
155120341|NCT00977938|559870997|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
155120342|NCT00977938|559870998|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
155120343|NCT00977938|559870995|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
155120344|NCT00977938|559870996|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
154989058|NCT02605993|559387124|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
154989059|NCT01468818|559387128|FG000|Overall Study|Death during treatment|2|||
154989060|NCT01442688|559387129|FG000|First Intervention|Withdrawal by Subject|1|||
154989061|NCT01442688|559387130|FG001|First Intervention|Withdrawal by Subject|0|||
154989062|NCT01442688|559387129|FG000|First Intervention|subject incarcerated|1|||
154989063|NCT01442688|559387130|FG001|First Intervention|subject incarcerated|0|||
154989064|NCT01442688|559387129|FG000|Second Intervention|Adverse Event|1|||
154989065|NCT01442688|559387130|FG001|Second Intervention|Adverse Event|0|||
155120345|NCT00977938|559870997|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
155120346|NCT00977938|559870998|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
154989066|NCT00302081|559387131|FG000|Overall Study|Adverse Event|6|||
155120347|NCT00977938|559870995|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
154989067|NCT00302081|559387132|FG001|Overall Study|Adverse Event|5|||
154989068|NCT00302081|559387133|FG002|Overall Study|Adverse Event|4|||
154989069|NCT00302081|559387131|FG000|Overall Study|Lost to Follow-up|21|||
154989070|NCT00302081|559387132|FG001|Overall Study|Lost to Follow-up|18|||
154989071|NCT00302081|559387133|FG002|Overall Study|Lost to Follow-up|28|||
154989072|NCT00302081|559387131|FG000|Overall Study|Withdrawal by Subject|8|||
154989073|NCT00302081|559387132|FG001|Overall Study|Withdrawal by Subject|12|||
154989074|NCT00302081|559387133|FG002|Overall Study|Withdrawal by Subject|8|||
154989075|NCT00302081|559387131|FG000|Overall Study|Protocol Violation|5|||
154989076|NCT00302081|559387132|FG001|Overall Study|Protocol Violation|1|||
154989077|NCT00302081|559387133|FG002|Overall Study|Protocol Violation|2|||
154989078|NCT00302081|559387131|FG000|Overall Study|Lack of Efficacy|1|||
154989079|NCT00302081|559387132|FG001|Overall Study|Lack of Efficacy|0|||
154989080|NCT00302081|559387133|FG002|Overall Study|Lack of Efficacy|5|||
154989081|NCT00302081|559387131|FG000|Overall Study|Death|2|||
154989082|NCT00302081|559387132|FG001|Overall Study|Death|1|||
154989083|NCT00302081|559387133|FG002|Overall Study|Death|0|||
154989084|NCT00302081|559387131|FG000|Overall Study|Other|13|||
154989085|NCT00302081|559387132|FG001|Overall Study|Other|6|||
154989086|NCT00302081|559387133|FG002|Overall Study|Other|5|||
154989087|NCT02685202|559387134|FG000|Overall Study|Lost to Follow-up|9|||
154989088|NCT01229735|559387135|FG000|Overall Study|Lack of Efficacy|8|||
154989089|NCT01229735|559387136|FG001|Overall Study|Lack of Efficacy|8|||
154989090|NCT01229735|559387135|FG000|Overall Study|Protocol Violation|13|||
154989091|NCT01229735|559387136|FG001|Overall Study|Protocol Violation|8|||
154989092|NCT01229735|559387135|FG000|Overall Study|Lost to Follow-up|0|||
154989093|NCT01229735|559387136|FG001|Overall Study|Lost to Follow-up|2|||
154989094|NCT01229735|559387135|FG000|Overall Study|Withdrawal by Subject|18|||
154989095|NCT01229735|559387136|FG001|Overall Study|Withdrawal by Subject|17|||
154989096|NCT01229735|559387135|FG000|Overall Study|Other Reason|13|||
154989097|NCT01229735|559387136|FG001|Overall Study|Other Reason|10|||
154989098|NCT01229735|559387135|FG000|Overall Study|SAE, non-fatal|0|||
154989099|NCT01229735|559387136|FG001|Overall Study|SAE, non-fatal|4|||
154989100|NCT01229735|559387135|FG000|Overall Study|AE, non-serious non-fatal|13|||
154989101|NCT01229735|559387136|FG001|Overall Study|AE, non-serious non-fatal|17|||
154989102|NCT01229735|559387135|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
154989103|NCT01229735|559387136|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
154989104|NCT02130882|559387137|FG000|Overall Study|Withdrawal by Subject|0|||
154989105|NCT02130882|559387138|FG001|Overall Study|Withdrawal by Subject|1|||
154989106|NCT00826449|559387143|FG000|Overall Study|Disease Progression|4|||
154989107|NCT00826449|559387143|FG000|Overall Study|Withdrawal by Subject|1|||
154989108|NCT02331368|559387144|FG000|Overall Study|Withdrawal by Subject|3|||
154989109|NCT02302859|559387150|FG000|Overall Study|Lost Phone|1|||
154989110|NCT02302859|559387151|FG001|Overall Study|Lost Phone|1|||
154989111|NCT02302859|559387150|FG000|Overall Study|Withdrawal by Subject|0|||
154989112|NCT02302859|559387151|FG001|Overall Study|Withdrawal by Subject|1|||
154989113|NCT04453202|559387158|FG000|Overall Study|Adverse Event|0|||
154989114|NCT04453202|559387159|FG001|Overall Study|Adverse Event|0|||
154989115|NCT04453202|559387160|FG002|Overall Study|Adverse Event|0|||
154989116|NCT04453202|559387161|FG003|Overall Study|Adverse Event|0|||
154989117|NCT04453202|559387162|FG004|Overall Study|Adverse Event|0|||
154989118|NCT04453202|559387163|FG005|Overall Study|Adverse Event|0|||
154989119|NCT04453202|559387164|FG006|Overall Study|Adverse Event|1|||
154989120|NCT04453202|559387165|FG007|Overall Study|Adverse Event|0|||
154989121|NCT04453202|559387166|FG008|Overall Study|Adverse Event|0|||
154989122|NCT04453202|559387167|FG009|Overall Study|Adverse Event|0|||
154989123|NCT04453202|559387168|FG010|Overall Study|Adverse Event|0|||
154989124|NCT04453202|559387158|FG000|Overall Study|Death|0|||
154989125|NCT04453202|559387159|FG001|Overall Study|Death|0|||
154989126|NCT04453202|559387160|FG002|Overall Study|Death|0|||
154989127|NCT04453202|559387161|FG003|Overall Study|Death|0|||
154989128|NCT04453202|559387162|FG004|Overall Study|Death|0|||
154989129|NCT04453202|559387163|FG005|Overall Study|Death|0|||
154989130|NCT04453202|559387164|FG006|Overall Study|Death|0|||
154989131|NCT04453202|559387165|FG007|Overall Study|Death|0|||
154989132|NCT04453202|559387166|FG008|Overall Study|Death|0|||
154989133|NCT04453202|559387167|FG009|Overall Study|Death|1|||
154989134|NCT04453202|559387168|FG010|Overall Study|Death|0|||
154989135|NCT04453202|559387158|FG000|Overall Study|Lost to Follow-up|0|||
154989136|NCT04453202|559387159|FG001|Overall Study|Lost to Follow-up|1|||
154989137|NCT04453202|559387160|FG002|Overall Study|Lost to Follow-up|0|||
154989138|NCT04453202|559387161|FG003|Overall Study|Lost to Follow-up|1|||
154989139|NCT04453202|559387162|FG004|Overall Study|Lost to Follow-up|0|||
154989140|NCT04453202|559387163|FG005|Overall Study|Lost to Follow-up|0|||
154989141|NCT04453202|559387164|FG006|Overall Study|Lost to Follow-up|0|||
154989142|NCT04453202|559387165|FG007|Overall Study|Lost to Follow-up|0|||
154989143|NCT04453202|559387166|FG008|Overall Study|Lost to Follow-up|0|||
154989144|NCT04453202|559387167|FG009|Overall Study|Lost to Follow-up|1|||
154989145|NCT04453202|559387168|FG010|Overall Study|Lost to Follow-up|1|||
154989146|NCT04453202|559387158|FG000|Overall Study|Withdrawal by Subject|1|||
154989147|NCT04453202|559387159|FG001|Overall Study|Withdrawal by Subject|2|||
154989148|NCT04453202|559387160|FG002|Overall Study|Withdrawal by Subject|1|||
154989149|NCT04453202|559387161|FG003|Overall Study|Withdrawal by Subject|2|||
154989150|NCT04453202|559387162|FG004|Overall Study|Withdrawal by Subject|1|||
154989151|NCT04453202|559387163|FG005|Overall Study|Withdrawal by Subject|1|||
154989152|NCT04453202|559387164|FG006|Overall Study|Withdrawal by Subject|0|||
154989153|NCT04453202|559387165|FG007|Overall Study|Withdrawal by Subject|0|||
154989154|NCT04453202|559387166|FG008|Overall Study|Withdrawal by Subject|0|||
154989155|NCT04453202|559387167|FG009|Overall Study|Withdrawal by Subject|1|||
154989156|NCT04453202|559387168|FG010|Overall Study|Withdrawal by Subject|0|||
154989157|NCT04453202|559387158|FG000|Overall Study|Adverse Event|0|||
154989158|NCT04453202|559387159|FG001|Overall Study|Adverse Event|0|||
154989159|NCT04453202|559387160|FG002|Overall Study|Adverse Event|0|||
154989160|NCT04453202|559387161|FG003|Overall Study|Adverse Event|0|||
154989161|NCT04453202|559387162|FG004|Overall Study|Adverse Event|0|||
154989162|NCT04453202|559387163|FG005|Overall Study|Adverse Event|1|||
154989163|NCT04453202|559387164|FG006|Overall Study|Adverse Event|0|||
154989164|NCT04453202|559387165|FG007|Overall Study|Adverse Event|0|||
154989165|NCT04453202|559387166|FG008|Overall Study|Adverse Event|0|||
154989166|NCT04453202|559387167|FG009|Overall Study|Adverse Event|0|||
154989167|NCT04453202|559387168|FG010|Overall Study|Adverse Event|0|||
154989168|NCT02615171|559387169|FG000|Overall Study|Lost to Follow-up|2|||
154989169|NCT02615171|559387170|FG001|Overall Study|Lost to Follow-up|1|||
154989170|NCT00741936|559387172|FG000|Overall Study|Lost to Follow-up|1|||
154989171|NCT00741936|559387173|FG001|Overall Study|Lost to Follow-up|1|||
154989172|NCT00741936|559387172|FG000|Overall Study|Adverse Event|3|||
154989173|NCT00741936|559387173|FG001|Overall Study|Adverse Event|4|||
154989174|NCT00741936|559387172|FG000|Overall Study|Pregnancy|0|||
154989175|NCT00741936|559387173|FG001|Overall Study|Pregnancy|1|||
154989176|NCT00741936|559387172|FG000|Overall Study|Protocol Violation|2|||
154989177|NCT00741936|559387173|FG001|Overall Study|Protocol Violation|0|||
154989178|NCT00741936|559387172|FG000|Overall Study|Lack of Efficacy|0|||
154989179|NCT00741936|559387173|FG001|Overall Study|Lack of Efficacy|2|||
154989180|NCT00741936|559387172|FG000|Overall Study|Low compliance|3|||
154989181|NCT00741936|559387173|FG001|Overall Study|Low compliance|0|||
154989182|NCT03176459|559387174|FG000|Overall Study|Lost to Follow-up|5|||
154989183|NCT03176459|559387175|FG001|Overall Study|Lost to Follow-up|7|||
154989184|NCT00446199|559387176|FG000|Overall Study|Adverse Event|7|||
154989185|NCT00446199|559387177|FG001|Overall Study|Adverse Event|4|||
154989186|NCT00446199|559387178|FG002|Overall Study|Adverse Event|6|||
154989187|NCT00446199|559387179|FG003|Overall Study|Adverse Event|4|||
154989188|NCT00446199|559387176|FG000|Overall Study|Lost to Follow-up|4|||
154989189|NCT00446199|559387177|FG001|Overall Study|Lost to Follow-up|5|||
154989190|NCT00446199|559387178|FG002|Overall Study|Lost to Follow-up|2|||
154989191|NCT00446199|559387179|FG003|Overall Study|Lost to Follow-up|6|||
154989192|NCT00446199|559387176|FG000|Overall Study|Protocol Violation|1|||
154989193|NCT00446199|559387177|FG001|Overall Study|Protocol Violation|2|||
154989194|NCT00446199|559387178|FG002|Overall Study|Protocol Violation|1|||
154989195|NCT00446199|559387179|FG003|Overall Study|Protocol Violation|3|||
154989196|NCT00446199|559387176|FG000|Overall Study|Withdrawal by Subject|2|||
154989197|NCT00446199|559387177|FG001|Overall Study|Withdrawal by Subject|5|||
154989198|NCT00446199|559387178|FG002|Overall Study|Withdrawal by Subject|9|||
154989199|NCT00446199|559387179|FG003|Overall Study|Withdrawal by Subject|10|||
154989200|NCT00446199|559387176|FG000|Overall Study|Site termination|2|||
154989201|NCT00446199|559387177|FG001|Overall Study|Site termination|0|||
154989202|NCT00446199|559387178|FG002|Overall Study|Site termination|0|||
154989203|NCT00446199|559387179|FG003|Overall Study|Site termination|1|||
154989204|NCT00446199|559387176|FG000|Overall Study|Randomization in Error|2|||
154989205|NCT00446199|559387177|FG001|Overall Study|Randomization in Error|0|||
154989206|NCT00446199|559387178|FG002|Overall Study|Randomization in Error|1|||
154989207|NCT00446199|559387179|FG003|Overall Study|Randomization in Error|1|||
154989208|NCT00446199|559387176|FG000|Overall Study|Lack of Efficacy|1|||
154989209|NCT00446199|559387177|FG001|Overall Study|Lack of Efficacy|0|||
154989210|NCT00446199|559387178|FG002|Overall Study|Lack of Efficacy|0|||
154989211|NCT00446199|559387179|FG003|Overall Study|Lack of Efficacy|1|||
154989212|NCT00446199|559387176|FG000|Overall Study|Non-compliant with study drug|1|||
154989213|NCT00446199|559387177|FG001|Overall Study|Non-compliant with study drug|0|||
154989214|NCT00446199|559387178|FG002|Overall Study|Non-compliant with study drug|5|||
154989215|NCT00446199|559387179|FG003|Overall Study|Non-compliant with study drug|0|||
154989216|NCT00446199|559387176|FG000|Overall Study|Non-compliant with visit schedule|1|||
154989217|NCT00446199|559387177|FG001|Overall Study|Non-compliant with visit schedule|1|||
154989218|NCT00446199|559387178|FG002|Overall Study|Non-compliant with visit schedule|1|||
154989219|NCT00446199|559387179|FG003|Overall Study|Non-compliant with visit schedule|2|||
155120348|NCT00977938|559870996|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
155120349|NCT00977938|559870997|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
154989220|NCT00446199|559387176|FG000|Overall Study|Hormone fear|0|||
154989221|NCT00446199|559387177|FG001|Overall Study|Hormone fear|0|||
154989222|NCT00446199|559387178|FG002|Overall Study|Hormone fear|0|||
154989223|NCT00446199|559387179|FG003|Overall Study|Hormone fear|1|||
155177055|NCT02081859|560086529|FG000|Overall Study|< 4 embryos|27|||
155177056|NCT02081859|560086530|FG001|Overall Study|< 4 embryos|23|||
155177057|NCT02081859|560086529|FG000|Overall Study|Other reasons|2|||
155177058|NCT02081859|560086530|FG001|Overall Study|Other reasons|0|||
155177059|NCT00883688|560088156|FG000|Overall Study|Ineligible|2|||
155177060|NCT00464490|560088157|FG000|Overall Study|Physician Decision|11|||
155177061|NCT00464490|560088158|FG001|Overall Study|Physician Decision|11|||
155177062|NCT03188042|560088159|FG000|Overall Study|Withdrawal by Subject|1|||
155177063|NCT03188042|560088160|FG001|Overall Study|Withdrawal by Subject|1|||
155177064|NCT00137839|560088164|FG000|Overall Study|Adverse Event|7|||
155177065|NCT00137839|560088164|FG000|Overall Study|Physician Decision|7|||
155177066|NCT00137839|560088164|FG000|Overall Study|Death|8|||
155177067|NCT00137839|560088164|FG000|Overall Study|Disease Progression|60|||
155177068|NCT00137839|560088164|FG000|Overall Study|Not Start Treatment|1|||
155177069|NCT00137839|560088164|FG000|Overall Study|Prolonged Treatment Delay|1|||
155177070|NCT02446743|560088165|FG000|Overall Study|Withdrawal by Subject|1|||
155177071|NCT02446743|560088166|FG001|Overall Study|Withdrawal by Subject|1|||
155177072|NCT02446743|560088165|FG000|Overall Study|Lost to Follow-up|1|||
155177073|NCT02446743|560088166|FG001|Overall Study|Lost to Follow-up|0|||
155177074|NCT02446743|560088165|FG000|Overall Study|Adverse Event|1|||
155177075|NCT02446743|560088166|FG001|Overall Study|Adverse Event|1|||
155177076|NCT02446743|560088165|FG000|Overall Study|Other|2|||
155177077|NCT02446743|560088166|FG001|Overall Study|Other|3|||
155177078|NCT03086967|560088167|FG000|Overall Study|Screen Failure|2|||
155177079|NCT03086967|560088168|FG001|Overall Study|Screen Failure|2|||
155177080|NCT02230527|560088170|FG000|Overall Study|Withdrawal by Subject|1|||
155177081|NCT02230527|560088171|FG001|Overall Study|Withdrawal by Subject|1|||
155177082|NCT02230527|560088170|FG000|Overall Study|Death|1|||
155177083|NCT02230527|560088171|FG001|Overall Study|Death|0|||
155177084|NCT02230527|560088170|FG000|Overall Study|Lost to Follow-up|2|||
155177085|NCT02230527|560088171|FG001|Overall Study|Lost to Follow-up|1|||
155177086|NCT02230527|560088170|FG000|Overall Study|Other|1|||
155177087|NCT02230527|560088171|FG001|Overall Study|Other|0|||
155177088|NCT01752036|560088172|FG000|Overall Study|Death|2|||
155177089|NCT01205581|560088174|FG000|Overall Study|Withdrawal by Subject|1|||
155177090|NCT01205581|560088175|FG001|Overall Study|Withdrawal by Subject|0|||
155177091|NCT01205581|560088176|FG002|Overall Study|Withdrawal by Subject|0|||
155177092|NCT01205581|560088177|FG003|Overall Study|Withdrawal by Subject|0|||
155177093|NCT01205581|560088178|FG004|Overall Study|Withdrawal by Subject|0|||
155177094|NCT01205581|560088179|FG005|Overall Study|Withdrawal by Subject|0|||
155177095|NCT04896229|560088181|FG000|Overall Study|Lost to Follow-up|113|||
155177096|NCT04896229|560088182|FG001|Overall Study|Lost to Follow-up|113|||
155177097|NCT00045942|560088183|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
155177098|NCT00045942|560088184|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177099|NCT00045942|560088185|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177100|NCT00045942|560088186|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177101|NCT00045942|560088187|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177102|NCT00045942|560088188|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177103|NCT00045942|560088189|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
154989224|NCT00446199|559387176|FG000|Overall Study|Lost interest in study participation|0|||
154989225|NCT00446199|559387177|FG001|Overall Study|Lost interest in study participation|1|||
154989226|NCT00446199|559387178|FG002|Overall Study|Lost interest in study participation|0|||
154989227|NCT00446199|559387179|FG003|Overall Study|Lost interest in study participation|0|||
154989228|NCT00446199|559387176|FG000|Overall Study|In-/Exclusion criterion violated|2|||
154989229|NCT00446199|559387177|FG001|Overall Study|In-/Exclusion criterion violated|1|||
154989230|NCT00446199|559387178|FG002|Overall Study|In-/Exclusion criterion violated|2|||
154989231|NCT00446199|559387179|FG003|Overall Study|In-/Exclusion criterion violated|1|||
154989232|NCT00446199|559387176|FG000|Overall Study|Move|0|||
154989233|NCT00446199|559387177|FG001|Overall Study|Move|1|||
154989234|NCT00446199|559387178|FG002|Overall Study|Move|0|||
154989235|NCT00446199|559387179|FG003|Overall Study|Move|0|||
154989236|NCT03071094|559387183|FG000|Overall Study|Death|1|||
154989237|NCT03071094|559387184|FG001|Overall Study|Death|1|||
155177104|NCT00045942|560088190|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177105|NCT00045942|560088191|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
155177106|NCT00045942|560088183|FG000|PKC412A2104 (Core)|Adverse Event|5|||
155177107|NCT00045942|560088184|FG001|PKC412A2104 (Core)|Adverse Event|0|||
155177108|NCT00045942|560088185|FG002|PKC412A2104 (Core)|Adverse Event|0|||
155177109|NCT00045942|560088186|FG003|PKC412A2104 (Core)|Adverse Event|0|||
155177110|NCT00045942|560088187|FG004|PKC412A2104 (Core)|Adverse Event|0|||
155177111|NCT00045942|560088188|FG005|PKC412A2104 (Core)|Adverse Event|0|||
155177112|NCT00045942|560088189|FG006|PKC412A2104 (Core)|Adverse Event|0|||
155177113|NCT00045942|560088190|FG007|PKC412A2104 (Core)|Adverse Event|0|||
155177114|NCT00045942|560088191|FG008|PKC412A2104 (Core)|Adverse Event|0|||
155177115|NCT00045942|560088183|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
155177116|NCT00045942|560088184|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
155177117|NCT00045942|560088185|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
155177118|NCT00045942|560088186|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
155177119|NCT00045942|560088187|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
154989238|NCT03071094|559387183|FG000|Overall Study|Adverse Event|1|||
154989239|NCT03071094|559387184|FG001|Overall Study|Adverse Event|0|||
154989240|NCT01079832|559387185|FG000|Overall Study|Withdrawal by Subject|1|||
154989241|NCT04969861|559387186|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
154989242|NCT04969861|559387187|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
154989243|NCT00290251|559387188|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
154989244|NCT00290251|559387189|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
154989245|NCT00290251|559387190|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
154989246|NCT00290251|559387191|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
154989247|NCT00290251|559387192|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
154989248|NCT00290251|559387193|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
154989249|NCT00290251|559387188|FG000|Treatment 1 (Months 2-4)|headache|0|||
154989250|NCT00290251|559387189|FG001|Treatment 1 (Months 2-4)|headache|0|||
154989251|NCT00290251|559387190|FG002|Treatment 1 (Months 2-4)|headache|0|||
154916879|NCT01072175|559118487|FG008|Part D (HPMC Capsules)|Death|0|||
154916880|NCT01072175|559118488|FG009|Part D (HPMC Capsules)|Death|10|||
154916881|NCT01072175|559118489|FG010|Part D (HPMC Capsules)|Death|12|||
154916882|NCT01072175|559118490|FG011|Part D (HPMC Capsules)|Death|28|||
154989252|NCT00290251|559387191|FG003|Treatment 1 (Months 2-4)|headache|0|||
154989253|NCT00290251|559387192|FG004|Treatment 1 (Months 2-4)|headache|1|||
154989254|NCT00290251|559387193|FG005|Treatment 1 (Months 2-4)|headache|0|||
154989255|NCT00290251|559387188|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
154989256|NCT00290251|559387189|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
154989257|NCT00290251|559387190|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
154989258|NCT00290251|559387191|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
154989259|NCT00290251|559387192|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
154989260|NCT00290251|559387193|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
154989261|NCT05011123|559389632|FG000|Overall Study|Withdrawal by Subject|4|||
155120350|NCT00977938|559870998|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
155120351|NCT00977938|559870995|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
155120352|NCT00977938|559870996|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
155120353|NCT00977938|559870997|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
155120354|NCT00977938|559870998|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
155120355|NCT00977938|559870995|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
155120356|NCT00977938|559870996|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
155120357|NCT00977938|559870997|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
155120358|NCT00977938|559870998|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
155120359|NCT02142283|559870999|FG000|Overall Study|Death|20|||
155120360|NCT02142283|559871000|FG001|Overall Study|Death|18|||
155120361|NCT02142283|559870999|FG000|Overall Study|Withdrawal by Subject|1|||
155120362|NCT02142283|559871000|FG001|Overall Study|Withdrawal by Subject|3|||
155120363|NCT00747344|559871003|FG000|Controlled Period|Adverse Event|3|||
155120364|NCT00747344|559871004|FG001|Controlled Period|Adverse Event|0|||
155120365|NCT00747344|559871005|FG002|Controlled Period|Adverse Event|0|||
155120366|NCT00747344|559871006|FG003|Controlled Period|Adverse Event|0|||
154916883|NCT01072175|559118491|FG012|Part D (HPMC Capsules)|Death|26|||
154916884|NCT01072175|559118479|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
154916885|NCT01072175|559118480|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
154916886|NCT01072175|559118481|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
154916887|NCT01072175|559118482|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
154916888|NCT01072175|559118483|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
154916889|NCT01072175|559118484|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
154916890|NCT01072175|559118485|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
154916891|NCT01072175|559118486|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
154916892|NCT01072175|559118487|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
154916893|NCT01072175|559118488|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
154916894|NCT01072175|559118489|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
154916895|NCT01072175|559118490|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
154916896|NCT01072175|559118491|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
154916897|NCT01072175|559118479|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916898|NCT01072175|559118480|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916899|NCT01072175|559118481|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916900|NCT01072175|559118482|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916901|NCT01072175|559118483|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916902|NCT01072175|559118484|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916903|NCT01072175|559118485|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916904|NCT01072175|559118486|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916905|NCT01072175|559118487|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
154916906|NCT01072175|559118488|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
155120367|NCT00747344|559871003|FG000|Controlled Period|Lack of Efficacy|2|||
154916907|NCT01072175|559118489|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
154916908|NCT01072175|559118490|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
154916909|NCT01072175|559118491|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
154989262|NCT05011123|559389633|FG001|Overall Study|Withdrawal by Subject|2|||
154989263|NCT05011123|559389632|FG000|Overall Study|Lost to Follow-up|7|||
154989264|NCT05011123|559389633|FG001|Overall Study|Lost to Follow-up|6|||
154989265|NCT05011123|559389632|FG000|Overall Study|Ongoing at the time of DBL date|36|||
154989266|NCT05011123|559389633|FG001|Overall Study|Ongoing at the time of DBL date|10|||
154989267|NCT05011123|559389632|FG000|Overall Study|Randomized but did not receive vaccination|1|||
154989268|NCT05011123|559389633|FG001|Overall Study|Randomized but did not receive vaccination|0|||
154989269|NCT03653507|559389634|FG000|Overall Study|Miscellaneous|28|||
154989270|NCT03653507|559389635|FG001|Overall Study|Miscellaneous|19|||
154989271|NCT03653507|559389634|FG000|Overall Study|Withdrawal by Subject|37|||
154989272|NCT03653507|559389635|FG001|Overall Study|Withdrawal by Subject|22|||
154989273|NCT03653507|559389634|FG000|Overall Study|Protocol Deviation|2|||
154989274|NCT03653507|559389635|FG001|Overall Study|Protocol Deviation|1|||
154989275|NCT03653507|559389634|FG000|Overall Study|Progressive disease|117|||
154989276|NCT03653507|559389635|FG001|Overall Study|Progressive disease|168|||
154989277|NCT03653507|559389634|FG000|Overall Study|Lost to Follow-up|1|||
154989278|NCT03653507|559389635|FG001|Overall Study|Lost to Follow-up|1|||
154989279|NCT03653507|559389634|FG000|Overall Study|Death|25|||
154989280|NCT03653507|559389635|FG001|Overall Study|Death|22|||
154989281|NCT03653507|559389634|FG000|Overall Study|Adverse Event|35|||
154989282|NCT03653507|559389635|FG001|Overall Study|Adverse Event|14|||
154989283|NCT02799095|559389642|FG000|Part A|Adverse Event|1|||
154989284|NCT02799095|559389643|FG001|Part A|Adverse Event|0|||
154989285|NCT02799095|559389644|FG002|Part A|Adverse Event|1|||
154989286|NCT02799095|559389645|FG003|Part A|Adverse Event|4|||
154989287|NCT02799095|559389646|FG004|Part A|Adverse Event|1|||
154989288|NCT02799095|559389647|FG005|Part A|Adverse Event|0|||
154989289|NCT02799095|559389648|FG006|Part A|Adverse Event|0|||
154989290|NCT02799095|559389649|FG007|Part A|Adverse Event|0|||
154989291|NCT02799095|559389650|FG008|Part A|Adverse Event|0|||
154989292|NCT02799095|559389651|FG009|Part A|Adverse Event|0|||
154989293|NCT02799095|559389652|FG010|Part A|Adverse Event|0|||
154989294|NCT02799095|559389653|FG011|Part A|Adverse Event|0|||
154989295|NCT02799095|559389654|FG012|Part A|Adverse Event|0|||
154989296|NCT02799095|559389655|FG013|Part A|Adverse Event|0|||
154989297|NCT02799095|559389656|FG014|Part A|Adverse Event|0|||
154989298|NCT02799095|559389657|FG015|Part A|Adverse Event|0|||
154989299|NCT02799095|559389658|FG016|Part A|Adverse Event|0|||
154989300|NCT02799095|559389642|FG000|Part A|Death|0|||
154989301|NCT02799095|559389643|FG001|Part A|Death|0|||
154989302|NCT02799095|559389644|FG002|Part A|Death|0|||
154989303|NCT02799095|559389645|FG003|Part A|Death|0|||
154989304|NCT02799095|559389646|FG004|Part A|Death|0|||
154989305|NCT02799095|559389647|FG005|Part A|Death|0|||
154989306|NCT02799095|559389648|FG006|Part A|Death|3|||
154989307|NCT02799095|559389649|FG007|Part A|Death|0|||
154989308|NCT02799095|559389650|FG008|Part A|Death|0|||
154989309|NCT02799095|559389651|FG009|Part A|Death|0|||
154989310|NCT02799095|559389652|FG010|Part A|Death|0|||
154989311|NCT02799095|559389653|FG011|Part A|Death|0|||
154989312|NCT02799095|559389654|FG012|Part A|Death|0|||
154989313|NCT02799095|559389655|FG013|Part A|Death|0|||
154989314|NCT02799095|559389656|FG014|Part A|Death|0|||
154989315|NCT02799095|559389657|FG015|Part A|Death|0|||
154989316|NCT02799095|559389658|FG016|Part A|Death|0|||
154989317|NCT02799095|559389642|FG000|Part A|Lost to Follow-up|0|||
154989318|NCT02799095|559389643|FG001|Part A|Lost to Follow-up|1|||
155177120|NCT00045942|560088188|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
155177121|NCT00045942|560088189|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
154989319|NCT02799095|559389644|FG002|Part A|Lost to Follow-up|0|||
154989320|NCT02799095|559389645|FG003|Part A|Lost to Follow-up|0|||
154989321|NCT02799095|559389646|FG004|Part A|Lost to Follow-up|0|||
154989322|NCT02799095|559389647|FG005|Part A|Lost to Follow-up|0|||
154989323|NCT02799095|559389648|FG006|Part A|Lost to Follow-up|1|||
154989324|NCT02799095|559389649|FG007|Part A|Lost to Follow-up|0|||
154989325|NCT02799095|559389650|FG008|Part A|Lost to Follow-up|0|||
154989326|NCT02799095|559389651|FG009|Part A|Lost to Follow-up|0|||
154989327|NCT02799095|559389652|FG010|Part A|Lost to Follow-up|0|||
154989328|NCT02799095|559389653|FG011|Part A|Lost to Follow-up|0|||
154989329|NCT02799095|559389654|FG012|Part A|Lost to Follow-up|0|||
154989330|NCT02799095|559389655|FG013|Part A|Lost to Follow-up|0|||
154989331|NCT02799095|559389656|FG014|Part A|Lost to Follow-up|0|||
154989332|NCT02799095|559389657|FG015|Part A|Lost to Follow-up|0|||
154989333|NCT02799095|559389658|FG016|Part A|Lost to Follow-up|0|||
154989334|NCT02799095|559389642|FG000|Part A|Progressive Disease|3|||
154989335|NCT02799095|559389643|FG001|Part A|Progressive Disease|3|||
154989336|NCT02799095|559389644|FG002|Part A|Progressive Disease|3|||
155177122|NCT00045942|560088190|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
154989337|NCT02799095|559389645|FG003|Part A|Progressive Disease|2|||
154989338|NCT02799095|559389646|FG004|Part A|Progressive Disease|2|||
154989339|NCT02799095|559389647|FG005|Part A|Progressive Disease|0|||
154989340|NCT02799095|559389648|FG006|Part A|Progressive Disease|0|||
154989341|NCT02799095|559389649|FG007|Part A|Progressive Disease|0|||
154989342|NCT02799095|559389650|FG008|Part A|Progressive Disease|0|||
154989343|NCT02799095|559389651|FG009|Part A|Progressive Disease|0|||
154989344|NCT02799095|559389652|FG010|Part A|Progressive Disease|0|||
155177123|NCT00045942|560088191|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
155177124|NCT00045942|560088183|FG000|PKC412A2104 (Core)|Death|1|||
155177125|NCT00045942|560088184|FG001|PKC412A2104 (Core)|Death|0|||
155177126|NCT00045942|560088185|FG002|PKC412A2104 (Core)|Death|0|||
155177127|NCT00045942|560088186|FG003|PKC412A2104 (Core)|Death|0|||
155177128|NCT00045942|560088187|FG004|PKC412A2104 (Core)|Death|0|||
155177129|NCT00045942|560088188|FG005|PKC412A2104 (Core)|Death|0|||
155177130|NCT00045942|560088189|FG006|PKC412A2104 (Core)|Death|0|||
155177131|NCT00045942|560088190|FG007|PKC412A2104 (Core)|Death|0|||
155177132|NCT00045942|560088191|FG008|PKC412A2104 (Core)|Death|0|||
155177133|NCT00045942|560088183|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
155177134|NCT00045942|560088184|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
155177135|NCT00045942|560088185|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
155177136|NCT00045942|560088186|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
155177137|NCT00045942|560088187|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
155177138|NCT00045942|560088188|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
155177139|NCT00045942|560088189|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
155177140|NCT00045942|560088190|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
155177141|NCT00045942|560088191|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
155177142|NCT00045942|560088183|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
155177143|NCT00045942|560088184|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
155177144|NCT00045942|560088185|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
155177145|NCT00045942|560088186|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
155177146|NCT00045942|560088187|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
155177147|NCT00045942|560088188|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
155177148|NCT00045942|560088189|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
155177149|NCT00045942|560088190|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
155177150|NCT00045942|560088191|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
155177151|NCT00045942|560088183|FG000|PKC412A2104E1|Lack of Efficacy|0|||
155177152|NCT00045942|560088184|FG001|PKC412A2104E1|Lack of Efficacy|11|||
155177153|NCT00045942|560088185|FG002|PKC412A2104E1|Lack of Efficacy|11|||
155177154|NCT00045942|560088186|FG003|PKC412A2104E1|Lack of Efficacy|23|||
155177155|NCT00045942|560088187|FG004|PKC412A2104E1|Lack of Efficacy|17|||
155177156|NCT00045942|560088188|FG005|PKC412A2104E1|Lack of Efficacy|0|||
155177157|NCT00045942|560088189|FG006|PKC412A2104E1|Lack of Efficacy|0|||
155177158|NCT00045942|560088190|FG007|PKC412A2104E1|Lack of Efficacy|0|||
155177159|NCT00045942|560088191|FG008|PKC412A2104E1|Lack of Efficacy|0|||
155177160|NCT00045942|560088183|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
155177161|NCT00045942|560088184|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
155177162|NCT00045942|560088185|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
155177163|NCT00045942|560088186|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
155177164|NCT00045942|560088187|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
155177165|NCT00045942|560088188|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
155177166|NCT00045942|560088189|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
155177167|NCT00045942|560088190|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
154989345|NCT02799095|559389653|FG011|Part A|Progressive Disease|0|||
154989346|NCT02799095|559389654|FG012|Part A|Progressive Disease|0|||
154989347|NCT02799095|559389655|FG013|Part A|Progressive Disease|0|||
154989348|NCT02799095|559389656|FG014|Part A|Progressive Disease|0|||
154989349|NCT02799095|559389657|FG015|Part A|Progressive Disease|0|||
154989350|NCT02799095|559389658|FG016|Part A|Progressive Disease|0|||
154989351|NCT02799095|559389642|FG000|Part A|Clinical Progression|1|||
154989352|NCT02799095|559389643|FG001|Part A|Clinical Progression|0|||
154989353|NCT02799095|559389644|FG002|Part A|Clinical Progression|2|||
154989354|NCT02799095|559389645|FG003|Part A|Clinical Progression|1|||
154989355|NCT02799095|559389646|FG004|Part A|Clinical Progression|5|||
154989356|NCT02799095|559389647|FG005|Part A|Clinical Progression|0|||
155177168|NCT00045942|560088191|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
155177169|NCT00045942|560088183|FG000|PKC412A2104E1|Adverse Event|0|||
155177170|NCT00045942|560088184|FG001|PKC412A2104E1|Adverse Event|1|||
154989357|NCT02799095|559389648|FG006|Part A|Clinical Progression|0|||
155177171|NCT00045942|560088185|FG002|PKC412A2104E1|Adverse Event|1|||
154989358|NCT02799095|559389649|FG007|Part A|Clinical Progression|0|||
154989359|NCT02799095|559389650|FG008|Part A|Clinical Progression|0|||
154989360|NCT02799095|559389651|FG009|Part A|Clinical Progression|0|||
154989361|NCT02799095|559389652|FG010|Part A|Clinical Progression|0|||
154989362|NCT02799095|559389653|FG011|Part A|Clinical Progression|0|||
154989363|NCT02799095|559389654|FG012|Part A|Clinical Progression|0|||
155177172|NCT00045942|560088186|FG003|PKC412A2104E1|Adverse Event|3|||
155177173|NCT00045942|560088187|FG004|PKC412A2104E1|Adverse Event|6|||
154989364|NCT02799095|559389655|FG013|Part A|Clinical Progression|0|||
154989365|NCT02799095|559389656|FG014|Part A|Clinical Progression|0|||
154989366|NCT02799095|559389657|FG015|Part A|Clinical Progression|0|||
154989367|NCT02799095|559389658|FG016|Part A|Clinical Progression|0|||
155177174|NCT00045942|560088188|FG005|PKC412A2104E1|Adverse Event|0|||
155177175|NCT00045942|560088189|FG006|PKC412A2104E1|Adverse Event|0|||
155177176|NCT00045942|560088190|FG007|PKC412A2104E1|Adverse Event|0|||
154989368|NCT02799095|559389642|FG000|Part A|Protocol Deviation|0|||
154989369|NCT02799095|559389643|FG001|Part A|Protocol Deviation|0|||
154989370|NCT02799095|559389644|FG002|Part A|Protocol Deviation|1|||
154989371|NCT02799095|559389645|FG003|Part A|Protocol Deviation|0|||
154989372|NCT02799095|559389646|FG004|Part A|Protocol Deviation|0|||
154989373|NCT02799095|559389647|FG005|Part A|Protocol Deviation|0|||
154989374|NCT02799095|559389648|FG006|Part A|Protocol Deviation|0|||
154989375|NCT02799095|559389649|FG007|Part A|Protocol Deviation|0|||
154989376|NCT02799095|559389650|FG008|Part A|Protocol Deviation|0|||
154989377|NCT02799095|559389651|FG009|Part A|Protocol Deviation|0|||
154989378|NCT02799095|559389652|FG010|Part A|Protocol Deviation|0|||
154989379|NCT02799095|559389653|FG011|Part A|Protocol Deviation|0|||
154989380|NCT02799095|559389654|FG012|Part A|Protocol Deviation|0|||
154989381|NCT02799095|559389655|FG013|Part A|Protocol Deviation|0|||
154989382|NCT02799095|559389656|FG014|Part A|Protocol Deviation|0|||
154989383|NCT02799095|559389657|FG015|Part A|Protocol Deviation|0|||
154989384|NCT02799095|559389658|FG016|Part A|Protocol Deviation|0|||
154989385|NCT02799095|559389642|FG000|Part A|Withdrawal by Subject|0|||
154989386|NCT02799095|559389643|FG001|Part A|Withdrawal by Subject|0|||
154989387|NCT02799095|559389644|FG002|Part A|Withdrawal by Subject|0|||
154989388|NCT02799095|559389645|FG003|Part A|Withdrawal by Subject|1|||
154989389|NCT02799095|559389646|FG004|Part A|Withdrawal by Subject|3|||
154989390|NCT02799095|559389647|FG005|Part A|Withdrawal by Subject|1|||
154989391|NCT02799095|559389648|FG006|Part A|Withdrawal by Subject|1|||
154989392|NCT02799095|559389649|FG007|Part A|Withdrawal by Subject|0|||
154989393|NCT02799095|559389650|FG008|Part A|Withdrawal by Subject|0|||
154989394|NCT02799095|559389651|FG009|Part A|Withdrawal by Subject|0|||
154989395|NCT02799095|559389652|FG010|Part A|Withdrawal by Subject|0|||
154989396|NCT02799095|559389653|FG011|Part A|Withdrawal by Subject|0|||
154989397|NCT02799095|559389654|FG012|Part A|Withdrawal by Subject|0|||
154989398|NCT02799095|559389655|FG013|Part A|Withdrawal by Subject|0|||
154989399|NCT02799095|559389656|FG014|Part A|Withdrawal by Subject|0|||
154989400|NCT02799095|559389657|FG015|Part A|Withdrawal by Subject|0|||
154989401|NCT02799095|559389658|FG016|Part A|Withdrawal by Subject|0|||
154989402|NCT02799095|559389642|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
154989403|NCT02799095|559389643|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
154989404|NCT02799095|559389644|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
154989405|NCT02799095|559389645|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
154989406|NCT02799095|559389646|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
154989407|NCT02799095|559389647|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
154989408|NCT02799095|559389648|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
154989409|NCT02799095|559389649|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
154989410|NCT02799095|559389650|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
154989411|NCT02799095|559389651|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
154989412|NCT02799095|559389652|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
154989413|NCT02799095|559389653|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
154989414|NCT02799095|559389654|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
154989415|NCT02799095|559389655|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
154989416|NCT02799095|559389656|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
154989417|NCT02799095|559389657|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
154989418|NCT02799095|559389658|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
154989419|NCT02799095|559389642|FG000|Part B|Death|0|||
154989420|NCT02799095|559389643|FG001|Part B|Death|0|||
154989421|NCT02799095|559389644|FG002|Part B|Death|0|||
154989422|NCT02799095|559389645|FG003|Part B|Death|0|||
154989423|NCT02799095|559389646|FG004|Part B|Death|0|||
154989424|NCT02799095|559389647|FG005|Part B|Death|0|||
154989425|NCT02799095|559389648|FG006|Part B|Death|0|||
154989426|NCT02799095|559389649|FG007|Part B|Death|7|||
154989427|NCT02799095|559389650|FG008|Part B|Death|7|||
154989428|NCT02799095|559389651|FG009|Part B|Death|0|||
154989429|NCT02799095|559389652|FG010|Part B|Death|0|||
154989430|NCT02799095|559389653|FG011|Part B|Death|0|||
154989431|NCT02799095|559389654|FG012|Part B|Death|0|||
154989432|NCT02799095|559389655|FG013|Part B|Death|0|||
154989433|NCT02799095|559389656|FG014|Part B|Death|0|||
154989434|NCT02799095|559389657|FG015|Part B|Death|0|||
154989435|NCT02799095|559389658|FG016|Part B|Death|0|||
154989436|NCT02799095|559389642|FG000|Part B|Progressive Disease|0|||
154989437|NCT02799095|559389643|FG001|Part B|Progressive Disease|0|||
154989438|NCT02799095|559389644|FG002|Part B|Progressive Disease|0|||
154989439|NCT02799095|559389645|FG003|Part B|Progressive Disease|0|||
154989440|NCT02799095|559389646|FG004|Part B|Progressive Disease|0|||
154989441|NCT02799095|559389647|FG005|Part B|Progressive Disease|0|||
154989442|NCT02799095|559389648|FG006|Part B|Progressive Disease|0|||
154989443|NCT02799095|559389649|FG007|Part B|Progressive Disease|1|||
154989444|NCT02799095|559389650|FG008|Part B|Progressive Disease|0|||
154989445|NCT02799095|559389651|FG009|Part B|Progressive Disease|0|||
154989446|NCT02799095|559389652|FG010|Part B|Progressive Disease|0|||
154989447|NCT02799095|559389653|FG011|Part B|Progressive Disease|0|||
154989448|NCT02799095|559389654|FG012|Part B|Progressive Disease|0|||
154989449|NCT02799095|559389655|FG013|Part B|Progressive Disease|0|||
154989450|NCT02799095|559389656|FG014|Part B|Progressive Disease|0|||
154989451|NCT02799095|559389657|FG015|Part B|Progressive Disease|0|||
154989452|NCT02799095|559389658|FG016|Part B|Progressive Disease|0|||
154989453|NCT02799095|559389642|FG000|Part B|Withdrawal by Subject|0|||
154989454|NCT02799095|559389643|FG001|Part B|Withdrawal by Subject|0|||
154989455|NCT02799095|559389644|FG002|Part B|Withdrawal by Subject|0|||
154989456|NCT02799095|559389645|FG003|Part B|Withdrawal by Subject|0|||
154989457|NCT02799095|559389646|FG004|Part B|Withdrawal by Subject|0|||
154989458|NCT02799095|559389647|FG005|Part B|Withdrawal by Subject|0|||
154989459|NCT02799095|559389648|FG006|Part B|Withdrawal by Subject|0|||
154989460|NCT02799095|559389649|FG007|Part B|Withdrawal by Subject|10|||
154989461|NCT02799095|559389650|FG008|Part B|Withdrawal by Subject|7|||
154989462|NCT02799095|559389651|FG009|Part B|Withdrawal by Subject|0|||
154989463|NCT02799095|559389652|FG010|Part B|Withdrawal by Subject|0|||
154989464|NCT02799095|559389653|FG011|Part B|Withdrawal by Subject|0|||
154989465|NCT02799095|559389654|FG012|Part B|Withdrawal by Subject|0|||
154989466|NCT02799095|559389655|FG013|Part B|Withdrawal by Subject|0|||
154989467|NCT02799095|559389656|FG014|Part B|Withdrawal by Subject|0|||
154989468|NCT02799095|559389657|FG015|Part B|Withdrawal by Subject|0|||
154989469|NCT02799095|559389658|FG016|Part B|Withdrawal by Subject|0|||
154989470|NCT02799095|559389642|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
154989471|NCT02799095|559389643|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
154989472|NCT02799095|559389644|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
154989473|NCT02799095|559389645|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
154989474|NCT02799095|559389646|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
154989475|NCT02799095|559389647|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
154989476|NCT02799095|559389648|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
154989477|NCT02799095|559389649|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
154989478|NCT02799095|559389650|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
154989479|NCT02799095|559389651|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
154989480|NCT02799095|559389652|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
154989481|NCT02799095|559389653|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
154989482|NCT02799095|559389654|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
154989483|NCT02799095|559389655|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
154989484|NCT02799095|559389656|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
154989485|NCT02799095|559389657|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
154989486|NCT02799095|559389658|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
154989487|NCT02799095|559389642|FG000|Part C|Adverse Event|0|||
154989488|NCT02799095|559389643|FG001|Part C|Adverse Event|0|||
154989489|NCT02799095|559389644|FG002|Part C|Adverse Event|0|||
154989490|NCT02799095|559389645|FG003|Part C|Adverse Event|0|||
154989491|NCT02799095|559389646|FG004|Part C|Adverse Event|0|||
154989492|NCT02799095|559389647|FG005|Part C|Adverse Event|0|||
154989493|NCT02799095|559389648|FG006|Part C|Adverse Event|0|||
154989494|NCT02799095|559389649|FG007|Part C|Adverse Event|0|||
154989495|NCT02799095|559389650|FG008|Part C|Adverse Event|0|||
154989496|NCT02799095|559389651|FG009|Part C|Adverse Event|0|||
154989497|NCT02799095|559389652|FG010|Part C|Adverse Event|3|||
154989498|NCT02799095|559389653|FG011|Part C|Adverse Event|1|||
154989499|NCT02799095|559389654|FG012|Part C|Adverse Event|0|||
154989500|NCT02799095|559389655|FG013|Part C|Adverse Event|1|||
154989501|NCT02799095|559389656|FG014|Part C|Adverse Event|0|||
154989502|NCT02799095|559389657|FG015|Part C|Adverse Event|0|||
154989503|NCT02799095|559389658|FG016|Part C|Adverse Event|0|||
154989504|NCT02799095|559389642|FG000|Part C|Death|0|||
154989505|NCT02799095|559389643|FG001|Part C|Death|0|||
154989506|NCT02799095|559389644|FG002|Part C|Death|0|||
154989507|NCT02799095|559389645|FG003|Part C|Death|0|||
154989508|NCT02799095|559389646|FG004|Part C|Death|0|||
154989509|NCT02799095|559389647|FG005|Part C|Death|0|||
154989510|NCT02799095|559389648|FG006|Part C|Death|0|||
154989511|NCT02799095|559389649|FG007|Part C|Death|0|||
154989512|NCT02799095|559389650|FG008|Part C|Death|0|||
154989513|NCT02799095|559389651|FG009|Part C|Death|0|||
154989514|NCT02799095|559389652|FG010|Part C|Death|7|||
154989515|NCT02799095|559389653|FG011|Part C|Death|5|||
154989516|NCT02799095|559389654|FG012|Part C|Death|6|||
154989517|NCT02799095|559389655|FG013|Part C|Death|8|||
154989518|NCT02799095|559389656|FG014|Part C|Death|1|||
154989519|NCT02799095|559389657|FG015|Part C|Death|8|||
154989520|NCT02799095|559389658|FG016|Part C|Death|1|||
154989521|NCT02799095|559389642|FG000|Part C|Lost to Follow-up|0|||
154989522|NCT02799095|559389643|FG001|Part C|Lost to Follow-up|0|||
154989523|NCT02799095|559389644|FG002|Part C|Lost to Follow-up|0|||
154989524|NCT02799095|559389645|FG003|Part C|Lost to Follow-up|0|||
154989525|NCT02799095|559389646|FG004|Part C|Lost to Follow-up|0|||
154989526|NCT02799095|559389647|FG005|Part C|Lost to Follow-up|0|||
154989527|NCT02799095|559389648|FG006|Part C|Lost to Follow-up|0|||
154989528|NCT02799095|559389649|FG007|Part C|Lost to Follow-up|0|||
154989529|NCT02799095|559389650|FG008|Part C|Lost to Follow-up|0|||
154989530|NCT02799095|559389651|FG009|Part C|Lost to Follow-up|0|||
154989531|NCT02799095|559389652|FG010|Part C|Lost to Follow-up|1|||
154989532|NCT02799095|559389653|FG011|Part C|Lost to Follow-up|1|||
154989533|NCT02799095|559389654|FG012|Part C|Lost to Follow-up|1|||
154989534|NCT02799095|559389655|FG013|Part C|Lost to Follow-up|3|||
154989535|NCT02799095|559389656|FG014|Part C|Lost to Follow-up|0|||
154989536|NCT02799095|559389657|FG015|Part C|Lost to Follow-up|0|||
155120368|NCT00747344|559871004|FG001|Controlled Period|Lack of Efficacy|1|||
155120369|NCT00747344|559871005|FG002|Controlled Period|Lack of Efficacy|0|||
155120370|NCT00747344|559871006|FG003|Controlled Period|Lack of Efficacy|0|||
155120371|NCT00747344|559871003|FG000|Controlled Period|Other|0|||
155120372|NCT00747344|559871004|FG001|Controlled Period|Other|3|||
155120373|NCT00747344|559871005|FG002|Controlled Period|Other|0|||
155120374|NCT00747344|559871006|FG003|Controlled Period|Other|0|||
155120375|NCT00747344|559871003|FG000|After Controlled Period|Adverse Event|0|||
155120376|NCT00747344|559871004|FG001|After Controlled Period|Adverse Event|0|||
155120377|NCT00747344|559871005|FG002|After Controlled Period|Adverse Event|0|||
155120378|NCT00747344|559871006|FG003|After Controlled Period|Adverse Event|1|||
155120379|NCT02460783|559871007|FG000|Overall Study|Withdrawal by Subject|1|||
155120380|NCT02460783|559871008|FG001|Overall Study|Withdrawal by Subject|3|||
155120381|NCT02460783|559871007|FG000|Overall Study|Lost to Follow-up|1|||
155120382|NCT02460783|559871008|FG001|Overall Study|Lost to Follow-up|1|||
155120383|NCT01484834|559871009|FG000|Overall Study|Lost to Follow-up|5|||
155120384|NCT01484834|559871010|FG001|Overall Study|Lost to Follow-up|8|||
155120385|NCT01484834|559871011|FG002|Overall Study|Lost to Follow-up|1|||
155120386|NCT01484834|559871012|FG003|Overall Study|Lost to Follow-up|4|||
155120387|NCT01166958|559871022|FG000|Overall Study|Withdrawal by Subject|1|||
155120388|NCT01166958|559871023|FG001|Overall Study|Withdrawal by Subject|0|||
155120389|NCT02680574|559871024|FG000|Overall Study|Death|137|||
155120390|NCT02680574|559871025|FG001|Overall Study|Death|137|||
155120391|NCT02680574|559871024|FG000|Overall Study|Withdrawal by Subject|17|||
155120392|NCT02680574|559871025|FG001|Overall Study|Withdrawal by Subject|9|||
155120393|NCT02680574|559871024|FG000|Overall Study|Lost to Follow-up|4|||
155120394|NCT02680574|559871025|FG001|Overall Study|Lost to Follow-up|6|||
155120395|NCT01605227|559871026|FG000|Overall Study|Did not receive study treatment|2|||
155120396|NCT01605227|559871027|FG001|Overall Study|Did not receive study treatment|3|||
155120397|NCT01605227|559871026|FG000|Overall Study|Adverse Event|228|||
155120398|NCT01605227|559871027|FG001|Overall Study|Adverse Event|42|||
155120399|NCT01605227|559871026|FG000|Overall Study|Progressive Disease|132|||
155120400|NCT01605227|559871027|FG001|Overall Study|Progressive Disease|128|||
155120401|NCT01605227|559871026|FG000|Overall Study|Clinical Deterioration|227|||
155120402|NCT01605227|559871027|FG001|Overall Study|Clinical Deterioration|133|||
155120403|NCT01605227|559871026|FG000|Overall Study|Lost to Follow-up|1|||
155120404|NCT01605227|559871027|FG001|Overall Study|Lost to Follow-up|0|||
155120405|NCT01605227|559871026|FG000|Overall Study|Protocol Violation|1|||
155120406|NCT01605227|559871027|FG001|Overall Study|Protocol Violation|0|||
155120407|NCT01605227|559871026|FG000|Overall Study|Physician Decision|9|||
155120408|NCT01605227|559871027|FG001|Overall Study|Physician Decision|7|||
155120409|NCT01605227|559871026|FG000|Overall Study|Withdrawal by Subject|18|||
155120410|NCT01605227|559871027|FG001|Overall Study|Withdrawal by Subject|14|||
155120411|NCT01605227|559871026|FG000|Overall Study|Sponsor Decision|2|||
155120412|NCT01605227|559871027|FG001|Overall Study|Sponsor Decision|0|||
155120413|NCT01605227|559871026|FG000|Overall Study|Started New Therapy|1|||
155120414|NCT01605227|559871027|FG001|Overall Study|Started New Therapy|0|||
155120415|NCT01605227|559871026|FG000|Overall Study|Subject Decision|0|||
155120416|NCT01605227|559871027|FG001|Overall Study|Subject Decision|1|||
155120417|NCT01605227|559871026|FG000|Overall Study|Dose Held >6 weeks|0|||
155120418|NCT01605227|559871027|FG001|Overall Study|Dose Held >6 weeks|1|||
155120419|NCT01286987|559871028|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
155120420|NCT01286987|559871029|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
155120421|NCT01286987|559871030|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
155120422|NCT01286987|559871031|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
155120423|NCT01286987|559871032|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
155120424|NCT01286987|559871033|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
155120425|NCT01286987|559871034|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
155120426|NCT01286987|559871035|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
155120427|NCT01286987|559871036|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
155120428|NCT01286987|559871037|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
155120429|NCT01286987|559871038|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
155120430|NCT01286987|559871039|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
155120431|NCT01286987|559871040|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
155120432|NCT01286987|559871041|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
155120433|NCT01286987|559871042|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
155120434|NCT01286987|559871028|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
155120435|NCT01286987|559871029|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
155120436|NCT01286987|559871030|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
155120437|NCT01286987|559871031|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
155120438|NCT01286987|559871032|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
155120439|NCT01286987|559871033|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
155120440|NCT01286987|559871034|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
155120441|NCT01286987|559871035|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
155120442|NCT01286987|559871036|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
155120443|NCT01286987|559871037|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
154989537|NCT02799095|559389658|FG016|Part C|Lost to Follow-up|0|||
154989538|NCT02799095|559389642|FG000|Part C|Progressive Disease|0|||
154989539|NCT02799095|559389643|FG001|Part C|Progressive Disease|0|||
154989540|NCT02799095|559389644|FG002|Part C|Progressive Disease|0|||
154989541|NCT02799095|559389645|FG003|Part C|Progressive Disease|0|||
154989542|NCT02799095|559389646|FG004|Part C|Progressive Disease|0|||
154989543|NCT02799095|559389647|FG005|Part C|Progressive Disease|0|||
154989544|NCT02799095|559389648|FG006|Part C|Progressive Disease|0|||
154989545|NCT02799095|559389649|FG007|Part C|Progressive Disease|0|||
154989546|NCT02799095|559389650|FG008|Part C|Progressive Disease|0|||
154989547|NCT02799095|559389651|FG009|Part C|Progressive Disease|2|||
154989548|NCT02799095|559389652|FG010|Part C|Progressive Disease|13|||
154989549|NCT02799095|559389653|FG011|Part C|Progressive Disease|2|||
154989550|NCT02799095|559389654|FG012|Part C|Progressive Disease|0|||
154989551|NCT02799095|559389655|FG013|Part C|Progressive Disease|1|||
154989552|NCT02799095|559389656|FG014|Part C|Progressive Disease|0|||
154989553|NCT02799095|559389657|FG015|Part C|Progressive Disease|0|||
154989554|NCT02799095|559389658|FG016|Part C|Progressive Disease|0|||
154989555|NCT02799095|559389642|FG000|Part C|Clinical Progression|0|||
154989556|NCT02799095|559389643|FG001|Part C|Clinical Progression|0|||
154989557|NCT02799095|559389644|FG002|Part C|Clinical Progression|0|||
154989558|NCT02799095|559389645|FG003|Part C|Clinical Progression|0|||
154989559|NCT02799095|559389646|FG004|Part C|Clinical Progression|0|||
154989560|NCT02799095|559389647|FG005|Part C|Clinical Progression|0|||
154989561|NCT02799095|559389648|FG006|Part C|Clinical Progression|0|||
154989562|NCT02799095|559389649|FG007|Part C|Clinical Progression|0|||
154989563|NCT02799095|559389650|FG008|Part C|Clinical Progression|0|||
154989564|NCT02799095|559389651|FG009|Part C|Clinical Progression|1|||
154989565|NCT02799095|559389652|FG010|Part C|Clinical Progression|3|||
154989566|NCT02799095|559389653|FG011|Part C|Clinical Progression|0|||
154989567|NCT02799095|559389654|FG012|Part C|Clinical Progression|0|||
154989568|NCT02799095|559389655|FG013|Part C|Clinical Progression|1|||
154989569|NCT02799095|559389656|FG014|Part C|Clinical Progression|0|||
154989570|NCT02799095|559389657|FG015|Part C|Clinical Progression|0|||
154989571|NCT02799095|559389658|FG016|Part C|Clinical Progression|0|||
154989572|NCT02799095|559389642|FG000|Part C|Withdrawal by Subject|0|||
154989573|NCT02799095|559389643|FG001|Part C|Withdrawal by Subject|0|||
154989574|NCT02799095|559389644|FG002|Part C|Withdrawal by Subject|0|||
154989575|NCT02799095|559389645|FG003|Part C|Withdrawal by Subject|0|||
154989576|NCT02799095|559389646|FG004|Part C|Withdrawal by Subject|0|||
154989577|NCT02799095|559389647|FG005|Part C|Withdrawal by Subject|0|||
154989578|NCT02799095|559389648|FG006|Part C|Withdrawal by Subject|0|||
154989579|NCT02799095|559389649|FG007|Part C|Withdrawal by Subject|0|||
154989580|NCT02799095|559389650|FG008|Part C|Withdrawal by Subject|0|||
154989581|NCT02799095|559389651|FG009|Part C|Withdrawal by Subject|0|||
154989582|NCT02799095|559389652|FG010|Part C|Withdrawal by Subject|13|||
154989583|NCT02799095|559389653|FG011|Part C|Withdrawal by Subject|15|||
154989584|NCT02799095|559389654|FG012|Part C|Withdrawal by Subject|13|||
154989585|NCT02799095|559389655|FG013|Part C|Withdrawal by Subject|21|||
154989586|NCT02799095|559389656|FG014|Part C|Withdrawal by Subject|0|||
154989587|NCT02799095|559389657|FG015|Part C|Withdrawal by Subject|12|||
154989588|NCT02799095|559389658|FG016|Part C|Withdrawal by Subject|1|||
154989589|NCT02799095|559389642|FG000|Part C|Physician Decision|0|||
154989590|NCT02799095|559389643|FG001|Part C|Physician Decision|0|||
154989591|NCT02799095|559389644|FG002|Part C|Physician Decision|0|||
154989592|NCT02799095|559389645|FG003|Part C|Physician Decision|0|||
154989593|NCT02799095|559389646|FG004|Part C|Physician Decision|0|||
154989594|NCT02799095|559389647|FG005|Part C|Physician Decision|0|||
154989595|NCT02799095|559389648|FG006|Part C|Physician Decision|0|||
154989596|NCT02799095|559389649|FG007|Part C|Physician Decision|0|||
154989597|NCT02799095|559389650|FG008|Part C|Physician Decision|0|||
154989598|NCT02799095|559389651|FG009|Part C|Physician Decision|0|||
154989599|NCT02799095|559389652|FG010|Part C|Physician Decision|1|||
154989600|NCT02799095|559389653|FG011|Part C|Physician Decision|0|||
154989601|NCT02799095|559389654|FG012|Part C|Physician Decision|0|||
154989602|NCT02799095|559389655|FG013|Part C|Physician Decision|0|||
154989603|NCT02799095|559389656|FG014|Part C|Physician Decision|0|||
154989604|NCT02799095|559389657|FG015|Part C|Physician Decision|0|||
154989605|NCT02799095|559389658|FG016|Part C|Physician Decision|0|||
154989606|NCT02799095|559389642|FG000|Part C|Other|0|||
154989607|NCT02799095|559389643|FG001|Part C|Other|0|||
154989608|NCT02799095|559389644|FG002|Part C|Other|0|||
154989609|NCT02799095|559389645|FG003|Part C|Other|0|||
154989610|NCT02799095|559389646|FG004|Part C|Other|0|||
154989611|NCT02799095|559389647|FG005|Part C|Other|0|||
154989612|NCT02799095|559389648|FG006|Part C|Other|0|||
154989613|NCT02799095|559389649|FG007|Part C|Other|0|||
154989614|NCT02799095|559389650|FG008|Part C|Other|0|||
154989615|NCT02799095|559389651|FG009|Part C|Other|0|||
154989616|NCT02799095|559389652|FG010|Part C|Other|0|||
154989617|NCT02799095|559389653|FG011|Part C|Other|2|||
154989618|NCT02799095|559389654|FG012|Part C|Other|2|||
154989619|NCT02799095|559389655|FG013|Part C|Other|0|||
154989620|NCT02799095|559389656|FG014|Part C|Other|0|||
154989621|NCT02799095|559389657|FG015|Part C|Other|0|||
154989622|NCT02799095|559389658|FG016|Part C|Other|0|||
154989623|NCT02128217|559389665|FG000|Overall Study|Lost to Follow-up|0|||
154989624|NCT02128217|559389666|FG001|Overall Study|Lost to Follow-up|1|||
154989625|NCT00541970|559389669|FG000|Month 7|Protocol Violation|9|||
154989626|NCT00541970|559389670|FG001|Month 7|Protocol Violation|13|||
154989627|NCT00541970|559389671|FG002|Month 7|Protocol Violation|11|||
154989628|NCT00541970|559389672|FG003|Month 7|Protocol Violation|5|||
154989629|NCT00541970|559389669|FG000|Month 12|Adverse Event|0|||
154989630|NCT00541970|559389670|FG001|Month 12|Adverse Event|1|||
154989631|NCT00541970|559389671|FG002|Month 12|Adverse Event|1|||
154989632|NCT00541970|559389672|FG003|Month 12|Adverse Event|1|||
154989633|NCT00541970|559389669|FG000|Month 12|Protocol Violation|12|||
154989634|NCT00541970|559389670|FG001|Month 12|Protocol Violation|21|||
154989635|NCT00541970|559389671|FG002|Month 12|Protocol Violation|20|||
154989636|NCT00541970|559389672|FG003|Month 12|Protocol Violation|15|||
154989637|NCT00541970|559389669|FG000|Month 18|Adverse Event|0|||
154989638|NCT00541970|559389670|FG001|Month 18|Adverse Event|1|||
154989639|NCT00541970|559389671|FG002|Month 18|Adverse Event|1|||
154989640|NCT00541970|559389672|FG003|Month 18|Adverse Event|1|||
154989641|NCT00541970|559389669|FG000|Month 18|Protocol Violation|14|||
154989642|NCT00541970|559389670|FG001|Month 18|Protocol Violation|23|||
154989643|NCT00541970|559389671|FG002|Month 18|Protocol Violation|24|||
154989644|NCT00541970|559389672|FG003|Month 18|Protocol Violation|16|||
154989645|NCT00541970|559389669|FG000|Month 24|Adverse Event|0|||
154989646|NCT00541970|559389670|FG001|Month 24|Adverse Event|1|||
154989647|NCT00541970|559389671|FG002|Month 24|Adverse Event|1|||
154989648|NCT00541970|559389672|FG003|Month 24|Adverse Event|1|||
154989649|NCT00541970|559389669|FG000|Month 24|Protocol Violation|29|||
154989650|NCT00541970|559389670|FG001|Month 24|Protocol Violation|31|||
154989651|NCT00541970|559389671|FG002|Month 24|Protocol Violation|31|||
154989652|NCT00541970|559389672|FG003|Month 24|Protocol Violation|21|||
154989653|NCT00541970|559389669|FG000|Month 36|Protocol Violation|61|||
154989654|NCT00541970|559389670|FG001|Month 36|Protocol Violation|66|||
154989655|NCT00541970|559389671|FG002|Month 36|Protocol Violation|66|||
154989656|NCT00541970|559389672|FG003|Month 36|Protocol Violation|60|||
154989657|NCT00541970|559389669|FG000|Month 48|Withdrawal by Subject|2|||
154989658|NCT00541970|559389670|FG001|Month 48|Withdrawal by Subject|4|||
154989659|NCT00541970|559389671|FG002|Month 48|Withdrawal by Subject|4|||
154989660|NCT00541970|559389672|FG003|Month 48|Withdrawal by Subject|2|||
154989661|NCT00541970|559389669|FG000|Month 48|Other|3|||
154989662|NCT00541970|559389670|FG001|Month 48|Other|1|||
154989663|NCT00541970|559389671|FG002|Month 48|Other|1|||
154989664|NCT00541970|559389672|FG003|Month 48|Other|0|||
154989665|NCT00541970|559389669|FG000|Month 48|Lost to Follow-up|66|||
154989666|NCT00541970|559389670|FG001|Month 48|Lost to Follow-up|68|||
154989667|NCT00541970|559389671|FG002|Month 48|Lost to Follow-up|68|||
154989668|NCT00541970|559389672|FG003|Month 48|Lost to Follow-up|73|||
154989669|NCT00541970|559389669|FG000|Month 60|Protocol Violation|78|||
154989670|NCT00541970|559389670|FG001|Month 60|Protocol Violation|77|||
155120444|NCT01286987|559871038|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
155120445|NCT01286987|559871039|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
155120446|NCT01286987|559871040|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
155120447|NCT01286987|559871041|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
155120448|NCT01286987|559871042|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
155120449|NCT01286987|559871028|FG000|Part 1: Dose Escalation|Physician Decision|0|||
155120450|NCT01286987|559871029|FG001|Part 1: Dose Escalation|Physician Decision|0|||
155120451|NCT01286987|559871030|FG002|Part 1: Dose Escalation|Physician Decision|0|||
155120452|NCT01286987|559871031|FG003|Part 1: Dose Escalation|Physician Decision|0|||
155120453|NCT01286987|559871032|FG004|Part 1: Dose Escalation|Physician Decision|1|||
155120454|NCT01286987|559871033|FG005|Part 1: Dose Escalation|Physician Decision|0|||
155120455|NCT01286987|559871034|FG006|Part 1: Dose Escalation|Physician Decision|0|||
155120456|NCT01286987|559871035|FG007|Part 1: Dose Escalation|Physician Decision|0|||
154989671|NCT00541970|559389671|FG002|Month 60|Protocol Violation|82|||
154989672|NCT00541970|559389672|FG003|Month 60|Protocol Violation|72|||
154989673|NCT03222583|559389673|FG000|Overall Study|Withdrawal by Subject|3|||
155120457|NCT01286987|559871036|FG008|Part 1: Dose Escalation|Physician Decision|0|||
154989674|NCT03222583|559389674|FG001|Overall Study|Withdrawal by Subject|3|||
154989675|NCT03222583|559389673|FG000|Overall Study|Lost to Follow-up|1|||
154989676|NCT03222583|559389674|FG001|Overall Study|Lost to Follow-up|0|||
155120458|NCT01286987|559871037|FG009|Part 1: Dose Escalation|Physician Decision|0|||
154989677|NCT03222583|559389673|FG000|Overall Study|Other|1|||
154989678|NCT03222583|559389674|FG001|Overall Study|Other|3|||
154989679|NCT04280705|559389675|FG000|Overall Study|Enrolled but not treated|4|||
154989680|NCT04280705|559389676|FG001|Overall Study|Enrolled but not treated|10|||
154989681|NCT04280705|559389675|FG000|Overall Study|Physician Decision|1|||
154989682|NCT04280705|559389676|FG001|Overall Study|Physician Decision|0|||
154989683|NCT04280705|559389675|FG000|Overall Study|Withdrawal by Subject|7|||
154989684|NCT04280705|559389676|FG001|Overall Study|Withdrawal by Subject|9|||
154989685|NCT04280705|559389675|FG000|Overall Study|Adverse Event|0|||
154989686|NCT04280705|559389676|FG001|Overall Study|Adverse Event|4|||
154989687|NCT04280705|559389675|FG000|Overall Study|Transferred to another hospital|1|||
154989688|NCT04280705|559389676|FG001|Overall Study|Transferred to another hospital|1|||
154989689|NCT03986138|559389677|FG000|First MRI Examination|Physician Decision|0|||
154989690|NCT03986138|559389678|FG001|First MRI Examination|Physician Decision|1|||
154989691|NCT03986138|559389677|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
154989692|NCT03986138|559389678|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
154989693|NCT03986138|559389677|FG000|Washout|Withdrawal by Subject|4|||
154989694|NCT03986138|559389678|FG001|Washout|Withdrawal by Subject|5|||
154989695|NCT03986138|559389677|FG000|Washout|Lost to Follow-up|0|||
154989696|NCT03986138|559389678|FG001|Washout|Lost to Follow-up|2|||
154989697|NCT03986138|559389677|FG000|Washout|Adverse Event|1|||
154989698|NCT03986138|559389678|FG001|Washout|Adverse Event|1|||
154989699|NCT03986138|559389677|FG000|Washout|Other reason|5|||
154989700|NCT03986138|559389678|FG001|Washout|Other reason|5|||
154989701|NCT03986138|559389677|FG000|Second MRI Examination|Withdrawal by Subject|0|||
154989702|NCT03986138|559389678|FG001|Second MRI Examination|Withdrawal by Subject|2|||
154989703|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Death|89|||
154989704|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Death|193|||
154989705|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Death|198|||
154989706|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
154989707|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
154989708|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
154989709|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
154989710|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
154989711|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
154989712|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
154989713|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
154989714|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
154989715|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
154989716|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
154989717|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
154989718|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
154989719|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
154989720|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
154989721|NCT02031458|559389679|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
154989722|NCT02031458|559389680|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
154989723|NCT02031458|559389681|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
154989724|NCT02031458|559389679|FG000|Baseline to May 8, 2015|Death|36|||
154989725|NCT02031458|559389680|FG001|Baseline to May 8, 2015|Death|87|||
154989726|NCT02031458|559389681|FG002|Baseline to May 8, 2015|Death|100|||
154989727|NCT02031458|559389679|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
154989728|NCT02031458|559389680|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
154989729|NCT02031458|559389681|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
154989730|NCT02031458|559389679|FG000|Baseline to May 8, 2015|Physician Decision|0|||
154989731|NCT02031458|559389680|FG001|Baseline to May 8, 2015|Physician Decision|1|||
154989732|NCT02031458|559389681|FG002|Baseline to May 8, 2015|Physician Decision|0|||
154989733|NCT02031458|559389679|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
154989734|NCT02031458|559389680|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
154989735|NCT02031458|559389681|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
154989736|NCT02031458|559389679|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
154989737|NCT02031458|559389680|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
154989738|NCT02031458|559389681|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
154989739|NCT02031458|559389679|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
154989740|NCT02031458|559389680|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
154989741|NCT02031458|559389681|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
154989742|NCT02031458|559389679|FG000|Baseline to May 8, 2015|On Treatment|43|||
154989743|NCT02031458|559389680|FG001|Baseline to May 8, 2015|On Treatment|81|||
154989744|NCT02031458|559389681|FG002|Baseline to May 8, 2015|On Treatment|73|||
154989745|NCT02031458|559389679|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
154989746|NCT02031458|559389680|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
154989747|NCT02031458|559389681|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
154989748|NCT00721630|559389682|FG000|Overall Study|Participant found to be ineligible|1|||
154989749|NCT00667810|559389685|FG000|Overall Study|Adverse Event|13|||
154989750|NCT00667810|559389686|FG001|Overall Study|Adverse Event|14|||
154989751|NCT00667810|559389687|FG002|Overall Study|Adverse Event|19|||
154989752|NCT00667810|559389688|FG003|Overall Study|Adverse Event|1|||
154989753|NCT00667810|559389685|FG000|Overall Study|Death|1|||
154989754|NCT00667810|559389686|FG001|Overall Study|Death|1|||
154989755|NCT00667810|559389687|FG002|Overall Study|Death|3|||
154989756|NCT00667810|559389688|FG003|Overall Study|Death|0|||
154989757|NCT00667810|559389685|FG000|Overall Study|Lack of Efficacy|1|||
154989758|NCT00667810|559389686|FG001|Overall Study|Lack of Efficacy|0|||
154989759|NCT00667810|559389687|FG002|Overall Study|Lack of Efficacy|2|||
154989760|NCT00667810|559389688|FG003|Overall Study|Lack of Efficacy|0|||
154989761|NCT00667810|559389685|FG000|Overall Study|Lost to Follow-up|1|||
154989762|NCT00667810|559389686|FG001|Overall Study|Lost to Follow-up|4|||
154989763|NCT00667810|559389687|FG002|Overall Study|Lost to Follow-up|2|||
154989764|NCT00667810|559389688|FG003|Overall Study|Lost to Follow-up|0|||
154989765|NCT00667810|559389685|FG000|Overall Study|Physician Decision|1|||
154989766|NCT00667810|559389686|FG001|Overall Study|Physician Decision|1|||
154989767|NCT00667810|559389687|FG002|Overall Study|Physician Decision|2|||
154989768|NCT00667810|559389688|FG003|Overall Study|Physician Decision|0|||
154989769|NCT00667810|559389685|FG000|Overall Study|Protocol Violation|0|||
154989770|NCT00667810|559389686|FG001|Overall Study|Protocol Violation|2|||
154989771|NCT00667810|559389687|FG002|Overall Study|Protocol Violation|0|||
154989772|NCT00667810|559389688|FG003|Overall Study|Protocol Violation|0|||
154989773|NCT00667810|559389685|FG000|Overall Study|Withdrawal by Subject|14|||
154989774|NCT00667810|559389686|FG001|Overall Study|Withdrawal by Subject|20|||
154989775|NCT00667810|559389687|FG002|Overall Study|Withdrawal by Subject|29|||
154989776|NCT00667810|559389688|FG003|Overall Study|Withdrawal by Subject|1|||
154989777|NCT00667810|559389685|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
154989778|NCT00667810|559389686|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
154989779|NCT00667810|559389687|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
154989780|NCT00667810|559389688|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
154989781|NCT00667810|559389685|FG000|Overall Study|Failed to Return|0|||
154989782|NCT00667810|559389686|FG001|Overall Study|Failed to Return|0|||
154989783|NCT00667810|559389687|FG002|Overall Study|Failed to Return|2|||
154989784|NCT00667810|559389688|FG003|Overall Study|Failed to Return|0|||
154989785|NCT00667810|559389685|FG000|Overall Study|Loss of Caregiver|0|||
154989786|NCT00667810|559389686|FG001|Overall Study|Loss of Caregiver|1|||
154989787|NCT00667810|559389687|FG002|Overall Study|Loss of Caregiver|3|||
154989788|NCT00667810|559389688|FG003|Overall Study|Loss of Caregiver|0|||
154989789|NCT00667810|559389685|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
154989790|NCT00667810|559389686|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
154989791|NCT00667810|559389687|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
154989792|NCT00667810|559389688|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
154989793|NCT00667810|559389685|FG000|Overall Study|Other|6|||
154989794|NCT00667810|559389686|FG001|Overall Study|Other|6|||
154989795|NCT00667810|559389687|FG002|Overall Study|Other|5|||
154989796|NCT00667810|559389688|FG003|Overall Study|Other|0|||
154989797|NCT03412396|559389699|FG000|Overall Study|Withdrawal by Subject|2|||
154989798|NCT03412396|559389699|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
154989799|NCT03412396|559389699|FG000|Overall Study|Did not undergo RP|2|||
154989800|NCT01383135|559389702|FG000|Overall Study|Not Scanned / Imaged|1|||
154989801|NCT01383135|559389703|FG001|Overall Study|Not Scanned / Imaged|0|||
154989802|NCT01383135|559389704|FG002|Overall Study|Not Scanned / Imaged|1|||
154989803|NCT01383135|559389705|FG003|Overall Study|Not Scanned / Imaged|0|||
154989804|NCT03167723|559389706|FG000|Overall Study|Protocol Violation|4|||
154989805|NCT03167723|559389707|FG001|Overall Study|Protocol Violation|6|||
154989806|NCT01259115|559389710|FG000|Period 1|Adverse Event|1|||
154989807|NCT01259115|559389711|FG001|Period 1|Adverse Event|0|||
154989808|NCT01259115|559389710|FG000|Period 1|Protocol Violation|2|||
154989809|NCT01259115|559389711|FG001|Period 1|Protocol Violation|0|||
154989810|NCT01259115|559389710|FG000|Period 1|Lost to Follow-up|0|||
154989811|NCT01259115|559389711|FG001|Period 1|Lost to Follow-up|1|||
154989812|NCT01259115|559389710|FG000|Period 2|Adverse Event|1|||
154989813|NCT01259115|559389711|FG001|Period 2|Adverse Event|0|||
154989814|NCT01971970|559389712|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
154989815|NCT01971970|559389713|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
154989816|NCT01971970|559389712|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
154989817|NCT01971970|559389713|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
154989818|NCT01971970|559389712|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
154989819|NCT01971970|559389713|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
154989820|NCT01971970|559389712|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
154989821|NCT01971970|559389713|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
154989822|NCT01971970|559389712|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
154989823|NCT01971970|559389713|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
154989824|NCT01971970|559389712|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
154989825|NCT01971970|559389713|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
154989826|NCT01971970|559389712|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
154989827|NCT01971970|559389713|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
154989828|NCT00848107|559389714|FG000|Overall Study|Lost to Follow-up|2|||
154989829|NCT00848107|559389714|FG000|Overall Study|Withdrawal by Subject|8|||
154989830|NCT00848107|559389714|FG000|Overall Study|Adverse Event|9|||
154989831|NCT00848107|559389714|FG000|Overall Study|Death|1|||
154989832|NCT00848107|559389714|FG000|Overall Study|Pregnancy|1|||
154989833|NCT02524730|559389715|FG000|Overall Study|Lost to Follow-up|5|||
154989834|NCT02524730|559389715|FG000|Overall Study|Withdrawal by Subject|18|||
154989835|NCT02524730|559389715|FG000|Overall Study|Death|10|||
154989836|NCT02524730|559389715|FG000|Overall Study|Adverse Event|8|||
154989837|NCT02524730|559389715|FG000|Overall Study|Protocol Violation|1|||
154989838|NCT02524730|559389715|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
154989839|NCT00859586|559389716|FG000|Overall Study|Donors|4|||
154989840|NCT03493386|559389719|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154989841|NCT03493386|559389720|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
154989842|NCT03493386|559389721|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154989843|NCT03493386|559389722|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
154989844|NCT02266134|559389734|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
154989845|NCT02266134|559389735|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
154989846|NCT02266134|559389736|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
154989847|NCT02266134|559389737|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
154989848|NCT02266134|559389734|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
154989849|NCT02266134|559389735|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
154989850|NCT02266134|559389736|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
154989851|NCT02266134|559389737|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
154989852|NCT02266134|559389734|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
154989853|NCT02266134|559389735|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
154989854|NCT02266134|559389736|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
154989855|NCT02266134|559389737|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
154989856|NCT02266134|559389734|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
154989857|NCT02266134|559389735|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
154989858|NCT02266134|559389736|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
154989859|NCT02266134|559389737|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
154989860|NCT02266134|559389734|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
154989861|NCT02266134|559389735|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
154989862|NCT02266134|559389736|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
154989863|NCT02266134|559389737|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
154989864|NCT02266134|559389734|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
154989865|NCT02266134|559389735|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
154989866|NCT02266134|559389736|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
154989867|NCT02266134|559389737|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
154989868|NCT02731326|559389742|FG000|Overall Study|Withdrawal by Subject|4|||
154989869|NCT02731326|559389743|FG001|Overall Study|Withdrawal by Subject|1|||
154989870|NCT02731326|559389742|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
154989871|NCT02731326|559389743|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
154989872|NCT02731326|559389742|FG000|Overall Study|Discharged without AliveCor|10|||
154989873|NCT02731326|559389743|FG001|Overall Study|Discharged without AliveCor|0|||
154989874|NCT02731326|559389742|FG000|Overall Study|Duplicate Participant|1|||
154989875|NCT02731326|559389743|FG001|Overall Study|Duplicate Participant|1|||
154989876|NCT05084963|559389745|FG000|Overall Study|Withdrawal by Subject|0|||
154989877|NCT05084963|559389746|FG001|Overall Study|Withdrawal by Subject|0|||
154989878|NCT05084963|559389747|FG002|Overall Study|Withdrawal by Subject|1|||
154989879|NCT01986010|559389748|FG000|Overall Study|Adverse Event|0|||
154989880|NCT01986010|559389749|FG001|Overall Study|Adverse Event|1|||
154989881|NCT01986010|559389750|FG002|Overall Study|Adverse Event|0|||
154989882|NCT01986010|559389751|FG003|Overall Study|Adverse Event|0|||
154989883|NCT01986010|559389752|FG004|Overall Study|Adverse Event|0|||
154989884|NCT01986010|559389753|FG005|Overall Study|Adverse Event|0|||
154989885|NCT01986010|559389754|FG006|Overall Study|Adverse Event|0|||
154989886|NCT01986010|559389755|FG007|Overall Study|Adverse Event|0|||
154989887|NCT01986010|559389756|FG008|Overall Study|Adverse Event|0|||
154989888|NCT01986010|559389757|FG009|Overall Study|Adverse Event|0|||
154989889|NCT01986010|559389758|FG010|Overall Study|Adverse Event|0|||
154989890|NCT01986010|559389759|FG011|Overall Study|Adverse Event|0|||
154989891|NCT01986010|559389760|FG012|Overall Study|Adverse Event|0|||
154989892|NCT01986010|559389761|FG013|Overall Study|Adverse Event|0|||
154989893|NCT01986010|559389762|FG014|Overall Study|Adverse Event|0|||
154989894|NCT01986010|559389763|FG015|Overall Study|Adverse Event|1|||
154989895|NCT01986010|559389764|FG016|Overall Study|Adverse Event|0|||
154989896|NCT01986010|559389748|FG000|Overall Study|Lost to Follow-up|2|||
154989897|NCT01986010|559389749|FG001|Overall Study|Lost to Follow-up|1|||
154989898|NCT01986010|559389750|FG002|Overall Study|Lost to Follow-up|2|||
154989899|NCT01986010|559389751|FG003|Overall Study|Lost to Follow-up|2|||
155177177|NCT00045942|560088191|FG008|PKC412A2104E1|Adverse Event|0|||
154989900|NCT01986010|559389752|FG004|Overall Study|Lost to Follow-up|2|||
154989901|NCT01986010|559389753|FG005|Overall Study|Lost to Follow-up|2|||
154989902|NCT01986010|559389754|FG006|Overall Study|Lost to Follow-up|0|||
154989903|NCT01986010|559389755|FG007|Overall Study|Lost to Follow-up|0|||
154989904|NCT01986010|559389756|FG008|Overall Study|Lost to Follow-up|4|||
154989905|NCT01986010|559389757|FG009|Overall Study|Lost to Follow-up|2|||
154989906|NCT01986010|559389758|FG010|Overall Study|Lost to Follow-up|0|||
154989907|NCT01986010|559389759|FG011|Overall Study|Lost to Follow-up|1|||
154989908|NCT01986010|559389760|FG012|Overall Study|Lost to Follow-up|1|||
154989909|NCT01986010|559389761|FG013|Overall Study|Lost to Follow-up|1|||
154989910|NCT01986010|559389762|FG014|Overall Study|Lost to Follow-up|2|||
154989911|NCT01986010|559389763|FG015|Overall Study|Lost to Follow-up|0|||
154989912|NCT01986010|559389764|FG016|Overall Study|Lost to Follow-up|0|||
154989913|NCT01986010|559389748|FG000|Overall Study|Physician Decision|0|||
154989914|NCT01986010|559389749|FG001|Overall Study|Physician Decision|0|||
154989915|NCT01986010|559389750|FG002|Overall Study|Physician Decision|0|||
154989916|NCT01986010|559389751|FG003|Overall Study|Physician Decision|0|||
154989917|NCT01986010|559389752|FG004|Overall Study|Physician Decision|0|||
154989918|NCT01986010|559389753|FG005|Overall Study|Physician Decision|0|||
154989919|NCT01986010|559389754|FG006|Overall Study|Physician Decision|0|||
154989920|NCT01986010|559389755|FG007|Overall Study|Physician Decision|0|||
154989921|NCT01986010|559389756|FG008|Overall Study|Physician Decision|0|||
154989922|NCT01986010|559389757|FG009|Overall Study|Physician Decision|0|||
154989923|NCT01986010|559389758|FG010|Overall Study|Physician Decision|0|||
154989924|NCT01986010|559389759|FG011|Overall Study|Physician Decision|0|||
154989925|NCT01986010|559389760|FG012|Overall Study|Physician Decision|0|||
154989926|NCT01986010|559389761|FG013|Overall Study|Physician Decision|0|||
154989927|NCT01986010|559389762|FG014|Overall Study|Physician Decision|1|||
154989928|NCT01986010|559389763|FG015|Overall Study|Physician Decision|0|||
154989929|NCT01986010|559389764|FG016|Overall Study|Physician Decision|0|||
154989930|NCT01986010|559389748|FG000|Overall Study|Withdrawal by Subject|2|||
154989931|NCT01986010|559389749|FG001|Overall Study|Withdrawal by Subject|2|||
154989932|NCT01986010|559389750|FG002|Overall Study|Withdrawal by Subject|3|||
154989933|NCT01986010|559389751|FG003|Overall Study|Withdrawal by Subject|0|||
154989934|NCT01986010|559389752|FG004|Overall Study|Withdrawal by Subject|2|||
154989935|NCT01986010|559389753|FG005|Overall Study|Withdrawal by Subject|4|||
154989936|NCT01986010|559389754|FG006|Overall Study|Withdrawal by Subject|0|||
154989937|NCT01986010|559389755|FG007|Overall Study|Withdrawal by Subject|0|||
154989938|NCT01986010|559389756|FG008|Overall Study|Withdrawal by Subject|0|||
154989939|NCT01986010|559389757|FG009|Overall Study|Withdrawal by Subject|0|||
154989940|NCT01986010|559389758|FG010|Overall Study|Withdrawal by Subject|0|||
154989941|NCT01986010|559389759|FG011|Overall Study|Withdrawal by Subject|2|||
154989942|NCT01986010|559389760|FG012|Overall Study|Withdrawal by Subject|0|||
154989943|NCT01986010|559389761|FG013|Overall Study|Withdrawal by Subject|1|||
154989944|NCT01986010|559389762|FG014|Overall Study|Withdrawal by Subject|2|||
154989945|NCT01986010|559389763|FG015|Overall Study|Withdrawal by Subject|0|||
154989946|NCT01986010|559389764|FG016|Overall Study|Withdrawal by Subject|0|||
154989947|NCT01986010|559389748|FG000|Overall Study|Status Not Recorded|2|||
154989948|NCT01986010|559389749|FG001|Overall Study|Status Not Recorded|4|||
154989949|NCT01986010|559389750|FG002|Overall Study|Status Not Recorded|2|||
154989950|NCT01986010|559389751|FG003|Overall Study|Status Not Recorded|0|||
154989951|NCT01986010|559389752|FG004|Overall Study|Status Not Recorded|1|||
154989952|NCT01986010|559389753|FG005|Overall Study|Status Not Recorded|2|||
154989953|NCT01986010|559389754|FG006|Overall Study|Status Not Recorded|0|||
154989954|NCT01986010|559389755|FG007|Overall Study|Status Not Recorded|0|||
154989955|NCT01986010|559389756|FG008|Overall Study|Status Not Recorded|2|||
154989956|NCT01986010|559389757|FG009|Overall Study|Status Not Recorded|1|||
154989957|NCT01986010|559389758|FG010|Overall Study|Status Not Recorded|7|||
154989958|NCT01986010|559389759|FG011|Overall Study|Status Not Recorded|7|||
154989959|NCT01986010|559389760|FG012|Overall Study|Status Not Recorded|9|||
154989960|NCT01986010|559389761|FG013|Overall Study|Status Not Recorded|9|||
154989961|NCT01986010|559389762|FG014|Overall Study|Status Not Recorded|5|||
154989962|NCT01986010|559389763|FG015|Overall Study|Status Not Recorded|10|||
154989963|NCT01986010|559389764|FG016|Overall Study|Status Not Recorded|4|||
154989964|NCT01335997|559389767|FG000|Period I and II|Adverse Event|63|||
154989965|NCT01335997|559389768|FG001|Period I and II|Adverse Event|43|||
155120459|NCT01286987|559871038|FG010|Part 1: Dose Escalation|Physician Decision|0|||
155120460|NCT01286987|559871039|FG011|Part 1: Dose Escalation|Physician Decision|0|||
154989966|NCT01335997|559389767|FG000|Period I and II|Noncompliance with Study Drug|1|||
154989967|NCT01335997|559389768|FG001|Period I and II|Noncompliance with Study Drug|1|||
154989968|NCT01335997|559389767|FG000|Period I and II|Lost to Follow-up|3|||
154989969|NCT01335997|559389768|FG001|Period I and II|Lost to Follow-up|5|||
154989970|NCT01335997|559389767|FG000|Period I and II|Withdrawal by Subject|9|||
155120461|NCT01286987|559871040|FG012|Part 1: Dose Escalation|Physician Decision|0|||
155120462|NCT01286987|559871041|FG013|Part 1: Dose Escalation|Physician Decision|0|||
154989971|NCT01335997|559389768|FG001|Period I and II|Withdrawal by Subject|4|||
154989972|NCT01335997|559389767|FG000|Period I and II|Study Terminated by Sponsor|406|||
154989973|NCT01335997|559389768|FG001|Period I and II|Study Terminated by Sponsor|415|||
154989974|NCT01335997|559389767|FG000|Period I and II|Protocol Violation|9|||
154989975|NCT01335997|559389768|FG001|Period I and II|Protocol Violation|10|||
154989976|NCT01335997|559389767|FG000|Period I and II|Physician Decision|2|||
154989977|NCT01335997|559389768|FG001|Period I and II|Physician Decision|1|||
154989978|NCT01335997|559389767|FG000|Period III|Adverse Event|0|||
154989979|NCT01335997|559389768|FG001|Period III|Adverse Event|2|||
155120463|NCT01286987|559871042|FG014|Part 1: Dose Escalation|Physician Decision|0|||
154989980|NCT01335997|559389767|FG000|Period III|Study Terminated by Sponsor|77|||
154989981|NCT01335997|559389768|FG001|Period III|Study Terminated by Sponsor|76|||
154989982|NCT01335997|559389767|FG000|Period III|Protocol Violation|0|||
154989983|NCT01335997|559389768|FG001|Period III|Protocol Violation|1|||
154989984|NCT01335997|559389767|FG000|Period III|Lost to Follow-up|1|||
154989985|NCT01335997|559389768|FG001|Period III|Lost to Follow-up|0|||
154989986|NCT01103466|559389769|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
154989987|NCT01103466|559389770|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
154989988|NCT01103466|559389771|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
154989989|NCT01103466|559389769|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
154989990|NCT01103466|559389770|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
154989991|NCT01103466|559389771|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
154989992|NCT01103466|559389769|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
154989993|NCT01103466|559389770|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
154989994|NCT01103466|559389771|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
154989995|NCT01103466|559389769|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
154989996|NCT01103466|559389770|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
154989997|NCT01103466|559389771|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
154989998|NCT01103466|559389769|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
154989999|NCT01103466|559389770|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
154990000|NCT01103466|559389771|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
154990001|NCT01103466|559389769|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
154990002|NCT01103466|559389770|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
154990003|NCT01103466|559389771|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
154990004|NCT02994940|559389772|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
154990005|NCT02994940|559389773|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
154990006|NCT02994940|559389772|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
154990007|NCT02994940|559389773|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
154990008|NCT02994940|559389772|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
154990009|NCT02994940|559389773|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
154990010|NCT03283761|559389780|FG000|Study Treatment|Patient Non-Compliance|1|||
154990011|NCT03283761|559389780|FG000|Study Treatment|Alternative Cancer Therapy|7|||
154990012|NCT03283761|559389780|FG000|Study Treatment|Disease progression|21|||
154990013|NCT03283761|559389780|FG000|Study Treatment|Adverse Event|3|||
154990014|NCT03283761|559389780|FG000|Study Treatment|Withdrawal by Subject|4|||
154990015|NCT03283761|559389780|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
154990016|NCT03283761|559389780|FG000|Study Treatment|Symptomatic Deterioration|1|||
154990017|NCT03283761|559389780|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
154990018|NCT03283761|559389780|FG000|Follow up|Lost to Follow-up|1|||
154990019|NCT03283761|559389780|FG000|Follow up|Symptomatic Deterioration|1|||
154990020|NCT03283761|559389780|FG000|Follow up|Death|29|||
154990021|NCT03283761|559389780|FG000|Follow up|study terminated|4|||
154990022|NCT03283761|559389780|FG000|Follow up|Primary Investigator Withdrawal|1|||
154990023|NCT03283761|559389780|FG000|Follow up|Switched to alternative therapy|1|||
154990024|NCT03283761|559389780|FG000|Follow up|Subject is now in Hospice|1|||
154990025|NCT01355159|559389787|FG000|Overall Study|Withdrew consent|39|||
154990026|NCT01355159|559389788|FG001|Overall Study|Withdrew consent|47|||
154990027|NCT01355159|559389787|FG000|Overall Study|No primary outcome data|17|||
154990028|NCT01355159|559389788|FG001|Overall Study|No primary outcome data|11|||
154990029|NCT01355159|559389787|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
154990030|NCT01355159|559389788|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
154990031|NCT01355159|559389787|FG000|Overall Study|Early intrauterine fetal death|6|||
154990032|NCT01355159|559389788|FG001|Overall Study|Early intrauterine fetal death|6|||
154990033|NCT03276221|559389789|FG000|Overall Study|Lost to Follow-up|6|||
154990034|NCT03276221|559389790|FG001|Overall Study|Lost to Follow-up|2|||
154990035|NCT03276221|559389791|FG002|Overall Study|Lost to Follow-up|0|||
154990036|NCT03276221|559389789|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
154990037|NCT03276221|559389790|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
154990038|NCT03276221|559389791|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
155120464|NCT01286987|559871028|FG000|Part 2: Dose Expansion|Death|0|||
155120465|NCT01286987|559871029|FG001|Part 2: Dose Expansion|Death|0|||
155120466|NCT01286987|559871030|FG002|Part 2: Dose Expansion|Death|0|||
154990039|NCT00681590|559389792|FG000|Overall Study|Withdrawal by Subject|2|||
154990040|NCT00681590|559389793|FG001|Overall Study|Withdrawal by Subject|12|||
154990041|NCT02912650|559389794|FG000|Overall Study|Withdrawal by Subject|1|||
154990042|NCT02912650|559389795|FG001|Overall Study|Withdrawal by Subject|0|||
154990043|NCT02912650|559389796|FG002|Overall Study|Withdrawal by Subject|1|||
154990044|NCT02912650|559389797|FG003|Overall Study|Withdrawal by Subject|5|||
154990045|NCT02912650|559389794|FG000|Overall Study|Adverse Event|0|||
154990046|NCT02912650|559389795|FG001|Overall Study|Adverse Event|0|||
154990047|NCT02912650|559389796|FG002|Overall Study|Adverse Event|1|||
155120467|NCT01286987|559871031|FG003|Part 2: Dose Expansion|Death|0|||
155120468|NCT01286987|559871032|FG004|Part 2: Dose Expansion|Death|0|||
154990048|NCT02912650|559389797|FG003|Overall Study|Adverse Event|0|||
154990049|NCT02562482|559389798|FG000|Overall Study|Enrolled, but did not receive product|4|||
154990050|NCT02562482|559389799|FG001|Overall Study|Enrolled, but did not receive product|0|||
154990051|NCT02562482|559389798|FG000|Overall Study|Lost to Follow-up|9|||
154990052|NCT02562482|559389799|FG001|Overall Study|Lost to Follow-up|6|||
154990053|NCT02562482|559389798|FG000|Overall Study|Moved from area|2|||
154990054|NCT02562482|559389799|FG001|Overall Study|Moved from area|3|||
154990055|NCT02562482|559389798|FG000|Overall Study|Withdrawal by Subject|5|||
154990056|NCT02562482|559389799|FG001|Overall Study|Withdrawal by Subject|3|||
154990057|NCT02562482|559389798|FG000|Overall Study|Physician Decision|1|||
154990058|NCT02562482|559389799|FG001|Overall Study|Physician Decision|3|||
154990059|NCT02562482|559389798|FG000|Overall Study|Illness/Injury unrelated to product|0|||
154990060|NCT02562482|559389799|FG001|Overall Study|Illness/Injury unrelated to product|1|||
154990061|NCT00975286|559389802|FG000|Overall Study|Adverse Event|9|||
154990062|NCT00975286|559389803|FG001|Overall Study|Adverse Event|19|||
154990063|NCT00975286|559389802|FG000|Overall Study|Protocol Violation|1|||
154990064|NCT00975286|559389803|FG001|Overall Study|Protocol Violation|2|||
154990065|NCT00975286|559389802|FG000|Overall Study|Withdrawal by Subject|0|||
154990066|NCT00975286|559389803|FG001|Overall Study|Withdrawal by Subject|2|||
154990067|NCT00975286|559389802|FG000|Overall Study|Familial and Personal Reasons|2|||
154990068|NCT00975286|559389803|FG001|Overall Study|Familial and Personal Reasons|2|||
154990069|NCT00975286|559389802|FG000|Overall Study|Poor Compliance to Protocol|0|||
154990070|NCT00975286|559389803|FG001|Overall Study|Poor Compliance to Protocol|2|||
154990071|NCT00975286|559389802|FG000|Overall Study|Sponsor Decision|0|||
154990072|NCT00975286|559389803|FG001|Overall Study|Sponsor Decision|2|||
154990073|NCT01674647|559389804|FG000|Treatment Period|Death|4|||
154990074|NCT01674647|559389805|FG001|Treatment Period|Death|1|||
154990075|NCT01674647|559389804|FG000|Treatment Period|Efficacy outcome reached|0|||
154990076|NCT01674647|559389805|FG001|Treatment Period|Efficacy outcome reached|1|||
154990077|NCT01674647|559389804|FG000|Treatment Period|Physician Decision|3|||
154990078|NCT01674647|559389805|FG001|Treatment Period|Physician Decision|1|||
154990079|NCT01674647|559389804|FG000|Treatment Period|Adverse Event|60|||
154990080|NCT01674647|559389805|FG001|Treatment Period|Adverse Event|22|||
154990081|NCT01674647|559389804|FG000|Treatment Period|Non-compliance with study drug|3|||
154990082|NCT01674647|559389805|FG001|Treatment Period|Non-compliance with study drug|0|||
154990083|NCT01674647|559389804|FG000|Treatment Period|Lost to Follow-up|1|||
154990084|NCT01674647|559389805|FG001|Treatment Period|Lost to Follow-up|1|||
154990085|NCT01674647|559389804|FG000|Treatment Period|Withdrawal by Subject|19|||
154990086|NCT01674647|559389805|FG001|Treatment Period|Withdrawal by Subject|16|||
154990087|NCT01674647|559389804|FG000|Treatment Period|Switching to other therapy|5|||
154990088|NCT01674647|559389805|FG001|Treatment Period|Switching to other therapy|2|||
154990089|NCT01674647|559389804|FG000|Treatment Period|Logistical difficulties|5|||
154990090|NCT01674647|559389805|FG001|Treatment Period|Logistical difficulties|8|||
154990091|NCT01674647|559389804|FG000|Treatment Period|Treatment failure|0|||
154990092|NCT01674647|559389805|FG001|Treatment Period|Treatment failure|14|||
154990093|NCT01674647|559389804|FG000|Treatment Period|Protocol Violation|56|||
154990094|NCT01674647|559389805|FG001|Treatment Period|Protocol Violation|36|||
154990095|NCT01674647|559389804|FG000|30-day Safety Follow-up Period|Death|3|||
154990096|NCT01674647|559389805|FG001|30-day Safety Follow-up Period|Death|2|||
154990097|NCT01674647|559389804|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
154990098|NCT01674647|559389805|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
154990099|NCT01674647|559389804|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
154990100|NCT01674647|559389805|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
154990101|NCT01674647|559389804|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
154990102|NCT01674647|559389805|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
154990103|NCT01674647|559389804|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
154990104|NCT01674647|559389805|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
154990105|NCT01674647|559389804|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
154990106|NCT01674647|559389805|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
155120469|NCT01286987|559871033|FG005|Part 2: Dose Expansion|Death|0|||
155120470|NCT01286987|559871034|FG006|Part 2: Dose Expansion|Death|0|||
154990107|NCT01941940|559389806|FG000|Overall Study|Adverse Event|11|||
154990108|NCT01941940|559389806|FG000|Overall Study|Lost to Follow-up|2|||
154990109|NCT01941940|559389806|FG000|Overall Study|Physician Decision|2|||
154990110|NCT01941940|559389806|FG000|Overall Study|Withdrawal by Subject|15|||
155120471|NCT01286987|559871035|FG007|Part 2: Dose Expansion|Death|0|||
155120472|NCT01286987|559871036|FG008|Part 2: Dose Expansion|Death|0|||
155120473|NCT01286987|559871037|FG009|Part 2: Dose Expansion|Death|0|||
154990111|NCT01941940|559389806|FG000|Overall Study|Death|1|||
154990112|NCT01941940|559389806|FG000|Overall Study|Other|1|||
154990113|NCT01941940|559389806|FG000|Overall Study|Other|1|||
154990114|NCT04135196|559389807|FG000|Overall Study|Lost to Follow-up|8|||
155120474|NCT01286987|559871038|FG010|Part 2: Dose Expansion|Death|0|||
155120475|NCT01286987|559871039|FG011|Part 2: Dose Expansion|Death|0|||
154990115|NCT04135196|559389808|FG001|Overall Study|Lost to Follow-up|7|||
154990116|NCT04135196|559389809|FG002|Overall Study|Lost to Follow-up|8|||
154990117|NCT04135196|559389810|FG003|Overall Study|Lost to Follow-up|9|||
154990118|NCT04135196|559389811|FG004|Overall Study|Lost to Follow-up|1|||
154990119|NCT04135196|559389807|FG000|Overall Study|Pregnancy|0|||
154990120|NCT04135196|559389808|FG001|Overall Study|Pregnancy|0|||
154990121|NCT04135196|559389809|FG002|Overall Study|Pregnancy|1|||
154990122|NCT04135196|559389810|FG003|Overall Study|Pregnancy|0|||
154990123|NCT04135196|559389811|FG004|Overall Study|Pregnancy|0|||
154990124|NCT04135196|559389807|FG000|Overall Study|Withdrawal by Subject|0|||
154990125|NCT04135196|559389808|FG001|Overall Study|Withdrawal by Subject|0|||
154990126|NCT04135196|559389809|FG002|Overall Study|Withdrawal by Subject|0|||
154990127|NCT04135196|559389810|FG003|Overall Study|Withdrawal by Subject|0|||
154990128|NCT04135196|559389811|FG004|Overall Study|Withdrawal by Subject|1|||
154990129|NCT03212521|559389815|FG000|Overall Study|Adverse Event|1|||
154990130|NCT03212521|559389815|FG000|Overall Study|Lost to Follow-up|4|||
154990131|NCT03212521|559389815|FG000|Overall Study|Withdrawal by Subject|1|||
154990132|NCT03212521|559389815|FG000|Overall Study|Other|1|||
154990133|NCT00444457|559389816|FG000|Infant Series|Other|0|||
154990134|NCT00444457|559389817|FG001|Infant Series|Other|1|||
154990135|NCT00444457|559389818|FG002|Infant Series|Other|0|||
154990136|NCT00444457|559389819|FG003|Infant Series|Other|0|||
154990137|NCT00444457|559389816|FG000|Infant Series|Parent or legal guardian request|18|||
154990138|NCT00444457|559389817|FG001|Infant Series|Parent or legal guardian request|29|||
154990139|NCT00444457|559389818|FG002|Infant Series|Parent or legal guardian request|34|||
154990140|NCT00444457|559389819|FG003|Infant Series|Parent or legal guardian request|14|||
154990141|NCT00444457|559389816|FG000|Infant Series|Lost to Follow-up|10|||
154990142|NCT00444457|559389817|FG001|Infant Series|Lost to Follow-up|11|||
154990143|NCT00444457|559389818|FG002|Infant Series|Lost to Follow-up|7|||
154990144|NCT00444457|559389819|FG003|Infant Series|Lost to Follow-up|6|||
154990145|NCT00444457|559389816|FG000|Infant Series|Protocol Violation|16|||
154990146|NCT00444457|559389817|FG001|Infant Series|Protocol Violation|8|||
154990147|NCT00444457|559389818|FG002|Infant Series|Protocol Violation|6|||
154990148|NCT00444457|559389819|FG003|Infant Series|Protocol Violation|3|||
154990149|NCT00444457|559389816|FG000|Infant Series|Failed to return|5|||
154990150|NCT00444457|559389817|FG001|Infant Series|Failed to return|4|||
154990151|NCT00444457|559389818|FG002|Infant Series|Failed to return|4|||
154990152|NCT00444457|559389819|FG003|Infant Series|Failed to return|2|||
154990153|NCT00444457|559389816|FG000|Infant Series|Investigator request|4|||
154990154|NCT00444457|559389817|FG001|Infant Series|Investigator request|3|||
154990155|NCT00444457|559389818|FG002|Infant Series|Investigator request|3|||
154990156|NCT00444457|559389819|FG003|Infant Series|Investigator request|2|||
154990157|NCT00444457|559389816|FG000|Infant Series|Other|0|||
154990158|NCT00444457|559389817|FG001|Infant Series|Other|2|||
154990159|NCT00444457|559389818|FG002|Infant Series|Other|4|||
154990160|NCT00444457|559389819|FG003|Infant Series|Other|0|||
154990161|NCT00444457|559389816|FG000|Infant Series|Adverse Event|1|||
154990162|NCT00444457|559389817|FG001|Infant Series|Adverse Event|2|||
154990163|NCT00444457|559389818|FG002|Infant Series|Adverse Event|2|||
154990164|NCT00444457|559389819|FG003|Infant Series|Adverse Event|0|||
154990165|NCT00444457|559389816|FG000|Infant Series|Death|0|||
154990166|NCT00444457|559389817|FG001|Infant Series|Death|1|||
154990167|NCT00444457|559389818|FG002|Infant Series|Death|1|||
154990168|NCT00444457|559389819|FG003|Infant Series|Death|1|||
154990169|NCT00444457|559389816|FG000|After Infant Series|Other|0|||
154990170|NCT00444457|559389817|FG001|After Infant Series|Other|1|||
154990171|NCT00444457|559389818|FG002|After Infant Series|Other|1|||
155120476|NCT01286987|559871040|FG012|Part 2: Dose Expansion|Death|1|||
155120477|NCT01286987|559871041|FG013|Part 2: Dose Expansion|Death|1|||
155120478|NCT01286987|559871042|FG014|Part 2: Dose Expansion|Death|0|||
155120479|NCT01286987|559871028|FG000|Part 2: Dose Expansion|Physician Decision|0|||
154990172|NCT00444457|559389819|FG003|After Infant Series|Other|1|||
154990173|NCT00444457|559389816|FG000|After Infant Series|Parent or legal guardian request|4|||
154990174|NCT00444457|559389817|FG001|After Infant Series|Parent or legal guardian request|11|||
154990175|NCT00444457|559389818|FG002|After Infant Series|Parent or legal guardian request|6|||
154990176|NCT00444457|559389819|FG003|After Infant Series|Parent or legal guardian request|3|||
154990177|NCT00444457|559389816|FG000|After Infant Series|Failed to return|7|||
154990178|NCT00444457|559389817|FG001|After Infant Series|Failed to return|6|||
154990179|NCT00444457|559389818|FG002|After Infant Series|Failed to return|5|||
154990180|NCT00444457|559389819|FG003|After Infant Series|Failed to return|1|||
154990181|NCT00444457|559389816|FG000|After Infant Series|Lost to Follow-up|5|||
154990182|NCT00444457|559389817|FG001|After Infant Series|Lost to Follow-up|5|||
154990183|NCT00444457|559389818|FG002|After Infant Series|Lost to Follow-up|5|||
154990184|NCT00444457|559389819|FG003|After Infant Series|Lost to Follow-up|2|||
154990185|NCT00444457|559389816|FG000|After Infant Series|Protocol Violation|2|||
154990186|NCT00444457|559389817|FG001|After Infant Series|Protocol Violation|4|||
154990187|NCT00444457|559389818|FG002|After Infant Series|Protocol Violation|2|||
154990188|NCT00444457|559389819|FG003|After Infant Series|Protocol Violation|2|||
155120480|NCT01286987|559871029|FG001|Part 2: Dose Expansion|Physician Decision|0|||
155120481|NCT01286987|559871030|FG002|Part 2: Dose Expansion|Physician Decision|0|||
155120482|NCT01286987|559871031|FG003|Part 2: Dose Expansion|Physician Decision|0|||
155120483|NCT01286987|559871032|FG004|Part 2: Dose Expansion|Physician Decision|0|||
155120484|NCT01286987|559871033|FG005|Part 2: Dose Expansion|Physician Decision|0|||
155120485|NCT01286987|559871034|FG006|Part 2: Dose Expansion|Physician Decision|0|||
155120486|NCT01286987|559871035|FG007|Part 2: Dose Expansion|Physician Decision|0|||
155120487|NCT01286987|559871036|FG008|Part 2: Dose Expansion|Physician Decision|0|||
155120488|NCT01286987|559871037|FG009|Part 2: Dose Expansion|Physician Decision|0|||
155120489|NCT01286987|559871038|FG010|Part 2: Dose Expansion|Physician Decision|1|||
155120490|NCT01286987|559871039|FG011|Part 2: Dose Expansion|Physician Decision|1|||
155120491|NCT01286987|559871040|FG012|Part 2: Dose Expansion|Physician Decision|0|||
155120492|NCT01286987|559871041|FG013|Part 2: Dose Expansion|Physician Decision|1|||
155120493|NCT01286987|559871042|FG014|Part 2: Dose Expansion|Physician Decision|0|||
155120494|NCT01286987|559871028|FG000|Part 2: Dose Expansion|Other|0|||
155120495|NCT01286987|559871029|FG001|Part 2: Dose Expansion|Other|0|||
155120496|NCT01286987|559871030|FG002|Part 2: Dose Expansion|Other|0|||
155120497|NCT01286987|559871031|FG003|Part 2: Dose Expansion|Other|0|||
155120498|NCT01286987|559871032|FG004|Part 2: Dose Expansion|Other|0|||
155120499|NCT01286987|559871033|FG005|Part 2: Dose Expansion|Other|0|||
155120500|NCT01286987|559871034|FG006|Part 2: Dose Expansion|Other|0|||
155120501|NCT01286987|559871035|FG007|Part 2: Dose Expansion|Other|0|||
155120502|NCT01286987|559871036|FG008|Part 2: Dose Expansion|Other|0|||
155120503|NCT01286987|559871037|FG009|Part 2: Dose Expansion|Other|0|||
155120504|NCT01286987|559871038|FG010|Part 2: Dose Expansion|Other|0|||
155120505|NCT01286987|559871039|FG011|Part 2: Dose Expansion|Other|0|||
155120506|NCT01286987|559871040|FG012|Part 2: Dose Expansion|Other|0|||
155120507|NCT01286987|559871041|FG013|Part 2: Dose Expansion|Other|1|||
155120508|NCT01286987|559871042|FG014|Part 2: Dose Expansion|Other|0|||
155120509|NCT01286987|559871028|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
155120510|NCT01286987|559871029|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
155120511|NCT01286987|559871030|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
155120512|NCT01286987|559871031|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
155120513|NCT01286987|559871032|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
155120514|NCT01286987|559871033|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
155120515|NCT01286987|559871034|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
155120516|NCT01286987|559871035|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
155120517|NCT01286987|559871036|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
155120518|NCT01286987|559871037|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
155120519|NCT01286987|559871038|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
155120520|NCT01286987|559871039|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
155120521|NCT01286987|559871040|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
155120522|NCT01286987|559871041|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
155120523|NCT01286987|559871042|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
155120524|NCT01286987|559871028|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
155120525|NCT01286987|559871029|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
155120526|NCT01286987|559871030|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
155120527|NCT01286987|559871031|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
155120528|NCT01286987|559871032|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
155120529|NCT01286987|559871033|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
155120530|NCT01286987|559871034|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
155120531|NCT01286987|559871035|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
155120532|NCT01286987|559871036|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
155120533|NCT01286987|559871037|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
155120534|NCT01286987|559871038|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
155120535|NCT01286987|559871039|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
155120536|NCT01286987|559871040|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
155120537|NCT01286987|559871041|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
155120538|NCT01286987|559871042|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
155120539|NCT01286987|559871028|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154990189|NCT00444457|559389816|FG000|After Infant Series|Adverse Event|2|||
154990190|NCT00444457|559389817|FG001|After Infant Series|Adverse Event|2|||
154990191|NCT00444457|559389818|FG002|After Infant Series|Adverse Event|0|||
154990192|NCT00444457|559389819|FG003|After Infant Series|Adverse Event|0|||
154990193|NCT00444457|559389816|FG000|After Infant Series|Investigator request|0|||
155120540|NCT01286987|559871029|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120541|NCT01286987|559871030|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120542|NCT01286987|559871031|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120543|NCT01286987|559871032|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120544|NCT01286987|559871033|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154990194|NCT00444457|559389817|FG001|After Infant Series|Investigator request|0|||
155120545|NCT01286987|559871034|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154990195|NCT00444457|559389818|FG002|After Infant Series|Investigator request|0|||
155120546|NCT01286987|559871035|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120547|NCT01286987|559871036|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
154990196|NCT00444457|559389819|FG003|After Infant Series|Investigator request|1|||
154990197|NCT00444457|559389816|FG000|After Infant Series|Other|0|||
154990198|NCT00444457|559389817|FG001|After Infant Series|Other|1|||
154990199|NCT00444457|559389818|FG002|After Infant Series|Other|0|||
154990200|NCT00444457|559389819|FG003|After Infant Series|Other|0|||
154990201|NCT00444457|559389816|FG000|Toddler Dose|Lost to Follow-up|4|||
154990202|NCT00444457|559389817|FG001|Toddler Dose|Lost to Follow-up|1|||
154990203|NCT00444457|559389818|FG002|Toddler Dose|Lost to Follow-up|1|||
154990204|NCT00444457|559389819|FG003|Toddler Dose|Lost to Follow-up|3|||
154990205|NCT00444457|559389816|FG000|Toddler Dose|Failed to return|2|||
154990206|NCT00444457|559389817|FG001|Toddler Dose|Failed to return|2|||
154990207|NCT00444457|559389818|FG002|Toddler Dose|Failed to return|1|||
154990208|NCT00444457|559389819|FG003|Toddler Dose|Failed to return|3|||
154990209|NCT00444457|559389816|FG000|Toddler Dose|Parent or legal guardian request|0|||
154990210|NCT00444457|559389817|FG001|Toddler Dose|Parent or legal guardian request|3|||
154990211|NCT00444457|559389818|FG002|Toddler Dose|Parent or legal guardian request|2|||
154990212|NCT00444457|559389819|FG003|Toddler Dose|Parent or legal guardian request|1|||
154990213|NCT00444457|559389816|FG000|Toddler Dose|Protocol Violation|1|||
154990214|NCT00444457|559389817|FG001|Toddler Dose|Protocol Violation|0|||
154990215|NCT00444457|559389818|FG002|Toddler Dose|Protocol Violation|0|||
154990216|NCT00444457|559389819|FG003|Toddler Dose|Protocol Violation|1|||
154990217|NCT00914459|559389822|FG000|Overall Study|Protocol Violation|0|||
154990218|NCT00914459|559389823|FG001|Overall Study|Protocol Violation|1|||
154990219|NCT00914459|559389822|FG000|Overall Study|Parent/Legal guardian request|1|||
154990220|NCT00914459|559389823|FG001|Overall Study|Parent/Legal guardian request|0|||
154990221|NCT01661179|559389824|FG000|Overall Study|Death|1|||
154990222|NCT01661179|559389824|FG000|Overall Study|Withdrawal by Subject|1|||
154990223|NCT01661179|559389824|FG000|Overall Study|Other Eligibility criteria|4|||
154990224|NCT01083810|559389825|FG000|Overall Study|Lost to Follow-up|23|||
154990225|NCT01083810|559389826|FG001|Overall Study|Lost to Follow-up|11|||
154990226|NCT01083810|559389827|FG002|Overall Study|Lost to Follow-up|4|||
154990227|NCT01083810|559389825|FG000|Overall Study|Adverse Event|15|||
154990228|NCT01083810|559389826|FG001|Overall Study|Adverse Event|11|||
154990229|NCT01083810|559389827|FG002|Overall Study|Adverse Event|4|||
154990230|NCT01083810|559389825|FG000|Overall Study|Withdrawal by Subject|7|||
154990231|NCT01083810|559389826|FG001|Overall Study|Withdrawal by Subject|2|||
155120548|NCT01286987|559871037|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120549|NCT01286987|559871038|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
155120550|NCT01286987|559871039|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120551|NCT01286987|559871040|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120552|NCT01286987|559871041|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120553|NCT01286987|559871042|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
155120554|NCT02847858|559871043|FG000|Overall Study|Lost to Follow-up|401|||
155120555|NCT02847858|559871044|FG001|Overall Study|Lost to Follow-up|269|||
155120556|NCT00624819|559871045|FG000|Follow-up Period: Year 4|Parents decision|0|||
155120557|NCT00624819|559871046|FG001|Follow-up Period: Year 4|Parents decision|0|||
155120558|NCT00624819|559871047|FG002|Follow-up Period: Year 4|Parents decision|1|||
155120559|NCT00624819|559871048|FG003|Follow-up Period: Year 4|Parents decision|0|||
155120560|NCT00624819|559871045|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
155120561|NCT00624819|559871046|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
155120562|NCT00624819|559871047|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
155120563|NCT00624819|559871048|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
155120564|NCT00681564|559871049|FG000|Overall Study|Lost to Follow-up|6|||
155120565|NCT00681564|559871050|FG001|Overall Study|Lost to Follow-up|6|||
155120566|NCT00681564|559871049|FG000|Overall Study|Withdrawal by Subject|0|||
155120567|NCT00681564|559871050|FG001|Overall Study|Withdrawal by Subject|1|||
155120568|NCT00681564|559871049|FG000|Overall Study|Death|0|||
155120569|NCT00681564|559871050|FG001|Overall Study|Death|1|||
155120570|NCT03093974|559871053|FG000|Overall Study|Withdrawal by Subject|32|||
155120571|NCT03093974|559871054|FG001|Overall Study|Withdrawal by Subject|27|||
155120572|NCT03093974|559871053|FG000|Overall Study|Adverse Event|17|||
155120573|NCT03093974|559871054|FG001|Overall Study|Adverse Event|24|||
155120574|NCT03093974|559871053|FG000|Overall Study|Death|0|||
155120575|NCT03093974|559871054|FG001|Overall Study|Death|1|||
155120576|NCT03093974|559871053|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155120577|NCT03093974|559871054|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155120578|NCT03093974|559871053|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
155120579|NCT03093974|559871054|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
155120580|NCT03093974|559871053|FG000|Overall Study|Lost to Follow-up|0|||
155120581|NCT03093974|559871054|FG001|Overall Study|Lost to Follow-up|1|||
154990232|NCT01083810|559389827|FG002|Overall Study|Withdrawal by Subject|4|||
154990233|NCT01083810|559389825|FG000|Overall Study|Reason not reported|6|||
154990234|NCT01083810|559389826|FG001|Overall Study|Reason not reported|1|||
154990235|NCT01083810|559389827|FG002|Overall Study|Reason not reported|1|||
155120582|NCT03093974|559871053|FG000|Overall Study|Other|1|||
155120583|NCT03093974|559871054|FG001|Overall Study|Other|2|||
155120584|NCT02387164|559871055|FG000|Overall Study|Lost to Follow-up|2|||
155120585|NCT02387164|559871056|FG001|Overall Study|Lost to Follow-up|0|||
154990236|NCT01083810|559389825|FG000|Overall Study|Non-compliance|4|||
154990237|NCT01083810|559389826|FG001|Overall Study|Non-compliance|7|||
154990238|NCT01083810|559389827|FG002|Overall Study|Non-compliance|2|||
154990239|NCT01083810|559389825|FG000|Overall Study|Simplification|4|||
154990240|NCT01083810|559389826|FG001|Overall Study|Simplification|1|||
154990241|NCT01083810|559389827|FG002|Overall Study|Simplification|0|||
154990242|NCT01083810|559389825|FG000|Overall Study|Death|2|||
154990243|NCT01083810|559389826|FG001|Overall Study|Death|2|||
154990244|NCT01083810|559389827|FG002|Overall Study|Death|3|||
154990245|NCT01083810|559389825|FG000|Overall Study|Co-morbidities|1|||
154990246|NCT01083810|559389826|FG001|Overall Study|Co-morbidities|0|||
154990247|NCT01083810|559389827|FG002|Overall Study|Co-morbidities|0|||
154990248|NCT01083810|559389825|FG000|Overall Study|Participation in study|1|||
154990249|NCT01083810|559389826|FG001|Overall Study|Participation in study|0|||
154990250|NCT01083810|559389827|FG002|Overall Study|Participation in study|0|||
154990251|NCT01083810|559389825|FG000|Overall Study|Therapy break|1|||
154990252|NCT01083810|559389826|FG001|Overall Study|Therapy break|2|||
154990253|NCT01083810|559389827|FG002|Overall Study|Therapy break|2|||
154990254|NCT01083810|559389825|FG000|Overall Study|Virologic failure|1|||
154990255|NCT01083810|559389826|FG001|Overall Study|Virologic failure|8|||
154990256|NCT01083810|559389827|FG002|Overall Study|Virologic failure|0|||
154990257|NCT01602965|559389828|FG000|Overall Study|Lost to Follow-up|4|||
154990258|NCT01602965|559389829|FG001|Overall Study|Lost to Follow-up|2|||
154990259|NCT02312063|559389830|FG000|Overall Study|Withdrawal by Subject|0|||
154990260|NCT02312063|559389831|FG001|Overall Study|Withdrawal by Subject|1|||
154990261|NCT00759902|559391784|FG000|Overall Study|Adverse Event|0|||
154990262|NCT00759902|559391785|FG001|Overall Study|Adverse Event|1|||
154990263|NCT04305587|559391786|FG000|Overall Study|Withdrawal by Subject|0|||
154990264|NCT04305587|559391787|FG001|Overall Study|Withdrawal by Subject|0|||
154990265|NCT04305587|559391788|FG002|Overall Study|Withdrawal by Subject|0|||
154990266|NCT04305587|559391789|FG003|Overall Study|Withdrawal by Subject|1|||
154990267|NCT04305587|559391790|FG004|Overall Study|Withdrawal by Subject|0|||
154990268|NCT04305587|559391791|FG005|Overall Study|Withdrawal by Subject|0|||
154990269|NCT04305587|559391792|FG006|Overall Study|Withdrawal by Subject|0|||
154990270|NCT04305587|559391793|FG007|Overall Study|Withdrawal by Subject|0|||
154990271|NCT04305587|559391794|FG008|Overall Study|Withdrawal by Subject|0|||
154990272|NCT01523457|559391795|FG000|Overall Study|Withdrawal by Subject|7|||
154990273|NCT01523457|559391796|FG001|Overall Study|Withdrawal by Subject|2|||
154990274|NCT02752906|559391797|FG000|Overall Study|Protocol Violation|2|||
154990275|NCT02752906|559391798|FG001|Overall Study|Protocol Violation|1|||
154990276|NCT02752906|559391797|FG000|Overall Study|Withdrawal by Subject|2|||
154990277|NCT02752906|559391798|FG001|Overall Study|Withdrawal by Subject|2|||
154990278|NCT02752906|559391797|FG000|Overall Study|Lost to Follow-up|3|||
154990279|NCT02752906|559391798|FG001|Overall Study|Lost to Follow-up|2|||
154990280|NCT04711902|559391803|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
154990281|NCT04711902|559391804|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
154990282|NCT04711902|559391805|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
154990283|NCT04711902|559391806|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
154990284|NCT04711902|559391807|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
154990285|NCT04711902|559391808|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
154990286|NCT03786718|559391809|FG000|Overall Study|Lost to Follow-up|3|||
154990287|NCT03786718|559391809|FG000|Overall Study|Withdrawal by Subject|1|||
154990288|NCT03786718|559391809|FG000|Overall Study|Did not use the intervention|2|||
154990289|NCT03786718|559391809|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
154990290|NCT00372411|559391814|FG000|Overall Study|Withdrawal by Subject|3|||
154990291|NCT00372411|559391815|FG001|Overall Study|Withdrawal by Subject|4|||
154990292|NCT00372411|559391816|FG002|Overall Study|Withdrawal by Subject|1|||
154990293|NCT00372411|559391814|FG000|Overall Study|Death|0|||
154990294|NCT00372411|559391815|FG001|Overall Study|Death|2|||
154990295|NCT00372411|559391816|FG002|Overall Study|Death|1|||
154990296|NCT00372411|559391814|FG000|Overall Study|Lost to Follow-up|1|||
154990297|NCT00372411|559391815|FG001|Overall Study|Lost to Follow-up|1|||
154990298|NCT00372411|559391816|FG002|Overall Study|Lost to Follow-up|1|||
154990299|NCT00372411|559391814|FG000|Overall Study|Adverse Event|1|||
154990300|NCT00372411|559391815|FG001|Overall Study|Adverse Event|1|||
154990301|NCT00372411|559391816|FG002|Overall Study|Adverse Event|0|||
154990302|NCT01398514|559391817|FG000|Overall Study|Adverse Event|1|||
154990303|NCT01398514|559391818|FG001|Overall Study|Adverse Event|0|||
154990304|NCT01398514|559391817|FG000|Overall Study|Non-compliance with study procedures|2|||
155120586|NCT02387164|559871055|FG000|Overall Study|Diagnosed|1|||
154990305|NCT01398514|559391818|FG001|Overall Study|Non-compliance with study procedures|0|||
154990306|NCT01398514|559391817|FG000|Overall Study|Physiologic non-responsiveness|1|||
154990307|NCT01398514|559391818|FG001|Overall Study|Physiologic non-responsiveness|3|||
154990308|NCT01398514|559391817|FG000|Overall Study|Failure to show a conditioned response|4|||
154990309|NCT01398514|559391818|FG001|Overall Study|Failure to show a conditioned response|3|||
154990310|NCT02622113|559391820|FG000|Overall Study|Adverse Event|4|||
154990311|NCT02622113|559391821|FG001|Overall Study|Adverse Event|4|||
154990312|NCT02622113|559391820|FG000|Overall Study|Physician Decision|0|||
154990313|NCT02622113|559391821|FG001|Overall Study|Physician Decision|1|||
154990314|NCT02622113|559391820|FG000|Overall Study|Withdrawal by Subject|0|||
154990315|NCT02622113|559391821|FG001|Overall Study|Withdrawal by Subject|2|||
154990316|NCT02622113|559391820|FG000|Overall Study|Stopping Criteria|1|||
154990317|NCT02622113|559391821|FG001|Overall Study|Stopping Criteria|3|||
154990318|NCT01570686|559391824|FG000|Overall Study|Abnormal test procedure result(s)|1|||
154990319|NCT01570686|559391825|FG001|Overall Study|Abnormal test procedure result(s)|1|||
154990320|NCT01570686|559391824|FG000|Overall Study|Administrative problems|0|||
154990321|NCT01570686|559391825|FG001|Overall Study|Administrative problems|1|||
154990322|NCT01570686|559391824|FG000|Overall Study|Adverse Event|8|||
154990323|NCT01570686|559391825|FG001|Overall Study|Adverse Event|6|||
154990324|NCT01570686|559391824|FG000|Overall Study|Lost to Follow-up|4|||
154990325|NCT01570686|559391825|FG001|Overall Study|Lost to Follow-up|3|||
154990326|NCT01570686|559391824|FG000|Overall Study|Protocol Deviation|3|||
154990327|NCT01570686|559391825|FG001|Overall Study|Protocol Deviation|0|||
154990328|NCT01570686|559391824|FG000|Overall Study|Withdrawal by Subject|4|||
154990329|NCT01570686|559391825|FG001|Overall Study|Withdrawal by Subject|4|||
154990330|NCT01570686|559391824|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
154990331|NCT01570686|559391825|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
154990332|NCT01345175|559391828|FG000|Overall Study|Physician Decision|0|||
154990333|NCT01345175|559391829|FG001|Overall Study|Physician Decision|1|||
154990334|NCT01345175|559391828|FG000|Overall Study|Withdrawal by Subject|1|||
154990335|NCT01345175|559391829|FG001|Overall Study|Withdrawal by Subject|1|||
154990336|NCT01345175|559391828|FG000|Overall Study|Failed to complete BFI|3|||
154990337|NCT01345175|559391829|FG001|Overall Study|Failed to complete BFI|2|||
154990338|NCT01345175|559391828|FG000|Overall Study|Stopped taking medication|2|||
154990339|NCT01345175|559391829|FG001|Overall Study|Stopped taking medication|2|||
154990340|NCT00505375|559391830|FG000|Overall Study|Death|1|||
154990341|NCT00505375|559391831|FG001|Overall Study|Death|0|||
154990342|NCT00505375|559391830|FG000|Overall Study|Withdrawal by Subject|2|||
154990343|NCT00505375|559391831|FG001|Overall Study|Withdrawal by Subject|2|||
154990344|NCT00505375|559391830|FG000|Overall Study|Lost to Follow-up|0|||
154990345|NCT00505375|559391831|FG001|Overall Study|Lost to Follow-up|2|||
154990346|NCT00505375|559391830|FG000|Overall Study|Pregnancy|1|||
154990347|NCT00505375|559391831|FG001|Overall Study|Pregnancy|0|||
154990348|NCT00505375|559391830|FG000|Overall Study|Travel issues|0|||
154990349|NCT00505375|559391831|FG001|Overall Study|Travel issues|1|||
154990350|NCT01561430|559391833|FG000|Overall Study|Adverse Event|0|||
154990351|NCT01561430|559391834|FG001|Overall Study|Adverse Event|0|||
154990352|NCT01561430|559391835|FG002|Overall Study|Adverse Event|3|||
154990353|NCT01561430|559391836|FG003|Overall Study|Adverse Event|1|||
154990354|NCT01561430|559391833|FG000|Overall Study|Withdrawal by Subject|0|||
154990355|NCT01561430|559391834|FG001|Overall Study|Withdrawal by Subject|0|||
154990356|NCT01561430|559391835|FG002|Overall Study|Withdrawal by Subject|1|||
154990357|NCT01561430|559391836|FG003|Overall Study|Withdrawal by Subject|0|||
154990358|NCT01561430|559391833|FG000|Overall Study|Physician Decision|0|||
154990359|NCT01561430|559391834|FG001|Overall Study|Physician Decision|1|||
154990360|NCT01561430|559391835|FG002|Overall Study|Physician Decision|0|||
154990361|NCT01561430|559391836|FG003|Overall Study|Physician Decision|0|||
154990362|NCT01561430|559391833|FG000|Overall Study|Sponsor Decision|1|||
154990363|NCT01561430|559391834|FG001|Overall Study|Sponsor Decision|14|||
154990364|NCT01561430|559391835|FG002|Overall Study|Sponsor Decision|13|||
154990365|NCT01561430|559391836|FG003|Overall Study|Sponsor Decision|12|||
154990366|NCT04112173|559391837|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
154990367|NCT01055132|559391838|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
154990368|NCT01055132|559391839|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
154990369|NCT01055132|559391838|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
154990370|NCT01055132|559391839|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
154990371|NCT02746471|559391840|FG000|Overall Study|Death|43|||
154990372|NCT02746471|559391840|FG000|Overall Study|Exited before 36 months|1119|||
154990373|NCT04645966|559391844|FG000|Vaccination Phase|Adverse Event|1|||
154990374|NCT04645966|559391845|FG001|Vaccination Phase|Adverse Event|0|||
154990375|NCT04645966|559391846|FG002|Vaccination Phase|Adverse Event|0|||
154990376|NCT04645966|559391847|FG003|Vaccination Phase|Adverse Event|0|||
154990377|NCT04645966|559391848|FG004|Vaccination Phase|Adverse Event|0|||
154990378|NCT04645966|559391849|FG005|Vaccination Phase|Adverse Event|0|||
154990379|NCT04645966|559391850|FG006|Vaccination Phase|Adverse Event|1|||
154990380|NCT04645966|559391851|FG007|Vaccination Phase|Adverse Event|0|||
154990381|NCT04645966|559391852|FG008|Vaccination Phase|Adverse Event|0|||
154990382|NCT04645966|559391844|FG000|Vaccination Phase|Death|0|||
154990383|NCT04645966|559391845|FG001|Vaccination Phase|Death|0|||
154990384|NCT04645966|559391846|FG002|Vaccination Phase|Death|0|||
154990385|NCT04645966|559391847|FG003|Vaccination Phase|Death|0|||
154990386|NCT04645966|559391848|FG004|Vaccination Phase|Death|0|||
154990387|NCT04645966|559391849|FG005|Vaccination Phase|Death|1|||
154990388|NCT04645966|559391850|FG006|Vaccination Phase|Death|0|||
154990389|NCT04645966|559391851|FG007|Vaccination Phase|Death|0|||
154990390|NCT04645966|559391852|FG008|Vaccination Phase|Death|0|||
154990391|NCT04645966|559391844|FG000|Vaccination Phase|Protocol Violation|0|||
154990392|NCT04645966|559391845|FG001|Vaccination Phase|Protocol Violation|0|||
154990393|NCT04645966|559391846|FG002|Vaccination Phase|Protocol Violation|0|||
154990394|NCT04645966|559391847|FG003|Vaccination Phase|Protocol Violation|0|||
154990395|NCT04645966|559391848|FG004|Vaccination Phase|Protocol Violation|1|||
154990396|NCT04645966|559391849|FG005|Vaccination Phase|Protocol Violation|0|||
154990397|NCT04645966|559391850|FG006|Vaccination Phase|Protocol Violation|0|||
154990398|NCT04645966|559391851|FG007|Vaccination Phase|Protocol Violation|0|||
154990399|NCT04645966|559391852|FG008|Vaccination Phase|Protocol Violation|0|||
154990400|NCT04645966|559391844|FG000|Vaccination Phase|Study terminated by sponsor|0|||
154990401|NCT04645966|559391845|FG001|Vaccination Phase|Study terminated by sponsor|0|||
154990402|NCT04645966|559391846|FG002|Vaccination Phase|Study terminated by sponsor|14|||
154990403|NCT04645966|559391847|FG003|Vaccination Phase|Study terminated by sponsor|15|||
154990404|NCT04645966|559391848|FG004|Vaccination Phase|Study terminated by sponsor|47|||
154990405|NCT04645966|559391849|FG005|Vaccination Phase|Study terminated by sponsor|43|||
154990406|NCT04645966|559391850|FG006|Vaccination Phase|Study terminated by sponsor|29|||
154990407|NCT04645966|559391851|FG007|Vaccination Phase|Study terminated by sponsor|29|||
154990408|NCT04645966|559391852|FG008|Vaccination Phase|Study terminated by sponsor|12|||
154990409|NCT04645966|559391844|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
154990410|NCT04645966|559391845|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
154990411|NCT04645966|559391846|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
154990412|NCT04645966|559391847|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
154990413|NCT04645966|559391848|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
154990414|NCT04645966|559391849|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
154990415|NCT04645966|559391850|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
154990416|NCT04645966|559391851|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
154990417|NCT04645966|559391852|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
154990418|NCT04645966|559391844|FG000|Vaccination Phase|Other|0|||
154990419|NCT04645966|559391845|FG001|Vaccination Phase|Other|0|||
154990420|NCT04645966|559391846|FG002|Vaccination Phase|Other|0|||
154990421|NCT04645966|559391847|FG003|Vaccination Phase|Other|0|||
154990422|NCT04645966|559391848|FG004|Vaccination Phase|Other|0|||
154990423|NCT04645966|559391849|FG005|Vaccination Phase|Other|2|||
154990424|NCT04645966|559391850|FG006|Vaccination Phase|Other|0|||
154990425|NCT04645966|559391851|FG007|Vaccination Phase|Other|0|||
154990426|NCT04645966|559391852|FG008|Vaccination Phase|Other|0|||
154990427|NCT04645966|559391844|FG000|Vaccination Phase|Lost to Follow-up|0|||
154990428|NCT04645966|559391845|FG001|Vaccination Phase|Lost to Follow-up|0|||
154990429|NCT04645966|559391846|FG002|Vaccination Phase|Lost to Follow-up|0|||
154990430|NCT04645966|559391847|FG003|Vaccination Phase|Lost to Follow-up|0|||
154990431|NCT04645966|559391848|FG004|Vaccination Phase|Lost to Follow-up|0|||
154990432|NCT04645966|559391849|FG005|Vaccination Phase|Lost to Follow-up|0|||
154990433|NCT04645966|559391850|FG006|Vaccination Phase|Lost to Follow-up|0|||
154990434|NCT04645966|559391851|FG007|Vaccination Phase|Lost to Follow-up|1|||
154990435|NCT04645966|559391852|FG008|Vaccination Phase|Lost to Follow-up|0|||
154990436|NCT04645966|559391844|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
154990437|NCT04645966|559391845|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
154990438|NCT04645966|559391846|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
154990439|NCT04645966|559391847|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
154990440|NCT04645966|559391848|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
154990441|NCT04645966|559391849|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
154990442|NCT04645966|559391850|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
154990443|NCT04645966|559391851|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
154990444|NCT04645966|559391852|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
154990445|NCT04645966|559391844|FG000|Follow-up Phase|Lost to Follow-up|0|||
154990446|NCT04645966|559391845|FG001|Follow-up Phase|Lost to Follow-up|0|||
154990447|NCT04645966|559391846|FG002|Follow-up Phase|Lost to Follow-up|0|||
154990448|NCT04645966|559391847|FG003|Follow-up Phase|Lost to Follow-up|0|||
154990449|NCT04645966|559391848|FG004|Follow-up Phase|Lost to Follow-up|0|||
154990450|NCT04645966|559391849|FG005|Follow-up Phase|Lost to Follow-up|0|||
154990451|NCT04645966|559391850|FG006|Follow-up Phase|Lost to Follow-up|0|||
154990452|NCT04645966|559391851|FG007|Follow-up Phase|Lost to Follow-up|1|||
154990453|NCT04645966|559391852|FG008|Follow-up Phase|Lost to Follow-up|0|||
154990454|NCT01460901|559391853|FG000|Overall Study|Withdrawal by Subject|2|||
155120587|NCT02387164|559871056|FG001|Overall Study|Diagnosed|2|||
155120588|NCT00541099|559871060|FG000|Overall Study|Ineligible|3|||
154990455|NCT00470067|559391854|FG000|Overall Study|Death|1|||
154990456|NCT00470067|559391854|FG000|Overall Study|Disease Progression|6|||
154990457|NCT00895947|559391858|FG000|Overall Study|Adverse Event|3|||
154990458|NCT00895947|559391859|FG001|Overall Study|Adverse Event|4|||
154990459|NCT00895947|559391858|FG000|Overall Study|Lost to Follow-up|3|||
154990460|NCT00895947|559391859|FG001|Overall Study|Lost to Follow-up|4|||
154990461|NCT00895947|559391858|FG000|Overall Study|Protocol Violation|4|||
154990462|NCT00895947|559391859|FG001|Overall Study|Protocol Violation|2|||
154990463|NCT00895947|559391858|FG000|Overall Study|Withdrawal by Subject|2|||
154990464|NCT00895947|559391859|FG001|Overall Study|Withdrawal by Subject|0|||
154990465|NCT01059344|559391868|FG000|Overall Study|Adverse Event|12|||
154990466|NCT01059344|559391869|FG001|Overall Study|Adverse Event|30|||
154990467|NCT01059344|559391868|FG000|Overall Study|Withdrawal by Subject|6|||
154990468|NCT01059344|559391869|FG001|Overall Study|Withdrawal by Subject|9|||
154990469|NCT01059344|559391868|FG000|Overall Study|Lost to Follow-up|1|||
154990470|NCT01059344|559391869|FG001|Overall Study|Lost to Follow-up|1|||
154990471|NCT01059344|559391868|FG000|Overall Study|Other|3|||
154990472|NCT01059344|559391869|FG001|Overall Study|Other|6|||
154990473|NCT01739348|559391870|FG000|Part I (Base Study)|Adverse Event|41|||
154990474|NCT01739348|559391871|FG001|Part I (Base Study)|Adverse Event|52|||
154990475|NCT01739348|559391872|FG002|Part I (Base Study)|Adverse Event|8|||
154990476|NCT01739348|559391873|FG003|Part I (Base Study)|Adverse Event|33|||
154990477|NCT01739348|559391870|FG000|Part I (Base Study)|Death|10|||
154990478|NCT01739348|559391871|FG001|Part I (Base Study)|Death|7|||
154990479|NCT01739348|559391872|FG002|Part I (Base Study)|Death|2|||
154990480|NCT01739348|559391873|FG003|Part I (Base Study)|Death|8|||
154990481|NCT01739348|559391870|FG000|Part I (Base Study)|Lack of Efficacy|3|||
154990482|NCT01739348|559391871|FG001|Part I (Base Study)|Lack of Efficacy|8|||
154990483|NCT01739348|559391872|FG002|Part I (Base Study)|Lack of Efficacy|0|||
154990484|NCT01739348|559391873|FG003|Part I (Base Study)|Lack of Efficacy|7|||
154990485|NCT01739348|559391870|FG000|Part I (Base Study)|Lost to Follow-up|4|||
154990486|NCT01739348|559391871|FG001|Part I (Base Study)|Lost to Follow-up|2|||
154990487|NCT01739348|559391872|FG002|Part I (Base Study)|Lost to Follow-up|4|||
154990488|NCT01739348|559391873|FG003|Part I (Base Study)|Lost to Follow-up|4|||
154990489|NCT01739348|559391870|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
154990490|NCT01739348|559391871|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
154990491|NCT01739348|559391872|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
154990492|NCT01739348|559391873|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
154990493|NCT01739348|559391870|FG000|Part I (Base Study)|Physician Decision|10|||
154990494|NCT01739348|559391871|FG001|Part I (Base Study)|Physician Decision|7|||
154990495|NCT01739348|559391872|FG002|Part I (Base Study)|Physician Decision|1|||
154990496|NCT01739348|559391873|FG003|Part I (Base Study)|Physician Decision|4|||
154990497|NCT01739348|559391870|FG000|Part I (Base Study)|Protocol Violation|2|||
154990498|NCT01739348|559391871|FG001|Part I (Base Study)|Protocol Violation|0|||
154990499|NCT01739348|559391872|FG002|Part I (Base Study)|Protocol Violation|1|||
154990500|NCT01739348|559391873|FG003|Part I (Base Study)|Protocol Violation|2|||
154990501|NCT01739348|559391870|FG000|Part I (Base Study)|Screen Failure|2|||
154990502|NCT01739348|559391871|FG001|Part I (Base Study)|Screen Failure|0|||
154990503|NCT01739348|559391872|FG002|Part I (Base Study)|Screen Failure|0|||
154990504|NCT01739348|559391873|FG003|Part I (Base Study)|Screen Failure|0|||
154990505|NCT01739348|559391870|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
154990506|NCT01739348|559391871|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
154990507|NCT01739348|559391872|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
154990508|NCT01739348|559391873|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
154990509|NCT01739348|559391870|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
154990510|NCT01739348|559391871|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
154990511|NCT01739348|559391872|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
154990512|NCT01739348|559391873|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
154990513|NCT01739348|559391870|FG000|Part I (Base Study)|Participant Moved|4|||
154990514|NCT01739348|559391871|FG001|Part I (Base Study)|Participant Moved|3|||
154990515|NCT01739348|559391872|FG002|Part I (Base Study)|Participant Moved|1|||
154990516|NCT01739348|559391873|FG003|Part I (Base Study)|Participant Moved|7|||
154990517|NCT01739348|559391870|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
154990518|NCT01739348|559391871|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
154990519|NCT01739348|559391872|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
154990520|NCT01739348|559391873|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
154990521|NCT01739348|559391870|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
154990522|NCT01739348|559391871|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
154990523|NCT01739348|559391872|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
154990524|NCT01739348|559391873|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
154990525|NCT01739348|559391870|FG000|Part II (Extension Study)|Adverse Event|10|||
154990526|NCT01739348|559391871|FG001|Part II (Extension Study)|Adverse Event|11|||
154990527|NCT01739348|559391872|FG002|Part II (Extension Study)|Adverse Event|7|||
154990528|NCT01739348|559391873|FG003|Part II (Extension Study)|Adverse Event|26|||
154990529|NCT01739348|559391870|FG000|Part II (Extension Study)|Death|3|||
154990530|NCT01739348|559391871|FG001|Part II (Extension Study)|Death|3|||
154990531|NCT01739348|559391872|FG002|Part II (Extension Study)|Death|2|||
154990532|NCT01739348|559391873|FG003|Part II (Extension Study)|Death|6|||
154990533|NCT01739348|559391870|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
154990534|NCT01739348|559391871|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
154990535|NCT01739348|559391872|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
154990536|NCT01739348|559391873|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
154990537|NCT01739348|559391870|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
155177178|NCT00045942|560088183|FG000|PKC412A2104E1|Death|0|||
155177179|NCT00045942|560088184|FG001|PKC412A2104E1|Death|4|||
155177180|NCT00045942|560088185|FG002|PKC412A2104E1|Death|1|||
155177181|NCT00045942|560088186|FG003|PKC412A2104E1|Death|1|||
155177182|NCT00045942|560088187|FG004|PKC412A2104E1|Death|1|||
155177183|NCT00045942|560088188|FG005|PKC412A2104E1|Death|0|||
155177184|NCT00045942|560088189|FG006|PKC412A2104E1|Death|0|||
155177185|NCT00045942|560088190|FG007|PKC412A2104E1|Death|0|||
155177186|NCT00045942|560088191|FG008|PKC412A2104E1|Death|0|||
155177187|NCT00045942|560088183|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177188|NCT00045942|560088184|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177189|NCT00045942|560088185|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
155177190|NCT00045942|560088186|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
155177191|NCT00045942|560088187|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177192|NCT00045942|560088188|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177193|NCT00045942|560088189|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177194|NCT00045942|560088190|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177195|NCT00045942|560088191|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
155177196|NCT00045942|560088183|FG000|PKC412A2104E2|Lost to Follow-up|0|||
155177197|NCT00045942|560088184|FG001|PKC412A2104E2|Lost to Follow-up|0|||
155177198|NCT00045942|560088185|FG002|PKC412A2104E2|Lost to Follow-up|0|||
155177199|NCT00045942|560088186|FG003|PKC412A2104E2|Lost to Follow-up|0|||
155177200|NCT00045942|560088187|FG004|PKC412A2104E2|Lost to Follow-up|0|||
155177201|NCT00045942|560088188|FG005|PKC412A2104E2|Lost to Follow-up|0|||
155177202|NCT00045942|560088189|FG006|PKC412A2104E2|Lost to Follow-up|0|||
155177203|NCT00045942|560088190|FG007|PKC412A2104E2|Lost to Follow-up|3|||
155177204|NCT00045942|560088191|FG008|PKC412A2104E2|Lost to Follow-up|0|||
155177205|NCT00045942|560088183|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
154916910|NCT01072175|559118479|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916911|NCT01072175|559118480|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916912|NCT01072175|559118481|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916913|NCT01072175|559118482|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916914|NCT01072175|559118483|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916915|NCT01072175|559118484|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916916|NCT01072175|559118485|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916917|NCT01072175|559118486|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916918|NCT01072175|559118487|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
154916919|NCT01072175|559118488|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
154916920|NCT01072175|559118489|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
154916921|NCT01072175|559118490|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
154916922|NCT01072175|559118491|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
154916923|NCT01072175|559118479|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916924|NCT01072175|559118480|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916925|NCT01072175|559118481|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916926|NCT01072175|559118482|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916927|NCT01072175|559118483|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916928|NCT01072175|559118484|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916929|NCT01072175|559118485|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916930|NCT01072175|559118486|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916931|NCT01072175|559118487|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916932|NCT01072175|559118488|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916933|NCT01072175|559118489|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
154916934|NCT01072175|559118490|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
154916935|NCT01072175|559118491|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
154916936|NCT02839330|559118492|FG000|Overall Study|Adverse Event|0|||
154916937|NCT02839330|559118493|FG001|Overall Study|Adverse Event|1|||
154916938|NCT02839330|559118494|FG002|Overall Study|Adverse Event|2|||
154916939|NCT02839330|559118495|FG003|Overall Study|Adverse Event|2|||
154916940|NCT02839330|559118492|FG000|Overall Study|Death|4|||
154916941|NCT02839330|559118493|FG001|Overall Study|Death|6|||
154916942|NCT02839330|559118494|FG002|Overall Study|Death|1|||
154916943|NCT02839330|559118495|FG003|Overall Study|Death|1|||
154916944|NCT02839330|559118492|FG000|Overall Study|Withdrawal by Subject|27|||
154916945|NCT02839330|559118493|FG001|Overall Study|Withdrawal by Subject|19|||
154916946|NCT02839330|559118494|FG002|Overall Study|Withdrawal by Subject|11|||
154916947|NCT02839330|559118495|FG003|Overall Study|Withdrawal by Subject|13|||
154916948|NCT02839330|559118492|FG000|Overall Study|Lost to Follow-up|22|||
154916949|NCT02839330|559118493|FG001|Overall Study|Lost to Follow-up|27|||
154916950|NCT02839330|559118494|FG002|Overall Study|Lost to Follow-up|29|||
154916951|NCT02839330|559118495|FG003|Overall Study|Lost to Follow-up|25|||
154916952|NCT02839330|559118492|FG000|Overall Study|Administrative Reason|0|||
154916953|NCT02839330|559118493|FG001|Overall Study|Administrative Reason|0|||
154916954|NCT02839330|559118494|FG002|Overall Study|Administrative Reason|0|||
154916955|NCT02839330|559118495|FG003|Overall Study|Administrative Reason|1|||
154916956|NCT02839330|559118492|FG000|Overall Study|Protocol Violation|1|||
155177206|NCT00045942|560088184|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
154990538|NCT01739348|559391871|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
154990539|NCT01739348|559391872|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
154990540|NCT01739348|559391873|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
154990541|NCT01739348|559391870|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
154990542|NCT01739348|559391871|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
154990543|NCT01739348|559391872|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
154990544|NCT01739348|559391873|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
154990545|NCT01739348|559391870|FG000|Part II (Extension Study)|Physician Decision|7|||
154990546|NCT01739348|559391871|FG001|Part II (Extension Study)|Physician Decision|11|||
154990547|NCT01739348|559391872|FG002|Part II (Extension Study)|Physician Decision|6|||
154990548|NCT01739348|559391873|FG003|Part II (Extension Study)|Physician Decision|12|||
154990549|NCT01739348|559391870|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
154990550|NCT01739348|559391871|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
154990551|NCT01739348|559391872|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
154990552|NCT01739348|559391873|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
154990553|NCT01739348|559391870|FG000|Part II (Extension Study)|Participant Moved|3|||
154990554|NCT01739348|559391871|FG001|Part II (Extension Study)|Participant Moved|3|||
154990555|NCT01739348|559391872|FG002|Part II (Extension Study)|Participant Moved|0|||
154990556|NCT01739348|559391873|FG003|Part II (Extension Study)|Participant Moved|3|||
154990557|NCT01739348|559391870|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
154990558|NCT01739348|559391871|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
154990559|NCT01739348|559391872|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
154990560|NCT01739348|559391873|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
154990561|NCT01739348|559391870|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
154990562|NCT01739348|559391871|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
154990563|NCT01739348|559391872|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
154990564|NCT01739348|559391873|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
154990565|NCT01447420|559391878|FG000|Overall Study|Adverse Event|2|||
154990566|NCT01447420|559391879|FG001|Overall Study|Adverse Event|4|||
154990567|NCT01447420|559391880|FG002|Overall Study|Adverse Event|2|||
154990568|NCT01447420|559391878|FG000|Overall Study|Protocol Violation|3|||
154990569|NCT01447420|559391879|FG001|Overall Study|Protocol Violation|3|||
154990570|NCT01447420|559391880|FG002|Overall Study|Protocol Violation|0|||
154990571|NCT01447420|559391878|FG000|Overall Study|Withdrawal by Subject|4|||
154990572|NCT01447420|559391879|FG001|Overall Study|Withdrawal by Subject|1|||
154990573|NCT01447420|559391880|FG002|Overall Study|Withdrawal by Subject|0|||
154990574|NCT01447420|559391878|FG000|Overall Study|Lack of Efficacy|1|||
154990575|NCT01447420|559391879|FG001|Overall Study|Lack of Efficacy|19|||
154990576|NCT01447420|559391880|FG002|Overall Study|Lack of Efficacy|8|||
154990577|NCT04480710|559391882|FG000|Overall Study|Adverse Event|0|||
154990578|NCT04480710|559391883|FG001|Overall Study|Adverse Event|2|||
154990579|NCT04480710|559391884|FG002|Overall Study|Adverse Event|0|||
154990580|NCT04480710|559391885|FG003|Overall Study|Adverse Event|0|||
154990581|NCT04480710|559391882|FG000|Overall Study|Withdrawal by Subject|0|||
154990582|NCT04480710|559391883|FG001|Overall Study|Withdrawal by Subject|1|||
154990583|NCT04480710|559391884|FG002|Overall Study|Withdrawal by Subject|0|||
154990584|NCT04480710|559391885|FG003|Overall Study|Withdrawal by Subject|0|||
154990585|NCT04480710|559391882|FG000|Overall Study|Physician Decision|0|||
154990586|NCT04480710|559391883|FG001|Overall Study|Physician Decision|0|||
154990587|NCT04480710|559391884|FG002|Overall Study|Physician Decision|1|||
154990588|NCT04480710|559391885|FG003|Overall Study|Physician Decision|0|||
154990589|NCT04480021|559391886|FG000|Overall Study|Lost to Follow-up|3|||
154990590|NCT04480021|559391887|FG001|Overall Study|Lost to Follow-up|4|||
154990591|NCT03569228|559391888|FG000|Overall Study|Withdrawal by PI|0|||
154990592|NCT03569228|559391889|FG001|Overall Study|Withdrawal by PI|0|||
154990593|NCT03569228|559391890|FG002|Overall Study|Withdrawal by PI|2|||
154990594|NCT03569228|559391891|FG003|Overall Study|Withdrawal by PI|2|||
154990595|NCT03569228|559391892|FG004|Overall Study|Withdrawal by PI|1|||
154990596|NCT03569228|559391893|FG005|Overall Study|Withdrawal by PI|0|||
154990597|NCT03569228|559391894|FG006|Overall Study|Withdrawal by PI|0|||
154990598|NCT03569228|559391895|FG007|Overall Study|Withdrawal by PI|0|||
154990599|NCT03569228|559391896|FG008|Overall Study|Withdrawal by PI|0|||
154990600|NCT03569228|559391888|FG000|Overall Study|Lost to Follow-up|0|||
154990601|NCT03569228|559391889|FG001|Overall Study|Lost to Follow-up|0|||
154990602|NCT03569228|559391890|FG002|Overall Study|Lost to Follow-up|0|||
154990603|NCT03569228|559391891|FG003|Overall Study|Lost to Follow-up|0|||
154990604|NCT03569228|559391892|FG004|Overall Study|Lost to Follow-up|0|||
155177207|NCT00045942|560088185|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
154990605|NCT03569228|559391893|FG005|Overall Study|Lost to Follow-up|0|||
154990606|NCT03569228|559391894|FG006|Overall Study|Lost to Follow-up|0|||
154990607|NCT03569228|559391895|FG007|Overall Study|Lost to Follow-up|0|||
154990608|NCT03569228|559391896|FG008|Overall Study|Lost to Follow-up|1|||
154990609|NCT03569228|559391888|FG000|Overall Study|Screen Fail|2|||
154990610|NCT03569228|559391889|FG001|Overall Study|Screen Fail|2|||
154990611|NCT03569228|559391890|FG002|Overall Study|Screen Fail|1|||
154990612|NCT03569228|559391891|FG003|Overall Study|Screen Fail|1|||
154990613|NCT03569228|559391892|FG004|Overall Study|Screen Fail|1|||
154990614|NCT03569228|559391893|FG005|Overall Study|Screen Fail|3|||
154990615|NCT03569228|559391894|FG006|Overall Study|Screen Fail|1|||
154990616|NCT03569228|559391895|FG007|Overall Study|Screen Fail|5|||
154990617|NCT03569228|559391896|FG008|Overall Study|Screen Fail|2|||
154990618|NCT03819049|559391897|FG000|Overall Study|Lost to Follow-up|1|||
154990619|NCT03819049|559391898|FG001|Overall Study|Lost to Follow-up|2|||
154990620|NCT03819049|559391899|FG002|Overall Study|Lost to Follow-up|9|||
154990621|NCT03819049|559391900|FG003|Overall Study|Lost to Follow-up|0|||
154990622|NCT03819049|559391901|FG004|Overall Study|Lost to Follow-up|3|||
154990623|NCT03819049|559391902|FG005|Overall Study|Lost to Follow-up|1|||
154990624|NCT03819049|559391903|FG006|Overall Study|Lost to Follow-up|0|||
154990625|NCT03819049|559391897|FG000|Overall Study|Withdrawal by Subject|0|||
154990626|NCT03819049|559391898|FG001|Overall Study|Withdrawal by Subject|0|||
154990627|NCT03819049|559391899|FG002|Overall Study|Withdrawal by Subject|18|||
154990628|NCT03819049|559391900|FG003|Overall Study|Withdrawal by Subject|0|||
154990629|NCT03819049|559391901|FG004|Overall Study|Withdrawal by Subject|10|||
154990630|NCT03819049|559391902|FG005|Overall Study|Withdrawal by Subject|9|||
154990631|NCT03819049|559391903|FG006|Overall Study|Withdrawal by Subject|1|||
154990632|NCT03819049|559391897|FG000|Overall Study|Ongoing|0|||
154990633|NCT03819049|559391898|FG001|Overall Study|Ongoing|0|||
154990634|NCT03819049|559391899|FG002|Overall Study|Ongoing|75|||
154990635|NCT03819049|559391900|FG003|Overall Study|Ongoing|0|||
154990636|NCT03819049|559391901|FG004|Overall Study|Ongoing|41|||
154990637|NCT03819049|559391902|FG005|Overall Study|Ongoing|0|||
154990638|NCT03819049|559391903|FG006|Overall Study|Ongoing|0|||
154990639|NCT03819049|559391897|FG000|Overall Study|Other|0|||
154990640|NCT03819049|559391898|FG001|Overall Study|Other|0|||
154990641|NCT03819049|559391899|FG002|Overall Study|Other|2|||
154990642|NCT03819049|559391900|FG003|Overall Study|Other|0|||
154990643|NCT03819049|559391901|FG004|Overall Study|Other|0|||
154990644|NCT03819049|559391902|FG005|Overall Study|Other|0|||
154990645|NCT03819049|559391903|FG006|Overall Study|Other|0|||
154990646|NCT03819049|559391897|FG000|Overall Study|Randomized but not vaccinated|0|||
154990647|NCT03819049|559391898|FG001|Overall Study|Randomized but not vaccinated|0|||
154990648|NCT03819049|559391899|FG002|Overall Study|Randomized but not vaccinated|0|||
154990649|NCT03819049|559391900|FG003|Overall Study|Randomized but not vaccinated|1|||
154990650|NCT03819049|559391901|FG004|Overall Study|Randomized but not vaccinated|0|||
154990651|NCT03819049|559391902|FG005|Overall Study|Randomized but not vaccinated|2|||
154990652|NCT03819049|559391903|FG006|Overall Study|Randomized but not vaccinated|1|||
154990653|NCT03819049|559391897|FG000|Overall Study|Physician Decision|0|||
154990654|NCT03819049|559391898|FG001|Overall Study|Physician Decision|0|||
154990655|NCT03819049|559391899|FG002|Overall Study|Physician Decision|0|||
154990656|NCT03819049|559391900|FG003|Overall Study|Physician Decision|0|||
154990657|NCT03819049|559391901|FG004|Overall Study|Physician Decision|0|||
154990658|NCT03819049|559391902|FG005|Overall Study|Physician Decision|0|||
154990659|NCT03819049|559391903|FG006|Overall Study|Physician Decision|1|||
154990660|NCT02853370|559391904|FG000|Overall Study|Physician Decision|1|||
154990661|NCT02853370|559391904|FG000|Overall Study|Lack of Efficacy|2|||
154990662|NCT02853370|559391904|FG000|Overall Study|Death|1|||
154990663|NCT02853370|559391904|FG000|Overall Study|Adverse Event|4|||
154990664|NCT02853370|559391904|FG000|Overall Study|Withdrawal by Subject|3|||
154990665|NCT00643565|559391907|FG000|Overall Study|Death|12|||
154990666|NCT00643565|559391908|FG001|Overall Study|Death|11|||
154990667|NCT00643565|559391907|FG000|Overall Study|Withdrawal by Subject|4|||
154990668|NCT00643565|559391908|FG001|Overall Study|Withdrawal by Subject|1|||
154990669|NCT00643565|559391907|FG000|Overall Study|Lost to Follow-up|0|||
154990670|NCT00643565|559391908|FG001|Overall Study|Lost to Follow-up|6|||
154990671|NCT00643565|559391907|FG000|Overall Study|Other|7|||
154990672|NCT00643565|559391908|FG001|Overall Study|Other|8|||
154990673|NCT00643565|559391907|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
154990674|NCT00643565|559391908|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
154990675|NCT00643565|559391907|FG000|Overall Study|Recurrence of Disease|2|||
154990676|NCT00643565|559391908|FG001|Overall Study|Recurrence of Disease|1|||
154990677|NCT00643565|559391907|FG000|Overall Study|Progression of Disease|18|||
154990678|NCT00643565|559391908|FG001|Overall Study|Progression of Disease|14|||
154990679|NCT00643565|559391907|FG000|Overall Study|Protocol Violation|3|||
154990680|NCT00643565|559391908|FG001|Overall Study|Protocol Violation|0|||
154990681|NCT00643565|559391907|FG000|Overall Study|Did Not Cooperate|0|||
154990682|NCT00643565|559391908|FG001|Overall Study|Did Not Cooperate|1|||
154990683|NCT00643565|559391907|FG000|Overall Study|Administrative|22|||
154990684|NCT00643565|559391908|FG001|Overall Study|Administrative|16|||
154990685|NCT00643565|559391907|FG000|Overall Study|Adverse Event|5|||
154990686|NCT00643565|559391908|FG001|Overall Study|Adverse Event|8|||
154990687|NCT02317614|559391909|FG000|Overall Study|Lost to Follow-up|1|||
154990688|NCT02317614|559391910|FG001|Overall Study|Lost to Follow-up|1|||
154990689|NCT02317614|559391909|FG000|Overall Study|Withdrawal by Subject|1|||
154990690|NCT02317614|559391910|FG001|Overall Study|Withdrawal by Subject|0|||
154990691|NCT02317614|559391909|FG000|Overall Study|Death|1|||
154990692|NCT02317614|559391910|FG001|Overall Study|Death|1|||
154990693|NCT03285308|559391913|FG000|Overall Study|Adverse Event|3|||
154990694|NCT03285308|559391914|FG001|Overall Study|Adverse Event|7|||
154990695|NCT03285308|559391913|FG000|Overall Study|Withdrawal by Subject|8|||
154990696|NCT03285308|559391914|FG001|Overall Study|Withdrawal by Subject|9|||
154990697|NCT03285308|559391913|FG000|Overall Study|Lost to Follow-up|3|||
154990698|NCT03285308|559391914|FG001|Overall Study|Lost to Follow-up|1|||
154990699|NCT03285308|559391913|FG000|Overall Study|Protocol Deviation|6|||
154990700|NCT03285308|559391914|FG001|Overall Study|Protocol Deviation|5|||
154990701|NCT03285308|559391913|FG000|Overall Study|Reason not Specified|0|||
155120589|NCT01038713|559871062|FG000|Overall Study|Patient to hospice|1|||
155120590|NCT01038713|559871063|FG001|Overall Study|Patient to hospice|1|||
155120591|NCT01038713|559871064|FG002|Overall Study|Patient to hospice|1|||
155120592|NCT01038713|559871062|FG000|Overall Study|Lost to Follow-up|3|||
155120593|NCT01038713|559871063|FG001|Overall Study|Lost to Follow-up|0|||
155120594|NCT01038713|559871064|FG002|Overall Study|Lost to Follow-up|0|||
155120595|NCT01038713|559871062|FG000|Overall Study|Neuroendocrine Tumor|0|||
155120596|NCT01038713|559871063|FG001|Overall Study|Neuroendocrine Tumor|1|||
155120597|NCT01038713|559871064|FG002|Overall Study|Neuroendocrine Tumor|0|||
155120598|NCT01038713|559871062|FG000|Overall Study|died from PEP|0|||
155120599|NCT01038713|559871063|FG001|Overall Study|died from PEP|1|||
155120600|NCT01038713|559871064|FG002|Overall Study|died from PEP|0|||
155120601|NCT01038713|559871062|FG000|Overall Study|Autoimmune Pancreatitis|1|||
155120602|NCT01038713|559871063|FG001|Overall Study|Autoimmune Pancreatitis|0|||
155120603|NCT01038713|559871064|FG002|Overall Study|Autoimmune Pancreatitis|0|||
155120604|NCT02653495|559871069|FG000|Overall Study|Lost to Follow-up|2|||
155120605|NCT02653495|559871070|FG001|Overall Study|Lost to Follow-up|0|||
155120606|NCT02653495|559871069|FG000|Overall Study|Screening Failure|10|||
155120607|NCT02653495|559871070|FG001|Overall Study|Screening Failure|0|||
155120608|NCT00526110|559871073|FG000|Overall Study|Adverse Event|2|||
155120609|NCT00526110|559871074|FG001|Overall Study|Adverse Event|9|||
155120610|NCT00526110|559871073|FG000|Overall Study|Disease Progression|0|||
155120611|NCT00526110|559871074|FG001|Overall Study|Disease Progression|19|||
155120612|NCT00526110|559871073|FG000|Overall Study|Maximal Response|0|||
155120613|NCT00526110|559871074|FG001|Overall Study|Maximal Response|6|||
155120614|NCT00526110|559871073|FG000|Overall Study|Withdrawal by Subject|0|||
155120615|NCT00526110|559871074|FG001|Overall Study|Withdrawal by Subject|2|||
155120616|NCT00526110|559871073|FG000|Overall Study|Poor Tolerance|0|||
155120617|NCT00526110|559871074|FG001|Overall Study|Poor Tolerance|5|||
155120618|NCT01400243|559871075|FG000|Overall Study|Protocol Violation|8|||
155120619|NCT01400243|559871076|FG001|Overall Study|Protocol Violation|11|||
155120620|NCT01309269|559872816|FG000|Overall Study|Adverse Event|56|||
155120621|NCT01309269|559872816|FG000|Overall Study|Withdrawal by Subject|25|||
155120622|NCT01309269|559872816|FG000|Overall Study|Lack of Acceptance|15|||
155120623|NCT01309269|559872816|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
155120624|NCT01309269|559872816|FG000|Overall Study|Kidney Transplant|25|||
155120625|NCT01309269|559872816|FG000|Overall Study|Administrative Problems|141|||
155120626|NCT01309269|559872816|FG000|Overall Study|Other|256|||
155120627|NCT01309269|559872816|FG000|Overall Study|Other|1|||
155120628|NCT01309269|559872816|FG000|Overall Study|Study Completion Data Not Recorded|95|||
155120629|NCT01309269|559872816|FG000|Overall Study|Enrolled but not Treated|107|||
155120630|NCT01703117|559872838|FG000|Overall Study|Adverse Event|4|||
155120631|NCT01703117|559872839|FG001|Overall Study|Adverse Event|3|||
155120632|NCT01703117|559872838|FG000|Overall Study|Withdrawal by Subject|0|||
155120633|NCT01703117|559872839|FG001|Overall Study|Withdrawal by Subject|1|||
155120634|NCT00440310|559872841|FG000|Overall Study|Lost to Follow-up|4|||
155120635|NCT00440310|559872842|FG001|Overall Study|Lost to Follow-up|5|||
155120636|NCT00440310|559872841|FG000|Overall Study|Protocol Violation|0|||
155120637|NCT00440310|559872842|FG001|Overall Study|Protocol Violation|1|||
155120638|NCT00440310|559872841|FG000|Overall Study|Withdrawal by Subject|15|||
155120639|NCT00440310|559872842|FG001|Overall Study|Withdrawal by Subject|14|||
155120640|NCT00440310|559872841|FG000|Overall Study|No Reply at EOS|7|||
155120641|NCT00440310|559872842|FG001|Overall Study|No Reply at EOS|7|||
155120642|NCT00440310|559872841|FG000|Overall Study|Other|1|||
155120643|NCT00440310|559872842|FG001|Overall Study|Other|0|||
155120644|NCT00440310|559872841|FG000|Overall Study|Status Unknown|1|||
155120645|NCT00440310|559872842|FG001|Overall Study|Status Unknown|3|||
155120646|NCT02119156|559872843|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
155120647|NCT02119156|559872844|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
155120648|NCT02119156|559872845|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
155120649|NCT02119156|559872843|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
155120650|NCT02119156|559872844|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
155120651|NCT02119156|559872845|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
155120652|NCT02119156|559872843|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
154990702|NCT03285308|559391914|FG001|Overall Study|Reason not Specified|1|||
155120653|NCT02119156|559872844|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
155120654|NCT02119156|559872845|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
155177208|NCT00045942|560088186|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
155177209|NCT00045942|560088187|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
154990703|NCT02283983|559391915|FG000|Overall Study|Inclusion criteria not met|0|||
154990704|NCT02283983|559391916|FG001|Overall Study|Inclusion criteria not met|1|||
154990705|NCT02283983|559391915|FG000|Overall Study|Withdrawal by Subject|4|||
154990706|NCT02283983|559391916|FG001|Overall Study|Withdrawal by Subject|2|||
154990707|NCT02283983|559391915|FG000|Overall Study|Protocol Violation|0|||
154990708|NCT02283983|559391916|FG001|Overall Study|Protocol Violation|4|||
154990709|NCT02283983|559391915|FG000|Overall Study|Physician Decision|2|||
154990710|NCT02283983|559391916|FG001|Overall Study|Physician Decision|4|||
154990711|NCT02283983|559391915|FG000|Overall Study|Death|1|||
154990712|NCT02283983|559391916|FG001|Overall Study|Death|0|||
154990713|NCT02283983|559391915|FG000|Overall Study|Adverse Event|1|||
154990714|NCT02283983|559391916|FG001|Overall Study|Adverse Event|0|||
154990715|NCT02283983|559391915|FG000|Overall Study|Lost to Follow-up|9|||
154990716|NCT02283983|559391916|FG001|Overall Study|Lost to Follow-up|8|||
154990717|NCT02283983|559391915|FG000|Overall Study|Relapse|1|||
154990718|NCT02283983|559391916|FG001|Overall Study|Relapse|0|||
154990719|NCT00669071|559391921|FG000|Overall Study|Lost to Follow-up|3|||
154990720|NCT00669071|559391921|FG000|Overall Study|Final visit 40 days out of window|1|||
154990721|NCT00424775|559391922|FG000|Overall Study|Adverse Event|2|||
154990722|NCT00424775|559391923|FG001|Overall Study|Adverse Event|0|||
154990723|NCT00424775|559391922|FG000|Overall Study|Lack of Efficacy|1|||
154990724|NCT00424775|559391923|FG001|Overall Study|Lack of Efficacy|0|||
154990725|NCT03201211|559391931|FG000|Overall Study|Adverse Event|1|||
154990726|NCT03201211|559391932|FG001|Overall Study|Adverse Event|0|||
154990727|NCT03201211|559391933|FG002|Overall Study|Adverse Event|0|||
154990728|NCT03201211|559391931|FG000|Overall Study|Protocol Violation|1|||
154990729|NCT03201211|559391932|FG001|Overall Study|Protocol Violation|0|||
154990730|NCT03201211|559391933|FG002|Overall Study|Protocol Violation|0|||
154990731|NCT03201211|559391931|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154990732|NCT03201211|559391932|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
154990733|NCT03201211|559391933|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
154990734|NCT03201211|559391931|FG000|Overall Study|OTHER unknown reasons|0|||
154990735|NCT03201211|559391932|FG001|Overall Study|OTHER unknown reasons|1|||
154990736|NCT03201211|559391933|FG002|Overall Study|OTHER unknown reasons|0|||
154990737|NCT01970865|559391934|FG000|Overall Study|Death|3|||
154990738|NCT01970865|559391935|FG001|Overall Study|Death|2|||
154990739|NCT01970865|559391936|FG002|Overall Study|Death|3|||
154990740|NCT01970865|559391937|FG003|Overall Study|Death|6|||
154990741|NCT01970865|559391938|FG004|Overall Study|Death|9|||
154990742|NCT01970865|559391939|FG005|Overall Study|Death|3|||
154990743|NCT01970865|559391940|FG006|Overall Study|Death|2|||
154990744|NCT01970865|559391941|FG007|Overall Study|Death|3|||
154990745|NCT01970865|559391942|FG008|Overall Study|Death|2|||
154990746|NCT01970865|559391943|FG009|Overall Study|Death|2|||
154990747|NCT01970865|559391944|FG010|Overall Study|Death|8|||
154990748|NCT01970865|559391945|FG011|Overall Study|Death|13|||
154990749|NCT01970865|559391946|FG012|Overall Study|Death|25|||
154990750|NCT01970865|559391947|FG013|Overall Study|Death|46|||
154990751|NCT01970865|559391948|FG014|Overall Study|Death|37|||
154990752|NCT01970865|559391949|FG015|Overall Study|Death|22|||
154990753|NCT01970865|559391950|FG016|Overall Study|Death|1|||
154990754|NCT01970865|559391951|FG017|Overall Study|Death|17|||
154990755|NCT01970865|559391934|FG000|Overall Study|Lost to Follow-up|0|||
154990756|NCT01970865|559391935|FG001|Overall Study|Lost to Follow-up|0|||
154990757|NCT01970865|559391936|FG002|Overall Study|Lost to Follow-up|0|||
154990758|NCT01970865|559391937|FG003|Overall Study|Lost to Follow-up|1|||
155177210|NCT00045942|560088188|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
155177211|NCT00045942|560088189|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
155177212|NCT00045942|560088190|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
154990759|NCT01970865|559391938|FG004|Overall Study|Lost to Follow-up|1|||
154990760|NCT01970865|559391939|FG005|Overall Study|Lost to Follow-up|0|||
154990761|NCT01970865|559391940|FG006|Overall Study|Lost to Follow-up|0|||
154990762|NCT01970865|559391941|FG007|Overall Study|Lost to Follow-up|0|||
155177213|NCT00045942|560088191|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
155177214|NCT00045942|560088183|FG000|PKC412A2104E2|Lack of Efficacy|0|||
154990763|NCT01970865|559391942|FG008|Overall Study|Lost to Follow-up|0|||
154990764|NCT01970865|559391943|FG009|Overall Study|Lost to Follow-up|0|||
154990765|NCT01970865|559391944|FG010|Overall Study|Lost to Follow-up|1|||
154990766|NCT01970865|559391945|FG011|Overall Study|Lost to Follow-up|0|||
154990767|NCT01970865|559391946|FG012|Overall Study|Lost to Follow-up|2|||
154990768|NCT01970865|559391947|FG013|Overall Study|Lost to Follow-up|0|||
154990769|NCT01970865|559391948|FG014|Overall Study|Lost to Follow-up|1|||
154990770|NCT01970865|559391949|FG015|Overall Study|Lost to Follow-up|4|||
154990771|NCT01970865|559391950|FG016|Overall Study|Lost to Follow-up|0|||
154990772|NCT01970865|559391951|FG017|Overall Study|Lost to Follow-up|1|||
154990773|NCT01970865|559391934|FG000|Overall Study|Other|0|||
154990774|NCT01970865|559391935|FG001|Overall Study|Other|1|||
154990775|NCT01970865|559391936|FG002|Overall Study|Other|0|||
154990776|NCT01970865|559391937|FG003|Overall Study|Other|1|||
154990777|NCT01970865|559391938|FG004|Overall Study|Other|1|||
154990778|NCT01970865|559391939|FG005|Overall Study|Other|0|||
154990779|NCT01970865|559391940|FG006|Overall Study|Other|1|||
154990780|NCT01970865|559391941|FG007|Overall Study|Other|0|||
154990781|NCT01970865|559391942|FG008|Overall Study|Other|0|||
154990782|NCT01970865|559391943|FG009|Overall Study|Other|0|||
154990783|NCT01970865|559391944|FG010|Overall Study|Other|2|||
154990784|NCT01970865|559391945|FG011|Overall Study|Other|3|||
154990785|NCT01970865|559391946|FG012|Overall Study|Other|8|||
154990786|NCT01970865|559391947|FG013|Overall Study|Other|3|||
154990787|NCT01970865|559391948|FG014|Overall Study|Other|2|||
154990788|NCT01970865|559391949|FG015|Overall Study|Other|3|||
154990789|NCT01970865|559391950|FG016|Overall Study|Other|0|||
154990790|NCT01970865|559391951|FG017|Overall Study|Other|2|||
154990791|NCT01970865|559391934|FG000|Overall Study|Participant refused further follow-up|0|||
154990792|NCT01970865|559391935|FG001|Overall Study|Participant refused further follow-up|0|||
154990793|NCT01970865|559391936|FG002|Overall Study|Participant refused further follow-up|0|||
154990794|NCT01970865|559391937|FG003|Overall Study|Participant refused further follow-up|2|||
154990795|NCT01970865|559391938|FG004|Overall Study|Participant refused further follow-up|3|||
154990796|NCT01970865|559391939|FG005|Overall Study|Participant refused further follow-up|0|||
154990797|NCT01970865|559391940|FG006|Overall Study|Participant refused further follow-up|0|||
154990798|NCT01970865|559391941|FG007|Overall Study|Participant refused further follow-up|0|||
154990799|NCT01970865|559391942|FG008|Overall Study|Participant refused further follow-up|0|||
154990800|NCT01970865|559391943|FG009|Overall Study|Participant refused further follow-up|0|||
154990801|NCT01970865|559391944|FG010|Overall Study|Participant refused further follow-up|1|||
154990802|NCT01970865|559391945|FG011|Overall Study|Participant refused further follow-up|4|||
154990803|NCT01970865|559391946|FG012|Overall Study|Participant refused further follow-up|7|||
154990804|NCT01970865|559391947|FG013|Overall Study|Participant refused further follow-up|8|||
154990805|NCT01970865|559391948|FG014|Overall Study|Participant refused further follow-up|3|||
154990806|NCT01970865|559391949|FG015|Overall Study|Participant refused further follow-up|11|||
154990807|NCT01970865|559391950|FG016|Overall Study|Participant refused further follow-up|0|||
154990808|NCT01970865|559391951|FG017|Overall Study|Participant refused further follow-up|6|||
154990809|NCT02041091|559391952|FG000|Treatment|Adverse Event|3|||
154990810|NCT02041091|559391953|FG001|Treatment|Adverse Event|3|||
154990811|NCT02041091|559391952|FG000|Treatment|Withdrawal by Subject|2|||
154990812|NCT02041091|559391953|FG001|Treatment|Withdrawal by Subject|4|||
154990813|NCT02041091|559391952|FG000|Treatment|Physician Decision|1|||
154990814|NCT02041091|559391953|FG001|Treatment|Physician Decision|0|||
154990815|NCT02041091|559391952|FG000|Treatment|Sponsor Decision|15|||
154990816|NCT02041091|559391953|FG001|Treatment|Sponsor Decision|16|||
154990817|NCT02041091|559391952|FG000|Treatment|Lost to Follow-up|1|||
154990818|NCT02041091|559391953|FG001|Treatment|Lost to Follow-up|0|||
154990819|NCT02041091|559391952|FG000|Optional Safety Extension Period|Adverse Event|4|||
154990820|NCT02041091|559391953|FG001|Optional Safety Extension Period|Adverse Event|2|||
154990821|NCT02041091|559391952|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
154990822|NCT02041091|559391953|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
154990823|NCT02041091|559391952|FG000|Optional Safety Extension Period|Protocol Violation|2|||
154990824|NCT02041091|559391953|FG001|Optional Safety Extension Period|Protocol Violation|0|||
154990825|NCT02041091|559391952|FG000|Optional Safety Extension Period|Physician Decision|2|||
154990826|NCT02041091|559391953|FG001|Optional Safety Extension Period|Physician Decision|1|||
154990827|NCT02041091|559391952|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
154990828|NCT02041091|559391953|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
154990829|NCT02041091|559391952|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
154990830|NCT02041091|559391953|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
154990831|NCT00321737|559391957|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
154990832|NCT00321737|559391958|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
154990833|NCT00321737|559391959|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
154990834|NCT00321737|559391957|FG000|Overall Study|Adverse Event|11|||
154990835|NCT00321737|559391958|FG001|Overall Study|Adverse Event|3|||
154990836|NCT00321737|559391959|FG002|Overall Study|Adverse Event|6|||
154990837|NCT00321737|559391957|FG000|Overall Study|Lost to Follow-up|5|||
154990838|NCT00321737|559391958|FG001|Overall Study|Lost to Follow-up|5|||
154990839|NCT00321737|559391959|FG002|Overall Study|Lost to Follow-up|6|||
154990840|NCT00321737|559391957|FG000|Overall Study|Withdrawal by Subject|19|||
155120655|NCT02119156|559872843|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
155120656|NCT02119156|559872844|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
155120657|NCT02119156|559872845|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
155120658|NCT02119156|559872843|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
155120659|NCT02119156|559872844|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
155120660|NCT02119156|559872845|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
155120661|NCT02469415|559872846|FG000|Overall Study|Withdrawal by Subject|1|||
155120662|NCT02469415|559872846|FG000|Overall Study|Investigational agent placed on hold|2|||
155120663|NCT00330928|559872852|FG000|Overall Study|Lost to Follow-up|6|||
154990841|NCT00321737|559391958|FG001|Overall Study|Withdrawal by Subject|12|||
154990842|NCT00321737|559391959|FG002|Overall Study|Withdrawal by Subject|17|||
154990843|NCT00321737|559391957|FG000|Overall Study|Protocol Violation|0|||
154990844|NCT00321737|559391958|FG001|Overall Study|Protocol Violation|0|||
154990845|NCT00321737|559391959|FG002|Overall Study|Protocol Violation|1|||
154990846|NCT00321737|559391957|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
154990847|NCT00321737|559391958|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
154990848|NCT00321737|559391959|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
154990849|NCT00321737|559391957|FG000|Overall Study|Possible Barrett's Esophagus|2|||
154990850|NCT00321737|559391958|FG001|Overall Study|Possible Barrett's Esophagus|1|||
154990851|NCT00321737|559391959|FG002|Overall Study|Possible Barrett's Esophagus|1|||
154990852|NCT00321737|559391957|FG000|Overall Study|Therapeutic Failure|6|||
154990853|NCT00321737|559391958|FG001|Overall Study|Therapeutic Failure|0|||
154990854|NCT00321737|559391959|FG002|Overall Study|Therapeutic Failure|2|||
154990855|NCT00321737|559391957|FG000|Overall Study|Pregnancy|0|||
154990856|NCT00321737|559391958|FG001|Overall Study|Pregnancy|2|||
154990857|NCT00321737|559391959|FG002|Overall Study|Pregnancy|0|||
154990858|NCT00321737|559391957|FG000|Overall Study|Noncompliance|2|||
154990859|NCT00321737|559391958|FG001|Overall Study|Noncompliance|0|||
154990860|NCT00321737|559391959|FG002|Overall Study|Noncompliance|0|||
154990861|NCT00321737|559391957|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
154990862|NCT00321737|559391958|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
154990863|NCT00321737|559391959|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
154990864|NCT02283294|559391960|FG000|Overall Study|Lost to Follow-up|1|||
154990865|NCT02283294|559391961|FG001|Overall Study|Lost to Follow-up|1|||
154990866|NCT02283294|559391960|FG000|Overall Study|Withdrawal by Subject|1|||
154990867|NCT02283294|559391961|FG001|Overall Study|Withdrawal by Subject|6|||
154990868|NCT02283294|559391960|FG000|Overall Study|Protocol Violation|1|||
154990869|NCT02283294|559391961|FG001|Overall Study|Protocol Violation|0|||
154990870|NCT02283294|559391960|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
154990871|NCT02283294|559391961|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
154990872|NCT00594646|559391962|FG000|Overall Study|Withdrawal by Subject|1|||
154990873|NCT00594646|559391962|FG000|Overall Study|Lost to Follow-up|15|||
154990874|NCT01195272|559391963|FG000|Overall Study|Adverse Event|1|||
155120664|NCT00330928|559872852|FG000|Overall Study|Physician Decision|9|||
154916957|NCT02839330|559118493|FG001|Overall Study|Protocol Violation|2|||
154916958|NCT02839330|559118494|FG002|Overall Study|Protocol Violation|2|||
154916959|NCT02839330|559118495|FG003|Overall Study|Protocol Violation|3|||
154916960|NCT02839330|559118492|FG000|Overall Study|Other reason, not specified|4|||
154916961|NCT02839330|559118493|FG001|Overall Study|Other reason, not specified|3|||
154916962|NCT02839330|559118494|FG002|Overall Study|Other reason, not specified|3|||
154916963|NCT02839330|559118495|FG003|Overall Study|Other reason, not specified|6|||
154916964|NCT00438815|559118496|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
154916965|NCT00438815|559118496|FG000|Overall Study|3-month follow-up no longer required|12|||
154916966|NCT00438815|559118496|FG000|Overall Study|Noncompliance with protocol requirements|9|||
154916967|NCT00438815|559118496|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
154916968|NCT00438815|559118496|FG000|Overall Study|Lost to Follow-up|6|||
154916969|NCT00438815|559118496|FG000|Overall Study|Withdrawal by Subject|6|||
154916970|NCT00438815|559118496|FG000|Overall Study|Death|1|||
154916971|NCT01733758|559118497|FG000|Overall Study|Adverse Event|5|||
154916972|NCT01733758|559118498|FG001|Overall Study|Adverse Event|7|||
154916973|NCT01733758|559118499|FG002|Overall Study|Adverse Event|8|||
154916974|NCT01733758|559118500|FG003|Overall Study|Adverse Event|1|||
154916975|NCT01733758|559118497|FG000|Overall Study|Withdrawal by Subject|1|||
154916976|NCT01733758|559118498|FG001|Overall Study|Withdrawal by Subject|1|||
154916977|NCT01733758|559118499|FG002|Overall Study|Withdrawal by Subject|5|||
154916978|NCT01733758|559118500|FG003|Overall Study|Withdrawal by Subject|3|||
154916979|NCT01733758|559118497|FG000|Overall Study|Persistent Hyperglycemia|3|||
154916980|NCT01733758|559118498|FG001|Overall Study|Persistent Hyperglycemia|2|||
154916981|NCT01733758|559118499|FG002|Overall Study|Persistent Hyperglycemia|0|||
154916982|NCT01733758|559118500|FG003|Overall Study|Persistent Hyperglycemia|0|||
154916983|NCT01733758|559118497|FG000|Overall Study|Protocol Violation|0|||
154916984|NCT01733758|559118498|FG001|Overall Study|Protocol Violation|1|||
154916985|NCT01733758|559118499|FG002|Overall Study|Protocol Violation|2|||
154916986|NCT01733758|559118500|FG003|Overall Study|Protocol Violation|2|||
154916987|NCT01733758|559118497|FG000|Overall Study|Non-compliance|1|||
154916988|NCT01733758|559118498|FG001|Overall Study|Non-compliance|0|||
154916989|NCT01733758|559118499|FG002|Overall Study|Non-compliance|0|||
154916990|NCT01733758|559118500|FG003|Overall Study|Non-compliance|0|||
154916991|NCT01733758|559118497|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
154916992|NCT01733758|559118498|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
154916993|NCT01733758|559118499|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
154916994|NCT01733758|559118500|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
154990875|NCT01195272|559391963|FG000|Overall Study|Lack of Efficacy|3|||
154990876|NCT01769339|559391966|FG000|Overall Study|Lost to Follow-up|42|||
154990877|NCT01769339|559391966|FG000|Overall Study|Adverse Event|1|||
155177215|NCT00045942|560088184|FG001|PKC412A2104E2|Lack of Efficacy|0|||
155177216|NCT00045942|560088185|FG002|PKC412A2104E2|Lack of Efficacy|0|||
155177217|NCT00045942|560088186|FG003|PKC412A2104E2|Lack of Efficacy|0|||
155177218|NCT00045942|560088187|FG004|PKC412A2104E2|Lack of Efficacy|0|||
155177219|NCT00045942|560088188|FG005|PKC412A2104E2|Lack of Efficacy|3|||
155177220|NCT00045942|560088189|FG006|PKC412A2104E2|Lack of Efficacy|2|||
155177221|NCT00045942|560088190|FG007|PKC412A2104E2|Lack of Efficacy|2|||
155177222|NCT00045942|560088191|FG008|PKC412A2104E2|Lack of Efficacy|6|||
155177223|NCT00045942|560088183|FG000|PKC412A2104E2|Adverse Event|0|||
155177224|NCT00045942|560088184|FG001|PKC412A2104E2|Adverse Event|0|||
155177225|NCT00045942|560088185|FG002|PKC412A2104E2|Adverse Event|0|||
155177226|NCT00045942|560088186|FG003|PKC412A2104E2|Adverse Event|0|||
155177227|NCT00045942|560088187|FG004|PKC412A2104E2|Adverse Event|0|||
155177228|NCT00045942|560088188|FG005|PKC412A2104E2|Adverse Event|4|||
155177229|NCT00045942|560088189|FG006|PKC412A2104E2|Adverse Event|3|||
155177230|NCT00045942|560088190|FG007|PKC412A2104E2|Adverse Event|1|||
155177231|NCT00045942|560088191|FG008|PKC412A2104E2|Adverse Event|0|||
155177232|NCT00045942|560088183|FG000|PKC412A2104E2|Death|0|||
155177233|NCT00045942|560088184|FG001|PKC412A2104E2|Death|0|||
155177234|NCT00045942|560088185|FG002|PKC412A2104E2|Death|0|||
155177235|NCT00045942|560088186|FG003|PKC412A2104E2|Death|0|||
155177236|NCT00045942|560088187|FG004|PKC412A2104E2|Death|0|||
155177237|NCT00045942|560088188|FG005|PKC412A2104E2|Death|1|||
155177238|NCT00045942|560088189|FG006|PKC412A2104E2|Death|2|||
155177239|NCT00045942|560088190|FG007|PKC412A2104E2|Death|0|||
155177240|NCT00045942|560088191|FG008|PKC412A2104E2|Death|0|||
155177241|NCT05508074|560088192|FG000|Overall Study|Death|2|||
155177242|NCT05508074|560088193|FG001|Overall Study|Death|5|||
155177243|NCT05508074|560088192|FG000|Overall Study|Withdrawal by Subject|1|||
155177244|NCT05508074|560088193|FG001|Overall Study|Withdrawal by Subject|2|||
155177245|NCT05508074|560088192|FG000|Overall Study|Adverse Event|0|||
155177246|NCT05508074|560088193|FG001|Overall Study|Adverse Event|1|||
155177247|NCT05508074|560088192|FG000|Overall Study|Physician Decision|0|||
155177248|NCT05508074|560088193|FG001|Overall Study|Physician Decision|1|||
155177249|NCT05508074|560088192|FG000|Overall Study|wrongly randomized|0|||
155177250|NCT05508074|560088193|FG001|Overall Study|wrongly randomized|1|||
155177251|NCT05508074|560088192|FG000|Overall Study|non-compliance|0|||
155177252|NCT05508074|560088193|FG001|Overall Study|non-compliance|1|||
155177253|NCT02984943|560088194|FG000|Overall Study|Withdrawal by Subject|3|||
155177254|NCT02984943|560088194|FG000|Overall Study|Physician Decision|1|||
155177255|NCT02480712|560088201|FG000|Overall Study|Enrolled but Never Treated|1|||
155177256|NCT02480712|560088201|FG000|Overall Study|Lost to Follow-up|5|||
155177257|NCT02480712|560088201|FG000|Overall Study|Withdrew Consent|3|||
155177258|NCT02480712|560088201|FG000|Overall Study|Death|1|||
155177259|NCT02480712|560088201|FG000|Overall Study|Lack of Efficacy|1|||
155177260|NCT01860846|560088202|FG000|Overall Study|Lost to Follow-up|33|||
155177261|NCT00466687|560088203|FG000|Overall Study|Adverse Event|1|||
155177262|NCT00466687|560088203|FG000|Overall Study|Other complicating illness|3|||
155177263|NCT00466687|560088203|FG000|Overall Study|Withdrawal by Subject|1|||
155177264|NCT00466687|560088203|FG000|Overall Study|Disease progression|29|||
155177265|NCT01944839|560088207|FG000|Overall Study|Physician Decision|2|||
155177266|NCT01944839|560088208|FG001|Overall Study|Physician Decision|2|||
155177267|NCT01944839|560088207|FG000|Overall Study|Protocol Violation|0|||
155177268|NCT01944839|560088208|FG001|Overall Study|Protocol Violation|1|||
155177269|NCT01944839|560088207|FG000|Overall Study|Adverse Event|10|||
155177270|NCT01944839|560088208|FG001|Overall Study|Adverse Event|5|||
155177271|NCT01944839|560088207|FG000|Overall Study|Withdrawal by Subject|9|||
155177272|NCT01944839|560088208|FG001|Overall Study|Withdrawal by Subject|17|||
155177273|NCT01944839|560088207|FG000|Overall Study|Lost to Follow-up|1|||
155177274|NCT01944839|560088208|FG001|Overall Study|Lost to Follow-up|0|||
155177275|NCT01944839|560088207|FG000|Overall Study|Subject non-compliance|0|||
155177276|NCT01944839|560088208|FG001|Overall Study|Subject non-compliance|3|||
155177277|NCT00171834|560088209|FG000|Overall Study|Adverse Event|2|||
155177278|NCT00171834|560088210|FG001|Overall Study|Adverse Event|1|||
155177279|NCT00171834|560088211|FG002|Overall Study|Adverse Event|3|||
155177280|NCT00171834|560088212|FG003|Overall Study|Adverse Event|2|||
155177281|NCT00171834|560088213|FG004|Overall Study|Adverse Event|2|||
155177282|NCT00171834|560088214|FG005|Overall Study|Adverse Event|15|||
155177283|NCT00171834|560088215|FG006|Overall Study|Adverse Event|1|||
155177284|NCT00171834|560088209|FG000|Overall Study|Withdrawal by Subject|0|||
155177285|NCT00171834|560088210|FG001|Overall Study|Withdrawal by Subject|2|||
155177286|NCT00171834|560088211|FG002|Overall Study|Withdrawal by Subject|0|||
155177287|NCT00171834|560088212|FG003|Overall Study|Withdrawal by Subject|1|||
155177288|NCT00171834|560088213|FG004|Overall Study|Withdrawal by Subject|1|||
155177289|NCT00171834|560088214|FG005|Overall Study|Withdrawal by Subject|1|||
155177290|NCT00171834|560088215|FG006|Overall Study|Withdrawal by Subject|0|||
155177291|NCT00171834|560088209|FG000|Overall Study|Death from study indication|0|||
155177292|NCT00171834|560088210|FG001|Overall Study|Death from study indication|1|||
155177293|NCT00171834|560088211|FG002|Overall Study|Death from study indication|0|||
155177294|NCT00171834|560088212|FG003|Overall Study|Death from study indication|0|||
154990878|NCT03548064|559394790|FG000|Overall Study|Withdrawal by Subject|0|||
154990879|NCT03548064|559394791|FG001|Overall Study|Withdrawal by Subject|0|||
154990880|NCT03548064|559394792|FG002|Overall Study|Withdrawal by Subject|0|||
154990881|NCT03548064|559394793|FG003|Overall Study|Withdrawal by Subject|1|||
154990882|NCT03548064|559394794|FG004|Overall Study|Withdrawal by Subject|0|||
154990883|NCT03548064|559394795|FG005|Overall Study|Withdrawal by Subject|0|||
154990884|NCT03548064|559394796|FG006|Overall Study|Withdrawal by Subject|0|||
154990885|NCT03548064|559394797|FG007|Overall Study|Withdrawal by Subject|0|||
154990886|NCT03548064|559394790|FG000|Overall Study|Lost to Follow-up|0|||
154990887|NCT03548064|559394791|FG001|Overall Study|Lost to Follow-up|0|||
154990888|NCT03548064|559394792|FG002|Overall Study|Lost to Follow-up|0|||
154990889|NCT03548064|559394793|FG003|Overall Study|Lost to Follow-up|0|||
154990890|NCT03548064|559394794|FG004|Overall Study|Lost to Follow-up|2|||
154990891|NCT03548064|559394795|FG005|Overall Study|Lost to Follow-up|0|||
154990892|NCT03548064|559394796|FG006|Overall Study|Lost to Follow-up|0|||
154990893|NCT03548064|559394797|FG007|Overall Study|Lost to Follow-up|0|||
154990894|NCT03548064|559394790|FG000|Overall Study|Covid-19 Pandemic|0|||
154990895|NCT03548064|559394791|FG001|Overall Study|Covid-19 Pandemic|0|||
154990896|NCT03548064|559394792|FG002|Overall Study|Covid-19 Pandemic|0|||
154990897|NCT03548064|559394793|FG003|Overall Study|Covid-19 Pandemic|0|||
154990898|NCT03548064|559394794|FG004|Overall Study|Covid-19 Pandemic|10|||
154990899|NCT03548064|559394795|FG005|Overall Study|Covid-19 Pandemic|3|||
154990900|NCT03548064|559394796|FG006|Overall Study|Covid-19 Pandemic|0|||
154990901|NCT03548064|559394797|FG007|Overall Study|Covid-19 Pandemic|0|||
154990902|NCT04941729|559394800|FG000|Overall Study|Death|0|||
154990903|NCT04941729|559394801|FG001|Overall Study|Death|1|||
154990904|NCT04941729|559394800|FG000|Overall Study|Study terminated by sponsor|11|||
154990905|NCT04941729|559394801|FG001|Overall Study|Study terminated by sponsor|10|||
154990906|NCT03845296|559394802|FG000|Overall Study|On Treatment|2|||
154990907|NCT03845296|559394803|FG001|Overall Study|On Treatment|1|||
154990908|NCT03845296|559394802|FG000|Overall Study|Adverse Event|4|||
154990909|NCT03845296|559394803|FG001|Overall Study|Adverse Event|11|||
154990910|NCT03845296|559394802|FG000|Overall Study|Refusal unrelated to adverse event|0|||
154990911|NCT03845296|559394803|FG001|Overall Study|Refusal unrelated to adverse event|1|||
154990912|NCT03845296|559394802|FG000|Overall Study|Progression/relapse|14|||
154990913|NCT03845296|559394803|FG001|Overall Study|Progression/relapse|18|||
154990914|NCT03845296|559394802|FG000|Overall Study|Death|4|||
154990915|NCT03845296|559394803|FG001|Overall Study|Death|0|||
154990916|NCT03845296|559394802|FG000|Overall Study|Other - not protocol specified|1|||
154990917|NCT03845296|559394803|FG001|Overall Study|Other - not protocol specified|3|||
154990918|NCT05091307|559394804|FG000|Overall Study|Death|0|||
154990919|NCT05091307|559394805|FG001|Overall Study|Death|0|||
154990920|NCT05091307|559394806|FG002|Overall Study|Death|1|||
154990921|NCT05091307|559394807|FG003|Overall Study|Death|0|||
154990922|NCT05091307|559394804|FG000|Overall Study|Lost to Follow-up|33|||
154990923|NCT05091307|559394805|FG001|Overall Study|Lost to Follow-up|33|||
154990924|NCT05091307|559394806|FG002|Overall Study|Lost to Follow-up|2|||
154990925|NCT05091307|559394807|FG003|Overall Study|Lost to Follow-up|0|||
154990926|NCT05091307|559394804|FG000|Overall Study|Physician Decision|1|||
154990927|NCT05091307|559394805|FG001|Overall Study|Physician Decision|0|||
154990928|NCT05091307|559394806|FG002|Overall Study|Physician Decision|0|||
154990929|NCT05091307|559394807|FG003|Overall Study|Physician Decision|0|||
154990930|NCT05091307|559394804|FG000|Overall Study|Protocol Violation|1|||
154990931|NCT05091307|559394805|FG001|Overall Study|Protocol Violation|0|||
154990932|NCT05091307|559394806|FG002|Overall Study|Protocol Violation|0|||
154990933|NCT05091307|559394807|FG003|Overall Study|Protocol Violation|0|||
154990934|NCT05091307|559394804|FG000|Overall Study|Withdrawal by Subject|16|||
154990935|NCT05091307|559394805|FG001|Overall Study|Withdrawal by Subject|16|||
154990936|NCT05091307|559394806|FG002|Overall Study|Withdrawal by Subject|0|||
154990937|NCT05091307|559394807|FG003|Overall Study|Withdrawal by Subject|1|||
155120665|NCT00330928|559872852|FG000|Overall Study|Death|1|||
155120666|NCT00330928|559872852|FG000|Overall Study|IVUS could not be performed.|1|||
154990938|NCT05091307|559394804|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
154990939|NCT05091307|559394805|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
154990940|NCT05091307|559394806|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
154990941|NCT05091307|559394807|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
154990942|NCT05091307|559394804|FG000|Overall Study|Initiated Prohibited Medication|1|||
154990943|NCT05091307|559394805|FG001|Overall Study|Initiated Prohibited Medication|0|||
154990944|NCT05091307|559394806|FG002|Overall Study|Initiated Prohibited Medication|0|||
154990945|NCT05091307|559394807|FG003|Overall Study|Initiated Prohibited Medication|0|||
154990946|NCT05091307|559394804|FG000|Overall Study|Other|4|||
154990947|NCT05091307|559394805|FG001|Overall Study|Other|4|||
154990948|NCT05091307|559394806|FG002|Overall Study|Other|0|||
154990949|NCT05091307|559394807|FG003|Overall Study|Other|0|||
154990950|NCT05091307|559394804|FG000|Overall Study|Randomized but not vaccinated|0|||
154990951|NCT05091307|559394805|FG001|Overall Study|Randomized but not vaccinated|2|||
154990952|NCT05091307|559394806|FG002|Overall Study|Randomized but not vaccinated|0|||
154990953|NCT05091307|559394807|FG003|Overall Study|Randomized but not vaccinated|0|||
154990954|NCT04732221|559394810|FG000|Base Period|Death|2|||
154990955|NCT04732221|559394811|FG001|Base Period|Death|0|||
154990956|NCT04732221|559394812|FG002|Base Period|Death|0|||
154990957|NCT04732221|559394813|FG003|Base Period|Death|0|||
154990958|NCT04732221|559394814|FG004|Base Period|Death|0|||
154990959|NCT04732221|559394815|FG005|Base Period|Death|0|||
154990960|NCT04732221|559394816|FG006|Base Period|Death|0|||
154990961|NCT04732221|559394810|FG000|Base Period|Withdrawal by Subject|0|||
154990962|NCT04732221|559394811|FG001|Base Period|Withdrawal by Subject|1|||
154990963|NCT04732221|559394812|FG002|Base Period|Withdrawal by Subject|1|||
154990964|NCT04732221|559394813|FG003|Base Period|Withdrawal by Subject|0|||
154990965|NCT04732221|559394814|FG004|Base Period|Withdrawal by Subject|0|||
154990966|NCT04732221|559394815|FG005|Base Period|Withdrawal by Subject|0|||
154990967|NCT04732221|559394816|FG006|Base Period|Withdrawal by Subject|0|||
154990968|NCT04732221|559394810|FG000|Extension Period|Adverse Event|0|||
154990969|NCT04732221|559394811|FG001|Extension Period|Adverse Event|0|||
154990970|NCT04732221|559394812|FG002|Extension Period|Adverse Event|0|||
154990971|NCT04732221|559394813|FG003|Extension Period|Adverse Event|0|||
154990972|NCT04732221|559394814|FG004|Extension Period|Adverse Event|0|||
154990973|NCT04732221|559394815|FG005|Extension Period|Adverse Event|1|||
154990974|NCT04732221|559394816|FG006|Extension Period|Adverse Event|0|||
154990975|NCT04732221|559394810|FG000|Extension Period|Death|0|||
154990976|NCT04732221|559394811|FG001|Extension Period|Death|0|||
154990977|NCT04732221|559394812|FG002|Extension Period|Death|0|||
154990978|NCT04732221|559394813|FG003|Extension Period|Death|0|||
154990979|NCT04732221|559394814|FG004|Extension Period|Death|1|||
154990980|NCT04732221|559394815|FG005|Extension Period|Death|0|||
154990981|NCT04732221|559394816|FG006|Extension Period|Death|2|||
154990982|NCT04732221|559394810|FG000|Extension Period|Pregnancy|0|||
154990983|NCT04732221|559394811|FG001|Extension Period|Pregnancy|0|||
154990984|NCT04732221|559394812|FG002|Extension Period|Pregnancy|0|||
154990985|NCT04732221|559394813|FG003|Extension Period|Pregnancy|0|||
154990986|NCT04732221|559394814|FG004|Extension Period|Pregnancy|1|||
154990987|NCT04732221|559394815|FG005|Extension Period|Pregnancy|0|||
154990988|NCT04732221|559394816|FG006|Extension Period|Pregnancy|0|||
154990989|NCT04732221|559394810|FG000|Extension Period|Sponsors Decision|0|||
154990990|NCT04732221|559394811|FG001|Extension Period|Sponsors Decision|0|||
154990991|NCT04732221|559394812|FG002|Extension Period|Sponsors Decision|0|||
154990992|NCT04732221|559394813|FG003|Extension Period|Sponsors Decision|0|||
154990993|NCT04732221|559394814|FG004|Extension Period|Sponsors Decision|41|||
154990994|NCT04732221|559394815|FG005|Extension Period|Sponsors Decision|40|||
154990995|NCT04732221|559394816|FG006|Extension Period|Sponsors Decision|40|||
154990996|NCT04732221|559394810|FG000|Extension Period|Withdrawal by Subject|0|||
154990997|NCT04732221|559394811|FG001|Extension Period|Withdrawal by Subject|0|||
154990998|NCT04732221|559394812|FG002|Extension Period|Withdrawal by Subject|0|||
154990999|NCT04732221|559394813|FG003|Extension Period|Withdrawal by Subject|0|||
154991000|NCT04732221|559394814|FG004|Extension Period|Withdrawal by Subject|1|||
154991001|NCT04732221|559394815|FG005|Extension Period|Withdrawal by Subject|5|||
154991002|NCT04732221|559394816|FG006|Extension Period|Withdrawal by Subject|2|||
154991003|NCT00379340|559394821|FG000|Overall Study|Death|0|||
154991004|NCT00379340|559394822|FG001|Overall Study|Death|0|||
154991005|NCT00379340|559394823|FG002|Overall Study|Death|0|||
154991006|NCT00379340|559394824|FG003|Overall Study|Death|2|||
154991007|NCT00379340|559394825|FG004|Overall Study|Death|0|||
154991008|NCT00379340|559394821|FG000|Overall Study|Lack of Efficacy|6|||
154991009|NCT00379340|559394822|FG001|Overall Study|Lack of Efficacy|1|||
154991010|NCT00379340|559394823|FG002|Overall Study|Lack of Efficacy|0|||
154991011|NCT00379340|559394824|FG003|Overall Study|Lack of Efficacy|4|||
154991012|NCT00379340|559394825|FG004|Overall Study|Lack of Efficacy|3|||
154991013|NCT00379340|559394821|FG000|Overall Study|Physician Decision|6|||
154991014|NCT00379340|559394822|FG001|Overall Study|Physician Decision|2|||
154991015|NCT00379340|559394823|FG002|Overall Study|Physician Decision|1|||
154991016|NCT00379340|559394824|FG003|Overall Study|Physician Decision|2|||
154991017|NCT00379340|559394825|FG004|Overall Study|Physician Decision|3|||
154991018|NCT00379340|559394821|FG000|Overall Study|Withdrawal by Subject|0|||
154991019|NCT00379340|559394822|FG001|Overall Study|Withdrawal by Subject|0|||
154991020|NCT00379340|559394823|FG002|Overall Study|Withdrawal by Subject|0|||
154991021|NCT00379340|559394824|FG003|Overall Study|Withdrawal by Subject|1|||
154991022|NCT00379340|559394825|FG004|Overall Study|Withdrawal by Subject|0|||
154991023|NCT00379340|559394821|FG000|Overall Study|Refusal of further protocol therapy|1|||
154991024|NCT00379340|559394822|FG001|Overall Study|Refusal of further protocol therapy|0|||
154991025|NCT00379340|559394823|FG002|Overall Study|Refusal of further protocol therapy|1|||
154991026|NCT00379340|559394824|FG003|Overall Study|Refusal of further protocol therapy|1|||
154991027|NCT00379340|559394825|FG004|Overall Study|Refusal of further protocol therapy|7|||
154991028|NCT00379340|559394821|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
154991029|NCT00379340|559394822|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
154991030|NCT00379340|559394823|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
154991031|NCT00379340|559394824|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
154991032|NCT00379340|559394825|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
154991033|NCT00379340|559394821|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
154991034|NCT00379340|559394822|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
154991035|NCT00379340|559394823|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
154991036|NCT00379340|559394824|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
154991037|NCT00379340|559394825|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
154991038|NCT05327816|559394829|FG000|Overall Study|Lost to Follow-up|1|||
154991039|NCT05327816|559394830|FG001|Overall Study|Lost to Follow-up|0|||
154991040|NCT05327816|559394831|FG002|Overall Study|Lost to Follow-up|0|||
154991041|NCT05327816|559394832|FG003|Overall Study|Lost to Follow-up|0|||
154991042|NCT05327816|559394833|FG004|Overall Study|Lost to Follow-up|0|||
154991043|NCT05327816|559394834|FG005|Overall Study|Lost to Follow-up|0|||
154991044|NCT05327816|559394835|FG006|Overall Study|Lost to Follow-up|0|||
154991045|NCT05327816|559394836|FG007|Overall Study|Lost to Follow-up|0|||
154991046|NCT05327816|559394837|FG008|Overall Study|Lost to Follow-up|0|||
154991047|NCT05327816|559394838|FG009|Overall Study|Lost to Follow-up|1|||
154991048|NCT05327816|559394839|FG010|Overall Study|Lost to Follow-up|0|||
154991049|NCT05327816|559394829|FG000|Overall Study|Withdrawal by Subject|0|||
154991050|NCT05327816|559394830|FG001|Overall Study|Withdrawal by Subject|0|||
154991051|NCT05327816|559394831|FG002|Overall Study|Withdrawal by Subject|0|||
154991052|NCT05327816|559394832|FG003|Overall Study|Withdrawal by Subject|0|||
154991053|NCT05327816|559394833|FG004|Overall Study|Withdrawal by Subject|1|||
154991054|NCT05327816|559394834|FG005|Overall Study|Withdrawal by Subject|1|||
154991055|NCT05327816|559394835|FG006|Overall Study|Withdrawal by Subject|0|||
154991056|NCT05327816|559394836|FG007|Overall Study|Withdrawal by Subject|0|||
154991057|NCT05327816|559394837|FG008|Overall Study|Withdrawal by Subject|0|||
154991058|NCT05327816|559394838|FG009|Overall Study|Withdrawal by Subject|0|||
154991059|NCT05327816|559394839|FG010|Overall Study|Withdrawal by Subject|0|||
154991060|NCT05327816|559394829|FG000|Overall Study|Study Terminated by Sponsor|11|||
154991061|NCT05327816|559394830|FG001|Overall Study|Study Terminated by Sponsor|12|||
154991062|NCT05327816|559394831|FG002|Overall Study|Study Terminated by Sponsor|12|||
154991063|NCT05327816|559394832|FG003|Overall Study|Study Terminated by Sponsor|12|||
154991064|NCT05327816|559394833|FG004|Overall Study|Study Terminated by Sponsor|11|||
154991065|NCT05327816|559394834|FG005|Overall Study|Study Terminated by Sponsor|11|||
154991066|NCT05327816|559394835|FG006|Overall Study|Study Terminated by Sponsor|11|||
154991067|NCT05327816|559394836|FG007|Overall Study|Study Terminated by Sponsor|11|||
154991068|NCT05327816|559394837|FG008|Overall Study|Study Terminated by Sponsor|11|||
154991069|NCT05327816|559394838|FG009|Overall Study|Study Terminated by Sponsor|11|||
154991070|NCT05327816|559394839|FG010|Overall Study|Study Terminated by Sponsor|12|||
154991071|NCT05327816|559394829|FG000|Overall Study|Randomized but not treated|0|||
154991072|NCT05327816|559394830|FG001|Overall Study|Randomized but not treated|0|||
154991073|NCT05327816|559394831|FG002|Overall Study|Randomized but not treated|0|||
154991074|NCT05327816|559394832|FG003|Overall Study|Randomized but not treated|0|||
154991075|NCT05327816|559394833|FG004|Overall Study|Randomized but not treated|0|||
154991076|NCT05327816|559394834|FG005|Overall Study|Randomized but not treated|0|||
154991077|NCT05327816|559394835|FG006|Overall Study|Randomized but not treated|1|||
154991078|NCT05327816|559394836|FG007|Overall Study|Randomized but not treated|1|||
154991079|NCT05327816|559394837|FG008|Overall Study|Randomized but not treated|1|||
154991080|NCT05327816|559394838|FG009|Overall Study|Randomized but not treated|0|||
154991081|NCT05327816|559394839|FG010|Overall Study|Randomized but not treated|0|||
154991082|NCT00658658|559394846|FG000|Overall Study|Withdrawal by Subject|0|||
154991083|NCT00658658|559394847|FG001|Overall Study|Withdrawal by Subject|1|||
154991084|NCT00658658|559394848|FG002|Overall Study|Withdrawal by Subject|0|||
154991085|NCT00658658|559394849|FG003|Overall Study|Withdrawal by Subject|0|||
154991086|NCT00658658|559394850|FG004|Overall Study|Withdrawal by Subject|0|||
154991087|NCT00658658|559394846|FG000|Overall Study|Death|4|||
154991088|NCT00658658|559394847|FG001|Overall Study|Death|0|||
154991089|NCT00658658|559394848|FG002|Overall Study|Death|0|||
154991090|NCT00658658|559394849|FG003|Overall Study|Death|1|||
154991091|NCT00658658|559394850|FG004|Overall Study|Death|1|||
154991092|NCT00658658|559394846|FG000|Overall Study|Disease Progression|0|||
154991093|NCT00658658|559394847|FG001|Overall Study|Disease Progression|1|||
154991094|NCT00658658|559394848|FG002|Overall Study|Disease Progression|0|||
154991095|NCT00658658|559394849|FG003|Overall Study|Disease Progression|1|||
154991096|NCT00658658|559394850|FG004|Overall Study|Disease Progression|3|||
154991097|NCT00658658|559394846|FG000|Overall Study|Protocol-specified Criteria|1|||
154991098|NCT00658658|559394847|FG001|Overall Study|Protocol-specified Criteria|0|||
154991099|NCT00658658|559394848|FG002|Overall Study|Protocol-specified Criteria|0|||
154991100|NCT00658658|559394849|FG003|Overall Study|Protocol-specified Criteria|0|||
154991101|NCT00658658|559394850|FG004|Overall Study|Protocol-specified Criteria|0|||
154991102|NCT00658658|559394846|FG000|Overall Study|Other|0|||
154991103|NCT00658658|559394847|FG001|Overall Study|Other|0|||
154991104|NCT00658658|559394848|FG002|Overall Study|Other|0|||
154991105|NCT00658658|559394849|FG003|Overall Study|Other|0|||
154991106|NCT00658658|559394850|FG004|Overall Study|Other|1|||
154991107|NCT01367665|559394851|FG000|Overall Study|Death|102|||
154991108|NCT01367665|559394852|FG001|Overall Study|Death|19|||
154991109|NCT01367665|559394851|FG000|Overall Study|Lost to Follow-up|222|||
154991110|NCT01367665|559394852|FG001|Overall Study|Lost to Follow-up|22|||
154991111|NCT01367665|559394851|FG000|Overall Study|Not Done|118|||
154991112|NCT01367665|559394852|FG001|Overall Study|Not Done|14|||
154991113|NCT03283319|559394853|FG000|Overall Study|Lost to Follow-up|5|||
154991114|NCT03283319|559394854|FG001|Overall Study|Lost to Follow-up|4|||
154991115|NCT03283319|559394855|FG002|Overall Study|Lost to Follow-up|5|||
154991116|NCT03283319|559394856|FG003|Overall Study|Lost to Follow-up|5|||
154991117|NCT03283319|559394857|FG004|Overall Study|Lost to Follow-up|4|||
154991118|NCT03283319|559394858|FG005|Overall Study|Lost to Follow-up|3|||
154991119|NCT03283319|559394853|FG000|Overall Study|Withdrawal by Subject|2|||
154991120|NCT03283319|559394854|FG001|Overall Study|Withdrawal by Subject|2|||
154991121|NCT03283319|559394855|FG002|Overall Study|Withdrawal by Subject|2|||
154991122|NCT03283319|559394856|FG003|Overall Study|Withdrawal by Subject|1|||
154991123|NCT03283319|559394857|FG004|Overall Study|Withdrawal by Subject|0|||
154991124|NCT03283319|559394858|FG005|Overall Study|Withdrawal by Subject|1|||
154991125|NCT03283319|559394853|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
154991126|NCT03283319|559394854|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
154991127|NCT03283319|559394855|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
154991128|NCT03283319|559394856|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
154991129|NCT03283319|559394857|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
154991130|NCT03283319|559394858|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
154991131|NCT03954834|559394860|FG000|Overall Study|Adverse Event|1|||
154991132|NCT03954834|559394861|FG001|Overall Study|Adverse Event|3|||
154991133|NCT03954834|559394862|FG002|Overall Study|Adverse Event|1|||
154991134|NCT03954834|559394863|FG003|Overall Study|Adverse Event|1|||
154991135|NCT03954834|559394860|FG000|Overall Study|Death|0|||
154991136|NCT03954834|559394861|FG001|Overall Study|Death|0|||
154991137|NCT03954834|559394862|FG002|Overall Study|Death|0|||
154991138|NCT03954834|559394863|FG003|Overall Study|Death|1|||
154991139|NCT03954834|559394860|FG000|Overall Study|Physician Decision|0|||
154991140|NCT03954834|559394861|FG001|Overall Study|Physician Decision|1|||
154991141|NCT03954834|559394862|FG002|Overall Study|Physician Decision|0|||
154991142|NCT03954834|559394863|FG003|Overall Study|Physician Decision|2|||
154991143|NCT03954834|559394860|FG000|Overall Study|Protocol Violation|1|||
154991144|NCT03954834|559394861|FG001|Overall Study|Protocol Violation|0|||
154991145|NCT03954834|559394862|FG002|Overall Study|Protocol Violation|0|||
154991146|NCT03954834|559394863|FG003|Overall Study|Protocol Violation|1|||
154991147|NCT03954834|559394860|FG000|Overall Study|Withdrawal by Subject|2|||
154991148|NCT03954834|559394861|FG001|Overall Study|Withdrawal by Subject|3|||
154991149|NCT03954834|559394862|FG002|Overall Study|Withdrawal by Subject|13|||
154991150|NCT03954834|559394863|FG003|Overall Study|Withdrawal by Subject|6|||
154991151|NCT03954834|559394860|FG000|Overall Study|Participant left the country|0|||
154991152|NCT03954834|559394861|FG001|Overall Study|Participant left the country|0|||
154991153|NCT03954834|559394862|FG002|Overall Study|Participant left the country|1|||
154991154|NCT03954834|559394863|FG003|Overall Study|Participant left the country|0|||
154991155|NCT03954834|559394860|FG000|Overall Study|Lost to Follow-up|3|||
154991156|NCT03954834|559394861|FG001|Overall Study|Lost to Follow-up|2|||
154991157|NCT03954834|559394862|FG002|Overall Study|Lost to Follow-up|3|||
154991158|NCT03954834|559394863|FG003|Overall Study|Lost to Follow-up|5|||
154991159|NCT00754650|559394866|FG000|Overall Study|Disease Progression|2|||
154991160|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
154991161|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
154991162|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
154991163|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
154991164|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
154991165|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
154991166|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
154991167|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
154991168|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
154991169|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
154991170|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
154991171|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
154991172|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
154991173|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
154991174|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
154991175|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
154991176|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
154991177|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
154991178|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
154991179|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
154991180|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
154991181|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
154991182|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
154991183|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
155120667|NCT03028480|559872855|FG000|Overall Study|No revisit after the first prescription date|2|||
154991184|NCT03514641|559394871|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
154991185|NCT03514641|559394872|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
154991186|NCT03514641|559394873|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
154991187|NCT03514641|559394874|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
154991188|NCT03514641|559394871|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
154991189|NCT03514641|559394872|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
154991190|NCT03514641|559394873|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
154991191|NCT03514641|559394874|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
154991192|NCT03514641|559394871|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
154991193|NCT03514641|559394872|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
154991194|NCT03514641|559394873|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
154991195|NCT03514641|559394874|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
154991196|NCT03514641|559394871|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
154991197|NCT03514641|559394872|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
154991198|NCT03514641|559394873|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
154991199|NCT03514641|559394874|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
154991200|NCT03514641|559394871|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
154991201|NCT03514641|559394872|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
154991202|NCT03514641|559394873|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
154991203|NCT03514641|559394874|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
154991204|NCT03514641|559394871|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
154991205|NCT03514641|559394872|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
154991206|NCT03514641|559394873|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
154991207|NCT03514641|559394874|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
154991208|NCT02906930|559394877|FG000|Overall Study|Withdrawal by Subject|0|||
154991209|NCT02906930|559394878|FG001|Overall Study|Withdrawal by Subject|5|||
154991210|NCT02906930|559394879|FG002|Overall Study|Withdrawal by Subject|5|||
154991211|NCT02906930|559394880|FG003|Overall Study|Withdrawal by Subject|4|||
154991212|NCT02906930|559394877|FG000|Overall Study|Lost to Follow-up|5|||
154991213|NCT02906930|559394878|FG001|Overall Study|Lost to Follow-up|7|||
154991214|NCT02906930|559394879|FG002|Overall Study|Lost to Follow-up|5|||
154991215|NCT02906930|559394880|FG003|Overall Study|Lost to Follow-up|2|||
154991216|NCT02906930|559394877|FG000|Overall Study|Death|0|||
154991217|NCT02906930|559394878|FG001|Overall Study|Death|0|||
154991218|NCT02906930|559394879|FG002|Overall Study|Death|1|||
154991219|NCT02906930|559394880|FG003|Overall Study|Death|0|||
154991220|NCT02906930|559394877|FG000|Overall Study|Other|1|||
154991221|NCT02906930|559394878|FG001|Overall Study|Other|2|||
154991222|NCT02906930|559394879|FG002|Overall Study|Other|1|||
154991223|NCT02906930|559394880|FG003|Overall Study|Other|2|||
154991224|NCT04234984|559394890|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
154991225|NCT04234984|559394890|FG000|Follow-up at the Second Time Point|Death|1|||
154991226|NCT04234984|559394890|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
154991227|NCT02570113|559394891|FG000|Overall Study|Withdrawal by Subject|3|||
154991228|NCT02564211|559394892|FG000|Overall Study|Adverse Event|4|||
154991229|NCT00910091|559394894|FG000|Pre-assignment|Withdrawal by Subject|0|||
154991230|NCT00910091|559394895|FG001|Pre-assignment|Withdrawal by Subject|2|||
154991231|NCT00910091|559394894|FG000|Treatment and Survival|Withdrawal by Subject|3|||
154991232|NCT00910091|559394895|FG001|Treatment and Survival|Withdrawal by Subject|4|||
154991233|NCT00910091|559394894|FG000|Treatment and Survival|Adverse Event|1|||
154991234|NCT00910091|559394895|FG001|Treatment and Survival|Adverse Event|0|||
154991235|NCT01908816|559394896|FG000|Overall Study|Subject's no longer requires study drug|0|||
154991236|NCT01908816|559394897|FG001|Overall Study|Subject's no longer requires study drug|0|||
154991237|NCT01908816|559394898|FG002|Overall Study|Subject's no longer requires study drug|0|||
154991238|NCT01908816|559394899|FG003|Overall Study|Subject's no longer requires study drug|1|||
154991239|NCT01908816|559394896|FG000|Overall Study|Protocol deviation|1|||
154991240|NCT01908816|559394897|FG001|Overall Study|Protocol deviation|2|||
154991241|NCT01908816|559394898|FG002|Overall Study|Protocol deviation|1|||
154991242|NCT01908816|559394899|FG003|Overall Study|Protocol deviation|1|||
154991243|NCT01908816|559394896|FG000|Overall Study|Withdrawal by Subject|0|||
154991244|NCT01908816|559394897|FG001|Overall Study|Withdrawal by Subject|4|||
154991245|NCT01908816|559394898|FG002|Overall Study|Withdrawal by Subject|2|||
154991246|NCT01908816|559394899|FG003|Overall Study|Withdrawal by Subject|2|||
154991247|NCT01908816|559394896|FG000|Overall Study|Lost to Follow-up|3|||
154991248|NCT01908816|559394897|FG001|Overall Study|Lost to Follow-up|5|||
154991249|NCT01908816|559394898|FG002|Overall Study|Lost to Follow-up|4|||
154991250|NCT01908816|559394899|FG003|Overall Study|Lost to Follow-up|2|||
154991251|NCT01908816|559394896|FG000|Overall Study|Death|1|||
154991252|NCT01908816|559394897|FG001|Overall Study|Death|0|||
154991253|NCT01908816|559394898|FG002|Overall Study|Death|7|||
154991254|NCT01908816|559394899|FG003|Overall Study|Death|1|||
155177295|NCT00171834|560088213|FG004|Overall Study|Death from study indication|1|||
154991255|NCT01908816|559394896|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155177296|NCT00171834|560088214|FG005|Overall Study|Death from study indication|0|||
155177297|NCT00171834|560088215|FG006|Overall Study|Death from study indication|0|||
155177298|NCT00171834|560088209|FG000|Overall Study|Disease Progression|4|||
155177299|NCT00171834|560088210|FG001|Overall Study|Disease Progression|8|||
155177300|NCT00171834|560088211|FG002|Overall Study|Disease Progression|8|||
155177301|NCT00171834|560088212|FG003|Overall Study|Disease Progression|9|||
155177302|NCT00171834|560088213|FG004|Overall Study|Disease Progression|2|||
155177303|NCT00171834|560088214|FG005|Overall Study|Disease Progression|18|||
155177304|NCT00171834|560088215|FG006|Overall Study|Disease Progression|3|||
155177305|NCT00171834|560088209|FG000|Overall Study|Treatment Duration Completed|0|||
155177306|NCT00171834|560088210|FG001|Overall Study|Treatment Duration Completed|0|||
155177307|NCT00171834|560088211|FG002|Overall Study|Treatment Duration Completed|1|||
155177308|NCT00171834|560088212|FG003|Overall Study|Treatment Duration Completed|0|||
155177309|NCT00171834|560088213|FG004|Overall Study|Treatment Duration Completed|2|||
155120668|NCT03028480|559872855|FG000|Overall Study|Did not use the drug|1|||
155120669|NCT03028480|559872855|FG000|Overall Study|Violation of the enrollment deadline|10|||
155120670|NCT03028480|559872855|FG000|Overall Study|Case report forms were not collected|21|||
155120671|NCT01030874|559872858|FG000|Overall Study|Withdrawal by Subject|1|||
155120672|NCT01030874|559872859|FG001|Overall Study|Withdrawal by Subject|0|||
155120673|NCT01030874|559872858|FG000|Overall Study|Discharged in first 2 weeks|17|||
155120674|NCT01030874|559872859|FG001|Overall Study|Discharged in first 2 weeks|16|||
155120675|NCT02403635|559872863|FG000|Overall Study|Not eligible|9|||
155120676|NCT03554772|559872866|FG000|Overall Study|Lost to Follow-up|0|||
155120677|NCT03554772|559872867|FG001|Overall Study|Lost to Follow-up|0|||
155120678|NCT03554772|559872868|FG002|Overall Study|Lost to Follow-up|0|||
155177310|NCT00171834|560088214|FG005|Overall Study|Treatment Duration Completed|1|||
155177311|NCT00171834|560088215|FG006|Overall Study|Treatment Duration Completed|0|||
155177312|NCT01284491|560088218|FG000|Overall Study|Study termination|13|||
155177313|NCT01978938|560088219|FG000|Overall Study|Lost to Follow-up|12|||
155177314|NCT01978938|560088220|FG001|Overall Study|Lost to Follow-up|6|||
155177315|NCT01978938|560088219|FG000|Overall Study|Withdrawal by Subject|8|||
155177316|NCT01978938|560088220|FG001|Overall Study|Withdrawal by Subject|4|||
155177317|NCT01978938|560088219|FG000|Overall Study|Adverse Event, non-fatal|2|||
155177318|NCT01978938|560088220|FG001|Overall Study|Adverse Event, non-fatal|1|||
155177319|NCT01978938|560088219|FG000|Overall Study|Participant noncompliance|1|||
155177320|NCT01978938|560088220|FG001|Overall Study|Participant noncompliance|1|||
155177321|NCT01978938|560088219|FG000|Overall Study|Did not meet inclusion criteria|0|||
155120679|NCT03554772|559872869|FG003|Overall Study|Lost to Follow-up|2|||
155120680|NCT03362931|559872871|FG000|Overall Study|Adverse Event|1|||
155120681|NCT03362931|559872871|FG000|Overall Study|Death|2|||
155120682|NCT01998893|559872872|FG000|Overall Study|Adverse Event|2|||
155120683|NCT01998893|559872872|FG000|Overall Study|Death|1|||
155120684|NCT01998893|559872872|FG000|Overall Study|Lost to Follow-up|8|||
155120685|NCT01998893|559872872|FG000|Overall Study|Physician Decision|2|||
155120686|NCT01998893|559872872|FG000|Overall Study|Protocol Violation|2|||
155120687|NCT01998893|559872872|FG000|Overall Study|Withdrawal by Subject|1|||
155120688|NCT01998893|559872872|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
155120689|NCT05136898|559872877|FG000|Overall Study|Adverse Event|2|||
155120690|NCT01133405|559872878|FG000|Period 1|Withdrawal by Subject|0|||
155120691|NCT01133405|559872879|FG001|Period 1|Withdrawal by Subject|1|||
155120692|NCT01133405|559872880|FG002|Period 1|Withdrawal by Subject|0|||
155120693|NCT01133405|559872881|FG003|Period 1|Withdrawal by Subject|1|||
155120694|NCT01133405|559872882|FG004|Period 1|Withdrawal by Subject|0|||
155177322|NCT01978938|560088220|FG001|Overall Study|Did not meet inclusion criteria|1|||
154991256|NCT01908816|559394897|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
154991257|NCT01908816|559394898|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
154991258|NCT01908816|559394899|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
154991259|NCT01908816|559394896|FG000|Overall Study|Early termination|87|||
154991260|NCT01908816|559394897|FG001|Overall Study|Early termination|60|||
154991261|NCT01908816|559394898|FG002|Overall Study|Early termination|43|||
154991262|NCT01908816|559394899|FG003|Overall Study|Early termination|28|||
154991263|NCT01007942|559394901|FG000|Overall Study|Adverse Event|29|||
154991264|NCT01007942|559394902|FG001|Overall Study|Adverse Event|14|||
154991265|NCT01007942|559394901|FG000|Overall Study|Abnormal test procedure|0|||
154991266|NCT01007942|559394902|FG001|Overall Study|Abnormal test procedure|1|||
155120695|NCT01133405|559872883|FG005|Period 1|Withdrawal by Subject|1|||
155120696|NCT01133405|559872884|FG006|Period 1|Withdrawal by Subject|0|||
155120697|NCT01133405|559872885|FG007|Period 1|Withdrawal by Subject|0|||
155120698|NCT01133405|559872886|FG008|Period 1|Withdrawal by Subject|0|||
155177323|NCT01978938|560088219|FG000|Overall Study|Previously scheduled procedure|0|||
154991267|NCT01007942|559394901|FG000|Overall Study|Disease progression|217|||
155120699|NCT01133405|559872887|FG009|Period 1|Withdrawal by Subject|0|||
155120700|NCT01133405|559872878|FG000|Period 1|Physician Decision|0|||
155177324|NCT01978938|560088220|FG001|Overall Study|Previously scheduled procedure|1|||
155120701|NCT01133405|559872879|FG001|Period 1|Physician Decision|0|||
155120702|NCT01133405|559872880|FG002|Period 1|Physician Decision|0|||
155120703|NCT01133405|559872881|FG003|Period 1|Physician Decision|1|||
154991268|NCT01007942|559394902|FG001|Overall Study|Disease progression|242|||
154991269|NCT01007942|559394901|FG000|Overall Study|New cancer therapy|5|||
154991270|NCT01007942|559394902|FG001|Overall Study|New cancer therapy|1|||
154991271|NCT01007942|559394901|FG000|Overall Study|Protocol Violation|1|||
154991272|NCT01007942|559394902|FG001|Overall Study|Protocol Violation|1|||
154991273|NCT01007942|559394901|FG000|Overall Study|Withdrawal by Subject|19|||
154991274|NCT01007942|559394902|FG001|Overall Study|Withdrawal by Subject|14|||
154991275|NCT01007942|559394901|FG000|Overall Study|Lost to Follow-up|1|||
154991276|NCT01007942|559394902|FG001|Overall Study|Lost to Follow-up|0|||
154991277|NCT01007942|559394901|FG000|Overall Study|Administrative problems|2|||
154991278|NCT01007942|559394902|FG001|Overall Study|Administrative problems|0|||
154991279|NCT01007942|559394901|FG000|Overall Study|Death|3|||
154991280|NCT01007942|559394902|FG001|Overall Study|Death|2|||
154991281|NCT01007942|559394901|FG000|Overall Study|Patients untreated|4|||
154991282|NCT01007942|559394902|FG001|Overall Study|Patients untreated|3|||
154991283|NCT04492020|559394903|FG000|Overall Study|Adverse Event|1|||
154991284|NCT04492020|559394904|FG001|Overall Study|Adverse Event|3|||
154991285|NCT04492020|559394903|FG000|Overall Study|Withdrawal by Subject|4|||
154991286|NCT04492020|559394904|FG001|Overall Study|Withdrawal by Subject|3|||
154991287|NCT04492020|559394903|FG000|Overall Study|Lost to Follow-up|4|||
154991288|NCT04492020|559394904|FG001|Overall Study|Lost to Follow-up|3|||
154991289|NCT04492020|559394903|FG000|Overall Study|Protocol Violation|5|||
154991290|NCT04492020|559394904|FG001|Overall Study|Protocol Violation|2|||
154991291|NCT04492020|559394903|FG000|Overall Study|Lack of Qualifying Event|25|||
154991292|NCT04492020|559394904|FG001|Overall Study|Lack of Qualifying Event|27|||
154991293|NCT04492020|559394903|FG000|Overall Study|Non-compliance with Study Drug|2|||
154991294|NCT04492020|559394904|FG001|Overall Study|Non-compliance with Study Drug|1|||
154991295|NCT04594707|559394905|FG000|Overall Study|Adverse Event|0|||
154991296|NCT04594707|559394906|FG001|Overall Study|Adverse Event|0|||
154991297|NCT04594707|559394907|FG002|Overall Study|Adverse Event|1|||
154991298|NCT04594707|559394905|FG000|Overall Study|Death|0|||
154991299|NCT04594707|559394906|FG001|Overall Study|Death|2|||
154991300|NCT04594707|559394907|FG002|Overall Study|Death|2|||
154991301|NCT04594707|559394905|FG000|Overall Study|Lung Transplant|0|||
154991302|NCT04594707|559394906|FG001|Overall Study|Lung Transplant|0|||
154991303|NCT04594707|559394907|FG002|Overall Study|Lung Transplant|1|||
154991304|NCT04594707|559394905|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
154991305|NCT04594707|559394906|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
154991306|NCT04594707|559394907|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
154991307|NCT04594707|559394905|FG000|Overall Study|Study Terminated By Sponsor|19|||
154991308|NCT04594707|559394906|FG001|Overall Study|Study Terminated By Sponsor|47|||
154991309|NCT04594707|559394907|FG002|Overall Study|Study Terminated By Sponsor|41|||
154991310|NCT04594707|559394905|FG000|Overall Study|Withdrawal by Subject|1|||
154991311|NCT04594707|559394906|FG001|Overall Study|Withdrawal by Subject|0|||
154991312|NCT04594707|559394907|FG002|Overall Study|Withdrawal by Subject|2|||
154991313|NCT04585789|559394908|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
154991314|NCT04585789|559394909|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
154991315|NCT04585789|559394910|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
154991316|NCT04585789|559394908|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
154991317|NCT04585789|559394909|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
154991318|NCT04585789|559394910|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
154991319|NCT01175811|559394911|FG000|Overall Study|Adverse Event|1|||
154991320|NCT01175811|559394912|FG001|Overall Study|Adverse Event|1|||
154991321|NCT01175811|559394911|FG000|Overall Study|Entry criteria not met|3|||
155120704|NCT01133405|559872882|FG004|Period 1|Physician Decision|0|||
155120705|NCT01133405|559872883|FG005|Period 1|Physician Decision|0|||
155120706|NCT01133405|559872884|FG006|Period 1|Physician Decision|0|||
155120707|NCT01133405|559872885|FG007|Period 1|Physician Decision|0|||
155120708|NCT01133405|559872886|FG008|Period 1|Physician Decision|0|||
155120709|NCT01133405|559872887|FG009|Period 1|Physician Decision|0|||
155120710|NCT01133405|559872878|FG000|Period 1|Discontinued after randomization|1|||
155120711|NCT01133405|559872879|FG001|Period 1|Discontinued after randomization|0|||
155120712|NCT01133405|559872880|FG002|Period 1|Discontinued after randomization|0|||
155120713|NCT01133405|559872881|FG003|Period 1|Discontinued after randomization|0|||
155120714|NCT01133405|559872882|FG004|Period 1|Discontinued after randomization|0|||
155177325|NCT02694757|560088221|FG000|Overall Study|Lack of Efficacy|3|||
154991322|NCT01175811|559394912|FG001|Overall Study|Entry criteria not met|1|||
154991323|NCT01175811|559394911|FG000|Overall Study|Lack of Efficacy|1|||
154991324|NCT01175811|559394912|FG001|Overall Study|Lack of Efficacy|0|||
154991325|NCT01175811|559394911|FG000|Overall Study|Lost to Follow-up|3|||
154991326|NCT01175811|559394912|FG001|Overall Study|Lost to Follow-up|2|||
155120715|NCT01133405|559872883|FG005|Period 1|Discontinued after randomization|0|||
154991327|NCT01175811|559394911|FG000|Overall Study|Physician Decision|1|||
154991328|NCT01175811|559394912|FG001|Overall Study|Physician Decision|1|||
154991329|NCT01175811|559394911|FG000|Overall Study|Protocol Violation|1|||
154991330|NCT01175811|559394912|FG001|Overall Study|Protocol Violation|2|||
155120716|NCT01133405|559872884|FG006|Period 1|Discontinued after randomization|1|||
154991331|NCT01175811|559394911|FG000|Overall Study|Withdrawal by Subject|6|||
154991332|NCT01175811|559394912|FG001|Overall Study|Withdrawal by Subject|7|||
154991333|NCT02628743|559394914|FG000|Overall Study|Other|3|||
154991334|NCT02628743|559394914|FG000|Overall Study|Withdrawal by Subject|50|||
154991335|NCT02628743|559394914|FG000|Overall Study|Study Terminated by Sponsor|76|||
154991336|NCT02628743|559394914|FG000|Overall Study|Physician Decision|2|||
154991337|NCT00655876|559394915|FG000|Overall Study|Protocol Violation|9|||
154991338|NCT00655876|559394916|FG001|Overall Study|Protocol Violation|7|||
154991339|NCT00326963|559394917|FG000|Overall Study|Adverse Event|2|||
154991340|NCT00326963|559394917|FG000|Overall Study|Injection site reaction|1|||
154991341|NCT00326963|559394917|FG000|Overall Study|Death|1|||
154991342|NCT00326963|559394917|FG000|Overall Study|Failure to return|10|||
154991343|NCT00326963|559394917|FG000|Overall Study|Withdrawal by Subject|10|||
154991344|NCT00326963|559394917|FG000|Overall Study|Refused treatment / did not cooperate|5|||
154991345|NCT00326963|559394917|FG000|Overall Study|Violation of selection criteria at entry|2|||
154991346|NCT00326963|559394917|FG000|Overall Study|Other protocol violation|1|||
154991347|NCT00326963|559394917|FG000|Overall Study|Administrative / other|1|||
154991348|NCT00552578|559394921|FG000|Overall Study|Lost to Follow-up|1|||
154991349|NCT00552578|559394922|FG001|Overall Study|Lost to Follow-up|1|||
154991350|NCT04091659|559394924|FG000|Overall Study|Protocol Violation|3|||
154991351|NCT04091659|559394925|FG001|Overall Study|Protocol Violation|0|||
154991352|NCT04091659|559394924|FG000|Overall Study|Lost to Follow-up|0|||
154991353|NCT04091659|559394925|FG001|Overall Study|Lost to Follow-up|1|||
154991354|NCT03678285|559394926|FG000|Overall Study|Adverse Event|2|||
154991355|NCT03678285|559394926|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
154991356|NCT03678285|559394926|FG000|Overall Study|Dehydrated prior to start of workout|1|||
154991357|NCT00123474|559394927|FG000|Randomized to Treatment|Randomized, never treated|1|||
154991358|NCT00123474|559394928|FG001|Randomized to Treatment|Randomized, never treated|4|||
154991359|NCT00123474|559394929|FG002|Randomized to Treatment|Randomized, never treated|2|||
154991360|NCT00123474|559394930|FG003|Randomized to Treatment|Randomized, never treated|1|||
154991361|NCT00123474|559394927|FG000|As Treated at Study Closure|not reported when site closed|1|||
154991362|NCT00123474|559394928|FG001|As Treated at Study Closure|not reported when site closed|0|||
154991363|NCT00123474|559394929|FG002|As Treated at Study Closure|not reported when site closed|1|||
154991364|NCT00123474|559394930|FG003|As Treated at Study Closure|not reported when site closed|0|||
154991365|NCT00123474|559394927|FG000|As Treated at Study Closure|Adverse Event|10|||
154991366|NCT00123474|559394928|FG001|As Treated at Study Closure|Adverse Event|4|||
154991367|NCT00123474|559394929|FG002|As Treated at Study Closure|Adverse Event|10|||
154991368|NCT00123474|559394930|FG003|As Treated at Study Closure|Adverse Event|8|||
154991369|NCT00123474|559394927|FG000|As Treated at Study Closure|Disease Progression|35|||
154991370|NCT00123474|559394928|FG001|As Treated at Study Closure|Disease Progression|42|||
154991371|NCT00123474|559394929|FG002|As Treated at Study Closure|Disease Progression|29|||
154991372|NCT00123474|559394930|FG003|As Treated at Study Closure|Disease Progression|27|||
154991373|NCT00123474|559394927|FG000|As Treated at Study Closure|Investigator Request|12|||
154991374|NCT00123474|559394928|FG001|As Treated at Study Closure|Investigator Request|6|||
154991375|NCT00123474|559394929|FG002|As Treated at Study Closure|Investigator Request|7|||
154991376|NCT00123474|559394930|FG003|As Treated at Study Closure|Investigator Request|5|||
154991377|NCT00123474|559394927|FG000|As Treated at Study Closure|non-specified|54|||
154991378|NCT00123474|559394928|FG001|As Treated at Study Closure|non-specified|47|||
154991379|NCT00123474|559394929|FG002|As Treated at Study Closure|non-specified|57|||
154991380|NCT00123474|559394930|FG003|As Treated at Study Closure|non-specified|60|||
154991381|NCT00123474|559394927|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
154991382|NCT00123474|559394928|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
154991383|NCT00123474|559394929|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
154991384|NCT00123474|559394930|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
154991385|NCT00123474|559394927|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
154991386|NCT00123474|559394928|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
154991387|NCT00123474|559394929|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
154991388|NCT00123474|559394930|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
154991389|NCT00616629|559394931|FG000|Overall Study|Protocol Violation|1|||
154991390|NCT00616629|559394932|FG001|Overall Study|Protocol Violation|2|||
154991391|NCT00616629|559394933|FG002|Overall Study|Protocol Violation|1|||
154991392|NCT00616629|559394934|FG003|Overall Study|Protocol Violation|0|||
154991393|NCT00616629|559394935|FG004|Overall Study|Protocol Violation|0|||
154991394|NCT00616629|559394931|FG000|Overall Study|AV-block|1|||
154991395|NCT00616629|559394932|FG001|Overall Study|AV-block|0|||
154991396|NCT00616629|559394933|FG002|Overall Study|AV-block|0|||
154991397|NCT00616629|559394934|FG003|Overall Study|AV-block|0|||
154991398|NCT00616629|559394935|FG004|Overall Study|AV-block|0|||
154991399|NCT01085201|559394938|FG000|Overall Study|Scheduling conflict|1|||
154991400|NCT01085201|559394939|FG001|Overall Study|Scheduling conflict|0|||
154991401|NCT01085201|559394940|FG002|Overall Study|Scheduling conflict|1|||
154991402|NCT01085201|559394941|FG003|Overall Study|Scheduling conflict|0|||
154991403|NCT01085201|559394942|FG004|Overall Study|Scheduling conflict|0|||
154991404|NCT01085201|559394938|FG000|Overall Study|Unknown- no study drug|2|||
154991405|NCT01085201|559394939|FG001|Overall Study|Unknown- no study drug|0|||
154991406|NCT01085201|559394940|FG002|Overall Study|Unknown- no study drug|0|||
154991407|NCT01085201|559394941|FG003|Overall Study|Unknown- no study drug|0|||
154991408|NCT01085201|559394942|FG004|Overall Study|Unknown- no study drug|0|||
154991409|NCT01085201|559394938|FG000|Overall Study|Fond ineligible after consent|0|||
154991410|NCT01085201|559394939|FG001|Overall Study|Fond ineligible after consent|1|||
154991411|NCT01085201|559394940|FG002|Overall Study|Fond ineligible after consent|1|||
154991412|NCT01085201|559394941|FG003|Overall Study|Fond ineligible after consent|0|||
154991413|NCT01085201|559394942|FG004|Overall Study|Fond ineligible after consent|0|||
154991414|NCT00528411|559394943|FG000|Overall Study|Adverse Event|4|||
154991415|NCT00528411|559394944|FG001|Overall Study|Adverse Event|0|||
154991416|NCT00528411|559394945|FG002|Overall Study|Adverse Event|1|||
154991417|NCT00528411|559394943|FG000|Overall Study|Incorrect Enrolment|1|||
154991418|NCT00528411|559394944|FG001|Overall Study|Incorrect Enrolment|1|||
154991419|NCT00528411|559394945|FG002|Overall Study|Incorrect Enrolment|0|||
154991420|NCT00528411|559394943|FG000|Overall Study|Severe non-compliance to protocol|0|||
154991421|NCT00528411|559394944|FG001|Overall Study|Severe non-compliance to protocol|1|||
154991422|NCT00528411|559394945|FG002|Overall Study|Severe non-compliance to protocol|0|||
154991423|NCT00528411|559394943|FG000|Overall Study|Prior commitment medication|0|||
154991424|NCT00528411|559394944|FG001|Overall Study|Prior commitment medication|1|||
154991425|NCT00528411|559394945|FG002|Overall Study|Prior commitment medication|0|||
154991426|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
154991427|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
154991428|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
154991429|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
154991430|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
154991431|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
154991432|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
154991433|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
154991434|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
154991435|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991436|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
154991437|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991438|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991439|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991440|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991441|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991442|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991443|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
154991444|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991445|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
154991446|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991447|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
154991448|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991449|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991450|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991451|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991452|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991453|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991454|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
154991455|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991456|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
154991457|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991458|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991459|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991460|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991461|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
154991462|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
155120717|NCT01133405|559872885|FG007|Period 1|Discontinued after randomization|0|||
155120718|NCT01133405|559872886|FG008|Period 1|Discontinued after randomization|0|||
155120719|NCT01133405|559872887|FG009|Period 1|Discontinued after randomization|0|||
155120720|NCT01133405|559872878|FG000|Period 1|Received drug only in period 2|0|||
155120721|NCT01133405|559872879|FG001|Period 1|Received drug only in period 2|1|||
155120722|NCT01133405|559872880|FG002|Period 1|Received drug only in period 2|0|||
155120723|NCT01133405|559872881|FG003|Period 1|Received drug only in period 2|2|||
155120724|NCT01133405|559872882|FG004|Period 1|Received drug only in period 2|0|||
155120725|NCT01133405|559872883|FG005|Period 1|Received drug only in period 2|1|||
155120726|NCT01133405|559872884|FG006|Period 1|Received drug only in period 2|0|||
155120727|NCT01133405|559872885|FG007|Period 1|Received drug only in period 2|0|||
155120728|NCT01133405|559872886|FG008|Period 1|Received drug only in period 2|0|||
154991463|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
154991464|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
154991465|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991466|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
154991467|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991468|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991469|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991470|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991471|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991472|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
154991473|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991474|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991475|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991476|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991477|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991478|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991479|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
154991480|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991481|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991482|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991483|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
155120729|NCT01133405|559872887|FG009|Period 1|Received drug only in period 2|0|||
155120730|NCT01133405|559872878|FG000|Period 1|Received drug only in period 3|0|||
155120731|NCT01133405|559872879|FG001|Period 1|Received drug only in period 3|1|||
155120732|NCT01133405|559872880|FG002|Period 1|Received drug only in period 3|1|||
154991484|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991485|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991486|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991487|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991488|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991489|NCT03893565|559394946|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
154991490|NCT03893565|559394947|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
154991491|NCT03893565|559394948|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
154991492|NCT03893565|559394949|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
154991493|NCT03893565|559394950|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
154991494|NCT03893565|559394951|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
154991495|NCT03893565|559394952|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
154991496|NCT03893565|559394953|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
154991497|NCT03893565|559394954|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
154991498|NCT03893565|559394946|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
154991499|NCT03893565|559394947|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
154991500|NCT03893565|559394948|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
154991501|NCT03893565|559394949|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
154991502|NCT03893565|559394950|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
154991503|NCT03893565|559394951|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
154991504|NCT03893565|559394952|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
154991505|NCT03893565|559394953|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
154991506|NCT03893565|559394954|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
154991507|NCT03893565|559394946|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991508|NCT03893565|559394947|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991509|NCT03893565|559394948|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991510|NCT03893565|559394949|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991511|NCT03893565|559394950|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991512|NCT03893565|559394951|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991513|NCT03893565|559394952|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
154991514|NCT03893565|559394953|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991515|NCT03893565|559394954|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
154991516|NCT03893565|559394946|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
154991517|NCT03893565|559394947|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
154991518|NCT03893565|559394948|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
154991519|NCT03893565|559394949|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
155120733|NCT01133405|559872881|FG003|Period 1|Received drug only in period 3|0|||
154991520|NCT03893565|559394950|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
154991521|NCT03893565|559394951|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
154991522|NCT03893565|559394952|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
154991523|NCT03893565|559394953|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
154991524|NCT03893565|559394954|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
154991525|NCT03893565|559394946|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
154991526|NCT03893565|559394947|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
154991527|NCT03893565|559394948|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
154991528|NCT03893565|559394949|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
154991529|NCT03893565|559394950|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
154991530|NCT03893565|559394951|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
154991531|NCT03893565|559394952|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
154991532|NCT03893565|559394953|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
154991533|NCT03893565|559394954|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
154991534|NCT03893565|559394946|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991535|NCT03893565|559394947|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991536|NCT03893565|559394948|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991537|NCT03893565|559394949|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991538|NCT03893565|559394950|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991539|NCT03893565|559394951|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991540|NCT03893565|559394952|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991541|NCT03893565|559394953|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
154991542|NCT03893565|559394954|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
154991543|NCT03893565|559394946|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991544|NCT03893565|559394947|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991545|NCT03893565|559394948|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991546|NCT03893565|559394949|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991547|NCT03893565|559394950|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991548|NCT03893565|559394951|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991549|NCT03893565|559394952|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991550|NCT03893565|559394953|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
154991551|NCT03893565|559394954|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
154991552|NCT03893565|559394946|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991553|NCT03893565|559394947|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991554|NCT03893565|559394948|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991555|NCT03893565|559394949|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991556|NCT03893565|559394950|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991557|NCT03893565|559394951|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991558|NCT03893565|559394952|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991559|NCT03893565|559394953|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
154991560|NCT03893565|559394954|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
154991561|NCT03893565|559394946|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991562|NCT03893565|559394947|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991563|NCT03893565|559394948|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991564|NCT03893565|559394949|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991565|NCT03893565|559394950|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991566|NCT03893565|559394951|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991567|NCT03893565|559394952|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991568|NCT03893565|559394953|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
154991569|NCT03893565|559394954|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
154991570|NCT05005312|559394955|FG000|Overall Study|Enrolled, but not treated|0|||
154991571|NCT05005312|559394956|FG001|Overall Study|Enrolled, but not treated|1|||
154991572|NCT01283035|559394957|FG000|Overall Study|Subject later found ineligible|1|||
154991573|NCT00851318|559394958|FG000|Overall Study|Withdrawal by Subject|7|||
154991574|NCT00851318|559394959|FG001|Overall Study|Withdrawal by Subject|1|||
154991575|NCT00851318|559394960|FG002|Overall Study|Withdrawal by Subject|5|||
154991576|NCT00851318|559394961|FG003|Overall Study|Withdrawal by Subject|3|||
154991577|NCT00851318|559394958|FG000|Overall Study|Adverse Event|13|||
154991578|NCT00851318|559394959|FG001|Overall Study|Adverse Event|2|||
155120734|NCT01133405|559872882|FG004|Period 1|Received drug only in period 3|0|||
155120735|NCT01133405|559872883|FG005|Period 1|Received drug only in period 3|0|||
155120736|NCT01133405|559872884|FG006|Period 1|Received drug only in period 3|0|||
155120737|NCT01133405|559872885|FG007|Period 1|Received drug only in period 3|0|||
154991579|NCT00851318|559394960|FG002|Overall Study|Adverse Event|9|||
154991580|NCT00851318|559394961|FG003|Overall Study|Adverse Event|12|||
154991581|NCT00851318|559394958|FG000|Overall Study|Pregnancy|0|||
154991582|NCT00851318|559394959|FG001|Overall Study|Pregnancy|0|||
154991583|NCT00851318|559394960|FG002|Overall Study|Pregnancy|1|||
154991584|NCT00851318|559394961|FG003|Overall Study|Pregnancy|1|||
154991585|NCT00851318|559394958|FG000|Overall Study|Lack of Efficacy|8|||
154991586|NCT00851318|559394959|FG001|Overall Study|Lack of Efficacy|2|||
154991587|NCT00851318|559394960|FG002|Overall Study|Lack of Efficacy|4|||
154991588|NCT00851318|559394961|FG003|Overall Study|Lack of Efficacy|2|||
154991589|NCT00851318|559394958|FG000|Overall Study|Non-compliance with Study Procedures|2|||
154991590|NCT00851318|559394959|FG001|Overall Study|Non-compliance with Study Procedures|0|||
154991591|NCT00851318|559394960|FG002|Overall Study|Non-compliance with Study Procedures|1|||
154991592|NCT00851318|559394961|FG003|Overall Study|Non-compliance with Study Procedures|0|||
154991593|NCT00851318|559394958|FG000|Overall Study|Physician Decision|0|||
154991594|NCT00851318|559394959|FG001|Overall Study|Physician Decision|0|||
154991595|NCT00851318|559394960|FG002|Overall Study|Physician Decision|1|||
154991596|NCT00851318|559394961|FG003|Overall Study|Physician Decision|1|||
154991597|NCT02695537|559394971|FG000|Overall Study|Adverse Event|3|||
154991598|NCT02695537|559394971|FG000|Overall Study|Lack of Efficacy|28|||
154991599|NCT02695537|559394971|FG000|Overall Study|Withdrawal by Subject|4|||
154991600|NCT02695537|559394971|FG000|Overall Study|Protocol Violation|3|||
154991601|NCT02792699|559394972|FG000|Overall Study|Adverse Event|1|||
154991602|NCT02792699|559394973|FG001|Overall Study|Adverse Event|2|||
154991603|NCT02792699|559394974|FG002|Overall Study|Adverse Event|4|||
154991604|NCT02792699|559394972|FG000|Overall Study|Withdrawal by Subject|4|||
154991605|NCT02792699|559394973|FG001|Overall Study|Withdrawal by Subject|4|||
154991606|NCT02792699|559394974|FG002|Overall Study|Withdrawal by Subject|3|||
154991607|NCT02792699|559394972|FG000|Overall Study|Lost to Follow-up|0|||
154991608|NCT02792699|559394973|FG001|Overall Study|Lost to Follow-up|1|||
154991609|NCT02792699|559394974|FG002|Overall Study|Lost to Follow-up|2|||
154991610|NCT02792699|559394972|FG000|Overall Study|Physician Decision|2|||
154991611|NCT02792699|559394973|FG001|Overall Study|Physician Decision|0|||
154991612|NCT02792699|559394974|FG002|Overall Study|Physician Decision|0|||
154991613|NCT02792699|559394972|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
154991614|NCT02792699|559394973|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
154991615|NCT02792699|559394974|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
154991616|NCT02792699|559394972|FG000|Overall Study|Other|1|||
154991617|NCT02792699|559394973|FG001|Overall Study|Other|0|||
154991618|NCT02792699|559394974|FG002|Overall Study|Other|0|||
154991619|NCT01715571|559394977|FG000|Overall Study|Lost to Follow-up|8|||
154991620|NCT03870477|559394980|FG000|Overall Study|Early Study Termination|1|||
154991621|NCT02256436|559394989|FG000|Overall Study|Adverse Event|9|||
154991622|NCT02256436|559394990|FG001|Overall Study|Adverse Event|14|||
154991623|NCT02256436|559394989|FG000|Overall Study|Death|216|||
154991624|NCT02256436|559394990|FG001|Overall Study|Death|208|||
154991625|NCT02256436|559394989|FG000|Overall Study|Lost to Follow-up|1|||
154991626|NCT02256436|559394990|FG001|Overall Study|Lost to Follow-up|2|||
154991627|NCT02256436|559394989|FG000|Overall Study|Physician Decision|1|||
154991628|NCT02256436|559394990|FG001|Overall Study|Physician Decision|0|||
154991629|NCT02256436|559394989|FG000|Overall Study|Protocol Violation|0|||
154991630|NCT02256436|559394990|FG001|Overall Study|Protocol Violation|1|||
154991631|NCT02256436|559394989|FG000|Overall Study|Withdrawal by Subject|26|||
154991632|NCT02256436|559394990|FG001|Overall Study|Withdrawal by Subject|10|||
154991633|NCT02256436|559394989|FG000|Overall Study|Transferred to Extension Study|11|||
154991634|NCT02256436|559394990|FG001|Overall Study|Transferred to Extension Study|23|||
154991635|NCT02256436|559394989|FG000|Overall Study|Did Not Continue on Extension Study|8|||
154991636|NCT02256436|559394990|FG001|Overall Study|Did Not Continue on Extension Study|12|||
154991637|NCT05961215|559394991|FG000|Overall Study|Withdrawal by Subject|1|||
154991638|NCT01394952|559394995|FG000|Overall Study|Lost to Follow-up|0|||
154991639|NCT01394952|559394996|FG001|Overall Study|Lost to Follow-up|5|||
154991640|NCT01394952|559394995|FG000|Overall Study|Withdrawal by Subject|10|||
154991641|NCT01394952|559394996|FG001|Overall Study|Withdrawal by Subject|5|||
154991642|NCT01394952|559394995|FG000|Overall Study|Physician Decision|2|||
154991643|NCT01394952|559394996|FG001|Overall Study|Physician Decision|0|||
154991644|NCT01394952|559394995|FG000|Overall Study|Sponsor Decision|5|||
154991645|NCT01394952|559394996|FG001|Overall Study|Sponsor Decision|7|||
154991646|NCT04740814|559394997|FG000|Overall Study|Adverse Event|3|||
154991647|NCT04740814|559394997|FG000|Overall Study|Protocol Violation|2|||
154991648|NCT04740814|559394997|FG000|Overall Study|Lost to Follow-up|2|||
154991649|NCT04740814|559394997|FG000|Overall Study|Withdrawal by Subject|3|||
154991650|NCT00085423|559394998|FG000|Overall Study|Withdrawal by Subject|1|||
154991651|NCT00085423|559394998|FG000|Overall Study|screen failure|1|||
154991652|NCT02440568|559394999|FG000|Overall Study|Death|1|||
154991653|NCT02440568|559395000|FG001|Overall Study|Death|3|||
154991654|NCT02440568|559395001|FG002|Overall Study|Death|4|||
154991655|NCT02440568|559395002|FG003|Overall Study|Death|2|||
154991656|NCT02440568|559394999|FG000|Overall Study|Lack of Efficacy|2|||
154991657|NCT02440568|559395000|FG001|Overall Study|Lack of Efficacy|0|||
154991658|NCT02440568|559395001|FG002|Overall Study|Lack of Efficacy|1|||
154991659|NCT02440568|559395002|FG003|Overall Study|Lack of Efficacy|0|||
154991660|NCT02440568|559394999|FG000|Overall Study|Lost to Follow-up|1|||
154991661|NCT02440568|559395000|FG001|Overall Study|Lost to Follow-up|0|||
154991662|NCT02440568|559395001|FG002|Overall Study|Lost to Follow-up|0|||
154991663|NCT02440568|559395002|FG003|Overall Study|Lost to Follow-up|0|||
154991664|NCT01763684|559395009|FG000|Overall Study|Study terminated early due to low enrollment|126|||
154991665|NCT01763684|559395010|FG001|Overall Study|Study terminated early due to low enrollment|127|||
154991666|NCT01763684|559395009|FG000|Overall Study|Study surgery not performed|7|||
154991667|NCT01763684|559395010|FG001|Overall Study|Study surgery not performed|6|||
154991668|NCT02987959|559395011|FG000|Overall Study|Grantor stopped supply of drugs|6|||
154991669|NCT04305496|559395014|FG000|Global Cohort|Withdrawal by Subject|13|||
154991670|NCT04305496|559395015|FG001|Global Cohort|Withdrawal by Subject|6|||
154991671|NCT04305496|559395014|FG000|Global Cohort|Physician Decision|1|||
154991672|NCT04305496|559395015|FG001|Global Cohort|Physician Decision|1|||
154991673|NCT04305496|559395014|FG000|Global Cohort|Subjective disease progression|16|||
154991674|NCT04305496|559395015|FG001|Global Cohort|Subjective disease progression|17|||
154991675|NCT04305496|559395014|FG000|Global Cohort|Condition under investigation worsened|209|||
154991676|NCT04305496|559395015|FG001|Global Cohort|Condition under investigation worsened|273|||
154991677|NCT04305496|559395014|FG000|Global Cohort|Protocol Violation|2|||
154991678|NCT04305496|559395015|FG001|Global Cohort|Protocol Violation|0|||
154991679|NCT04305496|559395014|FG000|Global Cohort|Adverse Event|44|||
154991680|NCT04305496|559395015|FG001|Global Cohort|Adverse Event|6|||
154991681|NCT04305496|559395014|FG000|Global Cohort|Death|3|||
154991682|NCT04305496|559395015|FG001|Global Cohort|Death|2|||
154991683|NCT04305496|559395014|FG000|Global Cohort|Any reason not specifically recorded|4|||
154991684|NCT04305496|559395015|FG001|Global Cohort|Any reason not specifically recorded|5|||
154991685|NCT04305496|559395014|FG000|China Cohort|Any reason not specifically recorded|1|||
154991686|NCT04305496|559395015|FG001|China Cohort|Any reason not specifically recorded|1|||
154991687|NCT04305496|559395014|FG000|China Cohort|Adverse Event|8|||
154991688|NCT04305496|559395015|FG001|China Cohort|Adverse Event|2|||
154991689|NCT04305496|559395014|FG000|China Cohort|Condition under investigation worsened|40|||
154991690|NCT04305496|559395015|FG001|China Cohort|Condition under investigation worsened|47|||
154991691|NCT04305496|559395014|FG000|China Cohort|Subjective disease progression|2|||
154991692|NCT04305496|559395015|FG001|China Cohort|Subjective disease progression|2|||
154991693|NCT04305496|559395014|FG000|China Cohort|Withdrawal by Subject|2|||
154991694|NCT04305496|559395015|FG001|China Cohort|Withdrawal by Subject|1|||
154991695|NCT02357342|559395016|FG000|First 6 Months|Death|2|||
154991696|NCT02357342|559395017|FG001|First 6 Months|Death|0|||
154991697|NCT01490866|559395018|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
154991698|NCT01490866|559395018|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
154991699|NCT01490866|559395018|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
154991700|NCT01490866|559395018|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
154991701|NCT01490866|559395018|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
154991702|NCT01490866|559395018|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
154991703|NCT01490866|559395018|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
154991704|NCT01490866|559395018|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
154991705|NCT01490866|559395018|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
154991706|NCT01490866|559395018|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
154991707|NCT01490866|559395018|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
154991708|NCT03118570|559395019|FG000|Overall Study|Adverse Event|2|||
154991709|NCT03118570|559395020|FG001|Overall Study|Adverse Event|0|||
154991710|NCT03118570|559395021|FG002|Overall Study|Adverse Event|0|||
154991711|NCT03118570|559395022|FG003|Overall Study|Adverse Event|0|||
154991712|NCT03118570|559395023|FG004|Overall Study|Adverse Event|3|||
154991713|NCT03118570|559395019|FG000|Overall Study|Withdrawal by Subject|0|||
154991714|NCT03118570|559395020|FG001|Overall Study|Withdrawal by Subject|1|||
154991715|NCT03118570|559395021|FG002|Overall Study|Withdrawal by Subject|4|||
154991716|NCT03118570|559395022|FG003|Overall Study|Withdrawal by Subject|0|||
154991717|NCT03118570|559395023|FG004|Overall Study|Withdrawal by Subject|1|||
154991718|NCT03118570|559395019|FG000|Overall Study|Lost to Follow-up|2|||
154991719|NCT03118570|559395020|FG001|Overall Study|Lost to Follow-up|3|||
154991720|NCT03118570|559395021|FG002|Overall Study|Lost to Follow-up|1|||
154991721|NCT03118570|559395022|FG003|Overall Study|Lost to Follow-up|0|||
154991722|NCT03118570|559395023|FG004|Overall Study|Lost to Follow-up|1|||
154991723|NCT03118570|559395019|FG000|Overall Study|Other, Not Specified|1|||
154991724|NCT03118570|559395020|FG001|Overall Study|Other, Not Specified|3|||
154991725|NCT03118570|559395021|FG002|Overall Study|Other, Not Specified|0|||
154991726|NCT03118570|559395022|FG003|Overall Study|Other, Not Specified|0|||
154991727|NCT03118570|559395023|FG004|Overall Study|Other, Not Specified|0|||
154991728|NCT00006721|559397508|FG000|Overall Study|Adverse Event|0|||
154991729|NCT00006721|559397509|FG001|Overall Study|Adverse Event|4|||
154991730|NCT00006721|559397510|FG002|Overall Study|Adverse Event|4|||
154991731|NCT00006721|559397508|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
154991732|NCT00006721|559397509|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
154991733|NCT00006721|559397510|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
154991734|NCT00006721|559397508|FG000|Overall Study|Progression/Relapse|0|||
154991735|NCT00006721|559397509|FG001|Overall Study|Progression/Relapse|1|||
154991736|NCT00006721|559397510|FG002|Overall Study|Progression/Relapse|2|||
154991737|NCT00006721|559397508|FG000|Overall Study|Death|0|||
154991738|NCT00006721|559397509|FG001|Overall Study|Death|1|||
154991739|NCT00006721|559397510|FG002|Overall Study|Death|2|||
154991740|NCT00006721|559397508|FG000|Overall Study|Other - Not Protocol Specified|0|||
154991741|NCT00006721|559397509|FG001|Overall Study|Other - Not Protocol Specified|7|||
154991742|NCT00006721|559397510|FG002|Overall Study|Other - Not Protocol Specified|7|||
154991743|NCT00006721|559397508|FG000|Overall Study|Ineligible|2|||
154991744|NCT00006721|559397509|FG001|Overall Study|Ineligible|12|||
154991745|NCT00006721|559397510|FG002|Overall Study|Ineligible|10|||
154991746|NCT00006721|559397508|FG000|Overall Study|Eligible but no Treatment Received|1|||
154991747|NCT00006721|559397509|FG001|Overall Study|Eligible but no Treatment Received|0|||
154991748|NCT00006721|559397510|FG002|Overall Study|Eligible but no Treatment Received|0|||
154991749|NCT05424042|559397511|FG000|Overall Study|Withdrawal by Subject|2|||
154991750|NCT05424042|559397512|FG001|Overall Study|Withdrawal by Subject|0|||
154991751|NCT05424042|559397513|FG002|Overall Study|Withdrawal by Subject|4|||
154991752|NCT05424042|559397511|FG000|Overall Study|Lost to Follow-up|0|||
154991753|NCT05424042|559397512|FG001|Overall Study|Lost to Follow-up|0|||
154991754|NCT05424042|559397513|FG002|Overall Study|Lost to Follow-up|1|||
154991755|NCT03611543|559397514|FG000|Overall Study|Withdrawal by Subject|4|||
154991756|NCT03611543|559397515|FG001|Overall Study|Withdrawal by Subject|4|||
154991757|NCT03611543|559397514|FG000|Overall Study|Physician Decision|1|||
154991758|NCT03611543|559397515|FG001|Overall Study|Physician Decision|1|||
154991759|NCT03611543|559397514|FG000|Overall Study|Protocol Violation|2|||
154991760|NCT03611543|559397515|FG001|Overall Study|Protocol Violation|2|||
154991761|NCT03611543|559397514|FG000|Overall Study|Device failure|2|||
154991762|NCT03611543|559397515|FG001|Overall Study|Device failure|2|||
154991763|NCT03611543|559397514|FG000|Overall Study|Missing information|5|||
154991764|NCT03611543|559397515|FG001|Overall Study|Missing information|5|||
154991765|NCT03047473|559397516|FG000|Overall Study|Lost to Follow-up|2|||
154991766|NCT01167257|559397517|FG000|Overall Study|Lost to Follow-up|2|||
154991767|NCT01167257|559397518|FG001|Overall Study|Lost to Follow-up|2|||
154991768|NCT01167257|559397517|FG000|Overall Study|Withdrew consent|1|||
154991769|NCT01167257|559397518|FG001|Overall Study|Withdrew consent|1|||
154991770|NCT01059539|559397520|FG000|Overall Study|Adverse Event|66|||
154991771|NCT01059539|559397520|FG000|Overall Study|Insufficient Therapeutic Response|26|||
154991772|NCT01059539|559397520|FG000|Overall Study|Protocol Violation|55|||
154991773|NCT01059539|559397520|FG000|Overall Study|Withdrawal of Consent|80|||
154991774|NCT01059539|559397520|FG000|Overall Study|Lost to Follow-up|42|||
154991775|NCT01059539|559397520|FG000|Overall Study|Reason Not Specified|2|||
154991776|NCT00626392|559397526|FG000|Run-in Period|Adverse Event|0|||
154991777|NCT00626392|559397527|FG001|Run-in Period|Adverse Event|0|||
154991778|NCT00626392|559397528|FG002|Run-in Period|Adverse Event|1|||
154991779|NCT00626392|559397529|FG003|Run-in Period|Adverse Event|0|||
154991780|NCT00626392|559397530|FG004|Run-in Period|Adverse Event|1|||
154991781|NCT00626392|559397531|FG005|Run-in Period|Adverse Event|0|||
154991782|NCT00626392|559397526|FG000|Run-in Period|Withdrawal by Subject|0|||
154991783|NCT00626392|559397527|FG001|Run-in Period|Withdrawal by Subject|1|||
154991784|NCT00626392|559397528|FG002|Run-in Period|Withdrawal by Subject|1|||
154991785|NCT00626392|559397529|FG003|Run-in Period|Withdrawal by Subject|1|||
154991786|NCT00626392|559397530|FG004|Run-in Period|Withdrawal by Subject|3|||
154991787|NCT00626392|559397531|FG005|Run-in Period|Withdrawal by Subject|1|||
154991788|NCT00626392|559397526|FG000|Run-in Period|Noncompliance|1|||
154991789|NCT00626392|559397527|FG001|Run-in Period|Noncompliance|0|||
154991790|NCT00626392|559397528|FG002|Run-in Period|Noncompliance|1|||
155120738|NCT01133405|559872886|FG008|Period 1|Received drug only in period 3|0|||
155120739|NCT01133405|559872887|FG009|Period 1|Received drug only in period 3|0|||
155120740|NCT01133405|559872878|FG000|Period 2|Adverse Event|0|||
155120741|NCT01133405|559872879|FG001|Period 2|Adverse Event|0|||
154991791|NCT00626392|559397529|FG003|Run-in Period|Noncompliance|0|||
155120742|NCT01133405|559872880|FG002|Period 2|Adverse Event|1|||
155120743|NCT01133405|559872881|FG003|Period 2|Adverse Event|0|||
155120744|NCT01133405|559872882|FG004|Period 2|Adverse Event|0|||
155120745|NCT01133405|559872883|FG005|Period 2|Adverse Event|0|||
154991792|NCT00626392|559397530|FG004|Run-in Period|Noncompliance|0|||
154991793|NCT00626392|559397531|FG005|Run-in Period|Noncompliance|0|||
155120746|NCT01133405|559872884|FG006|Period 2|Adverse Event|0|||
154991794|NCT00626392|559397526|FG000|Coadministration Period|Adverse Event|3|||
154991795|NCT00626392|559397527|FG001|Coadministration Period|Adverse Event|1|||
154991796|NCT00626392|559397528|FG002|Coadministration Period|Adverse Event|7|||
154991797|NCT00626392|559397529|FG003|Coadministration Period|Adverse Event|4|||
154991798|NCT00626392|559397530|FG004|Coadministration Period|Adverse Event|3|||
154991799|NCT00626392|559397531|FG005|Coadministration Period|Adverse Event|4|||
154991800|NCT00626392|559397526|FG000|Coadministration Period|Withdrawal by Subject|1|||
154991801|NCT00626392|559397527|FG001|Coadministration Period|Withdrawal by Subject|1|||
154991802|NCT00626392|559397528|FG002|Coadministration Period|Withdrawal by Subject|0|||
155120747|NCT01133405|559872885|FG007|Period 2|Adverse Event|0|||
154991803|NCT00626392|559397529|FG003|Coadministration Period|Withdrawal by Subject|1|||
154991804|NCT00626392|559397530|FG004|Coadministration Period|Withdrawal by Subject|0|||
154991805|NCT00626392|559397531|FG005|Coadministration Period|Withdrawal by Subject|1|||
154991806|NCT00626392|559397526|FG000|Coadministration Period|Protocol Violation|0|||
154991807|NCT00626392|559397527|FG001|Coadministration Period|Protocol Violation|1|||
154991808|NCT00626392|559397528|FG002|Coadministration Period|Protocol Violation|0|||
154991809|NCT00626392|559397529|FG003|Coadministration Period|Protocol Violation|1|||
154991810|NCT00626392|559397530|FG004|Coadministration Period|Protocol Violation|1|||
154991811|NCT00626392|559397531|FG005|Coadministration Period|Protocol Violation|0|||
154991812|NCT00626392|559397526|FG000|Coadministration Period|Other|0|||
154991813|NCT00626392|559397527|FG001|Coadministration Period|Other|2|||
154991814|NCT00626392|559397528|FG002|Coadministration Period|Other|3|||
154991815|NCT00626392|559397529|FG003|Coadministration Period|Other|1|||
154991816|NCT00626392|559397530|FG004|Coadministration Period|Other|1|||
154991817|NCT00626392|559397531|FG005|Coadministration Period|Other|1|||
154991818|NCT00338455|559397532|FG000|Overall Study|Death|2|||
154991819|NCT00338455|559397533|FG001|Overall Study|Death|1|||
154991820|NCT00338455|559397532|FG000|Overall Study|Physician Decision|1|||
154991821|NCT00338455|559397533|FG001|Overall Study|Physician Decision|0|||
154991822|NCT01517373|559397534|FG000|Run-in Period|Death|1|||
154991823|NCT01517373|559397535|FG001|Run-in Period|Death|0|||
154991824|NCT01517373|559397536|FG002|Run-in Period|Death|0|||
154991825|NCT01517373|559397537|FG003|Run-in Period|Death|0|||
154991826|NCT01517373|559397538|FG004|Run-in Period|Death|0|||
154991827|NCT01517373|559397539|FG005|Run-in Period|Death|0|||
154991828|NCT01517373|559397534|FG000|Run-in Period|Adverse Event|5|||
154991829|NCT01517373|559397535|FG001|Run-in Period|Adverse Event|0|||
154991830|NCT01517373|559397536|FG002|Run-in Period|Adverse Event|0|||
154991831|NCT01517373|559397537|FG003|Run-in Period|Adverse Event|0|||
154991832|NCT01517373|559397538|FG004|Run-in Period|Adverse Event|0|||
154991833|NCT01517373|559397539|FG005|Run-in Period|Adverse Event|0|||
154991834|NCT01517373|559397534|FG000|Run-in Period|Did not meet eligibility criteria|34|||
154991835|NCT01517373|559397535|FG001|Run-in Period|Did not meet eligibility criteria|0|||
154991836|NCT01517373|559397536|FG002|Run-in Period|Did not meet eligibility criteria|0|||
154991837|NCT01517373|559397537|FG003|Run-in Period|Did not meet eligibility criteria|0|||
154991838|NCT01517373|559397538|FG004|Run-in Period|Did not meet eligibility criteria|0|||
154991839|NCT01517373|559397539|FG005|Run-in Period|Did not meet eligibility criteria|0|||
154991840|NCT01517373|559397534|FG000|Run-in Period|Lost to Follow-up|1|||
154991841|NCT01517373|559397535|FG001|Run-in Period|Lost to Follow-up|0|||
154991842|NCT01517373|559397536|FG002|Run-in Period|Lost to Follow-up|0|||
154991843|NCT01517373|559397537|FG003|Run-in Period|Lost to Follow-up|0|||
154991844|NCT01517373|559397538|FG004|Run-in Period|Lost to Follow-up|0|||
154991845|NCT01517373|559397539|FG005|Run-in Period|Lost to Follow-up|0|||
154991846|NCT01517373|559397534|FG000|Run-in Period|Withdrawal by Subject|12|||
154991847|NCT01517373|559397535|FG001|Run-in Period|Withdrawal by Subject|0|||
154991848|NCT01517373|559397536|FG002|Run-in Period|Withdrawal by Subject|0|||
154991849|NCT01517373|559397537|FG003|Run-in Period|Withdrawal by Subject|0|||
154991850|NCT01517373|559397538|FG004|Run-in Period|Withdrawal by Subject|0|||
154991851|NCT01517373|559397539|FG005|Run-in Period|Withdrawal by Subject|0|||
154991852|NCT01517373|559397534|FG000|Run-in Period|Sponsor Decision|3|||
154991853|NCT01517373|559397535|FG001|Run-in Period|Sponsor Decision|0|||
154991854|NCT01517373|559397536|FG002|Run-in Period|Sponsor Decision|0|||
154991855|NCT01517373|559397537|FG003|Run-in Period|Sponsor Decision|0|||
154991856|NCT01517373|559397538|FG004|Run-in Period|Sponsor Decision|0|||
154991857|NCT01517373|559397539|FG005|Run-in Period|Sponsor Decision|0|||
154991858|NCT01517373|559397534|FG000|Run-in Period|Other|1|||
154991859|NCT01517373|559397535|FG001|Run-in Period|Other|0|||
154991860|NCT01517373|559397536|FG002|Run-in Period|Other|0|||
154991861|NCT01517373|559397537|FG003|Run-in Period|Other|0|||
154991862|NCT01517373|559397538|FG004|Run-in Period|Other|0|||
154991863|NCT01517373|559397539|FG005|Run-in Period|Other|0|||
154991864|NCT01517373|559397534|FG000|Treatment Period|Adverse Event|0|||
154991865|NCT01517373|559397535|FG001|Treatment Period|Adverse Event|0|||
154991866|NCT01517373|559397536|FG002|Treatment Period|Adverse Event|0|||
155120748|NCT01133405|559872886|FG008|Period 2|Adverse Event|0|||
155120749|NCT01133405|559872887|FG009|Period 2|Adverse Event|0|||
155120750|NCT01133405|559872878|FG000|Period 2|Withdrawal by Subject|0|||
154991867|NCT01517373|559397537|FG003|Treatment Period|Adverse Event|0|||
155120751|NCT01133405|559872879|FG001|Period 2|Withdrawal by Subject|0|||
155120752|NCT01133405|559872880|FG002|Period 2|Withdrawal by Subject|0|||
154991868|NCT01517373|559397538|FG004|Treatment Period|Adverse Event|0|||
154991869|NCT01517373|559397539|FG005|Treatment Period|Adverse Event|2|||
154991870|NCT01517373|559397534|FG000|Treatment Period|Lost to Follow-up|0|||
154991871|NCT01517373|559397535|FG001|Treatment Period|Lost to Follow-up|0|||
154991872|NCT01517373|559397536|FG002|Treatment Period|Lost to Follow-up|1|||
154991873|NCT01517373|559397537|FG003|Treatment Period|Lost to Follow-up|1|||
154991874|NCT01517373|559397538|FG004|Treatment Period|Lost to Follow-up|0|||
154991875|NCT01517373|559397539|FG005|Treatment Period|Lost to Follow-up|0|||
155120753|NCT01133405|559872881|FG003|Period 2|Withdrawal by Subject|1|||
154991876|NCT01517373|559397534|FG000|Treatment Period|Withdrawal by Subject|0|||
154991877|NCT01517373|559397535|FG001|Treatment Period|Withdrawal by Subject|3|||
154991878|NCT01517373|559397536|FG002|Treatment Period|Withdrawal by Subject|2|||
154991879|NCT01517373|559397537|FG003|Treatment Period|Withdrawal by Subject|2|||
154991880|NCT01517373|559397538|FG004|Treatment Period|Withdrawal by Subject|2|||
154991881|NCT01517373|559397539|FG005|Treatment Period|Withdrawal by Subject|3|||
154991882|NCT01517373|559397534|FG000|Treatment Period|Other|0|||
154991883|NCT01517373|559397535|FG001|Treatment Period|Other|0|||
154991884|NCT01517373|559397536|FG002|Treatment Period|Other|0|||
154991885|NCT01517373|559397537|FG003|Treatment Period|Other|0|||
154991886|NCT01517373|559397538|FG004|Treatment Period|Other|1|||
154991887|NCT01517373|559397539|FG005|Treatment Period|Other|0|||
154991888|NCT01517373|559397534|FG000|Treatment Period|Protocol Violation|0|||
154991889|NCT01517373|559397535|FG001|Treatment Period|Protocol Violation|0|||
154991890|NCT01517373|559397536|FG002|Treatment Period|Protocol Violation|0|||
154991891|NCT01517373|559397537|FG003|Treatment Period|Protocol Violation|0|||
154991892|NCT01517373|559397538|FG004|Treatment Period|Protocol Violation|1|||
154991893|NCT01517373|559397539|FG005|Treatment Period|Protocol Violation|0|||
154991894|NCT01517373|559397534|FG000|Treatment Period|Lack of Efficacy|0|||
154991895|NCT01517373|559397535|FG001|Treatment Period|Lack of Efficacy|1|||
154991896|NCT01517373|559397536|FG002|Treatment Period|Lack of Efficacy|1|||
154991897|NCT01517373|559397537|FG003|Treatment Period|Lack of Efficacy|3|||
154991898|NCT01517373|559397538|FG004|Treatment Period|Lack of Efficacy|2|||
154991899|NCT01517373|559397539|FG005|Treatment Period|Lack of Efficacy|0|||
154991900|NCT01517373|559397534|FG000|Treatment Period|Medication error without AEs|0|||
154991901|NCT01517373|559397535|FG001|Treatment Period|Medication error without AEs|0|||
154991902|NCT01517373|559397536|FG002|Treatment Period|Medication error without AEs|2|||
154991903|NCT01517373|559397537|FG003|Treatment Period|Medication error without AEs|1|||
154991904|NCT01517373|559397538|FG004|Treatment Period|Medication error without AEs|0|||
154991905|NCT01517373|559397539|FG005|Treatment Period|Medication error without AEs|2|||
154991906|NCT01085734|559397540|FG000|Overall Study|Adverse Event|0|||
154991907|NCT01085734|559397541|FG001|Overall Study|Adverse Event|2|||
154991908|NCT01085734|559397540|FG000|Overall Study|Death|1|||
154991909|NCT01085734|559397541|FG001|Overall Study|Death|0|||
154991910|NCT01085734|559397540|FG000|Overall Study|Lost to Follow-up|0|||
154991911|NCT01085734|559397541|FG001|Overall Study|Lost to Follow-up|1|||
154991912|NCT01085734|559397540|FG000|Overall Study|Withdrawal by Subject|0|||
154991913|NCT01085734|559397541|FG001|Overall Study|Withdrawal by Subject|1|||
154991914|NCT04005352|559397551|FG000|Overall Study|Adverse Event|4|||
154991915|NCT04005352|559397552|FG001|Overall Study|Adverse Event|5|||
154991916|NCT04005352|559397551|FG000|Overall Study|Death|4|||
154991917|NCT04005352|559397552|FG001|Overall Study|Death|2|||
155120754|NCT01133405|559872882|FG004|Period 2|Withdrawal by Subject|0|||
155120755|NCT01133405|559872883|FG005|Period 2|Withdrawal by Subject|1|||
155120756|NCT01133405|559872884|FG006|Period 2|Withdrawal by Subject|0|||
155120757|NCT01133405|559872885|FG007|Period 2|Withdrawal by Subject|0|||
155120758|NCT01133405|559872886|FG008|Period 2|Withdrawal by Subject|0|||
155120759|NCT01133405|559872887|FG009|Period 2|Withdrawal by Subject|0|||
155120760|NCT01133405|559872878|FG000|Period 2|Entry Criteria Not Met|0|||
155120761|NCT01133405|559872879|FG001|Period 2|Entry Criteria Not Met|1|||
155120762|NCT01133405|559872880|FG002|Period 2|Entry Criteria Not Met|0|||
155120763|NCT01133405|559872881|FG003|Period 2|Entry Criteria Not Met|0|||
155120764|NCT01133405|559872882|FG004|Period 2|Entry Criteria Not Met|0|||
155120765|NCT01133405|559872883|FG005|Period 2|Entry Criteria Not Met|0|||
154991918|NCT04005352|559397551|FG000|Overall Study|Lost to Follow-up|6|||
154991919|NCT04005352|559397552|FG001|Overall Study|Lost to Follow-up|2|||
154991920|NCT04005352|559397551|FG000|Overall Study|Physician Decision|7|||
155120766|NCT01133405|559872884|FG006|Period 2|Entry Criteria Not Met|0|||
155120767|NCT01133405|559872885|FG007|Period 2|Entry Criteria Not Met|0|||
155120768|NCT01133405|559872886|FG008|Period 2|Entry Criteria Not Met|0|||
155120769|NCT01133405|559872887|FG009|Period 2|Entry Criteria Not Met|0|||
155120770|NCT01133405|559872878|FG000|Period 2|Physician Decision|0|||
155120771|NCT01133405|559872879|FG001|Period 2|Physician Decision|0|||
154991921|NCT04005352|559397552|FG001|Overall Study|Physician Decision|13|||
154991922|NCT04005352|559397551|FG000|Overall Study|Protocol Violation|0|||
155120772|NCT01133405|559872880|FG002|Period 2|Physician Decision|0|||
155120773|NCT01133405|559872881|FG003|Period 2|Physician Decision|0|||
154991923|NCT04005352|559397552|FG001|Overall Study|Protocol Violation|1|||
154991924|NCT04005352|559397551|FG000|Overall Study|Withdrawal by Subject|28|||
154991925|NCT04005352|559397552|FG001|Overall Study|Withdrawal by Subject|38|||
154991926|NCT00077857|559397559|FG000|Overall Study|Adverse Event|30|||
154991927|NCT00077857|559397560|FG001|Overall Study|Adverse Event|32|||
154991928|NCT00077857|559397559|FG000|Overall Study|Death|7|||
154991929|NCT00077857|559397560|FG001|Overall Study|Death|3|||
154991930|NCT00077857|559397559|FG000|Overall Study|Insufficient therapeutic response|112|||
154991931|NCT00077857|559397560|FG001|Overall Study|Insufficient therapeutic response|128|||
155120774|NCT01133405|559872882|FG004|Period 2|Physician Decision|0|||
154991932|NCT00077857|559397559|FG000|Overall Study|Violation of selection criteria at entry|3|||
155120775|NCT01133405|559872883|FG005|Period 2|Physician Decision|1|||
154991933|NCT00077857|559397560|FG001|Overall Study|Violation of selection criteria at entry|1|||
154991934|NCT00077857|559397559|FG000|Overall Study|Other protocol violation|0|||
154991935|NCT00077857|559397560|FG001|Overall Study|Other protocol violation|1|||
154991936|NCT00077857|559397559|FG000|Overall Study|Refused treatment|29|||
154991937|NCT00077857|559397560|FG001|Overall Study|Refused treatment|21|||
154991938|NCT00077857|559397559|FG000|Overall Study|Failure to return|5|||
154991939|NCT00077857|559397560|FG001|Overall Study|Failure to return|5|||
154991940|NCT00077857|559397559|FG000|Overall Study|Other|15|||
154991941|NCT00077857|559397560|FG001|Overall Study|Other|13|||
154991942|NCT01096368|559397561|FG000|Overall Study|Death|0|||
154991943|NCT01096368|559397562|FG001|Overall Study|Death|1|||
154991944|NCT01096368|559397563|FG002|Overall Study|Death|0|||
154991945|NCT01096368|559397564|FG003|Overall Study|Death|0|||
154991946|NCT01096368|559397565|FG004|Overall Study|Death|0|||
154991947|NCT01096368|559397561|FG000|Overall Study|Physician Decision|0|||
154991948|NCT01096368|559397562|FG001|Overall Study|Physician Decision|13|||
154991949|NCT01096368|559397563|FG002|Overall Study|Physician Decision|2|||
154991950|NCT01096368|559397564|FG003|Overall Study|Physician Decision|4|||
154991951|NCT01096368|559397565|FG004|Overall Study|Physician Decision|6|||
154991952|NCT01096368|559397561|FG000|Overall Study|Withdrawal by Subject|0|||
154991953|NCT01096368|559397562|FG001|Overall Study|Withdrawal by Subject|52|||
154991954|NCT01096368|559397563|FG002|Overall Study|Withdrawal by Subject|0|||
154991955|NCT01096368|559397564|FG003|Overall Study|Withdrawal by Subject|10|||
154991956|NCT01096368|559397565|FG004|Overall Study|Withdrawal by Subject|14|||
154991957|NCT01096368|559397561|FG000|Overall Study|Ineligible|0|||
154991958|NCT01096368|559397562|FG001|Overall Study|Ineligible|3|||
154991959|NCT01096368|559397563|FG002|Overall Study|Ineligible|2|||
154991960|NCT01096368|559397564|FG003|Overall Study|Ineligible|0|||
154991961|NCT01096368|559397565|FG004|Overall Study|Ineligible|25|||
154991962|NCT01096368|559397561|FG000|Overall Study|Did not start treatment|0|||
154991963|NCT01096368|559397562|FG001|Overall Study|Did not start treatment|4|||
154991964|NCT01096368|559397563|FG002|Overall Study|Did not start treatment|4|||
154991965|NCT01096368|559397564|FG003|Overall Study|Did not start treatment|0|||
154991966|NCT01096368|559397565|FG004|Overall Study|Did not start treatment|0|||
154991967|NCT01096368|559397561|FG000|Overall Study|Progressive disease|0|||
154991968|NCT01096368|559397562|FG001|Overall Study|Progressive disease|6|||
154991969|NCT01096368|559397563|FG002|Overall Study|Progressive disease|0|||
154991970|NCT01096368|559397564|FG003|Overall Study|Progressive disease|10|||
154991971|NCT01096368|559397565|FG004|Overall Study|Progressive disease|3|||
154991972|NCT01096368|559397561|FG000|Overall Study|Other|0|||
154991973|NCT01096368|559397562|FG001|Overall Study|Other|0|||
154991974|NCT01096368|559397563|FG002|Overall Study|Other|1|||
154991975|NCT01096368|559397564|FG003|Overall Study|Other|0|||
154991976|NCT01096368|559397565|FG004|Overall Study|Other|0|||
154991977|NCT01096368|559397561|FG000|Overall Study|Treated with institutional review|0|||
154991978|NCT01096368|559397562|FG001|Overall Study|Treated with institutional review|0|||
154991979|NCT01096368|559397563|FG002|Overall Study|Treated with institutional review|0|||
154991980|NCT01096368|559397564|FG003|Overall Study|Treated with institutional review|0|||
154991981|NCT01096368|559397565|FG004|Overall Study|Treated with institutional review|1|||
154991982|NCT06187909|559397566|FG000|Overall Study|Withdrawal by Subject|2|||
154991983|NCT06187909|559397567|FG001|Overall Study|Withdrawal by Subject|2|||
154991984|NCT06354998|559397568|FG000|Overall Study|Withdrawal by Subject|3|||
154991985|NCT06354998|559397569|FG001|Overall Study|Withdrawal by Subject|0|||
154991986|NCT05442866|559397570|FG000|Overall Study|Death|1|||
154991987|NCT05442866|559397570|FG000|Overall Study|Lost to Follow-up|9|||
154991988|NCT05442866|559397570|FG000|Overall Study|Protocol Violation|1|||
154991989|NCT04126213|559397578|FG000|Overall Study|Lost to Follow-up|9|||
154991990|NCT04126213|559397579|FG001|Overall Study|Lost to Follow-up|1|||
154991991|NCT04126213|559397580|FG002|Overall Study|Lost to Follow-up|5|||
154991992|NCT04126213|559397581|FG003|Overall Study|Lost to Follow-up|10|||
154991993|NCT04126213|559397582|FG004|Overall Study|Lost to Follow-up|4|||
154991994|NCT04126213|559397583|FG005|Overall Study|Lost to Follow-up|7|||
154991995|NCT04126213|559397578|FG000|Overall Study|Withdrawal by Subject|3|||
154991996|NCT04126213|559397579|FG001|Overall Study|Withdrawal by Subject|2|||
154991997|NCT04126213|559397580|FG002|Overall Study|Withdrawal by Subject|1|||
154991998|NCT04126213|559397581|FG003|Overall Study|Withdrawal by Subject|1|||
154991999|NCT04126213|559397582|FG004|Overall Study|Withdrawal by Subject|1|||
154992000|NCT04126213|559397583|FG005|Overall Study|Withdrawal by Subject|1|||
154992001|NCT04126213|559397578|FG000|Overall Study|Other|0|||
154992002|NCT04126213|559397579|FG001|Overall Study|Other|0|||
154992003|NCT04126213|559397580|FG002|Overall Study|Other|2|||
154992004|NCT04126213|559397581|FG003|Overall Study|Other|2|||
154992005|NCT04126213|559397582|FG004|Overall Study|Other|0|||
154992006|NCT04126213|559397583|FG005|Overall Study|Other|1|||
154992007|NCT04126213|559397578|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154992008|NCT04126213|559397579|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
154992009|NCT04126213|559397580|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154992010|NCT04126213|559397581|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
154992011|NCT04126213|559397582|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
154992012|NCT04126213|559397583|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
154992013|NCT02196701|559397584|FG000|Overall Study|Adverse Event|1|||
154992014|NCT02196701|559397584|FG000|Overall Study|Lost to Follow-up|1|||
154992015|NCT02196701|559397584|FG000|Overall Study|Non-adherence to Protocol|1|||
154992016|NCT03275064|559397585|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
154992017|NCT03275064|559397586|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
154992018|NCT03275064|559397587|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
154992019|NCT03275064|559397588|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
154992020|NCT03275064|559397589|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
154992021|NCT03275064|559397585|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
154992022|NCT03275064|559397586|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
154992023|NCT03275064|559397587|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
154992024|NCT03275064|559397588|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
154992025|NCT03275064|559397589|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
154992026|NCT03275064|559397585|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
154992027|NCT03275064|559397586|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
154992028|NCT03275064|559397587|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
154992029|NCT03275064|559397588|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
154992030|NCT03275064|559397589|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
154992031|NCT03275064|559397585|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
154992032|NCT03275064|559397586|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
154992033|NCT03275064|559397587|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
154992034|NCT03275064|559397588|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
154992035|NCT03275064|559397589|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
154992036|NCT03275064|559397585|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
154992037|NCT03275064|559397586|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
154992038|NCT03275064|559397587|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
154992039|NCT03275064|559397588|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
154992040|NCT03275064|559397589|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
154992041|NCT00620555|559397591|FG000|Overall Study|Adverse Event|4|||
154992042|NCT00620555|559397591|FG000|Overall Study|Protocol Violation|2|||
154992043|NCT00620555|559397591|FG000|Overall Study|Lack of Efficacy|12|||
154992044|NCT00620555|559397591|FG000|Overall Study|Withdrawal by Subject|1|||
154992045|NCT00620555|559397591|FG000|Overall Study|Choice of other treatment|1|||
154992046|NCT00620555|559397591|FG000|Overall Study|Visit failure against planned|1|||
154992047|NCT03796039|559397592|FG000|Overall Study|Death|2|||
154992048|NCT03796039|559397593|FG001|Overall Study|Death|1|||
154992049|NCT03796039|559397592|FG000|Overall Study|Withdrawal by Subject|7|||
154992050|NCT03796039|559397593|FG001|Overall Study|Withdrawal by Subject|4|||
154992051|NCT01140503|559397594|FG000|Overall Study|Withdrawal by Subject|1|||
154992052|NCT01157897|559397596|FG000|Overall Study|Lost to Follow-up|2|||
154992053|NCT01157897|559397597|FG001|Overall Study|Lost to Follow-up|0|||
154992054|NCT01157897|559397598|FG002|Overall Study|Lost to Follow-up|0|||
154992055|NCT01157897|559397599|FG003|Overall Study|Lost to Follow-up|1|||
154992056|NCT01157897|559397596|FG000|Overall Study|Relocated|0|||
154992057|NCT01157897|559397597|FG001|Overall Study|Relocated|2|||
154992058|NCT01157897|559397598|FG002|Overall Study|Relocated|0|||
154992059|NCT01157897|559397599|FG003|Overall Study|Relocated|0|||
154992060|NCT03734666|559397600|FG000|Overall Study|Other|7|||
154992061|NCT03734666|559397601|FG001|Overall Study|Other|4|||
154992062|NCT03734666|559397600|FG000|Overall Study|Lost to Follow-up|12|||
154992063|NCT03734666|559397601|FG001|Overall Study|Lost to Follow-up|12|||
154992064|NCT01910389|559397603|FG000|Overall Study|Withdrawal by Subject|2|||
154992065|NCT01910389|559397604|FG001|Overall Study|Withdrawal by Subject|0|||
154992066|NCT01910389|559397603|FG000|Overall Study|Study Closed|13|||
154992067|NCT01910389|559397604|FG001|Overall Study|Study Closed|8|||
154992068|NCT01898650|559397605|FG000|Overall Study|the subject would not lie still for imaging|1|||
154992069|NCT01791153|559397608|FG000|Part 1: Blinded Period|Adverse Event|7|||
154992070|NCT01791153|559397609|FG001|Part 1: Blinded Period|Adverse Event|3|||
154992071|NCT01791153|559397610|FG002|Part 1: Blinded Period|Adverse Event|2|||
154992072|NCT01791153|559397611|FG003|Part 1: Blinded Period|Adverse Event|0|||
154992073|NCT01791153|559397612|FG004|Part 1: Blinded Period|Adverse Event|0|||
154992074|NCT01791153|559397613|FG005|Part 1: Blinded Period|Adverse Event|0|||
154992075|NCT01791153|559397614|FG006|Part 1: Blinded Period|Adverse Event|0|||
154992076|NCT01791153|559397615|FG007|Part 1: Blinded Period|Adverse Event|0|||
154992077|NCT01791153|559397608|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
154992078|NCT01791153|559397609|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
154992079|NCT01791153|559397610|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
155120776|NCT01133405|559872884|FG006|Period 2|Physician Decision|0|||
154992080|NCT01791153|559397611|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
154992081|NCT01791153|559397612|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
154992082|NCT01791153|559397613|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
154992083|NCT01791153|559397614|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
154992084|NCT01791153|559397615|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
154992085|NCT01791153|559397608|FG000|Part 1: Blinded Period|Non-Compliance|1|||
154992086|NCT01791153|559397609|FG001|Part 1: Blinded Period|Non-Compliance|0|||
154992087|NCT01791153|559397610|FG002|Part 1: Blinded Period|Non-Compliance|0|||
154992088|NCT01791153|559397611|FG003|Part 1: Blinded Period|Non-Compliance|0|||
154992089|NCT01791153|559397612|FG004|Part 1: Blinded Period|Non-Compliance|0|||
154992090|NCT01791153|559397613|FG005|Part 1: Blinded Period|Non-Compliance|0|||
154992091|NCT01791153|559397614|FG006|Part 1: Blinded Period|Non-Compliance|0|||
154992092|NCT01791153|559397615|FG007|Part 1: Blinded Period|Non-Compliance|0|||
154992093|NCT01791153|559397608|FG000|Part 1: Blinded Period|Physician Decision|0|||
154992094|NCT01791153|559397609|FG001|Part 1: Blinded Period|Physician Decision|0|||
154992095|NCT01791153|559397610|FG002|Part 1: Blinded Period|Physician Decision|0|||
154992096|NCT01791153|559397611|FG003|Part 1: Blinded Period|Physician Decision|1|||
154992097|NCT01791153|559397612|FG004|Part 1: Blinded Period|Physician Decision|0|||
154992098|NCT01791153|559397613|FG005|Part 1: Blinded Period|Physician Decision|0|||
154992099|NCT01791153|559397614|FG006|Part 1: Blinded Period|Physician Decision|0|||
154992100|NCT01791153|559397615|FG007|Part 1: Blinded Period|Physician Decision|0|||
154992101|NCT01791153|559397608|FG000|Part 1: Blinded Period|Protocol Violation|0|||
154992102|NCT01791153|559397609|FG001|Part 1: Blinded Period|Protocol Violation|0|||
154992103|NCT01791153|559397610|FG002|Part 1: Blinded Period|Protocol Violation|0|||
154992104|NCT01791153|559397611|FG003|Part 1: Blinded Period|Protocol Violation|1|||
154992105|NCT01791153|559397612|FG004|Part 1: Blinded Period|Protocol Violation|0|||
154992106|NCT01791153|559397613|FG005|Part 1: Blinded Period|Protocol Violation|0|||
154992107|NCT01791153|559397614|FG006|Part 1: Blinded Period|Protocol Violation|0|||
154992108|NCT01791153|559397615|FG007|Part 1: Blinded Period|Protocol Violation|0|||
154992109|NCT01791153|559397608|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
154992110|NCT01791153|559397609|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
154992111|NCT01791153|559397610|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
154992112|NCT01791153|559397611|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
154992113|NCT01791153|559397612|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
154992114|NCT01791153|559397613|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
154992115|NCT01791153|559397614|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
154992116|NCT01791153|559397615|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
154992117|NCT01791153|559397608|FG000|Part 2: Open-label Period|Adverse Event|0|||
154992118|NCT01791153|559397609|FG001|Part 2: Open-label Period|Adverse Event|0|||
154992119|NCT01791153|559397610|FG002|Part 2: Open-label Period|Adverse Event|0|||
154992120|NCT01791153|559397611|FG003|Part 2: Open-label Period|Adverse Event|0|||
154992121|NCT01791153|559397612|FG004|Part 2: Open-label Period|Adverse Event|0|||
154992122|NCT01791153|559397613|FG005|Part 2: Open-label Period|Adverse Event|1|||
154992123|NCT01791153|559397614|FG006|Part 2: Open-label Period|Adverse Event|1|||
154992124|NCT01791153|559397615|FG007|Part 2: Open-label Period|Adverse Event|2|||
154992125|NCT01791153|559397608|FG000|Part 2: Open-label Period|Death|0|||
154992126|NCT01791153|559397609|FG001|Part 2: Open-label Period|Death|0|||
154992127|NCT01791153|559397610|FG002|Part 2: Open-label Period|Death|0|||
154992128|NCT01791153|559397611|FG003|Part 2: Open-label Period|Death|0|||
154992129|NCT01791153|559397612|FG004|Part 2: Open-label Period|Death|0|||
154992130|NCT01791153|559397613|FG005|Part 2: Open-label Period|Death|1|||
154992131|NCT01791153|559397614|FG006|Part 2: Open-label Period|Death|1|||
154992132|NCT01791153|559397615|FG007|Part 2: Open-label Period|Death|1|||
154992133|NCT01791153|559397608|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
154992134|NCT01791153|559397609|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
154992135|NCT01791153|559397610|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
154992136|NCT01791153|559397611|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
154992137|NCT01791153|559397612|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
154992138|NCT01791153|559397613|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
154992139|NCT01791153|559397614|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
154992140|NCT01791153|559397615|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
154992141|NCT01791153|559397608|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
154992142|NCT01791153|559397609|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
154992143|NCT01791153|559397610|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
154992144|NCT01791153|559397611|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
154992145|NCT01791153|559397612|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
154992146|NCT01791153|559397613|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
154992147|NCT01791153|559397614|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
154992148|NCT01791153|559397615|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
154992149|NCT01791153|559397608|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
154992150|NCT01791153|559397609|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
154992151|NCT01791153|559397610|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
154992152|NCT01791153|559397611|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
154992153|NCT01791153|559397612|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
154992154|NCT01791153|559397613|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
154992155|NCT01791153|559397614|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
154992156|NCT01791153|559397615|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
154992157|NCT01791153|559397608|FG000|Part 2: Open-label Period|Physician Decision|0|||
154992158|NCT01791153|559397609|FG001|Part 2: Open-label Period|Physician Decision|0|||
154992159|NCT01791153|559397610|FG002|Part 2: Open-label Period|Physician Decision|0|||
154992160|NCT01791153|559397611|FG003|Part 2: Open-label Period|Physician Decision|0|||
154992161|NCT01791153|559397612|FG004|Part 2: Open-label Period|Physician Decision|1|||
154992162|NCT01791153|559397613|FG005|Part 2: Open-label Period|Physician Decision|1|||
154992163|NCT01791153|559397614|FG006|Part 2: Open-label Period|Physician Decision|0|||
154992164|NCT01791153|559397615|FG007|Part 2: Open-label Period|Physician Decision|0|||
154992165|NCT05896202|559397618|FG000|Overall Study|Lost to Follow-up|2|||
154992166|NCT05896202|559397619|FG001|Overall Study|Lost to Follow-up|2|||
154992167|NCT02435836|559397620|FG000|Overall Study|Lost to Follow-up|21|||
154992168|NCT02435836|559397620|FG000|Overall Study|Lack of Efficacy|1|||
154992169|NCT02435836|559397620|FG000|Overall Study|Withdrawal by Subject|236|||
154992170|NCT02435836|559397620|FG000|Overall Study|Insufficient Clinical Response|26|||
154992171|NCT02435836|559397620|FG000|Overall Study|Adverse Event|44|||
154992172|NCT02435836|559397620|FG000|Overall Study|Sponsor discontinued trial|167|||
154992173|NCT02435836|559397620|FG000|Overall Study|Noncompliance|27|||
154992174|NCT02435836|559397620|FG000|Overall Study|Protocol Violation|6|||
154992175|NCT02435836|559397620|FG000|Overall Study|Met Withdrawal Criteria|7|||
154992176|NCT02435836|559397620|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
154992177|NCT01946191|559397621|FG000|Allocation|Did not complete orientation|1|||
154992178|NCT01946191|559397622|FG001|Allocation|Did not complete orientation|1|||
154992179|NCT01946191|559397621|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
154992180|NCT01946191|559397622|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
154992181|NCT01946191|559397621|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
154992182|NCT01946191|559397622|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
154992183|NCT01946191|559397621|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
154992184|NCT01946191|559397622|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
154992185|NCT01855074|559397623|FG000|Overall Study|Adverse Event|1|||
154992186|NCT01855074|559397623|FG000|Overall Study|Lost to Follow-up|4|||
154992187|NCT01855074|559397623|FG000|Overall Study|Withdrawal by Subject|8|||
154992188|NCT01855074|559397623|FG000|Overall Study|Started but not treated|1|||
154992189|NCT02991430|559397624|FG000|Treatment Period 1|Adverse Event|1|||
154992190|NCT02991430|559397625|FG001|Treatment Period 1|Adverse Event|0|||
154992191|NCT02991430|559397626|FG002|Treatment Period 1|Adverse Event|2|||
154992192|NCT02991430|559397624|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154992193|NCT02991430|559397625|FG001|Treatment Period 1|Withdrawal by Subject|4|||
154992194|NCT02991430|559397626|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154992195|NCT02991430|559397624|FG000|Treatment Period 2|Study Termination|6|||
154992196|NCT02991430|559397625|FG001|Treatment Period 2|Study Termination|3|||
154992197|NCT02991430|559397626|FG002|Treatment Period 2|Study Termination|3|||
154992198|NCT02991430|559397624|FG000|Treatment Period 2|Lost to Follow-up|0|||
154992199|NCT02991430|559397625|FG001|Treatment Period 2|Lost to Follow-up|0|||
154992200|NCT02991430|559397626|FG002|Treatment Period 2|Lost to Follow-up|1|||
154992201|NCT02991430|559397624|FG000|Post-treatment Observation Period|Study Termination|3|||
154992202|NCT02991430|559397625|FG001|Post-treatment Observation Period|Study Termination|6|||
154992203|NCT02991430|559397626|FG002|Post-treatment Observation Period|Study Termination|5|||
154992204|NCT01150890|559397627|FG000|Overall Study|Other|0|||
154992205|NCT01150890|559397628|FG001|Overall Study|Other|1|||
154992206|NCT01150890|559397629|FG002|Overall Study|Other|0|||
154992207|NCT01150890|559397630|FG003|Overall Study|Other|2|||
154992208|NCT01150890|559397627|FG000|Overall Study|Pregnancy|0|||
154992209|NCT01150890|559397628|FG001|Overall Study|Pregnancy|0|||
154992210|NCT01150890|559397629|FG002|Overall Study|Pregnancy|0|||
154992211|NCT01150890|559397630|FG003|Overall Study|Pregnancy|1|||
154992212|NCT01150890|559397627|FG000|Overall Study|Administrative Decision|4|||
154992213|NCT01150890|559397628|FG001|Overall Study|Administrative Decision|4|||
154992214|NCT01150890|559397629|FG002|Overall Study|Administrative Decision|5|||
154992215|NCT01150890|559397630|FG003|Overall Study|Administrative Decision|6|||
154992216|NCT01150890|559397627|FG000|Overall Study|Ineligibility determined|0|||
154992217|NCT01150890|559397628|FG001|Overall Study|Ineligibility determined|1|||
154992218|NCT01150890|559397629|FG002|Overall Study|Ineligibility determined|0|||
154992219|NCT01150890|559397630|FG003|Overall Study|Ineligibility determined|0|||
154992220|NCT01150890|559397627|FG000|Overall Study|Adverse Event|0|||
154992221|NCT01150890|559397628|FG001|Overall Study|Adverse Event|0|||
154992222|NCT01150890|559397629|FG002|Overall Study|Adverse Event|2|||
154992223|NCT01150890|559397630|FG003|Overall Study|Adverse Event|0|||
154992224|NCT01150890|559397627|FG000|Overall Study|Withdrawal by Subject|0|||
154992225|NCT01150890|559397628|FG001|Overall Study|Withdrawal by Subject|0|||
154992226|NCT01150890|559397629|FG002|Overall Study|Withdrawal by Subject|2|||
154992227|NCT01150890|559397630|FG003|Overall Study|Withdrawal by Subject|1|||
154992228|NCT01150890|559397627|FG000|Overall Study|Disease progression|0|||
154992229|NCT01150890|559397628|FG001|Overall Study|Disease progression|7|||
154992230|NCT01150890|559397629|FG002|Overall Study|Disease progression|3|||
154992231|NCT01150890|559397630|FG003|Overall Study|Disease progression|7|||
154992232|NCT03970837|559397631|FG000|Overall Study|Adverse Event|23|||
154992233|NCT03970837|559397632|FG001|Overall Study|Adverse Event|20|||
154992234|NCT03970837|559397633|FG002|Overall Study|Adverse Event|16|||
154992235|NCT03970837|559397634|FG003|Overall Study|Adverse Event|6|||
154992236|NCT03970837|559397635|FG004|Overall Study|Adverse Event|4|||
154992237|NCT03970837|559397636|FG005|Overall Study|Adverse Event|5|||
154992238|NCT03970837|559397637|FG006|Overall Study|Adverse Event|1|||
154992239|NCT03970837|559397638|FG007|Overall Study|Adverse Event|5|||
154992240|NCT03970837|559397639|FG008|Overall Study|Adverse Event|0|||
154992241|NCT03970837|559397640|FG009|Overall Study|Adverse Event|0|||
154992242|NCT03970837|559397641|FG010|Overall Study|Adverse Event|1|||
154992243|NCT03970837|559397642|FG011|Overall Study|Adverse Event|1|||
154992244|NCT03970837|559397631|FG000|Overall Study|Lack of Efficacy|14|||
154992245|NCT03970837|559397632|FG001|Overall Study|Lack of Efficacy|12|||
154992246|NCT03970837|559397633|FG002|Overall Study|Lack of Efficacy|1|||
154992247|NCT03970837|559397634|FG003|Overall Study|Lack of Efficacy|2|||
154992248|NCT03970837|559397635|FG004|Overall Study|Lack of Efficacy|3|||
154992249|NCT03970837|559397636|FG005|Overall Study|Lack of Efficacy|4|||
154992250|NCT03970837|559397637|FG006|Overall Study|Lack of Efficacy|6|||
154992251|NCT03970837|559397638|FG007|Overall Study|Lack of Efficacy|1|||
154992252|NCT03970837|559397639|FG008|Overall Study|Lack of Efficacy|1|||
154992253|NCT03970837|559397640|FG009|Overall Study|Lack of Efficacy|0|||
154992254|NCT03970837|559397641|FG010|Overall Study|Lack of Efficacy|0|||
154992255|NCT03970837|559397642|FG011|Overall Study|Lack of Efficacy|0|||
154992256|NCT03970837|559397631|FG000|Overall Study|Lost to Follow-up|6|||
154992257|NCT03970837|559397632|FG001|Overall Study|Lost to Follow-up|5|||
154992258|NCT03970837|559397633|FG002|Overall Study|Lost to Follow-up|5|||
154992259|NCT03970837|559397634|FG003|Overall Study|Lost to Follow-up|1|||
154992260|NCT03970837|559397635|FG004|Overall Study|Lost to Follow-up|0|||
154992261|NCT03970837|559397636|FG005|Overall Study|Lost to Follow-up|2|||
154992262|NCT03970837|559397637|FG006|Overall Study|Lost to Follow-up|0|||
154992263|NCT03970837|559397638|FG007|Overall Study|Lost to Follow-up|0|||
154992264|NCT03970837|559397639|FG008|Overall Study|Lost to Follow-up|0|||
154992265|NCT03970837|559397640|FG009|Overall Study|Lost to Follow-up|0|||
154992266|NCT03970837|559397641|FG010|Overall Study|Lost to Follow-up|0|||
154992267|NCT03970837|559397642|FG011|Overall Study|Lost to Follow-up|0|||
154992268|NCT03970837|559397631|FG000|Overall Study|Protocol Violation|1|||
154992269|NCT03970837|559397632|FG001|Overall Study|Protocol Violation|0|||
154992270|NCT03970837|559397633|FG002|Overall Study|Protocol Violation|0|||
154992271|NCT03970837|559397634|FG003|Overall Study|Protocol Violation|0|||
154992272|NCT03970837|559397635|FG004|Overall Study|Protocol Violation|0|||
154992273|NCT03970837|559397636|FG005|Overall Study|Protocol Violation|0|||
154992274|NCT03970837|559397637|FG006|Overall Study|Protocol Violation|0|||
154992275|NCT03970837|559397638|FG007|Overall Study|Protocol Violation|0|||
154992276|NCT03970837|559397639|FG008|Overall Study|Protocol Violation|0|||
154992277|NCT03970837|559397640|FG009|Overall Study|Protocol Violation|0|||
154992278|NCT03970837|559397641|FG010|Overall Study|Protocol Violation|0|||
154992279|NCT03970837|559397642|FG011|Overall Study|Protocol Violation|0|||
154992280|NCT03970837|559397631|FG000|Overall Study|Physician Decision|5|||
154992281|NCT03970837|559397632|FG001|Overall Study|Physician Decision|8|||
154992282|NCT03970837|559397633|FG002|Overall Study|Physician Decision|4|||
154992283|NCT03970837|559397634|FG003|Overall Study|Physician Decision|1|||
154992284|NCT03970837|559397635|FG004|Overall Study|Physician Decision|5|||
154992285|NCT03970837|559397636|FG005|Overall Study|Physician Decision|2|||
154992286|NCT03970837|559397637|FG006|Overall Study|Physician Decision|4|||
155120777|NCT01133405|559872885|FG007|Period 2|Physician Decision|0|||
155120778|NCT01133405|559872886|FG008|Period 2|Physician Decision|0|||
155120779|NCT01133405|559872887|FG009|Period 2|Physician Decision|0|||
155120780|NCT03300024|559872890|FG000|Overall Study|Physician Decision|4|||
155120781|NCT03300024|559872891|FG001|Overall Study|Physician Decision|6|||
155120782|NCT01238835|559872892|FG000|Overall Study|Death|124|||
155120783|NCT01238835|559872892|FG000|Overall Study|Withdrawal by Subject|9|||
154992287|NCT03970837|559397638|FG007|Overall Study|Physician Decision|5|||
154992288|NCT03970837|559397639|FG008|Overall Study|Physician Decision|0|||
154992289|NCT03970837|559397640|FG009|Overall Study|Physician Decision|1|||
154992290|NCT03970837|559397641|FG010|Overall Study|Physician Decision|0|||
154992291|NCT03970837|559397642|FG011|Overall Study|Physician Decision|0|||
155120784|NCT01238835|559872892|FG000|Overall Study|Lost to Follow-up|1|||
154992292|NCT03970837|559397631|FG000|Overall Study|Withdrawal by Subject|32|||
154992293|NCT03970837|559397632|FG001|Overall Study|Withdrawal by Subject|35|||
154992294|NCT03970837|559397633|FG002|Overall Study|Withdrawal by Subject|12|||
154992295|NCT03970837|559397634|FG003|Overall Study|Withdrawal by Subject|8|||
155120785|NCT01238835|559872892|FG000|Overall Study|Site early discontinuation|2|||
154992296|NCT03970837|559397635|FG004|Overall Study|Withdrawal by Subject|6|||
154992297|NCT03970837|559397636|FG005|Overall Study|Withdrawal by Subject|8|||
154992298|NCT03970837|559397637|FG006|Overall Study|Withdrawal by Subject|2|||
154992299|NCT03970837|559397638|FG007|Overall Study|Withdrawal by Subject|3|||
154992300|NCT03970837|559397639|FG008|Overall Study|Withdrawal by Subject|0|||
155120786|NCT00554619|559872893|FG000|Overall Study|Adverse Event|1|||
155120787|NCT00554619|559872893|FG000|Overall Study|Physician Decision|1|||
155120788|NCT00554619|559872893|FG000|Overall Study|Liver Function Test Abnormality|1|||
155120789|NCT00907803|559872897|FG000|Overall Study|Withdrawal of consent - long commute|1|||
155120790|NCT00907803|559872898|FG001|Overall Study|Withdrawal of consent - long commute|0|||
155120791|NCT00907803|559872899|FG002|Overall Study|Withdrawal of consent - long commute|0|||
155120792|NCT00907803|559872897|FG000|Overall Study|Adverse Event|2|||
155120793|NCT00907803|559872898|FG001|Overall Study|Adverse Event|0|||
155120794|NCT00907803|559872899|FG002|Overall Study|Adverse Event|0|||
155120795|NCT00907803|559872897|FG000|Overall Study|Withdrawal by Subject|0|||
155120796|NCT00907803|559872898|FG001|Overall Study|Withdrawal by Subject|1|||
155120797|NCT00907803|559872899|FG002|Overall Study|Withdrawal by Subject|0|||
155120798|NCT00907803|559872897|FG000|Overall Study|Lost to Follow-up|0|||
155120799|NCT00907803|559872898|FG001|Overall Study|Lost to Follow-up|1|||
155120800|NCT00907803|559872899|FG002|Overall Study|Lost to Follow-up|0|||
155120801|NCT00907803|559872897|FG000|Overall Study|Protocol Violation|0|||
155120802|NCT00907803|559872898|FG001|Overall Study|Protocol Violation|1|||
155120803|NCT00907803|559872899|FG002|Overall Study|Protocol Violation|0|||
155120804|NCT05426031|559872904|FG000|Overall Study|Circulatory Arrest|3|||
155120805|NCT05426031|559872905|FG001|Overall Study|Circulatory Arrest|2|||
155120806|NCT00241631|559872910|FG000|Run in (2 Weeks)|Physician Decision|3|||
155120807|NCT00241631|559872911|FG001|Run in (2 Weeks)|Physician Decision|3|||
155120808|NCT00241631|559872910|FG000|Phase 1 (4 Weeks)|sore throat|1|||
155120809|NCT00241631|559872911|FG001|Phase 1 (4 Weeks)|sore throat|0|||
155120810|NCT00241631|559872910|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
155120811|NCT00241631|559872911|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
155120812|NCT00241631|559872910|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
155120813|NCT00241631|559872911|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
155120814|NCT00241631|559872910|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
155120815|NCT00241631|559872911|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
155120816|NCT01118520|559872912|FG000|Overall Study|AAA repair|9|||
155120817|NCT01118520|559872913|FG001|Overall Study|AAA repair|7|||
155120818|NCT01118520|559872914|FG002|Overall Study|AAA repair|9|||
155120819|NCT01118520|559872912|FG000|Overall Study|Adverse Event|3|||
155120820|NCT01118520|559872913|FG001|Overall Study|Adverse Event|3|||
155120821|NCT01118520|559872914|FG002|Overall Study|Adverse Event|3|||
155120822|NCT01118520|559872912|FG000|Overall Study|Withdrawal by Subject|8|||
155120823|NCT01118520|559872913|FG001|Overall Study|Withdrawal by Subject|13|||
155120824|NCT01118520|559872914|FG002|Overall Study|Withdrawal by Subject|8|||
155120825|NCT03958656|559872915|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
155120826|NCT03958656|559872916|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
155120827|NCT03958656|559872917|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
155120828|NCT03958656|559872918|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
155120829|NCT03958656|559872915|FG000|Overall Study|No longer meets eligibility criteria|0|||
155120830|NCT03958656|559872916|FG001|Overall Study|No longer meets eligibility criteria|0|||
155120831|NCT03958656|559872917|FG002|Overall Study|No longer meets eligibility criteria|1|||
155120832|NCT03958656|559872918|FG003|Overall Study|No longer meets eligibility criteria|0|||
155120833|NCT03958656|559872915|FG000|Overall Study|Started anti-cancer treatment|0|||
155120834|NCT03958656|559872916|FG001|Overall Study|Started anti-cancer treatment|0|||
155120835|NCT03958656|559872917|FG002|Overall Study|Started anti-cancer treatment|1|||
155120836|NCT03958656|559872918|FG003|Overall Study|Started anti-cancer treatment|0|||
155120837|NCT03158012|559872919|FG000|Overall Study|Withdrawal by Subject|0|||
155120838|NCT03158012|559872920|FG001|Overall Study|Withdrawal by Subject|1|||
155120839|NCT01852825|559872921|FG000|Overall Study|Withdrawal by Subject|2|||
155120840|NCT01852825|559872922|FG001|Overall Study|Withdrawal by Subject|0|||
155120841|NCT01852825|559872923|FG002|Overall Study|Withdrawal by Subject|0|||
155120842|NCT02214225|559872930|FG000|Overall Study|Lost to Follow-up|46|||
155120843|NCT02214225|559872931|FG001|Overall Study|Lost to Follow-up|18|||
155120844|NCT02214225|559872932|FG002|Overall Study|Lost to Follow-up|18|||
155120845|NCT02214225|559872930|FG000|Overall Study|Withdrawal by Subject|2|||
155120846|NCT02214225|559872931|FG001|Overall Study|Withdrawal by Subject|0|||
155120847|NCT02214225|559872932|FG002|Overall Study|Withdrawal by Subject|2|||
155120848|NCT02214225|559872930|FG000|Overall Study|Death|5|||
155120849|NCT02214225|559872931|FG001|Overall Study|Death|0|||
155120850|NCT02214225|559872932|FG002|Overall Study|Death|1|||
155120851|NCT02214225|559872930|FG000|Overall Study|randomized in error, not vaccinated|2|||
155120852|NCT02214225|559872931|FG001|Overall Study|randomized in error, not vaccinated|1|||
155120853|NCT02214225|559872932|FG002|Overall Study|randomized in error, not vaccinated|1|||
155120854|NCT03987932|559872933|FG000|Overall Study|Lost to Follow-up|2|||
155120855|NCT03987932|559872934|FG001|Overall Study|Lost to Follow-up|1|||
155120856|NCT03987932|559872935|FG002|Overall Study|Lost to Follow-up|1|||
155120857|NCT03987932|559872933|FG000|Overall Study|Non-study related elective surgery|0|||
155120858|NCT03987932|559872934|FG001|Overall Study|Non-study related elective surgery|0|||
155120859|NCT03987932|559872935|FG002|Overall Study|Non-study related elective surgery|1|||
155120860|NCT02078102|559872937|FG000|Overall Study|Adverse Event|1|||
155120861|NCT02078102|559872938|FG001|Overall Study|Adverse Event|0|||
155120862|NCT02078102|559872937|FG000|Overall Study|Withdrawal by Subject|1|||
155120863|NCT02078102|559872938|FG001|Overall Study|Withdrawal by Subject|0|||
155120864|NCT02078102|559872937|FG000|Overall Study|Physician Decision|0|||
155120865|NCT02078102|559872938|FG001|Overall Study|Physician Decision|1|||
155120866|NCT02185014|559872939|FG000|Overall Study|Adverse Event|18|||
155120867|NCT02185014|559872939|FG000|Overall Study|Withdrew Consent|8|||
155120868|NCT02185014|559872939|FG000|Overall Study|Lost to Follow-up|4|||
155120869|NCT02185014|559872939|FG000|Overall Study|Lack of Efficacy|14|||
155120870|NCT02185014|559872939|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
155120871|NCT02185014|559872939|FG000|Overall Study|Subject Noncompliance|1|||
155120872|NCT02185014|559872939|FG000|Overall Study|Other|4|||
155120873|NCT02141490|559872941|FG000|Overall Study|Screening failures|4|||
155120874|NCT02141490|559872942|FG001|Overall Study|Screening failures|0|||
155120875|NCT02141490|559872943|FG002|Overall Study|Screening failures|0|||
155120876|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
155120877|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
155120878|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
155120879|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
155120880|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
155120881|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
155120882|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
155120883|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
155120884|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
155120885|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
155120886|NCT03906656|559872944|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
155120887|NCT03906656|559872945|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
155120888|NCT03906656|559872944|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
155120889|NCT03906656|559872945|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
155120890|NCT03906656|559872944|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
155120891|NCT03906656|559872945|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
155120892|NCT03906656|559872944|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
155120893|NCT03906656|559872945|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
155120894|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
155120895|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
155120896|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
155120897|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
155120898|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
155120899|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
155120900|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
155120901|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
155120902|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
155120903|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
155120904|NCT03906656|559872944|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
155120905|NCT03906656|559872945|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
155120906|NCT03906656|559872944|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
155120907|NCT03906656|559872945|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
155120908|NCT03906656|559872944|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
155120909|NCT03906656|559872945|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
155120910|NCT03906656|559872944|FG000|Home Use 2 (3 Months)|Death|2|||
155120911|NCT03906656|559872945|FG001|Home Use 2 (3 Months)|Death|0|||
155120912|NCT03906656|559872944|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
155120913|NCT03906656|559872945|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
155120914|NCT03906656|559872944|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
155120915|NCT03906656|559872945|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
155120916|NCT00033540|559872946|FG000|Overall Study|Adverse Event|14|||
155120917|NCT00033540|559872946|FG000|Overall Study|Death|1|||
155120918|NCT00033540|559872946|FG000|Overall Study|Progression|26|||
155120919|NCT00033540|559872946|FG000|Overall Study|Withdrawal by Subject|6|||
155120920|NCT00033540|559872946|FG000|Overall Study|Other|5|||
155120921|NCT00033540|559872946|FG000|Overall Study|Ineligible|3|||
155120922|NCT00033540|559872946|FG000|Overall Study|Never received treatment|2|||
155120923|NCT01036529|559872947|FG000|Overall Study|Adverse Event|0|||
155120924|NCT01036529|559872948|FG001|Overall Study|Adverse Event|1|||
154916995|NCT01733758|559118497|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
154916996|NCT01733758|559118498|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
154916997|NCT01733758|559118499|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
154916998|NCT01733758|559118500|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
155120925|NCT01036529|559872947|FG000|Overall Study|Lost to Follow-up|0|||
155120926|NCT01036529|559872948|FG001|Overall Study|Lost to Follow-up|1|||
155120927|NCT01036529|559872947|FG000|Overall Study|Physician Decision|1|||
155120928|NCT01036529|559872948|FG001|Overall Study|Physician Decision|0|||
155120929|NCT01036529|559872947|FG000|Overall Study|Withdrawal by Subject|1|||
155120930|NCT01036529|559872948|FG001|Overall Study|Withdrawal by Subject|1|||
155120931|NCT01036529|559872947|FG000|Overall Study|Sponsor study termination|11|||
155120932|NCT01036529|559872948|FG001|Overall Study|Sponsor study termination|12|||
155120933|NCT01253265|559872957|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
155120934|NCT01253265|559872958|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
155120935|NCT01253265|559872959|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
155120936|NCT01253265|559872960|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
155120937|NCT01253265|559872961|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
155120938|NCT01253265|559872957|FG000|Overall Study|Withdrawal by Subject|0|||
155120939|NCT01253265|559872958|FG001|Overall Study|Withdrawal by Subject|0|||
155120940|NCT01253265|559872959|FG002|Overall Study|Withdrawal by Subject|0|||
155120941|NCT01253265|559872960|FG003|Overall Study|Withdrawal by Subject|0|||
155120942|NCT01253265|559872961|FG004|Overall Study|Withdrawal by Subject|1|||
155120943|NCT00066469|559872962|FG000|Overall Study|Death|3|||
155120944|NCT00066469|559872962|FG000|Overall Study|Lack of Efficacy|9|||
155120945|NCT00066469|559872962|FG000|Overall Study|Lost to Follow-up|1|||
155120946|NCT00066469|559872962|FG000|Overall Study|Physician Decision|1|||
155120947|NCT00066469|559872962|FG000|Overall Study|Withdrawal by Subject|1|||
155120948|NCT00066469|559872962|FG000|Overall Study|ineligible|1|||
155120949|NCT01853072|559872963|FG000|Overall Study|Adverse event prior to treatment|0|||
155120950|NCT01853072|559872964|FG001|Overall Study|Adverse event prior to treatment|1|||
155120951|NCT01853072|559872963|FG000|Overall Study|Adverse Event|0|||
155120952|NCT01853072|559872964|FG001|Overall Study|Adverse Event|3|||
155120953|NCT01853072|559872963|FG000|Overall Study|Death|1|||
155120954|NCT01853072|559872964|FG001|Overall Study|Death|4|||
155120955|NCT01853072|559872963|FG000|Overall Study|Lost to Follow-up|0|||
155120956|NCT01853072|559872964|FG001|Overall Study|Lost to Follow-up|3|||
155120957|NCT01853072|559872963|FG000|Overall Study|Non-compliance with study drug|0|||
155120958|NCT01853072|559872964|FG001|Overall Study|Non-compliance with study drug|1|||
155120959|NCT01853072|559872963|FG000|Overall Study|Physician Decision|1|||
155120960|NCT01853072|559872964|FG001|Overall Study|Physician Decision|1|||
155120961|NCT01853072|559872963|FG000|Overall Study|Withdrawal by Subject|1|||
155120962|NCT01853072|559872964|FG001|Overall Study|Withdrawal by Subject|2|||
155120963|NCT01853072|559872963|FG000|Overall Study|Reason not specified|9|||
155120964|NCT01853072|559872964|FG001|Overall Study|Reason not specified|6|||
155120965|NCT00930969|559872965|FG000|Overall Study|Death|5|||
155120966|NCT00930969|559872965|FG000|Overall Study|Lost to Follow-up|1|||
155120967|NCT00930969|559872965|FG000|Overall Study|Physician Decision|13|||
155120968|NCT00930969|559872965|FG000|Overall Study|Withdrawal by Subject|19|||
155120969|NCT00657150|559872966|FG000|Overall Study|Adverse Event|19|||
155120970|NCT00657150|559872967|FG001|Overall Study|Adverse Event|10|||
155120971|NCT00657150|559872966|FG000|Overall Study|Non-compliant with protocol|5|||
155120972|NCT00657150|559872967|FG001|Overall Study|Non-compliant with protocol|9|||
155120973|NCT00657150|559872966|FG000|Overall Study|Lost to Follow-up|2|||
155120974|NCT00657150|559872967|FG001|Overall Study|Lost to Follow-up|0|||
155120975|NCT00657150|559872966|FG000|Overall Study|Withdrawal by Subject|51|||
155120976|NCT00657150|559872967|FG001|Overall Study|Withdrawal by Subject|36|||
155120977|NCT00657150|559872966|FG000|Overall Study|Other|38|||
155120978|NCT00657150|559872967|FG001|Overall Study|Other|38|||
155120979|NCT00657150|559872966|FG000|Treatment|Adverse Event|60|||
155120980|NCT00657150|559872967|FG001|Treatment|Adverse Event|53|||
154992301|NCT03970837|559397640|FG009|Overall Study|Withdrawal by Subject|0|||
154992302|NCT03970837|559397641|FG010|Overall Study|Withdrawal by Subject|0|||
154992303|NCT03970837|559397642|FG011|Overall Study|Withdrawal by Subject|1|||
154992304|NCT03970837|559397631|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
154992305|NCT03970837|559397632|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
154992306|NCT03970837|559397633|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
154992307|NCT03970837|559397634|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
154992308|NCT03970837|559397635|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
154992309|NCT03970837|559397636|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155120981|NCT00657150|559872966|FG000|Treatment|Non-compliant with protocol|10|||
155120982|NCT00657150|559872967|FG001|Treatment|Non-compliant with protocol|9|||
155120983|NCT00657150|559872966|FG000|Treatment|Lost to Follow-up|1|||
155120984|NCT00657150|559872967|FG001|Treatment|Lost to Follow-up|0|||
155120985|NCT00657150|559872966|FG000|Treatment|Withdrawal by Subject|23|||
154992310|NCT03970837|559397637|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
154992311|NCT03970837|559397638|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155120986|NCT00657150|559872967|FG001|Treatment|Withdrawal by Subject|20|||
155120987|NCT00657150|559872966|FG000|Treatment|Other|13|||
155120988|NCT00657150|559872967|FG001|Treatment|Other|15|||
154992312|NCT03970837|559397639|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
155120989|NCT01416441|559872968|FG000|Overall Study|Lost to Follow-up|5|||
155120990|NCT01416441|559872968|FG000|Overall Study|Adverse Event|6|||
155120991|NCT01416441|559872968|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
155120992|NCT01416441|559872968|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
155120993|NCT01416441|559872968|FG000|Overall Study|Investigator Withdrew Subject|2|||
155120994|NCT01416441|559872968|FG000|Overall Study|Subject Withdrew Consent|12|||
155120995|NCT01416441|559872968|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
155120996|NCT03515941|559872981|FG000|Overall Study|Adverse Event|1|||
155120997|NCT03515941|559872982|FG001|Overall Study|Adverse Event|0|||
155120998|NCT00461305|559872983|FG000|Treatment|Adverse Event|26|||
155120999|NCT00461305|559872984|FG001|Treatment|Adverse Event|3|||
155121000|NCT00461305|559872983|FG000|Treatment|Lost to Follow-up|4|||
155121001|NCT00461305|559872984|FG001|Treatment|Lost to Follow-up|2|||
155121002|NCT00461305|559872983|FG000|Treatment|Protocol Violation|13|||
155121003|NCT00461305|559872984|FG001|Treatment|Protocol Violation|2|||
155121004|NCT00461305|559872983|FG000|Treatment|Withdrawal by Subject|48|||
155121005|NCT00461305|559872984|FG001|Treatment|Withdrawal by Subject|2|||
155121006|NCT00461305|559872983|FG000|Treatment|Never dispensed|5|||
155121007|NCT00461305|559872984|FG001|Treatment|Never dispensed|0|||
155121008|NCT00461305|559872983|FG000|Treatment|Study drug not taken|1|||
155121009|NCT00461305|559872984|FG001|Treatment|Study drug not taken|0|||
155121010|NCT00461305|559872983|FG000|Treatment|Partially missing diary|2|||
155121011|NCT00461305|559872984|FG001|Treatment|Partially missing diary|0|||
155121012|NCT00461305|559872983|FG000|Treatment|Other (missing drug etc)|2|||
155121013|NCT00461305|559872984|FG001|Treatment|Other (missing drug etc)|0|||
155121014|NCT00461305|559872983|FG000|Continued Treatment|Adverse Event|26|||
155121015|NCT00461305|559872984|FG001|Continued Treatment|Adverse Event|0|||
155121016|NCT00461305|559872983|FG000|Continued Treatment|Lost to Follow-up|4|||
155121017|NCT00461305|559872984|FG001|Continued Treatment|Lost to Follow-up|0|||
155121018|NCT00461305|559872983|FG000|Continued Treatment|Protocol Violation|13|||
155121019|NCT00461305|559872984|FG001|Continued Treatment|Protocol Violation|0|||
155121020|NCT00461305|559872983|FG000|Continued Treatment|Withdrawal by Subject|48|||
155121021|NCT00461305|559872984|FG001|Continued Treatment|Withdrawal by Subject|0|||
155121022|NCT00461305|559872983|FG000|Continued Treatment|Partially missing diary|2|||
155121023|NCT00461305|559872984|FG001|Continued Treatment|Partially missing diary|0|||
155121024|NCT00461305|559872983|FG000|Continued Treatment|Other (missing drug etc)|2|||
155121025|NCT00461305|559872984|FG001|Continued Treatment|Other (missing drug etc)|0|||
155121026|NCT01896271|559872986|FG000|Overall Study|Physician Decision|10|||
155121027|NCT02743780|559872987|FG000|Part 3 (7 Days)|Adverse Event|0|||
155121028|NCT02743780|559872988|FG001|Part 3 (7 Days)|Adverse Event|0|||
155121029|NCT02743780|559872989|FG002|Part 3 (7 Days)|Adverse Event|1|||
155121030|NCT02743780|559872990|FG003|Part 3 (7 Days)|Adverse Event|0|||
155121031|NCT02743780|559872991|FG004|Part 3 (7 Days)|Adverse Event|0|||
155121032|NCT01294462|559872992|FG000|Overall Study|Lost to Follow-up|1|||
155121033|NCT01294462|559872993|FG001|Overall Study|Lost to Follow-up|0|||
155121034|NCT01294462|559872992|FG000|Overall Study|Withdrawal by Subject|65|||
154916999|NCT02545270|559118505|FG000|Overall Study|technical difficulties|0|||
154917000|NCT02545270|559118506|FG001|Overall Study|technical difficulties|1|||
154917001|NCT02545270|559118507|FG002|Overall Study|technical difficulties|0|||
154917002|NCT02545270|559118505|FG000|Overall Study|Videos being too similar to other|0|||
154917003|NCT02545270|559118506|FG001|Overall Study|Videos being too similar to other|0|||
154917004|NCT02545270|559118507|FG002|Overall Study|Videos being too similar to other|2|||
154917005|NCT00661362|559118508|FG000|Overall Study|Adverse Event|5|||
154917006|NCT00661362|559118509|FG001|Overall Study|Adverse Event|4|||
154917007|NCT00661362|559118508|FG000|Overall Study|Incorrect enrollment|2|||
154917008|NCT00661362|559118509|FG001|Overall Study|Incorrect enrollment|0|||
154917009|NCT00661362|559118508|FG000|Overall Study|Study specific discontinuation criteria|4|||
154917010|NCT00661362|559118509|FG001|Overall Study|Study specific discontinuation criteria|11|||
154917011|NCT00661362|559118508|FG000|Overall Study|Withdrawal by Subject|13|||
154917012|NCT00661362|559118509|FG001|Overall Study|Withdrawal by Subject|23|||
154917013|NCT00661362|559118508|FG000|Overall Study|Lost to Follow-up|3|||
154917014|NCT00661362|559118509|FG001|Overall Study|Lost to Follow-up|1|||
154917015|NCT00661362|559118508|FG000|Overall Study|Severe non-compliance to protocol|0|||
154917016|NCT00661362|559118509|FG001|Overall Study|Severe non-compliance to protocol|1|||
154917017|NCT00661362|559118508|FG000|Overall Study|Safety reasons|1|||
154917018|NCT00661362|559118509|FG001|Overall Study|Safety reasons|0|||
154917019|NCT00661362|559118508|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
154917020|NCT00661362|559118509|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
154917021|NCT00535262|559118512|FG000|Overall Study|No funding|3|||
154917022|NCT01707667|559118513|FG000|Period 1|expulsion of colonic sensor catheter|1|||
154917023|NCT01707667|559118514|FG001|Period 1|expulsion of colonic sensor catheter|0|||
154917024|NCT04382066|559118515|FG000|Overall Study|Adverse Event|1|||
154917025|NCT04382066|559118516|FG001|Overall Study|Adverse Event|0|||
154917026|NCT04382066|559118517|FG002|Overall Study|Adverse Event|0|||
154917027|NCT04382066|559118515|FG000|Overall Study|Death|1|||
154917028|NCT04382066|559118516|FG001|Overall Study|Death|0|||
154917029|NCT04382066|559118517|FG002|Overall Study|Death|1|||
154917030|NCT01430559|559118518|FG000|Overall Study|Adverse Event|7|||
154917031|NCT01430559|559118519|FG001|Overall Study|Adverse Event|3|||
155121035|NCT01294462|559872993|FG001|Overall Study|Withdrawal by Subject|63|||
155121036|NCT01460407|559872999|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
155121037|NCT01460407|559873000|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
154917032|NCT01430559|559118518|FG000|Overall Study|Entry criteria not met|1|||
154917033|NCT01430559|559118519|FG001|Overall Study|Entry criteria not met|1|||
154917034|NCT01430559|559118518|FG000|Overall Study|Lost to Follow-up|1|||
154917035|NCT01430559|559118519|FG001|Overall Study|Lost to Follow-up|0|||
154917036|NCT01430559|559118518|FG000|Overall Study|Medication error|1|||
154917037|NCT01430559|559118519|FG001|Overall Study|Medication error|0|||
154917038|NCT01430559|559118518|FG000|Overall Study|Withdrawal by Subject|3|||
154917039|NCT01430559|559118519|FG001|Overall Study|Withdrawal by Subject|2|||
154917040|NCT01430559|559118518|FG000|Overall Study|Protocol Violation|1|||
154917041|NCT01430559|559118519|FG001|Overall Study|Protocol Violation|0|||
154917042|NCT01430559|559118518|FG000|Overall Study|Other|3|||
154917043|NCT01430559|559118519|FG001|Overall Study|Other|3|||
154917044|NCT01430559|559118518|FG000|Overall Study|Randomized, Not Treated|3|||
154917045|NCT01430559|559118519|FG001|Overall Study|Randomized, Not Treated|3|||
154917046|NCT01220024|559118521|FG000|Overall Study|Lost to Follow-up|1|||
154917047|NCT01220024|559118522|FG001|Overall Study|Lost to Follow-up|1|||
154917048|NCT00174460|559118525|FG000|Overall Study|Withdrawal by Subject|0|||
154917049|NCT00174460|559118526|FG001|Overall Study|Withdrawal by Subject|1|||
154917050|NCT04225026|559118527|FG000|Overall Study|Withdrawal by Subject|4|||
154917051|NCT04225026|559118527|FG000|Overall Study|Adverse Event|1|||
154917052|NCT04225026|559118527|FG000|Overall Study|Other|1|||
154917053|NCT04225026|559118527|FG000|Overall Study|Death|11|||
154917054|NCT04225026|559118527|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
154917055|NCT00579059|559118528|FG000|Overall Study|Study Canceled at 1 Year|21|||
154917056|NCT00579059|559118529|FG001|Overall Study|Study Canceled at 1 Year|10|||
154917057|NCT04738123|559118532|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
154917058|NCT04738123|559118533|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
154917059|NCT04738123|559118532|FG000|Overall Study|Progressive Disease|0|||
154917060|NCT04738123|559118533|FG001|Overall Study|Progressive Disease|4|||
154917061|NCT04738123|559118532|FG000|Overall Study|Adverse Event|8|||
154917062|NCT04738123|559118533|FG001|Overall Study|Adverse Event|7|||
154917063|NCT04738123|559118532|FG000|Overall Study|Other Reasons|0|||
154917064|NCT04738123|559118533|FG001|Overall Study|Other Reasons|1|||
154917065|NCT04738123|559118532|FG000|Overall Study|Suicidal or assaultive behavior|0|||
154917066|NCT04738123|559118533|FG001|Overall Study|Suicidal or assaultive behavior|2|||
154917067|NCT04738123|559118532|FG000|Overall Study|Protocol Violation|2|||
154917068|NCT04738123|559118533|FG001|Overall Study|Protocol Violation|2|||
154917069|NCT04738123|559118532|FG000|Overall Study|Consent Withdrawn|35|||
154917070|NCT04738123|559118533|FG001|Overall Study|Consent Withdrawn|22|||
154917071|NCT00779506|559118534|FG000|Overall Study|Screening Failed|2|||
154917072|NCT00779506|559118534|FG000|Overall Study|Adverse Event|4|||
154917073|NCT00779506|559118534|FG000|Overall Study|Lack of Efficacy|11|||
154917074|NCT00779506|559118534|FG000|Overall Study|Protocol Violation|5|||
154917075|NCT00779506|559118534|FG000|Overall Study|Withdrawal by Subject|6|||
154917076|NCT00779506|559118534|FG000|Overall Study|Lost to Follow-up|1|||
154917077|NCT03982069|559118535|FG000|Overall Study|Lost to Follow-up|5|||
154917078|NCT03982069|559118536|FG001|Overall Study|Lost to Follow-up|5|||
154917079|NCT03982069|559118537|FG002|Overall Study|Lost to Follow-up|3|||
154917080|NCT03982069|559118538|FG003|Overall Study|Lost to Follow-up|5|||
154917081|NCT03982069|559118535|FG000|Overall Study|Physician Decision|0|||
154917082|NCT03982069|559118536|FG001|Overall Study|Physician Decision|1|||
154917083|NCT03982069|559118537|FG002|Overall Study|Physician Decision|0|||
154917084|NCT03982069|559118538|FG003|Overall Study|Physician Decision|0|||
154917085|NCT03982069|559118535|FG000|Overall Study|Withdrawal by Subject|2|||
154917086|NCT03982069|559118536|FG001|Overall Study|Withdrawal by Subject|1|||
154917087|NCT03982069|559118537|FG002|Overall Study|Withdrawal by Subject|5|||
154917088|NCT03982069|559118538|FG003|Overall Study|Withdrawal by Subject|2|||
154917089|NCT03982069|559118535|FG000|Overall Study|Specimen loss|3|||
154917090|NCT03982069|559118536|FG001|Overall Study|Specimen loss|3|||
154917091|NCT03982069|559118537|FG002|Overall Study|Specimen loss|1|||
154917092|NCT03982069|559118538|FG003|Overall Study|Specimen loss|1|||
154917093|NCT03137433|559118539|FG000|Overall Study|Withdrawal by Subject|11|||
154917094|NCT03137433|559118540|FG001|Overall Study|Withdrawal by Subject|11|||
154917095|NCT03137433|559118539|FG000|Overall Study|Lost to Follow-up|5|||
154917096|NCT03137433|559118540|FG001|Overall Study|Lost to Follow-up|6|||
154917097|NCT03137433|559118539|FG000|Overall Study|Physician Decision|2|||
154917098|NCT03137433|559118540|FG001|Overall Study|Physician Decision|0|||
154917099|NCT03137433|559118539|FG000|Overall Study|Moved out of study area|1|||
154917100|NCT03137433|559118540|FG001|Overall Study|Moved out of study area|0|||
154917101|NCT03137433|559118539|FG000|Overall Study|Too far out of window due to COVID|0|||
154917102|NCT03137433|559118540|FG001|Overall Study|Too far out of window due to COVID|1|||
154917103|NCT00914940|559118541|FG000|D0 to D100 Post-transplant|Death|2|||
154917104|NCT00914940|559118541|FG000|D101 to 2 Years Post-transplant|Death|8|||
154917105|NCT00914940|559118541|FG000|2 Years to 5 Years Post-transplant|Death|3|||
154917106|NCT01853397|559118542|FG000|Overall Study|Withdrawal by Subject|0|||
154917107|NCT01853397|559118543|FG001|Overall Study|Withdrawal by Subject|0|||
154917108|NCT01853397|559118544|FG002|Overall Study|Withdrawal by Subject|0|||
154917109|NCT01853397|559118545|FG003|Overall Study|Withdrawal by Subject|1|||
154992313|NCT03970837|559397640|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
154992314|NCT03970837|559397641|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
155121038|NCT00953680|559873001|FG000|Period 1|Withdrawal by Subject|0|||
154917110|NCT01853397|559118542|FG000|Overall Study|Subject Noncompliance|0|||
154917111|NCT01853397|559118543|FG001|Overall Study|Subject Noncompliance|0|||
154917112|NCT01853397|559118544|FG002|Overall Study|Subject Noncompliance|0|||
154917113|NCT01853397|559118545|FG003|Overall Study|Subject Noncompliance|1|||
154917114|NCT01724021|559118546|FG000|Overall Study|Adverse Event|11|||
154917115|NCT01724021|559118547|FG001|Overall Study|Adverse Event|6|||
154917116|NCT01724021|559118546|FG000|Overall Study|Death|46|||
154917117|NCT01724021|559118547|FG001|Overall Study|Death|58|||
154917118|NCT01724021|559118546|FG000|Overall Study|Participant request/ Withdrew consent|18|||
154917119|NCT01724021|559118547|FG001|Overall Study|Participant request/ Withdrew consent|14|||
154917120|NCT01724021|559118546|FG000|Overall Study|Lost to Follow-up|15|||
154917121|NCT01724021|559118547|FG001|Overall Study|Lost to Follow-up|15|||
154917122|NCT01724021|559118546|FG000|Overall Study|Reason Not Specified|36|||
154917123|NCT01724021|559118547|FG001|Overall Study|Reason Not Specified|39|||
154917124|NCT01724021|559118546|FG000|Overall Study|Missing|1|||
154917125|NCT01724021|559118547|FG001|Overall Study|Missing|1|||
154917126|NCT01005875|559118548|FG000|Overall Study|Death|3|||
154917127|NCT00606931|559118549|FG000|Overall Study|Withdrawal by Subject|3|||
154917128|NCT00286234|559118550|FG000|Overall Study|Protocol Violation|1|||
154917129|NCT00286234|559118551|FG001|Overall Study|Protocol Violation|2|||
154917130|NCT00286234|559118552|FG002|Overall Study|Protocol Violation|0|||
154917131|NCT00286234|559118553|FG003|Overall Study|Protocol Violation|1|||
154917132|NCT00286234|559118550|FG000|Overall Study|Physician Decision|1|||
154917133|NCT00286234|559118551|FG001|Overall Study|Physician Decision|0|||
154917134|NCT00286234|559118552|FG002|Overall Study|Physician Decision|0|||
154917135|NCT00286234|559118553|FG003|Overall Study|Physician Decision|1|||
154917136|NCT00286234|559118550|FG000|Overall Study|Adverse Event|0|||
154917137|NCT00286234|559118551|FG001|Overall Study|Adverse Event|0|||
154917138|NCT00286234|559118552|FG002|Overall Study|Adverse Event|0|||
154917139|NCT00286234|559118553|FG003|Overall Study|Adverse Event|1|||
154917140|NCT00286234|559118550|FG000|Overall Study|Adverse Event|0|||
154917141|NCT00286234|559118551|FG001|Overall Study|Adverse Event|0|||
154917142|NCT00286234|559118552|FG002|Overall Study|Adverse Event|0|||
154917143|NCT00286234|559118553|FG003|Overall Study|Adverse Event|1|||
154917144|NCT03742271|559118562|FG000|Overall Study|Unsatisfactory Visual Response|1|||
154917145|NCT03742271|559118562|FG000|Overall Study|Withdrawal by Subject|3|||
154917146|NCT03742271|559118562|FG000|Overall Study|Lost to Follow-up|4|||
154917147|NCT03742271|559118562|FG000|Overall Study|Failed Insertion & removal|3|||
154917148|NCT03742271|559118562|FG000|Overall Study|Protocol Violation|1|||
154917149|NCT01468844|559118563|FG000|Overall Study|Adverse Event|1|||
154917150|NCT01468844|559118564|FG001|Overall Study|Adverse Event|0|||
154917151|NCT01468844|559118563|FG000|Overall Study|Withdrawal by Subject|1|||
154917152|NCT01468844|559118564|FG001|Overall Study|Withdrawal by Subject|0|||
154917153|NCT00266695|559118567|FG000|Overall Study|Adverse Event|1|||
154917154|NCT00266695|559118567|FG000|Overall Study|Death|9|||
154917155|NCT00266695|559118567|FG000|Overall Study|Physician Decision|1|||
154917156|NCT00266695|559118567|FG000|Overall Study|Lost to Follow-up|3|||
154917157|NCT00266695|559118567|FG000|Overall Study|Withdrawal by Subject|15|||
154917158|NCT02853318|559118568|FG000|Overall Study|Withdrawal by Subject|1|||
154917159|NCT04490499|559118569|FG000|Overall Study|Withdrawal by Subject|2|||
154917160|NCT03125902|559118572|FG000|Overall Study|Adverse Event|0|||
154917161|NCT03125902|559118573|FG001|Overall Study|Adverse Event|1|||
154917162|NCT03125902|559118572|FG000|Overall Study|Death|119|||
154917163|NCT03125902|559118573|FG001|Overall Study|Death|229|||
154917164|NCT03125902|559118572|FG000|Overall Study|Lost to Follow-up|4|||
154917165|NCT03125902|559118573|FG001|Overall Study|Lost to Follow-up|13|||
154917166|NCT03125902|559118572|FG000|Overall Study|Other|0|||
154917167|NCT03125902|559118573|FG001|Overall Study|Other|4|||
154917168|NCT03125902|559118572|FG000|Overall Study|Physician Decision|2|||
154917169|NCT03125902|559118573|FG001|Overall Study|Physician Decision|1|||
154917170|NCT03125902|559118572|FG000|Overall Study|Progressive Disease|0|||
154917171|NCT03125902|559118573|FG001|Overall Study|Progressive Disease|3|||
154917172|NCT03125902|559118572|FG000|Overall Study|Study Terminated By Sponsor|74|||
154917173|NCT03125902|559118573|FG001|Overall Study|Study Terminated By Sponsor|143|||
154917174|NCT03125902|559118572|FG000|Overall Study|Withdrawal by Subject|21|||
154917175|NCT03125902|559118573|FG001|Overall Study|Withdrawal by Subject|37|||
154917176|NCT01843933|559118574|FG000|Overall Study|Data lost|6|||
154917177|NCT01843933|559118575|FG001|Overall Study|Data lost|4|||
154917178|NCT00440232|559118578|FG000|Overall Study|Lost to Follow-up|1|||
154917179|NCT00440232|559118579|FG001|Overall Study|Lost to Follow-up|1|||
154917180|NCT00440232|559118578|FG000|Overall Study|Unable to treat within allowed time|0|||
154917181|NCT00440232|559118579|FG001|Overall Study|Unable to treat within allowed time|1|||
154917182|NCT00440232|559118578|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
154917183|NCT00440232|559118579|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
154917184|NCT00819052|559118580|FG000|Overall Study|Adverse Event|0|||
154917185|NCT00819052|559118581|FG001|Overall Study|Adverse Event|5|||
154992315|NCT03970837|559397642|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
154992316|NCT03970837|559397631|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
154992317|NCT03970837|559397632|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
154992318|NCT03970837|559397633|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
154992319|NCT03970837|559397634|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
154992320|NCT03970837|559397635|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
154992321|NCT03970837|559397636|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
154992322|NCT03970837|559397637|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
154992323|NCT03970837|559397638|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
154992324|NCT03970837|559397639|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
154992325|NCT03970837|559397640|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
154992326|NCT03970837|559397641|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
154992327|NCT03970837|559397642|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
154992328|NCT02582866|559397650|FG000|Overall Study|Death|1|||
154992329|NCT02582866|559397650|FG000|Overall Study|Lack of Efficacy|2|||
154992330|NCT02582866|559397650|FG000|Overall Study|Lost to Follow-up|2|||
154992331|NCT02582866|559397650|FG000|Overall Study|Withdrawal by Subject|7|||
154992332|NCT02582866|559397650|FG000|Overall Study|Investigator decision|5|||
154992333|NCT02582866|559397650|FG000|Overall Study|Participant wants to get pregnant|1|||
154992334|NCT02582866|559397650|FG000|Overall Study|Pregnancy|2|||
154992335|NCT02582866|559397650|FG000|Overall Study|Sponsor decision|1|||
154992336|NCT02582866|559397650|FG000|Overall Study|Withdrawal due to personal reasons|1|||
154992337|NCT03567382|559397655|FG000|Overall Study|Lost to Follow-up|1|||
154992338|NCT03567382|559397656|FG001|Overall Study|Lost to Follow-up|21|||
154992339|NCT03567382|559397657|FG002|Overall Study|Lost to Follow-up|1|||
154992340|NCT03567382|559397658|FG003|Overall Study|Lost to Follow-up|21|||
154992341|NCT03567382|559397655|FG000|Overall Study|Withdrawal by Subject|2|||
154992342|NCT03567382|559397656|FG001|Overall Study|Withdrawal by Subject|14|||
154992343|NCT03567382|559397657|FG002|Overall Study|Withdrawal by Subject|1|||
154992344|NCT03567382|559397658|FG003|Overall Study|Withdrawal by Subject|12|||
154992345|NCT02011386|559397663|FG000|Overall Study|Non-compliance|2|||
154992346|NCT02011386|559397663|FG000|Overall Study|Lack of Efficacy|3|||
154992347|NCT01193127|559397664|FG000|Randomized|Surgery Cancelled|0|||
154992348|NCT01193127|559397665|FG001|Randomized|Surgery Cancelled|0|||
154992349|NCT01193127|559397666|FG002|Randomized|Surgery Cancelled|0|||
154992350|NCT01193127|559397667|FG003|Randomized|Surgery Cancelled|1|||
154992351|NCT01193127|559397664|FG000|Treated|Withdrawal by Subject|0|||
154992352|NCT01193127|559397665|FG001|Treated|Withdrawal by Subject|0|||
154992353|NCT01193127|559397666|FG002|Treated|Withdrawal by Subject|0|||
154992354|NCT01193127|559397667|FG003|Treated|Withdrawal by Subject|1|||
154992355|NCT02352779|559397675|FG000|Overall Study|Personal Issues|1|||
154992356|NCT02352779|559397676|FG001|Overall Study|Personal Issues|1|||
154992357|NCT02352779|559397677|FG002|Overall Study|Personal Issues|0|||
154992358|NCT02352779|559397675|FG000|Overall Study|Too Many Forms|2|||
154992359|NCT02352779|559397676|FG001|Overall Study|Too Many Forms|0|||
154992360|NCT02352779|559397677|FG002|Overall Study|Too Many Forms|0|||
154992361|NCT02352779|559397675|FG000|Overall Study|Feeling Overwhelmed|1|||
154992362|NCT02352779|559397676|FG001|Overall Study|Feeling Overwhelmed|0|||
154992363|NCT02352779|559397677|FG002|Overall Study|Feeling Overwhelmed|0|||
154992364|NCT02352779|559397675|FG000|Overall Study|Disliked Intervention|1|||
154992365|NCT02352779|559397676|FG001|Overall Study|Disliked Intervention|0|||
154992366|NCT02352779|559397677|FG002|Overall Study|Disliked Intervention|0|||
154992367|NCT02352779|559397675|FG000|Overall Study|Changed Mind|1|||
155121039|NCT00953680|559873002|FG001|Period 1|Withdrawal by Subject|1|||
155121040|NCT02032407|559874948|FG000|Overall Study|Lost to Follow-up|2|||
155121041|NCT02032407|559874948|FG000|Overall Study|Pregnancy|1|||
155121042|NCT02032407|559874948|FG000|Overall Study|Other Miscellaneous Reasons|2|||
154917186|NCT00819052|559118580|FG000|Overall Study|Protocol Violation|1|||
154917187|NCT00819052|559118581|FG001|Overall Study|Protocol Violation|2|||
154917188|NCT00819052|559118580|FG000|Overall Study|Lost to Follow-up|1|||
154917189|NCT00819052|559118581|FG001|Overall Study|Lost to Follow-up|2|||
154917190|NCT00819052|559118580|FG000|Overall Study|Withdrawal by Subject|1|||
154917191|NCT00819052|559118581|FG001|Overall Study|Withdrawal by Subject|2|||
154917192|NCT00819052|559118580|FG000|Overall Study|Lack of Efficacy|1|||
154917193|NCT00819052|559118581|FG001|Overall Study|Lack of Efficacy|1|||
154917194|NCT00819052|559118580|FG000|Overall Study|Pregnancy|1|||
154917195|NCT00819052|559118581|FG001|Overall Study|Pregnancy|2|||
154917196|NCT00819052|559118580|FG000|Overall Study|Death or events leading to death|1|||
154917197|NCT00819052|559118581|FG001|Overall Study|Death or events leading to death|0|||
154917198|NCT00362297|559118582|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
154917199|NCT00362297|559118583|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
154917200|NCT03512028|559118584|FG000|Overall Study|Withdrawal by Subject|2|||
154917201|NCT03512028|559118585|FG001|Overall Study|Withdrawal by Subject|0|||
154917202|NCT03512028|559118584|FG000|Overall Study|Protocol Violation|2|||
154992368|NCT02352779|559397676|FG001|Overall Study|Changed Mind|0|||
154992369|NCT02352779|559397677|FG002|Overall Study|Changed Mind|0|||
154992370|NCT02352779|559397675|FG000|Overall Study|Study Related Symptoms|1|||
154992371|NCT02352779|559397676|FG001|Overall Study|Study Related Symptoms|0|||
154992372|NCT02352779|559397677|FG002|Overall Study|Study Related Symptoms|0|||
154992373|NCT02352779|559397675|FG000|Overall Study|Absence of Symptoms|1|||
154992374|NCT02352779|559397676|FG001|Overall Study|Absence of Symptoms|0|||
154992375|NCT02352779|559397677|FG002|Overall Study|Absence of Symptoms|0|||
154992376|NCT02352779|559397675|FG000|Overall Study|Other Medical Reason|0|||
154992377|NCT02352779|559397676|FG001|Overall Study|Other Medical Reason|0|||
154992378|NCT02352779|559397677|FG002|Overall Study|Other Medical Reason|1|||
154992379|NCT02352779|559397675|FG000|Overall Study|No Reason|0|||
154992380|NCT02352779|559397676|FG001|Overall Study|No Reason|0|||
154992381|NCT02352779|559397677|FG002|Overall Study|No Reason|1|||
154992382|NCT04555720|559397678|FG000|Overall Study|Lost to Follow-up|2|||
154992383|NCT04555720|559397679|FG001|Overall Study|Lost to Follow-up|0|||
154992384|NCT04555720|559397680|FG002|Overall Study|Lost to Follow-up|0|||
154992385|NCT04555720|559397681|FG003|Overall Study|Lost to Follow-up|0|||
154992386|NCT04555720|559397678|FG000|Overall Study|Withdrawal by Subject|4|||
154992387|NCT04555720|559397679|FG001|Overall Study|Withdrawal by Subject|6|||
154992388|NCT04555720|559397680|FG002|Overall Study|Withdrawal by Subject|0|||
154992389|NCT04555720|559397681|FG003|Overall Study|Withdrawal by Subject|0|||
154992390|NCT00719849|559397682|FG000|Overall Study|Death|0|||
154992391|NCT00719849|559397683|FG001|Overall Study|Death|1|||
154992392|NCT02213510|559400601|FG000|Overall Study|Death|0|||
154992393|NCT02213510|559400602|FG001|Overall Study|Death|1|||
154992394|NCT02213510|559400601|FG000|Overall Study|Lost to Follow-up|1|||
154992395|NCT02213510|559400602|FG001|Overall Study|Lost to Follow-up|0|||
154992396|NCT04590040|559400607|FG000|Treatment Period|Lost to Follow-up|2|||
154992397|NCT04590040|559400608|FG001|Treatment Period|Lost to Follow-up|5|||
154992398|NCT04590040|559400609|FG002|Treatment Period|Lost to Follow-up|0|||
154992399|NCT04590040|559400607|FG000|Treatment Period|Physician Decision|0|||
154992400|NCT04590040|559400608|FG001|Treatment Period|Physician Decision|0|||
154992401|NCT04590040|559400609|FG002|Treatment Period|Physician Decision|2|||
154992402|NCT00000378|559400615|FG000|Overall Study|Lack of Efficacy|16|||
154992403|NCT00000378|559400616|FG001|Overall Study|Lack of Efficacy|14|||
154992404|NCT01284361|559400619|FG000|Overall Study|Withdrawal by Subject|1|||
154992405|NCT01284361|559400619|FG000|Overall Study|Protocol Violation|5|||
154992406|NCT01284361|559400619|FG000|Overall Study|Adverse Event|1|||
154992407|NCT01284361|559400619|FG000|Overall Study|Lost to Follow-up|2|||
154992408|NCT00805675|559400620|FG000|Overall Study|Adverse Event|0|||
154992409|NCT00805675|559400621|FG001|Overall Study|Adverse Event|0|||
154992410|NCT00805675|559400622|FG002|Overall Study|Adverse Event|1|||
154992411|NCT01957397|559400626|FG000|Test Period 1|sudden leakage/small bag|1|||
154992412|NCT01957397|559400627|FG001|Test Period 1|sudden leakage/small bag|1|||
154992413|NCT01957397|559400626|FG000|Test Period 1|Withdrawal by Subject|1|||
154992414|NCT01957397|559400627|FG001|Test Period 1|Withdrawal by Subject|0|||
154992415|NCT01957397|559400626|FG000|Test Period 2|Adverse Event|0|||
154992416|NCT01957397|559400627|FG001|Test Period 2|Adverse Event|1|||
154992417|NCT01957397|559400626|FG000|Test Period 3|Adverse Event|1|||
154992418|NCT01957397|559400627|FG001|Test Period 3|Adverse Event|2|||
154992419|NCT01957397|559400626|FG000|Test Period 3|the adhesive did not work|1|||
154992420|NCT01957397|559400627|FG001|Test Period 3|the adhesive did not work|0|||
154992421|NCT00540293|559400628|FG000|Overall Study|Adverse event related to study drug|10|||
154992422|NCT00540293|559400628|FG000|Overall Study|Adverse event not related to study drug|7|||
154992423|NCT00540293|559400628|FG000|Overall Study|Withdrawal by Subject|6|||
154992424|NCT00540293|559400628|FG000|Overall Study|Protocol violation, & subject schedule|12|||
154992425|NCT00325195|559400631|FG000|Randomized|Not dosed|5|||
154992426|NCT00325195|559400632|FG001|Randomized|Not dosed|5|||
154992427|NCT00325195|559400633|FG002|Randomized|Not dosed|3|||
154992428|NCT00325195|559400631|FG000|Received Intervention: ITT Population|Adverse Event|15|||
154992429|NCT00325195|559400632|FG001|Received Intervention: ITT Population|Adverse Event|17|||
154992430|NCT00325195|559400633|FG002|Received Intervention: ITT Population|Adverse Event|1|||
154992431|NCT00325195|559400631|FG000|Received Intervention: ITT Population|Death|3|||
154992432|NCT00325195|559400632|FG001|Received Intervention: ITT Population|Death|1|||
154992433|NCT00325195|559400633|FG002|Received Intervention: ITT Population|Death|0|||
154992434|NCT00325195|559400631|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
154992435|NCT00325195|559400632|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
154992436|NCT00325195|559400633|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
154992437|NCT00325195|559400631|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
154992438|NCT00325195|559400632|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
154992439|NCT00325195|559400633|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
154992440|NCT00325195|559400631|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
154992441|NCT00325195|559400632|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
154992442|NCT00325195|559400633|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
154992443|NCT04715932|559400634|FG000|Overall Study|Lost to Follow-up|1|||
154992444|NCT04715932|559400635|FG001|Overall Study|Lost to Follow-up|0|||
154992445|NCT03560986|559400636|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
154992446|NCT03560986|559400637|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
154992447|NCT03560986|559400636|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
154992448|NCT03560986|559400637|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
154992449|NCT03560986|559400636|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
154992450|NCT03560986|559400637|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
154992451|NCT03560986|559400636|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
154992452|NCT03560986|559400637|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
154992453|NCT03560986|559400636|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
154992454|NCT03560986|559400637|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
154992455|NCT03560986|559400636|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
154992456|NCT03560986|559400637|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
154992457|NCT03560986|559400636|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
154992458|NCT03560986|559400637|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
154992459|NCT01868893|559400639|FG000|Overall Study|Adverse Event|2|||
154992460|NCT01868893|559400639|FG000|Overall Study|Commercial availability of study drug|17|||
154992461|NCT01868893|559400639|FG000|Overall Study|Neutropenia|1|||
154992462|NCT01783548|559400640|FG000|Overall Study|Adverse Event|8|||
154992463|NCT01783548|559400641|FG001|Overall Study|Adverse Event|4|||
154992464|NCT01783548|559400640|FG000|Overall Study|Withdrawal by Subject|11|||
154992465|NCT01783548|559400641|FG001|Overall Study|Withdrawal by Subject|8|||
154992466|NCT01783548|559400640|FG000|Overall Study|Non-compliance|4|||
154992467|NCT01783548|559400641|FG001|Overall Study|Non-compliance|0|||
154992468|NCT01783548|559400640|FG000|Overall Study|Protocol Violation|2|||
154992469|NCT01783548|559400641|FG001|Overall Study|Protocol Violation|2|||
154992470|NCT01783548|559400640|FG000|Overall Study|Lost to Follow-up|8|||
154992471|NCT01783548|559400641|FG001|Overall Study|Lost to Follow-up|3|||
154992472|NCT01783548|559400640|FG000|Overall Study|Lack of Efficacy|1|||
154992473|NCT01783548|559400641|FG001|Overall Study|Lack of Efficacy|1|||
154992474|NCT03825341|559400642|FG000|Overall Study|Withdrawal by Subject|0|||
154992475|NCT03825341|559400643|FG001|Overall Study|Withdrawal by Subject|1|||
154992476|NCT04283500|559400646|FG000|Overall Study|Lost to Follow-up|8|||
154992477|NCT04283500|559400646|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
154992478|NCT04053465|559400651|FG000|Overall Study|Withdrawal by Subject|4|||
154992479|NCT04053465|559400652|FG001|Overall Study|Withdrawal by Subject|4|||
154992480|NCT02085135|559400653|FG000|Overall Study|Adverse Event|4|||
154992481|NCT02085135|559400654|FG001|Overall Study|Adverse Event|7|||
154992482|NCT02085135|559400653|FG000|Overall Study|Lost to Follow-up|2|||
154992483|NCT02085135|559400654|FG001|Overall Study|Lost to Follow-up|2|||
154992484|NCT02085135|559400653|FG000|Overall Study|Withdrawal by Subject|3|||
154992485|NCT02085135|559400654|FG001|Overall Study|Withdrawal by Subject|0|||
154992486|NCT02085135|559400653|FG000|Overall Study|Lack of Efficacy|2|||
154992487|NCT02085135|559400654|FG001|Overall Study|Lack of Efficacy|0|||
154992488|NCT02885181|559400655|FG000|Overall Study|Investigator's Discretion|0|||
154992489|NCT02885181|559400656|FG001|Overall Study|Investigator's Discretion|1|||
154992490|NCT02885181|559400657|FG002|Overall Study|Investigator's Discretion|0|||
154992491|NCT02885181|559400658|FG003|Overall Study|Investigator's Discretion|1|||
154992492|NCT02885181|559400655|FG000|Overall Study|Adverse Event|0|||
154992493|NCT02885181|559400656|FG001|Overall Study|Adverse Event|0|||
154992494|NCT02885181|559400657|FG002|Overall Study|Adverse Event|0|||
154992495|NCT02885181|559400658|FG003|Overall Study|Adverse Event|1|||
154992496|NCT02885181|559400655|FG000|Overall Study|Withdrawal by Subject|0|||
154992497|NCT02885181|559400656|FG001|Overall Study|Withdrawal by Subject|0|||
154992498|NCT02885181|559400657|FG002|Overall Study|Withdrawal by Subject|0|||
154992499|NCT02885181|559400658|FG003|Overall Study|Withdrawal by Subject|1|||
154992500|NCT03317834|559400659|FG000|Overall Study|Death|2|||
154992501|NCT03317834|559400659|FG000|Overall Study|Device Revision|5|||
154992502|NCT03317834|559400659|FG000|Overall Study|Withdrawal by Subject|13|||
154992503|NCT03317834|559400659|FG000|Overall Study|Lost to Follow-up|13|||
154992504|NCT04228783|559400660|FG000|Overall Study|Adverse Event|1|||
154992505|NCT04228783|559400661|FG001|Overall Study|Adverse Event|0|||
154992506|NCT04228783|559400662|FG002|Overall Study|Adverse Event|2|||
154992507|NCT04228783|559400663|FG003|Overall Study|Adverse Event|0|||
154992508|NCT04228783|559400664|FG004|Overall Study|Adverse Event|0|||
154992509|NCT04228783|559400665|FG005|Overall Study|Adverse Event|1|||
154992510|NCT04228783|559400660|FG000|Overall Study|Death|0|||
154992511|NCT04228783|559400661|FG001|Overall Study|Death|0|||
154992512|NCT04228783|559400662|FG002|Overall Study|Death|0|||
154992513|NCT04228783|559400663|FG003|Overall Study|Death|0|||
154992514|NCT04228783|559400664|FG004|Overall Study|Death|1|||
154992515|NCT04228783|559400665|FG005|Overall Study|Death|0|||
154992516|NCT04228783|559400660|FG000|Overall Study|Lost to Follow-up|36|||
154992517|NCT04228783|559400661|FG001|Overall Study|Lost to Follow-up|36|||
154992518|NCT04228783|559400662|FG002|Overall Study|Lost to Follow-up|28|||
154992519|NCT04228783|559400663|FG003|Overall Study|Lost to Follow-up|6|||
154992520|NCT04228783|559400664|FG004|Overall Study|Lost to Follow-up|14|||
154992521|NCT04228783|559400665|FG005|Overall Study|Lost to Follow-up|3|||
154992522|NCT04228783|559400660|FG000|Overall Study|Physician Decision|1|||
154992523|NCT04228783|559400661|FG001|Overall Study|Physician Decision|2|||
154992524|NCT04228783|559400662|FG002|Overall Study|Physician Decision|0|||
154992525|NCT04228783|559400663|FG003|Overall Study|Physician Decision|0|||
154992526|NCT04228783|559400664|FG004|Overall Study|Physician Decision|0|||
154992527|NCT04228783|559400665|FG005|Overall Study|Physician Decision|0|||
154992528|NCT04228783|559400660|FG000|Overall Study|Protocol Violation|0|||
154992529|NCT04228783|559400661|FG001|Overall Study|Protocol Violation|0|||
154992530|NCT04228783|559400662|FG002|Overall Study|Protocol Violation|0|||
154992531|NCT04228783|559400663|FG003|Overall Study|Protocol Violation|1|||
154992532|NCT04228783|559400664|FG004|Overall Study|Protocol Violation|0|||
154992533|NCT04228783|559400665|FG005|Overall Study|Protocol Violation|0|||
154992534|NCT04228783|559400660|FG000|Overall Study|Withdrawal by Subject|6|||
154992535|NCT04228783|559400661|FG001|Overall Study|Withdrawal by Subject|10|||
154992536|NCT04228783|559400662|FG002|Overall Study|Withdrawal by Subject|19|||
154992537|NCT04228783|559400663|FG003|Overall Study|Withdrawal by Subject|1|||
154992538|NCT04228783|559400664|FG004|Overall Study|Withdrawal by Subject|2|||
154992539|NCT04228783|559400665|FG005|Overall Study|Withdrawal by Subject|0|||
154992540|NCT04228783|559400660|FG000|Overall Study|Other|4|||
154992541|NCT04228783|559400661|FG001|Overall Study|Other|3|||
154992542|NCT04228783|559400662|FG002|Overall Study|Other|2|||
154992543|NCT04228783|559400663|FG003|Overall Study|Other|1|||
154992544|NCT04228783|559400664|FG004|Overall Study|Other|0|||
154992545|NCT04228783|559400665|FG005|Overall Study|Other|0|||
154992546|NCT03151811|559400668|FG000|Overall Study|Randomized But Not Treated|18|||
154992547|NCT03151811|559400669|FG001|Overall Study|Randomized But Not Treated|3|||
154992548|NCT03151811|559400668|FG000|Overall Study|Progressive Disease|130|||
154992549|NCT03151811|559400669|FG001|Overall Study|Progressive Disease|170|||
154992550|NCT03151811|559400668|FG000|Overall Study|Adverse Event|49|||
154992551|NCT03151811|559400669|FG001|Overall Study|Adverse Event|40|||
154992552|NCT03151811|559400668|FG000|Overall Study|Lack of Efficacy|6|||
154992553|NCT03151811|559400669|FG001|Overall Study|Lack of Efficacy|8|||
154992554|NCT03151811|559400668|FG000|Overall Study|Physician Decision|21|||
154992555|NCT03151811|559400669|FG001|Overall Study|Physician Decision|9|||
154992556|NCT03151811|559400668|FG000|Overall Study|Withdrawal by Subject|17|||
154992557|NCT03151811|559400669|FG001|Overall Study|Withdrawal by Subject|7|||
154992558|NCT03151811|559400668|FG000|Overall Study|Lost to Follow-up|0|||
154992559|NCT03151811|559400669|FG001|Overall Study|Lost to Follow-up|1|||
154992560|NCT03151811|559400668|FG000|Overall Study|Study Terminated by Sponsor|5|||
154992561|NCT03151811|559400669|FG001|Overall Study|Study Terminated by Sponsor|11|||
154992562|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
154992563|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
154992564|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
154992565|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
154992566|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
154992567|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
154992568|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
154992569|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
154992570|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
154992571|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
154992572|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Death|1|||
154992573|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Death|0|||
154992574|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Death|0|||
154992575|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Death|0|||
154992576|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Death|0|||
154992577|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
154992578|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
154992579|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
154992580|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
154992581|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
154992582|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
154992583|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
154992584|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
154992585|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
154992586|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
154992587|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
154992588|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
154992589|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
154992590|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
154992591|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
154992592|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
154992593|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
154992594|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
154992595|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
154992596|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
154992597|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
154992598|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
154992599|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
154992600|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
154992601|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
154992602|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Other|4|||
154992603|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Other|4|||
154992604|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Other|3|||
154992605|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Other|1|||
154992606|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Other|0|||
154992607|NCT01081834|559400678|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
154992608|NCT01081834|559400679|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
154992609|NCT01081834|559400680|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
154992610|NCT01081834|559400681|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
154992611|NCT01081834|559400682|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
154992612|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
154992613|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
154992614|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
154992615|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
154992616|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
154992617|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Death|1|||
154992618|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Death|0|||
154992619|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Death|0|||
154992620|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Death|0|||
154992621|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Death|0|||
154992622|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
154992623|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
154992624|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
154992625|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
154992626|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
154992627|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
154992628|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
154992629|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
154992630|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
154992631|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
154992632|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
154992633|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
154992634|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
154992635|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
154992636|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
154992637|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
154992638|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
154992639|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
154992640|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
154992641|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
154992642|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
154992643|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
154992644|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
154992645|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
154992646|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
154992647|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Other|4|||
154992648|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Other|5|||
154992649|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Other|4|||
154992650|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Other|0|||
154992651|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Other|0|||
154992652|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
154992653|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
154992654|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
154992655|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
154992656|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
154992657|NCT01081834|559400678|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
154992658|NCT01081834|559400679|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
155121043|NCT02091284|559874949|FG000|Overall Study|Withdrawal by Subject|2|||
155121044|NCT02091284|559874950|FG001|Overall Study|Withdrawal by Subject|1|||
154917203|NCT03512028|559118585|FG001|Overall Study|Protocol Violation|0|||
154917204|NCT03529162|559118586|FG000|Overall Study|Lost to Follow-up|2|||
154917205|NCT03529162|559118587|FG001|Overall Study|Lost to Follow-up|2|||
154917206|NCT00517634|559118588|FG000|Second Treatment Period|Withdrawal by Subject|0|||
154917207|NCT00517634|559118589|FG001|Second Treatment Period|Withdrawal by Subject|0|||
154917208|NCT00517634|559118590|FG002|Second Treatment Period|Withdrawal by Subject|0|||
154917209|NCT00517634|559118591|FG003|Second Treatment Period|Withdrawal by Subject|0|||
154917210|NCT00517634|559118592|FG004|Second Treatment Period|Withdrawal by Subject|1|||
154917211|NCT00517634|559118593|FG005|Second Treatment Period|Withdrawal by Subject|0|||
154917212|NCT00701064|559118594|FG000|Overall Study|Protocol Violation|1|||
154917213|NCT00701064|559118595|FG001|Overall Study|Protocol Violation|1|||
154917214|NCT00701064|559118594|FG000|Overall Study|Withdrawal by Subject|1|||
154917215|NCT00701064|559118595|FG001|Overall Study|Withdrawal by Subject|1|||
154917216|NCT00701064|559118594|FG000|Overall Study|initiated other PTSD treatment|2|||
154917217|NCT00701064|559118595|FG001|Overall Study|initiated other PTSD treatment|2|||
154917218|NCT02098733|559118596|FG000|Overall Study|Data Not Available|5|||
154917219|NCT02098733|559118596|FG000|Overall Study|Lost to Follow-up|5|||
154917220|NCT00939094|559118597|FG000|Overall Study|Adverse Event|9|||
154917221|NCT00939094|559118598|FG001|Overall Study|Adverse Event|0|||
154917222|NCT00939094|559118597|FG000|Overall Study|Withdrawal by Subject|1|||
154917223|NCT00939094|559118598|FG001|Overall Study|Withdrawal by Subject|6|||
154917224|NCT00939094|559118597|FG000|Overall Study|Lost to Follow-up|1|||
154917225|NCT00939094|559118598|FG001|Overall Study|Lost to Follow-up|1|||
154917226|NCT00939094|559118597|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
154917227|NCT00939094|559118598|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
154917228|NCT00939094|559118597|FG000|Overall Study|Severe non-compliance to protocol|0|||
154917229|NCT00939094|559118598|FG001|Overall Study|Severe non-compliance to protocol|1|||
154917230|NCT00939094|559118597|FG000|Overall Study|Study stopped by sponsor|0|||
154917231|NCT00939094|559118598|FG001|Overall Study|Study stopped by sponsor|2|||
154917232|NCT00939094|559118597|FG000|Overall Study|Abnormal ECG findings|1|||
154917233|NCT00939094|559118598|FG001|Overall Study|Abnormal ECG findings|0|||
154917234|NCT01078389|559120240|FG000|Overall Study|Adverse Event|10|||
154917235|NCT01078389|559120241|FG001|Overall Study|Adverse Event|6|||
154917236|NCT01078389|559120240|FG000|Overall Study|Major Protocol Deviation|2|||
154917237|NCT01078389|559120241|FG001|Overall Study|Major Protocol Deviation|0|||
154917238|NCT01078389|559120240|FG000|Overall Study|Lost to Follow-up|23|||
154917239|NCT01078389|559120241|FG001|Overall Study|Lost to Follow-up|23|||
154917240|NCT01078389|559120240|FG000|Overall Study|Voluntary Withdrawal|20|||
154917241|NCT01078389|559120241|FG001|Overall Study|Voluntary Withdrawal|36|||
154917242|NCT01078389|559120240|FG000|Overall Study|Other|9|||
154917243|NCT01078389|559120241|FG001|Overall Study|Other|2|||
154917244|NCT04823494|559120242|FG000|Overall Study|Programming software malfunction.|1|||
154917245|NCT04823494|559120243|FG001|Overall Study|Programming software malfunction.|0|||
154917246|NCT04823494|559120242|FG000|Overall Study|Withdrawal by Subject|1|||
154917247|NCT04823494|559120243|FG001|Overall Study|Withdrawal by Subject|0|||
154917248|NCT04823494|559120242|FG000|Overall Study|Devices lost|0|||
154917249|NCT04823494|559120243|FG001|Overall Study|Devices lost|1|||
154917250|NCT01884675|559120244|FG000|Overall Study|Study closed/terminated|3|||
154917251|NCT01884675|559120245|FG001|Overall Study|Study closed/terminated|2|||
154917252|NCT02361307|559120246|FG000|Overall Study|Unstable medical condition.|0|||
154917253|NCT02361307|559120247|FG001|Overall Study|Unstable medical condition.|1|||
154917254|NCT01277757|559120248|FG000|Overall Study|Disease Progression|1|||
154917255|NCT01277757|559120248|FG000|Overall Study|Withdrawal by Subject|1|||
154917256|NCT00421928|559120249|FG000|Overall Study|Adverse Event|61|||
154917257|NCT00421928|559120250|FG001|Overall Study|Adverse Event|140|||
154917258|NCT00421928|559120251|FG002|Overall Study|Adverse Event|22|||
154917259|NCT00421928|559120249|FG000|Overall Study|Lost to Follow-up|5|||
154917260|NCT00421928|559120250|FG001|Overall Study|Lost to Follow-up|0|||
154917261|NCT00421928|559120251|FG002|Overall Study|Lost to Follow-up|3|||
154917262|NCT00421928|559120249|FG000|Overall Study|Withdrawal by Subject|50|||
154917263|NCT00421928|559120250|FG001|Overall Study|Withdrawal by Subject|48|||
154917264|NCT00421928|559120251|FG002|Overall Study|Withdrawal by Subject|43|||
154917265|NCT00421928|559120249|FG000|Overall Study|Lack of Efficacy|15|||
154917266|NCT00421928|559120250|FG001|Overall Study|Lack of Efficacy|7|||
154917267|NCT00421928|559120251|FG002|Overall Study|Lack of Efficacy|35|||
154917268|NCT00421928|559120249|FG000|Overall Study|Study drug non-compliant|6|||
154917269|NCT00421928|559120250|FG001|Overall Study|Study drug non-compliant|7|||
154917270|NCT00421928|559120251|FG002|Overall Study|Study drug non-compliant|4|||
154917271|NCT00421928|559120249|FG000|Overall Study|All other|26|||
154917272|NCT00421928|559120250|FG001|Overall Study|All other|21|||
154917273|NCT00421928|559120251|FG002|Overall Study|All other|27|||
154917274|NCT00421928|559120249|FG000|Overall Study|Death|0|||
154917275|NCT00421928|559120250|FG001|Overall Study|Death|1|||
154917276|NCT00421928|559120251|FG002|Overall Study|Death|0|||
154917277|NCT00965458|559120252|FG000|Overall Study|Adverse Event|1|||
155121045|NCT02091284|559874949|FG000|Overall Study|unreliable data|1|||
155121046|NCT02091284|559874950|FG001|Overall Study|unreliable data|0|||
155121047|NCT03383783|559874951|FG000|Overall Study|Withdrawal by Subject|2|||
154917278|NCT00965458|559120253|FG001|Overall Study|Adverse Event|0|||
154992659|NCT01081834|559400680|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
154992660|NCT01081834|559400681|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
154992661|NCT01081834|559400682|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
154992662|NCT00742924|559400685|FG000|Overall Study|Adverse Event|0|||
154992663|NCT00742924|559400686|FG001|Overall Study|Adverse Event|0|||
154992664|NCT00742924|559400687|FG002|Overall Study|Adverse Event|1|||
154992665|NCT00742924|559400688|FG003|Overall Study|Adverse Event|1|||
154992666|NCT00742924|559400685|FG000|Overall Study|Lack of Efficacy|5|||
154992667|NCT00742924|559400686|FG001|Overall Study|Lack of Efficacy|1|||
154992668|NCT00742924|559400687|FG002|Overall Study|Lack of Efficacy|2|||
154992669|NCT00742924|559400688|FG003|Overall Study|Lack of Efficacy|4|||
154992670|NCT00742924|559400685|FG000|Overall Study|Physician Decision|0|||
154992671|NCT00742924|559400686|FG001|Overall Study|Physician Decision|0|||
154992672|NCT00742924|559400687|FG002|Overall Study|Physician Decision|0|||
154992673|NCT00742924|559400688|FG003|Overall Study|Physician Decision|1|||
154992674|NCT00742924|559400685|FG000|Overall Study|Withdrawal by Subject|0|||
154992675|NCT00742924|559400686|FG001|Overall Study|Withdrawal by Subject|1|||
154992676|NCT00742924|559400687|FG002|Overall Study|Withdrawal by Subject|1|||
154992677|NCT00742924|559400688|FG003|Overall Study|Withdrawal by Subject|0|||
154992678|NCT00660400|559400689|FG000|Overall Study|Lack of insurance approval|1|||
154992679|NCT00660400|559400689|FG000|Overall Study|Suboptimal organ function|1|||
154992680|NCT00660400|559400689|FG000|Overall Study|Intracranial hemorrhage|1|||
154992681|NCT00660400|559400689|FG000|Overall Study|Withdrawal by Subject|1|||
154992682|NCT01161407|559400690|FG000|Overall Study|Protocol Violation|3|||
154917279|NCT00965458|559120252|FG000|Overall Study|Lost to Follow-up|1|||
154917280|NCT00965458|559120253|FG001|Overall Study|Lost to Follow-up|3|||
154917281|NCT00965458|559120252|FG000|Overall Study|Withdrawal by Subject|0|||
154917282|NCT00965458|559120253|FG001|Overall Study|Withdrawal by Subject|1|||
154917283|NCT01545375|559120255|FG000|Overall Study|Adverse Event|2|||
154917284|NCT01545375|559120256|FG001|Overall Study|Adverse Event|1|||
154917285|NCT01545375|559120255|FG000|Overall Study|Lost to Follow-up|34|||
154917286|NCT01545375|559120256|FG001|Overall Study|Lost to Follow-up|31|||
154917287|NCT01545375|559120255|FG000|Overall Study|Protocol Violation|3|||
154917288|NCT01545375|559120256|FG001|Overall Study|Protocol Violation|3|||
154917289|NCT01545375|559120255|FG000|Overall Study|Withdrawal by Subject|58|||
154917290|NCT01545375|559120256|FG001|Overall Study|Withdrawal by Subject|55|||
154917291|NCT04177862|559120258|FG000|Overall Study|Protocol Violation|2|||
154917292|NCT04177862|559120259|FG001|Overall Study|Protocol Violation|7|||
154917293|NCT05637515|559120260|FG000|Overall Study|Withdrawal by Subject|17|||
154917294|NCT05637515|559120261|FG001|Overall Study|Withdrawal by Subject|17|||
154917295|NCT03233009|559120262|FG000|Overall Study|Lost to Follow-up|1|||
154917296|NCT04516291|559120264|FG000|Treatment Period (24 Weeks)|Other|1|||
154917297|NCT04516291|559120265|FG001|Treatment Period (24 Weeks)|Other|0|||
154917298|NCT04516291|559120266|FG002|Treatment Period (24 Weeks)|Other|0|||
154917299|NCT04516291|559120267|FG003|Treatment Period (24 Weeks)|Other|2|||
154917300|NCT04516291|559120268|FG004|Treatment Period (24 Weeks)|Other|2|||
154917301|NCT04516291|559120269|FG005|Treatment Period (24 Weeks)|Other|4|||
154917302|NCT04516291|559120270|FG006|Treatment Period (24 Weeks)|Other|2|||
154917303|NCT04516291|559120271|FG007|Treatment Period (24 Weeks)|Other|0|||
154917304|NCT04516291|559120264|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154917305|NCT04516291|559120265|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
154917306|NCT04516291|559120266|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
154917307|NCT04516291|559120267|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154917308|NCT04516291|559120268|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
154917309|NCT04516291|559120269|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154917310|NCT04516291|559120270|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154917311|NCT04516291|559120271|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
154917312|NCT04516291|559120264|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917313|NCT04516291|559120265|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917314|NCT04516291|559120266|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917315|NCT04516291|559120267|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
154917316|NCT04516291|559120268|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917317|NCT04516291|559120269|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917318|NCT04516291|559120270|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917319|NCT04516291|559120271|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
154917320|NCT04516291|559120264|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154917321|NCT04516291|559120265|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
154992683|NCT01161407|559400691|FG001|Overall Study|Protocol Violation|1|||
154992684|NCT01777620|559400692|FG000|Overall Study|Subject Withdrawal|1|||
154992685|NCT01777620|559400693|FG001|Overall Study|Subject Withdrawal|0|||
154917322|NCT04516291|559120266|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154992686|NCT04562155|559400694|FG000|Overall Study|COVID-19 pandemic|0|||
155121048|NCT01340937|559874952|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
155121049|NCT01340937|559874953|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
155121050|NCT01340937|559874954|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
155121051|NCT01340937|559874955|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
155121052|NCT01340937|559874952|FG000|Period 1: Infant Series|Adverse Event|0|||
155121053|NCT01340937|559874953|FG001|Period 1: Infant Series|Adverse Event|1|||
155121054|NCT01340937|559874954|FG002|Period 1: Infant Series|Adverse Event|4|||
155121055|NCT01340937|559874955|FG003|Period 1: Infant Series|Adverse Event|0|||
155121056|NCT01340937|559874952|FG000|Period 1: Infant Series|Death|2|||
155121057|NCT01340937|559874953|FG001|Period 1: Infant Series|Death|0|||
155121058|NCT01340937|559874954|FG002|Period 1: Infant Series|Death|2|||
155121059|NCT01340937|559874955|FG003|Period 1: Infant Series|Death|0|||
155121060|NCT01340937|559874952|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
155121061|NCT01340937|559874953|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
155121062|NCT01340937|559874954|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
155121063|NCT01340937|559874955|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
155121064|NCT01340937|559874952|FG000|Period 1: Infant Series|Physician Decision|2|||
155121065|NCT01340937|559874953|FG001|Period 1: Infant Series|Physician Decision|3|||
155121066|NCT01340937|559874954|FG002|Period 1: Infant Series|Physician Decision|1|||
155121067|NCT01340937|559874955|FG003|Period 1: Infant Series|Physician Decision|0|||
155121068|NCT01340937|559874952|FG000|Period 1: Infant Series|Protocol Violation|1|||
155121069|NCT01340937|559874953|FG001|Period 1: Infant Series|Protocol Violation|4|||
155121070|NCT01340937|559874954|FG002|Period 1: Infant Series|Protocol Violation|4|||
155121071|NCT01340937|559874955|FG003|Period 1: Infant Series|Protocol Violation|3|||
155121072|NCT01340937|559874952|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
155121073|NCT01340937|559874953|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
155121074|NCT01340937|559874954|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
155121075|NCT01340937|559874955|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
155121076|NCT01340937|559874952|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
155121077|NCT01340937|559874953|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
155121078|NCT01340937|559874954|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
155121079|NCT01340937|559874955|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
155121080|NCT01340937|559874952|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
155121081|NCT01340937|559874953|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
155121082|NCT01340937|559874954|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
155121083|NCT01340937|559874955|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
155121084|NCT01340937|559874952|FG000|Period 2: Interim Period|Adverse Event|1|||
155121085|NCT01340937|559874953|FG001|Period 2: Interim Period|Adverse Event|0|||
155121086|NCT01340937|559874954|FG002|Period 2: Interim Period|Adverse Event|1|||
155121087|NCT01340937|559874955|FG003|Period 2: Interim Period|Adverse Event|0|||
155121088|NCT01340937|559874952|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
155121089|NCT01340937|559874953|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
155121090|NCT01340937|559874954|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
155121091|NCT01340937|559874955|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
155121092|NCT01340937|559874952|FG000|Period 2: Interim Period|Physician Decision|0|||
155121093|NCT01340937|559874953|FG001|Period 2: Interim Period|Physician Decision|1|||
155121094|NCT01340937|559874954|FG002|Period 2: Interim Period|Physician Decision|1|||
155121095|NCT01340937|559874955|FG003|Period 2: Interim Period|Physician Decision|0|||
155121096|NCT01340937|559874952|FG000|Period 2: Interim Period|Protocol Violation|5|||
155121097|NCT01340937|559874953|FG001|Period 2: Interim Period|Protocol Violation|3|||
155121098|NCT01340937|559874954|FG002|Period 2: Interim Period|Protocol Violation|6|||
155121099|NCT01340937|559874955|FG003|Period 2: Interim Period|Protocol Violation|3|||
155121100|NCT01340937|559874952|FG000|Period 2: Interim Period|Technical problems|4|||
155121101|NCT01340937|559874953|FG001|Period 2: Interim Period|Technical problems|4|||
155121102|NCT01340937|559874954|FG002|Period 2: Interim Period|Technical problems|6|||
155121103|NCT01340937|559874955|FG003|Period 2: Interim Period|Technical problems|3|||
155121104|NCT01340937|559874952|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
155121105|NCT01340937|559874953|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
155121106|NCT01340937|559874954|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
155121107|NCT01340937|559874955|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
155121108|NCT01340937|559874952|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
155121109|NCT01340937|559874953|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
155121110|NCT01340937|559874954|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
154917323|NCT04516291|559120267|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154917324|NCT04516291|559120268|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
155121111|NCT01340937|559874955|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
155121112|NCT01340937|559874952|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
155121113|NCT01340937|559874953|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
155121114|NCT01340937|559874954|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
155121115|NCT01340937|559874955|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
155121116|NCT01340937|559874952|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
155121117|NCT01340937|559874953|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
155121118|NCT01340937|559874954|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
155121119|NCT01340937|559874955|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
155121120|NCT02233738|559874956|FG000|Overall Study|Lost to Follow-up|5|||
155121121|NCT02233738|559874957|FG001|Overall Study|Lost to Follow-up|12|||
155121122|NCT02233738|559874956|FG000|Overall Study|Death|0|||
155121123|NCT02233738|559874957|FG001|Overall Study|Death|1|||
155121124|NCT02233738|559874956|FG000|Overall Study|Withdrawal by Subject|0|||
155121125|NCT02233738|559874957|FG001|Overall Study|Withdrawal by Subject|1|||
155121126|NCT02233738|559874956|FG000|Overall Study|Did not return after Baseline|3|||
155121127|NCT02233738|559874957|FG001|Overall Study|Did not return after Baseline|2|||
155121128|NCT00096174|559874961|FG000|Overall Study|Lack of Efficacy|9|||
155121129|NCT00096174|559874961|FG000|Overall Study|Adverse Event|15|||
155121130|NCT00096174|559874961|FG000|Overall Study|Death|6|||
155121131|NCT00096174|559874961|FG000|Overall Study|Withdrawal by Subject|15|||
155121132|NCT00096174|559874961|FG000|Overall Study|Not started protocol therapy|3|||
155121133|NCT00096174|559874961|FG000|Overall Study|Ineligible|6|||
155121134|NCT00096174|559874961|FG000|Overall Study|other reason|8|||
155121135|NCT02098369|559874962|FG000|Overall Study|Withdrawal by Subject|1|||
155121136|NCT02098369|559874963|FG001|Overall Study|Withdrawal by Subject|5|||
155121137|NCT02098369|559874964|FG002|Overall Study|Withdrawal by Subject|0|||
155121138|NCT02098369|559874962|FG000|Overall Study|Lost to Follow-up|5|||
155121139|NCT02098369|559874963|FG001|Overall Study|Lost to Follow-up|1|||
155121140|NCT02098369|559874964|FG002|Overall Study|Lost to Follow-up|3|||
155121141|NCT02098369|559874962|FG000|Overall Study|Death|1|||
155121142|NCT02098369|559874963|FG001|Overall Study|Death|1|||
155121143|NCT02098369|559874964|FG002|Overall Study|Death|1|||
155121144|NCT02098369|559874962|FG000|Overall Study|Other|0|||
155121145|NCT02098369|559874963|FG001|Overall Study|Other|2|||
155121146|NCT02098369|559874964|FG002|Overall Study|Other|1|||
155121147|NCT03276052|559874965|FG000|Overall Study|Withdrawal by Subject|5|||
155121148|NCT03276052|559874965|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
155121149|NCT01669421|559874968|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
155121150|NCT01669421|559874968|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
155121151|NCT02961790|559874972|FG000|Overall Study|Canceled|4|||
155121152|NCT02961790|559874973|FG001|Overall Study|Canceled|5|||
155121153|NCT02961790|559874974|FG002|Overall Study|Canceled|1|||
154917325|NCT04516291|559120269|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154917326|NCT04516291|559120270|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154917327|NCT04516291|559120271|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
154917328|NCT04516291|559120264|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
154917329|NCT04516291|559120265|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
154917330|NCT04516291|559120266|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
154917331|NCT04516291|559120267|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
154917332|NCT04516291|559120268|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
154917333|NCT04516291|559120269|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
154917334|NCT04516291|559120270|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
154917335|NCT04516291|559120271|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
154917336|NCT04516291|559120264|FG000|Follow-up Period (12 Weeks)|Other|0|||
154917337|NCT04516291|559120265|FG001|Follow-up Period (12 Weeks)|Other|1|||
154917338|NCT04516291|559120266|FG002|Follow-up Period (12 Weeks)|Other|0|||
154917339|NCT04516291|559120267|FG003|Follow-up Period (12 Weeks)|Other|2|||
154917340|NCT04516291|559120268|FG004|Follow-up Period (12 Weeks)|Other|0|||
154917341|NCT04516291|559120269|FG005|Follow-up Period (12 Weeks)|Other|0|||
154917342|NCT04516291|559120270|FG006|Follow-up Period (12 Weeks)|Other|0|||
154917343|NCT04516291|559120271|FG007|Follow-up Period (12 Weeks)|Other|0|||
154917344|NCT04516291|559120264|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917345|NCT04516291|559120265|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917346|NCT04516291|559120266|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917347|NCT04516291|559120267|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917348|NCT04516291|559120268|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
154917349|NCT04516291|559120269|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917350|NCT04516291|559120270|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917351|NCT04516291|559120271|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
154917352|NCT04516291|559120264|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
154917353|NCT04516291|559120265|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
155121154|NCT02961790|559874975|FG003|Overall Study|Canceled|4|||
155121155|NCT02961790|559874972|FG000|Overall Study|without baseline data|4|||
154917354|NCT04516291|559120266|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
154917355|NCT04516291|559120267|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
154917356|NCT04516291|559120268|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
154917357|NCT04516291|559120269|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
155121156|NCT02961790|559874973|FG001|Overall Study|without baseline data|0|||
155121157|NCT02961790|559874974|FG002|Overall Study|without baseline data|1|||
155121158|NCT02961790|559874975|FG003|Overall Study|without baseline data|0|||
155121159|NCT02961790|559874972|FG000|Overall Study|without post baseline data|7|||
155121160|NCT02961790|559874973|FG001|Overall Study|without post baseline data|6|||
155121161|NCT02961790|559874974|FG002|Overall Study|without post baseline data|4|||
155121162|NCT02961790|559874975|FG003|Overall Study|without post baseline data|1|||
155121163|NCT02594098|559874978|FG000|Overall Study|Lack of Efficacy|17|||
155121164|NCT02594098|559874979|FG001|Overall Study|Lack of Efficacy|6|||
155121165|NCT02594098|559874978|FG000|Overall Study|Withdrawal by Subject|1|||
155121166|NCT02594098|559874979|FG001|Overall Study|Withdrawal by Subject|3|||
155121167|NCT02594098|559874978|FG000|Overall Study|Terminated participation|6|||
155121168|NCT02594098|559874979|FG001|Overall Study|Terminated participation|2|||
155121169|NCT02594098|559874978|FG000|Overall Study|Seek alternative treatment|2|||
155121170|NCT02594098|559874979|FG001|Overall Study|Seek alternative treatment|1|||
155121171|NCT02594098|559874978|FG000|Overall Study|Other|0|||
155121172|NCT02594098|559874979|FG001|Overall Study|Other|1|||
155121173|NCT02133664|559874986|FG000|Overall Study|Lost to Follow-up|2|||
155121174|NCT02133664|559874987|FG001|Overall Study|Lost to Follow-up|1|||
155121175|NCT02133664|559874986|FG000|Overall Study|Adverse Event|3|||
155121176|NCT02133664|559874987|FG001|Overall Study|Adverse Event|6|||
155121177|NCT01009346|559874988|FG000|Overall Study|Adverse Event|4|||
155121178|NCT00343915|559874991|FG000|Primary Study|Withdrawal by Subject|1|||
155121179|NCT00343915|559874992|FG001|Primary Study|Withdrawal by Subject|0|||
155121180|NCT00343915|559874991|FG000|Primary Study|Lost to Follow-up|2|||
155121181|NCT00343915|559874992|FG001|Primary Study|Lost to Follow-up|3|||
155121182|NCT00343915|559874991|FG000|Primary Study|Other|1|||
155121183|NCT00343915|559874992|FG001|Primary Study|Other|0|||
155121184|NCT01719003|559874998|FG000|Overall Study|Non compliant with protocol|1|||
155121185|NCT01719003|559874999|FG001|Overall Study|Non compliant with protocol|1|||
155121186|NCT01719003|559875000|FG002|Overall Study|Non compliant with protocol|0|||
154992687|NCT04562155|559400695|FG001|Overall Study|COVID-19 pandemic|0|||
154992688|NCT04562155|559400696|FG002|Overall Study|COVID-19 pandemic|0|||
154992689|NCT04562155|559400697|FG003|Overall Study|COVID-19 pandemic|1|||
154992690|NCT04562155|559400694|FG000|Overall Study|Adverse Event|7|||
154992691|NCT04562155|559400695|FG001|Overall Study|Adverse Event|3|||
154992692|NCT04562155|559400696|FG002|Overall Study|Adverse Event|8|||
154992693|NCT04562155|559400697|FG003|Overall Study|Adverse Event|1|||
154992694|NCT04562155|559400694|FG000|Overall Study|Withdrawal by Subject|3|||
154992695|NCT04562155|559400695|FG001|Overall Study|Withdrawal by Subject|6|||
154992696|NCT04562155|559400696|FG002|Overall Study|Withdrawal by Subject|3|||
154992697|NCT04562155|559400697|FG003|Overall Study|Withdrawal by Subject|3|||
154992698|NCT04562155|559400694|FG000|Overall Study|Participant personal reason|1|||
154992699|NCT04562155|559400695|FG001|Overall Study|Participant personal reason|0|||
154992700|NCT04562155|559400696|FG002|Overall Study|Participant personal reason|2|||
154992701|NCT04562155|559400697|FG003|Overall Study|Participant personal reason|1|||
154992702|NCT04015908|559400710|FG000|Overall Study|Lost to Follow-up|0|||
154992703|NCT04015908|559400711|FG001|Overall Study|Lost to Follow-up|1|||
154992704|NCT03464630|559400712|FG000|Overall Study|Lost to Follow-up|62|||
154992705|NCT03464630|559400713|FG001|Overall Study|Lost to Follow-up|52|||
154992706|NCT03464630|559400712|FG000|Overall Study|Withdrawal by Subject|16|||
154992707|NCT03464630|559400713|FG001|Overall Study|Withdrawal by Subject|10|||
154992708|NCT03464630|559400712|FG000|Overall Study|Passive Disengagement|8|||
154992709|NCT03464630|559400713|FG001|Overall Study|Passive Disengagement|4|||
154992710|NCT02865460|559400714|FG000|Overall Study|Adverse Event|1|||
154992711|NCT02865460|559400715|FG001|Overall Study|Adverse Event|0|||
154992712|NCT02865460|559400714|FG000|Overall Study|Withdrawal by Subject|1|||
154992713|NCT02865460|559400715|FG001|Overall Study|Withdrawal by Subject|1|||
154992714|NCT02865460|559400714|FG000|Overall Study|Lost to Follow-up|7|||
154992715|NCT02865460|559400715|FG001|Overall Study|Lost to Follow-up|4|||
154992716|NCT02865460|559400714|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
154992717|NCT02865460|559400715|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
154992718|NCT00901576|559400716|FG000|Second Intervention|Withdrawal by Subject|0|||
154992719|NCT00901576|559400717|FG001|Second Intervention|Withdrawal by Subject|0|||
154992720|NCT00901576|559400718|FG002|Second Intervention|Withdrawal by Subject|0|||
154992721|NCT00901576|559400719|FG003|Second Intervention|Withdrawal by Subject|1|||
154992722|NCT00901576|559400720|FG004|Second Intervention|Withdrawal by Subject|0|||
154992723|NCT00901576|559400721|FG005|Second Intervention|Withdrawal by Subject|1|||
154992724|NCT00901576|559400716|FG000|Second Intervention|Physician Decision|1|||
154992725|NCT00901576|559400717|FG001|Second Intervention|Physician Decision|0|||
155121187|NCT01719003|559875001|FG003|Overall Study|Non compliant with protocol|1|||
155121188|NCT01719003|559875002|FG004|Overall Study|Non compliant with protocol|2|||
155121189|NCT01719003|559875003|FG005|Overall Study|Non compliant with protocol|1|||
154992726|NCT00901576|559400718|FG002|Second Intervention|Physician Decision|0|||
154992727|NCT00901576|559400719|FG003|Second Intervention|Physician Decision|0|||
154992728|NCT00901576|559400720|FG004|Second Intervention|Physician Decision|0|||
154992729|NCT00901576|559400721|FG005|Second Intervention|Physician Decision|0|||
154992730|NCT01696279|559400724|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
155121190|NCT01719003|559875004|FG006|Overall Study|Non compliant with protocol|2|||
154992731|NCT01696279|559400725|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
154992732|NCT01696279|559400726|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
154992733|NCT01696279|559400727|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
154992734|NCT01696279|559400724|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
154992735|NCT01696279|559400725|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
154992736|NCT01696279|559400726|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
154992737|NCT01696279|559400727|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
154992738|NCT01696279|559400724|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
154992739|NCT01696279|559400725|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
154992740|NCT01696279|559400726|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
154992741|NCT01696279|559400727|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
154992742|NCT01696279|559400724|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
154992743|NCT01696279|559400725|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
154992744|NCT01696279|559400726|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
154992745|NCT01696279|559400727|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
154992746|NCT01696279|559400724|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
154992747|NCT01696279|559400725|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
154992748|NCT01696279|559400726|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
154992749|NCT01696279|559400727|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
154992750|NCT01696279|559400724|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
154992751|NCT01696279|559400725|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
154992752|NCT01696279|559400726|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
154992753|NCT01696279|559400727|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
154992754|NCT01696279|559400724|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
154992755|NCT01696279|559400725|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
154992756|NCT01696279|559400726|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
154992757|NCT01696279|559400727|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
154992758|NCT01696279|559400724|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
154992759|NCT01696279|559400725|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
154992760|NCT01696279|559400726|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
154992761|NCT01696279|559400727|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
154992762|NCT01696279|559400724|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
154992763|NCT01696279|559400725|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
154992764|NCT01696279|559400726|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
154992765|NCT01696279|559400727|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
154992766|NCT01696279|559400724|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
154992767|NCT01696279|559400725|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
154992768|NCT01696279|559400726|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
154992769|NCT01696279|559400727|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
154992770|NCT01696279|559400724|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
154992771|NCT01696279|559400725|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
154992772|NCT01696279|559400726|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
154992773|NCT01696279|559400727|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
154992774|NCT00171951|559400728|FG000|Overall Study|Adverse Event|1|||
154992775|NCT00171951|559400728|FG000|Overall Study|Abnormal Laboratory Values|2|||
154992776|NCT00171951|559400728|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
154992777|NCT00171951|559400728|FG000|Overall Study|Participants Withdrew Consent|3|||
154992778|NCT00171951|559400728|FG000|Overall Study|New Cancer Therapy|5|||
154992779|NCT00171951|559400728|FG000|Overall Study|Reason not Specified|2|||
154992780|NCT06077149|559400729|FG000|Overall Study|Death|1|||
154992781|NCT06077149|559400730|FG001|Overall Study|Death|0|||
154992782|NCT06077149|559400729|FG000|Overall Study|Withdrawal by Subject|2|||
154992783|NCT06077149|559400730|FG001|Overall Study|Withdrawal by Subject|0|||
154992784|NCT06077149|559400729|FG000|Overall Study|RSV infection before vaccination|3|||
154992785|NCT06077149|559400730|FG001|Overall Study|RSV infection before vaccination|0|||
154992786|NCT04658095|559400731|FG000|Overall Study|Study terminated|5|||
154992787|NCT04658095|559400732|FG001|Overall Study|Study terminated|1|||
154992788|NCT04658095|559400733|FG002|Overall Study|Study terminated|4|||
154992789|NCT05788289|559400734|FG000|Overall Study|Death|3|||
154992790|NCT02970318|559400737|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
154992791|NCT02970318|559400738|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
154992792|NCT02970318|559400739|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
154992793|NCT02970318|559400740|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
154992794|NCT02970318|559400737|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
154992795|NCT02970318|559400738|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
154992796|NCT02970318|559400739|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
154992797|NCT02970318|559400740|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
154992798|NCT02970318|559400737|FG000|Overall for Arm A & Main for Arm B|Death|41|||
154992799|NCT02970318|559400738|FG001|Overall for Arm A & Main for Arm B|Death|33|||
154992800|NCT02970318|559400739|FG002|Overall for Arm A & Main for Arm B|Death|0|||
154992801|NCT02970318|559400740|FG003|Overall for Arm A & Main for Arm B|Death|0|||
154992802|NCT02970318|559400737|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
154992803|NCT02970318|559400738|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
154992804|NCT02970318|559400739|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
154992805|NCT02970318|559400740|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
154992806|NCT02970318|559400737|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
154992807|NCT02970318|559400738|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
154992808|NCT02970318|559400739|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
154992809|NCT02970318|559400740|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
154992810|NCT02970318|559400737|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
154992811|NCT02970318|559400738|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
154992812|NCT02970318|559400739|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
154992813|NCT02970318|559400740|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
154992814|NCT02970318|559400737|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
154992815|NCT02970318|559400738|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
154992816|NCT02970318|559400739|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
154992817|NCT02970318|559400740|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
154992818|NCT03384654|559400741|FG000|Overall Study|Withdrawal by Subject|0|||
154992819|NCT03384654|559400742|FG001|Overall Study|Withdrawal by Subject|0|||
154992820|NCT03384654|559400743|FG002|Overall Study|Withdrawal by Subject|1|||
154992821|NCT03384654|559400744|FG003|Overall Study|Withdrawal by Subject|0|||
154992822|NCT01616953|559400745|FG000|Overall Study|Lost to Follow-up|1|||
154992823|NCT01616953|559400746|FG001|Overall Study|Lost to Follow-up|0|||
154992824|NCT01616953|559400745|FG000|Overall Study|lack of bone and soft tissue|1|||
154992825|NCT01616953|559400746|FG001|Overall Study|lack of bone and soft tissue|0|||
154992826|NCT01568320|559400747|FG000|Overall Study|Death|20|||
154992827|NCT01568320|559400747|FG000|Overall Study|Lost to Follow-up|9|||
154992828|NCT01568320|559400747|FG000|Overall Study|Withdrawal by Subject|10|||
154992829|NCT01568320|559400747|FG000|Overall Study|Conversion to open repair|1|||
154992830|NCT01568320|559400747|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
154992831|NCT00816361|559400749|FG000|Overall Study|Withdrawal by Subject|0|||
154992832|NCT00816361|559400750|FG001|Overall Study|Withdrawal by Subject|0|||
154992833|NCT00816361|559400751|FG002|Overall Study|Withdrawal by Subject|0|||
154992834|NCT00816361|559400752|FG003|Overall Study|Withdrawal by Subject|0|||
154992835|NCT00816361|559400753|FG004|Overall Study|Withdrawal by Subject|1|||
154992836|NCT00816361|559400754|FG005|Overall Study|Withdrawal by Subject|2|||
154992837|NCT00816361|559400755|FG006|Overall Study|Withdrawal by Subject|0|||
154992838|NCT00816361|559400756|FG007|Overall Study|Withdrawal by Subject|2|||
154992839|NCT00816361|559400757|FG008|Overall Study|Withdrawal by Subject|1|||
154992840|NCT00816361|559400749|FG000|Overall Study|Death|4|||
154992841|NCT00816361|559400750|FG001|Overall Study|Death|3|||
154992842|NCT00816361|559400751|FG002|Overall Study|Death|3|||
154992843|NCT00816361|559400752|FG003|Overall Study|Death|3|||
154992844|NCT00816361|559400753|FG004|Overall Study|Death|1|||
154992845|NCT00816361|559400754|FG005|Overall Study|Death|1|||
154992846|NCT00816361|559400755|FG006|Overall Study|Death|3|||
154992847|NCT00816361|559400756|FG007|Overall Study|Death|7|||
154992848|NCT00816361|559400757|FG008|Overall Study|Death|8|||
154992849|NCT00816361|559400749|FG000|Overall Study|Other|0|||
154992850|NCT00816361|559400750|FG001|Overall Study|Other|0|||
154992851|NCT00816361|559400751|FG002|Overall Study|Other|0|||
154992852|NCT00816361|559400752|FG003|Overall Study|Other|0|||
154992853|NCT00816361|559400753|FG004|Overall Study|Other|0|||
154992854|NCT00816361|559400754|FG005|Overall Study|Other|0|||
154992855|NCT00816361|559400755|FG006|Overall Study|Other|0|||
154992856|NCT00816361|559400756|FG007|Overall Study|Other|0|||
154992857|NCT00816361|559400757|FG008|Overall Study|Other|1|||
154992858|NCT02500641|559400760|FG000|Overall Study|Adverse Event|0|||
154992859|NCT02500641|559400761|FG001|Overall Study|Adverse Event|2|||
154992860|NCT02500641|559400760|FG000|Overall Study|Withdrawal by Subject|4|||
154992861|NCT02500641|559400761|FG001|Overall Study|Withdrawal by Subject|5|||
154992862|NCT02500641|559400760|FG000|Overall Study|Unable to follow study procedures|3|||
154992863|NCT02500641|559400761|FG001|Overall Study|Unable to follow study procedures|2|||
154992864|NCT02500641|559400760|FG000|Overall Study|Protocol Violation|1|||
154992865|NCT02500641|559400761|FG001|Overall Study|Protocol Violation|2|||
154992866|NCT02500641|559400760|FG000|Overall Study|Lost to Follow-up|1|||
154992867|NCT02500641|559400761|FG001|Overall Study|Lost to Follow-up|0|||
154992868|NCT02500641|559400760|FG000|Overall Study|Sponsor decision|1|||
154992869|NCT02500641|559400761|FG001|Overall Study|Sponsor decision|0|||
154992870|NCT02500641|559400760|FG000|Overall Study|Non compliance to study drug|0|||
154992871|NCT02500641|559400761|FG001|Overall Study|Non compliance to study drug|1|||
154992872|NCT03233230|559400762|FG000|Overall Study|Adverse Event|6|||
154992873|NCT03233230|559400763|FG001|Overall Study|Adverse Event|3|||
154992874|NCT03233230|559400764|FG002|Overall Study|Adverse Event|6|||
154992875|NCT03233230|559400765|FG003|Overall Study|Adverse Event|3|||
154992876|NCT03233230|559400762|FG000|Overall Study|Protocol Violation|1|||
154992877|NCT03233230|559400763|FG001|Overall Study|Protocol Violation|2|||
154992878|NCT03233230|559400764|FG002|Overall Study|Protocol Violation|1|||
154992879|NCT03233230|559400765|FG003|Overall Study|Protocol Violation|1|||
154992880|NCT03233230|559400762|FG000|Overall Study|Lack of Efficacy|1|||
154992881|NCT03233230|559400763|FG001|Overall Study|Lack of Efficacy|0|||
154992882|NCT03233230|559400764|FG002|Overall Study|Lack of Efficacy|0|||
154992883|NCT03233230|559400765|FG003|Overall Study|Lack of Efficacy|0|||
154992884|NCT03233230|559400762|FG000|Overall Study|Other|5|||
154992885|NCT03233230|559400763|FG001|Overall Study|Other|5|||
154992886|NCT03233230|559400764|FG002|Overall Study|Other|5|||
154992887|NCT03233230|559400765|FG003|Overall Study|Other|3|||
154992888|NCT03233230|559400762|FG000|Overall Study|Withdrawal by Subject|2|||
154992889|NCT03233230|559400763|FG001|Overall Study|Withdrawal by Subject|2|||
154992890|NCT03233230|559400764|FG002|Overall Study|Withdrawal by Subject|0|||
154992891|NCT03233230|559400765|FG003|Overall Study|Withdrawal by Subject|1|||
154992892|NCT03233230|559400762|FG000|Overall Study|Lost to Follow-up|0|||
154992893|NCT03233230|559400763|FG001|Overall Study|Lost to Follow-up|3|||
154992894|NCT03233230|559400764|FG002|Overall Study|Lost to Follow-up|0|||
154992895|NCT03233230|559400765|FG003|Overall Study|Lost to Follow-up|0|||
154992896|NCT01584843|559400766|FG000|First Treatment Period|Adverse Event|0|||
154992897|NCT01584843|559400767|FG001|First Treatment Period|Adverse Event|0|||
154992898|NCT01584843|559400768|FG002|First Treatment Period|Adverse Event|1|||
154992899|NCT01584843|559400769|FG003|First Treatment Period|Adverse Event|0|||
154992900|NCT01584843|559400770|FG004|First Treatment Period|Adverse Event|0|||
154992901|NCT01584843|559400771|FG005|First Treatment Period|Adverse Event|0|||
154992902|NCT01584843|559400766|FG000|First Treatment Period|Protocol Violation|0|||
154992903|NCT01584843|559400767|FG001|First Treatment Period|Protocol Violation|0|||
154992904|NCT01584843|559400768|FG002|First Treatment Period|Protocol Violation|0|||
154992905|NCT01584843|559400769|FG003|First Treatment Period|Protocol Violation|0|||
154992906|NCT01584843|559400770|FG004|First Treatment Period|Protocol Violation|0|||
154992907|NCT01584843|559400771|FG005|First Treatment Period|Protocol Violation|1|||
154992908|NCT01584843|559400766|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155121191|NCT01719003|559875005|FG007|Overall Study|Non compliant with protocol|3|||
155121192|NCT01719003|559875006|FG008|Overall Study|Non compliant with protocol|0|||
155121193|NCT01719003|559874998|FG000|Overall Study|Adverse Event|6|||
155121194|NCT01719003|559874999|FG001|Overall Study|Adverse Event|5|||
155121195|NCT01719003|559875000|FG002|Overall Study|Adverse Event|4|||
155121196|NCT01719003|559875001|FG003|Overall Study|Adverse Event|3|||
155121197|NCT01719003|559875002|FG004|Overall Study|Adverse Event|4|||
155121198|NCT01719003|559875003|FG005|Overall Study|Adverse Event|3|||
155121199|NCT01719003|559875004|FG006|Overall Study|Adverse Event|6|||
155121200|NCT01719003|559875005|FG007|Overall Study|Adverse Event|5|||
155121201|NCT01719003|559875006|FG008|Overall Study|Adverse Event|0|||
155121202|NCT01719003|559874998|FG000|Overall Study|Lost to Follow-up|0|||
155121203|NCT01719003|559874999|FG001|Overall Study|Lost to Follow-up|6|||
155121204|NCT01719003|559875000|FG002|Overall Study|Lost to Follow-up|7|||
155121205|NCT01719003|559875001|FG003|Overall Study|Lost to Follow-up|2|||
155121206|NCT01719003|559875002|FG004|Overall Study|Lost to Follow-up|3|||
155121207|NCT01719003|559875003|FG005|Overall Study|Lost to Follow-up|4|||
155121208|NCT01719003|559875004|FG006|Overall Study|Lost to Follow-up|3|||
155121209|NCT01719003|559875005|FG007|Overall Study|Lost to Follow-up|2|||
155121210|NCT01719003|559875006|FG008|Overall Study|Lost to Follow-up|2|||
155121211|NCT01719003|559874998|FG000|Overall Study|Refusal to continue, not due to AE|2|||
155121212|NCT01719003|559874999|FG001|Overall Study|Refusal to continue, not due to AE|5|||
155121213|NCT01719003|559875000|FG002|Overall Study|Refusal to continue, not due to AE|4|||
155121214|NCT01719003|559875001|FG003|Overall Study|Refusal to continue, not due to AE|4|||
155121215|NCT01719003|559875002|FG004|Overall Study|Refusal to continue, not due to AE|4|||
155121216|NCT01719003|559875003|FG005|Overall Study|Refusal to continue, not due to AE|3|||
155121217|NCT01719003|559875004|FG006|Overall Study|Refusal to continue, not due to AE|8|||
155121218|NCT01719003|559875005|FG007|Overall Study|Refusal to continue, not due to AE|7|||
155121219|NCT01719003|559875006|FG008|Overall Study|Refusal to continue, not due to AE|1|||
155121220|NCT01719003|559874998|FG000|Overall Study|Reason other than those specified|0|||
155121221|NCT01719003|559874999|FG001|Overall Study|Reason other than those specified|0|||
155121222|NCT01719003|559875000|FG002|Overall Study|Reason other than those specified|2|||
155121223|NCT01719003|559875001|FG003|Overall Study|Reason other than those specified|3|||
155121224|NCT01719003|559875002|FG004|Overall Study|Reason other than those specified|4|||
155121225|NCT01719003|559875003|FG005|Overall Study|Reason other than those specified|1|||
155121226|NCT01719003|559875004|FG006|Overall Study|Reason other than those specified|0|||
155121227|NCT01719003|559875005|FG007|Overall Study|Reason other than those specified|3|||
155121228|NCT01719003|559875006|FG008|Overall Study|Reason other than those specified|1|||
154992909|NCT01584843|559400767|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
155121229|NCT01719003|559874998|FG000|Overall Study|Lack of Efficacy|0|||
155121230|NCT01719003|559874999|FG001|Overall Study|Lack of Efficacy|0|||
155121231|NCT01719003|559875000|FG002|Overall Study|Lack of Efficacy|0|||
155121232|NCT01719003|559875001|FG003|Overall Study|Lack of Efficacy|0|||
155121233|NCT01719003|559875002|FG004|Overall Study|Lack of Efficacy|0|||
155121234|NCT01719003|559875003|FG005|Overall Study|Lack of Efficacy|0|||
155121235|NCT01719003|559875004|FG006|Overall Study|Lack of Efficacy|1|||
155121236|NCT01719003|559875005|FG007|Overall Study|Lack of Efficacy|0|||
155121237|NCT01719003|559875006|FG008|Overall Study|Lack of Efficacy|0|||
155121238|NCT03271047|559875007|FG000|Phase 1b: Dose Finding Period|Death|8|||
155121239|NCT03271047|559875008|FG001|Phase 1b: Dose Finding Period|Death|8|||
155121240|NCT03271047|559875009|FG002|Phase 1b: Dose Finding Period|Death|0|||
155121241|NCT03271047|559875010|FG003|Phase 1b: Dose Finding Period|Death|0|||
155121242|NCT03271047|559875007|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
155121243|NCT03271047|559875008|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
155121244|NCT03271047|559875009|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
155121245|NCT03271047|559875010|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
155121246|NCT03271047|559875007|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
155121247|NCT03271047|559875008|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
155121248|NCT03271047|559875009|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
155121249|NCT03271047|559875010|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
155121250|NCT03271047|559875007|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
155121251|NCT03271047|559875008|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
155121252|NCT03271047|559875009|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
155121253|NCT03271047|559875010|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
155121254|NCT03271047|559875007|FG000|Randomized Phase 2 Period|Other|0|||
155121255|NCT03271047|559875008|FG001|Randomized Phase 2 Period|Other|0|||
155121256|NCT03271047|559875009|FG002|Randomized Phase 2 Period|Other|0|||
155121257|NCT03271047|559875010|FG003|Randomized Phase 2 Period|Other|1|||
155121258|NCT03271047|559875007|FG000|Randomized Phase 2 Period|Death|0|||
155121259|NCT03271047|559875008|FG001|Randomized Phase 2 Period|Death|0|||
155121260|NCT03271047|559875009|FG002|Randomized Phase 2 Period|Death|20|||
155121261|NCT03271047|559875010|FG003|Randomized Phase 2 Period|Death|21|||
155121262|NCT03271047|559875007|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
155121263|NCT03271047|559875008|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
155121264|NCT03271047|559875009|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
155121265|NCT03271047|559875010|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
155121266|NCT03271047|559875007|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
155121267|NCT03271047|559875008|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
155121268|NCT03271047|559875009|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
155121269|NCT03271047|559875010|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
155121270|NCT03271047|559875007|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
155121271|NCT03271047|559875008|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
155121272|NCT03271047|559875009|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
155121273|NCT03271047|559875010|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
155121274|NCT00711802|559875011|FG000|Overall Study|Not treated (no further detail)|2|||
155121275|NCT00711802|559875012|FG001|Overall Study|Not treated (no further detail)|1|||
155121276|NCT00711802|559875013|FG002|Overall Study|Not treated (no further detail)|2|||
155121277|NCT00711802|559875014|FG003|Overall Study|Not treated (no further detail)|0|||
155121278|NCT00711802|559875015|FG004|Overall Study|Not treated (no further detail)|2|||
155121279|NCT00711802|559875016|FG005|Overall Study|Not treated (no further detail)|0|||
154917358|NCT04516291|559120270|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
154917359|NCT04516291|559120271|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
154917360|NCT03039686|559120272|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
154917361|NCT03039686|559120273|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
154917362|NCT03039686|559120274|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
154917363|NCT03039686|559120272|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
154917364|NCT03039686|559120273|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
154917365|NCT03039686|559120274|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
154917366|NCT03039686|559120272|FG000|Double-blind Period|Withdrawal by Subject|2|||
154917367|NCT03039686|559120273|FG001|Double-blind Period|Withdrawal by Subject|2|||
154917368|NCT03039686|559120274|FG002|Double-blind Period|Withdrawal by Subject|1|||
154917369|NCT03039686|559120272|FG000|Double-blind Period|Death|0|||
154917370|NCT03039686|559120273|FG001|Double-blind Period|Death|0|||
154917371|NCT03039686|559120274|FG002|Double-blind Period|Death|1|||
155121280|NCT00711802|559875017|FG006|Overall Study|Not treated (no further detail)|0|||
155121281|NCT00711802|559875018|FG007|Overall Study|Not treated (no further detail)|0|||
155121282|NCT00711802|559875011|FG000|Overall Study|Adverse Event|0|||
154917372|NCT03039686|559120272|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
155121283|NCT00711802|559875012|FG001|Overall Study|Adverse Event|0|||
155121284|NCT00711802|559875013|FG002|Overall Study|Adverse Event|0|||
155121285|NCT00711802|559875014|FG003|Overall Study|Adverse Event|0|||
154917373|NCT03039686|559120273|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
154917374|NCT03039686|559120274|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
154917375|NCT03039686|559120272|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
154917376|NCT03039686|559120273|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
154917377|NCT03039686|559120274|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
154917378|NCT03039686|559120272|FG000|Open Label Period|Withdrawal by Subject|0|||
154917379|NCT03039686|559120273|FG001|Open Label Period|Withdrawal by Subject|3|||
154917380|NCT03039686|559120274|FG002|Open Label Period|Withdrawal by Subject|1|||
154917381|NCT02158949|559120275|FG000|Overall Study|Withdrawal by Subject|1|||
154917382|NCT02158949|559120276|FG001|Overall Study|Withdrawal by Subject|0|||
155121286|NCT00711802|559875015|FG004|Overall Study|Adverse Event|1|||
155121287|NCT00711802|559875016|FG005|Overall Study|Adverse Event|1|||
155121288|NCT00711802|559875017|FG006|Overall Study|Adverse Event|0|||
155121289|NCT00711802|559875018|FG007|Overall Study|Adverse Event|0|||
155121290|NCT00711802|559875011|FG000|Overall Study|Microbiological failure|0|||
155121291|NCT00711802|559875012|FG001|Overall Study|Microbiological failure|1|||
155121292|NCT00711802|559875013|FG002|Overall Study|Microbiological failure|0|||
155121293|NCT00711802|559875014|FG003|Overall Study|Microbiological failure|0|||
155121294|NCT00711802|559875015|FG004|Overall Study|Microbiological failure|0|||
155121295|NCT00711802|559875016|FG005|Overall Study|Microbiological failure|1|||
155121296|NCT00711802|559875017|FG006|Overall Study|Microbiological failure|0|||
155121297|NCT00711802|559875018|FG007|Overall Study|Microbiological failure|0|||
155121298|NCT00711802|559875011|FG000|Overall Study|Protocol Violation|0|||
155121299|NCT00711802|559875012|FG001|Overall Study|Protocol Violation|0|||
155121300|NCT00711802|559875013|FG002|Overall Study|Protocol Violation|0|||
155121301|NCT00711802|559875014|FG003|Overall Study|Protocol Violation|1|||
155121302|NCT00711802|559875015|FG004|Overall Study|Protocol Violation|0|||
155121303|NCT00711802|559875016|FG005|Overall Study|Protocol Violation|0|||
155121304|NCT00711802|559875017|FG006|Overall Study|Protocol Violation|0|||
155121305|NCT00711802|559875018|FG007|Overall Study|Protocol Violation|0|||
155121306|NCT00711802|559875011|FG000|Overall Study|Physician Decision|0|||
155121307|NCT00711802|559875012|FG001|Overall Study|Physician Decision|2|||
155121308|NCT00711802|559875013|FG002|Overall Study|Physician Decision|0|||
155121309|NCT00711802|559875014|FG003|Overall Study|Physician Decision|0|||
155121310|NCT00711802|559875015|FG004|Overall Study|Physician Decision|0|||
155121311|NCT00711802|559875016|FG005|Overall Study|Physician Decision|0|||
155121312|NCT00711802|559875017|FG006|Overall Study|Physician Decision|0|||
155121313|NCT00711802|559875018|FG007|Overall Study|Physician Decision|0|||
155121314|NCT00711802|559875011|FG000|Overall Study|Withdrawal by Subject|0|||
155121315|NCT00711802|559875012|FG001|Overall Study|Withdrawal by Subject|1|||
155121316|NCT00711802|559875013|FG002|Overall Study|Withdrawal by Subject|0|||
155121317|NCT00711802|559875014|FG003|Overall Study|Withdrawal by Subject|1|||
155121318|NCT00711802|559875015|FG004|Overall Study|Withdrawal by Subject|0|||
155121319|NCT00711802|559875016|FG005|Overall Study|Withdrawal by Subject|0|||
155121320|NCT00711802|559875017|FG006|Overall Study|Withdrawal by Subject|0|||
155121321|NCT00711802|559875018|FG007|Overall Study|Withdrawal by Subject|0|||
155121322|NCT00711802|559875011|FG000|Overall Study|Lost to Follow-up|0|||
155121323|NCT00711802|559875012|FG001|Overall Study|Lost to Follow-up|0|||
155121324|NCT00711802|559875013|FG002|Overall Study|Lost to Follow-up|3|||
155121325|NCT00711802|559875014|FG003|Overall Study|Lost to Follow-up|1|||
155121326|NCT00711802|559875015|FG004|Overall Study|Lost to Follow-up|10|||
155121327|NCT00711802|559875016|FG005|Overall Study|Lost to Follow-up|6|||
155121328|NCT00711802|559875017|FG006|Overall Study|Lost to Follow-up|4|||
155121329|NCT00711802|559875018|FG007|Overall Study|Lost to Follow-up|2|||
155121330|NCT00711802|559875011|FG000|Overall Study|Reason not reported|0|||
155121331|NCT00711802|559875012|FG001|Overall Study|Reason not reported|1|||
155121332|NCT00711802|559875013|FG002|Overall Study|Reason not reported|1|||
155121333|NCT00711802|559875014|FG003|Overall Study|Reason not reported|0|||
155121334|NCT00711802|559875015|FG004|Overall Study|Reason not reported|1|||
155121335|NCT00711802|559875016|FG005|Overall Study|Reason not reported|0|||
155121336|NCT00711802|559875017|FG006|Overall Study|Reason not reported|1|||
155121337|NCT00711802|559875018|FG007|Overall Study|Reason not reported|0|||
155121338|NCT00882908|559875020|FG000|Overall Study|Adverse Event|0|||
155121339|NCT00882908|559875021|FG001|Overall Study|Adverse Event|0|||
155121340|NCT00882908|559875022|FG002|Overall Study|Adverse Event|1|||
155121341|NCT00882908|559875023|FG003|Overall Study|Adverse Event|0|||
155121342|NCT00882908|559875024|FG004|Overall Study|Adverse Event|1|||
155121343|NCT00882908|559875020|FG000|Overall Study|Lost to Follow-up|3|||
155121344|NCT00882908|559875021|FG001|Overall Study|Lost to Follow-up|5|||
155121345|NCT00882908|559875022|FG002|Overall Study|Lost to Follow-up|3|||
155121346|NCT00882908|559875023|FG003|Overall Study|Lost to Follow-up|1|||
155121347|NCT00882908|559875024|FG004|Overall Study|Lost to Follow-up|2|||
155121348|NCT00882908|559875020|FG000|Overall Study|Protocol Violation|0|||
155121349|NCT00882908|559875021|FG001|Overall Study|Protocol Violation|1|||
155121350|NCT00882908|559875022|FG002|Overall Study|Protocol Violation|0|||
155121351|NCT00882908|559875023|FG003|Overall Study|Protocol Violation|0|||
155121352|NCT00882908|559875024|FG004|Overall Study|Protocol Violation|0|||
155121353|NCT00882908|559875020|FG000|Overall Study|Withdrawal by Subject|0|||
154992910|NCT01584843|559400768|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
154992911|NCT01584843|559400769|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
154992912|NCT01584843|559400770|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
154992913|NCT01584843|559400771|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
154992914|NCT01584843|559400766|FG000|Second Treatment Period|Withdrawal by Subject|0|||
154992915|NCT01584843|559400767|FG001|Second Treatment Period|Withdrawal by Subject|0|||
154992916|NCT01584843|559400768|FG002|Second Treatment Period|Withdrawal by Subject|0|||
154992917|NCT01584843|559400769|FG003|Second Treatment Period|Withdrawal by Subject|0|||
154992918|NCT01584843|559400770|FG004|Second Treatment Period|Withdrawal by Subject|0|||
154992919|NCT01584843|559400771|FG005|Second Treatment Period|Withdrawal by Subject|1|||
154992920|NCT03923530|559400772|FG000|Overall Study|Withdrawal by Subject|1|||
154992921|NCT03923530|559400772|FG000|Overall Study|screen failure|3|||
154992922|NCT01181271|559400775|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
154992923|NCT01181271|559400775|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
154992924|NCT01181271|559400775|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
154992925|NCT01181271|559400775|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
154992926|NCT01408628|559400776|FG000|Consented|Withdrawal by Subject|12|||
154992927|NCT01408628|559400776|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
154992928|NCT01408628|559400776|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
154992929|NCT01408628|559400776|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
154992930|NCT04156620|559400777|FG000|Overall Study|Adverse event - TP 1|5|||
154992931|NCT04156620|559400778|FG001|Overall Study|Adverse event - TP 1|2|||
154992932|NCT04156620|559400777|FG000|Overall Study|Lost to follow-up TP 1|1|||
154992933|NCT04156620|559400778|FG001|Overall Study|Lost to follow-up TP 1|1|||
154992934|NCT04156620|559400777|FG000|Overall Study|Progressive disease - TP 1|0|||
154992935|NCT04156620|559400778|FG001|Overall Study|Progressive disease - TP 1|1|||
154992936|NCT04156620|559400777|FG000|Overall Study|Subject decision - TP 1|3|||
154992937|NCT04156620|559400778|FG001|Overall Study|Subject decision - TP 1|5|||
154992938|NCT04156620|559400777|FG000|Overall Study|Adverse event - TP 2|5|||
154992939|NCT04156620|559400778|FG001|Overall Study|Adverse event - TP 2|6|||
154992940|NCT04156620|559400777|FG000|Overall Study|Death - TP 2|1|||
154992941|NCT04156620|559400778|FG001|Overall Study|Death - TP 2|0|||
154992942|NCT04156620|559400777|FG000|Overall Study|Lost to follow-up - TP 2|5|||
154992943|NCT04156620|559400778|FG001|Overall Study|Lost to follow-up - TP 2|2|||
154992944|NCT04156620|559400777|FG000|Overall Study|Physician decision - TP 2|4|||
154992945|NCT04156620|559400778|FG001|Overall Study|Physician decision - TP 2|2|||
154992946|NCT04156620|559400777|FG000|Overall Study|Pregnancy - TP 2|1|||
154992947|NCT04156620|559400778|FG001|Overall Study|Pregnancy - TP 2|1|||
154992948|NCT04156620|559400777|FG000|Overall Study|Subject decision - TP 2|11|||
154992949|NCT04156620|559400778|FG001|Overall Study|Subject decision - TP 2|9|||
154992950|NCT04156620|559400777|FG000|Overall Study|New therapy for study indication - TP 2|1|||
154992951|NCT04156620|559400778|FG001|Overall Study|New therapy for study indication - TP 2|0|||
154992952|NCT01753336|559400779|FG000|Overall Study|Patient decision|12|||
154992953|NCT01753336|559400779|FG000|Overall Study|Lost to Follow-up|3|||
154992954|NCT01753336|559400779|FG000|Overall Study|Physician Decision|2|||
154992955|NCT01753336|559400779|FG000|Overall Study|Sponsor's decision|2|||
154992956|NCT01753336|559400779|FG000|Overall Study|Withdrawal by Subject|1|||
154992957|NCT01121666|559400780|FG000|Overall Study|Protocol Violation|29|||
154992958|NCT01121666|559400781|FG001|Overall Study|Protocol Violation|10|||
154992959|NCT01629966|559400782|FG000|Overall Study|Pregnancy|0|||
154992960|NCT01629966|559400783|FG001|Overall Study|Pregnancy|1|||
154992961|NCT01629966|559400784|FG002|Overall Study|Pregnancy|0|||
154992962|NCT01629966|559400782|FG000|Overall Study|Lost to Follow-up|10|||
154992963|NCT01629966|559400783|FG001|Overall Study|Lost to Follow-up|13|||
154992964|NCT01629966|559400784|FG002|Overall Study|Lost to Follow-up|9|||
154992965|NCT01629966|559400782|FG000|Overall Study|Withdrawal by Subject|8|||
154917383|NCT02158949|559120275|FG000|Overall Study|Lost to Follow-up|5|||
154917384|NCT02158949|559120276|FG001|Overall Study|Lost to Follow-up|11|||
154917385|NCT01855607|559120277|FG000|Overall Study|Withdrawal by Subject|1|||
154917386|NCT01855607|559120277|FG000|Overall Study|Study was terminated|11|||
154917387|NCT02181634|559120278|FG000|Overall Study|Lack of Efficacy|33|||
154917388|NCT02181634|559120278|FG000|Overall Study|Adverse Event|17|||
154917389|NCT02181634|559120278|FG000|Overall Study|Physician Decision|8|||
154917390|NCT02181634|559120278|FG000|Overall Study|Withdrawal by Subject|5|||
154917391|NCT02181634|559120278|FG000|Overall Study|Death|2|||
154917392|NCT02181634|559120278|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
154917393|NCT02181634|559120278|FG000|Overall Study|Ineligible|1|||
154917394|NCT02181634|559120278|FG000|Overall Study|Max number of dose reduction|1|||
154917395|NCT02181634|559120278|FG000|Overall Study|Symptomatic progression|1|||
154917396|NCT02181634|559120278|FG000|Overall Study|Patient opted to proceed to surgery|1|||
154917397|NCT02528331|559120283|FG000|Overall Study|Withdrawal by Subject|2|||
154917398|NCT02392078|559120287|FG000|Overall Study|Did not have procedure|32|||
154992966|NCT01629966|559400783|FG001|Overall Study|Withdrawal by Subject|9|||
154992967|NCT01629966|559400784|FG002|Overall Study|Withdrawal by Subject|16|||
155121354|NCT00882908|559875021|FG001|Overall Study|Withdrawal by Subject|0|||
154992968|NCT01629966|559400782|FG000|Overall Study|Protocol Violation|7|||
154992969|NCT01629966|559400783|FG001|Overall Study|Protocol Violation|9|||
154992970|NCT01629966|559400784|FG002|Overall Study|Protocol Violation|7|||
154992971|NCT01629966|559400782|FG000|Overall Study|Lack of Efficacy|5|||
154992972|NCT01629966|559400783|FG001|Overall Study|Lack of Efficacy|2|||
154992973|NCT01629966|559400784|FG002|Overall Study|Lack of Efficacy|4|||
154992974|NCT01629966|559400782|FG000|Overall Study|Adverse Event|11|||
154992975|NCT01629966|559400783|FG001|Overall Study|Adverse Event|18|||
154992976|NCT01629966|559400784|FG002|Overall Study|Adverse Event|30|||
154992977|NCT01672970|559400785|FG000|Overall Study|Lack of Efficacy|12|||
154992978|NCT01672970|559400785|FG000|Overall Study|Adverse Event|18|||
154992979|NCT01672970|559400785|FG000|Overall Study|Withdrawal by Subject|2|||
154992980|NCT01672970|559400785|FG000|Overall Study|Lost to Follow-up|5|||
154992981|NCT01672970|559400785|FG000|Overall Study|Other|9|||
154992982|NCT01672970|559400785|FG000|Overall Study|Enrolled but not treated|1|||
154992983|NCT02132754|559400786|FG000|Overall Study|Adverse Event|0|||
154992984|NCT02132754|559400787|FG001|Overall Study|Adverse Event|0|||
154992985|NCT02132754|559400788|FG002|Overall Study|Adverse Event|0|||
154992986|NCT02132754|559400789|FG003|Overall Study|Adverse Event|0|||
154992987|NCT02132754|559400790|FG004|Overall Study|Adverse Event|0|||
154992988|NCT02132754|559400791|FG005|Overall Study|Adverse Event|0|||
154992989|NCT02132754|559400792|FG006|Overall Study|Adverse Event|0|||
154992990|NCT02132754|559400793|FG007|Overall Study|Adverse Event|0|||
154992991|NCT02132754|559400794|FG008|Overall Study|Adverse Event|0|||
154992992|NCT02132754|559400795|FG009|Overall Study|Adverse Event|0|||
154992993|NCT02132754|559400796|FG010|Overall Study|Adverse Event|0|||
154992994|NCT02132754|559400797|FG011|Overall Study|Adverse Event|0|||
154992995|NCT02132754|559400798|FG012|Overall Study|Adverse Event|0|||
154992996|NCT02132754|559400799|FG013|Overall Study|Adverse Event|0|||
154992997|NCT02132754|559400800|FG014|Overall Study|Adverse Event|0|||
154992998|NCT02132754|559400801|FG015|Overall Study|Adverse Event|0|||
154992999|NCT02132754|559400802|FG016|Overall Study|Adverse Event|0|||
154993000|NCT02132754|559400803|FG017|Overall Study|Adverse Event|1|||
154993001|NCT02132754|559400804|FG018|Overall Study|Adverse Event|0|||
154993002|NCT02132754|559400805|FG019|Overall Study|Adverse Event|0|||
154993003|NCT02132754|559400806|FG020|Overall Study|Adverse Event|0|||
154993004|NCT02132754|559400807|FG021|Overall Study|Adverse Event|0|||
154993005|NCT02132754|559400808|FG022|Overall Study|Adverse Event|0|||
154993006|NCT02132754|559400809|FG023|Overall Study|Adverse Event|0|||
154993007|NCT02132754|559400810|FG024|Overall Study|Adverse Event|0|||
154993008|NCT02132754|559400811|FG025|Overall Study|Adverse Event|1|||
154993009|NCT02132754|559400812|FG026|Overall Study|Adverse Event|1|||
154993010|NCT02132754|559400813|FG027|Overall Study|Adverse Event|0|||
154993011|NCT02132754|559400814|FG028|Overall Study|Adverse Event|0|||
154993012|NCT02132754|559400815|FG029|Overall Study|Adverse Event|0|||
154993013|NCT02132754|559400816|FG030|Overall Study|Adverse Event|1|||
154993014|NCT02132754|559400817|FG031|Overall Study|Adverse Event|0|||
154993015|NCT02132754|559400818|FG032|Overall Study|Adverse Event|1|||
154993016|NCT02132754|559400819|FG033|Overall Study|Adverse Event|1|||
154993017|NCT02132754|559400786|FG000|Overall Study|Clinical Progression|0|||
154993018|NCT02132754|559400787|FG001|Overall Study|Clinical Progression|0|||
154993019|NCT02132754|559400788|FG002|Overall Study|Clinical Progression|0|||
154993020|NCT02132754|559400789|FG003|Overall Study|Clinical Progression|0|||
154993021|NCT02132754|559400790|FG004|Overall Study|Clinical Progression|0|||
154993022|NCT02132754|559400791|FG005|Overall Study|Clinical Progression|0|||
154993023|NCT02132754|559400792|FG006|Overall Study|Clinical Progression|0|||
154993024|NCT02132754|559400793|FG007|Overall Study|Clinical Progression|0|||
154993025|NCT02132754|559400794|FG008|Overall Study|Clinical Progression|0|||
154993026|NCT02132754|559400795|FG009|Overall Study|Clinical Progression|1|||
154993027|NCT02132754|559400796|FG010|Overall Study|Clinical Progression|0|||
155121355|NCT00882908|559875022|FG002|Overall Study|Withdrawal by Subject|3|||
155121356|NCT00882908|559875023|FG003|Overall Study|Withdrawal by Subject|5|||
155121357|NCT00882908|559875024|FG004|Overall Study|Withdrawal by Subject|2|||
155121358|NCT00882908|559875020|FG000|Overall Study|Subject reached a virologic endpoint|0|||
154993028|NCT02132754|559400797|FG011|Overall Study|Clinical Progression|0|||
154993029|NCT02132754|559400798|FG012|Overall Study|Clinical Progression|0|||
154993030|NCT02132754|559400799|FG013|Overall Study|Clinical Progression|0|||
154993031|NCT02132754|559400800|FG014|Overall Study|Clinical Progression|0|||
154993032|NCT02132754|559400801|FG015|Overall Study|Clinical Progression|0|||
154993033|NCT02132754|559400802|FG016|Overall Study|Clinical Progression|1|||
154993034|NCT02132754|559400803|FG017|Overall Study|Clinical Progression|1|||
154993035|NCT02132754|559400804|FG018|Overall Study|Clinical Progression|0|||
154993036|NCT02132754|559400805|FG019|Overall Study|Clinical Progression|1|||
154993037|NCT02132754|559400806|FG020|Overall Study|Clinical Progression|0|||
154993038|NCT02132754|559400807|FG021|Overall Study|Clinical Progression|0|||
154993039|NCT02132754|559400808|FG022|Overall Study|Clinical Progression|1|||
154993040|NCT02132754|559400809|FG023|Overall Study|Clinical Progression|0|||
154993041|NCT02132754|559400810|FG024|Overall Study|Clinical Progression|1|||
155177326|NCT02650921|560088222|FG000|Overall Study|Withdrawal by Subject|4|||
155177327|NCT02650921|560088222|FG000|Overall Study|Lost to Follow-up|2|||
155177328|NCT02650921|560088222|FG000|Overall Study|Adverse Event|1|||
155177329|NCT02650921|560088222|FG000|Overall Study|Due to Medical Condition|1|||
155177330|NCT00783302|560088223|FG000|Overall Study|Lost to Follow-up|17|||
155177331|NCT00783302|560088223|FG000|Overall Study|Technical Problems|11|||
155177332|NCT00783302|560088223|FG000|Overall Study|Protocol Violation|3|||
155177333|NCT00783302|560088223|FG000|Overall Study|Physician Decision|1|||
154993042|NCT02132754|559400811|FG025|Overall Study|Clinical Progression|1|||
154993043|NCT02132754|559400812|FG026|Overall Study|Clinical Progression|0|||
154993044|NCT02132754|559400813|FG027|Overall Study|Clinical Progression|1|||
154993045|NCT02132754|559400814|FG028|Overall Study|Clinical Progression|1|||
154993046|NCT02132754|559400815|FG029|Overall Study|Clinical Progression|0|||
154993047|NCT02132754|559400816|FG030|Overall Study|Clinical Progression|1|||
154993048|NCT02132754|559400817|FG031|Overall Study|Clinical Progression|0|||
154993049|NCT02132754|559400818|FG032|Overall Study|Clinical Progression|0|||
154993050|NCT02132754|559400819|FG033|Overall Study|Clinical Progression|2|||
154993051|NCT02132754|559400786|FG000|Overall Study|Death|0|||
154993052|NCT02132754|559400787|FG001|Overall Study|Death|0|||
154993053|NCT02132754|559400788|FG002|Overall Study|Death|0|||
154993054|NCT02132754|559400789|FG003|Overall Study|Death|0|||
154993055|NCT02132754|559400790|FG004|Overall Study|Death|0|||
154993056|NCT02132754|559400791|FG005|Overall Study|Death|0|||
154993057|NCT02132754|559400792|FG006|Overall Study|Death|0|||
154993058|NCT02132754|559400793|FG007|Overall Study|Death|0|||
154993059|NCT02132754|559400794|FG008|Overall Study|Death|0|||
154993060|NCT02132754|559400795|FG009|Overall Study|Death|0|||
155121359|NCT00882908|559875021|FG001|Overall Study|Subject reached a virologic endpoint|0|||
155121360|NCT00882908|559875022|FG002|Overall Study|Subject reached a virologic endpoint|0|||
155121361|NCT00882908|559875023|FG003|Overall Study|Subject reached a virologic endpoint|0|||
155121362|NCT00882908|559875024|FG004|Overall Study|Subject reached a virologic endpoint|1|||
155121363|NCT00882908|559875020|FG000|Overall Study|Study terminated in error|0|||
155121364|NCT00882908|559875021|FG001|Overall Study|Study terminated in error|0|||
155121365|NCT00882908|559875022|FG002|Overall Study|Study terminated in error|0|||
155121366|NCT00882908|559875023|FG003|Overall Study|Study terminated in error|1|||
155121367|NCT00882908|559875024|FG004|Overall Study|Study terminated in error|0|||
155121368|NCT03283150|559875026|FG000|Overall Study|Withdrawal by Subject|6|||
155121369|NCT03283150|559875027|FG001|Overall Study|Withdrawal by Subject|0|||
155121370|NCT03283150|559875028|FG002|Overall Study|Withdrawal by Subject|0|||
155121371|NCT05291936|559875029|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
155121372|NCT05291936|559875030|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
155121373|NCT05291936|559875029|FG000|Period 1|Withdrew Consent during study|1|||
155121374|NCT05291936|559875030|FG001|Period 1|Withdrew Consent during study|0|||
155121375|NCT05291936|559875029|FG000|Period 2|Adverse Event|0|||
155121376|NCT05291936|559875030|FG001|Period 2|Adverse Event|1|||
155121377|NCT05291936|559875029|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
155121378|NCT05291936|559875030|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155121379|NCT00581828|559875031|FG000|Overall Study|Protocol Violation|1|||
155121380|NCT00700102|559875032|FG000|Overall Study|Died|394|||
155121381|NCT00700102|559875033|FG001|Overall Study|Died|385|||
155121382|NCT00700102|559875032|FG000|Overall Study|Lost to Follow-up|8|||
155121383|NCT00700102|559875033|FG001|Overall Study|Lost to Follow-up|10|||
155121384|NCT02525939|559875034|FG000|Overall Study|Lost to Follow-up|27|||
155121385|NCT02525939|559875035|FG001|Overall Study|Lost to Follow-up|24|||
155121386|NCT02525939|559875034|FG000|Overall Study|Physician Decision|0|||
155121387|NCT02525939|559875035|FG001|Overall Study|Physician Decision|1|||
155121388|NCT02525939|559875034|FG000|Overall Study|Withdrawal by Subject|24|||
155121389|NCT02525939|559875035|FG001|Overall Study|Withdrawal by Subject|39|||
155121390|NCT02525939|559875034|FG000|Overall Study|Death|180|||
155121391|NCT02525939|559875035|FG001|Overall Study|Death|179|||
155121392|NCT01667562|559875036|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
155121393|NCT01667562|559875037|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
155177334|NCT00783302|560088223|FG000|Overall Study|Withdrawal by Subject|3|||
155177335|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
155177336|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
155177337|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
154993061|NCT02132754|559400796|FG010|Overall Study|Death|0|||
155121394|NCT01667562|559875036|FG000|Erlotinib Phase|Lost to Follow-up|0|||
155121395|NCT01667562|559875037|FG001|Erlotinib Phase|Lost to Follow-up|1|||
155121396|NCT01667562|559875036|FG000|Erlotinib Phase|Adverse Event|0|||
155121397|NCT01667562|559875037|FG001|Erlotinib Phase|Adverse Event|1|||
155121398|NCT01667562|559875036|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
155177338|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
154993062|NCT02132754|559400797|FG011|Overall Study|Death|0|||
154993063|NCT02132754|559400798|FG012|Overall Study|Death|0|||
154993064|NCT02132754|559400799|FG013|Overall Study|Death|0|||
154993065|NCT02132754|559400800|FG014|Overall Study|Death|0|||
154993066|NCT02132754|559400801|FG015|Overall Study|Death|1|||
154993067|NCT02132754|559400802|FG016|Overall Study|Death|0|||
154993068|NCT02132754|559400803|FG017|Overall Study|Death|0|||
154993069|NCT02132754|559400804|FG018|Overall Study|Death|0|||
154993070|NCT02132754|559400805|FG019|Overall Study|Death|1|||
154993071|NCT02132754|559400806|FG020|Overall Study|Death|0|||
154993072|NCT02132754|559400807|FG021|Overall Study|Death|1|||
154993073|NCT02132754|559400808|FG022|Overall Study|Death|0|||
154993074|NCT02132754|559400809|FG023|Overall Study|Death|0|||
154993075|NCT02132754|559400810|FG024|Overall Study|Death|0|||
154993076|NCT02132754|559400811|FG025|Overall Study|Death|0|||
154993077|NCT02132754|559400812|FG026|Overall Study|Death|1|||
154993078|NCT02132754|559400813|FG027|Overall Study|Death|0|||
154993079|NCT02132754|559400814|FG028|Overall Study|Death|0|||
154993080|NCT02132754|559400815|FG029|Overall Study|Death|0|||
154993081|NCT02132754|559400816|FG030|Overall Study|Death|0|||
154993082|NCT02132754|559400817|FG031|Overall Study|Death|0|||
154993083|NCT02132754|559400818|FG032|Overall Study|Death|0|||
154993084|NCT02132754|559400819|FG033|Overall Study|Death|2|||
154993085|NCT02132754|559400786|FG000|Overall Study|Excluded Medication|0|||
154993086|NCT02132754|559400787|FG001|Overall Study|Excluded Medication|0|||
154993087|NCT02132754|559400788|FG002|Overall Study|Excluded Medication|0|||
154993088|NCT02132754|559400789|FG003|Overall Study|Excluded Medication|0|||
154993089|NCT02132754|559400790|FG004|Overall Study|Excluded Medication|0|||
154993090|NCT02132754|559400791|FG005|Overall Study|Excluded Medication|0|||
154993091|NCT02132754|559400792|FG006|Overall Study|Excluded Medication|0|||
154993092|NCT02132754|559400793|FG007|Overall Study|Excluded Medication|0|||
154993093|NCT02132754|559400794|FG008|Overall Study|Excluded Medication|0|||
154993094|NCT02132754|559400795|FG009|Overall Study|Excluded Medication|0|||
154993095|NCT02132754|559400796|FG010|Overall Study|Excluded Medication|0|||
154993096|NCT02132754|559400797|FG011|Overall Study|Excluded Medication|0|||
154993097|NCT02132754|559400798|FG012|Overall Study|Excluded Medication|0|||
154993098|NCT02132754|559400799|FG013|Overall Study|Excluded Medication|0|||
154993099|NCT02132754|559400800|FG014|Overall Study|Excluded Medication|0|||
154993100|NCT02132754|559400801|FG015|Overall Study|Excluded Medication|0|||
154993101|NCT02132754|559400802|FG016|Overall Study|Excluded Medication|0|||
154993102|NCT02132754|559400803|FG017|Overall Study|Excluded Medication|0|||
154993103|NCT02132754|559400804|FG018|Overall Study|Excluded Medication|0|||
154993104|NCT02132754|559400805|FG019|Overall Study|Excluded Medication|0|||
154993105|NCT02132754|559400806|FG020|Overall Study|Excluded Medication|1|||
154993106|NCT02132754|559400807|FG021|Overall Study|Excluded Medication|0|||
154993107|NCT02132754|559400808|FG022|Overall Study|Excluded Medication|0|||
154993108|NCT02132754|559400809|FG023|Overall Study|Excluded Medication|0|||
154993109|NCT02132754|559400810|FG024|Overall Study|Excluded Medication|0|||
154993110|NCT02132754|559400811|FG025|Overall Study|Excluded Medication|0|||
154993111|NCT02132754|559400812|FG026|Overall Study|Excluded Medication|0|||
154993112|NCT02132754|559400813|FG027|Overall Study|Excluded Medication|0|||
154993113|NCT02132754|559400814|FG028|Overall Study|Excluded Medication|0|||
154993114|NCT02132754|559400815|FG029|Overall Study|Excluded Medication|0|||
154993115|NCT02132754|559400816|FG030|Overall Study|Excluded Medication|0|||
154993116|NCT02132754|559400817|FG031|Overall Study|Excluded Medication|0|||
154993117|NCT02132754|559400818|FG032|Overall Study|Excluded Medication|0|||
154993118|NCT02132754|559400819|FG033|Overall Study|Excluded Medication|1|||
154993119|NCT02132754|559400786|FG000|Overall Study|Physician Decision|0|||
154993120|NCT02132754|559400787|FG001|Overall Study|Physician Decision|0|||
154993121|NCT02132754|559400788|FG002|Overall Study|Physician Decision|0|||
154993122|NCT02132754|559400789|FG003|Overall Study|Physician Decision|0|||
154993123|NCT02132754|559400790|FG004|Overall Study|Physician Decision|0|||
154993124|NCT02132754|559400791|FG005|Overall Study|Physician Decision|0|||
155121399|NCT01667562|559875037|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
155121400|NCT01129882|559875038|FG000|Overall Study|Adverse Event|39|||
155121401|NCT01129882|559875038|FG000|Overall Study|Death|6|||
155121402|NCT01129882|559875038|FG000|Overall Study|Lack of Efficacy|5|||
154993125|NCT02132754|559400792|FG006|Overall Study|Physician Decision|0|||
155121403|NCT01129882|559875038|FG000|Overall Study|Lost to Follow-up|13|||
155121404|NCT01129882|559875038|FG000|Overall Study|Physician Decision|27|||
154993126|NCT02132754|559400793|FG007|Overall Study|Physician Decision|0|||
154993127|NCT02132754|559400794|FG008|Overall Study|Physician Decision|0|||
154993128|NCT02132754|559400795|FG009|Overall Study|Physician Decision|1|||
154993129|NCT02132754|559400796|FG010|Overall Study|Physician Decision|0|||
154993130|NCT02132754|559400797|FG011|Overall Study|Physician Decision|1|||
155121405|NCT01129882|559875038|FG000|Overall Study|Protocol Deviation|3|||
155121406|NCT01129882|559875038|FG000|Overall Study|Withdrawal Criteria Met|19|||
154993131|NCT02132754|559400798|FG012|Overall Study|Physician Decision|1|||
154993132|NCT02132754|559400799|FG013|Overall Study|Physician Decision|0|||
154993133|NCT02132754|559400800|FG014|Overall Study|Physician Decision|0|||
154993134|NCT02132754|559400801|FG015|Overall Study|Physician Decision|1|||
154993135|NCT02132754|559400802|FG016|Overall Study|Physician Decision|0|||
155121407|NCT01129882|559875038|FG000|Overall Study|Trial Termination by Sponsor|6|||
154993136|NCT02132754|559400803|FG017|Overall Study|Physician Decision|0|||
154993137|NCT02132754|559400804|FG018|Overall Study|Physician Decision|0|||
154993138|NCT02132754|559400805|FG019|Overall Study|Physician Decision|0|||
154993139|NCT02132754|559400806|FG020|Overall Study|Physician Decision|0|||
155177339|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
155177340|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
155177341|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
154993140|NCT02132754|559400807|FG021|Overall Study|Physician Decision|0|||
154993141|NCT02132754|559400808|FG022|Overall Study|Physician Decision|0|||
154993142|NCT02132754|559400809|FG023|Overall Study|Physician Decision|0|||
154993143|NCT02132754|559400810|FG024|Overall Study|Physician Decision|1|||
154993144|NCT02132754|559400811|FG025|Overall Study|Physician Decision|0|||
154993145|NCT02132754|559400812|FG026|Overall Study|Physician Decision|0|||
154993146|NCT02132754|559400813|FG027|Overall Study|Physician Decision|0|||
154993147|NCT02132754|559400814|FG028|Overall Study|Physician Decision|0|||
154993148|NCT02132754|559400815|FG029|Overall Study|Physician Decision|0|||
155177342|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
155177343|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
155177344|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
154993149|NCT02132754|559400816|FG030|Overall Study|Physician Decision|0|||
154993150|NCT02132754|559400817|FG031|Overall Study|Physician Decision|1|||
154993151|NCT02132754|559400818|FG032|Overall Study|Physician Decision|0|||
154993152|NCT02132754|559400819|FG033|Overall Study|Physician Decision|3|||
154993153|NCT02132754|559400786|FG000|Overall Study|Progressive Disease|1|||
154993154|NCT02132754|559400787|FG001|Overall Study|Progressive Disease|1|||
154993155|NCT02132754|559400788|FG002|Overall Study|Progressive Disease|1|||
154993156|NCT02132754|559400789|FG003|Overall Study|Progressive Disease|1|||
154993157|NCT02132754|559400790|FG004|Overall Study|Progressive Disease|1|||
154993158|NCT02132754|559400791|FG005|Overall Study|Progressive Disease|1|||
155177345|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
155177346|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
155177347|NCT01087788|560088224|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
155177348|NCT01087788|560088225|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
155177349|NCT01087788|560088226|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
155177350|NCT01087788|560088224|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
155177351|NCT01087788|560088225|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
155177352|NCT01087788|560088226|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
155177353|NCT01087788|560088224|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
155177354|NCT01087788|560088225|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
155177355|NCT01087788|560088226|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
155177356|NCT01087788|560088224|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
155177357|NCT01087788|560088225|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
155177358|NCT01087788|560088226|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
155177359|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
155177360|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
155177361|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
155177362|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
155177363|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
155177364|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
155177365|NCT01087788|560088224|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
155177366|NCT01087788|560088225|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
155177367|NCT01087788|560088226|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
155177368|NCT01087788|560088224|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
155177369|NCT01087788|560088225|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
155177370|NCT01087788|560088226|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
155177371|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
155177372|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
154993159|NCT02132754|559400792|FG006|Overall Study|Progressive Disease|1|||
154993160|NCT02132754|559400793|FG007|Overall Study|Progressive Disease|1|||
154993161|NCT02132754|559400794|FG008|Overall Study|Progressive Disease|1|||
154993162|NCT02132754|559400795|FG009|Overall Study|Progressive Disease|3|||
154993163|NCT02132754|559400796|FG010|Overall Study|Progressive Disease|3|||
154993164|NCT02132754|559400797|FG011|Overall Study|Progressive Disease|2|||
154993165|NCT02132754|559400798|FG012|Overall Study|Progressive Disease|2|||
154993166|NCT02132754|559400799|FG013|Overall Study|Progressive Disease|3|||
154993167|NCT02132754|559400800|FG014|Overall Study|Progressive Disease|2|||
154993168|NCT02132754|559400801|FG015|Overall Study|Progressive Disease|1|||
155177373|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
155177374|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
155177375|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
155177376|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
154993169|NCT02132754|559400802|FG016|Overall Study|Progressive Disease|2|||
154993170|NCT02132754|559400803|FG017|Overall Study|Progressive Disease|1|||
154993171|NCT02132754|559400804|FG018|Overall Study|Progressive Disease|3|||
154993172|NCT02132754|559400805|FG019|Overall Study|Progressive Disease|1|||
154993173|NCT02132754|559400806|FG020|Overall Study|Progressive Disease|1|||
155121408|NCT01129882|559875038|FG000|Overall Study|Withdrawal by Subject|160|||
155121409|NCT01028716|559875039|FG000|Overall Study|Physician Decision|1|||
155121410|NCT00536874|559875040|FG000|Overall Study|Adverse Event|1|||
155121411|NCT00536874|559875040|FG000|Overall Study|Death|2|||
155121412|NCT00536874|559875040|FG000|Overall Study|Withdrawal by Subject|1|||
154917399|NCT02392078|559120288|FG001|Overall Study|Did not have procedure|43|||
154917400|NCT02392078|559120289|FG002|Overall Study|Did not have procedure|20|||
154917401|NCT02392078|559120290|FG003|Overall Study|Did not have procedure|1|||
154917402|NCT02079077|559120291|FG000|Overall Study|Lost to Follow-up|5|||
154917403|NCT02079077|559120292|FG001|Overall Study|Lost to Follow-up|7|||
154917404|NCT02079077|559120291|FG000|Overall Study|Became STIs Positive|1|||
154917405|NCT02079077|559120292|FG001|Overall Study|Became STIs Positive|2|||
154917406|NCT02087085|559120293|FG000|Overall Study|Adverse Event|10|||
154917407|NCT02087085|559120294|FG001|Overall Study|Adverse Event|14|||
154917408|NCT02087085|559120293|FG000|Overall Study|Lack of Efficacy|4|||
154917409|NCT02087085|559120294|FG001|Overall Study|Lack of Efficacy|3|||
154917410|NCT02087085|559120293|FG000|Overall Study|Lost to Follow-up|6|||
154917411|NCT02087085|559120294|FG001|Overall Study|Lost to Follow-up|4|||
154917412|NCT02087085|559120293|FG000|Overall Study|Withdrawal by Subject|9|||
154917413|NCT02087085|559120294|FG001|Overall Study|Withdrawal by Subject|11|||
154917414|NCT02087085|559120293|FG000|Overall Study|Protocol Violation|1|||
154917415|NCT02087085|559120294|FG001|Overall Study|Protocol Violation|0|||
154917416|NCT02087085|559120293|FG000|Overall Study|Study Terminated by Sponsor|87|||
154917417|NCT02087085|559120294|FG001|Overall Study|Study Terminated by Sponsor|80|||
154917418|NCT02087085|559120293|FG000|Overall Study|Other Miscellaneous Reasons|3|||
154917419|NCT02087085|559120294|FG001|Overall Study|Other Miscellaneous Reasons|4|||
154917420|NCT00635804|559120295|FG000|Overall Study|Adverse Event|0|||
154917421|NCT00635804|559120296|FG001|Overall Study|Adverse Event|0|||
154917422|NCT00635804|559120297|FG002|Overall Study|Adverse Event|0|||
154917423|NCT00635804|559120298|FG003|Overall Study|Adverse Event|0|||
154917424|NCT00635804|559120299|FG004|Overall Study|Adverse Event|0|||
154917425|NCT00635804|559120300|FG005|Overall Study|Adverse Event|1|||
154917426|NCT00635804|559120301|FG006|Overall Study|Adverse Event|0|||
154917427|NCT00635804|559120302|FG007|Overall Study|Adverse Event|0|||
154917428|NCT00635804|559120295|FG000|Overall Study|Withdrawal by Subject|1|||
154917429|NCT00635804|559120296|FG001|Overall Study|Withdrawal by Subject|0|||
154917430|NCT00635804|559120297|FG002|Overall Study|Withdrawal by Subject|0|||
154917431|NCT00635804|559120298|FG003|Overall Study|Withdrawal by Subject|0|||
154917432|NCT00635804|559120299|FG004|Overall Study|Withdrawal by Subject|0|||
154917433|NCT00635804|559120300|FG005|Overall Study|Withdrawal by Subject|0|||
154917434|NCT00635804|559120301|FG006|Overall Study|Withdrawal by Subject|0|||
154917435|NCT00635804|559120302|FG007|Overall Study|Withdrawal by Subject|0|||
154917436|NCT01425268|559120310|FG000|Overall Study|Withdrawal by Subject|2|||
154917437|NCT01425268|559120311|FG001|Overall Study|Withdrawal by Subject|0|||
154917438|NCT01425268|559120310|FG000|Overall Study|Sponsor Decision|5|||
154917439|NCT01425268|559120311|FG001|Overall Study|Sponsor Decision|0|||
154917440|NCT01425268|559120310|FG000|Overall Study|Physician Decision|1|||
154917441|NCT01425268|559120311|FG001|Overall Study|Physician Decision|0|||
154917442|NCT00719706|559120312|FG000|Overall Study|Adverse Event|5|||
154917443|NCT00719706|559120313|FG001|Overall Study|Adverse Event|4|||
154917444|NCT00719706|559120312|FG000|Overall Study|Withdrawal by Subject|1|||
154917445|NCT00719706|559120313|FG001|Overall Study|Withdrawal by Subject|2|||
154917446|NCT00719706|559120312|FG000|Overall Study|Protocol Violation|3|||
154917447|NCT00719706|559120313|FG001|Overall Study|Protocol Violation|0|||
154917448|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
154917449|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
154917450|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
154917451|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
154917452|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
154917453|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
154917454|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
154917455|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
154917456|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
154917457|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
154917458|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
154917459|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
154917460|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
154917461|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
154917462|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
154917463|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|Other|6|||
155121413|NCT00762996|559875041|FG000|Period One|Protocol Violation|0|||
155121414|NCT00762996|559875042|FG001|Period One|Protocol Violation|0|||
155121415|NCT00762996|559875043|FG002|Period One|Protocol Violation|1|||
155121416|NCT00762996|559875044|FG003|Period One|Protocol Violation|0|||
155121417|NCT00762996|559875041|FG000|Period One|ineligible|0|||
155121418|NCT00762996|559875042|FG001|Period One|ineligible|0|||
155121419|NCT00762996|559875043|FG002|Period One|ineligible|1|||
155121420|NCT00762996|559875044|FG003|Period One|ineligible|1|||
155121421|NCT00762996|559875041|FG000|Period One|Adverse Event|0|||
155121422|NCT00762996|559875042|FG001|Period One|Adverse Event|0|||
155121423|NCT00762996|559875043|FG002|Period One|Adverse Event|1|||
155121424|NCT00762996|559875044|FG003|Period One|Adverse Event|0|||
155121425|NCT00762996|559875041|FG000|Period One|Withdrawal by Subject|0|||
155121426|NCT00762996|559875042|FG001|Period One|Withdrawal by Subject|0|||
155121427|NCT00762996|559875043|FG002|Period One|Withdrawal by Subject|1|||
155121428|NCT00762996|559875044|FG003|Period One|Withdrawal by Subject|0|||
155121429|NCT00434759|559875046|FG000|Overall Study|Lack of Efficacy|5|||
155121430|NCT00434759|559875047|FG001|Overall Study|Lack of Efficacy|4|||
155121431|NCT00434759|559875046|FG000|Overall Study|Withdrawal by Subject|17|||
155121432|NCT00434759|559875047|FG001|Overall Study|Withdrawal by Subject|1|||
155121433|NCT00434759|559875046|FG000|Overall Study|family affairs|2|||
155121434|NCT00434759|559875047|FG001|Overall Study|family affairs|0|||
155121435|NCT00495521|559875052|FG000|Overall Study|Physician Decision|0|||
155121436|NCT00495521|559875053|FG001|Overall Study|Physician Decision|1|||
155121437|NCT02410824|559875054|FG000|First Intervention (One Week)|Headache|0|||
155121438|NCT02410824|559875055|FG001|First Intervention (One Week)|Headache|1|||
155121439|NCT02436408|559875056|FG000|Overall Study|Death|1|||
155121440|NCT00392808|559875057|FG000|Overall Study|Lost to Follow-up|3|||
155121441|NCT00392808|559875058|FG001|Overall Study|Lost to Follow-up|2|||
155121442|NCT00392808|559875059|FG002|Overall Study|Lost to Follow-up|1|||
155121443|NCT00392808|559875060|FG003|Overall Study|Lost to Follow-up|2|||
155121444|NCT00392808|559875057|FG000|Overall Study|Unable to withdraw blood|3|||
155121445|NCT00392808|559875058|FG001|Overall Study|Unable to withdraw blood|1|||
155121446|NCT00392808|559875059|FG002|Overall Study|Unable to withdraw blood|1|||
155121447|NCT00392808|559875060|FG003|Overall Study|Unable to withdraw blood|2|||
155121448|NCT02084238|559875061|FG000|Overall Study|Lost to Follow-up|2|||
155121449|NCT02649855|559875062|FG000|Overall Study|Refused further treatment|2|||
155121450|NCT02649855|559875063|FG001|Overall Study|Refused further treatment|1|||
155121451|NCT02649855|559875064|FG002|Overall Study|Refused further treatment|1|||
155121452|NCT02649855|559875062|FG000|Overall Study|Withdrew consent|0|||
155121453|NCT02649855|559875063|FG001|Overall Study|Withdrew consent|1|||
155121454|NCT02649855|559875064|FG002|Overall Study|Withdrew consent|0|||
155121455|NCT02649855|559875062|FG000|Overall Study|Switched to alternative treatment|0|||
155121456|NCT02649855|559875063|FG001|Overall Study|Switched to alternative treatment|1|||
155121457|NCT02649855|559875064|FG002|Overall Study|Switched to alternative treatment|1|||
155121458|NCT02649855|559875062|FG000|Overall Study|Principal investigator discretion|0|||
155121459|NCT02649855|559875063|FG001|Overall Study|Principal investigator discretion|1|||
155121460|NCT02649855|559875064|FG002|Overall Study|Principal investigator discretion|1|||
155121461|NCT02649855|559875062|FG000|Overall Study|No treatment, per protocol|1|||
155121462|NCT02649855|559875063|FG001|Overall Study|No treatment, per protocol|0|||
155121463|NCT02649855|559875064|FG002|Overall Study|No treatment, per protocol|0|||
155121464|NCT02649855|559875062|FG000|Overall Study|Initiate new treatment|1|||
155121465|NCT02649855|559875063|FG001|Overall Study|Initiate new treatment|0|||
155121466|NCT02649855|559875064|FG002|Overall Study|Initiate new treatment|0|||
155121467|NCT02782325|559875065|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
155121468|NCT02782325|559875066|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
155121469|NCT02782325|559875067|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
155121470|NCT02782325|559875065|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
155121471|NCT02782325|559875066|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
155121472|NCT02782325|559875067|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
155121473|NCT03777917|559875068|FG000|Overall Study|Withdrawal by Subject|1|||
155121474|NCT03777917|559875069|FG001|Overall Study|Withdrawal by Subject|0|||
155121475|NCT03777917|559875068|FG000|Overall Study|Physician Decision|1|||
155121476|NCT03777917|559875069|FG001|Overall Study|Physician Decision|0|||
155121477|NCT03777917|559875068|FG000|Overall Study|Lost to Follow-up|6|||
155121478|NCT03777917|559875069|FG001|Overall Study|Lost to Follow-up|2|||
154993174|NCT02132754|559400807|FG021|Overall Study|Progressive Disease|3|||
155121479|NCT03777917|559875068|FG000|Overall Study|Other|1|||
154993175|NCT02132754|559400808|FG022|Overall Study|Progressive Disease|2|||
154993176|NCT02132754|559400809|FG023|Overall Study|Progressive Disease|3|||
155121480|NCT03777917|559875069|FG001|Overall Study|Other|0|||
155121481|NCT01154283|559875070|FG000|0-6 Weeks|Withdrawal by Subject|7|||
154993177|NCT02132754|559400810|FG024|Overall Study|Progressive Disease|0|||
155121482|NCT01154283|559875071|FG001|0-6 Weeks|Withdrawal by Subject|2|||
155121483|NCT01154283|559875070|FG000|0-6 Weeks|Death|0|||
155121484|NCT01154283|559875071|FG001|0-6 Weeks|Death|1|||
155121485|NCT01154283|559875070|FG000|7-12 Weeks|Death|1|||
155121486|NCT01154283|559875071|FG001|7-12 Weeks|Death|0|||
155121487|NCT01154283|559875070|FG000|7-12 Weeks|Withdrawal by Subject|0|||
154993178|NCT02132754|559400811|FG025|Overall Study|Progressive Disease|1|||
154993179|NCT02132754|559400812|FG026|Overall Study|Progressive Disease|2|||
155121488|NCT01154283|559875071|FG001|7-12 Weeks|Withdrawal by Subject|1|||
155121489|NCT00042432|559875072|FG000|Overall Study|Adverse Event|4|||
155121490|NCT00042432|559875073|FG001|Overall Study|Adverse Event|1|||
155121491|NCT00042432|559875072|FG000|Overall Study|Withdrawal by Subject|1|||
155121492|NCT00042432|559875073|FG001|Overall Study|Withdrawal by Subject|3|||
155121493|NCT00042432|559875072|FG000|Overall Study|Death|0|||
155121494|NCT00042432|559875073|FG001|Overall Study|Death|2|||
155121495|NCT00042432|559875072|FG000|Overall Study|Ineligibility determined|1|||
155121496|NCT00042432|559875073|FG001|Overall Study|Ineligibility determined|0|||
155121497|NCT00042432|559875072|FG000|Overall Study|Initiation of maintenance dialysis|1|||
155121498|NCT00042432|559875073|FG001|Overall Study|Initiation of maintenance dialysis|1|||
155121499|NCT00042432|559875072|FG000|Overall Study|Other|2|||
155121500|NCT00042432|559875073|FG001|Overall Study|Other|0|||
155121501|NCT00320372|559875074|FG000|Overall Study|Physician Decision|4|||
155121502|NCT00320372|559875075|FG001|Overall Study|Physician Decision|7|||
155121503|NCT00320372|559875074|FG000|Overall Study|Death|7|||
155121504|NCT00320372|559875075|FG001|Overall Study|Death|8|||
155121505|NCT00320372|559875074|FG000|Overall Study|Withdrawal by Subject|55|||
155121506|NCT00320372|559875075|FG001|Overall Study|Withdrawal by Subject|37|||
155121507|NCT00320372|559875074|FG000|Overall Study|Non-Compliance|40|||
155121508|NCT00320372|559875075|FG001|Overall Study|Non-Compliance|39|||
155121509|NCT00320372|559875074|FG000|Overall Study|Did not Meet (I/E)|3|||
155121510|NCT00320372|559875075|FG001|Overall Study|Did not Meet (I/E)|1|||
155121511|NCT00320372|559875074|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
155121512|NCT00320372|559875075|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
155121513|NCT01287221|559875076|FG000|Overall Study|Lack of Perceived Benefit|1|||
155121514|NCT01287221|559875077|FG001|Overall Study|Lack of Perceived Benefit|1|||
155121515|NCT01287221|559875076|FG000|Overall Study|Adverse Event|3|||
155121516|NCT01287221|559875077|FG001|Overall Study|Adverse Event|3|||
155121517|NCT01287221|559875076|FG000|Overall Study|Withdrawal by Subject|0|||
155121518|NCT01287221|559875077|FG001|Overall Study|Withdrawal by Subject|1|||
155121519|NCT02966795|559875078|FG000|Overall Study|Patient Left the Country|0|||
155121520|NCT02966795|559875079|FG001|Overall Study|Patient Left the Country|1|||
155121521|NCT00432744|559875080|FG000|Months 0-6|Withdrawal by Subject|4|||
155121522|NCT00432744|559875081|FG001|Months 0-6|Withdrawal by Subject|4|||
155121523|NCT00432744|559875080|FG000|Months 0-6|Too disabled to score|1|||
155121524|NCT00432744|559875081|FG001|Months 0-6|Too disabled to score|0|||
155121525|NCT00432744|559875080|FG000|Months 7 - 12|Withdrawal by Subject|1|||
155121526|NCT00432744|559875081|FG001|Months 7 - 12|Withdrawal by Subject|0|||
155121527|NCT00432744|559875080|FG000|Months 7 - 12|Too disabled to score|0|||
155121528|NCT00432744|559875081|FG001|Months 7 - 12|Too disabled to score|1|||
155121529|NCT02761694|559875086|FG000|Overall Study|Lack of Efficacy|0|||
155121530|NCT02761694|559875087|FG001|Overall Study|Lack of Efficacy|0|||
155121531|NCT02761694|559875088|FG002|Overall Study|Lack of Efficacy|0|||
155121532|NCT02761694|559875089|FG003|Overall Study|Lack of Efficacy|0|||
155121533|NCT02761694|559875090|FG004|Overall Study|Lack of Efficacy|0|||
155121534|NCT02761694|559875091|FG005|Overall Study|Lack of Efficacy|0|||
155121535|NCT02761694|559875092|FG006|Overall Study|Lack of Efficacy|6|||
155121536|NCT02761694|559875093|FG007|Overall Study|Lack of Efficacy|0|||
155121537|NCT02761694|559875094|FG008|Overall Study|Lack of Efficacy|0|||
155121538|NCT02761694|559875095|FG009|Overall Study|Lack of Efficacy|1|||
155121539|NCT02761694|559875096|FG010|Overall Study|Lack of Efficacy|1|||
155121540|NCT02761694|559875097|FG011|Overall Study|Lack of Efficacy|4|||
155121541|NCT02761694|559875086|FG000|Overall Study|Death|0|||
155121542|NCT02761694|559875087|FG001|Overall Study|Death|0|||
155121543|NCT02761694|559875088|FG002|Overall Study|Death|0|||
155121544|NCT02761694|559875089|FG003|Overall Study|Death|0|||
155121545|NCT02761694|559875090|FG004|Overall Study|Death|0|||
155121546|NCT02761694|559875091|FG005|Overall Study|Death|0|||
155121547|NCT02761694|559875092|FG006|Overall Study|Death|2|||
155121548|NCT02761694|559875093|FG007|Overall Study|Death|0|||
155121549|NCT02761694|559875094|FG008|Overall Study|Death|2|||
155121550|NCT02761694|559875095|FG009|Overall Study|Death|2|||
155121551|NCT02761694|559875096|FG010|Overall Study|Death|1|||
155121552|NCT02761694|559875097|FG011|Overall Study|Death|0|||
155121553|NCT02761694|559875086|FG000|Overall Study|Physician Decision|0|||
155121554|NCT02761694|559875087|FG001|Overall Study|Physician Decision|0|||
155121555|NCT02761694|559875088|FG002|Overall Study|Physician Decision|0|||
155121556|NCT02761694|559875089|FG003|Overall Study|Physician Decision|0|||
155121557|NCT02761694|559875090|FG004|Overall Study|Physician Decision|0|||
155121558|NCT02761694|559875091|FG005|Overall Study|Physician Decision|0|||
155121559|NCT02761694|559875092|FG006|Overall Study|Physician Decision|1|||
155121560|NCT02761694|559875093|FG007|Overall Study|Physician Decision|0|||
155121561|NCT02761694|559875094|FG008|Overall Study|Physician Decision|0|||
155121562|NCT02761694|559875095|FG009|Overall Study|Physician Decision|0|||
155121563|NCT02761694|559875096|FG010|Overall Study|Physician Decision|0|||
155121564|NCT02761694|559875097|FG011|Overall Study|Physician Decision|0|||
155121565|NCT02761694|559875086|FG000|Overall Study|Withdrawal by Subject|0|||
155121566|NCT02761694|559875087|FG001|Overall Study|Withdrawal by Subject|0|||
155121567|NCT02761694|559875088|FG002|Overall Study|Withdrawal by Subject|0|||
155121568|NCT02761694|559875089|FG003|Overall Study|Withdrawal by Subject|1|||
155121569|NCT02761694|559875090|FG004|Overall Study|Withdrawal by Subject|0|||
155177377|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
155177378|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
155177379|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
155177380|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
155177381|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
154993180|NCT02132754|559400813|FG027|Overall Study|Progressive Disease|1|||
154993181|NCT02132754|559400814|FG028|Overall Study|Progressive Disease|2|||
154993182|NCT02132754|559400815|FG029|Overall Study|Progressive Disease|3|||
154993183|NCT02132754|559400816|FG030|Overall Study|Progressive Disease|1|||
154993184|NCT02132754|559400817|FG031|Overall Study|Progressive Disease|1|||
154993185|NCT02132754|559400818|FG032|Overall Study|Progressive Disease|3|||
154993186|NCT02132754|559400819|FG033|Overall Study|Progressive Disease|6|||
154993187|NCT02132754|559400786|FG000|Overall Study|Screen Failure|0|||
154993188|NCT02132754|559400787|FG001|Overall Study|Screen Failure|0|||
154993189|NCT02132754|559400788|FG002|Overall Study|Screen Failure|0|||
154993190|NCT02132754|559400789|FG003|Overall Study|Screen Failure|0|||
154993191|NCT02132754|559400790|FG004|Overall Study|Screen Failure|0|||
154993192|NCT02132754|559400791|FG005|Overall Study|Screen Failure|0|||
154993193|NCT02132754|559400792|FG006|Overall Study|Screen Failure|0|||
154993194|NCT02132754|559400793|FG007|Overall Study|Screen Failure|0|||
154993195|NCT02132754|559400794|FG008|Overall Study|Screen Failure|0|||
154993196|NCT02132754|559400795|FG009|Overall Study|Screen Failure|0|||
154993197|NCT02132754|559400796|FG010|Overall Study|Screen Failure|0|||
154993198|NCT02132754|559400797|FG011|Overall Study|Screen Failure|0|||
154993199|NCT02132754|559400798|FG012|Overall Study|Screen Failure|0|||
154993200|NCT02132754|559400799|FG013|Overall Study|Screen Failure|0|||
154993201|NCT02132754|559400800|FG014|Overall Study|Screen Failure|0|||
154993202|NCT02132754|559400801|FG015|Overall Study|Screen Failure|0|||
154993203|NCT02132754|559400802|FG016|Overall Study|Screen Failure|0|||
154993204|NCT02132754|559400803|FG017|Overall Study|Screen Failure|0|||
154993205|NCT02132754|559400804|FG018|Overall Study|Screen Failure|0|||
154993206|NCT02132754|559400805|FG019|Overall Study|Screen Failure|1|||
154993207|NCT02132754|559400806|FG020|Overall Study|Screen Failure|0|||
154993208|NCT02132754|559400807|FG021|Overall Study|Screen Failure|1|||
154993209|NCT02132754|559400808|FG022|Overall Study|Screen Failure|0|||
154993210|NCT02132754|559400809|FG023|Overall Study|Screen Failure|0|||
154993211|NCT02132754|559400810|FG024|Overall Study|Screen Failure|0|||
154993212|NCT02132754|559400811|FG025|Overall Study|Screen Failure|0|||
154993213|NCT02132754|559400812|FG026|Overall Study|Screen Failure|0|||
154993214|NCT02132754|559400813|FG027|Overall Study|Screen Failure|0|||
154993215|NCT02132754|559400814|FG028|Overall Study|Screen Failure|0|||
154993216|NCT02132754|559400815|FG029|Overall Study|Screen Failure|0|||
154993217|NCT02132754|559400816|FG030|Overall Study|Screen Failure|0|||
154993218|NCT02132754|559400817|FG031|Overall Study|Screen Failure|0|||
154993219|NCT02132754|559400818|FG032|Overall Study|Screen Failure|0|||
154993220|NCT02132754|559400819|FG033|Overall Study|Screen Failure|0|||
154993221|NCT02132754|559400786|FG000|Overall Study|Transferred to Extension Study|0|||
154993222|NCT02132754|559400787|FG001|Overall Study|Transferred to Extension Study|0|||
154993223|NCT02132754|559400788|FG002|Overall Study|Transferred to Extension Study|0|||
154993224|NCT02132754|559400789|FG003|Overall Study|Transferred to Extension Study|0|||
155177382|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
155177383|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
155177384|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
155177385|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
155177386|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
155177387|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
155177388|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
155177389|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
155177390|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
154993225|NCT02132754|559400790|FG004|Overall Study|Transferred to Extension Study|0|||
154993226|NCT02132754|559400791|FG005|Overall Study|Transferred to Extension Study|0|||
154993227|NCT02132754|559400792|FG006|Overall Study|Transferred to Extension Study|0|||
154993228|NCT02132754|559400793|FG007|Overall Study|Transferred to Extension Study|0|||
154993229|NCT02132754|559400794|FG008|Overall Study|Transferred to Extension Study|0|||
154993230|NCT02132754|559400795|FG009|Overall Study|Transferred to Extension Study|0|||
154993231|NCT02132754|559400796|FG010|Overall Study|Transferred to Extension Study|0|||
154993232|NCT02132754|559400797|FG011|Overall Study|Transferred to Extension Study|0|||
154993233|NCT02132754|559400798|FG012|Overall Study|Transferred to Extension Study|0|||
154993234|NCT02132754|559400799|FG013|Overall Study|Transferred to Extension Study|0|||
154993235|NCT02132754|559400800|FG014|Overall Study|Transferred to Extension Study|0|||
154993236|NCT02132754|559400801|FG015|Overall Study|Transferred to Extension Study|0|||
154993237|NCT02132754|559400802|FG016|Overall Study|Transferred to Extension Study|0|||
155177391|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
154993238|NCT02132754|559400803|FG017|Overall Study|Transferred to Extension Study|0|||
154993239|NCT02132754|559400804|FG018|Overall Study|Transferred to Extension Study|0|||
154993240|NCT02132754|559400805|FG019|Overall Study|Transferred to Extension Study|0|||
154993241|NCT02132754|559400806|FG020|Overall Study|Transferred to Extension Study|0|||
154993242|NCT02132754|559400807|FG021|Overall Study|Transferred to Extension Study|0|||
154993243|NCT02132754|559400808|FG022|Overall Study|Transferred to Extension Study|0|||
154993244|NCT02132754|559400809|FG023|Overall Study|Transferred to Extension Study|0|||
154993245|NCT02132754|559400810|FG024|Overall Study|Transferred to Extension Study|0|||
154993246|NCT02132754|559400811|FG025|Overall Study|Transferred to Extension Study|0|||
154993247|NCT02132754|559400812|FG026|Overall Study|Transferred to Extension Study|0|||
154993248|NCT02132754|559400813|FG027|Overall Study|Transferred to Extension Study|0|||
154993249|NCT02132754|559400814|FG028|Overall Study|Transferred to Extension Study|0|||
154993250|NCT02132754|559400815|FG029|Overall Study|Transferred to Extension Study|0|||
154993251|NCT02132754|559400816|FG030|Overall Study|Transferred to Extension Study|0|||
154993252|NCT02132754|559400817|FG031|Overall Study|Transferred to Extension Study|0|||
154993253|NCT02132754|559400818|FG032|Overall Study|Transferred to Extension Study|0|||
154993254|NCT02132754|559400819|FG033|Overall Study|Transferred to Extension Study|6|||
154993255|NCT02132754|559400786|FG000|Overall Study|Withdrawal by Subject|0|||
154993256|NCT02132754|559400787|FG001|Overall Study|Withdrawal by Subject|0|||
154993257|NCT02132754|559400788|FG002|Overall Study|Withdrawal by Subject|0|||
154993258|NCT02132754|559400789|FG003|Overall Study|Withdrawal by Subject|0|||
154993259|NCT02132754|559400790|FG004|Overall Study|Withdrawal by Subject|0|||
154993260|NCT02132754|559400791|FG005|Overall Study|Withdrawal by Subject|0|||
154993261|NCT02132754|559400792|FG006|Overall Study|Withdrawal by Subject|0|||
154993262|NCT02132754|559400793|FG007|Overall Study|Withdrawal by Subject|0|||
154993263|NCT02132754|559400794|FG008|Overall Study|Withdrawal by Subject|0|||
154993264|NCT02132754|559400795|FG009|Overall Study|Withdrawal by Subject|1|||
154993265|NCT02132754|559400796|FG010|Overall Study|Withdrawal by Subject|0|||
154993266|NCT02132754|559400797|FG011|Overall Study|Withdrawal by Subject|0|||
154993267|NCT02132754|559400798|FG012|Overall Study|Withdrawal by Subject|1|||
154993268|NCT02132754|559400799|FG013|Overall Study|Withdrawal by Subject|0|||
154993269|NCT02132754|559400800|FG014|Overall Study|Withdrawal by Subject|1|||
154993270|NCT02132754|559400801|FG015|Overall Study|Withdrawal by Subject|2|||
154993271|NCT02132754|559400802|FG016|Overall Study|Withdrawal by Subject|1|||
154993272|NCT02132754|559400803|FG017|Overall Study|Withdrawal by Subject|0|||
154993273|NCT02132754|559400804|FG018|Overall Study|Withdrawal by Subject|0|||
154993274|NCT02132754|559400805|FG019|Overall Study|Withdrawal by Subject|0|||
154993275|NCT02132754|559400806|FG020|Overall Study|Withdrawal by Subject|1|||
154993276|NCT02132754|559400807|FG021|Overall Study|Withdrawal by Subject|0|||
154993277|NCT02132754|559400808|FG022|Overall Study|Withdrawal by Subject|0|||
154993278|NCT02132754|559400809|FG023|Overall Study|Withdrawal by Subject|0|||
154993279|NCT02132754|559400810|FG024|Overall Study|Withdrawal by Subject|1|||
154993280|NCT02132754|559400811|FG025|Overall Study|Withdrawal by Subject|0|||
154993281|NCT02132754|559400812|FG026|Overall Study|Withdrawal by Subject|0|||
154993282|NCT02132754|559400813|FG027|Overall Study|Withdrawal by Subject|1|||
154993283|NCT02132754|559400814|FG028|Overall Study|Withdrawal by Subject|0|||
154993284|NCT02132754|559400815|FG029|Overall Study|Withdrawal by Subject|0|||
154993285|NCT02132754|559400816|FG030|Overall Study|Withdrawal by Subject|0|||
154993286|NCT02132754|559400817|FG031|Overall Study|Withdrawal by Subject|1|||
154993287|NCT02132754|559400818|FG032|Overall Study|Withdrawal by Subject|0|||
154993288|NCT02132754|559400819|FG033|Overall Study|Withdrawal by Subject|2|||
154993289|NCT03401450|559400820|FG000|Overall Study|Lost to Follow-up|4|||
154993290|NCT03401450|559400821|FG001|Overall Study|Lost to Follow-up|6|||
154993291|NCT03401450|559400820|FG000|Overall Study|Anesthesia plan changed|2|||
154993292|NCT03401450|559400821|FG001|Overall Study|Anesthesia plan changed|2|||
154993293|NCT03401450|559400820|FG000|Overall Study|Did not complete medication diary|4|||
154993294|NCT03401450|559400821|FG001|Overall Study|Did not complete medication diary|2|||
154993295|NCT03401450|559400820|FG000|Overall Study|post surgery medication change|2|||
154993296|NCT03401450|559400821|FG001|Overall Study|post surgery medication change|1|||
154993297|NCT03401450|559400820|FG000|Overall Study|Cancelled surgery|0|||
154993298|NCT03401450|559400821|FG001|Overall Study|Cancelled surgery|2|||
154993299|NCT00761865|559400822|FG000|Overall Study|Lost to Follow-up|8|||
154993300|NCT00761865|559400823|FG001|Overall Study|Lost to Follow-up|7|||
154993301|NCT01372774|559400826|FG000|Overall Study|Withdrawal prior to treatment|4|||
154993302|NCT01372774|559400827|FG001|Overall Study|Withdrawal prior to treatment|5|||
154993303|NCT00389831|559400828|FG000|Overall Study|Lack of Efficacy|0|||
154993304|NCT00389831|559400829|FG001|Overall Study|Lack of Efficacy|2|||
154993305|NCT00389831|559400828|FG000|Overall Study|Did not receive treatment.|0|||
154993306|NCT00389831|559400829|FG001|Overall Study|Did not receive treatment.|2|||
154993307|NCT00389831|559400828|FG000|Overall Study|Other reasons|0|||
154993308|NCT00389831|559400829|FG001|Overall Study|Other reasons|2|||
154993309|NCT00389831|559400828|FG000|Overall Study|Lost to Follow-up|0|||
154993310|NCT00389831|559400829|FG001|Overall Study|Lost to Follow-up|1|||
154993311|NCT02201290|559400830|FG000|Overall Study|Withdrawal by Subject|2|||
154993312|NCT02201290|559400830|FG000|Overall Study|Lack of Efficacy|2|||
154993313|NCT02201290|559400830|FG000|Overall Study|Adverse Event|1|||
154917464|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|Other|6|||
154917465|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|Other|7|||
154917466|NCT02681094|559120314|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
154917467|NCT02681094|559120315|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
154917468|NCT02681094|559120316|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
154917469|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|Participant decision|7|||
154917470|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|Participant decision|10|||
154917471|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|Participant decision|9|||
154917472|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
154917473|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
154917474|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
154917475|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
154917476|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
154917477|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
154917478|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
154917479|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
154917480|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
154917481|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
154917482|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
154917483|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
154917484|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|Other|6|||
154917485|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|Other|6|||
154917486|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|Other|7|||
154917487|NCT02681094|559120314|FG000|2 - Enrolled Participants Set|No treatment given|0|||
154917488|NCT02681094|559120315|FG001|2 - Enrolled Participants Set|No treatment given|1|||
154917489|NCT02681094|559120316|FG002|2 - Enrolled Participants Set|No treatment given|1|||
154917490|NCT00134563|559120317|FG000|Overall Study|Not treated due to protocol violation|0|||
154917491|NCT00134563|559120318|FG001|Overall Study|Not treated due to protocol violation|1|||
154917492|NCT00134563|559120319|FG002|Overall Study|Not treated due to protocol violation|1|||
154917493|NCT00134563|559120317|FG000|Overall Study|Adverse Event|29|||
154917494|NCT00134563|559120318|FG001|Overall Study|Adverse Event|37|||
154917495|NCT00134563|559120319|FG002|Overall Study|Adverse Event|38|||
154917496|NCT00134563|559120317|FG000|Overall Study|Lack of Efficacy|24|||
154917497|NCT00134563|559120318|FG001|Overall Study|Lack of Efficacy|14|||
154917498|NCT00134563|559120319|FG002|Overall Study|Lack of Efficacy|17|||
154917499|NCT00134563|559120317|FG000|Overall Study|Protocol Violation|3|||
154917500|NCT00134563|559120318|FG001|Overall Study|Protocol Violation|2|||
154917501|NCT00134563|559120319|FG002|Overall Study|Protocol Violation|5|||
154917502|NCT00134563|559120317|FG000|Overall Study|Lost to Follow-up|4|||
154917503|NCT00134563|559120318|FG001|Overall Study|Lost to Follow-up|0|||
154917504|NCT00134563|559120319|FG002|Overall Study|Lost to Follow-up|2|||
154917505|NCT00134563|559120317|FG000|Overall Study|progressive disease|11|||
154917506|NCT00134563|559120318|FG001|Overall Study|progressive disease|4|||
154917507|NCT00134563|559120319|FG002|Overall Study|progressive disease|2|||
154917508|NCT00134563|559120317|FG000|Overall Study|did not wish to continue|33|||
154917509|NCT00134563|559120318|FG001|Overall Study|did not wish to continue|32|||
154917510|NCT00134563|559120319|FG002|Overall Study|did not wish to continue|26|||
154917511|NCT00134563|559120317|FG000|Overall Study|Reason other than above|0|||
154917512|NCT00134563|559120318|FG001|Overall Study|Reason other than above|2|||
154917513|NCT00134563|559120319|FG002|Overall Study|Reason other than above|5|||
154917514|NCT03382639|559120320|FG000|Overall Study|Adverse Event|2|||
154917515|NCT03382639|559120321|FG001|Overall Study|Adverse Event|0|||
154917516|NCT03382639|559120322|FG002|Overall Study|Adverse Event|1|||
154917517|NCT03382639|559120323|FG003|Overall Study|Adverse Event|1|||
154917518|NCT03382639|559120320|FG000|Overall Study|Lost to Follow-up|1|||
154917519|NCT03382639|559120321|FG001|Overall Study|Lost to Follow-up|0|||
154917520|NCT03382639|559120322|FG002|Overall Study|Lost to Follow-up|0|||
154917521|NCT03382639|559120323|FG003|Overall Study|Lost to Follow-up|0|||
154917522|NCT03382639|559120320|FG000|Overall Study|Withdrawal by Subject|4|||
154917523|NCT03382639|559120321|FG001|Overall Study|Withdrawal by Subject|3|||
154917524|NCT03382639|559120322|FG002|Overall Study|Withdrawal by Subject|2|||
154917525|NCT03382639|559120323|FG003|Overall Study|Withdrawal by Subject|3|||
154917526|NCT03382639|559120320|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
154917527|NCT03382639|559120321|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
154917528|NCT03382639|559120322|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
154917529|NCT03382639|559120323|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
154917530|NCT03382639|559120320|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
154917531|NCT03382639|559120321|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
154917532|NCT03382639|559120322|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
155177392|NCT01087788|560088224|FG000|24-weeks Dose-blind Period|Patient moved|0|||
155177393|NCT01087788|560088225|FG001|24-weeks Dose-blind Period|Patient moved|0|||
155177394|NCT01087788|560088226|FG002|24-weeks Dose-blind Period|Patient moved|1|||
154917533|NCT03382639|559120323|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
154917534|NCT03382639|559120320|FG000|Overall Study|Other|2|||
154917535|NCT03382639|559120321|FG001|Overall Study|Other|0|||
154917536|NCT03382639|559120322|FG002|Overall Study|Other|0|||
154917537|NCT03382639|559120323|FG003|Overall Study|Other|3|||
154917538|NCT00682539|559120326|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
154917539|NCT00682539|559120327|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
154917540|NCT00682539|559120328|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
154917541|NCT00682539|559120326|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
154917542|NCT00682539|559120327|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
154917543|NCT00682539|559120328|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
154917544|NCT02477215|559120333|FG000|Dose Escalation Phase|Physician Decision|1|||
154917545|NCT02477215|559120334|FG001|Dose Escalation Phase|Physician Decision|2|||
154917546|NCT02477215|559120335|FG002|Dose Escalation Phase|Physician Decision|0|||
154917547|NCT02477215|559120333|FG000|Fixed Dose Phase|Physician Decision|0|||
154917548|NCT02477215|559120334|FG001|Fixed Dose Phase|Physician Decision|7|||
154917549|NCT02477215|559120335|FG002|Fixed Dose Phase|Physician Decision|0|||
154917550|NCT00285857|559120336|FG000|Overall Study|Withdrawal by Subject|2|||
154917551|NCT00285857|559120336|FG000|Overall Study|Inadequate initial breast cytology|1|||
154917552|NCT00285857|559120336|FG000|Overall Study|Adverse Event|1|||
154917553|NCT00508872|559120337|FG000|Overall Study|Lost to Follow-up|1|||
154917554|NCT00508872|559120337|FG000|Overall Study|Physician Decision|1|||
154917555|NCT02210559|559120342|FG000|Overall Study|Progressive Disease|3|||
154917556|NCT02210559|559120343|FG001|Overall Study|Progressive Disease|2|||
154917557|NCT02210559|559120342|FG000|Overall Study|Adverse Event|2|||
154917558|NCT02210559|559120343|FG001|Overall Study|Adverse Event|2|||
154917559|NCT02210559|559120342|FG000|Overall Study|Physician Decision|1|||
154917560|NCT02210559|559120343|FG001|Overall Study|Physician Decision|0|||
154917561|NCT02210559|559120342|FG000|Overall Study|Withdrawal by Subject|0|||
154917562|NCT02210559|559120343|FG001|Overall Study|Withdrawal by Subject|1|||
154917563|NCT02210559|559120342|FG000|Overall Study|Other than specified|0|||
154917564|NCT02210559|559120343|FG001|Overall Study|Other than specified|1|||
154917565|NCT00310440|559120344|FG000|Overall Study|Lost to Follow-up|17|||
154917566|NCT00310440|559120345|FG001|Overall Study|Lost to Follow-up|8|||
154917567|NCT00310440|559120344|FG000|Overall Study|Withdrawal by Subject|2|||
154917568|NCT00310440|559120345|FG001|Overall Study|Withdrawal by Subject|1|||
154917569|NCT00310440|559120344|FG000|Overall Study|Missed 12 Month Visit|7|||
154917570|NCT00310440|559120345|FG001|Overall Study|Missed 12 Month Visit|4|||
154917571|NCT00792467|559120346|FG000|Overall Study|progression of disease|17|||
154917572|NCT00792467|559120346|FG000|Overall Study|Adverse Event|1|||
154917573|NCT00792467|559120346|FG000|Overall Study|patient request|1|||
154917574|NCT00792467|559120346|FG000|Overall Study|Lost to Follow-up|1|||
154917575|NCT00792467|559120346|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
154917576|NCT00792467|559120346|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
154917577|NCT01287403|559120351|FG000|1st Intervention (1 Day)|Adverse Event|1|||
154917578|NCT01098266|559120352|FG000|Overall Study|Physician Decision|1|||
154917579|NCT01098266|559120353|FG001|Overall Study|Physician Decision|0|||
154917580|NCT01098266|559120352|FG000|Overall Study|Death|3|||
154917581|NCT01098266|559120353|FG001|Overall Study|Death|2|||
154917582|NCT01098266|559120352|FG000|Overall Study|Withdrawal by Subject|3|||
154917583|NCT01098266|559120353|FG001|Overall Study|Withdrawal by Subject|5|||
154917584|NCT00727246|559120357|FG000|Overall Study|could not complete MRI|0|||
154917585|NCT00727246|559120358|FG001|Overall Study|could not complete MRI|1|||
154917586|NCT00727246|559120359|FG002|Overall Study|could not complete MRI|0|||
154917587|NCT00727246|559120360|FG003|Overall Study|could not complete MRI|1|||
154917588|NCT00727246|559120357|FG000|Overall Study|incidental finding|0|||
154917589|NCT00727246|559120358|FG001|Overall Study|incidental finding|0|||
154917590|NCT00727246|559120359|FG002|Overall Study|incidental finding|0|||
154917591|NCT00727246|559120360|FG003|Overall Study|incidental finding|1|||
154917592|NCT00727246|559120357|FG000|Overall Study|withdrawn|0|||
154917593|NCT00727246|559120358|FG001|Overall Study|withdrawn|0|||
154917594|NCT00727246|559120359|FG002|Overall Study|withdrawn|1|||
154917595|NCT00727246|559120360|FG003|Overall Study|withdrawn|0|||
154917596|NCT04594213|559120361|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
154917597|NCT04594213|559120362|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
154917598|NCT04594213|559120363|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
154917599|NCT04594213|559120364|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
154917600|NCT04594213|559120365|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
154917601|NCT04594213|559120366|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
154917602|NCT04594213|559120361|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
154917603|NCT04594213|559120362|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
154917604|NCT04594213|559120363|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
154917605|NCT04594213|559120364|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
154917606|NCT04594213|559120365|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
154993314|NCT02081209|559402733|FG000|Overall Study|Withdrawal by Subject|1|||
155121570|NCT02761694|559875091|FG005|Overall Study|Withdrawal by Subject|0|||
155121571|NCT02761694|559875092|FG006|Overall Study|Withdrawal by Subject|4|||
155121572|NCT02761694|559875093|FG007|Overall Study|Withdrawal by Subject|0|||
155121573|NCT02761694|559875094|FG008|Overall Study|Withdrawal by Subject|2|||
155121574|NCT02761694|559875095|FG009|Overall Study|Withdrawal by Subject|1|||
155121575|NCT02761694|559875096|FG010|Overall Study|Withdrawal by Subject|0|||
155121576|NCT02761694|559875097|FG011|Overall Study|Withdrawal by Subject|0|||
155121577|NCT02761694|559875086|FG000|Overall Study|Lost to Follow-up|0|||
155121578|NCT02761694|559875087|FG001|Overall Study|Lost to Follow-up|0|||
155121579|NCT02761694|559875088|FG002|Overall Study|Lost to Follow-up|0|||
155121580|NCT02761694|559875089|FG003|Overall Study|Lost to Follow-up|0|||
155121581|NCT02761694|559875090|FG004|Overall Study|Lost to Follow-up|0|||
155121582|NCT02761694|559875091|FG005|Overall Study|Lost to Follow-up|0|||
155121583|NCT02761694|559875092|FG006|Overall Study|Lost to Follow-up|1|||
155121584|NCT02761694|559875093|FG007|Overall Study|Lost to Follow-up|0|||
155121585|NCT02761694|559875094|FG008|Overall Study|Lost to Follow-up|0|||
155121586|NCT02761694|559875095|FG009|Overall Study|Lost to Follow-up|0|||
155121587|NCT02761694|559875096|FG010|Overall Study|Lost to Follow-up|0|||
155121588|NCT02761694|559875097|FG011|Overall Study|Lost to Follow-up|1|||
155121589|NCT02761694|559875086|FG000|Overall Study|Adverse Event|0|||
155121590|NCT02761694|559875087|FG001|Overall Study|Adverse Event|0|||
155121591|NCT02761694|559875088|FG002|Overall Study|Adverse Event|0|||
155121592|NCT02761694|559875089|FG003|Overall Study|Adverse Event|0|||
155121593|NCT02761694|559875090|FG004|Overall Study|Adverse Event|0|||
155121594|NCT02761694|559875091|FG005|Overall Study|Adverse Event|0|||
155121595|NCT02761694|559875092|FG006|Overall Study|Adverse Event|1|||
155121596|NCT02761694|559875093|FG007|Overall Study|Adverse Event|0|||
155121597|NCT02761694|559875094|FG008|Overall Study|Adverse Event|1|||
155121598|NCT02761694|559875095|FG009|Overall Study|Adverse Event|0|||
155121599|NCT02761694|559875096|FG010|Overall Study|Adverse Event|0|||
155121600|NCT02761694|559875097|FG011|Overall Study|Adverse Event|1|||
155121601|NCT02761694|559875086|FG000|Overall Study|Other|4|||
155121602|NCT02761694|559875087|FG001|Overall Study|Other|4|||
155121603|NCT02761694|559875088|FG002|Overall Study|Other|1|||
155121604|NCT02761694|559875089|FG003|Overall Study|Other|2|||
155121605|NCT02761694|559875090|FG004|Overall Study|Other|3|||
155121606|NCT02761694|559875091|FG005|Overall Study|Other|3|||
155121607|NCT02761694|559875092|FG006|Overall Study|Other|18|||
155121608|NCT02761694|559875093|FG007|Overall Study|Other|8|||
155121609|NCT02761694|559875094|FG008|Overall Study|Other|0|||
155121610|NCT02761694|559875095|FG009|Overall Study|Other|1|||
155121611|NCT02761694|559875096|FG010|Overall Study|Other|1|||
155121612|NCT02761694|559875097|FG011|Overall Study|Other|0|||
155121613|NCT02395055|559875102|FG000|Overall Study|Withdrawal by Subject|7|||
155121614|NCT02395055|559875103|FG001|Overall Study|Withdrawal by Subject|3|||
155121615|NCT00787930|559875104|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
155121616|NCT02513823|559875105|FG000|Overall Study|Lost to Follow-up|4|||
155121617|NCT02513823|559875105|FG000|Overall Study|Physician Decision|1|||
155121618|NCT00844805|559875108|FG000|Treatment Phase|Adverse Event|5|||
155121619|NCT00844805|559875109|FG001|Treatment Phase|Adverse Event|1|||
155121620|NCT00844805|559875110|FG002|Treatment Phase|Adverse Event|0|||
155121621|NCT00844805|559875111|FG003|Treatment Phase|Adverse Event|0|||
155121622|NCT00844805|559875108|FG000|Treatment Phase|Withdrawal by Subject|3|||
155121623|NCT00844805|559875109|FG001|Treatment Phase|Withdrawal by Subject|4|||
155121624|NCT00844805|559875110|FG002|Treatment Phase|Withdrawal by Subject|0|||
155121625|NCT00844805|559875111|FG003|Treatment Phase|Withdrawal by Subject|0|||
155121626|NCT00844805|559875108|FG000|Treatment Phase|Noncompliance With Protocol|1|||
155121627|NCT00844805|559875109|FG001|Treatment Phase|Noncompliance With Protocol|0|||
155121628|NCT00844805|559875110|FG002|Treatment Phase|Noncompliance With Protocol|0|||
155121629|NCT00844805|559875111|FG003|Treatment Phase|Noncompliance With Protocol|0|||
155121630|NCT00844805|559875108|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
155121631|NCT00844805|559875109|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
155121632|NCT00844805|559875110|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
155121633|NCT00844805|559875111|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
155121634|NCT00844805|559875108|FG000|Follow-Up Phase|Adverse Event|0|||
155121635|NCT00844805|559875109|FG001|Follow-Up Phase|Adverse Event|0|||
155121636|NCT00844805|559875110|FG002|Follow-Up Phase|Adverse Event|1|||
154917607|NCT04594213|559120366|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
154917608|NCT04594213|559120361|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
154917609|NCT04594213|559120362|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
154917610|NCT04594213|559120363|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
154917611|NCT04594213|559120364|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
154917612|NCT04594213|559120365|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155121637|NCT00844805|559875111|FG003|Follow-Up Phase|Adverse Event|0|||
155121638|NCT00844805|559875108|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
155121639|NCT00844805|559875109|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
155121640|NCT00844805|559875110|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
155121641|NCT00844805|559875111|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
154917613|NCT04594213|559120366|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
154917614|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
154917615|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
154917616|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
154993315|NCT02370329|559402734|FG000|Overall Study|Alternate treatment|1|||
154993316|NCT02370329|559402734|FG000|Overall Study|Adverse Event|1|||
155121642|NCT00844805|559875108|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
154993317|NCT02370329|559402734|FG000|Overall Study|Disease progression|3|||
154993318|NCT02370329|559402734|FG000|Overall Study|Physician Decision|2|||
154993319|NCT02370329|559402734|FG000|Overall Study|Study closure|4|||
154993320|NCT00633243|559402735|FG000|Overall Study|Withdrawal by Subject|0|||
154993321|NCT00633243|559402736|FG001|Overall Study|Withdrawal by Subject|1|||
154993322|NCT00633243|559402735|FG000|Overall Study|incarceration|0|||
154993323|NCT00633243|559402736|FG001|Overall Study|incarceration|2|||
154993324|NCT00633243|559402735|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
154993325|NCT00633243|559402736|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
154993326|NCT00633243|559402735|FG000|Overall Study|Not comfortable with self-injecting|0|||
154993327|NCT00633243|559402736|FG001|Overall Study|Not comfortable with self-injecting|1|||
154993328|NCT00633243|559402735|FG000|Overall Study|Mental Health--Depression|0|||
155121643|NCT00844805|559875109|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
155121644|NCT00844805|559875110|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
155121645|NCT00844805|559875111|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
155121646|NCT00844805|559875108|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
155121647|NCT00844805|559875109|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
154917617|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
154917618|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
154917619|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
154917620|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
154917621|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
154917622|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
154917623|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
154917624|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
154917625|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
154917626|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
154917627|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
154917628|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
154917629|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
154917630|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
154917631|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
154917632|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
154917633|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
154917634|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
154917635|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
154917636|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
154917637|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
154917638|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
154917639|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
154917640|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
154917641|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
154917642|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
154917643|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
154917644|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
154917645|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
154917646|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
154917647|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
154917648|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
154917649|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
154917650|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
154917651|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
154917652|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
154917653|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
154917654|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
154917655|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
154917656|NCT04594213|559120361|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
154917657|NCT04594213|559120362|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
154917658|NCT04594213|559120363|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
154917659|NCT04594213|559120364|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
154917660|NCT04594213|559120365|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
154917661|NCT04594213|559120366|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
154993329|NCT00633243|559402736|FG001|Overall Study|Mental Health--Depression|1|||
155177395|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
155177396|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
155177397|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
155177398|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
155177399|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
155177400|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
155177401|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
155177402|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
155177403|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
155177404|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
155177405|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
155177406|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
155177407|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
155177408|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
155177409|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
155177410|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
155177411|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
155177412|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
155177413|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
155177414|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
155177415|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
155177416|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
155177417|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
155177418|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
155177419|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
155177420|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
155177421|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
155177422|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
155177423|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
155177424|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
155177425|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
155177426|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
155177427|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
155177428|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
155177429|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
155177430|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
155177431|NCT01087788|560088224|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
155177432|NCT01087788|560088225|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
155177433|NCT01087788|560088226|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
155177434|NCT01917656|560088233|FG000|Overall Study|Adverse Event|11|||
155177435|NCT01917656|560088234|FG001|Overall Study|Adverse Event|0|||
155177436|NCT01917656|560088233|FG000|Overall Study|Withdrawal criteria|8|||
155177437|NCT01917656|560088234|FG001|Overall Study|Withdrawal criteria|14|||
155177438|NCT01917656|560088233|FG000|Overall Study|Unclassified|0|||
155177439|NCT01917656|560088234|FG001|Overall Study|Unclassified|3|||
155177440|NCT01917656|560088233|FG000|Overall Study|Withdrawal by Subject|4|||
155177441|NCT01917656|560088234|FG001|Overall Study|Withdrawal by Subject|3|||
155177442|NCT01917656|560088233|FG000|Overall Study|Lost to Follow-up|3|||
155177443|NCT01917656|560088234|FG001|Overall Study|Lost to Follow-up|4|||
155177444|NCT02015221|560088235|FG000|Overall Study|Withdrawal by Subject|8|||
155177445|NCT02015221|560088236|FG001|Overall Study|Withdrawal by Subject|6|||
155177446|NCT02015221|560088235|FG000|Overall Study|Lost to Follow-up|1|||
155177447|NCT02015221|560088236|FG001|Overall Study|Lost to Follow-up|0|||
155177448|NCT01306929|560088237|FG000|Overall Study|Withdrawal by Subject|23|||
155177449|NCT01306929|560088237|FG000|Overall Study|Adverse Event|21|||
155177450|NCT01306929|560088237|FG000|Overall Study|Physician Decision|13|||
155177451|NCT01306929|560088237|FG000|Overall Study|Death|8|||
155177452|NCT01306929|560088237|FG000|Overall Study|Withdrawal by parent/guardian|5|||
155177453|NCT01306929|560088237|FG000|Overall Study|Protocol Violation|3|||
155177454|NCT01306929|560088237|FG000|Overall Study|Non-compliance with study drug|2|||
155177455|NCT01306929|560088237|FG000|Overall Study|Lost to Follow-up|2|||
155177456|NCT01306929|560088237|FG000|Overall Study|Various|17|||
155177457|NCT03709576|560088238|FG000|Overall Study|progression prior to enrollment|1|||
155177458|NCT03041129|560088246|FG000|Overall Study|Withdrawal by Subject|2|||
155177459|NCT03041129|560088247|FG001|Overall Study|Withdrawal by Subject|0|||
155177460|NCT03041129|560088248|FG002|Overall Study|Withdrawal by Subject|0|||
155177461|NCT03041129|560088249|FG003|Overall Study|Withdrawal by Subject|0|||
155177462|NCT00510653|560088252|FG000|Overall Study|Withdrawal by Subject|8|||
155177463|NCT00510653|560088252|FG000|Overall Study|Monetary|3|||
155177464|NCT00483756|560088255|FG000|Overall Study|Death|2|||
155177465|NCT00483756|560088256|FG001|Overall Study|Death|0|||
155177466|NCT00483756|560088257|FG002|Overall Study|Death|1|||
155177467|NCT00483756|560088255|FG000|Overall Study|Adverse Event|19|||
154993330|NCT00633243|559402735|FG000|Overall Study|Couldn't tolerate side-effects|1|||
154993331|NCT00633243|559402736|FG001|Overall Study|Couldn't tolerate side-effects|1|||
154993332|NCT02022748|559402737|FG000|Overall Study|Adverse Event|1|||
154993333|NCT02022748|559402738|FG001|Overall Study|Adverse Event|1|||
154993334|NCT02022748|559402739|FG002|Overall Study|Adverse Event|0|||
154993335|NCT02022748|559402737|FG000|Overall Study|Withdrawal by Subject|0|||
154993336|NCT02022748|559402738|FG001|Overall Study|Withdrawal by Subject|1|||
154993337|NCT02022748|559402739|FG002|Overall Study|Withdrawal by Subject|0|||
154993338|NCT02903030|559402740|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
154993339|NCT02903030|559402741|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
154993340|NCT01502410|559402742|FG000|Overall Study|Adverse Event|1|||
154993341|NCT01502410|559402743|FG001|Overall Study|Adverse Event|2|||
154993342|NCT01502410|559402744|FG002|Overall Study|Adverse Event|0|||
154993343|NCT01502410|559402745|FG003|Overall Study|Adverse Event|0|||
154993344|NCT01502410|559402742|FG000|Overall Study|Lack of Efficacy|7|||
154993345|NCT01502410|559402743|FG001|Overall Study|Lack of Efficacy|7|||
154993346|NCT01502410|559402744|FG002|Overall Study|Lack of Efficacy|0|||
154993347|NCT01502410|559402745|FG003|Overall Study|Lack of Efficacy|0|||
154993348|NCT01502410|559402742|FG000|Overall Study|Physician Decision|0|||
154993349|NCT01502410|559402743|FG001|Overall Study|Physician Decision|1|||
154993350|NCT01502410|559402744|FG002|Overall Study|Physician Decision|0|||
154993351|NCT01502410|559402745|FG003|Overall Study|Physician Decision|0|||
154993352|NCT01502410|559402742|FG000|Overall Study|Withdrawal by Subject|2|||
154993353|NCT01502410|559402743|FG001|Overall Study|Withdrawal by Subject|0|||
154993354|NCT01502410|559402744|FG002|Overall Study|Withdrawal by Subject|0|||
154993355|NCT01502410|559402745|FG003|Overall Study|Withdrawal by Subject|0|||
154993356|NCT03700385|559402747|FG000|Overall Study|Lost to Follow-up|1|||
154993357|NCT00699283|559402748|FG000|Overall Study|Lack of Efficacy|15|||
154993358|NCT00699283|559402749|FG001|Overall Study|Lack of Efficacy|5|||
154993359|NCT00699283|559402748|FG000|Overall Study|Lost to Follow-up|2|||
154993360|NCT00699283|559402749|FG001|Overall Study|Lost to Follow-up|0|||
154993361|NCT00699283|559402748|FG000|Overall Study|Withdrawal by Subject|1|||
154993362|NCT00699283|559402749|FG001|Overall Study|Withdrawal by Subject|0|||
154993363|NCT00699283|559402748|FG000|Overall Study|Other Reason|5|||
154993364|NCT00699283|559402749|FG001|Overall Study|Other Reason|1|||
154993365|NCT00699283|559402748|FG000|Overall Study|SAE, non-fatal|1|||
154993366|NCT00699283|559402749|FG001|Overall Study|SAE, non-fatal|1|||
155121648|NCT00844805|559875110|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
154993367|NCT00699283|559402748|FG000|Overall Study|AE, non-serious non-fatal|8|||
154993368|NCT00699283|559402749|FG001|Overall Study|AE, non-serious non-fatal|1|||
154993369|NCT00699283|559402748|FG000|Overall Study|AE of unknown type|1|||
154993370|NCT00699283|559402749|FG001|Overall Study|AE of unknown type|0|||
154993371|NCT02771795|559402757|FG000|Overall Study|Withdrawal by Subject|47|||
154993372|NCT02771795|559402758|FG001|Overall Study|Withdrawal by Subject|37|||
154993373|NCT02771795|559402757|FG000|Overall Study|Termination by premature discontinuation of study|168|||
154993374|NCT02771795|559402758|FG001|Overall Study|Termination by premature discontinuation of study|185|||
154993375|NCT03537599|559402759|FG000|Overall Study|Disease Progression|2|||
154993376|NCT03537599|559402760|FG001|Overall Study|Disease Progression|1|||
154993377|NCT03537599|559402759|FG000|Overall Study|Death|0|||
154993378|NCT03537599|559402760|FG001|Overall Study|Death|1|||
154993379|NCT05083585|559402761|FG000|Overall Study|Death|1|||
154993380|NCT05083585|559402762|FG001|Overall Study|Death|1|||
154993381|NCT05083585|559402761|FG000|Overall Study|Lost to Follow-up|1|||
154993382|NCT05083585|559402762|FG001|Overall Study|Lost to Follow-up|1|||
154993383|NCT05083585|559402761|FG000|Overall Study|Withdrawal by Subject|2|||
154993384|NCT05083585|559402762|FG001|Overall Study|Withdrawal by Subject|0|||
154993385|NCT05083585|559402761|FG000|Overall Study|Randomized but not vaccinated|2|||
154993386|NCT05083585|559402762|FG001|Overall Study|Randomized but not vaccinated|0|||
154993387|NCT00114166|559402763|FG000|Overall Study|Wrong primary|0|||
154993388|NCT00114166|559402764|FG001|Overall Study|Wrong primary|1|||
154993389|NCT03469336|559402765|FG000|Overall Study|Adverse Event|1|||
155121649|NCT00844805|559875111|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
155121650|NCT00844805|559875108|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
155121651|NCT00844805|559875109|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
155121652|NCT00844805|559875110|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
154993390|NCT02740699|559402768|FG000|Overall Study|Lost to Follow-up|5|||
154993391|NCT02740699|559402768|FG000|Overall Study|Withdrawal by Subject|14|||
154993392|NCT02740699|559402768|FG000|Overall Study|Physician Decision|5|||
154993393|NCT02393248|559402769|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993394|NCT02393248|559402770|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
154993395|NCT02393248|559402771|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993396|NCT02393248|559402772|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155121653|NCT00844805|559875111|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
155121654|NCT00475865|559875112|FG000|Overall Study|Adverse Event|0|||
154993397|NCT02393248|559402773|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
155121655|NCT00475865|559875113|FG001|Overall Study|Adverse Event|3|||
154993398|NCT02393248|559402774|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
154993399|NCT02393248|559402775|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
154993400|NCT02393248|559402776|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993401|NCT02393248|559402777|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993402|NCT02393248|559402778|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993403|NCT02393248|559402779|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993404|NCT02393248|559402780|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993405|NCT02393248|559402781|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993406|NCT02393248|559402782|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993407|NCT02393248|559402783|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993408|NCT02393248|559402784|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993409|NCT02393248|559402785|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993410|NCT02393248|559402786|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993411|NCT02393248|559402787|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993412|NCT02393248|559402788|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993413|NCT02393248|559402789|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993414|NCT02393248|559402790|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993415|NCT02393248|559402791|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993416|NCT02393248|559402792|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993417|NCT02393248|559402793|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
154993418|NCT02393248|559402769|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
155121656|NCT00475865|559875114|FG002|Overall Study|Adverse Event|4|||
155121657|NCT00475865|559875112|FG000|Overall Study|Lack of Efficacy|1|||
155121658|NCT00475865|559875113|FG001|Overall Study|Lack of Efficacy|0|||
155121659|NCT00475865|559875114|FG002|Overall Study|Lack of Efficacy|0|||
155121660|NCT00475865|559875112|FG000|Overall Study|Progressive disease|0|||
155121661|NCT00475865|559875113|FG001|Overall Study|Progressive disease|1|||
155121662|NCT00475865|559875114|FG002|Overall Study|Progressive disease|2|||
155121663|NCT00475865|559875112|FG000|Overall Study|Participant did not wish to continue|1|||
155121664|NCT00475865|559875113|FG001|Overall Study|Participant did not wish to continue|0|||
155121665|NCT00475865|559875114|FG002|Overall Study|Participant did not wish to continue|0|||
155121666|NCT00475865|559875112|FG000|Overall Study|Other than above|0|||
155121667|NCT00475865|559875113|FG001|Overall Study|Other than above|1|||
155121668|NCT00475865|559875114|FG002|Overall Study|Other than above|0|||
155121669|NCT04316741|559875115|FG000|Baseline Enrollment|Lost to Follow-up|1|||
155121670|NCT04316741|559875116|FG001|Baseline Enrollment|Lost to Follow-up|1|||
155121671|NCT04316741|559875115|FG000|Immediate Post-Test|Lost to Follow-up|5|||
155121672|NCT04316741|559875116|FG001|Immediate Post-Test|Lost to Follow-up|1|||
155121673|NCT04316741|559875115|FG000|1-month Post-test|Lost to Follow-up|7|||
155121674|NCT04316741|559875116|FG001|1-month Post-test|Lost to Follow-up|2|||
155121675|NCT04316741|559875115|FG000|3-month Follow-up|Lost to Follow-up|10|||
155121676|NCT04316741|559875116|FG001|3-month Follow-up|Lost to Follow-up|2|||
155121677|NCT02278614|559875120|FG000|Overall Study|Withdrawal by Subject|3|||
155121678|NCT02278614|559875121|FG001|Overall Study|Withdrawal by Subject|5|||
155121679|NCT02278614|559875120|FG000|Overall Study|Adverse Event|1|||
155121680|NCT02278614|559875121|FG001|Overall Study|Adverse Event|0|||
155121681|NCT02278614|559875120|FG000|Overall Study|left eye was not eligible|1|||
155121682|NCT02278614|559875121|FG001|Overall Study|left eye was not eligible|0|||
155121683|NCT02279498|559875122|FG000|Overall Study|Adverse Event|3|||
155121684|NCT02279498|559875123|FG001|Overall Study|Adverse Event|0|||
155121685|NCT02279498|559875122|FG000|Overall Study|Lack of Efficacy|4|||
155121686|NCT02279498|559875123|FG001|Overall Study|Lack of Efficacy|0|||
155121687|NCT02279498|559875122|FG000|Overall Study|Lost to Follow-up|0|||
155121688|NCT02279498|559875123|FG001|Overall Study|Lost to Follow-up|1|||
155121689|NCT02279498|559875122|FG000|Overall Study|Withdrawal by Subject|9|||
155121690|NCT02279498|559875123|FG001|Overall Study|Withdrawal by Subject|2|||
155121691|NCT02279498|559875122|FG000|Overall Study|Undefined|2|||
155121692|NCT02279498|559875123|FG001|Overall Study|Undefined|1|||
155121693|NCT00737711|559875124|FG000|Overall Study|Adverse Event|2|||
155121694|NCT00737711|559875124|FG000|Overall Study|Death|8|||
155121695|NCT00737711|559875124|FG000|Overall Study|Failure to return|4|||
155121696|NCT00737711|559875124|FG000|Overall Study|Protocol Violation|1|||
155121697|NCT00737711|559875124|FG000|Overall Study|Withdrawal by Subject|5|||
155121698|NCT00737711|559875124|FG000|Overall Study|Blood transfusion|6|||
155121699|NCT00737711|559875124|FG000|Overall Study|Other|5|||
155121700|NCT00624780|559875125|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
155121701|NCT00624780|559875126|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
155121702|NCT00624780|559875127|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
155121703|NCT00624780|559875128|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
155121704|NCT00624780|559875129|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
155121705|NCT00624780|559875130|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
155121706|NCT00624780|559875125|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
155121707|NCT00624780|559875126|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
154993419|NCT02393248|559402770|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
154993420|NCT02393248|559402771|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993421|NCT02393248|559402772|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993422|NCT02393248|559402773|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993423|NCT02393248|559402774|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993424|NCT02393248|559402775|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993425|NCT02393248|559402776|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993426|NCT02393248|559402777|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993427|NCT02393248|559402778|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993428|NCT02393248|559402779|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993429|NCT02393248|559402780|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993430|NCT02393248|559402781|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993431|NCT02393248|559402782|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993432|NCT02393248|559402783|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993433|NCT02393248|559402784|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993434|NCT02393248|559402785|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993435|NCT02393248|559402786|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993436|NCT02393248|559402787|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993437|NCT02393248|559402788|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993438|NCT02393248|559402789|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993439|NCT02393248|559402790|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993440|NCT02393248|559402791|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993441|NCT02393248|559402792|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993442|NCT02393248|559402793|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
154993443|NCT02393248|559402769|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
154993444|NCT02393248|559402770|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
154993445|NCT02393248|559402771|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
154993446|NCT02393248|559402772|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
154993447|NCT02393248|559402773|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
154993448|NCT02393248|559402774|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
154993449|NCT02393248|559402775|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
154993450|NCT02393248|559402776|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
154993451|NCT02393248|559402777|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
154993452|NCT02393248|559402778|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
154993453|NCT02393248|559402779|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
154993454|NCT02393248|559402780|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
154993455|NCT02393248|559402781|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
154993456|NCT02393248|559402782|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
154993457|NCT02393248|559402783|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
154993458|NCT02393248|559402784|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
154993459|NCT02393248|559402785|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
154993460|NCT02393248|559402786|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
154993461|NCT02393248|559402787|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
154993462|NCT02393248|559402788|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
154993463|NCT02393248|559402789|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
154993464|NCT02393248|559402790|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
154993465|NCT02393248|559402791|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
154993466|NCT02393248|559402792|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
154993467|NCT02393248|559402793|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
154993468|NCT02393248|559402769|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
154993469|NCT02393248|559402770|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993470|NCT02393248|559402771|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993471|NCT02393248|559402772|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993472|NCT02393248|559402773|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993473|NCT02393248|559402774|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993474|NCT02393248|559402775|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993475|NCT02393248|559402776|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993476|NCT02393248|559402777|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993477|NCT02393248|559402778|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993478|NCT02393248|559402779|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993479|NCT02393248|559402780|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993480|NCT02393248|559402781|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993481|NCT02393248|559402782|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993482|NCT02393248|559402783|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993483|NCT02393248|559402784|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993484|NCT02393248|559402785|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993485|NCT02393248|559402786|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993486|NCT02393248|559402787|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993487|NCT02393248|559402788|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993488|NCT02393248|559402789|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993489|NCT02393248|559402790|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993490|NCT02393248|559402791|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993491|NCT02393248|559402792|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993492|NCT02393248|559402793|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
154993493|NCT02393248|559402769|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993494|NCT02393248|559402770|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993495|NCT02393248|559402771|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993496|NCT02393248|559402772|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993497|NCT02393248|559402773|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993498|NCT02393248|559402774|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
154993499|NCT02393248|559402775|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
154993500|NCT02393248|559402776|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993501|NCT02393248|559402777|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993502|NCT02393248|559402778|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
154993503|NCT02393248|559402779|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993504|NCT02393248|559402780|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993505|NCT02393248|559402781|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993506|NCT02393248|559402782|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993507|NCT02393248|559402783|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993508|NCT02393248|559402784|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993509|NCT02393248|559402785|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993510|NCT02393248|559402786|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993511|NCT02393248|559402787|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993512|NCT02393248|559402788|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993513|NCT02393248|559402789|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993514|NCT02393248|559402790|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993515|NCT02393248|559402791|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993516|NCT02393248|559402792|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993517|NCT02393248|559402793|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
154993518|NCT02393248|559402769|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993519|NCT02393248|559402770|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993520|NCT02393248|559402771|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993521|NCT02393248|559402772|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993522|NCT02393248|559402773|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993523|NCT02393248|559402774|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993524|NCT02393248|559402775|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
154993525|NCT02393248|559402776|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993526|NCT02393248|559402777|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993527|NCT02393248|559402778|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993528|NCT02393248|559402779|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993529|NCT02393248|559402780|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993530|NCT02393248|559402781|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993531|NCT02393248|559402782|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993532|NCT02393248|559402783|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993533|NCT02393248|559402784|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993534|NCT02393248|559402785|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
155121708|NCT00624780|559875127|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
155121709|NCT00624780|559875128|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
155121710|NCT00624780|559875129|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
155121711|NCT00624780|559875130|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
154917662|NCT01654666|559120367|FG000|Overall Study|Protocol Violation|7|||
154917663|NCT01654666|559120368|FG001|Overall Study|Protocol Violation|4|||
154917664|NCT01654666|559120369|FG002|Overall Study|Protocol Violation|8|||
154917665|NCT01654666|559120367|FG000|Overall Study|Lost to Follow-up|4|||
154917666|NCT01654666|559120368|FG001|Overall Study|Lost to Follow-up|5|||
154917667|NCT01654666|559120369|FG002|Overall Study|Lost to Follow-up|5|||
154917668|NCT01654666|559120367|FG000|Overall Study|Withdrawal by Subject|4|||
154917669|NCT01654666|559120368|FG001|Overall Study|Withdrawal by Subject|4|||
154917670|NCT01654666|559120369|FG002|Overall Study|Withdrawal by Subject|1|||
154917671|NCT01218477|559120377|FG000|Overall Study|Disease progression|2|||
154917672|NCT01218477|559120378|FG001|Overall Study|Disease progression|3|||
154993535|NCT02393248|559402786|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993536|NCT02393248|559402787|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993537|NCT02393248|559402788|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993538|NCT02393248|559402789|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993539|NCT02393248|559402790|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993540|NCT02393248|559402791|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993541|NCT02393248|559402792|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993542|NCT02393248|559402793|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
154993543|NCT02393248|559402769|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993544|NCT02393248|559402770|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993545|NCT02393248|559402771|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993546|NCT02393248|559402772|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993547|NCT02393248|559402773|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993548|NCT02393248|559402774|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993549|NCT02393248|559402775|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993550|NCT02393248|559402776|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993551|NCT02393248|559402777|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993552|NCT02393248|559402778|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993553|NCT02393248|559402779|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993554|NCT02393248|559402780|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
154993555|NCT02393248|559402781|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
154993556|NCT02393248|559402782|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
154993557|NCT02393248|559402783|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
154993558|NCT02393248|559402784|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993559|NCT02393248|559402785|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993560|NCT02393248|559402786|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993561|NCT02393248|559402787|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993562|NCT02393248|559402788|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993563|NCT02393248|559402789|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993564|NCT02393248|559402790|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993565|NCT02393248|559402791|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993566|NCT02393248|559402792|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993567|NCT02393248|559402793|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
154993568|NCT02393248|559402769|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993569|NCT02393248|559402770|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993570|NCT02393248|559402771|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993571|NCT02393248|559402772|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993572|NCT02393248|559402773|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993573|NCT02393248|559402774|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993574|NCT02393248|559402775|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993575|NCT02393248|559402776|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993576|NCT02393248|559402777|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993577|NCT02393248|559402778|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993578|NCT02393248|559402779|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
154993579|NCT02393248|559402780|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
154993580|NCT02393248|559402781|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
155121712|NCT00624780|559875125|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
155121713|NCT00624780|559875126|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
155121714|NCT00624780|559875127|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
155121715|NCT00624780|559875128|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
155121716|NCT00624780|559875129|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
155121717|NCT00624780|559875130|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
155121718|NCT00624780|559875125|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
155121719|NCT00624780|559875126|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
155121720|NCT00624780|559875127|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
155121721|NCT00624780|559875128|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
155121722|NCT00624780|559875129|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
155177468|NCT00483756|560088256|FG001|Overall Study|Adverse Event|38|||
155177469|NCT00483756|560088257|FG002|Overall Study|Adverse Event|40|||
155177470|NCT00483756|560088255|FG000|Overall Study|Lack of Efficacy|1|||
155177471|NCT00483756|560088256|FG001|Overall Study|Lack of Efficacy|0|||
155177472|NCT00483756|560088257|FG002|Overall Study|Lack of Efficacy|0|||
155177473|NCT00483756|560088255|FG000|Overall Study|Lost to Follow-up|3|||
155177474|NCT00483756|560088256|FG001|Overall Study|Lost to Follow-up|1|||
155177475|NCT00483756|560088257|FG002|Overall Study|Lost to Follow-up|0|||
154993581|NCT02393248|559402782|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993582|NCT02393248|559402783|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993583|NCT02393248|559402784|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993584|NCT02393248|559402785|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993585|NCT02393248|559402786|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993586|NCT02393248|559402787|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993587|NCT02393248|559402788|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993588|NCT02393248|559402789|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993589|NCT02393248|559402790|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993590|NCT02393248|559402791|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993591|NCT02393248|559402792|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993592|NCT02393248|559402793|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
154993593|NCT02393248|559402769|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
154993594|NCT02393248|559402770|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
154993595|NCT02393248|559402771|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
154993596|NCT02393248|559402772|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
154993597|NCT02393248|559402773|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
154993598|NCT02393248|559402774|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
154993599|NCT02393248|559402775|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
155121723|NCT00624780|559875130|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
155121724|NCT00624780|559875125|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
155121725|NCT00624780|559875126|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
155121726|NCT00624780|559875127|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
155121727|NCT00624780|559875128|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
154993600|NCT02393248|559402776|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
154993601|NCT02393248|559402777|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
154993602|NCT02393248|559402778|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
154993603|NCT02393248|559402779|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
154993604|NCT02393248|559402780|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
154993605|NCT02393248|559402781|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
154993606|NCT02393248|559402782|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
154993607|NCT02393248|559402783|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
154993608|NCT02393248|559402784|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
154993609|NCT02393248|559402785|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
154993610|NCT02393248|559402786|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
155121728|NCT00624780|559875129|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
155121729|NCT00624780|559875130|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
155121730|NCT00624780|559875125|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
155121731|NCT00624780|559875126|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
155121732|NCT00624780|559875127|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
155121733|NCT00624780|559875128|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
155121734|NCT00624780|559875129|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
155121735|NCT00624780|559875130|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
155121736|NCT00624780|559875125|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
155121737|NCT00624780|559875126|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
155121738|NCT00624780|559875127|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
155121739|NCT00624780|559875128|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
155121740|NCT00624780|559875129|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
155121741|NCT00624780|559875130|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
155121742|NCT00624780|559875125|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155121743|NCT00624780|559875126|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
155121744|NCT00624780|559875127|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155121745|NCT00624780|559875128|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
155121746|NCT00624780|559875129|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155121747|NCT00624780|559875130|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
155121748|NCT00624780|559875125|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
155121749|NCT00624780|559875126|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
155121750|NCT00624780|559875127|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
155121751|NCT00624780|559875128|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
155121752|NCT00624780|559875129|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
155121753|NCT00624780|559875130|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
155121754|NCT00624780|559875125|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
155121755|NCT00624780|559875126|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
155121756|NCT00624780|559875127|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
155121757|NCT00624780|559875128|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
154993611|NCT02393248|559402787|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
154993612|NCT02393248|559402788|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
154993613|NCT02393248|559402789|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
154993614|NCT02393248|559402790|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
154993615|NCT02393248|559402791|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
154993616|NCT02393248|559402792|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
154993617|NCT02393248|559402793|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
154993618|NCT02393248|559402769|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993619|NCT02393248|559402770|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993620|NCT02393248|559402771|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993621|NCT02393248|559402772|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993622|NCT02393248|559402773|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993623|NCT02393248|559402774|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993624|NCT02393248|559402775|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993625|NCT02393248|559402776|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993626|NCT02393248|559402777|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993627|NCT02393248|559402778|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993628|NCT02393248|559402779|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993629|NCT02393248|559402780|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
154993630|NCT02393248|559402781|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993631|NCT02393248|559402782|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
154993632|NCT02393248|559402783|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993633|NCT02393248|559402784|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993634|NCT02393248|559402785|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993635|NCT02393248|559402786|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993636|NCT02393248|559402787|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993637|NCT02393248|559402788|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993638|NCT02393248|559402789|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993639|NCT02393248|559402790|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993640|NCT02393248|559402791|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993641|NCT02393248|559402792|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993642|NCT02393248|559402793|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
154993643|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993644|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993645|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993646|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993647|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993648|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993649|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993650|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993651|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993652|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993653|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993654|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993655|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993656|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993657|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993658|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993659|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993660|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993661|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
154993662|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993663|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
154993664|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
154993665|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993666|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
154993667|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
154993668|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Death|0|||
154993669|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Death|0|||
154993670|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Death|0|||
154993671|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Death|0|||
154993672|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Death|0|||
154993673|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Death|0|||
155121758|NCT00624780|559875129|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
154993674|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Death|0|||
154993675|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Death|0|||
154993676|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Death|0|||
155121759|NCT00624780|559875130|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
154993677|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Death|0|||
154993678|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Death|0|||
155121760|NCT00624780|559875125|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
155121761|NCT00624780|559875126|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
154993679|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Death|0|||
154993680|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Death|0|||
154993681|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Death|0|||
154993682|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Death|0|||
154993683|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Death|1|||
154993684|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Death|7|||
154993685|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Death|5|||
154993686|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Death|5|||
154993687|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Death|3|||
154993688|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Death|7|||
154993689|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Death|5|||
154993690|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Death|6|||
154993691|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Death|3|||
154993692|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Death|0|||
154993693|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993694|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993695|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993696|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993697|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993698|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993699|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993700|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993701|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993702|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993703|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993704|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993705|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993706|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993707|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993708|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993709|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993710|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
154993711|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
154993712|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
154993713|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
154993714|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
154993715|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
154993716|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
154993717|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
154993718|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Disease Progression|0|||
154993719|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Disease Progression|0|||
154993720|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Disease Progression|0|||
154993721|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Disease Progression|0|||
154993722|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Disease Progression|0|||
154993723|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Disease Progression|0|||
154993724|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Disease Progression|0|||
154993725|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Disease Progression|0|||
154993726|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Disease Progression|0|||
154993727|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Disease Progression|0|||
154993728|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Disease Progression|0|||
154993729|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Disease Progression|0|||
154993730|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Disease Progression|0|||
154993731|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Disease Progression|0|||
154993732|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Disease Progression|0|||
154993733|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Disease Progression|0|||
154993734|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Disease Progression|0|||
154993735|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Disease Progression|0|||
154993736|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Disease Progression|0|||
154993737|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Disease Progression|0|||
154993738|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Disease Progression|2|||
154993739|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Disease Progression|1|||
154993740|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Disease Progression|0|||
154993741|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Disease Progression|0|||
154993742|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Disease Progression|0|||
154993743|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993744|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993745|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993746|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993747|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993748|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
155177476|NCT00483756|560088255|FG000|Overall Study|Withdrawal by Subject|5|||
155177477|NCT00483756|560088256|FG001|Overall Study|Withdrawal by Subject|3|||
155177478|NCT00483756|560088257|FG002|Overall Study|Withdrawal by Subject|4|||
155177479|NCT00483756|560088255|FG000|Overall Study|Other|2|||
155121762|NCT00624780|559875127|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
155121763|NCT00624780|559875128|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
155121764|NCT00624780|559875129|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
155121765|NCT00624780|559875130|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
155121766|NCT00624780|559875125|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
155121767|NCT00624780|559875126|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155121768|NCT00624780|559875127|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155121769|NCT00624780|559875128|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155121770|NCT00624780|559875129|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155121771|NCT00624780|559875130|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
155121772|NCT00624780|559875125|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155121773|NCT00624780|559875126|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155121774|NCT00624780|559875127|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
155121775|NCT00624780|559875128|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155121776|NCT00624780|559875129|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155121777|NCT00624780|559875130|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
155121778|NCT00624780|559875125|FG000|Follow-up (Week 26)|Death|0|||
155121779|NCT00624780|559875126|FG001|Follow-up (Week 26)|Death|0|||
155121780|NCT00624780|559875127|FG002|Follow-up (Week 26)|Death|1|||
155121781|NCT00624780|559875128|FG003|Follow-up (Week 26)|Death|0|||
155121782|NCT00624780|559875129|FG004|Follow-up (Week 26)|Death|0|||
155121783|NCT00624780|559875130|FG005|Follow-up (Week 26)|Death|0|||
155121784|NCT00624780|559875125|FG000|Follow-up (Week 26)|Adverse Event|0|||
155121785|NCT00624780|559875126|FG001|Follow-up (Week 26)|Adverse Event|0|||
155121786|NCT00624780|559875127|FG002|Follow-up (Week 26)|Adverse Event|0|||
155121787|NCT00624780|559875128|FG003|Follow-up (Week 26)|Adverse Event|0|||
155121788|NCT00624780|559875129|FG004|Follow-up (Week 26)|Adverse Event|1|||
155121789|NCT00624780|559875130|FG005|Follow-up (Week 26)|Adverse Event|0|||
155121790|NCT00624780|559875125|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
155121791|NCT00624780|559875126|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
155121792|NCT00624780|559875127|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
155121793|NCT00624780|559875128|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
155121794|NCT00624780|559875129|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
155121795|NCT00624780|559875130|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
155121796|NCT00624780|559875125|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
155121797|NCT00624780|559875126|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
155121798|NCT00624780|559875127|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
155121799|NCT00624780|559875128|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
155121800|NCT00624780|559875129|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
155121801|NCT00624780|559875130|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
155121802|NCT00624780|559875125|FG000|Follow-up (Week 26)|Other|1|||
155121803|NCT00624780|559875126|FG001|Follow-up (Week 26)|Other|1|||
155121804|NCT00624780|559875127|FG002|Follow-up (Week 26)|Other|0|||
155121805|NCT00624780|559875128|FG003|Follow-up (Week 26)|Other|0|||
155121806|NCT00624780|559875129|FG004|Follow-up (Week 26)|Other|0|||
155121807|NCT00624780|559875130|FG005|Follow-up (Week 26)|Other|0|||
155121808|NCT04068519|559875131|FG000|Dose Verification|Death|15|||
155121809|NCT04068519|559875131|FG000|Dose Verification|Withdrawal by Subject|1|||
155121810|NCT04068519|559875131|FG000|Pharmacokinetic Sub-study|Death|35|||
155121811|NCT04068519|559875131|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
155121812|NCT04068519|559875131|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
155121813|NCT04068519|559875131|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
155121814|NCT04068519|559875131|FG000|Indication Expansion|Death|152|||
155121815|NCT04068519|559875131|FG000|Indication Expansion|Withdrawal by Subject|10|||
155121816|NCT04068519|559875131|FG000|Indication Expansion|Lost to Follow-up|7|||
154917673|NCT01218477|559120379|FG002|Overall Study|Disease progression|6|||
154917674|NCT01218477|559120380|FG003|Overall Study|Disease progression|2|||
155121817|NCT03762616|559875132|FG000|Overall Study|Protocol Violation|2|||
155121818|NCT03081858|559877806|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
155121819|NCT03081858|559877807|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
155121820|NCT03081858|559877808|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
155121821|NCT03081858|559877809|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
155121822|NCT05438602|559877812|FG000|Treatment (15 Days)|Adverse Event|2|||
155121823|NCT05438602|559877813|FG001|Treatment (15 Days)|Adverse Event|1|||
155121824|NCT05438602|559877814|FG002|Treatment (15 Days)|Adverse Event|3|||
155177480|NCT00483756|560088256|FG001|Overall Study|Other|4|||
155177481|NCT00483756|560088257|FG002|Overall Study|Other|3|||
154917675|NCT01218477|559120377|FG000|Overall Study|Study drug toxicity|0|||
154917676|NCT01218477|559120378|FG001|Overall Study|Study drug toxicity|2|||
154917677|NCT01218477|559120379|FG002|Overall Study|Study drug toxicity|5|||
155177482|NCT00483756|560088255|FG000|Overall Study|Randomized, Not Treated|1|||
155177483|NCT00483756|560088256|FG001|Overall Study|Randomized, Not Treated|4|||
154917678|NCT01218477|559120380|FG003|Overall Study|Study drug toxicity|0|||
154917679|NCT01218477|559120377|FG000|Overall Study|No longer meets study criteria|1|||
154917680|NCT01218477|559120378|FG001|Overall Study|No longer meets study criteria|0|||
154917681|NCT01218477|559120379|FG002|Overall Study|No longer meets study criteria|0|||
154917682|NCT01218477|559120380|FG003|Overall Study|No longer meets study criteria|0|||
154917683|NCT01218477|559120377|FG000|Overall Study|Withdrawal by Subject|0|||
154917684|NCT01218477|559120378|FG001|Overall Study|Withdrawal by Subject|0|||
154917685|NCT01218477|559120379|FG002|Overall Study|Withdrawal by Subject|1|||
154917686|NCT01218477|559120380|FG003|Overall Study|Withdrawal by Subject|0|||
154917687|NCT01218477|559120377|FG000|Overall Study|Prepared for cell transplantation|0|||
154917688|NCT01218477|559120378|FG001|Overall Study|Prepared for cell transplantation|1|||
154917689|NCT01218477|559120379|FG002|Overall Study|Prepared for cell transplantation|1|||
154917690|NCT01218477|559120380|FG003|Overall Study|Prepared for cell transplantation|0|||
154917691|NCT01218477|559120377|FG000|Overall Study|Administrative reason by sponsor|0|||
154917692|NCT01218477|559120378|FG001|Overall Study|Administrative reason by sponsor|0|||
154917693|NCT01218477|559120379|FG002|Overall Study|Administrative reason by sponsor|1|||
154917694|NCT01218477|559120380|FG003|Overall Study|Administrative reason by sponsor|0|||
154917695|NCT01218477|559120377|FG000|Overall Study|Maximum clinical benefit|0|||
154917696|NCT01218477|559120378|FG001|Overall Study|Maximum clinical benefit|2|||
154917697|NCT01218477|559120379|FG002|Overall Study|Maximum clinical benefit|0|||
154917698|NCT01218477|559120380|FG003|Overall Study|Maximum clinical benefit|0|||
154917699|NCT00787527|559120383|FG000|Overall Study|Toxicity|3|||
154917700|NCT02132312|559120392|FG000|Overall Study|Adverse Event|2|||
154917701|NCT02132312|559120393|FG001|Overall Study|Adverse Event|0|||
154917702|NCT02132312|559120392|FG000|Overall Study|Physician Decision|1|||
154917703|NCT02132312|559120393|FG001|Overall Study|Physician Decision|1|||
154917704|NCT02132312|559120392|FG000|Overall Study|Protocol Violation|0|||
154917705|NCT02132312|559120393|FG001|Overall Study|Protocol Violation|1|||
154917706|NCT02132312|559120392|FG000|Overall Study|Withdrawal by Subject|1|||
154917707|NCT02132312|559120393|FG001|Overall Study|Withdrawal by Subject|0|||
154917708|NCT02132312|559120392|FG000|Overall Study|Lost to Follow-up|2|||
154917709|NCT02132312|559120393|FG001|Overall Study|Lost to Follow-up|1|||
154917710|NCT00089505|559120394|FG000|Overall Study|Death|4|||
154917711|NCT00089505|559120395|FG001|Overall Study|Death|1|||
154917712|NCT00089505|559120396|FG002|Overall Study|Death|5|||
154917713|NCT00089505|559120397|FG003|Overall Study|Death|8|||
154917714|NCT00089505|559120394|FG000|Overall Study|Withdrawal by Subject|3|||
154917715|NCT00089505|559120395|FG001|Overall Study|Withdrawal by Subject|0|||
154917716|NCT00089505|559120396|FG002|Overall Study|Withdrawal by Subject|6|||
154917717|NCT00089505|559120397|FG003|Overall Study|Withdrawal by Subject|6|||
154917718|NCT00089505|559120394|FG000|Overall Study|Lost to Follow-up|1|||
154917719|NCT00089505|559120395|FG001|Overall Study|Lost to Follow-up|1|||
154917720|NCT00089505|559120396|FG002|Overall Study|Lost to Follow-up|9|||
154917721|NCT00089505|559120397|FG003|Overall Study|Lost to Follow-up|7|||
154917722|NCT00089505|559120394|FG000|Overall Study|Physician Decision|1|||
154917723|NCT00089505|559120395|FG001|Overall Study|Physician Decision|0|||
154917724|NCT00089505|559120396|FG002|Overall Study|Physician Decision|0|||
154917725|NCT00089505|559120397|FG003|Overall Study|Physician Decision|0|||
154917726|NCT00089505|559120394|FG000|Overall Study|Protocol Violation|0|||
154917727|NCT00089505|559120395|FG001|Overall Study|Protocol Violation|0|||
154917728|NCT00089505|559120396|FG002|Overall Study|Protocol Violation|1|||
154917729|NCT00089505|559120397|FG003|Overall Study|Protocol Violation|0|||
154917730|NCT02543918|559120398|FG000|Overall Study|Never treated|0|||
154917731|NCT02543918|559120399|FG001|Overall Study|Never treated|1|||
154917732|NCT02543918|559120398|FG000|Overall Study|Lost to Follow-up|1|||
154917733|NCT02543918|559120399|FG001|Overall Study|Lost to Follow-up|1|||
154917734|NCT02543918|559120398|FG000|Overall Study|Withdrawal by Subject|1|||
154917735|NCT02543918|559120399|FG001|Overall Study|Withdrawal by Subject|1|||
154917736|NCT02543918|559120398|FG000|Overall Study|Adverse Event|1|||
154917737|NCT02543918|559120399|FG001|Overall Study|Adverse Event|1|||
154917738|NCT00486720|559120402|FG000|Overall Study|Adverse Event|1|||
154917739|NCT00486720|559120403|FG001|Overall Study|Adverse Event|2|||
154917740|NCT00486720|559120402|FG000|Overall Study|Lack of Efficacy|4|||
154917741|NCT00486720|559120403|FG001|Overall Study|Lack of Efficacy|6|||
154917742|NCT00486720|559120402|FG000|Overall Study|Physician Decision|1|||
154917743|NCT00486720|559120403|FG001|Overall Study|Physician Decision|2|||
154917744|NCT00486720|559120402|FG000|Overall Study|Protocol Violation|1|||
154917745|NCT00486720|559120403|FG001|Overall Study|Protocol Violation|0|||
154917746|NCT00486720|559120402|FG000|Overall Study|Withdrawal by Subject|3|||
154917747|NCT00486720|559120403|FG001|Overall Study|Withdrawal by Subject|1|||
154917748|NCT00486720|559120402|FG000|Overall Study|Progressive Disease|0|||
154917749|NCT00486720|559120403|FG001|Overall Study|Progressive Disease|1|||
154917750|NCT00423267|559120408|FG000|Period A|Withdrawal by Subject|0|||
154917751|NCT00423267|559120409|FG001|Period A|Withdrawal by Subject|1|||
154917752|NCT00423267|559120408|FG000|Period A|Non-compliance with protocol|1|||
154917753|NCT00423267|559120409|FG001|Period A|Non-compliance with protocol|0|||
155121825|NCT05438602|559877812|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
155121826|NCT05438602|559877813|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
155121827|NCT05438602|559877814|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
155121828|NCT05438602|559877812|FG000|Treatment (15 Days)|Other|0|||
155121829|NCT05438602|559877813|FG001|Treatment (15 Days)|Other|0|||
155121830|NCT05438602|559877814|FG002|Treatment (15 Days)|Other|1|||
155121831|NCT05438602|559877812|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
155121832|NCT05438602|559877813|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
154917754|NCT00423267|559120408|FG000|Period A|Administrative|1|||
154917755|NCT00423267|559120409|FG001|Period A|Administrative|0|||
154917756|NCT01333865|559120410|FG000|Overall Study|Adverse Event|2|||
154917757|NCT00784836|559120416|FG000|Overall Study|Early Study Termination|3|||
154917758|NCT03417999|559120418|FG000|Overall Study|Withdrawal by Subject|1|||
154917759|NCT03417999|559120419|FG001|Overall Study|Withdrawal by Subject|0|||
154917760|NCT03417999|559120420|FG002|Overall Study|Withdrawal by Subject|0|||
154917761|NCT03417999|559120418|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
154917762|NCT03417999|559120419|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
154917763|NCT03417999|559120420|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
154917764|NCT03417999|559120418|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
154917765|NCT03417999|559120419|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
154917766|NCT03417999|559120420|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
154917767|NCT03417999|559120418|FG000|Overall Study|Inadequate study staff available to process samples|0|||
154917768|NCT03417999|559120419|FG001|Overall Study|Inadequate study staff available to process samples|0|||
154917769|NCT03417999|559120420|FG002|Overall Study|Inadequate study staff available to process samples|1|||
154917770|NCT02613910|559120421|FG000|Overall Study|Termination of study|1|||
154917771|NCT00695318|559120422|FG000|Overall Study|Lost to Follow-up|1|||
154917772|NCT00695318|559120423|FG001|Overall Study|Lost to Follow-up|0|||
154917773|NCT00695318|559120422|FG000|Overall Study|Withdrawal by Subject|2|||
154917774|NCT00695318|559120423|FG001|Overall Study|Withdrawal by Subject|0|||
154917775|NCT00695318|559120422|FG000|Overall Study|Death|1|||
154917776|NCT00695318|559120423|FG001|Overall Study|Death|1|||
154917777|NCT00695318|559120422|FG000|Overall Study|Study Terminated|1|||
154917778|NCT00695318|559120423|FG001|Overall Study|Study Terminated|0|||
154917779|NCT03726320|559122338|FG000|Overall Study|Lost to Follow-up|2|||
154917780|NCT03726320|559122339|FG001|Overall Study|Lost to Follow-up|4|||
154917781|NCT03726320|559122340|FG002|Overall Study|Lost to Follow-up|0|||
154917782|NCT03726320|559122338|FG000|Overall Study|Time Constraints|4|||
154917783|NCT03726320|559122339|FG001|Overall Study|Time Constraints|1|||
154917784|NCT03726320|559122340|FG002|Overall Study|Time Constraints|0|||
154917785|NCT03726320|559122338|FG000|Overall Study|Ineligible after enrollment|3|||
154917786|NCT03726320|559122339|FG001|Overall Study|Ineligible after enrollment|3|||
154917787|NCT03726320|559122340|FG002|Overall Study|Ineligible after enrollment|0|||
154917788|NCT03726320|559122338|FG000|Overall Study|Clinic / insurance issue|2|||
154917789|NCT03726320|559122339|FG001|Overall Study|Clinic / insurance issue|0|||
154917790|NCT03726320|559122340|FG002|Overall Study|Clinic / insurance issue|0|||
154917791|NCT03726320|559122338|FG000|Overall Study|Language barrier|1|||
154917792|NCT03726320|559122339|FG001|Overall Study|Language barrier|0|||
154917793|NCT03726320|559122340|FG002|Overall Study|Language barrier|0|||
154917794|NCT03726320|559122338|FG000|Overall Study|Provider left the clinic|0|||
154917795|NCT03726320|559122339|FG001|Overall Study|Provider left the clinic|0|||
154917796|NCT03726320|559122340|FG002|Overall Study|Provider left the clinic|1|||
154917797|NCT02028182|559122343|FG000|Overall Study|Protocol Violation|2|||
154917798|NCT01684930|559122346|FG000|Overall Study|Withdrawal by Subject|3|||
154917799|NCT01684930|559122347|FG001|Overall Study|Withdrawal by Subject|1|||
154917800|NCT01336647|559122348|FG000|Overall Study|Lost to Follow-up|4|||
154917801|NCT01336647|559122349|FG001|Overall Study|Lost to Follow-up|1|||
154917802|NCT01336647|559122350|FG002|Overall Study|Lost to Follow-up|3|||
154917803|NCT03808298|559122351|FG000|Overall Study|Adverse Event|3|||
154917804|NCT03808298|559122351|FG000|Overall Study|Physician Decision|1|||
154917805|NCT03808298|559122351|FG000|Overall Study|Withdrawal by Subject|1|||
154917806|NCT03808298|559122351|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
154917807|NCT01004822|559122352|FG000|Overall Study|Objective progression or relapse|3|||
154917808|NCT01004822|559122353|FG001|Overall Study|Objective progression or relapse|3|||
154917809|NCT01004822|559122354|FG002|Overall Study|Objective progression or relapse|0|||
154917810|NCT01004822|559122355|FG003|Overall Study|Objective progression or relapse|1|||
154917811|NCT01004822|559122356|FG004|Overall Study|Objective progression or relapse|2|||
154917812|NCT01004822|559122357|FG005|Overall Study|Objective progression or relapse|2|||
154917813|NCT01004822|559122358|FG006|Overall Study|Objective progression or relapse|1|||
154917814|NCT01004822|559122359|FG007|Overall Study|Objective progression or relapse|4|||
154917815|NCT01004822|559122352|FG000|Overall Study|Global deterioration of health status|0|||
154917816|NCT01004822|559122353|FG001|Overall Study|Global deterioration of health status|0|||
154917817|NCT01004822|559122354|FG002|Overall Study|Global deterioration of health status|0|||
155121833|NCT05438602|559877814|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
155121834|NCT05438602|559877812|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
155121835|NCT05438602|559877813|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
155121836|NCT05438602|559877814|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
154917818|NCT01004822|559122355|FG003|Overall Study|Global deterioration of health status|1|||
154917819|NCT01004822|559122356|FG004|Overall Study|Global deterioration of health status|0|||
154917820|NCT01004822|559122357|FG005|Overall Study|Global deterioration of health status|0|||
154917821|NCT01004822|559122358|FG006|Overall Study|Global deterioration of health status|1|||
154917822|NCT01004822|559122359|FG007|Overall Study|Global deterioration of health status|0|||
154917823|NCT01004822|559122352|FG000|Overall Study|No longer willing to continue|0|||
154917824|NCT01004822|559122353|FG001|Overall Study|No longer willing to continue|0|||
154917825|NCT01004822|559122354|FG002|Overall Study|No longer willing to continue|0|||
154917826|NCT01004822|559122355|FG003|Overall Study|No longer willing to continue|1|||
154917827|NCT01004822|559122356|FG004|Overall Study|No longer willing to continue|2|||
154917828|NCT01004822|559122357|FG005|Overall Study|No longer willing to continue|1|||
154917829|NCT01004822|559122358|FG006|Overall Study|No longer willing to continue|1|||
154917830|NCT01004822|559122359|FG007|Overall Study|No longer willing to continue|0|||
154917831|NCT01004822|559122352|FG000|Overall Study|Adverse Event|0|||
154917832|NCT01004822|559122353|FG001|Overall Study|Adverse Event|0|||
154917833|NCT01004822|559122354|FG002|Overall Study|Adverse Event|0|||
154917834|NCT01004822|559122355|FG003|Overall Study|Adverse Event|0|||
154917835|NCT01004822|559122356|FG004|Overall Study|Adverse Event|0|||
154917836|NCT01004822|559122357|FG005|Overall Study|Adverse Event|0|||
154917837|NCT01004822|559122358|FG006|Overall Study|Adverse Event|1|||
154917838|NCT01004822|559122359|FG007|Overall Study|Adverse Event|1|||
154917839|NCT01004822|559122352|FG000|Overall Study|Other|0|||
154917840|NCT01004822|559122353|FG001|Overall Study|Other|0|||
154917841|NCT01004822|559122354|FG002|Overall Study|Other|4|||
154917842|NCT01004822|559122355|FG003|Overall Study|Other|1|||
154917843|NCT01004822|559122356|FG004|Overall Study|Other|0|||
154917844|NCT01004822|559122357|FG005|Overall Study|Other|1|||
154917845|NCT01004822|559122358|FG006|Overall Study|Other|0|||
154917846|NCT01004822|559122359|FG007|Overall Study|Other|0|||
154917847|NCT01858701|559122360|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
154917848|NCT01858701|559122361|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
154917849|NCT01858701|559122360|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
154917850|NCT01858701|559122361|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
154917851|NCT01858701|559122360|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
154917852|NCT01858701|559122361|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
154917853|NCT01858701|559122360|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
154917854|NCT01858701|559122361|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
154917855|NCT01674010|559122362|FG000|Open Treatment Phase 1|Adverse Event|10|||
154917856|NCT01674010|559122363|FG001|Open Treatment Phase 1|Adverse Event|0|||
154917857|NCT01674010|559122364|FG002|Open Treatment Phase 1|Adverse Event|0|||
154917858|NCT01674010|559122362|FG000|Open Treatment Phase 1|Death|1|||
154917859|NCT01674010|559122363|FG001|Open Treatment Phase 1|Death|0|||
154917860|NCT01674010|559122364|FG002|Open Treatment Phase 1|Death|0|||
154917861|NCT01674010|559122362|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
154917862|NCT01674010|559122363|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
154917863|NCT01674010|559122364|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
154917864|NCT01674010|559122362|FG000|Open Treatment Phase 1|Physician Decision|9|||
154917865|NCT01674010|559122363|FG001|Open Treatment Phase 1|Physician Decision|0|||
154917866|NCT01674010|559122364|FG002|Open Treatment Phase 1|Physician Decision|0|||
154917867|NCT01674010|559122362|FG000|Open Treatment Phase 1|Protocol Violation|7|||
154917868|NCT01674010|559122363|FG001|Open Treatment Phase 1|Protocol Violation|0|||
154917869|NCT01674010|559122364|FG002|Open Treatment Phase 1|Protocol Violation|0|||
154917870|NCT01674010|559122362|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
154917871|NCT01674010|559122363|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
154917872|NCT01674010|559122364|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
154917873|NCT01674010|559122362|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
154917874|NCT01674010|559122363|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
154917875|NCT01674010|559122364|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
154917876|NCT01674010|559122362|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
154917877|NCT01674010|559122363|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
154917878|NCT01674010|559122364|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
154917879|NCT01674010|559122362|FG000|Randomization Phase 2|Adverse Event|0|||
154917880|NCT01674010|559122363|FG001|Randomization Phase 2|Adverse Event|1|||
154917881|NCT01674010|559122364|FG002|Randomization Phase 2|Adverse Event|1|||
154917882|NCT01674010|559122362|FG000|Randomization Phase 2|Lost to Follow-up|0|||
154917883|NCT01674010|559122363|FG001|Randomization Phase 2|Lost to Follow-up|1|||
154917884|NCT01674010|559122364|FG002|Randomization Phase 2|Lost to Follow-up|2|||
154917885|NCT01674010|559122362|FG000|Randomization Phase 2|Mood episode recurrence|0|||
154917886|NCT01674010|559122363|FG001|Randomization Phase 2|Mood episode recurrence|8|||
154917887|NCT01674010|559122364|FG002|Randomization Phase 2|Mood episode recurrence|2|||
154917888|NCT01674010|559122362|FG000|Randomization Phase 2|Physician Decision|0|||
154917889|NCT01674010|559122363|FG001|Randomization Phase 2|Physician Decision|0|||
155177484|NCT00483756|560088257|FG002|Overall Study|Randomized, Not Treated|4|||
155177485|NCT00710762|560088258|FG000|Overall Study|Progressive disease|27|||
155177486|NCT00710762|560088259|FG001|Overall Study|Progressive disease|30|||
155177487|NCT00710762|560088258|FG000|Overall Study|Adverse Event other disease worsening|2|||
155177488|NCT00710762|560088259|FG001|Overall Study|Adverse Event other disease worsening|1|||
155177489|NCT00710762|560088258|FG000|Overall Study|Other Adverse Event|7|||
155177490|NCT00710762|560088259|FG001|Overall Study|Other Adverse Event|7|||
155177491|NCT00710762|560088258|FG000|Overall Study|Lost to Follow-up|1|||
155177492|NCT00710762|560088259|FG001|Overall Study|Lost to Follow-up|0|||
155177493|NCT00710762|560088258|FG000|Overall Study|Reason other than listed above|2|||
155177494|NCT00710762|560088259|FG001|Overall Study|Reason other than listed above|2|||
155177495|NCT00436501|560088260|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
155177496|NCT00436501|560088261|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
155177497|NCT00436501|560088260|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
155177498|NCT00436501|560088261|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
155177499|NCT00495040|560088262|FG000|Overall Study|Withdrawal by Subject|3|||
155177500|NCT02282293|560088267|FG000|Overall Study|Lost to Follow-up|2|||
155177501|NCT02282293|560088268|FG001|Overall Study|Lost to Follow-up|2|||
155177502|NCT02282293|560088267|FG000|Overall Study|Unable to comply with study procedures|1|||
155177503|NCT02282293|560088268|FG001|Overall Study|Unable to comply with study procedures|0|||
155177504|NCT02282293|560088267|FG000|Overall Study|Moved out of study area|0|||
155177505|NCT02282293|560088268|FG001|Overall Study|Moved out of study area|1|||
155177506|NCT03011892|560088269|FG000|Double Blind (DB) Period|Adverse Event|0|||
155177507|NCT03011892|560088270|FG001|Double Blind (DB) Period|Adverse Event|1|||
155177508|NCT03011892|560088271|FG002|Double Blind (DB) Period|Adverse Event|1|||
155177509|NCT03011892|560088272|FG003|Double Blind (DB) Period|Adverse Event|0|||
155177510|NCT03011892|560088273|FG004|Double Blind (DB) Period|Adverse Event|0|||
155177511|NCT03011892|560088274|FG005|Double Blind (DB) Period|Adverse Event|0|||
155177512|NCT03011892|560088275|FG006|Double Blind (DB) Period|Adverse Event|0|||
155177513|NCT03011892|560088276|FG007|Double Blind (DB) Period|Adverse Event|0|||
155177514|NCT03011892|560088277|FG008|Double Blind (DB) Period|Adverse Event|0|||
155177515|NCT03011892|560088278|FG009|Double Blind (DB) Period|Adverse Event|0|||
155177516|NCT03011892|560088279|FG010|Double Blind (DB) Period|Adverse Event|0|||
155177517|NCT03011892|560088280|FG011|Double Blind (DB) Period|Adverse Event|0|||
155177518|NCT03011892|560088269|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
155177519|NCT03011892|560088270|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
155177520|NCT03011892|560088271|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
155177521|NCT03011892|560088272|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
155177522|NCT03011892|560088273|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
155177523|NCT03011892|560088274|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
155177524|NCT03011892|560088275|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
155177525|NCT03011892|560088276|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
155177526|NCT03011892|560088277|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
155177527|NCT03011892|560088278|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
155177528|NCT03011892|560088279|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
155177529|NCT03011892|560088280|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
155177530|NCT03011892|560088269|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
155177531|NCT03011892|560088270|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
155177532|NCT03011892|560088271|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
155177533|NCT03011892|560088272|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
155177534|NCT03011892|560088273|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
155177535|NCT03011892|560088274|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
155177536|NCT03011892|560088275|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
155177537|NCT03011892|560088276|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
155177538|NCT03011892|560088277|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
155177539|NCT03011892|560088278|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
155177540|NCT03011892|560088279|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
155177541|NCT03011892|560088280|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
155177542|NCT03011892|560088269|FG000|Double Blind (DB) Period|Other|1|||
155177543|NCT03011892|560088270|FG001|Double Blind (DB) Period|Other|1|||
155177544|NCT03011892|560088271|FG002|Double Blind (DB) Period|Other|1|||
155177545|NCT03011892|560088272|FG003|Double Blind (DB) Period|Other|0|||
155177546|NCT03011892|560088273|FG004|Double Blind (DB) Period|Other|1|||
155177547|NCT03011892|560088274|FG005|Double Blind (DB) Period|Other|0|||
155177548|NCT03011892|560088275|FG006|Double Blind (DB) Period|Other|0|||
155177549|NCT03011892|560088276|FG007|Double Blind (DB) Period|Other|0|||
155177550|NCT03011892|560088277|FG008|Double Blind (DB) Period|Other|0|||
155177551|NCT03011892|560088278|FG009|Double Blind (DB) Period|Other|0|||
155177552|NCT03011892|560088279|FG010|Double Blind (DB) Period|Other|0|||
155177553|NCT03011892|560088280|FG011|Double Blind (DB) Period|Other|0|||
155177554|NCT03011892|560088269|FG000|Double Blind (DB) Period|Physician Decision|1|||
155177555|NCT03011892|560088270|FG001|Double Blind (DB) Period|Physician Decision|0|||
155177556|NCT03011892|560088271|FG002|Double Blind (DB) Period|Physician Decision|1|||
155177557|NCT03011892|560088272|FG003|Double Blind (DB) Period|Physician Decision|0|||
155177558|NCT03011892|560088273|FG004|Double Blind (DB) Period|Physician Decision|0|||
155177559|NCT03011892|560088274|FG005|Double Blind (DB) Period|Physician Decision|0|||
155177560|NCT03011892|560088275|FG006|Double Blind (DB) Period|Physician Decision|0|||
155177561|NCT03011892|560088276|FG007|Double Blind (DB) Period|Physician Decision|0|||
155177562|NCT03011892|560088277|FG008|Double Blind (DB) Period|Physician Decision|0|||
154993749|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993750|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993751|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993752|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993753|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993754|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993755|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993756|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993757|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993758|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993759|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993760|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993761|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993762|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993763|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
154993764|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
154993765|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993766|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
154993767|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
155121837|NCT05438602|559877812|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
155121838|NCT05438602|559877813|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
155121839|NCT05438602|559877814|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
155121840|NCT05438602|559877812|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
155121841|NCT05438602|559877813|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
155121842|NCT05438602|559877814|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
155121843|NCT05438602|559877812|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
155121844|NCT05438602|559877813|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
155121845|NCT05438602|559877814|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
155121846|NCT05438602|559877812|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
155121847|NCT05438602|559877813|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
155121848|NCT05438602|559877814|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
155121849|NCT05438602|559877812|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
155121850|NCT05438602|559877813|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
155121851|NCT05438602|559877814|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
155121852|NCT04524455|559877824|FG000|Overall Study|Death|3|||
155121853|NCT04524455|559877825|FG001|Overall Study|Death|3|||
155121854|NCT04524455|559877824|FG000|Overall Study|Decision by Sponsor|0|||
155121855|NCT04524455|559877825|FG001|Overall Study|Decision by Sponsor|2|||
155121856|NCT04524455|559877824|FG000|Overall Study|Withdrawal of Consent From Study|1|||
155121857|NCT04524455|559877825|FG001|Overall Study|Withdrawal of Consent From Study|0|||
155121858|NCT04524455|559877824|FG000|Overall Study|Lost to Follow-up|0|||
155121859|NCT04524455|559877825|FG001|Overall Study|Lost to Follow-up|1|||
155121860|NCT01688739|559877826|FG000|Overall Study|Administrative Decision|1|||
155121861|NCT01688739|559877827|FG001|Overall Study|Administrative Decision|0|||
155121862|NCT01688739|559877828|FG002|Overall Study|Administrative Decision|0|||
155121863|NCT01688739|559877829|FG003|Overall Study|Administrative Decision|0|||
155121864|NCT01688739|559877830|FG004|Overall Study|Administrative Decision|0|||
155121865|NCT01688739|559877831|FG005|Overall Study|Administrative Decision|0|||
155121866|NCT01688739|559877832|FG006|Overall Study|Administrative Decision|0|||
155121867|NCT01688739|559877833|FG007|Overall Study|Administrative Decision|0|||
155121868|NCT01688739|559877834|FG008|Overall Study|Administrative Decision|0|||
155121869|NCT01688739|559877835|FG009|Overall Study|Administrative Decision|0|||
155121870|NCT00953524|559877843|FG000|Overall Study|Adverse Event|2|||
155121871|NCT00953524|559877844|FG001|Overall Study|Adverse Event|0|||
155121872|NCT00953524|559877845|FG002|Overall Study|Adverse Event|1|||
155121873|NCT00953524|559877846|FG003|Overall Study|Adverse Event|2|||
155121874|NCT00953524|559877843|FG000|Overall Study|Protocol Violation|18|||
155121875|NCT00953524|559877844|FG001|Overall Study|Protocol Violation|10|||
155121876|NCT00953524|559877845|FG002|Overall Study|Protocol Violation|11|||
155121877|NCT00953524|559877846|FG003|Overall Study|Protocol Violation|6|||
155121878|NCT00953524|559877843|FG000|Overall Study|Lost to Follow-up|0|||
154993768|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
155121879|NCT00953524|559877844|FG001|Overall Study|Lost to Follow-up|1|||
155121880|NCT00953524|559877845|FG002|Overall Study|Lost to Follow-up|1|||
155121881|NCT00953524|559877846|FG003|Overall Study|Lost to Follow-up|0|||
155121882|NCT00953524|559877843|FG000|Overall Study|Withdrawal by Subject|2|||
155121883|NCT00953524|559877844|FG001|Overall Study|Withdrawal by Subject|4|||
154993769|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993770|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993771|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993772|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993773|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993774|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993775|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993776|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993777|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993778|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993779|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993780|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993781|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993782|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993783|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993784|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993785|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993786|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993787|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993788|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
154993789|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993790|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993791|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993792|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
154993793|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Adverse Event|0|||
154993794|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Adverse Event|0|||
154993795|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Adverse Event|0|||
154993796|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Adverse Event|0|||
154993797|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Adverse Event|0|||
154993798|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Adverse Event|0|||
154993799|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Adverse Event|0|||
154993800|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Adverse Event|0|||
154993801|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Adverse Event|0|||
154993802|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Adverse Event|0|||
154993803|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Adverse Event|0|||
154993804|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Adverse Event|0|||
154993805|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Adverse Event|0|||
154993806|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Adverse Event|0|||
154993807|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Adverse Event|0|||
154993808|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Adverse Event|0|||
154993809|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Adverse Event|0|||
154993810|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Adverse Event|0|||
154993811|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Adverse Event|0|||
154993812|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Adverse Event|0|||
154993813|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Adverse Event|0|||
154993814|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Adverse Event|0|||
154993815|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Adverse Event|0|||
154993816|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Adverse Event|1|||
154993817|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Adverse Event|0|||
154993818|NCT02393248|559402769|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
155121884|NCT00953524|559877845|FG002|Overall Study|Withdrawal by Subject|1|||
155121885|NCT00953524|559877846|FG003|Overall Study|Withdrawal by Subject|0|||
155121886|NCT00294645|559877849|FG000|Overall Study|Death|10|||
155121887|NCT00294645|559877850|FG001|Overall Study|Death|18|||
155121888|NCT00294645|559877849|FG000|Overall Study|Lost to Follow-up|1|||
155121889|NCT00294645|559877850|FG001|Overall Study|Lost to Follow-up|10|||
155121890|NCT00294645|559877849|FG000|Overall Study|Withdrawal by Subject|18|||
155121891|NCT00294645|559877850|FG001|Overall Study|Withdrawal by Subject|34|||
155121892|NCT00294645|559877849|FG000|Overall Study|Physician Decision|15|||
155121893|NCT00294645|559877850|FG001|Overall Study|Physician Decision|20|||
155121894|NCT00294645|559877849|FG000|Overall Study|Other|4|||
155121895|NCT00294645|559877850|FG001|Overall Study|Other|10|||
155121896|NCT03784846|559877853|FG000|Pre-COVID Study|Lost to Follow-up|3|||
154993819|NCT02393248|559402770|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993820|NCT02393248|559402771|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993821|NCT02393248|559402772|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993822|NCT02393248|559402773|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993823|NCT02393248|559402774|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993824|NCT02393248|559402775|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993825|NCT02393248|559402776|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993826|NCT02393248|559402777|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993827|NCT02393248|559402778|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993828|NCT02393248|559402779|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993829|NCT02393248|559402780|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993830|NCT02393248|559402781|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993831|NCT02393248|559402782|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993832|NCT02393248|559402783|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993833|NCT02393248|559402784|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993834|NCT02393248|559402785|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993835|NCT02393248|559402786|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993836|NCT02393248|559402787|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993837|NCT02393248|559402788|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993838|NCT02393248|559402789|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993839|NCT02393248|559402790|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993840|NCT02393248|559402791|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993841|NCT02393248|559402792|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
154993842|NCT02393248|559402793|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
154993843|NCT02585934|559402794|FG000|Overall Study|Lost to Follow-up|2|||
154993844|NCT02585934|559402795|FG001|Overall Study|Lost to Follow-up|2|||
154993845|NCT02585934|559402794|FG000|Overall Study|Protocol Violation|14|||
154993846|NCT02585934|559402795|FG001|Overall Study|Protocol Violation|11|||
154993847|NCT02585934|559402794|FG000|Overall Study|Adverse Event|21|||
154993848|NCT02585934|559402795|FG001|Overall Study|Adverse Event|22|||
154993849|NCT02585934|559402794|FG000|Overall Study|Physician Decision|3|||
154993850|NCT02585934|559402795|FG001|Overall Study|Physician Decision|2|||
154993851|NCT02585934|559402794|FG000|Overall Study|Withdrawal by Subject|7|||
154993852|NCT02585934|559402795|FG001|Overall Study|Withdrawal by Subject|21|||
154993853|NCT02585934|559402794|FG000|Overall Study|Lack of Efficacy|2|||
154993854|NCT02585934|559402795|FG001|Overall Study|Lack of Efficacy|1|||
154993855|NCT02585934|559402794|FG000|Overall Study|Death|2|||
154993856|NCT02585934|559402795|FG001|Overall Study|Death|0|||
154993857|NCT02585934|559402794|FG000|Overall Study|Caregiver Withdrew Consent|7|||
154993858|NCT02585934|559402795|FG001|Overall Study|Caregiver Withdrew Consent|7|||
154993859|NCT02585934|559402794|FG000|Overall Study|Sponsor Termination|1|||
154993860|NCT02585934|559402795|FG001|Overall Study|Sponsor Termination|2|||
154993861|NCT02585934|559402794|FG000|Overall Study|Another Reason|10|||
154993862|NCT02585934|559402795|FG001|Overall Study|Another Reason|5|||
154993863|NCT04713553|559402796|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
154993864|NCT04713553|559402797|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
154993865|NCT04713553|559402798|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
154993866|NCT04713553|559402799|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
154993867|NCT04713553|559402800|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
154993868|NCT04713553|559402801|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
154993869|NCT04713553|559402802|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
154993870|NCT04713553|559402796|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
154993871|NCT04713553|559402797|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
154993872|NCT04713553|559402798|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
154993873|NCT04713553|559402799|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
154993874|NCT04713553|559402800|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
154993875|NCT04713553|559402801|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
154993876|NCT04713553|559402802|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
154993877|NCT04713553|559402796|FG000|Primary Study (2 Months)|Other|1|||
154993878|NCT04713553|559402797|FG001|Primary Study (2 Months)|Other|2|||
154993879|NCT04713553|559402798|FG002|Primary Study (2 Months)|Other|0|||
154993880|NCT04713553|559402799|FG003|Primary Study (2 Months)|Other|0|||
154993881|NCT04713553|559402800|FG004|Primary Study (2 Months)|Other|1|||
154993882|NCT04713553|559402801|FG005|Primary Study (2 Months)|Other|0|||
154993883|NCT04713553|559402802|FG006|Primary Study (2 Months)|Other|0|||
154993884|NCT04713553|559402796|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
154993885|NCT04713553|559402797|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
155177563|NCT03011892|560088278|FG009|Double Blind (DB) Period|Physician Decision|0|||
155177564|NCT03011892|560088279|FG010|Double Blind (DB) Period|Physician Decision|0|||
155177565|NCT03011892|560088280|FG011|Double Blind (DB) Period|Physician Decision|0|||
155177566|NCT03011892|560088269|FG000|Double Blind (DB) Period|Pregnancy|0|||
155177567|NCT03011892|560088270|FG001|Double Blind (DB) Period|Pregnancy|0|||
155177568|NCT03011892|560088271|FG002|Double Blind (DB) Period|Pregnancy|0|||
155177569|NCT03011892|560088272|FG003|Double Blind (DB) Period|Pregnancy|0|||
155177570|NCT03011892|560088273|FG004|Double Blind (DB) Period|Pregnancy|1|||
155177571|NCT03011892|560088274|FG005|Double Blind (DB) Period|Pregnancy|0|||
155177572|NCT03011892|560088275|FG006|Double Blind (DB) Period|Pregnancy|0|||
155177573|NCT03011892|560088276|FG007|Double Blind (DB) Period|Pregnancy|0|||
155177574|NCT03011892|560088277|FG008|Double Blind (DB) Period|Pregnancy|0|||
155177575|NCT03011892|560088278|FG009|Double Blind (DB) Period|Pregnancy|0|||
155177576|NCT03011892|560088279|FG010|Double Blind (DB) Period|Pregnancy|0|||
155177577|NCT03011892|560088280|FG011|Double Blind (DB) Period|Pregnancy|0|||
155177578|NCT03011892|560088269|FG000|Double Blind (DB) Period|Protocol Violation|1|||
155177579|NCT03011892|560088270|FG001|Double Blind (DB) Period|Protocol Violation|0|||
155177580|NCT03011892|560088271|FG002|Double Blind (DB) Period|Protocol Violation|0|||
155177581|NCT03011892|560088272|FG003|Double Blind (DB) Period|Protocol Violation|0|||
155177582|NCT03011892|560088273|FG004|Double Blind (DB) Period|Protocol Violation|0|||
155177583|NCT03011892|560088274|FG005|Double Blind (DB) Period|Protocol Violation|0|||
155177584|NCT03011892|560088275|FG006|Double Blind (DB) Period|Protocol Violation|0|||
155177585|NCT03011892|560088276|FG007|Double Blind (DB) Period|Protocol Violation|0|||
155177586|NCT03011892|560088277|FG008|Double Blind (DB) Period|Protocol Violation|0|||
155177587|NCT03011892|560088278|FG009|Double Blind (DB) Period|Protocol Violation|0|||
155177588|NCT03011892|560088279|FG010|Double Blind (DB) Period|Protocol Violation|0|||
155177589|NCT03011892|560088280|FG011|Double Blind (DB) Period|Protocol Violation|0|||
155177590|NCT03011892|560088269|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
155177591|NCT03011892|560088270|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
155177592|NCT03011892|560088271|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
155177593|NCT03011892|560088272|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
155177594|NCT03011892|560088273|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
155177595|NCT03011892|560088274|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
155177596|NCT03011892|560088275|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
155177597|NCT03011892|560088276|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
155177598|NCT03011892|560088277|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
155177599|NCT03011892|560088278|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
155177600|NCT03011892|560088279|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
155177601|NCT03011892|560088280|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
155177602|NCT03011892|560088269|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
155177603|NCT03011892|560088270|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
155177604|NCT03011892|560088271|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
155177605|NCT03011892|560088272|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
155177606|NCT03011892|560088273|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
155177607|NCT03011892|560088274|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
155177608|NCT03011892|560088275|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
155177609|NCT03011892|560088276|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
155177610|NCT03011892|560088277|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
155177611|NCT03011892|560088278|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
155177612|NCT03011892|560088279|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
155177613|NCT03011892|560088280|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
154917890|NCT01674010|559122364|FG002|Randomization Phase 2|Physician Decision|2|||
154917891|NCT01674010|559122362|FG000|Randomization Phase 2|Pregnancy|0|||
154917892|NCT01674010|559122363|FG001|Randomization Phase 2|Pregnancy|1|||
154917893|NCT01674010|559122364|FG002|Randomization Phase 2|Pregnancy|1|||
154917894|NCT01674010|559122362|FG000|Randomization Phase 2|Protocol Violation|0|||
154917895|NCT01674010|559122363|FG001|Randomization Phase 2|Protocol Violation|1|||
154917896|NCT01674010|559122364|FG002|Randomization Phase 2|Protocol Violation|1|||
154917897|NCT01674010|559122362|FG000|Randomization Phase 2|Sponsor Decision|0|||
154917898|NCT01674010|559122363|FG001|Randomization Phase 2|Sponsor Decision|42|||
154917899|NCT01674010|559122364|FG002|Randomization Phase 2|Sponsor Decision|45|||
154917900|NCT01674010|559122362|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
154917901|NCT01674010|559122363|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
154917902|NCT01674010|559122364|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
154917903|NCT01801475|559122371|FG000|Overall Study|Withdrawal by Subject|0|||
154917904|NCT01801475|559122372|FG001|Overall Study|Withdrawal by Subject|0|||
154917905|NCT01801475|559122373|FG002|Overall Study|Withdrawal by Subject|0|||
154917906|NCT01801475|559122374|FG003|Overall Study|Withdrawal by Subject|0|||
154917907|NCT01801475|559122375|FG004|Overall Study|Withdrawal by Subject|1|||
154917908|NCT01786707|559122378|FG000|Overall Study|Lost to Follow-up|1|||
154917909|NCT01786707|559122379|FG001|Overall Study|Lost to Follow-up|1|||
154917910|NCT00346775|559122386|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
154993886|NCT04713553|559402798|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
154993887|NCT04713553|559402799|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
154993888|NCT04713553|559402800|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
154993889|NCT04713553|559402801|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
154993890|NCT04713553|559402802|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
154993891|NCT04713553|559402796|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
154993892|NCT04713553|559402797|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
154993893|NCT04713553|559402798|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
154993894|NCT04713553|559402799|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
154993895|NCT04713553|559402800|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
154993896|NCT04713553|559402801|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
154993897|NCT04713553|559402802|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
154993898|NCT02603393|559402815|FG000|Overall Study|Patient/guardian decision|32|||
154993899|NCT02603393|559402816|FG001|Overall Study|Patient/guardian decision|18|||
154993900|NCT02603393|559402815|FG000|Overall Study|Adverse Event|17|||
154993901|NCT02603393|559402816|FG001|Overall Study|Adverse Event|15|||
154993902|NCT02603393|559402815|FG000|Overall Study|Technical problems|4|||
154993903|NCT02603393|559402816|FG001|Overall Study|Technical problems|7|||
154917911|NCT00346775|559122387|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
154917912|NCT00346775|559122386|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
154917913|NCT00346775|559122387|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
154917914|NCT00346775|559122386|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
154917915|NCT00346775|559122387|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
154917916|NCT02946515|559122388|FG000|Overall Study|Lost to Follow-up|2|||
154917917|NCT02946515|559122389|FG001|Overall Study|Lost to Follow-up|1|||
154917918|NCT01096017|559122396|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
154917919|NCT01096017|559122397|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
154917920|NCT02600559|559122398|FG000|Overall Study|Withdrawal by Subject|3|||
154917921|NCT02600559|559122398|FG000|Overall Study|Lost to Follow-up|20|||
154917922|NCT00594958|559122402|FG000|Overall Study|Withdrawal by Subject|1|||
154917923|NCT00594958|559122403|FG001|Overall Study|Withdrawal by Subject|0|||
154917924|NCT00594958|559122404|FG002|Overall Study|Withdrawal by Subject|1|||
154917925|NCT00594958|559122402|FG000|Overall Study|Adverse Event|4|||
154917926|NCT00594958|559122403|FG001|Overall Study|Adverse Event|1|||
154917927|NCT00594958|559122404|FG002|Overall Study|Adverse Event|2|||
154917928|NCT00594958|559122402|FG000|Overall Study|Pregnancy|0|||
154917929|NCT00594958|559122403|FG001|Overall Study|Pregnancy|2|||
154917930|NCT00594958|559122404|FG002|Overall Study|Pregnancy|0|||
154917931|NCT00594958|559122402|FG000|Overall Study|Protocol Violation|1|||
154917932|NCT00594958|559122403|FG001|Overall Study|Protocol Violation|0|||
154917933|NCT00594958|559122404|FG002|Overall Study|Protocol Violation|2|||
154917934|NCT00594958|559122402|FG000|Overall Study|Lost to Follow-up|5|||
154917935|NCT00594958|559122403|FG001|Overall Study|Lost to Follow-up|0|||
154917936|NCT00594958|559122404|FG002|Overall Study|Lost to Follow-up|3|||
154917937|NCT00594958|559122402|FG000|Overall Study|administrative|3|||
154917938|NCT00594958|559122403|FG001|Overall Study|administrative|0|||
154917939|NCT00594958|559122404|FG002|Overall Study|administrative|2|||
154917940|NCT00408408|559122412|FG000|Overall Study|No follow up data|2|||
154917941|NCT00408408|559122413|FG001|Overall Study|No follow up data|3|||
154917942|NCT00408408|559122414|FG002|Overall Study|No follow up data|0|||
154917943|NCT00408408|559122415|FG003|Overall Study|No follow up data|7|||
154917944|NCT00408408|559122416|FG004|Overall Study|No follow up data|5|||
154917945|NCT00408408|559122417|FG005|Overall Study|No follow up data|3|||
154917946|NCT00917553|559122420|FG000|Overall Study|Lost to Follow-up|2|||
154917947|NCT00917553|559122421|FG001|Overall Study|Lost to Follow-up|1|||
154917948|NCT01616173|559122422|FG000|Overall Study|Lost to Follow-up|0|||
154917949|NCT01616173|559122423|FG001|Overall Study|Lost to Follow-up|2|||
154917950|NCT01616173|559122424|FG002|Overall Study|Lost to Follow-up|0|||
154917951|NCT03172026|559122426|FG000|Overall Study|Withdrawal by Subject|1|||
154917952|NCT03172026|559122427|FG001|Overall Study|Withdrawal by Subject|0|||
154917953|NCT03172026|559122426|FG000|Overall Study|COVID restrictions|1|||
154917954|NCT03172026|559122427|FG001|Overall Study|COVID restrictions|0|||
154917955|NCT01177943|559122432|FG000|First Intervention|Withdrawal by Subject|2|||
154993904|NCT02603393|559402815|FG000|Overall Study|Lack of Efficacy|7|||
154917956|NCT01177943|559122433|FG001|First Intervention|Withdrawal by Subject|0|||
154917957|NCT00504595|559122434|FG000|Overall Study|Lack of Efficacy|1|||
154917958|NCT00504595|559122435|FG001|Overall Study|Lack of Efficacy|0|||
154917959|NCT00504595|559122436|FG002|Overall Study|Lack of Efficacy|0|||
154917960|NCT00504595|559122437|FG003|Overall Study|Lack of Efficacy|0|||
154917961|NCT00504595|559122434|FG000|Overall Study|Other|0|||
154917962|NCT00504595|559122435|FG001|Overall Study|Other|0|||
154917963|NCT00504595|559122436|FG002|Overall Study|Other|2|||
154917964|NCT00504595|559122437|FG003|Overall Study|Other|0|||
154917965|NCT00779142|559122439|FG000|Overall Study|Screen Failures|3|||
154917966|NCT01303159|559122443|FG000|Overall Study|Death|16|||
154993905|NCT02603393|559402816|FG001|Overall Study|Lack of Efficacy|2|||
154993906|NCT02603393|559402815|FG000|Overall Study|Death|3|||
154993907|NCT02603393|559402816|FG001|Overall Study|Death|4|||
154993908|NCT02603393|559402815|FG000|Overall Study|Physician Decision|3|||
154993909|NCT02603393|559402816|FG001|Overall Study|Physician Decision|3|||
154993910|NCT02603393|559402815|FG000|Overall Study|Protocol deviation|2|||
154993911|NCT02603393|559402816|FG001|Overall Study|Protocol deviation|3|||
154993912|NCT02603393|559402815|FG000|Overall Study|Lost to Follow-up|1|||
154993913|NCT02603393|559402816|FG001|Overall Study|Lost to Follow-up|2|||
154993914|NCT02603393|559402815|FG000|Overall Study|Non-compliance with study treatment|1|||
154993915|NCT02603393|559402816|FG001|Overall Study|Non-compliance with study treatment|0|||
154993916|NCT02603393|559402815|FG000|Overall Study|Sponsor decision|1|||
154993917|NCT02603393|559402816|FG001|Overall Study|Sponsor decision|0|||
154993918|NCT00699374|559402817|FG000|Overall Study|Death|93|||
154993919|NCT00699374|559402818|FG001|Overall Study|Death|83|||
154993920|NCT00699374|559402817|FG000|Overall Study|Adverse Event|70|||
154993921|NCT00699374|559402818|FG001|Overall Study|Adverse Event|67|||
154993922|NCT00699374|559402817|FG000|Overall Study|Global deterioration of health status|7|||
154993923|NCT00699374|559402818|FG001|Overall Study|Global deterioration of health status|8|||
154993924|NCT00699374|559402817|FG000|Overall Study|Lost to Follow-up|3|||
154993925|NCT00699374|559402818|FG001|Overall Study|Lost to Follow-up|5|||
154993926|NCT00699374|559402817|FG000|Overall Study|Withdrawal by Subject|34|||
154993927|NCT00699374|559402818|FG001|Overall Study|Withdrawal by Subject|44|||
154993928|NCT00699374|559402817|FG000|Overall Study|Objective progression or relapse|281|||
154993929|NCT00699374|559402818|FG001|Overall Study|Objective progression or relapse|277|||
154993930|NCT00699374|559402817|FG000|Overall Study|Other|18|||
154993931|NCT00699374|559402818|FG001|Overall Study|Other|15|||
154993932|NCT00699374|559402817|FG000|Overall Study|Protocol Violation|2|||
154993933|NCT00699374|559402818|FG001|Overall Study|Protocol Violation|6|||
154993934|NCT00699374|559402817|FG000|Overall Study|Study terminated by sponsor|13|||
154993935|NCT00699374|559402818|FG001|Overall Study|Study terminated by sponsor|28|||
154993936|NCT00699374|559402817|FG000|Overall Study|Randomized but not treated|4|||
154993937|NCT00699374|559402818|FG001|Overall Study|Randomized but not treated|2|||
154993938|NCT00699374|559402817|FG000|Overall Study|Died 28 days after last dose|5|||
154993939|NCT00699374|559402818|FG001|Overall Study|Died 28 days after last dose|9|||
154993940|NCT01359969|559402819|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
154993941|NCT00593736|559402826|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
154993942|NCT00593736|559402827|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
154993943|NCT00593736|559402828|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
154993944|NCT00593736|559402829|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
154993945|NCT00593736|559402826|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
154993946|NCT00593736|559402827|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
154993947|NCT00593736|559402828|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
154993948|NCT00593736|559402829|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
154993949|NCT00593736|559402826|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
154993950|NCT00593736|559402827|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
154993951|NCT00593736|559402828|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
154993952|NCT00593736|559402829|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
154993953|NCT00593736|559402826|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
154993954|NCT00593736|559402827|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
154993955|NCT00593736|559402828|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
154993956|NCT00593736|559402829|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
154993957|NCT00593736|559402826|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
154993958|NCT00593736|559402827|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
154993959|NCT00593736|559402828|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
154993960|NCT00593736|559402829|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
154993961|NCT00593736|559402826|FG000|Screening Period and Placebo Run-in|Various|0|||
154993962|NCT00593736|559402827|FG001|Screening Period and Placebo Run-in|Various|0|||
154993963|NCT00593736|559402828|FG002|Screening Period and Placebo Run-in|Various|0|||
154993964|NCT00593736|559402829|FG003|Screening Period and Placebo Run-in|Various|25|||
154993965|NCT00593736|559402826|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
154993966|NCT00593736|559402827|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
154993967|NCT00593736|559402828|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
154993968|NCT00593736|559402829|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
155121897|NCT03784846|559877854|FG001|Pre-COVID Study|Lost to Follow-up|3|||
155121898|NCT03784846|559877855|FG002|Pre-COVID Study|Lost to Follow-up|2|||
155121899|NCT03784846|559877853|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
154993969|NCT00593736|559402826|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
154993970|NCT00593736|559402827|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
154993971|NCT00593736|559402828|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
155121900|NCT03784846|559877854|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
155121901|NCT03784846|559877855|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
155121902|NCT03784846|559877853|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
155121903|NCT03784846|559877854|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
154993972|NCT00593736|559402829|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
154993973|NCT00593736|559402826|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
154993974|NCT00593736|559402827|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
154993975|NCT00593736|559402828|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
154993976|NCT00593736|559402829|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
154993977|NCT00593736|559402826|FG000|Treatment Period and Placebo Run-out|Various|1|||
154993978|NCT00593736|559402827|FG001|Treatment Period and Placebo Run-out|Various|1|||
154993979|NCT00593736|559402828|FG002|Treatment Period and Placebo Run-out|Various|1|||
154993980|NCT00593736|559402829|FG003|Treatment Period and Placebo Run-out|Various|0|||
154993981|NCT01857271|559402830|FG000|Overall Study|Lost to Follow-up|1|||
154993982|NCT04729309|559402837|FG000|Period 1|Subject unable to return for Period 2|3|||
154993983|NCT04729309|559402838|FG001|Period 1|Subject unable to return for Period 2|0|||
154993984|NCT04729309|559402837|FG000|Period 1|Lost to Follow-up|1|||
154993985|NCT04729309|559402838|FG001|Period 1|Lost to Follow-up|0|||
154993986|NCT01212588|559402839|FG000|Overall Study|Physician Decision|0|||
154993987|NCT01212588|559402840|FG001|Overall Study|Physician Decision|1|||
154993988|NCT01212588|559402839|FG000|Overall Study|Protocol Violation|1|||
154993989|NCT01212588|559402840|FG001|Overall Study|Protocol Violation|1|||
154993990|NCT00849186|559402842|FG000|Overall Study|Adverse Event|2|||
154993991|NCT00849186|559402842|FG000|Overall Study|Withdrawal by Subject|1|||
154993992|NCT00849186|559402842|FG000|Overall Study|not treated|6|||
154993993|NCT00849186|559402842|FG000|Overall Study|Other|1|||
154993994|NCT00936897|559402845|FG000|Overall Study|Withdrawal by Subject|9|||
154993995|NCT00936897|559402846|FG001|Overall Study|Withdrawal by Subject|19|||
154993996|NCT00936897|559402845|FG000|Overall Study|Adverse Event|4|||
154993997|NCT00936897|559402846|FG001|Overall Study|Adverse Event|13|||
154993998|NCT00936897|559402845|FG000|Overall Study|Other|3|||
154993999|NCT00936897|559402846|FG001|Overall Study|Other|9|||
154994000|NCT00936897|559402845|FG000|Overall Study|Lost to Follow-up|1|||
154994001|NCT00936897|559402846|FG001|Overall Study|Lost to Follow-up|10|||
154994002|NCT00936897|559402845|FG000|Overall Study|Administrative Decision|1|||
154994003|NCT00936897|559402846|FG001|Overall Study|Administrative Decision|2|||
154994004|NCT00936897|559402845|FG000|Overall Study|Protocol Violation|1|||
154994005|NCT00936897|559402846|FG001|Overall Study|Protocol Violation|1|||
154994006|NCT00936897|559402845|FG000|Overall Study|Ineligibility Determined|0|||
154994007|NCT00936897|559402846|FG001|Overall Study|Ineligibility Determined|3|||
154994008|NCT00936897|559402845|FG000|Overall Study|Noncompliance|0|||
154994009|NCT00936897|559402846|FG001|Overall Study|Noncompliance|2|||
154994010|NCT00936897|559402845|FG000|Overall Study|Death|0|||
154994011|NCT00936897|559402846|FG001|Overall Study|Death|1|||
154994012|NCT00417170|559402847|FG000|Overall Study|Adverse Event|1|||
154994013|NCT00417170|559402848|FG001|Overall Study|Adverse Event|1|||
154994014|NCT00417170|559402847|FG000|Overall Study|Withdrawal by Subject|1|||
154994015|NCT00417170|559402848|FG001|Overall Study|Withdrawal by Subject|1|||
154994016|NCT00417170|559402847|FG000|Overall Study|Lost to Follow-up|0|||
154994017|NCT00417170|559402848|FG001|Overall Study|Lost to Follow-up|1|||
154994018|NCT01756079|559402852|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
154994019|NCT01756079|559402852|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
154994020|NCT01756079|559402852|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
154994021|NCT01756079|559402852|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
154994022|NCT01756079|559402852|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
154994023|NCT04154631|559402858|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
154994024|NCT04154631|559402859|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
154994025|NCT01441947|559402860|FG000|Overall Study|Withdrawal by Subject|3|||
154994026|NCT01441947|559402861|FG001|Overall Study|Withdrawal by Subject|0|||
154994027|NCT02238795|559402862|FG000|Overall Study|Patient without purpura fulminans|1|||
154994028|NCT05187013|559402864|FG000|Overall Study|Withdrawal by Subject|1|||
154994029|NCT05187013|559402865|FG001|Overall Study|Withdrawal by Subject|1|||
154994030|NCT05187013|559402866|FG002|Overall Study|Withdrawal by Subject|0|||
154994031|NCT05187013|559402864|FG000|Overall Study|Death|0|||
154994032|NCT05187013|559402865|FG001|Overall Study|Death|1|||
155121904|NCT03784846|559877855|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
155121905|NCT03784846|559877853|FG000|Post-COVID Study|Lost to Follow-up|3|||
155121906|NCT03784846|559877854|FG001|Post-COVID Study|Lost to Follow-up|5|||
155121907|NCT03784846|559877855|FG002|Post-COVID Study|Lost to Follow-up|1|||
154994033|NCT05187013|559402866|FG002|Overall Study|Death|0|||
154994034|NCT05187013|559402864|FG000|Overall Study|Lost to Follow-up|20|||
154994035|NCT05187013|559402865|FG001|Overall Study|Lost to Follow-up|17|||
154994036|NCT05187013|559402866|FG002|Overall Study|Lost to Follow-up|0|||
154994037|NCT05187013|559402864|FG000|Overall Study|Ongoing Participants|3|||
154994038|NCT05187013|559402865|FG001|Overall Study|Ongoing Participants|5|||
154994039|NCT05187013|559402866|FG002|Overall Study|Ongoing Participants|0|||
155121908|NCT03784846|559877853|FG000|Post-COVID Study|Withdrawal by Subject|1|||
155121909|NCT03784846|559877854|FG001|Post-COVID Study|Withdrawal by Subject|2|||
154994040|NCT02387983|559402867|FG000|Overall Study|Adverse Event|4|||
154994041|NCT02387983|559402867|FG000|Overall Study|Protocol Violation|1|||
154994042|NCT02387983|559402867|FG000|Overall Study|Withdrawal by Subject|2|||
154994043|NCT04159935|559402868|FG000|Overall Study|Study terminated due to COVID-19|1|||
154994044|NCT04159935|559402869|FG001|Overall Study|Study terminated due to COVID-19|3|||
154994045|NCT01341782|559402870|FG000|Overall Study|Adverse Event|1|||
154994046|NCT01341782|559402871|FG001|Overall Study|Adverse Event|1|||
154994047|NCT01341782|559402870|FG000|Overall Study|Withdrawal by Subject|6|||
154994048|NCT01341782|559402871|FG001|Overall Study|Withdrawal by Subject|5|||
154994049|NCT01341782|559402870|FG000|Overall Study|Missed 3 consecutive doses|0|||
154994050|NCT01341782|559402871|FG001|Overall Study|Missed 3 consecutive doses|4|||
154994051|NCT01341782|559402870|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
154994052|NCT01341782|559402871|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
154994053|NCT01341782|559402870|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
154994054|NCT01341782|559402871|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
154994055|NCT01341782|559402870|FG000|Overall Study|Other|5|||
154994056|NCT01341782|559402871|FG001|Overall Study|Other|0|||
154994057|NCT00724048|559402874|FG000|Overall Study|Adverse Event|1|||
154994058|NCT00724048|559402875|FG001|Overall Study|Adverse Event|1|||
154994059|NCT00724048|559402876|FG002|Overall Study|Adverse Event|1|||
154994060|NCT00724048|559402877|FG003|Overall Study|Adverse Event|0|||
154994061|NCT00724048|559402874|FG000|Overall Study|Lost to Follow-up|0|||
154994062|NCT00724048|559402875|FG001|Overall Study|Lost to Follow-up|1|||
154994063|NCT00724048|559402876|FG002|Overall Study|Lost to Follow-up|0|||
154994064|NCT00724048|559402877|FG003|Overall Study|Lost to Follow-up|0|||
154994065|NCT00724048|559402874|FG000|Overall Study|Withdrawal by Subject|1|||
154994066|NCT00724048|559402875|FG001|Overall Study|Withdrawal by Subject|2|||
154994067|NCT00724048|559402876|FG002|Overall Study|Withdrawal by Subject|1|||
154994068|NCT00724048|559402877|FG003|Overall Study|Withdrawal by Subject|2|||
154994069|NCT00724048|559402874|FG000|Overall Study|Investigator decision|0|||
154994070|NCT00724048|559402875|FG001|Overall Study|Investigator decision|0|||
154994071|NCT00724048|559402876|FG002|Overall Study|Investigator decision|1|||
154994072|NCT00724048|559402877|FG003|Overall Study|Investigator decision|0|||
154994073|NCT00724048|559402874|FG000|Overall Study|Did not tolerate study drug|0|||
154994074|NCT00724048|559402875|FG001|Overall Study|Did not tolerate study drug|0|||
154994075|NCT00724048|559402876|FG002|Overall Study|Did not tolerate study drug|0|||
154994076|NCT00724048|559402877|FG003|Overall Study|Did not tolerate study drug|1|||
154994077|NCT00724048|559402874|FG000|Overall Study|Other than specified|1|||
154994078|NCT00724048|559402875|FG001|Overall Study|Other than specified|1|||
154994079|NCT00724048|559402876|FG002|Overall Study|Other than specified|0|||
154994080|NCT00724048|559402877|FG003|Overall Study|Other than specified|0|||
154994081|NCT00206323|559402882|FG000|Overall Study|Lack of Efficacy|4|||
154994082|NCT00206323|559402883|FG001|Overall Study|Lack of Efficacy|1|||
154994083|NCT00206323|559402882|FG000|Overall Study|Adverse Event|1|||
154994084|NCT00206323|559402883|FG001|Overall Study|Adverse Event|1|||
154994085|NCT00206323|559402882|FG000|Overall Study|Lost to Follow-up|1|||
154994086|NCT00206323|559402883|FG001|Overall Study|Lost to Follow-up|1|||
154994087|NCT02329847|559402884|FG000|Overall Study|Death|4|||
154994088|NCT02329847|559402885|FG001|Overall Study|Death|4|||
154994089|NCT02329847|559402886|FG002|Overall Study|Death|22|||
154994090|NCT02329847|559402887|FG003|Overall Study|Death|12|||
154994091|NCT02329847|559402888|FG004|Overall Study|Death|20|||
154994092|NCT02329847|559402889|FG005|Overall Study|Death|13|||
154994093|NCT02329847|559402884|FG000|Overall Study|Lost to Follow-up|0|||
154994094|NCT02329847|559402885|FG001|Overall Study|Lost to Follow-up|0|||
154994095|NCT02329847|559402886|FG002|Overall Study|Lost to Follow-up|2|||
154994096|NCT02329847|559402887|FG003|Overall Study|Lost to Follow-up|3|||
154994097|NCT02329847|559402888|FG004|Overall Study|Lost to Follow-up|0|||
155121910|NCT03784846|559877855|FG002|Post-COVID Study|Withdrawal by Subject|0|||
155121911|NCT00867087|559877856|FG000|Overall Study|Other|1|||
155121912|NCT00867087|559877856|FG000|Overall Study|Withdrawal by Subject|4|||
155121913|NCT00867087|559877856|FG000|Overall Study|Death|37|||
154994098|NCT02329847|559402889|FG005|Overall Study|Lost to Follow-up|1|||
154994099|NCT02329847|559402884|FG000|Overall Study|Physician Decision|0|||
155121914|NCT00570037|559877857|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
154994100|NCT02329847|559402885|FG001|Overall Study|Physician Decision|0|||
154994101|NCT02329847|559402886|FG002|Overall Study|Physician Decision|0|||
155121915|NCT00570037|559877858|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
154994102|NCT02329847|559402887|FG003|Overall Study|Physician Decision|0|||
154994103|NCT02329847|559402888|FG004|Overall Study|Physician Decision|1|||
154994104|NCT02329847|559402889|FG005|Overall Study|Physician Decision|0|||
154994105|NCT02329847|559402884|FG000|Overall Study|Withdrawal by Subject|2|||
154994106|NCT02329847|559402885|FG001|Overall Study|Withdrawal by Subject|1|||
154994107|NCT02329847|559402886|FG002|Overall Study|Withdrawal by Subject|5|||
154994108|NCT02329847|559402887|FG003|Overall Study|Withdrawal by Subject|7|||
154994109|NCT02329847|559402888|FG004|Overall Study|Withdrawal by Subject|8|||
154994110|NCT02329847|559402889|FG005|Overall Study|Withdrawal by Subject|3|||
154994111|NCT02329847|559402884|FG000|Overall Study|Other|1|||
155121916|NCT04612842|559877859|FG000|Overall Study|Lost to Follow-up|20|||
155121917|NCT04612842|559877860|FG001|Overall Study|Lost to Follow-up|11|||
155121918|NCT04612842|559877859|FG000|Overall Study|Withdrawal by Subject|26|||
155121919|NCT04612842|559877860|FG001|Overall Study|Withdrawal by Subject|15|||
155121920|NCT04612842|559877859|FG000|Overall Study|Death|2|||
155121921|NCT04612842|559877860|FG001|Overall Study|Death|2|||
154994112|NCT02329847|559402885|FG001|Overall Study|Other|2|||
154994113|NCT02329847|559402886|FG002|Overall Study|Other|6|||
154994114|NCT02329847|559402887|FG003|Overall Study|Other|13|||
154994115|NCT02329847|559402888|FG004|Overall Study|Other|10|||
154994116|NCT02329847|559402889|FG005|Overall Study|Other|3|||
154994117|NCT03657342|559402890|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
154994118|NCT03657342|559402891|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
154994119|NCT03657342|559402890|FG000|Overall Study|Withdrawal by Subject|4|||
154994120|NCT03657342|559402891|FG001|Overall Study|Withdrawal by Subject|4|||
154994121|NCT03657342|559402890|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
154994122|NCT03657342|559402891|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
154994123|NCT03657342|559402890|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
154994124|NCT03657342|559402891|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
154994125|NCT00407758|559402892|FG000|Overall Study|ineligible -improper prior treatment|1|||
154994126|NCT00750308|559402893|FG000|First Treatment|Adverse Event|0|||
154994127|NCT00750308|559402894|FG001|First Treatment|Adverse Event|1|||
154994128|NCT00750308|559402895|FG002|First Treatment|Adverse Event|0|||
154994129|NCT00750308|559402896|FG003|First Treatment|Adverse Event|0|||
154994130|NCT00750308|559402897|FG004|First Treatment|Adverse Event|0|||
154994131|NCT00750308|559402898|FG005|First Treatment|Adverse Event|0|||
154994132|NCT00750308|559402899|FG006|First Treatment|Adverse Event|0|||
154994133|NCT00750308|559402900|FG007|First Treatment|Adverse Event|0|||
154994134|NCT00750308|559402901|FG008|First Treatment|Adverse Event|0|||
154994135|NCT00750308|559402902|FG009|First Treatment|Adverse Event|0|||
154994136|NCT00750308|559402903|FG010|First Treatment|Adverse Event|1|||
154994137|NCT00750308|559402904|FG011|First Treatment|Adverse Event|1|||
154994138|NCT00750308|559402893|FG000|First Treatment|Withdrawal by Subject|0|||
154994139|NCT00750308|559402894|FG001|First Treatment|Withdrawal by Subject|0|||
154994140|NCT00750308|559402895|FG002|First Treatment|Withdrawal by Subject|0|||
154994141|NCT00750308|559402896|FG003|First Treatment|Withdrawal by Subject|1|||
154994142|NCT00750308|559402897|FG004|First Treatment|Withdrawal by Subject|0|||
154994143|NCT00750308|559402898|FG005|First Treatment|Withdrawal by Subject|0|||
154994144|NCT00750308|559402899|FG006|First Treatment|Withdrawal by Subject|0|||
154994145|NCT00750308|559402900|FG007|First Treatment|Withdrawal by Subject|1|||
154994146|NCT00750308|559402901|FG008|First Treatment|Withdrawal by Subject|0|||
154994147|NCT00750308|559402902|FG009|First Treatment|Withdrawal by Subject|0|||
154994148|NCT00750308|559402903|FG010|First Treatment|Withdrawal by Subject|0|||
154994149|NCT00750308|559402904|FG011|First Treatment|Withdrawal by Subject|0|||
154994150|NCT00750308|559402893|FG000|Second Treatment|Adverse Event|0|||
154994151|NCT00750308|559402894|FG001|Second Treatment|Adverse Event|0|||
154994152|NCT00750308|559402895|FG002|Second Treatment|Adverse Event|0|||
154994153|NCT00750308|559402896|FG003|Second Treatment|Adverse Event|0|||
154994154|NCT00750308|559402897|FG004|Second Treatment|Adverse Event|0|||
154994155|NCT00750308|559402898|FG005|Second Treatment|Adverse Event|1|||
154994156|NCT00750308|559402899|FG006|Second Treatment|Adverse Event|0|||
154994157|NCT00750308|559402900|FG007|Second Treatment|Adverse Event|0|||
154994158|NCT00750308|559402901|FG008|Second Treatment|Adverse Event|1|||
154994159|NCT00750308|559402902|FG009|Second Treatment|Adverse Event|0|||
154994160|NCT00750308|559402903|FG010|Second Treatment|Adverse Event|0|||
154994161|NCT00750308|559402904|FG011|Second Treatment|Adverse Event|0|||
154994162|NCT00750308|559402893|FG000|Second Treatment|Withdrawal by Subject|0|||
154994163|NCT00750308|559402894|FG001|Second Treatment|Withdrawal by Subject|0|||
154994164|NCT00750308|559402895|FG002|Second Treatment|Withdrawal by Subject|0|||
154994165|NCT00750308|559402896|FG003|Second Treatment|Withdrawal by Subject|0|||
154994166|NCT00750308|559402897|FG004|Second Treatment|Withdrawal by Subject|1|||
155121922|NCT02419131|559877861|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
155121923|NCT02419131|559877862|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
155121924|NCT02419131|559877863|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
155121925|NCT02419131|559877861|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
154994167|NCT00750308|559402898|FG005|Second Treatment|Withdrawal by Subject|0|||
154994168|NCT00750308|559402899|FG006|Second Treatment|Withdrawal by Subject|0|||
154994169|NCT00750308|559402900|FG007|Second Treatment|Withdrawal by Subject|0|||
154994170|NCT00750308|559402901|FG008|Second Treatment|Withdrawal by Subject|0|||
154994171|NCT00750308|559402902|FG009|Second Treatment|Withdrawal by Subject|0|||
154994172|NCT00750308|559402903|FG010|Second Treatment|Withdrawal by Subject|0|||
154994173|NCT00750308|559402904|FG011|Second Treatment|Withdrawal by Subject|0|||
154994174|NCT00750308|559402893|FG000|Third Treatment|Withdrawal by Subject|0|||
154994175|NCT00750308|559402894|FG001|Third Treatment|Withdrawal by Subject|1|||
154994176|NCT00750308|559402895|FG002|Third Treatment|Withdrawal by Subject|0|||
154994177|NCT00750308|559402896|FG003|Third Treatment|Withdrawal by Subject|0|||
155177614|NCT03011892|560088269|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
155177615|NCT03011892|560088270|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
155177616|NCT03011892|560088271|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
155177617|NCT03011892|560088272|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
155177618|NCT03011892|560088273|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
155177619|NCT03011892|560088274|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
155177620|NCT03011892|560088275|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
155177621|NCT03011892|560088276|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
155177622|NCT03011892|560088277|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
155177623|NCT03011892|560088278|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
155177624|NCT03011892|560088279|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
155177625|NCT03011892|560088280|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
155177626|NCT03011892|560088269|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
155177627|NCT03011892|560088270|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
155177628|NCT03011892|560088271|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
155177629|NCT03011892|560088272|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
155177630|NCT03011892|560088273|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
155177631|NCT03011892|560088274|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
155177632|NCT03011892|560088275|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
155177633|NCT03011892|560088276|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
155177634|NCT03011892|560088277|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
155177635|NCT03011892|560088278|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
155177636|NCT03011892|560088279|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
155177637|NCT03011892|560088280|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
155177638|NCT03011892|560088269|FG000|Open Label (OL) Period|Reason not specified|0|||
155177639|NCT03011892|560088270|FG001|Open Label (OL) Period|Reason not specified|0|||
155177640|NCT03011892|560088271|FG002|Open Label (OL) Period|Reason not specified|0|||
155177641|NCT03011892|560088272|FG003|Open Label (OL) Period|Reason not specified|0|||
155177642|NCT03011892|560088273|FG004|Open Label (OL) Period|Reason not specified|0|||
155177643|NCT03011892|560088274|FG005|Open Label (OL) Period|Reason not specified|0|||
155177644|NCT03011892|560088275|FG006|Open Label (OL) Period|Reason not specified|0|||
155177645|NCT03011892|560088276|FG007|Open Label (OL) Period|Reason not specified|1|||
155177646|NCT03011892|560088277|FG008|Open Label (OL) Period|Reason not specified|0|||
155177647|NCT03011892|560088278|FG009|Open Label (OL) Period|Reason not specified|0|||
155177648|NCT03011892|560088279|FG010|Open Label (OL) Period|Reason not specified|0|||
155177649|NCT03011892|560088280|FG011|Open Label (OL) Period|Reason not specified|0|||
155177650|NCT00906971|560088289|FG000|Overall Study|Withdrawal by Subject|8|||
155177651|NCT00906971|560088290|FG001|Overall Study|Withdrawal by Subject|2|||
155177652|NCT00906971|560088289|FG000|Overall Study|Lost to Follow-up|0|||
155177653|NCT00906971|560088290|FG001|Overall Study|Lost to Follow-up|1|||
155177654|NCT03678870|560088293|FG000|Overall Study|prescribed non- protocol medications|10|||
155177655|NCT03678870|560088294|FG001|Overall Study|prescribed non- protocol medications|6|||
155177656|NCT03678870|560088293|FG000|Overall Study|Lost to Follow-up|3|||
155177657|NCT03678870|560088294|FG001|Overall Study|Lost to Follow-up|2|||
155177658|NCT03104816|560088295|FG000|Overall Study|Lack of Efficacy|0|||
155177659|NCT03104816|560088296|FG001|Overall Study|Lack of Efficacy|2|||
155177660|NCT03104816|560088297|FG002|Overall Study|Lack of Efficacy|0|||
155177661|NCT03104816|560088295|FG000|Overall Study|Protocol Violation|2|||
155177662|NCT03104816|560088296|FG001|Overall Study|Protocol Violation|0|||
155177663|NCT03104816|560088297|FG002|Overall Study|Protocol Violation|2|||
154917967|NCT01303159|559122443|FG000|Overall Study|Study Termination|7|||
154917968|NCT00496782|559122444|FG000|Overall Study|Protocol Violation|1|||
154917969|NCT00496782|559122445|FG001|Overall Study|Protocol Violation|2|||
154917970|NCT01288911|559122446|FG000|Double-blind Period|Death|11|||
154917971|NCT01288911|559122447|FG001|Double-blind Period|Death|7|||
154917972|NCT01288911|559122446|FG000|Double-blind Period|Lost to Follow-up|0|||
154917973|NCT01288911|559122447|FG001|Double-blind Period|Lost to Follow-up|2|||
154917974|NCT01288911|559122446|FG000|Double-blind Period|Progressive Disease|75|||
154917975|NCT01288911|559122447|FG001|Double-blind Period|Progressive Disease|103|||
154917976|NCT01288911|559122446|FG000|Double-blind Period|Protocol Violation|1|||
154917977|NCT01288911|559122447|FG001|Double-blind Period|Protocol Violation|0|||
154917978|NCT01288911|559122446|FG000|Double-blind Period|Withdrawal by Subject|25|||
154917979|NCT01288911|559122447|FG001|Double-blind Period|Withdrawal by Subject|26|||
154917980|NCT01288911|559122446|FG000|Double-blind Period|Miscellaneous Reason|29|||
154917981|NCT01288911|559122447|FG001|Double-blind Period|Miscellaneous Reason|42|||
154917982|NCT01288911|559122446|FG000|Double-blind Period|Randomized but never received study drug|1|||
154917983|NCT01288911|559122447|FG001|Double-blind Period|Randomized but never received study drug|2|||
154917984|NCT01288911|559122446|FG000|Open-label Period (All Enzalutamide)|Death|0|||
154917985|NCT01288911|559122447|FG001|Open-label Period (All Enzalutamide)|Death|1|||
154917986|NCT01288911|559122446|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
154917987|NCT01288911|559122447|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
154917988|NCT01288911|559122446|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
154917989|NCT01288911|559122447|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
155121926|NCT02419131|559877862|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
155121927|NCT02419131|559877863|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
155121928|NCT03060512|559877864|FG000|Overall Study|Adverse Event|4|||
155121929|NCT03060512|559877865|FG001|Overall Study|Adverse Event|6|||
155121930|NCT03060512|559877864|FG000|Overall Study|Lost to Follow-up|1|||
155121931|NCT03060512|559877865|FG001|Overall Study|Lost to Follow-up|1|||
155121932|NCT03060512|559877864|FG000|Overall Study|Withdrawal by Subject|1|||
155121933|NCT03060512|559877865|FG001|Overall Study|Withdrawal by Subject|0|||
155121934|NCT03060512|559877864|FG000|Overall Study|Non-compliance with study medication|1|||
155121935|NCT03060512|559877865|FG001|Overall Study|Non-compliance with study medication|2|||
155121936|NCT00089986|559877866|FG000|Overall Study|Adverse Event|6|||
155121937|NCT00089986|559877867|FG001|Overall Study|Adverse Event|9|||
155121938|NCT00089986|559877868|FG002|Overall Study|Adverse Event|6|||
155121939|NCT00089986|559877866|FG000|Overall Study|Lost to Follow-up|3|||
155121940|NCT00089986|559877867|FG001|Overall Study|Lost to Follow-up|1|||
155121941|NCT00089986|559877868|FG002|Overall Study|Lost to Follow-up|1|||
155121942|NCT00089986|559877866|FG000|Overall Study|Protocol Violation|0|||
155121943|NCT00089986|559877867|FG001|Overall Study|Protocol Violation|1|||
155121944|NCT00089986|559877868|FG002|Overall Study|Protocol Violation|0|||
154994178|NCT00750308|559402897|FG004|Third Treatment|Withdrawal by Subject|0|||
154994179|NCT00750308|559402898|FG005|Third Treatment|Withdrawal by Subject|0|||
154994180|NCT00750308|559402899|FG006|Third Treatment|Withdrawal by Subject|0|||
154994181|NCT00750308|559402900|FG007|Third Treatment|Withdrawal by Subject|0|||
154994182|NCT00750308|559402901|FG008|Third Treatment|Withdrawal by Subject|0|||
154994183|NCT00750308|559402902|FG009|Third Treatment|Withdrawal by Subject|0|||
154994184|NCT00750308|559402903|FG010|Third Treatment|Withdrawal by Subject|0|||
154994185|NCT00750308|559402904|FG011|Third Treatment|Withdrawal by Subject|0|||
154994186|NCT02980874|559402905|FG000|Overall Study|Adverse Event|2|||
154994187|NCT02980874|559402906|FG001|Overall Study|Adverse Event|7|||
154994188|NCT02980874|559402905|FG000|Overall Study|Withdrawal by Subject|7|||
154994189|NCT02980874|559402906|FG001|Overall Study|Withdrawal by Subject|2|||
154994190|NCT02980874|559402905|FG000|Overall Study|Lost to Follow-up|5|||
154994191|NCT02980874|559402906|FG001|Overall Study|Lost to Follow-up|5|||
154994192|NCT02980874|559402905|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
154994193|NCT02980874|559402906|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
154994194|NCT02980874|559402905|FG000|Overall Study|Unknown study completion status|1|||
154994195|NCT02980874|559402906|FG001|Overall Study|Unknown study completion status|0|||
154994196|NCT04430855|559402909|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
154994197|NCT04430855|559402910|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
154994198|NCT04430855|559402909|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
154994199|NCT04430855|559402910|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
154994200|NCT04430855|559402909|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
154994201|NCT04430855|559402910|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
154994202|NCT04430855|559402909|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
154994203|NCT04430855|559402910|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
154994204|NCT04430855|559402909|FG000|Period 1 (Weeks 1-12)|Other|0|||
154994205|NCT04430855|559402910|FG001|Period 1 (Weeks 1-12)|Other|1|||
154994206|NCT04430855|559402909|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
154994207|NCT04430855|559402910|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
154994208|NCT04430855|559402909|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
154994209|NCT04430855|559402910|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
154994210|NCT04430855|559402909|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
154994211|NCT04430855|559402910|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
154994212|NCT01770392|559402911|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
154994213|NCT00390221|559402914|FG000|Overall Study|Lost to Follow-up|0|||
154994214|NCT00390221|559402915|FG001|Overall Study|Lost to Follow-up|3|||
154994215|NCT00390221|559402916|FG002|Overall Study|Lost to Follow-up|0|||
154994216|NCT00390221|559402914|FG000|Overall Study|Adverse Event|1|||
154994217|NCT00390221|559402915|FG001|Overall Study|Adverse Event|4|||
154994218|NCT00390221|559402916|FG002|Overall Study|Adverse Event|3|||
154994219|NCT00390221|559402914|FG000|Overall Study|Investigator Decision|0|||
154994220|NCT00390221|559402915|FG001|Overall Study|Investigator Decision|0|||
154994221|NCT00390221|559402916|FG002|Overall Study|Investigator Decision|1|||
155121945|NCT00089986|559877866|FG000|Overall Study|Patient transferred to another hospital|2|||
155121946|NCT00089986|559877867|FG001|Overall Study|Patient transferred to another hospital|1|||
155121947|NCT00089986|559877868|FG002|Overall Study|Patient transferred to another hospital|0|||
155121948|NCT00089986|559877866|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
155121949|NCT00089986|559877867|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
154994222|NCT00390221|559402914|FG000|Overall Study|Withdrawal by Subject|13|||
154994223|NCT00390221|559402915|FG001|Overall Study|Withdrawal by Subject|9|||
155121950|NCT00089986|559877868|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
154994224|NCT00390221|559402916|FG002|Overall Study|Withdrawal by Subject|7|||
154994225|NCT00390221|559402914|FG000|Overall Study|Subject Non-compliance|1|||
154994226|NCT00390221|559402915|FG001|Overall Study|Subject Non-compliance|0|||
154994227|NCT00390221|559402916|FG002|Overall Study|Subject Non-compliance|2|||
154994228|NCT00390221|559402914|FG000|Overall Study|Other|3|||
154994229|NCT00390221|559402915|FG001|Overall Study|Other|4|||
154994230|NCT00390221|559402916|FG002|Overall Study|Other|2|||
154994231|NCT03258853|559402931|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
154994232|NCT03258853|559402932|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
154994233|NCT01709838|559402933|FG000|Overall Study|Withdrawal by Subject|21|||
154994234|NCT01709838|559402933|FG000|Overall Study|Lost to Follow-up|16|||
154994235|NCT01709838|559402933|FG000|Overall Study|Pregnancy|10|||
154994236|NCT01709838|559402933|FG000|Overall Study|Subject/guardian decision|8|||
154994237|NCT01709838|559402933|FG000|Overall Study|Adverse Event|4|||
154994238|NCT01709838|559402933|FG000|Overall Study|Physician Decision|4|||
154994239|NCT01709838|559402933|FG000|Overall Study|Death|3|||
154994240|NCT01709838|559402933|FG000|Overall Study|Protocol Violation|1|||
154994241|NCT00968799|559402934|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
154994242|NCT03907462|559402937|FG000|Overall Study|Physician Decision|1|||
154994243|NCT03907462|559402938|FG001|Overall Study|Physician Decision|3|||
154994244|NCT03907462|559402939|FG002|Overall Study|Physician Decision|1|||
154994245|NCT03907462|559402937|FG000|Overall Study|Withdrawal by Subject|6|||
154994246|NCT03907462|559402938|FG001|Overall Study|Withdrawal by Subject|3|||
154994247|NCT03907462|559402939|FG002|Overall Study|Withdrawal by Subject|3|||
154994248|NCT03907462|559402937|FG000|Overall Study|Pregnancy|4|||
154994249|NCT03907462|559402938|FG001|Overall Study|Pregnancy|2|||
154994250|NCT03907462|559402939|FG002|Overall Study|Pregnancy|6|||
154994251|NCT03907462|559402937|FG000|Overall Study|Lost to Follow-up|16|||
154994252|NCT03907462|559402938|FG001|Overall Study|Lost to Follow-up|18|||
154994253|NCT03907462|559402939|FG002|Overall Study|Lost to Follow-up|22|||
154994254|NCT04639713|559402940|FG000|Overall Study|Protocol Noncompliance|2|||
154994255|NCT04639713|559402940|FG000|Overall Study|Withdrawal by Subject|1|||
154994256|NCT03190330|559405287|FG000|Overall Study|Adverse Event|2|||
154994257|NCT03190330|559405287|FG000|Overall Study|Death|10|||
154994258|NCT03190330|559405287|FG000|Overall Study|Lost to Follow-up|1|||
154994259|NCT03190330|559405287|FG000|Overall Study|Withdrawal by Subject|6|||
154994260|NCT03190330|559405287|FG000|Overall Study|Progressive Disease|1|||
154994261|NCT04347122|559405289|FG000|Overall Study|Physician Decision|0|||
154994262|NCT04347122|559405290|FG001|Overall Study|Physician Decision|3|||
154994263|NCT04347122|559405291|FG002|Overall Study|Physician Decision|3|||
154994264|NCT04347122|559405292|FG003|Overall Study|Physician Decision|6|||
154994265|NCT03510598|559405293|FG000|Overall Study|Withdrawal by Subject|1|||
154994266|NCT04994483|559405294|FG000|Overall Study|Adverse Event|26|||
154994267|NCT04994483|559405295|FG001|Overall Study|Adverse Event|17|||
154994268|NCT04994483|559405294|FG000|Overall Study|Lost to Follow-up|6|||
154994269|NCT04994483|559405295|FG001|Overall Study|Lost to Follow-up|10|||
154994270|NCT04994483|559405294|FG000|Overall Study|Noncompliance with study drug|8|||
154994271|NCT04994483|559405295|FG001|Overall Study|Noncompliance with study drug|5|||
154994272|NCT04994483|559405294|FG000|Overall Study|Physician Decision|5|||
154994273|NCT04994483|559405295|FG001|Overall Study|Physician Decision|0|||
154994274|NCT04994483|559405294|FG000|Overall Study|Withdrawal by Subject|41|||
154994275|NCT04994483|559405295|FG001|Overall Study|Withdrawal by Subject|38|||
154994276|NCT04994483|559405294|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
154994277|NCT04994483|559405295|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
154994278|NCT04994483|559405294|FG000|Overall Study|Met stopping criteria|1|||
154994279|NCT04994483|559405295|FG001|Overall Study|Met stopping criteria|0|||
154994280|NCT04994483|559405294|FG000|Overall Study|Randomized in error, not treated|4|||
154994281|NCT04994483|559405295|FG001|Overall Study|Randomized in error, not treated|3|||
154994282|NCT04994483|559405294|FG000|Overall Study|Lack of a reliable study partner|0|||
154994283|NCT04994483|559405295|FG001|Overall Study|Lack of a reliable study partner|1|||
154994284|NCT04994483|559405294|FG000|Overall Study|Met MRI exclusion criteria|0|||
154994285|NCT04994483|559405295|FG001|Overall Study|Met MRI exclusion criteria|1|||
154994286|NCT03589768|559405296|FG000|Overall Study|Death|1|||
154994287|NCT03589768|559405297|FG001|Overall Study|Death|0|||
155121951|NCT00089986|559877866|FG000|Overall Study|Hemohlobin stopping rule|0|||
155121952|NCT00089986|559877867|FG001|Overall Study|Hemohlobin stopping rule|1|||
155121953|NCT00089986|559877868|FG002|Overall Study|Hemohlobin stopping rule|0|||
155121954|NCT00089986|559877866|FG000|Overall Study|Investigator decision to withdrew|0|||
155121955|NCT00089986|559877867|FG001|Overall Study|Investigator decision to withdrew|1|||
154994288|NCT03589768|559405298|FG002|Overall Study|Death|8|||
154994289|NCT03589768|559405299|FG003|Overall Study|Death|3|||
155121956|NCT00089986|559877868|FG002|Overall Study|Investigator decision to withdrew|0|||
155121957|NCT00089986|559877866|FG000|Overall Study|Enrollment in another study|0|||
154994290|NCT03589768|559405296|FG000|Overall Study|Withdrawal by Subject|2|||
154994291|NCT03589768|559405297|FG001|Overall Study|Withdrawal by Subject|0|||
154994292|NCT03589768|559405298|FG002|Overall Study|Withdrawal by Subject|0|||
154994293|NCT03589768|559405299|FG003|Overall Study|Withdrawal by Subject|0|||
154994294|NCT03589768|559405296|FG000|Overall Study|Protocol Violation|1|||
154994295|NCT03589768|559405297|FG001|Overall Study|Protocol Violation|0|||
154994296|NCT03589768|559405298|FG002|Overall Study|Protocol Violation|0|||
155121958|NCT00089986|559877867|FG001|Overall Study|Enrollment in another study|1|||
154994297|NCT03589768|559405299|FG003|Overall Study|Protocol Violation|0|||
154994298|NCT00112866|559405300|FG000|Overall Study|Protocol Violation|1|||
154994299|NCT00112866|559405301|FG001|Overall Study|Protocol Violation|0|||
154994300|NCT00112866|559405300|FG000|Overall Study|did not start treatment post-op|1|||
154994301|NCT00112866|559405301|FG001|Overall Study|did not start treatment post-op|2|||
154994302|NCT04663295|559405304|FG000|Run-in Period|Withdrawal by Subject|3|||
154994303|NCT04663295|559405304|FG000|Overall Study Period|Pregnancy|1|||
154994304|NCT04663295|559405304|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
154994305|NCT00554190|559405305|FG000|Overall Study|Termination forms not completed|10|||
154994306|NCT00191113|559405306|FG000|Core Study|Withdrawal by Subject|25|||
154994307|NCT00191113|559405307|FG001|Core Study|Withdrawal by Subject|9|||
154994308|NCT00191113|559405306|FG000|Core Study|Protocol Violation|6|||
154994309|NCT00191113|559405307|FG001|Core Study|Protocol Violation|2|||
154994310|NCT00191113|559405306|FG000|Core Study|Lost to Follow-up|3|||
154994311|NCT00191113|559405307|FG001|Core Study|Lost to Follow-up|0|||
154994312|NCT00191113|559405306|FG000|Core Study|Adverse Event|0|||
154994313|NCT00191113|559405307|FG001|Core Study|Adverse Event|2|||
154994314|NCT00191113|559405306|FG000|Core Study|Lack of Efficacy|0|||
154994315|NCT00191113|559405307|FG001|Core Study|Lack of Efficacy|2|||
154994316|NCT00191113|559405306|FG000|Core Study|Death|1|||
154994317|NCT00191113|559405307|FG001|Core Study|Death|0|||
154994318|NCT01555671|559405314|FG000|Overall Study|Physician Decision|20|||
154994319|NCT01555671|559405315|FG001|Overall Study|Physician Decision|25|||
154994320|NCT03047330|559405316|FG000|Sleep Block 1|Withdrawal by Subject|3|||
154994321|NCT03929757|559405317|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
154994322|NCT03929757|559405318|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
154994323|NCT03929757|559405319|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
154994324|NCT03929757|559405317|FG000|Main Study: Up to Day 365|Other|1|||
154994325|NCT03929757|559405318|FG001|Main Study: Up to Day 365|Other|0|||
154994326|NCT03929757|559405319|FG002|Main Study: Up to Day 365|Other|0|||
154994327|NCT03929757|559405317|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
154994328|NCT03929757|559405318|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
154994329|NCT03929757|559405319|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
154994330|NCT01154816|559405320|FG000|Overall Study|Withdrawal by Subject|1|||
154994331|NCT01154816|559405321|FG001|Overall Study|Withdrawal by Subject|0|||
154994332|NCT01154816|559405322|FG002|Overall Study|Withdrawal by Subject|0|||
154994333|NCT01154816|559405323|FG003|Overall Study|Withdrawal by Subject|1|||
154994334|NCT01154816|559405324|FG004|Overall Study|Withdrawal by Subject|0|||
154994335|NCT01154816|559405325|FG005|Overall Study|Withdrawal by Subject|0|||
154994336|NCT01154816|559405326|FG006|Overall Study|Withdrawal by Subject|0|||
154994337|NCT01154816|559405327|FG007|Overall Study|Withdrawal by Subject|0|||
154994338|NCT01154816|559405328|FG008|Overall Study|Withdrawal by Subject|1|||
154994339|NCT01154816|559405329|FG009|Overall Study|Withdrawal by Subject|3|||
154994340|NCT01154816|559405330|FG010|Overall Study|Withdrawal by Subject|0|||
154994341|NCT01154816|559405331|FG011|Overall Study|Withdrawal by Subject|0|||
154994342|NCT01154816|559405320|FG000|Overall Study|Progressive Disease|13|||
154994343|NCT01154816|559405321|FG001|Overall Study|Progressive Disease|8|||
154994344|NCT01154816|559405322|FG002|Overall Study|Progressive Disease|9|||
154994345|NCT01154816|559405323|FG003|Overall Study|Progressive Disease|9|||
154994346|NCT01154816|559405324|FG004|Overall Study|Progressive Disease|8|||
154994347|NCT01154816|559405325|FG005|Overall Study|Progressive Disease|8|||
154994348|NCT01154816|559405326|FG006|Overall Study|Progressive Disease|5|||
154994349|NCT01154816|559405327|FG007|Overall Study|Progressive Disease|6|||
154994350|NCT01154816|559405328|FG008|Overall Study|Progressive Disease|8|||
154994351|NCT01154816|559405329|FG009|Overall Study|Progressive Disease|6|||
154994352|NCT01154816|559405330|FG010|Overall Study|Progressive Disease|10|||
154994353|NCT01154816|559405331|FG011|Overall Study|Progressive Disease|3|||
154994354|NCT01154816|559405320|FG000|Overall Study|Physician Decision|1|||
154994355|NCT01154816|559405321|FG001|Overall Study|Physician Decision|0|||
154994356|NCT01154816|559405322|FG002|Overall Study|Physician Decision|1|||
154994357|NCT01154816|559405323|FG003|Overall Study|Physician Decision|0|||
154994358|NCT01154816|559405324|FG004|Overall Study|Physician Decision|2|||
154994359|NCT01154816|559405325|FG005|Overall Study|Physician Decision|0|||
154994360|NCT01154816|559405326|FG006|Overall Study|Physician Decision|0|||
154994361|NCT01154816|559405327|FG007|Overall Study|Physician Decision|0|||
154994362|NCT01154816|559405328|FG008|Overall Study|Physician Decision|0|||
154994363|NCT01154816|559405329|FG009|Overall Study|Physician Decision|1|||
154994364|NCT01154816|559405330|FG010|Overall Study|Physician Decision|1|||
154994365|NCT01154816|559405331|FG011|Overall Study|Physician Decision|1|||
154994366|NCT01154816|559405320|FG000|Overall Study|Adverse Event|5|||
154994367|NCT01154816|559405321|FG001|Overall Study|Adverse Event|2|||
154994368|NCT01154816|559405322|FG002|Overall Study|Adverse Event|0|||
154994369|NCT01154816|559405323|FG003|Overall Study|Adverse Event|0|||
154994370|NCT01154816|559405324|FG004|Overall Study|Adverse Event|0|||
154994371|NCT01154816|559405325|FG005|Overall Study|Adverse Event|0|||
154994372|NCT01154816|559405326|FG006|Overall Study|Adverse Event|1|||
154994373|NCT01154816|559405327|FG007|Overall Study|Adverse Event|1|||
154994374|NCT01154816|559405328|FG008|Overall Study|Adverse Event|0|||
155121959|NCT00089986|559877868|FG002|Overall Study|Enrollment in another study|0|||
155121960|NCT00089986|559877866|FG000|Overall Study|Family decision|0|||
155121961|NCT00089986|559877867|FG001|Overall Study|Family decision|1|||
155121962|NCT00089986|559877868|FG002|Overall Study|Family decision|0|||
155121963|NCT00089986|559877866|FG000|Overall Study|Do not resuscitate (DNR)|0|||
155121964|NCT00089986|559877867|FG001|Overall Study|Do not resuscitate (DNR)|0|||
155121965|NCT00089986|559877868|FG002|Overall Study|Do not resuscitate (DNR)|1|||
155121966|NCT00089986|559877866|FG000|Overall Study|Withdrawal by Subject|3|||
155121967|NCT00089986|559877867|FG001|Overall Study|Withdrawal by Subject|6|||
155121968|NCT00089986|559877868|FG002|Overall Study|Withdrawal by Subject|2|||
155121969|NCT03946124|559877869|FG000|Overall Study|Withdrawal by Subject|19|||
155121970|NCT02334683|559877870|FG000|First 12 Week Period|Lost to Follow-up|1|||
155121971|NCT02334683|559877871|FG001|First 12 Week Period|Lost to Follow-up|0|||
155121972|NCT02334683|559877870|FG000|Second 12 Week Period|Adverse Event|0|||
155121973|NCT02334683|559877871|FG001|Second 12 Week Period|Adverse Event|1|||
155121974|NCT01062841|559877872|FG000|Overall Study|Indwelling Device Removed|41|||
155121975|NCT01062841|559877873|FG001|Overall Study|Indwelling Device Removed|48|||
155121976|NCT01062841|559877872|FG000|Overall Study|Death|3|||
155121977|NCT01062841|559877873|FG001|Overall Study|Death|5|||
155121978|NCT01062841|559877872|FG000|Overall Study|Withdrawal by Subject|2|||
155121979|NCT01062841|559877873|FG001|Overall Study|Withdrawal by Subject|0|||
155121980|NCT01062841|559877872|FG000|Overall Study|Withdrawal by Study|3|||
155121981|NCT01062841|559877873|FG001|Overall Study|Withdrawal by Study|0|||
155121982|NCT02046174|559877874|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
155121983|NCT02046174|559877875|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
155121984|NCT00413920|559877879|FG000|Overall Study|Adverse Event|9|||
155121985|NCT00413920|559877880|FG001|Overall Study|Adverse Event|11|||
155121986|NCT00413920|559877879|FG000|Overall Study|Lack of Efficacy|11|||
155121987|NCT00413920|559877880|FG001|Overall Study|Lack of Efficacy|9|||
155121988|NCT00413920|559877879|FG000|Overall Study|Death|3|||
155121989|NCT00413920|559877880|FG001|Overall Study|Death|5|||
155121990|NCT00413920|559877879|FG000|Overall Study|Graft Loss|5|||
155121991|NCT00413920|559877880|FG001|Overall Study|Graft Loss|3|||
155121992|NCT03831880|559877881|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
155121993|NCT03831880|559877882|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
155121994|NCT03831880|559877881|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
155121995|NCT03831880|559877882|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
155121996|NCT01891344|559877883|FG000|Overall Study|Ongoing|6|||
155121997|NCT01891344|559877884|FG001|Overall Study|Ongoing|2|||
155121998|NCT01891344|559877885|FG002|Overall Study|Ongoing|0|||
155121999|NCT01891344|559877886|FG003|Overall Study|Ongoing|1|||
155122000|NCT01891344|559877887|FG004|Overall Study|Ongoing|4|||
155122001|NCT01891344|559877888|FG005|Overall Study|Ongoing|1|||
155122002|NCT01891344|559877889|FG006|Overall Study|Ongoing|0|||
155122003|NCT01891344|559877890|FG007|Overall Study|Ongoing|0|||
155122004|NCT01414205|559877894|FG000|Overall Study|Death|5|||
155122005|NCT01414205|559877895|FG001|Overall Study|Death|1|||
154917990|NCT01288911|559122446|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
154917991|NCT01288911|559122447|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
154917992|NCT01288911|559122446|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
154917993|NCT01288911|559122447|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
154917994|NCT01288911|559122446|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
154917995|NCT01288911|559122447|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
154917996|NCT01632345|559122448|FG000|Treatment: Part I|Adverse Event|1|||
154917997|NCT01632345|559122449|FG001|Treatment: Part I|Adverse Event|4|||
154917998|NCT01632345|559122450|FG002|Treatment: Part I|Adverse Event|2|||
154917999|NCT01632345|559122451|FG003|Treatment: Part I|Adverse Event|1|||
154918000|NCT01632345|559122452|FG004|Treatment: Part I|Adverse Event|3|||
154918001|NCT01632345|559122453|FG005|Treatment: Part I|Adverse Event|0|||
154918002|NCT01632345|559122454|FG006|Treatment: Part I|Adverse Event|0|||
154918003|NCT01632345|559122448|FG000|Treatment: Part I|Lack of Efficacy|0|||
154918004|NCT01632345|559122449|FG001|Treatment: Part I|Lack of Efficacy|1|||
154918005|NCT01632345|559122450|FG002|Treatment: Part I|Lack of Efficacy|0|||
154918006|NCT01632345|559122451|FG003|Treatment: Part I|Lack of Efficacy|1|||
154918007|NCT01632345|559122452|FG004|Treatment: Part I|Lack of Efficacy|1|||
154918008|NCT01632345|559122453|FG005|Treatment: Part I|Lack of Efficacy|0|||
154918009|NCT01632345|559122454|FG006|Treatment: Part I|Lack of Efficacy|0|||
155122006|NCT01414205|559877894|FG000|Overall Study|Lost to Follow-up|1|||
155122007|NCT01414205|559877895|FG001|Overall Study|Lost to Follow-up|4|||
155122008|NCT01414205|559877894|FG000|Overall Study|Physician Decision|0|||
155122009|NCT01414205|559877895|FG001|Overall Study|Physician Decision|1|||
155122010|NCT01414205|559877894|FG000|Overall Study|Randomized but not Treated|1|||
155122011|NCT01414205|559877895|FG001|Overall Study|Randomized but not Treated|1|||
155122012|NCT01166373|559877896|FG000|Overall Study|Lost to Follow-up|3|||
155122013|NCT01166373|559877897|FG001|Overall Study|Lost to Follow-up|2|||
155122014|NCT01166373|559877898|FG002|Overall Study|Lost to Follow-up|2|||
155122015|NCT01166373|559877899|FG003|Overall Study|Lost to Follow-up|2|||
154918010|NCT01632345|559122448|FG000|Treatment: Part I|Lost to Follow-up|3|||
154918011|NCT01632345|559122449|FG001|Treatment: Part I|Lost to Follow-up|2|||
154918012|NCT01632345|559122450|FG002|Treatment: Part I|Lost to Follow-up|1|||
154918013|NCT01632345|559122451|FG003|Treatment: Part I|Lost to Follow-up|3|||
154918014|NCT01632345|559122452|FG004|Treatment: Part I|Lost to Follow-up|4|||
154918015|NCT01632345|559122453|FG005|Treatment: Part I|Lost to Follow-up|0|||
154918016|NCT01632345|559122454|FG006|Treatment: Part I|Lost to Follow-up|0|||
154918017|NCT01632345|559122448|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
154918018|NCT01632345|559122449|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
154918019|NCT01632345|559122450|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
154918020|NCT01632345|559122451|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
154918021|NCT01632345|559122452|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
154918022|NCT01632345|559122453|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
154918023|NCT01632345|559122454|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
154918024|NCT01632345|559122448|FG000|Treatment: Part I|Physician Decision|2|||
154918025|NCT01632345|559122449|FG001|Treatment: Part I|Physician Decision|1|||
154918026|NCT01632345|559122450|FG002|Treatment: Part I|Physician Decision|0|||
154918027|NCT01632345|559122451|FG003|Treatment: Part I|Physician Decision|0|||
154918028|NCT01632345|559122452|FG004|Treatment: Part I|Physician Decision|1|||
154918029|NCT01632345|559122453|FG005|Treatment: Part I|Physician Decision|0|||
154918030|NCT01632345|559122454|FG006|Treatment: Part I|Physician Decision|0|||
154918031|NCT01632345|559122448|FG000|Treatment: Part I|Pregnancy|0|||
154918032|NCT01632345|559122449|FG001|Treatment: Part I|Pregnancy|1|||
154918033|NCT01632345|559122450|FG002|Treatment: Part I|Pregnancy|0|||
154918034|NCT01632345|559122451|FG003|Treatment: Part I|Pregnancy|0|||
154918035|NCT01632345|559122452|FG004|Treatment: Part I|Pregnancy|0|||
154918036|NCT01632345|559122453|FG005|Treatment: Part I|Pregnancy|0|||
154918037|NCT01632345|559122454|FG006|Treatment: Part I|Pregnancy|0|||
154918038|NCT01632345|559122448|FG000|Treatment: Part I|Protocol Deviation|0|||
154918039|NCT01632345|559122449|FG001|Treatment: Part I|Protocol Deviation|0|||
154918040|NCT01632345|559122450|FG002|Treatment: Part I|Protocol Deviation|1|||
154918041|NCT01632345|559122451|FG003|Treatment: Part I|Protocol Deviation|1|||
154918042|NCT01632345|559122452|FG004|Treatment: Part I|Protocol Deviation|0|||
154918043|NCT01632345|559122453|FG005|Treatment: Part I|Protocol Deviation|0|||
154918044|NCT01632345|559122454|FG006|Treatment: Part I|Protocol Deviation|0|||
154918045|NCT01632345|559122448|FG000|Treatment: Part I|Withdrawal by Subject|3|||
154918046|NCT01632345|559122449|FG001|Treatment: Part I|Withdrawal by Subject|4|||
154918047|NCT01632345|559122450|FG002|Treatment: Part I|Withdrawal by Subject|4|||
154918048|NCT01632345|559122451|FG003|Treatment: Part I|Withdrawal by Subject|1|||
154918049|NCT01632345|559122452|FG004|Treatment: Part I|Withdrawal by Subject|4|||
154918050|NCT01632345|559122453|FG005|Treatment: Part I|Withdrawal by Subject|0|||
154918051|NCT01632345|559122454|FG006|Treatment: Part I|Withdrawal by Subject|0|||
154918052|NCT01632345|559122448|FG000|Treatment: Part II|Adverse Event|0|||
154918053|NCT01632345|559122449|FG001|Treatment: Part II|Adverse Event|0|||
154918054|NCT01632345|559122450|FG002|Treatment: Part II|Adverse Event|0|||
154918055|NCT01632345|559122451|FG003|Treatment: Part II|Adverse Event|0|||
154918056|NCT01632345|559122452|FG004|Treatment: Part II|Adverse Event|0|||
154918057|NCT01632345|559122453|FG005|Treatment: Part II|Adverse Event|3|||
154918058|NCT01632345|559122454|FG006|Treatment: Part II|Adverse Event|8|||
154918059|NCT01632345|559122448|FG000|Treatment: Part II|Lost to Follow-up|0|||
154918060|NCT01632345|559122449|FG001|Treatment: Part II|Lost to Follow-up|0|||
154918061|NCT01632345|559122450|FG002|Treatment: Part II|Lost to Follow-up|0|||
154918062|NCT01632345|559122451|FG003|Treatment: Part II|Lost to Follow-up|0|||
154918063|NCT01632345|559122452|FG004|Treatment: Part II|Lost to Follow-up|0|||
154918064|NCT01632345|559122453|FG005|Treatment: Part II|Lost to Follow-up|3|||
154918065|NCT01632345|559122454|FG006|Treatment: Part II|Lost to Follow-up|1|||
154918066|NCT01632345|559122448|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
154918067|NCT01632345|559122449|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
154918068|NCT01632345|559122450|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
154918069|NCT01632345|559122451|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
154918070|NCT01632345|559122452|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
154918071|NCT01632345|559122453|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
154918072|NCT01632345|559122454|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
154918073|NCT01632345|559122448|FG000|Treatment: Part II|Withdrawal by Subject|0|||
154918074|NCT01632345|559122449|FG001|Treatment: Part II|Withdrawal by Subject|0|||
154918075|NCT01632345|559122450|FG002|Treatment: Part II|Withdrawal by Subject|0|||
154918076|NCT01632345|559122451|FG003|Treatment: Part II|Withdrawal by Subject|0|||
154918077|NCT01632345|559122452|FG004|Treatment: Part II|Withdrawal by Subject|0|||
154918078|NCT01632345|559122453|FG005|Treatment: Part II|Withdrawal by Subject|2|||
154918079|NCT01632345|559122454|FG006|Treatment: Part II|Withdrawal by Subject|2|||
154918080|NCT02431559|559122455|FG000|Overall Study|Adverse Event|0|||
154918081|NCT02431559|559122456|FG001|Overall Study|Adverse Event|1|||
154918082|NCT02431559|559122457|FG002|Overall Study|Adverse Event|0|||
154918083|NCT02431559|559122458|FG003|Overall Study|Adverse Event|4|||
154918084|NCT02431559|559122455|FG000|Overall Study|Progressive disease|2|||
154918085|NCT02431559|559122456|FG001|Overall Study|Progressive disease|1|||
154918086|NCT02431559|559122457|FG002|Overall Study|Progressive disease|4|||
154918087|NCT02431559|559122458|FG003|Overall Study|Progressive disease|22|||
154918088|NCT02431559|559122455|FG000|Overall Study|Withdrawal by Subject|0|||
154918089|NCT02431559|559122456|FG001|Overall Study|Withdrawal by Subject|1|||
154918090|NCT02431559|559122457|FG002|Overall Study|Withdrawal by Subject|0|||
154918091|NCT02431559|559122458|FG003|Overall Study|Withdrawal by Subject|4|||
154918092|NCT02431559|559122455|FG000|Overall Study|Physician Decision|0|||
154918093|NCT02431559|559122456|FG001|Overall Study|Physician Decision|0|||
154918094|NCT02431559|559122457|FG002|Overall Study|Physician Decision|0|||
154918095|NCT02431559|559122458|FG003|Overall Study|Physician Decision|1|||
154918096|NCT02452892|559122459|FG000|Week 1 Initial Randommization|Adverse Event|1|||
154918097|NCT02452892|559122460|FG001|Week 1 Initial Randommization|Adverse Event|0|||
154918098|NCT02452892|559122461|FG002|Week 1 Initial Randommization|Adverse Event|0|||
154918099|NCT02452892|559122462|FG003|Week 1 Initial Randommization|Adverse Event|0|||
154918100|NCT02452892|559122459|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
154918101|NCT02452892|559122460|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
154918102|NCT02452892|559122461|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
154918103|NCT02452892|559122462|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
154918104|NCT02452892|559122459|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
154918105|NCT02452892|559122460|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
154918106|NCT02452892|559122461|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
154918107|NCT02452892|559122462|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
154918108|NCT02452892|559122459|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
154918109|NCT02452892|559122460|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
154918110|NCT02452892|559122461|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
154918111|NCT02452892|559122462|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
154918112|NCT02452892|559122459|FG000|Follow-up|Withdrawal by Subject|0|||
154918113|NCT02452892|559122460|FG001|Follow-up|Withdrawal by Subject|0|||
154918114|NCT02452892|559122461|FG002|Follow-up|Withdrawal by Subject|0|||
154918115|NCT02452892|559122462|FG003|Follow-up|Withdrawal by Subject|1|||
154918116|NCT02452892|559122459|FG000|Follow-up|Subject left town on Day 42|1|||
154918117|NCT02452892|559122460|FG001|Follow-up|Subject left town on Day 42|0|||
154918118|NCT02452892|559122461|FG002|Follow-up|Subject left town on Day 42|0|||
154918119|NCT02452892|559122462|FG003|Follow-up|Subject left town on Day 42|0|||
154918120|NCT05047601|559122470|FG000|Overall Study|Lost to Follow-up|9|||
154918121|NCT05047601|559122471|FG001|Overall Study|Lost to Follow-up|11|||
154918122|NCT05047601|559122472|FG002|Overall Study|Lost to Follow-up|7|||
154918123|NCT05047601|559122470|FG000|Overall Study|Withdrawal by Subject|25|||
154918124|NCT05047601|559122471|FG001|Overall Study|Withdrawal by Subject|36|||
154918125|NCT05047601|559122472|FG002|Overall Study|Withdrawal by Subject|23|||
154918126|NCT05047601|559122470|FG000|Overall Study|Other|10|||
154918127|NCT05047601|559122471|FG001|Overall Study|Other|6|||
154918128|NCT05047601|559122472|FG002|Overall Study|Other|5|||
154918129|NCT00302731|559122485|FG000|Overall Study|Lost to Follow-up|1|||
154918130|NCT00302731|559122486|FG001|Overall Study|Lost to Follow-up|2|||
154918131|NCT00302731|559122487|FG002|Overall Study|Lost to Follow-up|0|||
154918132|NCT00302731|559122488|FG003|Overall Study|Lost to Follow-up|0|||
154918133|NCT00302731|559122485|FG000|Overall Study|Adverse Event|0|||
154918134|NCT00302731|559122486|FG001|Overall Study|Adverse Event|2|||
154918135|NCT00302731|559122487|FG002|Overall Study|Adverse Event|2|||
154918136|NCT00302731|559122488|FG003|Overall Study|Adverse Event|0|||
154918137|NCT00302731|559122485|FG000|Overall Study|Withdrawal by Subject|1|||
154918138|NCT00302731|559122486|FG001|Overall Study|Withdrawal by Subject|1|||
154918139|NCT00302731|559122487|FG002|Overall Study|Withdrawal by Subject|0|||
154918140|NCT00302731|559122488|FG003|Overall Study|Withdrawal by Subject|0|||
154918141|NCT00302731|559122485|FG000|Overall Study|Protocol Violation|1|||
154918142|NCT00302731|559122486|FG001|Overall Study|Protocol Violation|0|||
154918143|NCT00302731|559122487|FG002|Overall Study|Protocol Violation|0|||
154918144|NCT00302731|559122488|FG003|Overall Study|Protocol Violation|0|||
154918145|NCT00302731|559122485|FG000|Overall Study|cancer unrelated to study discovered|1|||
154918146|NCT00302731|559122486|FG001|Overall Study|cancer unrelated to study discovered|0|||
154918147|NCT00302731|559122487|FG002|Overall Study|cancer unrelated to study discovered|1|||
154918148|NCT00302731|559122488|FG003|Overall Study|cancer unrelated to study discovered|0|||
154918149|NCT00252499|559122489|FG000|Overall Study|Lost to Follow-up|1|||
154918150|NCT00252499|559122490|FG001|Overall Study|Lost to Follow-up|0|||
154918151|NCT00252499|559122491|FG002|Overall Study|Lost to Follow-up|0|||
154918152|NCT03137173|559122492|FG000|Overall Study|Withdrawal by Subject|8|||
154918153|NCT03137173|559122493|FG001|Overall Study|Withdrawal by Subject|13|||
154918154|NCT03137173|559122492|FG000|Overall Study|Death|1|||
154918155|NCT03137173|559122493|FG001|Overall Study|Death|3|||
154918156|NCT03137173|559122492|FG000|Overall Study|Physician Decision|1|||
154918157|NCT03137173|559122493|FG001|Overall Study|Physician Decision|0|||
154918158|NCT03137173|559122492|FG000|Overall Study|Lost to Follow-up|13|||
154918159|NCT03137173|559122493|FG001|Overall Study|Lost to Follow-up|18|||
154918160|NCT03137173|559122492|FG000|Overall Study|Other reasons|3|||
154994375|NCT01154816|559405329|FG009|Overall Study|Adverse Event|0|||
154994376|NCT01154816|559405330|FG010|Overall Study|Adverse Event|0|||
154994377|NCT01154816|559405331|FG011|Overall Study|Adverse Event|0|||
154994378|NCT00806286|559405332|FG000|Overall Study|Adverse Event|5|||
154994379|NCT00806286|559405333|FG001|Overall Study|Adverse Event|2|||
154994380|NCT00806286|559405334|FG002|Overall Study|Adverse Event|0|||
154994381|NCT00806286|559405332|FG000|Overall Study|Disease progression|31|||
154994382|NCT00806286|559405333|FG001|Overall Study|Disease progression|38|||
154994383|NCT00806286|559405334|FG002|Overall Study|Disease progression|1|||
154994384|NCT00806286|559405332|FG000|Overall Study|Death|1|||
154994385|NCT00806286|559405333|FG001|Overall Study|Death|6|||
154994386|NCT00806286|559405334|FG002|Overall Study|Death|0|||
154994387|NCT00806286|559405332|FG000|Overall Study|Lost to Follow-up|0|||
154994388|NCT00806286|559405333|FG001|Overall Study|Lost to Follow-up|1|||
154994389|NCT00806286|559405334|FG002|Overall Study|Lost to Follow-up|0|||
154994390|NCT00806286|559405332|FG000|Overall Study|Withdrawal by Subject|8|||
154994391|NCT00806286|559405333|FG001|Overall Study|Withdrawal by Subject|3|||
154994392|NCT00806286|559405334|FG002|Overall Study|Withdrawal by Subject|1|||
154994393|NCT00806286|559405332|FG000|Overall Study|Physician Decision|2|||
154994394|NCT00806286|559405333|FG001|Overall Study|Physician Decision|2|||
154994395|NCT00806286|559405334|FG002|Overall Study|Physician Decision|0|||
154994396|NCT00806286|559405332|FG000|Overall Study|Due to a variety of reasons|7|||
154994397|NCT00806286|559405333|FG001|Overall Study|Due to a variety of reasons|2|||
154994398|NCT00806286|559405334|FG002|Overall Study|Due to a variety of reasons|1|||
154994399|NCT00686075|559405335|FG000|Overall Study|Withdrawal by Subject|4|||
154994400|NCT00686075|559405336|FG001|Overall Study|Withdrawal by Subject|3|||
154994401|NCT00686075|559405337|FG002|Overall Study|Withdrawal by Subject|3|||
154994402|NCT00686075|559405338|FG003|Overall Study|Withdrawal by Subject|7|||
154994403|NCT00686075|559405339|FG004|Overall Study|Withdrawal by Subject|1|||
154994404|NCT00686075|559405340|FG005|Overall Study|Withdrawal by Subject|0|||
154994405|NCT00686075|559405341|FG006|Overall Study|Withdrawal by Subject|0|||
154994406|NCT00686075|559405342|FG007|Overall Study|Withdrawal by Subject|2|||
154994407|NCT00686075|559405343|FG008|Overall Study|Withdrawal by Subject|4|||
154994408|NCT00686075|559405344|FG009|Overall Study|Withdrawal by Subject|6|||
154994409|NCT00686075|559405335|FG000|Overall Study|Lost to Follow-up|3|||
154994410|NCT00686075|559405336|FG001|Overall Study|Lost to Follow-up|6|||
154994411|NCT00686075|559405337|FG002|Overall Study|Lost to Follow-up|3|||
154994412|NCT00686075|559405338|FG003|Overall Study|Lost to Follow-up|2|||
154994413|NCT00686075|559405339|FG004|Overall Study|Lost to Follow-up|3|||
154994414|NCT00686075|559405340|FG005|Overall Study|Lost to Follow-up|3|||
154994415|NCT00686075|559405341|FG006|Overall Study|Lost to Follow-up|0|||
154994416|NCT00686075|559405342|FG007|Overall Study|Lost to Follow-up|0|||
154994417|NCT00686075|559405343|FG008|Overall Study|Lost to Follow-up|2|||
154994418|NCT00686075|559405344|FG009|Overall Study|Lost to Follow-up|3|||
154994419|NCT00686075|559405335|FG000|Overall Study|Other|1|||
154994420|NCT00686075|559405336|FG001|Overall Study|Other|1|||
154994421|NCT00686075|559405337|FG002|Overall Study|Other|0|||
154994422|NCT00686075|559405338|FG003|Overall Study|Other|0|||
154994423|NCT00686075|559405339|FG004|Overall Study|Other|0|||
154994424|NCT00686075|559405340|FG005|Overall Study|Other|0|||
154994425|NCT00686075|559405341|FG006|Overall Study|Other|0|||
154994426|NCT00686075|559405342|FG007|Overall Study|Other|0|||
154994427|NCT00686075|559405343|FG008|Overall Study|Other|0|||
155177664|NCT01894568|560088300|FG000|Overall Study|Adverse Event|2|||
154994428|NCT00686075|559405344|FG009|Overall Study|Other|1|||
154994429|NCT00977379|559405345|FG000|Overall Study|Withdrawal by Subject|1|||
154994430|NCT00977379|559405346|FG001|Overall Study|Withdrawal by Subject|1|||
154994431|NCT00977379|559405345|FG000|Overall Study|Death|7|||
154994432|NCT00977379|559405346|FG001|Overall Study|Death|9|||
154994433|NCT00977379|559405345|FG000|Overall Study|Premature Study Termination|4|||
154994434|NCT00977379|559405346|FG001|Overall Study|Premature Study Termination|0|||
154994435|NCT00977379|559405345|FG000|Overall Study|Participant Moving House|0|||
154994436|NCT00977379|559405346|FG001|Overall Study|Participant Moving House|1|||
154994437|NCT00977379|559405345|FG000|Overall Study|Randomization Error|0|||
154994438|NCT00977379|559405346|FG001|Overall Study|Randomization Error|1|||
154994439|NCT02006693|559405347|FG000|Overall Study|No Reason Specified|6|||
154994440|NCT02006693|559405348|FG001|Overall Study|No Reason Specified|8|||
154994441|NCT02006693|559405347|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
154994442|NCT02006693|559405348|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
155122016|NCT01166373|559877896|FG000|Overall Study|Withdrawal by Subject|1|||
155122017|NCT01166373|559877897|FG001|Overall Study|Withdrawal by Subject|2|||
155122018|NCT01166373|559877898|FG002|Overall Study|Withdrawal by Subject|2|||
155122019|NCT01166373|559877899|FG003|Overall Study|Withdrawal by Subject|3|||
155122020|NCT01166373|559877896|FG000|Overall Study|Physician Decision|1|||
155122021|NCT01166373|559877897|FG001|Overall Study|Physician Decision|0|||
155122022|NCT01166373|559877898|FG002|Overall Study|Physician Decision|0|||
155122023|NCT01166373|559877899|FG003|Overall Study|Physician Decision|0|||
154994443|NCT02006693|559405347|FG000|Overall Study|XEN Implant Explantation|0|||
154994444|NCT02006693|559405348|FG001|Overall Study|XEN Implant Explantation|1|||
155122024|NCT02498067|559877900|FG000|Overall Study|Lost to Follow-up|22|||
154994445|NCT02006693|559405347|FG000|Overall Study|Death|2|||
154994446|NCT02006693|559405348|FG001|Overall Study|Death|2|||
154994447|NCT02006693|559405347|FG000|Overall Study|Lost to Follow-up|4|||
154994448|NCT02006693|559405348|FG001|Overall Study|Lost to Follow-up|1|||
154994449|NCT02006693|559405347|FG000|Overall Study|Patient Decision|4|||
154994450|NCT02006693|559405348|FG001|Overall Study|Patient Decision|0|||
154994451|NCT01119508|559405349|FG000|Overall Study|Adverse Event|56|||
154994452|NCT01119508|559405349|FG000|Overall Study|Withdrawal by Subject|2|||
154994453|NCT01119508|559405349|FG000|Overall Study|Died before tumor response evaluation|1|||
154994454|NCT00265395|559405350|FG000|Overall Study|Adverse Event|3|||
154994455|NCT00265395|559405351|FG001|Overall Study|Adverse Event|6|||
154994456|NCT00265395|559405350|FG000|Overall Study|Lost to Follow-up|2|||
154994457|NCT00265395|559405351|FG001|Overall Study|Lost to Follow-up|1|||
154994458|NCT00265395|559405350|FG000|Overall Study|Withdrawal by Subject|1|||
154994459|NCT00265395|559405351|FG001|Overall Study|Withdrawal by Subject|6|||
154994460|NCT00265395|559405350|FG000|Overall Study|Protocol Violation|2|||
154994461|NCT00265395|559405351|FG001|Overall Study|Protocol Violation|2|||
154994462|NCT00265395|559405350|FG000|Overall Study|Lack of Efficacy|0|||
154994463|NCT00265395|559405351|FG001|Overall Study|Lack of Efficacy|1|||
154994464|NCT00265395|559405350|FG000|Overall Study|Administrative|0|||
154994465|NCT00265395|559405351|FG001|Overall Study|Administrative|1|||
154994466|NCT02563106|559405354|FG000|Overall Study|Withdrawal by Subject|7|||
154994467|NCT02563106|559405355|FG001|Overall Study|Withdrawal by Subject|8|||
154994468|NCT02563106|559405354|FG000|Overall Study|Adverse Event|17|||
154994469|NCT02563106|559405355|FG001|Overall Study|Adverse Event|15|||
154994470|NCT02563106|559405354|FG000|Overall Study|Protocol Violation|1|||
154994471|NCT02563106|559405355|FG001|Overall Study|Protocol Violation|0|||
154994472|NCT02563106|559405354|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
154994473|NCT02563106|559405355|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
154994474|NCT02563106|559405354|FG000|Overall Study|Lost to Follow-up|3|||
154994475|NCT02563106|559405355|FG001|Overall Study|Lost to Follow-up|2|||
154994476|NCT02563106|559405354|FG000|Overall Study|Physician Decision|3|||
154994477|NCT02563106|559405355|FG001|Overall Study|Physician Decision|1|||
154994478|NCT02563106|559405354|FG000|Overall Study|Other reason - not specified|2|||
154994479|NCT02563106|559405355|FG001|Overall Study|Other reason - not specified|1|||
154994480|NCT02338193|559405356|FG000|Overall Study|Withdrawal by Subject|0|||
154994481|NCT02338193|559405357|FG001|Overall Study|Withdrawal by Subject|0|||
154994482|NCT02338193|559405358|FG002|Overall Study|Withdrawal by Subject|2|||
154994483|NCT02338193|559405356|FG000|Overall Study|Pregnancy|0|||
154994484|NCT02338193|559405357|FG001|Overall Study|Pregnancy|1|||
154994485|NCT02338193|559405358|FG002|Overall Study|Pregnancy|1|||
154994486|NCT02338193|559405356|FG000|Overall Study|Noncompliant with visits|2|||
154994487|NCT02338193|559405357|FG001|Overall Study|Noncompliant with visits|2|||
154994488|NCT02338193|559405358|FG002|Overall Study|Noncompliant with visits|7|||
154994489|NCT02338193|559405356|FG000|Overall Study|moved out of state|0|||
154994490|NCT02338193|559405357|FG001|Overall Study|moved out of state|1|||
154994491|NCT02338193|559405358|FG002|Overall Study|moved out of state|0|||
154994492|NCT02338193|559405356|FG000|Overall Study|intolerant of side effects|1|||
154994493|NCT02338193|559405357|FG001|Overall Study|intolerant of side effects|0|||
154994494|NCT02338193|559405358|FG002|Overall Study|intolerant of side effects|0|||
154994495|NCT01136967|559405359|FG000|Overall Study|Adverse Event|9|||
154994496|NCT01136967|559405360|FG001|Overall Study|Adverse Event|12|||
154994497|NCT01136967|559405359|FG000|Overall Study|Participant Choice|8|||
154994498|NCT01136967|559405360|FG001|Overall Study|Participant Choice|3|||
154994499|NCT01136967|559405359|FG000|Overall Study|Lost to Follow-up|0|||
154994500|NCT01136967|559405360|FG001|Overall Study|Lost to Follow-up|1|||
154994501|NCT01136967|559405359|FG000|Overall Study|Withdrawal by Subject|1|||
154994502|NCT01136967|559405360|FG001|Overall Study|Withdrawal by Subject|2|||
154994503|NCT01136967|559405359|FG000|Overall Study|Clinical Progression|3|||
154994504|NCT01136967|559405360|FG001|Overall Study|Clinical Progression|5|||
154994505|NCT01136967|559405359|FG000|Overall Study|Radiation|1|||
154994506|NCT01136967|559405360|FG001|Overall Study|Radiation|0|||
154994507|NCT01136967|559405359|FG000|Overall Study|Non-compliance|1|||
154994508|NCT01136967|559405360|FG001|Overall Study|Non-compliance|0|||
154994509|NCT01136967|559405359|FG000|Overall Study|Investigator's Choice|1|||
154994510|NCT01136967|559405360|FG001|Overall Study|Investigator's Choice|1|||
154994511|NCT01136967|559405359|FG000|Overall Study|Increase in Lesion Size|0|||
154994512|NCT01136967|559405360|FG001|Overall Study|Increase in Lesion Size|2|||
154994513|NCT01136967|559405359|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
154994514|NCT01136967|559405360|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
154994515|NCT01735955|559405365|FG000|Overall Study|Administrative problems|1|||
154994516|NCT01735955|559405365|FG000|Overall Study|Patient/guardian decision|1|||
154994517|NCT01735955|559405365|FG000|Overall Study|Patient withdrew consent|2|||
154994518|NCT01735955|559405365|FG000|Overall Study|Physician Decision|4|||
155177665|NCT01894568|560088301|FG001|Overall Study|Adverse Event|3|||
154994519|NCT01735955|559405365|FG000|Overall Study|Disease progression|24|||
154994520|NCT01735955|559405365|FG000|Overall Study|Adverse Event|5|||
154994521|NCT03839823|559405369|FG000|Overall Study|Adverse Event|8|||
154918161|NCT03137173|559122493|FG001|Overall Study|Other reasons|2|||
154918162|NCT01535638|559122494|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
154918163|NCT01535638|559122495|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
154918164|NCT01535638|559122496|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
154918165|NCT01535638|559122497|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
154918166|NCT01535638|559122498|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
154918167|NCT01535638|559122499|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
154918168|NCT01535638|559122494|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
154918169|NCT01535638|559122495|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
154918170|NCT01535638|559122496|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
154918171|NCT01535638|559122497|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
154918172|NCT01535638|559122498|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
154918173|NCT01535638|559122499|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
154918174|NCT03702166|559122500|FG000|Overall Study|Lost to Follow-up|1|||
154918175|NCT03702166|559122500|FG000|Overall Study|Withdrawal by Subject|1|||
154918176|NCT00434876|559122506|FG000|Overall Study|Lost to Follow-up|1|||
154918177|NCT00434876|559122507|FG001|Overall Study|Lost to Follow-up|1|||
154918178|NCT03159455|559124784|FG000|Overall Study|Adverse Event|0|||
154918179|NCT03159455|559124785|FG001|Overall Study|Adverse Event|0|||
154918180|NCT03159455|559124786|FG002|Overall Study|Adverse Event|0|||
154918181|NCT03159455|559124787|FG003|Overall Study|Adverse Event|0|||
154918182|NCT03159455|559124788|FG004|Overall Study|Adverse Event|0|||
154918183|NCT03159455|559124789|FG005|Overall Study|Adverse Event|1|||
154918184|NCT02713490|559124792|FG000|Overall Study|Withdrawal by Subject|2|||
154918185|NCT02713490|559124793|FG001|Overall Study|Withdrawal by Subject|1|||
154918186|NCT02713490|559124792|FG000|Overall Study|Did not receive study drug|1|||
154918187|NCT02713490|559124793|FG001|Overall Study|Did not receive study drug|0|||
154918188|NCT02713490|559124792|FG000|Overall Study|Met exclusion criteria|0|||
154918189|NCT02713490|559124793|FG001|Overall Study|Met exclusion criteria|1|||
154918190|NCT01714726|559124794|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
154918191|NCT01714726|559124795|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
154918192|NCT01714726|559124796|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
154918193|NCT01714726|559124797|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
154918194|NCT01714726|559124794|FG000|Double-Blinded Induction Period|Adverse Event|0|||
154918195|NCT01714726|559124795|FG001|Double-Blinded Induction Period|Adverse Event|1|||
154918196|NCT01714726|559124796|FG002|Double-Blinded Induction Period|Adverse Event|0|||
154918197|NCT01714726|559124797|FG003|Double-Blinded Induction Period|Adverse Event|0|||
154918198|NCT01714726|559124794|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
154918199|NCT01714726|559124795|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
154918200|NCT01714726|559124796|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
154918201|NCT01714726|559124797|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
154918202|NCT01714726|559124794|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
154918203|NCT01714726|559124795|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
154918204|NCT01714726|559124796|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
154918205|NCT01714726|559124797|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
154918206|NCT01714726|559124794|FG000|Open-Label Period|Other|0|||
154918207|NCT01714726|559124795|FG001|Open-Label Period|Other|0|||
154918208|NCT01714726|559124796|FG002|Open-Label Period|Other|1|||
154918209|NCT01714726|559124797|FG003|Open-Label Period|Other|3|||
154918210|NCT01714726|559124794|FG000|Open-Label Period|Adverse Event|0|||
154918211|NCT01714726|559124795|FG001|Open-Label Period|Adverse Event|0|||
154918212|NCT01714726|559124796|FG002|Open-Label Period|Adverse Event|1|||
154918213|NCT01714726|559124797|FG003|Open-Label Period|Adverse Event|0|||
154918214|NCT01714726|559124794|FG000|Open-Label Period|Withdrawal by Subject|0|||
154918215|NCT01714726|559124795|FG001|Open-Label Period|Withdrawal by Subject|0|||
154918216|NCT01714726|559124796|FG002|Open-Label Period|Withdrawal by Subject|9|||
154918217|NCT01714726|559124797|FG003|Open-Label Period|Withdrawal by Subject|19|||
154918218|NCT01714726|559124794|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
154918219|NCT01714726|559124795|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
154918220|NCT01714726|559124796|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
154918221|NCT01714726|559124797|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
154918222|NCT01714726|559124794|FG000|Open-Label Period|Lost to Follow-up|0|||
154918223|NCT01714726|559124795|FG001|Open-Label Period|Lost to Follow-up|0|||
154918224|NCT01714726|559124796|FG002|Open-Label Period|Lost to Follow-up|3|||
154918225|NCT01714726|559124797|FG003|Open-Label Period|Lost to Follow-up|4|||
154918226|NCT00501969|559124798|FG000|Overall Study|Major Protocol Violation|4|||
154918227|NCT00501969|559124798|FG000|Overall Study|Lack of Efficacy|29|||
154918228|NCT00501969|559124798|FG000|Overall Study|Adverse Event|76|||
154918229|NCT00501969|559124798|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
154918230|NCT00501969|559124798|FG000|Overall Study|Subject withdrew consent|51|||
154918231|NCT00501969|559124798|FG000|Overall Study|Lost to Follow-up|4|||
154918232|NCT00501969|559124798|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
154918233|NCT00501969|559124798|FG000|Overall Study|Other: Sponsors Request|10|||
154994522|NCT03839823|559405370|FG001|Overall Study|Adverse Event|4|||
154994523|NCT03839823|559405369|FG000|Overall Study|Death|1|||
154994524|NCT03839823|559405370|FG001|Overall Study|Death|0|||
154994525|NCT03839823|559405369|FG000|Overall Study|Physician Decision|1|||
154994526|NCT03839823|559405370|FG001|Overall Study|Physician Decision|5|||
154994527|NCT03839823|559405369|FG000|Overall Study|Progressive Disease (PD)|65|||
154994528|NCT03839823|559405370|FG001|Overall Study|Progressive Disease (PD)|65|||
154994529|NCT03839823|559405369|FG000|Overall Study|Subject Decision|2|||
154994530|NCT03839823|559405370|FG001|Overall Study|Subject Decision|9|||
154994531|NCT03839823|559405369|FG000|Overall Study|Not Treated|0|||
154994532|NCT03839823|559405370|FG001|Overall Study|Not Treated|10|||
154994533|NCT01716715|559405371|FG000|Overall Study|Never Treated|2|||
154994534|NCT01716715|559405372|FG001|Overall Study|Never Treated|4|||
154994535|NCT03511326|559405379|FG000|Overall Study|Withdrawal by Subject|1|||
154994536|NCT04058067|559405382|FG000|Overall Study|Adverse Event|2|||
154994537|NCT04058067|559405383|FG001|Overall Study|Adverse Event|0|||
154994538|NCT04058067|559405382|FG000|Overall Study|Death|0|||
154994539|NCT04058067|559405383|FG001|Overall Study|Death|1|||
154994540|NCT04058067|559405382|FG000|Overall Study|Physician Decision|3|||
154994541|NCT04058067|559405383|FG001|Overall Study|Physician Decision|1|||
154994542|NCT04058067|559405382|FG000|Overall Study|Protocol Violation|0|||
154994543|NCT04058067|559405383|FG001|Overall Study|Protocol Violation|1|||
154994544|NCT04058067|559405382|FG000|Overall Study|Withdrawal by Subject|7|||
154994545|NCT04058067|559405383|FG001|Overall Study|Withdrawal by Subject|8|||
154994546|NCT01001988|559405393|FG000|Overall Study|Protocol Violation|84|||
154994547|NCT01001988|559405393|FG000|Overall Study|Withdrawal by Subject|18|||
154994548|NCT01001988|559405393|FG000|Overall Study|Lost to Follow-up|15|||
154994549|NCT01844856|559405394|FG000|Overall Study|Lost to Follow-up|15|||
154994550|NCT01844856|559405395|FG001|Overall Study|Lost to Follow-up|3|||
154994551|NCT01844856|559405394|FG000|Overall Study|Adverse Event|3|||
154994552|NCT01844856|559405395|FG001|Overall Study|Adverse Event|6|||
154994553|NCT01844856|559405394|FG000|Overall Study|Withdrawal by Subject|3|||
154994554|NCT01844856|559405395|FG001|Overall Study|Withdrawal by Subject|2|||
154994555|NCT01844856|559405394|FG000|Overall Study|Noncompliance|2|||
154994556|NCT01844856|559405395|FG001|Overall Study|Noncompliance|3|||
154994557|NCT01844856|559405394|FG000|Overall Study|Enterococcus Resistant|0|||
154994558|NCT01844856|559405395|FG001|Overall Study|Enterococcus Resistant|1|||
154994559|NCT01844856|559405394|FG000|Overall Study|Inadvertently Not Scheduled|1|||
154994560|NCT01844856|559405395|FG001|Overall Study|Inadvertently Not Scheduled|0|||
154994561|NCT01844856|559405394|FG000|Overall Study|Randomized but was a Screen Failure|0|||
154994562|NCT01844856|559405395|FG001|Overall Study|Randomized but was a Screen Failure|1|||
154994563|NCT00927394|559405398|FG000|Overall Study|Adverse Event|14|||
154994564|NCT00927394|559405399|FG001|Overall Study|Adverse Event|9|||
154994565|NCT00927394|559405398|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
154994566|NCT00927394|559405399|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
154994567|NCT00927394|559405398|FG000|Overall Study|Withdrawal by Subject|20|||
154994568|NCT00927394|559405399|FG001|Overall Study|Withdrawal by Subject|24|||
154994569|NCT00927394|559405398|FG000|Overall Study|Lost to Follow-up|8|||
154994570|NCT00927394|559405399|FG001|Overall Study|Lost to Follow-up|14|||
154994571|NCT00927394|559405398|FG000|Overall Study|Administrative Problem|1|||
154994572|NCT00927394|559405399|FG001|Overall Study|Administrative Problem|0|||
154994573|NCT00927394|559405398|FG000|Overall Study|Death|1|||
154994574|NCT00927394|559405399|FG001|Overall Study|Death|1|||
154994575|NCT00927394|559405398|FG000|Overall Study|Protocol deviation|16|||
154994576|NCT00927394|559405399|FG001|Overall Study|Protocol deviation|13|||
154994577|NCT00927394|559405398|FG000|Overall Study|Randomized in error|0|||
154994578|NCT00927394|559405399|FG001|Overall Study|Randomized in error|1|||
154994579|NCT01221363|559405400|FG000|Overall Study|Pregnancy|1|||
154994580|NCT01221363|559405401|FG001|Overall Study|Pregnancy|0|||
154994581|NCT01221363|559405400|FG000|Overall Study|Withdrawal by Subject|11|||
154994582|NCT01221363|559405401|FG001|Overall Study|Withdrawal by Subject|5|||
154994583|NCT04628793|559405402|FG000|Overall Study|Study terminated by sponsor|0|||
154994584|NCT04628793|559405403|FG001|Overall Study|Study terminated by sponsor|0|||
154994585|NCT04628793|559405404|FG002|Overall Study|Study terminated by sponsor|8|||
154994586|NCT04628793|559405402|FG000|Overall Study|Withdrawal by Subject|2|||
154994587|NCT04628793|559405403|FG001|Overall Study|Withdrawal by Subject|3|||
154994588|NCT04628793|559405404|FG002|Overall Study|Withdrawal by Subject|0|||
154994589|NCT04628793|559405402|FG000|Overall Study|Lost to Follow-up|0|||
154994590|NCT04628793|559405403|FG001|Overall Study|Lost to Follow-up|1|||
154994591|NCT04628793|559405404|FG002|Overall Study|Lost to Follow-up|0|||
154994592|NCT01329549|559405410|FG000|Overall Study|Withdrawal by Subject|1|||
154994593|NCT01329549|559405410|FG000|Overall Study|Adverse Event|1|||
154994594|NCT03597529|559405413|FG000|Overall Study|Lost to Follow-up|10|||
154994595|NCT03597529|559405414|FG001|Overall Study|Lost to Follow-up|12|||
154994596|NCT03597529|559405413|FG000|Overall Study|Physician Decision|3|||
154994597|NCT03597529|559405414|FG001|Overall Study|Physician Decision|1|||
154994598|NCT03597529|559405413|FG000|Overall Study|Withdrawal by Subject|6|||
154994599|NCT03597529|559405414|FG001|Overall Study|Withdrawal by Subject|3|||
154994600|NCT03597529|559405413|FG000|Overall Study|Non-compliant with study activities|1|||
154994601|NCT03597529|559405414|FG001|Overall Study|Non-compliant with study activities|2|||
154994602|NCT01755767|559405417|FG000|Overall Study|Progressive Disease|8|||
154994603|NCT01755767|559405418|FG001|Overall Study|Progressive Disease|7|||
154994604|NCT01755767|559405419|FG002|Overall Study|Progressive Disease|91|||
154994605|NCT01755767|559405420|FG003|Overall Study|Progressive Disease|43|||
154994606|NCT01755767|559405417|FG000|Overall Study|Clinical Disease Progression|4|||
154994607|NCT01755767|559405418|FG001|Overall Study|Clinical Disease Progression|2|||
154994608|NCT01755767|559405419|FG002|Overall Study|Clinical Disease Progression|29|||
154994609|NCT01755767|559405420|FG003|Overall Study|Clinical Disease Progression|20|||
154994610|NCT01755767|559405417|FG000|Overall Study|Radiographic Disease Progression|9|||
154994611|NCT01755767|559405418|FG001|Overall Study|Radiographic Disease Progression|4|||
154994612|NCT01755767|559405419|FG002|Overall Study|Radiographic Disease Progression|44|||
154994613|NCT01755767|559405420|FG003|Overall Study|Radiographic Disease Progression|27|||
154994614|NCT01755767|559405417|FG000|Overall Study|Adverse Event|6|||
154994615|NCT01755767|559405418|FG001|Overall Study|Adverse Event|0|||
154994616|NCT01755767|559405419|FG002|Overall Study|Adverse Event|28|||
154994617|NCT01755767|559405420|FG003|Overall Study|Adverse Event|11|||
154994618|NCT01755767|559405417|FG000|Overall Study|Death|1|||
154994619|NCT01755767|559405418|FG001|Overall Study|Death|2|||
154994620|NCT01755767|559405419|FG002|Overall Study|Death|15|||
154994621|NCT01755767|559405420|FG003|Overall Study|Death|4|||
154994622|NCT01755767|559405417|FG000|Overall Study|Subject Decision|0|||
154994623|NCT01755767|559405418|FG001|Overall Study|Subject Decision|0|||
154994624|NCT01755767|559405419|FG002|Overall Study|Subject Decision|10|||
154994625|NCT01755767|559405420|FG003|Overall Study|Subject Decision|3|||
154994626|NCT01755767|559405417|FG000|Overall Study|Withdrawal by Subject|0|||
154994627|NCT01755767|559405418|FG001|Overall Study|Withdrawal by Subject|0|||
154994628|NCT01755767|559405419|FG002|Overall Study|Withdrawal by Subject|2|||
154994629|NCT01755767|559405420|FG003|Overall Study|Withdrawal by Subject|1|||
154994630|NCT01755767|559405417|FG000|Overall Study|Other|0|||
154994631|NCT01755767|559405418|FG001|Overall Study|Other|0|||
154994632|NCT01755767|559405419|FG002|Overall Study|Other|2|||
154994633|NCT01755767|559405420|FG003|Overall Study|Other|3|||
154994634|NCT01755767|559405417|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
154994635|NCT01755767|559405418|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
154994636|NCT01755767|559405419|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
154994637|NCT01755767|559405420|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
154994638|NCT04623086|559405421|FG000|Overall Study|Withdrawal by Subject|0|||
154994639|NCT04623086|559405422|FG001|Overall Study|Withdrawal by Subject|0|||
154994640|NCT04623086|559405423|FG002|Overall Study|Withdrawal by Subject|10|||
154994641|NCT00191165|559405424|FG000|Overall Study|Adverse Event|2|||
154994642|NCT00191165|559405425|FG001|Overall Study|Adverse Event|0|||
154994643|NCT00191165|559405424|FG000|Overall Study|Protocol Violation|0|||
154994644|NCT00191165|559405425|FG001|Overall Study|Protocol Violation|1|||
154994645|NCT00191165|559405424|FG000|Overall Study|Participant Moved Away|0|||
154994646|NCT00191165|559405425|FG001|Overall Study|Participant Moved Away|1|||
154994647|NCT00715624|559405426|FG000|Overall Study|Adverse Event|12|||
154994648|NCT00715624|559405427|FG001|Overall Study|Adverse Event|37|||
154994649|NCT00715624|559405426|FG000|Overall Study|Lack of Efficacy|11|||
154994650|NCT00715624|559405427|FG001|Overall Study|Lack of Efficacy|11|||
154994651|NCT00715624|559405426|FG000|Overall Study|Lost to Follow-up|1|||
154994652|NCT00715624|559405427|FG001|Overall Study|Lost to Follow-up|2|||
154994653|NCT00715624|559405426|FG000|Overall Study|Protocol Violation|1|||
154994654|NCT00715624|559405427|FG001|Overall Study|Protocol Violation|0|||
154994655|NCT00715624|559405426|FG000|Overall Study|Withdrawal by Subject|11|||
154994656|NCT00715624|559405427|FG001|Overall Study|Withdrawal by Subject|25|||
154994657|NCT00715624|559405426|FG000|Overall Study|Familial and personal reasons|10|||
154994658|NCT00715624|559405427|FG001|Overall Study|Familial and personal reasons|22|||
154994659|NCT00715624|559405426|FG000|Overall Study|Poor compliance|6|||
154994660|NCT00715624|559405427|FG001|Overall Study|Poor compliance|13|||
154994661|NCT00715624|559405426|FG000|Overall Study|Sponsor decision|0|||
154994662|NCT00715624|559405427|FG001|Overall Study|Sponsor decision|4|||
154994663|NCT00715624|559405426|FG000|Overall Study|Incorrect randomization (not treated)|0|||
154994664|NCT00715624|559405427|FG001|Overall Study|Incorrect randomization (not treated)|1|||
154994665|NCT00715624|559405426|FG000|Overall Study|Other|0|||
155122025|NCT02498067|559877900|FG000|Overall Study|Did not meet inclusion criteria|11|||
155122026|NCT01874275|559877901|FG000|Overall Study|Lost to Follow-up|1|||
155122027|NCT01874275|559877902|FG001|Overall Study|Lost to Follow-up|0|||
155122028|NCT03351114|559877903|FG000|Overall Study|Withdrawal by Subject|1|||
155122029|NCT01665430|559877904|FG000|Overall Study|Adverse Event|1|||
155122030|NCT01665430|559877904|FG000|Overall Study|Withdrawal by Subject|6|||
155122031|NCT01665430|559877904|FG000|Overall Study|Other Unspecified|2|||
155122032|NCT02310230|559877905|FG000|Overall Study|Physician Decision|1|||
154994666|NCT00715624|559405427|FG001|Overall Study|Other|1|||
154994667|NCT03200912|559405428|FG000|Overall Study|Adverse Event|3|||
154994668|NCT03200912|559405429|FG001|Overall Study|Adverse Event|0|||
154994669|NCT03200912|559405430|FG002|Overall Study|Adverse Event|0|||
155122033|NCT02310230|559877906|FG001|Overall Study|Physician Decision|3|||
154994670|NCT03200912|559405428|FG000|Overall Study|Withdrawal by Subject|1|||
154994671|NCT03200912|559405429|FG001|Overall Study|Withdrawal by Subject|2|||
154994672|NCT03200912|559405430|FG002|Overall Study|Withdrawal by Subject|4|||
154994673|NCT03200912|559405428|FG000|Overall Study|Non-compliance with study drug|0|||
154994674|NCT03200912|559405429|FG001|Overall Study|Non-compliance with study drug|1|||
154994675|NCT03200912|559405430|FG002|Overall Study|Non-compliance with study drug|0|||
154994676|NCT03196635|559405432|FG000|Overall Study|Withdrawal by Subject|1|||
154994677|NCT00587990|559405433|FG000|Overall Study|Death|0|||
154994678|NCT00587990|559405434|FG001|Overall Study|Death|0|||
154994679|NCT00587990|559405435|FG002|Overall Study|Death|1|||
154994680|NCT03334617|559405436|FG000|Overall Study|Adverse Event|0|||
154994681|NCT03334617|559405437|FG001|Overall Study|Adverse Event|0|||
154994682|NCT03334617|559405438|FG002|Overall Study|Adverse Event|0|||
154994683|NCT03334617|559405439|FG003|Overall Study|Adverse Event|0|||
154994684|NCT03334617|559405440|FG004|Overall Study|Adverse Event|0|||
154994685|NCT03334617|559405441|FG005|Overall Study|Adverse Event|0|||
154994686|NCT03334617|559405442|FG006|Overall Study|Adverse Event|0|||
154994687|NCT03334617|559405443|FG007|Overall Study|Adverse Event|0|||
154994688|NCT03334617|559405444|FG008|Overall Study|Adverse Event|1|||
154994689|NCT03334617|559405445|FG009|Overall Study|Adverse Event|0|||
154994690|NCT03334617|559405446|FG010|Overall Study|Adverse Event|0|||
154994691|NCT03334617|559405447|FG011|Overall Study|Adverse Event|0|||
154994692|NCT03334617|559405448|FG012|Overall Study|Adverse Event|1|||
154994693|NCT03334617|559405449|FG013|Overall Study|Adverse Event|0|||
154994694|NCT03334617|559405450|FG014|Overall Study|Adverse Event|0|||
154994695|NCT03334617|559405451|FG015|Overall Study|Adverse Event|0|||
154994696|NCT03334617|559405452|FG016|Overall Study|Adverse Event|0|||
154994697|NCT03334617|559405453|FG017|Overall Study|Adverse Event|0|||
154994698|NCT03334617|559405454|FG018|Overall Study|Adverse Event|0|||
154994699|NCT03334617|559405455|FG019|Overall Study|Adverse Event|0|||
154994700|NCT03334617|559405456|FG020|Overall Study|Adverse Event|0|||
154994701|NCT03334617|559405457|FG021|Overall Study|Adverse Event|0|||
154994702|NCT03334617|559405436|FG000|Overall Study|Death|18|||
154994703|NCT03334617|559405437|FG001|Overall Study|Death|18|||
154994704|NCT03334617|559405438|FG002|Overall Study|Death|20|||
154994705|NCT03334617|559405439|FG003|Overall Study|Death|21|||
154994706|NCT03334617|559405440|FG004|Overall Study|Death|20|||
154994707|NCT03334617|559405441|FG005|Overall Study|Death|16|||
154994708|NCT03334617|559405442|FG006|Overall Study|Death|28|||
154994709|NCT03334617|559405443|FG007|Overall Study|Death|35|||
154994710|NCT03334617|559405444|FG008|Overall Study|Death|47|||
154994711|NCT03334617|559405445|FG009|Overall Study|Death|0|||
154994712|NCT03334617|559405446|FG010|Overall Study|Death|19|||
154994713|NCT03334617|559405447|FG011|Overall Study|Death|6|||
154994714|NCT03334617|559405448|FG012|Overall Study|Death|20|||
154994715|NCT03334617|559405449|FG013|Overall Study|Death|22|||
154994716|NCT03334617|559405450|FG014|Overall Study|Death|17|||
154994717|NCT03334617|559405451|FG015|Overall Study|Death|18|||
154994718|NCT03334617|559405452|FG016|Overall Study|Death|12|||
154994719|NCT03334617|559405453|FG017|Overall Study|Death|15|||
154994720|NCT03334617|559405454|FG018|Overall Study|Death|16|||
154994721|NCT03334617|559405455|FG019|Overall Study|Death|27|||
154994722|NCT03334617|559405456|FG020|Overall Study|Death|14|||
154994723|NCT03334617|559405457|FG021|Overall Study|Death|27|||
154994724|NCT03334617|559405436|FG000|Overall Study|Lost to Follow-up|0|||
154994725|NCT03334617|559405437|FG001|Overall Study|Lost to Follow-up|0|||
154994726|NCT03334617|559405438|FG002|Overall Study|Lost to Follow-up|0|||
154994727|NCT03334617|559405439|FG003|Overall Study|Lost to Follow-up|1|||
154994728|NCT03334617|559405440|FG004|Overall Study|Lost to Follow-up|0|||
154994729|NCT03334617|559405441|FG005|Overall Study|Lost to Follow-up|1|||
154994730|NCT03334617|559405442|FG006|Overall Study|Lost to Follow-up|0|||
154994731|NCT03334617|559405443|FG007|Overall Study|Lost to Follow-up|0|||
154994732|NCT03334617|559405444|FG008|Overall Study|Lost to Follow-up|1|||
154994733|NCT03334617|559405445|FG009|Overall Study|Lost to Follow-up|0|||
154994734|NCT03334617|559405446|FG010|Overall Study|Lost to Follow-up|0|||
154994735|NCT03334617|559405447|FG011|Overall Study|Lost to Follow-up|0|||
154994736|NCT03334617|559405448|FG012|Overall Study|Lost to Follow-up|0|||
154994737|NCT03334617|559405449|FG013|Overall Study|Lost to Follow-up|0|||
154994738|NCT03334617|559405450|FG014|Overall Study|Lost to Follow-up|0|||
154994739|NCT03334617|559405451|FG015|Overall Study|Lost to Follow-up|0|||
154994740|NCT03334617|559405452|FG016|Overall Study|Lost to Follow-up|0|||
154994741|NCT03334617|559405453|FG017|Overall Study|Lost to Follow-up|0|||
154994742|NCT03334617|559405454|FG018|Overall Study|Lost to Follow-up|0|||
154994743|NCT03334617|559405455|FG019|Overall Study|Lost to Follow-up|0|||
154994744|NCT03334617|559405456|FG020|Overall Study|Lost to Follow-up|0|||
154994745|NCT03334617|559405457|FG021|Overall Study|Lost to Follow-up|0|||
154994746|NCT03334617|559405436|FG000|Overall Study|Withdrawal by Subject|0|||
154994747|NCT03334617|559405437|FG001|Overall Study|Withdrawal by Subject|1|||
154994748|NCT03334617|559405438|FG002|Overall Study|Withdrawal by Subject|0|||
154994749|NCT03334617|559405439|FG003|Overall Study|Withdrawal by Subject|0|||
154994750|NCT03334617|559405440|FG004|Overall Study|Withdrawal by Subject|1|||
154994751|NCT03334617|559405441|FG005|Overall Study|Withdrawal by Subject|1|||
154994752|NCT03334617|559405442|FG006|Overall Study|Withdrawal by Subject|1|||
154994753|NCT03334617|559405443|FG007|Overall Study|Withdrawal by Subject|2|||
154994754|NCT03334617|559405444|FG008|Overall Study|Withdrawal by Subject|0|||
154994755|NCT03334617|559405445|FG009|Overall Study|Withdrawal by Subject|0|||
154994756|NCT03334617|559405446|FG010|Overall Study|Withdrawal by Subject|0|||
154994757|NCT03334617|559405447|FG011|Overall Study|Withdrawal by Subject|1|||
154994758|NCT03334617|559405448|FG012|Overall Study|Withdrawal by Subject|1|||
154994759|NCT03334617|559405449|FG013|Overall Study|Withdrawal by Subject|0|||
154994760|NCT03334617|559405450|FG014|Overall Study|Withdrawal by Subject|2|||
154994761|NCT03334617|559405451|FG015|Overall Study|Withdrawal by Subject|1|||
154994762|NCT03334617|559405452|FG016|Overall Study|Withdrawal by Subject|0|||
154994763|NCT03334617|559405453|FG017|Overall Study|Withdrawal by Subject|1|||
154994764|NCT03334617|559405454|FG018|Overall Study|Withdrawal by Subject|1|||
154994765|NCT03334617|559405455|FG019|Overall Study|Withdrawal by Subject|1|||
154994766|NCT03334617|559405456|FG020|Overall Study|Withdrawal by Subject|0|||
154994767|NCT03334617|559405457|FG021|Overall Study|Withdrawal by Subject|1|||
154994768|NCT03334617|559405436|FG000|Overall Study|Other|1|||
154994769|NCT03334617|559405437|FG001|Overall Study|Other|2|||
154994770|NCT03334617|559405438|FG002|Overall Study|Other|0|||
154994771|NCT03334617|559405439|FG003|Overall Study|Other|1|||
154994772|NCT03334617|559405440|FG004|Overall Study|Other|1|||
154994773|NCT03334617|559405441|FG005|Overall Study|Other|0|||
154994774|NCT03334617|559405442|FG006|Overall Study|Other|2|||
154994775|NCT03334617|559405443|FG007|Overall Study|Other|1|||
154994776|NCT03334617|559405444|FG008|Overall Study|Other|8|||
154994777|NCT03334617|559405445|FG009|Overall Study|Other|0|||
154994778|NCT03334617|559405446|FG010|Overall Study|Other|3|||
154994779|NCT03334617|559405447|FG011|Overall Study|Other|1|||
154994780|NCT03334617|559405448|FG012|Overall Study|Other|3|||
154994781|NCT03334617|559405449|FG013|Overall Study|Other|1|||
154994782|NCT03334617|559405450|FG014|Overall Study|Other|1|||
154994783|NCT03334617|559405451|FG015|Overall Study|Other|3|||
154994784|NCT03334617|559405452|FG016|Overall Study|Other|3|||
154994785|NCT03334617|559405453|FG017|Overall Study|Other|3|||
154994786|NCT03334617|559405454|FG018|Overall Study|Other|7|||
154994787|NCT03334617|559405455|FG019|Overall Study|Other|4|||
154994788|NCT03334617|559405456|FG020|Overall Study|Other|1|||
154994789|NCT03334617|559405457|FG021|Overall Study|Other|4|||
154994790|NCT03334617|559405436|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
154994791|NCT03334617|559405437|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
154994792|NCT03334617|559405438|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
154994793|NCT03334617|559405439|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
154994794|NCT03334617|559405440|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
154994795|NCT03334617|559405441|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
154994796|NCT03334617|559405442|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
154994797|NCT03334617|559405443|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
154994798|NCT03334617|559405444|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
154994799|NCT03334617|559405445|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
154994800|NCT03334617|559405446|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
154994801|NCT03334617|559405447|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
154994802|NCT03334617|559405448|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
154994803|NCT03334617|559405449|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
154994804|NCT03334617|559405450|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
154994805|NCT03334617|559405451|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
154994806|NCT03334617|559405452|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
154994807|NCT03334617|559405453|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
154994808|NCT03334617|559405454|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
154994809|NCT03334617|559405455|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
154994810|NCT03334617|559405456|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
154994811|NCT03334617|559405457|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
154994812|NCT00513682|559405458|FG000|Washout Phase|Adverse Event|2|||
154994813|NCT02450526|559405459|FG000|DB Period (Cycle 1)|Adverse Event|0|||
154994814|NCT02450526|559405460|FG001|DB Period (Cycle 1)|Adverse Event|0|||
154994815|NCT02450526|559405461|FG002|DB Period (Cycle 1)|Adverse Event|2|||
154994816|NCT02450526|559405462|FG003|DB Period (Cycle 1)|Adverse Event|0|||
154994817|NCT02450526|559405463|FG004|DB Period (Cycle 1)|Adverse Event|0|||
154994818|NCT02450526|559405459|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
154994819|NCT02450526|559405460|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
154994820|NCT02450526|559405461|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
154994821|NCT02450526|559405462|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
154994822|NCT02450526|559405463|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
154994823|NCT02450526|559405459|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
154994824|NCT02450526|559405460|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
154994825|NCT02450526|559405461|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
155122034|NCT02310230|559877905|FG000|Overall Study|monitor baseline taken after induction|2|||
155122035|NCT02310230|559877906|FG001|Overall Study|monitor baseline taken after induction|7|||
155122036|NCT02310230|559877905|FG000|Overall Study|Poor signal quality|5|||
155122037|NCT02310230|559877906|FG001|Overall Study|Poor signal quality|8|||
155122038|NCT02310230|559877905|FG000|Overall Study|Case cancelled|1|||
155122039|NCT02310230|559877906|FG001|Overall Study|Case cancelled|0|||
155122040|NCT03249935|559877907|FG000|Overall Study|Discharged from facility early|36|||
155122041|NCT03249935|559877907|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
155122042|NCT03249935|559877907|FG000|Overall Study|Protocol Violation|5|||
155122043|NCT01135914|559877910|FG000|Overall Study|Withdrawal by Subject|1|||
155122044|NCT01135914|559877911|FG001|Overall Study|Withdrawal by Subject|3|||
155122045|NCT01135914|559877912|FG002|Overall Study|Withdrawal by Subject|6|||
155122046|NCT01135914|559877910|FG000|Overall Study|Lost to Follow-up|1|||
155122047|NCT01135914|559877911|FG001|Overall Study|Lost to Follow-up|0|||
155122048|NCT01135914|559877912|FG002|Overall Study|Lost to Follow-up|1|||
155122049|NCT01135914|559877910|FG000|Overall Study|Protocol Violation|0|||
155122050|NCT01135914|559877911|FG001|Overall Study|Protocol Violation|0|||
155122051|NCT01135914|559877912|FG002|Overall Study|Protocol Violation|3|||
155122052|NCT01135914|559877910|FG000|Overall Study|Lack of Efficacy|2|||
155122053|NCT01135914|559877911|FG001|Overall Study|Lack of Efficacy|1|||
155122054|NCT01135914|559877912|FG002|Overall Study|Lack of Efficacy|10|||
155122055|NCT01135914|559877910|FG000|Overall Study|Adverse Event|0|||
155122056|NCT01135914|559877911|FG001|Overall Study|Adverse Event|1|||
155122057|NCT01135914|559877912|FG002|Overall Study|Adverse Event|2|||
155122058|NCT02370641|559877915|FG000|Overall Study|dropped study|4|||
155122059|NCT02370641|559877916|FG001|Overall Study|dropped study|2|||
155122060|NCT02120365|559877919|FG000|Overall Study|Withdrawal by Subject|0|||
155122061|NCT02120365|559877920|FG001|Overall Study|Withdrawal by Subject|0|||
155122062|NCT02120365|559877921|FG002|Overall Study|Withdrawal by Subject|2|||
155122063|NCT02120365|559877922|FG003|Overall Study|Withdrawal by Subject|4|||
155122064|NCT02120365|559877923|FG004|Overall Study|Withdrawal by Subject|0|||
155122065|NCT02120365|559877924|FG005|Overall Study|Withdrawal by Subject|2|||
155122066|NCT02370095|559877926|FG000|Overall Study|Withdrawal by Subject|0|||
155122067|NCT02370095|559877927|FG001|Overall Study|Withdrawal by Subject|1|||
155122068|NCT02130986|559877928|FG000|Overall Study|Withdrawal by Subject|4|||
155122069|NCT02130986|559877929|FG001|Overall Study|Withdrawal by Subject|4|||
155122070|NCT02130986|559877928|FG000|Overall Study|Lost to Follow-up|151|||
155122071|NCT02130986|559877929|FG001|Overall Study|Lost to Follow-up|160|||
155122072|NCT01635764|559877930|FG000|Overall Study|Adverse Event|46|||
155122073|NCT01635764|559877930|FG000|Overall Study|Lack of Efficacy|76|||
155122074|NCT01635764|559877930|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
155122075|NCT01635764|559877930|FG000|Overall Study|Protocol Deviation|1|||
155122076|NCT01635764|559877930|FG000|Overall Study|Withdrew Consent|67|||
155122077|NCT01635764|559877930|FG000|Overall Study|Lost to Follow-up|53|||
155122078|NCT01635764|559877930|FG000|Overall Study|Other|28|||
155122079|NCT02305849|559877931|FG000|Overall Study|Adverse Event|10|||
155122080|NCT02305849|559877932|FG001|Overall Study|Adverse Event|12|||
155122081|NCT02305849|559877933|FG002|Overall Study|Adverse Event|7|||
155122082|NCT02305849|559877934|FG003|Overall Study|Adverse Event|3|||
155122083|NCT02305849|559877931|FG000|Overall Study|Lack of Efficacy|10|||
155122084|NCT02305849|559877932|FG001|Overall Study|Lack of Efficacy|6|||
155122085|NCT02305849|559877933|FG002|Overall Study|Lack of Efficacy|3|||
155122086|NCT02305849|559877934|FG003|Overall Study|Lack of Efficacy|9|||
155122087|NCT02305849|559877931|FG000|Overall Study|Withdrawal by Subject|2|||
155122088|NCT02305849|559877932|FG001|Overall Study|Withdrawal by Subject|2|||
155122089|NCT02305849|559877933|FG002|Overall Study|Withdrawal by Subject|1|||
155122090|NCT02305849|559877934|FG003|Overall Study|Withdrawal by Subject|4|||
155122091|NCT02305849|559877931|FG000|Overall Study|Lost to Follow-up|0|||
155122092|NCT02305849|559877932|FG001|Overall Study|Lost to Follow-up|2|||
155122093|NCT02305849|559877933|FG002|Overall Study|Lost to Follow-up|0|||
155122094|NCT02305849|559877934|FG003|Overall Study|Lost to Follow-up|0|||
155122095|NCT02305849|559877931|FG000|Overall Study|Protocol Violation|3|||
154918234|NCT00501969|559124798|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
154918235|NCT00501969|559124798|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
154918236|NCT00501969|559124798|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
155177666|NCT01894568|560088300|FG000|Overall Study|Protocol required discontinuation|2|||
155122096|NCT02305849|559877932|FG001|Overall Study|Protocol Violation|2|||
155122097|NCT02305849|559877933|FG002|Overall Study|Protocol Violation|1|||
155122098|NCT02305849|559877934|FG003|Overall Study|Protocol Violation|1|||
155122099|NCT02305849|559877931|FG000|Overall Study|Lab data met discontinuation criteria|0|||
155122100|NCT02305849|559877932|FG001|Overall Study|Lab data met discontinuation criteria|1|||
155122101|NCT02305849|559877933|FG002|Overall Study|Lab data met discontinuation criteria|2|||
155122102|NCT02305849|559877934|FG003|Overall Study|Lab data met discontinuation criteria|1|||
155122103|NCT02305849|559877931|FG000|Overall Study|Miscellaneous|1|||
155122104|NCT02305849|559877932|FG001|Overall Study|Miscellaneous|2|||
155122105|NCT02305849|559877933|FG002|Overall Study|Miscellaneous|4|||
155122106|NCT02305849|559877934|FG003|Overall Study|Miscellaneous|1|||
154994826|NCT02450526|559405462|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
154994827|NCT02450526|559405463|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
154994828|NCT02450526|559405459|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
154994829|NCT02450526|559405460|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
154994830|NCT02450526|559405461|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
154994831|NCT02450526|559405462|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
154994832|NCT02450526|559405463|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
154994833|NCT02450526|559405459|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
154994834|NCT02450526|559405460|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
154994835|NCT02450526|559405461|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
154994836|NCT02450526|559405462|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
154994837|NCT02450526|559405463|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
154994838|NCT02450526|559405459|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
154994839|NCT02450526|559405460|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
154994840|NCT02450526|559405461|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
154994841|NCT02450526|559405462|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
154994842|NCT02450526|559405463|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
154994843|NCT02450526|559405459|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
154994844|NCT02450526|559405460|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
154994845|NCT02450526|559405461|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
154994846|NCT02450526|559405462|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
154994847|NCT02450526|559405463|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
154994848|NCT02450526|559405459|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
154994849|NCT02450526|559405460|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
154994850|NCT02450526|559405461|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
154994851|NCT02450526|559405462|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
154994852|NCT02450526|559405463|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
154994853|NCT02722148|559405464|FG000|Overall Study|Lost to Follow-up|2|||
154994854|NCT02722148|559405464|FG000|Overall Study|Non compliant with treatment regimen|3|||
154994855|NCT00911807|559405465|FG000|Overall Study|Adverse Event|2|||
154994856|NCT00911807|559405466|FG001|Overall Study|Adverse Event|1|||
154994857|NCT00911807|559405467|FG002|Overall Study|Adverse Event|5|||
154994858|NCT00911807|559405465|FG000|Overall Study|Death|0|||
154994859|NCT00911807|559405466|FG001|Overall Study|Death|0|||
154994860|NCT00911807|559405467|FG002|Overall Study|Death|1|||
154994861|NCT00911807|559405465|FG000|Overall Study|Protocol Violation|6|||
154994862|NCT00911807|559405466|FG001|Overall Study|Protocol Violation|4|||
154994863|NCT00911807|559405467|FG002|Overall Study|Protocol Violation|9|||
154994864|NCT00911807|559405465|FG000|Overall Study|Withdrawal by Subject|8|||
154994865|NCT00911807|559405466|FG001|Overall Study|Withdrawal by Subject|10|||
154994866|NCT00911807|559405467|FG002|Overall Study|Withdrawal by Subject|7|||
154994867|NCT00911807|559405465|FG000|Overall Study|Organizational reasons|1|||
154994868|NCT00911807|559405466|FG001|Overall Study|Organizational reasons|3|||
154994869|NCT00911807|559405467|FG002|Overall Study|Organizational reasons|1|||
154994870|NCT00855803|559405469|FG000|Overall Study|Death|2|||
154994871|NCT00855803|559405469|FG000|Overall Study|Lost to Follow-up|2|||
154994872|NCT00855803|559405469|FG000|Overall Study|Technical inability to undergo procedure|2|||
154994873|NCT00855803|559405469|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
154994874|NCT00855803|559405469|FG000|Overall Study|Withdrawal by Subject|3|||
154994875|NCT00855803|559405469|FG000|Overall Study|Physician Decision|3|||
154994876|NCT04568031|559405472|FG000|Overall Study|Lost to Follow-up|1|||
154994877|NCT04568031|559405473|FG001|Overall Study|Lost to Follow-up|0|||
154994878|NCT04568031|559405474|FG002|Overall Study|Lost to Follow-up|0|||
154994879|NCT04568031|559405475|FG003|Overall Study|Lost to Follow-up|0|||
154994880|NCT04568031|559405472|FG000|Overall Study|Physician Decision|1|||
154994881|NCT04568031|559405473|FG001|Overall Study|Physician Decision|0|||
154994882|NCT04568031|559405474|FG002|Overall Study|Physician Decision|1|||
154994883|NCT04568031|559405475|FG003|Overall Study|Physician Decision|0|||
154994884|NCT04568031|559405472|FG000|Overall Study|Withdrawal by Subject|1|||
154994885|NCT04568031|559405473|FG001|Overall Study|Withdrawal by Subject|0|||
154994886|NCT04568031|559405474|FG002|Overall Study|Withdrawal by Subject|4|||
154994887|NCT04568031|559405475|FG003|Overall Study|Withdrawal by Subject|1|||
154994888|NCT02304458|559405476|FG000|Overall Study|Adverse Event|0|||
154994889|NCT02304458|559405477|FG001|Overall Study|Adverse Event|0|||
154994890|NCT02304458|559405478|FG002|Overall Study|Adverse Event|7|||
154994891|NCT02304458|559405479|FG003|Overall Study|Adverse Event|0|||
154994892|NCT02304458|559405480|FG004|Overall Study|Adverse Event|0|||
154994893|NCT02304458|559405481|FG005|Overall Study|Adverse Event|0|||
155122107|NCT02305849|559877931|FG000|Overall Study|Not fulfill eligibility criteria|1|||
155122108|NCT02305849|559877932|FG001|Overall Study|Not fulfill eligibility criteria|1|||
155122109|NCT02305849|559877933|FG002|Overall Study|Not fulfill eligibility criteria|0|||
154994894|NCT02304458|559405482|FG006|Overall Study|Adverse Event|3|||
154994895|NCT02304458|559405483|FG007|Overall Study|Adverse Event|4|||
154994896|NCT02304458|559405476|FG000|Overall Study|Death|0|||
154994897|NCT02304458|559405477|FG001|Overall Study|Death|0|||
154994898|NCT02304458|559405478|FG002|Overall Study|Death|2|||
155122110|NCT02305849|559877934|FG003|Overall Study|Not fulfill eligibility criteria|0|||
154994899|NCT02304458|559405479|FG003|Overall Study|Death|0|||
154994900|NCT02304458|559405480|FG004|Overall Study|Death|0|||
154994901|NCT02304458|559405481|FG005|Overall Study|Death|0|||
154994902|NCT02304458|559405482|FG006|Overall Study|Death|1|||
154994903|NCT02304458|559405483|FG007|Overall Study|Death|0|||
154994904|NCT02304458|559405476|FG000|Overall Study|Lack of Efficacy|4|||
154994905|NCT02304458|559405477|FG001|Overall Study|Lack of Efficacy|6|||
154994906|NCT02304458|559405478|FG002|Overall Study|Lack of Efficacy|38|||
154994907|NCT02304458|559405479|FG003|Overall Study|Lack of Efficacy|5|||
154994908|NCT02304458|559405480|FG004|Overall Study|Lack of Efficacy|6|||
154994909|NCT02304458|559405481|FG005|Overall Study|Lack of Efficacy|6|||
154994910|NCT02304458|559405482|FG006|Overall Study|Lack of Efficacy|21|||
154994911|NCT02304458|559405483|FG007|Overall Study|Lack of Efficacy|4|||
154994912|NCT02304458|559405476|FG000|Overall Study|Physician Decision|2|||
154994913|NCT02304458|559405477|FG001|Overall Study|Physician Decision|0|||
154994914|NCT02304458|559405478|FG002|Overall Study|Physician Decision|16|||
154994915|NCT02304458|559405479|FG003|Overall Study|Physician Decision|1|||
154994916|NCT02304458|559405480|FG004|Overall Study|Physician Decision|0|||
154994917|NCT02304458|559405481|FG005|Overall Study|Physician Decision|0|||
154994918|NCT02304458|559405482|FG006|Overall Study|Physician Decision|3|||
154994919|NCT02304458|559405483|FG007|Overall Study|Physician Decision|0|||
154994920|NCT02304458|559405476|FG000|Overall Study|Protocol Violation|0|||
154994921|NCT02304458|559405477|FG001|Overall Study|Protocol Violation|0|||
154994922|NCT02304458|559405478|FG002|Overall Study|Protocol Violation|1|||
154994923|NCT02304458|559405479|FG003|Overall Study|Protocol Violation|0|||
154994924|NCT02304458|559405480|FG004|Overall Study|Protocol Violation|0|||
154994925|NCT02304458|559405481|FG005|Overall Study|Protocol Violation|0|||
154994926|NCT02304458|559405482|FG006|Overall Study|Protocol Violation|0|||
154994927|NCT02304458|559405483|FG007|Overall Study|Protocol Violation|0|||
154994928|NCT02304458|559405476|FG000|Overall Study|Withdrawal by Subject|1|||
154994929|NCT02304458|559405477|FG001|Overall Study|Withdrawal by Subject|0|||
154994930|NCT02304458|559405478|FG002|Overall Study|Withdrawal by Subject|7|||
155122111|NCT00355342|559877935|FG000|Overall Study|Adverse Event|13|||
155122112|NCT00355342|559877936|FG001|Overall Study|Adverse Event|15|||
155122113|NCT00355342|559877935|FG000|Overall Study|Lost to Follow-up|4|||
155122114|NCT00355342|559877936|FG001|Overall Study|Lost to Follow-up|2|||
155122115|NCT00355342|559877935|FG000|Overall Study|Withdrawal by Subject|14|||
155122116|NCT00355342|559877936|FG001|Overall Study|Withdrawal by Subject|11|||
155122117|NCT00355342|559877935|FG000|Overall Study|Sponsor terminated study|2|||
154918237|NCT00501969|559124798|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
154918238|NCT00501969|559124798|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
154918239|NCT00501969|559124798|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
154918240|NCT00501969|559124798|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
154918241|NCT00501969|559124798|FG000|Overall Study|Other: As Required by Local EC|2|||
154918242|NCT00501969|559124798|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
154918243|NCT00501969|559124798|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
154918244|NCT00665366|559124801|FG000|Overall Study|Lack of Efficacy|11|||
154918245|NCT00665366|559124802|FG001|Overall Study|Lack of Efficacy|10|||
154918246|NCT00665366|559124801|FG000|Overall Study|Adverse Event|25|||
154918247|NCT00665366|559124802|FG001|Overall Study|Adverse Event|23|||
154918248|NCT00665366|559124801|FG000|Overall Study|Withdrawal by Subject|11|||
154918249|NCT00665366|559124802|FG001|Overall Study|Withdrawal by Subject|14|||
154918250|NCT00665366|559124801|FG000|Overall Study|Lost to Follow-up|3|||
154918251|NCT00665366|559124802|FG001|Overall Study|Lost to Follow-up|5|||
154918252|NCT00665366|559124801|FG000|Overall Study|Poor compliance/noncompliance|3|||
154918253|NCT00665366|559124802|FG001|Overall Study|Poor compliance/noncompliance|5|||
154918254|NCT00665366|559124801|FG000|Overall Study|Pregnancy|1|||
154918255|NCT00665366|559124802|FG001|Overall Study|Pregnancy|0|||
154918256|NCT00665366|559124801|FG000|Overall Study|No longer meets study criteria|0|||
154918257|NCT00665366|559124802|FG001|Overall Study|No longer meets study criteria|1|||
154918258|NCT00665366|559124801|FG000|Overall Study|Other reasons|4|||
154918259|NCT00665366|559124802|FG001|Overall Study|Other reasons|1|||
154918260|NCT03628781|559124803|FG000|Overall Study|Lost to Follow-up|16|||
154918261|NCT03628781|559124804|FG001|Overall Study|Lost to Follow-up|8|||
154918262|NCT03628781|559124803|FG000|Overall Study|Withdrawal by Subject|16|||
154918263|NCT03628781|559124804|FG001|Overall Study|Withdrawal by Subject|1|||
154918264|NCT02687815|559124808|FG000|Overall Study|Lost to Follow-up|2|||
154918265|NCT02687815|559124809|FG001|Overall Study|Lost to Follow-up|4|||
154918266|NCT02687815|559124808|FG000|Overall Study|Withdrawal by Subject|2|||
154918267|NCT02687815|559124809|FG001|Overall Study|Withdrawal by Subject|4|||
154918268|NCT00379639|559124810|FG000|Overall Study|Disease Progression|3|||
154918269|NCT00379639|559124811|FG001|Overall Study|Disease Progression|3|||
154918270|NCT00379639|559124812|FG002|Overall Study|Disease Progression|3|||
154918271|NCT00379639|559124813|FG003|Overall Study|Disease Progression|4|||
154994931|NCT02304458|559405479|FG003|Overall Study|Withdrawal by Subject|0|||
154994932|NCT02304458|559405480|FG004|Overall Study|Withdrawal by Subject|0|||
154994933|NCT02304458|559405481|FG005|Overall Study|Withdrawal by Subject|0|||
155122118|NCT00355342|559877936|FG001|Overall Study|Sponsor terminated study|2|||
155122119|NCT00355342|559877935|FG000|Overall Study|Overcompliant-PI discretion|1|||
155122120|NCT00355342|559877936|FG001|Overall Study|Overcompliant-PI discretion|0|||
155122121|NCT00355342|559877935|FG000|Overall Study|Use of prohibited medication|1|||
154918272|NCT00379639|559124814|FG004|Overall Study|Disease Progression|4|||
154918273|NCT00379639|559124810|FG000|Overall Study|Physician Decision|0|||
154918274|NCT00379639|559124811|FG001|Overall Study|Physician Decision|2|||
154918275|NCT00379639|559124812|FG002|Overall Study|Physician Decision|1|||
154918276|NCT00379639|559124813|FG003|Overall Study|Physician Decision|1|||
154918277|NCT00379639|559124814|FG004|Overall Study|Physician Decision|0|||
154918278|NCT00379639|559124810|FG000|Overall Study|Symptomatic Deterioration|0|||
154918279|NCT00379639|559124811|FG001|Overall Study|Symptomatic Deterioration|0|||
154918280|NCT00379639|559124812|FG002|Overall Study|Symptomatic Deterioration|1|||
154918281|NCT00379639|559124813|FG003|Overall Study|Symptomatic Deterioration|0|||
154918282|NCT00379639|559124814|FG004|Overall Study|Symptomatic Deterioration|1|||
154918283|NCT00379639|559124810|FG000|Overall Study|Adverse Event|0|||
154918284|NCT00379639|559124811|FG001|Overall Study|Adverse Event|0|||
154918285|NCT00379639|559124812|FG002|Overall Study|Adverse Event|1|||
154918286|NCT00379639|559124813|FG003|Overall Study|Adverse Event|0|||
154918287|NCT00379639|559124814|FG004|Overall Study|Adverse Event|1|||
154918288|NCT00379639|559124810|FG000|Overall Study|Lost to Follow-up|0|||
154918289|NCT00379639|559124811|FG001|Overall Study|Lost to Follow-up|0|||
154918290|NCT00379639|559124812|FG002|Overall Study|Lost to Follow-up|0|||
154918291|NCT00379639|559124813|FG003|Overall Study|Lost to Follow-up|1|||
154918292|NCT00379639|559124814|FG004|Overall Study|Lost to Follow-up|0|||
154918293|NCT00379639|559124810|FG000|Overall Study|Other|0|||
154918294|NCT00379639|559124811|FG001|Overall Study|Other|0|||
154918295|NCT00379639|559124812|FG002|Overall Study|Other|3|||
154918296|NCT00379639|559124813|FG003|Overall Study|Other|0|||
154918297|NCT00379639|559124814|FG004|Overall Study|Other|0|||
154918298|NCT01238861|559124817|FG000|Overall Study|Lost to Follow-up|4|||
154918299|NCT01238861|559124818|FG001|Overall Study|Lost to Follow-up|2|||
154918300|NCT01238861|559124819|FG002|Overall Study|Lost to Follow-up|3|||
154918301|NCT01238861|559124820|FG003|Overall Study|Lost to Follow-up|1|||
154918302|NCT01238861|559124821|FG004|Overall Study|Lost to Follow-up|1|||
154918303|NCT01238861|559124822|FG005|Overall Study|Lost to Follow-up|2|||
154918304|NCT01238861|559124817|FG000|Overall Study|Unplanned surgery|1|||
154918305|NCT01238861|559124818|FG001|Overall Study|Unplanned surgery|0|||
154918306|NCT01238861|559124819|FG002|Overall Study|Unplanned surgery|0|||
154918307|NCT01238861|559124820|FG003|Overall Study|Unplanned surgery|0|||
154918308|NCT01238861|559124821|FG004|Overall Study|Unplanned surgery|0|||
154918309|NCT01238861|559124822|FG005|Overall Study|Unplanned surgery|0|||
154918310|NCT01238861|559124817|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
154918311|NCT01238861|559124818|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
154918312|NCT01238861|559124819|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
154918313|NCT01238861|559124820|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
154918314|NCT01238861|559124821|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
154918315|NCT01238861|559124822|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
154918316|NCT01238861|559124817|FG000|Overall Study|Incorrect enrollment/randomization|0|||
154918317|NCT01238861|559124818|FG001|Overall Study|Incorrect enrollment/randomization|0|||
154918318|NCT01238861|559124819|FG002|Overall Study|Incorrect enrollment/randomization|1|||
154918319|NCT01238861|559124820|FG003|Overall Study|Incorrect enrollment/randomization|0|||
154918320|NCT01238861|559124821|FG004|Overall Study|Incorrect enrollment/randomization|1|||
154918321|NCT01238861|559124822|FG005|Overall Study|Incorrect enrollment/randomization|0|||
154918322|NCT01238861|559124817|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
154918323|NCT01238861|559124818|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
154918324|NCT01238861|559124819|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
154918325|NCT01238861|559124820|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
154918326|NCT01238861|559124821|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
154918327|NCT01238861|559124822|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
154918328|NCT01238861|559124817|FG000|Overall Study|Subject moved out of state/area|0|||
154918329|NCT01238861|559124818|FG001|Overall Study|Subject moved out of state/area|0|||
154918330|NCT01238861|559124819|FG002|Overall Study|Subject moved out of state/area|1|||
154918331|NCT01238861|559124820|FG003|Overall Study|Subject moved out of state/area|1|||
154918332|NCT01238861|559124821|FG004|Overall Study|Subject moved out of state/area|0|||
154994934|NCT02304458|559405482|FG006|Overall Study|Withdrawal by Subject|1|||
154994935|NCT02304458|559405483|FG007|Overall Study|Withdrawal by Subject|0|||
154918333|NCT01238861|559124822|FG005|Overall Study|Subject moved out of state/area|0|||
154918334|NCT01238861|559124817|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
154918335|NCT01238861|559124818|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
154918336|NCT01238861|559124819|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
154918337|NCT01238861|559124820|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
154918338|NCT01238861|559124821|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
154918339|NCT01238861|559124822|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
154994936|NCT00186043|559405484|FG000|Overall Study|Lack of Efficacy|1|||
155122122|NCT00355342|559877936|FG001|Overall Study|Use of prohibited medication|0|||
154994937|NCT00186043|559405485|FG001|Overall Study|Lack of Efficacy|3|||
154994938|NCT00186043|559405484|FG000|Overall Study|Lost to Follow-up|4|||
154994939|NCT00186043|559405485|FG001|Overall Study|Lost to Follow-up|6|||
154994940|NCT00186043|559405484|FG000|Overall Study|Withdrawal by Subject|1|||
154994941|NCT00186043|559405485|FG001|Overall Study|Withdrawal by Subject|0|||
154994942|NCT00186043|559405484|FG000|Overall Study|Adverse Event|7|||
154994943|NCT00186043|559405485|FG001|Overall Study|Adverse Event|3|||
154994944|NCT00186043|559405484|FG000|Overall Study|Protocol Violation|2|||
154994945|NCT00186043|559405485|FG001|Overall Study|Protocol Violation|1|||
154994946|NCT04874636|559405486|FG000|Overall Study|Adverse Event|17|||
154994947|NCT04874636|559405487|FG001|Overall Study|Adverse Event|7|||
154994948|NCT04874636|559405486|FG000|Overall Study|Lost to Follow-up|1|||
154994949|NCT04874636|559405487|FG001|Overall Study|Lost to Follow-up|0|||
154994950|NCT04874636|559405486|FG000|Overall Study|Non-Compliance with Study Drug|2|||
154994951|NCT04874636|559405487|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155122123|NCT00355342|559877935|FG000|Overall Study|COPD exacerbation|1|||
155122124|NCT00355342|559877936|FG001|Overall Study|COPD exacerbation|1|||
155122125|NCT00355342|559877935|FG000|Overall Study|Dispensed wrong study drug kit|1|||
155122126|NCT00355342|559877936|FG001|Overall Study|Dispensed wrong study drug kit|0|||
155122127|NCT00355342|559877935|FG000|Overall Study|Non-compliance with Dexa scans|1|||
155122128|NCT00355342|559877936|FG001|Overall Study|Non-compliance with Dexa scans|0|||
155122129|NCT00355342|559877935|FG000|Overall Study|Withdrawal by participant and physician|1|||
155122130|NCT00355342|559877936|FG001|Overall Study|Withdrawal by participant and physician|0|||
155122131|NCT00355342|559877935|FG000|Overall Study|Participant relocated|0|||
155122132|NCT00355342|559877936|FG001|Overall Study|Participant relocated|1|||
155122133|NCT00355342|559877935|FG000|Overall Study|Participant discontinued study drug|0|||
155122134|NCT00355342|559877936|FG001|Overall Study|Participant discontinued study drug|1|||
155122135|NCT00355342|559877935|FG000|Overall Study|Study management|0|||
155122136|NCT00355342|559877936|FG001|Overall Study|Study management|1|||
155122137|NCT00355342|559877935|FG000|Overall Study|Protocol Violation|0|||
155122138|NCT00355342|559877936|FG001|Overall Study|Protocol Violation|1|||
155122139|NCT00355342|559877935|FG000|Overall Study|Use of protocol excluded medication|0|||
155122140|NCT00355342|559877936|FG001|Overall Study|Use of protocol excluded medication|1|||
155122141|NCT00391391|559877939|FG000|Overall Study|Adverse Event|0|||
155122142|NCT00391391|559877940|FG001|Overall Study|Adverse Event|0|||
155122143|NCT00391391|559877941|FG002|Overall Study|Adverse Event|0|||
155122144|NCT00391391|559877942|FG003|Overall Study|Adverse Event|1|||
155122145|NCT00391391|559877939|FG000|Overall Study|Lost to Follow-up|1|||
155122146|NCT00391391|559877940|FG001|Overall Study|Lost to Follow-up|3|||
155122147|NCT00391391|559877941|FG002|Overall Study|Lost to Follow-up|7|||
155122148|NCT00391391|559877942|FG003|Overall Study|Lost to Follow-up|4|||
155122149|NCT00391391|559877939|FG000|Overall Study|Protocol Violation|2|||
155122150|NCT00391391|559877940|FG001|Overall Study|Protocol Violation|3|||
155122151|NCT00391391|559877941|FG002|Overall Study|Protocol Violation|6|||
155122152|NCT00391391|559877942|FG003|Overall Study|Protocol Violation|7|||
155122153|NCT00391391|559877939|FG000|Overall Study|Withdrawal by Subject|6|||
155122154|NCT00391391|559877940|FG001|Overall Study|Withdrawal by Subject|4|||
155122155|NCT00391391|559877941|FG002|Overall Study|Withdrawal by Subject|10|||
155122156|NCT00391391|559877942|FG003|Overall Study|Withdrawal by Subject|7|||
155122157|NCT00693472|559877943|FG000|Part 1|Adverse Event|1|||
155122158|NCT00693472|559877944|FG001|Part 1|Adverse Event|1|||
155122159|NCT00693472|559877945|FG002|Part 1|Adverse Event|0|||
155122160|NCT00693472|559877946|FG003|Part 1|Adverse Event|0|||
155122161|NCT00693472|559877943|FG000|Part 1|Lost to Follow-up|0|||
155122162|NCT00693472|559877944|FG001|Part 1|Lost to Follow-up|1|||
155122163|NCT00693472|559877945|FG002|Part 1|Lost to Follow-up|0|||
155122164|NCT00693472|559877946|FG003|Part 1|Lost to Follow-up|0|||
154994952|NCT04874636|559405486|FG000|Overall Study|Physician Decision|1|||
154994953|NCT04874636|559405487|FG001|Overall Study|Physician Decision|0|||
154994954|NCT04874636|559405486|FG000|Overall Study|Withdrawal by Subject|6|||
154994955|NCT04874636|559405487|FG001|Overall Study|Withdrawal by Subject|5|||
154994956|NCT04188301|559405490|FG000|Month 3|Lost to Follow-up|0|||
154994957|NCT04188301|559405491|FG001|Month 3|Lost to Follow-up|0|||
154994958|NCT04188301|559405492|FG002|Month 3|Lost to Follow-up|1|||
154994959|NCT04188301|559405490|FG000|Month 12|Lost to Follow-up|0|||
154994960|NCT04188301|559405491|FG001|Month 12|Lost to Follow-up|0|||
154994961|NCT04188301|559405492|FG002|Month 12|Lost to Follow-up|2|||
154994962|NCT04188301|559405490|FG000|Month 12|Death|1|||
154994963|NCT04188301|559405491|FG001|Month 12|Death|1|||
155122165|NCT00693472|559877943|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
155122166|NCT00693472|559877944|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
155122167|NCT00693472|559877945|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
155122168|NCT00693472|559877946|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
155122169|NCT00693472|559877943|FG000|Part 2|Adverse Event|0|||
155122170|NCT00693472|559877944|FG001|Part 2|Adverse Event|0|||
155122171|NCT00693472|559877945|FG002|Part 2|Adverse Event|1|||
155122172|NCT00693472|559877946|FG003|Part 2|Adverse Event|0|||
155122173|NCT00693472|559877943|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
155122174|NCT00693472|559877944|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
154994964|NCT04188301|559405492|FG002|Month 12|Death|0|||
154994965|NCT04188301|559405490|FG000|Month 18|Lost to Follow-up|6|||
154994966|NCT04188301|559405491|FG001|Month 18|Lost to Follow-up|0|||
154994967|NCT04188301|559405492|FG002|Month 18|Lost to Follow-up|0|||
154994968|NCT00228423|559405493|FG000|Overall Study|Adverse Event|2|||
154994969|NCT00228423|559405494|FG001|Overall Study|Adverse Event|5|||
154994970|NCT00228423|559405493|FG000|Overall Study|Withdrawal by Subject|7|||
154994971|NCT00228423|559405494|FG001|Overall Study|Withdrawal by Subject|3|||
154994972|NCT00228423|559405493|FG000|Overall Study|Protocol Violation|1|||
154994973|NCT00228423|559405494|FG001|Overall Study|Protocol Violation|3|||
154994974|NCT00228423|559405493|FG000|Overall Study|Physician Decision|0|||
154994975|NCT00228423|559405494|FG001|Overall Study|Physician Decision|1|||
154994976|NCT00620659|559405499|FG000|Treatment Period 1|Adverse Event|1|||
154994977|NCT00620659|559405500|FG001|Treatment Period 1|Adverse Event|0|||
154994978|NCT00620659|559405501|FG002|Treatment Period 1|Adverse Event|0|||
154994979|NCT00620659|559405502|FG003|Treatment Period 1|Adverse Event|3|||
154994980|NCT00620659|559405503|FG004|Treatment Period 1|Adverse Event|0|||
154994981|NCT00620659|559405504|FG005|Treatment Period 1|Adverse Event|0|||
154994982|NCT00620659|559405499|FG000|Treatment Period 1|Protocol Violation|1|||
154994983|NCT00620659|559405500|FG001|Treatment Period 1|Protocol Violation|0|||
154994984|NCT00620659|559405501|FG002|Treatment Period 1|Protocol Violation|0|||
154994985|NCT00620659|559405502|FG003|Treatment Period 1|Protocol Violation|0|||
154994986|NCT00620659|559405503|FG004|Treatment Period 1|Protocol Violation|0|||
154994987|NCT00620659|559405504|FG005|Treatment Period 1|Protocol Violation|0|||
154994988|NCT00620659|559405499|FG000|Treatment Period 1|Withdrawal by Subject|1|||
154994989|NCT00620659|559405500|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154994990|NCT00620659|559405501|FG002|Treatment Period 1|Withdrawal by Subject|1|||
154994991|NCT00620659|559405502|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154994992|NCT00620659|559405503|FG004|Treatment Period 1|Withdrawal by Subject|1|||
154994993|NCT00620659|559405504|FG005|Treatment Period 1|Withdrawal by Subject|0|||
154994994|NCT00620659|559405499|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
154994995|NCT00620659|559405500|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
154994996|NCT00620659|559405501|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
154994997|NCT00620659|559405502|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
154994998|NCT00620659|559405503|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
154994999|NCT00620659|559405504|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
154995000|NCT00620659|559405499|FG000|Treatment Period 2|Adverse Event|0|||
154995001|NCT00620659|559405500|FG001|Treatment Period 2|Adverse Event|3|||
154995002|NCT00620659|559405501|FG002|Treatment Period 2|Adverse Event|0|||
154995003|NCT00620659|559405502|FG003|Treatment Period 2|Adverse Event|0|||
154995004|NCT00620659|559405503|FG004|Treatment Period 2|Adverse Event|2|||
154995005|NCT00620659|559405504|FG005|Treatment Period 2|Adverse Event|0|||
154995006|NCT00620659|559405499|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154995007|NCT00620659|559405500|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154995008|NCT00620659|559405501|FG002|Treatment Period 2|Withdrawal by Subject|1|||
154995009|NCT00620659|559405502|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154995010|NCT00620659|559405503|FG004|Treatment Period 2|Withdrawal by Subject|3|||
154995011|NCT00620659|559405504|FG005|Treatment Period 2|Withdrawal by Subject|0|||
154995012|NCT00620659|559405499|FG000|Placebo Washout Period 2|Adverse Event|2|||
154995013|NCT00620659|559405500|FG001|Placebo Washout Period 2|Adverse Event|0|||
154995014|NCT00620659|559405501|FG002|Placebo Washout Period 2|Adverse Event|0|||
154995015|NCT00620659|559405502|FG003|Placebo Washout Period 2|Adverse Event|0|||
154995016|NCT00620659|559405503|FG004|Placebo Washout Period 2|Adverse Event|0|||
154995017|NCT00620659|559405504|FG005|Placebo Washout Period 2|Adverse Event|0|||
154995018|NCT00620659|559405499|FG000|Treatment Period 3|Adverse Event|0|||
154995019|NCT00620659|559405500|FG001|Treatment Period 3|Adverse Event|2|||
154995020|NCT00620659|559405501|FG002|Treatment Period 3|Adverse Event|0|||
154995021|NCT00620659|559405502|FG003|Treatment Period 3|Adverse Event|0|||
154995022|NCT00620659|559405503|FG004|Treatment Period 3|Adverse Event|0|||
154995023|NCT00620659|559405504|FG005|Treatment Period 3|Adverse Event|0|||
154995024|NCT00620659|559405499|FG000|Treatment Period 3|Withdrawal by Subject|0|||
154995025|NCT00620659|559405500|FG001|Treatment Period 3|Withdrawal by Subject|0|||
154995026|NCT00620659|559405501|FG002|Treatment Period 3|Withdrawal by Subject|0|||
154995027|NCT00620659|559405502|FG003|Treatment Period 3|Withdrawal by Subject|1|||
154995028|NCT00620659|559405503|FG004|Treatment Period 3|Withdrawal by Subject|0|||
154995029|NCT00620659|559405504|FG005|Treatment Period 3|Withdrawal by Subject|0|||
154995030|NCT03246646|559405507|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
154995031|NCT03246646|559405508|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
154995032|NCT03246646|559405507|FG000|Overall Study|Withdrawal by Subject|3|||
154995033|NCT03246646|559405508|FG001|Overall Study|Withdrawal by Subject|0|||
154995034|NCT03246646|559405507|FG000|Overall Study|Lost to Follow-up|7|||
154995035|NCT03246646|559405508|FG001|Overall Study|Lost to Follow-up|0|||
154995036|NCT04241315|559407748|FG000|Overall Study|Withdrawal by Subject|0|||
154995037|NCT04241315|559407749|FG001|Overall Study|Withdrawal by Subject|1|||
154995038|NCT01682863|559407760|FG000|Overall Study|Subject/guardian decision|19|||
154995039|NCT01682863|559407761|FG001|Overall Study|Subject/guardian decision|12|||
154995040|NCT01682863|559407762|FG002|Overall Study|Subject/guardian decision|10|||
154995041|NCT01682863|559407760|FG000|Overall Study|Lost to Follow-up|5|||
154995042|NCT01682863|559407761|FG001|Overall Study|Lost to Follow-up|1|||
154995043|NCT01682863|559407762|FG002|Overall Study|Lost to Follow-up|6|||
154995044|NCT01682863|559407760|FG000|Overall Study|Death|1|||
154995045|NCT01682863|559407761|FG001|Overall Study|Death|3|||
154995046|NCT01682863|559407762|FG002|Overall Study|Death|4|||
154995047|NCT01682863|559407760|FG000|Overall Study|Protocol deviation|1|||
154995048|NCT01682863|559407761|FG001|Overall Study|Protocol deviation|0|||
154995049|NCT01682863|559407762|FG002|Overall Study|Protocol deviation|1|||
154995050|NCT01682863|559407760|FG000|Overall Study|Technical problems|1|||
154995051|NCT01682863|559407761|FG001|Overall Study|Technical problems|0|||
154995052|NCT01682863|559407762|FG002|Overall Study|Technical problems|0|||
154995053|NCT01682863|559407760|FG000|Overall Study|Adverse Event|0|||
154995054|NCT01682863|559407761|FG001|Overall Study|Adverse Event|1|||
154995055|NCT01682863|559407762|FG002|Overall Study|Adverse Event|2|||
154995056|NCT01682863|559407760|FG000|Overall Study|Physician Decision|0|||
154995057|NCT01682863|559407761|FG001|Overall Study|Physician Decision|0|||
154995058|NCT01682863|559407762|FG002|Overall Study|Physician Decision|1|||
154995059|NCT00918138|559407763|FG000|Overall Study|Subject withdrew consent|1|||
154995060|NCT00918138|559407764|FG001|Overall Study|Subject withdrew consent|1|||
154995061|NCT00918138|559407763|FG000|Overall Study|Death|1|||
154995062|NCT00918138|559407764|FG001|Overall Study|Death|0|||
154995063|NCT03972163|559407765|FG000|Overall Study|Death|0|||
154995064|NCT03972163|559407766|FG001|Overall Study|Death|1|||
154995065|NCT00837473|559407767|FG000|Overall Study|Lost to Follow-up|1|||
154995066|NCT00837473|559407767|FG000|Overall Study|Withdrawal by Subject|2|||
154995067|NCT03400943|559407768|FG000|Treatment Period 1|Adverse Event|0|||
154995068|NCT03400943|559407769|FG001|Treatment Period 1|Adverse Event|0|||
154995069|NCT03400943|559407770|FG002|Treatment Period 1|Adverse Event|0|||
154995070|NCT03400943|559407771|FG003|Treatment Period 1|Adverse Event|1|||
154995071|NCT03400943|559407768|FG000|Treatment Period 1|Lost to Follow-up|1|||
154995072|NCT03400943|559407769|FG001|Treatment Period 1|Lost to Follow-up|0|||
154995073|NCT03400943|559407770|FG002|Treatment Period 1|Lost to Follow-up|0|||
154995074|NCT03400943|559407771|FG003|Treatment Period 1|Lost to Follow-up|0|||
154995075|NCT03400943|559407768|FG000|Treatment Period 1|Protocol Violation|0|||
154995076|NCT03400943|559407769|FG001|Treatment Period 1|Protocol Violation|1|||
154995077|NCT03400943|559407770|FG002|Treatment Period 1|Protocol Violation|1|||
154995078|NCT03400943|559407771|FG003|Treatment Period 1|Protocol Violation|0|||
154995079|NCT03400943|559407768|FG000|Treatment Period 1|Study terminated by sponsor|2|||
154995080|NCT03400943|559407769|FG001|Treatment Period 1|Study terminated by sponsor|0|||
154995081|NCT03400943|559407770|FG002|Treatment Period 1|Study terminated by sponsor|0|||
154918340|NCT01238861|559124817|FG000|Overall Study|Personal problems|0|||
154918341|NCT01238861|559124818|FG001|Overall Study|Personal problems|0|||
154918342|NCT01238861|559124819|FG002|Overall Study|Personal problems|0|||
154918343|NCT01238861|559124820|FG003|Overall Study|Personal problems|1|||
154918344|NCT01238861|559124821|FG004|Overall Study|Personal problems|0|||
154918345|NCT01238861|559124822|FG005|Overall Study|Personal problems|0|||
154918346|NCT01238861|559124817|FG000|Overall Study|Unable to continue visits|0|||
154918347|NCT01238861|559124818|FG001|Overall Study|Unable to continue visits|0|||
154918348|NCT01238861|559124819|FG002|Overall Study|Unable to continue visits|0|||
154918349|NCT01238861|559124820|FG003|Overall Study|Unable to continue visits|1|||
154918350|NCT01238861|559124821|FG004|Overall Study|Unable to continue visits|0|||
154918351|NCT01238861|559124822|FG005|Overall Study|Unable to continue visits|1|||
154918352|NCT01238861|559124817|FG000|Overall Study|Serious adverse event|0|||
154918353|NCT01238861|559124818|FG001|Overall Study|Serious adverse event|0|||
154918354|NCT01238861|559124819|FG002|Overall Study|Serious adverse event|0|||
154918355|NCT01238861|559124820|FG003|Overall Study|Serious adverse event|0|||
154918356|NCT01238861|559124821|FG004|Overall Study|Serious adverse event|0|||
154918357|NCT01238861|559124822|FG005|Overall Study|Serious adverse event|1|||
154918358|NCT01238861|559124817|FG000|Overall Study|Lack of compliance|0|||
154918359|NCT01238861|559124818|FG001|Overall Study|Lack of compliance|0|||
154918360|NCT01238861|559124819|FG002|Overall Study|Lack of compliance|0|||
154918361|NCT01238861|559124820|FG003|Overall Study|Lack of compliance|0|||
154918362|NCT01238861|559124821|FG004|Overall Study|Lack of compliance|0|||
154918363|NCT01238861|559124822|FG005|Overall Study|Lack of compliance|1|||
154918364|NCT01238861|559124817|FG000|Overall Study|Adverse Event|0|||
154918365|NCT01238861|559124818|FG001|Overall Study|Adverse Event|1|||
154918366|NCT01238861|559124819|FG002|Overall Study|Adverse Event|0|||
154918367|NCT01238861|559124820|FG003|Overall Study|Adverse Event|0|||
154918368|NCT01238861|559124821|FG004|Overall Study|Adverse Event|0|||
154918369|NCT01238861|559124822|FG005|Overall Study|Adverse Event|0|||
154918370|NCT01238861|559124817|FG000|Overall Study|Withdrawal by Subject|6|||
154995082|NCT03400943|559407771|FG003|Treatment Period 1|Study terminated by sponsor|1|||
154995083|NCT03400943|559407768|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154995084|NCT03400943|559407769|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154995085|NCT03400943|559407770|FG002|Treatment Period 1|Withdrawal by Subject|3|||
154995086|NCT03400943|559407771|FG003|Treatment Period 1|Withdrawal by Subject|1|||
154995087|NCT03400943|559407768|FG000|Treatment Period 1|Other|2|||
155177667|NCT01894568|560088301|FG001|Overall Study|Protocol required discontinuation|1|||
155177668|NCT01894568|560088300|FG000|Overall Study|Withdrawal by Subject|5|||
154918371|NCT01238861|559124818|FG001|Overall Study|Withdrawal by Subject|5|||
154918372|NCT01238861|559124819|FG002|Overall Study|Withdrawal by Subject|4|||
154918373|NCT01238861|559124820|FG003|Overall Study|Withdrawal by Subject|8|||
154918374|NCT01238861|559124821|FG004|Overall Study|Withdrawal by Subject|10|||
154918375|NCT01238861|559124822|FG005|Overall Study|Withdrawal by Subject|9|||
154918376|NCT03868410|559124823|FG000|Overall Study|Physician Decision|0|||
154918377|NCT03868410|559124824|FG001|Overall Study|Physician Decision|1|||
154918378|NCT03737812|559124825|FG000|Overall Study|Withdrawal by Subject|1|||
154918379|NCT03737812|559124826|FG001|Overall Study|Withdrawal by Subject|2|||
154918380|NCT03737812|559124827|FG002|Overall Study|Withdrawal by Subject|1|||
154918381|NCT03737812|559124825|FG000|Overall Study|Sponsor Discontinued the Study|4|||
154918382|NCT03737812|559124826|FG001|Overall Study|Sponsor Discontinued the Study|3|||
154918383|NCT03737812|559124827|FG002|Overall Study|Sponsor Discontinued the Study|2|||
154918384|NCT03737812|559124825|FG000|Overall Study|Adverse Event|0|||
154918385|NCT03737812|559124826|FG001|Overall Study|Adverse Event|1|||
154918386|NCT03737812|559124827|FG002|Overall Study|Adverse Event|0|||
154918387|NCT03737812|559124825|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
154918388|NCT03737812|559124826|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
154918389|NCT03737812|559124827|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
154918390|NCT06104423|559124828|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
154918391|NCT06104423|559124829|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
154918392|NCT06104423|559124830|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
154918393|NCT06104423|559124828|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
154918394|NCT06104423|559124829|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
154918395|NCT06104423|559124830|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
154918396|NCT03814499|559124831|FG000|Overall Study|Lost to Follow-up|3|||
154918397|NCT00462501|559124837|FG000|Overall Study|Not treated|3|||
154918398|NCT00462501|559124837|FG000|Overall Study|Adverse Event|2|||
154918399|NCT03764813|559124839|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
154918400|NCT03764813|559124840|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
154918401|NCT03764813|559124841|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
154918402|NCT03764813|559124842|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
154918403|NCT02898662|559124847|FG000|Overall Study|Adverse Event|1|||
154918404|NCT02898662|559124848|FG001|Overall Study|Adverse Event|0|||
154918405|NCT02898662|559124847|FG000|Overall Study|Loss of asthma control|23|||
154918406|NCT02898662|559124848|FG001|Overall Study|Loss of asthma control|24|||
154918407|NCT02898662|559124847|FG000|Overall Study|Withdrawal by Subject|4|||
154918408|NCT02898662|559124848|FG001|Overall Study|Withdrawal by Subject|1|||
154918409|NCT02898662|559124847|FG000|Overall Study|Technical issue|0|||
154918410|NCT02898662|559124848|FG001|Overall Study|Technical issue|1|||
154918411|NCT02898662|559124847|FG000|Overall Study|Randomized in error|0|||
154918412|NCT02898662|559124848|FG001|Overall Study|Randomized in error|1|||
154918413|NCT02898662|559124847|FG000|Overall Study|Subject decision|1|||
154918414|NCT02898662|559124848|FG001|Overall Study|Subject decision|0|||
154918415|NCT02898662|559124847|FG000|Overall Study|Other|0|||
154918416|NCT02898662|559124848|FG001|Overall Study|Other|1|||
154918417|NCT00399542|559124849|FG000|Overall Study|Adverse Event|18|||
154918418|NCT00399542|559124850|FG001|Overall Study|Adverse Event|15|||
154918419|NCT00399542|559124849|FG000|Overall Study|Protocol Violation|13|||
154918420|NCT00399542|559124850|FG001|Overall Study|Protocol Violation|3|||
154918421|NCT00399542|559124849|FG000|Overall Study|Withdrawal by Subject|28|||
154918422|NCT00399542|559124850|FG001|Overall Study|Withdrawal by Subject|10|||
154918423|NCT00399542|559124849|FG000|Overall Study|Lack of Efficacy|18|||
154918424|NCT00399542|559124850|FG001|Overall Study|Lack of Efficacy|8|||
154918425|NCT00399542|559124849|FG000|Overall Study|Lost to Follow-up|6|||
154918426|NCT00399542|559124850|FG001|Overall Study|Lost to Follow-up|6|||
154918427|NCT00399542|559124849|FG000|Overall Study|Other|1|||
154918428|NCT00399542|559124850|FG001|Overall Study|Other|0|||
154918429|NCT00399542|559124849|FG000|Overall Study|Physician Decision|0|||
154918430|NCT00399542|559124850|FG001|Overall Study|Physician Decision|1|||
154918431|NCT04652245|559124851|FG000|Wash-Out Period|Adverse Event|0|||
154918432|NCT04652245|559124852|FG001|Wash-Out Period|Adverse Event|2|||
154918433|NCT04652245|559124851|FG000|Wash-Out Period|Withdrawal by Subject|0|||
154918434|NCT04652245|559124852|FG001|Wash-Out Period|Withdrawal by Subject|2|||
154918435|NCT00851721|559124855|FG000|Overall Study|planned surgery|1|||
154918436|NCT00851721|559124856|FG001|Overall Study|planned surgery|0|||
154918437|NCT00851721|559124855|FG000|Overall Study|Death|1|||
154918438|NCT00851721|559124856|FG001|Overall Study|Death|0|||
154918439|NCT00851721|559124855|FG000|Overall Study|Adverse Event|0|||
154918440|NCT00851721|559124856|FG001|Overall Study|Adverse Event|1|||
154918441|NCT04047472|559124857|FG000|Overall Study|Adverse Event|3|||
154918442|NCT04047472|559124858|FG001|Overall Study|Adverse Event|3|||
154918443|NCT04047472|559124857|FG000|Overall Study|Death|0|||
155177669|NCT01894568|560088301|FG001|Overall Study|Withdrawal by Subject|5|||
155177670|NCT01894568|560088300|FG000|Overall Study|Physician Decision|1|||
155177671|NCT01894568|560088301|FG001|Overall Study|Physician Decision|0|||
155177672|NCT01894568|560088300|FG000|Overall Study|Lost to Follow-up|0|||
155177673|NCT01894568|560088301|FG001|Overall Study|Lost to Follow-up|1|||
155177674|NCT03720652|560088302|FG000|Overall Study|Withdrawal by Subject|2|||
155177675|NCT03720652|560088303|FG001|Overall Study|Withdrawal by Subject|7|||
155177676|NCT03720652|560088302|FG000|Overall Study|Lost to Follow-up|0|||
155177677|NCT03720652|560088303|FG001|Overall Study|Lost to Follow-up|4|||
155177678|NCT03353740|560088307|FG000|Overall Study|Images for these participants not viable|52|||
155177679|NCT03976648|560088308|FG000|Overall Study|Adverse Event|0|||
155177680|NCT03976648|560088309|FG001|Overall Study|Adverse Event|2|||
155177681|NCT03976648|560088308|FG000|Overall Study|Study terminated by sponsor|21|||
155177682|NCT03976648|560088309|FG001|Overall Study|Study terminated by sponsor|8|||
155177683|NCT01155167|560088310|FG000|Overall Study|Insufficient ultrasound data|2|||
155177684|NCT01155167|560088311|FG001|Overall Study|Insufficient ultrasound data|0|||
155177685|NCT01155167|560088310|FG000|Overall Study|Access site changed to femoral artery|1|||
155177686|NCT01155167|560088311|FG001|Overall Study|Access site changed to femoral artery|0|||
155177687|NCT00336583|560089353|FG000|Overall Study|Lost to Follow-up|1|||
155177688|NCT00336583|560089353|FG000|Overall Study|Death|1|||
155177689|NCT03603509|560089354|FG000|Overall Study|Lost to Follow-up|3|||
155177690|NCT03603509|560089355|FG001|Overall Study|Lost to Follow-up|4|||
154918444|NCT04047472|559124858|FG001|Overall Study|Death|1|||
154918445|NCT04047472|559124857|FG000|Overall Study|Lost to Follow-up|1|||
154918446|NCT04047472|559124858|FG001|Overall Study|Lost to Follow-up|0|||
154918447|NCT04047472|559124857|FG000|Overall Study|Physician Decision|1|||
154918448|NCT04047472|559124858|FG001|Overall Study|Physician Decision|2|||
154918449|NCT04047472|559124857|FG000|Overall Study|Protocol Violation|1|||
154918450|NCT04047472|559124858|FG001|Overall Study|Protocol Violation|0|||
154918451|NCT04047472|559124857|FG000|Overall Study|Withdrawal by Subject|10|||
154918452|NCT04047472|559124858|FG001|Overall Study|Withdrawal by Subject|10|||
154918453|NCT01016912|559124859|FG000|End of Treatment Period|Lack of Efficacy|0|||
154918454|NCT01016912|559124860|FG001|End of Treatment Period|Lack of Efficacy|1|||
154918455|NCT01016912|559124861|FG002|End of Treatment Period|Lack of Efficacy|0|||
154918456|NCT01016912|559124862|FG003|End of Treatment Period|Lack of Efficacy|4|||
154918457|NCT01016912|559124863|FG004|End of Treatment Period|Lack of Efficacy|4|||
154918458|NCT01016912|559124859|FG000|End of Treatment Period|Adverse Event|0|||
154918459|NCT01016912|559124860|FG001|End of Treatment Period|Adverse Event|1|||
154918460|NCT01016912|559124861|FG002|End of Treatment Period|Adverse Event|1|||
154918461|NCT01016912|559124862|FG003|End of Treatment Period|Adverse Event|0|||
154918462|NCT01016912|559124863|FG004|End of Treatment Period|Adverse Event|0|||
154918463|NCT01016912|559124859|FG000|End of Treatment Period|Completed double-blind period only|0|||
154918464|NCT01016912|559124860|FG001|End of Treatment Period|Completed double-blind period only|1|||
154918465|NCT01016912|559124861|FG002|End of Treatment Period|Completed double-blind period only|0|||
154918466|NCT01016912|559124862|FG003|End of Treatment Period|Completed double-blind period only|0|||
154918467|NCT01016912|559124863|FG004|End of Treatment Period|Completed double-blind period only|0|||
154918468|NCT01016912|559124859|FG000|Follow-up Period|Other reason|0|||
154918469|NCT01016912|559124860|FG001|Follow-up Period|Other reason|0|||
154918470|NCT01016912|559124861|FG002|Follow-up Period|Other reason|1|||
154918471|NCT01016912|559124862|FG003|Follow-up Period|Other reason|1|||
154918472|NCT01016912|559124863|FG004|Follow-up Period|Other reason|0|||
154918473|NCT00955682|559124864|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
154918474|NCT00955682|559124865|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
154918475|NCT02924129|559124872|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
154918476|NCT02924129|559124873|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
154918477|NCT02924129|559124872|FG000|Overall Study|Withdrawal by Subject|2|||
154918478|NCT02924129|559124873|FG001|Overall Study|Withdrawal by Subject|2|||
154918479|NCT02924129|559124872|FG000|Overall Study|Physician Decision|1|||
154918480|NCT02924129|559124873|FG001|Overall Study|Physician Decision|0|||
154918481|NCT02924129|559124872|FG000|Overall Study|Missed Visit|0|||
154918482|NCT02924129|559124873|FG001|Overall Study|Missed Visit|1|||
154918483|NCT01348828|559124874|FG000|Overall Study|Death|20|||
154918484|NCT01348828|559124874|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
154918485|NCT01348828|559124874|FG000|Overall Study|Conversion|2|||
154918486|NCT01348828|559124874|FG000|Overall Study|missed visit|1|||
154918487|NCT01610752|559124876|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
154918488|NCT01610752|559124877|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
154918489|NCT01610752|559124878|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
154918490|NCT00283062|559124879|FG000|Overall Study|Did not receive any study medication|5|||
154918491|NCT00283062|559124880|FG001|Overall Study|Did not receive any study medication|4|||
154918492|NCT00283062|559124881|FG002|Overall Study|Did not receive any study medication|36|||
154918493|NCT00283062|559124882|FG003|Overall Study|Did not receive any study medication|45|||
154918494|NCT00283062|559124879|FG000|Overall Study|Adverse Event|2|||
154918495|NCT00283062|559124880|FG001|Overall Study|Adverse Event|0|||
154918496|NCT00283062|559124881|FG002|Overall Study|Adverse Event|1|||
155122175|NCT00693472|559877945|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
155122176|NCT00693472|559877946|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
155122177|NCT04063787|559877947|FG000|Overall Study|Inadequate Doppler data|4|||
154918497|NCT00283062|559124882|FG003|Overall Study|Adverse Event|0|||
154918498|NCT00283062|559124879|FG000|Overall Study|Lost to Follow-up|1|||
154918499|NCT00283062|559124880|FG001|Overall Study|Lost to Follow-up|0|||
154918500|NCT00283062|559124881|FG002|Overall Study|Lost to Follow-up|1|||
154918501|NCT00283062|559124882|FG003|Overall Study|Lost to Follow-up|0|||
154918502|NCT00283062|559124879|FG000|Overall Study|Progressive disease|0|||
154918503|NCT00283062|559124880|FG001|Overall Study|Progressive disease|0|||
154918504|NCT00283062|559124881|FG002|Overall Study|Progressive disease|1|||
154918505|NCT00283062|559124882|FG003|Overall Study|Progressive disease|0|||
154918506|NCT00283062|559124879|FG000|Overall Study|Participant did not wish to continue|3|||
154918507|NCT00283062|559124880|FG001|Overall Study|Participant did not wish to continue|2|||
154918508|NCT00283062|559124881|FG002|Overall Study|Participant did not wish to continue|1|||
154918509|NCT00283062|559124882|FG003|Overall Study|Participant did not wish to continue|0|||
154918510|NCT00283062|559124879|FG000|Overall Study|Undefined|0|||
154918511|NCT00283062|559124880|FG001|Overall Study|Undefined|1|||
154918512|NCT00283062|559124881|FG002|Overall Study|Undefined|1|||
154918513|NCT00283062|559124882|FG003|Overall Study|Undefined|4|||
154918514|NCT00283062|559124879|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
154918515|NCT00283062|559124880|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
154918516|NCT00283062|559124881|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
154918517|NCT00283062|559124882|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
154918518|NCT03524664|559124883|FG000|Overall Study|Withdrawal by Subject|1|||
154918519|NCT03524664|559124884|FG001|Overall Study|Withdrawal by Subject|2|||
154918520|NCT03524664|559124883|FG000|Overall Study|Lost to Follow-up|4|||
154918521|NCT03524664|559124884|FG001|Overall Study|Lost to Follow-up|13|||
154918522|NCT01482598|559124885|FG000|Overall Study|Death|7|||
154918523|NCT01482598|559124886|FG001|Overall Study|Death|10|||
154918524|NCT01482598|559124885|FG000|Overall Study|Physician Decision|0|||
154918525|NCT01482598|559124886|FG001|Overall Study|Physician Decision|3|||
154918526|NCT01482598|559124885|FG000|Overall Study|Withdrawal by Subject|4|||
154918527|NCT01482598|559124886|FG001|Overall Study|Withdrawal by Subject|5|||
154918528|NCT01482598|559124885|FG000|Overall Study|Lost to Follow-up|5|||
154918529|NCT01482598|559124886|FG001|Overall Study|Lost to Follow-up|4|||
154918530|NCT02694562|559124887|FG000|Overall Study|Death|8|||
154918531|NCT02694562|559124887|FG000|Overall Study|Protocol Violation|4|||
154918532|NCT02694562|559124887|FG000|Overall Study|Lost to Follow-up|3|||
154918533|NCT02694562|559124887|FG000|Overall Study|Screen Failure|2|||
154918534|NCT02694562|559124887|FG000|Overall Study|Physician Decision|1|||
154918535|NCT00827112|559124888|FG000|Overall Study|Adverse Event|2|||
154918536|NCT00827112|559124889|FG001|Overall Study|Adverse Event|0|||
154918537|NCT00827112|559124888|FG000|Overall Study|Lack of Efficacy|2|||
154918538|NCT00827112|559124889|FG001|Overall Study|Lack of Efficacy|0|||
154918539|NCT00827112|559124888|FG000|Overall Study|Lost to Follow-up|3|||
154918540|NCT00827112|559124889|FG001|Overall Study|Lost to Follow-up|2|||
154918541|NCT00827112|559124888|FG000|Overall Study|Pregnancy|0|||
154918542|NCT00827112|559124889|FG001|Overall Study|Pregnancy|1|||
154918543|NCT00827112|559124888|FG000|Overall Study|Protocol Violation|0|||
154918544|NCT00827112|559124889|FG001|Overall Study|Protocol Violation|2|||
154918545|NCT00827112|559124888|FG000|Overall Study|Withdrawal by Subject|2|||
154918546|NCT00827112|559124889|FG001|Overall Study|Withdrawal by Subject|1|||
154918547|NCT00827112|559124888|FG000|Overall Study|Randomized but not treated|5|||
154918548|NCT00827112|559124889|FG001|Overall Study|Randomized but not treated|3|||
154918549|NCT00827112|559124888|FG000|Overall Study|Other|1|||
154918550|NCT00827112|559124889|FG001|Overall Study|Other|3|||
154918551|NCT01521494|559124892|FG000|Overall Study|Adverse Event|1|||
154918552|NCT01521494|559124893|FG001|Overall Study|Adverse Event|2|||
154918553|NCT01521494|559124894|FG002|Overall Study|Adverse Event|9|||
154918554|NCT01521494|559124895|FG003|Overall Study|Adverse Event|6|||
154918555|NCT01521494|559124896|FG004|Overall Study|Adverse Event|2|||
154918556|NCT01521494|559124892|FG000|Overall Study|Lack of Efficacy|0|||
154918557|NCT01521494|559124893|FG001|Overall Study|Lack of Efficacy|0|||
154918558|NCT01521494|559124894|FG002|Overall Study|Lack of Efficacy|0|||
154918559|NCT01521494|559124895|FG003|Overall Study|Lack of Efficacy|0|||
154918560|NCT01521494|559124896|FG004|Overall Study|Lack of Efficacy|2|||
154918561|NCT01521494|559124892|FG000|Overall Study|Withdrawal by Subject|1|||
154918562|NCT01521494|559124893|FG001|Overall Study|Withdrawal by Subject|1|||
154918563|NCT01521494|559124894|FG002|Overall Study|Withdrawal by Subject|0|||
154918564|NCT01521494|559124895|FG003|Overall Study|Withdrawal by Subject|2|||
154918565|NCT01521494|559124896|FG004|Overall Study|Withdrawal by Subject|0|||
154918566|NCT01521494|559124892|FG000|Overall Study|Decrease in serum phosphate|0|||
154918567|NCT01521494|559124893|FG001|Overall Study|Decrease in serum phosphate|2|||
154918568|NCT01521494|559124894|FG002|Overall Study|Decrease in serum phosphate|3|||
154918569|NCT01521494|559124895|FG003|Overall Study|Decrease in serum phosphate|12|||
154918570|NCT01521494|559124896|FG004|Overall Study|Decrease in serum phosphate|0|||
154918571|NCT01521494|559124892|FG000|Overall Study|Decrease in serum calcium|0|||
154995088|NCT03400943|559407769|FG001|Treatment Period 1|Other|1|||
154995089|NCT03400943|559407770|FG002|Treatment Period 1|Other|2|||
154995090|NCT03400943|559407771|FG003|Treatment Period 1|Other|2|||
154995091|NCT03400943|559407768|FG000|Post-treatment Period 1|Adverse Event|2|||
154995092|NCT03400943|559407769|FG001|Post-treatment Period 1|Adverse Event|0|||
154995093|NCT03400943|559407770|FG002|Post-treatment Period 1|Adverse Event|0|||
154995094|NCT03400943|559407771|FG003|Post-treatment Period 1|Adverse Event|0|||
154995095|NCT03400943|559407768|FG000|Post-treatment Period 1|Protocol Violation|1|||
154995096|NCT03400943|559407769|FG001|Post-treatment Period 1|Protocol Violation|0|||
154995097|NCT03400943|559407770|FG002|Post-treatment Period 1|Protocol Violation|0|||
154995098|NCT03400943|559407771|FG003|Post-treatment Period 1|Protocol Violation|0|||
154995099|NCT03400943|559407768|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
154995100|NCT03400943|559407769|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
154995101|NCT03400943|559407770|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
154995102|NCT03400943|559407771|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
154995103|NCT03400943|559407768|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
154995104|NCT03400943|559407769|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
154995105|NCT03400943|559407770|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
154995106|NCT03400943|559407771|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
154995107|NCT03400943|559407768|FG000|Post-treatment Period 1|Other|2|||
154995108|NCT03400943|559407769|FG001|Post-treatment Period 1|Other|0|||
154995109|NCT03400943|559407770|FG002|Post-treatment Period 1|Other|4|||
154995110|NCT03400943|559407771|FG003|Post-treatment Period 1|Other|5|||
154995111|NCT03400943|559407768|FG000|Treatment Period 2|Study terminated by sponsor|0|||
154995112|NCT03400943|559407769|FG001|Treatment Period 2|Study terminated by sponsor|1|||
154995113|NCT03400943|559407770|FG002|Treatment Period 2|Study terminated by sponsor|0|||
154995114|NCT03400943|559407771|FG003|Treatment Period 2|Study terminated by sponsor|0|||
154995115|NCT03400943|559407768|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154995116|NCT03400943|559407769|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155122178|NCT04063787|559877947|FG000|Overall Study|Lost to Follow-up|2|||
155122179|NCT04063787|559877947|FG000|Overall Study|Death|3|||
155122180|NCT01527383|559877948|FG000|Overall Study|Adverse Event|5|||
155122181|NCT01527383|559877949|FG001|Overall Study|Adverse Event|0|||
155122182|NCT01527383|559877948|FG000|Overall Study|Lost to Follow-up|3|||
155122183|NCT01527383|559877949|FG001|Overall Study|Lost to Follow-up|0|||
155122184|NCT01527383|559877948|FG000|Overall Study|Physician Decision|2|||
155122185|NCT01527383|559877949|FG001|Overall Study|Physician Decision|0|||
155122186|NCT01527383|559877948|FG000|Overall Study|Pregnancy|1|||
155122187|NCT01527383|559877949|FG001|Overall Study|Pregnancy|0|||
155122188|NCT01527383|559877948|FG000|Overall Study|Protocol Violation|1|||
155122189|NCT01527383|559877949|FG001|Overall Study|Protocol Violation|0|||
155122190|NCT01527383|559877948|FG000|Overall Study|Screen failure|1|||
155122191|NCT01527383|559877949|FG001|Overall Study|Screen failure|0|||
155122192|NCT01527383|559877948|FG000|Overall Study|Participant moved|0|||
155122193|NCT01527383|559877949|FG001|Overall Study|Participant moved|1|||
155122194|NCT01527383|559877948|FG000|Overall Study|Withdrawal by Subject|2|||
155122195|NCT01527383|559877949|FG001|Overall Study|Withdrawal by Subject|3|||
155122196|NCT02075632|559877954|FG000|Overall Study|Adverse Event|1|||
155122197|NCT02075632|559877955|FG001|Overall Study|Adverse Event|1|||
155122198|NCT02075632|559877954|FG000|Overall Study|Lost to Follow-up|0|||
155122199|NCT02075632|559877955|FG001|Overall Study|Lost to Follow-up|3|||
155122200|NCT02075632|559877954|FG000|Overall Study|Withdrawal by Subject|0|||
155122201|NCT02075632|559877955|FG001|Overall Study|Withdrawal by Subject|1|||
155122202|NCT00740714|559877958|FG000|Overall Study|Withdrawal by Subject|17|||
155122203|NCT00740714|559877959|FG001|Overall Study|Withdrawal by Subject|19|||
155122204|NCT00740714|559877960|FG002|Overall Study|Withdrawal by Subject|29|||
155122205|NCT00394901|559877961|FG000|Baseline Phase|Protocol Violation|0|||
155122206|NCT00394901|559877962|FG001|Baseline Phase|Protocol Violation|0|||
155122207|NCT00394901|559877963|FG002|Baseline Phase|Protocol Violation|1|||
154995117|NCT03400943|559407770|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155122208|NCT00394901|559877964|FG003|Baseline Phase|Protocol Violation|0|||
155122209|NCT00394901|559877961|FG000|Double-blind Phase|Adverse Event|5|||
155122210|NCT00394901|559877962|FG001|Double-blind Phase|Adverse Event|7|||
155122211|NCT00394901|559877963|FG002|Double-blind Phase|Adverse Event|16|||
155122212|NCT00394901|559877964|FG003|Double-blind Phase|Adverse Event|20|||
155122213|NCT00394901|559877961|FG000|Double-blind Phase|Lack of Efficacy|6|||
154995118|NCT03400943|559407771|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154995119|NCT03400943|559407768|FG000|Treatment Period 2|Other|1|||
154995120|NCT03400943|559407769|FG001|Treatment Period 2|Other|6|||
154995121|NCT03400943|559407770|FG002|Treatment Period 2|Other|0|||
155122214|NCT00394901|559877962|FG001|Double-blind Phase|Lack of Efficacy|4|||
155122215|NCT00394901|559877963|FG002|Double-blind Phase|Lack of Efficacy|1|||
155122216|NCT00394901|559877964|FG003|Double-blind Phase|Lack of Efficacy|3|||
155122217|NCT00394901|559877961|FG000|Double-blind Phase|Withdrawal by Subject|2|||
155122218|NCT00394901|559877962|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155122219|NCT00394901|559877963|FG002|Double-blind Phase|Withdrawal by Subject|0|||
155122220|NCT00394901|559877964|FG003|Double-blind Phase|Withdrawal by Subject|0|||
154995122|NCT03400943|559407771|FG003|Treatment Period 2|Other|0|||
154995123|NCT03400943|559407768|FG000|Follow-up Period|Withdrawal by Subject|1|||
154995124|NCT03400943|559407769|FG001|Follow-up Period|Withdrawal by Subject|0|||
154995125|NCT03400943|559407770|FG002|Follow-up Period|Withdrawal by Subject|0|||
154995126|NCT03400943|559407771|FG003|Follow-up Period|Withdrawal by Subject|0|||
154995127|NCT00537303|559407772|FG000|Overall Study|Adverse Event|1|||
154995128|NCT00537303|559407773|FG001|Overall Study|Adverse Event|4|||
154995129|NCT00537303|559407772|FG000|Overall Study|Lack of Efficacy|6|||
154995130|NCT00537303|559407773|FG001|Overall Study|Lack of Efficacy|7|||
154995131|NCT00537303|559407772|FG000|Overall Study|Protocol Violation|8|||
154995132|NCT00537303|559407773|FG001|Overall Study|Protocol Violation|4|||
154995133|NCT00537303|559407772|FG000|Overall Study|Withdrawal criteria|3|||
154995134|NCT00537303|559407773|FG001|Overall Study|Withdrawal criteria|3|||
154995135|NCT00537303|559407772|FG000|Overall Study|Unclassified|8|||
154995136|NCT00537303|559407773|FG001|Overall Study|Unclassified|7|||
154995137|NCT03327792|559407774|FG000|Overall Study|Adverse Event|4|||
154995138|NCT03327792|559407775|FG001|Overall Study|Adverse Event|0|||
154995139|NCT03327792|559407774|FG000|Overall Study|Family/Personal issues|3|||
154995140|NCT03327792|559407775|FG001|Overall Study|Family/Personal issues|2|||
154995141|NCT03327792|559407774|FG000|Overall Study|Lost to Follow-up|0|||
155122221|NCT00394901|559877961|FG000|Double-blind Phase|Lost to Follow-up|0|||
155122222|NCT00394901|559877962|FG001|Double-blind Phase|Lost to Follow-up|0|||
155122223|NCT00394901|559877963|FG002|Double-blind Phase|Lost to Follow-up|0|||
155122224|NCT00394901|559877964|FG003|Double-blind Phase|Lost to Follow-up|1|||
155122225|NCT00394901|559877961|FG000|Double-blind Phase|Protocol Violation|0|||
155122226|NCT00394901|559877962|FG001|Double-blind Phase|Protocol Violation|0|||
155122227|NCT00394901|559877963|FG002|Double-blind Phase|Protocol Violation|0|||
155122228|NCT00394901|559877964|FG003|Double-blind Phase|Protocol Violation|1|||
155122229|NCT00394901|559877961|FG000|Double-blind Phase|Death|1|||
155122230|NCT00394901|559877962|FG001|Double-blind Phase|Death|0|||
155122231|NCT00394901|559877963|FG002|Double-blind Phase|Death|0|||
155122232|NCT00394901|559877964|FG003|Double-blind Phase|Death|0|||
155122233|NCT00394901|559877961|FG000|Double-blind Phase|Subject's Personal Reason|1|||
155122234|NCT00394901|559877962|FG001|Double-blind Phase|Subject's Personal Reason|0|||
155122235|NCT00394901|559877963|FG002|Double-blind Phase|Subject's Personal Reason|0|||
155122236|NCT00394901|559877964|FG003|Double-blind Phase|Subject's Personal Reason|1|||
155122237|NCT00394901|559877961|FG000|Double-blind Phase|Lack of Compliance|0|||
155122238|NCT00394901|559877962|FG001|Double-blind Phase|Lack of Compliance|3|||
155122239|NCT00394901|559877963|FG002|Double-blind Phase|Lack of Compliance|0|||
155122240|NCT00394901|559877964|FG003|Double-blind Phase|Lack of Compliance|0|||
155122241|NCT00394901|559877961|FG000|Double-blind Phase|Entry into another study was found|0|||
155122242|NCT00394901|559877962|FG001|Double-blind Phase|Entry into another study was found|0|||
155122243|NCT00394901|559877963|FG002|Double-blind Phase|Entry into another study was found|1|||
155122244|NCT00394901|559877964|FG003|Double-blind Phase|Entry into another study was found|0|||
155122245|NCT00394901|559877961|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
155122246|NCT00394901|559877962|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
155122247|NCT00394901|559877963|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
155122248|NCT00394901|559877964|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
155122249|NCT03002623|559877965|FG000|Overall Study|Lost to Follow-up|1|||
155122250|NCT03002623|559877966|FG001|Overall Study|Lost to Follow-up|0|||
155122251|NCT03002623|559877965|FG000|Overall Study|Physician Decision|1|||
155122252|NCT03002623|559877966|FG001|Overall Study|Physician Decision|1|||
155122253|NCT04342689|559877970|FG000|Overall Study|Withdrawal by Subject|32|||
155122254|NCT04342689|559877971|FG001|Overall Study|Withdrawal by Subject|33|||
155122255|NCT04342689|559877970|FG000|Overall Study|Lost to Follow-up|10|||
155122256|NCT04342689|559877971|FG001|Overall Study|Lost to Follow-up|12|||
155122257|NCT04070326|559877974|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
155122258|NCT04070326|559877975|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
155122259|NCT01367704|559877979|FG000|Overall Study|Lost to Follow-up|47|||
155122260|NCT01367704|559877980|FG001|Overall Study|Lost to Follow-up|161|||
155122261|NCT02193087|559877982|FG000|Overall Study|Adverse Event|2|||
155122262|NCT02193087|559877983|FG001|Overall Study|Adverse Event|0|||
155122263|NCT02193087|559877984|FG002|Overall Study|Adverse Event|0|||
155122264|NCT02193087|559877985|FG003|Overall Study|Adverse Event|11|||
155122265|NCT02193087|559877982|FG000|Overall Study|Lost to Follow-up|14|||
155122266|NCT02193087|559877983|FG001|Overall Study|Lost to Follow-up|6|||
154995142|NCT03327792|559407775|FG001|Overall Study|Lost to Follow-up|1|||
154995143|NCT00867503|559407777|FG000|Overall Study|Withdrawal by Subject|1|||
154995144|NCT04524364|559407780|FG000|Overall Study|Physician Decision|3|||
154995145|NCT04524364|559407781|FG001|Overall Study|Physician Decision|6|||
155122267|NCT02193087|559877984|FG002|Overall Study|Lost to Follow-up|4|||
154995146|NCT04524364|559407780|FG000|Overall Study|Adverse Event|0|||
154995147|NCT04524364|559407781|FG001|Overall Study|Adverse Event|1|||
154995148|NCT04524364|559407780|FG000|Overall Study|Investigational device deficiency|0|||
155122268|NCT02193087|559877985|FG003|Overall Study|Lost to Follow-up|37|||
154995149|NCT04524364|559407781|FG001|Overall Study|Investigational device deficiency|1|||
154995150|NCT04524364|559407780|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
154995151|NCT04524364|559407781|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
154995152|NCT04524364|559407780|FG000|Overall Study|Device unavailability|0|||
154995153|NCT04524364|559407781|FG001|Overall Study|Device unavailability|2|||
154995154|NCT04524364|559407780|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
154995155|NCT04524364|559407781|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
154995156|NCT04524364|559407780|FG000|Overall Study|Low International normalized ratio (INR)|1|||
154995157|NCT04524364|559407781|FG001|Overall Study|Low International normalized ratio (INR)|0|||
154995158|NCT00229723|559407782|FG000|Concomitant Phase|Adverse Event|4|||
154995159|NCT00229723|559407783|FG001|Concomitant Phase|Adverse Event|2|||
154995160|NCT00229723|559407784|FG002|Concomitant Phase|Adverse Event|5|||
154995161|NCT00229723|559407785|FG003|Concomitant Phase|Adverse Event|2|||
154995162|NCT00229723|559407786|FG004|Concomitant Phase|Adverse Event|0|||
154995163|NCT00229723|559407787|FG005|Concomitant Phase|Adverse Event|1|||
154995164|NCT00229723|559407788|FG006|Concomitant Phase|Adverse Event|2|||
154995165|NCT00229723|559407782|FG000|Concomitant Phase|Objective disease progression|0|||
154995166|NCT00229723|559407783|FG001|Concomitant Phase|Objective disease progression|0|||
154995167|NCT00229723|559407784|FG002|Concomitant Phase|Objective disease progression|0|||
154995168|NCT00229723|559407785|FG003|Concomitant Phase|Objective disease progression|0|||
154995169|NCT00229723|559407786|FG004|Concomitant Phase|Objective disease progression|0|||
154995170|NCT00229723|559407787|FG005|Concomitant Phase|Objective disease progression|0|||
154995171|NCT00229723|559407788|FG006|Concomitant Phase|Objective disease progression|0|||
154995172|NCT00229723|559407782|FG000|Concomitant Phase|Clinical progression|0|||
154995173|NCT00229723|559407783|FG001|Concomitant Phase|Clinical progression|0|||
154995174|NCT00229723|559407784|FG002|Concomitant Phase|Clinical progression|0|||
154995175|NCT00229723|559407785|FG003|Concomitant Phase|Clinical progression|0|||
154995176|NCT00229723|559407786|FG004|Concomitant Phase|Clinical progression|0|||
154995177|NCT00229723|559407787|FG005|Concomitant Phase|Clinical progression|0|||
154995178|NCT00229723|559407788|FG006|Concomitant Phase|Clinical progression|1|||
154995179|NCT00229723|559407782|FG000|Concomitant Phase|Lost to Follow-up|0|||
154995180|NCT00229723|559407783|FG001|Concomitant Phase|Lost to Follow-up|0|||
154995181|NCT00229723|559407784|FG002|Concomitant Phase|Lost to Follow-up|0|||
154995182|NCT00229723|559407785|FG003|Concomitant Phase|Lost to Follow-up|0|||
154995183|NCT00229723|559407786|FG004|Concomitant Phase|Lost to Follow-up|1|||
154995184|NCT00229723|559407787|FG005|Concomitant Phase|Lost to Follow-up|0|||
154995185|NCT00229723|559407788|FG006|Concomitant Phase|Lost to Follow-up|0|||
154995186|NCT00229723|559407782|FG000|Concomitant Phase|Informed consent withdrawn|3|||
154995187|NCT00229723|559407783|FG001|Concomitant Phase|Informed consent withdrawn|2|||
154995188|NCT00229723|559407784|FG002|Concomitant Phase|Informed consent withdrawn|0|||
154995189|NCT00229723|559407785|FG003|Concomitant Phase|Informed consent withdrawn|2|||
154995190|NCT00229723|559407786|FG004|Concomitant Phase|Informed consent withdrawn|0|||
154995191|NCT00229723|559407787|FG005|Concomitant Phase|Informed consent withdrawn|0|||
154995192|NCT00229723|559407788|FG006|Concomitant Phase|Informed consent withdrawn|0|||
154995193|NCT00229723|559407782|FG000|Concomitant Phase|Severe non-compliance|0|||
154995194|NCT00229723|559407783|FG001|Concomitant Phase|Severe non-compliance|1|||
154995195|NCT00229723|559407784|FG002|Concomitant Phase|Severe non-compliance|0|||
154995196|NCT00229723|559407785|FG003|Concomitant Phase|Severe non-compliance|0|||
154995197|NCT00229723|559407786|FG004|Concomitant Phase|Severe non-compliance|1|||
154995198|NCT00229723|559407787|FG005|Concomitant Phase|Severe non-compliance|0|||
154995199|NCT00229723|559407788|FG006|Concomitant Phase|Severe non-compliance|0|||
154995200|NCT00229723|559407782|FG000|Concomitant Phase|Other|3|||
154995201|NCT00229723|559407783|FG001|Concomitant Phase|Other|0|||
154995202|NCT00229723|559407784|FG002|Concomitant Phase|Other|1|||
154995203|NCT00229723|559407785|FG003|Concomitant Phase|Other|1|||
154995204|NCT00229723|559407786|FG004|Concomitant Phase|Other|0|||
154995205|NCT00229723|559407787|FG005|Concomitant Phase|Other|2|||
154995206|NCT00229723|559407788|FG006|Concomitant Phase|Other|0|||
154995207|NCT00229723|559407782|FG000|Maintenance Phase|Adverse Event|7|||
154995208|NCT00229723|559407783|FG001|Maintenance Phase|Adverse Event|2|||
155122269|NCT02193087|559877982|FG000|Overall Study|Protocol Violation|2|||
155122270|NCT02193087|559877983|FG001|Overall Study|Protocol Violation|0|||
155122271|NCT02193087|559877984|FG002|Overall Study|Protocol Violation|1|||
155122272|NCT02193087|559877985|FG003|Overall Study|Protocol Violation|2|||
155122273|NCT02193087|559877982|FG000|Overall Study|Withdrawal by Subject|10|||
154995209|NCT00229723|559407784|FG002|Maintenance Phase|Adverse Event|1|||
154995210|NCT00229723|559407785|FG003|Maintenance Phase|Adverse Event|4|||
154995211|NCT00229723|559407786|FG004|Maintenance Phase|Adverse Event|7|||
155177691|NCT01143389|560089358|FG000|Overall Study|Lost to Follow-up|26|||
154995212|NCT00229723|559407787|FG005|Maintenance Phase|Adverse Event|5|||
154995213|NCT00229723|559407788|FG006|Maintenance Phase|Adverse Event|2|||
154995214|NCT00229723|559407782|FG000|Maintenance Phase|Objective disease progression|5|||
154995215|NCT00229723|559407783|FG001|Maintenance Phase|Objective disease progression|5|||
154995216|NCT00229723|559407784|FG002|Maintenance Phase|Objective disease progression|3|||
154995217|NCT00229723|559407785|FG003|Maintenance Phase|Objective disease progression|6|||
154995218|NCT00229723|559407786|FG004|Maintenance Phase|Objective disease progression|2|||
154995219|NCT00229723|559407787|FG005|Maintenance Phase|Objective disease progression|9|||
154995220|NCT00229723|559407788|FG006|Maintenance Phase|Objective disease progression|5|||
154995221|NCT00229723|559407782|FG000|Maintenance Phase|Clinical progression|4|||
154995222|NCT00229723|559407783|FG001|Maintenance Phase|Clinical progression|1|||
154995223|NCT00229723|559407784|FG002|Maintenance Phase|Clinical progression|2|||
154995224|NCT00229723|559407785|FG003|Maintenance Phase|Clinical progression|2|||
154995225|NCT00229723|559407786|FG004|Maintenance Phase|Clinical progression|1|||
154995226|NCT00229723|559407787|FG005|Maintenance Phase|Clinical progression|1|||
154995227|NCT00229723|559407788|FG006|Maintenance Phase|Clinical progression|1|||
154995228|NCT00229723|559407782|FG000|Maintenance Phase|Lost to Follow-up|0|||
154995229|NCT00229723|559407783|FG001|Maintenance Phase|Lost to Follow-up|1|||
154995230|NCT00229723|559407784|FG002|Maintenance Phase|Lost to Follow-up|2|||
154995231|NCT00229723|559407785|FG003|Maintenance Phase|Lost to Follow-up|2|||
154995232|NCT00229723|559407786|FG004|Maintenance Phase|Lost to Follow-up|0|||
154995233|NCT00229723|559407787|FG005|Maintenance Phase|Lost to Follow-up|0|||
154995234|NCT00229723|559407788|FG006|Maintenance Phase|Lost to Follow-up|1|||
154995235|NCT00229723|559407782|FG000|Maintenance Phase|Informed consent withdrawn|1|||
154995236|NCT00229723|559407783|FG001|Maintenance Phase|Informed consent withdrawn|0|||
154995237|NCT00229723|559407784|FG002|Maintenance Phase|Informed consent withdrawn|0|||
154995238|NCT00229723|559407785|FG003|Maintenance Phase|Informed consent withdrawn|1|||
154995239|NCT00229723|559407786|FG004|Maintenance Phase|Informed consent withdrawn|1|||
154995240|NCT00229723|559407787|FG005|Maintenance Phase|Informed consent withdrawn|1|||
154995241|NCT00229723|559407788|FG006|Maintenance Phase|Informed consent withdrawn|0|||
154995242|NCT00229723|559407782|FG000|Maintenance Phase|Severe non-compliance|3|||
154995243|NCT00229723|559407783|FG001|Maintenance Phase|Severe non-compliance|1|||
154995244|NCT00229723|559407784|FG002|Maintenance Phase|Severe non-compliance|0|||
154995245|NCT00229723|559407785|FG003|Maintenance Phase|Severe non-compliance|0|||
154995246|NCT00229723|559407786|FG004|Maintenance Phase|Severe non-compliance|1|||
154995247|NCT00229723|559407787|FG005|Maintenance Phase|Severe non-compliance|0|||
154995248|NCT00229723|559407788|FG006|Maintenance Phase|Severe non-compliance|0|||
154995249|NCT00229723|559407782|FG000|Maintenance Phase|Other|5|||
154995250|NCT00229723|559407783|FG001|Maintenance Phase|Other|4|||
154995251|NCT00229723|559407784|FG002|Maintenance Phase|Other|1|||
154995252|NCT00229723|559407785|FG003|Maintenance Phase|Other|2|||
154995253|NCT00229723|559407786|FG004|Maintenance Phase|Other|3|||
154995254|NCT00229723|559407787|FG005|Maintenance Phase|Other|3|||
154995255|NCT00229723|559407788|FG006|Maintenance Phase|Other|1|||
154995256|NCT00998309|559407791|FG000|Overall Study|Protocol Violation|4|||
154995257|NCT00735397|559407795|FG000|Overall Study|Adverse Event|194|||
154995258|NCT00735397|559407795|FG000|Overall Study|Lost to Follow-up|33|||
154995259|NCT00735397|559407795|FG000|Overall Study|Participant choice|252|||
154995260|NCT00735397|559407795|FG000|Overall Study|Inadequate therapeutic effect|202|||
154995261|NCT00735397|559407795|FG000|Overall Study|Administrative/Other|502|||
154995262|NCT02677714|559407796|FG000|Overall Study|Withdrawal by Subject|2|||
154995263|NCT02677714|559407797|FG001|Overall Study|Withdrawal by Subject|0|||
154995264|NCT03421730|559407798|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995265|NCT03421730|559407799|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
154995266|NCT03421730|559407800|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995267|NCT03421730|559407801|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995268|NCT03421730|559407802|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995269|NCT03421730|559407803|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995270|NCT03421730|559407804|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995271|NCT03421730|559407805|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995272|NCT03421730|559407806|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995273|NCT03421730|559407807|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995274|NCT03421730|559407808|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995275|NCT03421730|559407809|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
154995276|NCT03421730|559407798|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995277|NCT03421730|559407799|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995278|NCT03421730|559407800|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995279|NCT03421730|559407801|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995280|NCT03421730|559407802|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
154995281|NCT03421730|559407803|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995282|NCT03421730|559407804|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995283|NCT03421730|559407805|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995284|NCT03421730|559407806|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995285|NCT03421730|559407807|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
155122274|NCT02193087|559877983|FG001|Overall Study|Withdrawal by Subject|3|||
154995286|NCT03421730|559407808|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995287|NCT03421730|559407809|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
154995288|NCT00380744|559407810|FG000|Overall Study|Death|0|||
154995289|NCT00380744|559407811|FG001|Overall Study|Death|0|||
154995290|NCT00380744|559407812|FG002|Overall Study|Death|0|||
154995291|NCT00380744|559407813|FG003|Overall Study|Death|0|||
154995292|NCT00380744|559407814|FG004|Overall Study|Death|0|||
154995293|NCT00380744|559407815|FG005|Overall Study|Death|0|||
154995294|NCT00380744|559407816|FG006|Overall Study|Death|1|||
154995295|NCT00380744|559407810|FG000|Overall Study|Withdrawal by Subject|1|||
154995296|NCT00380744|559407811|FG001|Overall Study|Withdrawal by Subject|0|||
154995297|NCT00380744|559407812|FG002|Overall Study|Withdrawal by Subject|0|||
154995298|NCT00380744|559407813|FG003|Overall Study|Withdrawal by Subject|0|||
154995299|NCT00380744|559407814|FG004|Overall Study|Withdrawal by Subject|0|||
154995300|NCT00380744|559407815|FG005|Overall Study|Withdrawal by Subject|0|||
154995301|NCT00380744|559407816|FG006|Overall Study|Withdrawal by Subject|0|||
154995302|NCT01338870|559407824|FG000|Overall Study|Lost to Follow-up|0|||
154995303|NCT01338870|559407825|FG001|Overall Study|Lost to Follow-up|0|||
154995304|NCT01338870|559407826|FG002|Overall Study|Lost to Follow-up|1|||
154995305|NCT01338870|559407827|FG003|Overall Study|Lost to Follow-up|0|||
154995306|NCT01338870|559407828|FG004|Overall Study|Lost to Follow-up|1|||
154995307|NCT01338870|559407829|FG005|Overall Study|Lost to Follow-up|0|||
154995308|NCT01338870|559407824|FG000|Overall Study|Withdrawal by Subject|2|||
154995309|NCT01338870|559407825|FG001|Overall Study|Withdrawal by Subject|3|||
154995310|NCT01338870|559407826|FG002|Overall Study|Withdrawal by Subject|4|||
154995311|NCT01338870|559407827|FG003|Overall Study|Withdrawal by Subject|0|||
154995312|NCT01338870|559407828|FG004|Overall Study|Withdrawal by Subject|0|||
154995313|NCT01338870|559407829|FG005|Overall Study|Withdrawal by Subject|2|||
154995314|NCT01338870|559407824|FG000|Overall Study|Other|3|||
154995315|NCT01338870|559407825|FG001|Overall Study|Other|3|||
154995316|NCT01338870|559407826|FG002|Overall Study|Other|3|||
154995317|NCT01338870|559407827|FG003|Overall Study|Other|2|||
154995318|NCT01338870|559407828|FG004|Overall Study|Other|0|||
154995319|NCT01338870|559407829|FG005|Overall Study|Other|2|||
154995320|NCT01338870|559407824|FG000|Overall Study|Protocol Violation|0|||
154995321|NCT01338870|559407825|FG001|Overall Study|Protocol Violation|2|||
154995322|NCT01338870|559407826|FG002|Overall Study|Protocol Violation|2|||
154995323|NCT01338870|559407827|FG003|Overall Study|Protocol Violation|2|||
154995324|NCT01338870|559407828|FG004|Overall Study|Protocol Violation|1|||
154995325|NCT01338870|559407829|FG005|Overall Study|Protocol Violation|1|||
154995326|NCT01338870|559407824|FG000|Overall Study|Adverse Event|4|||
154995327|NCT01338870|559407825|FG001|Overall Study|Adverse Event|4|||
154995328|NCT01338870|559407826|FG002|Overall Study|Adverse Event|1|||
154995329|NCT01338870|559407827|FG003|Overall Study|Adverse Event|5|||
154995330|NCT01338870|559407828|FG004|Overall Study|Adverse Event|4|||
154995331|NCT01338870|559407829|FG005|Overall Study|Adverse Event|1|||
154995332|NCT01955083|559407830|FG000|Overall Study|Lost to Follow-up|1|||
154995333|NCT01955083|559407831|FG001|Overall Study|Lost to Follow-up|1|||
154995334|NCT01559389|559407844|FG000|Overall Study|Withdrawal by Subject|20|||
154995335|NCT01559389|559407845|FG001|Overall Study|Withdrawal by Subject|20|||
154995336|NCT02871492|559407846|FG000|Overall Study|Lost to Follow-up|6|||
154995337|NCT02871492|559407847|FG001|Overall Study|Lost to Follow-up|3|||
154995338|NCT02871492|559407848|FG002|Overall Study|Lost to Follow-up|5|||
154995339|NCT02871492|559407846|FG000|Overall Study|Withdrawal by Subject|0|||
154995340|NCT02871492|559407847|FG001|Overall Study|Withdrawal by Subject|0|||
154995341|NCT02871492|559407848|FG002|Overall Study|Withdrawal by Subject|1|||
154995342|NCT04546724|559407849|FG000|Overall Study|Withdrawal by Subject|145|||
154995343|NCT04546724|559407850|FG001|Overall Study|Withdrawal by Subject|41|||
154995344|NCT04546724|559407849|FG000|Overall Study|Adverse Event|1|||
154995345|NCT04546724|559407850|FG001|Overall Study|Adverse Event|1|||
154995346|NCT04546724|559407849|FG000|Overall Study|Lost to Follow-up|186|||
155177692|NCT01143389|560089359|FG001|Overall Study|Lost to Follow-up|25|||
154995347|NCT04546724|559407850|FG001|Overall Study|Lost to Follow-up|63|||
154995348|NCT04546724|559407849|FG000|Overall Study|Physician Decision|8|||
154995349|NCT04546724|559407850|FG001|Overall Study|Physician Decision|2|||
154995350|NCT04546724|559407849|FG000|Overall Study|Death|2|||
154995351|NCT04546724|559407850|FG001|Overall Study|Death|1|||
154995352|NCT04546724|559407849|FG000|Overall Study|subject has been out of town|1|||
154995353|NCT04546724|559407850|FG001|Overall Study|subject has been out of town|0|||
154995354|NCT04546724|559407849|FG000|Overall Study|subject is incarcerated|2|||
154995355|NCT04546724|559407850|FG001|Overall Study|subject is incarcerated|0|||
154995356|NCT04546724|559407849|FG000|Overall Study|subject is relocating|12|||
154995357|NCT04546724|559407850|FG001|Overall Study|subject is relocating|4|||
154995358|NCT04546724|559407849|FG000|Overall Study|Subject in another study|1|||
154995359|NCT04546724|559407850|FG001|Overall Study|Subject in another study|1|||
154995360|NCT03583086|559407851|FG000|Overall Study|Death|2|||
154995361|NCT03583086|559407852|FG001|Overall Study|Death|6|||
154995362|NCT03583086|559407853|FG002|Overall Study|Death|12|||
154995363|NCT03583086|559407854|FG003|Overall Study|Death|10|||
154995364|NCT03583086|559407855|FG004|Overall Study|Death|14|||
154995365|NCT03583086|559407856|FG005|Overall Study|Death|14|||
154995366|NCT03583086|559407857|FG006|Overall Study|Death|4|||
154995367|NCT03583086|559407851|FG000|Overall Study|Withdrawal by Subject|0|||
154995368|NCT03583086|559407852|FG001|Overall Study|Withdrawal by Subject|0|||
154995369|NCT03583086|559407853|FG002|Overall Study|Withdrawal by Subject|1|||
154995370|NCT03583086|559407854|FG003|Overall Study|Withdrawal by Subject|0|||
154995371|NCT03583086|559407855|FG004|Overall Study|Withdrawal by Subject|0|||
154995372|NCT03583086|559407856|FG005|Overall Study|Withdrawal by Subject|0|||
154995373|NCT03583086|559407857|FG006|Overall Study|Withdrawal by Subject|1|||
154995374|NCT03583086|559407851|FG000|Overall Study|Refused follow-up|0|||
154995375|NCT03583086|559407852|FG001|Overall Study|Refused follow-up|0|||
154995376|NCT03583086|559407853|FG002|Overall Study|Refused follow-up|1|||
154995377|NCT03583086|559407854|FG003|Overall Study|Refused follow-up|0|||
154995378|NCT03583086|559407855|FG004|Overall Study|Refused follow-up|1|||
154995379|NCT03583086|559407856|FG005|Overall Study|Refused follow-up|0|||
154995380|NCT03583086|559407857|FG006|Overall Study|Refused follow-up|0|||
154995381|NCT03583086|559407851|FG000|Overall Study|Declining Performance Status|0|||
154995382|NCT03583086|559407852|FG001|Overall Study|Declining Performance Status|0|||
154995383|NCT03583086|559407853|FG002|Overall Study|Declining Performance Status|1|||
154995384|NCT03583086|559407854|FG003|Overall Study|Declining Performance Status|0|||
154995385|NCT03583086|559407855|FG004|Overall Study|Declining Performance Status|0|||
154995386|NCT03583086|559407856|FG005|Overall Study|Declining Performance Status|0|||
154995387|NCT03583086|559407857|FG006|Overall Study|Declining Performance Status|0|||
154995388|NCT03583086|559407851|FG000|Overall Study|Still on study|0|||
154995389|NCT03583086|559407852|FG001|Overall Study|Still on study|0|||
154995390|NCT03583086|559407853|FG002|Overall Study|Still on study|0|||
154995391|NCT03583086|559407854|FG003|Overall Study|Still on study|1|||
154995392|NCT03583086|559407855|FG004|Overall Study|Still on study|0|||
154995393|NCT03583086|559407856|FG005|Overall Study|Still on study|0|||
154995394|NCT03583086|559407857|FG006|Overall Study|Still on study|1|||
154995395|NCT03583086|559407851|FG000|Overall Study|Disease progression|0|||
155122275|NCT02193087|559877984|FG002|Overall Study|Withdrawal by Subject|1|||
155122276|NCT02193087|559877985|FG003|Overall Study|Withdrawal by Subject|19|||
155122277|NCT02193087|559877982|FG000|Overall Study|Other Reason Not Specified|7|||
155122278|NCT02193087|559877983|FG001|Overall Study|Other Reason Not Specified|2|||
155122279|NCT02193087|559877984|FG002|Overall Study|Other Reason Not Specified|1|||
155122280|NCT02193087|559877985|FG003|Overall Study|Other Reason Not Specified|9|||
155122281|NCT02193087|559877982|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
154918572|NCT01521494|559124893|FG001|Overall Study|Decrease in serum calcium|0|||
154918573|NCT01521494|559124894|FG002|Overall Study|Decrease in serum calcium|0|||
154918574|NCT01521494|559124895|FG003|Overall Study|Decrease in serum calcium|1|||
154918575|NCT01521494|559124896|FG004|Overall Study|Decrease in serum calcium|1|||
154918576|NCT01521494|559124892|FG000|Overall Study|Physician Decision|0|||
154918577|NCT01521494|559124893|FG001|Overall Study|Physician Decision|0|||
154918578|NCT01521494|559124894|FG002|Overall Study|Physician Decision|0|||
154918579|NCT01521494|559124895|FG003|Overall Study|Physician Decision|0|||
154918580|NCT01521494|559124896|FG004|Overall Study|Physician Decision|2|||
154918581|NCT00877929|559124897|FG000|Overall Study|Adverse Event|11|||
154918582|NCT00877929|559124898|FG001|Overall Study|Adverse Event|20|||
154918583|NCT00877929|559124897|FG000|Overall Study|Protocol Violation|3|||
154918584|NCT00877929|559124898|FG001|Overall Study|Protocol Violation|3|||
154918585|NCT00877929|559124897|FG000|Overall Study|Lost to Follow-up|0|||
154918586|NCT00877929|559124898|FG001|Overall Study|Lost to Follow-up|1|||
154918587|NCT00877929|559124897|FG000|Overall Study|Withdrawal by Subject|4|||
154918588|NCT00877929|559124898|FG001|Overall Study|Withdrawal by Subject|4|||
154918589|NCT00877929|559124897|FG000|Overall Study|Lack of Efficacy|0|||
154918590|NCT00877929|559124898|FG001|Overall Study|Lack of Efficacy|1|||
154918591|NCT00877929|559124897|FG000|Overall Study|Other reason (not specified)|2|||
154918592|NCT00877929|559124898|FG001|Overall Study|Other reason (not specified)|6|||
154918593|NCT01140646|559124899|FG000|Overall Study|Adverse Event|4|||
154918594|NCT01140646|559124899|FG000|Overall Study|Refused Further Treatment|5|||
154918595|NCT00689728|559124902|FG000|Double-Blind Treatment|Adverse Event|1|||
154918596|NCT00689728|559124903|FG001|Double-Blind Treatment|Adverse Event|0|||
154918597|NCT00689728|559124904|FG002|Double-Blind Treatment|Adverse Event|0|||
154918598|NCT00689728|559124902|FG000|Double-Blind Treatment|Protocol Violation|0|||
154918599|NCT00689728|559124903|FG001|Double-Blind Treatment|Protocol Violation|0|||
154995396|NCT03583086|559407852|FG001|Overall Study|Disease progression|0|||
154995397|NCT03583086|559407853|FG002|Overall Study|Disease progression|0|||
154995398|NCT03583086|559407854|FG003|Overall Study|Disease progression|0|||
154995399|NCT03583086|559407855|FG004|Overall Study|Disease progression|0|||
154995400|NCT03583086|559407856|FG005|Overall Study|Disease progression|0|||
154995401|NCT03583086|559407857|FG006|Overall Study|Disease progression|1|||
154918600|NCT00689728|559124904|FG002|Double-Blind Treatment|Protocol Violation|1|||
154918601|NCT00689728|559124902|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
154918602|NCT00689728|559124903|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
155122282|NCT02193087|559877983|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
154918603|NCT00689728|559124904|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
154918604|NCT00689728|559124902|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
154918605|NCT00689728|559124903|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
154918606|NCT00689728|559124904|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
154918607|NCT00689728|559124902|FG000|Rescue|Adverse Event|0|||
154918608|NCT00689728|559124903|FG001|Rescue|Adverse Event|1|||
154918609|NCT00689728|559124904|FG002|Rescue|Adverse Event|0|||
154918610|NCT00689728|559124902|FG000|Rescue|Withdrawal by Subject|1|||
154918611|NCT00689728|559124903|FG001|Rescue|Withdrawal by Subject|1|||
154918612|NCT00689728|559124904|FG002|Rescue|Withdrawal by Subject|1|||
154918613|NCT00689728|559124902|FG000|Optional Follow-Up|Adverse Event|1|||
154918614|NCT00689728|559124903|FG001|Optional Follow-Up|Adverse Event|0|||
154918615|NCT00689728|559124904|FG002|Optional Follow-Up|Adverse Event|0|||
154918616|NCT00689728|559124902|FG000|Optional Follow-Up|Lack of Efficacy|0|||
154918617|NCT00689728|559124903|FG001|Optional Follow-Up|Lack of Efficacy|1|||
154918618|NCT00689728|559124904|FG002|Optional Follow-Up|Lack of Efficacy|1|||
154918619|NCT00689728|559124902|FG000|Optional Follow-Up|Lost to Follow-up|0|||
154918620|NCT00689728|559124903|FG001|Optional Follow-Up|Lost to Follow-up|1|||
154918621|NCT00689728|559124904|FG002|Optional Follow-Up|Lost to Follow-up|1|||
154918622|NCT00689728|559124902|FG000|Optional Follow-Up|Protocol Violation|0|||
154918623|NCT00689728|559124903|FG001|Optional Follow-Up|Protocol Violation|0|||
154918624|NCT00689728|559124904|FG002|Optional Follow-Up|Protocol Violation|1|||
154918625|NCT00689728|559124902|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
154918626|NCT00689728|559124903|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
154918627|NCT00689728|559124904|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
154918628|NCT00842829|559124909|FG000|Dose Titration Period|Adverse Event|11|||
154918629|NCT00842829|559124910|FG001|Dose Titration Period|Adverse Event|10|||
154995402|NCT03583086|559407851|FG000|Overall Study|Undergoing radiation therapy|0|||
154995403|NCT03583086|559407852|FG001|Overall Study|Undergoing radiation therapy|0|||
154995404|NCT03583086|559407853|FG002|Overall Study|Undergoing radiation therapy|0|||
154995405|NCT03583086|559407854|FG003|Overall Study|Undergoing radiation therapy|0|||
154995406|NCT03583086|559407855|FG004|Overall Study|Undergoing radiation therapy|0|||
154995407|NCT03583086|559407856|FG005|Overall Study|Undergoing radiation therapy|0|||
154995408|NCT03583086|559407857|FG006|Overall Study|Undergoing radiation therapy|1|||
154995409|NCT03583086|559407851|FG000|Overall Study|Lost to Follow-up|0|||
154995410|NCT03583086|559407852|FG001|Overall Study|Lost to Follow-up|0|||
154995411|NCT03583086|559407853|FG002|Overall Study|Lost to Follow-up|0|||
154995412|NCT03583086|559407854|FG003|Overall Study|Lost to Follow-up|0|||
154918630|NCT00842829|559124911|FG002|Dose Titration Period|Adverse Event|0|||
154918631|NCT00842829|559124909|FG000|Dose Titration Period|Lack of Efficacy|4|||
154918632|NCT00842829|559124910|FG001|Dose Titration Period|Lack of Efficacy|1|||
154918633|NCT00842829|559124911|FG002|Dose Titration Period|Lack of Efficacy|0|||
154918634|NCT00842829|559124909|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
154918635|NCT00842829|559124910|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
154918636|NCT00842829|559124911|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
154918637|NCT00842829|559124909|FG000|Dose Titration Period|Withdrawal by Subject|2|||
154995413|NCT03583086|559407855|FG004|Overall Study|Lost to Follow-up|0|||
154995414|NCT03583086|559407856|FG005|Overall Study|Lost to Follow-up|1|||
154995415|NCT03583086|559407857|FG006|Overall Study|Lost to Follow-up|0|||
154995416|NCT03583086|559407851|FG000|Overall Study|Adverse Event|0|||
154995417|NCT03583086|559407852|FG001|Overall Study|Adverse Event|0|||
154995418|NCT03583086|559407853|FG002|Overall Study|Adverse Event|0|||
154995419|NCT03583086|559407854|FG003|Overall Study|Adverse Event|0|||
154995420|NCT03583086|559407855|FG004|Overall Study|Adverse Event|0|||
154995421|NCT03583086|559407856|FG005|Overall Study|Adverse Event|1|||
154995422|NCT03583086|559407857|FG006|Overall Study|Adverse Event|0|||
154995423|NCT00396812|559407861|FG000|Overall Study|Physician Decision|1|||
154995424|NCT03201445|559407863|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
154995425|NCT03201445|559407864|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
154995426|NCT03201445|559407863|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
154995427|NCT03201445|559407864|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
154995428|NCT03201445|559407863|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
154995429|NCT03201445|559407864|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
154995430|NCT03201445|559407863|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
154995431|NCT03201445|559407864|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
154995432|NCT03201445|559407863|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
154995433|NCT03201445|559407864|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
154995434|NCT03201445|559407863|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
154995435|NCT03201445|559407864|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
155122283|NCT02193087|559877984|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
155122284|NCT02193087|559877985|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
155122285|NCT02726880|559877986|FG000|Overall Study|Withdrawal by Subject|2|||
154918638|NCT00842829|559124910|FG001|Dose Titration Period|Withdrawal by Subject|6|||
154918639|NCT00842829|559124911|FG002|Dose Titration Period|Withdrawal by Subject|0|||
154918640|NCT00842829|559124909|FG000|Dose Titration Period|Other|5|||
154918641|NCT00842829|559124910|FG001|Dose Titration Period|Other|4|||
154918642|NCT00842829|559124911|FG002|Dose Titration Period|Other|0|||
154995436|NCT03201445|559407863|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
154995437|NCT03201445|559407864|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
154995438|NCT03201445|559407863|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
154995439|NCT03201445|559407864|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
154995440|NCT03201445|559407863|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
154995441|NCT03201445|559407864|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
154995442|NCT03201445|559407863|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
154995443|NCT03201445|559407864|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
154995444|NCT03201445|559407863|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
154995445|NCT03201445|559407864|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
154995446|NCT03201445|559407863|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
154995447|NCT03201445|559407864|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
154995448|NCT03201445|559407863|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
154995449|NCT03201445|559407864|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
154995450|NCT03201445|559407863|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
154995451|NCT03201445|559407864|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
154995452|NCT03201445|559407863|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
154995453|NCT03201445|559407864|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
154995454|NCT03201445|559407863|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
154995455|NCT03201445|559407864|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
154995456|NCT03201445|559407863|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
154995457|NCT03201445|559407864|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
154995458|NCT03201445|559407863|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
154995459|NCT03201445|559407864|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
154995460|NCT03201445|559407863|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
154995461|NCT03201445|559407864|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
154995462|NCT03201445|559407863|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
154995463|NCT03201445|559407864|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
154995464|NCT03201445|559407863|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
154995465|NCT03201445|559407864|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
154995466|NCT01228019|559407865|FG000|Overall Study|Dose Violation|70|||
154995467|NCT01228019|559407865|FG000|Overall Study|Duplicate enrollment|1|||
154995468|NCT01228019|559407865|FG000|Overall Study|Missing pre-treatment data|72|||
154995469|NCT01228019|559407865|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
154995470|NCT01228019|559407865|FG000|Overall Study|Violation of Entry Criterion|9|||
154995471|NCT01346293|559407868|FG000|Overall Study|Protocol Violation|30|||
154995472|NCT01346293|559407869|FG001|Overall Study|Protocol Violation|9|||
154995473|NCT01346293|559407868|FG000|Overall Study|Lost to Follow-up|21|||
154995474|NCT01346293|559407869|FG001|Overall Study|Lost to Follow-up|8|||
154995475|NCT01346293|559407868|FG000|Overall Study|Withdrawal by Subject|15|||
154995476|NCT01346293|559407869|FG001|Overall Study|Withdrawal by Subject|4|||
154995477|NCT01346293|559407868|FG000|Overall Study|Other|1|||
154995478|NCT01346293|559407869|FG001|Overall Study|Other|0|||
154918643|NCT00842829|559124909|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
154918644|NCT00842829|559124910|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
154918645|NCT00842829|559124911|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
154918646|NCT00842829|559124909|FG000|Dose Titration Period|Non-compliance to study drug|2|||
154918647|NCT00842829|559124910|FG001|Dose Titration Period|Non-compliance to study drug|1|||
154918648|NCT00842829|559124911|FG002|Dose Titration Period|Non-compliance to study drug|0|||
154918649|NCT00842829|559124909|FG000|Treatment Period|Adverse Event|0|||
154918650|NCT00842829|559124910|FG001|Treatment Period|Adverse Event|0|||
154918651|NCT00842829|559124911|FG002|Treatment Period|Adverse Event|15|||
154918652|NCT00842829|559124909|FG000|Treatment Period|Lack of Efficacy|0|||
154995479|NCT01844505|559407872|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
154995480|NCT01844505|559407873|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
154995481|NCT01844505|559407874|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
155122286|NCT02726880|559877987|FG001|Overall Study|Withdrawal by Subject|0|||
155122287|NCT02726880|559877986|FG000|Overall Study|Lost to Follow-up|1|||
154918653|NCT00842829|559124910|FG001|Treatment Period|Lack of Efficacy|0|||
154918654|NCT00842829|559124911|FG002|Treatment Period|Lack of Efficacy|6|||
154918655|NCT00842829|559124909|FG000|Treatment Period|Unstable persistent cancer pain|0|||
154918656|NCT00842829|559124910|FG001|Treatment Period|Unstable persistent cancer pain|0|||
154918657|NCT00842829|559124911|FG002|Treatment Period|Unstable persistent cancer pain|5|||
154918658|NCT00842829|559124909|FG000|Treatment Period|Withdrawal by Subject|0|||
154918659|NCT00842829|559124910|FG001|Treatment Period|Withdrawal by Subject|0|||
154995482|NCT01844505|559407872|FG000|Treatment Period|Other Reasons|120|||
154995483|NCT01844505|559407873|FG001|Treatment Period|Other Reasons|136|||
154918660|NCT00842829|559124911|FG002|Treatment Period|Withdrawal by Subject|11|||
154918661|NCT00842829|559124909|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
154995484|NCT01844505|559407874|FG002|Treatment Period|Other Reasons|58|||
154995485|NCT01844505|559407872|FG000|Treatment Period|Lost to Follow-up|9|||
154995486|NCT01844505|559407873|FG001|Treatment Period|Lost to Follow-up|11|||
154995487|NCT01844505|559407874|FG002|Treatment Period|Lost to Follow-up|6|||
154995488|NCT01844505|559407872|FG000|Treatment Period|Death|175|||
154995489|NCT01844505|559407873|FG001|Treatment Period|Death|154|||
154995490|NCT01844505|559407874|FG002|Treatment Period|Death|228|||
154995491|NCT00128830|559407875|FG000|Overall Study|Adverse Event|10|||
154995492|NCT00128830|559407875|FG000|Overall Study|Withdrawal by Subject|14|||
154995493|NCT00128830|559407875|FG000|Overall Study|Lost to Follow-up|4|||
154995494|NCT00128830|559407875|FG000|Overall Study|Reached a virologic endpoint|29|||
154995495|NCT00128830|559407875|FG000|Overall Study|Non-compliant|4|||
154995496|NCT00128830|559407875|FG000|Overall Study|Discontinued or ineligible for study|2|||
154995497|NCT00128830|559407875|FG000|Overall Study|Other|9|||
154995498|NCT02730351|559407876|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
154995499|NCT02730351|559407877|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
154995500|NCT02730351|559407876|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
154995501|NCT02730351|559407877|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
154918662|NCT00842829|559124910|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
154918663|NCT00842829|559124911|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
154918664|NCT00842829|559124909|FG000|Treatment Period|Protocol Violation|0|||
154918665|NCT00842829|559124910|FG001|Treatment Period|Protocol Violation|0|||
154918666|NCT00842829|559124911|FG002|Treatment Period|Protocol Violation|2|||
154918667|NCT00842829|559124909|FG000|Treatment Period|Other|0|||
154918668|NCT00842829|559124910|FG001|Treatment Period|Other|0|||
154918669|NCT00842829|559124911|FG002|Treatment Period|Other|18|||
154918670|NCT00842829|559124909|FG000|Treatment Period|Non-compliance to study procedures|0|||
154918671|NCT00842829|559124910|FG001|Treatment Period|Non-compliance to study procedures|0|||
154918672|NCT00842829|559124911|FG002|Treatment Period|Non-compliance to study procedures|4|||
154918673|NCT00842829|559124909|FG000|Treatment Period|Unclear completion status|0|||
154918674|NCT00842829|559124910|FG001|Treatment Period|Unclear completion status|0|||
154918675|NCT00842829|559124911|FG002|Treatment Period|Unclear completion status|1|||
154918676|NCT00842829|559124909|FG000|Continuation Period|Adverse Event|0|||
154918677|NCT00842829|559124910|FG001|Continuation Period|Adverse Event|0|||
154918678|NCT00842829|559124911|FG002|Continuation Period|Adverse Event|32|||
154918679|NCT00842829|559124909|FG000|Continuation Period|Lack of Efficacy|0|||
154918680|NCT00842829|559124910|FG001|Continuation Period|Lack of Efficacy|0|||
154918681|NCT00842829|559124911|FG002|Continuation Period|Lack of Efficacy|6|||
154918682|NCT00842829|559124909|FG000|Continuation Period|Unstable persistent cancer pain|0|||
154918683|NCT00842829|559124910|FG001|Continuation Period|Unstable persistent cancer pain|0|||
154918684|NCT00842829|559124911|FG002|Continuation Period|Unstable persistent cancer pain|3|||
154918685|NCT00842829|559124909|FG000|Continuation Period|Withdrawal by Subject|0|||
154918686|NCT00842829|559124910|FG001|Continuation Period|Withdrawal by Subject|0|||
154918687|NCT00842829|559124911|FG002|Continuation Period|Withdrawal by Subject|10|||
154918688|NCT00842829|559124909|FG000|Continuation Period|Other|0|||
154995502|NCT02730351|559407876|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
154995503|NCT02730351|559407877|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
154995504|NCT02730351|559407876|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
154995505|NCT02730351|559407877|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
154995506|NCT02730351|559407876|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
154995507|NCT02730351|559407877|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
154995508|NCT00311402|559407878|FG000|Overall Study|Adverse Event|118|||
154995509|NCT00311402|559407879|FG001|Overall Study|Adverse Event|105|||
154995510|NCT00311402|559407878|FG000|Overall Study|Lost to Follow-up|0|||
154995511|NCT00311402|559407879|FG001|Overall Study|Lost to Follow-up|3|||
154995512|NCT00311402|559407878|FG000|Overall Study|Withdrawal by Subject|17|||
154995513|NCT00311402|559407879|FG001|Overall Study|Withdrawal by Subject|18|||
154995514|NCT00311402|559407878|FG000|Overall Study|Lack of Efficacy|58|||
155122288|NCT02726880|559877987|FG001|Overall Study|Lost to Follow-up|3|||
155122289|NCT00787202|559877988|FG000|Overall Study|Adverse Event|3|||
155122290|NCT00787202|559877989|FG001|Overall Study|Adverse Event|2|||
155122291|NCT00787202|559877990|FG002|Overall Study|Adverse Event|0|||
155122292|NCT00787202|559877991|FG003|Overall Study|Adverse Event|0|||
154918689|NCT00842829|559124910|FG001|Continuation Period|Other|0|||
154918690|NCT00842829|559124911|FG002|Continuation Period|Other|7|||
154995515|NCT00311402|559407879|FG001|Overall Study|Lack of Efficacy|42|||
154995516|NCT00311402|559407878|FG000|Overall Study|Protocol Violation|7|||
154995517|NCT00311402|559407879|FG001|Overall Study|Protocol Violation|6|||
154995518|NCT00311402|559407878|FG000|Overall Study|IRB's rejection etc.|10|||
155122293|NCT00787202|559877992|FG004|Overall Study|Adverse Event|2|||
155122294|NCT00787202|559877988|FG000|Overall Study|Lack of Efficacy|5|||
155122295|NCT00787202|559877989|FG001|Overall Study|Lack of Efficacy|6|||
154918691|NCT00842829|559124909|FG000|Continuation Period|Non-compliance to study procedures|0|||
154918692|NCT00842829|559124910|FG001|Continuation Period|Non-compliance to study procedures|0|||
154918693|NCT00842829|559124911|FG002|Continuation Period|Non-compliance to study procedures|2|||
155122296|NCT00787202|559877990|FG002|Overall Study|Lack of Efficacy|5|||
154995519|NCT00311402|559407879|FG001|Overall Study|IRB's rejection etc.|3|||
154995520|NCT02640053|559407880|FG000|Overall Study|Withdrawal by Subject|2|||
154995521|NCT02640053|559407881|FG001|Overall Study|Withdrawal by Subject|1|||
154995522|NCT02640053|559407880|FG000|Overall Study|Adverse Event|1|||
154995523|NCT02640053|559407881|FG001|Overall Study|Adverse Event|1|||
154995524|NCT02640053|559407880|FG000|Overall Study|Alternative Therapy|1|||
154995525|NCT02640053|559407881|FG001|Overall Study|Alternative Therapy|1|||
154995526|NCT02640053|559407880|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
154995527|NCT02640053|559407881|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
154995528|NCT02036775|559407882|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
154995529|NCT02036775|559407883|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
154995530|NCT02036775|559407884|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
154995531|NCT02036775|559407885|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
154918694|NCT00842829|559124909|FG000|Continuation Period|Non-compliance to study drug|0|||
154918695|NCT00842829|559124910|FG001|Continuation Period|Non-compliance to study drug|0|||
154918696|NCT00842829|559124911|FG002|Continuation Period|Non-compliance to study drug|1|||
154918697|NCT02612194|559124918|FG000|Overall Study|Death|5|||
154918698|NCT02612194|559124919|FG001|Overall Study|Death|0|||
154918699|NCT02612194|559124920|FG002|Overall Study|Death|2|||
154918700|NCT02612194|559124918|FG000|Overall Study|Early Study Termination|1|||
154918701|NCT02612194|559124919|FG001|Overall Study|Early Study Termination|0|||
154918702|NCT02612194|559124920|FG002|Overall Study|Early Study Termination|0|||
154918703|NCT02539160|559124921|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
154918704|NCT02539160|559124922|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
154918705|NCT02539160|559124923|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
154918706|NCT02539160|559124924|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
154918707|NCT02539160|559124921|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
154918708|NCT02539160|559124922|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
154918709|NCT02539160|559124923|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
154918710|NCT02539160|559124924|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
154918711|NCT02539160|559124921|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
154918712|NCT02539160|559124922|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
154918713|NCT02539160|559124923|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
154918714|NCT02539160|559124924|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
154918715|NCT01681004|559124925|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
154918716|NCT01681004|559124926|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
154918717|NCT01681004|559124925|FG000|Study Completion|Lost to Follow-up|8|||
154918718|NCT01681004|559124926|FG001|Study Completion|Lost to Follow-up|3|||
154918719|NCT01681004|559124925|FG000|Study Completion|Physician Decision|1|||
154918720|NCT01681004|559124926|FG001|Study Completion|Physician Decision|3|||
154918721|NCT01681004|559124925|FG000|Study Completion|Site Termination|2|||
154995532|NCT02036775|559407886|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
154995533|NCT02036775|559407887|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
154995534|NCT01268501|559407888|FG000|Overall Study|Lost to Follow-up|1|||
154995535|NCT01268501|559407888|FG000|Overall Study|Withdrawal by Subject|3|||
154995536|NCT01268501|559407888|FG000|Overall Study|Unacceptable Subjective Vision|3|||
154995537|NCT01268501|559407888|FG000|Overall Study|Handling Difficulties|2|||
154995538|NCT02927366|559407890|FG000|Overall Study|Adverse Event|1|||
154995539|NCT02927366|559407891|FG001|Overall Study|Adverse Event|0|||
154995540|NCT02927366|559407890|FG000|Overall Study|Patient schedule|1|||
154995541|NCT02927366|559407891|FG001|Overall Study|Patient schedule|0|||
154995542|NCT02910063|559407894|FG000|Phase 2|Withdrawal by Subject|3|||
154995543|NCT02910063|559407895|FG001|Phase 2|Withdrawal by Subject|0|||
154995544|NCT02910063|559407896|FG002|Phase 2|Withdrawal by Subject|0|||
154995545|NCT02910063|559407894|FG000|Phase 2|Lost to Follow-up|1|||
154995546|NCT02910063|559407895|FG001|Phase 2|Lost to Follow-up|0|||
154995547|NCT02910063|559407896|FG002|Phase 2|Lost to Follow-up|0|||
154995548|NCT02910063|559407894|FG000|Phase 2|Death|24|||
154995549|NCT02910063|559407895|FG001|Phase 2|Death|0|||
155122297|NCT00787202|559877991|FG003|Overall Study|Lack of Efficacy|2|||
155122298|NCT00787202|559877992|FG004|Overall Study|Lack of Efficacy|1|||
154918722|NCT01681004|559124926|FG001|Study Completion|Site Termination|1|||
154918723|NCT01681004|559124925|FG000|Study Completion|Death|1|||
154918724|NCT01681004|559124926|FG001|Study Completion|Death|1|||
154995550|NCT02910063|559407896|FG002|Phase 2|Death|0|||
154995551|NCT03496610|559407897|FG000|Overall Study|Lost to Follow-up|3|||
154995552|NCT03496610|559407898|FG001|Overall Study|Lost to Follow-up|2|||
154995553|NCT03496610|559407897|FG000|Overall Study|Physician Decision|1|||
155122299|NCT00787202|559877988|FG000|Overall Study|Lost to Follow-up|1|||
154918725|NCT00372905|559124927|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
154918726|NCT00372905|559124928|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
154918727|NCT00372905|559124929|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
154918728|NCT00372905|559124930|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
154995554|NCT03496610|559407898|FG001|Overall Study|Physician Decision|0|||
154995555|NCT03496610|559407897|FG000|Overall Study|Withdrawal by Subject|1|||
154995556|NCT03496610|559407898|FG001|Overall Study|Withdrawal by Subject|0|||
154995557|NCT02774642|559407902|FG000|Overall Study|Lost to Follow-up|9|||
155177693|NCT04966910|560089360|FG000|Baseline|Participant did not complete measure|0|||
155177694|NCT04966910|560089361|FG001|Baseline|Participant did not complete measure|0|||
154918729|NCT00372905|559124927|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
154918730|NCT00372905|559124928|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
154918731|NCT00372905|559124929|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
154918732|NCT00372905|559124930|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
154918733|NCT00372905|559124927|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
154918734|NCT00372905|559124928|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
154918735|NCT00372905|559124929|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
154918736|NCT00372905|559124930|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
154918737|NCT00372905|559124927|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
154918738|NCT00372905|559124928|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
154918739|NCT00372905|559124929|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
154918740|NCT00372905|559124930|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
154918741|NCT00372905|559124927|FG000|Follow up Until Relapse or Progression|Study closed|0|||
154918742|NCT00372905|559124928|FG001|Follow up Until Relapse or Progression|Study closed|0|||
154918743|NCT00372905|559124929|FG002|Follow up Until Relapse or Progression|Study closed|0|||
154918744|NCT00372905|559124930|FG003|Follow up Until Relapse or Progression|Study closed|3|||
154918745|NCT00372905|559124927|FG000|Follow up Until Relapse or Progression|Other|0|||
154918746|NCT00372905|559124928|FG001|Follow up Until Relapse or Progression|Other|1|||
154918747|NCT00372905|559124929|FG002|Follow up Until Relapse or Progression|Other|0|||
154918748|NCT00372905|559124930|FG003|Follow up Until Relapse or Progression|Other|0|||
154918749|NCT01728454|559124931|FG000|Stage 1 and 2|Pregnancy|1|||
154918750|NCT01728454|559124932|FG001|Stage 1 and 2|Pregnancy|0|||
154918751|NCT01728454|559124933|FG002|Stage 1 and 2|Pregnancy|0|||
154918752|NCT01728454|559124931|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
154918753|NCT01728454|559124932|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
154918754|NCT01728454|559124933|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
154918755|NCT01728454|559124931|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
154918756|NCT01728454|559124932|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
154918757|NCT01728454|559124933|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
154918758|NCT01728454|559124931|FG000|Stage 1 and 2|Lost to Follow-up|1|||
154918759|NCT01728454|559124932|FG001|Stage 1 and 2|Lost to Follow-up|1|||
154918760|NCT01728454|559124933|FG002|Stage 1 and 2|Lost to Follow-up|0|||
154918761|NCT01728454|559124931|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
154918762|NCT01728454|559124932|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
154918763|NCT01728454|559124933|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
154918764|NCT01728454|559124931|FG000|Stage 3|Reason Missing|0|||
154918765|NCT01728454|559124932|FG001|Stage 3|Reason Missing|0|||
154918766|NCT01728454|559124933|FG002|Stage 3|Reason Missing|1|||
154918767|NCT01728454|559124931|FG000|Stage 3|Subject Required Other Treatment|0|||
154918768|NCT01728454|559124932|FG001|Stage 3|Subject Required Other Treatment|1|||
154918769|NCT01728454|559124933|FG002|Stage 3|Subject Required Other Treatment|0|||
154918770|NCT01728454|559124931|FG000|Stage 3|Pregnancy|1|||
154918771|NCT01728454|559124932|FG001|Stage 3|Pregnancy|0|||
154918772|NCT01728454|559124933|FG002|Stage 3|Pregnancy|0|||
154918773|NCT01728454|559124931|FG000|Stage 3|Withdrew Consent|1|||
154918774|NCT01728454|559124932|FG001|Stage 3|Withdrew Consent|0|||
154918775|NCT01728454|559124933|FG002|Stage 3|Withdrew Consent|1|||
154918776|NCT01728454|559124931|FG000|Stage 3|Non-compliance with Protocol|0|||
154918777|NCT01728454|559124932|FG001|Stage 3|Non-compliance with Protocol|0|||
154918778|NCT01728454|559124933|FG002|Stage 3|Non-compliance with Protocol|1|||
154918779|NCT01728454|559124931|FG000|Stage 3|Lost to Follow-up|0|||
154918780|NCT01728454|559124932|FG001|Stage 3|Lost to Follow-up|3|||
154918781|NCT01728454|559124933|FG002|Stage 3|Lost to Follow-up|1|||
154918782|NCT01728454|559124931|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
154918783|NCT01728454|559124932|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
154918784|NCT01728454|559124933|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
154918785|NCT00689299|559124936|FG000|Overall Study|Adverse Event|2|||
154918786|NCT00689299|559124937|FG001|Overall Study|Adverse Event|1|||
154918787|NCT00689299|559124938|FG002|Overall Study|Adverse Event|1|||
154918788|NCT00689299|559124936|FG000|Overall Study|Lost to Follow-up|0|||
154918789|NCT00689299|559124937|FG001|Overall Study|Lost to Follow-up|1|||
154918790|NCT00689299|559124938|FG002|Overall Study|Lost to Follow-up|1|||
154918791|NCT00689299|559124936|FG000|Overall Study|Withdrawal by Subject|4|||
154918792|NCT00689299|559124937|FG001|Overall Study|Withdrawal by Subject|1|||
154918793|NCT00689299|559124938|FG002|Overall Study|Withdrawal by Subject|3|||
154918794|NCT00689299|559124936|FG000|Overall Study|Protocol Violation|1|||
154918795|NCT00689299|559124937|FG001|Overall Study|Protocol Violation|0|||
154918796|NCT00689299|559124938|FG002|Overall Study|Protocol Violation|0|||
154995558|NCT02774642|559407903|FG001|Overall Study|Lost to Follow-up|7|||
154918797|NCT01190839|559124939|FG000|Overall Study|Adverse Event|32|||
154918798|NCT01190839|559124940|FG001|Overall Study|Adverse Event|41|||
154918799|NCT01190839|559124939|FG000|Overall Study|Protocol Violation|2|||
154995559|NCT00827632|559407904|FG000|Overall Study|Lost to Follow-up|8|||
154918800|NCT01190839|559124940|FG001|Overall Study|Protocol Violation|2|||
154918801|NCT01190839|559124939|FG000|Overall Study|Lost to Follow-up|7|||
154918802|NCT01190839|559124940|FG001|Overall Study|Lost to Follow-up|1|||
154918803|NCT01190839|559124939|FG000|Overall Study|Death|1|||
154918804|NCT01190839|559124940|FG001|Overall Study|Death|0|||
154918805|NCT01190839|559124939|FG000|Overall Study|Trial stopped by Sponsor|71|||
154918806|NCT01190839|559124940|FG001|Overall Study|Trial stopped by Sponsor|68|||
154918807|NCT01190839|559124939|FG000|Overall Study|Undefined|35|||
154918808|NCT01190839|559124940|FG001|Overall Study|Undefined|31|||
154918809|NCT01190839|559124939|FG000|Overall Study|Randomized but not treated|2|||
154918810|NCT01190839|559124940|FG001|Overall Study|Randomized but not treated|4|||
154918811|NCT03077646|559124947|FG000|Overall Study|Lost to Follow-up|29|||
154918812|NCT03077646|559124948|FG001|Overall Study|Lost to Follow-up|30|||
154918813|NCT03077646|559124949|FG002|Overall Study|Lost to Follow-up|31|||
154918814|NCT00765726|559124950|FG000|Overall Study|Withdrawal by Subject|1|||
154918815|NCT00765726|559124950|FG000|Overall Study|Discontinuation of study by sponsor|8|||
154918816|NCT02058966|559124951|FG000|Open-Label Methamphetamine|Adverse Event|1|||
154918817|NCT02058966|559124951|FG000|First Intervention|Withdrawal by Subject|1|||
154918818|NCT01265511|559124952|FG000|Overall Study|Lack of Efficacy|2|||
154918819|NCT01265511|559124953|FG001|Overall Study|Lack of Efficacy|1|||
154918820|NCT01265511|559124952|FG000|Overall Study|Met stopping rules|0|||
154918821|NCT01265511|559124953|FG001|Overall Study|Met stopping rules|2|||
154918822|NCT02993731|559124954|FG000|Overall Study|Study Termination|101|||
154918823|NCT02993731|559124955|FG001|Overall Study|Study Termination|105|||
154918824|NCT01362062|559124956|FG000|Overall Study|Adverse Event|1|||
154918825|NCT01362062|559124957|FG001|Overall Study|Adverse Event|0|||
154918826|NCT01362062|559124956|FG000|Overall Study|Lost to Follow-up|11|||
154918827|NCT01362062|559124957|FG001|Overall Study|Lost to Follow-up|0|||
154918828|NCT01362062|559124956|FG000|Overall Study|Withdrawal by Subject|2|||
154918829|NCT01362062|559124957|FG001|Overall Study|Withdrawal by Subject|0|||
154918830|NCT01362062|559124956|FG000|Overall Study|Non-compliant participant|2|||
154918831|NCT01362062|559124957|FG001|Overall Study|Non-compliant participant|0|||
154918832|NCT01362062|559124956|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
154918833|NCT01362062|559124957|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
154918834|NCT01362062|559124956|FG000|Overall Study|Had significant improvement|9|||
154918835|NCT01362062|559124957|FG001|Overall Study|Had significant improvement|0|||
154918836|NCT02545504|559124961|FG000|Overall Study|Death|174|||
154918837|NCT02545504|559124962|FG001|Overall Study|Death|168|||
154918838|NCT02545504|559124961|FG000|Overall Study|Unknown reason|30|||
154918839|NCT02545504|559124962|FG001|Overall Study|Unknown reason|32|||
154918840|NCT02545504|559124961|FG000|Overall Study|Withdrew consent|9|||
154918841|NCT02545504|559124962|FG001|Overall Study|Withdrew consent|11|||
154918842|NCT02545504|559124961|FG000|Overall Study|Investigator's discretion|3|||
154918843|NCT02545504|559124962|FG001|Overall Study|Investigator's discretion|1|||
154918844|NCT02545504|559124961|FG000|Overall Study|Lost to Follow-up|2|||
154918845|NCT02545504|559124962|FG001|Overall Study|Lost to Follow-up|2|||
154918846|NCT00758394|559124963|FG000|2nd Intervention Order|Lost to Follow-up|0|||
154918847|NCT00758394|559124964|FG001|2nd Intervention Order|Lost to Follow-up|1|||
154918848|NCT00758394|559124965|FG002|2nd Intervention Order|Lost to Follow-up|0|||
154918849|NCT00758394|559124966|FG003|2nd Intervention Order|Lost to Follow-up|0|||
154918850|NCT00758394|559124963|FG000|3rd Intervention|Lost to Follow-up|1|||
154918851|NCT00758394|559124964|FG001|3rd Intervention|Lost to Follow-up|0|||
154918852|NCT00758394|559124965|FG002|3rd Intervention|Lost to Follow-up|0|||
154918853|NCT00758394|559124966|FG003|3rd Intervention|Lost to Follow-up|1|||
154918854|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
154918855|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
154918856|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
154918857|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
154918858|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
154918859|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
154918860|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
154995560|NCT00827632|559407905|FG001|Overall Study|Lost to Follow-up|12|||
154995561|NCT00827632|559407904|FG000|Overall Study|Early withdrawal|14|||
154995562|NCT00827632|559407905|FG001|Overall Study|Early withdrawal|11|||
154995563|NCT04669691|559407915|FG000|Overall Study|Death|0|||
154918861|NCT00950755|559124972|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
154918862|NCT00950755|559124972|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
154918863|NCT00950755|559124972|FG000|Long-Term Follow-Up|Death|8|||
154918864|NCT00508820|559124973|FG000|Overall Study|Adverse Event|6|||
154918865|NCT00508820|559124974|FG001|Overall Study|Adverse Event|10|||
154918866|NCT00508820|559124973|FG000|Overall Study|Death|6|||
154918867|NCT00508820|559124974|FG001|Overall Study|Death|8|||
154918868|NCT00508820|559124973|FG000|Overall Study|Lost to Follow-up|1|||
154918869|NCT00508820|559124974|FG001|Overall Study|Lost to Follow-up|1|||
154918870|NCT00508820|559124973|FG000|Overall Study|Physician Decision|8|||
154995564|NCT04669691|559407916|FG001|Overall Study|Death|1|||
154995565|NCT04669691|559407917|FG002|Overall Study|Death|0|||
154995566|NCT04669691|559407918|FG003|Overall Study|Death|0|||
154995567|NCT04669691|559407919|FG004|Overall Study|Death|0|||
154995568|NCT04669691|559407920|FG005|Overall Study|Death|0|||
154995569|NCT01822275|559407922|FG000|Overall Study|Withdrawal by Subject|3|||
154995570|NCT01822275|559407922|FG000|Overall Study|Adverse Event|3|||
154918871|NCT00508820|559124974|FG001|Overall Study|Physician Decision|2|||
154918872|NCT00508820|559124973|FG000|Overall Study|Pregnancy|0|||
154918873|NCT00508820|559124974|FG001|Overall Study|Pregnancy|2|||
154918874|NCT00508820|559124973|FG000|Overall Study|Protocol Violation|2|||
154918875|NCT00508820|559124974|FG001|Overall Study|Protocol Violation|0|||
154918876|NCT00508820|559124973|FG000|Overall Study|Withdrawal by Subject|10|||
154918877|NCT00508820|559124974|FG001|Overall Study|Withdrawal by Subject|12|||
154918878|NCT00508820|559124973|FG000|Overall Study|Other|11|||
154918879|NCT00508820|559124974|FG001|Overall Study|Other|2|||
154918880|NCT00508820|559124973|FG000|Overall Study|Noncompliance|1|||
154995571|NCT01822275|559407922|FG000|Overall Study|Progression|14|||
154995572|NCT01822275|559407922|FG000|Overall Study|Physician Decision|2|||
154995573|NCT00809159|559407924|FG000|Part 1|Adverse Event|1|||
154995574|NCT00809159|559407925|FG001|Part 1|Adverse Event|1|||
154995575|NCT00809159|559407926|FG002|Part 1|Adverse Event|0|||
154995576|NCT00809159|559407927|FG003|Part 1|Adverse Event|0|||
154995577|NCT00809159|559407928|FG004|Part 1|Adverse Event|0|||
154995578|NCT00809159|559407929|FG005|Part 1|Adverse Event|0|||
154995579|NCT00809159|559407924|FG000|Part 1|Lost to Follow-up|1|||
154995580|NCT00809159|559407925|FG001|Part 1|Lost to Follow-up|0|||
154995581|NCT00809159|559407926|FG002|Part 1|Lost to Follow-up|0|||
154995582|NCT00809159|559407927|FG003|Part 1|Lost to Follow-up|0|||
154995583|NCT00809159|559407928|FG004|Part 1|Lost to Follow-up|0|||
154995584|NCT00809159|559407929|FG005|Part 1|Lost to Follow-up|0|||
154995585|NCT00809159|559407924|FG000|Part 1|Withdrawal by Subject|3|||
154995586|NCT00809159|559407925|FG001|Part 1|Withdrawal by Subject|1|||
154995587|NCT00809159|559407926|FG002|Part 1|Withdrawal by Subject|0|||
154995588|NCT00809159|559407927|FG003|Part 1|Withdrawal by Subject|0|||
154995589|NCT00809159|559407928|FG004|Part 1|Withdrawal by Subject|0|||
154995590|NCT00809159|559407929|FG005|Part 1|Withdrawal by Subject|0|||
154995591|NCT00809159|559407924|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
154995592|NCT00809159|559407925|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
154995593|NCT00809159|559407926|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
154995594|NCT00809159|559407927|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
154995595|NCT00809159|559407928|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
154995596|NCT00809159|559407929|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
154995597|NCT00809159|559407924|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
154995598|NCT00809159|559407925|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
154995599|NCT00809159|559407926|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
154995600|NCT00809159|559407927|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
154995601|NCT00809159|559407928|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
154995602|NCT00809159|559407929|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
154995603|NCT00809159|559407924|FG000|Part 1 and 2|Administrative problems|0|||
154995604|NCT00809159|559407925|FG001|Part 1 and 2|Administrative problems|0|||
154995605|NCT00809159|559407926|FG002|Part 1 and 2|Administrative problems|0|||
154995606|NCT00809159|559407927|FG003|Part 1 and 2|Administrative problems|1|||
154995607|NCT00809159|559407928|FG004|Part 1 and 2|Administrative problems|0|||
154995608|NCT00809159|559407929|FG005|Part 1 and 2|Administrative problems|0|||
154995609|NCT00809159|559407924|FG000|Part 1 and 2|Adverse Event|0|||
154995610|NCT00809159|559407925|FG001|Part 1 and 2|Adverse Event|0|||
154995611|NCT00809159|559407926|FG002|Part 1 and 2|Adverse Event|1|||
154995612|NCT00809159|559407927|FG003|Part 1 and 2|Adverse Event|0|||
154995613|NCT00809159|559407928|FG004|Part 1 and 2|Adverse Event|1|||
154995614|NCT00809159|559407929|FG005|Part 1 and 2|Adverse Event|1|||
154995615|NCT00809159|559407924|FG000|Part 1 and 2|Lost to Follow-up|0|||
154995616|NCT00809159|559407925|FG001|Part 1 and 2|Lost to Follow-up|0|||
154995617|NCT00809159|559407926|FG002|Part 1 and 2|Lost to Follow-up|1|||
154995618|NCT00809159|559407927|FG003|Part 1 and 2|Lost to Follow-up|1|||
154995619|NCT00809159|559407928|FG004|Part 1 and 2|Lost to Follow-up|0|||
154995620|NCT00809159|559407929|FG005|Part 1 and 2|Lost to Follow-up|0|||
154995621|NCT00809159|559407924|FG000|Part 1 and 2|Withdrawal by Subject|0|||
154995622|NCT00809159|559407925|FG001|Part 1 and 2|Withdrawal by Subject|0|||
154995623|NCT00809159|559407926|FG002|Part 1 and 2|Withdrawal by Subject|4|||
154995624|NCT00809159|559407927|FG003|Part 1 and 2|Withdrawal by Subject|0|||
154995625|NCT00809159|559407928|FG004|Part 1 and 2|Withdrawal by Subject|0|||
154995626|NCT00809159|559407929|FG005|Part 1 and 2|Withdrawal by Subject|1|||
154995627|NCT03918109|559407933|FG000|Overall Study|Withdrawal by Subject|0|||
154995628|NCT03918109|559407934|FG001|Overall Study|Withdrawal by Subject|0|||
154995629|NCT03918109|559407935|FG002|Overall Study|Withdrawal by Subject|2|||
154995630|NCT03918109|559407936|FG003|Overall Study|Withdrawal by Subject|1|||
154918881|NCT00508820|559124974|FG001|Overall Study|Noncompliance|0|||
154918882|NCT00508820|559124973|FG000|Overall Study|Requirement for alternative therapy|7|||
154918883|NCT00508820|559124974|FG001|Overall Study|Requirement for alternative therapy|15|||
154995631|NCT03918109|559407933|FG000|Overall Study|Lost to Follow-up|0|||
154995632|NCT03918109|559407934|FG001|Overall Study|Lost to Follow-up|0|||
154995633|NCT03918109|559407935|FG002|Overall Study|Lost to Follow-up|0|||
154995634|NCT03918109|559407936|FG003|Overall Study|Lost to Follow-up|1|||
154918884|NCT00508820|559124973|FG000|Overall Study|Protocol-specified Criteria|3|||
154918885|NCT00508820|559124974|FG001|Overall Study|Protocol-specified Criteria|12|||
154918886|NCT01002573|559126400|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
154918887|NCT01002573|559126401|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
154918888|NCT00690612|559126402|FG000|Overall Study|Adverse Event|1|||
154918889|NCT00690612|559126402|FG000|Overall Study|Withdrawal by Subject|2|||
154918890|NCT02926833|559126403|FG000|Overall Study|Death|1|||
154918891|NCT02926833|559126404|FG001|Overall Study|Death|1|||
154918892|NCT02926833|559126405|FG002|Overall Study|Death|2|||
154918893|NCT02926833|559126406|FG003|Overall Study|Death|13|||
154918894|NCT02926833|559126403|FG000|Overall Study|Lost to Follow-up|1|||
154918895|NCT02926833|559126404|FG001|Overall Study|Lost to Follow-up|2|||
154918896|NCT02926833|559126405|FG002|Overall Study|Lost to Follow-up|0|||
154918897|NCT02926833|559126406|FG003|Overall Study|Lost to Follow-up|3|||
154918898|NCT02926833|559126403|FG000|Overall Study|Full Consent Withdrawal|0|||
154918899|NCT02926833|559126404|FG001|Overall Study|Full Consent Withdrawal|0|||
154918900|NCT02926833|559126405|FG002|Overall Study|Full Consent Withdrawal|0|||
154918901|NCT02926833|559126406|FG003|Overall Study|Full Consent Withdrawal|2|||
154918902|NCT02926833|559126403|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
154918903|NCT02926833|559126404|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
154918904|NCT02926833|559126405|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
154918905|NCT02926833|559126406|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
154918906|NCT02926833|559126403|FG000|Overall Study|Investigator Decision|0|||
154918907|NCT02926833|559126404|FG001|Overall Study|Investigator Decision|1|||
154918908|NCT02926833|559126405|FG002|Overall Study|Investigator Decision|0|||
154918909|NCT02926833|559126406|FG003|Overall Study|Investigator Decision|0|||
154918910|NCT02926833|559126403|FG000|Overall Study|Adverse Event|0|||
154918911|NCT02926833|559126404|FG001|Overall Study|Adverse Event|0|||
154918912|NCT02926833|559126405|FG002|Overall Study|Adverse Event|1|||
154918913|NCT02926833|559126406|FG003|Overall Study|Adverse Event|0|||
154918914|NCT02926833|559126403|FG000|Overall Study|Partial Withdrawal of Consent|0|||
154918915|NCT02926833|559126404|FG001|Overall Study|Partial Withdrawal of Consent|0|||
154918916|NCT02926833|559126405|FG002|Overall Study|Partial Withdrawal of Consent|0|||
154918917|NCT02926833|559126406|FG003|Overall Study|Partial Withdrawal of Consent|1|||
154995635|NCT00477295|559407941|FG000|Overall Study|Adverse Event|31|||
154995636|NCT00477295|559407942|FG001|Overall Study|Adverse Event|35|||
154995637|NCT00477295|559407941|FG000|Overall Study|Withdrawal by Subject|35|||
154995638|NCT00477295|559407942|FG001|Overall Study|Withdrawal by Subject|24|||
154995639|NCT00477295|559407941|FG000|Overall Study|Lack of Efficacy|23|||
155122300|NCT00787202|559877989|FG001|Overall Study|Lost to Follow-up|0|||
155122301|NCT00787202|559877990|FG002|Overall Study|Lost to Follow-up|0|||
155122302|NCT00787202|559877991|FG003|Overall Study|Lost to Follow-up|0|||
155122303|NCT00787202|559877992|FG004|Overall Study|Lost to Follow-up|0|||
155122304|NCT00787202|559877988|FG000|Overall Study|Withdrawal by Subject|2|||
155122305|NCT00787202|559877989|FG001|Overall Study|Withdrawal by Subject|2|||
154918918|NCT01945866|559126407|FG000|Overall Study|Eyes did not complete or were dropped|2|||
154918919|NCT01945866|559126408|FG001|Overall Study|Eyes did not complete or were dropped|0|||
154918920|NCT02930889|559126412|FG000|Overall Study|Lost to Follow-up|2|||
154918921|NCT02930889|559126412|FG000|Overall Study|Withdrawal by Subject|6|||
154918922|NCT02930889|559126412|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
154918923|NCT04398030|559126413|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
154918924|NCT04398030|559126414|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
154918925|NCT04398030|559126413|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
154918926|NCT04398030|559126414|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
154918927|NCT00548340|559126424|FG000|Overall Study|Protocol Violation|2|||
154918928|NCT00548340|559126425|FG001|Overall Study|Protocol Violation|3|||
154918929|NCT00548340|559126426|FG002|Overall Study|Protocol Violation|3|||
154918930|NCT00548340|559126424|FG000|Overall Study|Adverse Event|2|||
154918931|NCT00548340|559126425|FG001|Overall Study|Adverse Event|2|||
154918932|NCT00548340|559126426|FG002|Overall Study|Adverse Event|2|||
154918933|NCT00548340|559126424|FG000|Overall Study|Lost to Follow-up|1|||
154918934|NCT00548340|559126425|FG001|Overall Study|Lost to Follow-up|1|||
154918935|NCT00548340|559126426|FG002|Overall Study|Lost to Follow-up|0|||
154918936|NCT00548340|559126424|FG000|Overall Study|Withdrawal by Subject|2|||
154918937|NCT00548340|559126425|FG001|Overall Study|Withdrawal by Subject|4|||
154995640|NCT00477295|559407942|FG001|Overall Study|Lack of Efficacy|23|||
154995641|NCT00477295|559407941|FG000|Overall Study|Protocol Violation|3|||
155122306|NCT00787202|559877990|FG002|Overall Study|Withdrawal by Subject|2|||
155122307|NCT00787202|559877991|FG003|Overall Study|Withdrawal by Subject|0|||
154995642|NCT00477295|559407942|FG001|Overall Study|Protocol Violation|8|||
154995643|NCT00477295|559407941|FG000|Overall Study|Physician Decision|4|||
154995644|NCT00477295|559407942|FG001|Overall Study|Physician Decision|5|||
154918938|NCT00548340|559126426|FG002|Overall Study|Withdrawal by Subject|3|||
154918939|NCT00548340|559126424|FG000|Overall Study|Other|1|||
154918940|NCT00548340|559126425|FG001|Overall Study|Other|1|||
154918941|NCT00548340|559126426|FG002|Overall Study|Other|1|||
154918942|NCT03410693|559126427|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
154918943|NCT03410693|559126428|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
154918944|NCT03410693|559126427|FG000|Overall Study|Disc trt: Lost to follow up|0|||
154918945|NCT03410693|559126428|FG001|Overall Study|Disc trt: Lost to follow up|1|||
154918946|NCT03410693|559126427|FG000|Overall Study|Disc trt: radiological progression|58|||
154918947|NCT03410693|559126428|FG001|Overall Study|Disc trt: radiological progression|50|||
154918948|NCT03410693|559126427|FG000|Overall Study|Disc trt: Other|1|||
154918949|NCT03410693|559126428|FG001|Overall Study|Disc trt: Other|0|||
154918950|NCT03410693|559126427|FG000|Overall Study|Study drug never administered|1|||
154918951|NCT03410693|559126428|FG001|Overall Study|Study drug never administered|6|||
154918952|NCT03410693|559126427|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
154918953|NCT03410693|559126428|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
154918954|NCT03410693|559126427|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
154918955|NCT03410693|559126428|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
154918956|NCT03410693|559126427|FG000|Overall Study|Disc trt: Physician decision|0|||
154918957|NCT03410693|559126428|FG001|Overall Study|Disc trt: Physician decision|5|||
154918958|NCT03410693|559126427|FG000|Overall Study|Disc trt: clinical progression|1|||
154918959|NCT03410693|559126428|FG001|Overall Study|Disc trt: clinical progression|5|||
154918960|NCT03410693|559126427|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
154918961|NCT03410693|559126428|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
154918962|NCT01789476|559126429|FG000|Overall Study|Lack of Efficacy|6|||
154918963|NCT01789476|559126430|FG001|Overall Study|Lack of Efficacy|2|||
154918964|NCT01789476|559126429|FG000|Overall Study|Adverse Event|1|||
154918965|NCT01789476|559126430|FG001|Overall Study|Adverse Event|0|||
154918966|NCT01789476|559126429|FG000|Overall Study|Unable to get IV access|1|||
154918967|NCT01789476|559126430|FG001|Overall Study|Unable to get IV access|0|||
154918968|NCT00953576|559126431|FG000|Overall Study|Adverse Event|0|||
154918969|NCT00953576|559126432|FG001|Overall Study|Adverse Event|1|||
154918970|NCT00953576|559126431|FG000|Overall Study|Ineligible after Consent|2|||
154918971|NCT00953576|559126432|FG001|Overall Study|Ineligible after Consent|0|||
154918972|NCT03778021|559126433|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
154918973|NCT03778021|559126434|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
154918974|NCT00679042|559126435|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
154918975|NCT00679042|559126435|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
154918976|NCT00679042|559126435|FG000|5-Year Follow Up|Death|1|||
154918977|NCT00679042|559126435|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
154918978|NCT00679042|559126435|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
154918979|NCT03053102|559126436|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
154918980|NCT03053102|559126436|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
154918981|NCT01798056|559126437|FG000|Overall Study|Serious Adverse Event|13|||
154918982|NCT01798056|559126438|FG001|Overall Study|Serious Adverse Event|12|||
154918983|NCT01798056|559126437|FG000|Overall Study|Withdrawal by Subject|12|||
154918984|NCT01798056|559126438|FG001|Overall Study|Withdrawal by Subject|9|||
154918985|NCT01798056|559126437|FG000|Overall Study|Migrated/moved from study area|1|||
154918986|NCT01798056|559126438|FG001|Overall Study|Migrated/moved from study area|1|||
154918987|NCT01798056|559126437|FG000|Overall Study|Lost to Follow-up|1|||
154918988|NCT01798056|559126438|FG001|Overall Study|Lost to Follow-up|1|||
154918989|NCT01798056|559126437|FG000|Overall Study|Other|0|||
154918990|NCT01798056|559126438|FG001|Overall Study|Other|2|||
154918991|NCT01269346|559126439|FG000|Treatment Phase|Disease progression|3|||
154918992|NCT01269346|559126439|FG000|Treatment Phase|Adverse Event|3|||
154918993|NCT01269346|559126439|FG000|Treatment Phase|Withdrawal by Subject|1|||
154918994|NCT01269346|559126439|FG000|Treatment Phase|Other|2|||
154918995|NCT01269346|559126439|FG000|Extension Phase|Adverse Event|6|||
154918996|NCT01269346|559126439|FG000|Extension Phase|Withdrawal by Subject|4|||
154918997|NCT01269346|559126439|FG000|Extension Phase|Disease progression|22|||
155177695|NCT04966910|560089362|FG002|Baseline|Participant did not complete measure|1|||
155177696|NCT04966910|560089363|FG003|Baseline|Participant did not complete measure|0|||
155177697|NCT04966910|560089360|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
154918998|NCT01269346|559126439|FG000|Extension Phase|Physician decision or participant choice|9|||
155177698|NCT04966910|560089361|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
155177699|NCT04966910|560089362|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
155177700|NCT04966910|560089363|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
155177701|NCT04966910|560089360|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
155177702|NCT04966910|560089361|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
154918999|NCT01269346|559126439|FG000|Extension Phase|Clinical progression|1|||
154919000|NCT01269346|559126439|FG000|Extension Phase|Started a prohibited con med|1|||
154919001|NCT04963231|559126447|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
154919002|NCT04963231|559126448|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
154919003|NCT04963231|559126449|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
154919004|NCT04963231|559126447|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
154919005|NCT04963231|559126448|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
154919006|NCT04963231|559126449|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
154919007|NCT04963231|559126447|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
154919008|NCT04963231|559126448|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
154919009|NCT04963231|559126449|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
154919010|NCT04963231|559126447|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
154919011|NCT04963231|559126448|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
154919012|NCT04963231|559126449|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
154919013|NCT04963231|559126447|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
154919014|NCT04963231|559126448|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
154919015|NCT04963231|559126449|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
154919016|NCT04963231|559126447|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
154919017|NCT04963231|559126448|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
154919018|NCT04963231|559126449|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
154919019|NCT04963231|559126447|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
154919020|NCT04963231|559126448|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
154919021|NCT04963231|559126449|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
154919022|NCT01059175|559126452|FG000|Overall Study|Death|17|||
154919023|NCT01059175|559126453|FG001|Overall Study|Death|17|||
154919024|NCT01059175|559126452|FG000|Overall Study|Adverse Event|4|||
154919025|NCT01059175|559126453|FG001|Overall Study|Adverse Event|2|||
154919026|NCT01059175|559126452|FG000|Overall Study|Lost to Follow-up|0|||
154919027|NCT01059175|559126453|FG001|Overall Study|Lost to Follow-up|1|||
154919028|NCT02957149|559126454|FG000|Overall Study|Withdrawal by Subject|5|||
154919029|NCT06045026|559126455|FG000|Overall Study|Lost to Follow-up|60|||
154919030|NCT06045026|559126455|FG000|Overall Study|Adverse Event|12|||
154919031|NCT06045026|559126455|FG000|Overall Study|Withdrawal by Subject|3|||
154919032|NCT06045026|559126455|FG000|Overall Study|Enrollment closed|1|||
154919033|NCT02452320|559126459|FG000|Overall Study|Adverse Event|0|||
154919034|NCT02452320|559126460|FG001|Overall Study|Adverse Event|1|||
154919035|NCT02624713|559126461|FG000|Overall Study|Lost to Follow-up|14|||
154919036|NCT02624713|559126462|FG001|Overall Study|Lost to Follow-up|0|||
154919037|NCT00148109|559126463|FG000|Overall Study|Lack of Efficacy|10|||
154919038|NCT00148109|559126464|FG001|Overall Study|Lack of Efficacy|18|||
154919039|NCT00148109|559126463|FG000|Overall Study|Adverse Event|0|||
154919040|NCT00148109|559126464|FG001|Overall Study|Adverse Event|2|||
154919041|NCT00148109|559126463|FG000|Overall Study|Withdrawal by Subject|2|||
154919042|NCT00148109|559126464|FG001|Overall Study|Withdrawal by Subject|0|||
154919043|NCT02557308|559126467|FG000|Overall Study|Withdrawal by Subject|11|||
154919044|NCT02557308|559126468|FG001|Overall Study|Withdrawal by Subject|3|||
154919045|NCT02557308|559126469|FG002|Overall Study|Withdrawal by Subject|2|||
154919046|NCT02557308|559126470|FG003|Overall Study|Withdrawal by Subject|0|||
154919047|NCT02557308|559126471|FG004|Overall Study|Withdrawal by Subject|1|||
154919048|NCT02557308|559126472|FG005|Overall Study|Withdrawal by Subject|0|||
154919049|NCT02557308|559126473|FG006|Overall Study|Withdrawal by Subject|10|||
154919050|NCT02557308|559126474|FG007|Overall Study|Withdrawal by Subject|1|||
154919051|NCT02557308|559126467|FG000|Overall Study|Disease Progression|0|||
154919052|NCT02557308|559126468|FG001|Overall Study|Disease Progression|1|||
154919053|NCT02557308|559126469|FG002|Overall Study|Disease Progression|0|||
154919054|NCT02557308|559126470|FG003|Overall Study|Disease Progression|0|||
154919055|NCT02557308|559126471|FG004|Overall Study|Disease Progression|0|||
154919056|NCT02557308|559126472|FG005|Overall Study|Disease Progression|0|||
154919057|NCT02557308|559126473|FG006|Overall Study|Disease Progression|0|||
154919058|NCT02557308|559126474|FG007|Overall Study|Disease Progression|0|||
154919059|NCT02557308|559126467|FG000|Overall Study|Lack of Efficacy|3|||
154919060|NCT02557308|559126468|FG001|Overall Study|Lack of Efficacy|0|||
154919061|NCT02557308|559126469|FG002|Overall Study|Lack of Efficacy|0|||
154919062|NCT02557308|559126470|FG003|Overall Study|Lack of Efficacy|0|||
154919063|NCT02557308|559126471|FG004|Overall Study|Lack of Efficacy|0|||
154919064|NCT02557308|559126472|FG005|Overall Study|Lack of Efficacy|0|||
154919065|NCT02557308|559126473|FG006|Overall Study|Lack of Efficacy|1|||
154995645|NCT00477295|559407941|FG000|Overall Study|Lost to Follow-up|21|||
154995646|NCT00477295|559407942|FG001|Overall Study|Lost to Follow-up|11|||
154919066|NCT02557308|559126474|FG007|Overall Study|Lack of Efficacy|0|||
154919067|NCT02557308|559126467|FG000|Overall Study|Adverse Event|4|||
154919068|NCT02557308|559126468|FG001|Overall Study|Adverse Event|1|||
154919069|NCT02557308|559126469|FG002|Overall Study|Adverse Event|2|||
154919070|NCT02557308|559126470|FG003|Overall Study|Adverse Event|0|||
154919071|NCT02557308|559126471|FG004|Overall Study|Adverse Event|0|||
154919072|NCT02557308|559126472|FG005|Overall Study|Adverse Event|0|||
154919073|NCT02557308|559126473|FG006|Overall Study|Adverse Event|4|||
154919074|NCT02557308|559126474|FG007|Overall Study|Adverse Event|1|||
154919075|NCT02557308|559126467|FG000|Overall Study|Lost to Follow-up|2|||
154995647|NCT00477295|559407941|FG000|Overall Study|Other|4|||
154919076|NCT02557308|559126468|FG001|Overall Study|Lost to Follow-up|0|||
154919077|NCT02557308|559126469|FG002|Overall Study|Lost to Follow-up|1|||
154919078|NCT02557308|559126470|FG003|Overall Study|Lost to Follow-up|0|||
154919079|NCT02557308|559126471|FG004|Overall Study|Lost to Follow-up|0|||
154919080|NCT02557308|559126472|FG005|Overall Study|Lost to Follow-up|0|||
154919081|NCT02557308|559126473|FG006|Overall Study|Lost to Follow-up|2|||
154919082|NCT02557308|559126474|FG007|Overall Study|Lost to Follow-up|0|||
154919083|NCT02557308|559126467|FG000|Overall Study|Death|1|||
154919084|NCT02557308|559126468|FG001|Overall Study|Death|0|||
154919085|NCT02557308|559126469|FG002|Overall Study|Death|0|||
154919086|NCT02557308|559126470|FG003|Overall Study|Death|0|||
154919087|NCT02557308|559126471|FG004|Overall Study|Death|0|||
154919088|NCT02557308|559126472|FG005|Overall Study|Death|0|||
154919089|NCT02557308|559126473|FG006|Overall Study|Death|0|||
154919090|NCT02557308|559126474|FG007|Overall Study|Death|0|||
154919091|NCT02557308|559126467|FG000|Overall Study|Study Close|98|||
154919092|NCT02557308|559126468|FG001|Overall Study|Study Close|18|||
154919093|NCT02557308|559126469|FG002|Overall Study|Study Close|5|||
154919094|NCT02557308|559126470|FG003|Overall Study|Study Close|3|||
154919095|NCT02557308|559126471|FG004|Overall Study|Study Close|1|||
154919096|NCT02557308|559126472|FG005|Overall Study|Study Close|0|||
154919097|NCT02557308|559126473|FG006|Overall Study|Study Close|123|||
154919098|NCT02557308|559126474|FG007|Overall Study|Study Close|5|||
154995648|NCT00477295|559407942|FG001|Overall Study|Other|3|||
154995649|NCT03276780|559407945|FG000|Overall Study|Withdrawal by Subject|5|||
154995650|NCT03276780|559407946|FG001|Overall Study|Withdrawal by Subject|3|||
154995651|NCT03276780|559407945|FG000|Overall Study|Lost to Follow-up|3|||
155122308|NCT00787202|559877992|FG004|Overall Study|Withdrawal by Subject|0|||
155122309|NCT00787202|559877988|FG000|Overall Study|Protocol Violation|2|||
154919099|NCT02557308|559126467|FG000|Overall Study|Except for study close|5|||
154919100|NCT02557308|559126468|FG001|Overall Study|Except for study close|0|||
154919101|NCT02557308|559126469|FG002|Overall Study|Except for study close|0|||
154919102|NCT02557308|559126470|FG003|Overall Study|Except for study close|0|||
154919103|NCT02557308|559126471|FG004|Overall Study|Except for study close|3|||
154919104|NCT02557308|559126472|FG005|Overall Study|Except for study close|0|||
154919105|NCT02557308|559126473|FG006|Overall Study|Except for study close|6|||
154919106|NCT02557308|559126474|FG007|Overall Study|Except for study close|10|||
154919107|NCT03911401|559126475|FG000|Overall Study|Adverse Event|1|||
154919108|NCT03911401|559126476|FG001|Overall Study|Adverse Event|2|||
154919109|NCT03911401|559126477|FG002|Overall Study|Adverse Event|5|||
154919110|NCT03911401|559126475|FG000|Overall Study|Lack of Efficacy|1|||
154919111|NCT03911401|559126476|FG001|Overall Study|Lack of Efficacy|1|||
154919112|NCT03911401|559126477|FG002|Overall Study|Lack of Efficacy|8|||
154919113|NCT03911401|559126475|FG000|Overall Study|Physician Decision|0|||
154919114|NCT03911401|559126476|FG001|Overall Study|Physician Decision|0|||
154919115|NCT03911401|559126477|FG002|Overall Study|Physician Decision|1|||
154919116|NCT03911401|559126475|FG000|Overall Study|Withdrawal by Subject|1|||
154919117|NCT03911401|559126476|FG001|Overall Study|Withdrawal by Subject|2|||
154919118|NCT03911401|559126477|FG002|Overall Study|Withdrawal by Subject|0|||
154919119|NCT03911401|559126475|FG000|Overall Study|Withdrawal by parent/guardian|4|||
154919120|NCT03911401|559126476|FG001|Overall Study|Withdrawal by parent/guardian|4|||
154919121|NCT03911401|559126477|FG002|Overall Study|Withdrawal by parent/guardian|11|||
154919122|NCT00351611|559126483|FG000|Overall Study|Adverse Event|11|||
154919123|NCT00351611|559126484|FG001|Overall Study|Adverse Event|3|||
154919124|NCT00351611|559126483|FG000|Overall Study|Death|1|||
154919125|NCT00351611|559126484|FG001|Overall Study|Death|0|||
154919126|NCT00351611|559126483|FG000|Overall Study|Lost to Follow-up|1|||
154919127|NCT00351611|559126484|FG001|Overall Study|Lost to Follow-up|0|||
154919128|NCT00351611|559126483|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
154919129|NCT00351611|559126484|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
154919130|NCT00351611|559126483|FG000|Overall Study|Other|1|||
154919131|NCT00351611|559126484|FG001|Overall Study|Other|0|||
154919132|NCT00351611|559126483|FG000|Overall Study|Protocol Violation|0|||
154919133|NCT00351611|559126484|FG001|Overall Study|Protocol Violation|2|||
154995652|NCT03276780|559407946|FG001|Overall Study|Lost to Follow-up|5|||
154995653|NCT03276780|559407945|FG000|Overall Study|Moved out of state|1|||
154919134|NCT01589185|559126485|FG000|Overall Study|Death|1|||
154919135|NCT01589185|559126486|FG001|Overall Study|Death|2|||
154919136|NCT01589185|559126487|FG002|Overall Study|Death|2|||
154919137|NCT01589185|559126488|FG003|Overall Study|Death|0|||
154919138|NCT01589185|559126489|FG004|Overall Study|Death|1|||
154919139|NCT01589185|559126485|FG000|Overall Study|Lost to Follow-up|1|||
154919140|NCT01589185|559126486|FG001|Overall Study|Lost to Follow-up|0|||
154995654|NCT03276780|559407946|FG001|Overall Study|Moved out of state|1|||
155122310|NCT00787202|559877989|FG001|Overall Study|Protocol Violation|1|||
155122311|NCT00787202|559877990|FG002|Overall Study|Protocol Violation|0|||
154919141|NCT01589185|559126487|FG002|Overall Study|Lost to Follow-up|2|||
154919142|NCT01589185|559126488|FG003|Overall Study|Lost to Follow-up|3|||
154919143|NCT01589185|559126489|FG004|Overall Study|Lost to Follow-up|0|||
154919144|NCT02046993|559126490|FG000|Overall Study|Withdrawal by Subject|2|||
154919145|NCT02046993|559126491|FG001|Overall Study|Withdrawal by Subject|10|||
154919146|NCT02046993|559126490|FG000|Overall Study|Lost to Follow-up|1|||
154919147|NCT02046993|559126491|FG001|Overall Study|Lost to Follow-up|1|||
154919148|NCT03417245|559126492|FG000|Overall Study|Adverse Event|1|||
154919149|NCT03417245|559126493|FG001|Overall Study|Adverse Event|0|||
154919150|NCT03417245|559126492|FG000|Overall Study|Protocol Violation|1|||
154919151|NCT03417245|559126493|FG001|Overall Study|Protocol Violation|0|||
154919152|NCT03417245|559126492|FG000|Overall Study|Withdrawal by Subject|1|||
154919153|NCT03417245|559126493|FG001|Overall Study|Withdrawal by Subject|1|||
154919154|NCT02708524|559126500|FG000|Overall Study|Adverse Event|0|||
154919155|NCT02708524|559126501|FG001|Overall Study|Adverse Event|1|||
154919156|NCT02708524|559126502|FG002|Overall Study|Adverse Event|0|||
154919157|NCT02708524|559126503|FG003|Overall Study|Adverse Event|0|||
154919158|NCT02708524|559126500|FG000|Overall Study|Lens Discomfort|1|||
154919159|NCT02708524|559126501|FG001|Overall Study|Lens Discomfort|0|||
154919160|NCT02708524|559126502|FG002|Overall Study|Lens Discomfort|1|||
154919161|NCT02708524|559126503|FG003|Overall Study|Lens Discomfort|0|||
154919162|NCT02708524|559126500|FG000|Overall Study|Lost to Follow-up|1|||
154919163|NCT02708524|559126501|FG001|Overall Study|Lost to Follow-up|1|||
154919164|NCT02708524|559126502|FG002|Overall Study|Lost to Follow-up|1|||
154919165|NCT02708524|559126503|FG003|Overall Study|Lost to Follow-up|0|||
154919166|NCT02708524|559126500|FG000|Overall Study|Protocol Violation|0|||
154919167|NCT02708524|559126501|FG001|Overall Study|Protocol Violation|1|||
154919168|NCT02708524|559126502|FG002|Overall Study|Protocol Violation|0|||
154919169|NCT02708524|559126503|FG003|Overall Study|Protocol Violation|0|||
154919170|NCT02708524|559126500|FG000|Overall Study|Withdrawal by Subject|1|||
154919171|NCT02708524|559126501|FG001|Overall Study|Withdrawal by Subject|1|||
154919172|NCT02708524|559126502|FG002|Overall Study|Withdrawal by Subject|0|||
154919173|NCT02708524|559126503|FG003|Overall Study|Withdrawal by Subject|0|||
154919174|NCT02708524|559126500|FG000|Overall Study|Dispensed incorrect study lens|0|||
154919175|NCT02708524|559126501|FG001|Overall Study|Dispensed incorrect study lens|1|||
154919176|NCT02708524|559126502|FG002|Overall Study|Dispensed incorrect study lens|1|||
154919177|NCT02708524|559126503|FG003|Overall Study|Dispensed incorrect study lens|0|||
154919178|NCT02708524|559126500|FG000|Overall Study|Did not wear lens at final visit|0|||
154919179|NCT02708524|559126501|FG001|Overall Study|Did not wear lens at final visit|1|||
154919180|NCT02708524|559126502|FG002|Overall Study|Did not wear lens at final visit|0|||
154919181|NCT02708524|559126503|FG003|Overall Study|Did not wear lens at final visit|0|||
154919182|NCT02708524|559126500|FG000|Overall Study|Subject lost study lens|1|||
154919183|NCT02708524|559126501|FG001|Overall Study|Subject lost study lens|0|||
154919184|NCT02708524|559126502|FG002|Overall Study|Subject lost study lens|0|||
154919185|NCT02708524|559126503|FG003|Overall Study|Subject lost study lens|0|||
154919186|NCT03781167|559126507|FG000|Overall Study|Adverse Event|23|||
154919187|NCT03781167|559126508|FG001|Overall Study|Adverse Event|25|||
154919188|NCT03781167|559126507|FG000|Overall Study|Withdrew consent|16|||
154919189|NCT03781167|559126508|FG001|Overall Study|Withdrew consent|12|||
154919190|NCT03781167|559126507|FG000|Overall Study|Lost to Follow-up|0|||
154919191|NCT03781167|559126508|FG001|Overall Study|Lost to Follow-up|1|||
154919192|NCT03781167|559126507|FG000|Overall Study|Lack of Efficacy|4|||
154919193|NCT03781167|559126508|FG001|Overall Study|Lack of Efficacy|5|||
154919194|NCT03781167|559126507|FG000|Overall Study|Difficulty with drug delivery system|2|||
154919195|NCT03781167|559126508|FG001|Overall Study|Difficulty with drug delivery system|3|||
154919196|NCT03781167|559126507|FG000|Overall Study|Other, not specified|2|||
154919197|NCT03781167|559126508|FG001|Overall Study|Other, not specified|2|||
154919198|NCT00679354|559126514|FG000|Overall Study|Death|3|||
154919199|NCT00679354|559126514|FG000|Overall Study|Lack of Efficacy|22|||
154919200|NCT00679354|559126514|FG000|Overall Study|Physician Decision|4|||
154919201|NCT00679354|559126514|FG000|Overall Study|Ineligible|1|||
154919202|NCT00267202|559126515|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
154919203|NCT00267202|559126516|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
154919204|NCT00267202|559126515|FG000|Overall Study|Withdrawal by Subject|12|||
154919205|NCT00267202|559126516|FG001|Overall Study|Withdrawal by Subject|15|||
154919206|NCT00267202|559126515|FG000|Overall Study|Adverse Event|13|||
154919207|NCT00267202|559126516|FG001|Overall Study|Adverse Event|7|||
154919208|NCT00267202|559126515|FG000|Overall Study|Protocol Violation|2|||
154919209|NCT00267202|559126516|FG001|Overall Study|Protocol Violation|3|||
154919210|NCT00267202|559126515|FG000|Overall Study|Administrative problems|2|||
154919211|NCT00267202|559126516|FG001|Overall Study|Administrative problems|1|||
154919212|NCT00267202|559126515|FG000|Overall Study|Lost to Follow-up|3|||
154919213|NCT00267202|559126516|FG001|Overall Study|Lost to Follow-up|0|||
154919214|NCT03831282|559126517|FG000|Overall Study|Could not place sensor|1|||
154919215|NCT00334893|559126518|FG000|Overall Study|Not Treated|1|||
154919216|NCT00334893|559126519|FG001|Overall Study|Not Treated|0|||
154919217|NCT00920582|559126520|FG000|Overall Study|Lost to Follow-up|5|||
154919218|NCT00920582|559126521|FG001|Overall Study|Lost to Follow-up|1|||
154919219|NCT00920582|559126522|FG002|Overall Study|Lost to Follow-up|2|||
154919220|NCT00920582|559126523|FG003|Overall Study|Lost to Follow-up|0|||
154919221|NCT00920582|559126520|FG000|Overall Study|Withdrawal by Subject|5|||
154919222|NCT00920582|559126521|FG001|Overall Study|Withdrawal by Subject|4|||
154919223|NCT00920582|559126522|FG002|Overall Study|Withdrawal by Subject|6|||
154919224|NCT00920582|559126523|FG003|Overall Study|Withdrawal by Subject|3|||
154919225|NCT00920582|559126520|FG000|Overall Study|Protocol Violation|1|||
154919226|NCT00920582|559126521|FG001|Overall Study|Protocol Violation|0|||
154919227|NCT00920582|559126522|FG002|Overall Study|Protocol Violation|0|||
154919228|NCT00920582|559126523|FG003|Overall Study|Protocol Violation|0|||
154919229|NCT00920582|559126520|FG000|Overall Study|Other|2|||
154919230|NCT00920582|559126521|FG001|Overall Study|Other|1|||
154919231|NCT00920582|559126522|FG002|Overall Study|Other|3|||
154919232|NCT00920582|559126523|FG003|Overall Study|Other|2|||
154919233|NCT01552408|559126530|FG000|Overall Study|Lost to Follow-up|2|||
154919234|NCT01552408|559126531|FG001|Overall Study|Lost to Follow-up|0|||
154919235|NCT01552408|559126530|FG000|Overall Study|Relocation|0|||
154919236|NCT01552408|559126531|FG001|Overall Study|Relocation|1|||
154919237|NCT01552408|559126530|FG000|Overall Study|Withdrawal by Subject|2|||
154919238|NCT01552408|559126531|FG001|Overall Study|Withdrawal by Subject|1|||
154919239|NCT01333501|559126532|FG000|Overall Study|Adverse Event|3|||
154919240|NCT01333501|559126533|FG001|Overall Study|Adverse Event|1|||
154919241|NCT01333501|559126532|FG000|Overall Study|Abnormal laboratory value|2|||
154919242|NCT01333501|559126533|FG001|Overall Study|Abnormal laboratory value|1|||
154919243|NCT01333501|559126532|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
154919244|NCT01333501|559126533|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
154919245|NCT01333501|559126532|FG000|Overall Study|Withdrawn consent|3|||
154919246|NCT01333501|559126533|FG001|Overall Study|Withdrawn consent|12|||
154919247|NCT02442284|559126534|FG000|Overall Study|Adverse Event|1|||
154919248|NCT02442284|559126534|FG000|Overall Study|Withdrew Consent|2|||
154919249|NCT02442284|559126534|FG000|Overall Study|Lost to Follow-up|3|||
154919250|NCT02442284|559126534|FG000|Overall Study|Other|1|||
154919251|NCT01365468|559126538|FG000|Overall Study|Physician Decision|1|||
154919252|NCT01365468|559126539|FG001|Overall Study|Physician Decision|0|||
154919253|NCT01365468|559126538|FG000|Overall Study|Disease progression|1|||
154919254|NCT01365468|559126539|FG001|Overall Study|Disease progression|0|||
154919255|NCT01365468|559126538|FG000|Overall Study|Lost to Follow-up|2|||
154919256|NCT01365468|559126539|FG001|Overall Study|Lost to Follow-up|0|||
154919257|NCT01018680|559128296|FG000|Overall Study|Adverse Event|23|||
154919258|NCT01018680|559128297|FG001|Overall Study|Adverse Event|40|||
154919259|NCT01018680|559128296|FG000|Overall Study|Withdrawal by Subject|10|||
154919260|NCT01018680|559128297|FG001|Overall Study|Withdrawal by Subject|10|||
154919261|NCT01018680|559128296|FG000|Overall Study|Protocol Violation|5|||
154919262|NCT01018680|559128297|FG001|Overall Study|Protocol Violation|8|||
154919263|NCT01018680|559128296|FG000|Overall Study|Sponsor Decision|6|||
154919264|NCT01018680|559128297|FG001|Overall Study|Sponsor Decision|7|||
154919265|NCT01018680|559128296|FG000|Overall Study|Lack of Efficacy|8|||
154919266|NCT01018680|559128297|FG001|Overall Study|Lack of Efficacy|2|||
154919267|NCT01018680|559128296|FG000|Overall Study|Lost to Follow-up|5|||
154919268|NCT01018680|559128297|FG001|Overall Study|Lost to Follow-up|3|||
154919269|NCT01018680|559128296|FG000|Overall Study|Entry Criteria Not Met|1|||
154919270|NCT01018680|559128297|FG001|Overall Study|Entry Criteria Not Met|4|||
154919271|NCT01018680|559128296|FG000|Overall Study|Physician Decision|3|||
154919272|NCT01018680|559128297|FG001|Overall Study|Physician Decision|1|||
154919273|NCT05056311|559128298|FG000|Overall Study|Lost to Follow-up|14|||
154919274|NCT05056311|559128298|FG000|Overall Study|Withdrawal by Subject|1|||
154919275|NCT05056311|559128298|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
154919276|NCT03799198|559128299|FG000|Overall Study|Lost to Follow-up|4|||
154919277|NCT03799198|559128300|FG001|Overall Study|Lost to Follow-up|8|||
154919278|NCT03799198|559128299|FG000|Overall Study|Death|0|||
154919279|NCT03799198|559128300|FG001|Overall Study|Death|1|||
154919280|NCT00960869|559128301|FG000|Overall Study|Adverse Event|17|||
154919281|NCT00960869|559128302|FG001|Overall Study|Adverse Event|26|||
154919282|NCT00960869|559128301|FG000|Overall Study|Withdrawal by Subject|16|||
154919283|NCT00960869|559128302|FG001|Overall Study|Withdrawal by Subject|14|||
154919284|NCT00960869|559128301|FG000|Overall Study|Lost to Follow-up|1|||
154919285|NCT00960869|559128302|FG001|Overall Study|Lost to Follow-up|4|||
154919286|NCT00960869|559128301|FG000|Overall Study|Misc|19|||
154919287|NCT00960869|559128302|FG001|Overall Study|Misc|18|||
154919288|NCT02501642|559128303|FG000|Overall Study|Lost to Follow-up|7|||
154919289|NCT02501642|559128304|FG001|Overall Study|Lost to Follow-up|11|||
154919290|NCT01153971|559128311|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
154919291|NCT01153971|559128311|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
155177703|NCT04966910|560089362|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
154919292|NCT01153971|559128311|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
154919293|NCT01153971|559128311|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
155177704|NCT04966910|560089363|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
155177705|NCT04966910|560089360|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
154919294|NCT01153971|559128311|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
154919295|NCT01153971|559128311|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
154919296|NCT01153971|559128311|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
154919297|NCT03472586|559128319|FG000|Overall Study|Physician Decision|6|||
154919298|NCT03472586|559128319|FG000|Overall Study|Death|6|||
154919299|NCT03472586|559128319|FG000|Overall Study|Adverse Event|1|||
154919300|NCT01342445|559128320|FG000|Overall Study|Experienced side effects|0|||
154919301|NCT01342445|559128321|FG001|Overall Study|Experienced side effects|2|||
154919302|NCT02652793|559128322|FG000|Overall Study|Adverse Event|1|||
154919303|NCT02652793|559128322|FG000|Overall Study|Lost to Follow-up|2|||
154919304|NCT02652793|559128322|FG000|Overall Study|Withdrawal by Subject|1|||
154919305|NCT04511533|559128323|FG000|Treatment|Other|2|||
154919306|NCT04511533|559128323|FG000|Treatment|Withdrawal by Subject|11|||
154919307|NCT04511533|559128323|FG000|Treatment|Death|5|||
154919308|NCT04511533|559128323|FG000|Treatment|Physician Decision|1|||
154919309|NCT04511533|559128323|FG000|Treatment|Progressive Disease|61|||
154919310|NCT04511533|559128323|FG000|Follow-Up|Other|7|||
154919311|NCT04511533|559128323|FG000|Follow-Up|Withdrawal by Subject|5|||
154919312|NCT04511533|559128323|FG000|Follow-Up|Lost to Follow-up|2|||
154919313|NCT04511533|559128323|FG000|Follow-Up|Death|4|||
154919314|NCT01928758|559128324|FG000|Overall Study|Lost to Follow-up|14|||
154919315|NCT01928758|559128325|FG001|Overall Study|Lost to Follow-up|9|||
154919316|NCT01928758|559128324|FG000|Overall Study|Withdrawal by Subject|5|||
154919317|NCT01928758|559128325|FG001|Overall Study|Withdrawal by Subject|2|||
154919318|NCT01928758|559128324|FG000|Overall Study|Adverse Event|3|||
154919319|NCT01928758|559128325|FG001|Overall Study|Adverse Event|5|||
154919320|NCT01928758|559128324|FG000|Overall Study|Protocol Violation|3|||
154919321|NCT01928758|559128325|FG001|Overall Study|Protocol Violation|4|||
154919322|NCT02718131|559128326|FG000|Overall Study|Withdrawal by Subject|1|||
154919323|NCT02718131|559128327|FG001|Overall Study|Withdrawal by Subject|0|||
154919324|NCT02718131|559128326|FG000|Overall Study|Adverse Event|1|||
154919325|NCT02718131|559128327|FG001|Overall Study|Adverse Event|0|||
154919326|NCT02718131|559128326|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
154919327|NCT02718131|559128327|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
154919328|NCT03198559|559128328|FG000|Overall Study|Adverse Event|2|||
154919329|NCT01474291|559128332|FG000|Overall Study|Not Evaluable for Efficacy|26|||
154919330|NCT01474291|559128332|FG000|Overall Study|Lack of Treatment Efficacy|88|||
154919331|NCT01474291|559128332|FG000|Overall Study|Adverse Event|53|||
154919332|NCT01474291|559128332|FG000|Overall Study|Lost to Follow-up|29|||
154919333|NCT01474291|559128332|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
154919334|NCT01474291|559128332|FG000|Overall Study|No Reason Reported|10|||
154919335|NCT01474291|559128332|FG000|Overall Study|Death|2|||
154919336|NCT03471507|559128333|FG000|Overall Study|Lost to Follow-up|1|||
154919337|NCT03471507|559128334|FG001|Overall Study|Lost to Follow-up|3|||
154919338|NCT03471507|559128333|FG000|Overall Study|Physician Decision|0|||
154919339|NCT03471507|559128334|FG001|Overall Study|Physician Decision|1|||
154919340|NCT03471507|559128333|FG000|Overall Study|Withdrawal by Subject|2|||
154919341|NCT03471507|559128334|FG001|Overall Study|Withdrawal by Subject|1|||
154919342|NCT00598442|559128339|FG000|Overall Study|Adverse Event|3|||
154919343|NCT00598442|559128340|FG001|Overall Study|Adverse Event|0|||
154919344|NCT00598442|559128341|FG002|Overall Study|Adverse Event|0|||
154919345|NCT00598442|559128339|FG000|Overall Study|Death|19|||
154919346|NCT00598442|559128340|FG001|Overall Study|Death|11|||
154919347|NCT00598442|559128341|FG002|Overall Study|Death|11|||
154919348|NCT00598442|559128339|FG000|Overall Study|Lost to Follow-up|4|||
154919349|NCT00598442|559128340|FG001|Overall Study|Lost to Follow-up|3|||
154919350|NCT00598442|559128341|FG002|Overall Study|Lost to Follow-up|3|||
154919351|NCT00598442|559128339|FG000|Overall Study|Physician Decision|2|||
154919352|NCT00598442|559128340|FG001|Overall Study|Physician Decision|1|||
155122312|NCT00787202|559877991|FG003|Overall Study|Protocol Violation|0|||
155122313|NCT00787202|559877992|FG004|Overall Study|Protocol Violation|1|||
155122314|NCT00787202|559877988|FG000|Overall Study|Randomized, not treated|1|||
155122315|NCT00787202|559877989|FG001|Overall Study|Randomized, not treated|0|||
155122316|NCT00787202|559877990|FG002|Overall Study|Randomized, not treated|0|||
154919353|NCT00598442|559128341|FG002|Overall Study|Physician Decision|1|||
154919354|NCT00598442|559128339|FG000|Overall Study|Withdrawal by Subject|8|||
154919355|NCT00598442|559128340|FG001|Overall Study|Withdrawal by Subject|16|||
154919356|NCT00598442|559128341|FG002|Overall Study|Withdrawal by Subject|6|||
154919357|NCT00598442|559128339|FG000|Overall Study|Noncompliance|0|||
154919358|NCT00598442|559128340|FG001|Overall Study|Noncompliance|2|||
154919359|NCT00598442|559128341|FG002|Overall Study|Noncompliance|1|||
154919360|NCT00598442|559128339|FG000|Overall Study|Relocation|1|||
155122317|NCT00787202|559877991|FG003|Overall Study|Randomized, not treated|0|||
154919361|NCT00598442|559128340|FG001|Overall Study|Relocation|4|||
154919362|NCT00598442|559128341|FG002|Overall Study|Relocation|0|||
154919363|NCT00598442|559128339|FG000|Overall Study|Renal transplant|0|||
155122318|NCT00787202|559877992|FG004|Overall Study|Randomized, not treated|0|||
154919364|NCT00598442|559128340|FG001|Overall Study|Renal transplant|0|||
154919365|NCT00598442|559128341|FG002|Overall Study|Renal transplant|1|||
154919366|NCT00598442|559128339|FG000|Overall Study|Site closed by sponsor|5|||
155122319|NCT00969761|559877995|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155177706|NCT04966910|560089361|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
154919367|NCT00598442|559128340|FG001|Overall Study|Site closed by sponsor|2|||
154919368|NCT00598442|559128341|FG002|Overall Study|Site closed by sponsor|1|||
154919369|NCT00598442|559128339|FG000|Overall Study|Started dialysis|1|||
154919370|NCT00598442|559128340|FG001|Overall Study|Started dialysis|0|||
154919371|NCT00598442|559128341|FG002|Overall Study|Started dialysis|0|||
154919372|NCT01590628|559128350|FG000|Overall Study|Death|2|||
154919373|NCT01590628|559128351|FG001|Overall Study|Death|0|||
154919374|NCT04629534|559128366|FG000|Overall Study|Physician Decision|1|||
154919375|NCT04629534|559128367|FG001|Overall Study|Physician Decision|0|||
154919376|NCT04629534|559128366|FG000|Overall Study|Protocol Violation|0|||
154919377|NCT04629534|559128367|FG001|Overall Study|Protocol Violation|2|||
154919378|NCT00808665|559128368|FG000|Overall Study|Withdrawal by Subject|1|||
154919379|NCT00808665|559128369|FG001|Overall Study|Withdrawal by Subject|0|||
154919380|NCT00808665|559128368|FG000|Overall Study|only required minimally invasive surgery|1|||
154919381|NCT00808665|559128369|FG001|Overall Study|only required minimally invasive surgery|0|||
154919382|NCT00808665|559128368|FG000|Overall Study|surgery cancelled|1|||
155122320|NCT00969761|559877996|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122321|NCT00969761|559877997|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122322|NCT00969761|559877998|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155122323|NCT00969761|559877999|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122324|NCT00969761|559878000|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122325|NCT00969761|559878001|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122326|NCT00969761|559878002|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122327|NCT00969761|559878003|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155122328|NCT00969761|559878004|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
155122329|NCT00969761|559878005|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122330|NCT00969761|559878006|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
155122331|NCT00969761|559877995|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122332|NCT00969761|559877996|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122333|NCT00969761|559877997|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
155122334|NCT00969761|559877998|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122335|NCT00969761|559877999|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122336|NCT00969761|559878000|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122337|NCT00969761|559878001|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122338|NCT00969761|559878002|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122339|NCT00969761|559878003|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122340|NCT00969761|559878004|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122341|NCT00969761|559878005|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122342|NCT00969761|559878006|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
155122343|NCT00969761|559877995|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122344|NCT00969761|559877996|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122345|NCT00969761|559877997|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
155122346|NCT00969761|559877998|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122347|NCT00969761|559877999|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122348|NCT00969761|559878000|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122349|NCT00969761|559878001|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122350|NCT00969761|559878002|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122351|NCT00969761|559878003|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122352|NCT00969761|559878004|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
154919383|NCT00808665|559128369|FG001|Overall Study|surgery cancelled|0|||
154919384|NCT00808665|559128368|FG000|Overall Study|required an additional procedure|0|||
154919385|NCT00808665|559128369|FG001|Overall Study|required an additional procedure|1|||
155122353|NCT00969761|559878005|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122354|NCT00969761|559878006|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
155122355|NCT00969761|559877995|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122356|NCT00969761|559877996|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122357|NCT00969761|559877997|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122358|NCT00969761|559877998|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122359|NCT00969761|559877999|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122360|NCT00969761|559878000|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122361|NCT00969761|559878001|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122362|NCT00969761|559878002|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122363|NCT00969761|559878003|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
155122364|NCT00969761|559878004|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
154919386|NCT00808665|559128368|FG000|Overall Study|Physician Decision|3|||
154919387|NCT00808665|559128369|FG001|Overall Study|Physician Decision|1|||
154919388|NCT00808665|559128368|FG000|Overall Study|Medication stopped by resident|0|||
154919389|NCT00808665|559128369|FG001|Overall Study|Medication stopped by resident|1|||
154919390|NCT05146999|559128370|FG000|Overall Study|Withdrew consent|6|||
154919391|NCT05146999|559128371|FG001|Overall Study|Withdrew consent|1|||
154919392|NCT05146999|559128370|FG000|Overall Study|Lost to Follow-up|3|||
154919393|NCT05146999|559128371|FG001|Overall Study|Lost to Follow-up|2|||
154919394|NCT05146999|559128370|FG000|Overall Study|Other|1|||
154919395|NCT05146999|559128371|FG001|Overall Study|Other|3|||
154919396|NCT03319160|559128372|FG000|Overall Study|Data not available.|7|||
154919397|NCT00383292|559128375|FG000|Overall Study|Adverse Event|4|||
154919398|NCT00383292|559128376|FG001|Overall Study|Adverse Event|1|||
154919399|NCT00383292|559128377|FG002|Overall Study|Adverse Event|2|||
154919400|NCT00383292|559128375|FG000|Overall Study|Death|3|||
154919401|NCT00383292|559128376|FG001|Overall Study|Death|3|||
154919402|NCT00383292|559128377|FG002|Overall Study|Death|3|||
154919403|NCT00383292|559128375|FG000|Overall Study|Physician Decision|4|||
154919404|NCT00383292|559128376|FG001|Overall Study|Physician Decision|0|||
154919405|NCT00383292|559128377|FG002|Overall Study|Physician Decision|1|||
154919406|NCT00383292|559128375|FG000|Overall Study|Withdrawal by Subject|3|||
154919407|NCT00383292|559128376|FG001|Overall Study|Withdrawal by Subject|2|||
154919408|NCT00383292|559128377|FG002|Overall Study|Withdrawal by Subject|2|||
154919409|NCT00383292|559128375|FG000|Overall Study|Other|1|||
154919410|NCT00383292|559128376|FG001|Overall Study|Other|0|||
154919411|NCT00383292|559128377|FG002|Overall Study|Other|0|||
154919412|NCT04533204|559128378|FG000|Overall Study|Unable to understand training instructions|1|||
154919413|NCT04533204|559128379|FG001|Overall Study|Unable to understand training instructions|1|||
154919414|NCT00697255|559128380|FG000|Stage 1a|Insufficient ovarian response|1|||
154919415|NCT00697255|559128381|FG001|Stage 1a|Insufficient ovarian response|0|||
154919416|NCT00697255|559128380|FG000|Stage 1a|Multifollicular growth|1|||
154919417|NCT00697255|559128381|FG001|Stage 1a|Multifollicular growth|0|||
154919418|NCT00697255|559128380|FG000|Stage 1a|Not growing of dominant follicle|1|||
154919419|NCT00697255|559128381|FG001|Stage 1a|Not growing of dominant follicle|0|||
154919420|NCT00697255|559128380|FG000|Stage 1b|Not growing of dominant follicle|0|||
154919421|NCT00697255|559128381|FG001|Stage 1b|Not growing of dominant follicle|1|||
154919422|NCT00697255|559128380|FG000|Stage 1b|Insufficient ovarian response|0|||
154919423|NCT00697255|559128381|FG001|Stage 1b|Insufficient ovarian response|1|||
154919424|NCT04034225|559128385|FG000|Overall Study|Death|3|||
154919425|NCT04034225|559128385|FG000|Overall Study|Withdrawal by Subject|2|||
154919426|NCT04034225|559128385|FG000|Overall Study|Study termination by Sponsor|18|||
154919427|NCT04034225|559128385|FG000|Overall Study|Physician Decision|1|||
154919428|NCT04034225|559128385|FG000|Overall Study|Lack of Efficacy|1|||
154919429|NCT02260791|559128390|FG000|Overall Study|Lost to Follow-up|4|||
154919430|NCT02260791|559128391|FG001|Overall Study|Lost to Follow-up|4|||
154919431|NCT02260791|559128390|FG000|Overall Study|Lack of Efficacy|2|||
154919432|NCT02260791|559128391|FG001|Overall Study|Lack of Efficacy|1|||
154919433|NCT02260791|559128390|FG000|Overall Study|Adverse Event|13|||
154919434|NCT02260791|559128391|FG001|Overall Study|Adverse Event|9|||
154919435|NCT02260791|559128390|FG000|Overall Study|Death|1|||
154919436|NCT02260791|559128391|FG001|Overall Study|Death|0|||
154919437|NCT02260791|559128390|FG000|Overall Study|Withdrawal by Subject|11|||
154919438|NCT02260791|559128391|FG001|Overall Study|Withdrawal by Subject|16|||
154919439|NCT02260791|559128390|FG000|Overall Study|Screen failure|0|||
154919440|NCT02260791|559128391|FG001|Overall Study|Screen failure|1|||
154919441|NCT02260791|559128390|FG000|Overall Study|Protocol deviation|2|||
154919442|NCT02260791|559128391|FG001|Overall Study|Protocol deviation|3|||
154919443|NCT04246996|559128395|FG000|Overall Study|Physician Decision|1|||
154919444|NCT04246996|559128396|FG001|Overall Study|Physician Decision|1|||
154919445|NCT04246996|559128395|FG000|Overall Study|Did not meet eligibility criteria|1|||
154919446|NCT04246996|559128396|FG001|Overall Study|Did not meet eligibility criteria|4|||
154919447|NCT00736840|559128399|FG000|Overall Study|Lost to Follow-up|13|||
154919448|NCT01411917|559128400|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
154919449|NCT01411917|559128401|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
154919450|NCT02815670|559128402|FG000|Overall Study|Prematurely discontinued of the trial|1|||
154919451|NCT01815099|559128405|FG000|Overall Study|Lack of Efficacy|1|||
154919452|NCT01815099|559128405|FG000|Overall Study|unable to attend study visits|1|||
154919453|NCT01475214|559128406|FG000|Overall Study|Lost to Follow-up|1|||
154919454|NCT01475214|559128407|FG001|Overall Study|Lost to Follow-up|0|||
154919455|NCT01475214|559128408|FG002|Overall Study|Lost to Follow-up|1|||
154919456|NCT01475214|559128406|FG000|Overall Study|Physician Decision|2|||
154919457|NCT01475214|559128407|FG001|Overall Study|Physician Decision|0|||
154919458|NCT01475214|559128408|FG002|Overall Study|Physician Decision|0|||
154919459|NCT01475214|559128406|FG000|Overall Study|Withdrawal by Subject|2|||
154919460|NCT01475214|559128407|FG001|Overall Study|Withdrawal by Subject|4|||
154919461|NCT01475214|559128408|FG002|Overall Study|Withdrawal by Subject|1|||
154919462|NCT03289676|559128409|FG000|Overall Study|Withdrawal by Subject|2|||
154919463|NCT03289676|559128410|FG001|Overall Study|Withdrawal by Subject|0|||
154919464|NCT03289676|559128409|FG000|Overall Study|Protocol Violation|2|||
154919465|NCT03289676|559128410|FG001|Overall Study|Protocol Violation|0|||
154919466|NCT03289676|559128409|FG000|Overall Study|Lost to Follow-up|0|||
154919467|NCT03289676|559128410|FG001|Overall Study|Lost to Follow-up|1|||
154919468|NCT02354599|559128411|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
154919469|NCT02354599|559128412|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
154919470|NCT02354599|559128413|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
154919471|NCT02354599|559128414|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
154919472|NCT02354599|559128415|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
154919473|NCT02354599|559128416|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
154919474|NCT02354599|559128411|FG000|Overall Study|Withdrawal by Subject|1|||
154919475|NCT02354599|559128412|FG001|Overall Study|Withdrawal by Subject|1|||
154919476|NCT02354599|559128413|FG002|Overall Study|Withdrawal by Subject|0|||
154919477|NCT02354599|559128414|FG003|Overall Study|Withdrawal by Subject|0|||
154919478|NCT02354599|559128415|FG004|Overall Study|Withdrawal by Subject|0|||
154919479|NCT02354599|559128416|FG005|Overall Study|Withdrawal by Subject|0|||
154919480|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Death|2|||
154919481|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Death|0|||
154919482|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Adverse Event|33|||
154919483|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Adverse Event|31|||
154919484|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
154919485|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
154919486|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
154919487|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
154919488|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
154919489|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
155122365|NCT00969761|559878005|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122366|NCT00969761|559878006|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
155122367|NCT00969761|559877995|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
155122368|NCT00969761|559877996|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155122369|NCT00969761|559877997|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
155122370|NCT00969761|559877998|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155122371|NCT00969761|559877999|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
155122372|NCT00969761|559878000|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155122373|NCT00969761|559878001|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155122374|NCT00969761|559878002|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
154919490|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Other|7|||
154919491|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Other|8|||
154919492|NCT00280059|559128417|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
154919493|NCT00280059|559128418|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
154919494|NCT00495794|559128421|FG000|Overall Study|Pharmacist did not activate patient|522|||
154919495|NCT00495794|559128422|FG001|Overall Study|Pharmacist did not activate patient|0|||
154919496|NCT02127931|559128423|FG000|Overall Study|Glitch in Game|1|||
154919497|NCT01636076|559128424|FG000|Overall Study|Terminated by sponsor|1|||
154919498|NCT01636076|559128425|FG001|Overall Study|Terminated by sponsor|1|||
155122375|NCT00969761|559878003|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
155122376|NCT00969761|559878004|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
155122377|NCT00969761|559878005|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155122378|NCT00969761|559878006|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
155122379|NCT00969761|559877995|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122380|NCT00969761|559877996|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122381|NCT00969761|559877997|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122382|NCT00969761|559877998|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
155122383|NCT00969761|559877999|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
155122384|NCT00969761|559878000|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122385|NCT00969761|559878001|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122386|NCT00969761|559878002|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122387|NCT00969761|559878003|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
155122388|NCT00969761|559878004|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122389|NCT00969761|559878005|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122390|NCT00969761|559878006|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
155122391|NCT03959982|559879759|FG000|Overall Study|Withdrawal by Subject|1|||
155122392|NCT03959982|559879760|FG001|Overall Study|Withdrawal by Subject|0|||
154919499|NCT01636076|559128424|FG000|Overall Study|Lack of Efficacy|0|||
154919500|NCT01636076|559128425|FG001|Overall Study|Lack of Efficacy|1|||
154919501|NCT01636076|559128424|FG000|Overall Study|Lost to Follow-up|1|||
154919502|NCT01636076|559128425|FG001|Overall Study|Lost to Follow-up|0|||
154919503|NCT01636076|559128424|FG000|Overall Study|Physician Decision|1|||
154919504|NCT01636076|559128425|FG001|Overall Study|Physician Decision|1|||
154919505|NCT01636076|559128424|FG000|Overall Study|Non-compliance with study treatment|1|||
154919506|NCT01636076|559128425|FG001|Overall Study|Non-compliance with study treatment|1|||
154919507|NCT01636076|559128424|FG000|Overall Study|Adverse Event|6|||
154919508|NCT01636076|559128425|FG001|Overall Study|Adverse Event|11|||
154919509|NCT01636076|559128424|FG000|Overall Study|Withdrawal by Subject|7|||
154919510|NCT01636076|559128425|FG001|Overall Study|Withdrawal by Subject|10|||
154919511|NCT01130831|559128426|FG000|Overall Study|Withdrawal by Subject|7|||
154919512|NCT01130831|559128426|FG000|Overall Study|Death|4|||
154919513|NCT01130831|559128426|FG000|Overall Study|Information was missing|3|||
154919514|NCT01159665|559128427|FG000|Overall Study|Withdrawal by Subject|0|||
154919515|NCT01159665|559128428|FG001|Overall Study|Withdrawal by Subject|1|||
154919516|NCT01159665|559128429|FG002|Overall Study|Withdrawal by Subject|0|||
154919517|NCT01159665|559128430|FG003|Overall Study|Withdrawal by Subject|0|||
154919518|NCT01159665|559128431|FG004|Overall Study|Withdrawal by Subject|0|||
155122393|NCT03959982|559879759|FG000|Overall Study|Physician Decision|2|||
155122394|NCT03959982|559879760|FG001|Overall Study|Physician Decision|0|||
155122395|NCT03959982|559879759|FG000|Overall Study|Lost to Follow-up|1|||
155122396|NCT03959982|559879760|FG001|Overall Study|Lost to Follow-up|0|||
155122397|NCT00262847|559879763|FG000|Overall Study|Disease Progression|309|||
155122398|NCT00262847|559879764|FG001|Overall Study|Disease Progression|274|||
155122399|NCT00262847|559879765|FG002|Overall Study|Disease Progression|195|||
155122400|NCT00262847|559879763|FG000|Overall Study|Patient Refusal|41|||
155122401|NCT00262847|559879764|FG001|Overall Study|Patient Refusal|52|||
155122402|NCT00262847|559879765|FG002|Overall Study|Patient Refusal|47|||
155122403|NCT00262847|559879763|FG000|Overall Study|Adverse Event|74|||
155122404|NCT00262847|559879764|FG001|Overall Study|Adverse Event|88|||
155122405|NCT00262847|559879765|FG002|Overall Study|Adverse Event|108|||
155122406|NCT00262847|559879763|FG000|Overall Study|Death|8|||
155122407|NCT00262847|559879764|FG001|Overall Study|Death|8|||
155122408|NCT00262847|559879765|FG002|Overall Study|Death|11|||
155122409|NCT00262847|559879763|FG000|Overall Study|Concomitant disease|3|||
155122410|NCT00262847|559879764|FG001|Overall Study|Concomitant disease|2|||
155122411|NCT00262847|559879765|FG002|Overall Study|Concomitant disease|4|||
155122412|NCT00262847|559879763|FG000|Overall Study|Other Reasons|79|||
155122413|NCT00262847|559879764|FG001|Overall Study|Other Reasons|88|||
155122414|NCT00262847|559879765|FG002|Overall Study|Other Reasons|27|||
155122415|NCT00262847|559879763|FG000|Overall Study|Did not receive study treatment|4|||
155122416|NCT00262847|559879764|FG001|Overall Study|Did not receive study treatment|1|||
155122417|NCT00262847|559879765|FG002|Overall Study|Did not receive study treatment|4|||
155122418|NCT00387647|559879766|FG000|Overall Study|Death|18|||
155122419|NCT00758589|559879767|FG000|Overall Study|Adverse Event|3|||
155122420|NCT00758589|559879768|FG001|Overall Study|Adverse Event|2|||
155122421|NCT00758589|559879769|FG002|Overall Study|Adverse Event|5|||
155122422|NCT00758589|559879770|FG003|Overall Study|Adverse Event|4|||
155122423|NCT00758589|559879767|FG000|Overall Study|Withdrawal by Subject|0|||
155122424|NCT00758589|559879768|FG001|Overall Study|Withdrawal by Subject|1|||
155122425|NCT00758589|559879769|FG002|Overall Study|Withdrawal by Subject|1|||
155122426|NCT00758589|559879770|FG003|Overall Study|Withdrawal by Subject|1|||
155122427|NCT00758589|559879767|FG000|Overall Study|Palm stopped to work|0|||
155122428|NCT00758589|559879768|FG001|Overall Study|Palm stopped to work|0|||
155122429|NCT00758589|559879769|FG002|Overall Study|Palm stopped to work|0|||
155122430|NCT00758589|559879770|FG003|Overall Study|Palm stopped to work|1|||
155122431|NCT02191605|559879771|FG000|Overall Study|Lost to Follow-up|9|||
155122432|NCT02191605|559879772|FG001|Overall Study|Lost to Follow-up|4|||
155122433|NCT02191605|559879773|FG002|Overall Study|Lost to Follow-up|7|||
155122434|NCT02191605|559879774|FG003|Overall Study|Lost to Follow-up|3|||
155122435|NCT02191605|559879775|FG004|Overall Study|Lost to Follow-up|4|||
155122436|NCT05079477|559879778|FG000|Overall Study|Lost to Follow-up|2|||
155122437|NCT05079477|559879779|FG001|Overall Study|Lost to Follow-up|0|||
155122438|NCT05079477|559879778|FG000|Overall Study|Withdrawal by Subject|1|||
155122439|NCT05079477|559879779|FG001|Overall Study|Withdrawal by Subject|0|||
155122440|NCT05079477|559879778|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
155122441|NCT05079477|559879779|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
155122442|NCT05079477|559879778|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
155122443|NCT05079477|559879779|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
155122444|NCT05275582|559879782|FG000|Overall Study|Lost to Follow-up|1|||
155122445|NCT05275582|559879783|FG001|Overall Study|Lost to Follow-up|0|||
155122446|NCT05275582|559879782|FG000|Overall Study|Withdrawal by Subject|0|||
155122447|NCT05275582|559879783|FG001|Overall Study|Withdrawal by Subject|2|||
154919519|NCT01159665|559128432|FG005|Overall Study|Withdrawal by Subject|0|||
154919520|NCT00951912|559128433|FG000|Overall Study|Lack of Efficacy|1|||
155122448|NCT05275582|559879782|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
155122449|NCT05275582|559879783|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
155122450|NCT05275582|559879782|FG000|Overall Study|Death|1|||
155122451|NCT05275582|559879783|FG001|Overall Study|Death|0|||
155122452|NCT05275582|559879782|FG000|Overall Study|Protocol Violation|1|||
155122453|NCT05275582|559879783|FG001|Overall Study|Protocol Violation|0|||
155122454|NCT00240110|559879784|FG000|Overall Study|Lost to Follow-up|6|||
155122455|NCT00240110|559879785|FG001|Overall Study|Lost to Follow-up|7|||
155122456|NCT00583791|559879786|FG000|Overall Study|Other|67|||
155122457|NCT00583791|559879786|FG000|Overall Study|Death|6|||
154919521|NCT00951912|559128434|FG001|Overall Study|Lack of Efficacy|0|||
155177707|NCT04966910|560089362|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
155177708|NCT04966910|560089363|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
155177709|NCT02446171|560089366|FG000|Overall Study|Withdrawal by Subject|0|||
155177710|NCT02446171|560089367|FG001|Overall Study|Withdrawal by Subject|0|||
155177711|NCT02446171|560089368|FG002|Overall Study|Withdrawal by Subject|2|||
155177712|NCT02446171|560089369|FG003|Overall Study|Withdrawal by Subject|0|||
155177713|NCT03328182|560089370|FG000|Overall Study|Withdrawal by Subject|1|||
155177714|NCT03328182|560089370|FG000|Overall Study|Protocol Violation|2|||
155177715|NCT03328182|560089370|FG000|Overall Study|No Product Evaluated|1|||
155177716|NCT00504582|560089371|FG000|Overall Study|Lost to Follow-up|1|||
155177717|NCT00504582|560089372|FG001|Overall Study|Lost to Follow-up|0|||
155177718|NCT00504582|560089373|FG002|Overall Study|Lost to Follow-up|0|||
155177719|NCT00773383|560089375|FG000|Overall Study|Adverse Event|4|||
155177720|NCT00773383|560089375|FG000|Overall Study|Death|1|||
155177721|NCT00773383|560089375|FG000|Overall Study|Progression of Disease|23|||
155177722|NCT00773383|560089375|FG000|Overall Study|Other|2|||
155177723|NCT00773383|560089375|FG000|Overall Study|No study dose received|1|||
155177724|NCT00003830|560089378|FG000|Overall Study|No follow up data|3|||
155177725|NCT00003830|560089379|FG001|Overall Study|No follow up data|0|||
155177726|NCT00003830|560089378|FG000|Overall Study|Sentinel node positive patients|829|||
155177727|NCT00003830|560089379|FG001|Overall Study|Sentinel node positive patients|793|||
155177728|NCT03860935|560089380|FG000|Overall Study|Withdrawal of Consent|15|||
155177729|NCT03860935|560089381|FG001|Overall Study|Withdrawal of Consent|6|||
155177730|NCT03860935|560089380|FG000|Overall Study|Death|75|||
155177731|NCT03860935|560089381|FG001|Overall Study|Death|51|||
155177732|NCT01122394|560089385|FG000|Overall Study|Withdrawal by Subject|1|||
155177733|NCT01122394|560089386|FG001|Overall Study|Withdrawal by Subject|1|||
155177734|NCT01122394|560089385|FG000|Overall Study|Lost to Follow-up|2|||
155177735|NCT01122394|560089386|FG001|Overall Study|Lost to Follow-up|2|||
155177736|NCT01122394|560089385|FG000|Overall Study|Adverse Event|0|||
155177737|NCT01122394|560089386|FG001|Overall Study|Adverse Event|1|||
155177738|NCT00039871|560089387|FG000|Overall Study|Adverse Event|165|||
155177739|NCT00039871|560089387|FG000|Overall Study|Lost to Follow-up|18|||
155177740|NCT00039871|560089387|FG000|Overall Study|Protocol Violation|24|||
155177741|NCT00039871|560089387|FG000|Overall Study|Withdrawal by Subject|97|||
155177742|NCT00039871|560089387|FG000|Overall Study|Did not meet eligibility criteria|11|||
155177743|NCT00039871|560089387|FG000|Overall Study|Administrative|1|||
155177744|NCT00039871|560089387|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
155177745|NCT00039871|560089387|FG000|Overall Study|Never entered follow-up|7|||
155177746|NCT03361176|560089388|FG000|Overall Study|Lost to Follow-up|1|||
155177747|NCT03361176|560089389|FG001|Overall Study|Lost to Follow-up|2|||
155177748|NCT03361176|560089388|FG000|Overall Study|Adverse Event|0|||
155177749|NCT03361176|560089389|FG001|Overall Study|Adverse Event|2|||
155177750|NCT03361176|560089388|FG000|Overall Study|Withdrawal by Subject|0|||
155177751|NCT03361176|560089389|FG001|Overall Study|Withdrawal by Subject|1|||
155177752|NCT02478398|560089390|FG000|Overall Study|Adverse Event|20|||
155177753|NCT02478398|560089391|FG001|Overall Study|Adverse Event|5|||
155177754|NCT02478398|560089390|FG000|Overall Study|Lost to Follow-up|5|||
155177755|NCT02478398|560089391|FG001|Overall Study|Lost to Follow-up|4|||
155177756|NCT02478398|560089390|FG000|Overall Study|Non-Compliance With Study Drug|5|||
155177757|NCT02478398|560089391|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155177758|NCT02478398|560089390|FG000|Overall Study|Protocol Violation|3|||
155177759|NCT02478398|560089391|FG001|Overall Study|Protocol Violation|1|||
155177760|NCT02478398|560089390|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
155177761|NCT02478398|560089391|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
155177762|NCT02478398|560089390|FG000|Overall Study|Withdrawal By Participant|10|||
155177763|NCT02478398|560089391|FG001|Overall Study|Withdrawal By Participant|4|||
155177764|NCT00704522|560089394|FG000|Overall Study|Lack of Efficacy|65|||
155177765|NCT00704522|560089395|FG001|Overall Study|Lack of Efficacy|17|||
155177766|NCT00704522|560089394|FG000|Overall Study|Failure to appear again at hospital|56|||
155177767|NCT00704522|560089395|FG001|Overall Study|Failure to appear again at hospital|10|||
155177768|NCT00704522|560089394|FG000|Overall Study|Withdrawal by Subject|17|||
155177769|NCT00704522|560089395|FG001|Overall Study|Withdrawal by Subject|8|||
155177770|NCT00704522|560089394|FG000|Overall Study|Adverse Event|9|||
155177771|NCT00704522|560089395|FG001|Overall Study|Adverse Event|1|||
155177772|NCT00704522|560089394|FG000|Overall Study|Undefined causes|9|||
155177773|NCT00704522|560089395|FG001|Overall Study|Undefined causes|7|||
155177774|NCT00704522|560089394|FG000|Overall Study|No information on therapy end|27|||
155177775|NCT00704522|560089395|FG001|Overall Study|No information on therapy end|2|||
155177776|NCT01895361|560089399|FG000|Overall Study|Adverse Event|1|||
155177777|NCT01895361|560089400|FG001|Overall Study|Adverse Event|1|||
155177778|NCT01895361|560089401|FG002|Overall Study|Adverse Event|3|||
155177779|NCT01895361|560089399|FG000|Overall Study|Death|2|||
154919522|NCT00951912|559128435|FG002|Overall Study|Lack of Efficacy|0|||
155177780|NCT01895361|560089400|FG001|Overall Study|Death|1|||
155177781|NCT01895361|560089401|FG002|Overall Study|Death|2|||
155177782|NCT01895361|560089399|FG000|Overall Study|Lost to Follow-up|4|||
155177783|NCT01895361|560089400|FG001|Overall Study|Lost to Follow-up|4|||
154919523|NCT00951912|559128433|FG000|Overall Study|Adverse Event|0|||
154919524|NCT00951912|559128434|FG001|Overall Study|Adverse Event|1|||
154919525|NCT00951912|559128435|FG002|Overall Study|Adverse Event|1|||
154919526|NCT00951912|559128433|FG000|Overall Study|Lost to Follow-up|2|||
154919527|NCT00951912|559128434|FG001|Overall Study|Lost to Follow-up|2|||
154919528|NCT00951912|559128435|FG002|Overall Study|Lost to Follow-up|0|||
154919529|NCT00951912|559128433|FG000|Overall Study|Physician Decision|1|||
154919530|NCT00951912|559128434|FG001|Overall Study|Physician Decision|0|||
154919531|NCT00951912|559128435|FG002|Overall Study|Physician Decision|1|||
154919532|NCT00951912|559128433|FG000|Overall Study|Withdrawal by Subject|1|||
154919533|NCT00951912|559128434|FG001|Overall Study|Withdrawal by Subject|1|||
154919534|NCT00951912|559128435|FG002|Overall Study|Withdrawal by Subject|0|||
154919535|NCT00951912|559128433|FG000|Overall Study|Other:Depression|1|||
154919536|NCT00951912|559128434|FG001|Overall Study|Other:Depression|0|||
154919537|NCT00951912|559128435|FG002|Overall Study|Other:Depression|0|||
154919538|NCT00951912|559128433|FG000|Overall Study|Other: Colon cancer|1|||
154919539|NCT00951912|559128434|FG001|Overall Study|Other: Colon cancer|0|||
154919540|NCT00951912|559128435|FG002|Overall Study|Other: Colon cancer|0|||
154919541|NCT00951912|559128433|FG000|Overall Study|Other: Stroke|0|||
154919542|NCT00951912|559128434|FG001|Overall Study|Other: Stroke|1|||
154919543|NCT00951912|559128435|FG002|Overall Study|Other: Stroke|0|||
154919544|NCT02173158|559128438|FG000|Efficacy Phase|Adverse Event|1|||
154919545|NCT01377194|559128439|FG000|Overall Study|Adverse Event|3|||
154919546|NCT01377194|559128440|FG001|Overall Study|Adverse Event|12|||
154919547|NCT01377194|559128441|FG002|Overall Study|Adverse Event|19|||
154919548|NCT01377194|559128439|FG000|Overall Study|Lack of Efficacy|3|||
154919549|NCT01377194|559128440|FG001|Overall Study|Lack of Efficacy|3|||
154919550|NCT01377194|559128441|FG002|Overall Study|Lack of Efficacy|3|||
154919551|NCT01377194|559128439|FG000|Overall Study|Protocol Violation|4|||
154919552|NCT01377194|559128440|FG001|Overall Study|Protocol Violation|10|||
154919553|NCT01377194|559128441|FG002|Overall Study|Protocol Violation|6|||
154919554|NCT01377194|559128439|FG000|Overall Study|Withdrawal by Subject|8|||
154919555|NCT01377194|559128440|FG001|Overall Study|Withdrawal by Subject|10|||
154919556|NCT01377194|559128441|FG002|Overall Study|Withdrawal by Subject|7|||
154919557|NCT01377194|559128439|FG000|Overall Study|Lost to Follow-up|14|||
154919558|NCT01377194|559128440|FG001|Overall Study|Lost to Follow-up|8|||
154919559|NCT01377194|559128441|FG002|Overall Study|Lost to Follow-up|11|||
154919560|NCT00323479|559128444|FG000|Overall Study|Adverse Event|2|||
154919561|NCT00323479|559128444|FG000|Overall Study|Withdrawal by Subject|2|||
154919562|NCT00323479|559128444|FG000|Overall Study|Protocol Violation|3|||
154919563|NCT00323479|559128444|FG000|Overall Study|house moving|1|||
154919564|NCT00967343|559128446|FG000|Overall Study|Study termination by sponsor|12|||
154919565|NCT00967343|559128446|FG000|Overall Study|Death|24|||
154919566|NCT00967343|559128446|FG000|Overall Study|Relapse|1|||
154919567|NCT00967343|559128446|FG000|Overall Study|Lost to Follow-up|1|||
154919568|NCT05450198|559129837|FG000|Overall Study|Withdrawal by Subject|1|||
154919569|NCT05450198|559129838|FG001|Overall Study|Withdrawal by Subject|1|||
154919570|NCT05450198|559129839|FG002|Overall Study|Withdrawal by Subject|2|||
154919571|NCT05450198|559129840|FG003|Overall Study|Withdrawal by Subject|0|||
154919572|NCT05450198|559129837|FG000|Overall Study|Lost to Follow-up|1|||
154919573|NCT05450198|559129838|FG001|Overall Study|Lost to Follow-up|0|||
154919574|NCT05450198|559129839|FG002|Overall Study|Lost to Follow-up|2|||
154919575|NCT05450198|559129840|FG003|Overall Study|Lost to Follow-up|1|||
154919576|NCT01224171|559129846|FG000|Overall Study|Adverse Event|8|||
154919577|NCT01224171|559129847|FG001|Overall Study|Adverse Event|4|||
154919578|NCT01224171|559129846|FG000|Overall Study|Protocol Violation|0|||
154919579|NCT01224171|559129847|FG001|Overall Study|Protocol Violation|1|||
154919580|NCT01224171|559129846|FG000|Overall Study|Lack of Efficacy|5|||
154919581|NCT01224171|559129847|FG001|Overall Study|Lack of Efficacy|1|||
154919582|NCT01224171|559129846|FG000|Overall Study|Withdrawal of Consent|2|||
154919583|NCT01224171|559129847|FG001|Overall Study|Withdrawal of Consent|4|||
154919584|NCT01224171|559129846|FG000|Overall Study|Lost to Follow-up|0|||
154919585|NCT01224171|559129847|FG001|Overall Study|Lost to Follow-up|3|||
154919586|NCT01097057|559129848|FG000|Overall Study|Physician Decision|3|||
154919587|NCT01270139|559129849|FG000|Overall Study|Adverse Event|8|||
154919588|NCT01270139|559129850|FG001|Overall Study|Adverse Event|17|||
154919589|NCT01270139|559129851|FG002|Overall Study|Adverse Event|18|||
154919590|NCT01270139|559129849|FG000|Overall Study|Lost to Follow-up|10|||
154919591|NCT01270139|559129850|FG001|Overall Study|Lost to Follow-up|9|||
154919592|NCT01270139|559129851|FG002|Overall Study|Lost to Follow-up|2|||
154919593|NCT01161173|559129860|FG000|Overall Study|Protocol Violation|13|||
154919594|NCT01161173|559129860|FG000|Overall Study|Lost to Follow-up|7|||
154919595|NCT01161173|559129860|FG000|Overall Study|Progressive Disease|82|||
154919596|NCT01161173|559129860|FG000|Overall Study|Withdrawal of Consent|5|||
154919597|NCT01161173|559129860|FG000|Overall Study|Unacceptable Toxicity|21|||
154919598|NCT01161173|559129860|FG000|Overall Study|Death|194|||
154919599|NCT01161173|559129860|FG000|Overall Study|End of Study|2|||
154919600|NCT01161173|559129860|FG000|Overall Study|Reasons Not Specified|23|||
154919601|NCT01911546|559129861|FG000|Overall Study|Lost to Follow-up|1|||
154919602|NCT01911546|559129861|FG000|Overall Study|Everolimus was discontinued|5|||
154919603|NCT02213666|559129863|FG000|Overall Study|Withdrawal by Subject|1|||
154919604|NCT01319422|559129864|FG000|Overall Study|Withdrawal by Subject|1|||
154919605|NCT01319422|559129865|FG001|Overall Study|Withdrawal by Subject|0|||
154919606|NCT01399619|559129866|FG000|Overall Study|Adverse Event|10|||
154919607|NCT01399619|559129867|FG001|Overall Study|Adverse Event|0|||
154919608|NCT01399619|559129868|FG002|Overall Study|Adverse Event|4|||
154919609|NCT01399619|559129869|FG003|Overall Study|Adverse Event|10|||
154919610|NCT01399619|559129866|FG000|Overall Study|Lack of Efficacy|9|||
154919611|NCT01399619|559129867|FG001|Overall Study|Lack of Efficacy|0|||
154919612|NCT01399619|559129868|FG002|Overall Study|Lack of Efficacy|5|||
154919613|NCT01399619|559129869|FG003|Overall Study|Lack of Efficacy|0|||
154919614|NCT01399619|559129866|FG000|Overall Study|Withdrawal by Subject|6|||
154919615|NCT01399619|559129867|FG001|Overall Study|Withdrawal by Subject|0|||
154919616|NCT01399619|559129868|FG002|Overall Study|Withdrawal by Subject|3|||
154919617|NCT01399619|559129869|FG003|Overall Study|Withdrawal by Subject|4|||
154919618|NCT01399619|559129866|FG000|Overall Study|Protocol Violation|0|||
154919619|NCT01399619|559129867|FG001|Overall Study|Protocol Violation|0|||
154919620|NCT01399619|559129868|FG002|Overall Study|Protocol Violation|0|||
154919621|NCT01399619|559129869|FG003|Overall Study|Protocol Violation|1|||
154919622|NCT01399619|559129866|FG000|Overall Study|Not treated|0|||
154919623|NCT01399619|559129867|FG001|Overall Study|Not treated|0|||
154919624|NCT01399619|559129868|FG002|Overall Study|Not treated|0|||
154919625|NCT01399619|559129869|FG003|Overall Study|Not treated|2|||
154919626|NCT02918968|559129870|FG000|1st Line AAT|Progressive disease|9|||
154919627|NCT02918968|559129871|FG001|1st Line AAT|Progressive disease|4|||
154919628|NCT02918968|559129870|FG000|1st Line AAT|Adverse Event|12|||
154919629|NCT02918968|559129871|FG001|1st Line AAT|Adverse Event|3|||
154919630|NCT02918968|559129870|FG000|1st Line AAT|Physician Decision|4|||
154919631|NCT02918968|559129871|FG001|1st Line AAT|Physician Decision|2|||
154919632|NCT02918968|559129870|FG000|1st Line AAT|Withdrawal by Subject|2|||
154919633|NCT02918968|559129871|FG001|1st Line AAT|Withdrawal by Subject|1|||
154919634|NCT02918968|559129870|FG000|1st Line AAT|Lost to Follow-up|0|||
154919635|NCT02918968|559129871|FG001|1st Line AAT|Lost to Follow-up|1|||
154919636|NCT02918968|559129870|FG000|1st Line AAT|Death|1|||
154919637|NCT02918968|559129871|FG001|1st Line AAT|Death|0|||
154919638|NCT02918968|559129870|FG000|1st Line AAT|Miscellaneous|1|||
154919639|NCT02918968|559129871|FG001|1st Line AAT|Miscellaneous|0|||
154919640|NCT02918968|559129870|FG000|2nd Line AAT|Progressive disease|21|||
154919641|NCT02918968|559129871|FG001|2nd Line AAT|Progressive disease|3|||
154919642|NCT02918968|559129870|FG000|2nd Line AAT|Adverse Event|2|||
154919643|NCT02918968|559129871|FG001|2nd Line AAT|Adverse Event|5|||
154919644|NCT02918968|559129870|FG000|2nd Line AAT|Physician Decision|0|||
154919645|NCT02918968|559129871|FG001|2nd Line AAT|Physician Decision|1|||
154919646|NCT02918968|559129870|FG000|2nd Line AAT|Withdrawal by Subject|2|||
154919647|NCT02918968|559129871|FG001|2nd Line AAT|Withdrawal by Subject|2|||
154919648|NCT02918968|559129870|FG000|2nd Line AAT|Death|0|||
154919649|NCT02918968|559129871|FG001|2nd Line AAT|Death|1|||
154919650|NCT05602818|559129872|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
154919651|NCT05602818|559129873|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
154919652|NCT05602818|559129874|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
154919653|NCT05602818|559129875|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
154919654|NCT05602818|559129876|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
154919655|NCT05602818|559129877|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
154919656|NCT05602818|559129878|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
154919657|NCT05602818|559129879|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
154919658|NCT05602818|559129880|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
154919659|NCT05602818|559129881|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
154919660|NCT05602818|559129882|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
154919661|NCT05602818|559129883|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
154919662|NCT05602818|559129872|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
154919663|NCT05602818|559129873|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
154919664|NCT05602818|559129874|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919665|NCT05602818|559129875|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919666|NCT05602818|559129876|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919667|NCT05602818|559129877|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919668|NCT05602818|559129878|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919669|NCT05602818|559129879|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919670|NCT05602818|559129880|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919671|NCT05602818|559129881|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919672|NCT05602818|559129882|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919673|NCT05602818|559129883|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
154919674|NCT05602818|559129872|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
154919675|NCT05602818|559129873|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919676|NCT05602818|559129874|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154995655|NCT03276780|559407945|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
154995656|NCT03276780|559407946|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
154995657|NCT03276780|559407945|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
154919677|NCT05602818|559129875|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919678|NCT05602818|559129876|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919679|NCT05602818|559129877|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919680|NCT05602818|559129878|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919681|NCT05602818|559129879|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919682|NCT05602818|559129880|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919683|NCT05602818|559129881|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919684|NCT05602818|559129882|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919685|NCT05602818|559129883|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
154919686|NCT05602818|559129872|FG000|Qualification Phase (3 Days)|Other|1|||
154919687|NCT05602818|559129873|FG001|Qualification Phase (3 Days)|Other|0|||
154919688|NCT05602818|559129874|FG002|Qualification Phase (3 Days)|Other|0|||
154919689|NCT05602818|559129875|FG003|Qualification Phase (3 Days)|Other|0|||
154919690|NCT05602818|559129876|FG004|Qualification Phase (3 Days)|Other|0|||
154919691|NCT05602818|559129877|FG005|Qualification Phase (3 Days)|Other|0|||
154919692|NCT05602818|559129878|FG006|Qualification Phase (3 Days)|Other|0|||
154919693|NCT05602818|559129879|FG007|Qualification Phase (3 Days)|Other|0|||
154919694|NCT05602818|559129880|FG008|Qualification Phase (3 Days)|Other|0|||
154919695|NCT05602818|559129881|FG009|Qualification Phase (3 Days)|Other|0|||
154919696|NCT05602818|559129882|FG010|Qualification Phase (3 Days)|Other|0|||
154919697|NCT05602818|559129883|FG011|Qualification Phase (3 Days)|Other|0|||
154919698|NCT05602818|559129872|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919699|NCT05602818|559129873|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
154919700|NCT05602818|559129874|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919701|NCT05602818|559129875|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919702|NCT05602818|559129876|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919703|NCT05602818|559129877|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919704|NCT05602818|559129878|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919705|NCT05602818|559129879|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919706|NCT05602818|559129880|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919707|NCT05602818|559129881|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919708|NCT05602818|559129882|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919709|NCT05602818|559129883|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
154919710|NCT05602818|559129872|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
154919711|NCT05602818|559129873|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
154919712|NCT05602818|559129874|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
154919713|NCT05602818|559129875|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
154919714|NCT05602818|559129876|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
154919715|NCT05602818|559129877|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
154919716|NCT05602818|559129878|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
154919717|NCT05602818|559129879|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
154919718|NCT05602818|559129880|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
154919719|NCT05602818|559129881|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
154919720|NCT05602818|559129882|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
154919721|NCT05602818|559129883|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
154919722|NCT05602818|559129872|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919723|NCT05602818|559129873|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919724|NCT05602818|559129874|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919725|NCT05602818|559129875|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919726|NCT05602818|559129876|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919727|NCT05602818|559129877|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919728|NCT05602818|559129878|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919729|NCT05602818|559129879|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919730|NCT05602818|559129880|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919731|NCT05602818|559129881|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
154919732|NCT05602818|559129882|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
154919733|NCT05602818|559129883|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
154919734|NCT05602818|559129872|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
154919735|NCT05602818|559129873|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
154919736|NCT05602818|559129874|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
154919737|NCT05602818|559129875|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
154995658|NCT03276780|559407946|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
154995659|NCT01425723|559407947|FG000|Overall Study|Lack of Efficacy|0|||
154995660|NCT01425723|559407948|FG001|Overall Study|Lack of Efficacy|1|||
154995661|NCT01425723|559407947|FG000|Overall Study|Withdrawal by Subject|1|||
154995662|NCT01425723|559407948|FG001|Overall Study|Withdrawal by Subject|4|||
154995663|NCT01425723|559407947|FG000|Overall Study|Lost to Follow-up|0|||
154995664|NCT01425723|559407948|FG001|Overall Study|Lost to Follow-up|3|||
154995665|NCT01425723|559407947|FG000|Overall Study|Physician Decision|2|||
154995666|NCT01425723|559407948|FG001|Overall Study|Physician Decision|0|||
154995667|NCT01425723|559407947|FG000|Overall Study|Other|1|||
154995668|NCT01425723|559407948|FG001|Overall Study|Other|10|||
154995669|NCT02288182|559407949|FG000|Overall Study|Adverse Event|0|||
154995670|NCT02288182|559407950|FG001|Overall Study|Adverse Event|1|||
154995671|NCT02288182|559407949|FG000|Overall Study|Lost to Follow-up|0|||
154995672|NCT02288182|559407950|FG001|Overall Study|Lost to Follow-up|1|||
154995673|NCT04619992|559407952|FG000|Overall Study|Withdrawal by Subject|1|||
154995674|NCT04619992|559407953|FG001|Overall Study|Withdrawal by Subject|0|||
154995675|NCT01197755|559407954|FG000|Overall Study|Adverse Event|8|||
154995676|NCT01197755|559407955|FG001|Overall Study|Adverse Event|10|||
154995677|NCT01197755|559407956|FG002|Overall Study|Adverse Event|10|||
155122458|NCT00203021|559879787|FG000|Overall Study|Death|4|||
155122459|NCT00203021|559879788|FG001|Overall Study|Death|1|||
154995678|NCT01197755|559407954|FG000|Overall Study|Study-specific discontinuation criteria|2|||
154995679|NCT01197755|559407955|FG001|Overall Study|Study-specific discontinuation criteria|1|||
154995680|NCT01197755|559407956|FG002|Overall Study|Study-specific discontinuation criteria|0|||
154995681|NCT01197755|559407954|FG000|Overall Study|Entered the long-term extension study|18|||
154995682|NCT01197755|559407955|FG001|Overall Study|Entered the long-term extension study|21|||
154995683|NCT01197755|559407956|FG002|Overall Study|Entered the long-term extension study|35|||
154995684|NCT01197755|559407954|FG000|Overall Study|Lack of therapeutic response|0|||
154995685|NCT01197755|559407955|FG001|Overall Study|Lack of therapeutic response|7|||
154995686|NCT01197755|559407956|FG002|Overall Study|Lack of therapeutic response|4|||
154995687|NCT01197755|559407954|FG000|Overall Study|Severe non-compliance to the protocol|2|||
154995688|NCT01197755|559407955|FG001|Overall Study|Severe non-compliance to the protocol|1|||
154995689|NCT01197755|559407956|FG002|Overall Study|Severe non-compliance to the protocol|2|||
154995690|NCT01197755|559407954|FG000|Overall Study|Withdrawal by Subject|1|||
154995691|NCT01197755|559407955|FG001|Overall Study|Withdrawal by Subject|0|||
154995692|NCT01197755|559407956|FG002|Overall Study|Withdrawal by Subject|0|||
154995693|NCT01197755|559407954|FG000|Overall Study|Lost to Follow-up|0|||
154919738|NCT05602818|559129876|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
154919739|NCT05602818|559129877|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
154919740|NCT05602818|559129878|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
154919741|NCT05602818|559129879|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
154919742|NCT05602818|559129880|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
154919743|NCT05602818|559129881|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
154919744|NCT05602818|559129882|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
154995694|NCT01197755|559407955|FG001|Overall Study|Lost to Follow-up|0|||
154995695|NCT01197755|559407956|FG002|Overall Study|Lost to Follow-up|1|||
154995696|NCT01197755|559407954|FG000|Overall Study|eg, change in circumstances|7|||
154995697|NCT01197755|559407955|FG001|Overall Study|eg, change in circumstances|3|||
154995698|NCT01197755|559407956|FG002|Overall Study|eg, change in circumstances|2|||
154995699|NCT03365011|559407957|FG000|Overall Study|Withdrawal by Subject|1|||
155122460|NCT00203021|559879787|FG000|Overall Study|Adverse Event|10|||
155122461|NCT00203021|559879788|FG001|Overall Study|Adverse Event|5|||
155122462|NCT00203021|559879787|FG000|Overall Study|Withdrawal by Subject|45|||
155122463|NCT00203021|559879788|FG001|Overall Study|Withdrawal by Subject|48|||
155122464|NCT00203021|559879787|FG000|Overall Study|Lost to Follow-up|9|||
154919745|NCT05602818|559129883|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
154919746|NCT00750061|559129884|FG000|Overall Study|Adverse Event|2|||
154919747|NCT00750061|559129885|FG001|Overall Study|Adverse Event|0|||
154919748|NCT00750061|559129884|FG000|Overall Study|Withdrawal by Subject|0|||
154919749|NCT00750061|559129885|FG001|Overall Study|Withdrawal by Subject|1|||
154919750|NCT00750061|559129884|FG000|Overall Study|Physician Decision|0|||
154919751|NCT00750061|559129885|FG001|Overall Study|Physician Decision|1|||
154919752|NCT00229931|559129891|FG000|Overall Study|Death|1|||
154919753|NCT00229931|559129892|FG001|Overall Study|Death|0|||
154919754|NCT00229931|559129891|FG000|Overall Study|Lost to Follow-up|3|||
154919755|NCT00229931|559129892|FG001|Overall Study|Lost to Follow-up|2|||
154919756|NCT00475657|559129893|FG000|Overall Study|Death|1|||
154919757|NCT00475657|559129893|FG000|Overall Study|Sponsor's Decision|3|||
154919758|NCT02992743|559129894|FG000|Overall Study|Withdrawal by Subject|1|||
154919759|NCT02992743|559129895|FG001|Overall Study|Withdrawal by Subject|1|||
154919760|NCT02992743|559129894|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
154995700|NCT03365011|559407958|FG001|Overall Study|Withdrawal by Subject|2|||
154995701|NCT03582826|559407959|FG000|Overall Study|Lost to Follow-up|39|||
154995702|NCT03582826|559407960|FG001|Overall Study|Lost to Follow-up|0|||
155122465|NCT00203021|559879788|FG001|Overall Study|Lost to Follow-up|7|||
155122466|NCT00203021|559879787|FG000|Overall Study|Other than specified|11|||
154919761|NCT02992743|559129895|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
154919762|NCT02992743|559129894|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
154919763|NCT02992743|559129895|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
154919764|NCT02992743|559129894|FG000|Overall Study|No measurable disease|1|||
154919765|NCT02992743|559129895|FG001|Overall Study|No measurable disease|0|||
154919766|NCT02992743|559129894|FG000|Overall Study|Lost to Follow-up|0|||
154919767|NCT02992743|559129895|FG001|Overall Study|Lost to Follow-up|1|||
154919768|NCT00761735|559129896|FG000|Overall Study|Lost to Follow-up|6|||
154919769|NCT00761735|559129896|FG000|Overall Study|Withdrawal by Subject|6|||
154919770|NCT00761735|559129896|FG000|Overall Study|Non-compliance with protocol|1|||
154995703|NCT03582826|559407959|FG000|Overall Study|Withdrawal by Subject|2|||
154995704|NCT03582826|559407960|FG001|Overall Study|Withdrawal by Subject|0|||
154995705|NCT03753763|559407961|FG000|Overall Study|Adverse Event|2|||
154995706|NCT03753763|559407962|FG001|Overall Study|Adverse Event|0|||
154995707|NCT03753763|559407961|FG000|Overall Study|Withdrawal by Subject|3|||
154995708|NCT03753763|559407962|FG001|Overall Study|Withdrawal by Subject|1|||
154995709|NCT03753763|559407961|FG000|Overall Study|clinical deterioration|1|||
154995710|NCT03753763|559407962|FG001|Overall Study|clinical deterioration|0|||
154995711|NCT01104779|559407963|FG000|Overall Study|Protocol Violation|1|||
154995712|NCT01104779|559407964|FG001|Overall Study|Protocol Violation|2|||
154995713|NCT01104779|559407965|FG002|Overall Study|Protocol Violation|2|||
154995714|NCT01104779|559407963|FG000|Overall Study|Lack of Efficacy|26|||
154995715|NCT01104779|559407964|FG001|Overall Study|Lack of Efficacy|12|||
154995716|NCT01104779|559407965|FG002|Overall Study|Lack of Efficacy|13|||
154995717|NCT01104779|559407963|FG000|Overall Study|Adverse Event|13|||
154995718|NCT01104779|559407964|FG001|Overall Study|Adverse Event|14|||
154995719|NCT01104779|559407965|FG002|Overall Study|Adverse Event|13|||
154995720|NCT01104779|559407963|FG000|Overall Study|Did not meet inc/exc criteria|1|||
154995721|NCT01104779|559407964|FG001|Overall Study|Did not meet inc/exc criteria|1|||
154995722|NCT01104779|559407965|FG002|Overall Study|Did not meet inc/exc criteria|1|||
154995723|NCT01104779|559407963|FG000|Overall Study|Other reasons|0|||
154919771|NCT00761735|559129896|FG000|Overall Study|Administrative|1|||
154919772|NCT00381680|559129899|FG000|Overall Study|Adverse Event|9|||
154919773|NCT00381680|559129900|FG001|Overall Study|Adverse Event|3|||
154919774|NCT00381680|559129899|FG000|Overall Study|Death|10|||
154919775|NCT00381680|559129900|FG001|Overall Study|Death|7|||
154919776|NCT00381680|559129899|FG000|Overall Study|Lost to Follow-up|3|||
154919777|NCT00381680|559129900|FG001|Overall Study|Lost to Follow-up|2|||
154919778|NCT00381680|559129899|FG000|Overall Study|Physician Decision|25|||
154995724|NCT01104779|559407964|FG001|Overall Study|Other reasons|1|||
154995725|NCT01104779|559407965|FG002|Overall Study|Other reasons|0|||
154995726|NCT01104779|559407963|FG000|Overall Study|Lost to Follow-up|2|||
154995727|NCT01104779|559407964|FG001|Overall Study|Lost to Follow-up|0|||
154995728|NCT01104779|559407965|FG002|Overall Study|Lost to Follow-up|1|||
154995729|NCT01104779|559407963|FG000|Overall Study|Withdrawal by Subject|16|||
154995730|NCT01104779|559407964|FG001|Overall Study|Withdrawal by Subject|25|||
154995731|NCT01104779|559407965|FG002|Overall Study|Withdrawal by Subject|32|||
154995732|NCT04240392|559409394|FG000|Overall Study|Withdrawal by Subject|13|||
154995733|NCT04240392|559409395|FG001|Overall Study|Withdrawal by Subject|4|||
154995734|NCT04240392|559409394|FG000|Overall Study|Lost to Follow-up|11|||
155122467|NCT00203021|559879788|FG001|Overall Study|Other than specified|16|||
155122468|NCT02080260|559879790|FG000|Overall Study|Death|18|||
155122469|NCT02080260|559879790|FG000|Overall Study|Withdrawal by Subject|1|||
155122470|NCT03204890|559879795|FG000|Overall Study|Withdrawal by Subject|1|||
155122471|NCT03747120|559879796|FG000|Overall Study|treatment related toxicity|3|||
154919779|NCT00381680|559129900|FG001|Overall Study|Physician Decision|6|||
154919780|NCT00381680|559129899|FG000|Overall Study|Withdrawal by Subject|3|||
154919781|NCT00381680|559129900|FG001|Overall Study|Withdrawal by Subject|1|||
154919782|NCT00381680|559129899|FG000|Overall Study|Entry onto another COG Trial|1|||
154995735|NCT04240392|559409395|FG001|Overall Study|Lost to Follow-up|12|||
154995736|NCT03665441|559409403|FG000|Overall Study|survival follow up ongoing|23|||
154995737|NCT03665441|559409404|FG001|Overall Study|survival follow up ongoing|0|||
155122472|NCT03747120|559879797|FG001|Overall Study|treatment related toxicity|0|||
155122473|NCT03747120|559879798|FG002|Overall Study|treatment related toxicity|0|||
155122474|NCT03747120|559879796|FG000|Overall Study|Withdrawal by Subject|0|||
155122475|NCT03747120|559879797|FG001|Overall Study|Withdrawal by Subject|1|||
155122476|NCT03747120|559879798|FG002|Overall Study|Withdrawal by Subject|2|||
155177784|NCT01895361|560089401|FG002|Overall Study|Lost to Follow-up|6|||
155177785|NCT01895361|560089399|FG000|Overall Study|Non-compliance with study|1|||
154919783|NCT00381680|559129900|FG001|Overall Study|Entry onto another COG Trial|2|||
154919784|NCT00381680|559129899|FG000|Overall Study|Alternative Therapy|11|||
154995738|NCT03665441|559409403|FG000|Overall Study|Patients ongoing on treatment|9|||
154995739|NCT03665441|559409404|FG001|Overall Study|Patients ongoing on treatment|6|||
154995740|NCT03665441|559409403|FG000|Overall Study|Randomized but not treated|7|||
154995741|NCT03665441|559409404|FG001|Overall Study|Randomized but not treated|11|||
154995742|NCT05307510|559409405|FG000|Overall Study|Lost to Follow-up|3|||
154995743|NCT05307510|559409406|FG001|Overall Study|Lost to Follow-up|6|||
155122477|NCT01266317|559879799|FG000|Overall Study|Withdrawal by Subject|2|||
154919785|NCT00381680|559129900|FG001|Overall Study|Alternative Therapy|5|||
154919786|NCT00381680|559129899|FG000|Overall Study|Secondary Malignancy|3|||
154919787|NCT00381680|559129900|FG001|Overall Study|Secondary Malignancy|0|||
154919788|NCT00381680|559129899|FG000|Overall Study|Delay initiation|1|||
154919789|NCT00381680|559129900|FG001|Overall Study|Delay initiation|0|||
154919790|NCT00381680|559129899|FG000|Overall Study|Stem Cell Transplant|26|||
154919791|NCT00381680|559129900|FG001|Overall Study|Stem Cell Transplant|10|||
154919792|NCT00381680|559129899|FG000|Overall Study|Relapse|18|||
154919793|NCT00381680|559129900|FG001|Overall Study|Relapse|9|||
154919794|NCT00381680|559129899|FG000|Overall Study|Induction Failure|4|||
154919795|NCT00381680|559129900|FG001|Overall Study|Induction Failure|1|||
155177786|NCT01895361|560089400|FG001|Overall Study|Non-compliance with study|3|||
155177787|NCT01895361|560089401|FG002|Overall Study|Non-compliance with study|1|||
155177788|NCT01895361|560089399|FG000|Overall Study|Physician Decision|2|||
155177789|NCT01895361|560089400|FG001|Overall Study|Physician Decision|2|||
155177790|NCT01895361|560089401|FG002|Overall Study|Physician Decision|2|||
155177791|NCT01895361|560089399|FG000|Overall Study|Withdrawal by Subject|7|||
155177792|NCT01895361|560089400|FG001|Overall Study|Withdrawal by Subject|6|||
154919796|NCT00381680|559129899|FG000|Overall Study|Progression|1|||
154919797|NCT00381680|559129900|FG001|Overall Study|Progression|1|||
154919798|NCT00381680|559129899|FG000|Overall Study|Other not otherwise specified|7|||
154919799|NCT00381680|559129900|FG001|Overall Study|Other not otherwise specified|2|||
154919800|NCT00381680|559129899|FG000|Overall Study|Ineligible|3|||
154995744|NCT05307510|559409405|FG000|Overall Study|Withdrawal by Subject|0|||
154995745|NCT05307510|559409406|FG001|Overall Study|Withdrawal by Subject|1|||
154995746|NCT04345601|559409407|FG000|Overall Study|Death|0|||
154995747|NCT04345601|559409408|FG001|Overall Study|Death|3|||
154995748|NCT04345601|559409409|FG002|Overall Study|Death|2|||
154995749|NCT04345601|559409407|FG000|Overall Study|Lost to Follow-up|0|||
154995750|NCT04345601|559409408|FG001|Overall Study|Lost to Follow-up|0|||
154995751|NCT04345601|559409409|FG002|Overall Study|Lost to Follow-up|2|||
154995752|NCT03610516|559409410|FG000|Treatment Epoch|Adverse Event|3|||
154995753|NCT03610516|559409411|FG001|Treatment Epoch|Adverse Event|1|||
154995754|NCT03610516|559409410|FG000|Treatment Epoch|Death|1|||
154995755|NCT03610516|559409411|FG001|Treatment Epoch|Death|0|||
154995756|NCT03610516|559409410|FG000|Treatment Epoch|Lack of Efficacy|0|||
154995757|NCT03610516|559409411|FG001|Treatment Epoch|Lack of Efficacy|1|||
154995758|NCT03610516|559409410|FG000|Treatment Epoch|No longer requires treatment|1|||
154995759|NCT03610516|559409411|FG001|Treatment Epoch|No longer requires treatment|0|||
154995760|NCT03610516|559409410|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
155177793|NCT01895361|560089401|FG002|Overall Study|Withdrawal by Subject|6|||
154919801|NCT00381680|559129900|FG001|Overall Study|Ineligible|1|||
154919802|NCT00998166|559129901|FG000|Overall Study|Early Study Termination|8|||
154919803|NCT00450814|559129904|FG000|Overall Study|Failed to complete the initial therapy|0|||
154919804|NCT00450814|559129905|FG001|Overall Study|Failed to complete the initial therapy|0|||
154919805|NCT00450814|559129906|FG002|Overall Study|Failed to complete the initial therapy|0|||
154919806|NCT00450814|559129907|FG003|Overall Study|Failed to complete the initial therapy|1|||
154919807|NCT00450814|559129908|FG004|Overall Study|Failed to complete the initial therapy|1|||
154919808|NCT00450814|559129909|FG005|Overall Study|Failed to complete the initial therapy|1|||
154919809|NCT00450814|559129910|FG006|Overall Study|Failed to complete the initial therapy|0|||
154919810|NCT00450814|559129911|FG007|Overall Study|Failed to complete the initial therapy|0|||
154919811|NCT00450814|559129912|FG008|Overall Study|Failed to complete the initial therapy|0|||
154919812|NCT00450814|559129913|FG009|Overall Study|Failed to complete the initial therapy|0|||
154919813|NCT00450814|559129914|FG010|Overall Study|Failed to complete the initial therapy|0|||
154919814|NCT00450814|559129904|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
154919815|NCT00450814|559129905|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
154919816|NCT00450814|559129906|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
154919817|NCT00450814|559129907|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
154919818|NCT00450814|559129908|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
154919819|NCT00450814|559129909|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
154919820|NCT00450814|559129910|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
154919821|NCT00450814|559129911|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
154919822|NCT00450814|559129912|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
154919823|NCT00450814|559129913|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
154919824|NCT00450814|559129914|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
154919825|NCT03602976|559129917|FG000|Overall Study|Withdrawal by Subject|1|||
154919826|NCT04837807|559129918|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
154919827|NCT04837807|559129919|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
154995761|NCT03610516|559409411|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
154919828|NCT03732534|559129920|FG000|Overall Study|Study terminated by Sponsor|6|||
154995762|NCT03610516|559409410|FG000|Treatment Epoch|Physician Decision|8|||
154995763|NCT03610516|559409411|FG001|Treatment Epoch|Physician Decision|5|||
154995764|NCT03610516|559409410|FG000|Treatment Epoch|Protocol Deviation|1|||
155177794|NCT01895361|560089399|FG000|Overall Study|Lack of Efficacy|0|||
155177795|NCT01895361|560089400|FG001|Overall Study|Lack of Efficacy|1|||
155122478|NCT00490776|559879800|FG000|Overall Study|Withdrawal by Subject|1|||
155122479|NCT00490776|559879800|FG000|Overall Study|Administrative Problems|1|||
154919829|NCT03735849|559129921|FG000|Overall Study|Lost to Follow-up|1|||
154919830|NCT03735849|559129922|FG001|Overall Study|Lost to Follow-up|0|||
154919831|NCT03735849|559129923|FG002|Overall Study|Lost to Follow-up|0|||
154919832|NCT03735849|559129921|FG000|Overall Study|Participant unable to adhere to visit|1|||
154919833|NCT03735849|559129922|FG001|Overall Study|Participant unable to adhere to visit|0|||
154919834|NCT03735849|559129923|FG002|Overall Study|Participant unable to adhere to visit|0|||
154919835|NCT03735849|559129921|FG000|Overall Study|Not Randomized|0|||
154919836|NCT03735849|559129922|FG001|Overall Study|Not Randomized|0|||
154919837|NCT03735849|559129923|FG002|Overall Study|Not Randomized|4|||
154919838|NCT03125382|559129926|FG000|Randomization|screening failure|1|||
154919839|NCT03125382|559129927|FG001|Randomization|screening failure|4|||
154919840|NCT03125382|559129928|FG002|Randomization|screening failure|2|||
154919841|NCT03125382|559129929|FG003|Randomization|screening failure|0|||
154919842|NCT03125382|559129926|FG000|Follow-up|Death|1|||
154919843|NCT03125382|559129927|FG001|Follow-up|Death|2|||
154919844|NCT03125382|559129928|FG002|Follow-up|Death|1|||
154919845|NCT03125382|559129929|FG003|Follow-up|Death|2|||
154919846|NCT03125382|559129926|FG000|Follow-up|Lost to Follow-up|1|||
154919847|NCT03125382|559129927|FG001|Follow-up|Lost to Follow-up|4|||
154919848|NCT03125382|559129928|FG002|Follow-up|Lost to Follow-up|3|||
154919849|NCT03125382|559129929|FG003|Follow-up|Lost to Follow-up|1|||
154919850|NCT00612456|559129930|FG000|Overall Study|Adverse Event|1|||
154919851|NCT00612456|559129931|FG001|Overall Study|Adverse Event|0|||
154919852|NCT00612456|559129932|FG002|Overall Study|Adverse Event|0|||
154919853|NCT00612456|559129930|FG000|Overall Study|Lack of Efficacy|1|||
154919854|NCT00612456|559129931|FG001|Overall Study|Lack of Efficacy|1|||
154919855|NCT00612456|559129932|FG002|Overall Study|Lack of Efficacy|0|||
154919856|NCT00612456|559129930|FG000|Overall Study|Withdrawal by Subject|0|||
154919857|NCT00612456|559129931|FG001|Overall Study|Withdrawal by Subject|1|||
154919858|NCT00612456|559129932|FG002|Overall Study|Withdrawal by Subject|0|||
154919859|NCT03907072|559129933|FG000|Overall Study|Study Terminated by Sponsor|2|||
154919860|NCT03907072|559129934|FG001|Overall Study|Study Terminated by Sponsor|2|||
154919861|NCT03907072|559129935|FG002|Overall Study|Study Terminated by Sponsor|2|||
154919862|NCT02463097|559129936|FG000|Overall Study|Withdrawal by Subject|1|||
154919863|NCT03326323|559129937|FG000|Overall Study|Unable to receive ANH protocol|3|||
154919864|NCT01258803|559129940|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
154919865|NCT01258803|559129941|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
154919866|NCT01258803|559129942|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
154919867|NCT01258803|559129943|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
154919868|NCT01258803|559129944|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
154919869|NCT01258803|559129945|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
154919870|NCT01258803|559129940|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
154919871|NCT01258803|559129941|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
154919872|NCT01258803|559129942|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
154919873|NCT01258803|559129943|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
154919874|NCT01258803|559129944|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
154919875|NCT01258803|559129945|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
154919876|NCT01258803|559129940|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
154919877|NCT01258803|559129941|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
154919878|NCT01258803|559129942|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
154919879|NCT01258803|559129943|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
154919880|NCT01258803|559129944|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
154919881|NCT01258803|559129945|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
154919882|NCT03556202|559129950|FG000|Extension Treatment Period|Adverse Event|18|||
154919883|NCT03556202|559129951|FG001|Extension Treatment Period|Adverse Event|14|||
154919884|NCT03556202|559129952|FG002|Extension Treatment Period|Adverse Event|9|||
154919885|NCT03556202|559129950|FG000|Extension Treatment Period|Death|2|||
154919886|NCT03556202|559129951|FG001|Extension Treatment Period|Death|6|||
154919887|NCT03556202|559129952|FG002|Extension Treatment Period|Death|0|||
154919888|NCT03556202|559129950|FG000|Extension Treatment Period|Lack of Efficacy|5|||
154919889|NCT03556202|559129951|FG001|Extension Treatment Period|Lack of Efficacy|12|||
154919890|NCT03556202|559129952|FG002|Extension Treatment Period|Lack of Efficacy|18|||
154919891|NCT03556202|559129950|FG000|Extension Treatment Period|Lost to Follow-up|9|||
155122480|NCT00490776|559879800|FG000|Overall Study|Death|1|||
154919892|NCT03556202|559129951|FG001|Extension Treatment Period|Lost to Follow-up|20|||
154919893|NCT03556202|559129952|FG002|Extension Treatment Period|Lost to Follow-up|2|||
154919894|NCT03556202|559129950|FG000|Extension Treatment Period|Pregnancy|2|||
154919895|NCT03556202|559129951|FG001|Extension Treatment Period|Pregnancy|4|||
154919896|NCT03556202|559129952|FG002|Extension Treatment Period|Pregnancy|3|||
154919897|NCT03556202|559129950|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
155122481|NCT00490776|559879800|FG000|Overall Study|New Cancer Therapy|1|||
154919898|NCT03556202|559129951|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
154919899|NCT03556202|559129952|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
154919900|NCT03556202|559129950|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
154919901|NCT03556202|559129951|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
154919902|NCT03556202|559129952|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
154919903|NCT03556202|559129950|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
154919904|NCT03556202|559129951|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
154919905|NCT03556202|559129952|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
154919906|NCT03556202|559129950|FG000|Extension Treatment Period|Physician Decision|0|||
154919907|NCT03556202|559129951|FG001|Extension Treatment Period|Physician Decision|8|||
154919908|NCT03556202|559129952|FG002|Extension Treatment Period|Physician Decision|2|||
154919909|NCT03556202|559129950|FG000|Extension Treatment Period|Protocol Violation|0|||
154919910|NCT03556202|559129951|FG001|Extension Treatment Period|Protocol Violation|1|||
154919911|NCT03556202|559129952|FG002|Extension Treatment Period|Protocol Violation|1|||
154919912|NCT03556202|559129950|FG000|Extension Treatment Period|Sponsor Decision|0|||
154995765|NCT03610516|559409411|FG001|Treatment Epoch|Protocol Deviation|0|||
154995766|NCT03610516|559409410|FG000|Treatment Epoch|Withdrawal by Subject|3|||
154995767|NCT03610516|559409411|FG001|Treatment Epoch|Withdrawal by Subject|1|||
154995768|NCT03610516|559409410|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
154995769|NCT03610516|559409411|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
154995770|NCT03610516|559409410|FG000|Post-Treatment Follow-up|Death|1|||
154995771|NCT03610516|559409411|FG001|Post-Treatment Follow-up|Death|0|||
154995772|NCT00631657|559409412|FG000|6-Month Treatment Period|Adverse Event|47|||
154995773|NCT00631657|559409413|FG001|6-Month Treatment Period|Adverse Event|0|||
154995774|NCT00631657|559409414|FG002|6-Month Treatment Period|Adverse Event|7|||
154995775|NCT00631657|559409412|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
154995776|NCT00631657|559409413|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
154995777|NCT00631657|559409414|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
154995778|NCT00631657|559409412|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
154995779|NCT00631657|559409413|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
154995780|NCT00631657|559409414|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
154995781|NCT00631657|559409412|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
154995782|NCT00631657|559409413|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
154995783|NCT00631657|559409414|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
154995784|NCT00631657|559409412|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
154995785|NCT00631657|559409413|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
154995786|NCT00631657|559409414|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
154995787|NCT00631657|559409412|FG000|6-Month Treatment Period|Other|16|||
154995788|NCT00631657|559409413|FG001|6-Month Treatment Period|Other|0|||
154995789|NCT00631657|559409414|FG002|6-Month Treatment Period|Other|4|||
154995790|NCT00631657|559409412|FG000|6-Month Treatment Period|Not Treated|2|||
154995791|NCT00631657|559409413|FG001|6-Month Treatment Period|Not Treated|0|||
154995792|NCT00631657|559409414|FG002|6-Month Treatment Period|Not Treated|1|||
154995793|NCT00631657|559409412|FG000|7-Day Discontinuation Period|Not Treated|1|||
154995794|NCT00631657|559409413|FG001|7-Day Discontinuation Period|Not Treated|1|||
154995795|NCT00631657|559409414|FG002|7-Day Discontinuation Period|Not Treated|1|||
154995796|NCT00631657|559409412|FG000|7-Day Discontinuation Period|Other|1|||
154995797|NCT00631657|559409413|FG001|7-Day Discontinuation Period|Other|0|||
154995798|NCT00631657|559409414|FG002|7-Day Discontinuation Period|Other|0|||
154995799|NCT00663026|559409430|FG000|Overall Study|Lost to Follow-up|1|||
154995800|NCT00663026|559409431|FG001|Overall Study|Lost to Follow-up|0|||
154995801|NCT00663026|559409432|FG002|Overall Study|Lost to Follow-up|0|||
154995802|NCT00663026|559409430|FG000|Overall Study|Other|1|||
154995803|NCT00663026|559409431|FG001|Overall Study|Other|2|||
154995804|NCT00663026|559409432|FG002|Overall Study|Other|0|||
154995805|NCT00663026|559409430|FG000|Overall Study|Adverse Event|0|||
154995806|NCT00663026|559409431|FG001|Overall Study|Adverse Event|2|||
154995807|NCT00663026|559409432|FG002|Overall Study|Adverse Event|3|||
154995808|NCT00663026|559409430|FG000|Overall Study|Caregiver Request|0|||
154995809|NCT00663026|559409431|FG001|Overall Study|Caregiver Request|2|||
154995810|NCT00663026|559409432|FG002|Overall Study|Caregiver Request|0|||
154995811|NCT00663026|559409430|FG000|Overall Study|Withdrawal by Subject|0|||
154995812|NCT00663026|559409431|FG001|Overall Study|Withdrawal by Subject|0|||
154995813|NCT00663026|559409432|FG002|Overall Study|Withdrawal by Subject|1|||
154995814|NCT04003896|559409436|FG000|Overall Study|Withdrawal by Subject|3|||
154995815|NCT04003896|559409436|FG000|Overall Study|Physician Decision|1|||
154995816|NCT03783039|559409437|FG000|Overall Study|Death|2|||
154995817|NCT03783039|559409438|FG001|Overall Study|Death|1|||
154995818|NCT01199471|559409439|FG000|Overall Study|Protocol Violation|4|||
154995819|NCT01199471|559409439|FG000|Overall Study|Withdrawal by Subject|1|||
154919913|NCT03556202|559129951|FG001|Extension Treatment Period|Sponsor Decision|1|||
154919914|NCT03556202|559129952|FG002|Extension Treatment Period|Sponsor Decision|0|||
154919915|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
154995820|NCT01199471|559409439|FG000|Overall Study|Physician Decision|1|||
154995821|NCT03151408|559409440|FG000|Overall Study|Adverse Event|24|||
154995822|NCT03151408|559409441|FG001|Overall Study|Adverse Event|23|||
154995823|NCT03151408|559409440|FG000|Overall Study|Death|46|||
154995824|NCT03151408|559409441|FG001|Overall Study|Death|26|||
154995825|NCT03151408|559409440|FG000|Overall Study|Physician Decision|13|||
154995826|NCT03151408|559409441|FG001|Overall Study|Physician Decision|19|||
154995827|NCT03151408|559409440|FG000|Overall Study|Withdrawal by Subject|16|||
154995828|NCT03151408|559409441|FG001|Overall Study|Withdrawal by Subject|20|||
154995829|NCT03151408|559409440|FG000|Overall Study|Progressive disease|45|||
154995830|NCT03151408|559409441|FG001|Overall Study|Progressive disease|61|||
154995831|NCT03151408|559409440|FG000|Overall Study|non-compliance by patient|1|||
154995832|NCT03151408|559409441|FG001|Overall Study|non-compliance by patient|0|||
154995833|NCT03151408|559409440|FG000|Overall Study|other reasons|56|||
154995834|NCT03151408|559409441|FG001|Overall Study|other reasons|52|||
154995835|NCT03151408|559409440|FG000|Overall Study|randomized and not treated|2|||
154995836|NCT03151408|559409441|FG001|Overall Study|randomized and not treated|2|||
154995837|NCT02315196|559409444|FG000|Overall Study|Withdrew consent|9|||
154995838|NCT04576923|559409445|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
154995839|NCT01475097|559409446|FG000|Overall Study|Protocol Violation|1|||
154995840|NCT01475097|559409447|FG001|Overall Study|Protocol Violation|1|||
154995841|NCT02383810|559409448|FG000|Overall Study|Physician Decision|1|||
154995842|NCT02383810|559409449|FG001|Overall Study|Physician Decision|1|||
154995843|NCT02383810|559409450|FG002|Overall Study|Physician Decision|0|||
154995844|NCT02383810|559409451|FG003|Overall Study|Physician Decision|0|||
154995845|NCT02383810|559409452|FG004|Overall Study|Physician Decision|0|||
154995846|NCT02383810|559409453|FG005|Overall Study|Physician Decision|0|||
154995847|NCT02383810|559409454|FG006|Overall Study|Physician Decision|0|||
154995848|NCT02383810|559409455|FG007|Overall Study|Physician Decision|0|||
154995849|NCT02383810|559409448|FG000|Overall Study|Withdrawal by Subject|2|||
154995850|NCT02383810|559409449|FG001|Overall Study|Withdrawal by Subject|3|||
154995851|NCT02383810|559409450|FG002|Overall Study|Withdrawal by Subject|3|||
154995852|NCT02383810|559409451|FG003|Overall Study|Withdrawal by Subject|3|||
154995853|NCT02383810|559409452|FG004|Overall Study|Withdrawal by Subject|0|||
154995854|NCT02383810|559409453|FG005|Overall Study|Withdrawal by Subject|0|||
154995855|NCT02383810|559409454|FG006|Overall Study|Withdrawal by Subject|0|||
154995856|NCT02383810|559409455|FG007|Overall Study|Withdrawal by Subject|0|||
154995857|NCT02383810|559409448|FG000|Overall Study|Adverse Event|0|||
154995858|NCT02383810|559409449|FG001|Overall Study|Adverse Event|2|||
154995859|NCT02383810|559409450|FG002|Overall Study|Adverse Event|4|||
154995860|NCT02383810|559409451|FG003|Overall Study|Adverse Event|5|||
154995861|NCT02383810|559409452|FG004|Overall Study|Adverse Event|0|||
154995862|NCT02383810|559409453|FG005|Overall Study|Adverse Event|1|||
154995863|NCT02383810|559409454|FG006|Overall Study|Adverse Event|1|||
154995864|NCT02383810|559409455|FG007|Overall Study|Adverse Event|0|||
154995865|NCT02383810|559409448|FG000|Overall Study|Lost to Follow-up|0|||
154995866|NCT02383810|559409449|FG001|Overall Study|Lost to Follow-up|1|||
154995867|NCT02383810|559409450|FG002|Overall Study|Lost to Follow-up|0|||
154995868|NCT02383810|559409451|FG003|Overall Study|Lost to Follow-up|1|||
154995869|NCT02383810|559409452|FG004|Overall Study|Lost to Follow-up|0|||
154995870|NCT02383810|559409453|FG005|Overall Study|Lost to Follow-up|0|||
154995871|NCT02383810|559409454|FG006|Overall Study|Lost to Follow-up|0|||
154995872|NCT02383810|559409455|FG007|Overall Study|Lost to Follow-up|0|||
154995873|NCT02383810|559409448|FG000|Overall Study|other|0|||
154995874|NCT02383810|559409449|FG001|Overall Study|other|0|||
154995875|NCT02383810|559409450|FG002|Overall Study|other|0|||
154995876|NCT02383810|559409451|FG003|Overall Study|other|2|||
154995877|NCT02383810|559409452|FG004|Overall Study|other|0|||
154995878|NCT02383810|559409453|FG005|Overall Study|other|0|||
154995879|NCT02383810|559409454|FG006|Overall Study|other|0|||
154995880|NCT02383810|559409455|FG007|Overall Study|other|0|||
154995881|NCT02383810|559409448|FG000|Overall Study|subject did not receive study treatment|0|||
154995882|NCT02383810|559409449|FG001|Overall Study|subject did not receive study treatment|1|||
154995883|NCT02383810|559409450|FG002|Overall Study|subject did not receive study treatment|0|||
154995884|NCT02383810|559409451|FG003|Overall Study|subject did not receive study treatment|0|||
154995885|NCT02383810|559409452|FG004|Overall Study|subject did not receive study treatment|0|||
154995886|NCT02383810|559409453|FG005|Overall Study|subject did not receive study treatment|0|||
154995887|NCT02383810|559409454|FG006|Overall Study|subject did not receive study treatment|0|||
154995888|NCT02383810|559409455|FG007|Overall Study|subject did not receive study treatment|0|||
154995889|NCT01635283|559409458|FG000|Overall Study|Tumor Progression|3|||
154995890|NCT01635283|559409458|FG000|Overall Study|Lost to Follow-up|1|||
155177796|NCT01895361|560089401|FG002|Overall Study|Lack of Efficacy|0|||
154995891|NCT04516759|559409459|FG000|Overall Study|Withdrawal by Subject|1|||
154995892|NCT04516759|559409460|FG001|Overall Study|Withdrawal by Subject|1|||
154995893|NCT04516759|559409459|FG000|Overall Study|Other|0|||
154995894|NCT04516759|559409460|FG001|Overall Study|Other|1|||
154995895|NCT01305044|559409461|FG000|Overall Study|Withdrawal by Subject|3|||
154995896|NCT01305044|559409462|FG001|Overall Study|Withdrawal by Subject|6|||
154995897|NCT02309138|559409463|FG000|Overall Study|Withdrawal by Subject|44|||
154995898|NCT02309138|559409464|FG001|Overall Study|Withdrawal by Subject|15|||
154995899|NCT02309138|559409463|FG000|Overall Study|Protocol Violation|4|||
154995900|NCT02309138|559409464|FG001|Overall Study|Protocol Violation|2|||
154995901|NCT02309138|559409463|FG000|Overall Study|delivered before visit 2|0|||
154995902|NCT02309138|559409464|FG001|Overall Study|delivered before visit 2|1|||
154995903|NCT01661062|559409471|FG000|Overall Study|Completed Treatment Off Study|3|||
154919916|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
154919917|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
154919918|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Death|1|||
154919919|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Death|0|||
154919920|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Death|0|||
154919921|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
154919922|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
154919923|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
154919924|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
154995904|NCT01661062|559409471|FG000|Overall Study|Withdrawal by Subject|2|||
154995905|NCT00838435|559409473|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
154995906|NCT00838435|559409473|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
155122482|NCT00490776|559879800|FG000|Overall Study|Disease Progression|5|||
155122483|NCT00098722|559879803|FG000|Double Blind Phase|Adverse Event|7|||
155122484|NCT00098722|559879804|FG001|Double Blind Phase|Adverse Event|7|||
155122485|NCT00098722|559879805|FG002|Double Blind Phase|Adverse Event|3|||
154995907|NCT00838435|559409473|FG000|Part 2 (7 Years)|Adverse Event|2|||
154995908|NCT00838435|559409473|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
154995909|NCT00838435|559409473|FG000|Part 2 (7 Years)|Physician Decision|1|||
154995910|NCT00838435|559409473|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
154995911|NCT00838435|559409473|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
154995912|NCT02754856|559409475|FG000|Overall Study|Withdrawal by Subject|1|||
154995913|NCT04874155|559409478|FG000|Overall Study|Lost to Follow-up|1|||
154995914|NCT04874155|559409479|FG001|Overall Study|Lost to Follow-up|1|||
154995915|NCT04874155|559409478|FG000|Overall Study|Withdrawal by Subject|2|||
154995916|NCT04874155|559409479|FG001|Overall Study|Withdrawal by Subject|2|||
154995917|NCT00530218|559409480|FG000|Overall Study|CMV Not Detected|13|||
154995918|NCT00530218|559409480|FG000|Overall Study|Death|12|||
154995919|NCT00678886|559409483|FG000|Overall Study|Withdrawal by Subject|0|||
154995920|NCT00678886|559409484|FG001|Overall Study|Withdrawal by Subject|0|||
154995921|NCT00678886|559409485|FG002|Overall Study|Withdrawal by Subject|4|||
154995922|NCT00678886|559409486|FG003|Overall Study|Withdrawal by Subject|6|||
154995923|NCT00678886|559409483|FG000|Overall Study|Physician Decision|0|||
154995924|NCT00678886|559409484|FG001|Overall Study|Physician Decision|0|||
154995925|NCT00678886|559409485|FG002|Overall Study|Physician Decision|1|||
154995926|NCT00678886|559409486|FG003|Overall Study|Physician Decision|1|||
154995927|NCT00678886|559409483|FG000|Overall Study|Lost to Follow-up|0|||
154995928|NCT00678886|559409484|FG001|Overall Study|Lost to Follow-up|0|||
154995929|NCT00678886|559409485|FG002|Overall Study|Lost to Follow-up|3|||
154995930|NCT00678886|559409486|FG003|Overall Study|Lost to Follow-up|2|||
154995931|NCT00678886|559409483|FG000|Overall Study|Other|0|||
154995932|NCT00678886|559409484|FG001|Overall Study|Other|0|||
154995933|NCT00678886|559409485|FG002|Overall Study|Other|1|||
154995934|NCT00678886|559409486|FG003|Overall Study|Other|0|||
154995935|NCT03477903|559409487|FG000|Overall Study|Study Terminated by Sponsor|1|||
154995936|NCT01147107|559409488|FG000|Overall Study|Lack of Efficacy|5|||
154995937|NCT01147107|559409489|FG001|Overall Study|Lack of Efficacy|0|||
154995938|NCT01147107|559409488|FG000|Overall Study|Withdrawal by Subject|1|||
154995939|NCT01147107|559409489|FG001|Overall Study|Withdrawal by Subject|1|||
154995940|NCT04435184|559409490|FG000|Overall Study|follow-up blood draws missing|3|||
154995941|NCT04435184|559409491|FG001|Overall Study|follow-up blood draws missing|5|||
154995942|NCT04693416|559409492|FG000|Overall Study|Lost to Follow-up|13|||
154995943|NCT04693416|559409493|FG001|Overall Study|Lost to Follow-up|0|||
154995944|NCT00474266|559409494|FG000|Overall Study|Withdrawal by Subject|7|||
154995945|NCT00474266|559409495|FG001|Overall Study|Withdrawal by Subject|20|||
154995946|NCT00474266|559409496|FG002|Overall Study|Withdrawal by Subject|4|||
154995947|NCT00474266|559409497|FG003|Overall Study|Withdrawal by Subject|7|||
155122486|NCT00098722|559879806|FG003|Double Blind Phase|Adverse Event|0|||
155122487|NCT00098722|559879807|FG004|Double Blind Phase|Adverse Event|0|||
154995948|NCT00369317|559409500|FG000|Overall Study|Adverse Event|3|||
154995949|NCT00369317|559409500|FG000|Overall Study|Death|1|||
154995950|NCT00369317|559409500|FG000|Overall Study|Lack of Efficacy|5|||
154995951|NCT00369317|559409500|FG000|Overall Study|Physician Decision|2|||
155122488|NCT00098722|559879808|FG005|Double Blind Phase|Adverse Event|0|||
154919925|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
154995952|NCT00369317|559409500|FG000|Overall Study|Withdrawal by Subject|8|||
154995953|NCT00369317|559409500|FG000|Overall Study|Ineligible|1|||
154995954|NCT06281171|559409504|FG000|Timepoint 2|Lost to Follow-up|6|||
154995955|NCT06281171|559409505|FG001|Timepoint 2|Lost to Follow-up|4|||
154995956|NCT06281171|559409504|FG000|Timepoint 3|Lost to Follow-up|0|||
154995957|NCT06281171|559409505|FG001|Timepoint 3|Lost to Follow-up|5|||
154995958|NCT00073021|559409510|FG000|Overall Study|Protocol Violation|2|||
154995959|NCT00073021|559409511|FG001|Overall Study|Protocol Violation|1|||
155122489|NCT00098722|559879809|FG006|Double Blind Phase|Adverse Event|0|||
154995960|NCT00073021|559409510|FG000|Overall Study|Adverse Event|4|||
154995961|NCT00073021|559409511|FG001|Overall Study|Adverse Event|4|||
154995962|NCT00073021|559409510|FG000|Overall Study|Withdrawal by Subject|6|||
154995963|NCT00073021|559409511|FG001|Overall Study|Withdrawal by Subject|5|||
154995964|NCT00073021|559409510|FG000|Overall Study|Physician Decision|3|||
154995965|NCT00073021|559409511|FG001|Overall Study|Physician Decision|1|||
154995966|NCT00073021|559409510|FG000|Overall Study|Lack of Efficacy|11|||
154995967|NCT00073021|559409511|FG001|Overall Study|Lack of Efficacy|5|||
154995968|NCT03050060|559409514|FG000|Overall Study|Adverse Event|7|||
154995969|NCT03050060|559409514|FG000|Overall Study|Withdrawal by Subject|1|||
154919926|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
154919927|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
154919928|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
154919929|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
154919930|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
154919931|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
154919932|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
154919933|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
154919934|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
154919935|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
154919936|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
154919937|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
154919938|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
154919939|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
154919940|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
154919941|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
154919942|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
154919943|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
154919944|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
154919945|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
154919946|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
154919947|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
154919948|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
154919949|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
154919950|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
154919951|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
154919952|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
154919953|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
154919954|NCT03556202|559129950|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
154919955|NCT03556202|559129951|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
154919956|NCT03556202|559129952|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
154919957|NCT00678652|559129953|FG000|Overall Study|Protocol Violation|2|||
154919958|NCT00678652|559129954|FG001|Overall Study|Protocol Violation|0|||
154919959|NCT00678652|559129955|FG002|Overall Study|Protocol Violation|0|||
154919960|NCT00678652|559129956|FG003|Overall Study|Protocol Violation|0|||
154919961|NCT00678652|559129953|FG000|Overall Study|Pregnancy|0|||
154919962|NCT00678652|559129954|FG001|Overall Study|Pregnancy|0|||
154919963|NCT00678652|559129955|FG002|Overall Study|Pregnancy|1|||
154919964|NCT00678652|559129956|FG003|Overall Study|Pregnancy|0|||
154919965|NCT00678652|559129953|FG000|Overall Study|Relocation|1|||
154919966|NCT00678652|559129954|FG001|Overall Study|Relocation|0|||
154919967|NCT00678652|559129955|FG002|Overall Study|Relocation|0|||
154919968|NCT00678652|559129956|FG003|Overall Study|Relocation|0|||
154919969|NCT00665002|559129957|FG000|Overall Study|Progression/relapse during treatment|11|||
154919970|NCT00665002|559129957|FG000|Overall Study|Cytogenetic resistance|1|||
154919971|NCT00643851|559129966|FG000|Overall Study|Death|0|||
154919972|NCT00643851|559129967|FG001|Overall Study|Death|1|||
154919973|NCT00643851|559129968|FG002|Overall Study|Death|0|||
154919974|NCT00643851|559129966|FG000|Overall Study|Lack of Efficacy|0|||
154919975|NCT00643851|559129967|FG001|Overall Study|Lack of Efficacy|1|||
154919976|NCT00643851|559129968|FG002|Overall Study|Lack of Efficacy|0|||
154919977|NCT00643851|559129966|FG000|Overall Study|Adverse Event|2|||
154919978|NCT00643851|559129967|FG001|Overall Study|Adverse Event|6|||
154919979|NCT00643851|559129968|FG002|Overall Study|Adverse Event|6|||
154919980|NCT00643851|559129966|FG000|Overall Study|Lost to Follow-up|4|||
154919981|NCT00643851|559129967|FG001|Overall Study|Lost to Follow-up|6|||
154919982|NCT00643851|559129968|FG002|Overall Study|Lost to Follow-up|9|||
154919983|NCT00643851|559129966|FG000|Overall Study|Withdrawal by Subject|8|||
154919984|NCT00643851|559129967|FG001|Overall Study|Withdrawal by Subject|15|||
154919985|NCT00643851|559129968|FG002|Overall Study|Withdrawal by Subject|9|||
154919986|NCT00643851|559129966|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
154919987|NCT00643851|559129967|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
155122490|NCT00098722|559879803|FG000|Double Blind Phase|Death|2|||
155122491|NCT00098722|559879804|FG001|Double Blind Phase|Death|5|||
155122492|NCT00098722|559879805|FG002|Double Blind Phase|Death|0|||
155122493|NCT00098722|559879806|FG003|Double Blind Phase|Death|0|||
155122494|NCT00098722|559879807|FG004|Double Blind Phase|Death|0|||
155122495|NCT00098722|559879808|FG005|Double Blind Phase|Death|0|||
155122496|NCT00098722|559879809|FG006|Double Blind Phase|Death|0|||
155122497|NCT00098722|559879803|FG000|Double Blind Phase|Lack of Efficacy|21|||
154919988|NCT00643851|559129968|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
154919989|NCT04806334|559129971|FG000|Overall Study|Withdrawal by Subject|1|||
154919990|NCT00660829|559129972|FG000|Overall Study|Adverse Event|3|||
154919991|NCT00660829|559129973|FG001|Overall Study|Adverse Event|4|||
154919992|NCT00660829|559129972|FG000|Overall Study|Lack of Efficacy|2|||
154919993|NCT00660829|559129973|FG001|Overall Study|Lack of Efficacy|3|||
154919994|NCT00660829|559129972|FG000|Overall Study|Non-Compliance|0|||
154919995|NCT00660829|559129973|FG001|Overall Study|Non-Compliance|4|||
154919996|NCT00660829|559129972|FG000|Overall Study|Withdrawal by Subject|1|||
154919997|NCT00660829|559129973|FG001|Overall Study|Withdrawal by Subject|2|||
154919998|NCT00660829|559129972|FG000|Overall Study|Lost to Follow-up|3|||
154919999|NCT00660829|559129973|FG001|Overall Study|Lost to Follow-up|2|||
154920000|NCT00660829|559129972|FG000|Overall Study|Other|9|||
154920001|NCT00660829|559129973|FG001|Overall Study|Other|4|||
154920002|NCT01977573|559129976|FG000|Overall Study|Adverse Event|7|||
154920003|NCT01977573|559129977|FG001|Overall Study|Adverse Event|0|||
154920004|NCT01977573|559129978|FG002|Overall Study|Adverse Event|2|||
154920005|NCT01977573|559129979|FG003|Overall Study|Adverse Event|1|||
154920006|NCT01977573|559129976|FG000|Overall Study|Lost to Follow-up|1|||
154920007|NCT01977573|559129977|FG001|Overall Study|Lost to Follow-up|0|||
154920008|NCT01977573|559129978|FG002|Overall Study|Lost to Follow-up|0|||
154920009|NCT01977573|559129979|FG003|Overall Study|Lost to Follow-up|1|||
154920010|NCT01977573|559129976|FG000|Overall Study|Physician Decision|1|||
154920011|NCT01977573|559129977|FG001|Overall Study|Physician Decision|0|||
154920012|NCT01977573|559129978|FG002|Overall Study|Physician Decision|0|||
154920013|NCT01977573|559129979|FG003|Overall Study|Physician Decision|0|||
154920014|NCT01977573|559129976|FG000|Overall Study|Protocol Violation|3|||
154920015|NCT01977573|559129977|FG001|Overall Study|Protocol Violation|1|||
154920016|NCT01977573|559129978|FG002|Overall Study|Protocol Violation|0|||
154920017|NCT01977573|559129979|FG003|Overall Study|Protocol Violation|0|||
154920018|NCT01977573|559129976|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
154920019|NCT01977573|559129977|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
154920020|NCT01977573|559129978|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
154920021|NCT01977573|559129979|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
154920022|NCT01977573|559129976|FG000|Overall Study|Withdrawal by Subject|6|||
154920023|NCT01977573|559129977|FG001|Overall Study|Withdrawal by Subject|1|||
154920024|NCT01977573|559129978|FG002|Overall Study|Withdrawal by Subject|1|||
154920025|NCT01977573|559129979|FG003|Overall Study|Withdrawal by Subject|1|||
154920026|NCT03044730|559129980|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
154920027|NCT03044730|559129980|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
154920028|NCT03044730|559129980|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
154920029|NCT03044730|559129980|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
154920030|NCT03044730|559129980|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
154920031|NCT03044730|559129980|FG000|Cycles 4 and Beyond|Adverse Event|1|||
154920032|NCT03044730|559129980|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
154920033|NCT03044730|559129980|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
154920034|NCT03044730|559129980|FG000|On Follow-up for 2 Years|Death|17|||
154920035|NCT00934661|559131513|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
154920036|NCT00934661|559131514|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
154920037|NCT01846442|559131516|FG000|Overall Study|Adverse Event|2|||
154920038|NCT01846442|559131517|FG001|Overall Study|Adverse Event|4|||
154920039|NCT01846442|559131518|FG002|Overall Study|Adverse Event|2|||
154920040|NCT01846442|559131519|FG003|Overall Study|Adverse Event|1|||
154920041|NCT01846442|559131516|FG000|Overall Study|Lost to Follow-up|0|||
154920042|NCT01846442|559131517|FG001|Overall Study|Lost to Follow-up|0|||
154920043|NCT01846442|559131518|FG002|Overall Study|Lost to Follow-up|1|||
154920044|NCT01846442|559131519|FG003|Overall Study|Lost to Follow-up|0|||
154920045|NCT01846442|559131516|FG000|Overall Study|Withdrawal by Subject|3|||
154920046|NCT01846442|559131517|FG001|Overall Study|Withdrawal by Subject|2|||
154920047|NCT01846442|559131518|FG002|Overall Study|Withdrawal by Subject|0|||
154920048|NCT01846442|559131519|FG003|Overall Study|Withdrawal by Subject|1|||
154920049|NCT01846442|559131516|FG000|Overall Study|Left the city/Lost medication|1|||
154920050|NCT01846442|559131517|FG001|Overall Study|Left the city/Lost medication|0|||
154920051|NCT01846442|559131518|FG002|Overall Study|Left the city/Lost medication|1|||
154920052|NCT01846442|559131519|FG003|Overall Study|Left the city/Lost medication|1|||
154920053|NCT02777554|559131526|FG000|Overall Study|Adverse Event|4|||
154920054|NCT02777554|559131527|FG001|Overall Study|Adverse Event|4|||
155122498|NCT00098722|559879804|FG001|Double Blind Phase|Lack of Efficacy|23|||
155122499|NCT00098722|559879805|FG002|Double Blind Phase|Lack of Efficacy|15|||
155122500|NCT00098722|559879806|FG003|Double Blind Phase|Lack of Efficacy|0|||
155177797|NCT01895361|560089399|FG000|Overall Study|Reasons different from categories above|7|||
155177798|NCT01895361|560089400|FG001|Overall Study|Reasons different from categories above|3|||
155177799|NCT01895361|560089401|FG002|Overall Study|Reasons different from categories above|4|||
155177800|NCT01209832|560089405|FG000|Period 1|Sponsor Decision and was not dosed|1|||
154920055|NCT02777554|559131528|FG002|Overall Study|Adverse Event|0|||
154920056|NCT02777554|559131529|FG003|Overall Study|Adverse Event|1|||
154920057|NCT02777554|559131530|FG004|Overall Study|Adverse Event|0|||
154920058|NCT02777554|559131531|FG005|Overall Study|Adverse Event|0|||
155177801|NCT01209832|560089405|FG000|Period 2|Sponsor Decision|1|||
155177802|NCT01268579|560089406|FG000|Overall Study|Adverse Event|1|||
155177803|NCT01268579|560089406|FG000|Overall Study|Withdrawal by Subject|2|||
155177804|NCT02692651|560089407|FG000|Study Treatment|Death|7|||
155177805|NCT02692651|560089408|FG001|Study Treatment|Death|3|||
155177806|NCT02692651|560089407|FG000|Study Treatment|comfort care|1|||
155177807|NCT02692651|560089408|FG001|Study Treatment|comfort care|1|||
155177808|NCT02692651|560089407|FG000|Study Treatment|Protocol violation per treating team preference|8|||
155177809|NCT02692651|560089408|FG001|Study Treatment|Protocol violation per treating team preference|6|||
155177810|NCT02692651|560089407|FG000|Post Study Treatment Follow-up|Death|4|||
154920059|NCT02777554|559131526|FG000|Overall Study|Withdrawal by Subject|3|||
154920060|NCT02777554|559131527|FG001|Overall Study|Withdrawal by Subject|1|||
154920061|NCT02777554|559131528|FG002|Overall Study|Withdrawal by Subject|1|||
154920062|NCT02777554|559131529|FG003|Overall Study|Withdrawal by Subject|0|||
154920063|NCT02777554|559131530|FG004|Overall Study|Withdrawal by Subject|0|||
154920064|NCT02777554|559131531|FG005|Overall Study|Withdrawal by Subject|0|||
154920065|NCT02777554|559131526|FG000|Overall Study|Discharged early due to hurricane|22|||
154920066|NCT02777554|559131527|FG001|Overall Study|Discharged early due to hurricane|20|||
154920067|NCT02777554|559131528|FG002|Overall Study|Discharged early due to hurricane|0|||
154920068|NCT02777554|559131529|FG003|Overall Study|Discharged early due to hurricane|0|||
154920069|NCT02777554|559131530|FG004|Overall Study|Discharged early due to hurricane|0|||
154920070|NCT02777554|559131531|FG005|Overall Study|Discharged early due to hurricane|0|||
154920071|NCT02777554|559131526|FG000|Overall Study|Other - Miscellaneous|1|||
154920072|NCT02777554|559131527|FG001|Overall Study|Other - Miscellaneous|0|||
154920073|NCT02777554|559131528|FG002|Overall Study|Other - Miscellaneous|0|||
154920074|NCT02777554|559131529|FG003|Overall Study|Other - Miscellaneous|0|||
154920075|NCT02777554|559131530|FG004|Overall Study|Other - Miscellaneous|0|||
154920076|NCT02777554|559131531|FG005|Overall Study|Other - Miscellaneous|0|||
154920077|NCT01013207|559131532|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
154920078|NCT01541644|559131533|FG000|Overall Study|Withdrawal by Subject|3|||
154920079|NCT01458535|559131534|FG000|Overall Study|Other|0|||
154920080|NCT01458535|559131535|FG001|Overall Study|Other|0|||
154920081|NCT01458535|559131536|FG002|Overall Study|Other|0|||
154920082|NCT01458535|559131537|FG003|Overall Study|Other|0|||
154920083|NCT01458535|559131538|FG004|Overall Study|Other|1|||
154920084|NCT01458535|559131539|FG005|Overall Study|Other|1|||
154920085|NCT01458535|559131534|FG000|Overall Study|Withdrawal by Subject|0|||
154920086|NCT01458535|559131535|FG001|Overall Study|Withdrawal by Subject|0|||
154920087|NCT01458535|559131536|FG002|Overall Study|Withdrawal by Subject|2|||
154920088|NCT01458535|559131537|FG003|Overall Study|Withdrawal by Subject|0|||
154920089|NCT01458535|559131538|FG004|Overall Study|Withdrawal by Subject|1|||
154920090|NCT01458535|559131539|FG005|Overall Study|Withdrawal by Subject|1|||
154920091|NCT01458535|559131534|FG000|Overall Study|Lost to Follow-up|0|||
154920092|NCT01458535|559131535|FG001|Overall Study|Lost to Follow-up|2|||
154920093|NCT01458535|559131536|FG002|Overall Study|Lost to Follow-up|0|||
154920094|NCT01458535|559131537|FG003|Overall Study|Lost to Follow-up|3|||
154920095|NCT01458535|559131538|FG004|Overall Study|Lost to Follow-up|2|||
154920096|NCT01458535|559131539|FG005|Overall Study|Lost to Follow-up|2|||
154920097|NCT01458535|559131534|FG000|Overall Study|Adverse Event|0|||
154920098|NCT01458535|559131535|FG001|Overall Study|Adverse Event|0|||
154920099|NCT01458535|559131536|FG002|Overall Study|Adverse Event|0|||
154920100|NCT01458535|559131537|FG003|Overall Study|Adverse Event|1|||
155177811|NCT02692651|560089408|FG001|Post Study Treatment Follow-up|Death|4|||
154920101|NCT01458535|559131538|FG004|Overall Study|Adverse Event|0|||
154920102|NCT01458535|559131539|FG005|Overall Study|Adverse Event|0|||
154920103|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
154920104|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
154920105|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920106|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920107|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920108|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920109|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920110|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920111|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920112|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
155177812|NCT03490981|560089409|FG000|Overall Study|Lost to Follow-up|1|||
155177813|NCT03490981|560089410|FG001|Overall Study|Lost to Follow-up|2|||
154920113|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920114|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
154920115|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
154920116|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920117|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920118|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920119|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920120|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920121|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
154920122|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920123|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920124|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920125|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
154920126|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
154920127|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920128|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
154920129|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920130|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920131|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920132|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920133|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920134|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920135|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154995970|NCT03050060|559409514|FG000|Overall Study|Progression|7|||
154995971|NCT00510289|559409515|FG000|Overall Study|Withdrawal by Subject|7|||
154995972|NCT00510289|559409515|FG000|Overall Study|Refused bone marrow biopsy|2|||
154995973|NCT00510289|559409515|FG000|Overall Study|Lost to Follow-up|1|||
154920136|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920137|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920138|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
154920139|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
154920140|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
154920141|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
154920142|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
154920143|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
154920144|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
154920145|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
154920146|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
154920147|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
154920148|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
154920149|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
154920150|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
154920151|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154995974|NCT00510289|559409515|FG000|Overall Study|Progressed prior to starting drug|2|||
154920152|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920153|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920154|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920155|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920156|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
154920157|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920158|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920159|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920160|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920161|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920162|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
154920163|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920164|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920165|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920166|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920167|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920168|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
154920169|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920170|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920171|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920172|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920173|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920174|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
154920175|NCT00151775|559131540|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920176|NCT00151775|559131541|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920177|NCT00151775|559131542|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920178|NCT00151775|559131543|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920179|NCT00151775|559131544|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920180|NCT00151775|559131545|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920181|NCT00151775|559131546|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
154920182|NCT00151775|559131547|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920183|NCT00151775|559131548|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920184|NCT00151775|559131549|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920185|NCT00151775|559131550|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920186|NCT00151775|559131551|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
154920187|NCT00151775|559131540|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920188|NCT00151775|559131541|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920189|NCT00151775|559131542|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920190|NCT00151775|559131543|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920191|NCT00151775|559131544|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920192|NCT00151775|559131545|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
154920193|NCT00151775|559131546|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920194|NCT00151775|559131547|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920195|NCT00151775|559131548|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920196|NCT00151775|559131549|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920197|NCT00151775|559131550|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
155122501|NCT00098722|559879807|FG004|Double Blind Phase|Lack of Efficacy|0|||
155122502|NCT00098722|559879808|FG005|Double Blind Phase|Lack of Efficacy|0|||
155122503|NCT00098722|559879809|FG006|Double Blind Phase|Lack of Efficacy|0|||
155122504|NCT00098722|559879803|FG000|Double Blind Phase|Participant defaulted|16|||
154920198|NCT00151775|559131551|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
154920199|NCT00151775|559131540|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
154920200|NCT00151775|559131541|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
154920201|NCT00151775|559131542|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
154920202|NCT00151775|559131543|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
154920203|NCT00151775|559131544|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
154920204|NCT00151775|559131545|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
154920205|NCT00151775|559131546|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
154920206|NCT00151775|559131547|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
154920207|NCT00151775|559131548|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
154920208|NCT00151775|559131549|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
154920209|NCT00151775|559131550|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
154920210|NCT00151775|559131551|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
154920211|NCT00151775|559131540|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920212|NCT00151775|559131541|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920213|NCT00151775|559131542|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920214|NCT00151775|559131543|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920215|NCT00151775|559131544|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154995975|NCT03835221|559409516|FG000|Methafilcon A|Withdrawal by Subject|1|||
154995976|NCT00861198|559409517|FG000|Overall Study|SpyGlass Failed|5|||
154995977|NCT00499174|559409518|FG000|Overall Study|Physician Decision|78|||
154995978|NCT00499174|559409519|FG001|Overall Study|Physician Decision|9|||
154920216|NCT00151775|559131545|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920217|NCT00151775|559131546|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
154920218|NCT00151775|559131547|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920219|NCT00151775|559131548|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920220|NCT00151775|559131549|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920221|NCT00151775|559131550|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920222|NCT00151775|559131551|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
154920223|NCT00151775|559131540|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920224|NCT00151775|559131541|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920225|NCT00151775|559131542|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
154920226|NCT00151775|559131543|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920227|NCT00151775|559131544|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920228|NCT00151775|559131545|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920229|NCT00151775|559131546|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920230|NCT00151775|559131547|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154995979|NCT01214915|559409523|FG000|Overall Study|Adverse Event|8|||
154995980|NCT01214915|559409523|FG000|Overall Study|Lack of Efficacy|3|||
155122505|NCT00098722|559879804|FG001|Double Blind Phase|Participant defaulted|11|||
154920231|NCT00151775|559131548|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920232|NCT00151775|559131549|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920233|NCT00151775|559131550|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920234|NCT00151775|559131551|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
154920235|NCT00151775|559131540|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920236|NCT00151775|559131541|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154995981|NCT00319982|559409524|FG000|Overall Study|Withdrawal by Subject|1|||
154995982|NCT00319982|559409525|FG001|Overall Study|Withdrawal by Subject|0|||
154995983|NCT00758680|559409526|FG000|Overall Study|Adverse Event|0|||
154995984|NCT00758680|559409527|FG001|Overall Study|Adverse Event|0|||
154995985|NCT00758680|559409528|FG002|Overall Study|Adverse Event|0|||
154995986|NCT00758680|559409529|FG003|Overall Study|Adverse Event|0|||
155122506|NCT00098722|559879805|FG002|Double Blind Phase|Participant defaulted|9|||
155122507|NCT00098722|559879806|FG003|Double Blind Phase|Participant defaulted|0|||
154920237|NCT00151775|559131542|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
154920238|NCT00151775|559131543|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920239|NCT00151775|559131544|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920240|NCT00151775|559131545|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920241|NCT00151775|559131546|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920242|NCT00151775|559131547|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920243|NCT00151775|559131548|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920244|NCT00151775|559131549|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920245|NCT00151775|559131550|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920246|NCT00151775|559131551|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
154920247|NCT00151775|559131540|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920248|NCT00151775|559131541|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920249|NCT00151775|559131542|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920250|NCT00151775|559131543|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920251|NCT00151775|559131544|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920252|NCT00151775|559131545|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920253|NCT00151775|559131546|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920254|NCT00151775|559131547|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920255|NCT00151775|559131548|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920256|NCT00151775|559131549|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920257|NCT00151775|559131550|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
154920258|NCT00151775|559131551|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
154920259|NCT00151775|559131540|FG000|Period 4: Open Label|Increased blood pressure|0|||
154920260|NCT00151775|559131541|FG001|Period 4: Open Label|Increased blood pressure|0|||
154920261|NCT00151775|559131542|FG002|Period 4: Open Label|Increased blood pressure|0|||
154920262|NCT00151775|559131543|FG003|Period 4: Open Label|Increased blood pressure|0|||
154920263|NCT00151775|559131544|FG004|Period 4: Open Label|Increased blood pressure|1|||
154920264|NCT00151775|559131545|FG005|Period 4: Open Label|Increased blood pressure|0|||
154920265|NCT00151775|559131546|FG006|Period 4: Open Label|Increased blood pressure|0|||
154920266|NCT00151775|559131547|FG007|Period 4: Open Label|Increased blood pressure|0|||
154920267|NCT00151775|559131548|FG008|Period 4: Open Label|Increased blood pressure|0|||
154920268|NCT00151775|559131549|FG009|Period 4: Open Label|Increased blood pressure|1|||
154920269|NCT00151775|559131550|FG010|Period 4: Open Label|Increased blood pressure|0|||
155122508|NCT00098722|559879807|FG004|Double Blind Phase|Participant defaulted|0|||
155122509|NCT00098722|559879808|FG005|Double Blind Phase|Participant defaulted|0|||
155122510|NCT00098722|559879809|FG006|Double Blind Phase|Participant defaulted|0|||
155122511|NCT00098722|559879803|FG000|Double Blind Phase|Pregnancy|1|||
155122512|NCT00098722|559879804|FG001|Double Blind Phase|Pregnancy|0|||
155122513|NCT00098722|559879805|FG002|Double Blind Phase|Pregnancy|0|||
155122514|NCT00098722|559879806|FG003|Double Blind Phase|Pregnancy|0|||
155122515|NCT00098722|559879807|FG004|Double Blind Phase|Pregnancy|0|||
155122516|NCT00098722|559879808|FG005|Double Blind Phase|Pregnancy|0|||
155122517|NCT00098722|559879809|FG006|Double Blind Phase|Pregnancy|0|||
155122518|NCT00098722|559879803|FG000|Double Blind Phase|Randomized, not treated|4|||
155122519|NCT00098722|559879804|FG001|Double Blind Phase|Randomized, not treated|3|||
154920270|NCT00151775|559131551|FG011|Period 4: Open Label|Increased blood pressure|0|||
154920271|NCT00151775|559131540|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
154920272|NCT00151775|559131541|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
154920273|NCT00151775|559131542|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
154920274|NCT00151775|559131543|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
154995987|NCT00758680|559409530|FG004|Overall Study|Adverse Event|0|||
155122520|NCT00098722|559879805|FG002|Double Blind Phase|Randomized, not treated|3|||
155122521|NCT00098722|559879806|FG003|Double Blind Phase|Randomized, not treated|0|||
154920275|NCT00151775|559131544|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
154920276|NCT00151775|559131545|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
154995988|NCT00758680|559409531|FG005|Overall Study|Adverse Event|0|||
155122522|NCT00098722|559879807|FG004|Double Blind Phase|Randomized, not treated|0|||
154920277|NCT00151775|559131546|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
154920278|NCT00151775|559131547|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
154920279|NCT00151775|559131548|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
155122523|NCT00098722|559879808|FG005|Double Blind Phase|Randomized, not treated|0|||
155122524|NCT00098722|559879809|FG006|Double Blind Phase|Randomized, not treated|0|||
154920280|NCT00151775|559131549|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
154920281|NCT00151775|559131550|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
154920282|NCT00151775|559131551|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
154920283|NCT00151775|559131540|FG000|Period 4: Open Label|Adverse Event|0|||
154920284|NCT00151775|559131541|FG001|Period 4: Open Label|Adverse Event|0|||
154920285|NCT00151775|559131542|FG002|Period 4: Open Label|Adverse Event|0|||
154920286|NCT00151775|559131543|FG003|Period 4: Open Label|Adverse Event|0|||
154920287|NCT00151775|559131544|FG004|Period 4: Open Label|Adverse Event|1|||
154920288|NCT00151775|559131545|FG005|Period 4: Open Label|Adverse Event|0|||
154920289|NCT00151775|559131546|FG006|Period 4: Open Label|Adverse Event|0|||
154920290|NCT00151775|559131547|FG007|Period 4: Open Label|Adverse Event|0|||
154920291|NCT00151775|559131548|FG008|Period 4: Open Label|Adverse Event|0|||
154920292|NCT00151775|559131549|FG009|Period 4: Open Label|Adverse Event|2|||
154920293|NCT00151775|559131550|FG010|Period 4: Open Label|Adverse Event|0|||
154920294|NCT00151775|559131551|FG011|Period 4: Open Label|Adverse Event|0|||
154920295|NCT00151775|559131540|FG000|Period 4: Open Label|Lost to Follow-up|0|||
154920296|NCT00151775|559131541|FG001|Period 4: Open Label|Lost to Follow-up|0|||
154920297|NCT00151775|559131542|FG002|Period 4: Open Label|Lost to Follow-up|0|||
154920298|NCT00151775|559131543|FG003|Period 4: Open Label|Lost to Follow-up|0|||
154920299|NCT00151775|559131544|FG004|Period 4: Open Label|Lost to Follow-up|17|||
154920300|NCT00151775|559131545|FG005|Period 4: Open Label|Lost to Follow-up|0|||
154920301|NCT00151775|559131546|FG006|Period 4: Open Label|Lost to Follow-up|0|||
154920302|NCT00151775|559131547|FG007|Period 4: Open Label|Lost to Follow-up|0|||
154920303|NCT00151775|559131548|FG008|Period 4: Open Label|Lost to Follow-up|0|||
154920304|NCT00151775|559131549|FG009|Period 4: Open Label|Lost to Follow-up|7|||
154920305|NCT00151775|559131550|FG010|Period 4: Open Label|Lost to Follow-up|0|||
154920306|NCT00151775|559131551|FG011|Period 4: Open Label|Lost to Follow-up|0|||
154920307|NCT00151775|559131540|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
154920308|NCT00151775|559131541|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
154920309|NCT00151775|559131542|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
154920310|NCT00151775|559131543|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
154920311|NCT00151775|559131544|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
154920312|NCT00151775|559131545|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
154920313|NCT00151775|559131546|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
154920314|NCT00151775|559131547|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
154920315|NCT00151775|559131548|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
154920316|NCT00151775|559131549|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
154920317|NCT00151775|559131550|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
154920318|NCT00151775|559131551|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
154920319|NCT00151775|559131540|FG000|Period 4: Open Label|Other|0|||
154920320|NCT00151775|559131541|FG001|Period 4: Open Label|Other|0|||
154920321|NCT00151775|559131542|FG002|Period 4: Open Label|Other|0|||
154920322|NCT00151775|559131543|FG003|Period 4: Open Label|Other|0|||
154920323|NCT00151775|559131544|FG004|Period 4: Open Label|Other|1|||
154920324|NCT00151775|559131545|FG005|Period 4: Open Label|Other|0|||
154920325|NCT00151775|559131546|FG006|Period 4: Open Label|Other|0|||
154920326|NCT00151775|559131547|FG007|Period 4: Open Label|Other|0|||
154920327|NCT00151775|559131548|FG008|Period 4: Open Label|Other|0|||
154920328|NCT00151775|559131549|FG009|Period 4: Open Label|Other|3|||
154920329|NCT00151775|559131550|FG010|Period 4: Open Label|Other|0|||
154920330|NCT00151775|559131551|FG011|Period 4: Open Label|Other|0|||
154920331|NCT00151775|559131540|FG000|Period 4: Open Label|Physician Decision|0|||
154920332|NCT00151775|559131541|FG001|Period 4: Open Label|Physician Decision|0|||
154920333|NCT00151775|559131542|FG002|Period 4: Open Label|Physician Decision|0|||
154920334|NCT00151775|559131543|FG003|Period 4: Open Label|Physician Decision|0|||
154920335|NCT00151775|559131544|FG004|Period 4: Open Label|Physician Decision|0|||
154920336|NCT00151775|559131545|FG005|Period 4: Open Label|Physician Decision|0|||
154920337|NCT00151775|559131546|FG006|Period 4: Open Label|Physician Decision|0|||
154920338|NCT00151775|559131547|FG007|Period 4: Open Label|Physician Decision|0|||
154920339|NCT00151775|559131548|FG008|Period 4: Open Label|Physician Decision|0|||
154920340|NCT00151775|559131549|FG009|Period 4: Open Label|Physician Decision|2|||
154920341|NCT00151775|559131550|FG010|Period 4: Open Label|Physician Decision|0|||
154920342|NCT00151775|559131551|FG011|Period 4: Open Label|Physician Decision|0|||
154920343|NCT00151775|559131540|FG000|Period 4: Open Label|Protocol Violation|0|||
154920344|NCT00151775|559131541|FG001|Period 4: Open Label|Protocol Violation|0|||
154920345|NCT00151775|559131542|FG002|Period 4: Open Label|Protocol Violation|0|||
154920346|NCT00151775|559131543|FG003|Period 4: Open Label|Protocol Violation|0|||
154920347|NCT00151775|559131544|FG004|Period 4: Open Label|Protocol Violation|1|||
154920348|NCT00151775|559131545|FG005|Period 4: Open Label|Protocol Violation|0|||
154920349|NCT00151775|559131546|FG006|Period 4: Open Label|Protocol Violation|0|||
154920350|NCT00151775|559131547|FG007|Period 4: Open Label|Protocol Violation|0|||
154920351|NCT00151775|559131548|FG008|Period 4: Open Label|Protocol Violation|0|||
154920352|NCT00151775|559131549|FG009|Period 4: Open Label|Protocol Violation|0|||
154920353|NCT00151775|559131550|FG010|Period 4: Open Label|Protocol Violation|0|||
154920354|NCT00151775|559131551|FG011|Period 4: Open Label|Protocol Violation|0|||
154920355|NCT00247416|559131552|FG000|Overall Study|3 patients were found to be ineligible|1|||
154920356|NCT00247416|559131553|FG001|Overall Study|3 patients were found to be ineligible|2|||
154920357|NCT02660489|559131554|FG000|Overall Study|Lost to Follow-up|1|||
154920358|NCT02660489|559131555|FG001|Overall Study|Lost to Follow-up|1|||
154920359|NCT02660489|559131554|FG000|Overall Study|Adverse Event|1|||
154920360|NCT02660489|559131555|FG001|Overall Study|Adverse Event|3|||
154920361|NCT02660489|559131554|FG000|Overall Study|no rhinovirus infection|4|||
154920362|NCT02660489|559131555|FG001|Overall Study|no rhinovirus infection|4|||
154920363|NCT00474994|559131556|FG000|Overall Study|Patient Not treated|1|||
154920364|NCT00474994|559131556|FG000|Overall Study|Patient evaluable for toxicity only|3|||
154920365|NCT00474994|559131556|FG000|Overall Study|Patient found to be ineligible|1|||
154920366|NCT00278473|559131557|FG000|Overall Study|drop out|4|||
154920367|NCT00278473|559131558|FG001|Overall Study|drop out|3|||
154920368|NCT02322866|559131559|FG000|Overall Study|Adverse Event|6|||
154920369|NCT02322866|559131560|FG001|Overall Study|Adverse Event|11|||
154920370|NCT02322866|559131559|FG000|Overall Study|Withdrawal of Consent|16|||
154920371|NCT02322866|559131560|FG001|Overall Study|Withdrawal of Consent|25|||
155177814|NCT05463198|560089411|FG000|Overall Study|Withdrawal by Subject|19|||
154920372|NCT02322866|559131559|FG000|Overall Study|Lost to Follow-up|36|||
154920373|NCT02322866|559131560|FG001|Overall Study|Lost to Follow-up|39|||
154920374|NCT02322866|559131559|FG000|Overall Study|Protocol Violation|1|||
154920375|NCT02322866|559131560|FG001|Overall Study|Protocol Violation|0|||
154920376|NCT02322866|559131559|FG000|Overall Study|Noncompliance with Treatment|3|||
154920377|NCT02322866|559131560|FG001|Overall Study|Noncompliance with Treatment|4|||
154920378|NCT02322866|559131559|FG000|Overall Study|Lack of Efficacy|3|||
154920379|NCT02322866|559131560|FG001|Overall Study|Lack of Efficacy|1|||
154920380|NCT02322866|559131559|FG000|Overall Study|Other Miscellaneous Reasons|6|||
154920381|NCT02322866|559131560|FG001|Overall Study|Other Miscellaneous Reasons|6|||
154920382|NCT03735680|559131561|FG000|Overall Study|Withdrawal by Subject|0|||
154920383|NCT03735680|559131562|FG001|Overall Study|Withdrawal by Subject|1|||
154920384|NCT03735680|559131563|FG002|Overall Study|Withdrawal by Subject|0|||
154920385|NCT03735680|559131564|FG003|Overall Study|Withdrawal by Subject|0|||
154920386|NCT03735680|559131565|FG004|Overall Study|Withdrawal by Subject|0|||
154920387|NCT03735680|559131566|FG005|Overall Study|Withdrawal by Subject|1|||
154920388|NCT03735680|559131561|FG000|Overall Study|Patient unable or unwilling to continue|0|||
154920389|NCT03735680|559131562|FG001|Overall Study|Patient unable or unwilling to continue|0|||
154920390|NCT03735680|559131563|FG002|Overall Study|Patient unable or unwilling to continue|1|||
154920391|NCT03735680|559131564|FG003|Overall Study|Patient unable or unwilling to continue|0|||
154920392|NCT03735680|559131565|FG004|Overall Study|Patient unable or unwilling to continue|0|||
154920393|NCT03735680|559131566|FG005|Overall Study|Patient unable or unwilling to continue|0|||
154920394|NCT00761761|559131574|FG000|Overall Study|Lost to Follow-up|3|||
154920395|NCT00761761|559131575|FG001|Overall Study|Lost to Follow-up|1|||
154920396|NCT00761761|559131574|FG000|Overall Study|Withdrawal by Subject|3|||
154920397|NCT00761761|559131575|FG001|Overall Study|Withdrawal by Subject|0|||
154920398|NCT05064436|559131580|FG000|Overall Study|Other Reasons|1|||
154920399|NCT05064436|559131581|FG001|Overall Study|Other Reasons|0|||
154920400|NCT01711736|559131582|FG000|Overall Study|Lost to Follow-up|4|||
154920401|NCT01711736|559131583|FG001|Overall Study|Lost to Follow-up|1|||
154920402|NCT01711736|559131582|FG000|Overall Study|Withdrawal by Subject|6|||
154920403|NCT01711736|559131583|FG001|Overall Study|Withdrawal by Subject|6|||
154920404|NCT01711736|559131582|FG000|Overall Study|Migrated/moved from study area|2|||
154920405|NCT01711736|559131583|FG001|Overall Study|Migrated/moved from study area|1|||
154920406|NCT02706327|559131584|FG000|Overall Study|Lost to Follow-up|1|||
154920407|NCT02706327|559131585|FG001|Overall Study|Lost to Follow-up|1|||
154920408|NCT02706327|559131586|FG002|Overall Study|Lost to Follow-up|2|||
154920409|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Adverse Event|4|||
154920410|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Adverse Event|3|||
154920411|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Adverse Event|0|||
154920412|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Adverse Event|0|||
154920413|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Death|24|||
154920414|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Death|9|||
154920415|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Death|0|||
154920416|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Death|0|||
154920417|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
154920418|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
154920419|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
154920420|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
154920421|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Physician Decision|4|||
154920422|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Physician Decision|1|||
154920423|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Physician Decision|0|||
155177815|NCT05463198|560089411|FG000|Overall Study|Procedure Notes Missing|18|||
154995989|NCT00758680|559409532|FG006|Overall Study|Adverse Event|0|||
154995990|NCT00758680|559409533|FG007|Overall Study|Adverse Event|1|||
154995991|NCT00758680|559409534|FG008|Overall Study|Adverse Event|0|||
154995992|NCT00758680|559409535|FG009|Overall Study|Adverse Event|1|||
154995993|NCT00758680|559409526|FG000|Overall Study|Laboratory Adverse Event|0|||
154995994|NCT00758680|559409527|FG001|Overall Study|Laboratory Adverse Event|0|||
154995995|NCT00758680|559409528|FG002|Overall Study|Laboratory Adverse Event|0|||
154995996|NCT00758680|559409529|FG003|Overall Study|Laboratory Adverse Event|0|||
154995997|NCT00758680|559409530|FG004|Overall Study|Laboratory Adverse Event|0|||
154995998|NCT00758680|559409531|FG005|Overall Study|Laboratory Adverse Event|0|||
154995999|NCT00758680|559409532|FG006|Overall Study|Laboratory Adverse Event|0|||
154996000|NCT00758680|559409533|FG007|Overall Study|Laboratory Adverse Event|0|||
154996001|NCT00758680|559409534|FG008|Overall Study|Laboratory Adverse Event|1|||
154996002|NCT00758680|559409535|FG009|Overall Study|Laboratory Adverse Event|0|||
154996003|NCT00758680|559409526|FG000|Overall Study|Withdrawal by Subject|0|||
154996004|NCT00758680|559409527|FG001|Overall Study|Withdrawal by Subject|0|||
154996005|NCT00758680|559409528|FG002|Overall Study|Withdrawal by Subject|0|||
154996006|NCT00758680|559409529|FG003|Overall Study|Withdrawal by Subject|0|||
154996007|NCT00758680|559409530|FG004|Overall Study|Withdrawal by Subject|0|||
154996008|NCT00758680|559409531|FG005|Overall Study|Withdrawal by Subject|0|||
154996009|NCT00758680|559409532|FG006|Overall Study|Withdrawal by Subject|1|||
154996010|NCT00758680|559409533|FG007|Overall Study|Withdrawal by Subject|0|||
154996011|NCT00758680|559409534|FG008|Overall Study|Withdrawal by Subject|1|||
154996012|NCT00758680|559409535|FG009|Overall Study|Withdrawal by Subject|0|||
154996013|NCT03480386|559409536|FG000|Overall Study|Did not complete measures at 3-months|17|||
154996014|NCT03480386|559409537|FG001|Overall Study|Did not complete measures at 3-months|14|||
154996015|NCT03480386|559409536|FG000|Overall Study|No baseline measures|11|||
154996016|NCT03480386|559409537|FG001|Overall Study|No baseline measures|14|||
154996017|NCT03480386|559409536|FG000|Overall Study|Death|0|||
154996018|NCT03480386|559409537|FG001|Overall Study|Death|5|||
154996019|NCT03480386|559409536|FG000|Overall Study|Withdrawal by Subject|12|||
154996020|NCT03480386|559409537|FG001|Overall Study|Withdrawal by Subject|8|||
154996021|NCT03480386|559409536|FG000|Overall Study|Lost to Follow-up|2|||
154996022|NCT03480386|559409537|FG001|Overall Study|Lost to Follow-up|1|||
154996023|NCT03480386|559409536|FG000|Overall Study|Complicating disease|0|||
154996024|NCT03480386|559409537|FG001|Overall Study|Complicating disease|1|||
154996025|NCT03480386|559409536|FG000|Overall Study|Disease progression|3|||
154996026|NCT03480386|559409537|FG001|Overall Study|Disease progression|0|||
154996027|NCT03480386|559409536|FG000|Overall Study|Became ineligible|0|||
154996028|NCT03480386|559409537|FG001|Overall Study|Became ineligible|2|||
154996029|NCT00574912|559409538|FG000|Overall Study|Could not place IV lines.|3|||
154996030|NCT00574912|559409538|FG000|Overall Study|scheduling conflicts|3|||
154996031|NCT00574912|559409538|FG000|Overall Study|Physician Decision|2|||
154996032|NCT00871741|559409541|FG000|Overall Study|Premature study termination|9|||
154996033|NCT00871741|559409542|FG001|Overall Study|Premature study termination|7|||
154996034|NCT05323123|559409543|FG000|Overall Study|Withdrawal by Subject|2|||
154996035|NCT05323123|559409544|FG001|Overall Study|Withdrawal by Subject|1|||
154996036|NCT05323123|559409543|FG000|Overall Study|Lost to Follow-up|4|||
154996037|NCT05323123|559409544|FG001|Overall Study|Lost to Follow-up|2|||
154996038|NCT05323123|559409543|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
154996039|NCT05323123|559409544|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
154996040|NCT05529472|559409545|FG000|Overall Study|Withdrawal by Subject|1|||
154996041|NCT05529472|559409546|FG001|Overall Study|Withdrawal by Subject|1|||
154996042|NCT04975191|559411345|FG000|Overall Study|Protocol Violation|1|||
154996043|NCT04975191|559411346|FG001|Overall Study|Protocol Violation|2|||
154996044|NCT04975191|559411347|FG002|Overall Study|Protocol Violation|2|||
154996045|NCT04975191|559411348|FG003|Overall Study|Protocol Violation|2|||
155122525|NCT00098722|559879803|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
155122526|NCT00098722|559879804|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
155122527|NCT00098722|559879805|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
155122528|NCT00098722|559879806|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
154996046|NCT04975191|559411345|FG000|Overall Study|Lost to Follow-up|13|||
155122529|NCT00098722|559879807|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
154996047|NCT04975191|559411346|FG001|Overall Study|Lost to Follow-up|3|||
154996048|NCT04975191|559411347|FG002|Overall Study|Lost to Follow-up|8|||
154996049|NCT04975191|559411348|FG003|Overall Study|Lost to Follow-up|8|||
154996050|NCT00761657|559411349|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
154996051|NCT00761657|559411350|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
154996052|NCT00761657|559411351|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
154996053|NCT00761657|559411352|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
154996054|NCT00761657|559411353|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
154996055|NCT00761657|559411354|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
154996056|NCT00761657|559411355|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
155122530|NCT00098722|559879808|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
155122531|NCT00098722|559879809|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
155122532|NCT00098722|559879803|FG000|Double Blind Phase|Other|7|||
155122533|NCT00098722|559879804|FG001|Double Blind Phase|Other|8|||
155122534|NCT00098722|559879805|FG002|Double Blind Phase|Other|7|||
155122535|NCT00098722|559879806|FG003|Double Blind Phase|Other|0|||
155122536|NCT00098722|559879807|FG004|Double Blind Phase|Other|0|||
155122537|NCT00098722|559879808|FG005|Double Blind Phase|Other|0|||
155122538|NCT00098722|559879809|FG006|Double Blind Phase|Other|0|||
155122539|NCT00098722|559879803|FG000|Open Label Phase|Adverse Event|0|||
155122540|NCT00098722|559879804|FG001|Open Label Phase|Adverse Event|0|||
155122541|NCT00098722|559879805|FG002|Open Label Phase|Adverse Event|0|||
155122542|NCT00098722|559879806|FG003|Open Label Phase|Adverse Event|5|||
155122543|NCT00098722|559879807|FG004|Open Label Phase|Adverse Event|0|||
155122544|NCT00098722|559879808|FG005|Open Label Phase|Adverse Event|0|||
155122545|NCT00098722|559879809|FG006|Open Label Phase|Adverse Event|0|||
155122546|NCT00098722|559879803|FG000|Open Label Phase|Death|0|||
155122547|NCT00098722|559879804|FG001|Open Label Phase|Death|0|||
155122548|NCT00098722|559879805|FG002|Open Label Phase|Death|0|||
155122549|NCT00098722|559879806|FG003|Open Label Phase|Death|2|||
155122550|NCT00098722|559879807|FG004|Open Label Phase|Death|0|||
155122551|NCT00098722|559879808|FG005|Open Label Phase|Death|0|||
155122552|NCT00098722|559879809|FG006|Open Label Phase|Death|0|||
155122553|NCT00098722|559879803|FG000|Open Label Phase|Lack of Efficacy|0|||
155122554|NCT00098722|559879804|FG001|Open Label Phase|Lack of Efficacy|0|||
155122555|NCT00098722|559879805|FG002|Open Label Phase|Lack of Efficacy|0|||
155122556|NCT00098722|559879806|FG003|Open Label Phase|Lack of Efficacy|8|||
154996057|NCT00761657|559411356|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
154996058|NCT00761657|559411357|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
154996059|NCT00761657|559411349|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996060|NCT00761657|559411350|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996061|NCT00761657|559411351|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
154996062|NCT00761657|559411352|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
154996063|NCT00761657|559411353|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996064|NCT00761657|559411354|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996065|NCT00761657|559411355|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996066|NCT00761657|559411356|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996067|NCT00761657|559411357|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
154996068|NCT00761657|559411349|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
154996069|NCT00761657|559411350|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
154996070|NCT00761657|559411351|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
154996071|NCT00761657|559411352|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
154996072|NCT00761657|559411353|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
154996073|NCT00761657|559411354|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
154996074|NCT00761657|559411355|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
154996075|NCT00761657|559411356|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
154996076|NCT00761657|559411357|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
154996077|NCT00761657|559411349|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
154996078|NCT00761657|559411350|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
154996079|NCT00761657|559411351|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
154996080|NCT00761657|559411352|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
154996081|NCT00761657|559411353|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
154996082|NCT00761657|559411354|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
154996083|NCT00761657|559411355|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
154996084|NCT00761657|559411356|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
154996085|NCT00761657|559411357|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
154996086|NCT00359801|559411361|FG000|Overall Study|Lost to Follow-up|72|||
154996087|NCT00359801|559411362|FG001|Overall Study|Lost to Follow-up|58|||
154996088|NCT00359801|559411361|FG000|Overall Study|Withdrawal by Subject|143|||
154996089|NCT00359801|559411362|FG001|Overall Study|Withdrawal by Subject|96|||
154996090|NCT00359801|559411361|FG000|Overall Study|Other|66|||
154996091|NCT00359801|559411362|FG001|Overall Study|Other|46|||
154996092|NCT00359801|559411361|FG000|Overall Study|Final Status Unknown: missing data|7|||
154996093|NCT00359801|559411362|FG001|Overall Study|Final Status Unknown: missing data|4|||
155122557|NCT00098722|559879807|FG004|Open Label Phase|Lack of Efficacy|0|||
154996094|NCT00359801|559411361|FG000|Overall Study|Sponsor Decision|17|||
154996095|NCT00359801|559411362|FG001|Overall Study|Sponsor Decision|16|||
154996096|NCT01564537|559411363|FG000|Overall Study|Site Terminated by Sponsor|1|||
155122558|NCT00098722|559879808|FG005|Open Label Phase|Lack of Efficacy|0|||
155122559|NCT00098722|559879809|FG006|Open Label Phase|Lack of Efficacy|0|||
154996097|NCT01564537|559411364|FG001|Overall Study|Site Terminated by Sponsor|0|||
154996098|NCT01564537|559411363|FG000|Overall Study|Withdrawal by Subject|12|||
154996099|NCT01564537|559411364|FG001|Overall Study|Withdrawal by Subject|14|||
155122560|NCT00098722|559879803|FG000|Open Label Phase|Pregnancy|0|||
155122561|NCT00098722|559879804|FG001|Open Label Phase|Pregnancy|0|||
155122562|NCT00098722|559879805|FG002|Open Label Phase|Pregnancy|0|||
155122563|NCT00098722|559879806|FG003|Open Label Phase|Pregnancy|1|||
155122564|NCT00098722|559879807|FG004|Open Label Phase|Pregnancy|0|||
155122565|NCT00098722|559879808|FG005|Open Label Phase|Pregnancy|0|||
155122566|NCT00098722|559879809|FG006|Open Label Phase|Pregnancy|0|||
155122567|NCT00098722|559879803|FG000|Open Label Phase|Participant defaulted|0|||
154996100|NCT01564537|559411363|FG000|Overall Study|Lost to Follow-up|7|||
154996101|NCT01564537|559411364|FG001|Overall Study|Lost to Follow-up|3|||
154996102|NCT01564537|559411363|FG000|Overall Study|Reason not specified|81|||
154996103|NCT01564537|559411364|FG001|Overall Study|Reason not specified|82|||
154996104|NCT05776862|559411365|FG000|Overall Study|Adverse Event|0|||
154996105|NCT05776862|559411366|FG001|Overall Study|Adverse Event|1|||
154996106|NCT05776862|559411365|FG000|Overall Study|non-compliance|1|||
154996107|NCT05776862|559411366|FG001|Overall Study|non-compliance|0|||
154996108|NCT02448706|559411367|FG000|Overall Study|Withdrawal by Subject|4|||
154996109|NCT02448706|559411368|FG001|Overall Study|Withdrawal by Subject|3|||
154996110|NCT02448706|559411367|FG000|Overall Study|Protocol Violation|1|||
154996111|NCT02448706|559411368|FG001|Overall Study|Protocol Violation|1|||
154996112|NCT02065700|559411369|FG000|Overall Study|Adverse Event|165|||
154996113|NCT02065700|559411370|FG001|Overall Study|Adverse Event|101|||
154996114|NCT02065700|559411369|FG000|Overall Study|Withdrawal by Subject|90|||
154996115|NCT02065700|559411370|FG001|Overall Study|Withdrawal by Subject|29|||
154996116|NCT02065700|559411369|FG000|Overall Study|Lost to Follow-up|12|||
154996117|NCT02065700|559411370|FG001|Overall Study|Lost to Follow-up|9|||
154996118|NCT02065700|559411369|FG000|Overall Study|Physician Decision|2|||
154996119|NCT02065700|559411370|FG001|Overall Study|Physician Decision|0|||
154996120|NCT02065700|559411369|FG000|Overall Study|Sponsor Request|38|||
154996121|NCT02065700|559411370|FG001|Overall Study|Sponsor Request|15|||
154996122|NCT02065700|559411369|FG000|Overall Study|Treatment Failure|3|||
154996123|NCT02065700|559411370|FG001|Overall Study|Treatment Failure|2|||
154996124|NCT02065700|559411369|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
154996125|NCT02065700|559411370|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
154996126|NCT02065700|559411369|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
154996127|NCT02065700|559411370|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
154996128|NCT02065700|559411369|FG000|Overall Study|Non-compliance with Study Procedures|2|||
154996129|NCT02065700|559411370|FG001|Overall Study|Non-compliance with Study Procedures|0|||
154996130|NCT02065700|559411369|FG000|Overall Study|Not Defined|21|||
154996131|NCT02065700|559411370|FG001|Overall Study|Not Defined|3|||
154996132|NCT01635218|559411371|FG000|Overall Study|Lost to Follow-up|3|||
154996133|NCT01635218|559411372|FG001|Overall Study|Lost to Follow-up|7|||
154996134|NCT01635218|559411373|FG002|Overall Study|Lost to Follow-up|6|||
154996135|NCT03262038|559411378|FG000|Overall Study|Withdrawal by Subject|0|||
154996136|NCT03262038|559411379|FG001|Overall Study|Withdrawal by Subject|1|||
154996137|NCT04933968|559411380|FG000|Overall Study|Adverse Event|0|||
154996138|NCT04933968|559411381|FG001|Overall Study|Adverse Event|0|||
154996139|NCT04933968|559411382|FG002|Overall Study|Adverse Event|1|||
154996140|NCT04933968|559411383|FG003|Overall Study|Adverse Event|1|||
154996141|NCT04933968|559411384|FG004|Overall Study|Adverse Event|0|||
154996142|NCT04933968|559411385|FG005|Overall Study|Adverse Event|0|||
154996143|NCT04933968|559411380|FG000|Overall Study|Lost to Follow-up|1|||
154996144|NCT04933968|559411381|FG001|Overall Study|Lost to Follow-up|0|||
154996145|NCT04933968|559411382|FG002|Overall Study|Lost to Follow-up|1|||
154996146|NCT04933968|559411383|FG003|Overall Study|Lost to Follow-up|0|||
154996147|NCT04933968|559411384|FG004|Overall Study|Lost to Follow-up|0|||
154996148|NCT04933968|559411385|FG005|Overall Study|Lost to Follow-up|0|||
154996149|NCT04933968|559411380|FG000|Overall Study|Randomized not treated|1|||
154996150|NCT04933968|559411381|FG001|Overall Study|Randomized not treated|0|||
154996151|NCT04933968|559411382|FG002|Overall Study|Randomized not treated|0|||
154996152|NCT04933968|559411383|FG003|Overall Study|Randomized not treated|0|||
154996153|NCT04933968|559411384|FG004|Overall Study|Randomized not treated|0|||
154996154|NCT04933968|559411385|FG005|Overall Study|Randomized not treated|0|||
154996155|NCT04933968|559411380|FG000|Overall Study|Sponsor terminated study|0|||
154996156|NCT04933968|559411381|FG001|Overall Study|Sponsor terminated study|0|||
154996157|NCT04933968|559411382|FG002|Overall Study|Sponsor terminated study|0|||
154996158|NCT04933968|559411383|FG003|Overall Study|Sponsor terminated study|1|||
154996159|NCT04933968|559411384|FG004|Overall Study|Sponsor terminated study|2|||
154996160|NCT04933968|559411385|FG005|Overall Study|Sponsor terminated study|0|||
154996161|NCT04933968|559411380|FG000|Overall Study|Other|0|||
154996162|NCT04933968|559411381|FG001|Overall Study|Other|0|||
154996163|NCT04933968|559411382|FG002|Overall Study|Other|0|||
154996164|NCT04933968|559411383|FG003|Overall Study|Other|1|||
154996165|NCT04933968|559411384|FG004|Overall Study|Other|0|||
154996166|NCT04933968|559411385|FG005|Overall Study|Other|0|||
154996167|NCT04933968|559411380|FG000|Overall Study|Missing|1|||
154996168|NCT04933968|559411381|FG001|Overall Study|Missing|3|||
154996169|NCT04933968|559411382|FG002|Overall Study|Missing|2|||
154996170|NCT04933968|559411383|FG003|Overall Study|Missing|1|||
154996171|NCT04933968|559411384|FG004|Overall Study|Missing|1|||
155122568|NCT00098722|559879804|FG001|Open Label Phase|Participant defaulted|0|||
154996172|NCT04933968|559411385|FG005|Overall Study|Missing|0|||
154996173|NCT01724489|559411386|FG000|Overall Study|Adverse Event|8|||
154996174|NCT01724489|559411387|FG001|Overall Study|Adverse Event|3|||
154996175|NCT01724489|559411386|FG000|Overall Study|Surgery, medication|1|||
154996176|NCT01724489|559411387|FG001|Overall Study|Surgery, medication|1|||
154996177|NCT01724489|559411386|FG000|Overall Study|Lost to Follow-up|1|||
154996178|NCT01724489|559411387|FG001|Overall Study|Lost to Follow-up|2|||
154996179|NCT01724489|559411386|FG000|Overall Study|Withdrawal by Subject|6|||
154996180|NCT01724489|559411387|FG001|Overall Study|Withdrawal by Subject|6|||
154996181|NCT01664130|559411390|FG000|Overall Study|competing secondary disease|2|||
154996182|NCT02045147|559411391|FG000|Overall Study|Withdrawal by Subject|2|||
154996183|NCT02045147|559411392|FG001|Overall Study|Withdrawal by Subject|0|||
154996184|NCT02045147|559411393|FG002|Overall Study|Withdrawal by Subject|0|||
154996185|NCT02045147|559411394|FG003|Overall Study|Withdrawal by Subject|0|||
154996186|NCT02045147|559411395|FG004|Overall Study|Withdrawal by Subject|0|||
154996187|NCT02045147|559411396|FG005|Overall Study|Withdrawal by Subject|0|||
154996188|NCT02045147|559411397|FG006|Overall Study|Withdrawal by Subject|0|||
154996189|NCT02045147|559411398|FG007|Overall Study|Withdrawal by Subject|1|||
154996190|NCT02045147|559411391|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
154996191|NCT02045147|559411392|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
154996192|NCT02045147|559411393|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
154996193|NCT02045147|559411394|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
154996194|NCT02045147|559411395|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
154996195|NCT02045147|559411396|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
154996196|NCT02045147|559411397|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
154996197|NCT02045147|559411398|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
154996198|NCT04839692|559411399|FG000|Overall Study|Withdrawal by Subject|0|||
154996199|NCT04839692|559411400|FG001|Overall Study|Withdrawal by Subject|3|||
154996200|NCT04839692|559411399|FG000|Overall Study|Physician Decision|1|||
154996201|NCT04839692|559411400|FG001|Overall Study|Physician Decision|0|||
155122569|NCT00098722|559879805|FG002|Open Label Phase|Participant defaulted|0|||
155122570|NCT00098722|559879806|FG003|Open Label Phase|Participant defaulted|18|||
154996202|NCT03146962|559411401|FG000|Overall Study|Lost to Follow-up|1|||
154996203|NCT03146962|559411402|FG001|Overall Study|Lost to Follow-up|1|||
154996204|NCT03146962|559411403|FG002|Overall Study|Lost to Follow-up|0|||
154996205|NCT03146962|559411404|FG003|Overall Study|Lost to Follow-up|0|||
154996206|NCT03146962|559411405|FG004|Overall Study|Lost to Follow-up|0|||
154996207|NCT03146962|559411406|FG005|Overall Study|Lost to Follow-up|0|||
154996208|NCT03146962|559411407|FG006|Overall Study|Lost to Follow-up|0|||
154996209|NCT03146962|559411408|FG007|Overall Study|Lost to Follow-up|0|||
154996210|NCT03146962|559411409|FG008|Overall Study|Lost to Follow-up|0|||
154996211|NCT03146962|559411410|FG009|Overall Study|Lost to Follow-up|0|||
154996212|NCT03146962|559411401|FG000|Overall Study|Adverse Event|0|||
154996213|NCT03146962|559411402|FG001|Overall Study|Adverse Event|3|||
154996214|NCT03146962|559411403|FG002|Overall Study|Adverse Event|0|||
154996215|NCT03146962|559411404|FG003|Overall Study|Adverse Event|0|||
154996216|NCT03146962|559411405|FG004|Overall Study|Adverse Event|0|||
154996217|NCT03146962|559411406|FG005|Overall Study|Adverse Event|0|||
154996218|NCT03146962|559411407|FG006|Overall Study|Adverse Event|0|||
154996219|NCT03146962|559411408|FG007|Overall Study|Adverse Event|1|||
154996220|NCT03146962|559411409|FG008|Overall Study|Adverse Event|0|||
154996221|NCT03146962|559411410|FG009|Overall Study|Adverse Event|0|||
154996222|NCT03146962|559411401|FG000|Overall Study|Withdrawal by Subject|0|||
154996223|NCT03146962|559411402|FG001|Overall Study|Withdrawal by Subject|0|||
155122571|NCT00098722|559879807|FG004|Open Label Phase|Participant defaulted|0|||
155122572|NCT00098722|559879808|FG005|Open Label Phase|Participant defaulted|0|||
155122573|NCT00098722|559879809|FG006|Open Label Phase|Participant defaulted|0|||
155122574|NCT00098722|559879803|FG000|Open Label Phase|Ongoing at cut-off date|0|||
155122575|NCT00098722|559879804|FG001|Open Label Phase|Ongoing at cut-off date|0|||
155122576|NCT00098722|559879805|FG002|Open Label Phase|Ongoing at cut-off date|0|||
155122577|NCT00098722|559879806|FG003|Open Label Phase|Ongoing at cut-off date|220|||
155122578|NCT00098722|559879807|FG004|Open Label Phase|Ongoing at cut-off date|50|||
155122579|NCT00098722|559879808|FG005|Open Label Phase|Ongoing at cut-off date|0|||
155122580|NCT00098722|559879809|FG006|Open Label Phase|Ongoing at cut-off date|0|||
155122581|NCT00098722|559879803|FG000|Open Label Phase|Other|0|||
155122582|NCT00098722|559879804|FG001|Open Label Phase|Other|0|||
155122583|NCT00098722|559879805|FG002|Open Label Phase|Other|0|||
155122584|NCT00098722|559879806|FG003|Open Label Phase|Other|18|||
155177816|NCT02239120|560089414|FG000|Overall Study|Death|56|||
155177817|NCT02239120|560089415|FG001|Overall Study|Death|58|||
154996224|NCT03146962|559411403|FG002|Overall Study|Withdrawal by Subject|0|||
154996225|NCT03146962|559411404|FG003|Overall Study|Withdrawal by Subject|0|||
154996226|NCT03146962|559411405|FG004|Overall Study|Withdrawal by Subject|1|||
154996227|NCT03146962|559411406|FG005|Overall Study|Withdrawal by Subject|0|||
154996228|NCT03146962|559411407|FG006|Overall Study|Withdrawal by Subject|0|||
155122585|NCT00098722|559879807|FG004|Open Label Phase|Other|0|||
155122586|NCT00098722|559879808|FG005|Open Label Phase|Other|0|||
154996229|NCT03146962|559411408|FG007|Overall Study|Withdrawal by Subject|0|||
154996230|NCT03146962|559411409|FG008|Overall Study|Withdrawal by Subject|0|||
154996231|NCT03146962|559411410|FG009|Overall Study|Withdrawal by Subject|0|||
154996232|NCT03146962|559411401|FG000|Overall Study|Death|0|||
154996233|NCT03146962|559411402|FG001|Overall Study|Death|1|||
154996234|NCT03146962|559411403|FG002|Overall Study|Death|0|||
154996235|NCT03146962|559411404|FG003|Overall Study|Death|0|||
154996236|NCT03146962|559411405|FG004|Overall Study|Death|0|||
154996237|NCT03146962|559411406|FG005|Overall Study|Death|0|||
154996238|NCT03146962|559411407|FG006|Overall Study|Death|0|||
154996239|NCT03146962|559411408|FG007|Overall Study|Death|0|||
154996240|NCT03146962|559411409|FG008|Overall Study|Death|0|||
154996241|NCT03146962|559411410|FG009|Overall Study|Death|0|||
154996242|NCT03146962|559411401|FG000|Overall Study|COVID Precautions|1|||
154996243|NCT03146962|559411402|FG001|Overall Study|COVID Precautions|0|||
154996244|NCT03146962|559411403|FG002|Overall Study|COVID Precautions|0|||
154996245|NCT03146962|559411404|FG003|Overall Study|COVID Precautions|0|||
154996246|NCT03146962|559411405|FG004|Overall Study|COVID Precautions|0|||
154996247|NCT03146962|559411406|FG005|Overall Study|COVID Precautions|0|||
154996248|NCT03146962|559411407|FG006|Overall Study|COVID Precautions|0|||
154996249|NCT03146962|559411408|FG007|Overall Study|COVID Precautions|0|||
154996250|NCT03146962|559411409|FG008|Overall Study|COVID Precautions|0|||
154996251|NCT03146962|559411410|FG009|Overall Study|COVID Precautions|0|||
154996252|NCT03146962|559411401|FG000|Overall Study|Physician Decision|0|||
154996253|NCT03146962|559411402|FG001|Overall Study|Physician Decision|0|||
154996254|NCT03146962|559411403|FG002|Overall Study|Physician Decision|0|||
154996255|NCT03146962|559411404|FG003|Overall Study|Physician Decision|0|||
154996256|NCT03146962|559411405|FG004|Overall Study|Physician Decision|0|||
154996257|NCT03146962|559411406|FG005|Overall Study|Physician Decision|0|||
154996258|NCT03146962|559411407|FG006|Overall Study|Physician Decision|0|||
154996259|NCT03146962|559411408|FG007|Overall Study|Physician Decision|0|||
154996260|NCT03146962|559411409|FG008|Overall Study|Physician Decision|0|||
154996261|NCT03146962|559411410|FG009|Overall Study|Physician Decision|1|||
154920424|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Physician Decision|0|||
154920425|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Progressive disease|1|||
154920426|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Progressive disease|0|||
154920427|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Progressive disease|0|||
154920428|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Progressive disease|0|||
154920429|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
154920430|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
154920431|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
154920432|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
154920433|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
154920434|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
154920435|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
154920436|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
154920437|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
154920438|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
154920439|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
154920440|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
154920441|NCT04579666|559131587|FG000|RTP (Up to Week 52)|Other|2|||
154920442|NCT04579666|559131588|FG001|RTP (Up to Week 52)|Other|0|||
154920443|NCT04579666|559131589|FG002|RTP (Up to Week 52)|Other|0|||
154920444|NCT04579666|559131590|FG003|RTP (Up to Week 52)|Other|0|||
154920445|NCT04579666|559131587|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
154920446|NCT04579666|559131588|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
154920447|NCT04579666|559131589|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
154920448|NCT04579666|559131590|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
154920449|NCT04579666|559131587|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
154920450|NCT04579666|559131588|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
154920451|NCT04579666|559131589|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
154920452|NCT04579666|559131590|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
154920453|NCT04579666|559131587|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
154920454|NCT04579666|559131588|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
154920455|NCT04579666|559131589|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
154920456|NCT04579666|559131590|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
154920457|NCT04579666|559131587|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
154920458|NCT04579666|559131588|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
154920459|NCT04579666|559131589|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
154920460|NCT04579666|559131590|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
154920461|NCT04579666|559131587|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
154996262|NCT03146962|559411401|FG000|Overall Study|Started New Treatment|0|||
154996263|NCT03146962|559411402|FG001|Overall Study|Started New Treatment|1|||
154996264|NCT03146962|559411403|FG002|Overall Study|Started New Treatment|0|||
154996265|NCT03146962|559411404|FG003|Overall Study|Started New Treatment|0|||
154996266|NCT03146962|559411405|FG004|Overall Study|Started New Treatment|0|||
154996267|NCT03146962|559411406|FG005|Overall Study|Started New Treatment|0|||
154996268|NCT03146962|559411407|FG006|Overall Study|Started New Treatment|0|||
154996269|NCT03146962|559411408|FG007|Overall Study|Started New Treatment|0|||
154996270|NCT03146962|559411409|FG008|Overall Study|Started New Treatment|0|||
154996271|NCT03146962|559411410|FG009|Overall Study|Started New Treatment|0|||
154996272|NCT00049530|559411411|FG000|Overall Study|Lack of Efficacy|25|||
154996273|NCT00049530|559411411|FG000|Overall Study|Adverse Event|2|||
154996274|NCT00049530|559411411|FG000|Overall Study|Death|1|||
154996275|NCT00049530|559411411|FG000|Overall Study|symptomatic deterioration|1|||
154996276|NCT00049530|559411411|FG000|Overall Study|ineligible|3|||
154996277|NCT00492024|559411414|FG000|Treatment|Adverse Event|3|||
154996278|NCT00492024|559411415|FG001|Treatment|Adverse Event|1|||
154996279|NCT00492024|559411414|FG000|Treatment|Lack of Efficacy|21|||
154996280|NCT00492024|559411415|FG001|Treatment|Lack of Efficacy|20|||
154996281|NCT00492024|559411414|FG000|Treatment|Lost to Follow-up|3|||
154996282|NCT00492024|559411415|FG001|Treatment|Lost to Follow-up|1|||
154996283|NCT00492024|559411414|FG000|Treatment|Withdrawal by Subject|2|||
154996284|NCT00492024|559411415|FG001|Treatment|Withdrawal by Subject|0|||
154996285|NCT00492024|559411414|FG000|Follow up|Lack of Efficacy|0|||
154996286|NCT00492024|559411415|FG001|Follow up|Lack of Efficacy|1|||
154996287|NCT00492024|559411414|FG000|Follow up|Lost to Follow-up|1|||
154996288|NCT00492024|559411415|FG001|Follow up|Lost to Follow-up|1|||
154996289|NCT03247816|559411421|FG000|Overall Study|Adverse Event|12|||
154996290|NCT03247816|559411421|FG000|Overall Study|Physician Decision|3|||
154996291|NCT03247816|559411421|FG000|Overall Study|Lack of Efficacy|1|||
154996292|NCT03247816|559411421|FG000|Overall Study|Lost to Follow-up|10|||
154996293|NCT03247816|559411421|FG000|Overall Study|Missing Feraccru stop date|3|||
154996294|NCT02861014|559411422|FG000|Primary Analysis|Adverse Event|7|||
154996295|NCT02861014|559411422|FG000|Primary Analysis|Death|1|||
154996296|NCT02861014|559411422|FG000|Primary Analysis|Lack of Efficacy|3|||
154996297|NCT02861014|559411422|FG000|Primary Analysis|Physician Decision|2|||
154996298|NCT02861014|559411422|FG000|Primary Analysis|Pregnancy|4|||
154996299|NCT02861014|559411422|FG000|Primary Analysis|Protocol Violation|2|||
154996300|NCT02861014|559411422|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
154996301|NCT02861014|559411422|FG000|Primary Analysis|Withdrawal by Subject|14|||
154996302|NCT02861014|559411422|FG000|Primary Analysis|Commercial ocrelizumab|3|||
154996303|NCT02861014|559411422|FG000|Safety Follow-up|Adverse Event|1|||
154996304|NCT02861014|559411422|FG000|Safety Follow-up|Pregnancy|1|||
154996305|NCT02861014|559411422|FG000|Safety Follow-up|Withdrawal by Subject|9|||
154996306|NCT02861014|559411422|FG000|Safety Follow-up|Study terminated by sponsor|1|||
154996307|NCT02861014|559411422|FG000|Safety Follow-up|Physician Decision|1|||
154996308|NCT02861014|559411422|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
154996309|NCT02861014|559411422|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
154996310|NCT00926783|559411423|FG000|Overall Study|Incomplete CFAE Procedures|3|||
154996311|NCT00926783|559411424|FG001|Overall Study|Incomplete CFAE Procedures|3|||
154996312|NCT00696787|559411427|FG000|Overall Study|Adverse Event|1|||
154996313|NCT00696787|559411428|FG001|Overall Study|Adverse Event|0|||
154996314|NCT00696787|559411429|FG002|Overall Study|Adverse Event|6|||
154996315|NCT00696787|559411427|FG000|Overall Study|Discontinuation by Sponsor|9|||
154996316|NCT00696787|559411428|FG001|Overall Study|Discontinuation by Sponsor|13|||
154996317|NCT00696787|559411429|FG002|Overall Study|Discontinuation by Sponsor|14|||
154996318|NCT00696787|559411427|FG000|Overall Study|Lack of Efficacy|0|||
154996319|NCT00696787|559411428|FG001|Overall Study|Lack of Efficacy|1|||
154996320|NCT00696787|559411429|FG002|Overall Study|Lack of Efficacy|0|||
154996321|NCT00696787|559411427|FG000|Overall Study|Lost to Follow-up|4|||
154996322|NCT00696787|559411428|FG001|Overall Study|Lost to Follow-up|0|||
154996323|NCT00696787|559411429|FG002|Overall Study|Lost to Follow-up|3|||
154996324|NCT00696787|559411427|FG000|Overall Study|Withdrawal by Subject|0|||
154996325|NCT00696787|559411428|FG001|Overall Study|Withdrawal by Subject|3|||
154996326|NCT00696787|559411429|FG002|Overall Study|Withdrawal by Subject|2|||
154996327|NCT00696787|559411427|FG000|Overall Study|Failed to return|1|||
154996328|NCT00696787|559411428|FG001|Overall Study|Failed to return|3|||
154996329|NCT00696787|559411429|FG002|Overall Study|Failed to return|1|||
155177818|NCT02239120|560089414|FG000|Overall Study|Lost to Follow-up|19|||
155177819|NCT02239120|560089415|FG001|Overall Study|Lost to Follow-up|14|||
154996330|NCT02704403|559411430|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
154996331|NCT02704403|559411431|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
154996332|NCT02704403|559411430|FG000|Overall Study|Administrative reasons by sponsor|1251|||
154996333|NCT02704403|559411431|FG001|Overall Study|Administrative reasons by sponsor|616|||
154996334|NCT02704403|559411430|FG000|Overall Study|Death|4|||
154996335|NCT02704403|559411431|FG001|Overall Study|Death|3|||
154996336|NCT02704403|559411430|FG000|Overall Study|Endpoint event|52|||
154996337|NCT02704403|559411431|FG001|Overall Study|Endpoint event|24|||
154996338|NCT02704403|559411430|FG000|Overall Study|Lost to Follow-up|22|||
154996339|NCT02704403|559411431|FG001|Overall Study|Lost to Follow-up|11|||
154996340|NCT02704403|559411430|FG000|Overall Study|Protocol Violation|15|||
154996341|NCT02704403|559411431|FG001|Overall Study|Protocol Violation|15|||
154996342|NCT02704403|559411430|FG000|Overall Study|Adverse Event|2|||
154996343|NCT02704403|559411431|FG001|Overall Study|Adverse Event|0|||
154996344|NCT02704403|559411430|FG000|Overall Study|Withdrawal by Subject|85|||
154996345|NCT02704403|559411431|FG001|Overall Study|Withdrawal by Subject|45|||
154996346|NCT02704403|559411430|FG000|Overall Study|Investigator decision|1|||
154996347|NCT02704403|559411431|FG001|Overall Study|Investigator decision|1|||
154996348|NCT02704403|559411430|FG000|Overall Study|Follow-up not possible|1|||
154996349|NCT02704403|559411431|FG001|Overall Study|Follow-up not possible|2|||
154996350|NCT00469144|559411434|FG000|Overall Study|Death|0|||
154996351|NCT00469144|559411435|FG001|Overall Study|Death|1|||
154996352|NCT00469144|559411434|FG000|Overall Study|No Response|5|||
154996353|NCT00469144|559411435|FG001|Overall Study|No Response|5|||
154996354|NCT00469144|559411434|FG000|Overall Study|Progressive Disease|1|||
154996355|NCT00469144|559411435|FG001|Overall Study|Progressive Disease|0|||
154996356|NCT01994291|559411436|FG000|Overall Study|Adverse Event|4|||
154996357|NCT01994291|559411437|FG001|Overall Study|Adverse Event|1|||
154996358|NCT01994291|559411438|FG002|Overall Study|Adverse Event|3|||
154996359|NCT01994291|559411436|FG000|Overall Study|Lost to Follow-up|1|||
154996360|NCT01994291|559411437|FG001|Overall Study|Lost to Follow-up|1|||
154996361|NCT01994291|559411438|FG002|Overall Study|Lost to Follow-up|0|||
154996362|NCT01994291|559411436|FG000|Overall Study|Does not meet entrance criteria|1|||
154996363|NCT01994291|559411437|FG001|Overall Study|Does not meet entrance criteria|0|||
154996364|NCT01994291|559411438|FG002|Overall Study|Does not meet entrance criteria|0|||
154996365|NCT01994291|559411436|FG000|Overall Study|Medication error without associated AE|1|||
154996366|NCT01994291|559411437|FG001|Overall Study|Medication error without associated AE|0|||
154996367|NCT01994291|559411438|FG002|Overall Study|Medication error without associated AE|1|||
154996368|NCT01994291|559411436|FG000|Overall Study|Protocol Violation|1|||
154996369|NCT01994291|559411437|FG001|Overall Study|Protocol Violation|0|||
154996370|NCT01994291|559411438|FG002|Overall Study|Protocol Violation|0|||
154996371|NCT01994291|559411436|FG000|Overall Study|Withdrawal by Subject|6|||
154996372|NCT01994291|559411437|FG001|Overall Study|Withdrawal by Subject|3|||
154996373|NCT01994291|559411438|FG002|Overall Study|Withdrawal by Subject|5|||
154996374|NCT01994291|559411436|FG000|Overall Study|Other|1|||
154996375|NCT01994291|559411437|FG001|Overall Study|Other|2|||
154996376|NCT01994291|559411438|FG002|Overall Study|Other|0|||
154996377|NCT01775189|559411439|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
154996378|NCT01775189|559411440|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
154996379|NCT01775189|559411441|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
154996380|NCT01775189|559411442|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
154996381|NCT01775189|559411443|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
154996382|NCT01775189|559411444|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
154996383|NCT01775189|559411445|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
154996384|NCT01775189|559411439|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154996385|NCT01775189|559411440|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
154996386|NCT01775189|559411441|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154996387|NCT01775189|559411442|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154996388|NCT01775189|559411443|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154996389|NCT01775189|559411444|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154996390|NCT01775189|559411445|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
154996391|NCT01775189|559411439|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
154996392|NCT01775189|559411440|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
154996393|NCT01775189|559411441|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
154996394|NCT01775189|559411442|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
154996395|NCT01775189|559411443|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
154996396|NCT01775189|559411444|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
154996397|NCT01775189|559411445|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
154996398|NCT01775189|559411439|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
154996399|NCT01775189|559411440|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
154996400|NCT01775189|559411441|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
154996401|NCT01775189|559411442|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
154996402|NCT01775189|559411443|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
154996403|NCT01775189|559411444|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
154996404|NCT01775189|559411445|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
154996405|NCT01775189|559411439|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
154996406|NCT01775189|559411440|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
154996407|NCT01775189|559411441|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
154996408|NCT01775189|559411442|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
154996409|NCT01775189|559411443|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
154996410|NCT01775189|559411444|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
154996411|NCT01775189|559411445|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
154996412|NCT01775189|559411439|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
154996413|NCT01775189|559411440|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
154996414|NCT01775189|559411441|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
154996415|NCT01775189|559411442|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
154996416|NCT01775189|559411443|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
154996417|NCT01775189|559411444|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
154996418|NCT01775189|559411445|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
154996419|NCT02227446|559411446|FG000|Overall Study|not eligible post randomization|18|||
154996420|NCT02227446|559411447|FG001|Overall Study|not eligible post randomization|29|||
154996421|NCT02227446|559411446|FG000|Overall Study|Withdrawal by Subject|4|||
154996422|NCT02227446|559411447|FG001|Overall Study|Withdrawal by Subject|5|||
154996423|NCT03016975|559411448|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
154996424|NCT03016975|559411449|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
154996425|NCT03016975|559411450|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
154996426|NCT03016975|559411448|FG000|At 6 Months Follow-up|Death|2|||
154996427|NCT03016975|559411449|FG001|At 6 Months Follow-up|Death|0|||
154996428|NCT03016975|559411450|FG002|At 6 Months Follow-up|Death|0|||
154996429|NCT03016975|559411448|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
154996430|NCT03016975|559411449|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
154996431|NCT03016975|559411450|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
154996432|NCT03016975|559411448|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
154996433|NCT03016975|559411449|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
154996434|NCT03016975|559411450|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
154996435|NCT03016975|559411448|FG000|At 6 Months Follow-up|Aborted implant|1|||
154996436|NCT03016975|559411449|FG001|At 6 Months Follow-up|Aborted implant|0|||
154996437|NCT03016975|559411450|FG002|At 6 Months Follow-up|Aborted implant|0|||
154996438|NCT03016975|559411448|FG000|At 2 Year Follow-up|Death|1|||
154996439|NCT03016975|559411449|FG001|At 2 Year Follow-up|Death|0|||
154996440|NCT03016975|559411450|FG002|At 2 Year Follow-up|Death|0|||
154996441|NCT03016975|559411448|FG000|At 3 Year Follow-up|Death|1|||
154996442|NCT03016975|559411449|FG001|At 3 Year Follow-up|Death|0|||
154996443|NCT03016975|559411450|FG002|At 3 Year Follow-up|Death|0|||
154996444|NCT03016975|559411448|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
154996445|NCT03016975|559411449|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
154996446|NCT03016975|559411450|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
154996447|NCT03016975|559411448|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
154996448|NCT03016975|559411449|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
154996449|NCT03016975|559411450|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
154996450|NCT02901548|559411451|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
154996451|NCT02348723|559411452|FG000|Overall Study|No ablation|21|||
154996452|NCT02348723|559411453|FG001|Overall Study|No ablation|20|||
154996453|NCT02348723|559411452|FG000|Overall Study|Non-compliant with Protocol|1|||
154996454|NCT02348723|559411453|FG001|Overall Study|Non-compliant with Protocol|0|||
154996455|NCT02348723|559411452|FG000|Overall Study|Lost to Follow-up|1|||
154996456|NCT02348723|559411453|FG001|Overall Study|Lost to Follow-up|1|||
154996457|NCT02348723|559411452|FG000|Overall Study|Consent withdrawn|1|||
154996458|NCT02348723|559411453|FG001|Overall Study|Consent withdrawn|3|||
154996459|NCT02348723|559411452|FG000|Overall Study|Reason other than specified|1|||
154996460|NCT02348723|559411453|FG001|Overall Study|Reason other than specified|1|||
154996461|NCT02348723|559411452|FG000|Overall Study|Adverse Event|3|||
154996462|NCT02348723|559411453|FG001|Overall Study|Adverse Event|1|||
154996463|NCT05330468|559411455|FG000|Overall Study|Death|6|||
154996464|NCT05330468|559411455|FG000|Overall Study|Withdrawal by Subject|4|||
154996465|NCT05330468|559411455|FG000|Overall Study|Lost to Follow-up|4|||
154996466|NCT02365558|559411456|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
154996467|NCT02365558|559411457|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
154996468|NCT02365558|559411456|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
154996469|NCT02365558|559411457|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
154996470|NCT00426361|559411461|FG000|Overall Study|Lost to Follow-up|3|||
154996471|NCT00426361|559411462|FG001|Overall Study|Lost to Follow-up|2|||
154996472|NCT00426361|559411463|FG002|Overall Study|Lost to Follow-up|5|||
154996473|NCT00426361|559411461|FG000|Overall Study|Withdrawal by Subject|1|||
154996474|NCT00426361|559411462|FG001|Overall Study|Withdrawal by Subject|3|||
154996475|NCT00426361|559411463|FG002|Overall Study|Withdrawal by Subject|0|||
154996476|NCT02828241|559411464|FG000|Overall Study|Adverse Event|7|||
154996477|NCT02828241|559411465|FG001|Overall Study|Adverse Event|2|||
154996478|NCT02828241|559411464|FG000|Overall Study|Protocol Violation|1|||
154996479|NCT02828241|559411465|FG001|Overall Study|Protocol Violation|0|||
154996480|NCT01671332|559411480|FG000|Overall Study|Withdrawal by Subject|1|||
154996481|NCT01671332|559411481|FG001|Overall Study|Withdrawal by Subject|1|||
154996482|NCT04572893|559411487|FG000|Part A|Adverse Event|1|||
154996483|NCT04572893|559411488|FG001|Part A|Adverse Event|0|||
154996484|NCT04572893|559411489|FG002|Part A|Adverse Event|0|||
154996485|NCT04572893|559411490|FG003|Part A|Adverse Event|0|||
154996486|NCT04572893|559411491|FG004|Part A|Adverse Event|0|||
154996487|NCT04572893|559411492|FG005|Part A|Adverse Event|0|||
154996488|NCT04572893|559411493|FG006|Part A|Adverse Event|0|||
154996489|NCT04572893|559411487|FG000|Part B|Withdrawal by Subject|0|||
154996490|NCT04572893|559411488|FG001|Part B|Withdrawal by Subject|0|||
154996491|NCT04572893|559411489|FG002|Part B|Withdrawal by Subject|0|||
154996492|NCT04572893|559411490|FG003|Part B|Withdrawal by Subject|0|||
154996493|NCT04572893|559411491|FG004|Part B|Withdrawal by Subject|0|||
154996494|NCT04572893|559411492|FG005|Part B|Withdrawal by Subject|1|||
154996495|NCT04572893|559411493|FG006|Part B|Withdrawal by Subject|0|||
154996496|NCT04572893|559411487|FG000|Part B|Study terminated by sponsor|0|||
154996497|NCT04572893|559411488|FG001|Part B|Study terminated by sponsor|0|||
154996498|NCT04572893|559411489|FG002|Part B|Study terminated by sponsor|0|||
154996499|NCT04572893|559411490|FG003|Part B|Study terminated by sponsor|0|||
154996500|NCT04572893|559411491|FG004|Part B|Study terminated by sponsor|7|||
154996501|NCT04572893|559411492|FG005|Part B|Study terminated by sponsor|5|||
154996502|NCT04572893|559411493|FG006|Part B|Study terminated by sponsor|3|||
154996503|NCT04572893|559411487|FG000|Part B|Lost to Follow-up|0|||
154996504|NCT04572893|559411488|FG001|Part B|Lost to Follow-up|0|||
154996505|NCT04572893|559411489|FG002|Part B|Lost to Follow-up|0|||
154996506|NCT04572893|559411490|FG003|Part B|Lost to Follow-up|0|||
154996507|NCT04572893|559411491|FG004|Part B|Lost to Follow-up|0|||
154996508|NCT04572893|559411492|FG005|Part B|Lost to Follow-up|0|||
154996509|NCT04572893|559411493|FG006|Part B|Lost to Follow-up|1|||
154996510|NCT04572893|559411487|FG000|Part B|Adverse Event|0|||
154996511|NCT04572893|559411488|FG001|Part B|Adverse Event|0|||
154996512|NCT04572893|559411489|FG002|Part B|Adverse Event|0|||
154996513|NCT04572893|559411490|FG003|Part B|Adverse Event|0|||
154996514|NCT04572893|559411491|FG004|Part B|Adverse Event|1|||
154996515|NCT04572893|559411492|FG005|Part B|Adverse Event|1|||
154996516|NCT04572893|559411493|FG006|Part B|Adverse Event|0|||
154996517|NCT02269163|559411496|FG000|Overall Study|Lost to Follow-up|1|||
154996518|NCT02269163|559411497|FG001|Overall Study|Lost to Follow-up|0|||
154996519|NCT02269163|559411496|FG000|Overall Study|Major protocol violation|0|||
154996520|NCT02269163|559411497|FG001|Overall Study|Major protocol violation|1|||
154996521|NCT02269163|559411496|FG000|Overall Study|Other|2|||
154996522|NCT02269163|559411497|FG001|Overall Study|Other|2|||
154996523|NCT02269163|559411496|FG000|Overall Study|Withdrawal by Subject|0|||
154996524|NCT02269163|559411497|FG001|Overall Study|Withdrawal by Subject|3|||
154996525|NCT02269163|559411496|FG000|Overall Study|Physician Decision|0|||
154996526|NCT02269163|559411497|FG001|Overall Study|Physician Decision|1|||
154996527|NCT04730349|559411503|FG000|Overall Study|Participant withdrew consent|1|||
154996528|NCT04730349|559411504|FG001|Overall Study|Participant withdrew consent|0|||
154996529|NCT04730349|559411503|FG000|Overall Study|Disease progression|6|||
154996530|NCT04730349|559411504|FG001|Overall Study|Disease progression|4|||
154996531|NCT04730349|559411503|FG000|Overall Study|Study drug toxicity|0|||
154996532|NCT04730349|559411504|FG001|Overall Study|Study drug toxicity|1|||
154996533|NCT00638027|559411507|FG000|Overall Study|Adverse Event|0|||
154996534|NCT00638027|559411508|FG001|Overall Study|Adverse Event|2|||
154996535|NCT05065567|559411517|FG000|Overall Study|Lost to Follow-up|10|||
154996536|NCT05065567|559411518|FG001|Overall Study|Lost to Follow-up|9|||
154996537|NCT05065567|559411519|FG002|Overall Study|Lost to Follow-up|6|||
154996538|NCT03395405|559413104|FG000|Overall Study|Death|0|||
154996539|NCT03395405|559413105|FG001|Overall Study|Death|2|||
154996540|NCT03395405|559413104|FG000|Overall Study|Lost to Follow-up|0|||
154996541|NCT03395405|559413105|FG001|Overall Study|Lost to Follow-up|1|||
154996542|NCT03395405|559413104|FG000|Overall Study|Protocol Violation|0|||
154996543|NCT03395405|559413105|FG001|Overall Study|Protocol Violation|1|||
154996544|NCT03395405|559413104|FG000|Overall Study|Withdrawal by Subject|3|||
154996545|NCT03395405|559413105|FG001|Overall Study|Withdrawal by Subject|1|||
154996546|NCT03395405|559413104|FG000|Overall Study|COVID-19 Pandemic|1|||
154996547|NCT03395405|559413105|FG001|Overall Study|COVID-19 Pandemic|0|||
154996548|NCT00213135|559413106|FG000|Overall Study|Adverse Event|9|||
154996549|NCT00213135|559413107|FG001|Overall Study|Adverse Event|5|||
154996550|NCT00213135|559413108|FG002|Overall Study|Adverse Event|5|||
154996551|NCT00213135|559413106|FG000|Overall Study|Lost to Follow-up|11|||
154996552|NCT00213135|559413107|FG001|Overall Study|Lost to Follow-up|8|||
154996553|NCT00213135|559413108|FG002|Overall Study|Lost to Follow-up|4|||
154996554|NCT00213135|559413106|FG000|Overall Study|Protocol Violation|4|||
154996555|NCT00213135|559413107|FG001|Overall Study|Protocol Violation|4|||
154996556|NCT00213135|559413108|FG002|Overall Study|Protocol Violation|10|||
154996557|NCT00213135|559413106|FG000|Overall Study|Death|1|||
155122587|NCT00098722|559879809|FG006|Open Label Phase|Other|0|||
155122588|NCT00098722|559879803|FG000|Observation Phase|Death|0|||
155122589|NCT00098722|559879804|FG001|Observation Phase|Death|0|||
155122590|NCT00098722|559879805|FG002|Observation Phase|Death|0|||
154996558|NCT00213135|559413107|FG001|Overall Study|Death|1|||
154996559|NCT00213135|559413108|FG002|Overall Study|Death|2|||
154996560|NCT00213135|559413106|FG000|Overall Study|Disease progression|4|||
154996561|NCT00213135|559413107|FG001|Overall Study|Disease progression|5|||
154996562|NCT00213135|559413108|FG002|Overall Study|Disease progression|21|||
154996563|NCT00213135|559413106|FG000|Overall Study|Other|21|||
154996564|NCT00213135|559413107|FG001|Overall Study|Other|12|||
154996565|NCT00213135|559413108|FG002|Overall Study|Other|15|||
154996566|NCT02886624|559413111|FG000|12-week Post Treatment Follow-up|Death|1|||
154996567|NCT02886624|559413111|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
154996568|NCT02152605|559413119|FG000|Overall Study|Adverse Event|6|||
154996569|NCT02152605|559413120|FG001|Overall Study|Adverse Event|8|||
154996570|NCT02152605|559413119|FG000|Overall Study|Lack of Efficacy|7|||
154996571|NCT02152605|559413120|FG001|Overall Study|Lack of Efficacy|4|||
155122591|NCT00098722|559879806|FG003|Observation Phase|Death|0|||
154996572|NCT02152605|559413119|FG000|Overall Study|Protocol deviation|1|||
154996573|NCT02152605|559413120|FG001|Overall Study|Protocol deviation|4|||
154996574|NCT02152605|559413119|FG000|Overall Study|Lost to Follow-up|1|||
154996575|NCT02152605|559413120|FG001|Overall Study|Lost to Follow-up|0|||
154996576|NCT02152605|559413119|FG000|Overall Study|Withdrew consent|4|||
154996577|NCT02152605|559413120|FG001|Overall Study|Withdrew consent|2|||
154996578|NCT02500043|559413127|FG000|Overall Study|Randomized, but not Treated|2|||
154996579|NCT02500043|559413128|FG001|Overall Study|Randomized, but not Treated|2|||
154996580|NCT02500043|559413127|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
154996581|NCT02500043|559413128|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
154996582|NCT02500043|559413127|FG000|Overall Study|Adverse Event|33|||
154996583|NCT02500043|559413128|FG001|Overall Study|Adverse Event|11|||
154996584|NCT02500043|559413127|FG000|Overall Study|Clinical Progression|54|||
154996585|NCT02500043|559413128|FG001|Overall Study|Clinical Progression|35|||
154996586|NCT02500043|559413127|FG000|Overall Study|Radiological Progression|192|||
154996587|NCT02500043|559413128|FG001|Overall Study|Radiological Progression|110|||
154996588|NCT02500043|559413127|FG000|Overall Study|Physician's Decision|11|||
154996589|NCT02500043|559413128|FG001|Overall Study|Physician's Decision|3|||
154996590|NCT02500043|559413127|FG000|Overall Study|Withdrawal by Subject|14|||
154996591|NCT02500043|559413128|FG001|Overall Study|Withdrawal by Subject|4|||
154996592|NCT02500043|559413127|FG000|Overall Study|Death|11|||
154996593|NCT02500043|559413128|FG001|Overall Study|Death|2|||
154996594|NCT02500043|559413127|FG000|Overall Study|Protocol Deviation|1|||
154996595|NCT02500043|559413128|FG001|Overall Study|Protocol Deviation|0|||
154996596|NCT02932306|559413132|FG000|Overall Study|Withdrawal by Subject|16|||
154996597|NCT02932306|559413133|FG001|Overall Study|Withdrawal by Subject|25|||
154996598|NCT02932306|559413132|FG000|Overall Study|Adverse Event|3|||
154996599|NCT02932306|559413133|FG001|Overall Study|Adverse Event|0|||
154996600|NCT02932306|559413132|FG000|Overall Study|Pregnancy|2|||
154996601|NCT02932306|559413133|FG001|Overall Study|Pregnancy|0|||
154996602|NCT02932306|559413132|FG000|Overall Study|Protocol Violation|1|||
154996603|NCT02932306|559413133|FG001|Overall Study|Protocol Violation|1|||
154996604|NCT02932306|559413132|FG000|Overall Study|Noncompliance with Study Drug|1|||
154996605|NCT02932306|559413133|FG001|Overall Study|Noncompliance with Study Drug|1|||
154996606|NCT02932306|559413132|FG000|Overall Study|Lost to Follow-up|36|||
154996607|NCT02932306|559413133|FG001|Overall Study|Lost to Follow-up|40|||
154996608|NCT02932306|559413132|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
154996609|NCT02932306|559413133|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
154996610|NCT02932306|559413132|FG000|Overall Study|Lack of Efficacy|0|||
154996611|NCT02932306|559413133|FG001|Overall Study|Lack of Efficacy|2|||
154996612|NCT02932306|559413132|FG000|Overall Study|Worsening condition|2|||
154996613|NCT02932306|559413133|FG001|Overall Study|Worsening condition|0|||
154996614|NCT02932306|559413132|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
154996615|NCT02932306|559413133|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
154996616|NCT03559400|559413134|FG000|Overall Study|Lost to Follow-up|9|||
154996617|NCT03559400|559413135|FG001|Overall Study|Lost to Follow-up|7|||
154996618|NCT03559400|559413134|FG000|Overall Study|Death|0|||
154996619|NCT03559400|559413135|FG001|Overall Study|Death|2|||
154996620|NCT03323437|559413138|FG000|Overall Study|Withdrawal by Subject|0|||
154996621|NCT03323437|559413139|FG001|Overall Study|Withdrawal by Subject|4|||
154996622|NCT01473524|559413142|FG000|DB Phase|Adverse Event|4|||
154996623|NCT01473524|559413143|FG001|DB Phase|Adverse Event|8|||
154996624|NCT01473524|559413144|FG002|DB Phase|Adverse Event|2|||
154996625|NCT01473524|559413145|FG003|DB Phase|Adverse Event|0|||
154996626|NCT01473524|559413146|FG004|DB Phase|Adverse Event|0|||
154996627|NCT01473524|559413147|FG005|DB Phase|Adverse Event|0|||
154996628|NCT01473524|559413142|FG000|DB Phase|Death|1|||
154996629|NCT01473524|559413143|FG001|DB Phase|Death|0|||
154996630|NCT01473524|559413144|FG002|DB Phase|Death|0|||
154996631|NCT01473524|559413145|FG003|DB Phase|Death|0|||
154996632|NCT01473524|559413146|FG004|DB Phase|Death|0|||
154996633|NCT01473524|559413147|FG005|DB Phase|Death|0|||
154996634|NCT01473524|559413142|FG000|DB Phase|Withdrawal by Subject|2|||
154996635|NCT01473524|559413143|FG001|DB Phase|Withdrawal by Subject|1|||
154996636|NCT01473524|559413144|FG002|DB Phase|Withdrawal by Subject|1|||
154996637|NCT01473524|559413145|FG003|DB Phase|Withdrawal by Subject|0|||
154996638|NCT01473524|559413146|FG004|DB Phase|Withdrawal by Subject|0|||
154996639|NCT01473524|559413147|FG005|DB Phase|Withdrawal by Subject|0|||
154996640|NCT01473524|559413142|FG000|LTSE Phase|Withdrawal by Subject|0|||
154996641|NCT01473524|559413143|FG001|LTSE Phase|Withdrawal by Subject|0|||
154996642|NCT01473524|559413144|FG002|LTSE Phase|Withdrawal by Subject|0|||
154996643|NCT01473524|559413145|FG003|LTSE Phase|Withdrawal by Subject|3|||
154996644|NCT01473524|559413146|FG004|LTSE Phase|Withdrawal by Subject|3|||
154996645|NCT01473524|559413147|FG005|LTSE Phase|Withdrawal by Subject|6|||
154996646|NCT01473524|559413142|FG000|LTSE Phase|Death|0|||
154996647|NCT01473524|559413143|FG001|LTSE Phase|Death|0|||
154996648|NCT01473524|559413144|FG002|LTSE Phase|Death|0|||
154996649|NCT01473524|559413145|FG003|LTSE Phase|Death|0|||
154996650|NCT01473524|559413146|FG004|LTSE Phase|Death|1|||
154996651|NCT01473524|559413147|FG005|LTSE Phase|Death|0|||
154996652|NCT01473524|559413142|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
154996653|NCT01473524|559413143|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
154996654|NCT01473524|559413144|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
154996655|NCT01473524|559413145|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
154996656|NCT01473524|559413146|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
154996657|NCT01473524|559413147|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
154996658|NCT01473524|559413142|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
154996659|NCT01473524|559413143|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
154996660|NCT01473524|559413144|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
154996661|NCT01473524|559413145|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
154996662|NCT01473524|559413146|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
154996663|NCT01473524|559413147|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
154996664|NCT01473524|559413142|FG000|LTSE Phase|Lost to Follow-up|0|||
154996665|NCT01473524|559413143|FG001|LTSE Phase|Lost to Follow-up|0|||
154996666|NCT01473524|559413144|FG002|LTSE Phase|Lost to Follow-up|0|||
154996667|NCT01473524|559413145|FG003|LTSE Phase|Lost to Follow-up|1|||
154996668|NCT01473524|559413146|FG004|LTSE Phase|Lost to Follow-up|3|||
154996669|NCT01473524|559413147|FG005|LTSE Phase|Lost to Follow-up|2|||
154996670|NCT01473524|559413142|FG000|LTSE Phase|Principal Investigator Decision|0|||
154996671|NCT01473524|559413143|FG001|LTSE Phase|Principal Investigator Decision|0|||
154996672|NCT01473524|559413144|FG002|LTSE Phase|Principal Investigator Decision|0|||
154996673|NCT01473524|559413145|FG003|LTSE Phase|Principal Investigator Decision|1|||
154996674|NCT01473524|559413146|FG004|LTSE Phase|Principal Investigator Decision|1|||
154996675|NCT01473524|559413147|FG005|LTSE Phase|Principal Investigator Decision|3|||
154996676|NCT01473524|559413142|FG000|LTSE Phase|Liver Transplantation|0|||
154996677|NCT01473524|559413143|FG001|LTSE Phase|Liver Transplantation|0|||
154996678|NCT01473524|559413144|FG002|LTSE Phase|Liver Transplantation|0|||
154996679|NCT01473524|559413145|FG003|LTSE Phase|Liver Transplantation|0|||
154996680|NCT01473524|559413146|FG004|LTSE Phase|Liver Transplantation|0|||
154996681|NCT01473524|559413147|FG005|LTSE Phase|Liver Transplantation|1|||
154996682|NCT01473524|559413142|FG000|LTSE Phase|Pregnancy|0|||
154996683|NCT01473524|559413143|FG001|LTSE Phase|Pregnancy|0|||
154996684|NCT01473524|559413144|FG002|LTSE Phase|Pregnancy|0|||
154996685|NCT01473524|559413145|FG003|LTSE Phase|Pregnancy|1|||
154996686|NCT01473524|559413146|FG004|LTSE Phase|Pregnancy|0|||
154996687|NCT01473524|559413147|FG005|LTSE Phase|Pregnancy|0|||
154996688|NCT01473524|559413142|FG000|LTSE Phase|Protocol Violation|0|||
154996689|NCT01473524|559413143|FG001|LTSE Phase|Protocol Violation|0|||
154996690|NCT01473524|559413144|FG002|LTSE Phase|Protocol Violation|0|||
154996691|NCT01473524|559413145|FG003|LTSE Phase|Protocol Violation|0|||
154996692|NCT01473524|559413146|FG004|LTSE Phase|Protocol Violation|0|||
154996693|NCT01473524|559413147|FG005|LTSE Phase|Protocol Violation|1|||
154996694|NCT01544179|559413148|FG000|Overall Study|Death|50|||
154996695|NCT01544179|559413149|FG001|Overall Study|Death|37|||
154996696|NCT01544179|559413148|FG000|Overall Study|Lost to Follow-up|0|||
154996697|NCT01544179|559413149|FG001|Overall Study|Lost to Follow-up|1|||
154996698|NCT01544179|559413148|FG000|Overall Study|Adverse Event|0|||
154996699|NCT01544179|559413149|FG001|Overall Study|Adverse Event|1|||
154996700|NCT01544179|559413148|FG000|Overall Study|Withdrawal by Subject|12|||
154996701|NCT01544179|559413149|FG001|Overall Study|Withdrawal by Subject|7|||
154996702|NCT01544179|559413148|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
154996703|NCT01544179|559413149|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
154996704|NCT02278055|559413152|FG000|Overall Study|Adverse Event|1|||
154996705|NCT02278055|559413152|FG000|Overall Study|Lost to Follow-up|1|||
154996706|NCT02278055|559413152|FG000|Overall Study|Withdrawal by Subject|2|||
154996707|NCT02278055|559413152|FG000|Overall Study|Progressive Disease|4|||
154996708|NCT01934335|559413153|FG000|Overall Study|Withdrawal by Subject|1|||
154996709|NCT01934335|559413154|FG001|Overall Study|Withdrawal by Subject|1|||
154996710|NCT01111825|559413155|FG000|Overall Study|Withdrawal by Subject|0|||
154996711|NCT01111825|559413156|FG001|Overall Study|Withdrawal by Subject|0|||
154996712|NCT01111825|559413157|FG002|Overall Study|Withdrawal by Subject|1|||
154996713|NCT01111825|559413158|FG003|Overall Study|Withdrawal by Subject|0|||
154996714|NCT01111825|559413155|FG000|Overall Study|Lost to Follow-up|0|||
154996715|NCT01111825|559413156|FG001|Overall Study|Lost to Follow-up|0|||
154996716|NCT01111825|559413157|FG002|Overall Study|Lost to Follow-up|3|||
154996717|NCT01111825|559413158|FG003|Overall Study|Lost to Follow-up|1|||
154996718|NCT01111825|559413155|FG000|Overall Study|Adverse Event|2|||
154996719|NCT01111825|559413156|FG001|Overall Study|Adverse Event|1|||
154996720|NCT01111825|559413157|FG002|Overall Study|Adverse Event|4|||
154996721|NCT01111825|559413158|FG003|Overall Study|Adverse Event|0|||
154996722|NCT01111825|559413155|FG000|Overall Study|Disease Progression|1|||
154996723|NCT01111825|559413156|FG001|Overall Study|Disease Progression|0|||
154996724|NCT01111825|559413157|FG002|Overall Study|Disease Progression|0|||
154996725|NCT01111825|559413158|FG003|Overall Study|Disease Progression|0|||
154996726|NCT01111825|559413155|FG000|Overall Study|Discontinuation by Sponsor|0|||
154996727|NCT01111825|559413156|FG001|Overall Study|Discontinuation by Sponsor|0|||
154996728|NCT01111825|559413157|FG002|Overall Study|Discontinuation by Sponsor|0|||
154996729|NCT01111825|559413158|FG003|Overall Study|Discontinuation by Sponsor|20|||
154996730|NCT01377987|559413159|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
154996731|NCT01377987|559413160|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
154996732|NCT02121392|559413162|FG000|Prior to Intervention|Protocol Violation|40|||
154996733|NCT02121392|559413163|FG001|Prior to Intervention|Protocol Violation|35|||
154996734|NCT02121392|559413162|FG000|Prior to Intervention|Withdrawal by Subject|8|||
154996735|NCT02121392|559413163|FG001|Prior to Intervention|Withdrawal by Subject|6|||
154996736|NCT02121392|559413162|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
154996737|NCT02121392|559413163|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
154996738|NCT02121392|559413162|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
154996739|NCT02121392|559413163|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
154996740|NCT01352416|559413164|FG000|Overall Study|Physician Decision|1|||
154996741|NCT01352416|559413165|FG001|Overall Study|Physician Decision|2|||
154996742|NCT01352416|559413166|FG002|Overall Study|Physician Decision|2|||
154996743|NCT01352416|559413167|FG003|Overall Study|Physician Decision|1|||
154996744|NCT02087189|559413180|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
154996745|NCT01458106|559413183|FG000|Overall Study|Withdrawal by Subject|2|||
154996746|NCT01458106|559413184|FG001|Overall Study|Withdrawal by Subject|0|||
154996747|NCT01458106|559413183|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
154996748|NCT01458106|559413184|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
154996749|NCT01458106|559413183|FG000|Overall Study|Withdrawn Per Protocol|0|||
154996750|NCT01458106|559413184|FG001|Overall Study|Withdrawn Per Protocol|1|||
154996751|NCT04428333|559413188|FG000|Overall Study|Physician Decision|5|||
154996752|NCT04428333|559413189|FG001|Overall Study|Physician Decision|6|||
154996753|NCT04428333|559413188|FG000|Overall Study|Withdrawal by Subject|1|||
154996754|NCT04428333|559413189|FG001|Overall Study|Withdrawal by Subject|3|||
154996755|NCT04428333|559413188|FG000|Overall Study|Study Terminated By Sponsor|14|||
154996756|NCT04428333|559413189|FG001|Overall Study|Study Terminated By Sponsor|16|||
154996757|NCT04853992|559413190|FG000|Treatment Period A|Adverse Event|0|||
154996758|NCT04853992|559413191|FG001|Treatment Period A|Adverse Event|1|||
154996759|NCT04853992|559413190|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
154996760|NCT04853992|559413191|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
154996761|NCT02351960|559413192|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
154996762|NCT02351960|559413193|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
154996763|NCT02351960|559413192|FG000|Overall Study|Voluntary Withdrawal|5|||
154996764|NCT02351960|559413193|FG001|Overall Study|Voluntary Withdrawal|4|||
154996765|NCT02351960|559413192|FG000|Overall Study|Significant Protocol Deviation|0|||
154996766|NCT02351960|559413193|FG001|Overall Study|Significant Protocol Deviation|5|||
154996767|NCT01094886|559413194|FG000|Overall Study|Adverse Event|2|||
154996768|NCT01094886|559413194|FG000|Overall Study|Withdrawal by Subject|5|||
154996769|NCT03866902|559413195|FG000|Overall Study|Lost to Follow-up|98|||
154996770|NCT03866902|559413196|FG001|Overall Study|Lost to Follow-up|82|||
154996771|NCT03866902|559413195|FG000|Overall Study|Pregnancy|18|||
154996772|NCT03866902|559413196|FG001|Overall Study|Pregnancy|24|||
154996773|NCT02092467|559413201|FG000|Overall Study|Death|49|||
154996774|NCT02092467|559413202|FG001|Overall Study|Death|66|||
154996775|NCT02092467|559413203|FG002|Overall Study|Death|38|||
154996776|NCT02092467|559413201|FG000|Overall Study|Lost to Follow-up|38|||
154996777|NCT02092467|559413202|FG001|Overall Study|Lost to Follow-up|35|||
154996778|NCT02092467|559413203|FG002|Overall Study|Lost to Follow-up|40|||
154996779|NCT02092467|559413201|FG000|Overall Study|Global Deterioration of Health Status|1|||
154996780|NCT02092467|559413202|FG001|Overall Study|Global Deterioration of Health Status|0|||
154996781|NCT02092467|559413203|FG002|Overall Study|Global Deterioration of Health Status|0|||
154996782|NCT02092467|559413201|FG000|Overall Study|Other|32|||
154996783|NCT02092467|559413202|FG001|Overall Study|Other|30|||
154996784|NCT02092467|559413203|FG002|Overall Study|Other|24|||
154996785|NCT02092467|559413201|FG000|Overall Study|Withdrawal by Subject|282|||
154996786|NCT02092467|559413202|FG001|Overall Study|Withdrawal by Subject|327|||
154996787|NCT02092467|559413203|FG002|Overall Study|Withdrawal by Subject|289|||
154996788|NCT02092467|559413201|FG000|Overall Study|Randomized but not treated|2|||
154996789|NCT02092467|559413202|FG001|Overall Study|Randomized but not treated|1|||
154996790|NCT02092467|559413203|FG002|Overall Study|Randomized but not treated|7|||
154996791|NCT00371397|559413204|FG000|Session 1|Withdrawal by Subject|1|||
154996792|NCT00371397|559413205|FG001|Session 1|Withdrawal by Subject|0|||
154996793|NCT00371397|559413206|FG002|Session 1|Withdrawal by Subject|0|||
155122592|NCT00098722|559879807|FG004|Observation Phase|Death|0|||
155122593|NCT00098722|559879808|FG005|Observation Phase|Death|5|||
154996794|NCT00371397|559413207|FG003|Session 1|Withdrawal by Subject|0|||
154996795|NCT00371397|559413208|FG004|Session 1|Withdrawal by Subject|0|||
155122594|NCT00098722|559879809|FG006|Observation Phase|Death|3|||
155122595|NCT00098722|559879803|FG000|Observation Phase|Lack of Efficacy|0|||
155122596|NCT00098722|559879804|FG001|Observation Phase|Lack of Efficacy|0|||
155122597|NCT00098722|559879805|FG002|Observation Phase|Lack of Efficacy|0|||
154996796|NCT00371397|559413209|FG005|Session 1|Withdrawal by Subject|0|||
154996797|NCT00371397|559413210|FG006|Session 1|Withdrawal by Subject|0|||
154996798|NCT00371397|559413211|FG007|Session 1|Withdrawal by Subject|1|||
154996799|NCT00371397|559413212|FG008|Session 1|Withdrawal by Subject|0|||
154996800|NCT00371397|559413213|FG009|Session 1|Withdrawal by Subject|0|||
154996801|NCT00371397|559413214|FG010|Session 1|Withdrawal by Subject|0|||
154996802|NCT00371397|559413215|FG011|Session 1|Withdrawal by Subject|0|||
154996803|NCT01284621|559413216|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
154996804|NCT01284621|559413217|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
154996805|NCT01284621|559413218|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
154996806|NCT01284621|559413219|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
154996807|NCT01284621|559413220|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
154996808|NCT01284621|559413221|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
154996809|NCT02377427|559413224|FG000|Part A (Up to Week 20)|Physician Decision|1|||
154996810|NCT02377427|559413225|FG001|Part A (Up to Week 20)|Physician Decision|0|||
154996811|NCT02377427|559413226|FG002|Part A (Up to Week 20)|Physician Decision|0|||
154996812|NCT02377427|559413227|FG003|Part A (Up to Week 20)|Physician Decision|0|||
154996813|NCT02377427|559413228|FG004|Part A (Up to Week 20)|Physician Decision|0|||
154996814|NCT02377427|559413224|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
154996815|NCT02377427|559413225|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
154996816|NCT02377427|559413226|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
154996817|NCT02377427|559413227|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
154996818|NCT02377427|559413228|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
154996819|NCT02377427|559413224|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
154996820|NCT02377427|559413225|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
154996821|NCT02377427|559413226|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
154996822|NCT02377427|559413227|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
154996823|NCT02377427|559413228|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
154996824|NCT02377427|559413224|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
154996825|NCT02377427|559413225|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
154996826|NCT02377427|559413226|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
154996827|NCT02377427|559413227|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
154996828|NCT02377427|559413228|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
154996829|NCT02293863|559413229|FG000|Overall Study|Death|4|||
154996830|NCT02293863|559413230|FG001|Overall Study|Death|6|||
154996831|NCT02293863|559413231|FG002|Overall Study|Death|4|||
154996832|NCT02293863|559413229|FG000|Overall Study|Lost to Follow-up|2|||
154996833|NCT02293863|559413230|FG001|Overall Study|Lost to Follow-up|2|||
154996834|NCT02293863|559413231|FG002|Overall Study|Lost to Follow-up|2|||
154996835|NCT02293863|559413229|FG000|Overall Study|Withdrawal by Subject|3|||
154996836|NCT02293863|559413230|FG001|Overall Study|Withdrawal by Subject|3|||
154996837|NCT02293863|559413231|FG002|Overall Study|Withdrawal by Subject|1|||
154996838|NCT02293863|559413229|FG000|Overall Study|Reason Not Specified|0|||
154996839|NCT02293863|559413230|FG001|Overall Study|Reason Not Specified|2|||
154996840|NCT02293863|559413231|FG002|Overall Study|Reason Not Specified|2|||
154996841|NCT02342639|559413232|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
154996842|NCT02342639|559413233|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
154996843|NCT02342639|559413232|FG000|Overall Study|Protocol Violation|0|||
154996844|NCT02342639|559413233|FG001|Overall Study|Protocol Violation|2|||
154996845|NCT00416884|559413236|FG000|Overall Study|Study terminated due to low accrual|1|||
154996846|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
154996847|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
154996848|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996849|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996850|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996851|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996852|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996853|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996854|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996855|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996856|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996857|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996858|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996859|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
154996860|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
154996861|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
154996862|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155122598|NCT00098722|559879806|FG003|Observation Phase|Lack of Efficacy|0|||
154996863|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155122599|NCT00098722|559879807|FG004|Observation Phase|Lack of Efficacy|0|||
154996864|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996865|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996866|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996867|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
155122600|NCT00098722|559879808|FG005|Observation Phase|Lack of Efficacy|2|||
155122601|NCT00098722|559879809|FG006|Observation Phase|Lack of Efficacy|0|||
154996868|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996869|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996870|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996871|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996872|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996873|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
154996874|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
154996875|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
154996876|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996877|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996878|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996879|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996880|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996881|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996882|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996883|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996884|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996885|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996886|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996887|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
154996888|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
154996889|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
154996890|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996891|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996892|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996893|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996894|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996895|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996896|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996897|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996898|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996899|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996900|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996901|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
154996902|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
154996903|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
154996904|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996905|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996906|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996907|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996908|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996909|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996910|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996911|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996912|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996913|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996914|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996915|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
154996916|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
154996917|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
154996918|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996919|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996920|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996921|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996922|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996923|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996924|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996925|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996926|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996927|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996928|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996929|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
154996930|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
154996931|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
155122602|NCT00098722|559879803|FG000|Observation Phase|Participant defaulted|0|||
155122603|NCT00098722|559879804|FG001|Observation Phase|Participant defaulted|0|||
154996932|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
155122604|NCT00098722|559879805|FG002|Observation Phase|Participant defaulted|0|||
154996933|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996934|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996935|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996936|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996937|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996938|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996939|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996940|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996941|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996942|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996943|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
154996944|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
154996945|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
154996946|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996947|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996948|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996949|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996950|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996951|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996952|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996953|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996954|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996955|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996956|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996957|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
154996958|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
154996959|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
154996960|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996961|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996962|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996963|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996964|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996965|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996966|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996967|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996968|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996969|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996970|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996971|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
154996972|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
154996973|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
154996974|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996975|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996976|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996977|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996978|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996979|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996980|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996981|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155122605|NCT00098722|559879806|FG003|Observation Phase|Participant defaulted|0|||
155122606|NCT00098722|559879807|FG004|Observation Phase|Participant defaulted|0|||
154996982|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996983|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996984|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
154996985|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
155122607|NCT00098722|559879808|FG005|Observation Phase|Participant defaulted|17|||
155122608|NCT00098722|559879809|FG006|Observation Phase|Participant defaulted|4|||
155122609|NCT00098722|559879803|FG000|Observation Phase|Other|0|||
155122610|NCT00098722|559879804|FG001|Observation Phase|Other|0|||
155122611|NCT00098722|559879805|FG002|Observation Phase|Other|0|||
155122612|NCT00098722|559879806|FG003|Observation Phase|Other|0|||
155122613|NCT00098722|559879807|FG004|Observation Phase|Other|0|||
155122614|NCT00098722|559879808|FG005|Observation Phase|Other|21|||
155122615|NCT00098722|559879809|FG006|Observation Phase|Other|10|||
155122616|NCT01657760|559879810|FG000|Overall Study|Withdrawal by Subject|0|||
155122617|NCT01657760|559879811|FG001|Overall Study|Withdrawal by Subject|0|||
155122618|NCT01657760|559879812|FG002|Overall Study|Withdrawal by Subject|0|||
155122619|NCT01657760|559879813|FG003|Overall Study|Withdrawal by Subject|1|||
155122620|NCT01657760|559879810|FG000|Overall Study|Physician Decision|1|||
155122621|NCT01657760|559879811|FG001|Overall Study|Physician Decision|1|||
155122622|NCT01657760|559879812|FG002|Overall Study|Physician Decision|1|||
154996986|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
154996987|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
154996988|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996989|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996990|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996991|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996992|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996993|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996994|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996995|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996996|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996997|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996998|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154996999|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
154997000|NCT03982199|559413239|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
154997001|NCT03982199|559413240|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
154997002|NCT03982199|559413241|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997003|NCT03982199|559413242|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997004|NCT03982199|559413243|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997005|NCT03982199|559413244|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997006|NCT03982199|559413245|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997007|NCT03982199|559413246|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997008|NCT03982199|559413247|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997009|NCT03982199|559413248|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997010|NCT03982199|559413249|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997011|NCT03982199|559413250|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997012|NCT03982199|559413251|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997013|NCT03982199|559413252|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
154997014|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997015|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997016|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997017|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
154997018|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997019|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997020|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997021|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997022|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997023|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997024|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997025|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997026|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997027|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
154997028|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997029|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997030|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
154997031|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997032|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997033|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997034|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997035|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997036|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997037|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997038|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997039|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997040|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997041|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
154997042|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997043|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
155122623|NCT01657760|559879813|FG003|Overall Study|Physician Decision|2|||
155122624|NCT04599166|559879825|FG000|Overall Study|Technological failure connecting to study app|80|||
155122625|NCT01974752|559879826|FG000|Overall Study|Death|33|||
154997044|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
154997045|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997046|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997047|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997048|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997049|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997050|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997051|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997052|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997053|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997054|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997055|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
154997056|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997057|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997058|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
154997059|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
154997060|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997061|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997062|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997063|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997064|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997065|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997066|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997067|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997068|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997069|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
154997070|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997071|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997072|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997073|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
154997074|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997075|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997076|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997077|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997078|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997079|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997080|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997081|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997082|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997083|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
154997084|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997085|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997086|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
154997087|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
154997088|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
155122626|NCT01974752|559879827|FG001|Overall Study|Death|11|||
155122627|NCT01974752|559879826|FG000|Overall Study|Lost to Follow-up|2|||
155122628|NCT01974752|559879827|FG001|Overall Study|Lost to Follow-up|0|||
155122629|NCT01974752|559879826|FG000|Overall Study|Withdrawal by Subject|2|||
155122630|NCT01974752|559879827|FG001|Overall Study|Withdrawal by Subject|3|||
155122631|NCT01974752|559879826|FG000|Overall Study|Other Eligibility Criteria|0|||
155122632|NCT01974752|559879827|FG001|Overall Study|Other Eligibility Criteria|1|||
154997089|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997090|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997091|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997092|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997093|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997094|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997095|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997096|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997097|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
154997098|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997099|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997100|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
155122633|NCT02317809|559879828|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
155122634|NCT02317809|559879829|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
154997101|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997102|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997103|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997104|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997105|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997106|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
154997107|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997108|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997109|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997110|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997111|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
154997112|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997113|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997114|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997115|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997116|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997117|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997118|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997119|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997120|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
154997121|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997122|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997123|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997124|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997125|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
154997126|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997127|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997128|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997129|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997130|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997131|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997132|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997133|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997134|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
154997135|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997136|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997137|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997138|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997139|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
154997140|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997141|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997142|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997143|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997144|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997145|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997146|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997147|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997148|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
154997149|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997150|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997151|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997152|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997153|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
154997154|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997155|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997156|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997157|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997158|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997159|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
155122635|NCT02317809|559879828|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
155122636|NCT02317809|559879829|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
155122637|NCT02435680|559879830|FG000|Overall Study|Physician Decision|3|||
155122638|NCT02435680|559879831|FG001|Overall Study|Physician Decision|0|||
155122639|NCT02435680|559879832|FG002|Overall Study|Physician Decision|0|||
155177820|NCT00046891|560089418|FG000|Overall Study|Cancels|5|||
155177821|NCT00046891|560089419|FG001|Overall Study|Cancels|9|||
155177822|NCT00046891|560089418|FG000|Overall Study|Ineligible|1|||
155177823|NCT00046891|560089419|FG001|Overall Study|Ineligible|1|||
155177824|NCT00046891|560089418|FG000|Overall Study|Withdrawal by Subject|18|||
155177825|NCT00046891|560089419|FG001|Overall Study|Withdrawal by Subject|15|||
155177826|NCT00046891|560089418|FG000|Overall Study|Adverse Event|5|||
155177827|NCT00046891|560089419|FG001|Overall Study|Adverse Event|5|||
155177828|NCT02158364|560089425|FG000|Overall Study|Case report forms uncollected|10|||
155177829|NCT02158364|560089425|FG000|Overall Study|Protocol Deviation|50|||
154997160|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997161|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997162|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
154997163|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997164|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997165|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997166|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997167|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
154997168|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997169|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997170|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997171|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
155122640|NCT02435680|559879830|FG000|Overall Study|subject / guardian decision|0|||
155122641|NCT02435680|559879831|FG001|Overall Study|subject / guardian decision|3|||
155122642|NCT02435680|559879832|FG002|Overall Study|subject / guardian decision|2|||
155122643|NCT02435680|559879830|FG000|Overall Study|Adverse Event|8|||
155122644|NCT02435680|559879831|FG001|Overall Study|Adverse Event|3|||
155122645|NCT02435680|559879832|FG002|Overall Study|Adverse Event|2|||
155122646|NCT02435680|559879830|FG000|Overall Study|progressive disease|10|||
155122647|NCT02435680|559879831|FG001|Overall Study|progressive disease|7|||
155122648|NCT02435680|559879832|FG002|Overall Study|progressive disease|11|||
155122649|NCT02435680|559879830|FG000|Overall Study|not treated|0|||
155122650|NCT02435680|559879831|FG001|Overall Study|not treated|0|||
155122651|NCT02435680|559879832|FG002|Overall Study|not treated|1|||
155122652|NCT01994863|559879835|FG000|Period 1|Adverse Event|4|||
155122653|NCT01994863|559879836|FG001|Period 1|Adverse Event|0|||
155122654|NCT01994863|559879835|FG000|Period 1|Withdrawal by Subject|1|||
155122655|NCT01994863|559879836|FG001|Period 1|Withdrawal by Subject|0|||
155122656|NCT01994863|559879835|FG000|Period 1|Trial stopped by sponsor|1|||
155122657|NCT01994863|559879836|FG001|Period 1|Trial stopped by sponsor|3|||
155122658|NCT01994863|559879835|FG000|Period 1|Lack of Efficacy|1|||
155122659|NCT01994863|559879836|FG001|Period 1|Lack of Efficacy|0|||
155122660|NCT01994863|559879835|FG000|Period 2|Adverse Event|0|||
155122661|NCT01994863|559879836|FG001|Period 2|Adverse Event|1|||
155122662|NCT01994863|559879835|FG000|Period 2|Lack of Efficacy|0|||
155122663|NCT01994863|559879836|FG001|Period 2|Lack of Efficacy|2|||
155122664|NCT01994863|559879835|FG000|Period 2|Withdrawal by Subject|1|||
155122665|NCT01994863|559879836|FG001|Period 2|Withdrawal by Subject|1|||
155122666|NCT02088073|559879837|FG000|Acute Phase|Withdrawal by Subject|5|||
155122667|NCT02088073|559879838|FG001|Acute Phase|Withdrawal by Subject|0|||
155122668|NCT02088073|559879839|FG002|Acute Phase|Withdrawal by Subject|0|||
155122669|NCT02088073|559879840|FG003|Acute Phase|Withdrawal by Subject|0|||
155122670|NCT02088073|559879841|FG004|Acute Phase|Withdrawal by Subject|0|||
155122671|NCT02088073|559879837|FG000|Acute Phase|Hyperkalemia|2|||
155122672|NCT02088073|559879838|FG001|Acute Phase|Hyperkalemia|0|||
155122673|NCT02088073|559879839|FG002|Acute Phase|Hyperkalemia|0|||
155122674|NCT02088073|559879840|FG003|Acute Phase|Hyperkalemia|0|||
155122675|NCT02088073|559879841|FG004|Acute Phase|Hyperkalemia|0|||
155122676|NCT02088073|559879837|FG000|Maintanance Phase|Withdrawal by Subject|0|||
155122677|NCT02088073|559879838|FG001|Maintanance Phase|Withdrawal by Subject|2|||
155122678|NCT02088073|559879839|FG002|Maintanance Phase|Withdrawal by Subject|0|||
155122679|NCT02088073|559879840|FG003|Maintanance Phase|Withdrawal by Subject|0|||
155122680|NCT02088073|559879841|FG004|Maintanance Phase|Withdrawal by Subject|0|||
155122681|NCT02088073|559879837|FG000|Maintanance Phase|Adverse Event|0|||
155122682|NCT02088073|559879838|FG001|Maintanance Phase|Adverse Event|0|||
155122683|NCT02088073|559879839|FG002|Maintanance Phase|Adverse Event|3|||
155122684|NCT02088073|559879840|FG003|Maintanance Phase|Adverse Event|0|||
155122685|NCT02088073|559879841|FG004|Maintanance Phase|Adverse Event|1|||
155122686|NCT02088073|559879837|FG000|Maintanance Phase|Physician Decision|0|||
155122687|NCT02088073|559879838|FG001|Maintanance Phase|Physician Decision|0|||
155122688|NCT02088073|559879839|FG002|Maintanance Phase|Physician Decision|0|||
155122689|NCT02088073|559879840|FG003|Maintanance Phase|Physician Decision|0|||
155122690|NCT02088073|559879841|FG004|Maintanance Phase|Physician Decision|1|||
155122691|NCT02088073|559879837|FG000|Maintanance Phase|Sponsor's decision|0|||
155122692|NCT02088073|559879838|FG001|Maintanance Phase|Sponsor's decision|2|||
155177830|NCT00609362|560089426|FG000|Overall Study|Withdrawal by Subject|2|||
155177831|NCT00609362|560089427|FG001|Overall Study|Withdrawal by Subject|1|||
155177832|NCT00609362|560089426|FG000|Overall Study|Adverse Event|1|||
155122693|NCT02088073|559879839|FG002|Maintanance Phase|Sponsor's decision|0|||
155122694|NCT02088073|559879840|FG003|Maintanance Phase|Sponsor's decision|2|||
155122695|NCT02088073|559879841|FG004|Maintanance Phase|Sponsor's decision|1|||
155122696|NCT02088073|559879837|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
155122697|NCT02088073|559879838|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
155122698|NCT02088073|559879839|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
155122699|NCT02088073|559879840|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
155122700|NCT02088073|559879841|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
155122701|NCT02088073|559879837|FG000|Maintanance Phase|Miscellaneous|0|||
155122702|NCT02088073|559879838|FG001|Maintanance Phase|Miscellaneous|2|||
155122703|NCT02088073|559879839|FG002|Maintanance Phase|Miscellaneous|1|||
155122704|NCT02088073|559879840|FG003|Maintanance Phase|Miscellaneous|2|||
155122705|NCT02088073|559879841|FG004|Maintanance Phase|Miscellaneous|1|||
155122706|NCT02088073|559879837|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
155122707|NCT02088073|559879838|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
155122708|NCT02088073|559879839|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
154920462|NCT04579666|559131588|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
154920463|NCT04579666|559131589|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
154920464|NCT04579666|559131590|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
154920465|NCT03290131|559131591|FG000|Overall Study|Adverse Event|22|||
154920466|NCT03290131|559131592|FG001|Overall Study|Adverse Event|57|||
154920467|NCT03290131|559131593|FG002|Overall Study|Adverse Event|11|||
154920468|NCT03290131|559131591|FG000|Overall Study|Withdrawal by Subject|18|||
154920469|NCT03290131|559131592|FG001|Overall Study|Withdrawal by Subject|13|||
154920470|NCT03290131|559131593|FG002|Overall Study|Withdrawal by Subject|8|||
154920471|NCT03290131|559131591|FG000|Overall Study|MS Relapse|2|||
154920472|NCT03290131|559131592|FG001|Overall Study|MS Relapse|1|||
154920473|NCT03290131|559131593|FG002|Overall Study|MS Relapse|0|||
154920474|NCT03290131|559131591|FG000|Overall Study|Unknown reason|0|||
154920475|NCT03290131|559131592|FG001|Overall Study|Unknown reason|1|||
154920476|NCT03290131|559131593|FG002|Overall Study|Unknown reason|0|||
154920477|NCT03099096|559131594|FG000|Overall Study|Adverse Event|1|||
154920478|NCT03099096|559131594|FG000|Overall Study|Physician Decision|1|||
154920479|NCT00361504|559131595|FG000|Overall Study|Withdrawal by Subject|94|||
154920480|NCT00361504|559131596|FG001|Overall Study|Withdrawal by Subject|31|||
154920481|NCT00361504|559131595|FG000|Overall Study|Lost to Follow-up|40|||
154920482|NCT00361504|559131596|FG001|Overall Study|Lost to Follow-up|7|||
154920483|NCT00361504|559131595|FG000|Overall Study|Adverse Event|203|||
154920484|NCT00361504|559131596|FG001|Overall Study|Adverse Event|82|||
154920485|NCT00361504|559131595|FG000|Overall Study|Lack of Efficacy|72|||
154920486|NCT00361504|559131596|FG001|Overall Study|Lack of Efficacy|7|||
154920487|NCT00361504|559131595|FG000|Overall Study|Resolution of Pain|2|||
154920488|NCT00361504|559131596|FG001|Overall Study|Resolution of Pain|0|||
154920489|NCT00361504|559131595|FG000|Overall Study|Study medication non compliant|42|||
154920490|NCT00361504|559131596|FG001|Overall Study|Study medication non compliant|15|||
154920491|NCT00361504|559131595|FG000|Overall Study|All other|28|||
154920492|NCT00361504|559131596|FG001|Overall Study|All other|3|||
154920493|NCT01374516|559131597|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
154920494|NCT01374516|559131598|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
154920495|NCT01374516|559131597|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
154920496|NCT01374516|559131598|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
154920497|NCT01374516|559131597|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
154920498|NCT01374516|559131598|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
154920499|NCT01374516|559131597|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
154920500|NCT01374516|559131598|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
154920501|NCT01374516|559131597|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
154920502|NCT01374516|559131598|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
154920503|NCT01374516|559131597|FG000|Surveillance Expansion Period|Protocol Violation|386|||
154920504|NCT01374516|559131598|FG001|Surveillance Expansion Period|Protocol Violation|217|||
154920505|NCT01374516|559131597|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
154920506|NCT01374516|559131598|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
154920507|NCT01374516|559131597|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
154920508|NCT01374516|559131598|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
154920509|NCT01374516|559131597|FG000|Surveillance Expansion Period|Serious adverse event|20|||
155122709|NCT02088073|559879840|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
155122710|NCT02088073|559879841|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
154920510|NCT01374516|559131598|FG001|Surveillance Expansion Period|Serious adverse event|5|||
154920511|NCT02190604|559131605|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920512|NCT02190604|559131606|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920513|NCT02190604|559131607|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920514|NCT02190604|559131608|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920515|NCT02190604|559131609|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920516|NCT02190604|559131610|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920517|NCT02190604|559131611|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154997172|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997173|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
154997174|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997175|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
154997176|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
154997177|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997178|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997179|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997180|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997181|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
154997182|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997183|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997184|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997185|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997186|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997187|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997188|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997189|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997190|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
154997191|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997192|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997193|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997194|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997195|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
154997196|NCT03982199|559413239|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997197|NCT03982199|559413240|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997198|NCT03982199|559413241|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997199|NCT03982199|559413242|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997200|NCT03982199|559413243|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997201|NCT03982199|559413244|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
154997202|NCT03982199|559413245|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997203|NCT03982199|559413246|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
154997204|NCT03982199|559413247|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
154997205|NCT03982199|559413248|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997206|NCT03982199|559413249|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997207|NCT03982199|559413250|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997208|NCT03982199|559413251|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997209|NCT03982199|559413252|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
154997210|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997211|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997212|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997213|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997214|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997215|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997216|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997217|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997218|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
154997219|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
154997220|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
154997221|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
154997222|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
154997223|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
154997224|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997225|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997226|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997227|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997228|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997229|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997230|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997231|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
155122711|NCT02088073|559879837|FG000|Maintanance Phase|Subject compliance|0|||
155122712|NCT02088073|559879838|FG001|Maintanance Phase|Subject compliance|1|||
155122713|NCT02088073|559879839|FG002|Maintanance Phase|Subject compliance|0|||
155122714|NCT02088073|559879840|FG003|Maintanance Phase|Subject compliance|0|||
155122715|NCT02088073|559879841|FG004|Maintanance Phase|Subject compliance|0|||
155122716|NCT02788201|559879847|FG000|Overall Study|Death|1|||
155122717|NCT02788201|559879848|FG001|Overall Study|Death|1|||
155122718|NCT02788201|559879849|FG002|Overall Study|Death|1|||
155122719|NCT02788201|559879850|FG003|Overall Study|Death|1|||
155122720|NCT02788201|559879851|FG004|Overall Study|Death|0|||
154920518|NCT02190604|559131612|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920519|NCT02190604|559131613|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920520|NCT02190604|559131614|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920521|NCT02190604|559131615|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920522|NCT02190604|559131616|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920523|NCT02190604|559131617|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920524|NCT02190604|559131618|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920525|NCT02190604|559131619|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
154920526|NCT02190604|559131620|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920527|NCT02190604|559131621|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920528|NCT02190604|559131622|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920529|NCT02190604|559131623|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
154920530|NCT02190604|559131605|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920531|NCT02190604|559131606|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920532|NCT02190604|559131607|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920533|NCT02190604|559131608|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920534|NCT02190604|559131609|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920535|NCT02190604|559131610|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920536|NCT02190604|559131611|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920537|NCT02190604|559131612|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920538|NCT02190604|559131613|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920539|NCT02190604|559131614|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920540|NCT02190604|559131615|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920541|NCT02190604|559131616|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920542|NCT02190604|559131617|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920543|NCT02190604|559131618|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
154920544|NCT02190604|559131619|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920545|NCT02190604|559131620|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920546|NCT02190604|559131621|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920547|NCT02190604|559131622|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920548|NCT02190604|559131623|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
154920549|NCT02797951|559131624|FG000|Overall Study|Adverse Event|4|||
154920550|NCT02797951|559131624|FG000|Overall Study|Death|1|||
154920551|NCT02797951|559131624|FG000|Overall Study|Lack of Efficacy|19|||
154920552|NCT02797951|559131624|FG000|Overall Study|Lost to Follow-up|4|||
154920553|NCT02797951|559131624|FG000|Overall Study|Physician Decision|6|||
154920554|NCT02797951|559131624|FG000|Overall Study|Withdrawal by Subject|15|||
154920555|NCT00814502|559131625|FG000|Overall Study|Adverse Event|1|||
154920556|NCT00814502|559131626|FG001|Overall Study|Adverse Event|0|||
154920557|NCT00814502|559131625|FG000|Overall Study|Withdrawal by Subject|0|||
154920558|NCT00814502|559131626|FG001|Overall Study|Withdrawal by Subject|2|||
154920559|NCT01901393|559131627|FG000|Overall Study|Adverse Event|1|||
154920560|NCT01901393|559131628|FG001|Overall Study|Adverse Event|0|||
154920561|NCT00265109|559131635|FG000|Overall Study|Withdrawal by Subject|5|||
154920562|NCT00265109|559131635|FG000|Overall Study|Adverse Event|1|||
154920563|NCT01757821|559131636|FG000|Overall Study|Adverse Event|1|||
154920564|NCT00499694|559131639|FG000|Overall Study|Patient never received treatment.|1|||
154920565|NCT03604159|559131640|FG000|Overall Study|Lost to Follow-up|6|||
154920566|NCT03604159|559131641|FG001|Overall Study|Lost to Follow-up|7|||
154920567|NCT02243306|559131648|FG000|Overall Study|Adverse Event|0|||
154920568|NCT02243306|559131649|FG001|Overall Study|Adverse Event|1|||
154920569|NCT02243306|559131648|FG000|Overall Study|Other: Reached stopping criteria|0|||
154920570|NCT02243306|559131649|FG001|Overall Study|Other: Reached stopping criteria|1|||
155122721|NCT02788201|559879852|FG005|Overall Study|Death|1|||
155122722|NCT02788201|559879847|FG000|Overall Study|Ineligible|0|||
155122723|NCT02788201|559879848|FG001|Overall Study|Ineligible|0|||
154920571|NCT02243306|559131648|FG000|Overall Study|Physician Decision|0|||
154920572|NCT02243306|559131649|FG001|Overall Study|Physician Decision|1|||
154920573|NCT04236986|559131654|FG000|Overall Study|Withdrawal by Subject|3|||
154920574|NCT04236986|559131655|FG001|Overall Study|Withdrawal by Subject|1|||
154920575|NCT00307736|559131658|FG000|Overall Study|Adverse Event|0|||
154920576|NCT00307736|559131659|FG001|Overall Study|Adverse Event|0|||
154920577|NCT00307736|559131660|FG002|Overall Study|Adverse Event|1|||
155122724|NCT02788201|559879849|FG002|Overall Study|Ineligible|0|||
155122725|NCT02788201|559879850|FG003|Overall Study|Ineligible|0|||
155122726|NCT02788201|559879851|FG004|Overall Study|Ineligible|0|||
155122727|NCT02788201|559879852|FG005|Overall Study|Ineligible|1|||
155122728|NCT02788201|559879847|FG000|Overall Study|Withdrawal by Subject|0|||
155122729|NCT02788201|559879848|FG001|Overall Study|Withdrawal by Subject|0|||
155122730|NCT02788201|559879849|FG002|Overall Study|Withdrawal by Subject|0|||
155122731|NCT02788201|559879850|FG003|Overall Study|Withdrawal by Subject|0|||
155122732|NCT02788201|559879851|FG004|Overall Study|Withdrawal by Subject|0|||
155122733|NCT02788201|559879852|FG005|Overall Study|Withdrawal by Subject|1|||
155122734|NCT02969590|559879853|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
155122735|NCT02969590|559879854|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
155122736|NCT02969590|559879855|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
155122737|NCT00186537|559879856|FG000|Overall Study|Withdrawal by Subject|4|||
155122738|NCT00186537|559879857|FG001|Overall Study|Withdrawal by Subject|0|||
155122739|NCT00186537|559879858|FG002|Overall Study|Withdrawal by Subject|3|||
155122740|NCT00186537|559879856|FG000|Overall Study|ALT > 1.5 x ULN|3|||
155122741|NCT00186537|559879857|FG001|Overall Study|ALT > 1.5 x ULN|0|||
154997232|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997233|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
154997234|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997235|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997236|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997237|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
154997238|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997239|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997240|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997241|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997242|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997243|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997244|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997245|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997246|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997247|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997248|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997249|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997250|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
154997251|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
154997252|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997253|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997254|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997255|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997256|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997257|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997258|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997259|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
155122742|NCT00186537|559879858|FG002|Overall Study|ALT > 1.5 x ULN|0|||
155122743|NCT01765426|559879861|FG000|Overall Study|Lost to Follow-up|0|||
155122744|NCT01765426|559879862|FG001|Overall Study|Lost to Follow-up|1|||
155122745|NCT01765426|559879863|FG002|Overall Study|Lost to Follow-up|0|||
155122746|NCT01765426|559879864|FG003|Overall Study|Lost to Follow-up|0|||
155122747|NCT01510184|559879865|FG000|Overall Study|Sponsor discretion|28|||
155122748|NCT01510184|559879866|FG001|Overall Study|Sponsor discretion|28|||
155122749|NCT01510184|559879865|FG000|Overall Study|Death|1|||
155122750|NCT01510184|559879866|FG001|Overall Study|Death|2|||
155122751|NCT01510184|559879865|FG000|Overall Study|Withdrawal by Subject|1|||
155122752|NCT01510184|559879866|FG001|Overall Study|Withdrawal by Subject|4|||
155122753|NCT01510184|559879865|FG000|Overall Study|Other|0|||
155122754|NCT01510184|559879866|FG001|Overall Study|Other|1|||
155122755|NCT01143051|559879867|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
155122756|NCT01143051|559879868|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
155122757|NCT01143051|559879869|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
155122758|NCT01143051|559879870|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
155122759|NCT01143051|559879871|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
155122760|NCT01143051|559879872|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
155122761|NCT01143051|559879867|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
155122762|NCT01143051|559879868|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
155122763|NCT01143051|559879869|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
155122764|NCT01143051|559879870|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
155122765|NCT01143051|559879871|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
155122766|NCT01143051|559879872|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
155122767|NCT02231762|559879876|FG000|Combination Phase|Adverse Event|10|||
155122768|NCT02231762|559879877|FG001|Combination Phase|Adverse Event|0|||
155122769|NCT02231762|559879878|FG002|Combination Phase|Adverse Event|0|||
155122770|NCT02231762|559879879|FG003|Combination Phase|Adverse Event|0|||
155122771|NCT02231762|559879876|FG000|Combination Phase|Withdrawal by Subject|2|||
154920578|NCT00307736|559131661|FG003|Overall Study|Adverse Event|3|||
154920579|NCT00307736|559131658|FG000|Overall Study|Withdrawal by Subject|0|||
154920580|NCT00307736|559131659|FG001|Overall Study|Withdrawal by Subject|0|||
154920581|NCT00307736|559131660|FG002|Overall Study|Withdrawal by Subject|2|||
154920582|NCT00307736|559131661|FG003|Overall Study|Withdrawal by Subject|0|||
154920583|NCT01365182|559131664|FG000|Overall Study|Withdrawal by Subject|10|||
154920584|NCT01365182|559131665|FG001|Overall Study|Withdrawal by Subject|13|||
154920585|NCT01365182|559131666|FG002|Overall Study|Withdrawal by Subject|12|||
154920586|NCT01990339|559131671|FG000|Overall Study|Data Not Available|49|||
154920587|NCT01990339|559131671|FG000|Overall Study|Voluntary Withdrawal|1402|||
154920588|NCT01990339|559131671|FG000|Overall Study|Lost to Follow-up|861|||
154920589|NCT01728194|559131674|FG000|Overall Study|Lost to Follow-up|4|||
154920590|NCT01728194|559131675|FG001|Overall Study|Lost to Follow-up|3|||
154920591|NCT01728194|559131674|FG000|Overall Study|Physician Decision|4|||
154920592|NCT01728194|559131675|FG001|Overall Study|Physician Decision|0|||
154920593|NCT01728194|559131674|FG000|Overall Study|Withdrawal by Subject|7|||
154920594|NCT01728194|559131675|FG001|Overall Study|Withdrawal by Subject|3|||
154920595|NCT01728194|559131674|FG000|Overall Study|Perceived Medication Side Effects|4|||
154920596|NCT01728194|559131675|FG001|Overall Study|Perceived Medication Side Effects|0|||
154920597|NCT01728194|559131674|FG000|Overall Study|Family Member Request|1|||
154920598|NCT01728194|559131675|FG001|Overall Study|Family Member Request|0|||
154920599|NCT02309372|559131676|FG000|Overall Study|Lost to Follow-up|3|||
154920600|NCT02309372|559131677|FG001|Overall Study|Lost to Follow-up|2|||
154920601|NCT00242658|559131678|FG000|Overall Study|Lost to Follow-up|22|||
154920602|NCT00242658|559131679|FG001|Overall Study|Lost to Follow-up|19|||
154920603|NCT02576652|559131684|FG000|Overall Study|Withdrawal by Subject|2|||
154920604|NCT00553319|559131688|FG000|Overall Study|Lost to Follow-up|10|||
154920605|NCT00553319|559131689|FG001|Overall Study|Lost to Follow-up|9|||
154920606|NCT00553319|559131690|FG002|Overall Study|Lost to Follow-up|5|||
154920607|NCT00553319|559131688|FG000|Overall Study|wanted treatment elsewhere|2|||
154920608|NCT00553319|559131689|FG001|Overall Study|wanted treatment elsewhere|1|||
154920609|NCT00553319|559131690|FG002|Overall Study|wanted treatment elsewhere|1|||
154920610|NCT00553319|559131688|FG000|Overall Study|non-compliance|0|||
154920611|NCT00553319|559131689|FG001|Overall Study|non-compliance|0|||
154920612|NCT00553319|559131690|FG002|Overall Study|non-compliance|2|||
154920613|NCT00553319|559131688|FG000|Overall Study|incarceration|1|||
154920614|NCT00553319|559131689|FG001|Overall Study|incarceration|0|||
154920615|NCT00553319|559131690|FG002|Overall Study|incarceration|0|||
154920616|NCT00553319|559131688|FG000|Overall Study|moved|1|||
154920617|NCT00553319|559131689|FG001|Overall Study|moved|0|||
154920618|NCT00553319|559131690|FG002|Overall Study|moved|1|||
154920619|NCT03575975|559131691|FG000|Overall Study|Lost to Follow-up|1|||
154920620|NCT03575975|559131692|FG001|Overall Study|Lost to Follow-up|0|||
154920621|NCT03575975|559131693|FG002|Overall Study|Lost to Follow-up|0|||
154920622|NCT04369742|559131694|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
154920623|NCT04369742|559131695|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
154920624|NCT04369742|559131694|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
154920625|NCT04369742|559131695|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
154920626|NCT00465894|559131696|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
154920627|NCT00465894|559131697|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
154920628|NCT00465894|559131696|FG000|Treatment For 12 Weeks|Family Issues|1|||
154920629|NCT00465894|559131697|FG001|Treatment For 12 Weeks|Family Issues|1|||
154920630|NCT00465894|559131696|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
154920631|NCT00465894|559131697|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
154920632|NCT01349816|559131698|FG000|Overall Study|Withdrawal by Subject|4|||
154920633|NCT01349816|559131698|FG000|Overall Study|Physician Decision|1|||
154920634|NCT01349816|559131698|FG000|Overall Study|Adverse Event|14|||
154920635|NCT01349816|559131698|FG000|Overall Study|Lost to Follow-up|2|||
154920636|NCT01349816|559131698|FG000|Overall Study|Protocol Violation|1|||
154920637|NCT01349816|559131698|FG000|Overall Study|Protocol-specified criteria|8|||
154920638|NCT02451137|559131699|FG000|Overall Study|Randomized but not treated|19|||
154920639|NCT02451137|559131700|FG001|Overall Study|Randomized but not treated|27|||
154920640|NCT02451137|559131699|FG000|Overall Study|Adverse Event|43|||
154920641|NCT02451137|559131700|FG001|Overall Study|Adverse Event|42|||
154920642|NCT02451137|559131699|FG000|Overall Study|Lack of Efficacy|4|||
154920643|NCT02451137|559131700|FG001|Overall Study|Lack of Efficacy|9|||
154920644|NCT02451137|559131699|FG000|Overall Study|Participant decision:discontinue insulin|41|||
154920645|NCT02451137|559131700|FG001|Overall Study|Participant decision:discontinue insulin|43|||
154920646|NCT02451137|559131699|FG000|Overall Study|Hypoglycemia|2|||
154920647|NCT02451137|559131700|FG001|Overall Study|Hypoglycemia|1|||
154920648|NCT02451137|559131699|FG000|Overall Study|Investigator's decision|23|||
154920649|NCT02451137|559131700|FG001|Overall Study|Investigator's decision|19|||
154920650|NCT02451137|559131699|FG000|Overall Study|Lost to Follow-up|53|||
154920651|NCT02451137|559131700|FG001|Overall Study|Lost to Follow-up|61|||
155122772|NCT02231762|559879877|FG001|Combination Phase|Withdrawal by Subject|0|||
154997260|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997261|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997262|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
154997263|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
154997264|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
154997265|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
154997266|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997267|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
155177833|NCT00609362|560089427|FG001|Overall Study|Adverse Event|0|||
154997268|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997269|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997270|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997271|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997272|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997273|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997274|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997275|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997276|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997277|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997278|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
154997279|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
154997280|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997281|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997282|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997283|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997284|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997285|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997286|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997287|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997288|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997289|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997290|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997291|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
154997292|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
154997293|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
154997294|NCT03982199|559413239|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997295|NCT03982199|559413240|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997296|NCT03982199|559413241|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997297|NCT03982199|559413242|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997298|NCT03982199|559413243|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997299|NCT03982199|559413244|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997300|NCT03982199|559413245|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997301|NCT03982199|559413246|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997302|NCT03982199|559413247|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997303|NCT03982199|559413248|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997304|NCT03982199|559413249|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997305|NCT03982199|559413250|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997306|NCT03982199|559413251|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
154997307|NCT03982199|559413252|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
154997308|NCT03433755|559413253|FG000|Overall Study|Lost to Follow-up|1|||
154997309|NCT03433755|559413254|FG001|Overall Study|Lost to Follow-up|0|||
154997310|NCT03433755|559413255|FG002|Overall Study|Lost to Follow-up|0|||
154997311|NCT03433755|559413256|FG003|Overall Study|Lost to Follow-up|0|||
154997312|NCT03433755|559413253|FG000|Overall Study|Decision by Sponsor|1|||
154997313|NCT03433755|559413254|FG001|Overall Study|Decision by Sponsor|0|||
154997314|NCT03433755|559413255|FG002|Overall Study|Decision by Sponsor|0|||
154997315|NCT03433755|559413256|FG003|Overall Study|Decision by Sponsor|0|||
154997316|NCT01565850|559413257|FG000|Overall Study|Adverse Event|0|||
154997317|NCT01565850|559413258|FG001|Overall Study|Adverse Event|1|||
154997318|NCT01565850|559413257|FG000|Overall Study|Lost to Follow-up|12|||
154997319|NCT01565850|559413258|FG001|Overall Study|Lost to Follow-up|4|||
154997320|NCT01565850|559413257|FG000|Overall Study|Investigator's Discretion|2|||
154997321|NCT01565850|559413258|FG001|Overall Study|Investigator's Discretion|1|||
154997322|NCT01565850|559413257|FG000|Overall Study|Participant noncompliance|2|||
154997323|NCT01565850|559413258|FG001|Overall Study|Participant noncompliance|0|||
154997324|NCT01565850|559413257|FG000|Overall Study|Withdrew Consent|4|||
154997325|NCT01565850|559413258|FG001|Overall Study|Withdrew Consent|2|||
154997326|NCT02245412|559414659|FG000|Treatment Period|Death|1|||
155122773|NCT02231762|559879878|FG002|Combination Phase|Withdrawal by Subject|0|||
155122774|NCT02231762|559879879|FG003|Combination Phase|Withdrawal by Subject|0|||
155122775|NCT02231762|559879876|FG000|Combination Phase|Disease Progression|6|||
155122776|NCT02231762|559879877|FG001|Combination Phase|Disease Progression|0|||
155122777|NCT02231762|559879878|FG002|Combination Phase|Disease Progression|0|||
155122778|NCT02231762|559879879|FG003|Combination Phase|Disease Progression|0|||
155122779|NCT02231762|559879876|FG000|Combination Phase|Did not meet inclusion criteria|1|||
155122780|NCT02231762|559879877|FG001|Combination Phase|Did not meet inclusion criteria|0|||
155122781|NCT02231762|559879878|FG002|Combination Phase|Did not meet inclusion criteria|0|||
155122782|NCT02231762|559879879|FG003|Combination Phase|Did not meet inclusion criteria|0|||
155122783|NCT02231762|559879876|FG000|Combination Phase|Protocol Violation|1|||
155122784|NCT02231762|559879877|FG001|Combination Phase|Protocol Violation|0|||
155122785|NCT02231762|559879878|FG002|Combination Phase|Protocol Violation|0|||
155122786|NCT02231762|559879879|FG003|Combination Phase|Protocol Violation|0|||
154997327|NCT02245412|559414660|FG001|Treatment Period|Death|1|||
154997328|NCT02245412|559414661|FG002|Treatment Period|Death|0|||
154997329|NCT02245412|559414659|FG000|Treatment Period|Physician Decision|1|||
154997330|NCT02245412|559414660|FG001|Treatment Period|Physician Decision|1|||
154997331|NCT02245412|559414661|FG002|Treatment Period|Physician Decision|0|||
154997332|NCT02245412|559414659|FG000|Treatment Period|Withdrawal by Subject|2|||
154997333|NCT02245412|559414660|FG001|Treatment Period|Withdrawal by Subject|1|||
154997334|NCT02245412|559414661|FG002|Treatment Period|Withdrawal by Subject|0|||
154997335|NCT02245412|559414659|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
154997336|NCT02245412|559414660|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
154997337|NCT02245412|559414661|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
154997338|NCT02245412|559414659|FG000|Follow-Up Period|Death|4|||
154997339|NCT02245412|559414660|FG001|Follow-Up Period|Death|2|||
154997340|NCT02245412|559414661|FG002|Follow-Up Period|Death|1|||
154997341|NCT02245412|559414659|FG000|Follow-Up Period|Physician Decision|1|||
154997342|NCT02245412|559414660|FG001|Follow-Up Period|Physician Decision|0|||
154997343|NCT02245412|559414661|FG002|Follow-Up Period|Physician Decision|0|||
154997344|NCT02245412|559414659|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
154997345|NCT02245412|559414660|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
154997346|NCT02245412|559414661|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
154997347|NCT01056289|559414662|FG000|Open-label Phase|Adverse Event|29|||
154997348|NCT01056289|559414663|FG001|Open-label Phase|Adverse Event|0|||
154997349|NCT01056289|559414664|FG002|Open-label Phase|Adverse Event|0|||
154997350|NCT01056289|559414665|FG003|Open-label Phase|Adverse Event|0|||
154997351|NCT01056289|559414662|FG000|Open-label Phase|Lost to Follow-up|30|||
154997352|NCT01056289|559414663|FG001|Open-label Phase|Lost to Follow-up|0|||
154997353|NCT01056289|559414664|FG002|Open-label Phase|Lost to Follow-up|0|||
154997354|NCT01056289|559414665|FG003|Open-label Phase|Lost to Follow-up|0|||
154997355|NCT01056289|559414662|FG000|Open-label Phase|Other|9|||
154997356|NCT01056289|559414663|FG001|Open-label Phase|Other|0|||
154997357|NCT01056289|559414664|FG002|Open-label Phase|Other|0|||
154997358|NCT01056289|559414665|FG003|Open-label Phase|Other|0|||
154997359|NCT01056289|559414662|FG000|Open-label Phase|Protocol Violation|6|||
154997360|NCT01056289|559414663|FG001|Open-label Phase|Protocol Violation|0|||
154997361|NCT01056289|559414664|FG002|Open-label Phase|Protocol Violation|0|||
154997362|NCT01056289|559414665|FG003|Open-label Phase|Protocol Violation|0|||
154997363|NCT01056289|559414662|FG000|Open-label Phase|Withdrawal by Subject|26|||
154997364|NCT01056289|559414663|FG001|Open-label Phase|Withdrawal by Subject|0|||
154997365|NCT01056289|559414664|FG002|Open-label Phase|Withdrawal by Subject|0|||
154997366|NCT01056289|559414665|FG003|Open-label Phase|Withdrawal by Subject|0|||
154997367|NCT01056289|559414662|FG000|Open-label Phase|Lack of Efficacy|18|||
154997368|NCT01056289|559414663|FG001|Open-label Phase|Lack of Efficacy|0|||
155122787|NCT02231762|559879876|FG000|Maintenance Phase|Disease progression|0|||
155122788|NCT02231762|559879877|FG001|Maintenance Phase|Disease progression|3|||
155122789|NCT02231762|559879878|FG002|Maintenance Phase|Disease progression|4|||
154997369|NCT01056289|559414664|FG002|Open-label Phase|Lack of Efficacy|0|||
154997370|NCT01056289|559414665|FG003|Open-label Phase|Lack of Efficacy|0|||
154997371|NCT01056289|559414662|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
154997372|NCT01056289|559414663|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
154997373|NCT01056289|559414664|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
154997374|NCT01056289|559414665|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
155122790|NCT02231762|559879879|FG003|Maintenance Phase|Disease progression|3|||
155122791|NCT02231762|559879876|FG000|Maintenance Phase|Adverse Event|0|||
155122792|NCT02231762|559879877|FG001|Maintenance Phase|Adverse Event|0|||
154997375|NCT01056289|559414662|FG000|Double-blind Phase|Adverse Event|0|||
154997376|NCT01056289|559414663|FG001|Double-blind Phase|Adverse Event|1|||
155122793|NCT02231762|559879878|FG002|Maintenance Phase|Adverse Event|1|||
155122794|NCT02231762|559879879|FG003|Maintenance Phase|Adverse Event|2|||
155122795|NCT00989235|559879884|FG000|Overall Study|Death|0|||
154997377|NCT01056289|559414664|FG002|Double-blind Phase|Adverse Event|2|||
154997378|NCT01056289|559414665|FG003|Double-blind Phase|Adverse Event|1|||
155122796|NCT00989235|559879885|FG001|Overall Study|Death|1|||
154997379|NCT01056289|559414662|FG000|Double-blind Phase|Lost to Follow-up|0|||
154997380|NCT01056289|559414663|FG001|Double-blind Phase|Lost to Follow-up|2|||
154997381|NCT01056289|559414664|FG002|Double-blind Phase|Lost to Follow-up|2|||
154997382|NCT01056289|559414665|FG003|Double-blind Phase|Lost to Follow-up|2|||
154997383|NCT01056289|559414662|FG000|Double-blind Phase|Other|0|||
154997384|NCT01056289|559414663|FG001|Double-blind Phase|Other|0|||
154997385|NCT01056289|559414664|FG002|Double-blind Phase|Other|1|||
154997386|NCT01056289|559414665|FG003|Double-blind Phase|Other|2|||
154997387|NCT01056289|559414662|FG000|Double-blind Phase|Protocol Violation|0|||
154997388|NCT01056289|559414663|FG001|Double-blind Phase|Protocol Violation|0|||
154997389|NCT01056289|559414664|FG002|Double-blind Phase|Protocol Violation|1|||
154997390|NCT01056289|559414665|FG003|Double-blind Phase|Protocol Violation|1|||
154997391|NCT01056289|559414662|FG000|Double-blind Phase|Withdrawal by Subject|0|||
154997392|NCT01056289|559414663|FG001|Double-blind Phase|Withdrawal by Subject|0|||
154997393|NCT01056289|559414664|FG002|Double-blind Phase|Withdrawal by Subject|4|||
154997394|NCT01056289|559414665|FG003|Double-blind Phase|Withdrawal by Subject|2|||
154997395|NCT01056289|559414662|FG000|Double-blind Phase|Discontinuation symptom|0|||
154997396|NCT01056289|559414663|FG001|Double-blind Phase|Discontinuation symptom|1|||
154997397|NCT01056289|559414664|FG002|Double-blind Phase|Discontinuation symptom|2|||
154997398|NCT01056289|559414665|FG003|Double-blind Phase|Discontinuation symptom|2|||
154997399|NCT01056289|559414662|FG000|Double-blind Phase|Physician Decision|0|||
154997400|NCT01056289|559414663|FG001|Double-blind Phase|Physician Decision|0|||
154997401|NCT01056289|559414664|FG002|Double-blind Phase|Physician Decision|1|||
154997402|NCT01056289|559414665|FG003|Double-blind Phase|Physician Decision|0|||
154997403|NCT01392963|559414672|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
154997404|NCT01392963|559414673|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
154997405|NCT01392963|559414672|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
154997406|NCT01392963|559414673|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
154997407|NCT01392963|559414672|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
154997408|NCT01392963|559414673|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
154997409|NCT00270855|559414674|FG000|Overall Study|Withdrawal by Subject|8|||
154997410|NCT00270855|559414675|FG001|Overall Study|Withdrawal by Subject|8|||
154997411|NCT00450801|559414680|FG000|Overall Study|Death|1|||
154997412|NCT00324649|559414681|FG000|Overall Study|Adverse Event|1|||
154997413|NCT00324649|559414682|FG001|Overall Study|Adverse Event|4|||
154997414|NCT00324649|559414681|FG000|Overall Study|Withdrawal by Subject|0|||
154997415|NCT00324649|559414682|FG001|Overall Study|Withdrawal by Subject|1|||
154997416|NCT00324649|559414681|FG000|Overall Study|Noncompliance|1|||
154997417|NCT00324649|559414682|FG001|Overall Study|Noncompliance|0|||
154997418|NCT01396512|559414685|FG000|Overall Study|Withdrawal by Subject|0|||
154997419|NCT01396512|559414686|FG001|Overall Study|Withdrawal by Subject|1|||
154997420|NCT02618759|559414687|FG000|Overall Study|Lost to Follow-up|0|||
154997421|NCT02618759|559414688|FG001|Overall Study|Lost to Follow-up|1|||
154997422|NCT02618759|559414687|FG000|Overall Study|Withdrawal by Subject|1|||
154997423|NCT02618759|559414688|FG001|Overall Study|Withdrawal by Subject|0|||
154997424|NCT02618759|559414687|FG000|Overall Study|Other Reasons|1|||
154997425|NCT02618759|559414688|FG001|Overall Study|Other Reasons|4|||
154997426|NCT00580788|559414689|FG000|Overall Study|Adverse Event|0|||
154997427|NCT00580788|559414690|FG001|Overall Study|Adverse Event|0|||
154997428|NCT00580788|559414691|FG002|Overall Study|Adverse Event|0|||
154997429|NCT00580788|559414692|FG003|Overall Study|Adverse Event|1|||
154997430|NCT03301649|559414693|FG000|Overall Study|Need alternate therapy due to live lice|17|||
154997431|NCT03301649|559414694|FG001|Overall Study|Need alternate therapy due to live lice|25|||
154997432|NCT03301649|559414695|FG002|Overall Study|Need alternate therapy due to live lice|81|||
154997433|NCT03301649|559414693|FG000|Overall Study|Lost to Follow-up|11|||
154997434|NCT03301649|559414694|FG001|Overall Study|Lost to Follow-up|11|||
154997435|NCT03301649|559414695|FG002|Overall Study|Lost to Follow-up|3|||
154997436|NCT03301649|559414693|FG000|Overall Study|Protocol Violation|0|||
154997437|NCT03301649|559414694|FG001|Overall Study|Protocol Violation|1|||
154997438|NCT03301649|559414695|FG002|Overall Study|Protocol Violation|1|||
155122797|NCT00989235|559879884|FG000|Overall Study|Adverse Event|0|||
155122798|NCT00989235|559879885|FG001|Overall Study|Adverse Event|1|||
154997439|NCT03301649|559414693|FG000|Overall Study|Withdrawal by Subject|10|||
154997440|NCT03301649|559414694|FG001|Overall Study|Withdrawal by Subject|4|||
155122799|NCT00989235|559879884|FG000|Overall Study|Lack of Efficacy|1|||
154997441|NCT03301649|559414695|FG002|Overall Study|Withdrawal by Subject|0|||
154997442|NCT03301649|559414693|FG000|Overall Study|Other than specified|5|||
154997443|NCT03301649|559414694|FG001|Overall Study|Other than specified|3|||
154997444|NCT03301649|559414695|FG002|Overall Study|Other than specified|0|||
154997445|NCT00887289|559414700|FG000|Overall Study|Lack of Efficacy|14|||
154997446|NCT00887289|559414700|FG000|Overall Study|Adverse Event|27|||
154997447|NCT00887289|559414700|FG000|Overall Study|Withdrawal by Subject|26|||
154997448|NCT00887289|559414700|FG000|Overall Study|Lost to Follow-up|8|||
154997449|NCT00887289|559414700|FG000|Overall Study|Other|20|||
155122800|NCT00989235|559879885|FG001|Overall Study|Lack of Efficacy|0|||
154997450|NCT03022084|559414707|FG000|Overall Study|Lost to Follow-up|2|||
154997451|NCT03022084|559414708|FG001|Overall Study|Lost to Follow-up|3|||
154997452|NCT02679235|559414713|FG000|Overall Study|Withdrawal by Subject|3|||
154997453|NCT02679235|559414713|FG000|Overall Study|Adverse Event|1|||
154997454|NCT00554606|559414715|FG000|Overall Study|Adverse Event|3|||
154997455|NCT00554606|559414715|FG000|Overall Study|Abnormal laboratory values|1|||
154997456|NCT00554606|559414715|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
154997457|NCT00554606|559414715|FG000|Overall Study|Subject withdrew consent|2|||
154997458|NCT00554606|559414715|FG000|Overall Study|Lost to Follow-up|2|||
154997459|NCT00554606|559414715|FG000|Overall Study|Administrative problems|60|||
154997460|NCT00554606|559414715|FG000|Overall Study|Death|1|||
154997461|NCT00554606|559414715|FG000|Overall Study|Protocol deviation|2|||
154997462|NCT00923273|559414716|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
154997463|NCT00923273|559414717|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
154997464|NCT00923273|559414718|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
154997465|NCT00923273|559414719|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
154997466|NCT00923273|559414720|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
154997467|NCT00923273|559414716|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
154997468|NCT00923273|559414717|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
154997469|NCT00923273|559414718|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
154997470|NCT00923273|559414719|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
154997471|NCT00923273|559414720|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
154997472|NCT00605540|559414721|FG000|Overall Study|Death|15|||
154997473|NCT00605540|559414721|FG000|Overall Study|Lost to Follow-up|23|||
154997474|NCT00509366|559414722|FG000|Overall Study|Not Treated (Screen Failure)|1|||
154997475|NCT00509366|559414723|FG001|Overall Study|Not Treated (Screen Failure)|1|||
154997476|NCT00509366|559414724|FG002|Overall Study|Not Treated (Screen Failure)|1|||
154997477|NCT00509366|559414725|FG003|Overall Study|Not Treated (Screen Failure)|0|||
154997478|NCT00509366|559414726|FG004|Overall Study|Not Treated (Screen Failure)|0|||
154997479|NCT02119819|559414730|FG000|Overall Study|Adverse Event|3|||
154997480|NCT02119819|559414731|FG001|Overall Study|Adverse Event|1|||
154997481|NCT02119819|559414732|FG002|Overall Study|Adverse Event|2|||
154997482|NCT02119819|559414733|FG003|Overall Study|Adverse Event|3|||
154997483|NCT02119819|559414734|FG004|Overall Study|Adverse Event|0|||
154997484|NCT02119819|559414735|FG005|Overall Study|Adverse Event|1|||
154997485|NCT02119819|559414730|FG000|Overall Study|Lack of Efficacy|0|||
154997486|NCT02119819|559414731|FG001|Overall Study|Lack of Efficacy|0|||
154997487|NCT02119819|559414732|FG002|Overall Study|Lack of Efficacy|0|||
154997488|NCT02119819|559414733|FG003|Overall Study|Lack of Efficacy|0|||
154997489|NCT02119819|559414734|FG004|Overall Study|Lack of Efficacy|0|||
154997490|NCT02119819|559414735|FG005|Overall Study|Lack of Efficacy|1|||
154997491|NCT02119819|559414730|FG000|Overall Study|Lost to Follow-up|0|||
154997492|NCT02119819|559414731|FG001|Overall Study|Lost to Follow-up|0|||
154997493|NCT02119819|559414732|FG002|Overall Study|Lost to Follow-up|1|||
154997494|NCT02119819|559414733|FG003|Overall Study|Lost to Follow-up|2|||
154997495|NCT02119819|559414734|FG004|Overall Study|Lost to Follow-up|1|||
154997496|NCT02119819|559414735|FG005|Overall Study|Lost to Follow-up|2|||
154997497|NCT02119819|559414730|FG000|Overall Study|Physician Decision|1|||
154997498|NCT02119819|559414731|FG001|Overall Study|Physician Decision|1|||
154997499|NCT02119819|559414732|FG002|Overall Study|Physician Decision|0|||
154997500|NCT02119819|559414733|FG003|Overall Study|Physician Decision|0|||
154997501|NCT02119819|559414734|FG004|Overall Study|Physician Decision|0|||
154997502|NCT02119819|559414735|FG005|Overall Study|Physician Decision|1|||
154997503|NCT02119819|559414730|FG000|Overall Study|Withdrawal by Subject|5|||
154997504|NCT02119819|559414731|FG001|Overall Study|Withdrawal by Subject|3|||
154997505|NCT02119819|559414732|FG002|Overall Study|Withdrawal by Subject|0|||
154997506|NCT02119819|559414733|FG003|Overall Study|Withdrawal by Subject|0|||
154997507|NCT02119819|559414734|FG004|Overall Study|Withdrawal by Subject|6|||
154997508|NCT02119819|559414735|FG005|Overall Study|Withdrawal by Subject|10|||
155122801|NCT00989235|559879884|FG000|Overall Study|Withdrawal of Consent|1|||
155122802|NCT00989235|559879885|FG001|Overall Study|Withdrawal of Consent|1|||
155122803|NCT00989235|559879884|FG000|Overall Study|Desire to Become Pregnant|1|||
155122804|NCT00989235|559879885|FG001|Overall Study|Desire to Become Pregnant|0|||
155122805|NCT00989235|559879884|FG000|Overall Study|Randomized by Mistake|0|||
155122806|NCT00989235|559879885|FG001|Overall Study|Randomized by Mistake|2|||
154997509|NCT02119819|559414730|FG000|Overall Study|Jury Duty|0|||
154997510|NCT02119819|559414731|FG001|Overall Study|Jury Duty|0|||
154997511|NCT02119819|559414732|FG002|Overall Study|Jury Duty|1|||
154997512|NCT02119819|559414733|FG003|Overall Study|Jury Duty|0|||
154997513|NCT02119819|559414734|FG004|Overall Study|Jury Duty|0|||
155122807|NCT00989235|559879884|FG000|Overall Study|Lost to Follow-up|0|||
155122808|NCT00989235|559879885|FG001|Overall Study|Lost to Follow-up|1|||
154997514|NCT02119819|559414735|FG005|Overall Study|Jury Duty|0|||
154997515|NCT02119819|559414730|FG000|Overall Study|Protocol Violation|0|||
154997516|NCT02119819|559414731|FG001|Overall Study|Protocol Violation|0|||
154997517|NCT02119819|559414732|FG002|Overall Study|Protocol Violation|0|||
155122809|NCT03593681|559879888|FG000|Overall Study|Inadequate sample collected|12|||
154997518|NCT02119819|559414733|FG003|Overall Study|Protocol Violation|1|||
154997519|NCT02119819|559414734|FG004|Overall Study|Protocol Violation|0|||
154997520|NCT02119819|559414735|FG005|Overall Study|Protocol Violation|0|||
154997521|NCT02119819|559414730|FG000|Overall Study|Left the city to get a job|0|||
154997522|NCT02119819|559414731|FG001|Overall Study|Left the city to get a job|0|||
154997523|NCT02119819|559414732|FG002|Overall Study|Left the city to get a job|0|||
154997524|NCT02119819|559414733|FG003|Overall Study|Left the city to get a job|1|||
154997525|NCT02119819|559414734|FG004|Overall Study|Left the city to get a job|0|||
154997526|NCT02119819|559414735|FG005|Overall Study|Left the city to get a job|0|||
154997527|NCT00282919|559414738|FG000|Overall Study|Lack of Efficacy|4|||
154997528|NCT00282919|559414738|FG000|Overall Study|Withdrawal by Subject|1|||
154997529|NCT00282919|559414738|FG000|Overall Study|Asymptomatic Parasitemia|2|||
154997530|NCT01438996|559414739|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
154997531|NCT01438996|559414740|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
154997532|NCT01438996|559414741|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
154997533|NCT04497948|559414746|FG000|Overall Study|Death|2|||
154997534|NCT02246114|559414749|FG000|Overall Study|miscarriage|1|||
154997535|NCT02246114|559414750|FG001|Overall Study|miscarriage|0|||
154997536|NCT01439009|559414753|FG000|Overall Study|Physician Decision|5|||
154997537|NCT01439009|559414754|FG001|Overall Study|Physician Decision|3|||
154997538|NCT01439009|559414753|FG000|Overall Study|Protocol Violation|2|||
154997539|NCT01439009|559414754|FG001|Overall Study|Protocol Violation|0|||
154997540|NCT01439009|559414753|FG000|Overall Study|Deviation of exclusion criteria|1|||
154997541|NCT01439009|559414754|FG001|Overall Study|Deviation of exclusion criteria|0|||
154997542|NCT03257865|559414756|FG000|Overall Study|Adverse Event|4|||
154997543|NCT03257865|559414757|FG001|Overall Study|Adverse Event|8|||
154997544|NCT03257865|559414756|FG000|Overall Study|Lack of Efficacy|1|||
154997545|NCT03257865|559414757|FG001|Overall Study|Lack of Efficacy|2|||
154997546|NCT03257865|559414756|FG000|Overall Study|Non-compliance with Study Drug|0|||
154997547|NCT03257865|559414757|FG001|Overall Study|Non-compliance with Study Drug|2|||
154997548|NCT03257865|559414756|FG000|Overall Study|Withdrawal by Subject|23|||
154997549|NCT03257865|559414757|FG001|Overall Study|Withdrawal by Subject|17|||
154997550|NCT03257865|559414756|FG000|Overall Study|Physician Decision|3|||
154997551|NCT03257865|559414757|FG001|Overall Study|Physician Decision|1|||
154997552|NCT03257865|559414756|FG000|Overall Study|Other|0|||
154997553|NCT03257865|559414757|FG001|Overall Study|Other|1|||
154997554|NCT03257865|559414756|FG000|Overall Study|Lost to Follow-up|4|||
154997555|NCT03257865|559414757|FG001|Overall Study|Lost to Follow-up|4|||
154997556|NCT01421511|559414761|FG000|Overall Study|Lost to Follow-up|11|||
154997557|NCT01421511|559414762|FG001|Overall Study|Lost to Follow-up|14|||
154997558|NCT01421511|559414761|FG000|Overall Study|Randomized but didn't receive study drug|1|||
154997559|NCT01421511|559414762|FG001|Overall Study|Randomized but didn't receive study drug|7|||
154997560|NCT01421511|559414761|FG000|Overall Study|Physician Decision|0|||
154997561|NCT01421511|559414762|FG001|Overall Study|Physician Decision|1|||
154997562|NCT01421511|559414761|FG000|Overall Study|Withdrawal by Subject|6|||
154997563|NCT01421511|559414762|FG001|Overall Study|Withdrawal by Subject|5|||
154997564|NCT01421511|559414761|FG000|Overall Study|Death|1|||
154997565|NCT01421511|559414762|FG001|Overall Study|Death|1|||
154997566|NCT05384171|559414763|FG000|Overall Study|Lost to Follow-up|9|||
154997567|NCT05384171|559414764|FG001|Overall Study|Lost to Follow-up|9|||
154997568|NCT05384171|559414763|FG000|Overall Study|Withdrawal by Subject|3|||
154997569|NCT05384171|559414764|FG001|Overall Study|Withdrawal by Subject|0|||
154997570|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
154997571|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
154997572|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
154997573|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
154997574|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
154997575|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
154997576|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
154997577|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
154997578|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
154997579|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
154997580|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
154997581|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
154997582|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
154997583|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
154997584|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
154997585|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
154997586|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
154997587|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
154997588|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
154997589|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
154997590|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
154997591|NCT04040192|559414765|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
154997592|NCT04040192|559414766|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
154997593|NCT04040192|559414767|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
154997594|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
154997595|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
154997596|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
154997597|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
154997598|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
154997599|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
154997600|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
154997601|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
154997602|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
154997603|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
154997604|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
154997605|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
154997606|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
154997607|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
154997608|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
154997609|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
154997610|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
154997611|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
154997612|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
154997613|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
154997614|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
154997615|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
154997616|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
154997617|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
154997618|NCT04040192|559414765|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
154997619|NCT04040192|559414766|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
154997620|NCT04040192|559414767|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
154997621|NCT00195338|559414774|FG000|Overall Study|Lost to Follow-up|2|||
154997622|NCT00195338|559414774|FG000|Overall Study|Adverse Event|5|||
154997623|NCT00195338|559414774|FG000|Overall Study|Lack of Efficacy|1|||
154997624|NCT00195338|559414774|FG000|Overall Study|Early closure of the site|4|||
154997625|NCT02910011|559414775|FG000|Overall Study|Physician Decision|2|||
154997626|NCT00182325|559414776|FG000|Overall Study|Lost to Follow-up|7|||
154997627|NCT00182325|559414777|FG001|Overall Study|Lost to Follow-up|7|||
154997628|NCT00182325|559414776|FG000|Overall Study|Miscarriage|5|||
154997629|NCT00182325|559414777|FG001|Overall Study|Miscarriage|3|||
154997630|NCT00182325|559414776|FG000|Overall Study|Did not complete survey|22|||
154997631|NCT00182325|559414777|FG001|Overall Study|Did not complete survey|43|||
154997632|NCT01210612|559414781|FG000|Overall Study|Withdrawal by Subject|0|||
154997633|NCT01210612|559414782|FG001|Overall Study|Withdrawal by Subject|2|||
154997634|NCT00813800|559414786|FG000|Overall Study|Screen Failure after Consent|2|||
154997635|NCT00813800|559414786|FG000|Overall Study|Adverse Event|1|||
154997636|NCT00813800|559414786|FG000|Overall Study|Worsening of depression|2|||
154997637|NCT00813800|559414786|FG000|Overall Study|Physician Decision|1|||
154997638|NCT01860677|559414787|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
154997639|NCT01860677|559414788|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
154997640|NCT00418821|559414790|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
154997641|NCT02823652|559414791|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
154997642|NCT02823652|559414792|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
154997643|NCT02823652|559414793|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
154997644|NCT02823652|559414791|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
154997645|NCT02823652|559414792|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
154997646|NCT02823652|559414793|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
154997647|NCT02823652|559414791|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
154997648|NCT02823652|559414792|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
154997649|NCT02823652|559414793|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
154997650|NCT02823652|559414791|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
154997651|NCT02823652|559414792|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
154997652|NCT02823652|559414793|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
154997653|NCT03155945|559414794|FG000|Overall Study|Lost to Follow-up|0|||
154997654|NCT03155945|559414795|FG001|Overall Study|Lost to Follow-up|1|||
154997655|NCT03155945|559414794|FG000|Overall Study|Withdrawal by Subject|0|||
154997656|NCT03155945|559414795|FG001|Overall Study|Withdrawal by Subject|1|||
155122810|NCT03593681|559879888|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
155122811|NCT03593681|559879888|FG000|Overall Study|Protocol Violation|3|||
155122812|NCT03593681|559879888|FG000|Overall Study|Withdrawal by Subject|3|||
154997657|NCT03155945|559414794|FG000|Overall Study|Other Reason|0|||
154997658|NCT03155945|559414795|FG001|Overall Study|Other Reason|1|||
154997659|NCT02013674|559414796|FG000|Overall Study|Death|0|||
154997660|NCT02013674|559414797|FG001|Overall Study|Death|1|||
154997661|NCT02013674|559414796|FG000|Overall Study|Lost to Follow-up|1|||
154997662|NCT02013674|559414797|FG001|Overall Study|Lost to Follow-up|0|||
154997663|NCT04998851|559416691|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
154997664|NCT04998851|559416692|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
154997665|NCT04998851|559416691|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
154997666|NCT04998851|559416692|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
154997667|NCT00070499|559416693|FG000|Overall Study|Adverse Event|6|||
154997668|NCT00070499|559416694|FG001|Overall Study|Adverse Event|6|||
154997669|NCT00070499|559416695|FG002|Overall Study|Adverse Event|19|||
154997670|NCT00070499|559416696|FG003|Overall Study|Adverse Event|15|||
154997671|NCT00070499|559416693|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
154997672|NCT00070499|559416694|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
154997673|NCT00070499|559416695|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
154997674|NCT00070499|559416696|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
154997675|NCT00070499|559416693|FG000|Overall Study|Progression/relapse|4|||
154997676|NCT00070499|559416694|FG001|Overall Study|Progression/relapse|2|||
154997677|NCT00070499|559416695|FG002|Overall Study|Progression/relapse|1|||
154997678|NCT00070499|559416696|FG003|Overall Study|Progression/relapse|4|||
154997679|NCT00070499|559416693|FG000|Overall Study|Death|1|||
154997680|NCT00070499|559416694|FG001|Overall Study|Death|1|||
154997681|NCT00070499|559416695|FG002|Overall Study|Death|1|||
154997682|NCT00070499|559416696|FG003|Overall Study|Death|2|||
154997683|NCT00070499|559416693|FG000|Overall Study|Other - not protocol specified|7|||
154997684|NCT00070499|559416694|FG001|Overall Study|Other - not protocol specified|3|||
154997685|NCT00070499|559416695|FG002|Overall Study|Other - not protocol specified|12|||
154997686|NCT00070499|559416696|FG003|Overall Study|Other - not protocol specified|20|||
154997687|NCT00070499|559416693|FG000|Overall Study|Still on protocol treatment|10|||
154997688|NCT00070499|559416694|FG001|Overall Study|Still on protocol treatment|4|||
154997689|NCT00070499|559416695|FG002|Overall Study|Still on protocol treatment|79|||
154997690|NCT00070499|559416696|FG003|Overall Study|Still on protocol treatment|57|||
154997691|NCT00070499|559416693|FG000|Overall Study|Did not start treatment|1|||
154997692|NCT00070499|559416694|FG001|Overall Study|Did not start treatment|0|||
154997693|NCT00070499|559416695|FG002|Overall Study|Did not start treatment|0|||
154997694|NCT00070499|559416696|FG003|Overall Study|Did not start treatment|2|||
154997695|NCT00070499|559416693|FG000|Overall Study|Not eligible|2|||
154997696|NCT00070499|559416694|FG001|Overall Study|Not eligible|5|||
154997697|NCT00070499|559416695|FG002|Overall Study|Not eligible|3|||
154997698|NCT00070499|559416696|FG003|Overall Study|Not eligible|2|||
154997699|NCT00805467|559416697|FG000|Overall Study|Lack of Efficacy|0|||
154997700|NCT00805467|559416698|FG001|Overall Study|Lack of Efficacy|8|||
154997701|NCT00805467|559416699|FG002|Overall Study|Lack of Efficacy|13|||
154997702|NCT00805467|559416700|FG003|Overall Study|Lack of Efficacy|86|||
154997703|NCT00805467|559416697|FG000|Overall Study|Lost to Follow-up|0|||
154997704|NCT00805467|559416698|FG001|Overall Study|Lost to Follow-up|1|||
154997705|NCT00805467|559416699|FG002|Overall Study|Lost to Follow-up|7|||
154997706|NCT00805467|559416700|FG003|Overall Study|Lost to Follow-up|21|||
154997707|NCT00805467|559416697|FG000|Overall Study|Withdrawal by Subject|0|||
154997708|NCT00805467|559416698|FG001|Overall Study|Withdrawal by Subject|6|||
154997709|NCT00805467|559416699|FG002|Overall Study|Withdrawal by Subject|45|||
154997710|NCT00805467|559416700|FG003|Overall Study|Withdrawal by Subject|50|||
154997711|NCT00805467|559416697|FG000|Overall Study|Protocol Violation|0|||
154997712|NCT00805467|559416698|FG001|Overall Study|Protocol Violation|3|||
154997713|NCT00805467|559416699|FG002|Overall Study|Protocol Violation|0|||
154997714|NCT00805467|559416700|FG003|Overall Study|Protocol Violation|5|||
154997715|NCT00805467|559416697|FG000|Overall Study|Adverse Event|0|||
154997716|NCT00805467|559416698|FG001|Overall Study|Adverse Event|13|||
154997717|NCT00805467|559416699|FG002|Overall Study|Adverse Event|26|||
154997718|NCT00805467|559416700|FG003|Overall Study|Adverse Event|57|||
154997719|NCT00805467|559416697|FG000|Overall Study|Death|0|||
154997720|NCT00805467|559416698|FG001|Overall Study|Death|2|||
154997721|NCT00805467|559416699|FG002|Overall Study|Death|7|||
154997722|NCT00805467|559416700|FG003|Overall Study|Death|5|||
154997723|NCT00805467|559416697|FG000|Overall Study|Physician Decision|0|||
154997724|NCT00805467|559416698|FG001|Overall Study|Physician Decision|1|||
154997725|NCT00805467|559416699|FG002|Overall Study|Physician Decision|2|||
154997726|NCT00805467|559416700|FG003|Overall Study|Physician Decision|6|||
154997727|NCT00805467|559416697|FG000|Overall Study|Not reported|0|||
154997728|NCT00805467|559416698|FG001|Overall Study|Not reported|0|||
154997729|NCT00805467|559416699|FG002|Overall Study|Not reported|3|||
154997730|NCT00805467|559416700|FG003|Overall Study|Not reported|7|||
154997731|NCT01908907|559416707|FG000|Overall Study|Physician Decision|1|||
154997732|NCT01908907|559416708|FG001|Overall Study|Physician Decision|0|||
154997733|NCT01908907|559416707|FG000|Overall Study|Protocol Violation|1|||
155177834|NCT05093790|560089428|FG000|Overall Study|Failure to meet continuation criteria|0|||
155122813|NCT03593681|559879888|FG000|Overall Study|Procedure not attempted|3|||
155122814|NCT03593681|559879888|FG000|Overall Study|Adverse Event|2|||
154920652|NCT02451137|559131699|FG000|Overall Study|Physician Decision|6|||
154920653|NCT02451137|559131700|FG001|Overall Study|Physician Decision|5|||
154920654|NCT02451137|559131699|FG000|Overall Study|Sponsor decision|13|||
154920655|NCT02451137|559131700|FG001|Overall Study|Sponsor decision|25|||
154920656|NCT02451137|559131699|FG000|Overall Study|Withdrawal by Subject|40|||
154920657|NCT02451137|559131700|FG001|Overall Study|Withdrawal by Subject|63|||
154920658|NCT02451137|559131699|FG000|Overall Study|Other than specified above|2|||
154920659|NCT02451137|559131700|FG001|Overall Study|Other than specified above|3|||
154920660|NCT01302366|559133504|FG000|Overall Study|patient choice or noncompliance|5|||
154920661|NCT00198107|559133507|FG000|Double-Blind Period|Adverse Event|1|||
154920662|NCT00198107|559133508|FG001|Double-Blind Period|Adverse Event|1|||
154920663|NCT00198107|559133509|FG002|Double-Blind Period|Adverse Event|0|||
154920664|NCT00198107|559133507|FG000|Double-Blind Period|Lack of Efficacy|2|||
154920665|NCT00198107|559133508|FG001|Double-Blind Period|Lack of Efficacy|0|||
154920666|NCT00198107|559133509|FG002|Double-Blind Period|Lack of Efficacy|0|||
154920667|NCT00198107|559133507|FG000|Double-Blind Period|Lost to Follow-up|2|||
154920668|NCT00198107|559133508|FG001|Double-Blind Period|Lost to Follow-up|1|||
154920669|NCT00198107|559133509|FG002|Double-Blind Period|Lost to Follow-up|0|||
154920670|NCT00198107|559133507|FG000|Double-Blind Period|Physician Decision|1|||
154920671|NCT00198107|559133508|FG001|Double-Blind Period|Physician Decision|0|||
154920672|NCT00198107|559133509|FG002|Double-Blind Period|Physician Decision|0|||
154920673|NCT00198107|559133507|FG000|Double-Blind Period|Withdrawal by Subject|0|||
154920674|NCT00198107|559133508|FG001|Double-Blind Period|Withdrawal by Subject|1|||
154920675|NCT00198107|559133509|FG002|Double-Blind Period|Withdrawal by Subject|0|||
154920676|NCT00198107|559133507|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
154920677|NCT00198107|559133508|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
154920678|NCT00198107|559133509|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
154920679|NCT02513732|559133510|FG000|Overall Study|Lost to Follow-up|11|||
154920680|NCT02513732|559133510|FG000|Overall Study|Death|9|||
154920681|NCT02513732|559133510|FG000|Overall Study|Changing hospital|2|||
154920682|NCT00467051|559133511|FG000|Overall Study|Adverse Event|2|||
154920683|NCT02842736|559133518|FG000|Overall Study|Lost to Follow-up|13|||
154920684|NCT02842736|559133518|FG000|Overall Study|Intervention for menstrual bleeding|17|||
154920685|NCT02842736|559133518|FG000|Overall Study|Withdrawal by Subject|4|||
154920686|NCT02842736|559133518|FG000|Overall Study|Pregnancy|3|||
154920687|NCT02842736|559133518|FG000|Overall Study|Hysterectomy for fibroids|2|||
154920688|NCT02842736|559133518|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
154920689|NCT02842736|559133518|FG000|Overall Study|IUD: Mirena|1|||
154920690|NCT02646566|559133523|FG000|Overall Study|Lost to Follow-up|5|||
154920691|NCT02646566|559133524|FG001|Overall Study|Lost to Follow-up|4|||
154920692|NCT02646566|559133525|FG002|Overall Study|Lost to Follow-up|5|||
154920693|NCT02646566|559133523|FG000|Overall Study|Treatment failure|1|||
154920694|NCT02646566|559133524|FG001|Overall Study|Treatment failure|0|||
154920695|NCT02646566|559133525|FG002|Overall Study|Treatment failure|0|||
154920696|NCT04887922|559133535|FG000|1st Randomization|Decided not to have surgery|0|||
154920697|NCT04887922|559133536|FG001|1st Randomization|Decided not to have surgery|1|||
154920698|NCT04887922|559133537|FG002|1st Randomization|Decided not to have surgery|0|||
154920699|NCT04887922|559133538|FG003|1st Randomization|Decided not to have surgery|0|||
154920700|NCT04887922|559133539|FG004|1st Randomization|Decided not to have surgery|0|||
154920701|NCT00953017|559133540|FG000|Overall Study|DId not show up for colonoscopy|4|||
154920702|NCT00953017|559133541|FG001|Overall Study|DId not show up for colonoscopy|4|||
154920703|NCT00953017|559133542|FG002|Overall Study|DId not show up for colonoscopy|5|||
154920704|NCT00953017|559133543|FG003|Overall Study|DId not show up for colonoscopy|4|||
154920705|NCT00953017|559133540|FG000|Overall Study|Incomplete data|1|||
154920706|NCT00953017|559133541|FG001|Overall Study|Incomplete data|1|||
154920707|NCT00953017|559133542|FG002|Overall Study|Incomplete data|0|||
154920708|NCT00953017|559133543|FG003|Overall Study|Incomplete data|0|||
154920709|NCT00953017|559133540|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
154920710|NCT00953017|559133541|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
154920711|NCT00953017|559133542|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
154920712|NCT00953017|559133543|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
154920713|NCT00953017|559133540|FG000|Overall Study|Brown stool prior to procedure|0|||
154920714|NCT00953017|559133541|FG001|Overall Study|Brown stool prior to procedure|0|||
154920715|NCT00953017|559133542|FG002|Overall Study|Brown stool prior to procedure|1|||
155122815|NCT03593681|559879888|FG000|Overall Study|Physician Decision|1|||
154920716|NCT00953017|559133543|FG003|Overall Study|Brown stool prior to procedure|0|||
154920717|NCT04854421|559133544|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
154920718|NCT04854421|559133545|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
154920719|NCT00718809|559133547|FG000|Overall Study|Disease progression|9|||
154920720|NCT00718809|559133548|FG001|Overall Study|Disease progression|7|||
155122816|NCT01149486|559879889|FG000|First Intervention|Adverse Event|0|||
154920721|NCT00718809|559133547|FG000|Overall Study|Adverse Event|1|||
154920722|NCT00718809|559133548|FG001|Overall Study|Adverse Event|1|||
154997734|NCT01908907|559416708|FG001|Overall Study|Protocol Violation|0|||
154997735|NCT00660907|559416709|FG000|Overall Study|Incorrect Enrollment|1|||
154997736|NCT00660907|559416710|FG001|Overall Study|Incorrect Enrollment|1|||
154997737|NCT00660907|559416709|FG000|Overall Study|Adverse Event|33|||
154997738|NCT00660907|559416710|FG001|Overall Study|Adverse Event|19|||
154997739|NCT00660907|559416709|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
154997740|NCT00660907|559416710|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
154997741|NCT00660907|559416709|FG000|Overall Study|Withdrawal by Subject|23|||
154997742|NCT00660907|559416710|FG001|Overall Study|Withdrawal by Subject|32|||
154997743|NCT00660907|559416709|FG000|Overall Study|Lost to Follow-up|3|||
154997744|NCT00660907|559416710|FG001|Overall Study|Lost to Follow-up|3|||
154997745|NCT00660907|559416709|FG000|Overall Study|Poor/Non-Compliance|5|||
154997746|NCT00660907|559416710|FG001|Overall Study|Poor/Non-Compliance|1|||
154997747|NCT00660907|559416709|FG000|Overall Study|Safety|1|||
154997748|NCT00660907|559416710|FG001|Overall Study|Safety|0|||
154997749|NCT00660907|559416709|FG000|Overall Study|Death|1|||
154997750|NCT00660907|559416710|FG001|Overall Study|Death|3|||
154997751|NCT00660907|559416709|FG000|Overall Study|Various|11|||
154997752|NCT00660907|559416710|FG001|Overall Study|Various|8|||
154997753|NCT00478244|559416713|FG000|Overall Study|Did not receive transplant|1|||
154997754|NCT02929056|559416714|FG000|Overall Study|Lost to Follow-up|0|||
154997755|NCT02929056|559416715|FG001|Overall Study|Lost to Follow-up|1|||
154997756|NCT05048329|559416716|FG000|Overall Study|Withdrawal by Subject|1|||
154997757|NCT05048329|559416716|FG000|Overall Study|Screenfail|1|||
154997758|NCT01403051|559416717|FG000|Overall Study|Protocol Violation|2|||
154997759|NCT01403051|559416718|FG001|Overall Study|Protocol Violation|0|||
154997760|NCT01403051|559416717|FG000|Overall Study|Death|1|||
154997761|NCT01403051|559416718|FG001|Overall Study|Death|0|||
154997762|NCT01403051|559416717|FG000|Overall Study|Withdrawal by Subject|2|||
154997763|NCT01403051|559416718|FG001|Overall Study|Withdrawal by Subject|1|||
154997764|NCT01403051|559416717|FG000|Overall Study|Lost to Follow-up|5|||
154997765|NCT01403051|559416718|FG001|Overall Study|Lost to Follow-up|5|||
154997766|NCT00591773|559416719|FG000|Overall Study|Adverse Event|9|||
154997767|NCT00591773|559416720|FG001|Overall Study|Adverse Event|9|||
154997768|NCT00591773|559416721|FG002|Overall Study|Adverse Event|6|||
154997769|NCT00591773|559416719|FG000|Overall Study|Protocol Violation|2|||
154997770|NCT00591773|559416720|FG001|Overall Study|Protocol Violation|3|||
154997771|NCT00591773|559416721|FG002|Overall Study|Protocol Violation|0|||
154997772|NCT00591773|559416719|FG000|Overall Study|Lost to Follow-up|1|||
154997773|NCT00591773|559416720|FG001|Overall Study|Lost to Follow-up|4|||
154997774|NCT00591773|559416721|FG002|Overall Study|Lost to Follow-up|1|||
154997775|NCT00591773|559416719|FG000|Overall Study|Withdrawal by Subject|2|||
155122817|NCT01149486|559879890|FG001|First Intervention|Adverse Event|1|||
154997776|NCT00591773|559416720|FG001|Overall Study|Withdrawal by Subject|5|||
154997777|NCT00591773|559416721|FG002|Overall Study|Withdrawal by Subject|3|||
154997778|NCT00591773|559416719|FG000|Overall Study|Lack of Efficacy|1|||
154997779|NCT00591773|559416720|FG001|Overall Study|Lack of Efficacy|2|||
154997780|NCT00591773|559416721|FG002|Overall Study|Lack of Efficacy|2|||
154997781|NCT00591773|559416719|FG000|Overall Study|Other|1|||
154997782|NCT00591773|559416720|FG001|Overall Study|Other|1|||
154997783|NCT00591773|559416721|FG002|Overall Study|Other|4|||
154997784|NCT02135614|559416722|FG000|Overall Study|Randomized but Not Treated|2|||
154997785|NCT02135614|559416723|FG001|Overall Study|Randomized but Not Treated|1|||
154997786|NCT02135614|559416722|FG000|Overall Study|Adverse Event|0|||
154997787|NCT02135614|559416723|FG001|Overall Study|Adverse Event|1|||
154997788|NCT02135614|559416722|FG000|Overall Study|Death|1|||
154997789|NCT02135614|559416723|FG001|Overall Study|Death|0|||
154997790|NCT02135614|559416722|FG000|Overall Study|Investigator's Discretion|0|||
154997791|NCT02135614|559416723|FG001|Overall Study|Investigator's Discretion|1|||
154997792|NCT02135614|559416722|FG000|Overall Study|Withdrew Consent|2|||
154997793|NCT02135614|559416723|FG001|Overall Study|Withdrew Consent|2|||
154997794|NCT02135614|559416722|FG000|Overall Study|Lost to Follow-up|3|||
154997795|NCT02135614|559416723|FG001|Overall Study|Lost to Follow-up|0|||
154997796|NCT01433549|559416724|FG000|Phase 2: Second Study Product|Adverse Event|0|||
154997797|NCT01433549|559416725|FG001|Phase 2: Second Study Product|Adverse Event|1|||
154997798|NCT02549027|559416728|FG000|Washout After Period 4|Withdrawal by Subject|0|||
154997799|NCT02549027|559416729|FG001|Washout After Period 4|Withdrawal by Subject|1|||
154997800|NCT02549027|559416730|FG002|Washout After Period 4|Withdrawal by Subject|1|||
155122818|NCT02813668|559879891|FG000|Overall Study|Death|4|||
155122819|NCT02813668|559879891|FG000|Overall Study|Lost to Follow-up|509|||
154997801|NCT02549027|559416731|FG003|Washout After Period 4|Withdrawal by Subject|1|||
154997802|NCT02549027|559416732|FG004|Washout After Period 4|Withdrawal by Subject|0|||
154997803|NCT02549027|559416733|FG005|Washout After Period 4|Withdrawal by Subject|0|||
154997804|NCT02549027|559416728|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
154997805|NCT02549027|559416729|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
154997806|NCT02549027|559416730|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
154997807|NCT02549027|559416731|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
154997808|NCT02549027|559416732|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
155122820|NCT02813668|559879891|FG000|Overall Study|Withdrawal by Subject|148|||
154997809|NCT02549027|559416733|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
154997810|NCT02242045|559416736|FG000|Overall Study|Investigator's Discretion|1|||
154997811|NCT02242045|559416736|FG000|Overall Study|Progressive Disease|2|||
154997812|NCT02242045|559416736|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
154997813|NCT02242045|559416736|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
154997814|NCT00749892|559416737|FG000|Overall Study|Withdrawal by Subject|3|||
154997815|NCT04581369|559416738|FG000|Overall Study|Death|7|||
154997816|NCT04581369|559416739|FG001|Overall Study|Death|6|||
154997817|NCT04581369|559416740|FG002|Overall Study|Death|0|||
154997818|NCT04581369|559416738|FG000|Overall Study|Lost to Follow-up|7|||
154997819|NCT04581369|559416739|FG001|Overall Study|Lost to Follow-up|3|||
154997820|NCT04581369|559416740|FG002|Overall Study|Lost to Follow-up|0|||
154997821|NCT04581369|559416738|FG000|Overall Study|liver transplant|2|||
154997822|NCT04581369|559416739|FG001|Overall Study|liver transplant|2|||
154997823|NCT04581369|559416740|FG002|Overall Study|liver transplant|0|||
154997824|NCT04581369|559416738|FG000|Overall Study|transitioned to hospice care|0|||
154997825|NCT04581369|559416739|FG001|Overall Study|transitioned to hospice care|5|||
154997826|NCT04581369|559416740|FG002|Overall Study|transitioned to hospice care|0|||
154997827|NCT00780910|559416741|FG000|Overall Study|Adverse Event|2|||
154997828|NCT00106964|559416743|FG000|Overall Study|Lost to Follow-up|8|||
154997829|NCT00106964|559416744|FG001|Overall Study|Lost to Follow-up|6|||
154997830|NCT00106964|559416745|FG002|Overall Study|Lost to Follow-up|2|||
154997831|NCT00106964|559416743|FG000|Overall Study|Pregnancy|2|||
154997832|NCT00106964|559416744|FG001|Overall Study|Pregnancy|3|||
154997833|NCT00106964|559416745|FG002|Overall Study|Pregnancy|2|||
154997834|NCT00106964|559416743|FG000|Overall Study|Death|1|||
154997835|NCT00106964|559416744|FG001|Overall Study|Death|1|||
154997836|NCT00106964|559416745|FG002|Overall Study|Death|0|||
154997837|NCT00106964|559416743|FG000|Overall Study|Incarceration|0|||
154997838|NCT00106964|559416744|FG001|Overall Study|Incarceration|1|||
154997839|NCT00106964|559416745|FG002|Overall Study|Incarceration|0|||
154997840|NCT00106964|559416743|FG000|Overall Study|Site Funding Terminated|0|||
154997841|NCT00106964|559416744|FG001|Overall Study|Site Funding Terminated|1|||
154997842|NCT00106964|559416745|FG002|Overall Study|Site Funding Terminated|1|||
154997843|NCT00106964|559416743|FG000|Overall Study|Failure to adhere|2|||
154997844|NCT00106964|559416744|FG001|Overall Study|Failure to adhere|0|||
154997845|NCT00106964|559416745|FG002|Overall Study|Failure to adhere|0|||
154997846|NCT00106964|559416743|FG000|Overall Study|Did not meet eligibility criteria|0|||
154997847|NCT00106964|559416744|FG001|Overall Study|Did not meet eligibility criteria|2|||
154997848|NCT00106964|559416745|FG002|Overall Study|Did not meet eligibility criteria|2|||
154997849|NCT00106964|559416743|FG000|Overall Study|Required disallowed medication|0|||
154997850|NCT00106964|559416744|FG001|Overall Study|Required disallowed medication|1|||
154997851|NCT00106964|559416745|FG002|Overall Study|Required disallowed medication|0|||
154997852|NCT03207243|559416746|FG000|Overall Study|Adverse Event|2|||
154997853|NCT03207243|559416747|FG001|Overall Study|Adverse Event|2|||
154997854|NCT03207243|559416746|FG000|Overall Study|Loss of Asthma Control|47|||
154997855|NCT03207243|559416747|FG001|Overall Study|Loss of Asthma Control|31|||
154997856|NCT03207243|559416746|FG000|Overall Study|Withdrawal by Subject|2|||
154997857|NCT03207243|559416747|FG001|Overall Study|Withdrawal by Subject|4|||
154997858|NCT03207243|559416746|FG000|Overall Study|Physician Decision|1|||
154997859|NCT03207243|559416747|FG001|Overall Study|Physician Decision|1|||
154997860|NCT03207243|559416746|FG000|Overall Study|Lost to Follow-up|0|||
154997861|NCT03207243|559416747|FG001|Overall Study|Lost to Follow-up|1|||
154997862|NCT03207243|559416746|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
154997863|NCT03207243|559416747|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
154997864|NCT03207243|559416746|FG000|Overall Study|Protocol Violation|0|||
154997865|NCT03207243|559416747|FG001|Overall Study|Protocol Violation|3|||
154997866|NCT00168818|559416752|FG000|Overall Study|Adverse Event|23|||
154997867|NCT00168818|559416753|FG001|Overall Study|Adverse Event|29|||
154997868|NCT00168818|559416754|FG002|Overall Study|Adverse Event|31|||
154997869|NCT00168818|559416752|FG000|Overall Study|Protocol Violation|16|||
154997870|NCT00168818|559416753|FG001|Overall Study|Protocol Violation|11|||
154997871|NCT00168818|559416754|FG002|Overall Study|Protocol Violation|11|||
154997872|NCT00168818|559416752|FG000|Overall Study|Lost to Follow-up|13|||
154997873|NCT00168818|559416753|FG001|Overall Study|Lost to Follow-up|4|||
154997874|NCT00168818|559416754|FG002|Overall Study|Lost to Follow-up|15|||
154997875|NCT00168818|559416752|FG000|Overall Study|Withdrawal by Subject|43|||
154997876|NCT00168818|559416753|FG001|Overall Study|Withdrawal by Subject|41|||
154997877|NCT00168818|559416754|FG002|Overall Study|Withdrawal by Subject|37|||
154997878|NCT00168818|559416752|FG000|Overall Study|Other|22|||
154997879|NCT00168818|559416753|FG001|Overall Study|Other|24|||
154997880|NCT00168818|559416754|FG002|Overall Study|Other|30|||
154997881|NCT00168818|559416752|FG000|Treatment|Adverse Event|77|||
154997882|NCT00168818|559416753|FG001|Treatment|Adverse Event|89|||
154997883|NCT00168818|559416754|FG002|Treatment|Adverse Event|68|||
154997884|NCT00168818|559416752|FG000|Treatment|Protocol Violation|8|||
154997885|NCT00168818|559416753|FG001|Treatment|Protocol Violation|11|||
154997886|NCT00168818|559416754|FG002|Treatment|Protocol Violation|11|||
154997887|NCT00168818|559416752|FG000|Treatment|Lost to Follow-up|0|||
154997888|NCT00168818|559416753|FG001|Treatment|Lost to Follow-up|2|||
154997889|NCT00168818|559416754|FG002|Treatment|Lost to Follow-up|1|||
154997890|NCT00168818|559416752|FG000|Treatment|Withdrawal by Subject|25|||
154997891|NCT00168818|559416753|FG001|Treatment|Withdrawal by Subject|20|||
154997892|NCT00168818|559416754|FG002|Treatment|Withdrawal by Subject|22|||
154997893|NCT00168818|559416752|FG000|Treatment|Other|23|||
154997894|NCT00168818|559416753|FG001|Treatment|Other|29|||
154997895|NCT00168818|559416754|FG002|Treatment|Other|31|||
154997896|NCT00603837|559416757|FG000|Overall Study|Physician Decision|3|||
154997897|NCT00603837|559416758|FG001|Overall Study|Physician Decision|0|||
154997898|NCT00856375|559416819|FG000|Overall Study|Other|0|||
154997899|NCT00856375|559416820|FG001|Overall Study|Other|1|||
154997900|NCT00856375|559416819|FG000|Overall Study|Death|32|||
154997901|NCT00856375|559416820|FG001|Overall Study|Death|30|||
154997902|NCT00856375|559416819|FG000|Overall Study|Sponsor Terminated Study|7|||
154997903|NCT00856375|559416820|FG001|Overall Study|Sponsor Terminated Study|7|||
154997904|NCT00856375|559416819|FG000|Overall Study|Withdrawal by Subject|2|||
154997905|NCT00856375|559416820|FG001|Overall Study|Withdrawal by Subject|1|||
154997906|NCT00856375|559416819|FG000|Overall Study|Lost to Follow-up|1|||
154997907|NCT00856375|559416820|FG001|Overall Study|Lost to Follow-up|2|||
154997908|NCT02538965|559416821|FG000|Treatment Period|Other = Death due to disease progression|1|||
154997909|NCT02538965|559416821|FG000|Treatment Period|Adverse Event|2|||
154997910|NCT02538965|559416821|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
154997911|NCT02538965|559416821|FG000|Treatment Period|Treatment Failure|9|||
154997912|NCT02538965|559416821|FG000|Treatment Period|Disease Progression|1|||
154997913|NCT02538965|559416821|FG000|Treatment Period|Physician Decision|2|||
154997914|NCT02538965|559416821|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
154997915|NCT02538965|559416821|FG000|Follow-Up Period|Withdrawal by Parent|4|||
154997916|NCT00875797|559416822|FG000|Overall Study|Protocol Violation|6|||
154997917|NCT00875797|559416823|FG001|Overall Study|Protocol Violation|3|||
154997918|NCT04893018|559416826|FG000|Overall Study|Lost to Follow-up|1|||
154997919|NCT04893018|559416827|FG001|Overall Study|Lost to Follow-up|0|||
154997920|NCT04893018|559416826|FG000|Overall Study|Withdrawal by Subject|2|||
154997921|NCT04893018|559416827|FG001|Overall Study|Withdrawal by Subject|0|||
154997922|NCT04893018|559416826|FG000|Overall Study|Study Terminated|1|||
154997923|NCT04893018|559416827|FG001|Overall Study|Study Terminated|2|||
154997924|NCT00811928|559416832|FG000|Overall Study|AEs and SAEs Including Death|7|||
154997925|NCT00811928|559416833|FG001|Overall Study|AEs and SAEs Including Death|11|||
154997926|NCT00811928|559416832|FG000|Overall Study|Withdrawal by Subject|18|||
154997927|NCT00811928|559416833|FG001|Overall Study|Withdrawal by Subject|12|||
154997928|NCT00811928|559416832|FG000|Overall Study|Did Not Take Study Drug|3|||
154997929|NCT00811928|559416833|FG001|Overall Study|Did Not Take Study Drug|0|||
154997930|NCT00811928|559416832|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
154997931|NCT00811928|559416833|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
154997932|NCT00811928|559416832|FG000|Overall Study|Investigator Decision|2|||
154997933|NCT00811928|559416833|FG001|Overall Study|Investigator Decision|1|||
154997934|NCT00811928|559416832|FG000|Overall Study|Poor Compliance|2|||
154997935|NCT00811928|559416833|FG001|Overall Study|Poor Compliance|5|||
154997936|NCT01085357|559416834|FG000|Overall Study|Adverse Event|1|||
154997937|NCT01085357|559416835|FG001|Overall Study|Adverse Event|1|||
154997938|NCT01085357|559416834|FG000|Overall Study|Subject Decision|4|||
154997939|NCT01085357|559416835|FG001|Overall Study|Subject Decision|3|||
154997940|NCT01085357|559416834|FG000|Overall Study|Investigator Decision|1|||
154997941|NCT01085357|559416835|FG001|Overall Study|Investigator Decision|1|||
154997942|NCT01085357|559416834|FG000|Overall Study|Death|11|||
154997943|NCT01085357|559416835|FG001|Overall Study|Death|1|||
154997944|NCT01085357|559416834|FG000|Overall Study|Lost to Follow-up|2|||
154997945|NCT01085357|559416835|FG001|Overall Study|Lost to Follow-up|0|||
154997946|NCT00314951|559416836|FG000|Treatment|Didn't meet criteria for mITT population|16|||
154997947|NCT00314951|559416837|FG001|Treatment|Didn't meet criteria for mITT population|11|||
154997948|NCT00314951|559416836|FG000|Follow-up|mITT failure|44|||
154997949|NCT00314951|559416837|FG001|Follow-up|mITT failure|34|||
155122821|NCT02813668|559879891|FG000|Overall Study|No longer at worksite|85|||
154997950|NCT04411914|559416838|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
154997951|NCT04411914|559416839|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
154997952|NCT01420965|559416844|FG000|Overall Study|Withdrawal by Subject|1|||
154997953|NCT01420965|559416845|FG001|Overall Study|Withdrawal by Subject|0|||
154997954|NCT01420965|559416846|FG002|Overall Study|Withdrawal by Subject|0|||
154997955|NCT01420965|559416844|FG000|Overall Study|Adverse Event|0|||
154997956|NCT01420965|559416845|FG001|Overall Study|Adverse Event|1|||
154997957|NCT01420965|559416846|FG002|Overall Study|Adverse Event|0|||
154997958|NCT02015065|559416847|FG000|Overall Study|Death on study|1|||
154997959|NCT02015065|559416848|FG001|Overall Study|Death on study|2|||
154997960|NCT02015065|559416849|FG002|Overall Study|Death on study|1|||
154997961|NCT01292226|559416882|FG000|Overall Study|Adverse Event|5|||
154997962|NCT01292226|559416882|FG000|Overall Study|Death|1|||
154997963|NCT01292226|559416882|FG000|Overall Study|Graft loss|1|||
154997964|NCT01292226|559416882|FG000|Overall Study|Protocol Violation|3|||
154997965|NCT01292226|559416882|FG000|Overall Study|Withdrawal by Subject|1|||
154997966|NCT01292226|559416882|FG000|Overall Study|Other|2|||
154997967|NCT04106661|559416883|FG000|Overall Study|Protocol Violation|3|||
154997968|NCT04106661|559416884|FG001|Overall Study|Protocol Violation|0|||
154997969|NCT04106661|559416883|FG000|Overall Study|Scheduling difficulties|1|||
154997970|NCT04106661|559416884|FG001|Overall Study|Scheduling difficulties|1|||
154997971|NCT00233402|559416885|FG000|Overall Study|No pathology data|12|||
154997972|NCT00233402|559416886|FG001|Overall Study|No pathology data|9|||
154997973|NCT00233402|559416885|FG000|Overall Study|No Ta/T1|89|||
154997974|NCT00233402|559416886|FG001|Overall Study|No Ta/T1|94|||
154997975|NCT00233402|559416885|FG000|Overall Study|Lost to follow up etc|3|||
154997976|NCT00233402|559416886|FG001|Overall Study|Lost to follow up etc|21|||
154997977|NCT03503864|559416887|FG000|Overall Study|Protocol Violation|6|||
154997978|NCT03503864|559416887|FG000|Overall Study|Withdrawal by Subject|7|||
154997979|NCT00423319|559416888|FG000|Overall Study|Death|2|||
154997980|NCT00423319|559416889|FG001|Overall Study|Death|0|||
154997981|NCT00423319|559416888|FG000|Overall Study|Adverse Event|93|||
154997982|NCT00423319|559416889|FG001|Overall Study|Adverse Event|112|||
154997983|NCT00423319|559416888|FG000|Overall Study|Withdrawal by Subject|86|||
154997984|NCT00423319|559416889|FG001|Overall Study|Withdrawal by Subject|99|||
154997985|NCT00423319|559416888|FG000|Overall Study|Lost to Follow-up|4|||
154997986|NCT00423319|559416889|FG001|Overall Study|Lost to Follow-up|3|||
154997987|NCT00423319|559416888|FG000|Overall Study|Poor compliance or noncompliance|1|||
154997988|NCT00423319|559416889|FG001|Overall Study|Poor compliance or noncompliance|1|||
154997989|NCT00423319|559416888|FG000|Overall Study|No longer meets study criteria|15|||
154997990|NCT00423319|559416889|FG001|Overall Study|No longer meets study criteria|15|||
154997991|NCT00423319|559416888|FG000|Overall Study|Other|23|||
154997992|NCT00423319|559416889|FG001|Overall Study|Other|22|||
154997993|NCT02639052|559416890|FG000|Overall Study|Lost to Follow-up|1|||
154997994|NCT00895414|559416891|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
154997995|NCT00895414|559416892|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
154997996|NCT00895414|559416891|FG000|First Intervention (14 Days)|Physician Decision|0|||
154997997|NCT00895414|559416892|FG001|First Intervention (14 Days)|Physician Decision|1|||
154997998|NCT00478426|559416893|FG000|Overall Study|Withdrawal by Subject|1|||
154997999|NCT01189487|559416894|FG000|Overall Study|Lack of Efficacy|2|||
154998000|NCT01189487|559416894|FG000|Overall Study|Adverse Event|1|||
154998001|NCT04630158|559416895|FG000|Overall Study|Adverse Event|1|||
154998002|NCT04630158|559416896|FG001|Overall Study|Adverse Event|1|||
154998003|NCT04630158|559416897|FG002|Overall Study|Adverse Event|1|||
154998004|NCT04630158|559416895|FG000|Overall Study|Physician Decision|0|||
154998005|NCT04630158|559416896|FG001|Overall Study|Physician Decision|2|||
154998006|NCT04630158|559416897|FG002|Overall Study|Physician Decision|0|||
154998007|NCT04630158|559416895|FG000|Overall Study|Protocol Violation|1|||
154998008|NCT04630158|559416896|FG001|Overall Study|Protocol Violation|0|||
154998009|NCT04630158|559416897|FG002|Overall Study|Protocol Violation|1|||
154998010|NCT04630158|559416895|FG000|Overall Study|Withdrawal by Subject|2|||
154998011|NCT04630158|559416896|FG001|Overall Study|Withdrawal by Subject|1|||
154998012|NCT04630158|559416897|FG002|Overall Study|Withdrawal by Subject|2|||
154998013|NCT02752087|559416902|FG000|Washout|Physician Decision|1|||
154998014|NCT02752087|559416903|FG001|Washout|Physician Decision|0|||
154998015|NCT02458287|559416904|FG000|Overall Study|Adverse Event|0|||
154998016|NCT02458287|559416905|FG001|Overall Study|Adverse Event|0|||
154998017|NCT02458287|559416906|FG002|Overall Study|Adverse Event|0|||
154998018|NCT02458287|559416907|FG003|Overall Study|Adverse Event|1|||
154998019|NCT02458287|559416904|FG000|Overall Study|Lost to Follow-up|0|||
154998020|NCT02458287|559416905|FG001|Overall Study|Lost to Follow-up|1|||
154998021|NCT02458287|559416906|FG002|Overall Study|Lost to Follow-up|1|||
154998022|NCT02458287|559416907|FG003|Overall Study|Lost to Follow-up|0|||
154998023|NCT02458287|559416904|FG000|Overall Study|Protocol Violation|0|||
154998024|NCT02458287|559416905|FG001|Overall Study|Protocol Violation|1|||
154998025|NCT02458287|559416906|FG002|Overall Study|Protocol Violation|0|||
154998026|NCT02458287|559416907|FG003|Overall Study|Protocol Violation|0|||
154998027|NCT02458287|559416904|FG000|Overall Study|Withdrawal by Subject|0|||
154998028|NCT02458287|559416905|FG001|Overall Study|Withdrawal by Subject|2|||
154998029|NCT02458287|559416906|FG002|Overall Study|Withdrawal by Subject|2|||
154998030|NCT02458287|559416907|FG003|Overall Study|Withdrawal by Subject|1|||
154998031|NCT02458287|559416904|FG000|Overall Study|Relocated Out of State|0|||
154998032|NCT02458287|559416905|FG001|Overall Study|Relocated Out of State|0|||
154998033|NCT02458287|559416906|FG002|Overall Study|Relocated Out of State|0|||
154998034|NCT02458287|559416907|FG003|Overall Study|Relocated Out of State|1|||
154998035|NCT00843635|559416908|FG000|Overall Study|Adverse Event|2|||
154998036|NCT00843635|559416909|FG001|Overall Study|Adverse Event|2|||
154998037|NCT00843635|559416910|FG002|Overall Study|Adverse Event|0|||
154998038|NCT02290223|559416911|FG000|6 Months|Lost to Follow-up|9|||
154998039|NCT02290223|559416912|FG001|6 Months|Lost to Follow-up|6|||
154998040|NCT02290223|559416911|FG000|6 Months|Withdrawal by Subject|5|||
154998041|NCT02290223|559416912|FG001|6 Months|Withdrawal by Subject|0|||
154998042|NCT02290223|559416911|FG000|6 Months|deceased (not related to study)|2|||
154998043|NCT02290223|559416912|FG001|6 Months|deceased (not related to study)|0|||
154998044|NCT02290223|559416911|FG000|12 Months|Lost to Follow-up|16|||
154998045|NCT02290223|559416912|FG001|12 Months|Lost to Follow-up|10|||
154998046|NCT02290223|559416911|FG000|12 Months|Refusal|0|||
154998047|NCT02290223|559416912|FG001|12 Months|Refusal|1|||
154998048|NCT05293639|559416913|FG000|Overall Study|Withdrawal by Subject|1|||
154998049|NCT05293639|559416914|FG001|Overall Study|Withdrawal by Subject|1|||
154998050|NCT05293639|559416915|FG002|Overall Study|Withdrawal by Subject|2|||
154998051|NCT05293639|559416913|FG000|Overall Study|Death|0|||
154998052|NCT05293639|559416914|FG001|Overall Study|Death|1|||
154998053|NCT05293639|559416915|FG002|Overall Study|Death|0|||
154998054|NCT05293639|559416913|FG000|Overall Study|Lost to Follow-up|0|||
154998055|NCT05293639|559416914|FG001|Overall Study|Lost to Follow-up|0|||
154998056|NCT05293639|559416915|FG002|Overall Study|Lost to Follow-up|5|||
154998057|NCT05293639|559416913|FG000|Overall Study|Other|0|||
154998058|NCT05293639|559416914|FG001|Overall Study|Other|0|||
154998059|NCT05293639|559416915|FG002|Overall Study|Other|1|||
154998060|NCT00090363|559416920|FG000|Overall Study|Lost to Follow-up|1|||
154998061|NCT00090363|559416921|FG001|Overall Study|Lost to Follow-up|2|||
154998062|NCT00090363|559416922|FG002|Overall Study|Lost to Follow-up|1|||
154998063|NCT00090363|559416920|FG000|Overall Study|Withdrawal by Subject|7|||
154998064|NCT00090363|559416921|FG001|Overall Study|Withdrawal by Subject|7|||
154998065|NCT00090363|559416922|FG002|Overall Study|Withdrawal by Subject|6|||
154998066|NCT00090363|559416920|FG000|Overall Study|Study-specific discontinuation criteria|75|||
154998067|NCT00090363|559416921|FG001|Overall Study|Study-specific discontinuation criteria|74|||
154998068|NCT00090363|559416922|FG002|Overall Study|Study-specific discontinuation criteria|62|||
154998069|NCT00090363|559416920|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
154998070|NCT00090363|559416921|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
154998071|NCT00090363|559416922|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
154998072|NCT00090363|559416920|FG000|Overall Study|Consent expired|7|||
154998073|NCT00090363|559416921|FG001|Overall Study|Consent expired|10|||
154998074|NCT00090363|559416922|FG002|Overall Study|Consent expired|9|||
154998075|NCT00090363|559416920|FG000|Overall Study|Reasons not specified|2|||
154998076|NCT00090363|559416921|FG001|Overall Study|Reasons not specified|1|||
154998077|NCT00090363|559416922|FG002|Overall Study|Reasons not specified|1|||
154998078|NCT00090363|559416920|FG000|Overall Study|Continuing on study off treatment|14|||
154998079|NCT00090363|559416921|FG001|Overall Study|Continuing on study off treatment|13|||
154998080|NCT00090363|559416922|FG002|Overall Study|Continuing on study off treatment|16|||
154998081|NCT05038800|559416925|FG000|Overall Study|Death|1|||
154998082|NCT05038800|559416926|FG001|Overall Study|Death|1|||
154998083|NCT05038800|559416927|FG002|Overall Study|Death|5|||
154998084|NCT05038800|559416928|FG003|Overall Study|Death|3|||
154998085|NCT05038800|559416929|FG004|Overall Study|Death|1|||
154998086|NCT05038800|559416925|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
154998087|NCT05038800|559416926|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
154998088|NCT05038800|559416927|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
154998089|NCT05038800|559416928|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
154998090|NCT05038800|559416929|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
154998091|NCT05038800|559416925|FG000|Overall Study|Lack of Efficacy|0|||
154998092|NCT05038800|559416926|FG001|Overall Study|Lack of Efficacy|0|||
154998093|NCT05038800|559416927|FG002|Overall Study|Lack of Efficacy|0|||
154998094|NCT05038800|559416928|FG003|Overall Study|Lack of Efficacy|0|||
154998095|NCT05038800|559416929|FG004|Overall Study|Lack of Efficacy|1|||
154998096|NCT00121134|559416930|FG000|Overall Study|Progression of Disease|5|||
154998097|NCT00121134|559416931|FG001|Overall Study|Progression of Disease|3|||
154998098|NCT00121134|559416932|FG002|Overall Study|Progression of Disease|4|||
154998099|NCT00121134|559416933|FG003|Overall Study|Progression of Disease|2|||
154998100|NCT00121134|559416930|FG000|Overall Study|Toxicity|4|||
154998101|NCT00121134|559416931|FG001|Overall Study|Toxicity|7|||
154998102|NCT00121134|559416932|FG002|Overall Study|Toxicity|13|||
154998103|NCT00121134|559416933|FG003|Overall Study|Toxicity|5|||
154998104|NCT00121134|559416930|FG000|Overall Study|Physician Decision|6|||
154998105|NCT00121134|559416931|FG001|Overall Study|Physician Decision|4|||
154998106|NCT00121134|559416932|FG002|Overall Study|Physician Decision|4|||
154998107|NCT00121134|559416933|FG003|Overall Study|Physician Decision|1|||
154998108|NCT00121134|559416930|FG000|Overall Study|Treatment Delay|1|||
154998109|NCT00121134|559416931|FG001|Overall Study|Treatment Delay|0|||
154998110|NCT00121134|559416932|FG002|Overall Study|Treatment Delay|0|||
154998111|NCT00121134|559416933|FG003|Overall Study|Treatment Delay|0|||
154998112|NCT00121134|559416930|FG000|Overall Study|Intercurrent Illness|0|||
154998113|NCT00121134|559416931|FG001|Overall Study|Intercurrent Illness|0|||
154998114|NCT00121134|559416932|FG002|Overall Study|Intercurrent Illness|0|||
154998115|NCT00121134|559416933|FG003|Overall Study|Intercurrent Illness|1|||
154998116|NCT00121134|559416930|FG000|Overall Study|Patient Personal Reasons|0|||
154998117|NCT00121134|559416931|FG001|Overall Study|Patient Personal Reasons|1|||
154998118|NCT00121134|559416932|FG002|Overall Study|Patient Personal Reasons|0|||
154920723|NCT00718809|559133547|FG000|Overall Study|Withdrawal by Subject|0|||
154920724|NCT00718809|559133548|FG001|Overall Study|Withdrawal by Subject|1|||
154920725|NCT00718809|559133547|FG000|Overall Study|Lost to Follow-up|1|||
154920726|NCT00718809|559133548|FG001|Overall Study|Lost to Follow-up|0|||
154920727|NCT00718809|559133547|FG000|Overall Study|Noncompliance|1|||
154920728|NCT00718809|559133548|FG001|Overall Study|Noncompliance|0|||
154920729|NCT00798161|559133549|FG000|Overall Study|Adverse Event|3|||
154920730|NCT00798161|559133550|FG001|Overall Study|Adverse Event|4|||
154920731|NCT00798161|559133551|FG002|Overall Study|Adverse Event|6|||
154920732|NCT00798161|559133552|FG003|Overall Study|Adverse Event|6|||
154920733|NCT00798161|559133553|FG004|Overall Study|Adverse Event|5|||
154920734|NCT00798161|559133554|FG005|Overall Study|Adverse Event|2|||
154920735|NCT00798161|559133555|FG006|Overall Study|Adverse Event|4|||
154920736|NCT00798161|559133549|FG000|Overall Study|Protocol Violation|2|||
154920737|NCT00798161|559133550|FG001|Overall Study|Protocol Violation|1|||
154920738|NCT00798161|559133551|FG002|Overall Study|Protocol Violation|3|||
154920739|NCT00798161|559133552|FG003|Overall Study|Protocol Violation|3|||
154920740|NCT00798161|559133553|FG004|Overall Study|Protocol Violation|3|||
154920741|NCT00798161|559133554|FG005|Overall Study|Protocol Violation|2|||
154920742|NCT00798161|559133555|FG006|Overall Study|Protocol Violation|0|||
154920743|NCT00798161|559133549|FG000|Overall Study|Lost to Follow-up|1|||
154920744|NCT00798161|559133550|FG001|Overall Study|Lost to Follow-up|3|||
154920745|NCT00798161|559133551|FG002|Overall Study|Lost to Follow-up|4|||
154920746|NCT00798161|559133552|FG003|Overall Study|Lost to Follow-up|3|||
154920747|NCT00798161|559133553|FG004|Overall Study|Lost to Follow-up|4|||
154920748|NCT00798161|559133554|FG005|Overall Study|Lost to Follow-up|0|||
154920749|NCT00798161|559133555|FG006|Overall Study|Lost to Follow-up|0|||
154920750|NCT00798161|559133549|FG000|Overall Study|Withdrawal by Subject|5|||
154920751|NCT00798161|559133550|FG001|Overall Study|Withdrawal by Subject|4|||
154920752|NCT00798161|559133551|FG002|Overall Study|Withdrawal by Subject|5|||
154920753|NCT00798161|559133552|FG003|Overall Study|Withdrawal by Subject|4|||
154920754|NCT00798161|559133553|FG004|Overall Study|Withdrawal by Subject|2|||
154920755|NCT00798161|559133554|FG005|Overall Study|Withdrawal by Subject|3|||
154920756|NCT00798161|559133555|FG006|Overall Study|Withdrawal by Subject|1|||
154920757|NCT00798161|559133549|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
154920758|NCT00798161|559133550|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
154920759|NCT00798161|559133551|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
154920760|NCT00798161|559133552|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
154920761|NCT00798161|559133553|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
154920762|NCT00798161|559133554|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
154920763|NCT00798161|559133555|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
154920764|NCT00344968|559133556|FG000|Overall Study|Adverse Event|5|||
154920765|NCT00344968|559133557|FG001|Overall Study|Adverse Event|4|||
154920766|NCT00344968|559133558|FG002|Overall Study|Adverse Event|15|||
154920767|NCT00344968|559133556|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
154920768|NCT00344968|559133557|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
154920769|NCT00344968|559133558|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
154920770|NCT00344968|559133556|FG000|Overall Study|Protocol Violation|2|||
154920771|NCT00344968|559133557|FG001|Overall Study|Protocol Violation|2|||
154920772|NCT00344968|559133558|FG002|Overall Study|Protocol Violation|5|||
154920773|NCT00344968|559133556|FG000|Overall Study|Withdrawal by Subject|14|||
154920774|NCT00344968|559133557|FG001|Overall Study|Withdrawal by Subject|31|||
154920775|NCT00344968|559133558|FG002|Overall Study|Withdrawal by Subject|27|||
154920776|NCT00344968|559133556|FG000|Overall Study|Lost to Follow-up|24|||
154920777|NCT00344968|559133557|FG001|Overall Study|Lost to Follow-up|37|||
154920778|NCT00344968|559133558|FG002|Overall Study|Lost to Follow-up|37|||
154920779|NCT00344968|559133556|FG000|Overall Study|Death|11|||
154920780|NCT00344968|559133557|FG001|Overall Study|Death|27|||
154920781|NCT00344968|559133558|FG002|Overall Study|Death|31|||
154920782|NCT00344968|559133556|FG000|Overall Study|Other|0|||
154920783|NCT00344968|559133557|FG001|Overall Study|Other|1|||
154920784|NCT00344968|559133558|FG002|Overall Study|Other|0|||
154920785|NCT04001790|559133562|FG000|Overall Study|Withdrawal by Subject|1|||
154920786|NCT04001790|559133563|FG001|Overall Study|Withdrawal by Subject|2|||
154920787|NCT00465101|559133564|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
154920788|NCT00465101|559133564|FG000|Overall Study|Change in health precluded follow up|4|||
154920789|NCT00465101|559133564|FG000|Overall Study|Did not meet study criteria|4|||
154920790|NCT00465101|559133564|FG000|Overall Study|Lost to Follow-up|5|||
154920791|NCT00465101|559133564|FG000|Overall Study|Other|6|||
154920792|NCT00465101|559133564|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
154920793|NCT00465101|559133564|FG000|Overall Study|Patient postponed procedure|1|||
154920794|NCT00465101|559133564|FG000|Overall Study|Site closed due to IRB expiration|1|||
154920795|NCT00465101|559133564|FG000|Overall Study|Unable to obtain IRB approval|1|||
154920796|NCT00465101|559133564|FG000|Overall Study|Death|3|||
154920797|NCT00465101|559133564|FG000|Overall Study|Withdrawal by Subject|25|||
154920798|NCT00465101|559133564|FG000|Overall Study|Physician Decision|1|||
154920799|NCT00465101|559133564|FG000|Overall Study|Withdrew consent prior to procedure|3|||
154998119|NCT00121134|559416933|FG003|Overall Study|Patient Personal Reasons|0|||
154998120|NCT00857584|559416939|FG000|Overall Study|Lack of Efficacy|1|||
154998121|NCT00857584|559416940|FG001|Overall Study|Lack of Efficacy|2|||
154998122|NCT00857584|559416939|FG000|Overall Study|Adverse Event|2|||
154998123|NCT00857584|559416940|FG001|Overall Study|Adverse Event|2|||
154998124|NCT00857584|559416939|FG000|Overall Study|Physician Decision|1|||
154998125|NCT00857584|559416940|FG001|Overall Study|Physician Decision|1|||
154998126|NCT02533375|559416941|FG000|Overall Study|Lack of Efficacy|3|||
154998127|NCT02533375|559416941|FG000|Overall Study|Adverse Event|2|||
154998128|NCT00673387|559416942|FG000|Overall Study|Withdrawal by Subject|15|||
154998129|NCT00673387|559416943|FG001|Overall Study|Withdrawal by Subject|16|||
154998130|NCT00673387|559416944|FG002|Overall Study|Withdrawal by Subject|20|||
154998131|NCT00673387|559416945|FG003|Overall Study|Withdrawal by Subject|16|||
154998132|NCT00673387|559416946|FG004|Overall Study|Withdrawal by Subject|18|||
154998133|NCT00673387|559416947|FG005|Overall Study|Withdrawal by Subject|21|||
154998134|NCT00673387|559416948|FG006|Overall Study|Withdrawal by Subject|15|||
154998135|NCT00673387|559416949|FG007|Overall Study|Withdrawal by Subject|21|||
154998136|NCT00673387|559416942|FG000|Overall Study|Adverse Event|3|||
154998137|NCT00673387|559416943|FG001|Overall Study|Adverse Event|1|||
154998138|NCT00673387|559416944|FG002|Overall Study|Adverse Event|5|||
154998139|NCT00673387|559416945|FG003|Overall Study|Adverse Event|2|||
154998140|NCT00673387|559416946|FG004|Overall Study|Adverse Event|6|||
154998141|NCT00673387|559416947|FG005|Overall Study|Adverse Event|2|||
154998142|NCT00673387|559416948|FG006|Overall Study|Adverse Event|5|||
154998143|NCT00673387|559416949|FG007|Overall Study|Adverse Event|5|||
154998144|NCT00673387|559416942|FG000|Overall Study|Physician Decision|0|||
154998145|NCT00673387|559416943|FG001|Overall Study|Physician Decision|0|||
154998146|NCT00673387|559416944|FG002|Overall Study|Physician Decision|0|||
154998147|NCT00673387|559416945|FG003|Overall Study|Physician Decision|0|||
154998148|NCT00673387|559416946|FG004|Overall Study|Physician Decision|0|||
154998149|NCT00673387|559416947|FG005|Overall Study|Physician Decision|5|||
154998150|NCT00673387|559416948|FG006|Overall Study|Physician Decision|1|||
154998151|NCT00673387|559416949|FG007|Overall Study|Physician Decision|1|||
154998152|NCT00673387|559416942|FG000|Overall Study|Protocol Violation|3|||
154998153|NCT00673387|559416943|FG001|Overall Study|Protocol Violation|0|||
154998154|NCT00673387|559416944|FG002|Overall Study|Protocol Violation|1|||
154998155|NCT00673387|559416945|FG003|Overall Study|Protocol Violation|2|||
154998156|NCT00673387|559416946|FG004|Overall Study|Protocol Violation|0|||
154998157|NCT00673387|559416947|FG005|Overall Study|Protocol Violation|1|||
154998158|NCT00673387|559416948|FG006|Overall Study|Protocol Violation|1|||
154998159|NCT00673387|559416949|FG007|Overall Study|Protocol Violation|3|||
154998160|NCT00673387|559416942|FG000|Overall Study|Lost to Follow-up|8|||
154998161|NCT00673387|559416943|FG001|Overall Study|Lost to Follow-up|6|||
154998162|NCT00673387|559416944|FG002|Overall Study|Lost to Follow-up|5|||
154998163|NCT00673387|559416945|FG003|Overall Study|Lost to Follow-up|6|||
154998164|NCT00673387|559416946|FG004|Overall Study|Lost to Follow-up|6|||
154998165|NCT00673387|559416947|FG005|Overall Study|Lost to Follow-up|5|||
154998166|NCT00673387|559416948|FG006|Overall Study|Lost to Follow-up|8|||
154998167|NCT00673387|559416949|FG007|Overall Study|Lost to Follow-up|5|||
154998168|NCT01102374|559416950|FG000|Overall Study|Death|9|||
154998169|NCT01102374|559416951|FG001|Overall Study|Death|13|||
154998170|NCT01102374|559416950|FG000|Overall Study|Lost to Follow-up|7|||
154998171|NCT01102374|559416951|FG001|Overall Study|Lost to Follow-up|6|||
154998172|NCT04324073|559419126|FG000|Overall Study|withdrew consent|0|||
154998173|NCT04324073|559419127|FG001|Overall Study|withdrew consent|4|||
154998174|NCT04324073|559419128|FG002|Overall Study|withdrew consent|2|||
154998175|NCT04324073|559419129|FG003|Overall Study|withdrew consent|8|||
154998176|NCT01200069|559419135|FG000|Overall Study|Withdrawal by Subject|0|||
154998177|NCT01200069|559419136|FG001|Overall Study|Withdrawal by Subject|1|||
154998178|NCT00459043|559419140|FG000|Overall Study|Withdrawal by Subject|1|||
154998179|NCT00459043|559419141|FG001|Overall Study|Withdrawal by Subject|0|||
154998180|NCT03156504|559419143|FG000|Overall Study|Withdrawal by Subject|1|||
154998181|NCT03452137|559419144|FG000|Overall Study|Death|67|||
154998182|NCT03452137|559419145|FG001|Overall Study|Death|70|||
154998183|NCT03452137|559419144|FG000|Overall Study|Lost to Follow-up|4|||
154998184|NCT03452137|559419145|FG001|Overall Study|Lost to Follow-up|2|||
154998185|NCT03452137|559419144|FG000|Overall Study|Physician Decision|0|||
154998186|NCT03452137|559419145|FG001|Overall Study|Physician Decision|1|||
154998187|NCT03452137|559419144|FG000|Overall Study|Study Terminated by Sponsor|120|||
154998188|NCT03452137|559419145|FG001|Overall Study|Study Terminated by Sponsor|121|||
154998189|NCT03452137|559419144|FG000|Overall Study|Withdrawal by Subject|12|||
154998190|NCT03452137|559419145|FG001|Overall Study|Withdrawal by Subject|9|||
154998191|NCT02755649|559419146|FG000|Overall Study|Transitioned into OLE study|99|||
154998192|NCT02755649|559419147|FG001|Overall Study|Transitioned into OLE study|98|||
154998193|NCT02755649|559419148|FG002|Overall Study|Transitioned into OLE study|100|||
154998194|NCT02755649|559419146|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
154998195|NCT02755649|559419147|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
154998196|NCT02755649|559419148|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
154998197|NCT02755649|559419146|FG000|Overall Study|Physician Decision|0|||
154998198|NCT02755649|559419147|FG001|Overall Study|Physician Decision|0|||
154998199|NCT02755649|559419148|FG002|Overall Study|Physician Decision|2|||
154998200|NCT02755649|559419146|FG000|Overall Study|Withdrawal by Subject|0|||
154998201|NCT02755649|559419147|FG001|Overall Study|Withdrawal by Subject|1|||
154998202|NCT02755649|559419148|FG002|Overall Study|Withdrawal by Subject|0|||
154998203|NCT02755649|559419146|FG000|Overall Study|Undecided|1|||
154998204|NCT02755649|559419147|FG001|Overall Study|Undecided|0|||
154998205|NCT02755649|559419148|FG002|Overall Study|Undecided|0|||
154998206|NCT01286753|559419149|FG000|Overall Study|Adverse Event|7|||
154998207|NCT01286753|559419150|FG001|Overall Study|Adverse Event|6|||
154998208|NCT01286753|559419149|FG000|Overall Study|Progression|11|||
154998209|NCT01286753|559419150|FG001|Overall Study|Progression|13|||
154998210|NCT01286753|559419149|FG000|Overall Study|Refused Treatment|1|||
154998211|NCT01286753|559419150|FG001|Overall Study|Refused Treatment|0|||
154998212|NCT01286753|559419149|FG000|Overall Study|Withdrawal of Consent|0|||
154998213|NCT01286753|559419150|FG001|Overall Study|Withdrawal of Consent|2|||
154998214|NCT01286753|559419149|FG000|Overall Study|Discontinued to Join Extension Study|6|||
154998215|NCT01286753|559419150|FG001|Overall Study|Discontinued to Join Extension Study|4|||
154998216|NCT01286753|559419149|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
154998217|NCT01286753|559419150|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
154998218|NCT02126826|559419154|FG000|Overall Study|Withdrawal by Subject|0|||
154998219|NCT02126826|559419155|FG001|Overall Study|Withdrawal by Subject|0|||
154998220|NCT02126826|559419156|FG002|Overall Study|Withdrawal by Subject|0|||
154998221|NCT02126826|559419157|FG003|Overall Study|Withdrawal by Subject|1|||
154998222|NCT02126826|559419158|FG004|Overall Study|Withdrawal by Subject|0|||
154998223|NCT02126826|559419159|FG005|Overall Study|Withdrawal by Subject|0|||
154998224|NCT02126826|559419160|FG006|Overall Study|Withdrawal by Subject|0|||
154998225|NCT01371747|559419161|FG000|Overall Study|Adverse Event|4|||
154998226|NCT01371747|559419162|FG001|Overall Study|Adverse Event|2|||
154998227|NCT01371747|559419163|FG002|Overall Study|Adverse Event|7|||
154998228|NCT01371747|559419164|FG003|Overall Study|Adverse Event|2|||
154998229|NCT01371747|559419165|FG004|Overall Study|Adverse Event|2|||
154998230|NCT01371747|559419166|FG005|Overall Study|Adverse Event|2|||
154998231|NCT01371747|559419161|FG000|Overall Study|Death|1|||
154998232|NCT01371747|559419162|FG001|Overall Study|Death|0|||
154998233|NCT01371747|559419163|FG002|Overall Study|Death|4|||
154998234|NCT01371747|559419164|FG003|Overall Study|Death|1|||
154998235|NCT01371747|559419165|FG004|Overall Study|Death|2|||
154998236|NCT01371747|559419166|FG005|Overall Study|Death|0|||
154998237|NCT01371747|559419161|FG000|Overall Study|Abnormal Renal Function|0|||
154998238|NCT01371747|559419162|FG001|Overall Study|Abnormal Renal Function|2|||
154998239|NCT01371747|559419163|FG002|Overall Study|Abnormal Renal Function|0|||
154998240|NCT01371747|559419164|FG003|Overall Study|Abnormal Renal Function|1|||
154998241|NCT01371747|559419165|FG004|Overall Study|Abnormal Renal Function|0|||
154998242|NCT01371747|559419166|FG005|Overall Study|Abnormal Renal Function|1|||
154998243|NCT01371747|559419161|FG000|Overall Study|High Serum Potassium Results|1|||
154998244|NCT01371747|559419162|FG001|Overall Study|High Serum Potassium Results|1|||
154998245|NCT01371747|559419163|FG002|Overall Study|High Serum Potassium Results|1|||
154998246|NCT01371747|559419164|FG003|Overall Study|High Serum Potassium Results|2|||
154998247|NCT01371747|559419165|FG004|Overall Study|High Serum Potassium Results|0|||
154998248|NCT01371747|559419166|FG005|Overall Study|High Serum Potassium Results|2|||
154998249|NCT01371747|559419161|FG000|Overall Study|Low Serum Potassium Results|1|||
154998250|NCT01371747|559419162|FG001|Overall Study|Low Serum Potassium Results|1|||
154998251|NCT01371747|559419163|FG002|Overall Study|Low Serum Potassium Results|1|||
154998252|NCT01371747|559419164|FG003|Overall Study|Low Serum Potassium Results|1|||
154998253|NCT01371747|559419165|FG004|Overall Study|Low Serum Potassium Results|0|||
154998254|NCT01371747|559419166|FG005|Overall Study|Low Serum Potassium Results|3|||
154998255|NCT01371747|559419161|FG000|Overall Study|Protocol Violation|0|||
154998256|NCT01371747|559419162|FG001|Overall Study|Protocol Violation|0|||
154998257|NCT01371747|559419163|FG002|Overall Study|Protocol Violation|1|||
154998258|NCT01371747|559419164|FG003|Overall Study|Protocol Violation|0|||
154998259|NCT01371747|559419165|FG004|Overall Study|Protocol Violation|0|||
154998260|NCT01371747|559419166|FG005|Overall Study|Protocol Violation|0|||
154998261|NCT01371747|559419161|FG000|Overall Study|Non-Compliance|3|||
154998262|NCT01371747|559419162|FG001|Overall Study|Non-Compliance|4|||
154998263|NCT01371747|559419163|FG002|Overall Study|Non-Compliance|3|||
154998264|NCT01371747|559419164|FG003|Overall Study|Non-Compliance|0|||
154998265|NCT01371747|559419165|FG004|Overall Study|Non-Compliance|0|||
154998266|NCT01371747|559419166|FG005|Overall Study|Non-Compliance|1|||
154998267|NCT01371747|559419161|FG000|Overall Study|Physician Decision|0|||
154998268|NCT01371747|559419162|FG001|Overall Study|Physician Decision|0|||
154998269|NCT01371747|559419163|FG002|Overall Study|Physician Decision|0|||
154998270|NCT01371747|559419164|FG003|Overall Study|Physician Decision|0|||
154998271|NCT01371747|559419165|FG004|Overall Study|Physician Decision|1|||
154998272|NCT01371747|559419166|FG005|Overall Study|Physician Decision|0|||
154998273|NCT01371747|559419161|FG000|Overall Study|Withdrawal by Subject|6|||
154998274|NCT01371747|559419162|FG001|Overall Study|Withdrawal by Subject|12|||
154998275|NCT01371747|559419163|FG002|Overall Study|Withdrawal by Subject|5|||
154998276|NCT01371747|559419164|FG003|Overall Study|Withdrawal by Subject|2|||
155122822|NCT02813668|559879891|FG000|Overall Study|Medical reasons not related to the study|4|||
155122823|NCT04662073|559879892|FG000|Overall Study|Withdrawal by Subject|1|||
155122824|NCT04662073|559879893|FG001|Overall Study|Withdrawal by Subject|0|||
155122825|NCT00598078|559879894|FG000|Period 2 (Day 2)|Adverse Event|1|||
155122826|NCT00598078|559879895|FG001|Period 2 (Day 2)|Adverse Event|0|||
155122827|NCT01813721|559879896|FG000|Overall Study|Ineligibility determined|63|||
155122828|NCT01813721|559879896|FG000|Overall Study|Withdrawal by Subject|1|||
155122829|NCT03366103|559879899|FG000|Overall Study|Disease Progression|3|||
155122830|NCT03366103|559879900|FG001|Overall Study|Disease Progression|1|||
155122831|NCT03366103|559879901|FG002|Overall Study|Disease Progression|0|||
155122832|NCT03366103|559879899|FG000|Overall Study|Adverse Event|0|||
155122833|NCT03366103|559879900|FG001|Overall Study|Adverse Event|1|||
155122834|NCT03366103|559879901|FG002|Overall Study|Adverse Event|0|||
155122835|NCT01344629|559879904|FG000|Crossover Period 2|Withdrawal by Subject|0|||
155122836|NCT01344629|559879905|FG001|Crossover Period 2|Withdrawal by Subject|1|||
155122837|NCT00900146|559879906|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
155122838|NCT00900146|559879907|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
155122839|NCT00900146|559879908|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
155122840|NCT00900146|559879909|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
155122841|NCT00900146|559879910|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
155122842|NCT00900146|559879906|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
155122843|NCT00900146|559879907|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
155122844|NCT00900146|559879908|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
155122845|NCT00900146|559879909|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
154998277|NCT01371747|559419165|FG004|Overall Study|Withdrawal by Subject|2|||
154998278|NCT01371747|559419166|FG005|Overall Study|Withdrawal by Subject|4|||
154998279|NCT01371747|559419161|FG000|Overall Study|Other Reasons|2|||
154998280|NCT01371747|559419162|FG001|Overall Study|Other Reasons|1|||
154998281|NCT01371747|559419163|FG002|Overall Study|Other Reasons|2|||
154998282|NCT01371747|559419164|FG003|Overall Study|Other Reasons|0|||
154998283|NCT01371747|559419165|FG004|Overall Study|Other Reasons|0|||
154998284|NCT01371747|559419166|FG005|Overall Study|Other Reasons|1|||
154998285|NCT02856555|559419167|FG000|Overall Study|Adverse Event|1|||
154998286|NCT02856555|559419168|FG001|Overall Study|Adverse Event|0|||
154998287|NCT02856555|559419169|FG002|Overall Study|Adverse Event|0|||
154998288|NCT02856555|559419167|FG000|Overall Study|Lost to Follow-up|1|||
154998289|NCT02856555|559419168|FG001|Overall Study|Lost to Follow-up|3|||
154998290|NCT02856555|559419169|FG002|Overall Study|Lost to Follow-up|0|||
154998291|NCT02856555|559419167|FG000|Overall Study|Withdrawal by Subject|3|||
154998292|NCT02856555|559419168|FG001|Overall Study|Withdrawal by Subject|0|||
154998293|NCT02856555|559419169|FG002|Overall Study|Withdrawal by Subject|0|||
154998294|NCT02856555|559419167|FG000|Overall Study|Randomized but Never Treated|0|||
154998295|NCT02856555|559419168|FG001|Overall Study|Randomized but Never Treated|1|||
154998296|NCT02856555|559419169|FG002|Overall Study|Randomized but Never Treated|0|||
154998297|NCT04971187|559419170|FG000|Overall Study|Screen failures|2|||
154998298|NCT01207583|559419173|FG000|Overall Study|Withdrawal by Subject|0|||
154998299|NCT01207583|559419174|FG001|Overall Study|Withdrawal by Subject|3|||
154998300|NCT01207583|559419175|FG002|Overall Study|Withdrawal by Subject|1|||
154998301|NCT01207583|559419173|FG000|Overall Study|Participant failed to return|1|||
154998302|NCT01207583|559419174|FG001|Overall Study|Participant failed to return|0|||
154998303|NCT01207583|559419175|FG002|Overall Study|Participant failed to return|0|||
154998304|NCT01207583|559419173|FG000|Overall Study|Lost to Follow-up|0|||
154998305|NCT01207583|559419174|FG001|Overall Study|Lost to Follow-up|2|||
154998306|NCT01207583|559419175|FG002|Overall Study|Lost to Follow-up|0|||
154998307|NCT01696058|559419177|FG000|Overall Study|Adverse Event|21|||
155122846|NCT00900146|559879910|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
155122847|NCT00900146|559879906|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
155122848|NCT00900146|559879907|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155122849|NCT00900146|559879908|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155122850|NCT00900146|559879909|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155177835|NCT05093790|560089429|FG001|Overall Study|Failure to meet continuation criteria|0|||
155122851|NCT00900146|559879910|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
155122852|NCT00900146|559879906|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
155122853|NCT00900146|559879907|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
155122854|NCT00900146|559879908|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
155122855|NCT00900146|559879909|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
154998308|NCT01696058|559419178|FG001|Overall Study|Adverse Event|11|||
154998309|NCT01696058|559419177|FG000|Overall Study|Lack of Efficacy|2|||
154998310|NCT01696058|559419178|FG001|Overall Study|Lack of Efficacy|3|||
154998311|NCT01696058|559419177|FG000|Overall Study|Protocol Violation|9|||
154998312|NCT01696058|559419178|FG001|Overall Study|Protocol Violation|3|||
154998313|NCT01696058|559419177|FG000|Overall Study|Lost to Follow-up|2|||
154998314|NCT01696058|559419178|FG001|Overall Study|Lost to Follow-up|5|||
155122856|NCT00900146|559879910|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
155122857|NCT00900146|559879906|FG000|Intermediate: Period III|Lost to Follow-up|2|||
155122858|NCT00900146|559879907|FG001|Intermediate: Period III|Lost to Follow-up|0|||
155122859|NCT00900146|559879908|FG002|Intermediate: Period III|Lost to Follow-up|0|||
155122860|NCT00900146|559879909|FG003|Intermediate: Period III|Lost to Follow-up|0|||
154998315|NCT01696058|559419177|FG000|Overall Study|Withdrawal by Subject|4|||
154998316|NCT01696058|559419178|FG001|Overall Study|Withdrawal by Subject|6|||
154998317|NCT01696058|559419177|FG000|Overall Study|Other reason prematurely discontinued|5|||
154998318|NCT01696058|559419178|FG001|Overall Study|Other reason prematurely discontinued|3|||
154998319|NCT02186834|559419180|FG000|Dose Escalation|Death|0|||
154998320|NCT02186834|559419181|FG001|Dose Escalation|Death|0|||
154998321|NCT02186834|559419182|FG002|Dose Escalation|Death|0|||
154998322|NCT02186834|559419183|FG003|Dose Escalation|Death|1|||
154998323|NCT02186834|559419184|FG004|Dose Escalation|Death|0|||
154998324|NCT02186834|559419185|FG005|Dose Escalation|Death|0|||
154998325|NCT02186834|559419180|FG000|Treatment at RP2D|Died prior to treatment|0|||
154998326|NCT02186834|559419181|FG001|Treatment at RP2D|Died prior to treatment|0|||
154998327|NCT02186834|559419182|FG002|Treatment at RP2D|Died prior to treatment|0|||
154998328|NCT02186834|559419183|FG003|Treatment at RP2D|Died prior to treatment|0|||
155122861|NCT00900146|559879910|FG004|Intermediate: Period III|Lost to Follow-up|1|||
154998329|NCT02186834|559419184|FG004|Treatment at RP2D|Died prior to treatment|0|||
154998330|NCT02186834|559419185|FG005|Treatment at RP2D|Died prior to treatment|1|||
154998331|NCT04746794|559419188|FG000|Overall Study|Did not complete any study assessment|50303|||
154998332|NCT04746794|559419189|FG001|Overall Study|Did not complete any study assessment|44997|||
154998333|NCT01422187|559419190|FG000|Overall Study|Personal reason|1|||
154998334|NCT01422187|559419191|FG001|Overall Study|Personal reason|0|||
154998335|NCT01422187|559419192|FG002|Overall Study|Personal reason|0|||
154998336|NCT01422187|559419190|FG000|Overall Study|Lost to Follow-up|0|||
154998337|NCT01422187|559419191|FG001|Overall Study|Lost to Follow-up|1|||
154998338|NCT01422187|559419192|FG002|Overall Study|Lost to Follow-up|0|||
154998339|NCT04611529|559419194|FG000|2-day Follow up|Lost to Follow-up|5|||
154998340|NCT04611529|559419195|FG001|2-day Follow up|Lost to Follow-up|6|||
154998341|NCT04611529|559419196|FG002|2-day Follow up|Lost to Follow-up|3|||
154998342|NCT00425373|559419201|FG000|Overall Study|Adverse Event|2|||
154998343|NCT00425373|559419202|FG001|Overall Study|Adverse Event|2|||
154998344|NCT00425373|559419203|FG002|Overall Study|Adverse Event|0|||
154998345|NCT00425373|559419204|FG003|Overall Study|Adverse Event|1|||
154998346|NCT00425373|559419205|FG004|Overall Study|Adverse Event|4|||
154998347|NCT00425373|559419206|FG005|Overall Study|Adverse Event|6|||
154998348|NCT00425373|559419207|FG006|Overall Study|Adverse Event|2|||
154998349|NCT00425373|559419208|FG007|Overall Study|Adverse Event|3|||
154998350|NCT00425373|559419209|FG008|Overall Study|Adverse Event|8|||
154998351|NCT00425373|559419201|FG000|Overall Study|Lost to Follow-up|0|||
154998352|NCT00425373|559419202|FG001|Overall Study|Lost to Follow-up|1|||
154998353|NCT00425373|559419203|FG002|Overall Study|Lost to Follow-up|0|||
154998354|NCT00425373|559419204|FG003|Overall Study|Lost to Follow-up|0|||
154998355|NCT00425373|559419205|FG004|Overall Study|Lost to Follow-up|1|||
154998356|NCT00425373|559419206|FG005|Overall Study|Lost to Follow-up|0|||
154998357|NCT00425373|559419207|FG006|Overall Study|Lost to Follow-up|0|||
154998358|NCT00425373|559419208|FG007|Overall Study|Lost to Follow-up|0|||
154998359|NCT00425373|559419209|FG008|Overall Study|Lost to Follow-up|0|||
154998360|NCT00425373|559419201|FG000|Overall Study|Protocol Violation|1|||
154998361|NCT00425373|559419202|FG001|Overall Study|Protocol Violation|0|||
154998362|NCT00425373|559419203|FG002|Overall Study|Protocol Violation|1|||
154998363|NCT00425373|559419204|FG003|Overall Study|Protocol Violation|0|||
154998364|NCT00425373|559419205|FG004|Overall Study|Protocol Violation|0|||
154998365|NCT00425373|559419206|FG005|Overall Study|Protocol Violation|0|||
154998366|NCT00425373|559419207|FG006|Overall Study|Protocol Violation|0|||
154998367|NCT00425373|559419208|FG007|Overall Study|Protocol Violation|5|||
154998368|NCT00425373|559419209|FG008|Overall Study|Protocol Violation|3|||
155122862|NCT00900146|559879906|FG000|Intermediate: Period III|Administrative problems|85|||
154998369|NCT00425373|559419201|FG000|Overall Study|Withdrawal by Subject|2|||
155122863|NCT00900146|559879907|FG001|Intermediate: Period III|Administrative problems|92|||
155122864|NCT00900146|559879908|FG002|Intermediate: Period III|Administrative problems|84|||
155122865|NCT00900146|559879909|FG003|Intermediate: Period III|Administrative problems|90|||
155122866|NCT00900146|559879910|FG004|Intermediate: Period III|Administrative problems|163|||
155122867|NCT05590000|559879911|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
155122868|NCT00746733|559879917|FG000|Second Intervention|Adverse Event|1|||
155177836|NCT05093790|560089430|FG002|Overall Study|Failure to meet continuation criteria|1|||
154998370|NCT00425373|559419202|FG001|Overall Study|Withdrawal by Subject|0|||
154998371|NCT00425373|559419203|FG002|Overall Study|Withdrawal by Subject|2|||
154998372|NCT00425373|559419204|FG003|Overall Study|Withdrawal by Subject|1|||
154998373|NCT00425373|559419205|FG004|Overall Study|Withdrawal by Subject|4|||
154998374|NCT00425373|559419206|FG005|Overall Study|Withdrawal by Subject|0|||
154998375|NCT00425373|559419207|FG006|Overall Study|Withdrawal by Subject|2|||
154998376|NCT00425373|559419208|FG007|Overall Study|Withdrawal by Subject|2|||
154998377|NCT00425373|559419209|FG008|Overall Study|Withdrawal by Subject|2|||
154998378|NCT00425373|559419201|FG000|Overall Study|Lack of Efficacy|0|||
154998379|NCT00425373|559419202|FG001|Overall Study|Lack of Efficacy|0|||
154998380|NCT00425373|559419203|FG002|Overall Study|Lack of Efficacy|0|||
154998381|NCT00425373|559419204|FG003|Overall Study|Lack of Efficacy|0|||
154998382|NCT00425373|559419205|FG004|Overall Study|Lack of Efficacy|1|||
154998383|NCT00425373|559419206|FG005|Overall Study|Lack of Efficacy|3|||
154998384|NCT00425373|559419207|FG006|Overall Study|Lack of Efficacy|3|||
154998385|NCT00425373|559419208|FG007|Overall Study|Lack of Efficacy|0|||
154998386|NCT00425373|559419209|FG008|Overall Study|Lack of Efficacy|5|||
154998387|NCT02960490|559419211|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
154998388|NCT02960490|559419212|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
154998389|NCT02960490|559419213|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998390|NCT02960490|559419214|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
155122869|NCT00746733|559879918|FG001|Second Intervention|Adverse Event|0|||
155122870|NCT00746733|559879917|FG000|Third Intervention|Withdrawal by Subject|1|||
155122871|NCT00746733|559879918|FG001|Third Intervention|Withdrawal by Subject|1|||
155122872|NCT00849875|559879919|FG000|Overall Study|Death|28|||
155122873|NCT00849875|559879919|FG000|Overall Study|Ongoing (unknown completion status)|11|||
155122874|NCT00849875|559879919|FG000|Overall Study|Others|6|||
155122875|NCT00849875|559879919|FG000|Overall Study|Lost to Follow-up|2|||
155122876|NCT04096820|559879926|FG000|Overall Study|Did not return for intervention|2|||
155177837|NCT05093790|560089431|FG003|Overall Study|Failure to meet continuation criteria|0|||
155177838|NCT05093790|560089428|FG000|Overall Study|Adverse Event|1|||
155177839|NCT05093790|560089429|FG001|Overall Study|Adverse Event|0|||
154998391|NCT02960490|559419215|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998392|NCT02960490|559419216|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998393|NCT02960490|559419217|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998394|NCT02960490|559419218|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998395|NCT02960490|559419219|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998396|NCT02960490|559419220|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
154998397|NCT02960490|559419211|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998398|NCT02960490|559419212|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
154998399|NCT02960490|559419213|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998400|NCT02960490|559419214|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998401|NCT02960490|559419215|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998402|NCT02960490|559419216|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998403|NCT02960490|559419217|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998404|NCT02960490|559419218|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998405|NCT02960490|559419219|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998406|NCT02960490|559419220|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
154998407|NCT02960490|559419211|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
154998408|NCT02960490|559419212|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
154998409|NCT02960490|559419213|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998410|NCT02960490|559419214|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998411|NCT02960490|559419215|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998412|NCT02960490|559419216|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998413|NCT02960490|559419217|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998414|NCT02960490|559419218|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998415|NCT02960490|559419219|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998416|NCT02960490|559419220|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
154998417|NCT02960490|559419211|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
154998418|NCT02960490|559419212|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
154998419|NCT02960490|559419213|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
154998420|NCT02960490|559419214|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
154998421|NCT02960490|559419215|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155122877|NCT04096820|559879926|FG000|Overall Study|Death|1|||
155122878|NCT00664326|559881782|FG000|Overall Study|Adverse Event|14|||
155122879|NCT00664326|559881782|FG000|Overall Study|Noncompliance with study medication|3|||
155122880|NCT00664326|559881782|FG000|Overall Study|Withdrawal by Subject|1|||
155122881|NCT00664326|559881782|FG000|Overall Study|Physician Decision|1|||
155122882|NCT00664326|559881782|FG000|Overall Study|Other Reasons|3|||
155122883|NCT00664326|559881782|FG000|Overall Study|Death|2|||
155122884|NCT00664326|559881782|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
155122885|NCT03647267|559881785|FG000|Overall Study|Lost to Follow-up|1|||
154998422|NCT02960490|559419216|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
154998423|NCT02960490|559419217|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
155122886|NCT03647267|559881786|FG001|Overall Study|Lost to Follow-up|0|||
155122887|NCT03131596|559881789|FG000|Overall Study|Protocol Violation|3|||
155122888|NCT03131596|559881790|FG001|Overall Study|Protocol Violation|3|||
155122889|NCT03131596|559881789|FG000|Overall Study|Lost to Follow-up|3|||
155177840|NCT05093790|560089430|FG002|Overall Study|Adverse Event|0|||
155122890|NCT03131596|559881790|FG001|Overall Study|Lost to Follow-up|0|||
155122891|NCT00734071|559881791|FG000|Overall Study|Adverse Event|4|||
155122892|NCT00734071|559881792|FG001|Overall Study|Adverse Event|3|||
155122893|NCT00734071|559881791|FG000|Overall Study|Lack of Efficacy|3|||
155122894|NCT00734071|559881792|FG001|Overall Study|Lack of Efficacy|1|||
154920800|NCT04585906|559133568|FG000|Overall Study|Lost to Follow-up|8|||
154920801|NCT04585906|559133569|FG001|Overall Study|Lost to Follow-up|5|||
154920802|NCT04626947|559133570|FG000|Overall Study|Study terminated|14|||
154920803|NCT04246593|559133578|FG000|Overall Study|Withdrawal by Subject|14|||
154920804|NCT04246593|559133579|FG001|Overall Study|Withdrawal by Subject|13|||
154920805|NCT04246593|559133578|FG000|Overall Study|Lost to Follow-up|124|||
154920806|NCT04246593|559133579|FG001|Overall Study|Lost to Follow-up|71|||
154920807|NCT04246593|559133578|FG000|Overall Study|Moved out of area/became ineligible|3|||
154920808|NCT04246593|559133579|FG001|Overall Study|Moved out of area/became ineligible|1|||
154920809|NCT04246593|559133578|FG000|Overall Study|Reason unknown|4|||
154920810|NCT04246593|559133579|FG001|Overall Study|Reason unknown|2|||
154920811|NCT01012765|559133582|FG000|Treatment Period 1|Adverse Event|1|||
154920812|NCT01012765|559133583|FG001|Treatment Period 1|Adverse Event|0|||
154920813|NCT01012765|559133584|FG002|Treatment Period 1|Adverse Event|1|||
154920814|NCT01012765|559133585|FG003|Treatment Period 1|Adverse Event|0|||
154920815|NCT01012765|559133586|FG004|Treatment Period 1|Adverse Event|0|||
154920816|NCT01012765|559133587|FG005|Treatment Period 1|Adverse Event|0|||
154920817|NCT01012765|559133582|FG000|Treatment Period 1|Withdrawal by Subject|2|||
154920818|NCT01012765|559133583|FG001|Treatment Period 1|Withdrawal by Subject|0|||
154920819|NCT01012765|559133584|FG002|Treatment Period 1|Withdrawal by Subject|0|||
154920820|NCT01012765|559133585|FG003|Treatment Period 1|Withdrawal by Subject|0|||
154920821|NCT01012765|559133586|FG004|Treatment Period 1|Withdrawal by Subject|0|||
154920822|NCT01012765|559133587|FG005|Treatment Period 1|Withdrawal by Subject|0|||
154920823|NCT01012765|559133582|FG000|Treatment Period 1|Administrative problems|0|||
154920824|NCT01012765|559133583|FG001|Treatment Period 1|Administrative problems|0|||
154920825|NCT01012765|559133584|FG002|Treatment Period 1|Administrative problems|1|||
154920826|NCT01012765|559133585|FG003|Treatment Period 1|Administrative problems|1|||
154920827|NCT01012765|559133586|FG004|Treatment Period 1|Administrative problems|1|||
154920828|NCT01012765|559133587|FG005|Treatment Period 1|Administrative problems|0|||
154920829|NCT01012765|559133582|FG000|Treatment Period 1|Protocol Violation|0|||
154920830|NCT01012765|559133583|FG001|Treatment Period 1|Protocol Violation|0|||
154920831|NCT01012765|559133584|FG002|Treatment Period 1|Protocol Violation|0|||
154920832|NCT01012765|559133585|FG003|Treatment Period 1|Protocol Violation|2|||
154920833|NCT01012765|559133586|FG004|Treatment Period 1|Protocol Violation|1|||
154920834|NCT01012765|559133587|FG005|Treatment Period 1|Protocol Violation|0|||
154920835|NCT01012765|559133582|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
154920836|NCT01012765|559133583|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
154920837|NCT01012765|559133584|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
154920838|NCT01012765|559133585|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
154920839|NCT01012765|559133586|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
154920840|NCT01012765|559133587|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
154920841|NCT01012765|559133582|FG000|Treatment Period 2|Withdrawal by Subject|1|||
154920842|NCT01012765|559133583|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154920843|NCT01012765|559133584|FG002|Treatment Period 2|Withdrawal by Subject|1|||
154920844|NCT01012765|559133585|FG003|Treatment Period 2|Withdrawal by Subject|0|||
154920845|NCT01012765|559133586|FG004|Treatment Period 2|Withdrawal by Subject|1|||
154920846|NCT01012765|559133587|FG005|Treatment Period 2|Withdrawal by Subject|0|||
154920847|NCT01012765|559133582|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
154920848|NCT01012765|559133583|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
154920849|NCT01012765|559133584|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
154920850|NCT01012765|559133585|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
154920851|NCT01012765|559133586|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
154920852|NCT01012765|559133587|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
154920853|NCT01012765|559133582|FG000|Treatment Period 2|Adverse Event|0|||
154920854|NCT01012765|559133583|FG001|Treatment Period 2|Adverse Event|1|||
154920855|NCT01012765|559133584|FG002|Treatment Period 2|Adverse Event|1|||
154920856|NCT01012765|559133585|FG003|Treatment Period 2|Adverse Event|0|||
154920857|NCT01012765|559133586|FG004|Treatment Period 2|Adverse Event|0|||
154920858|NCT01012765|559133587|FG005|Treatment Period 2|Adverse Event|0|||
154920859|NCT01012765|559133582|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
154920860|NCT01012765|559133583|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
154920861|NCT01012765|559133584|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
154920862|NCT01012765|559133585|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
154920863|NCT01012765|559133586|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
154920864|NCT01012765|559133587|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
154920865|NCT01326312|559133588|FG000|Overall Study|Adverse Event|11|||
154920866|NCT01326312|559133589|FG001|Overall Study|Adverse Event|11|||
154920867|NCT01326312|559133590|FG002|Overall Study|Adverse Event|1|||
154920868|NCT01326312|559133588|FG000|Overall Study|Withdrawal by Subject|1|||
154998424|NCT02960490|559419218|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
154998425|NCT02960490|559419219|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
154998426|NCT02960490|559419220|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
154998427|NCT02960490|559419211|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998428|NCT02960490|559419212|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998429|NCT02960490|559419213|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
154998430|NCT02960490|559419214|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
154998431|NCT02960490|559419215|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998432|NCT02960490|559419216|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
154998433|NCT02960490|559419217|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998434|NCT02960490|559419218|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998435|NCT02960490|559419219|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998436|NCT02960490|559419220|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
154998437|NCT02960490|559419211|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998438|NCT02960490|559419212|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998439|NCT02960490|559419213|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
154998440|NCT02960490|559419214|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998441|NCT02960490|559419215|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
154998442|NCT02960490|559419216|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998443|NCT02960490|559419217|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998444|NCT02960490|559419218|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998445|NCT02960490|559419219|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998446|NCT02960490|559419220|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
154998447|NCT02960490|559419211|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
154998448|NCT02960490|559419212|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
154998449|NCT02960490|559419213|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
154998450|NCT02960490|559419214|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
154998451|NCT02960490|559419215|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
154998452|NCT02960490|559419216|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
154998453|NCT02960490|559419217|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
154998454|NCT02960490|559419218|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
154998455|NCT02960490|559419219|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
154998456|NCT02960490|559419220|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
154998457|NCT02960490|559419211|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998458|NCT02960490|559419212|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998459|NCT02960490|559419213|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998460|NCT02960490|559419214|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998461|NCT02960490|559419215|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998462|NCT02960490|559419216|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998463|NCT02960490|559419217|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
154998464|NCT02960490|559419218|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
154998465|NCT02960490|559419219|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
154998466|NCT02960490|559419220|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
154998467|NCT02960490|559419211|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998468|NCT02960490|559419212|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998469|NCT02960490|559419213|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998470|NCT02960490|559419214|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998471|NCT02960490|559419215|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998472|NCT02960490|559419216|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998473|NCT02960490|559419217|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998474|NCT02960490|559419218|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
154998475|NCT02960490|559419219|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998476|NCT02960490|559419220|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
154998477|NCT02960490|559419211|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
154998478|NCT02960490|559419212|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
154998479|NCT02960490|559419213|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
154998480|NCT02960490|559419214|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
154998481|NCT02960490|559419215|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
154998482|NCT02960490|559419216|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
154998483|NCT02960490|559419217|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
154998484|NCT02960490|559419218|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
154998485|NCT02960490|559419219|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
154998486|NCT02960490|559419220|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
154998487|NCT02960490|559419211|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998488|NCT02960490|559419212|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
155122895|NCT00734071|559881791|FG000|Overall Study|Noncompliance|2|||
154998489|NCT02960490|559419213|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998490|NCT02960490|559419214|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998491|NCT02960490|559419215|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998492|NCT02960490|559419216|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998493|NCT02960490|559419217|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
154998494|NCT02960490|559419218|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998495|NCT02960490|559419219|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998496|NCT02960490|559419220|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
154998497|NCT02960490|559419211|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998498|NCT02960490|559419212|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998499|NCT02960490|559419213|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998500|NCT02960490|559419214|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998501|NCT02960490|559419215|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998502|NCT02960490|559419216|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998503|NCT02960490|559419217|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998504|NCT02960490|559419218|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
154998505|NCT02960490|559419219|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998506|NCT02960490|559419220|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
154998507|NCT01590797|559419221|FG000|Overall Study|Adverse Event|4|||
154998508|NCT01590797|559419222|FG001|Overall Study|Adverse Event|3|||
154998509|NCT01590797|559419221|FG000|Overall Study|Lack of Efficacy|0|||
154998510|NCT01590797|559419222|FG001|Overall Study|Lack of Efficacy|2|||
154998511|NCT01590797|559419221|FG000|Overall Study|Lost to Follow-up|0|||
154998512|NCT01590797|559419222|FG001|Overall Study|Lost to Follow-up|1|||
154998513|NCT01590797|559419221|FG000|Overall Study|Protocol Violation|4|||
154998514|NCT01590797|559419222|FG001|Overall Study|Protocol Violation|1|||
154998515|NCT01590797|559419221|FG000|Overall Study|Withdrawal by Subject|7|||
154998516|NCT01590797|559419222|FG001|Overall Study|Withdrawal by Subject|5|||
154998517|NCT01590797|559419221|FG000|Overall Study|Other Protocol Specified Criteria|2|||
154998518|NCT01590797|559419222|FG001|Overall Study|Other Protocol Specified Criteria|4|||
154998519|NCT03106987|559419225|FG000|Overall Study|Death|37|||
154998520|NCT03106987|559419226|FG001|Overall Study|Death|22|||
154998521|NCT03106987|559419227|FG002|Overall Study|Death|12|||
154998522|NCT03106987|559419228|FG003|Overall Study|Death|8|||
154998523|NCT03106987|559419225|FG000|Overall Study|Lost to Follow-up|2|||
154998524|NCT03106987|559419226|FG001|Overall Study|Lost to Follow-up|0|||
154998525|NCT03106987|559419227|FG002|Overall Study|Lost to Follow-up|2|||
154998526|NCT03106987|559419228|FG003|Overall Study|Lost to Follow-up|2|||
154998527|NCT03106987|559419225|FG000|Overall Study|Withdrawal by Subject|5|||
154998528|NCT03106987|559419226|FG001|Overall Study|Withdrawal by Subject|1|||
154998529|NCT03106987|559419227|FG002|Overall Study|Withdrawal by Subject|4|||
154998530|NCT03106987|559419228|FG003|Overall Study|Withdrawal by Subject|1|||
154998531|NCT03336528|559419229|FG000|Overall Study|Protocol Violation|1|||
154998532|NCT03336528|559419230|FG001|Overall Study|Protocol Violation|1|||
155122896|NCT00734071|559881792|FG001|Overall Study|Noncompliance|2|||
155122897|NCT00734071|559881791|FG000|Overall Study|Protocol Deviations|3|||
155122898|NCT00734071|559881792|FG001|Overall Study|Protocol Deviations|4|||
155122899|NCT00734071|559881791|FG000|Overall Study|Voluntary Withdrawal|9|||
155122900|NCT00734071|559881792|FG001|Overall Study|Voluntary Withdrawal|7|||
155122901|NCT00734071|559881791|FG000|Overall Study|Lost to Follow-up|16|||
155122902|NCT00734071|559881792|FG001|Overall Study|Lost to Follow-up|8|||
155122903|NCT00734071|559881791|FG000|Overall Study|Other|1|||
155122904|NCT00734071|559881792|FG001|Overall Study|Other|2|||
155122905|NCT03654885|559881793|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
155122906|NCT03654885|559881794|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
155122907|NCT03654885|559881793|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
155122908|NCT03654885|559881794|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
155122909|NCT03654885|559881793|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
155122910|NCT03654885|559881794|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
155122911|NCT03654885|559881793|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
155122912|NCT03654885|559881794|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
155122913|NCT03654885|559881793|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
155122914|NCT03654885|559881794|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
155122915|NCT03654885|559881793|FG000|Overall Study|Adverse Event in Study Eye|3|||
155122916|NCT03654885|559881794|FG001|Overall Study|Adverse Event in Study Eye|0|||
155122917|NCT03654885|559881793|FG000|Overall Study|Consent Withdrawn|1|||
154998533|NCT03336528|559419229|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
154998534|NCT03336528|559419230|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
154998535|NCT03336528|559419229|FG000|Overall Study|Did not receive study medication|1|||
154998536|NCT03336528|559419230|FG001|Overall Study|Did not receive study medication|2|||
154998537|NCT00920790|559419233|FG000|Overall Study|aggravation of general condition|14|||
154998538|NCT02460679|559419234|FG000|Overall Study|Investigator Decision|1|||
154998539|NCT02460679|559419234|FG000|Overall Study|Withdrawal by Subject|4|||
154998540|NCT03280381|559419236|FG000|Overall Study|Physician Decision|0|||
154998541|NCT03280381|559419237|FG001|Overall Study|Physician Decision|2|||
154998542|NCT00468650|559419238|FG000|Overall Study|Lost to Follow-up|4|||
155122918|NCT03654885|559881794|FG001|Overall Study|Consent Withdrawn|0|||
155122919|NCT03654885|559881793|FG000|Overall Study|Death|3|||
155122920|NCT03654885|559881794|FG001|Overall Study|Death|1|||
155122921|NCT03654885|559881793|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
155122922|NCT03654885|559881794|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
155122923|NCT03654885|559881793|FG000|Overall Study|Lost to Follow-up|3|||
155122924|NCT03654885|559881794|FG001|Overall Study|Lost to Follow-up|3|||
155122925|NCT02943915|559881798|FG000|Overall Study|Withdrawal by Subject|2|||
155122926|NCT02943915|559881799|FG001|Overall Study|Withdrawal by Subject|1|||
155122927|NCT02943915|559881800|FG002|Overall Study|Withdrawal by Subject|0|||
155122928|NCT02943915|559881801|FG003|Overall Study|Withdrawal by Subject|0|||
155122929|NCT02943915|559881798|FG000|Overall Study|Lost to Follow-up|3|||
155122930|NCT02943915|559881799|FG001|Overall Study|Lost to Follow-up|1|||
155122931|NCT02943915|559881800|FG002|Overall Study|Lost to Follow-up|0|||
155122932|NCT02943915|559881801|FG003|Overall Study|Lost to Follow-up|0|||
154920869|NCT01326312|559133589|FG001|Overall Study|Withdrawal by Subject|2|||
154920870|NCT01326312|559133590|FG002|Overall Study|Withdrawal by Subject|1|||
154920871|NCT01326312|559133588|FG000|Overall Study|Protocol Violation|0|||
154920872|NCT01326312|559133589|FG001|Overall Study|Protocol Violation|1|||
154920873|NCT01326312|559133590|FG002|Overall Study|Protocol Violation|0|||
154920874|NCT01326312|559133588|FG000|Overall Study|Lack of Efficacy|13|||
154920875|NCT01326312|559133589|FG001|Overall Study|Lack of Efficacy|7|||
154920876|NCT01326312|559133590|FG002|Overall Study|Lack of Efficacy|1|||
154920877|NCT01326312|559133588|FG000|Overall Study|Death|1|||
154920878|NCT01326312|559133589|FG001|Overall Study|Death|0|||
154920879|NCT01326312|559133590|FG002|Overall Study|Death|1|||
154920880|NCT01326312|559133588|FG000|Overall Study|progressive disease|0|||
154920881|NCT01326312|559133589|FG001|Overall Study|progressive disease|1|||
154920882|NCT01326312|559133590|FG002|Overall Study|progressive disease|1|||
154920883|NCT01326312|559133588|FG000|Overall Study|Study terminated by Sponsor|8|||
154920884|NCT01326312|559133589|FG001|Overall Study|Study terminated by Sponsor|32|||
155122933|NCT02943915|559881798|FG000|Overall Study|excluded|0|||
155122934|NCT02943915|559881799|FG001|Overall Study|excluded|1|||
155122935|NCT02943915|559881800|FG002|Overall Study|excluded|0|||
155122936|NCT02943915|559881801|FG003|Overall Study|excluded|0|||
155122937|NCT03769311|559881802|FG000|Overall Study|Withdrawal by Subject|1|||
155122938|NCT02853435|559881803|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155122939|NCT02853435|559881804|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155122940|NCT02853435|559881805|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155122941|NCT02853435|559881806|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155122942|NCT02853435|559881807|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
155122943|NCT02853435|559881808|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
155122944|NCT03627065|559881811|FG000|Overall Study|Study Terminated by sponsor|1|||
155122945|NCT03627065|559881811|FG000|Overall Study|Withdrawal by Subject|2|||
155122946|NCT00996801|559881819|FG000|Overall Study|Adverse Event|6|||
155122947|NCT00996801|559881820|FG001|Overall Study|Adverse Event|4|||
155122948|NCT00996801|559881821|FG002|Overall Study|Adverse Event|12|||
155122949|NCT00996801|559881822|FG003|Overall Study|Adverse Event|17|||
155122950|NCT00996801|559881823|FG004|Overall Study|Adverse Event|31|||
155122951|NCT00996801|559881824|FG005|Overall Study|Adverse Event|3|||
155122952|NCT00996801|559881819|FG000|Overall Study|Lack of Efficacy|3|||
155122953|NCT00996801|559881820|FG001|Overall Study|Lack of Efficacy|0|||
155122954|NCT00996801|559881821|FG002|Overall Study|Lack of Efficacy|1|||
155122955|NCT00996801|559881822|FG003|Overall Study|Lack of Efficacy|3|||
155122956|NCT00996801|559881823|FG004|Overall Study|Lack of Efficacy|0|||
155122957|NCT00996801|559881824|FG005|Overall Study|Lack of Efficacy|1|||
155122958|NCT00996801|559881819|FG000|Overall Study|Lost to Follow-up|0|||
155122959|NCT00996801|559881820|FG001|Overall Study|Lost to Follow-up|0|||
155122960|NCT00996801|559881821|FG002|Overall Study|Lost to Follow-up|0|||
155122961|NCT00996801|559881822|FG003|Overall Study|Lost to Follow-up|3|||
155122962|NCT00996801|559881823|FG004|Overall Study|Lost to Follow-up|3|||
155122963|NCT00996801|559881824|FG005|Overall Study|Lost to Follow-up|2|||
155122964|NCT00996801|559881819|FG000|Overall Study|Physician Decision|0|||
155122965|NCT00996801|559881820|FG001|Overall Study|Physician Decision|0|||
155122966|NCT00996801|559881821|FG002|Overall Study|Physician Decision|0|||
155122967|NCT00996801|559881822|FG003|Overall Study|Physician Decision|1|||
155122968|NCT00996801|559881823|FG004|Overall Study|Physician Decision|0|||
154920885|NCT01326312|559133590|FG002|Overall Study|Study terminated by Sponsor|46|||
154998543|NCT00468650|559419238|FG000|Overall Study|Withdrawal by Subject|2|||
155122969|NCT00996801|559881824|FG005|Overall Study|Physician Decision|0|||
155122970|NCT00996801|559881819|FG000|Overall Study|Progressive Disease|0|||
155122971|NCT00996801|559881820|FG001|Overall Study|Progressive Disease|1|||
154920886|NCT01326312|559133588|FG000|Overall Study|Treatment arm terminated|19|||
154998544|NCT00468650|559419238|FG000|Overall Study|Protocol Violation|1|||
154998545|NCT02655666|559419239|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
154998546|NCT00789737|559419244|FG000|Overall Study|Withdrawal by Subject|13|||
154998547|NCT00789737|559419245|FG001|Overall Study|Withdrawal by Subject|22|||
154998548|NCT00789737|559419244|FG000|Overall Study|Lost to Follow-up|10|||
154998549|NCT00789737|559419245|FG001|Overall Study|Lost to Follow-up|14|||
154998550|NCT00789737|559419244|FG000|Overall Study|Adverse Event|8|||
154998551|NCT00789737|559419245|FG001|Overall Study|Adverse Event|8|||
154998552|NCT00789737|559419244|FG000|Overall Study|Protocol Violation|3|||
154998553|NCT00789737|559419245|FG001|Overall Study|Protocol Violation|0|||
154998554|NCT00789737|559419244|FG000|Overall Study|Lack of Efficacy|3|||
154998555|NCT00789737|559419245|FG001|Overall Study|Lack of Efficacy|0|||
154998556|NCT00789737|559419244|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
154998557|NCT00789737|559419245|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
154998558|NCT00789737|559419244|FG000|Overall Study|Other|11|||
154998559|NCT00789737|559419245|FG001|Overall Study|Other|7|||
154998560|NCT03136965|559419246|FG000|Overall Study|Lost to Follow-up|0|||
154998561|NCT03136965|559419247|FG001|Overall Study|Lost to Follow-up|1|||
154998562|NCT03136965|559419248|FG002|Overall Study|Lost to Follow-up|0|||
154998563|NCT02785952|559419249|FG000|Overall Study|Adverse Event|31|||
154998564|NCT02785952|559419250|FG001|Overall Study|Adverse Event|19|||
154998565|NCT02785952|559419249|FG000|Overall Study|Refusal unrelated to adverse events|10|||
154998566|NCT02785952|559419250|FG001|Overall Study|Refusal unrelated to adverse events|5|||
154998567|NCT02785952|559419249|FG000|Overall Study|Disease progression/relapse|61|||
154998568|NCT02785952|559419250|FG001|Overall Study|Disease progression/relapse|89|||
154998569|NCT02785952|559419249|FG000|Overall Study|Death|11|||
154998570|NCT02785952|559419250|FG001|Overall Study|Death|7|||
154998571|NCT02785952|559419249|FG000|Overall Study|Other- not protocol specified|6|||
154998572|NCT02785952|559419250|FG001|Overall Study|Other- not protocol specified|4|||
154998573|NCT02785952|559419249|FG000|Overall Study|On protocol treatment|6|||
154998574|NCT02785952|559419250|FG001|Overall Study|On protocol treatment|3|||
154998575|NCT00642278|559419251|FG000|Overall Study|Adverse Event|2|||
154998576|NCT00642278|559419252|FG001|Overall Study|Adverse Event|1|||
154998577|NCT00642278|559419253|FG002|Overall Study|Adverse Event|3|||
154998578|NCT00642278|559419254|FG003|Overall Study|Adverse Event|1|||
154998579|NCT00642278|559419255|FG004|Overall Study|Adverse Event|2|||
154998580|NCT00642278|559419256|FG005|Overall Study|Adverse Event|2|||
154998581|NCT00642278|559419257|FG006|Overall Study|Adverse Event|0|||
154998582|NCT00642278|559419251|FG000|Overall Study|Lack of Efficacy|0|||
154998583|NCT00642278|559419252|FG001|Overall Study|Lack of Efficacy|1|||
154998584|NCT00642278|559419253|FG002|Overall Study|Lack of Efficacy|0|||
154998585|NCT00642278|559419254|FG003|Overall Study|Lack of Efficacy|0|||
154998586|NCT00642278|559419255|FG004|Overall Study|Lack of Efficacy|0|||
154998587|NCT00642278|559419256|FG005|Overall Study|Lack of Efficacy|0|||
154998588|NCT00642278|559419257|FG006|Overall Study|Lack of Efficacy|0|||
154998589|NCT00642278|559419251|FG000|Overall Study|Lost to Follow-up|5|||
154998590|NCT00642278|559419252|FG001|Overall Study|Lost to Follow-up|1|||
154998591|NCT00642278|559419253|FG002|Overall Study|Lost to Follow-up|0|||
154998592|NCT00642278|559419254|FG003|Overall Study|Lost to Follow-up|1|||
154998593|NCT00642278|559419255|FG004|Overall Study|Lost to Follow-up|0|||
154998594|NCT00642278|559419256|FG005|Overall Study|Lost to Follow-up|1|||
154998595|NCT00642278|559419257|FG006|Overall Study|Lost to Follow-up|1|||
154998596|NCT00642278|559419251|FG000|Overall Study|Physician Decision|0|||
154998597|NCT00642278|559419252|FG001|Overall Study|Physician Decision|0|||
154998598|NCT00642278|559419253|FG002|Overall Study|Physician Decision|0|||
154998599|NCT00642278|559419254|FG003|Overall Study|Physician Decision|1|||
154998600|NCT00642278|559419255|FG004|Overall Study|Physician Decision|0|||
154998601|NCT00642278|559419256|FG005|Overall Study|Physician Decision|0|||
154998602|NCT00642278|559419257|FG006|Overall Study|Physician Decision|0|||
154998603|NCT00642278|559419251|FG000|Overall Study|Protocol Violation|0|||
154998604|NCT00642278|559419252|FG001|Overall Study|Protocol Violation|0|||
154998605|NCT00642278|559419253|FG002|Overall Study|Protocol Violation|1|||
154998606|NCT00642278|559419254|FG003|Overall Study|Protocol Violation|1|||
154998607|NCT00642278|559419255|FG004|Overall Study|Protocol Violation|0|||
154998608|NCT00642278|559419256|FG005|Overall Study|Protocol Violation|1|||
154998609|NCT00642278|559419257|FG006|Overall Study|Protocol Violation|2|||
154998610|NCT00642278|559419251|FG000|Overall Study|Withdrawal by Subject|1|||
154998611|NCT00642278|559419252|FG001|Overall Study|Withdrawal by Subject|1|||
154998612|NCT00642278|559419253|FG002|Overall Study|Withdrawal by Subject|1|||
154998613|NCT00642278|559419254|FG003|Overall Study|Withdrawal by Subject|3|||
154998614|NCT00642278|559419255|FG004|Overall Study|Withdrawal by Subject|6|||
154998615|NCT00642278|559419256|FG005|Overall Study|Withdrawal by Subject|2|||
154998616|NCT00642278|559419257|FG006|Overall Study|Withdrawal by Subject|2|||
155122972|NCT00996801|559881821|FG002|Overall Study|Progressive Disease|0|||
154998617|NCT00642278|559419251|FG000|Overall Study|Noncompliance with study drug regimen|0|||
154998618|NCT00642278|559419252|FG001|Overall Study|Noncompliance with study drug regimen|0|||
154998619|NCT00642278|559419253|FG002|Overall Study|Noncompliance with study drug regimen|0|||
154998620|NCT00642278|559419254|FG003|Overall Study|Noncompliance with study drug regimen|1|||
154998621|NCT00642278|559419255|FG004|Overall Study|Noncompliance with study drug regimen|0|||
154998622|NCT00642278|559419256|FG005|Overall Study|Noncompliance with study drug regimen|0|||
154998623|NCT00642278|559419257|FG006|Overall Study|Noncompliance with study drug regimen|0|||
154998624|NCT00642278|559419251|FG000|Overall Study|Other|2|||
154998625|NCT00642278|559419252|FG001|Overall Study|Other|1|||
154998626|NCT00642278|559419253|FG002|Overall Study|Other|0|||
154998627|NCT00642278|559419254|FG003|Overall Study|Other|1|||
154998628|NCT00642278|559419255|FG004|Overall Study|Other|0|||
154998629|NCT00642278|559419256|FG005|Overall Study|Other|1|||
154998630|NCT00642278|559419257|FG006|Overall Study|Other|0|||
154998631|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
154998632|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
154998633|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
154998634|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
154998635|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
154998636|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
154998637|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
154998638|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
154998639|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
154998640|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
154998641|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
154998642|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
154998643|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
154998644|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
154998645|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
154998646|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
154998647|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
154998648|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
154998649|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
154998650|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
154998651|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
154998652|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
154998653|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
154998654|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
154998655|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
154998656|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
154998657|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
154998658|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
154998659|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
154998660|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
154998661|NCT03713619|559419258|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
154998662|NCT03713619|559419259|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
154998663|NCT03713619|559419260|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
154998664|NCT03713619|559419261|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
154998665|NCT03713619|559419262|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
154998666|NCT03713619|559419258|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
154998667|NCT03713619|559419259|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
154998668|NCT03713619|559419260|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
154998669|NCT03713619|559419261|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
154998670|NCT03713619|559419262|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
154998671|NCT03713619|559419258|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
154998672|NCT03713619|559419259|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
154998673|NCT03713619|559419260|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155122973|NCT00996801|559881822|FG003|Overall Study|Progressive Disease|0|||
155122974|NCT00996801|559881823|FG004|Overall Study|Progressive Disease|0|||
155122975|NCT00996801|559881824|FG005|Overall Study|Progressive Disease|0|||
155122976|NCT00996801|559881819|FG000|Overall Study|Protocol Violation|3|||
155122977|NCT00996801|559881820|FG001|Overall Study|Protocol Violation|4|||
155122978|NCT00996801|559881821|FG002|Overall Study|Protocol Violation|1|||
155122979|NCT00996801|559881822|FG003|Overall Study|Protocol Violation|2|||
155122980|NCT00996801|559881823|FG004|Overall Study|Protocol Violation|3|||
155122981|NCT00996801|559881824|FG005|Overall Study|Protocol Violation|4|||
155122982|NCT00996801|559881819|FG000|Overall Study|Study Terminated by Sponsor|0|||
155122983|NCT00996801|559881820|FG001|Overall Study|Study Terminated by Sponsor|1|||
155122984|NCT00996801|559881821|FG002|Overall Study|Study Terminated by Sponsor|0|||
155122985|NCT00996801|559881822|FG003|Overall Study|Study Terminated by Sponsor|0|||
155122986|NCT00996801|559881823|FG004|Overall Study|Study Terminated by Sponsor|46|||
155122987|NCT00996801|559881824|FG005|Overall Study|Study Terminated by Sponsor|0|||
155122988|NCT00996801|559881819|FG000|Overall Study|Withdrawal by Subject|8|||
155122989|NCT00996801|559881820|FG001|Overall Study|Withdrawal by Subject|6|||
154998674|NCT03713619|559419261|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
154998675|NCT03713619|559419262|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
154998676|NCT03713619|559419258|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
154998677|NCT03713619|559419259|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
154998678|NCT03713619|559419260|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
154998679|NCT03713619|559419261|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
154998680|NCT03713619|559419262|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
154998681|NCT03713619|559419258|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
154998682|NCT03713619|559419259|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
154998683|NCT03713619|559419260|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
154998684|NCT03713619|559419261|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
154998685|NCT03713619|559419262|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
154998686|NCT03713619|559419258|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
154998687|NCT03713619|559419259|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
154998688|NCT03713619|559419260|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
154998689|NCT03713619|559419261|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
154998690|NCT03713619|559419262|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
154998691|NCT03713619|559419258|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
154998692|NCT03713619|559419259|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
154998693|NCT03713619|559419260|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
154998694|NCT03713619|559419261|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
154998695|NCT03713619|559419262|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
154998696|NCT04642365|559419264|FG000|Overall Study|Death|3|||
154998697|NCT04642365|559419265|FG001|Overall Study|Death|2|||
154998698|NCT04642365|559419266|FG002|Overall Study|Death|4|||
154998699|NCT04642365|559419267|FG003|Overall Study|Death|5|||
154998700|NCT04642365|559419268|FG004|Overall Study|Death|5|||
154998701|NCT04642365|559419269|FG005|Overall Study|Death|3|||
154998702|NCT04642365|559419270|FG006|Overall Study|Death|2|||
154998703|NCT04642365|559419271|FG007|Overall Study|Death|1|||
154998704|NCT04642365|559419264|FG000|Overall Study|Physician Decision|1|||
154998705|NCT04642365|559419265|FG001|Overall Study|Physician Decision|0|||
154998706|NCT04642365|559419266|FG002|Overall Study|Physician Decision|0|||
154998707|NCT04642365|559419267|FG003|Overall Study|Physician Decision|0|||
154998708|NCT04642365|559419268|FG004|Overall Study|Physician Decision|0|||
154998709|NCT04642365|559419269|FG005|Overall Study|Physician Decision|0|||
154998710|NCT04642365|559419270|FG006|Overall Study|Physician Decision|0|||
154998711|NCT04642365|559419271|FG007|Overall Study|Physician Decision|0|||
154998712|NCT04642365|559419264|FG000|Overall Study|Progressive Disease|1|||
154998713|NCT04642365|559419265|FG001|Overall Study|Progressive Disease|1|||
154998714|NCT04642365|559419266|FG002|Overall Study|Progressive Disease|1|||
154998715|NCT04642365|559419267|FG003|Overall Study|Progressive Disease|0|||
154998716|NCT04642365|559419268|FG004|Overall Study|Progressive Disease|0|||
154998717|NCT04642365|559419269|FG005|Overall Study|Progressive Disease|0|||
154998718|NCT04642365|559419270|FG006|Overall Study|Progressive Disease|1|||
154998719|NCT04642365|559419271|FG007|Overall Study|Progressive Disease|0|||
154998720|NCT04642365|559419264|FG000|Overall Study|Study Terminated By Sponsor|0|||
154998721|NCT04642365|559419265|FG001|Overall Study|Study Terminated By Sponsor|2|||
154998722|NCT04642365|559419266|FG002|Overall Study|Study Terminated By Sponsor|1|||
154998723|NCT04642365|559419267|FG003|Overall Study|Study Terminated By Sponsor|1|||
154998724|NCT04642365|559419268|FG004|Overall Study|Study Terminated By Sponsor|1|||
154998725|NCT04642365|559419269|FG005|Overall Study|Study Terminated By Sponsor|2|||
154998726|NCT04642365|559419270|FG006|Overall Study|Study Terminated By Sponsor|2|||
154998727|NCT04642365|559419271|FG007|Overall Study|Study Terminated By Sponsor|1|||
154998728|NCT04642365|559419264|FG000|Overall Study|Symptomatic Deterioration|1|||
154998729|NCT04642365|559419265|FG001|Overall Study|Symptomatic Deterioration|1|||
154998730|NCT04642365|559419266|FG002|Overall Study|Symptomatic Deterioration|0|||
154998731|NCT04642365|559419267|FG003|Overall Study|Symptomatic Deterioration|0|||
154998732|NCT04642365|559419268|FG004|Overall Study|Symptomatic Deterioration|0|||
154998733|NCT04642365|559419269|FG005|Overall Study|Symptomatic Deterioration|1|||
154998734|NCT04642365|559419270|FG006|Overall Study|Symptomatic Deterioration|0|||
154998735|NCT04642365|559419271|FG007|Overall Study|Symptomatic Deterioration|0|||
154998736|NCT04642365|559419264|FG000|Overall Study|Withdrawal by Subject|0|||
154998737|NCT04642365|559419265|FG001|Overall Study|Withdrawal by Subject|0|||
154998738|NCT04642365|559419266|FG002|Overall Study|Withdrawal by Subject|1|||
154998739|NCT04642365|559419267|FG003|Overall Study|Withdrawal by Subject|1|||
154998740|NCT04642365|559419268|FG004|Overall Study|Withdrawal by Subject|0|||
154998741|NCT04642365|559419269|FG005|Overall Study|Withdrawal by Subject|0|||
154998742|NCT04642365|559419270|FG006|Overall Study|Withdrawal by Subject|2|||
154998743|NCT04642365|559419271|FG007|Overall Study|Withdrawal by Subject|0|||
155122990|NCT00996801|559881821|FG002|Overall Study|Withdrawal by Subject|9|||
155122991|NCT00996801|559881822|FG003|Overall Study|Withdrawal by Subject|5|||
155122992|NCT00996801|559881823|FG004|Overall Study|Withdrawal by Subject|5|||
154998744|NCT04642365|559419264|FG000|Overall Study|Adverse Event|0|||
154998745|NCT04642365|559419265|FG001|Overall Study|Adverse Event|0|||
154998746|NCT04642365|559419266|FG002|Overall Study|Adverse Event|0|||
154998747|NCT04642365|559419267|FG003|Overall Study|Adverse Event|0|||
154998748|NCT04642365|559419268|FG004|Overall Study|Adverse Event|0|||
154998749|NCT04642365|559419269|FG005|Overall Study|Adverse Event|0|||
154998750|NCT04642365|559419270|FG006|Overall Study|Adverse Event|0|||
154998751|NCT04642365|559419271|FG007|Overall Study|Adverse Event|1|||
154998752|NCT01144715|559419272|FG000|Overall Study|Lost to Follow-up|2|||
154998753|NCT01144715|559419273|FG001|Overall Study|Lost to Follow-up|1|||
154998754|NCT01144715|559419272|FG000|Overall Study|Withdrawal by Subject|2|||
154998755|NCT01144715|559419273|FG001|Overall Study|Withdrawal by Subject|1|||
154998756|NCT01144715|559419272|FG000|Overall Study|Adverse Event|0|||
154998757|NCT01144715|559419273|FG001|Overall Study|Adverse Event|1|||
154998758|NCT03553576|559419274|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
154998759|NCT03553576|559419275|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
154998760|NCT03553576|559419274|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
154998761|NCT03553576|559419275|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
154998762|NCT03553576|559419274|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
154998763|NCT03553576|559419275|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
154998764|NCT03553576|559419274|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
154998765|NCT03553576|559419275|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
154998766|NCT03553576|559419274|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
154998767|NCT03553576|559419275|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
154998768|NCT03553576|559419274|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
154998769|NCT03553576|559419275|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
154998770|NCT03553576|559419274|FG000|Overall Study|Physician Decision|2|||
154998771|NCT03553576|559419275|FG001|Overall Study|Physician Decision|5|||
154998772|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
154998773|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
154998774|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
154998775|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
154998776|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
154998777|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
154998778|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
154998779|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
154998780|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
154998781|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
154998782|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
154998783|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
154998784|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
154998785|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
154998786|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
154998787|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
154998788|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
154998789|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
154998790|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
154998791|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
154998792|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
154998793|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
154998794|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
154998795|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
154998796|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
154998797|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
154998798|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
154998799|NCT02552212|559419276|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
154998800|NCT02552212|559419277|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
154998801|NCT02552212|559419278|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
154998802|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
154998803|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
154998804|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
154998805|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
154998806|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
154998807|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
154998808|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
154998809|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
154998810|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
154998811|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
154998812|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
155177841|NCT05093790|560089431|FG003|Overall Study|Adverse Event|0|||
155177842|NCT00827931|560089432|FG000|Overall Study|Death|3|||
155177843|NCT00827931|560089433|FG001|Overall Study|Death|5|||
154998813|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
154998814|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
154998815|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
154998816|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
154998817|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
154998818|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
154998819|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
154998820|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
154998821|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
154998822|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
154998823|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
154998824|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
154998825|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
154998826|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
154998827|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
154998828|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
154998829|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
154998830|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
154998831|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
154998832|NCT02552212|559419276|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
154998833|NCT02552212|559419277|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
154998834|NCT02552212|559419278|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
154998835|NCT02728843|559419279|FG000|Overall Study|Adverse Event|0|||
154998836|NCT02728843|559419280|FG001|Overall Study|Adverse Event|2|||
154998837|NCT02728843|559419281|FG002|Overall Study|Adverse Event|3|||
154998838|NCT02728843|559419282|FG003|Overall Study|Adverse Event|1|||
154998839|NCT02728843|559419283|FG004|Overall Study|Adverse Event|2|||
154998840|NCT02728843|559419279|FG000|Overall Study|Lack of Efficacy|0|||
154998841|NCT02728843|559419280|FG001|Overall Study|Lack of Efficacy|1|||
154998842|NCT02728843|559419281|FG002|Overall Study|Lack of Efficacy|1|||
154998843|NCT02728843|559419282|FG003|Overall Study|Lack of Efficacy|0|||
154998844|NCT02728843|559419283|FG004|Overall Study|Lack of Efficacy|0|||
154998845|NCT02728843|559419279|FG000|Overall Study|Protocol Violation|2|||
154998846|NCT02728843|559419280|FG001|Overall Study|Protocol Violation|0|||
154998847|NCT02728843|559419281|FG002|Overall Study|Protocol Violation|4|||
154998848|NCT02728843|559419282|FG003|Overall Study|Protocol Violation|2|||
154998849|NCT02728843|559419283|FG004|Overall Study|Protocol Violation|2|||
154998850|NCT02728843|559419279|FG000|Overall Study|Withdrawal by Subject|1|||
154998851|NCT02728843|559419280|FG001|Overall Study|Withdrawal by Subject|0|||
154998852|NCT02728843|559419281|FG002|Overall Study|Withdrawal by Subject|0|||
154998853|NCT02728843|559419282|FG003|Overall Study|Withdrawal by Subject|1|||
154998854|NCT02728843|559419283|FG004|Overall Study|Withdrawal by Subject|0|||
154998855|NCT02728843|559419279|FG000|Overall Study|Use of rescue medication|0|||
154998856|NCT02728843|559419280|FG001|Overall Study|Use of rescue medication|2|||
154998857|NCT02728843|559419281|FG002|Overall Study|Use of rescue medication|0|||
154998858|NCT02728843|559419282|FG003|Overall Study|Use of rescue medication|2|||
154998859|NCT02728843|559419283|FG004|Overall Study|Use of rescue medication|1|||
154998860|NCT02478320|559419284|FG000|Overall Study|Adverse Event|2|||
154998861|NCT02478320|559419285|FG001|Overall Study|Adverse Event|0|||
154998862|NCT02478320|559419284|FG000|Overall Study|Death|1|||
154998863|NCT02478320|559419285|FG001|Overall Study|Death|0|||
154998864|NCT02478320|559419284|FG000|Overall Study|Lack of Efficacy|4|||
154998865|NCT02478320|559419285|FG001|Overall Study|Lack of Efficacy|0|||
154998866|NCT02478320|559419284|FG000|Overall Study|Withdrawal by Subject|2|||
154998867|NCT02478320|559419285|FG001|Overall Study|Withdrawal by Subject|0|||
154998868|NCT02478320|559419284|FG000|Overall Study|Screen Failure|3|||
154998869|NCT02478320|559419285|FG001|Overall Study|Screen Failure|0|||
154998870|NCT00197496|559419289|FG000|Baseline to Discharge|not interested|1|||
154998871|NCT00197496|559419290|FG001|Baseline to Discharge|not interested|0|||
154998872|NCT00197496|559419289|FG000|Baseline to Discharge|MRSA|1|||
154998873|NCT00197496|559419290|FG001|Baseline to Discharge|MRSA|0|||
154998874|NCT00197496|559419289|FG000|Baseline to Discharge|Physician Decision|0|||
154998875|NCT00197496|559419290|FG001|Baseline to Discharge|Physician Decision|1|||
154998876|NCT00197496|559419289|FG000|Baseline to Discharge|Protocol Violation|0|||
154998877|NCT00197496|559419290|FG001|Baseline to Discharge|Protocol Violation|1|||
154998878|NCT00197496|559419289|FG000|Follow-up|Lost to Follow-up|2|||
154998879|NCT00197496|559419290|FG001|Follow-up|Lost to Follow-up|1|||
154998880|NCT00960115|559419291|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
154998881|NCT00960115|559419292|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
155177844|NCT00827931|560089432|FG000|Overall Study|Adverse Event|1|||
154998882|NCT03014180|559419296|FG000|Overall Study|Protocol Violation|2|||
154998883|NCT02952898|559419299|FG000|Overall Study|Withdrawal by Subject|10|||
154998884|NCT02952898|559419300|FG001|Overall Study|Withdrawal by Subject|8|||
154998885|NCT02952898|559419301|FG002|Overall Study|Withdrawal by Subject|8|||
154998886|NCT02952898|559419299|FG000|Overall Study|Adverse Event|8|||
154998887|NCT02952898|559419300|FG001|Overall Study|Adverse Event|8|||
154998888|NCT02952898|559419301|FG002|Overall Study|Adverse Event|3|||
154998889|NCT02952898|559419299|FG000|Overall Study|Lost to Follow-up|3|||
154998890|NCT02952898|559419300|FG001|Overall Study|Lost to Follow-up|2|||
154998891|NCT02952898|559419301|FG002|Overall Study|Lost to Follow-up|2|||
154998892|NCT02952898|559419299|FG000|Overall Study|Non-compliance with study drug|1|||
154998893|NCT02952898|559419300|FG001|Overall Study|Non-compliance with study drug|1|||
154998894|NCT02952898|559419301|FG002|Overall Study|Non-compliance with study drug|2|||
154998895|NCT02099682|559419302|FG000|Overall Study|Data Not Available|51|||
154998896|NCT02099682|559419302|FG000|Overall Study|Lost to Follow-up|31|||
154998897|NCT02099682|559419302|FG000|Overall Study|Other|29|||
154998898|NCT02802631|559419303|FG000|Overall Study|Withdrawal by Subject|1|||
154998899|NCT02802631|559419304|FG001|Overall Study|Withdrawal by Subject|0|||
154998900|NCT02802631|559419305|FG002|Overall Study|Withdrawal by Subject|0|||
154998901|NCT02802631|559419306|FG003|Overall Study|Withdrawal by Subject|0|||
154998902|NCT02802631|559419307|FG004|Overall Study|Withdrawal by Subject|0|||
154998903|NCT02802631|559419308|FG005|Overall Study|Withdrawal by Subject|0|||
154998904|NCT02802631|559419309|FG006|Overall Study|Withdrawal by Subject|0|||
154998905|NCT02802631|559419310|FG007|Overall Study|Withdrawal by Subject|0|||
154998906|NCT02802631|559419303|FG000|Overall Study|Physician Decision|1|||
154998907|NCT02802631|559419304|FG001|Overall Study|Physician Decision|0|||
154998908|NCT02802631|559419305|FG002|Overall Study|Physician Decision|0|||
154998909|NCT02802631|559419306|FG003|Overall Study|Physician Decision|0|||
154998910|NCT02802631|559419307|FG004|Overall Study|Physician Decision|0|||
154998911|NCT02802631|559419308|FG005|Overall Study|Physician Decision|0|||
154998912|NCT02802631|559419309|FG006|Overall Study|Physician Decision|1|||
154998913|NCT02802631|559419310|FG007|Overall Study|Physician Decision|0|||
154998914|NCT02802631|559419303|FG000|Overall Study|Adverse Event|0|||
154998915|NCT02802631|559419304|FG001|Overall Study|Adverse Event|2|||
154998916|NCT02802631|559419305|FG002|Overall Study|Adverse Event|0|||
154998917|NCT02802631|559419306|FG003|Overall Study|Adverse Event|1|||
154998918|NCT02802631|559419307|FG004|Overall Study|Adverse Event|6|||
154998919|NCT02802631|559419308|FG005|Overall Study|Adverse Event|1|||
154998920|NCT02802631|559419309|FG006|Overall Study|Adverse Event|4|||
154998921|NCT02802631|559419310|FG007|Overall Study|Adverse Event|0|||
154998922|NCT02802631|559419303|FG000|Overall Study|Sponsor Decision|0|||
154998923|NCT02802631|559419304|FG001|Overall Study|Sponsor Decision|0|||
154998924|NCT02802631|559419305|FG002|Overall Study|Sponsor Decision|6|||
154998925|NCT02802631|559419306|FG003|Overall Study|Sponsor Decision|0|||
154998926|NCT02802631|559419307|FG004|Overall Study|Sponsor Decision|2|||
154998927|NCT02802631|559419308|FG005|Overall Study|Sponsor Decision|0|||
154998928|NCT02802631|559419309|FG006|Overall Study|Sponsor Decision|0|||
154998929|NCT02802631|559419310|FG007|Overall Study|Sponsor Decision|4|||
154998930|NCT02212379|559419311|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
154998931|NCT02212379|559419311|FG000|From Baseline to Week 48|Adverse Event|7|||
154998932|NCT02212379|559419311|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
154998933|NCT02212379|559419311|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
154998934|NCT02212379|559419311|FG000|From Week 48 to Week 96|Adverse Event|1|||
154998935|NCT02212379|559419311|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
154998936|NCT02105974|559419312|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
154998937|NCT02105974|559419313|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
154998938|NCT02105974|559419314|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
154998939|NCT02105974|559419312|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
155122993|NCT00996801|559881824|FG005|Overall Study|Withdrawal by Subject|9|||
155122994|NCT00289198|559881825|FG000|Overall Study|Adverse Event|0|||
155122995|NCT00289198|559881826|FG001|Overall Study|Adverse Event|2|||
155122996|NCT00289198|559881825|FG000|Overall Study|Protocol Violation|2|||
155122997|NCT00289198|559881826|FG001|Overall Study|Protocol Violation|1|||
155122998|NCT00289198|559881825|FG000|Overall Study|Withdrawal by Subject|4|||
155122999|NCT00289198|559881826|FG001|Overall Study|Withdrawal by Subject|1|||
155123000|NCT00289198|559881825|FG000|Overall Study|Lack of Efficacy|2|||
155123001|NCT00289198|559881826|FG001|Overall Study|Lack of Efficacy|0|||
154998940|NCT02105974|559419313|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
154998941|NCT02105974|559419314|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
154998942|NCT02105974|559419312|FG000|2 Week Run-in Period|Adverse Event|6|||
154998943|NCT02105974|559419313|FG001|2 Week Run-in Period|Adverse Event|0|||
154998944|NCT02105974|559419314|FG002|2 Week Run-in Period|Adverse Event|0|||
154998945|NCT02105974|559419312|FG000|2 Week Run-in Period|Study closed/terminated|1|||
154998946|NCT02105974|559419313|FG001|2 Week Run-in Period|Study closed/terminated|0|||
154998947|NCT02105974|559419314|FG002|2 Week Run-in Period|Study closed/terminated|0|||
155123002|NCT00289198|559881825|FG000|Overall Study|Other: Low compliance|0|||
155177845|NCT00827931|560089433|FG001|Overall Study|Adverse Event|0|||
154998948|NCT02105974|559419312|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
154998949|NCT02105974|559419313|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
154998950|NCT02105974|559419314|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
154998951|NCT02105974|559419312|FG000|2 Week Run-in Period|Withdrew consent|23|||
154998952|NCT02105974|559419313|FG001|2 Week Run-in Period|Withdrew consent|0|||
154998953|NCT02105974|559419314|FG002|2 Week Run-in Period|Withdrew consent|0|||
154998954|NCT02105974|559419312|FG000|2 Week Run-in Period|Investigator discretion|8|||
154998955|NCT02105974|559419313|FG001|2 Week Run-in Period|Investigator discretion|0|||
154998956|NCT02105974|559419314|FG002|2 Week Run-in Period|Investigator discretion|0|||
154998957|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
154998958|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
154998959|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
154998960|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
154998961|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
154998962|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
154998963|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
154998964|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
154998965|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
154998966|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
154998967|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
154998968|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
154998969|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
154998970|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
154998971|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
154998972|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
154998973|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
154998974|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
154998975|NCT02105974|559419312|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
154998976|NCT02105974|559419313|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
154998977|NCT02105974|559419314|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
154998978|NCT02968849|559419315|FG000|Overall Study|Death|8|||
154998979|NCT02968849|559419316|FG001|Overall Study|Death|10|||
154998980|NCT02968849|559419315|FG000|Overall Study|Lost to Follow-up|31|||
154998981|NCT02968849|559419316|FG001|Overall Study|Lost to Follow-up|29|||
154998982|NCT02968849|559419315|FG000|Overall Study|Withdrawal by Subject|73|||
154998983|NCT02968849|559419316|FG001|Overall Study|Withdrawal by Subject|64|||
154998984|NCT02968849|559419315|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
154998985|NCT02968849|559419316|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
154998986|NCT02968849|559419315|FG000|Overall Study|Physician Decision|6|||
154998987|NCT02968849|559419316|FG001|Overall Study|Physician Decision|9|||
154998988|NCT02968849|559419315|FG000|Overall Study|Other|16|||
154998989|NCT02968849|559419316|FG001|Overall Study|Other|10|||
154998990|NCT00704730|559419319|FG000|Overall Study|Adverse Event|35|||
154998991|NCT00704730|559419320|FG001|Overall Study|Adverse Event|9|||
154998992|NCT00704730|559419319|FG000|Overall Study|Death|11|||
154998993|NCT00704730|559419320|FG001|Overall Study|Death|5|||
154998994|NCT00704730|559419319|FG000|Overall Study|Physician Decision|2|||
154998995|NCT00704730|559419320|FG001|Overall Study|Physician Decision|0|||
154998996|NCT00704730|559419319|FG000|Overall Study|Did not receive drug|5|||
154998997|NCT00704730|559419320|FG001|Overall Study|Did not receive drug|2|||
154998998|NCT00704730|559419319|FG000|Overall Study|Disease progression per PI|58|||
154998999|NCT00704730|559419320|FG001|Overall Study|Disease progression per PI|67|||
154999000|NCT00704730|559419319|FG000|Overall Study|data unavailable|1|||
154999001|NCT00704730|559419320|FG001|Overall Study|data unavailable|0|||
154999002|NCT00704730|559419319|FG000|Overall Study|Withdrawal by Subject|9|||
154999003|NCT00704730|559419320|FG001|Overall Study|Withdrawal by Subject|13|||
154999004|NCT03408639|559420829|FG000|Overall Study|Death|5|||
154999005|NCT03408639|559420830|FG001|Overall Study|Death|5|||
154999006|NCT03408639|559420829|FG000|Overall Study|Lost to Follow-up|1|||
154999007|NCT03408639|559420830|FG001|Overall Study|Lost to Follow-up|4|||
154999008|NCT03408639|559420829|FG000|Overall Study|Withdrawal by Subject|2|||
154999009|NCT03408639|559420830|FG001|Overall Study|Withdrawal by Subject|7|||
154999010|NCT03408639|559420829|FG000|Overall Study|Physician Decision|3|||
154999011|NCT03408639|559420830|FG001|Overall Study|Physician Decision|6|||
154999012|NCT01924754|559420832|FG000|Overall Study|Lost to Follow-up|1|||
154999013|NCT01924754|559420833|FG001|Overall Study|Lost to Follow-up|2|||
154999014|NCT01924754|559420834|FG002|Overall Study|Lost to Follow-up|1|||
154999015|NCT01924754|559420832|FG000|Overall Study|Pregnancy|0|||
154999016|NCT01924754|559420833|FG001|Overall Study|Pregnancy|1|||
154999017|NCT01924754|559420834|FG002|Overall Study|Pregnancy|2|||
154999018|NCT03132155|559420835|FG000|Overall Study|Lack of Efficacy|6|||
154999019|NCT03132155|559420835|FG000|Overall Study|Lost to Follow-up|1|||
154999020|NCT03132155|559420835|FG000|Overall Study|Withdrawal by Subject|1|||
154999021|NCT02925403|559420838|FG000|Overall Study|Lost to Follow-up|0|||
154999022|NCT02925403|559420839|FG001|Overall Study|Lost to Follow-up|1|||
154999023|NCT00402116|559420840|FG000|Overall Study|Jaw infection after surgery-other|1|||
154999024|NCT00402116|559420841|FG001|Overall Study|Jaw infection after surgery-other|0|||
154999025|NCT00402116|559420842|FG002|Overall Study|Jaw infection after surgery-other|0|||
154999026|NCT00402116|559420840|FG000|Overall Study|Withdrawal by Subject|1|||
154999027|NCT00402116|559420841|FG001|Overall Study|Withdrawal by Subject|0|||
154999028|NCT00402116|559420842|FG002|Overall Study|Withdrawal by Subject|5|||
154999029|NCT00402116|559420840|FG000|Overall Study|Treatment completed per protocol|1|||
154999030|NCT00402116|559420841|FG001|Overall Study|Treatment completed per protocol|1|||
154999031|NCT00402116|559420842|FG002|Overall Study|Treatment completed per protocol|2|||
154999032|NCT00402116|559420840|FG000|Overall Study|other complicating disease|0|||
154999033|NCT00402116|559420841|FG001|Overall Study|other complicating disease|0|||
154999034|NCT00402116|559420842|FG002|Overall Study|other complicating disease|2|||
154999035|NCT00402116|559420840|FG000|Overall Study|Disease Progression|0|||
154999036|NCT00402116|559420841|FG001|Overall Study|Disease Progression|4|||
154999037|NCT00402116|559420842|FG002|Overall Study|Disease Progression|38|||
154999038|NCT00402116|559420840|FG000|Overall Study|mistaken thrombocytopenia|0|||
154999039|NCT00402116|559420841|FG001|Overall Study|mistaken thrombocytopenia|0|||
154999040|NCT00402116|559420842|FG002|Overall Study|mistaken thrombocytopenia|1|||
154999041|NCT00402116|559420840|FG000|Overall Study|decline related hyponatremia/tumor|0|||
154999042|NCT00402116|559420841|FG001|Overall Study|decline related hyponatremia/tumor|0|||
154999043|NCT00402116|559420842|FG002|Overall Study|decline related hyponatremia/tumor|1|||
154999044|NCT00402116|559420840|FG000|Overall Study|Adverse Event|0|||
154999045|NCT00402116|559420841|FG001|Overall Study|Adverse Event|1|||
154999046|NCT00402116|559420842|FG002|Overall Study|Adverse Event|6|||
154999047|NCT02899195|559420843|FG000|Concurrent Durvalumab|Adverse Event|4|||
154999048|NCT02899195|559420843|FG000|Concurrent Durvalumab|Physician Decision|1|||
154999049|NCT02899195|559420843|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
154999050|NCT02899195|559420843|FG000|Concurrent Durvalumab|Progressive Disease|5|||
154999051|NCT02899195|559420843|FG000|Maintenance Durvalumab|Adverse Event|1|||
154999052|NCT02899195|559420843|FG000|Maintenance Durvalumab|Physician Decision|1|||
154999053|NCT02899195|559420843|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
154999054|NCT02899195|559420843|FG000|Maintenance Durvalumab|Progressive Disease|31|||
154999055|NCT04778904|559420844|FG000|Overall Study|Protocol Violation|1|||
154999056|NCT04778904|559420845|FG001|Overall Study|Protocol Violation|0|||
154999057|NCT04778904|559420846|FG002|Overall Study|Protocol Violation|0|||
154999058|NCT04778904|559420847|FG003|Overall Study|Protocol Violation|0|||
154999059|NCT04778904|559420844|FG000|Overall Study|Withdrawal by Subject|0|||
154999060|NCT04778904|559420845|FG001|Overall Study|Withdrawal by Subject|0|||
154999061|NCT04778904|559420846|FG002|Overall Study|Withdrawal by Subject|1|||
154999062|NCT04778904|559420847|FG003|Overall Study|Withdrawal by Subject|0|||
154999063|NCT04138043|559420848|FG000|Overall Study|Withdrawal by Subject|0|||
154999064|NCT04138043|559420849|FG001|Overall Study|Withdrawal by Subject|1|||
154999065|NCT02856802|559420850|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
154999066|NCT02856802|559420851|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
154999067|NCT02856802|559420850|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
154999068|NCT02856802|559420851|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
154999069|NCT02856802|559420850|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
154999070|NCT02856802|559420851|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
154999071|NCT02856802|559420850|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
154999072|NCT02856802|559420851|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
154999073|NCT02856802|559420850|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
154999074|NCT02856802|559420851|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
154999075|NCT02856802|559420850|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
154999076|NCT02856802|559420851|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
154999077|NCT03772717|559420852|FG000|Overall Study|Withdrawal by Subject|2|||
154999078|NCT00587860|559420853|FG000|Overall Study|Lost to Follow-up|2|||
154999079|NCT00587860|559420854|FG001|Overall Study|Lost to Follow-up|2|||
154999080|NCT00587860|559420853|FG000|Overall Study|Withdrawal by Subject|3|||
154999081|NCT00587860|559420854|FG001|Overall Study|Withdrawal by Subject|3|||
154999082|NCT01659125|559420855|FG000|Overall Study|Withdrawal by Subject|2|||
154999083|NCT01659125|559420855|FG000|Overall Study|Lost to Follow-up|7|||
154999084|NCT01659125|559420855|FG000|Overall Study|Technical Problem|1|||
154999085|NCT01659125|559420855|FG000|Overall Study|Time Constraints|2|||
154999086|NCT01659125|559420855|FG000|Overall Study|Failed to Start Treatment|2|||
154999087|NCT03092219|559420856|FG000|Overall Study|Protocol Violation|7|||
154999088|NCT03092219|559420857|FG001|Overall Study|Protocol Violation|4|||
154999089|NCT03278626|559420858|FG000|Overall Study|Death|2|||
154999090|NCT03278626|559420858|FG000|Overall Study|Toxicity|1|||
154999091|NCT03278626|559420858|FG000|Overall Study|Disease Progression|2|||
154999092|NCT05013008|559420862|FG000|Overall Study|Exclusion from mBFAS|5|||
154999093|NCT05013008|559420863|FG001|Overall Study|Exclusion from mBFAS|25|||
154999094|NCT02094417|559420864|FG000|Overall Study|Adverse Event|0|||
154999095|NCT02094417|559420865|FG001|Overall Study|Adverse Event|0|||
154999096|NCT02094417|559420866|FG002|Overall Study|Adverse Event|0|||
155123003|NCT00289198|559881826|FG001|Overall Study|Other: Low compliance|1|||
154999097|NCT02094417|559420867|FG003|Overall Study|Adverse Event|1|||
154999098|NCT02094417|559420864|FG000|Overall Study|Eligibility criteria|0|||
154999099|NCT02094417|559420865|FG001|Overall Study|Eligibility criteria|1|||
154999100|NCT02094417|559420866|FG002|Overall Study|Eligibility criteria|0|||
154999101|NCT02094417|559420867|FG003|Overall Study|Eligibility criteria|0|||
154999102|NCT02094417|559420864|FG000|Overall Study|No responder|4|||
154999103|NCT02094417|559420865|FG001|Overall Study|No responder|4|||
154999104|NCT02094417|559420866|FG002|Overall Study|No responder|4|||
154999105|NCT02094417|559420867|FG003|Overall Study|No responder|3|||
154999106|NCT02094417|559420864|FG000|Overall Study|Unable to conduct observations or assess|0|||
154999107|NCT02094417|559420865|FG001|Overall Study|Unable to conduct observations or assess|1|||
154999108|NCT02094417|559420866|FG002|Overall Study|Unable to conduct observations or assess|0|||
154999109|NCT02094417|559420867|FG003|Overall Study|Unable to conduct observations or assess|0|||
154999110|NCT02094417|559420864|FG000|Overall Study|Withdrawal by Subject|1|||
154999111|NCT02094417|559420865|FG001|Overall Study|Withdrawal by Subject|2|||
154999112|NCT02094417|559420866|FG002|Overall Study|Withdrawal by Subject|1|||
154999113|NCT02094417|559420867|FG003|Overall Study|Withdrawal by Subject|3|||
154999114|NCT03333941|559420868|FG000|Overall Study|Lost to Follow-up|10|||
154999115|NCT03333941|559420868|FG000|Overall Study|Death|2|||
154999116|NCT03333941|559420868|FG000|Overall Study|Adverse Event|1|||
154999117|NCT00741286|559420879|FG000|Overall Study|Lost to Follow-up|15|||
154999118|NCT00741286|559420880|FG001|Overall Study|Lost to Follow-up|10|||
154999119|NCT00741286|559420879|FG000|Overall Study|Adverse Event|1|||
154999120|NCT00741286|559420880|FG001|Overall Study|Adverse Event|6|||
154999121|NCT00741286|559420879|FG000|Overall Study|Protocol Violation|3|||
154999122|NCT00741286|559420880|FG001|Overall Study|Protocol Violation|2|||
154999123|NCT00741286|559420879|FG000|Overall Study|Primary Outcome|1|||
154999124|NCT00741286|559420880|FG001|Overall Study|Primary Outcome|1|||
154999125|NCT00253448|559420889|FG000|Overall Study|Withdrawal by Subject|1|||
154999126|NCT02564887|559420891|FG000|Overall Study|Lost to Follow-up|6|||
154999127|NCT02564887|559420892|FG001|Overall Study|Lost to Follow-up|0|||
154999128|NCT00000620|559420893|FG000|Overall Study|Death|86|||
154999129|NCT00000620|559420894|FG001|Overall Study|Death|67|||
154999130|NCT00000620|559420895|FG002|Overall Study|Death|112|||
154999131|NCT00000620|559420896|FG003|Overall Study|Death|126|||
154999132|NCT00000620|559420897|FG004|Overall Study|Death|64|||
154999133|NCT00000620|559420898|FG005|Overall Study|Death|77|||
154999134|NCT00000620|559420899|FG006|Overall Study|Death|91|||
154999135|NCT00000620|559420900|FG007|Overall Study|Death|95|||
154999136|NCT00000620|559420893|FG000|Overall Study|Lost to Follow-up|14|||
154999137|NCT00000620|559420894|FG001|Overall Study|Lost to Follow-up|14|||
154999138|NCT00000620|559420895|FG002|Overall Study|Lost to Follow-up|14|||
154999139|NCT00000620|559420896|FG003|Overall Study|Lost to Follow-up|14|||
154999140|NCT00000620|559420897|FG004|Overall Study|Lost to Follow-up|15|||
154999141|NCT00000620|559420898|FG005|Overall Study|Lost to Follow-up|15|||
154999142|NCT00000620|559420899|FG006|Overall Study|Lost to Follow-up|13|||
154999143|NCT00000620|559420900|FG007|Overall Study|Lost to Follow-up|14|||
154999144|NCT00000620|559420893|FG000|Overall Study|Withdrawal by Subject|40|||
154999145|NCT00000620|559420894|FG001|Overall Study|Withdrawal by Subject|27|||
154999146|NCT00000620|559420895|FG002|Overall Study|Withdrawal by Subject|28|||
154999147|NCT00000620|559420896|FG003|Overall Study|Withdrawal by Subject|27|||
154999148|NCT00000620|559420897|FG004|Overall Study|Withdrawal by Subject|30|||
154999149|NCT00000620|559420898|FG005|Overall Study|Withdrawal by Subject|32|||
154999150|NCT00000620|559420899|FG006|Overall Study|Withdrawal by Subject|32|||
154999151|NCT00000620|559420900|FG007|Overall Study|Withdrawal by Subject|21|||
154999152|NCT00000620|559420893|FG000|Overall Study|missed closeout visit|22|||
154999153|NCT00000620|559420894|FG001|Overall Study|missed closeout visit|28|||
154999154|NCT00000620|559420895|FG002|Overall Study|missed closeout visit|16|||
154999155|NCT00000620|559420896|FG003|Overall Study|missed closeout visit|11|||
154999156|NCT00000620|559420897|FG004|Overall Study|missed closeout visit|26|||
155123004|NCT00289198|559881825|FG000|Overall Study|Other: Physician's decision|0|||
154999157|NCT00000620|559420898|FG005|Overall Study|missed closeout visit|28|||
154999158|NCT00000620|559420899|FG006|Overall Study|missed closeout visit|13|||
154999159|NCT00000620|559420900|FG007|Overall Study|missed closeout visit|16|||
154999160|NCT02648932|559420901|FG000|Overall Study|No transplant|3|||
154999161|NCT02648932|559420902|FG001|Overall Study|No transplant|1|||
154999162|NCT01199016|559420903|FG000|Overall Study|No longer meets eligibility criteria|4|||
154999163|NCT01199016|559420903|FG000|Overall Study|Entrance criteria|5|||
154999164|NCT01199016|559420903|FG000|Overall Study|Protocol Violation|9|||
154999165|NCT01199016|559420903|FG000|Overall Study|Other|13|||
154999166|NCT01199016|559420903|FG000|Overall Study|Withdrawal by Subject|21|||
154999167|NCT01199016|559420903|FG000|Overall Study|Lost to Follow-up|25|||
154999168|NCT02368314|559420907|FG000|Overall Study|Withdrawal by Subject|2|||
154999169|NCT02368314|559420908|FG001|Overall Study|Withdrawal by Subject|1|||
154999170|NCT02368314|559420907|FG000|Overall Study|Adverse Event|1|||
154999171|NCT02368314|559420908|FG001|Overall Study|Adverse Event|2|||
154999172|NCT01266031|559420909|FG000|Overall Study|Not treated|0|||
154999173|NCT01266031|559420910|FG001|Overall Study|Not treated|3|||
155123005|NCT00289198|559881826|FG001|Overall Study|Other: Physician's decision|1|||
155123006|NCT00289198|559881825|FG000|Overall Study|Other: Unable to attend on schedule|2|||
155123007|NCT00289198|559881826|FG001|Overall Study|Other: Unable to attend on schedule|1|||
154999174|NCT01266031|559420911|FG002|Overall Study|Not treated|2|||
154999175|NCT01307111|559420912|FG000|IUD Insertion|Lost to Follow-up|2|||
154999176|NCT01307111|559420913|FG001|IUD Insertion|Lost to Follow-up|0|||
154999177|NCT01307111|559420912|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
154999178|NCT01307111|559420913|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
154999179|NCT02842073|559420915|FG000|Overall Study|Withdrawal by Subject|1|||
154999180|NCT01333397|559420918|FG000|Overall Study|Lost to Follow-up|1|||
154999181|NCT01333397|559420919|FG001|Overall Study|Lost to Follow-up|0|||
154999182|NCT01333397|559420920|FG002|Overall Study|Lost to Follow-up|0|||
154999183|NCT01333397|559420921|FG003|Overall Study|Lost to Follow-up|1|||
154999184|NCT01333397|559420922|FG004|Overall Study|Lost to Follow-up|0|||
154999185|NCT01994850|559420929|FG000|Overall Study|Physician Decision|1|||
154999186|NCT01994850|559420929|FG000|Overall Study|Withdrawal by Subject|1|||
154999187|NCT03485365|559420936|FG000|Overall Study|Protocol Violation|0|||
154999188|NCT03485365|559420937|FG001|Overall Study|Protocol Violation|0|||
154999189|NCT03485365|559420938|FG002|Overall Study|Protocol Violation|0|||
154999190|NCT03485365|559420939|FG003|Overall Study|Protocol Violation|1|||
154999191|NCT03485365|559420940|FG004|Overall Study|Protocol Violation|0|||
154999192|NCT03485365|559420941|FG005|Overall Study|Protocol Violation|0|||
154999193|NCT03485365|559420942|FG006|Overall Study|Protocol Violation|1|||
154999194|NCT03485365|559420943|FG007|Overall Study|Protocol Violation|0|||
154999195|NCT03485365|559420944|FG008|Overall Study|Protocol Violation|0|||
154999196|NCT00863772|559420949|FG000|Overall Study|Adverse Event|1|||
154999197|NCT00863772|559420950|FG001|Overall Study|Adverse Event|4|||
154999198|NCT00863772|559420951|FG002|Overall Study|Adverse Event|0|||
154999199|NCT00863772|559420949|FG000|Overall Study|Lack of Efficacy|4|||
154999200|NCT00863772|559420950|FG001|Overall Study|Lack of Efficacy|2|||
154999201|NCT00863772|559420951|FG002|Overall Study|Lack of Efficacy|4|||
154999202|NCT00863772|559420949|FG000|Overall Study|Lost to Follow-up|5|||
154999203|NCT00863772|559420950|FG001|Overall Study|Lost to Follow-up|1|||
154999204|NCT00863772|559420951|FG002|Overall Study|Lost to Follow-up|1|||
154999205|NCT00863772|559420949|FG000|Overall Study|Protocol Violation|2|||
154999206|NCT00863772|559420950|FG001|Overall Study|Protocol Violation|0|||
154999207|NCT00863772|559420951|FG002|Overall Study|Protocol Violation|2|||
154999208|NCT00863772|559420949|FG000|Overall Study|Withdrawal by Subject|4|||
154999209|NCT00863772|559420950|FG001|Overall Study|Withdrawal by Subject|7|||
154999210|NCT00863772|559420951|FG002|Overall Study|Withdrawal by Subject|5|||
154999211|NCT00863772|559420949|FG000|Overall Study|Study terminated by sponsor|44|||
154999212|NCT00863772|559420950|FG001|Overall Study|Study terminated by sponsor|45|||
154999213|NCT00863772|559420951|FG002|Overall Study|Study terminated by sponsor|36|||
154999214|NCT00863772|559420949|FG000|Overall Study|Entered extension study|6|||
154999215|NCT00863772|559420950|FG001|Overall Study|Entered extension study|4|||
154999216|NCT00863772|559420951|FG002|Overall Study|Entered extension study|9|||
154999217|NCT00863772|559420949|FG000|Overall Study|Other|1|||
154999218|NCT00863772|559420950|FG001|Overall Study|Other|2|||
154999219|NCT00863772|559420951|FG002|Overall Study|Other|4|||
154999220|NCT00863772|559420949|FG000|Overall Study|Randomized but not Treated|1|||
154999221|NCT00863772|559420950|FG001|Overall Study|Randomized but not Treated|0|||
154999222|NCT00863772|559420951|FG002|Overall Study|Randomized but not Treated|0|||
154999223|NCT04844762|559420962|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999224|NCT04844762|559420963|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999225|NCT04844762|559420964|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
154999226|NCT04844762|559420965|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999227|NCT04844762|559420966|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999228|NCT04844762|559420967|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999229|NCT04844762|559420962|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
154999230|NCT04844762|559420963|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
154999231|NCT04844762|559420964|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
154999232|NCT04844762|559420965|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
154999233|NCT04844762|559420966|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
154999234|NCT04844762|559420967|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
154999235|NCT04844762|559420962|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999236|NCT04844762|559420963|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999237|NCT04844762|559420964|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
154999238|NCT04844762|559420965|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
154999239|NCT04844762|559420966|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999240|NCT04844762|559420967|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
154999241|NCT04844762|559420962|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999242|NCT04844762|559420963|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999243|NCT04844762|559420964|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
154999244|NCT04844762|559420965|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
154999245|NCT04844762|559420966|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
154999246|NCT04844762|559420967|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999247|NCT04844762|559420962|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
154999248|NCT04844762|559420963|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
154999249|NCT04844762|559420964|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999250|NCT04844762|559420965|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999251|NCT04844762|559420966|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999252|NCT04844762|559420967|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999253|NCT04844762|559420962|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
154999254|NCT04844762|559420963|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999255|NCT04844762|559420964|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999256|NCT04844762|559420965|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999257|NCT04844762|559420966|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999258|NCT04844762|559420967|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999259|NCT04844762|559420962|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999260|NCT04844762|559420963|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999261|NCT04844762|559420964|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999262|NCT04844762|559420965|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999263|NCT04844762|559420966|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
154999264|NCT04844762|559420967|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
154999265|NCT04844762|559420962|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
154999266|NCT04844762|559420963|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999267|NCT04844762|559420964|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999268|NCT04844762|559420965|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999269|NCT04844762|559420966|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999270|NCT04844762|559420967|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
154999271|NCT04844762|559420962|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
154999272|NCT04844762|559420963|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999273|NCT04844762|559420964|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999274|NCT04844762|559420965|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
155123008|NCT00289198|559881825|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
155123009|NCT00289198|559881826|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
155123010|NCT00289198|559881825|FG000|Overall Study|Other: Impossible to come on visit|0|||
155123011|NCT00289198|559881826|FG001|Overall Study|Other: Impossible to come on visit|1|||
155123012|NCT03369431|559881834|FG000|Overall Study|Lost to Follow-up|1|||
155123013|NCT03369431|559881835|FG001|Overall Study|Lost to Follow-up|3|||
155123014|NCT03369431|559881834|FG000|Overall Study|Withdrawal by Subject|2|||
155123015|NCT03369431|559881835|FG001|Overall Study|Withdrawal by Subject|3|||
155123016|NCT03369431|559881834|FG000|Overall Study|Protocol Violation|1|||
155123017|NCT03369431|559881835|FG001|Overall Study|Protocol Violation|1|||
155123018|NCT01062061|559881836|FG000|Overall Study|Enrolled more than once|2|||
155123019|NCT01062061|559881836|FG000|Overall Study|Investigated before study start|13|||
155123020|NCT01062061|559881836|FG000|Overall Study|Outside chief indications|10|||
155123021|NCT01062061|559881836|FG000|Overall Study|Failed to meet inclusion criteria|2|||
155123022|NCT00004445|559881837|FG000|Overall Study|Physician Decision|2|||
155123023|NCT00004445|559881837|FG000|Overall Study|Withdrawal by Subject|1|||
155123024|NCT00076336|559881838|FG000|Overall Study|Death|13|||
155123025|NCT00076336|559881839|FG001|Overall Study|Death|17|||
155123026|NCT00076336|559881838|FG000|Overall Study|Adverse Event|4|||
155123027|NCT00076336|559881839|FG001|Overall Study|Adverse Event|4|||
155123028|NCT00076336|559881838|FG000|Overall Study|Lost to Follow-up|4|||
155123029|NCT00076336|559881839|FG001|Overall Study|Lost to Follow-up|4|||
155123030|NCT00076336|559881838|FG000|Overall Study|Non-Compliance|2|||
155123031|NCT00076336|559881839|FG001|Overall Study|Non-Compliance|0|||
155123032|NCT00076336|559881838|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
155123033|NCT00076336|559881839|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
155123034|NCT00076336|559881838|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
155123035|NCT00076336|559881839|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
155123036|NCT00076336|559881838|FG000|Overall Study|Liver Transplantation|3|||
155123037|NCT00076336|559881839|FG001|Overall Study|Liver Transplantation|3|||
155123038|NCT00076336|559881838|FG000|Overall Study|Virologic Breakthrough|14|||
155123039|NCT00076336|559881839|FG001|Overall Study|Virologic Breakthrough|16|||
155123040|NCT00076336|559881838|FG000|Overall Study|Treatment failure|4|||
155123041|NCT00076336|559881839|FG001|Overall Study|Treatment failure|5|||
155123042|NCT00524589|559881840|FG000|Overall Study|Withdrawal by Subject|2|||
155123043|NCT00524589|559881840|FG000|Overall Study|Disease Progression|16|||
155123044|NCT02753127|559881844|FG000|Overall Study|Lost to Follow-up|13|||
155123045|NCT02753127|559881845|FG001|Overall Study|Lost to Follow-up|11|||
155123046|NCT02753127|559881844|FG000|Overall Study|Withdrawal by Subject|37|||
154999275|NCT04844762|559420966|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
154999276|NCT04844762|559420967|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
154999277|NCT04844762|559420962|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
154999278|NCT04844762|559420963|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
154999279|NCT04844762|559420964|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
154999280|NCT04844762|559420965|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
154999281|NCT04844762|559420966|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
154999282|NCT04844762|559420967|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
154999283|NCT04844762|559420962|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
154999284|NCT04844762|559420963|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
154999285|NCT04844762|559420964|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
154999286|NCT04844762|559420965|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
154999287|NCT04844762|559420966|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
154999288|NCT04844762|559420967|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
154999289|NCT04400682|559420970|FG000|Period 1|Withdrawal by Subject|1|||
154999290|NCT04400682|559420971|FG001|Period 1|Withdrawal by Subject|4|||
154999291|NCT00477633|559420972|FG000|Overall Study|Did not receive treatment|23|||
154999292|NCT00477633|559420972|FG000|Overall Study|Adverse Event|143|||
154999293|NCT00477633|559420972|FG000|Overall Study|Pregnancy|23|||
154999294|NCT00477633|559420972|FG000|Overall Study|Lost to Follow-up|271|||
154999295|NCT00477633|559420972|FG000|Overall Study|Withdrawal by Subject|149|||
154999296|NCT00477633|559420972|FG000|Overall Study|Protocol Violation|25|||
154999297|NCT00477633|559420972|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
154999298|NCT02542605|559420980|FG000|Part B: Challenge Phase|Sponsor decision|1|||
154999299|NCT02542605|559420981|FG001|Part B: Challenge Phase|Sponsor decision|0|||
154999300|NCT02542605|559420982|FG002|Part B: Challenge Phase|Sponsor decision|0|||
154999301|NCT02542605|559420980|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
154999302|NCT02542605|559420981|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
154999303|NCT02542605|559420982|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
154999304|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
154999305|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
154999306|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
154999307|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
154999308|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
154999309|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
154999310|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
154999311|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
154999312|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
154999313|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
154999314|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
154999315|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
154999316|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
154999317|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
154999318|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
154999319|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
154999320|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
154999321|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
154999322|NCT00261443|559422455|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
154999323|NCT00261443|559422456|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
154999324|NCT00261443|559422457|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
154999325|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
154999326|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
154999327|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
154999328|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
154999329|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
154999330|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
154999331|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
154999332|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
154999333|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
154999334|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
154999335|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
154999336|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
154999337|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
154999338|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
154999339|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
154999340|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
154999341|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
154999342|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
154999343|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
154999344|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
154999345|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
154999346|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
154999347|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
154999348|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
154999349|NCT00261443|559422455|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
154999350|NCT00261443|559422456|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
154999351|NCT00261443|559422457|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
154999352|NCT00261443|559422455|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
154999353|NCT00261443|559422456|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
154999354|NCT00261443|559422457|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
154999355|NCT00261443|559422455|FG000|3: Assessment of Relapse|Adverse Event|0|||
154999356|NCT00261443|559422456|FG001|3: Assessment of Relapse|Adverse Event|15|||
154999357|NCT00261443|559422457|FG002|3: Assessment of Relapse|Adverse Event|19|||
154999358|NCT00261443|559422455|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
154999359|NCT00261443|559422456|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
154999360|NCT00261443|559422457|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
154999361|NCT00261443|559422455|FG000|3: Assessment of Relapse|Death|0|||
154999362|NCT00261443|559422456|FG001|3: Assessment of Relapse|Death|0|||
155123047|NCT02753127|559881845|FG001|Overall Study|Withdrawal by Subject|47|||
155123048|NCT02753127|559881844|FG000|Overall Study|Other|3|||
155123049|NCT02753127|559881845|FG001|Overall Study|Other|8|||
155177846|NCT00827931|560089432|FG000|Overall Study|Lost to Follow-up|1|||
155177847|NCT00827931|560089433|FG001|Overall Study|Lost to Follow-up|0|||
155177848|NCT00827931|560089432|FG000|Overall Study|Withdrawal by Subject|0|||
155177849|NCT00827931|560089433|FG001|Overall Study|Withdrawal by Subject|1|||
155177850|NCT00827931|560089432|FG000|Overall Study|Other|1|||
155177851|NCT00827931|560089433|FG001|Overall Study|Other|0|||
155177852|NCT02312687|560089436|FG000|Overall Study|Other, Not Specified|1|||
155177853|NCT01514370|560089439|FG000|Overall Study|Protocol Violation|2|||
155177854|NCT01514370|560089440|FG001|Overall Study|Protocol Violation|3|||
155177855|NCT01514370|560089439|FG000|Overall Study|Lost to Follow-up|0|||
155177856|NCT01514370|560089440|FG001|Overall Study|Lost to Follow-up|2|||
155177857|NCT01514370|560089439|FG000|Overall Study|Withdrawal by Subject|2|||
155123050|NCT02753127|559881844|FG000|Overall Study|Hospice|0|||
155177858|NCT01514370|560089440|FG001|Overall Study|Withdrawal by Subject|1|||
155177859|NCT01514370|560089439|FG000|Overall Study|Adverse Event|1|||
155177860|NCT01514370|560089440|FG001|Overall Study|Adverse Event|3|||
155177861|NCT01514370|560089439|FG000|Overall Study|Other|6|||
155123051|NCT02753127|559881845|FG001|Overall Study|Hospice|2|||
155123052|NCT00046930|559881848|FG000|Overall Study|Ineligible|12|||
155123053|NCT00046930|559881849|FG001|Overall Study|Ineligible|4|||
155123054|NCT00940485|559881855|FG000|Overall Study|HBeAb positive at Baseline|3|||
155123055|NCT00940485|559881856|FG001|Overall Study|HBeAb positive at Baseline|2|||
155123056|NCT00940485|559881855|FG000|Overall Study|Lost to Follow-up|2|||
155123057|NCT00940485|559881856|FG001|Overall Study|Lost to Follow-up|3|||
155123058|NCT00940485|559881855|FG000|Overall Study|Adverse Event|8|||
155123059|NCT00940485|559881856|FG001|Overall Study|Adverse Event|0|||
155123060|NCT00940485|559881855|FG000|Overall Study|Withdrawal by Subject|1|||
155123061|NCT00940485|559881856|FG001|Overall Study|Withdrawal by Subject|1|||
155123062|NCT00940485|559881855|FG000|Overall Study|Others|1|||
155123063|NCT00940485|559881856|FG001|Overall Study|Others|1|||
155123064|NCT01113580|559881857|FG000|Overall Study|Protocol Violation|1|||
155123065|NCT01113580|559881858|FG001|Overall Study|Protocol Violation|0|||
155123066|NCT01457950|559881862|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
155123067|NCT01457950|559881863|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
155123068|NCT01457950|559881864|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
155123069|NCT01457950|559881865|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
155123070|NCT01457950|559881862|FG000|Double-Blind Phase|Protocol Violation|2|||
155177862|NCT01514370|560089440|FG001|Overall Study|Other|7|||
155177863|NCT01089361|560089441|FG000|Overall Study|Death|1|||
155177864|NCT01089361|560089442|FG001|Overall Study|Death|0|||
154999363|NCT00261443|559422457|FG002|3: Assessment of Relapse|Death|1|||
154999364|NCT00261443|559422455|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
155123071|NCT01457950|559881863|FG001|Double-Blind Phase|Protocol Violation|1|||
155123072|NCT01457950|559881864|FG002|Double-Blind Phase|Protocol Violation|0|||
155123073|NCT01457950|559881865|FG003|Double-Blind Phase|Protocol Violation|0|||
155123074|NCT01457950|559881862|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
155123075|NCT01457950|559881863|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
155177865|NCT00960570|560089445|FG000|21 Day Washout Period|Adverse Event|1|||
155177866|NCT00960570|560089445|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
155177867|NCT00960570|560089445|FG000|1 Day Period Between Dosing|Adverse Event|2|||
155177868|NCT00960570|560089445|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
154999365|NCT00261443|559422456|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
154999366|NCT00261443|559422457|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
154999367|NCT00261443|559422455|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
154999368|NCT00261443|559422456|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
154999369|NCT00261443|559422457|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
154999370|NCT00261443|559422455|FG000|3: Assessment of Relapse|Pregnancy|0|||
154999371|NCT00261443|559422456|FG001|3: Assessment of Relapse|Pregnancy|2|||
154999372|NCT00261443|559422457|FG002|3: Assessment of Relapse|Pregnancy|1|||
154999373|NCT00261443|559422455|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
154999374|NCT00261443|559422456|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
154999375|NCT00261443|559422457|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
154999376|NCT00261443|559422455|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
154999377|NCT00261443|559422456|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
154999378|NCT00261443|559422457|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
154999379|NCT00261443|559422455|FG000|3: Assessment of Relapse|Other Reasons|0|||
154999380|NCT00261443|559422456|FG001|3: Assessment of Relapse|Other Reasons|4|||
154999381|NCT00261443|559422457|FG002|3: Assessment of Relapse|Other Reasons|3|||
154999382|NCT00261443|559422455|FG000|4: Extension Phase|Adverse Event|0|||
154999383|NCT00261443|559422456|FG001|4: Extension Phase|Adverse Event|1|||
154999384|NCT00261443|559422457|FG002|4: Extension Phase|Adverse Event|0|||
154999385|NCT00261443|559422455|FG000|4: Extension Phase|Withdrawal by Subject|0|||
154999386|NCT00261443|559422456|FG001|4: Extension Phase|Withdrawal by Subject|1|||
154999387|NCT00261443|559422457|FG002|4: Extension Phase|Withdrawal by Subject|2|||
154999388|NCT00261443|559422455|FG000|4: Extension Phase|Lost to Follow-up|0|||
154999389|NCT00261443|559422456|FG001|4: Extension Phase|Lost to Follow-up|1|||
154999390|NCT00261443|559422457|FG002|4: Extension Phase|Lost to Follow-up|0|||
154999391|NCT01443728|559422461|FG000|Overall Study|Lost to Follow-up|2|||
154999392|NCT01443728|559422462|FG001|Overall Study|Lost to Follow-up|0|||
154999393|NCT01443728|559422461|FG000|Overall Study|Withdrawal by Subject|1|||
154999394|NCT01443728|559422462|FG001|Overall Study|Withdrawal by Subject|1|||
154999395|NCT01443728|559422461|FG000|Overall Study|Adverse Event|0|||
154999396|NCT01443728|559422462|FG001|Overall Study|Adverse Event|2|||
154999397|NCT02052011|559422463|FG000|Overall Study|Lost to Follow-up|3|||
154999398|NCT02052011|559422464|FG001|Overall Study|Lost to Follow-up|0|||
154999399|NCT02052011|559422463|FG000|Overall Study|Withdrawal by Subject|1|||
154999400|NCT02052011|559422464|FG001|Overall Study|Withdrawal by Subject|2|||
154999401|NCT01851330|559422466|FG000|Overall Study|Lack of Efficacy|10|||
154999402|NCT01851330|559422467|FG001|Overall Study|Lack of Efficacy|9|||
154999403|NCT01851330|559422468|FG002|Overall Study|Lack of Efficacy|2|||
154999404|NCT01851330|559422466|FG000|Overall Study|Lost to Follow-up|1|||
154999405|NCT01851330|559422467|FG001|Overall Study|Lost to Follow-up|6|||
154999406|NCT01851330|559422468|FG002|Overall Study|Lost to Follow-up|9|||
154999407|NCT01851330|559422466|FG000|Overall Study|Withdrew Consent|2|||
154999408|NCT01851330|559422467|FG001|Overall Study|Withdrew Consent|1|||
154999409|NCT01851330|559422468|FG002|Overall Study|Withdrew Consent|0|||
154999410|NCT01851330|559422466|FG000|Overall Study|Investigator's Discretion|0|||
154999411|NCT01851330|559422467|FG001|Overall Study|Investigator's Discretion|0|||
154999412|NCT01851330|559422468|FG002|Overall Study|Investigator's Discretion|1|||
154999413|NCT02114385|559422479|FG000|Overall Study|Withdrawal by Subject|3|||
154999414|NCT02114385|559422480|FG001|Overall Study|Withdrawal by Subject|2|||
154999415|NCT02114385|559422479|FG000|Overall Study|Lost to Follow-up|0|||
154999416|NCT02114385|559422480|FG001|Overall Study|Lost to Follow-up|6|||
154999417|NCT02047734|559422484|FG000|Overall Study|Adverse Event|18|||
154999418|NCT02047734|559422485|FG001|Overall Study|Adverse Event|13|||
154999419|NCT02047734|559422486|FG002|Overall Study|Adverse Event|13|||
154999420|NCT02047734|559422484|FG000|Overall Study|Lack of Efficacy|4|||
154999421|NCT02047734|559422485|FG001|Overall Study|Lack of Efficacy|5|||
154999422|NCT02047734|559422486|FG002|Overall Study|Lack of Efficacy|1|||
154999423|NCT02047734|559422484|FG000|Overall Study|Protocol Violation|3|||
154999424|NCT02047734|559422485|FG001|Overall Study|Protocol Violation|1|||
154999425|NCT02047734|559422486|FG002|Overall Study|Protocol Violation|1|||
154999426|NCT02047734|559422484|FG000|Overall Study|Lost to Follow-up|1|||
155123076|NCT01457950|559881864|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155123077|NCT01457950|559881865|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155123078|NCT01457950|559881862|FG000|Open-Label Phase|Adverse Event|0|||
154999427|NCT02047734|559422485|FG001|Overall Study|Lost to Follow-up|4|||
154999428|NCT02047734|559422486|FG002|Overall Study|Lost to Follow-up|0|||
154999429|NCT02047734|559422484|FG000|Overall Study|Death|0|||
154999430|NCT02047734|559422485|FG001|Overall Study|Death|1|||
154999431|NCT02047734|559422486|FG002|Overall Study|Death|0|||
154999432|NCT02047734|559422484|FG000|Overall Study|Withdrawal by Subject|30|||
154999433|NCT02047734|559422485|FG001|Overall Study|Withdrawal by Subject|31|||
154999434|NCT02047734|559422486|FG002|Overall Study|Withdrawal by Subject|19|||
154999435|NCT02047734|559422484|FG000|Overall Study|Physician Decision|7|||
154999436|NCT02047734|559422485|FG001|Overall Study|Physician Decision|6|||
154999437|NCT02047734|559422486|FG002|Overall Study|Physician Decision|5|||
154999438|NCT02047734|559422484|FG000|Overall Study|Miscellaneous|2|||
154999439|NCT02047734|559422485|FG001|Overall Study|Miscellaneous|4|||
154999440|NCT02047734|559422486|FG002|Overall Study|Miscellaneous|6|||
154999441|NCT02047734|559422484|FG000|Overall Study|Did Not Receive Study Drug|2|||
154999442|NCT02047734|559422485|FG001|Overall Study|Did Not Receive Study Drug|4|||
154999443|NCT02047734|559422486|FG002|Overall Study|Did Not Receive Study Drug|1|||
154999444|NCT01174043|559422487|FG000|Overall Study|Disease progression|5|||
154999445|NCT01174043|559422487|FG000|Overall Study|Adverse Event|3|||
154999446|NCT01174043|559422487|FG000|Overall Study|Death|1|||
154999447|NCT01174043|559422487|FG000|Overall Study|Withdrawal by Subject|2|||
154999448|NCT00582010|559422490|FG000|Overall Study|Death|0|||
154999449|NCT00582010|559422491|FG001|Overall Study|Death|1|||
154999450|NCT05320887|559422501|FG000|Overall Study|Lost to Follow-up|0|||
154999451|NCT05320887|559422502|FG001|Overall Study|Lost to Follow-up|3|||
154999452|NCT05320887|559422503|FG002|Overall Study|Lost to Follow-up|0|||
154999453|NCT05320887|559422504|FG003|Overall Study|Lost to Follow-up|0|||
154999454|NCT02289456|559422507|FG000|Induction Period|Death|2|||
154999455|NCT02289456|559422507|FG000|Induction Period|Adverse Event|11|||
154999456|NCT02289456|559422507|FG000|Induction Period|Progressive Disease (PD)|4|||
154999457|NCT02289456|559422507|FG000|Induction Period|Symptomatic Deterioration|4|||
154999458|NCT02289456|559422507|FG000|Induction Period|Withdrawal by Subject|2|||
154999459|NCT02289456|559422507|FG000|Induction Period|Miscellaneous|1|||
154999460|NCT02289456|559422507|FG000|Monotherapy Period|Death|1|||
154999461|NCT02289456|559422507|FG000|Monotherapy Period|Adverse Event|1|||
154999462|NCT02289456|559422507|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
154999463|NCT02289456|559422507|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
154999464|NCT02289456|559422507|FG000|Monotherapy Period|Withdrawal by Subject|2|||
154999465|NCT02289456|559422507|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
154999466|NCT02289456|559422507|FG000|Monotherapy Period|Miscellaneous|1|||
154999467|NCT01721317|559422510|FG000|Overall Study|Study Closed / Terminated|2|||
154999468|NCT01721317|559422511|FG001|Overall Study|Study Closed / Terminated|2|||
154999469|NCT01721317|559422510|FG000|Overall Study|Physician Decision|0|||
154999470|NCT01721317|559422511|FG001|Overall Study|Physician Decision|1|||
154999471|NCT01721317|559422510|FG000|Overall Study|Withdrawal by Subject|0|||
154999472|NCT01721317|559422511|FG001|Overall Study|Withdrawal by Subject|1|||
154999473|NCT00339144|559422523|FG000|Overall Study|Disease progression|5|||
154999474|NCT00339144|559422524|FG001|Overall Study|Disease progression|2|||
154999475|NCT00339144|559422525|FG002|Overall Study|Disease progression|2|||
154999476|NCT00339144|559422523|FG000|Overall Study|Study drug toxicity|3|||
154999477|NCT00339144|559422524|FG001|Overall Study|Study drug toxicity|1|||
154999478|NCT00339144|559422525|FG002|Overall Study|Study drug toxicity|1|||
154999479|NCT00339144|559422523|FG000|Overall Study|Participant's request to discontinuation|1|||
154999480|NCT00339144|559422524|FG001|Overall Study|Participant's request to discontinuation|0|||
154999481|NCT00339144|559422525|FG002|Overall Study|Participant's request to discontinuation|1|||
154999482|NCT02181790|559422530|FG000|Overall Study|study terminated|2|||
154999483|NCT02181790|559422531|FG001|Overall Study|study terminated|0|||
154999484|NCT01275430|559422532|FG000|Overall Study|Adverse Event|1|||
154999485|NCT01275430|559422532|FG000|Overall Study|No Contrast Injection|6|||
154999486|NCT01275430|559422532|FG000|Overall Study|Device Malfunction|1|||
154999487|NCT01275430|559422532|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
154999488|NCT04988087|559422534|FG000|Overall Study|Adverse Event|4|||
154999489|NCT04988087|559422535|FG001|Overall Study|Adverse Event|0|||
154999490|NCT04988087|559422536|FG002|Overall Study|Adverse Event|0|||
154999491|NCT04988087|559422537|FG003|Overall Study|Adverse Event|0|||
154999492|NCT04988087|559422534|FG000|Overall Study|Withdrawal by Subject|1|||
154999493|NCT04988087|559422535|FG001|Overall Study|Withdrawal by Subject|1|||
154999494|NCT04988087|559422536|FG002|Overall Study|Withdrawal by Subject|0|||
154999495|NCT04988087|559422537|FG003|Overall Study|Withdrawal by Subject|0|||
154999496|NCT04988087|559422534|FG000|Overall Study|Technical problems|7|||
154999497|NCT04988087|559422535|FG001|Overall Study|Technical problems|9|||
154999498|NCT04988087|559422536|FG002|Overall Study|Technical problems|1|||
154999499|NCT04988087|559422537|FG003|Overall Study|Technical problems|2|||
154999500|NCT02613182|559422538|FG000|Overall Study|Death|6|||
154999501|NCT02613182|559422538|FG000|Overall Study|Physician Decision|1|||
154999502|NCT02613182|559422538|FG000|Overall Study|Study Terminated by Sponsor|21|||
154999503|NCT02613182|559422538|FG000|Overall Study|Withdrawal by Subject|6|||
154999504|NCT02714426|559422539|FG000|Overall Study|Withdrawal by Subject|2|||
154999505|NCT02714426|559422540|FG001|Overall Study|Withdrawal by Subject|2|||
154999506|NCT00896480|559422544|FG000|Overall Study|Disease progression/recurrence|21|||
154999507|NCT03185013|559422547|FG000|Overall Study|Withdrawal by Subject|5|||
154999508|NCT03185013|559422548|FG001|Overall Study|Withdrawal by Subject|3|||
154999509|NCT03185013|559422547|FG000|Overall Study|Adverse Event|1|||
154999510|NCT03185013|559422548|FG001|Overall Study|Adverse Event|0|||
154999511|NCT03185013|559422547|FG000|Overall Study|Progressive Disease|1|||
154999512|NCT03185013|559422548|FG001|Overall Study|Progressive Disease|0|||
154999513|NCT03185013|559422547|FG000|Overall Study|Lost to Follow-up|8|||
154999514|NCT03185013|559422548|FG001|Overall Study|Lost to Follow-up|2|||
154999515|NCT03185013|559422547|FG000|Overall Study|Physician Decision|1|||
154999516|NCT03185013|559422548|FG001|Overall Study|Physician Decision|0|||
154999517|NCT03185013|559422547|FG000|Overall Study|Protocol Deviation|2|||
154999518|NCT03185013|559422548|FG001|Overall Study|Protocol Deviation|0|||
154999519|NCT03185013|559422547|FG000|Overall Study|Reason not Specified|3|||
155177869|NCT01451437|560089446|FG000|Overall Study|Adverse Event|0|||
155177870|NCT01451437|560089447|FG001|Overall Study|Adverse Event|0|||
155177871|NCT01451437|560089448|FG002|Overall Study|Adverse Event|0|||
155177872|NCT01451437|560089449|FG003|Overall Study|Adverse Event|0|||
155177873|NCT01451437|560089450|FG004|Overall Study|Adverse Event|0|||
155177874|NCT01451437|560089451|FG005|Overall Study|Adverse Event|1|||
155177875|NCT01451437|560089452|FG006|Overall Study|Adverse Event|1|||
155177876|NCT01451437|560089453|FG007|Overall Study|Adverse Event|2|||
154999520|NCT03185013|559422548|FG001|Overall Study|Reason not Specified|2|||
154999521|NCT03185013|559422547|FG000|Overall Study|Death|1|||
154999522|NCT03185013|559422548|FG001|Overall Study|Death|0|||
154999523|NCT01104792|559422554|FG000|Overall Study|Adverse Event|77|||
154999524|NCT01104792|559422554|FG000|Overall Study|Insufficient Therapeutic Response|22|||
154999525|NCT01104792|559422554|FG000|Overall Study|Protocol Violation|45|||
154999526|NCT01104792|559422554|FG000|Overall Study|Withdrawal of Consent|179|||
154999527|NCT01104792|559422554|FG000|Overall Study|Lost to Follow-up|43|||
154999528|NCT01104792|559422554|FG000|Overall Study|Reasons Not Specified|27|||
154999529|NCT01104792|559422554|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
154999530|NCT02071849|559422556|FG000|6-month Primary Endpoint|Did not receive device|4|||
154999531|NCT02071849|559422556|FG000|6-month Primary Endpoint|Adverse Event|1|||
154999532|NCT02071849|559422556|FG000|2-year Extended Follow-up|Adverse Event|1|||
154999533|NCT03255655|559422557|FG000|Overall Study|Lost to Follow-up|7|||
154999534|NCT03255655|559422558|FG001|Overall Study|Lost to Follow-up|4|||
154999535|NCT00658021|559422559|FG000|28-Week Treatment Period|Adverse Event|3|||
154999536|NCT00658021|559422560|FG001|28-Week Treatment Period|Adverse Event|1|||
154999537|NCT00658021|559422561|FG002|28-Week Treatment Period|Adverse Event|0|||
154999538|NCT00658021|559422559|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
154999539|NCT00658021|559422560|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
154999540|NCT00658021|559422561|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
154999541|NCT00658021|559422559|FG000|28-Week Treatment Period|Protocol Violation|0|||
154999542|NCT00658021|559422560|FG001|28-Week Treatment Period|Protocol Violation|2|||
154999543|NCT00658021|559422561|FG002|28-Week Treatment Period|Protocol Violation|1|||
154999544|NCT00658021|559422559|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
154999545|NCT00658021|559422560|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
154999546|NCT00658021|559422561|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
154999547|NCT00658021|559422559|FG000|28-Week Treatment Period|Physician Decision|1|||
154999548|NCT00658021|559422560|FG001|28-Week Treatment Period|Physician Decision|2|||
154999549|NCT00658021|559422561|FG002|28-Week Treatment Period|Physician Decision|1|||
154999550|NCT00658021|559422559|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
154999551|NCT00658021|559422560|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
154999552|NCT00658021|559422561|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
154999553|NCT00658021|559422559|FG000|28-Week Treatment Period|Loss of glucose control|1|||
154999554|NCT00658021|559422560|FG001|28-Week Treatment Period|Loss of glucose control|1|||
154999555|NCT00658021|559422561|FG002|28-Week Treatment Period|Loss of glucose control|10|||
154999556|NCT00658021|559422559|FG000|28-Week Treatment Period|Other|2|||
154999557|NCT00658021|559422560|FG001|28-Week Treatment Period|Other|3|||
154999558|NCT00658021|559422561|FG002|28-Week Treatment Period|Other|1|||
154999559|NCT00658021|559422559|FG000|28-Week Treatment Period|Did not receive treatment|2|||
154999560|NCT00658021|559422560|FG001|28-Week Treatment Period|Did not receive treatment|0|||
154999561|NCT00658021|559422561|FG002|28-Week Treatment Period|Did not receive treatment|0|||
154999562|NCT00658021|559422559|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
154999563|NCT00658021|559422560|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
154999564|NCT00658021|559422561|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
154999565|NCT00658021|559422559|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
154999566|NCT00658021|559422560|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
154999567|NCT00658021|559422561|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
154999568|NCT01806506|559422562|FG000|Overall Study|Lost to Follow-up|2|||
154999569|NCT01806506|559422563|FG001|Overall Study|Lost to Follow-up|1|||
154999570|NCT00725205|559422564|FG000|Overall Study|Adverse Event|22|||
154999571|NCT00725205|559422564|FG000|Overall Study|Investigator Discontinued|1|||
154999572|NCT00725205|559422564|FG000|Overall Study|Non-compliance With Protocol|14|||
154999573|NCT00725205|559422564|FG000|Overall Study|Other|8|||
154999574|NCT00725205|559422564|FG000|Overall Study|Protocol Defined Clinical Event|1|||
154999575|NCT00725205|559422564|FG000|Overall Study|Treatment Failure|41|||
154999576|NCT01680497|559422565|FG000|Overall Study|Lost to Follow-up|2|||
154999577|NCT05819203|559422567|FG000|Overall Study|Protocol Violation|1|||
154999578|NCT05819203|559422568|FG001|Overall Study|Protocol Violation|2|||
155177877|NCT01451437|560089454|FG008|Overall Study|Adverse Event|1|||
155177878|NCT01451437|560089446|FG000|Overall Study|Physician Decision|1|||
155177879|NCT01451437|560089447|FG001|Overall Study|Physician Decision|1|||
155177880|NCT01451437|560089448|FG002|Overall Study|Physician Decision|2|||
155177881|NCT01451437|560089449|FG003|Overall Study|Physician Decision|0|||
154920887|NCT01326312|559133589|FG001|Overall Study|Treatment arm terminated|0|||
154920888|NCT01326312|559133590|FG002|Overall Study|Treatment arm terminated|0|||
154920889|NCT01326312|559133588|FG000|Overall Study|QTc > 500|0|||
154920890|NCT01326312|559133589|FG001|Overall Study|QTc > 500|1|||
154920891|NCT01326312|559133590|FG002|Overall Study|QTc > 500|0|||
154920892|NCT00903357|559133595|FG000|First Intervention|Withdrawal by Subject|5|||
154920893|NCT00903357|559133596|FG001|First Intervention|Withdrawal by Subject|3|||
154920894|NCT00903357|559133595|FG000|First Intervention|Flu|0|||
154920895|NCT00903357|559133596|FG001|First Intervention|Flu|1|||
154920896|NCT00903357|559133595|FG000|Wash Out Period of 2 Weeks|Flu|0|||
154920897|NCT00903357|559133596|FG001|Wash Out Period of 2 Weeks|Flu|1|||
154920898|NCT00903357|559133595|FG000|Second Intervention|Lost to Follow-up|1|||
154920899|NCT00903357|559133596|FG001|Second Intervention|Lost to Follow-up|0|||
154920900|NCT01463631|559133600|FG000|Overall Study|Withdrawal by Subject|0|||
154920901|NCT01463631|559133601|FG001|Overall Study|Withdrawal by Subject|0|||
154920902|NCT01463631|559133602|FG002|Overall Study|Withdrawal by Subject|0|||
154920903|NCT01463631|559133603|FG003|Overall Study|Withdrawal by Subject|1|||
154920904|NCT01463631|559133600|FG000|Overall Study|Death|0|||
154920905|NCT01463631|559133601|FG001|Overall Study|Death|0|||
154920906|NCT01463631|559133602|FG002|Overall Study|Death|1|||
154920907|NCT01463631|559133603|FG003|Overall Study|Death|0|||
154920908|NCT01463631|559133600|FG000|Overall Study|Progressive Disease|0|||
154920909|NCT01463631|559133601|FG001|Overall Study|Progressive Disease|0|||
154920910|NCT01463631|559133602|FG002|Overall Study|Progressive Disease|0|||
154920911|NCT01463631|559133603|FG003|Overall Study|Progressive Disease|5|||
154920912|NCT05664672|559133607|FG000|Overall Study|Adverse Event|0|||
154920913|NCT05664672|559133608|FG001|Overall Study|Adverse Event|0|||
154920914|NCT05664672|559133609|FG002|Overall Study|Adverse Event|0|||
154920915|NCT05664672|559133610|FG003|Overall Study|Adverse Event|0|||
154920916|NCT05664672|559133611|FG004|Overall Study|Adverse Event|0|||
154920917|NCT05664672|559133612|FG005|Overall Study|Adverse Event|1|||
154920918|NCT05664672|559133607|FG000|Overall Study|Withdrawal by Subject|0|||
154920919|NCT05664672|559133608|FG001|Overall Study|Withdrawal by Subject|1|||
154920920|NCT05664672|559133609|FG002|Overall Study|Withdrawal by Subject|3|||
154920921|NCT05664672|559133610|FG003|Overall Study|Withdrawal by Subject|0|||
154920922|NCT05664672|559133611|FG004|Overall Study|Withdrawal by Subject|5|||
154920923|NCT05664672|559133612|FG005|Overall Study|Withdrawal by Subject|6|||
154920924|NCT05664672|559133607|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
154920925|NCT05664672|559133608|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
154920926|NCT05664672|559133609|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
154920927|NCT05664672|559133610|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
154920928|NCT05664672|559133611|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
154920929|NCT05664672|559133612|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
154920930|NCT05664672|559133607|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
154920931|NCT05664672|559133608|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
154920932|NCT05664672|559133609|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
154920933|NCT05664672|559133610|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
154920934|NCT05664672|559133611|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
154920935|NCT05664672|559133612|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
154920936|NCT04768881|559133623|FG000|Overall Study|Completed Study Follow-up|0|||
154920937|NCT04768881|559133624|FG001|Overall Study|Completed Study Follow-up|2|||
154920938|NCT04768881|559133623|FG000|Overall Study|Death|3|||
154920939|NCT04768881|559133624|FG001|Overall Study|Death|2|||
154920940|NCT04768881|559133623|FG000|Overall Study|Study Terminated by Sponsor|2|||
154920941|NCT04768881|559133624|FG001|Overall Study|Study Terminated by Sponsor|2|||
154920942|NCT04768881|559133623|FG000|Overall Study|Withdrawal by Subject|2|||
154920943|NCT04768881|559133624|FG001|Overall Study|Withdrawal by Subject|0|||
154920944|NCT04768881|559133623|FG000|Overall Study|Other|2|||
154920945|NCT04768881|559133624|FG001|Overall Study|Other|0|||
154920946|NCT02370173|559133625|FG000|Overall Study|Protocol Violation|1|||
154920947|NCT02370173|559133626|FG001|Overall Study|Protocol Violation|1|||
154920948|NCT02370173|559133625|FG000|Overall Study|Withdrawal by Subject|2|||
154920949|NCT02370173|559133626|FG001|Overall Study|Withdrawal by Subject|2|||
154920950|NCT01326481|559133627|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
154920951|NCT01038609|559133630|FG000|Overall Study|Adverse Event|0|||
154920952|NCT01038609|559133631|FG001|Overall Study|Adverse Event|0|||
154920953|NCT01038609|559133632|FG002|Overall Study|Adverse Event|1|||
154920954|NCT01038609|559133633|FG003|Overall Study|Adverse Event|0|||
154920955|NCT01038609|559133634|FG004|Overall Study|Adverse Event|0|||
154920956|NCT01038609|559133630|FG000|Overall Study|Dosing Error|0|||
154920957|NCT01038609|559133631|FG001|Overall Study|Dosing Error|0|||
154920958|NCT01038609|559133632|FG002|Overall Study|Dosing Error|0|||
154920959|NCT01038609|559133633|FG003|Overall Study|Dosing Error|1|||
154920960|NCT01038609|559133634|FG004|Overall Study|Dosing Error|1|||
154920961|NCT01038609|559133630|FG000|Overall Study|Death in the Family|1|||
154920962|NCT01038609|559133631|FG001|Overall Study|Death in the Family|0|||
155123079|NCT01457950|559881863|FG001|Open-Label Phase|Adverse Event|0|||
155123080|NCT01457950|559881864|FG002|Open-Label Phase|Adverse Event|0|||
155123081|NCT01457950|559881865|FG003|Open-Label Phase|Adverse Event|1|||
155123082|NCT01457950|559881862|FG000|Open-Label Phase|Protocol Violation|0|||
155123083|NCT01457950|559881863|FG001|Open-Label Phase|Protocol Violation|0|||
155123084|NCT01457950|559881864|FG002|Open-Label Phase|Protocol Violation|0|||
155123085|NCT01457950|559881865|FG003|Open-Label Phase|Protocol Violation|1|||
155177882|NCT01451437|560089450|FG004|Overall Study|Physician Decision|0|||
154920963|NCT01038609|559133632|FG002|Overall Study|Death in the Family|0|||
154920964|NCT01038609|559133633|FG003|Overall Study|Death in the Family|0|||
154920965|NCT01038609|559133634|FG004|Overall Study|Death in the Family|0|||
154920966|NCT01038609|559133630|FG000|Overall Study|Refusal of Blood Draws|0|||
154920967|NCT01038609|559133631|FG001|Overall Study|Refusal of Blood Draws|1|||
154920968|NCT01038609|559133632|FG002|Overall Study|Refusal of Blood Draws|0|||
154920969|NCT01038609|559133633|FG003|Overall Study|Refusal of Blood Draws|0|||
154920970|NCT01038609|559133634|FG004|Overall Study|Refusal of Blood Draws|0|||
154920971|NCT04604015|559133635|FG000|Overall Study|Incomplete Data Collection|33|||
154920972|NCT02811640|559133636|FG000|Overall Study|Technology malfunction|2|||
154920973|NCT03590613|559133652|FG000|Period 2, 4 Days|Physician Decision|0|||
154920974|NCT03590613|559133653|FG001|Period 2, 4 Days|Physician Decision|0|||
154920975|NCT03590613|559133654|FG002|Period 2, 4 Days|Physician Decision|0|||
154920976|NCT03590613|559133655|FG003|Period 2, 4 Days|Physician Decision|1|||
154920977|NCT01087944|559133656|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
154920978|NCT01087944|559133657|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
154920979|NCT01087944|559133656|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
154920980|NCT01087944|559133657|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
154920981|NCT01731600|559133663|FG000|Overall Study|Adverse Event|2|||
154920982|NCT01731600|559133664|FG001|Overall Study|Adverse Event|0|||
154920983|NCT01731600|559133663|FG000|Overall Study|Withdrawal criteria|1|||
154920984|NCT01731600|559133664|FG001|Overall Study|Withdrawal criteria|0|||
154920985|NCT01731600|559133663|FG000|Overall Study|Other reasons|3|||
154920986|NCT01731600|559133664|FG001|Overall Study|Other reasons|0|||
154920987|NCT00129220|559133666|FG000|Study Period II|Adverse Event|9|||
154920988|NCT00129220|559133667|FG001|Study Period II|Adverse Event|5|||
154920989|NCT00129220|559133668|FG002|Study Period II|Adverse Event|7|||
154920990|NCT00129220|559133666|FG000|Study Period II|Lack of Efficacy|15|||
154920991|NCT00129220|559133667|FG001|Study Period II|Lack of Efficacy|1|||
154920992|NCT00129220|559133668|FG002|Study Period II|Lack of Efficacy|28|||
154920993|NCT00129220|559133666|FG000|Study Period II|Entry Criteria Not Met|2|||
154920994|NCT00129220|559133667|FG001|Study Period II|Entry Criteria Not Met|0|||
154920995|NCT00129220|559133668|FG002|Study Period II|Entry Criteria Not Met|2|||
154920996|NCT00129220|559133666|FG000|Study Period II|Protocol Violation|4|||
154920997|NCT00129220|559133667|FG001|Study Period II|Protocol Violation|2|||
154920998|NCT00129220|559133668|FG002|Study Period II|Protocol Violation|1|||
154920999|NCT00129220|559133666|FG000|Study Period II|Physician Decision|0|||
154921000|NCT00129220|559133667|FG001|Study Period II|Physician Decision|1|||
154921001|NCT00129220|559133668|FG002|Study Period II|Physician Decision|0|||
154921002|NCT00129220|559133666|FG000|Study Period II|Withdrawal by Subject|1|||
154921003|NCT00129220|559133667|FG001|Study Period II|Withdrawal by Subject|3|||
154921004|NCT00129220|559133668|FG002|Study Period II|Withdrawal by Subject|4|||
154921005|NCT00129220|559133666|FG000|Study Period II|Reason Not Specified|2|||
154921006|NCT00129220|559133667|FG001|Study Period II|Reason Not Specified|0|||
154921007|NCT00129220|559133668|FG002|Study Period II|Reason Not Specified|5|||
154921008|NCT00129220|559133666|FG000|Study Period III|Adverse Event|1|||
154921009|NCT00129220|559133667|FG001|Study Period III|Adverse Event|0|||
154921010|NCT00129220|559133668|FG002|Study Period III|Adverse Event|3|||
154921011|NCT00129220|559133666|FG000|Study Period III|Protocol Violation|1|||
154921012|NCT00129220|559133667|FG001|Study Period III|Protocol Violation|1|||
154921013|NCT00129220|559133668|FG002|Study Period III|Protocol Violation|2|||
154921014|NCT00129220|559133666|FG000|Study Period III|Withdrawal by Subject|1|||
154921015|NCT00129220|559133667|FG001|Study Period III|Withdrawal by Subject|0|||
154921016|NCT00129220|559133668|FG002|Study Period III|Withdrawal by Subject|3|||
154921017|NCT00129220|559133666|FG000|Study Period III|Sponsor Decision|1|||
154921018|NCT00129220|559133667|FG001|Study Period III|Sponsor Decision|0|||
154921019|NCT00129220|559133668|FG002|Study Period III|Sponsor Decision|0|||
154921020|NCT00129220|559133666|FG000|Study Period III|Reason Not Specified|9|||
154921021|NCT00129220|559133667|FG001|Study Period III|Reason Not Specified|0|||
154921022|NCT00129220|559133668|FG002|Study Period III|Reason Not Specified|2|||
154921023|NCT00540228|559133669|FG000|Overall Study|Adverse Event|2|||
154921024|NCT00540228|559133670|FG001|Overall Study|Adverse Event|0|||
154921025|NCT00540228|559133671|FG002|Overall Study|Adverse Event|0|||
154921026|NCT00540228|559133672|FG003|Overall Study|Adverse Event|0|||
154921027|NCT00540228|559133673|FG004|Overall Study|Adverse Event|0|||
154921028|NCT00540228|559133669|FG000|Overall Study|Lost to Follow-up|1|||
154921029|NCT00540228|559133670|FG001|Overall Study|Lost to Follow-up|1|||
155123086|NCT01457950|559881862|FG000|Open-Label Phase|Withdrawal by Subject|0|||
155123087|NCT01457950|559881863|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155177883|NCT01451437|560089451|FG005|Overall Study|Physician Decision|0|||
154999579|NCT05819203|559422567|FG000|Overall Study|Withdrawal by Subject|1|||
154999580|NCT05819203|559422568|FG001|Overall Study|Withdrawal by Subject|0|||
154999581|NCT01243775|559422569|FG000|Overall Study|Withdrawal by Subject|2|||
154999582|NCT01177059|559422570|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
154999583|NCT01177059|559422570|FG000|Overall Study|Withdrew consent|2|||
154999584|NCT01177059|559422570|FG000|Overall Study|Lost to Follow-up|18|||
154999585|NCT04051619|559422571|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
154999586|NCT04051619|559422572|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
154999587|NCT04051619|559422571|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
154999588|NCT04051619|559422572|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
154999589|NCT05833139|559424397|FG000|Study Period 2|Adverse Event|1|||
154999590|NCT03996447|559424398|FG000|First MRI Examination|Adverse Event|2|||
154999591|NCT03996447|559424399|FG001|First MRI Examination|Adverse Event|0|||
154999592|NCT03996447|559424398|FG000|First MRI Examination|Withdrawal by Subject|1|||
154999593|NCT03996447|559424399|FG001|First MRI Examination|Withdrawal by Subject|2|||
154999594|NCT03996447|559424398|FG000|First MRI Examination|Protocol Violation|0|||
154999595|NCT03996447|559424399|FG001|First MRI Examination|Protocol Violation|1|||
154999596|NCT03996447|559424398|FG000|Washout|Adverse Event|2|||
154999597|NCT03996447|559424399|FG001|Washout|Adverse Event|0|||
154999598|NCT03996447|559424398|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
154999599|NCT03996447|559424399|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
154999600|NCT03996447|559424398|FG000|Washout|Withdrawal by Subject|0|||
154999601|NCT03996447|559424399|FG001|Washout|Withdrawal by Subject|1|||
154999602|NCT03996447|559424398|FG000|Washout|Other reason|1|||
154999603|NCT03996447|559424399|FG001|Washout|Other reason|1|||
154999604|NCT01810302|559424400|FG000|Overall Study|Death|1|||
154999605|NCT01810302|559424401|FG001|Overall Study|Death|0|||
154999606|NCT01810302|559424400|FG000|Overall Study|Physician Decision|0|||
154999607|NCT01810302|559424401|FG001|Overall Study|Physician Decision|1|||
154999608|NCT04981717|559424402|FG000|Overall Study|Protocol Violation|0|||
154999609|NCT04981717|559424403|FG001|Overall Study|Protocol Violation|3|||
154999610|NCT04981717|559424402|FG000|Overall Study|Adverse Event|1|||
154999611|NCT04981717|559424403|FG001|Overall Study|Adverse Event|3|||
154999612|NCT04981717|559424402|FG000|Overall Study|Pregnancy|1|||
154999613|NCT04981717|559424403|FG001|Overall Study|Pregnancy|0|||
154999614|NCT04981717|559424402|FG000|Overall Study|Physician Decision|1|||
154999615|NCT04981717|559424403|FG001|Overall Study|Physician Decision|0|||
154999616|NCT04981717|559424402|FG000|Overall Study|Sponsor Request|157|||
154999617|NCT04981717|559424403|FG001|Overall Study|Sponsor Request|172|||
154999618|NCT04981717|559424402|FG000|Overall Study|Lost to Follow-up|4|||
154999619|NCT04981717|559424403|FG001|Overall Study|Lost to Follow-up|5|||
154999620|NCT04981717|559424402|FG000|Overall Study|Withdrawal by Subject|50|||
154999621|NCT04981717|559424403|FG001|Overall Study|Withdrawal by Subject|37|||
154999622|NCT02207634|559424404|FG000|Overall Study|Withdrawal by Subject|21|||
154999623|NCT02207634|559424405|FG001|Overall Study|Withdrawal by Subject|31|||
154999624|NCT02207634|559424404|FG000|Overall Study|Lost to Follow-up|1|||
154999625|NCT02207634|559424405|FG001|Overall Study|Lost to Follow-up|0|||
154999626|NCT00974922|559424406|FG000|Overall Study|study terminated|24|||
154999627|NCT00287586|559424407|FG000|Overall Study|Withdrew Consent|19|||
154999628|NCT00287586|559424408|FG001|Overall Study|Withdrew Consent|30|||
154999629|NCT00287586|559424407|FG000|Overall Study|Lost to Follow-up|5|||
154999630|NCT00287586|559424408|FG001|Overall Study|Lost to Follow-up|4|||
154999631|NCT00287586|559424407|FG000|Overall Study|Death|2|||
154999632|NCT00287586|559424408|FG001|Overall Study|Death|3|||
154999633|NCT00287586|559424407|FG000|Overall Study|Elevated Hematocrit|3|||
154999634|NCT00287586|559424408|FG001|Overall Study|Elevated Hematocrit|0|||
154999635|NCT00287586|559424407|FG000|Overall Study|Rash|3|||
154999636|NCT00287586|559424408|FG001|Overall Study|Rash|0|||
154999637|NCT00287586|559424407|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
154999638|NCT00287586|559424408|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
154999639|NCT00287586|559424407|FG000|Overall Study|Stroke|2|||
154999640|NCT00287586|559424408|FG001|Overall Study|Stroke|0|||
154999641|NCT00287586|559424407|FG000|Overall Study|Myocardial Infarction|1|||
154999642|NCT00287586|559424408|FG001|Overall Study|Myocardial Infarction|0|||
154999643|NCT00287586|559424407|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
154999644|NCT00287586|559424408|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
154999645|NCT00287586|559424407|FG000|Overall Study|Cognitive Impairment|1|||
154999646|NCT00287586|559424408|FG001|Overall Study|Cognitive Impairment|0|||
154999647|NCT00287586|559424407|FG000|Overall Study|Pancreatic Cancer|1|||
154999648|NCT00287586|559424408|FG001|Overall Study|Pancreatic Cancer|3|||
154999649|NCT00287586|559424407|FG000|Overall Study|Sleep Apnea|1|||
154999650|NCT00287586|559424408|FG001|Overall Study|Sleep Apnea|0|||
154999651|NCT00287586|559424407|FG000|Overall Study|Shoulder Pain|1|||
154999652|NCT00287586|559424408|FG001|Overall Study|Shoulder Pain|0|||
154999653|NCT00287586|559424407|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
154999654|NCT00287586|559424408|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
154999655|NCT00287586|559424407|FG000|Overall Study|Nonadherence|1|||
154999656|NCT00287586|559424408|FG001|Overall Study|Nonadherence|1|||
154999657|NCT00287586|559424407|FG000|Overall Study|Enrolled in Another Study|1|||
155123088|NCT01457950|559881864|FG002|Open-Label Phase|Withdrawal by Subject|2|||
155123089|NCT01457950|559881865|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155123090|NCT01866423|559881869|FG000|Overall Study|Lack of Efficacy|3|||
155123091|NCT01866423|559881869|FG000|Overall Study|Sponsor Decision|1|||
155123092|NCT01479595|559881870|FG000|Overall Study|Protocol deviation|0|||
154999658|NCT00287586|559424408|FG001|Overall Study|Enrolled in Another Study|0|||
154999659|NCT00287586|559424407|FG000|Overall Study|Major Depression|0|||
154999660|NCT00287586|559424408|FG001|Overall Study|Major Depression|2|||
154999661|NCT00287586|559424407|FG000|Overall Study|Lung Cancer|0|||
154999662|NCT00287586|559424408|FG001|Overall Study|Lung Cancer|2|||
154999663|NCT00287586|559424407|FG000|Overall Study|Elevated IPSS Score|0|||
154999664|NCT00287586|559424408|FG001|Overall Study|Elevated IPSS Score|1|||
154999665|NCT00287586|559424407|FG000|Overall Study|Retroperitoneal Cancer|0|||
154999666|NCT00287586|559424408|FG001|Overall Study|Retroperitoneal Cancer|1|||
154999667|NCT00287586|559424407|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
154999668|NCT00287586|559424408|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
154999669|NCT00287586|559424407|FG000|Overall Study|Mood Swings and Irritability|0|||
154999670|NCT00287586|559424408|FG001|Overall Study|Mood Swings and Irritability|1|||
154999671|NCT00287586|559424407|FG000|Overall Study|Bradycardia|0|||
154999672|NCT00287586|559424408|FG001|Overall Study|Bradycardia|1|||
154999673|NCT00287586|559424407|FG000|Overall Study|Itchy Swollen Eyes|0|||
154999674|NCT00287586|559424408|FG001|Overall Study|Itchy Swollen Eyes|1|||
154999675|NCT00287586|559424407|FG000|Overall Study|Recurrent Melanoma|0|||
154999676|NCT00287586|559424408|FG001|Overall Study|Recurrent Melanoma|1|||
154999677|NCT02640482|559424410|FG000|Overall Study|Lost to Follow-up|3|||
154999678|NCT02640482|559424411|FG001|Overall Study|Lost to Follow-up|0|||
154999679|NCT00113763|559424412|FG000|Overall Study|Adverse Event|5|||
154999680|NCT00113763|559424413|FG001|Overall Study|Adverse Event|2|||
154999681|NCT00113763|559424412|FG000|Overall Study|Disease Progression|28|||
154999682|NCT00113763|559424413|FG001|Overall Study|Disease Progression|14|||
154999683|NCT00113763|559424412|FG000|Overall Study|Lost to Follow-up|10|||
154999684|NCT00113763|559424413|FG001|Overall Study|Lost to Follow-up|0|||
154999685|NCT00113763|559424412|FG000|Overall Study|Withdrawal by Subject|1|||
154999686|NCT00113763|559424413|FG001|Overall Study|Withdrawal by Subject|4|||
154999687|NCT00113763|559424412|FG000|Overall Study|Other|27|||
154999688|NCT00113763|559424413|FG001|Overall Study|Other|6|||
154999689|NCT00113763|559424412|FG000|Overall Study|Non-compliance|1|||
154999690|NCT00113763|559424413|FG001|Overall Study|Non-compliance|0|||
154999691|NCT00113763|559424412|FG000|Overall Study|Ongoing|1|||
154999692|NCT00113763|559424413|FG001|Overall Study|Ongoing|0|||
154999693|NCT00517881|559424414|FG000|Overall Study|Protocol Violation|2|||
154999694|NCT00517881|559424414|FG000|Overall Study|Adverse Event|1|||
154999695|NCT00517881|559424414|FG000|Overall Study|Renal transplantation|2|||
154999696|NCT03743415|559424415|FG000|Overall Study|Death|5|||
154999697|NCT03743415|559424416|FG001|Overall Study|Death|3|||
154999698|NCT03743415|559424417|FG002|Overall Study|Death|1|||
154999699|NCT03743415|559424418|FG003|Overall Study|Death|4|||
154999700|NCT03743415|559424419|FG004|Overall Study|Death|0|||
154999701|NCT03743415|559424420|FG005|Overall Study|Death|0|||
154999702|NCT03743415|559424421|FG006|Overall Study|Death|0|||
154999703|NCT03743415|559424422|FG007|Overall Study|Death|0|||
154999704|NCT03743415|559424423|FG008|Overall Study|Death|1|||
154999705|NCT03743415|559424424|FG009|Overall Study|Death|0|||
154999706|NCT03743415|559424415|FG000|Overall Study|Withdrawal by Subject|1|||
154999707|NCT03743415|559424416|FG001|Overall Study|Withdrawal by Subject|0|||
154999708|NCT03743415|559424417|FG002|Overall Study|Withdrawal by Subject|4|||
154999709|NCT03743415|559424418|FG003|Overall Study|Withdrawal by Subject|5|||
154999710|NCT03743415|559424419|FG004|Overall Study|Withdrawal by Subject|5|||
154999711|NCT03743415|559424420|FG005|Overall Study|Withdrawal by Subject|2|||
154999712|NCT03743415|559424421|FG006|Overall Study|Withdrawal by Subject|2|||
154999713|NCT03743415|559424422|FG007|Overall Study|Withdrawal by Subject|5|||
154999714|NCT03743415|559424423|FG008|Overall Study|Withdrawal by Subject|9|||
154999715|NCT03743415|559424424|FG009|Overall Study|Withdrawal by Subject|10|||
154999716|NCT03743415|559424415|FG000|Overall Study|Lost to Follow-up|2|||
155123093|NCT01479595|559881871|FG001|Overall Study|Protocol deviation|1|||
154999717|NCT03743415|559424416|FG001|Overall Study|Lost to Follow-up|0|||
154999718|NCT03743415|559424417|FG002|Overall Study|Lost to Follow-up|2|||
154999719|NCT03743415|559424418|FG003|Overall Study|Lost to Follow-up|1|||
154999720|NCT03743415|559424419|FG004|Overall Study|Lost to Follow-up|1|||
154999721|NCT03743415|559424420|FG005|Overall Study|Lost to Follow-up|0|||
154999722|NCT03743415|559424421|FG006|Overall Study|Lost to Follow-up|1|||
154999723|NCT03743415|559424422|FG007|Overall Study|Lost to Follow-up|4|||
154999724|NCT03743415|559424423|FG008|Overall Study|Lost to Follow-up|13|||
154999725|NCT03743415|559424424|FG009|Overall Study|Lost to Follow-up|13|||
155123094|NCT01479595|559881870|FG000|Overall Study|Adverse Event|2|||
155123095|NCT01479595|559881871|FG001|Overall Study|Adverse Event|1|||
154999726|NCT00094861|559424427|FG000|Overall Study|Adverse Event|5|||
154999727|NCT00094861|559424428|FG001|Overall Study|Adverse Event|2|||
154999728|NCT00094861|559424427|FG000|Overall Study|Withdrawal by Subject|5|||
155177884|NCT01451437|560089452|FG006|Overall Study|Physician Decision|0|||
154999729|NCT00094861|559424428|FG001|Overall Study|Withdrawal by Subject|3|||
154999730|NCT00094861|559424427|FG000|Overall Study|Physician Decision|1|||
154999731|NCT00094861|559424428|FG001|Overall Study|Physician Decision|1|||
154999732|NCT00094861|559424427|FG000|Overall Study|Lost to Follow-up|0|||
154999733|NCT00094861|559424428|FG001|Overall Study|Lost to Follow-up|1|||
154999734|NCT00094861|559424427|FG000|Overall Study|Death|4|||
154999735|NCT00094861|559424428|FG001|Overall Study|Death|2|||
154999736|NCT00094861|559424427|FG000|Overall Study|Other|3|||
154999737|NCT00094861|559424428|FG001|Overall Study|Other|0|||
154999738|NCT00264550|559424429|FG000|Overall Study|Death|0|||
154999739|NCT00264550|559424430|FG001|Overall Study|Death|3|||
154999740|NCT00264550|559424431|FG002|Overall Study|Death|0|||
154999741|NCT00264550|559424432|FG003|Overall Study|Death|0|||
154999742|NCT00264550|559424429|FG000|Overall Study|Lost to Follow-up|3|||
154999743|NCT00264550|559424430|FG001|Overall Study|Lost to Follow-up|1|||
154999744|NCT00264550|559424431|FG002|Overall Study|Lost to Follow-up|1|||
154999745|NCT00264550|559424432|FG003|Overall Study|Lost to Follow-up|1|||
154999746|NCT00264550|559424429|FG000|Overall Study|Adverse Event|23|||
154999747|NCT00264550|559424430|FG001|Overall Study|Adverse Event|18|||
154999748|NCT00264550|559424431|FG002|Overall Study|Adverse Event|9|||
154999749|NCT00264550|559424432|FG003|Overall Study|Adverse Event|14|||
154999750|NCT00264550|559424429|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
154999751|NCT00264550|559424430|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
154999752|NCT00264550|559424431|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
154999753|NCT00264550|559424432|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
154999754|NCT00264550|559424429|FG000|Overall Study|Discontinued oral study agent|0|||
154999755|NCT00264550|559424430|FG001|Overall Study|Discontinued oral study agent|1|||
154999756|NCT00264550|559424431|FG002|Overall Study|Discontinued oral study agent|0|||
154999757|NCT00264550|559424432|FG003|Overall Study|Discontinued oral study agent|0|||
154999758|NCT00264550|559424429|FG000|Overall Study|Other|13|||
154999759|NCT00264550|559424430|FG001|Overall Study|Other|7|||
154999760|NCT00264550|559424431|FG002|Overall Study|Other|3|||
154999761|NCT00264550|559424432|FG003|Overall Study|Other|9|||
154999762|NCT00129389|559424433|FG000|Overall Study|Adverse Event|19|||
154999763|NCT00129389|559424434|FG001|Overall Study|Adverse Event|87|||
154999764|NCT00129389|559424433|FG000|Overall Study|Death|0|||
154999765|NCT00129389|559424434|FG001|Overall Study|Death|1|||
154999766|NCT00129389|559424433|FG000|Overall Study|Lost to Follow-up|2|||
154999767|NCT00129389|559424434|FG001|Overall Study|Lost to Follow-up|1|||
154999768|NCT00129389|559424433|FG000|Overall Study|Physician Decision|0|||
154999769|NCT00129389|559424434|FG001|Overall Study|Physician Decision|4|||
154999770|NCT00129389|559424433|FG000|Overall Study|Protocol Violation|0|||
154999771|NCT00129389|559424434|FG001|Overall Study|Protocol Violation|6|||
154999772|NCT00129389|559424433|FG000|Overall Study|Withdrawal by Subject|9|||
154999773|NCT00129389|559424434|FG001|Overall Study|Withdrawal by Subject|23|||
154999774|NCT00129389|559424433|FG000|Overall Study|Relapse|1|||
154999775|NCT00129389|559424434|FG001|Overall Study|Relapse|0|||
154999776|NCT00129389|559424433|FG000|Overall Study|Not eligible|1|||
154999777|NCT00129389|559424434|FG001|Overall Study|Not eligible|2|||
154999778|NCT00129389|559424433|FG000|Overall Study|Crossed to the other arm|1|||
154999779|NCT00129389|559424434|FG001|Overall Study|Crossed to the other arm|16|||
154999780|NCT00451204|559424435|FG000|Overall Study|Adverse Event|4|||
154999781|NCT00451204|559424436|FG001|Overall Study|Adverse Event|6|||
154999782|NCT00451204|559424435|FG000|Overall Study|Lack of Efficacy|4|||
154999783|NCT00451204|559424436|FG001|Overall Study|Lack of Efficacy|4|||
154999784|NCT00451204|559424435|FG000|Overall Study|Lost to Follow-up|4|||
154999785|NCT00451204|559424436|FG001|Overall Study|Lost to Follow-up|4|||
154999786|NCT00451204|559424435|FG000|Overall Study|Protocol Violation|1|||
154999787|NCT00451204|559424436|FG001|Overall Study|Protocol Violation|0|||
154999788|NCT00451204|559424435|FG000|Overall Study|Patient refusal|8|||
154999789|NCT00451204|559424436|FG001|Overall Study|Patient refusal|4|||
155177885|NCT01451437|560089453|FG007|Overall Study|Physician Decision|0|||
154999790|NCT00451204|559424435|FG000|Overall Study|Other|1|||
154999791|NCT00451204|559424436|FG001|Overall Study|Other|2|||
154999792|NCT03760185|559424437|FG000|Overall Study|Lost to Follow-up|1|||
154999793|NCT03760185|559424438|FG001|Overall Study|Lost to Follow-up|1|||
154999794|NCT00976911|559424444|FG000|Overall Study|Withdrawal by Subject|4|||
154999795|NCT00976911|559424445|FG001|Overall Study|Withdrawal by Subject|6|||
154999796|NCT00976911|559424444|FG000|Overall Study|Death|138|||
154999797|NCT00976911|559424445|FG001|Overall Study|Death|126|||
154999798|NCT00976911|559424444|FG000|Overall Study|Adverse Event|0|||
154999799|NCT00976911|559424445|FG001|Overall Study|Adverse Event|1|||
154999800|NCT00976911|559424444|FG000|Overall Study|Protocol Violation|2|||
154999801|NCT00976911|559424445|FG001|Overall Study|Protocol Violation|0|||
154999802|NCT00976911|559424444|FG000|Overall Study|Other|8|||
154999803|NCT00976911|559424445|FG001|Overall Study|Other|9|||
154999804|NCT00976911|559424444|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
155177886|NCT01451437|560089454|FG008|Overall Study|Physician Decision|0|||
154999805|NCT00976911|559424445|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
154999806|NCT01191944|559424446|FG000|Overall Study|Adverse Event|11|||
154999807|NCT01191944|559424447|FG001|Overall Study|Adverse Event|12|||
155177887|NCT01451437|560089446|FG000|Overall Study|Disease Progression|0|||
155177888|NCT01451437|560089447|FG001|Overall Study|Disease Progression|0|||
155177889|NCT01451437|560089448|FG002|Overall Study|Disease Progression|1|||
155177890|NCT01451437|560089449|FG003|Overall Study|Disease Progression|1|||
155177891|NCT01451437|560089450|FG004|Overall Study|Disease Progression|3|||
155177892|NCT01451437|560089451|FG005|Overall Study|Disease Progression|2|||
155177893|NCT01451437|560089452|FG006|Overall Study|Disease Progression|3|||
155177894|NCT01451437|560089453|FG007|Overall Study|Disease Progression|1|||
155177895|NCT01451437|560089454|FG008|Overall Study|Disease Progression|3|||
155177896|NCT01451437|560089446|FG000|Overall Study|Protocol Violation|0|||
155177897|NCT01451437|560089447|FG001|Overall Study|Protocol Violation|0|||
155177898|NCT01451437|560089448|FG002|Overall Study|Protocol Violation|0|||
155177899|NCT01451437|560089449|FG003|Overall Study|Protocol Violation|0|||
155177900|NCT01451437|560089450|FG004|Overall Study|Protocol Violation|0|||
154921030|NCT00540228|559133671|FG002|Overall Study|Lost to Follow-up|0|||
154921031|NCT00540228|559133672|FG003|Overall Study|Lost to Follow-up|0|||
154921032|NCT00540228|559133673|FG004|Overall Study|Lost to Follow-up|0|||
154921033|NCT01883362|559133674|FG000|Treatment|Adverse Event|1|||
154921034|NCT01883362|559133675|FG001|Treatment|Adverse Event|8|||
154921035|NCT01883362|559133674|FG000|Treatment|Withdrawal by Subject|6|||
154921036|NCT01883362|559133675|FG001|Treatment|Withdrawal by Subject|2|||
154921037|NCT01883362|559133674|FG000|Treatment|Administrative problems|4|||
154921038|NCT01883362|559133675|FG001|Treatment|Administrative problems|1|||
154921039|NCT01883362|559133674|FG000|Treatment|Relapse|4|||
154921040|NCT01883362|559133675|FG001|Treatment|Relapse|2|||
154921041|NCT01883362|559133674|FG000|Treatment|Randomized, not treated|1|||
154921042|NCT01883362|559133675|FG001|Treatment|Randomized, not treated|1|||
154921043|NCT01883362|559133674|FG000|Post Treatment Follow-up|Protocol Violation|0|||
154921044|NCT01883362|559133675|FG001|Post Treatment Follow-up|Protocol Violation|1|||
154921045|NCT01883362|559133674|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
154921046|NCT01883362|559133675|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
154921047|NCT01883362|559133674|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
154921048|NCT01883362|559133675|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
154921049|NCT01883362|559133674|FG000|Post Treatment Follow-up|Administrative problems|2|||
154921050|NCT01883362|559133675|FG001|Post Treatment Follow-up|Administrative problems|0|||
154921051|NCT01883362|559133674|FG000|Post Treatment Follow-up|Death|8|||
154921052|NCT01883362|559133675|FG001|Post Treatment Follow-up|Death|4|||
154921053|NCT01883362|559133674|FG000|Post Treatment Follow-up|Relapse|1|||
154921054|NCT01883362|559133675|FG001|Post Treatment Follow-up|Relapse|2|||
154921055|NCT02569996|559133678|FG000|Overall Study|Adverse Event|6|||
154921056|NCT02569996|559133678|FG000|Overall Study|Physician Decision|3|||
154921057|NCT02569996|559133678|FG000|Overall Study|Progression of the disease|18|||
154921058|NCT02569996|559133678|FG000|Overall Study|New anti-lymphoma treatment|1|||
154921059|NCT02569996|559133678|FG000|Overall Study|Non-compliance|9|||
154921060|NCT02569996|559133678|FG000|Overall Study|Withdrawal by Subject|5|||
154921061|NCT02569996|559133678|FG000|Overall Study|Lost to Follow-up|5|||
154921062|NCT02569996|559133678|FG000|Overall Study|Complete remission|7|||
154921063|NCT02569996|559133678|FG000|Overall Study|Unknown reason|1|||
154921064|NCT01383317|559133679|FG000|Overall Study|Lost to Follow-up|2|||
154921065|NCT01383317|559133680|FG001|Overall Study|Lost to Follow-up|1|||
154921066|NCT01383317|559133679|FG000|Overall Study|Death|1|||
154921067|NCT01383317|559133680|FG001|Overall Study|Death|0|||
154921068|NCT01383317|559133679|FG000|Overall Study|Adverse Event|0|||
154921069|NCT01383317|559133680|FG001|Overall Study|Adverse Event|1|||
154921070|NCT01207427|559133682|FG000|Double-blind Treatment Period|Adverse Event|0|||
154921071|NCT01207427|559133683|FG001|Double-blind Treatment Period|Adverse Event|1|||
154921072|NCT01207427|559133684|FG002|Double-blind Treatment Period|Adverse Event|0|||
154921073|NCT01207427|559133682|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
154921074|NCT01207427|559133683|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
154921075|NCT01207427|559133684|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
154921076|NCT01207427|559133682|FG000|Double-blind Treatment Period|Protocol Violation|2|||
154921077|NCT01207427|559133683|FG001|Double-blind Treatment Period|Protocol Violation|1|||
154921078|NCT01207427|559133684|FG002|Double-blind Treatment Period|Protocol Violation|1|||
154921079|NCT01207427|559133682|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
154921080|NCT01207427|559133683|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
154921081|NCT01207427|559133684|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
154921082|NCT01230489|559133685|FG000|Overall Study|Death|2|||
154921083|NCT01230489|559133685|FG000|Overall Study|Adverse Event|2|||
154921084|NCT01230489|559133685|FG000|Overall Study|Treatment modality changed|1|||
154921085|NCT03996694|559136083|FG000|First Washout (7 Days)|positive urine drug screen|0|||
154921086|NCT03996694|559136084|FG001|First Washout (7 Days)|positive urine drug screen|0|||
154921087|NCT03996694|559136085|FG002|First Washout (7 Days)|positive urine drug screen|1|||
154921088|NCT03996694|559136086|FG003|First Washout (7 Days)|positive urine drug screen|0|||
155177901|NCT01451437|560089451|FG005|Overall Study|Protocol Violation|0|||
155177902|NCT01451437|560089452|FG006|Overall Study|Protocol Violation|1|||
155177903|NCT01451437|560089453|FG007|Overall Study|Protocol Violation|0|||
154921089|NCT03996694|559136087|FG004|First Washout (7 Days)|positive urine drug screen|0|||
154999808|NCT01191944|559424446|FG000|Overall Study|Protocol Violation|1|||
154999809|NCT01191944|559424447|FG001|Overall Study|Protocol Violation|2|||
154999810|NCT01191944|559424446|FG000|Overall Study|Withdrawal by Subject|4|||
154999811|NCT01191944|559424447|FG001|Overall Study|Withdrawal by Subject|2|||
154999812|NCT01191944|559424446|FG000|Overall Study|Other|1|||
154999813|NCT01191944|559424447|FG001|Overall Study|Other|3|||
154999814|NCT02954991|559424450|FG000|Overall Study|Death|92|||
154999815|NCT02954991|559424451|FG001|Overall Study|Death|11|||
154999816|NCT02954991|559424452|FG002|Overall Study|Death|2|||
154999817|NCT02954991|559424450|FG000|Overall Study|Lost to Follow-up|3|||
154999818|NCT02954991|559424451|FG001|Overall Study|Lost to Follow-up|2|||
154999819|NCT02954991|559424452|FG002|Overall Study|Lost to Follow-up|0|||
154999820|NCT02954991|559424450|FG000|Overall Study|Withdrawal by Subject|9|||
154999821|NCT02954991|559424451|FG001|Overall Study|Withdrawal by Subject|8|||
154999822|NCT02954991|559424452|FG002|Overall Study|Withdrawal by Subject|1|||
154999823|NCT02954991|559424450|FG000|Overall Study|Study Terminated by Sponsor|18|||
154999824|NCT02954991|559424451|FG001|Overall Study|Study Terminated by Sponsor|10|||
154999825|NCT02954991|559424452|FG002|Overall Study|Study Terminated by Sponsor|1|||
154999826|NCT02954991|559424450|FG000|Overall Study|Miscellaneous|2|||
154999827|NCT02954991|559424451|FG001|Overall Study|Miscellaneous|1|||
154999828|NCT02954991|559424452|FG002|Overall Study|Miscellaneous|1|||
154999829|NCT00576316|559424453|FG000|Overall Study|Adverse Event|9|||
154999830|NCT00576316|559424453|FG000|Overall Study|Withdrawal by Subject|2|||
154999831|NCT00576316|559424453|FG000|Overall Study|Protocol Violation|9|||
154999832|NCT04602546|559424460|FG000|Overall Study|Training|2|||
154999833|NCT04602546|559424461|FG001|Overall Study|Training|2|||
154999834|NCT04602546|559424462|FG002|Overall Study|Training|1|||
154999835|NCT04602546|559424463|FG003|Overall Study|Training|2|||
154999836|NCT04602546|559424464|FG004|Overall Study|Training|0|||
154999837|NCT04602546|559424460|FG000|Overall Study|Randomized with disqualified data|2|||
154999838|NCT04602546|559424461|FG001|Overall Study|Randomized with disqualified data|0|||
154999839|NCT04602546|559424462|FG002|Overall Study|Randomized with disqualified data|2|||
154999840|NCT04602546|559424463|FG003|Overall Study|Randomized with disqualified data|5|||
154999841|NCT04602546|559424464|FG004|Overall Study|Randomized with disqualified data|3|||
154999842|NCT02794246|559424465|FG000|Overall Study|Withdrawal by Subject|2|||
154999843|NCT02794246|559424465|FG000|Overall Study|Physician Decision|4|||
154999844|NCT00005957|559424469|FG000|Overall Study|No treated|3|||
154999845|NCT00005957|559424470|FG001|Overall Study|No treated|9|||
154999846|NCT00005957|559424469|FG000|Overall Study|Crossover to the other arm|5|||
154999847|NCT00005957|559424470|FG001|Overall Study|Crossover to the other arm|19|||
154999848|NCT01609023|559424471|FG000|Overall Study|Lack of Efficacy|3|||
154999849|NCT01609023|559424471|FG000|Overall Study|Withdrawal by Subject|4|||
154999850|NCT01609023|559424471|FG000|Overall Study|Lost to Follow-up|8|||
154999851|NCT01609023|559424471|FG000|Overall Study|Toxicity|3|||
154999852|NCT01609023|559424471|FG000|Overall Study|Disease progression|10|||
154999853|NCT01609023|559424471|FG000|Overall Study|Physician Decision|2|||
154999854|NCT01609023|559424471|FG000|Overall Study|Death|2|||
154999855|NCT01609023|559424471|FG000|Overall Study|Personal reasons|1|||
154999856|NCT04172597|559424475|FG000|Overall Study|Disease Progression|0|||
154999857|NCT04172597|559424476|FG001|Overall Study|Disease Progression|0|||
154999858|NCT04172597|559424477|FG002|Overall Study|Disease Progression|0|||
154999859|NCT04172597|559424478|FG003|Overall Study|Disease Progression|0|||
154999860|NCT04172597|559424479|FG004|Overall Study|Disease Progression|1|||
154999861|NCT03717012|559424480|FG000|Overall Study|Due to trial termination|1|||
154999862|NCT03717012|559424481|FG001|Overall Study|Due to trial termination|2|||
154999863|NCT03717012|559424480|FG000|Overall Study|Protocol Violation|0|||
154999864|NCT03717012|559424481|FG001|Overall Study|Protocol Violation|2|||
155123096|NCT02266875|559881882|FG000|Overall Study|Withdrawal by Subject|9|||
155123097|NCT02266875|559881883|FG001|Overall Study|Withdrawal by Subject|0|||
155123098|NCT02266875|559881882|FG000|Overall Study|Lost to Follow-up|2|||
155123099|NCT02266875|559881883|FG001|Overall Study|Lost to Follow-up|0|||
154999865|NCT03717012|559424480|FG000|Overall Study|Adverse Event|0|||
154999866|NCT03717012|559424481|FG001|Overall Study|Adverse Event|1|||
154999867|NCT03717012|559424480|FG000|Overall Study|Lung transplant|0|||
154999868|NCT03717012|559424481|FG001|Overall Study|Lung transplant|1|||
154999869|NCT00789035|559424482|FG000|Overall Study|Adverse Event|0|||
154999870|NCT00789035|559424483|FG001|Overall Study|Adverse Event|2|||
154999871|NCT00789035|559424484|FG002|Overall Study|Adverse Event|0|||
154999872|NCT00789035|559424485|FG003|Overall Study|Adverse Event|1|||
154999873|NCT00789035|559424486|FG004|Overall Study|Adverse Event|3|||
154999874|NCT00789035|559424482|FG000|Overall Study|Lack of Efficacy|3|||
154999875|NCT00789035|559424483|FG001|Overall Study|Lack of Efficacy|0|||
154999876|NCT00789035|559424484|FG002|Overall Study|Lack of Efficacy|0|||
154999877|NCT00789035|559424485|FG003|Overall Study|Lack of Efficacy|0|||
154999878|NCT00789035|559424486|FG004|Overall Study|Lack of Efficacy|2|||
154999879|NCT00789035|559424482|FG000|Overall Study|Protocol Violation|1|||
154999880|NCT00789035|559424483|FG001|Overall Study|Protocol Violation|0|||
155123100|NCT01510145|559881893|FG000|Overall Study|Adverse Event|6|||
154999881|NCT00789035|559424484|FG002|Overall Study|Protocol Violation|0|||
154999882|NCT00789035|559424485|FG003|Overall Study|Protocol Violation|0|||
154999883|NCT00789035|559424486|FG004|Overall Study|Protocol Violation|0|||
154999884|NCT00789035|559424482|FG000|Overall Study|Withdrawal by Subject|0|||
154999885|NCT00789035|559424483|FG001|Overall Study|Withdrawal by Subject|2|||
154999886|NCT00789035|559424484|FG002|Overall Study|Withdrawal by Subject|0|||
154999887|NCT00789035|559424485|FG003|Overall Study|Withdrawal by Subject|0|||
154999888|NCT00789035|559424486|FG004|Overall Study|Withdrawal by Subject|0|||
154999889|NCT00789035|559424482|FG000|Overall Study|Other reason not defined above|2|||
154999890|NCT00789035|559424483|FG001|Overall Study|Other reason not defined above|3|||
154999891|NCT00789035|559424484|FG002|Overall Study|Other reason not defined above|1|||
154999892|NCT00789035|559424485|FG003|Overall Study|Other reason not defined above|0|||
154999893|NCT00789035|559424486|FG004|Overall Study|Other reason not defined above|1|||
154999894|NCT01520870|559424487|FG000|Overall Study|Withdrawal by Subject|2|||
154999895|NCT02463357|559424488|FG000|Overall Study|Withdrawal by Subject|1|||
154999896|NCT02463357|559424489|FG001|Overall Study|Withdrawal by Subject|0|||
154999897|NCT02463357|559424490|FG002|Overall Study|Withdrawal by Subject|0|||
154999898|NCT02463357|559424491|FG003|Overall Study|Withdrawal by Subject|0|||
154999899|NCT02463357|559424492|FG004|Overall Study|Withdrawal by Subject|0|||
154999900|NCT02463357|559424488|FG000|Overall Study|Withdrawal by Subject|0|||
154999901|NCT02463357|559424489|FG001|Overall Study|Withdrawal by Subject|0|||
154999902|NCT02463357|559424490|FG002|Overall Study|Withdrawal by Subject|0|||
154999903|NCT02463357|559424491|FG003|Overall Study|Withdrawal by Subject|0|||
154999904|NCT02463357|559424492|FG004|Overall Study|Withdrawal by Subject|1|||
154999905|NCT01371539|559424495|FG000|Period One: One Week|Lost to Follow-up|0|||
154999906|NCT01371539|559424496|FG001|Period One: One Week|Lost to Follow-up|1|||
154999907|NCT01371539|559424495|FG000|Period Two: One Week|Lost to Follow-up|0|||
154999908|NCT01371539|559424496|FG001|Period Two: One Week|Lost to Follow-up|1|||
154999909|NCT01371539|559424495|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
154999910|NCT01371539|559424496|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
154999911|NCT01371539|559424495|FG000|Period Two: One Week|Time/job conflict|0|||
154999912|NCT01371539|559424496|FG001|Period Two: One Week|Time/job conflict|1|||
154999913|NCT00958893|559424497|FG000|Overall Study|Study prematurely terminated|4|||
154999914|NCT00378573|559424498|FG000|Treatment Period|Adverse Event|9|||
154999915|NCT00378573|559424498|FG000|Treatment Period|Physician Decision|1|||
154999916|NCT00378573|559424498|FG000|Treatment Period|Withdrawal by Subject|2|||
154999917|NCT00378573|559424498|FG000|Treatment Period|Disease Progression|4|||
154999918|NCT00378573|559424498|FG000|Treatment Period|Sponsor decision to close study|1|||
154999919|NCT00378573|559424498|FG000|Follow-up|Death|12|||
154999920|NCT00378573|559424498|FG000|Follow-up|Lost to Follow-up|1|||
154999921|NCT00378573|559424498|FG000|Follow-up|Withdrawal by Subject|1|||
154999922|NCT00711880|559424504|FG000|Overall Study|Adverse Event|11|||
154999923|NCT00711880|559424505|FG001|Overall Study|Adverse Event|2|||
154999924|NCT00711880|559424504|FG000|Overall Study|Patient non-compliance|1|||
154999925|NCT00711880|559424505|FG001|Overall Study|Patient non-compliance|0|||
154999926|NCT00711880|559424504|FG000|Overall Study|Lack of Efficacy|1|||
155123101|NCT01510145|559881893|FG000|Overall Study|Lost to Follow-up|5|||
155123102|NCT01510145|559881893|FG000|Overall Study|Withdrawal by Subject|6|||
155123103|NCT01510145|559881893|FG000|Overall Study|Relative reported subject withdrew|1|||
155123104|NCT01442064|559881894|FG000|Overall Study|Adverse Event|2|||
155123105|NCT01442064|559881895|FG001|Overall Study|Adverse Event|2|||
155123106|NCT01442064|559881896|FG002|Overall Study|Adverse Event|2|||
155123107|NCT01442064|559881897|FG003|Overall Study|Adverse Event|1|||
155123108|NCT01442064|559881898|FG004|Overall Study|Adverse Event|2|||
155123109|NCT01442064|559881899|FG005|Overall Study|Adverse Event|0|||
155123110|NCT01442064|559881894|FG000|Overall Study|Death|0|||
155123111|NCT01442064|559881895|FG001|Overall Study|Death|1|||
155123112|NCT01442064|559881896|FG002|Overall Study|Death|3|||
155123113|NCT01442064|559881897|FG003|Overall Study|Death|3|||
155123114|NCT01442064|559881898|FG004|Overall Study|Death|1|||
155123115|NCT01442064|559881899|FG005|Overall Study|Death|3|||
155123116|NCT01442064|559881894|FG000|Overall Study|Lost to Follow-up|5|||
154999927|NCT00711880|559424505|FG001|Overall Study|Lack of Efficacy|5|||
154999928|NCT00704132|559424506|FG000|Overall Study|Clinical Adverse Experience|1|||
154999929|NCT00704132|559424507|FG001|Overall Study|Clinical Adverse Experience|0|||
154999930|NCT00704132|559424506|FG000|Overall Study|Lack of Efficacy|0|||
154999931|NCT00704132|559424507|FG001|Overall Study|Lack of Efficacy|1|||
154999932|NCT00704132|559424506|FG000|Overall Study|Withdrawal by Subject|0|||
154999933|NCT00704132|559424507|FG001|Overall Study|Withdrawal by Subject|1|||
154999934|NCT00442962|559424508|FG000|Overall Study|Pregnancy|1|||
154999935|NCT00442962|559424508|FG000|Overall Study|Lost to Follow-up|7|||
154999936|NCT03348163|559424509|FG000|Overall Study|Withdrawal by Subject|2|||
154999937|NCT03348163|559424510|FG001|Overall Study|Withdrawal by Subject|0|||
154999938|NCT02585778|559424511|FG000|Overall Study|Adverse Event|17|||
155123117|NCT01442064|559881895|FG001|Overall Study|Lost to Follow-up|5|||
155123118|NCT01442064|559881896|FG002|Overall Study|Lost to Follow-up|1|||
155123119|NCT01442064|559881897|FG003|Overall Study|Lost to Follow-up|1|||
155123120|NCT01442064|559881898|FG004|Overall Study|Lost to Follow-up|3|||
155123121|NCT01442064|559881899|FG005|Overall Study|Lost to Follow-up|3|||
155177904|NCT01451437|560089454|FG008|Overall Study|Protocol Violation|0|||
155177905|NCT01451437|560089446|FG000|Overall Study|Withdrawal by Subject|0|||
155177906|NCT01451437|560089447|FG001|Overall Study|Withdrawal by Subject|0|||
155177907|NCT01451437|560089448|FG002|Overall Study|Withdrawal by Subject|0|||
155177908|NCT01451437|560089449|FG003|Overall Study|Withdrawal by Subject|0|||
155177909|NCT01451437|560089450|FG004|Overall Study|Withdrawal by Subject|1|||
155177910|NCT01451437|560089451|FG005|Overall Study|Withdrawal by Subject|0|||
155177911|NCT01451437|560089452|FG006|Overall Study|Withdrawal by Subject|1|||
155177912|NCT01451437|560089453|FG007|Overall Study|Withdrawal by Subject|0|||
155177913|NCT01451437|560089454|FG008|Overall Study|Withdrawal by Subject|0|||
155177914|NCT00853970|560089459|FG000|Overall Study|Withdrawal by Subject|2|||
155177915|NCT00853970|560089460|FG001|Overall Study|Withdrawal by Subject|1|||
155177916|NCT00853970|560089459|FG000|Overall Study|Cancelled surgery|4|||
155177917|NCT00853970|560089460|FG001|Overall Study|Cancelled surgery|2|||
155177918|NCT02276027|560091359|FG000|Overall Study|Death|1|||
155177919|NCT02276027|560091360|FG001|Overall Study|Death|0|||
155177920|NCT02276027|560091361|FG002|Overall Study|Death|0|||
155177921|NCT02276027|560091362|FG003|Overall Study|Death|2|||
155177922|NCT02276027|560091359|FG000|Overall Study|Physician Decision|0|||
155177923|NCT02276027|560091360|FG001|Overall Study|Physician Decision|0|||
155177924|NCT02276027|560091361|FG002|Overall Study|Physician Decision|0|||
155177925|NCT02276027|560091362|FG003|Overall Study|Physician Decision|1|||
155177926|NCT02276027|560091359|FG000|Overall Study|Progressive disease|1|||
155177927|NCT02276027|560091360|FG001|Overall Study|Progressive disease|13|||
155177928|NCT02276027|560091361|FG002|Overall Study|Progressive disease|12|||
155177929|NCT02276027|560091362|FG003|Overall Study|Progressive disease|14|||
155177930|NCT02276027|560091359|FG000|Overall Study|Subject/guardian decision|0|||
155177931|NCT02276027|560091360|FG001|Overall Study|Subject/guardian decision|1|||
155177932|NCT02276027|560091361|FG002|Overall Study|Subject/guardian decision|0|||
155177933|NCT02276027|560091362|FG003|Overall Study|Subject/guardian decision|3|||
155177934|NCT02276027|560091359|FG000|Overall Study|Adverse Event|0|||
155177935|NCT02276027|560091360|FG001|Overall Study|Adverse Event|2|||
155177936|NCT02276027|560091361|FG002|Overall Study|Adverse Event|8|||
155177937|NCT02276027|560091362|FG003|Overall Study|Adverse Event|2|||
155177938|NCT03739242|560091364|FG000|Overall Study|Withdrawal by Subject|1|||
155177939|NCT03739242|560091365|FG001|Overall Study|Withdrawal by Subject|1|||
155177940|NCT03739242|560091364|FG000|Overall Study|Protocol Violation|0|||
155177941|NCT03739242|560091365|FG001|Overall Study|Protocol Violation|1|||
155177942|NCT00640835|560091367|FG000|Overall Study|Adverse Event|5|||
155177943|NCT00640835|560091368|FG001|Overall Study|Adverse Event|3|||
155177944|NCT00640835|560091367|FG000|Overall Study|Withdrawal by Subject|12|||
155177945|NCT00640835|560091368|FG001|Overall Study|Withdrawal by Subject|14|||
155177946|NCT00640835|560091367|FG000|Overall Study|Physician Decision|10|||
155177947|NCT00640835|560091368|FG001|Overall Study|Physician Decision|14|||
155177948|NCT00640835|560091367|FG000|Overall Study|Sponsor's Decision|11|||
155177949|NCT00640835|560091368|FG001|Overall Study|Sponsor's Decision|7|||
155177950|NCT00640835|560091367|FG000|Overall Study|Protocol Violation|2|||
155177951|NCT00640835|560091368|FG001|Overall Study|Protocol Violation|2|||
155177952|NCT00640835|560091367|FG000|Overall Study|Lost to Follow-up|17|||
155177953|NCT00640835|560091368|FG001|Overall Study|Lost to Follow-up|13|||
155177954|NCT00640835|560091367|FG000|Overall Study|Other Reason|19|||
155177955|NCT00640835|560091368|FG001|Overall Study|Other Reason|4|||
155177956|NCT02160002|560091369|FG000|Overall Study|Withdrawal by Subject|2|||
155177957|NCT02160002|560091370|FG001|Overall Study|Withdrawal by Subject|1|||
155177958|NCT00775203|560091371|FG000|Overall Study|Adverse Event|25|||
155177959|NCT00775203|560091372|FG001|Overall Study|Adverse Event|6|||
155177960|NCT00775203|560091371|FG000|Overall Study|Lack of Efficacy|8|||
155177961|NCT00775203|560091372|FG001|Overall Study|Lack of Efficacy|9|||
155177962|NCT00775203|560091371|FG000|Overall Study|Withdrawal by Subject|11|||
155177963|NCT00775203|560091372|FG001|Overall Study|Withdrawal by Subject|9|||
155177964|NCT00775203|560091371|FG000|Overall Study|Lost to Follow-up|11|||
155177965|NCT00775203|560091372|FG001|Overall Study|Lost to Follow-up|15|||
155177966|NCT00775203|560091371|FG000|Overall Study|Administrative reason|2|||
155177967|NCT00775203|560091372|FG001|Overall Study|Administrative reason|0|||
155177968|NCT00775203|560091371|FG000|Overall Study|Noncompliance|4|||
155177969|NCT00775203|560091372|FG001|Overall Study|Noncompliance|2|||
155177970|NCT00775203|560091371|FG000|Overall Study|Protocol Violation|0|||
155177971|NCT00775203|560091372|FG001|Overall Study|Protocol Violation|1|||
155177972|NCT00775203|560091371|FG000|Overall Study|Entered other study|1|||
155177973|NCT00775203|560091372|FG001|Overall Study|Entered other study|0|||
155177974|NCT00775203|560091371|FG000|Overall Study|Physician Decision|0|||
155177975|NCT00775203|560091372|FG001|Overall Study|Physician Decision|1|||
155177976|NCT04395001|560091373|FG000|Overall Study|Lost to Follow-up|8|||
155177977|NCT04395001|560091374|FG001|Overall Study|Lost to Follow-up|9|||
155177978|NCT04395001|560091375|FG002|Overall Study|Lost to Follow-up|5|||
155177979|NCT04395001|560091373|FG000|Overall Study|Withdrawal by Subject|3|||
155177980|NCT04395001|560091374|FG001|Overall Study|Withdrawal by Subject|1|||
155177981|NCT04395001|560091375|FG002|Overall Study|Withdrawal by Subject|3|||
155177982|NCT04395001|560091373|FG000|Overall Study|missed appointment|7|||
154999939|NCT02585778|559424512|FG001|Overall Study|Adverse Event|4|||
154999940|NCT02585778|559424511|FG000|Overall Study|Participant did not wish to continue|9|||
154999941|NCT02585778|559424512|FG001|Overall Study|Participant did not wish to continue|4|||
154999942|NCT02585778|559424511|FG000|Overall Study|Poor compliance to study protocol|0|||
154999943|NCT02585778|559424512|FG001|Overall Study|Poor compliance to study protocol|2|||
154999944|NCT02585778|559424511|FG000|Overall Study|Death|0|||
154999945|NCT02585778|559424512|FG001|Overall Study|Death|1|||
154999946|NCT02585778|559424511|FG000|Overall Study|Randomized but not treated|1|||
154999947|NCT02585778|559424512|FG001|Overall Study|Randomized but not treated|2|||
154999948|NCT02585778|559424511|FG000|Overall Study|Other than specified above|6|||
154999949|NCT02585778|559424512|FG001|Overall Study|Other than specified above|2|||
154999950|NCT04841577|559424513|FG000|Overall Study|Adverse Event|5|||
154999951|NCT04841577|559424514|FG001|Overall Study|Adverse Event|10|||
154999952|NCT04841577|559424513|FG000|Overall Study|Lost to Follow-up|8|||
154999953|NCT04841577|559424514|FG001|Overall Study|Lost to Follow-up|7|||
154999954|NCT04841577|559424513|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
154999955|NCT04841577|559424514|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
154999956|NCT04841577|559424513|FG000|Overall Study|Other|0|||
154999957|NCT04841577|559424514|FG001|Overall Study|Other|1|||
154999958|NCT01267994|559424516|FG000|Overall Study|Adverse Event|2|||
154999959|NCT03276078|559424519|FG000|Overall Study|Adverse Event|1|||
154999960|NCT03968978|559424521|FG000|Overall Study|Adverse Event|1|||
154999961|NCT03968978|559424522|FG001|Overall Study|Adverse Event|0|||
154999962|NCT00086281|559424523|FG000|Phase 1|Adverse Event|0|||
154999963|NCT00086281|559424524|FG001|Phase 1|Adverse Event|0|||
155123122|NCT01442064|559881894|FG000|Overall Study|Physician Decision|1|||
155123123|NCT01442064|559881895|FG001|Overall Study|Physician Decision|1|||
155123124|NCT01442064|559881896|FG002|Overall Study|Physician Decision|2|||
155123125|NCT01442064|559881897|FG003|Overall Study|Physician Decision|3|||
155123126|NCT01442064|559881898|FG004|Overall Study|Physician Decision|3|||
155123127|NCT01442064|559881899|FG005|Overall Study|Physician Decision|1|||
155123128|NCT01442064|559881894|FG000|Overall Study|Withdrawal by Subject|6|||
155123129|NCT01442064|559881895|FG001|Overall Study|Withdrawal by Subject|3|||
155123130|NCT01442064|559881896|FG002|Overall Study|Withdrawal by Subject|2|||
155123131|NCT01442064|559881897|FG003|Overall Study|Withdrawal by Subject|2|||
155123132|NCT01442064|559881898|FG004|Overall Study|Withdrawal by Subject|2|||
155123133|NCT01442064|559881899|FG005|Overall Study|Withdrawal by Subject|1|||
155123134|NCT01442064|559881894|FG000|Overall Study|Sponsor decision|82|||
155123135|NCT01442064|559881895|FG001|Overall Study|Sponsor decision|88|||
155123136|NCT01442064|559881896|FG002|Overall Study|Sponsor decision|92|||
155123137|NCT01442064|559881897|FG003|Overall Study|Sponsor decision|88|||
155123138|NCT01442064|559881898|FG004|Overall Study|Sponsor decision|95|||
155123139|NCT01442064|559881899|FG005|Overall Study|Sponsor decision|87|||
155123140|NCT01442064|559881894|FG000|Overall Study|Subject non-compliance|0|||
155123141|NCT01442064|559881895|FG001|Overall Study|Subject non-compliance|0|||
155123142|NCT01442064|559881896|FG002|Overall Study|Subject non-compliance|0|||
155123143|NCT01442064|559881897|FG003|Overall Study|Subject non-compliance|0|||
155123144|NCT01442064|559881898|FG004|Overall Study|Subject non-compliance|0|||
155123145|NCT01442064|559881899|FG005|Overall Study|Subject non-compliance|2|||
155123146|NCT01442064|559881894|FG000|Overall Study|Condition mandated other intervention|1|||
155123147|NCT01442064|559881895|FG001|Overall Study|Condition mandated other intervention|1|||
155123148|NCT01442064|559881896|FG002|Overall Study|Condition mandated other intervention|2|||
155123149|NCT01442064|559881897|FG003|Overall Study|Condition mandated other intervention|0|||
155123150|NCT01442064|559881898|FG004|Overall Study|Condition mandated other intervention|0|||
155123151|NCT01442064|559881899|FG005|Overall Study|Condition mandated other intervention|2|||
155123152|NCT01360398|559881900|FG000|Overall Study|Withdrawal by Subject|14|||
155123153|NCT01360398|559881900|FG000|Overall Study|Other|7|||
155123154|NCT01360398|559881900|FG000|Overall Study|Migrated/moved from study area|1|||
155123155|NCT00846040|559881901|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
154999964|NCT00086281|559424525|FG002|Phase 1|Adverse Event|0|||
155123156|NCT00846040|559881902|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
155123157|NCT00846040|559881903|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
155123158|NCT00846040|559881901|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
154999965|NCT00086281|559424526|FG003|Phase 1|Adverse Event|0|||
155123159|NCT00846040|559881902|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
155123160|NCT00846040|559881903|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
155123161|NCT02153346|559881904|FG000|Overall Study|Lost to Follow-up|11|||
154999966|NCT00086281|559424527|FG004|Phase 1|Adverse Event|0|||
154999967|NCT00086281|559424528|FG005|Phase 1|Adverse Event|0|||
154999968|NCT00086281|559424529|FG006|Phase 1|Adverse Event|0|||
154999969|NCT00086281|559424530|FG007|Phase 1|Adverse Event|0|||
154999970|NCT00086281|559424531|FG008|Phase 1|Adverse Event|0|||
154999971|NCT00086281|559424532|FG009|Phase 1|Adverse Event|1|||
154999972|NCT00086281|559424533|FG010|Phase 1|Adverse Event|2|||
155123162|NCT03158272|559881905|FG000|Overall Study|Disease progression|3|||
154999973|NCT00086281|559424534|FG011|Phase 1|Adverse Event|1|||
155123163|NCT03158272|559881906|FG001|Overall Study|Disease progression|3|||
154999974|NCT00086281|559424535|FG012|Phase 1|Adverse Event|1|||
154999975|NCT00086281|559424536|FG013|Phase 1|Adverse Event|1|||
154999976|NCT00086281|559424537|FG014|Phase 1|Adverse Event|2|||
154999977|NCT00086281|559424523|FG000|Phase 1|Protocol Violation|0|||
154999978|NCT00086281|559424524|FG001|Phase 1|Protocol Violation|0|||
154999979|NCT00086281|559424525|FG002|Phase 1|Protocol Violation|0|||
154999980|NCT00086281|559424526|FG003|Phase 1|Protocol Violation|0|||
154999981|NCT00086281|559424527|FG004|Phase 1|Protocol Violation|0|||
154999982|NCT00086281|559424528|FG005|Phase 1|Protocol Violation|0|||
154999983|NCT00086281|559424529|FG006|Phase 1|Protocol Violation|0|||
154999984|NCT00086281|559424530|FG007|Phase 1|Protocol Violation|0|||
154999985|NCT00086281|559424531|FG008|Phase 1|Protocol Violation|0|||
154999986|NCT00086281|559424532|FG009|Phase 1|Protocol Violation|0|||
154999987|NCT00086281|559424533|FG010|Phase 1|Protocol Violation|1|||
154999988|NCT00086281|559424534|FG011|Phase 1|Protocol Violation|0|||
154999989|NCT00086281|559424535|FG012|Phase 1|Protocol Violation|0|||
154999990|NCT00086281|559424536|FG013|Phase 1|Protocol Violation|0|||
154999991|NCT00086281|559424537|FG014|Phase 1|Protocol Violation|0|||
154999992|NCT00086281|559424523|FG000|Phase 1|Serious Adverse Event|0|||
154999993|NCT00086281|559424524|FG001|Phase 1|Serious Adverse Event|0|||
154999994|NCT00086281|559424525|FG002|Phase 1|Serious Adverse Event|0|||
154999995|NCT00086281|559424526|FG003|Phase 1|Serious Adverse Event|0|||
154999996|NCT00086281|559424527|FG004|Phase 1|Serious Adverse Event|0|||
154999997|NCT00086281|559424528|FG005|Phase 1|Serious Adverse Event|0|||
154999998|NCT00086281|559424529|FG006|Phase 1|Serious Adverse Event|0|||
154999999|NCT00086281|559424530|FG007|Phase 1|Serious Adverse Event|0|||
155000000|NCT00086281|559424531|FG008|Phase 1|Serious Adverse Event|0|||
155000001|NCT00086281|559424532|FG009|Phase 1|Serious Adverse Event|0|||
155000002|NCT00086281|559424533|FG010|Phase 1|Serious Adverse Event|0|||
155000003|NCT00086281|559424534|FG011|Phase 1|Serious Adverse Event|0|||
155000004|NCT00086281|559424535|FG012|Phase 1|Serious Adverse Event|0|||
155000005|NCT00086281|559424536|FG013|Phase 1|Serious Adverse Event|0|||
155000006|NCT00086281|559424537|FG014|Phase 1|Serious Adverse Event|1|||
155000007|NCT00086281|559424523|FG000|Phase 2|Adverse Event|0|||
155000008|NCT00086281|559424524|FG001|Phase 2|Adverse Event|0|||
155000009|NCT00086281|559424525|FG002|Phase 2|Adverse Event|0|||
155000010|NCT00086281|559424526|FG003|Phase 2|Adverse Event|0|||
155000011|NCT00086281|559424527|FG004|Phase 2|Adverse Event|0|||
155000012|NCT00086281|559424528|FG005|Phase 2|Adverse Event|0|||
155000013|NCT00086281|559424529|FG006|Phase 2|Adverse Event|0|||
155000014|NCT00086281|559424530|FG007|Phase 2|Adverse Event|0|||
155000015|NCT00086281|559424531|FG008|Phase 2|Adverse Event|0|||
155000016|NCT00086281|559424532|FG009|Phase 2|Adverse Event|0|||
155000017|NCT00086281|559424533|FG010|Phase 2|Adverse Event|0|||
155000018|NCT00086281|559424534|FG011|Phase 2|Adverse Event|0|||
155000019|NCT00086281|559424535|FG012|Phase 2|Adverse Event|1|||
155000020|NCT00086281|559424536|FG013|Phase 2|Adverse Event|1|||
155000021|NCT00086281|559424537|FG014|Phase 2|Adverse Event|0|||
155000022|NCT00205803|559424540|FG000|Infant Series|Lost to Follow-up|10|||
155000023|NCT00205803|559424541|FG001|Infant Series|Lost to Follow-up|4|||
155000024|NCT00205803|559424540|FG000|Infant Series|Withdrawal by Subject|2|||
155000025|NCT00205803|559424541|FG001|Infant Series|Withdrawal by Subject|5|||
155000026|NCT00205803|559424540|FG000|Infant Series|Physician Decision|3|||
155000027|NCT00205803|559424541|FG001|Infant Series|Physician Decision|1|||
155000028|NCT00205803|559424540|FG000|Infant Series|Protocol Violation|1|||
155000029|NCT00205803|559424541|FG001|Infant Series|Protocol Violation|0|||
155000030|NCT00205803|559424540|FG000|Infant Series|Lost Kaiser coverage|0|||
155000031|NCT00205803|559424541|FG001|Infant Series|Lost Kaiser coverage|1|||
155000032|NCT00205803|559424540|FG000|Infant Series|Non-compliant|1|||
155000033|NCT00205803|559424541|FG001|Infant Series|Non-compliant|0|||
155000034|NCT00205803|559424540|FG000|Infant Series|Sponsor request|1|||
155000035|NCT00205803|559424541|FG001|Infant Series|Sponsor request|0|||
155000036|NCT00205803|559424540|FG000|After Infant Series|Adverse Event|1|||
155000037|NCT00205803|559424541|FG001|After Infant Series|Adverse Event|1|||
155000038|NCT00205803|559424540|FG000|After Infant Series|Protocol Violation|1|||
155000039|NCT00205803|559424541|FG001|After Infant Series|Protocol Violation|1|||
155000040|NCT00205803|559424540|FG000|After Infant Series|Lost to Follow-up|2|||
155000041|NCT00205803|559424541|FG001|After Infant Series|Lost to Follow-up|1|||
155000042|NCT00205803|559424540|FG000|After Infant Series|Physician Decision|3|||
155000043|NCT00205803|559424541|FG001|After Infant Series|Physician Decision|2|||
155000044|NCT00205803|559424540|FG000|After Infant Series|Withdrawal by Subject|1|||
155000045|NCT00205803|559424541|FG001|After Infant Series|Withdrawal by Subject|4|||
155000046|NCT00205803|559424540|FG000|After Infant Series|Other|10|||
155000047|NCT00205803|559424541|FG001|After Infant Series|Other|4|||
155000048|NCT00205803|559424540|FG000|Toddler Dose|Lost to Follow-up|2|||
155000049|NCT00205803|559424541|FG001|Toddler Dose|Lost to Follow-up|3|||
155000050|NCT00351533|559424542|FG000|Overall Study|Extubated before first BAL|1|||
155000051|NCT00351533|559424543|FG001|Overall Study|Extubated before first BAL|0|||
155000052|NCT00351533|559424542|FG000|Overall Study|Lost to Follow-up|1|||
155000053|NCT00351533|559424543|FG001|Overall Study|Lost to Follow-up|3|||
155000054|NCT00351533|559424542|FG000|Overall Study|Physician Decision|0|||
155000055|NCT00351533|559424543|FG001|Overall Study|Physician Decision|1|||
155177983|NCT04395001|560091374|FG001|Overall Study|missed appointment|4|||
155177984|NCT04395001|560091375|FG002|Overall Study|missed appointment|1|||
155177985|NCT04418661|560091376|FG000|Overall Study|Adverse Event|0|||
154921090|NCT03996694|559136088|FG005|First Washout (7 Days)|positive urine drug screen|0|||
154921091|NCT03996694|559136083|FG000|First Washout (7 Days)|Adverse Event|0|||
154921092|NCT03996694|559136084|FG001|First Washout (7 Days)|Adverse Event|1|||
154921093|NCT03996694|559136085|FG002|First Washout (7 Days)|Adverse Event|0|||
154921094|NCT03996694|559136086|FG003|First Washout (7 Days)|Adverse Event|0|||
154921095|NCT03996694|559136087|FG004|First Washout (7 Days)|Adverse Event|0|||
154921096|NCT03996694|559136088|FG005|First Washout (7 Days)|Adverse Event|0|||
154921097|NCT03996694|559136083|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
154921098|NCT03996694|559136084|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
154921099|NCT03996694|559136085|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
154921100|NCT03996694|559136086|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
154921101|NCT03996694|559136087|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
154921102|NCT03996694|559136088|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
154921103|NCT03996694|559136083|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
154921104|NCT03996694|559136084|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
154921105|NCT03996694|559136085|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
154921106|NCT03996694|559136086|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
154921107|NCT03996694|559136087|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
154921108|NCT03996694|559136088|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
154921109|NCT02147132|559136093|FG000|Overall Study|Lost to Follow-up|1|||
154921110|NCT02147132|559136094|FG001|Overall Study|Lost to Follow-up|0|||
154921111|NCT02147132|559136095|FG002|Overall Study|Lost to Follow-up|0|||
154921112|NCT02147132|559136096|FG003|Overall Study|Lost to Follow-up|0|||
154921113|NCT03323034|559136097|FG000|Overall Study|Lack of Efficacy|5|||
154921114|NCT03323034|559136098|FG001|Overall Study|Lack of Efficacy|5|||
154921115|NCT03323034|559136099|FG002|Overall Study|Lack of Efficacy|6|||
154921116|NCT03323034|559136100|FG003|Overall Study|Lack of Efficacy|5|||
154921117|NCT03323034|559136101|FG004|Overall Study|Lack of Efficacy|5|||
154921118|NCT03323034|559136097|FG000|Overall Study|Physician Decision|0|||
154921119|NCT03323034|559136098|FG001|Overall Study|Physician Decision|0|||
154921120|NCT03323034|559136099|FG002|Overall Study|Physician Decision|0|||
154921121|NCT03323034|559136100|FG003|Overall Study|Physician Decision|0|||
154921122|NCT03323034|559136101|FG004|Overall Study|Physician Decision|1|||
154921123|NCT03323034|559136097|FG000|Overall Study|Withdrawal by Subject|1|||
154921124|NCT03323034|559136098|FG001|Overall Study|Withdrawal by Subject|1|||
154921125|NCT03323034|559136099|FG002|Overall Study|Withdrawal by Subject|0|||
154921126|NCT03323034|559136100|FG003|Overall Study|Withdrawal by Subject|1|||
154921127|NCT03323034|559136101|FG004|Overall Study|Withdrawal by Subject|0|||
154921128|NCT01300741|559136105|FG000|Overall Study|Lens deposits|1|||
154921129|NCT01300741|559136105|FG000|Overall Study|Lost to Follow-up|1|||
154921130|NCT01300741|559136105|FG000|Overall Study|Discomfort|1|||
154921131|NCT00463385|559136107|FG000|Overall Study|Other|4|||
154921132|NCT00463385|559136108|FG001|Overall Study|Other|3|||
154921133|NCT00463385|559136109|FG002|Overall Study|Other|6|||
154921134|NCT00463385|559136110|FG003|Overall Study|Other|4|||
154921135|NCT00463385|559136107|FG000|Overall Study|Adverse Event|5|||
154921136|NCT00463385|559136108|FG001|Overall Study|Adverse Event|8|||
154921137|NCT00463385|559136109|FG002|Overall Study|Adverse Event|4|||
154921138|NCT00463385|559136110|FG003|Overall Study|Adverse Event|2|||
154921139|NCT00463385|559136107|FG000|Overall Study|Lack of Efficacy|6|||
154921140|NCT00463385|559136108|FG001|Overall Study|Lack of Efficacy|6|||
154921141|NCT00463385|559136109|FG002|Overall Study|Lack of Efficacy|7|||
154921142|NCT00463385|559136110|FG003|Overall Study|Lack of Efficacy|9|||
154921143|NCT00463385|559136107|FG000|Overall Study|Withdrawal by Subject|3|||
154921144|NCT00463385|559136108|FG001|Overall Study|Withdrawal by Subject|3|||
154921145|NCT00463385|559136109|FG002|Overall Study|Withdrawal by Subject|3|||
154921146|NCT00463385|559136110|FG003|Overall Study|Withdrawal by Subject|4|||
154921147|NCT00463385|559136107|FG000|Overall Study|Lost to Follow-up|0|||
154921148|NCT00463385|559136108|FG001|Overall Study|Lost to Follow-up|0|||
154921149|NCT00463385|559136109|FG002|Overall Study|Lost to Follow-up|0|||
154921150|NCT00463385|559136110|FG003|Overall Study|Lost to Follow-up|1|||
154921151|NCT00463385|559136107|FG000|Overall Study|Death|2|||
154921152|NCT00463385|559136108|FG001|Overall Study|Death|1|||
154921153|NCT00463385|559136109|FG002|Overall Study|Death|2|||
154921154|NCT00463385|559136110|FG003|Overall Study|Death|0|||
154921155|NCT00463385|559136107|FG000|Overall Study|Missing|2|||
154921156|NCT00463385|559136108|FG001|Overall Study|Missing|0|||
154921157|NCT00463385|559136109|FG002|Overall Study|Missing|0|||
154921158|NCT00463385|559136110|FG003|Overall Study|Missing|2|||
154921159|NCT00463385|559136107|FG000|Overall Study|1 participant received commercial drug|0|||
154921160|NCT00463385|559136108|FG001|Overall Study|1 participant received commercial drug|1|||
154921161|NCT00463385|559136109|FG002|Overall Study|1 participant received commercial drug|0|||
154921162|NCT00463385|559136110|FG003|Overall Study|1 participant received commercial drug|0|||
154921163|NCT01548573|559136112|FG000|Overall Study|Death|3|||
154921164|NCT01548573|559136112|FG000|Overall Study|Withdrawal by Subject|2|||
155000056|NCT00351533|559424542|FG000|Overall Study|Withdrawal by Subject|0|||
155000057|NCT00351533|559424543|FG001|Overall Study|Withdrawal by Subject|1|||
155000058|NCT02056392|559424546|FG000|Overall Study|Lost to Follow-up|0|||
155000059|NCT02056392|559424547|FG001|Overall Study|Lost to Follow-up|1|||
155000060|NCT02056392|559424548|FG002|Overall Study|Lost to Follow-up|2|||
155000061|NCT02056392|559424549|FG003|Overall Study|Lost to Follow-up|0|||
155000062|NCT02056392|559424550|FG004|Overall Study|Lost to Follow-up|0|||
155123164|NCT03158272|559881907|FG002|Overall Study|Disease progression|4|||
155123165|NCT03158272|559881908|FG003|Overall Study|Disease progression|6|||
155123166|NCT03158272|559881905|FG000|Overall Study|Death|0|||
155123167|NCT03158272|559881906|FG001|Overall Study|Death|0|||
155123168|NCT03158272|559881907|FG002|Overall Study|Death|1|||
155123169|NCT03158272|559881908|FG003|Overall Study|Death|0|||
155123170|NCT03158272|559881905|FG000|Overall Study|Other reasons|0|||
155123171|NCT03158272|559881906|FG001|Overall Study|Other reasons|0|||
155123172|NCT03158272|559881907|FG002|Overall Study|Other reasons|1|||
155123173|NCT03158272|559881908|FG003|Overall Study|Other reasons|0|||
155123174|NCT03158272|559881905|FG000|Overall Study|Adverse event unrelated to the drug|0|||
155123175|NCT03158272|559881906|FG001|Overall Study|Adverse event unrelated to the drug|1|||
155123176|NCT03158272|559881907|FG002|Overall Study|Adverse event unrelated to the drug|0|||
155000063|NCT02056392|559424551|FG005|Overall Study|Lost to Follow-up|0|||
155000064|NCT02056392|559424546|FG000|Overall Study|Protocol Violation|1|||
155000065|NCT02056392|559424547|FG001|Overall Study|Protocol Violation|0|||
155000066|NCT02056392|559424548|FG002|Overall Study|Protocol Violation|1|||
155000067|NCT02056392|559424549|FG003|Overall Study|Protocol Violation|0|||
155000068|NCT02056392|559424550|FG004|Overall Study|Protocol Violation|0|||
155000069|NCT02056392|559424551|FG005|Overall Study|Protocol Violation|0|||
155000070|NCT02056392|559424546|FG000|Overall Study|Withdrawal by Subject|1|||
155000071|NCT02056392|559424547|FG001|Overall Study|Withdrawal by Subject|0|||
155000072|NCT02056392|559424548|FG002|Overall Study|Withdrawal by Subject|0|||
155000073|NCT02056392|559424549|FG003|Overall Study|Withdrawal by Subject|0|||
155000074|NCT02056392|559424550|FG004|Overall Study|Withdrawal by Subject|1|||
155000075|NCT02056392|559424551|FG005|Overall Study|Withdrawal by Subject|0|||
155000076|NCT00103610|559424552|FG000|Overall Study|Entered Rescue Procedure|10|||
155000077|NCT00103610|559424553|FG001|Overall Study|Entered Rescue Procedure|52|||
155000078|NCT00103610|559424552|FG000|Overall Study|Death|16|||
155000079|NCT00103610|559424553|FG001|Overall Study|Death|12|||
155000080|NCT00103610|559424552|FG000|Overall Study|Elective Withdrawal|4|||
155000081|NCT00103610|559424553|FG001|Overall Study|Elective Withdrawal|0|||
155000082|NCT00103610|559424552|FG000|Overall Study|Lost to Follow-up|3|||
155000083|NCT00103610|559424553|FG001|Overall Study|Lost to Follow-up|1|||
155000084|NCT00103610|559424552|FG000|Overall Study|Adverse Event|2|||
155000085|NCT00103610|559424553|FG001|Overall Study|Adverse Event|2|||
155000086|NCT00103610|559424552|FG000|Overall Study|Other|2|||
155000087|NCT00103610|559424553|FG001|Overall Study|Other|7|||
155000088|NCT00103610|559424552|FG000|Overall Study|Failed mobilization|1|||
155000089|NCT00103610|559424553|FG001|Overall Study|Failed mobilization|5|||
155000090|NCT00103610|559424552|FG000|Overall Study|Noncompliance|0|||
155000091|NCT00103610|559424553|FG001|Overall Study|Noncompliance|1|||
155000092|NCT04784533|559424556|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
155000093|NCT04784533|559424557|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
155000094|NCT04784533|559424558|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155000095|NCT04784533|559424559|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155000096|NCT04784533|559424560|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155000097|NCT04784533|559424561|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155123177|NCT03158272|559881908|FG003|Overall Study|Adverse event unrelated to the drug|0|||
155000098|NCT04784533|559424562|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155123178|NCT01822535|559881909|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
155123179|NCT01822535|559881910|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
155123180|NCT01822535|559881909|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
155123181|NCT01822535|559881910|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
155123182|NCT01822535|559881909|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
155000099|NCT04784533|559424563|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155000100|NCT04784533|559424564|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155000101|NCT04784533|559424565|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
155000102|NCT04784533|559424556|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
155000103|NCT04784533|559424557|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
155000104|NCT04784533|559424558|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000105|NCT04784533|559424559|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000106|NCT04784533|559424560|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155123183|NCT01822535|559881910|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
155123184|NCT01048866|559881911|FG000|Overall Study|Adverse Event|1|||
155123185|NCT01048866|559881912|FG001|Overall Study|Adverse Event|0|||
155000107|NCT04784533|559424561|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000108|NCT04784533|559424562|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000109|NCT04784533|559424563|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000110|NCT04784533|559424564|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000111|NCT04784533|559424565|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
155000112|NCT04784533|559424556|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000113|NCT04784533|559424557|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
155000114|NCT04784533|559424558|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000115|NCT04784533|559424559|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000116|NCT04784533|559424560|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000117|NCT04784533|559424561|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000118|NCT04784533|559424562|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000119|NCT04784533|559424563|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000120|NCT04784533|559424564|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000121|NCT04784533|559424565|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
155000122|NCT04784533|559424556|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
155000123|NCT04784533|559424557|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000124|NCT04784533|559424558|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000125|NCT04784533|559424559|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000126|NCT04784533|559424560|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000127|NCT04784533|559424561|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000128|NCT04784533|559424562|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000129|NCT04784533|559424563|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000130|NCT04784533|559424564|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000131|NCT04784533|559424565|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
155000132|NCT04784533|559424556|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
155000133|NCT04784533|559424557|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
155000134|NCT04784533|559424558|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000135|NCT04784533|559424559|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000136|NCT04784533|559424560|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000137|NCT04784533|559424561|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000138|NCT04784533|559424562|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000139|NCT04784533|559424563|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000140|NCT04784533|559424564|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000141|NCT04784533|559424565|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
155000142|NCT04784533|559424556|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
155000143|NCT04784533|559424557|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
155000144|NCT04784533|559424558|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000145|NCT04784533|559424559|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000146|NCT04784533|559424560|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000147|NCT04784533|559424561|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000148|NCT04784533|559424562|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000149|NCT04784533|559424563|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000150|NCT04784533|559424564|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000151|NCT04784533|559424565|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
155000152|NCT04784533|559424556|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000153|NCT04784533|559424557|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000154|NCT04784533|559424558|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
155000155|NCT04784533|559424559|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000156|NCT04784533|559424560|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000157|NCT04784533|559424561|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000158|NCT04784533|559424562|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000159|NCT04784533|559424563|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000160|NCT04784533|559424564|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000161|NCT04784533|559424565|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
155000162|NCT04784533|559424556|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000163|NCT04784533|559424557|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155123186|NCT01048866|559881911|FG000|Overall Study|Protocol Violation|1|||
155123187|NCT01048866|559881912|FG001|Overall Study|Protocol Violation|0|||
155123188|NCT01048866|559881911|FG000|Overall Study|Physician Decision|1|||
155123189|NCT01048866|559881912|FG001|Overall Study|Physician Decision|0|||
155123190|NCT01048866|559881911|FG000|Overall Study|Withdrawal by Subject|0|||
155123191|NCT01048866|559881912|FG001|Overall Study|Withdrawal by Subject|2|||
155123192|NCT01048866|559881911|FG000|Overall Study|Lost to Follow-up|0|||
155000164|NCT04784533|559424558|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000165|NCT04784533|559424559|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000166|NCT04784533|559424560|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000167|NCT04784533|559424561|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000168|NCT04784533|559424562|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000169|NCT04784533|559424563|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000170|NCT04784533|559424564|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
155000171|NCT04784533|559424565|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
155000172|NCT04784533|559424556|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000173|NCT04784533|559424557|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000174|NCT04784533|559424558|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000175|NCT04784533|559424559|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000176|NCT04784533|559424560|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000177|NCT04784533|559424561|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000178|NCT04784533|559424562|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000179|NCT04784533|559424563|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
155000180|NCT04784533|559424564|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
155000181|NCT04784533|559424565|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
155000182|NCT04123561|559424566|FG000|Overall Study|Lost to Follow-up|20|||
155000183|NCT04123561|559424567|FG001|Overall Study|Lost to Follow-up|12|||
155000184|NCT04123561|559424568|FG002|Overall Study|Lost to Follow-up|5|||
155000185|NCT04123561|559424566|FG000|Overall Study|Withdrawal by Subject|9|||
155000186|NCT04123561|559424567|FG001|Overall Study|Withdrawal by Subject|7|||
155000187|NCT04123561|559424568|FG002|Overall Study|Withdrawal by Subject|9|||
155000188|NCT04123561|559424566|FG000|Overall Study|Lack of Efficacy|7|||
155000189|NCT04123561|559424567|FG001|Overall Study|Lack of Efficacy|8|||
155000190|NCT04123561|559424568|FG002|Overall Study|Lack of Efficacy|6|||
155000191|NCT04123561|559424566|FG000|Overall Study|Adverse Event|5|||
155000192|NCT04123561|559424567|FG001|Overall Study|Adverse Event|2|||
155000193|NCT04123561|559424568|FG002|Overall Study|Adverse Event|3|||
155000194|NCT04123561|559424566|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
155000195|NCT04123561|559424567|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
155000196|NCT04123561|559424568|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
155000197|NCT04123561|559424566|FG000|Overall Study|Death|0|||
155000198|NCT04123561|559424567|FG001|Overall Study|Death|0|||
155000199|NCT04123561|559424568|FG002|Overall Study|Death|1|||
155000200|NCT04123561|559424566|FG000|Overall Study|Protocol Violation|0|||
155000201|NCT04123561|559424567|FG001|Overall Study|Protocol Violation|1|||
155000202|NCT04123561|559424568|FG002|Overall Study|Protocol Violation|0|||
155000203|NCT02203331|559424573|FG000|Overall Study|Pregnancy|1|||
155000204|NCT02203331|559424574|FG001|Overall Study|Pregnancy|0|||
155000205|NCT02203331|559424575|FG002|Overall Study|Pregnancy|0|||
155000206|NCT02203331|559424576|FG003|Overall Study|Pregnancy|0|||
155000207|NCT02203331|559424577|FG004|Overall Study|Pregnancy|2|||
155000208|NCT02203331|559424578|FG005|Overall Study|Pregnancy|0|||
155000209|NCT02203331|559424573|FG000|Overall Study|Withdrawal by Subject|1|||
155000210|NCT02203331|559424574|FG001|Overall Study|Withdrawal by Subject|0|||
155000211|NCT02203331|559424575|FG002|Overall Study|Withdrawal by Subject|1|||
155000212|NCT02203331|559424576|FG003|Overall Study|Withdrawal by Subject|0|||
155000213|NCT02203331|559424577|FG004|Overall Study|Withdrawal by Subject|0|||
155000214|NCT02203331|559424578|FG005|Overall Study|Withdrawal by Subject|3|||
155000215|NCT02203331|559424573|FG000|Overall Study|Adverse Event|4|||
155000216|NCT02203331|559424574|FG001|Overall Study|Adverse Event|8|||
155000217|NCT02203331|559424575|FG002|Overall Study|Adverse Event|3|||
155000218|NCT02203331|559424576|FG003|Overall Study|Adverse Event|4|||
155000219|NCT02203331|559424577|FG004|Overall Study|Adverse Event|3|||
155000220|NCT02203331|559424578|FG005|Overall Study|Adverse Event|3|||
155000221|NCT02203331|559424573|FG000|Overall Study|Other Reasons|1|||
155000222|NCT02203331|559424574|FG001|Overall Study|Other Reasons|2|||
155000223|NCT02203331|559424575|FG002|Overall Study|Other Reasons|0|||
155000224|NCT02203331|559424576|FG003|Overall Study|Other Reasons|2|||
155000225|NCT02203331|559424577|FG004|Overall Study|Other Reasons|0|||
155000226|NCT02203331|559424578|FG005|Overall Study|Other Reasons|0|||
155000227|NCT02203331|559424573|FG000|Overall Study|Lack of Efficacy|0|||
155000228|NCT02203331|559424574|FG001|Overall Study|Lack of Efficacy|2|||
155000229|NCT02203331|559424575|FG002|Overall Study|Lack of Efficacy|1|||
155000230|NCT02203331|559424576|FG003|Overall Study|Lack of Efficacy|0|||
155000231|NCT02203331|559424577|FG004|Overall Study|Lack of Efficacy|0|||
155000232|NCT02203331|559424578|FG005|Overall Study|Lack of Efficacy|1|||
155000233|NCT02203331|559424573|FG000|Overall Study|Protocol Violation|0|||
155000234|NCT02203331|559424574|FG001|Overall Study|Protocol Violation|2|||
155000235|NCT02203331|559424575|FG002|Overall Study|Protocol Violation|0|||
155000236|NCT02203331|559424576|FG003|Overall Study|Protocol Violation|1|||
155000237|NCT02203331|559424577|FG004|Overall Study|Protocol Violation|1|||
155000238|NCT02203331|559424578|FG005|Overall Study|Protocol Violation|0|||
155000239|NCT02203331|559424573|FG000|Overall Study|Lost to Follow-up|0|||
155000240|NCT02203331|559424574|FG001|Overall Study|Lost to Follow-up|0|||
155000241|NCT02203331|559424575|FG002|Overall Study|Lost to Follow-up|0|||
155000242|NCT02203331|559424576|FG003|Overall Study|Lost to Follow-up|0|||
155000243|NCT02203331|559424577|FG004|Overall Study|Lost to Follow-up|1|||
155000244|NCT02203331|559424578|FG005|Overall Study|Lost to Follow-up|0|||
155000245|NCT03597464|559424583|FG000|Overall Study|Withdrawal by Subject|4|||
155000246|NCT03597464|559424584|FG001|Overall Study|Withdrawal by Subject|5|||
155000247|NCT03597464|559424583|FG000|Overall Study|Lost to Follow-up|3|||
155000248|NCT03597464|559424584|FG001|Overall Study|Lost to Follow-up|1|||
155000249|NCT03597464|559424583|FG000|Overall Study|Pregnancy|3|||
155000250|NCT03597464|559424584|FG001|Overall Study|Pregnancy|1|||
155000251|NCT03597464|559424583|FG000|Overall Study|Lack of Efficacy|2|||
155000252|NCT03597464|559424584|FG001|Overall Study|Lack of Efficacy|0|||
155000253|NCT03597464|559424583|FG000|Overall Study|Physician Decision|2|||
155000254|NCT03597464|559424584|FG001|Overall Study|Physician Decision|2|||
155000255|NCT03597464|559424583|FG000|Overall Study|Protocol Violation|1|||
155000256|NCT03597464|559424584|FG001|Overall Study|Protocol Violation|1|||
155000257|NCT03597464|559424583|FG000|Overall Study|Adverse Event|0|||
155000258|NCT03597464|559424584|FG001|Overall Study|Adverse Event|2|||
155000259|NCT03597464|559424583|FG000|Overall Study|Death|0|||
155000260|NCT03597464|559424584|FG001|Overall Study|Death|3|||
155000261|NCT02682927|559424587|FG000|Overall Study|Adverse Event|0|||
155000262|NCT02682927|559424588|FG001|Overall Study|Adverse Event|0|||
155000263|NCT02682927|559424589|FG002|Overall Study|Adverse Event|5|||
155000264|NCT02682927|559424590|FG003|Overall Study|Adverse Event|1|||
155000265|NCT02682927|559424591|FG004|Overall Study|Adverse Event|0|||
155000266|NCT02682927|559424592|FG005|Overall Study|Adverse Event|2|||
155000267|NCT02682927|559424587|FG000|Overall Study|Death|0|||
155000268|NCT02682927|559424588|FG001|Overall Study|Death|0|||
155000269|NCT02682927|559424589|FG002|Overall Study|Death|0|||
155000270|NCT02682927|559424590|FG003|Overall Study|Death|1|||
155000271|NCT02682927|559424591|FG004|Overall Study|Death|0|||
155000272|NCT02682927|559424592|FG005|Overall Study|Death|0|||
155000273|NCT02682927|559424587|FG000|Overall Study|Lack of Efficacy|1|||
155000274|NCT02682927|559424588|FG001|Overall Study|Lack of Efficacy|0|||
155000275|NCT02682927|559424589|FG002|Overall Study|Lack of Efficacy|0|||
155000276|NCT02682927|559424590|FG003|Overall Study|Lack of Efficacy|1|||
155000277|NCT02682927|559424591|FG004|Overall Study|Lack of Efficacy|0|||
154921165|NCT00447265|559136118|FG000|Overall Study|Physician Decision|1|||
154921166|NCT00447265|559136119|FG001|Overall Study|Physician Decision|0|||
154921167|NCT00503035|559136120|FG000|Overall Study|Lost to Follow-up|2|||
154921168|NCT00503035|559136120|FG000|Overall Study|Physician Decision|3|||
154921169|NCT00503035|559136120|FG000|Overall Study|Ineligible|15|||
154921170|NCT05028816|559136121|FG000|Overall Study|Lost to Follow-up|5|||
154921171|NCT05028816|559136122|FG001|Overall Study|Lost to Follow-up|3|||
154921172|NCT05028816|559136121|FG000|Overall Study|Withdrawal by Subject|4|||
154921173|NCT05028816|559136122|FG001|Overall Study|Withdrawal by Subject|1|||
154921174|NCT05028816|559136121|FG000|Overall Study|Physician Decision|1|||
154921175|NCT05028816|559136122|FG001|Overall Study|Physician Decision|0|||
154921176|NCT04576702|559136128|FG000|Overall Study|Death|1|||
154921177|NCT04576702|559136129|FG001|Overall Study|Death|0|||
154921178|NCT04576702|559136130|FG002|Overall Study|Death|0|||
154921179|NCT04576702|559136131|FG003|Overall Study|Death|0|||
154921180|NCT04576702|559136128|FG000|Overall Study|Withdrawal by Subject|0|||
154921181|NCT04576702|559136129|FG001|Overall Study|Withdrawal by Subject|2|||
154921182|NCT04576702|559136130|FG002|Overall Study|Withdrawal by Subject|1|||
154921183|NCT04576702|559136131|FG003|Overall Study|Withdrawal by Subject|0|||
154921184|NCT04576702|559136128|FG000|Overall Study|Lost to Follow-up|3|||
154921185|NCT04576702|559136129|FG001|Overall Study|Lost to Follow-up|3|||
154921186|NCT04576702|559136130|FG002|Overall Study|Lost to Follow-up|3|||
154921187|NCT04576702|559136131|FG003|Overall Study|Lost to Follow-up|4|||
154921188|NCT02985996|559136134|FG000|Overall Study|Withdrawal by Subject|0|||
154921189|NCT02985996|559136135|FG001|Overall Study|Withdrawal by Subject|0|||
154921190|NCT02985996|559136136|FG002|Overall Study|Withdrawal by Subject|1|||
154921191|NCT02985996|559136137|FG003|Overall Study|Withdrawal by Subject|0|||
154921192|NCT02985996|559136138|FG004|Overall Study|Withdrawal by Subject|0|||
154921193|NCT02985996|559136134|FG000|Overall Study|Protocol Violation|0|||
154921194|NCT02985996|559136135|FG001|Overall Study|Protocol Violation|1|||
154921195|NCT02985996|559136136|FG002|Overall Study|Protocol Violation|0|||
154921196|NCT02985996|559136137|FG003|Overall Study|Protocol Violation|0|||
154921197|NCT02985996|559136138|FG004|Overall Study|Protocol Violation|0|||
154921198|NCT00401726|559136139|FG000|Overall Study|Adverse Event|34|||
154921199|NCT00401726|559136140|FG001|Overall Study|Adverse Event|45|||
154921200|NCT00401726|559136139|FG000|Overall Study|Death|0|||
154921201|NCT00401726|559136140|FG001|Overall Study|Death|3|||
154921202|NCT00401726|559136139|FG000|Overall Study|Sponsor Request|0|||
154921203|NCT00401726|559136140|FG001|Overall Study|Sponsor Request|1|||
154921204|NCT00401726|559136139|FG000|Overall Study|Physician Decision|3|||
154921205|NCT00401726|559136140|FG001|Overall Study|Physician Decision|6|||
155000278|NCT02682927|559424592|FG005|Overall Study|Lack of Efficacy|0|||
155000279|NCT02682927|559424587|FG000|Overall Study|Other|0|||
154921206|NCT00401726|559136139|FG000|Overall Study|Lost to Follow-up|23|||
154921207|NCT00401726|559136140|FG001|Overall Study|Lost to Follow-up|20|||
154921208|NCT00401726|559136139|FG000|Overall Study|Protocol Violation|6|||
154921209|NCT00401726|559136140|FG001|Overall Study|Protocol Violation|3|||
155000280|NCT02682927|559424588|FG001|Overall Study|Other|0|||
155000281|NCT02682927|559424589|FG002|Overall Study|Other|0|||
155000282|NCT02682927|559424590|FG003|Overall Study|Other|2|||
155000283|NCT02682927|559424591|FG004|Overall Study|Other|0|||
155000284|NCT02682927|559424592|FG005|Overall Study|Other|0|||
155000285|NCT02682927|559424587|FG000|Overall Study|Withdrawal by Subject|2|||
155000286|NCT02682927|559424588|FG001|Overall Study|Withdrawal by Subject|0|||
155000287|NCT02682927|559424589|FG002|Overall Study|Withdrawal by Subject|1|||
155000288|NCT02682927|559424590|FG003|Overall Study|Withdrawal by Subject|0|||
155000289|NCT02682927|559424591|FG004|Overall Study|Withdrawal by Subject|1|||
155000290|NCT02682927|559424592|FG005|Overall Study|Withdrawal by Subject|1|||
155000291|NCT05292183|559426958|FG000|Overall Study|Adverse Event|1|||
155000292|NCT00369486|559426966|FG000|4-Week Visit|Missed visit|2|||
155000293|NCT00369486|559426967|FG001|4-Week Visit|Missed visit|2|||
155000294|NCT00369486|559426968|FG002|4-Week Visit|Missed visit|0|||
155000295|NCT00369486|559426969|FG003|4-Week Visit|Missed visit|2|||
155000296|NCT00369486|559426970|FG004|4-Week Visit|Missed visit|1|||
155000297|NCT00369486|559426966|FG000|4-Week Visit|Dropped|0|||
155000298|NCT00369486|559426967|FG001|4-Week Visit|Dropped|0|||
155000299|NCT00369486|559426968|FG002|4-Week Visit|Dropped|1|||
155000300|NCT00369486|559426969|FG003|4-Week Visit|Dropped|0|||
155000301|NCT00369486|559426970|FG004|4-Week Visit|Dropped|0|||
155000302|NCT00369486|559426966|FG000|8-Week Visit|Missed visit|0|||
155000303|NCT00369486|559426967|FG001|8-Week Visit|Missed visit|1|||
155000304|NCT00369486|559426968|FG002|8-Week Visit|Missed visit|0|||
155000305|NCT00369486|559426969|FG003|8-Week Visit|Missed visit|0|||
155000306|NCT00369486|559426970|FG004|8-Week Visit|Missed visit|1|||
155000307|NCT00369486|559426966|FG000|8-Week Visit|Dropped|0|||
155000308|NCT00369486|559426967|FG001|8-Week Visit|Dropped|0|||
155000309|NCT00369486|559426968|FG002|8-Week Visit|Dropped|0|||
155000310|NCT00369486|559426969|FG003|8-Week Visit|Dropped|1|||
155000311|NCT00369486|559426970|FG004|8-Week Visit|Dropped|0|||
155000312|NCT00369486|559426966|FG000|17-Week Visit|Missed visit|0|||
155000313|NCT00369486|559426967|FG001|17-Week Visit|Missed visit|0|||
155000314|NCT00369486|559426968|FG002|17-Week Visit|Missed visit|1|||
155000315|NCT00369486|559426969|FG003|17-Week Visit|Missed visit|1|||
155000316|NCT00369486|559426970|FG004|17-Week Visit|Missed visit|1|||
155000317|NCT00369486|559426966|FG000|34-Week Visit|Dropped|0|||
155000318|NCT00369486|559426967|FG001|34-Week Visit|Dropped|1|||
155000319|NCT00369486|559426968|FG002|34-Week Visit|Dropped|1|||
155000320|NCT00369486|559426969|FG003|34-Week Visit|Dropped|3|||
155000321|NCT00369486|559426970|FG004|34-Week Visit|Dropped|3|||
155000322|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #1|24|||
155000323|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #1|0|||
155000324|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
155000325|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
155000326|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000327|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000328|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
155000329|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
155000330|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
155000331|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
155000332|NCT03888066|559426971|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000333|NCT03888066|559426972|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000334|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000335|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155123193|NCT01048866|559881912|FG001|Overall Study|Lost to Follow-up|2|||
155123194|NCT01048866|559881911|FG000|Overall Study|Other|1|||
155000336|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
155000337|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
155000338|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000339|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000340|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
155000341|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000342|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #2|5|||
155000343|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #2|0|||
155000344|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
155000345|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
155000346|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
155000347|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
155000348|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
155000349|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
155000350|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #3|11|||
155000351|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #3|0|||
155000352|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
155000353|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
155000354|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
155000355|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155000356|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000357|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000358|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #4|3|||
155000359|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #4|0|||
155000360|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
155000361|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
155000362|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
155000363|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
155000364|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
155000365|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155000366|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
155000367|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
155000368|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
155000369|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000370|NCT03888066|559426971|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
155000371|NCT03888066|559426972|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155000372|NCT03888066|559426971|FG000|Run-in Phase|AE (Adverse Event)|17|||
155000373|NCT03888066|559426972|FG001|Run-in Phase|AE (Adverse Event)|0|||
155000374|NCT03888066|559426971|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
155000375|NCT03888066|559426972|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
155000376|NCT03888066|559426971|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000377|NCT03888066|559426972|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000378|NCT03888066|559426971|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
155000379|NCT03888066|559426972|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000380|NCT03888066|559426971|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
155000381|NCT03888066|559426972|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155000382|NCT03888066|559426971|FG000|Run-in Phase|Withdrawal by Subject|43|||
155000383|NCT03888066|559426972|FG001|Run-in Phase|Withdrawal by Subject|0|||
155000384|NCT03888066|559426971|FG000|Run-in Phase|AE; Physician Decision|1|||
155000385|NCT03888066|559426972|FG001|Run-in Phase|AE; Physician Decision|0|||
155000386|NCT03888066|559426971|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
155000387|NCT03888066|559426972|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
155000388|NCT03888066|559426971|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
155000389|NCT03888066|559426972|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
155000390|NCT03888066|559426971|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
155000391|NCT03888066|559426972|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
155000392|NCT03888066|559426971|FG000|Run-in Phase|Death|1|||
155000393|NCT03888066|559426972|FG001|Run-in Phase|Death|0|||
155000394|NCT03888066|559426971|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
155000395|NCT03888066|559426972|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
155000396|NCT03888066|559426971|FG000|Run-in Phase|Physician Decision|1|||
155000397|NCT03888066|559426972|FG001|Run-in Phase|Physician Decision|0|||
155000398|NCT03888066|559426971|FG000|Run-in Phase|Protocol Violation|13|||
155000399|NCT03888066|559426972|FG001|Run-in Phase|Protocol Violation|0|||
155000400|NCT03888066|559426971|FG000|Run-in Phase|Sponsor Request|34|||
155000401|NCT03888066|559426972|FG001|Run-in Phase|Sponsor Request|0|||
155000402|NCT03888066|559426971|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
155000403|NCT03888066|559426972|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
155000404|NCT03888066|559426971|FG000|Run-in Phase|Withdrawal Of Consent|1|||
155000405|NCT03888066|559426972|FG001|Run-in Phase|Withdrawal Of Consent|0|||
155000406|NCT03888066|559426971|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
155000407|NCT03888066|559426972|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
155000408|NCT03888066|559426971|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
155000409|NCT03888066|559426972|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
155000410|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
155000411|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
155000412|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
155000413|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
155000414|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
155000415|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
155123195|NCT01048866|559881912|FG001|Overall Study|Other|1|||
155000416|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
155000417|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
155000418|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
155000419|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
155000420|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
155000421|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
155000422|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
155000423|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
155000424|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
155000425|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
155000426|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
155000427|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
155000428|NCT03888066|559426971|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
155000429|NCT03888066|559426972|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
155000430|NCT02077140|559426973|FG000|Overall Study|Lost to Follow-up|4|||
155000431|NCT02077140|559426974|FG001|Overall Study|Lost to Follow-up|1|||
155000432|NCT02077140|559426975|FG002|Overall Study|Lost to Follow-up|2|||
155000433|NCT02077140|559426976|FG003|Overall Study|Lost to Follow-up|2|||
155000434|NCT02077140|559426977|FG004|Overall Study|Lost to Follow-up|3|||
155000435|NCT02077140|559426973|FG000|Overall Study|Withdrawal by Subject|0|||
155000436|NCT02077140|559426974|FG001|Overall Study|Withdrawal by Subject|1|||
155000437|NCT02077140|559426975|FG002|Overall Study|Withdrawal by Subject|0|||
155000438|NCT02077140|559426976|FG003|Overall Study|Withdrawal by Subject|2|||
155000439|NCT02077140|559426977|FG004|Overall Study|Withdrawal by Subject|2|||
155000440|NCT01762800|559426980|FG000|Overall Study|Adverse Event|8|||
155000441|NCT01762800|559426981|FG001|Overall Study|Adverse Event|13|||
155000442|NCT01762800|559426980|FG000|Overall Study|Lack of Efficacy|3|||
155000443|NCT01762800|559426981|FG001|Overall Study|Lack of Efficacy|2|||
155000444|NCT01762800|559426980|FG000|Overall Study|Study Closed/Terminated|0|||
155000445|NCT01762800|559426981|FG001|Overall Study|Study Closed/Terminated|1|||
155000446|NCT01762800|559426980|FG000|Overall Study|Physician Decision|1|||
155000447|NCT01762800|559426981|FG001|Overall Study|Physician Decision|1|||
155000448|NCT01762800|559426980|FG000|Overall Study|Withdrawal by Subject|7|||
155000449|NCT01762800|559426981|FG001|Overall Study|Withdrawal by Subject|4|||
155000450|NCT02847260|559426982|FG000|Overall Study|Adverse Event|3|||
155000451|NCT02847260|559426982|FG000|Overall Study|Withdrawal by Subject|2|||
155000452|NCT02847260|559426982|FG000|Overall Study|Clinical Deterioration|1|||
155000453|NCT02847260|559426982|FG000|Overall Study|Physician Decision|1|||
155000454|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
155000455|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
155000456|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
155000457|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
155000458|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
155000459|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
155123196|NCT03582813|559881913|FG000|Overall Study|Lost to Follow-up|18|||
155123197|NCT03582813|559881914|FG001|Overall Study|Lost to Follow-up|21|||
155123198|NCT03582813|559881913|FG000|Overall Study|Withdrawal by Subject|1|||
155123199|NCT03582813|559881914|FG001|Overall Study|Withdrawal by Subject|0|||
155123200|NCT02366767|559881917|FG000|Overall Study|left for home after 1 day at camp|1|||
155123201|NCT02366767|559881918|FG001|Overall Study|left for home after 1 day at camp|0|||
155123202|NCT02230683|559881922|FG000|Overall Study|Adverse Event|1|||
155123203|NCT04573881|559881924|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
155123204|NCT02936284|559883336|FG000|Overall Study|Withdrawal by Subject|3|||
155123205|NCT02936284|559883337|FG001|Overall Study|Withdrawal by Subject|1|||
155123206|NCT02936284|559883336|FG000|Overall Study|Lost to Follow-up|7|||
155123207|NCT02936284|559883337|FG001|Overall Study|Lost to Follow-up|8|||
155123208|NCT01519674|559883344|FG000|Overall Study|Adverse Event|3|||
155123209|NCT01519674|559883345|FG001|Overall Study|Adverse Event|3|||
155123210|NCT01519674|559883346|FG002|Overall Study|Adverse Event|0|||
155123211|NCT01519674|559883344|FG000|Overall Study|Lack of Efficacy|1|||
155123212|NCT01519674|559883345|FG001|Overall Study|Lack of Efficacy|1|||
155123213|NCT01519674|559883346|FG002|Overall Study|Lack of Efficacy|1|||
155123214|NCT01519674|559883344|FG000|Overall Study|Protocol Violation|0|||
155123215|NCT01519674|559883345|FG001|Overall Study|Protocol Violation|3|||
155123216|NCT01519674|559883346|FG002|Overall Study|Protocol Violation|1|||
155000460|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
155000461|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
155000462|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
155000463|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
155000464|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
155000465|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
155123217|NCT01519674|559883344|FG000|Overall Study|Withdrawal Criteria|7|||
155000466|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
155123218|NCT01519674|559883345|FG001|Overall Study|Withdrawal Criteria|2|||
155000467|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
155000468|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
155000469|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155000470|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155000471|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155000472|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155000473|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
155000474|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
155000475|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
155000476|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
155000477|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
155000478|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
155000479|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155000480|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155000481|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155000482|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155000483|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
155000484|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
155000485|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
155000486|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
155000487|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
155000488|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
155000489|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155000490|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155000491|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155000492|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155000493|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
155000494|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000495|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000496|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000497|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
155000498|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000499|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000500|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000501|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000502|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000503|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
155000504|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
155000505|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
155000506|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
155000507|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
155000508|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
155000509|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
155000510|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
155000511|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
155000512|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
155000513|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
155000514|NCT03104400|559426983|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000515|NCT03104400|559426984|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000516|NCT03104400|559426985|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000517|NCT03104400|559426986|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
155000518|NCT03104400|559426987|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000519|NCT03104400|559426988|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000520|NCT03104400|559426989|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000521|NCT03104400|559426990|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000522|NCT03104400|559426991|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000523|NCT03104400|559426992|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
155000524|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
155000525|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
155000526|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
155000527|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
155000528|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
155000529|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
155000530|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
155000531|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
155000532|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
155000533|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
155000534|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155000535|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155000536|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155000537|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155123219|NCT01519674|559883346|FG002|Overall Study|Withdrawal Criteria|7|||
155123220|NCT01519674|559883344|FG000|Overall Study|Unsclassified|10|||
155123221|NCT01519674|559883345|FG001|Overall Study|Unsclassified|4|||
155123222|NCT01519674|559883346|FG002|Overall Study|Unsclassified|3|||
155123223|NCT01610596|559883347|FG000|Overall Study|Lost to Follow-up|0|||
155123224|NCT01610596|559883348|FG001|Overall Study|Lost to Follow-up|1|||
155123225|NCT00799591|559883349|FG000|Overall Study|De-escalation of doses|20|||
155123226|NCT00799591|559883349|FG000|Overall Study|Death|14|||
155123227|NCT00799591|559883349|FG000|Overall Study|Technical failure|12|||
155123228|NCT00799591|559883349|FG000|Overall Study|Resistant germ|11|||
155123229|NCT00799591|559883349|FG000|Overall Study|New infection|4|||
155123230|NCT00799591|559883349|FG000|Overall Study|Resistance germ and technical failure|2|||
155123231|NCT00799591|559883349|FG000|Overall Study|Persistance of fever undetermined origin|1|||
155123232|NCT00799591|559883349|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
155123233|NCT00799591|559883349|FG000|Overall Study|Infectious origin not probable|1|||
155123234|NCT02590562|559883353|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
155123235|NCT00765882|559883354|FG000|Overall Study|Adverse Event|10|||
155123236|NCT00765882|559883355|FG001|Overall Study|Adverse Event|21|||
155123237|NCT00765882|559883356|FG002|Overall Study|Adverse Event|20|||
155123238|NCT00765882|559883354|FG000|Overall Study|Lack of Efficacy|4|||
155000538|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
155000539|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
155000540|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
155000541|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
155000542|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
155000543|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
155000544|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155000545|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155000546|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155000547|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155000548|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
155000549|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
155000550|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
155000551|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
155000552|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
155000553|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
155000554|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155000555|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155000556|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155000557|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155000558|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
155000559|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
155000560|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
155000561|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
155000562|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
155000563|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
155000564|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000565|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000566|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000567|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000568|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000569|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000570|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
155000571|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
155000572|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
155000573|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
155000574|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155000575|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155123239|NCT00765882|559883355|FG001|Overall Study|Lack of Efficacy|0|||
155123240|NCT00765882|559883356|FG002|Overall Study|Lack of Efficacy|1|||
155123241|NCT00765882|559883354|FG000|Overall Study|Protocol Violation|4|||
155123242|NCT00765882|559883355|FG001|Overall Study|Protocol Violation|3|||
155123243|NCT00765882|559883356|FG002|Overall Study|Protocol Violation|1|||
155123244|NCT00765882|559883354|FG000|Overall Study|Withdrawal by Subject|2|||
155123245|NCT00765882|559883355|FG001|Overall Study|Withdrawal by Subject|6|||
155000576|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155000577|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155000578|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155000579|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155123246|NCT00765882|559883356|FG002|Overall Study|Withdrawal by Subject|6|||
155123247|NCT00765882|559883354|FG000|Overall Study|Lost to Follow-up|1|||
155123248|NCT00765882|559883355|FG001|Overall Study|Lost to Follow-up|9|||
155123249|NCT00765882|559883356|FG002|Overall Study|Lost to Follow-up|6|||
155123250|NCT00765882|559883354|FG000|Overall Study|Other Reason|3|||
155000580|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155000581|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
155000582|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
155000583|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
155000584|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
155000585|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
155000586|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
155000587|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
155000588|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
155000589|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
155000590|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
155000591|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
155000592|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
155000593|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
155000594|NCT03104400|559426983|FG000|Period 2 Week 56 - 260)|Other|0|||
155000595|NCT03104400|559426984|FG001|Period 2 Week 56 - 260)|Other|0|||
155000596|NCT03104400|559426985|FG002|Period 2 Week 56 - 260)|Other|0|||
155000597|NCT03104400|559426986|FG003|Period 2 Week 56 - 260)|Other|0|||
155000598|NCT03104400|559426987|FG004|Period 2 Week 56 - 260)|Other|0|||
155000599|NCT03104400|559426988|FG005|Period 2 Week 56 - 260)|Other|0|||
155000600|NCT03104400|559426989|FG006|Period 2 Week 56 - 260)|Other|0|||
155000601|NCT03104400|559426990|FG007|Period 2 Week 56 - 260)|Other|0|||
155000602|NCT03104400|559426991|FG008|Period 2 Week 56 - 260)|Other|1|||
155000603|NCT03104400|559426992|FG009|Period 2 Week 56 - 260)|Other|1|||
155000604|NCT02540850|559426993|FG000|Overall Study|Lost to Follow-up|69|||
155000605|NCT02540850|559426994|FG001|Overall Study|Lost to Follow-up|66|||
155000606|NCT02540850|559426995|FG002|Overall Study|Lost to Follow-up|34|||
155000607|NCT02129608|559427000|FG000|Overall Study|Lost to Follow-up|0|||
155000608|NCT02129608|559427001|FG001|Overall Study|Lost to Follow-up|1|||
155000609|NCT02129608|559427002|FG002|Overall Study|Lost to Follow-up|1|||
155000610|NCT02129608|559427000|FG000|Overall Study|Withdrawal by Subject|0|||
155000611|NCT02129608|559427001|FG001|Overall Study|Withdrawal by Subject|0|||
155000612|NCT02129608|559427002|FG002|Overall Study|Withdrawal by Subject|2|||
155000613|NCT02473523|559427003|FG000|Overall Study|Death|1|||
155000614|NCT02473523|559427003|FG000|Overall Study|Lost to Follow-up|1|||
155000615|NCT02552303|559427004|FG000|Allocation|Withdrawal by Subject|2|||
155000616|NCT02552303|559427005|FG001|Allocation|Withdrawal by Subject|1|||
155000617|NCT02552303|559427006|FG002|Allocation|Withdrawal by Subject|1|||
155000618|NCT02552303|559427007|FG003|Allocation|Withdrawal by Subject|1|||
155000619|NCT02552303|559427004|FG000|Allocation|ineligible|1|||
155000620|NCT02552303|559427005|FG001|Allocation|ineligible|1|||
155000621|NCT02552303|559427006|FG002|Allocation|ineligible|0|||
155000622|NCT02552303|559427007|FG003|Allocation|ineligible|0|||
155000623|NCT02552303|559427004|FG000|Follow-Up|Lost to Follow-up|0|||
155000624|NCT02552303|559427005|FG001|Follow-Up|Lost to Follow-up|0|||
155000625|NCT02552303|559427006|FG002|Follow-Up|Lost to Follow-up|1|||
155000626|NCT02552303|559427007|FG003|Follow-Up|Lost to Follow-up|0|||
155000627|NCT02552303|559427004|FG000|Follow-Up|ineligible|0|||
155000628|NCT02552303|559427005|FG001|Follow-Up|ineligible|2|||
155000629|NCT02552303|559427006|FG002|Follow-Up|ineligible|0|||
155000630|NCT02552303|559427007|FG003|Follow-Up|ineligible|0|||
155000631|NCT01831258|559427010|FG000|Overall Study|Withdrawal by Subject|2|||
155000632|NCT01831258|559427011|FG001|Overall Study|Withdrawal by Subject|1|||
155000633|NCT01831258|559427010|FG000|Overall Study|Lost to Follow-up|3|||
155000634|NCT01831258|559427011|FG001|Overall Study|Lost to Follow-up|2|||
155000635|NCT01275729|559427014|FG000|Overall Study|Death|3|||
155000636|NCT01275729|559427014|FG000|Overall Study|Withdrawal by Subject|1|||
155000637|NCT00447876|559427015|FG000|Overall Study|Withdrawal by Subject|1|||
155000638|NCT00447876|559427016|FG001|Overall Study|Withdrawal by Subject|4|||
155000639|NCT00447876|559427015|FG000|Overall Study|Lost to Follow-up|1|||
155000640|NCT00447876|559427016|FG001|Overall Study|Lost to Follow-up|0|||
155000641|NCT00447876|559427015|FG000|Overall Study|Deterioration of symptomology|1|||
155000642|NCT00447876|559427016|FG001|Overall Study|Deterioration of symptomology|0|||
155000643|NCT02533180|559427017|FG000|Overall Study|Death|0|||
155000644|NCT02533180|559427018|FG001|Overall Study|Death|2|||
155000645|NCT02533180|559427017|FG000|Overall Study|Lost to Follow-up|0|||
155000646|NCT02533180|559427018|FG001|Overall Study|Lost to Follow-up|1|||
155000647|NCT02533180|559427017|FG000|Overall Study|Physician Decision|0|||
155000648|NCT02533180|559427018|FG001|Overall Study|Physician Decision|1|||
155000649|NCT02533180|559427017|FG000|Overall Study|Withdrawal by Subject|2|||
155000650|NCT02533180|559427018|FG001|Overall Study|Withdrawal by Subject|5|||
155000651|NCT02533180|559427017|FG000|Overall Study|Screen Failure|37|||
155123251|NCT00765882|559883355|FG001|Overall Study|Other Reason|1|||
155123252|NCT00765882|559883356|FG002|Overall Study|Other Reason|2|||
155123253|NCT02699450|559883357|FG000|Overall Study|Death|2|||
155123254|NCT02699450|559883358|FG001|Overall Study|Death|1|||
155123255|NCT02699450|559883359|FG002|Overall Study|Death|2|||
155123256|NCT02699450|559883357|FG000|Overall Study|Met Criteria for Study Exit|0|||
155123257|NCT02699450|559883358|FG001|Overall Study|Met Criteria for Study Exit|0|||
155000652|NCT02533180|559427018|FG001|Overall Study|Screen Failure|0|||
155000653|NCT02533180|559427017|FG000|Overall Study|Protocol Deviation|0|||
155000654|NCT02533180|559427018|FG001|Overall Study|Protocol Deviation|1|||
155000655|NCT02533180|559427017|FG000|Overall Study|Non-compliance|0|||
155000656|NCT02533180|559427018|FG001|Overall Study|Non-compliance|1|||
155000657|NCT02640690|559427031|FG000|Overall Study|Lost to Follow-up|7|||
155000658|NCT02640690|559427032|FG001|Overall Study|Lost to Follow-up|7|||
155000659|NCT02640690|559427031|FG000|Overall Study|Withdrawal by Subject|16|||
155000660|NCT02640690|559427032|FG001|Overall Study|Withdrawal by Subject|20|||
155000661|NCT02640690|559427031|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
155000662|NCT02640690|559427032|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
155000663|NCT01118975|559427033|FG000|Overall Study|Adverse Event|0|||
155000664|NCT01118975|559427034|FG001|Overall Study|Adverse Event|1|||
155000665|NCT01645787|559427035|FG000|Washout (2 Weeks)|Adverse Event|1|||
155000666|NCT01645787|559427036|FG001|Washout (2 Weeks)|Adverse Event|0|||
155000667|NCT02620579|559427037|FG000|Overall Study|Physician Decision|0|||
155123258|NCT02699450|559883359|FG002|Overall Study|Met Criteria for Study Exit|1|||
154921210|NCT00401726|559136139|FG000|Overall Study|Withdrawal by Subject|18|||
154921211|NCT00401726|559136140|FG001|Overall Study|Withdrawal by Subject|24|||
154921212|NCT00401726|559136139|FG000|Overall Study|Lack of Efficacy|4|||
154921213|NCT00401726|559136140|FG001|Overall Study|Lack of Efficacy|6|||
154921214|NCT00401726|559136139|FG000|Overall Study|Protocol Deviation|9|||
154921215|NCT00401726|559136140|FG001|Overall Study|Protocol Deviation|4|||
154921216|NCT02067728|559136141|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
154921217|NCT02067728|559136142|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
154921218|NCT02067728|559136141|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
154921219|NCT02067728|559136142|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
154921220|NCT02067728|559136141|FG000|6 Month Measurements|Unable to attend|114|||
154921221|NCT02067728|559136142|FG001|6 Month Measurements|Unable to attend|97|||
154921222|NCT00933543|559136144|FG000|Overall Study|Adverse Event|2|||
154921223|NCT00933543|559136145|FG001|Overall Study|Adverse Event|1|||
154921224|NCT00933543|559136144|FG000|Overall Study|Lost to Follow-up|0|||
154921225|NCT00933543|559136145|FG001|Overall Study|Lost to Follow-up|1|||
154921226|NCT00933543|559136144|FG000|Overall Study|Withdrawal by Subject|0|||
154921227|NCT00933543|559136145|FG001|Overall Study|Withdrawal by Subject|1|||
154921228|NCT00933543|559136144|FG000|Overall Study|Lack of Efficacy|0|||
154921229|NCT00933543|559136145|FG001|Overall Study|Lack of Efficacy|3|||
154921230|NCT00933543|559136144|FG000|Overall Study|Other|1|||
154921231|NCT00933543|559136145|FG001|Overall Study|Other|1|||
154921232|NCT04988035|559136147|FG000|Overall Study|Death|19|||
154921233|NCT04988035|559136148|FG001|Overall Study|Death|13|||
154921234|NCT04988035|559136147|FG000|Overall Study|Lost to Follow-up|12|||
154921235|NCT04988035|559136148|FG001|Overall Study|Lost to Follow-up|6|||
154921236|NCT04988035|559136147|FG000|Overall Study|Protocol Violation|0|||
154921237|NCT04988035|559136148|FG001|Overall Study|Protocol Violation|1|||
154921238|NCT04988035|559136147|FG000|Overall Study|Withdrawal by Subject|2|||
154921239|NCT04988035|559136148|FG001|Overall Study|Withdrawal by Subject|4|||
154921240|NCT04988035|559136147|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
154921241|NCT04988035|559136148|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
154921242|NCT03532048|559136149|FG000|Overall Study|Lost to Follow-up|12|||
154921243|NCT03532048|559136150|FG001|Overall Study|Lost to Follow-up|17|||
154921244|NCT03532048|559136149|FG000|Overall Study|Withdrawal by Subject|7|||
154921245|NCT03532048|559136150|FG001|Overall Study|Withdrawal by Subject|0|||
154921246|NCT03557775|559136151|FG000|Overall Study|Withdrawal by Subject|1|||
154921247|NCT03557775|559136152|FG001|Overall Study|Withdrawal by Subject|2|||
154921248|NCT03557775|559136153|FG002|Overall Study|Withdrawal by Subject|4|||
154921249|NCT03557775|559136151|FG000|Overall Study|Physician Decision|0|||
154921250|NCT03557775|559136152|FG001|Overall Study|Physician Decision|1|||
154921251|NCT03557775|559136153|FG002|Overall Study|Physician Decision|0|||
154921252|NCT00308555|559136156|FG000|Overall Study|Withdrawal by Subject|1|||
154921253|NCT00308555|559136157|FG001|Overall Study|Withdrawal by Subject|0|||
154921254|NCT00308555|559136156|FG000|Overall Study|Physician Decision|2|||
154921255|NCT00308555|559136157|FG001|Overall Study|Physician Decision|0|||
154921256|NCT04113746|559136165|FG000|Overall Study|Lost to Follow-up|4|||
154921257|NCT04113746|559136166|FG001|Overall Study|Lost to Follow-up|4|||
154921258|NCT01050998|559136168|FG000|Overall Study|Adverse Event|1|||
154921259|NCT01050998|559136169|FG001|Overall Study|Adverse Event|0|||
154921260|NCT01050998|559136170|FG002|Overall Study|Adverse Event|1|||
155000668|NCT02620579|559427038|FG001|Overall Study|Physician Decision|0|||
154921261|NCT01050998|559136171|FG003|Overall Study|Adverse Event|0|||
154921262|NCT01050998|559136172|FG004|Overall Study|Adverse Event|2|||
154921263|NCT01050998|559136168|FG000|Overall Study|Withdrawal by Subject|0|||
154921264|NCT01050998|559136169|FG001|Overall Study|Withdrawal by Subject|0|||
154921265|NCT01050998|559136170|FG002|Overall Study|Withdrawal by Subject|0|||
154921266|NCT01050998|559136171|FG003|Overall Study|Withdrawal by Subject|1|||
155000669|NCT02620579|559427039|FG002|Overall Study|Physician Decision|0|||
155000670|NCT02620579|559427040|FG003|Overall Study|Physician Decision|1|||
155000671|NCT02620579|559427037|FG000|Overall Study|Withdrawal by Subject|0|||
155000672|NCT02620579|559427038|FG001|Overall Study|Withdrawal by Subject|1|||
155000673|NCT02620579|559427039|FG002|Overall Study|Withdrawal by Subject|1|||
155000674|NCT02620579|559427040|FG003|Overall Study|Withdrawal by Subject|0|||
155000675|NCT02892149|559427043|FG000|Overall Study|Death|262|||
155000676|NCT02892149|559427044|FG001|Overall Study|Death|278|||
155123259|NCT02699450|559883357|FG000|Overall Study|Protocol Violation|4|||
155123260|NCT02699450|559883358|FG001|Overall Study|Protocol Violation|3|||
155123261|NCT02699450|559883359|FG002|Overall Study|Protocol Violation|5|||
155123262|NCT02699450|559883357|FG000|Overall Study|Lost to Follow-up|3|||
155123263|NCT02699450|559883358|FG001|Overall Study|Lost to Follow-up|0|||
155123264|NCT02699450|559883359|FG002|Overall Study|Lost to Follow-up|5|||
155123265|NCT02699450|559883357|FG000|Overall Study|Physician Decision|2|||
155123266|NCT02699450|559883358|FG001|Overall Study|Physician Decision|0|||
155123267|NCT02699450|559883359|FG002|Overall Study|Physician Decision|0|||
155123268|NCT02699450|559883357|FG000|Overall Study|Withdrawal by Subject|3|||
155123269|NCT02699450|559883358|FG001|Overall Study|Withdrawal by Subject|1|||
155123270|NCT02699450|559883359|FG002|Overall Study|Withdrawal by Subject|2|||
155123271|NCT02699450|559883357|FG000|Overall Study|Adverse Event|1|||
155123272|NCT02699450|559883358|FG001|Overall Study|Adverse Event|0|||
155123273|NCT02699450|559883359|FG002|Overall Study|Adverse Event|0|||
155123274|NCT00810901|559883360|FG000|Overall Study|Lost to Follow-up|88|||
155123275|NCT00810901|559883361|FG001|Overall Study|Lost to Follow-up|58|||
155123276|NCT00933244|559883362|FG000|Overall Study|Withdrawal by Subject|5|||
155123277|NCT00933244|559883363|FG001|Overall Study|Withdrawal by Subject|1|||
155123278|NCT00933244|559883364|FG002|Overall Study|Withdrawal by Subject|3|||
155123279|NCT01174004|559883365|FG000|Overall Study|Adverse Event|2|||
155123280|NCT01174004|559883366|FG001|Overall Study|Adverse Event|10|||
155123281|NCT01174004|559883365|FG000|Overall Study|Withdrawal by Subject|2|||
155123282|NCT01174004|559883366|FG001|Overall Study|Withdrawal by Subject|3|||
155123283|NCT01174004|559883365|FG000|Overall Study|At Discretion of Sponsor|2|||
155123284|NCT01174004|559883366|FG001|Overall Study|At Discretion of Sponsor|2|||
155123285|NCT01174004|559883365|FG000|Overall Study|Protocol Violation|0|||
155123286|NCT01174004|559883366|FG001|Overall Study|Protocol Violation|1|||
155123287|NCT01174004|559883365|FG000|Overall Study|Physician Decision|1|||
155123288|NCT01174004|559883366|FG001|Overall Study|Physician Decision|0|||
155123289|NCT01143896|559883367|FG000|Overall Study|Did not complete Baseline Interview|5|||
155177986|NCT04418661|560091377|FG001|Overall Study|Adverse Event|1|||
155177987|NCT04418661|560091378|FG002|Overall Study|Adverse Event|5|||
155177988|NCT04418661|560091379|FG003|Overall Study|Adverse Event|3|||
155000677|NCT02892149|559427043|FG000|Overall Study|Withdrawal by Subject|53|||
155000678|NCT02892149|559427044|FG001|Overall Study|Withdrawal by Subject|47|||
155000679|NCT02892149|559427043|FG000|Overall Study|Lost to Follow-up|37|||
155000680|NCT02892149|559427044|FG001|Overall Study|Lost to Follow-up|31|||
155000681|NCT01098474|559427049|FG000|Active Phase|Other|0|||
155000682|NCT01098474|559427050|FG001|Active Phase|Other|0|||
155000683|NCT01098474|559427051|FG002|Active Phase|Other|3|||
155000684|NCT01098474|559427052|FG003|Active Phase|Other|0|||
155000685|NCT01098474|559427053|FG004|Active Phase|Other|0|||
155000686|NCT01098474|559427054|FG005|Active Phase|Other|0|||
155000687|NCT01098474|559427049|FG000|Active Phase|Withdrawal by Subject|1|||
155000688|NCT01098474|559427050|FG001|Active Phase|Withdrawal by Subject|1|||
155000689|NCT01098474|559427051|FG002|Active Phase|Withdrawal by Subject|2|||
155000690|NCT01098474|559427052|FG003|Active Phase|Withdrawal by Subject|0|||
155000691|NCT01098474|559427053|FG004|Active Phase|Withdrawal by Subject|0|||
155000692|NCT01098474|559427054|FG005|Active Phase|Withdrawal by Subject|0|||
155000693|NCT01098474|559427049|FG000|Active Phase|Lost to Follow-up|1|||
155000694|NCT01098474|559427050|FG001|Active Phase|Lost to Follow-up|0|||
155000695|NCT01098474|559427051|FG002|Active Phase|Lost to Follow-up|0|||
155000696|NCT01098474|559427052|FG003|Active Phase|Lost to Follow-up|0|||
155000697|NCT01098474|559427053|FG004|Active Phase|Lost to Follow-up|0|||
155000698|NCT01098474|559427054|FG005|Active Phase|Lost to Follow-up|0|||
155123290|NCT01143896|559883368|FG001|Overall Study|Did not complete Baseline Interview|4|||
155123291|NCT01143896|559883367|FG000|Overall Study|Lost to Follow-up|18|||
155123292|NCT01143896|559883368|FG001|Overall Study|Lost to Follow-up|13|||
155123293|NCT01143896|559883367|FG000|Overall Study|Withdrawal by Subject|13|||
155123294|NCT01143896|559883368|FG001|Overall Study|Withdrawal by Subject|5|||
155123295|NCT01143896|559883367|FG000|Overall Study|Death|6|||
155123296|NCT01143896|559883368|FG001|Overall Study|Death|3|||
155123297|NCT01318070|559883369|FG000|Overall Study|Adverse Event|1|||
155177989|NCT04418661|560091380|FG004|Overall Study|Adverse Event|0|||
155123298|NCT01318070|559883370|FG001|Overall Study|Adverse Event|1|||
155123299|NCT01318070|559883371|FG002|Overall Study|Adverse Event|5|||
155000699|NCT01098474|559427049|FG000|Follow Up Phase|Travelled out of study area|0|||
155000700|NCT01098474|559427050|FG001|Follow Up Phase|Travelled out of study area|0|||
155000701|NCT01098474|559427051|FG002|Follow Up Phase|Travelled out of study area|0|||
155000702|NCT01098474|559427052|FG003|Follow Up Phase|Travelled out of study area|0|||
155123300|NCT01318070|559883369|FG000|Overall Study|Withdrawal by Subject|0|||
155123301|NCT01318070|559883370|FG001|Overall Study|Withdrawal by Subject|1|||
155000703|NCT01098474|559427053|FG004|Follow Up Phase|Travelled out of study area|1|||
155000704|NCT01098474|559427054|FG005|Follow Up Phase|Travelled out of study area|0|||
155000705|NCT01098474|559427049|FG000|Follow Up Phase|Other|0|||
155000706|NCT01098474|559427050|FG001|Follow Up Phase|Other|0|||
155000707|NCT01098474|559427051|FG002|Follow Up Phase|Other|0|||
155000708|NCT01098474|559427052|FG003|Follow Up Phase|Other|0|||
155000709|NCT01098474|559427053|FG004|Follow Up Phase|Other|0|||
155000710|NCT01098474|559427054|FG005|Follow Up Phase|Other|4|||
155000711|NCT01098474|559427049|FG000|Follow Up Phase|Withdrawal by Subject|0|||
155000712|NCT01098474|559427050|FG001|Follow Up Phase|Withdrawal by Subject|0|||
155000713|NCT01098474|559427051|FG002|Follow Up Phase|Withdrawal by Subject|0|||
155000714|NCT01098474|559427052|FG003|Follow Up Phase|Withdrawal by Subject|2|||
155000715|NCT01098474|559427053|FG004|Follow Up Phase|Withdrawal by Subject|0|||
155000716|NCT01098474|559427054|FG005|Follow Up Phase|Withdrawal by Subject|1|||
155000717|NCT01098474|559427049|FG000|Follow Up Phase|Lost to Follow-up|0|||
155000718|NCT01098474|559427050|FG001|Follow Up Phase|Lost to Follow-up|0|||
155000719|NCT01098474|559427051|FG002|Follow Up Phase|Lost to Follow-up|0|||
155000720|NCT01098474|559427052|FG003|Follow Up Phase|Lost to Follow-up|0|||
155000721|NCT01098474|559427053|FG004|Follow Up Phase|Lost to Follow-up|1|||
155000722|NCT01098474|559427054|FG005|Follow Up Phase|Lost to Follow-up|0|||
155000723|NCT02165735|559427055|FG000|Overall Study|Lost to Follow-up|12|||
155000724|NCT02165735|559427056|FG001|Overall Study|Lost to Follow-up|10|||
155000725|NCT02165735|559427055|FG000|Overall Study|Withdrawal by Subject|3|||
155000726|NCT02165735|559427056|FG001|Overall Study|Withdrawal by Subject|0|||
155000727|NCT02165735|559427055|FG000|Overall Study|Participant indicated lack of time|1|||
155000728|NCT02165735|559427056|FG001|Overall Study|Participant indicated lack of time|3|||
155000729|NCT02165735|559427055|FG000|Overall Study|Protocol Violation|0|||
155000730|NCT02165735|559427056|FG001|Overall Study|Protocol Violation|1|||
155000731|NCT03066258|559427057|FG000|Overall Study|Death|1|||
155000732|NCT03066258|559427058|FG001|Overall Study|Death|0|||
155000733|NCT03066258|559427059|FG002|Overall Study|Death|0|||
155000734|NCT03066258|559427060|FG003|Overall Study|Death|0|||
155000735|NCT03066258|559427061|FG004|Overall Study|Death|1|||
155000736|NCT02784795|559427062|FG000|Overall Study|Progressive Disease|2|||
155000737|NCT02784795|559427063|FG001|Overall Study|Progressive Disease|1|||
155000738|NCT02784795|559427064|FG002|Overall Study|Progressive Disease|1|||
155000739|NCT02784795|559427065|FG003|Overall Study|Progressive Disease|0|||
155000740|NCT02784795|559427066|FG004|Overall Study|Progressive Disease|2|||
155000741|NCT02784795|559427067|FG005|Overall Study|Progressive Disease|0|||
155000742|NCT02784795|559427068|FG006|Overall Study|Progressive Disease|2|||
155000743|NCT02784795|559427069|FG007|Overall Study|Progressive Disease|0|||
155000744|NCT02784795|559427070|FG008|Overall Study|Progressive Disease|0|||
155000745|NCT02784795|559427071|FG009|Overall Study|Progressive Disease|0|||
155000746|NCT02784795|559427072|FG010|Overall Study|Progressive Disease|1|||
155000747|NCT02784795|559427073|FG011|Overall Study|Progressive Disease|0|||
155000748|NCT02784795|559427062|FG000|Overall Study|Adverse Event|1|||
155000749|NCT02784795|559427063|FG001|Overall Study|Adverse Event|0|||
155000750|NCT02784795|559427064|FG002|Overall Study|Adverse Event|0|||
155000751|NCT02784795|559427065|FG003|Overall Study|Adverse Event|1|||
155000752|NCT02784795|559427066|FG004|Overall Study|Adverse Event|0|||
155000753|NCT02784795|559427067|FG005|Overall Study|Adverse Event|0|||
155000754|NCT02784795|559427068|FG006|Overall Study|Adverse Event|1|||
155000755|NCT02784795|559427069|FG007|Overall Study|Adverse Event|0|||
155000756|NCT02784795|559427070|FG008|Overall Study|Adverse Event|0|||
155000757|NCT02784795|559427071|FG009|Overall Study|Adverse Event|0|||
155000758|NCT02784795|559427072|FG010|Overall Study|Adverse Event|0|||
155123302|NCT01318070|559883371|FG002|Overall Study|Withdrawal by Subject|1|||
155123303|NCT01318070|559883369|FG000|Overall Study|Lack of Efficacy|0|||
155123304|NCT01318070|559883370|FG001|Overall Study|Lack of Efficacy|0|||
155123305|NCT01318070|559883371|FG002|Overall Study|Lack of Efficacy|1|||
155123306|NCT01318070|559883369|FG000|Overall Study|Principal Investigator Discretion|1|||
155000759|NCT02784795|559427073|FG011|Overall Study|Adverse Event|2|||
155000760|NCT02784795|559427062|FG000|Overall Study|Withdrawal by Subject|1|||
155000761|NCT02784795|559427063|FG001|Overall Study|Withdrawal by Subject|0|||
155000762|NCT02784795|559427064|FG002|Overall Study|Withdrawal by Subject|2|||
155000763|NCT02784795|559427065|FG003|Overall Study|Withdrawal by Subject|1|||
155123307|NCT01318070|559883370|FG001|Overall Study|Principal Investigator Discretion|0|||
155000764|NCT02784795|559427066|FG004|Overall Study|Withdrawal by Subject|3|||
155000765|NCT02784795|559427067|FG005|Overall Study|Withdrawal by Subject|0|||
155000766|NCT02784795|559427068|FG006|Overall Study|Withdrawal by Subject|0|||
155000767|NCT02784795|559427069|FG007|Overall Study|Withdrawal by Subject|1|||
155000768|NCT02784795|559427070|FG008|Overall Study|Withdrawal by Subject|0|||
155000769|NCT02784795|559427071|FG009|Overall Study|Withdrawal by Subject|0|||
155000770|NCT02784795|559427072|FG010|Overall Study|Withdrawal by Subject|0|||
155000771|NCT02784795|559427073|FG011|Overall Study|Withdrawal by Subject|2|||
155000772|NCT02784795|559427062|FG000|Overall Study|Death|0|||
155000773|NCT02784795|559427063|FG001|Overall Study|Death|0|||
155000774|NCT02784795|559427064|FG002|Overall Study|Death|0|||
155000775|NCT02784795|559427065|FG003|Overall Study|Death|0|||
155000776|NCT02784795|559427066|FG004|Overall Study|Death|1|||
155000777|NCT02784795|559427067|FG005|Overall Study|Death|0|||
155000778|NCT02784795|559427068|FG006|Overall Study|Death|0|||
155000779|NCT02784795|559427069|FG007|Overall Study|Death|0|||
155000780|NCT02784795|559427070|FG008|Overall Study|Death|0|||
155000781|NCT02784795|559427071|FG009|Overall Study|Death|0|||
155000782|NCT02784795|559427072|FG010|Overall Study|Death|0|||
155000783|NCT02784795|559427073|FG011|Overall Study|Death|0|||
155000784|NCT02784795|559427062|FG000|Overall Study|Physician Decision|0|||
155000785|NCT02784795|559427063|FG001|Overall Study|Physician Decision|0|||
155000786|NCT02784795|559427064|FG002|Overall Study|Physician Decision|0|||
155000787|NCT02784795|559427065|FG003|Overall Study|Physician Decision|0|||
155000788|NCT02784795|559427066|FG004|Overall Study|Physician Decision|0|||
155000789|NCT02784795|559427067|FG005|Overall Study|Physician Decision|0|||
155000790|NCT02784795|559427068|FG006|Overall Study|Physician Decision|1|||
155000791|NCT02784795|559427069|FG007|Overall Study|Physician Decision|0|||
155000792|NCT02784795|559427070|FG008|Overall Study|Physician Decision|0|||
155000793|NCT02784795|559427071|FG009|Overall Study|Physician Decision|0|||
155000794|NCT02784795|559427072|FG010|Overall Study|Physician Decision|0|||
155000795|NCT02784795|559427073|FG011|Overall Study|Physician Decision|0|||
155000796|NCT00595309|559427074|FG000|Overall Study|Lost to Follow-up|1|||
155000797|NCT00595309|559427074|FG000|Overall Study|planned vaccination against yellow fever|1|||
155000798|NCT00595309|559427074|FG000|Overall Study|acute infection after V0|1|||
155000799|NCT00595309|559427074|FG000|Overall Study|personal reason|1|||
155000800|NCT00101283|559427075|FG000|Overall Study|Withdrawal by Subject|0|||
155000801|NCT00101283|559427076|FG001|Overall Study|Withdrawal by Subject|1|||
155000802|NCT00101283|559427075|FG000|Overall Study|Insurance Refusal|0|||
155000803|NCT00101283|559427076|FG001|Overall Study|Insurance Refusal|1|||
155000804|NCT00101283|559427075|FG000|Overall Study|Prostate Cancer Recurrence|0|||
155000805|NCT00101283|559427076|FG001|Overall Study|Prostate Cancer Recurrence|1|||
155000806|NCT02797171|559427077|FG000|Overall Study|Lost to Follow-up|2|||
155000807|NCT02797171|559427078|FG001|Overall Study|Lost to Follow-up|0|||
155000808|NCT02797171|559427079|FG002|Overall Study|Lost to Follow-up|2|||
155000809|NCT02797171|559427080|FG003|Overall Study|Lost to Follow-up|1|||
155000810|NCT02797171|559427081|FG004|Overall Study|Lost to Follow-up|2|||
155000811|NCT02797171|559427082|FG005|Overall Study|Lost to Follow-up|0|||
155000812|NCT02797171|559427077|FG000|Overall Study|Withdrawal by Subject|1|||
155000813|NCT02797171|559427078|FG001|Overall Study|Withdrawal by Subject|1|||
155000814|NCT02797171|559427079|FG002|Overall Study|Withdrawal by Subject|0|||
155000815|NCT02797171|559427080|FG003|Overall Study|Withdrawal by Subject|0|||
155000816|NCT02797171|559427081|FG004|Overall Study|Withdrawal by Subject|0|||
155000817|NCT02797171|559427082|FG005|Overall Study|Withdrawal by Subject|0|||
155000818|NCT02797171|559427077|FG000|Overall Study|Protocol Violation|1|||
155000819|NCT02797171|559427078|FG001|Overall Study|Protocol Violation|0|||
155000820|NCT02797171|559427079|FG002|Overall Study|Protocol Violation|0|||
155000821|NCT02797171|559427080|FG003|Overall Study|Protocol Violation|0|||
155000822|NCT02797171|559427081|FG004|Overall Study|Protocol Violation|0|||
155000823|NCT02797171|559427082|FG005|Overall Study|Protocol Violation|0|||
155000824|NCT02797171|559427077|FG000|Overall Study|Participant unable to adhere|0|||
155000825|NCT02797171|559427078|FG001|Overall Study|Participant unable to adhere|1|||
155000826|NCT02797171|559427079|FG002|Overall Study|Participant unable to adhere|0|||
155000827|NCT02797171|559427080|FG003|Overall Study|Participant unable to adhere|0|||
155000828|NCT02797171|559427081|FG004|Overall Study|Participant unable to adhere|0|||
155000829|NCT02797171|559427082|FG005|Overall Study|Participant unable to adhere|0|||
155000830|NCT02797171|559427077|FG000|Overall Study|Not Randomized|0|||
155000831|NCT02797171|559427078|FG001|Overall Study|Not Randomized|0|||
155000832|NCT02797171|559427079|FG002|Overall Study|Not Randomized|0|||
155000833|NCT02797171|559427080|FG003|Overall Study|Not Randomized|0|||
155000834|NCT02797171|559427081|FG004|Overall Study|Not Randomized|0|||
155000835|NCT02797171|559427082|FG005|Overall Study|Not Randomized|1|||
155000836|NCT02756208|559427083|FG000|Overall Study|Withdrawal by Subject|1|||
155000837|NCT02756208|559427084|FG001|Overall Study|Withdrawal by Subject|0|||
155000838|NCT02756208|559427085|FG002|Overall Study|Withdrawal by Subject|1|||
155000839|NCT02756208|559427086|FG003|Overall Study|Withdrawal by Subject|3|||
155000840|NCT02756208|559427083|FG000|Overall Study|Lost to Follow-up|3|||
155000841|NCT02756208|559427084|FG001|Overall Study|Lost to Follow-up|1|||
155000842|NCT02756208|559427085|FG002|Overall Study|Lost to Follow-up|1|||
155000843|NCT02756208|559427086|FG003|Overall Study|Lost to Follow-up|1|||
155123308|NCT01318070|559883371|FG002|Overall Study|Principal Investigator Discretion|0|||
155000844|NCT02756208|559427083|FG000|Overall Study|Physician Decision|1|||
155000845|NCT02756208|559427084|FG001|Overall Study|Physician Decision|0|||
155000846|NCT02756208|559427085|FG002|Overall Study|Physician Decision|0|||
155000847|NCT02756208|559427086|FG003|Overall Study|Physician Decision|0|||
155000848|NCT02756208|559427083|FG000|Overall Study|Protocol Violation|0|||
155000849|NCT02756208|559427084|FG001|Overall Study|Protocol Violation|1|||
155000850|NCT02756208|559427085|FG002|Overall Study|Protocol Violation|0|||
155000851|NCT02756208|559427086|FG003|Overall Study|Protocol Violation|0|||
155000852|NCT00356525|559427091|FG000|Overall Study|Progressive Disease|8|||
155000853|NCT00356525|559427092|FG001|Overall Study|Progressive Disease|5|||
155000854|NCT00356525|559427093|FG002|Overall Study|Progressive Disease|4|||
155000855|NCT00356525|559427094|FG003|Overall Study|Progressive Disease|2|||
155000856|NCT00356525|559427091|FG000|Overall Study|Adverse Event|1|||
155000857|NCT00356525|559427092|FG001|Overall Study|Adverse Event|3|||
155000858|NCT00356525|559427093|FG002|Overall Study|Adverse Event|1|||
155000859|NCT00356525|559427094|FG003|Overall Study|Adverse Event|1|||
155000860|NCT00356525|559427091|FG000|Overall Study|Lost to Follow-up|1|||
155000861|NCT00356525|559427092|FG001|Overall Study|Lost to Follow-up|0|||
155000862|NCT00356525|559427093|FG002|Overall Study|Lost to Follow-up|0|||
155000863|NCT00356525|559427094|FG003|Overall Study|Lost to Follow-up|0|||
155000864|NCT00356525|559427091|FG000|Overall Study|Physician Decision|2|||
155000865|NCT00356525|559427092|FG001|Overall Study|Physician Decision|2|||
155000866|NCT00356525|559427093|FG002|Overall Study|Physician Decision|2|||
155000867|NCT00356525|559427094|FG003|Overall Study|Physician Decision|1|||
155000868|NCT00356525|559427091|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
155000869|NCT00356525|559427092|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
155000870|NCT00356525|559427093|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
155000871|NCT00356525|559427094|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
155000872|NCT00356525|559427091|FG000|Overall Study|Withdrawal by Subject|1|||
155000873|NCT00356525|559427092|FG001|Overall Study|Withdrawal by Subject|1|||
155000874|NCT00356525|559427093|FG002|Overall Study|Withdrawal by Subject|0|||
155000875|NCT00356525|559427094|FG003|Overall Study|Withdrawal by Subject|3|||
155000876|NCT00356525|559427091|FG000|Overall Study|Death|0|||
155000877|NCT00356525|559427092|FG001|Overall Study|Death|0|||
155000878|NCT00356525|559427093|FG002|Overall Study|Death|0|||
155000879|NCT00356525|559427094|FG003|Overall Study|Death|1|||
155000880|NCT00356525|559427091|FG000|Overall Study|Sponsor Decision|0|||
155000881|NCT00356525|559427092|FG001|Overall Study|Sponsor Decision|0|||
155000882|NCT00356525|559427093|FG002|Overall Study|Sponsor Decision|0|||
155000883|NCT00356525|559427094|FG003|Overall Study|Sponsor Decision|1|||
155000884|NCT00652340|559427100|FG000|Overall Study|Had not progressed.|4|||
155000885|NCT00652340|559427101|FG001|Overall Study|Had not progressed.|3|||
155000886|NCT03682107|559427102|FG000|Overall Study|Withdrawal by Subject|0|||
155000887|NCT03682107|559427103|FG001|Overall Study|Withdrawal by Subject|1|||
155000888|NCT03682107|559427104|FG002|Overall Study|Withdrawal by Subject|0|||
155000889|NCT03682107|559427105|FG003|Overall Study|Withdrawal by Subject|0|||
155000890|NCT03682107|559427106|FG004|Overall Study|Withdrawal by Subject|0|||
155000891|NCT00879411|559427107|FG000|Overall Study|lost to follow-up (non-AE)|162|||
155000892|NCT05211726|559427108|FG000|Overall Study|Withdrawal by Subject|2|||
155000893|NCT05211726|559427109|FG001|Overall Study|Withdrawal by Subject|3|||
155000894|NCT05211726|559427108|FG000|Overall Study|Protocol Violation|0|||
155000895|NCT05211726|559427109|FG001|Overall Study|Protocol Violation|1|||
155000896|NCT01890434|559427110|FG000|Overall Study|Adverse Event|8|||
155000897|NCT01890434|559427110|FG000|Overall Study|PCI at external hospital|1|||
155000898|NCT01890434|559427110|FG000|Overall Study|Assessment discrepancy|1|||
155000899|NCT01890434|559427110|FG000|Overall Study|CRC didn't contact participant for FU|1|||
155000900|NCT01890434|559427110|FG000|Overall Study|Could not get whole set of images|1|||
155000901|NCT01890434|559427110|FG000|Overall Study|Decline to return for GSPECT|1|||
155000902|NCT01890434|559427110|FG000|Overall Study|GSPECT at rest was not done|1|||
155000903|NCT01890434|559427110|FG000|Overall Study|Participant didn't complete MRI|1|||
155000904|NCT01890434|559427110|FG000|Overall Study|Uncontactable by phone|1|||
155000905|NCT01890434|559427110|FG000|Overall Study|Moved out of position|1|||
155000906|NCT01890434|559427110|FG000|Overall Study|Unable to contact|1|||
155000907|NCT01890434|559427110|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
155000908|NCT00428116|559427111|FG000|Overall Study|Death|1|||
155000909|NCT00428116|559427112|FG001|Overall Study|Death|0|||
155000910|NCT00428116|559427111|FG000|Overall Study|Withdrawal by Subject|1|||
155000911|NCT00428116|559427112|FG001|Overall Study|Withdrawal by Subject|0|||
155000912|NCT00428116|559427111|FG000|Overall Study|Lost to Follow-up|1|||
155000913|NCT00428116|559427112|FG001|Overall Study|Lost to Follow-up|0|||
155123309|NCT01816906|559883374|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
155000914|NCT01038297|559427113|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
155000915|NCT01038297|559427114|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
155000916|NCT01038297|559427115|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
155000917|NCT01449370|559427123|FG000|Overall Study|Disease Progression|5|||
155000918|NCT01449370|559427124|FG001|Overall Study|Disease Progression|4|||
155000919|NCT01449370|559427125|FG002|Overall Study|Disease Progression|8|||
155000920|NCT01449370|559427126|FG003|Overall Study|Disease Progression|3|||
155000921|NCT01449370|559427127|FG004|Overall Study|Disease Progression|3|||
155123310|NCT01816906|559883375|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
155000922|NCT01449370|559427128|FG005|Overall Study|Disease Progression|3|||
155000923|NCT01449370|559427129|FG006|Overall Study|Disease Progression|3|||
155000924|NCT01449370|559427130|FG007|Overall Study|Disease Progression|2|||
155000925|NCT01449370|559427131|FG008|Overall Study|Disease Progression|9|||
155000926|NCT01449370|559427132|FG009|Overall Study|Disease Progression|1|||
155000927|NCT01449370|559427133|FG010|Overall Study|Disease Progression|3|||
155000928|NCT01449370|559427134|FG011|Overall Study|Disease Progression|3|||
155000929|NCT01449370|559427135|FG012|Overall Study|Disease Progression|2|||
155123311|NCT01816906|559883374|FG000|Six Months|Lost to Follow-up|14|||
155000930|NCT01449370|559427136|FG013|Overall Study|Disease Progression|8|||
155000931|NCT01449370|559427137|FG014|Overall Study|Disease Progression|3|||
155000932|NCT01449370|559427138|FG015|Overall Study|Disease Progression|1|||
155000933|NCT01449370|559427139|FG016|Overall Study|Disease Progression|4|||
155000934|NCT01449370|559427140|FG017|Overall Study|Disease Progression|3|||
155000935|NCT01449370|559427141|FG018|Overall Study|Disease Progression|1|||
155000936|NCT01449370|559427142|FG019|Overall Study|Disease Progression|2|||
155000937|NCT01449370|559427143|FG020|Overall Study|Disease Progression|5|||
155000938|NCT01449370|559427144|FG021|Overall Study|Disease Progression|2|||
155000939|NCT01449370|559427145|FG022|Overall Study|Disease Progression|3|||
155000940|NCT01449370|559427146|FG023|Overall Study|Disease Progression|7|||
155000941|NCT01449370|559427147|FG024|Overall Study|Disease Progression|3|||
155000942|NCT01449370|559427123|FG000|Overall Study|Adverse Event|1|||
155000943|NCT01449370|559427124|FG001|Overall Study|Adverse Event|2|||
155000944|NCT01449370|559427125|FG002|Overall Study|Adverse Event|0|||
155000945|NCT01449370|559427126|FG003|Overall Study|Adverse Event|1|||
155000946|NCT01449370|559427127|FG004|Overall Study|Adverse Event|0|||
155000947|NCT01449370|559427128|FG005|Overall Study|Adverse Event|0|||
155000948|NCT01449370|559427129|FG006|Overall Study|Adverse Event|0|||
155000949|NCT01449370|559427130|FG007|Overall Study|Adverse Event|0|||
155000950|NCT01449370|559427131|FG008|Overall Study|Adverse Event|1|||
155000951|NCT01449370|559427132|FG009|Overall Study|Adverse Event|1|||
155000952|NCT01449370|559427133|FG010|Overall Study|Adverse Event|0|||
155000953|NCT01449370|559427134|FG011|Overall Study|Adverse Event|0|||
155000954|NCT01449370|559427135|FG012|Overall Study|Adverse Event|0|||
155000955|NCT01449370|559427136|FG013|Overall Study|Adverse Event|2|||
155000956|NCT01449370|559427137|FG014|Overall Study|Adverse Event|0|||
155000957|NCT01449370|559427138|FG015|Overall Study|Adverse Event|1|||
155000958|NCT01449370|559427139|FG016|Overall Study|Adverse Event|0|||
155000959|NCT01449370|559427140|FG017|Overall Study|Adverse Event|0|||
155000960|NCT01449370|559427141|FG018|Overall Study|Adverse Event|1|||
155000961|NCT01449370|559427142|FG019|Overall Study|Adverse Event|1|||
155000962|NCT01449370|559427143|FG020|Overall Study|Adverse Event|0|||
155000963|NCT01449370|559427144|FG021|Overall Study|Adverse Event|1|||
155000964|NCT01449370|559427145|FG022|Overall Study|Adverse Event|0|||
155000965|NCT01449370|559427146|FG023|Overall Study|Adverse Event|1|||
155000966|NCT01449370|559427147|FG024|Overall Study|Adverse Event|3|||
155000967|NCT01449370|559427123|FG000|Overall Study|Participant Decision|0|||
155000968|NCT01449370|559427124|FG001|Overall Study|Participant Decision|0|||
155000969|NCT01449370|559427125|FG002|Overall Study|Participant Decision|0|||
155000970|NCT01449370|559427126|FG003|Overall Study|Participant Decision|0|||
155000971|NCT01449370|559427127|FG004|Overall Study|Participant Decision|0|||
155000972|NCT01449370|559427128|FG005|Overall Study|Participant Decision|0|||
155000973|NCT01449370|559427129|FG006|Overall Study|Participant Decision|0|||
155000974|NCT01449370|559427130|FG007|Overall Study|Participant Decision|1|||
155000975|NCT01449370|559427131|FG008|Overall Study|Participant Decision|1|||
155000976|NCT01449370|559427132|FG009|Overall Study|Participant Decision|0|||
155000977|NCT01449370|559427133|FG010|Overall Study|Participant Decision|0|||
155000978|NCT01449370|559427134|FG011|Overall Study|Participant Decision|0|||
155000979|NCT01449370|559427135|FG012|Overall Study|Participant Decision|1|||
155000980|NCT01449370|559427136|FG013|Overall Study|Participant Decision|1|||
155000981|NCT01449370|559427137|FG014|Overall Study|Participant Decision|0|||
155123312|NCT01816906|559883375|FG001|Six Months|Lost to Follow-up|16|||
155123313|NCT01816906|559883374|FG000|12 Months|Adverse Event|2|||
155123314|NCT01816906|559883375|FG001|12 Months|Adverse Event|2|||
155123315|NCT01816906|559883374|FG000|12 Months|Death|0|||
155123316|NCT01816906|559883375|FG001|12 Months|Death|2|||
155123317|NCT01816906|559883374|FG000|12 Months|Lost to Follow-up|2|||
155123318|NCT01816906|559883375|FG001|12 Months|Lost to Follow-up|1|||
155000982|NCT01449370|559427138|FG015|Overall Study|Participant Decision|1|||
155000983|NCT01449370|559427139|FG016|Overall Study|Participant Decision|3|||
155000984|NCT01449370|559427140|FG017|Overall Study|Participant Decision|0|||
155000985|NCT01449370|559427141|FG018|Overall Study|Participant Decision|1|||
155000986|NCT01449370|559427142|FG019|Overall Study|Participant Decision|0|||
155000987|NCT01449370|559427143|FG020|Overall Study|Participant Decision|0|||
155000988|NCT01449370|559427144|FG021|Overall Study|Participant Decision|1|||
155000989|NCT01449370|559427145|FG022|Overall Study|Participant Decision|0|||
155000990|NCT01449370|559427146|FG023|Overall Study|Participant Decision|0|||
155000991|NCT01449370|559427147|FG024|Overall Study|Participant Decision|1|||
155000992|NCT01449370|559427123|FG000|Overall Study|Lost to Follow-up|0|||
155000993|NCT01449370|559427124|FG001|Overall Study|Lost to Follow-up|0|||
155000994|NCT01449370|559427125|FG002|Overall Study|Lost to Follow-up|0|||
155123319|NCT04375397|559883376|FG000|Overall Study|Death|1|||
155000995|NCT01449370|559427126|FG003|Overall Study|Lost to Follow-up|0|||
155000996|NCT01449370|559427127|FG004|Overall Study|Lost to Follow-up|0|||
155000997|NCT01449370|559427128|FG005|Overall Study|Lost to Follow-up|0|||
155000998|NCT01449370|559427129|FG006|Overall Study|Lost to Follow-up|0|||
155123320|NCT04375397|559883377|FG001|Overall Study|Death|1|||
155123321|NCT04375397|559883376|FG000|Overall Study|Withdrew consent|2|||
155123322|NCT04375397|559883377|FG001|Overall Study|Withdrew consent|0|||
155123323|NCT04375397|559883376|FG000|Overall Study|Lost to Follow-up|6|||
155123324|NCT04375397|559883377|FG001|Overall Study|Lost to Follow-up|4|||
155123325|NCT04375397|559883376|FG000|Overall Study|Other, not specified|0|||
155123326|NCT04375397|559883377|FG001|Overall Study|Other, not specified|1|||
155123327|NCT00086502|559883378|FG000|Overall Study|Adverse Event|11|||
155123328|NCT00086502|559883379|FG001|Overall Study|Adverse Event|2|||
155123329|NCT00086502|559883378|FG000|Overall Study|Lack of Efficacy|0|||
155123330|NCT00086502|559883379|FG001|Overall Study|Lack of Efficacy|2|||
155123331|NCT00086502|559883378|FG000|Overall Study|Lost to Follow-up|3|||
155123332|NCT00086502|559883379|FG001|Overall Study|Lost to Follow-up|1|||
155123333|NCT00086502|559883378|FG000|Overall Study|Physician Decision|1|||
155123334|NCT00086502|559883379|FG001|Overall Study|Physician Decision|1|||
155123335|NCT00086502|559883378|FG000|Overall Study|Pregnancy|0|||
155123336|NCT00086502|559883379|FG001|Overall Study|Pregnancy|1|||
155123337|NCT00086502|559883378|FG000|Overall Study|Protocol Violation|3|||
155123338|NCT00086502|559883379|FG001|Overall Study|Protocol Violation|3|||
155123339|NCT00086502|559883378|FG000|Overall Study|Withdrawal by Subject|5|||
155123340|NCT00086502|559883379|FG001|Overall Study|Withdrawal by Subject|6|||
155123341|NCT00086502|559883378|FG000|Overall Study|Patient Moved|1|||
155123342|NCT00086502|559883379|FG001|Overall Study|Patient Moved|1|||
155123343|NCT00086502|559883378|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
155123344|NCT00086502|559883379|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
155123345|NCT00086502|559883378|FG000|Overall Study|Patient Accidentally Unblinded|1|||
155123346|NCT00086502|559883379|FG001|Overall Study|Patient Accidentally Unblinded|0|||
155123347|NCT01304329|559883380|FG000|Third Intervention (3 Days)|Adverse Event|0|||
155123348|NCT01304329|559883381|FG001|Third Intervention (3 Days)|Adverse Event|1|||
155123349|NCT01304329|559883382|FG002|Third Intervention (3 Days)|Adverse Event|0|||
155123350|NCT01304329|559883383|FG003|Third Intervention (3 Days)|Adverse Event|0|||
155123351|NCT01304329|559883384|FG004|Third Intervention (3 Days)|Adverse Event|0|||
155123352|NCT01304329|559883385|FG005|Third Intervention (3 Days)|Adverse Event|0|||
155123353|NCT05545644|559883387|FG000|Overall Study|Lost to Follow-up|4|||
155123354|NCT05545644|559883388|FG001|Overall Study|Lost to Follow-up|3|||
155123355|NCT00610441|559883389|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
155123356|NCT00610441|559883390|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
155123357|NCT00610441|559883391|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
155123358|NCT00610441|559883392|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
155123359|NCT00610441|559883389|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
155123360|NCT00610441|559883390|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
155123361|NCT00610441|559883391|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
155123362|NCT00610441|559883392|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
155177990|NCT04418661|560091381|FG005|Overall Study|Adverse Event|2|||
155177991|NCT04418661|560091376|FG000|Overall Study|Progressive disease|4|||
155000999|NCT01449370|559427130|FG007|Overall Study|Lost to Follow-up|0|||
155001000|NCT01449370|559427131|FG008|Overall Study|Lost to Follow-up|0|||
155001001|NCT01449370|559427132|FG009|Overall Study|Lost to Follow-up|0|||
155001002|NCT01449370|559427133|FG010|Overall Study|Lost to Follow-up|0|||
155001003|NCT01449370|559427134|FG011|Overall Study|Lost to Follow-up|0|||
155001004|NCT01449370|559427135|FG012|Overall Study|Lost to Follow-up|0|||
155001005|NCT01449370|559427136|FG013|Overall Study|Lost to Follow-up|0|||
155001006|NCT01449370|559427137|FG014|Overall Study|Lost to Follow-up|0|||
155001007|NCT01449370|559427138|FG015|Overall Study|Lost to Follow-up|0|||
155001008|NCT01449370|559427139|FG016|Overall Study|Lost to Follow-up|0|||
155001009|NCT01449370|559427140|FG017|Overall Study|Lost to Follow-up|0|||
155001010|NCT01449370|559427141|FG018|Overall Study|Lost to Follow-up|0|||
155001011|NCT01449370|559427142|FG019|Overall Study|Lost to Follow-up|0|||
155001012|NCT01449370|559427143|FG020|Overall Study|Lost to Follow-up|1|||
155001013|NCT01449370|559427144|FG021|Overall Study|Lost to Follow-up|0|||
155001014|NCT01449370|559427145|FG022|Overall Study|Lost to Follow-up|0|||
155001015|NCT01449370|559427146|FG023|Overall Study|Lost to Follow-up|0|||
155001016|NCT01449370|559427147|FG024|Overall Study|Lost to Follow-up|0|||
155123363|NCT00610441|559883389|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
155177992|NCT04418661|560091377|FG001|Overall Study|Progressive disease|11|||
155001017|NCT01449370|559427123|FG000|Overall Study|Other|0|||
155001018|NCT01449370|559427124|FG001|Overall Study|Other|0|||
155001019|NCT01449370|559427125|FG002|Overall Study|Other|0|||
155123364|NCT00610441|559883390|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
155123365|NCT00610441|559883391|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
155123366|NCT00610441|559883392|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
155123367|NCT00610441|559883389|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
155123368|NCT00610441|559883390|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
155123369|NCT00610441|559883391|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
155123370|NCT00610441|559883392|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
155123371|NCT00610441|559883389|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
155123372|NCT00610441|559883390|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
155123373|NCT00610441|559883391|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
155001020|NCT01449370|559427126|FG003|Overall Study|Other|0|||
155001021|NCT01449370|559427127|FG004|Overall Study|Other|0|||
155001022|NCT01449370|559427128|FG005|Overall Study|Other|0|||
155001023|NCT01449370|559427129|FG006|Overall Study|Other|0|||
155001024|NCT01449370|559427130|FG007|Overall Study|Other|0|||
155001025|NCT01449370|559427131|FG008|Overall Study|Other|1|||
155001026|NCT01449370|559427132|FG009|Overall Study|Other|1|||
155001027|NCT01449370|559427133|FG010|Overall Study|Other|0|||
155001028|NCT01449370|559427134|FG011|Overall Study|Other|0|||
155001029|NCT01449370|559427135|FG012|Overall Study|Other|0|||
155001030|NCT01449370|559427136|FG013|Overall Study|Other|0|||
155001031|NCT01449370|559427137|FG014|Overall Study|Other|0|||
155001032|NCT01449370|559427138|FG015|Overall Study|Other|0|||
155001033|NCT01449370|559427139|FG016|Overall Study|Other|0|||
155001034|NCT01449370|559427140|FG017|Overall Study|Other|0|||
155001035|NCT01449370|559427141|FG018|Overall Study|Other|0|||
155001036|NCT01449370|559427142|FG019|Overall Study|Other|0|||
155001037|NCT01449370|559427143|FG020|Overall Study|Other|0|||
155001038|NCT01449370|559427144|FG021|Overall Study|Other|0|||
155001039|NCT01449370|559427145|FG022|Overall Study|Other|1|||
155001040|NCT01449370|559427146|FG023|Overall Study|Other|1|||
155001041|NCT01449370|559427147|FG024|Overall Study|Other|0|||
155001042|NCT01449370|559427123|FG000|Overall Study|Medication Prohibited by Protocol|0|||
155001043|NCT01449370|559427124|FG001|Overall Study|Medication Prohibited by Protocol|0|||
155001044|NCT01449370|559427125|FG002|Overall Study|Medication Prohibited by Protocol|0|||
155001045|NCT01449370|559427126|FG003|Overall Study|Medication Prohibited by Protocol|0|||
155001046|NCT01449370|559427127|FG004|Overall Study|Medication Prohibited by Protocol|0|||
155001047|NCT01449370|559427128|FG005|Overall Study|Medication Prohibited by Protocol|0|||
155001048|NCT01449370|559427129|FG006|Overall Study|Medication Prohibited by Protocol|0|||
155001049|NCT01449370|559427130|FG007|Overall Study|Medication Prohibited by Protocol|0|||
155001050|NCT01449370|559427131|FG008|Overall Study|Medication Prohibited by Protocol|0|||
155001051|NCT01449370|559427132|FG009|Overall Study|Medication Prohibited by Protocol|0|||
155001052|NCT01449370|559427133|FG010|Overall Study|Medication Prohibited by Protocol|0|||
155001053|NCT01449370|559427134|FG011|Overall Study|Medication Prohibited by Protocol|0|||
155001054|NCT01449370|559427135|FG012|Overall Study|Medication Prohibited by Protocol|0|||
155001055|NCT01449370|559427136|FG013|Overall Study|Medication Prohibited by Protocol|0|||
155001056|NCT01449370|559427137|FG014|Overall Study|Medication Prohibited by Protocol|0|||
155001057|NCT01449370|559427138|FG015|Overall Study|Medication Prohibited by Protocol|0|||
155001058|NCT01449370|559427139|FG016|Overall Study|Medication Prohibited by Protocol|0|||
155001059|NCT01449370|559427140|FG017|Overall Study|Medication Prohibited by Protocol|0|||
155001060|NCT01449370|559427141|FG018|Overall Study|Medication Prohibited by Protocol|0|||
155001061|NCT01449370|559427142|FG019|Overall Study|Medication Prohibited by Protocol|0|||
155001062|NCT01449370|559427143|FG020|Overall Study|Medication Prohibited by Protocol|0|||
155001063|NCT01449370|559427144|FG021|Overall Study|Medication Prohibited by Protocol|0|||
155001064|NCT01449370|559427145|FG022|Overall Study|Medication Prohibited by Protocol|0|||
155001065|NCT01449370|559427146|FG023|Overall Study|Medication Prohibited by Protocol|1|||
155001066|NCT01449370|559427147|FG024|Overall Study|Medication Prohibited by Protocol|0|||
155001067|NCT01449370|559427123|FG000|Overall Study|Death|0|||
155001068|NCT01449370|559427124|FG001|Overall Study|Death|0|||
155001069|NCT01449370|559427125|FG002|Overall Study|Death|0|||
155001070|NCT01449370|559427126|FG003|Overall Study|Death|0|||
155001071|NCT01449370|559427127|FG004|Overall Study|Death|0|||
155001072|NCT01449370|559427128|FG005|Overall Study|Death|0|||
155001073|NCT01449370|559427129|FG006|Overall Study|Death|0|||
155001074|NCT01449370|559427130|FG007|Overall Study|Death|0|||
155001075|NCT01449370|559427131|FG008|Overall Study|Death|0|||
155001076|NCT01449370|559427132|FG009|Overall Study|Death|0|||
155001077|NCT01449370|559427133|FG010|Overall Study|Death|0|||
155001078|NCT01449370|559427134|FG011|Overall Study|Death|0|||
155001079|NCT01449370|559427135|FG012|Overall Study|Death|0|||
155001080|NCT01449370|559427136|FG013|Overall Study|Death|0|||
155001081|NCT01449370|559427137|FG014|Overall Study|Death|0|||
155001082|NCT01449370|559427138|FG015|Overall Study|Death|0|||
155123374|NCT00610441|559883392|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
155123375|NCT00610441|559883389|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155123376|NCT00610441|559883390|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
155123377|NCT00610441|559883391|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155001083|NCT01449370|559427139|FG016|Overall Study|Death|0|||
155001084|NCT01449370|559427140|FG017|Overall Study|Death|0|||
155001085|NCT01449370|559427141|FG018|Overall Study|Death|0|||
155001086|NCT01449370|559427142|FG019|Overall Study|Death|0|||
155001087|NCT01449370|559427143|FG020|Overall Study|Death|0|||
155001088|NCT01449370|559427144|FG021|Overall Study|Death|0|||
155001089|NCT01449370|559427145|FG022|Overall Study|Death|0|||
155001090|NCT01449370|559427146|FG023|Overall Study|Death|0|||
155001091|NCT01449370|559427147|FG024|Overall Study|Death|1|||
155001092|NCT00710866|559427148|FG000|Overall Study|Protocol Violation|5|||
155001093|NCT00710866|559427149|FG001|Overall Study|Protocol Violation|4|||
155001094|NCT00710866|559427148|FG000|Overall Study|Withdrawal by Subject|2|||
155123378|NCT00610441|559883392|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
155001095|NCT00710866|559427149|FG001|Overall Study|Withdrawal by Subject|1|||
155123379|NCT00610441|559883389|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
155123380|NCT00610441|559883390|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
155123381|NCT00610441|559883391|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
155123382|NCT00610441|559883392|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
155123383|NCT00610441|559883389|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
155123384|NCT00610441|559883390|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
155123385|NCT00610441|559883391|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
155123386|NCT00610441|559883392|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
155123387|NCT00610441|559883389|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
155123388|NCT00610441|559883390|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
155123389|NCT00610441|559883391|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
155123390|NCT00610441|559883392|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
155123391|NCT01945775|559883402|FG000|Overall Study|Death|214|||
155123392|NCT01945775|559883403|FG001|Overall Study|Death|98|||
155123393|NCT01945775|559883402|FG000|Overall Study|Lost to Follow-up|12|||
155123394|NCT01945775|559883403|FG001|Overall Study|Lost to Follow-up|7|||
155123395|NCT01945775|559883402|FG000|Overall Study|Withdrawal by Subject|11|||
155123396|NCT01945775|559883403|FG001|Overall Study|Withdrawal by Subject|21|||
155123397|NCT01945775|559883402|FG000|Overall Study|Other|50|||
155123398|NCT01945775|559883403|FG001|Overall Study|Other|18|||
155123399|NCT02876328|559883404|FG000|Overall Study|Death|2|||
155123400|NCT02876328|559883405|FG001|Overall Study|Death|1|||
155123401|NCT02876328|559883406|FG002|Overall Study|Death|3|||
155123402|NCT02876328|559883407|FG003|Overall Study|Death|0|||
155123403|NCT02876328|559883408|FG004|Overall Study|Death|0|||
155123404|NCT02876328|559883409|FG005|Overall Study|Death|0|||
155123405|NCT02876328|559883410|FG006|Overall Study|Death|1|||
155123406|NCT02876328|559883411|FG007|Overall Study|Death|3|||
155123407|NCT02876328|559883412|FG008|Overall Study|Death|0|||
155123408|NCT02876328|559883413|FG009|Overall Study|Death|1|||
154921267|NCT01050998|559136172|FG004|Overall Study|Withdrawal by Subject|3|||
155123409|NCT02876328|559883414|FG010|Overall Study|Death|1|||
155123410|NCT02876328|559883415|FG011|Overall Study|Death|0|||
154921268|NCT01050998|559136168|FG000|Overall Study|Other|3|||
154921269|NCT01050998|559136169|FG001|Overall Study|Other|2|||
154921270|NCT01050998|559136170|FG002|Overall Study|Other|1|||
154921271|NCT01050998|559136171|FG003|Overall Study|Other|1|||
154921272|NCT01050998|559136172|FG004|Overall Study|Other|5|||
154921273|NCT01050998|559136168|FG000|Overall Study|Data integrity issues|0|||
154921274|NCT01050998|559136169|FG001|Overall Study|Data integrity issues|0|||
154921275|NCT01050998|559136170|FG002|Overall Study|Data integrity issues|1|||
154921276|NCT01050998|559136171|FG003|Overall Study|Data integrity issues|1|||
154921277|NCT01050998|559136172|FG004|Overall Study|Data integrity issues|4|||
154921278|NCT01428882|559136175|FG000|Overall Study|Lack of Efficacy|2|||
154921279|NCT01428882|559136176|FG001|Overall Study|Lack of Efficacy|7|||
154921280|NCT01428882|559136175|FG000|Overall Study|Protocol Violation|4|||
154921281|NCT01428882|559136176|FG001|Overall Study|Protocol Violation|3|||
154921282|NCT00429026|559136183|FG000|Overall Study|Inevaluable for response.|40|||
154921283|NCT01694849|559136184|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
154921284|NCT01694849|559136185|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
154921285|NCT01694849|559136186|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
154921286|NCT01694849|559136184|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
154921287|NCT01694849|559136185|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
154921288|NCT01694849|559136186|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
154921289|NCT01694849|559136184|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
154921290|NCT01694849|559136185|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
154921291|NCT01694849|559136186|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
154921292|NCT01694849|559136184|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
154921293|NCT01694849|559136185|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
154921294|NCT01694849|559136186|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
154921295|NCT01694849|559136184|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
154921296|NCT01694849|559136185|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
154921297|NCT01694849|559136186|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
154921298|NCT01694849|559136184|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
154921299|NCT01694849|559136185|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
154921300|NCT01694849|559136186|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
154921301|NCT01694849|559136184|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
154921302|NCT01694849|559136185|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
154921303|NCT01694849|559136186|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
154921304|NCT01694849|559136184|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
154921305|NCT01694849|559136185|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
155001096|NCT00710866|559427148|FG000|Overall Study|Lost to Follow-up|1|||
155123411|NCT02876328|559883416|FG012|Overall Study|Death|0|||
155123412|NCT02876328|559883417|FG013|Overall Study|Death|0|||
155123413|NCT02876328|559883418|FG014|Overall Study|Death|0|||
155001097|NCT00710866|559427149|FG001|Overall Study|Lost to Follow-up|0|||
155001098|NCT00710866|559427148|FG000|Overall Study|Failed to meet eligibility|1|||
155001099|NCT00710866|559427149|FG001|Overall Study|Failed to meet eligibility|1|||
155001100|NCT00908310|559427151|FG000|Overall Study|Death|37|||
155001101|NCT00908310|559427151|FG000|Overall Study|Withdrawal by Subject|7|||
155001102|NCT00908310|559427151|FG000|Overall Study|Lost to Follow-up|7|||
155001103|NCT00908310|559427151|FG000|Overall Study|Screening failure|5|||
155001104|NCT00908310|559427151|FG000|Overall Study|Other reasons|4|||
155001105|NCT00246324|559427154|FG000|Overall Study|Withdrawal by Subject|1|||
155001106|NCT03456453|559427155|FG000|Overall Study|Withdrawal by Subject|2|||
155001107|NCT03456453|559427156|FG001|Overall Study|Withdrawal by Subject|0|||
155001108|NCT03456453|559427155|FG000|Overall Study|Not released to community|1|||
155001109|NCT03456453|559427156|FG001|Overall Study|Not released to community|5|||
155001110|NCT03456453|559427155|FG000|Overall Study|Lost to Follow-up|0|||
155001111|NCT03456453|559427156|FG001|Overall Study|Lost to Follow-up|2|||
155001112|NCT00315731|559427159|FG000|Overall Study|Lost to Follow-up|1|||
155001113|NCT00315731|559427159|FG000|Overall Study|Death|5|||
155001114|NCT03316547|559427170|FG000|Overall Study|Death|3|||
155001115|NCT03316547|559427171|FG001|Overall Study|Death|1|||
155001116|NCT03316547|559427170|FG000|Overall Study|Lost to Follow-up|6|||
155001117|NCT03316547|559427171|FG001|Overall Study|Lost to Follow-up|6|||
155001118|NCT03316547|559427170|FG000|Overall Study|Withdrawal by Subject|3|||
155001119|NCT03316547|559427171|FG001|Overall Study|Withdrawal by Subject|2|||
155001120|NCT03316547|559427170|FG000|Overall Study|Transfer to another hospital|6|||
155001121|NCT03316547|559427171|FG001|Overall Study|Transfer to another hospital|4|||
155001122|NCT00278889|559427172|FG000|Overall Study|Withdrawal by Subject|0|||
155001123|NCT00278889|559427173|FG001|Overall Study|Withdrawal by Subject|5|||
155001124|NCT00278889|559427174|FG002|Overall Study|Withdrawal by Subject|3|||
155001125|NCT00278889|559427172|FG000|Overall Study|Lost to Follow-up|1|||
155001126|NCT00278889|559427173|FG001|Overall Study|Lost to Follow-up|1|||
155001127|NCT00278889|559427174|FG002|Overall Study|Lost to Follow-up|0|||
155001128|NCT00278889|559427172|FG000|Overall Study|Death|24|||
155001129|NCT00278889|559427173|FG001|Overall Study|Death|21|||
155001130|NCT00278889|559427174|FG002|Overall Study|Death|17|||
155001131|NCT03462459|559427175|FG000|Overall Study|Death|1|||
155001132|NCT03462459|559427176|FG001|Overall Study|Death|0|||
155001133|NCT03462459|559427175|FG000|Overall Study|Lack of Efficacy|2|||
155001134|NCT03462459|559427176|FG001|Overall Study|Lack of Efficacy|4|||
155001135|NCT03462459|559427175|FG000|Overall Study|Lost to Follow-up|1|||
155001136|NCT03462459|559427176|FG001|Overall Study|Lost to Follow-up|3|||
155001137|NCT03462459|559427175|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
155001138|NCT03462459|559427176|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
155001139|NCT03462459|559427175|FG000|Overall Study|Withdrawal by Subject|3|||
155001140|NCT03462459|559427176|FG001|Overall Study|Withdrawal by Subject|2|||
155001141|NCT03462459|559427175|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
155001142|NCT03462459|559427176|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
155001143|NCT02551666|559427178|FG000|Overall Study|Withdrawal by Subject|1|||
155001144|NCT02551666|559427179|FG001|Overall Study|Withdrawal by Subject|3|||
155001145|NCT02017015|559428952|FG000|Overall Study|Adverse Event|9|||
155001146|NCT02017015|559428952|FG000|Overall Study|Withdrawal by Subject|21|||
155001147|NCT02017015|559428952|FG000|Overall Study|Death|4|||
155001148|NCT02017015|559428952|FG000|Overall Study|Progressive Disease|31|||
155001149|NCT02017015|559428952|FG000|Overall Study|Non-compliance with study drug|2|||
155001150|NCT02017015|559428952|FG000|Overall Study|Physician Decision|2|||
155001151|NCT01277601|559428955|FG000|Overall Study|Adverse Event|5|||
155001152|NCT01277601|559428956|FG001|Overall Study|Adverse Event|3|||
155001153|NCT01277601|559428957|FG002|Overall Study|Adverse Event|0|||
155001154|NCT01277601|559428958|FG003|Overall Study|Adverse Event|7|||
155001155|NCT01277601|559428955|FG000|Overall Study|Withdrawal by Subject|18|||
155001156|NCT01277601|559428956|FG001|Overall Study|Withdrawal by Subject|21|||
155001157|NCT01277601|559428957|FG002|Overall Study|Withdrawal by Subject|8|||
155001158|NCT01277601|559428958|FG003|Overall Study|Withdrawal by Subject|17|||
155123414|NCT02876328|559883419|FG015|Overall Study|Death|0|||
155123415|NCT02876328|559883420|FG016|Overall Study|Death|1|||
155123416|NCT02876328|559883421|FG017|Overall Study|Death|1|||
155001159|NCT01277601|559428955|FG000|Overall Study|Lost to Follow-up|7|||
155001160|NCT01277601|559428956|FG001|Overall Study|Lost to Follow-up|9|||
155001161|NCT01277601|559428957|FG002|Overall Study|Lost to Follow-up|4|||
155001162|NCT01277601|559428958|FG003|Overall Study|Lost to Follow-up|2|||
155001163|NCT01277601|559428955|FG000|Overall Study|Physician Decision|3|||
155001164|NCT01277601|559428956|FG001|Overall Study|Physician Decision|5|||
155001165|NCT01277601|559428957|FG002|Overall Study|Physician Decision|1|||
155001166|NCT01277601|559428958|FG003|Overall Study|Physician Decision|6|||
155001167|NCT01277601|559428955|FG000|Overall Study|Pregnancy|2|||
155001168|NCT01277601|559428956|FG001|Overall Study|Pregnancy|2|||
155001169|NCT01277601|559428957|FG002|Overall Study|Pregnancy|4|||
155001170|NCT01277601|559428958|FG003|Overall Study|Pregnancy|1|||
155001171|NCT01277601|559428955|FG000|Overall Study|Noncompliance with Study Drug|1|||
155123417|NCT02876328|559883422|FG018|Overall Study|Death|0|||
155001172|NCT01277601|559428956|FG001|Overall Study|Noncompliance with Study Drug|3|||
155001173|NCT01277601|559428957|FG002|Overall Study|Noncompliance with Study Drug|2|||
155001174|NCT01277601|559428958|FG003|Overall Study|Noncompliance with Study Drug|0|||
155177993|NCT04418661|560091378|FG002|Overall Study|Progressive disease|6|||
155177994|NCT04418661|560091379|FG003|Overall Study|Progressive disease|11|||
155001175|NCT01277601|559428955|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
155001176|NCT01277601|559428956|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
155001177|NCT01277601|559428957|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
155001178|NCT01277601|559428958|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
155001179|NCT01277601|559428955|FG000|Overall Study|Protocol Violation|0|||
155001180|NCT01277601|559428956|FG001|Overall Study|Protocol Violation|2|||
155001181|NCT01277601|559428957|FG002|Overall Study|Protocol Violation|5|||
155001182|NCT01277601|559428958|FG003|Overall Study|Protocol Violation|0|||
155001183|NCT01277601|559428955|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
155001184|NCT01277601|559428956|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
155001185|NCT01277601|559428957|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
155001186|NCT01277601|559428958|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
155177995|NCT04418661|560091380|FG004|Overall Study|Progressive disease|1|||
154921306|NCT01694849|559136186|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
154921307|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
154921308|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
154921309|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
154921310|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
154921311|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
154921312|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
154921313|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
154921314|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
154921315|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
154921316|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
154921317|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
154921318|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
154921319|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
154921320|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
154921321|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
154921322|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
154921323|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
154921324|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
154921325|NCT00570492|559136191|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
154921326|NCT00570492|559136192|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
154921327|NCT00570492|559136193|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
154921328|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
154921329|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
154921330|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
154921331|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
154921332|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
154921333|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
154921334|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
154921335|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
154921336|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
154921337|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
154921338|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
154921339|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
154921340|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
154921341|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
154921342|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
154921343|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
154921344|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
154921345|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
154921346|NCT00570492|559136191|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
154921347|NCT00570492|559136192|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
154921348|NCT00570492|559136193|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
154921349|NCT00976989|559136194|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
154921350|NCT00976989|559136195|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155001187|NCT02260570|559428960|FG000|Overall Study|Withdrawal by Subject|2|||
155001188|NCT02260570|559428961|FG001|Overall Study|Withdrawal by Subject|1|||
155123418|NCT02876328|559883423|FG019|Overall Study|Death|0|||
155123419|NCT02876328|559883424|FG020|Overall Study|Death|0|||
155123420|NCT02876328|559883425|FG021|Overall Study|Death|1|||
155123421|NCT02876328|559883426|FG022|Overall Study|Death|0|||
155123422|NCT02876328|559883427|FG023|Overall Study|Death|0|||
154921351|NCT00976989|559136196|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
154921352|NCT00976989|559136194|FG000|Overall Study|Death|5|||
154921353|NCT00976989|559136195|FG001|Overall Study|Death|7|||
154921354|NCT00976989|559136196|FG002|Overall Study|Death|10|||
154921355|NCT00976989|559136194|FG000|Overall Study|Refused Treatment|4|||
154921356|NCT00976989|559136195|FG001|Overall Study|Refused Treatment|3|||
154921357|NCT00976989|559136196|FG002|Overall Study|Refused Treatment|5|||
154921358|NCT00976989|559136194|FG000|Overall Study|Failure to Return|2|||
154921359|NCT00976989|559136195|FG001|Overall Study|Failure to Return|1|||
154921360|NCT00976989|559136196|FG002|Overall Study|Failure to Return|0|||
154921361|NCT00976989|559136194|FG000|Overall Study|Recurrence of Disease|0|||
154921362|NCT00976989|559136195|FG001|Overall Study|Recurrence of Disease|1|||
154921363|NCT00976989|559136196|FG002|Overall Study|Recurrence of Disease|0|||
154921364|NCT00976989|559136194|FG000|Overall Study|Other|1|||
154921365|NCT00976989|559136195|FG001|Overall Study|Other|0|||
154921366|NCT00976989|559136196|FG002|Overall Study|Other|1|||
154921367|NCT00752206|559136199|FG000|Overall Study|Disease progression|8|||
154921368|NCT00752206|559136200|FG001|Overall Study|Disease progression|11|||
154921369|NCT00752206|559136199|FG000|Overall Study|Pregnancy|1|||
154921370|NCT00752206|559136200|FG001|Overall Study|Pregnancy|0|||
154921371|NCT01484691|559136201|FG000|Overall Study|Withdrawal by Subject|1|||
154921372|NCT01484691|559136202|FG001|Overall Study|Withdrawal by Subject|1|||
154921373|NCT01484691|559136203|FG002|Overall Study|Withdrawal by Subject|1|||
154921374|NCT01484691|559136201|FG000|Overall Study|Physician Decision|0|||
154921375|NCT01484691|559136202|FG001|Overall Study|Physician Decision|2|||
154921376|NCT01484691|559136203|FG002|Overall Study|Physician Decision|1|||
154921377|NCT04668157|559136208|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
154921378|NCT04668157|559136209|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
154921379|NCT04668157|559136208|FG000|Treatment Period (52 Weeks)|Other|0|||
154921380|NCT04668157|559136209|FG001|Treatment Period (52 Weeks)|Other|2|||
154921381|NCT03958045|559136210|FG000|Overall Study|Withdrawal by Subject|1|||
154921382|NCT05437211|559136215|FG000|Overall Study|Patient's decision|1|||
154921383|NCT05437211|559136216|FG001|Overall Study|Patient's decision|1|||
154921384|NCT00674440|559136217|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
154921385|NCT00674440|559136217|FG000|Overall Study|did not have surgery, so unevaluable|7|||
154921386|NCT00674440|559136217|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
154921387|NCT02221882|559136218|FG000|Overall Study|Withdrawal by Subject|0|||
154921388|NCT02221882|559136219|FG001|Overall Study|Withdrawal by Subject|0|||
154921389|NCT02221882|559136220|FG002|Overall Study|Withdrawal by Subject|4|||
154921390|NCT02221882|559136221|FG003|Overall Study|Withdrawal by Subject|2|||
154921391|NCT02221882|559136222|FG004|Overall Study|Withdrawal by Subject|2|||
154921392|NCT02221882|559136223|FG005|Overall Study|Withdrawal by Subject|2|||
154921393|NCT02221882|559136218|FG000|Overall Study|Death|0|||
154921394|NCT02221882|559136219|FG001|Overall Study|Death|1|||
154921395|NCT02221882|559136220|FG002|Overall Study|Death|0|||
154921396|NCT02221882|559136221|FG003|Overall Study|Death|0|||
154921397|NCT02221882|559136222|FG004|Overall Study|Death|0|||
154921398|NCT02221882|559136223|FG005|Overall Study|Death|0|||
154921399|NCT00796367|559136224|FG000|Overall Study|Adverse Event|6|||
154921400|NCT00796367|559136225|FG001|Overall Study|Adverse Event|4|||
154921401|NCT00796367|559136226|FG002|Overall Study|Adverse Event|7|||
154921402|NCT00796367|559136224|FG000|Overall Study|Lost to Follow-up|5|||
154921403|NCT00796367|559136225|FG001|Overall Study|Lost to Follow-up|4|||
154921404|NCT00796367|559136226|FG002|Overall Study|Lost to Follow-up|21|||
154921405|NCT00796367|559136224|FG000|Overall Study|Withdrawal by Subject|9|||
154921406|NCT00796367|559136225|FG001|Overall Study|Withdrawal by Subject|11|||
154921407|NCT00796367|559136226|FG002|Overall Study|Withdrawal by Subject|12|||
154921408|NCT00796367|559136224|FG000|Overall Study|Lack of Efficacy|2|||
154921409|NCT00796367|559136225|FG001|Overall Study|Lack of Efficacy|1|||
154921410|NCT00796367|559136226|FG002|Overall Study|Lack of Efficacy|0|||
154921411|NCT00796367|559136224|FG000|Overall Study|non compliance|3|||
154921412|NCT00796367|559136225|FG001|Overall Study|non compliance|1|||
154921413|NCT00796367|559136226|FG002|Overall Study|non compliance|1|||
154921414|NCT00796367|559136224|FG000|Overall Study|Pregnancy|1|||
154921415|NCT00796367|559136225|FG001|Overall Study|Pregnancy|0|||
154921416|NCT00796367|559136226|FG002|Overall Study|Pregnancy|1|||
154921417|NCT00796367|559136224|FG000|Overall Study|Requirement for restricted medication|2|||
154921418|NCT00796367|559136225|FG001|Overall Study|Requirement for restricted medication|0|||
154921419|NCT00796367|559136226|FG002|Overall Study|Requirement for restricted medication|2|||
154921420|NCT00796367|559136224|FG000|Overall Study|other|2|||
154921421|NCT00796367|559136225|FG001|Overall Study|other|4|||
154921422|NCT00796367|559136226|FG002|Overall Study|other|3|||
154921423|NCT04095039|559136232|FG000|Overall Study|Withdrawal by Subject|2|||
154921424|NCT04095039|559136233|FG001|Overall Study|Withdrawal by Subject|16|||
155123423|NCT02876328|559883404|FG000|Overall Study|Withdrawal by Subject|0|||
155123424|NCT02876328|559883405|FG001|Overall Study|Withdrawal by Subject|2|||
155123425|NCT02876328|559883406|FG002|Overall Study|Withdrawal by Subject|3|||
155123426|NCT02876328|559883407|FG003|Overall Study|Withdrawal by Subject|3|||
155123427|NCT02876328|559883408|FG004|Overall Study|Withdrawal by Subject|0|||
155123428|NCT02876328|559883409|FG005|Overall Study|Withdrawal by Subject|1|||
155123429|NCT02876328|559883410|FG006|Overall Study|Withdrawal by Subject|0|||
155123430|NCT02876328|559883411|FG007|Overall Study|Withdrawal by Subject|1|||
155123431|NCT02876328|559883412|FG008|Overall Study|Withdrawal by Subject|1|||
155123432|NCT02876328|559883413|FG009|Overall Study|Withdrawal by Subject|2|||
155123433|NCT02876328|559883414|FG010|Overall Study|Withdrawal by Subject|0|||
155123434|NCT02876328|559883415|FG011|Overall Study|Withdrawal by Subject|0|||
155123435|NCT02876328|559883416|FG012|Overall Study|Withdrawal by Subject|0|||
155123436|NCT02876328|559883417|FG013|Overall Study|Withdrawal by Subject|0|||
155123437|NCT02876328|559883418|FG014|Overall Study|Withdrawal by Subject|0|||
155123438|NCT02876328|559883419|FG015|Overall Study|Withdrawal by Subject|0|||
155123439|NCT02876328|559883420|FG016|Overall Study|Withdrawal by Subject|1|||
155123440|NCT02876328|559883421|FG017|Overall Study|Withdrawal by Subject|3|||
155123441|NCT02876328|559883422|FG018|Overall Study|Withdrawal by Subject|0|||
155123442|NCT02876328|559883423|FG019|Overall Study|Withdrawal by Subject|0|||
155123443|NCT02876328|559883424|FG020|Overall Study|Withdrawal by Subject|1|||
155123444|NCT02876328|559883425|FG021|Overall Study|Withdrawal by Subject|0|||
155123445|NCT02876328|559883426|FG022|Overall Study|Withdrawal by Subject|0|||
155123446|NCT02876328|559883427|FG023|Overall Study|Withdrawal by Subject|0|||
155123447|NCT02876328|559883404|FG000|Overall Study|Missed 12 Month Visit|15|||
155123448|NCT02876328|559883405|FG001|Overall Study|Missed 12 Month Visit|10|||
155123449|NCT02876328|559883406|FG002|Overall Study|Missed 12 Month Visit|11|||
155123450|NCT02876328|559883407|FG003|Overall Study|Missed 12 Month Visit|6|||
155123451|NCT02876328|559883408|FG004|Overall Study|Missed 12 Month Visit|10|||
155123452|NCT02876328|559883409|FG005|Overall Study|Missed 12 Month Visit|14|||
154921425|NCT04095039|559136232|FG000|Overall Study|Transplanted|21|||
154921426|NCT04095039|559136233|FG001|Overall Study|Transplanted|24|||
154921427|NCT04095039|559136232|FG000|Overall Study|Transferred to Non-study Facility|47|||
154921428|NCT04095039|559136233|FG001|Overall Study|Transferred to Non-study Facility|44|||
154921429|NCT04095039|559136232|FG000|Overall Study|Withdrawal from internvention target|0|||
154921430|NCT04095039|559136233|FG001|Overall Study|Withdrawal from internvention target|2|||
154921431|NCT04095039|559136232|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
154921432|NCT04095039|559136233|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
154921433|NCT04095039|559136232|FG000|Overall Study|Cacliphylaxis|0|||
154921434|NCT04095039|559136233|FG001|Overall Study|Cacliphylaxis|1|||
154921435|NCT04095039|559136232|FG000|Overall Study|Pregnancy|1|||
154921436|NCT04095039|559136233|FG001|Overall Study|Pregnancy|0|||
154921437|NCT04794491|559136234|FG000|Overall Study|Adverse Event|1|||
154921438|NCT04794491|559136234|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
154921439|NCT04794491|559136234|FG000|Overall Study|Noncompliance With Study Intervention|1|||
154921440|NCT04794491|559136234|FG000|Overall Study|Withdrawal by Subject|2|||
154921441|NCT01314261|559136237|FG000|Overall Study|Adverse Event|1|||
154921442|NCT01314261|559136238|FG001|Overall Study|Adverse Event|0|||
154921443|NCT01314261|559136239|FG002|Overall Study|Adverse Event|0|||
154921444|NCT01314261|559136240|FG003|Overall Study|Adverse Event|0|||
154921445|NCT01314261|559136237|FG000|Overall Study|Withdrawal by Subject|0|||
154921446|NCT01314261|559136238|FG001|Overall Study|Withdrawal by Subject|3|||
154921447|NCT01314261|559136239|FG002|Overall Study|Withdrawal by Subject|1|||
154921448|NCT01314261|559136240|FG003|Overall Study|Withdrawal by Subject|0|||
154921449|NCT01314261|559136237|FG000|Overall Study|Lost to Follow-up|1|||
154921450|NCT01314261|559136238|FG001|Overall Study|Lost to Follow-up|0|||
154921451|NCT01314261|559136239|FG002|Overall Study|Lost to Follow-up|2|||
154921452|NCT01314261|559136240|FG003|Overall Study|Lost to Follow-up|2|||
154921453|NCT01314261|559136237|FG000|Overall Study|Virologic Failure|0|||
154921454|NCT01314261|559136238|FG001|Overall Study|Virologic Failure|1|||
154921455|NCT01314261|559136239|FG002|Overall Study|Virologic Failure|0|||
154921456|NCT01314261|559136240|FG003|Overall Study|Virologic Failure|1|||
154921457|NCT02129192|559136241|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
154921458|NCT02129192|559136242|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
154921459|NCT01231620|559136244|FG000|Overall Study|Physician Decision|3|||
154921460|NCT01231620|559136245|FG001|Overall Study|Physician Decision|5|||
154921461|NCT01231620|559136246|FG002|Overall Study|Physician Decision|10|||
154921462|NCT01231620|559136244|FG000|Overall Study|Death|12|||
154921463|NCT01231620|559136245|FG001|Overall Study|Death|14|||
155123453|NCT02876328|559883410|FG006|Overall Study|Missed 12 Month Visit|3|||
154921464|NCT01231620|559136246|FG002|Overall Study|Death|11|||
154921465|NCT01231620|559136244|FG000|Overall Study|Adverse Event|2|||
154921466|NCT01231620|559136245|FG001|Overall Study|Adverse Event|2|||
154921467|NCT01231620|559136246|FG002|Overall Study|Adverse Event|1|||
155123454|NCT02876328|559883411|FG007|Overall Study|Missed 12 Month Visit|8|||
155123455|NCT02876328|559883412|FG008|Overall Study|Missed 12 Month Visit|9|||
155001189|NCT02260570|559428960|FG000|Overall Study|Physician Decision|1|||
155001190|NCT02260570|559428961|FG001|Overall Study|Physician Decision|1|||
155001191|NCT04034927|559428962|FG000|Overall Study|Adverse Event|4|||
155001192|NCT04034927|559428963|FG001|Overall Study|Adverse Event|9|||
155001193|NCT04034927|559428962|FG000|Overall Study|Death|0|||
155001194|NCT04034927|559428963|FG001|Overall Study|Death|1|||
155001195|NCT04034927|559428962|FG000|Overall Study|Withdrawal by Subject|0|||
155001196|NCT04034927|559428963|FG001|Overall Study|Withdrawal by Subject|3|||
155001197|NCT04034927|559428962|FG000|Overall Study|Still on Treatment|2|||
155001198|NCT04034927|559428963|FG001|Overall Study|Still on Treatment|1|||
155001199|NCT04034927|559428962|FG000|Overall Study|Other|1|||
155001200|NCT04034927|559428963|FG001|Overall Study|Other|1|||
155001201|NCT01753297|559428966|FG000|Overall Study|Lost to Follow-up|7|||
155001202|NCT01753297|559428967|FG001|Overall Study|Lost to Follow-up|2|||
155001203|NCT01753297|559428966|FG000|Overall Study|Withdrawal by Subject|26|||
155001204|NCT01753297|559428967|FG001|Overall Study|Withdrawal by Subject|23|||
155001205|NCT01753297|559428966|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
155001206|NCT01753297|559428967|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
155001207|NCT01753297|559428966|FG000|Overall Study|Death|0|||
155001208|NCT01753297|559428967|FG001|Overall Study|Death|2|||
155001209|NCT01753297|559428966|FG000|Overall Study|Did not attend end of study visit|7|||
155001210|NCT01753297|559428967|FG001|Overall Study|Did not attend end of study visit|8|||
155001211|NCT00230178|559428968|FG000|Overall Study|Adverse Event|1|||
155001212|NCT00230178|559428969|FG001|Overall Study|Adverse Event|5|||
155001213|NCT00230178|559428970|FG002|Overall Study|Adverse Event|2|||
155001214|NCT00230178|559428968|FG000|Overall Study|Withdrawal by Subject|0|||
155001215|NCT00230178|559428969|FG001|Overall Study|Withdrawal by Subject|0|||
155001216|NCT00230178|559428970|FG002|Overall Study|Withdrawal by Subject|1|||
155001217|NCT00230178|559428968|FG000|Overall Study|Various other reasons|3|||
155001218|NCT00230178|559428969|FG001|Overall Study|Various other reasons|2|||
155001219|NCT00230178|559428970|FG002|Overall Study|Various other reasons|4|||
155001220|NCT02252406|559428971|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
155001221|NCT02252406|559428972|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
155123456|NCT02876328|559883413|FG009|Overall Study|Missed 12 Month Visit|5|||
155123457|NCT02876328|559883414|FG010|Overall Study|Missed 12 Month Visit|4|||
155123458|NCT02876328|559883415|FG011|Overall Study|Missed 12 Month Visit|1|||
155123459|NCT02876328|559883416|FG012|Overall Study|Missed 12 Month Visit|5|||
155123460|NCT02876328|559883417|FG013|Overall Study|Missed 12 Month Visit|4|||
155123461|NCT02876328|559883418|FG014|Overall Study|Missed 12 Month Visit|4|||
155123462|NCT02876328|559883419|FG015|Overall Study|Missed 12 Month Visit|4|||
155123463|NCT02876328|559883420|FG016|Overall Study|Missed 12 Month Visit|3|||
155123464|NCT02876328|559883421|FG017|Overall Study|Missed 12 Month Visit|6|||
155123465|NCT02876328|559883422|FG018|Overall Study|Missed 12 Month Visit|2|||
155123466|NCT02876328|559883423|FG019|Overall Study|Missed 12 Month Visit|2|||
155123467|NCT02876328|559883424|FG020|Overall Study|Missed 12 Month Visit|11|||
155123468|NCT02876328|559883425|FG021|Overall Study|Missed 12 Month Visit|7|||
155123469|NCT02876328|559883426|FG022|Overall Study|Missed 12 Month Visit|1|||
155123470|NCT02876328|559883427|FG023|Overall Study|Missed 12 Month Visit|0|||
155123471|NCT01996592|559883439|FG000|Overall Study|no response to text/no diary entry|32|||
155123472|NCT01996592|559883439|FG000|Overall Study|change in surgical date|4|||
155123473|NCT01996592|559883439|FG000|Overall Study|Withdrawal by Subject|5|||
155123474|NCT01996592|559883439|FG000|Overall Study|change in mode of delivery|4|||
155123475|NCT02759315|559883442|FG000|Overall Study|Adverse Event|0|||
155123476|NCT02759315|559883443|FG001|Overall Study|Adverse Event|0|||
155123477|NCT02759315|559883444|FG002|Overall Study|Adverse Event|0|||
155123478|NCT02759315|559883445|FG003|Overall Study|Adverse Event|1|||
155123479|NCT02759315|559883446|FG004|Overall Study|Adverse Event|0|||
155123480|NCT02759315|559883442|FG000|Overall Study|Death|0|||
155123481|NCT02759315|559883443|FG001|Overall Study|Death|0|||
155001222|NCT02252406|559428971|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
155123482|NCT02759315|559883444|FG002|Overall Study|Death|1|||
155123483|NCT02759315|559883445|FG003|Overall Study|Death|0|||
155001223|NCT02252406|559428972|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
155001224|NCT02252406|559428971|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
155001225|NCT02252406|559428972|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
155001226|NCT02252406|559428971|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
155001227|NCT02252406|559428972|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
155001228|NCT02252406|559428971|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
155001229|NCT02252406|559428972|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
155123484|NCT02759315|559883446|FG004|Overall Study|Death|0|||
155123485|NCT02759315|559883442|FG000|Overall Study|Lost to Follow-up|2|||
155123486|NCT02759315|559883443|FG001|Overall Study|Lost to Follow-up|0|||
155123487|NCT02759315|559883444|FG002|Overall Study|Lost to Follow-up|4|||
155123488|NCT02759315|559883445|FG003|Overall Study|Lost to Follow-up|0|||
155123489|NCT02759315|559883446|FG004|Overall Study|Lost to Follow-up|0|||
155123490|NCT02759315|559883442|FG000|Overall Study|Protocol Violation|0|||
155123491|NCT02759315|559883443|FG001|Overall Study|Protocol Violation|1|||
155177996|NCT04418661|560091381|FG005|Overall Study|Progressive disease|12|||
155177997|NCT04418661|560091376|FG000|Overall Study|Withdrawal by Subject|0|||
155177998|NCT04418661|560091377|FG001|Overall Study|Withdrawal by Subject|1|||
155177999|NCT04418661|560091378|FG002|Overall Study|Withdrawal by Subject|0|||
155178000|NCT04418661|560091379|FG003|Overall Study|Withdrawal by Subject|1|||
155178001|NCT04418661|560091380|FG004|Overall Study|Withdrawal by Subject|0|||
155178002|NCT04418661|560091381|FG005|Overall Study|Withdrawal by Subject|0|||
155178003|NCT04418661|560091376|FG000|Overall Study|Other|0|||
155178004|NCT04418661|560091377|FG001|Overall Study|Other|0|||
155178005|NCT04418661|560091378|FG002|Overall Study|Other|1|||
155178006|NCT04418661|560091379|FG003|Overall Study|Other|3|||
155178007|NCT04418661|560091380|FG004|Overall Study|Other|0|||
155178008|NCT04418661|560091381|FG005|Overall Study|Other|1|||
155178009|NCT00713310|560091383|FG000|Overall Study|Adverse Event|5|||
155178010|NCT00713310|560091384|FG001|Overall Study|Adverse Event|2|||
155178011|NCT00713310|560091383|FG000|Overall Study|Lack of Efficacy|0|||
155178012|NCT00713310|560091384|FG001|Overall Study|Lack of Efficacy|2|||
155178013|NCT00713310|560091383|FG000|Overall Study|Withdrawal by Subject|0|||
155178014|NCT00713310|560091384|FG001|Overall Study|Withdrawal by Subject|2|||
155178015|NCT00992589|560091385|FG000|Open-Label Phase|Adverse Event|4|||
155178016|NCT00992589|560091386|FG001|Open-Label Phase|Adverse Event|0|||
155178017|NCT00992589|560091387|FG002|Open-Label Phase|Adverse Event|0|||
155178018|NCT00992589|560091388|FG003|Open-Label Phase|Adverse Event|0|||
155178019|NCT00992589|560091385|FG000|Open-Label Phase|Withdrawal by Subject|20|||
155178020|NCT00992589|560091386|FG001|Open-Label Phase|Withdrawal by Subject|0|||
155001230|NCT00794339|559428975|FG000|Overall Study|Withdrawal by Subject|3|||
155001231|NCT00794339|559428975|FG000|Overall Study|Ineligible|4|||
155001232|NCT00794339|559428975|FG000|Overall Study|Tx prior to ATSM|3|||
155001233|NCT00794339|559428975|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
155001234|NCT00794339|559428975|FG000|Overall Study|Tx not per protocol|1|||
155001235|NCT02952586|559428978|FG000|Lead-In Phase (7 Days)|Death|0|||
155001236|NCT02952586|559428979|FG001|Lead-In Phase (7 Days)|Death|1|||
155001237|NCT02952586|559428978|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
155001238|NCT02952586|559428979|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
155001239|NCT02952586|559428978|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
155001240|NCT02952586|559428979|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
155001241|NCT02952586|559428978|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
155001242|NCT02952586|559428979|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
155001243|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
155001244|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
155001245|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
155001246|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
155001247|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
155001248|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
155001249|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
155001250|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
155001251|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
155001252|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
155001253|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
155001254|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
155001255|NCT02952586|559428978|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
155001256|NCT02952586|559428979|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
155001257|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Death|3|||
155001258|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Death|8|||
155001259|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
155001260|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
155001261|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
155001262|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
155001263|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
155001264|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
155001265|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
155178021|NCT00992589|560091387|FG002|Open-Label Phase|Withdrawal by Subject|0|||
155178022|NCT00992589|560091388|FG003|Open-Label Phase|Withdrawal by Subject|0|||
155178023|NCT00992589|560091385|FG000|Open-Label Phase|Lost to Follow-up|1|||
155001266|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
155001267|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
155001268|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
155001269|NCT02952586|559428978|FG000|CRT for Cisplatin (63 Days)|Other|1|||
155001270|NCT02952586|559428979|FG001|CRT for Cisplatin (63 Days)|Other|1|||
155001271|NCT02952586|559428978|FG000|CRT for IMRT (63 Days)|Death|5|||
155178024|NCT00992589|560091386|FG001|Open-Label Phase|Lost to Follow-up|0|||
155178025|NCT00992589|560091387|FG002|Open-Label Phase|Lost to Follow-up|0|||
155178026|NCT00992589|560091388|FG003|Open-Label Phase|Lost to Follow-up|0|||
155178027|NCT00992589|560091385|FG000|Open-Label Phase|Protocol Violation|3|||
155001272|NCT02952586|559428979|FG001|CRT for IMRT (63 Days)|Death|8|||
155001273|NCT02952586|559428978|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
155001274|NCT02952586|559428979|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
155001275|NCT02952586|559428978|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
155001276|NCT02952586|559428979|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
155001277|NCT02952586|559428978|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
155001278|NCT02952586|559428979|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
155001279|NCT02952586|559428978|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
155001280|NCT02952586|559428979|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
155001281|NCT02952586|559428978|FG000|CRT for IMRT (63 Days)|Other|1|||
155001282|NCT02952586|559428979|FG001|CRT for IMRT (63 Days)|Other|0|||
155001283|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Death|17|||
155001284|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Death|11|||
155001285|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
155001286|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
155001287|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
155001288|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
155001289|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
155001290|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
155001291|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
155001292|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
155001293|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
155001294|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
155001295|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
155001296|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
155001297|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
155001298|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
155001299|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Other|2|||
155001300|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Other|1|||
155001301|NCT02952586|559428978|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
155001302|NCT02952586|559428979|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
155001303|NCT02952586|559428978|FG000|Follow-Up Phase (90 Days)|Death|12|||
155001304|NCT02952586|559428979|FG001|Follow-Up Phase (90 Days)|Death|10|||
155001305|NCT02952586|559428978|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
155001306|NCT02952586|559428979|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
155001307|NCT02952586|559428978|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
155001308|NCT02952586|559428979|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
155001309|NCT02952586|559428978|FG000|Follow-Up Phase (90 Days)|Other|7|||
155001310|NCT02952586|559428979|FG001|Follow-Up Phase (90 Days)|Other|5|||
155001311|NCT02952586|559428978|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
155001312|NCT02952586|559428979|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
155001313|NCT02952586|559428978|FG000|LT Follow-up (up to 45 Months)|Death|51|||
155001314|NCT02952586|559428979|FG001|LT Follow-up (up to 45 Months)|Death|31|||
155001315|NCT02952586|559428978|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
155001316|NCT02952586|559428979|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
155001317|NCT02952586|559428978|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
155001318|NCT02952586|559428979|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
155001319|NCT02952586|559428978|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
155001320|NCT02952586|559428979|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
155001321|NCT00492778|559428980|FG000|Overall Study|Ineligible by Pathology Review|8|||
155001322|NCT00492778|559428981|FG001|Overall Study|Ineligible by Pathology Review|1|||
155001323|NCT04414618|559428986|FG000|Overall Study|Death|3|||
155001324|NCT04414618|559428987|FG001|Overall Study|Death|3|||
155001325|NCT04414618|559428986|FG000|Overall Study|Withdrawal by Subject|2|||
155001326|NCT04414618|559428987|FG001|Overall Study|Withdrawal by Subject|1|||
155001327|NCT04414618|559428986|FG000|Overall Study|Lost to Follow-up|2|||
155001328|NCT04414618|559428987|FG001|Overall Study|Lost to Follow-up|3|||
155001329|NCT04414618|559428986|FG000|Overall Study|Physician Decision|1|||
155001330|NCT04414618|559428987|FG001|Overall Study|Physician Decision|0|||
155001331|NCT00362336|559428988|FG000|Overall Study|Serious Adverse Event|1|||
155001332|NCT00362336|559428989|FG001|Overall Study|Serious Adverse Event|0|||
155001333|NCT00362336|559428990|FG002|Overall Study|Serious Adverse Event|1|||
155001334|NCT00362336|559428988|FG000|Overall Study|Protocol Violation|0|||
155123492|NCT02759315|559883444|FG002|Overall Study|Protocol Violation|0|||
155123493|NCT02759315|559883445|FG003|Overall Study|Protocol Violation|0|||
155123494|NCT02759315|559883446|FG004|Overall Study|Protocol Violation|0|||
155001335|NCT00362336|559428989|FG001|Overall Study|Protocol Violation|0|||
155001336|NCT00362336|559428990|FG002|Overall Study|Protocol Violation|1|||
155001337|NCT00362336|559428988|FG000|Overall Study|Lost to Follow-up|6|||
155001338|NCT00362336|559428989|FG001|Overall Study|Lost to Follow-up|4|||
155001339|NCT00362336|559428990|FG002|Overall Study|Lost to Follow-up|0|||
155123495|NCT02759315|559883442|FG000|Overall Study|Study terminated prior to completion|2|||
154921468|NCT01231620|559136244|FG000|Overall Study|Withdrawal by Subject|6|||
154921469|NCT01231620|559136245|FG001|Overall Study|Withdrawal by Subject|6|||
154921470|NCT01231620|559136246|FG002|Overall Study|Withdrawal by Subject|8|||
154921471|NCT01231620|559136244|FG000|Overall Study|Lost to Follow-up|3|||
154921472|NCT01231620|559136245|FG001|Overall Study|Lost to Follow-up|4|||
154921473|NCT01231620|559136246|FG002|Overall Study|Lost to Follow-up|9|||
154921474|NCT04557189|559136255|FG000|Overall Study|Adverse Event|0|||
154921475|NCT04557189|559136256|FG001|Overall Study|Adverse Event|1|||
154921476|NCT04557189|559136255|FG000|Overall Study|Lost to Follow-up|1|||
154921477|NCT04557189|559136256|FG001|Overall Study|Lost to Follow-up|1|||
154921478|NCT04557189|559136255|FG000|Overall Study|Withdrawal by Subject|2|||
154921479|NCT04557189|559136256|FG001|Overall Study|Withdrawal by Subject|1|||
154921480|NCT04557189|559136255|FG000|Overall Study|Reason not Specified|3|||
154921481|NCT04557189|559136256|FG001|Overall Study|Reason not Specified|6|||
154921482|NCT01241591|559137983|FG000|Overall Study|Lack of Efficacy|5|||
154921483|NCT01241591|559137984|FG001|Overall Study|Lack of Efficacy|2|||
154921484|NCT01241591|559137985|FG002|Overall Study|Lack of Efficacy|2|||
154921485|NCT01241591|559137986|FG003|Overall Study|Lack of Efficacy|3|||
154921486|NCT01241591|559137983|FG000|Overall Study|Protocol Violation|5|||
154921487|NCT01241591|559137984|FG001|Overall Study|Protocol Violation|2|||
154921488|NCT01241591|559137985|FG002|Overall Study|Protocol Violation|3|||
154921489|NCT01241591|559137986|FG003|Overall Study|Protocol Violation|0|||
154921490|NCT01241591|559137983|FG000|Overall Study|Lost to Follow-up|1|||
154921491|NCT01241591|559137984|FG001|Overall Study|Lost to Follow-up|2|||
154921492|NCT01241591|559137985|FG002|Overall Study|Lost to Follow-up|2|||
154921493|NCT01241591|559137986|FG003|Overall Study|Lost to Follow-up|2|||
154921494|NCT01241591|559137983|FG000|Overall Study|Screen Failure|3|||
154921495|NCT01241591|559137984|FG001|Overall Study|Screen Failure|2|||
154921496|NCT01241591|559137985|FG002|Overall Study|Screen Failure|1|||
154921497|NCT01241591|559137986|FG003|Overall Study|Screen Failure|0|||
154921498|NCT01241591|559137983|FG000|Overall Study|Withdrawal by Subject|6|||
154921499|NCT01241591|559137984|FG001|Overall Study|Withdrawal by Subject|4|||
154921500|NCT01241591|559137985|FG002|Overall Study|Withdrawal by Subject|2|||
154921501|NCT01241591|559137986|FG003|Overall Study|Withdrawal by Subject|2|||
154921502|NCT01241591|559137983|FG000|Overall Study|Other|0|||
154921503|NCT01241591|559137984|FG001|Overall Study|Other|1|||
154921504|NCT01241591|559137985|FG002|Overall Study|Other|0|||
154921505|NCT01241591|559137986|FG003|Overall Study|Other|1|||
154921506|NCT01241591|559137983|FG000|Overall Study|Adverse Event|3|||
154921507|NCT01241591|559137984|FG001|Overall Study|Adverse Event|11|||
154921508|NCT01241591|559137985|FG002|Overall Study|Adverse Event|12|||
154921509|NCT01241591|559137986|FG003|Overall Study|Adverse Event|4|||
154921510|NCT02815540|559137991|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
154921511|NCT00726882|559137992|FG000|Overall Study|Withdrawal by Subject|5|||
154921512|NCT00726882|559137992|FG000|Overall Study|Lost to Follow-up|7|||
154921513|NCT00726882|559137992|FG000|Overall Study|Other|10|||
154921514|NCT00594568|559137993|FG000|Initial Treatment|Adverse Event|51|||
154921515|NCT00594568|559137994|FG001|Initial Treatment|Adverse Event|121|||
154921516|NCT00594568|559137995|FG002|Initial Treatment|Adverse Event|144|||
154921517|NCT00594568|559137993|FG000|Initial Treatment|Death|6|||
154921518|NCT00594568|559137994|FG001|Initial Treatment|Death|11|||
154921519|NCT00594568|559137995|FG002|Initial Treatment|Death|15|||
154921520|NCT00594568|559137993|FG000|Initial Treatment|Lost to Follow-up|4|||
154921521|NCT00594568|559137994|FG001|Initial Treatment|Lost to Follow-up|1|||
154921522|NCT00594568|559137995|FG002|Initial Treatment|Lost to Follow-up|4|||
154921523|NCT00594568|559137993|FG000|Initial Treatment|Physician Decision|3|||
154921524|NCT00594568|559137994|FG001|Initial Treatment|Physician Decision|2|||
154921525|NCT00594568|559137995|FG002|Initial Treatment|Physician Decision|4|||
154921526|NCT00594568|559137993|FG000|Initial Treatment|Protocol Violation|2|||
154921527|NCT00594568|559137994|FG001|Initial Treatment|Protocol Violation|2|||
154921528|NCT00594568|559137995|FG002|Initial Treatment|Protocol Violation|5|||
154921529|NCT00594568|559137993|FG000|Initial Treatment|Withdrawal by Subject|25|||
154921530|NCT00594568|559137994|FG001|Initial Treatment|Withdrawal by Subject|31|||
154921531|NCT00594568|559137995|FG002|Initial Treatment|Withdrawal by Subject|46|||
154921532|NCT00594568|559137993|FG000|Initial Treatment|Sponsor decision|193|||
154921533|NCT00594568|559137994|FG001|Initial Treatment|Sponsor decision|142|||
154921534|NCT00594568|559137995|FG002|Initial Treatment|Sponsor decision|147|||
154921535|NCT00594568|559137993|FG000|Initial Treatment|Caregiver decision|21|||
154921536|NCT00594568|559137994|FG001|Initial Treatment|Caregiver decision|36|||
154921537|NCT00594568|559137995|FG002|Initial Treatment|Caregiver decision|36|||
154921538|NCT00594568|559137993|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
154921539|NCT00594568|559137994|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
154921540|NCT00594568|559137995|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
154921541|NCT00594568|559137993|FG000|Initial Treatment|Entry criteria exclusion|0|||
154921542|NCT00594568|559137994|FG001|Initial Treatment|Entry criteria exclusion|1|||
155001340|NCT00362336|559428988|FG000|Overall Study|Withdrawal by Subject|3|||
155001341|NCT00362336|559428989|FG001|Overall Study|Withdrawal by Subject|3|||
155001342|NCT00362336|559428990|FG002|Overall Study|Withdrawal by Subject|1|||
155001343|NCT00658879|559428991|FG000|Overall Study|Protocol Violation|1|||
155123496|NCT02759315|559883443|FG001|Overall Study|Study terminated prior to completion|0|||
155123497|NCT02759315|559883444|FG002|Overall Study|Study terminated prior to completion|5|||
155123498|NCT02759315|559883445|FG003|Overall Study|Study terminated prior to completion|0|||
155123499|NCT02759315|559883446|FG004|Overall Study|Study terminated prior to completion|1|||
155123500|NCT01406015|559883447|FG000|Overall Study|Withdrawal by Subject|3|||
155123501|NCT01406015|559883448|FG001|Overall Study|Withdrawal by Subject|3|||
155123502|NCT00787137|559883449|FG000|Overall Study|Study Termination|0|||
155123503|NCT00787137|559883450|FG001|Overall Study|Study Termination|0|||
155123504|NCT00787137|559883451|FG002|Overall Study|Study Termination|1|||
155123505|NCT00554099|559883455|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
155123506|NCT00554099|559883456|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
155123507|NCT00554099|559883457|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
155123508|NCT00554099|559883455|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
155123509|NCT00554099|559883456|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
155123510|NCT00554099|559883457|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
155123511|NCT00554099|559883455|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155123512|NCT00554099|559883456|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155123513|NCT00554099|559883457|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
155123514|NCT00554099|559883455|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
155123515|NCT00554099|559883456|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
155123516|NCT00554099|559883457|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
155123517|NCT00554099|559883455|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
155123518|NCT00554099|559883456|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
155123519|NCT00554099|559883457|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
155123520|NCT00554099|559883455|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155123521|NCT00554099|559883456|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
155123522|NCT00554099|559883457|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155123523|NCT00554099|559883455|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
155123524|NCT00554099|559883456|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
155001344|NCT01399658|559428992|FG000|Overall Study|Ineligible|1|||
155001345|NCT01399658|559428992|FG000|Overall Study|Machine Technical Issue|3|||
155001346|NCT01399658|559428992|FG000|Overall Study|Alternative therapy|1|||
155001347|NCT01399658|559428992|FG000|Overall Study|No reason given|1|||
155001348|NCT00796107|559428998|FG000|Overall Study|Lack of Efficacy|1|||
155001349|NCT00796107|559428998|FG000|Overall Study|Progressive Disease|5|||
155001350|NCT02681510|559429003|FG000|Overall Study|Withdrawal by Subject|1|||
155001351|NCT02681510|559429003|FG000|Overall Study|Lost to Follow-up|9|||
155001352|NCT04315506|559429008|FG000|Overall Study|Lost to Follow-up|74|||
155001353|NCT04315506|559429009|FG001|Overall Study|Lost to Follow-up|82|||
155001354|NCT04315506|559429008|FG000|Overall Study|Withdrawal by Subject|8|||
155001355|NCT04315506|559429009|FG001|Overall Study|Withdrawal by Subject|8|||
155001356|NCT04315506|559429008|FG000|Overall Study|Physician Decision|0|||
155001357|NCT04315506|559429009|FG001|Overall Study|Physician Decision|1|||
155001358|NCT02661217|559429012|FG000|Overall Study|Physician Decision|12|||
155001359|NCT02661217|559429013|FG001|Overall Study|Physician Decision|15|||
155001360|NCT02661217|559429012|FG000|Overall Study|Lost to Follow-up|1|||
155001361|NCT02661217|559429013|FG001|Overall Study|Lost to Follow-up|4|||
155001362|NCT02661217|559429012|FG000|Overall Study|Protocol Deviation|0|||
155001363|NCT02661217|559429013|FG001|Overall Study|Protocol Deviation|4|||
155001364|NCT02661217|559429012|FG000|Overall Study|Non-compliance with study treatment|5|||
155001365|NCT02661217|559429013|FG001|Overall Study|Non-compliance with study treatment|5|||
155001366|NCT02661217|559429012|FG000|Overall Study|Death|21|||
155001367|NCT02661217|559429013|FG001|Overall Study|Death|15|||
155001368|NCT02661217|559429012|FG000|Overall Study|Adverse Event|10|||
155001369|NCT02661217|559429013|FG001|Overall Study|Adverse Event|8|||
155001370|NCT02661217|559429012|FG000|Overall Study|Withdrawal by Subject|15|||
155001371|NCT02661217|559429013|FG001|Overall Study|Withdrawal by Subject|19|||
155001372|NCT02661217|559429012|FG000|Overall Study|Did not enter follow-up epoch|7|||
155123525|NCT00554099|559883457|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
155123526|NCT00554099|559883455|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
155123527|NCT00554099|559883456|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
155123528|NCT00554099|559883457|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
155178028|NCT00992589|560091386|FG001|Open-Label Phase|Protocol Violation|0|||
155123529|NCT00554099|559883455|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
155001373|NCT02661217|559429013|FG001|Overall Study|Did not enter follow-up epoch|10|||
155001374|NCT02661217|559429012|FG000|Overall Study|Death - no study drug received|1|||
155001375|NCT02661217|559429013|FG001|Overall Study|Death - no study drug received|2|||
155001376|NCT02661217|559429012|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
155001377|NCT02661217|559429013|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
155001378|NCT02075515|559429016|FG000|Overall Study|Serious Adverse Event|1|||
155001379|NCT02075515|559429017|FG001|Overall Study|Serious Adverse Event|1|||
155001380|NCT02075515|559429018|FG002|Overall Study|Serious Adverse Event|1|||
155001381|NCT02075515|559429016|FG000|Overall Study|Non-Serious Adverse Event|0|||
155001382|NCT02075515|559429017|FG001|Overall Study|Non-Serious Adverse Event|1|||
155001383|NCT02075515|559429018|FG002|Overall Study|Non-Serious Adverse Event|0|||
155001384|NCT02075515|559429016|FG000|Overall Study|Withdrawal by Subject|2|||
155001385|NCT02075515|559429017|FG001|Overall Study|Withdrawal by Subject|0|||
155001386|NCT02075515|559429018|FG002|Overall Study|Withdrawal by Subject|1|||
155001387|NCT02075515|559429016|FG000|Overall Study|Lost to Follow-up|1|||
155001388|NCT02075515|559429017|FG001|Overall Study|Lost to Follow-up|3|||
155001389|NCT02075515|559429018|FG002|Overall Study|Lost to Follow-up|6|||
155001390|NCT02806024|559429027|FG000|Overall Study|Night Delivery|1|||
155001391|NCT02806024|559429028|FG001|Overall Study|Night Delivery|1|||
155001392|NCT02806024|559429027|FG000|Overall Study|DVT during antepartum admission|0|||
155001393|NCT02806024|559429028|FG001|Overall Study|DVT during antepartum admission|1|||
155001394|NCT00626561|559429029|FG000|Overall Study|Withdrawal by Subject|2|||
155001395|NCT00626561|559429029|FG000|Overall Study|Disease Progression|2|||
155001396|NCT01372748|559429034|FG000|Overall Study|Lost to Follow-up|16|||
155001397|NCT01372748|559429035|FG001|Overall Study|Lost to Follow-up|34|||
155001398|NCT01372748|559429034|FG000|Overall Study|Withdrawal by Subject|7|||
155001399|NCT01372748|559429035|FG001|Overall Study|Withdrawal by Subject|5|||
155001400|NCT00134901|559429036|FG000|Overall Study|Lost to Follow-up|5|||
155001401|NCT00134901|559429037|FG001|Overall Study|Lost to Follow-up|5|||
155001402|NCT00134901|559429036|FG000|Overall Study|discontinued intervention|12|||
155001403|NCT00134901|559429037|FG001|Overall Study|discontinued intervention|10|||
155001404|NCT00606632|559429038|FG000|Overall Study|Withdrawal by Subject|13|||
155001405|NCT00606632|559429038|FG000|Overall Study|Miscellaneous reasons|9|||
155001406|NCT04238650|559429039|FG000|Overall Study|Withdrawal by Subject|0|||
155001407|NCT04238650|559429040|FG001|Overall Study|Withdrawal by Subject|1|||
155001408|NCT00214383|559429043|FG000|Overall Study|Lost to Follow-up|16|||
155001409|NCT00214383|559429044|FG001|Overall Study|Lost to Follow-up|26|||
155001410|NCT04152291|559429045|FG000|Overall Study|Covid-19 restrictions|27|||
155001411|NCT04152291|559429045|FG000|Overall Study|Withdrawal by Subject|3|||
155001412|NCT03597295|559429046|FG000|Overall Study|Death|70|||
155001413|NCT03597295|559429046|FG000|Overall Study|Lost to Follow-up|7|||
155001414|NCT05124691|559429047|FG000|Phase II|Eligibility criteria|0|||
155123530|NCT00554099|559883456|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
155123531|NCT00554099|559883457|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
155123532|NCT03464422|559883458|FG000|Overall Study|Lost to Follow-up|2|||
155123533|NCT03464422|559883458|FG000|Overall Study|Withdrawal by Subject|2|||
155123534|NCT01628367|559883462|FG000|Overall Study|Adverse Event|1|||
155123535|NCT01628367|559883463|FG001|Overall Study|Adverse Event|0|||
155123536|NCT04957758|559883466|FG000|Overall Study|Adverse Event|1|||
155123537|NCT04957758|559883467|FG001|Overall Study|Adverse Event|0|||
155123538|NCT04957758|559883466|FG000|Overall Study|Lost to Follow-up|0|||
155123539|NCT04957758|559883467|FG001|Overall Study|Lost to Follow-up|2|||
155123540|NCT04957758|559883466|FG000|Overall Study|Withdrawal by Subject|4|||
155123541|NCT04957758|559883467|FG001|Overall Study|Withdrawal by Subject|2|||
155123542|NCT04957758|559883466|FG000|Overall Study|Protocol Violation|0|||
155123543|NCT04957758|559883467|FG001|Overall Study|Protocol Violation|1|||
155123544|NCT03353922|559883468|FG000|Overall Study|Withdrawal by Subject|1|||
155123545|NCT03353922|559883469|FG001|Overall Study|Withdrawal by Subject|0|||
155123546|NCT03353922|559883470|FG002|Overall Study|Withdrawal by Subject|1|||
155123547|NCT03353922|559883471|FG003|Overall Study|Withdrawal by Subject|1|||
155001415|NCT05124691|559429048|FG001|Phase II|Eligibility criteria|1|||
155001416|NCT05124691|559429049|FG002|Phase II|Eligibility criteria|0|||
155001417|NCT05124691|559429047|FG000|Phase II|Withdrawal by Subject|6|||
155001418|NCT05124691|559429048|FG001|Phase II|Withdrawal by Subject|2|||
155001419|NCT05124691|559429049|FG002|Phase II|Withdrawal by Subject|3|||
155001420|NCT05124691|559429047|FG000|Phase III|Withdrawal by Subject|6|||
155001421|NCT05124691|559429048|FG001|Phase III|Withdrawal by Subject|4|||
155001422|NCT05124691|559429049|FG002|Phase III|Withdrawal by Subject|4|||
155001423|NCT05124691|559429047|FG000|Phase III|Lost to Follow-up|1|||
155001424|NCT05124691|559429048|FG001|Phase III|Lost to Follow-up|0|||
155001425|NCT05124691|559429049|FG002|Phase III|Lost to Follow-up|0|||
155001426|NCT03837743|559429055|FG000|Overall Study|Adverse Event|1|||
155001427|NCT03837743|559429055|FG000|Overall Study|Withdrawal by Subject|2|||
155001428|NCT00252239|559429056|FG000|Overall Study|Withdrawal by Subject|1|||
155123548|NCT03353922|559883472|FG004|Overall Study|Withdrawal by Subject|0|||
155123549|NCT03353922|559883473|FG005|Overall Study|Withdrawal by Subject|0|||
155123550|NCT03353922|559883468|FG000|Overall Study|Adverse Event|0|||
155123551|NCT03353922|559883469|FG001|Overall Study|Adverse Event|1|||
155123552|NCT03353922|559883470|FG002|Overall Study|Adverse Event|0|||
155123553|NCT03353922|559883471|FG003|Overall Study|Adverse Event|0|||
155001429|NCT00252239|559429057|FG001|Overall Study|Withdrawal by Subject|0|||
155001430|NCT00252239|559429058|FG002|Overall Study|Withdrawal by Subject|0|||
155001431|NCT00252239|559429059|FG003|Overall Study|Withdrawal by Subject|1|||
155001432|NCT00252239|559429056|FG000|Overall Study|Lost to Follow-up|0|||
155001433|NCT00252239|559429057|FG001|Overall Study|Lost to Follow-up|0|||
155001434|NCT00252239|559429058|FG002|Overall Study|Lost to Follow-up|2|||
155001435|NCT00252239|559429059|FG003|Overall Study|Lost to Follow-up|0|||
155001436|NCT02257385|559429061|FG000|Overall Study|Adverse Event|12|||
155001437|NCT02257385|559429062|FG001|Overall Study|Adverse Event|8|||
155001438|NCT02257385|559429061|FG000|Overall Study|Lack of Efficacy|1|||
155001439|NCT02257385|559429062|FG001|Overall Study|Lack of Efficacy|2|||
155001440|NCT02257385|559429061|FG000|Overall Study|Protocol Violation|5|||
155001441|NCT02257385|559429062|FG001|Overall Study|Protocol Violation|7|||
155001442|NCT02257385|559429061|FG000|Overall Study|Lost to Follow-up|0|||
155001443|NCT02257385|559429062|FG001|Overall Study|Lost to Follow-up|1|||
155001444|NCT02257385|559429061|FG000|Overall Study|Withdrawal by Subject|4|||
155001445|NCT02257385|559429062|FG001|Overall Study|Withdrawal by Subject|4|||
155001446|NCT01822366|559429069|FG000|Overall Study|Lost to Follow-up|5|||
155001447|NCT01822366|559429070|FG001|Overall Study|Lost to Follow-up|1|||
155001448|NCT01822366|559429071|FG002|Overall Study|Lost to Follow-up|5|||
155001449|NCT01822366|559429072|FG003|Overall Study|Lost to Follow-up|1|||
155001450|NCT01822366|559429069|FG000|Overall Study|Withdrawal by Subject|0|||
155001451|NCT01822366|559429070|FG001|Overall Study|Withdrawal by Subject|6|||
155001452|NCT01822366|559429071|FG002|Overall Study|Withdrawal by Subject|0|||
155001453|NCT01822366|559429072|FG003|Overall Study|Withdrawal by Subject|6|||
155001454|NCT01822366|559429069|FG000|Overall Study|Partial Intervention Completion|0|||
155001455|NCT01822366|559429070|FG001|Overall Study|Partial Intervention Completion|15|||
155001456|NCT01822366|559429071|FG002|Overall Study|Partial Intervention Completion|0|||
155001457|NCT01822366|559429072|FG003|Overall Study|Partial Intervention Completion|15|||
155001458|NCT05199090|559429073|FG000|Overall Study|Adverse Event|1|||
155001459|NCT05199090|559429074|FG001|Overall Study|Adverse Event|4|||
155001460|NCT05199090|559429075|FG002|Overall Study|Adverse Event|0|||
155001461|NCT05199090|559429076|FG003|Overall Study|Adverse Event|0|||
155001462|NCT05199090|559429077|FG004|Overall Study|Adverse Event|0|||
155001463|NCT05199090|559429078|FG005|Overall Study|Adverse Event|0|||
155001464|NCT05199090|559429073|FG000|Overall Study|Lost to Follow-up|1|||
155001465|NCT05199090|559429074|FG001|Overall Study|Lost to Follow-up|0|||
155001466|NCT05199090|559429075|FG002|Overall Study|Lost to Follow-up|1|||
155001467|NCT05199090|559429076|FG003|Overall Study|Lost to Follow-up|4|||
155001468|NCT05199090|559429077|FG004|Overall Study|Lost to Follow-up|0|||
155001469|NCT05199090|559429078|FG005|Overall Study|Lost to Follow-up|5|||
155001470|NCT05199090|559429073|FG000|Overall Study|Physician Decision|0|||
155001471|NCT05199090|559429074|FG001|Overall Study|Physician Decision|0|||
155001472|NCT05199090|559429075|FG002|Overall Study|Physician Decision|0|||
155001473|NCT05199090|559429076|FG003|Overall Study|Physician Decision|0|||
155001474|NCT05199090|559429077|FG004|Overall Study|Physician Decision|0|||
155001475|NCT05199090|559429078|FG005|Overall Study|Physician Decision|1|||
155001476|NCT05199090|559429073|FG000|Overall Study|Study terminated by sponsor|0|||
155001477|NCT05199090|559429074|FG001|Overall Study|Study terminated by sponsor|6|||
155001478|NCT05199090|559429075|FG002|Overall Study|Study terminated by sponsor|0|||
155001479|NCT05199090|559429076|FG003|Overall Study|Study terminated by sponsor|0|||
155001480|NCT05199090|559429077|FG004|Overall Study|Study terminated by sponsor|0|||
155001481|NCT05199090|559429078|FG005|Overall Study|Study terminated by sponsor|5|||
155001482|NCT05199090|559429073|FG000|Overall Study|Subject decision|0|||
155123554|NCT03353922|559883472|FG004|Overall Study|Adverse Event|0|||
155001483|NCT05199090|559429074|FG001|Overall Study|Subject decision|4|||
155001484|NCT05199090|559429075|FG002|Overall Study|Subject decision|0|||
155001485|NCT05199090|559429076|FG003|Overall Study|Subject decision|2|||
155001486|NCT05199090|559429077|FG004|Overall Study|Subject decision|5|||
155001487|NCT05199090|559429078|FG005|Overall Study|Subject decision|2|||
155001488|NCT03489109|559429079|FG000|Overall Study|Lost to Follow-up|1|||
155001489|NCT03489109|559429080|FG001|Overall Study|Lost to Follow-up|2|||
155001490|NCT04868968|559429083|FG000|Overall Study|Lost to Follow-up|1|||
155123555|NCT03353922|559883473|FG005|Overall Study|Adverse Event|0|||
155001491|NCT00384930|559429084|FG000|Overall Study|Adverse Event|5|||
155001492|NCT00384930|559429085|FG001|Overall Study|Adverse Event|4|||
155001493|NCT00384930|559429086|FG002|Overall Study|Adverse Event|12|||
155001494|NCT00384930|559429087|FG003|Overall Study|Adverse Event|11|||
155001495|NCT00384930|559429088|FG004|Overall Study|Adverse Event|14|||
155001496|NCT00384930|559429084|FG000|Overall Study|Entry Criteria Not Met|2|||
155001497|NCT00384930|559429085|FG001|Overall Study|Entry Criteria Not Met|6|||
155001498|NCT00384930|559429086|FG002|Overall Study|Entry Criteria Not Met|7|||
155001499|NCT00384930|559429087|FG003|Overall Study|Entry Criteria Not Met|8|||
155001500|NCT00384930|559429088|FG004|Overall Study|Entry Criteria Not Met|4|||
155001501|NCT00384930|559429084|FG000|Overall Study|Lack of Efficacy|1|||
155001502|NCT00384930|559429085|FG001|Overall Study|Lack of Efficacy|1|||
155001503|NCT00384930|559429086|FG002|Overall Study|Lack of Efficacy|2|||
155001504|NCT00384930|559429087|FG003|Overall Study|Lack of Efficacy|1|||
155001505|NCT00384930|559429088|FG004|Overall Study|Lack of Efficacy|2|||
155001506|NCT00384930|559429084|FG000|Overall Study|Lost to Follow-up|5|||
155123556|NCT03688555|559883474|FG000|Treatment Period|Adverse Event|0|||
155001507|NCT00384930|559429085|FG001|Overall Study|Lost to Follow-up|3|||
155001508|NCT00384930|559429086|FG002|Overall Study|Lost to Follow-up|0|||
155001509|NCT00384930|559429087|FG003|Overall Study|Lost to Follow-up|4|||
155001510|NCT00384930|559429088|FG004|Overall Study|Lost to Follow-up|6|||
155001511|NCT00384930|559429084|FG000|Overall Study|Physician Decision|0|||
155001512|NCT00384930|559429085|FG001|Overall Study|Physician Decision|1|||
155001513|NCT00384930|559429086|FG002|Overall Study|Physician Decision|1|||
155001514|NCT00384930|559429087|FG003|Overall Study|Physician Decision|0|||
155001515|NCT00384930|559429088|FG004|Overall Study|Physician Decision|1|||
155001516|NCT00384930|559429084|FG000|Overall Study|Protocol Violation|1|||
155001517|NCT00384930|559429085|FG001|Overall Study|Protocol Violation|0|||
155001518|NCT00384930|559429086|FG002|Overall Study|Protocol Violation|1|||
155001519|NCT00384930|559429087|FG003|Overall Study|Protocol Violation|6|||
155001520|NCT00384930|559429088|FG004|Overall Study|Protocol Violation|4|||
155001521|NCT00384930|559429084|FG000|Overall Study|Sponsor Decision|3|||
155001522|NCT00384930|559429085|FG001|Overall Study|Sponsor Decision|4|||
155001523|NCT00384930|559429086|FG002|Overall Study|Sponsor Decision|0|||
155001524|NCT00384930|559429087|FG003|Overall Study|Sponsor Decision|5|||
155001525|NCT00384930|559429088|FG004|Overall Study|Sponsor Decision|0|||
155001526|NCT00384930|559429084|FG000|Overall Study|Withdrawal by Subject|9|||
155001527|NCT00384930|559429085|FG001|Overall Study|Withdrawal by Subject|7|||
155001528|NCT00384930|559429086|FG002|Overall Study|Withdrawal by Subject|7|||
155001529|NCT00384930|559429087|FG003|Overall Study|Withdrawal by Subject|6|||
155001530|NCT00384930|559429088|FG004|Overall Study|Withdrawal by Subject|16|||
155001531|NCT00384930|559429084|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
155001532|NCT00384930|559429085|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
155001533|NCT00384930|559429086|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
155001534|NCT00384930|559429087|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
155001535|NCT00384930|559429088|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
155001536|NCT02552732|559429091|FG000|Overall Study|Lost to Follow-up|2|||
155001537|NCT02552732|559429091|FG000|Overall Study|Physician Decision|1|||
155001538|NCT02552732|559429091|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
155001539|NCT02552732|559429091|FG000|Overall Study|Withdrawal by Subject|6|||
155001540|NCT01547130|559429094|FG000|Overall Study|Lost to Follow-up|9|||
155001541|NCT01547130|559429095|FG001|Overall Study|Lost to Follow-up|5|||
155001542|NCT00025259|559429097|FG000|Overall Study|Death|1|||
155001543|NCT00025259|559429098|FG001|Overall Study|Death|3|||
155001544|NCT00025259|559429099|FG002|Overall Study|Death|0|||
155001545|NCT00025259|559429100|FG003|Overall Study|Death|3|||
155001546|NCT00025259|559429101|FG004|Overall Study|Death|0|||
155001547|NCT00025259|559429102|FG005|Overall Study|Death|1|||
155001548|NCT00025259|559429103|FG006|Overall Study|Death|2|||
155001549|NCT00025259|559429097|FG000|Overall Study|Lack of Efficacy|2|||
155001550|NCT00025259|559429098|FG001|Overall Study|Lack of Efficacy|46|||
155001551|NCT00025259|559429099|FG002|Overall Study|Lack of Efficacy|60|||
155001552|NCT00025259|559429100|FG003|Overall Study|Lack of Efficacy|78|||
155001553|NCT00025259|559429101|FG004|Overall Study|Lack of Efficacy|11|||
155001554|NCT00025259|559429102|FG005|Overall Study|Lack of Efficacy|30|||
155001555|NCT00025259|559429103|FG006|Overall Study|Lack of Efficacy|38|||
155001556|NCT00025259|559429097|FG000|Overall Study|Lost to Follow-up|2|||
155001557|NCT00025259|559429098|FG001|Overall Study|Lost to Follow-up|9|||
155001558|NCT00025259|559429099|FG002|Overall Study|Lost to Follow-up|13|||
155001559|NCT00025259|559429100|FG003|Overall Study|Lost to Follow-up|13|||
155001560|NCT00025259|559429101|FG004|Overall Study|Lost to Follow-up|1|||
155001561|NCT00025259|559429102|FG005|Overall Study|Lost to Follow-up|3|||
155001562|NCT00025259|559429103|FG006|Overall Study|Lost to Follow-up|1|||
155001563|NCT00025259|559429097|FG000|Overall Study|Physician Decision|12|||
155001564|NCT00025259|559429098|FG001|Overall Study|Physician Decision|1|||
155001565|NCT00025259|559429099|FG002|Overall Study|Physician Decision|0|||
155001566|NCT00025259|559429100|FG003|Overall Study|Physician Decision|5|||
155001567|NCT00025259|559429101|FG004|Overall Study|Physician Decision|4|||
155001568|NCT00025259|559429102|FG005|Overall Study|Physician Decision|2|||
155001569|NCT00025259|559429103|FG006|Overall Study|Physician Decision|1|||
155001570|NCT00025259|559429097|FG000|Overall Study|Protocol Violation|3|||
155001571|NCT00025259|559429098|FG001|Overall Study|Protocol Violation|2|||
155001572|NCT00025259|559429099|FG002|Overall Study|Protocol Violation|2|||
155001573|NCT00025259|559429100|FG003|Overall Study|Protocol Violation|1|||
155001574|NCT00025259|559429101|FG004|Overall Study|Protocol Violation|2|||
155001575|NCT00025259|559429102|FG005|Overall Study|Protocol Violation|1|||
155123557|NCT03688555|559883475|FG001|Treatment Period|Adverse Event|0|||
155123558|NCT03688555|559883476|FG002|Treatment Period|Adverse Event|1|||
155123559|NCT01886690|559883479|FG000|Overall Study|Protocol Violation|0|||
155001576|NCT00025259|559429103|FG006|Overall Study|Protocol Violation|3|||
155001577|NCT00025259|559429097|FG000|Overall Study|Withdrawal by Subject|9|||
155001578|NCT00025259|559429098|FG001|Overall Study|Withdrawal by Subject|27|||
155001579|NCT00025259|559429099|FG002|Overall Study|Withdrawal by Subject|6|||
155001580|NCT00025259|559429100|FG003|Overall Study|Withdrawal by Subject|14|||
155001581|NCT00025259|559429101|FG004|Overall Study|Withdrawal by Subject|11|||
155001582|NCT00025259|559429102|FG005|Overall Study|Withdrawal by Subject|8|||
155123560|NCT01886690|559883480|FG001|Overall Study|Protocol Violation|1|||
155001583|NCT00025259|559429103|FG006|Overall Study|Withdrawal by Subject|3|||
155001584|NCT00025259|559429097|FG000|Overall Study|Ineligible|14|||
155001585|NCT00025259|559429098|FG001|Overall Study|Ineligible|1|||
155001586|NCT00025259|559429099|FG002|Overall Study|Ineligible|0|||
155001587|NCT00025259|559429100|FG003|Overall Study|Ineligible|0|||
155001588|NCT00025259|559429101|FG004|Overall Study|Ineligible|6|||
155001589|NCT00025259|559429102|FG005|Overall Study|Ineligible|0|||
155001590|NCT00025259|559429103|FG006|Overall Study|Ineligible|1|||
155001591|NCT00025259|559429097|FG000|Overall Study|Randomization error|1|||
155001592|NCT00025259|559429098|FG001|Overall Study|Randomization error|0|||
155001593|NCT00025259|559429099|FG002|Overall Study|Randomization error|0|||
155001594|NCT00025259|559429100|FG003|Overall Study|Randomization error|0|||
155001595|NCT00025259|559429101|FG004|Overall Study|Randomization error|1|||
155001596|NCT00025259|559429102|FG005|Overall Study|Randomization error|7|||
155001597|NCT00025259|559429103|FG006|Overall Study|Randomization error|2|||
155001598|NCT00025259|559429097|FG000|Overall Study|Adverse Event|1|||
155001599|NCT00025259|559429098|FG001|Overall Study|Adverse Event|0|||
155001600|NCT00025259|559429099|FG002|Overall Study|Adverse Event|0|||
155001601|NCT00025259|559429100|FG003|Overall Study|Adverse Event|0|||
155001602|NCT00025259|559429101|FG004|Overall Study|Adverse Event|0|||
155001603|NCT00025259|559429102|FG005|Overall Study|Adverse Event|0|||
155001604|NCT00025259|559429103|FG006|Overall Study|Adverse Event|0|||
155001605|NCT01685840|559429104|FG000|Overall Study|Death|77|||
155001606|NCT01685840|559429105|FG001|Overall Study|Death|66|||
155001607|NCT01685840|559429104|FG000|Overall Study|Lost to Follow-up|27|||
155001608|NCT01685840|559429105|FG001|Overall Study|Lost to Follow-up|25|||
155001609|NCT01685840|559429104|FG000|Overall Study|Physician Decision|3|||
155001610|NCT01685840|559429105|FG001|Overall Study|Physician Decision|7|||
155001611|NCT01685840|559429104|FG000|Overall Study|Withdrawal by Subject|14|||
155001612|NCT01685840|559429105|FG001|Overall Study|Withdrawal by Subject|17|||
155001613|NCT01685840|559429104|FG000|Overall Study|Futility|197|||
155001614|NCT01685840|559429105|FG001|Overall Study|Futility|200|||
155001615|NCT01685840|559429104|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
155001616|NCT01685840|559429105|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
155001617|NCT01004003|559429106|FG000|Overall Study|Progressive disease|2|||
155001618|NCT01004003|559429107|FG001|Overall Study|Progressive disease|1|||
155001619|NCT01004003|559429108|FG002|Overall Study|Progressive disease|1|||
155001620|NCT01004003|559429109|FG003|Overall Study|Progressive disease|0|||
155001621|NCT01004003|559429110|FG004|Overall Study|Progressive disease|2|||
155001622|NCT01004003|559429111|FG005|Overall Study|Progressive disease|1|||
155001623|NCT01004003|559429112|FG006|Overall Study|Progressive disease|1|||
155001624|NCT01004003|559429113|FG007|Overall Study|Progressive disease|39|||
155001625|NCT01004003|559429114|FG008|Overall Study|Progressive disease|22|||
155001626|NCT01004003|559429106|FG000|Overall Study|Adverse Event|4|||
155001627|NCT01004003|559429107|FG001|Overall Study|Adverse Event|2|||
155001628|NCT01004003|559429108|FG002|Overall Study|Adverse Event|3|||
155001629|NCT01004003|559429109|FG003|Overall Study|Adverse Event|3|||
155001630|NCT01004003|559429110|FG004|Overall Study|Adverse Event|2|||
155001631|NCT01004003|559429111|FG005|Overall Study|Adverse Event|2|||
155001632|NCT01004003|559429112|FG006|Overall Study|Adverse Event|7|||
155001633|NCT01004003|559429113|FG007|Overall Study|Adverse Event|21|||
155001634|NCT01004003|559429114|FG008|Overall Study|Adverse Event|6|||
155001635|NCT01004003|559429106|FG000|Overall Study|Refused to continue taking trial med.|0|||
155001636|NCT01004003|559429107|FG001|Overall Study|Refused to continue taking trial med.|0|||
155001637|NCT01004003|559429108|FG002|Overall Study|Refused to continue taking trial med.|0|||
155001638|NCT01004003|559429109|FG003|Overall Study|Refused to continue taking trial med.|0|||
155001639|NCT01004003|559429110|FG004|Overall Study|Refused to continue taking trial med.|0|||
155001640|NCT01004003|559429111|FG005|Overall Study|Refused to continue taking trial med.|0|||
155001641|NCT01004003|559429112|FG006|Overall Study|Refused to continue taking trial med.|0|||
155001642|NCT01004003|559429113|FG007|Overall Study|Refused to continue taking trial med.|0|||
155001643|NCT01004003|559429114|FG008|Overall Study|Refused to continue taking trial med.|2|||
155001644|NCT01004003|559429106|FG000|Overall Study|Other|0|||
155001645|NCT01004003|559429107|FG001|Overall Study|Other|0|||
155001646|NCT01004003|559429108|FG002|Overall Study|Other|0|||
155001647|NCT01004003|559429109|FG003|Overall Study|Other|0|||
155001648|NCT01004003|559429110|FG004|Overall Study|Other|0|||
155001649|NCT01004003|559429111|FG005|Overall Study|Other|1|||
155001650|NCT01004003|559429112|FG006|Overall Study|Other|0|||
155001651|NCT01004003|559429113|FG007|Overall Study|Other|0|||
155001652|NCT01004003|559429114|FG008|Overall Study|Other|0|||
155001653|NCT02521376|559429117|FG000|Overall Study|Enrolled, But Not Treated|1|||
155001654|NCT02521376|559429118|FG001|Overall Study|Enrolled, But Not Treated|0|||
155001655|NCT02521376|559429119|FG002|Overall Study|Enrolled, But Not Treated|0|||
155001656|NCT02521376|559429120|FG003|Overall Study|Enrolled, But Not Treated|0|||
155001657|NCT01374269|559429122|FG000|Overall Study|Withdrawal by Subject|4|||
155001658|NCT01374269|559429123|FG001|Overall Study|Withdrawal by Subject|0|||
155001659|NCT01374269|559429122|FG000|Overall Study|Lost to Follow-up|1|||
155001660|NCT01374269|559429123|FG001|Overall Study|Lost to Follow-up|3|||
155001661|NCT01374269|559429122|FG000|Overall Study|closed research|1|||
155001662|NCT01374269|559429123|FG001|Overall Study|closed research|2|||
155001663|NCT01987479|559429124|FG000|Overall Study|Protocol Violation|1|||
155001664|NCT01987479|559429124|FG000|Overall Study|Physician Decision|2|||
155001665|NCT01987479|559429124|FG000|Overall Study|Participant/legal guardian decision|1|||
155001666|NCT01987479|559429124|FG000|Overall Study|Other|5|||
155001667|NCT01987479|559429124|FG000|Overall Study|Lost to Follow-up|1|||
155001668|NCT01987479|559429124|FG000|Overall Study|Adverse Event|7|||
155001669|NCT01954745|559429125|FG000|Overall Study|Radiological Progression|11|||
155001670|NCT01954745|559429125|FG000|Overall Study|Clinical Progression|5|||
155001671|NCT01954745|559429125|FG000|Overall Study|Adverse Event|2|||
155001672|NCT01954745|559429125|FG000|Overall Study|Death|1|||
155001673|NCT03654599|559429128|FG000|Overall Study|Lost to Follow-up|14|||
155001674|NCT03654599|559429129|FG001|Overall Study|Lost to Follow-up|12|||
155001675|NCT03654599|559429128|FG000|Overall Study|Death|8|||
155001676|NCT03654599|559429129|FG001|Overall Study|Death|6|||
155001677|NCT03654599|559429128|FG000|Overall Study|Withdrawal by Subject|6|||
155001678|NCT03654599|559429129|FG001|Overall Study|Withdrawal by Subject|4|||
155001679|NCT04158245|559430421|FG000|Overall Study|Lost to Follow-up|1|||
155001680|NCT02906358|559430422|FG000|Overall Study|Withdrawal by Subject|10|||
155001681|NCT02906358|559430423|FG001|Overall Study|Withdrawal by Subject|7|||
155001682|NCT02906358|559430422|FG000|Overall Study|Lost to Follow-up|12|||
155001683|NCT02906358|559430423|FG001|Overall Study|Lost to Follow-up|15|||
155001684|NCT02699684|559430424|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
155001685|NCT02699684|559430425|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
155001686|NCT02111603|559430428|FG000|Overall Study|Withdrawal by Subject|1|||
155001687|NCT01582152|559430429|FG000|Overall Study|Disease Progression|4|||
155001688|NCT01582152|559430430|FG001|Overall Study|Disease Progression|5|||
155001689|NCT01582152|559430429|FG000|Overall Study|Adverse Event|2|||
155001690|NCT01582152|559430430|FG001|Overall Study|Adverse Event|1|||
155001691|NCT02437903|559430433|FG000|Overall Study|Adverse Event|1|||
155001692|NCT02437903|559430433|FG000|Overall Study|Withdrawal by Subject|1|||
155001693|NCT02437903|559430433|FG000|Overall Study|Lost to Follow-up|3|||
155001694|NCT01611857|559430442|FG000|Overall Study|Withdrawal by Subject|0|||
155001695|NCT01611857|559430443|FG001|Overall Study|Withdrawal by Subject|2|||
155001696|NCT02439970|559430447|FG000|Overall Study|Study Terminated|2|||
155001697|NCT02439970|559430448|FG001|Overall Study|Study Terminated|3|||
155001698|NCT04974749|559430449|FG000|Overall Study|Withdrawal by Subject|2|||
155001699|NCT04974749|559430449|FG000|Overall Study|Gestation|1|||
155001700|NCT00741338|559430454|FG000|Overall Study|Adverse Event|0|||
155001701|NCT00741338|559430455|FG001|Overall Study|Adverse Event|1|||
155001702|NCT03593395|559430456|FG000|Overall Study|Lost to Follow-up|48|||
155001703|NCT03593395|559430457|FG001|Overall Study|Lost to Follow-up|3|||
155001704|NCT03593395|559430456|FG000|Overall Study|Withdrawal by Subject|5|||
155001705|NCT03593395|559430457|FG001|Overall Study|Withdrawal by Subject|24|||
155001706|NCT03593395|559430456|FG000|Overall Study|Death|2|||
155001707|NCT03593395|559430457|FG001|Overall Study|Death|3|||
155001708|NCT03593395|559430456|FG000|Overall Study|Physician Decision|0|||
155001709|NCT03593395|559430457|FG001|Overall Study|Physician Decision|6|||
155001710|NCT03593395|559430456|FG000|Overall Study|Participant Relocated|19|||
155001711|NCT03593395|559430457|FG001|Overall Study|Participant Relocated|3|||
155001712|NCT03593395|559430456|FG000|Overall Study|No Information|1|||
155001713|NCT03593395|559430457|FG001|Overall Study|No Information|7|||
155001714|NCT03908437|559430458|FG000|Overall Study|Death|0|||
155123561|NCT01886690|559883479|FG000|Overall Study|Personal Reasons|0|||
155123562|NCT01886690|559883480|FG001|Overall Study|Personal Reasons|1|||
155123563|NCT03461406|559883481|FG000|Overall Study|Death|1|||
155123564|NCT03461406|559883482|FG001|Overall Study|Death|2|||
155123565|NCT03461406|559883481|FG000|Overall Study|Consent Withdrawn by Participant|0|||
155123566|NCT03461406|559883482|FG001|Overall Study|Consent Withdrawn by Participant|1|||
155123567|NCT03461406|559883481|FG000|Overall Study|Screen Failure|3|||
155001715|NCT03908437|559430459|FG001|Overall Study|Death|1|||
155001716|NCT03908437|559430458|FG000|Overall Study|Lost to Follow-up|31|||
155001717|NCT03908437|559430459|FG001|Overall Study|Lost to Follow-up|24|||
155123568|NCT03461406|559883482|FG001|Overall Study|Screen Failure|1|||
155123569|NCT03461406|559883481|FG000|Overall Study|Reason not Specified|1|||
155123570|NCT03461406|559883482|FG001|Overall Study|Reason not Specified|3|||
155001718|NCT03633825|559430460|FG000|Enrollment|Did not post on network|5066|||
155001719|NCT03633825|559430461|FG001|Enrollment|Did not post on network|5080|||
155123571|NCT03461406|559883481|FG000|Overall Study|Lost to Follow-up|3|||
155123572|NCT03461406|559883482|FG001|Overall Study|Lost to Follow-up|0|||
155001720|NCT03633825|559430460|FG000|Enrollment|Post not classified as crisis|13967|||
155123573|NCT01140568|559883483|FG000|Overall Study|disease progression|31|||
155123574|NCT01140568|559883483|FG000|Overall Study|Withdrawal by Subject|1|||
155123575|NCT01140568|559883483|FG000|Overall Study|Screen Fail|4|||
155123576|NCT03618628|559883484|FG000|Overall Study|Death|1|||
155001721|NCT03633825|559430461|FG001|Enrollment|Post not classified as crisis|13757|||
155123577|NCT03618628|559883484|FG000|Overall Study|Lost to Follow-up|1|||
155123578|NCT01591863|559883496|FG000|Overall Study|Adverse Event|3|||
155123579|NCT01591863|559883496|FG000|Overall Study|Withdrawal by Subject|1|||
155001722|NCT03633825|559430460|FG000|Follow up|Lost to Follow-up|478|||
155001723|NCT03633825|559430461|FG001|Follow up|Lost to Follow-up|450|||
155001724|NCT05246670|559430462|FG000|Overall Study|Withdrawal by Subject|2|||
155001725|NCT05246670|559430463|FG001|Overall Study|Withdrawal by Subject|3|||
155001726|NCT05246670|559430464|FG002|Overall Study|Withdrawal by Subject|0|||
155001727|NCT05246670|559430465|FG003|Overall Study|Withdrawal by Subject|1|||
155001728|NCT05246670|559430462|FG000|Overall Study|Adverse Event|0|||
155001729|NCT05246670|559430463|FG001|Overall Study|Adverse Event|0|||
155001730|NCT05246670|559430464|FG002|Overall Study|Adverse Event|1|||
155001731|NCT05246670|559430465|FG003|Overall Study|Adverse Event|0|||
155001732|NCT05246670|559430462|FG000|Overall Study|Physician Decision|1|||
155001733|NCT05246670|559430463|FG001|Overall Study|Physician Decision|0|||
155001734|NCT05246670|559430464|FG002|Overall Study|Physician Decision|0|||
155001735|NCT05246670|559430465|FG003|Overall Study|Physician Decision|0|||
155001736|NCT05246670|559430462|FG000|Overall Study|Protocol Violation|1|||
155001737|NCT05246670|559430463|FG001|Overall Study|Protocol Violation|0|||
155001738|NCT05246670|559430464|FG002|Overall Study|Protocol Violation|0|||
155001739|NCT05246670|559430465|FG003|Overall Study|Protocol Violation|0|||
155001740|NCT01141205|559430466|FG000|Overall Study|Physician Decision|1|||
155001741|NCT01141205|559430467|FG001|Overall Study|Physician Decision|1|||
155001742|NCT01141205|559430466|FG000|Overall Study|Lost to Follow-up|1|||
155001743|NCT01141205|559430467|FG001|Overall Study|Lost to Follow-up|0|||
155001744|NCT01141205|559430466|FG000|Overall Study|Withdrawal by Subject|1|||
155001745|NCT01141205|559430467|FG001|Overall Study|Withdrawal by Subject|1|||
155001746|NCT00534404|559430475|FG000|Overall Study|Death|0|||
155001747|NCT00534404|559430476|FG001|Overall Study|Death|0|||
155001748|NCT00534404|559430477|FG002|Overall Study|Death|2|||
155001749|NCT00534404|559430475|FG000|Overall Study|Withdrawal by Subject|8|||
155001750|NCT00534404|559430476|FG001|Overall Study|Withdrawal by Subject|2|||
155001751|NCT00534404|559430477|FG002|Overall Study|Withdrawal by Subject|38|||
155001752|NCT00534404|559430475|FG000|Overall Study|Removed by study staff|2|||
155001753|NCT00534404|559430476|FG001|Overall Study|Removed by study staff|3|||
155001754|NCT00534404|559430477|FG002|Overall Study|Removed by study staff|1|||
155001755|NCT00534404|559430475|FG000|Overall Study|Lost to Follow-up|170|||
155001756|NCT00534404|559430476|FG001|Overall Study|Lost to Follow-up|138|||
155001757|NCT00534404|559430477|FG002|Overall Study|Lost to Follow-up|201|||
155001758|NCT02996487|559430480|FG000|Overall Study|Lost to Follow-up|1|||
155001759|NCT02996487|559430481|FG001|Overall Study|Lost to Follow-up|1|||
155001760|NCT02996487|559430482|FG002|Overall Study|Lost to Follow-up|0|||
155001761|NCT02996487|559430480|FG000|Overall Study|Death|0|||
155001762|NCT02996487|559430481|FG001|Overall Study|Death|1|||
155001763|NCT02996487|559430482|FG002|Overall Study|Death|0|||
155001764|NCT02996487|559430480|FG000|Overall Study|Withdrawal by Subject|2|||
155001765|NCT02996487|559430481|FG001|Overall Study|Withdrawal by Subject|3|||
155001766|NCT02996487|559430482|FG002|Overall Study|Withdrawal by Subject|0|||
155001767|NCT02027428|559430483|FG000|Induction|Never treated|7|||
155001768|NCT02027428|559430484|FG001|Induction|Never treated|0|||
155001769|NCT02027428|559430485|FG002|Induction|Never treated|0|||
155001770|NCT02027428|559430483|FG000|Induction|Progressive disease|77|||
155001771|NCT02027428|559430484|FG001|Induction|Progressive disease|0|||
155001772|NCT02027428|559430485|FG002|Induction|Progressive disease|0|||
155001773|NCT02027428|559430483|FG000|Induction|Adverse Event|51|||
155001774|NCT02027428|559430484|FG001|Induction|Adverse Event|0|||
155001775|NCT02027428|559430485|FG002|Induction|Adverse Event|0|||
155001776|NCT02027428|559430483|FG000|Induction|Withdrawal by Subject|22|||
155001777|NCT02027428|559430484|FG001|Induction|Withdrawal by Subject|0|||
155001778|NCT02027428|559430485|FG002|Induction|Withdrawal by Subject|0|||
155001779|NCT02027428|559430483|FG000|Induction|Death|21|||
155001780|NCT02027428|559430484|FG001|Induction|Death|0|||
155001781|NCT02027428|559430485|FG002|Induction|Death|0|||
155001782|NCT02027428|559430483|FG000|Induction|Symptomatic deterioration|16|||
155001783|NCT02027428|559430484|FG001|Induction|Symptomatic deterioration|0|||
155001784|NCT02027428|559430485|FG002|Induction|Symptomatic deterioration|0|||
155001785|NCT02027428|559430483|FG000|Induction|Study terminated by sponsor|12|||
155001786|NCT02027428|559430484|FG001|Induction|Study terminated by sponsor|0|||
155001787|NCT02027428|559430485|FG002|Induction|Study terminated by sponsor|0|||
155001788|NCT02027428|559430483|FG000|Induction|Protocol Violation|1|||
155001789|NCT02027428|559430484|FG001|Induction|Protocol Violation|0|||
155001790|NCT02027428|559430485|FG002|Induction|Protocol Violation|0|||
155001791|NCT02027428|559430483|FG000|Induction|Miscellaneous|14|||
155001792|NCT02027428|559430484|FG001|Induction|Miscellaneous|0|||
155001793|NCT02027428|559430485|FG002|Induction|Miscellaneous|0|||
155001794|NCT02027428|559430483|FG000|Induction|Induction Treatment Ongoing|4|||
155001795|NCT02027428|559430484|FG001|Induction|Induction Treatment Ongoing|0|||
155001796|NCT02027428|559430485|FG002|Induction|Induction Treatment Ongoing|0|||
155001797|NCT02027428|559430483|FG000|Maintenance|Death|0|||
155001798|NCT02027428|559430484|FG001|Maintenance|Death|3|||
155001799|NCT02027428|559430485|FG002|Maintenance|Death|2|||
155001800|NCT02027428|559430483|FG000|Maintenance|Adverse Event|0|||
155001801|NCT02027428|559430484|FG001|Maintenance|Adverse Event|21|||
155001802|NCT02027428|559430485|FG002|Maintenance|Adverse Event|1|||
155001803|NCT02027428|559430483|FG000|Maintenance|Progressive disease|0|||
155001804|NCT02027428|559430484|FG001|Maintenance|Progressive disease|84|||
155001805|NCT02027428|559430485|FG002|Maintenance|Progressive disease|47|||
155001806|NCT02027428|559430483|FG000|Maintenance|Symptomatic deterioration|0|||
155001807|NCT02027428|559430484|FG001|Maintenance|Symptomatic deterioration|4|||
155001808|NCT02027428|559430485|FG002|Maintenance|Symptomatic deterioration|1|||
155001809|NCT02027428|559430483|FG000|Maintenance|Withdrawal by Subject|0|||
155001810|NCT02027428|559430484|FG001|Maintenance|Withdrawal by Subject|6|||
155001811|NCT02027428|559430485|FG002|Maintenance|Withdrawal by Subject|5|||
155001812|NCT02027428|559430483|FG000|Maintenance|Protocol Violation|0|||
155001813|NCT02027428|559430484|FG001|Maintenance|Protocol Violation|0|||
155001814|NCT02027428|559430485|FG002|Maintenance|Protocol Violation|1|||
155001815|NCT02027428|559430483|FG000|Maintenance|Other|0|||
155001816|NCT02027428|559430484|FG001|Maintenance|Other|6|||
155001817|NCT02027428|559430485|FG002|Maintenance|Other|3|||
155001818|NCT02027428|559430483|FG000|Survival Follow-up|Death|0|||
155001819|NCT02027428|559430484|FG001|Survival Follow-up|Death|78|||
155001820|NCT02027428|559430485|FG002|Survival Follow-up|Death|45|||
155001821|NCT02027428|559430483|FG000|Survival Follow-up|Lost to Follow-up|0|||
155001822|NCT02027428|559430484|FG001|Survival Follow-up|Lost to Follow-up|1|||
155001823|NCT02027428|559430485|FG002|Survival Follow-up|Lost to Follow-up|1|||
155001824|NCT01128543|559430486|FG000|Overall Study|Withdrawal by Subject|3|||
155001825|NCT01128543|559430486|FG000|Overall Study|Protocol Violation|1|||
155001826|NCT04487067|559430490|FG000|Overall Study|Adverse Event|3|||
155001827|NCT04487067|559430490|FG000|Overall Study|Death Other Than Progressive Disease|60|||
155001828|NCT04487067|559430490|FG000|Overall Study|Death Due To Progressive Disease|40|||
155001829|NCT04487067|559430490|FG000|Overall Study|Lost to Follow-up|3|||
155001830|NCT04487067|559430490|FG000|Overall Study|Progressive Disease|1|||
155001831|NCT04487067|559430490|FG000|Overall Study|Protocol Violation|3|||
155001832|NCT04487067|559430490|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
155001833|NCT04487067|559430490|FG000|Overall Study|Withdrawal by Subject|15|||
155001834|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
155001835|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
155001836|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
155001837|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Death|1|||
155001838|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Death|3|||
155001839|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Death|1|||
155001840|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
155001841|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
155001842|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
155001843|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
155001844|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
155001845|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
155001846|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
155001847|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
155001848|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
155001849|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
155001850|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
155001851|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
155001852|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
155001853|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
155001854|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
155001855|NCT00299130|559430491|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
155001856|NCT00299130|559430492|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
155001857|NCT00299130|559430493|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
155001858|NCT00299130|559430491|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
155001859|NCT00299130|559430492|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
155001860|NCT00299130|559430493|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
155001861|NCT00299130|559430491|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
155001862|NCT00299130|559430492|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
155123580|NCT01591863|559883496|FG000|Overall Study|recurrence|9|||
155123581|NCT01591863|559883496|FG000|Overall Study|Lack of Efficacy|1|||
155123582|NCT00160654|559883497|FG000|Overall Study|Adverse Event|14|||
155123583|NCT00160654|559883497|FG000|Overall Study|Lack of Efficacy|4|||
155001863|NCT00299130|559430493|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
155001864|NCT00299130|559430491|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
155001865|NCT00299130|559430492|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
155001866|NCT00299130|559430493|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
155001867|NCT00299130|559430491|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
155001868|NCT00299130|559430492|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
155001869|NCT00299130|559430493|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
155001870|NCT00299130|559430491|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
155001871|NCT00299130|559430492|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
155123584|NCT00160654|559883497|FG000|Overall Study|Lost to Follow-up|2|||
155123585|NCT00160654|559883497|FG000|Overall Study|Intake of expired drug|7|||
155123586|NCT00160654|559883497|FG000|Overall Study|Psychological trauma|1|||
155123587|NCT00160654|559883497|FG000|Overall Study|Sponsor decision|1|||
155123588|NCT00160654|559883497|FG000|Overall Study|Patient met exclusion criteria|1|||
155123589|NCT00160654|559883497|FG000|Overall Study|Patient decision|1|||
155123590|NCT00160654|559883497|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
155123591|NCT00160654|559883497|FG000|Overall Study|Met exclusion criteria|1|||
155123592|NCT03474081|559883502|FG000|Overall Study|Adverse Event|6|||
155123593|NCT03474081|559883503|FG001|Overall Study|Adverse Event|3|||
155123594|NCT03474081|559883502|FG000|Overall Study|Lost to Follow-up|2|||
155123595|NCT03474081|559883503|FG001|Overall Study|Lost to Follow-up|1|||
155123596|NCT03474081|559883502|FG000|Overall Study|Physician Decision|3|||
155123597|NCT03474081|559883503|FG001|Overall Study|Physician Decision|2|||
155123598|NCT03474081|559883502|FG000|Overall Study|Withdrawal by Subject|5|||
155123599|NCT03474081|559883503|FG001|Overall Study|Withdrawal by Subject|7|||
155123600|NCT03474081|559883502|FG000|Overall Study|Investigator site closed|1|||
155123601|NCT03474081|559883503|FG001|Overall Study|Investigator site closed|0|||
155123602|NCT02558400|559883506|FG000|Overall Study|Adverse Event|47|||
155123603|NCT02558400|559883507|FG001|Overall Study|Adverse Event|53|||
155123604|NCT02558400|559883508|FG002|Overall Study|Adverse Event|4|||
155123605|NCT02558400|559883506|FG000|Overall Study|Withdrawal by Subject|13|||
155123606|NCT02558400|559883507|FG001|Overall Study|Withdrawal by Subject|9|||
155123607|NCT02558400|559883508|FG002|Overall Study|Withdrawal by Subject|8|||
155123608|NCT02558400|559883506|FG000|Overall Study|Non-Compliant|0|||
155123609|NCT02558400|559883507|FG001|Overall Study|Non-Compliant|1|||
155123610|NCT02558400|559883508|FG002|Overall Study|Non-Compliant|3|||
155123611|NCT02558400|559883506|FG000|Overall Study|Lost to Follow-up|5|||
155123612|NCT02558400|559883507|FG001|Overall Study|Lost to Follow-up|5|||
155123613|NCT02558400|559883508|FG002|Overall Study|Lost to Follow-up|4|||
155123614|NCT02558400|559883506|FG000|Overall Study|Lack of Efficacy|0|||
155123615|NCT02558400|559883507|FG001|Overall Study|Lack of Efficacy|13|||
155123616|NCT02558400|559883508|FG002|Overall Study|Lack of Efficacy|1|||
155123617|NCT02558400|559883506|FG000|Overall Study|Disallowed Concurrent Medication|6|||
155123618|NCT02558400|559883507|FG001|Overall Study|Disallowed Concurrent Medication|7|||
155123619|NCT02558400|559883508|FG002|Overall Study|Disallowed Concurrent Medication|5|||
155123620|NCT02558400|559883506|FG000|Overall Study|Physician Decision|2|||
155123621|NCT02558400|559883507|FG001|Overall Study|Physician Decision|2|||
155123622|NCT02558400|559883508|FG002|Overall Study|Physician Decision|0|||
155123623|NCT02558400|559883506|FG000|Overall Study|Protocol Violation|6|||
155123624|NCT02558400|559883507|FG001|Overall Study|Protocol Violation|3|||
155123625|NCT02558400|559883508|FG002|Overall Study|Protocol Violation|8|||
155123626|NCT02558400|559883506|FG000|Overall Study|Death|0|||
155123627|NCT02558400|559883507|FG001|Overall Study|Death|1|||
155123628|NCT02558400|559883508|FG002|Overall Study|Death|0|||
155123629|NCT02558400|559883506|FG000|Overall Study|Ineligible for the study|0|||
155123630|NCT02558400|559883507|FG001|Overall Study|Ineligible for the study|2|||
155123631|NCT02558400|559883508|FG002|Overall Study|Ineligible for the study|0|||
155123632|NCT00456599|559883510|FG000|Overall Study|Non-compliance|1|||
155123633|NCT00456599|559883510|FG000|Overall Study|Withdrawal by Subject|2|||
155123634|NCT00260065|559883511|FG000|Overall Study|Progressive Disease|22|||
155123635|NCT00260065|559883511|FG000|Overall Study|Adverse Event|17|||
155123636|NCT00260065|559883511|FG000|Overall Study|Death|13|||
155123637|NCT00260065|559883511|FG000|Overall Study|Withdrawal by Subject|13|||
155123638|NCT00260065|559883511|FG000|Overall Study|Physician Decision|19|||
155123639|NCT00260065|559883511|FG000|Overall Study|Not otherwise specified|8|||
155123640|NCT00260065|559883511|FG000|Overall Study|Medication Noncompliance|1|||
155123641|NCT02198235|559883512|FG000|Overall Study|Lost to Follow-up|3|||
155123642|NCT02198235|559883513|FG001|Overall Study|Lost to Follow-up|2|||
155123643|NCT02198235|559883514|FG002|Overall Study|Lost to Follow-up|2|||
155123644|NCT01999218|559883518|FG000|Overall Study|Hyperglycemia|18|||
155123645|NCT01999218|559883519|FG001|Overall Study|Hyperglycemia|17|||
155123646|NCT01999218|559883520|FG002|Overall Study|Hyperglycemia|17|||
155123647|NCT01999218|559883518|FG000|Overall Study|Lack of Efficacy|1|||
155123648|NCT01999218|559883519|FG001|Overall Study|Lack of Efficacy|0|||
155123649|NCT01999218|559883520|FG002|Overall Study|Lack of Efficacy|1|||
155123650|NCT01999218|559883518|FG000|Overall Study|Lost to Follow-up|22|||
155123651|NCT01999218|559883519|FG001|Overall Study|Lost to Follow-up|17|||
155123652|NCT01999218|559883520|FG002|Overall Study|Lost to Follow-up|18|||
155123653|NCT01999218|559883518|FG000|Overall Study|Non-Compliance With Study Drug|6|||
155123654|NCT01999218|559883519|FG001|Overall Study|Non-Compliance With Study Drug|4|||
155123655|NCT01999218|559883520|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155123656|NCT01999218|559883518|FG000|Overall Study|Physician Decision|1|||
155123657|NCT01999218|559883519|FG001|Overall Study|Physician Decision|4|||
155123658|NCT01999218|559883520|FG002|Overall Study|Physician Decision|6|||
155123659|NCT01999218|559883518|FG000|Overall Study|Protocol Violation|4|||
155123660|NCT01999218|559883519|FG001|Overall Study|Protocol Violation|5|||
155178029|NCT00992589|560091387|FG002|Open-Label Phase|Protocol Violation|0|||
155123661|NCT01999218|559883520|FG002|Overall Study|Protocol Violation|4|||
155123662|NCT01999218|559883518|FG000|Overall Study|Screen failure|0|||
155123663|NCT01999218|559883519|FG001|Overall Study|Screen failure|1|||
155123664|NCT01999218|559883520|FG002|Overall Study|Screen failure|0|||
155123665|NCT01999218|559883518|FG000|Overall Study|Study Terminated By Sponsor|7|||
155123666|NCT01999218|559883519|FG001|Overall Study|Study Terminated By Sponsor|5|||
155123667|NCT01999218|559883520|FG002|Overall Study|Study Terminated By Sponsor|12|||
155123668|NCT01999218|559883518|FG000|Overall Study|Participant moves|2|||
155123669|NCT01999218|559883519|FG001|Overall Study|Participant moves|5|||
155123670|NCT01999218|559883520|FG002|Overall Study|Participant moves|3|||
155123671|NCT01999218|559883518|FG000|Overall Study|Withdrawal by Subject|28|||
155123672|NCT01999218|559883519|FG001|Overall Study|Withdrawal by Subject|29|||
155123673|NCT01999218|559883520|FG002|Overall Study|Withdrawal by Subject|34|||
155123674|NCT01999218|559883518|FG000|Overall Study|Creatinine/eGFR|0|||
155123675|NCT01999218|559883519|FG001|Overall Study|Creatinine/eGFR|0|||
155123676|NCT01999218|559883520|FG002|Overall Study|Creatinine/eGFR|1|||
155123677|NCT01999218|559883518|FG000|Overall Study|Death|7|||
155123678|NCT01999218|559883519|FG001|Overall Study|Death|1|||
155123679|NCT01999218|559883520|FG002|Overall Study|Death|2|||
155123680|NCT01999218|559883518|FG000|Overall Study|Excluded Medication|1|||
155123681|NCT01999218|559883519|FG001|Overall Study|Excluded Medication|1|||
155123682|NCT01999218|559883520|FG002|Overall Study|Excluded Medication|2|||
155123683|NCT01999218|559883518|FG000|Overall Study|Adverse Event|9|||
155123684|NCT01999218|559883519|FG001|Overall Study|Adverse Event|7|||
155123685|NCT01999218|559883520|FG002|Overall Study|Adverse Event|7|||
155123686|NCT01999218|559883518|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
155123687|NCT01999218|559883519|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
155123688|NCT01999218|559883520|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
155123689|NCT00546260|559883523|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
155123690|NCT00546260|559883524|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
155123691|NCT00528996|559885558|FG000|Overall Study|Other reasons than listing|6|||
155123692|NCT00528996|559885559|FG001|Overall Study|Other reasons than listing|7|||
155123693|NCT00528996|559885560|FG002|Overall Study|Other reasons than listing|14|||
155123694|NCT00528996|559885561|FG003|Overall Study|Other reasons than listing|11|||
155123695|NCT00528996|559885562|FG004|Overall Study|Other reasons than listing|5|||
155123696|NCT00528996|559885558|FG000|Overall Study|Refused continue medication|16|||
155123697|NCT00528996|559885559|FG001|Overall Study|Refused continue medication|0|||
155123698|NCT00528996|559885560|FG002|Overall Study|Refused continue medication|3|||
155123699|NCT00528996|559885561|FG003|Overall Study|Refused continue medication|3|||
155123700|NCT00528996|559885562|FG004|Overall Study|Refused continue medication|6|||
155123701|NCT00528996|559885558|FG000|Overall Study|Lost to Follow-up|2|||
155123702|NCT00528996|559885559|FG001|Overall Study|Lost to Follow-up|0|||
155123703|NCT00528996|559885560|FG002|Overall Study|Lost to Follow-up|4|||
155123704|NCT00528996|559885561|FG003|Overall Study|Lost to Follow-up|1|||
155123705|NCT00528996|559885562|FG004|Overall Study|Lost to Follow-up|3|||
155123706|NCT00528996|559885558|FG000|Overall Study|Protocol Violation|1|||
155123707|NCT00528996|559885559|FG001|Overall Study|Protocol Violation|2|||
155123708|NCT00528996|559885560|FG002|Overall Study|Protocol Violation|3|||
155123709|NCT00528996|559885561|FG003|Overall Study|Protocol Violation|3|||
155123710|NCT00528996|559885562|FG004|Overall Study|Protocol Violation|2|||
155123711|NCT00528996|559885558|FG000|Overall Study|Lack of Efficacy|7|||
155123712|NCT00528996|559885559|FG001|Overall Study|Lack of Efficacy|2|||
155123713|NCT00528996|559885560|FG002|Overall Study|Lack of Efficacy|1|||
155123714|NCT00528996|559885561|FG003|Overall Study|Lack of Efficacy|3|||
155123715|NCT00528996|559885562|FG004|Overall Study|Lack of Efficacy|3|||
155123716|NCT00528996|559885558|FG000|Overall Study|Adverse Event|32|||
155123717|NCT00528996|559885559|FG001|Overall Study|Adverse Event|13|||
155178030|NCT00992589|560091388|FG003|Open-Label Phase|Protocol Violation|0|||
155178031|NCT00992589|560091385|FG000|Open-Label Phase|Physician Decision|4|||
155178032|NCT00992589|560091386|FG001|Open-Label Phase|Physician Decision|0|||
155178033|NCT00992589|560091387|FG002|Open-Label Phase|Physician Decision|0|||
155178034|NCT00992589|560091388|FG003|Open-Label Phase|Physician Decision|0|||
155178035|NCT00992589|560091385|FG000|Open-Label Phase|Other|45|||
155178036|NCT00992589|560091386|FG001|Open-Label Phase|Other|0|||
155123718|NCT00528996|559885560|FG002|Overall Study|Adverse Event|18|||
155178037|NCT00992589|560091387|FG002|Open-Label Phase|Other|0|||
155178038|NCT00992589|560091388|FG003|Open-Label Phase|Other|0|||
155178039|NCT00992589|560091385|FG000|Double-Blind Phase|Adverse Event|0|||
155123719|NCT00528996|559885561|FG003|Overall Study|Adverse Event|29|||
155123720|NCT00528996|559885562|FG004|Overall Study|Adverse Event|18|||
155123721|NCT02559414|559885566|FG000|Overall Study|Lost to Follow-up|0|||
155178040|NCT00992589|560091386|FG001|Double-Blind Phase|Adverse Event|6|||
155178041|NCT00992589|560091387|FG002|Double-Blind Phase|Adverse Event|2|||
155123722|NCT02559414|559885567|FG001|Overall Study|Lost to Follow-up|1|||
155123723|NCT02559414|559885568|FG002|Overall Study|Lost to Follow-up|0|||
155123724|NCT02559414|559885566|FG000|Overall Study|Withdrawal by Subject|1|||
155178042|NCT00992589|560091388|FG003|Double-Blind Phase|Adverse Event|3|||
155178043|NCT00992589|560091385|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155123725|NCT02559414|559885567|FG001|Overall Study|Withdrawal by Subject|0|||
155123726|NCT02559414|559885568|FG002|Overall Study|Withdrawal by Subject|1|||
155123727|NCT02559414|559885566|FG000|Overall Study|Other|0|||
155123728|NCT02559414|559885567|FG001|Overall Study|Other|1|||
155123729|NCT02559414|559885568|FG002|Overall Study|Other|1|||
155123730|NCT01145053|559885575|FG000|Overall Study|Adverse Event|22|||
155123731|NCT01145053|559885575|FG000|Overall Study|Lost to Follow-up|28|||
155123732|NCT01145053|559885575|FG000|Overall Study|Withdrawal by Subject|25|||
155123733|NCT01145053|559885575|FG000|Overall Study|Other|18|||
155123734|NCT02785458|559885576|FG000|1 Month|Withdrawal by Subject|2|||
155123735|NCT02785458|559885577|FG001|1 Month|Withdrawal by Subject|1|||
155123736|NCT02785458|559885576|FG000|1 Month|Lost to Follow-up|38|||
155123737|NCT02785458|559885577|FG001|1 Month|Lost to Follow-up|31|||
155123738|NCT02785458|559885576|FG000|1 Month|Deemed Ineligible|1|||
155123739|NCT02785458|559885577|FG001|1 Month|Deemed Ineligible|0|||
155123740|NCT02785458|559885576|FG000|1 Month|Completed Evaluation by Baseline|42|||
155123741|NCT02785458|559885577|FG001|1 Month|Completed Evaluation by Baseline|39|||
155123742|NCT02785458|559885576|FG000|1 Month|Partial Interview|0|||
155123743|NCT02785458|559885577|FG001|1 Month|Partial Interview|4|||
155123744|NCT02785458|559885576|FG000|3 Months|Withdrawal by Subject|3|||
155123745|NCT02785458|559885577|FG001|3 Months|Withdrawal by Subject|1|||
155123746|NCT02785458|559885576|FG000|3 Months|Lost to Follow-up|25|||
155123747|NCT02785458|559885577|FG001|3 Months|Lost to Follow-up|21|||
155123748|NCT02785458|559885576|FG000|3 Months|Completed Evaluation at 1 Month|100|||
155123749|NCT02785458|559885577|FG001|3 Months|Completed Evaluation at 1 Month|89|||
155123750|NCT01146652|559885578|FG000|Overall Study|Adverse Event|506|||
155123751|NCT01146652|559885579|FG001|Overall Study|Adverse Event|15|||
155123752|NCT01146652|559885578|FG000|Overall Study|Lack of Efficacy|91|||
155123753|NCT01146652|559885579|FG001|Overall Study|Lack of Efficacy|7|||
155123754|NCT01146652|559885578|FG000|Overall Study|Poor compliance to protocol|38|||
155123755|NCT01146652|559885579|FG001|Overall Study|Poor compliance to protocol|1|||
155123756|NCT01146652|559885578|FG000|Overall Study|Other unspecified reasons|314|||
155123757|NCT01146652|559885579|FG001|Overall Study|Other unspecified reasons|22|||
155123758|NCT01146652|559885578|FG000|Overall Study|Enrolled but not treated|2|||
155123759|NCT01146652|559885579|FG001|Overall Study|Enrolled but not treated|0|||
155123760|NCT02981524|559885580|FG000|Overall Study|Progressive Disease|14|||
155123761|NCT02981524|559885580|FG000|Overall Study|Death (unrelated)|1|||
155123762|NCT02981524|559885580|FG000|Overall Study|Treatment Related Toxicity|1|||
155123763|NCT02981524|559885580|FG000|Overall Study|Withdrawal by Subject|1|||
155123764|NCT00520013|559885581|FG000|Overall Study|Withdrawal by Subject|0|||
155123765|NCT00520013|559885582|FG001|Overall Study|Withdrawal by Subject|0|||
155123766|NCT00520013|559885583|FG002|Overall Study|Withdrawal by Subject|1|||
155123767|NCT00520013|559885581|FG000|Overall Study|Adverse Event|2|||
155123768|NCT00520013|559885582|FG001|Overall Study|Adverse Event|10|||
155123769|NCT00520013|559885583|FG002|Overall Study|Adverse Event|7|||
155123770|NCT00520013|559885581|FG000|Overall Study|Progressive Disease|7|||
155123771|NCT00520013|559885582|FG001|Overall Study|Progressive Disease|3|||
155123772|NCT00520013|559885583|FG002|Overall Study|Progressive Disease|0|||
155123773|NCT00520013|559885581|FG000|Overall Study|Clinical Progression|3|||
155123774|NCT00520013|559885582|FG001|Overall Study|Clinical Progression|1|||
155123775|NCT00520013|559885583|FG002|Overall Study|Clinical Progression|0|||
155123776|NCT00520013|559885581|FG000|Overall Study|Death|0|||
155001872|NCT00299130|559430493|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
155001873|NCT00299130|559430491|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
155001874|NCT00299130|559430492|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
155001875|NCT00299130|559430493|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
155001876|NCT00299130|559430491|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
155001877|NCT00299130|559430492|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
155001878|NCT00299130|559430493|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
155001879|NCT00299130|559430491|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
155001880|NCT00299130|559430492|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
155001881|NCT00299130|559430493|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
155123777|NCT00520013|559885582|FG001|Overall Study|Death|1|||
155123778|NCT00520013|559885583|FG002|Overall Study|Death|0|||
155123779|NCT00520013|559885581|FG000|Overall Study|Physician Decision|0|||
155123780|NCT00520013|559885582|FG001|Overall Study|Physician Decision|0|||
155123781|NCT00520013|559885583|FG002|Overall Study|Physician Decision|3|||
155123782|NCT02118597|559885584|FG000|Overall Study|Sponsor terminated the study|14|||
155123783|NCT02118597|559885584|FG000|Overall Study|Serious Adverse Event|1|||
155123784|NCT02118597|559885584|FG000|Overall Study|Investigator's decision|1|||
155001882|NCT00299130|559430491|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
155123785|NCT03294135|559885586|FG000|Overall Study|Serious Adverse Event|1|||
155123786|NCT03294135|559885587|FG001|Overall Study|Serious Adverse Event|0|||
155123787|NCT03294135|559885588|FG002|Overall Study|Serious Adverse Event|0|||
155123788|NCT03294135|559885586|FG000|Overall Study|Lost to Follow-up|1|||
155123789|NCT03294135|559885587|FG001|Overall Study|Lost to Follow-up|0|||
155123790|NCT03294135|559885588|FG002|Overall Study|Lost to Follow-up|1|||
155123791|NCT03294135|559885586|FG000|Overall Study|Withdrawal by Subject|0|||
155123792|NCT03294135|559885587|FG001|Overall Study|Withdrawal by Subject|0|||
155123793|NCT03294135|559885588|FG002|Overall Study|Withdrawal by Subject|1|||
155123794|NCT03294135|559885586|FG000|Overall Study|Other|2|||
155123795|NCT03294135|559885587|FG001|Overall Study|Other|0|||
155123796|NCT03294135|559885588|FG002|Overall Study|Other|0|||
155123797|NCT03684304|559885591|FG000|Overall Study|Lost to Follow-up|19|||
155123798|NCT03684304|559885592|FG001|Overall Study|Lost to Follow-up|17|||
155123799|NCT00824005|559885595|FG000|Overall Study|Death|0|||
155123800|NCT00824005|559885596|FG001|Overall Study|Death|1|||
155123801|NCT00824005|559885595|FG000|Overall Study|Lost to Follow-up|0|||
155123802|NCT00824005|559885596|FG001|Overall Study|Lost to Follow-up|1|||
155123803|NCT01146288|559885597|FG000|First Intervention(1 Day)|Adverse Event|0|||
155123804|NCT01146288|559885598|FG001|First Intervention(1 Day)|Adverse Event|1|||
155123805|NCT02677844|559885599|FG000|Period 3|Withdrawal by Subject|0|||
155123806|NCT02677844|559885600|FG001|Period 3|Withdrawal by Subject|0|||
155123807|NCT02677844|559885601|FG002|Period 3|Withdrawal by Subject|0|||
155123808|NCT02677844|559885602|FG003|Period 3|Withdrawal by Subject|1|||
155123809|NCT02677844|559885603|FG004|Period 3|Withdrawal by Subject|0|||
155123810|NCT02677844|559885604|FG005|Period 3|Withdrawal by Subject|0|||
155123811|NCT02677844|559885605|FG006|Period 3|Withdrawal by Subject|0|||
155123812|NCT00545532|559885606|FG000|Overall Study|Withdrawal by Subject|1|||
155123813|NCT00545532|559885607|FG001|Overall Study|Withdrawal by Subject|3|||
155123814|NCT00545532|559885606|FG000|Overall Study|Lost to Follow-up|5|||
155123815|NCT00545532|559885607|FG001|Overall Study|Lost to Follow-up|6|||
155123816|NCT00545532|559885606|FG000|Overall Study|Death|0|||
155123817|NCT00545532|559885607|FG001|Overall Study|Death|1|||
155123818|NCT03630302|559885608|FG000|Surgery|hardware issue prevented LFP recordings|1|||
155123819|NCT03630302|559885608|FG000|3 Month Visit|Adverse Event|2|||
155123820|NCT03630302|559885608|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
155123821|NCT03532932|559885612|FG000|Overall Study|Protocol Deviation|33|||
155123822|NCT03532932|559885613|FG001|Overall Study|Protocol Deviation|31|||
155123823|NCT03532932|559885612|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
155123824|NCT03532932|559885613|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
155123825|NCT03532932|559885612|FG000|Overall Study|Withdrawal by Subject|2|||
155123826|NCT03532932|559885613|FG001|Overall Study|Withdrawal by Subject|0|||
155123827|NCT03532932|559885612|FG000|Overall Study|Lost to Follow-up|15|||
155123828|NCT03532932|559885613|FG001|Overall Study|Lost to Follow-up|9|||
155123829|NCT03532932|559885612|FG000|Overall Study|Adverse Event|4|||
155123830|NCT03532932|559885613|FG001|Overall Study|Adverse Event|3|||
155123831|NCT03532932|559885612|FG000|Overall Study|Death|0|||
155123832|NCT03532932|559885613|FG001|Overall Study|Death|2|||
155123833|NCT03532932|559885612|FG000|Overall Study|Other|11|||
155123834|NCT03532932|559885613|FG001|Overall Study|Other|16|||
155123835|NCT02255565|559885615|FG000|Overall Study|Withdrawal by Subject|0|||
155123836|NCT02255565|559885616|FG001|Overall Study|Withdrawal by Subject|1|||
155123837|NCT02255565|559885617|FG002|Overall Study|Withdrawal by Subject|0|||
155123838|NCT00931801|559885618|FG000|Overall Study|Adverse Event|0|||
155123839|NCT00931801|559885619|FG001|Overall Study|Adverse Event|0|||
155123840|NCT00931801|559885620|FG002|Overall Study|Adverse Event|1|||
155123841|NCT00931801|559885618|FG000|Overall Study|Lost to Follow-up|0|||
155123842|NCT00931801|559885619|FG001|Overall Study|Lost to Follow-up|1|||
155123843|NCT00931801|559885620|FG002|Overall Study|Lost to Follow-up|0|||
155123844|NCT00931801|559885618|FG000|Overall Study|Withdrawal by Subject|1|||
155123845|NCT00931801|559885619|FG001|Overall Study|Withdrawal by Subject|0|||
155123846|NCT00931801|559885620|FG002|Overall Study|Withdrawal by Subject|0|||
155123847|NCT00931801|559885618|FG000|Overall Study|Confirmed Virologic Failure|0|||
155123848|NCT00931801|559885619|FG001|Overall Study|Confirmed Virologic Failure|0|||
155123849|NCT00931801|559885620|FG002|Overall Study|Confirmed Virologic Failure|3|||
155123850|NCT01133275|559885621|FG000|Overall Study|Withdrawal by Subject|1|||
155123851|NCT01133275|559885621|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
155123852|NCT02689076|559885622|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
155123853|NCT02689076|559885623|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
155123854|NCT02689076|559885624|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
155123855|NCT02689076|559885622|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
155123856|NCT02689076|559885623|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
155123857|NCT02689076|559885624|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
155123858|NCT02689076|559885622|FG000|Overall Study|Did not have an HIE match|2|||
155123859|NCT02689076|559885623|FG001|Overall Study|Did not have an HIE match|0|||
155123860|NCT02689076|559885624|FG002|Overall Study|Did not have an HIE match|0|||
155178044|NCT00992589|560091386|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
155123861|NCT02689076|559885622|FG000|Overall Study|Death during non-VA encounter|2|||
155123862|NCT02689076|559885623|FG001|Overall Study|Death during non-VA encounter|5|||
155123863|NCT02689076|559885624|FG002|Overall Study|Death during non-VA encounter|0|||
155123864|NCT02689076|559885622|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
155123865|NCT02689076|559885623|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
155123866|NCT02689076|559885624|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
155001883|NCT00299130|559430492|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
155001884|NCT00299130|559430493|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
155001885|NCT03516513|559430494|FG000|Overall Study|Withdrawal by Subject|2|||
155001886|NCT03516513|559430495|FG001|Overall Study|Withdrawal by Subject|2|||
155001887|NCT03516513|559430496|FG002|Overall Study|Withdrawal by Subject|0|||
155001888|NCT03516513|559430497|FG003|Overall Study|Withdrawal by Subject|0|||
155001889|NCT01098487|559430499|FG000|Overall Study|Adverse Event|22|||
155001890|NCT01098487|559430499|FG000|Overall Study|Lack of Efficacy|11|||
155001891|NCT01098487|559430499|FG000|Overall Study|Withdrawal by Subject|7|||
155001892|NCT01098487|559430499|FG000|Overall Study|Lost to Follow-up|3|||
155001893|NCT01098487|559430499|FG000|Overall Study|Physician Decision|1|||
155001894|NCT00345631|559430500|FG000|Overall Study|Withdrawal by Subject|1|||
155001895|NCT00345631|559430501|FG001|Overall Study|Withdrawal by Subject|0|||
155001896|NCT00345631|559430502|FG002|Overall Study|Withdrawal by Subject|1|||
155001897|NCT00345631|559430500|FG000|Overall Study|Adverse Event|0|||
155001898|NCT00345631|559430501|FG001|Overall Study|Adverse Event|1|||
155001899|NCT00345631|559430502|FG002|Overall Study|Adverse Event|0|||
155001900|NCT00345631|559430500|FG000|Overall Study|Lost to Follow-up|3|||
155001901|NCT00345631|559430501|FG001|Overall Study|Lost to Follow-up|7|||
155001902|NCT00345631|559430502|FG002|Overall Study|Lost to Follow-up|4|||
155001903|NCT00345631|559430500|FG000|Overall Study|Other reasons|0|||
155001904|NCT00345631|559430501|FG001|Overall Study|Other reasons|0|||
155001905|NCT00345631|559430502|FG002|Overall Study|Other reasons|1|||
155001906|NCT01589497|559430509|FG000|Overall Study|Withdrawal by Subject|0|||
155001907|NCT01589497|559430510|FG001|Overall Study|Withdrawal by Subject|1|||
155001908|NCT01589497|559430511|FG002|Overall Study|Withdrawal by Subject|0|||
155001909|NCT01589497|559430512|FG003|Overall Study|Withdrawal by Subject|1|||
155001910|NCT01589497|559430509|FG000|Overall Study|Death|1|||
155001911|NCT01589497|559430510|FG001|Overall Study|Death|0|||
155001912|NCT01589497|559430511|FG002|Overall Study|Death|0|||
155001913|NCT01589497|559430512|FG003|Overall Study|Death|0|||
155001914|NCT01589497|559430509|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
155001915|NCT01589497|559430510|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
155001916|NCT01589497|559430511|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
155001917|NCT01589497|559430512|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
155001918|NCT03390426|559430515|FG000|Overall Study|Protocol Violation|0|||
155001919|NCT03390426|559430516|FG001|Overall Study|Protocol Violation|1|||
155001920|NCT00259272|559430523|FG000|Overall Study|Adverse Event|2|||
155001921|NCT00259272|559430524|FG001|Overall Study|Adverse Event|1|||
155001922|NCT00259272|559430525|FG002|Overall Study|Adverse Event|0|||
155001923|NCT00259272|559430526|FG003|Overall Study|Adverse Event|3|||
155001924|NCT00259272|559430523|FG000|Overall Study|Lack of Efficacy|5|||
155001925|NCT00259272|559430524|FG001|Overall Study|Lack of Efficacy|1|||
155001926|NCT00259272|559430525|FG002|Overall Study|Lack of Efficacy|2|||
155001927|NCT00259272|559430526|FG003|Overall Study|Lack of Efficacy|6|||
155001928|NCT00259272|559430523|FG000|Overall Study|Physician Decision|1|||
155001929|NCT00259272|559430524|FG001|Overall Study|Physician Decision|2|||
155001930|NCT00259272|559430525|FG002|Overall Study|Physician Decision|1|||
155001931|NCT00259272|559430526|FG003|Overall Study|Physician Decision|3|||
155001932|NCT00259272|559430523|FG000|Overall Study|Protocol Violation|2|||
155001933|NCT00259272|559430524|FG001|Overall Study|Protocol Violation|0|||
155001934|NCT00259272|559430525|FG002|Overall Study|Protocol Violation|0|||
155001935|NCT00259272|559430526|FG003|Overall Study|Protocol Violation|1|||
155001936|NCT00259272|559430523|FG000|Overall Study|Sponsor Decision|0|||
155001937|NCT00259272|559430524|FG001|Overall Study|Sponsor Decision|1|||
155001938|NCT00259272|559430525|FG002|Overall Study|Sponsor Decision|0|||
155001939|NCT00259272|559430526|FG003|Overall Study|Sponsor Decision|0|||
155001940|NCT00259272|559430523|FG000|Overall Study|Withdrawal by Subject|4|||
155001941|NCT00259272|559430524|FG001|Overall Study|Withdrawal by Subject|2|||
155001942|NCT00259272|559430525|FG002|Overall Study|Withdrawal by Subject|2|||
155001943|NCT00259272|559430526|FG003|Overall Study|Withdrawal by Subject|7|||
155001944|NCT00259272|559430523|FG000|Overall Study|Lost to Follow-up|1|||
155001945|NCT00259272|559430524|FG001|Overall Study|Lost to Follow-up|0|||
155001946|NCT00259272|559430525|FG002|Overall Study|Lost to Follow-up|0|||
155001947|NCT00259272|559430526|FG003|Overall Study|Lost to Follow-up|1|||
155001948|NCT03301623|559430529|FG000|Overall Study|Death|3|||
155001949|NCT03301623|559430530|FG001|Overall Study|Death|1|||
155001950|NCT03301623|559430529|FG000|Overall Study|Withdrawal by Subject|11|||
155001951|NCT03301623|559430530|FG001|Overall Study|Withdrawal by Subject|13|||
155001952|NCT03301623|559430529|FG000|Overall Study|Lost to Follow-up|3|||
155001953|NCT03301623|559430530|FG001|Overall Study|Lost to Follow-up|1|||
155123867|NCT02689076|559885622|FG000|Overall Study|Participant no longer active in VA system|1|||
155001954|NCT01653912|559430532|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155001955|NCT01653912|559430533|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
155001956|NCT01653912|559430534|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155001957|NCT01653912|559430535|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155001958|NCT01653912|559430536|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155123868|NCT02689076|559885623|FG001|Overall Study|Participant no longer active in VA system|0|||
155123869|NCT02689076|559885624|FG002|Overall Study|Participant no longer active in VA system|0|||
155123870|NCT02689076|559885622|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
155123871|NCT02689076|559885623|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
155123872|NCT02689076|559885624|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
155123873|NCT02956850|559885625|FG000|Overall Study|Withdrawal by Subject|0|||
155123874|NCT02956850|559885626|FG001|Overall Study|Withdrawal by Subject|0|||
155123875|NCT02956850|559885627|FG002|Overall Study|Withdrawal by Subject|0|||
155123876|NCT02956850|559885628|FG003|Overall Study|Withdrawal by Subject|0|||
155123877|NCT02956850|559885629|FG004|Overall Study|Withdrawal by Subject|0|||
155123878|NCT02956850|559885630|FG005|Overall Study|Withdrawal by Subject|0|||
155123879|NCT02956850|559885631|FG006|Overall Study|Withdrawal by Subject|0|||
155123880|NCT02956850|559885632|FG007|Overall Study|Withdrawal by Subject|0|||
155123881|NCT02956850|559885633|FG008|Overall Study|Withdrawal by Subject|0|||
155123882|NCT02956850|559885634|FG009|Overall Study|Withdrawal by Subject|0|||
155123883|NCT02956850|559885635|FG010|Overall Study|Withdrawal by Subject|0|||
155123884|NCT02956850|559885636|FG011|Overall Study|Withdrawal by Subject|0|||
155123885|NCT02956850|559885637|FG012|Overall Study|Withdrawal by Subject|0|||
155123886|NCT02956850|559885638|FG013|Overall Study|Withdrawal by Subject|0|||
155123887|NCT02956850|559885639|FG014|Overall Study|Withdrawal by Subject|0|||
155123888|NCT02956850|559885640|FG015|Overall Study|Withdrawal by Subject|0|||
155123889|NCT02956850|559885641|FG016|Overall Study|Withdrawal by Subject|0|||
155123890|NCT02956850|559885642|FG017|Overall Study|Withdrawal by Subject|1|||
155123891|NCT01920152|559885643|FG000|Overall Study|Withdrawal by Subject|1|||
155123892|NCT01920152|559885644|FG001|Overall Study|Withdrawal by Subject|2|||
155123893|NCT00993499|559885645|FG000|Run-in Period (8 Days)|Adverse Event|0|||
155123894|NCT00993499|559885646|FG001|Run-in Period (8 Days)|Adverse Event|1|||
155123895|NCT00993499|559885647|FG002|Run-in Period (8 Days)|Adverse Event|0|||
155123896|NCT00993499|559885648|FG003|Run-in Period (8 Days)|Adverse Event|0|||
155123897|NCT00993499|559885649|FG004|Run-in Period (8 Days)|Adverse Event|0|||
155123898|NCT00993499|559885650|FG005|Run-in Period (8 Days)|Adverse Event|0|||
155123899|NCT00993499|559885645|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
155123900|NCT00993499|559885646|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155123901|NCT00993499|559885647|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155123902|NCT00993499|559885648|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155123903|NCT00993499|559885649|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155123904|NCT00993499|559885650|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
155123905|NCT00993499|559885645|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
155123906|NCT00993499|559885646|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
155123907|NCT00993499|559885647|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
155123908|NCT00993499|559885648|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
155123909|NCT00993499|559885649|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
155123910|NCT00993499|559885650|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
155123911|NCT00993499|559885645|FG000|Run-in Period (8 Days)|Progressive disease|0|||
155123912|NCT00993499|559885646|FG001|Run-in Period (8 Days)|Progressive disease|1|||
155178045|NCT00992589|560091387|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
155178046|NCT00992589|560091388|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
155001959|NCT01653912|559430537|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
155001960|NCT01653912|559430532|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155001961|NCT01653912|559430533|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155001962|NCT01653912|559430534|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
155001963|NCT01653912|559430535|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155001964|NCT01653912|559430536|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155001965|NCT01653912|559430537|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
155001966|NCT01653912|559430532|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155001967|NCT01653912|559430533|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155001968|NCT01653912|559430534|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155123913|NCT00993499|559885647|FG002|Run-in Period (8 Days)|Progressive disease|1|||
155123914|NCT00993499|559885648|FG003|Run-in Period (8 Days)|Progressive disease|0|||
155123915|NCT00993499|559885649|FG004|Run-in Period (8 Days)|Progressive disease|0|||
155123916|NCT00993499|559885650|FG005|Run-in Period (8 Days)|Progressive disease|0|||
155123917|NCT00993499|559885645|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
155123918|NCT00993499|559885646|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
155123919|NCT00993499|559885647|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
155123920|NCT00993499|559885648|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
155123921|NCT00993499|559885649|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
155123922|NCT00993499|559885650|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
155123923|NCT00993499|559885645|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
155123924|NCT00993499|559885646|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
155123925|NCT00993499|559885647|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155001969|NCT01653912|559430535|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
155001970|NCT01653912|559430536|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155001971|NCT01653912|559430537|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
155001972|NCT01653912|559430532|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001973|NCT01653912|559430533|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001974|NCT01653912|559430534|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001975|NCT01653912|559430535|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
155001976|NCT01653912|559430536|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001977|NCT01653912|559430537|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001978|NCT01653912|559430532|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155001979|NCT01653912|559430533|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155001980|NCT01653912|559430534|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155001981|NCT01653912|559430535|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155001982|NCT01653912|559430536|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
155001983|NCT01653912|559430537|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
155001984|NCT01653912|559430532|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155001985|NCT01653912|559430533|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155001986|NCT01653912|559430534|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155001987|NCT01653912|559430535|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155001988|NCT01653912|559430536|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
155001989|NCT01653912|559430537|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
155001990|NCT01653912|559430532|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001991|NCT01653912|559430533|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001992|NCT01653912|559430534|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001993|NCT01653912|559430535|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001994|NCT01653912|559430536|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
155001995|NCT01653912|559430537|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
155001996|NCT05314816|559430538|FG000|Overall Study|Lost to Follow-up|5|||
155001997|NCT05314816|559430539|FG001|Overall Study|Lost to Follow-up|0|||
155001998|NCT05314816|559430540|FG002|Overall Study|Lost to Follow-up|1|||
155001999|NCT05314816|559430538|FG000|Overall Study|Protocol Violation|13|||
155002000|NCT05314816|559430539|FG001|Overall Study|Protocol Violation|8|||
155002001|NCT05314816|559430540|FG002|Overall Study|Protocol Violation|0|||
155002002|NCT01290302|559432423|FG000|Overall Study|Adverse Event|2|||
155002003|NCT01290302|559432424|FG001|Overall Study|Adverse Event|0|||
155002004|NCT01290302|559432423|FG000|Overall Study|Withdrawal by Subject|1|||
155002005|NCT01290302|559432424|FG001|Overall Study|Withdrawal by Subject|0|||
155002006|NCT01290302|559432423|FG000|Overall Study|Physician Decision|0|||
155002007|NCT01290302|559432424|FG001|Overall Study|Physician Decision|2|||
155002008|NCT01290302|559432423|FG000|Overall Study|Expiration of time for screening window|1|||
155002009|NCT01290302|559432424|FG001|Overall Study|Expiration of time for screening window|0|||
155002010|NCT05938621|559432425|FG000|Overall Study|Lost to Follow-up|1|||
155002011|NCT05938621|559432426|FG001|Overall Study|Lost to Follow-up|5|||
155002012|NCT05938621|559432427|FG002|Overall Study|Lost to Follow-up|2|||
155002013|NCT05938621|559432428|FG003|Overall Study|Lost to Follow-up|2|||
155002014|NCT03922529|559432431|FG000|Overall Study|Withdrawal by Subject|13|||
155002015|NCT03922529|559432432|FG001|Overall Study|Withdrawal by Subject|12|||
155002016|NCT03922529|559432431|FG000|Overall Study|Death|7|||
155002017|NCT03922529|559432432|FG001|Overall Study|Death|12|||
155002018|NCT03922529|559432431|FG000|Overall Study|Lost to Follow-up|12|||
155002019|NCT03922529|559432432|FG001|Overall Study|Lost to Follow-up|19|||
155002020|NCT03922529|559432431|FG000|Overall Study|Adverse Event|1|||
155002021|NCT03922529|559432432|FG001|Overall Study|Adverse Event|0|||
155002022|NCT03922529|559432431|FG000|Overall Study|Death after withdrawal|1|||
155002023|NCT03922529|559432432|FG001|Overall Study|Death after withdrawal|0|||
155002024|NCT03922529|559432431|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
155002025|NCT03922529|559432432|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
155002026|NCT03922529|559432431|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
155002027|NCT03922529|559432432|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
155123926|NCT00993499|559885648|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155123927|NCT00993499|559885649|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155123928|NCT00993499|559885650|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
155123929|NCT00993499|559885645|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155123930|NCT00993499|559885646|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155002028|NCT03355469|559432433|FG000|Overall Study|COVID-19|3|||
155002029|NCT03355469|559432434|FG001|Overall Study|COVID-19|2|||
155002030|NCT03355469|559432435|FG002|Overall Study|COVID-19|3|||
155002031|NCT03355469|559432436|FG003|Overall Study|COVID-19|3|||
155002032|NCT03355469|559432433|FG000|Overall Study|Lost to Follow-up|1|||
155002033|NCT03355469|559432434|FG001|Overall Study|Lost to Follow-up|0|||
155002034|NCT03355469|559432435|FG002|Overall Study|Lost to Follow-up|1|||
155123931|NCT00993499|559885647|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
155123932|NCT00993499|559885648|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
155123933|NCT00993499|559885649|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155123934|NCT00993499|559885650|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
155123935|NCT00993499|559885645|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155123936|NCT00993499|559885646|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155123937|NCT00993499|559885647|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
155123938|NCT00993499|559885648|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155123939|NCT00993499|559885649|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155123940|NCT00993499|559885650|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
155123941|NCT00993499|559885645|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155123942|NCT00993499|559885646|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
155123943|NCT00993499|559885647|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155123944|NCT00993499|559885648|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155123945|NCT00993499|559885649|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155123946|NCT00993499|559885650|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
155123947|NCT00993499|559885645|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
155123948|NCT00993499|559885646|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
155123949|NCT00993499|559885647|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
155123950|NCT00993499|559885648|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
155123951|NCT00993499|559885649|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
155123952|NCT00993499|559885650|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
155123953|NCT00993499|559885645|FG000|Discontinued After Starting Course 3|DLT|1|||
155123954|NCT00993499|559885646|FG001|Discontinued After Starting Course 3|DLT|0|||
155123955|NCT00993499|559885647|FG002|Discontinued After Starting Course 3|DLT|2|||
155123956|NCT00993499|559885648|FG003|Discontinued After Starting Course 3|DLT|1|||
155123957|NCT00993499|559885649|FG004|Discontinued After Starting Course 3|DLT|0|||
155123958|NCT00993499|559885650|FG005|Discontinued After Starting Course 3|DLT|0|||
155123959|NCT00993499|559885645|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
155123960|NCT00993499|559885646|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
155123961|NCT00993499|559885647|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
155123962|NCT00993499|559885648|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
155123963|NCT00993499|559885649|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
155123964|NCT00993499|559885650|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
155123965|NCT00334282|559885651|FG000|Overall Study|Lost to Follow-up|11|||
155123966|NCT00334282|559885652|FG001|Overall Study|Lost to Follow-up|5|||
155123967|NCT00334282|559885651|FG000|Overall Study|Withdrawal by Subject|17|||
155123968|NCT00334282|559885652|FG001|Overall Study|Withdrawal by Subject|3|||
155123969|NCT00334282|559885651|FG000|Overall Study|Death|194|||
155123970|NCT00334282|559885652|FG001|Overall Study|Death|100|||
155123971|NCT01420627|559885653|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
155123972|NCT00837876|559885654|FG000|Overall Study|Death|2|||
155123973|NCT00837876|559885654|FG000|Overall Study|Adverse Event|7|||
155123974|NCT00837876|559885654|FG000|Overall Study|Physician Decision|1|||
155123975|NCT00837876|559885654|FG000|Overall Study|Withdrawal by Subject|3|||
155123976|NCT00837876|559885654|FG000|Overall Study|disease progression|24|||
155123977|NCT00453973|559885657|FG000|Overall Study|Adverse Event|4|||
155123978|NCT00453973|559885658|FG001|Overall Study|Adverse Event|9|||
155123979|NCT00453973|559885657|FG000|Overall Study|Withdrawal by Subject|7|||
155123980|NCT00453973|559885658|FG001|Overall Study|Withdrawal by Subject|6|||
155002035|NCT03355469|559432436|FG003|Overall Study|Lost to Follow-up|0|||
155002036|NCT03355469|559432433|FG000|Overall Study|Withdrawal by Subject|2|||
155002037|NCT03355469|559432434|FG001|Overall Study|Withdrawal by Subject|1|||
155002038|NCT03355469|559432435|FG002|Overall Study|Withdrawal by Subject|0|||
155002039|NCT03355469|559432436|FG003|Overall Study|Withdrawal by Subject|3|||
155123981|NCT00453973|559885657|FG000|Overall Study|PI Decision|0|||
155123982|NCT00453973|559885658|FG001|Overall Study|PI Decision|2|||
155123983|NCT00453973|559885657|FG000|Overall Study|Relocation|1|||
155002040|NCT02731638|559432437|FG000|Overall Study|Lost to Follow-up|6|||
155123984|NCT00453973|559885658|FG001|Overall Study|Relocation|0|||
155123985|NCT00453973|559885657|FG000|Overall Study|Renal transplant|1|||
155123986|NCT00453973|559885658|FG001|Overall Study|Renal transplant|1|||
155123987|NCT00453973|559885657|FG000|Overall Study|Site closed by sponsor|3|||
155123988|NCT00453973|559885658|FG001|Overall Study|Site closed by sponsor|0|||
155123989|NCT00453973|559885657|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
155123990|NCT00453973|559885658|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
155123991|NCT00276094|559885659|FG000|Overall Study|Adverse Event|15|||
155123992|NCT00276094|559885660|FG001|Overall Study|Adverse Event|13|||
155123993|NCT00276094|559885661|FG002|Overall Study|Adverse Event|11|||
155123994|NCT00276094|559885659|FG000|Overall Study|Withdrawal by Subject|14|||
155123995|NCT00276094|559885660|FG001|Overall Study|Withdrawal by Subject|14|||
155123996|NCT00276094|559885661|FG002|Overall Study|Withdrawal by Subject|12|||
155123997|NCT00276094|559885659|FG000|Overall Study|Protocol Violation|16|||
155123998|NCT00276094|559885660|FG001|Overall Study|Protocol Violation|7|||
155123999|NCT00276094|559885661|FG002|Overall Study|Protocol Violation|10|||
155124000|NCT00276094|559885659|FG000|Overall Study|Lost to Follow-up|8|||
155124001|NCT00276094|559885660|FG001|Overall Study|Lost to Follow-up|6|||
155124002|NCT00276094|559885661|FG002|Overall Study|Lost to Follow-up|4|||
155124003|NCT00276094|559885659|FG000|Overall Study|Other-Subject moved out of country|1|||
155124004|NCT00276094|559885660|FG001|Overall Study|Other-Subject moved out of country|0|||
155124005|NCT00276094|559885661|FG002|Overall Study|Other-Subject moved out of country|0|||
155124006|NCT00276094|559885659|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
155124007|NCT00276094|559885660|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
155124008|NCT00276094|559885661|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
155124009|NCT00276094|559885659|FG000|Overall Study|Other-Lack of efficacy|1|||
155124010|NCT00276094|559885660|FG001|Overall Study|Other-Lack of efficacy|0|||
155124011|NCT00276094|559885661|FG002|Overall Study|Other-Lack of efficacy|0|||
155124012|NCT00276094|559885659|FG000|Overall Study|Other-Refused follow-up visit|1|||
155124013|NCT00276094|559885660|FG001|Overall Study|Other-Refused follow-up visit|0|||
155124014|NCT00276094|559885661|FG002|Overall Study|Other-Refused follow-up visit|0|||
155124015|NCT00276094|559885659|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
155124016|NCT00276094|559885660|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
155124017|NCT00276094|559885661|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
155124018|NCT00276094|559885659|FG000|Overall Study|Other-Relocation|0|||
155124019|NCT00276094|559885660|FG001|Overall Study|Other-Relocation|1|||
155124020|NCT00276094|559885661|FG002|Overall Study|Other-Relocation|0|||
155124021|NCT00276094|559885659|FG000|Overall Study|Other-Study medication lost|0|||
155124022|NCT00276094|559885660|FG001|Overall Study|Other-Study medication lost|0|||
155124023|NCT00276094|559885661|FG002|Overall Study|Other-Study medication lost|1|||
155124024|NCT00707746|559885662|FG000|Treatment Period|Adverse Event|2|||
155124025|NCT00707746|559885663|FG001|Treatment Period|Adverse Event|4|||
155124026|NCT00707746|559885662|FG000|Treatment Period|Ineligibility|0|||
155124027|NCT00707746|559885663|FG001|Treatment Period|Ineligibility|1|||
155124028|NCT00886119|559885666|FG000|Period 1|Did not meet inclusion criteria|1|||
155124029|NCT00886119|559885667|FG001|Period 1|Did not meet inclusion criteria|0|||
155124030|NCT00357656|559885668|FG000|Overall Study|Other, No surgery performed|0|||
155124031|NCT00357656|559885669|FG001|Overall Study|Other, No surgery performed|3|||
155124032|NCT01219933|559885673|FG000|Overall Study|Adverse Event|8|||
155124033|NCT01219933|559885673|FG000|Overall Study|No LDA reached|5|||
155124034|NCT01219933|559885673|FG000|Overall Study|No LDA maintained|7|||
155124035|NCT01219933|559885673|FG000|Overall Study|Lost to Follow-up|3|||
155124036|NCT01219933|559885673|FG000|Overall Study|GC free|1|||
155124037|NCT01219933|559885673|FG000|Overall Study|Withdrawal by Subject|5|||
155124038|NCT01219933|559885673|FG000|Overall Study|Protocol Violation|8|||
155124039|NCT01219933|559885673|FG000|Overall Study|Lack of Efficacy|1|||
155124040|NCT02256267|559885674|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
155124041|NCT02256267|559885674|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
155124042|NCT01352741|559885680|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
155124043|NCT01352741|559885681|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
155124044|NCT01352741|559885680|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
155124045|NCT01352741|559885681|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
155124046|NCT01352741|559885680|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
155124047|NCT01352741|559885681|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
155124048|NCT01352741|559885680|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
155124049|NCT01352741|559885681|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
155124050|NCT01352741|559885680|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
155124051|NCT01352741|559885681|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
155124052|NCT01352741|559885680|FG000|Open-label Tapentadol Titration Period|Other|4|||
155124053|NCT01352741|559885681|FG001|Open-label Tapentadol Titration Period|Other|0|||
155124054|NCT01352741|559885680|FG000|Double-blind Comparative Period|Protocol Violation|2|||
155124055|NCT01352741|559885681|FG001|Double-blind Comparative Period|Protocol Violation|0|||
155124056|NCT01352741|559885680|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
155124057|NCT01352741|559885681|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
155178047|NCT00992589|560091385|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155178048|NCT00992589|560091386|FG001|Double-Blind Phase|Lost to Follow-up|0|||
155124058|NCT01352741|559885680|FG000|Double-blind Comparative Period|Adverse Event|16|||
155124059|NCT01352741|559885681|FG001|Double-blind Comparative Period|Adverse Event|17|||
155124060|NCT01352741|559885680|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
155124061|NCT01352741|559885681|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
155124062|NCT01352741|559885680|FG000|Double-blind Comparative Period|Death|0|||
155124063|NCT01352741|559885681|FG001|Double-blind Comparative Period|Death|1|||
155124064|NCT01352741|559885680|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
155124065|NCT01352741|559885681|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
155124066|NCT01352741|559885680|FG000|Double-blind Comparative Period|Other|1|||
155124067|NCT01352741|559885681|FG001|Double-blind Comparative Period|Other|2|||
155124068|NCT01352741|559885680|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
155124069|NCT01352741|559885681|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
155124070|NCT01352741|559885680|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
155124071|NCT01352741|559885681|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
155124072|NCT01352741|559885680|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
155124073|NCT01352741|559885681|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
155124074|NCT01352741|559885680|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
155124075|NCT01352741|559885681|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
155124076|NCT00259298|559885682|FG000|Overall Study|Withdrawal by Subject|1|||
155124077|NCT00259298|559885682|FG000|Overall Study|Physician Decision|2|||
155124078|NCT00645528|559885683|FG000|Overall Study|Did not show up for Visit 2|7|||
155124079|NCT03077698|559885684|FG000|Progestin Monotherapy|Stable Disease|8|||
155124080|NCT03077698|559885685|FG001|Progestin Monotherapy|Stable Disease|0|||
155124081|NCT03077698|559885684|FG000|Progestin Monotherapy|Adverse Event|1|||
155124082|NCT03077698|559885685|FG001|Progestin Monotherapy|Adverse Event|0|||
155124083|NCT03077698|559885684|FG000|Progestin Monotherapy|Death|1|||
155124084|NCT03077698|559885685|FG001|Progestin Monotherapy|Death|0|||
155124085|NCT03077698|559885684|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
155124086|NCT03077698|559885685|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
155124087|NCT03077698|559885684|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
155124088|NCT03077698|559885685|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
155124089|NCT03077698|559885684|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
155124090|NCT03077698|559885685|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
155124091|NCT03077698|559885684|FG000|Safety Follow Up|Withdrawal by Subject|2|||
155124092|NCT03077698|559885685|FG001|Safety Follow Up|Withdrawal by Subject|1|||
155124093|NCT03077698|559885684|FG000|Safety Follow Up|Transfer of care to hospice|1|||
155124094|NCT03077698|559885685|FG001|Safety Follow Up|Transfer of care to hospice|0|||
155124095|NCT01969500|559885687|FG000|Overall Study|Death|0|||
155124096|NCT01969500|559885688|FG001|Overall Study|Death|1|||
155124097|NCT01969500|559885687|FG000|Overall Study|extended hospitalization|1|||
155124098|NCT01969500|559885688|FG001|Overall Study|extended hospitalization|1|||
155124099|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
155124100|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
155124101|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
155124102|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
155124103|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
155124104|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
155124105|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
155124106|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
155124107|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
155124108|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
155124109|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
155124110|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
155124111|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
155124112|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
155124113|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
155124114|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
155124115|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
155124116|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
155124117|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
155124118|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
155124119|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
155124120|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
155124121|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
155124122|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
155124123|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
155124124|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
155124125|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
155124126|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
155124127|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
155124128|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
155124129|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
155124130|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
155124131|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
155124132|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
155124133|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
155124134|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
155124135|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
155124136|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
155124137|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
155124138|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
155124139|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
155124140|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
155124141|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
155124142|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
155124143|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
155124144|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
155124145|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
155124146|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
155124147|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
155124148|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
155124149|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
155124150|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
155124151|NCT02008357|559885692|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
155124152|NCT02008357|559885693|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
155124153|NCT02008357|559885692|FG000|Open-label Extension Period|Adverse Event|8|||
155124154|NCT02008357|559885693|FG001|Open-label Extension Period|Adverse Event|7|||
155124155|NCT02008357|559885692|FG000|Open-label Extension Period|Death|7|||
155124156|NCT02008357|559885693|FG001|Open-label Extension Period|Death|4|||
155124157|NCT02008357|559885692|FG000|Open-label Extension Period|Lack of Efficacy|9|||
155124158|NCT02008357|559885693|FG001|Open-label Extension Period|Lack of Efficacy|5|||
155124159|NCT02008357|559885692|FG000|Open-label Extension Period|Lost to Follow-up|2|||
155124160|NCT02008357|559885693|FG001|Open-label Extension Period|Lost to Follow-up|2|||
155124161|NCT02008357|559885692|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
155124162|NCT02008357|559885693|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
155124163|NCT02008357|559885692|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
155124164|NCT02008357|559885693|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
155124165|NCT02008357|559885692|FG000|Open-label Extension Period|Safety Risk|2|||
155124166|NCT02008357|559885693|FG001|Open-label Extension Period|Safety Risk|1|||
155124167|NCT02008357|559885692|FG000|Open-label Extension Period|Non-Compliance|0|||
155124168|NCT02008357|559885693|FG001|Open-label Extension Period|Non-Compliance|1|||
155124169|NCT02008357|559885692|FG000|Open-label Extension Period|Investigator Recommendation|0|||
155124170|NCT02008357|559885693|FG001|Open-label Extension Period|Investigator Recommendation|1|||
155124171|NCT02008357|559885692|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
155124172|NCT02008357|559885693|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
155124173|NCT02008357|559885692|FG000|Open-label Extension Period|Coordinating Center Request|2|||
155124174|NCT02008357|559885693|FG001|Open-label Extension Period|Coordinating Center Request|4|||
155124175|NCT02008357|559885692|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
155124176|NCT02008357|559885693|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
155124177|NCT02008357|559885692|FG000|Open-label Extension Period|Study Ended|20|||
155124178|NCT02008357|559885693|FG001|Open-label Extension Period|Study Ended|25|||
155124179|NCT02008357|559885692|FG000|Open-label Extension Period|Personal Reasons|0|||
155124180|NCT02008357|559885693|FG001|Open-label Extension Period|Personal Reasons|1|||
155124181|NCT02008357|559885692|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
155124182|NCT02008357|559885693|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
155124183|NCT02008357|559885692|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
155124184|NCT02008357|559885693|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
155124185|NCT02008357|559885692|FG000|Open-label Extension Period|Other|2|||
155124186|NCT02008357|559885693|FG001|Open-label Extension Period|Other|0|||
155124187|NCT01269385|559885694|FG000|Overall Study|Adverse Event|1|||
155124188|NCT01269385|559885695|FG001|Overall Study|Adverse Event|1|||
155124189|NCT01269385|559885696|FG002|Overall Study|Adverse Event|0|||
155124190|NCT01269385|559885697|FG003|Overall Study|Adverse Event|0|||
155124191|NCT04941807|559885699|FG000|Overall Study|Lost to Follow-up|1|||
155124192|NCT04941807|559885700|FG001|Overall Study|Lost to Follow-up|1|||
155124193|NCT03553498|559885701|FG000|Overall Study|Missing primary outcome|1|||
155124194|NCT03553498|559885702|FG001|Overall Study|Missing primary outcome|2|||
155124195|NCT02741570|559885703|FG000|Pre-Treatment Period|Other reasons|0|||
155124196|NCT02741570|559885704|FG001|Pre-Treatment Period|Other reasons|3|||
155124197|NCT02741570|559885703|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
155124198|NCT02741570|559885704|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
155124199|NCT02741570|559885703|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
155124200|NCT02741570|559885704|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
155124201|NCT02741570|559885703|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
155124202|NCT02741570|559885704|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
155124203|NCT02741570|559885703|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
155124204|NCT02741570|559885704|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
155124205|NCT02741570|559885703|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
155124206|NCT02741570|559885704|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
155124207|NCT02741570|559885703|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
155124208|NCT02741570|559885704|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
155124209|NCT02741570|559885703|FG000|Pre-Treatment Period|Death|0|||
155124210|NCT02741570|559885704|FG001|Pre-Treatment Period|Death|1|||
155124211|NCT02741570|559885703|FG000|Pre-Treatment Period|Disease progression|0|||
155124212|NCT02741570|559885704|FG001|Pre-Treatment Period|Disease progression|1|||
155124213|NCT02741570|559885703|FG000|Treatment Period|Other reasons|47|||
155124214|NCT02741570|559885704|FG001|Treatment Period|Other reasons|12|||
155124215|NCT02741570|559885703|FG000|Treatment Period|Poor/non-compliance|0|||
155124216|NCT02741570|559885704|FG001|Treatment Period|Poor/non-compliance|2|||
155124217|NCT02741570|559885703|FG000|Treatment Period|Maximum clinical benefit|4|||
155124218|NCT02741570|559885704|FG001|Treatment Period|Maximum clinical benefit|6|||
155124219|NCT02741570|559885703|FG000|Treatment Period|Lost to Follow-up|1|||
155124220|NCT02741570|559885704|FG001|Treatment Period|Lost to Follow-up|3|||
155124221|NCT02741570|559885703|FG000|Treatment Period|Participant withdrew consent|9|||
155124222|NCT02741570|559885704|FG001|Treatment Period|Participant withdrew consent|13|||
155124223|NCT02741570|559885703|FG000|Treatment Period|Participant request to discontinue treatment|8|||
155124224|NCT02741570|559885704|FG001|Treatment Period|Participant request to discontinue treatment|23|||
155124225|NCT02741570|559885703|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
155124226|NCT02741570|559885704|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
155124227|NCT02741570|559885703|FG000|Treatment Period|Death|9|||
155124228|NCT02741570|559885704|FG001|Treatment Period|Death|7|||
155124229|NCT02741570|559885703|FG000|Treatment Period|Study drug toxicity|55|||
155124230|NCT02741570|559885704|FG001|Treatment Period|Study drug toxicity|47|||
155124231|NCT02741570|559885703|FG000|Treatment Period|Disease progression|294|||
155124232|NCT02741570|559885704|FG001|Treatment Period|Disease progression|301|||
155124233|NCT02741570|559885703|FG000|Treatment Period|Administrative reason by sponsor|0|||
155124234|NCT02741570|559885704|FG001|Treatment Period|Administrative reason by sponsor|1|||
155124235|NCT01453946|559885705|FG000|Overall Study|Did not receive drug for the taper phase|1|||
155124236|NCT01453946|559885705|FG000|Overall Study|Protocol Violation|2|||
155124237|NCT01453946|559885705|FG000|Overall Study|Lack of Efficacy|3|||
155124238|NCT01453946|559885705|FG000|Overall Study|Adverse Event|3|||
155124239|NCT01710527|559885706|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
155124240|NCT01710527|559885707|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
155124241|NCT01688921|559885709|FG000|Overall Study|Lost to Follow-up|7|||
155124242|NCT01688921|559885710|FG001|Overall Study|Lost to Follow-up|13|||
155124243|NCT01688921|559885709|FG000|Overall Study|Physician Decision|6|||
155124244|NCT01688921|559885710|FG001|Overall Study|Physician Decision|1|||
155124245|NCT01688921|559885709|FG000|Overall Study|Protocol Violation|0|||
155124246|NCT01688921|559885710|FG001|Overall Study|Protocol Violation|1|||
155124247|NCT01688921|559885709|FG000|Overall Study|informed consent|3|||
155124248|NCT01688921|559885710|FG001|Overall Study|informed consent|0|||
155124249|NCT03697993|559885713|FG000|Overall Study|Became Ineligible after Enrollment|1|||
155124250|NCT03697993|559885714|FG001|Overall Study|Became Ineligible after Enrollment|3|||
155124251|NCT03697993|559885713|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
155124252|NCT03697993|559885714|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
155124253|NCT03697993|559885713|FG000|Overall Study|Lost to Follow-up|3|||
155124254|NCT03697993|559885714|FG001|Overall Study|Lost to Follow-up|0|||
155124255|NCT03697993|559885713|FG000|Overall Study|Physician Decision|4|||
155124256|NCT03697993|559885714|FG001|Overall Study|Physician Decision|0|||
155124257|NCT03697993|559885713|FG000|Overall Study|Initial Urine Culture Negative|0|||
155124258|NCT03697993|559885714|FG001|Overall Study|Initial Urine Culture Negative|1|||
155124259|NCT04384107|559885715|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
155124260|NCT04384107|559885716|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
155124261|NCT04384107|559885715|FG000|Overall Study|Lost to Follow-up|1|||
155124262|NCT04384107|559885716|FG001|Overall Study|Lost to Follow-up|0|||
155002041|NCT02731638|559432438|FG001|Overall Study|Lost to Follow-up|9|||
155002042|NCT02291510|559432439|FG000|Overall Study|Adverse Event|0|||
155002043|NCT02291510|559432440|FG001|Overall Study|Adverse Event|0|||
155002044|NCT02291510|559432441|FG002|Overall Study|Adverse Event|0|||
155124263|NCT02242981|559885717|FG000|Overall Study|Withdrawal by Subject|1|||
155002045|NCT02291510|559432442|FG003|Overall Study|Adverse Event|1|||
155124264|NCT02739321|559885718|FG000|Overall Study|Lack of Efficacy|1|||
155124265|NCT02739321|559885719|FG001|Overall Study|Lack of Efficacy|1|||
155002046|NCT02454608|559432443|FG000|Double-Blind Period|Lack of Efficacy|0|||
155002047|NCT02454608|559432444|FG001|Double-Blind Period|Lack of Efficacy|2|||
155002048|NCT02454608|559432445|FG002|Double-Blind Period|Lack of Efficacy|0|||
155002049|NCT02454608|559432443|FG000|Open Label Period|Lost to Follow-up|0|||
155002050|NCT02454608|559432444|FG001|Open Label Period|Lost to Follow-up|0|||
155002051|NCT02454608|559432445|FG002|Open Label Period|Lost to Follow-up|11|||
155002052|NCT02454608|559432443|FG000|Open Label Period|Withdrawal by Subject|0|||
155002053|NCT02454608|559432444|FG001|Open Label Period|Withdrawal by Subject|0|||
155002054|NCT02454608|559432445|FG002|Open Label Period|Withdrawal by Subject|8|||
155002055|NCT02465398|559432446|FG000|Overall Study|Death|7|||
155002056|NCT02465398|559432446|FG000|Overall Study|Revision|7|||
155002057|NCT02465398|559432446|FG000|Overall Study|did not receive study device|1|||
155002058|NCT02465398|559432446|FG000|Overall Study|Withdrawal by Subject|1|||
155002059|NCT02465398|559432446|FG000|Overall Study|Lost to Follow-up|14|||
155002060|NCT00678210|559432447|FG000|Overall Study|Adverse Event|1|||
155002061|NCT00678210|559432448|FG001|Overall Study|Adverse Event|2|||
155002062|NCT00678210|559432449|FG002|Overall Study|Adverse Event|3|||
155002063|NCT00678210|559432450|FG003|Overall Study|Adverse Event|3|||
155002064|NCT00678210|559432447|FG000|Overall Study|Lack of Efficacy|2|||
155002065|NCT00678210|559432448|FG001|Overall Study|Lack of Efficacy|3|||
155002066|NCT00678210|559432449|FG002|Overall Study|Lack of Efficacy|1|||
155002067|NCT00678210|559432450|FG003|Overall Study|Lack of Efficacy|9|||
155002068|NCT00678210|559432447|FG000|Overall Study|Lost to Follow-up|4|||
155002069|NCT00678210|559432448|FG001|Overall Study|Lost to Follow-up|2|||
155002070|NCT00678210|559432449|FG002|Overall Study|Lost to Follow-up|0|||
155002071|NCT00678210|559432450|FG003|Overall Study|Lost to Follow-up|1|||
155002072|NCT00678210|559432447|FG000|Overall Study|Withdrawal by Subject|3|||
155002073|NCT00678210|559432448|FG001|Overall Study|Withdrawal by Subject|4|||
155002074|NCT00678210|559432449|FG002|Overall Study|Withdrawal by Subject|1|||
155002075|NCT00678210|559432450|FG003|Overall Study|Withdrawal by Subject|7|||
155002076|NCT00678210|559432447|FG000|Overall Study|Other|1|||
155002077|NCT00678210|559432448|FG001|Overall Study|Other|0|||
155002078|NCT00678210|559432449|FG002|Overall Study|Other|1|||
155002079|NCT00678210|559432450|FG003|Overall Study|Other|0|||
155002080|NCT04825912|559432451|FG000|Overall Study|Death|3|||
155002081|NCT04825912|559432451|FG000|Overall Study|Withdrawal by Subject|1|||
155002082|NCT00459355|559432452|FG000|Overall Study|Subject no longer met inc criteria|20|||
155002083|NCT00459355|559432453|FG001|Overall Study|Subject no longer met inc criteria|18|||
155002084|NCT00618371|559432456|FG000|Overall Study|Withdrawal by Subject|2|||
155002085|NCT03965689|559432457|FG000|Overall Study|Too sick to get study intervention|2|||
155002086|NCT01173120|559432459|FG000|Overall Study|Lack of Efficacy|2|||
155002087|NCT01173120|559432459|FG000|Overall Study|Lost to Follow-up|1|||
155002088|NCT01173120|559432459|FG000|Overall Study|Participant Decision|2|||
155002089|NCT01173120|559432459|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
155002090|NCT01173120|559432459|FG000|Overall Study|Switch-Participant Decision|12|||
155002091|NCT01173120|559432459|FG000|Overall Study|Switch-Difficulty With Device|12|||
155002092|NCT01383707|559432469|FG000|Overall Study|Consent withdrawal|6|||
155002093|NCT01383707|559432469|FG000|Overall Study|Death|19|||
155002094|NCT01383707|559432469|FG000|Overall Study|Other|8|||
155002095|NCT01383707|559432469|FG000|Overall Study|Sponsor's decision|2|||
155002096|NCT01383707|559432469|FG000|Overall Study|Adverse Event|14|||
155002097|NCT01383707|559432469|FG000|Overall Study|Progressive disease|23|||
155002098|NCT02013817|559432470|FG000|Overall Study|Adverse Event|12|||
155002099|NCT02013817|559432470|FG000|Overall Study|Withdrawal by Subject|4|||
155002100|NCT02013817|559432470|FG000|Overall Study|Death|2|||
155124266|NCT02739321|559885718|FG000|Overall Study|Lost to Follow-up|1|||
154921543|NCT00594568|559137995|FG002|Initial Treatment|Entry criteria exclusion|1|||
154921544|NCT00594568|559137993|FG000|Delayed Start|Death|0|||
154921545|NCT00594568|559137994|FG001|Delayed Start|Death|0|||
154921546|NCT00594568|559137995|FG002|Delayed Start|Death|1|||
154921547|NCT00594568|559137993|FG000|Delayed Start|Adverse Event|12|||
154921548|NCT00594568|559137994|FG001|Delayed Start|Adverse Event|2|||
154921549|NCT00594568|559137995|FG002|Delayed Start|Adverse Event|2|||
154921550|NCT00594568|559137993|FG000|Delayed Start|Withdrawal by Subject|4|||
154921551|NCT00594568|559137994|FG001|Delayed Start|Withdrawal by Subject|3|||
154921552|NCT00594568|559137995|FG002|Delayed Start|Withdrawal by Subject|0|||
154921553|NCT00594568|559137993|FG000|Delayed Start|Physician Decision|0|||
155002101|NCT02013817|559432470|FG000|Overall Study|Other|9|||
155124267|NCT02739321|559885719|FG001|Overall Study|Lost to Follow-up|1|||
155124268|NCT02739321|559885718|FG000|Overall Study|Withdrawal by Subject|1|||
154921554|NCT00594568|559137994|FG001|Delayed Start|Physician Decision|0|||
154921555|NCT00594568|559137995|FG002|Delayed Start|Physician Decision|1|||
155002102|NCT01434810|559432482|FG000|Overall Study|Did not receive treatment|11|||
155002103|NCT01434810|559432483|FG001|Overall Study|Did not receive treatment|3|||
155002104|NCT01434810|559432482|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
155002105|NCT01434810|559432483|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
154921556|NCT00594568|559137993|FG000|Delayed Start|Lost to Follow-up|0|||
155002106|NCT00799825|559432486|FG000|Overall Study|Adverse Event|1|||
154921557|NCT00594568|559137994|FG001|Delayed Start|Lost to Follow-up|0|||
155124269|NCT02739321|559885719|FG001|Overall Study|Withdrawal by Subject|2|||
155124270|NCT00459537|559885720|FG000|Overall Study|Adverse Event|1|||
155124271|NCT00459537|559885721|FG001|Overall Study|Adverse Event|6|||
154921558|NCT00594568|559137995|FG002|Delayed Start|Lost to Follow-up|1|||
154921559|NCT00594568|559137993|FG000|Delayed Start|Caregiver Decision|5|||
154921560|NCT00594568|559137994|FG001|Delayed Start|Caregiver Decision|6|||
154921561|NCT00594568|559137995|FG002|Delayed Start|Caregiver Decision|2|||
154921562|NCT00594568|559137993|FG000|Delayed Start|Sponsor Decision|77|||
154921563|NCT00594568|559137994|FG001|Delayed Start|Sponsor Decision|66|||
154921564|NCT00594568|559137995|FG002|Delayed Start|Sponsor Decision|59|||
154921565|NCT00594568|559137993|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
155124272|NCT00459537|559885720|FG000|Overall Study|Lack of Efficacy|10|||
155124273|NCT00459537|559885721|FG001|Overall Study|Lack of Efficacy|11|||
155124274|NCT00459537|559885720|FG000|Overall Study|Withdrawal by Subject|20|||
155124275|NCT00459537|559885721|FG001|Overall Study|Withdrawal by Subject|26|||
155124276|NCT00459537|559885720|FG000|Overall Study|Lost to Follow-up|27|||
155124277|NCT00459537|559885721|FG001|Overall Study|Lost to Follow-up|30|||
155124278|NCT00459537|559885720|FG000|Overall Study|Administrative problems|3|||
155124279|NCT00459537|559885721|FG001|Overall Study|Administrative problems|0|||
155124280|NCT00459537|559885720|FG000|Overall Study|Protocol Violation|4|||
155124281|NCT00459537|559885721|FG001|Overall Study|Protocol Violation|3|||
155124282|NCT00459537|559885720|FG000|Overall Study|Missing|1|||
154921566|NCT00594568|559137994|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
154921567|NCT00594568|559137995|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
154921568|NCT00594568|559137993|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
154921569|NCT00594568|559137994|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
154921570|NCT00594568|559137995|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
154921571|NCT00594568|559137993|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
154921572|NCT00594568|559137994|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
154921573|NCT00594568|559137995|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
154921574|NCT00594568|559137993|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
154921575|NCT00594568|559137994|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
154921576|NCT00594568|559137995|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
154921577|NCT00594568|559137993|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
154921578|NCT00594568|559137994|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
154921579|NCT00594568|559137995|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
154921580|NCT00594568|559137993|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
154921581|NCT00594568|559137994|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
154921582|NCT00594568|559137995|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
154921583|NCT02526017|559137996|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921584|NCT02526017|559137997|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921585|NCT02526017|559137998|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921586|NCT02526017|559137999|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921587|NCT02526017|559138000|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
154921588|NCT02526017|559138001|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921589|NCT02526017|559138002|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921590|NCT02526017|559138003|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921591|NCT02526017|559138004|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
154921592|NCT00290511|559138009|FG000|Overall Study|Adverse Event|1|||
154921593|NCT00290511|559138009|FG000|Overall Study|Death|1|||
154921594|NCT00290511|559138009|FG000|Overall Study|Physician Decision|1|||
154921595|NCT00290511|559138009|FG000|Overall Study|Withdrawal by Subject|1|||
154921596|NCT02204449|559138010|FG000|Overall Study|Lost to Follow-up|7|||
154921597|NCT02204449|559138011|FG001|Overall Study|Lost to Follow-up|9|||
154921598|NCT02204449|559138010|FG000|Overall Study|Death|0|||
154921599|NCT02204449|559138011|FG001|Overall Study|Death|1|||
154921600|NCT02204449|559138010|FG000|Overall Study|Withdrawal by Subject|0|||
154921601|NCT02204449|559138011|FG001|Overall Study|Withdrawal by Subject|1|||
154921602|NCT01976663|559138017|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
154921603|NCT01976663|559138017|FG000|Overall Study|Personal Reasons|6|||
154921604|NCT01976663|559138017|FG000|Overall Study|Withdrawal by Subject|4|||
154921605|NCT01976663|559138017|FG000|Overall Study|Screen Failure|3|||
154921606|NCT01976663|559138017|FG000|Overall Study|Adverse Event|2|||
155124283|NCT00459537|559885721|FG001|Overall Study|Missing|0|||
155124284|NCT03780959|559885722|FG000|Part 1|Adverse Event|1|||
155124285|NCT03780959|559885723|FG001|Part 1|Adverse Event|0|||
155124286|NCT03780959|559885724|FG002|Part 1|Adverse Event|0|||
155124287|NCT03780959|559885722|FG000|Part 1|Withdrawal by Subject|1|||
155124288|NCT03780959|559885723|FG001|Part 1|Withdrawal by Subject|0|||
154921607|NCT01976663|559138017|FG000|Overall Study|Lost to Follow-up|3|||
155124289|NCT03780959|559885724|FG002|Part 1|Withdrawal by Subject|0|||
155124290|NCT03780959|559885722|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
155124291|NCT03780959|559885723|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
155124292|NCT03780959|559885724|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
155124293|NCT03780959|559885722|FG000|Part 1|Response Status|2|||
155124294|NCT03780959|559885723|FG001|Part 1|Response Status|0|||
155124295|NCT03780959|559885724|FG002|Part 1|Response Status|0|||
155124296|NCT03780959|559885722|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
155124297|NCT03780959|559885723|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
155124298|NCT03780959|559885724|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
155124299|NCT03780959|559885722|FG000|Part 2|Response Status|0|||
155124300|NCT03780959|559885723|FG001|Part 2|Response Status|18|||
155124301|NCT03780959|559885724|FG002|Part 2|Response Status|6|||
155150946|NCT00770653|559988131|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
155150947|NCT00770653|559988132|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
155150948|NCT00770653|559988131|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
155150949|NCT00770653|559988132|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
155150950|NCT00770653|559988131|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
155150951|NCT00770653|559988132|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
155150952|NCT00770653|559988131|FG000|Overall Study|Lost to Follow-up|1|||
155150953|NCT00770653|559988132|FG001|Overall Study|Lost to Follow-up|2|||
155150954|NCT00770653|559988131|FG000|Overall Study|Physician Decision|1|||
155150955|NCT00770653|559988132|FG001|Overall Study|Physician Decision|0|||
155150956|NCT04906499|559988138|FG000|Overall Study|Lack of time|1|||
155150957|NCT03346434|559988139|FG000|Overall Study|Randomized in Error|0|||
155150958|NCT03346434|559988140|FG001|Overall Study|Randomized in Error|0|||
155150959|NCT03346434|559988141|FG002|Overall Study|Randomized in Error|0|||
155150960|NCT03346434|559988142|FG003|Overall Study|Randomized in Error|0|||
155150961|NCT03346434|559988143|FG004|Overall Study|Randomized in Error|1|||
155150962|NCT03346434|559988144|FG005|Overall Study|Randomized in Error|0|||
155150963|NCT03346434|559988139|FG000|Overall Study|Withdrawal by Subject|0|||
155150964|NCT03346434|559988140|FG001|Overall Study|Withdrawal by Subject|0|||
155150965|NCT03346434|559988141|FG002|Overall Study|Withdrawal by Subject|1|||
155150966|NCT03346434|559988142|FG003|Overall Study|Withdrawal by Subject|0|||
155150967|NCT03346434|559988143|FG004|Overall Study|Withdrawal by Subject|1|||
155150968|NCT03346434|559988144|FG005|Overall Study|Withdrawal by Subject|0|||
155150969|NCT03346434|559988139|FG000|Overall Study|Lost to Follow-up|0|||
155150970|NCT03346434|559988140|FG001|Overall Study|Lost to Follow-up|0|||
155150971|NCT03346434|559988141|FG002|Overall Study|Lost to Follow-up|0|||
155150972|NCT03346434|559988142|FG003|Overall Study|Lost to Follow-up|0|||
155150973|NCT03346434|559988143|FG004|Overall Study|Lost to Follow-up|1|||
155150974|NCT03346434|559988144|FG005|Overall Study|Lost to Follow-up|1|||
155150975|NCT03346434|559988139|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155150976|NCT03346434|559988140|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155150977|NCT03346434|559988141|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155150978|NCT03346434|559988142|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
155150979|NCT03346434|559988143|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
155150980|NCT03346434|559988144|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
155150981|NCT02741128|559988146|FG000|Overall Study|Protocol Violation|4|||
155150982|NCT02741128|559988147|FG001|Overall Study|Protocol Violation|1|||
155150983|NCT02741128|559988146|FG000|Overall Study|Withdrawal by Subject|2|||
155150984|NCT02741128|559988147|FG001|Overall Study|Withdrawal by Subject|0|||
155150985|NCT02741128|559988146|FG000|Overall Study|Lost to Follow-up|1|||
155150986|NCT02741128|559988147|FG001|Overall Study|Lost to Follow-up|0|||
155150987|NCT02081677|559988148|FG000|Overall Study|Adverse Event|0|||
155150988|NCT02081677|559988149|FG001|Overall Study|Adverse Event|0|||
155150989|NCT02081677|559988150|FG002|Overall Study|Adverse Event|1|||
155150990|NCT02081677|559988151|FG003|Overall Study|Adverse Event|0|||
155150991|NCT02081677|559988148|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155150992|NCT02081677|559988149|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155150993|NCT02081677|559988150|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
155150994|NCT02081677|559988151|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155150995|NCT02081677|559988148|FG000|Overall Study|Not comfortable with lens care system|1|||
155150996|NCT02081677|559988149|FG001|Overall Study|Not comfortable with lens care system|0|||
155150997|NCT02081677|559988150|FG002|Overall Study|Not comfortable with lens care system|0|||
155150998|NCT02081677|559988151|FG003|Overall Study|Not comfortable with lens care system|0|||
155150999|NCT02081677|559988148|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155151000|NCT02081677|559988149|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155151001|NCT02081677|559988150|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
155151002|NCT02081677|559988151|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
155151003|NCT01419769|559988152|FG000|Overall Study|Did not receive the AXIOS stent|3|||
155151004|NCT01419769|559988152|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
155151005|NCT00812708|559988155|FG000|Overall Study|Device could not be implanted|2|||
155151006|NCT00812708|559988155|FG000|Overall Study|Lack of medical insurance|1|||
155151007|NCT00812708|559988155|FG000|Overall Study|Switched to another study|1|||
155151008|NCT00812708|559988155|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
155151009|NCT00812708|559988155|FG000|Overall Study|Signed consent but later withdrew|3|||
155151010|NCT04235140|559988159|FG000|Overall Study|Adverse Event|2|||
155151011|NCT04235140|559988159|FG000|Overall Study|Lost to Follow-up|1|||
155124302|NCT02046070|559887382|FG000|Overall Study|Progressive Disease|18|||
155124303|NCT02046070|559887383|FG001|Overall Study|Progressive Disease|11|||
155124304|NCT02046070|559887384|FG002|Overall Study|Progressive Disease|40|||
155124305|NCT02046070|559887382|FG000|Overall Study|Adverse Event|8|||
155124306|NCT02046070|559887383|FG001|Overall Study|Adverse Event|10|||
155124307|NCT02046070|559887384|FG002|Overall Study|Adverse Event|17|||
155124308|NCT02046070|559887382|FG000|Overall Study|Withdrawal by Subject|1|||
155124309|NCT02046070|559887383|FG001|Overall Study|Withdrawal by Subject|2|||
155124310|NCT02046070|559887384|FG002|Overall Study|Withdrawal by Subject|6|||
155124311|NCT02046070|559887382|FG000|Overall Study|Study Terminated by Sponsor|1|||
155124312|NCT02046070|559887383|FG001|Overall Study|Study Terminated by Sponsor|1|||
155124313|NCT02046070|559887384|FG002|Overall Study|Study Terminated by Sponsor|1|||
155124314|NCT02046070|559887382|FG000|Overall Study|Reason not Specified|4|||
155124315|NCT02046070|559887383|FG001|Overall Study|Reason not Specified|4|||
155124316|NCT02046070|559887384|FG002|Overall Study|Reason not Specified|6|||
155124317|NCT04619004|559887385|FG000|Overall Study|Death|114|||
155124318|NCT04619004|559887386|FG001|Overall Study|Death|28|||
155124319|NCT04619004|559887385|FG000|Overall Study|Lost to Follow-up|1|||
155124320|NCT04619004|559887386|FG001|Overall Study|Lost to Follow-up|1|||
155124321|NCT04619004|559887385|FG000|Overall Study|Withdrawal by Subject|24|||
155124322|NCT04619004|559887386|FG001|Overall Study|Withdrawal by Subject|7|||
155124323|NCT04619004|559887385|FG000|Overall Study|Other - Not specified|0|||
155124324|NCT04619004|559887386|FG001|Overall Study|Other - Not specified|1|||
155124325|NCT03007745|559887390|FG000|Overall Study|Sleep test negative for OSA|53|||
155124326|NCT03007745|559887391|FG001|Overall Study|Sleep test negative for OSA|49|||
155124327|NCT03007745|559887390|FG000|Overall Study|Physician Decision|6|||
155124328|NCT03007745|559887391|FG001|Overall Study|Physician Decision|9|||
155124329|NCT03007745|559887390|FG000|Overall Study|Withdrawal by Subject|38|||
155124330|NCT03007745|559887391|FG001|Overall Study|Withdrawal by Subject|16|||
155124331|NCT03007745|559887390|FG000|Overall Study|Lost to Follow-up|19|||
155124332|NCT03007745|559887391|FG001|Overall Study|Lost to Follow-up|25|||
155124333|NCT03007745|559887390|FG000|Overall Study|Unable to login to website|17|||
155124334|NCT03007745|559887391|FG001|Overall Study|Unable to login to website|4|||
155124335|NCT04912895|559887392|FG000|Overall Study|Unable to provide specimen|2|||
155124336|NCT04912895|559887393|FG001|Overall Study|Unable to provide specimen|0|||
155124337|NCT04912895|559887394|FG002|Overall Study|Unable to provide specimen|0|||
155124338|NCT00293709|559887395|FG000|Overall Study|Other|47|||
155124339|NCT00159913|559887398|FG000|Overall Study|Adverse Event|1|||
155124340|NCT00159913|559887399|FG001|Overall Study|Adverse Event|0|||
155124341|NCT00159913|559887400|FG002|Overall Study|Adverse Event|1|||
155124342|NCT00159913|559887401|FG003|Overall Study|Adverse Event|0|||
155124343|NCT00159913|559887398|FG000|Overall Study|Withdrawal by Subject|0|||
155124344|NCT00159913|559887399|FG001|Overall Study|Withdrawal by Subject|0|||
155124345|NCT00159913|559887400|FG002|Overall Study|Withdrawal by Subject|0|||
155124346|NCT00159913|559887401|FG003|Overall Study|Withdrawal by Subject|1|||
155124347|NCT00159913|559887398|FG000|Overall Study|Lost to Follow-up|0|||
155124348|NCT00159913|559887399|FG001|Overall Study|Lost to Follow-up|0|||
155124349|NCT00159913|559887400|FG002|Overall Study|Lost to Follow-up|0|||
155124350|NCT00159913|559887401|FG003|Overall Study|Lost to Follow-up|1|||
155124351|NCT00159913|559887398|FG000|Overall Study|Protocol Violation|1|||
155124352|NCT00159913|559887399|FG001|Overall Study|Protocol Violation|0|||
155124353|NCT00159913|559887400|FG002|Overall Study|Protocol Violation|1|||
155124354|NCT00159913|559887401|FG003|Overall Study|Protocol Violation|0|||
155124355|NCT02763254|559887402|FG000|Overall Study|Adverse Event|1|||
155124356|NCT00431951|559887403|FG000|Overall Study|Inability to follow study procedures|1|||
155124357|NCT00431951|559887404|FG001|Overall Study|Inability to follow study procedures|0|||
155124358|NCT00431951|559887405|FG002|Overall Study|Inability to follow study procedures|1|||
155124359|NCT00431951|559887406|FG003|Overall Study|Inability to follow study procedures|2|||
155124360|NCT00431951|559887403|FG000|Overall Study|Lost to Follow-up|0|||
155124361|NCT00431951|559887404|FG001|Overall Study|Lost to Follow-up|1|||
155124362|NCT00431951|559887405|FG002|Overall Study|Lost to Follow-up|0|||
155124363|NCT00431951|559887406|FG003|Overall Study|Lost to Follow-up|0|||
155124364|NCT00431951|559887403|FG000|Overall Study|Withdrawal by Subject|0|||
155124365|NCT00431951|559887404|FG001|Overall Study|Withdrawal by Subject|1|||
155124366|NCT00431951|559887405|FG002|Overall Study|Withdrawal by Subject|0|||
155124367|NCT00431951|559887406|FG003|Overall Study|Withdrawal by Subject|0|||
155124368|NCT00431951|559887403|FG000|Overall Study|Adverse Event|0|||
155124369|NCT00431951|559887404|FG001|Overall Study|Adverse Event|0|||
155124370|NCT00431951|559887405|FG002|Overall Study|Adverse Event|1|||
155124371|NCT00431951|559887406|FG003|Overall Study|Adverse Event|0|||
155124372|NCT03458702|559887407|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
155124373|NCT03458702|559887408|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
155124374|NCT03458702|559887407|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
155124375|NCT03458702|559887408|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
155124376|NCT01697462|559887409|FG000|Overall Study|Disease Progression|1|||
155124377|NCT01697462|559887409|FG000|Overall Study|Adverse Event|6|||
155124378|NCT01697462|559887409|FG000|Overall Study|Lost to Follow-up|21|||
154921608|NCT04780776|559138018|FG000|Titration Week 1-5|Lost to Follow-up|2|||
154921609|NCT04780776|559138019|FG001|Titration Week 1-5|Lost to Follow-up|8|||
154921610|NCT04780776|559138018|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
154921611|NCT04780776|559138019|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
154921612|NCT04780776|559138018|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
154921613|NCT04780776|559138019|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
154921614|NCT03113760|559138021|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
154921615|NCT03113760|559138022|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
154921616|NCT03113760|559138023|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
154921617|NCT03113760|559138024|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
154921618|NCT03113760|559138021|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
154921619|NCT03113760|559138022|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
154921620|NCT03113760|559138023|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
154921621|NCT03113760|559138024|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
154921622|NCT03113760|559138021|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
154921623|NCT03113760|559138022|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
154921624|NCT03113760|559138023|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
154921625|NCT03113760|559138024|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
154921626|NCT01982942|559138025|FG000|Overall Study|Adverse Event|10|||
154921627|NCT01982942|559138026|FG001|Overall Study|Adverse Event|5|||
154921628|NCT01982942|559138025|FG000|Overall Study|Lost to Follow-up|4|||
154921629|NCT01982942|559138026|FG001|Overall Study|Lost to Follow-up|3|||
154921630|NCT01982942|559138025|FG000|Overall Study|Multiple sclerosis progression|3|||
154921631|NCT01982942|559138026|FG001|Overall Study|Multiple sclerosis progression|2|||
154921632|NCT01982942|559138025|FG000|Overall Study|Wanted to try therapy not permitted|1|||
154921633|NCT01982942|559138026|FG001|Overall Study|Wanted to try therapy not permitted|0|||
154921634|NCT01982942|559138025|FG000|Overall Study|Subject declined future visits|0|||
154921635|NCT01982942|559138026|FG001|Overall Study|Subject declined future visits|1|||
154921636|NCT01982942|559138025|FG000|Overall Study|Left geographical area|2|||
154921637|NCT01982942|559138026|FG001|Overall Study|Left geographical area|0|||
154921638|NCT01982942|559138025|FG000|Overall Study|Too many pills|1|||
154921639|NCT01982942|559138026|FG001|Overall Study|Too many pills|0|||
154921640|NCT01982942|559138025|FG000|Overall Study|MS Relapse|0|||
154921641|NCT01982942|559138026|FG001|Overall Study|MS Relapse|1|||
154921642|NCT01982942|559138025|FG000|Overall Study|Chose to join a stem cell trial|0|||
154921643|NCT01982942|559138026|FG001|Overall Study|Chose to join a stem cell trial|1|||
154921644|NCT01982942|559138025|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
154921645|NCT01982942|559138026|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
154921646|NCT01151085|559138029|FG000|Overall Study|Lost to Follow-up|31|||
154921647|NCT01151085|559138029|FG000|Overall Study|Protocol Violation|25|||
154921648|NCT03246152|559138030|FG000|Overall Study|Lost to Follow-up|2|||
154921649|NCT03246152|559138030|FG000|Overall Study|Protocol Violation|1|||
154921650|NCT01243762|559138031|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
154921651|NCT01243762|559138032|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
154921652|NCT01243762|559138033|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
154921653|NCT01243762|559138034|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
154921654|NCT01243762|559138035|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
154921655|NCT01243762|559138036|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
154921656|NCT01243762|559138037|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
154921657|NCT01243762|559138031|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
154921658|NCT01243762|559138032|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
154921659|NCT01243762|559138033|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
154921660|NCT01243762|559138034|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
154921661|NCT01243762|559138035|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
154921662|NCT01243762|559138036|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
154921663|NCT01243762|559138037|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
155124379|NCT01697462|559887409|FG000|Overall Study|Withdrawal by Subject|12|||
155124380|NCT01697462|559887409|FG000|Overall Study|Investigator Decision|21|||
155124381|NCT01697462|559887409|FG000|Overall Study|Death|1|||
155124382|NCT01697462|559887409|FG000|Overall Study|Other|10|||
155124383|NCT01697462|559887409|FG000|Overall Study|Missing|5|||
155124384|NCT00168103|559887410|FG000|Overall Study|Withdrawal by Subject|1|||
155124385|NCT00168103|559887411|FG001|Overall Study|Withdrawal by Subject|2|||
154921664|NCT01243762|559138031|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
155002107|NCT00799825|559432486|FG000|Overall Study|Withdrawal by Subject|6|||
155124386|NCT00168103|559887412|FG002|Overall Study|Withdrawal by Subject|1|||
154921665|NCT01243762|559138032|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
154921666|NCT01243762|559138033|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
154921667|NCT01243762|559138034|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
155124387|NCT00168103|559887413|FG003|Overall Study|Withdrawal by Subject|0|||
154921668|NCT01243762|559138035|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
155002108|NCT00799825|559432486|FG000|Overall Study|Lost to Follow-up|38|||
155124388|NCT00168103|559887410|FG000|Overall Study|Lost to Follow-up|1|||
155124389|NCT00168103|559887411|FG001|Overall Study|Lost to Follow-up|3|||
155124390|NCT00168103|559887412|FG002|Overall Study|Lost to Follow-up|0|||
155124391|NCT00168103|559887413|FG003|Overall Study|Lost to Follow-up|0|||
155124392|NCT03412604|559887415|FG000|Overall Study|Withdrawal by Subject|1|||
155124393|NCT01287195|559887418|FG000|Overall Study|Withdrawal by Subject|2|||
155124394|NCT02068118|559887419|FG000|18-month Comparative Study Period|Death|90|||
155124395|NCT02068118|559887420|FG001|18-month Comparative Study Period|Death|97|||
155124396|NCT02068118|559887419|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
155124397|NCT02068118|559887420|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
155124398|NCT02068118|559887419|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
155124399|NCT02068118|559887420|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
155124400|NCT02068118|559887419|FG000|18-month Comparative Study Period|Heart transplant|9|||
155124401|NCT02068118|559887420|FG001|18-month Comparative Study Period|Heart transplant|15|||
155124402|NCT02068118|559887419|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
155124403|NCT02068118|559887420|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
155124404|NCT02068118|559887419|FG000|18-month Comparative Study Period|Hemiplegia|0|||
155124405|NCT02068118|559887420|FG001|18-month Comparative Study Period|Hemiplegia|1|||
155124406|NCT02068118|559887419|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
155124407|NCT02068118|559887420|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
155124408|NCT02068118|559887419|FG000|18-month Comparative Study Period|Move|0|||
155124409|NCT02068118|559887420|FG001|18-month Comparative Study Period|Move|1|||
155124410|NCT02068118|559887419|FG000|18-month Comparative Study Period|Hearing loss|0|||
155124411|NCT02068118|559887420|FG001|18-month Comparative Study Period|Hearing loss|1|||
155124412|NCT02068118|559887419|FG000|Extension Period|Death|0|||
155124413|NCT02068118|559887420|FG001|Extension Period|Death|2|||
155124414|NCT02068118|559887419|FG000|Extension Period|Withdrawal by Subject|1|||
155124415|NCT02068118|559887420|FG001|Extension Period|Withdrawal by Subject|0|||
155124416|NCT02068118|559887419|FG000|Extension Period|Heart transplant|1|||
155124417|NCT02068118|559887420|FG001|Extension Period|Heart transplant|0|||
155124418|NCT02068118|559887419|FG000|Extension Period|Wrong device use|0|||
155124419|NCT02068118|559887420|FG001|Extension Period|Wrong device use|1|||
155124420|NCT01902888|559887425|FG000|Overall Study|Study Terminated|3|||
155124421|NCT01685983|559887426|FG000|Overall Study|Adverse Event|7|||
155124422|NCT01685983|559887426|FG000|Overall Study|Death|1|||
155124423|NCT01685983|559887426|FG000|Overall Study|Withdrawal by Subject|19|||
155124424|NCT01685983|559887426|FG000|Overall Study|Protocol Violation|2|||
155124425|NCT01685983|559887426|FG000|Overall Study|Physician Decision|13|||
155124426|NCT01685983|559887426|FG000|Overall Study|Other|7|||
155124427|NCT01685983|559887426|FG000|Overall Study|Progressive Disease|32|||
155124428|NCT01685983|559887426|FG000|Overall Study|Noncompliance with Study Drug|1|||
155124429|NCT00685373|559887430|FG000|Overall Study|Adverse Event|3|||
155124430|NCT00685373|559887430|FG000|Overall Study|Withdrawal by Subject|5|||
155124431|NCT00685373|559887430|FG000|Overall Study|Lack of Efficacy|3|||
155124432|NCT00685373|559887430|FG000|Overall Study|Condition no longer requires study drug|1|||
155124433|NCT00685373|559887430|FG000|Overall Study|Lost to Follow-up|2|||
155124434|NCT00685373|559887430|FG000|Overall Study|Protocol Violation|1|||
155124435|NCT00582738|559887431|FG000|Overall Study|Administrative Problems|7|||
155124436|NCT00582738|559887432|FG001|Overall Study|Administrative Problems|8|||
155124437|NCT00582738|559887431|FG000|Overall Study|Adverse Event|0|||
155124438|NCT00582738|559887432|FG001|Overall Study|Adverse Event|5|||
155124439|NCT00582738|559887431|FG000|Overall Study|Graft Lost|0|||
155124440|NCT00582738|559887432|FG001|Overall Study|Graft Lost|1|||
155124441|NCT00582738|559887431|FG000|Overall Study|Other|1|||
155124442|NCT00582738|559887432|FG001|Overall Study|Other|0|||
155124443|NCT00582738|559887431|FG000|Overall Study|Protocol Violation|1|||
155124444|NCT00582738|559887432|FG001|Overall Study|Protocol Violation|1|||
155124445|NCT00582738|559887431|FG000|Overall Study|Withdrawal by Subject|0|||
155124446|NCT00582738|559887432|FG001|Overall Study|Withdrawal by Subject|3|||
155124447|NCT01167907|559887435|FG000|Overall Study|Protocol Violation|1|||
155124448|NCT01167907|559887436|FG001|Overall Study|Protocol Violation|0|||
155124449|NCT01167907|559887435|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
155124450|NCT01167907|559887436|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
155124451|NCT01011933|559887440|FG000|Overall Study|Wrong cell type|1|||
155124452|NCT01011933|559887440|FG000|Overall Study|Improper pre-protocol Rx|1|||
155124453|NCT01011933|559887440|FG000|Overall Study|Inadequate pathology|1|||
155124454|NCT01011933|559887440|FG000|Overall Study|Never treated|1|||
155124455|NCT01439074|559887441|FG000|Overall Study|Lost to Follow-up|3|||
155124456|NCT01439074|559887442|FG001|Overall Study|Lost to Follow-up|4|||
155124457|NCT01439074|559887441|FG000|Overall Study|Subject shedding|1|||
155124458|NCT01439074|559887442|FG001|Overall Study|Subject shedding|0|||
155124459|NCT01439074|559887441|FG000|Overall Study|Withdrawal by Subject|1|||
155124460|NCT01439074|559887442|FG001|Overall Study|Withdrawal by Subject|5|||
155124461|NCT01439074|559887441|FG000|Overall Study|Other|4|||
155124462|NCT01439074|559887442|FG001|Overall Study|Other|4|||
155124463|NCT01873729|559887443|FG000|Overall Study|Withdrawal by Subject|1|||
155124464|NCT02463032|559887444|FG000|Overall Study|Lack of Efficacy|61|||
155124465|NCT02463032|559887445|FG001|Overall Study|Lack of Efficacy|50|||
155124466|NCT02463032|559887444|FG000|Overall Study|Death|8|||
155124467|NCT02463032|559887445|FG001|Overall Study|Death|8|||
155124468|NCT02463032|559887444|FG000|Overall Study|Adverse Event|2|||
155124469|NCT02463032|559887445|FG001|Overall Study|Adverse Event|6|||
155124470|NCT01741532|559887446|FG000|Overall Study|Adverse Event|4|||
155124471|NCT01741532|559887447|FG001|Overall Study|Adverse Event|0|||
155124472|NCT01741532|559887446|FG000|Overall Study|Withdrawal by Subject|1|||
155124473|NCT01741532|559887447|FG001|Overall Study|Withdrawal by Subject|1|||
155124474|NCT01741532|559887446|FG000|Overall Study|Protocol Violation|0|||
155124475|NCT01741532|559887447|FG001|Overall Study|Protocol Violation|1|||
155124476|NCT01741532|559887446|FG000|Overall Study|Worsening of the disease|3|||
155124477|NCT01741532|559887447|FG001|Overall Study|Worsening of the disease|1|||
155124478|NCT01741532|559887446|FG000|Overall Study|Sponsor decision|1|||
155124479|NCT01741532|559887447|FG001|Overall Study|Sponsor decision|0|||
155124480|NCT01741532|559887446|FG000|Overall Study|Medical event|1|||
155124481|NCT01741532|559887447|FG001|Overall Study|Medical event|0|||
155124482|NCT01066780|559887448|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
155124483|NCT01066780|559887449|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
155124484|NCT00613080|559887450|FG000|Overall Study|Ineligible / no protocol treatment|11|||
155124485|NCT02226549|559887451|FG000|Overall Study|Randomized but Never Treated|1|||
155124486|NCT02226549|559887452|FG001|Overall Study|Randomized but Never Treated|0|||
155124487|NCT02226549|559887451|FG000|Overall Study|Lost to Follow-up|0|||
155124488|NCT02226549|559887452|FG001|Overall Study|Lost to Follow-up|1|||
155124489|NCT00612508|559887454|FG000|Overall Study|Withdrawal by Subject|3|||
155124490|NCT00612508|559887455|FG001|Overall Study|Withdrawal by Subject|4|||
155124491|NCT03099148|559887457|FG000|Wash-out|scheduling conflict|0|||
155124492|NCT03099148|559887458|FG001|Wash-out|scheduling conflict|1|||
155124493|NCT03099148|559887459|FG002|Wash-out|scheduling conflict|0|||
155124494|NCT03099148|559887460|FG003|Wash-out|scheduling conflict|0|||
155124495|NCT03099148|559887457|FG000|Wash-out|Adverse Event|0|||
155124496|NCT03099148|559887458|FG001|Wash-out|Adverse Event|1|||
155124497|NCT03099148|559887459|FG002|Wash-out|Adverse Event|0|||
155124498|NCT03099148|559887460|FG003|Wash-out|Adverse Event|0|||
155124499|NCT02312219|559887461|FG000|Overall Study|Withdrawal by Subject|1|||
155124500|NCT02312219|559887462|FG001|Overall Study|Withdrawal by Subject|2|||
155124501|NCT02312219|559887461|FG000|Overall Study|could not schedule imaging in time|0|||
155124502|NCT02312219|559887462|FG001|Overall Study|could not schedule imaging in time|2|||
155124503|NCT02312219|559887461|FG000|Overall Study|Other|0|||
155124504|NCT02312219|559887462|FG001|Overall Study|Other|1|||
155124505|NCT02312219|559887461|FG000|Overall Study|Not randomized. Ineligible|0|||
155124506|NCT02312219|559887462|FG001|Overall Study|Not randomized. Ineligible|1|||
155124507|NCT01100567|559887463|FG000|Overall Study|Withdrawal by Subject|5|||
155124508|NCT01100567|559887464|FG001|Overall Study|Withdrawal by Subject|8|||
155124509|NCT01100567|559887463|FG000|Overall Study|Early Hospital Discharge|6|||
155124510|NCT01100567|559887464|FG001|Overall Study|Early Hospital Discharge|4|||
155124511|NCT01100567|559887463|FG000|Overall Study|Lost to Follow-up|1|||
155124512|NCT01100567|559887464|FG001|Overall Study|Lost to Follow-up|2|||
155124513|NCT01100567|559887463|FG000|Overall Study|Physician Decision|0|||
155124514|NCT01100567|559887464|FG001|Overall Study|Physician Decision|1|||
155124515|NCT01100567|559887463|FG000|Overall Study|Deemed ineligible after consent|0|||
155124516|NCT01100567|559887464|FG001|Overall Study|Deemed ineligible after consent|1|||
155124517|NCT01498185|559887466|FG000|Overall Study|Adverse Event|0|||
155124518|NCT01498185|559887467|FG001|Overall Study|Adverse Event|0|||
155124519|NCT01498185|559887468|FG002|Overall Study|Adverse Event|0|||
155124520|NCT01498185|559887469|FG003|Overall Study|Adverse Event|1|||
155124521|NCT01498185|559887470|FG004|Overall Study|Adverse Event|0|||
155124522|NCT01498185|559887466|FG000|Overall Study|Withdrawal by Subject|1|||
155124523|NCT01498185|559887467|FG001|Overall Study|Withdrawal by Subject|1|||
155124524|NCT01498185|559887468|FG002|Overall Study|Withdrawal by Subject|0|||
155124525|NCT01498185|559887469|FG003|Overall Study|Withdrawal by Subject|2|||
155124526|NCT01498185|559887470|FG004|Overall Study|Withdrawal by Subject|1|||
155124527|NCT01498185|559887466|FG000|Overall Study|No longer met criteria, etc|0|||
155124528|NCT01498185|559887467|FG001|Overall Study|No longer met criteria, etc|0|||
155002109|NCT00799825|559432486|FG000|Overall Study|Pregnancy|3|||
155124529|NCT01498185|559887468|FG002|Overall Study|No longer met criteria, etc|0|||
155124530|NCT01498185|559887469|FG003|Overall Study|No longer met criteria, etc|0|||
155124531|NCT01498185|559887470|FG004|Overall Study|No longer met criteria, etc|2|||
155124532|NCT00946322|559887471|FG000|Pre-treatment|participant failure to follow up|1|||
155124533|NCT00946322|559887471|FG000|Post-treatment|participant failure to follow up|2|||
155124534|NCT03352453|559887472|FG000|Overall Study|Miscellaneous Reasons|1|||
155124535|NCT03352453|559887473|FG001|Overall Study|Miscellaneous Reasons|2|||
155124536|NCT03352453|559887472|FG000|Overall Study|Lack of Efficacy|1|||
155124537|NCT03352453|559887473|FG001|Overall Study|Lack of Efficacy|0|||
155124538|NCT03352453|559887472|FG000|Overall Study|Withdrawal by Subject|8|||
155124539|NCT03352453|559887473|FG001|Overall Study|Withdrawal by Subject|14|||
155124540|NCT03352453|559887472|FG000|Overall Study|Study Terminated by Sponsor|2|||
155124541|NCT03352453|559887473|FG001|Overall Study|Study Terminated by Sponsor|1|||
155124542|NCT03352453|559887472|FG000|Overall Study|Protocol Deviation|1|||
155124543|NCT03352453|559887473|FG001|Overall Study|Protocol Deviation|0|||
155124544|NCT03352453|559887472|FG000|Overall Study|Lost to Follow-up|7|||
155124545|NCT03352453|559887473|FG001|Overall Study|Lost to Follow-up|6|||
155124546|NCT03352453|559887472|FG000|Overall Study|Adverse Event|2|||
155124547|NCT03352453|559887473|FG001|Overall Study|Adverse Event|9|||
155124548|NCT02827500|559887476|FG000|Overall Study|Death|7|||
155124549|NCT02827500|559887477|FG001|Overall Study|Death|3|||
155124550|NCT02827500|559887476|FG000|Overall Study|Lost to Follow-up|1|||
155124551|NCT02827500|559887477|FG001|Overall Study|Lost to Follow-up|1|||
155124552|NCT02827500|559887476|FG000|Overall Study|Withdrawal by Subject|3|||
155124553|NCT02827500|559887477|FG001|Overall Study|Withdrawal by Subject|1|||
155124554|NCT02827500|559887476|FG000|Overall Study|Missing primary endpoint data|3|||
155124555|NCT02827500|559887477|FG001|Overall Study|Missing primary endpoint data|1|||
155124556|NCT02827500|559887476|FG000|Overall Study|Other|5|||
155124557|NCT02827500|559887477|FG001|Overall Study|Other|1|||
155124558|NCT01241760|559887480|FG000|Overall Study|Adverse Event|1|||
155124559|NCT01241760|559887481|FG001|Overall Study|Adverse Event|0|||
155124560|NCT01241760|559887480|FG000|Overall Study|Lost to Follow-up|18|||
155124561|NCT01241760|559887481|FG001|Overall Study|Lost to Follow-up|22|||
155124562|NCT01241760|559887480|FG000|Overall Study|Withdrawal by Subject|13|||
155124563|NCT01241760|559887481|FG001|Overall Study|Withdrawal by Subject|13|||
155124564|NCT01241760|559887480|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
155124565|NCT01241760|559887481|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
155124566|NCT01241760|559887480|FG000|Overall Study|Other|1|||
155124567|NCT01241760|559887481|FG001|Overall Study|Other|1|||
155124568|NCT01636713|559887483|FG000|Overall Study|Adverse Event|16|||
155124569|NCT01636713|559887484|FG001|Overall Study|Adverse Event|16|||
155124570|NCT01636713|559887485|FG002|Overall Study|Adverse Event|7|||
155124571|NCT01636713|559887483|FG000|Overall Study|Lack of Efficacy|6|||
155124572|NCT01636713|559887484|FG001|Overall Study|Lack of Efficacy|6|||
155124573|NCT01636713|559887485|FG002|Overall Study|Lack of Efficacy|2|||
155124574|NCT01636713|559887483|FG000|Overall Study|Protocol Violation|3|||
155124575|NCT01636713|559887484|FG001|Overall Study|Protocol Violation|0|||
155124576|NCT01636713|559887485|FG002|Overall Study|Protocol Violation|1|||
155124577|NCT01636713|559887483|FG000|Overall Study|Lost to Follow-up|0|||
155124578|NCT01636713|559887484|FG001|Overall Study|Lost to Follow-up|0|||
155124579|NCT01636713|559887485|FG002|Overall Study|Lost to Follow-up|1|||
155124580|NCT01636713|559887483|FG000|Overall Study|Withdrawal by Subject|5|||
155124581|NCT01636713|559887484|FG001|Overall Study|Withdrawal by Subject|4|||
155124582|NCT01636713|559887485|FG002|Overall Study|Withdrawal by Subject|8|||
155124583|NCT01636713|559887483|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
155124584|NCT01636713|559887484|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
155124585|NCT01636713|559887485|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
155124586|NCT01522404|559887489|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
155124587|NCT01522404|559887490|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
155124588|NCT01522404|559887489|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
155124589|NCT01522404|559887490|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
155124590|NCT01522404|559887489|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
155124591|NCT01522404|559887490|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
155124592|NCT02525094|559887491|FG000|Overall Study|Lost to Follow-up|2|||
155124593|NCT02525094|559887492|FG001|Overall Study|Lost to Follow-up|1|||
155124594|NCT02525094|559887491|FG000|Overall Study|Withdrawal by Subject|5|||
155124595|NCT02525094|559887492|FG001|Overall Study|Withdrawal by Subject|6|||
155124596|NCT02525094|559887491|FG000|Overall Study|Not Treated|1|||
155124597|NCT02525094|559887492|FG001|Overall Study|Not Treated|1|||
155124598|NCT01490294|559887493|FG000|Overall Study|Prematurely discontinuation|4|||
155124599|NCT01490294|559887494|FG001|Overall Study|Prematurely discontinuation|0|||
155124600|NCT01490294|559887495|FG002|Overall Study|Prematurely discontinuation|1|||
155124601|NCT01490294|559887496|FG003|Overall Study|Prematurely discontinuation|1|||
155124602|NCT01490294|559887493|FG000|Overall Study|Adverse Event|1|||
155124603|NCT01490294|559887494|FG001|Overall Study|Adverse Event|0|||
155124604|NCT01490294|559887495|FG002|Overall Study|Adverse Event|0|||
155124605|NCT01490294|559887496|FG003|Overall Study|Adverse Event|0|||
155124606|NCT01751776|559887499|FG000|Overall Study|Adverse Event|0|||
155124607|NCT01751776|559887500|FG001|Overall Study|Adverse Event|0|||
155124608|NCT01751776|559887501|FG002|Overall Study|Adverse Event|0|||
155124609|NCT01751776|559887502|FG003|Overall Study|Adverse Event|0|||
155124610|NCT01751776|559887503|FG004|Overall Study|Adverse Event|0|||
155124611|NCT01751776|559887504|FG005|Overall Study|Adverse Event|0|||
155124612|NCT01751776|559887505|FG006|Overall Study|Adverse Event|4|||
155124613|NCT01751776|559887506|FG007|Overall Study|Adverse Event|2|||
155124614|NCT01751776|559887499|FG000|Overall Study|Consent withdrawn|0|||
155124615|NCT01751776|559887500|FG001|Overall Study|Consent withdrawn|0|||
155124616|NCT01751776|559887501|FG002|Overall Study|Consent withdrawn|0|||
155124617|NCT01751776|559887502|FG003|Overall Study|Consent withdrawn|0|||
155124618|NCT01751776|559887503|FG004|Overall Study|Consent withdrawn|0|||
155124619|NCT01751776|559887504|FG005|Overall Study|Consent withdrawn|0|||
155124620|NCT01751776|559887505|FG006|Overall Study|Consent withdrawn|0|||
155124621|NCT01751776|559887506|FG007|Overall Study|Consent withdrawn|1|||
155124622|NCT01751776|559887499|FG000|Overall Study|Other reason not specified above|0|||
155124623|NCT01751776|559887500|FG001|Overall Study|Other reason not specified above|0|||
155124624|NCT01751776|559887501|FG002|Overall Study|Other reason not specified above|0|||
155124625|NCT01751776|559887502|FG003|Overall Study|Other reason not specified above|0|||
155124626|NCT01751776|559887503|FG004|Overall Study|Other reason not specified above|0|||
155124627|NCT01751776|559887504|FG005|Overall Study|Other reason not specified above|0|||
155124628|NCT01751776|559887505|FG006|Overall Study|Other reason not specified above|0|||
155124629|NCT01751776|559887506|FG007|Overall Study|Other reason not specified above|1|||
155124630|NCT00831701|559887507|FG000|Overall Study|Withdrawal by Subject|2|||
155124631|NCT00831701|559887508|FG001|Overall Study|Withdrawal by Subject|0|||
155124632|NCT00831701|559887507|FG000|Overall Study|Stone expulsion before first medication|2|||
155124633|NCT00831701|559887508|FG001|Overall Study|Stone expulsion before first medication|2|||
155124634|NCT00831701|559887507|FG000|Overall Study|Lost to Follow-up|1|||
155124635|NCT00831701|559887508|FG001|Overall Study|Lost to Follow-up|3|||
155124636|NCT02117349|559887509|FG000|Overall Study|Withdrawal by Subject|1|||
155124637|NCT02117349|559887510|FG001|Overall Study|Withdrawal by Subject|0|||
155124638|NCT02117349|559887509|FG000|Overall Study|Lost to Follow-up|1|||
155124639|NCT02117349|559887510|FG001|Overall Study|Lost to Follow-up|1|||
155124640|NCT02117349|559887509|FG000|Overall Study|Death|1|||
155124641|NCT02117349|559887510|FG001|Overall Study|Death|0|||
155124642|NCT02535416|559887511|FG000|Overall Study|Family bereavement overseas|1|||
155124643|NCT02535416|559887512|FG001|Overall Study|Family bereavement overseas|0|||
155124644|NCT02535416|559887513|FG002|Overall Study|Family bereavement overseas|0|||
155124645|NCT02535416|559887514|FG003|Overall Study|Family bereavement overseas|0|||
155124646|NCT02535416|559887515|FG004|Overall Study|Family bereavement overseas|0|||
155124647|NCT02535416|559887516|FG005|Overall Study|Family bereavement overseas|0|||
155124648|NCT02535416|559887517|FG006|Overall Study|Family bereavement overseas|0|||
155124649|NCT02535416|559887518|FG007|Overall Study|Family bereavement overseas|0|||
155124650|NCT02535416|559887519|FG008|Overall Study|Family bereavement overseas|0|||
155124651|NCT01977690|559887520|FG000|Overall Study|Withdrawal by Subject|0|||
155124652|NCT01977690|559887521|FG001|Overall Study|Withdrawal by Subject|4|||
155124653|NCT02644356|559887524|FG000|Overall Study|Withdrawal by Subject|2|||
155124654|NCT02210091|559887526|FG000|Overall Study|Physician Decision|0|||
155124655|NCT02210091|559887527|FG001|Overall Study|Physician Decision|1|||
155124656|NCT02210091|559887526|FG000|Overall Study|Withdrawal by Sponsor|0|||
155124657|NCT02210091|559887527|FG001|Overall Study|Withdrawal by Sponsor|1|||
155124658|NCT01711866|559887531|FG000|Overall Study|Noncompliant|3|||
155124659|NCT01711866|559887531|FG000|Overall Study|Withdrawal by Subject|3|||
155124660|NCT01711866|559887531|FG000|Overall Study|Adverse Event|2|||
155124661|NCT00897390|559887532|FG000|Overall Study|Adverse Event|2|||
155124662|NCT00897390|559887532|FG000|Overall Study|No Longer Met Study Criteria|1|||
155124663|NCT00897390|559887532|FG000|Overall Study|Personal Reasons|1|||
155124664|NCT00897390|559887532|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
155124665|NCT01831817|559887533|FG000|Overall Study|Lost to Follow-up|1|||
155124666|NCT01831817|559887534|FG001|Overall Study|Lost to Follow-up|0|||
155124667|NCT01831817|559887535|FG002|Overall Study|Lost to Follow-up|0|||
155124668|NCT01831817|559887536|FG003|Overall Study|Lost to Follow-up|0|||
155124669|NCT01831817|559887533|FG000|Overall Study|Withdrawl of Consent|3|||
155124670|NCT01831817|559887534|FG001|Overall Study|Withdrawl of Consent|0|||
155124671|NCT01831817|559887535|FG002|Overall Study|Withdrawl of Consent|0|||
155124672|NCT01831817|559887536|FG003|Overall Study|Withdrawl of Consent|0|||
155124673|NCT03159104|559887537|FG000|Overall Study|Violation of inclusion criteria|1|||
155124674|NCT03159104|559887538|FG001|Overall Study|Violation of inclusion criteria|2|||
155124675|NCT00958217|559887539|FG000|Overall Study|Death|2|||
155124676|NCT00958217|559887540|FG001|Overall Study|Death|1|||
155124677|NCT00958217|559887539|FG000|Overall Study|Withdrawal by Subject|4|||
155124678|NCT00958217|559887540|FG001|Overall Study|Withdrawal by Subject|3|||
155124679|NCT00958217|559887539|FG000|Overall Study|Lost to Follow-up|17|||
155124680|NCT00958217|559887540|FG001|Overall Study|Lost to Follow-up|19|||
155124681|NCT00958217|559887539|FG000|Overall Study|Moved out of area|1|||
155124682|NCT00958217|559887540|FG001|Overall Study|Moved out of area|1|||
155124683|NCT00958217|559887539|FG000|Overall Study|Inpatient hospitalization|0|||
155124684|NCT00958217|559887540|FG001|Overall Study|Inpatient hospitalization|1|||
155124685|NCT02440789|559887543|FG000|Overall Study|Withdrawal by Subject|3|||
155124686|NCT02440789|559887543|FG000|Overall Study|Not willing to adhere to reqs|1|||
155124687|NCT03172130|559889226|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
155124688|NCT03172130|559889227|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
155124689|NCT02831933|559889229|FG000|Overall Study|Physician Decision|11|||
155124690|NCT05065190|559889230|FG000|Overall Study|Other than listed|2|||
155124691|NCT05065190|559889231|FG001|Overall Study|Other than listed|12|||
155124692|NCT05065190|559889230|FG000|Overall Study|Lack of Efficacy|4|||
155124693|NCT05065190|559889231|FG001|Overall Study|Lack of Efficacy|0|||
155124694|NCT05065190|559889230|FG000|Overall Study|Adverse Event|1|||
155124695|NCT05065190|559889231|FG001|Overall Study|Adverse Event|10|||
155124696|NCT05160766|559889232|FG000|Overall Study|Adverse Event|0|||
155124697|NCT05160766|559889233|FG001|Overall Study|Adverse Event|1|||
155124698|NCT05160766|559889234|FG002|Overall Study|Adverse Event|0|||
155124699|NCT05160766|559889235|FG003|Overall Study|Adverse Event|0|||
155124700|NCT05160766|559889232|FG000|Overall Study|COVID-19 infection|0|||
155124701|NCT05160766|559889233|FG001|Overall Study|COVID-19 infection|1|||
155124702|NCT05160766|559889234|FG002|Overall Study|COVID-19 infection|0|||
155124703|NCT05160766|559889235|FG003|Overall Study|COVID-19 infection|0|||
155124704|NCT05160766|559889232|FG000|Overall Study|travel time|1|||
155124705|NCT05160766|559889233|FG001|Overall Study|travel time|0|||
155124706|NCT05160766|559889234|FG002|Overall Study|travel time|0|||
155124707|NCT05160766|559889235|FG003|Overall Study|travel time|1|||
155124708|NCT05160766|559889232|FG000|Overall Study|Withdrawal by Subject|3|||
155124709|NCT05160766|559889233|FG001|Overall Study|Withdrawal by Subject|5|||
155124710|NCT05160766|559889234|FG002|Overall Study|Withdrawal by Subject|4|||
155124711|NCT05160766|559889235|FG003|Overall Study|Withdrawal by Subject|2|||
155124712|NCT05160766|559889232|FG000|Overall Study|Death|0|||
155124713|NCT05160766|559889233|FG001|Overall Study|Death|0|||
155124714|NCT05160766|559889234|FG002|Overall Study|Death|2|||
155124715|NCT05160766|559889235|FG003|Overall Study|Death|5|||
155124716|NCT05160766|559889232|FG000|Overall Study|Lost to Follow-up|0|||
155124717|NCT05160766|559889233|FG001|Overall Study|Lost to Follow-up|0|||
155124718|NCT05160766|559889234|FG002|Overall Study|Lost to Follow-up|1|||
155124719|NCT05160766|559889235|FG003|Overall Study|Lost to Follow-up|2|||
155124720|NCT05160766|559889232|FG000|Overall Study|No show|0|||
155124721|NCT05160766|559889233|FG001|Overall Study|No show|0|||
155124722|NCT05160766|559889234|FG002|Overall Study|No show|1|||
155124723|NCT05160766|559889235|FG003|Overall Study|No show|1|||
155124724|NCT05160766|559889232|FG000|Overall Study|Physician Decision|0|||
155124725|NCT05160766|559889233|FG001|Overall Study|Physician Decision|0|||
155124726|NCT05160766|559889234|FG002|Overall Study|Physician Decision|0|||
155124727|NCT05160766|559889235|FG003|Overall Study|Physician Decision|1|||
155124728|NCT05160766|559889232|FG000|Overall Study|Protocol Violation|0|||
155124729|NCT05160766|559889233|FG001|Overall Study|Protocol Violation|0|||
155124730|NCT05160766|559889234|FG002|Overall Study|Protocol Violation|1|||
155124731|NCT05160766|559889235|FG003|Overall Study|Protocol Violation|0|||
155124732|NCT04030962|559889241|FG000|Stage 2|Adverse Event|0|||
155124733|NCT04030962|559889242|FG001|Stage 2|Adverse Event|0|||
155124734|NCT04030962|559889243|FG002|Stage 2|Adverse Event|0|||
155124735|NCT04030962|559889244|FG003|Stage 2|Adverse Event|0|||
155124736|NCT04030962|559889245|FG004|Stage 2|Adverse Event|0|||
155124737|NCT04030962|559889246|FG005|Stage 2|Adverse Event|0|||
155124738|NCT04030962|559889247|FG006|Stage 2|Adverse Event|0|||
155124739|NCT04030962|559889248|FG007|Stage 2|Adverse Event|0|||
155124740|NCT04030962|559889249|FG008|Stage 2|Adverse Event|1|||
155124741|NCT04030962|559889250|FG009|Stage 2|Adverse Event|0|||
155124742|NCT04030962|559889251|FG010|Stage 2|Adverse Event|1|||
155124743|NCT04030962|559889252|FG011|Stage 2|Adverse Event|1|||
155124744|NCT04030962|559889253|FG012|Stage 2|Adverse Event|1|||
155124745|NCT04030962|559889241|FG000|Stage 2|Withdrawal by Subject|0|||
155124746|NCT04030962|559889242|FG001|Stage 2|Withdrawal by Subject|0|||
155124747|NCT04030962|559889243|FG002|Stage 2|Withdrawal by Subject|0|||
155124748|NCT04030962|559889244|FG003|Stage 2|Withdrawal by Subject|0|||
155124749|NCT04030962|559889245|FG004|Stage 2|Withdrawal by Subject|0|||
155124750|NCT04030962|559889246|FG005|Stage 2|Withdrawal by Subject|0|||
155124751|NCT04030962|559889247|FG006|Stage 2|Withdrawal by Subject|0|||
155124752|NCT04030962|559889248|FG007|Stage 2|Withdrawal by Subject|0|||
155124753|NCT04030962|559889249|FG008|Stage 2|Withdrawal by Subject|1|||
155124754|NCT04030962|559889250|FG009|Stage 2|Withdrawal by Subject|0|||
155124755|NCT04030962|559889251|FG010|Stage 2|Withdrawal by Subject|0|||
155124756|NCT04030962|559889252|FG011|Stage 2|Withdrawal by Subject|2|||
155124757|NCT04030962|559889253|FG012|Stage 2|Withdrawal by Subject|1|||
155124758|NCT04030962|559889241|FG000|Stage 2|Lost to Follow-up|0|||
155124759|NCT04030962|559889242|FG001|Stage 2|Lost to Follow-up|0|||
155124760|NCT04030962|559889243|FG002|Stage 2|Lost to Follow-up|0|||
155124761|NCT04030962|559889244|FG003|Stage 2|Lost to Follow-up|0|||
155124762|NCT04030962|559889245|FG004|Stage 2|Lost to Follow-up|0|||
155124763|NCT04030962|559889246|FG005|Stage 2|Lost to Follow-up|0|||
155124764|NCT04030962|559889247|FG006|Stage 2|Lost to Follow-up|0|||
155124765|NCT04030962|559889248|FG007|Stage 2|Lost to Follow-up|0|||
155124766|NCT04030962|559889249|FG008|Stage 2|Lost to Follow-up|1|||
155124767|NCT04030962|559889250|FG009|Stage 2|Lost to Follow-up|0|||
155124768|NCT04030962|559889251|FG010|Stage 2|Lost to Follow-up|0|||
155124769|NCT04030962|559889252|FG011|Stage 2|Lost to Follow-up|0|||
155124770|NCT04030962|559889253|FG012|Stage 2|Lost to Follow-up|0|||
155124771|NCT04030962|559889241|FG000|Stage 2|Technical Problems|0|||
155124772|NCT04030962|559889242|FG001|Stage 2|Technical Problems|0|||
155124773|NCT04030962|559889243|FG002|Stage 2|Technical Problems|0|||
155124774|NCT04030962|559889244|FG003|Stage 2|Technical Problems|0|||
155124775|NCT04030962|559889245|FG004|Stage 2|Technical Problems|0|||
155124776|NCT04030962|559889246|FG005|Stage 2|Technical Problems|0|||
155124777|NCT04030962|559889247|FG006|Stage 2|Technical Problems|0|||
155124778|NCT04030962|559889248|FG007|Stage 2|Technical Problems|0|||
155124779|NCT04030962|559889249|FG008|Stage 2|Technical Problems|0|||
155124780|NCT04030962|559889250|FG009|Stage 2|Technical Problems|0|||
155124781|NCT04030962|559889251|FG010|Stage 2|Technical Problems|0|||
154921669|NCT01243762|559138036|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
154921670|NCT01243762|559138037|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
155124782|NCT04030962|559889252|FG011|Stage 2|Technical Problems|1|||
155124783|NCT04030962|559889253|FG012|Stage 2|Technical Problems|0|||
155124784|NCT05601102|559889254|FG000|Overall Study|Death|1|||
155124785|NCT05601102|559889255|FG001|Overall Study|Death|2|||
154921671|NCT01243762|559138031|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
154921672|NCT01243762|559138032|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
154921673|NCT01243762|559138033|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
154921674|NCT01243762|559138034|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
154921675|NCT01243762|559138035|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
154921676|NCT01243762|559138036|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
154921677|NCT01243762|559138037|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
154921678|NCT01243762|559138031|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
154921679|NCT01243762|559138032|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
154921680|NCT01243762|559138033|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
154921681|NCT01243762|559138034|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
154921682|NCT01243762|559138035|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
154921683|NCT01243762|559138036|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
154921684|NCT01243762|559138037|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
154921685|NCT01243762|559138031|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
154921686|NCT01243762|559138032|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
154921687|NCT01243762|559138033|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
154921688|NCT01243762|559138034|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
154921689|NCT01243762|559138035|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
154921690|NCT01243762|559138036|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
154921691|NCT01243762|559138037|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
154921692|NCT01243762|559138031|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
154921693|NCT01243762|559138032|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
154921694|NCT01243762|559138033|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
154921695|NCT01243762|559138034|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
154921696|NCT01243762|559138035|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
154921697|NCT01243762|559138036|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
154921698|NCT01243762|559138037|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
154921699|NCT01243762|559138031|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
154921700|NCT01243762|559138032|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
154921701|NCT01243762|559138033|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
154921702|NCT01243762|559138034|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
154921703|NCT01243762|559138035|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
154921704|NCT01243762|559138036|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
154921705|NCT01243762|559138037|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
154921706|NCT00003526|559138038|FG000|Overall Study|Not evaluable|6|||
154921707|NCT02059265|559138039|FG000|Overall Study|Ineligible|4|||
154921708|NCT03358407|559138044|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921709|NCT03358407|559138045|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921710|NCT03358407|559138046|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
154921711|NCT03358407|559138047|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921712|NCT03358407|559138048|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921713|NCT03358407|559138049|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921714|NCT03358407|559138050|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921715|NCT03358407|559138051|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921716|NCT03358407|559138052|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921717|NCT03358407|559138053|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
154921718|NCT03358407|559138044|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921719|NCT03358407|559138045|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921720|NCT03358407|559138046|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921721|NCT03358407|559138047|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921722|NCT03358407|559138048|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
154921723|NCT03358407|559138049|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921724|NCT03358407|559138050|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921725|NCT03358407|559138051|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921726|NCT03358407|559138052|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921727|NCT03358407|559138053|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921728|NCT03358407|559138044|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
155124786|NCT05601102|559889254|FG000|Overall Study|Withdrawal by Subject|1|||
155124787|NCT05601102|559889255|FG001|Overall Study|Withdrawal by Subject|1|||
155124788|NCT05601102|559889254|FG000|Overall Study|Lost to Follow-up|0|||
155124789|NCT05601102|559889255|FG001|Overall Study|Lost to Follow-up|2|||
155124790|NCT04284813|559889262|FG000|Overall Study|Withdrawal by Subject|1|||
155124791|NCT03106415|559889263|FG000|Phase 1|Withdrawal by Subject|1|||
155124792|NCT03106415|559889264|FG001|Phase 1|Withdrawal by Subject|0|||
155124793|NCT03106415|559889265|FG002|Phase 1|Withdrawal by Subject|0|||
155124794|NCT03106415|559889263|FG000|Phase 1|Adverse Event|1|||
155124795|NCT03106415|559889264|FG001|Phase 1|Adverse Event|1|||
155124796|NCT03106415|559889265|FG002|Phase 1|Adverse Event|0|||
155124797|NCT03106415|559889263|FG000|Phase 1|Protocol Violation|0|||
155124798|NCT03106415|559889264|FG001|Phase 1|Protocol Violation|1|||
155124799|NCT03106415|559889265|FG002|Phase 1|Protocol Violation|0|||
155124800|NCT03921554|559889266|FG000|Overall Study|Adverse Event|2|||
155124801|NCT03921554|559889266|FG000|Overall Study|Withdrawal by Subject|1|||
155124802|NCT03921554|559889266|FG000|Overall Study|Death|3|||
155124803|NCT01804582|559889267|FG000|Overall Study|Lost to Follow-up|47|||
155124804|NCT01804582|559889268|FG001|Overall Study|Lost to Follow-up|56|||
155124805|NCT01804582|559889267|FG000|Overall Study|Physician Decision|2|||
155124806|NCT01804582|559889268|FG001|Overall Study|Physician Decision|0|||
155124807|NCT00385723|559889270|FG000|Overall Study|Lost to Follow-up|1|||
155124808|NCT00385723|559889271|FG001|Overall Study|Lost to Follow-up|1|||
155124809|NCT00385723|559889272|FG002|Overall Study|Lost to Follow-up|0|||
155124810|NCT00385723|559889270|FG000|Overall Study|Withdrawal by Subject|1|||
155124811|NCT00385723|559889271|FG001|Overall Study|Withdrawal by Subject|0|||
155124812|NCT00385723|559889272|FG002|Overall Study|Withdrawal by Subject|2|||
155124813|NCT03455829|559889273|FG000|Overall Study|Death|2|||
155124814|NCT03455829|559889274|FG001|Overall Study|Death|3|||
155124815|NCT03455829|559889275|FG002|Overall Study|Death|2|||
155124816|NCT03455829|559889276|FG003|Overall Study|Death|4|||
155124817|NCT03455829|559889277|FG004|Overall Study|Death|2|||
155124818|NCT03455829|559889273|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
155124819|NCT03455829|559889274|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
155124820|NCT03455829|559889275|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
155124821|NCT03455829|559889276|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
155124822|NCT03455829|559889277|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
155124823|NCT03455829|559889273|FG000|Overall Study|Disease progression|0|||
155124824|NCT03455829|559889274|FG001|Overall Study|Disease progression|0|||
155124825|NCT03455829|559889275|FG002|Overall Study|Disease progression|0|||
155124826|NCT03455829|559889276|FG003|Overall Study|Disease progression|1|||
155124827|NCT03455829|559889277|FG004|Overall Study|Disease progression|1|||
155124828|NCT00875056|559889289|FG000|Overall Study|Adverse Event|6|||
155124829|NCT00875056|559889290|FG001|Overall Study|Adverse Event|1|||
155124830|NCT00875056|559889291|FG002|Overall Study|Adverse Event|2|||
155124831|NCT00875056|559889289|FG000|Overall Study|Progressive Disease|14|||
155124832|NCT00875056|559889290|FG001|Overall Study|Progressive Disease|8|||
155124833|NCT00875056|559889291|FG002|Overall Study|Progressive Disease|3|||
155124834|NCT00875056|559889289|FG000|Overall Study|Withdrawal by Subject|3|||
155124835|NCT00875056|559889290|FG001|Overall Study|Withdrawal by Subject|0|||
155124836|NCT00875056|559889291|FG002|Overall Study|Withdrawal by Subject|1|||
155124837|NCT00708734|559889296|FG000|Overall Study|scheduling conflict|2|||
155124838|NCT00708734|559889296|FG000|Overall Study|moved|1|||
155124839|NCT00708734|559889296|FG000|Overall Study|leg injury|1|||
155124840|NCT00708734|559889296|FG000|Overall Study|knee replacement|1|||
155124841|NCT00708734|559889296|FG000|Overall Study|vertigo|1|||
155124842|NCT00708734|559889296|FG000|Overall Study|leg fracture|1|||
155124843|NCT02634606|559889297|FG000|Overall Study|unable to obtain the drug at start|13|||
155124844|NCT01842581|559889298|FG000|Overall Study|Adverse Event|6|||
155124845|NCT01842581|559889299|FG001|Overall Study|Adverse Event|4|||
155124846|NCT01842581|559889298|FG000|Overall Study|HE breakthrough|26|||
155124847|NCT01842581|559889299|FG001|Overall Study|HE breakthrough|13|||
155124848|NCT01842581|559889298|FG000|Overall Study|Liver transplant|2|||
155124849|NCT01842581|559889299|FG001|Overall Study|Liver transplant|0|||
155124850|NCT01842581|559889298|FG000|Overall Study|Lost to Follow-up|2|||
155124851|NCT01842581|559889299|FG001|Overall Study|Lost to Follow-up|5|||
155124852|NCT01842581|559889298|FG000|Overall Study|Withdrawal by Subject|5|||
155124853|NCT01842581|559889299|FG001|Overall Study|Withdrawal by Subject|7|||
155124854|NCT01842581|559889298|FG000|Overall Study|Other than specified|3|||
155124855|NCT01842581|559889299|FG001|Overall Study|Other than specified|1|||
155124856|NCT01995552|559889300|FG000|Overall Study|Protocol Violation|1|||
155124857|NCT01995552|559889300|FG000|Overall Study|Lack of Efficacy|15|||
155124858|NCT01995552|559889300|FG000|Overall Study|Death|1|||
155178049|NCT00992589|560091387|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155124859|NCT00283868|559889303|FG000|Overall Study|Lost to Follow-up|7|||
155124860|NCT00283868|559889304|FG001|Overall Study|Lost to Follow-up|8|||
155178050|NCT00992589|560091388|FG003|Double-Blind Phase|Lost to Follow-up|2|||
155124861|NCT03743064|559889306|FG000|Overall Study|Adverse Event|7|||
155124862|NCT03743064|559889307|FG001|Overall Study|Adverse Event|9|||
155124863|NCT03743064|559889306|FG000|Overall Study|Death|25|||
155124864|NCT03743064|559889307|FG001|Overall Study|Death|28|||
155124865|NCT03743064|559889306|FG000|Overall Study|Lost to Follow-up|3|||
155124866|NCT03743064|559889307|FG001|Overall Study|Lost to Follow-up|6|||
155124867|NCT03743064|559889306|FG000|Overall Study|Withdrawal by Subject|28|||
155124868|NCT03743064|559889307|FG001|Overall Study|Withdrawal by Subject|25|||
155124869|NCT03743064|559889306|FG000|Overall Study|Physician Decision|2|||
155124870|NCT03743064|559889307|FG001|Overall Study|Physician Decision|4|||
155124871|NCT03743064|559889306|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
155124872|NCT03743064|559889307|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
155124873|NCT03149003|559889309|FG000|Overall Study|Randomized but not treated|0|||
155124874|NCT03149003|559889310|FG001|Overall Study|Randomized but not treated|1|||
155124875|NCT03149003|559889311|FG002|Overall Study|Randomized but not treated|18|||
155124876|NCT01443130|559889312|FG000|Overall Study|Lost to Follow-up|44|||
155124877|NCT01443130|559889313|FG001|Overall Study|Lost to Follow-up|42|||
155124878|NCT01443130|559889314|FG002|Overall Study|Lost to Follow-up|50|||
155124879|NCT01443130|559889315|FG003|Overall Study|Lost to Follow-up|23|||
155124880|NCT01443130|559889316|FG004|Overall Study|Lost to Follow-up|25|||
155124881|NCT01443130|559889317|FG005|Overall Study|Lost to Follow-up|21|||
155124882|NCT01443130|559889312|FG000|Overall Study|Death|0|||
155124883|NCT01443130|559889313|FG001|Overall Study|Death|1|||
155124884|NCT01443130|559889314|FG002|Overall Study|Death|0|||
155124885|NCT01443130|559889315|FG003|Overall Study|Death|7|||
155124886|NCT01443130|559889316|FG004|Overall Study|Death|10|||
155124887|NCT01443130|559889317|FG005|Overall Study|Death|8|||
155124888|NCT01443130|559889312|FG000|Overall Study|Adverse Event|2|||
155124889|NCT01443130|559889313|FG001|Overall Study|Adverse Event|1|||
155124890|NCT01443130|559889314|FG002|Overall Study|Adverse Event|1|||
155124891|NCT01443130|559889315|FG003|Overall Study|Adverse Event|0|||
155124892|NCT01443130|559889316|FG004|Overall Study|Adverse Event|0|||
155124893|NCT01443130|559889317|FG005|Overall Study|Adverse Event|0|||
155124894|NCT01443130|559889312|FG000|Overall Study|Protocol Violation|2|||
155124895|NCT01443130|559889313|FG001|Overall Study|Protocol Violation|1|||
155124896|NCT01443130|559889314|FG002|Overall Study|Protocol Violation|3|||
155124897|NCT01443130|559889315|FG003|Overall Study|Protocol Violation|2|||
155124898|NCT01443130|559889316|FG004|Overall Study|Protocol Violation|2|||
155124899|NCT01443130|559889317|FG005|Overall Study|Protocol Violation|3|||
155124900|NCT01443130|559889312|FG000|Overall Study|Withdrawal by Subject|15|||
155124901|NCT01443130|559889313|FG001|Overall Study|Withdrawal by Subject|14|||
155124902|NCT01443130|559889314|FG002|Overall Study|Withdrawal by Subject|12|||
155124903|NCT01443130|559889315|FG003|Overall Study|Withdrawal by Subject|7|||
155124904|NCT01443130|559889316|FG004|Overall Study|Withdrawal by Subject|7|||
155124905|NCT01443130|559889317|FG005|Overall Study|Withdrawal by Subject|2|||
155124906|NCT01443130|559889312|FG000|Overall Study|Death of Subject's Infant|5|||
155124907|NCT01443130|559889313|FG001|Overall Study|Death of Subject's Infant|10|||
155124908|NCT01443130|559889314|FG002|Overall Study|Death of Subject's Infant|11|||
155124909|NCT01443130|559889315|FG003|Overall Study|Death of Subject's Infant|0|||
155124910|NCT01443130|559889316|FG004|Overall Study|Death of Subject's Infant|0|||
155124911|NCT01443130|559889317|FG005|Overall Study|Death of Subject's Infant|0|||
155124912|NCT02758301|559889318|FG000|Overall Study|Death|12|||
155124913|NCT02758301|559889319|FG001|Overall Study|Death|0|||
155124914|NCT02758301|559889318|FG000|Overall Study|Physician Decision|10|||
155124915|NCT02758301|559889319|FG001|Overall Study|Physician Decision|1|||
155124916|NCT02758301|559889318|FG000|Overall Study|Withdrawal by Subject|5|||
155124917|NCT02758301|559889319|FG001|Overall Study|Withdrawal by Subject|6|||
155124918|NCT02758301|559889318|FG000|Overall Study|Lost to Follow-up|7|||
155124919|NCT02758301|559889319|FG001|Overall Study|Lost to Follow-up|0|||
155124920|NCT02758301|559889318|FG000|Overall Study|Protocol Violation|0|||
155124921|NCT02758301|559889319|FG001|Overall Study|Protocol Violation|1|||
155124922|NCT00364533|559889320|FG000|Overall Study|Adverse Event|8|||
155124923|NCT00364533|559889321|FG001|Overall Study|Adverse Event|7|||
155124924|NCT00364533|559889322|FG002|Overall Study|Adverse Event|15|||
155124925|NCT00364533|559889323|FG003|Overall Study|Adverse Event|5|||
155124926|NCT00364533|559889324|FG004|Overall Study|Adverse Event|2|||
155124927|NCT00364533|559889320|FG000|Overall Study|Withdrawal by Subject|4|||
155124928|NCT00364533|559889321|FG001|Overall Study|Withdrawal by Subject|8|||
155124929|NCT00364533|559889322|FG002|Overall Study|Withdrawal by Subject|6|||
155124930|NCT00364533|559889323|FG003|Overall Study|Withdrawal by Subject|6|||
155124931|NCT00364533|559889324|FG004|Overall Study|Withdrawal by Subject|6|||
155124932|NCT00364533|559889320|FG000|Overall Study|Lack of Efficacy|22|||
155124933|NCT00364533|559889321|FG001|Overall Study|Lack of Efficacy|22|||
155178051|NCT00992589|560091385|FG000|Double-Blind Phase|Other|0|||
155178052|NCT00992589|560091386|FG001|Double-Blind Phase|Other|1|||
155124934|NCT00364533|559889322|FG002|Overall Study|Lack of Efficacy|21|||
155124935|NCT00364533|559889323|FG003|Overall Study|Lack of Efficacy|17|||
155124936|NCT00364533|559889324|FG004|Overall Study|Lack of Efficacy|42|||
155124937|NCT00364533|559889320|FG000|Overall Study|Subject discharged from hospital|4|||
155178053|NCT00992589|560091387|FG002|Double-Blind Phase|Other|6|||
155124938|NCT00364533|559889321|FG001|Overall Study|Subject discharged from hospital|1|||
154921729|NCT03358407|559138045|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921730|NCT03358407|559138046|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921731|NCT03358407|559138047|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921732|NCT03358407|559138048|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921733|NCT03358407|559138049|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
154921734|NCT03358407|559138050|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921735|NCT03358407|559138051|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
154921736|NCT03358407|559138052|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921737|NCT03358407|559138053|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
154921738|NCT03358407|559138044|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921739|NCT03358407|559138045|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921740|NCT03358407|559138046|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921741|NCT03358407|559138047|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921742|NCT03358407|559138048|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921743|NCT03358407|559138049|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
154921744|NCT03358407|559138050|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921745|NCT03358407|559138051|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
154921746|NCT03358407|559138052|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921747|NCT03358407|559138053|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
154921748|NCT03358407|559138044|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921749|NCT03358407|559138045|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921750|NCT03358407|559138046|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921751|NCT03358407|559138047|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921752|NCT03358407|559138048|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921753|NCT03358407|559138049|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
154921754|NCT03358407|559138050|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
154921755|NCT03358407|559138051|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
155124939|NCT00364533|559889322|FG002|Overall Study|Subject discharged from hospital|2|||
154921756|NCT03358407|559138052|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921757|NCT03358407|559138053|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
154921758|NCT03358407|559138044|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921759|NCT03358407|559138045|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921760|NCT03358407|559138046|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921761|NCT03358407|559138047|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921762|NCT03358407|559138048|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921763|NCT03358407|559138049|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
154921764|NCT03358407|559138050|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
154921765|NCT03358407|559138051|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
154921766|NCT03358407|559138052|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921767|NCT03358407|559138053|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
154921768|NCT00483574|559138054|FG000|Overall Study|Adverse Event|6|||
154921769|NCT00483574|559138055|FG001|Overall Study|Adverse Event|0|||
154921770|NCT00483574|559138054|FG000|Overall Study|Protocol Violation|28|||
154921771|NCT00483574|559138055|FG001|Overall Study|Protocol Violation|9|||
154921772|NCT00483574|559138054|FG000|Overall Study|Lost to Follow-up|16|||
154921773|NCT00483574|559138055|FG001|Overall Study|Lost to Follow-up|4|||
154921774|NCT00483574|559138054|FG000|Overall Study|Withdrawal by Subject|52|||
154921775|NCT00483574|559138055|FG001|Overall Study|Withdrawal by Subject|0|||
154921776|NCT03605758|559138056|FG000|Overall Study|Lost to Follow-up|2|||
154921777|NCT03605758|559138057|FG001|Overall Study|Lost to Follow-up|1|||
154921778|NCT03605758|559138056|FG000|Overall Study|Illness|0|||
154921779|NCT03605758|559138057|FG001|Overall Study|Illness|1|||
154921780|NCT03605758|559138056|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
154921781|NCT03605758|559138057|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
154921782|NCT00489411|559138060|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
154921783|NCT00489411|559138061|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
154921784|NCT00489411|559138060|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
154921785|NCT00489411|559138061|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
154921786|NCT00489411|559138060|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
154921787|NCT00489411|559138061|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
154921788|NCT00489411|559138060|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
155124940|NCT00364533|559889323|FG003|Overall Study|Subject discharged from hospital|3|||
155124941|NCT00364533|559889324|FG004|Overall Study|Subject discharged from hospital|1|||
154921789|NCT00489411|559138061|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
154921790|NCT00489411|559138060|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
154921791|NCT00489411|559138061|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
154921792|NCT01748162|559138064|FG000|Overall Study|no additional croup episodes to evaluate|2|||
154921793|NCT01748162|559138065|FG001|Overall Study|no additional croup episodes to evaluate|2|||
154921794|NCT01748162|559138064|FG000|Overall Study|participant consented but did not begin|0|||
154921795|NCT01748162|559138065|FG001|Overall Study|participant consented but did not begin|1|||
154921796|NCT01748162|559138064|FG000|Overall Study|reasons not available|3|||
154921797|NCT01748162|559138065|FG001|Overall Study|reasons not available|2|||
154921798|NCT03219372|559138066|FG000|Overall Study|Withdrawal by Subject|1|||
154921799|NCT03219372|559138067|FG001|Overall Study|Withdrawal by Subject|0|||
154921800|NCT03841331|559138068|FG000|Overall Study|Withdrawal by Subject|4|||
154921801|NCT03841331|559138069|FG001|Overall Study|Withdrawal by Subject|9|||
154921802|NCT03841331|559138068|FG000|Overall Study|Lost to Follow-up|5|||
154921803|NCT03841331|559138069|FG001|Overall Study|Lost to Follow-up|1|||
154921804|NCT04145531|559138070|FG000|Part A|Adverse Event|2|||
154921805|NCT04145531|559138071|FG001|Part A|Adverse Event|12|||
154921806|NCT04145531|559138072|FG002|Part A|Adverse Event|6|||
154921807|NCT04145531|559138073|FG003|Part A|Adverse Event|0|||
154921808|NCT04145531|559138070|FG000|Part A|Death|1|||
154921809|NCT04145531|559138071|FG001|Part A|Death|2|||
154921810|NCT04145531|559138072|FG002|Part A|Death|0|||
154921811|NCT04145531|559138073|FG003|Part A|Death|0|||
154921812|NCT04145531|559138070|FG000|Part A|Physician Decision|2|||
154921813|NCT04145531|559138071|FG001|Part A|Physician Decision|5|||
154921814|NCT04145531|559138072|FG002|Part A|Physician Decision|2|||
154921815|NCT04145531|559138073|FG003|Part A|Physician Decision|0|||
154921816|NCT04145531|559138070|FG000|Part A|Progressive disease|0|||
154921817|NCT04145531|559138071|FG001|Part A|Progressive disease|2|||
154921818|NCT04145531|559138072|FG002|Part A|Progressive disease|1|||
154921819|NCT04145531|559138073|FG003|Part A|Progressive disease|0|||
154921820|NCT04145531|559138070|FG000|Part A|Protocol deviation|0|||
154921821|NCT04145531|559138071|FG001|Part A|Protocol deviation|0|||
154921822|NCT04145531|559138072|FG002|Part A|Protocol deviation|1|||
154921823|NCT04145531|559138073|FG003|Part A|Protocol deviation|0|||
154921824|NCT04145531|559138070|FG000|Part A|Withdrawal by parent or guardian|1|||
154921825|NCT04145531|559138071|FG001|Part A|Withdrawal by parent or guardian|0|||
154921826|NCT04145531|559138072|FG002|Part A|Withdrawal by parent or guardian|0|||
154921827|NCT04145531|559138073|FG003|Part A|Withdrawal by parent or guardian|0|||
154921828|NCT04145531|559138070|FG000|Part A|Withdrawal by participant|0|||
154921829|NCT04145531|559138071|FG001|Part A|Withdrawal by participant|0|||
154921830|NCT04145531|559138072|FG002|Part A|Withdrawal by participant|1|||
154921831|NCT04145531|559138073|FG003|Part A|Withdrawal by participant|0|||
154921832|NCT04145531|559138070|FG000|Part A|Other|0|||
154921833|NCT04145531|559138071|FG001|Part A|Other|0|||
154921834|NCT04145531|559138072|FG002|Part A|Other|1|||
154921835|NCT04145531|559138073|FG003|Part A|Other|0|||
154921836|NCT04145531|559138070|FG000|Part B|Adverse Event|0|||
154921837|NCT04145531|559138071|FG001|Part B|Adverse Event|0|||
154921838|NCT04145531|559138072|FG002|Part B|Adverse Event|0|||
154921839|NCT04145531|559138073|FG003|Part B|Adverse Event|21|||
154921840|NCT04145531|559138070|FG000|Part B|Physician Decision|0|||
154921841|NCT04145531|559138071|FG001|Part B|Physician Decision|0|||
154921842|NCT04145531|559138072|FG002|Part B|Physician Decision|0|||
154921843|NCT04145531|559138073|FG003|Part B|Physician Decision|7|||
154921844|NCT04145531|559138070|FG000|Part B|Progressive disease|0|||
154921845|NCT04145531|559138071|FG001|Part B|Progressive disease|0|||
154921846|NCT04145531|559138072|FG002|Part B|Progressive disease|0|||
154921847|NCT04145531|559138073|FG003|Part B|Progressive disease|1|||
154921848|NCT04145531|559138070|FG000|Part B|Recurrent disease|0|||
154921849|NCT04145531|559138071|FG001|Part B|Recurrent disease|0|||
154921850|NCT04145531|559138072|FG002|Part B|Recurrent disease|0|||
154921851|NCT04145531|559138073|FG003|Part B|Recurrent disease|1|||
154921852|NCT04145531|559138070|FG000|Part B|Withdrawal by parent or guardian|0|||
154921853|NCT04145531|559138071|FG001|Part B|Withdrawal by parent or guardian|0|||
154921854|NCT04145531|559138072|FG002|Part B|Withdrawal by parent or guardian|0|||
154921855|NCT04145531|559138073|FG003|Part B|Withdrawal by parent or guardian|3|||
154921856|NCT04145531|559138070|FG000|Part B|Withdrawal by participant|0|||
154921857|NCT04145531|559138071|FG001|Part B|Withdrawal by participant|0|||
154921858|NCT04145531|559138072|FG002|Part B|Withdrawal by participant|0|||
154921859|NCT04145531|559138073|FG003|Part B|Withdrawal by participant|1|||
154921860|NCT04145531|559138070|FG000|Part B|Other|0|||
154921861|NCT04145531|559138071|FG001|Part B|Other|0|||
154921862|NCT04145531|559138072|FG002|Part B|Other|0|||
154921863|NCT04145531|559138073|FG003|Part B|Other|1|||
154921864|NCT04640168|559138074|FG000|Overall Study|Withdrawal by Subject|8|||
154921865|NCT04640168|559138075|FG001|Overall Study|Withdrawal by Subject|7|||
154921866|NCT04640168|559138074|FG000|Overall Study|Lost to Follow-up|1|||
154921867|NCT04640168|559138075|FG001|Overall Study|Lost to Follow-up|0|||
154921868|NCT04640168|559138074|FG000|Overall Study|Enrolled but not treated|12|||
154921869|NCT04640168|559138075|FG001|Overall Study|Enrolled but not treated|12|||
154921870|NCT00779857|559138076|FG000|Overall Study|Death|1|||
154921871|NCT00779857|559138076|FG000|Overall Study|Withdrawal by Subject|3|||
154921872|NCT00779857|559138076|FG000|Overall Study|Missed Visit|2|||
155124942|NCT00364533|559889320|FG000|Overall Study|Variations in drug compliance|2|||
155124943|NCT00364533|559889321|FG001|Overall Study|Variations in drug compliance|1|||
155124944|NCT00364533|559889322|FG002|Overall Study|Variations in drug compliance|1|||
155124945|NCT00364533|559889323|FG003|Overall Study|Variations in drug compliance|0|||
155124946|NCT00364533|559889324|FG004|Overall Study|Variations in drug compliance|0|||
155124947|NCT00364533|559889320|FG000|Overall Study|Non-compliance|1|||
155124948|NCT00364533|559889321|FG001|Overall Study|Non-compliance|0|||
155124949|NCT00364533|559889322|FG002|Overall Study|Non-compliance|0|||
155124950|NCT00364533|559889323|FG003|Overall Study|Non-compliance|0|||
155124951|NCT00364533|559889324|FG004|Overall Study|Non-compliance|0|||
155124952|NCT00364533|559889320|FG000|Overall Study|Protocol Violation|1|||
155124953|NCT00364533|559889321|FG001|Overall Study|Protocol Violation|1|||
155124954|NCT00364533|559889322|FG002|Overall Study|Protocol Violation|0|||
155124955|NCT00364533|559889323|FG003|Overall Study|Protocol Violation|0|||
155124956|NCT00364533|559889324|FG004|Overall Study|Protocol Violation|0|||
155124957|NCT00815191|559889331|FG000|Overall Study|Protocol Violation|1|||
155124958|NCT00815191|559889332|FG001|Overall Study|Protocol Violation|1|||
155124959|NCT02639338|559889333|FG000|Overall Study|Lost to Follow-up|2|||
155124960|NCT02639338|559889334|FG001|Overall Study|Lost to Follow-up|2|||
155124961|NCT02639338|559889333|FG000|Overall Study|Withdrew Consent|1|||
155124962|NCT02639338|559889334|FG001|Overall Study|Withdrew Consent|2|||
155124963|NCT02639338|559889333|FG000|Overall Study|Death|1|||
155124964|NCT02639338|559889334|FG001|Overall Study|Death|0|||
155124965|NCT02639338|559889333|FG000|Overall Study|Randomized but Not Treated|0|||
155124966|NCT02639338|559889334|FG001|Overall Study|Randomized but Not Treated|1|||
155124967|NCT02900170|559889335|FG000|Overall Study|Lost to Follow-up|8|||
155124968|NCT01703065|559889340|FG000|Overall Study|Lack of Efficacy|1|||
155124969|NCT01703065|559889341|FG001|Overall Study|Lack of Efficacy|0|||
155124970|NCT02124772|559889342|FG000|Overall Study|Lack of Efficacy|2|||
155124971|NCT02124772|559889343|FG001|Overall Study|Lack of Efficacy|0|||
155124972|NCT02124772|559889344|FG002|Overall Study|Lack of Efficacy|0|||
155124973|NCT02124772|559889345|FG003|Overall Study|Lack of Efficacy|1|||
155124974|NCT02124772|559889346|FG004|Overall Study|Lack of Efficacy|2|||
155124975|NCT02124772|559889347|FG005|Overall Study|Lack of Efficacy|3|||
155124976|NCT02124772|559889348|FG006|Overall Study|Lack of Efficacy|0|||
155124977|NCT02124772|559889349|FG007|Overall Study|Lack of Efficacy|2|||
155124978|NCT02124772|559889350|FG008|Overall Study|Lack of Efficacy|0|||
155124979|NCT02124772|559889351|FG009|Overall Study|Lack of Efficacy|1|||
155124980|NCT02124772|559889352|FG010|Overall Study|Lack of Efficacy|0|||
155124981|NCT02124772|559889353|FG011|Overall Study|Lack of Efficacy|0|||
155124982|NCT02124772|559889354|FG012|Overall Study|Lack of Efficacy|1|||
155124983|NCT02124772|559889342|FG000|Overall Study|Adverse Event|1|||
155124984|NCT02124772|559889343|FG001|Overall Study|Adverse Event|4|||
155124985|NCT02124772|559889344|FG002|Overall Study|Adverse Event|1|||
155124986|NCT02124772|559889345|FG003|Overall Study|Adverse Event|5|||
155124987|NCT02124772|559889346|FG004|Overall Study|Adverse Event|2|||
155124988|NCT02124772|559889347|FG005|Overall Study|Adverse Event|1|||
155124989|NCT02124772|559889348|FG006|Overall Study|Adverse Event|1|||
155124990|NCT02124772|559889349|FG007|Overall Study|Adverse Event|5|||
155124991|NCT02124772|559889350|FG008|Overall Study|Adverse Event|0|||
155124992|NCT02124772|559889351|FG009|Overall Study|Adverse Event|3|||
155124993|NCT02124772|559889352|FG010|Overall Study|Adverse Event|1|||
155124994|NCT02124772|559889353|FG011|Overall Study|Adverse Event|3|||
155124995|NCT02124772|559889354|FG012|Overall Study|Adverse Event|1|||
155124996|NCT02124772|559889342|FG000|Overall Study|Withdrawal consent|0|||
155124997|NCT02124772|559889343|FG001|Overall Study|Withdrawal consent|1|||
155124998|NCT02124772|559889344|FG002|Overall Study|Withdrawal consent|1|||
155124999|NCT02124772|559889345|FG003|Overall Study|Withdrawal consent|1|||
155125000|NCT02124772|559889346|FG004|Overall Study|Withdrawal consent|0|||
155125001|NCT02124772|559889347|FG005|Overall Study|Withdrawal consent|1|||
155125002|NCT02124772|559889348|FG006|Overall Study|Withdrawal consent|1|||
155178054|NCT00992589|560091388|FG003|Double-Blind Phase|Other|3|||
155178055|NCT02142387|560091389|FG000|Overall Study|<19 years old|49|||
155125003|NCT02124772|559889349|FG007|Overall Study|Withdrawal consent|0|||
155125004|NCT02124772|559889350|FG008|Overall Study|Withdrawal consent|0|||
155125005|NCT02124772|559889351|FG009|Overall Study|Withdrawal consent|1|||
155125006|NCT02124772|559889352|FG010|Overall Study|Withdrawal consent|0|||
155125007|NCT02124772|559889353|FG011|Overall Study|Withdrawal consent|1|||
155125008|NCT02124772|559889354|FG012|Overall Study|Withdrawal consent|0|||
155125009|NCT02124772|559889342|FG000|Overall Study|Investigator discretion|0|||
155125010|NCT02124772|559889343|FG001|Overall Study|Investigator discretion|2|||
155125011|NCT02124772|559889344|FG002|Overall Study|Investigator discretion|2|||
155125012|NCT02124772|559889345|FG003|Overall Study|Investigator discretion|1|||
155178056|NCT02142387|560091390|FG001|Overall Study|<19 years old|326|||
155125013|NCT02124772|559889346|FG004|Overall Study|Investigator discretion|1|||
155125014|NCT02124772|559889347|FG005|Overall Study|Investigator discretion|0|||
155125015|NCT02124772|559889348|FG006|Overall Study|Investigator discretion|1|||
155125016|NCT02124772|559889349|FG007|Overall Study|Investigator discretion|0|||
155125017|NCT02124772|559889350|FG008|Overall Study|Investigator discretion|0|||
155125018|NCT02124772|559889351|FG009|Overall Study|Investigator discretion|1|||
154921873|NCT04338685|559138079|FG000|Overall Study|Death|3|||
154921874|NCT04338685|559138080|FG001|Overall Study|Death|4|||
154921875|NCT04338685|559138081|FG002|Overall Study|Death|2|||
154921876|NCT04338685|559138082|FG003|Overall Study|Death|4|||
154921877|NCT04338685|559138083|FG004|Overall Study|Death|4|||
154921878|NCT04338685|559138084|FG005|Overall Study|Death|8|||
154921879|NCT04338685|559138085|FG006|Overall Study|Death|1|||
154921880|NCT04338685|559138086|FG007|Overall Study|Death|0|||
154921881|NCT04338685|559138087|FG008|Overall Study|Death|0|||
154921882|NCT04338685|559138079|FG000|Overall Study|Study terminated by Sponsor|0|||
154921883|NCT04338685|559138080|FG001|Overall Study|Study terminated by Sponsor|0|||
154921884|NCT04338685|559138081|FG002|Overall Study|Study terminated by Sponsor|1|||
154921885|NCT04338685|559138082|FG003|Overall Study|Study terminated by Sponsor|4|||
154921886|NCT04338685|559138083|FG004|Overall Study|Study terminated by Sponsor|0|||
154921887|NCT04338685|559138084|FG005|Overall Study|Study terminated by Sponsor|5|||
154921888|NCT04338685|559138085|FG006|Overall Study|Study terminated by Sponsor|2|||
154921889|NCT04338685|559138086|FG007|Overall Study|Study terminated by Sponsor|4|||
154921890|NCT04338685|559138087|FG008|Overall Study|Study terminated by Sponsor|1|||
154921891|NCT04338685|559138079|FG000|Overall Study|Withdrawal by Subject|1|||
154921892|NCT04338685|559138080|FG001|Overall Study|Withdrawal by Subject|2|||
154921893|NCT04338685|559138081|FG002|Overall Study|Withdrawal by Subject|0|||
154921894|NCT04338685|559138082|FG003|Overall Study|Withdrawal by Subject|2|||
154921895|NCT04338685|559138083|FG004|Overall Study|Withdrawal by Subject|0|||
154921896|NCT04338685|559138084|FG005|Overall Study|Withdrawal by Subject|5|||
154921897|NCT04338685|559138085|FG006|Overall Study|Withdrawal by Subject|1|||
154921898|NCT04338685|559138086|FG007|Overall Study|Withdrawal by Subject|1|||
154921899|NCT04338685|559138087|FG008|Overall Study|Withdrawal by Subject|0|||
154921900|NCT00234533|559138088|FG000|Overall Study|Withdrawal by Subject|6|||
154921901|NCT00234533|559138088|FG000|Overall Study|Adverse Event|2|||
154921902|NCT00234533|559138088|FG000|Overall Study|Enrolled but not treated|3|||
154921903|NCT02967055|559138089|FG000|Overall Study|Excluded|40|||
154921904|NCT02967055|559138089|FG000|Overall Study|Screen fail|3|||
154921905|NCT02967055|559138089|FG000|Overall Study|Lost to Follow-up|2|||
154921906|NCT02967055|559138089|FG000|Overall Study|Stopped due to side effects|3|||
154921907|NCT02967055|559138089|FG000|Overall Study|Stopped due to drug cost|1|||
154921908|NCT00908375|559138090|FG000|Overall Study|Withdrawal by Subject|2|||
154921909|NCT00908375|559138091|FG001|Overall Study|Withdrawal by Subject|4|||
154921910|NCT00908375|559138090|FG000|Overall Study|Lost to Follow-up|8|||
154921911|NCT00908375|559138091|FG001|Overall Study|Lost to Follow-up|6|||
154921912|NCT02279888|559138092|FG000|Overall Study|Death|326|||
154921913|NCT02279888|559138092|FG000|Overall Study|Withdrawal by Subject|38|||
154921914|NCT02279888|559138092|FG000|Overall Study|Lost to Follow-up|21|||
154921915|NCT02279888|559138092|FG000|Overall Study|Physician Decision|62|||
154921916|NCT02279888|559138092|FG000|Overall Study|Subject Non-compliance|43|||
154921917|NCT02279888|559138092|FG000|Overall Study|Not implanted|14|||
154921918|NCT02279888|559138092|FG000|Overall Study|Visit not performed|26|||
154921919|NCT02283411|559138095|FG000|Overall Study|Withdrawal by Subject|3|||
154921920|NCT02283411|559138095|FG000|Overall Study|Screen Failed|28|||
154921921|NCT01683565|559138096|FG000|Overall Study|Lost to Follow-up|2|||
154921922|NCT01683565|559138097|FG001|Overall Study|Lost to Follow-up|0|||
154921923|NCT01683565|559138096|FG000|Overall Study|Discontinued Intervention|1|||
154921924|NCT01683565|559138097|FG001|Overall Study|Discontinued Intervention|1|||
154921925|NCT00945815|559138099|FG000|Overall Study|Death|3|||
154921926|NCT00945815|559138099|FG000|Overall Study|Not protocol specified|1|||
155178057|NCT02142387|560091389|FG000|Overall Study|non-cardiac etiology|504|||
155178058|NCT02142387|560091390|FG001|Overall Study|non-cardiac etiology|3431|||
154921927|NCT00945815|559138099|FG000|Overall Study|Ineligible|3|||
154921928|NCT00945815|559138099|FG000|Overall Study|Did not begin protocol therapy|1|||
154921929|NCT02400281|559138100|FG000|Overall Study|Adverse Event|0|||
154921930|NCT02400281|559138101|FG001|Overall Study|Adverse Event|0|||
154921931|NCT02400281|559138102|FG002|Overall Study|Adverse Event|1|||
154921932|NCT02400281|559138103|FG003|Overall Study|Adverse Event|0|||
154921933|NCT02400281|559138104|FG004|Overall Study|Adverse Event|1|||
154921934|NCT02400281|559138105|FG005|Overall Study|Adverse Event|0|||
154921935|NCT02400281|559138100|FG000|Overall Study|Physician Decision|0|||
154921936|NCT02400281|559138101|FG001|Overall Study|Physician Decision|0|||
154921937|NCT02400281|559138102|FG002|Overall Study|Physician Decision|1|||
154921938|NCT02400281|559138103|FG003|Overall Study|Physician Decision|0|||
154921939|NCT02400281|559138104|FG004|Overall Study|Physician Decision|0|||
154921940|NCT02400281|559138105|FG005|Overall Study|Physician Decision|0|||
155178059|NCT02142387|560091389|FG000|Overall Study|CPR not performed|74|||
154921941|NCT04524507|559138106|FG000|Overall Study|Lost to Follow-up|2|||
154921942|NCT04524507|559138107|FG001|Overall Study|Lost to Follow-up|4|||
154921943|NCT04524507|559138106|FG000|Overall Study|Withdrawal by Subject|2|||
154921944|NCT04524507|559138107|FG001|Overall Study|Withdrawal by Subject|9|||
154921945|NCT04524507|559138106|FG000|Overall Study|Death|2|||
154921946|NCT04524507|559138107|FG001|Overall Study|Death|10|||
154921947|NCT02441517|559138114|FG000|Overall Study|Lost to Follow-up|1|||
154921948|NCT02441517|559138114|FG000|Overall Study|Withdrawal by Subject|2|||
155125019|NCT02124772|559889352|FG010|Overall Study|Investigator discretion|0|||
155125020|NCT02124772|559889353|FG011|Overall Study|Investigator discretion|1|||
155125021|NCT02124772|559889354|FG012|Overall Study|Investigator discretion|0|||
155125022|NCT02124772|559889342|FG000|Overall Study|Progressive disease|0|||
155125023|NCT02124772|559889343|FG001|Overall Study|Progressive disease|0|||
155125024|NCT02124772|559889344|FG002|Overall Study|Progressive disease|0|||
155125025|NCT02124772|559889345|FG003|Overall Study|Progressive disease|0|||
155125026|NCT02124772|559889346|FG004|Overall Study|Progressive disease|0|||
155125027|NCT02124772|559889347|FG005|Overall Study|Progressive disease|0|||
155125028|NCT02124772|559889348|FG006|Overall Study|Progressive disease|1|||
155125029|NCT02124772|559889349|FG007|Overall Study|Progressive disease|1|||
155125030|NCT02124772|559889350|FG008|Overall Study|Progressive disease|0|||
155125031|NCT02124772|559889351|FG009|Overall Study|Progressive disease|0|||
155125032|NCT02124772|559889352|FG010|Overall Study|Progressive disease|0|||
155125033|NCT02124772|559889353|FG011|Overall Study|Progressive disease|0|||
155125034|NCT02124772|559889354|FG012|Overall Study|Progressive disease|0|||
155125035|NCT02124772|559889342|FG000|Overall Study|Other|0|||
155125036|NCT02124772|559889343|FG001|Overall Study|Other|7|||
155125037|NCT02124772|559889344|FG002|Overall Study|Other|2|||
155125038|NCT02124772|559889345|FG003|Overall Study|Other|5|||
155125039|NCT02124772|559889346|FG004|Overall Study|Other|4|||
155125040|NCT02124772|559889347|FG005|Overall Study|Other|3|||
155125041|NCT02124772|559889348|FG006|Overall Study|Other|4|||
155125042|NCT02124772|559889349|FG007|Overall Study|Other|1|||
155125043|NCT02124772|559889350|FG008|Overall Study|Other|1|||
155125044|NCT02124772|559889351|FG009|Overall Study|Other|1|||
155125045|NCT02124772|559889352|FG010|Overall Study|Other|1|||
155125046|NCT02124772|559889353|FG011|Overall Study|Other|1|||
155125047|NCT02124772|559889354|FG012|Overall Study|Other|0|||
155125048|NCT02713529|559889355|FG000|Overall Study|Withdrawal by Subject|3|||
155125049|NCT02713529|559889356|FG001|Overall Study|Withdrawal by Subject|1|||
155125050|NCT02713529|559889357|FG002|Overall Study|Withdrawal by Subject|4|||
155125051|NCT02713529|559889358|FG003|Overall Study|Withdrawal by Subject|2|||
155125052|NCT02713529|559889359|FG004|Overall Study|Withdrawal by Subject|0|||
155125053|NCT02713529|559889360|FG005|Overall Study|Withdrawal by Subject|1|||
155125054|NCT02713529|559889361|FG006|Overall Study|Withdrawal by Subject|1|||
155125055|NCT02713529|559889355|FG000|Overall Study|Lost to Follow-up|1|||
155125056|NCT02713529|559889356|FG001|Overall Study|Lost to Follow-up|0|||
155125057|NCT02713529|559889357|FG002|Overall Study|Lost to Follow-up|1|||
155125058|NCT02713529|559889358|FG003|Overall Study|Lost to Follow-up|0|||
155125059|NCT02713529|559889359|FG004|Overall Study|Lost to Follow-up|0|||
155125060|NCT02713529|559889360|FG005|Overall Study|Lost to Follow-up|0|||
155125061|NCT02713529|559889361|FG006|Overall Study|Lost to Follow-up|0|||
155125062|NCT02713529|559889355|FG000|Overall Study|Death|3|||
155125063|NCT02713529|559889356|FG001|Overall Study|Death|3|||
155125064|NCT02713529|559889357|FG002|Overall Study|Death|26|||
155125065|NCT02713529|559889358|FG003|Overall Study|Death|27|||
155125066|NCT02713529|559889359|FG004|Overall Study|Death|3|||
155125067|NCT02713529|559889360|FG005|Overall Study|Death|13|||
155125068|NCT02713529|559889361|FG006|Overall Study|Death|3|||
155125069|NCT01827332|559889362|FG000|Overall Study|Lost to Follow-up|2|||
155125070|NCT01827332|559889363|FG001|Overall Study|Lost to Follow-up|1|||
155125071|NCT00514020|559889364|FG000|Overall Study|Adverse Event|6|||
155125072|NCT00514020|559889364|FG000|Overall Study|Withdrawal by Subject|3|||
155125073|NCT00514020|559889364|FG000|Overall Study|Physician Decision|1|||
155125074|NCT00514020|559889364|FG000|Overall Study|disease progression|9|||
155125075|NCT00514020|559889364|FG000|Overall Study|other complicating disease|2|||
155125076|NCT00514020|559889364|FG000|Overall Study|patient went to radiation treatment|1|||
155125077|NCT00514020|559889364|FG000|Overall Study|"patients moved to the no tx group"|6|||
155125078|NCT02725593|559889365|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
155125079|NCT02725593|559889366|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
155125080|NCT02725593|559889365|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
155125081|NCT02725593|559889366|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
155125082|NCT02725593|559889365|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
155125083|NCT02725593|559889366|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
155125084|NCT02725593|559889365|FG000|Long Term Extension|Withdrawal by Subject|1|||
155125085|NCT02725593|559889366|FG001|Long Term Extension|Withdrawal by Subject|3|||
155125086|NCT00276614|559889374|FG000|Overall Study|Progression of disease under study|3|||
155125087|NCT02698371|559889378|FG000|All Participants Flow|Lost to Follow-up|3|||
155125088|NCT02698371|559889378|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
155125089|NCT02698371|559889378|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
155125090|NCT02698371|559889378|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
155125091|NCT02698371|559889378|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
155125092|NCT02698371|559889378|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
155178060|NCT02142387|560091390|FG001|Overall Study|CPR not performed|473|||
155125093|NCT02698371|559889378|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
155125094|NCT01440881|559889386|FG000|Overall Study|Death|0|||
155125095|NCT01440881|559889387|FG001|Overall Study|Death|1|||
155125096|NCT02290938|559889390|FG000|Overall Study|Lost to Follow-up|14|||
154921949|NCT02441517|559138114|FG000|Overall Study|Study Terminated by Sponsor|1|||
154921950|NCT03039699|559138115|FG000|Overall Study|Incorrect inclusion|5|||
154921951|NCT03039699|559138116|FG001|Overall Study|Incorrect inclusion|4|||
154921952|NCT03039699|559138115|FG000|Overall Study|Lack of data to assess study endpoint|5|||
154921953|NCT03039699|559138116|FG001|Overall Study|Lack of data to assess study endpoint|3|||
154921954|NCT03039699|559138115|FG000|Overall Study|Bacterial infection|12|||
154921955|NCT03039699|559138116|FG001|Overall Study|Bacterial infection|28|||
154921956|NCT02911285|559138117|FG000|Overall Study|Lost to Follow-up|8|||
154921957|NCT02911285|559138118|FG001|Overall Study|Lost to Follow-up|5|||
154921958|NCT02911285|559138117|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
154921959|NCT02911285|559138118|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
154921960|NCT00422227|559138119|FG000|Overall Study|Adverse Event|3|||
154921961|NCT00422227|559138120|FG001|Overall Study|Adverse Event|8|||
154921962|NCT00422227|559138119|FG000|Overall Study|Lost to Follow-up|1|||
154921963|NCT00422227|559138120|FG001|Overall Study|Lost to Follow-up|3|||
154921964|NCT00422227|559138119|FG000|Overall Study|Withdrawal by Subject|0|||
154921965|NCT00422227|559138120|FG001|Overall Study|Withdrawal by Subject|4|||
154921966|NCT00686894|559138122|FG000|Overall Study|Relapse|2|||
154921967|NCT00686894|559138122|FG000|Overall Study|Protocol Violation|4|||
154921968|NCT01790633|559138127|FG000|Overall Study|Protocol Violation|1|||
154921969|NCT01790633|559138128|FG001|Overall Study|Protocol Violation|2|||
154921970|NCT01790633|559138127|FG000|Overall Study|Did not have serology performed|47|||
154921971|NCT01790633|559138128|FG001|Overall Study|Did not have serology performed|0|||
154921972|NCT01790633|559138127|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
154921973|NCT01790633|559138128|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
154921974|NCT00761462|559140073|FG000|Treatment|Subjects never received study medication|23|||
154921975|NCT00761462|559140074|FG001|Treatment|Subjects never received study medication|12|||
154921976|NCT00761462|559140073|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
154921977|NCT00761462|559140074|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
154921978|NCT00761462|559140073|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
154921979|NCT00761462|559140074|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
154921980|NCT00761462|559140073|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
154921981|NCT00761462|559140074|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
154921982|NCT02985541|559140078|FG000|Overall Study|Withdrawal by Subject|33|||
154921983|NCT02985541|559140078|FG000|Overall Study|Lost to Follow-up|26|||
154921984|NCT02985541|559140078|FG000|Overall Study|Adverse Event|27|||
154921985|NCT02985541|559140078|FG000|Overall Study|Physician Decision|2|||
154921986|NCT02985541|559140078|FG000|Overall Study|Pregnancy|2|||
154921987|NCT02985541|559140078|FG000|Overall Study|Wish for pregnancy|44|||
154921988|NCT02985541|559140078|FG000|Overall Study|Other reason|5|||
154921989|NCT02985541|559140078|FG000|Overall Study|Not valid for analysis|2|||
154921990|NCT02163759|559140082|FG000|Overall Study|Withdrawal by Subject|1|||
154921991|NCT02163759|559140083|FG001|Overall Study|Withdrawal by Subject|5|||
154921992|NCT02163759|559140084|FG002|Overall Study|Withdrawal by Subject|1|||
154921993|NCT02163759|559140082|FG000|Overall Study|Adverse Event|0|||
154921994|NCT02163759|559140083|FG001|Overall Study|Adverse Event|0|||
154921995|NCT02163759|559140084|FG002|Overall Study|Adverse Event|1|||
154921996|NCT02163759|559140082|FG000|Overall Study|Death|0|||
154921997|NCT02163759|559140083|FG001|Overall Study|Death|0|||
154921998|NCT02163759|559140084|FG002|Overall Study|Death|1|||
154921999|NCT01479777|559140095|FG000|Overall Study|Physician Decision|2|||
154922000|NCT00451191|559140096|FG000|Overall Study|withdrawal or received alternate tx|15|||
154922001|NCT00451191|559140097|FG001|Overall Study|withdrawal or received alternate tx|11|||
154922002|NCT00656669|559140105|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
154922003|NCT00656669|559140105|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
154922004|NCT00656669|559140105|FG000|AC (Cycles 6-9)|Adverse Event|1|||
154922005|NCT00656669|559140105|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
154922006|NCT03575806|559140108|FG000|Overall Study|Withdrawal by Subject|0|||
154922007|NCT03575806|559140109|FG001|Overall Study|Withdrawal by Subject|2|||
154922008|NCT03575806|559140108|FG000|Overall Study|Protocol Violation|0|||
155125097|NCT02290938|559889391|FG001|Overall Study|Lost to Follow-up|43|||
154922009|NCT03575806|559140109|FG001|Overall Study|Protocol Violation|2|||
154922010|NCT00219349|559140110|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
155125098|NCT01825941|559890542|FG000|Overall Study|Lost to Follow-up|4|||
155125099|NCT01825941|559890543|FG001|Overall Study|Lost to Follow-up|1|||
155125100|NCT03938324|559890551|FG000|Overall Study|Lost to Follow-up|42|||
154922011|NCT00219349|559140110|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
154922012|NCT00219349|559140110|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
154922013|NCT00219349|559140110|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
154922014|NCT00869362|559140115|FG000|Overall Study|Death|0|||
154922015|NCT00869362|559140116|FG001|Overall Study|Death|2|||
154922016|NCT00869362|559140115|FG000|Overall Study|Lost to Follow-up|1|||
154922017|NCT00869362|559140116|FG001|Overall Study|Lost to Follow-up|3|||
154922018|NCT01945034|559140117|FG000|Overall Study|Medication Error|0|||
155125101|NCT03938324|559890552|FG001|Overall Study|Lost to Follow-up|21|||
154922019|NCT01945034|559140118|FG001|Overall Study|Medication Error|1|||
154922020|NCT01945034|559140119|FG002|Overall Study|Medication Error|0|||
154922021|NCT01945034|559140117|FG000|Overall Study|Withdrawal by Subject|0|||
154922022|NCT01945034|559140118|FG001|Overall Study|Withdrawal by Subject|3|||
154922023|NCT01945034|559140119|FG002|Overall Study|Withdrawal by Subject|1|||
154922024|NCT01945034|559140117|FG000|Overall Study|Other|0|||
154922025|NCT01945034|559140118|FG001|Overall Study|Other|1|||
154922026|NCT01945034|559140119|FG002|Overall Study|Other|3|||
154922027|NCT01945034|559140117|FG000|Overall Study|Lost to Follow-up|0|||
154922028|NCT01945034|559140118|FG001|Overall Study|Lost to Follow-up|0|||
154922029|NCT01945034|559140119|FG002|Overall Study|Lost to Follow-up|2|||
154922030|NCT01945034|559140117|FG000|Overall Study|Protocol Violation|1|||
154922031|NCT01945034|559140118|FG001|Overall Study|Protocol Violation|0|||
154922032|NCT01945034|559140119|FG002|Overall Study|Protocol Violation|1|||
154922033|NCT02389621|559140121|FG000|Treatment Period|Withdrawal by Subject|1|||
154922034|NCT02389621|559140122|FG001|Treatment Period|Withdrawal by Subject|1|||
154922035|NCT02389621|559140121|FG000|Posttreatment Period|Adverse Event|3|||
154922036|NCT02389621|559140122|FG001|Posttreatment Period|Adverse Event|1|||
154922037|NCT02389621|559140121|FG000|Posttreatment Period|Withdrawal by Subject|3|||
154922038|NCT02389621|559140122|FG001|Posttreatment Period|Withdrawal by Subject|2|||
154922039|NCT02389621|559140121|FG000|Posttreatment Period|Lost to Follow-up|1|||
154922040|NCT02389621|559140122|FG001|Posttreatment Period|Lost to Follow-up|1|||
154922041|NCT02389621|559140121|FG000|Posttreatment Period|Other - Miscellaneous|2|||
154922042|NCT02389621|559140122|FG001|Posttreatment Period|Other - Miscellaneous|0|||
154922043|NCT02222246|559140126|FG000|Overall Study|No Emergency Department Visits|27|||
154922044|NCT02222246|559140127|FG001|Overall Study|No Emergency Department Visits|26|||
154922045|NCT02222246|559140126|FG000|Overall Study|Physician Decision|0|||
154922046|NCT02222246|559140127|FG001|Overall Study|Physician Decision|1|||
154922047|NCT01339273|559140129|FG000|Overall Study|Lost to Follow-up|8|||
154922048|NCT01339273|559140130|FG001|Overall Study|Lost to Follow-up|8|||
154922049|NCT00560573|559140131|FG000|Overall Study|Death|4|||
154922050|NCT00560573|559140132|FG001|Overall Study|Death|1|||
154922051|NCT00560573|559140133|FG002|Overall Study|Death|4|||
154922052|NCT00560573|559140134|FG003|Overall Study|Death|5|||
154922053|NCT00560573|559140135|FG004|Overall Study|Death|1|||
154922054|NCT00560573|559140136|FG005|Overall Study|Death|10|||
154922055|NCT00560573|559140131|FG000|Overall Study|Lost to Follow-up|0|||
154922056|NCT00560573|559140132|FG001|Overall Study|Lost to Follow-up|0|||
154922057|NCT00560573|559140133|FG002|Overall Study|Lost to Follow-up|0|||
154922058|NCT00560573|559140134|FG003|Overall Study|Lost to Follow-up|1|||
154922059|NCT00560573|559140135|FG004|Overall Study|Lost to Follow-up|1|||
154922060|NCT00560573|559140136|FG005|Overall Study|Lost to Follow-up|0|||
154922061|NCT00560573|559140131|FG000|Overall Study|Withdrawal by Subject|0|||
154922062|NCT00560573|559140132|FG001|Overall Study|Withdrawal by Subject|0|||
154922063|NCT00560573|559140133|FG002|Overall Study|Withdrawal by Subject|0|||
154922064|NCT00560573|559140134|FG003|Overall Study|Withdrawal by Subject|1|||
154922065|NCT00560573|559140135|FG004|Overall Study|Withdrawal by Subject|1|||
154922066|NCT00560573|559140136|FG005|Overall Study|Withdrawal by Subject|0|||
154922067|NCT00560573|559140131|FG000|Overall Study|Other|2|||
154922068|NCT00560573|559140132|FG001|Overall Study|Other|2|||
154922069|NCT00560573|559140133|FG002|Overall Study|Other|2|||
154922070|NCT00560573|559140134|FG003|Overall Study|Other|3|||
154922071|NCT00560573|559140135|FG004|Overall Study|Other|3|||
154922072|NCT00560573|559140136|FG005|Overall Study|Other|3|||
154922073|NCT00560573|559140131|FG000|Overall Study|Enrolled, not treated|0|||
154922074|NCT00560573|559140132|FG001|Overall Study|Enrolled, not treated|0|||
154922075|NCT00560573|559140133|FG002|Overall Study|Enrolled, not treated|0|||
154922076|NCT00560573|559140134|FG003|Overall Study|Enrolled, not treated|0|||
154922077|NCT00560573|559140135|FG004|Overall Study|Enrolled, not treated|1|||
154922078|NCT00560573|559140136|FG005|Overall Study|Enrolled, not treated|0|||
154922079|NCT00423137|559140144|FG000|Overall Study|Lost to Follow-up|0|||
154922080|NCT00423137|559140145|FG001|Overall Study|Lost to Follow-up|0|||
154922081|NCT00423137|559140146|FG002|Overall Study|Lost to Follow-up|1|||
154922082|NCT00423137|559140147|FG003|Overall Study|Lost to Follow-up|0|||
154922083|NCT00423137|559140144|FG000|Overall Study|Protocol Violation|0|||
154922084|NCT00423137|559140145|FG001|Overall Study|Protocol Violation|0|||
154922085|NCT00423137|559140146|FG002|Overall Study|Protocol Violation|0|||
154922086|NCT00423137|559140147|FG003|Overall Study|Protocol Violation|1|||
154922087|NCT00423137|559140144|FG000|Overall Study|Adverse Event Study disease worse|1|||
154922088|NCT00423137|559140145|FG001|Overall Study|Adverse Event Study disease worse|0|||
155002110|NCT01121562|559432487|FG000|Overall Study|Objective progression or relapse|8|||
154922089|NCT00423137|559140146|FG002|Overall Study|Adverse Event Study disease worse|3|||
154922090|NCT00423137|559140147|FG003|Overall Study|Adverse Event Study disease worse|1|||
154922091|NCT00423137|559140144|FG000|Overall Study|Adverse Event Other|0|||
154922092|NCT00423137|559140145|FG001|Overall Study|Adverse Event Other|0|||
154922093|NCT00423137|559140146|FG002|Overall Study|Adverse Event Other|2|||
154922094|NCT00423137|559140147|FG003|Overall Study|Adverse Event Other|0|||
154922095|NCT04196023|559140149|FG000|Overall Study|Withdrawal by Subject|0|||
155002111|NCT01121562|559432487|FG000|Overall Study|Withdrawal by Subject|1|||
154922096|NCT04196023|559140150|FG001|Overall Study|Withdrawal by Subject|1|||
154922097|NCT04196023|559140149|FG000|Overall Study|Adverse Event|3|||
154922098|NCT04196023|559140150|FG001|Overall Study|Adverse Event|1|||
154922099|NCT04196023|559140149|FG000|Overall Study|Lost to Follow-up|0|||
154922100|NCT04196023|559140150|FG001|Overall Study|Lost to Follow-up|1|||
154922101|NCT04359758|559140153|FG000|Overall Study|Protocol Violation|3|||
154922102|NCT04359758|559140154|FG001|Overall Study|Protocol Violation|2|||
154922103|NCT04753606|559140158|FG000|Overall Study|Adverse Event|1|||
154922104|NCT04753606|559140159|FG001|Overall Study|Adverse Event|0|||
154922105|NCT04753606|559140160|FG002|Overall Study|Adverse Event|0|||
154922106|NCT00442572|559140164|FG000|Overall Study|Relapse|8|||
154922107|NCT00442572|559140165|FG001|Overall Study|Relapse|1|||
154922108|NCT00442572|559140164|FG000|Overall Study|Lost to Follow-up|0|||
154922109|NCT00442572|559140165|FG001|Overall Study|Lost to Follow-up|1|||
154922110|NCT00442572|559140164|FG000|Overall Study|Withdrawal by Subject|0|||
154922111|NCT00442572|559140165|FG001|Overall Study|Withdrawal by Subject|1|||
154922112|NCT04366258|559140166|FG000|Baseline Assessments|Screen Failure|21|||
154922113|NCT04366258|559140166|FG000|Baseline Assessments|Early Termination|3|||
154922114|NCT00276458|559140167|FG000|Overall Study|Adverse Event|0|||
154922115|NCT00276458|559140168|FG001|Overall Study|Adverse Event|2|||
154922116|NCT00276458|559140167|FG000|Overall Study|Lost to Follow-up|2|||
154922117|NCT00276458|559140168|FG001|Overall Study|Lost to Follow-up|2|||
154922118|NCT00276458|559140167|FG000|Overall Study|Protocol Violation|4|||
154922119|NCT00276458|559140168|FG001|Overall Study|Protocol Violation|3|||
154922120|NCT03205046|559140172|FG000|Overall Study|Death|10|||
154922121|NCT03205046|559140173|FG001|Overall Study|Death|6|||
154922122|NCT03205046|559140172|FG000|Overall Study|Withdrawal by Subject|1|||
154922123|NCT03205046|559140173|FG001|Overall Study|Withdrawal by Subject|2|||
154922124|NCT03205046|559140172|FG000|Overall Study|Lost to Follow-up|0|||
154922125|NCT03205046|559140173|FG001|Overall Study|Lost to Follow-up|1|||
154922126|NCT03205046|559140172|FG000|Overall Study|Study terminated by sponsor|2|||
154922127|NCT03205046|559140173|FG001|Overall Study|Study terminated by sponsor|1|||
154922128|NCT01023815|559140174|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
154922129|NCT01023815|559140175|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
154922130|NCT01023815|559140176|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
154922131|NCT01023815|559140177|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
154922132|NCT01023815|559140174|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
154922133|NCT01023815|559140175|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
154922134|NCT01023815|559140176|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
154922135|NCT01023815|559140177|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
154922136|NCT01023815|559140174|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
154922137|NCT01023815|559140175|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
154922138|NCT01023815|559140176|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
154922139|NCT01023815|559140177|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
154922140|NCT01023815|559140174|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
154922141|NCT01023815|559140175|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
154922142|NCT01023815|559140176|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
154922143|NCT01023815|559140177|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
154922144|NCT01023815|559140174|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
154922145|NCT01023815|559140175|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
154922146|NCT01023815|559140176|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
154922147|NCT01023815|559140177|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
154922148|NCT01977625|559140183|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
154922149|NCT01977625|559140184|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
154922150|NCT01977625|559140183|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
154922151|NCT01977625|559140184|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
154922152|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
154922153|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
154922154|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
154922155|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
154922156|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
154922157|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Death|1|||
154922158|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Death|0|||
154922159|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Death|0|||
154922160|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Death|0|||
155178061|NCT02142387|560091389|FG000|Overall Study|witnessed by paramedic|139|||
155178062|NCT02142387|560091390|FG001|Overall Study|witnessed by paramedic|917|||
155178063|NCT02142387|560091389|FG000|Overall Study|incomplete data|1|||
155178064|NCT02142387|560091390|FG001|Overall Study|incomplete data|9|||
154922161|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Death|0|||
154922162|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
154922163|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
154922164|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
155125102|NCT03938324|559890551|FG000|Overall Study|Withdrawal by Subject|6|||
155125103|NCT03938324|559890552|FG001|Overall Study|Withdrawal by Subject|1|||
155125104|NCT02769962|559890553|FG000|Overall Study|Physician Decision|0|||
155125105|NCT02769962|559890554|FG001|Overall Study|Physician Decision|0|||
155125106|NCT02769962|559890555|FG002|Overall Study|Physician Decision|0|||
155125107|NCT02769962|559890556|FG003|Overall Study|Physician Decision|0|||
155125108|NCT02769962|559890557|FG004|Overall Study|Physician Decision|0|||
155125109|NCT02769962|559890558|FG005|Overall Study|Physician Decision|1|||
155125110|NCT02769962|559890559|FG006|Overall Study|Physician Decision|0|||
155125111|NCT02769962|559890560|FG007|Overall Study|Physician Decision|1|||
155125112|NCT02769962|559890553|FG000|Overall Study|Refused further treatment|0|||
155125113|NCT02769962|559890554|FG001|Overall Study|Refused further treatment|0|||
155125114|NCT02769962|559890555|FG002|Overall Study|Refused further treatment|0|||
155125115|NCT02769962|559890556|FG003|Overall Study|Refused further treatment|0|||
155125116|NCT02769962|559890557|FG004|Overall Study|Refused further treatment|0|||
155125117|NCT02769962|559890558|FG005|Overall Study|Refused further treatment|1|||
155125118|NCT02769962|559890559|FG006|Overall Study|Refused further treatment|1|||
155125119|NCT02769962|559890560|FG007|Overall Study|Refused further treatment|0|||
155125120|NCT05565937|559890561|FG000|Overall Study|Adverse Event|0|||
155125121|NCT05565937|559890562|FG001|Overall Study|Adverse Event|1|||
155125122|NCT05565937|559890561|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
155125123|NCT05565937|559890562|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
155125124|NCT05565937|559890561|FG000|Overall Study|Lost to Follow-up|2|||
155125125|NCT05565937|559890562|FG001|Overall Study|Lost to Follow-up|0|||
155125126|NCT05565937|559890561|FG000|Overall Study|Pregnancy|0|||
155125127|NCT05565937|559890562|FG001|Overall Study|Pregnancy|2|||
155125128|NCT05565937|559890561|FG000|Overall Study|Anisometropia|0|||
155125129|NCT05565937|559890562|FG001|Overall Study|Anisometropia|1|||
155125130|NCT04544683|559890563|FG000|Overall Study|Lost to Follow-up|2|||
155125131|NCT04544683|559890563|FG000|Overall Study|Underwent cervical spine surgery|6|||
155125132|NCT00151372|559890564|FG000|Overall Study|Death|12|||
155125133|NCT00151372|559890565|FG001|Overall Study|Death|11|||
154922165|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
154922166|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
154922167|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
154922168|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
154922169|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
154922170|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
154922171|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
154922172|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
154922173|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
154922174|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
154922175|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
154922176|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
154922177|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
154922178|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
154922179|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
154922180|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
154922181|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
154922182|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
154922183|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
154922184|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
154922185|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
154922186|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
154922187|NCT00634933|559140187|FG000|Part A: Baseline to Week 24|Other|1|||
154922188|NCT00634933|559140188|FG001|Part A: Baseline to Week 24|Other|8|||
154922189|NCT00634933|559140189|FG002|Part A: Baseline to Week 24|Other|5|||
154922190|NCT00634933|559140190|FG003|Part A: Baseline to Week 24|Other|0|||
154922191|NCT00634933|559140191|FG004|Part A: Baseline to Week 24|Other|0|||
154922192|NCT00634933|559140187|FG000|Between Part A and Part B|Physician Decision|0|||
154922193|NCT00634933|559140188|FG001|Between Part A and Part B|Physician Decision|1|||
154922194|NCT00634933|559140189|FG002|Between Part A and Part B|Physician Decision|0|||
154922195|NCT00634933|559140190|FG003|Between Part A and Part B|Physician Decision|0|||
155125134|NCT00151372|559890564|FG000|Overall Study|Lost to Follow-up|5|||
155125135|NCT00151372|559890565|FG001|Overall Study|Lost to Follow-up|5|||
155125136|NCT00151372|559890564|FG000|Overall Study|Too sick medically to continue|5|||
154922196|NCT00634933|559140191|FG004|Between Part A and Part B|Physician Decision|0|||
154922197|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
154922198|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
154922199|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
155125137|NCT00151372|559890565|FG001|Overall Study|Too sick medically to continue|6|||
155125138|NCT00151372|559890564|FG000|Overall Study|Withdrawal by Subject|7|||
155125139|NCT00151372|559890565|FG001|Overall Study|Withdrawal by Subject|7|||
155125140|NCT01266590|559890566|FG000|Overall Study|Adverse Event|3|||
155125141|NCT01266590|559890566|FG000|Overall Study|Lost to Follow-up|1|||
154922200|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
154922201|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
154922202|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
154922203|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
154922204|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
154922205|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
154922206|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
154922207|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
154922208|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
154922209|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
154922210|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
154922211|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
154922212|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
154922213|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
154922214|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
154922215|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
154922216|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
154922217|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
154922218|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
154922219|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
154922220|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
154922221|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
154922222|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
154922223|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
154922224|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
154922225|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
154922226|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
154922227|NCT00634933|559140187|FG000|Part B: Week 24 to Week 52|Other|0|||
154922228|NCT00634933|559140188|FG001|Part B: Week 24 to Week 52|Other|0|||
155125142|NCT01266590|559890566|FG000|Overall Study|Withdrawal by Subject|1|||
155125143|NCT01266590|559890566|FG000|Overall Study|Physician Decision|1|||
155125144|NCT04732949|559890569|FG000|Overall Study|Withdrawal by Subject|23|||
155125145|NCT04732949|559890570|FG001|Overall Study|Withdrawal by Subject|27|||
155125146|NCT04732949|559890569|FG000|Overall Study|Protocol Violation|0|||
155125147|NCT04732949|559890570|FG001|Overall Study|Protocol Violation|1|||
155125148|NCT04732949|559890569|FG000|Overall Study|Non-compliance|0|||
155125149|NCT04732949|559890570|FG001|Overall Study|Non-compliance|2|||
155125150|NCT04732949|559890569|FG000|Overall Study|Physician Decision|2|||
155125151|NCT04732949|559890570|FG001|Overall Study|Physician Decision|1|||
155125152|NCT04732949|559890569|FG000|Overall Study|Serious adverse event (Fatal)|16|||
155125153|NCT04732949|559890570|FG001|Overall Study|Serious adverse event (Fatal)|18|||
155125154|NCT04732949|559890569|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
155125155|NCT04732949|559890570|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
155125156|NCT04732949|559890569|FG000|Overall Study|Non-serious adverse event|1|||
155125157|NCT04732949|559890570|FG001|Overall Study|Non-serious adverse event|3|||
155125158|NCT04732949|559890569|FG000|Overall Study|Lost to Follow-up|26|||
155125159|NCT04732949|559890570|FG001|Overall Study|Lost to Follow-up|27|||
155125160|NCT04732949|559890569|FG000|Overall Study|Other|6|||
155125161|NCT04732949|559890570|FG001|Overall Study|Other|3|||
155125162|NCT01286077|559890571|FG000|Overall Study|Adverse Event|2|||
155125163|NCT01286077|559890572|FG001|Overall Study|Adverse Event|0|||
155125164|NCT01286077|559890571|FG000|Overall Study|Death|1|||
155125165|NCT01286077|559890572|FG001|Overall Study|Death|0|||
155125166|NCT01286077|559890571|FG000|Overall Study|Protocol Violation|1|||
155125167|NCT01286077|559890572|FG001|Overall Study|Protocol Violation|1|||
155125168|NCT01286077|559890571|FG000|Overall Study|Withdrawal by Subject|0|||
155125169|NCT01286077|559890572|FG001|Overall Study|Withdrawal by Subject|2|||
155125170|NCT01286077|559890571|FG000|Overall Study|Intercurrent illness|1|||
155125171|NCT01286077|559890572|FG001|Overall Study|Intercurrent illness|0|||
155125172|NCT01286077|559890571|FG000|Overall Study|Non-compliance|1|||
155125173|NCT01286077|559890572|FG001|Overall Study|Non-compliance|0|||
155125174|NCT01286077|559890571|FG000|Overall Study|The subject starts with alternative MMY|0|||
155125175|NCT01286077|559890572|FG001|Overall Study|The subject starts with alternative MMY|3|||
155125176|NCT01286077|559890571|FG000|Overall Study|Patient's decision to stop treatment|3|||
155125177|NCT01286077|559890572|FG001|Overall Study|Patient's decision to stop treatment|0|||
155125178|NCT01286077|559890571|FG000|Overall Study|Progression of disease|0|||
155125179|NCT01286077|559890572|FG001|Overall Study|Progression of disease|1|||
155125180|NCT01286077|559890571|FG000|Overall Study|refill medication not received in time|1|||
155125181|NCT01286077|559890572|FG001|Overall Study|refill medication not received in time|0|||
155125182|NCT01282294|559890573|FG000|Overall Study|Lost to Follow-up|14|||
155125183|NCT01282294|559890573|FG000|Overall Study|Screening failure|1|||
155125184|NCT01282294|559890573|FG000|Overall Study|Adverse Event|1|||
155125185|NCT01282294|559890573|FG000|Overall Study|Patient non-compliance|2|||
155125186|NCT01282294|559890573|FG000|Overall Study|Physician Decision|1|||
154922229|NCT00634933|559140189|FG002|Part B: Week 24 to Week 52|Other|5|||
154922230|NCT00634933|559140190|FG003|Part B: Week 24 to Week 52|Other|0|||
154922231|NCT00634933|559140191|FG004|Part B: Week 24 to Week 52|Other|1|||
154922232|NCT02304484|559140192|FG000|Overall Study|Death|9|||
154922233|NCT02304484|559140192|FG000|Overall Study|Withdrawal by Subject|14|||
154922234|NCT02304484|559140192|FG000|Overall Study|Lost to Follow-up|2|||
154922235|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Adverse Event|6|||
154922236|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Adverse Event|6|||
154922237|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Death|14|||
154922238|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Death|11|||
154922239|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
154922240|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
154922241|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
154922242|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
154922243|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
154922244|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
154922245|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Disease Progression|1|||
154922246|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Disease Progression|0|||
154922247|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
154922248|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
154922249|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
154922250|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
154922251|NCT04419558|559140193|FG000|DB Period (48 Weeks)|Participant Decision|4|||
154922252|NCT04419558|559140194|FG001|DB Period (48 Weeks)|Participant Decision|3|||
154922253|NCT04419558|559140193|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
154922254|NCT04419558|559140194|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
154922255|NCT04419558|559140193|FG000|OLE Period (48 Weeks)|Death|4|||
154922256|NCT04419558|559140194|FG001|OLE Period (48 Weeks)|Death|6|||
154922257|NCT04419558|559140193|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
154922258|NCT04419558|559140194|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
154922259|NCT04419558|559140193|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
154922260|NCT04419558|559140194|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
154922261|NCT03522506|559140195|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
154922262|NCT03522506|559140196|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
154922263|NCT03522506|559140197|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
154922264|NCT03522506|559140198|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
154922265|NCT03522506|559140195|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
154922266|NCT03522506|559140196|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
154922267|NCT03522506|559140197|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
154922268|NCT03522506|559140198|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
154922269|NCT03480243|559140199|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
154922270|NCT03480243|559140199|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
154922271|NCT04410991|559140213|FG000|Overall Study|Poor compliance to protocol|5|||
154922272|NCT04410991|559140214|FG001|Overall Study|Poor compliance to protocol|4|||
154922273|NCT04410991|559140213|FG000|Overall Study|Withdrawal by Subject|59|||
154922274|NCT04410991|559140214|FG001|Overall Study|Withdrawal by Subject|55|||
154922275|NCT04410991|559140213|FG000|Overall Study|Other|10|||
154922276|NCT04410991|559140214|FG001|Overall Study|Other|4|||
154922277|NCT03282123|559140215|FG000|Overall Study|Withdrawal by Subject|5|||
154922278|NCT00764465|559140216|FG000|Overall Study|Adverse Event|2|||
154922279|NCT00764465|559140217|FG001|Overall Study|Adverse Event|0|||
154922280|NCT00764465|559140218|FG002|Overall Study|Adverse Event|0|||
154922281|NCT00764465|559140219|FG003|Overall Study|Adverse Event|1|||
154922282|NCT00764465|559140220|FG004|Overall Study|Adverse Event|1|||
154922283|NCT00764465|559140221|FG005|Overall Study|Adverse Event|1|||
154922284|NCT00764465|559140216|FG000|Overall Study|Withdrawal by Subject|0|||
154922285|NCT00764465|559140217|FG001|Overall Study|Withdrawal by Subject|1|||
154922286|NCT00764465|559140218|FG002|Overall Study|Withdrawal by Subject|1|||
154922287|NCT00764465|559140219|FG003|Overall Study|Withdrawal by Subject|0|||
154922288|NCT00764465|559140220|FG004|Overall Study|Withdrawal by Subject|0|||
154922289|NCT00764465|559140221|FG005|Overall Study|Withdrawal by Subject|0|||
154922290|NCT01195662|559140222|FG000|Double Blind Treatment Period|Adverse Event|4|||
154922291|NCT01195662|559140223|FG001|Double Blind Treatment Period|Adverse Event|1|||
154922292|NCT01195662|559140224|FG002|Double Blind Treatment Period|Adverse Event|2|||
154922293|NCT01195662|559140222|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
154922294|NCT01195662|559140223|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
154922295|NCT01195662|559140224|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
154922296|NCT01195662|559140222|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
154922297|NCT01195662|559140223|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
154922298|NCT01195662|559140224|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
154922299|NCT01195662|559140222|FG000|Double Blind Treatment Period|Administrative reason|2|||
154922300|NCT01195662|559140223|FG001|Double Blind Treatment Period|Administrative reason|1|||
154922301|NCT01195662|559140224|FG002|Double Blind Treatment Period|Administrative reason|1|||
155002112|NCT01121562|559432487|FG000|Overall Study|Adverse Event|1|||
154922302|NCT01195662|559140222|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
154922303|NCT01195662|559140223|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
154922304|NCT01195662|559140224|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
154922305|NCT01195662|559140222|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
154922306|NCT01195662|559140223|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
154922307|NCT01195662|559140224|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
154922308|NCT01195662|559140222|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
154922309|NCT01195662|559140223|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
154922310|NCT01195662|559140224|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
154922311|NCT01195662|559140222|FG000|Double Blind Treatment Period|Non-specified|3|||
154922312|NCT01195662|559140223|FG001|Double Blind Treatment Period|Non-specified|0|||
154922313|NCT01195662|559140224|FG002|Double Blind Treatment Period|Non-specified|0|||
154922314|NCT01195662|559140222|FG000|Double Blind Treatment Period|Missing disposition information|0|||
154922315|NCT01195662|559140223|FG001|Double Blind Treatment Period|Missing disposition information|1|||
154922316|NCT01195662|559140224|FG002|Double Blind Treatment Period|Missing disposition information|1|||
154922317|NCT01195662|559140222|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
154922318|NCT01195662|559140223|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
154922319|NCT01195662|559140224|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
154922320|NCT01195662|559140222|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
154922321|NCT01195662|559140223|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
154922322|NCT01195662|559140224|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
154922323|NCT03457701|559140225|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
154922324|NCT03457701|559140226|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
154922325|NCT03457701|559140225|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
154922326|NCT03457701|559140226|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
154922327|NCT03329404|559140227|FG000|Overall Study|The study was suspended.|1|||
154922328|NCT03329404|559140228|FG001|Overall Study|The study was suspended.|4|||
154922329|NCT01250418|559140229|FG000|Overall Study|monitor data failure|1|||
154922330|NCT01250418|559140230|FG001|Overall Study|monitor data failure|1|||
154922331|NCT01298323|559140233|FG000|Overall Study|Adverse Event|2|||
154922332|NCT01298323|559140234|FG001|Overall Study|Adverse Event|4|||
154922333|NCT01298323|559140233|FG000|Overall Study|Death|11|||
154922334|NCT01298323|559140234|FG001|Overall Study|Death|16|||
154922335|NCT01298323|559140233|FG000|Overall Study|Lost to Follow-up|1|||
154922336|NCT01298323|559140234|FG001|Overall Study|Lost to Follow-up|0|||
154922337|NCT01298323|559140233|FG000|Overall Study|Withdrawal by Subject|6|||
154922338|NCT01298323|559140234|FG001|Overall Study|Withdrawal by Subject|3|||
154922339|NCT01298323|559140233|FG000|Overall Study|Protocol Violation|1|||
154922340|NCT01298323|559140234|FG001|Overall Study|Protocol Violation|0|||
154922341|NCT01298323|559140233|FG000|Overall Study|Other|10|||
154922342|NCT01298323|559140234|FG001|Overall Study|Other|9|||
154922343|NCT01298323|559140233|FG000|Overall Study|Ongoing|55|||
154922344|NCT01298323|559140234|FG001|Overall Study|Ongoing|55|||
154922345|NCT01298323|559140233|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
154922346|NCT01298323|559140234|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
154922347|NCT01761565|559140235|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
154922348|NCT02161380|559140236|FG000|Overall Study|Lost to Follow-up|0|||
154922349|NCT02161380|559140237|FG001|Overall Study|Lost to Follow-up|1|||
154922350|NCT02161380|559140238|FG002|Overall Study|Lost to Follow-up|0|||
154922351|NCT02161380|559140239|FG003|Overall Study|Lost to Follow-up|0|||
154922352|NCT04409262|559140240|FG000|Overall Study|Adverse Event|0|||
154922353|NCT04409262|559140241|FG001|Overall Study|Adverse Event|2|||
154922354|NCT04409262|559140240|FG000|Overall Study|Death|55|||
154922355|NCT04409262|559140241|FG001|Overall Study|Death|97|||
154922356|NCT04409262|559140240|FG000|Overall Study|Lost to Follow-up|12|||
154922357|NCT04409262|559140241|FG001|Overall Study|Lost to Follow-up|23|||
154922358|NCT04409262|559140240|FG000|Overall Study|Lack of Staff|0|||
154922359|NCT04409262|559140241|FG001|Overall Study|Lack of Staff|1|||
154922360|NCT04409262|559140240|FG000|Overall Study|Protocol Violation|3|||
154922361|NCT04409262|559140241|FG001|Overall Study|Protocol Violation|1|||
154922362|NCT04409262|559140240|FG000|Overall Study|Withdrawal by Subject|5|||
154922363|NCT04409262|559140241|FG001|Overall Study|Withdrawal by Subject|10|||
154922364|NCT00948896|559140244|FG000|Randomization to 24 Months of Age|Death|1|||
154922365|NCT00948896|559140245|FG001|Randomization to 24 Months of Age|Death|0|||
154922366|NCT00948896|559140246|FG002|Randomization to 24 Months of Age|Death|0|||
154922367|NCT00948896|559140247|FG003|Randomization to 24 Months of Age|Death|0|||
154922368|NCT00948896|559140248|FG004|Randomization to 24 Months of Age|Death|2|||
154922369|NCT00948896|559140249|FG005|Randomization to 24 Months of Age|Death|1|||
154922370|NCT00948896|559140250|FG006|Randomization to 24 Months of Age|Death|2|||
154922371|NCT00948896|559140251|FG007|Randomization to 24 Months of Age|Death|1|||
154922372|NCT00948896|559140244|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
154922373|NCT00948896|559140245|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
155178065|NCT02142387|560091389|FG000|Overall Study|occurred not at home|298|||
155178066|NCT02142387|560091390|FG001|Overall Study|occurred not at home|2474|||
155178067|NCT00779259|560091391|FG000|Quinine Alone|Adverse Event|2|||
155178068|NCT00282464|560091392|FG000|Overall Study|Adverse Event|26|||
155178069|NCT00282464|560091393|FG001|Overall Study|Adverse Event|20|||
155178070|NCT00282464|560091392|FG000|Overall Study|Lack of Efficacy|8|||
155178071|NCT00282464|560091393|FG001|Overall Study|Lack of Efficacy|8|||
154922374|NCT00948896|559140246|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
154922375|NCT00948896|559140247|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
154922376|NCT00948896|559140248|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
154922377|NCT00948896|559140249|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
154922378|NCT00948896|559140250|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
154922379|NCT00948896|559140251|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
154922380|NCT00948896|559140244|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
154922381|NCT00948896|559140245|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
154922382|NCT00948896|559140246|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
154922383|NCT00948896|559140247|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
154922384|NCT00948896|559140248|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
154922385|NCT00948896|559140249|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
154922386|NCT00948896|559140250|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
154922387|NCT00948896|559140251|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
154922388|NCT00948896|559140244|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
154922389|NCT00948896|559140245|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
154922390|NCT00948896|559140246|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
154922391|NCT00948896|559140247|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
154922392|NCT00948896|559140248|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
154922393|NCT00948896|559140249|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
154922394|NCT00948896|559140250|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
154922395|NCT00948896|559140251|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
154922396|NCT00948896|559140244|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
154922397|NCT00948896|559140245|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
154922398|NCT00948896|559140246|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
154922399|NCT00948896|559140247|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
154922400|NCT00948896|559140248|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
154922401|NCT00948896|559140249|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
154922402|NCT00948896|559140250|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
154922403|NCT00948896|559140251|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
154922404|NCT00948896|559140244|FG000|24 Months of Age to 36 Months of Age|Death|0|||
154922405|NCT00948896|559140245|FG001|24 Months of Age to 36 Months of Age|Death|2|||
154922406|NCT00948896|559140246|FG002|24 Months of Age to 36 Months of Age|Death|2|||
154922407|NCT00948896|559140247|FG003|24 Months of Age to 36 Months of Age|Death|0|||
154922408|NCT00948896|559140248|FG004|24 Months of Age to 36 Months of Age|Death|0|||
154922409|NCT00948896|559140249|FG005|24 Months of Age to 36 Months of Age|Death|1|||
154922410|NCT00948896|559140250|FG006|24 Months of Age to 36 Months of Age|Death|0|||
154922411|NCT00948896|559140251|FG007|24 Months of Age to 36 Months of Age|Death|0|||
154922412|NCT00948896|559140244|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
154922413|NCT00948896|559140245|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
154922414|NCT00948896|559140246|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
154922415|NCT00948896|559140247|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
154922416|NCT00948896|559140248|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
154922417|NCT00948896|559140249|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
154922418|NCT00948896|559140250|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
154922419|NCT00948896|559140251|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
154922420|NCT00948896|559140244|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
154922421|NCT00948896|559140245|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
154922422|NCT00948896|559140246|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
154922423|NCT00948896|559140247|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
154922424|NCT00948896|559140248|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
154922425|NCT00948896|559140249|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
154922426|NCT00948896|559140250|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
154922427|NCT00948896|559140251|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
154922428|NCT00948896|559140244|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
154922429|NCT00948896|559140245|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
154922430|NCT00948896|559140246|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
155178072|NCT00282464|560091392|FG000|Overall Study|Lost to Follow-up|10|||
155178073|NCT00282464|560091393|FG001|Overall Study|Lost to Follow-up|10|||
155178074|NCT00282464|560091392|FG000|Overall Study|Withdrawal by Subject|24|||
154922431|NCT00948896|559140247|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
154922432|NCT00948896|559140248|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
154922433|NCT00948896|559140249|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
154922434|NCT00948896|559140250|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
154922435|NCT00948896|559140251|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
154922436|NCT00948896|559140244|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922437|NCT00948896|559140245|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922438|NCT00948896|559140246|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922439|NCT00948896|559140247|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
154922440|NCT00948896|559140248|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922441|NCT00948896|559140249|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922442|NCT00948896|559140250|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922443|NCT00948896|559140251|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
154922444|NCT01590810|559140252|FG000|Overall Study|Physician Decision|0|||
154922445|NCT01590810|559140253|FG001|Overall Study|Physician Decision|1|||
154922446|NCT01590810|559140254|FG002|Overall Study|Physician Decision|1|||
154922447|NCT01590810|559140255|FG003|Overall Study|Physician Decision|0|||
154922448|NCT01590810|559140256|FG004|Overall Study|Physician Decision|0|||
154922449|NCT01740297|559142061|FG000|Overall Study|Withdrawal by Subject|4|||
154922450|NCT01740297|559142062|FG001|Overall Study|Withdrawal by Subject|16|||
154922451|NCT01740297|559142063|FG002|Overall Study|Withdrawal by Subject|17|||
154922452|NCT01740297|559142061|FG000|Overall Study|Death|8|||
154922453|NCT01740297|559142062|FG001|Overall Study|Death|46|||
154922454|NCT01740297|559142063|FG002|Overall Study|Death|40|||
154922455|NCT01740297|559142061|FG000|Overall Study|Lost to Follow-up|1|||
154922456|NCT01740297|559142062|FG001|Overall Study|Lost to Follow-up|2|||
154922457|NCT01740297|559142063|FG002|Overall Study|Lost to Follow-up|4|||
154922458|NCT00563706|559142068|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
154922459|NCT00563706|559142069|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
154922460|NCT00563706|559142070|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
154922461|NCT00563706|559142071|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
154922462|NCT00563706|559142072|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
154922463|NCT00563706|559142073|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
154922464|NCT00563706|559142074|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
154922465|NCT00563706|559142075|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
154922466|NCT00563706|559142076|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
154922467|NCT00563706|559142068|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
154922468|NCT00563706|559142069|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
154922469|NCT00563706|559142070|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
154922470|NCT00563706|559142071|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
154922471|NCT00563706|559142072|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
154922472|NCT00563706|559142073|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
154922473|NCT00563706|559142074|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
154922474|NCT00563706|559142075|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
154922475|NCT00563706|559142076|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
154922476|NCT00563706|559142068|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
154922477|NCT00563706|559142069|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
154922478|NCT00563706|559142070|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
154922479|NCT00563706|559142071|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
154922480|NCT00563706|559142072|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
154922481|NCT00563706|559142073|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
154922482|NCT00563706|559142074|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
154922483|NCT00563706|559142075|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
154922484|NCT00563706|559142076|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
154922485|NCT00563706|559142068|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
154922486|NCT00563706|559142069|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
154922487|NCT00563706|559142070|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
154922488|NCT00563706|559142071|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
154922489|NCT00563706|559142072|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
154922490|NCT00563706|559142073|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
154922491|NCT00563706|559142074|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
155002113|NCT01121562|559432487|FG000|Overall Study|Sponsor Decision|1|||
155002114|NCT01121562|559432487|FG000|Overall Study|Met study discontinuation criteria|1|||
154922492|NCT00563706|559142075|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
155002115|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
155125187|NCT06250738|559890577|FG000|Overall Study|Lost to Follow-up|1|||
154922493|NCT00563706|559142076|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
154922494|NCT00563706|559142068|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922495|NCT00563706|559142069|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922496|NCT00563706|559142070|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922497|NCT00563706|559142071|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922498|NCT00563706|559142072|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922499|NCT00563706|559142073|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922500|NCT00563706|559142074|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
154922501|NCT00563706|559142075|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
154922502|NCT00563706|559142076|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
154922503|NCT02383966|559142079|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
154922504|NCT02383966|559142080|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
154922505|NCT02383966|559142079|FG000|Overall Study|Randomized, but not treated|1|||
154922506|NCT02383966|559142080|FG001|Overall Study|Randomized, but not treated|3|||
154922507|NCT00270205|559142084|FG000|Overall Study|Lost to Follow-up|1|||
154922508|NCT00270205|559142085|FG001|Overall Study|Lost to Follow-up|0|||
154922509|NCT00270205|559142086|FG002|Overall Study|Lost to Follow-up|0|||
154922510|NCT00270205|559142087|FG003|Overall Study|Lost to Follow-up|1|||
154922511|NCT00066573|559142088|FG000|Overall Study|Did not received protocol treatment|28|||
155002116|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
155002117|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
155002118|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
155002119|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
155002120|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
155002121|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
155002122|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
155002123|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155002124|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
155002125|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155002126|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155002127|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
155002128|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
155002129|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
155002130|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
155002131|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
155002132|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
155002133|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
155002134|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
155002135|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
155002136|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155002137|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
155002138|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155002139|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
155002140|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155002141|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155002142|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
155002143|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155002144|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
155002145|NCT03713632|559432488|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
155002146|NCT03713632|559432489|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155002147|NCT03713632|559432490|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155002148|NCT03713632|559432491|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155002149|NCT03713632|559432492|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
155002150|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
155002151|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
155002152|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
155002153|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
155002154|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
155002155|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
155002156|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
155002157|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
155002158|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
155178075|NCT00282464|560091393|FG001|Overall Study|Withdrawal by Subject|10|||
155178076|NCT00282464|560091392|FG000|Overall Study|laboratory abnormality|1|||
154922512|NCT00066573|559142089|FG001|Overall Study|Did not received protocol treatment|28|||
154922513|NCT00437294|559142094|FG000|Overall Study|Adverse Event|5|||
154922514|NCT00437294|559142095|FG001|Overall Study|Adverse Event|4|||
154922515|NCT00437294|559142094|FG000|Overall Study|Death|5|||
155002159|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
155002160|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
155002161|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
155002162|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
155002163|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
155002164|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
155002165|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
155002166|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
155002167|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
155002168|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
155002169|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
155002170|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
155002171|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
155002172|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
155002173|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
155002174|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
155002175|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
155002176|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155002177|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155002178|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155002179|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
155002180|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Death|0|||
155002181|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Death|1|||
155002182|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Death|0|||
155002183|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Death|0|||
155002184|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Death|0|||
155002185|NCT03713632|559432488|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155002186|NCT03713632|559432489|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
155002187|NCT03713632|559432490|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155002188|NCT03713632|559432491|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155002189|NCT03713632|559432492|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
155002190|NCT03971474|559432496|FG000|Overall Study|Adverse Event|11|||
155002191|NCT03971474|559432497|FG001|Overall Study|Adverse Event|7|||
155002192|NCT03971474|559432496|FG000|Overall Study|Refusal unrelated to adverse event|5|||
155002193|NCT03971474|559432497|FG001|Overall Study|Refusal unrelated to adverse event|1|||
155002194|NCT03971474|559432496|FG000|Overall Study|Progression/relapse|40|||
155002195|NCT03971474|559432497|FG001|Overall Study|Progression/relapse|47|||
155002196|NCT03971474|559432496|FG000|Overall Study|Death|6|||
155002197|NCT03971474|559432497|FG001|Overall Study|Death|3|||
155002198|NCT03971474|559432496|FG000|Overall Study|Other - not protocol specified|5|||
155002199|NCT03971474|559432497|FG001|Overall Study|Other - not protocol specified|4|||
155002200|NCT03971474|559432496|FG000|Overall Study|On treatment|0|||
155002201|NCT03971474|559432497|FG001|Overall Study|On treatment|7|||
155002202|NCT02370238|559432504|FG000|Overall Study|Death|42|||
155002203|NCT02370238|559432505|FG001|Overall Study|Death|35|||
155002204|NCT02370238|559432504|FG000|Overall Study|Lost to Follow-up|1|||
155002205|NCT02370238|559432505|FG001|Overall Study|Lost to Follow-up|3|||
155002206|NCT02370238|559432504|FG000|Overall Study|Withdrawal by Subject|2|||
155002207|NCT02370238|559432505|FG001|Overall Study|Withdrawal by Subject|6|||
155002208|NCT02370238|559432504|FG000|Overall Study|Other|2|||
155002209|NCT02370238|559432505|FG001|Overall Study|Other|1|||
155002210|NCT01153425|559432506|FG000|Overall Study|Withdrawal by Subject|3|||
155002211|NCT01153425|559432507|FG001|Overall Study|Withdrawal by Subject|3|||
155002212|NCT01482312|559432508|FG000|Period 1, 90 Minutes of Wear|Other|1|||
155002213|NCT01482312|559432509|FG001|Period 1, 90 Minutes of Wear|Other|0|||
155002214|NCT01482312|559432510|FG002|Period 1, 90 Minutes of Wear|Other|0|||
155002215|NCT01482312|559432508|FG000|Period 2, 90 Minutes of Wear|Other|1|||
155002216|NCT01482312|559432509|FG001|Period 2, 90 Minutes of Wear|Other|0|||
155002217|NCT01482312|559432510|FG002|Period 2, 90 Minutes of Wear|Other|0|||
155002218|NCT03154125|559432511|FG000|Overall Study|Lost to Follow-up|11|||
155002219|NCT03154125|559432512|FG001|Overall Study|Lost to Follow-up|11|||
155002220|NCT03154125|559432513|FG002|Overall Study|Lost to Follow-up|0|||
155002221|NCT03154125|559432511|FG000|Overall Study|Withdrawal by Subject|49|||
155125188|NCT05288166|559890578|FG000|Overall Study|Adverse Event|1|||
155125189|NCT05288166|559890579|FG001|Overall Study|Adverse Event|0|||
155002222|NCT03154125|559432512|FG001|Overall Study|Withdrawal by Subject|55|||
155002223|NCT03154125|559432513|FG002|Overall Study|Withdrawal by Subject|8|||
155002224|NCT03154125|559432511|FG000|Overall Study|Physician Decision|13|||
155002225|NCT03154125|559432512|FG001|Overall Study|Physician Decision|6|||
155002226|NCT03154125|559432513|FG002|Overall Study|Physician Decision|0|||
155002227|NCT03154125|559432511|FG000|Overall Study|Protocol Violation|3|||
155002228|NCT03154125|559432512|FG001|Overall Study|Protocol Violation|5|||
155002229|NCT03154125|559432513|FG002|Overall Study|Protocol Violation|0|||
155002230|NCT01295320|559432514|FG000|Overall Study|Adverse Event|2|||
155002231|NCT01295320|559432514|FG000|Overall Study|Lost to Follow-up|4|||
155002232|NCT01295320|559432514|FG000|Overall Study|Withdrawal by Subject|2|||
155002233|NCT01295320|559432514|FG000|Overall Study|Subject was bedridden|1|||
155002234|NCT01295320|559432514|FG000|Overall Study|Unable to travel|1|||
155002235|NCT00462904|559432515|FG000|Overall Study|Lost to Follow-up|1|||
155002236|NCT01569295|559432516|FG000|Overall Study|Progressive Disease|75|||
155002237|NCT01569295|559432517|FG001|Overall Study|Progressive Disease|139|||
155002238|NCT01569295|559432516|FG000|Overall Study|Adverse Event|39|||
155002239|NCT01569295|559432517|FG001|Overall Study|Adverse Event|14|||
155002240|NCT01569295|559432516|FG000|Overall Study|Withdrawal by Subject|25|||
155002241|NCT01569295|559432517|FG001|Overall Study|Withdrawal by Subject|12|||
155002242|NCT01569295|559432516|FG000|Overall Study|Death|19|||
155002243|NCT01569295|559432517|FG001|Overall Study|Death|15|||
155002244|NCT01569295|559432516|FG000|Overall Study|Physician Decision|13|||
155002245|NCT01569295|559432517|FG001|Overall Study|Physician Decision|18|||
155002246|NCT01569295|559432516|FG000|Overall Study|Study Terminated by Sponsor|24|||
155002247|NCT01569295|559432517|FG001|Overall Study|Study Terminated by Sponsor|2|||
155002248|NCT01569295|559432516|FG000|Overall Study|Other Reason not Specified|3|||
155002249|NCT01569295|559432517|FG001|Overall Study|Other Reason not Specified|5|||
155002250|NCT01569295|559432516|FG000|Overall Study|Non-Compliance with Study Drug|6|||
155002251|NCT01569295|559432517|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155002252|NCT01569295|559432516|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
155002253|NCT01569295|559432517|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
155002254|NCT01569295|559432516|FG000|Overall Study|Lost to Follow-up|1|||
155002255|NCT01569295|559432517|FG001|Overall Study|Lost to Follow-up|1|||
155002256|NCT01973595|559432518|FG000|Washout|Withdrawal by Subject|1|||
155002257|NCT01973595|559432519|FG001|Washout|Withdrawal by Subject|0|||
155002258|NCT01973595|559432520|FG002|Washout|Withdrawal by Subject|1|||
155002259|NCT01973595|559432521|FG003|Washout|Withdrawal by Subject|0|||
155002260|NCT02125877|559432522|FG000|Overall Study|Physician Decision|1|||
155002261|NCT02125877|559432523|FG001|Overall Study|Physician Decision|0|||
155002262|NCT02125877|559432522|FG000|Overall Study|Death|0|||
155002263|NCT02125877|559432523|FG001|Overall Study|Death|1|||
155002264|NCT02125877|559432522|FG000|Overall Study|Administrative problems|0|||
155002265|NCT02125877|559432523|FG001|Overall Study|Administrative problems|1|||
155002266|NCT02125877|559432522|FG000|Overall Study|Participant/guardian decision|0|||
155002267|NCT02125877|559432523|FG001|Overall Study|Participant/guardian decision|2|||
155002268|NCT02125877|559432522|FG000|Overall Study|Withdrawal by Subject|2|||
155002269|NCT02125877|559432523|FG001|Overall Study|Withdrawal by Subject|1|||
155002270|NCT02125877|559432522|FG000|Overall Study|Protocol deviation|4|||
155002271|NCT02125877|559432523|FG001|Overall Study|Protocol deviation|1|||
155002272|NCT02125877|559432522|FG000|Overall Study|Adverse Event|6|||
155002273|NCT02125877|559432523|FG001|Overall Study|Adverse Event|4|||
155002274|NCT03138655|559432527|FG000|Overall Study|Adverse Event|2|||
155002275|NCT03138655|559432528|FG001|Overall Study|Adverse Event|1|||
155002276|NCT03138655|559432529|FG002|Overall Study|Adverse Event|2|||
155002277|NCT03138655|559432530|FG003|Overall Study|Adverse Event|1|||
155002278|NCT03138655|559432531|FG004|Overall Study|Adverse Event|1|||
155002279|NCT03138655|559432532|FG005|Overall Study|Adverse Event|4|||
155002280|NCT03138655|559432533|FG006|Overall Study|Adverse Event|2|||
155002281|NCT03138655|559432534|FG007|Overall Study|Adverse Event|2|||
155002282|NCT03138655|559432527|FG000|Overall Study|Withdrawal by Subject|0|||
155002283|NCT03138655|559432528|FG001|Overall Study|Withdrawal by Subject|1|||
155002284|NCT03138655|559432529|FG002|Overall Study|Withdrawal by Subject|0|||
155002285|NCT03138655|559432530|FG003|Overall Study|Withdrawal by Subject|0|||
155002286|NCT03138655|559432531|FG004|Overall Study|Withdrawal by Subject|0|||
155002287|NCT03138655|559432532|FG005|Overall Study|Withdrawal by Subject|0|||
155002288|NCT03138655|559432533|FG006|Overall Study|Withdrawal by Subject|1|||
155002289|NCT03138655|559432534|FG007|Overall Study|Withdrawal by Subject|0|||
155002290|NCT03138655|559432527|FG000|Overall Study|Reason not Specified|1|||
155002291|NCT03138655|559432528|FG001|Overall Study|Reason not Specified|0|||
155002292|NCT03138655|559432529|FG002|Overall Study|Reason not Specified|0|||
155002293|NCT03138655|559432530|FG003|Overall Study|Reason not Specified|2|||
155125190|NCT05288166|559890578|FG000|Overall Study|Lost to Follow-up|2|||
155125191|NCT05288166|559890579|FG001|Overall Study|Lost to Follow-up|0|||
155002294|NCT03138655|559432531|FG004|Overall Study|Reason not Specified|1|||
155002295|NCT03138655|559432532|FG005|Overall Study|Reason not Specified|1|||
155002296|NCT03138655|559432533|FG006|Overall Study|Reason not Specified|0|||
155002297|NCT03138655|559432534|FG007|Overall Study|Reason not Specified|0|||
155002298|NCT04759768|559432535|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
155002299|NCT04759768|559432536|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
155002300|NCT04759768|559432535|FG000|Washout (7 Days)|Physician Decision|0|||
155002301|NCT04759768|559432536|FG001|Washout (7 Days)|Physician Decision|1|||
155002302|NCT04868500|559432537|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
155002303|NCT04868500|559432538|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
155002304|NCT04868500|559432537|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
155002305|NCT04868500|559432538|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
155002306|NCT02859142|559432539|FG000|Overall Study|Adverse Event|1|||
155002307|NCT02859142|559432540|FG001|Overall Study|Adverse Event|2|||
155002308|NCT02859142|559432539|FG000|Overall Study|Lost to Follow-up|1|||
155002309|NCT02859142|559432540|FG001|Overall Study|Lost to Follow-up|4|||
155002310|NCT02859142|559432539|FG000|Overall Study|Withdrawal by Subject|2|||
155002311|NCT02859142|559432540|FG001|Overall Study|Withdrawal by Subject|0|||
155002312|NCT02859142|559432539|FG000|Overall Study|Scheduling difficulties|0|||
155002313|NCT02859142|559432540|FG001|Overall Study|Scheduling difficulties|3|||
155002314|NCT02676765|559432541|FG000|Overall Study|Lost to Follow-up|0|||
155002315|NCT02676765|559432542|FG001|Overall Study|Lost to Follow-up|1|||
155002316|NCT03340974|559432543|FG000|Completion of Study -Long Term Follow up|Death|8|||
155002317|NCT03340974|559432544|FG001|Completion of Study -Long Term Follow up|Death|5|||
155002318|NCT03340974|559432545|FG002|Completion of Study -Long Term Follow up|Death|5|||
155002319|NCT03340974|559432546|FG003|Completion of Study -Long Term Follow up|Death|7|||
155002320|NCT03340974|559432543|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
155002321|NCT03340974|559432544|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
155002322|NCT03340974|559432545|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
155002323|NCT03340974|559432546|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
155002324|NCT03340974|559432543|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
155002325|NCT03340974|559432544|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
155002326|NCT03340974|559432545|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
155002327|NCT03340974|559432546|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
155002328|NCT03340974|559432543|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
155002329|NCT03340974|559432544|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
155002330|NCT03340974|559432545|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
155002331|NCT03340974|559432546|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
155002332|NCT02374346|559432550|FG000|Overall Study|operated or discharged during weekend|48|||
155002333|NCT00396565|559432558|FG000|Overall Study|Physician Decision|3|||
155002334|NCT00396565|559432559|FG001|Overall Study|Physician Decision|1|||
154922516|NCT00437294|559142095|FG001|Overall Study|Death|2|||
154922517|NCT00437294|559142094|FG000|Overall Study|Physician Decision|0|||
154922518|NCT00437294|559142095|FG001|Overall Study|Physician Decision|3|||
154922519|NCT00437294|559142094|FG000|Overall Study|Withdrawal by Subject|5|||
154922520|NCT00437294|559142095|FG001|Overall Study|Withdrawal by Subject|0|||
154922521|NCT00437294|559142094|FG000|Overall Study|Progressive Disease|19|||
154922522|NCT00437294|559142095|FG001|Overall Study|Progressive Disease|23|||
154922523|NCT00437294|559142094|FG000|Overall Study|Sponsor Decision|8|||
154922524|NCT00437294|559142095|FG001|Overall Study|Sponsor Decision|9|||
154922525|NCT00437294|559142094|FG000|Overall Study|Protocol Violation|0|||
154922526|NCT00437294|559142095|FG001|Overall Study|Protocol Violation|1|||
154922527|NCT00437294|559142094|FG000|Overall Study|Entry criteria not met|1|||
154922528|NCT00437294|559142095|FG001|Overall Study|Entry criteria not met|1|||
154922529|NCT02064231|559142098|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
154922530|NCT02064231|559142099|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
154922531|NCT02064231|559142100|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
154922532|NCT02064231|559142101|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
154922533|NCT02064231|559142098|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
154922534|NCT02064231|559142099|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
154922535|NCT02064231|559142100|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
154922536|NCT02064231|559142101|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
154922537|NCT02064231|559142098|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
154922538|NCT02064231|559142099|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
154922539|NCT02064231|559142100|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
154922540|NCT02064231|559142101|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
154922541|NCT02064231|559142098|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
154922542|NCT02064231|559142099|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
154922543|NCT02064231|559142100|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
154922544|NCT02064231|559142101|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
154922545|NCT01422876|559142104|FG000|Week 24|Lost to Follow-up|1|||
154922546|NCT01422876|559142105|FG001|Week 24|Lost to Follow-up|1|||
154922547|NCT01422876|559142106|FG002|Week 24|Lost to Follow-up|2|||
154922548|NCT01422876|559142107|FG003|Week 24|Lost to Follow-up|4|||
154922549|NCT01422876|559142108|FG004|Week 24|Lost to Follow-up|2|||
154922550|NCT01422876|559142109|FG005|Week 24|Lost to Follow-up|0|||
155002335|NCT00396565|559432560|FG002|Overall Study|Physician Decision|2|||
155002336|NCT00396565|559432558|FG000|Overall Study|Adverse Event|5|||
155002337|NCT00396565|559432559|FG001|Overall Study|Adverse Event|13|||
154922551|NCT01422876|559142110|FG006|Week 24|Lost to Follow-up|1|||
154922552|NCT01422876|559142111|FG007|Week 24|Lost to Follow-up|3|||
154922553|NCT01422876|559142112|FG008|Week 24|Lost to Follow-up|3|||
154922554|NCT01422876|559142113|FG009|Week 24|Lost to Follow-up|4|||
154922555|NCT01422876|559142104|FG000|Week 24|Consent withdrawn|5|||
154922556|NCT01422876|559142105|FG001|Week 24|Consent withdrawn|1|||
155002338|NCT00396565|559432560|FG002|Overall Study|Adverse Event|3|||
155002339|NCT00396565|559432558|FG000|Overall Study|Withdrawal by Subject|8|||
155002340|NCT00396565|559432559|FG001|Overall Study|Withdrawal by Subject|13|||
155002341|NCT00396565|559432560|FG002|Overall Study|Withdrawal by Subject|1|||
155002342|NCT00396565|559432558|FG000|Overall Study|Lack of Efficacy|32|||
155002343|NCT00396565|559432559|FG001|Overall Study|Lack of Efficacy|64|||
155002344|NCT00396565|559432560|FG002|Overall Study|Lack of Efficacy|11|||
155002345|NCT04324021|559432562|FG000|Overall Study|Adverse Event|1|||
155002346|NCT04324021|559432563|FG001|Overall Study|Adverse Event|0|||
155002347|NCT04324021|559432564|FG002|Overall Study|Adverse Event|0|||
155002348|NCT04324021|559432562|FG000|Overall Study|Lack of Efficacy|0|||
155002349|NCT04324021|559432563|FG001|Overall Study|Lack of Efficacy|0|||
155002350|NCT04324021|559432564|FG002|Overall Study|Lack of Efficacy|1|||
155002351|NCT04324021|559432562|FG000|Overall Study|Death|1|||
155002352|NCT04324021|559432563|FG001|Overall Study|Death|1|||
155002353|NCT04324021|559432564|FG002|Overall Study|Death|0|||
155002354|NCT04877457|559432565|FG000|Overall Study|Early termination of study due to low enrollment|2|||
155002355|NCT04877457|559432566|FG001|Overall Study|Early termination of study due to low enrollment|1|||
155002356|NCT02211417|559432567|FG000|Overall Study|Withdrawal by Subject|11|||
155002357|NCT02211417|559432568|FG001|Overall Study|Withdrawal by Subject|8|||
155002358|NCT02211417|559432567|FG000|Overall Study|Protocol Violation|1|||
155002359|NCT02211417|559432568|FG001|Overall Study|Protocol Violation|0|||
155002360|NCT02211417|559432567|FG000|Overall Study|Pregnancy|0|||
155002361|NCT02211417|559432568|FG001|Overall Study|Pregnancy|1|||
155002362|NCT02211417|559432567|FG000|Overall Study|Lost to Follow-up|2|||
155002363|NCT02211417|559432568|FG001|Overall Study|Lost to Follow-up|3|||
155002364|NCT02211417|559432567|FG000|Overall Study|Adverse Event|1|||
155002365|NCT02211417|559432568|FG001|Overall Study|Adverse Event|4|||
155002366|NCT01198132|559432569|FG000|Overall Study|Withdrawal by Subject|4|||
155002367|NCT01198132|559432570|FG001|Overall Study|Withdrawal by Subject|5|||
155002368|NCT01198132|559432569|FG000|Overall Study|Physician Decision|5|||
155002369|NCT01198132|559432570|FG001|Overall Study|Physician Decision|4|||
155002370|NCT01198132|559432569|FG000|Overall Study|Other Unspecified|3|||
155002371|NCT01198132|559432570|FG001|Overall Study|Other Unspecified|6|||
155002372|NCT01198132|559432569|FG000|Overall Study|Lack of Efficacy|2|||
155002373|NCT01198132|559432570|FG001|Overall Study|Lack of Efficacy|3|||
155002374|NCT01198132|559432569|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
155002375|NCT01198132|559432570|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
155002376|NCT01198132|559432569|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
155002377|NCT01198132|559432570|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
155002378|NCT01198132|559432569|FG000|Overall Study|Adverse Event|0|||
155002379|NCT01198132|559432570|FG001|Overall Study|Adverse Event|1|||
155002380|NCT01198132|559432569|FG000|Overall Study|Protocol Violation|1|||
155002381|NCT01198132|559432570|FG001|Overall Study|Protocol Violation|0|||
155002382|NCT01277211|559432571|FG000|Overall Study|Adverse Event|60|||
155002383|NCT01277211|559432572|FG001|Overall Study|Adverse Event|22|||
155002384|NCT01277211|559432571|FG000|Overall Study|Pregnancy|9|||
155002385|NCT01277211|559432572|FG001|Overall Study|Pregnancy|4|||
155002386|NCT01277211|559432571|FG000|Overall Study|Lost to Follow-up|14|||
155002387|NCT01277211|559432572|FG001|Overall Study|Lost to Follow-up|9|||
155002388|NCT01277211|559432571|FG000|Overall Study|Did not wish to continue|17|||
155002389|NCT01277211|559432572|FG001|Overall Study|Did not wish to continue|0|||
155002390|NCT01277211|559432571|FG000|Overall Study|Withdrew Consent|9|||
155002391|NCT01277211|559432572|FG001|Overall Study|Withdrew Consent|9|||
155002392|NCT01277211|559432571|FG000|Overall Study|Non-compliance with protocol|13|||
155002393|NCT01277211|559432572|FG001|Overall Study|Non-compliance with protocol|4|||
155002394|NCT01277211|559432571|FG000|Overall Study|Did not meet protocol eligibility|1|||
155002395|NCT01277211|559432572|FG001|Overall Study|Did not meet protocol eligibility|0|||
155002396|NCT01277211|559432571|FG000|Overall Study|Administrative|3|||
155002397|NCT01277211|559432572|FG001|Overall Study|Administrative|0|||
155002398|NCT01277211|559432571|FG000|Overall Study|Pregnancy wish|0|||
155002399|NCT01277211|559432572|FG001|Overall Study|Pregnancy wish|2|||
155002400|NCT01277211|559432571|FG000|Overall Study|Discontinued prior to treatment|24|||
155002401|NCT01277211|559432572|FG001|Overall Study|Discontinued prior to treatment|13|||
155002402|NCT01885195|559432573|FG000|Overall Study|Adverse Event|29|||
155002403|NCT01885195|559432573|FG000|Overall Study|Death|1|||
155002404|NCT01885195|559432573|FG000|Overall Study|Disease Progression|67|||
155002405|NCT01885195|559432573|FG000|Overall Study|Protocol Deviation|2|||
155002406|NCT01885195|559432573|FG000|Overall Study|Physician Decision|3|||
155002407|NCT01885195|559432573|FG000|Overall Study|Patient/guardian decision|8|||
155002408|NCT04614246|559432574|FG000|Overall Study|Adverse Event|0|||
155002409|NCT04614246|559432575|FG001|Overall Study|Adverse Event|1|||
155002410|NCT04614246|559432576|FG002|Overall Study|Adverse Event|1|||
155002411|NCT04614246|559432577|FG003|Overall Study|Adverse Event|2|||
155002412|NCT04614246|559432578|FG004|Overall Study|Adverse Event|1|||
155002413|NCT04614246|559432574|FG000|Overall Study|Lost to Follow-up|0|||
155002414|NCT04614246|559432575|FG001|Overall Study|Lost to Follow-up|1|||
155002415|NCT04614246|559432576|FG002|Overall Study|Lost to Follow-up|0|||
155002416|NCT04614246|559432577|FG003|Overall Study|Lost to Follow-up|1|||
155125192|NCT05288166|559890578|FG000|Overall Study|Physician Decision|0|||
155125193|NCT05288166|559890579|FG001|Overall Study|Physician Decision|2|||
155125194|NCT05288166|559890578|FG000|Overall Study|Screen Failure|1|||
154922557|NCT01422876|559142106|FG002|Week 24|Consent withdrawn|3|||
154922558|NCT01422876|559142107|FG003|Week 24|Consent withdrawn|4|||
154922559|NCT01422876|559142108|FG004|Week 24|Consent withdrawn|5|||
154922560|NCT01422876|559142109|FG005|Week 24|Consent withdrawn|6|||
154922561|NCT01422876|559142110|FG006|Week 24|Consent withdrawn|5|||
154922562|NCT01422876|559142111|FG007|Week 24|Consent withdrawn|4|||
154922563|NCT01422876|559142112|FG008|Week 24|Consent withdrawn|3|||
154922564|NCT01422876|559142113|FG009|Week 24|Consent withdrawn|6|||
154922565|NCT01422876|559142104|FG000|Week 24|Death|0|||
154922566|NCT01422876|559142105|FG001|Week 24|Death|1|||
154922567|NCT01422876|559142106|FG002|Week 24|Death|0|||
154922568|NCT01422876|559142107|FG003|Week 24|Death|0|||
154922569|NCT01422876|559142108|FG004|Week 24|Death|0|||
154922570|NCT01422876|559142109|FG005|Week 24|Death|0|||
154922571|NCT01422876|559142110|FG006|Week 24|Death|0|||
154922572|NCT01422876|559142111|FG007|Week 24|Death|0|||
154922573|NCT01422876|559142112|FG008|Week 24|Death|0|||
154922574|NCT01422876|559142113|FG009|Week 24|Death|0|||
154922575|NCT01422876|559142104|FG000|Week 52|Lost to Follow-up|3|||
154922576|NCT01422876|559142105|FG001|Week 52|Lost to Follow-up|5|||
154922577|NCT01422876|559142106|FG002|Week 52|Lost to Follow-up|7|||
154922578|NCT01422876|559142107|FG003|Week 52|Lost to Follow-up|5|||
154922579|NCT01422876|559142108|FG004|Week 52|Lost to Follow-up|8|||
154922580|NCT01422876|559142109|FG005|Week 52|Lost to Follow-up|5|||
154922581|NCT01422876|559142110|FG006|Week 52|Lost to Follow-up|5|||
154922582|NCT01422876|559142111|FG007|Week 52|Lost to Follow-up|8|||
154922583|NCT01422876|559142112|FG008|Week 52|Lost to Follow-up|7|||
154922584|NCT01422876|559142113|FG009|Week 52|Lost to Follow-up|8|||
154922585|NCT01422876|559142104|FG000|Week 52|Consent withdrawn|9|||
154922586|NCT01422876|559142105|FG001|Week 52|Consent withdrawn|4|||
154922587|NCT01422876|559142106|FG002|Week 52|Consent withdrawn|6|||
154922588|NCT01422876|559142107|FG003|Week 52|Consent withdrawn|12|||
154922589|NCT01422876|559142108|FG004|Week 52|Consent withdrawn|7|||
154922590|NCT01422876|559142109|FG005|Week 52|Consent withdrawn|12|||
154922591|NCT01422876|559142110|FG006|Week 52|Consent withdrawn|10|||
154922592|NCT01422876|559142111|FG007|Week 52|Consent withdrawn|12|||
154922593|NCT01422876|559142112|FG008|Week 52|Consent withdrawn|13|||
154922594|NCT01422876|559142113|FG009|Week 52|Consent withdrawn|9|||
154922595|NCT01422876|559142104|FG000|Week 52|Death|0|||
154922596|NCT01422876|559142105|FG001|Week 52|Death|1|||
154922597|NCT01422876|559142106|FG002|Week 52|Death|0|||
154922598|NCT01422876|559142107|FG003|Week 52|Death|1|||
154922599|NCT01422876|559142108|FG004|Week 52|Death|0|||
154922600|NCT01422876|559142109|FG005|Week 52|Death|0|||
154922601|NCT01422876|559142110|FG006|Week 52|Death|1|||
154922602|NCT01422876|559142111|FG007|Week 52|Death|3|||
154922603|NCT01422876|559142112|FG008|Week 52|Death|1|||
154922604|NCT01422876|559142113|FG009|Week 52|Death|0|||
154922605|NCT00536991|559142115|FG000|Overall Study|Withdrawal by Subject|10|||
154922606|NCT00536991|559142115|FG000|Overall Study|Physician Decision|1|||
154922607|NCT00536991|559142115|FG000|Overall Study|patient ineligible|2|||
154922608|NCT01600755|559142116|FG000|Overall Study|Withdrawal by Subject|6|||
154922609|NCT01366846|559142117|FG000|Overall Study|Withdrawal by Subject|2|||
154922610|NCT01366846|559142118|FG001|Overall Study|Withdrawal by Subject|0|||
154922611|NCT01366846|559142119|FG002|Overall Study|Withdrawal by Subject|0|||
154922612|NCT01366846|559142120|FG003|Overall Study|Withdrawal by Subject|0|||
154922613|NCT01366846|559142117|FG000|Overall Study|Communication Difficulties|1|||
154922614|NCT01366846|559142118|FG001|Overall Study|Communication Difficulties|4|||
154922615|NCT01366846|559142119|FG002|Overall Study|Communication Difficulties|0|||
154922616|NCT01366846|559142120|FG003|Overall Study|Communication Difficulties|1|||
154922617|NCT01366846|559142117|FG000|Overall Study|Scheduling Conflicts|0|||
154922618|NCT01366846|559142118|FG001|Overall Study|Scheduling Conflicts|0|||
154922619|NCT01366846|559142119|FG002|Overall Study|Scheduling Conflicts|1|||
154922620|NCT01366846|559142120|FG003|Overall Study|Scheduling Conflicts|0|||
154922621|NCT00558831|559142123|FG000|Overall Study|Lost to Follow-up|1|||
154922622|NCT04341727|559142124|FG000|Overall Study|Withdrawal by Subject|0|||
154922623|NCT04341727|559142125|FG001|Overall Study|Withdrawal by Subject|0|||
154922624|NCT04341727|559142126|FG002|Overall Study|Withdrawal by Subject|1|||
154922625|NCT04341727|559142127|FG003|Overall Study|Withdrawal by Subject|0|||
154922626|NCT04341727|559142124|FG000|Overall Study|Lost to Follow-up|0|||
154922627|NCT04341727|559142125|FG001|Overall Study|Lost to Follow-up|0|||
154922628|NCT04341727|559142126|FG002|Overall Study|Lost to Follow-up|0|||
154922629|NCT04341727|559142127|FG003|Overall Study|Lost to Follow-up|1|||
154922630|NCT00057330|559142128|FG000|Overall Study|Adverse Event|9|||
154922631|NCT00057330|559142129|FG001|Overall Study|Adverse Event|12|||
154922632|NCT00057330|559142128|FG000|Overall Study|Death|1|||
154922633|NCT00057330|559142129|FG001|Overall Study|Death|0|||
154922634|NCT00057330|559142128|FG000|Overall Study|Protocol Violation|1|||
154922635|NCT00057330|559142129|FG001|Overall Study|Protocol Violation|1|||
154922636|NCT00057330|559142128|FG000|Overall Study|Withdrawal by Subject|115|||
154922637|NCT00057330|559142129|FG001|Overall Study|Withdrawal by Subject|84|||
154922638|NCT00057330|559142128|FG000|Overall Study|Lost to Follow-up|745|||
155002417|NCT04614246|559432578|FG004|Overall Study|Lost to Follow-up|3|||
155002418|NCT04614246|559432574|FG000|Overall Study|Other reason|0|||
155002419|NCT04614246|559432575|FG001|Overall Study|Other reason|1|||
155002420|NCT04614246|559432576|FG002|Overall Study|Other reason|2|||
155002421|NCT04614246|559432577|FG003|Overall Study|Other reason|0|||
155002422|NCT04614246|559432578|FG004|Overall Study|Other reason|0|||
155002423|NCT04614246|559432574|FG000|Overall Study|Withdrawal by Subject|4|||
155002424|NCT04614246|559432575|FG001|Overall Study|Withdrawal by Subject|2|||
155002425|NCT04614246|559432576|FG002|Overall Study|Withdrawal by Subject|4|||
155002426|NCT04614246|559432577|FG003|Overall Study|Withdrawal by Subject|3|||
155002427|NCT04614246|559432578|FG004|Overall Study|Withdrawal by Subject|4|||
155002428|NCT04614246|559432574|FG000|Overall Study|Physician Decision|0|||
155002429|NCT04614246|559432575|FG001|Overall Study|Physician Decision|2|||
155002430|NCT04614246|559432576|FG002|Overall Study|Physician Decision|1|||
155002431|NCT04614246|559432577|FG003|Overall Study|Physician Decision|0|||
155002432|NCT04614246|559432578|FG004|Overall Study|Physician Decision|0|||
155002433|NCT04614246|559432574|FG000|Overall Study|Study terminated by sponsor|10|||
155002434|NCT04614246|559432575|FG001|Overall Study|Study terminated by sponsor|15|||
155002435|NCT04614246|559432576|FG002|Overall Study|Study terminated by sponsor|12|||
155002436|NCT04614246|559432577|FG003|Overall Study|Study terminated by sponsor|13|||
155002437|NCT04614246|559432578|FG004|Overall Study|Study terminated by sponsor|9|||
155002438|NCT04614246|559432574|FG000|Overall Study|Pregnancy|2|||
155002439|NCT04614246|559432575|FG001|Overall Study|Pregnancy|0|||
155002440|NCT04614246|559432576|FG002|Overall Study|Pregnancy|1|||
155002441|NCT04614246|559432577|FG003|Overall Study|Pregnancy|0|||
155002442|NCT04614246|559432578|FG004|Overall Study|Pregnancy|0|||
155002443|NCT00340678|559432579|FG000|Overall Study|Lost to Follow-up|1|||
155002444|NCT00340678|559432580|FG001|Overall Study|Lost to Follow-up|0|||
155002445|NCT00340678|559432581|FG002|Overall Study|Lost to Follow-up|0|||
155002446|NCT00340678|559432582|FG003|Overall Study|Lost to Follow-up|0|||
155002447|NCT00996892|559432586|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
155002448|NCT00996892|559432587|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
155002449|NCT00996892|559432588|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
155002450|NCT00996892|559432589|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
155002451|NCT00996892|559432590|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
155002452|NCT00996892|559432591|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
155002453|NCT00996892|559432592|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
155002454|NCT00996892|559432593|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
155002455|NCT00996892|559432594|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
155002456|NCT00996892|559432595|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
155002457|NCT00996892|559432596|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
155002458|NCT00996892|559432597|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
155002459|NCT00996892|559432598|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
155002460|NCT00996892|559432599|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
155002461|NCT00996892|559432600|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
155002462|NCT00996892|559432601|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
155002463|NCT00996892|559432602|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
155002464|NCT00996892|559432603|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
155002465|NCT00996892|559432604|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
155002466|NCT00996892|559432605|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
155002467|NCT00996892|559432586|FG000|Dose-Escalation Stage 1|Death|1|||
155002468|NCT00996892|559432587|FG001|Dose-Escalation Stage 1|Death|0|||
155002469|NCT00996892|559432588|FG002|Dose-Escalation Stage 1|Death|0|||
155002470|NCT00996892|559432589|FG003|Dose-Escalation Stage 1|Death|0|||
155002471|NCT00996892|559432590|FG004|Dose-Escalation Stage 1|Death|0|||
155002472|NCT00996892|559432591|FG005|Dose-Escalation Stage 1|Death|1|||
155002473|NCT00996892|559432592|FG006|Dose-Escalation Stage 1|Death|0|||
155002474|NCT00996892|559432593|FG007|Dose-Escalation Stage 1|Death|0|||
155002475|NCT00996892|559432594|FG008|Dose-Escalation Stage 1|Death|0|||
155002476|NCT00996892|559432595|FG009|Dose-Escalation Stage 1|Death|0|||
155002477|NCT00996892|559432596|FG010|Dose-Escalation Stage 1|Death|0|||
155002478|NCT00996892|559432597|FG011|Dose-Escalation Stage 1|Death|0|||
155002479|NCT00996892|559432598|FG012|Dose-Escalation Stage 1|Death|0|||
155002480|NCT00996892|559432599|FG013|Dose-Escalation Stage 1|Death|0|||
155002481|NCT00996892|559432600|FG014|Dose-Escalation Stage 1|Death|0|||
155002482|NCT00996892|559432601|FG015|Dose-Escalation Stage 1|Death|0|||
155002483|NCT00996892|559432602|FG016|Dose-Escalation Stage 1|Death|0|||
155002484|NCT00996892|559432603|FG017|Dose-Escalation Stage 1|Death|0|||
155002485|NCT00996892|559432604|FG018|Dose-Escalation Stage 1|Death|0|||
155002486|NCT00996892|559432605|FG019|Dose-Escalation Stage 1|Death|0|||
155002487|NCT00996892|559432586|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
155002488|NCT00996892|559432587|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
155002489|NCT00996892|559432588|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
155002490|NCT00996892|559432589|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
155002491|NCT00996892|559432590|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
155002492|NCT00996892|559432591|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
155125195|NCT05288166|559890579|FG001|Overall Study|Screen Failure|1|||
155002493|NCT00996892|559432592|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
155002494|NCT00996892|559432593|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
155002495|NCT00996892|559432594|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
155002496|NCT00996892|559432595|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
155002497|NCT00996892|559432596|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
155002498|NCT00996892|559432597|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
155002499|NCT00996892|559432598|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
155002500|NCT00996892|559432599|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
155002501|NCT00996892|559432600|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
155002502|NCT00996892|559432601|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
155002503|NCT00996892|559432602|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
155002504|NCT00996892|559432603|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
155002505|NCT00996892|559432604|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
155002506|NCT00996892|559432605|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
155002507|NCT00996892|559432586|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002508|NCT00996892|559432587|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155002509|NCT00996892|559432588|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002510|NCT00996892|559432589|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
155002511|NCT00996892|559432590|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155002512|NCT00996892|559432591|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155002513|NCT00996892|559432592|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
155002514|NCT00996892|559432593|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002515|NCT00996892|559432594|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002516|NCT00996892|559432595|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002517|NCT00996892|559432596|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002518|NCT00996892|559432597|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002519|NCT00996892|559432598|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002520|NCT00996892|559432599|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002521|NCT00996892|559432600|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002522|NCT00996892|559432601|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002523|NCT00996892|559432602|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002524|NCT00996892|559432603|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002525|NCT00996892|559432604|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002526|NCT00996892|559432605|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
155002527|NCT00996892|559432586|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
155002528|NCT00996892|559432587|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
155002529|NCT00996892|559432588|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
155002530|NCT00996892|559432589|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
155002531|NCT00996892|559432590|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
155002532|NCT00996892|559432591|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
155002533|NCT00996892|559432592|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
155002534|NCT00996892|559432593|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
155002535|NCT00996892|559432594|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
155002536|NCT00996892|559432595|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
155002537|NCT00996892|559432596|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
155002538|NCT00996892|559432597|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
155002539|NCT00996892|559432598|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
155002540|NCT00996892|559432599|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
155002541|NCT00996892|559432600|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
155002542|NCT00996892|559432601|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
155002543|NCT00996892|559432602|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
155002544|NCT00996892|559432603|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
155002545|NCT00996892|559432604|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
155002546|NCT00996892|559432605|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
155002547|NCT00996892|559432586|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
155002548|NCT00996892|559432587|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
155178077|NCT00282464|560091393|FG001|Overall Study|laboratory abnormality|2|||
155178078|NCT00282464|560091392|FG000|Overall Study|Protocol Violation|0|||
155178079|NCT00282464|560091393|FG001|Overall Study|Protocol Violation|7|||
155002549|NCT00996892|559432588|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
155002550|NCT00996892|559432589|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
155002551|NCT00996892|559432590|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
155002552|NCT00996892|559432591|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
155002553|NCT00996892|559432592|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
155002554|NCT00996892|559432593|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
155002555|NCT00996892|559432594|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
155002556|NCT00996892|559432595|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
155002557|NCT00996892|559432596|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
155002558|NCT00996892|559432597|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
155002559|NCT00996892|559432598|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
155002560|NCT00996892|559432599|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
155002561|NCT00996892|559432600|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
155002562|NCT00996892|559432601|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
155002563|NCT00996892|559432602|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
155002564|NCT00996892|559432603|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
155002565|NCT00996892|559432604|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
155002566|NCT00996892|559432605|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
155002567|NCT00996892|559432586|FG000|Dose-Escalation Stage 1A|Death|0|||
155002568|NCT00996892|559432587|FG001|Dose-Escalation Stage 1A|Death|0|||
155002569|NCT00996892|559432588|FG002|Dose-Escalation Stage 1A|Death|0|||
155002570|NCT00996892|559432589|FG003|Dose-Escalation Stage 1A|Death|0|||
155002571|NCT00996892|559432590|FG004|Dose-Escalation Stage 1A|Death|0|||
155002572|NCT00996892|559432591|FG005|Dose-Escalation Stage 1A|Death|0|||
155002573|NCT00996892|559432592|FG006|Dose-Escalation Stage 1A|Death|0|||
155002574|NCT00996892|559432593|FG007|Dose-Escalation Stage 1A|Death|0|||
155002575|NCT00996892|559432594|FG008|Dose-Escalation Stage 1A|Death|0|||
155002576|NCT00996892|559432595|FG009|Dose-Escalation Stage 1A|Death|2|||
155002577|NCT00996892|559432596|FG010|Dose-Escalation Stage 1A|Death|0|||
155002578|NCT00996892|559432597|FG011|Dose-Escalation Stage 1A|Death|1|||
155002579|NCT00996892|559432598|FG012|Dose-Escalation Stage 1A|Death|1|||
155002580|NCT00996892|559432599|FG013|Dose-Escalation Stage 1A|Death|0|||
155002581|NCT00996892|559432600|FG014|Dose-Escalation Stage 1A|Death|0|||
155002582|NCT00996892|559432601|FG015|Dose-Escalation Stage 1A|Death|0|||
155002583|NCT00996892|559432602|FG016|Dose-Escalation Stage 1A|Death|0|||
155002584|NCT00996892|559432603|FG017|Dose-Escalation Stage 1A|Death|0|||
155002585|NCT00996892|559432604|FG018|Dose-Escalation Stage 1A|Death|0|||
155002586|NCT00996892|559432605|FG019|Dose-Escalation Stage 1A|Death|0|||
155002587|NCT00996892|559432586|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
155002588|NCT00996892|559432587|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
155002589|NCT00996892|559432588|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
155002590|NCT00996892|559432589|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
155002591|NCT00996892|559432590|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
155002592|NCT00996892|559432591|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
155002593|NCT00996892|559432592|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
155002594|NCT00996892|559432593|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
155002595|NCT00996892|559432594|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
155002596|NCT00996892|559432595|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
155002597|NCT00996892|559432596|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
155002598|NCT00996892|559432597|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
155002599|NCT00996892|559432598|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
155002600|NCT00996892|559432599|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
155002601|NCT00996892|559432600|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
155002602|NCT00996892|559432601|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
155002603|NCT00996892|559432602|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
155002604|NCT00996892|559432603|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
155002605|NCT00996892|559432604|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
155002606|NCT00996892|559432605|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
155002607|NCT00996892|559432586|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002608|NCT00996892|559432587|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002609|NCT00996892|559432588|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002610|NCT00996892|559432589|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002611|NCT00996892|559432590|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002612|NCT00996892|559432591|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002613|NCT00996892|559432592|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002614|NCT00996892|559432593|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002615|NCT00996892|559432594|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002616|NCT00996892|559432595|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155002617|NCT00996892|559432596|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155002618|NCT00996892|559432597|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155002619|NCT00996892|559432598|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
155002620|NCT00996892|559432599|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002621|NCT00996892|559432600|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002622|NCT00996892|559432601|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002623|NCT00996892|559432602|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002624|NCT00996892|559432603|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002625|NCT00996892|559432604|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002626|NCT00996892|559432605|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
155002627|NCT00996892|559432586|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
155002628|NCT00996892|559432587|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
155002629|NCT00996892|559432588|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
155002630|NCT00996892|559432589|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
155002631|NCT00996892|559432590|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
155002632|NCT00996892|559432591|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
155002633|NCT00996892|559432592|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
155002634|NCT00996892|559432593|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
155002635|NCT00996892|559432594|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
155002636|NCT00996892|559432595|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
155002637|NCT00996892|559432596|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
155002638|NCT00996892|559432597|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
155002639|NCT00996892|559432598|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
155002640|NCT00996892|559432599|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
155002641|NCT00996892|559432600|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
155002642|NCT00996892|559432601|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
155002643|NCT00996892|559432602|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
155002644|NCT00996892|559432603|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
155002645|NCT00996892|559432604|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
155002646|NCT00996892|559432605|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
155002647|NCT00996892|559432586|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
155002648|NCT00996892|559432587|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
155002649|NCT00996892|559432588|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
155002650|NCT00996892|559432589|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
155002651|NCT00996892|559432590|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
155002652|NCT00996892|559432591|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
155002653|NCT00996892|559432592|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
155002654|NCT00996892|559432593|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
155002655|NCT00996892|559432594|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
155002656|NCT00996892|559432595|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
155002657|NCT00996892|559432596|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
155002658|NCT00996892|559432597|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
155002659|NCT00996892|559432598|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
155002660|NCT00996892|559432599|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
155002661|NCT00996892|559432600|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
155002662|NCT00996892|559432601|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
155002663|NCT00996892|559432602|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
155002664|NCT00996892|559432603|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
155002665|NCT00996892|559432604|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
155002666|NCT00996892|559432605|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
155002667|NCT00996892|559432586|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
155002668|NCT00996892|559432587|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
155002669|NCT00996892|559432588|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
155002670|NCT00996892|559432589|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
155002671|NCT00996892|559432590|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
155002672|NCT00996892|559432591|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
155002673|NCT00996892|559432592|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
155002674|NCT00996892|559432593|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
155002675|NCT00996892|559432594|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
155002676|NCT00996892|559432595|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
155002677|NCT00996892|559432596|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
155002678|NCT00996892|559432597|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
155002679|NCT00996892|559432598|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
155002680|NCT00996892|559432599|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
155002681|NCT00996892|559432600|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
155002682|NCT00996892|559432601|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
155002683|NCT00996892|559432602|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
155002684|NCT00996892|559432603|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
155002685|NCT00996892|559432604|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
155002686|NCT00996892|559432605|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
155002687|NCT00996892|559432586|FG000|Expansion Stage 2|Adverse Event|0|||
155002688|NCT00996892|559432587|FG001|Expansion Stage 2|Adverse Event|0|||
155002689|NCT00996892|559432588|FG002|Expansion Stage 2|Adverse Event|0|||
155002690|NCT00996892|559432589|FG003|Expansion Stage 2|Adverse Event|0|||
155002691|NCT00996892|559432590|FG004|Expansion Stage 2|Adverse Event|0|||
155002692|NCT00996892|559432591|FG005|Expansion Stage 2|Adverse Event|0|||
155002693|NCT00996892|559432592|FG006|Expansion Stage 2|Adverse Event|0|||
155002694|NCT00996892|559432593|FG007|Expansion Stage 2|Adverse Event|0|||
155002695|NCT00996892|559432594|FG008|Expansion Stage 2|Adverse Event|0|||
155002696|NCT00996892|559432595|FG009|Expansion Stage 2|Adverse Event|0|||
155002697|NCT00996892|559432596|FG010|Expansion Stage 2|Adverse Event|0|||
155178080|NCT00282464|560091392|FG000|Overall Study|Patient moved|1|||
155178081|NCT00282464|560091393|FG001|Overall Study|Patient moved|0|||
155178082|NCT00282464|560091392|FG000|Overall Study|patient non-compliant|3|||
155178083|NCT00282464|560091393|FG001|Overall Study|patient non-compliant|0|||
155002698|NCT00996892|559432597|FG011|Expansion Stage 2|Adverse Event|0|||
155002699|NCT00996892|559432598|FG012|Expansion Stage 2|Adverse Event|0|||
155002700|NCT00996892|559432599|FG013|Expansion Stage 2|Adverse Event|0|||
155002701|NCT00996892|559432600|FG014|Expansion Stage 2|Adverse Event|0|||
155178084|NCT00282464|560091392|FG000|Overall Study|patient no show|0|||
155178085|NCT00282464|560091393|FG001|Overall Study|patient no show|1|||
155002702|NCT00996892|559432601|FG015|Expansion Stage 2|Adverse Event|0|||
155002703|NCT00996892|559432602|FG016|Expansion Stage 2|Adverse Event|0|||
155002704|NCT00996892|559432603|FG017|Expansion Stage 2|Adverse Event|0|||
155002705|NCT00996892|559432604|FG018|Expansion Stage 2|Adverse Event|3|||
155002706|NCT00996892|559432605|FG019|Expansion Stage 2|Adverse Event|0|||
155002707|NCT00996892|559432586|FG000|Expansion Stage 2|Death|0|||
155002708|NCT00996892|559432587|FG001|Expansion Stage 2|Death|0|||
155002709|NCT00996892|559432588|FG002|Expansion Stage 2|Death|0|||
155002710|NCT00996892|559432589|FG003|Expansion Stage 2|Death|0|||
155002711|NCT00996892|559432590|FG004|Expansion Stage 2|Death|0|||
155002712|NCT00996892|559432591|FG005|Expansion Stage 2|Death|0|||
155002713|NCT00996892|559432592|FG006|Expansion Stage 2|Death|0|||
155002714|NCT00996892|559432593|FG007|Expansion Stage 2|Death|0|||
155002715|NCT00996892|559432594|FG008|Expansion Stage 2|Death|0|||
155002716|NCT00996892|559432595|FG009|Expansion Stage 2|Death|0|||
155002717|NCT00996892|559432596|FG010|Expansion Stage 2|Death|0|||
155002718|NCT00996892|559432597|FG011|Expansion Stage 2|Death|0|||
155002719|NCT00996892|559432598|FG012|Expansion Stage 2|Death|0|||
155002720|NCT00996892|559432599|FG013|Expansion Stage 2|Death|0|||
155002721|NCT00996892|559432600|FG014|Expansion Stage 2|Death|0|||
155002722|NCT00996892|559432601|FG015|Expansion Stage 2|Death|0|||
155002723|NCT00996892|559432602|FG016|Expansion Stage 2|Death|0|||
155002724|NCT00996892|559432603|FG017|Expansion Stage 2|Death|0|||
155002725|NCT00996892|559432604|FG018|Expansion Stage 2|Death|2|||
155002726|NCT00996892|559432605|FG019|Expansion Stage 2|Death|0|||
155002727|NCT00996892|559432586|FG000|Expansion Stage 2|Physician Decision|0|||
155002728|NCT00996892|559432587|FG001|Expansion Stage 2|Physician Decision|0|||
155002729|NCT00996892|559432588|FG002|Expansion Stage 2|Physician Decision|0|||
155002730|NCT00996892|559432589|FG003|Expansion Stage 2|Physician Decision|0|||
155002731|NCT00996892|559432590|FG004|Expansion Stage 2|Physician Decision|0|||
155002732|NCT00996892|559432591|FG005|Expansion Stage 2|Physician Decision|0|||
155002733|NCT00996892|559432592|FG006|Expansion Stage 2|Physician Decision|0|||
155002734|NCT00996892|559432593|FG007|Expansion Stage 2|Physician Decision|0|||
155002735|NCT00996892|559432594|FG008|Expansion Stage 2|Physician Decision|0|||
155002736|NCT00996892|559432595|FG009|Expansion Stage 2|Physician Decision|0|||
155002737|NCT00996892|559432596|FG010|Expansion Stage 2|Physician Decision|0|||
155002738|NCT00996892|559432597|FG011|Expansion Stage 2|Physician Decision|0|||
155002739|NCT00996892|559432598|FG012|Expansion Stage 2|Physician Decision|0|||
155002740|NCT00996892|559432599|FG013|Expansion Stage 2|Physician Decision|0|||
155002741|NCT00996892|559432600|FG014|Expansion Stage 2|Physician Decision|0|||
155178086|NCT00282464|560091392|FG000|Overall Study|patient incarcerated|0|||
155178087|NCT00282464|560091393|FG001|Overall Study|patient incarcerated|1|||
154922639|NCT00057330|559142129|FG001|Overall Study|Lost to Follow-up|617|||
154922640|NCT00057330|559142128|FG000|Overall Study|Physician Decision|1|||
154922641|NCT00057330|559142129|FG001|Overall Study|Physician Decision|0|||
154922642|NCT00057330|559142128|FG000|Overall Study|Other|260|||
154922643|NCT00057330|559142129|FG001|Overall Study|Other|206|||
154922644|NCT04311411|559142133|FG000|Overall Study|Adverse Event|2|||
154922645|NCT04311411|559142134|FG001|Overall Study|Adverse Event|3|||
154922646|NCT04311411|559142135|FG002|Overall Study|Adverse Event|2|||
154922647|NCT04311411|559142133|FG000|Overall Study|Withdrawal by Subject|3|||
154922648|NCT04311411|559142134|FG001|Overall Study|Withdrawal by Subject|3|||
154922649|NCT04311411|559142135|FG002|Overall Study|Withdrawal by Subject|0|||
154922650|NCT00978120|559142147|FG000|Overall Study|Death|0|||
154922651|NCT00978120|559142148|FG001|Overall Study|Death|0|||
154922652|NCT00978120|559142149|FG002|Overall Study|Death|0|||
154922653|NCT00978120|559142150|FG003|Overall Study|Death|1|||
154922654|NCT00978120|559142147|FG000|Overall Study|Lost to Follow-up|0|||
154922655|NCT00978120|559142148|FG001|Overall Study|Lost to Follow-up|0|||
154922656|NCT00978120|559142149|FG002|Overall Study|Lost to Follow-up|3|||
154922657|NCT00978120|559142150|FG003|Overall Study|Lost to Follow-up|0|||
154922658|NCT00978120|559142147|FG000|Overall Study|Withdrawal by Subject|2|||
154922659|NCT00978120|559142148|FG001|Overall Study|Withdrawal by Subject|0|||
154922660|NCT00978120|559142149|FG002|Overall Study|Withdrawal by Subject|0|||
154922661|NCT00978120|559142150|FG003|Overall Study|Withdrawal by Subject|0|||
154922662|NCT00978120|559142147|FG000|Overall Study|Moved out of state|0|||
154922663|NCT00978120|559142148|FG001|Overall Study|Moved out of state|0|||
154922664|NCT00978120|559142149|FG002|Overall Study|Moved out of state|0|||
155002742|NCT00996892|559432601|FG015|Expansion Stage 2|Physician Decision|0|||
155002743|NCT00996892|559432602|FG016|Expansion Stage 2|Physician Decision|0|||
155002744|NCT00996892|559432603|FG017|Expansion Stage 2|Physician Decision|0|||
155002745|NCT00996892|559432604|FG018|Expansion Stage 2|Physician Decision|1|||
155002746|NCT00996892|559432605|FG019|Expansion Stage 2|Physician Decision|0|||
155002747|NCT00996892|559432586|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
154922665|NCT00978120|559142150|FG003|Overall Study|Moved out of state|1|||
155002748|NCT00996892|559432587|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
155002749|NCT00996892|559432588|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
155002750|NCT00996892|559432589|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
155002751|NCT00996892|559432590|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
155002752|NCT00996892|559432591|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
155002753|NCT00996892|559432592|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
155002754|NCT00996892|559432593|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
155002755|NCT00996892|559432594|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
155002756|NCT00996892|559432595|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
155002757|NCT00996892|559432596|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
155002758|NCT00996892|559432597|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
155002759|NCT00996892|559432598|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
155002760|NCT00996892|559432599|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
155002761|NCT00996892|559432600|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
155002762|NCT00996892|559432601|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
155002763|NCT00996892|559432602|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
155002764|NCT00996892|559432603|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
155002765|NCT00996892|559432604|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
155002766|NCT00996892|559432605|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
155002767|NCT00996892|559432586|FG000|Expansion Stage 2|Disease Progression|0|||
155002768|NCT00996892|559432587|FG001|Expansion Stage 2|Disease Progression|0|||
155002769|NCT00996892|559432588|FG002|Expansion Stage 2|Disease Progression|0|||
155002770|NCT00996892|559432589|FG003|Expansion Stage 2|Disease Progression|0|||
155002771|NCT00996892|559432590|FG004|Expansion Stage 2|Disease Progression|0|||
155002772|NCT00996892|559432591|FG005|Expansion Stage 2|Disease Progression|0|||
155002773|NCT00996892|559432592|FG006|Expansion Stage 2|Disease Progression|0|||
155002774|NCT00996892|559432593|FG007|Expansion Stage 2|Disease Progression|0|||
155002775|NCT00996892|559432594|FG008|Expansion Stage 2|Disease Progression|0|||
155002776|NCT00996892|559432595|FG009|Expansion Stage 2|Disease Progression|0|||
155002777|NCT00996892|559432596|FG010|Expansion Stage 2|Disease Progression|0|||
155002778|NCT00996892|559432597|FG011|Expansion Stage 2|Disease Progression|0|||
155002779|NCT00996892|559432598|FG012|Expansion Stage 2|Disease Progression|0|||
155002780|NCT00996892|559432599|FG013|Expansion Stage 2|Disease Progression|0|||
155002781|NCT00996892|559432600|FG014|Expansion Stage 2|Disease Progression|0|||
155002782|NCT00996892|559432601|FG015|Expansion Stage 2|Disease Progression|0|||
155002783|NCT00996892|559432602|FG016|Expansion Stage 2|Disease Progression|0|||
155002784|NCT00996892|559432603|FG017|Expansion Stage 2|Disease Progression|0|||
155002785|NCT00996892|559432604|FG018|Expansion Stage 2|Disease Progression|28|||
155002786|NCT00996892|559432605|FG019|Expansion Stage 2|Disease Progression|0|||
155002787|NCT00996892|559432586|FG000|Expansion Stage 2A|Adverse Event|0|||
155002788|NCT00996892|559432587|FG001|Expansion Stage 2A|Adverse Event|0|||
155125196|NCT05288166|559890578|FG000|Overall Study|Withdrawal by Subject|4|||
154922666|NCT02940392|559142151|FG000|Overall Study|Lost to Follow-up|3|||
154922667|NCT02940392|559142151|FG000|Overall Study|Retreatment|3|||
154922668|NCT02940392|559142151|FG000|Overall Study|Death|2|||
154922669|NCT03253809|559142152|FG000|Overall Study|Unable to obtain study related data|14|||
154922670|NCT03992456|559142155|FG000|Overall Study|Withdrawal by Subject|1|||
154922671|NCT03992456|559142156|FG001|Overall Study|Withdrawal by Subject|0|||
154922672|NCT03992456|559142155|FG000|Overall Study|Disease progression|4|||
154922673|NCT03992456|559142156|FG001|Overall Study|Disease progression|5|||
154922674|NCT03992456|559142155|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
154922675|NCT03992456|559142156|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
154922676|NCT00762073|559142157|FG000|Overall Study|Lack of Efficacy|1|||
154922677|NCT00762073|559142158|FG001|Overall Study|Lack of Efficacy|1|||
154922678|NCT00762073|559142159|FG002|Overall Study|Lack of Efficacy|0|||
154922679|NCT00762073|559142160|FG003|Overall Study|Lack of Efficacy|0|||
154922680|NCT00762073|559142157|FG000|Overall Study|Adverse Event|1|||
154922681|NCT00762073|559142158|FG001|Overall Study|Adverse Event|0|||
154922682|NCT00762073|559142159|FG002|Overall Study|Adverse Event|1|||
154922683|NCT00762073|559142160|FG003|Overall Study|Adverse Event|1|||
154922684|NCT00762073|559142157|FG000|Overall Study|Significant Subject Noncompliance|0|||
154922685|NCT00762073|559142158|FG001|Overall Study|Significant Subject Noncompliance|1|||
154922686|NCT00762073|559142159|FG002|Overall Study|Significant Subject Noncompliance|0|||
154922687|NCT00762073|559142160|FG003|Overall Study|Significant Subject Noncompliance|1|||
154922688|NCT00762073|559142157|FG000|Overall Study|Withdrawal by Subject|1|||
154922689|NCT00762073|559142158|FG001|Overall Study|Withdrawal by Subject|2|||
154922690|NCT00762073|559142159|FG002|Overall Study|Withdrawal by Subject|1|||
154922691|NCT00762073|559142160|FG003|Overall Study|Withdrawal by Subject|1|||
154922692|NCT00762073|559142157|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
154922693|NCT00762073|559142158|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
154922694|NCT00762073|559142159|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
154922695|NCT00762073|559142160|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
154922696|NCT01068418|559142161|FG000|Overall Study|Physician Decision|12|||
154922697|NCT00910000|559142162|FG000|Overall Study|Adverse Event|0|||
154922698|NCT00910000|559142163|FG001|Overall Study|Adverse Event|3|||
155002789|NCT00996892|559432588|FG002|Expansion Stage 2A|Adverse Event|0|||
155002790|NCT00996892|559432589|FG003|Expansion Stage 2A|Adverse Event|0|||
155002791|NCT00996892|559432590|FG004|Expansion Stage 2A|Adverse Event|0|||
155002792|NCT00996892|559432591|FG005|Expansion Stage 2A|Adverse Event|0|||
155002793|NCT00996892|559432592|FG006|Expansion Stage 2A|Adverse Event|0|||
155002794|NCT00996892|559432593|FG007|Expansion Stage 2A|Adverse Event|0|||
155178088|NCT00282464|560091392|FG000|Overall Study|family crisis|0|||
154922699|NCT00910000|559142164|FG002|Overall Study|Adverse Event|2|||
154922700|NCT00910000|559142165|FG003|Overall Study|Adverse Event|2|||
154922701|NCT00910000|559142166|FG004|Overall Study|Adverse Event|0|||
154922702|NCT00910000|559142167|FG005|Overall Study|Adverse Event|1|||
154922703|NCT00910000|559142162|FG000|Overall Study|Withdrawal by Subject|0|||
154922704|NCT00910000|559142163|FG001|Overall Study|Withdrawal by Subject|0|||
154922705|NCT00910000|559142164|FG002|Overall Study|Withdrawal by Subject|1|||
154922706|NCT00910000|559142165|FG003|Overall Study|Withdrawal by Subject|0|||
154922707|NCT00910000|559142166|FG004|Overall Study|Withdrawal by Subject|1|||
154922708|NCT00910000|559142167|FG005|Overall Study|Withdrawal by Subject|0|||
154922709|NCT04637815|559142168|FG000|Overall Study|Death|1|||
154922710|NCT04637815|559142169|FG001|Overall Study|Death|0|||
154922711|NCT04637815|559142168|FG000|Overall Study|Lost to Follow-up|5|||
154922712|NCT04637815|559142169|FG001|Overall Study|Lost to Follow-up|2|||
154922713|NCT02594384|559142170|FG000|Overall Study|Disease Progression|3|||
154922714|NCT02594384|559142171|FG001|Overall Study|Disease Progression|7|||
154922715|NCT02594384|559142172|FG002|Overall Study|Disease Progression|0|||
154922716|NCT02594384|559142173|FG003|Overall Study|Disease Progression|2|||
154922717|NCT02594384|559142174|FG004|Overall Study|Disease Progression|2|||
154922718|NCT02594384|559142175|FG005|Overall Study|Disease Progression|12|||
154922719|NCT02594384|559142176|FG006|Overall Study|Disease Progression|5|||
154922720|NCT02594384|559142177|FG007|Overall Study|Disease Progression|5|||
154922721|NCT02594384|559142170|FG000|Overall Study|Adverse Event|0|||
154922722|NCT02594384|559142171|FG001|Overall Study|Adverse Event|1|||
154922723|NCT02594384|559142172|FG002|Overall Study|Adverse Event|4|||
154922724|NCT02594384|559142173|FG003|Overall Study|Adverse Event|1|||
154922725|NCT02594384|559142174|FG004|Overall Study|Adverse Event|0|||
154922726|NCT02594384|559142175|FG005|Overall Study|Adverse Event|6|||
154922727|NCT02594384|559142176|FG006|Overall Study|Adverse Event|1|||
154922728|NCT02594384|559142177|FG007|Overall Study|Adverse Event|1|||
154922729|NCT02594384|559142170|FG000|Overall Study|Withdrawal by Subject|0|||
154922730|NCT02594384|559142171|FG001|Overall Study|Withdrawal by Subject|0|||
154922731|NCT02594384|559142172|FG002|Overall Study|Withdrawal by Subject|0|||
154922732|NCT02594384|559142173|FG003|Overall Study|Withdrawal by Subject|1|||
154922733|NCT02594384|559142174|FG004|Overall Study|Withdrawal by Subject|0|||
154922734|NCT02594384|559142175|FG005|Overall Study|Withdrawal by Subject|0|||
154922735|NCT02594384|559142176|FG006|Overall Study|Withdrawal by Subject|0|||
154922736|NCT02594384|559142177|FG007|Overall Study|Withdrawal by Subject|1|||
154922737|NCT02594384|559142170|FG000|Overall Study|Physician Decision|0|||
154922738|NCT02594384|559142171|FG001|Overall Study|Physician Decision|0|||
154922739|NCT02594384|559142172|FG002|Overall Study|Physician Decision|0|||
154922740|NCT02594384|559142173|FG003|Overall Study|Physician Decision|0|||
154922741|NCT02594384|559142174|FG004|Overall Study|Physician Decision|0|||
154922742|NCT02594384|559142175|FG005|Overall Study|Physician Decision|1|||
154922743|NCT02594384|559142176|FG006|Overall Study|Physician Decision|2|||
154922744|NCT02594384|559142177|FG007|Overall Study|Physician Decision|0|||
154922745|NCT02594384|559142170|FG000|Overall Study|Progressive Leukocytosis|0|||
154922746|NCT02594384|559142171|FG001|Overall Study|Progressive Leukocytosis|0|||
154922747|NCT02594384|559142172|FG002|Overall Study|Progressive Leukocytosis|1|||
154922748|NCT02594384|559142173|FG003|Overall Study|Progressive Leukocytosis|0|||
154922749|NCT02594384|559142174|FG004|Overall Study|Progressive Leukocytosis|0|||
154922750|NCT02594384|559142175|FG005|Overall Study|Progressive Leukocytosis|0|||
154922751|NCT02594384|559142176|FG006|Overall Study|Progressive Leukocytosis|0|||
154922752|NCT02594384|559142177|FG007|Overall Study|Progressive Leukocytosis|0|||
154922753|NCT02594384|559142170|FG000|Overall Study|Lack of Efficacy|0|||
154922754|NCT02594384|559142171|FG001|Overall Study|Lack of Efficacy|0|||
154922755|NCT02594384|559142172|FG002|Overall Study|Lack of Efficacy|0|||
154922756|NCT02594384|559142173|FG003|Overall Study|Lack of Efficacy|0|||
154922757|NCT02594384|559142174|FG004|Overall Study|Lack of Efficacy|1|||
154922758|NCT02594384|559142175|FG005|Overall Study|Lack of Efficacy|0|||
154922759|NCT02594384|559142176|FG006|Overall Study|Lack of Efficacy|0|||
154922760|NCT02594384|559142177|FG007|Overall Study|Lack of Efficacy|0|||
154922761|NCT02594384|559142170|FG000|Overall Study|Substantial noncompliance|0|||
154922762|NCT02594384|559142171|FG001|Overall Study|Substantial noncompliance|0|||
154922763|NCT02594384|559142172|FG002|Overall Study|Substantial noncompliance|0|||
154922764|NCT02594384|559142173|FG003|Overall Study|Substantial noncompliance|0|||
154922765|NCT02594384|559142174|FG004|Overall Study|Substantial noncompliance|0|||
154922766|NCT02594384|559142175|FG005|Overall Study|Substantial noncompliance|0|||
154922767|NCT02594384|559142176|FG006|Overall Study|Substantial noncompliance|1|||
154922768|NCT02594384|559142177|FG007|Overall Study|Substantial noncompliance|0|||
154922769|NCT02058849|559142180|FG000|Overall Study|Hospitalization|1|||
154922770|NCT02058849|559142181|FG001|Overall Study|Hospitalization|1|||
154922771|NCT02058849|559142180|FG000|Overall Study|Death|1|||
154922772|NCT02058849|559142181|FG001|Overall Study|Death|0|||
154922773|NCT02058849|559142180|FG000|Overall Study|Lost to Follow-up|1|||
154922774|NCT02058849|559142181|FG001|Overall Study|Lost to Follow-up|0|||
154922775|NCT02058849|559142180|FG000|Overall Study|Withdrawal by Subject|4|||
154922776|NCT02058849|559142181|FG001|Overall Study|Withdrawal by Subject|0|||
155002795|NCT00996892|559432594|FG008|Expansion Stage 2A|Adverse Event|0|||
155002796|NCT00996892|559432595|FG009|Expansion Stage 2A|Adverse Event|0|||
155002797|NCT00996892|559432596|FG010|Expansion Stage 2A|Adverse Event|0|||
155002798|NCT00996892|559432597|FG011|Expansion Stage 2A|Adverse Event|0|||
155002799|NCT00996892|559432598|FG012|Expansion Stage 2A|Adverse Event|0|||
155002800|NCT00996892|559432599|FG013|Expansion Stage 2A|Adverse Event|0|||
155002801|NCT00996892|559432600|FG014|Expansion Stage 2A|Adverse Event|0|||
155002802|NCT00996892|559432601|FG015|Expansion Stage 2A|Adverse Event|0|||
155002803|NCT00996892|559432602|FG016|Expansion Stage 2A|Adverse Event|0|||
155002804|NCT00996892|559432603|FG017|Expansion Stage 2A|Adverse Event|0|||
155002805|NCT00996892|559432604|FG018|Expansion Stage 2A|Adverse Event|0|||
155002806|NCT00996892|559432605|FG019|Expansion Stage 2A|Adverse Event|8|||
155002807|NCT00996892|559432586|FG000|Expansion Stage 2A|Physician Decision|0|||
155002808|NCT00996892|559432587|FG001|Expansion Stage 2A|Physician Decision|0|||
155002809|NCT00996892|559432588|FG002|Expansion Stage 2A|Physician Decision|0|||
155002810|NCT00996892|559432589|FG003|Expansion Stage 2A|Physician Decision|0|||
155002811|NCT00996892|559432590|FG004|Expansion Stage 2A|Physician Decision|0|||
155002812|NCT00996892|559432591|FG005|Expansion Stage 2A|Physician Decision|0|||
155002813|NCT00996892|559432592|FG006|Expansion Stage 2A|Physician Decision|0|||
155002814|NCT00996892|559432593|FG007|Expansion Stage 2A|Physician Decision|0|||
155002815|NCT00996892|559432594|FG008|Expansion Stage 2A|Physician Decision|0|||
155002816|NCT00996892|559432595|FG009|Expansion Stage 2A|Physician Decision|0|||
155002817|NCT00996892|559432596|FG010|Expansion Stage 2A|Physician Decision|0|||
155002818|NCT00996892|559432597|FG011|Expansion Stage 2A|Physician Decision|0|||
155002819|NCT00996892|559432598|FG012|Expansion Stage 2A|Physician Decision|0|||
155002820|NCT00996892|559432599|FG013|Expansion Stage 2A|Physician Decision|0|||
155002821|NCT00996892|559432600|FG014|Expansion Stage 2A|Physician Decision|0|||
155002822|NCT00996892|559432601|FG015|Expansion Stage 2A|Physician Decision|0|||
155002823|NCT00996892|559432602|FG016|Expansion Stage 2A|Physician Decision|0|||
155002824|NCT00996892|559432603|FG017|Expansion Stage 2A|Physician Decision|0|||
155002825|NCT00996892|559432604|FG018|Expansion Stage 2A|Physician Decision|0|||
155002826|NCT00996892|559432605|FG019|Expansion Stage 2A|Physician Decision|2|||
155002827|NCT00996892|559432586|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
155002828|NCT00996892|559432587|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
155002829|NCT00996892|559432588|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
155002830|NCT00996892|559432589|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
155002831|NCT00996892|559432590|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
155002832|NCT00996892|559432591|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
155002833|NCT00996892|559432592|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
155002834|NCT00996892|559432593|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
155002835|NCT00996892|559432594|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
155002836|NCT00996892|559432595|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
155002837|NCT00996892|559432596|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
155125197|NCT05288166|559890579|FG001|Overall Study|Withdrawal by Subject|2|||
155125198|NCT05288166|559890578|FG000|Overall Study|On Study Treatment|408|||
155125199|NCT05288166|559890579|FG001|Overall Study|On Study Treatment|418|||
155125200|NCT01390779|559890580|FG000|Overall Study|Physician Decision|1|||
155125201|NCT03689712|559890581|FG000|Overall Study|Adverse Event|1|||
155125202|NCT03689712|559890582|FG001|Overall Study|Adverse Event|0|||
155125203|NCT03689712|559890581|FG000|Overall Study|Death|20|||
155125204|NCT03689712|559890582|FG001|Overall Study|Death|10|||
155125205|NCT03689712|559890581|FG000|Overall Study|Lost to Follow-up|6|||
155125206|NCT03689712|559890582|FG001|Overall Study|Lost to Follow-up|6|||
155125207|NCT03689712|559890581|FG000|Overall Study|Other|1|||
155125208|NCT03689712|559890582|FG001|Overall Study|Other|0|||
155125209|NCT03689712|559890581|FG000|Overall Study|Patient Non-Compliance|0|||
155125210|NCT03689712|559890582|FG001|Overall Study|Patient Non-Compliance|1|||
155125211|NCT03689712|559890581|FG000|Overall Study|Withdrawal by Subject|20|||
155125212|NCT03689712|559890582|FG001|Overall Study|Withdrawal by Subject|4|||
155125213|NCT03689712|559890581|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
155125214|NCT03689712|559890582|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
155125215|NCT03689712|559890581|FG000|Overall Study|Randomized but not Treated|13|||
155125216|NCT03689712|559890582|FG001|Overall Study|Randomized but not Treated|7|||
155125217|NCT03689712|559890581|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
155125218|NCT03689712|559890582|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
155002838|NCT00996892|559432597|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
155002839|NCT00996892|559432598|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
155002840|NCT00996892|559432599|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
155002841|NCT00996892|559432600|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
155002842|NCT00996892|559432601|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
155002843|NCT00996892|559432602|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
155002844|NCT00996892|559432603|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
155002845|NCT00996892|559432604|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
155002846|NCT00996892|559432605|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
155002847|NCT00996892|559432586|FG000|Expansion Stage 2A|Disease Progression|0|||
155002848|NCT00996892|559432587|FG001|Expansion Stage 2A|Disease Progression|0|||
155002849|NCT00996892|559432588|FG002|Expansion Stage 2A|Disease Progression|0|||
155002850|NCT00996892|559432589|FG003|Expansion Stage 2A|Disease Progression|0|||
155002851|NCT00996892|559432590|FG004|Expansion Stage 2A|Disease Progression|0|||
155002852|NCT00996892|559432591|FG005|Expansion Stage 2A|Disease Progression|0|||
155002853|NCT00996892|559432592|FG006|Expansion Stage 2A|Disease Progression|0|||
155002854|NCT00996892|559432593|FG007|Expansion Stage 2A|Disease Progression|0|||
155002855|NCT00996892|559432594|FG008|Expansion Stage 2A|Disease Progression|0|||
155002856|NCT00996892|559432595|FG009|Expansion Stage 2A|Disease Progression|0|||
155002857|NCT00996892|559432596|FG010|Expansion Stage 2A|Disease Progression|0|||
155002858|NCT00996892|559432597|FG011|Expansion Stage 2A|Disease Progression|0|||
155002859|NCT00996892|559432598|FG012|Expansion Stage 2A|Disease Progression|0|||
155002860|NCT00996892|559432599|FG013|Expansion Stage 2A|Disease Progression|0|||
155002861|NCT00996892|559432600|FG014|Expansion Stage 2A|Disease Progression|0|||
155002862|NCT00996892|559432601|FG015|Expansion Stage 2A|Disease Progression|0|||
155002863|NCT00996892|559432602|FG016|Expansion Stage 2A|Disease Progression|0|||
155002864|NCT00996892|559432603|FG017|Expansion Stage 2A|Disease Progression|0|||
155002865|NCT00996892|559432604|FG018|Expansion Stage 2A|Disease Progression|0|||
155002866|NCT00996892|559432605|FG019|Expansion Stage 2A|Disease Progression|31|||
155002867|NCT02759692|559432606|FG000|Period 1|Test article no longer available|1|||
155002868|NCT02759692|559432607|FG001|Period 1|Test article no longer available|1|||
155002869|NCT02759692|559432606|FG000|Period 1|No longer meets eligibility criteria.|1|||
155002870|NCT02759692|559432607|FG001|Period 1|No longer meets eligibility criteria.|0|||
155002871|NCT02759692|559432606|FG000|Period 1|Miss-Randomized|1|||
155002872|NCT02759692|559432607|FG001|Period 1|Miss-Randomized|1|||
155002873|NCT02759692|559432606|FG000|Period 2|Lost to Follow-up|1|||
155002874|NCT02759692|559432607|FG001|Period 2|Lost to Follow-up|0|||
155002875|NCT02759692|559432606|FG000|Period 2|Test article no longer available|0|||
155002876|NCT02759692|559432607|FG001|Period 2|Test article no longer available|1|||
155002877|NCT00708227|559432612|FG000|Overall Study|Physician Decision|0|||
155002878|NCT00708227|559432613|FG001|Overall Study|Physician Decision|3|||
155002879|NCT00708227|559432614|FG002|Overall Study|Physician Decision|1|||
155002880|NCT00708227|559432615|FG003|Overall Study|Physician Decision|2|||
155002881|NCT00708227|559432612|FG000|Overall Study|Withdrawal by Subject|1|||
155002882|NCT00708227|559432613|FG001|Overall Study|Withdrawal by Subject|2|||
155002883|NCT00708227|559432614|FG002|Overall Study|Withdrawal by Subject|0|||
155002884|NCT00708227|559432615|FG003|Overall Study|Withdrawal by Subject|1|||
155002885|NCT04007991|559432617|FG000|Overall Study|Withdrawal by Subject|1|||
155002886|NCT04007991|559432618|FG001|Overall Study|Withdrawal by Subject|1|||
155002887|NCT04007991|559432617|FG000|Overall Study|Physician Decision|1|||
155002888|NCT04007991|559432618|FG001|Overall Study|Physician Decision|1|||
155002889|NCT04007991|559432617|FG000|Overall Study|Non-compliance with Study Drug|0|||
155002890|NCT04007991|559432618|FG001|Overall Study|Non-compliance with Study Drug|1|||
155002891|NCT04007991|559432617|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
155002892|NCT04007991|559432618|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
155002893|NCT04007991|559432617|FG000|Overall Study|Adverse event, non-fatal|5|||
155002894|NCT04007991|559432618|FG001|Overall Study|Adverse event, non-fatal|0|||
155002895|NCT04007991|559432617|FG000|Overall Study|Lost to Follow-up|2|||
155002896|NCT04007991|559432618|FG001|Overall Study|Lost to Follow-up|1|||
155002897|NCT04042376|559432619|FG000|Overall Study|Withdrawal by Subject|1|||
155002898|NCT04042376|559432619|FG000|Overall Study|Death|3|||
155002899|NCT01059786|559434601|FG000|Overall Study|Did not receive 6 cycles.|0|||
155002900|NCT01059786|559434602|FG001|Overall Study|Did not receive 6 cycles.|0|||
155002901|NCT01059786|559434603|FG002|Overall Study|Did not receive 6 cycles.|4|||
155002902|NCT01059786|559434604|FG003|Overall Study|Did not receive 6 cycles.|1|||
155002903|NCT01059786|559434605|FG004|Overall Study|Did not receive 6 cycles.|0|||
155002904|NCT04205812|559434606|FG000|Randomized Treatment Period|Ongoing|28|||
155002905|NCT04205812|559434607|FG001|Randomized Treatment Period|Ongoing|138|||
155002906|NCT04205812|559434606|FG000|Randomized Treatment Period|Death|94|||
155002907|NCT04205812|559434607|FG001|Randomized Treatment Period|Death|226|||
155002908|NCT04205812|559434606|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
155125219|NCT00689793|559890583|FG000|Overall Study|Lost to Follow-up|4|||
155125220|NCT00689793|559890584|FG001|Overall Study|Lost to Follow-up|5|||
155002909|NCT04205812|559434607|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
155002910|NCT04205812|559434606|FG000|Randomized Treatment Period|Physician Decision|1|||
155002911|NCT04205812|559434607|FG001|Randomized Treatment Period|Physician Decision|4|||
155002912|NCT04205812|559434606|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
155002913|NCT04205812|559434607|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
155002914|NCT04205812|559434606|FG000|Randomized Treatment Period|Progressive Disease|0|||
155002915|NCT04205812|559434607|FG001|Randomized Treatment Period|Progressive Disease|1|||
155002916|NCT04205812|559434606|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
155002917|NCT04205812|559434607|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
155002918|NCT04205812|559434606|FG000|Monotherapy Treatment Period|Ongoing|17|||
155002919|NCT04205812|559434607|FG001|Monotherapy Treatment Period|Ongoing|0|||
155002920|NCT04205812|559434606|FG000|Monotherapy Treatment Period|Death|39|||
155002921|NCT04205812|559434607|FG001|Monotherapy Treatment Period|Death|0|||
155002922|NCT04205812|559434606|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
155002923|NCT04205812|559434607|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
155002924|NCT04205812|559434606|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
155002925|NCT04205812|559434607|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
155002926|NCT04559347|559434608|FG000|Overall Study|Death|1|||
155002927|NCT04559347|559434609|FG001|Overall Study|Death|0|||
155002928|NCT04559347|559434608|FG000|Overall Study|Thoracotomy conversion|1|||
155002929|NCT04559347|559434609|FG001|Overall Study|Thoracotomy conversion|1|||
155002930|NCT04559347|559434608|FG000|Overall Study|Provider unavailable|2|||
155002931|NCT04559347|559434609|FG001|Overall Study|Provider unavailable|1|||
155002932|NCT04559347|559434608|FG000|Overall Study|Other|2|||
155002933|NCT04559347|559434609|FG001|Overall Study|Other|1|||
155002934|NCT00371033|559434610|FG000|Overall Study|Lost to Follow-up|3|||
155002935|NCT00371033|559434611|FG001|Overall Study|Lost to Follow-up|2|||
155002936|NCT00371033|559434610|FG000|Overall Study|No longer interested|2|||
155002937|NCT00371033|559434611|FG001|Overall Study|No longer interested|0|||
155002938|NCT00371033|559434610|FG000|Overall Study|Uknown|3|||
155002939|NCT00371033|559434611|FG001|Overall Study|Uknown|1|||
155002940|NCT05929651|559434618|FG000|Overall Study|Protocol Deviation|1|||
155002941|NCT05929651|559434618|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
155002942|NCT05026177|559434619|FG000|Overall Study|Adverse Event|33|||
155002943|NCT05026177|559434620|FG001|Overall Study|Adverse Event|33|||
155002944|NCT05026177|559434621|FG002|Overall Study|Adverse Event|17|||
155002945|NCT05026177|559434619|FG000|Overall Study|Lost to Follow-up|7|||
155002946|NCT05026177|559434620|FG001|Overall Study|Lost to Follow-up|6|||
155002947|NCT05026177|559434621|FG002|Overall Study|Lost to Follow-up|8|||
155002948|NCT05026177|559434619|FG000|Overall Study|Noncompliance with study drug|6|||
155002949|NCT05026177|559434620|FG001|Overall Study|Noncompliance with study drug|2|||
155002950|NCT05026177|559434621|FG002|Overall Study|Noncompliance with study drug|1|||
155002951|NCT05026177|559434619|FG000|Overall Study|Physician Decision|4|||
155002952|NCT05026177|559434620|FG001|Overall Study|Physician Decision|1|||
155002953|NCT05026177|559434621|FG002|Overall Study|Physician Decision|0|||
155002954|NCT05026177|559434619|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
155002955|NCT05026177|559434620|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
155002956|NCT05026177|559434621|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
155002957|NCT05026177|559434619|FG000|Overall Study|Withdrawal by Subject|53|||
155002958|NCT05026177|559434620|FG001|Overall Study|Withdrawal by Subject|51|||
155002959|NCT05026177|559434621|FG002|Overall Study|Withdrawal by Subject|55|||
155002960|NCT05026177|559434619|FG000|Overall Study|Protocol Violation|0|||
155002961|NCT05026177|559434620|FG001|Overall Study|Protocol Violation|1|||
155002962|NCT05026177|559434621|FG002|Overall Study|Protocol Violation|0|||
155002963|NCT05026177|559434619|FG000|Overall Study|Study terminated by sponsor|70|||
155002964|NCT05026177|559434620|FG001|Overall Study|Study terminated by sponsor|74|||
155002965|NCT05026177|559434621|FG002|Overall Study|Study terminated by sponsor|67|||
155002966|NCT05026177|559434619|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
155002967|NCT05026177|559434620|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
155002968|NCT05026177|559434621|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
155002969|NCT05026177|559434619|FG000|Overall Study|Starting alternative treatment|0|||
155002970|NCT05026177|559434620|FG001|Overall Study|Starting alternative treatment|1|||
155002971|NCT05026177|559434621|FG002|Overall Study|Starting alternative treatment|1|||
155002972|NCT05026177|559434619|FG000|Overall Study|Noncompliance with study procedures|0|||
155002973|NCT05026177|559434620|FG001|Overall Study|Noncompliance with study procedures|1|||
155002974|NCT05026177|559434621|FG002|Overall Study|Noncompliance with study procedures|1|||
155002975|NCT05026177|559434619|FG000|Overall Study|Met stopping criteria|0|||
155002976|NCT05026177|559434620|FG001|Overall Study|Met stopping criteria|0|||
155002977|NCT05026177|559434621|FG002|Overall Study|Met stopping criteria|1|||
155002978|NCT05026177|559434619|FG000|Overall Study|Health issues preventing continuation|0|||
155002979|NCT05026177|559434620|FG001|Overall Study|Health issues preventing continuation|0|||
155002980|NCT05026177|559434621|FG002|Overall Study|Health issues preventing continuation|1|||
155002981|NCT05026177|559434619|FG000|Overall Study|Randomized in error, not treated|0|||
155002982|NCT05026177|559434620|FG001|Overall Study|Randomized in error, not treated|0|||
155002983|NCT05026177|559434621|FG002|Overall Study|Randomized in error, not treated|2|||
155002984|NCT03816878|559434624|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
155002985|NCT03816878|559434625|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
155002986|NCT03816878|559434624|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
155002987|NCT03816878|559434625|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
155125221|NCT01299571|559890590|FG000|Overall Study|Protocol Violation|107|||
155002988|NCT04856930|559434630|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
155002989|NCT04856930|559434631|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
155125222|NCT00413010|559890591|FG000|Overall Study|Adverse Event|8|||
155125223|NCT00413010|559890592|FG001|Overall Study|Adverse Event|4|||
155125224|NCT00413010|559890591|FG000|Overall Study|Laboratory abnormality|0|||
155002990|NCT04856930|559434632|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
155002991|NCT04856930|559434630|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
155002992|NCT04856930|559434631|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
155002993|NCT04856930|559434632|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
155002994|NCT04856930|559434630|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
155002995|NCT04856930|559434631|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
155002996|NCT04856930|559434632|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
155002997|NCT04856930|559434630|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
155002998|NCT04856930|559434631|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
155002999|NCT04856930|559434632|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
155003000|NCT04856930|559434630|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
155003001|NCT04856930|559434631|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
155003002|NCT04856930|559434632|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
155003003|NCT04856930|559434630|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155003004|NCT04856930|559434631|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
155003005|NCT04856930|559434632|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155003006|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
155003007|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
155003008|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
155003009|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
155003010|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
155003011|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
155003012|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
155003013|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
155003014|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
155003015|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
155003016|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
155003017|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
155003018|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
155003019|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155003020|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
155003021|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
155003022|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
155003023|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
155003024|NCT04856930|559434630|FG000|Extension Period (16 Weeks)|Other than specified|0|||
155003025|NCT04856930|559434631|FG001|Extension Period (16 Weeks)|Other than specified|0|||
155003026|NCT04856930|559434632|FG002|Extension Period (16 Weeks)|Other than specified|1|||
155003027|NCT04856930|559434630|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
155003028|NCT04856930|559434631|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
155003029|NCT04856930|559434632|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
155003030|NCT04856930|559434630|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
155003031|NCT04856930|559434631|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
155003032|NCT04856930|559434632|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
155003033|NCT04856930|559434630|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
155003034|NCT04856930|559434631|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
155003035|NCT04856930|559434632|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
155003036|NCT04856930|559434630|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
155003037|NCT04856930|559434631|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
155003038|NCT04856930|559434632|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
155003039|NCT01433055|559434634|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
155003040|NCT01433055|559434635|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
155003041|NCT01433055|559434634|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
155003042|NCT01433055|559434635|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
155003043|NCT00733005|559434641|FG000|Overall Study|Adverse Event|0|||
155003044|NCT00733005|559434642|FG001|Overall Study|Adverse Event|1|||
155003045|NCT00733005|559434641|FG000|Overall Study|Treatment Failure|0|||
155003046|NCT00733005|559434642|FG001|Overall Study|Treatment Failure|1|||
155003047|NCT00733005|559434641|FG000|Overall Study|Withdrawal by Subject|0|||
155003048|NCT00733005|559434642|FG001|Overall Study|Withdrawal by Subject|1|||
155178089|NCT00282464|560091393|FG001|Overall Study|family crisis|1|||
155178090|NCT00282464|560091392|FG000|Overall Study|dispensed wrong kit|0|||
155178091|NCT00282464|560091393|FG001|Overall Study|dispensed wrong kit|1|||
155178092|NCT00282464|560091392|FG000|Overall Study|dropped due to missed visits|0|||
155178093|NCT00282464|560091393|FG001|Overall Study|dropped due to missed visits|1|||
155003049|NCT00733005|559434641|FG000|Overall Study|Protocol Violation|2|||
155003050|NCT00733005|559434642|FG001|Overall Study|Protocol Violation|0|||
155003051|NCT01009814|559434653|FG000|Overall Study|No longer met study criteria|1|||
155003052|NCT01009814|559434654|FG001|Overall Study|No longer met study criteria|1|||
155178094|NCT00420641|560091396|FG000|Overall Study|Adverse Event|3|||
155003053|NCT01009814|559434655|FG002|Overall Study|No longer met study criteria|0|||
155003054|NCT01009814|559434656|FG003|Overall Study|No longer met study criteria|0|||
155003055|NCT01009814|559434657|FG004|Overall Study|No longer met study criteria|0|||
155003056|NCT01977417|559434659|FG000|Overall Study|Adverse Event|1|||
155003057|NCT01977417|559434660|FG001|Overall Study|Adverse Event|0|||
155003058|NCT01977417|559434659|FG000|Overall Study|Withdrawal by Subject|2|||
155003059|NCT01977417|559434660|FG001|Overall Study|Withdrawal by Subject|4|||
155003060|NCT01977417|559434659|FG000|Overall Study|Female enrollment goal met|0|||
155003061|NCT01977417|559434660|FG001|Overall Study|Female enrollment goal met|2|||
155003062|NCT01145508|559434661|FG000|Overall Study|Adverse Event|1|||
155003063|NCT01145508|559434662|FG001|Overall Study|Adverse Event|0|||
155003064|NCT01145508|559434661|FG000|Overall Study|Death|1|||
155003065|NCT01145508|559434662|FG001|Overall Study|Death|0|||
155003066|NCT01145508|559434661|FG000|Overall Study|Physician Decision|2|||
155003067|NCT01145508|559434662|FG001|Overall Study|Physician Decision|1|||
155003068|NCT01145508|559434661|FG000|Overall Study|Never started treatment|1|||
155003069|NCT01145508|559434662|FG001|Overall Study|Never started treatment|1|||
155003070|NCT03055624|559434663|FG000|Overall Study|Study closed|9|||
155003071|NCT01524978|559434667|FG000|Overall Study|Other|16|||
155003072|NCT01524978|559434668|FG001|Overall Study|Other|2|||
155003073|NCT01524978|559434669|FG002|Overall Study|Other|1|||
155003074|NCT01524978|559434670|FG003|Overall Study|Other|2|||
155003075|NCT01524978|559434671|FG004|Overall Study|Other|1|||
155003076|NCT01524978|559434672|FG005|Overall Study|Other|3|||
155003077|NCT01524978|559434673|FG006|Overall Study|Other|17|||
155003078|NCT01524978|559434674|FG007|Overall Study|Other|1|||
155003079|NCT01524978|559434675|FG008|Overall Study|Other|2|||
155003080|NCT01524978|559434676|FG009|Overall Study|Other|2|||
155003081|NCT01524978|559434677|FG010|Overall Study|Other|5|||
155003082|NCT01524978|559434667|FG000|Overall Study|Withdrawal by Subject|12|||
155003083|NCT01524978|559434668|FG001|Overall Study|Withdrawal by Subject|0|||
155003084|NCT01524978|559434669|FG002|Overall Study|Withdrawal by Subject|1|||
155003085|NCT01524978|559434670|FG003|Overall Study|Withdrawal by Subject|1|||
155003086|NCT01524978|559434671|FG004|Overall Study|Withdrawal by Subject|3|||
155003087|NCT01524978|559434672|FG005|Overall Study|Withdrawal by Subject|1|||
155003088|NCT01524978|559434673|FG006|Overall Study|Withdrawal by Subject|6|||
155003089|NCT01524978|559434674|FG007|Overall Study|Withdrawal by Subject|2|||
155003090|NCT01524978|559434675|FG008|Overall Study|Withdrawal by Subject|4|||
155003091|NCT01524978|559434676|FG009|Overall Study|Withdrawal by Subject|0|||
155003092|NCT01524978|559434677|FG010|Overall Study|Withdrawal by Subject|5|||
155003093|NCT01524978|559434667|FG000|Overall Study|Lost to Follow-up|0|||
155003094|NCT01524978|559434668|FG001|Overall Study|Lost to Follow-up|0|||
155003095|NCT01524978|559434669|FG002|Overall Study|Lost to Follow-up|3|||
155003096|NCT01524978|559434670|FG003|Overall Study|Lost to Follow-up|0|||
155003097|NCT01524978|559434671|FG004|Overall Study|Lost to Follow-up|1|||
155003098|NCT01524978|559434672|FG005|Overall Study|Lost to Follow-up|1|||
155003099|NCT01524978|559434673|FG006|Overall Study|Lost to Follow-up|2|||
155003100|NCT01524978|559434674|FG007|Overall Study|Lost to Follow-up|0|||
155003101|NCT01524978|559434675|FG008|Overall Study|Lost to Follow-up|1|||
155003102|NCT01524978|559434676|FG009|Overall Study|Lost to Follow-up|1|||
155003103|NCT01524978|559434677|FG010|Overall Study|Lost to Follow-up|1|||
155003104|NCT01524978|559434667|FG000|Overall Study|Death|34|||
155003105|NCT01524978|559434668|FG001|Overall Study|Death|2|||
155003106|NCT01524978|559434669|FG002|Overall Study|Death|5|||
155003107|NCT01524978|559434670|FG003|Overall Study|Death|24|||
155003108|NCT01524978|559434671|FG004|Overall Study|Death|4|||
155003109|NCT01524978|559434672|FG005|Overall Study|Death|4|||
155003110|NCT01524978|559434673|FG006|Overall Study|Death|1|||
155003111|NCT01524978|559434674|FG007|Overall Study|Death|9|||
155003112|NCT01524978|559434675|FG008|Overall Study|Death|5|||
155003113|NCT01524978|559434676|FG009|Overall Study|Death|6|||
155003114|NCT01524978|559434677|FG010|Overall Study|Death|17|||
155003115|NCT02540083|559434682|FG000|Overall Study|Withdrawal by Subject|16|||
155003116|NCT05445492|559434685|FG000|Overall Study|Physician Decision|1|||
155003117|NCT03126435|559434690|FG000|Overall Study|Death|90|||
155003118|NCT03126435|559434691|FG001|Overall Study|Death|84|||
155003119|NCT03126435|559434690|FG000|Overall Study|Lost to Follow-up|4|||
155003120|NCT03126435|559434691|FG001|Overall Study|Lost to Follow-up|3|||
155003121|NCT03126435|559434690|FG000|Overall Study|Physician Decision|0|||
155003122|NCT03126435|559434691|FG001|Overall Study|Physician Decision|1|||
155003123|NCT03126435|559434690|FG000|Overall Study|Withdrawal by Subject|6|||
155003124|NCT03126435|559434691|FG001|Overall Study|Withdrawal by Subject|12|||
155003125|NCT03126435|559434690|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
155003126|NCT03126435|559434691|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
155003127|NCT01807065|559434692|FG000|Overall Study|Receive no sip-T due to IV access|1|||
155003128|NCT01807065|559434693|FG001|Overall Study|Receive no sip-T due to IV access|1|||
155003129|NCT01937871|559434695|FG000|Overall Study|Adverse Event|6|||
155003130|NCT01937871|559434696|FG001|Overall Study|Adverse Event|6|||
155003131|NCT01937871|559434697|FG002|Overall Study|Adverse Event|2|||
155003132|NCT01937871|559434695|FG000|Overall Study|Lost to Follow-up|8|||
155003133|NCT01937871|559434696|FG001|Overall Study|Lost to Follow-up|2|||
155003134|NCT01937871|559434697|FG002|Overall Study|Lost to Follow-up|4|||
155003135|NCT01937871|559434695|FG000|Overall Study|Withdrawal by Subject|9|||
155003136|NCT01937871|559434696|FG001|Overall Study|Withdrawal by Subject|6|||
155003137|NCT01937871|559434697|FG002|Overall Study|Withdrawal by Subject|4|||
155003138|NCT01937871|559434695|FG000|Overall Study|Physician Decision|0|||
155003139|NCT01937871|559434696|FG001|Overall Study|Physician Decision|1|||
155003140|NCT01937871|559434697|FG002|Overall Study|Physician Decision|0|||
155003141|NCT01937871|559434695|FG000|Overall Study|Entry Criteria Not Met|1|||
155003142|NCT01937871|559434696|FG001|Overall Study|Entry Criteria Not Met|2|||
155003143|NCT01937871|559434697|FG002|Overall Study|Entry Criteria Not Met|1|||
155003144|NCT01699815|559434698|FG000|Overall Study|Protocol Violation|4|||
155003145|NCT01699815|559434699|FG001|Overall Study|Protocol Violation|7|||
155003146|NCT01699815|559434698|FG000|Overall Study|record could not be located|1|||
155003147|NCT01699815|559434699|FG001|Overall Study|record could not be located|0|||
155003148|NCT01699815|559434698|FG000|Overall Study|Adverse Event|0|||
155003149|NCT01699815|559434699|FG001|Overall Study|Adverse Event|1|||
155003150|NCT00810511|559434700|FG000|Overall Study|Protocol Violation|0|||
155003151|NCT00810511|559434701|FG001|Overall Study|Protocol Violation|1|||
155003152|NCT00810511|559434700|FG000|Overall Study|Lack of Efficacy|9|||
155003153|NCT00810511|559434701|FG001|Overall Study|Lack of Efficacy|1|||
155003154|NCT00810511|559434700|FG000|Overall Study|death in the family|0|||
155003155|NCT00810511|559434701|FG001|Overall Study|death in the family|1|||
155003156|NCT00810511|559434700|FG000|Overall Study|Lost to Follow-up|1|||
155003157|NCT00810511|559434701|FG001|Overall Study|Lost to Follow-up|0|||
155003158|NCT00810511|559434700|FG000|Overall Study|deposits on contact lens|0|||
155003159|NCT00810511|559434701|FG001|Overall Study|deposits on contact lens|1|||
155003160|NCT00699816|559434702|FG000|Overall Study|Protocol Violation|1|||
155003161|NCT00699816|559434703|FG001|Overall Study|Protocol Violation|3|||
155003162|NCT02508935|559434704|FG000|Overall Study|Withdrawal by Subject|1|||
155003163|NCT02508935|559434704|FG000|Overall Study|Withdrawal by Caregiver|8|||
155003164|NCT02508935|559434704|FG000|Overall Study|Pain Score <4|1|||
155003165|NCT02508935|559434704|FG000|Overall Study|Emesis|3|||
155003166|NCT02508935|559434704|FG000|Overall Study|Adverse Event|3|||
155003167|NCT02508935|559434704|FG000|Overall Study|Protocol Violation|1|||
155003168|NCT02508935|559434704|FG000|Overall Study|Physician Decision|1|||
155003169|NCT02508935|559434704|FG000|Overall Study|Trial terminated by sponsor|5|||
155003170|NCT02800642|559434708|FG000|Overall Study|Death|3|||
155003171|NCT02800642|559434708|FG000|Overall Study|Other|10|||
155003172|NCT02800642|559434708|FG000|Overall Study|Physician Decision|2|||
155003173|NCT02800642|559434708|FG000|Overall Study|Adverse Event|6|||
155003174|NCT02800642|559434708|FG000|Overall Study|Withdrawal by Subject|3|||
155003175|NCT02800642|559434708|FG000|Overall Study|Lost to Follow-up|1|||
155003176|NCT05299528|559434712|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155003177|NCT05299528|559434713|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
155003178|NCT05299528|559434714|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155003179|NCT05299528|559434715|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155003180|NCT05299528|559434716|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155003181|NCT05299528|559434717|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155003182|NCT05299528|559434718|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
155003183|NCT05299528|559434712|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155003184|NCT05299528|559434713|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155003185|NCT05299528|559434714|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155003186|NCT05299528|559434715|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155003187|NCT05299528|559434716|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155003188|NCT05299528|559434717|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
155003189|NCT05299528|559434718|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
155003190|NCT05299528|559434712|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
155003191|NCT05299528|559434713|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
155003192|NCT05299528|559434714|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
155003193|NCT05299528|559434715|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
155003194|NCT05299528|559434716|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
155003195|NCT05299528|559434717|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
155003196|NCT05299528|559434718|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
155003197|NCT03097991|559434719|FG000|Overall Study|Didn't meet study criteria|8|||
155003198|NCT03097991|559434720|FG001|Overall Study|Didn't meet study criteria|0|||
155003199|NCT03097991|559434719|FG000|Overall Study|Withdrawal by Subject|12|||
155003200|NCT03097991|559434720|FG001|Overall Study|Withdrawal by Subject|6|||
155003201|NCT03097991|559434719|FG000|Overall Study|Death of Baby|3|||
155003202|NCT03097991|559434720|FG001|Overall Study|Death of Baby|1|||
155003203|NCT03097991|559434719|FG000|Overall Study|Lost to Follow-up|24|||
155003204|NCT03097991|559434720|FG001|Overall Study|Lost to Follow-up|38|||
155003205|NCT03097991|559434719|FG000|Overall Study|Adverse Event|3|||
155003206|NCT03097991|559434720|FG001|Overall Study|Adverse Event|5|||
155003207|NCT02006732|559434721|FG000|Overall Study|Adverse Event|10|||
155003208|NCT02006732|559434722|FG001|Overall Study|Adverse Event|7|||
155003209|NCT02006732|559434723|FG002|Overall Study|Adverse Event|4|||
155003210|NCT02006732|559434724|FG003|Overall Study|Adverse Event|2|||
155003211|NCT02006732|559434721|FG000|Overall Study|Lack of Efficacy|6|||
155003212|NCT02006732|559434722|FG001|Overall Study|Lack of Efficacy|3|||
155003213|NCT02006732|559434723|FG002|Overall Study|Lack of Efficacy|1|||
155003214|NCT02006732|559434724|FG003|Overall Study|Lack of Efficacy|1|||
155003215|NCT02006732|559434721|FG000|Overall Study|Protocol Violation|1|||
155003216|NCT02006732|559434722|FG001|Overall Study|Protocol Violation|1|||
155003217|NCT02006732|559434723|FG002|Overall Study|Protocol Violation|0|||
155003218|NCT02006732|559434724|FG003|Overall Study|Protocol Violation|0|||
155003219|NCT02006732|559434721|FG000|Overall Study|Lost to Follow-up|0|||
155003220|NCT02006732|559434722|FG001|Overall Study|Lost to Follow-up|1|||
155003221|NCT02006732|559434723|FG002|Overall Study|Lost to Follow-up|0|||
155003222|NCT02006732|559434724|FG003|Overall Study|Lost to Follow-up|0|||
155003223|NCT02006732|559434721|FG000|Overall Study|Withdrawal by Subject|3|||
155003224|NCT02006732|559434722|FG001|Overall Study|Withdrawal by Subject|0|||
155003225|NCT02006732|559434723|FG002|Overall Study|Withdrawal by Subject|4|||
155003226|NCT02006732|559434724|FG003|Overall Study|Withdrawal by Subject|1|||
155003227|NCT01755091|559434725|FG000|Overall Study|Withdrawal by Subject|6|||
155003228|NCT01755091|559434726|FG001|Overall Study|Withdrawal by Subject|1|||
155003229|NCT01755091|559434727|FG002|Overall Study|Withdrawal by Subject|3|||
155003230|NCT01755091|559434725|FG000|Overall Study|Adverse Event|1|||
155003231|NCT01755091|559434726|FG001|Overall Study|Adverse Event|1|||
155003232|NCT01755091|559434727|FG002|Overall Study|Adverse Event|1|||
155003233|NCT01755091|559434725|FG000|Overall Study|Lost to Follow-up|1|||
155003234|NCT01755091|559434726|FG001|Overall Study|Lost to Follow-up|0|||
155003235|NCT01755091|559434727|FG002|Overall Study|Lost to Follow-up|1|||
155003236|NCT01755091|559434725|FG000|Overall Study|Physician Decision|1|||
155003237|NCT01755091|559434726|FG001|Overall Study|Physician Decision|1|||
155003238|NCT01755091|559434727|FG002|Overall Study|Physician Decision|2|||
155003239|NCT00490841|559434728|FG000|Overall Study|Death|5|||
155003240|NCT00490841|559434728|FG000|Overall Study|Withdrawal by Subject|4|||
155003241|NCT00490841|559434728|FG000|Overall Study|Lost to Follow-up|1|||
155003242|NCT00490841|559434728|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
155003243|NCT03452943|559434729|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
155003244|NCT03452943|559434730|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
155003245|NCT03452943|559434729|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
155003246|NCT03452943|559434730|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
155003247|NCT03452943|559434729|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
155003248|NCT03452943|559434730|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
155003249|NCT03452943|559434729|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
155003250|NCT03452943|559434730|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
155003251|NCT03452943|559434729|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
155003252|NCT03452943|559434730|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
155003253|NCT03452943|559434729|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
155003254|NCT03452943|559434730|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
155003255|NCT01107197|559434737|FG000|Overall Study|Death|12|||
155003256|NCT01107197|559434738|FG001|Overall Study|Death|10|||
155003257|NCT01107197|559434737|FG000|Overall Study|Lost to Follow-up|5|||
155003258|NCT01107197|559434738|FG001|Overall Study|Lost to Follow-up|8|||
155003259|NCT01107197|559434737|FG000|Overall Study|Withdrawal by Subject|3|||
155003260|NCT01107197|559434738|FG001|Overall Study|Withdrawal by Subject|5|||
155003261|NCT04697069|559434739|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
155003262|NCT04697069|559434740|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
155003263|NCT04697069|559434739|FG000|Overall Study|Study termination|2|||
155003264|NCT04697069|559434740|FG001|Overall Study|Study termination|1|||
155003265|NCT05180227|559434741|FG000|Overall Study|Hypertension at screening|1|||
155125225|NCT00413010|559890592|FG001|Overall Study|Laboratory abnormality|2|||
155003266|NCT05180227|559434741|FG000|Overall Study|Lost to Follow-up|1|||
155003267|NCT01130597|559434743|FG000|Overall Study|Protocol-specified (High K+)|1|||
155003268|NCT01130597|559434743|FG000|Overall Study|Adverse Event|4|||
155003269|NCT01130597|559434743|FG000|Overall Study|Death|1|||
155003270|NCT01130597|559434743|FG000|Overall Study|Protocol Violation|1|||
155003271|NCT03371459|559434744|FG000|Washout|Lost to Follow-up|0|||
155003272|NCT03371459|559434745|FG001|Washout|Lost to Follow-up|1|||
155003273|NCT03071276|559434746|FG000|Overall Study|Adverse Event|1|||
155003274|NCT03071276|559434746|FG000|Overall Study|Lack of Efficacy|14|||
155003275|NCT02516553|559434749|FG000|Overall Study|Progressive disease|2|||
155003276|NCT02516553|559434750|FG001|Overall Study|Progressive disease|2|||
155003277|NCT02516553|559434751|FG002|Overall Study|Progressive disease|3|||
155003278|NCT02516553|559434752|FG003|Overall Study|Progressive disease|5|||
155003279|NCT02516553|559434753|FG004|Overall Study|Progressive disease|3|||
155003280|NCT02516553|559434754|FG005|Overall Study|Progressive disease|0|||
155003281|NCT02516553|559434755|FG006|Overall Study|Progressive disease|5|||
155003282|NCT02516553|559434756|FG007|Overall Study|Progressive disease|5|||
155003283|NCT02516553|559434757|FG008|Overall Study|Progressive disease|11|||
155003284|NCT02516553|559434758|FG009|Overall Study|Progressive disease|3|||
155003285|NCT02516553|559434759|FG010|Overall Study|Progressive disease|10|||
155003286|NCT02516553|559434760|FG011|Overall Study|Progressive disease|8|||
155003287|NCT02516553|559434761|FG012|Overall Study|Progressive disease|8|||
155003288|NCT02516553|559434762|FG013|Overall Study|Progressive disease|2|||
155003289|NCT02516553|559434763|FG014|Overall Study|Progressive disease|2|||
155003290|NCT02516553|559434764|FG015|Overall Study|Progressive disease|2|||
155003291|NCT02516553|559434765|FG016|Overall Study|Progressive disease|1|||
155003292|NCT02516553|559434766|FG017|Overall Study|Progressive disease|9|||
155003293|NCT02516553|559434767|FG018|Overall Study|Progressive disease|12|||
155003294|NCT02516553|559434768|FG019|Overall Study|Progressive disease|7|||
155003295|NCT02516553|559434769|FG020|Overall Study|Progressive disease|16|||
155003296|NCT02516553|559434770|FG021|Overall Study|Progressive disease|18|||
155003297|NCT02516553|559434749|FG000|Overall Study|Dose limiting toxicity|0|||
155178095|NCT00420641|560091397|FG001|Overall Study|Adverse Event|25|||
155178096|NCT00420641|560091398|FG002|Overall Study|Adverse Event|10|||
154922777|NCT01049360|559142182|FG000|Period 1|Adverse Event|0|||
154922778|NCT01049360|559142183|FG001|Period 1|Adverse Event|1|||
154922779|NCT01049360|559142184|FG002|Period 1|Adverse Event|0|||
154922780|NCT01049360|559142185|FG003|Period 1|Adverse Event|1|||
154922781|NCT01049360|559142186|FG004|Period 1|Adverse Event|0|||
154922782|NCT01049360|559142187|FG005|Period 1|Adverse Event|0|||
154922783|NCT01049360|559142188|FG006|Period 1|Adverse Event|0|||
154922784|NCT01049360|559142189|FG007|Period 1|Adverse Event|1|||
154922785|NCT01049360|559142190|FG008|Period 1|Adverse Event|0|||
154922786|NCT01049360|559142191|FG009|Period 1|Adverse Event|0|||
154922787|NCT01049360|559142192|FG010|Period 1|Adverse Event|0|||
154922788|NCT01049360|559142193|FG011|Period 1|Adverse Event|0|||
154922789|NCT01049360|559142194|FG012|Period 1|Adverse Event|1|||
154922790|NCT01049360|559142195|FG013|Period 1|Adverse Event|1|||
154922791|NCT01049360|559142196|FG014|Period 1|Adverse Event|0|||
154922792|NCT01049360|559142197|FG015|Period 1|Adverse Event|0|||
154922793|NCT01049360|559142198|FG016|Period 1|Adverse Event|1|||
154922794|NCT01049360|559142199|FG017|Period 1|Adverse Event|0|||
154922795|NCT01049360|559142200|FG018|Period 1|Adverse Event|1|||
154922796|NCT01049360|559142201|FG019|Period 1|Adverse Event|0|||
154922797|NCT01049360|559142182|FG000|Period 1|Did not meet inc/exc criteria|0|||
154922798|NCT01049360|559142183|FG001|Period 1|Did not meet inc/exc criteria|0|||
154922799|NCT01049360|559142184|FG002|Period 1|Did not meet inc/exc criteria|0|||
154922800|NCT01049360|559142185|FG003|Period 1|Did not meet inc/exc criteria|0|||
154922801|NCT01049360|559142186|FG004|Period 1|Did not meet inc/exc criteria|0|||
154922802|NCT01049360|559142187|FG005|Period 1|Did not meet inc/exc criteria|0|||
154922803|NCT01049360|559142188|FG006|Period 1|Did not meet inc/exc criteria|0|||
154922804|NCT01049360|559142189|FG007|Period 1|Did not meet inc/exc criteria|1|||
154922805|NCT01049360|559142190|FG008|Period 1|Did not meet inc/exc criteria|1|||
154922806|NCT01049360|559142191|FG009|Period 1|Did not meet inc/exc criteria|0|||
154922807|NCT01049360|559142192|FG010|Period 1|Did not meet inc/exc criteria|0|||
154922808|NCT01049360|559142193|FG011|Period 1|Did not meet inc/exc criteria|0|||
154922809|NCT01049360|559142194|FG012|Period 1|Did not meet inc/exc criteria|0|||
154922810|NCT01049360|559142195|FG013|Period 1|Did not meet inc/exc criteria|0|||
154922811|NCT01049360|559142196|FG014|Period 1|Did not meet inc/exc criteria|0|||
154922812|NCT01049360|559142197|FG015|Period 1|Did not meet inc/exc criteria|0|||
154922813|NCT01049360|559142198|FG016|Period 1|Did not meet inc/exc criteria|0|||
154922814|NCT01049360|559142199|FG017|Period 1|Did not meet inc/exc criteria|0|||
154922815|NCT01049360|559142200|FG018|Period 1|Did not meet inc/exc criteria|0|||
154922816|NCT01049360|559142201|FG019|Period 1|Did not meet inc/exc criteria|0|||
154922817|NCT01049360|559142182|FG000|Period 1|Withdrawal by Subject|0|||
154922818|NCT01049360|559142183|FG001|Period 1|Withdrawal by Subject|0|||
154922819|NCT01049360|559142184|FG002|Period 1|Withdrawal by Subject|0|||
154922820|NCT01049360|559142185|FG003|Period 1|Withdrawal by Subject|0|||
154922821|NCT01049360|559142186|FG004|Period 1|Withdrawal by Subject|0|||
154922822|NCT01049360|559142187|FG005|Period 1|Withdrawal by Subject|0|||
154922823|NCT01049360|559142188|FG006|Period 1|Withdrawal by Subject|0|||
154922824|NCT01049360|559142189|FG007|Period 1|Withdrawal by Subject|0|||
154922825|NCT01049360|559142190|FG008|Period 1|Withdrawal by Subject|1|||
154922826|NCT01049360|559142191|FG009|Period 1|Withdrawal by Subject|0|||
154922827|NCT01049360|559142192|FG010|Period 1|Withdrawal by Subject|1|||
154922828|NCT01049360|559142193|FG011|Period 1|Withdrawal by Subject|0|||
154922829|NCT01049360|559142194|FG012|Period 1|Withdrawal by Subject|1|||
154922830|NCT01049360|559142195|FG013|Period 1|Withdrawal by Subject|0|||
154922831|NCT01049360|559142196|FG014|Period 1|Withdrawal by Subject|0|||
154922832|NCT01049360|559142197|FG015|Period 1|Withdrawal by Subject|0|||
154922833|NCT01049360|559142198|FG016|Period 1|Withdrawal by Subject|0|||
154922834|NCT01049360|559142199|FG017|Period 1|Withdrawal by Subject|0|||
154922835|NCT01049360|559142200|FG018|Period 1|Withdrawal by Subject|0|||
154922836|NCT01049360|559142201|FG019|Period 1|Withdrawal by Subject|0|||
154922837|NCT01049360|559142182|FG000|Period 2|Protocol Violation|0|||
154922838|NCT01049360|559142183|FG001|Period 2|Protocol Violation|0|||
155003298|NCT02516553|559434750|FG001|Overall Study|Dose limiting toxicity|0|||
155003299|NCT02516553|559434751|FG002|Overall Study|Dose limiting toxicity|0|||
155003300|NCT02516553|559434752|FG003|Overall Study|Dose limiting toxicity|0|||
155003301|NCT02516553|559434753|FG004|Overall Study|Dose limiting toxicity|3|||
155003302|NCT02516553|559434754|FG005|Overall Study|Dose limiting toxicity|1|||
154922839|NCT01049360|559142184|FG002|Period 2|Protocol Violation|0|||
154922840|NCT01049360|559142185|FG003|Period 2|Protocol Violation|1|||
154922841|NCT01049360|559142186|FG004|Period 2|Protocol Violation|0|||
154922842|NCT01049360|559142187|FG005|Period 2|Protocol Violation|0|||
154922843|NCT01049360|559142188|FG006|Period 2|Protocol Violation|0|||
154922844|NCT01049360|559142189|FG007|Period 2|Protocol Violation|0|||
154922845|NCT01049360|559142190|FG008|Period 2|Protocol Violation|0|||
154922846|NCT01049360|559142191|FG009|Period 2|Protocol Violation|0|||
154922847|NCT01049360|559142192|FG010|Period 2|Protocol Violation|0|||
154922848|NCT01049360|559142193|FG011|Period 2|Protocol Violation|0|||
154922849|NCT01049360|559142194|FG012|Period 2|Protocol Violation|0|||
154922850|NCT01049360|559142195|FG013|Period 2|Protocol Violation|0|||
154922851|NCT01049360|559142196|FG014|Period 2|Protocol Violation|1|||
154922852|NCT01049360|559142197|FG015|Period 2|Protocol Violation|1|||
154922853|NCT01049360|559142198|FG016|Period 2|Protocol Violation|0|||
154922854|NCT01049360|559142199|FG017|Period 2|Protocol Violation|0|||
154922855|NCT01049360|559142200|FG018|Period 2|Protocol Violation|0|||
154922856|NCT01049360|559142201|FG019|Period 2|Protocol Violation|0|||
154922857|NCT01049360|559142182|FG000|Period 2|Adverse Event|0|||
154922858|NCT01049360|559142183|FG001|Period 2|Adverse Event|1|||
154922859|NCT01049360|559142184|FG002|Period 2|Adverse Event|0|||
154922860|NCT01049360|559142185|FG003|Period 2|Adverse Event|0|||
154922861|NCT01049360|559142186|FG004|Period 2|Adverse Event|0|||
154922862|NCT01049360|559142187|FG005|Period 2|Adverse Event|0|||
154922863|NCT01049360|559142188|FG006|Period 2|Adverse Event|0|||
154922864|NCT01049360|559142189|FG007|Period 2|Adverse Event|0|||
154922865|NCT01049360|559142190|FG008|Period 2|Adverse Event|1|||
154922866|NCT01049360|559142191|FG009|Period 2|Adverse Event|0|||
154922867|NCT01049360|559142192|FG010|Period 2|Adverse Event|0|||
154922868|NCT01049360|559142193|FG011|Period 2|Adverse Event|0|||
154922869|NCT01049360|559142194|FG012|Period 2|Adverse Event|0|||
154922870|NCT01049360|559142195|FG013|Period 2|Adverse Event|0|||
154922871|NCT01049360|559142196|FG014|Period 2|Adverse Event|0|||
154922872|NCT01049360|559142197|FG015|Period 2|Adverse Event|0|||
154922873|NCT01049360|559142198|FG016|Period 2|Adverse Event|0|||
154922874|NCT01049360|559142199|FG017|Period 2|Adverse Event|0|||
154922875|NCT01049360|559142200|FG018|Period 2|Adverse Event|0|||
154922876|NCT01049360|559142201|FG019|Period 2|Adverse Event|1|||
154922877|NCT01049360|559142182|FG000|Period 2|Withdrawal by Subject|0|||
154922878|NCT01049360|559142183|FG001|Period 2|Withdrawal by Subject|0|||
154922879|NCT01049360|559142184|FG002|Period 2|Withdrawal by Subject|0|||
154922880|NCT01049360|559142185|FG003|Period 2|Withdrawal by Subject|1|||
154922881|NCT01049360|559142186|FG004|Period 2|Withdrawal by Subject|0|||
154922882|NCT01049360|559142187|FG005|Period 2|Withdrawal by Subject|0|||
154922883|NCT01049360|559142188|FG006|Period 2|Withdrawal by Subject|0|||
154922884|NCT01049360|559142189|FG007|Period 2|Withdrawal by Subject|0|||
154922885|NCT01049360|559142190|FG008|Period 2|Withdrawal by Subject|0|||
154922886|NCT01049360|559142191|FG009|Period 2|Withdrawal by Subject|0|||
154922887|NCT01049360|559142192|FG010|Period 2|Withdrawal by Subject|0|||
154922888|NCT01049360|559142193|FG011|Period 2|Withdrawal by Subject|0|||
154922889|NCT01049360|559142194|FG012|Period 2|Withdrawal by Subject|0|||
154922890|NCT01049360|559142195|FG013|Period 2|Withdrawal by Subject|0|||
154922891|NCT01049360|559142196|FG014|Period 2|Withdrawal by Subject|1|||
154922892|NCT01049360|559142197|FG015|Period 2|Withdrawal by Subject|0|||
154922893|NCT01049360|559142198|FG016|Period 2|Withdrawal by Subject|0|||
154922894|NCT01049360|559142199|FG017|Period 2|Withdrawal by Subject|0|||
154922895|NCT01049360|559142200|FG018|Period 2|Withdrawal by Subject|0|||
154922896|NCT01049360|559142201|FG019|Period 2|Withdrawal by Subject|1|||
154922897|NCT01049360|559142182|FG000|Period 2|Lack of Efficacy|0|||
154922898|NCT01049360|559142183|FG001|Period 2|Lack of Efficacy|0|||
154922899|NCT01049360|559142184|FG002|Period 2|Lack of Efficacy|0|||
154922900|NCT01049360|559142185|FG003|Period 2|Lack of Efficacy|0|||
154922901|NCT01049360|559142186|FG004|Period 2|Lack of Efficacy|0|||
154922902|NCT01049360|559142187|FG005|Period 2|Lack of Efficacy|1|||
154922903|NCT01049360|559142188|FG006|Period 2|Lack of Efficacy|0|||
154922904|NCT01049360|559142189|FG007|Period 2|Lack of Efficacy|0|||
154922905|NCT01049360|559142190|FG008|Period 2|Lack of Efficacy|0|||
154922906|NCT01049360|559142191|FG009|Period 2|Lack of Efficacy|0|||
154922907|NCT01049360|559142192|FG010|Period 2|Lack of Efficacy|0|||
154922908|NCT01049360|559142193|FG011|Period 2|Lack of Efficacy|0|||
154922909|NCT01049360|559142194|FG012|Period 2|Lack of Efficacy|0|||
154922910|NCT01049360|559142195|FG013|Period 2|Lack of Efficacy|0|||
154922911|NCT01049360|559142196|FG014|Period 2|Lack of Efficacy|0|||
154922912|NCT01049360|559142197|FG015|Period 2|Lack of Efficacy|0|||
154922913|NCT01049360|559142198|FG016|Period 2|Lack of Efficacy|0|||
154922914|NCT01049360|559142199|FG017|Period 2|Lack of Efficacy|0|||
154922915|NCT01049360|559142200|FG018|Period 2|Lack of Efficacy|0|||
154922916|NCT01049360|559142201|FG019|Period 2|Lack of Efficacy|0|||
154922917|NCT01049360|559142182|FG000|Period 4|Protocol Violation|0|||
155003303|NCT02516553|559434755|FG006|Overall Study|Dose limiting toxicity|1|||
155003304|NCT02516553|559434756|FG007|Overall Study|Dose limiting toxicity|0|||
155003305|NCT02516553|559434757|FG008|Overall Study|Dose limiting toxicity|1|||
155003306|NCT02516553|559434758|FG009|Overall Study|Dose limiting toxicity|0|||
155003307|NCT02516553|559434759|FG010|Overall Study|Dose limiting toxicity|0|||
155003308|NCT02516553|559434760|FG011|Overall Study|Dose limiting toxicity|1|||
155003309|NCT02516553|559434761|FG012|Overall Study|Dose limiting toxicity|0|||
155003310|NCT02516553|559434762|FG013|Overall Study|Dose limiting toxicity|1|||
155003311|NCT02516553|559434763|FG014|Overall Study|Dose limiting toxicity|0|||
155003312|NCT02516553|559434764|FG015|Overall Study|Dose limiting toxicity|0|||
155003313|NCT02516553|559434765|FG016|Overall Study|Dose limiting toxicity|1|||
155003314|NCT02516553|559434766|FG017|Overall Study|Dose limiting toxicity|1|||
155003315|NCT02516553|559434767|FG018|Overall Study|Dose limiting toxicity|0|||
155003316|NCT02516553|559434768|FG019|Overall Study|Dose limiting toxicity|2|||
155003317|NCT02516553|559434769|FG020|Overall Study|Dose limiting toxicity|0|||
155003318|NCT02516553|559434770|FG021|Overall Study|Dose limiting toxicity|0|||
155003319|NCT02516553|559434749|FG000|Overall Study|Other Adverse Events|0|||
155003320|NCT02516553|559434750|FG001|Overall Study|Other Adverse Events|0|||
155003321|NCT02516553|559434751|FG002|Overall Study|Other Adverse Events|0|||
155003322|NCT02516553|559434752|FG003|Overall Study|Other Adverse Events|1|||
155003323|NCT02516553|559434753|FG004|Overall Study|Other Adverse Events|0|||
155003324|NCT02516553|559434754|FG005|Overall Study|Other Adverse Events|1|||
155003325|NCT02516553|559434755|FG006|Overall Study|Other Adverse Events|0|||
155003326|NCT02516553|559434756|FG007|Overall Study|Other Adverse Events|0|||
155003327|NCT02516553|559434757|FG008|Overall Study|Other Adverse Events|0|||
155003328|NCT02516553|559434758|FG009|Overall Study|Other Adverse Events|1|||
155003329|NCT02516553|559434759|FG010|Overall Study|Other Adverse Events|3|||
155003330|NCT02516553|559434760|FG011|Overall Study|Other Adverse Events|2|||
155003331|NCT02516553|559434761|FG012|Overall Study|Other Adverse Events|0|||
155003332|NCT02516553|559434762|FG013|Overall Study|Other Adverse Events|1|||
155003333|NCT02516553|559434763|FG014|Overall Study|Other Adverse Events|0|||
155003334|NCT02516553|559434764|FG015|Overall Study|Other Adverse Events|0|||
155003335|NCT02516553|559434765|FG016|Overall Study|Other Adverse Events|0|||
155003336|NCT02516553|559434766|FG017|Overall Study|Other Adverse Events|2|||
155003337|NCT02516553|559434767|FG018|Overall Study|Other Adverse Events|1|||
155003338|NCT02516553|559434768|FG019|Overall Study|Other Adverse Events|2|||
155003339|NCT02516553|559434769|FG020|Overall Study|Other Adverse Events|2|||
155003340|NCT02516553|559434770|FG021|Overall Study|Other Adverse Events|1|||
155003341|NCT02516553|559434749|FG000|Overall Study|Refused to continue trial medication|0|||
155003342|NCT02516553|559434750|FG001|Overall Study|Refused to continue trial medication|0|||
155003343|NCT02516553|559434751|FG002|Overall Study|Refused to continue trial medication|0|||
155003344|NCT02516553|559434752|FG003|Overall Study|Refused to continue trial medication|0|||
155003345|NCT02516553|559434753|FG004|Overall Study|Refused to continue trial medication|0|||
155003346|NCT02516553|559434754|FG005|Overall Study|Refused to continue trial medication|0|||
155003347|NCT02516553|559434755|FG006|Overall Study|Refused to continue trial medication|0|||
155003348|NCT02516553|559434756|FG007|Overall Study|Refused to continue trial medication|0|||
155003349|NCT02516553|559434757|FG008|Overall Study|Refused to continue trial medication|0|||
155003350|NCT02516553|559434758|FG009|Overall Study|Refused to continue trial medication|0|||
155003351|NCT02516553|559434759|FG010|Overall Study|Refused to continue trial medication|1|||
155003352|NCT02516553|559434760|FG011|Overall Study|Refused to continue trial medication|0|||
155003353|NCT02516553|559434761|FG012|Overall Study|Refused to continue trial medication|0|||
155003354|NCT02516553|559434762|FG013|Overall Study|Refused to continue trial medication|0|||
155003355|NCT02516553|559434763|FG014|Overall Study|Refused to continue trial medication|0|||
155003356|NCT02516553|559434764|FG015|Overall Study|Refused to continue trial medication|0|||
155003357|NCT02516553|559434765|FG016|Overall Study|Refused to continue trial medication|0|||
155003358|NCT02516553|559434766|FG017|Overall Study|Refused to continue trial medication|0|||
155003359|NCT02516553|559434767|FG018|Overall Study|Refused to continue trial medication|1|||
155003360|NCT02516553|559434768|FG019|Overall Study|Refused to continue trial medication|0|||
155125226|NCT00413010|559890591|FG000|Overall Study|Lack of Efficacy|0|||
155125227|NCT00413010|559890592|FG001|Overall Study|Lack of Efficacy|3|||
155125228|NCT00413010|559890591|FG000|Overall Study|Lost to Follow-up|3|||
155125229|NCT00413010|559890592|FG001|Overall Study|Lost to Follow-up|0|||
155125230|NCT00413010|559890591|FG000|Overall Study|Withdrawal by Subject|7|||
155003361|NCT02516553|559434769|FG020|Overall Study|Refused to continue trial medication|0|||
155003362|NCT02516553|559434770|FG021|Overall Study|Refused to continue trial medication|1|||
155125231|NCT00413010|559890592|FG001|Overall Study|Withdrawal by Subject|2|||
155003363|NCT02516553|559434749|FG000|Overall Study|other reasons than listed|0|||
155003364|NCT02516553|559434750|FG001|Overall Study|other reasons than listed|0|||
155003365|NCT02516553|559434751|FG002|Overall Study|other reasons than listed|0|||
155003366|NCT02516553|559434752|FG003|Overall Study|other reasons than listed|0|||
155003367|NCT02516553|559434753|FG004|Overall Study|other reasons than listed|0|||
155003368|NCT02516553|559434754|FG005|Overall Study|other reasons than listed|0|||
155003369|NCT02516553|559434755|FG006|Overall Study|other reasons than listed|0|||
155003370|NCT02516553|559434756|FG007|Overall Study|other reasons than listed|1|||
155003371|NCT02516553|559434757|FG008|Overall Study|other reasons than listed|1|||
155003372|NCT02516553|559434758|FG009|Overall Study|other reasons than listed|0|||
155003373|NCT02516553|559434759|FG010|Overall Study|other reasons than listed|1|||
155003374|NCT02516553|559434760|FG011|Overall Study|other reasons than listed|1|||
155003375|NCT02516553|559434761|FG012|Overall Study|other reasons than listed|0|||
155003376|NCT02516553|559434762|FG013|Overall Study|other reasons than listed|0|||
155003377|NCT02516553|559434763|FG014|Overall Study|other reasons than listed|0|||
154922918|NCT01049360|559142183|FG001|Period 4|Protocol Violation|0|||
154922919|NCT01049360|559142184|FG002|Period 4|Protocol Violation|0|||
154922920|NCT01049360|559142185|FG003|Period 4|Protocol Violation|0|||
154922921|NCT01049360|559142186|FG004|Period 4|Protocol Violation|0|||
154922922|NCT01049360|559142187|FG005|Period 4|Protocol Violation|0|||
154922923|NCT01049360|559142188|FG006|Period 4|Protocol Violation|0|||
154922924|NCT01049360|559142189|FG007|Period 4|Protocol Violation|0|||
154922925|NCT01049360|559142190|FG008|Period 4|Protocol Violation|0|||
154922926|NCT01049360|559142191|FG009|Period 4|Protocol Violation|0|||
154922927|NCT01049360|559142192|FG010|Period 4|Protocol Violation|0|||
154922928|NCT01049360|559142193|FG011|Period 4|Protocol Violation|0|||
154922929|NCT01049360|559142194|FG012|Period 4|Protocol Violation|0|||
154922930|NCT01049360|559142195|FG013|Period 4|Protocol Violation|0|||
154922931|NCT01049360|559142196|FG014|Period 4|Protocol Violation|0|||
154922932|NCT01049360|559142197|FG015|Period 4|Protocol Violation|0|||
154922933|NCT01049360|559142198|FG016|Period 4|Protocol Violation|0|||
154922934|NCT01049360|559142199|FG017|Period 4|Protocol Violation|1|||
154922935|NCT01049360|559142200|FG018|Period 4|Protocol Violation|0|||
154922936|NCT01049360|559142201|FG019|Period 4|Protocol Violation|0|||
154922937|NCT01049360|559142182|FG000|Period 4|Withdrawal by Subject|0|||
155003378|NCT02516553|559434764|FG015|Overall Study|other reasons than listed|0|||
155003379|NCT02516553|559434765|FG016|Overall Study|other reasons than listed|0|||
155003380|NCT02516553|559434766|FG017|Overall Study|other reasons than listed|0|||
155003381|NCT02516553|559434767|FG018|Overall Study|other reasons than listed|0|||
155003382|NCT02516553|559434768|FG019|Overall Study|other reasons than listed|0|||
155003383|NCT02516553|559434769|FG020|Overall Study|other reasons than listed|2|||
155003384|NCT02516553|559434770|FG021|Overall Study|other reasons than listed|2|||
155003385|NCT03052127|559434771|FG000|Overall Study|Withdrawal by Subject|0|||
155003386|NCT03052127|559434772|FG001|Overall Study|Withdrawal by Subject|0|||
155003387|NCT03052127|559434773|FG002|Overall Study|Withdrawal by Subject|0|||
155003388|NCT03052127|559434774|FG003|Overall Study|Withdrawal by Subject|0|||
155003389|NCT03052127|559434775|FG004|Overall Study|Withdrawal by Subject|0|||
155003390|NCT03052127|559434776|FG005|Overall Study|Withdrawal by Subject|0|||
155003391|NCT03052127|559434777|FG006|Overall Study|Withdrawal by Subject|0|||
155003392|NCT03052127|559434778|FG007|Overall Study|Withdrawal by Subject|1|||
155003393|NCT03052127|559434779|FG008|Overall Study|Withdrawal by Subject|1|||
155003394|NCT03052127|559434780|FG009|Overall Study|Withdrawal by Subject|1|||
155003395|NCT03052127|559434781|FG010|Overall Study|Withdrawal by Subject|0|||
155003396|NCT03052127|559434782|FG011|Overall Study|Withdrawal by Subject|0|||
155003397|NCT03052127|559434771|FG000|Overall Study|Discontinuation by Sponsor|0|||
155003398|NCT03052127|559434772|FG001|Overall Study|Discontinuation by Sponsor|0|||
155003399|NCT03052127|559434773|FG002|Overall Study|Discontinuation by Sponsor|0|||
155003400|NCT03052127|559434774|FG003|Overall Study|Discontinuation by Sponsor|0|||
155003401|NCT03052127|559434775|FG004|Overall Study|Discontinuation by Sponsor|0|||
155003402|NCT03052127|559434776|FG005|Overall Study|Discontinuation by Sponsor|0|||
155003403|NCT03052127|559434777|FG006|Overall Study|Discontinuation by Sponsor|0|||
155003404|NCT03052127|559434778|FG007|Overall Study|Discontinuation by Sponsor|0|||
155003405|NCT03052127|559434779|FG008|Overall Study|Discontinuation by Sponsor|4|||
155003406|NCT03052127|559434780|FG009|Overall Study|Discontinuation by Sponsor|2|||
155178097|NCT00420641|560091396|FG000|Overall Study|Lost to Follow-up|2|||
155178098|NCT00420641|560091397|FG001|Overall Study|Lost to Follow-up|4|||
155178099|NCT00420641|560091398|FG002|Overall Study|Lost to Follow-up|2|||
155178100|NCT00420641|560091396|FG000|Overall Study|Protocol Violation|8|||
155003407|NCT03052127|559434781|FG010|Overall Study|Discontinuation by Sponsor|5|||
155003408|NCT03052127|559434782|FG011|Overall Study|Discontinuation by Sponsor|13|||
155003409|NCT03052127|559434771|FG000|Overall Study|Inability to comply with trial requirements|0|||
155003410|NCT03052127|559434772|FG001|Overall Study|Inability to comply with trial requirements|0|||
155003411|NCT03052127|559434773|FG002|Overall Study|Inability to comply with trial requirements|1|||
155003412|NCT03052127|559434774|FG003|Overall Study|Inability to comply with trial requirements|0|||
155003413|NCT03052127|559434775|FG004|Overall Study|Inability to comply with trial requirements|0|||
155003414|NCT03052127|559434776|FG005|Overall Study|Inability to comply with trial requirements|0|||
155003415|NCT03052127|559434777|FG006|Overall Study|Inability to comply with trial requirements|0|||
155003416|NCT03052127|559434778|FG007|Overall Study|Inability to comply with trial requirements|0|||
155178101|NCT00420641|560091397|FG001|Overall Study|Protocol Violation|8|||
155178102|NCT00420641|560091398|FG002|Overall Study|Protocol Violation|7|||
154922938|NCT01049360|559142183|FG001|Period 4|Withdrawal by Subject|0|||
154922939|NCT01049360|559142184|FG002|Period 4|Withdrawal by Subject|0|||
155003417|NCT03052127|559434779|FG008|Overall Study|Inability to comply with trial requirements|0|||
155003418|NCT03052127|559434780|FG009|Overall Study|Inability to comply with trial requirements|0|||
155003419|NCT03052127|559434781|FG010|Overall Study|Inability to comply with trial requirements|0|||
155003420|NCT03052127|559434782|FG011|Overall Study|Inability to comply with trial requirements|0|||
155003421|NCT03052127|559434771|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155003422|NCT03052127|559434772|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003423|NCT03052127|559434773|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003424|NCT03052127|559434774|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003425|NCT03052127|559434775|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155003426|NCT03052127|559434776|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155003427|NCT03052127|559434777|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
155003428|NCT03052127|559434778|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003429|NCT03052127|559434779|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003430|NCT03052127|559434780|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003431|NCT03052127|559434781|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003432|NCT03052127|559434782|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
155003433|NCT03694327|559434783|FG000|Overall Study|Lost to Follow-up|13|||
155003434|NCT03694327|559434784|FG001|Overall Study|Lost to Follow-up|23|||
155003435|NCT02185053|559434785|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
155003436|NCT02185053|559434786|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
155003437|NCT02185053|559434787|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
155003438|NCT02185053|559434785|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
155003439|NCT02185053|559434786|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155003440|NCT02185053|559434787|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155003441|NCT02185053|559434785|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
155003442|NCT02185053|559434786|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
155003443|NCT02185053|559434787|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
155003444|NCT02185053|559434785|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
155003445|NCT02185053|559434786|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
155003446|NCT02185053|559434787|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
155003447|NCT02185053|559434785|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155003448|NCT02185053|559434786|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
155003449|NCT02185053|559434787|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
155003450|NCT02185053|559434785|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
155003451|NCT02185053|559434786|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
155003452|NCT02185053|559434787|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
155003453|NCT02185053|559434785|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
155003454|NCT02185053|559434786|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
155003455|NCT02185053|559434787|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
155003456|NCT02185053|559434785|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
155003457|NCT02185053|559434786|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
155003458|NCT02185053|559434787|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
155003459|NCT05109611|559436643|FG000|Overall Study|Adverse Event|13|||
155003460|NCT05109611|559436644|FG001|Overall Study|Adverse Event|10|||
155003461|NCT05109611|559436643|FG000|Overall Study|Withdrawal by Subject|1|||
155003462|NCT05109611|559436644|FG001|Overall Study|Withdrawal by Subject|0|||
155003463|NCT05109611|559436643|FG000|Overall Study|Lost to Follow-up|1|||
155003464|NCT05109611|559436644|FG001|Overall Study|Lost to Follow-up|2|||
155003465|NCT05109611|559436643|FG000|Overall Study|Protocol Violation|0|||
155003466|NCT05109611|559436644|FG001|Overall Study|Protocol Violation|4|||
155003467|NCT05109611|559436643|FG000|Overall Study|Information unavailable|1|||
155003468|NCT05109611|559436644|FG001|Overall Study|Information unavailable|1|||
155003469|NCT03203850|559436648|FG000|Overall Study|Subject/guardian decision|4|||
155003470|NCT03203850|559436649|FG001|Overall Study|Subject/guardian decision|3|||
155003471|NCT03203850|559436648|FG000|Overall Study|Adverse Event|3|||
155003472|NCT03203850|559436649|FG001|Overall Study|Adverse Event|0|||
155003473|NCT03203850|559436648|FG000|Overall Study|Death|1|||
155003474|NCT03203850|559436649|FG001|Overall Study|Death|0|||
155003475|NCT02717455|559436650|FG000|Overall Study|Adverse Event|1|||
155003476|NCT02717455|559436651|FG001|Overall Study|Adverse Event|0|||
155003477|NCT02717455|559436652|FG002|Overall Study|Adverse Event|0|||
155003478|NCT02717455|559436653|FG003|Overall Study|Adverse Event|2|||
155003479|NCT02717455|559436654|FG004|Overall Study|Adverse Event|2|||
155003480|NCT02717455|559436655|FG005|Overall Study|Adverse Event|2|||
155003481|NCT02717455|559436650|FG000|Overall Study|Withdrawal by Subject|1|||
155003482|NCT02717455|559436651|FG001|Overall Study|Withdrawal by Subject|1|||
155003483|NCT02717455|559436652|FG002|Overall Study|Withdrawal by Subject|0|||
155003484|NCT02717455|559436653|FG003|Overall Study|Withdrawal by Subject|2|||
155003485|NCT02717455|559436654|FG004|Overall Study|Withdrawal by Subject|2|||
155003486|NCT02717455|559436655|FG005|Overall Study|Withdrawal by Subject|1|||
155003487|NCT02717455|559436650|FG000|Overall Study|Death|1|||
155003488|NCT02717455|559436651|FG001|Overall Study|Death|0|||
155003489|NCT02717455|559436652|FG002|Overall Study|Death|0|||
155003490|NCT02717455|559436653|FG003|Overall Study|Death|0|||
155003491|NCT02717455|559436654|FG004|Overall Study|Death|1|||
155003492|NCT02717455|559436655|FG005|Overall Study|Death|0|||
155003493|NCT02717455|559436650|FG000|Overall Study|Did not receive study drug|0|||
155003494|NCT02717455|559436651|FG001|Overall Study|Did not receive study drug|0|||
155003495|NCT02717455|559436652|FG002|Overall Study|Did not receive study drug|0|||
155003496|NCT02717455|559436653|FG003|Overall Study|Did not receive study drug|1|||
155003497|NCT02717455|559436654|FG004|Overall Study|Did not receive study drug|0|||
155003498|NCT02717455|559436655|FG005|Overall Study|Did not receive study drug|1|||
155003499|NCT02717455|559436650|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155003500|NCT02717455|559436651|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155003501|NCT02717455|559436652|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155003502|NCT02717455|559436653|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155003503|NCT02717455|559436654|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
155003504|NCT02717455|559436655|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
155003505|NCT02717455|559436650|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
155003506|NCT02717455|559436651|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
155003507|NCT02717455|559436652|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
155003508|NCT02717455|559436653|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
155003509|NCT02717455|559436654|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
155003510|NCT02717455|559436655|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
155003511|NCT01769456|559436656|FG000|Overall Study|Lost to Follow-up|19|||
155003512|NCT01769456|559436656|FG000|Overall Study|Withdrawal by Subject|3|||
155003513|NCT01769456|559436656|FG000|Overall Study|Did not receive PCC intervention|6|||
155003514|NCT01769456|559436656|FG000|Overall Study|Moved out of the area|3|||
155003515|NCT01769456|559436656|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
155003516|NCT01769456|559436656|FG000|Overall Study|Parental request to youth to withdraw|1|||
155003517|NCT05244122|559436659|FG000|Overall Study|Withdrawal by Subject|318|||
155003518|NCT00615199|559436660|FG000|Overall Study|Adverse Event|3|||
155003519|NCT00615199|559436661|FG001|Overall Study|Adverse Event|1|||
155003520|NCT00615199|559436662|FG002|Overall Study|Adverse Event|1|||
155003521|NCT00615199|559436663|FG003|Overall Study|Adverse Event|0|||
155003522|NCT00615199|559436660|FG000|Overall Study|Lack of Efficacy|2|||
155003523|NCT00615199|559436661|FG001|Overall Study|Lack of Efficacy|0|||
155003524|NCT00615199|559436662|FG002|Overall Study|Lack of Efficacy|0|||
155003525|NCT00615199|559436663|FG003|Overall Study|Lack of Efficacy|1|||
155003526|NCT00615199|559436660|FG000|Overall Study|Lost to Follow-up|1|||
155003527|NCT00615199|559436661|FG001|Overall Study|Lost to Follow-up|0|||
155003528|NCT00615199|559436662|FG002|Overall Study|Lost to Follow-up|0|||
155003529|NCT00615199|559436663|FG003|Overall Study|Lost to Follow-up|0|||
155003530|NCT00615199|559436660|FG000|Overall Study|Other|0|||
155003531|NCT00615199|559436661|FG001|Overall Study|Other|0|||
155003532|NCT00615199|559436662|FG002|Overall Study|Other|0|||
155003533|NCT00615199|559436663|FG003|Overall Study|Other|1|||
155003534|NCT00615199|559436660|FG000|Overall Study|Withdrawal by Subject|2|||
155003535|NCT00615199|559436661|FG001|Overall Study|Withdrawal by Subject|1|||
155003536|NCT00615199|559436662|FG002|Overall Study|Withdrawal by Subject|0|||
155003537|NCT00615199|559436663|FG003|Overall Study|Withdrawal by Subject|0|||
155003538|NCT02653625|559436664|FG000|Overall Study|Adverse Event|1|||
155003539|NCT02653625|559436664|FG000|Overall Study|Non-compliance with Study Drug|1|||
155003540|NCT02653625|559436664|FG000|Overall Study|Protocol Violation|1|||
155003541|NCT02653625|559436664|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
155003542|NCT05377749|559436667|FG000|3 Weeks|Lost to Follow-up|2|||
155003543|NCT05377749|559436668|FG001|3 Weeks|Lost to Follow-up|4|||
155003544|NCT05377749|559436667|FG000|3 Weeks|Withdrawal by Subject|1|||
155003545|NCT05377749|559436668|FG001|3 Weeks|Withdrawal by Subject|1|||
155003546|NCT02969382|559436669|FG000|Overall Study|Adverse Event|8|||
155003547|NCT02969382|559436670|FG001|Overall Study|Adverse Event|10|||
155003548|NCT02969382|559436669|FG000|Overall Study|Lack of Efficacy|4|||
155003549|NCT02969382|559436670|FG001|Overall Study|Lack of Efficacy|5|||
155003550|NCT02969382|559436669|FG000|Overall Study|Death|0|||
155003551|NCT02969382|559436670|FG001|Overall Study|Death|1|||
155003552|NCT02969382|559436669|FG000|Overall Study|PROTOCOL DEVIATION|0|||
155003553|NCT02969382|559436670|FG001|Overall Study|PROTOCOL DEVIATION|1|||
155003554|NCT02969382|559436669|FG000|Overall Study|Withdrawal by Subject|14|||
155003555|NCT02969382|559436670|FG001|Overall Study|Withdrawal by Subject|9|||
155003556|NCT02090725|559436671|FG000|Overall Study|Withdrawal by Subject|1|||
155003557|NCT02090725|559436671|FG000|Overall Study|participants moved from area|3|||
155003558|NCT00764881|559436672|FG000|Overall Study|Adverse Event|5|||
155003559|NCT00764881|559436673|FG001|Overall Study|Adverse Event|1|||
155003560|NCT00764881|559436672|FG000|Overall Study|Withdrawal by Subject|1|||
155003561|NCT00764881|559436673|FG001|Overall Study|Withdrawal by Subject|3|||
155003562|NCT00764881|559436672|FG000|Overall Study|Protocol Violation|2|||
155003563|NCT00764881|559436673|FG001|Overall Study|Protocol Violation|2|||
155003564|NCT00764881|559436672|FG000|Overall Study|Lost to Follow-up|2|||
155003565|NCT00764881|559436673|FG001|Overall Study|Lost to Follow-up|0|||
155003566|NCT00764881|559436672|FG000|Overall Study|Noncompliant|1|||
155003567|NCT00764881|559436673|FG001|Overall Study|Noncompliant|0|||
155003568|NCT00764881|559436672|FG000|Overall Study|Accidentally discontinued study drug|1|||
155003569|NCT00764881|559436673|FG001|Overall Study|Accidentally discontinued study drug|0|||
155003570|NCT00764881|559436672|FG000|Overall Study|Wished to become pregnant|1|||
155003571|NCT00764881|559436673|FG001|Overall Study|Wished to become pregnant|0|||
155003572|NCT00764881|559436672|FG000|Overall Study|Carcinoma detected|1|||
155003573|NCT00764881|559436673|FG001|Overall Study|Carcinoma detected|0|||
155003574|NCT00764881|559436672|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
155003575|NCT00764881|559436673|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
155003576|NCT00764881|559436672|FG000|Overall Study|no treatment or no observation|2|||
155003577|NCT00764881|559436673|FG001|Overall Study|no treatment or no observation|2|||
155003578|NCT01214655|559436674|FG000|Part A|Progressive Disease|7|||
155003579|NCT01214655|559436675|FG001|Part A|Progressive Disease|0|||
155003580|NCT01214655|559436676|FG002|Part A|Progressive Disease|0|||
155003581|NCT01214655|559436674|FG000|Part A|Physician Decision|1|||
155003582|NCT01214655|559436675|FG001|Part A|Physician Decision|0|||
155003583|NCT01214655|559436676|FG002|Part A|Physician Decision|0|||
155003584|NCT01214655|559436674|FG000|Part B|Progressive disease|0|||
155003585|NCT01214655|559436675|FG001|Part B|Progressive disease|10|||
155003586|NCT01214655|559436676|FG002|Part B|Progressive disease|0|||
155003587|NCT01214655|559436674|FG000|Part B|Death|0|||
155003588|NCT01214655|559436675|FG001|Part B|Death|1|||
155003589|NCT01214655|559436676|FG002|Part B|Death|0|||
155003590|NCT01214655|559436674|FG000|Part B|Withdrawal by Subject|0|||
155003591|NCT01214655|559436675|FG001|Part B|Withdrawal by Subject|2|||
155003592|NCT01214655|559436676|FG002|Part B|Withdrawal by Subject|0|||
155003593|NCT01214655|559436674|FG000|Part C|Progressive Disease|0|||
155003594|NCT01214655|559436675|FG001|Part C|Progressive Disease|0|||
155003595|NCT01214655|559436676|FG002|Part C|Progressive Disease|5|||
155003596|NCT01214655|559436674|FG000|Part C|Death|0|||
155003597|NCT01214655|559436675|FG001|Part C|Death|0|||
155003598|NCT01214655|559436676|FG002|Part C|Death|1|||
155003599|NCT01214655|559436674|FG000|Part C|Physician Decision|0|||
155003600|NCT01214655|559436675|FG001|Part C|Physician Decision|0|||
155003601|NCT01214655|559436676|FG002|Part C|Physician Decision|1|||
155003602|NCT05256134|559436681|FG000|Overall Study|Study Terminated by Sponsor|11|||
155003603|NCT05256134|559436682|FG001|Overall Study|Study Terminated by Sponsor|10|||
155003604|NCT05256134|559436681|FG000|Overall Study|Withdrawal by Subject|1|||
155003605|NCT05256134|559436682|FG001|Overall Study|Withdrawal by Subject|3|||
155003606|NCT00886015|559436683|FG000|Overall Study|Death|0|||
155003607|NCT00886015|559436684|FG001|Overall Study|Death|2|||
155003608|NCT01692626|559436685|FG000|Overall Study|Death|0|||
155003609|NCT01692626|559436686|FG001|Overall Study|Death|1|||
155003610|NCT01692626|559436685|FG000|Overall Study|Adverse Event|2|||
155003611|NCT01692626|559436686|FG001|Overall Study|Adverse Event|3|||
155003612|NCT01692626|559436685|FG000|Overall Study|Protocol Violation|1|||
155003613|NCT01692626|559436686|FG001|Overall Study|Protocol Violation|2|||
155125232|NCT00413010|559890591|FG000|Overall Study|Due to termination of the study|54|||
155125233|NCT00413010|559890592|FG001|Overall Study|Due to termination of the study|52|||
155125234|NCT01515475|559890593|FG000|Overall Study|Lost to Follow-up|20|||
155125235|NCT01515475|559890594|FG001|Overall Study|Lost to Follow-up|15|||
155125236|NCT01515475|559890595|FG002|Overall Study|Lost to Follow-up|12|||
155125237|NCT01515475|559890596|FG003|Overall Study|Lost to Follow-up|12|||
155125238|NCT00353873|559890597|FG000|Overall Study|Protocol Violation|1|||
155125239|NCT00353873|559890598|FG001|Overall Study|Protocol Violation|2|||
155125240|NCT00353873|559890597|FG000|Overall Study|Exacerbation|1|||
155125241|NCT00353873|559890598|FG001|Overall Study|Exacerbation|0|||
155125242|NCT00353873|559890597|FG000|Overall Study|Adverse Event|1|||
155003614|NCT01692626|559436685|FG000|Overall Study|Withdrawal by Subject|1|||
155003615|NCT01692626|559436686|FG001|Overall Study|Withdrawal by Subject|0|||
155003616|NCT00855894|559436687|FG000|Overall Study|Death|31|||
155003617|NCT00855894|559436687|FG000|Overall Study|Patient's decision|1|||
155003618|NCT00855894|559436687|FG000|Overall Study|Disease progression|1|||
155003619|NCT02794870|559436700|FG000|Overall Study|Withdrawal by Subject|2|||
155003620|NCT02794870|559436701|FG001|Overall Study|Withdrawal by Subject|0|||
155003621|NCT01625988|559436706|FG000|Overall Study|Lost to Follow-up|5|||
155003622|NCT01625988|559436707|FG001|Overall Study|Lost to Follow-up|6|||
155003623|NCT01625988|559436706|FG000|Overall Study|Withdrawal by Subject|8|||
155003624|NCT01625988|559436707|FG001|Overall Study|Withdrawal by Subject|3|||
155003625|NCT01625988|559436706|FG000|Overall Study|Adverse Event|0|||
155003626|NCT01625988|559436707|FG001|Overall Study|Adverse Event|1|||
155003627|NCT01625988|559436706|FG000|Overall Study|Lack of Efficacy|0|||
155003628|NCT01625988|559436707|FG001|Overall Study|Lack of Efficacy|1|||
155003629|NCT01625988|559436706|FG000|Overall Study|Randomized Inappropriately|1|||
155003630|NCT01625988|559436707|FG001|Overall Study|Randomized Inappropriately|0|||
155003631|NCT01625988|559436706|FG000|Overall Study|Protocol Violation|0|||
155003632|NCT01625988|559436707|FG001|Overall Study|Protocol Violation|2|||
155003633|NCT00616421|559436708|FG000|Overall Study|Withdrawal by Subject|9|||
155003634|NCT00616421|559436709|FG001|Overall Study|Withdrawal by Subject|11|||
155003635|NCT00616421|559436710|FG002|Overall Study|Withdrawal by Subject|8|||
155003636|NCT00616421|559436708|FG000|Overall Study|Lost to Follow-up|12|||
155003637|NCT00616421|559436709|FG001|Overall Study|Lost to Follow-up|26|||
155003638|NCT00616421|559436710|FG002|Overall Study|Lost to Follow-up|30|||
155003639|NCT00616421|559436708|FG000|Overall Study|Inappropriate enrollment|3|||
155003640|NCT00616421|559436709|FG001|Overall Study|Inappropriate enrollment|0|||
155003641|NCT00616421|559436710|FG002|Overall Study|Inappropriate enrollment|1|||
155003642|NCT00616421|559436708|FG000|Overall Study|Administrative reason|1|||
155003643|NCT00616421|559436709|FG001|Overall Study|Administrative reason|0|||
155003644|NCT00616421|559436710|FG002|Overall Study|Administrative reason|0|||
155003645|NCT00616421|559436708|FG000|Overall Study|Protocol Violation|0|||
155003646|NCT00616421|559436709|FG001|Overall Study|Protocol Violation|1|||
155003647|NCT00616421|559436710|FG002|Overall Study|Protocol Violation|2|||
155003648|NCT00616421|559436708|FG000|Overall Study|Unable to classify|1|||
155003649|NCT00616421|559436709|FG001|Overall Study|Unable to classify|0|||
155003650|NCT00616421|559436710|FG002|Overall Study|Unable to classify|0|||
155003651|NCT01495702|559436711|FG000|Randomized Phase|Randomized But Not Treated|1|||
155003652|NCT01495702|559436712|FG001|Randomized Phase|Randomized But Not Treated|4|||
155003653|NCT01495702|559436711|FG000|Randomized Phase|Adverse Event|2|||
155003654|NCT01495702|559436712|FG001|Randomized Phase|Adverse Event|2|||
155003655|NCT01495702|559436711|FG000|Randomized Phase|Death|1|||
155003656|NCT01495702|559436712|FG001|Randomized Phase|Death|0|||
155003657|NCT01495702|559436711|FG000|Randomized Phase|Lack of Efficacy|2|||
155003658|NCT01495702|559436712|FG001|Randomized Phase|Lack of Efficacy|0|||
155003659|NCT01495702|559436711|FG000|Randomized Phase|Investigators Discretion|2|||
155003660|NCT01495702|559436712|FG001|Randomized Phase|Investigators Discretion|0|||
155003661|NCT01495702|559436711|FG000|Randomized Phase|Withdrew Consent|10|||
155003662|NCT01495702|559436712|FG001|Randomized Phase|Withdrew Consent|18|||
155003663|NCT01495702|559436711|FG000|Randomized Phase|Lost to Follow-up|4|||
155003664|NCT01495702|559436712|FG001|Randomized Phase|Lost to Follow-up|3|||
155003665|NCT01495702|559436711|FG000|Randomized Phase|Participant Noncompliance|1|||
155003666|NCT01495702|559436712|FG001|Randomized Phase|Participant Noncompliance|0|||
155003667|NCT01495702|559436711|FG000|Randomized Phase|Protocol Violation|3|||
155003668|NCT01495702|559436712|FG001|Randomized Phase|Protocol Violation|1|||
155003669|NCT04152863|559436713|FG000|Overall Study|Death|13|||
155003670|NCT04152863|559436714|FG001|Overall Study|Death|12|||
155003671|NCT04152863|559436715|FG002|Overall Study|Death|7|||
155003672|NCT04152863|559436713|FG000|Overall Study|Physician Decision|1|||
155003673|NCT04152863|559436714|FG001|Overall Study|Physician Decision|1|||
155003674|NCT04152863|559436715|FG002|Overall Study|Physician Decision|1|||
155003675|NCT04152863|559436713|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
155003676|NCT04152863|559436714|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
155003677|NCT04152863|559436715|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
155003678|NCT04152863|559436713|FG000|Overall Study|Withdrawal by Subject|2|||
155003679|NCT04152863|559436714|FG001|Overall Study|Withdrawal by Subject|1|||
155003680|NCT04152863|559436715|FG002|Overall Study|Withdrawal by Subject|3|||
155003681|NCT01644617|559436719|FG000|Overall Study|Withdrawal by Subject|3|||
155003682|NCT01644617|559436720|FG001|Overall Study|Withdrawal by Subject|4|||
155003683|NCT01644617|559436721|FG002|Overall Study|Withdrawal by Subject|1|||
155003684|NCT01644617|559436719|FG000|Overall Study|Lost to Follow-up|0|||
155003685|NCT01644617|559436720|FG001|Overall Study|Lost to Follow-up|1|||
155003686|NCT01644617|559436721|FG002|Overall Study|Lost to Follow-up|0|||
155003687|NCT01644617|559436719|FG000|Overall Study|Adverse Event|3|||
155003688|NCT01644617|559436720|FG001|Overall Study|Adverse Event|0|||
155003689|NCT01644617|559436721|FG002|Overall Study|Adverse Event|6|||
155003690|NCT02301390|559436722|FG000|Overall Study|Withdrawal by Subject|3|||
155003691|NCT02301390|559436723|FG001|Overall Study|Withdrawal by Subject|5|||
155003692|NCT02301390|559436722|FG000|Overall Study|Protocol Violation|1|||
155003693|NCT02301390|559436723|FG001|Overall Study|Protocol Violation|0|||
155125243|NCT00353873|559890598|FG001|Overall Study|Adverse Event|0|||
155125244|NCT00353873|559890597|FG000|Overall Study|Physician Decision|2|||
155003694|NCT02301390|559436722|FG000|Overall Study|Physician Decision|1|||
155003695|NCT02301390|559436723|FG001|Overall Study|Physician Decision|0|||
155003696|NCT02301390|559436722|FG000|Overall Study|Lost to Follow-up|0|||
155003697|NCT02301390|559436723|FG001|Overall Study|Lost to Follow-up|1|||
155003698|NCT02301390|559436722|FG000|Overall Study|Death|2|||
155003699|NCT02301390|559436723|FG001|Overall Study|Death|2|||
155003700|NCT02301390|559436722|FG000|Overall Study|Procedure not completed|0|||
155003701|NCT02301390|559436723|FG001|Overall Study|Procedure not completed|4|||
155003702|NCT02301390|559436722|FG000|Overall Study|Missed multiple visits|1|||
155003703|NCT02301390|559436723|FG001|Overall Study|Missed multiple visits|1|||
155003704|NCT02301390|559436722|FG000|Overall Study|study terminated|2|||
155003705|NCT02301390|559436723|FG001|Overall Study|study terminated|0|||
155003706|NCT02604407|559436724|FG000|Overall Study|Adverse Event|0|||
155003707|NCT02604407|559436725|FG001|Overall Study|Adverse Event|7|||
155003708|NCT02604407|559436726|FG002|Overall Study|Adverse Event|5|||
155003709|NCT02604407|559436724|FG000|Overall Study|Protocol Violation|2|||
155003710|NCT02604407|559436725|FG001|Overall Study|Protocol Violation|0|||
155003711|NCT02604407|559436726|FG002|Overall Study|Protocol Violation|0|||
155003712|NCT02604407|559436724|FG000|Overall Study|Withdrawal by Subject|3|||
155003713|NCT02604407|559436725|FG001|Overall Study|Withdrawal by Subject|3|||
155003714|NCT02604407|559436726|FG002|Overall Study|Withdrawal by Subject|5|||
155003715|NCT02604407|559436724|FG000|Overall Study|Lost to Follow-up|2|||
155003716|NCT02604407|559436725|FG001|Overall Study|Lost to Follow-up|1|||
155003717|NCT02604407|559436726|FG002|Overall Study|Lost to Follow-up|2|||
155003718|NCT02604407|559436724|FG000|Overall Study|Lack of Efficacy|1|||
155003719|NCT02604407|559436725|FG001|Overall Study|Lack of Efficacy|0|||
155003720|NCT02604407|559436726|FG002|Overall Study|Lack of Efficacy|0|||
155003721|NCT02604407|559436724|FG000|Overall Study|Other|3|||
155003722|NCT02604407|559436725|FG001|Overall Study|Other|1|||
155003723|NCT02604407|559436726|FG002|Overall Study|Other|4|||
155003724|NCT00185588|559436727|FG000|Overall Study|Adverse Event|3|||
155003725|NCT00185588|559436728|FG001|Overall Study|Adverse Event|1|||
155003726|NCT00185588|559436729|FG002|Overall Study|Adverse Event|4|||
155003727|NCT00185588|559436730|FG003|Overall Study|Adverse Event|2|||
155003728|NCT00185588|559436727|FG000|Overall Study|Lost to Follow-up|0|||
155003729|NCT00185588|559436728|FG001|Overall Study|Lost to Follow-up|0|||
155003730|NCT00185588|559436729|FG002|Overall Study|Lost to Follow-up|1|||
155003731|NCT00185588|559436730|FG003|Overall Study|Lost to Follow-up|2|||
155003732|NCT00185588|559436727|FG000|Overall Study|Withdrawal by Subject|0|||
155003733|NCT00185588|559436728|FG001|Overall Study|Withdrawal by Subject|1|||
155003734|NCT00185588|559436729|FG002|Overall Study|Withdrawal by Subject|0|||
155003735|NCT00185588|559436730|FG003|Overall Study|Withdrawal by Subject|0|||
155003736|NCT00185588|559436727|FG000|Overall Study|Physician Decision|0|||
155003737|NCT00185588|559436728|FG001|Overall Study|Physician Decision|0|||
155003738|NCT00185588|559436729|FG002|Overall Study|Physician Decision|1|||
155003739|NCT00185588|559436730|FG003|Overall Study|Physician Decision|0|||
155003740|NCT00398866|559436731|FG000|Overall Study|Adverse Event|1|||
155003741|NCT00398866|559436732|FG001|Overall Study|Adverse Event|0|||
155003742|NCT00398866|559436733|FG002|Overall Study|Adverse Event|0|||
155003743|NCT00398866|559436731|FG000|Overall Study|Lack of Efficacy|0|||
155003744|NCT00398866|559436732|FG001|Overall Study|Lack of Efficacy|0|||
155003745|NCT00398866|559436733|FG002|Overall Study|Lack of Efficacy|1|||
155003746|NCT00398866|559436731|FG000|Overall Study|Lost to Follow-up|7|||
155003747|NCT00398866|559436732|FG001|Overall Study|Lost to Follow-up|6|||
155003748|NCT00398866|559436733|FG002|Overall Study|Lost to Follow-up|4|||
155003749|NCT00398866|559436731|FG000|Overall Study|Withdrawal by Subject|5|||
155003750|NCT00398866|559436732|FG001|Overall Study|Withdrawal by Subject|1|||
155003751|NCT00398866|559436733|FG002|Overall Study|Withdrawal by Subject|2|||
155003752|NCT00398866|559436731|FG000|Overall Study|Unable to complete requirements of study|1|||
155003753|NCT00398866|559436732|FG001|Overall Study|Unable to complete requirements of study|1|||
155003754|NCT00398866|559436733|FG002|Overall Study|Unable to complete requirements of study|1|||
155003755|NCT02481869|559436736|FG000|Overall Study|Lost to Follow-up|3|||
155003756|NCT02481869|559436737|FG001|Overall Study|Lost to Follow-up|4|||
155003757|NCT02481869|559436736|FG000|Overall Study|Withdrawal by Subject|2|||
155003758|NCT02481869|559436737|FG001|Overall Study|Withdrawal by Subject|0|||
155003759|NCT00191191|559436740|FG000|Overall Study|Entry Criteria Exclusion|2|||
155003760|NCT00191191|559436741|FG001|Overall Study|Entry Criteria Exclusion|0|||
155003761|NCT00191191|559436740|FG000|Overall Study|Treated with Another Systemic Agent|1|||
155003762|NCT00191191|559436741|FG001|Overall Study|Treated with Another Systemic Agent|1|||
155003763|NCT00191191|559436740|FG000|Overall Study|Adverse Event|11|||
155125245|NCT00353873|559890598|FG001|Overall Study|Physician Decision|0|||
155003764|NCT00191191|559436741|FG001|Overall Study|Adverse Event|21|||
155003765|NCT00191191|559436740|FG000|Overall Study|Progressive Disease|84|||
155003766|NCT00191191|559436741|FG001|Overall Study|Progressive Disease|72|||
155003767|NCT00191191|559436740|FG000|Overall Study|Toxicity After Dose Reduction|7|||
155003768|NCT00191191|559436741|FG001|Overall Study|Toxicity After Dose Reduction|8|||
155003769|NCT00191191|559436740|FG000|Overall Study|Family/Caregiver Decision|5|||
155003770|NCT00191191|559436741|FG001|Overall Study|Family/Caregiver Decision|7|||
155003771|NCT00191191|559436740|FG000|Overall Study|Lost to Follow-up|1|||
155003772|NCT00191191|559436741|FG001|Overall Study|Lost to Follow-up|0|||
155003773|NCT00191191|559436740|FG000|Overall Study|Physician Decision|3|||
155003774|NCT00191191|559436741|FG001|Overall Study|Physician Decision|2|||
155003775|NCT00191191|559436740|FG000|Overall Study|Good Clinical Practice Violation|0|||
155003776|NCT00191191|559436741|FG001|Overall Study|Good Clinical Practice Violation|1|||
155003777|NCT04289363|559436742|FG000|Overall Study|Lost to Follow-up|14|||
155003778|NCT04289363|559436743|FG001|Overall Study|Lost to Follow-up|0|||
155003779|NCT03790657|559436744|FG000|Overall Study|Adverse Event|1|||
155003780|NCT03790657|559436745|FG001|Overall Study|Adverse Event|1|||
155003781|NCT03790657|559436744|FG000|Overall Study|Withdrawal by Subject|1|||
155003782|NCT03790657|559436745|FG001|Overall Study|Withdrawal by Subject|1|||
155003783|NCT02652949|559436746|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
155003784|NCT02652949|559436746|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
155003785|NCT02652949|559436746|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
155003786|NCT02652949|559436746|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
155003787|NCT02652949|559436746|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
155003788|NCT02652949|559436746|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
155003789|NCT02652949|559436746|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
155003790|NCT02652949|559436746|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
155003791|NCT02652949|559436746|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
155003792|NCT02652949|559436746|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
155003793|NCT02652949|559436746|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
155003794|NCT02652949|559436746|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
155003795|NCT02652949|559436746|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
155003796|NCT02652949|559436746|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
155003797|NCT02652949|559436746|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155003798|NCT02652949|559436746|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
155003799|NCT02652949|559436746|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
155003800|NCT00911300|559436748|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
155003801|NCT00911300|559436749|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
155003802|NCT00911300|559436748|FG000|Overall Study|Death|1|||
155003803|NCT00911300|559436749|FG001|Overall Study|Death|0|||
155003804|NCT00911300|559436748|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
155003805|NCT00911300|559436749|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
155003806|NCT00911300|559436748|FG000|Overall Study|Adverse Event|14|||
155003807|NCT00911300|559436749|FG001|Overall Study|Adverse Event|6|||
155003808|NCT00911300|559436748|FG000|Overall Study|Protocol Violation|3|||
155003809|NCT00911300|559436749|FG001|Overall Study|Protocol Violation|2|||
155003810|NCT00911300|559436748|FG000|Overall Study|Consent Withdrawn|4|||
155003811|NCT00911300|559436749|FG001|Overall Study|Consent Withdrawn|12|||
155003812|NCT00911300|559436748|FG000|Overall Study|Coronary Angiography Performed|1|||
155003813|NCT00911300|559436749|FG001|Overall Study|Coronary Angiography Performed|0|||
155003814|NCT00911300|559436748|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
155003815|NCT00911300|559436749|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
155003816|NCT00911300|559436748|FG000|Overall Study|Received Commercial Treatment|1|||
155003817|NCT00911300|559436749|FG001|Overall Study|Received Commercial Treatment|0|||
155003818|NCT00911300|559436748|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
155003819|NCT00911300|559436749|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
155003820|NCT00911300|559436748|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
155003821|NCT00911300|559436749|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
155003822|NCT00911300|559436748|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
155003823|NCT00911300|559436749|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
155003824|NCT00911300|559436748|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
155003825|NCT00911300|559436749|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
155003826|NCT00911300|559436748|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
155003827|NCT00911300|559436749|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
155003828|NCT00911300|559436748|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
155003829|NCT00911300|559436749|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
155003830|NCT00911300|559436748|FG000|Overall Study|International Normalized Ratio Too High|0|||
155003831|NCT00911300|559436749|FG001|Overall Study|International Normalized Ratio Too High|1|||
155003832|NCT00911300|559436748|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
155003833|NCT00911300|559436749|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
155003834|NCT00911300|559436748|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
155003835|NCT00911300|559436749|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
155003836|NCT00911300|559436748|FG000|Overall Study|Physician Decision|0|||
155003837|NCT00911300|559436749|FG001|Overall Study|Physician Decision|1|||
155003838|NCT00911300|559436748|FG000|Overall Study|Treatment Stopped by Mistake|0|||
155003839|NCT00911300|559436749|FG001|Overall Study|Treatment Stopped by Mistake|1|||
155003840|NCT00911300|559436748|FG000|Overall Study|Randomized; No Study Medication Received|0|||
155003841|NCT00911300|559436749|FG001|Overall Study|Randomized; No Study Medication Received|2|||
155003842|NCT01895777|559436750|FG000|Overall Study|Adverse Event|1|||
155003843|NCT01895777|559436751|FG001|Overall Study|Adverse Event|2|||
155003844|NCT01895777|559436750|FG000|Overall Study|Lost to Follow-up|2|||
155003845|NCT01895777|559436751|FG001|Overall Study|Lost to Follow-up|0|||
155003846|NCT01895777|559436750|FG000|Overall Study|Not treated|1|||
155125246|NCT00353873|559890597|FG000|Overall Study|Withdrawal by Subject|1|||
155125247|NCT00353873|559890598|FG001|Overall Study|Withdrawal by Subject|1|||
155003847|NCT01895777|559436751|FG001|Overall Study|Not treated|0|||
155003848|NCT01895777|559436750|FG000|Overall Study|Other reasons|3|||
155003849|NCT01895777|559436751|FG001|Overall Study|Other reasons|2|||
155003850|NCT01895777|559436750|FG000|Overall Study|Non-compliance with the CTP|2|||
155125248|NCT00870194|559890599|FG000|Overall Study|Adverse Event|10|||
155003851|NCT01895777|559436751|FG001|Overall Study|Non-compliance with the CTP|1|||
154922940|NCT01049360|559142185|FG003|Period 4|Withdrawal by Subject|1|||
154922941|NCT01049360|559142186|FG004|Period 4|Withdrawal by Subject|0|||
154922942|NCT01049360|559142187|FG005|Period 4|Withdrawal by Subject|0|||
154922943|NCT01049360|559142188|FG006|Period 4|Withdrawal by Subject|0|||
154922944|NCT01049360|559142189|FG007|Period 4|Withdrawal by Subject|0|||
154922945|NCT01049360|559142190|FG008|Period 4|Withdrawal by Subject|0|||
154922946|NCT01049360|559142191|FG009|Period 4|Withdrawal by Subject|0|||
154922947|NCT01049360|559142192|FG010|Period 4|Withdrawal by Subject|0|||
154922948|NCT01049360|559142193|FG011|Period 4|Withdrawal by Subject|0|||
154922949|NCT01049360|559142194|FG012|Period 4|Withdrawal by Subject|0|||
154922950|NCT01049360|559142195|FG013|Period 4|Withdrawal by Subject|0|||
154922951|NCT01049360|559142196|FG014|Period 4|Withdrawal by Subject|0|||
154922952|NCT01049360|559142197|FG015|Period 4|Withdrawal by Subject|0|||
154922953|NCT01049360|559142198|FG016|Period 4|Withdrawal by Subject|0|||
154922954|NCT01049360|559142199|FG017|Period 4|Withdrawal by Subject|0|||
154922955|NCT01049360|559142200|FG018|Period 4|Withdrawal by Subject|0|||
154922956|NCT01049360|559142201|FG019|Period 4|Withdrawal by Subject|0|||
154922957|NCT05147311|559142204|FG000|Overall Study|Did not complete survey|2|||
154922958|NCT05147311|559142205|FG001|Overall Study|Did not complete survey|1|||
154922959|NCT05147311|559142204|FG000|Overall Study|Patient too sick|1|||
154922960|NCT05147311|559142205|FG001|Overall Study|Patient too sick|2|||
154922961|NCT05147311|559142204|FG000|Overall Study|Death|0|||
154922962|NCT05147311|559142205|FG001|Overall Study|Death|1|||
154922963|NCT05147311|559142204|FG000|Overall Study|Declined survey|1|||
154922964|NCT05147311|559142205|FG001|Overall Study|Declined survey|0|||
154922965|NCT00145795|559142207|FG000|Overall Study|Adverse Event|1|||
154922966|NCT00145795|559142208|FG001|Overall Study|Adverse Event|0|||
154922967|NCT01539512|559142213|FG000|Overall Study|Adverse Event|9|||
154922968|NCT01539512|559142214|FG001|Overall Study|Adverse Event|7|||
154922969|NCT01539512|559142213|FG000|Overall Study|Physician Decision|1|||
154922970|NCT01539512|559142214|FG001|Overall Study|Physician Decision|1|||
154922971|NCT01539512|559142213|FG000|Overall Study|Withdrawal by Subject|12|||
154922972|NCT01539512|559142214|FG001|Overall Study|Withdrawal by Subject|5|||
154922973|NCT01539512|559142213|FG000|Overall Study|Richter's Transformation|1|||
154922974|NCT01539512|559142214|FG001|Overall Study|Richter's Transformation|0|||
154922975|NCT02388906|559142219|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
154922976|NCT02388906|559142220|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
154922977|NCT02388906|559142219|FG000|Treatment Period|Disease progression|121|||
154922978|NCT02388906|559142220|FG001|Treatment Period|Disease progression|100|||
154922979|NCT02388906|559142219|FG000|Treatment Period|Study drug toxicity|41|||
154922980|NCT02388906|559142220|FG001|Treatment Period|Study drug toxicity|208|||
154922981|NCT02388906|559142219|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
154922982|NCT02388906|559142220|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
154922983|NCT02388906|559142219|FG000|Treatment Period|Participant request to stop treatment|5|||
154922984|NCT02388906|559142220|FG001|Treatment Period|Participant request to stop treatment|9|||
154922985|NCT02388906|559142219|FG000|Treatment Period|Participant withdrew consent|2|||
154922986|NCT02388906|559142220|FG001|Treatment Period|Participant withdrew consent|3|||
154922987|NCT02388906|559142219|FG000|Treatment Period|Poor/non-compliance|0|||
154922988|NCT02388906|559142220|FG001|Treatment Period|Poor/non-compliance|1|||
154922989|NCT02388906|559142219|FG000|Treatment Period|Participant no longer meets study criteria|0|||
154922990|NCT02388906|559142220|FG001|Treatment Period|Participant no longer meets study criteria|1|||
154922991|NCT02388906|559142219|FG000|Treatment Period|Other reasons|3|||
154922992|NCT02388906|559142220|FG001|Treatment Period|Other reasons|3|||
154922993|NCT04365387|559142229|FG000|Overall Study|Adverse Event|4|||
154922994|NCT04365387|559142230|FG001|Overall Study|Adverse Event|2|||
154922995|NCT04365387|559142229|FG000|Overall Study|Participants request|14|||
154922996|NCT04365387|559142230|FG001|Overall Study|Participants request|14|||
154922997|NCT04365387|559142229|FG000|Overall Study|Lost to Follow-up|8|||
154922998|NCT04365387|559142230|FG001|Overall Study|Lost to Follow-up|5|||
154922999|NCT04365387|559142229|FG000|Overall Study|Protocol deviation|3|||
154923000|NCT04365387|559142230|FG001|Overall Study|Protocol deviation|4|||
154923001|NCT04365387|559142229|FG000|Overall Study|Participant compliance with visit schedule|1|||
154923002|NCT04365387|559142230|FG001|Overall Study|Participant compliance with visit schedule|0|||
154923003|NCT04365387|559142229|FG000|Overall Study|Participant incarcerated|1|||
154923004|NCT04365387|559142230|FG001|Overall Study|Participant incarcerated|0|||
154923005|NCT04365387|559142229|FG000|Overall Study|Participant moved out of town (relocated)|0|||
154923006|NCT04365387|559142230|FG001|Overall Study|Participant moved out of town (relocated)|1|||
154923007|NCT04365387|559142229|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
154923008|NCT04365387|559142230|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
154923009|NCT04365387|559142229|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
154923010|NCT04365387|559142230|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
155003852|NCT03607487|559436755|FG000|Overall Study|Withdrawal by Subject|2|||
155003853|NCT03607487|559436756|FG001|Overall Study|Withdrawal by Subject|0|||
155003854|NCT03607487|559436757|FG002|Overall Study|Withdrawal by Subject|0|||
155003855|NCT03607487|559436758|FG003|Overall Study|Withdrawal by Subject|1|||
155003856|NCT04223752|559436762|FG000|Overall Study|Participant enrolled in error|0|||
155003857|NCT04223752|559436763|FG001|Overall Study|Participant enrolled in error|0|||
155003858|NCT04223752|559436764|FG002|Overall Study|Participant enrolled in error|0|||
155003859|NCT04223752|559436765|FG003|Overall Study|Participant enrolled in error|0|||
155003860|NCT04223752|559436766|FG004|Overall Study|Participant enrolled in error|1|||
155003861|NCT04223752|559436762|FG000|Overall Study|Death|0|||
155003862|NCT04223752|559436763|FG001|Overall Study|Death|0|||
155003863|NCT04223752|559436764|FG002|Overall Study|Death|0|||
155003864|NCT04223752|559436765|FG003|Overall Study|Death|2|||
155003865|NCT04223752|559436766|FG004|Overall Study|Death|1|||
155003866|NCT04759703|559436767|FG000|Overall Study|Withdrawal by Subject|4|||
155003867|NCT04759703|559436768|FG001|Overall Study|Withdrawal by Subject|9|||
155003868|NCT04759703|559436767|FG000|Overall Study|Adverse Event|1|||
155003869|NCT04759703|559436768|FG001|Overall Study|Adverse Event|0|||
155003870|NCT04759703|559436767|FG000|Overall Study|Lost to Follow-up|2|||
155003871|NCT04759703|559436768|FG001|Overall Study|Lost to Follow-up|0|||
155003872|NCT05061420|559436773|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
155003873|NCT05061420|559436774|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155003874|NCT05061420|559436775|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
155003875|NCT05061420|559436773|FG000|Overall Study|Progressive disease|11|||
155003876|NCT05061420|559436774|FG001|Overall Study|Progressive disease|15|||
155003877|NCT05061420|559436775|FG002|Overall Study|Progressive disease|14|||
155003878|NCT05061420|559436773|FG000|Overall Study|Withdrawal by Subject|2|||
155003879|NCT05061420|559436774|FG001|Overall Study|Withdrawal by Subject|0|||
155003880|NCT05061420|559436775|FG002|Overall Study|Withdrawal by Subject|1|||
155003881|NCT05061420|559436773|FG000|Overall Study|Not related to COVID-19|2|||
155003882|NCT05061420|559436774|FG001|Overall Study|Not related to COVID-19|0|||
155003883|NCT05061420|559436775|FG002|Overall Study|Not related to COVID-19|0|||
155003884|NCT01814553|559436776|FG000|Overall Study|PD per clinical progression|6|||
155003885|NCT01814553|559436777|FG001|Overall Study|PD per clinical progression|8|||
155003886|NCT01814553|559436776|FG000|Overall Study|Other Adverse Event|4|||
155003887|NCT01814553|559436777|FG001|Overall Study|Other Adverse Event|5|||
155003888|NCT01814553|559436776|FG000|Overall Study|Withdrawal by Subject|1|||
155003889|NCT01814553|559436777|FG001|Overall Study|Withdrawal by Subject|1|||
155003890|NCT01814553|559436776|FG000|Overall Study|Other than stated|7|||
155003891|NCT01814553|559436777|FG001|Overall Study|Other than stated|8|||
155003892|NCT04036110|559436778|FG000|Overall Study|Lost to Follow-up|3|||
155003893|NCT04036110|559436779|FG001|Overall Study|Lost to Follow-up|2|||
155003894|NCT04036110|559436780|FG002|Overall Study|Lost to Follow-up|1|||
155003895|NCT04036110|559436778|FG000|Overall Study|Study Suspended|4|||
155003896|NCT04036110|559436779|FG001|Overall Study|Study Suspended|5|||
155003897|NCT04036110|559436780|FG002|Overall Study|Study Suspended|1|||
155003898|NCT01941498|559436781|FG000|Overall Study|Relocated out of state|1|||
155003899|NCT01301729|559436782|FG000|Overall Study|Withdrawal by Subject|2|||
155003900|NCT01301729|559436782|FG000|Overall Study|Participant did not Return for Treatment|1|||
155003901|NCT01301729|559436782|FG000|Overall Study|Violated Selection Criteria|1|||
155003902|NCT05794503|559436783|FG000|Overall Study|Operation Cancelled|2|||
155003903|NCT05794503|559436784|FG001|Overall Study|Operation Cancelled|0|||
155003904|NCT05794503|559436783|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
155003905|NCT05794503|559436784|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
155003906|NCT05794503|559436783|FG000|Overall Study|Protocol Violation|1|||
155003907|NCT05794503|559436784|FG001|Overall Study|Protocol Violation|0|||
155003908|NCT00447993|559436785|FG000|Overall Study|Lost to Follow-up|0|||
155003909|NCT00447993|559436786|FG001|Overall Study|Lost to Follow-up|0|||
155003910|NCT00447993|559436787|FG002|Overall Study|Lost to Follow-up|2|||
155003911|NCT00447993|559436788|FG003|Overall Study|Lost to Follow-up|2|||
155003912|NCT00447993|559436785|FG000|Overall Study|Withdrawal by Subject|0|||
155003913|NCT00447993|559436786|FG001|Overall Study|Withdrawal by Subject|0|||
155003914|NCT00447993|559436787|FG002|Overall Study|Withdrawal by Subject|2|||
155003915|NCT00447993|559436788|FG003|Overall Study|Withdrawal by Subject|2|||
155003916|NCT02924727|559436789|FG000|Overall Study|Withdrawal by Subject|2|||
155003917|NCT02924727|559436790|FG001|Overall Study|Withdrawal by Subject|4|||
155003918|NCT02924727|559436789|FG000|Overall Study|Lost to Follow-up|2|||
155003919|NCT02924727|559436790|FG001|Overall Study|Lost to Follow-up|5|||
155003920|NCT02924727|559436789|FG000|Overall Study|Death|221|||
155003921|NCT02924727|559436790|FG001|Overall Study|Death|247|||
155003922|NCT02924727|559436789|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
155003923|NCT02924727|559436790|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
155003924|NCT01464931|559436793|FG000|Overall Study|Withdrawal by Subject|1|||
155003925|NCT01464931|559436794|FG001|Overall Study|Withdrawal by Subject|0|||
155003926|NCT01982812|559436795|FG000|Overall Study|Death|1|||
155125249|NCT00870194|559890600|FG001|Overall Study|Adverse Event|5|||
155003927|NCT01982812|559436796|FG001|Overall Study|Death|5|||
155003928|NCT01982812|559436795|FG000|Overall Study|Adverse Event|0|||
155003929|NCT01982812|559436796|FG001|Overall Study|Adverse Event|5|||
155003930|NCT00307437|559436798|FG000|Controlled Period|Adverse Event|7|||
155003931|NCT00307437|559436799|FG001|Controlled Period|Adverse Event|2|||
155003932|NCT00307437|559436800|FG002|Controlled Period|Adverse Event|5|||
155003933|NCT00307437|559436801|FG003|Controlled Period|Adverse Event|0|||
155003934|NCT00307437|559436802|FG004|Controlled Period|Adverse Event|0|||
155003935|NCT00307437|559436803|FG005|Controlled Period|Adverse Event|0|||
155003936|NCT00307437|559436804|FG006|Controlled Period|Adverse Event|0|||
155003937|NCT00307437|559436798|FG000|Controlled Period|Death|0|||
155003938|NCT00307437|559436799|FG001|Controlled Period|Death|0|||
155003939|NCT00307437|559436800|FG002|Controlled Period|Death|1|||
155003940|NCT00307437|559436801|FG003|Controlled Period|Death|0|||
155003941|NCT00307437|559436802|FG004|Controlled Period|Death|0|||
155003942|NCT00307437|559436803|FG005|Controlled Period|Death|0|||
155003943|NCT00307437|559436804|FG006|Controlled Period|Death|0|||
155003944|NCT00307437|559436798|FG000|Controlled Period|Lack of Efficacy|2|||
155003945|NCT00307437|559436799|FG001|Controlled Period|Lack of Efficacy|0|||
155003946|NCT00307437|559436800|FG002|Controlled Period|Lack of Efficacy|0|||
155003947|NCT00307437|559436801|FG003|Controlled Period|Lack of Efficacy|0|||
155003948|NCT00307437|559436802|FG004|Controlled Period|Lack of Efficacy|0|||
155003949|NCT00307437|559436803|FG005|Controlled Period|Lack of Efficacy|0|||
155003950|NCT00307437|559436804|FG006|Controlled Period|Lack of Efficacy|0|||
155003951|NCT00307437|559436798|FG000|Controlled Period|Lost to Follow-up|2|||
155003952|NCT00307437|559436799|FG001|Controlled Period|Lost to Follow-up|3|||
155003953|NCT00307437|559436800|FG002|Controlled Period|Lost to Follow-up|0|||
155003954|NCT00307437|559436801|FG003|Controlled Period|Lost to Follow-up|0|||
155003955|NCT00307437|559436802|FG004|Controlled Period|Lost to Follow-up|0|||
155003956|NCT00307437|559436803|FG005|Controlled Period|Lost to Follow-up|0|||
155003957|NCT00307437|559436804|FG006|Controlled Period|Lost to Follow-up|0|||
155003958|NCT00307437|559436798|FG000|Controlled Period|Other|5|||
155003959|NCT00307437|559436799|FG001|Controlled Period|Other|1|||
155003960|NCT00307437|559436800|FG002|Controlled Period|Other|3|||
155003961|NCT00307437|559436801|FG003|Controlled Period|Other|0|||
155003962|NCT00307437|559436802|FG004|Controlled Period|Other|0|||
155003963|NCT00307437|559436803|FG005|Controlled Period|Other|0|||
155003964|NCT00307437|559436804|FG006|Controlled Period|Other|0|||
155003965|NCT00307437|559436798|FG000|After Controlled Period|Adverse Event|0|||
155003966|NCT00307437|559436799|FG001|After Controlled Period|Adverse Event|0|||
155003967|NCT00307437|559436800|FG002|After Controlled Period|Adverse Event|0|||
155003968|NCT00307437|559436801|FG003|After Controlled Period|Adverse Event|18|||
155003969|NCT00307437|559436802|FG004|After Controlled Period|Adverse Event|16|||
155003970|NCT00307437|559436803|FG005|After Controlled Period|Adverse Event|31|||
155003971|NCT00307437|559436804|FG006|After Controlled Period|Adverse Event|40|||
155003972|NCT00307437|559436798|FG000|After Controlled Period|Death|0|||
155003973|NCT00307437|559436799|FG001|After Controlled Period|Death|0|||
155003974|NCT00307437|559436800|FG002|After Controlled Period|Death|0|||
155003975|NCT00307437|559436801|FG003|After Controlled Period|Death|3|||
155003976|NCT00307437|559436802|FG004|After Controlled Period|Death|1|||
155003977|NCT00307437|559436803|FG005|After Controlled Period|Death|1|||
155003978|NCT00307437|559436804|FG006|After Controlled Period|Death|3|||
155003979|NCT00307437|559436798|FG000|After Controlled Period|Lack of Efficacy|0|||
155003980|NCT00307437|559436799|FG001|After Controlled Period|Lack of Efficacy|0|||
155003981|NCT00307437|559436800|FG002|After Controlled Period|Lack of Efficacy|0|||
155003982|NCT00307437|559436801|FG003|After Controlled Period|Lack of Efficacy|15|||
155003983|NCT00307437|559436802|FG004|After Controlled Period|Lack of Efficacy|17|||
155003984|NCT00307437|559436803|FG005|After Controlled Period|Lack of Efficacy|37|||
155003985|NCT00307437|559436804|FG006|After Controlled Period|Lack of Efficacy|24|||
155003986|NCT00307437|559436798|FG000|After Controlled Period|Lost to Follow-up|0|||
155003987|NCT00307437|559436799|FG001|After Controlled Period|Lost to Follow-up|0|||
155003988|NCT00307437|559436800|FG002|After Controlled Period|Lost to Follow-up|0|||
155003989|NCT00307437|559436801|FG003|After Controlled Period|Lost to Follow-up|7|||
155003990|NCT00307437|559436802|FG004|After Controlled Period|Lost to Follow-up|12|||
155003991|NCT00307437|559436803|FG005|After Controlled Period|Lost to Follow-up|13|||
155003992|NCT00307437|559436804|FG006|After Controlled Period|Lost to Follow-up|18|||
155003993|NCT00307437|559436798|FG000|After Controlled Period|Other|0|||
155003994|NCT00307437|559436799|FG001|After Controlled Period|Other|0|||
155003995|NCT00307437|559436800|FG002|After Controlled Period|Other|0|||
155003996|NCT00307437|559436801|FG003|After Controlled Period|Other|15|||
155003997|NCT00307437|559436802|FG004|After Controlled Period|Other|9|||
155003998|NCT00307437|559436803|FG005|After Controlled Period|Other|40|||
155003999|NCT00307437|559436804|FG006|After Controlled Period|Other|28|||
155004000|NCT00338728|559436805|FG000|Overall Study|Screen Failure|14|||
155004001|NCT04380961|559436808|FG000|Overall Study|Lost to Follow-up|17|||
155004002|NCT04380961|559436809|FG001|Overall Study|Lost to Follow-up|11|||
155004003|NCT04380961|559436808|FG000|Overall Study|Withdrawal by Subject|3|||
155004004|NCT04380961|559436809|FG001|Overall Study|Withdrawal by Subject|0|||
155004005|NCT04380961|559436808|FG000|Overall Study|Death|22|||
155004006|NCT04380961|559436809|FG001|Overall Study|Death|16|||
155004007|NCT04380961|559436808|FG000|Overall Study|Other|1|||
155004008|NCT04380961|559436809|FG001|Overall Study|Other|0|||
155004009|NCT04380961|559436808|FG000|Overall Study|Randomized but Not Treated|1|||
155004010|NCT04380961|559436809|FG001|Overall Study|Randomized but Not Treated|2|||
155004011|NCT01862484|559436810|FG000|Overall Study|Lack of Efficacy|1|||
155004012|NCT01862484|559436811|FG001|Overall Study|Lack of Efficacy|1|||
155004013|NCT01862484|559436810|FG000|Overall Study|Lost to Follow-up|1|||
155004014|NCT01862484|559436811|FG001|Overall Study|Lost to Follow-up|2|||
155004015|NCT01862484|559436810|FG000|Overall Study|Protocol Violation|0|||
155004016|NCT01862484|559436811|FG001|Overall Study|Protocol Violation|2|||
155004017|NCT01862484|559436810|FG000|Overall Study|Withdrawal by Subject|0|||
155004018|NCT01862484|559436811|FG001|Overall Study|Withdrawal by Subject|3|||
155004019|NCT00721227|559436812|FG000|Overall Study|Lost to Follow-up|3|||
155004020|NCT00721227|559436813|FG001|Overall Study|Lost to Follow-up|0|||
155004021|NCT00721227|559436812|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
155004022|NCT00721227|559436813|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
155004023|NCT06419907|559439145|FG000|Overall Study|Protocol Violation|0|||
155004024|NCT06419907|559439146|FG001|Overall Study|Protocol Violation|3|||
155004025|NCT06419907|559439147|FG002|Overall Study|Protocol Violation|0|||
155004026|NCT06419907|559439148|FG003|Overall Study|Protocol Violation|1|||
155004027|NCT06419907|559439145|FG000|Overall Study|Lost to Follow-up|0|||
155004028|NCT06419907|559439146|FG001|Overall Study|Lost to Follow-up|0|||
155004029|NCT06419907|559439147|FG002|Overall Study|Lost to Follow-up|2|||
155004030|NCT06419907|559439148|FG003|Overall Study|Lost to Follow-up|1|||
155004031|NCT01427608|559439149|FG000|Overall Study|Death|1|||
155004032|NCT01427608|559439150|FG001|Overall Study|Death|0|||
155004033|NCT01427608|559439149|FG000|Overall Study|Withdrawal by Subject|7|||
155004034|NCT01427608|559439150|FG001|Overall Study|Withdrawal by Subject|3|||
155004035|NCT01427608|559439149|FG000|Overall Study|Relapsed-all cause|13|||
155004036|NCT01427608|559439150|FG001|Overall Study|Relapsed-all cause|34|||
155004037|NCT01427608|559439149|FG000|Overall Study|Events not attributed to study meds|0|||
155004038|NCT01427608|559439150|FG001|Overall Study|Events not attributed to study meds|1|||
155004039|NCT01473407|559439151|FG000|Overall Study|Physician Decision|1|||
155004040|NCT01473407|559439152|FG001|Overall Study|Physician Decision|4|||
155004041|NCT01473407|559439151|FG000|Overall Study|Lost to Follow-up|10|||
155004042|NCT01473407|559439152|FG001|Overall Study|Lost to Follow-up|4|||
155004043|NCT01473407|559439151|FG000|Overall Study|Adverse Event|8|||
155004044|NCT01473407|559439152|FG001|Overall Study|Adverse Event|8|||
155004045|NCT01473407|559439151|FG000|Overall Study|Randomization Error|3|||
155004046|NCT01473407|559439152|FG001|Overall Study|Randomization Error|1|||
155004047|NCT01473407|559439151|FG000|Overall Study|Withdrawal by Subject|4|||
155004048|NCT01473407|559439152|FG001|Overall Study|Withdrawal by Subject|7|||
155004049|NCT01473407|559439151|FG000|Overall Study|Kidney Transplant|7|||
155004050|NCT01473407|559439152|FG001|Overall Study|Kidney Transplant|6|||
155004051|NCT01473407|559439151|FG000|Overall Study|Vacation/Travel|1|||
155004052|NCT01473407|559439152|FG001|Overall Study|Vacation/Travel|1|||
155004053|NCT01473407|559439151|FG000|Overall Study|Elevated Hemoglobin|1|||
155004054|NCT01473407|559439152|FG001|Overall Study|Elevated Hemoglobin|0|||
155004055|NCT01473407|559439151|FG000|Overall Study|Patient Received Aranesp|1|||
155004056|NCT01473407|559439152|FG001|Overall Study|Patient Received Aranesp|0|||
155004057|NCT01473407|559439151|FG000|Overall Study|Patient Lost Green Card Status|1|||
155004058|NCT01473407|559439152|FG001|Overall Study|Patient Lost Green Card Status|0|||
155004059|NCT01473407|559439151|FG000|Overall Study|Temperature Excursion|2|||
155004060|NCT01473407|559439152|FG001|Overall Study|Temperature Excursion|3|||
155004061|NCT01473407|559439151|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
155004062|NCT01473407|559439152|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
155004063|NCT01473407|559439151|FG000|Overall Study|Sponsor's Decision|10|||
155004064|NCT01473407|559439152|FG001|Overall Study|Sponsor's Decision|10|||
155004065|NCT01473407|559439151|FG000|Overall Study|Site Closure|1|||
155004066|NCT01473407|559439152|FG001|Overall Study|Site Closure|0|||
155004067|NCT04071405|559439153|FG000|Overall Study|Protocol Violation|3|||
155004068|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
155004069|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
155004070|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
155004071|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
155004072|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
155125250|NCT00870194|559890599|FG000|Overall Study|Lack of Efficacy|0|||
155125251|NCT00870194|559890600|FG001|Overall Study|Lack of Efficacy|1|||
155125252|NCT00870194|559890599|FG000|Overall Study|Lost to Follow-up|2|||
155125253|NCT00870194|559890600|FG001|Overall Study|Lost to Follow-up|0|||
155125254|NCT00870194|559890599|FG000|Overall Study|Physician Decision|3|||
155004073|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
155004074|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
155004075|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
155004076|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
155004077|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
155125255|NCT00870194|559890600|FG001|Overall Study|Physician Decision|1|||
155004078|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
155004079|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
155004080|NCT02422797|559439154|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
155004081|NCT02422797|559439155|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
155004082|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
155004083|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
155004084|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
155004085|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
155004086|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
155004087|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
155004088|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
155004089|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
155004090|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
155004091|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
155004092|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
155004093|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
155004094|NCT02422797|559439154|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
155004095|NCT02422797|559439155|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
155004096|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
155004097|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
155004098|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
155004099|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
155004100|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
155004101|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
155004102|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
155004103|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
155004104|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
155004105|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
155004106|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
155004107|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
155004108|NCT02422797|559439154|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
155004109|NCT02422797|559439155|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
155004110|NCT01027702|559439160|FG000|Overall Study|Received subsequent therapy|1|||
155004111|NCT01027702|559439161|FG001|Overall Study|Received subsequent therapy|2|||
155004112|NCT01027702|559439162|FG002|Overall Study|Received subsequent therapy|0|||
155004113|NCT01027702|559439163|FG003|Overall Study|Received subsequent therapy|4|||
155004114|NCT01027702|559439164|FG004|Overall Study|Received subsequent therapy|1|||
155004115|NCT01027702|559439165|FG005|Overall Study|Received subsequent therapy|0|||
155004116|NCT01027702|559439166|FG006|Overall Study|Received subsequent therapy|1|||
155004117|NCT01027702|559439160|FG000|Overall Study|Death|0|||
155004118|NCT01027702|559439161|FG001|Overall Study|Death|0|||
155004119|NCT01027702|559439162|FG002|Overall Study|Death|1|||
155004120|NCT01027702|559439163|FG003|Overall Study|Death|0|||
155004121|NCT01027702|559439164|FG004|Overall Study|Death|0|||
155004122|NCT01027702|559439165|FG005|Overall Study|Death|0|||
155004123|NCT01027702|559439166|FG006|Overall Study|Death|0|||
155125256|NCT00870194|559890599|FG000|Overall Study|Protocol Violation|3|||
155125257|NCT00870194|559890600|FG001|Overall Study|Protocol Violation|3|||
155125258|NCT00870194|559890599|FG000|Overall Study|Entry Criteria Not Met|1|||
155125259|NCT00870194|559890600|FG001|Overall Study|Entry Criteria Not Met|2|||
155125260|NCT00870194|559890599|FG000|Overall Study|Subject Decision|7|||
155125261|NCT00870194|559890600|FG001|Overall Study|Subject Decision|2|||
155125262|NCT02573246|559890601|FG000|Overall Study|Lost to Follow-up|2|||
154923011|NCT05770401|559142231|FG000|Overall Study|Lost to Follow-up|5|||
154923012|NCT05770401|559142232|FG001|Overall Study|Lost to Follow-up|4|||
154923013|NCT00402298|559142233|FG000|Overall Study|Withdrawal by Subject|1|||
154923014|NCT00402298|559142234|FG001|Overall Study|Withdrawal by Subject|0|||
154923015|NCT00480077|559142235|FG000|Overall Study|Death|19|||
154923016|NCT00480077|559142236|FG001|Overall Study|Death|15|||
154923017|NCT00480077|559142235|FG000|Overall Study|early exit|12|||
154923018|NCT00480077|559142236|FG001|Overall Study|early exit|11|||
154923019|NCT05966129|559142237|FG000|Overall Study|Death|1|||
154923020|NCT05966129|559142238|FG001|Overall Study|Death|2|||
154923021|NCT05966129|559142237|FG000|Overall Study|Lost to Follow-up|63|||
154923022|NCT05966129|559142238|FG001|Overall Study|Lost to Follow-up|66|||
154923023|NCT05966129|559142237|FG000|Overall Study|Protocol Violation|1|||
154923024|NCT05966129|559142238|FG001|Overall Study|Protocol Violation|0|||
154923025|NCT05966129|559142237|FG000|Overall Study|Withdrawal by Subject|26|||
154923026|NCT05966129|559142238|FG001|Overall Study|Withdrawal by Subject|25|||
154923027|NCT05966129|559142237|FG000|Overall Study|Surgery not completed|63|||
154923028|NCT05966129|559142238|FG001|Overall Study|Surgery not completed|69|||
155004124|NCT00403585|559439167|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
155004125|NCT00403585|559439167|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
155004126|NCT00403585|559439167|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
155004127|NCT03685344|559439172|FG000|Overall Study|Withdrawal by Subject|1|||
155004128|NCT03685344|559439173|FG001|Overall Study|Withdrawal by Subject|1|||
155004129|NCT03685344|559439174|FG002|Overall Study|Withdrawal by Subject|2|||
155004130|NCT03685344|559439175|FG003|Overall Study|Withdrawal by Subject|0|||
155004131|NCT03685344|559439172|FG000|Overall Study|Physician Decision|1|||
155004132|NCT03685344|559439173|FG001|Overall Study|Physician Decision|1|||
155004133|NCT03685344|559439174|FG002|Overall Study|Physician Decision|5|||
155004134|NCT03685344|559439175|FG003|Overall Study|Physician Decision|0|||
155004135|NCT03685344|559439172|FG000|Overall Study|Death|1|||
155004136|NCT03685344|559439173|FG001|Overall Study|Death|1|||
155004137|NCT03685344|559439174|FG002|Overall Study|Death|0|||
155004138|NCT03685344|559439175|FG003|Overall Study|Death|0|||
155004139|NCT02121652|559439178|FG000|Overall Study|Lost to Follow-up|2|||
155004140|NCT02121652|559439179|FG001|Overall Study|Lost to Follow-up|1|||
155004141|NCT02121652|559439178|FG000|Overall Study|Death|1|||
155004142|NCT02121652|559439179|FG001|Overall Study|Death|0|||
155004143|NCT02121652|559439178|FG000|Overall Study|Withdrawal by Subject|3|||
155004144|NCT02121652|559439179|FG001|Overall Study|Withdrawal by Subject|3|||
155004145|NCT02276807|559439180|FG000|Overall Study|Withdrawal by Subject|8|||
155004146|NCT02276807|559439181|FG001|Overall Study|Withdrawal by Subject|7|||
155004147|NCT02276807|559439180|FG000|Overall Study|Lost to Follow-up|10|||
155004148|NCT02276807|559439181|FG001|Overall Study|Lost to Follow-up|10|||
155004149|NCT00261950|559439184|FG000|Overall Study|Lost to Follow-up|2|||
155004150|NCT00261950|559439184|FG000|Overall Study|Death|6|||
155004151|NCT00261950|559439184|FG000|Overall Study|Withdrawal by Subject|5|||
155004152|NCT00261950|559439184|FG000|Overall Study|Other|1|||
155004153|NCT00261950|559439184|FG000|Overall Study|Physician Decision|1|||
155004154|NCT00261950|559439184|FG000|Overall Study|Protocol specified Criteria|11|||
155004155|NCT01023035|559439185|FG000|Treatment Period|Adverse Event|27|||
155004156|NCT01023035|559439186|FG001|Treatment Period|Adverse Event|32|||
155004157|NCT01023035|559439187|FG002|Treatment Period|Adverse Event|50|||
155004158|NCT01023035|559439185|FG000|Treatment Period|Non-Medical Reasons|19|||
155004159|NCT01023035|559439186|FG001|Treatment Period|Non-Medical Reasons|22|||
155004160|NCT01023035|559439187|FG002|Treatment Period|Non-Medical Reasons|44|||
155004161|NCT01023035|559439185|FG000|Treatment Period|Treatment Failure|26|||
155004162|NCT01023035|559439186|FG001|Treatment Period|Treatment Failure|31|||
155004163|NCT01023035|559439187|FG002|Treatment Period|Treatment Failure|24|||
155004164|NCT01023035|559439185|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
155004165|NCT01023035|559439186|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
155004166|NCT01023035|559439187|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
155004167|NCT01023035|559439185|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
155004168|NCT01023035|559439186|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
155004169|NCT01023035|559439187|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
155004170|NCT00247676|559439192|FG000|Overall Study|Death|5|||
155004171|NCT00247676|559439192|FG000|Overall Study|Adverse Event|11|||
155004172|NCT00247676|559439192|FG000|Overall Study|Lack of Efficacy|15|||
155004173|NCT00247676|559439192|FG000|Overall Study|Other|3|||
155004174|NCT00247676|559439192|FG000|Overall Study|Withdrawal by Subject|2|||
155004175|NCT04342819|559439193|FG000|Overall Study|Declined|4|||
155004176|NCT04342819|559439193|FG000|Overall Study|Not meeeting selection criteria|1|||
155004177|NCT00560391|559439196|FG000|Overall Study|Still on treatment|0|||
155004178|NCT00560391|559439197|FG001|Overall Study|Still on treatment|0|||
155004179|NCT00560391|559439198|FG002|Overall Study|Still on treatment|0|||
155004180|NCT00560391|559439199|FG003|Overall Study|Still on treatment|1|||
155004181|NCT00560391|559439200|FG004|Overall Study|Still on treatment|2|||
155004182|NCT01526655|559439203|FG000|Overall Study|Withdrawal by Subject|0|||
155125263|NCT02573246|559890602|FG001|Overall Study|Lost to Follow-up|0|||
155125264|NCT02573246|559890603|FG002|Overall Study|Lost to Follow-up|0|||
155125265|NCT02573246|559890604|FG003|Overall Study|Lost to Follow-up|0|||
155125266|NCT02573246|559890605|FG004|Overall Study|Lost to Follow-up|1|||
155125267|NCT02573246|559890601|FG000|Overall Study|Withdrawal by Subject|0|||
155125268|NCT02573246|559890602|FG001|Overall Study|Withdrawal by Subject|0|||
155125269|NCT02573246|559890603|FG002|Overall Study|Withdrawal by Subject|0|||
155125270|NCT02573246|559890604|FG003|Overall Study|Withdrawal by Subject|0|||
155125271|NCT02573246|559890605|FG004|Overall Study|Withdrawal by Subject|1|||
155125272|NCT02573246|559890601|FG000|Overall Study|Physician Decision|1|||
155125273|NCT02573246|559890602|FG001|Overall Study|Physician Decision|1|||
155004183|NCT01526655|559439204|FG001|Overall Study|Withdrawal by Subject|1|||
155125274|NCT02573246|559890603|FG002|Overall Study|Physician Decision|3|||
155004184|NCT00280735|559439205|FG000|Overall Study|Adverse Event|5|||
155004185|NCT00280735|559439205|FG000|Overall Study|Lack of Efficacy|3|||
155004186|NCT00280735|559439205|FG000|Overall Study|Withdrawal by Subject|8|||
155004187|NCT00280735|559439205|FG000|Overall Study|Intercurrent Illness|2|||
155004188|NCT04753216|559439206|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
155125275|NCT02573246|559890604|FG003|Overall Study|Physician Decision|2|||
155004189|NCT04753216|559439206|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
155004190|NCT04753216|559439206|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
155004191|NCT01965860|559439207|FG000|Overall Study|Pregnancy|1|||
155004192|NCT01965860|559439208|FG001|Overall Study|Pregnancy|0|||
155004193|NCT01965860|559439209|FG002|Overall Study|Pregnancy|1|||
155004194|NCT01965860|559439207|FG000|Overall Study|Logistics|1|||
155004195|NCT01965860|559439208|FG001|Overall Study|Logistics|0|||
155004196|NCT01965860|559439209|FG002|Overall Study|Logistics|0|||
155004197|NCT00666328|559439224|FG000|Overall Study|Death|2|||
155004198|NCT00666328|559439224|FG000|Overall Study|Lost to Follow-up|2|||
155004199|NCT00666328|559439224|FG000|Overall Study|No longer met eligibility criteria|1|||
155004200|NCT02288325|559439225|FG000|Run-in Period|Adverse Event|48|||
155004201|NCT02288325|559439226|FG001|Run-in Period|Adverse Event|0|||
155004202|NCT02288325|559439227|FG002|Run-in Period|Adverse Event|0|||
155004203|NCT02288325|559439225|FG000|Run-in Period|Lack of Efficacy|16|||
155004204|NCT02288325|559439226|FG001|Run-in Period|Lack of Efficacy|0|||
155004205|NCT02288325|559439227|FG002|Run-in Period|Lack of Efficacy|0|||
155004206|NCT02288325|559439225|FG000|Run-in Period|Withdrawal of Consent|28|||
155004207|NCT02288325|559439226|FG001|Run-in Period|Withdrawal of Consent|0|||
155004208|NCT02288325|559439227|FG002|Run-in Period|Withdrawal of Consent|0|||
155004209|NCT02288325|559439225|FG000|Run-in Period|Lost to Follow-up|25|||
155004210|NCT02288325|559439226|FG001|Run-in Period|Lost to Follow-up|0|||
155004211|NCT02288325|559439227|FG002|Run-in Period|Lost to Follow-up|0|||
155004212|NCT02288325|559439225|FG000|Run-in Period|Protocol Violation|17|||
155004213|NCT02288325|559439226|FG001|Run-in Period|Protocol Violation|0|||
155004214|NCT02288325|559439227|FG002|Run-in Period|Protocol Violation|0|||
155004215|NCT02288325|559439225|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
155004216|NCT02288325|559439226|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
155004217|NCT02288325|559439227|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
155004218|NCT02288325|559439225|FG000|Run-in Period|Reason not Specified|8|||
155004219|NCT02288325|559439226|FG001|Run-in Period|Reason not Specified|0|||
155004220|NCT02288325|559439227|FG002|Run-in Period|Reason not Specified|0|||
155004221|NCT02288325|559439225|FG000|Stabilization Period|Adverse Event|13|||
155004222|NCT02288325|559439226|FG001|Stabilization Period|Adverse Event|0|||
155004223|NCT02288325|559439227|FG002|Stabilization Period|Adverse Event|0|||
155004224|NCT02288325|559439225|FG000|Stabilization Period|Lack of Efficacy|22|||
155004225|NCT02288325|559439226|FG001|Stabilization Period|Lack of Efficacy|0|||
155004226|NCT02288325|559439227|FG002|Stabilization Period|Lack of Efficacy|0|||
155004227|NCT02288325|559439225|FG000|Stabilization Period|Withdrawal of Consent|23|||
155004228|NCT02288325|559439226|FG001|Stabilization Period|Withdrawal of Consent|0|||
155004229|NCT02288325|559439227|FG002|Stabilization Period|Withdrawal of Consent|0|||
155004230|NCT02288325|559439225|FG000|Stabilization Period|Lost to Follow-up|12|||
155004231|NCT02288325|559439226|FG001|Stabilization Period|Lost to Follow-up|0|||
155004232|NCT02288325|559439227|FG002|Stabilization Period|Lost to Follow-up|0|||
155004233|NCT02288325|559439225|FG000|Stabilization Period|Protocol Violation|8|||
155004234|NCT02288325|559439226|FG001|Stabilization Period|Protocol Violation|0|||
155004235|NCT02288325|559439227|FG002|Stabilization Period|Protocol Violation|0|||
155004236|NCT02288325|559439225|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
155004237|NCT02288325|559439226|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
155004238|NCT02288325|559439227|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
155004239|NCT02288325|559439225|FG000|Stabilization Period|Reason not Specified|15|||
155004240|NCT02288325|559439226|FG001|Stabilization Period|Reason not Specified|0|||
155004241|NCT02288325|559439227|FG002|Stabilization Period|Reason not Specified|0|||
155004242|NCT02288325|559439225|FG000|Double-blind Treatment Period|Adverse Event|0|||
155004243|NCT02288325|559439226|FG001|Double-blind Treatment Period|Adverse Event|2|||
155004244|NCT02288325|559439227|FG002|Double-blind Treatment Period|Adverse Event|5|||
155004245|NCT02288325|559439225|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
155004246|NCT02288325|559439226|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
155004247|NCT02288325|559439227|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
155004248|NCT02288325|559439225|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155004249|NCT02288325|559439226|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
155004250|NCT02288325|559439227|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
155004251|NCT02288325|559439225|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155004252|NCT02288325|559439226|FG001|Double-blind Treatment Period|Protocol Violation|1|||
155004253|NCT02288325|559439227|FG002|Double-blind Treatment Period|Protocol Violation|2|||
155004254|NCT02288325|559439225|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
155004255|NCT02288325|559439226|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
155125276|NCT02573246|559890605|FG004|Overall Study|Physician Decision|2|||
155125277|NCT00493636|559890609|FG000|Overall Study|Withdrawal by Subject|1|||
155125278|NCT00493636|559890610|FG001|Overall Study|Withdrawal by Subject|0|||
155125279|NCT00493636|559890609|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
155125280|NCT00493636|559890610|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
155125281|NCT00493636|559890609|FG000|Overall Study|Mis-randomization|1|||
155125282|NCT00493636|559890610|FG001|Overall Study|Mis-randomization|1|||
155004256|NCT02288325|559439227|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
155004257|NCT02288325|559439225|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
155004258|NCT02288325|559439226|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
155004259|NCT02288325|559439227|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
155004260|NCT01884337|559439230|FG000|Treatment|Adverse Event|2|||
155004261|NCT01884337|559439231|FG001|Treatment|Adverse Event|2|||
155004262|NCT01884337|559439230|FG000|Treatment|Subj. request to discont. treatment|2|||
155004263|NCT01884337|559439231|FG001|Treatment|Subj. request to discont. treatment|0|||
155004264|NCT01884337|559439230|FG000|Follow-up Period|Lost to Follow-up|1|||
155004265|NCT01884337|559439231|FG001|Follow-up Period|Lost to Follow-up|1|||
155004266|NCT02455518|559439232|FG000|Overall Study|Protocol Violation|0|||
155004267|NCT02455518|559439233|FG001|Overall Study|Protocol Violation|1|||
155004268|NCT02455518|559439234|FG002|Overall Study|Protocol Violation|1|||
155004269|NCT02455518|559439235|FG003|Overall Study|Protocol Violation|3|||
155004270|NCT00796757|559439236|FG000|Overall Study|Withdrawal by Subject|14|||
155004271|NCT00796757|559439236|FG000|Overall Study|Death|61|||
155004272|NCT00796757|559439236|FG000|Overall Study|Protocol Violation|1|||
155004273|NCT00796757|559439236|FG000|Overall Study|Participant noncompliance|1|||
155004274|NCT00796757|559439236|FG000|Overall Study|Investigator's decision|2|||
155004275|NCT00796757|559439236|FG000|Overall Study|Other|7|||
155004276|NCT00174954|559439240|FG000|Overall Study|Adverse Event|2|||
155004277|NCT00174954|559439240|FG000|Overall Study|No tophi found in MRI|1|||
155004278|NCT00174954|559439240|FG000|Overall Study|Physician Decision|1|||
155004279|NCT00839254|559439241|FG000|Overall Study|Protocol Violation|0|||
155004280|NCT00839254|559439242|FG001|Overall Study|Protocol Violation|1|||
155004281|NCT00839254|559439243|FG002|Overall Study|Protocol Violation|1|||
155004282|NCT00839254|559439244|FG003|Overall Study|Protocol Violation|1|||
155004283|NCT00839254|559439245|FG004|Overall Study|Protocol Violation|0|||
155004284|NCT00839254|559439246|FG005|Overall Study|Protocol Violation|0|||
155004285|NCT00839254|559439247|FG006|Overall Study|Protocol Violation|1|||
155004286|NCT00839254|559439248|FG007|Overall Study|Protocol Violation|2|||
155004287|NCT00839254|559439241|FG000|Overall Study|Physician Decision|0|||
155004288|NCT00839254|559439242|FG001|Overall Study|Physician Decision|1|||
155004289|NCT00839254|559439243|FG002|Overall Study|Physician Decision|0|||
155004290|NCT00839254|559439244|FG003|Overall Study|Physician Decision|0|||
155004291|NCT00839254|559439245|FG004|Overall Study|Physician Decision|0|||
155004292|NCT00839254|559439246|FG005|Overall Study|Physician Decision|0|||
155004293|NCT00839254|559439247|FG006|Overall Study|Physician Decision|0|||
155004294|NCT00839254|559439248|FG007|Overall Study|Physician Decision|1|||
155004295|NCT00839254|559439241|FG000|Overall Study|Wrong treatment number allocation|0|||
155004296|NCT00839254|559439242|FG001|Overall Study|Wrong treatment number allocation|1|||
155004297|NCT00839254|559439243|FG002|Overall Study|Wrong treatment number allocation|0|||
155004298|NCT00839254|559439244|FG003|Overall Study|Wrong treatment number allocation|0|||
155004299|NCT00839254|559439245|FG004|Overall Study|Wrong treatment number allocation|0|||
155004300|NCT00839254|559439246|FG005|Overall Study|Wrong treatment number allocation|1|||
155004301|NCT00839254|559439247|FG006|Overall Study|Wrong treatment number allocation|0|||
155004302|NCT00839254|559439248|FG007|Overall Study|Wrong treatment number allocation|0|||
155004303|NCT00839254|559439241|FG000|Overall Study|Adverse Event|12|||
155004304|NCT00839254|559439242|FG001|Overall Study|Adverse Event|6|||
155004305|NCT00839254|559439243|FG002|Overall Study|Adverse Event|3|||
155004306|NCT00839254|559439244|FG003|Overall Study|Adverse Event|5|||
155004307|NCT00839254|559439245|FG004|Overall Study|Adverse Event|2|||
155004308|NCT00839254|559439246|FG005|Overall Study|Adverse Event|1|||
155004309|NCT00839254|559439247|FG006|Overall Study|Adverse Event|0|||
155004310|NCT00839254|559439248|FG007|Overall Study|Adverse Event|1|||
155004311|NCT00839254|559439241|FG000|Overall Study|Withdrawal by Subject|87|||
155004312|NCT00839254|559439242|FG001|Overall Study|Withdrawal by Subject|53|||
155004313|NCT00839254|559439243|FG002|Overall Study|Withdrawal by Subject|54|||
155004314|NCT00839254|559439244|FG003|Overall Study|Withdrawal by Subject|32|||
155004315|NCT00839254|559439245|FG004|Overall Study|Withdrawal by Subject|27|||
155004316|NCT00839254|559439246|FG005|Overall Study|Withdrawal by Subject|15|||
155004317|NCT00839254|559439247|FG006|Overall Study|Withdrawal by Subject|22|||
155004318|NCT00839254|559439248|FG007|Overall Study|Withdrawal by Subject|9|||
155004319|NCT00839254|559439241|FG000|Overall Study|Wrong group allocation|0|||
155004320|NCT00839254|559439242|FG001|Overall Study|Wrong group allocation|0|||
155004321|NCT00839254|559439243|FG002|Overall Study|Wrong group allocation|0|||
155004322|NCT00839254|559439244|FG003|Overall Study|Wrong group allocation|0|||
155004323|NCT00839254|559439245|FG004|Overall Study|Wrong group allocation|0|||
155004324|NCT00839254|559439246|FG005|Overall Study|Wrong group allocation|0|||
155004325|NCT00839254|559439247|FG006|Overall Study|Wrong group allocation|1|||
155004326|NCT00839254|559439248|FG007|Overall Study|Wrong group allocation|0|||
155004327|NCT00839254|559439241|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
155004328|NCT00839254|559439242|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
155004329|NCT00839254|559439243|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
155004330|NCT00839254|559439244|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
155004331|NCT00839254|559439245|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
155125283|NCT01814670|559890611|FG000|Overall Study|Protocol Violation|12|||
155004332|NCT00839254|559439246|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
155004333|NCT00839254|559439247|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
155004334|NCT00839254|559439248|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
155004335|NCT00839254|559439241|FG000|Overall Study|Withdrawn due to non-compliance|2|||
155004336|NCT00839254|559439242|FG001|Overall Study|Withdrawn due to non-compliance|0|||
155004337|NCT00839254|559439243|FG002|Overall Study|Withdrawn due to non-compliance|0|||
155004338|NCT00839254|559439244|FG003|Overall Study|Withdrawn due to non-compliance|0|||
155004339|NCT00839254|559439245|FG004|Overall Study|Withdrawn due to non-compliance|0|||
155004340|NCT00839254|559439246|FG005|Overall Study|Withdrawn due to non-compliance|0|||
155004341|NCT00839254|559439247|FG006|Overall Study|Withdrawn due to non-compliance|0|||
155004342|NCT00839254|559439248|FG007|Overall Study|Withdrawn due to non-compliance|0|||
155004343|NCT00839254|559439241|FG000|Overall Study|Lost to Follow-up|51|||
155004344|NCT00839254|559439242|FG001|Overall Study|Lost to Follow-up|30|||
155004345|NCT00839254|559439243|FG002|Overall Study|Lost to Follow-up|32|||
155004346|NCT00839254|559439244|FG003|Overall Study|Lost to Follow-up|24|||
155004347|NCT00839254|559439245|FG004|Overall Study|Lost to Follow-up|8|||
155004348|NCT00839254|559439246|FG005|Overall Study|Lost to Follow-up|8|||
155004349|NCT00839254|559439247|FG006|Overall Study|Lost to Follow-up|4|||
155004350|NCT00839254|559439248|FG007|Overall Study|Lost to Follow-up|2|||
155004351|NCT00143247|559439254|FG000|Overall Study|Death|8|||
155004352|NCT00143247|559439254|FG000|Overall Study|Adverse Event|19|||
155004353|NCT00143247|559439254|FG000|Overall Study|Lack of Efficacy|3|||
155004354|NCT00143247|559439254|FG000|Overall Study|Withdrawal by Subject|55|||
155004355|NCT00143247|559439254|FG000|Overall Study|Study terminated by sponsor|31|||
155004356|NCT00143247|559439254|FG000|Overall Study|Protocol Violation|15|||
155004357|NCT00143247|559439254|FG000|Overall Study|Lost to Follow-up|12|||
155004358|NCT00143247|559439254|FG000|Overall Study|following inaccurate lab adverse event|1|||
155004359|NCT00143247|559439254|FG000|Overall Study|Other|12|||
155004360|NCT02933255|559439257|FG000|Overall Study|Discontinued due to study closure.|1|||
155178103|NCT00420641|560091396|FG000|Overall Study|Withdrawal by Subject|15|||
155178104|NCT00420641|560091397|FG001|Overall Study|Withdrawal by Subject|21|||
155178105|NCT00420641|560091398|FG002|Overall Study|Withdrawal by Subject|14|||
155178106|NCT00420641|560091396|FG000|Overall Study|Lack of Efficacy|6|||
155178107|NCT00420641|560091397|FG001|Overall Study|Lack of Efficacy|5|||
155178108|NCT00420641|560091398|FG002|Overall Study|Lack of Efficacy|4|||
155178109|NCT00420641|560091396|FG000|Overall Study|Non-compliance|7|||
155178110|NCT00420641|560091397|FG001|Overall Study|Non-compliance|5|||
155178111|NCT00420641|560091398|FG002|Overall Study|Non-compliance|4|||
154923029|NCT05966129|559142237|FG000|Overall Study|Surgery logistics issue|2|||
154923030|NCT05966129|559142238|FG001|Overall Study|Surgery logistics issue|1|||
154923031|NCT05182840|559142239|FG000|Run-in Period|Not treated|0|||
154923032|NCT05182840|559142240|FG001|Run-in Period|Not treated|1|||
154923033|NCT05182840|559142241|FG002|Run-in Period|Not treated|0|||
154923034|NCT05182840|559142242|FG003|Run-in Period|Not treated|0|||
154923035|NCT05182840|559142243|FG004|Run-in Period|Not treated|0|||
154923036|NCT05182840|559142244|FG005|Run-in Period|Not treated|0|||
154923037|NCT05182840|559142245|FG006|Run-in Period|Not treated|0|||
154923038|NCT05182840|559142246|FG007|Run-in Period|Not treated|0|||
154923039|NCT05182840|559142247|FG008|Run-in Period|Not treated|0|||
154923040|NCT05182840|559142248|FG009|Run-in Period|Not treated|0|||
154923041|NCT05182840|559142239|FG000|Run-in Period|Other reason but not sponsor termination|14|||
154923042|NCT05182840|559142240|FG001|Run-in Period|Other reason but not sponsor termination|18|||
154923043|NCT05182840|559142241|FG002|Run-in Period|Other reason but not sponsor termination|0|||
154923044|NCT05182840|559142242|FG003|Run-in Period|Other reason but not sponsor termination|0|||
154923045|NCT05182840|559142243|FG004|Run-in Period|Other reason but not sponsor termination|0|||
154923046|NCT05182840|559142244|FG005|Run-in Period|Other reason but not sponsor termination|0|||
154923047|NCT05182840|559142245|FG006|Run-in Period|Other reason but not sponsor termination|0|||
154923048|NCT05182840|559142246|FG007|Run-in Period|Other reason but not sponsor termination|0|||
154923049|NCT05182840|559142247|FG008|Run-in Period|Other reason but not sponsor termination|0|||
154923050|NCT05182840|559142248|FG009|Run-in Period|Other reason but not sponsor termination|0|||
154923051|NCT05182840|559142239|FG000|Run-in Period|No reason available|2|||
154923052|NCT05182840|559142240|FG001|Run-in Period|No reason available|2|||
154923053|NCT05182840|559142241|FG002|Run-in Period|No reason available|0|||
154923054|NCT05182840|559142242|FG003|Run-in Period|No reason available|0|||
154923055|NCT05182840|559142243|FG004|Run-in Period|No reason available|0|||
154923056|NCT05182840|559142244|FG005|Run-in Period|No reason available|0|||
154923057|NCT05182840|559142245|FG006|Run-in Period|No reason available|0|||
154923058|NCT05182840|559142246|FG007|Run-in Period|No reason available|0|||
154923059|NCT05182840|559142247|FG008|Run-in Period|No reason available|0|||
154923060|NCT05182840|559142248|FG009|Run-in Period|No reason available|0|||
154923061|NCT05182840|559142239|FG000|Run-in Period|Burden of study procedures|2|||
154923062|NCT05182840|559142240|FG001|Run-in Period|Burden of study procedures|2|||
154923063|NCT05182840|559142241|FG002|Run-in Period|Burden of study procedures|0|||
154923064|NCT05182840|559142242|FG003|Run-in Period|Burden of study procedures|0|||
155004361|NCT02933255|559439258|FG001|Overall Study|Discontinued due to study closure.|0|||
155178112|NCT00420641|560091396|FG000|Overall Study|Other|4|||
155178113|NCT00420641|560091397|FG001|Overall Study|Other|4|||
155004362|NCT02766283|559439259|FG000|Overall Study|Lost to Follow-up|27|||
155004363|NCT00805961|559439260|FG000|Modality Therapy|Withdrawal by Subject|1|||
155004364|NCT00805961|559439260|FG000|Modality Therapy|Adverse Event|1|||
155004365|NCT00805961|559439260|FG000|Modality Therapy|Disease Progression|2|||
155004366|NCT00805961|559439260|FG000|Treatment-Free Interval|Adverse Event|3|||
155004367|NCT00805961|559439260|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
155004368|NCT00805961|559439260|FG000|Treatment-Free Interval|Physician Decision|1|||
155004369|NCT00805961|559439260|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
155004370|NCT00805961|559439260|FG000|Maintenance Treatment|Lack of Efficacy|13|||
155004371|NCT00805961|559439260|FG000|Maintenance Treatment|Intercurrent Illness|7|||
155004372|NCT00805961|559439260|FG000|Maintenance Treatment|Adverse Event|6|||
155004373|NCT00805961|559439260|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
155004374|NCT00805961|559439260|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
155004375|NCT00805961|559439260|FG000|Maintenance Treatment|Withdrawn Consent|1|||
155004376|NCT04803305|559439261|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
155004377|NCT04803305|559439262|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
155004378|NCT04803305|559439261|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
155004379|NCT04803305|559439262|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
155004380|NCT04803305|559439261|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
155004381|NCT04803305|559439262|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
155004382|NCT04803305|559439261|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
155004383|NCT04803305|559439262|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
155004384|NCT04803305|559439261|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
155004385|NCT04803305|559439262|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
155004386|NCT04803305|559439261|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
155004387|NCT04803305|559439262|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
155004388|NCT04803305|559439261|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
155004389|NCT04803305|559439262|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
155004390|NCT04803305|559439261|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
155004391|NCT04803305|559439262|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
155004392|NCT00993421|559439263|FG000|Overall Study|Adverse Event|2|||
155004393|NCT00993421|559439264|FG001|Overall Study|Adverse Event|7|||
155004394|NCT00993421|559439265|FG002|Overall Study|Adverse Event|6|||
155004395|NCT00993421|559439266|FG003|Overall Study|Adverse Event|9|||
155004396|NCT00993421|559439267|FG004|Overall Study|Adverse Event|5|||
155004397|NCT00993421|559439268|FG005|Overall Study|Adverse Event|7|||
155004398|NCT00993421|559439269|FG006|Overall Study|Adverse Event|1|||
155004399|NCT00993421|559439263|FG000|Overall Study|Sponsor Decision|36|||
155004400|NCT00993421|559439264|FG001|Overall Study|Sponsor Decision|31|||
155004401|NCT00993421|559439265|FG002|Overall Study|Sponsor Decision|28|||
155004402|NCT00993421|559439266|FG003|Overall Study|Sponsor Decision|30|||
155004403|NCT00993421|559439267|FG004|Overall Study|Sponsor Decision|38|||
155004404|NCT00993421|559439268|FG005|Overall Study|Sponsor Decision|30|||
155004405|NCT00993421|559439269|FG006|Overall Study|Sponsor Decision|29|||
155004406|NCT00993421|559439263|FG000|Overall Study|Lost to Follow-up|3|||
155004407|NCT00993421|559439264|FG001|Overall Study|Lost to Follow-up|5|||
155004408|NCT00993421|559439265|FG002|Overall Study|Lost to Follow-up|5|||
155004409|NCT00993421|559439266|FG003|Overall Study|Lost to Follow-up|0|||
155004410|NCT00993421|559439267|FG004|Overall Study|Lost to Follow-up|0|||
155004411|NCT00993421|559439268|FG005|Overall Study|Lost to Follow-up|0|||
155004412|NCT00993421|559439269|FG006|Overall Study|Lost to Follow-up|6|||
155004413|NCT00993421|559439263|FG000|Overall Study|Withdrawal by Subject|3|||
155004414|NCT00993421|559439264|FG001|Overall Study|Withdrawal by Subject|2|||
155004415|NCT00993421|559439265|FG002|Overall Study|Withdrawal by Subject|3|||
155004416|NCT00993421|559439266|FG003|Overall Study|Withdrawal by Subject|3|||
155004417|NCT00993421|559439267|FG004|Overall Study|Withdrawal by Subject|3|||
155004418|NCT00993421|559439268|FG005|Overall Study|Withdrawal by Subject|5|||
155004419|NCT00993421|559439269|FG006|Overall Study|Withdrawal by Subject|3|||
155004420|NCT00993421|559439263|FG000|Overall Study|Death|0|||
155004421|NCT00993421|559439264|FG001|Overall Study|Death|0|||
155004422|NCT00993421|559439265|FG002|Overall Study|Death|0|||
155004423|NCT00993421|559439266|FG003|Overall Study|Death|0|||
155004424|NCT00993421|559439267|FG004|Overall Study|Death|0|||
155004425|NCT00993421|559439268|FG005|Overall Study|Death|0|||
155004426|NCT00993421|559439269|FG006|Overall Study|Death|1|||
155004427|NCT00993421|559439263|FG000|Overall Study|Entry Criteria Exclusion|0|||
155004428|NCT00993421|559439264|FG001|Overall Study|Entry Criteria Exclusion|0|||
155004429|NCT00993421|559439265|FG002|Overall Study|Entry Criteria Exclusion|1|||
155004430|NCT00993421|559439266|FG003|Overall Study|Entry Criteria Exclusion|3|||
155004431|NCT00993421|559439267|FG004|Overall Study|Entry Criteria Exclusion|0|||
155004432|NCT00993421|559439268|FG005|Overall Study|Entry Criteria Exclusion|1|||
155004433|NCT00993421|559439269|FG006|Overall Study|Entry Criteria Exclusion|0|||
155004434|NCT00993421|559439263|FG000|Overall Study|Physician Decision|0|||
155004435|NCT00993421|559439264|FG001|Overall Study|Physician Decision|0|||
155004436|NCT00993421|559439265|FG002|Overall Study|Physician Decision|0|||
155004437|NCT00993421|559439266|FG003|Overall Study|Physician Decision|0|||
155004438|NCT00993421|559439267|FG004|Overall Study|Physician Decision|0|||
155004439|NCT00993421|559439268|FG005|Overall Study|Physician Decision|1|||
155004440|NCT00993421|559439269|FG006|Overall Study|Physician Decision|1|||
155004441|NCT00993421|559439263|FG000|Overall Study|Protocol Violation|0|||
155004442|NCT00993421|559439264|FG001|Overall Study|Protocol Violation|0|||
155004443|NCT00993421|559439265|FG002|Overall Study|Protocol Violation|0|||
155004444|NCT00993421|559439266|FG003|Overall Study|Protocol Violation|0|||
155004445|NCT00993421|559439267|FG004|Overall Study|Protocol Violation|0|||
155004446|NCT00993421|559439268|FG005|Overall Study|Protocol Violation|2|||
155004447|NCT00993421|559439269|FG006|Overall Study|Protocol Violation|1|||
155004448|NCT00352417|559439275|FG000|Overall Study|Adverse Event|1|||
155004449|NCT00352417|559439276|FG001|Overall Study|Adverse Event|0|||
155004450|NCT00352417|559439275|FG000|Overall Study|Protocol Violation|0|||
155004451|NCT00352417|559439276|FG001|Overall Study|Protocol Violation|2|||
155004452|NCT00352417|559439275|FG000|Overall Study|Withdrawal by Subject|1|||
155004453|NCT00352417|559439276|FG001|Overall Study|Withdrawal by Subject|2|||
155004454|NCT00352417|559439275|FG000|Overall Study|Lost to Follow-up|1|||
155004455|NCT00352417|559439276|FG001|Overall Study|Lost to Follow-up|0|||
155004456|NCT00352417|559439275|FG000|Overall Study|Schedule Change|2|||
155004457|NCT00352417|559439276|FG001|Overall Study|Schedule Change|1|||
155004458|NCT03207867|559439277|FG000|Overall Study|Adverse Event|1|||
155004459|NCT03207867|559439278|FG001|Overall Study|Adverse Event|0|||
155004460|NCT03207867|559439279|FG002|Overall Study|Adverse Event|1|||
155004461|NCT03207867|559439280|FG003|Overall Study|Adverse Event|0|||
155004462|NCT03207867|559439281|FG004|Overall Study|Adverse Event|0|||
155004463|NCT03207867|559439282|FG005|Overall Study|Adverse Event|2|||
155004464|NCT03207867|559439283|FG006|Overall Study|Adverse Event|1|||
155004465|NCT03207867|559439284|FG007|Overall Study|Adverse Event|1|||
155004466|NCT03207867|559439285|FG008|Overall Study|Adverse Event|2|||
155004467|NCT03207867|559439286|FG009|Overall Study|Adverse Event|2|||
155004468|NCT03207867|559439287|FG010|Overall Study|Adverse Event|0|||
155004469|NCT03207867|559439288|FG011|Overall Study|Adverse Event|0|||
155004470|NCT03207867|559439289|FG012|Overall Study|Adverse Event|0|||
155004471|NCT03207867|559439290|FG013|Overall Study|Adverse Event|0|||
155004472|NCT03207867|559439291|FG014|Overall Study|Adverse Event|0|||
155004473|NCT03207867|559439292|FG015|Overall Study|Adverse Event|0|||
155004474|NCT03207867|559439293|FG016|Overall Study|Adverse Event|3|||
155004475|NCT03207867|559439294|FG017|Overall Study|Adverse Event|1|||
155004476|NCT03207867|559439295|FG018|Overall Study|Adverse Event|2|||
155004477|NCT03207867|559439296|FG019|Overall Study|Adverse Event|1|||
155004478|NCT03207867|559439297|FG020|Overall Study|Adverse Event|0|||
155004479|NCT03207867|559439298|FG021|Overall Study|Adverse Event|0|||
155004480|NCT03207867|559439299|FG022|Overall Study|Adverse Event|0|||
155004481|NCT03207867|559439300|FG023|Overall Study|Adverse Event|0|||
155004482|NCT03207867|559439277|FG000|Overall Study|Death|0|||
155004483|NCT03207867|559439278|FG001|Overall Study|Death|0|||
155004484|NCT03207867|559439279|FG002|Overall Study|Death|0|||
155004485|NCT03207867|559439280|FG003|Overall Study|Death|0|||
155004486|NCT03207867|559439281|FG004|Overall Study|Death|0|||
155004487|NCT03207867|559439282|FG005|Overall Study|Death|1|||
155004488|NCT03207867|559439283|FG006|Overall Study|Death|0|||
155004489|NCT03207867|559439284|FG007|Overall Study|Death|3|||
155004490|NCT03207867|559439285|FG008|Overall Study|Death|1|||
155178114|NCT00420641|560091398|FG002|Overall Study|Other|3|||
155178115|NCT02586506|560091399|FG000|Overall Study|Protocol Violation|6|||
155178116|NCT02586506|560091399|FG000|Overall Study|Lost to Follow-up|1|||
155004491|NCT03207867|559439286|FG009|Overall Study|Death|2|||
155004492|NCT03207867|559439287|FG010|Overall Study|Death|0|||
155178117|NCT02586506|560091399|FG000|Overall Study|Other Reason|2|||
155178118|NCT02815280|560091404|FG000|Double-Blind Phase|Adverse Event|1|||
155178119|NCT02815280|560091405|FG001|Double-Blind Phase|Adverse Event|1|||
155004493|NCT03207867|559439288|FG011|Overall Study|Death|1|||
155004494|NCT03207867|559439289|FG012|Overall Study|Death|0|||
155004495|NCT03207867|559439290|FG013|Overall Study|Death|1|||
155004496|NCT03207867|559439291|FG014|Overall Study|Death|0|||
155004497|NCT03207867|559439292|FG015|Overall Study|Death|0|||
155004498|NCT03207867|559439293|FG016|Overall Study|Death|0|||
155004499|NCT03207867|559439294|FG017|Overall Study|Death|2|||
155004500|NCT03207867|559439295|FG018|Overall Study|Death|0|||
155004501|NCT03207867|559439296|FG019|Overall Study|Death|1|||
155004502|NCT03207867|559439297|FG020|Overall Study|Death|0|||
155004503|NCT03207867|559439298|FG021|Overall Study|Death|0|||
155004504|NCT03207867|559439299|FG022|Overall Study|Death|0|||
155004505|NCT03207867|559439300|FG023|Overall Study|Death|0|||
155004506|NCT03207867|559439277|FG000|Overall Study|Physician Decision|3|||
155004507|NCT03207867|559439278|FG001|Overall Study|Physician Decision|5|||
155004508|NCT03207867|559439279|FG002|Overall Study|Physician Decision|0|||
155004509|NCT03207867|559439280|FG003|Overall Study|Physician Decision|3|||
155004510|NCT03207867|559439281|FG004|Overall Study|Physician Decision|2|||
155004511|NCT03207867|559439282|FG005|Overall Study|Physician Decision|0|||
155004512|NCT03207867|559439283|FG006|Overall Study|Physician Decision|0|||
155004513|NCT03207867|559439284|FG007|Overall Study|Physician Decision|0|||
155178120|NCT02815280|560091404|FG000|Double-Blind Phase|Lost to Follow-up|10|||
155004514|NCT03207867|559439285|FG008|Overall Study|Physician Decision|4|||
155004515|NCT03207867|559439286|FG009|Overall Study|Physician Decision|2|||
155004516|NCT03207867|559439287|FG010|Overall Study|Physician Decision|0|||
155004517|NCT03207867|559439288|FG011|Overall Study|Physician Decision|4|||
155004518|NCT03207867|559439289|FG012|Overall Study|Physician Decision|0|||
155004519|NCT03207867|559439290|FG013|Overall Study|Physician Decision|0|||
155004520|NCT03207867|559439291|FG014|Overall Study|Physician Decision|2|||
155004521|NCT03207867|559439292|FG015|Overall Study|Physician Decision|1|||
155004522|NCT03207867|559439293|FG016|Overall Study|Physician Decision|1|||
155004523|NCT03207867|559439294|FG017|Overall Study|Physician Decision|2|||
155004524|NCT03207867|559439295|FG018|Overall Study|Physician Decision|1|||
155004525|NCT03207867|559439296|FG019|Overall Study|Physician Decision|3|||
155004526|NCT03207867|559439297|FG020|Overall Study|Physician Decision|0|||
155004527|NCT03207867|559439298|FG021|Overall Study|Physician Decision|0|||
155004528|NCT03207867|559439299|FG022|Overall Study|Physician Decision|0|||
155004529|NCT03207867|559439300|FG023|Overall Study|Physician Decision|0|||
155004530|NCT03207867|559439277|FG000|Overall Study|Progressive Disease|7|||
155004531|NCT03207867|559439278|FG001|Overall Study|Progressive Disease|7|||
155004532|NCT03207867|559439279|FG002|Overall Study|Progressive Disease|9|||
155004533|NCT03207867|559439280|FG003|Overall Study|Progressive Disease|10|||
155004534|NCT03207867|559439281|FG004|Overall Study|Progressive Disease|11|||
155004535|NCT03207867|559439282|FG005|Overall Study|Progressive Disease|10|||
155004536|NCT03207867|559439283|FG006|Overall Study|Progressive Disease|9|||
155004537|NCT03207867|559439284|FG007|Overall Study|Progressive Disease|8|||
155004538|NCT03207867|559439285|FG008|Overall Study|Progressive Disease|19|||
155004539|NCT03207867|559439286|FG009|Overall Study|Progressive Disease|23|||
155004540|NCT03207867|559439287|FG010|Overall Study|Progressive Disease|2|||
155004541|NCT03207867|559439288|FG011|Overall Study|Progressive Disease|24|||
155004542|NCT03207867|559439289|FG012|Overall Study|Progressive Disease|3|||
155004543|NCT03207867|559439290|FG013|Overall Study|Progressive Disease|11|||
155004544|NCT03207867|559439291|FG014|Overall Study|Progressive Disease|9|||
155004545|NCT03207867|559439292|FG015|Overall Study|Progressive Disease|5|||
155004546|NCT03207867|559439293|FG016|Overall Study|Progressive Disease|10|||
155004547|NCT03207867|559439294|FG017|Overall Study|Progressive Disease|14|||
155004548|NCT03207867|559439295|FG018|Overall Study|Progressive Disease|13|||
155004549|NCT03207867|559439296|FG019|Overall Study|Progressive Disease|14|||
155004550|NCT03207867|559439297|FG020|Overall Study|Progressive Disease|6|||
155004551|NCT03207867|559439298|FG021|Overall Study|Progressive Disease|3|||
155004552|NCT03207867|559439299|FG022|Overall Study|Progressive Disease|3|||
155004553|NCT03207867|559439300|FG023|Overall Study|Progressive Disease|3|||
155004554|NCT03207867|559439277|FG000|Overall Study|Patient/guardian Decision|0|||
155004555|NCT03207867|559439278|FG001|Overall Study|Patient/guardian Decision|0|||
155004556|NCT03207867|559439279|FG002|Overall Study|Patient/guardian Decision|1|||
155004557|NCT03207867|559439280|FG003|Overall Study|Patient/guardian Decision|1|||
155004558|NCT03207867|559439281|FG004|Overall Study|Patient/guardian Decision|1|||
155004559|NCT03207867|559439282|FG005|Overall Study|Patient/guardian Decision|2|||
155004560|NCT03207867|559439283|FG006|Overall Study|Patient/guardian Decision|1|||
155004561|NCT03207867|559439284|FG007|Overall Study|Patient/guardian Decision|0|||
155004562|NCT03207867|559439285|FG008|Overall Study|Patient/guardian Decision|1|||
155004563|NCT03207867|559439286|FG009|Overall Study|Patient/guardian Decision|0|||
155004564|NCT03207867|559439287|FG010|Overall Study|Patient/guardian Decision|0|||
155004565|NCT03207867|559439288|FG011|Overall Study|Patient/guardian Decision|1|||
155004566|NCT03207867|559439289|FG012|Overall Study|Patient/guardian Decision|0|||
155004567|NCT03207867|559439290|FG013|Overall Study|Patient/guardian Decision|1|||
155004568|NCT03207867|559439291|FG014|Overall Study|Patient/guardian Decision|2|||
155004569|NCT03207867|559439292|FG015|Overall Study|Patient/guardian Decision|0|||
155004570|NCT03207867|559439293|FG016|Overall Study|Patient/guardian Decision|1|||
155004571|NCT03207867|559439294|FG017|Overall Study|Patient/guardian Decision|3|||
155004572|NCT03207867|559439295|FG018|Overall Study|Patient/guardian Decision|4|||
155004573|NCT03207867|559439296|FG019|Overall Study|Patient/guardian Decision|1|||
155004574|NCT03207867|559439297|FG020|Overall Study|Patient/guardian Decision|0|||
155004575|NCT03207867|559439298|FG021|Overall Study|Patient/guardian Decision|0|||
155004576|NCT03207867|559439299|FG022|Overall Study|Patient/guardian Decision|0|||
155004577|NCT03207867|559439300|FG023|Overall Study|Patient/guardian Decision|0|||
155004578|NCT00912912|559439301|FG000|Overall Study|Withdrawal by Subject|1|||
155004579|NCT00912912|559439301|FG000|Overall Study|Disease Progression|3|||
155004580|NCT02447744|559439302|FG000|Overall Study|Withdrawal by Subject|3|||
155004581|NCT02447744|559439303|FG001|Overall Study|Withdrawal by Subject|1|||
155004582|NCT02447744|559439302|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
155004583|NCT02447744|559439303|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
155004584|NCT00306995|559439304|FG000|Study Part I|Withdrawal by Subject|0|||
155004585|NCT00306995|559439305|FG001|Study Part I|Withdrawal by Subject|0|||
155004586|NCT00306995|559439306|FG002|Study Part I|Withdrawal by Subject|0|||
155004587|NCT00306995|559439307|FG003|Study Part I|Withdrawal by Subject|0|||
155125284|NCT02360293|559890612|FG000|Overall Study|Lost to Follow-up|73|||
155004588|NCT00306995|559439308|FG004|Study Part I|Withdrawal by Subject|0|||
155004589|NCT00306995|559439309|FG005|Study Part I|Withdrawal by Subject|0|||
155004590|NCT00306995|559439310|FG006|Study Part I|Withdrawal by Subject|1|||
155004591|NCT00306995|559439304|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
155004592|NCT00306995|559439305|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
155004593|NCT00306995|559439306|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
155004594|NCT00306995|559439307|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
155004595|NCT00306995|559439308|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
155004596|NCT00306995|559439309|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
155004597|NCT00306995|559439310|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
155004598|NCT05422625|559439311|FG000|Overall Study|Withdrawal by Subject|1|||
155004599|NCT05422625|559439312|FG001|Overall Study|Withdrawal by Subject|0|||
155004600|NCT03130777|559440667|FG000|Overall Study|Death|0|||
155004601|NCT03130777|559440668|FG001|Overall Study|Death|1|||
155004602|NCT03130777|559440667|FG000|Overall Study|Did not meet eligibility criteria|1|||
155004603|NCT03130777|559440668|FG001|Overall Study|Did not meet eligibility criteria|0|||
155004604|NCT02586688|559440669|FG000|Overall Study|Lost to Follow-up|2|||
155004605|NCT02586688|559440670|FG001|Overall Study|Lost to Follow-up|1|||
155004606|NCT02586688|559440669|FG000|Overall Study|Withdrawal by Subject|1|||
155004607|NCT02586688|559440670|FG001|Overall Study|Withdrawal by Subject|1|||
155004608|NCT02586688|559440669|FG000|Overall Study|Adverse Event|3|||
155004609|NCT02586688|559440670|FG001|Overall Study|Adverse Event|1|||
155004610|NCT04856917|559440671|FG000|Overall Study|Withdrawal by Subject|4|||
155004611|NCT04856917|559440672|FG001|Overall Study|Withdrawal by Subject|3|||
155004612|NCT04856917|559440673|FG002|Overall Study|Withdrawal by Subject|1|||
155004613|NCT04856917|559440671|FG000|Overall Study|Lost to Follow-up|3|||
155004614|NCT04856917|559440672|FG001|Overall Study|Lost to Follow-up|1|||
155004615|NCT04856917|559440673|FG002|Overall Study|Lost to Follow-up|1|||
155004616|NCT04856917|559440671|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
155004617|NCT04856917|559440672|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
155004618|NCT04856917|559440673|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
155004619|NCT04856917|559440671|FG000|Overall Study|Other|1|||
155004620|NCT04856917|559440672|FG001|Overall Study|Other|1|||
155004621|NCT04856917|559440673|FG002|Overall Study|Other|0|||
155004622|NCT03560037|559440674|FG000|Overall Study|Protocol Violation|1|||
155004623|NCT03560037|559440675|FG001|Overall Study|Protocol Violation|0|||
155004624|NCT03560037|559440674|FG000|Overall Study|Physician Decision|0|||
155004625|NCT03560037|559440675|FG001|Overall Study|Physician Decision|1|||
155004626|NCT00233948|559440676|FG000|Overall Study|Adverse Event|1|||
155004627|NCT00233948|559440677|FG001|Overall Study|Adverse Event|0|||
155004628|NCT00233948|559440678|FG002|Overall Study|Adverse Event|0|||
155004629|NCT00233948|559440679|FG003|Overall Study|Adverse Event|0|||
155004630|NCT00233948|559440680|FG004|Overall Study|Adverse Event|0|||
155004631|NCT00233948|559440681|FG005|Overall Study|Adverse Event|0|||
155004632|NCT00064987|559440682|FG000|Overall Study|Physician Decision|3|||
155004633|NCT00064987|559440683|FG001|Overall Study|Physician Decision|0|||
155004634|NCT01567462|559440684|FG000|Overall Study|Withdrawal by Subject|4|||
155004635|NCT01567462|559440685|FG001|Overall Study|Withdrawal by Subject|7|||
155004636|NCT05223920|559440688|FG000|Overall Study|Adverse Event|6|||
155004637|NCT05223920|559440689|FG001|Overall Study|Adverse Event|3|||
155004638|NCT05223920|559440688|FG000|Overall Study|Death|2|||
155004639|NCT05223920|559440689|FG001|Overall Study|Death|0|||
155004640|NCT05223920|559440688|FG000|Overall Study|Disease Progression|1|||
155004641|NCT05223920|559440689|FG001|Overall Study|Disease Progression|2|||
155004642|NCT05223920|559440688|FG000|Overall Study|Physician Decision|1|||
155004643|NCT05223920|559440689|FG001|Overall Study|Physician Decision|2|||
155004644|NCT05223920|559440688|FG000|Overall Study|Sponsor decision|11|||
155004645|NCT05223920|559440689|FG001|Overall Study|Sponsor decision|9|||
155004646|NCT05223920|559440688|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
155004647|NCT05223920|559440689|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
155004648|NCT05223920|559440688|FG000|Overall Study|Subject decision|1|||
155004649|NCT05223920|559440689|FG001|Overall Study|Subject decision|0|||
155004650|NCT05223920|559440688|FG000|Overall Study|Withdrawal by Subject|1|||
155004651|NCT05223920|559440689|FG001|Overall Study|Withdrawal by Subject|6|||
155004652|NCT02862730|559440690|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155004653|NCT02862730|559440691|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155004654|NCT02862730|559440692|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
155004655|NCT02862730|559440693|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155004656|NCT02862730|559440694|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155004657|NCT02862730|559440695|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155004658|NCT02862730|559440696|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
155004659|NCT02862730|559440690|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
155004660|NCT02862730|559440691|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155004661|NCT02862730|559440692|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155004662|NCT02862730|559440693|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155004663|NCT02862730|559440694|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155004664|NCT02862730|559440695|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155004665|NCT02862730|559440696|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
155004666|NCT02862730|559440690|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155004667|NCT02862730|559440691|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155004668|NCT02862730|559440692|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
155004669|NCT02862730|559440693|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155004670|NCT02862730|559440694|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
155004671|NCT02862730|559440695|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155004672|NCT02862730|559440696|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
155004673|NCT02862730|559440690|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155004674|NCT02862730|559440691|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155004675|NCT02862730|559440692|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155004676|NCT02862730|559440693|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
155004677|NCT02862730|559440694|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155004678|NCT02862730|559440695|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155004679|NCT02862730|559440696|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
155004680|NCT00445432|559440699|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
155004681|NCT00445432|559440700|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
155004682|NCT00445432|559440701|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
155004683|NCT00445432|559440702|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
155004684|NCT00445432|559440699|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
155004685|NCT00445432|559440700|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
155004686|NCT00445432|559440701|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
155004687|NCT00445432|559440702|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
155004688|NCT00445432|559440699|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
155004689|NCT00445432|559440700|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
155004690|NCT00445432|559440701|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
155004691|NCT00445432|559440702|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
155004692|NCT00445432|559440699|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
155004693|NCT00445432|559440700|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
155004694|NCT00445432|559440701|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
155004695|NCT00445432|559440702|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
155004696|NCT00445432|559440699|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
155004697|NCT00445432|559440700|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
155004698|NCT00445432|559440701|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
155004699|NCT00445432|559440702|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
155004700|NCT00445432|559440699|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
155004701|NCT00445432|559440700|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
155004702|NCT00445432|559440701|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
155004703|NCT00445432|559440702|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
155004704|NCT00445432|559440699|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
155004705|NCT00445432|559440700|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
155004706|NCT00445432|559440701|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
155004707|NCT00445432|559440702|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
155004708|NCT02789137|559440703|FG000|Overall Study|Dropped out/Died|58|||
155004709|NCT01090414|559440704|FG000|Study 101-99|Progressive Disease|28|||
155004710|NCT01090414|559440705|FG001|Study 101-99|Progressive Disease|48|||
155004711|NCT01090414|559440706|FG002|Study 101-99|Progressive Disease|10|||
155004712|NCT01090414|559440707|FG003|Study 101-99|Progressive Disease|4|||
155004713|NCT01090414|559440704|FG000|Study 101-99|Adverse Event|10|||
155004714|NCT01090414|559440705|FG001|Study 101-99|Adverse Event|28|||
155004715|NCT01090414|559440706|FG002|Study 101-99|Adverse Event|18|||
155004716|NCT01090414|559440707|FG003|Study 101-99|Adverse Event|0|||
155004717|NCT01090414|559440704|FG000|Study 101-99|Investigator Request|1|||
155004718|NCT01090414|559440705|FG001|Study 101-99|Investigator Request|11|||
155004719|NCT01090414|559440706|FG002|Study 101-99|Investigator Request|4|||
155004720|NCT01090414|559440707|FG003|Study 101-99|Investigator Request|0|||
155004721|NCT01090414|559440704|FG000|Study 101-99|Death|3|||
155004722|NCT01090414|559440705|FG001|Study 101-99|Death|8|||
155004723|NCT01090414|559440706|FG002|Study 101-99|Death|1|||
155004724|NCT01090414|559440707|FG003|Study 101-99|Death|0|||
155004725|NCT01090414|559440704|FG000|Study 101-99|Sponsor Discontinued Study|0|||
155004726|NCT01090414|559440705|FG001|Study 101-99|Sponsor Discontinued Study|7|||
155004727|NCT01090414|559440706|FG002|Study 101-99|Sponsor Discontinued Study|5|||
155004728|NCT01090414|559440707|FG003|Study 101-99|Sponsor Discontinued Study|0|||
155004729|NCT01090414|559440704|FG000|Study 101-99|Other (Unknown Reasons)|3|||
155004730|NCT01090414|559440705|FG001|Study 101-99|Other (Unknown Reasons)|3|||
155004731|NCT01090414|559440706|FG002|Study 101-99|Other (Unknown Reasons)|0|||
155004732|NCT01090414|559440707|FG003|Study 101-99|Other (Unknown Reasons)|0|||
155004733|NCT01090414|559440704|FG000|Study 101-99|Withdrew Consent|0|||
155004734|NCT01090414|559440705|FG001|Study 101-99|Withdrew Consent|2|||
155178121|NCT02815280|560091405|FG001|Double-Blind Phase|Lost to Follow-up|9|||
155178122|NCT02815280|560091404|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
155004735|NCT01090414|559440706|FG002|Study 101-99|Withdrew Consent|3|||
155004736|NCT01090414|559440707|FG003|Study 101-99|Withdrew Consent|1|||
155004737|NCT01090414|559440704|FG000|Study 101-99|Participant Request|3|||
155004738|NCT01090414|559440705|FG001|Study 101-99|Participant Request|1|||
155004739|NCT01090414|559440706|FG002|Study 101-99|Participant Request|0|||
155004740|NCT01090414|559440707|FG003|Study 101-99|Participant Request|0|||
155004741|NCT00799058|559440714|FG000|Overall Study|Withdrawal by Subject|2|||
155004742|NCT00799058|559440715|FG001|Overall Study|Withdrawal by Subject|2|||
155004743|NCT00799058|559440716|FG002|Overall Study|Withdrawal by Subject|2|||
155004744|NCT00799058|559440714|FG000|Overall Study|Lost to Follow-up|1|||
155004745|NCT00799058|559440715|FG001|Overall Study|Lost to Follow-up|2|||
155004746|NCT00799058|559440716|FG002|Overall Study|Lost to Follow-up|1|||
155004747|NCT00799058|559440714|FG000|Overall Study|Adverse Event|0|||
155004748|NCT00799058|559440715|FG001|Overall Study|Adverse Event|2|||
155004749|NCT00799058|559440716|FG002|Overall Study|Adverse Event|0|||
155004750|NCT00799058|559440714|FG000|Overall Study|Pregnancy|1|||
155004751|NCT00799058|559440715|FG001|Overall Study|Pregnancy|0|||
155004752|NCT00799058|559440716|FG002|Overall Study|Pregnancy|0|||
155004753|NCT00799058|559440714|FG000|Overall Study|Not adherent|3|||
155004754|NCT00799058|559440715|FG001|Overall Study|Not adherent|2|||
155004755|NCT00799058|559440716|FG002|Overall Study|Not adherent|1|||
155004756|NCT00799058|559440714|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
155004757|NCT00799058|559440715|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
155004758|NCT00799058|559440716|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
155004759|NCT00799058|559440714|FG000|Overall Study|IP dispensing error|1|||
155004760|NCT00799058|559440715|FG001|Overall Study|IP dispensing error|0|||
155004761|NCT00799058|559440716|FG002|Overall Study|IP dispensing error|0|||
155004762|NCT00799058|559440714|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
155004763|NCT00799058|559440715|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
155004764|NCT00799058|559440716|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
155004765|NCT00799058|559440714|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
155004766|NCT00799058|559440715|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
155004767|NCT00799058|559440716|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
155004768|NCT00799058|559440714|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
155004769|NCT00799058|559440715|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
155004770|NCT00799058|559440716|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
155004771|NCT00799058|559440714|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
155004772|NCT00799058|559440715|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
155004773|NCT00799058|559440716|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
155004774|NCT02088697|559440721|FG000|Period I|Physician Decision|1|||
155004775|NCT02088697|559440722|FG001|Period I|Physician Decision|4|||
155004776|NCT02088697|559440721|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
155004777|NCT02088697|559440722|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
155004778|NCT03594071|559440723|FG000|Overall Study|Re-operation|3|||
155004779|NCT03594071|559440723|FG000|Overall Study|Missed visit|2|||
155004780|NCT03022370|559440724|FG000|Overall Study|Death|6|||
155004781|NCT03022370|559440725|FG001|Overall Study|Death|12|||
155004782|NCT03022370|559440724|FG000|Overall Study|Lost to Follow-up|174|||
155004783|NCT03022370|559440725|FG001|Overall Study|Lost to Follow-up|109|||
155004784|NCT00668317|559440726|FG000|Overall Study|Adverse Event|2|||
155004785|NCT02064296|559440731|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
155004786|NCT02064296|559440732|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
155004787|NCT02064296|559440733|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
155004788|NCT02064296|559440731|FG000|Intervention|Withdrawal by Subject|0|||
155004789|NCT02064296|559440732|FG001|Intervention|Withdrawal by Subject|1|||
155004790|NCT02064296|559440733|FG002|Intervention|Withdrawal by Subject|2|||
155004791|NCT04186845|559440737|FG000|Overall Study|Death|2|||
155004792|NCT04186845|559440737|FG000|Overall Study|Lost to Follow-up|1|||
155004793|NCT04186845|559440737|FG000|Overall Study|Physician Decision|1|||
155004794|NCT04186845|559440737|FG000|Overall Study|Protocol Violation|1|||
155004795|NCT04186845|559440737|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
155004796|NCT04186845|559440737|FG000|Overall Study|Biopsy ordered but not done|1|||
155004797|NCT04186845|559440737|FG000|Overall Study|It was previously confirmed|1|||
155004798|NCT04186845|559440737|FG000|Overall Study|Patient cancelled scheduled scans|2|||
155004799|NCT04186845|559440737|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
155004800|NCT04186845|559440737|FG000|Overall Study|Subject refused confirmatory imaging|1|||
155004801|NCT04186845|559440737|FG000|Overall Study|Too small to biopsy|1|||
155004802|NCT03151304|559440738|FG000|Overall Study|Termination of study by Sponsor|23|||
155004803|NCT03151304|559440738|FG000|Overall Study|missing|3|||
155004804|NCT03151304|559440738|FG000|Overall Study|Withdrawal by Subject|8|||
155004805|NCT03151304|559440738|FG000|Overall Study|multiple reasons|30|||
155004806|NCT01332292|559440740|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155004807|NCT01332292|559440741|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155004808|NCT01332292|559440740|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
155004809|NCT01332292|559440741|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
155004810|NCT01332292|559440740|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
155004811|NCT01332292|559440741|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
155004812|NCT00098774|559440743|FG000|Overall Study|Adverse Event|2|||
155004813|NCT00098774|559440743|FG000|Overall Study|Disease Progression|9|||
155004814|NCT00098774|559440743|FG000|Overall Study|Withdrawal by Subject|1|||
155004815|NCT00098774|559440743|FG000|Overall Study|Failed (to respond) during induction|4|||
155004816|NCT00098774|559440743|FG000|Overall Study|Physician Decision|2|||
155004817|NCT01330303|559440744|FG000|Period 1|Adverse Event|1|||
155004818|NCT01330303|559440745|FG001|Period 1|Adverse Event|0|||
155004819|NCT01330303|559440744|FG000|Period 1|Protocol Violation|0|||
155004820|NCT01330303|559440745|FG001|Period 1|Protocol Violation|1|||
155004821|NCT01330303|559440744|FG000|Period 1|Withdrawal by Subject|0|||
155004822|NCT01330303|559440745|FG001|Period 1|Withdrawal by Subject|1|||
155004823|NCT02593110|559440747|FG000|Overall Study|Withdrawal by Subject|0|||
155004824|NCT02593110|559440748|FG001|Overall Study|Withdrawal by Subject|3|||
155004825|NCT02593110|559440749|FG002|Overall Study|Withdrawal by Subject|3|||
155004826|NCT02593110|559440750|FG003|Overall Study|Withdrawal by Subject|2|||
155004827|NCT02593110|559440747|FG000|Overall Study|Death|0|||
155004828|NCT02593110|559440748|FG001|Overall Study|Death|0|||
155004829|NCT02593110|559440749|FG002|Overall Study|Death|1|||
155004830|NCT02593110|559440750|FG003|Overall Study|Death|0|||
155004831|NCT03548337|559440751|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
155004832|NCT03548337|559440752|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
155004833|NCT03548337|559440751|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
155004834|NCT03548337|559440752|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
155004835|NCT03548337|559440751|FG000|Infant Series|Lost to Follow-up|2|||
155004836|NCT03548337|559440752|FG001|Infant Series|Lost to Follow-up|1|||
155004837|NCT03548337|559440751|FG000|Infant Series|Adverse Event|0|||
155004838|NCT03548337|559440752|FG001|Infant Series|Adverse Event|2|||
155004839|NCT03548337|559440751|FG000|Infant Series|Randomized but Not Vaccinated|1|||
155004840|NCT03548337|559440752|FG001|Infant Series|Randomized but Not Vaccinated|0|||
155004841|NCT03548337|559440751|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
155004842|NCT03548337|559440752|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
155004843|NCT04502212|559440755|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
155004844|NCT04502212|559440755|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
155004845|NCT01911273|559440760|FG000|Overall Study|Progression of Disease|1|||
155004846|NCT01911273|559440761|FG001|Overall Study|Progression of Disease|0|||
155004847|NCT01911273|559440760|FG000|Overall Study|Withdrawal by Subject|0|||
155004848|NCT01911273|559440761|FG001|Overall Study|Withdrawal by Subject|2|||
155004849|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
155004850|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Off-label use|283|||
155004851|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
155004852|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
155004853|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
155004854|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
155004855|NCT01070953|559440766|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
155004856|NCT01070953|559440766|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
155004857|NCT01070953|559440766|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
155004858|NCT01070953|559440766|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
155004859|NCT02503787|559440767|FG000|Enrollment|Withdrawal by Subject|6|||
155004860|NCT02503787|559440767|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
155004861|NCT02503787|559440767|FG000|Enrollment|Physician Decision|2|||
155004862|NCT02503787|559440767|FG000|Enrollment|Insurance issue|2|||
155004863|NCT02503787|559440767|FG000|Enrollment|Lost to Follow-up|1|||
155004864|NCT02503787|559440767|FG000|Enrollment|Study closure|1|||
155004865|NCT02503787|559440767|FG000|Enrollment|Adverse Event|1|||
155004866|NCT02503787|559440767|FG000|Enrollment|Protocol Violation|1|||
155004867|NCT02503787|559440767|FG000|Enrollment|Inability to implant system|1|||
155004868|NCT02503787|559440767|FG000|Enrollment|Unable to be programmed|1|||
155004869|NCT02503787|559440767|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
155004870|NCT02503787|559440767|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
155125285|NCT02360293|559890613|FG001|Overall Study|Lost to Follow-up|95|||
155125286|NCT02360293|559890612|FG000|Overall Study|Withdrawal by Subject|2|||
155004871|NCT02503787|559440767|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
155004872|NCT02503787|559440767|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
155125287|NCT02360293|559890613|FG001|Overall Study|Withdrawal by Subject|1|||
155004873|NCT02503787|559440767|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
155004874|NCT02503787|559440767|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
155125288|NCT02360293|559890612|FG000|Overall Study|Excluded|1|||
155004875|NCT04700137|559440768|FG000|Overall Study|Lost to Follow-up|1|||
155004876|NCT04700137|559440769|FG001|Overall Study|Lost to Follow-up|6|||
155004877|NCT04700137|559440770|FG002|Overall Study|Lost to Follow-up|1|||
155004878|NCT04700137|559440771|FG003|Overall Study|Lost to Follow-up|1|||
155004879|NCT04700137|559440768|FG000|Overall Study|Withdrawal by Subject|0|||
155004880|NCT04700137|559440769|FG001|Overall Study|Withdrawal by Subject|0|||
155004881|NCT04700137|559440770|FG002|Overall Study|Withdrawal by Subject|1|||
155004882|NCT04700137|559440771|FG003|Overall Study|Withdrawal by Subject|0|||
155004883|NCT04700137|559440768|FG000|Overall Study|Death|0|||
155004884|NCT04700137|559440769|FG001|Overall Study|Death|0|||
155004885|NCT04700137|559440770|FG002|Overall Study|Death|1|||
155004886|NCT04700137|559440771|FG003|Overall Study|Death|0|||
155004887|NCT04787627|559440772|FG000|Overall Study|Withdrawal by Subject|3|||
155004888|NCT04787627|559440773|FG001|Overall Study|Withdrawal by Subject|0|||
155004889|NCT04787627|559440772|FG000|Overall Study|Physician Decision|2|||
155004890|NCT04787627|559440773|FG001|Overall Study|Physician Decision|0|||
155004891|NCT04787627|559440772|FG000|Overall Study|Excluded|0|||
155004892|NCT04787627|559440773|FG001|Overall Study|Excluded|1|||
155004893|NCT03017612|559440777|FG000|Overall Study|Adverse Event|2|||
155004894|NCT02517463|559440778|FG000|Overall Study|Lost to Follow-up|5|||
155004895|NCT02517463|559440779|FG001|Overall Study|Lost to Follow-up|2|||
155004896|NCT02296931|559440785|FG000|Overall Study|Protocol Violation|0|||
155004897|NCT02296931|559440786|FG001|Overall Study|Protocol Violation|2|||
155004898|NCT01590277|559440787|FG000|Overall Study|Withdrawal by Subject|3|||
155004899|NCT01590277|559440787|FG000|Overall Study|Withdrawal by Subject|2|||
155004900|NCT01590277|559440787|FG000|Overall Study|Withdrawal by Subject|1|||
155004901|NCT01590277|559440787|FG000|Overall Study|Withdrawal by Subject|1|||
155004902|NCT04386616|559440788|FG000|Overall Study|Death|22|||
155004903|NCT04386616|559440789|FG001|Overall Study|Death|22|||
155004904|NCT04386616|559440790|FG002|Overall Study|Death|21|||
155004905|NCT04386616|559440788|FG000|Overall Study|Lost to Follow-up|5|||
155004906|NCT04386616|559440789|FG001|Overall Study|Lost to Follow-up|8|||
155004907|NCT04386616|559440790|FG002|Overall Study|Lost to Follow-up|6|||
155004908|NCT04386616|559440788|FG000|Overall Study|Withdrawal by Subject|2|||
155004909|NCT04386616|559440789|FG001|Overall Study|Withdrawal by Subject|4|||
155004910|NCT04386616|559440790|FG002|Overall Study|Withdrawal by Subject|1|||
155004911|NCT04386616|559440788|FG000|Overall Study|Adverse Event|1|||
155004912|NCT04386616|559440789|FG001|Overall Study|Adverse Event|1|||
155004913|NCT04386616|559440790|FG002|Overall Study|Adverse Event|0|||
155004914|NCT01377012|559440791|FG000|Core Study|Study terminated by Sponsor|47|||
155004915|NCT01377012|559440792|FG001|Core Study|Study terminated by Sponsor|54|||
155004916|NCT01377012|559440793|FG002|Core Study|Study terminated by Sponsor|46|||
155004917|NCT01377012|559440791|FG000|Core Study|Technical problems|1|||
155004918|NCT01377012|559440792|FG001|Core Study|Technical problems|0|||
155004919|NCT01377012|559440793|FG002|Core Study|Technical problems|0|||
155004920|NCT01377012|559440791|FG000|Core Study|Withdrawal by Subject|15|||
155004921|NCT01377012|559440792|FG001|Core Study|Withdrawal by Subject|23|||
155004922|NCT01377012|559440793|FG002|Core Study|Withdrawal by Subject|18|||
155004923|NCT01377012|559440791|FG000|Core Study|Protocol Violation|7|||
155004924|NCT01377012|559440792|FG001|Core Study|Protocol Violation|3|||
155004925|NCT01377012|559440793|FG002|Core Study|Protocol Violation|2|||
155004926|NCT01377012|559440791|FG000|Core Study|Pregnancy|0|||
155004927|NCT01377012|559440792|FG001|Core Study|Pregnancy|0|||
155004928|NCT01377012|559440793|FG002|Core Study|Pregnancy|1|||
155004929|NCT01377012|559440791|FG000|Core Study|Physician Decision|5|||
155004930|NCT01377012|559440792|FG001|Core Study|Physician Decision|4|||
155004931|NCT01377012|559440793|FG002|Core Study|Physician Decision|10|||
155004932|NCT01377012|559440791|FG000|Core Study|Non-Compliant with study treatment|0|||
155004933|NCT01377012|559440792|FG001|Core Study|Non-Compliant with study treatment|0|||
155004934|NCT01377012|559440793|FG002|Core Study|Non-Compliant with study treatment|1|||
155004935|NCT01377012|559440791|FG000|Core Study|No Longer require treatment|0|||
155004936|NCT01377012|559440792|FG001|Core Study|No Longer require treatment|0|||
155004937|NCT01377012|559440793|FG002|Core Study|No Longer require treatment|1|||
155004938|NCT01377012|559440791|FG000|Core Study|Lost to Follow-up|7|||
155004939|NCT01377012|559440792|FG001|Core Study|Lost to Follow-up|5|||
155004940|NCT01377012|559440793|FG002|Core Study|Lost to Follow-up|4|||
155004941|NCT01377012|559440791|FG000|Core Study|Lack of Efficacy|41|||
155004942|NCT01377012|559440792|FG001|Core Study|Lack of Efficacy|28|||
155178123|NCT02815280|560091405|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
155004943|NCT01377012|559440793|FG002|Core Study|Lack of Efficacy|37|||
155004944|NCT01377012|559440791|FG000|Core Study|Death|1|||
155004945|NCT01377012|559440792|FG001|Core Study|Death|1|||
155004946|NCT01377012|559440793|FG002|Core Study|Death|1|||
155004947|NCT01377012|559440791|FG000|Core Study|Adverse Event|10|||
155004948|NCT01377012|559440792|FG001|Core Study|Adverse Event|14|||
155004949|NCT01377012|559440793|FG002|Core Study|Adverse Event|13|||
155004950|NCT01377012|559440791|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
155004951|NCT01377012|559440792|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
155004952|NCT01377012|559440793|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
155004953|NCT01377012|559440791|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
155004954|NCT01377012|559440792|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
155004955|NCT01377012|559440793|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
155004956|NCT01377012|559440791|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
155004957|NCT01377012|559440792|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
155004958|NCT01377012|559440793|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
155004959|NCT01377012|559440791|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
155004960|NCT01377012|559440792|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
155004961|NCT01377012|559440793|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
155004962|NCT01377012|559440791|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
155004963|NCT01377012|559440792|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
155004964|NCT01377012|559440793|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
155004965|NCT01377012|559440791|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
155004966|NCT01377012|559440792|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
155004967|NCT01377012|559440793|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
155004968|NCT00451178|559440798|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
155004969|NCT00451178|559440799|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
155004970|NCT00451178|559440798|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
155004971|NCT00451178|559440799|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
155004972|NCT00451178|559440798|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
155004973|NCT00451178|559440799|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
155125289|NCT02360293|559890613|FG001|Overall Study|Excluded|0|||
155125290|NCT02012686|559890616|FG000|Overall Study|muscle contraction|0|||
155125291|NCT02012686|559890617|FG001|Overall Study|muscle contraction|1|||
155125292|NCT02012686|559890616|FG000|Overall Study|electrocardiography monitoring noise|0|||
155125293|NCT02012686|559890617|FG001|Overall Study|electrocardiography monitoring noise|1|||
155125294|NCT00966719|559890618|FG000|Overall Study|Lost to Follow-up|6|||
155125295|NCT00966719|559890619|FG001|Overall Study|Lost to Follow-up|11|||
155125296|NCT03242018|559890620|FG000|Overall Study|Adverse Event|7|||
155125297|NCT03242018|559890621|FG001|Overall Study|Adverse Event|7|||
155125298|NCT03242018|559890622|FG002|Overall Study|Adverse Event|6|||
155125299|NCT03242018|559890620|FG000|Overall Study|Lost to Follow-up|2|||
155125300|NCT03242018|559890621|FG001|Overall Study|Lost to Follow-up|2|||
155125301|NCT03242018|559890622|FG002|Overall Study|Lost to Follow-up|2|||
154923065|NCT05182840|559142243|FG004|Run-in Period|Burden of study procedures|0|||
154923066|NCT05182840|559142244|FG005|Run-in Period|Burden of study procedures|0|||
154923067|NCT05182840|559142245|FG006|Run-in Period|Burden of study procedures|0|||
154923068|NCT05182840|559142246|FG007|Run-in Period|Burden of study procedures|0|||
154923069|NCT05182840|559142247|FG008|Run-in Period|Burden of study procedures|0|||
154923070|NCT05182840|559142248|FG009|Run-in Period|Burden of study procedures|0|||
154923071|NCT05182840|559142239|FG000|Run-in Period|Change of residence|1|||
154923072|NCT05182840|559142240|FG001|Run-in Period|Change of residence|0|||
154923073|NCT05182840|559142241|FG002|Run-in Period|Change of residence|0|||
154923074|NCT05182840|559142242|FG003|Run-in Period|Change of residence|0|||
154923075|NCT05182840|559142243|FG004|Run-in Period|Change of residence|0|||
154923076|NCT05182840|559142244|FG005|Run-in Period|Change of residence|0|||
154923077|NCT05182840|559142245|FG006|Run-in Period|Change of residence|0|||
154923078|NCT05182840|559142246|FG007|Run-in Period|Change of residence|0|||
154923079|NCT05182840|559142247|FG008|Run-in Period|Change of residence|0|||
154923080|NCT05182840|559142248|FG009|Run-in Period|Change of residence|0|||
154923081|NCT05182840|559142239|FG000|Run-in Period|Adverse Event|5|||
154923082|NCT05182840|559142240|FG001|Run-in Period|Adverse Event|5|||
154923083|NCT05182840|559142241|FG002|Run-in Period|Adverse Event|0|||
154923084|NCT05182840|559142242|FG003|Run-in Period|Adverse Event|0|||
154923085|NCT05182840|559142243|FG004|Run-in Period|Adverse Event|0|||
154923086|NCT05182840|559142244|FG005|Run-in Period|Adverse Event|0|||
154923087|NCT05182840|559142245|FG006|Run-in Period|Adverse Event|0|||
154923088|NCT05182840|559142246|FG007|Run-in Period|Adverse Event|0|||
154923089|NCT05182840|559142247|FG008|Run-in Period|Adverse Event|0|||
154923090|NCT05182840|559142248|FG009|Run-in Period|Adverse Event|0|||
154923091|NCT05182840|559142239|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
154923092|NCT05182840|559142240|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
154923093|NCT05182840|559142241|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
154923094|NCT05182840|559142242|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
154923095|NCT05182840|559142243|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
154923096|NCT05182840|559142244|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
154923097|NCT05182840|559142245|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
154923098|NCT05182840|559142246|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
154923099|NCT05182840|559142247|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155125302|NCT03242018|559890620|FG000|Overall Study|At the Participant's Own Request|5|||
155178124|NCT02815280|560091404|FG000|Double-Blind Phase|Protocol Violation|2|||
155178125|NCT02815280|560091405|FG001|Double-Blind Phase|Protocol Violation|2|||
155178126|NCT02815280|560091404|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
155178127|NCT02815280|560091405|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
155178128|NCT02815280|560091404|FG000|Open-Label Phase|Adverse Event|2|||
155178129|NCT02815280|560091405|FG001|Open-Label Phase|Adverse Event|3|||
155178130|NCT02815280|560091404|FG000|Open-Label Phase|Lost to Follow-up|18|||
155178131|NCT02815280|560091405|FG001|Open-Label Phase|Lost to Follow-up|9|||
155178132|NCT02815280|560091404|FG000|Open-Label Phase|Withdrawal by Subject|33|||
155178133|NCT02815280|560091405|FG001|Open-Label Phase|Withdrawal by Subject|18|||
155178134|NCT02815280|560091404|FG000|Open-Label Phase|Protocol Violation|3|||
155178135|NCT02815280|560091405|FG001|Open-Label Phase|Protocol Violation|0|||
155178136|NCT02815280|560091404|FG000|Open-Label Phase|Administrative|26|||
155178137|NCT02815280|560091405|FG001|Open-Label Phase|Administrative|12|||
155178138|NCT02815280|560091404|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
155178139|NCT02815280|560091405|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
155125303|NCT03242018|559890621|FG001|Overall Study|At the Participant's Own Request|1|||
155125304|NCT03242018|559890622|FG002|Overall Study|At the Participant's Own Request|4|||
155125305|NCT03242018|559890620|FG000|Overall Study|Reason Not Specified|3|||
155125306|NCT03242018|559890621|FG001|Overall Study|Reason Not Specified|4|||
155125307|NCT03242018|559890622|FG002|Overall Study|Reason Not Specified|1|||
155125308|NCT03242018|559890620|FG000|Overall Study|Study Terminated by Sponsor|1|||
155125309|NCT03242018|559890621|FG001|Overall Study|Study Terminated by Sponsor|0|||
155125310|NCT03242018|559890622|FG002|Overall Study|Study Terminated by Sponsor|1|||
155125311|NCT02635347|559890624|FG000|Overall Study|Failed screening|20|||
155125312|NCT02635347|559890625|FG001|Overall Study|Failed screening|7|||
155125313|NCT03089944|559890626|FG000|Overall Study|Lost to Follow-up|8|||
155125314|NCT03089944|559890626|FG000|Overall Study|Withdrew Consent|2|||
155125315|NCT03089944|559890626|FG000|Overall Study|Adverse Event|1|||
155125316|NCT03089944|559890626|FG000|Overall Study|Other|1|||
155125317|NCT02308488|559890627|FG000|Overall Study|Withdrawal by Subject|2|||
155125318|NCT01541917|559890628|FG000|Overall Study|Lost to Follow-up|2|||
155125319|NCT01541917|559890629|FG001|Overall Study|Lost to Follow-up|2|||
155125320|NCT01541917|559890628|FG000|Overall Study|Withdrawal by Subject|13|||
155125321|NCT01541917|559890629|FG001|Overall Study|Withdrawal by Subject|7|||
155125322|NCT01739803|559890630|FG000|Overall Study|Lost to Follow-up|9|||
155125323|NCT01739803|559890631|FG001|Overall Study|Lost to Follow-up|6|||
155125324|NCT01565564|559890642|FG000|Overall Study|Lost to Follow-up|5|||
155125325|NCT01565564|559890643|FG001|Overall Study|Lost to Follow-up|1|||
155125326|NCT03759041|559890644|FG000|Overall Study|Withdrawal by Subject|4|||
155125327|NCT03759041|559890645|FG001|Overall Study|Withdrawal by Subject|10|||
155125328|NCT03759041|559890646|FG002|Overall Study|Withdrawal by Subject|10|||
155125329|NCT03759041|559890644|FG000|Overall Study|Adverse Event|1|||
155125330|NCT03759041|559890645|FG001|Overall Study|Adverse Event|3|||
155125331|NCT03759041|559890646|FG002|Overall Study|Adverse Event|4|||
155125332|NCT03759041|559890644|FG000|Overall Study|Lack of Efficacy|0|||
155125333|NCT03759041|559890645|FG001|Overall Study|Lack of Efficacy|0|||
155125334|NCT03759041|559890646|FG002|Overall Study|Lack of Efficacy|1|||
155125335|NCT03759041|559890644|FG000|Overall Study|Study Terminated by Sponsor|15|||
155125336|NCT03759041|559890645|FG001|Overall Study|Study Terminated by Sponsor|16|||
155125337|NCT03759041|559890646|FG002|Overall Study|Study Terminated by Sponsor|10|||
155125338|NCT03759041|559890644|FG000|Overall Study|Other reason for discontinuation|0|||
155125339|NCT03759041|559890645|FG001|Overall Study|Other reason for discontinuation|2|||
155125340|NCT03759041|559890646|FG002|Overall Study|Other reason for discontinuation|1|||
155125341|NCT03759041|559890644|FG000|Overall Study|Lost to Follow-up|7|||
155125342|NCT03759041|559890645|FG001|Overall Study|Lost to Follow-up|2|||
155125343|NCT03759041|559890646|FG002|Overall Study|Lost to Follow-up|2|||
155178140|NCT02514473|560091415|FG000|Overall Study|Adverse Event|0|||
155125344|NCT03759041|559890644|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
155125345|NCT03759041|559890645|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
155125346|NCT03759041|559890646|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
155125347|NCT02449018|559890647|FG000|Overall Study|Abnormal laboratory value|0|||
155125348|NCT02449018|559890648|FG001|Overall Study|Abnormal laboratory value|1|||
155125349|NCT02449018|559890647|FG000|Overall Study|Administrative problems|1|||
155125350|NCT02449018|559890648|FG001|Overall Study|Administrative problems|0|||
155125351|NCT02449018|559890647|FG000|Overall Study|Adverse Event|5|||
155125352|NCT02449018|559890648|FG001|Overall Study|Adverse Event|1|||
155125353|NCT02449018|559890647|FG000|Overall Study|Protocol deviation|4|||
155125354|NCT02449018|559890648|FG001|Overall Study|Protocol deviation|0|||
155125355|NCT02449018|559890647|FG000|Overall Study|Patient decision|2|||
155125356|NCT02449018|559890648|FG001|Overall Study|Patient decision|0|||
155125357|NCT00525824|559890653|FG000|Overall Study|Adverse Event|7|||
155125358|NCT00525824|559890654|FG001|Overall Study|Adverse Event|11|||
155125359|NCT00525824|559890655|FG002|Overall Study|Adverse Event|6|||
155125360|NCT00525824|559890656|FG003|Overall Study|Adverse Event|7|||
155125361|NCT00525824|559890653|FG000|Overall Study|Withdrawal by Subject|5|||
155125362|NCT00525824|559890654|FG001|Overall Study|Withdrawal by Subject|9|||
155125363|NCT00525824|559890655|FG002|Overall Study|Withdrawal by Subject|3|||
155125364|NCT00525824|559890656|FG003|Overall Study|Withdrawal by Subject|4|||
155125365|NCT00525824|559890653|FG000|Overall Study|Lost to Follow-up|4|||
155125366|NCT00525824|559890654|FG001|Overall Study|Lost to Follow-up|2|||
155125367|NCT00525824|559890655|FG002|Overall Study|Lost to Follow-up|4|||
155125368|NCT00525824|559890656|FG003|Overall Study|Lost to Follow-up|0|||
155125369|NCT00525824|559890653|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
155125370|NCT00525824|559890654|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
155125371|NCT00525824|559890655|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
155125372|NCT00525824|559890656|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
155125373|NCT00525824|559890653|FG000|Overall Study|Severe non-compliance|0|||
155125374|NCT00525824|559890654|FG001|Overall Study|Severe non-compliance|1|||
155125375|NCT00525824|559890655|FG002|Overall Study|Severe non-compliance|1|||
155125376|NCT00525824|559890656|FG003|Overall Study|Severe non-compliance|1|||
155125377|NCT00525824|559890653|FG000|Overall Study|Safety reasons|1|||
155125378|NCT00525824|559890654|FG001|Overall Study|Safety reasons|0|||
155125379|NCT00525824|559890655|FG002|Overall Study|Safety reasons|1|||
155125380|NCT00525824|559890656|FG003|Overall Study|Safety reasons|0|||
155125381|NCT00525824|559890653|FG000|Overall Study|Other|1|||
155125382|NCT00525824|559890654|FG001|Overall Study|Other|3|||
155125383|NCT00525824|559890655|FG002|Overall Study|Other|3|||
155125384|NCT00525824|559890656|FG003|Overall Study|Other|1|||
155125385|NCT01161537|559891560|FG000|Part B|Withdrawal by Subject|2|||
155125386|NCT00358436|559891563|FG000|Overall Study|Adverse Event|29|||
155125387|NCT00358436|559891564|FG001|Overall Study|Adverse Event|13|||
155125388|NCT00358436|559891563|FG000|Overall Study|Lack of Efficacy|34|||
155125389|NCT00358436|559891564|FG001|Overall Study|Lack of Efficacy|36|||
155125390|NCT00358436|559891563|FG000|Overall Study|Lost to Follow-up|11|||
155125391|NCT00358436|559891564|FG001|Overall Study|Lost to Follow-up|6|||
155125392|NCT00358436|559891563|FG000|Overall Study|Protocol Violation|8|||
155125393|NCT00358436|559891564|FG001|Overall Study|Protocol Violation|3|||
155125394|NCT00358436|559891563|FG000|Overall Study|Withdrawal by Subject|40|||
155125395|NCT00358436|559891564|FG001|Overall Study|Withdrawal by Subject|17|||
155125396|NCT00358436|559891563|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
155125397|NCT00358436|559891564|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
155125398|NCT00358436|559891563|FG000|Overall Study|COPD exacerbation|22|||
155125399|NCT00358436|559891564|FG001|Overall Study|COPD exacerbation|10|||
155125400|NCT00358436|559891563|FG000|Overall Study|Other|6|||
155125401|NCT00358436|559891564|FG001|Overall Study|Other|1|||
155125402|NCT01073930|559891565|FG000|Overall Study|Withdrawal by Subject|3|||
155125403|NCT01073930|559891566|FG001|Overall Study|Withdrawal by Subject|2|||
155125404|NCT01073930|559891565|FG000|Overall Study|Lost to Follow-up|0|||
155125405|NCT01073930|559891566|FG001|Overall Study|Lost to Follow-up|1|||
155125406|NCT01073930|559891565|FG000|Overall Study|Adverse Event|0|||
155125407|NCT01073930|559891566|FG001|Overall Study|Adverse Event|1|||
155125408|NCT01073930|559891565|FG000|Overall Study|Noncompliance with study drug|0|||
155125409|NCT01073930|559891566|FG001|Overall Study|Noncompliance with study drug|1|||
155125410|NCT01073930|559891565|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
155125411|NCT01073930|559891566|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
155125412|NCT04938037|559891569|FG000|Overall Study|Lost to Follow-up|4|||
155125413|NCT04938037|559891570|FG001|Overall Study|Lost to Follow-up|3|||
155125414|NCT03323736|559891573|FG000|Overall Study|Screen Failure|14|||
155125415|NCT03323736|559891574|FG001|Overall Study|Screen Failure|9|||
155125416|NCT03323736|559891575|FG002|Overall Study|Screen Failure|1|||
155125417|NCT03323736|559891573|FG000|Overall Study|Withdrawal Before Treatment|3|||
155125418|NCT03323736|559891574|FG001|Overall Study|Withdrawal Before Treatment|1|||
155125419|NCT03323736|559891575|FG002|Overall Study|Withdrawal Before Treatment|1|||
155125420|NCT03323736|559891573|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
155125421|NCT03323736|559891574|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
155125422|NCT03323736|559891575|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
155125423|NCT01023672|559891578|FG000|Overall Study|Worsening disease|2|||
155125424|NCT01023672|559891578|FG000|Overall Study|Death|1|||
154923100|NCT05182840|559142248|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
155125425|NCT02654236|559891583|FG000|Overall Study|Withdrawal by Subject|0|||
155125426|NCT02654236|559891584|FG001|Overall Study|Withdrawal by Subject|0|||
155125427|NCT02654236|559891585|FG002|Overall Study|Withdrawal by Subject|2|||
155125428|NCT02408523|559891586|FG000|Overall Study|Adverse Event|4|||
155125429|NCT02408523|559891587|FG001|Overall Study|Adverse Event|10|||
155125430|NCT02408523|559891586|FG000|Overall Study|Lack of Efficacy|0|||
155125431|NCT02408523|559891587|FG001|Overall Study|Lack of Efficacy|1|||
155125432|NCT02408523|559891586|FG000|Overall Study|Protocol Violation|1|||
155125433|NCT02408523|559891587|FG001|Overall Study|Protocol Violation|2|||
155125434|NCT02408523|559891586|FG000|Overall Study|Lost to Follow-up|2|||
155125435|NCT02408523|559891587|FG001|Overall Study|Lost to Follow-up|3|||
155178141|NCT02514473|560091416|FG001|Overall Study|Adverse Event|2|||
155178142|NCT02514473|560091415|FG000|Overall Study|Withdrawal by Subject|2|||
155178143|NCT02514473|560091416|FG001|Overall Study|Withdrawal by Subject|1|||
155178144|NCT02514473|560091415|FG000|Overall Study|Lost to Follow-up|0|||
155178145|NCT02514473|560091416|FG001|Overall Study|Lost to Follow-up|1|||
155178146|NCT02514473|560091415|FG000|Overall Study|Other|1|||
155178147|NCT02514473|560091416|FG001|Overall Study|Other|1|||
155178148|NCT04381988|560091419|FG000|Overall Study|The study was terminated|4|||
155178149|NCT04381988|560091420|FG001|Overall Study|The study was terminated|0|||
155178150|NCT01624870|560091421|FG000|Overall Study|Death|19|||
155178151|NCT01624870|560091421|FG000|Overall Study|Withdrawal by Subject|1|||
155178152|NCT01624870|560091421|FG000|Overall Study|CoreValve not implanted|6|||
155178153|NCT01624870|560091421|FG000|Overall Study|Lost to follow up|1|||
155178154|NCT04098224|560091423|FG000|Overall Study|Adverse Event|1|||
155178155|NCT04098224|560091424|FG001|Overall Study|Adverse Event|0|||
155178156|NCT04098224|560091423|FG000|Overall Study|Physician Decision|1|||
155178157|NCT04098224|560091424|FG001|Overall Study|Physician Decision|0|||
155178158|NCT04098224|560091423|FG000|Overall Study|Patient not required enteral feeding|1|||
155178159|NCT04098224|560091424|FG001|Overall Study|Patient not required enteral feeding|0|||
155178160|NCT04098224|560091423|FG000|Overall Study|Patient failure nasogastric tube|1|||
155178161|NCT04098224|560091424|FG001|Overall Study|Patient failure nasogastric tube|0|||
155178162|NCT04098224|560091423|FG000|Overall Study|Patient early extubation|1|||
155178163|NCT04098224|560091424|FG001|Overall Study|Patient early extubation|3|||
155178164|NCT01239732|560091432|FG000|Overall Study|Termination of study per protocol|667|||
155178165|NCT01239732|560091432|FG000|Overall Study|Death|226|||
155178166|NCT01239732|560091432|FG000|Overall Study|Withdrawal by Subject|87|||
155178167|NCT01239732|560091432|FG000|Overall Study|Adverse Event|6|||
155178168|NCT01239732|560091432|FG000|Overall Study|Protocol Violation|3|||
155178169|NCT01239732|560091432|FG000|Overall Study|Participant non compliance|5|||
155178170|NCT01239732|560091432|FG000|Overall Study|Study termination by sponsor|2|||
155178171|NCT01239732|560091432|FG000|Overall Study|Investigator's decision|4|||
155178172|NCT01239732|560091432|FG000|Overall Study|Treatment failure|2|||
155178173|NCT01239732|560091432|FG000|Overall Study|Other|19|||
155178174|NCT00095147|560091434|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
155178175|NCT00095147|560091435|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
155178176|NCT00095147|560091436|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
155178177|NCT00095147|560091437|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
155178178|NCT00095147|560091438|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
155004974|NCT00451178|559440798|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
155004975|NCT00451178|559440799|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
155004976|NCT00451178|559440798|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
155004977|NCT00451178|559440799|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
155004978|NCT00451178|559440798|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
155004979|NCT00451178|559440799|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
155004980|NCT00451178|559440798|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
155004981|NCT00451178|559440799|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
155004982|NCT00451178|559440798|FG000|Prior to Maintenance Therapy|PD|2|||
155004983|NCT00451178|559440799|FG001|Prior to Maintenance Therapy|PD|0|||
155004984|NCT00451178|559440798|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
155004985|NCT00451178|559440799|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
155004986|NCT00451178|559440798|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
155004987|NCT00451178|559440799|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
155004988|NCT00451178|559440798|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
155004989|NCT00451178|559440799|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
155004990|NCT00451178|559440798|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
155004991|NCT00451178|559440799|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
155004992|NCT00451178|559440798|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
155004993|NCT00451178|559440799|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
155004994|NCT00451178|559440798|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
155004995|NCT00451178|559440799|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
155004996|NCT00451178|559440798|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
155004997|NCT00451178|559440799|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
155004998|NCT02215967|559440800|FG000|Overall Study|Patient became ineligible for treatment|0|||
155178179|NCT00095147|560091434|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
155178180|NCT00095147|560091435|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
155178181|NCT00095147|560091436|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
155178182|NCT00095147|560091437|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
155178183|NCT00095147|560091438|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
155178184|NCT00095147|560091434|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
155178185|NCT00095147|560091435|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
155178186|NCT00095147|560091436|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
155004999|NCT02215967|559440801|FG001|Overall Study|Patient became ineligible for treatment|0|||
155125436|NCT02408523|559891586|FG000|Overall Study|Withdrawal by Subject|3|||
155125437|NCT02408523|559891587|FG001|Overall Study|Withdrawal by Subject|1|||
155125438|NCT02408523|559891586|FG000|Overall Study|Sponsor request|1|||
155125439|NCT02408523|559891587|FG001|Overall Study|Sponsor request|0|||
155125440|NCT02408523|559891586|FG000|Overall Study|Did not satisfy extension conditions|0|||
155125441|NCT02408523|559891587|FG001|Overall Study|Did not satisfy extension conditions|1|||
155125442|NCT01549873|559891588|FG000|Overall Study|Physician Decision|0|||
155125443|NCT01549873|559891589|FG001|Overall Study|Physician Decision|1|||
155125444|NCT00701805|559891590|FG000|Overall Study|Withdrawal by Subject|3|||
155125445|NCT00701805|559891591|FG001|Overall Study|Withdrawal by Subject|1|||
155125446|NCT00701805|559891592|FG002|Overall Study|Withdrawal by Subject|4|||
155125447|NCT00701805|559891593|FG003|Overall Study|Withdrawal by Subject|3|||
155125448|NCT00701805|559891590|FG000|Overall Study|Adverse Event|0|||
155125449|NCT00701805|559891591|FG001|Overall Study|Adverse Event|1|||
155125450|NCT00701805|559891592|FG002|Overall Study|Adverse Event|1|||
155125451|NCT00701805|559891593|FG003|Overall Study|Adverse Event|0|||
155125452|NCT00701805|559891590|FG000|Overall Study|Missed 7 consecutive doses|0|||
155125453|NCT00701805|559891591|FG001|Overall Study|Missed 7 consecutive doses|1|||
155125454|NCT00701805|559891592|FG002|Overall Study|Missed 7 consecutive doses|0|||
155125455|NCT00701805|559891593|FG003|Overall Study|Missed 7 consecutive doses|0|||
155125456|NCT00701805|559891590|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
155125457|NCT00701805|559891591|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
155125458|NCT00701805|559891592|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
155125459|NCT00701805|559891593|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
155125460|NCT00701805|559891590|FG000|Overall Study|Physician decision, change of therapy|0|||
155125461|NCT00701805|559891591|FG001|Overall Study|Physician decision, change of therapy|0|||
155125462|NCT00701805|559891592|FG002|Overall Study|Physician decision, change of therapy|0|||
155125463|NCT00701805|559891593|FG003|Overall Study|Physician decision, change of therapy|1|||
155125464|NCT00701805|559891590|FG000|Overall Study|Difficult to travel to dialysis site|0|||
155178187|NCT00095147|560091437|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
155178188|NCT00095147|560091438|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
155178189|NCT00095147|560091434|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
155178190|NCT00095147|560091435|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
155178191|NCT00095147|560091436|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
155178192|NCT00095147|560091437|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
155178193|NCT00095147|560091438|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
154923101|NCT05182840|559142239|FG000|Treatment Period|Reason missing|0|||
154923102|NCT05182840|559142240|FG001|Treatment Period|Reason missing|0|||
154923103|NCT05182840|559142241|FG002|Treatment Period|Reason missing|1|||
154923104|NCT05182840|559142242|FG003|Treatment Period|Reason missing|0|||
154923105|NCT05182840|559142243|FG004|Treatment Period|Reason missing|0|||
154923106|NCT05182840|559142244|FG005|Treatment Period|Reason missing|0|||
154923107|NCT05182840|559142245|FG006|Treatment Period|Reason missing|0|||
154923108|NCT05182840|559142246|FG007|Treatment Period|Reason missing|0|||
154923109|NCT05182840|559142247|FG008|Treatment Period|Reason missing|0|||
154923110|NCT05182840|559142248|FG009|Treatment Period|Reason missing|0|||
154923111|NCT05182840|559142239|FG000|Treatment Period|Other but not sponsor termination|0|||
154923112|NCT05182840|559142240|FG001|Treatment Period|Other but not sponsor termination|0|||
154923113|NCT05182840|559142241|FG002|Treatment Period|Other but not sponsor termination|8|||
154923114|NCT05182840|559142242|FG003|Treatment Period|Other but not sponsor termination|6|||
154923115|NCT05182840|559142243|FG004|Treatment Period|Other but not sponsor termination|6|||
154923116|NCT05182840|559142244|FG005|Treatment Period|Other but not sponsor termination|7|||
154923117|NCT05182840|559142245|FG006|Treatment Period|Other but not sponsor termination|5|||
154923118|NCT05182840|559142246|FG007|Treatment Period|Other but not sponsor termination|8|||
154923119|NCT05182840|559142247|FG008|Treatment Period|Other but not sponsor termination|7|||
154923120|NCT05182840|559142248|FG009|Treatment Period|Other but not sponsor termination|2|||
154923121|NCT05182840|559142239|FG000|Treatment Period|Protocol deviation|0|||
154923122|NCT05182840|559142240|FG001|Treatment Period|Protocol deviation|0|||
154923123|NCT05182840|559142241|FG002|Treatment Period|Protocol deviation|0|||
154923124|NCT05182840|559142242|FG003|Treatment Period|Protocol deviation|0|||
154923125|NCT05182840|559142243|FG004|Treatment Period|Protocol deviation|0|||
154923126|NCT05182840|559142244|FG005|Treatment Period|Protocol deviation|0|||
154923127|NCT05182840|559142245|FG006|Treatment Period|Protocol deviation|0|||
154923128|NCT05182840|559142246|FG007|Treatment Period|Protocol deviation|0|||
154923129|NCT05182840|559142247|FG008|Treatment Period|Protocol deviation|1|||
154923130|NCT05182840|559142248|FG009|Treatment Period|Protocol deviation|0|||
154923131|NCT05182840|559142239|FG000|Treatment Period|No reason available|0|||
154923132|NCT05182840|559142240|FG001|Treatment Period|No reason available|0|||
154923133|NCT05182840|559142241|FG002|Treatment Period|No reason available|0|||
154923134|NCT05182840|559142242|FG003|Treatment Period|No reason available|1|||
154923135|NCT05182840|559142243|FG004|Treatment Period|No reason available|0|||
154923136|NCT05182840|559142244|FG005|Treatment Period|No reason available|2|||
155005000|NCT02215967|559440802|FG002|Overall Study|Patient became ineligible for treatment|0|||
155005001|NCT02215967|559440803|FG003|Overall Study|Patient became ineligible for treatment|3|||
155005002|NCT02215967|559440800|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
155005003|NCT02215967|559440801|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
155005004|NCT02215967|559440802|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
155005005|NCT02215967|559440803|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
155005006|NCT06473519|559442658|FG000|Overall Study|Lost to Follow-up|2|||
155005007|NCT06473519|559442659|FG001|Overall Study|Lost to Follow-up|5|||
155005008|NCT06473519|559442658|FG000|Overall Study|Withdrawal by Subject|1|||
155005009|NCT06473519|559442659|FG001|Overall Study|Withdrawal by Subject|4|||
155005010|NCT06473519|559442658|FG000|Overall Study|Randomized but not vaccinated|1|||
155005011|NCT06473519|559442659|FG001|Overall Study|Randomized but not vaccinated|2|||
155005012|NCT05626231|559442661|FG000|Provider Enrollment|Worked part-time|4|||
155005013|NCT05626231|559442661|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
155005014|NCT05626231|559442661|FG000|Provider Enrollment|Non-clinical employee|1|||
155005015|NCT05626231|559442661|FG000|Provider Enrollment|Provider does not see clients|3|||
155005016|NCT05626231|559442661|FG000|Provider Enrollment|Other|5|||
155005017|NCT03765788|559442662|FG000|Overall Study|Subject decision|2|||
155005018|NCT03765788|559442663|FG001|Overall Study|Subject decision|3|||
155005019|NCT03765788|559442662|FG000|Overall Study|Physician Decision|2|||
155005020|NCT03765788|559442663|FG001|Overall Study|Physician Decision|4|||
155005021|NCT03765788|559442662|FG000|Overall Study|Death|0|||
155005022|NCT03765788|559442663|FG001|Overall Study|Death|1|||
155005023|NCT03765788|559442662|FG000|Overall Study|Lost to Follow-up|1|||
155005024|NCT03765788|559442663|FG001|Overall Study|Lost to Follow-up|0|||
155005025|NCT03573830|559442672|FG000|Overall Study|Dropped without completing treatment|0|||
155005026|NCT03573830|559442673|FG001|Overall Study|Dropped without completing treatment|7|||
155005027|NCT03573830|559442672|FG000|Overall Study|Lost to Follow-up|4|||
155005028|NCT03573830|559442673|FG001|Overall Study|Lost to Follow-up|0|||
155005029|NCT04909853|559442679|FG000|Part 1|Assigned but not treated|0|||
155005030|NCT04909853|559442680|FG001|Part 1|Assigned but not treated|0|||
155005031|NCT04909853|559442681|FG002|Part 1|Assigned but not treated|1|||
155005032|NCT04909853|559442682|FG003|Part 1|Assigned but not treated|0|||
155005033|NCT04909853|559442679|FG000|Part 2|Adverse Event|0|||
155005034|NCT04909853|559442680|FG001|Part 2|Adverse Event|0|||
155005035|NCT04909853|559442681|FG002|Part 2|Adverse Event|0|||
155005036|NCT04909853|559442682|FG003|Part 2|Adverse Event|1|||
155005037|NCT00444587|559442687|FG000|Overall Study|Death|2|||
155005038|NCT00444587|559442688|FG001|Overall Study|Death|1|||
155005039|NCT00444587|559442687|FG000|Overall Study|Progression of the disease|73|||
155005040|NCT00444587|559442688|FG001|Overall Study|Progression of the disease|8|||
155005041|NCT00444587|559442687|FG000|Overall Study|Refused treatment/did not cooperate|4|||
155005042|NCT00444587|559442688|FG001|Overall Study|Refused treatment/did not cooperate|1|||
155005043|NCT00444587|559442687|FG000|Overall Study|Investigator decision|3|||
155005044|NCT00444587|559442688|FG001|Overall Study|Investigator decision|0|||
155005045|NCT00444587|559442687|FG000|Overall Study|Protocol Violation|1|||
155005046|NCT00444587|559442688|FG001|Overall Study|Protocol Violation|0|||
155005047|NCT00444587|559442687|FG000|Overall Study|Missing|0|||
155005048|NCT00444587|559442688|FG001|Overall Study|Missing|5|||
155005049|NCT00196326|559442689|FG000|Overall Study|Did not meet protocol requirements|64|||
155005050|NCT00196326|559442689|FG000|Overall Study|Non-compliance with the protocol|81|||
155005051|NCT00196326|559442689|FG000|Overall Study|Physician Decision|3|||
155005052|NCT00196326|559442689|FG000|Overall Study|Withdrawal by Subject|225|||
155005053|NCT00196326|559442689|FG000|Overall Study|Adverse Event|253|||
155005054|NCT00196326|559442689|FG000|Overall Study|Pregnancy|34|||
155005055|NCT00196326|559442689|FG000|Overall Study|Lost to Follow-up|304|||
155005056|NCT00196326|559442689|FG000|Overall Study|Other|22|||
155005057|NCT01720225|559442690|FG000|Overall Study|Withdrawal by Subject|0|||
155005058|NCT01720225|559442691|FG001|Overall Study|Withdrawal by Subject|1|||
155005059|NCT01720225|559442690|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
155005060|NCT01720225|559442691|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
155005061|NCT00369941|559442692|FG000|Overall Study|Never Treated|1|||
155005062|NCT00369941|559442693|FG001|Overall Study|Never Treated|2|||
155005063|NCT00369941|559442692|FG000|Overall Study|Adverse Event|14|||
155005064|NCT00369941|559442693|FG001|Overall Study|Adverse Event|28|||
155005065|NCT00369941|559442692|FG000|Overall Study|Lack of Efficacy|6|||
155005066|NCT00369941|559442693|FG001|Overall Study|Lack of Efficacy|10|||
155005067|NCT00369941|559442692|FG000|Overall Study|Lost to Follow-up|12|||
155005068|NCT00369941|559442693|FG001|Overall Study|Lost to Follow-up|22|||
155005069|NCT00369941|559442692|FG000|Overall Study|Protocol Violation|5|||
155005070|NCT00369941|559442693|FG001|Overall Study|Protocol Violation|3|||
155005071|NCT00369941|559442692|FG000|Overall Study|Withdrawal by Subject|5|||
155005072|NCT00369941|559442693|FG001|Overall Study|Withdrawal by Subject|18|||
155005073|NCT00369941|559442692|FG000|Overall Study|Pregnancy|4|||
155005074|NCT00369941|559442693|FG001|Overall Study|Pregnancy|2|||
155005075|NCT00369941|559442692|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
155005076|NCT00369941|559442693|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
155005077|NCT00369941|559442692|FG000|Overall Study|Moved|11|||
155005078|NCT00369941|559442693|FG001|Overall Study|Moved|5|||
155005079|NCT00369941|559442692|FG000|Overall Study|Treatment with Prohibited Medication|3|||
155005080|NCT00369941|559442693|FG001|Overall Study|Treatment with Prohibited Medication|1|||
155005081|NCT00369941|559442692|FG000|Overall Study|Employment Interfered with Study Visits|1|||
155005082|NCT00369941|559442693|FG001|Overall Study|Employment Interfered with Study Visits|0|||
155005083|NCT00369941|559442692|FG000|Overall Study|Study Site Terminated|2|||
155005084|NCT00369941|559442693|FG001|Overall Study|Study Site Terminated|0|||
155005085|NCT00369941|559442692|FG000|Overall Study|Miscellaneous|3|||
155005086|NCT00369941|559442693|FG001|Overall Study|Miscellaneous|3|||
155005087|NCT02964312|559442700|FG000|Overall Study|Lost to Follow-up|28|||
155005088|NCT02964312|559442700|FG000|Overall Study|Withdrawal by Subject|11|||
155005089|NCT02964312|559442700|FG000|Overall Study|Lack of Efficacy|10|||
155005090|NCT02964312|559442700|FG000|Overall Study|Did not consent to long-term FU|14|||
155005091|NCT02964312|559442700|FG000|Overall Study|Death|1|||
155005092|NCT02738138|559442701|FG000|Overall Study|Adverse Event|0|||
155005093|NCT02738138|559442702|FG001|Overall Study|Adverse Event|1|||
155005094|NCT02738138|559442701|FG000|Overall Study|Lost to Follow-up|2|||
155005095|NCT02738138|559442702|FG001|Overall Study|Lost to Follow-up|0|||
155005096|NCT02738138|559442701|FG000|Overall Study|Other - not further specified|1|||
155005097|NCT02738138|559442702|FG001|Overall Study|Other - not further specified|0|||
155005098|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Other|34|||
155005099|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Other|0|||
155005100|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Other|0|||
155005101|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Other|0|||
155005102|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Death|14|||
155005103|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Death|0|||
155005104|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Death|0|||
155005105|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Death|0|||
155005106|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
155005107|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
155005108|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
155005109|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
155005110|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
155005111|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
155005112|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
155005113|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
155005114|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
155005115|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
155005116|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
155005117|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
155005118|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
155005119|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
155005120|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
155005121|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
155005122|NCT01995513|559442706|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
155005123|NCT01995513|559442707|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
155005124|NCT01995513|559442708|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
155005125|NCT01995513|559442709|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
155005126|NCT01995513|559442706|FG000|Period 1: Second Open Label Treatment|Other|0|||
155005127|NCT01995513|559442707|FG001|Period 1: Second Open Label Treatment|Other|2|||
155005128|NCT01995513|559442708|FG002|Period 1: Second Open Label Treatment|Other|0|||
155005129|NCT01995513|559442709|FG003|Period 1: Second Open Label Treatment|Other|0|||
155005130|NCT01995513|559442706|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
155005131|NCT01995513|559442707|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
155005132|NCT01995513|559442708|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
155005133|NCT01995513|559442709|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
155005134|NCT01995513|559442706|FG000|Period 2: Double Blind Treatment|Death|0|||
155005135|NCT01995513|559442707|FG001|Period 2: Double Blind Treatment|Death|0|||
155005136|NCT01995513|559442708|FG002|Period 2: Double Blind Treatment|Death|0|||
155005137|NCT01995513|559442709|FG003|Period 2: Double Blind Treatment|Death|1|||
155005138|NCT01995513|559442706|FG000|Period 2: Double Blind Treatment|Other|0|||
155005139|NCT01995513|559442707|FG001|Period 2: Double Blind Treatment|Other|0|||
155005140|NCT01995513|559442708|FG002|Period 2: Double Blind Treatment|Other|3|||
155005141|NCT01995513|559442709|FG003|Period 2: Double Blind Treatment|Other|3|||
155005142|NCT01995513|559442706|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
155005143|NCT01995513|559442707|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
155005144|NCT01995513|559442708|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
155005145|NCT01995513|559442709|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
155005146|NCT01995513|559442706|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
155005147|NCT01995513|559442707|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
155005148|NCT01995513|559442708|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
155005149|NCT01995513|559442709|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
155005150|NCT01995513|559442706|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
155005151|NCT01995513|559442707|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
155005152|NCT01995513|559442708|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
155005153|NCT01995513|559442709|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
155005154|NCT01995513|559442706|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
155005155|NCT01995513|559442707|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
155005156|NCT01995513|559442708|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
155005157|NCT01995513|559442709|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
155005158|NCT01232452|559442710|FG000|Overall Study|Adverse Event|17|||
155005159|NCT01232452|559442711|FG001|Overall Study|Adverse Event|15|||
155005160|NCT01232452|559442710|FG000|Overall Study|Withdrawal by Subject|11|||
155005161|NCT01232452|559442711|FG001|Overall Study|Withdrawal by Subject|8|||
155005162|NCT01232452|559442710|FG000|Overall Study|Physician Decision|8|||
155005163|NCT01232452|559442711|FG001|Overall Study|Physician Decision|12|||
155005164|NCT01232452|559442710|FG000|Overall Study|Protocol entry criterion not met|0|||
155005165|NCT01232452|559442711|FG001|Overall Study|Protocol entry criterion not met|2|||
155005166|NCT01232452|559442710|FG000|Overall Study|Sponsor Decision|3|||
155005167|NCT01232452|559442711|FG001|Overall Study|Sponsor Decision|1|||
155005168|NCT01232452|559442710|FG000|Overall Study|Protocol Violation|0|||
155005169|NCT01232452|559442711|FG001|Overall Study|Protocol Violation|1|||
155005170|NCT05219448|559442716|FG000|Overall Study|Lost to Follow-up|9|||
155005171|NCT05219448|559442717|FG001|Overall Study|Lost to Follow-up|0|||
155005172|NCT01750190|559442718|FG000|Overall Study|Adverse Event|47|||
155005173|NCT01750190|559442719|FG001|Overall Study|Adverse Event|19|||
155005174|NCT01750190|559442718|FG000|Overall Study|Death|38|||
155005175|NCT01750190|559442719|FG001|Overall Study|Death|11|||
155005176|NCT01750190|559442718|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
155005177|NCT01750190|559442719|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
155005178|NCT01750190|559442718|FG000|Overall Study|Lost to Follow-up|28|||
155005179|NCT01750190|559442719|FG001|Overall Study|Lost to Follow-up|7|||
155005180|NCT01750190|559442718|FG000|Overall Study|Physician Decision|16|||
155005181|NCT01750190|559442719|FG001|Overall Study|Physician Decision|17|||
155005182|NCT01750190|559442718|FG000|Overall Study|Protocol Violation|6|||
155005183|NCT01750190|559442719|FG001|Overall Study|Protocol Violation|5|||
155005184|NCT01750190|559442718|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
155005185|NCT01750190|559442719|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
155005186|NCT01750190|559442718|FG000|Overall Study|Withdrawal by Subject|83|||
155005187|NCT01750190|559442719|FG001|Overall Study|Withdrawal by Subject|89|||
155005188|NCT01750190|559442718|FG000|Overall Study|Kidney Transplant|8|||
155005189|NCT01750190|559442719|FG001|Overall Study|Kidney Transplant|4|||
155005190|NCT01750190|559442718|FG000|Overall Study|Dialysis|22|||
155005191|NCT01750190|559442719|FG001|Overall Study|Dialysis|8|||
155005192|NCT01750190|559442718|FG000|Overall Study|Other than Specified|13|||
155005193|NCT01750190|559442719|FG001|Overall Study|Other than Specified|4|||
155005194|NCT02287922|559442720|FG000|Overall Study|Adverse Event|1|||
155005195|NCT02287922|559442721|FG001|Overall Study|Adverse Event|1|||
155005196|NCT02287922|559442722|FG002|Overall Study|Adverse Event|3|||
155005197|NCT02287922|559442723|FG003|Overall Study|Adverse Event|4|||
155005198|NCT02287922|559442720|FG000|Overall Study|Withdrawal by Subject|1|||
155005199|NCT02287922|559442721|FG001|Overall Study|Withdrawal by Subject|1|||
155005200|NCT02287922|559442722|FG002|Overall Study|Withdrawal by Subject|1|||
155005201|NCT02287922|559442723|FG003|Overall Study|Withdrawal by Subject|2|||
155005202|NCT02287922|559442720|FG000|Overall Study|Lost to Follow-up|0|||
155005203|NCT02287922|559442721|FG001|Overall Study|Lost to Follow-up|0|||
155005204|NCT02287922|559442722|FG002|Overall Study|Lost to Follow-up|1|||
155005205|NCT02287922|559442723|FG003|Overall Study|Lost to Follow-up|0|||
155005206|NCT02287922|559442720|FG000|Overall Study|Sponsor's decision|0|||
155005207|NCT02287922|559442721|FG001|Overall Study|Sponsor's decision|0|||
155005208|NCT02287922|559442722|FG002|Overall Study|Sponsor's decision|0|||
155178194|NCT00095147|560091434|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
155178195|NCT00095147|560091435|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
155178196|NCT00095147|560091436|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
155005209|NCT02287922|559442723|FG003|Overall Study|Sponsor's decision|1|||
155178197|NCT00095147|560091437|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
155005210|NCT02287922|559442720|FG000|Overall Study|Other|1|||
155005211|NCT02287922|559442721|FG001|Overall Study|Other|0|||
155005212|NCT02287922|559442722|FG002|Overall Study|Other|2|||
155005213|NCT02287922|559442723|FG003|Overall Study|Other|0|||
155005214|NCT03668808|559442724|FG000|First Intervention|Withdrawal by Subject|2|||
155005215|NCT03668808|559442725|FG001|First Intervention|Withdrawal by Subject|2|||
155005216|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
155005217|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Death|1|||
155005218|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
155005219|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
155005220|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
155005221|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
155005222|NCT02001987|559442726|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
155005223|NCT02001987|559442726|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
155005224|NCT02001987|559442726|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
155005225|NCT02001987|559442726|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
155005226|NCT02001987|559442726|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
155005227|NCT02001987|559442726|FG000|LTE Period (52 Weeks)|Other|3|||
155005228|NCT03571828|559442727|FG000|Overall Study|Withdrawal by Subject|1|||
155005229|NCT03571828|559442728|FG001|Overall Study|Withdrawal by Subject|0|||
155005230|NCT03571828|559442727|FG000|Overall Study|Decision by sponsor|5|||
155005231|NCT03571828|559442728|FG001|Overall Study|Decision by sponsor|1|||
155005232|NCT03571828|559442727|FG000|Overall Study|Death|2|||
155005233|NCT03571828|559442728|FG001|Overall Study|Death|0|||
155005234|NCT04138823|559442737|FG000|Overall Study|Clinical disease progression|0|||
155005235|NCT04138823|559442738|FG001|Overall Study|Clinical disease progression|0|||
155005236|NCT04138823|559442739|FG002|Overall Study|Clinical disease progression|1|||
155005237|NCT04138823|559442737|FG000|Overall Study|Objective disease progression|3|||
155005238|NCT04138823|559442738|FG001|Overall Study|Objective disease progression|2|||
155005239|NCT04138823|559442739|FG002|Overall Study|Objective disease progression|5|||
155178198|NCT00095147|560091438|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
155178199|NCT00095147|560091434|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
155178200|NCT00095147|560091435|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
155178201|NCT00095147|560091436|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
155178202|NCT00095147|560091437|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
155178203|NCT00095147|560091438|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
155178204|NCT00095147|560091434|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
155178205|NCT00095147|560091435|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
155178206|NCT00095147|560091436|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
155178207|NCT00095147|560091437|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
155178208|NCT00095147|560091438|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
155178209|NCT00095147|560091434|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
155178210|NCT00095147|560091435|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
155178211|NCT00095147|560091436|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
155178212|NCT00095147|560091437|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
155178213|NCT00095147|560091438|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
155005240|NCT02466685|559442741|FG000|Overall Study|Adverse Event|5|||
155125465|NCT00701805|559891591|FG001|Overall Study|Difficult to travel to dialysis site|0|||
155125466|NCT00701805|559891592|FG002|Overall Study|Difficult to travel to dialysis site|1|||
155125467|NCT00701805|559891593|FG003|Overall Study|Difficult to travel to dialysis site|0|||
155125468|NCT00701805|559891590|FG000|Overall Study|Resumption criteria were not met|0|||
155125469|NCT00701805|559891591|FG001|Overall Study|Resumption criteria were not met|1|||
155125470|NCT00701805|559891592|FG002|Overall Study|Resumption criteria were not met|0|||
155125471|NCT00701805|559891593|FG003|Overall Study|Resumption criteria were not met|0|||
155125472|NCT04256512|559891594|FG000|Overall Study|Withdrawal by Subject|1|||
155125473|NCT04435600|559891604|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125474|NCT04435600|559891605|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125475|NCT04435600|559891606|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
155125476|NCT04435600|559891607|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125477|NCT04435600|559891608|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125478|NCT04435600|559891609|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125479|NCT04435600|559891610|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125480|NCT04435600|559891611|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155125481|NCT04435600|559891612|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155178214|NCT00095147|560091434|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
155178215|NCT00095147|560091435|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
155178216|NCT00095147|560091436|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
155178217|NCT00095147|560091437|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
155178218|NCT00095147|560091438|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
155178219|NCT00095147|560091434|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
155178220|NCT00095147|560091435|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
155178221|NCT00095147|560091436|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
155005241|NCT02466685|559442742|FG001|Overall Study|Adverse Event|2|||
155005242|NCT02466685|559442741|FG000|Overall Study|Lost to Follow-up|1|||
155005243|NCT02466685|559442742|FG001|Overall Study|Lost to Follow-up|1|||
155125482|NCT04435600|559891613|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155178222|NCT00095147|560091437|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
155125483|NCT04435600|559891604|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125484|NCT04435600|559891605|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125485|NCT04435600|559891606|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125486|NCT04435600|559891607|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125487|NCT04435600|559891608|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125488|NCT04435600|559891609|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125489|NCT04435600|559891610|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125490|NCT04435600|559891611|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125491|NCT04435600|559891612|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
155125492|NCT04435600|559891613|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
155125493|NCT04435600|559891604|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125494|NCT04435600|559891605|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125495|NCT04435600|559891606|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125496|NCT04435600|559891607|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125497|NCT04435600|559891608|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125498|NCT04435600|559891609|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125499|NCT04435600|559891610|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125500|NCT04435600|559891611|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125501|NCT04435600|559891612|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
155125502|NCT04435600|559891613|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
155125503|NCT04435600|559891604|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125504|NCT04435600|559891605|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125505|NCT04435600|559891606|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125506|NCT04435600|559891607|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
155178223|NCT00095147|560091438|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
155178224|NCT00095147|560091434|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
155178225|NCT00095147|560091435|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
155178226|NCT00095147|560091436|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
155178227|NCT00095147|560091437|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
155178228|NCT00095147|560091438|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
155178229|NCT00095147|560091434|FG000|Long-term Extension Period|Death|0|||
155178230|NCT00095147|560091435|FG001|Long-term Extension Period|Death|0|||
155178231|NCT00095147|560091436|FG002|Long-term Extension Period|Death|0|||
155178232|NCT00095147|560091437|FG003|Long-term Extension Period|Death|0|||
155178233|NCT00095147|560091438|FG004|Long-term Extension Period|Death|3|||
155178234|NCT00095147|560091434|FG000|Long-term Extension Period|Adverse Event|0|||
155178235|NCT00095147|560091435|FG001|Long-term Extension Period|Adverse Event|0|||
155178236|NCT00095147|560091436|FG002|Long-term Extension Period|Adverse Event|0|||
155178237|NCT00095147|560091437|FG003|Long-term Extension Period|Adverse Event|0|||
155178238|NCT00095147|560091438|FG004|Long-term Extension Period|Adverse Event|11|||
155178239|NCT00095147|560091434|FG000|Long-term Extension Period|Lack of Efficacy|0|||
155178240|NCT00095147|560091435|FG001|Long-term Extension Period|Lack of Efficacy|0|||
155178241|NCT00095147|560091436|FG002|Long-term Extension Period|Lack of Efficacy|0|||
155178242|NCT00095147|560091437|FG003|Long-term Extension Period|Lack of Efficacy|0|||
155178243|NCT00095147|560091438|FG004|Long-term Extension Period|Lack of Efficacy|9|||
155178244|NCT00095147|560091434|FG000|Long-term Extension Period|Lost to Follow-up|0|||
155178245|NCT00095147|560091435|FG001|Long-term Extension Period|Lost to Follow-up|0|||
155178246|NCT00095147|560091436|FG002|Long-term Extension Period|Lost to Follow-up|0|||
155178247|NCT00095147|560091437|FG003|Long-term Extension Period|Lost to Follow-up|0|||
155178248|NCT00095147|560091438|FG004|Long-term Extension Period|Lost to Follow-up|6|||
155178249|NCT00095147|560091434|FG000|Long-term Extension Period|Withdrawal of consent|0|||
155178250|NCT00095147|560091435|FG001|Long-term Extension Period|Withdrawal of consent|0|||
155178251|NCT00095147|560091436|FG002|Long-term Extension Period|Withdrawal of consent|0|||
155178252|NCT00095147|560091437|FG003|Long-term Extension Period|Withdrawal of consent|0|||
155178253|NCT00095147|560091438|FG004|Long-term Extension Period|Withdrawal of consent|12|||
155178254|NCT00095147|560091434|FG000|Long-term Extension Period|Pregnancy|0|||
155178255|NCT00095147|560091435|FG001|Long-term Extension Period|Pregnancy|0|||
155178256|NCT00095147|560091436|FG002|Long-term Extension Period|Pregnancy|0|||
155178257|NCT00095147|560091437|FG003|Long-term Extension Period|Pregnancy|0|||
155178258|NCT00095147|560091438|FG004|Long-term Extension Period|Pregnancy|1|||
155178259|NCT00095147|560091434|FG000|Long-term Extension Period|No longer meets study criteria|0|||
155178260|NCT00095147|560091435|FG001|Long-term Extension Period|No longer meets study criteria|0|||
155178261|NCT00095147|560091436|FG002|Long-term Extension Period|No longer meets study criteria|0|||
155178262|NCT00095147|560091437|FG003|Long-term Extension Period|No longer meets study criteria|0|||
155178263|NCT00095147|560091438|FG004|Long-term Extension Period|No longer meets study criteria|1|||
155125507|NCT04435600|559891608|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125508|NCT04435600|559891609|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125509|NCT04435600|559891610|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125510|NCT04435600|559891611|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125511|NCT04435600|559891612|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
155125512|NCT04435600|559891613|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
155125513|NCT02797184|559891618|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
155125514|NCT02797184|559891619|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
155125515|NCT02212678|559891629|FG000|Overall Study|Adverse Event|1|||
155125516|NCT01114360|559891632|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
155125517|NCT01114360|559891633|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
155125518|NCT03344172|559891636|FG000|Overall Study|Received <1 dose of treatment|1|||
155125519|NCT03344172|559891637|FG001|Overall Study|Received <1 dose of treatment|0|||
155125520|NCT01300351|559891638|FG000|Overall Study|Did not receive treatment|2|||
155125521|NCT01300351|559891639|FG001|Overall Study|Did not receive treatment|0|||
155125522|NCT01300351|559891638|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
155125523|NCT01300351|559891639|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
155125524|NCT01300351|559891638|FG000|Overall Study|Lost to Follow-up|0|||
155125525|NCT01300351|559891639|FG001|Overall Study|Lost to Follow-up|1|||
155125526|NCT01300351|559891638|FG000|Overall Study|Adverse Event|0|||
155125527|NCT01300351|559891639|FG001|Overall Study|Adverse Event|4|||
155125528|NCT01300351|559891638|FG000|Overall Study|Withdrawal by Subject|7|||
155125529|NCT01300351|559891639|FG001|Overall Study|Withdrawal by Subject|10|||
155125530|NCT00673881|559891640|FG000|Overall Study|Withdrawal by Subject|1|||
155125531|NCT03968159|559891643|FG000|Overall Study|Adverse Event|4|||
155125532|NCT03968159|559891644|FG001|Overall Study|Adverse Event|4|||
155125533|NCT03968159|559891643|FG000|Overall Study|Lost to Follow-up|1|||
155125534|NCT03968159|559891644|FG001|Overall Study|Lost to Follow-up|1|||
155125535|NCT03968159|559891643|FG000|Overall Study|Use of prohibited medication|0|||
155125536|NCT03968159|559891644|FG001|Overall Study|Use of prohibited medication|1|||
155125537|NCT03968159|559891643|FG000|Overall Study|Protocol Violation|2|||
155125538|NCT03968159|559891644|FG001|Overall Study|Protocol Violation|2|||
155125539|NCT03968159|559891643|FG000|Overall Study|Withdrawal by Subject|4|||
155125540|NCT03968159|559891644|FG001|Overall Study|Withdrawal by Subject|6|||
155125541|NCT03968159|559891643|FG000|Overall Study|Lack of Efficacy|0|||
155125542|NCT03968159|559891644|FG001|Overall Study|Lack of Efficacy|1|||
155125543|NCT03968159|559891643|FG000|Overall Study|Not further specified|2|||
155125544|NCT03968159|559891644|FG001|Overall Study|Not further specified|0|||
155125545|NCT02258529|559891645|FG000|Overall Study|Study Terminated by Sponsor|9|||
155125546|NCT02258529|559891645|FG000|Overall Study|Adverse Event|1|||
155125547|NCT00443781|559891646|FG000|Overall Study|Lost to Follow-up|10|||
155125548|NCT00443781|559891646|FG000|Overall Study|Physician Decision|2|||
155125549|NCT00443781|559891646|FG000|Overall Study|Protocol Violation|1|||
155125550|NCT00443781|559891646|FG000|Overall Study|Withdrawal by Subject|6|||
155125551|NCT00443781|559891646|FG000|Overall Study|Unable to comply with study follow up|2|||
155125552|NCT00443781|559891646|FG000|Overall Study|Investigator terminated participation|1|||
155125553|NCT00443781|559891646|FG000|Overall Study|Insurance not covered|2|||
155125554|NCT00443781|559891646|FG000|Overall Study|PD/FAD not done|1|||
155125555|NCT00430937|559891647|FG000|Overall Study|Adverse Event|3|||
155125556|NCT00430937|559891648|FG001|Overall Study|Adverse Event|8|||
155125557|NCT00430937|559891647|FG000|Overall Study|Death|0|||
155125558|NCT00430937|559891648|FG001|Overall Study|Death|1|||
155125559|NCT00430937|559891647|FG000|Overall Study|Lost to Follow-up|6|||
155125560|NCT00430937|559891648|FG001|Overall Study|Lost to Follow-up|6|||
155125561|NCT00430937|559891647|FG000|Overall Study|Withdrawal by Subject|5|||
155125562|NCT00430937|559891648|FG001|Overall Study|Withdrawal by Subject|2|||
155125563|NCT00430937|559891647|FG000|Overall Study|Protocol Violation|3|||
155125564|NCT00430937|559891648|FG001|Overall Study|Protocol Violation|2|||
155125565|NCT00430937|559891647|FG000|Overall Study|Lack of Efficacy|6|||
155125566|NCT00430937|559891648|FG001|Overall Study|Lack of Efficacy|5|||
155125567|NCT00430937|559891647|FG000|Overall Study|Inappropriate enrollment|2|||
155125568|NCT00430937|559891648|FG001|Overall Study|Inappropriate enrollment|1|||
155125569|NCT00430937|559891647|FG000|Overall Study|Administrative reasons|1|||
155125570|NCT00430937|559891648|FG001|Overall Study|Administrative reasons|0|||
155125571|NCT00430937|559891647|FG000|Overall Study|Protocol discontinuation criteria met|1|||
155125572|NCT00430937|559891648|FG001|Overall Study|Protocol discontinuation criteria met|2|||
155125573|NCT00430937|559891647|FG000|Overall Study|Unable to classify|0|||
155125574|NCT00430937|559891648|FG001|Overall Study|Unable to classify|1|||
155125575|NCT05432167|559891654|FG000|Overall Study|Adverse Event|0|||
155125576|NCT05432167|559891655|FG001|Overall Study|Adverse Event|2|||
155125577|NCT05432167|559891656|FG002|Overall Study|Adverse Event|1|||
155125578|NCT05432167|559891654|FG000|Overall Study|Lost to Follow-up|3|||
155125579|NCT05432167|559891655|FG001|Overall Study|Lost to Follow-up|3|||
155125580|NCT05432167|559891656|FG002|Overall Study|Lost to Follow-up|2|||
155125581|NCT05432167|559891654|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
155125582|NCT05432167|559891655|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
155125583|NCT05432167|559891656|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
155125584|NCT05432167|559891654|FG000|Overall Study|Physician Decision|1|||
155125585|NCT05432167|559891655|FG001|Overall Study|Physician Decision|0|||
155125586|NCT05432167|559891656|FG002|Overall Study|Physician Decision|0|||
155125587|NCT05432167|559891654|FG000|Overall Study|Withdrawal by Subject|7|||
155125588|NCT05432167|559891655|FG001|Overall Study|Withdrawal by Subject|4|||
155125589|NCT05432167|559891656|FG002|Overall Study|Withdrawal by Subject|11|||
155125590|NCT05432167|559891654|FG000|Overall Study|Other|0|||
155125591|NCT05432167|559891655|FG001|Overall Study|Other|0|||
155125592|NCT05432167|559891656|FG002|Overall Study|Other|1|||
155125593|NCT02006069|559891658|FG000|Overall Study|MPP other programming|239|||
155125594|NCT02006069|559891659|FG001|Overall Study|MPP other programming|0|||
155125595|NCT02006069|559891658|FG000|Overall Study|RV only pacing|0|||
155125596|NCT02006069|559891659|FG001|Overall Study|RV only pacing|3|||
155125597|NCT02642965|559891662|FG000|Overall Study|Lack of Efficacy|4|||
155125598|NCT02642965|559891662|FG000|Overall Study|Physician Decision|9|||
155125599|NCT00973102|559891668|FG000|Overall Study|Protocol Violation|1|||
155125600|NCT00973102|559891669|FG001|Overall Study|Protocol Violation|0|||
155125601|NCT00973102|559891668|FG000|Overall Study|Prisoner|0|||
155125602|NCT00973102|559891669|FG001|Overall Study|Prisoner|1|||
155125603|NCT01439126|559891670|FG000|Overall Study|Adverse Event|2|||
155125604|NCT01439126|559891671|FG001|Overall Study|Adverse Event|0|||
155125605|NCT01439126|559891670|FG000|Overall Study|Withdrawal by Subject|5|||
155125606|NCT01439126|559891671|FG001|Overall Study|Withdrawal by Subject|21|||
155125607|NCT01439126|559891670|FG000|Overall Study|Protocol Violation|6|||
155125608|NCT01439126|559891671|FG001|Overall Study|Protocol Violation|4|||
155125609|NCT01439126|559891670|FG000|Overall Study|Lost to Follow-up|6|||
155125610|NCT01439126|559891671|FG001|Overall Study|Lost to Follow-up|3|||
155125611|NCT01439126|559891670|FG000|Overall Study|Other-Use of prohibited treatment|0|||
155125612|NCT01439126|559891671|FG001|Overall Study|Other-Use of prohibited treatment|2|||
155125613|NCT01439126|559891670|FG000|Overall Study|Other-Miscellaneous|12|||
155125614|NCT01439126|559891671|FG001|Overall Study|Other-Miscellaneous|12|||
155125615|NCT00687609|559891672|FG000|Overall Study|Physician Decision|1|||
155125616|NCT00687609|559891672|FG000|Overall Study|Withdrawal by Subject|2|||
155125617|NCT00160199|559891673|FG000|Overall Study|Adverse Event|5|||
155125618|NCT00160199|559891674|FG001|Overall Study|Adverse Event|14|||
155125619|NCT00160199|559891673|FG000|Overall Study|Lack of Efficacy|0|||
155125620|NCT00160199|559891674|FG001|Overall Study|Lack of Efficacy|1|||
155125621|NCT00160199|559891673|FG000|Overall Study|Lost to Follow-up|7|||
155125622|NCT00160199|559891674|FG001|Overall Study|Lost to Follow-up|7|||
155125623|NCT00160199|559891673|FG000|Overall Study|Withdrawal by Subject|4|||
155125624|NCT00160199|559891674|FG001|Overall Study|Withdrawal by Subject|6|||
155125625|NCT00160199|559891673|FG000|Overall Study|Administrative|0|||
155125626|NCT00160199|559891674|FG001|Overall Study|Administrative|1|||
155125627|NCT00160199|559891673|FG000|Overall Study|Protocol Violation|8|||
155125628|NCT00160199|559891674|FG001|Overall Study|Protocol Violation|8|||
155125629|NCT03689244|559891675|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
155125630|NCT03689244|559891676|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
155125631|NCT03689244|559891677|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
155125632|NCT03689244|559891678|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
155125633|NCT03689244|559891675|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
155125634|NCT03689244|559891676|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
155125635|NCT03689244|559891677|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
155125636|NCT03689244|559891678|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
155125637|NCT03689244|559891675|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
155125638|NCT03689244|559891676|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
155125639|NCT03689244|559891677|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
155125640|NCT03689244|559891678|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
155125641|NCT03689244|559891675|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
155125642|NCT03689244|559891676|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
155125643|NCT03689244|559891677|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
155125644|NCT03689244|559891678|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
155125645|NCT03689244|559891675|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
155125646|NCT03689244|559891676|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
155125647|NCT03689244|559891677|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
155125648|NCT03689244|559891678|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
155125649|NCT03689244|559891675|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
155125650|NCT03689244|559891676|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
155125651|NCT03689244|559891677|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
155125652|NCT03689244|559891678|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
155125653|NCT03689244|559891675|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
155125654|NCT03689244|559891676|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
155125655|NCT03689244|559891677|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
155125656|NCT03689244|559891678|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
155125657|NCT03689244|559891675|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
155125658|NCT03689244|559891676|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
155005244|NCT02466685|559442741|FG000|Overall Study|Withdrawal by Subject|1|||
155005245|NCT02466685|559442742|FG001|Overall Study|Withdrawal by Subject|0|||
155005246|NCT02466685|559442741|FG000|Overall Study|Physician Decision|1|||
155005247|NCT02466685|559442742|FG001|Overall Study|Physician Decision|1|||
155005248|NCT02565511|559442743|FG000|Overall Study|Study terminated by Sponsor|35|||
155005249|NCT02565511|559442744|FG001|Overall Study|Study terminated by Sponsor|22|||
155005250|NCT02565511|559442745|FG002|Overall Study|Study terminated by Sponsor|235|||
155005251|NCT02565511|559442746|FG003|Overall Study|Study terminated by Sponsor|156|||
155005252|NCT02565511|559442743|FG000|Overall Study|Withdrawal by Subject|3|||
155005253|NCT02565511|559442744|FG001|Overall Study|Withdrawal by Subject|0|||
155005254|NCT02565511|559442745|FG002|Overall Study|Withdrawal by Subject|12|||
155005255|NCT02565511|559442746|FG003|Overall Study|Withdrawal by Subject|5|||
155005256|NCT02565511|559442743|FG000|Overall Study|Adverse Event|0|||
155005257|NCT02565511|559442744|FG001|Overall Study|Adverse Event|0|||
155005258|NCT02565511|559442745|FG002|Overall Study|Adverse Event|1|||
155005259|NCT02565511|559442746|FG003|Overall Study|Adverse Event|1|||
155005260|NCT02565511|559442743|FG000|Overall Study|Lost to Follow-up|4|||
155005261|NCT02565511|559442744|FG001|Overall Study|Lost to Follow-up|1|||
155005262|NCT02565511|559442745|FG002|Overall Study|Lost to Follow-up|0|||
155005263|NCT02565511|559442746|FG003|Overall Study|Lost to Follow-up|1|||
155005264|NCT02565511|559442743|FG000|Overall Study|Physician Decision|0|||
155005265|NCT02565511|559442744|FG001|Overall Study|Physician Decision|0|||
155005266|NCT02565511|559442745|FG002|Overall Study|Physician Decision|0|||
155005267|NCT02565511|559442746|FG003|Overall Study|Physician Decision|1|||
155005268|NCT02565511|559442743|FG000|Overall Study|Protocol deviation|0|||
155005269|NCT02565511|559442744|FG001|Overall Study|Protocol deviation|0|||
155005270|NCT02565511|559442745|FG002|Overall Study|Protocol deviation|3|||
155005271|NCT02565511|559442746|FG003|Overall Study|Protocol deviation|0|||
155005272|NCT02969044|559442747|FG000|Overall Study|Withdrawal by Subject|2|||
155005273|NCT02969044|559442748|FG001|Overall Study|Withdrawal by Subject|6|||
155005274|NCT02969044|559442747|FG000|Overall Study|Adverse Event|3|||
155005275|NCT02969044|559442748|FG001|Overall Study|Adverse Event|0|||
155005276|NCT00548093|559442749|FG000|Overall Study|Death|33|||
155005277|NCT00548093|559442750|FG001|Overall Study|Death|13|||
155005278|NCT00548093|559442749|FG000|Overall Study|Lost to Follow-up|3|||
155005279|NCT00548093|559442750|FG001|Overall Study|Lost to Follow-up|1|||
155005280|NCT00548093|559442749|FG000|Overall Study|Objective progression or relapse|1|||
155005281|NCT00548093|559442750|FG001|Overall Study|Objective progression or relapse|1|||
155005282|NCT00548093|559442749|FG000|Overall Study|Other|11|||
155005283|NCT00548093|559442750|FG001|Overall Study|Other|1|||
155005284|NCT00548093|559442749|FG000|Overall Study|Withdrawal by Subject|1|||
155005285|NCT00548093|559442750|FG001|Overall Study|Withdrawal by Subject|0|||
155005286|NCT00548093|559442749|FG000|Overall Study|Completed post-treatment follow-up|1|||
155005287|NCT00548093|559442750|FG001|Overall Study|Completed post-treatment follow-up|0|||
155005288|NCT02359994|559442753|FG000|Overall Population Study|Adverse Event|1|||
155005289|NCT02359994|559442754|FG001|Overall Population Study|Adverse Event|1|||
155005290|NCT02359994|559442753|FG000|Overall Population Study|Death|1|||
155005291|NCT02359994|559442754|FG001|Overall Population Study|Death|5|||
155005292|NCT02359994|559442753|FG000|Overall Population Study|Lost to Follow-up|1|||
155005293|NCT02359994|559442754|FG001|Overall Population Study|Lost to Follow-up|1|||
155005294|NCT02359994|559442753|FG000|Overall Population Study|Withdrawal by Subject|1|||
155005295|NCT02359994|559442754|FG001|Overall Population Study|Withdrawal by Subject|0|||
155005296|NCT02359994|559442753|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
155005297|NCT02359994|559442754|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
155005298|NCT02359994|559442753|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
155005299|NCT02359994|559442754|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
155005300|NCT02359994|559442753|FG000|Extended Oncology 24-Month Survival|Death|19|||
155005301|NCT02359994|559442754|FG001|Extended Oncology 24-Month Survival|Death|21|||
155005302|NCT02359994|559442753|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
155005303|NCT02359994|559442754|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
155125659|NCT03689244|559891677|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
155125660|NCT03689244|559891678|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
155125661|NCT00969436|559891681|FG000|Overall Study|Protocol Violation|1|||
155125662|NCT00969436|559891682|FG001|Overall Study|Protocol Violation|3|||
155005304|NCT04597632|559442755|FG000|Overall Study|Withdrawal by Subject|10|||
155005305|NCT04597632|559442755|FG000|Overall Study|Lost to Follow-up|1|||
155005306|NCT04597632|559442755|FG000|Overall Study|Death|1|||
155005307|NCT04597632|559442755|FG000|Overall Study|Adverse Event|5|||
155005308|NCT01823835|559442756|FG000|Overall Study|Adverse Event|0|||
155005309|NCT01823835|559442757|FG001|Overall Study|Adverse Event|0|||
155005310|NCT01823835|559442758|FG002|Overall Study|Adverse Event|0|||
155005311|NCT01823835|559442759|FG003|Overall Study|Adverse Event|0|||
155005312|NCT01823835|559442760|FG004|Overall Study|Adverse Event|1|||
155005313|NCT01823835|559442761|FG005|Overall Study|Adverse Event|0|||
155125663|NCT00969436|559891683|FG002|Overall Study|Protocol Violation|0|||
155125664|NCT00969436|559891681|FG000|Overall Study|Migrated/moved from study area|12|||
155125665|NCT00969436|559891682|FG001|Overall Study|Migrated/moved from study area|10|||
155125666|NCT00969436|559891683|FG002|Overall Study|Migrated/moved from study area|2|||
155125667|NCT00969436|559891681|FG000|Overall Study|Father - serious health problem|0|||
155125668|NCT00969436|559891682|FG001|Overall Study|Father - serious health problem|0|||
155125669|NCT00969436|559891683|FG002|Overall Study|Father - serious health problem|1|||
155125670|NCT00969436|559891681|FG000|Overall Study|Parents personal problem|0|||
155125671|NCT00969436|559891682|FG001|Overall Study|Parents personal problem|0|||
155125672|NCT00969436|559891683|FG002|Overall Study|Parents personal problem|1|||
155125673|NCT00969436|559891681|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
155125674|NCT00969436|559891682|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
155125675|NCT00969436|559891683|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
155125676|NCT00969436|559891681|FG000|Overall Study|Withdrawal by Subject|3|||
155125677|NCT00969436|559891682|FG001|Overall Study|Withdrawal by Subject|0|||
155125678|NCT00969436|559891683|FG002|Overall Study|Withdrawal by Subject|2|||
155125679|NCT00969436|559891681|FG000|Overall Study|Lost to Follow-up|8|||
155125680|NCT00969436|559891682|FG001|Overall Study|Lost to Follow-up|8|||
155125681|NCT00969436|559891683|FG002|Overall Study|Lost to Follow-up|5|||
155125682|NCT02544373|559891688|FG000|Overall Study|Lost to Follow-up|5|||
155125683|NCT02544373|559891689|FG001|Overall Study|Lost to Follow-up|3|||
155125684|NCT02544373|559891688|FG000|Overall Study|Withdrawal by Subject|8|||
155125685|NCT02544373|559891689|FG001|Overall Study|Withdrawal by Subject|2|||
155125686|NCT05011513|559893221|FG000|Overall Study|Death|0|||
155125687|NCT05011513|559893222|FG001|Overall Study|Death|1|||
155125688|NCT05011513|559893221|FG000|Overall Study|Lost to Follow-up|4|||
155125689|NCT05011513|559893222|FG001|Overall Study|Lost to Follow-up|0|||
155125690|NCT05011513|559893221|FG000|Overall Study|Withdrawal by Subject|18|||
155125691|NCT05011513|559893222|FG001|Overall Study|Withdrawal by Subject|17|||
155125692|NCT05011513|559893221|FG000|Overall Study|Other|4|||
155125693|NCT05011513|559893222|FG001|Overall Study|Other|2|||
155125694|NCT03667690|559893223|FG000|Overall Study|Adverse Event|0|||
155125695|NCT03667690|559893224|FG001|Overall Study|Adverse Event|3|||
155125696|NCT03667690|559893223|FG000|Overall Study|Death|22|||
155125697|NCT03667690|559893224|FG001|Overall Study|Death|21|||
155125698|NCT03667690|559893223|FG000|Overall Study|Lost to Follow-up|4|||
155125699|NCT03667690|559893224|FG001|Overall Study|Lost to Follow-up|5|||
155125700|NCT03667690|559893223|FG000|Overall Study|Withdrawal by Subject|7|||
155125701|NCT03667690|559893224|FG001|Overall Study|Withdrawal by Subject|8|||
155125702|NCT03667690|559893223|FG000|Overall Study|Subject could not return for additional investigational product|1|||
155125703|NCT03667690|559893224|FG001|Overall Study|Subject could not return for additional investigational product|0|||
155125704|NCT03667690|559893223|FG000|Overall Study|Subject discharged to hospice care|2|||
155125705|NCT03667690|559893224|FG001|Overall Study|Subject discharged to hospice care|0|||
155125706|NCT03667690|559893223|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
155125707|NCT03667690|559893224|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
155125708|NCT03667690|559893223|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
155125709|NCT03667690|559893224|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
155125710|NCT03667690|559893223|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
155125711|NCT03667690|559893224|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
155125712|NCT03667690|559893223|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
155125713|NCT03667690|559893224|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
155125714|NCT03667690|559893223|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
155125715|NCT03667690|559893224|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
155125716|NCT03495102|559893225|FG000|Overall Study|Adverse Event|5|||
155125717|NCT03495102|559893226|FG001|Overall Study|Adverse Event|7|||
155125718|NCT03495102|559893227|FG002|Overall Study|Adverse Event|10|||
155125719|NCT03495102|559893225|FG000|Overall Study|Death|3|||
155125720|NCT03495102|559893226|FG001|Overall Study|Death|4|||
155125721|NCT03495102|559893227|FG002|Overall Study|Death|4|||
155125722|NCT03495102|559893225|FG000|Overall Study|Lost to Follow-up|15|||
155125723|NCT03495102|559893226|FG001|Overall Study|Lost to Follow-up|16|||
155125724|NCT03495102|559893227|FG002|Overall Study|Lost to Follow-up|17|||
155125725|NCT03495102|559893225|FG000|Overall Study|Physician Decision|2|||
155125726|NCT03495102|559893226|FG001|Overall Study|Physician Decision|0|||
155005314|NCT01823835|559442762|FG006|Overall Study|Adverse Event|1|||
155005315|NCT01823835|559442763|FG007|Overall Study|Adverse Event|0|||
155125727|NCT03495102|559893227|FG002|Overall Study|Physician Decision|2|||
155125728|NCT03495102|559893225|FG000|Overall Study|Withdrawal by Subject|25|||
155125729|NCT03495102|559893226|FG001|Overall Study|Withdrawal by Subject|36|||
155005316|NCT01823835|559442764|FG008|Overall Study|Adverse Event|0|||
155125730|NCT03495102|559893227|FG002|Overall Study|Withdrawal by Subject|18|||
155125731|NCT03495102|559893225|FG000|Overall Study|Protocol Violation|1|||
155125732|NCT03495102|559893226|FG001|Overall Study|Protocol Violation|1|||
155005317|NCT01823835|559442765|FG009|Overall Study|Adverse Event|0|||
155005318|NCT01823835|559442766|FG010|Overall Study|Adverse Event|1|||
155005319|NCT01823835|559442767|FG011|Overall Study|Adverse Event|2|||
155005320|NCT01823835|559442768|FG012|Overall Study|Adverse Event|0|||
155005321|NCT01823835|559442769|FG013|Overall Study|Adverse Event|0|||
155005322|NCT01823835|559442770|FG014|Overall Study|Adverse Event|0|||
155005323|NCT01823835|559442756|FG000|Overall Study|Physician Decision|0|||
155005324|NCT01823835|559442757|FG001|Overall Study|Physician Decision|0|||
155005325|NCT01823835|559442758|FG002|Overall Study|Physician Decision|0|||
155005326|NCT01823835|559442759|FG003|Overall Study|Physician Decision|0|||
155005327|NCT01823835|559442760|FG004|Overall Study|Physician Decision|0|||
155005328|NCT01823835|559442761|FG005|Overall Study|Physician Decision|0|||
155005329|NCT01823835|559442762|FG006|Overall Study|Physician Decision|0|||
155005330|NCT01823835|559442763|FG007|Overall Study|Physician Decision|0|||
155005331|NCT01823835|559442764|FG008|Overall Study|Physician Decision|0|||
155005332|NCT01823835|559442765|FG009|Overall Study|Physician Decision|0|||
155005333|NCT01823835|559442766|FG010|Overall Study|Physician Decision|0|||
155005334|NCT01823835|559442767|FG011|Overall Study|Physician Decision|2|||
155005335|NCT01823835|559442768|FG012|Overall Study|Physician Decision|0|||
155005336|NCT01823835|559442769|FG013|Overall Study|Physician Decision|0|||
155005337|NCT01823835|559442770|FG014|Overall Study|Physician Decision|0|||
155005338|NCT01823835|559442756|FG000|Overall Study|Progressive Disease|3|||
155005339|NCT01823835|559442757|FG001|Overall Study|Progressive Disease|4|||
155005340|NCT01823835|559442758|FG002|Overall Study|Progressive Disease|3|||
155005341|NCT01823835|559442759|FG003|Overall Study|Progressive Disease|6|||
155005342|NCT01823835|559442760|FG004|Overall Study|Progressive Disease|4|||
155005343|NCT01823835|559442761|FG005|Overall Study|Progressive Disease|6|||
155005344|NCT01823835|559442762|FG006|Overall Study|Progressive Disease|5|||
155005345|NCT01823835|559442763|FG007|Overall Study|Progressive Disease|3|||
155005346|NCT01823835|559442764|FG008|Overall Study|Progressive Disease|3|||
155005347|NCT01823835|559442765|FG009|Overall Study|Progressive Disease|18|||
155005348|NCT01823835|559442766|FG010|Overall Study|Progressive Disease|8|||
155005349|NCT01823835|559442767|FG011|Overall Study|Progressive Disease|46|||
155005350|NCT01823835|559442768|FG012|Overall Study|Progressive Disease|18|||
155005351|NCT01823835|559442769|FG013|Overall Study|Progressive Disease|4|||
155005352|NCT01823835|559442770|FG014|Overall Study|Progressive Disease|6|||
155005353|NCT01823835|559442756|FG000|Overall Study|Study Termination|0|||
155005354|NCT01823835|559442757|FG001|Overall Study|Study Termination|0|||
155005355|NCT01823835|559442758|FG002|Overall Study|Study Termination|0|||
155005356|NCT01823835|559442759|FG003|Overall Study|Study Termination|0|||
155005357|NCT01823835|559442760|FG004|Overall Study|Study Termination|1|||
155005358|NCT01823835|559442761|FG005|Overall Study|Study Termination|0|||
155005359|NCT01823835|559442762|FG006|Overall Study|Study Termination|0|||
155005360|NCT01823835|559442763|FG007|Overall Study|Study Termination|0|||
155005361|NCT01823835|559442764|FG008|Overall Study|Study Termination|0|||
155005362|NCT01823835|559442765|FG009|Overall Study|Study Termination|0|||
155005363|NCT01823835|559442766|FG010|Overall Study|Study Termination|0|||
155005364|NCT01823835|559442767|FG011|Overall Study|Study Termination|1|||
155005365|NCT01823835|559442768|FG012|Overall Study|Study Termination|0|||
155005366|NCT01823835|559442769|FG013|Overall Study|Study Termination|0|||
155005367|NCT01823835|559442770|FG014|Overall Study|Study Termination|0|||
155005368|NCT01823835|559442756|FG000|Overall Study|Withdrawal by Subject|0|||
155005369|NCT01823835|559442757|FG001|Overall Study|Withdrawal by Subject|0|||
155005370|NCT01823835|559442758|FG002|Overall Study|Withdrawal by Subject|1|||
155005371|NCT01823835|559442759|FG003|Overall Study|Withdrawal by Subject|0|||
155005372|NCT01823835|559442760|FG004|Overall Study|Withdrawal by Subject|0|||
155005373|NCT01823835|559442761|FG005|Overall Study|Withdrawal by Subject|0|||
155005374|NCT01823835|559442762|FG006|Overall Study|Withdrawal by Subject|0|||
155005375|NCT01823835|559442763|FG007|Overall Study|Withdrawal by Subject|0|||
155005376|NCT01823835|559442764|FG008|Overall Study|Withdrawal by Subject|0|||
155005377|NCT01823835|559442765|FG009|Overall Study|Withdrawal by Subject|1|||
155005378|NCT01823835|559442766|FG010|Overall Study|Withdrawal by Subject|1|||
155125733|NCT03495102|559893227|FG002|Overall Study|Protocol Violation|0|||
155125734|NCT03495102|559893225|FG000|Overall Study|Site Closure|3|||
155125735|NCT03495102|559893226|FG001|Overall Study|Site Closure|1|||
155125736|NCT03495102|559893227|FG002|Overall Study|Site Closure|2|||
155125737|NCT03495102|559893225|FG000|Overall Study|Non-compliance|1|||
155125738|NCT03495102|559893226|FG001|Overall Study|Non-compliance|0|||
155125739|NCT03495102|559893227|FG002|Overall Study|Non-compliance|0|||
155005379|NCT01823835|559442767|FG011|Overall Study|Withdrawal by Subject|2|||
155005380|NCT01823835|559442768|FG012|Overall Study|Withdrawal by Subject|1|||
155005381|NCT01823835|559442769|FG013|Overall Study|Withdrawal by Subject|0|||
155005382|NCT01823835|559442770|FG014|Overall Study|Withdrawal by Subject|0|||
155005383|NCT00509795|559442771|FG000|Overall Study|Adverse Event|4|||
155005384|NCT00509795|559442772|FG001|Overall Study|Adverse Event|3|||
155005385|NCT00509795|559442773|FG002|Overall Study|Adverse Event|5|||
155005386|NCT00509795|559442774|FG003|Overall Study|Adverse Event|4|||
155005387|NCT00509795|559442771|FG000|Overall Study|Death|3|||
155005388|NCT00509795|559442772|FG001|Overall Study|Death|1|||
155005389|NCT00509795|559442773|FG002|Overall Study|Death|2|||
155178264|NCT00095147|560091434|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
155178265|NCT00095147|560091435|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
155178266|NCT00095147|560091436|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
155178267|NCT00095147|560091437|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
155178268|NCT00095147|560091438|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
155178269|NCT00095147|560091434|FG000|Long-term Extension Period|Leaving country|0|||
155178270|NCT00095147|560091435|FG001|Long-term Extension Period|Leaving country|0|||
155178271|NCT00095147|560091436|FG002|Long-term Extension Period|Leaving country|0|||
155178272|NCT00095147|560091437|FG003|Long-term Extension Period|Leaving country|0|||
155178273|NCT00095147|560091438|FG004|Long-term Extension Period|Leaving country|1|||
155178274|NCT03400956|560091439|FG000|Treatment Period 1|Adverse Event|0|||
155178275|NCT03400956|560091440|FG001|Treatment Period 1|Adverse Event|1|||
155178276|NCT03400956|560091441|FG002|Treatment Period 1|Adverse Event|0|||
155178277|NCT03400956|560091439|FG000|Treatment Period 1|Lost to Follow-up|0|||
155178278|NCT03400956|560091440|FG001|Treatment Period 1|Lost to Follow-up|0|||
155178279|NCT03400956|560091441|FG002|Treatment Period 1|Lost to Follow-up|1|||
155178280|NCT03400956|560091439|FG000|Treatment Period 1|Protocol Violation|0|||
155178281|NCT03400956|560091440|FG001|Treatment Period 1|Protocol Violation|2|||
155178282|NCT03400956|560091441|FG002|Treatment Period 1|Protocol Violation|0|||
155178283|NCT03400956|560091439|FG000|Treatment Period 1|Study terminated by sponsor|3|||
155178284|NCT03400956|560091440|FG001|Treatment Period 1|Study terminated by sponsor|1|||
154923137|NCT05182840|559142245|FG006|Treatment Period|No reason available|0|||
155125740|NCT03495102|559893225|FG000|Overall Study|Participant Duplicated at Another Site|0|||
155125741|NCT03495102|559893226|FG001|Overall Study|Participant Duplicated at Another Site|0|||
155125742|NCT03495102|559893227|FG002|Overall Study|Participant Duplicated at Another Site|1|||
155125743|NCT03495102|559893225|FG000|Overall Study|Primary Care Physician Recommendation|0|||
155125744|NCT03495102|559893226|FG001|Overall Study|Primary Care Physician Recommendation|1|||
155125745|NCT03495102|559893227|FG002|Overall Study|Primary Care Physician Recommendation|0|||
155125746|NCT03495102|559893225|FG000|Overall Study|Relocated to Another Country|0|||
155125747|NCT03495102|559893226|FG001|Overall Study|Relocated to Another Country|1|||
155125748|NCT03495102|559893227|FG002|Overall Study|Relocated to Another Country|0|||
155125749|NCT03495102|559893225|FG000|Overall Study|Participant was in Rehabilitation|1|||
155125750|NCT03495102|559893226|FG001|Overall Study|Participant was in Rehabilitation|0|||
155125751|NCT03495102|559893227|FG002|Overall Study|Participant was in Rehabilitation|0|||
155125752|NCT01350115|559893233|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
155125753|NCT01350115|559893234|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
155125754|NCT01350115|559893233|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
155178285|NCT03400956|560091441|FG002|Treatment Period 1|Study terminated by sponsor|1|||
155178286|NCT03400956|560091439|FG000|Treatment Period 1|Withdrawal by Subject|0|||
154923138|NCT05182840|559142246|FG007|Treatment Period|No reason available|1|||
154923139|NCT05182840|559142247|FG008|Treatment Period|No reason available|0|||
154923140|NCT05182840|559142248|FG009|Treatment Period|No reason available|0|||
154923141|NCT05182840|559142239|FG000|Treatment Period|Burden of study procedures|0|||
154923142|NCT05182840|559142240|FG001|Treatment Period|Burden of study procedures|0|||
154923143|NCT05182840|559142241|FG002|Treatment Period|Burden of study procedures|0|||
154923144|NCT05182840|559142242|FG003|Treatment Period|Burden of study procedures|0|||
154923145|NCT05182840|559142243|FG004|Treatment Period|Burden of study procedures|1|||
154923146|NCT05182840|559142244|FG005|Treatment Period|Burden of study procedures|0|||
154923147|NCT05182840|559142245|FG006|Treatment Period|Burden of study procedures|0|||
154923148|NCT05182840|559142246|FG007|Treatment Period|Burden of study procedures|0|||
154923149|NCT05182840|559142247|FG008|Treatment Period|Burden of study procedures|0|||
154923150|NCT05182840|559142248|FG009|Treatment Period|Burden of study procedures|0|||
154923151|NCT05182840|559142239|FG000|Treatment Period|Change of residence|0|||
154923152|NCT05182840|559142240|FG001|Treatment Period|Change of residence|0|||
154923153|NCT05182840|559142241|FG002|Treatment Period|Change of residence|0|||
154923154|NCT05182840|559142242|FG003|Treatment Period|Change of residence|0|||
154923155|NCT05182840|559142243|FG004|Treatment Period|Change of residence|0|||
154923156|NCT05182840|559142244|FG005|Treatment Period|Change of residence|1|||
154923157|NCT05182840|559142245|FG006|Treatment Period|Change of residence|0|||
154923158|NCT05182840|559142246|FG007|Treatment Period|Change of residence|0|||
154923159|NCT05182840|559142247|FG008|Treatment Period|Change of residence|0|||
154923160|NCT05182840|559142248|FG009|Treatment Period|Change of residence|0|||
154923161|NCT05182840|559142239|FG000|Treatment Period|Adverse Event|0|||
154923162|NCT05182840|559142240|FG001|Treatment Period|Adverse Event|0|||
154923163|NCT05182840|559142241|FG002|Treatment Period|Adverse Event|4|||
154923164|NCT05182840|559142242|FG003|Treatment Period|Adverse Event|16|||
155178287|NCT03400956|560091440|FG001|Treatment Period 1|Withdrawal by Subject|2|||
154923165|NCT05182840|559142243|FG004|Treatment Period|Adverse Event|12|||
154923166|NCT05182840|559142244|FG005|Treatment Period|Adverse Event|6|||
154923167|NCT05182840|559142245|FG006|Treatment Period|Adverse Event|4|||
154923168|NCT05182840|559142246|FG007|Treatment Period|Adverse Event|8|||
154923169|NCT05182840|559142247|FG008|Treatment Period|Adverse Event|16|||
155125755|NCT01350115|559893234|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
155125756|NCT01350115|559893233|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
155125757|NCT01350115|559893234|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
155125758|NCT04327024|559893235|FG000|Overall Study|Death|1|||
155125759|NCT04327024|559893236|FG001|Overall Study|Death|2|||
155125760|NCT04327024|559893237|FG002|Overall Study|Death|1|||
155125761|NCT04327024|559893235|FG000|Overall Study|Non-compliance with study drug|0|||
155125762|NCT04327024|559893236|FG001|Overall Study|Non-compliance with study drug|1|||
155125763|NCT04327024|559893237|FG002|Overall Study|Non-compliance with study drug|0|||
155125764|NCT04327024|559893235|FG000|Overall Study|Withdrawal by Subject|1|||
155125765|NCT04327024|559893236|FG001|Overall Study|Withdrawal by Subject|1|||
155125766|NCT04327024|559893237|FG002|Overall Study|Withdrawal by Subject|2|||
155125767|NCT00837759|559893241|FG000|Overall Study|Protocol Violation|3|||
155125768|NCT00837759|559893241|FG000|Overall Study|Lost to Follow-up|1|||
155125769|NCT01597635|559893242|FG000|Part A|Adverse Event|3|||
155125770|NCT01597635|559893243|FG001|Part A|Adverse Event|0|||
155125771|NCT01597635|559893244|FG002|Part A|Adverse Event|0|||
155125772|NCT01597635|559893242|FG000|Part B|Adverse Event|0|||
155125773|NCT01597635|559893243|FG001|Part B|Adverse Event|0|||
155125774|NCT01597635|559893244|FG002|Part B|Adverse Event|1|||
155125775|NCT01597635|559893242|FG000|Part B|Protocol Violation|0|||
155125776|NCT01597635|559893243|FG001|Part B|Protocol Violation|1|||
155125777|NCT01597635|559893244|FG002|Part B|Protocol Violation|0|||
155125778|NCT01597635|559893242|FG000|Part B|Protocol-defined stopping criteria|0|||
155125779|NCT01597635|559893243|FG001|Part B|Protocol-defined stopping criteria|4|||
155125780|NCT01597635|559893244|FG002|Part B|Protocol-defined stopping criteria|3|||
155125781|NCT01597635|559893242|FG000|Part B|Withdrawal by Subject|0|||
155125782|NCT01597635|559893243|FG001|Part B|Withdrawal by Subject|1|||
155125783|NCT01597635|559893244|FG002|Part B|Withdrawal by Subject|0|||
155125784|NCT01192568|559893245|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
155125785|NCT01192568|559893246|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
155125786|NCT01192568|559893247|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
155125787|NCT01192568|559893248|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
155125788|NCT01192568|559893245|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
155125789|NCT01192568|559893246|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
155125790|NCT01192568|559893247|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
155125791|NCT01192568|559893248|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
155125792|NCT02783170|559893251|FG000|Overall Study|Randomized but not Vaccinated|1|||
155125793|NCT02783170|559893252|FG001|Overall Study|Randomized but not Vaccinated|0|||
155125794|NCT00541346|559893253|FG000|Follow-up|Adverse Event|1|||
155125795|NCT02008773|559893254|FG000|Overall Study|Adverse Event|3|||
155125796|NCT02008773|559893255|FG001|Overall Study|Adverse Event|3|||
155125797|NCT02008773|559893256|FG002|Overall Study|Adverse Event|1|||
155125798|NCT02008773|559893257|FG003|Overall Study|Adverse Event|2|||
155125799|NCT02008773|559893254|FG000|Overall Study|Medication Non-compliance|2|||
155125800|NCT02008773|559893255|FG001|Overall Study|Medication Non-compliance|1|||
155125801|NCT02008773|559893256|FG002|Overall Study|Medication Non-compliance|3|||
155125802|NCT02008773|559893257|FG003|Overall Study|Medication Non-compliance|2|||
155125803|NCT02008773|559893254|FG000|Overall Study|Withdrawal by Subject|8|||
155125804|NCT02008773|559893255|FG001|Overall Study|Withdrawal by Subject|4|||
155125805|NCT02008773|559893256|FG002|Overall Study|Withdrawal by Subject|7|||
155125806|NCT02008773|559893257|FG003|Overall Study|Withdrawal by Subject|6|||
155125807|NCT02008773|559893254|FG000|Overall Study|Lost to Follow-up|0|||
155125808|NCT02008773|559893255|FG001|Overall Study|Lost to Follow-up|1|||
155125809|NCT02008773|559893256|FG002|Overall Study|Lost to Follow-up|3|||
155125810|NCT02008773|559893257|FG003|Overall Study|Lost to Follow-up|2|||
155125811|NCT01806064|559893258|FG000|Overall Study|Randomized Not Enrolled|0|||
155005390|NCT00509795|559442774|FG003|Overall Study|Death|7|||
155005391|NCT00509795|559442771|FG000|Overall Study|Lack of Efficacy|0|||
155005392|NCT00509795|559442772|FG001|Overall Study|Lack of Efficacy|0|||
155125812|NCT01806064|559893259|FG001|Overall Study|Randomized Not Enrolled|0|||
155125813|NCT01806064|559893260|FG002|Overall Study|Randomized Not Enrolled|0|||
155125814|NCT01806064|559893261|FG003|Overall Study|Randomized Not Enrolled|1|||
155125815|NCT01806064|559893262|FG004|Overall Study|Randomized Not Enrolled|2|||
155125816|NCT02905006|559893263|FG000|Overall Study|Adverse Event|1|||
155125817|NCT02905006|559893264|FG001|Overall Study|Adverse Event|1|||
155125818|NCT02905006|559893265|FG002|Overall Study|Adverse Event|1|||
155125819|NCT02905006|559893266|FG003|Overall Study|Adverse Event|1|||
155125820|NCT02905006|559893267|FG004|Overall Study|Adverse Event|0|||
155125821|NCT02905006|559893268|FG005|Overall Study|Adverse Event|1|||
155125822|NCT02905006|559893263|FG000|Overall Study|Lack of Efficacy|1|||
155125823|NCT02905006|559893264|FG001|Overall Study|Lack of Efficacy|0|||
155005393|NCT00509795|559442773|FG002|Overall Study|Lack of Efficacy|2|||
155125824|NCT02905006|559893265|FG002|Overall Study|Lack of Efficacy|0|||
155125825|NCT02905006|559893266|FG003|Overall Study|Lack of Efficacy|0|||
155125826|NCT02905006|559893267|FG004|Overall Study|Lack of Efficacy|0|||
155125827|NCT02905006|559893268|FG005|Overall Study|Lack of Efficacy|0|||
155125828|NCT02905006|559893263|FG000|Overall Study|Protocol Violation|2|||
155125829|NCT02905006|559893264|FG001|Overall Study|Protocol Violation|0|||
155125830|NCT02905006|559893265|FG002|Overall Study|Protocol Violation|0|||
155125831|NCT02905006|559893266|FG003|Overall Study|Protocol Violation|0|||
155125832|NCT02905006|559893267|FG004|Overall Study|Protocol Violation|0|||
155125833|NCT02905006|559893268|FG005|Overall Study|Protocol Violation|0|||
155125834|NCT02905006|559893263|FG000|Overall Study|Lost to Follow-up|0|||
155125835|NCT02905006|559893264|FG001|Overall Study|Lost to Follow-up|0|||
155125836|NCT02905006|559893265|FG002|Overall Study|Lost to Follow-up|0|||
155125837|NCT02905006|559893266|FG003|Overall Study|Lost to Follow-up|1|||
155125838|NCT02905006|559893267|FG004|Overall Study|Lost to Follow-up|1|||
155125839|NCT02905006|559893268|FG005|Overall Study|Lost to Follow-up|0|||
155125840|NCT02905006|559893263|FG000|Overall Study|Withdrawal by Subject|0|||
155125841|NCT02905006|559893264|FG001|Overall Study|Withdrawal by Subject|0|||
155125842|NCT02905006|559893265|FG002|Overall Study|Withdrawal by Subject|1|||
155125843|NCT02905006|559893266|FG003|Overall Study|Withdrawal by Subject|1|||
155125844|NCT02905006|559893267|FG004|Overall Study|Withdrawal by Subject|0|||
155125845|NCT02905006|559893268|FG005|Overall Study|Withdrawal by Subject|1|||
155125846|NCT02905006|559893263|FG000|Overall Study|Screening exclusion criteria met|1|||
155125847|NCT02905006|559893264|FG001|Overall Study|Screening exclusion criteria met|0|||
155125848|NCT02905006|559893265|FG002|Overall Study|Screening exclusion criteria met|0|||
155125849|NCT02905006|559893266|FG003|Overall Study|Screening exclusion criteria met|0|||
155125850|NCT02905006|559893267|FG004|Overall Study|Screening exclusion criteria met|0|||
155125851|NCT02905006|559893268|FG005|Overall Study|Screening exclusion criteria met|0|||
155125852|NCT02905006|559893263|FG000|Overall Study|Lab withdrawal criterion met|0|||
155125853|NCT02905006|559893264|FG001|Overall Study|Lab withdrawal criterion met|1|||
155125854|NCT02905006|559893265|FG002|Overall Study|Lab withdrawal criterion met|2|||
155125855|NCT02905006|559893266|FG003|Overall Study|Lab withdrawal criterion met|2|||
155125856|NCT02905006|559893267|FG004|Overall Study|Lab withdrawal criterion met|2|||
155125857|NCT02905006|559893268|FG005|Overall Study|Lab withdrawal criterion met|1|||
155125858|NCT02905006|559893263|FG000|Overall Study|Positive for Tuberculosis|0|||
155125859|NCT02905006|559893264|FG001|Overall Study|Positive for Tuberculosis|1|||
155125860|NCT02905006|559893265|FG002|Overall Study|Positive for Tuberculosis|0|||
155125861|NCT02905006|559893266|FG003|Overall Study|Positive for Tuberculosis|0|||
155125862|NCT02905006|559893267|FG004|Overall Study|Positive for Tuberculosis|0|||
155125863|NCT02905006|559893268|FG005|Overall Study|Positive for Tuberculosis|0|||
155125864|NCT02905006|559893263|FG000|Overall Study|Subject positive for Hep B|0|||
155125865|NCT02905006|559893264|FG001|Overall Study|Subject positive for Hep B|0|||
155125866|NCT02905006|559893265|FG002|Overall Study|Subject positive for Hep B|1|||
155125867|NCT02905006|559893266|FG003|Overall Study|Subject positive for Hep B|0|||
155125868|NCT02905006|559893267|FG004|Overall Study|Subject positive for Hep B|0|||
155125869|NCT02905006|559893268|FG005|Overall Study|Subject positive for Hep B|0|||
155125870|NCT02905006|559893263|FG000|Overall Study|Patient moved abroad|0|||
155125871|NCT02905006|559893264|FG001|Overall Study|Patient moved abroad|0|||
155125872|NCT02905006|559893265|FG002|Overall Study|Patient moved abroad|0|||
155125873|NCT02905006|559893266|FG003|Overall Study|Patient moved abroad|1|||
155125874|NCT02905006|559893267|FG004|Overall Study|Patient moved abroad|0|||
155125875|NCT02905006|559893268|FG005|Overall Study|Patient moved abroad|0|||
155125876|NCT02905006|559893263|FG000|Overall Study|Patient randomized by mistake|0|||
155125877|NCT02905006|559893264|FG001|Overall Study|Patient randomized by mistake|0|||
155125878|NCT02905006|559893265|FG002|Overall Study|Patient randomized by mistake|0|||
155125879|NCT02905006|559893266|FG003|Overall Study|Patient randomized by mistake|0|||
155125880|NCT02905006|559893267|FG004|Overall Study|Patient randomized by mistake|0|||
155125881|NCT02905006|559893268|FG005|Overall Study|Patient randomized by mistake|1|||
155125882|NCT05063539|559893269|FG000|Overall Study|Adverse Event|1|||
155125883|NCT05063539|559893270|FG001|Overall Study|Adverse Event|2|||
155125884|NCT05063539|559893271|FG002|Overall Study|Adverse Event|1|||
155125885|NCT05063539|559893269|FG000|Overall Study|Death|0|||
155125886|NCT05063539|559893270|FG001|Overall Study|Death|1|||
155125887|NCT05063539|559893271|FG002|Overall Study|Death|1|||
155125888|NCT05063539|559893269|FG000|Overall Study|Lost to Follow-up|0|||
155125889|NCT05063539|559893270|FG001|Overall Study|Lost to Follow-up|1|||
155125890|NCT05063539|559893271|FG002|Overall Study|Lost to Follow-up|0|||
155125891|NCT05063539|559893269|FG000|Overall Study|Physician Decision|4|||
155125892|NCT05063539|559893270|FG001|Overall Study|Physician Decision|3|||
155125893|NCT05063539|559893271|FG002|Overall Study|Physician Decision|1|||
155125894|NCT05063539|559893269|FG000|Overall Study|Progressive Disease|0|||
155125895|NCT05063539|559893270|FG001|Overall Study|Progressive Disease|2|||
155125896|NCT05063539|559893271|FG002|Overall Study|Progressive Disease|0|||
155178288|NCT03400956|560091441|FG002|Treatment Period 1|Withdrawal by Subject|4|||
155178289|NCT03400956|560091439|FG000|Treatment Period 1|Other|1|||
155125897|NCT05063539|559893269|FG000|Overall Study|Withdrawal by Subject|17|||
155125898|NCT05063539|559893270|FG001|Overall Study|Withdrawal by Subject|26|||
155125899|NCT05063539|559893271|FG002|Overall Study|Withdrawal by Subject|14|||
155125900|NCT05063539|559893269|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
155125901|NCT05063539|559893270|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
155125902|NCT05063539|559893271|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
155178290|NCT03400956|560091440|FG001|Treatment Period 1|Other|2|||
155125903|NCT05063539|559893269|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
155125904|NCT05063539|559893270|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
155125905|NCT05063539|559893271|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
155125906|NCT05063539|559893269|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
155125907|NCT05063539|559893270|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
155125908|NCT05063539|559893271|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
155125909|NCT05063539|559893269|FG000|Overall Study|Discontinued due to Common Close Design|0|||
155125910|NCT05063539|559893270|FG001|Overall Study|Discontinued due to Common Close Design|1|||
155125911|NCT05063539|559893271|FG002|Overall Study|Discontinued due to Common Close Design|0|||
155125912|NCT05063539|559893269|FG000|Overall Study|Participant not co-operative|0|||
155125913|NCT05063539|559893270|FG001|Overall Study|Participant not co-operative|1|||
155125914|NCT05063539|559893271|FG002|Overall Study|Participant not co-operative|0|||
155125915|NCT05063539|559893269|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
155125916|NCT05063539|559893270|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
155125917|NCT05063539|559893271|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
155125918|NCT05063539|559893269|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
155125919|NCT05063539|559893270|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
155125920|NCT05063539|559893271|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
155125921|NCT02804750|559893272|FG000|Period 1|Adverse Event|0|||
155125922|NCT02804750|559893273|FG001|Period 1|Adverse Event|2|||
155125923|NCT02804750|559893272|FG000|Period 1|Withdrawal by Subject|0|||
155125924|NCT02804750|559893273|FG001|Period 1|Withdrawal by Subject|1|||
155125925|NCT02804750|559893272|FG000|Period 2|Adverse Event|1|||
155125926|NCT02804750|559893273|FG001|Period 2|Adverse Event|0|||
155125927|NCT02804750|559893272|FG000|Period 3|Adverse Event|0|||
155125928|NCT02804750|559893273|FG001|Period 3|Adverse Event|2|||
155125929|NCT02804750|559893272|FG000|Period 4|Adverse Event|0|||
155125930|NCT02804750|559893273|FG001|Period 4|Adverse Event|5|||
155125931|NCT04692077|559893278|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
155125932|NCT05149313|559893279|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
155125933|NCT05149313|559893280|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
155125934|NCT05149313|559893281|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
155125935|NCT05149313|559893282|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
155005394|NCT00509795|559442774|FG003|Overall Study|Lack of Efficacy|2|||
155005395|NCT00509795|559442771|FG000|Overall Study|Lost to Follow-up|1|||
155005396|NCT00509795|559442772|FG001|Overall Study|Lost to Follow-up|2|||
155005397|NCT00509795|559442773|FG002|Overall Study|Lost to Follow-up|4|||
155005398|NCT00509795|559442774|FG003|Overall Study|Lost to Follow-up|4|||
155005399|NCT00509795|559442771|FG000|Overall Study|OTHER|1|||
155005400|NCT00509795|559442772|FG001|Overall Study|OTHER|0|||
155005401|NCT00509795|559442773|FG002|Overall Study|OTHER|4|||
155005402|NCT00509795|559442774|FG003|Overall Study|OTHER|1|||
155005403|NCT00509795|559442771|FG000|Overall Study|Protocol Violation|3|||
155005404|NCT00509795|559442772|FG001|Overall Study|Protocol Violation|0|||
155005405|NCT00509795|559442773|FG002|Overall Study|Protocol Violation|3|||
155005406|NCT00509795|559442774|FG003|Overall Study|Protocol Violation|1|||
155005407|NCT00509795|559442771|FG000|Overall Study|Withdrawal by Subject|10|||
155005408|NCT00509795|559442772|FG001|Overall Study|Withdrawal by Subject|5|||
155005409|NCT00509795|559442773|FG002|Overall Study|Withdrawal by Subject|7|||
155005410|NCT00509795|559442774|FG003|Overall Study|Withdrawal by Subject|8|||
155005411|NCT01320150|559442775|FG000|Overall Study|Protocol Violation|15|||
155005412|NCT01320150|559442775|FG000|Overall Study|Withdrawal by Subject|5|||
155005413|NCT01320150|559442775|FG000|Overall Study|Death|2|||
155005414|NCT01320150|559442775|FG000|Overall Study|Lost to Follow-up|44|||
155005415|NCT04895982|559442776|FG000|Overall Study|Withdrawal by Subject|0|||
155005416|NCT04895982|559442777|FG001|Overall Study|Withdrawal by Subject|0|||
155125936|NCT05149313|559893279|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
155125937|NCT05149313|559893280|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
155125938|NCT05149313|559893281|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
155125939|NCT05149313|559893282|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
155125940|NCT05149313|559893279|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
155125941|NCT05149313|559893280|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
155005417|NCT04895982|559442778|FG002|Overall Study|Withdrawal by Subject|0|||
155005418|NCT04895982|559442779|FG003|Overall Study|Withdrawal by Subject|0|||
155005419|NCT04895982|559442780|FG004|Overall Study|Withdrawal by Subject|0|||
155005420|NCT04895982|559442781|FG005|Overall Study|Withdrawal by Subject|1|||
155125942|NCT05149313|559893281|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
155005421|NCT04895982|559442782|FG006|Overall Study|Withdrawal by Subject|1|||
155005422|NCT04895982|559442783|FG007|Overall Study|Withdrawal by Subject|0|||
155005423|NCT04895982|559442784|FG008|Overall Study|Withdrawal by Subject|0|||
155005424|NCT04895982|559442785|FG009|Overall Study|Withdrawal by Subject|1|||
155005425|NCT04895982|559442786|FG010|Overall Study|Withdrawal by Subject|0|||
155005426|NCT04895982|559442787|FG011|Overall Study|Withdrawal by Subject|1|||
155005427|NCT04895982|559442776|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155005428|NCT04895982|559442777|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155005429|NCT04895982|559442778|FG002|Overall Study|Withdrawal by parent/guardian|3|||
155005430|NCT04895982|559442779|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155005431|NCT04895982|559442780|FG004|Overall Study|Withdrawal by parent/guardian|3|||
155005432|NCT04895982|559442781|FG005|Overall Study|Withdrawal by parent/guardian|2|||
155005433|NCT04895982|559442782|FG006|Overall Study|Withdrawal by parent/guardian|1|||
155005434|NCT04895982|559442783|FG007|Overall Study|Withdrawal by parent/guardian|0|||
155005435|NCT04895982|559442784|FG008|Overall Study|Withdrawal by parent/guardian|3|||
155005436|NCT04895982|559442785|FG009|Overall Study|Withdrawal by parent/guardian|0|||
155005437|NCT04895982|559442786|FG010|Overall Study|Withdrawal by parent/guardian|0|||
155005438|NCT04895982|559442787|FG011|Overall Study|Withdrawal by parent/guardian|0|||
155005439|NCT04895982|559442776|FG000|Overall Study|Other|0|||
155005440|NCT04895982|559442777|FG001|Overall Study|Other|0|||
155005441|NCT04895982|559442778|FG002|Overall Study|Other|1|||
155005442|NCT04895982|559442779|FG003|Overall Study|Other|1|||
155005443|NCT04895982|559442780|FG004|Overall Study|Other|0|||
155005444|NCT04895982|559442781|FG005|Overall Study|Other|0|||
155005445|NCT04895982|559442782|FG006|Overall Study|Other|0|||
155005446|NCT04895982|559442783|FG007|Overall Study|Other|0|||
155005447|NCT04895982|559442784|FG008|Overall Study|Other|0|||
155005448|NCT04895982|559442785|FG009|Overall Study|Other|1|||
155005449|NCT04895982|559442786|FG010|Overall Study|Other|0|||
155005450|NCT04895982|559442787|FG011|Overall Study|Other|0|||
155005451|NCT04895982|559442776|FG000|Overall Study|Protocol Violation|0|||
155005452|NCT04895982|559442777|FG001|Overall Study|Protocol Violation|0|||
155005453|NCT04895982|559442778|FG002|Overall Study|Protocol Violation|1|||
155005454|NCT04895982|559442779|FG003|Overall Study|Protocol Violation|1|||
155005455|NCT04895982|559442780|FG004|Overall Study|Protocol Violation|1|||
155005456|NCT04895982|559442781|FG005|Overall Study|Protocol Violation|0|||
155005457|NCT04895982|559442782|FG006|Overall Study|Protocol Violation|0|||
155005458|NCT04895982|559442783|FG007|Overall Study|Protocol Violation|1|||
155005459|NCT04895982|559442784|FG008|Overall Study|Protocol Violation|0|||
155005460|NCT04895982|559442785|FG009|Overall Study|Protocol Violation|0|||
155005461|NCT04895982|559442786|FG010|Overall Study|Protocol Violation|0|||
155005462|NCT04895982|559442787|FG011|Overall Study|Protocol Violation|0|||
155005463|NCT04895982|559442776|FG000|Overall Study|Lost to Follow-up|0|||
155005464|NCT04895982|559442777|FG001|Overall Study|Lost to Follow-up|0|||
155005465|NCT04895982|559442778|FG002|Overall Study|Lost to Follow-up|1|||
155005466|NCT04895982|559442779|FG003|Overall Study|Lost to Follow-up|0|||
155005467|NCT04895982|559442780|FG004|Overall Study|Lost to Follow-up|0|||
155005468|NCT04895982|559442781|FG005|Overall Study|Lost to Follow-up|1|||
155005469|NCT04895982|559442782|FG006|Overall Study|Lost to Follow-up|0|||
155005470|NCT04895982|559442783|FG007|Overall Study|Lost to Follow-up|0|||
155005471|NCT04895982|559442784|FG008|Overall Study|Lost to Follow-up|1|||
155005472|NCT04895982|559442785|FG009|Overall Study|Lost to Follow-up|0|||
155005473|NCT04895982|559442786|FG010|Overall Study|Lost to Follow-up|0|||
155005474|NCT04895982|559442787|FG011|Overall Study|Lost to Follow-up|0|||
155005475|NCT04895982|559442776|FG000|Overall Study|Refused further study procedures|0|||
155005476|NCT04895982|559442777|FG001|Overall Study|Refused further study procedures|0|||
155005477|NCT04895982|559442778|FG002|Overall Study|Refused further study procedures|1|||
155005478|NCT04895982|559442779|FG003|Overall Study|Refused further study procedures|0|||
155005479|NCT04895982|559442780|FG004|Overall Study|Refused further study procedures|0|||
155005480|NCT04895982|559442781|FG005|Overall Study|Refused further study procedures|0|||
155005481|NCT04895982|559442782|FG006|Overall Study|Refused further study procedures|0|||
155005482|NCT04895982|559442783|FG007|Overall Study|Refused further study procedures|0|||
155005483|NCT04895982|559442784|FG008|Overall Study|Refused further study procedures|0|||
155005484|NCT04895982|559442785|FG009|Overall Study|Refused further study procedures|0|||
155005485|NCT04895982|559442786|FG010|Overall Study|Refused further study procedures|0|||
155005486|NCT04895982|559442787|FG011|Overall Study|Refused further study procedures|0|||
155005487|NCT00919854|559442788|FG000|Overall Study|Adverse Event|1|||
155005488|NCT00985491|559442791|FG000|Overall Study|Adverse Event|8|||
155005489|NCT00985491|559442791|FG000|Overall Study|device migration|7|||
155005490|NCT00985491|559442791|FG000|Overall Study|Withdrawal by Subject|1|||
155005491|NCT00985491|559442791|FG000|Overall Study|implant failure|3|||
155125943|NCT05149313|559893282|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
155005492|NCT01893346|559442794|FG000|Overall Study|Lost to Follow-up|0|||
155005493|NCT01893346|559442795|FG001|Overall Study|Lost to Follow-up|1|||
155005494|NCT01893346|559442796|FG002|Overall Study|Lost to Follow-up|0|||
155005495|NCT01893346|559442797|FG003|Overall Study|Lost to Follow-up|0|||
155178291|NCT03400956|560091441|FG002|Treatment Period 1|Other|3|||
155005496|NCT01893346|559442794|FG000|Overall Study|Protocol Violation|1|||
155005497|NCT01893346|559442795|FG001|Overall Study|Protocol Violation|0|||
155005498|NCT01893346|559442796|FG002|Overall Study|Protocol Violation|0|||
155005499|NCT01893346|559442797|FG003|Overall Study|Protocol Violation|0|||
155005500|NCT01893346|559442794|FG000|Overall Study|Withdrawal by Subject|2|||
155005501|NCT01893346|559442795|FG001|Overall Study|Withdrawal by Subject|0|||
155005502|NCT01893346|559442796|FG002|Overall Study|Withdrawal by Subject|0|||
155005503|NCT01893346|559442797|FG003|Overall Study|Withdrawal by Subject|0|||
155005504|NCT00489827|559442803|FG000|Overall Study|Intraoperative exclusion criteria|1|||
155005505|NCT00489827|559442804|FG001|Overall Study|Intraoperative exclusion criteria|1|||
155005506|NCT00489827|559442803|FG000|Overall Study|Intraoperative exclusion criteria|1|||
155005507|NCT00489827|559442804|FG001|Overall Study|Intraoperative exclusion criteria|1|||
155005508|NCT01632280|559442824|FG000|Overall Study|Withdrawal by Subject|1|||
155005509|NCT01632280|559442825|FG001|Overall Study|Withdrawal by Subject|0|||
155005510|NCT03086551|559442831|FG000|First Intervention|Failure to meet inclusion criterion|1|||
155005511|NCT03086551|559442832|FG001|First Intervention|Failure to meet inclusion criterion|0|||
155005512|NCT03086551|559442831|FG000|First Intervention|Lost to Follow-up|0|||
155005513|NCT03086551|559442832|FG001|First Intervention|Lost to Follow-up|1|||
155005514|NCT03086551|559442831|FG000|Washout|Lost to Follow-up|1|||
155005515|NCT03086551|559442832|FG001|Washout|Lost to Follow-up|2|||
155005516|NCT03086551|559442831|FG000|Washout|Withdrawal by Subject|2|||
155005517|NCT03086551|559442832|FG001|Washout|Withdrawal by Subject|1|||
155005518|NCT03736031|559442835|FG000|Overall Study|Death|2|||
155005519|NCT03736031|559442836|FG001|Overall Study|Death|4|||
155005520|NCT03736031|559442835|FG000|Overall Study|Lost to Follow-up|21|||
155005521|NCT03736031|559442836|FG001|Overall Study|Lost to Follow-up|2|||
155005522|NCT03736031|559442835|FG000|Overall Study|Withdrawal by Subject|9|||
155005523|NCT03736031|559442836|FG001|Overall Study|Withdrawal by Subject|0|||
155005524|NCT05221320|559445220|FG000|Overall Study|Lack of Efficacy|3|||
155005525|NCT05221320|559445221|FG001|Overall Study|Lack of Efficacy|7|||
155125944|NCT05149313|559893279|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
155125945|NCT05149313|559893280|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
155125946|NCT05149313|559893281|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
155125947|NCT05149313|559893282|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
155125948|NCT05149313|559893279|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
155125949|NCT05149313|559893280|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
155125950|NCT05149313|559893281|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
155125951|NCT05149313|559893282|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
155125952|NCT05149313|559893279|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
154923170|NCT05182840|559142248|FG009|Treatment Period|Adverse Event|5|||
154923171|NCT05182840|559142239|FG000|Treatment Period|Not treated with study drug|0|||
154923172|NCT05182840|559142240|FG001|Treatment Period|Not treated with study drug|0|||
154923173|NCT05182840|559142241|FG002|Treatment Period|Not treated with study drug|0|||
154923174|NCT05182840|559142242|FG003|Treatment Period|Not treated with study drug|1|||
154923175|NCT05182840|559142243|FG004|Treatment Period|Not treated with study drug|0|||
154923176|NCT05182840|559142244|FG005|Treatment Period|Not treated with study drug|0|||
154923177|NCT05182840|559142245|FG006|Treatment Period|Not treated with study drug|1|||
154923178|NCT05182840|559142246|FG007|Treatment Period|Not treated with study drug|1|||
154923179|NCT05182840|559142247|FG008|Treatment Period|Not treated with study drug|0|||
154923180|NCT05182840|559142248|FG009|Treatment Period|Not treated with study drug|0|||
154923181|NCT00412360|559142252|FG000|Overall Study|Lost to Follow-up|0|||
154923182|NCT00412360|559142253|FG001|Overall Study|Lost to Follow-up|1|||
154923183|NCT00412360|559142252|FG000|Overall Study|Not Transplanted|1|||
154923184|NCT00412360|559142253|FG001|Overall Study|Not Transplanted|2|||
154923185|NCT01078974|559142256|FG000|Overall Study|Adverse Event|3|||
154923186|NCT01393444|559142257|FG000|Overall Study|Withdrawal by Subject|1|||
154923187|NCT01393444|559142257|FG000|Overall Study|Determined ineligible during screening.|2|||
154923188|NCT01397409|559142260|FG000|Stage 2|Adverse Event|0|||
154923189|NCT01397409|559142261|FG001|Stage 2|Adverse Event|0|||
154923190|NCT01397409|559142262|FG002|Stage 2|Adverse Event|0|||
154923191|NCT01397409|559142263|FG003|Stage 2|Adverse Event|0|||
154923192|NCT01397409|559142264|FG004|Stage 2|Adverse Event|6|||
154923193|NCT01397409|559142265|FG005|Stage 2|Adverse Event|3|||
154923194|NCT01397409|559142266|FG006|Stage 2|Adverse Event|0|||
154923195|NCT01397409|559142267|FG007|Stage 2|Adverse Event|0|||
154923196|NCT01397409|559142268|FG008|Stage 2|Adverse Event|0|||
154923197|NCT01397409|559142269|FG009|Stage 2|Adverse Event|0|||
154923198|NCT01397409|559142260|FG000|Stage 2|Personal Reasons|0|||
154923199|NCT01397409|559142261|FG001|Stage 2|Personal Reasons|0|||
154923200|NCT01397409|559142262|FG002|Stage 2|Personal Reasons|0|||
154923201|NCT01397409|559142263|FG003|Stage 2|Personal Reasons|0|||
154923202|NCT01397409|559142264|FG004|Stage 2|Personal Reasons|1|||
154923203|NCT01397409|559142265|FG005|Stage 2|Personal Reasons|0|||
154923204|NCT01397409|559142266|FG006|Stage 2|Personal Reasons|0|||
154923205|NCT01397409|559142267|FG007|Stage 2|Personal Reasons|0|||
154923206|NCT01397409|559142268|FG008|Stage 2|Personal Reasons|0|||
154923207|NCT01397409|559142269|FG009|Stage 2|Personal Reasons|0|||
154923208|NCT01397409|559142260|FG000|Stage 2|Other Miscellaneous Reasons|0|||
155005526|NCT05221320|559445222|FG002|Overall Study|Lack of Efficacy|10|||
155005527|NCT05221320|559445223|FG003|Overall Study|Lack of Efficacy|1|||
155005528|NCT05221320|559445224|FG004|Overall Study|Lack of Efficacy|0|||
155005529|NCT05221320|559445225|FG005|Overall Study|Lack of Efficacy|0|||
155005530|NCT05221320|559445220|FG000|Overall Study|Physician Decision|1|||
155005531|NCT05221320|559445221|FG001|Overall Study|Physician Decision|0|||
155005532|NCT05221320|559445222|FG002|Overall Study|Physician Decision|3|||
155005533|NCT05221320|559445223|FG003|Overall Study|Physician Decision|1|||
155005534|NCT05221320|559445224|FG004|Overall Study|Physician Decision|0|||
155005535|NCT05221320|559445225|FG005|Overall Study|Physician Decision|0|||
155005536|NCT05221320|559445220|FG000|Overall Study|Withdrawal by Subject|0|||
155005537|NCT05221320|559445221|FG001|Overall Study|Withdrawal by Subject|3|||
155005538|NCT05221320|559445222|FG002|Overall Study|Withdrawal by Subject|1|||
155005539|NCT05221320|559445223|FG003|Overall Study|Withdrawal by Subject|0|||
155005540|NCT05221320|559445224|FG004|Overall Study|Withdrawal by Subject|0|||
155005541|NCT05221320|559445225|FG005|Overall Study|Withdrawal by Subject|0|||
155005542|NCT05221320|559445220|FG000|Overall Study|Death|0|||
155005543|NCT05221320|559445221|FG001|Overall Study|Death|5|||
155005544|NCT05221320|559445222|FG002|Overall Study|Death|6|||
155005545|NCT05221320|559445223|FG003|Overall Study|Death|0|||
155005546|NCT05221320|559445224|FG004|Overall Study|Death|1|||
155005547|NCT05221320|559445225|FG005|Overall Study|Death|0|||
155005548|NCT02514447|559445229|FG000|Overall Study|Withdrawal by Subject|3|||
155005549|NCT02514447|559445230|FG001|Overall Study|Withdrawal by Subject|1|||
155005550|NCT02514447|559445231|FG002|Overall Study|Withdrawal by Subject|1|||
155005551|NCT02514447|559445232|FG003|Overall Study|Withdrawal by Subject|0|||
155005552|NCT02514447|559445233|FG004|Overall Study|Withdrawal by Subject|0|||
155005553|NCT02514447|559445234|FG005|Overall Study|Withdrawal by Subject|0|||
155005554|NCT02514447|559445235|FG006|Overall Study|Withdrawal by Subject|0|||
155005555|NCT02514447|559445236|FG007|Overall Study|Withdrawal by Subject|1|||
155005556|NCT02514447|559445237|FG008|Overall Study|Withdrawal by Subject|1|||
155005557|NCT02514447|559445229|FG000|Overall Study|Death|24|||
155005558|NCT02514447|559445230|FG001|Overall Study|Death|28|||
155005559|NCT02514447|559445231|FG002|Overall Study|Death|29|||
155005560|NCT02514447|559445232|FG003|Overall Study|Death|0|||
155005561|NCT02514447|559445233|FG004|Overall Study|Death|3|||
155005562|NCT02514447|559445234|FG005|Overall Study|Death|4|||
155005563|NCT02514447|559445235|FG006|Overall Study|Death|8|||
155005564|NCT02514447|559445236|FG007|Overall Study|Death|6|||
155005565|NCT02514447|559445237|FG008|Overall Study|Death|5|||
155005566|NCT02514447|559445229|FG000|Overall Study|Lost to Follow-up|1|||
155005567|NCT02514447|559445230|FG001|Overall Study|Lost to Follow-up|0|||
155005568|NCT02514447|559445231|FG002|Overall Study|Lost to Follow-up|0|||
155005569|NCT02514447|559445232|FG003|Overall Study|Lost to Follow-up|0|||
155005570|NCT02514447|559445233|FG004|Overall Study|Lost to Follow-up|0|||
155005571|NCT02514447|559445234|FG005|Overall Study|Lost to Follow-up|0|||
155005572|NCT02514447|559445235|FG006|Overall Study|Lost to Follow-up|0|||
155005573|NCT02514447|559445236|FG007|Overall Study|Lost to Follow-up|0|||
155005574|NCT02514447|559445237|FG008|Overall Study|Lost to Follow-up|1|||
155005575|NCT02514447|559445229|FG000|Overall Study|Sponsor Termination of Study|0|||
155005576|NCT02514447|559445230|FG001|Overall Study|Sponsor Termination of Study|1|||
155005577|NCT02514447|559445231|FG002|Overall Study|Sponsor Termination of Study|1|||
155005578|NCT02514447|559445232|FG003|Overall Study|Sponsor Termination of Study|0|||
155005579|NCT02514447|559445233|FG004|Overall Study|Sponsor Termination of Study|0|||
155005580|NCT02514447|559445234|FG005|Overall Study|Sponsor Termination of Study|0|||
155005581|NCT02514447|559445235|FG006|Overall Study|Sponsor Termination of Study|0|||
155005582|NCT02514447|559445236|FG007|Overall Study|Sponsor Termination of Study|0|||
155005583|NCT02514447|559445237|FG008|Overall Study|Sponsor Termination of Study|0|||
155005584|NCT02514447|559445229|FG000|Overall Study|Study completion per Investigator|1|||
155005585|NCT02514447|559445230|FG001|Overall Study|Study completion per Investigator|0|||
155005586|NCT02514447|559445231|FG002|Overall Study|Study completion per Investigator|1|||
155005587|NCT02514447|559445232|FG003|Overall Study|Study completion per Investigator|2|||
155005588|NCT02514447|559445233|FG004|Overall Study|Study completion per Investigator|0|||
155005589|NCT02514447|559445234|FG005|Overall Study|Study completion per Investigator|0|||
155005590|NCT02514447|559445235|FG006|Overall Study|Study completion per Investigator|0|||
155005591|NCT02514447|559445236|FG007|Overall Study|Study completion per Investigator|0|||
155005592|NCT02514447|559445237|FG008|Overall Study|Study completion per Investigator|1|||
155005593|NCT03620708|559445238|FG000|Overall Study|Lost to Follow-up|1|||
155005594|NCT03620708|559445239|FG001|Overall Study|Lost to Follow-up|1|||
155005595|NCT03620708|559445240|FG002|Overall Study|Lost to Follow-up|2|||
155005596|NCT03620708|559445238|FG000|Overall Study|Withdrawal by Subject|0|||
155005597|NCT03620708|559445239|FG001|Overall Study|Withdrawal by Subject|0|||
155005598|NCT03620708|559445240|FG002|Overall Study|Withdrawal by Subject|1|||
155005599|NCT02498613|559445241|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
155005600|NCT02498613|559445242|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
155005601|NCT02498613|559445243|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
155005602|NCT02498613|559445244|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
155005603|NCT02498613|559445241|FG000|Overall Study|Withdrawal by Subject|3|||
155005604|NCT02498613|559445242|FG001|Overall Study|Withdrawal by Subject|1|||
155005605|NCT02498613|559445243|FG002|Overall Study|Withdrawal by Subject|0|||
155005606|NCT02498613|559445244|FG003|Overall Study|Withdrawal by Subject|0|||
155005607|NCT05168202|559445245|FG000|Overall Study|Progressive Disease|4|||
155005608|NCT05168202|559445246|FG001|Overall Study|Progressive Disease|4|||
155005609|NCT05168202|559445247|FG002|Overall Study|Progressive Disease|2|||
155125953|NCT05149313|559893280|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
155125954|NCT05149313|559893281|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
155125955|NCT05149313|559893282|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
155125956|NCT05149313|559893279|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
155125957|NCT05149313|559893280|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
155125958|NCT05149313|559893281|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
155125959|NCT05149313|559893282|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
155125960|NCT05149313|559893279|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155125961|NCT05149313|559893280|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
155125962|NCT05149313|559893281|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
155125963|NCT05149313|559893282|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
155125964|NCT05149313|559893279|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155125965|NCT05149313|559893280|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
155125966|NCT05149313|559893281|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
155125967|NCT05149313|559893282|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
155125968|NCT05149313|559893279|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155125969|NCT05149313|559893280|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155125970|NCT05149313|559893281|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
155125971|NCT05149313|559893282|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
155125972|NCT05149313|559893279|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
155125973|NCT05149313|559893280|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
155125974|NCT05149313|559893281|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
155125975|NCT05149313|559893282|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
155125976|NCT01751139|559893287|FG000|Overall Study|Other|135|||
155125977|NCT01751139|559893287|FG000|Overall Study|Sponsor study termination|1609|||
155125978|NCT01751139|559893287|FG000|Overall Study|Lost to Follow-up|240|||
155125979|NCT01751139|559893287|FG000|Overall Study|Withdrawal by Subject|251|||
155125980|NCT01751139|559893287|FG000|Overall Study|Adverse Event|1|||
155125981|NCT01751139|559893287|FG000|Overall Study|Death|31|||
155125982|NCT03199391|559893288|FG000|Overall Study|Death|1|||
155125983|NCT03199391|559893288|FG000|Overall Study|Lost to Follow-up|3|||
155125984|NCT03199391|559893288|FG000|Overall Study|Adverse Event|2|||
155125985|NCT03199391|559893288|FG000|Overall Study|Withdrawal by Subject|10|||
155125986|NCT01867086|559893289|FG000|Overall Study|Disease Progression|1|||
155125987|NCT03826342|559893290|FG000|Overall Study|Withdrawal by Subject|8|||
155125988|NCT03826342|559893291|FG001|Overall Study|Withdrawal by Subject|1|||
155125989|NCT03826342|559893290|FG000|Overall Study|Lost to Follow-up|7|||
155125990|NCT03826342|559893291|FG001|Overall Study|Lost to Follow-up|7|||
155125991|NCT03826342|559893290|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
155125992|NCT03826342|559893291|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
155125993|NCT04271475|559893296|FG000|DB Period: Day 1 up to EODBT|Death|1|||
155125994|NCT04271475|559893297|FG001|DB Period: Day 1 up to EODBT|Death|0|||
155125995|NCT04271475|559893298|FG002|DB Period: Day 1 up to EODBT|Death|0|||
155125996|NCT04271475|559893299|FG003|DB Period: Day 1 up to EODBT|Death|0|||
155125997|NCT04271475|559893296|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
155125998|NCT04271475|559893297|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
155125999|NCT04271475|559893298|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
155126000|NCT04271475|559893299|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
155126001|NCT04271475|559893296|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
155005610|NCT05168202|559445248|FG003|Overall Study|Progressive Disease|3|||
155005611|NCT05168202|559445249|FG004|Overall Study|Progressive Disease|2|||
155005612|NCT05168202|559445250|FG005|Overall Study|Progressive Disease|3|||
155005613|NCT05168202|559445251|FG006|Overall Study|Progressive Disease|2|||
155005614|NCT05168202|559445245|FG000|Overall Study|Adverse Event|2|||
155005615|NCT05168202|559445246|FG001|Overall Study|Adverse Event|1|||
155005616|NCT05168202|559445247|FG002|Overall Study|Adverse Event|4|||
155005617|NCT05168202|559445248|FG003|Overall Study|Adverse Event|4|||
155005618|NCT05168202|559445249|FG004|Overall Study|Adverse Event|3|||
155126002|NCT04271475|559893297|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
155126003|NCT04271475|559893298|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
155126004|NCT04271475|559893299|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
155126005|NCT04271475|559893296|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
155126006|NCT04271475|559893297|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
155005619|NCT05168202|559445250|FG005|Overall Study|Adverse Event|2|||
155005620|NCT05168202|559445251|FG006|Overall Study|Adverse Event|0|||
155005621|NCT05168202|559445245|FG000|Overall Study|Lack of Efficacy|0|||
155005622|NCT05168202|559445246|FG001|Overall Study|Lack of Efficacy|1|||
155005623|NCT05168202|559445247|FG002|Overall Study|Lack of Efficacy|1|||
155005624|NCT05168202|559445248|FG003|Overall Study|Lack of Efficacy|0|||
155005625|NCT05168202|559445249|FG004|Overall Study|Lack of Efficacy|1|||
155005626|NCT05168202|559445250|FG005|Overall Study|Lack of Efficacy|2|||
155005627|NCT05168202|559445251|FG006|Overall Study|Lack of Efficacy|2|||
155005628|NCT05168202|559445245|FG000|Overall Study|Withdrawal by Subject|0|||
155005629|NCT05168202|559445246|FG001|Overall Study|Withdrawal by Subject|0|||
155005630|NCT05168202|559445247|FG002|Overall Study|Withdrawal by Subject|1|||
155005631|NCT05168202|559445248|FG003|Overall Study|Withdrawal by Subject|1|||
155005632|NCT05168202|559445249|FG004|Overall Study|Withdrawal by Subject|1|||
155005633|NCT05168202|559445250|FG005|Overall Study|Withdrawal by Subject|1|||
155005634|NCT05168202|559445251|FG006|Overall Study|Withdrawal by Subject|0|||
155005635|NCT05168202|559445245|FG000|Overall Study|Disease Relapse|0|||
155005636|NCT05168202|559445246|FG001|Overall Study|Disease Relapse|1|||
155005637|NCT05168202|559445247|FG002|Overall Study|Disease Relapse|0|||
155005638|NCT05168202|559445248|FG003|Overall Study|Disease Relapse|1|||
155005639|NCT05168202|559445249|FG004|Overall Study|Disease Relapse|1|||
155005640|NCT05168202|559445250|FG005|Overall Study|Disease Relapse|0|||
155005641|NCT05168202|559445251|FG006|Overall Study|Disease Relapse|0|||
155005642|NCT05168202|559445245|FG000|Overall Study|Other Reasons|0|||
155005643|NCT05168202|559445246|FG001|Overall Study|Other Reasons|0|||
155005644|NCT05168202|559445247|FG002|Overall Study|Other Reasons|0|||
155005645|NCT05168202|559445248|FG003|Overall Study|Other Reasons|0|||
155005646|NCT05168202|559445249|FG004|Overall Study|Other Reasons|0|||
155005647|NCT05168202|559445250|FG005|Overall Study|Other Reasons|2|||
155005648|NCT05168202|559445251|FG006|Overall Study|Other Reasons|1|||
155005649|NCT05168202|559445245|FG000|Overall Study|Physician Decision|0|||
155005650|NCT05168202|559445246|FG001|Overall Study|Physician Decision|1|||
155005651|NCT05168202|559445247|FG002|Overall Study|Physician Decision|1|||
155005652|NCT05168202|559445248|FG003|Overall Study|Physician Decision|0|||
155005653|NCT05168202|559445249|FG004|Overall Study|Physician Decision|0|||
155005654|NCT05168202|559445250|FG005|Overall Study|Physician Decision|0|||
155005655|NCT05168202|559445251|FG006|Overall Study|Physician Decision|0|||
155005656|NCT05168202|559445245|FG000|Overall Study|Study Terminated by Sponsor|0|||
155005657|NCT05168202|559445246|FG001|Overall Study|Study Terminated by Sponsor|0|||
155005658|NCT05168202|559445247|FG002|Overall Study|Study Terminated by Sponsor|0|||
155005659|NCT05168202|559445248|FG003|Overall Study|Study Terminated by Sponsor|1|||
155005660|NCT05168202|559445249|FG004|Overall Study|Study Terminated by Sponsor|0|||
155005661|NCT05168202|559445250|FG005|Overall Study|Study Terminated by Sponsor|0|||
155005662|NCT05168202|559445251|FG006|Overall Study|Study Terminated by Sponsor|0|||
155005663|NCT06195930|559445261|FG000|Overall Study|Adverse Event|4|||
155005664|NCT03631199|559445262|FG000|Overall Study|Progressive disease|9|||
155005665|NCT03631199|559445263|FG001|Overall Study|Progressive disease|5|||
155005666|NCT03631199|559445264|FG002|Overall Study|Progressive disease|5|||
155005667|NCT03631199|559445265|FG003|Overall Study|Progressive disease|149|||
155005668|NCT03631199|559445266|FG004|Overall Study|Progressive disease|148|||
155005669|NCT03631199|559445262|FG000|Overall Study|Physician Decision|0|||
155005670|NCT03631199|559445263|FG001|Overall Study|Physician Decision|2|||
155005671|NCT03631199|559445264|FG002|Overall Study|Physician Decision|3|||
155005672|NCT03631199|559445265|FG003|Overall Study|Physician Decision|19|||
155005673|NCT03631199|559445266|FG004|Overall Study|Physician Decision|13|||
155005674|NCT03631199|559445262|FG000|Overall Study|Adverse Event|1|||
155005675|NCT03631199|559445263|FG001|Overall Study|Adverse Event|1|||
155005676|NCT03631199|559445264|FG002|Overall Study|Adverse Event|0|||
155005677|NCT03631199|559445265|FG003|Overall Study|Adverse Event|28|||
155005678|NCT03631199|559445266|FG004|Overall Study|Adverse Event|29|||
155005679|NCT03631199|559445262|FG000|Overall Study|Death|0|||
155005680|NCT03631199|559445263|FG001|Overall Study|Death|1|||
155005681|NCT03631199|559445264|FG002|Overall Study|Death|0|||
155005682|NCT03631199|559445265|FG003|Overall Study|Death|35|||
155005683|NCT03631199|559445266|FG004|Overall Study|Death|48|||
155005684|NCT03631199|559445262|FG000|Overall Study|Subject decision|0|||
155005685|NCT03631199|559445263|FG001|Overall Study|Subject decision|1|||
155005686|NCT03631199|559445264|FG002|Overall Study|Subject decision|0|||
155005687|NCT03631199|559445265|FG003|Overall Study|Subject decision|12|||
155005688|NCT03631199|559445266|FG004|Overall Study|Subject decision|12|||
155005689|NCT03631199|559445262|FG000|Overall Study|No treated|0|||
155005690|NCT03631199|559445263|FG001|Overall Study|No treated|0|||
155005691|NCT03631199|559445264|FG002|Overall Study|No treated|0|||
155005692|NCT03631199|559445265|FG003|Overall Study|No treated|0|||
155005693|NCT03631199|559445266|FG004|Overall Study|No treated|1|||
155005694|NCT03631199|559445262|FG000|Overall Study|Treatment ongoing|0|||
155005695|NCT03631199|559445263|FG001|Overall Study|Treatment ongoing|1|||
155005696|NCT03631199|559445264|FG002|Overall Study|Treatment ongoing|1|||
155005697|NCT03631199|559445265|FG003|Overall Study|Treatment ongoing|76|||
155005698|NCT03631199|559445266|FG004|Overall Study|Treatment ongoing|71|||
155005699|NCT03631199|559445262|FG000|Overall Study|Guardian decision|0|||
155005700|NCT03631199|559445263|FG001|Overall Study|Guardian decision|0|||
155126007|NCT04271475|559893298|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
155126008|NCT04271475|559893299|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
155126009|NCT04271475|559893296|FG000|DB Period: Day 1 up to EODBT|Other|8|||
155126010|NCT04271475|559893297|FG001|DB Period: Day 1 up to EODBT|Other|5|||
155126011|NCT04271475|559893298|FG002|DB Period: Day 1 up to EODBT|Other|0|||
155126012|NCT04271475|559893299|FG003|DB Period: Day 1 up to EODBT|Other|0|||
155126013|NCT04271475|559893296|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
155126014|NCT04271475|559893297|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
155126015|NCT04271475|559893298|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
155126016|NCT04271475|559893299|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
155126017|NCT04271475|559893296|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
155126018|NCT04271475|559893297|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
155126019|NCT04271475|559893298|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
155126020|NCT04271475|559893299|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
155126021|NCT02337634|559893300|FG000|Overall Study|Protocol Violation|3|||
155126022|NCT02337634|559893301|FG001|Overall Study|Protocol Violation|1|||
155126023|NCT02337634|559893300|FG000|Overall Study|Lost to Follow-up|1|||
155126024|NCT02337634|559893301|FG001|Overall Study|Lost to Follow-up|0|||
155126025|NCT01818284|559893305|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
155126026|NCT01818284|559893306|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
155126027|NCT01818284|559893305|FG000|Overall Study|Death|0|||
155126028|NCT01818284|559893306|FG001|Overall Study|Death|2|||
155126029|NCT02276547|559893307|FG000|Overall Study|Death|2|||
155126030|NCT02276547|559893307|FG000|Overall Study|Explant|2|||
155126031|NCT00530920|559893308|FG000|Overall Study|Randomized but not treated|0|||
155126032|NCT00530920|559893309|FG001|Overall Study|Randomized but not treated|2|||
155126033|NCT00530920|559893310|FG002|Overall Study|Randomized but not treated|0|||
155126034|NCT00530920|559893308|FG000|Overall Study|Adverse Event|0|||
155126035|NCT00530920|559893309|FG001|Overall Study|Adverse Event|0|||
155178292|NCT03400956|560091439|FG000|Post-treatment Period 1|Adverse Event|0|||
155178293|NCT03400956|560091440|FG001|Post-treatment Period 1|Adverse Event|0|||
155178294|NCT03400956|560091441|FG002|Post-treatment Period 1|Adverse Event|1|||
155178295|NCT03400956|560091439|FG000|Post-treatment Period 1|Physician Decision|2|||
155178296|NCT03400956|560091440|FG001|Post-treatment Period 1|Physician Decision|3|||
155178297|NCT03400956|560091441|FG002|Post-treatment Period 1|Physician Decision|0|||
155178298|NCT03400956|560091439|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
155178299|NCT03400956|560091440|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
155178300|NCT03400956|560091441|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
155178301|NCT03400956|560091439|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
155178302|NCT03400956|560091440|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
155178303|NCT03400956|560091441|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
155178304|NCT03400956|560091439|FG000|Post-treatment Period 1|Other|4|||
155178305|NCT03400956|560091440|FG001|Post-treatment Period 1|Other|3|||
155178306|NCT03400956|560091441|FG002|Post-treatment Period 1|Other|4|||
155178307|NCT03400956|560091439|FG000|Treatment Period 2|Adverse Event|2|||
155178308|NCT03400956|560091440|FG001|Treatment Period 2|Adverse Event|1|||
155178309|NCT03400956|560091441|FG002|Treatment Period 2|Adverse Event|1|||
155178310|NCT03400956|560091439|FG000|Treatment Period 2|Lost to Follow-up|1|||
155178311|NCT03400956|560091440|FG001|Treatment Period 2|Lost to Follow-up|1|||
155178312|NCT03400956|560091441|FG002|Treatment Period 2|Lost to Follow-up|0|||
155178313|NCT03400956|560091439|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155178314|NCT03400956|560091440|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155178315|NCT03400956|560091441|FG002|Treatment Period 2|Withdrawal by Subject|3|||
155178316|NCT03400956|560091439|FG000|Treatment Period 2|Other|1|||
155178317|NCT03400956|560091440|FG001|Treatment Period 2|Other|1|||
155178318|NCT03400956|560091441|FG002|Treatment Period 2|Other|0|||
155178319|NCT03400956|560091439|FG000|Follow-up Period|Withdrawal by Subject|0|||
155178320|NCT03400956|560091440|FG001|Follow-up Period|Withdrawal by Subject|0|||
155178321|NCT03400956|560091441|FG002|Follow-up Period|Withdrawal by Subject|1|||
155178322|NCT03400956|560091439|FG000|Follow-up Period|Other|0|||
155178323|NCT03400956|560091440|FG001|Follow-up Period|Other|0|||
155178324|NCT03400956|560091441|FG002|Follow-up Period|Other|1|||
155178325|NCT02048241|560091442|FG000|Overall Study|Withdrawal by Subject|0|||
154923209|NCT01397409|559142261|FG001|Stage 2|Other Miscellaneous Reasons|0|||
155178326|NCT02048241|560091443|FG001|Overall Study|Withdrawal by Subject|1|||
154923210|NCT01397409|559142262|FG002|Stage 2|Other Miscellaneous Reasons|0|||
154923211|NCT01397409|559142263|FG003|Stage 2|Other Miscellaneous Reasons|0|||
155126036|NCT00530920|559893310|FG002|Overall Study|Adverse Event|3|||
155126037|NCT00530920|559893308|FG000|Overall Study|Withdrawal by Subject|0|||
155126038|NCT00530920|559893309|FG001|Overall Study|Withdrawal by Subject|0|||
155178327|NCT00534313|560091444|FG000|Short-term Period|Adverse Event|1|||
155178328|NCT00534313|560091445|FG001|Short-term Period|Adverse Event|2|||
155178329|NCT00534313|560091446|FG002|Short-term Period|Adverse Event|1|||
155178330|NCT00534313|560091447|FG003|Short-term Period|Adverse Event|3|||
154923212|NCT01397409|559142264|FG004|Stage 2|Other Miscellaneous Reasons|1|||
155126039|NCT00530920|559893310|FG002|Overall Study|Withdrawal by Subject|1|||
155126040|NCT02066129|559893311|FG000|Overall Study|Lost to Follow-up|13|||
155126041|NCT02066129|559893312|FG001|Overall Study|Lost to Follow-up|12|||
155126042|NCT02066129|559893311|FG000|Overall Study|Withdrawal by Subject|7|||
155126043|NCT02066129|559893312|FG001|Overall Study|Withdrawal by Subject|10|||
155126044|NCT02066129|559893311|FG000|Overall Study|Lack of Efficacy|8|||
155126045|NCT02066129|559893312|FG001|Overall Study|Lack of Efficacy|10|||
155126046|NCT02066129|559893311|FG000|Overall Study|Physician Decision|1|||
155126047|NCT02066129|559893312|FG001|Overall Study|Physician Decision|1|||
155126048|NCT02392403|559893313|FG000|Overall Study|Adverse Event|1|||
155126049|NCT02392403|559893313|FG000|Overall Study|Death|1|||
155126050|NCT02392403|559893313|FG000|Overall Study|Withdrawal by Subject|1|||
155126051|NCT03757130|559893317|FG000|Overall Study|Lost to Follow-up|0|||
155126052|NCT03757130|559893318|FG001|Overall Study|Lost to Follow-up|0|||
155126053|NCT03757130|559893319|FG002|Overall Study|Lost to Follow-up|0|||
155126054|NCT03757130|559893320|FG003|Overall Study|Lost to Follow-up|1|||
155126055|NCT03757130|559893321|FG004|Overall Study|Lost to Follow-up|0|||
155126056|NCT03757130|559893322|FG005|Overall Study|Lost to Follow-up|0|||
155126057|NCT03757130|559893323|FG006|Overall Study|Lost to Follow-up|0|||
155126058|NCT03757130|559893324|FG007|Overall Study|Lost to Follow-up|1|||
155126059|NCT03757130|559893317|FG000|Overall Study|Withdrawal by Subject|0|||
155126060|NCT03757130|559893318|FG001|Overall Study|Withdrawal by Subject|0|||
155126061|NCT03757130|559893319|FG002|Overall Study|Withdrawal by Subject|0|||
155126062|NCT03757130|559893320|FG003|Overall Study|Withdrawal by Subject|0|||
155126063|NCT03757130|559893321|FG004|Overall Study|Withdrawal by Subject|0|||
155126064|NCT03757130|559893322|FG005|Overall Study|Withdrawal by Subject|0|||
155126065|NCT03757130|559893323|FG006|Overall Study|Withdrawal by Subject|1|||
155126066|NCT03757130|559893324|FG007|Overall Study|Withdrawal by Subject|0|||
155126067|NCT02391961|559893325|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
155126068|NCT02391961|559893326|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
155126069|NCT02391961|559893325|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155126070|NCT02391961|559893326|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
155126071|NCT02391961|559893325|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155126072|NCT02391961|559893326|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155126073|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
155126074|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
155126075|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
155126076|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
155126077|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
155126078|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
155126079|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
155126080|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
155126081|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
155178331|NCT00534313|560091444|FG000|Short-term Period|Lack of Efficacy|3|||
155005701|NCT03631199|559445264|FG002|Overall Study|Guardian decision|0|||
155005702|NCT03631199|559445265|FG003|Overall Study|Guardian decision|1|||
155005703|NCT03631199|559445266|FG004|Overall Study|Guardian decision|1|||
155005704|NCT03999996|559445267|FG000|Prior to Booster|Adverse Event|2|||
155005705|NCT03999996|559445268|FG001|Prior to Booster|Adverse Event|0|||
155005706|NCT03999996|559445269|FG002|Prior to Booster|Adverse Event|0|||
155005707|NCT03999996|559445270|FG003|Prior to Booster|Adverse Event|0|||
155005708|NCT03999996|559445267|FG000|Prior to Booster|Lost to Follow-up|17|||
155005709|NCT03999996|559445268|FG001|Prior to Booster|Lost to Follow-up|22|||
155005710|NCT03999996|559445269|FG002|Prior to Booster|Lost to Follow-up|0|||
155005711|NCT03999996|559445270|FG003|Prior to Booster|Lost to Follow-up|0|||
155005712|NCT03999996|559445267|FG000|Prior to Booster|Withdrawal of Consent|51|||
155005713|NCT03999996|559445268|FG001|Prior to Booster|Withdrawal of Consent|8|||
155005714|NCT03999996|559445269|FG002|Prior to Booster|Withdrawal of Consent|0|||
155005715|NCT03999996|559445270|FG003|Prior to Booster|Withdrawal of Consent|0|||
155005716|NCT03999996|559445267|FG000|Prior to Booster|Death|0|||
155005717|NCT03999996|559445268|FG001|Prior to Booster|Death|1|||
155005718|NCT03999996|559445269|FG002|Prior to Booster|Death|0|||
155005719|NCT03999996|559445270|FG003|Prior to Booster|Death|0|||
155005720|NCT03999996|559445267|FG000|Prior to Booster|Reason Not Specified|27|||
155005721|NCT03999996|559445268|FG001|Prior to Booster|Reason Not Specified|4|||
155126082|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
155126083|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
155126084|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
155126085|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
155126086|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
155126087|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
155126088|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
155126089|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
155005722|NCT03999996|559445269|FG002|Prior to Booster|Reason Not Specified|0|||
155126090|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
155126091|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
155126092|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
155126093|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
155126094|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
155126095|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
155126096|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
155126097|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
155126098|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
155126099|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
155126100|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
155126101|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
155126102|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
155126103|NCT00121641|559893327|FG000|24-week Short-term Treatment Period|Other Reason|1|||
155126104|NCT00121641|559893328|FG001|24-week Short-term Treatment Period|Other Reason|0|||
155126105|NCT00121641|559893329|FG002|24-week Short-term Treatment Period|Other Reason|0|||
155126106|NCT00121641|559893330|FG003|24-week Short-term Treatment Period|Other Reason|0|||
155126107|NCT00121641|559893331|FG004|24-week Short-term Treatment Period|Other Reason|0|||
155126108|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
155126109|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
155126110|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
155126111|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
155126112|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
155126113|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
155126114|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
155126115|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
155126116|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
155126117|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
155126118|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
155126119|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
155126120|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
155126121|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
155126122|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
155126123|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
155126124|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
155126125|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
155126126|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
155126127|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
155126128|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
155126129|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
155126130|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
155126131|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
155126132|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
155126133|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
155126134|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
155126135|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
155126136|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
155126137|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
155126138|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
155126139|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
155126140|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
155126141|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
155126142|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
155126143|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
155126144|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
155126145|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
155126146|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
155126147|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
155126148|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Death|0|||
155126149|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Death|0|||
154923213|NCT01397409|559142265|FG005|Stage 2|Other Miscellaneous Reasons|1|||
154923214|NCT01397409|559142266|FG006|Stage 2|Other Miscellaneous Reasons|0|||
154923215|NCT01397409|559142267|FG007|Stage 2|Other Miscellaneous Reasons|0|||
155126150|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Death|0|||
155126151|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Death|1|||
155126152|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Death|0|||
155126153|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Missing|0|||
155126154|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Missing|0|||
155126155|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Missing|1|||
155126156|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Missing|0|||
155126157|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Missing|0|||
155126158|NCT00121641|559893327|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
155126159|NCT00121641|559893328|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
155126160|NCT00121641|559893329|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
155126161|NCT00121641|559893330|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
155126162|NCT00121641|559893331|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
155126163|NCT03263780|559893332|FG000|Overall Study|Withdrawal by Subject|3|||
155126164|NCT03263780|559893332|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
155126165|NCT03995355|559893335|FG000|Overall Study|Adverse Event|1|||
155126166|NCT03995355|559893336|FG001|Overall Study|Adverse Event|0|||
155126167|NCT03995355|559893335|FG000|Overall Study|Withdrawal by Subject|1|||
155126168|NCT03995355|559893336|FG001|Overall Study|Withdrawal by Subject|0|||
155126169|NCT03995355|559893335|FG000|Overall Study|Scheduling Issues|0|||
155126170|NCT03995355|559893336|FG001|Overall Study|Scheduling Issues|1|||
155126171|NCT00249613|559893337|FG000|12 Month Follow-up|Death|1|||
155126172|NCT00249613|559893338|FG001|12 Month Follow-up|Death|1|||
155126173|NCT00249613|559893337|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
155126174|NCT00249613|559893338|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
155126175|NCT00249613|559893337|FG000|12 Month Follow-up|Lost to Follow-up|10|||
155126176|NCT00249613|559893338|FG001|12 Month Follow-up|Lost to Follow-up|8|||
155126177|NCT00094107|559893339|FG000|Overall Study|Lack of Efficacy|23|||
155126178|NCT00094107|559893339|FG000|Overall Study|Death|5|||
155126179|NCT00094107|559893339|FG000|Overall Study|Adverse Event|3|||
155126180|NCT00094107|559893339|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
155126181|NCT00806442|559893364|FG000|Overall Study|Lost to Follow-up|3|||
155126182|NCT00806442|559893365|FG001|Overall Study|Lost to Follow-up|2|||
155126183|NCT00806442|559893364|FG000|Overall Study|Withdrawal by Subject|1|||
155126184|NCT00806442|559893365|FG001|Overall Study|Withdrawal by Subject|5|||
155126185|NCT01455220|559893368|FG000|Overall Study|screen fail|30|||
155126186|NCT00267150|559893369|FG000|Overall Study|Adverse Event|1|||
155126187|NCT00424190|559893371|FG000|Overall Study|Withdrew consent|3|||
155126188|NCT00424190|559893372|FG001|Overall Study|Withdrew consent|4|||
155126189|NCT00424190|559893371|FG000|Overall Study|Death|3|||
155126190|NCT00424190|559893372|FG001|Overall Study|Death|0|||
155126191|NCT00424190|559893371|FG000|Overall Study|Noncompliance|1|||
155126192|NCT00424190|559893372|FG001|Overall Study|Noncompliance|2|||
155126193|NCT00424190|559893371|FG000|Overall Study|Request of sponsor or investigator|0|||
155126194|NCT00424190|559893372|FG001|Overall Study|Request of sponsor or investigator|2|||
155126195|NCT00424190|559893371|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
155126196|NCT00424190|559893372|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
155126197|NCT00424190|559893371|FG000|Overall Study|Other|15|||
155126198|NCT00424190|559893372|FG001|Overall Study|Other|21|||
155126199|NCT00351273|559893373|FG000|Overall Study|Lost to Follow-up|1|||
155126200|NCT00351273|559893374|FG001|Overall Study|Lost to Follow-up|2|||
155178332|NCT00534313|560091445|FG001|Short-term Period|Lack of Efficacy|4|||
155178333|NCT00534313|560091446|FG002|Short-term Period|Lack of Efficacy|0|||
155178334|NCT00534313|560091447|FG003|Short-term Period|Lack of Efficacy|3|||
155126201|NCT00351273|559893375|FG002|Overall Study|Lost to Follow-up|5|||
155126202|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
155126203|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
155126204|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
155126205|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
155126206|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
155126207|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
155126208|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
155005723|NCT03999996|559445270|FG003|Prior to Booster|Reason Not Specified|0|||
155005724|NCT03999996|559445267|FG000|Booster Phase|Lost to Follow-up|0|||
155005725|NCT03999996|559445268|FG001|Booster Phase|Lost to Follow-up|0|||
155126209|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
155126210|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
155126211|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
155126212|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
155126213|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
155178335|NCT00534313|560091444|FG000|Short-term Period|Participant not meeting study criteria|0|||
155126214|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
155126215|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
155126216|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
155126217|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
155126218|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
155126219|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
155126220|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
155126221|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
155126222|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
155126223|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
155126224|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
155126225|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
155126226|NCT01672866|559893376|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
155126227|NCT01672866|559893377|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
155126228|NCT01672866|559893378|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
155126229|NCT01672866|559893376|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
155126230|NCT01672866|559893377|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
155126231|NCT01672866|559893378|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
155126232|NCT01672866|559893376|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
155126233|NCT01672866|559893377|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
155126234|NCT01672866|559893378|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
155126235|NCT01672866|559893376|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
155126236|NCT01672866|559893377|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
155126237|NCT01672866|559893378|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
155126238|NCT01672866|559893376|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
155126239|NCT01672866|559893377|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
155126240|NCT01672866|559893378|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
155126241|NCT00619489|559893381|FG000|Overall Study|Adverse Event|0|||
155126242|NCT00619489|559893382|FG001|Overall Study|Adverse Event|7|||
155126243|NCT00619489|559893381|FG000|Overall Study|Withdrawal by Subject|1|||
155126244|NCT00619489|559893382|FG001|Overall Study|Withdrawal by Subject|1|||
155126245|NCT00619489|559893381|FG000|Overall Study|Lack of Efficacy|0|||
155126246|NCT00619489|559893382|FG001|Overall Study|Lack of Efficacy|11|||
155126247|NCT00619489|559893381|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
155126248|NCT00619489|559893382|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
155126249|NCT03320330|559894854|FG000|Overall Study|Lack of Efficacy|5|||
155126250|NCT03320330|559894855|FG001|Overall Study|Lack of Efficacy|5|||
155126251|NCT03320330|559894856|FG002|Overall Study|Lack of Efficacy|14|||
155126252|NCT03320330|559894854|FG000|Overall Study|Physician Decision|1|||
155126253|NCT03320330|559894855|FG001|Overall Study|Physician Decision|0|||
155126254|NCT03320330|559894856|FG002|Overall Study|Physician Decision|0|||
155126255|NCT00527319|559894857|FG000|Overall Study|Withdrawal by Subject|5|||
155126256|NCT00527319|559894858|FG001|Overall Study|Withdrawal by Subject|0|||
155126257|NCT00527319|559894859|FG002|Overall Study|Withdrawal by Subject|1|||
155126258|NCT00527319|559894857|FG000|Overall Study|Lost to Follow-up|1|||
155126259|NCT00527319|559894858|FG001|Overall Study|Lost to Follow-up|0|||
155126260|NCT00527319|559894859|FG002|Overall Study|Lost to Follow-up|0|||
155126261|NCT00527319|559894857|FG000|Overall Study|Death|0|||
155126262|NCT00527319|559894858|FG001|Overall Study|Death|3|||
155126263|NCT00527319|559894859|FG002|Overall Study|Death|1|||
155126264|NCT00527319|559894857|FG000|Overall Study|Intercurrent Medical Illness|0|||
155126265|NCT00527319|559894858|FG001|Overall Study|Intercurrent Medical Illness|1|||
155126266|NCT00527319|559894859|FG002|Overall Study|Intercurrent Medical Illness|3|||
155126267|NCT00527319|559894857|FG000|Overall Study|Adverse Event|0|||
155126268|NCT00527319|559894858|FG001|Overall Study|Adverse Event|0|||
155126269|NCT00527319|559894859|FG002|Overall Study|Adverse Event|1|||
155126270|NCT05824936|559894862|FG000|Overall Study|Lost to Follow-up|1|||
155126271|NCT00096018|559894863|FG000|Overall Study|Became Ineligible (not treated)|0|||
155126272|NCT00096018|559894864|FG001|Overall Study|Became Ineligible (not treated)|3|||
155126273|NCT00096018|559894863|FG000|Overall Study|Miscellaneous (not treated)|0|||
155126274|NCT00096018|559894864|FG001|Overall Study|Miscellaneous (not treated)|2|||
155126275|NCT00096018|559894863|FG000|Overall Study|Adverse Event|0|||
155126276|NCT00096018|559894864|FG001|Overall Study|Adverse Event|5|||
155126277|NCT00096018|559894863|FG000|Overall Study|Death|0|||
155126278|NCT00096018|559894864|FG001|Overall Study|Death|1|||
155126279|NCT00096018|559894863|FG000|Overall Study|Withdrawal by Subject|0|||
155126280|NCT00096018|559894864|FG001|Overall Study|Withdrawal by Subject|2|||
155126281|NCT00096018|559894863|FG000|Overall Study|Miscellaneous|2|||
155126282|NCT00096018|559894864|FG001|Overall Study|Miscellaneous|1|||
155126283|NCT03779503|559894867|FG000|First Intervention|Adverse Event|0|||
155126284|NCT03779503|559894868|FG001|First Intervention|Adverse Event|1|||
155126285|NCT03779503|559894867|FG000|First Intervention|Withdrawal by Subject|1|||
155126286|NCT03779503|559894868|FG001|First Intervention|Withdrawal by Subject|0|||
155126287|NCT00864851|559894869|FG000|Overall Study|Withdrawal by Subject|0|||
155126288|NCT00864851|559894870|FG001|Overall Study|Withdrawal by Subject|1|||
155126289|NCT00864851|559894871|FG002|Overall Study|Withdrawal by Subject|0|||
155126290|NCT00864851|559894869|FG000|Overall Study|Physician Decision|1|||
155126291|NCT00864851|559894870|FG001|Overall Study|Physician Decision|0|||
155126292|NCT00864851|559894871|FG002|Overall Study|Physician Decision|0|||
155126293|NCT00864851|559894869|FG000|Overall Study|Death|1|||
155126294|NCT00864851|559894870|FG001|Overall Study|Death|0|||
155126295|NCT00864851|559894871|FG002|Overall Study|Death|0|||
155126296|NCT00864851|559894869|FG000|Overall Study|Patient uncooperative|1|||
155126297|NCT00864851|559894870|FG001|Overall Study|Patient uncooperative|0|||
155126298|NCT00864851|559894871|FG002|Overall Study|Patient uncooperative|0|||
155126299|NCT02066415|559894872|FG000|Overall Study|Decision by Sponsor|5|||
155126300|NCT02066415|559894873|FG001|Overall Study|Decision by Sponsor|4|||
155126301|NCT02066415|559894874|FG002|Overall Study|Decision by Sponsor|2|||
155126302|NCT02066415|559894872|FG000|Overall Study|Withdrawal by Subject|9|||
155126303|NCT02066415|559894873|FG001|Overall Study|Withdrawal by Subject|1|||
155126304|NCT02066415|559894874|FG002|Overall Study|Withdrawal by Subject|4|||
155126305|NCT02066415|559894872|FG000|Overall Study|Lost to Follow-up|7|||
155126306|NCT02066415|559894873|FG001|Overall Study|Lost to Follow-up|2|||
155126307|NCT02066415|559894874|FG002|Overall Study|Lost to Follow-up|2|||
155126308|NCT01533922|559894875|FG000|Overall Study|Adverse Event|5|||
155126309|NCT01533922|559894876|FG001|Overall Study|Adverse Event|8|||
155126310|NCT01533922|559894877|FG002|Overall Study|Adverse Event|6|||
155126311|NCT01533922|559894878|FG003|Overall Study|Adverse Event|3|||
155126312|NCT01533922|559894879|FG004|Overall Study|Adverse Event|4|||
155126313|NCT01533922|559894875|FG000|Overall Study|Lack of Efficacy|0|||
155126314|NCT01533922|559894876|FG001|Overall Study|Lack of Efficacy|0|||
155126315|NCT01533922|559894877|FG002|Overall Study|Lack of Efficacy|1|||
155126316|NCT01533922|559894878|FG003|Overall Study|Lack of Efficacy|0|||
155126317|NCT01533922|559894879|FG004|Overall Study|Lack of Efficacy|0|||
155126318|NCT01533922|559894875|FG000|Overall Study|Protocol Violation|0|||
155126319|NCT01533922|559894876|FG001|Overall Study|Protocol Violation|3|||
155126320|NCT01533922|559894877|FG002|Overall Study|Protocol Violation|0|||
155126321|NCT01533922|559894878|FG003|Overall Study|Protocol Violation|0|||
155126322|NCT01533922|559894879|FG004|Overall Study|Protocol Violation|1|||
155126323|NCT01533922|559894875|FG000|Overall Study|Withdrawal by Subject|3|||
155126324|NCT01533922|559894876|FG001|Overall Study|Withdrawal by Subject|1|||
155126325|NCT01533922|559894877|FG002|Overall Study|Withdrawal by Subject|2|||
155126326|NCT01533922|559894878|FG003|Overall Study|Withdrawal by Subject|2|||
155126327|NCT01533922|559894879|FG004|Overall Study|Withdrawal by Subject|1|||
155126328|NCT01533922|559894875|FG000|Overall Study|Other reason not defined above|2|||
155126329|NCT01533922|559894876|FG001|Overall Study|Other reason not defined above|0|||
155126330|NCT01533922|559894877|FG002|Overall Study|Other reason not defined above|1|||
155126331|NCT01533922|559894878|FG003|Overall Study|Other reason not defined above|0|||
155126332|NCT01533922|559894879|FG004|Overall Study|Other reason not defined above|0|||
155126333|NCT03242252|559894881|FG000|Overall Study|At the Participant's own Request|18|||
155126334|NCT03242252|559894882|FG001|Overall Study|At the Participant's own Request|10|||
155126335|NCT03242252|559894883|FG002|Overall Study|At the Participant's own Request|15|||
155126336|NCT03242252|559894881|FG000|Overall Study|Adverse Event|8|||
155126337|NCT03242252|559894882|FG001|Overall Study|Adverse Event|6|||
155126338|NCT03242252|559894883|FG002|Overall Study|Adverse Event|9|||
155126339|NCT03242252|559894881|FG000|Overall Study|Poor Compliance to Protocol|0|||
155126340|NCT03242252|559894882|FG001|Overall Study|Poor Compliance to Protocol|2|||
155126341|NCT03242252|559894883|FG002|Overall Study|Poor Compliance to Protocol|3|||
155126342|NCT03242252|559894881|FG000|Overall Study|Study Terminated by Sponsor|1|||
155126343|NCT03242252|559894882|FG001|Overall Study|Study Terminated by Sponsor|0|||
155126344|NCT03242252|559894883|FG002|Overall Study|Study Terminated by Sponsor|0|||
155126345|NCT03242252|559894881|FG000|Overall Study|Reason not Specified|4|||
155126346|NCT03242252|559894882|FG001|Overall Study|Reason not Specified|4|||
155126347|NCT03242252|559894883|FG002|Overall Study|Reason not Specified|1|||
155126348|NCT03242252|559894881|FG000|Overall Study|Lost to Follow-up|5|||
155126349|NCT03242252|559894882|FG001|Overall Study|Lost to Follow-up|1|||
155126350|NCT03242252|559894883|FG002|Overall Study|Lost to Follow-up|4|||
155126351|NCT01267175|559894886|FG000|Overall Study|Withdrawal by Subject|1|||
155126352|NCT01267175|559894886|FG000|Overall Study|Lost to Follow-up|1|||
155178336|NCT00534313|560091445|FG001|Short-term Period|Participant not meeting study criteria|0|||
155178337|NCT00534313|560091446|FG002|Short-term Period|Participant not meeting study criteria|0|||
155126353|NCT00895661|559894887|FG000|Overall Study|Death|1|||
155126354|NCT00895661|559894887|FG000|Overall Study|reason unknown|2|||
155126355|NCT02989805|559894890|FG000|Overall Study|invalid consent|6|||
155178338|NCT00534313|560091447|FG003|Short-term Period|Participant not meeting study criteria|1|||
155126356|NCT02989805|559894891|FG001|Overall Study|invalid consent|4|||
155126357|NCT00286221|559894892|FG000|Overall Study|Protocol Violation|2|||
155126358|NCT00286221|559894893|FG001|Overall Study|Protocol Violation|1|||
155126359|NCT00286221|559894894|FG002|Overall Study|Protocol Violation|6|||
155126360|NCT00286221|559894895|FG003|Overall Study|Protocol Violation|4|||
155126361|NCT00286221|559894892|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
155126362|NCT00286221|559894893|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
155126363|NCT00286221|559894894|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
155126364|NCT00286221|559894895|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
155126365|NCT00286221|559894892|FG000|Overall Study|Inability to trigger PCA|2|||
155126366|NCT00286221|559894893|FG001|Overall Study|Inability to trigger PCA|0|||
155126367|NCT00286221|559894894|FG002|Overall Study|Inability to trigger PCA|0|||
155126368|NCT00286221|559894895|FG003|Overall Study|Inability to trigger PCA|0|||
155126369|NCT00286221|559894892|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
155126370|NCT00286221|559894893|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
155126371|NCT00286221|559894894|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
155126372|NCT00286221|559894895|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
155126373|NCT02771626|559894896|FG000|Overall Study|Adverse Event|1|||
155126374|NCT02771626|559894897|FG001|Overall Study|Adverse Event|5|||
155126375|NCT02771626|559894898|FG002|Overall Study|Adverse Event|3|||
155126376|NCT02771626|559894899|FG003|Overall Study|Adverse Event|0|||
155126377|NCT02771626|559894900|FG004|Overall Study|Adverse Event|1|||
155126378|NCT02771626|559894901|FG005|Overall Study|Adverse Event|1|||
155126379|NCT02771626|559894896|FG000|Overall Study|Radiologic Disease Progression|6|||
155126380|NCT02771626|559894897|FG001|Overall Study|Radiologic Disease Progression|13|||
155126381|NCT02771626|559894898|FG002|Overall Study|Radiologic Disease Progression|10|||
155126382|NCT02771626|559894899|FG003|Overall Study|Radiologic Disease Progression|7|||
155126383|NCT02771626|559894900|FG004|Overall Study|Radiologic Disease Progression|28|||
155126384|NCT02771626|559894901|FG005|Overall Study|Radiologic Disease Progression|15|||
155126385|NCT02771626|559894896|FG000|Overall Study|Symptomatic Deterioration|0|||
155126386|NCT02771626|559894897|FG001|Overall Study|Symptomatic Deterioration|4|||
155126387|NCT02771626|559894898|FG002|Overall Study|Symptomatic Deterioration|2|||
155126388|NCT02771626|559894899|FG003|Overall Study|Symptomatic Deterioration|0|||
155126389|NCT02771626|559894900|FG004|Overall Study|Symptomatic Deterioration|5|||
155126390|NCT02771626|559894901|FG005|Overall Study|Symptomatic Deterioration|2|||
155126391|NCT02771626|559894896|FG000|Overall Study|Participant Request|0|||
155126392|NCT02771626|559894897|FG001|Overall Study|Participant Request|1|||
155126393|NCT02771626|559894898|FG002|Overall Study|Participant Request|0|||
155126394|NCT02771626|559894899|FG003|Overall Study|Participant Request|2|||
155126395|NCT02771626|559894900|FG004|Overall Study|Participant Request|0|||
155126396|NCT02771626|559894901|FG005|Overall Study|Participant Request|1|||
155126397|NCT02771626|559894896|FG000|Overall Study|Investigator Decision|0|||
155126398|NCT02771626|559894897|FG001|Overall Study|Investigator Decision|1|||
155126399|NCT02771626|559894898|FG002|Overall Study|Investigator Decision|0|||
155126400|NCT02771626|559894899|FG003|Overall Study|Investigator Decision|0|||
155126401|NCT02771626|559894900|FG004|Overall Study|Investigator Decision|1|||
155126402|NCT02771626|559894901|FG005|Overall Study|Investigator Decision|0|||
155126403|NCT02771626|559894896|FG000|Overall Study|Study Termination by Sponsor|0|||
155126404|NCT02771626|559894897|FG001|Overall Study|Study Termination by Sponsor|2|||
155126405|NCT02771626|559894898|FG002|Overall Study|Study Termination by Sponsor|1|||
155126406|NCT02771626|559894899|FG003|Overall Study|Study Termination by Sponsor|0|||
155126407|NCT02771626|559894900|FG004|Overall Study|Study Termination by Sponsor|1|||
155126408|NCT02771626|559894901|FG005|Overall Study|Study Termination by Sponsor|0|||
155126409|NCT02771626|559894896|FG000|Overall Study|Informed Consent Withdrawn|0|||
155126410|NCT02771626|559894897|FG001|Overall Study|Informed Consent Withdrawn|0|||
155126411|NCT02771626|559894898|FG002|Overall Study|Informed Consent Withdrawn|1|||
155126412|NCT02771626|559894899|FG003|Overall Study|Informed Consent Withdrawn|0|||
155126413|NCT02771626|559894900|FG004|Overall Study|Informed Consent Withdrawn|1|||
155126414|NCT02771626|559894901|FG005|Overall Study|Informed Consent Withdrawn|1|||
155126415|NCT02771626|559894896|FG000|Overall Study|Other, Not Specified|1|||
155126416|NCT02771626|559894897|FG001|Overall Study|Other, Not Specified|0|||
155126417|NCT02771626|559894898|FG002|Overall Study|Other, Not Specified|0|||
155126418|NCT02771626|559894899|FG003|Overall Study|Other, Not Specified|0|||
155126419|NCT02771626|559894900|FG004|Overall Study|Other, Not Specified|0|||
155126420|NCT02771626|559894901|FG005|Overall Study|Other, Not Specified|1|||
155126421|NCT02553538|559894902|FG000|Overall Study|Could Not Reach by Telephone|133|||
155126422|NCT02553538|559894903|FG001|Overall Study|Could Not Reach by Telephone|0|||
155126423|NCT02553538|559894902|FG000|Overall Study|Died or Left Network|54|||
155126424|NCT02553538|559894903|FG001|Overall Study|Died or Left Network|56|||
155005726|NCT03999996|559445269|FG002|Booster Phase|Lost to Follow-up|3|||
155005727|NCT03999996|559445270|FG003|Booster Phase|Lost to Follow-up|3|||
155005728|NCT03999996|559445267|FG000|Booster Phase|Withdrawal of Consent|0|||
155005729|NCT03999996|559445268|FG001|Booster Phase|Withdrawal of Consent|0|||
155126425|NCT02690649|559894904|FG000|Overall Study|Withdrawal by Subject|1|||
155126426|NCT02690649|559894905|FG001|Overall Study|Withdrawal by Subject|1|||
155126427|NCT02690649|559894904|FG000|Overall Study|Protocol Violation|0|||
155126428|NCT02690649|559894905|FG001|Overall Study|Protocol Violation|3|||
155126429|NCT00106691|559894906|FG000|Overall Study|Adverse Event|60|||
155126430|NCT00106691|559894907|FG001|Overall Study|Adverse Event|64|||
155005730|NCT03999996|559445269|FG002|Booster Phase|Withdrawal of Consent|0|||
155126431|NCT00106691|559894906|FG000|Overall Study|Lost to Follow-up|23|||
155005731|NCT03999996|559445270|FG003|Booster Phase|Withdrawal of Consent|1|||
155126432|NCT00106691|559894907|FG001|Overall Study|Lost to Follow-up|18|||
155126433|NCT00106691|559894906|FG000|Overall Study|Physician Decision|18|||
155126434|NCT00106691|559894907|FG001|Overall Study|Physician Decision|21|||
155126435|NCT00106691|559894906|FG000|Overall Study|Protocol Violation|13|||
155126436|NCT00106691|559894907|FG001|Overall Study|Protocol Violation|18|||
155126437|NCT00106691|559894906|FG000|Overall Study|Withdrawal by Subject|75|||
155126438|NCT00106691|559894907|FG001|Overall Study|Withdrawal by Subject|70|||
155126439|NCT00106691|559894906|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
155126440|NCT00106691|559894907|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
155126441|NCT00106691|559894906|FG000|Overall Study|QTc>480|3|||
155126442|NCT00106691|559894907|FG001|Overall Study|QTc>480|1|||
155126443|NCT00106691|559894906|FG000|Overall Study|mililtary deployment|2|||
155126444|NCT00106691|559894907|FG001|Overall Study|mililtary deployment|0|||
155126445|NCT00106691|559894906|FG000|Overall Study|Study Site Closing/PI Moved|1|||
155126446|NCT00106691|559894907|FG001|Overall Study|Study Site Closing/PI Moved|2|||
155126447|NCT00106691|559894906|FG000|Overall Study|Cardiologist recommendation|1|||
155126448|NCT00106691|559894907|FG001|Overall Study|Cardiologist recommendation|0|||
155126449|NCT00106691|559894906|FG000|Overall Study|Pt. moved to another state|1|||
155126450|NCT00106691|559894907|FG001|Overall Study|Pt. moved to another state|0|||
155126451|NCT00106691|559894906|FG000|Overall Study|Taking exclusionary avodart|1|||
155126452|NCT00106691|559894907|FG001|Overall Study|Taking exclusionary avodart|0|||
155126453|NCT00106691|559894906|FG000|Overall Study|Not able to discontinue plavix|0|||
155126454|NCT00106691|559894907|FG001|Overall Study|Not able to discontinue plavix|1|||
155126455|NCT01754194|559894908|FG000|Overall Study|Lost to Follow-up|39|||
155126456|NCT01754194|559894909|FG001|Overall Study|Lost to Follow-up|14|||
155126457|NCT01754194|559894908|FG000|Overall Study|Withdrawal by Subject|4|||
155126458|NCT01754194|559894909|FG001|Overall Study|Withdrawal by Subject|5|||
155126459|NCT01754194|559894908|FG000|Overall Study|Other|9|||
155126460|NCT01754194|559894909|FG001|Overall Study|Other|8|||
155126461|NCT00907296|559894910|FG000|Overall Study|Ineligibility Determined|1|||
155126462|NCT00907296|559894911|FG001|Overall Study|Ineligibility Determined|0|||
155126463|NCT00907296|559894912|FG002|Overall Study|Ineligibility Determined|0|||
155126464|NCT00907296|559894913|FG003|Overall Study|Ineligibility Determined|1|||
155126465|NCT00907296|559894914|FG004|Overall Study|Ineligibility Determined|0|||
155126466|NCT00907296|559894915|FG005|Overall Study|Ineligibility Determined|0|||
155126467|NCT00907296|559894916|FG006|Overall Study|Ineligibility Determined|0|||
155126468|NCT00907296|559894917|FG007|Overall Study|Ineligibility Determined|1|||
155126469|NCT00907296|559894918|FG008|Overall Study|Ineligibility Determined|0|||
155126470|NCT00907296|559894919|FG009|Overall Study|Ineligibility Determined|0|||
155126471|NCT00907296|559894910|FG000|Overall Study|Protocol Deviation|0|||
155126472|NCT00907296|559894911|FG001|Overall Study|Protocol Deviation|1|||
155126473|NCT00907296|559894912|FG002|Overall Study|Protocol Deviation|0|||
155126474|NCT00907296|559894913|FG003|Overall Study|Protocol Deviation|0|||
155126475|NCT00907296|559894914|FG004|Overall Study|Protocol Deviation|0|||
155126476|NCT00907296|559894915|FG005|Overall Study|Protocol Deviation|0|||
155126477|NCT00907296|559894916|FG006|Overall Study|Protocol Deviation|0|||
155126478|NCT00907296|559894917|FG007|Overall Study|Protocol Deviation|0|||
155005732|NCT03999996|559445267|FG000|Booster Phase|Reason Not Specified|0|||
155005733|NCT03999996|559445268|FG001|Booster Phase|Reason Not Specified|0|||
155005734|NCT03999996|559445269|FG002|Booster Phase|Reason Not Specified|0|||
155126479|NCT00907296|559894918|FG008|Overall Study|Protocol Deviation|0|||
155126480|NCT00907296|559894919|FG009|Overall Study|Protocol Deviation|0|||
155126481|NCT00907296|559894910|FG000|Overall Study|Noncompliance|1|||
155126482|NCT00907296|559894911|FG001|Overall Study|Noncompliance|1|||
155126483|NCT00907296|559894912|FG002|Overall Study|Noncompliance|1|||
155126484|NCT00907296|559894913|FG003|Overall Study|Noncompliance|0|||
155126485|NCT00907296|559894914|FG004|Overall Study|Noncompliance|0|||
155126486|NCT00907296|559894915|FG005|Overall Study|Noncompliance|1|||
155126487|NCT00907296|559894916|FG006|Overall Study|Noncompliance|0|||
155126488|NCT00907296|559894917|FG007|Overall Study|Noncompliance|2|||
155126489|NCT00907296|559894918|FG008|Overall Study|Noncompliance|0|||
155126490|NCT00907296|559894919|FG009|Overall Study|Noncompliance|0|||
155126491|NCT00907296|559894910|FG000|Overall Study|Adverse Event|2|||
155126492|NCT00907296|559894911|FG001|Overall Study|Adverse Event|0|||
155005735|NCT03999996|559445270|FG003|Booster Phase|Reason Not Specified|1|||
155126493|NCT00907296|559894912|FG002|Overall Study|Adverse Event|0|||
155126494|NCT00907296|559894913|FG003|Overall Study|Adverse Event|0|||
155126495|NCT00907296|559894914|FG004|Overall Study|Adverse Event|0|||
155126496|NCT00907296|559894915|FG005|Overall Study|Adverse Event|0|||
155126497|NCT00907296|559894916|FG006|Overall Study|Adverse Event|1|||
155126498|NCT00907296|559894917|FG007|Overall Study|Adverse Event|0|||
155126499|NCT00907296|559894918|FG008|Overall Study|Adverse Event|0|||
155126500|NCT00907296|559894919|FG009|Overall Study|Adverse Event|1|||
155126501|NCT00907296|559894910|FG000|Overall Study|Withdrawal by Subject|7|||
155126502|NCT00907296|559894911|FG001|Overall Study|Withdrawal by Subject|2|||
155126503|NCT00907296|559894912|FG002|Overall Study|Withdrawal by Subject|1|||
155126504|NCT00907296|559894913|FG003|Overall Study|Withdrawal by Subject|1|||
155126505|NCT00907296|559894914|FG004|Overall Study|Withdrawal by Subject|1|||
155126506|NCT00907296|559894915|FG005|Overall Study|Withdrawal by Subject|5|||
155005736|NCT03690388|559445271|FG000|Overall Study|Adverse Event|8|||
155005737|NCT03690388|559445272|FG001|Overall Study|Adverse Event|1|||
155005738|NCT03690388|559445271|FG000|Overall Study|Radiographic Progression|14|||
155005739|NCT03690388|559445272|FG001|Overall Study|Radiographic Progression|29|||
155005740|NCT03690388|559445271|FG000|Overall Study|Clinical deterioration|10|||
155005741|NCT03690388|559445272|FG001|Overall Study|Clinical deterioration|6|||
155005742|NCT03690388|559445271|FG000|Overall Study|Withdrawal by Subject|2|||
155005743|NCT03690388|559445272|FG001|Overall Study|Withdrawal by Subject|0|||
155005744|NCT03690388|559445271|FG000|Overall Study|Lack of Efficacy|1|||
155005745|NCT03690388|559445272|FG001|Overall Study|Lack of Efficacy|0|||
155005746|NCT03690388|559445271|FG000|Overall Study|Lost to Follow-up|1|||
155005747|NCT03690388|559445272|FG001|Overall Study|Lost to Follow-up|0|||
155005748|NCT03284723|559445277|FG000|Overall Study|Death|0|||
155005749|NCT03284723|559445278|FG001|Overall Study|Death|0|||
155005750|NCT03284723|559445279|FG002|Overall Study|Death|0|||
155005751|NCT03284723|559445280|FG003|Overall Study|Death|1|||
155005752|NCT03284723|559445281|FG004|Overall Study|Death|0|||
155005753|NCT03284723|559445282|FG005|Overall Study|Death|0|||
155005754|NCT03284723|559445283|FG006|Overall Study|Death|1|||
155005755|NCT03284723|559445284|FG007|Overall Study|Death|0|||
155005756|NCT03284723|559445285|FG008|Overall Study|Death|0|||
155005757|NCT03284723|559445286|FG009|Overall Study|Death|2|||
155005758|NCT03284723|559445287|FG010|Overall Study|Death|1|||
155005759|NCT03284723|559445288|FG011|Overall Study|Death|0|||
155005760|NCT03284723|559445277|FG000|Overall Study|Lost to Follow-up|0|||
155005761|NCT03284723|559445278|FG001|Overall Study|Lost to Follow-up|0|||
155005762|NCT03284723|559445279|FG002|Overall Study|Lost to Follow-up|0|||
155005763|NCT03284723|559445280|FG003|Overall Study|Lost to Follow-up|0|||
155005764|NCT03284723|559445281|FG004|Overall Study|Lost to Follow-up|0|||
155005765|NCT03284723|559445282|FG005|Overall Study|Lost to Follow-up|2|||
155005766|NCT03284723|559445283|FG006|Overall Study|Lost to Follow-up|1|||
155005767|NCT03284723|559445284|FG007|Overall Study|Lost to Follow-up|0|||
155005768|NCT03284723|559445285|FG008|Overall Study|Lost to Follow-up|0|||
155005769|NCT03284723|559445286|FG009|Overall Study|Lost to Follow-up|2|||
155005770|NCT03284723|559445287|FG010|Overall Study|Lost to Follow-up|0|||
155005771|NCT03284723|559445288|FG011|Overall Study|Lost to Follow-up|0|||
155005772|NCT03284723|559445277|FG000|Overall Study|Study Terminated By Sponsor|0|||
155005773|NCT03284723|559445278|FG001|Overall Study|Study Terminated By Sponsor|0|||
155005774|NCT03284723|559445279|FG002|Overall Study|Study Terminated By Sponsor|0|||
155005775|NCT03284723|559445280|FG003|Overall Study|Study Terminated By Sponsor|0|||
155005776|NCT03284723|559445281|FG004|Overall Study|Study Terminated By Sponsor|1|||
155005777|NCT03284723|559445282|FG005|Overall Study|Study Terminated By Sponsor|0|||
155005778|NCT03284723|559445283|FG006|Overall Study|Study Terminated By Sponsor|0|||
155005779|NCT03284723|559445284|FG007|Overall Study|Study Terminated By Sponsor|0|||
155005780|NCT03284723|559445285|FG008|Overall Study|Study Terminated By Sponsor|1|||
155005781|NCT03284723|559445286|FG009|Overall Study|Study Terminated By Sponsor|1|||
155005782|NCT03284723|559445287|FG010|Overall Study|Study Terminated By Sponsor|1|||
155005783|NCT03284723|559445288|FG011|Overall Study|Study Terminated By Sponsor|1|||
155005784|NCT03284723|559445277|FG000|Overall Study|Withdrawal by Subject|0|||
155005785|NCT03284723|559445278|FG001|Overall Study|Withdrawal by Subject|0|||
155005786|NCT03284723|559445279|FG002|Overall Study|Withdrawal by Subject|0|||
155005787|NCT03284723|559445280|FG003|Overall Study|Withdrawal by Subject|0|||
155005788|NCT03284723|559445281|FG004|Overall Study|Withdrawal by Subject|5|||
155005789|NCT03284723|559445282|FG005|Overall Study|Withdrawal by Subject|3|||
155005790|NCT03284723|559445283|FG006|Overall Study|Withdrawal by Subject|1|||
155126507|NCT00907296|559894916|FG006|Overall Study|Withdrawal by Subject|3|||
155126508|NCT00907296|559894917|FG007|Overall Study|Withdrawal by Subject|2|||
155005791|NCT03284723|559445284|FG007|Overall Study|Withdrawal by Subject|0|||
155005792|NCT03284723|559445285|FG008|Overall Study|Withdrawal by Subject|6|||
155005793|NCT03284723|559445286|FG009|Overall Study|Withdrawal by Subject|0|||
155005794|NCT03284723|559445287|FG010|Overall Study|Withdrawal by Subject|3|||
155005795|NCT03284723|559445288|FG011|Overall Study|Withdrawal by Subject|1|||
155005796|NCT03284723|559445277|FG000|Overall Study|Other|1|||
155005797|NCT03284723|559445278|FG001|Overall Study|Other|0|||
155005798|NCT03284723|559445279|FG002|Overall Study|Other|1|||
155005799|NCT03284723|559445280|FG003|Overall Study|Other|0|||
155005800|NCT03284723|559445281|FG004|Overall Study|Other|1|||
155005801|NCT03284723|559445282|FG005|Overall Study|Other|0|||
155005802|NCT03284723|559445283|FG006|Overall Study|Other|0|||
155005803|NCT03284723|559445284|FG007|Overall Study|Other|0|||
155005804|NCT03284723|559445285|FG008|Overall Study|Other|0|||
155005805|NCT03284723|559445286|FG009|Overall Study|Other|0|||
155005806|NCT03284723|559445287|FG010|Overall Study|Other|1|||
155005807|NCT03284723|559445288|FG011|Overall Study|Other|0|||
155005808|NCT03284723|559445277|FG000|Overall Study|Adverse Event|0|||
155005809|NCT03284723|559445278|FG001|Overall Study|Adverse Event|0|||
155005810|NCT03284723|559445279|FG002|Overall Study|Adverse Event|0|||
155005811|NCT03284723|559445280|FG003|Overall Study|Adverse Event|0|||
155005812|NCT03284723|559445281|FG004|Overall Study|Adverse Event|0|||
155005813|NCT03284723|559445282|FG005|Overall Study|Adverse Event|0|||
155005814|NCT03284723|559445283|FG006|Overall Study|Adverse Event|0|||
155126509|NCT00907296|559894918|FG008|Overall Study|Withdrawal by Subject|4|||
154923216|NCT01397409|559142268|FG008|Stage 2|Other Miscellaneous Reasons|0|||
154923217|NCT01397409|559142269|FG009|Stage 2|Other Miscellaneous Reasons|0|||
154923218|NCT01397409|559142260|FG000|Stage 3|Adverse Event|0|||
154923219|NCT01397409|559142261|FG001|Stage 3|Adverse Event|0|||
154923220|NCT01397409|559142262|FG002|Stage 3|Adverse Event|0|||
154923221|NCT01397409|559142263|FG003|Stage 3|Adverse Event|0|||
154923222|NCT01397409|559142264|FG004|Stage 3|Adverse Event|0|||
154923223|NCT01397409|559142265|FG005|Stage 3|Adverse Event|0|||
154923224|NCT01397409|559142266|FG006|Stage 3|Adverse Event|0|||
154923225|NCT01397409|559142267|FG007|Stage 3|Adverse Event|1|||
154923226|NCT01397409|559142268|FG008|Stage 3|Adverse Event|0|||
154923227|NCT01397409|559142269|FG009|Stage 3|Adverse Event|0|||
154923228|NCT01397409|559142260|FG000|Stage 3|Other Miscellaneous Reasons|0|||
154923229|NCT01397409|559142261|FG001|Stage 3|Other Miscellaneous Reasons|0|||
154923230|NCT01397409|559142262|FG002|Stage 3|Other Miscellaneous Reasons|0|||
154923231|NCT01397409|559142263|FG003|Stage 3|Other Miscellaneous Reasons|0|||
154923232|NCT01397409|559142264|FG004|Stage 3|Other Miscellaneous Reasons|0|||
154923233|NCT01397409|559142265|FG005|Stage 3|Other Miscellaneous Reasons|0|||
154923234|NCT01397409|559142266|FG006|Stage 3|Other Miscellaneous Reasons|0|||
154923235|NCT01397409|559142267|FG007|Stage 3|Other Miscellaneous Reasons|1|||
154923236|NCT01397409|559142268|FG008|Stage 3|Other Miscellaneous Reasons|0|||
154923237|NCT01397409|559142269|FG009|Stage 3|Other Miscellaneous Reasons|0|||
154923238|NCT03418727|559142270|FG000|Overall Study|Adverse Event|1|||
154923239|NCT03418727|559142271|FG001|Overall Study|Adverse Event|2|||
154923240|NCT03418727|559142272|FG002|Overall Study|Adverse Event|0|||
154923241|NCT03418727|559142270|FG000|Overall Study|Withdrawal by Subject|0|||
154923242|NCT03418727|559142271|FG001|Overall Study|Withdrawal by Subject|0|||
154923243|NCT03418727|559142272|FG002|Overall Study|Withdrawal by Subject|2|||
154923244|NCT01791543|559142273|FG000|Overall Study|Lost to Follow-up|1|||
154923245|NCT01791543|559142273|FG000|Overall Study|Adverse Event|1|||
154923246|NCT03145207|559142274|FG000|Overall Study|volunteer started taking allergy shots|1|||
154923247|NCT03145207|559142274|FG000|Overall Study|baseline blood pressure high|1|||
154923248|NCT01396434|559142276|FG000|Overall Study|Lost to Follow-up|1|||
154923249|NCT01396434|559142277|FG001|Overall Study|Lost to Follow-up|0|||
154923250|NCT01396434|559142278|FG002|Overall Study|Lost to Follow-up|0|||
154923251|NCT01396434|559142276|FG000|Overall Study|Other|10|||
154923252|NCT01396434|559142277|FG001|Overall Study|Other|0|||
154923253|NCT01396434|559142278|FG002|Overall Study|Other|0|||
154923254|NCT00509223|559143743|FG000|Overall Study|Lost to Follow-up|1|||
154923255|NCT00509223|559143744|FG001|Overall Study|Lost to Follow-up|1|||
154923256|NCT00509223|559143743|FG000|Overall Study|Adverse Event|1|||
154923257|NCT00509223|559143744|FG001|Overall Study|Adverse Event|1|||
154923258|NCT00509223|559143743|FG000|Overall Study|Withdrawal by Subject|25|||
154923259|NCT00509223|559143744|FG001|Overall Study|Withdrawal by Subject|6|||
154923260|NCT00509223|559143743|FG000|Overall Study|Including: subject change of address|5|||
154923261|NCT00509223|559143744|FG001|Overall Study|Including: subject change of address|2|||
154923262|NCT00509223|559143743|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
154923263|NCT00509223|559143744|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
154923264|NCT03839693|559143751|FG000|Overall Study|Lost to Follow-up|0|||
154923265|NCT03839693|559143752|FG001|Overall Study|Lost to Follow-up|2|||
154923266|NCT03839693|559143753|FG002|Overall Study|Lost to Follow-up|2|||
154923267|NCT03839693|559143751|FG000|Overall Study|Withdrawal by Subject|1|||
154923268|NCT03839693|559143752|FG001|Overall Study|Withdrawal by Subject|0|||
154923269|NCT03839693|559143753|FG002|Overall Study|Withdrawal by Subject|2|||
154923270|NCT03839693|559143751|FG000|Overall Study|subject moved out of the area|1|||
154923271|NCT03839693|559143752|FG001|Overall Study|subject moved out of the area|0|||
154923272|NCT03839693|559143753|FG002|Overall Study|subject moved out of the area|0|||
154923273|NCT00700115|559143762|FG000|Overall Study|Withdrawal by Subject|1|||
154923274|NCT00700115|559143763|FG001|Overall Study|Withdrawal by Subject|0|||
154923275|NCT00700115|559143762|FG000|Overall Study|Lost to Follow-up|0|||
154923276|NCT00700115|559143763|FG001|Overall Study|Lost to Follow-up|1|||
154923277|NCT02983305|559143764|FG000|Overall Study|incomplete data|2|||
154923278|NCT02983305|559143765|FG001|Overall Study|incomplete data|0|||
154923279|NCT00706901|559143766|FG000|Overall Study|Lost to Follow-up|2|||
154923280|NCT00706901|559143767|FG001|Overall Study|Lost to Follow-up|3|||
154923281|NCT00706901|559143768|FG002|Overall Study|Lost to Follow-up|2|||
154923282|NCT00706901|559143766|FG000|Overall Study|Withdrawal by Subject|4|||
154923283|NCT00706901|559143767|FG001|Overall Study|Withdrawal by Subject|2|||
154923284|NCT00706901|559143768|FG002|Overall Study|Withdrawal by Subject|5|||
154923285|NCT00706901|559143766|FG000|Overall Study|In Jail|1|||
154923286|NCT00706901|559143767|FG001|Overall Study|In Jail|0|||
154923287|NCT00706901|559143768|FG002|Overall Study|In Jail|1|||
154923288|NCT00706901|559143766|FG000|Overall Study|Death|1|||
154923289|NCT00706901|559143767|FG001|Overall Study|Death|0|||
154923290|NCT00706901|559143768|FG002|Overall Study|Death|0|||
154923291|NCT00822237|559143769|FG000|Dose 1 Vaccination|Not vaccinated|3|||
155126510|NCT00907296|559894919|FG009|Overall Study|Withdrawal by Subject|2|||
155126511|NCT00907296|559894910|FG000|Overall Study|Lost to Follow-up|9|||
155126512|NCT00907296|559894911|FG001|Overall Study|Lost to Follow-up|1|||
155126513|NCT00907296|559894912|FG002|Overall Study|Lost to Follow-up|0|||
155126514|NCT00907296|559894913|FG003|Overall Study|Lost to Follow-up|2|||
155126515|NCT00907296|559894914|FG004|Overall Study|Lost to Follow-up|0|||
155126516|NCT00907296|559894915|FG005|Overall Study|Lost to Follow-up|3|||
155126517|NCT00907296|559894916|FG006|Overall Study|Lost to Follow-up|2|||
155126518|NCT00907296|559894917|FG007|Overall Study|Lost to Follow-up|2|||
155126519|NCT00907296|559894918|FG008|Overall Study|Lost to Follow-up|0|||
155126520|NCT00907296|559894919|FG009|Overall Study|Lost to Follow-up|4|||
155126521|NCT02776033|559894924|FG000|Overall Study|Withdrawal by Subject|0|||
155126522|NCT02776033|559894925|FG001|Overall Study|Withdrawal by Subject|0|||
155126523|NCT02776033|559894926|FG002|Overall Study|Withdrawal by Subject|2|||
155126524|NCT02776033|559894924|FG000|Overall Study|Physician Decision|2|||
155126525|NCT02776033|559894925|FG001|Overall Study|Physician Decision|0|||
155126526|NCT02776033|559894926|FG002|Overall Study|Physician Decision|0|||
155126527|NCT02776033|559894924|FG000|Overall Study|Lost to Follow-up|1|||
155126528|NCT02776033|559894925|FG001|Overall Study|Lost to Follow-up|0|||
155126529|NCT02776033|559894926|FG002|Overall Study|Lost to Follow-up|0|||
155126530|NCT02776033|559894924|FG000|Overall Study|Adverse Event|1|||
155126531|NCT02776033|559894925|FG001|Overall Study|Adverse Event|2|||
155126532|NCT02776033|559894926|FG002|Overall Study|Adverse Event|0|||
155126533|NCT02616393|559894930|FG000|Overall Study|Death|5|||
155126534|NCT02616393|559894931|FG001|Overall Study|Death|12|||
155126535|NCT02616393|559894932|FG002|Overall Study|Death|1|||
155126536|NCT02616393|559894930|FG000|Overall Study|Termination by Sponsor|4|||
155126537|NCT02616393|559894931|FG001|Overall Study|Termination by Sponsor|5|||
155126538|NCT02616393|559894932|FG002|Overall Study|Termination by Sponsor|2|||
155126539|NCT02616393|559894930|FG000|Overall Study|Other|3|||
155126540|NCT02616393|559894931|FG001|Overall Study|Other|0|||
155126541|NCT02616393|559894932|FG002|Overall Study|Other|0|||
155126542|NCT02616393|559894930|FG000|Overall Study|Withdrawal by Subject|1|||
155126543|NCT02616393|559894931|FG001|Overall Study|Withdrawal by Subject|1|||
155126544|NCT02616393|559894932|FG002|Overall Study|Withdrawal by Subject|0|||
155126545|NCT02616393|559894930|FG000|Overall Study|Lost to Follow-up|0|||
155126546|NCT02616393|559894931|FG001|Overall Study|Lost to Follow-up|2|||
155126547|NCT02616393|559894932|FG002|Overall Study|Lost to Follow-up|0|||
155126548|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
155126549|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
155126550|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
155126551|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
155126552|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
155126553|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
155126554|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
155126555|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
155126556|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
155126557|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
155126558|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
155126559|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
155126560|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
154923292|NCT00822237|559143770|FG001|Dose 1 Vaccination|Not vaccinated|0|||
154923293|NCT00822237|559143769|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
154923294|NCT00822237|559143770|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
154923295|NCT00822237|559143769|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
154923296|NCT00822237|559143770|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
154923297|NCT00822237|559143769|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
154923298|NCT00822237|559143770|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
154923299|NCT00822237|559143769|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
154923300|NCT00822237|559143770|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
154923301|NCT03433482|559143771|FG000|Overall Study|Lost to Follow-up|1|||
154923302|NCT03433482|559143772|FG001|Overall Study|Lost to Follow-up|0|||
154923303|NCT03433482|559143773|FG002|Overall Study|Lost to Follow-up|1|||
154923304|NCT03433482|559143774|FG003|Overall Study|Lost to Follow-up|1|||
154923305|NCT03433482|559143771|FG000|Overall Study|Withdrawal by Subject|0|||
154923306|NCT03433482|559143772|FG001|Overall Study|Withdrawal by Subject|0|||
154923307|NCT03433482|559143773|FG002|Overall Study|Withdrawal by Subject|1|||
155126561|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
155126562|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
155126563|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
155126564|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
155126565|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
155126566|NCT01302054|559894933|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
155126567|NCT01302054|559894934|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
154923308|NCT03433482|559143774|FG003|Overall Study|Withdrawal by Subject|0|||
155005815|NCT03284723|559445284|FG007|Overall Study|Adverse Event|0|||
155005816|NCT03284723|559445285|FG008|Overall Study|Adverse Event|1|||
155005817|NCT03284723|559445286|FG009|Overall Study|Adverse Event|0|||
155005818|NCT03284723|559445287|FG010|Overall Study|Adverse Event|0|||
155005819|NCT03284723|559445288|FG011|Overall Study|Adverse Event|0|||
155005820|NCT00077207|559445289|FG000|Overall Study|Adverse Event|5|||
155005821|NCT00077207|559445289|FG000|Overall Study|Lack of Efficacy|12|||
155005822|NCT00077207|559445289|FG000|Overall Study|Physician Decision|6|||
155005823|NCT00077207|559445289|FG000|Overall Study|Withdrawal by Subject|6|||
155005824|NCT00077207|559445289|FG000|Overall Study|Ineligible|1|||
155005825|NCT00524420|559445306|FG000|Overall Study|Lack of Efficacy|1|||
155005826|NCT00524420|559445307|FG001|Overall Study|Lack of Efficacy|0|||
155005827|NCT00577863|559445308|FG000|Overall Study|Adverse Event|4|||
155005828|NCT00577863|559445309|FG001|Overall Study|Adverse Event|2|||
155005829|NCT00577863|559445308|FG000|Overall Study|Death|1|||
155005830|NCT00577863|559445309|FG001|Overall Study|Death|0|||
155005831|NCT00577863|559445308|FG000|Overall Study|Lost to Follow-up|2|||
155005832|NCT00577863|559445309|FG001|Overall Study|Lost to Follow-up|2|||
155005833|NCT00577863|559445308|FG000|Overall Study|Entry Criteria Exclusion|1|||
155005834|NCT00577863|559445309|FG001|Overall Study|Entry Criteria Exclusion|0|||
155126568|NCT01302054|559894935|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
155126569|NCT01302054|559894933|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
155126570|NCT01302054|559894934|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
155126571|NCT01302054|559894935|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
155126572|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155126573|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
155126574|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
155126575|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
155126576|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
155126577|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
155126578|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155126579|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
155126580|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
155126581|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
155126582|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
155126583|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
155126584|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155126585|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
155126586|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
155126587|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
155126588|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
155126589|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
155126590|NCT01302054|559894933|FG000|Double-Blind Treatment Phase|Other|0|||
155126591|NCT01302054|559894934|FG001|Double-Blind Treatment Phase|Other|4|||
155126592|NCT01302054|559894935|FG002|Double-Blind Treatment Phase|Other|9|||
155126593|NCT02445573|559894937|FG000|Overall Study|Withdrawal by Subject|1|||
155126594|NCT02445573|559894938|FG001|Overall Study|Withdrawal by Subject|1|||
155126595|NCT02445573|559894937|FG000|Overall Study|Lost to Follow-up|0|||
155126596|NCT02445573|559894938|FG001|Overall Study|Lost to Follow-up|1|||
155126597|NCT01639755|559894939|FG000|Overall Study|Study Ongoing|15|||
155126598|NCT01639755|559894939|FG000|Overall Study|Patient had device explantation|4|||
155126599|NCT03262116|559894940|FG000|Overall Study|Physician Decision|0|||
155126600|NCT03262116|559894941|FG001|Overall Study|Physician Decision|2|||
155126601|NCT03262116|559894942|FG002|Overall Study|Physician Decision|1|||
155126602|NCT03262116|559894943|FG003|Overall Study|Physician Decision|1|||
155126603|NCT03262116|559894944|FG004|Overall Study|Physician Decision|1|||
155126604|NCT03262116|559894945|FG005|Overall Study|Physician Decision|2|||
155126605|NCT02365285|559894946|FG000|Overall Study|Physician Decision|0|||
155126606|NCT02365285|559894947|FG001|Overall Study|Physician Decision|1|||
155126607|NCT02365285|559894948|FG002|Overall Study|Physician Decision|1|||
155126608|NCT02365285|559894949|FG003|Overall Study|Physician Decision|0|||
155126609|NCT02365285|559894946|FG000|Overall Study|Adverse Event|0|||
155126610|NCT02365285|559894947|FG001|Overall Study|Adverse Event|0|||
155178339|NCT00534313|560091444|FG000|Short-term Period|Participant withdrew consent|2|||
155005835|NCT00577863|559445308|FG000|Overall Study|Withdrawal by Subject|0|||
155005836|NCT00577863|559445309|FG001|Overall Study|Withdrawal by Subject|2|||
155005837|NCT00577863|559445308|FG000|Overall Study|Sponsor Decision|2|||
155005838|NCT00577863|559445309|FG001|Overall Study|Sponsor Decision|7|||
155005839|NCT00577863|559445308|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
155005840|NCT00577863|559445309|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
155005841|NCT03639779|559445317|FG000|Overall Study|Lost to Follow-up|1|||
155005842|NCT02932462|559445320|FG000|Overall Study|Adverse Event|1|||
155126611|NCT02365285|559894948|FG002|Overall Study|Adverse Event|0|||
155126612|NCT02365285|559894949|FG003|Overall Study|Adverse Event|2|||
155005843|NCT02932462|559445321|FG001|Overall Study|Adverse Event|2|||
155126613|NCT02608450|559894954|FG000|Overall Study|Lost to Follow-up|39|||
155126614|NCT02608450|559894955|FG001|Overall Study|Lost to Follow-up|32|||
155126615|NCT02608450|559894954|FG000|Overall Study|Withdrawal by Subject|21|||
155126616|NCT02608450|559894955|FG001|Overall Study|Withdrawal by Subject|15|||
155126617|NCT02608450|559894954|FG000|Overall Study|Adverse Event|3|||
155126618|NCT02608450|559894955|FG001|Overall Study|Adverse Event|6|||
155126619|NCT02608450|559894954|FG000|Overall Study|Withdrawal by parent|2|||
155126620|NCT02608450|559894955|FG001|Overall Study|Withdrawal by parent|3|||
155126621|NCT02608450|559894954|FG000|Overall Study|Lack of Efficacy|0|||
155126622|NCT02608450|559894955|FG001|Overall Study|Lack of Efficacy|3|||
155126623|NCT02608450|559894954|FG000|Overall Study|Noncompliance with study drug|0|||
155126624|NCT02608450|559894955|FG001|Overall Study|Noncompliance with study drug|2|||
155126625|NCT02608450|559894954|FG000|Overall Study|Physician Decision|0|||
155126626|NCT02608450|559894955|FG001|Overall Study|Physician Decision|1|||
155126627|NCT02608450|559894954|FG000|Overall Study|Pregnancy|0|||
155126628|NCT02608450|559894955|FG001|Overall Study|Pregnancy|1|||
155126629|NCT02608450|559894954|FG000|Overall Study|Progressive disease|1|||
155126630|NCT02608450|559894955|FG001|Overall Study|Progressive disease|0|||
155005844|NCT02932462|559445320|FG000|Overall Study|Lost to Follow-up|4|||
155005845|NCT02932462|559445321|FG001|Overall Study|Lost to Follow-up|1|||
155005846|NCT02932462|559445320|FG000|Overall Study|Protocol Violation|0|||
155005847|NCT02932462|559445321|FG001|Overall Study|Protocol Violation|5|||
155005848|NCT02932462|559445320|FG000|Overall Study|Withdrawal by Subject|1|||
155005849|NCT02932462|559445321|FG001|Overall Study|Withdrawal by Subject|4|||
155005850|NCT02932462|559445320|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155005851|NCT02932462|559445321|FG001|Overall Study|Non-Compliance With Study Drug|1|||
155005852|NCT02932462|559445320|FG000|Overall Study|Progressive Disease|1|||
155005853|NCT02932462|559445321|FG001|Overall Study|Progressive Disease|0|||
155005854|NCT02413229|559445322|FG000|Overall Study|Adverse Event|0|||
155005855|NCT02413229|559445323|FG001|Overall Study|Adverse Event|0|||
155005856|NCT02413229|559445324|FG002|Overall Study|Adverse Event|0|||
155005857|NCT02413229|559445325|FG003|Overall Study|Adverse Event|1|||
155005858|NCT02413229|559445326|FG004|Overall Study|Adverse Event|0|||
155005859|NCT02413229|559445327|FG005|Overall Study|Adverse Event|0|||
155005860|NCT02413229|559445328|FG006|Overall Study|Adverse Event|0|||
155005861|NCT02413229|559445329|FG007|Overall Study|Adverse Event|1|||
155005862|NCT02413229|559445322|FG000|Overall Study|Lost to Follow-up|0|||
155005863|NCT02413229|559445323|FG001|Overall Study|Lost to Follow-up|0|||
155005864|NCT02413229|559445324|FG002|Overall Study|Lost to Follow-up|1|||
155005865|NCT02413229|559445325|FG003|Overall Study|Lost to Follow-up|0|||
155005866|NCT02413229|559445326|FG004|Overall Study|Lost to Follow-up|2|||
155005867|NCT02413229|559445327|FG005|Overall Study|Lost to Follow-up|0|||
155005868|NCT02413229|559445328|FG006|Overall Study|Lost to Follow-up|0|||
155005869|NCT02413229|559445329|FG007|Overall Study|Lost to Follow-up|0|||
155005870|NCT02413229|559445322|FG000|Overall Study|Withdrawal by Subject|1|||
155005871|NCT02413229|559445323|FG001|Overall Study|Withdrawal by Subject|1|||
155005872|NCT02413229|559445324|FG002|Overall Study|Withdrawal by Subject|0|||
155005873|NCT02413229|559445325|FG003|Overall Study|Withdrawal by Subject|0|||
155005874|NCT02413229|559445326|FG004|Overall Study|Withdrawal by Subject|1|||
155005875|NCT02413229|559445327|FG005|Overall Study|Withdrawal by Subject|0|||
155005876|NCT02413229|559445328|FG006|Overall Study|Withdrawal by Subject|0|||
155005877|NCT02413229|559445329|FG007|Overall Study|Withdrawal by Subject|2|||
155005878|NCT02413229|559445322|FG000|Overall Study|Progressive Disease|0|||
155005879|NCT02413229|559445323|FG001|Overall Study|Progressive Disease|0|||
155005880|NCT02413229|559445324|FG002|Overall Study|Progressive Disease|0|||
155005881|NCT02413229|559445325|FG003|Overall Study|Progressive Disease|0|||
155005882|NCT02413229|559445326|FG004|Overall Study|Progressive Disease|0|||
155005883|NCT02413229|559445327|FG005|Overall Study|Progressive Disease|0|||
155126631|NCT02608450|559894954|FG000|Overall Study|Multiple reasons|0|||
155126632|NCT02608450|559894955|FG001|Overall Study|Multiple reasons|2|||
155126633|NCT00635089|559894958|FG000|Overall Study|Adverse Event|7|||
155178340|NCT00534313|560091445|FG001|Short-term Period|Participant withdrew consent|0|||
155005884|NCT02413229|559445328|FG006|Overall Study|Progressive Disease|0|||
155005885|NCT02413229|559445329|FG007|Overall Study|Progressive Disease|1|||
155005886|NCT02009722|559445336|FG000|Overall Study|Protocol Violation|1|||
155005887|NCT02009722|559445337|FG001|Overall Study|Protocol Violation|2|||
155005888|NCT02009722|559445336|FG000|Overall Study|Did not receive intervention|0|||
155005889|NCT02009722|559445337|FG001|Overall Study|Did not receive intervention|1|||
155005890|NCT02955212|559445338|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
155005891|NCT02955212|559445339|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
155005892|NCT02955212|559445338|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
155005893|NCT02955212|559445339|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
155005894|NCT02955212|559445338|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
155005895|NCT02955212|559445339|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
155005896|NCT02955212|559445338|FG000|Period 1: Double-blind Treatment Period|Other|3|||
155005897|NCT02955212|559445339|FG001|Period 1: Double-blind Treatment Period|Other|2|||
155126634|NCT00635089|559894958|FG000|Overall Study|Lack of Efficacy|28|||
155126635|NCT00635089|559894958|FG000|Overall Study|Protocol Deviation|4|||
155126636|NCT00635089|559894958|FG000|Overall Study|Lost to Follow-up|8|||
155126637|NCT00635089|559894958|FG000|Overall Study|Other|31|||
155126638|NCT01617447|559894959|FG000|Overall Study|Adverse Event|0|||
155126639|NCT01617447|559894960|FG001|Overall Study|Adverse Event|1|||
155126640|NCT01617447|559894959|FG000|Overall Study|Physician Decision|0|||
155126641|NCT01617447|559894960|FG001|Overall Study|Physician Decision|2|||
155126642|NCT01283542|559894961|FG000|Main Phase|Acute or progressive vision loss|1|||
155126643|NCT01283542|559894961|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
155126644|NCT01283542|559894961|FG000|Main Phase|abnormal laboratory values|5|||
155126645|NCT01283542|559894961|FG000|Extension Phase|Physician Decision|1|||
155126646|NCT01283542|559894961|FG000|Extension Phase|Adverse Event|1|||
155126647|NCT01283542|559894961|FG000|Extension Phase|Administrative problems|1|||
155126648|NCT02636946|559894962|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
155126649|NCT02636946|559894963|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
155126650|NCT02636946|559894962|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
155126651|NCT02636946|559894963|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
155126652|NCT02636946|559894962|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
155126653|NCT02636946|559894963|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
155126654|NCT02636946|559894962|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
155126655|NCT02636946|559894963|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
155126656|NCT02636946|559894962|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
155126657|NCT02636946|559894963|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
155126658|NCT02636946|559894962|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
155126659|NCT02636946|559894963|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
155126660|NCT05059977|559894964|FG000|Overall Study|Withdrawal by Subject|0|||
155126661|NCT05059977|559894965|FG001|Overall Study|Withdrawal by Subject|0|||
155126662|NCT05059977|559894966|FG002|Overall Study|Withdrawal by Subject|1|||
155126663|NCT04405245|559894967|FG000|Overall Study|Adverse Event|0|||
155126664|NCT04405245|559894968|FG001|Overall Study|Adverse Event|1|||
155126665|NCT04405245|559894969|FG002|Overall Study|Adverse Event|0|||
155126666|NCT00576472|559894970|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126667|NCT00576472|559894971|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126668|NCT00576472|559894972|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126669|NCT00576472|559894973|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
155126670|NCT00576472|559894974|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126671|NCT00576472|559894975|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126672|NCT00576472|559894976|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126673|NCT00576472|559894977|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126674|NCT00576472|559894978|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126675|NCT00576472|559894979|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126676|NCT00576472|559894980|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126677|NCT00576472|559894981|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126678|NCT00576472|559894982|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126679|NCT00576472|559894983|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126680|NCT00576472|559894984|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
155126681|NCT00576472|559894970|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
155126682|NCT00576472|559894971|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
155126683|NCT00576472|559894972|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
155126684|NCT00576472|559894973|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
155126685|NCT00576472|559894974|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
155126686|NCT00576472|559894975|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
155126687|NCT00576472|559894976|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
155126688|NCT00576472|559894977|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
155126689|NCT00576472|559894978|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
155126690|NCT00576472|559894979|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
155126691|NCT00576472|559894980|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
155126692|NCT00576472|559894981|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
155126693|NCT00576472|559894982|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
155126694|NCT00576472|559894983|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
155126695|NCT00576472|559894984|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
155126696|NCT00576472|559894970|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126697|NCT00576472|559894971|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126698|NCT00576472|559894972|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126699|NCT00576472|559894973|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
155126700|NCT00576472|559894974|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126701|NCT00576472|559894975|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126702|NCT00576472|559894976|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126703|NCT00576472|559894977|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126704|NCT00576472|559894978|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126705|NCT00576472|559894979|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126706|NCT00576472|559894980|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126707|NCT00576472|559894981|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126708|NCT00576472|559894982|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126709|NCT00576472|559894983|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126710|NCT00576472|559894984|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
155126711|NCT00576472|559894970|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
155126712|NCT00576472|559894971|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
155126713|NCT00576472|559894972|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
155126714|NCT00576472|559894973|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
155126715|NCT00576472|559894974|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
155126716|NCT00576472|559894975|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
155126717|NCT00576472|559894976|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
155126718|NCT00576472|559894977|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
155126719|NCT00576472|559894978|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
155126720|NCT00576472|559894979|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
155126721|NCT00576472|559894980|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
155126722|NCT00576472|559894981|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
155126723|NCT00576472|559894982|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
155126724|NCT00576472|559894983|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
155126725|NCT00576472|559894984|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
155126726|NCT00576472|559894970|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126727|NCT00576472|559894971|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126728|NCT00576472|559894972|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126729|NCT00576472|559894973|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
155126730|NCT00576472|559894974|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126731|NCT00576472|559894975|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126732|NCT00576472|559894976|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126733|NCT00576472|559894977|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126734|NCT00576472|559894978|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126735|NCT00576472|559894979|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126736|NCT00576472|559894980|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126737|NCT00576472|559894981|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126738|NCT00576472|559894982|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126739|NCT00576472|559894983|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126740|NCT00576472|559894984|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
155126741|NCT00576472|559894970|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126742|NCT00576472|559894971|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126743|NCT00576472|559894972|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126744|NCT00576472|559894973|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126745|NCT00576472|559894974|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126746|NCT00576472|559894975|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126747|NCT00576472|559894976|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
155126748|NCT00576472|559894977|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126749|NCT00576472|559894978|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126750|NCT00576472|559894979|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126751|NCT00576472|559894980|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126752|NCT00576472|559894981|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126753|NCT00576472|559894982|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126754|NCT00576472|559894983|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126755|NCT00576472|559894984|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
155126756|NCT00576472|559894970|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
155126757|NCT00576472|559894971|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
155126758|NCT00576472|559894972|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
155126759|NCT00576472|559894973|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
155126760|NCT00576472|559894974|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
155126761|NCT00576472|559894975|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
155126762|NCT00576472|559894976|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
155126763|NCT00576472|559894977|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
155126764|NCT00576472|559894978|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
155126765|NCT00576472|559894979|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
155126766|NCT00576472|559894980|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
155126767|NCT00576472|559894981|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
155126768|NCT00576472|559894982|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
155126769|NCT00576472|559894983|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
154923309|NCT03433482|559143771|FG000|Overall Study|Unknown reason|0|||
155126770|NCT00576472|559894984|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
155126771|NCT00576472|559894970|FG000|MPH Cross Over Phase|Physician Decision|0|||
155126772|NCT00576472|559894971|FG001|MPH Cross Over Phase|Physician Decision|0|||
155126773|NCT00576472|559894972|FG002|MPH Cross Over Phase|Physician Decision|0|||
155126774|NCT00576472|559894973|FG003|MPH Cross Over Phase|Physician Decision|0|||
154923310|NCT03433482|559143772|FG001|Overall Study|Unknown reason|0|||
155126775|NCT00576472|559894974|FG004|MPH Cross Over Phase|Physician Decision|0|||
155126776|NCT00576472|559894975|FG005|MPH Cross Over Phase|Physician Decision|0|||
155126777|NCT00576472|559894976|FG006|MPH Cross Over Phase|Physician Decision|4|||
155126778|NCT00576472|559894977|FG007|MPH Cross Over Phase|Physician Decision|0|||
155126779|NCT00576472|559894978|FG008|MPH Cross Over Phase|Physician Decision|0|||
155126780|NCT00576472|559894979|FG009|MPH Cross Over Phase|Physician Decision|0|||
155126781|NCT00576472|559894980|FG010|MPH Cross Over Phase|Physician Decision|0|||
155126782|NCT00576472|559894981|FG011|MPH Cross Over Phase|Physician Decision|0|||
155126783|NCT00576472|559894982|FG012|MPH Cross Over Phase|Physician Decision|0|||
155126784|NCT00576472|559894983|FG013|MPH Cross Over Phase|Physician Decision|0|||
155126785|NCT00576472|559894984|FG014|MPH Cross Over Phase|Physician Decision|0|||
155126786|NCT00576472|559894970|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
154923311|NCT03433482|559143773|FG002|Overall Study|Unknown reason|2|||
154923312|NCT03433482|559143774|FG003|Overall Study|Unknown reason|0|||
154923313|NCT01646268|559143778|FG000|Overall Study|Adverse Event|6|||
154923314|NCT01646268|559143779|FG001|Overall Study|Adverse Event|7|||
154923315|NCT01646268|559143778|FG000|Overall Study|Lack of Efficacy|1|||
154923316|NCT01646268|559143779|FG001|Overall Study|Lack of Efficacy|3|||
154923317|NCT01646268|559143778|FG000|Overall Study|Protocol Violation|0|||
154923318|NCT01646268|559143779|FG001|Overall Study|Protocol Violation|1|||
154923319|NCT01646268|559143778|FG000|Overall Study|Withdrawal by Subject|2|||
154923320|NCT01646268|559143779|FG001|Overall Study|Withdrawal by Subject|5|||
154923321|NCT01646268|559143778|FG000|Overall Study|Other|2|||
154923322|NCT01646268|559143779|FG001|Overall Study|Other|0|||
154923323|NCT01473602|559143784|FG000|Overall Study|Adverse Event|1|||
154923324|NCT01473602|559143785|FG001|Overall Study|Adverse Event|2|||
154923325|NCT01473602|559143784|FG000|Overall Study|Death|0|||
154923326|NCT01473602|559143785|FG001|Overall Study|Death|1|||
154923327|NCT01473602|559143784|FG000|Overall Study|Lost to Follow-up|1|||
154923328|NCT01473602|559143785|FG001|Overall Study|Lost to Follow-up|1|||
154923329|NCT01473602|559143784|FG000|Overall Study|Withdrawal by Subject|5|||
154923330|NCT01473602|559143785|FG001|Overall Study|Withdrawal by Subject|4|||
154923331|NCT01473602|559143784|FG000|Overall Study|Physician Decision|1|||
154923332|NCT01473602|559143785|FG001|Overall Study|Physician Decision|0|||
154923333|NCT00449761|559143786|FG000|Overall Study|Disease progression|12|||
154923334|NCT00449761|559143786|FG000|Overall Study|Death|5|||
154923335|NCT00449761|559143786|FG000|Overall Study|New cancer therapy|1|||
154923336|NCT00518531|559143789|FG000|Treatment Period 1|Adverse Event|5|||
154923337|NCT00518531|559143790|FG001|Treatment Period 1|Adverse Event|0|||
154923338|NCT00518531|559143789|FG000|Treatment Period 1|Lost to Follow-up|5|||
154923339|NCT00518531|559143790|FG001|Treatment Period 1|Lost to Follow-up|3|||
154923340|NCT00518531|559143789|FG000|Treatment Period 1|Physician Decision|1|||
154923341|NCT00518531|559143790|FG001|Treatment Period 1|Physician Decision|0|||
154923342|NCT00518531|559143789|FG000|Treatment Period 1|Protocol Violation|2|||
154923343|NCT00518531|559143790|FG001|Treatment Period 1|Protocol Violation|0|||
154923344|NCT00518531|559143789|FG000|Treatment Period 1|Withdrawal by Subject|4|||
154923345|NCT00518531|559143790|FG001|Treatment Period 1|Withdrawal by Subject|6|||
154923346|NCT00518531|559143789|FG000|Treatment Period 1|Early crossover|1|||
154923347|NCT00518531|559143790|FG001|Treatment Period 1|Early crossover|3|||
154923348|NCT00518531|559143789|FG000|Treatment Period 2|Withdrawal by Subject|0|||
154923349|NCT00518531|559143790|FG001|Treatment Period 2|Withdrawal by Subject|8|||
154923350|NCT00518531|559143789|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
154923351|NCT00518531|559143790|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
154923352|NCT00518531|559143789|FG000|Treatment Period 2|Adverse Event|1|||
154923353|NCT00518531|559143790|FG001|Treatment Period 2|Adverse Event|7|||
154923354|NCT00518531|559143789|FG000|Treatment Period 2|Protocol-specified criteria|0|||
154923355|NCT00518531|559143790|FG001|Treatment Period 2|Protocol-specified criteria|1|||
154923356|NCT00518531|559143789|FG000|Treatment Period 2|Non-compliance|1|||
154923357|NCT00518531|559143790|FG001|Treatment Period 2|Non-compliance|2|||
154923358|NCT00054639|559143791|FG000|Overall Study|Lack of Efficacy|1|||
154923359|NCT00054639|559143791|FG000|Overall Study|Physician Decision|1|||
154923360|NCT04621227|559143796|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
154923361|NCT04621227|559143796|FG000|Period 3 (29 Days)|Adverse Event|1|||
154923362|NCT04621227|559143796|FG000|Period 8 (2 Days)|Adverse Event|1|||
154923363|NCT00938392|559143797|FG000|Overall Study|Adverse Event|0|||
154923364|NCT00938392|559143798|FG001|Overall Study|Adverse Event|1|||
154923365|NCT00938392|559143797|FG000|Overall Study|Withdrawal by Subject|0|||
154923366|NCT00938392|559143798|FG001|Overall Study|Withdrawal by Subject|1|||
154923367|NCT00938392|559143797|FG000|Overall Study|Lost to Follow-up|2|||
154923368|NCT00938392|559143798|FG001|Overall Study|Lost to Follow-up|2|||
154923369|NCT02916056|559143799|FG000|Overall Study|Adverse Event|6|||
154923370|NCT02916056|559143799|FG000|Overall Study|Lost to Follow-up|1|||
154923371|NCT02916056|559143799|FG000|Overall Study|Other|12|||
154923372|NCT02916056|559143799|FG000|Overall Study|Protocol Violation|1|||
154923373|NCT02916056|559143799|FG000|Overall Study|Withdrawal by Subject|8|||
154923374|NCT02916056|559143799|FG000|Overall Study|Study Terminated by Sponsor|269|||
154923375|NCT00124709|559143800|FG000|Overall Study|Randomized but did not take medication|3|||
155126787|NCT00576472|559894971|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126788|NCT00576472|559894972|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126789|NCT00576472|559894973|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126790|NCT00576472|559894974|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126791|NCT00576472|559894975|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126792|NCT00576472|559894976|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126793|NCT00576472|559894977|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126794|NCT00576472|559894978|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
155126795|NCT00576472|559894979|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126796|NCT00576472|559894980|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
155126797|NCT00576472|559894981|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
155126798|NCT00576472|559894982|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126799|NCT00576472|559894983|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126800|NCT00576472|559894984|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
155126801|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126802|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126803|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126804|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126805|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126806|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126807|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126808|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126809|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126810|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126811|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126812|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126813|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126814|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
155126815|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
155126816|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
155126817|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
155126818|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
155126819|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
155126820|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
155126821|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
155126822|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
155126823|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
155126824|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
155126825|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
155126826|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
155126827|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
155126828|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
155126829|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
155126830|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
155126831|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
155126832|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
155126833|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
155126834|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
155126835|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
155126836|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
155126837|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
155126838|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
155126839|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
155126840|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
155126841|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
155126842|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
155126843|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
155126844|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
155126845|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
155126846|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Side effects|0|||
155178341|NCT00534313|560091446|FG002|Short-term Period|Participant withdrew consent|0|||
155178342|NCT00534313|560091447|FG003|Short-term Period|Participant withdrew consent|2|||
155126847|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Side effects|0|||
155126848|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Side effects|0|||
155126849|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Side effects|0|||
155126850|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Side effects|0|||
155178343|NCT00534313|560091444|FG000|Short-term Period|Pregnancy|0|||
155178344|NCT00534313|560091445|FG001|Short-term Period|Pregnancy|0|||
155126851|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Side effects|0|||
155126852|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Side effects|0|||
155126853|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Side effects|0|||
155126854|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Side effects|0|||
155126855|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Side effects|0|||
155126856|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Side effects|0|||
155126857|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Side effects|0|||
155126858|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Side effects|0|||
155126859|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Side effects|0|||
155126860|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Side effects|8|||
155126861|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126862|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126863|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126864|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126865|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126866|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126867|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126868|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126869|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126870|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126871|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126872|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126873|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126874|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
155126875|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
155126876|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
155126877|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
155126878|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
155126879|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
155126880|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
155126881|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
155126882|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
155126883|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
155126884|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
155126885|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
155126886|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
155126887|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
155126888|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
155126889|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
155126890|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
155126891|NCT00576472|559894970|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126892|NCT00576472|559894971|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126893|NCT00576472|559894972|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126894|NCT00576472|559894973|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126895|NCT00576472|559894974|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126896|NCT00576472|559894975|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126897|NCT00576472|559894976|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126898|NCT00576472|559894977|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126899|NCT00576472|559894978|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126900|NCT00576472|559894979|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126901|NCT00576472|559894980|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126902|NCT00576472|559894981|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126903|NCT00576472|559894982|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126904|NCT00576472|559894983|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
155126905|NCT00576472|559894984|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
155126906|NCT03443427|559894986|FG000|Overall Study|Adverse Event|2|||
155126907|NCT03443427|559894987|FG001|Overall Study|Adverse Event|3|||
155126908|NCT03443427|559894986|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
155126909|NCT03443427|559894987|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
155126910|NCT03443427|559894986|FG000|Overall Study|Other|4|||
155126911|NCT03443427|559894987|FG001|Overall Study|Other|6|||
155126912|NCT00780273|559894988|FG000|Overall Study|Death|1|||
155126913|NCT00780273|559894988|FG000|Overall Study|Lost to Follow-up|1|||
155126914|NCT02576860|559894989|FG000|Overall Study|Adverse Event|6|||
155126915|NCT02576860|559894990|FG001|Overall Study|Adverse Event|6|||
155126916|NCT02576860|559894989|FG000|Overall Study|Lost to Follow-up|5|||
155126917|NCT02576860|559894990|FG001|Overall Study|Lost to Follow-up|7|||
155126918|NCT02576860|559894989|FG000|Overall Study|Physician Decision|0|||
155126919|NCT02576860|559894990|FG001|Overall Study|Physician Decision|1|||
155126920|NCT02576860|559894989|FG000|Overall Study|Protocol Violation|0|||
155126921|NCT02576860|559894990|FG001|Overall Study|Protocol Violation|2|||
155126922|NCT02576860|559894989|FG000|Overall Study|Withdrawal by Subject|13|||
155126923|NCT02576860|559894990|FG001|Overall Study|Withdrawal by Subject|8|||
155005898|NCT02955212|559445338|FG000|Period 2: Open-label Extension|Adverse Event|11|||
155005899|NCT02955212|559445339|FG001|Period 2: Open-label Extension|Adverse Event|7|||
155005900|NCT02955212|559445338|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
155005901|NCT02955212|559445339|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
155005902|NCT02955212|559445338|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
155005903|NCT02955212|559445339|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
155005904|NCT02955212|559445338|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
155005905|NCT02955212|559445339|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
155005906|NCT02955212|559445338|FG000|Period 2: Open-label Extension|Other|2|||
155005907|NCT02955212|559445339|FG001|Period 2: Open-label Extension|Other|4|||
155005908|NCT02454933|559445342|FG000|Overall Study|Progressive disease|10|||
155005909|NCT02454933|559445343|FG001|Overall Study|Progressive disease|7|||
155005910|NCT02454933|559445342|FG000|Overall Study|Adverse Event|1|||
155005911|NCT02454933|559445343|FG001|Overall Study|Adverse Event|1|||
155005912|NCT02454933|559445342|FG000|Overall Study|Withdrawal by Subject|0|||
155005913|NCT02454933|559445343|FG001|Overall Study|Withdrawal by Subject|3|||
155005914|NCT02454933|559445342|FG000|Overall Study|Lost to Follow-up|1|||
155005915|NCT02454933|559445343|FG001|Overall Study|Lost to Follow-up|0|||
155005916|NCT02071225|559445351|FG000|Overall Study|Withdrawal of Consent|2|||
155005917|NCT02071225|559445351|FG000|Overall Study|Protocol Deviation|1|||
155005918|NCT02071225|559445351|FG000|Overall Study|Lost to Follow-up|2|||
155005919|NCT02071225|559445351|FG000|Overall Study|Death|25|||
155005920|NCT03762239|559445363|FG000|Overall Study|Appointment to the doctor|1|||
155005921|NCT03762239|559445364|FG001|Overall Study|Appointment to the doctor|1|||
155005922|NCT00535405|559445365|FG000|Overall Study|Adverse Event|6|||
155005923|NCT00535405|559445366|FG001|Overall Study|Adverse Event|8|||
155005924|NCT00535405|559445367|FG002|Overall Study|Adverse Event|3|||
155005925|NCT00535405|559445368|FG003|Overall Study|Adverse Event|8|||
155005926|NCT00535405|559445369|FG004|Overall Study|Adverse Event|6|||
155005927|NCT00535405|559445365|FG000|Overall Study|Lost to Follow-up|1|||
155005928|NCT00535405|559445366|FG001|Overall Study|Lost to Follow-up|3|||
155005929|NCT00535405|559445367|FG002|Overall Study|Lost to Follow-up|3|||
155005930|NCT00535405|559445368|FG003|Overall Study|Lost to Follow-up|2|||
155005931|NCT00535405|559445369|FG004|Overall Study|Lost to Follow-up|1|||
155005932|NCT00535405|559445365|FG000|Overall Study|Physician Decision|3|||
155005933|NCT00535405|559445366|FG001|Overall Study|Physician Decision|2|||
155005934|NCT00535405|559445367|FG002|Overall Study|Physician Decision|0|||
155005935|NCT00535405|559445368|FG003|Overall Study|Physician Decision|1|||
155005936|NCT00535405|559445369|FG004|Overall Study|Physician Decision|1|||
155005937|NCT00535405|559445365|FG000|Overall Study|Protocol Violation|2|||
155005938|NCT00535405|559445366|FG001|Overall Study|Protocol Violation|2|||
155005939|NCT00535405|559445367|FG002|Overall Study|Protocol Violation|2|||
155005940|NCT00535405|559445368|FG003|Overall Study|Protocol Violation|1|||
155005941|NCT00535405|559445369|FG004|Overall Study|Protocol Violation|0|||
155005942|NCT00535405|559445365|FG000|Overall Study|Withdrawal by Subject|5|||
155005943|NCT00535405|559445366|FG001|Overall Study|Withdrawal by Subject|11|||
155005944|NCT00535405|559445367|FG002|Overall Study|Withdrawal by Subject|10|||
155005945|NCT00535405|559445368|FG003|Overall Study|Withdrawal by Subject|10|||
155005946|NCT00535405|559445369|FG004|Overall Study|Withdrawal by Subject|8|||
155005947|NCT00104572|559445372|FG000|Overall Study|Withdrawal by Subject|3|||
155005948|NCT00104572|559445373|FG001|Overall Study|Withdrawal by Subject|3|||
155005949|NCT00104572|559445374|FG002|Overall Study|Withdrawal by Subject|0|||
155005950|NCT03910673|559445375|FG000|Overall Study|Adverse Event|0|||
155005951|NCT03910673|559445376|FG001|Overall Study|Adverse Event|0|||
155005952|NCT03910673|559445377|FG002|Overall Study|Adverse Event|0|||
155005953|NCT03910673|559445378|FG003|Overall Study|Adverse Event|2|||
155005954|NCT03910673|559445379|FG004|Overall Study|Adverse Event|0|||
155005955|NCT02290405|559445380|FG000|Overall Study|Withdrawal by Subject|1|||
155005956|NCT02290405|559445381|FG001|Overall Study|Withdrawal by Subject|0|||
155005957|NCT02016183|559445382|FG000|Overall Study|Case Report Forms Uncollected|13|||
155005958|NCT02016183|559445382|FG000|Overall Study|Protocol Violation|52|||
155005959|NCT03142191|559445383|FG000|Placebo Controlled Period|Death|0|||
155005960|NCT03142191|559445384|FG001|Placebo Controlled Period|Death|1|||
155005961|NCT03142191|559445385|FG002|Placebo Controlled Period|Death|1|||
155005962|NCT03142191|559445386|FG003|Placebo Controlled Period|Death|0|||
155005963|NCT03142191|559445387|FG004|Placebo Controlled Period|Death|0|||
155005964|NCT03142191|559445383|FG000|Placebo Controlled Period|Adverse Event|4|||
155005965|NCT03142191|559445384|FG001|Placebo Controlled Period|Adverse Event|5|||
155005966|NCT03142191|559445385|FG002|Placebo Controlled Period|Adverse Event|1|||
155005967|NCT03142191|559445386|FG003|Placebo Controlled Period|Adverse Event|0|||
155005968|NCT03142191|559445387|FG004|Placebo Controlled Period|Adverse Event|0|||
155005969|NCT03142191|559445383|FG000|Placebo Controlled Period|Progressive Disease|1|||
155005970|NCT03142191|559445384|FG001|Placebo Controlled Period|Progressive Disease|0|||
155005971|NCT03142191|559445385|FG002|Placebo Controlled Period|Progressive Disease|1|||
155005972|NCT03142191|559445386|FG003|Placebo Controlled Period|Progressive Disease|0|||
155005973|NCT03142191|559445387|FG004|Placebo Controlled Period|Progressive Disease|0|||
155005974|NCT03142191|559445383|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
155005975|NCT03142191|559445384|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
155005976|NCT03142191|559445385|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
155126924|NCT02576860|559894989|FG000|Overall Study|Disallowed medication|1|||
155126925|NCT02576860|559894990|FG001|Overall Study|Disallowed medication|0|||
155126926|NCT00477269|559894991|FG000|Core Study|Adverse Event|6|||
155126927|NCT00477269|559894992|FG001|Core Study|Adverse Event|4|||
155126928|NCT00477269|559894993|FG002|Core Study|Adverse Event|0|||
155126929|NCT00477269|559894991|FG000|Core Study|Death|3|||
155126930|NCT00477269|559894992|FG001|Core Study|Death|3|||
155126931|NCT00477269|559894993|FG002|Core Study|Death|0|||
155126932|NCT00477269|559894991|FG000|Core Study|Withdrawn Consent|0|||
155126933|NCT00477269|559894992|FG001|Core Study|Withdrawn Consent|1|||
155126934|NCT00477269|559894993|FG002|Core Study|Withdrawn Consent|0|||
155126935|NCT00477269|559894991|FG000|Open Label Extension|Adverse Event|0|||
155126936|NCT00477269|559894992|FG001|Open Label Extension|Adverse Event|0|||
155126937|NCT00477269|559894993|FG002|Open Label Extension|Adverse Event|4|||
155126938|NCT00477269|559894991|FG000|Open Label Extension|Abnormal laboratory values|0|||
155126939|NCT00477269|559894992|FG001|Open Label Extension|Abnormal laboratory values|0|||
155126940|NCT00477269|559894993|FG002|Open Label Extension|Abnormal laboratory values|1|||
155126941|NCT00477269|559894991|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
155126942|NCT00477269|559894992|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
155126943|NCT00477269|559894993|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
155126944|NCT00477269|559894991|FG000|Open Label Extension|Adminiatrative problems|0|||
155126945|NCT00477269|559894992|FG001|Open Label Extension|Adminiatrative problems|0|||
155126946|NCT00477269|559894993|FG002|Open Label Extension|Adminiatrative problems|2|||
155126947|NCT00477269|559894991|FG000|Open Label Extension|Death|0|||
155126948|NCT00477269|559894992|FG001|Open Label Extension|Death|0|||
155126949|NCT00477269|559894993|FG002|Open Label Extension|Death|4|||
155126950|NCT01792518|559894994|FG000|Overall Study|Adverse Event|3|||
155126951|NCT01792518|559894995|FG001|Overall Study|Adverse Event|4|||
155126952|NCT01792518|559894994|FG000|Overall Study|Protocol Violation|0|||
155126953|NCT01792518|559894995|FG001|Overall Study|Protocol Violation|1|||
155126954|NCT01792518|559894994|FG000|Overall Study|Lost to Follow-up|3|||
155126955|NCT01792518|559894995|FG001|Overall Study|Lost to Follow-up|1|||
155005977|NCT03142191|559445386|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
155005978|NCT03142191|559445387|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
155126956|NCT01792518|559894994|FG000|Overall Study|Withdrawal by Subject|2|||
155126957|NCT01792518|559894995|FG001|Overall Study|Withdrawal by Subject|0|||
155126958|NCT01792518|559894994|FG000|Overall Study|Other Reason|0|||
155126959|NCT01792518|559894995|FG001|Overall Study|Other Reason|1|||
155126960|NCT01378429|559895014|FG000|Overall Study|Noncompliance with study drug|1|||
155126961|NCT01378429|559895015|FG001|Overall Study|Noncompliance with study drug|0|||
155126962|NCT02356887|559895016|FG000|Overall Study|poor compliance|2|||
155126963|NCT04208087|559895017|FG000|Overall Study|Adverse Event|1|||
155126964|NCT04208087|559895018|FG001|Overall Study|Adverse Event|0|||
155126965|NCT04208087|559895019|FG002|Overall Study|Adverse Event|0|||
155126966|NCT04208087|559895020|FG003|Overall Study|Adverse Event|0|||
155126967|NCT04208087|559895021|FG004|Overall Study|Adverse Event|0|||
155126968|NCT04208087|559895017|FG000|Overall Study|Withdrawal by Subject|0|||
155126969|NCT04208087|559895018|FG001|Overall Study|Withdrawal by Subject|0|||
155126970|NCT04208087|559895019|FG002|Overall Study|Withdrawal by Subject|1|||
155126971|NCT04208087|559895020|FG003|Overall Study|Withdrawal by Subject|0|||
155126972|NCT04208087|559895021|FG004|Overall Study|Withdrawal by Subject|0|||
155126973|NCT04208087|559895017|FG000|Overall Study|Other|0|||
155126974|NCT04208087|559895018|FG001|Overall Study|Other|0|||
155126975|NCT04208087|559895019|FG002|Overall Study|Other|0|||
155126976|NCT04208087|559895020|FG003|Overall Study|Other|0|||
155005979|NCT03142191|559445383|FG000|Placebo Controlled Period|Other Reasons|1|||
155005980|NCT03142191|559445384|FG001|Placebo Controlled Period|Other Reasons|0|||
155126977|NCT04208087|559895021|FG004|Overall Study|Other|1|||
155126978|NCT01012323|559895022|FG000|Overall Study|Investigator Judgment|1|||
155126979|NCT00652951|559897189|FG000|Booster Phase|Adverse event, non-fatal|0|||
155178345|NCT00534313|560091446|FG002|Short-term Period|Pregnancy|1|||
155126980|NCT00652951|559897190|FG001|Booster Phase|Adverse event, non-fatal|1|||
155126981|NCT00652951|559897191|FG002|Booster Phase|Adverse event, non-fatal|0|||
155005981|NCT03142191|559445385|FG002|Placebo Controlled Period|Other Reasons|0|||
155126982|NCT00652951|559897189|FG000|Booster Phase|Other|1|||
155126983|NCT00652951|559897190|FG001|Booster Phase|Other|0|||
155126984|NCT00652951|559897191|FG002|Booster Phase|Other|0|||
155126985|NCT02593825|559897192|FG000|Intervention|Lost to Follow-up|10|||
155126986|NCT02593825|559897193|FG001|Intervention|Lost to Follow-up|12|||
155126987|NCT01022424|559897194|FG000|Overall Study|Adverse Event|1|||
155126988|NCT01022424|559897194|FG000|Overall Study|Physician Decision|1|||
155126989|NCT01022424|559897194|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
155126990|NCT06359080|559897195|FG000|Overall Study|Withdrawal by Subject|3|||
155126991|NCT00511134|559897196|FG000|Overall Study|Withdrawal by Subject|0|||
155126992|NCT00511134|559897197|FG001|Overall Study|Withdrawal by Subject|2|||
155178346|NCT00534313|560091447|FG003|Short-term Period|Pregnancy|0|||
155126993|NCT01949090|559897198|FG000|Overall Study|Serious Adverse Event|0|||
155126994|NCT01949090|559897199|FG001|Overall Study|Serious Adverse Event|1|||
155126995|NCT01949090|559897200|FG002|Overall Study|Serious Adverse Event|2|||
155126996|NCT01949090|559897201|FG003|Overall Study|Serious Adverse Event|0|||
155126997|NCT01949090|559897202|FG004|Overall Study|Serious Adverse Event|1|||
155126998|NCT01949090|559897198|FG000|Overall Study|Withdrawal by Subject|2|||
155126999|NCT01949090|559897199|FG001|Overall Study|Withdrawal by Subject|0|||
155127000|NCT01949090|559897200|FG002|Overall Study|Withdrawal by Subject|0|||
155127001|NCT01949090|559897201|FG003|Overall Study|Withdrawal by Subject|0|||
155127002|NCT01949090|559897202|FG004|Overall Study|Withdrawal by Subject|1|||
155127003|NCT01949090|559897198|FG000|Overall Study|Protocol non-compliance|0|||
155127004|NCT01949090|559897199|FG001|Overall Study|Protocol non-compliance|0|||
155127005|NCT01949090|559897200|FG002|Overall Study|Protocol non-compliance|0|||
155127006|NCT01949090|559897201|FG003|Overall Study|Protocol non-compliance|0|||
155127007|NCT01949090|559897202|FG004|Overall Study|Protocol non-compliance|1|||
155127008|NCT01949090|559897198|FG000|Overall Study|Lost to Follow-up|2|||
155127009|NCT01949090|559897199|FG001|Overall Study|Lost to Follow-up|1|||
155127010|NCT01949090|559897200|FG002|Overall Study|Lost to Follow-up|0|||
155127011|NCT01949090|559897201|FG003|Overall Study|Lost to Follow-up|1|||
155127012|NCT01949090|559897202|FG004|Overall Study|Lost to Follow-up|1|||
155127013|NCT03459365|559897203|FG000|Overall Study|Withdrawal by Subject|6|||
155127014|NCT03459365|559897203|FG000|Overall Study|Protocol Violation|8|||
155127015|NCT00599755|559897204|FG000|Overall Study|Adverse Event|11|||
155127016|NCT00599755|559897204|FG000|Overall Study|Withdrawal by Subject|2|||
155127017|NCT00599755|559897204|FG000|Overall Study|Progression of Disease|3|||
155127018|NCT00599755|559897204|FG000|Overall Study|Other Reason|2|||
155127019|NCT00599755|559897204|FG000|Overall Study|No data available|1|||
155127020|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
155127021|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
155127022|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
155127023|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
155127024|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
155127025|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
155127026|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
155127027|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
155127028|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
155127029|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
155127030|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
155127031|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
155127032|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
155127033|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
155127034|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
155127035|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
155127036|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
155127037|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
155127038|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
155127039|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
155127040|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
155127041|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
155127042|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
155127043|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
155127044|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
155127045|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
155127046|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
155127047|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
155127048|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
155127049|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
155127050|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
155127051|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
155127052|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
155127053|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
155127054|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
155127055|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
155127056|NCT02198794|559897205|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
155127057|NCT02198794|559897206|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
155127058|NCT02198794|559897207|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
155127059|NCT02198794|559897208|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
155127060|NCT02198794|559897205|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
155127061|NCT02198794|559897206|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
155127062|NCT02198794|559897207|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
155127063|NCT02198794|559897208|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
155127064|NCT02198794|559897205|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
155127065|NCT02198794|559897206|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
155127066|NCT02198794|559897207|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
155127067|NCT02198794|559897208|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
155127068|NCT02198794|559897205|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
155127069|NCT02198794|559897206|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
155127070|NCT02198794|559897207|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
155127071|NCT02198794|559897208|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
155127072|NCT02198794|559897205|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
155127073|NCT02198794|559897206|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
155127074|NCT02198794|559897207|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
155127075|NCT02198794|559897208|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
155127076|NCT02198794|559897205|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
155127077|NCT02198794|559897206|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
155127078|NCT02198794|559897207|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
155127079|NCT02198794|559897208|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
155127080|NCT01306656|559897209|FG000|Overall Study|Lost to Follow-up|1|||
155127081|NCT01306656|559897210|FG001|Overall Study|Lost to Follow-up|0|||
155127082|NCT01918332|559897214|FG000|Overall Study|Adverse Event|0|||
155127083|NCT01918332|559897215|FG001|Overall Study|Adverse Event|0|||
155127084|NCT01918332|559897216|FG002|Overall Study|Adverse Event|0|||
155127085|NCT01918332|559897217|FG003|Overall Study|Adverse Event|1|||
155127086|NCT01918332|559897214|FG000|Overall Study|Withdrawal by Subject|2|||
155127087|NCT01918332|559897215|FG001|Overall Study|Withdrawal by Subject|3|||
155127088|NCT01918332|559897216|FG002|Overall Study|Withdrawal by Subject|2|||
155127089|NCT01918332|559897217|FG003|Overall Study|Withdrawal by Subject|3|||
155127090|NCT01918332|559897214|FG000|Overall Study|Protocol Violation|6|||
155127091|NCT01918332|559897215|FG001|Overall Study|Protocol Violation|2|||
155127092|NCT01918332|559897216|FG002|Overall Study|Protocol Violation|6|||
155127093|NCT01918332|559897217|FG003|Overall Study|Protocol Violation|3|||
155127094|NCT01918332|559897214|FG000|Overall Study|lipid result by central lab did not meet|0|||
155127095|NCT01918332|559897215|FG001|Overall Study|lipid result by central lab did not meet|0|||
155127096|NCT01918332|559897216|FG002|Overall Study|lipid result by central lab did not meet|1|||
155127097|NCT01918332|559897217|FG003|Overall Study|lipid result by central lab did not meet|0|||
155127098|NCT04736628|559897218|FG000|Overall Study|Not treated|0|||
155127099|NCT04736628|559897219|FG001|Overall Study|Not treated|0|||
155127100|NCT04736628|559897220|FG002|Overall Study|Not treated|0|||
155127101|NCT04736628|559897221|FG003|Overall Study|Not treated|2|||
155127102|NCT04736628|559897218|FG000|Overall Study|Other reason than listed|1|||
155127103|NCT04736628|559897219|FG001|Overall Study|Other reason than listed|2|||
155127104|NCT04736628|559897220|FG002|Overall Study|Other reason than listed|2|||
155127105|NCT04736628|559897221|FG003|Overall Study|Other reason than listed|3|||
155127106|NCT04736628|559897218|FG000|Overall Study|Protocol deviation|0|||
155127107|NCT04736628|559897219|FG001|Overall Study|Protocol deviation|0|||
155127108|NCT04736628|559897220|FG002|Overall Study|Protocol deviation|0|||
155127109|NCT04736628|559897221|FG003|Overall Study|Protocol deviation|1|||
155127110|NCT04736628|559897218|FG000|Overall Study|Burden of study procedures|1|||
155127111|NCT04736628|559897219|FG001|Overall Study|Burden of study procedures|0|||
155127112|NCT04736628|559897220|FG002|Overall Study|Burden of study procedures|0|||
155127113|NCT04736628|559897221|FG003|Overall Study|Burden of study procedures|1|||
155127114|NCT04736628|559897218|FG000|Overall Study|Change of residence|0|||
155127115|NCT04736628|559897219|FG001|Overall Study|Change of residence|1|||
155127116|NCT04736628|559897220|FG002|Overall Study|Change of residence|0|||
155127117|NCT04736628|559897221|FG003|Overall Study|Change of residence|0|||
155127118|NCT04736628|559897218|FG000|Overall Study|Perceived lack of efficacy|1|||
155127119|NCT04736628|559897219|FG001|Overall Study|Perceived lack of efficacy|0|||
155127120|NCT04736628|559897220|FG002|Overall Study|Perceived lack of efficacy|0|||
155127121|NCT04736628|559897221|FG003|Overall Study|Perceived lack of efficacy|1|||
155127122|NCT04736628|559897218|FG000|Overall Study|Adverse Event|3|||
155127123|NCT04736628|559897219|FG001|Overall Study|Adverse Event|2|||
155127124|NCT04736628|559897220|FG002|Overall Study|Adverse Event|4|||
155127125|NCT04736628|559897221|FG003|Overall Study|Adverse Event|3|||
155127126|NCT02428205|559897222|FG000|Overall Study|Lack of Efficacy|1|||
155127127|NCT02428205|559897223|FG001|Overall Study|Lack of Efficacy|0|||
155127128|NCT02428205|559897222|FG000|Overall Study|Lost to Follow-up|1|||
155178347|NCT00534313|560091444|FG000|Long-term Period|Adverse Event|2|||
155127129|NCT02428205|559897223|FG001|Overall Study|Lost to Follow-up|1|||
155127130|NCT02428205|559897222|FG000|Overall Study|Worse behavior|0|||
155127131|NCT02428205|559897223|FG001|Overall Study|Worse behavior|1|||
155127132|NCT02888743|559897224|FG000|Overall Study|Withdrawal by Subject|1|||
155127133|NCT02888743|559897225|FG001|Overall Study|Withdrawal by Subject|2|||
155127134|NCT02888743|559897226|FG002|Overall Study|Withdrawal by Subject|2|||
155127135|NCT02888743|559897227|FG003|Overall Study|Withdrawal by Subject|0|||
155127136|NCT02888743|559897228|FG004|Overall Study|Withdrawal by Subject|1|||
155127137|NCT02888743|559897224|FG000|Overall Study|Disease progression before treatment|2|||
155127138|NCT02888743|559897225|FG001|Overall Study|Disease progression before treatment|0|||
155127139|NCT02888743|559897226|FG002|Overall Study|Disease progression before treatment|2|||
155127140|NCT02888743|559897227|FG003|Overall Study|Disease progression before treatment|0|||
155127141|NCT02888743|559897228|FG004|Overall Study|Disease progression before treatment|0|||
155127142|NCT02888743|559897224|FG000|Overall Study|Patient ineligible|1|||
155127143|NCT02888743|559897225|FG001|Overall Study|Patient ineligible|2|||
155127144|NCT02888743|559897226|FG002|Overall Study|Patient ineligible|0|||
155127145|NCT02888743|559897227|FG003|Overall Study|Patient ineligible|0|||
155127146|NCT02888743|559897228|FG004|Overall Study|Patient ineligible|0|||
155127147|NCT00680368|559897233|FG000|Overall Study|not supervised, not eligible|15|||
155127148|NCT00483041|559897236|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
155127149|NCT00483041|559897237|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
155127150|NCT04094584|559897241|FG000|Overall Study|No interest in study|88|||
155127151|NCT04094584|559897241|FG000|Overall Study|Unwilling to undergo screening tests|36|||
155127152|NCT04094584|559897241|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
155127153|NCT04094584|559897241|FG000|Overall Study|Opioid use|7|||
155127154|NCT04094584|559897241|FG000|Overall Study|Need for major surgery in study period|4|||
155127155|NCT04094584|559897241|FG000|Overall Study|eligible but declined enrollment|4|||
155127156|NCT04094584|559897241|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
155127157|NCT04094584|559897241|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
155127158|NCT04094584|559897241|FG000|Overall Study|Lost to Follow-up|3|||
155127159|NCT04094584|559897241|FG000|Overall Study|Withdrawal by Subject|2|||
155127160|NCT00316888|559897242|FG000|Overall Study|Adverse Event|4|||
155127161|NCT00316888|559897243|FG001|Overall Study|Adverse Event|5|||
155127162|NCT00316888|559897242|FG000|Overall Study|Withdrawal by Subject|2|||
155127163|NCT00316888|559897243|FG001|Overall Study|Withdrawal by Subject|2|||
155127164|NCT00316888|559897242|FG000|Overall Study|Not start protocol therapy|0|||
155127165|NCT00316888|559897243|FG001|Overall Study|Not start protocol therapy|1|||
155127166|NCT04047420|559897244|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
155127167|NCT04047420|559897244|FG000|Washout Period|Refused Participation|2|||
155127168|NCT03230292|559897247|FG000|Overall Study|Adverse Event|1|||
155127169|NCT03230292|559897247|FG000|Overall Study|Protocol Violation|1|||
155127170|NCT03230292|559897247|FG000|Overall Study|Lost to Follow-up|1|||
155127171|NCT03230292|559897247|FG000|Overall Study|Withdrawal by Subject|3|||
155127172|NCT02855944|559897248|FG000|Period 1: Treatment|Ongoing|14|||
155127173|NCT02855944|559897249|FG001|Period 1: Treatment|Ongoing|0|||
155127174|NCT02855944|559897248|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
155127175|NCT02855944|559897249|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
155127176|NCT02855944|559897248|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
155127177|NCT02855944|559897249|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
155127178|NCT03629912|559897255|FG000|Overall Study|Lost to Follow-up|19|||
155127179|NCT03629912|559897256|FG001|Overall Study|Lost to Follow-up|7|||
155127180|NCT03629912|559897257|FG002|Overall Study|Lost to Follow-up|5|||
155127181|NCT03629912|559897258|FG003|Overall Study|Lost to Follow-up|1|||
155127182|NCT03629912|559897255|FG000|Overall Study|Withdrawal by Subject|6|||
155127183|NCT03629912|559897256|FG001|Overall Study|Withdrawal by Subject|0|||
155127184|NCT03629912|559897257|FG002|Overall Study|Withdrawal by Subject|1|||
155127185|NCT03629912|559897258|FG003|Overall Study|Withdrawal by Subject|2|||
155127186|NCT03629912|559897255|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
155127187|NCT03629912|559897256|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
155127188|NCT03629912|559897257|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
155127189|NCT03629912|559897258|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
155127190|NCT03629912|559897255|FG000|Overall Study|Death|1|||
155127191|NCT03629912|559897256|FG001|Overall Study|Death|0|||
155127192|NCT03629912|559897257|FG002|Overall Study|Death|0|||
155127193|NCT03629912|559897258|FG003|Overall Study|Death|0|||
155127194|NCT02528357|559897261|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127195|NCT02528357|559897262|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
155127196|NCT02528357|559897263|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127197|NCT02528357|559897264|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127198|NCT02528357|559897265|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127199|NCT02528357|559897266|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127200|NCT02528357|559897267|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127201|NCT02528357|559897268|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127202|NCT02528357|559897269|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127203|NCT02528357|559897270|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127204|NCT02528357|559897271|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127205|NCT02528357|559897272|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127206|NCT02528357|559897273|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127207|NCT02528357|559897274|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127208|NCT02528357|559897275|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127209|NCT02528357|559897276|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127210|NCT02528357|559897277|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127211|NCT02528357|559897278|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127212|NCT02528357|559897279|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
155127213|NCT02528357|559897261|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127214|NCT02528357|559897262|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127215|NCT02528357|559897263|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127216|NCT02528357|559897264|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
155127217|NCT02528357|559897265|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127218|NCT02528357|559897266|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
155127219|NCT02528357|559897267|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127220|NCT02528357|559897268|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
155127221|NCT02528357|559897269|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127222|NCT02528357|559897270|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127223|NCT02528357|559897271|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127224|NCT02528357|559897272|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127225|NCT02528357|559897273|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127226|NCT02528357|559897274|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127227|NCT02528357|559897275|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127228|NCT02528357|559897276|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127229|NCT02528357|559897277|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127230|NCT02528357|559897278|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127231|NCT02528357|559897279|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
155127232|NCT02528357|559897261|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127233|NCT02528357|559897262|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127234|NCT02528357|559897263|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
155127235|NCT02528357|559897264|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127236|NCT02528357|559897265|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
155127237|NCT02528357|559897266|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127238|NCT02528357|559897267|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
155127239|NCT02528357|559897268|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
155127240|NCT02528357|559897269|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127241|NCT02528357|559897270|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127242|NCT02528357|559897271|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127243|NCT02528357|559897272|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127244|NCT02528357|559897273|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127245|NCT02528357|559897274|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127246|NCT02528357|559897275|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127247|NCT02528357|559897276|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127248|NCT02528357|559897277|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127249|NCT02528357|559897278|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127250|NCT02528357|559897279|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
155127251|NCT02528357|559897261|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127252|NCT02528357|559897262|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127253|NCT02528357|559897263|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127254|NCT02528357|559897264|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127255|NCT02528357|559897265|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155127256|NCT02528357|559897266|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127257|NCT02528357|559897267|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127258|NCT02528357|559897268|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127259|NCT02528357|559897269|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127260|NCT02528357|559897270|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127261|NCT02528357|559897271|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127262|NCT02528357|559897272|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127263|NCT02528357|559897273|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127264|NCT02528357|559897274|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127265|NCT02528357|559897275|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155005982|NCT03142191|559445386|FG003|Placebo Controlled Period|Other Reasons|0|||
155005983|NCT03142191|559445387|FG004|Placebo Controlled Period|Other Reasons|0|||
155005984|NCT03142191|559445383|FG000|Active Treatment Extension Period|Death|2|||
155005985|NCT03142191|559445384|FG001|Active Treatment Extension Period|Death|1|||
155005986|NCT03142191|559445385|FG002|Active Treatment Extension Period|Death|1|||
155005987|NCT03142191|559445386|FG003|Active Treatment Extension Period|Death|1|||
155005988|NCT03142191|559445387|FG004|Active Treatment Extension Period|Death|0|||
155005989|NCT03142191|559445383|FG000|Active Treatment Extension Period|Adverse Event|6|||
155005990|NCT03142191|559445384|FG001|Active Treatment Extension Period|Adverse Event|5|||
155005991|NCT03142191|559445385|FG002|Active Treatment Extension Period|Adverse Event|4|||
155005992|NCT03142191|559445386|FG003|Active Treatment Extension Period|Adverse Event|1|||
155005993|NCT03142191|559445387|FG004|Active Treatment Extension Period|Adverse Event|0|||
155005994|NCT03142191|559445383|FG000|Active Treatment Extension Period|Progressive Disease|10|||
155005995|NCT03142191|559445384|FG001|Active Treatment Extension Period|Progressive Disease|5|||
155005996|NCT03142191|559445385|FG002|Active Treatment Extension Period|Progressive Disease|4|||
155005997|NCT03142191|559445386|FG003|Active Treatment Extension Period|Progressive Disease|1|||
155005998|NCT03142191|559445387|FG004|Active Treatment Extension Period|Progressive Disease|2|||
155005999|NCT03142191|559445383|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
155006000|NCT03142191|559445384|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
155006001|NCT03142191|559445385|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
155006002|NCT03142191|559445386|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
155006003|NCT03142191|559445387|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
155006004|NCT03142191|559445383|FG000|Active Treatment Extension Period|Physician Decision|2|||
155006005|NCT03142191|559445384|FG001|Active Treatment Extension Period|Physician Decision|0|||
155006006|NCT03142191|559445385|FG002|Active Treatment Extension Period|Physician Decision|0|||
155006007|NCT03142191|559445386|FG003|Active Treatment Extension Period|Physician Decision|0|||
155006008|NCT03142191|559445387|FG004|Active Treatment Extension Period|Physician Decision|0|||
155006009|NCT03142191|559445383|FG000|Active Treatment Extension Period|Other Reasons|3|||
155006010|NCT03142191|559445384|FG001|Active Treatment Extension Period|Other Reasons|3|||
155006011|NCT03142191|559445385|FG002|Active Treatment Extension Period|Other Reasons|3|||
155006012|NCT03142191|559445386|FG003|Active Treatment Extension Period|Other Reasons|8|||
155006013|NCT03142191|559445387|FG004|Active Treatment Extension Period|Other Reasons|3|||
155006014|NCT03142191|559445383|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
155006015|NCT03142191|559445384|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
155006016|NCT03142191|559445385|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
155006017|NCT03142191|559445386|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
155006018|NCT03142191|559445387|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
155006019|NCT00770328|559445403|FG000|Overall Study|Adverse Event|11|||
155006020|NCT00770328|559445404|FG001|Overall Study|Adverse Event|2|||
155006021|NCT00770328|559445403|FG000|Overall Study|Lost to Follow-up|2|||
155006022|NCT00770328|559445404|FG001|Overall Study|Lost to Follow-up|2|||
155006023|NCT04650204|559445407|FG000|Overall Study|Study was Terminated|2|||
155006024|NCT04650204|559445408|FG001|Overall Study|Study was Terminated|1|||
155006025|NCT03164616|559445409|FG000|Overall Study|Death|250|||
155006026|NCT03164616|559445410|FG001|Overall Study|Death|264|||
155006027|NCT03164616|559445411|FG002|Overall Study|Death|279|||
155006028|NCT03164616|559445409|FG000|Overall Study|Lost to Follow-up|2|||
155006029|NCT03164616|559445410|FG001|Overall Study|Lost to Follow-up|2|||
155006030|NCT03164616|559445411|FG002|Overall Study|Lost to Follow-up|2|||
155006031|NCT03164616|559445409|FG000|Overall Study|Withdrawal by Subject|6|||
155006032|NCT03164616|559445410|FG001|Overall Study|Withdrawal by Subject|7|||
155006033|NCT03164616|559445411|FG002|Overall Study|Withdrawal by Subject|16|||
155127266|NCT02528357|559897276|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127267|NCT02528357|559897277|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127268|NCT02528357|559897278|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127269|NCT02528357|559897279|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127270|NCT02528357|559897261|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127271|NCT02528357|559897262|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127272|NCT02528357|559897263|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127273|NCT02528357|559897264|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127274|NCT02528357|559897265|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127275|NCT02528357|559897266|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127276|NCT02528357|559897267|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127277|NCT02528357|559897268|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127278|NCT02528357|559897269|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127279|NCT02528357|559897270|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127280|NCT02528357|559897271|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127281|NCT02528357|559897272|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127282|NCT02528357|559897273|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127283|NCT02528357|559897274|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
155127284|NCT02528357|559897275|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
155127285|NCT02528357|559897276|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127286|NCT02528357|559897277|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127287|NCT02528357|559897278|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127288|NCT02528357|559897279|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
155127289|NCT02528357|559897261|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127290|NCT02528357|559897262|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127291|NCT02528357|559897263|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127292|NCT02528357|559897264|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127293|NCT02528357|559897265|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127294|NCT02528357|559897266|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127295|NCT02528357|559897267|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127296|NCT02528357|559897268|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127297|NCT02528357|559897269|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127298|NCT02528357|559897270|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127299|NCT02528357|559897271|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127300|NCT02528357|559897272|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127301|NCT02528357|559897273|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127302|NCT02528357|559897274|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
155127303|NCT02528357|559897275|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127304|NCT02528357|559897276|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127305|NCT02528357|559897277|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127306|NCT02528357|559897278|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127307|NCT02528357|559897279|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
155127308|NCT02528357|559897261|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127309|NCT02528357|559897262|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127310|NCT02528357|559897263|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127311|NCT02528357|559897264|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127312|NCT02528357|559897265|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127313|NCT02528357|559897266|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127314|NCT02528357|559897267|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127315|NCT02528357|559897268|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127316|NCT02528357|559897269|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127317|NCT02528357|559897270|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127318|NCT02528357|559897271|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
155127319|NCT02528357|559897272|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127320|NCT02528357|559897273|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
155127321|NCT02528357|559897274|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
155127322|NCT02528357|559897275|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
155127323|NCT02528357|559897276|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127324|NCT02528357|559897277|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127325|NCT02528357|559897278|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127326|NCT02528357|559897279|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
155127327|NCT02528357|559897261|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127328|NCT02528357|559897262|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127329|NCT02528357|559897263|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127330|NCT02528357|559897264|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127331|NCT02528357|559897265|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127332|NCT02528357|559897266|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127333|NCT02528357|559897267|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
154923376|NCT00124709|559143801|FG001|Overall Study|Randomized but did not take medication|1|||
154923377|NCT00124709|559143800|FG000|Overall Study|Adverse Event|3|||
154923378|NCT00124709|559143801|FG001|Overall Study|Adverse Event|0|||
154923379|NCT00124709|559143800|FG000|Overall Study|Lack of Efficacy|5|||
154923380|NCT00124709|559143801|FG001|Overall Study|Lack of Efficacy|10|||
154923381|NCT00124709|559143800|FG000|Overall Study|Protocol Violation|3|||
154923382|NCT00124709|559143801|FG001|Overall Study|Protocol Violation|5|||
154923383|NCT00124709|559143800|FG000|Overall Study|Withdrawal by Subject|127|||
155006034|NCT04388553|559445412|FG000|Overall Study|Protocol Violation|1|||
155006035|NCT04388553|559445413|FG001|Overall Study|Protocol Violation|0|||
155006036|NCT04604795|559445414|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
155006037|NCT04604795|559445415|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
155006038|NCT04604795|559445416|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006039|NCT04604795|559445417|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006040|NCT04604795|559445418|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006041|NCT04604795|559445419|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006042|NCT04604795|559445420|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006043|NCT04604795|559445421|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006044|NCT04604795|559445422|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006045|NCT04604795|559445423|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
155006046|NCT04604795|559445414|FG000|Part B: Up to Day 14|Adverse Event|0|||
155006047|NCT04604795|559445415|FG001|Part B: Up to Day 14|Adverse Event|0|||
155006048|NCT04604795|559445416|FG002|Part B: Up to Day 14|Adverse Event|0|||
155006049|NCT04604795|559445417|FG003|Part B: Up to Day 14|Adverse Event|0|||
155006050|NCT04604795|559445418|FG004|Part B: Up to Day 14|Adverse Event|2|||
155006051|NCT04604795|559445419|FG005|Part B: Up to Day 14|Adverse Event|1|||
155006052|NCT04604795|559445420|FG006|Part B: Up to Day 14|Adverse Event|0|||
155006053|NCT04604795|559445421|FG007|Part B: Up to Day 14|Adverse Event|0|||
155006054|NCT04604795|559445422|FG008|Part B: Up to Day 14|Adverse Event|0|||
155006055|NCT04604795|559445423|FG009|Part B: Up to Day 14|Adverse Event|0|||
155006056|NCT04604795|559445414|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006057|NCT04604795|559445415|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006058|NCT04604795|559445416|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006059|NCT04604795|559445417|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006060|NCT04604795|559445418|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006061|NCT04604795|559445419|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006062|NCT04604795|559445420|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006063|NCT04604795|559445421|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006064|NCT04604795|559445422|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
155006065|NCT04604795|559445423|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
155006066|NCT04604795|559445414|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006067|NCT04604795|559445415|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006068|NCT04604795|559445416|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006069|NCT04604795|559445417|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006070|NCT04604795|559445418|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006071|NCT04604795|559445419|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006072|NCT04604795|559445420|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006073|NCT04604795|559445421|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006074|NCT04604795|559445422|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
155006075|NCT04604795|559445423|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
155006076|NCT04604795|559445414|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006077|NCT04604795|559445415|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006078|NCT04604795|559445416|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155178348|NCT00534313|560091445|FG001|Long-term Period|Adverse Event|1|||
155178349|NCT00534313|560091446|FG002|Long-term Period|Adverse Event|0|||
155178350|NCT00534313|560091447|FG003|Long-term Period|Adverse Event|1|||
155178351|NCT00534313|560091444|FG000|Long-term Period|Lack of Efficacy|14|||
155178352|NCT00534313|560091445|FG001|Long-term Period|Lack of Efficacy|10|||
155178353|NCT00534313|560091446|FG002|Long-term Period|Lack of Efficacy|14|||
155178354|NCT00534313|560091447|FG003|Long-term Period|Lack of Efficacy|12|||
155178355|NCT00534313|560091444|FG000|Long-term Period|Lost to Follow-up|1|||
155006079|NCT04604795|559445417|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006080|NCT04604795|559445418|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006081|NCT04604795|559445419|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006082|NCT04604795|559445420|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006083|NCT04604795|559445421|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006084|NCT04604795|559445422|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
155006085|NCT04604795|559445423|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
155006086|NCT04604795|559445414|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006087|NCT04604795|559445415|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006088|NCT04604795|559445416|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
155178356|NCT00534313|560091445|FG001|Long-term Period|Lost to Follow-up|2|||
155178357|NCT00534313|560091446|FG002|Long-term Period|Lost to Follow-up|0|||
155178358|NCT00534313|560091447|FG003|Long-term Period|Lost to Follow-up|0|||
155178359|NCT00534313|560091444|FG000|Long-term Period|Withdrawal by Subject|2|||
155178360|NCT00534313|560091445|FG001|Long-term Period|Withdrawal by Subject|2|||
154923384|NCT00124709|559143801|FG001|Overall Study|Withdrawal by Subject|136|||
154923385|NCT00124709|559143800|FG000|Overall Study|Lost to Follow-up|114|||
155127334|NCT02528357|559897268|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127335|NCT02528357|559897269|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155127336|NCT02528357|559897270|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155127337|NCT02528357|559897271|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127338|NCT02528357|559897272|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
155127339|NCT02528357|559897273|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
155127340|NCT02528357|559897274|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155127341|NCT02528357|559897275|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155127342|NCT02528357|559897276|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127343|NCT02528357|559897277|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127344|NCT02528357|559897278|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127345|NCT02528357|559897279|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127346|NCT02528357|559897261|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127347|NCT02528357|559897262|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127348|NCT02528357|559897263|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127349|NCT02528357|559897264|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127350|NCT02528357|559897265|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127351|NCT02528357|559897266|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127352|NCT02528357|559897267|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127353|NCT02528357|559897268|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127354|NCT02528357|559897269|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127355|NCT02528357|559897270|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127356|NCT02528357|559897271|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127357|NCT02528357|559897272|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127358|NCT02528357|559897273|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127359|NCT02528357|559897274|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127360|NCT02528357|559897275|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127361|NCT02528357|559897276|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127362|NCT02528357|559897277|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
155127363|NCT02528357|559897278|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127364|NCT02528357|559897279|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
155127365|NCT02528357|559897261|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127366|NCT02528357|559897262|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127367|NCT02528357|559897263|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127368|NCT02528357|559897264|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127369|NCT02528357|559897265|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
154923386|NCT00124709|559143801|FG001|Overall Study|Lost to Follow-up|120|||
154923387|NCT00122954|559143802|FG000|Overall Study|Withdrawal by Subject|2|||
154923388|NCT00122954|559143803|FG001|Overall Study|Withdrawal by Subject|2|||
154923389|NCT00122954|559143802|FG000|Overall Study|Protocol Violation|0|||
154923390|NCT00122954|559143803|FG001|Overall Study|Protocol Violation|1|||
154923391|NCT02856282|559143812|FG000|Overall Study|Withdrawal by Subject|1|||
154923392|NCT01491737|559143813|FG000|Overall Study|Withdrawal by Subject|20|||
154923393|NCT01491737|559143814|FG001|Overall Study|Withdrawal by Subject|17|||
154923394|NCT01491737|559143813|FG000|Overall Study|Lost to Follow-up|2|||
154923395|NCT01491737|559143814|FG001|Overall Study|Lost to Follow-up|10|||
154923396|NCT01491737|559143813|FG000|Overall Study|Death|63|||
154923397|NCT01491737|559143814|FG001|Overall Study|Death|57|||
154923398|NCT01491737|559143813|FG000|Overall Study|Study Termination by Sponsor|36|||
154923399|NCT01491737|559143814|FG001|Overall Study|Study Termination by Sponsor|36|||
154923400|NCT01491737|559143813|FG000|Overall Study|Reason Not Specified|8|||
154923401|NCT01491737|559143814|FG001|Overall Study|Reason Not Specified|9|||
154923402|NCT02506101|559143821|FG000|Overall Study|Transportation issues|1|||
154923403|NCT02506101|559143822|FG001|Overall Study|Transportation issues|0|||
154923404|NCT02506101|559143821|FG000|Overall Study|No enrollment and staff unavailability|1|||
154923405|NCT02506101|559143822|FG001|Overall Study|No enrollment and staff unavailability|0|||
154923406|NCT01308476|559143823|FG000|Overall Study|Lost to Follow-up|2|||
154923407|NCT01308476|559143824|FG001|Overall Study|Lost to Follow-up|2|||
154923408|NCT01308476|559143823|FG000|Overall Study|Other|1|||
154923409|NCT01308476|559143824|FG001|Overall Study|Other|0|||
155006089|NCT04604795|559445417|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006090|NCT04604795|559445418|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006091|NCT04604795|559445419|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006092|NCT04604795|559445420|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006093|NCT04604795|559445421|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006094|NCT04604795|559445422|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
155006095|NCT04604795|559445423|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
155006096|NCT01260701|559445432|FG000|Overall Study|Adverse Event|9|||
155178361|NCT00534313|560091446|FG002|Long-term Period|Withdrawal by Subject|0|||
155178362|NCT00534313|560091447|FG003|Long-term Period|Withdrawal by Subject|0|||
155178363|NCT00534313|560091444|FG000|Long-term Period|No longer meets study criteria|0|||
155178364|NCT00534313|560091445|FG001|Long-term Period|No longer meets study criteria|1|||
155178365|NCT00534313|560091446|FG002|Long-term Period|No longer meets study criteria|0|||
155178366|NCT00534313|560091447|FG003|Long-term Period|No longer meets study criteria|0|||
155178367|NCT00534313|560091444|FG000|Long-term Period|Poor compliance/noncompliance|0|||
155006097|NCT01260701|559445432|FG000|Overall Study|Withdrawal by Subject|2|||
155006098|NCT01260701|559445432|FG000|Overall Study|Progression|53|||
155006099|NCT01260701|559445432|FG000|Overall Study|Death|2|||
155006100|NCT01260701|559445432|FG000|Overall Study|Not protocol specified|3|||
155006101|NCT01260701|559445432|FG000|Overall Study|Under review|1|||
155006102|NCT01260701|559445432|FG000|Overall Study|Ineligible|4|||
155006103|NCT01260701|559445432|FG000|Overall Study|Did not begin protocol therapy|1|||
155006104|NCT03300817|559446967|FG000|Overall Study|Withdrawal by Subject|1|||
155006105|NCT03300817|559446967|FG000|Overall Study|Adverse Event|1|||
155006106|NCT03300817|559446967|FG000|Overall Study|Subject Found to be Ineligible|2|||
155006107|NCT03729596|559446969|FG000|Overall Study|Death|3|||
155006108|NCT03729596|559446970|FG001|Overall Study|Death|5|||
155006109|NCT03729596|559446971|FG002|Overall Study|Death|4|||
155006110|NCT03729596|559446972|FG003|Overall Study|Death|1|||
155006111|NCT03729596|559446973|FG004|Overall Study|Death|0|||
155006112|NCT03729596|559446974|FG005|Overall Study|Death|34|||
155006113|NCT03729596|559446975|FG006|Overall Study|Death|18|||
155006114|NCT03729596|559446976|FG007|Overall Study|Death|14|||
155006115|NCT03729596|559446977|FG008|Overall Study|Death|19|||
155006116|NCT03729596|559446978|FG009|Overall Study|Death|9|||
155006117|NCT03729596|559446969|FG000|Overall Study|Lost to Follow-up|0|||
155006118|NCT03729596|559446970|FG001|Overall Study|Lost to Follow-up|0|||
155006119|NCT03729596|559446971|FG002|Overall Study|Lost to Follow-up|0|||
155006120|NCT03729596|559446972|FG003|Overall Study|Lost to Follow-up|0|||
155006121|NCT03729596|559446973|FG004|Overall Study|Lost to Follow-up|0|||
155006122|NCT03729596|559446974|FG005|Overall Study|Lost to Follow-up|0|||
155006123|NCT03729596|559446975|FG006|Overall Study|Lost to Follow-up|1|||
155006124|NCT03729596|559446976|FG007|Overall Study|Lost to Follow-up|0|||
155006125|NCT03729596|559446977|FG008|Overall Study|Lost to Follow-up|0|||
155178368|NCT00534313|560091445|FG001|Long-term Period|Poor compliance/noncompliance|1|||
155178369|NCT00534313|560091446|FG002|Long-term Period|Poor compliance/noncompliance|1|||
155006126|NCT03729596|559446978|FG009|Overall Study|Lost to Follow-up|1|||
155006127|NCT03729596|559446969|FG000|Overall Study|protocol amendment|0|||
155006128|NCT03729596|559446970|FG001|Overall Study|protocol amendment|1|||
155006129|NCT03729596|559446971|FG002|Overall Study|protocol amendment|3|||
155006130|NCT03729596|559446972|FG003|Overall Study|protocol amendment|6|||
155006131|NCT03729596|559446973|FG004|Overall Study|protocol amendment|5|||
155006132|NCT03729596|559446974|FG005|Overall Study|protocol amendment|0|||
155006133|NCT03729596|559446975|FG006|Overall Study|protocol amendment|0|||
155006134|NCT03729596|559446976|FG007|Overall Study|protocol amendment|0|||
155006135|NCT03729596|559446977|FG008|Overall Study|protocol amendment|0|||
155006136|NCT03729596|559446978|FG009|Overall Study|protocol amendment|0|||
155006137|NCT03729596|559446969|FG000|Overall Study|Withdrawal by Subject|0|||
155006138|NCT03729596|559446970|FG001|Overall Study|Withdrawal by Subject|0|||
155006139|NCT03729596|559446971|FG002|Overall Study|Withdrawal by Subject|0|||
155006140|NCT03729596|559446972|FG003|Overall Study|Withdrawal by Subject|0|||
155006141|NCT03729596|559446973|FG004|Overall Study|Withdrawal by Subject|0|||
155006142|NCT03729596|559446974|FG005|Overall Study|Withdrawal by Subject|4|||
155006143|NCT03729596|559446975|FG006|Overall Study|Withdrawal by Subject|2|||
155006144|NCT03729596|559446976|FG007|Overall Study|Withdrawal by Subject|3|||
155006145|NCT03729596|559446977|FG008|Overall Study|Withdrawal by Subject|2|||
155006146|NCT03729596|559446978|FG009|Overall Study|Withdrawal by Subject|3|||
155006147|NCT03729596|559446969|FG000|Overall Study|study terminated by sponsor|0|||
155006148|NCT03729596|559446970|FG001|Overall Study|study terminated by sponsor|0|||
155006149|NCT03729596|559446971|FG002|Overall Study|study terminated by sponsor|0|||
155006150|NCT03729596|559446972|FG003|Overall Study|study terminated by sponsor|0|||
155006151|NCT03729596|559446973|FG004|Overall Study|study terminated by sponsor|1|||
155006152|NCT03729596|559446974|FG005|Overall Study|study terminated by sponsor|3|||
155006153|NCT03729596|559446975|FG006|Overall Study|study terminated by sponsor|0|||
155006154|NCT03729596|559446976|FG007|Overall Study|study terminated by sponsor|1|||
155006155|NCT03729596|559446977|FG008|Overall Study|study terminated by sponsor|0|||
155006156|NCT03729596|559446978|FG009|Overall Study|study terminated by sponsor|0|||
155006157|NCT04011722|559446979|FG000|30 Days|Death|5|||
155127370|NCT02528357|559897266|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127371|NCT02528357|559897267|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127372|NCT02528357|559897268|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127373|NCT02528357|559897269|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127374|NCT02528357|559897270|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127375|NCT02528357|559897271|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127376|NCT02528357|559897272|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127377|NCT02528357|559897273|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127378|NCT02528357|559897274|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127379|NCT02528357|559897275|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127380|NCT02528357|559897276|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
155127381|NCT02528357|559897277|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
155127382|NCT02528357|559897278|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
155127383|NCT02528357|559897279|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
155127384|NCT02241187|559897283|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
155127385|NCT02966015|559897284|FG000|Inclusion Visit|did not answer questionnaire|8|||
155127386|NCT02966015|559897285|FG001|Inclusion Visit|did not answer questionnaire|3|||
155127387|NCT00199888|559897286|FG000|Overall Study|Lost to Follow-up|1|||
155127388|NCT01198509|559897287|FG000|Overall Study|Withdrawal by Subject|1|||
155127389|NCT01198509|559897288|FG001|Overall Study|Withdrawal by Subject|0|||
155127390|NCT01198509|559897289|FG002|Overall Study|Withdrawal by Subject|0|||
155127391|NCT01198509|559897290|FG003|Overall Study|Withdrawal by Subject|0|||
155127392|NCT01198509|559897291|FG004|Overall Study|Withdrawal by Subject|0|||
155127393|NCT01198509|559897292|FG005|Overall Study|Withdrawal by Subject|0|||
155127394|NCT00330668|559897293|FG000|BID Dosing Period|Adverse Event|1|||
155127395|NCT00330668|559897293|FG000|BID Dosing Period|Lost to Follow-up|7|||
155127396|NCT00330668|559897293|FG000|BID Dosing Period|Non-Compliance|5|||
155127397|NCT00330668|559897293|FG000|BID Dosing Period|Withdrawal by Subject|19|||
155127398|NCT00330668|559897293|FG000|BID Dosing Period|Sponsor's decision|1|||
155127399|NCT00330668|559897293|FG000|BID Dosing Period|Other|3|||
155127400|NCT00330668|559897293|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
155127401|NCT00330668|559897293|FG000|QD Dosing Period|Other|1|||
155127402|NCT00330668|559897293|FG000|QD Dosing Period|Withdrawal by Subject|1|||
155127403|NCT00330668|559897293|FG000|QD Dosing Period|Lost to Follow-up|2|||
155127404|NCT01595581|559897294|FG000|Overall Study|Withdrawal by Subject|1|||
155127405|NCT01595581|559897295|FG001|Overall Study|Withdrawal by Subject|0|||
155127406|NCT02621073|559897301|FG000|Overall Study|Lost to Follow-up|0|||
155127407|NCT02621073|559897302|FG001|Overall Study|Lost to Follow-up|1|||
155127408|NCT02621073|559897301|FG000|Overall Study|Physician Decision|3|||
155127409|NCT02621073|559897302|FG001|Overall Study|Physician Decision|2|||
155127410|NCT01969721|559897314|FG000|Overall Study|Adverse Event|3|||
155127411|NCT01969721|559897315|FG001|Overall Study|Adverse Event|8|||
155127412|NCT01969721|559897316|FG002|Overall Study|Adverse Event|3|||
155127413|NCT01969721|559897317|FG003|Overall Study|Adverse Event|2|||
155127414|NCT01969721|559897314|FG000|Overall Study|Lack of Efficacy|0|||
155127415|NCT01969721|559897315|FG001|Overall Study|Lack of Efficacy|0|||
155127416|NCT01969721|559897316|FG002|Overall Study|Lack of Efficacy|1|||
155127417|NCT01969721|559897317|FG003|Overall Study|Lack of Efficacy|0|||
155127418|NCT01969721|559897314|FG000|Overall Study|Non compliant with protocol|1|||
155127419|NCT01969721|559897315|FG001|Overall Study|Non compliant with protocol|1|||
155127420|NCT01969721|559897316|FG002|Overall Study|Non compliant with protocol|0|||
155127421|NCT01969721|559897317|FG003|Overall Study|Non compliant with protocol|2|||
155127422|NCT01969721|559897314|FG000|Overall Study|Other not defined above|0|||
155127423|NCT01969721|559897315|FG001|Overall Study|Other not defined above|2|||
155127424|NCT01969721|559897316|FG002|Overall Study|Other not defined above|0|||
155127425|NCT01969721|559897317|FG003|Overall Study|Other not defined above|0|||
155127426|NCT01969721|559897314|FG000|Overall Study|Discontinued during washout periods.|0|||
155127427|NCT01969721|559897315|FG001|Overall Study|Discontinued during washout periods.|1|||
155127428|NCT01969721|559897316|FG002|Overall Study|Discontinued during washout periods.|1|||
155127429|NCT01969721|559897317|FG003|Overall Study|Discontinued during washout periods.|2|||
155127430|NCT00495755|559897319|FG000|Overall Study|Adverse Event|3|||
155127431|NCT02273960|559897320|FG000|Short Term Period|Lost to Follow-up|1|||
155127432|NCT02273960|559897321|FG001|Short Term Period|Lost to Follow-up|0|||
155006158|NCT04011722|559446980|FG001|30 Days|Death|1|||
155127433|NCT02273960|559897322|FG002|Short Term Period|Lost to Follow-up|0|||
155127434|NCT02273960|559897323|FG003|Short Term Period|Lost to Follow-up|0|||
155127435|NCT02273960|559897320|FG000|Short Term Period|Lack of Efficacy|0|||
155127436|NCT02273960|559897321|FG001|Short Term Period|Lack of Efficacy|0|||
155127437|NCT02273960|559897322|FG002|Short Term Period|Lack of Efficacy|0|||
155006159|NCT04011722|559446979|FG000|1 Year|Death|13|||
155006160|NCT04011722|559446980|FG001|1 Year|Death|5|||
155006161|NCT04011722|559446979|FG000|1 Year|Withdrawal by Subject|8|||
155006162|NCT04011722|559446980|FG001|1 Year|Withdrawal by Subject|2|||
155006163|NCT04011722|559446979|FG000|1 Year|Missed Visit|6|||
155006164|NCT04011722|559446980|FG001|1 Year|Missed Visit|1|||
155006165|NCT04011722|559446979|FG000|1 Year|Pending Visit|0|||
155006166|NCT04011722|559446980|FG001|1 Year|Pending Visit|11|||
155006167|NCT04011722|559446979|FG000|1 Year|Not Yet Due|0|||
155006168|NCT04011722|559446980|FG001|1 Year|Not Yet Due|9|||
155006169|NCT04011722|559446979|FG000|2 Year|Death|16|||
155006170|NCT04011722|559446980|FG001|2 Year|Death|1|||
155006171|NCT04011722|559446979|FG000|2 Year|Withdrawal by Subject|10|||
155006172|NCT04011722|559446980|FG001|2 Year|Withdrawal by Subject|1|||
155006173|NCT04011722|559446979|FG000|2 Year|Missed Visit|9|||
155006174|NCT04011722|559446980|FG001|2 Year|Missed Visit|0|||
155006175|NCT04011722|559446979|FG000|2 Year|Visit Pending|1|||
155006176|NCT04011722|559446980|FG001|2 Year|Visit Pending|3|||
155006177|NCT04011722|559446979|FG000|2 Year|Not Yet Due|43|||
155006178|NCT04011722|559446980|FG001|2 Year|Not Yet Due|54|||
155006179|NCT04011722|559446979|FG000|3 Year|Death|10|||
155006180|NCT04011722|559446980|FG001|3 Year|Death|0|||
155006181|NCT04011722|559446979|FG000|3 Year|Withdrawal by Subject|2|||
155006182|NCT04011722|559446980|FG001|3 Year|Withdrawal by Subject|0|||
155006183|NCT04011722|559446979|FG000|3 Year|Missed Visit|2|||
155006184|NCT04011722|559446980|FG001|3 Year|Missed Visit|0|||
155006185|NCT04011722|559446979|FG000|3 Year|Pending Visit|34|||
155006186|NCT04011722|559446980|FG001|3 Year|Pending Visit|0|||
155006187|NCT04011722|559446979|FG000|3 Year|Not Yet Due|99|||
155006188|NCT04011722|559446980|FG001|3 Year|Not Yet Due|0|||
155006189|NCT00001521|559446981|FG000|Overall Study|Withdrawal by Subject|3|||
155006190|NCT00001521|559446982|FG001|Overall Study|Withdrawal by Subject|3|||
155006191|NCT00001521|559446981|FG000|Overall Study|Physician Decision|1|||
155006192|NCT00001521|559446982|FG001|Overall Study|Physician Decision|1|||
155006193|NCT00001521|559446981|FG000|Overall Study|Noncompliant|6|||
155006194|NCT00001521|559446982|FG001|Overall Study|Noncompliant|3|||
155006195|NCT00266630|559446983|FG000|Overall Study|Adverse Event|8|||
155006196|NCT00266630|559446984|FG001|Overall Study|Adverse Event|6|||
155006197|NCT00266630|559446983|FG000|Overall Study|Lack of Efficacy|1|||
155006198|NCT00266630|559446984|FG001|Overall Study|Lack of Efficacy|4|||
155006199|NCT00266630|559446983|FG000|Overall Study|Entry Criteria not met|1|||
155006200|NCT00266630|559446984|FG001|Overall Study|Entry Criteria not met|0|||
155006201|NCT00266630|559446983|FG000|Overall Study|Protocol Violation|1|||
155006202|NCT00266630|559446984|FG001|Overall Study|Protocol Violation|3|||
155006203|NCT00266630|559446983|FG000|Overall Study|Physician Decision|1|||
155006204|NCT00266630|559446984|FG001|Overall Study|Physician Decision|2|||
155006205|NCT00266630|559446983|FG000|Overall Study|Withdrawal by Subject|10|||
155006206|NCT00266630|559446984|FG001|Overall Study|Withdrawal by Subject|2|||
155006207|NCT00266630|559446983|FG000|Overall Study|Lost to Follow-up|1|||
155006208|NCT00266630|559446984|FG001|Overall Study|Lost to Follow-up|0|||
155006209|NCT00266630|559446983|FG000|Overall Study|Other|19|||
155006210|NCT00266630|559446984|FG001|Overall Study|Other|11|||
155006211|NCT01499095|559446985|FG000|Overall Study|Randomized But Not Treated|1|||
155127438|NCT02273960|559897323|FG003|Short Term Period|Lack of Efficacy|1|||
155127439|NCT02273960|559897320|FG000|Short Term Period|ST complete, not entering LTE|4|||
155127440|NCT02273960|559897321|FG001|Short Term Period|ST complete, not entering LTE|6|||
155127441|NCT02273960|559897322|FG002|Short Term Period|ST complete, not entering LTE|4|||
155127442|NCT02273960|559897323|FG003|Short Term Period|ST complete, not entering LTE|5|||
155127443|NCT02273960|559897320|FG000|Long Term Extension|Death|0|||
155127444|NCT02273960|559897321|FG001|Long Term Extension|Death|0|||
155127445|NCT02273960|559897322|FG002|Long Term Extension|Death|0|||
155127446|NCT02273960|559897323|FG003|Long Term Extension|Death|1|||
155127447|NCT02920957|559897324|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
155127448|NCT02920957|559897325|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
155127449|NCT02920957|559897324|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
155127450|NCT02920957|559897325|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
155127451|NCT02920957|559897324|FG000|First Intervention : 1 Month|Adverse Event|1|||
155127452|NCT02920957|559897325|FG001|First Intervention : 1 Month|Adverse Event|0|||
155006212|NCT01499095|559446986|FG001|Overall Study|Randomized But Not Treated|1|||
155006213|NCT01499095|559446985|FG000|Overall Study|Adverse Event|12|||
155006214|NCT01499095|559446986|FG001|Overall Study|Adverse Event|7|||
155006215|NCT01499095|559446985|FG000|Overall Study|Lack of Efficacy|2|||
155006216|NCT01499095|559446986|FG001|Overall Study|Lack of Efficacy|1|||
155006217|NCT01499095|559446985|FG000|Overall Study|Protocol Violation|6|||
155006218|NCT01499095|559446986|FG001|Overall Study|Protocol Violation|7|||
155006219|NCT01499095|559446985|FG000|Overall Study|Received Rescue Therapy|32|||
155006220|NCT01499095|559446986|FG001|Overall Study|Received Rescue Therapy|40|||
155006221|NCT01499095|559446985|FG000|Overall Study|Diverse Reasons|22|||
155006222|NCT01499095|559446986|FG001|Overall Study|Diverse Reasons|25|||
155006223|NCT01499095|559446985|FG000|Overall Study|Lost to Follow-up|6|||
155006224|NCT01499095|559446986|FG001|Overall Study|Lost to Follow-up|4|||
155127453|NCT02920957|559897324|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
155127454|NCT02920957|559897325|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
155127455|NCT01789606|559897326|FG000|Overall Study|Participant not Purchased the Product|0|||
155127456|NCT01789606|559897327|FG001|Overall Study|Participant not Purchased the Product|20|||
155127457|NCT01789606|559897326|FG000|Overall Study|Withdrawal by Subject|0|||
155127458|NCT01789606|559897327|FG001|Overall Study|Withdrawal by Subject|1|||
155127459|NCT01789606|559897326|FG000|Overall Study|Ineligible|6|||
155127460|NCT01789606|559897327|FG001|Overall Study|Ineligible|2|||
155127461|NCT01789606|559897326|FG000|Overall Study|Administrative Reasons|17|||
155127462|NCT01789606|559897327|FG001|Overall Study|Administrative Reasons|6|||
155127463|NCT01789606|559897326|FG000|Overall Study|No Study Medication Taken|0|||
155127464|NCT01789606|559897327|FG001|Overall Study|No Study Medication Taken|1|||
155127465|NCT01789606|559897326|FG000|Overall Study|Protocol Violation|0|||
155127466|NCT01789606|559897327|FG001|Overall Study|Protocol Violation|55|||
155127467|NCT01789606|559897326|FG000|Overall Study|Adverse Event|0|||
155127468|NCT01789606|559897327|FG001|Overall Study|Adverse Event|3|||
155127469|NCT01789606|559897326|FG000|Overall Study|Lost to Follow-up|0|||
155127470|NCT01789606|559897327|FG001|Overall Study|Lost to Follow-up|14|||
155127471|NCT01789606|559897326|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
155127472|NCT01789606|559897327|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
155127473|NCT03180307|559897330|FG000|Overall Study|Lost to Follow-up|2|||
155127474|NCT03180307|559897331|FG001|Overall Study|Lost to Follow-up|0|||
155127475|NCT03180307|559897330|FG000|Overall Study|Death|1|||
155127476|NCT03180307|559897331|FG001|Overall Study|Death|0|||
155127477|NCT03180307|559897330|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
155127478|NCT03180307|559897331|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
155127479|NCT01563172|559897337|FG000|Overall Study|Adverse Event|5|||
155127480|NCT01563172|559897337|FG000|Overall Study|Lost to Follow-up|2|||
155127481|NCT01563172|559897337|FG000|Overall Study|Other (Protocol deviation)|5|||
155127482|NCT01563172|559897337|FG000|Overall Study|Other (Not specified)|1|||
155127483|NCT01105377|559897340|FG000|Overall Study|Withdrawal by Subject|0|||
155127484|NCT01105377|559897341|FG001|Overall Study|Withdrawal by Subject|1|||
155127485|NCT01638559|559897343|FG000|Overall Study|Lost to Follow-up|1|||
155127486|NCT01638559|559897343|FG000|Overall Study|Withdrawal by Subject|1|||
155127487|NCT01638559|559897343|FG000|Overall Study|Subject declined to travel for biopsy|1|||
155127488|NCT02014584|559897347|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155127489|NCT02014584|559897348|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
155127490|NCT02014584|559897349|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155127491|NCT02014584|559897350|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155127492|NCT02014584|559897351|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155127493|NCT02014584|559897352|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
155127494|NCT02014584|559897347|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
155127495|NCT02014584|559897348|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
155127496|NCT02014584|559897349|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155127497|NCT02014584|559897350|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155127498|NCT02014584|559897351|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155127499|NCT02014584|559897352|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
155127500|NCT02014584|559897347|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155127501|NCT02014584|559897348|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155127502|NCT02014584|559897349|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
155127503|NCT02014584|559897350|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155127504|NCT02014584|559897351|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155127505|NCT02014584|559897352|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
155127506|NCT02014584|559897347|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155127507|NCT02014584|559897348|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155127508|NCT02014584|559897349|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
155127509|NCT02014584|559897350|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
155127510|NCT02014584|559897351|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155127511|NCT02014584|559897352|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
155127512|NCT02014584|559897347|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155127513|NCT02014584|559897348|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155127514|NCT02014584|559897349|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155127515|NCT02014584|559897350|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155127516|NCT02014584|559897351|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
155127517|NCT02014584|559897352|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
155127518|NCT00483002|559897353|FG000|Overall Study|Adverse Event|68|||
155127519|NCT00483002|559897353|FG000|Overall Study|Lack of Efficacy|555|||
155127520|NCT00483002|559897353|FG000|Overall Study|Lost to Follow-up|962|||
155006225|NCT01499095|559446985|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
155127521|NCT00483002|559897353|FG000|Overall Study|Other|2|||
155006226|NCT01499095|559446986|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
155006227|NCT01499095|559446985|FG000|Overall Study|Hypoglycemia|3|||
155006228|NCT01499095|559446986|FG001|Overall Study|Hypoglycemia|1|||
155006229|NCT01499095|559446985|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
155006230|NCT01499095|559446986|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
155006231|NCT01499095|559446985|FG000|Overall Study|Change in Injection Schedule|2|||
155006232|NCT01499095|559446986|FG001|Overall Study|Change in Injection Schedule|0|||
155006233|NCT01499095|559446985|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155006234|NCT01499095|559446986|FG001|Overall Study|Perceived Lack of Efficacy|1|||
155006235|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
155006236|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
155006237|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
155006238|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
155006239|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
155006240|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
155006241|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
155006242|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
155006243|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
155006244|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
155006245|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
155006246|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
155006247|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
155006248|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
155006249|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
155006250|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
155006251|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
155006252|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
155006253|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
155006254|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
155006255|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
155006256|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
155006257|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
155006258|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
155006259|NCT01130532|559446987|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
155006260|NCT01130532|559446988|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
155006261|NCT01130532|559446989|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
155006262|NCT01130532|559446990|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
155006263|NCT01130532|559446987|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
155006264|NCT01130532|559446988|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
155006265|NCT01130532|559446989|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
155006266|NCT01130532|559446990|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
155006267|NCT01130532|559446987|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
155006268|NCT01130532|559446988|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
155006269|NCT01130532|559446989|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
155006270|NCT01130532|559446990|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
155006271|NCT01130532|559446987|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
155006272|NCT01130532|559446988|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
155006273|NCT01130532|559446989|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
155006274|NCT01130532|559446990|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
155006275|NCT01130532|559446987|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
155006276|NCT01130532|559446988|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
155006277|NCT01130532|559446989|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
155006278|NCT01130532|559446990|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
155006279|NCT02762929|559446991|FG000|Overall Study|Adverse Event|0|||
155006280|NCT02762929|559446992|FG001|Overall Study|Adverse Event|0|||
155006281|NCT02762929|559446993|FG002|Overall Study|Adverse Event|0|||
155006282|NCT02762929|559446994|FG003|Overall Study|Adverse Event|1|||
155006283|NCT02762929|559446995|FG004|Overall Study|Adverse Event|0|||
155006284|NCT02762929|559446996|FG005|Overall Study|Adverse Event|0|||
155006285|NCT02762929|559446991|FG000|Overall Study|Lost to Follow-up|1|||
155006286|NCT02762929|559446992|FG001|Overall Study|Lost to Follow-up|2|||
155006287|NCT02762929|559446993|FG002|Overall Study|Lost to Follow-up|0|||
155006288|NCT02762929|559446994|FG003|Overall Study|Lost to Follow-up|1|||
155006289|NCT02762929|559446995|FG004|Overall Study|Lost to Follow-up|0|||
155006290|NCT02762929|559446996|FG005|Overall Study|Lost to Follow-up|0|||
155006291|NCT02762929|559446991|FG000|Overall Study|Withdrawal by Subject|0|||
155127522|NCT00483002|559897353|FG000|Overall Study|Other|967|||
155127523|NCT02651220|559897354|FG000|Overall Study|Adverse Event|1|||
155127524|NCT02651220|559897355|FG001|Overall Study|Adverse Event|5|||
155127525|NCT02651220|559897356|FG002|Overall Study|Adverse Event|1|||
155127526|NCT02651220|559897354|FG000|Overall Study|Lost to Follow-up|8|||
155006292|NCT02762929|559446992|FG001|Overall Study|Withdrawal by Subject|1|||
155006293|NCT02762929|559446993|FG002|Overall Study|Withdrawal by Subject|0|||
155006294|NCT02762929|559446994|FG003|Overall Study|Withdrawal by Subject|0|||
155006295|NCT02762929|559446995|FG004|Overall Study|Withdrawal by Subject|0|||
155127527|NCT02651220|559897355|FG001|Overall Study|Lost to Follow-up|14|||
155127528|NCT02651220|559897356|FG002|Overall Study|Lost to Follow-up|14|||
155127529|NCT02651220|559897354|FG000|Overall Study|Non-Compliance with Study Drug|4|||
155127530|NCT02651220|559897355|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155127531|NCT02651220|559897356|FG002|Overall Study|Non-Compliance with Study Drug|1|||
155127532|NCT02651220|559897354|FG000|Overall Study|Pregnancy|1|||
155127533|NCT02651220|559897355|FG001|Overall Study|Pregnancy|0|||
155127534|NCT02651220|559897356|FG002|Overall Study|Pregnancy|1|||
155127535|NCT02651220|559897354|FG000|Overall Study|Protocol Violation|0|||
155127536|NCT02651220|559897355|FG001|Overall Study|Protocol Violation|0|||
155127537|NCT02651220|559897356|FG002|Overall Study|Protocol Violation|1|||
155127538|NCT02651220|559897354|FG000|Overall Study|Withdrawal by Subject|5|||
155127539|NCT02651220|559897355|FG001|Overall Study|Withdrawal by Subject|6|||
155127540|NCT02651220|559897356|FG002|Overall Study|Withdrawal by Subject|8|||
155127541|NCT02651220|559897354|FG000|Overall Study|Miscellaneous|4|||
155127542|NCT02651220|559897355|FG001|Overall Study|Miscellaneous|1|||
155127543|NCT02651220|559897356|FG002|Overall Study|Miscellaneous|2|||
155127544|NCT02651220|559897354|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155127545|NCT02651220|559897355|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155127546|NCT02651220|559897356|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
155127547|NCT00447122|559897357|FG000|Overall Study|worsening medical condition -came off|0|||
155127548|NCT00447122|559897358|FG001|Overall Study|worsening medical condition -came off|1|||
155127549|NCT00447122|559897359|FG002|Overall Study|worsening medical condition -came off|0|||
155127550|NCT00447122|559897360|FG003|Overall Study|worsening medical condition -came off|0|||
155127551|NCT01439373|559897365|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
155127552|NCT01439373|559897366|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
155127553|NCT01439373|559897365|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
155127554|NCT01439373|559897366|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
155127555|NCT04046250|559897369|FG000|Overall Study|Death|0|||
155127556|NCT04046250|559897370|FG001|Overall Study|Death|1|||
155127557|NCT04046250|559897369|FG000|Overall Study|Withdrawal by Subject|3|||
155127558|NCT04046250|559897370|FG001|Overall Study|Withdrawal by Subject|3|||
155127559|NCT03834220|559897375|FG000|Overall Study|Adverse Event|1|||
155127560|NCT03834220|559897376|FG001|Overall Study|Adverse Event|0|||
155127561|NCT03834220|559897377|FG002|Overall Study|Adverse Event|0|||
155127562|NCT03834220|559897375|FG000|Overall Study|Death|8|||
155127563|NCT03834220|559897376|FG001|Overall Study|Death|1|||
155127564|NCT03834220|559897377|FG002|Overall Study|Death|17|||
155127565|NCT03834220|559897375|FG000|Overall Study|Reason not Specified|9|||
155127566|NCT03834220|559897376|FG001|Overall Study|Reason not Specified|0|||
155127567|NCT03834220|559897377|FG002|Overall Study|Reason not Specified|6|||
155127568|NCT03834220|559897375|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
155127569|NCT03834220|559897376|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
155127570|NCT03834220|559897377|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
155127571|NCT03834220|559897375|FG000|Overall Study|Withdrawal of Consent|2|||
155127572|NCT03834220|559897376|FG001|Overall Study|Withdrawal of Consent|2|||
155127573|NCT03834220|559897377|FG002|Overall Study|Withdrawal of Consent|2|||
155127574|NCT02593318|559897380|FG000|Overall Study|Withdrawal by Subject|1|||
155127575|NCT02593318|559897381|FG001|Overall Study|Withdrawal by Subject|1|||
155127576|NCT03684694|559897383|FG000|Phase 1|Withdrawal by Subject|1|||
155127577|NCT03684694|559897384|FG001|Phase 1|Withdrawal by Subject|0|||
155127578|NCT03684694|559897385|FG002|Phase 1|Withdrawal by Subject|0|||
155127579|NCT03684694|559897386|FG003|Phase 1|Withdrawal by Subject|0|||
155127580|NCT03684694|559897387|FG004|Phase 1|Withdrawal by Subject|0|||
155127581|NCT03684694|559897388|FG005|Phase 1|Withdrawal by Subject|0|||
155127582|NCT03684694|559897383|FG000|Phase 1|Investigator/Sponsor Decision|12|||
155127583|NCT03684694|559897384|FG001|Phase 1|Investigator/Sponsor Decision|2|||
155127584|NCT03684694|559897385|FG002|Phase 1|Investigator/Sponsor Decision|1|||
155127585|NCT03684694|559897386|FG003|Phase 1|Investigator/Sponsor Decision|0|||
155127586|NCT03684694|559897387|FG004|Phase 1|Investigator/Sponsor Decision|0|||
155127587|NCT03684694|559897388|FG005|Phase 1|Investigator/Sponsor Decision|0|||
155127588|NCT03684694|559897383|FG000|Phase 1|Death|24|||
155127589|NCT03684694|559897384|FG001|Phase 1|Death|0|||
155178370|NCT00534313|560091447|FG003|Long-term Period|Poor compliance/noncompliance|0|||
155127590|NCT03684694|559897385|FG002|Phase 1|Death|3|||
155127591|NCT03684694|559897386|FG003|Phase 1|Death|0|||
155127592|NCT03684694|559897387|FG004|Phase 1|Death|0|||
155127593|NCT03684694|559897388|FG005|Phase 1|Death|0|||
155127594|NCT03684694|559897383|FG000|Phase 1|Lost to Follow-up|0|||
155127595|NCT03684694|559897384|FG001|Phase 1|Lost to Follow-up|0|||
155127596|NCT03684694|559897385|FG002|Phase 1|Lost to Follow-up|1|||
155127597|NCT03684694|559897386|FG003|Phase 1|Lost to Follow-up|0|||
155127598|NCT03684694|559897387|FG004|Phase 1|Lost to Follow-up|0|||
155127599|NCT03684694|559897388|FG005|Phase 1|Lost to Follow-up|0|||
155127600|NCT03684694|559897383|FG000|Phase 1|Miscellaneous|0|||
155127601|NCT03684694|559897384|FG001|Phase 1|Miscellaneous|1|||
155127602|NCT03684694|559897385|FG002|Phase 1|Miscellaneous|0|||
155127603|NCT03684694|559897386|FG003|Phase 1|Miscellaneous|0|||
155127604|NCT03684694|559897387|FG004|Phase 1|Miscellaneous|0|||
155006296|NCT02762929|559446996|FG005|Overall Study|Withdrawal by Subject|0|||
155006297|NCT02762929|559446991|FG000|Overall Study|exclusionary medication disclosed late|0|||
155006298|NCT02762929|559446992|FG001|Overall Study|exclusionary medication disclosed late|0|||
155006299|NCT02762929|559446993|FG002|Overall Study|exclusionary medication disclosed late|0|||
155006300|NCT02762929|559446994|FG003|Overall Study|exclusionary medication disclosed late|1|||
155006301|NCT02762929|559446995|FG004|Overall Study|exclusionary medication disclosed late|0|||
155006302|NCT02762929|559446996|FG005|Overall Study|exclusionary medication disclosed late|0|||
155006303|NCT02656303|559446998|FG000|Overall Study|Adverse Event|3|||
155006304|NCT02656303|559446999|FG001|Overall Study|Adverse Event|2|||
155006305|NCT02656303|559447000|FG002|Overall Study|Adverse Event|0|||
155006306|NCT02656303|559446998|FG000|Overall Study|Death|12|||
155006307|NCT02656303|559446999|FG001|Overall Study|Death|4|||
155006308|NCT02656303|559447000|FG002|Overall Study|Death|1|||
155006309|NCT02656303|559446998|FG000|Overall Study|Lack of Efficacy|1|||
155006310|NCT02656303|559446999|FG001|Overall Study|Lack of Efficacy|0|||
155006311|NCT02656303|559447000|FG002|Overall Study|Lack of Efficacy|0|||
155006312|NCT02656303|559446998|FG000|Overall Study|Non-Compliance with Study|1|||
155006313|NCT02656303|559446999|FG001|Overall Study|Non-Compliance with Study|1|||
155006314|NCT02656303|559447000|FG002|Overall Study|Non-Compliance with Study|0|||
155006315|NCT02656303|559446998|FG000|Overall Study|Investigator Decision|2|||
155006316|NCT02656303|559446999|FG001|Overall Study|Investigator Decision|1|||
155006317|NCT02656303|559447000|FG002|Overall Study|Investigator Decision|0|||
155006318|NCT02656303|559446998|FG000|Overall Study|Progressive Disease|25|||
155006319|NCT02656303|559446999|FG001|Overall Study|Progressive Disease|14|||
155006320|NCT02656303|559447000|FG002|Overall Study|Progressive Disease|10|||
155006321|NCT02656303|559446998|FG000|Overall Study|Study Terminated by Sponsor|20|||
155006322|NCT02656303|559446999|FG001|Overall Study|Study Terminated by Sponsor|7|||
155006323|NCT02656303|559447000|FG002|Overall Study|Study Terminated by Sponsor|5|||
155006324|NCT02656303|559446998|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
155006325|NCT02656303|559446999|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
155006326|NCT02656303|559447000|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
155006327|NCT02656303|559446998|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
155006328|NCT02656303|559446999|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
155006329|NCT02656303|559447000|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
155006330|NCT02656303|559446998|FG000|Overall Study|Reason not Specified|1|||
155006331|NCT02656303|559446999|FG001|Overall Study|Reason not Specified|1|||
155006332|NCT02656303|559447000|FG002|Overall Study|Reason not Specified|2|||
155006333|NCT02548156|559447006|FG000|Washout Period 1|Lost to Follow-up|0|||
155006334|NCT02548156|559447007|FG001|Washout Period 1|Lost to Follow-up|0|||
155006335|NCT02548156|559447008|FG002|Washout Period 1|Lost to Follow-up|0|||
155006336|NCT02548156|559447009|FG003|Washout Period 1|Lost to Follow-up|0|||
155006337|NCT02548156|559447010|FG004|Washout Period 1|Lost to Follow-up|1|||
155006338|NCT02548156|559447011|FG005|Washout Period 1|Lost to Follow-up|0|||
155006339|NCT03052751|559447012|FG000|Dosing Period 1|Adverse Event|0|||
155006340|NCT03052751|559447013|FG001|Dosing Period 1|Adverse Event|1|||
155006341|NCT03052751|559447014|FG002|Dosing Period 1|Adverse Event|0|||
155006342|NCT03052751|559447015|FG003|Dosing Period 1|Adverse Event|0|||
155006343|NCT03052751|559447016|FG004|Dosing Period 1|Adverse Event|0|||
155006344|NCT03052751|559447017|FG005|Dosing Period 1|Adverse Event|0|||
155006345|NCT03052751|559447012|FG000|Dosing Period 2|Adverse Event|0|||
155006346|NCT03052751|559447013|FG001|Dosing Period 2|Adverse Event|0|||
155006347|NCT03052751|559447014|FG002|Dosing Period 2|Adverse Event|3|||
155006348|NCT03052751|559447015|FG003|Dosing Period 2|Adverse Event|0|||
155006349|NCT03052751|559447016|FG004|Dosing Period 2|Adverse Event|0|||
155006350|NCT03052751|559447017|FG005|Dosing Period 2|Adverse Event|0|||
155006351|NCT03052751|559447012|FG000|Observation Period|Adverse Event|0|||
155006352|NCT03052751|559447013|FG001|Observation Period|Adverse Event|0|||
155006353|NCT03052751|559447014|FG002|Observation Period|Adverse Event|0|||
155006354|NCT03052751|559447015|FG003|Observation Period|Adverse Event|0|||
155006355|NCT03052751|559447016|FG004|Observation Period|Adverse Event|1|||
155006356|NCT03052751|559447017|FG005|Observation Period|Adverse Event|0|||
155127605|NCT03684694|559897388|FG005|Phase 1|Miscellaneous|0|||
155127606|NCT03684694|559897383|FG000|Phase 2|Withdrawal by Subject|0|||
155127607|NCT03684694|559897384|FG001|Phase 2|Withdrawal by Subject|0|||
155127608|NCT03684694|559897385|FG002|Phase 2|Withdrawal by Subject|0|||
155127609|NCT03684694|559897386|FG003|Phase 2|Withdrawal by Subject|0|||
155006357|NCT03288714|559447018|FG000|Overall Study|Lost to Follow-up|2|||
155006358|NCT03288714|559447019|FG001|Overall Study|Lost to Follow-up|1|||
155127610|NCT03684694|559897387|FG004|Phase 2|Withdrawal by Subject|0|||
155127611|NCT03684694|559897388|FG005|Phase 2|Withdrawal by Subject|1|||
155127612|NCT03684694|559897383|FG000|Phase 2|Investigator/Sponsor Decision|0|||
155006359|NCT03288714|559447018|FG000|Overall Study|Non-compliance with study schedule|2|||
155006360|NCT03288714|559447019|FG001|Overall Study|Non-compliance with study schedule|0|||
155006361|NCT03288714|559447018|FG000|Overall Study|Withdrawal by Subject|3|||
155006362|NCT03288714|559447019|FG001|Overall Study|Withdrawal by Subject|1|||
155006363|NCT03288714|559447018|FG000|Overall Study|Clinical Worsening|2|||
155127613|NCT03684694|559897384|FG001|Phase 2|Investigator/Sponsor Decision|0|||
155127614|NCT03684694|559897385|FG002|Phase 2|Investigator/Sponsor Decision|0|||
155127615|NCT03684694|559897386|FG003|Phase 2|Investigator/Sponsor Decision|17|||
155127616|NCT03684694|559897387|FG004|Phase 2|Investigator/Sponsor Decision|16|||
155127617|NCT03684694|559897388|FG005|Phase 2|Investigator/Sponsor Decision|6|||
155127618|NCT03684694|559897383|FG000|Phase 2|Death|0|||
155127619|NCT03684694|559897384|FG001|Phase 2|Death|0|||
155127620|NCT03684694|559897385|FG002|Phase 2|Death|0|||
155127621|NCT03684694|559897386|FG003|Phase 2|Death|28|||
155127622|NCT03684694|559897387|FG004|Phase 2|Death|14|||
155127623|NCT03684694|559897388|FG005|Phase 2|Death|3|||
155127624|NCT03684694|559897383|FG000|Phase 2|Lost to Follow-up|0|||
155127625|NCT03684694|559897384|FG001|Phase 2|Lost to Follow-up|0|||
155127626|NCT03684694|559897385|FG002|Phase 2|Lost to Follow-up|0|||
155127627|NCT03684694|559897386|FG003|Phase 2|Lost to Follow-up|1|||
155127628|NCT03684694|559897387|FG004|Phase 2|Lost to Follow-up|0|||
155127629|NCT03684694|559897388|FG005|Phase 2|Lost to Follow-up|0|||
155127630|NCT03684694|559897383|FG000|Phase 2|Miscellaneous|0|||
155127631|NCT03684694|559897384|FG001|Phase 2|Miscellaneous|0|||
155127632|NCT03684694|559897385|FG002|Phase 2|Miscellaneous|0|||
155127633|NCT03684694|559897386|FG003|Phase 2|Miscellaneous|3|||
155127634|NCT03684694|559897387|FG004|Phase 2|Miscellaneous|0|||
155127635|NCT03684694|559897388|FG005|Phase 2|Miscellaneous|0|||
155127636|NCT03268941|559899391|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155127637|NCT03268941|559899392|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155127638|NCT03268941|559899393|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155127639|NCT03268941|559899394|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
155127640|NCT03268941|559899395|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155127641|NCT03268941|559899396|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155127642|NCT03268941|559899397|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
155127643|NCT03268941|559899391|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
155127644|NCT03268941|559899392|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
155127645|NCT03268941|559899393|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
155127646|NCT03268941|559899394|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
155127647|NCT03268941|559899395|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
155127648|NCT03268941|559899396|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
155127649|NCT03268941|559899397|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
155127650|NCT03268941|559899391|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
155127651|NCT03268941|559899392|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155127652|NCT03268941|559899393|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155127653|NCT03268941|559899394|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155127654|NCT03268941|559899395|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155127655|NCT03268941|559899396|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155127656|NCT03268941|559899397|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
155127657|NCT03268941|559899391|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
155127658|NCT03268941|559899392|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
155127659|NCT03268941|559899393|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
155127660|NCT03268941|559899394|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
155127661|NCT03268941|559899395|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
155127662|NCT03268941|559899396|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
155127663|NCT03268941|559899397|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
155127664|NCT03268941|559899391|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155127665|NCT03268941|559899392|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155127666|NCT03268941|559899393|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155127667|NCT03268941|559899394|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155127668|NCT03268941|559899395|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155127669|NCT03268941|559899396|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
155127670|NCT03268941|559899397|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
155127671|NCT01216683|559899398|FG000|Induction|Never started treatment|0|||
155127672|NCT01216683|559899399|FG001|Induction|Never started treatment|6|||
155127673|NCT01216683|559899400|FG002|Induction|Never started treatment|3|||
155178371|NCT00534313|560091444|FG000|Long-term Period|Administrative reason by sponsor|17|||
155127674|NCT01216683|559899398|FG000|Induction|Lack of Efficacy|4|||
155127675|NCT01216683|559899399|FG001|Induction|Lack of Efficacy|3|||
155127676|NCT01216683|559899400|FG002|Induction|Lack of Efficacy|7|||
155127677|NCT01216683|559899398|FG000|Induction|Adverse Event|0|||
155127678|NCT01216683|559899399|FG001|Induction|Adverse Event|5|||
155127679|NCT01216683|559899400|FG002|Induction|Adverse Event|5|||
155127680|NCT01216683|559899398|FG000|Induction|Death|0|||
155127681|NCT01216683|559899399|FG001|Induction|Death|0|||
155127682|NCT01216683|559899400|FG002|Induction|Death|2|||
155127683|NCT01216683|559899398|FG000|Induction|Withdrawal by Subject|0|||
155127684|NCT01216683|559899399|FG001|Induction|Withdrawal by Subject|4|||
155127685|NCT01216683|559899400|FG002|Induction|Withdrawal by Subject|2|||
155127686|NCT01216683|559899398|FG000|Induction|Other disease|0|||
155127687|NCT01216683|559899399|FG001|Induction|Other disease|1|||
155127688|NCT01216683|559899400|FG002|Induction|Other disease|2|||
155127689|NCT01216683|559899398|FG000|Continuation|Lack of Efficacy|3|||
155127690|NCT01216683|559899399|FG001|Continuation|Lack of Efficacy|2|||
155006364|NCT03288714|559447019|FG001|Overall Study|Clinical Worsening|1|||
155006365|NCT03288714|559447018|FG000|Overall Study|Adverse Event|1|||
155006366|NCT03288714|559447019|FG001|Overall Study|Adverse Event|0|||
155127691|NCT01216683|559899400|FG002|Continuation|Lack of Efficacy|7|||
155127692|NCT01216683|559899398|FG000|Continuation|Adverse Event|5|||
155127693|NCT01216683|559899399|FG001|Continuation|Adverse Event|3|||
155127694|NCT01216683|559899400|FG002|Continuation|Adverse Event|16|||
155127695|NCT01216683|559899398|FG000|Continuation|Death|1|||
155127696|NCT01216683|559899399|FG001|Continuation|Death|0|||
155127697|NCT01216683|559899400|FG002|Continuation|Death|2|||
155127698|NCT01216683|559899398|FG000|Continuation|Withdrawal by Subject|4|||
155127699|NCT01216683|559899399|FG001|Continuation|Withdrawal by Subject|5|||
155127700|NCT01216683|559899400|FG002|Continuation|Withdrawal by Subject|9|||
155127701|NCT01216683|559899398|FG000|Continuation|Other diseases|0|||
155127702|NCT01216683|559899399|FG001|Continuation|Other diseases|2|||
155127703|NCT01216683|559899400|FG002|Continuation|Other diseases|1|||
155127704|NCT01216683|559899398|FG000|Continuation|Physician Decision|1|||
155127705|NCT01216683|559899399|FG001|Continuation|Physician Decision|0|||
155127706|NCT01216683|559899400|FG002|Continuation|Physician Decision|1|||
155127707|NCT01216683|559899398|FG000|Continuation|Non-compliance|1|||
155127708|NCT01216683|559899399|FG001|Continuation|Non-compliance|0|||
155127709|NCT01216683|559899400|FG002|Continuation|Non-compliance|1|||
155127710|NCT01216683|559899398|FG000|Continuation|Insurance change|0|||
155127711|NCT01216683|559899399|FG001|Continuation|Insurance change|1|||
155127712|NCT01216683|559899400|FG002|Continuation|Insurance change|0|||
155127713|NCT01216683|559899398|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
155127714|NCT01216683|559899399|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
155127715|NCT01216683|559899400|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
155127716|NCT01216683|559899398|FG000|Continuation|Not reported|0|||
155127717|NCT01216683|559899399|FG001|Continuation|Not reported|0|||
155127718|NCT01216683|559899400|FG002|Continuation|Not reported|1|||
155127719|NCT01216683|559899398|FG000|Continuation|Never started treatment|0|||
155127720|NCT01216683|559899399|FG001|Continuation|Never started treatment|1|||
155127721|NCT01216683|559899400|FG002|Continuation|Never started treatment|5|||
155127722|NCT04037254|559899401|FG000|Overall Study|Protocol Violation|1|||
155127723|NCT04037254|559899402|FG001|Overall Study|Protocol Violation|0|||
155127724|NCT04037254|559899403|FG002|Overall Study|Protocol Violation|0|||
155127725|NCT04037254|559899404|FG003|Overall Study|Protocol Violation|0|||
155127726|NCT04037254|559899405|FG004|Overall Study|Protocol Violation|0|||
155127727|NCT04037254|559899401|FG000|Overall Study|Withdrawal by Subject|0|||
155127728|NCT04037254|559899402|FG001|Overall Study|Withdrawal by Subject|0|||
155127729|NCT04037254|559899403|FG002|Overall Study|Withdrawal by Subject|1|||
155127730|NCT04037254|559899404|FG003|Overall Study|Withdrawal by Subject|0|||
155127731|NCT04037254|559899405|FG004|Overall Study|Withdrawal by Subject|0|||
155127732|NCT04037254|559899401|FG000|Overall Study|Delayed or incomplete treatment|0|||
155127733|NCT04037254|559899402|FG001|Overall Study|Delayed or incomplete treatment|2|||
155127734|NCT04037254|559899403|FG002|Overall Study|Delayed or incomplete treatment|1|||
155127735|NCT04037254|559899404|FG003|Overall Study|Delayed or incomplete treatment|0|||
155006367|NCT01342081|559447029|FG000|Overall Study|Did not receive allocated intervention|0|||
155006368|NCT01342081|559447030|FG001|Overall Study|Did not receive allocated intervention|0|||
155006369|NCT01342081|559447031|FG002|Overall Study|Did not receive allocated intervention|1|||
155006370|NCT01342081|559447029|FG000|Overall Study|Adverse Event|1|||
155006371|NCT01342081|559447030|FG001|Overall Study|Adverse Event|0|||
155006372|NCT01342081|559447031|FG002|Overall Study|Adverse Event|0|||
155006373|NCT01342081|559447029|FG000|Overall Study|Physician Decision|0|||
155006374|NCT01342081|559447030|FG001|Overall Study|Physician Decision|1|||
155006375|NCT01342081|559447031|FG002|Overall Study|Physician Decision|0|||
155006376|NCT01342081|559447029|FG000|Overall Study|Withdrawal by Subject|1|||
155006377|NCT01342081|559447030|FG001|Overall Study|Withdrawal by Subject|1|||
155006378|NCT01342081|559447031|FG002|Overall Study|Withdrawal by Subject|0|||
155006379|NCT04720053|559447036|FG000|Overall Study|Lost to Follow-up|12|||
155006380|NCT01960257|559447037|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
155006381|NCT01960257|559447038|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
155006382|NCT01960257|559447039|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
155006383|NCT01960257|559447037|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
155006384|NCT01960257|559447038|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
155006385|NCT01960257|559447039|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
155006386|NCT01960257|559447037|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
155006387|NCT01960257|559447038|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
155006388|NCT01960257|559447039|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
155127736|NCT04037254|559899405|FG004|Overall Study|Delayed or incomplete treatment|0|||
155127737|NCT00477152|559899406|FG000|Overall Study|Parent withdrew consent|2|||
155127738|NCT00477152|559899406|FG000|Overall Study|Adverse Event|1|||
155127739|NCT02478164|559899407|FG000|Overall Study|Lack of Efficacy|13|||
155127740|NCT02478164|559899407|FG000|Overall Study|Adverse Event|1|||
155127741|NCT02478164|559899407|FG000|Overall Study|Withdrawal by Subject|1|||
155006389|NCT01942993|559447040|FG000|Overall Study|Lost to Follow-up|1|||
155006390|NCT01942993|559447040|FG000|Overall Study|Physician Decision|1|||
155006391|NCT01350271|559447041|FG000|Overall Study|Lost to Follow-up|21|||
155006392|NCT01350271|559447042|FG001|Overall Study|Lost to Follow-up|17|||
155006393|NCT01350271|559447043|FG002|Overall Study|Lost to Follow-up|26|||
155006394|NCT02906670|559447047|FG000|Cohort 1, QW|Radiological Progression|1|||
155006395|NCT02906670|559447048|FG001|Cohort 1, QW|Radiological Progression|0|||
155006396|NCT02906670|559447049|FG002|Cohort 1, QW|Radiological Progression|0|||
155006397|NCT02906670|559447050|FG003|Cohort 1, QW|Radiological Progression|0|||
155006398|NCT02906670|559447051|FG004|Cohort 1, QW|Radiological Progression|0|||
155006399|NCT02906670|559447052|FG005|Cohort 1, QW|Radiological Progression|0|||
155006400|NCT02906670|559447053|FG006|Cohort 1, QW|Radiological Progression|0|||
155006401|NCT02906670|559447054|FG007|Cohort 1, QW|Radiological Progression|0|||
155006402|NCT02906670|559447055|FG008|Cohort 1, QW|Radiological Progression|0|||
155006403|NCT02906670|559447056|FG009|Cohort 1, QW|Radiological Progression|0|||
155006404|NCT02906670|559447047|FG000|Cohort 2, QW|Radiological Progression|0|||
155006405|NCT02906670|559447048|FG001|Cohort 2, QW|Radiological Progression|1|||
155006406|NCT02906670|559447049|FG002|Cohort 2, QW|Radiological Progression|0|||
155006407|NCT02906670|559447050|FG003|Cohort 2, QW|Radiological Progression|0|||
155006408|NCT02906670|559447051|FG004|Cohort 2, QW|Radiological Progression|0|||
155006409|NCT02906670|559447052|FG005|Cohort 2, QW|Radiological Progression|0|||
155006410|NCT02906670|559447053|FG006|Cohort 2, QW|Radiological Progression|0|||
155006411|NCT02906670|559447054|FG007|Cohort 2, QW|Radiological Progression|0|||
155006412|NCT02906670|559447055|FG008|Cohort 2, QW|Radiological Progression|0|||
155006413|NCT02906670|559447056|FG009|Cohort 2, QW|Radiological Progression|0|||
155006414|NCT02906670|559447047|FG000|Cohort 3, QW|Radiological Progression|0|||
155006415|NCT02906670|559447048|FG001|Cohort 3, QW|Radiological Progression|0|||
155006416|NCT02906670|559447049|FG002|Cohort 3, QW|Radiological Progression|2|||
155006417|NCT02906670|559447050|FG003|Cohort 3, QW|Radiological Progression|0|||
155006418|NCT02906670|559447051|FG004|Cohort 3, QW|Radiological Progression|0|||
155006419|NCT02906670|559447052|FG005|Cohort 3, QW|Radiological Progression|0|||
155006420|NCT02906670|559447053|FG006|Cohort 3, QW|Radiological Progression|0|||
155006421|NCT02906670|559447054|FG007|Cohort 3, QW|Radiological Progression|0|||
155006422|NCT02906670|559447055|FG008|Cohort 3, QW|Radiological Progression|0|||
155006423|NCT02906670|559447056|FG009|Cohort 3, QW|Radiological Progression|0|||
155006424|NCT02906670|559447047|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006425|NCT02906670|559447048|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006426|NCT02906670|559447049|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
155006427|NCT02906670|559447050|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006428|NCT02906670|559447051|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006429|NCT02906670|559447052|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006430|NCT02906670|559447053|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006431|NCT02906670|559447054|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006432|NCT02906670|559447055|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006433|NCT02906670|559447056|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
155006434|NCT02906670|559447047|FG000|Cohort 4, Q2W|Radiological Progression|0|||
155006435|NCT02906670|559447048|FG001|Cohort 4, Q2W|Radiological Progression|0|||
155006436|NCT02906670|559447049|FG002|Cohort 4, Q2W|Radiological Progression|0|||
155006437|NCT02906670|559447050|FG003|Cohort 4, Q2W|Radiological Progression|0|||
155006438|NCT02906670|559447051|FG004|Cohort 4, Q2W|Radiological Progression|0|||
155006439|NCT02906670|559447052|FG005|Cohort 4, Q2W|Radiological Progression|1|||
155006440|NCT02906670|559447053|FG006|Cohort 4, Q2W|Radiological Progression|0|||
155006441|NCT02906670|559447054|FG007|Cohort 4, Q2W|Radiological Progression|0|||
155006442|NCT02906670|559447055|FG008|Cohort 4, Q2W|Radiological Progression|0|||
155006443|NCT02906670|559447056|FG009|Cohort 4, Q2W|Radiological Progression|0|||
155006444|NCT02906670|559447047|FG000|Cohort 4, Q2W|Clinical Progression|0|||
155006445|NCT02906670|559447048|FG001|Cohort 4, Q2W|Clinical Progression|0|||
155006446|NCT02906670|559447049|FG002|Cohort 4, Q2W|Clinical Progression|0|||
155006447|NCT02906670|559447050|FG003|Cohort 4, Q2W|Clinical Progression|0|||
155006448|NCT02906670|559447051|FG004|Cohort 4, Q2W|Clinical Progression|0|||
155006449|NCT02906670|559447052|FG005|Cohort 4, Q2W|Clinical Progression|2|||
155006450|NCT02906670|559447053|FG006|Cohort 4, Q2W|Clinical Progression|0|||
155127742|NCT01116427|559899411|FG000|Core Phase|Adverse Event|0|||
155127743|NCT01116427|559899412|FG001|Core Phase|Adverse Event|1|||
155127744|NCT01116427|559899411|FG000|Core Phase|Lost to Follow-up|1|||
155127745|NCT01116427|559899412|FG001|Core Phase|Lost to Follow-up|0|||
155127746|NCT01116427|559899411|FG000|Core Phase|Withdrawal by Subject|3|||
155127747|NCT01116427|559899412|FG001|Core Phase|Withdrawal by Subject|0|||
155127748|NCT01116427|559899411|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
155127749|NCT01116427|559899412|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
155127750|NCT01116427|559899411|FG000|Extension Phase|Adverse Event|1|||
155127751|NCT01116427|559899412|FG001|Extension Phase|Adverse Event|1|||
155127752|NCT01116427|559899411|FG000|Extension Phase|Lost to Follow-up|2|||
155127753|NCT01116427|559899412|FG001|Extension Phase|Lost to Follow-up|0|||
155127754|NCT01116427|559899411|FG000|Extension Phase|Withdrawal by Subject|5|||
155006451|NCT02906670|559447054|FG007|Cohort 4, Q2W|Clinical Progression|0|||
155127755|NCT01116427|559899412|FG001|Extension Phase|Withdrawal by Subject|1|||
155006452|NCT02906670|559447055|FG008|Cohort 4, Q2W|Clinical Progression|0|||
155127756|NCT01116427|559899411|FG000|Extension Phase|Not using appropriate birth control|1|||
155127757|NCT01116427|559899412|FG001|Extension Phase|Not using appropriate birth control|0|||
155127758|NCT02648217|559899413|FG000|Overall Study|Adverse Event|0|||
155127759|NCT02648217|559899414|FG001|Overall Study|Adverse Event|1|||
155127760|NCT02648217|559899413|FG000|Overall Study|Lost to Follow-up|1|||
155127761|NCT02648217|559899414|FG001|Overall Study|Lost to Follow-up|1|||
155127762|NCT02648217|559899413|FG000|Overall Study|Withdrawal by Subject|4|||
154923410|NCT00812968|559143825|FG000|Overall Study|Relapse after erythroid response|6|||
154923411|NCT00812968|559143825|FG000|Overall Study|Disease progression|1|||
154923412|NCT00812968|559143825|FG000|Overall Study|No further treatment required|1|||
154923413|NCT00812968|559143825|FG000|Overall Study|Study closed due to marketing approval|3|||
154923414|NCT02696382|559143826|FG000|Overall Study|Death|7|||
154923415|NCT02696382|559143827|FG001|Overall Study|Death|2|||
154923416|NCT02696382|559143826|FG000|Overall Study|Withdrawal by Subject|5|||
154923417|NCT02696382|559143827|FG001|Overall Study|Withdrawal by Subject|12|||
154923418|NCT02696382|559143826|FG000|Overall Study|Lost to Follow-up|4|||
154923419|NCT02696382|559143827|FG001|Overall Study|Lost to Follow-up|7|||
154923420|NCT00494234|559143828|FG000|Overall Study|Withdrawal by Subject|1|||
154923421|NCT00494234|559143829|FG001|Overall Study|Withdrawal by Subject|0|||
154923422|NCT00494234|559143828|FG000|Overall Study|Disease progression|11|||
154923423|NCT00494234|559143829|FG001|Overall Study|Disease progression|8|||
154923424|NCT00494234|559143828|FG000|Overall Study|Death|2|||
154923425|NCT00494234|559143829|FG001|Overall Study|Death|1|||
154923426|NCT00505765|559143835|FG000|Overall Study|Withdrawal by Subject|1|||
154923427|NCT00505765|559143836|FG001|Overall Study|Withdrawal by Subject|0|||
154923428|NCT00505765|559143837|FG002|Overall Study|Withdrawal by Subject|0|||
154923429|NCT00505765|559143835|FG000|Overall Study|Adverse Event|1|||
154923430|NCT00505765|559143836|FG001|Overall Study|Adverse Event|2|||
154923431|NCT00505765|559143837|FG002|Overall Study|Adverse Event|0|||
154923432|NCT00505765|559143835|FG000|Overall Study|Noncompliance|0|||
154923433|NCT00505765|559143836|FG001|Overall Study|Noncompliance|1|||
154923434|NCT00505765|559143837|FG002|Overall Study|Noncompliance|3|||
154923435|NCT02743117|559143838|FG000|Overall Study|Lost to Follow-up|0|||
154923436|NCT02743117|559143839|FG001|Overall Study|Lost to Follow-up|1|||
154923437|NCT02743117|559143838|FG000|Overall Study|Other|1|||
154923438|NCT02743117|559143839|FG001|Overall Study|Other|0|||
154923439|NCT01207219|559143841|FG000|Overall Study|changed diagnosis during study period|5|||
154923440|NCT01207219|559143842|FG001|Overall Study|changed diagnosis during study period|3|||
154923441|NCT01207219|559143843|FG002|Overall Study|changed diagnosis during study period|1|||
154923442|NCT01207219|559143841|FG000|Overall Study|Lost to Follow-up|6|||
154923443|NCT01207219|559143842|FG001|Overall Study|Lost to Follow-up|8|||
154923444|NCT01207219|559143843|FG002|Overall Study|Lost to Follow-up|6|||
154923445|NCT01012609|559143844|FG000|Overall Study|Withdrawal by Subject|1|||
154923446|NCT01012609|559143845|FG001|Overall Study|Withdrawal by Subject|1|||
154923447|NCT00924820|559143846|FG000|Overall Study|Death|2|||
154923448|NCT00924820|559143846|FG000|Overall Study|Ineligible, Screen Failure|5|||
154923449|NCT01725217|559143847|FG000|Overall Study|Withdrawal by Subject|1|||
154923450|NCT01725217|559143848|FG001|Overall Study|Withdrawal by Subject|0|||
154923451|NCT01725217|559143849|FG002|Overall Study|Withdrawal by Subject|0|||
154923452|NCT00585468|559143850|FG000|First Intervention|Withdrawal by Subject|1|||
154923453|NCT00585468|559143851|FG001|First Intervention|Withdrawal by Subject|1|||
154923454|NCT03919669|559143852|FG000|Overall Study|Withdrawal by Subject|1|||
154923455|NCT03919669|559143853|FG001|Overall Study|Withdrawal by Subject|0|||
154923456|NCT03919669|559143854|FG002|Overall Study|Withdrawal by Subject|0|||
154923457|NCT01265875|559143855|FG000|Overall Study|Uncooperative/unreliable|1|||
154923458|NCT02331680|559143858|FG000|Overall Study|Adverse Event|3|||
154923459|NCT02331680|559143859|FG001|Overall Study|Adverse Event|0|||
154923460|NCT02331680|559143860|FG002|Overall Study|Adverse Event|2|||
154923461|NCT02331680|559143858|FG000|Overall Study|Physician Decision|1|||
154923462|NCT02331680|559143859|FG001|Overall Study|Physician Decision|1|||
154923463|NCT02331680|559143860|FG002|Overall Study|Physician Decision|2|||
154923464|NCT02331680|559143858|FG000|Overall Study|Withdrawal by Subject|0|||
154923465|NCT02331680|559143859|FG001|Overall Study|Withdrawal by Subject|1|||
154923466|NCT02331680|559143860|FG002|Overall Study|Withdrawal by Subject|2|||
154923467|NCT02331680|559143858|FG000|Overall Study|Met withdrawal criteria|2|||
154923468|NCT02331680|559143859|FG001|Overall Study|Met withdrawal criteria|2|||
154923469|NCT02331680|559143860|FG002|Overall Study|Met withdrawal criteria|5|||
154923470|NCT02331680|559143858|FG000|Overall Study|Non-compliance with study drug|0|||
154923471|NCT02331680|559143859|FG001|Overall Study|Non-compliance with study drug|0|||
154923472|NCT02331680|559143860|FG002|Overall Study|Non-compliance with study drug|1|||
155006453|NCT02906670|559447056|FG009|Cohort 4, Q2W|Clinical Progression|0|||
155127763|NCT02648217|559899414|FG001|Overall Study|Withdrawal by Subject|3|||
155127764|NCT02648217|559899413|FG000|Overall Study|Unclassified|5|||
154923473|NCT02331680|559143858|FG000|Overall Study|Protocol Violation|0|||
154923474|NCT02331680|559143859|FG001|Overall Study|Protocol Violation|0|||
154923475|NCT02331680|559143860|FG002|Overall Study|Protocol Violation|3|||
155127765|NCT02648217|559899414|FG001|Overall Study|Unclassified|0|||
155127766|NCT00791557|559899415|FG000|Overall Study|Adverse Event|1|||
155127767|NCT01079936|559899416|FG000|Phase I: MTD|First Remission Status|2|||
155127768|NCT01079936|559899417|FG001|Phase I: MTD|First Remission Status|0|||
155127769|NCT01079936|559899418|FG002|Phase I: MTD|First Remission Status|0|||
155127770|NCT01079936|559899419|FG003|Phase I: MTD|First Remission Status|0|||
155127771|NCT01079936|559899420|FG004|Phase I: MTD|First Remission Status|0|||
155127772|NCT01079936|559899416|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
155127773|NCT01079936|559899417|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
155127774|NCT01079936|559899418|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
155127775|NCT01079936|559899419|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
155127776|NCT01079936|559899420|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
155127777|NCT01079936|559899416|FG000|Phase II|Adverse Event|0|||
155127778|NCT01079936|559899417|FG001|Phase II|Adverse Event|0|||
155127779|NCT01079936|559899418|FG002|Phase II|Adverse Event|1|||
155127780|NCT01079936|559899419|FG003|Phase II|Adverse Event|0|||
155127781|NCT01079936|559899420|FG004|Phase II|Adverse Event|0|||
155127782|NCT01079936|559899416|FG000|Phase II|Insurance Issue|0|||
155127783|NCT01079936|559899417|FG001|Phase II|Insurance Issue|0|||
155127784|NCT01079936|559899418|FG002|Phase II|Insurance Issue|0|||
155127785|NCT01079936|559899419|FG003|Phase II|Insurance Issue|0|||
155127786|NCT01079936|559899420|FG004|Phase II|Insurance Issue|1|||
155127787|NCT02322190|559899421|FG000|Overall Study|Death on study|1|||
155127788|NCT02322190|559899422|FG001|Overall Study|Death on study|0|||
155127789|NCT03344640|559899423|FG000|Overall Study|Adverse Event|1|||
155127790|NCT03344640|559899424|FG001|Overall Study|Adverse Event|0|||
155127791|NCT03344640|559899423|FG000|Overall Study|Physician Decision|1|||
155127792|NCT03344640|559899424|FG001|Overall Study|Physician Decision|1|||
155127793|NCT03344640|559899423|FG000|Overall Study|Withdrawal by Subject|1|||
155127794|NCT03344640|559899424|FG001|Overall Study|Withdrawal by Subject|2|||
155127795|NCT03344640|559899423|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
155127796|NCT03344640|559899424|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
155127797|NCT00657371|559899430|FG000|Overall Study|Poor bowel preparation|15|||
155127798|NCT00657371|559899430|FG000|Overall Study|Unable to intubate the cecum|5|||
155127799|NCT00657371|559899430|FG000|Overall Study|Protocol Violation|2|||
155127800|NCT00657371|559899430|FG000|Overall Study|Device- related reasons|13|||
155127801|NCT00657371|559899430|FG000|Overall Study|Pre-existing medical condition|4|||
155127802|NCT00652899|559899436|FG000|Overall Study|Death|1|||
155127803|NCT00652899|559899436|FG000|Overall Study|Treating physician decision|1|||
155127804|NCT02713867|559899437|FG000|Randomization|Other Reason|2|||
155127805|NCT02713867|559899438|FG001|Randomization|Other Reason|1|||
155127806|NCT02713867|559899437|FG000|Randomization|Participant Withdrew consent|0|||
155127807|NCT02713867|559899438|FG001|Randomization|Participant Withdrew consent|2|||
155127808|NCT02713867|559899437|FG000|Treatment Period|Other Reasons|22|||
155127809|NCT02713867|559899438|FG001|Treatment Period|Other Reasons|28|||
155127810|NCT02713867|559899437|FG000|Treatment Period|Administrative reason by sponsor|21|||
155127811|NCT02713867|559899438|FG001|Treatment Period|Administrative reason by sponsor|16|||
155127812|NCT02713867|559899437|FG000|Treatment Period|No longer meets study criteria|2|||
155127813|NCT02713867|559899438|FG001|Treatment Period|No longer meets study criteria|1|||
155127814|NCT02713867|559899437|FG000|Treatment Period|Poor/Non Compliance|1|||
155127815|NCT02713867|559899438|FG001|Treatment Period|Poor/Non Compliance|0|||
155127816|NCT02713867|559899437|FG000|Treatment Period|Maximum Clinical Benefit|5|||
155127817|NCT02713867|559899438|FG001|Treatment Period|Maximum Clinical Benefit|6|||
155127818|NCT02713867|559899437|FG000|Treatment Period|Withdrew consent|3|||
155127819|NCT02713867|559899438|FG001|Treatment Period|Withdrew consent|6|||
155127820|NCT02713867|559899437|FG000|Treatment Period|Requested to Discontinue|8|||
155127821|NCT02713867|559899438|FG001|Treatment Period|Requested to Discontinue|8|||
155127822|NCT02713867|559899437|FG000|Treatment Period|AE unrelated to Study Drug|11|||
155127823|NCT02713867|559899438|FG001|Treatment Period|AE unrelated to Study Drug|10|||
155127824|NCT02713867|559899437|FG000|Treatment Period|Death|7|||
155127825|NCT02713867|559899438|FG001|Treatment Period|Death|3|||
155127826|NCT02713867|559899437|FG000|Treatment Period|Study Drug Toxicity|16|||
155127827|NCT02713867|559899438|FG001|Treatment Period|Study Drug Toxicity|19|||
155127828|NCT02713867|559899437|FG000|Treatment Period|Disease Progression|82|||
155127829|NCT02713867|559899438|FG001|Treatment Period|Disease Progression|83|||
155127830|NCT00857948|559899439|FG000|Overall Study|Withdrawal by Subject|2|||
155127831|NCT00857948|559899440|FG001|Overall Study|Withdrawal by Subject|0|||
155127832|NCT00857948|559899441|FG002|Overall Study|Withdrawal by Subject|0|||
155127833|NCT00857948|559899442|FG003|Overall Study|Withdrawal by Subject|0|||
155127834|NCT00857948|559899439|FG000|Overall Study|Protocol Violation|1|||
155127835|NCT00857948|559899440|FG001|Overall Study|Protocol Violation|0|||
155127836|NCT00857948|559899441|FG002|Overall Study|Protocol Violation|1|||
155127837|NCT00857948|559899442|FG003|Overall Study|Protocol Violation|0|||
155127838|NCT04135859|559899443|FG000|Overall Study|Withdrawal by Subject|1|||
155127839|NCT04135859|559899444|FG001|Overall Study|Withdrawal by Subject|0|||
155127840|NCT04135859|559899443|FG000|Overall Study|Withdrawal due to screening failure|1|||
155127841|NCT04135859|559899444|FG001|Overall Study|Withdrawal due to screening failure|2|||
155127842|NCT04135859|559899443|FG000|Overall Study|Did not complete stress test|3|||
155127843|NCT04135859|559899444|FG001|Overall Study|Did not complete stress test|3|||
155127844|NCT04135859|559899443|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
155127845|NCT04135859|559899444|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
155127846|NCT01600053|559899445|FG000|Overall Study|Adverse Event|2|||
155127847|NCT01600053|559899445|FG000|Overall Study|trial will not meet the interim endpoint|9|||
155127848|NCT02715726|559899446|FG000|Overall Study|Adverse Event|2|||
155127849|NCT02715726|559899447|FG001|Overall Study|Adverse Event|6|||
155127850|NCT02715726|559899446|FG000|Overall Study|Protocol Violation|1|||
155127851|NCT02715726|559899447|FG001|Overall Study|Protocol Violation|0|||
155127852|NCT02715726|559899446|FG000|Overall Study|Death|2|||
155127853|NCT02715726|559899447|FG001|Overall Study|Death|1|||
155127854|NCT02715726|559899446|FG000|Overall Study|Participant moved|1|||
155127855|NCT02715726|559899447|FG001|Overall Study|Participant moved|3|||
155127856|NCT02715726|559899446|FG000|Overall Study|Other than specified above|11|||
155127857|NCT02715726|559899447|FG001|Overall Study|Other than specified above|15|||
154923476|NCT04505592|559143861|FG000|Overall Study|Death|2|||
154923477|NCT04505592|559143862|FG001|Overall Study|Death|1|||
154923478|NCT04784455|559143867|FG000|Overall Study|Death|4|||
154923479|NCT04298229|559143868|FG000|Overall Study|Physician Decision|1|||
154923480|NCT04298229|559143869|FG001|Overall Study|Physician Decision|1|||
154923481|NCT04298229|559143868|FG000|Overall Study|Withdrawal by Subject|1|||
154923482|NCT04298229|559143869|FG001|Overall Study|Withdrawal by Subject|1|||
154923483|NCT04298229|559143868|FG000|Overall Study|Did not receive IV loop diuretics|2|||
154923484|NCT04298229|559143869|FG001|Overall Study|Did not receive IV loop diuretics|0|||
154923485|NCT00262119|559143870|FG000|Overall Study|Lost to Follow-up|38|||
154923486|NCT00262119|559143871|FG001|Overall Study|Lost to Follow-up|51|||
154923487|NCT00262119|559143872|FG002|Overall Study|Lost to Follow-up|42|||
154923488|NCT00262119|559143870|FG000|Overall Study|Death|20|||
154923489|NCT00262119|559143871|FG001|Overall Study|Death|19|||
154923490|NCT00262119|559143872|FG002|Overall Study|Death|16|||
154923491|NCT00859313|559143873|FG000|Overall Study|Lack of Efficacy|2|||
154923492|NCT00859313|559143873|FG000|Overall Study|Adverse Event|1|||
154923493|NCT00859313|559143873|FG000|Overall Study|staff error|1|||
154923494|NCT04479358|559143878|FG000|Overall Study|Withdrawal by Subject|0|||
154923495|NCT04479358|559143879|FG001|Overall Study|Withdrawal by Subject|0|||
154923496|NCT04479358|559143880|FG002|Overall Study|Withdrawal by Subject|1|||
154923497|NCT04479358|559143881|FG003|Overall Study|Withdrawal by Subject|0|||
154923498|NCT04479358|559143882|FG004|Overall Study|Withdrawal by Subject|0|||
154923499|NCT04479358|559143883|FG005|Overall Study|Withdrawal by Subject|1|||
154923500|NCT03655951|559143884|FG000|Overall Study|Lost to Follow-up|39|||
154923501|NCT03655951|559143885|FG001|Overall Study|Lost to Follow-up|20|||
154923502|NCT03655951|559143884|FG000|Overall Study|Withdrawal by Subject|0|||
154923503|NCT03655951|559143885|FG001|Overall Study|Withdrawal by Subject|1|||
154923504|NCT04678557|559143886|FG000|Overall Study|Withdrawal by Subject|1|||
154923505|NCT04678557|559143887|FG001|Overall Study|Withdrawal by Subject|0|||
154923506|NCT04678557|559143886|FG000|Overall Study|Lack of Efficacy|0|||
154923507|NCT04678557|559143887|FG001|Overall Study|Lack of Efficacy|13|||
154923508|NCT04678557|559143886|FG000|Overall Study|Safety Evaluation|0|||
154923509|NCT04678557|559143887|FG001|Overall Study|Safety Evaluation|1|||
154923510|NCT03280628|559146257|FG000|Overall Study|Lost to Follow-up|8|||
154923511|NCT03280628|559146258|FG001|Overall Study|Lost to Follow-up|6|||
154923512|NCT03280628|559146259|FG002|Overall Study|Lost to Follow-up|11|||
154923513|NCT01361308|559146260|FG000|Overall Study|Withdrawal by Subject|9|||
154923514|NCT01361308|559146261|FG001|Overall Study|Withdrawal by Subject|13|||
154923515|NCT01361308|559146260|FG000|Overall Study|Physician Decision|3|||
154923516|NCT01361308|559146261|FG001|Overall Study|Physician Decision|3|||
154923517|NCT01361308|559146260|FG000|Overall Study|Lack of Efficacy|2|||
154923518|NCT01361308|559146261|FG001|Overall Study|Lack of Efficacy|0|||
154923519|NCT01361308|559146260|FG000|Overall Study|Protocol Violation|1|||
154923520|NCT01361308|559146261|FG001|Overall Study|Protocol Violation|0|||
154923521|NCT01361308|559146260|FG000|Overall Study|Lost to Follow-up|5|||
154923522|NCT01361308|559146261|FG001|Overall Study|Lost to Follow-up|4|||
154923523|NCT01361308|559146260|FG000|Overall Study|Adverse Event|8|||
154923524|NCT01361308|559146261|FG001|Overall Study|Adverse Event|4|||
154923525|NCT01361308|559146260|FG000|Overall Study|Eligibility Criteria Not Met|2|||
154923526|NCT01361308|559146261|FG001|Overall Study|Eligibility Criteria Not Met|3|||
155127858|NCT02715726|559899446|FG000|Overall Study|Randomized but not treated|1|||
155127859|NCT02715726|559899447|FG001|Overall Study|Randomized but not treated|2|||
154923527|NCT01361308|559146260|FG000|Overall Study|Failed C-SSRS|5|||
154923528|NCT01361308|559146261|FG001|Overall Study|Failed C-SSRS|2|||
154923529|NCT01361308|559146260|FG000|Overall Study|Other|0|||
154923530|NCT01361308|559146261|FG001|Overall Study|Other|1|||
154923531|NCT02503215|559146262|FG000|Overall Study|Unable to wear compression stockings|1|||
154923532|NCT02503215|559146262|FG000|Overall Study|Unable to use positive airway pressure|2|||
154923533|NCT04478994|559146263|FG000|Overall Study|Withdrawal by Subject|1|||
154923534|NCT04478994|559146264|FG001|Overall Study|Withdrawal by Subject|1|||
154923535|NCT01728376|559146267|FG000|Overall Study|Adverse Event|1|||
155006454|NCT02906670|559447047|FG000|Cohort 5, Q2W|Radiological Progression|0|||
155006455|NCT02906670|559447048|FG001|Cohort 5, Q2W|Radiological Progression|0|||
155006456|NCT02906670|559447049|FG002|Cohort 5, Q2W|Radiological Progression|0|||
155006457|NCT02906670|559447050|FG003|Cohort 5, Q2W|Radiological Progression|0|||
155006458|NCT02906670|559447051|FG004|Cohort 5, Q2W|Radiological Progression|0|||
155006459|NCT02906670|559447052|FG005|Cohort 5, Q2W|Radiological Progression|0|||
155006460|NCT02906670|559447053|FG006|Cohort 5, Q2W|Radiological Progression|4|||
155006461|NCT02906670|559447054|FG007|Cohort 5, Q2W|Radiological Progression|0|||
155006462|NCT02906670|559447055|FG008|Cohort 5, Q2W|Radiological Progression|0|||
155006463|NCT02906670|559447056|FG009|Cohort 5, Q2W|Radiological Progression|0|||
155006464|NCT02906670|559447047|FG000|Cohort 5, Q2W|Clinical Progression|0|||
155006465|NCT02906670|559447048|FG001|Cohort 5, Q2W|Clinical Progression|0|||
155006466|NCT02906670|559447049|FG002|Cohort 5, Q2W|Clinical Progression|0|||
155006467|NCT02906670|559447050|FG003|Cohort 5, Q2W|Clinical Progression|0|||
155006468|NCT02906670|559447051|FG004|Cohort 5, Q2W|Clinical Progression|0|||
155006469|NCT02906670|559447052|FG005|Cohort 5, Q2W|Clinical Progression|0|||
155006470|NCT02906670|559447053|FG006|Cohort 5, Q2W|Clinical Progression|1|||
155006471|NCT02906670|559447054|FG007|Cohort 5, Q2W|Clinical Progression|0|||
155006472|NCT02906670|559447055|FG008|Cohort 5, Q2W|Clinical Progression|0|||
155006473|NCT02906670|559447056|FG009|Cohort 5, Q2W|Clinical Progression|0|||
155006474|NCT02906670|559447047|FG000|Cohort 5, Q2W|Adverse Event|0|||
155006475|NCT02906670|559447048|FG001|Cohort 5, Q2W|Adverse Event|0|||
155006476|NCT02906670|559447049|FG002|Cohort 5, Q2W|Adverse Event|0|||
155006477|NCT02906670|559447050|FG003|Cohort 5, Q2W|Adverse Event|0|||
155006478|NCT02906670|559447051|FG004|Cohort 5, Q2W|Adverse Event|0|||
155006479|NCT02906670|559447052|FG005|Cohort 5, Q2W|Adverse Event|0|||
155006480|NCT02906670|559447053|FG006|Cohort 5, Q2W|Adverse Event|1|||
155006481|NCT02906670|559447054|FG007|Cohort 5, Q2W|Adverse Event|0|||
155006482|NCT02906670|559447055|FG008|Cohort 5, Q2W|Adverse Event|0|||
155006483|NCT02906670|559447056|FG009|Cohort 5, Q2W|Adverse Event|0|||
155006484|NCT02906670|559447047|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006485|NCT02906670|559447048|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006486|NCT02906670|559447049|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006487|NCT02906670|559447050|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006488|NCT02906670|559447051|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006489|NCT02906670|559447052|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006490|NCT02906670|559447053|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
155006491|NCT02906670|559447054|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006492|NCT02906670|559447055|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006493|NCT02906670|559447056|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
155006494|NCT02906670|559447047|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
155006495|NCT02906670|559447048|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
155006496|NCT02906670|559447049|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
155006497|NCT02906670|559447050|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
155006498|NCT02906670|559447051|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
155006499|NCT02906670|559447052|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
155006500|NCT02906670|559447053|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
155006501|NCT02906670|559447054|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
155006502|NCT02906670|559447055|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
155006503|NCT02906670|559447056|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
155006504|NCT02906670|559447047|FG000|Cohort 5P, Q2W|Adverse Event|0|||
155006505|NCT02906670|559447048|FG001|Cohort 5P, Q2W|Adverse Event|0|||
155006506|NCT02906670|559447049|FG002|Cohort 5P, Q2W|Adverse Event|0|||
155006507|NCT02906670|559447050|FG003|Cohort 5P, Q2W|Adverse Event|0|||
155006508|NCT02906670|559447051|FG004|Cohort 5P, Q2W|Adverse Event|0|||
155006509|NCT02906670|559447052|FG005|Cohort 5P, Q2W|Adverse Event|0|||
155006510|NCT02906670|559447053|FG006|Cohort 5P, Q2W|Adverse Event|0|||
155006511|NCT02906670|559447054|FG007|Cohort 5P, Q2W|Adverse Event|1|||
155006512|NCT02906670|559447055|FG008|Cohort 5P, Q2W|Adverse Event|0|||
155006513|NCT02906670|559447056|FG009|Cohort 5P, Q2W|Adverse Event|0|||
155006514|NCT02906670|559447047|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
155006515|NCT02906670|559447048|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
155006516|NCT02906670|559447049|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
155006517|NCT02906670|559447050|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
155006518|NCT02906670|559447051|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
155006519|NCT02906670|559447052|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
155006520|NCT02906670|559447053|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
155127860|NCT01565941|559899448|FG000|Overall Study|Withdrawn by parent/guardian|3|||
155127861|NCT01565941|559899449|FG001|Overall Study|Withdrawn by parent/guardian|2|||
155006521|NCT02906670|559447054|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
155006522|NCT02906670|559447055|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
155006523|NCT02906670|559447056|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
155006524|NCT02906670|559447047|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
155006525|NCT02906670|559447048|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
155006526|NCT02906670|559447049|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
155006527|NCT02906670|559447050|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
155006528|NCT02906670|559447051|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
155006529|NCT02906670|559447052|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
155006530|NCT02906670|559447053|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
155006531|NCT02906670|559447054|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
155006532|NCT02906670|559447055|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
155006533|NCT02906670|559447056|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
155006534|NCT02906670|559447047|FG000|Cohort 4P, QW|Radiological Progression|0|||
155006535|NCT02906670|559447048|FG001|Cohort 4P, QW|Radiological Progression|0|||
155006536|NCT02906670|559447049|FG002|Cohort 4P, QW|Radiological Progression|0|||
155006537|NCT02906670|559447050|FG003|Cohort 4P, QW|Radiological Progression|3|||
155006538|NCT02906670|559447051|FG004|Cohort 4P, QW|Radiological Progression|0|||
155006539|NCT02906670|559447052|FG005|Cohort 4P, QW|Radiological Progression|0|||
155006540|NCT02906670|559447053|FG006|Cohort 4P, QW|Radiological Progression|0|||
155006541|NCT02906670|559447054|FG007|Cohort 4P, QW|Radiological Progression|0|||
155006542|NCT02906670|559447055|FG008|Cohort 4P, QW|Radiological Progression|0|||
155006543|NCT02906670|559447056|FG009|Cohort 4P, QW|Radiological Progression|0|||
155127862|NCT01565941|559899448|FG000|Overall Study|Randomized; did not receive intevention|8|||
155127863|NCT01565941|559899449|FG001|Overall Study|Randomized; did not receive intevention|2|||
155127864|NCT01504204|559899466|FG000|Overall Study|Lost to Follow-up|1|||
155127865|NCT01504204|559899467|FG001|Overall Study|Lost to Follow-up|1|||
155127866|NCT02049138|559899468|FG000|Overall Study|Adverse Event|46|||
155127867|NCT02049138|559899469|FG001|Overall Study|Adverse Event|25|||
155127868|NCT02049138|559899470|FG002|Overall Study|Adverse Event|1|||
155127869|NCT02049138|559899468|FG000|Overall Study|Withdrawal by Subject|57|||
155127870|NCT02049138|559899469|FG001|Overall Study|Withdrawal by Subject|21|||
155127871|NCT02049138|559899470|FG002|Overall Study|Withdrawal by Subject|5|||
155127872|NCT02049138|559899468|FG000|Overall Study|Lost to Follow-up|18|||
155127873|NCT02049138|559899469|FG001|Overall Study|Lost to Follow-up|5|||
155127874|NCT02049138|559899470|FG002|Overall Study|Lost to Follow-up|1|||
155127875|NCT02049138|559899468|FG000|Overall Study|Lack of Efficacy|10|||
155127876|NCT02049138|559899469|FG001|Overall Study|Lack of Efficacy|26|||
155127877|NCT02049138|559899470|FG002|Overall Study|Lack of Efficacy|1|||
155127878|NCT02049138|559899468|FG000|Overall Study|Non-Compliance|15|||
155127879|NCT02049138|559899469|FG001|Overall Study|Non-Compliance|6|||
155127880|NCT02049138|559899470|FG002|Overall Study|Non-Compliance|0|||
155127881|NCT02049138|559899468|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
155127882|NCT02049138|559899469|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
155127883|NCT02049138|559899470|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
155127884|NCT02049138|559899468|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
155127885|NCT02049138|559899469|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155127886|NCT02049138|559899470|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
155127887|NCT02049138|559899468|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155006544|NCT02906670|559447047|FG000|Cohort 7P, Q2W|Adverse Event|0|||
155006545|NCT02906670|559447048|FG001|Cohort 7P, Q2W|Adverse Event|0|||
155006546|NCT02906670|559447049|FG002|Cohort 7P, Q2W|Adverse Event|0|||
155006547|NCT02906670|559447050|FG003|Cohort 7P, Q2W|Adverse Event|0|||
155006548|NCT02906670|559447051|FG004|Cohort 7P, Q2W|Adverse Event|0|||
155006549|NCT02906670|559447052|FG005|Cohort 7P, Q2W|Adverse Event|0|||
155006550|NCT02906670|559447053|FG006|Cohort 7P, Q2W|Adverse Event|0|||
155006551|NCT02906670|559447054|FG007|Cohort 7P, Q2W|Adverse Event|0|||
155006552|NCT02906670|559447055|FG008|Cohort 7P, Q2W|Adverse Event|0|||
155006553|NCT02906670|559447056|FG009|Cohort 7P, Q2W|Adverse Event|1|||
155006554|NCT02906670|559447047|FG000|Cohort 7P, Q2W|Physician Decision|0|||
155006555|NCT02906670|559447048|FG001|Cohort 7P, Q2W|Physician Decision|0|||
155006556|NCT02906670|559447049|FG002|Cohort 7P, Q2W|Physician Decision|0|||
155006557|NCT02906670|559447050|FG003|Cohort 7P, Q2W|Physician Decision|0|||
155006558|NCT02906670|559447051|FG004|Cohort 7P, Q2W|Physician Decision|0|||
155006559|NCT02906670|559447052|FG005|Cohort 7P, Q2W|Physician Decision|0|||
155006560|NCT02906670|559447053|FG006|Cohort 7P, Q2W|Physician Decision|0|||
155006561|NCT02906670|559447054|FG007|Cohort 7P, Q2W|Physician Decision|0|||
155178372|NCT00534313|560091445|FG001|Long-term Period|Administrative reason by sponsor|15|||
155178373|NCT00534313|560091446|FG002|Long-term Period|Administrative reason by sponsor|26|||
155127888|NCT02049138|559899469|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
155178374|NCT00534313|560091447|FG003|Long-term Period|Administrative reason by sponsor|18|||
155006562|NCT02906670|559447055|FG008|Cohort 7P, Q2W|Physician Decision|0|||
155006563|NCT02906670|559447056|FG009|Cohort 7P, Q2W|Physician Decision|1|||
155006564|NCT02906670|559447047|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155127889|NCT02049138|559899470|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
155127890|NCT02049138|559899468|FG000|Overall Study|Other|15|||
155178375|NCT00534313|560091444|FG000|Long-term Period|Other|1|||
155006565|NCT02906670|559447048|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155006566|NCT02906670|559447049|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155127891|NCT02049138|559899469|FG001|Overall Study|Other|13|||
155127892|NCT02049138|559899470|FG002|Overall Study|Other|0|||
155178376|NCT00534313|560091445|FG001|Long-term Period|Other|2|||
155006567|NCT02906670|559447050|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155127893|NCT02049138|559899468|FG000|Overall Study|Missing|0|||
155127894|NCT02049138|559899469|FG001|Overall Study|Missing|1|||
155127895|NCT02049138|559899470|FG002|Overall Study|Missing|0|||
155127896|NCT05086510|559899471|FG000|Overall Study|Lost to Follow-up|0|||
155127897|NCT05086510|559899472|FG001|Overall Study|Lost to Follow-up|2|||
155127898|NCT05086510|559899471|FG000|Overall Study|Death|0|||
155127899|NCT05086510|559899472|FG001|Overall Study|Death|2|||
155127900|NCT00654004|559899474|FG000|Overall Study|Lost to Follow-up|1|||
155127901|NCT00654004|559899475|FG001|Overall Study|Lost to Follow-up|0|||
155127902|NCT01571453|559899476|FG000|Overall Study|Adverse Event|14|||
155127903|NCT01571453|559899477|FG001|Overall Study|Adverse Event|32|||
155127904|NCT01571453|559899476|FG000|Overall Study|Lack of Efficacy|8|||
155127905|NCT01571453|559899477|FG001|Overall Study|Lack of Efficacy|3|||
155127906|NCT01571453|559899476|FG000|Overall Study|Non-compliance|2|||
155127907|NCT01571453|559899477|FG001|Overall Study|Non-compliance|4|||
155127908|NCT01571453|559899476|FG000|Overall Study|Protocol Violation|1|||
155127909|NCT01571453|559899477|FG001|Overall Study|Protocol Violation|5|||
155127910|NCT01571453|559899476|FG000|Overall Study|Withdrawal of consent|5|||
155127911|NCT01571453|559899477|FG001|Overall Study|Withdrawal of consent|13|||
155127912|NCT01571453|559899476|FG000|Overall Study|Lost to Follow-up|4|||
155127913|NCT01571453|559899477|FG001|Overall Study|Lost to Follow-up|2|||
155127914|NCT01571453|559899476|FG000|Overall Study|Administrative or other reason(s)|4|||
155127915|NCT01571453|559899477|FG001|Overall Study|Administrative or other reason(s)|3|||
155127916|NCT00444067|559899478|FG000|Overall Study|Lost to Follow-up|0|||
155127917|NCT00444067|559899479|FG001|Overall Study|Lost to Follow-up|1|||
155127918|NCT04881747|559899480|FG000|Period 2 Washout|Adverse Event|1|||
155127919|NCT04881747|559899481|FG001|Period 2 Washout|Adverse Event|0|||
155127920|NCT04881747|559899482|FG002|Period 2 Washout|Adverse Event|0|||
155127921|NCT04881747|559899483|FG003|Period 2 Washout|Adverse Event|0|||
155127922|NCT04881747|559899484|FG004|Period 2 Washout|Adverse Event|1|||
155127923|NCT04881747|559899485|FG005|Period 2 Washout|Adverse Event|0|||
155127924|NCT04881747|559899480|FG000|Period 2 Washout|Withdrawal by Subject|1|||
155127925|NCT04881747|559899481|FG001|Period 2 Washout|Withdrawal by Subject|0|||
155127926|NCT04881747|559899482|FG002|Period 2 Washout|Withdrawal by Subject|0|||
155127927|NCT04881747|559899483|FG003|Period 2 Washout|Withdrawal by Subject|1|||
155127928|NCT04881747|559899484|FG004|Period 2 Washout|Withdrawal by Subject|0|||
155127929|NCT04881747|559899485|FG005|Period 2 Washout|Withdrawal by Subject|0|||
155127930|NCT00521222|559899486|FG000|Overall Study|Lost to Follow-up|0|||
155127931|NCT00521222|559899487|FG001|Overall Study|Lost to Follow-up|0|||
155127932|NCT00521222|559899488|FG002|Overall Study|Lost to Follow-up|1|||
155127933|NCT00521222|559899489|FG003|Overall Study|Lost to Follow-up|1|||
155127934|NCT00521222|559899486|FG000|Overall Study|Withdrawal by Subject|0|||
155127935|NCT00521222|559899487|FG001|Overall Study|Withdrawal by Subject|0|||
155127936|NCT00521222|559899488|FG002|Overall Study|Withdrawal by Subject|2|||
155127937|NCT00521222|559899489|FG003|Overall Study|Withdrawal by Subject|0|||
155127938|NCT00521222|559899486|FG000|Overall Study|Physician Decision|0|||
155127939|NCT00521222|559899487|FG001|Overall Study|Physician Decision|1|||
155127940|NCT00521222|559899488|FG002|Overall Study|Physician Decision|0|||
155127941|NCT00521222|559899489|FG003|Overall Study|Physician Decision|1|||
155127942|NCT03869333|559899495|FG000|Overall Study|Lost to Follow-up|1|||
155127943|NCT03869333|559899496|FG001|Overall Study|Lost to Follow-up|0|||
155127944|NCT03869333|559899497|FG002|Overall Study|Lost to Follow-up|0|||
155127945|NCT03869333|559899498|FG003|Overall Study|Lost to Follow-up|0|||
155127946|NCT03869333|559899495|FG000|Overall Study|Pregnancy|1|||
155127947|NCT03869333|559899496|FG001|Overall Study|Pregnancy|0|||
155127948|NCT03869333|559899497|FG002|Overall Study|Pregnancy|0|||
155127949|NCT03869333|559899498|FG003|Overall Study|Pregnancy|0|||
155127950|NCT03869333|559899495|FG000|Overall Study|Physician Decision|0|||
155127951|NCT03869333|559899496|FG001|Overall Study|Physician Decision|1|||
155178377|NCT00534313|560091446|FG002|Long-term Period|Other|2|||
155178378|NCT00534313|560091447|FG003|Long-term Period|Other|2|||
155178379|NCT00402233|560091448|FG000|Overall Study|Adverse Event|1|||
155178380|NCT00402233|560091449|FG001|Overall Study|Adverse Event|7|||
155178381|NCT00402233|560091450|FG002|Overall Study|Adverse Event|9|||
155178382|NCT00402233|560091451|FG003|Overall Study|Adverse Event|9|||
155178383|NCT00402233|560091448|FG000|Overall Study|Protocol Violation|0|||
155127952|NCT03869333|559899497|FG002|Overall Study|Physician Decision|0|||
155127953|NCT03869333|559899498|FG003|Overall Study|Physician Decision|0|||
155127954|NCT01927055|559899499|FG000|Open-label|Adverse Event|6|||
155127955|NCT01927055|559899500|FG001|Open-label|Adverse Event|0|||
155127956|NCT01927055|559899501|FG002|Open-label|Adverse Event|0|||
155127957|NCT01927055|559899499|FG000|Open-label|Withdrawal by Subject|1|||
155127958|NCT01927055|559899500|FG001|Open-label|Withdrawal by Subject|0|||
155127959|NCT01927055|559899501|FG002|Open-label|Withdrawal by Subject|0|||
155127960|NCT01927055|559899499|FG000|Open-label|Study Stopped|4|||
155127961|NCT01927055|559899500|FG001|Open-label|Study Stopped|0|||
155127962|NCT01927055|559899501|FG002|Open-label|Study Stopped|0|||
155127963|NCT01927055|559899499|FG000|Open-label|Supine Hypertension|4|||
155127964|NCT01927055|559899500|FG001|Open-label|Supine Hypertension|0|||
155127965|NCT01927055|559899501|FG002|Open-label|Supine Hypertension|0|||
155127966|NCT01927055|559899499|FG000|Open-label|Difficulty attending study visits|1|||
155127967|NCT01927055|559899500|FG001|Open-label|Difficulty attending study visits|0|||
155127968|NCT01927055|559899501|FG002|Open-label|Difficulty attending study visits|0|||
155127969|NCT01927055|559899499|FG000|Double-Blind|Adverse Event|0|||
155127970|NCT01927055|559899500|FG001|Double-Blind|Adverse Event|1|||
155127971|NCT01927055|559899501|FG002|Double-Blind|Adverse Event|1|||
155127972|NCT01927055|559899499|FG000|Double-Blind|Protocol Violation|0|||
155127973|NCT01927055|559899500|FG001|Double-Blind|Protocol Violation|0|||
155127974|NCT01927055|559899501|FG002|Double-Blind|Protocol Violation|1|||
155127975|NCT01927055|559899499|FG000|Double-Blind|Withdrawal by Subject|0|||
155127976|NCT01927055|559899500|FG001|Double-Blind|Withdrawal by Subject|2|||
155127977|NCT01927055|559899501|FG002|Double-Blind|Withdrawal by Subject|3|||
155127978|NCT01927055|559899499|FG000|Double-Blind|Study Stopped|0|||
155127979|NCT01927055|559899500|FG001|Double-Blind|Study Stopped|7|||
155127980|NCT01927055|559899501|FG002|Double-Blind|Study Stopped|7|||
155127981|NCT01927055|559899499|FG000|Double-Blind|Supine Hypertension|0|||
155127982|NCT01927055|559899500|FG001|Double-Blind|Supine Hypertension|0|||
155127983|NCT01927055|559899501|FG002|Double-Blind|Supine Hypertension|1|||
155127984|NCT01927055|559899499|FG000|Double-Blind|Extended Vacation|0|||
155127985|NCT01927055|559899500|FG001|Double-Blind|Extended Vacation|1|||
155127986|NCT01927055|559899501|FG002|Double-Blind|Extended Vacation|0|||
155127987|NCT02598128|559899502|FG000|Period A: Days -7 to -1|Adverse Event|1|||
155127988|NCT02598128|559899503|FG001|Period A: Days -7 to -1|Adverse Event|0|||
155127989|NCT02598128|559899504|FG002|Period A: Days -7 to -1|Adverse Event|0|||
155127990|NCT02598128|559899505|FG003|Period A: Days -7 to -1|Adverse Event|0|||
155127991|NCT01064687|559899508|FG000|Overall Study|Adverse Event|9|||
155127992|NCT01064687|559899509|FG001|Overall Study|Adverse Event|4|||
155127993|NCT01064687|559899510|FG002|Overall Study|Adverse Event|10|||
155127994|NCT01064687|559899511|FG003|Overall Study|Adverse Event|3|||
155127995|NCT01064687|559899508|FG000|Overall Study|Death|1|||
155127996|NCT01064687|559899509|FG001|Overall Study|Death|1|||
155127997|NCT01064687|559899510|FG002|Overall Study|Death|0|||
155127998|NCT01064687|559899511|FG003|Overall Study|Death|0|||
155127999|NCT01064687|559899508|FG000|Overall Study|Entry Criteria Not Met|3|||
155128000|NCT01064687|559899509|FG001|Overall Study|Entry Criteria Not Met|0|||
155128001|NCT01064687|559899510|FG002|Overall Study|Entry Criteria Not Met|0|||
155128002|NCT01064687|559899511|FG003|Overall Study|Entry Criteria Not Met|0|||
155128003|NCT01064687|559899508|FG000|Overall Study|Lack of Efficacy|1|||
155128004|NCT01064687|559899509|FG001|Overall Study|Lack of Efficacy|0|||
155128005|NCT01064687|559899510|FG002|Overall Study|Lack of Efficacy|2|||
155128006|NCT01064687|559899511|FG003|Overall Study|Lack of Efficacy|3|||
155128007|NCT01064687|559899508|FG000|Overall Study|Lost to Follow-up|7|||
155128008|NCT01064687|559899509|FG001|Overall Study|Lost to Follow-up|10|||
155128009|NCT01064687|559899510|FG002|Overall Study|Lost to Follow-up|13|||
155128010|NCT01064687|559899511|FG003|Overall Study|Lost to Follow-up|5|||
155128011|NCT01064687|559899508|FG000|Overall Study|Physician Decision|2|||
155128012|NCT01064687|559899509|FG001|Overall Study|Physician Decision|2|||
155128013|NCT01064687|559899510|FG002|Overall Study|Physician Decision|0|||
155128014|NCT01064687|559899511|FG003|Overall Study|Physician Decision|0|||
155128015|NCT01064687|559899508|FG000|Overall Study|Protocol Violation|1|||
155128016|NCT01064687|559899509|FG001|Overall Study|Protocol Violation|1|||
155128017|NCT01064687|559899510|FG002|Overall Study|Protocol Violation|0|||
155128018|NCT01064687|559899511|FG003|Overall Study|Protocol Violation|1|||
155128019|NCT01064687|559899508|FG000|Overall Study|Sponsor Decision|0|||
155128020|NCT01064687|559899509|FG001|Overall Study|Sponsor Decision|0|||
155128021|NCT01064687|559899510|FG002|Overall Study|Sponsor Decision|3|||
155128022|NCT01064687|559899511|FG003|Overall Study|Sponsor Decision|0|||
155128023|NCT01064687|559899508|FG000|Overall Study|Withdrawal by Subject|9|||
155128024|NCT01064687|559899509|FG001|Overall Study|Withdrawal by Subject|7|||
155128025|NCT01064687|559899510|FG002|Overall Study|Withdrawal by Subject|12|||
155128026|NCT01064687|559899511|FG003|Overall Study|Withdrawal by Subject|5|||
155128027|NCT01064687|559899508|FG000|Overall Study|Treatment Noncompliance|1|||
155128028|NCT01064687|559899509|FG001|Overall Study|Treatment Noncompliance|1|||
155128029|NCT01064687|559899510|FG002|Overall Study|Treatment Noncompliance|1|||
155128030|NCT01064687|559899511|FG003|Overall Study|Treatment Noncompliance|0|||
155128031|NCT05219669|559899516|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
155128032|NCT05219669|559899517|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
155178384|NCT00402233|560091449|FG001|Overall Study|Protocol Violation|1|||
155178385|NCT00402233|560091450|FG002|Overall Study|Protocol Violation|0|||
155128033|NCT05219669|559899518|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
155128034|NCT05219669|559899519|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
155128035|NCT05219669|559899520|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
155128036|NCT05219669|559899521|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
155128037|NCT03134183|559899523|FG000|Overall Study|Withdrawal by Subject|1|||
155128038|NCT03134183|559899524|FG001|Overall Study|Withdrawal by Subject|1|||
155128039|NCT02177838|559899527|FG000|Overall Study|Withdrawal by Subject|1|||
155128040|NCT02177838|559899527|FG000|Overall Study|Physician Decision|1|||
155128041|NCT02177838|559899527|FG000|Overall Study|Death|1|||
155128042|NCT02404649|559899529|FG000|Overall Study|Adverse Event|1|||
155128043|NCT02404649|559899530|FG001|Overall Study|Adverse Event|2|||
155128044|NCT00162266|559899534|FG000|Double-Blind Period|Adverse Event|5|||
155128045|NCT00162266|559899535|FG001|Double-Blind Period|Adverse Event|9|||
155128046|NCT00162266|559899536|FG002|Double-Blind Period|Adverse Event|11|||
155128047|NCT00162266|559899537|FG003|Double-Blind Period|Adverse Event|0|||
155128048|NCT00162266|559899534|FG000|Double-Blind Period|Death|0|||
155128049|NCT00162266|559899535|FG001|Double-Blind Period|Death|1|||
155128050|NCT00162266|559899536|FG002|Double-Blind Period|Death|0|||
155128051|NCT00162266|559899537|FG003|Double-Blind Period|Death|0|||
155128052|NCT00162266|559899534|FG000|Double-Blind Period|Lost to Follow-up|1|||
155128053|NCT00162266|559899535|FG001|Double-Blind Period|Lost to Follow-up|2|||
155128054|NCT00162266|559899536|FG002|Double-Blind Period|Lost to Follow-up|0|||
155128055|NCT00162266|559899537|FG003|Double-Blind Period|Lost to Follow-up|0|||
155128056|NCT00162266|559899534|FG000|Double-Blind Period|Other Reason|1|||
155128057|NCT00162266|559899535|FG001|Double-Blind Period|Other Reason|0|||
155128058|NCT00162266|559899536|FG002|Double-Blind Period|Other Reason|1|||
155128059|NCT00162266|559899537|FG003|Double-Blind Period|Other Reason|0|||
155128060|NCT00162266|559899534|FG000|Double-Blind Period|Lack of Efficacy|13|||
155128061|NCT00162266|559899535|FG001|Double-Blind Period|Lack of Efficacy|17|||
155128062|NCT00162266|559899536|FG002|Double-Blind Period|Lack of Efficacy|30|||
155128063|NCT00162266|559899537|FG003|Double-Blind Period|Lack of Efficacy|0|||
155128064|NCT00162266|559899534|FG000|Double-Blind Period|Withdrawal by Subject|5|||
155128065|NCT00162266|559899535|FG001|Double-Blind Period|Withdrawal by Subject|2|||
155128066|NCT00162266|559899536|FG002|Double-Blind Period|Withdrawal by Subject|6|||
155128067|NCT00162266|559899537|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155128068|NCT00162266|559899534|FG000|Open-Label Period|Death|0|||
155128069|NCT00162266|559899535|FG001|Open-Label Period|Death|0|||
155128070|NCT00162266|559899536|FG002|Open-Label Period|Death|0|||
155128071|NCT00162266|559899537|FG003|Open-Label Period|Death|7|||
155128072|NCT00162266|559899534|FG000|Open-Label Period|Adverse Event|0|||
155128073|NCT00162266|559899535|FG001|Open-Label Period|Adverse Event|0|||
155128074|NCT00162266|559899536|FG002|Open-Label Period|Adverse Event|0|||
155128075|NCT00162266|559899537|FG003|Open-Label Period|Adverse Event|46|||
155128076|NCT00162266|559899534|FG000|Open-Label Period|Lack of Efficacy|0|||
155128077|NCT00162266|559899535|FG001|Open-Label Period|Lack of Efficacy|0|||
155128078|NCT00162266|559899536|FG002|Open-Label Period|Lack of Efficacy|0|||
155128079|NCT00162266|559899537|FG003|Open-Label Period|Lack of Efficacy|26|||
155006568|NCT02906670|559447051|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155006569|NCT02906670|559447052|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155006570|NCT02906670|559447053|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155006571|NCT02906670|559447054|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155006572|NCT02906670|559447055|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
155006573|NCT02906670|559447056|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
155006574|NCT02906670|559447047|FG000|Cohort 5P, QW|Radiological Progression|0|||
155006575|NCT02906670|559447048|FG001|Cohort 5P, QW|Radiological Progression|0|||
155006576|NCT02906670|559447049|FG002|Cohort 5P, QW|Radiological Progression|0|||
155006577|NCT02906670|559447050|FG003|Cohort 5P, QW|Radiological Progression|0|||
155006578|NCT02906670|559447051|FG004|Cohort 5P, QW|Radiological Progression|3|||
155006579|NCT02906670|559447052|FG005|Cohort 5P, QW|Radiological Progression|0|||
155006580|NCT02906670|559447053|FG006|Cohort 5P, QW|Radiological Progression|0|||
155006581|NCT02906670|559447054|FG007|Cohort 5P, QW|Radiological Progression|0|||
155006582|NCT02906670|559447055|FG008|Cohort 5P, QW|Radiological Progression|0|||
155006583|NCT02906670|559447056|FG009|Cohort 5P, QW|Radiological Progression|0|||
155006584|NCT01349192|559447057|FG000|Overall Study|Protocol Violation|0|||
155006585|NCT01349192|559447058|FG001|Overall Study|Protocol Violation|1|||
155006586|NCT01349192|559447057|FG000|Overall Study|Withdrawal by Subject|0|||
155006587|NCT01349192|559447058|FG001|Overall Study|Withdrawal by Subject|2|||
155006588|NCT01349192|559447057|FG000|Overall Study|Lost to Follow-up|1|||
155006589|NCT01349192|559447058|FG001|Overall Study|Lost to Follow-up|3|||
155006590|NCT01349192|559447057|FG000|Overall Study|Failure to adhere to Protocol|2|||
155006591|NCT01349192|559447058|FG001|Overall Study|Failure to adhere to Protocol|0|||
155006592|NCT03749330|559447059|FG000|Overall Study|Clinicians left work in the CICU|0|||
155128080|NCT00162266|559899534|FG000|Open-Label Period|Lost to Follow-up|0|||
155128081|NCT00162266|559899535|FG001|Open-Label Period|Lost to Follow-up|0|||
155128082|NCT00162266|559899536|FG002|Open-Label Period|Lost to Follow-up|0|||
155128083|NCT00162266|559899537|FG003|Open-Label Period|Lost to Follow-up|3|||
155128084|NCT00162266|559899534|FG000|Open-Label Period|Withdrawal by Subject|0|||
155128085|NCT00162266|559899535|FG001|Open-Label Period|Withdrawal by Subject|0|||
155128086|NCT00162266|559899536|FG002|Open-Label Period|Withdrawal by Subject|0|||
155006593|NCT03749330|559447060|FG001|Overall Study|Clinicians left work in the CICU|2|||
155006594|NCT03749330|559447061|FG002|Overall Study|Clinicians left work in the CICU|0|||
155006595|NCT03749330|559447062|FG003|Overall Study|Clinicians left work in the CICU|0|||
155006596|NCT03749330|559447063|FG004|Overall Study|Clinicians left work in the CICU|0|||
155006597|NCT03749330|559447064|FG005|Overall Study|Clinicians left work in the CICU|0|||
155128087|NCT00162266|559899537|FG003|Open-Label Period|Withdrawal by Subject|31|||
155128088|NCT00162266|559899534|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
155128089|NCT00162266|559899535|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
155006598|NCT01973439|559447065|FG000|Overall Study|Lost samples from one PK Day|2|||
155128090|NCT00162266|559899536|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
155128091|NCT00162266|559899537|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
155128092|NCT00162266|559899534|FG000|Open-Label Period|Other Reasons|0|||
155128093|NCT00162266|559899535|FG001|Open-Label Period|Other Reasons|0|||
155128094|NCT00162266|559899536|FG002|Open-Label Period|Other Reasons|0|||
155128095|NCT00162266|559899537|FG003|Open-Label Period|Other Reasons|15|||
155128096|NCT02299076|559899538|FG000|Overall Study|Fraudulent Entries|20|||
155128097|NCT02299076|559899539|FG001|Overall Study|Fraudulent Entries|14|||
155128098|NCT01839656|559899540|FG000|Overall Study|Withdrawal by Subject|1|||
155128099|NCT01839656|559899541|FG001|Overall Study|Withdrawal by Subject|1|||
155128100|NCT01839656|559899540|FG000|Overall Study|Adverse event, serious fatal|1|||
155128101|NCT01839656|559899541|FG001|Overall Study|Adverse event, serious fatal|4|||
155128102|NCT01839656|559899540|FG000|Overall Study|Early study closure|0|||
155128103|NCT01839656|559899541|FG001|Overall Study|Early study closure|11|||
155128104|NCT01839656|559899540|FG000|Overall Study|Adverse Event|1|||
155128105|NCT01839656|559899541|FG001|Overall Study|Adverse Event|0|||
155128106|NCT00499746|559899542|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
155128107|NCT00499746|559899542|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
155128108|NCT00499746|559899542|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
155128109|NCT00499746|559899542|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
155128110|NCT00558272|559899545|FG000|Overall Study|Adverse Event|10|||
155128111|NCT00558272|559899546|FG001|Overall Study|Adverse Event|0|||
155128112|NCT00558272|559899545|FG000|Overall Study|Death|1|||
155128113|NCT00558272|559899546|FG001|Overall Study|Death|0|||
155128114|NCT00558272|559899545|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
155128115|NCT00558272|559899546|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
155128116|NCT00558272|559899545|FG000|Overall Study|AZ study team decision|0|||
155128117|NCT00558272|559899546|FG001|Overall Study|AZ study team decision|1|||
155128118|NCT00558272|559899545|FG000|Overall Study|Incorrectly enrolled|1|||
155128119|NCT00558272|559899546|FG001|Overall Study|Incorrectly enrolled|0|||
155128120|NCT00558272|559899545|FG000|Overall Study|Withdrawal by Subject|0|||
155128121|NCT00558272|559899546|FG001|Overall Study|Withdrawal by Subject|1|||
155128122|NCT04311463|559899547|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
155128123|NCT04311463|559899548|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
155128124|NCT04311463|559899547|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
155128125|NCT04311463|559899548|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
155128126|NCT04311463|559899547|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
155128127|NCT04311463|559899548|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
155128128|NCT01291277|559899554|FG000|Overall Study|Death|2|||
155128129|NCT01291277|559899555|FG001|Overall Study|Death|2|||
155128130|NCT01291277|559899554|FG000|Overall Study|Lost to Follow-up|3|||
155128131|NCT01291277|559899555|FG001|Overall Study|Lost to Follow-up|1|||
155128132|NCT02963701|559899556|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
155128133|NCT02963701|559899557|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
155128134|NCT03480009|559899558|FG000|Overall Study|Lost to Follow-up|4|||
155128135|NCT03480009|559899559|FG001|Overall Study|Lost to Follow-up|5|||
155128136|NCT03480009|559899560|FG002|Overall Study|Lost to Follow-up|4|||
155128137|NCT03480009|559899561|FG003|Overall Study|Lost to Follow-up|0|||
155128138|NCT00637572|559899562|FG000|Overall Study|Adverse Event|1|||
155128139|NCT00637572|559899563|FG001|Overall Study|Adverse Event|2|||
155128140|NCT00637572|559899562|FG000|Overall Study|Death|0|||
155128141|NCT00637572|559899563|FG001|Overall Study|Death|1|||
155128142|NCT00637572|559899562|FG000|Overall Study|Lost to Follow-up|0|||
155128143|NCT00637572|559899563|FG001|Overall Study|Lost to Follow-up|1|||
155128144|NCT00637572|559899562|FG000|Overall Study|Physician Decision|1|||
155128145|NCT00637572|559899563|FG001|Overall Study|Physician Decision|1|||
155128146|NCT00637572|559899562|FG000|Overall Study|Withdrawal by Subject|0|||
155128147|NCT00637572|559899563|FG001|Overall Study|Withdrawal by Subject|2|||
155128148|NCT00637572|559899562|FG000|Overall Study|Illicit Drug Use|1|||
155128149|NCT00637572|559899563|FG001|Overall Study|Illicit Drug Use|0|||
155128150|NCT00896649|559899564|FG000|Overall Study|Physician Decision|1|||
155128151|NCT00896649|559899564|FG000|Overall Study|Pregnancy|1|||
155006599|NCT01973439|559447065|FG000|Overall Study|Vomiting after commencing once daily|1|||
155006600|NCT01973439|559447065|FG000|Overall Study|PK curve incomplete|2|||
155006601|NCT02038010|559447066|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
155006602|NCT02038010|559447067|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
155128152|NCT00896649|559899564|FG000|Overall Study|missing documentation|1|||
155128153|NCT00896649|559899564|FG000|Overall Study|technical difficulties|2|||
155128154|NCT03652675|559899565|FG000|Overall Study|Lost to Follow-up|4|||
155128155|NCT03652675|559899566|FG001|Overall Study|Lost to Follow-up|4|||
155128156|NCT03442296|559899569|FG000|3 Month Follow-up|Death|3|||
155128157|NCT03442296|559899570|FG001|3 Month Follow-up|Death|1|||
155178386|NCT00402233|560091451|FG003|Overall Study|Protocol Violation|0|||
155128158|NCT03442296|559899569|FG000|3 Month Follow-up|Lost to Follow-up|1|||
155178387|NCT00402233|560091448|FG000|Overall Study|Withdrawal by Subject|2|||
155178388|NCT00402233|560091449|FG001|Overall Study|Withdrawal by Subject|1|||
155178389|NCT00402233|560091450|FG002|Overall Study|Withdrawal by Subject|2|||
155178390|NCT00402233|560091451|FG003|Overall Study|Withdrawal by Subject|2|||
155178391|NCT00402233|560091448|FG000|Overall Study|Worsening of disease under study|2|||
155178392|NCT00402233|560091449|FG001|Overall Study|Worsening of disease under study|0|||
155178393|NCT00402233|560091450|FG002|Overall Study|Worsening of disease under study|0|||
155178394|NCT00402233|560091451|FG003|Overall Study|Worsening of disease under study|0|||
155178395|NCT00402233|560091448|FG000|Overall Study|Worsening of other pre-existing disease|0|||
155178396|NCT00402233|560091449|FG001|Overall Study|Worsening of other pre-existing disease|1|||
155178397|NCT00402233|560091450|FG002|Overall Study|Worsening of other pre-existing disease|0|||
155178398|NCT00402233|560091451|FG003|Overall Study|Worsening of other pre-existing disease|0|||
155178399|NCT00927940|560091452|FG000|Overall Study|Death|1|||
155178400|NCT03007888|560091454|FG000|First Intervention (14 Days)|Adverse Event|1|||
155178401|NCT03007888|560091455|FG001|First Intervention (14 Days)|Adverse Event|0|||
155178402|NCT01870076|560091457|FG000|Overall Study|Withdrawal by Subject|1|||
155178403|NCT01870076|560091458|FG001|Overall Study|Withdrawal by Subject|0|||
155178404|NCT01870076|560091459|FG002|Overall Study|Withdrawal by Subject|1|||
155178405|NCT01870076|560091460|FG003|Overall Study|Withdrawal by Subject|0|||
155178406|NCT00890045|560091463|FG000|Overall Study|Death|0|||
155178407|NCT00890045|560091464|FG001|Overall Study|Death|1|||
155006603|NCT02038010|559447068|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
155006604|NCT02038010|559447069|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
155006605|NCT02038010|559447066|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
155006606|NCT02038010|559447067|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
155006607|NCT02038010|559447068|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
155006608|NCT02038010|559447069|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
155006609|NCT02038010|559447066|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
155128159|NCT03442296|559899570|FG001|3 Month Follow-up|Lost to Follow-up|1|||
155128160|NCT03442296|559899569|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
155128161|NCT03442296|559899570|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
155128162|NCT03442296|559899569|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
155128163|NCT03442296|559899570|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
155128164|NCT03442296|559899569|FG000|12 Month Follow-up|Incomplete measurement|1|||
155128165|NCT03442296|559899570|FG001|12 Month Follow-up|Incomplete measurement|1|||
155128166|NCT02720692|559901222|FG000|Overall Study|Withdrawal by Subject|3|||
155128167|NCT02720692|559901223|FG001|Overall Study|Withdrawal by Subject|0|||
155128168|NCT02720692|559901222|FG000|Overall Study|Physician Decision|1|||
155128169|NCT02720692|559901223|FG001|Overall Study|Physician Decision|0|||
155128170|NCT02720692|559901222|FG000|Overall Study|Lost to Follow-up|8|||
155128171|NCT02720692|559901223|FG001|Overall Study|Lost to Follow-up|3|||
155128172|NCT02720692|559901222|FG000|Overall Study|Subject unable to return for visit|1|||
155128173|NCT02720692|559901223|FG001|Overall Study|Subject unable to return for visit|0|||
155128174|NCT03878758|559901224|FG000|Overall Study|Withdrawal by Subject|1|||
155128175|NCT03878758|559901224|FG000|Overall Study|Protocol defined|2|||
155128176|NCT03878758|559901224|FG000|Overall Study|Improper consent documentation|1|||
155128177|NCT01769196|559901225|FG000|Overall Study|Adverse Event|24|||
155128178|NCT01769196|559901226|FG001|Overall Study|Adverse Event|20|||
155128179|NCT01769196|559901225|FG000|Overall Study|Death|21|||
155128180|NCT01769196|559901226|FG001|Overall Study|Death|26|||
155128181|NCT01769196|559901225|FG000|Overall Study|Investigator Discretion|7|||
155128182|NCT01769196|559901226|FG001|Overall Study|Investigator Discretion|3|||
155128183|NCT01769196|559901225|FG000|Overall Study|Lack of Efficacy|3|||
155128184|NCT01769196|559901226|FG001|Overall Study|Lack of Efficacy|2|||
155128185|NCT01769196|559901225|FG000|Overall Study|Progressive disease|11|||
155128186|NCT01769196|559901226|FG001|Overall Study|Progressive disease|6|||
155128187|NCT01769196|559901225|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
155128188|NCT01769196|559901226|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
155128189|NCT01769196|559901225|FG000|Overall Study|Protocol Violation|0|||
155128190|NCT01769196|559901226|FG001|Overall Study|Protocol Violation|3|||
155128191|NCT01769196|559901225|FG000|Overall Study|Study terminated by sponsor|160|||
155178408|NCT00890045|560091463|FG000|Overall Study|Did not receive HeRO Graft|0|||
155178409|NCT00890045|560091464|FG001|Overall Study|Did not receive HeRO Graft|2|||
155178410|NCT00890045|560091463|FG000|Overall Study|Lost to Follow-up|5|||
155178411|NCT00890045|560091464|FG001|Overall Study|Lost to Follow-up|7|||
155178412|NCT01947855|560091467|FG000|Overall Study|Withdrawal by Subject|1|||
155178413|NCT01947855|560091468|FG001|Overall Study|Withdrawal by Subject|0|||
155128192|NCT01769196|559901226|FG001|Overall Study|Study terminated by sponsor|161|||
155128193|NCT01769196|559901225|FG000|Overall Study|Participant never dosed with study drug|1|||
155128194|NCT01769196|559901226|FG001|Overall Study|Participant never dosed with study drug|0|||
155128195|NCT01769196|559901225|FG000|Overall Study|Withdrew consent|36|||
155178414|NCT01947855|560091469|FG002|Overall Study|Withdrawal by Subject|0|||
155178415|NCT01892384|560091473|FG000|Overall Study|Withdrawal by Subject|1|||
155178416|NCT01892384|560091474|FG001|Overall Study|Withdrawal by Subject|1|||
155128196|NCT01769196|559901226|FG001|Overall Study|Withdrew consent|40|||
155128197|NCT00765063|559901227|FG000|Overall Study|Lack of Efficacy|5|||
155128198|NCT00765063|559901227|FG000|Overall Study|Withdrawal by Subject|1|||
155128199|NCT00765063|559901227|FG000|Overall Study|Other|16|||
155128200|NCT00765063|559901227|FG000|Overall Study|Protocol Violation|6|||
155128201|NCT00765063|559901227|FG000|Overall Study|Adverse Event|4|||
155128202|NCT03614325|559901228|FG000|Overall Study|Withdrawal by Subject|0|||
155128203|NCT03614325|559901229|FG001|Overall Study|Withdrawal by Subject|2|||
155128204|NCT03614325|559901228|FG000|Overall Study|Surgery Cancelled|2|||
155128205|NCT03614325|559901229|FG001|Overall Study|Surgery Cancelled|1|||
155128206|NCT03614325|559901228|FG000|Overall Study|Lost to Follow-up|2|||
155128207|NCT03614325|559901229|FG001|Overall Study|Lost to Follow-up|1|||
155128208|NCT03614325|559901228|FG000|Overall Study|Surgery never scheduled|1|||
155128209|NCT03614325|559901229|FG001|Overall Study|Surgery never scheduled|0|||
155128210|NCT01206582|559901235|FG000|Overall Study|Withdrew prior to study|1|||
155128211|NCT01206582|559901236|FG001|Overall Study|Withdrew prior to study|0|||
155128212|NCT01206582|559901235|FG000|Overall Study|Discontinued intervention before week 8|1|||
155128213|NCT01206582|559901236|FG001|Overall Study|Discontinued intervention before week 8|2|||
155128214|NCT02522325|559901237|FG000|Overall Study|Adverse Event|0|||
155128215|NCT02522325|559901238|FG001|Overall Study|Adverse Event|1|||
155128216|NCT02100969|559901239|FG000|Overall Study|Did not pass screening phase|1|||
155128217|NCT02081599|559901242|FG000|Period 1：Double-blind Period|Adverse Event|3|||
155128218|NCT02081599|559901243|FG001|Period 1：Double-blind Period|Adverse Event|0|||
155128219|NCT02081599|559901242|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
155128220|NCT02081599|559901243|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
155128221|NCT02081599|559901242|FG000|Period 1：Double-blind Period|Physician Decision|1|||
155128222|NCT02081599|559901243|FG001|Period 1：Double-blind Period|Physician Decision|0|||
155128223|NCT02081599|559901242|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
155128224|NCT02081599|559901243|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
155128225|NCT02081599|559901242|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
155128226|NCT02081599|559901243|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
155128227|NCT02081599|559901242|FG000|Period 1：Double-blind Period|stopping criteria|1|||
155128228|NCT02081599|559901243|FG001|Period 1：Double-blind Period|stopping criteria|0|||
155128229|NCT02081599|559901242|FG000|Period 2：Open-label Period|Adverse Event|1|||
155128230|NCT02081599|559901243|FG001|Period 2：Open-label Period|Adverse Event|0|||
155128231|NCT02081599|559901242|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
155128232|NCT02081599|559901243|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
155128233|NCT02081599|559901242|FG000|Period 2：Open-label Period|Physician Decision|1|||
155128234|NCT02081599|559901243|FG001|Period 2：Open-label Period|Physician Decision|0|||
155128235|NCT02081599|559901242|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
155128236|NCT02081599|559901243|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
155128237|NCT01629953|559901244|FG000|Overall Study|Death|3|||
155128238|NCT01629953|559901245|FG001|Overall Study|Death|1|||
155128239|NCT01629953|559901244|FG000|Overall Study|Lost to Follow-up|10|||
155128240|NCT01629953|559901245|FG001|Overall Study|Lost to Follow-up|14|||
155128241|NCT00720343|559901246|FG000|Overall Study|Lost to Follow-up|1|||
155128242|NCT00720343|559901247|FG001|Overall Study|Lost to Follow-up|0|||
155128243|NCT00720343|559901246|FG000|Overall Study|Protocol Violation|0|||
155128244|NCT00720343|559901247|FG001|Overall Study|Protocol Violation|2|||
155128245|NCT00707954|559901250|FG000|Overall Study|Physician Decision|0|||
155128246|NCT00707954|559901251|FG001|Overall Study|Physician Decision|0|||
155128247|NCT00707954|559901252|FG002|Overall Study|Physician Decision|0|||
155128248|NCT00707954|559901253|FG003|Overall Study|Physician Decision|0|||
155128249|NCT00707954|559901254|FG004|Overall Study|Physician Decision|1|||
155128250|NCT02504580|559901259|FG000|Overall Study|Other|1|||
155128251|NCT02504580|559901260|FG001|Overall Study|Other|0|||
155128252|NCT02504580|559901261|FG002|Overall Study|Other|0|||
155128253|NCT02504580|559901262|FG003|Overall Study|Other|2|||
155128254|NCT02504580|559901263|FG004|Overall Study|Other|1|||
155128255|NCT02504580|559901264|FG005|Overall Study|Other|1|||
155128256|NCT02504580|559901265|FG006|Overall Study|Other|1|||
155128257|NCT02504580|559901266|FG007|Overall Study|Other|2|||
155128258|NCT02504580|559901267|FG008|Overall Study|Other|0|||
155128259|NCT02504580|559901268|FG009|Overall Study|Other|0|||
155128260|NCT02504580|559901269|FG010|Overall Study|Other|0|||
155128261|NCT02504580|559901270|FG011|Overall Study|Other|2|||
155128262|NCT02504580|559901259|FG000|Overall Study|Subject refusal to continue|0|||
155128263|NCT02504580|559901260|FG001|Overall Study|Subject refusal to continue|1|||
155128264|NCT02504580|559901261|FG002|Overall Study|Subject refusal to continue|0|||
155128265|NCT02504580|559901262|FG003|Overall Study|Subject refusal to continue|0|||
155128266|NCT02504580|559901263|FG004|Overall Study|Subject refusal to continue|0|||
155128267|NCT02504580|559901264|FG005|Overall Study|Subject refusal to continue|0|||
155128268|NCT02504580|559901265|FG006|Overall Study|Subject refusal to continue|0|||
155128269|NCT02504580|559901266|FG007|Overall Study|Subject refusal to continue|0|||
155128270|NCT02504580|559901267|FG008|Overall Study|Subject refusal to continue|0|||
155128271|NCT02504580|559901268|FG009|Overall Study|Subject refusal to continue|0|||
155128272|NCT02504580|559901269|FG010|Overall Study|Subject refusal to continue|0|||
155128273|NCT02504580|559901270|FG011|Overall Study|Subject refusal to continue|0|||
155128274|NCT02429791|559901276|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
155128275|NCT02429791|559901277|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
155128276|NCT02429791|559901276|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
155128277|NCT02429791|559901277|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
155128278|NCT02429791|559901276|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
155006610|NCT02038010|559447067|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
155006611|NCT02038010|559447068|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
155128279|NCT02429791|559901277|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
155128280|NCT02429791|559901276|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
155128281|NCT02429791|559901277|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
155128282|NCT02429791|559901276|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
155128283|NCT02429791|559901277|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
155128284|NCT02429791|559901276|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
155128285|NCT02429791|559901277|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
155128286|NCT02429791|559901276|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
155128287|NCT02429791|559901277|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
155128288|NCT02429791|559901276|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
155128289|NCT02429791|559901277|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
155128290|NCT02429791|559901276|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
155128291|NCT02429791|559901277|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
155128292|NCT02429791|559901276|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
155128293|NCT02429791|559901277|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
155128294|NCT02429791|559901276|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
155128295|NCT02429791|559901277|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
155128296|NCT02429791|559901276|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
155128297|NCT02429791|559901277|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
155128298|NCT02429791|559901276|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
155128299|NCT02429791|559901277|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
155128300|NCT02429791|559901276|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
155128301|NCT02429791|559901277|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
155128302|NCT02429791|559901276|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
155128303|NCT02429791|559901277|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
155128304|NCT02429791|559901276|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
155128305|NCT02429791|559901277|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
155128306|NCT02429791|559901276|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
155128307|NCT02429791|559901277|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
155128308|NCT02429791|559901276|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
155128309|NCT02429791|559901277|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
155128310|NCT02615691|559901278|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
155128311|NCT02615691|559901278|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
155128312|NCT02615691|559901278|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
155128313|NCT02615691|559901278|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
155128314|NCT00881504|559901279|FG000|Overall Study|Withdrawal by Subject|1|||
155128315|NCT01276223|559901280|FG000|Overall Study|Adverse Event|7|||
155128316|NCT01276223|559901281|FG001|Overall Study|Adverse Event|4|||
155128317|NCT01276223|559901282|FG002|Overall Study|Adverse Event|1|||
155128318|NCT01276223|559901280|FG000|Overall Study|Lost to Follow-up|0|||
155128319|NCT01276223|559901281|FG001|Overall Study|Lost to Follow-up|0|||
155128320|NCT01276223|559901282|FG002|Overall Study|Lost to Follow-up|1|||
155128321|NCT01276223|559901280|FG000|Overall Study|Other|0|||
155006612|NCT02038010|559447069|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
155006613|NCT02038010|559447066|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
155006614|NCT02038010|559447067|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
155006615|NCT02038010|559447068|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
155006616|NCT02038010|559447069|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
155006617|NCT02038010|559447066|FG000|Follow Up|Death|4|||
155006618|NCT02038010|559447067|FG001|Follow Up|Death|3|||
155006619|NCT02038010|559447068|FG002|Follow Up|Death|0|||
155006620|NCT02038010|559447069|FG003|Follow Up|Death|0|||
155006621|NCT02038010|559447066|FG000|Follow Up|Other|3|||
155128322|NCT01276223|559901281|FG001|Overall Study|Other|0|||
155128323|NCT01276223|559901282|FG002|Overall Study|Other|1|||
155178417|NCT01892384|560091475|FG002|Overall Study|Withdrawal by Subject|0|||
155178418|NCT01892384|560091476|FG003|Overall Study|Withdrawal by Subject|0|||
155006622|NCT02038010|559447067|FG001|Follow Up|Other|0|||
155006623|NCT02038010|559447068|FG002|Follow Up|Other|0|||
155006624|NCT02038010|559447069|FG003|Follow Up|Other|0|||
155006625|NCT02232984|559447077|FG000|Overall Study|Withdrawal by Subject|5|||
155128324|NCT01276223|559901280|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
155128325|NCT01276223|559901281|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
155128326|NCT01276223|559901282|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
155128327|NCT01276223|559901280|FG000|Overall Study|Protocol Violation|1|||
155128328|NCT01276223|559901281|FG001|Overall Study|Protocol Violation|0|||
155128329|NCT01276223|559901282|FG002|Overall Study|Protocol Violation|0|||
155128330|NCT02596230|559901283|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
155128331|NCT02596230|559901284|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
155128332|NCT02596230|559901285|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
155128333|NCT02596230|559901286|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
155128334|NCT02596230|559901287|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
155128335|NCT02596230|559901283|FG000|Objective 2, One Year|Lost to Follow-up|0|||
155128336|NCT02596230|559901284|FG001|Objective 2, One Year|Lost to Follow-up|41|||
155128337|NCT02596230|559901285|FG002|Objective 2, One Year|Lost to Follow-up|41|||
155128338|NCT02596230|559901286|FG003|Objective 2, One Year|Lost to Follow-up|32|||
155128339|NCT02596230|559901287|FG004|Objective 2, One Year|Lost to Follow-up|46|||
155128340|NCT02596230|559901283|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
155128341|NCT02596230|559901284|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
155128342|NCT02596230|559901285|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
155128343|NCT02596230|559901286|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
155128344|NCT02596230|559901287|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
155128345|NCT02596230|559901283|FG000|Objective 2, One Year|Adverse drug reaction|0|||
155128346|NCT02596230|559901284|FG001|Objective 2, One Year|Adverse drug reaction|1|||
155128347|NCT02596230|559901285|FG002|Objective 2, One Year|Adverse drug reaction|0|||
155128348|NCT02596230|559901286|FG003|Objective 2, One Year|Adverse drug reaction|0|||
155128349|NCT02596230|559901287|FG004|Objective 2, One Year|Adverse drug reaction|0|||
155128350|NCT02596230|559901283|FG000|Objective 2, One Year|Death|0|||
155128351|NCT02596230|559901284|FG001|Objective 2, One Year|Death|12|||
155128352|NCT02596230|559901285|FG002|Objective 2, One Year|Death|41|||
155128353|NCT02596230|559901286|FG003|Objective 2, One Year|Death|21|||
155128354|NCT02596230|559901287|FG004|Objective 2, One Year|Death|30|||
155128355|NCT02596230|559901283|FG000|Objective 2, One Year|Other|0|||
155128356|NCT02596230|559901284|FG001|Objective 2, One Year|Other|3|||
155128357|NCT02596230|559901285|FG002|Objective 2, One Year|Other|2|||
155128358|NCT02596230|559901286|FG003|Objective 2, One Year|Other|0|||
155128359|NCT02596230|559901287|FG004|Objective 2, One Year|Other|0|||
155128360|NCT04279613|559901289|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155128361|NCT04279613|559901290|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155128362|NCT04279613|559901291|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155128363|NCT04279613|559901292|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
155128364|NCT04279613|559901293|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
155128365|NCT04279613|559901289|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155128366|NCT04279613|559901290|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
155128367|NCT04279613|559901291|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155128368|NCT04279613|559901292|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155128369|NCT04279613|559901293|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
155128370|NCT04279613|559901289|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155128371|NCT04279613|559901290|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155128372|NCT04279613|559901291|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
155128373|NCT04279613|559901292|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155128374|NCT04279613|559901293|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
155128375|NCT04279613|559901289|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155128376|NCT04279613|559901290|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155128377|NCT04279613|559901291|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155128378|NCT04279613|559901292|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
155128379|NCT04279613|559901293|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
155128380|NCT04279613|559901289|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155128381|NCT04279613|559901290|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155128382|NCT04279613|559901291|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155128383|NCT04279613|559901292|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
155128384|NCT04279613|559901293|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
155128385|NCT02704689|559901294|FG000|Overall Study|Physician Decision|1|||
155128386|NCT02704689|559901294|FG000|Overall Study|Study device not implanted|2|||
155128387|NCT00320424|559901295|FG000|Overall Study|Adverse Event|3|||
155128388|NCT00320424|559901295|FG000|Overall Study|Other|3|||
155128389|NCT00849108|559901297|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
155128390|NCT00849108|559901298|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
155128391|NCT00849108|559901297|FG000|Cohort 2 Efficacy|Adverse Event|0|||
155128392|NCT00849108|559901298|FG001|Cohort 2 Efficacy|Adverse Event|1|||
155128393|NCT00849108|559901297|FG000|Cohort 2 Efficacy|Other|0|||
154923536|NCT01728376|559146268|FG001|Overall Study|Adverse Event|1|||
154923537|NCT01728376|559146269|FG002|Overall Study|Adverse Event|1|||
155128394|NCT00849108|559901298|FG001|Cohort 2 Efficacy|Other|9|||
155128395|NCT01100528|559901306|FG000|Overall Study|Death|1|||
155128396|NCT01100528|559901306|FG000|Overall Study|Withdrawal by Subject|2|||
155128397|NCT02211313|559901307|FG000|Overall Study|Treatment Failure|5|||
155128398|NCT02211313|559901308|FG001|Overall Study|Treatment Failure|2|||
155128399|NCT02211313|559901307|FG000|Overall Study|No Follow up Questionnaires|1|||
155128400|NCT02211313|559901308|FG001|Overall Study|No Follow up Questionnaires|1|||
155128401|NCT00551291|559901309|FG000|Overall Study|Physician Decision|1|||
155128402|NCT01943552|559901310|FG000|Overall Study|Adverse Event|3|||
155128403|NCT01943552|559901311|FG001|Overall Study|Adverse Event|2|||
155128404|NCT01943552|559901310|FG000|Overall Study|Withdrawal by Subject|6|||
155128405|NCT01943552|559901311|FG001|Overall Study|Withdrawal by Subject|6|||
155128406|NCT01943552|559901310|FG000|Overall Study|Other Reasons|16|||
155128407|NCT01943552|559901311|FG001|Overall Study|Other Reasons|17|||
155128408|NCT01177969|559901312|FG000|Overall Study|Protocol Violation|2|||
155128409|NCT01177969|559901313|FG001|Overall Study|Protocol Violation|1|||
155128410|NCT01177969|559901312|FG000|Overall Study|Withdrawal by Subject|1|||
155128411|NCT01177969|559901313|FG001|Overall Study|Withdrawal by Subject|2|||
155128412|NCT01475162|559901315|FG000|Overall Study|Physician Decision|1|||
155128413|NCT01475162|559901315|FG000|Overall Study|Death|10|||
155128414|NCT01475162|559901315|FG000|Overall Study|Study closed for safety|3|||
155128415|NCT00025155|559901316|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
155128416|NCT00025155|559901316|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
155128417|NCT00552760|559901317|FG000|Overall Study|Adverse Event|3|||
155128418|NCT00552760|559901318|FG001|Overall Study|Adverse Event|5|||
155128419|NCT00552760|559901317|FG000|Overall Study|Relapsed- Depressed Event|10|||
155128420|NCT00552760|559901318|FG001|Overall Study|Relapsed- Depressed Event|16|||
155128421|NCT00552760|559901317|FG000|Overall Study|Relapse- Manic Event|3|||
155128422|NCT00552760|559901318|FG001|Overall Study|Relapse- Manic Event|3|||
155128423|NCT00552760|559901317|FG000|Overall Study|Relapsed- Mixed Event|3|||
155128424|NCT00552760|559901318|FG001|Overall Study|Relapsed- Mixed Event|5|||
155128425|NCT00552760|559901317|FG000|Overall Study|Protocol Violation|0|||
155128426|NCT00552760|559901318|FG001|Overall Study|Protocol Violation|1|||
155128427|NCT00552760|559901317|FG000|Overall Study|Lost to Follow-up|1|||
155128428|NCT00552760|559901318|FG001|Overall Study|Lost to Follow-up|1|||
155128429|NCT00552760|559901317|FG000|Overall Study|Non-compliance|1|||
155128430|NCT00552760|559901318|FG001|Overall Study|Non-compliance|1|||
155128431|NCT00552760|559901317|FG000|Overall Study|Medical Condition|1|||
155128432|NCT00552760|559901318|FG001|Overall Study|Medical Condition|1|||
155128433|NCT00552760|559901317|FG000|Overall Study|Withdrawal by Subject|3|||
155128434|NCT00552760|559901318|FG001|Overall Study|Withdrawal by Subject|0|||
155128435|NCT00552760|559901317|FG000|Overall Study|Medication Change|1|||
155128436|NCT00552760|559901318|FG001|Overall Study|Medication Change|0|||
155128437|NCT03426631|559901321|FG000|Overall Study|Lost to Follow-up|0|||
155128438|NCT03426631|559901322|FG001|Overall Study|Lost to Follow-up|1|||
155128439|NCT00710385|559901329|FG000|Overall Study|Did not qualify|1|||
155128440|NCT00710385|559901329|FG000|Overall Study|Withdrawal by Subject|1|||
155128441|NCT00710385|559901329|FG000|Overall Study|Undisclosed back pain|1|||
155128442|NCT00710385|559901329|FG000|Overall Study|Physician Decision|1|||
155128443|NCT00710385|559901329|FG000|Overall Study|Undisclosed excessive methadone use|1|||
155128444|NCT00129961|559901330|FG000|Overall Study|Adverse Event|1|||
155006626|NCT02232984|559447077|FG000|Overall Study|Death|1|||
155006627|NCT02232984|559447077|FG000|Overall Study|Investigator withdrawal|10|||
155006628|NCT02232984|559447077|FG000|Overall Study|Device implant unsuccessful|53|||
155006629|NCT02232984|559447077|FG000|Overall Study|not disclosed by site|7|||
155006630|NCT02232984|559447077|FG000|Overall Study|Protocol Violation|1|||
155006631|NCT00769379|559447080|FG000|Overall Study|No follow up data mapped to Other.|3|||
155006632|NCT00769379|559447081|FG001|Overall Study|No follow up data mapped to Other.|13|||
155128445|NCT00129961|559901331|FG001|Overall Study|Adverse Event|0|||
155128446|NCT00129961|559901330|FG000|Overall Study|Death|1|||
155128447|NCT00129961|559901331|FG001|Overall Study|Death|1|||
155128448|NCT00129961|559901330|FG000|Overall Study|Withdrawal by Sponsor|14|||
155128449|NCT00129961|559901331|FG001|Overall Study|Withdrawal by Sponsor|20|||
155128450|NCT00129961|559901330|FG000|Overall Study|Physician Decision|1|||
155128451|NCT00129961|559901331|FG001|Overall Study|Physician Decision|0|||
155128452|NCT00129961|559901330|FG000|Overall Study|Withdrawal by Subject|2|||
155128453|NCT00129961|559901331|FG001|Overall Study|Withdrawal by Subject|1|||
155128454|NCT00129961|559901330|FG000|Overall Study|Missing Record|0|||
155128455|NCT00129961|559901331|FG001|Overall Study|Missing Record|1|||
155128456|NCT01264770|559901332|FG000|Overall Study|Not reported|0|||
155128457|NCT01264770|559901333|FG001|Overall Study|Not reported|0|||
155128458|NCT01264770|559901334|FG002|Overall Study|Not reported|1|||
155128459|NCT01264770|559901335|FG003|Overall Study|Not reported|0|||
155128460|NCT01264770|559901336|FG004|Overall Study|Not reported|0|||
155128461|NCT01264770|559901337|FG005|Overall Study|Not reported|0|||
155128462|NCT01264770|559901332|FG000|Overall Study|e.g., change in circumstances|8|||
155128463|NCT01264770|559901333|FG001|Overall Study|e.g., change in circumstances|3|||
155128464|NCT01264770|559901334|FG002|Overall Study|e.g., change in circumstances|3|||
155128465|NCT01264770|559901335|FG003|Overall Study|e.g., change in circumstances|3|||
155128466|NCT01264770|559901336|FG004|Overall Study|e.g., change in circumstances|4|||
155128467|NCT01264770|559901337|FG005|Overall Study|e.g., change in circumstances|4|||
155128468|NCT01264770|559901332|FG000|Overall Study|Severe non-compliance to protocol|0|||
155128469|NCT01264770|559901333|FG001|Overall Study|Severe non-compliance to protocol|0|||
155128470|NCT01264770|559901334|FG002|Overall Study|Severe non-compliance to protocol|1|||
155128471|NCT01264770|559901335|FG003|Overall Study|Severe non-compliance to protocol|1|||
155128472|NCT01264770|559901336|FG004|Overall Study|Severe non-compliance to protocol|0|||
155128473|NCT01264770|559901337|FG005|Overall Study|Severe non-compliance to protocol|0|||
155128474|NCT01264770|559901332|FG000|Overall Study|Lack of therapeutic response|1|||
155128475|NCT01264770|559901333|FG001|Overall Study|Lack of therapeutic response|0|||
155128476|NCT01264770|559901334|FG002|Overall Study|Lack of therapeutic response|2|||
155128477|NCT01264770|559901335|FG003|Overall Study|Lack of therapeutic response|1|||
155128478|NCT01264770|559901336|FG004|Overall Study|Lack of therapeutic response|1|||
155128479|NCT01264770|559901337|FG005|Overall Study|Lack of therapeutic response|0|||
155128480|NCT01264770|559901332|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
155128481|NCT01264770|559901333|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
155128482|NCT01264770|559901334|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
155128483|NCT01264770|559901335|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
155128484|NCT01264770|559901336|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
155128485|NCT01264770|559901337|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
155128486|NCT01264770|559901332|FG000|Overall Study|Lost to Follow-up|0|||
155128487|NCT01264770|559901333|FG001|Overall Study|Lost to Follow-up|0|||
155128488|NCT01264770|559901334|FG002|Overall Study|Lost to Follow-up|1|||
155128489|NCT01264770|559901335|FG003|Overall Study|Lost to Follow-up|1|||
155128490|NCT01264770|559901336|FG004|Overall Study|Lost to Follow-up|0|||
155128491|NCT01264770|559901337|FG005|Overall Study|Lost to Follow-up|0|||
155128492|NCT01264770|559901332|FG000|Overall Study|Adverse Event|7|||
155128493|NCT01264770|559901333|FG001|Overall Study|Adverse Event|7|||
155128494|NCT01264770|559901334|FG002|Overall Study|Adverse Event|8|||
155128495|NCT01264770|559901335|FG003|Overall Study|Adverse Event|0|||
155128496|NCT01264770|559901336|FG004|Overall Study|Adverse Event|2|||
155128497|NCT01264770|559901337|FG005|Overall Study|Adverse Event|1|||
155128498|NCT01985360|559901340|FG000|Overall Study|Withdrawal by Subject|4|||
155128499|NCT01985360|559901341|FG001|Overall Study|Withdrawal by Subject|0|||
155128500|NCT01985360|559901340|FG000|Overall Study|Lost to Follow-up|5|||
155128501|NCT01985360|559901341|FG001|Overall Study|Lost to Follow-up|3|||
155128502|NCT03691779|559901342|FG000|Part B (24 Weeks)|Adverse Event|0|||
155128503|NCT03691779|559901343|FG001|Part B (24 Weeks)|Adverse Event|1|||
155128504|NCT03691779|559901342|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
155128505|NCT03691779|559901343|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
155128506|NCT02745535|559901345|FG000|Overall Study|Death|1|||
155128507|NCT02745535|559901345|FG000|Overall Study|Adverse Event|3|||
155128508|NCT02745535|559901345|FG000|Overall Study|Lost to Follow-up|2|||
155128509|NCT00737633|559901346|FG000|Overall Study|Study terminated by sponsor|44|||
155128510|NCT00737633|559901347|FG001|Overall Study|Study terminated by sponsor|55|||
155128511|NCT00737633|559901346|FG000|Overall Study|Lost to Follow-up|0|||
155128512|NCT00737633|559901347|FG001|Overall Study|Lost to Follow-up|1|||
155128513|NCT00737633|559901346|FG000|Overall Study|protocol non-compliance|0|||
155128514|NCT00737633|559901347|FG001|Overall Study|protocol non-compliance|1|||
155128515|NCT00377364|559901352|FG000|Overall Study|Lost to Follow-up|1|||
155128516|NCT00377364|559901353|FG001|Overall Study|Lost to Follow-up|0|||
155128517|NCT00377364|559901352|FG000|Overall Study|Withdrawal by Subject|1|||
155128518|NCT00377364|559901353|FG001|Overall Study|Withdrawal by Subject|0|||
155128519|NCT01345682|559901362|FG000|Overall Study|Progressive disease per RECIST|226|||
155128520|NCT01345682|559901363|FG001|Overall Study|Progressive disease per RECIST|93|||
155128521|NCT01345682|559901362|FG000|Overall Study|Worsening of underlying cancer disease|23|||
155128522|NCT01345682|559901363|FG001|Overall Study|Worsening of underlying cancer disease|12|||
155128523|NCT01345682|559901362|FG000|Overall Study|Adverse Event|51|||
155128524|NCT01345682|559901363|FG001|Overall Study|Adverse Event|41|||
155128525|NCT01345682|559901362|FG000|Overall Study|Non-compliance with protocol|0|||
155178419|NCT00592774|560091477|FG000|Overall Study|Adverse Event|5|||
155128526|NCT01345682|559901363|FG001|Overall Study|Non-compliance with protocol|1|||
155128527|NCT01345682|559901362|FG000|Overall Study|Lost to Follow-up|0|||
155128528|NCT01345682|559901363|FG001|Overall Study|Lost to Follow-up|1|||
155128529|NCT01345682|559901362|FG000|Overall Study|Refused to continue trial medication|16|||
155128530|NCT01345682|559901363|FG001|Overall Study|Refused to continue trial medication|9|||
155128531|NCT01345682|559901362|FG000|Overall Study|Not treated|2|||
155128532|NCT01345682|559901363|FG001|Overall Study|Not treated|1|||
155128533|NCT01345682|559901362|FG000|Overall Study|Reason other than those specified above|4|||
155128534|NCT01345682|559901363|FG001|Overall Study|Reason other than those specified above|3|||
155128535|NCT01075984|559901364|FG000|Treatment Phase|Adverse Event|0|||
155128536|NCT01075984|559901365|FG001|Treatment Phase|Adverse Event|1|||
155128537|NCT01075984|559901366|FG002|Treatment Phase|Adverse Event|3|||
155128538|NCT01075984|559901367|FG003|Treatment Phase|Adverse Event|7|||
155128539|NCT01075984|559901368|FG004|Treatment Phase|Adverse Event|35|||
155128540|NCT01075984|559901364|FG000|Treatment Phase|Protocol Violation|0|||
155128541|NCT01075984|559901365|FG001|Treatment Phase|Protocol Violation|0|||
155128542|NCT01075984|559901366|FG002|Treatment Phase|Protocol Violation|1|||
155128543|NCT01075984|559901367|FG003|Treatment Phase|Protocol Violation|0|||
155128544|NCT01075984|559901368|FG004|Treatment Phase|Protocol Violation|3|||
155128545|NCT01075984|559901364|FG000|Treatment Phase|Withdrawal by Subject|0|||
155128546|NCT01075984|559901365|FG001|Treatment Phase|Withdrawal by Subject|0|||
155128547|NCT01075984|559901366|FG002|Treatment Phase|Withdrawal by Subject|2|||
155128548|NCT01075984|559901367|FG003|Treatment Phase|Withdrawal by Subject|0|||
155128549|NCT01075984|559901368|FG004|Treatment Phase|Withdrawal by Subject|15|||
155128550|NCT01075984|559901364|FG000|Treatment Phase|Treatment Failure|0|||
155128551|NCT01075984|559901365|FG001|Treatment Phase|Treatment Failure|0|||
155128552|NCT01075984|559901366|FG002|Treatment Phase|Treatment Failure|1|||
155128553|NCT01075984|559901367|FG003|Treatment Phase|Treatment Failure|0|||
155128554|NCT01075984|559901368|FG004|Treatment Phase|Treatment Failure|5|||
155128555|NCT01075984|559901364|FG000|Treatment Phase|Progression of disease|0|||
155128556|NCT01075984|559901365|FG001|Treatment Phase|Progression of disease|0|||
155128557|NCT01075984|559901366|FG002|Treatment Phase|Progression of disease|0|||
155128558|NCT01075984|559901367|FG003|Treatment Phase|Progression of disease|0|||
155128559|NCT01075984|559901368|FG004|Treatment Phase|Progression of disease|2|||
155128560|NCT01075984|559901364|FG000|Follow-up Phase|Protocol Violation|0|||
155178420|NCT00592774|560091478|FG001|Overall Study|Adverse Event|19|||
155178421|NCT00592774|560091479|FG002|Overall Study|Adverse Event|2|||
155006633|NCT02673775|559447086|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
155006634|NCT02673775|559447087|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
155006635|NCT02673775|559447086|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
155006636|NCT02673775|559447087|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
155006637|NCT02673775|559447086|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
155006638|NCT02673775|559447087|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
155006639|NCT02673775|559447086|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
155006640|NCT02673775|559447087|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
155006641|NCT03519087|559447088|FG000|Clinic Evaluation|Physician Decision|15|||
155006642|NCT03519087|559447089|FG001|Clinic Evaluation|Physician Decision|18|||
155006643|NCT03519087|559447090|FG002|Clinic Evaluation|Physician Decision|0|||
155006644|NCT03519087|559447091|FG003|Clinic Evaluation|Physician Decision|0|||
155006645|NCT03519087|559447092|FG004|Clinic Evaluation|Physician Decision|0|||
155006646|NCT03519087|559447088|FG000|Clinic Evaluation|Protocol Violation|1|||
155006647|NCT03519087|559447089|FG001|Clinic Evaluation|Protocol Violation|0|||
155006648|NCT03519087|559447090|FG002|Clinic Evaluation|Protocol Violation|0|||
155006649|NCT03519087|559447091|FG003|Clinic Evaluation|Protocol Violation|0|||
155006650|NCT03519087|559447092|FG004|Clinic Evaluation|Protocol Violation|0|||
155006651|NCT03519087|559447088|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
155006652|NCT03519087|559447089|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
155006653|NCT03519087|559447090|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
155006654|NCT03519087|559447091|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
155006655|NCT03519087|559447092|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
155006656|NCT03519087|559447088|FG000|Re-randomization for Treatment|Not appropriate|2|||
155006657|NCT03519087|559447089|FG001|Re-randomization for Treatment|Not appropriate|3|||
155006658|NCT03519087|559447090|FG002|Re-randomization for Treatment|Not appropriate|0|||
155006659|NCT03519087|559447091|FG003|Re-randomization for Treatment|Not appropriate|0|||
155006660|NCT03519087|559447092|FG004|Re-randomization for Treatment|Not appropriate|0|||
155006661|NCT03519087|559447088|FG000|Laboratory Testing|Lost to Follow-up|0|||
155006662|NCT03519087|559447089|FG001|Laboratory Testing|Lost to Follow-up|0|||
155006663|NCT03519087|559447090|FG002|Laboratory Testing|Lost to Follow-up|2|||
155006664|NCT03519087|559447091|FG003|Laboratory Testing|Lost to Follow-up|3|||
155006665|NCT03519087|559447092|FG004|Laboratory Testing|Lost to Follow-up|6|||
155006666|NCT03519087|559447088|FG000|Laboratory Testing|Protocol Violation|0|||
155006667|NCT03519087|559447089|FG001|Laboratory Testing|Protocol Violation|0|||
155006668|NCT03519087|559447090|FG002|Laboratory Testing|Protocol Violation|0|||
155006669|NCT03519087|559447091|FG003|Laboratory Testing|Protocol Violation|1|||
155128561|NCT01075984|559901365|FG001|Follow-up Phase|Protocol Violation|0|||
155178422|NCT00592774|560091480|FG003|Overall Study|Adverse Event|14|||
155006670|NCT03519087|559447092|FG004|Laboratory Testing|Protocol Violation|0|||
155006671|NCT01137071|559447093|FG000|Overall Study|Disease Progression|11|||
155006672|NCT01137071|559447093|FG000|Overall Study|Withdrawal by Subject|2|||
155006673|NCT01137071|559447093|FG000|Overall Study|Wrongly Included|1|||
155128562|NCT01075984|559901366|FG002|Follow-up Phase|Protocol Violation|1|||
155128563|NCT01075984|559901367|FG003|Follow-up Phase|Protocol Violation|0|||
155128564|NCT01075984|559901368|FG004|Follow-up Phase|Protocol Violation|3|||
155128565|NCT01075984|559901364|FG000|Follow-up Phase|Adverse Event|0|||
155128566|NCT01075984|559901365|FG001|Follow-up Phase|Adverse Event|0|||
155128567|NCT01075984|559901366|FG002|Follow-up Phase|Adverse Event|0|||
155128568|NCT01075984|559901367|FG003|Follow-up Phase|Adverse Event|2|||
155128569|NCT01075984|559901368|FG004|Follow-up Phase|Adverse Event|27|||
155128570|NCT01075984|559901364|FG000|Follow-up Phase|Administrative|0|||
155128571|NCT01075984|559901365|FG001|Follow-up Phase|Administrative|0|||
155128572|NCT01075984|559901366|FG002|Follow-up Phase|Administrative|0|||
155128573|NCT01075984|559901367|FG003|Follow-up Phase|Administrative|0|||
155128574|NCT01075984|559901368|FG004|Follow-up Phase|Administrative|1|||
155128575|NCT01075984|559901364|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155128576|NCT01075984|559901365|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155128577|NCT01075984|559901366|FG002|Follow-up Phase|Withdrawal by Subject|0|||
155128578|NCT01075984|559901367|FG003|Follow-up Phase|Withdrawal by Subject|0|||
155128579|NCT01075984|559901368|FG004|Follow-up Phase|Withdrawal by Subject|10|||
155128580|NCT01075984|559901364|FG000|Follow-up Phase|Progression of disease|0|||
155128581|NCT01075984|559901365|FG001|Follow-up Phase|Progression of disease|0|||
155128582|NCT01075984|559901366|FG002|Follow-up Phase|Progression of disease|0|||
155128583|NCT01075984|559901367|FG003|Follow-up Phase|Progression of disease|0|||
155128584|NCT01075984|559901368|FG004|Follow-up Phase|Progression of disease|2|||
155128585|NCT01075984|559901364|FG000|Follow-up Phase|Treatment failure|0|||
155128586|NCT01075984|559901365|FG001|Follow-up Phase|Treatment failure|0|||
155128587|NCT01075984|559901366|FG002|Follow-up Phase|Treatment failure|0|||
155128588|NCT01075984|559901367|FG003|Follow-up Phase|Treatment failure|0|||
155128589|NCT01075984|559901368|FG004|Follow-up Phase|Treatment failure|4|||
155128590|NCT03101085|559901369|FG000|Overall Study|Lost to Follow-up|0|||
155128591|NCT03101085|559901370|FG001|Overall Study|Lost to Follow-up|1|||
155128592|NCT02986854|559901372|FG000|Overall Study|Withdrawal by Subject|0|||
155128593|NCT02986854|559901373|FG001|Overall Study|Withdrawal by Subject|1|||
155128594|NCT02986854|559901374|FG002|Overall Study|Withdrawal by Subject|1|||
155128595|NCT02986854|559901372|FG000|Overall Study|Lost to Follow-up|3|||
155128596|NCT02986854|559901373|FG001|Overall Study|Lost to Follow-up|11|||
155128597|NCT02986854|559901374|FG002|Overall Study|Lost to Follow-up|2|||
155128598|NCT02409342|559901380|FG000|Overall Study|Death|211|||
155128599|NCT02409342|559901381|FG001|Overall Study|Death|201|||
155128600|NCT02409342|559901380|FG000|Overall Study|Withdrawal by Subject|24|||
155128601|NCT02409342|559901381|FG001|Overall Study|Withdrawal by Subject|17|||
155128602|NCT02409342|559901380|FG000|Overall Study|Study Terminated By Sponsor|48|||
155128603|NCT02409342|559901381|FG001|Overall Study|Study Terminated By Sponsor|59|||
155128604|NCT02409342|559901380|FG000|Overall Study|Lost to Follow-up|3|||
155128605|NCT02409342|559901381|FG001|Overall Study|Lost to Follow-up|5|||
155128606|NCT02409342|559901380|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
155128607|NCT02409342|559901381|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
155128608|NCT02409342|559901380|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
155128609|NCT02409342|559901381|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
155128610|NCT02409342|559901380|FG000|Overall Study|Sponsor Decision|1|||
155128611|NCT02409342|559901381|FG001|Overall Study|Sponsor Decision|0|||
155128612|NCT00279812|559901382|FG000|Overall Study|Protocol Violation|1|||
155128613|NCT00279812|559901383|FG001|Overall Study|Protocol Violation|1|||
155128614|NCT00279812|559901384|FG002|Overall Study|Protocol Violation|0|||
155128615|NCT00279812|559901385|FG003|Overall Study|Protocol Violation|0|||
155128616|NCT00279812|559901386|FG004|Overall Study|Protocol Violation|1|||
155128617|NCT00279812|559901387|FG005|Overall Study|Protocol Violation|0|||
155128618|NCT00279812|559901382|FG000|Overall Study|Withdrawal by Subject|0|||
155128619|NCT00279812|559901383|FG001|Overall Study|Withdrawal by Subject|4|||
155128620|NCT00279812|559901384|FG002|Overall Study|Withdrawal by Subject|2|||
155128621|NCT00279812|559901385|FG003|Overall Study|Withdrawal by Subject|0|||
155128622|NCT00279812|559901386|FG004|Overall Study|Withdrawal by Subject|0|||
155128623|NCT00279812|559901387|FG005|Overall Study|Withdrawal by Subject|0|||
155128624|NCT00279812|559901382|FG000|Overall Study|Adverse Event|0|||
155128625|NCT00279812|559901383|FG001|Overall Study|Adverse Event|1|||
155128626|NCT00279812|559901384|FG002|Overall Study|Adverse Event|1|||
155128627|NCT00279812|559901385|FG003|Overall Study|Adverse Event|0|||
155128628|NCT00279812|559901386|FG004|Overall Study|Adverse Event|2|||
155128629|NCT00279812|559901387|FG005|Overall Study|Adverse Event|1|||
155128630|NCT01274429|559901388|FG000|Overall Study|Study closed do to lack of funding|5|||
155178423|NCT00592774|560091481|FG004|Overall Study|Adverse Event|8|||
155128631|NCT04576897|559901393|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
155128632|NCT00527332|559901394|FG000|Overall Study|Protocol Violation|4|||
155128633|NCT00527332|559901395|FG001|Overall Study|Protocol Violation|8|||
155128634|NCT00527332|559901394|FG000|Overall Study|Withdrew consent|5|||
155128635|NCT00527332|559901395|FG001|Overall Study|Withdrew consent|1|||
155128636|NCT01673620|559903075|FG000|Overall Study|Adverse Event|1|||
155128637|NCT01673620|559903076|FG001|Overall Study|Adverse Event|0|||
155128638|NCT00528801|559903077|FG000|Overall Study|Withdrawal by Subject|1|||
155128639|NCT00528801|559903078|FG001|Overall Study|Withdrawal by Subject|1|||
155128640|NCT00528801|559903077|FG000|Overall Study|Protocol Violation|11|||
155128641|NCT00528801|559903078|FG001|Overall Study|Protocol Violation|5|||
155128642|NCT00528801|559903077|FG000|Overall Study|Lost to Follow-up|15|||
155128643|NCT00528801|559903078|FG001|Overall Study|Lost to Follow-up|4|||
155128644|NCT00528801|559903077|FG000|Overall Study|Administrative Reasons|0|||
155128645|NCT00528801|559903078|FG001|Overall Study|Administrative Reasons|1|||
155128646|NCT00344500|559903079|FG000|Overall Study|Adverse Event|6|||
155128647|NCT00344500|559903080|FG001|Overall Study|Adverse Event|2|||
155128648|NCT00344500|559903081|FG002|Overall Study|Adverse Event|0|||
155128649|NCT00344500|559903079|FG000|Overall Study|Lost to Follow-up|5|||
155128650|NCT00344500|559903080|FG001|Overall Study|Lost to Follow-up|13|||
155128651|NCT00344500|559903081|FG002|Overall Study|Lost to Follow-up|1|||
155128652|NCT00344500|559903079|FG000|Overall Study|Withdrawal by Subject|7|||
155128653|NCT00344500|559903080|FG001|Overall Study|Withdrawal by Subject|10|||
155128654|NCT00344500|559903081|FG002|Overall Study|Withdrawal by Subject|0|||
155128655|NCT00344500|559903079|FG000|Overall Study|Protocol Violation|4|||
155128656|NCT00344500|559903080|FG001|Overall Study|Protocol Violation|7|||
155128657|NCT00344500|559903081|FG002|Overall Study|Protocol Violation|1|||
155128658|NCT00344500|559903079|FG000|Overall Study|Not Noted|1|||
155128659|NCT00344500|559903080|FG001|Overall Study|Not Noted|3|||
155128660|NCT00344500|559903081|FG002|Overall Study|Not Noted|0|||
155128661|NCT02252965|559903082|FG000|Overall Study|Adverse Event|9|||
155128662|NCT02252965|559903083|FG001|Overall Study|Adverse Event|14|||
155128663|NCT02252965|559903082|FG000|Overall Study|Lost to Follow-up|16|||
155128664|NCT02252965|559903083|FG001|Overall Study|Lost to Follow-up|8|||
155128665|NCT02252965|559903082|FG000|Overall Study|Protocol Violation|4|||
155128666|NCT02252965|559903083|FG001|Overall Study|Protocol Violation|5|||
155128667|NCT02252965|559903082|FG000|Overall Study|Lack of Efficacy|0|||
155128668|NCT02252965|559903083|FG001|Overall Study|Lack of Efficacy|2|||
155128669|NCT02252965|559903082|FG000|Overall Study|Withdrawal by Subject|7|||
155128670|NCT02252965|559903083|FG001|Overall Study|Withdrawal by Subject|9|||
155128671|NCT02252965|559903082|FG000|Overall Study|Other|4|||
155128672|NCT02252965|559903083|FG001|Overall Study|Other|5|||
155128673|NCT04201093|559903090|FG000|Overall Study|Adverse Event|6|||
155128674|NCT04201093|559903091|FG001|Overall Study|Adverse Event|29|||
155128675|NCT04201093|559903092|FG002|Overall Study|Adverse Event|35|||
155128676|NCT04201093|559903090|FG000|Overall Study|Death|2|||
155128677|NCT04201093|559903091|FG001|Overall Study|Death|1|||
155128678|NCT04201093|559903092|FG002|Overall Study|Death|0|||
155128679|NCT04201093|559903090|FG000|Overall Study|Lack of Efficacy|5|||
155128680|NCT04201093|559903091|FG001|Overall Study|Lack of Efficacy|1|||
155128681|NCT04201093|559903092|FG002|Overall Study|Lack of Efficacy|2|||
155128682|NCT04201093|559903090|FG000|Overall Study|Lost to Follow-up|0|||
155128683|NCT04201093|559903091|FG001|Overall Study|Lost to Follow-up|0|||
155128684|NCT04201093|559903092|FG002|Overall Study|Lost to Follow-up|1|||
155128685|NCT04201093|559903090|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
155128686|NCT04201093|559903091|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155128687|NCT04201093|559903092|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
155128688|NCT04201093|559903090|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155128689|NCT04201093|559903091|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155128690|NCT04201093|559903092|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
155128691|NCT04201093|559903090|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
155128692|NCT04201093|559903091|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
155128693|NCT04201093|559903092|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
155128694|NCT04201093|559903090|FG000|Overall Study|Physician Decision|1|||
155128695|NCT04201093|559903091|FG001|Overall Study|Physician Decision|0|||
155128696|NCT04201093|559903092|FG002|Overall Study|Physician Decision|0|||
155128697|NCT04201093|559903090|FG000|Overall Study|Protocol Deviation|1|||
155128698|NCT04201093|559903091|FG001|Overall Study|Protocol Deviation|0|||
155128699|NCT04201093|559903092|FG002|Overall Study|Protocol Deviation|0|||
155128700|NCT04201093|559903090|FG000|Overall Study|Site Terminated by Sponsor|5|||
155128701|NCT04201093|559903091|FG001|Overall Study|Site Terminated by Sponsor|3|||
155128702|NCT04201093|559903092|FG002|Overall Study|Site Terminated by Sponsor|1|||
155128703|NCT04201093|559903090|FG000|Overall Study|Withdrawal by Subject|7|||
155128704|NCT04201093|559903091|FG001|Overall Study|Withdrawal by Subject|8|||
155128705|NCT04201093|559903092|FG002|Overall Study|Withdrawal by Subject|15|||
155128706|NCT04201093|559903090|FG000|Overall Study|Other|0|||
155128707|NCT04201093|559903091|FG001|Overall Study|Other|1|||
155128708|NCT04201093|559903092|FG002|Overall Study|Other|2|||
155128709|NCT02017522|559903093|FG000|Overall Study|Withdrawal by Subject|1|||
155128710|NCT00771615|559903094|FG000|Overall Study|Withdrawal by Subject|0|||
155128711|NCT00771615|559903095|FG001|Overall Study|Withdrawal by Subject|1|||
155128712|NCT00771615|559903096|FG002|Overall Study|Withdrawal by Subject|0|||
155128713|NCT00771615|559903097|FG003|Overall Study|Withdrawal by Subject|0|||
155128714|NCT00771615|559903098|FG004|Overall Study|Withdrawal by Subject|0|||
155128715|NCT00771615|559903099|FG005|Overall Study|Withdrawal by Subject|0|||
155128716|NCT00771615|559903100|FG006|Overall Study|Withdrawal by Subject|0|||
155128717|NCT00771615|559903101|FG007|Overall Study|Withdrawal by Subject|1|||
155128718|NCT00771615|559903102|FG008|Overall Study|Withdrawal by Subject|0|||
155128719|NCT00771615|559903094|FG000|Overall Study|Lost to Follow-up|1|||
155128720|NCT00771615|559903095|FG001|Overall Study|Lost to Follow-up|1|||
155128721|NCT00771615|559903096|FG002|Overall Study|Lost to Follow-up|1|||
155006674|NCT04807400|559447094|FG000|Overall Study|Adverse Event|2|||
155006675|NCT04807400|559447095|FG001|Overall Study|Adverse Event|3|||
155006676|NCT04807400|559447096|FG002|Overall Study|Adverse Event|3|||
155006677|NCT04807400|559447094|FG000|Overall Study|Death|2|||
155006678|NCT04807400|559447095|FG001|Overall Study|Death|0|||
155006679|NCT04807400|559447096|FG002|Overall Study|Death|0|||
155006680|NCT04807400|559447094|FG000|Overall Study|Lost to Follow-up|8|||
155006681|NCT04807400|559447095|FG001|Overall Study|Lost to Follow-up|6|||
155006682|NCT04807400|559447096|FG002|Overall Study|Lost to Follow-up|6|||
155006683|NCT04807400|559447094|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155006684|NCT04807400|559447095|FG001|Overall Study|Non-Compliance With Study Drug|4|||
155006685|NCT04807400|559447096|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155006686|NCT04807400|559447094|FG000|Overall Study|Participant Decision|20|||
155006687|NCT04807400|559447095|FG001|Overall Study|Participant Decision|19|||
155006688|NCT04807400|559447096|FG002|Overall Study|Participant Decision|26|||
155006689|NCT04807400|559447094|FG000|Overall Study|Physician Decision|0|||
155006690|NCT04807400|559447095|FG001|Overall Study|Physician Decision|1|||
155006691|NCT04807400|559447096|FG002|Overall Study|Physician Decision|0|||
155006692|NCT04807400|559447094|FG000|Overall Study|Protocol Violation|4|||
155006693|NCT04807400|559447095|FG001|Overall Study|Protocol Violation|3|||
155006694|NCT04807400|559447096|FG002|Overall Study|Protocol Violation|7|||
155006695|NCT04807400|559447094|FG000|Overall Study|Withdrawal by Subject|13|||
155006696|NCT04807400|559447095|FG001|Overall Study|Withdrawal by Subject|9|||
155006697|NCT04807400|559447096|FG002|Overall Study|Withdrawal by Subject|20|||
155006698|NCT04807400|559447094|FG000|Overall Study|Mis-randomized|1|||
155006699|NCT04807400|559447095|FG001|Overall Study|Mis-randomized|0|||
155006700|NCT04807400|559447096|FG002|Overall Study|Mis-randomized|0|||
155006701|NCT02123446|559447097|FG000|Washout Period (1 Day)|Physician Decision|1|||
155006702|NCT02123446|559447098|FG001|Washout Period (1 Day)|Physician Decision|0|||
155006703|NCT05022212|559447101|FG000|Overall Study|Lost to Follow-up|0|||
155006704|NCT05022212|559447102|FG001|Overall Study|Lost to Follow-up|2|||
155006705|NCT02905032|559447103|FG000|Overall Study|Withdrawal by Subject|2|||
155006706|NCT02905032|559447104|FG001|Overall Study|Withdrawal by Subject|0|||
155006707|NCT02905032|559447105|FG002|Overall Study|Withdrawal by Subject|0|||
155006708|NCT02905032|559447103|FG000|Overall Study|Protocol Violation|6|||
155006709|NCT02905032|559447104|FG001|Overall Study|Protocol Violation|12|||
155006710|NCT02905032|559447105|FG002|Overall Study|Protocol Violation|0|||
155006711|NCT02729909|559447106|FG000|Overall Study|Lost to Follow-up|0|||
155006712|NCT02729909|559447107|FG001|Overall Study|Lost to Follow-up|1|||
155006713|NCT02729909|559447106|FG000|Overall Study|Lack of Efficacy|0|||
155006714|NCT02729909|559447107|FG001|Overall Study|Lack of Efficacy|2|||
155006715|NCT02729909|559447106|FG000|Overall Study|Significant Protocol Deviation|0|||
155006716|NCT02729909|559447107|FG001|Overall Study|Significant Protocol Deviation|2|||
155006717|NCT02729909|559447106|FG000|Overall Study|Voluntary Withdrawal|1|||
155006718|NCT02729909|559447107|FG001|Overall Study|Voluntary Withdrawal|0|||
155006719|NCT00739063|559447108|FG000|Overall Study|Screen failures|8|||
155006720|NCT00866359|559447110|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
155006721|NCT00866359|559447111|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
155006722|NCT00866359|559447112|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
155006723|NCT00866359|559447113|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
155006724|NCT00866359|559447110|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
155006725|NCT00866359|559447111|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
155006726|NCT00866359|559447112|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
155006727|NCT00866359|559447113|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
155006728|NCT00866359|559447110|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
155006729|NCT00866359|559447111|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
155006730|NCT00866359|559447112|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
155006731|NCT00866359|559447113|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
155128722|NCT00771615|559903097|FG003|Overall Study|Lost to Follow-up|1|||
155128723|NCT00771615|559903098|FG004|Overall Study|Lost to Follow-up|0|||
155128724|NCT00771615|559903099|FG005|Overall Study|Lost to Follow-up|1|||
155128725|NCT00771615|559903100|FG006|Overall Study|Lost to Follow-up|1|||
155006732|NCT00866359|559447110|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
155006733|NCT00866359|559447111|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
155006734|NCT00866359|559447112|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
155006735|NCT00866359|559447113|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
155006736|NCT00866359|559447110|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
155006737|NCT00866359|559447111|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
155006738|NCT00866359|559447112|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
155006739|NCT00866359|559447113|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
155006740|NCT00866359|559447110|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
155006741|NCT00866359|559447111|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
155006742|NCT00866359|559447112|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
155006743|NCT00866359|559447113|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
155128726|NCT00771615|559903101|FG007|Overall Study|Lost to Follow-up|0|||
155128727|NCT00771615|559903102|FG008|Overall Study|Lost to Follow-up|0|||
155128728|NCT00802893|559903103|FG000|Overall Study|study terminated|3|||
155128729|NCT03270891|559903104|FG000|Overall Study|Lost to Follow-up|3|||
155128730|NCT03270891|559903105|FG001|Overall Study|Lost to Follow-up|6|||
155128731|NCT03270891|559903106|FG002|Overall Study|Lost to Follow-up|0|||
155128732|NCT03270891|559903104|FG000|Overall Study|Withdrawal by Subject|1|||
155128733|NCT03270891|559903105|FG001|Overall Study|Withdrawal by Subject|0|||
155128734|NCT03270891|559903106|FG002|Overall Study|Withdrawal by Subject|0|||
155128735|NCT03270891|559903104|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
155128736|NCT03270891|559903105|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
155128737|NCT03270891|559903106|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
155128738|NCT02540668|559903107|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
155128739|NCT02540668|559903108|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
155128740|NCT04051827|559903109|FG000|Overall Study|Death|1|||
155128741|NCT04051827|559903109|FG000|Overall Study|Withdrawal by Subject|4|||
155128742|NCT04051827|559903109|FG000|Overall Study|Progressive disease|16|||
155128743|NCT04051827|559903109|FG000|Overall Study|Physician Decision|1|||
155128744|NCT04051827|559903109|FG000|Overall Study|Other|4|||
155128745|NCT05779007|559903110|FG000|Overall Study|not meeting eligibility criteria|3517|||
155128746|NCT05779007|559903111|FG001|Overall Study|not meeting eligibility criteria|2009|||
155128747|NCT01424566|559903112|FG000|Single-blind Treatment|Adverse Event|71|||
155128748|NCT01424566|559903113|FG001|Single-blind Treatment|Adverse Event|0|||
155128749|NCT01424566|559903114|FG002|Single-blind Treatment|Adverse Event|0|||
155128750|NCT01424566|559903112|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
155128751|NCT01424566|559903113|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
155128752|NCT01424566|559903114|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
155128753|NCT01424566|559903112|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
155128754|NCT01424566|559903113|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
155128755|NCT01424566|559903114|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
155128756|NCT01424566|559903112|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
155128757|NCT01424566|559903113|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
155128758|NCT01424566|559903114|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
155128759|NCT01424566|559903112|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
155128760|NCT01424566|559903113|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
155128761|NCT01424566|559903114|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
155128762|NCT01424566|559903112|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
155128763|NCT01424566|559903113|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
155128764|NCT01424566|559903114|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
155128765|NCT01424566|559903112|FG000|Double-blind Treatment|Adverse Event|0|||
155128766|NCT01424566|559903113|FG001|Double-blind Treatment|Adverse Event|21|||
155128767|NCT01424566|559903114|FG002|Double-blind Treatment|Adverse Event|13|||
155128768|NCT01424566|559903112|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
155128769|NCT01424566|559903113|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
155128770|NCT01424566|559903114|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
155128771|NCT01424566|559903112|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
155128772|NCT01424566|559903113|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
155128773|NCT01424566|559903114|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
155128774|NCT01424566|559903112|FG000|Double-blind Treatment|Lack of Efficacy|0|||
155128775|NCT01424566|559903113|FG001|Double-blind Treatment|Lack of Efficacy|1|||
155128776|NCT01424566|559903114|FG002|Double-blind Treatment|Lack of Efficacy|1|||
155128777|NCT05147662|559903115|FG000|Overall Study|Withdrawal by parent/guardian|3|||
155128778|NCT05147662|559903115|FG000|Overall Study|Assigned to treatment but never treated|1|||
155128779|NCT00548717|559903116|FG000|Overall Study|Death|5|||
155128780|NCT00548717|559903117|FG001|Overall Study|Death|2|||
155128781|NCT00548717|559903116|FG000|Overall Study|Relapse|3|||
155128782|NCT00548717|559903117|FG001|Overall Study|Relapse|0|||
155128783|NCT00548717|559903116|FG000|Overall Study|Alternative treatment for GVHD|1|||
155128784|NCT00548717|559903117|FG001|Overall Study|Alternative treatment for GVHD|0|||
155128785|NCT02712424|559903118|FG000|Overall Study|Lost to Follow-up|34|||
155128786|NCT02712424|559903119|FG001|Overall Study|Lost to Follow-up|32|||
155128787|NCT02809053|559903123|FG000|Overall Study|Death|0|||
155178424|NCT00592774|560091477|FG000|Overall Study|Protocol Violation|0|||
155178425|NCT00592774|560091478|FG001|Overall Study|Protocol Violation|1|||
155128788|NCT02809053|559903124|FG001|Overall Study|Death|1|||
155128789|NCT02809053|559903123|FG000|Overall Study|Lost to Follow-up|3|||
155128790|NCT02809053|559903124|FG001|Overall Study|Lost to Follow-up|1|||
155128791|NCT02809053|559903123|FG000|Overall Study|Withdrawal by Subject|2|||
155128792|NCT02809053|559903124|FG001|Overall Study|Withdrawal by Subject|3|||
155128793|NCT02809053|559903123|FG000|Overall Study|Disease Progression|2|||
155128794|NCT02809053|559903124|FG001|Overall Study|Disease Progression|1|||
155128795|NCT00908037|559903129|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128796|NCT00908037|559903130|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128797|NCT00908037|559903131|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155178426|NCT00592774|560091479|FG002|Overall Study|Protocol Violation|0|||
155006744|NCT02163057|559447114|FG000|Overall Study|Participant Refusal to Continue|2|||
155006745|NCT02163057|559447115|FG001|Overall Study|Participant Refusal to Continue|2|||
155006746|NCT02163057|559447114|FG000|Overall Study|Participant Significant Noncompliance|0|||
155006747|NCT02163057|559447115|FG001|Overall Study|Participant Significant Noncompliance|1|||
155006748|NCT02163057|559447114|FG000|Overall Study|Progression of Disease|1|||
155006749|NCT02163057|559447115|FG001|Overall Study|Progression of Disease|2|||
155006750|NCT01625091|559447116|FG000|Intervention|Death|1|||
155006751|NCT01625091|559447117|FG001|Intervention|Death|1|||
155006752|NCT01625091|559447116|FG000|Intervention|Withdrawal by Subject|4|||
155006753|NCT01625091|559447117|FG001|Intervention|Withdrawal by Subject|1|||
155006754|NCT01625091|559447116|FG000|Intervention|Adverse Event|0|||
155006755|NCT01625091|559447117|FG001|Intervention|Adverse Event|2|||
155006756|NCT01625091|559447116|FG000|Intervention|Lost to Follow-up|4|||
155006757|NCT01625091|559447117|FG001|Intervention|Lost to Follow-up|4|||
155006758|NCT01625091|559447116|FG000|Intervention|Study termination|2|||
155006759|NCT01625091|559447117|FG001|Intervention|Study termination|3|||
155006760|NCT01625091|559447116|FG000|Post-intervention|Death|0|||
155006761|NCT01625091|559447117|FG001|Post-intervention|Death|1|||
155006762|NCT01625091|559447116|FG000|Post-intervention|Lost to Follow-up|2|||
155006763|NCT01625091|559447117|FG001|Post-intervention|Lost to Follow-up|0|||
155006764|NCT01625091|559447116|FG000|Post-intervention|Study termination|2|||
155006765|NCT01625091|559447117|FG001|Post-intervention|Study termination|1|||
155006766|NCT01547390|559447121|FG000|Overall Study|Withdrawal by Subject|10|||
155006767|NCT01547390|559447122|FG001|Overall Study|Withdrawal by Subject|7|||
155006768|NCT01547390|559447121|FG000|Overall Study|termination of pregnancy|0|||
155006769|NCT01547390|559447122|FG001|Overall Study|termination of pregnancy|1|||
155006770|NCT01547390|559447121|FG000|Overall Study|Lost to Follow-up|0|||
155006771|NCT01547390|559447122|FG001|Overall Study|Lost to Follow-up|2|||
155006772|NCT01547390|559447121|FG000|Overall Study|Adverse Event|3|||
155006773|NCT01547390|559447122|FG001|Overall Study|Adverse Event|0|||
155006774|NCT04917861|559447126|FG000|Main Study (196 Days)|Adverse Event|0|||
155006775|NCT04917861|559447127|FG001|Main Study (196 Days)|Adverse Event|1|||
155006776|NCT04917861|559447128|FG002|Main Study (196 Days)|Adverse Event|0|||
155006777|NCT04917861|559447129|FG003|Main Study (196 Days)|Adverse Event|0|||
155006778|NCT04917861|559447126|FG000|Main Study (196 Days)|Death|0|||
155006779|NCT04917861|559447127|FG001|Main Study (196 Days)|Death|0|||
155006780|NCT04917861|559447128|FG002|Main Study (196 Days)|Death|0|||
155006781|NCT04917861|559447129|FG003|Main Study (196 Days)|Death|1|||
155006782|NCT04917861|559447126|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
155006783|NCT04917861|559447127|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
155006784|NCT04917861|559447128|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
155006785|NCT04917861|559447129|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
155006786|NCT04917861|559447126|FG000|Main Study (196 Days)|Physician Decision|0|||
155006787|NCT04917861|559447127|FG001|Main Study (196 Days)|Physician Decision|0|||
155006788|NCT04917861|559447128|FG002|Main Study (196 Days)|Physician Decision|0|||
155006789|NCT04917861|559447129|FG003|Main Study (196 Days)|Physician Decision|1|||
155006790|NCT04917861|559447126|FG000|Main Study (196 Days)|Pregnancy|1|||
155006791|NCT04917861|559447127|FG001|Main Study (196 Days)|Pregnancy|1|||
155006792|NCT04917861|559447128|FG002|Main Study (196 Days)|Pregnancy|0|||
155006793|NCT04917861|559447129|FG003|Main Study (196 Days)|Pregnancy|0|||
155006794|NCT04917861|559447126|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
155006795|NCT04917861|559447127|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
155006796|NCT04917861|559447128|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
155006797|NCT04917861|559447129|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
155006798|NCT04917861|559447126|FG000|Main Study (196 Days)|Other Than Specified|1|||
155006799|NCT04917861|559447127|FG001|Main Study (196 Days)|Other Than Specified|0|||
155128798|NCT00908037|559903132|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128799|NCT00908037|559903133|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
155006800|NCT04917861|559447128|FG002|Main Study (196 Days)|Other Than Specified|1|||
155006801|NCT04917861|559447129|FG003|Main Study (196 Days)|Other Than Specified|2|||
155006802|NCT04917861|559447126|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
155006803|NCT04917861|559447127|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
155006804|NCT04917861|559447128|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
155006805|NCT04917861|559447129|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
155006806|NCT04917861|559447126|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
155006807|NCT04917861|559447127|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
155006808|NCT04917861|559447128|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
155006809|NCT04917861|559447129|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
155006810|NCT04917861|559447126|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
155006811|NCT04917861|559447127|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
155006812|NCT04917861|559447128|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
155006813|NCT04917861|559447129|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
155006814|NCT04917861|559447126|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
155128800|NCT00908037|559903134|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128801|NCT00908037|559903135|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
155128802|NCT00908037|559903136|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128803|NCT00908037|559903137|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
155128804|NCT00908037|559903138|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128805|NCT00908037|559903139|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128806|NCT00908037|559903140|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
155128807|NCT00908037|559903129|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128808|NCT00908037|559903130|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128809|NCT00908037|559903131|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128810|NCT00908037|559903132|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128811|NCT00908037|559903133|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
155128812|NCT00908037|559903134|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128813|NCT00908037|559903135|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128814|NCT00908037|559903136|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128815|NCT00908037|559903137|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
155128816|NCT00908037|559903138|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128817|NCT00908037|559903139|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128818|NCT00908037|559903140|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
155128819|NCT00908037|559903129|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128820|NCT00908037|559903130|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128821|NCT00908037|559903131|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128822|NCT00908037|559903132|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
155128823|NCT00908037|559903133|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128824|NCT00908037|559903134|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128825|NCT00908037|559903135|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
155128826|NCT00908037|559903136|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128827|NCT00908037|559903137|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128828|NCT00908037|559903138|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128829|NCT00908037|559903139|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128830|NCT00908037|559903140|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
155128831|NCT00908037|559903129|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128832|NCT00908037|559903130|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128833|NCT00908037|559903131|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128834|NCT00908037|559903132|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128835|NCT00908037|559903133|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128836|NCT00908037|559903134|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128837|NCT00908037|559903135|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128838|NCT00908037|559903136|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128839|NCT00908037|559903137|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128840|NCT00908037|559903138|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128841|NCT00908037|559903139|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
155128842|NCT00908037|559903140|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
155128843|NCT00908037|559903129|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128844|NCT00908037|559903130|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128845|NCT00908037|559903131|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128846|NCT00908037|559903132|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128847|NCT00908037|559903133|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128848|NCT00908037|559903134|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128849|NCT00908037|559903135|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128850|NCT00908037|559903136|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128851|NCT00908037|559903137|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128852|NCT00908037|559903138|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
155128853|NCT00908037|559903139|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
155128854|NCT00908037|559903140|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
155128855|NCT00908037|559903129|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128856|NCT00908037|559903130|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128857|NCT00908037|559903131|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128858|NCT00908037|559903132|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128859|NCT00908037|559903133|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128860|NCT00908037|559903134|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128861|NCT00908037|559903135|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128862|NCT00908037|559903136|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128863|NCT00908037|559903137|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155178427|NCT00592774|560091480|FG003|Overall Study|Protocol Violation|0|||
155128864|NCT00908037|559903138|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
155128865|NCT00908037|559903139|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128866|NCT00908037|559903140|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
155128867|NCT00908037|559903129|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128868|NCT00908037|559903130|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128869|NCT00908037|559903131|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128870|NCT00908037|559903132|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128871|NCT00908037|559903133|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128872|NCT00908037|559903134|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128873|NCT00908037|559903135|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128874|NCT00908037|559903136|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128875|NCT00908037|559903137|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128876|NCT00908037|559903138|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155128877|NCT00908037|559903139|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
155128878|NCT00908037|559903140|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
155006815|NCT04917861|559447127|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
155006816|NCT04917861|559447128|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
155006817|NCT04917861|559447129|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
155006818|NCT04917861|559447126|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
155006819|NCT04917861|559447127|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
155006820|NCT04917861|559447128|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
155006821|NCT04917861|559447129|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
155006822|NCT04917861|559447126|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
155006823|NCT04917861|559447127|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
155006824|NCT04917861|559447128|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
155006825|NCT04917861|559447129|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
155006826|NCT01128179|559447130|FG000|Overall Study|Death|1|||
155006827|NCT01128179|559447131|FG001|Overall Study|Death|0|||
155006828|NCT01128179|559447130|FG000|Overall Study|Protocol Violation|1|||
155006829|NCT01128179|559447131|FG001|Overall Study|Protocol Violation|0|||
155006830|NCT02694328|559447133|FG000|Overall Study|Adverse Event|27|||
155006831|NCT02694328|559447134|FG001|Overall Study|Adverse Event|33|||
155006832|NCT02694328|559447133|FG000|Overall Study|Withdrawal by Subject|27|||
155006833|NCT02694328|559447134|FG001|Overall Study|Withdrawal by Subject|23|||
155006834|NCT02694328|559447133|FG000|Overall Study|Lost to Follow-up|26|||
155006835|NCT02694328|559447134|FG001|Overall Study|Lost to Follow-up|22|||
155006836|NCT02694328|559447133|FG000|Overall Study|Noncompliant with study drug|11|||
155006837|NCT02694328|559447134|FG001|Overall Study|Noncompliant with study drug|8|||
155006838|NCT02694328|559447133|FG000|Overall Study|Incarceration|1|||
155006839|NCT02694328|559447134|FG001|Overall Study|Incarceration|1|||
155006840|NCT02694328|559447133|FG000|Overall Study|Lack of Efficacy|1|||
155006841|NCT02694328|559447134|FG001|Overall Study|Lack of Efficacy|2|||
155006842|NCT02694328|559447133|FG000|Overall Study|Pregnancy|1|||
155006843|NCT02694328|559447134|FG001|Overall Study|Pregnancy|1|||
155006844|NCT02694328|559447133|FG000|Overall Study|Protocol Violation|6|||
155006845|NCT02694328|559447134|FG001|Overall Study|Protocol Violation|5|||
155006846|NCT02694328|559447133|FG000|Overall Study|Abnormal Laboratory Value|0|||
155006847|NCT02694328|559447134|FG001|Overall Study|Abnormal Laboratory Value|3|||
155006848|NCT00720382|559447136|FG000|Overall Study|Adverse Event|54|||
155006849|NCT00720382|559447137|FG001|Overall Study|Adverse Event|17|||
155006850|NCT00720382|559447136|FG000|Overall Study|Lack of Efficacy|18|||
155006851|NCT00720382|559447137|FG001|Overall Study|Lack of Efficacy|7|||
155006852|NCT00720382|559447136|FG000|Overall Study|Non-Compliance|15|||
155006853|NCT00720382|559447137|FG001|Overall Study|Non-Compliance|5|||
155006854|NCT00720382|559447136|FG000|Overall Study|Withdrawal by Subject|47|||
155006855|NCT00720382|559447137|FG001|Overall Study|Withdrawal by Subject|11|||
155128879|NCT00908037|559903129|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128880|NCT00908037|559903130|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128881|NCT00908037|559903131|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128882|NCT00908037|559903132|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155006856|NCT00720382|559447136|FG000|Overall Study|Lost to Follow-up|28|||
155006857|NCT00720382|559447137|FG001|Overall Study|Lost to Follow-up|14|||
155006858|NCT00720382|559447136|FG000|Overall Study|administrative|14|||
155006859|NCT00720382|559447137|FG001|Overall Study|administrative|5|||
155006860|NCT05192889|559447138|FG000|Block 1: All Eligible Patients|Death|2|||
155006861|NCT05192889|559447139|FG001|Block 1: All Eligible Patients|Death|0|||
155006862|NCT05192889|559447140|FG002|Block 1: All Eligible Patients|Death|0|||
155006863|NCT05192889|559447138|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
155006864|NCT05192889|559447139|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
155006865|NCT05192889|559447140|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
155006866|NCT05192889|559447138|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
155006867|NCT05192889|559447139|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
155128883|NCT00908037|559903133|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128884|NCT00908037|559903134|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128885|NCT00908037|559903135|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128886|NCT00908037|559903136|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128887|NCT00908037|559903137|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128888|NCT00908037|559903138|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
155128889|NCT00908037|559903139|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128890|NCT00908037|559903140|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
155128891|NCT00908037|559903129|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128892|NCT00908037|559903130|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128893|NCT00908037|559903131|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128894|NCT00908037|559903132|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128895|NCT00908037|559903133|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128896|NCT00908037|559903134|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128897|NCT00908037|559903135|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128898|NCT00908037|559903136|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128899|NCT00908037|559903137|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128900|NCT00908037|559903138|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128901|NCT00908037|559903139|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
155128902|NCT00908037|559903140|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
155128903|NCT02565810|559903141|FG000|Overall Study|Withdrawal by Subject|1|||
155128904|NCT02358044|559903142|FG000|Overall Study|Adverse Event|0|||
155128905|NCT02358044|559903143|FG001|Overall Study|Adverse Event|1|||
155128906|NCT02358044|559903142|FG000|Overall Study|Lost to Follow-up|2|||
155128907|NCT02358044|559903143|FG001|Overall Study|Lost to Follow-up|1|||
155128908|NCT02358044|559903142|FG000|Overall Study|Physician Decision|0|||
155128909|NCT02358044|559903143|FG001|Overall Study|Physician Decision|1|||
155128910|NCT02358044|559903142|FG000|Overall Study|Withdrawal by Subject|0|||
155128911|NCT02358044|559903143|FG001|Overall Study|Withdrawal by Subject|4|||
155128912|NCT02723175|559903146|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
155128913|NCT02723175|559903147|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
155128914|NCT02723175|559903146|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
155128915|NCT02723175|559903147|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
155128916|NCT00491608|559903150|FG000|Overall Study|Death|2|||
155128917|NCT00491608|559903150|FG000|Overall Study|Withdrawal by Subject|1|||
155128918|NCT03022981|559903155|FG000|Overall Study|Adverse Event|0|||
155128919|NCT03022981|559903156|FG001|Overall Study|Adverse Event|1|||
155128920|NCT03022981|559903157|FG002|Overall Study|Adverse Event|0|||
155128921|NCT03022981|559903155|FG000|Overall Study|Investigator's Discretion|0|||
155128922|NCT03022981|559903156|FG001|Overall Study|Investigator's Discretion|1|||
155128923|NCT03022981|559903157|FG002|Overall Study|Investigator's Discretion|2|||
155128924|NCT03022981|559903155|FG000|Overall Study|Lost to Follow-up|6|||
155128925|NCT03022981|559903156|FG001|Overall Study|Lost to Follow-up|2|||
155128926|NCT03022981|559903157|FG002|Overall Study|Lost to Follow-up|1|||
155128927|NCT03022981|559903155|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155128928|NCT03022981|559903156|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155128929|NCT03022981|559903157|FG002|Overall Study|Non-Compliance With Study Drug|2|||
155128930|NCT03022981|559903155|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
155128931|NCT03022981|559903156|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
155128932|NCT03022981|559903157|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
155128933|NCT03615066|559903159|FG000|Main Study|Withdrew Consent|0|||
155128934|NCT03615066|559903160|FG001|Main Study|Withdrew Consent|1|||
155128935|NCT03615066|559903161|FG002|Main Study|Withdrew Consent|1|||
155128936|NCT03615066|559903159|FG000|Main Study|Lost to Follow-up|0|||
155128937|NCT03615066|559903160|FG001|Main Study|Lost to Follow-up|0|||
155128938|NCT03615066|559903161|FG002|Main Study|Lost to Follow-up|1|||
155128939|NCT03615066|559903159|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
155128940|NCT03615066|559903160|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
155128941|NCT03615066|559903161|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
155128942|NCT03615066|559903159|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
155128943|NCT03615066|559903160|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
155128944|NCT03615066|559903161|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
155128945|NCT03615066|559903159|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
155128946|NCT03615066|559903160|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
155128947|NCT03615066|559903161|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
155128948|NCT00924404|559903162|FG000|Overall Study|Lost to Follow-up|6|||
155128949|NCT00924404|559903163|FG001|Overall Study|Lost to Follow-up|4|||
155128950|NCT02437084|559903164|FG000|Overall Study|Withdrawal by Subject|2|||
155128951|NCT02437084|559903164|FG000|Overall Study|Physician Decision|1|||
155128952|NCT00587847|559903165|FG000|Overall Study|Lack of Efficacy|5|||
155128953|NCT00587847|559903165|FG000|Overall Study|Adverse Event|2|||
155128954|NCT00343382|559903166|FG000|Overall Study|Adverse Event|2|||
155128955|NCT00343382|559903167|FG001|Overall Study|Adverse Event|10|||
155128956|NCT00343382|559903168|FG002|Overall Study|Adverse Event|7|||
155128957|NCT00343382|559903166|FG000|Overall Study|Withdrawal by Subject|1|||
155128958|NCT00343382|559903167|FG001|Overall Study|Withdrawal by Subject|2|||
155128959|NCT00343382|559903168|FG002|Overall Study|Withdrawal by Subject|6|||
155128960|NCT00343382|559903166|FG000|Overall Study|Other Reason Not Specified|1|||
155128961|NCT00343382|559903167|FG001|Overall Study|Other Reason Not Specified|2|||
155128962|NCT00343382|559903168|FG002|Overall Study|Other Reason Not Specified|4|||
155128963|NCT04032080|559903172|FG000|Overall Study|Death|6|||
155128964|NCT02337725|559903174|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
155128965|NCT02337725|559903175|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
155128966|NCT02337725|559903174|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
155128967|NCT02337725|559903175|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
155128968|NCT02337725|559903174|FG000|Overall Study|Major Protocol Deviation|0|||
155128969|NCT02337725|559903175|FG001|Overall Study|Major Protocol Deviation|1|||
155128970|NCT02337725|559903174|FG000|Overall Study|Voluntary Withdrawal|14|||
155128971|NCT02337725|559903175|FG001|Overall Study|Voluntary Withdrawal|3|||
155128972|NCT02337725|559903174|FG000|Overall Study|Lack of Efficacy|4|||
155128973|NCT02337725|559903175|FG001|Overall Study|Lack of Efficacy|0|||
155128974|NCT00845065|559903181|FG000|Overall Study|Adverse Event|3|||
155128975|NCT00845065|559903182|FG001|Overall Study|Adverse Event|23|||
155128976|NCT00845065|559903181|FG000|Overall Study|Lack of Efficacy|43|||
155128977|NCT00845065|559903182|FG001|Overall Study|Lack of Efficacy|21|||
155128978|NCT00845065|559903181|FG000|Overall Study|Non-Medical Reasons|1|||
155128979|NCT00845065|559903182|FG001|Overall Study|Non-Medical Reasons|11|||
155128980|NCT02228096|559903186|FG000|Overall Study|Study terminated by Sponsor|24|||
155128981|NCT02228096|559903186|FG000|Overall Study|Lack of Efficacy|18|||
155128982|NCT02228096|559903186|FG000|Overall Study|Death|12|||
155128983|NCT02228096|559903186|FG000|Overall Study|Physician Decision|3|||
155128984|NCT02228096|559903186|FG000|Overall Study|Subject/guardian decision|2|||
155128985|NCT02228096|559903186|FG000|Overall Study|New therapy for study indication|1|||
155128986|NCT02228096|559903186|FG000|Overall Study|Enrolled, not infused|11|||
155128987|NCT02265796|559903187|FG000|Overall Study|Death|1|||
155128988|NCT02265796|559903188|FG001|Overall Study|Death|0|||
155128989|NCT02265796|559903187|FG000|Overall Study|started on excluded medication|1|||
155128990|NCT02265796|559903188|FG001|Overall Study|started on excluded medication|0|||
155128991|NCT02265796|559903187|FG000|Overall Study|Withdrawal by Subject|1|||
155128992|NCT02265796|559903188|FG001|Overall Study|Withdrawal by Subject|1|||
155128993|NCT00952614|559903191|FG000|Overall Study|Death|3|||
155128994|NCT00952614|559903191|FG000|Overall Study|Lost to Follow-up|3|||
155128995|NCT00952614|559903191|FG000|Overall Study|other reason|1|||
155128996|NCT01624090|559903196|FG000|Overall Study|DLT, taken off therapy|0|||
155128997|NCT01624090|559903197|FG001|Overall Study|DLT, taken off therapy|1|||
155128998|NCT01624090|559903198|FG002|Overall Study|DLT, taken off therapy|0|||
155128999|NCT01624090|559903199|FG003|Overall Study|DLT, taken off therapy|0|||
155129000|NCT01624090|559903196|FG000|Overall Study|Withdrew prior to treatment|0|||
155129001|NCT01624090|559903197|FG001|Overall Study|Withdrew prior to treatment|1|||
155129002|NCT01624090|559903198|FG002|Overall Study|Withdrew prior to treatment|0|||
155129003|NCT01624090|559903199|FG003|Overall Study|Withdrew prior to treatment|0|||
155129004|NCT01624090|559903196|FG000|Overall Study|Died on study|0|||
155129005|NCT01624090|559903197|FG001|Overall Study|Died on study|0|||
155129006|NCT01624090|559903198|FG002|Overall Study|Died on study|2|||
155129007|NCT01624090|559903199|FG003|Overall Study|Died on study|0|||
155129008|NCT01624090|559903196|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
155129009|NCT01624090|559903197|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
155129010|NCT01624090|559903198|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
155129011|NCT01624090|559903199|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
155129012|NCT01624090|559903196|FG000|Overall Study|Dose escalated|0|||
155129013|NCT01624090|559903197|FG001|Overall Study|Dose escalated|0|||
155129014|NCT01624090|559903198|FG002|Overall Study|Dose escalated|3|||
155129015|NCT01624090|559903199|FG003|Overall Study|Dose escalated|0|||
155129016|NCT01403116|559903200|FG000|Overall Study|Adverse Event|7|||
155129017|NCT01403116|559903201|FG001|Overall Study|Adverse Event|4|||
155129018|NCT01403116|559903200|FG000|Overall Study|Lost to Follow-up|7|||
155129019|NCT01403116|559903201|FG001|Overall Study|Lost to Follow-up|5|||
155129020|NCT01403116|559903200|FG000|Overall Study|Withdrawal by Subject|12|||
155129021|NCT01403116|559903201|FG001|Overall Study|Withdrawal by Subject|15|||
155129022|NCT01403116|559903200|FG000|Overall Study|Non-compliance of study drug|3|||
155129023|NCT01403116|559903201|FG001|Overall Study|Non-compliance of study drug|0|||
155129024|NCT01403116|559903200|FG000|Overall Study|Protocol Violation|0|||
155129025|NCT01403116|559903201|FG001|Overall Study|Protocol Violation|1|||
155129026|NCT01403116|559903200|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
155129027|NCT01403116|559903201|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
155129028|NCT01403116|559903200|FG000|Overall Study|Hct >54%|2|||
155129029|NCT01403116|559903201|FG001|Overall Study|Hct >54%|0|||
155129030|NCT01403116|559903200|FG000|Overall Study|unable to keep appointments|0|||
155129031|NCT01403116|559903201|FG001|Overall Study|unable to keep appointments|2|||
155129032|NCT01895309|559903202|FG000|Overall Study|Adverse Event|13|||
155129033|NCT01895309|559903203|FG001|Overall Study|Adverse Event|17|||
155129034|NCT01895309|559903202|FG000|Overall Study|Protocol Violation|1|||
155129035|NCT01895309|559903203|FG001|Overall Study|Protocol Violation|0|||
155129036|NCT01895309|559903202|FG000|Overall Study|Lack of Efficacy|1|||
155129037|NCT01895309|559903203|FG001|Overall Study|Lack of Efficacy|3|||
155129038|NCT01895309|559903202|FG000|Overall Study|Lost to Follow-up|1|||
155129039|NCT01895309|559903203|FG001|Overall Study|Lost to Follow-up|3|||
155129040|NCT01895309|559903202|FG000|Overall Study|Physician Decision|15|||
155129041|NCT01895309|559903203|FG001|Overall Study|Physician Decision|10|||
155129042|NCT01895309|559903202|FG000|Overall Study|Withdrawal by Subject|9|||
155129043|NCT01895309|559903203|FG001|Overall Study|Withdrawal by Subject|18|||
155129044|NCT00042666|559903204|FG000|Overall Study|Adverse Event|2|||
155129045|NCT00042666|559903204|FG000|Overall Study|Death|4|||
155129046|NCT00042666|559903204|FG000|Overall Study|Protocol Violation|1|||
155129047|NCT00042666|559903204|FG000|Overall Study|Participant/Physician Perception|1|||
155129048|NCT00042666|559903204|FG000|Overall Study|Progressive Disease|41|||
155129049|NCT00042666|559903204|FG000|Overall Study|Other|1|||
155129050|NCT00042666|559903204|FG000|Overall Study|Other|4|||
155129051|NCT01555125|559903207|FG000|Induction Period|Lost to Follow-up|0|||
155129052|NCT01555125|559903208|FG001|Induction Period|Lost to Follow-up|2|||
155129053|NCT01555125|559903209|FG002|Induction Period|Lost to Follow-up|0|||
155129054|NCT01555125|559903210|FG003|Induction Period|Lost to Follow-up|0|||
155129055|NCT01555125|559903211|FG004|Induction Period|Lost to Follow-up|0|||
155129056|NCT01555125|559903207|FG000|Induction Period|Adverse Event|0|||
155129057|NCT01555125|559903208|FG001|Induction Period|Adverse Event|1|||
155129058|NCT01555125|559903209|FG002|Induction Period|Adverse Event|0|||
155129059|NCT01555125|559903210|FG003|Induction Period|Adverse Event|0|||
155129060|NCT01555125|559903211|FG004|Induction Period|Adverse Event|1|||
155129061|NCT01555125|559903207|FG000|Induction Period|Subject / guardian decision|0|||
155129062|NCT01555125|559903208|FG001|Induction Period|Subject / guardian decision|0|||
155129063|NCT01555125|559903209|FG002|Induction Period|Subject / guardian decision|0|||
155129064|NCT01555125|559903210|FG003|Induction Period|Subject / guardian decision|0|||
155129065|NCT01555125|559903211|FG004|Induction Period|Subject / guardian decision|2|||
155129066|NCT01555125|559903207|FG000|Induction Period|Death|1|||
155129067|NCT01555125|559903208|FG001|Induction Period|Death|0|||
155129068|NCT01555125|559903209|FG002|Induction Period|Death|0|||
155129069|NCT01555125|559903210|FG003|Induction Period|Death|0|||
155129070|NCT01555125|559903211|FG004|Induction Period|Death|0|||
155129071|NCT01555125|559903207|FG000|Maintenance Period|Adverse Event|1|||
155129072|NCT01555125|559903208|FG001|Maintenance Period|Adverse Event|1|||
155129073|NCT01555125|559903209|FG002|Maintenance Period|Adverse Event|0|||
155129074|NCT01555125|559903210|FG003|Maintenance Period|Adverse Event|0|||
155129075|NCT01555125|559903211|FG004|Maintenance Period|Adverse Event|0|||
155129076|NCT01555125|559903207|FG000|Maintenance Period|Subject / guardian decision|1|||
155129077|NCT01555125|559903208|FG001|Maintenance Period|Subject / guardian decision|2|||
155129078|NCT01555125|559903209|FG002|Maintenance Period|Subject / guardian decision|0|||
155129079|NCT01555125|559903210|FG003|Maintenance Period|Subject / guardian decision|0|||
155129080|NCT01555125|559903211|FG004|Maintenance Period|Subject / guardian decision|0|||
155129081|NCT01555125|559903207|FG000|Maintenance Period|Lost to Follow-up|2|||
155129082|NCT01555125|559903208|FG001|Maintenance Period|Lost to Follow-up|0|||
155129083|NCT01555125|559903209|FG002|Maintenance Period|Lost to Follow-up|0|||
155129084|NCT01555125|559903210|FG003|Maintenance Period|Lost to Follow-up|1|||
155129085|NCT01555125|559903211|FG004|Maintenance Period|Lost to Follow-up|0|||
155129086|NCT01555125|559903207|FG000|Maintenance Period|Lack of Efficacy|6|||
155129087|NCT01555125|559903208|FG001|Maintenance Period|Lack of Efficacy|1|||
155129088|NCT01555125|559903209|FG002|Maintenance Period|Lack of Efficacy|3|||
155129089|NCT01555125|559903210|FG003|Maintenance Period|Lack of Efficacy|0|||
155129090|NCT01555125|559903211|FG004|Maintenance Period|Lack of Efficacy|0|||
155129091|NCT01555125|559903207|FG000|Maintenance Period|Physician Decision|0|||
155129092|NCT01555125|559903208|FG001|Maintenance Period|Physician Decision|0|||
155006868|NCT05192889|559447140|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
155129093|NCT01555125|559903209|FG002|Maintenance Period|Physician Decision|1|||
155129094|NCT01555125|559903210|FG003|Maintenance Period|Physician Decision|0|||
155129095|NCT01555125|559903211|FG004|Maintenance Period|Physician Decision|0|||
155129096|NCT01555125|559903207|FG000|Maintenance Period|Death|0|||
155129097|NCT01555125|559903208|FG001|Maintenance Period|Death|0|||
155129098|NCT01555125|559903209|FG002|Maintenance Period|Death|0|||
155129099|NCT01555125|559903210|FG003|Maintenance Period|Death|1|||
155129100|NCT01555125|559903211|FG004|Maintenance Period|Death|0|||
155129101|NCT01555125|559903207|FG000|Extension|Adverse Event|1|||
155129102|NCT01555125|559903208|FG001|Extension|Adverse Event|2|||
155129103|NCT01555125|559903209|FG002|Extension|Adverse Event|1|||
155129104|NCT01555125|559903210|FG003|Extension|Adverse Event|1|||
155129105|NCT01555125|559903211|FG004|Extension|Adverse Event|0|||
155129106|NCT01555125|559903207|FG000|Extension|Protocol deviation|1|||
155006869|NCT00265759|559448963|FG000|Overall Study|Withdrawal by Subject|0|||
155006870|NCT00265759|559448964|FG001|Overall Study|Withdrawal by Subject|1|||
155006871|NCT00265759|559448965|FG002|Overall Study|Withdrawal by Subject|2|||
155006872|NCT00265759|559448966|FG003|Overall Study|Withdrawal by Subject|2|||
155006873|NCT00265759|559448963|FG000|Overall Study|Cancel|0|||
155006874|NCT00265759|559448964|FG001|Overall Study|Cancel|0|||
155006875|NCT00265759|559448965|FG002|Overall Study|Cancel|0|||
155006876|NCT00265759|559448966|FG003|Overall Study|Cancel|3|||
155006877|NCT00265759|559448963|FG000|Overall Study|Ineligible|0|||
155006878|NCT00265759|559448964|FG001|Overall Study|Ineligible|0|||
155006879|NCT00265759|559448965|FG002|Overall Study|Ineligible|0|||
155006880|NCT00265759|559448966|FG003|Overall Study|Ineligible|1|||
155006881|NCT00265759|559448963|FG000|Overall Study|Bilateral disease|0|||
155006882|NCT00265759|559448964|FG001|Overall Study|Bilateral disease|0|||
155006883|NCT00265759|559448965|FG002|Overall Study|Bilateral disease|0|||
155006884|NCT00265759|559448966|FG003|Overall Study|Bilateral disease|2|||
155006885|NCT00265759|559448963|FG000|Overall Study|Discontinued due to intolerability|0|||
155006886|NCT00265759|559448964|FG001|Overall Study|Discontinued due to intolerability|0|||
155006887|NCT00265759|559448965|FG002|Overall Study|Discontinued due to intolerability|0|||
155006888|NCT00265759|559448966|FG003|Overall Study|Discontinued due to intolerability|1|||
155006889|NCT03713593|559448968|FG000|Overall Study|Sponsor Decision|73|||
155006890|NCT03713593|559448969|FG001|Overall Study|Sponsor Decision|41|||
155006891|NCT03713593|559448968|FG000|Overall Study|Lost to Follow-up|2|||
155006892|NCT03713593|559448969|FG001|Overall Study|Lost to Follow-up|1|||
155006893|NCT03713593|559448968|FG000|Overall Study|Death|314|||
155006894|NCT03713593|559448969|FG001|Overall Study|Death|349|||
155006895|NCT03713593|559448968|FG000|Overall Study|Withdrawal by Subject|6|||
155006896|NCT03713593|559448969|FG001|Overall Study|Withdrawal by Subject|8|||
155006897|NCT05061134|559448970|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
155006898|NCT05061134|559448971|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
155006899|NCT05061134|559448972|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
155006900|NCT05061134|559448970|FG000|Overall Study|Subject not treated|0|||
155006901|NCT05061134|559448971|FG001|Overall Study|Subject not treated|0|||
155006902|NCT05061134|559448972|FG002|Overall Study|Subject not treated|2|||
155006903|NCT05061134|559448970|FG000|Overall Study|Other|0|||
155006904|NCT05061134|559448971|FG001|Overall Study|Other|0|||
155006905|NCT05061134|559448972|FG002|Overall Study|Other|9|||
155006906|NCT05061134|559448970|FG000|Overall Study|Withdrawal by Subject|9|||
155006907|NCT05061134|559448971|FG001|Overall Study|Withdrawal by Subject|8|||
155006908|NCT05061134|559448972|FG002|Overall Study|Withdrawal by Subject|5|||
155006909|NCT05061134|559448970|FG000|Overall Study|Study Terminated by Sponsor|22|||
155006910|NCT05061134|559448971|FG001|Overall Study|Study Terminated by Sponsor|14|||
155006911|NCT05061134|559448972|FG002|Overall Study|Study Terminated by Sponsor|7|||
155006912|NCT05061134|559448970|FG000|Overall Study|Progressive Disease|1|||
155006913|NCT05061134|559448971|FG001|Overall Study|Progressive Disease|2|||
155006914|NCT05061134|559448972|FG002|Overall Study|Progressive Disease|0|||
155006915|NCT05061134|559448970|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
155006916|NCT05061134|559448971|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
155006917|NCT05061134|559448972|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
155006918|NCT05061134|559448970|FG000|Overall Study|Lost to Follow-up|1|||
155006919|NCT05061134|559448971|FG001|Overall Study|Lost to Follow-up|0|||
155006920|NCT05061134|559448972|FG002|Overall Study|Lost to Follow-up|0|||
155006921|NCT05061134|559448970|FG000|Overall Study|Physician Decision|1|||
155006922|NCT05061134|559448971|FG001|Overall Study|Physician Decision|1|||
155006923|NCT05061134|559448972|FG002|Overall Study|Physician Decision|0|||
155006924|NCT05061134|559448970|FG000|Overall Study|Disease progression|1|||
155006925|NCT05061134|559448971|FG001|Overall Study|Disease progression|0|||
155006926|NCT05061134|559448972|FG002|Overall Study|Disease progression|0|||
155006927|NCT05061134|559448970|FG000|Overall Study|Death|43|||
155006928|NCT05061134|559448971|FG001|Overall Study|Death|23|||
155006929|NCT05061134|559448972|FG002|Overall Study|Death|14|||
155006930|NCT05061134|559448970|FG000|Overall Study|Database lock|2|||
155006931|NCT05061134|559448971|FG001|Overall Study|Database lock|0|||
155006932|NCT05061134|559448972|FG002|Overall Study|Database lock|0|||
155006933|NCT03176134|559448973|FG000|Overall Study|Lost to Follow-up|0|||
155006934|NCT03176134|559448974|FG001|Overall Study|Lost to Follow-up|2|||
155006935|NCT03176134|559448975|FG002|Overall Study|Lost to Follow-up|0|||
155006936|NCT03176134|559448976|FG003|Overall Study|Lost to Follow-up|0|||
155006937|NCT03176134|559448977|FG004|Overall Study|Lost to Follow-up|0|||
155006938|NCT03176134|559448978|FG005|Overall Study|Lost to Follow-up|0|||
155006939|NCT03176134|559448979|FG006|Overall Study|Lost to Follow-up|0|||
155006940|NCT03176134|559448980|FG007|Overall Study|Lost to Follow-up|0|||
155006941|NCT03176134|559448973|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
155006942|NCT03176134|559448974|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155006943|NCT03176134|559448975|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155006944|NCT03176134|559448976|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155006945|NCT03176134|559448977|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155006946|NCT03176134|559448978|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
154923538|NCT01728376|559146270|FG003|Overall Study|Adverse Event|1|||
154923539|NCT01728376|559146271|FG004|Overall Study|Adverse Event|1|||
154923540|NCT01728376|559146272|FG005|Overall Study|Adverse Event|0|||
154923541|NCT01728376|559146267|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
154923542|NCT01728376|559146268|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
154923543|NCT01728376|559146269|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
154923544|NCT01728376|559146270|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
154923545|NCT01728376|559146271|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
154923546|NCT01728376|559146272|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
154923547|NCT01728376|559146267|FG000|Overall Study|No relevant bacteria|2|||
154923548|NCT01728376|559146268|FG001|Overall Study|No relevant bacteria|0|||
154923549|NCT01728376|559146269|FG002|Overall Study|No relevant bacteria|0|||
154923550|NCT01728376|559146270|FG003|Overall Study|No relevant bacteria|0|||
154923551|NCT01728376|559146271|FG004|Overall Study|No relevant bacteria|1|||
154923552|NCT01728376|559146272|FG005|Overall Study|No relevant bacteria|1|||
154923553|NCT01728376|559146267|FG000|Overall Study|Did not receive treatment|0|||
154923554|NCT01728376|559146268|FG001|Overall Study|Did not receive treatment|1|||
154923555|NCT01728376|559146269|FG002|Overall Study|Did not receive treatment|0|||
154923556|NCT01728376|559146270|FG003|Overall Study|Did not receive treatment|0|||
154923557|NCT01728376|559146271|FG004|Overall Study|Did not receive treatment|0|||
154923558|NCT01728376|559146272|FG005|Overall Study|Did not receive treatment|0|||
154923559|NCT01728376|559146267|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
154923560|NCT01728376|559146268|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
154923561|NCT01728376|559146269|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
154923562|NCT01728376|559146270|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
154923563|NCT01728376|559146271|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
154923564|NCT01728376|559146272|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
154923565|NCT05299359|559146275|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
154923566|NCT05299359|559146276|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
154923567|NCT05299359|559146275|FG000|Main Part: Day 1 up to Day 366|Other|2|||
154923568|NCT05299359|559146276|FG001|Main Part: Day 1 up to Day 366|Other|0|||
154923569|NCT05299359|559146275|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
154923570|NCT05299359|559146276|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
154923571|NCT05299359|559146275|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
154923572|NCT05299359|559146276|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
154923573|NCT05299359|559146275|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
154923574|NCT05299359|559146276|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
154923575|NCT05299359|559146275|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
154923576|NCT05299359|559146276|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
154923577|NCT05299359|559146275|FG000|Extension Part: Day 1 to Day 366|Other|0|||
154923578|NCT05299359|559146276|FG001|Extension Part: Day 1 to Day 366|Other|1|||
154923579|NCT03110107|559146277|FG000|Treatment Period|Disease Progression|3|||
154923580|NCT03110107|559146278|FG001|Treatment Period|Disease Progression|9|||
154923581|NCT03110107|559146279|FG002|Treatment Period|Disease Progression|8|||
154923582|NCT03110107|559146280|FG003|Treatment Period|Disease Progression|11|||
154923583|NCT03110107|559146281|FG004|Treatment Period|Disease Progression|8|||
154923584|NCT03110107|559146282|FG005|Treatment Period|Disease Progression|4|||
154923585|NCT03110107|559146283|FG006|Treatment Period|Disease Progression|6|||
154923586|NCT03110107|559146284|FG007|Treatment Period|Disease Progression|7|||
154923587|NCT03110107|559146285|FG008|Treatment Period|Disease Progression|2|||
154923588|NCT03110107|559146286|FG009|Treatment Period|Disease Progression|10|||
154923589|NCT03110107|559146287|FG010|Treatment Period|Disease Progression|5|||
154923590|NCT03110107|559146288|FG011|Treatment Period|Disease Progression|2|||
154923591|NCT03110107|559146289|FG012|Treatment Period|Disease Progression|0|||
154923592|NCT03110107|559146290|FG013|Treatment Period|Disease Progression|5|||
154923593|NCT03110107|559146291|FG014|Treatment Period|Disease Progression|14|||
154923594|NCT03110107|559146292|FG015|Treatment Period|Disease Progression|14|||
154923595|NCT03110107|559146293|FG016|Treatment Period|Disease Progression|4|||
154923596|NCT03110107|559146294|FG017|Treatment Period|Disease Progression|3|||
154923597|NCT03110107|559146295|FG018|Treatment Period|Disease Progression|16|||
154923598|NCT03110107|559146296|FG019|Treatment Period|Disease Progression|14|||
154923599|NCT03110107|559146297|FG020|Treatment Period|Disease Progression|12|||
154923600|NCT03110107|559146298|FG021|Treatment Period|Disease Progression|16|||
154923601|NCT03110107|559146299|FG022|Treatment Period|Disease Progression|18|||
154923602|NCT03110107|559146300|FG023|Treatment Period|Disease Progression|13|||
154923603|NCT03110107|559146301|FG024|Treatment Period|Disease Progression|16|||
154923604|NCT03110107|559146302|FG025|Treatment Period|Disease Progression|31|||
154923605|NCT03110107|559146277|FG000|Treatment Period|Study drug toxicity|1|||
154923606|NCT03110107|559146278|FG001|Treatment Period|Study drug toxicity|0|||
154923607|NCT03110107|559146279|FG002|Treatment Period|Study drug toxicity|1|||
155129107|NCT01555125|559903208|FG001|Extension|Protocol deviation|0|||
155129108|NCT01555125|559903209|FG002|Extension|Protocol deviation|0|||
155129109|NCT01555125|559903210|FG003|Extension|Protocol deviation|0|||
155129110|NCT01555125|559903211|FG004|Extension|Protocol deviation|0|||
155129111|NCT01555125|559903207|FG000|Extension|Lack of Efficacy|7|||
155129112|NCT01555125|559903208|FG001|Extension|Lack of Efficacy|6|||
155129113|NCT01555125|559903209|FG002|Extension|Lack of Efficacy|3|||
155129114|NCT01555125|559903210|FG003|Extension|Lack of Efficacy|0|||
155129115|NCT01555125|559903211|FG004|Extension|Lack of Efficacy|0|||
155129116|NCT01555125|559903207|FG000|Extension|Lost to Follow-up|2|||
155129117|NCT01555125|559903208|FG001|Extension|Lost to Follow-up|1|||
155129118|NCT01555125|559903209|FG002|Extension|Lost to Follow-up|2|||
155129119|NCT01555125|559903210|FG003|Extension|Lost to Follow-up|0|||
155129120|NCT01555125|559903211|FG004|Extension|Lost to Follow-up|0|||
155129121|NCT01555125|559903207|FG000|Extension|Study terminated by sponsor|32|||
155129122|NCT01555125|559903208|FG001|Extension|Study terminated by sponsor|33|||
155129123|NCT01555125|559903209|FG002|Extension|Study terminated by sponsor|16|||
155129124|NCT01555125|559903210|FG003|Extension|Study terminated by sponsor|20|||
155129125|NCT01555125|559903211|FG004|Extension|Study terminated by sponsor|0|||
155129126|NCT01555125|559903207|FG000|Extension|Subject/guardian decision|1|||
155129127|NCT01555125|559903208|FG001|Extension|Subject/guardian decision|9|||
155129128|NCT01555125|559903209|FG002|Extension|Subject/guardian decision|1|||
155129129|NCT01555125|559903210|FG003|Extension|Subject/guardian decision|0|||
155129130|NCT01555125|559903211|FG004|Extension|Subject/guardian decision|0|||
155129131|NCT01555125|559903207|FG000|Extension|Technical Problems|1|||
155129132|NCT01555125|559903208|FG001|Extension|Technical Problems|0|||
155129133|NCT01555125|559903209|FG002|Extension|Technical Problems|0|||
155129134|NCT01555125|559903210|FG003|Extension|Technical Problems|1|||
155129135|NCT01555125|559903211|FG004|Extension|Technical Problems|0|||
155129136|NCT01555125|559903207|FG000|Follow-Up Period|Lost to Follow-up|1|||
155129137|NCT01555125|559903208|FG001|Follow-Up Period|Lost to Follow-up|0|||
155129138|NCT01555125|559903209|FG002|Follow-Up Period|Lost to Follow-up|0|||
155129139|NCT01555125|559903210|FG003|Follow-Up Period|Lost to Follow-up|0|||
155129140|NCT01555125|559903211|FG004|Follow-Up Period|Lost to Follow-up|0|||
155129141|NCT01555125|559903207|FG000|Follow-Up Period|Subject / guardian decision|3|||
155129142|NCT01555125|559903208|FG001|Follow-Up Period|Subject / guardian decision|1|||
155129143|NCT01555125|559903209|FG002|Follow-Up Period|Subject / guardian decision|1|||
155129144|NCT01555125|559903210|FG003|Follow-Up Period|Subject / guardian decision|1|||
155129145|NCT01555125|559903211|FG004|Follow-Up Period|Subject / guardian decision|0|||
155129146|NCT04268745|559903212|FG000|Overall Study|Lost to Follow-up|2|||
155129147|NCT04268745|559903213|FG001|Overall Study|Lost to Follow-up|3|||
155129148|NCT04268745|559903212|FG000|Overall Study|Withdrawal by Subject|4|||
155129149|NCT04268745|559903213|FG001|Overall Study|Withdrawal by Subject|2|||
155129150|NCT04268745|559903212|FG000|Overall Study|Death in the family|1|||
155129151|NCT04268745|559903213|FG001|Overall Study|Death in the family|0|||
155129152|NCT05327361|559903217|FG000|Overall Study|Lost to Follow-up|4|||
155129153|NCT00626405|559903218|FG000|Overall Study|Deemed Ineligible|1|||
155129154|NCT00626405|559903219|FG001|Overall Study|Deemed Ineligible|0|||
155129155|NCT00626405|559903218|FG000|Overall Study|Withdrawal by Subject|0|||
155129156|NCT00626405|559903219|FG001|Overall Study|Withdrawal by Subject|1|||
155129157|NCT01174173|559903220|FG000|Overall Study|drug-drug interaction|1|||
155129158|NCT02100475|559905402|FG000|Overall Study|Unclassified|1|||
155129159|NCT02100475|559905403|FG001|Overall Study|Unclassified|2|||
155129160|NCT02100475|559905402|FG000|Overall Study|Withdrawal criteria|1|||
155129161|NCT02100475|559905403|FG001|Overall Study|Withdrawal criteria|0|||
155129162|NCT03109184|559905404|FG000|Overall Study|Lost to Follow-up|6|||
155129163|NCT03109184|559905405|FG001|Overall Study|Lost to Follow-up|6|||
155129164|NCT03109184|559905404|FG000|Overall Study|Withdrawal by Subject|1|||
155129165|NCT03109184|559905405|FG001|Overall Study|Withdrawal by Subject|1|||
155129166|NCT02503501|559905406|FG000|Overall Study|Physician Decision|1|||
155129167|NCT02503501|559905407|FG001|Overall Study|Physician Decision|0|||
155129168|NCT02503501|559905406|FG000|Overall Study|Protocol Violation|0|||
155129169|NCT02503501|559905407|FG001|Overall Study|Protocol Violation|1|||
155129170|NCT02503501|559905406|FG000|Overall Study|Withdrawal by Subject|0|||
155129171|NCT02503501|559905407|FG001|Overall Study|Withdrawal by Subject|2|||
155129172|NCT01740401|559905408|FG000|Overall Study|Progression of disease|6|||
155129173|NCT01740401|559905408|FG000|Overall Study|Adverse Event|2|||
155129174|NCT01740401|559905408|FG000|Overall Study|Did not reach primary endpoint|2|||
155129175|NCT02806960|559905409|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155129176|NCT02806960|559905410|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155129177|NCT02806960|559905411|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155129178|NCT02806960|559905412|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
155129179|NCT00321464|559905413|FG000|Overall Study|Death|169|||
155129180|NCT00321464|559905414|FG001|Overall Study|Death|174|||
155129181|NCT00321464|559905413|FG000|Overall Study|Disease progression|124|||
155129182|NCT00321464|559905414|FG001|Overall Study|Disease progression|124|||
155129183|NCT00321464|559905413|FG000|Overall Study|Withdrawal by Subject|117|||
155129184|NCT00321464|559905414|FG001|Overall Study|Withdrawal by Subject|118|||
155006947|NCT03176134|559448979|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
155006948|NCT03176134|559448980|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
155006949|NCT03410056|559448985|FG000|Overall Study|Decision by Sponsor|0|||
155006950|NCT03410056|559448986|FG001|Overall Study|Decision by Sponsor|0|||
155006951|NCT03410056|559448987|FG002|Overall Study|Decision by Sponsor|3|||
155006952|NCT03410056|559448988|FG003|Overall Study|Decision by Sponsor|0|||
155006953|NCT03410056|559448989|FG004|Overall Study|Decision by Sponsor|0|||
155006954|NCT03410056|559448990|FG005|Overall Study|Decision by Sponsor|0|||
155006955|NCT03410056|559448991|FG006|Overall Study|Decision by Sponsor|0|||
155006956|NCT03410056|559448985|FG000|Overall Study|Withdrawal by Subject|0|||
155006957|NCT03410056|559448986|FG001|Overall Study|Withdrawal by Subject|2|||
155006958|NCT03410056|559448987|FG002|Overall Study|Withdrawal by Subject|5|||
155006959|NCT03410056|559448988|FG003|Overall Study|Withdrawal by Subject|5|||
155006960|NCT03410056|559448989|FG004|Overall Study|Withdrawal by Subject|0|||
155006961|NCT03410056|559448990|FG005|Overall Study|Withdrawal by Subject|0|||
155006962|NCT03410056|559448991|FG006|Overall Study|Withdrawal by Subject|0|||
155006963|NCT01368497|559448996|FG000|Overall Study|Lost to Follow-up|2|||
155006964|NCT03041311|559448997|FG000|Overall Study|Death|39|||
155006965|NCT03041311|559448998|FG001|Overall Study|Death|42|||
155006966|NCT03041311|559448997|FG000|Overall Study|Lost to Follow-up|0|||
155006967|NCT03041311|559448998|FG001|Overall Study|Lost to Follow-up|1|||
155006968|NCT03041311|559448997|FG000|Overall Study|Withdrawal by Subject|8|||
155129185|NCT00321464|559905413|FG000|Overall Study|Participant request|57|||
155178428|NCT00592774|560091481|FG004|Overall Study|Protocol Violation|1|||
155178429|NCT00592774|560091477|FG000|Overall Study|Withdrawal by Subject|3|||
155178430|NCT00592774|560091478|FG001|Overall Study|Withdrawal by Subject|7|||
155178431|NCT00592774|560091479|FG002|Overall Study|Withdrawal by Subject|0|||
155178432|NCT00592774|560091480|FG003|Overall Study|Withdrawal by Subject|0|||
155129186|NCT00321464|559905414|FG001|Overall Study|Participant request|61|||
155129187|NCT00321464|559905413|FG000|Overall Study|Adverse Event|43|||
155129188|NCT00321464|559905414|FG001|Overall Study|Adverse Event|28|||
155129189|NCT00321464|559905413|FG000|Overall Study|Physician Decision|15|||
155129190|NCT00321464|559905414|FG001|Overall Study|Physician Decision|14|||
155129191|NCT00321464|559905413|FG000|Overall Study|Noncompliance|4|||
155129192|NCT00321464|559905414|FG001|Overall Study|Noncompliance|10|||
155129193|NCT00321464|559905413|FG000|Overall Study|Lost to Follow-up|7|||
155129194|NCT00321464|559905414|FG001|Overall Study|Lost to Follow-up|8|||
155129195|NCT00321464|559905413|FG000|Overall Study|Protocol deviation|0|||
155129196|NCT00321464|559905414|FG001|Overall Study|Protocol deviation|2|||
155129197|NCT00321464|559905413|FG000|Overall Study|Ineligibility determined|2|||
155129198|NCT00321464|559905414|FG001|Overall Study|Ineligibility determined|1|||
155129199|NCT00321464|559905413|FG000|Overall Study|Other|21|||
155129200|NCT00321464|559905414|FG001|Overall Study|Other|18|||
155129201|NCT01209078|559905415|FG000|Overall Study|Adverse Event|5|||
155129202|NCT01209078|559905416|FG001|Overall Study|Adverse Event|0|||
155129203|NCT01209078|559905415|FG000|Overall Study|Lost to Follow-up|4|||
155129204|NCT01209078|559905416|FG001|Overall Study|Lost to Follow-up|0|||
155129205|NCT01209078|559905415|FG000|Overall Study|Physician Decision|5|||
155129206|NCT01209078|559905416|FG001|Overall Study|Physician Decision|2|||
155129207|NCT01209078|559905415|FG000|Overall Study|Withdrawal by Subject|2|||
155129208|NCT01209078|559905416|FG001|Overall Study|Withdrawal by Subject|1|||
155129209|NCT02207491|559905419|FG000|Overall Study|Adverse Event|20|||
155006969|NCT03041311|559448998|FG001|Overall Study|Withdrawal by Subject|5|||
155006970|NCT03041311|559448997|FG000|Overall Study|Sponsor Terminated Study|2|||
155129210|NCT02207491|559905420|FG001|Overall Study|Adverse Event|4|||
155129211|NCT02207491|559905419|FG000|Overall Study|Withdrawal by Subject|3|||
155129212|NCT02207491|559905420|FG001|Overall Study|Withdrawal by Subject|2|||
155129213|NCT02207491|559905419|FG000|Overall Study|Non-compliant|0|||
155129214|NCT02207491|559905420|FG001|Overall Study|Non-compliant|1|||
155129215|NCT02207491|559905419|FG000|Overall Study|Lost to Follow-up|0|||
155006971|NCT03041311|559448998|FG001|Overall Study|Sponsor Terminated Study|4|||
155006972|NCT03041311|559448997|FG000|Overall Study|Disease Progression|3|||
155129216|NCT02207491|559905420|FG001|Overall Study|Lost to Follow-up|1|||
155129217|NCT02207491|559905419|FG000|Overall Study|Lack of Efficacy|3|||
155178433|NCT00592774|560091481|FG004|Overall Study|Withdrawal by Subject|0|||
155006973|NCT03041311|559448998|FG001|Overall Study|Disease Progression|1|||
155006974|NCT03041311|559448997|FG000|Overall Study|Randomized in error, did not receive drug|2|||
155006975|NCT03041311|559448998|FG001|Overall Study|Randomized in error, did not receive drug|0|||
155006976|NCT00443729|559448999|FG000|Overall Study|Never Treated|0|||
155129218|NCT02207491|559905420|FG001|Overall Study|Lack of Efficacy|0|||
155129219|NCT02207491|559905419|FG000|Overall Study|Physician Decision|2|||
155129220|NCT02207491|559905420|FG001|Overall Study|Physician Decision|0|||
155129221|NCT02207491|559905419|FG000|Overall Study|Protocol Violation|3|||
155129222|NCT02207491|559905420|FG001|Overall Study|Protocol Violation|5|||
155129223|NCT00126776|559905421|FG000|Overall Study|follow up complete on all patients|0|||
155129224|NCT00126776|559905422|FG001|Overall Study|follow up complete on all patients|0|||
155178434|NCT00592774|560091477|FG000|Overall Study|Lack of Efficacy|3|||
155129225|NCT00372697|559905434|FG000|Overall Study|Protocol Violation|1|||
155178435|NCT00592774|560091478|FG001|Overall Study|Lack of Efficacy|3|||
155129226|NCT00372697|559905435|FG001|Overall Study|Protocol Violation|1|||
155129227|NCT03221842|559905436|FG000|Period 1 (Open-label)|Adverse Event|4|||
155129228|NCT03221842|559905437|FG001|Period 1 (Open-label)|Adverse Event|0|||
155129229|NCT03221842|559905436|FG000|Period 1 (Open-label)|Physician Decision|2|||
155129230|NCT03221842|559905437|FG001|Period 1 (Open-label)|Physician Decision|0|||
155129231|NCT03221842|559905436|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
155129232|NCT03221842|559905437|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
155129233|NCT03221842|559905436|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
155129234|NCT03221842|559905437|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
155006977|NCT00443729|559449000|FG001|Overall Study|Never Treated|1|||
155006978|NCT00443729|559448999|FG000|Overall Study|Lack of Efficacy|4|||
155129235|NCT03221842|559905436|FG000|Period 1 (Open-label)|Other|2|||
155129236|NCT03221842|559905437|FG001|Period 1 (Open-label)|Other|0|||
155129237|NCT03221842|559905436|FG000|Period 2 (Randomized, Blinded)|Death|0|||
155129238|NCT03221842|559905437|FG001|Period 2 (Randomized, Blinded)|Death|1|||
155129239|NCT03221842|559905436|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
155129240|NCT03221842|559905437|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
155129241|NCT00448747|559905438|FG000|Overall Study|collapsed veins|1|||
155129242|NCT00448747|559905439|FG001|Overall Study|collapsed veins|0|||
155129243|NCT00387725|559905440|FG000|Overall Study|Adverse Event|0|||
155129244|NCT00387725|559905441|FG001|Overall Study|Adverse Event|0|||
155006979|NCT00443729|559449000|FG001|Overall Study|Lack of Efficacy|2|||
155006980|NCT00443729|559448999|FG000|Overall Study|Lost to Follow-up|0|||
155006981|NCT00443729|559449000|FG001|Overall Study|Lost to Follow-up|1|||
155006982|NCT00443729|559448999|FG000|Overall Study|Physician Decision|2|||
155006983|NCT00443729|559449000|FG001|Overall Study|Physician Decision|1|||
155006984|NCT00443729|559448999|FG000|Overall Study|Protocol Violation|1|||
155006985|NCT00443729|559449000|FG001|Overall Study|Protocol Violation|1|||
155006986|NCT00443729|559448999|FG000|Overall Study|Withdrawal by Subject|3|||
155006987|NCT00443729|559449000|FG001|Overall Study|Withdrawal by Subject|1|||
155006988|NCT01842438|559449001|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
155006989|NCT01842438|559449002|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
155006990|NCT01842438|559449001|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
155006991|NCT01842438|559449002|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
155006992|NCT01842438|559449001|FG000|T2: 6month Follow-up|Death|0|||
155006993|NCT01842438|559449002|FG001|T2: 6month Follow-up|Death|1|||
155006994|NCT00782626|559449006|FG000|Overall Study|Adverse Event|1|||
155006995|NCT00782626|559449006|FG000|Overall Study|Progressive Disease|5|||
155006996|NCT00782626|559449006|FG000|Overall Study|Other Complicating Disease|1|||
155006997|NCT03718832|559449008|FG000|Analysis Sample|Withdrawal by Subject|18|||
155006998|NCT03718832|559449009|FG001|Analysis Sample|Withdrawal by Subject|15|||
155006999|NCT03718832|559449008|FG000|Analysis Sample|Legal hold on data|1|||
155007000|NCT03718832|559449009|FG001|Analysis Sample|Legal hold on data|0|||
155007001|NCT03718832|559449008|FG000|Analysis Sample|Participant from treated household|0|||
155007002|NCT03718832|559449009|FG001|Analysis Sample|Participant from treated household|1|||
155007003|NCT03718832|559449008|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
155007004|NCT03718832|559449009|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
155007005|NCT01996241|559449010|FG000|Overall Study|Lost to Follow-up|252|||
155007006|NCT01996241|559449011|FG001|Overall Study|Lost to Follow-up|235|||
155007007|NCT01811472|559449012|FG000|Overall Study|Adverse Event|1|||
155007008|NCT01811472|559449013|FG001|Overall Study|Adverse Event|0|||
155007009|NCT01811472|559449014|FG002|Overall Study|Adverse Event|4|||
155007010|NCT01811472|559449012|FG000|Overall Study|Lost to Follow-up|0|||
155129245|NCT00387725|559905442|FG002|Overall Study|Adverse Event|0|||
155129246|NCT00387725|559905443|FG003|Overall Study|Adverse Event|1|||
155129247|NCT00387725|559905440|FG000|Overall Study|Protocol Violation|0|||
155129248|NCT00387725|559905441|FG001|Overall Study|Protocol Violation|1|||
155129249|NCT00387725|559905442|FG002|Overall Study|Protocol Violation|0|||
155129250|NCT00387725|559905443|FG003|Overall Study|Protocol Violation|0|||
155007011|NCT01811472|559449013|FG001|Overall Study|Lost to Follow-up|0|||
155007012|NCT01811472|559449014|FG002|Overall Study|Lost to Follow-up|1|||
155007013|NCT01811472|559449012|FG000|Overall Study|Subject/guardian decision|1|||
155007014|NCT01811472|559449013|FG001|Overall Study|Subject/guardian decision|0|||
155007015|NCT01811472|559449014|FG002|Overall Study|Subject/guardian decision|0|||
155007016|NCT03280264|559449015|FG000|Overall Study|Adverse Event|1|||
155007017|NCT03280264|559449015|FG000|Overall Study|Physician Decision|1|||
155007018|NCT03280264|559449015|FG000|Overall Study|Withdrawal by Subject|1|||
155007019|NCT04882241|559449017|FG000|Overall Study|Ongoing in study|46|||
155129251|NCT00387725|559905440|FG000|Overall Study|Withdrawal by Subject|1|||
155129252|NCT00387725|559905441|FG001|Overall Study|Withdrawal by Subject|0|||
155007020|NCT04882241|559449018|FG001|Overall Study|Ongoing in study|48|||
155007021|NCT04882241|559449019|FG002|Overall Study|Ongoing in study|0|||
155007022|NCT04882241|559449020|FG003|Overall Study|Ongoing in study|0|||
155007023|NCT04882241|559449017|FG000|Overall Study|Death|13|||
155129253|NCT00387725|559905442|FG002|Overall Study|Withdrawal by Subject|1|||
155129254|NCT00387725|559905443|FG003|Overall Study|Withdrawal by Subject|0|||
155129255|NCT00387725|559905440|FG000|Overall Study|Parent/legal guardian request|0|||
155129256|NCT00387725|559905441|FG001|Overall Study|Parent/legal guardian request|0|||
155129257|NCT00387725|559905442|FG002|Overall Study|Parent/legal guardian request|1|||
155129258|NCT00387725|559905443|FG003|Overall Study|Parent/legal guardian request|1|||
155129259|NCT00568126|559905444|FG000|Overall Study|Adverse Event|3|||
155129260|NCT00568126|559905445|FG001|Overall Study|Adverse Event|0|||
155129261|NCT00568126|559905444|FG000|Overall Study|Withdrawal by Subject|2|||
155129262|NCT00568126|559905445|FG001|Overall Study|Withdrawal by Subject|3|||
155129263|NCT00568126|559905444|FG000|Overall Study|Lost to Follow-up|4|||
155129264|NCT00568126|559905445|FG001|Overall Study|Lost to Follow-up|3|||
155129265|NCT00568126|559905444|FG000|Overall Study|Lack of Efficacy|0|||
155129266|NCT00568126|559905445|FG001|Overall Study|Lack of Efficacy|1|||
155129267|NCT00568126|559905444|FG000|Overall Study|Physician Decision|2|||
155129268|NCT00568126|559905445|FG001|Overall Study|Physician Decision|2|||
155129269|NCT00527982|559905447|FG000|Overall Study|Physician Decision|1|||
155129270|NCT00527982|559905448|FG001|Overall Study|Physician Decision|0|||
155129271|NCT01939366|559905449|FG000|Overall Study|Adverse Event|8|||
155129272|NCT01939366|559905450|FG001|Overall Study|Adverse Event|17|||
155129273|NCT01939366|559905451|FG002|Overall Study|Adverse Event|30|||
155129274|NCT01939366|559905452|FG003|Overall Study|Adverse Event|8|||
155129275|NCT01939366|559905453|FG004|Overall Study|Adverse Event|5|||
155129276|NCT01939366|559905449|FG000|Overall Study|Lack of Efficacy|2|||
155129277|NCT01939366|559905450|FG001|Overall Study|Lack of Efficacy|1|||
155129278|NCT01939366|559905451|FG002|Overall Study|Lack of Efficacy|1|||
155129279|NCT01939366|559905452|FG003|Overall Study|Lack of Efficacy|1|||
155129280|NCT01939366|559905453|FG004|Overall Study|Lack of Efficacy|3|||
155129281|NCT01939366|559905449|FG000|Overall Study|Lost to Follow-up|1|||
155129282|NCT01939366|559905450|FG001|Overall Study|Lost to Follow-up|1|||
155129283|NCT01939366|559905451|FG002|Overall Study|Lost to Follow-up|0|||
155129284|NCT01939366|559905452|FG003|Overall Study|Lost to Follow-up|0|||
155129285|NCT01939366|559905453|FG004|Overall Study|Lost to Follow-up|0|||
155129286|NCT01939366|559905449|FG000|Overall Study|Withdrawal by Subject|1|||
155129287|NCT01939366|559905450|FG001|Overall Study|Withdrawal by Subject|0|||
155129288|NCT01939366|559905451|FG002|Overall Study|Withdrawal by Subject|2|||
155129289|NCT01939366|559905452|FG003|Overall Study|Withdrawal by Subject|2|||
155129290|NCT01939366|559905453|FG004|Overall Study|Withdrawal by Subject|3|||
155129291|NCT01939366|559905449|FG000|Overall Study|Inclusion criteria not met|0|||
155129292|NCT01939366|559905450|FG001|Overall Study|Inclusion criteria not met|1|||
155129293|NCT01939366|559905451|FG002|Overall Study|Inclusion criteria not met|1|||
155129294|NCT01939366|559905452|FG003|Overall Study|Inclusion criteria not met|0|||
155129295|NCT01939366|559905453|FG004|Overall Study|Inclusion criteria not met|1|||
155129296|NCT01939366|559905449|FG000|Overall Study|Other|0|||
155129297|NCT01939366|559905450|FG001|Overall Study|Other|0|||
155129298|NCT01939366|559905451|FG002|Overall Study|Other|2|||
155129299|NCT01939366|559905452|FG003|Overall Study|Other|2|||
155129300|NCT01939366|559905453|FG004|Overall Study|Other|1|||
155129301|NCT01939366|559905449|FG000|Overall Study|Protocol Violation|0|||
155129302|NCT01939366|559905450|FG001|Overall Study|Protocol Violation|0|||
155129303|NCT01939366|559905451|FG002|Overall Study|Protocol Violation|0|||
155129304|NCT01939366|559905452|FG003|Overall Study|Protocol Violation|1|||
155129305|NCT01939366|559905453|FG004|Overall Study|Protocol Violation|0|||
155129306|NCT01939366|559905449|FG000|Overall Study|Sponsor decision|0|||
155129307|NCT01939366|559905450|FG001|Overall Study|Sponsor decision|0|||
155129308|NCT01939366|559905451|FG002|Overall Study|Sponsor decision|0|||
155129309|NCT01939366|559905452|FG003|Overall Study|Sponsor decision|0|||
155129310|NCT01939366|559905453|FG004|Overall Study|Sponsor decision|2|||
155129311|NCT01939366|559905449|FG000|Overall Study|GCP non-compliance at site|2|||
155129312|NCT01939366|559905450|FG001|Overall Study|GCP non-compliance at site|3|||
155129313|NCT01939366|559905451|FG002|Overall Study|GCP non-compliance at site|2|||
155129314|NCT01939366|559905452|FG003|Overall Study|GCP non-compliance at site|3|||
155129315|NCT01939366|559905453|FG004|Overall Study|GCP non-compliance at site|3|||
155129316|NCT00007020|559905455|FG000|Overall Study|Death|16|||
155129317|NCT00007020|559905455|FG000|Overall Study|Lost to Follow-up|13|||
155178436|NCT00592774|560091479|FG002|Overall Study|Lack of Efficacy|0|||
155178437|NCT00592774|560091480|FG003|Overall Study|Lack of Efficacy|0|||
155129318|NCT00007020|559905455|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
155129319|NCT00007020|559905455|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
155129320|NCT00007020|559905455|FG000|Overall Study|Pt cared for by outside physician|4|||
155129321|NCT00007020|559905455|FG000|Overall Study|No evidence of treatment|6|||
155129322|NCT05856227|559905456|FG000|Overall Study|Adverse Event|0|||
155129323|NCT05856227|559905457|FG001|Overall Study|Adverse Event|1|||
155129324|NCT05856227|559905456|FG000|Overall Study|Due to Investigator absence|1|||
155129325|NCT05856227|559905457|FG001|Overall Study|Due to Investigator absence|0|||
155129326|NCT05856227|559905456|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
155129327|NCT05856227|559905457|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
155129328|NCT05011058|559905458|FG000|Overall Study|Sponsor Decision|2|||
155129329|NCT05011058|559905459|FG001|Overall Study|Sponsor Decision|0|||
155129330|NCT05011058|559905460|FG002|Overall Study|Sponsor Decision|14|||
155129331|NCT05011058|559905461|FG003|Overall Study|Sponsor Decision|0|||
155129332|NCT05011058|559905462|FG004|Overall Study|Sponsor Decision|0|||
155129333|NCT05011058|559905463|FG005|Overall Study|Sponsor Decision|1|||
155129334|NCT05011058|559905464|FG006|Overall Study|Sponsor Decision|0|||
155129335|NCT05011058|559905465|FG007|Overall Study|Sponsor Decision|5|||
155129336|NCT01571232|559905466|FG000|Overall Study|Lost to Follow-up|0|||
155129337|NCT01571232|559905467|FG001|Overall Study|Lost to Follow-up|1|||
155129338|NCT01571232|559905466|FG000|Overall Study|Withdrawal by Subject|1|||
155129339|NCT01571232|559905467|FG001|Overall Study|Withdrawal by Subject|0|||
155129340|NCT01272869|559905468|FG000|Period 2 (14 Days)|Adverse Event|1|||
155129341|NCT01272869|559905469|FG001|Period 2 (14 Days)|Adverse Event|0|||
155129342|NCT02455076|559905470|FG000|Inpatient|Withdrawal by Subject|1|||
155129343|NCT02455076|559905471|FG001|Inpatient|Withdrawal by Subject|0|||
155129344|NCT02455076|559905472|FG002|Inpatient|Withdrawal by Subject|0|||
155129345|NCT02455076|559905473|FG003|Inpatient|Withdrawal by Subject|0|||
155129346|NCT02455076|559905474|FG004|Inpatient|Withdrawal by Subject|0|||
155129347|NCT02455076|559905470|FG000|Inpatient|Discharged <24 h after admission|0|||
155129348|NCT02455076|559905471|FG001|Inpatient|Discharged <24 h after admission|1|||
155129349|NCT02455076|559905472|FG002|Inpatient|Discharged <24 h after admission|0|||
155129350|NCT02455076|559905473|FG003|Inpatient|Discharged <24 h after admission|0|||
155129351|NCT02455076|559905474|FG004|Inpatient|Discharged <24 h after admission|0|||
155129352|NCT02455076|559905470|FG000|Inpatient|Adverse Event|3|||
155129353|NCT02455076|559905471|FG001|Inpatient|Adverse Event|0|||
155007024|NCT04882241|559449018|FG001|Overall Study|Death|13|||
155007025|NCT04882241|559449019|FG002|Overall Study|Death|0|||
155007026|NCT04882241|559449020|FG003|Overall Study|Death|0|||
155007027|NCT03908125|559449021|FG000|Overall Study|Withdrawal by Subject|92|||
155007028|NCT03908125|559449021|FG000|Overall Study|Lost to Follow-up|8|||
155007029|NCT03885661|559449024|FG000|Overall Study|Withdrawal by Subject|0|||
155007030|NCT03885661|559449025|FG001|Overall Study|Withdrawal by Subject|1|||
155007031|NCT03885661|559449024|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
155007032|NCT03885661|559449025|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
155007033|NCT00344448|559449026|FG000|Screening|Withdrawal by Subject|0|||
155007034|NCT00344448|559449027|FG001|Screening|Withdrawal by Subject|1|||
155007035|NCT00344448|559449026|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
155007036|NCT00344448|559449027|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
155007037|NCT00344448|559449026|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
155007038|NCT00344448|559449027|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
155007039|NCT00344448|559449026|FG000|Open Label|Withdrawal by Subject|1|||
155007040|NCT00344448|559449027|FG001|Open Label|Withdrawal by Subject|1|||
155007041|NCT00344448|559449026|FG000|Open Label|Study terminated|1|||
155007042|NCT00344448|559449027|FG001|Open Label|Study terminated|0|||
155007043|NCT02441686|559449028|FG000|Induction|Adverse Event|4|||
155007044|NCT02441686|559449028|FG000|Induction|Complicating disease|1|||
155007045|NCT02441686|559449028|FG000|Induction|Physician Decision|1|||
155007046|NCT02441686|559449028|FG000|Induction|Withdrawal by Subject|1|||
155007047|NCT02441686|559449028|FG000|Induction|Did not receive treatment|1|||
155007048|NCT02441686|559449028|FG000|Maintenance|Remaining on Treatment|23|||
155007049|NCT02441686|559449028|FG000|Maintenance|Physician Decision|1|||
155007050|NCT02441686|559449028|FG000|Maintenance|Adverse Event|3|||
155007051|NCT02441686|559449028|FG000|Maintenance|Progressive Disease|10|||
155007052|NCT02441686|559449028|FG000|Maintenance|Withdrawal by Subject|1|||
155007053|NCT04194645|559449031|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007054|NCT04194645|559449032|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007055|NCT04194645|559449033|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007056|NCT04194645|559449034|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007057|NCT04194645|559449035|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007058|NCT04194645|559449036|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007059|NCT04194645|559449037|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007060|NCT04194645|559449038|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007061|NCT04194645|559449039|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155129354|NCT02455076|559905472|FG002|Inpatient|Adverse Event|0|||
155007062|NCT04194645|559449040|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
155007063|NCT04194645|559449041|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155129355|NCT02455076|559905473|FG003|Inpatient|Adverse Event|0|||
155007064|NCT04194645|559449042|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007065|NCT04194645|559449043|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007066|NCT04194645|559449044|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155007067|NCT04194645|559449045|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
155129356|NCT02455076|559905474|FG004|Inpatient|Adverse Event|0|||
155129357|NCT02455076|559905470|FG000|Outpatient|Adverse Event|0|||
155129358|NCT02455076|559905471|FG001|Outpatient|Adverse Event|0|||
155129359|NCT02455076|559905472|FG002|Outpatient|Adverse Event|0|||
155129360|NCT02455076|559905473|FG003|Outpatient|Adverse Event|5|||
155129361|NCT02455076|559905474|FG004|Outpatient|Adverse Event|0|||
155129362|NCT02455076|559905470|FG000|Outpatient|Lost to Follow-up|0|||
155007068|NCT03656744|559449046|FG000|Overall Study|Adverse Event|1|||
155007069|NCT03656744|559449047|FG001|Overall Study|Adverse Event|4|||
155129363|NCT02455076|559905471|FG001|Outpatient|Lost to Follow-up|0|||
155129364|NCT02455076|559905472|FG002|Outpatient|Lost to Follow-up|0|||
155129365|NCT02455076|559905473|FG003|Outpatient|Lost to Follow-up|1|||
155129366|NCT02455076|559905474|FG004|Outpatient|Lost to Follow-up|12|||
155129367|NCT03908476|559905475|FG000|Overall Study|Death|3|||
155129368|NCT03908476|559905476|FG001|Overall Study|Death|0|||
155129369|NCT03908476|559905475|FG000|Overall Study|Lost to Follow-up|3|||
155129370|NCT03908476|559905476|FG001|Overall Study|Lost to Follow-up|1|||
155129371|NCT03908476|559905475|FG000|Overall Study|Withdrawal by Subject|7|||
155129372|NCT03908476|559905476|FG001|Overall Study|Withdrawal by Subject|1|||
155129373|NCT03908476|559905475|FG000|Overall Study|Physician Decision|2|||
155129374|NCT03908476|559905476|FG001|Overall Study|Physician Decision|0|||
155129375|NCT03908476|559905475|FG000|Overall Study|System Explanted and not Replaced|4|||
155129376|NCT03908476|559905476|FG001|Overall Study|System Explanted and not Replaced|0|||
155129377|NCT03908476|559905475|FG000|Overall Study|Intrathecal Pump|1|||
155129378|NCT03908476|559905476|FG001|Overall Study|Intrathecal Pump|0|||
155129379|NCT03908476|559905475|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
155129380|NCT03908476|559905476|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
155129381|NCT05194267|559905477|FG000|Overall Study|Withdrawal by Subject|2|||
155129382|NCT02868229|559905478|FG000|Overall Study|Adverse Event|1|||
155129383|NCT02868229|559905479|FG001|Overall Study|Adverse Event|0|||
155129384|NCT02868229|559905480|FG002|Overall Study|Adverse Event|0|||
155129385|NCT02868229|559905481|FG003|Overall Study|Adverse Event|1|||
155129386|NCT02868229|559905478|FG000|Overall Study|Death|0|||
155129387|NCT02868229|559905479|FG001|Overall Study|Death|0|||
155129388|NCT02868229|559905480|FG002|Overall Study|Death|1|||
155129389|NCT02868229|559905481|FG003|Overall Study|Death|1|||
155129390|NCT02868229|559905478|FG000|Overall Study|Missed dose|0|||
155129391|NCT02868229|559905479|FG001|Overall Study|Missed dose|0|||
155129392|NCT02868229|559905480|FG002|Overall Study|Missed dose|0|||
155129393|NCT02868229|559905481|FG003|Overall Study|Missed dose|3|||
155129394|NCT06151288|559905482|FG000|Overall Study|Lost to Follow-up|4|||
155129395|NCT06151288|559905483|FG001|Overall Study|Lost to Follow-up|2|||
155129396|NCT06151288|559905484|FG002|Overall Study|Lost to Follow-up|4|||
155129397|NCT06151288|559905485|FG003|Overall Study|Lost to Follow-up|3|||
155129398|NCT06151288|559905482|FG000|Overall Study|Withdrawal by Subject|4|||
155129399|NCT06151288|559905483|FG001|Overall Study|Withdrawal by Subject|5|||
155129400|NCT06151288|559905484|FG002|Overall Study|Withdrawal by Subject|1|||
155129401|NCT06151288|559905485|FG003|Overall Study|Withdrawal by Subject|1|||
155129402|NCT03194438|559905494|FG000|Overall Study|Withdrawal by Subject|2|||
155129403|NCT02708485|559905497|FG000|Overall Study|Withdrawal by Subject|3|||
155129404|NCT02708485|559905498|FG001|Overall Study|Withdrawal by Subject|2|||
155129405|NCT00231413|559905499|FG000|Overall Study|Non-serious AE|0|||
155129406|NCT00231413|559905500|FG001|Overall Study|Non-serious AE|0|||
155129407|NCT00231413|559905501|FG002|Overall Study|Non-serious AE|1|||
155129408|NCT00231413|559905502|FG003|Overall Study|Non-serious AE|0|||
155129409|NCT00231413|559905503|FG004|Overall Study|Non-serious AE|0|||
155129410|NCT00231413|559905504|FG005|Overall Study|Non-serious AE|0|||
155129411|NCT00231413|559905505|FG006|Overall Study|Non-serious AE|1|||
155129412|NCT00231413|559905499|FG000|Overall Study|Withdrawal by Subject|3|||
155129413|NCT00231413|559905500|FG001|Overall Study|Withdrawal by Subject|1|||
155129414|NCT00231413|559905501|FG002|Overall Study|Withdrawal by Subject|4|||
155129415|NCT00231413|559905502|FG003|Overall Study|Withdrawal by Subject|2|||
155129416|NCT00231413|559905503|FG004|Overall Study|Withdrawal by Subject|2|||
155129417|NCT00231413|559905504|FG005|Overall Study|Withdrawal by Subject|0|||
155129418|NCT00231413|559905505|FG006|Overall Study|Withdrawal by Subject|3|||
155129419|NCT00231413|559905499|FG000|Overall Study|Migrated/moved from study area|0|||
155129420|NCT00231413|559905500|FG001|Overall Study|Migrated/moved from study area|0|||
155129421|NCT00231413|559905501|FG002|Overall Study|Migrated/moved from study area|1|||
155129422|NCT00231413|559905502|FG003|Overall Study|Migrated/moved from study area|0|||
155129423|NCT00231413|559905503|FG004|Overall Study|Migrated/moved from study area|0|||
155129424|NCT00231413|559905504|FG005|Overall Study|Migrated/moved from study area|1|||
155129425|NCT00231413|559905505|FG006|Overall Study|Migrated/moved from study area|0|||
155129426|NCT00231413|559905499|FG000|Overall Study|Lost to Follow-up|4|||
155129427|NCT00231413|559905500|FG001|Overall Study|Lost to Follow-up|4|||
155129428|NCT00231413|559905501|FG002|Overall Study|Lost to Follow-up|1|||
155129429|NCT00231413|559905502|FG003|Overall Study|Lost to Follow-up|1|||
155129430|NCT00231413|559905503|FG004|Overall Study|Lost to Follow-up|1|||
155129431|NCT00231413|559905504|FG005|Overall Study|Lost to Follow-up|4|||
155129432|NCT00231413|559905505|FG006|Overall Study|Lost to Follow-up|0|||
155129433|NCT00231413|559905499|FG000|Overall Study|Pregnancy|1|||
155129434|NCT00231413|559905500|FG001|Overall Study|Pregnancy|0|||
155129435|NCT00231413|559905501|FG002|Overall Study|Pregnancy|0|||
155129436|NCT00231413|559905502|FG003|Overall Study|Pregnancy|0|||
155129437|NCT00231413|559905503|FG004|Overall Study|Pregnancy|0|||
155129438|NCT00231413|559905504|FG005|Overall Study|Pregnancy|0|||
155129439|NCT00231413|559905505|FG006|Overall Study|Pregnancy|0|||
155129440|NCT01646203|559905506|FG000|Overall Study|Adverse Event|2|||
155129441|NCT01646203|559905507|FG001|Overall Study|Adverse Event|0|||
155129442|NCT01646203|559905508|FG002|Overall Study|Adverse Event|1|||
155129443|NCT01646203|559905506|FG000|Overall Study|Withdrawal by Subject|0|||
155129444|NCT01646203|559905507|FG001|Overall Study|Withdrawal by Subject|1|||
155129445|NCT01646203|559905508|FG002|Overall Study|Withdrawal by Subject|0|||
155129446|NCT01646203|559905506|FG000|Overall Study|Physician's Decision|0|||
155129447|NCT01646203|559905507|FG001|Overall Study|Physician's Decision|1|||
155129448|NCT01646203|559905508|FG002|Overall Study|Physician's Decision|0|||
155129449|NCT01659255|559905509|FG000|Overall Study|Adverse Event|0|||
155129450|NCT01659255|559905510|FG001|Overall Study|Adverse Event|0|||
155129451|NCT01659255|559905511|FG002|Overall Study|Adverse Event|0|||
155129452|NCT01659255|559905512|FG003|Overall Study|Adverse Event|0|||
155129453|NCT01659255|559905513|FG004|Overall Study|Adverse Event|0|||
155129454|NCT01659255|559905514|FG005|Overall Study|Adverse Event|1|||
155129455|NCT01659255|559905515|FG006|Overall Study|Adverse Event|1|||
155129456|NCT01659255|559905516|FG007|Overall Study|Adverse Event|0|||
155129457|NCT01659255|559905517|FG008|Overall Study|Adverse Event|0|||
155129458|NCT01659255|559905518|FG009|Overall Study|Adverse Event|1|||
155129459|NCT01659255|559905519|FG010|Overall Study|Adverse Event|0|||
155129460|NCT01659255|559905520|FG011|Overall Study|Adverse Event|1|||
155129461|NCT01659255|559905521|FG012|Overall Study|Adverse Event|0|||
155129462|NCT01659255|559905522|FG013|Overall Study|Adverse Event|2|||
155129463|NCT01659255|559905523|FG014|Overall Study|Adverse Event|0|||
155129464|NCT01659255|559905524|FG015|Overall Study|Adverse Event|1|||
155129465|NCT01659255|559905525|FG016|Overall Study|Adverse Event|0|||
155129466|NCT01659255|559905509|FG000|Overall Study|Death|0|||
155129467|NCT01659255|559905510|FG001|Overall Study|Death|1|||
155129468|NCT01659255|559905511|FG002|Overall Study|Death|0|||
155129469|NCT01659255|559905512|FG003|Overall Study|Death|0|||
155129470|NCT01659255|559905513|FG004|Overall Study|Death|0|||
155129471|NCT01659255|559905514|FG005|Overall Study|Death|0|||
155129472|NCT01659255|559905515|FG006|Overall Study|Death|0|||
155129473|NCT01659255|559905516|FG007|Overall Study|Death|1|||
155129474|NCT01659255|559905517|FG008|Overall Study|Death|1|||
155129475|NCT01659255|559905518|FG009|Overall Study|Death|0|||
155129476|NCT01659255|559905519|FG010|Overall Study|Death|0|||
155129477|NCT01659255|559905520|FG011|Overall Study|Death|0|||
155129478|NCT01659255|559905521|FG012|Overall Study|Death|1|||
155129479|NCT01659255|559905522|FG013|Overall Study|Death|1|||
155129480|NCT01659255|559905523|FG014|Overall Study|Death|2|||
155129481|NCT01659255|559905524|FG015|Overall Study|Death|1|||
155129482|NCT01659255|559905525|FG016|Overall Study|Death|0|||
155129483|NCT01659255|559905509|FG000|Overall Study|Progressive Disease|2|||
155129484|NCT01659255|559905510|FG001|Overall Study|Progressive Disease|0|||
155129485|NCT01659255|559905511|FG002|Overall Study|Progressive Disease|0|||
155129486|NCT01659255|559905512|FG003|Overall Study|Progressive Disease|0|||
155129487|NCT01659255|559905513|FG004|Overall Study|Progressive Disease|0|||
155129488|NCT01659255|559905514|FG005|Overall Study|Progressive Disease|0|||
155129489|NCT01659255|559905515|FG006|Overall Study|Progressive Disease|0|||
155129490|NCT01659255|559905516|FG007|Overall Study|Progressive Disease|1|||
155129491|NCT01659255|559905517|FG008|Overall Study|Progressive Disease|0|||
155129492|NCT01659255|559905518|FG009|Overall Study|Progressive Disease|2|||
155129493|NCT01659255|559905519|FG010|Overall Study|Progressive Disease|2|||
155129494|NCT01659255|559905520|FG011|Overall Study|Progressive Disease|3|||
155129495|NCT01659255|559905521|FG012|Overall Study|Progressive Disease|5|||
155129496|NCT01659255|559905522|FG013|Overall Study|Progressive Disease|13|||
155129497|NCT01659255|559905523|FG014|Overall Study|Progressive Disease|6|||
155129498|NCT01659255|559905524|FG015|Overall Study|Progressive Disease|2|||
155129499|NCT01659255|559905525|FG016|Overall Study|Progressive Disease|3|||
155129500|NCT01659255|559905509|FG000|Overall Study|Withdrew Consent|0|||
155129501|NCT01659255|559905510|FG001|Overall Study|Withdrew Consent|0|||
155007070|NCT03656744|559449048|FG002|Overall Study|Adverse Event|1|||
155007071|NCT03656744|559449046|FG000|Overall Study|Protocol Violation|1|||
155129502|NCT01659255|559905511|FG002|Overall Study|Withdrew Consent|0|||
155129503|NCT01659255|559905512|FG003|Overall Study|Withdrew Consent|0|||
155007072|NCT03656744|559449047|FG001|Overall Study|Protocol Violation|0|||
155129504|NCT01659255|559905513|FG004|Overall Study|Withdrew Consent|0|||
155129505|NCT01659255|559905514|FG005|Overall Study|Withdrew Consent|0|||
155129506|NCT01659255|559905515|FG006|Overall Study|Withdrew Consent|0|||
155129507|NCT01659255|559905516|FG007|Overall Study|Withdrew Consent|0|||
155007073|NCT03656744|559449048|FG002|Overall Study|Protocol Violation|0|||
155129508|NCT01659255|559905517|FG008|Overall Study|Withdrew Consent|0|||
155007074|NCT03656744|559449046|FG000|Overall Study|Lost to Follow-up|2|||
155129509|NCT01659255|559905518|FG009|Overall Study|Withdrew Consent|0|||
155129510|NCT01659255|559905519|FG010|Overall Study|Withdrew Consent|1|||
155129511|NCT01659255|559905520|FG011|Overall Study|Withdrew Consent|0|||
155129512|NCT01659255|559905521|FG012|Overall Study|Withdrew Consent|0|||
155129513|NCT01659255|559905522|FG013|Overall Study|Withdrew Consent|1|||
155129514|NCT01659255|559905523|FG014|Overall Study|Withdrew Consent|0|||
155129515|NCT01659255|559905524|FG015|Overall Study|Withdrew Consent|0|||
155129516|NCT01659255|559905525|FG016|Overall Study|Withdrew Consent|0|||
155129517|NCT01659255|559905509|FG000|Overall Study|Investigator Decision|0|||
155129518|NCT01659255|559905510|FG001|Overall Study|Investigator Decision|0|||
155007075|NCT03656744|559449047|FG001|Overall Study|Lost to Follow-up|2|||
155007076|NCT03656744|559449048|FG002|Overall Study|Lost to Follow-up|0|||
155007077|NCT03656744|559449046|FG000|Overall Study|Withdrawal by Subject|0|||
155007078|NCT03656744|559449047|FG001|Overall Study|Withdrawal by Subject|1|||
155007079|NCT03656744|559449048|FG002|Overall Study|Withdrawal by Subject|0|||
155007080|NCT03656744|559449046|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
155007081|NCT03656744|559449047|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
155007082|NCT03656744|559449048|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
155007083|NCT03076775|559449049|FG000|Overall Study|Lost to Follow-up|1|||
155007084|NCT03076775|559449050|FG001|Overall Study|Lost to Follow-up|0|||
155007085|NCT00940316|559449051|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
155007086|NCT00940316|559449052|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
155007087|NCT00940316|559449053|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
155007088|NCT00940316|559449051|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
155007089|NCT00940316|559449052|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
155007090|NCT00940316|559449053|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
155007091|NCT00940316|559449051|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
155007092|NCT00940316|559449052|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
155007093|NCT00940316|559449053|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
155007094|NCT00940316|559449051|FG000|Treated After Cycle 5|Adverse Event|0|||
155007095|NCT00940316|559449052|FG001|Treated After Cycle 5|Adverse Event|0|||
155007096|NCT00940316|559449053|FG002|Treated After Cycle 5|Adverse Event|1|||
155007097|NCT00940316|559449051|FG000|Treated After Cycle 5|Progressive disease|0|||
155007098|NCT00940316|559449052|FG001|Treated After Cycle 5|Progressive disease|1|||
155007099|NCT00940316|559449053|FG002|Treated After Cycle 5|Progressive disease|0|||
155007100|NCT00996489|559449056|FG000|Overall Study|Device failure|45|||
155007101|NCT00996489|559449056|FG000|Overall Study|Discontinued|116|||
155007102|NCT00129545|559449059|FG000|Overall Study|Death|5|||
155007103|NCT00129545|559449060|FG001|Overall Study|Death|60|||
155007104|NCT00129545|559449061|FG002|Overall Study|Death|44|||
155007105|NCT00129545|559449059|FG000|Overall Study|Withdrawal by Subject|3|||
155007106|NCT00129545|559449060|FG001|Overall Study|Withdrawal by Subject|18|||
155007107|NCT00129545|559449061|FG002|Overall Study|Withdrawal by Subject|44|||
155007108|NCT00129545|559449059|FG000|Overall Study|Lost to Follow-up|2|||
155007109|NCT00129545|559449060|FG001|Overall Study|Lost to Follow-up|22|||
155007110|NCT00129545|559449061|FG002|Overall Study|Lost to Follow-up|13|||
155007111|NCT00129545|559449059|FG000|Overall Study|Physician Decision|0|||
155007112|NCT00129545|559449060|FG001|Overall Study|Physician Decision|3|||
155007113|NCT00129545|559449061|FG002|Overall Study|Physician Decision|10|||
155007114|NCT00129545|559449059|FG000|Overall Study|Device not implanted|16|||
155007115|NCT00129545|559449060|FG001|Overall Study|Device not implanted|61|||
155007116|NCT00129545|559449061|FG002|Overall Study|Device not implanted|0|||
155007117|NCT01130493|559449066|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
155007118|NCT01130493|559449067|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
155007119|NCT01130493|559449068|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
155007120|NCT01130493|559449066|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
155007121|NCT01130493|559449067|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
155007122|NCT01130493|559449068|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
155007123|NCT01130493|559449066|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
155007124|NCT01130493|559449067|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
155007125|NCT01130493|559449068|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
155007126|NCT01130493|559449066|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
155007127|NCT01130493|559449067|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
155007128|NCT01130493|559449068|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
155007129|NCT01130493|559449066|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
155007130|NCT01130493|559449067|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
155007131|NCT01130493|559449068|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
155007132|NCT01130493|559449066|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
155007133|NCT01130493|559449067|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
155007134|NCT01130493|559449068|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
155007135|NCT01130493|559449066|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
155007136|NCT01130493|559449067|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
155007137|NCT01130493|559449068|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
155007138|NCT01130493|559449066|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
155007139|NCT01130493|559449067|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
155007140|NCT01130493|559449068|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
155007141|NCT01130493|559449066|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
155007142|NCT01130493|559449067|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
155007143|NCT01130493|559449068|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
155007144|NCT01130493|559449066|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
155129519|NCT01659255|559905511|FG002|Overall Study|Investigator Decision|0|||
155129520|NCT01659255|559905512|FG003|Overall Study|Investigator Decision|0|||
155129521|NCT01659255|559905513|FG004|Overall Study|Investigator Decision|0|||
155129522|NCT01659255|559905514|FG005|Overall Study|Investigator Decision|0|||
155129523|NCT01659255|559905515|FG006|Overall Study|Investigator Decision|0|||
155129524|NCT01659255|559905516|FG007|Overall Study|Investigator Decision|0|||
155129525|NCT01659255|559905517|FG008|Overall Study|Investigator Decision|0|||
155129526|NCT01659255|559905518|FG009|Overall Study|Investigator Decision|0|||
155129527|NCT01659255|559905519|FG010|Overall Study|Investigator Decision|0|||
155129528|NCT01659255|559905520|FG011|Overall Study|Investigator Decision|0|||
155129529|NCT01659255|559905521|FG012|Overall Study|Investigator Decision|1|||
155129530|NCT01659255|559905522|FG013|Overall Study|Investigator Decision|1|||
155129531|NCT01659255|559905523|FG014|Overall Study|Investigator Decision|0|||
155129532|NCT01659255|559905524|FG015|Overall Study|Investigator Decision|0|||
155129533|NCT01659255|559905525|FG016|Overall Study|Investigator Decision|0|||
155129534|NCT01659255|559905509|FG000|Overall Study|Sponsor's Decision|0|||
155129535|NCT01659255|559905510|FG001|Overall Study|Sponsor's Decision|0|||
155129536|NCT01659255|559905511|FG002|Overall Study|Sponsor's Decision|0|||
155129537|NCT01659255|559905512|FG003|Overall Study|Sponsor's Decision|0|||
155129538|NCT01659255|559905513|FG004|Overall Study|Sponsor's Decision|0|||
155129539|NCT01659255|559905514|FG005|Overall Study|Sponsor's Decision|0|||
155129540|NCT01659255|559905515|FG006|Overall Study|Sponsor's Decision|1|||
155129541|NCT01659255|559905516|FG007|Overall Study|Sponsor's Decision|0|||
155129542|NCT01659255|559905517|FG008|Overall Study|Sponsor's Decision|0|||
155129543|NCT01659255|559905518|FG009|Overall Study|Sponsor's Decision|0|||
155129544|NCT01659255|559905519|FG010|Overall Study|Sponsor's Decision|0|||
155129545|NCT01659255|559905520|FG011|Overall Study|Sponsor's Decision|0|||
155129546|NCT01659255|559905521|FG012|Overall Study|Sponsor's Decision|0|||
155129547|NCT01659255|559905522|FG013|Overall Study|Sponsor's Decision|0|||
155129548|NCT01659255|559905523|FG014|Overall Study|Sponsor's Decision|0|||
155129549|NCT01659255|559905524|FG015|Overall Study|Sponsor's Decision|0|||
155129550|NCT01659255|559905525|FG016|Overall Study|Sponsor's Decision|0|||
155129551|NCT01659255|559905509|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129552|NCT01659255|559905510|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129553|NCT01659255|559905511|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129554|NCT01659255|559905512|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129555|NCT01659255|559905513|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129556|NCT01659255|559905514|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129557|NCT01659255|559905515|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129558|NCT01659255|559905516|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129559|NCT01659255|559905517|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129560|NCT01659255|559905518|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129561|NCT01659255|559905519|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129562|NCT01659255|559905520|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129563|NCT01659255|559905521|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129564|NCT01659255|559905522|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129565|NCT01659255|559905523|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129566|NCT01659255|559905524|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
155129567|NCT01659255|559905525|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
155129568|NCT01659255|559905509|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
155129569|NCT01659255|559905510|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
155129570|NCT01659255|559905511|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
155129571|NCT01659255|559905512|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
155129572|NCT01659255|559905513|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
155129573|NCT01659255|559905514|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
155129574|NCT01659255|559905515|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
155129575|NCT01659255|559905516|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
155129576|NCT01659255|559905517|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
155129577|NCT01659255|559905518|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
155129578|NCT01659255|559905519|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
155129579|NCT01659255|559905520|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
155129580|NCT01659255|559905521|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
155129581|NCT01659255|559905522|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
155129582|NCT01659255|559905523|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
155129583|NCT01659255|559905524|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
155129584|NCT01659255|559905525|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
155129585|NCT01423916|559905526|FG000|Overall Study|Adverse Event|5|||
155129586|NCT01423916|559905527|FG001|Overall Study|Adverse Event|9|||
155129587|NCT01423916|559905528|FG002|Overall Study|Adverse Event|2|||
155129588|NCT01423916|559905526|FG000|Overall Study|Met Withdrawal Criteria|1|||
155007145|NCT01130493|559449067|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
155007146|NCT01130493|559449068|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
155007147|NCT01130493|559449066|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
155007148|NCT01130493|559449067|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
155007149|NCT01130493|559449068|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
155007150|NCT01130493|559449066|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
155007151|NCT01130493|559449067|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
155007152|NCT01130493|559449068|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
155007153|NCT01130493|559449066|FG000|Part 2: OLE|Adverse Event|0|||
155007154|NCT01130493|559449067|FG001|Part 2: OLE|Adverse Event|2|||
155007155|NCT01130493|559449068|FG002|Part 2: OLE|Adverse Event|1|||
155007156|NCT01130493|559449066|FG000|Part 2: OLE|Withdrawal by Subject|0|||
155007157|NCT01130493|559449067|FG001|Part 2: OLE|Withdrawal by Subject|1|||
155007158|NCT01130493|559449068|FG002|Part 2: OLE|Withdrawal by Subject|4|||
155007159|NCT03541317|559449072|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
155007160|NCT03541317|559449073|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155007161|NCT03541317|559449074|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155007162|NCT03541317|559449075|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155007163|NCT03541317|559449076|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155007164|NCT03541317|559449077|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
155007165|NCT00879086|559449080|FG000|Overall Study|Adverse Event|3|||
155007166|NCT00879086|559449081|FG001|Overall Study|Adverse Event|15|||
155007167|NCT00879086|559449080|FG000|Overall Study|Participant choice|2|||
155007168|NCT00879086|559449081|FG001|Overall Study|Participant choice|2|||
155007169|NCT00879086|559449080|FG000|Overall Study|Progression of disease|40|||
155007170|NCT00879086|559449081|FG001|Overall Study|Progression of disease|26|||
155007171|NCT00879086|559449080|FG000|Overall Study|Withdrawal of consent|2|||
155007172|NCT00879086|559449081|FG001|Overall Study|Withdrawal of consent|1|||
155007173|NCT00879086|559449080|FG000|Overall Study|Other|4|||
155007174|NCT00879086|559449081|FG001|Overall Study|Other|6|||
155007175|NCT00879086|559449080|FG000|Overall Study|Death|1|||
155007176|NCT00879086|559449081|FG001|Overall Study|Death|2|||
155007177|NCT04728802|559449082|FG000|Overall Study|Withdrawal by Subject|4|||
155007178|NCT04728802|559449083|FG001|Overall Study|Withdrawal by Subject|20|||
155007179|NCT04728802|559449082|FG000|Overall Study|Physician Decision|7|||
155007180|NCT04728802|559449083|FG001|Overall Study|Physician Decision|7|||
155007181|NCT04728802|559449082|FG000|Overall Study|Protocol Violation|10|||
155007182|NCT04728802|559449083|FG001|Overall Study|Protocol Violation|4|||
155007183|NCT04728802|559449082|FG000|Overall Study|Transfer|1|||
155007184|NCT04728802|559449083|FG001|Overall Study|Transfer|0|||
155007185|NCT04728802|559449082|FG000|Overall Study|Death|4|||
155007186|NCT04728802|559449083|FG001|Overall Study|Death|5|||
155007187|NCT04728802|559449082|FG000|Overall Study|Other|3|||
155007188|NCT04728802|559449083|FG001|Overall Study|Other|0|||
155007189|NCT02286843|559449086|FG000|Overall Study|Not Treated|4|||
155007190|NCT02286843|559449086|FG000|Overall Study|Protocol Violation|1|||
155007191|NCT02286843|559449086|FG000|Overall Study|Withdrawal by Subject|1|||
155007192|NCT02536846|559449087|FG000|Overall Study|Withdrawal by Subject|1|||
155007193|NCT00111241|559449089|FG000|Overall Study|Lost to Follow-up|1|||
155007194|NCT00111241|559449090|FG001|Overall Study|Lost to Follow-up|0|||
155007195|NCT00111241|559449089|FG000|Overall Study|Withdrawal by Subject|4|||
155007196|NCT00111241|559449090|FG001|Overall Study|Withdrawal by Subject|0|||
155007197|NCT00111241|559449089|FG000|Overall Study|Protocol Violation|9|||
155007198|NCT00111241|559449090|FG001|Overall Study|Protocol Violation|8|||
155007199|NCT00111241|559449089|FG000|Overall Study|Adverse Event|1|||
155007200|NCT00111241|559449090|FG001|Overall Study|Adverse Event|0|||
155007201|NCT02096744|559449101|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
155129589|NCT01423916|559905527|FG001|Overall Study|Met Withdrawal Criteria|1|||
155129590|NCT01423916|559905528|FG002|Overall Study|Met Withdrawal Criteria|1|||
155129591|NCT01423916|559905526|FG000|Overall Study|Physician Decision|1|||
155129592|NCT01423916|559905527|FG001|Overall Study|Physician Decision|0|||
155129593|NCT01423916|559905528|FG002|Overall Study|Physician Decision|1|||
155007202|NCT02096744|559449102|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
155007203|NCT02096744|559449101|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
155007204|NCT02096744|559449102|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
155007205|NCT02096744|559449101|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
155007206|NCT02096744|559449102|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
155007207|NCT02445963|559449104|FG000|Overall Study|Lost to Follow-up|1|||
155007208|NCT02445963|559449105|FG001|Overall Study|Lost to Follow-up|0|||
155129594|NCT01423916|559905526|FG000|Overall Study|Withdrawal by Subject|3|||
155129595|NCT01423916|559905527|FG001|Overall Study|Withdrawal by Subject|10|||
155007209|NCT02445963|559449106|FG002|Overall Study|Lost to Follow-up|0|||
155007210|NCT02445963|559449107|FG003|Overall Study|Lost to Follow-up|0|||
155007211|NCT02445963|559449104|FG000|Overall Study|Change in employment|1|||
155129596|NCT01423916|559905528|FG002|Overall Study|Withdrawal by Subject|3|||
155129597|NCT01423916|559905526|FG000|Overall Study|Protocol Deviation|1|||
155007212|NCT02445963|559449105|FG001|Overall Study|Change in employment|0|||
155007213|NCT02445963|559449106|FG002|Overall Study|Change in employment|0|||
155007214|NCT02445963|559449107|FG003|Overall Study|Change in employment|0|||
155007215|NCT02445963|559449104|FG000|Overall Study|Symptoms post-vaccination|0|||
155007216|NCT02445963|559449105|FG001|Overall Study|Symptoms post-vaccination|0|||
155007217|NCT02445963|559449106|FG002|Overall Study|Symptoms post-vaccination|1|||
155007218|NCT02445963|559449107|FG003|Overall Study|Symptoms post-vaccination|0|||
155007219|NCT01957176|559449111|FG000|Overall Study|Adverse Event|2|||
155007220|NCT01957176|559449112|FG001|Overall Study|Adverse Event|0|||
155007221|NCT01957176|559449111|FG000|Overall Study|Physician Decision|2|||
155007222|NCT01957176|559449112|FG001|Overall Study|Physician Decision|1|||
155007223|NCT01957176|559449111|FG000|Overall Study|Withdrawal by Subject|1|||
155007224|NCT01957176|559449112|FG001|Overall Study|Withdrawal by Subject|0|||
155007225|NCT01449812|559449113|FG000|Overall Study|Migrated/moved from study area|1|||
155007226|NCT01449812|559449114|FG001|Overall Study|Migrated/moved from study area|0|||
155007227|NCT01449812|559449115|FG002|Overall Study|Migrated/moved from study area|0|||
155007228|NCT01449812|559449113|FG000|Overall Study|Withdrawal by Subject|0|||
155007229|NCT01449812|559449114|FG001|Overall Study|Withdrawal by Subject|0|||
155007230|NCT01449812|559449115|FG002|Overall Study|Withdrawal by Subject|1|||
155007231|NCT01449812|559449113|FG000|Overall Study|Lost to Follow-up|1|||
155007232|NCT01449812|559449114|FG001|Overall Study|Lost to Follow-up|0|||
155007233|NCT01449812|559449115|FG002|Overall Study|Lost to Follow-up|0|||
155007234|NCT03449446|559449116|FG000|Overall Study|Randomized but Never Treated|0|||
155007235|NCT03449446|559449117|FG001|Overall Study|Randomized but Never Treated|0|||
155007236|NCT03449446|559449118|FG002|Overall Study|Randomized but Never Treated|1|||
155007237|NCT03449446|559449119|FG003|Overall Study|Randomized but Never Treated|1|||
155007238|NCT03449446|559449120|FG004|Overall Study|Randomized but Never Treated|1|||
155007239|NCT03449446|559449121|FG005|Overall Study|Randomized but Never Treated|0|||
155007240|NCT03449446|559449122|FG006|Overall Study|Randomized but Never Treated|0|||
155007241|NCT03449446|559449116|FG000|Overall Study|Unknown Reason|33|||
155007242|NCT03449446|559449117|FG001|Overall Study|Unknown Reason|1|||
155007243|NCT03449446|559449118|FG002|Overall Study|Unknown Reason|1|||
155007244|NCT03449446|559449119|FG003|Overall Study|Unknown Reason|1|||
155007245|NCT03449446|559449120|FG004|Overall Study|Unknown Reason|2|||
155007246|NCT03449446|559449121|FG005|Overall Study|Unknown Reason|2|||
155007247|NCT03449446|559449122|FG006|Overall Study|Unknown Reason|0|||
155007248|NCT03449446|559449116|FG000|Overall Study|Withdrew Consent|1|||
155007249|NCT03449446|559449117|FG001|Overall Study|Withdrew Consent|3|||
155007250|NCT03449446|559449118|FG002|Overall Study|Withdrew Consent|1|||
155007251|NCT03449446|559449119|FG003|Overall Study|Withdrew Consent|4|||
155007252|NCT03449446|559449120|FG004|Overall Study|Withdrew Consent|4|||
155007253|NCT03449446|559449121|FG005|Overall Study|Withdrew Consent|4|||
155007254|NCT03449446|559449122|FG006|Overall Study|Withdrew Consent|1|||
155007255|NCT03449446|559449116|FG000|Overall Study|Adverse Event|1|||
155007256|NCT03449446|559449117|FG001|Overall Study|Adverse Event|2|||
155007257|NCT03449446|559449118|FG002|Overall Study|Adverse Event|1|||
155007258|NCT03449446|559449119|FG003|Overall Study|Adverse Event|0|||
155007259|NCT03449446|559449120|FG004|Overall Study|Adverse Event|0|||
155007260|NCT03449446|559449121|FG005|Overall Study|Adverse Event|2|||
155007261|NCT03449446|559449122|FG006|Overall Study|Adverse Event|0|||
155007262|NCT03449446|559449116|FG000|Overall Study|Lost to Follow-up|0|||
155007263|NCT03449446|559449117|FG001|Overall Study|Lost to Follow-up|0|||
155007264|NCT03449446|559449118|FG002|Overall Study|Lost to Follow-up|2|||
155007265|NCT03449446|559449119|FG003|Overall Study|Lost to Follow-up|1|||
155007266|NCT03449446|559449120|FG004|Overall Study|Lost to Follow-up|3|||
155007267|NCT03449446|559449121|FG005|Overall Study|Lost to Follow-up|0|||
155007268|NCT03449446|559449122|FG006|Overall Study|Lost to Follow-up|0|||
155007269|NCT03449446|559449116|FG000|Overall Study|Investigator's Discretion|0|||
155007270|NCT03449446|559449117|FG001|Overall Study|Investigator's Discretion|1|||
155007271|NCT03449446|559449118|FG002|Overall Study|Investigator's Discretion|1|||
155007272|NCT03449446|559449119|FG003|Overall Study|Investigator's Discretion|2|||
155007273|NCT03449446|559449120|FG004|Overall Study|Investigator's Discretion|0|||
155007274|NCT03449446|559449121|FG005|Overall Study|Investigator's Discretion|0|||
155007275|NCT03449446|559449122|FG006|Overall Study|Investigator's Discretion|0|||
155007276|NCT03449446|559449116|FG000|Overall Study|Non Compliance with Study Drug|1|||
155007277|NCT03449446|559449117|FG001|Overall Study|Non Compliance with Study Drug|0|||
155007278|NCT03449446|559449118|FG002|Overall Study|Non Compliance with Study Drug|0|||
155007279|NCT03449446|559449119|FG003|Overall Study|Non Compliance with Study Drug|0|||
155007280|NCT03449446|559449120|FG004|Overall Study|Non Compliance with Study Drug|0|||
155007281|NCT03449446|559449121|FG005|Overall Study|Non Compliance with Study Drug|0|||
155007282|NCT03449446|559449122|FG006|Overall Study|Non Compliance with Study Drug|0|||
155007283|NCT03449446|559449116|FG000|Overall Study|Protocol Violation|0|||
155007284|NCT03449446|559449117|FG001|Overall Study|Protocol Violation|0|||
155007285|NCT03449446|559449118|FG002|Overall Study|Protocol Violation|0|||
155007286|NCT03449446|559449119|FG003|Overall Study|Protocol Violation|0|||
155007287|NCT03449446|559449120|FG004|Overall Study|Protocol Violation|1|||
155007288|NCT03449446|559449121|FG005|Overall Study|Protocol Violation|1|||
155129598|NCT01423916|559905527|FG001|Overall Study|Protocol Deviation|0|||
155129599|NCT01423916|559905528|FG002|Overall Study|Protocol Deviation|0|||
155129600|NCT03316950|559905529|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
155129601|NCT03316950|559905530|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
155129602|NCT03316950|559905531|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
155129603|NCT03316950|559905532|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
155129604|NCT03316950|559905529|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
155129605|NCT03316950|559905530|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
155129606|NCT03316950|559905531|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
155129607|NCT03316950|559905532|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
155129608|NCT03316950|559905529|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
155129609|NCT03316950|559905530|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
155129610|NCT03316950|559905531|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
155129611|NCT03316950|559905532|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
155129612|NCT02717130|559905533|FG000|Overall Study|Withdrawal by Subject|1|||
155129613|NCT02717130|559905533|FG000|Overall Study|Adverse Event|1|||
155129614|NCT02717130|559905533|FG000|Overall Study|Physician Decision|1|||
155129615|NCT02717130|559905533|FG000|Overall Study|Study Closure|4|||
155129616|NCT02294734|559905536|FG000|Overall Study|Adverse Event|5|||
155129617|NCT02294734|559905537|FG001|Overall Study|Adverse Event|5|||
155129618|NCT02294734|559905536|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
155129619|NCT02294734|559905537|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
155129620|NCT02294734|559905536|FG000|Overall Study|Lost to Follow-up|2|||
155129621|NCT02294734|559905537|FG001|Overall Study|Lost to Follow-up|0|||
155129622|NCT02294734|559905536|FG000|Overall Study|Physician Decision|2|||
155129623|NCT02294734|559905537|FG001|Overall Study|Physician Decision|1|||
155129624|NCT02294734|559905536|FG000|Overall Study|Withdrawal by Subject|4|||
155129625|NCT02294734|559905537|FG001|Overall Study|Withdrawal by Subject|2|||
155129626|NCT02335424|559905538|FG000|Overall Study|Withdrawal by Subject|19|||
155129627|NCT02335424|559905538|FG000|Overall Study|Adverse Event|25|||
155129628|NCT02335424|559905538|FG000|Overall Study|Death|273|||
155129629|NCT02335424|559905538|FG000|Overall Study|Lost to Follow-up|3|||
155129630|NCT02335424|559905538|FG000|Overall Study|Physician Decision|13|||
155129631|NCT02335424|559905538|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
155129632|NCT02335424|559905538|FG000|Overall Study|Protocol Violation|1|||
155129633|NCT02335424|559905538|FG000|Overall Study|Screen failure|1|||
155129634|NCT03847909|559905539|FG000|Overall Study|Withdrawal by Subject|1|||
155129635|NCT03847909|559905540|FG001|Overall Study|Withdrawal by Subject|1|||
155129636|NCT01147900|559905541|FG000|At Year 10|Lost to Follow-up|0|||
155129637|NCT01147900|559905542|FG001|At Year 10|Lost to Follow-up|1|||
155129638|NCT01147900|559905543|FG002|At Year 10|Lost to Follow-up|0|||
155129639|NCT00903331|559905544|FG000|Overall Study|Death|4|||
155129640|NCT00903331|559905545|FG001|Overall Study|Death|8|||
155129641|NCT00903331|559905544|FG000|Overall Study|Withdrawal of consent|1|||
155129642|NCT00903331|559905545|FG001|Overall Study|Withdrawal of consent|8|||
155129643|NCT00903331|559905544|FG000|Overall Study|Lung transplant|0|||
155129644|NCT00903331|559905545|FG001|Overall Study|Lung transplant|2|||
155129645|NCT00257660|559905546|FG000|Overall Study|Lack of Efficacy|5|||
155129646|NCT00257660|559905547|FG001|Overall Study|Lack of Efficacy|23|||
155129647|NCT00257660|559905546|FG000|Overall Study|Withdrawal by Subject|2|||
155129648|NCT00257660|559905547|FG001|Overall Study|Withdrawal by Subject|0|||
155129649|NCT00257660|559905546|FG000|Overall Study|Lost to Follow-up|1|||
155129650|NCT00257660|559905547|FG001|Overall Study|Lost to Follow-up|0|||
155129651|NCT00257660|559905546|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
155129652|NCT00257660|559905547|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
155129653|NCT00257660|559905546|FG000|Overall Study|No longer wanted to do blood draws|1|||
155129654|NCT00257660|559905547|FG001|Overall Study|No longer wanted to do blood draws|0|||
155129655|NCT04109976|559905548|FG000|Overall Study|Withdrawal by Subject|1|||
155129656|NCT04109976|559905549|FG001|Overall Study|Withdrawal by Subject|0|||
155129657|NCT01561963|559905551|FG000|Overall Study|Adverse Event|1|||
155129658|NCT04598269|559905552|FG000|Overall Study|Adverse Event|0|||
155007289|NCT03449446|559449122|FG006|Overall Study|Protocol Violation|0|||
155007290|NCT03449446|559449116|FG000|Overall Study|Death|0|||
155129659|NCT04598269|559905553|FG001|Overall Study|Adverse Event|3|||
155129660|NCT04598269|559905552|FG000|Overall Study|Withdrawal by Subject|1|||
155129661|NCT04598269|559905553|FG001|Overall Study|Withdrawal by Subject|4|||
155007291|NCT03449446|559449117|FG001|Overall Study|Death|0|||
155007292|NCT03449446|559449118|FG002|Overall Study|Death|0|||
155129662|NCT04598269|559905552|FG000|Overall Study|Lost to Follow-up|1|||
155129663|NCT04598269|559905553|FG001|Overall Study|Lost to Follow-up|0|||
155129664|NCT04598269|559905552|FG000|Overall Study|Not Treated|2|||
155129665|NCT04598269|559905553|FG001|Overall Study|Not Treated|0|||
155151012|NCT04235140|559988159|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
155151013|NCT04235140|559988159|FG000|Overall Study|Commercial drug is available for participants|7|||
155151014|NCT02587520|559988160|FG000|Overall Study|Protocol Violation|2|||
155007293|NCT03449446|559449119|FG003|Overall Study|Death|0|||
155007294|NCT03449446|559449120|FG004|Overall Study|Death|1|||
155007295|NCT03449446|559449121|FG005|Overall Study|Death|0|||
155007296|NCT03449446|559449122|FG006|Overall Study|Death|0|||
155007297|NCT03180645|559449127|FG000|Overall Study|Adverse Event|0|||
155007298|NCT03180645|559449128|FG001|Overall Study|Adverse Event|1|||
155007299|NCT03180645|559449129|FG002|Overall Study|Adverse Event|2|||
155007300|NCT00625872|559449130|FG000|Overall Study|Withdrawal by Subject|1|||
155007301|NCT00625872|559449131|FG001|Overall Study|Withdrawal by Subject|0|||
155007302|NCT00625872|559449130|FG000|Overall Study|Does not meet inclusion criteria|1|||
155007303|NCT00625872|559449131|FG001|Overall Study|Does not meet inclusion criteria|0|||
155007304|NCT00625872|559449130|FG000|Overall Study|Terminated by sponsor|2|||
155007305|NCT00625872|559449131|FG001|Overall Study|Terminated by sponsor|5|||
155007306|NCT00625872|559449130|FG000|Overall Study|Randomized but not treated|0|||
155007307|NCT00625872|559449131|FG001|Overall Study|Randomized but not treated|1|||
155007308|NCT04208750|559449132|FG000|Overall Study|Lost to Follow-up|16|||
155007309|NCT04208750|559449133|FG001|Overall Study|Lost to Follow-up|15|||
155007310|NCT02201277|559449137|FG000|Overall Study|Death|3|||
155007311|NCT02201277|559449138|FG001|Overall Study|Death|4|||
155007312|NCT02201277|559449137|FG000|Overall Study|Lost to Follow-up|2|||
155007313|NCT02201277|559449138|FG001|Overall Study|Lost to Follow-up|1|||
155007314|NCT02201277|559449137|FG000|Overall Study|Failed retrieval|1|||
155007315|NCT02201277|559449138|FG001|Overall Study|Failed retrieval|0|||
155007316|NCT02201277|559449137|FG000|Overall Study|Physician Decision|1|||
155007317|NCT02201277|559449138|FG001|Overall Study|Physician Decision|0|||
155007318|NCT01512160|559449139|FG000|Overall Study|Lost to Follow-up|1|||
155007319|NCT01512160|559449140|FG001|Overall Study|Lost to Follow-up|0|||
155007320|NCT01512160|559449141|FG002|Overall Study|Lost to Follow-up|0|||
155007321|NCT01512160|559449142|FG003|Overall Study|Lost to Follow-up|0|||
155007322|NCT01512160|559449139|FG000|Overall Study|Withdrawal by Subject|1|||
155007323|NCT01512160|559449140|FG001|Overall Study|Withdrawal by Subject|0|||
155007324|NCT01512160|559449141|FG002|Overall Study|Withdrawal by Subject|0|||
155007325|NCT01512160|559449142|FG003|Overall Study|Withdrawal by Subject|1|||
155007326|NCT02603146|559451306|FG000|Overall Study|Lost to Follow-up|5|||
155007327|NCT02603146|559451307|FG001|Overall Study|Lost to Follow-up|6|||
155007328|NCT02603146|559451306|FG000|Overall Study|Withdrawal by Subject|8|||
155007329|NCT02603146|559451307|FG001|Overall Study|Withdrawal by Subject|10|||
155007330|NCT02603146|559451306|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
155007331|NCT02603146|559451307|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
155007332|NCT02603146|559451306|FG000|Overall Study|Participant moved|2|||
155007333|NCT02603146|559451307|FG001|Overall Study|Participant moved|0|||
155007334|NCT02603146|559451306|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
155007335|NCT02603146|559451307|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
155007336|NCT02366689|559451314|FG000|Overall Study|Withdrawal by Subject|1|||
155007337|NCT02366689|559451315|FG001|Overall Study|Withdrawal by Subject|0|||
155007338|NCT02366689|559451316|FG002|Overall Study|Withdrawal by Subject|1|||
155007339|NCT02366689|559451314|FG000|Overall Study|Lost to Follow-up|3|||
155007340|NCT02366689|559451315|FG001|Overall Study|Lost to Follow-up|2|||
155007341|NCT02366689|559451316|FG002|Overall Study|Lost to Follow-up|0|||
155007342|NCT02366689|559451314|FG000|Overall Study|Pregnancy|0|||
155007343|NCT02366689|559451315|FG001|Overall Study|Pregnancy|1|||
155007344|NCT02366689|559451316|FG002|Overall Study|Pregnancy|1|||
155007345|NCT01068262|559451322|FG000|Overall Study|Adverse Event|2|||
155007346|NCT01068262|559451323|FG001|Overall Study|Adverse Event|0|||
155007347|NCT01068262|559451324|FG002|Overall Study|Adverse Event|1|||
155007348|NCT01068262|559451325|FG003|Overall Study|Adverse Event|0|||
155007349|NCT01068262|559451322|FG000|Overall Study|Protocol Violation|1|||
155007350|NCT01068262|559451323|FG001|Overall Study|Protocol Violation|0|||
155007351|NCT01068262|559451324|FG002|Overall Study|Protocol Violation|0|||
155007352|NCT01068262|559451325|FG003|Overall Study|Protocol Violation|0|||
155007353|NCT01068262|559451322|FG000|Overall Study|Withdrawal by Subject|0|||
155007354|NCT01068262|559451323|FG001|Overall Study|Withdrawal by Subject|1|||
155007355|NCT01068262|559451324|FG002|Overall Study|Withdrawal by Subject|0|||
155007356|NCT01068262|559451325|FG003|Overall Study|Withdrawal by Subject|0|||
155007357|NCT04182490|559451326|FG000|Overall Study|Withdrawal by Subject|3|||
155007358|NCT04182490|559451327|FG001|Overall Study|Withdrawal by Subject|3|||
155007359|NCT04182490|559451326|FG000|Overall Study|Lost to Follow-up|0|||
155007360|NCT04182490|559451327|FG001|Overall Study|Lost to Follow-up|1|||
155007361|NCT04182490|559451326|FG000|Overall Study|Physician Decision|0|||
155007362|NCT04182490|559451327|FG001|Overall Study|Physician Decision|1|||
155007363|NCT00661193|559451339|FG000|Overall Study|Adverse Event|2|||
155007364|NCT00661193|559451340|FG001|Overall Study|Adverse Event|1|||
155007365|NCT00661193|559451339|FG000|Overall Study|Withdrawal by Subject|3|||
155007366|NCT00661193|559451340|FG001|Overall Study|Withdrawal by Subject|1|||
155007367|NCT00661193|559451339|FG000|Overall Study|Progression|27|||
155007368|NCT00661193|559451340|FG001|Overall Study|Progression|24|||
155007369|NCT00661193|559451339|FG000|Overall Study|Not protocol specified|1|||
155007370|NCT00661193|559451340|FG001|Overall Study|Not protocol specified|0|||
155007371|NCT04108299|559451353|FG000|Overall Study|Not interested in participating|2|||
155007372|NCT04108299|559451354|FG001|Overall Study|Not interested in participating|1|||
155007373|NCT04108299|559451355|FG002|Overall Study|Not interested in participating|2|||
155007374|NCT04108299|559451356|FG003|Overall Study|Not interested in participating|1|||
155007375|NCT05024747|559451360|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
155007376|NCT05024747|559451361|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
155007377|NCT05024747|559451360|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
155007378|NCT05024747|559451361|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
155007379|NCT05024747|559451360|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
155007380|NCT05024747|559451361|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
155007381|NCT00662649|559451362|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
155007382|NCT00662649|559451363|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
155007383|NCT00662649|559451364|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
155007384|NCT00662649|559451365|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
155007385|NCT00662649|559451366|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
155007386|NCT00662649|559451362|FG000|Core Study (24 Months)|Adverse Event|22|||
155007387|NCT00662649|559451363|FG001|Core Study (24 Months)|Adverse Event|13|||
155007388|NCT00662649|559451364|FG002|Core Study (24 Months)|Adverse Event|18|||
155007389|NCT00662649|559451365|FG003|Core Study (24 Months)|Adverse Event|0|||
155007390|NCT00662649|559451366|FG004|Core Study (24 Months)|Adverse Event|0|||
155007391|NCT00662649|559451362|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
155007392|NCT00662649|559451363|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
155007393|NCT00662649|559451364|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
155007394|NCT00662649|559451365|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
155007395|NCT00662649|559451366|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
155007396|NCT00662649|559451362|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
155007397|NCT00662649|559451363|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
155007398|NCT00662649|559451364|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
155007399|NCT00662649|559451365|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
155007400|NCT00662649|559451366|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
155007401|NCT00662649|559451362|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
155007402|NCT00662649|559451363|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
155007403|NCT00662649|559451364|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
155007404|NCT00662649|559451365|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
155007405|NCT00662649|559451366|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
155007406|NCT00662649|559451362|FG000|Core Study (24 Months)|Protocol Violation|5|||
155007407|NCT00662649|559451363|FG001|Core Study (24 Months)|Protocol Violation|5|||
155007408|NCT00662649|559451364|FG002|Core Study (24 Months)|Protocol Violation|4|||
155007409|NCT00662649|559451365|FG003|Core Study (24 Months)|Protocol Violation|0|||
155007410|NCT00662649|559451366|FG004|Core Study (24 Months)|Protocol Violation|0|||
155007411|NCT00662649|559451362|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
155007412|NCT00662649|559451363|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
155007413|NCT00662649|559451364|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
155007414|NCT00662649|559451365|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
155007415|NCT00662649|559451366|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
155007416|NCT00662649|559451362|FG000|Core Study (24 Months)|Death|1|||
155007417|NCT00662649|559451363|FG001|Core Study (24 Months)|Death|0|||
155007418|NCT00662649|559451364|FG002|Core Study (24 Months)|Death|2|||
155007419|NCT00662649|559451365|FG003|Core Study (24 Months)|Death|0|||
155007420|NCT00662649|559451366|FG004|Core Study (24 Months)|Death|0|||
155007421|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
155007422|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
155007423|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
155007424|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
155007425|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
155007426|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
155007427|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
155007428|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
155007429|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
155007430|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
155007431|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
155007432|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
155007433|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
155007434|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
155007435|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
155007436|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
155007437|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
155007438|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
155129666|NCT04023682|559905557|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
155129667|NCT00695864|559905558|FG000|Placebo|Withdrawal by Subject|1|||
155129668|NCT00695864|559905558|FG000|Placebo|Physician Decision|4|||
155129669|NCT00772109|559905562|FG000|Overall Study|Serious adverse event|1|||
155129670|NCT00772109|559905563|FG001|Overall Study|Serious adverse event|0|||
155129671|NCT00772109|559905564|FG002|Overall Study|Serious adverse event|1|||
155129672|NCT00772109|559905565|FG003|Overall Study|Serious adverse event|0|||
155129673|NCT00772109|559905562|FG000|Overall Study|Protocol Violation|5|||
155129674|NCT00772109|559905563|FG001|Overall Study|Protocol Violation|8|||
155129675|NCT00772109|559905564|FG002|Overall Study|Protocol Violation|7|||
155129676|NCT00772109|559905565|FG003|Overall Study|Protocol Violation|6|||
155129677|NCT00772109|559905562|FG000|Overall Study|Lost to Follow-up|7|||
155129678|NCT00772109|559905563|FG001|Overall Study|Lost to Follow-up|3|||
155129679|NCT00772109|559905564|FG002|Overall Study|Lost to Follow-up|5|||
155129680|NCT00772109|559905565|FG003|Overall Study|Lost to Follow-up|9|||
155129681|NCT00772109|559905562|FG000|Overall Study|Withdrawal by Subject|8|||
155129682|NCT00772109|559905563|FG001|Overall Study|Withdrawal by Subject|8|||
155129683|NCT00772109|559905564|FG002|Overall Study|Withdrawal by Subject|6|||
155129684|NCT00772109|559905565|FG003|Overall Study|Withdrawal by Subject|16|||
155129685|NCT02039856|559905566|FG000|Overall Study|Death|5|||
155129686|NCT02039856|559905567|FG001|Overall Study|Death|3|||
155129687|NCT02039856|559905566|FG000|Overall Study|Partial survey completion|61|||
155129688|NCT02039856|559905567|FG001|Overall Study|Partial survey completion|26|||
155129689|NCT02039856|559905566|FG000|Overall Study|Lost to Follow-up|388|||
155129690|NCT02039856|559905567|FG001|Overall Study|Lost to Follow-up|206|||
155129691|NCT02039856|559905566|FG000|Overall Study|Withdrawal by Subject|1573|||
155129692|NCT02039856|559905567|FG001|Overall Study|Withdrawal by Subject|618|||
155129693|NCT00602420|559907129|FG000|Overall Study|Death|1|||
155129694|NCT00602420|559907130|FG001|Overall Study|Death|4|||
155129695|NCT00602420|559907129|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
155129696|NCT00602420|559907130|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
155129697|NCT00602420|559907129|FG000|Overall Study|Withdrawal by Subject|18|||
155129698|NCT00602420|559907130|FG001|Overall Study|Withdrawal by Subject|17|||
155129699|NCT00602420|559907129|FG000|Overall Study|Adverse Event|1|||
155129700|NCT00602420|559907130|FG001|Overall Study|Adverse Event|0|||
155129701|NCT02315560|559907133|FG000|Overall Study|noncompliance by subjects|3|||
155129702|NCT02008227|559907134|FG000|Overall Study|Lost to Follow-up|7|||
155129703|NCT02008227|559907135|FG001|Overall Study|Lost to Follow-up|9|||
155129704|NCT02008227|559907134|FG000|Overall Study|Death|494|||
155129705|NCT02008227|559907135|FG001|Overall Study|Death|485|||
155007439|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
155007440|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
155007441|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
155007442|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
155007443|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
155007444|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
155007445|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
155007446|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
155007447|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
155007448|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
155007449|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
155007450|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
155007451|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
155007452|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
155007453|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
155007454|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
155007455|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
155007456|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155007457|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
155007458|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155007459|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155007460|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
155007461|NCT00662649|559451362|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
155007462|NCT00662649|559451363|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
155129706|NCT02008227|559907134|FG000|Overall Study|Withdrawal by Subject|67|||
155129707|NCT02008227|559907135|FG001|Overall Study|Withdrawal by Subject|36|||
155129708|NCT02008227|559907134|FG000|Overall Study|Study Terminated By Sponsor|44|||
155129709|NCT02008227|559907135|FG001|Overall Study|Study Terminated By Sponsor|83|||
155129710|NCT04599465|559907136|FG000|Overall Study|Physician Decision|1|||
155129711|NCT04599465|559907136|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
155129712|NCT00742417|559907137|FG000|Randomized|Withdrawal by legal representative|0|||
155129713|NCT00742417|559907138|FG001|Randomized|Withdrawal by legal representative|1|||
155007463|NCT00662649|559451364|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
155007464|NCT00662649|559451365|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
155007465|NCT00662649|559451366|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
155007466|NCT01026194|559451368|FG000|Period 1：Double Blind Period|Adverse Event|2|||
155007467|NCT01026194|559451369|FG001|Period 1：Double Blind Period|Adverse Event|1|||
155007468|NCT01026194|559451368|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
155007469|NCT01026194|559451369|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
155007470|NCT01026194|559451368|FG000|Period 1：Double Blind Period|Physician Decision|0|||
155007471|NCT01026194|559451369|FG001|Period 1：Double Blind Period|Physician Decision|4|||
155007472|NCT01026194|559451368|FG000|Period 2：Open-label Period|Adverse Event|4|||
155007473|NCT01026194|559451369|FG001|Period 2：Open-label Period|Adverse Event|5|||
155007474|NCT01026194|559451368|FG000|Period 2：Open-label Period|Physician Decision|3|||
155007475|NCT01026194|559451369|FG001|Period 2：Open-label Period|Physician Decision|1|||
155007476|NCT01026194|559451368|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
155007477|NCT01026194|559451369|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
155007478|NCT04428034|559451372|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
155007479|NCT02556801|559451375|FG000|Overall Study|Lost to Follow-up|1|||
155007480|NCT02556801|559451376|FG001|Overall Study|Lost to Follow-up|0|||
155007481|NCT02556801|559451377|FG002|Overall Study|Lost to Follow-up|2|||
155007482|NCT02556801|559451378|FG003|Overall Study|Lost to Follow-up|0|||
155007483|NCT02556801|559451375|FG000|Overall Study|Withdrawal by Subject|1|||
155007484|NCT02556801|559451376|FG001|Overall Study|Withdrawal by Subject|1|||
155007485|NCT02556801|559451377|FG002|Overall Study|Withdrawal by Subject|1|||
155007486|NCT02556801|559451378|FG003|Overall Study|Withdrawal by Subject|0|||
155007487|NCT02556801|559451375|FG000|Overall Study|Protocol Violation|0|||
155007488|NCT02556801|559451376|FG001|Overall Study|Protocol Violation|3|||
155007489|NCT02556801|559451377|FG002|Overall Study|Protocol Violation|1|||
155007490|NCT02556801|559451378|FG003|Overall Study|Protocol Violation|1|||
155007491|NCT02556801|559451375|FG000|Overall Study|Adverse Event|0|||
155007492|NCT02556801|559451376|FG001|Overall Study|Adverse Event|2|||
155007493|NCT02556801|559451377|FG002|Overall Study|Adverse Event|0|||
155007494|NCT02556801|559451378|FG003|Overall Study|Adverse Event|3|||
155007495|NCT02556801|559451375|FG000|Overall Study|Pregnancy|0|||
155007496|NCT02556801|559451376|FG001|Overall Study|Pregnancy|1|||
155007497|NCT02556801|559451377|FG002|Overall Study|Pregnancy|0|||
155007498|NCT02556801|559451378|FG003|Overall Study|Pregnancy|0|||
155007499|NCT02556801|559451375|FG000|Overall Study|Personal reasons patient|0|||
155007500|NCT02556801|559451376|FG001|Overall Study|Personal reasons patient|0|||
155007501|NCT02556801|559451377|FG002|Overall Study|Personal reasons patient|0|||
155007502|NCT02556801|559451378|FG003|Overall Study|Personal reasons patient|1|||
155007503|NCT02515331|559451383|FG000|Overall Study|Withdrawal by Subject|0|||
155007504|NCT02515331|559451384|FG001|Overall Study|Withdrawal by Subject|0|||
155007505|NCT02515331|559451385|FG002|Overall Study|Withdrawal by Subject|1|||
155007506|NCT02515331|559451383|FG000|Overall Study|Protocol deviation|0|||
155007507|NCT02515331|559451384|FG001|Overall Study|Protocol deviation|0|||
155007508|NCT02515331|559451385|FG002|Overall Study|Protocol deviation|3|||
155007509|NCT02515331|559451383|FG000|Overall Study|Adverse Event|2|||
155007510|NCT02515331|559451384|FG001|Overall Study|Adverse Event|0|||
155007511|NCT02515331|559451385|FG002|Overall Study|Adverse Event|0|||
155007512|NCT00124748|559451386|FG000|Overall Study|Adverse Event|8|||
155007513|NCT00124748|559451387|FG001|Overall Study|Adverse Event|39|||
155007514|NCT00124748|559451386|FG000|Overall Study|Abnormal laboratory Value|2|||
155007515|NCT00124748|559451387|FG001|Overall Study|Abnormal laboratory Value|2|||
155007516|NCT00124748|559451386|FG000|Overall Study|Abnormal Procedure|0|||
155007517|NCT00124748|559451387|FG001|Overall Study|Abnormal Procedure|1|||
155007518|NCT00124748|559451386|FG000|Overall Study|Lack of Efficacy|20|||
155007519|NCT00124748|559451387|FG001|Overall Study|Lack of Efficacy|41|||
155007520|NCT00124748|559451386|FG000|Overall Study|No longer requires study drug|1|||
155007521|NCT00124748|559451387|FG001|Overall Study|No longer requires study drug|1|||
155007522|NCT00124748|559451386|FG000|Overall Study|Protocol Violation|3|||
155007523|NCT00124748|559451387|FG001|Overall Study|Protocol Violation|1|||
155007524|NCT00124748|559451386|FG000|Overall Study|Withdrawal by Subject|5|||
155007525|NCT00124748|559451387|FG001|Overall Study|Withdrawal by Subject|15|||
155007526|NCT00124748|559451386|FG000|Overall Study|Lost to Follow-up|2|||
155007527|NCT00124748|559451387|FG001|Overall Study|Lost to Follow-up|7|||
155007528|NCT00124748|559451386|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
155007529|NCT00124748|559451387|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
155007530|NCT00124748|559451386|FG000|Overall Study|Death|1|||
155007531|NCT00124748|559451387|FG001|Overall Study|Death|3|||
155007532|NCT00322712|559451388|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
155007533|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
155007534|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
155007535|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
155007536|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007537|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
155129714|NCT00742417|559907137|FG000|Randomized|Withdrawal by Subject|1|||
155129715|NCT00742417|559907138|FG001|Randomized|Withdrawal by Subject|0|||
155129716|NCT00742417|559907137|FG000|Randomized|Physician Decision|1|||
155129717|NCT00742417|559907138|FG001|Randomized|Physician Decision|0|||
155129718|NCT00742417|559907137|FG000|Intensive Period|Withdrawal by Subject|1|||
155129719|NCT00742417|559907138|FG001|Intensive Period|Withdrawal by Subject|1|||
155129720|NCT00742417|559907137|FG000|Intensive Period|Adverse Event|2|||
155129721|NCT00742417|559907138|FG001|Intensive Period|Adverse Event|0|||
155129722|NCT00965575|559907141|FG000|Overall Study|subject unwillingness to swallow study c|1|||
155129723|NCT00965575|559907142|FG001|Overall Study|subject unwillingness to swallow study c|0|||
155129724|NCT01041287|559907145|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
155129725|NCT01041287|559907146|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
155129726|NCT01041287|559907145|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
155129727|NCT01041287|559907146|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
155129728|NCT03157583|559907148|FG000|Overall Study|Other (did not meet study criteria)|1|||
155129729|NCT01141478|559907149|FG000|Overall Study|Withdrawal by Subject|1|||
155129730|NCT01141478|559907150|FG001|Overall Study|Withdrawal by Subject|1|||
155129731|NCT00290498|559907155|FG000|Overall Study|Death|2|||
155129732|NCT00290498|559907156|FG001|Overall Study|Death|0|||
155129733|NCT00290498|559907155|FG000|Overall Study|Physician Decision|1|||
155129734|NCT00290498|559907156|FG001|Overall Study|Physician Decision|0|||
155129735|NCT00290498|559907155|FG000|Overall Study|Withdrawal by Subject|1|||
155129736|NCT00290498|559907156|FG001|Overall Study|Withdrawal by Subject|0|||
155129737|NCT00290498|559907155|FG000|Overall Study|Ineligible|3|||
155129738|NCT00290498|559907156|FG001|Overall Study|Ineligible|0|||
155129739|NCT00290498|559907155|FG000|Overall Study|Non-Compliance|1|||
155129740|NCT00290498|559907156|FG001|Overall Study|Non-Compliance|0|||
155129741|NCT00490022|559907159|FG000|Overall Study|Adverse Event|0|||
155129742|NCT00490022|559907160|FG001|Overall Study|Adverse Event|2|||
155129743|NCT00490022|559907159|FG000|Overall Study|Withdrawal by Subject|1|||
155129744|NCT00490022|559907160|FG001|Overall Study|Withdrawal by Subject|0|||
155129745|NCT00490022|559907159|FG000|Overall Study|Subject failed to disclose concommitant|0|||
155129746|NCT00490022|559907160|FG001|Overall Study|Subject failed to disclose concommitant|1|||
155129747|NCT04268173|559907161|FG000|Overall Study|Lost to Follow-up|75|||
155129748|NCT04268173|559907162|FG001|Overall Study|Lost to Follow-up|108|||
155129749|NCT00869401|559907163|FG000|Overall Study|Withdrawal by Subject|0|||
155129750|NCT00869401|559907164|FG001|Overall Study|Withdrawal by Subject|0|||
155129751|NCT00869401|559907165|FG002|Overall Study|Withdrawal by Subject|0|||
155129752|NCT00869401|559907166|FG003|Overall Study|Withdrawal by Subject|5|||
155129753|NCT00869401|559907167|FG004|Overall Study|Withdrawal by Subject|3|||
155129754|NCT00545103|559907168|FG000|Overall Study|Lack of Efficacy|48|||
155129755|NCT00545103|559907169|FG001|Overall Study|Lack of Efficacy|45|||
155129756|NCT00545103|559907170|FG002|Overall Study|Lack of Efficacy|31|||
155129757|NCT00545103|559907171|FG003|Overall Study|Lack of Efficacy|27|||
155129758|NCT00545103|559907168|FG000|Overall Study|Withdrawal by Subject|6|||
155129759|NCT00545103|559907169|FG001|Overall Study|Withdrawal by Subject|10|||
155129760|NCT00545103|559907170|FG002|Overall Study|Withdrawal by Subject|18|||
155129761|NCT00545103|559907171|FG003|Overall Study|Withdrawal by Subject|22|||
155129762|NCT00545103|559907168|FG000|Overall Study|Adverse Event|11|||
155129763|NCT00545103|559907169|FG001|Overall Study|Adverse Event|12|||
155129764|NCT00545103|559907170|FG002|Overall Study|Adverse Event|17|||
155129765|NCT00545103|559907171|FG003|Overall Study|Adverse Event|10|||
155129766|NCT00545103|559907168|FG000|Overall Study|Lost to Follow-up|4|||
155129767|NCT00545103|559907169|FG001|Overall Study|Lost to Follow-up|6|||
155129768|NCT00545103|559907170|FG002|Overall Study|Lost to Follow-up|3|||
155129769|NCT00545103|559907171|FG003|Overall Study|Lost to Follow-up|4|||
155129770|NCT00545103|559907168|FG000|Overall Study|Protocol Violation|1|||
155129771|NCT00545103|559907169|FG001|Overall Study|Protocol Violation|2|||
155129772|NCT00545103|559907170|FG002|Overall Study|Protocol Violation|3|||
155129773|NCT00545103|559907171|FG003|Overall Study|Protocol Violation|0|||
155129774|NCT00545103|559907168|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
155129775|NCT00545103|559907169|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
155129776|NCT00545103|559907170|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
155129777|NCT00545103|559907171|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
155129778|NCT00545103|559907168|FG000|Overall Study|Difficult to open package|0|||
155129779|NCT00545103|559907169|FG001|Overall Study|Difficult to open package|0|||
155129780|NCT00545103|559907170|FG002|Overall Study|Difficult to open package|0|||
155129781|NCT00545103|559907171|FG003|Overall Study|Difficult to open package|1|||
155129782|NCT00545103|559907168|FG000|Overall Study|Investigational product not taken|1|||
155129783|NCT00545103|559907169|FG001|Overall Study|Investigational product not taken|0|||
155129784|NCT00545103|559907170|FG002|Overall Study|Investigational product not taken|0|||
155129785|NCT00545103|559907171|FG003|Overall Study|Investigational product not taken|1|||
155129786|NCT00545103|559907168|FG000|Overall Study|Wish to start a family|0|||
155129787|NCT00545103|559907169|FG001|Overall Study|Wish to start a family|0|||
155129788|NCT00545103|559907170|FG002|Overall Study|Wish to start a family|0|||
155129789|NCT00545103|559907171|FG003|Overall Study|Wish to start a family|1|||
155129790|NCT00545103|559907168|FG000|Overall Study|Diverticulitis crisis|0|||
155129791|NCT00545103|559907169|FG001|Overall Study|Diverticulitis crisis|0|||
155129792|NCT00545103|559907170|FG002|Overall Study|Diverticulitis crisis|0|||
155129793|NCT00545103|559907171|FG003|Overall Study|Diverticulitis crisis|1|||
155129794|NCT00545103|559907168|FG000|Overall Study|Personal reasons|1|||
155129795|NCT00545103|559907169|FG001|Overall Study|Personal reasons|0|||
155129796|NCT00545103|559907170|FG002|Overall Study|Personal reasons|0|||
155129797|NCT00545103|559907171|FG003|Overall Study|Personal reasons|0|||
155129798|NCT00545103|559907168|FG000|Overall Study|Subject's decision|1|||
155129799|NCT00545103|559907169|FG001|Overall Study|Subject's decision|0|||
155129800|NCT00545103|559907170|FG002|Overall Study|Subject's decision|0|||
155178438|NCT00592774|560091481|FG004|Overall Study|Lack of Efficacy|2|||
155178439|NCT00592774|560091477|FG000|Overall Study|Physician Decision|0|||
155178440|NCT00592774|560091478|FG001|Overall Study|Physician Decision|1|||
155178441|NCT00592774|560091479|FG002|Overall Study|Physician Decision|1|||
155178442|NCT00592774|560091480|FG003|Overall Study|Physician Decision|0|||
155007538|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
155007539|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007540|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007541|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007542|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007543|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007544|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007545|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007546|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007547|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007548|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007549|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
155007550|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
155007551|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007552|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
155007553|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
155007554|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
155007555|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
155007556|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007557|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007558|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007559|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007560|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007561|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007562|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007563|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007564|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007565|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007566|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
155007567|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
155007568|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
155007569|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
155007570|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
155007571|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
155007572|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
155007573|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007574|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007575|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007576|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155129801|NCT00545103|559907171|FG003|Overall Study|Subject's decision|0|||
155007577|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007578|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007579|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007580|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007581|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007582|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007583|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
155007584|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007585|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
155129802|NCT00545103|559907168|FG000|Overall Study|Noncompliance|0|||
155129803|NCT00545103|559907169|FG001|Overall Study|Noncompliance|1|||
155129804|NCT00545103|559907170|FG002|Overall Study|Noncompliance|0|||
155129805|NCT00545103|559907171|FG003|Overall Study|Noncompliance|0|||
155129806|NCT00545103|559907168|FG000|Overall Study|Investigator decision|0|||
155178443|NCT00592774|560091481|FG004|Overall Study|Physician Decision|1|||
155178444|NCT00592774|560091477|FG000|Overall Study|Other|0|||
155007586|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
155007587|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007588|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
155007589|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
155007590|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007591|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007592|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007593|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007594|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007595|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007596|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007597|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007598|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007599|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007600|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
155007601|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007602|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007603|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
155007604|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
155007605|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007606|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007607|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007608|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007609|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007610|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007611|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007612|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007613|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007614|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007615|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007616|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007617|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
155007618|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007619|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007620|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007621|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007622|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
155007623|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007624|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007625|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007626|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007627|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007628|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007629|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007630|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007631|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007632|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007633|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007634|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
155007635|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007636|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
155007637|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007638|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007639|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007640|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007641|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007642|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007643|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007644|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007645|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007646|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007647|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007648|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007649|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007650|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155151015|NCT02587520|559988161|FG001|Overall Study|Protocol Violation|0|||
155129807|NCT00545103|559907169|FG001|Overall Study|Investigator decision|0|||
155129808|NCT00545103|559907170|FG002|Overall Study|Investigator decision|1|||
155129809|NCT00545103|559907171|FG003|Overall Study|Investigator decision|0|||
155129810|NCT00545103|559907168|FG000|Overall Study|Subject moved|0|||
155129811|NCT00545103|559907169|FG001|Overall Study|Subject moved|1|||
155129812|NCT00545103|559907170|FG002|Overall Study|Subject moved|0|||
155129813|NCT00545103|559907171|FG003|Overall Study|Subject moved|0|||
155129814|NCT00545103|559907168|FG000|Overall Study|Use of prohibited medication|0|||
155129815|NCT00545103|559907169|FG001|Overall Study|Use of prohibited medication|0|||
155129816|NCT00545103|559907170|FG002|Overall Study|Use of prohibited medication|1|||
155129817|NCT00545103|559907171|FG003|Overall Study|Use of prohibited medication|0|||
155129818|NCT00545103|559907168|FG000|Overall Study|Does not want to take study drug anymore|1|||
155129819|NCT00545103|559907169|FG001|Overall Study|Does not want to take study drug anymore|0|||
155129820|NCT00545103|559907170|FG002|Overall Study|Does not want to take study drug anymore|1|||
155129821|NCT00545103|559907171|FG003|Overall Study|Does not want to take study drug anymore|0|||
155129822|NCT00545103|559907168|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
155129823|NCT00545103|559907169|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
155129824|NCT00545103|559907170|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
155129825|NCT00545103|559907171|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
155129826|NCT00545103|559907168|FG000|Overall Study|Death|0|||
155129827|NCT00545103|559907169|FG001|Overall Study|Death|1|||
155129828|NCT00545103|559907170|FG002|Overall Study|Death|0|||
155129829|NCT00545103|559907171|FG003|Overall Study|Death|0|||
155129830|NCT01953913|559907172|FG000|Overall Study|Disease Progression|349|||
155129831|NCT01953913|559907172|FG000|Overall Study|Worsening of underlying cancer|22|||
155129832|NCT01953913|559907172|FG000|Overall Study|Adverse Event|20|||
155129833|NCT01953913|559907172|FG000|Overall Study|Protocol Violation|6|||
155129834|NCT01953913|559907172|FG000|Overall Study|Lost to Follow-up|4|||
155129835|NCT01953913|559907172|FG000|Overall Study|Withdrawal by Subject|32|||
155129836|NCT01953913|559907172|FG000|Overall Study|Other than listed|108|||
155129837|NCT01953913|559907172|FG000|Overall Study|Not Treated|1|||
155129838|NCT02925741|559907175|FG000|Overall Study|Withdrawal by Subject|11|||
155129839|NCT02925741|559907176|FG001|Overall Study|Withdrawal by Subject|0|||
155129840|NCT00413374|559907177|FG000|Overall Study|Ineligible due to screening criteria.|3|||
155129841|NCT00413374|559907178|FG001|Overall Study|Ineligible due to screening criteria.|0|||
155007651|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
155007652|NCT00758524|559451391|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007653|NCT00758524|559451392|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
155007654|NCT00758524|559451393|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007655|NCT00758524|559451394|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007656|NCT00758524|559451395|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007657|NCT00758524|559451396|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007658|NCT00758524|559451397|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155129842|NCT00413374|559907177|FG000|Overall Study|Adverse Event|1|||
155129843|NCT00413374|559907178|FG001|Overall Study|Adverse Event|0|||
155129844|NCT00413374|559907177|FG000|Overall Study|Lost to Follow-up|1|||
155129845|NCT00413374|559907178|FG001|Overall Study|Lost to Follow-up|0|||
155129846|NCT00413374|559907177|FG000|Overall Study|Surgery|1|||
155129847|NCT00413374|559907178|FG001|Overall Study|Surgery|0|||
155129848|NCT00494507|559907181|FG000|Double-Blind Phase|Adverse Event|2|||
155129849|NCT00494507|559907182|FG001|Double-Blind Phase|Adverse Event|0|||
155129850|NCT00494507|559907183|FG002|Double-Blind Phase|Adverse Event|1|||
155129851|NCT00494507|559907184|FG003|Double-Blind Phase|Adverse Event|0|||
155129852|NCT00494507|559907181|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
155129853|NCT00494507|559907182|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
155129854|NCT00494507|559907183|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155007659|NCT00758524|559451398|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155129855|NCT00494507|559907184|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155129856|NCT00494507|559907181|FG000|Double-Blind Phase|Subject Non-compliance|0|||
155129857|NCT00494507|559907182|FG001|Double-Blind Phase|Subject Non-compliance|0|||
155007660|NCT00758524|559451399|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007661|NCT00758524|559451400|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007662|NCT00758524|559451401|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007663|NCT00758524|559451402|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007664|NCT00758524|559451403|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007665|NCT00758524|559451404|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155129858|NCT00494507|559907183|FG002|Double-Blind Phase|Subject Non-compliance|1|||
155129859|NCT00494507|559907184|FG003|Double-Blind Phase|Subject Non-compliance|0|||
155129860|NCT00494507|559907181|FG000|Double-Blind Phase|Negative DNA test|0|||
155129861|NCT00494507|559907182|FG001|Double-Blind Phase|Negative DNA test|0|||
155007666|NCT00758524|559451405|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155129862|NCT00494507|559907183|FG002|Double-Blind Phase|Negative DNA test|0|||
155129863|NCT00494507|559907184|FG003|Double-Blind Phase|Negative DNA test|1|||
155007667|NCT00758524|559451406|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007668|NCT00758524|559451407|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
155007669|NCT00758524|559451391|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007670|NCT00758524|559451392|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007671|NCT00758524|559451393|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007672|NCT00758524|559451394|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007673|NCT00758524|559451395|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007674|NCT00758524|559451396|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007675|NCT00758524|559451397|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007676|NCT00758524|559451398|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007677|NCT00758524|559451399|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
155007678|NCT00758524|559451400|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007679|NCT00758524|559451401|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007680|NCT00758524|559451402|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007681|NCT00758524|559451403|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007682|NCT00758524|559451404|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007683|NCT00758524|559451405|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007684|NCT00758524|559451406|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007685|NCT00758524|559451407|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
155007686|NCT00758524|559451391|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007687|NCT00758524|559451392|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007688|NCT00758524|559451393|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007689|NCT00758524|559451394|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007690|NCT00758524|559451395|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007691|NCT00758524|559451396|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007692|NCT00758524|559451397|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
155007693|NCT00758524|559451398|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007694|NCT00758524|559451399|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007695|NCT00758524|559451400|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007696|NCT00758524|559451401|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007697|NCT00758524|559451402|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007698|NCT00758524|559451403|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007699|NCT00758524|559451404|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007700|NCT00758524|559451405|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007701|NCT00758524|559451406|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007702|NCT00758524|559451407|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
155007703|NCT04176250|559451408|FG000|Overall Study|Adverse Event|0|||
155007704|NCT04176250|559451409|FG001|Overall Study|Adverse Event|1|||
155007705|NCT04176250|559451410|FG002|Overall Study|Adverse Event|0|||
155007706|NCT04176250|559451411|FG003|Overall Study|Adverse Event|1|||
155007707|NCT04176250|559451412|FG004|Overall Study|Adverse Event|0|||
155007708|NCT04176250|559451413|FG005|Overall Study|Adverse Event|1|||
155007709|NCT04176250|559451408|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155007710|NCT04176250|559451409|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155007711|NCT04176250|559451410|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
155007712|NCT04176250|559451411|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
155007713|NCT04176250|559451412|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155007714|NCT04176250|559451413|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
155007715|NCT04176250|559451408|FG000|Overall Study|Withdrawal by Subject|0|||
155007716|NCT04176250|559451409|FG001|Overall Study|Withdrawal by Subject|0|||
155007717|NCT04176250|559451410|FG002|Overall Study|Withdrawal by Subject|0|||
155007718|NCT04176250|559451411|FG003|Overall Study|Withdrawal by Subject|0|||
155007719|NCT04176250|559451412|FG004|Overall Study|Withdrawal by Subject|0|||
155007720|NCT04176250|559451413|FG005|Overall Study|Withdrawal by Subject|1|||
155007721|NCT04176250|559451408|FG000|Overall Study|Randomized in error|0|||
155007722|NCT04176250|559451409|FG001|Overall Study|Randomized in error|0|||
155007723|NCT04176250|559451410|FG002|Overall Study|Randomized in error|0|||
155007724|NCT04176250|559451411|FG003|Overall Study|Randomized in error|0|||
155007725|NCT04176250|559451412|FG004|Overall Study|Randomized in error|1|||
155007726|NCT04176250|559451413|FG005|Overall Study|Randomized in error|0|||
155007727|NCT04747470|559451418|FG000|Overall Study|Death|0|||
155007728|NCT04747470|559451419|FG001|Overall Study|Death|3|||
155007729|NCT04747470|559451420|FG002|Overall Study|Death|2|||
155007730|NCT04747470|559451421|FG003|Overall Study|Death|2|||
155007731|NCT04747470|559451422|FG004|Overall Study|Death|2|||
155129864|NCT00494507|559907181|FG000|Open-Label Phase|Adverse Event|0|||
155129865|NCT00494507|559907182|FG001|Open-Label Phase|Adverse Event|1|||
155129866|NCT00494507|559907183|FG002|Open-Label Phase|Adverse Event|5|||
155129867|NCT00494507|559907184|FG003|Open-Label Phase|Adverse Event|3|||
155129868|NCT00494507|559907181|FG000|Open-Label Phase|Worsening Disease|0|||
155129869|NCT00494507|559907182|FG001|Open-Label Phase|Worsening Disease|0|||
155129870|NCT00494507|559907183|FG002|Open-Label Phase|Worsening Disease|0|||
155129871|NCT00494507|559907184|FG003|Open-Label Phase|Worsening Disease|2|||
155129872|NCT02613169|559907185|FG000|Overall Study|Withdrawal by Subject|4|||
155129873|NCT02613169|559907186|FG001|Overall Study|Withdrawal by Subject|1|||
155129874|NCT02613169|559907185|FG000|Overall Study|Lost to Follow-up|0|||
155129875|NCT02613169|559907186|FG001|Overall Study|Lost to Follow-up|5|||
155129876|NCT02613169|559907185|FG000|Overall Study|HIV|0|||
155129877|NCT02613169|559907186|FG001|Overall Study|HIV|2|||
155129878|NCT02613169|559907185|FG000|Overall Study|No TB infection endpoint|14|||
155129879|NCT02613169|559907186|FG001|Overall Study|No TB infection endpoint|9|||
155129880|NCT00500760|559907187|FG000|Overall Study|Death|32|||
155129881|NCT00500760|559907188|FG001|Overall Study|Death|15|||
155129882|NCT00500760|559907187|FG000|Overall Study|Withdrawal by Subject|5|||
155129883|NCT00500760|559907188|FG001|Overall Study|Withdrawal by Subject|7|||
155129884|NCT00500760|559907187|FG000|Overall Study|Administrative decision|2|||
155129885|NCT00500760|559907188|FG001|Overall Study|Administrative decision|0|||
155129886|NCT00500760|559907187|FG000|Overall Study|Lost to Follow-up|3|||
155129887|NCT00500760|559907188|FG001|Overall Study|Lost to Follow-up|0|||
155129888|NCT00500760|559907187|FG000|Overall Study|Other|1|||
155129889|NCT00500760|559907188|FG001|Overall Study|Other|2|||
155129890|NCT01600092|559907189|FG000|Overall Study|Adverse Event|2|||
155129891|NCT01600092|559907190|FG001|Overall Study|Adverse Event|0|||
155129892|NCT01600092|559907189|FG000|Overall Study|Lost to Follow-up|4|||
155129893|NCT01600092|559907190|FG001|Overall Study|Lost to Follow-up|6|||
155129894|NCT01600092|559907189|FG000|Overall Study|Withdrawal by parent/guardian|8|||
155129895|NCT01600092|559907190|FG001|Overall Study|Withdrawal by parent/guardian|6|||
155129896|NCT01600092|559907189|FG000|Overall Study|Physician Decision|1|||
155129897|NCT01600092|559907190|FG001|Overall Study|Physician Decision|1|||
155129898|NCT01600092|559907189|FG000|Overall Study|Randomized but not vaccinated|3|||
155129899|NCT01600092|559907190|FG001|Overall Study|Randomized but not vaccinated|3|||
155129900|NCT02976103|559907192|FG000|Overall Study|Withdrawal by Subject|1|||
155129901|NCT02976103|559907193|FG001|Overall Study|Withdrawal by Subject|0|||
155129902|NCT02976103|559907192|FG000|Overall Study|Lost to Follow-up|12|||
155129903|NCT02976103|559907193|FG001|Overall Study|Lost to Follow-up|8|||
155129904|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
155129905|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
155129906|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
155129907|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
155129908|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
155129909|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
155129910|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155129911|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155129912|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155129913|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155129914|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
155129915|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
155129916|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
155129917|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
155129918|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155129919|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
155129920|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
155129921|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155129922|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155129923|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155129924|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155129925|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
155129926|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155007732|NCT04747470|559451423|FG005|Overall Study|Death|0|||
155129927|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
155129928|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
155007733|NCT04747470|559451424|FG006|Overall Study|Death|0|||
155129929|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
155129930|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
155129931|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
155129932|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155007734|NCT04747470|559451425|FG007|Overall Study|Death|0|||
155129933|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155007735|NCT04747470|559451426|FG008|Overall Study|Death|0|||
155007736|NCT04747470|559451427|FG009|Overall Study|Death|0|||
155007737|NCT04747470|559451428|FG010|Overall Study|Death|0|||
155007738|NCT04747470|559451418|FG000|Overall Study|Withdrew Consent|0|||
155007739|NCT04747470|559451419|FG001|Overall Study|Withdrew Consent|0|||
155007740|NCT04747470|559451420|FG002|Overall Study|Withdrew Consent|0|||
155007741|NCT04747470|559451421|FG003|Overall Study|Withdrew Consent|1|||
155007742|NCT04747470|559451422|FG004|Overall Study|Withdrew Consent|0|||
155007743|NCT04747470|559451423|FG005|Overall Study|Withdrew Consent|0|||
155007744|NCT04747470|559451424|FG006|Overall Study|Withdrew Consent|0|||
155007745|NCT04747470|559451425|FG007|Overall Study|Withdrew Consent|0|||
155007746|NCT04747470|559451426|FG008|Overall Study|Withdrew Consent|0|||
155007747|NCT04747470|559451427|FG009|Overall Study|Withdrew Consent|0|||
155007748|NCT04747470|559451428|FG010|Overall Study|Withdrew Consent|0|||
155007749|NCT04747470|559451418|FG000|Overall Study|Study Terminated by Sponsor|0|||
155007750|NCT04747470|559451419|FG001|Overall Study|Study Terminated by Sponsor|0|||
155007751|NCT04747470|559451420|FG002|Overall Study|Study Terminated by Sponsor|1|||
155007752|NCT04747470|559451421|FG003|Overall Study|Study Terminated by Sponsor|0|||
155007753|NCT04747470|559451422|FG004|Overall Study|Study Terminated by Sponsor|2|||
155007754|NCT04747470|559451423|FG005|Overall Study|Study Terminated by Sponsor|0|||
155007755|NCT04747470|559451424|FG006|Overall Study|Study Terminated by Sponsor|0|||
155007756|NCT04747470|559451425|FG007|Overall Study|Study Terminated by Sponsor|0|||
155007757|NCT04747470|559451426|FG008|Overall Study|Study Terminated by Sponsor|0|||
155007758|NCT04747470|559451427|FG009|Overall Study|Study Terminated by Sponsor|0|||
155007759|NCT04747470|559451428|FG010|Overall Study|Study Terminated by Sponsor|0|||
155007760|NCT04688671|559451429|FG000|Overall Study|Adverse Event|3|||
155007761|NCT04688671|559451430|FG001|Overall Study|Adverse Event|1|||
155007762|NCT04688671|559451429|FG000|Overall Study|Withdrawal by Subject|3|||
155007763|NCT04688671|559451430|FG001|Overall Study|Withdrawal by Subject|1|||
155007764|NCT04688671|559451429|FG000|Overall Study|Lack of Efficacy|1|||
155007765|NCT04688671|559451430|FG001|Overall Study|Lack of Efficacy|1|||
155007766|NCT04688671|559451429|FG000|Overall Study|Protocol Violation|1|||
155007767|NCT04688671|559451430|FG001|Overall Study|Protocol Violation|0|||
155007768|NCT04688671|559451429|FG000|Overall Study|Lost to Follow-up|0|||
155007769|NCT04688671|559451430|FG001|Overall Study|Lost to Follow-up|1|||
155007770|NCT02105467|559451437|FG000|Period 1|Lost to Follow-up|1|||
155007771|NCT02105467|559451438|FG001|Period 1|Lost to Follow-up|0|||
155007772|NCT02105467|559451437|FG000|Period 1|Death|1|||
155007773|NCT02105467|559451438|FG001|Period 1|Death|0|||
155007774|NCT02105467|559451437|FG000|Period 2|Lost to Follow-up|1|||
155007775|NCT02105467|559451438|FG001|Period 2|Lost to Follow-up|0|||
155007776|NCT02105467|559451437|FG000|Period 2|Death|1|||
155007777|NCT02105467|559451438|FG001|Period 2|Death|0|||
155007778|NCT02105467|559451437|FG000|Period 2|Withdrawal by Subject|0|||
155007779|NCT02105467|559451438|FG001|Period 2|Withdrawal by Subject|2|||
155007780|NCT02105467|559451437|FG000|Period 3|Lost to Follow-up|0|||
155007781|NCT02105467|559451438|FG001|Period 3|Lost to Follow-up|1|||
155007782|NCT02262325|559451439|FG000|Overall Study|Death|16|||
155007783|NCT02262325|559451439|FG000|Overall Study|Lost to Follow-up|1|||
155007784|NCT02815995|559451440|FG000|Overall Study|Disease Progression|3|||
155007785|NCT02815995|559451441|FG001|Overall Study|Disease Progression|7|||
155007786|NCT02815995|559451442|FG002|Overall Study|Disease Progression|2|||
155007787|NCT02815995|559451443|FG003|Overall Study|Disease Progression|4|||
155007788|NCT02815995|559451444|FG004|Overall Study|Disease Progression|3|||
155178445|NCT00592774|560091478|FG001|Overall Study|Other|1|||
155007789|NCT02815995|559451445|FG005|Overall Study|Disease Progression|9|||
155007790|NCT02815995|559451446|FG006|Overall Study|Disease Progression|3|||
155007791|NCT02815995|559451447|FG007|Overall Study|Disease Progression|1|||
155007792|NCT02815995|559451440|FG000|Overall Study|Adverse Event|1|||
155007793|NCT02815995|559451441|FG001|Overall Study|Adverse Event|2|||
155007794|NCT02815995|559451442|FG002|Overall Study|Adverse Event|2|||
155007795|NCT02815995|559451443|FG003|Overall Study|Adverse Event|0|||
155007796|NCT02815995|559451444|FG004|Overall Study|Adverse Event|0|||
155007797|NCT02815995|559451445|FG005|Overall Study|Adverse Event|1|||
155007798|NCT02815995|559451446|FG006|Overall Study|Adverse Event|0|||
155007799|NCT02815995|559451447|FG007|Overall Study|Adverse Event|0|||
155007800|NCT02815995|559451440|FG000|Overall Study|Pregnancy|0|||
155007801|NCT02815995|559451441|FG001|Overall Study|Pregnancy|0|||
155178446|NCT00592774|560091479|FG002|Overall Study|Other|1|||
155007802|NCT02815995|559451442|FG002|Overall Study|Pregnancy|0|||
155007803|NCT02815995|559451443|FG003|Overall Study|Pregnancy|0|||
155007804|NCT02815995|559451444|FG004|Overall Study|Pregnancy|0|||
155007805|NCT02815995|559451445|FG005|Overall Study|Pregnancy|0|||
155007806|NCT02815995|559451446|FG006|Overall Study|Pregnancy|1|||
155007807|NCT02815995|559451447|FG007|Overall Study|Pregnancy|0|||
155007808|NCT02676882|559451448|FG000|Overall Study|Adverse Event|1|||
155007809|NCT02676882|559451449|FG001|Overall Study|Adverse Event|0|||
155007810|NCT02676882|559451448|FG000|Overall Study|Lost to Follow-up|1|||
155007811|NCT02676882|559451449|FG001|Overall Study|Lost to Follow-up|0|||
155007812|NCT02676882|559451448|FG000|Overall Study|Withdrawal by Subject|1|||
155007813|NCT02676882|559451449|FG001|Overall Study|Withdrawal by Subject|2|||
155178447|NCT00592774|560091480|FG003|Overall Study|Other|0|||
155129934|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155129935|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155129936|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
155129937|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
155129938|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
155129939|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
155129940|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155129941|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
155129942|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
155129943|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155129944|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155129945|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155007814|NCT01071915|559451454|FG000|Overall Study|Adverse Event|3|||
155007815|NCT01071915|559451454|FG000|Overall Study|Physician Decision|2|||
155007816|NCT01071915|559451454|FG000|Overall Study|Withdrawal by Subject|2|||
155007817|NCT01071915|559451454|FG000|Overall Study|Miscellaneous Reasons|2|||
155007818|NCT00958828|559451455|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
155007819|NCT00958828|559451456|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
155007820|NCT00958828|559451455|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
155007821|NCT00958828|559451456|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
155007822|NCT01125189|559451457|FG000|Treatment Period|Lack of Efficacy|15|||
155007823|NCT01125189|559451458|FG001|Treatment Period|Lack of Efficacy|18|||
155007824|NCT01125189|559451459|FG002|Treatment Period|Lack of Efficacy|25|||
155007825|NCT01125189|559451457|FG000|Treatment Period|Adverse Event|7|||
155007826|NCT01125189|559451458|FG001|Treatment Period|Adverse Event|8|||
155007827|NCT01125189|559451459|FG002|Treatment Period|Adverse Event|8|||
155007828|NCT01125189|559451457|FG000|Treatment Period|Withdrawal by Subject|3|||
155007829|NCT01125189|559451458|FG001|Treatment Period|Withdrawal by Subject|1|||
155007830|NCT01125189|559451459|FG002|Treatment Period|Withdrawal by Subject|1|||
155007831|NCT01125189|559451457|FG000|Treatment Period|Death|1|||
155007832|NCT01125189|559451458|FG001|Treatment Period|Death|0|||
155007833|NCT01125189|559451459|FG002|Treatment Period|Death|0|||
155007834|NCT01125189|559451457|FG000|Treatment Period|Lost to Follow-up|1|||
155007835|NCT01125189|559451458|FG001|Treatment Period|Lost to Follow-up|2|||
155007836|NCT01125189|559451459|FG002|Treatment Period|Lost to Follow-up|1|||
155007837|NCT01125189|559451457|FG000|Treatment Period|Poor compliance/noncompliance|0|||
155007838|NCT01125189|559451458|FG001|Treatment Period|Poor compliance/noncompliance|1|||
155007839|NCT01125189|559451459|FG002|Treatment Period|Poor compliance/noncompliance|0|||
155007840|NCT01125189|559451457|FG000|Treatment Period|Participants requested to discontinue|1|||
155007841|NCT01125189|559451458|FG001|Treatment Period|Participants requested to discontinue|3|||
155007842|NCT01125189|559451459|FG002|Treatment Period|Participants requested to discontinue|4|||
155129946|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155129947|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
155129948|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129949|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129950|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
155129951|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129952|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155007843|NCT01125189|559451457|FG000|Treatment Period|Other reasons|1|||
155007844|NCT01125189|559451458|FG001|Treatment Period|Other reasons|1|||
155007845|NCT01125189|559451459|FG002|Treatment Period|Other reasons|0|||
155007846|NCT01125189|559451457|FG000|Treatment Period|Completed 24 week treatment period only|2|||
155007847|NCT01125189|559451458|FG001|Treatment Period|Completed 24 week treatment period only|1|||
155007848|NCT01125189|559451459|FG002|Treatment Period|Completed 24 week treatment period only|2|||
155007849|NCT01125189|559451457|FG000|Follow up Period|Withdrawal by Subject|3|||
155007850|NCT01125189|559451458|FG001|Follow up Period|Withdrawal by Subject|2|||
155007851|NCT01125189|559451459|FG002|Follow up Period|Withdrawal by Subject|5|||
155007852|NCT01125189|559451457|FG000|Follow up Period|Death|1|||
155007853|NCT01125189|559451458|FG001|Follow up Period|Death|0|||
155007854|NCT01125189|559451459|FG002|Follow up Period|Death|0|||
155129953|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
155129954|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129955|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155178448|NCT00592774|560091481|FG004|Overall Study|Other|2|||
155007855|NCT01125189|559451457|FG000|Follow up Period|Lost to Follow-up|12|||
155007856|NCT01125189|559451458|FG001|Follow up Period|Lost to Follow-up|9|||
155007857|NCT01125189|559451459|FG002|Follow up Period|Lost to Follow-up|6|||
155007858|NCT01125189|559451457|FG000|Follow up Period|Other reasons|4|||
155007859|NCT01125189|559451458|FG001|Follow up Period|Other reasons|4|||
155007860|NCT01125189|559451459|FG002|Follow up Period|Other reasons|5|||
155007861|NCT00114140|559451460|FG000|Overall Study|Protocol Violation|7|||
155007862|NCT00110396|559451461|FG000|Overall Study|Adverse Event|15|||
155129956|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129957|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129958|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
155129959|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
155129960|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129961|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129962|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129963|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129964|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129965|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129966|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129967|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129968|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129969|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
155129970|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129971|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129972|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
155129973|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129974|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129975|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129976|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129977|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129978|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129979|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129980|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
155129981|NCT02914561|559907194|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
155129982|NCT02914561|559907195|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155129983|NCT02914561|559907196|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155129984|NCT02914561|559907197|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155129985|NCT02914561|559907198|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155129986|NCT02914561|559907199|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
155129987|NCT02914561|559907200|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155129988|NCT02914561|559907201|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155129989|NCT02914561|559907202|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155129990|NCT02914561|559907203|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155129991|NCT02914561|559907204|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
155129992|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155129993|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155129994|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155129995|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155129996|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155129997|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
155129998|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
155129999|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
155130000|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
155130001|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
155130002|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
155130003|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155130004|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155130005|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155130006|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155130007|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155130008|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
155130009|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
155130010|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
155130011|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
155130012|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
155130013|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
155130014|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155130015|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155130016|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155178449|NCT01700439|560091482|FG000|Overall Study|Lost to Follow-up|47|||
155178450|NCT01700439|560091482|FG000|Overall Study|Withdrawal by Subject|183|||
155007863|NCT00110396|559451461|FG000|Overall Study|Lost to Follow-up|1|||
155130017|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155130018|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155130019|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
155130020|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
155130021|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
155130022|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
155130023|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
155130024|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
155130025|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130026|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130027|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130028|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130029|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130030|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130031|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
155130032|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130033|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
155130034|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
155130035|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
155130036|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130037|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130038|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130039|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130040|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130041|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130042|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
155130043|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
155130044|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
155130045|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
155130046|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
155130047|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130048|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130049|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130050|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130051|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130052|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130053|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
155130054|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130055|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
155130056|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130057|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
155130058|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130059|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130060|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130061|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130062|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130063|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130064|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130065|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130066|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
155130067|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130068|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
155130069|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130070|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130071|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130072|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130073|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130074|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130075|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
155130076|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130077|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130078|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130079|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
155130080|NCT02914561|559907194|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155130081|NCT02914561|559907195|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155130082|NCT02914561|559907196|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155007864|NCT00110396|559451461|FG000|Overall Study|Administration of plasmapheresis|1|||
155007865|NCT00110396|559451461|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
155007866|NCT00110396|559451461|FG000|Overall Study|Lack of Efficacy|1|||
155007867|NCT00110396|559451461|FG000|Overall Study|Decided not to continue treatment|1|||
155007868|NCT00110396|559451461|FG000|Overall Study|Patient non-compliance|1|||
155007869|NCT00110396|559451461|FG000|Overall Study|Patient refused to continue|1|||
155007870|NCT00110396|559451461|FG000|Overall Study|Patient refused to participate|1|||
155007871|NCT00110396|559451461|FG000|Overall Study|Patient will|1|||
155007872|NCT00110396|559451461|FG000|Overall Study|Patient's decision|1|||
155007873|NCT00110396|559451461|FG000|Overall Study|Participation in MS vaccine study|1|||
155007874|NCT00110396|559451461|FG000|Overall Study|Pregnancy|1|||
155007875|NCT00110396|559451461|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
155007876|NCT00110396|559451461|FG000|Overall Study|Protocol Violation|2|||
155007877|NCT00110396|559451461|FG000|Overall Study|Patient refused to come back|1|||
155007878|NCT00110396|559451461|FG000|Overall Study|The patient has refused|2|||
155007879|NCT00110396|559451461|FG000|Overall Study|The patient has refused to visit site|1|||
155007880|NCT00110396|559451461|FG000|Overall Study|Patient is to be administered copaxone|1|||
155007881|NCT02414958|559451462|FG000|Overall Study|Adverse Event|6|||
155007882|NCT02414958|559451463|FG001|Overall Study|Adverse Event|6|||
155007883|NCT02414958|559451464|FG002|Overall Study|Adverse Event|3|||
155007884|NCT02414958|559451462|FG000|Overall Study|Protocol Violation|10|||
155007885|NCT02414958|559451463|FG001|Overall Study|Protocol Violation|3|||
155007886|NCT02414958|559451464|FG002|Overall Study|Protocol Violation|1|||
155007887|NCT02414958|559451462|FG000|Overall Study|Lost to Follow-up|7|||
155007888|NCT02414958|559451463|FG001|Overall Study|Lost to Follow-up|4|||
155007889|NCT02414958|559451464|FG002|Overall Study|Lost to Follow-up|0|||
155007890|NCT02414958|559451462|FG000|Overall Study|Withdrawal by Subject|5|||
155007891|NCT02414958|559451463|FG001|Overall Study|Withdrawal by Subject|3|||
155007892|NCT02414958|559451464|FG002|Overall Study|Withdrawal by Subject|5|||
155007893|NCT02414958|559451462|FG000|Overall Study|Other than specified|4|||
155007894|NCT02414958|559451463|FG001|Overall Study|Other than specified|4|||
155007895|NCT02414958|559451464|FG002|Overall Study|Other than specified|5|||
155007896|NCT01269918|559451465|FG000|Overall Study|Did not receive study drug|0|||
155007897|NCT01269918|559451466|FG001|Overall Study|Did not receive study drug|3|||
155007898|NCT02500589|559451468|FG000|Overall Study|Withdrawal by Subject|11|||
155007899|NCT02500589|559451469|FG001|Overall Study|Withdrawal by Subject|14|||
155007900|NCT02500589|559451468|FG000|Overall Study|Lost to Follow-up|10|||
155007901|NCT02500589|559451469|FG001|Overall Study|Lost to Follow-up|12|||
155007902|NCT02500589|559451468|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
155007903|NCT02500589|559451469|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
155007904|NCT02500589|559451468|FG000|Overall Study|Death|7|||
155007905|NCT02500589|559451469|FG001|Overall Study|Death|5|||
155007906|NCT00245466|559451470|FG000|Overall Study|Adverse Event|2|||
155007907|NCT00245466|559451471|FG001|Overall Study|Adverse Event|8|||
155007908|NCT00245466|559451472|FG002|Overall Study|Adverse Event|4|||
155007909|NCT00245466|559451470|FG000|Overall Study|Low prostate specific antigen suppr|16|||
155007910|NCT00245466|559451471|FG001|Overall Study|Low prostate specific antigen suppr|14|||
155007911|NCT00245466|559451472|FG002|Overall Study|Low prostate specific antigen suppr|5|||
155007912|NCT00245466|559451470|FG000|Overall Study|Insufficient testosterone suppr|12|||
155007913|NCT00245466|559451471|FG001|Overall Study|Insufficient testosterone suppr|12|||
155007914|NCT00245466|559451472|FG002|Overall Study|Insufficient testosterone suppr|21|||
155007915|NCT00245466|559451470|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
155007916|NCT00245466|559451471|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
155007917|NCT00245466|559451472|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
155007918|NCT00245466|559451470|FG000|Overall Study|Withdrawal by Subject|2|||
155007919|NCT00245466|559451471|FG001|Overall Study|Withdrawal by Subject|2|||
155007920|NCT00245466|559451472|FG002|Overall Study|Withdrawal by Subject|1|||
155007921|NCT00245466|559451470|FG000|Overall Study|Lost to Follow-up|3|||
155007922|NCT00245466|559451471|FG001|Overall Study|Lost to Follow-up|0|||
155007923|NCT00245466|559451472|FG002|Overall Study|Lost to Follow-up|0|||
155130083|NCT02914561|559907197|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155130084|NCT02914561|559907198|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155007924|NCT00245466|559451470|FG000|Overall Study|Disease progression|0|||
155007925|NCT00245466|559451471|FG001|Overall Study|Disease progression|3|||
155151016|NCT02587520|559988162|FG002|Overall Study|Protocol Violation|0|||
155007926|NCT00245466|559451472|FG002|Overall Study|Disease progression|1|||
155007927|NCT00245466|559451470|FG000|Overall Study|Protocol Violation|1|||
155007928|NCT00245466|559451471|FG001|Overall Study|Protocol Violation|2|||
155007929|NCT00245466|559451472|FG002|Overall Study|Protocol Violation|2|||
155007930|NCT00245466|559451470|FG000|Overall Study|Death|0|||
155007931|NCT00245466|559451471|FG001|Overall Study|Death|2|||
155007932|NCT00245466|559451472|FG002|Overall Study|Death|0|||
155007933|NCT00245466|559451470|FG000|Overall Study|Administrative reasons|0|||
155007934|NCT00245466|559451471|FG001|Overall Study|Administrative reasons|1|||
155007935|NCT00245466|559451472|FG002|Overall Study|Administrative reasons|0|||
155007936|NCT00856193|559451473|FG000|Period 2|Abnormal test procedure results|0|||
155007937|NCT00856193|559451474|FG001|Period 2|Abnormal test procedure results|1|||
155007938|NCT00856193|559451473|FG000|Period 2|Lost to Follow-up|0|||
155007939|NCT00856193|559451474|FG001|Period 2|Lost to Follow-up|1|||
155130085|NCT02914561|559907199|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155130086|NCT02914561|559907200|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155130087|NCT02914561|559907201|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
155130088|NCT02914561|559907202|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
155130089|NCT02914561|559907203|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
155130090|NCT02914561|559907204|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
155130091|NCT00084487|559907205|FG000|Overall Study|Death|1|||
155130092|NCT03332160|559907212|FG000|Overall Study|Withdrawal by Subject|1|||
155130093|NCT03332160|559907213|FG001|Overall Study|Withdrawal by Subject|1|||
155130094|NCT03332160|559907212|FG000|Overall Study|Adverse Event|0|||
155130095|NCT03332160|559907213|FG001|Overall Study|Adverse Event|1|||
155130096|NCT03332160|559907212|FG000|Overall Study|Developed Exclusion Criteria|0|||
155130097|NCT03332160|559907213|FG001|Overall Study|Developed Exclusion Criteria|1|||
155130098|NCT03332160|559907212|FG000|Overall Study|Non-adherence to treatment|0|||
155130099|NCT03332160|559907213|FG001|Overall Study|Non-adherence to treatment|2|||
155130100|NCT01459913|559907216|FG000|Overall Study|Adverse Event|0|||
155130101|NCT01459913|559907217|FG001|Overall Study|Adverse Event|0|||
155130102|NCT01459913|559907218|FG002|Overall Study|Adverse Event|0|||
155130103|NCT01459913|559907219|FG003|Overall Study|Adverse Event|3|||
155130104|NCT01459913|559907216|FG000|Overall Study|Withdrawal by Subject|4|||
155130105|NCT01459913|559907217|FG001|Overall Study|Withdrawal by Subject|0|||
155130106|NCT01459913|559907218|FG002|Overall Study|Withdrawal by Subject|0|||
155130107|NCT01459913|559907219|FG003|Overall Study|Withdrawal by Subject|5|||
155130108|NCT01459913|559907216|FG000|Overall Study|Lost to Follow-up|7|||
155130109|NCT01459913|559907217|FG001|Overall Study|Lost to Follow-up|4|||
155130110|NCT01459913|559907218|FG002|Overall Study|Lost to Follow-up|1|||
155130111|NCT01459913|559907219|FG003|Overall Study|Lost to Follow-up|8|||
155130112|NCT01459913|559907216|FG000|Overall Study|Death|0|||
155130113|NCT01459913|559907217|FG001|Overall Study|Death|0|||
155130114|NCT01459913|559907218|FG002|Overall Study|Death|0|||
155130115|NCT01459913|559907219|FG003|Overall Study|Death|1|||
155130116|NCT01459913|559907216|FG000|Overall Study|Non- Compliance|0|||
155130117|NCT01459913|559907217|FG001|Overall Study|Non- Compliance|0|||
155130118|NCT01459913|559907218|FG002|Overall Study|Non- Compliance|0|||
155130119|NCT01459913|559907219|FG003|Overall Study|Non- Compliance|3|||
155130120|NCT01459913|559907216|FG000|Overall Study|Physician Decision|0|||
155130121|NCT01459913|559907217|FG001|Overall Study|Physician Decision|1|||
155130122|NCT01459913|559907218|FG002|Overall Study|Physician Decision|0|||
155130123|NCT01459913|559907219|FG003|Overall Study|Physician Decision|0|||
155130124|NCT01459913|559907216|FG000|Overall Study|Study Terminated by Sponsor|30|||
155130125|NCT01459913|559907217|FG001|Overall Study|Study Terminated by Sponsor|15|||
155130126|NCT01459913|559907218|FG002|Overall Study|Study Terminated by Sponsor|9|||
155130127|NCT01459913|559907219|FG003|Overall Study|Study Terminated by Sponsor|11|||
155130128|NCT01459913|559907216|FG000|Overall Study|Other|0|||
155130129|NCT01459913|559907217|FG001|Overall Study|Other|0|||
155130130|NCT01459913|559907218|FG002|Overall Study|Other|3|||
155130131|NCT01459913|559907219|FG003|Overall Study|Other|1|||
155130132|NCT01459913|559907216|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
155130133|NCT01459913|559907217|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
155130134|NCT01459913|559907218|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
155130135|NCT01459913|559907219|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
155130136|NCT03040986|559907227|FG000|Overall Study|Hospice|1|||
155130137|NCT03040986|559907228|FG001|Overall Study|Hospice|0|||
155130138|NCT03040986|559907227|FG000|Overall Study|Adverse Event|2|||
155130139|NCT03040986|559907228|FG001|Overall Study|Adverse Event|1|||
155130140|NCT03040986|559907227|FG000|Overall Study|Disease progression on study|3|||
155130141|NCT03040986|559907228|FG001|Overall Study|Disease progression on study|1|||
155130142|NCT02383433|559907229|FG000|Overall Study|Disease progression|2|||
155130143|NCT02477553|559907230|FG000|Overall Study|Screening up-to-date|12|||
155130144|NCT02477553|559907231|FG001|Overall Study|Screening up-to-date|13|||
155130145|NCT02477553|559907230|FG000|Overall Study|No MD visit|1|||
155130146|NCT02477553|559907231|FG001|Overall Study|No MD visit|1|||
155007940|NCT05064397|559451475|FG000|Overall Study|Adverse Event|4|||
155007941|NCT05064397|559451475|FG000|Overall Study|Lack of Efficacy|12|||
155178451|NCT01700439|560091482|FG000|Overall Study|Death|186|||
155178452|NCT00621621|560091491|FG000|Overall Study|Subjects were exited at EP study|30|||
155007942|NCT05064397|559451475|FG000|Overall Study|Withdrawal by Subject|3|||
155130147|NCT02477553|559907230|FG000|Overall Study|Workup consistent w/CRC|1|||
155130148|NCT02477553|559907231|FG001|Overall Study|Workup consistent w/CRC|1|||
155130149|NCT02477553|559907230|FG000|Overall Study|Technical issues with intervention|2|||
155130150|NCT02477553|559907231|FG001|Overall Study|Technical issues with intervention|0|||
155130151|NCT02477553|559907230|FG000|Overall Study|Elevated risk for CRC|2|||
155130152|NCT02477553|559907231|FG001|Overall Study|Elevated risk for CRC|2|||
155130153|NCT02477553|559907230|FG000|Overall Study|MD advised against screening|1|||
155130154|NCT02477553|559907231|FG001|Overall Study|MD advised against screening|3|||
155130155|NCT02477553|559907230|FG000|Overall Study|patient deceased|1|||
155130156|NCT02477553|559907231|FG001|Overall Study|patient deceased|0|||
155130157|NCT00454649|559907236|FG000|Overall Study|Lack of Efficacy|2|||
155130158|NCT00454649|559907237|FG001|Overall Study|Lack of Efficacy|2|||
155130159|NCT00454649|559907238|FG002|Overall Study|Lack of Efficacy|10|||
155130160|NCT00454649|559907239|FG003|Overall Study|Lack of Efficacy|3|||
155130161|NCT00454649|559907240|FG004|Overall Study|Lack of Efficacy|0|||
155130162|NCT00454649|559907241|FG005|Overall Study|Lack of Efficacy|4|||
155130163|NCT00454649|559907242|FG006|Overall Study|Lack of Efficacy|5|||
155130164|NCT00454649|559907243|FG007|Overall Study|Lack of Efficacy|13|||
155130165|NCT00454649|559907244|FG008|Overall Study|Lack of Efficacy|10|||
155130166|NCT00454649|559907245|FG009|Overall Study|Lack of Efficacy|2|||
155130167|NCT00454649|559907236|FG000|Overall Study|Adverse Event|0|||
155130168|NCT00454649|559907237|FG001|Overall Study|Adverse Event|1|||
155130169|NCT00454649|559907238|FG002|Overall Study|Adverse Event|3|||
155130170|NCT00454649|559907239|FG003|Overall Study|Adverse Event|0|||
155130171|NCT00454649|559907240|FG004|Overall Study|Adverse Event|1|||
155130172|NCT00454649|559907241|FG005|Overall Study|Adverse Event|2|||
155130173|NCT00454649|559907242|FG006|Overall Study|Adverse Event|3|||
155130174|NCT00454649|559907243|FG007|Overall Study|Adverse Event|4|||
155130175|NCT00454649|559907244|FG008|Overall Study|Adverse Event|6|||
155130176|NCT00454649|559907245|FG009|Overall Study|Adverse Event|2|||
155130177|NCT00454649|559907236|FG000|Overall Study|Lost to Follow-up|0|||
155130178|NCT00454649|559907237|FG001|Overall Study|Lost to Follow-up|0|||
155130179|NCT00454649|559907238|FG002|Overall Study|Lost to Follow-up|1|||
155130180|NCT00454649|559907239|FG003|Overall Study|Lost to Follow-up|0|||
155130181|NCT00454649|559907240|FG004|Overall Study|Lost to Follow-up|0|||
155130182|NCT00454649|559907241|FG005|Overall Study|Lost to Follow-up|0|||
155130183|NCT00454649|559907242|FG006|Overall Study|Lost to Follow-up|1|||
155130184|NCT00454649|559907243|FG007|Overall Study|Lost to Follow-up|0|||
155130185|NCT00454649|559907244|FG008|Overall Study|Lost to Follow-up|0|||
155130186|NCT00454649|559907245|FG009|Overall Study|Lost to Follow-up|0|||
155130187|NCT00454649|559907236|FG000|Overall Study|Other|1|||
155130188|NCT00454649|559907237|FG001|Overall Study|Other|1|||
155130189|NCT00454649|559907238|FG002|Overall Study|Other|5|||
155130190|NCT00454649|559907239|FG003|Overall Study|Other|3|||
155130191|NCT00454649|559907240|FG004|Overall Study|Other|0|||
155130192|NCT00454649|559907241|FG005|Overall Study|Other|0|||
155130193|NCT00454649|559907242|FG006|Overall Study|Other|0|||
155130194|NCT00454649|559907243|FG007|Overall Study|Other|0|||
155130195|NCT00454649|559907244|FG008|Overall Study|Other|3|||
155130196|NCT00454649|559907245|FG009|Overall Study|Other|1|||
155130197|NCT00454649|559907236|FG000|Overall Study|Withdrawal by Subject|0|||
155130198|NCT00454649|559907237|FG001|Overall Study|Withdrawal by Subject|0|||
155130199|NCT00454649|559907238|FG002|Overall Study|Withdrawal by Subject|0|||
155130200|NCT00454649|559907239|FG003|Overall Study|Withdrawal by Subject|0|||
155130201|NCT00454649|559907240|FG004|Overall Study|Withdrawal by Subject|0|||
155130202|NCT00454649|559907241|FG005|Overall Study|Withdrawal by Subject|1|||
155130203|NCT00454649|559907242|FG006|Overall Study|Withdrawal by Subject|0|||
155130204|NCT00454649|559907243|FG007|Overall Study|Withdrawal by Subject|2|||
155130205|NCT00454649|559907244|FG008|Overall Study|Withdrawal by Subject|1|||
155130206|NCT00454649|559907245|FG009|Overall Study|Withdrawal by Subject|0|||
155130207|NCT02925728|559907246|FG000|Overall Study|Death|3|||
155130208|NCT02925728|559907247|FG001|Overall Study|Death|5|||
155130209|NCT02925728|559907246|FG000|Overall Study|Physician Decision|1|||
155130210|NCT02925728|559907247|FG001|Overall Study|Physician Decision|0|||
155130211|NCT02925728|559907246|FG000|Overall Study|Withdrawal by Subject|1|||
155007943|NCT05064397|559451475|FG000|Overall Study|Lost to Follow-up|1|||
155130212|NCT02925728|559907247|FG001|Overall Study|Withdrawal by Subject|0|||
155130213|NCT00086411|559907255|FG000|Overall Study|Lost to Follow-up|11|||
155007944|NCT05064397|559451475|FG000|Overall Study|Other reasons|3|||
155007945|NCT03934541|559451478|FG000|Overall Study|Study Terminated by Sponsor|0|||
155130214|NCT00086411|559907256|FG001|Overall Study|Lost to Follow-up|11|||
155130215|NCT00086411|559907257|FG002|Overall Study|Lost to Follow-up|13|||
155130216|NCT00086411|559907258|FG003|Overall Study|Lost to Follow-up|12|||
155130217|NCT00718770|559907259|FG000|Overall Study|Adverse Event|1|||
155130218|NCT00718770|559907259|FG000|Overall Study|Lack of Efficacy|1|||
155130219|NCT00718770|559907259|FG000|Overall Study|Lack of Efficacy|1|||
155130220|NCT00718770|559907259|FG000|Overall Study|Adverse Event|1|||
155130221|NCT00718770|559907259|FG000|Overall Study|Lack of Efficacy|1|||
155130222|NCT00718770|559907259|FG000|Overall Study|Adverse Event|1|||
155130223|NCT00718770|559907259|FG000|Overall Study|Lack of Efficacy|1|||
155130224|NCT00718770|559907259|FG000|Overall Study|Adverse Event|1|||
155130225|NCT00752726|559907262|FG000|Overall Study|Lost to Follow-up|2|||
155130226|NCT00752726|559907263|FG001|Overall Study|Lost to Follow-up|1|||
155130227|NCT00752726|559907262|FG000|Overall Study|Adverse Event|3|||
155130228|NCT00752726|559907263|FG001|Overall Study|Adverse Event|0|||
155130229|NCT00752726|559907262|FG000|Overall Study|Withdrawal by Subject|5|||
155130230|NCT00752726|559907263|FG001|Overall Study|Withdrawal by Subject|10|||
155130231|NCT00752726|559907262|FG000|Overall Study|Other Reason|1|||
155007946|NCT03934541|559451479|FG001|Overall Study|Study Terminated by Sponsor|1|||
155007947|NCT03934541|559451480|FG002|Overall Study|Study Terminated by Sponsor|0|||
155007948|NCT03934541|559451481|FG003|Overall Study|Study Terminated by Sponsor|0|||
155007949|NCT01783886|559451486|FG000|Overall Study|Lost to Follow-up|0|||
155007950|NCT01783886|559451487|FG001|Overall Study|Lost to Follow-up|3|||
155007951|NCT01783886|559451488|FG002|Overall Study|Lost to Follow-up|0|||
155007952|NCT01783886|559451486|FG000|Overall Study|Protocol deviation|0|||
155007953|NCT01783886|559451487|FG001|Overall Study|Protocol deviation|0|||
155007954|NCT01783886|559451488|FG002|Overall Study|Protocol deviation|2|||
155007955|NCT01783886|559451486|FG000|Overall Study|Withdrawal of consent by participant|1|||
155007956|NCT01783886|559451487|FG001|Overall Study|Withdrawal of consent by participant|3|||
155007957|NCT01783886|559451488|FG002|Overall Study|Withdrawal of consent by participant|4|||
155007958|NCT01783886|559451486|FG000|Overall Study|Adverse Event|4|||
155007959|NCT01783886|559451487|FG001|Overall Study|Adverse Event|5|||
155007960|NCT01783886|559451488|FG002|Overall Study|Adverse Event|4|||
155007961|NCT02324582|559451491|FG000|Overall Study|Screen Failures|0|||
155007962|NCT02324582|559451492|FG001|Overall Study|Screen Failures|5|||
155007963|NCT03624192|559451493|FG000|Overall Study|Lost to Follow-up|1|||
155007964|NCT03624192|559451494|FG001|Overall Study|Lost to Follow-up|1|||
155007965|NCT04660331|559451495|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
155007966|NCT04660331|559451496|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
155007967|NCT04660331|559451497|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
155007968|NCT00786409|559451498|FG000|Overall Study|Withdrawal by Subject|2|||
155007969|NCT00786409|559451498|FG000|Overall Study|Adverse Event|2|||
155007970|NCT00786409|559451498|FG000|Overall Study|Pregnancy|2|||
155007971|NCT00786409|559451498|FG000|Overall Study|Lost to Follow-up|1|||
155007972|NCT00610129|559451499|FG000|Overall Study|Not treated since patients ineligible|3|||
155007973|NCT04779879|559451505|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155007974|NCT04779879|559451506|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155007975|NCT04779879|559451507|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155007976|NCT04779879|559451508|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
155007977|NCT04779879|559451509|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155007978|NCT04779879|559451510|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
155007979|NCT04779879|559451505|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
155007980|NCT04779879|559451506|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
155007981|NCT04779879|559451507|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
155007982|NCT04779879|559451508|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
155007983|NCT04779879|559451509|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
155007984|NCT04779879|559451510|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
155007985|NCT04779879|559451505|FG000|Part C: Up to Week 36|Death|0|||
155007986|NCT04779879|559451506|FG001|Part C: Up to Week 36|Death|0|||
155007987|NCT04779879|559451507|FG002|Part C: Up to Week 36|Death|0|||
155007988|NCT04779879|559451508|FG003|Part C: Up to Week 36|Death|0|||
155007989|NCT04779879|559451509|FG004|Part C: Up to Week 36|Death|0|||
155007990|NCT04779879|559451510|FG005|Part C: Up to Week 36|Death|1|||
155007991|NCT04779879|559451505|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
155007992|NCT04779879|559451506|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
155007993|NCT04779879|559451507|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
155007994|NCT04779879|559451508|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
155007995|NCT04779879|559451509|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
155007996|NCT04779879|559451510|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
155007997|NCT05101343|559451511|FG000|Overall Study|Withdrawal by Subject|2|||
155007998|NCT05101343|559451512|FG001|Overall Study|Withdrawal by Subject|1|||
155007999|NCT02854527|559451513|FG000|Overall Study|Adverse Event|0|||
155130232|NCT00752726|559907263|FG001|Overall Study|Other Reason|2|||
155130233|NCT04232215|559907264|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155008000|NCT02854527|559451514|FG001|Overall Study|Adverse Event|0|||
155008001|NCT02854527|559451515|FG002|Overall Study|Adverse Event|0|||
155008002|NCT02854527|559451516|FG003|Overall Study|Adverse Event|0|||
155008003|NCT02854527|559451517|FG004|Overall Study|Adverse Event|1|||
155008004|NCT02854527|559451518|FG005|Overall Study|Adverse Event|0|||
155008005|NCT02854527|559451519|FG006|Overall Study|Adverse Event|0|||
155008006|NCT02854527|559451520|FG007|Overall Study|Adverse Event|0|||
155008007|NCT02854527|559451521|FG008|Overall Study|Adverse Event|0|||
155008008|NCT02854527|559451522|FG009|Overall Study|Adverse Event|0|||
155008009|NCT02854527|559451513|FG000|Overall Study|Lost to Follow-up|0|||
155008010|NCT02854527|559451514|FG001|Overall Study|Lost to Follow-up|0|||
155008011|NCT02854527|559451515|FG002|Overall Study|Lost to Follow-up|0|||
155008012|NCT02854527|559451516|FG003|Overall Study|Lost to Follow-up|1|||
155008013|NCT02854527|559451517|FG004|Overall Study|Lost to Follow-up|0|||
155008014|NCT02854527|559451518|FG005|Overall Study|Lost to Follow-up|0|||
155008015|NCT02854527|559451519|FG006|Overall Study|Lost to Follow-up|0|||
155008016|NCT02854527|559451520|FG007|Overall Study|Lost to Follow-up|0|||
155008017|NCT02854527|559451521|FG008|Overall Study|Lost to Follow-up|0|||
155130234|NCT04232215|559907265|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155130235|NCT00410605|559907266|FG000|Overall Study|Adverse Event|12|||
155130236|NCT00410605|559907266|FG000|Overall Study|Physician Decision|3|||
155130237|NCT00410605|559907266|FG000|Overall Study|Withdrawal by Subject|5|||
155130238|NCT00410605|559907266|FG000|Overall Study|Started Non-Protocol Therapy|3|||
155130239|NCT00410605|559907266|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
155130240|NCT00410605|559907266|FG000|Overall Study|Transferred to another Institution|1|||
155130241|NCT01887353|559907273|FG000|Overall Study|Study stopped early|4|||
155130242|NCT01887353|559907274|FG001|Overall Study|Study stopped early|3|||
155130243|NCT02540291|559907276|FG000|Overall Study|Death|7|||
155130244|NCT02540291|559907277|FG001|Overall Study|Death|7|||
155130245|NCT02540291|559907278|FG002|Overall Study|Death|5|||
155130246|NCT02540291|559907279|FG003|Overall Study|Death|7|||
155130247|NCT02540291|559907276|FG000|Overall Study|Lost to Follow-up|0|||
155130248|NCT02540291|559907277|FG001|Overall Study|Lost to Follow-up|0|||
155130249|NCT02540291|559907278|FG002|Overall Study|Lost to Follow-up|1|||
155130250|NCT02540291|559907279|FG003|Overall Study|Lost to Follow-up|0|||
155130251|NCT02540291|559907276|FG000|Overall Study|Withdrawal Of Consent|0|||
155130252|NCT02540291|559907277|FG001|Overall Study|Withdrawal Of Consent|1|||
155130253|NCT02540291|559907278|FG002|Overall Study|Withdrawal Of Consent|0|||
155130254|NCT02540291|559907279|FG003|Overall Study|Withdrawal Of Consent|0|||
155130255|NCT02540291|559907276|FG000|Overall Study|Study Terminated By Sponsor|1|||
155130256|NCT02540291|559907277|FG001|Overall Study|Study Terminated By Sponsor|0|||
155130257|NCT02540291|559907278|FG002|Overall Study|Study Terminated By Sponsor|0|||
155130258|NCT02540291|559907279|FG003|Overall Study|Study Terminated By Sponsor|0|||
155130259|NCT02540291|559907276|FG000|Overall Study|Other|0|||
155130260|NCT02540291|559907277|FG001|Overall Study|Other|0|||
155130261|NCT02540291|559907278|FG002|Overall Study|Other|1|||
155130262|NCT02540291|559907279|FG003|Overall Study|Other|0|||
155130263|NCT01879072|559907293|FG000|Overall Study|Withdrawal by Subject|121|||
155130264|NCT01879072|559907293|FG000|Overall Study|Not Transplanted|30|||
155130265|NCT04667104|559907302|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
155130266|NCT04667104|559907303|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
155130267|NCT04667104|559907304|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
155130268|NCT02666105|559907305|FG000|Overall Study|Death|1|||
155130269|NCT01078168|559907306|FG000|Overall Study|Physician Decision|0|||
155130270|NCT01078168|559907307|FG001|Overall Study|Physician Decision|1|||
155130271|NCT01264419|559907309|FG000|Overall Study|Lost to Follow-up|3|||
155130272|NCT00649428|559908940|FG000|Overall Study|Adverse Event|2|||
155130273|NCT00649428|559908941|FG001|Overall Study|Adverse Event|2|||
155130274|NCT00649428|559908940|FG000|Overall Study|Withdrawal by Subject|6|||
155130275|NCT00649428|559908941|FG001|Overall Study|Withdrawal by Subject|6|||
155130276|NCT00649428|559908940|FG000|Overall Study|Lost to Follow-up|1|||
155130277|NCT00649428|559908941|FG001|Overall Study|Lost to Follow-up|3|||
155130278|NCT00649428|559908940|FG000|Overall Study|Insufficient manufacturing yield|5|||
155130279|NCT00649428|559908941|FG001|Overall Study|Insufficient manufacturing yield|1|||
155130280|NCT00649428|559908940|FG000|Overall Study|Protocol Violation|6|||
155130281|NCT00649428|559908941|FG001|Overall Study|Protocol Violation|2|||
155130282|NCT00649428|559908940|FG000|Overall Study|Physician Decision|0|||
155130283|NCT00649428|559908941|FG001|Overall Study|Physician Decision|1|||
155130284|NCT00924508|559908944|FG000|Overall Study|Withdrawal by Subject|3|||
155130285|NCT01912339|559908945|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
155130286|NCT01912339|559908946|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
155130287|NCT01912339|559908947|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
155130288|NCT01912339|559908945|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
155130289|NCT01912339|559908946|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
155130290|NCT01912339|559908947|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
155130291|NCT01912339|559908945|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
155130292|NCT01912339|559908946|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
155130293|NCT01912339|559908947|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
155130294|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
155130295|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
155130296|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
155130297|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
155130298|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
155130299|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
155130300|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
155130301|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
155130302|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
155130303|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
155130304|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
155130305|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
155130306|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
155130307|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
155130308|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
155130309|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
155130310|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
155130311|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
155130312|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
155130313|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
155130314|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
155130315|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
155130316|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
155130317|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
155130318|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
155130319|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
155130320|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
155130321|NCT01912339|559908945|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
155130322|NCT01912339|559908946|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
155130323|NCT01912339|559908947|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
155130324|NCT00858208|559908949|FG000|Overall Study|Adverse Event|3|||
155130325|NCT00858208|559908949|FG000|Overall Study|Lost to Follow-up|26|||
155130326|NCT00858208|559908949|FG000|Overall Study|Participant refused|40|||
155130327|NCT00858208|559908949|FG000|Overall Study|Other|10|||
155130328|NCT01272635|559908950|FG000|Overall Study|Lost to Follow-up|31|||
155130329|NCT01272635|559908951|FG001|Overall Study|Lost to Follow-up|20|||
155130330|NCT01272635|559908952|FG002|Overall Study|Lost to Follow-up|31|||
155130331|NCT01272635|559908953|FG003|Overall Study|Lost to Follow-up|23|||
155130332|NCT01543776|559908956|FG000|Overall Study|Withdrawal by Subject|2|||
155130333|NCT01543776|559908957|FG001|Overall Study|Withdrawal by Subject|2|||
155130334|NCT00306527|559908958|FG000|Overall Study|Lost to Follow-up|3|||
155130335|NCT00306527|559908959|FG001|Overall Study|Lost to Follow-up|4|||
155130336|NCT00306527|559908960|FG002|Overall Study|Lost to Follow-up|3|||
155130337|NCT00306527|559908961|FG003|Overall Study|Lost to Follow-up|0|||
155130338|NCT00306527|559908958|FG000|Overall Study|Withdrawal by Subject|2|||
155130339|NCT00306527|559908959|FG001|Overall Study|Withdrawal by Subject|3|||
155130340|NCT00306527|559908960|FG002|Overall Study|Withdrawal by Subject|0|||
155130341|NCT00306527|559908961|FG003|Overall Study|Withdrawal by Subject|3|||
155130342|NCT00306527|559908958|FG000|Overall Study|Adverse Event|0|||
155130343|NCT00306527|559908959|FG001|Overall Study|Adverse Event|0|||
155130344|NCT00306527|559908960|FG002|Overall Study|Adverse Event|1|||
155130345|NCT00306527|559908961|FG003|Overall Study|Adverse Event|1|||
155130346|NCT00306527|559908958|FG000|Overall Study|Death|1|||
155130347|NCT00306527|559908959|FG001|Overall Study|Death|0|||
155130348|NCT00306527|559908960|FG002|Overall Study|Death|1|||
155130349|NCT00306527|559908961|FG003|Overall Study|Death|2|||
155130350|NCT02702180|559908962|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155130351|NCT02702180|559908963|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155130352|NCT02702180|559908964|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155130353|NCT02702180|559908962|FG000|Double-blind Treatment Period|Adverse Event|0|||
155130354|NCT02702180|559908963|FG001|Double-blind Treatment Period|Adverse Event|0|||
155130355|NCT02702180|559908964|FG002|Double-blind Treatment Period|Adverse Event|1|||
155130356|NCT02702180|559908962|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155130357|NCT02702180|559908963|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155130358|NCT02702180|559908964|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
155130359|NCT02702180|559908962|FG000|Double-blind Treatment Period|Protocol Violation|0|||
155130360|NCT02702180|559908963|FG001|Double-blind Treatment Period|Protocol Violation|0|||
155130361|NCT02702180|559908964|FG002|Double-blind Treatment Period|Protocol Violation|2|||
155130362|NCT02702180|559908962|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
155130363|NCT02702180|559908963|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
155130364|NCT02702180|559908964|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
155130365|NCT02702180|559908962|FG000|Open-label Treatment Period|Withdrawn in error|0|||
155130366|NCT02702180|559908963|FG001|Open-label Treatment Period|Withdrawn in error|0|||
155130367|NCT02702180|559908964|FG002|Open-label Treatment Period|Withdrawn in error|1|||
155130368|NCT00785980|559908965|FG000|7 Day Washout Period|Protocol Violation|3|||
155130369|NCT00417963|559908966|FG000|Overall Study|Lost to Follow-up|3|||
155130370|NCT00417963|559908966|FG000|Overall Study|Withdrawal by Subject|18|||
155130371|NCT00417963|559908966|FG000|Overall Study|Death|17|||
155130372|NCT00417963|559908966|FG000|Overall Study|Study device could not be deployed|3|||
155178453|NCT00621621|560091492|FG001|Overall Study|Subjects were exited at EP study|0|||
155008018|NCT02854527|559451522|FG009|Overall Study|Lost to Follow-up|0|||
155178454|NCT01829243|560091493|FG000|First Intervention|Screen Failure|4|||
155008019|NCT06082843|559453440|FG000|Overall Study|Withdrawal by Subject|0|||
155130373|NCT01815840|559908967|FG000|Overall Study|Missing|1|||
155130374|NCT01815840|559908968|FG001|Overall Study|Missing|0|||
155130375|NCT01815840|559908967|FG000|Overall Study|Withdrew Consent|31|||
155130376|NCT01815840|559908968|FG001|Overall Study|Withdrew Consent|30|||
155130377|NCT01815840|559908967|FG000|Overall Study|Administrative/Other|1|||
155130378|NCT01815840|559908968|FG001|Overall Study|Administrative/Other|3|||
155130379|NCT01815840|559908967|FG000|Overall Study|Adverse Event|10|||
155130380|NCT01815840|559908968|FG001|Overall Study|Adverse Event|16|||
155130381|NCT01815840|559908967|FG000|Overall Study|Death|2|||
155130382|NCT01815840|559908968|FG001|Overall Study|Death|2|||
155130383|NCT01815840|559908967|FG000|Overall Study|Disease progression|3|||
155130384|NCT01815840|559908968|FG001|Overall Study|Disease progression|2|||
155130385|NCT01815840|559908967|FG000|Overall Study|Investigators Decision|2|||
155130386|NCT01815840|559908968|FG001|Overall Study|Investigators Decision|3|||
155130387|NCT01815840|559908967|FG000|Overall Study|Lost to Follow-up|3|||
155130388|NCT01815840|559908968|FG001|Overall Study|Lost to Follow-up|6|||
155130389|NCT01815840|559908967|FG000|Overall Study|Refused Treatment|5|||
155130390|NCT01815840|559908968|FG001|Overall Study|Refused Treatment|1|||
155130391|NCT01815840|559908967|FG000|Overall Study|Sponsor Termination Treatment|1|||
155130392|NCT01815840|559908968|FG001|Overall Study|Sponsor Termination Treatment|0|||
155130393|NCT00704288|559908969|FG000|Overall Treatment Period|Adverse Event|11|||
155130394|NCT00704288|559908970|FG001|Overall Treatment Period|Adverse Event|8|||
155130395|NCT00704288|559908971|FG002|Overall Treatment Period|Adverse Event|22|||
155130396|NCT00704288|559908969|FG000|Overall Treatment Period|Death|0|||
155130397|NCT00704288|559908970|FG001|Overall Treatment Period|Death|0|||
155130398|NCT00704288|559908971|FG002|Overall Treatment Period|Death|1|||
155130399|NCT00704288|559908969|FG000|Overall Treatment Period|Physician Decision|0|||
155130400|NCT00704288|559908970|FG001|Overall Treatment Period|Physician Decision|2|||
155130401|NCT00704288|559908971|FG002|Overall Treatment Period|Physician Decision|0|||
155130402|NCT00704288|559908969|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
155130403|NCT00704288|559908970|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
155130404|NCT00704288|559908971|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
155130405|NCT00704288|559908969|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
155130406|NCT00704288|559908970|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
155130407|NCT00704288|559908971|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
155130408|NCT00704288|559908969|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
155130409|NCT00704288|559908970|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
155130410|NCT00704288|559908971|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
155130411|NCT00704288|559908969|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
155130412|NCT00704288|559908970|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
155130413|NCT00704288|559908971|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
155130414|NCT00704288|559908969|FG000|Overall Treatment Period|Roll-over to another study|1|||
155130415|NCT00704288|559908970|FG001|Overall Treatment Period|Roll-over to another study|0|||
155130416|NCT00704288|559908971|FG002|Overall Treatment Period|Roll-over to another study|4|||
155130417|NCT00704288|559908969|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
155130418|NCT00704288|559908970|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
155130419|NCT00704288|559908971|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
155130420|NCT00704288|559908969|FG000|Extended Post Treatment Follow Up Period|Death|41|||
155130421|NCT00704288|559908970|FG001|Extended Post Treatment Follow Up Period|Death|50|||
155130422|NCT00704288|559908971|FG002|Extended Post Treatment Follow Up Period|Death|93|||
155130423|NCT00704288|559908969|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
155130424|NCT00704288|559908970|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
155130425|NCT00704288|559908971|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
155130426|NCT00704288|559908969|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
155130427|NCT00704288|559908970|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
155130428|NCT00704288|559908971|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
155130429|NCT00704288|559908969|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
155130430|NCT00704288|559908970|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
155130431|NCT00704288|559908971|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
155008020|NCT06082843|559453441|FG001|Overall Study|Withdrawal by Subject|2|||
155008021|NCT06082843|559453440|FG000|Overall Study|Study terminated by sponsor|12|||
155008022|NCT06082843|559453441|FG001|Overall Study|Study terminated by sponsor|8|||
155008023|NCT04054765|559453443|FG000|Baseline|Withdrawal by Subject|5|||
155008024|NCT04054765|559453444|FG001|Baseline|Withdrawal by Subject|3|||
155008025|NCT04054765|559453443|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
155008026|NCT04054765|559453444|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
155008027|NCT04054765|559453443|FG000|3-month Follow up|Withdrawal by Subject|0|||
155008028|NCT04054765|559453444|FG001|3-month Follow up|Withdrawal by Subject|3|||
155008029|NCT04054765|559453443|FG000|6-month Follow up|Lost to Follow-up|32|||
155008030|NCT04054765|559453444|FG001|6-month Follow up|Lost to Follow-up|32|||
155008031|NCT01290068|559453448|FG000|Overall Study|Adverse Event|1|||
155008032|NCT01290068|559453449|FG001|Overall Study|Adverse Event|3|||
155130432|NCT01055314|559908972|FG000|Overall Study|Adverse Event|7|||
155130433|NCT01055314|559908973|FG001|Overall Study|Adverse Event|4|||
155008033|NCT01290068|559453448|FG000|Overall Study|Lost to Follow-up|3|||
155008034|NCT01290068|559453449|FG001|Overall Study|Lost to Follow-up|0|||
155008035|NCT01290068|559453448|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
155008036|NCT01290068|559453449|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
155008037|NCT01290068|559453448|FG000|Overall Study|Other|3|||
155008038|NCT01290068|559453449|FG001|Overall Study|Other|1|||
155008039|NCT02719184|559453452|FG000|Overall Study|Other than listed|1|||
155008040|NCT02719184|559453453|FG001|Overall Study|Other than listed|12|||
155008041|NCT02719184|559453454|FG002|Overall Study|Other than listed|13|||
155008042|NCT02719184|559453455|FG003|Overall Study|Other than listed|22|||
155008043|NCT02719184|559453456|FG004|Overall Study|Other than listed|9|||
155008044|NCT02719184|559453452|FG000|Overall Study|Withdrawal by Subject|5|||
155008045|NCT02719184|559453453|FG001|Overall Study|Withdrawal by Subject|3|||
155008046|NCT02719184|559453454|FG002|Overall Study|Withdrawal by Subject|6|||
155008047|NCT02719184|559453455|FG003|Overall Study|Withdrawal by Subject|6|||
155008048|NCT02719184|559453456|FG004|Overall Study|Withdrawal by Subject|0|||
155008049|NCT02719184|559453452|FG000|Overall Study|Lost to Follow-up|0|||
155008050|NCT02719184|559453453|FG001|Overall Study|Lost to Follow-up|4|||
155008051|NCT02719184|559453454|FG002|Overall Study|Lost to Follow-up|1|||
155008052|NCT02719184|559453455|FG003|Overall Study|Lost to Follow-up|3|||
155008053|NCT02719184|559453456|FG004|Overall Study|Lost to Follow-up|0|||
155008054|NCT02719184|559453452|FG000|Overall Study|Protocol Violation|0|||
155008055|NCT02719184|559453453|FG001|Overall Study|Protocol Violation|3|||
155008056|NCT02719184|559453454|FG002|Overall Study|Protocol Violation|0|||
155008057|NCT02719184|559453455|FG003|Overall Study|Protocol Violation|2|||
155008058|NCT02719184|559453456|FG004|Overall Study|Protocol Violation|0|||
155008059|NCT02719184|559453452|FG000|Overall Study|Adverse Event|0|||
155008060|NCT02719184|559453453|FG001|Overall Study|Adverse Event|0|||
155008061|NCT02719184|559453454|FG002|Overall Study|Adverse Event|0|||
155008062|NCT02719184|559453455|FG003|Overall Study|Adverse Event|3|||
155008063|NCT02719184|559453456|FG004|Overall Study|Adverse Event|0|||
155008064|NCT00793871|559453457|FG000|Overall Study|Death|50|||
155008065|NCT00793871|559453457|FG000|Overall Study|Lost to Follow-up|3|||
155008066|NCT00793871|559453457|FG000|Overall Study|Study terminated by the Sponsor|7|||
155008067|NCT01928472|559453458|FG000|Overall Study|Death|0|||
155008068|NCT01928472|559453459|FG001|Overall Study|Death|0|||
155008069|NCT01928472|559453460|FG002|Overall Study|Death|1|||
155008070|NCT01928472|559453461|FG003|Overall Study|Death|0|||
155008071|NCT01928472|559453458|FG000|Overall Study|Withdrawal by Subject|4|||
155008072|NCT01928472|559453459|FG001|Overall Study|Withdrawal by Subject|4|||
155008073|NCT01928472|559453460|FG002|Overall Study|Withdrawal by Subject|1|||
155008074|NCT01928472|559453461|FG003|Overall Study|Withdrawal by Subject|2|||
155008075|NCT01928472|559453458|FG000|Overall Study|Lost to Follow-up|2|||
155008076|NCT01928472|559453459|FG001|Overall Study|Lost to Follow-up|3|||
155008077|NCT01928472|559453460|FG002|Overall Study|Lost to Follow-up|4|||
155008078|NCT01928472|559453461|FG003|Overall Study|Lost to Follow-up|0|||
155008079|NCT01928472|559453458|FG000|Overall Study|Administrative Reason|2|||
155008080|NCT01928472|559453459|FG001|Overall Study|Administrative Reason|1|||
155008081|NCT01928472|559453460|FG002|Overall Study|Administrative Reason|0|||
155008082|NCT01928472|559453461|FG003|Overall Study|Administrative Reason|0|||
155008083|NCT01928472|559453458|FG000|Overall Study|Unclassified|0|||
155008084|NCT01928472|559453459|FG001|Overall Study|Unclassified|0|||
155008085|NCT01928472|559453460|FG002|Overall Study|Unclassified|1|||
155008086|NCT01928472|559453461|FG003|Overall Study|Unclassified|0|||
155008087|NCT00307086|559453464|FG000|Overall Study|ineligible|5|||
155008088|NCT00065156|559453467|FG000|Overall Study|Adverse Event|37|||
155008089|NCT00065156|559453467|FG000|Overall Study|Lack of Efficacy|52|||
155008090|NCT00065156|559453467|FG000|Overall Study|Withdrawal by Subject|8|||
155008091|NCT00065156|559453467|FG000|Overall Study|Lost to Follow-up|1|||
155008092|NCT00065156|559453467|FG000|Overall Study|Death|11|||
155008093|NCT00065156|559453467|FG000|Overall Study|Study Closed by Sponsor|2|||
155130434|NCT01055314|559908972|FG000|Overall Study|Death|2|||
155130435|NCT01055314|559908973|FG001|Overall Study|Death|1|||
155130436|NCT01055314|559908972|FG000|Overall Study|Lack of Efficacy|11|||
155008094|NCT00065156|559453467|FG000|Overall Study|Disease Progression|7|||
155008095|NCT00065156|559453467|FG000|Overall Study|Investigator Decision|2|||
155008096|NCT00065156|559453467|FG000|Overall Study|Non-Compliance|2|||
155130437|NCT01055314|559908973|FG001|Overall Study|Lack of Efficacy|19|||
155130438|NCT01055314|559908972|FG000|Overall Study|Physician Decision|10|||
155008097|NCT00065156|559453467|FG000|Overall Study|Loss of Response|1|||
155008098|NCT00065156|559453467|FG000|Overall Study|Secondary Malign Disease|1|||
155008099|NCT01176513|559453468|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
155008100|NCT04583735|559453469|FG000|Double-masked Treatment Period|Adverse Event|0|||
155008101|NCT04583735|559453470|FG001|Double-masked Treatment Period|Adverse Event|1|||
155130439|NCT01055314|559908973|FG001|Overall Study|Physician Decision|5|||
155008102|NCT04583735|559453469|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
155008103|NCT04583735|559453470|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
155008104|NCT04583735|559453469|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
155008105|NCT04583735|559453470|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
155008106|NCT04583735|559453469|FG000|Open-label Treatment Period|Adverse Event|1|||
155008107|NCT04583735|559453470|FG001|Open-label Treatment Period|Adverse Event|1|||
155008108|NCT04583735|559453469|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
155008109|NCT04583735|559453470|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155008110|NCT04583735|559453469|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155008111|NCT04583735|559453470|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
155008112|NCT01197911|559453471|FG000|Overall Study|Adverse Event|0|||
155008113|NCT01197911|559453472|FG001|Overall Study|Adverse Event|0|||
155008114|NCT01197911|559453473|FG002|Overall Study|Adverse Event|1|||
155008115|NCT00838526|559453476|FG000|Overall Study|Adverse Event|3|||
155008116|NCT00838526|559453477|FG001|Overall Study|Adverse Event|12|||
155008117|NCT00838526|559453476|FG000|Overall Study|Lost to Follow-up|4|||
155008118|NCT00838526|559453477|FG001|Overall Study|Lost to Follow-up|12|||
155008119|NCT00838526|559453476|FG000|Overall Study|Withdrawal by Subject|4|||
155008120|NCT00838526|559453477|FG001|Overall Study|Withdrawal by Subject|5|||
155008121|NCT00838526|559453476|FG000|Overall Study|Lack of Efficacy|2|||
155008122|NCT00838526|559453477|FG001|Overall Study|Lack of Efficacy|3|||
155008123|NCT00838526|559453476|FG000|Overall Study|Other|11|||
155008124|NCT00838526|559453477|FG001|Overall Study|Other|7|||
155008125|NCT02273388|559453483|FG000|Overall Study|Adverse Event|0|||
155008126|NCT02273388|559453484|FG001|Overall Study|Adverse Event|0|||
155008127|NCT02273388|559453485|FG002|Overall Study|Adverse Event|0|||
155008128|NCT02273388|559453486|FG003|Overall Study|Adverse Event|0|||
155008129|NCT02273388|559453487|FG004|Overall Study|Adverse Event|0|||
155008130|NCT02273388|559453488|FG005|Overall Study|Adverse Event|0|||
155008131|NCT02273388|559453489|FG006|Overall Study|Adverse Event|1|||
155008132|NCT02273388|559453490|FG007|Overall Study|Adverse Event|2|||
155008133|NCT02273388|559453491|FG008|Overall Study|Adverse Event|0|||
155008134|NCT02273388|559453492|FG009|Overall Study|Adverse Event|0|||
155008135|NCT02273388|559453493|FG010|Overall Study|Adverse Event|0|||
155008136|NCT02273388|559453494|FG011|Overall Study|Adverse Event|0|||
155008137|NCT02273388|559453483|FG000|Overall Study|Adverse Event study disease worse|4|||
155008138|NCT02273388|559453484|FG001|Overall Study|Adverse Event study disease worse|3|||
155008139|NCT02273388|559453485|FG002|Overall Study|Adverse Event study disease worse|3|||
155008140|NCT02273388|559453486|FG003|Overall Study|Adverse Event study disease worse|2|||
155008141|NCT02273388|559453487|FG004|Overall Study|Adverse Event study disease worse|4|||
155008142|NCT02273388|559453488|FG005|Overall Study|Adverse Event study disease worse|3|||
155008143|NCT02273388|559453489|FG006|Overall Study|Adverse Event study disease worse|14|||
155008144|NCT02273388|559453490|FG007|Overall Study|Adverse Event study disease worse|6|||
155008145|NCT02273388|559453491|FG008|Overall Study|Adverse Event study disease worse|6|||
155008146|NCT02273388|559453492|FG009|Overall Study|Adverse Event study disease worse|5|||
155008147|NCT02273388|559453493|FG010|Overall Study|Adverse Event study disease worse|10|||
155008148|NCT02273388|559453494|FG011|Overall Study|Adverse Event study disease worse|1|||
155008149|NCT02273388|559453483|FG000|Overall Study|Sponsor decision|0|||
155008150|NCT02273388|559453484|FG001|Overall Study|Sponsor decision|0|||
155008151|NCT02273388|559453485|FG002|Overall Study|Sponsor decision|0|||
155008152|NCT02273388|559453486|FG003|Overall Study|Sponsor decision|0|||
155008153|NCT02273388|559453487|FG004|Overall Study|Sponsor decision|0|||
155008154|NCT02273388|559453488|FG005|Overall Study|Sponsor decision|0|||
155008155|NCT02273388|559453489|FG006|Overall Study|Sponsor decision|0|||
155008156|NCT02273388|559453490|FG007|Overall Study|Sponsor decision|0|||
155008157|NCT02273388|559453491|FG008|Overall Study|Sponsor decision|0|||
155008158|NCT02273388|559453492|FG009|Overall Study|Sponsor decision|0|||
155008159|NCT02273388|559453493|FG010|Overall Study|Sponsor decision|0|||
155008160|NCT02273388|559453494|FG011|Overall Study|Sponsor decision|1|||
155008161|NCT04331808|559453495|FG000|Overall Study|Withdrew consent|1|||
155008162|NCT04331808|559453496|FG001|Overall Study|Withdrew consent|0|||
155008163|NCT04331808|559453497|FG002|Overall Study|Withdrew consent|2|||
155008164|NCT04331808|559453498|FG003|Overall Study|Withdrew consent|3|||
155008165|NCT00952731|559453499|FG000|Overall Study|Drug supply expired|1|||
155008166|NCT00952731|559453500|FG001|Overall Study|Drug supply expired|0|||
155008167|NCT01329900|559453501|FG000|Overall Study|Elevated creatinine/renal function|1|||
155008168|NCT01855828|559453502|FG000|Overall Study|Adverse Event|1|||
155008169|NCT01855828|559453502|FG000|Overall Study|Withdrawal by Subject|1|||
155008170|NCT01866098|559453507|FG000|Overall Study|Lost to Follow-up|11|||
155008171|NCT01866098|559453508|FG001|Overall Study|Lost to Follow-up|18|||
155008172|NCT01866098|559453509|FG002|Overall Study|Lost to Follow-up|13|||
155008173|NCT01866098|559453507|FG000|Overall Study|Physician Decision|0|||
155008174|NCT01866098|559453508|FG001|Overall Study|Physician Decision|1|||
155008175|NCT01866098|559453509|FG002|Overall Study|Physician Decision|2|||
155008176|NCT01866098|559453507|FG000|Overall Study|Adverse Event|1|||
155008177|NCT01866098|559453508|FG001|Overall Study|Adverse Event|5|||
155008178|NCT01866098|559453509|FG002|Overall Study|Adverse Event|4|||
155008179|NCT01866098|559453507|FG000|Overall Study|Protocol Violation|1|||
155008180|NCT01866098|559453508|FG001|Overall Study|Protocol Violation|0|||
155008181|NCT01866098|559453509|FG002|Overall Study|Protocol Violation|0|||
155008182|NCT01866098|559453507|FG000|Overall Study|Withdrawal by Subject|1|||
155130440|NCT01055314|559908972|FG000|Overall Study|Withdrawal by Subject|1|||
155130441|NCT01055314|559908973|FG001|Overall Study|Withdrawal by Subject|0|||
155130442|NCT01055314|559908972|FG000|Overall Study|Ineligible|3|||
155130443|NCT01055314|559908973|FG001|Overall Study|Ineligible|5|||
155130444|NCT01055314|559908972|FG000|Overall Study|Refusal of further protocol therapy|10|||
155130445|NCT01055314|559908973|FG001|Overall Study|Refusal of further protocol therapy|4|||
155130446|NCT01055314|559908972|FG000|Overall Study|No treatment|1|||
155130447|NCT01055314|559908973|FG001|Overall Study|No treatment|0|||
155130448|NCT02241343|559908974|FG000|Overall Study|Adverse Event|1|||
155130449|NCT04680975|559908975|FG000|Overall Study|Adverse Event|3|||
155130450|NCT04680975|559908975|FG000|Overall Study|Death|1|||
155130451|NCT04680975|559908975|FG000|Overall Study|Progressive Disease|1|||
155130452|NCT04680975|559908975|FG000|Overall Study|Withdrawal by Subject|1|||
155130453|NCT03927144|559908976|FG000|Core Phase|Adverse Event|9|||
155130454|NCT03927144|559908977|FG001|Core Phase|Adverse Event|5|||
155130455|NCT03927144|559908976|FG000|Core Phase|Lost to Follow-up|3|||
155130456|NCT03927144|559908977|FG001|Core Phase|Lost to Follow-up|2|||
155130457|NCT03927144|559908976|FG000|Core Phase|New Therapy for Study Indication|0|||
155130458|NCT03927144|559908977|FG001|Core Phase|New Therapy for Study Indication|1|||
155130459|NCT03927144|559908976|FG000|Core Phase|No Longer Clinically Benefiting|4|||
155130460|NCT03927144|559908977|FG001|Core Phase|No Longer Clinically Benefiting|4|||
155130461|NCT03927144|559908976|FG000|Core Phase|Physician Decision|2|||
155130462|NCT03927144|559908977|FG001|Core Phase|Physician Decision|8|||
155130463|NCT03927144|559908976|FG000|Core Phase|Protocol Violation|2|||
155130464|NCT03927144|559908977|FG001|Core Phase|Protocol Violation|2|||
155130465|NCT03927144|559908976|FG000|Core Phase|Withdrawal by Subject|16|||
155130466|NCT03927144|559908977|FG001|Core Phase|Withdrawal by Subject|40|||
155130467|NCT03927144|559908976|FG000|Extension Phase|Adverse Event|2|||
155130468|NCT03927144|559908977|FG001|Extension Phase|Adverse Event|1|||
155130469|NCT03927144|559908976|FG000|Extension Phase|No longer clinically benefiting|4|||
155130470|NCT03927144|559908977|FG001|Extension Phase|No longer clinically benefiting|5|||
155130471|NCT03927144|559908976|FG000|Extension Phase|Pregnancy|1|||
155130472|NCT03927144|559908977|FG001|Extension Phase|Pregnancy|0|||
155130473|NCT03927144|559908976|FG000|Extension Phase|Protocol Violation|0|||
155130474|NCT03927144|559908977|FG001|Extension Phase|Protocol Violation|1|||
155130475|NCT03927144|559908976|FG000|Extension Phase|Withdrawal by Subject|8|||
155130476|NCT03927144|559908977|FG001|Extension Phase|Withdrawal by Subject|3|||
155130477|NCT03909152|559908978|FG000|Overall Study|Adverse Event|14|||
155130478|NCT03909152|559908979|FG001|Overall Study|Adverse Event|5|||
155130479|NCT03909152|559908980|FG002|Overall Study|Adverse Event|1|||
155130480|NCT03909152|559908981|FG003|Overall Study|Adverse Event|14|||
155130481|NCT02702414|559908986|FG000|Overall Study|Death|96|||
155130482|NCT02702414|559908987|FG001|Overall Study|Death|42|||
155130483|NCT02702414|559908986|FG000|Overall Study|Lost to Follow-up|0|||
155130484|NCT02702414|559908987|FG001|Overall Study|Lost to Follow-up|1|||
155130485|NCT02702414|559908986|FG000|Overall Study|Withdrawal by Subject|0|||
155130486|NCT02702414|559908987|FG001|Overall Study|Withdrawal by Subject|1|||
155130487|NCT02702414|559908986|FG000|Overall Study|Protocol Violation|1|||
155130488|NCT02702414|559908987|FG001|Overall Study|Protocol Violation|0|||
155130489|NCT02702414|559908986|FG000|Overall Study|Sponsor Decision|8|||
155130490|NCT02702414|559908987|FG001|Overall Study|Sponsor Decision|7|||
155130491|NCT04099511|559908989|FG000|Overall Study|Lost to Follow-up|2|||
155130492|NCT04099511|559908990|FG001|Overall Study|Lost to Follow-up|2|||
155130493|NCT04099511|559908989|FG000|Overall Study|Withdrawal by Subject|8|||
155130494|NCT04099511|559908990|FG001|Overall Study|Withdrawal by Subject|4|||
155008183|NCT01866098|559453508|FG001|Overall Study|Withdrawal by Subject|2|||
155130495|NCT04369950|559908991|FG000|Overall Study|Protocol Violation|2|||
155130496|NCT04369950|559908992|FG001|Overall Study|Protocol Violation|2|||
155130497|NCT02473367|559908993|FG000|Wait 1|Withdrawal by Subject|1|||
155130498|NCT02473367|559908993|FG000|Period 4|Lost to Follow-up|1|||
155130499|NCT04816721|559908994|FG000|Overall Study|Withdrawal by Subject|0|||
155130500|NCT04816721|559908995|FG001|Overall Study|Withdrawal by Subject|2|||
155130501|NCT04816721|559908996|FG002|Overall Study|Withdrawal by Subject|0|||
155130502|NCT04816721|559908997|FG003|Overall Study|Withdrawal by Subject|1|||
155130503|NCT04816721|559908998|FG004|Overall Study|Withdrawal by Subject|1|||
155130504|NCT04816721|559908999|FG005|Overall Study|Withdrawal by Subject|0|||
155130505|NCT04816721|559909000|FG006|Overall Study|Withdrawal by Subject|0|||
155130506|NCT04816721|559909001|FG007|Overall Study|Withdrawal by Subject|0|||
155130507|NCT04816721|559908994|FG000|Overall Study|Miscellaneous|0|||
155130508|NCT04816721|559908995|FG001|Overall Study|Miscellaneous|0|||
155130509|NCT04816721|559908996|FG002|Overall Study|Miscellaneous|0|||
155130510|NCT04816721|559908997|FG003|Overall Study|Miscellaneous|0|||
155008184|NCT01866098|559453509|FG002|Overall Study|Withdrawal by Subject|0|||
155130511|NCT04816721|559908998|FG004|Overall Study|Miscellaneous|0|||
155130512|NCT04816721|559908999|FG005|Overall Study|Miscellaneous|1|||
155130513|NCT04816721|559909000|FG006|Overall Study|Miscellaneous|0|||
155130514|NCT04816721|559909001|FG007|Overall Study|Miscellaneous|0|||
155130515|NCT04816721|559908994|FG000|Overall Study|Lost to Follow-up|0|||
155130516|NCT04816721|559908995|FG001|Overall Study|Lost to Follow-up|0|||
155130517|NCT04816721|559908996|FG002|Overall Study|Lost to Follow-up|0|||
155130518|NCT04816721|559908997|FG003|Overall Study|Lost to Follow-up|1|||
155130519|NCT04816721|559908998|FG004|Overall Study|Lost to Follow-up|0|||
155130520|NCT04816721|559908999|FG005|Overall Study|Lost to Follow-up|0|||
155130521|NCT04816721|559909000|FG006|Overall Study|Lost to Follow-up|0|||
155130522|NCT04816721|559909001|FG007|Overall Study|Lost to Follow-up|0|||
155130523|NCT01286740|559909006|FG000|Overall Study|Enrolled but not treated|1|||
155130524|NCT01286740|559909006|FG000|Overall Study|Protocol Violation|1|||
155130525|NCT04676867|559909007|FG000|Overall Study|Screen failure|0|||
155130526|NCT04676867|559909008|FG001|Overall Study|Screen failure|0|||
155130527|NCT04676867|559909009|FG002|Overall Study|Screen failure|6|||
155130528|NCT04676867|559909010|FG003|Overall Study|Screen failure|2|||
155130529|NCT04676867|559909007|FG000|Overall Study|Death|0|||
155130530|NCT04676867|559909008|FG001|Overall Study|Death|0|||
155130531|NCT04676867|559909009|FG002|Overall Study|Death|1|||
155130532|NCT04676867|559909010|FG003|Overall Study|Death|0|||
155130533|NCT04676867|559909007|FG000|Overall Study|Withdrawal by Subject|2|||
155130534|NCT04676867|559909008|FG001|Overall Study|Withdrawal by Subject|2|||
155130535|NCT04676867|559909009|FG002|Overall Study|Withdrawal by Subject|4|||
155130536|NCT04676867|559909010|FG003|Overall Study|Withdrawal by Subject|4|||
155130537|NCT04676867|559909007|FG000|Overall Study|Lost to Follow-up|1|||
155130538|NCT04676867|559909008|FG001|Overall Study|Lost to Follow-up|0|||
155130539|NCT04676867|559909009|FG002|Overall Study|Lost to Follow-up|0|||
155130540|NCT04676867|559909010|FG003|Overall Study|Lost to Follow-up|0|||
155130541|NCT01554514|559909015|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
155130542|NCT01554514|559909015|FG000|Overall Study|Physician Decision|1|||
155130543|NCT00549770|559909018|FG000|Overall Study|Protocol deviation|1|||
155130544|NCT00549770|559909019|FG001|Overall Study|Protocol deviation|1|||
155130545|NCT00549770|559909020|FG002|Overall Study|Protocol deviation|1|||
155130546|NCT00549770|559909021|FG003|Overall Study|Protocol deviation|2|||
155130547|NCT00549770|559909022|FG004|Overall Study|Protocol deviation|2|||
155130548|NCT00549770|559909023|FG005|Overall Study|Protocol deviation|2|||
155130549|NCT00549770|559909024|FG006|Overall Study|Protocol deviation|1|||
155130550|NCT00549770|559909025|FG007|Overall Study|Protocol deviation|2|||
155130551|NCT00549770|559909018|FG000|Overall Study|Administrative problems|0|||
155130552|NCT00549770|559909019|FG001|Overall Study|Administrative problems|1|||
155130553|NCT00549770|559909020|FG002|Overall Study|Administrative problems|0|||
155130554|NCT00549770|559909021|FG003|Overall Study|Administrative problems|0|||
155130555|NCT00549770|559909022|FG004|Overall Study|Administrative problems|0|||
155008185|NCT01866098|559453507|FG000|Overall Study|Unrelated Hospitalization|2|||
155008186|NCT01866098|559453508|FG001|Overall Study|Unrelated Hospitalization|0|||
155008187|NCT01866098|559453509|FG002|Overall Study|Unrelated Hospitalization|1|||
155008188|NCT01866098|559453507|FG000|Overall Study|Non-compliance|1|||
155008189|NCT01866098|559453508|FG001|Overall Study|Non-compliance|0|||
155008190|NCT01866098|559453509|FG002|Overall Study|Non-compliance|1|||
155008191|NCT01866098|559453507|FG000|Overall Study|Pregnancy|2|||
155008192|NCT01866098|559453508|FG001|Overall Study|Pregnancy|0|||
155008193|NCT01866098|559453509|FG002|Overall Study|Pregnancy|0|||
155008194|NCT01866098|559453507|FG000|Overall Study|Death|0|||
155008195|NCT01866098|559453508|FG001|Overall Study|Death|1|||
155008196|NCT01866098|559453509|FG002|Overall Study|Death|0|||
155008197|NCT04239027|559453513|FG000|Overall Study|Adverse Event|4|||
155008198|NCT04239027|559453513|FG000|Overall Study|Withdrawal by Subject|9|||
155008199|NCT04239027|559453513|FG000|Overall Study|Death|1|||
155008200|NCT04239027|559453513|FG000|Overall Study|Physician Decision|9|||
155008201|NCT04239027|559453513|FG000|Overall Study|Lost to Follow-up|2|||
155008202|NCT04239027|559453513|FG000|Overall Study|Lack of Efficacy|1|||
155008203|NCT01184079|559453520|FG000|Overall Study|Lost to Follow-up|14|||
155008204|NCT01184079|559453521|FG001|Overall Study|Lost to Follow-up|2|||
155008205|NCT03172494|559453522|FG000|Overall Study|Adverse Event|5|||
155008206|NCT03172494|559453523|FG001|Overall Study|Adverse Event|1|||
155008207|NCT03172494|559453524|FG002|Overall Study|Adverse Event|15|||
155008208|NCT03172494|559453522|FG000|Overall Study|Protocol Violation|3|||
155008209|NCT03172494|559453523|FG001|Overall Study|Protocol Violation|2|||
155008210|NCT03172494|559453524|FG002|Overall Study|Protocol Violation|1|||
155008211|NCT03172494|559453522|FG000|Overall Study|Lack of Efficacy|0|||
155008212|NCT03172494|559453523|FG001|Overall Study|Lack of Efficacy|0|||
155008213|NCT03172494|559453524|FG002|Overall Study|Lack of Efficacy|4|||
155008214|NCT03172494|559453522|FG000|Overall Study|Pregnancy|0|||
155008215|NCT03172494|559453523|FG001|Overall Study|Pregnancy|1|||
155008216|NCT03172494|559453524|FG002|Overall Study|Pregnancy|0|||
155008217|NCT03172494|559453522|FG000|Overall Study|Withdrawal by Subject|10|||
155130556|NCT00549770|559909023|FG005|Overall Study|Administrative problems|0|||
155130557|NCT00549770|559909024|FG006|Overall Study|Administrative problems|0|||
155130558|NCT00549770|559909025|FG007|Overall Study|Administrative problems|1|||
155130559|NCT00549770|559909018|FG000|Overall Study|Lost to Follow-up|0|||
155130560|NCT00549770|559909019|FG001|Overall Study|Lost to Follow-up|0|||
155130561|NCT00549770|559909020|FG002|Overall Study|Lost to Follow-up|2|||
155130562|NCT00549770|559909021|FG003|Overall Study|Lost to Follow-up|2|||
155130563|NCT00549770|559909022|FG004|Overall Study|Lost to Follow-up|3|||
155130564|NCT00549770|559909023|FG005|Overall Study|Lost to Follow-up|2|||
155130565|NCT00549770|559909024|FG006|Overall Study|Lost to Follow-up|0|||
155008218|NCT03172494|559453523|FG001|Overall Study|Withdrawal by Subject|8|||
155008219|NCT03172494|559453524|FG002|Overall Study|Withdrawal by Subject|8|||
155008220|NCT03172494|559453522|FG000|Overall Study|Severe hypoglycaemic episode|0|||
155008221|NCT03172494|559453523|FG001|Overall Study|Severe hypoglycaemic episode|0|||
155008222|NCT03172494|559453524|FG002|Overall Study|Severe hypoglycaemic episode|1|||
155008223|NCT03172494|559453522|FG000|Overall Study|Non-compliance towards treatment|2|||
155008224|NCT03172494|559453523|FG001|Overall Study|Non-compliance towards treatment|0|||
155008225|NCT03172494|559453524|FG002|Overall Study|Non-compliance towards treatment|0|||
155008226|NCT04233073|559453525|FG000|Overall Study|Death|5|||
155008227|NCT00143390|559453526|FG000|Overall Study|Death|2|||
155008228|NCT00143390|559453527|FG001|Overall Study|Death|0|||
155008229|NCT00143390|559453526|FG000|Overall Study|Not meeting entry criteria|2|||
155008230|NCT00143390|559453527|FG001|Overall Study|Not meeting entry criteria|5|||
155008231|NCT00143390|559453526|FG000|Overall Study|Withdrawal by Subject|4|||
155008232|NCT00143390|559453527|FG001|Overall Study|Withdrawal by Subject|4|||
155178455|NCT01829243|560091494|FG001|First Intervention|Screen Failure|2|||
155178456|NCT00608569|560091497|FG000|Overall Study|Death|4|||
155008233|NCT00143390|559453526|FG000|Overall Study|Progressive disease|119|||
155008234|NCT00143390|559453527|FG001|Overall Study|Progressive disease|115|||
155008235|NCT00143390|559453526|FG000|Overall Study|Protocol Violation|2|||
155008236|NCT00143390|559453527|FG001|Overall Study|Protocol Violation|0|||
155008237|NCT00143390|559453526|FG000|Overall Study|Study termination|10|||
155008238|NCT00143390|559453527|FG001|Overall Study|Study termination|15|||
155008239|NCT00143390|559453526|FG000|Overall Study|Adverse Event|9|||
155008240|NCT00143390|559453527|FG001|Overall Study|Adverse Event|8|||
155008241|NCT00143390|559453526|FG000|Overall Study|Other|1|||
155008242|NCT00143390|559453527|FG001|Overall Study|Other|2|||
155008243|NCT00243412|559453529|FG000|Overall Study|Death|0|||
155008244|NCT00243412|559453530|FG001|Overall Study|Death|1|||
155008245|NCT00243412|559453529|FG000|Overall Study|Adverse Event|4|||
155008246|NCT00243412|559453530|FG001|Overall Study|Adverse Event|2|||
155008247|NCT00243412|559453529|FG000|Overall Study|Lost to Follow-up|0|||
155008248|NCT00243412|559453530|FG001|Overall Study|Lost to Follow-up|1|||
155008249|NCT00243412|559453529|FG000|Overall Study|Physician Decision|1|||
155008250|NCT00243412|559453530|FG001|Overall Study|Physician Decision|1|||
155008251|NCT00243412|559453529|FG000|Overall Study|Withdrawal by Subject|4|||
155008252|NCT00243412|559453530|FG001|Overall Study|Withdrawal by Subject|5|||
155008253|NCT00243412|559453529|FG000|Overall Study|Other|1|||
155008254|NCT00243412|559453530|FG001|Overall Study|Other|1|||
155008255|NCT00041132|559453531|FG000|Overall Study|Adverse Event|19|||
155008256|NCT00041132|559453531|FG000|Overall Study|Death|1|||
155008257|NCT00041132|559453531|FG000|Overall Study|Not Eligible|7|||
155008258|NCT00041132|559453531|FG000|Overall Study|Withdrawal by Subject|1|||
155008259|NCT00041132|559453531|FG000|Overall Study|Physician Decision|2|||
155008260|NCT02764151|559453532|FG000|Overall Study|Subject refused further follow-up|0|||
155008261|NCT02764151|559453533|FG001|Overall Study|Subject refused further follow-up|0|||
155008262|NCT02764151|559453534|FG002|Overall Study|Subject refused further follow-up|0|||
155008263|NCT02764151|559453535|FG003|Overall Study|Subject refused further follow-up|1|||
155008264|NCT02764151|559453532|FG000|Overall Study|Other|0|||
155008265|NCT02764151|559453533|FG001|Overall Study|Other|0|||
155008266|NCT02764151|559453534|FG002|Overall Study|Other|0|||
155008267|NCT02764151|559453535|FG003|Overall Study|Other|2|||
155008268|NCT01450683|559453539|FG000|Overall Study|Adverse Event|2|||
155008269|NCT02108912|559453542|FG000|Overall Study|Lost to Follow-up|1|||
155008270|NCT02108912|559453543|FG001|Overall Study|Lost to Follow-up|1|||
155008271|NCT02108912|559453542|FG000|Overall Study|lack of transportation|1|||
155008272|NCT02108912|559453543|FG001|Overall Study|lack of transportation|0|||
155008273|NCT02108912|559453542|FG000|Overall Study|high blood pressure|1|||
155008274|NCT02108912|559453543|FG001|Overall Study|high blood pressure|0|||
155008275|NCT01523002|559453546|FG000|Period 1|Withdrawal by Subject|1|||
155008276|NCT01523002|559453547|FG001|Period 1|Withdrawal by Subject|3|||
155008277|NCT01523002|559453546|FG000|Period 1|Lost to Follow-up|1|||
155008278|NCT01523002|559453547|FG001|Period 1|Lost to Follow-up|0|||
155008279|NCT01523002|559453546|FG000|Period 1|Adverse Event|0|||
155008280|NCT01523002|559453547|FG001|Period 1|Adverse Event|8|||
155008281|NCT01523002|559453546|FG000|Period 2|Withdrawal by Subject|4|||
155008282|NCT01523002|559453547|FG001|Period 2|Withdrawal by Subject|1|||
155008283|NCT01523002|559453546|FG000|Period 2|Adverse Event|2|||
155008284|NCT01523002|559453547|FG001|Period 2|Adverse Event|5|||
155008285|NCT01523002|559453546|FG000|Period 3|Withdrawal by Subject|1|||
155008286|NCT01523002|559453547|FG001|Period 3|Withdrawal by Subject|0|||
155008287|NCT01523002|559453546|FG000|Period 3|Adverse Event|3|||
155008288|NCT01523002|559453547|FG001|Period 3|Adverse Event|0|||
155008289|NCT01256502|559453548|FG000|Overall Study|Had scaffold removed|4|||
155008290|NCT01256502|559453548|FG000|Overall Study|Personal reasons|5|||
155008291|NCT01256502|559453548|FG000|Overall Study|Protocol deviation|1|||
155008292|NCT00489255|559453549|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
155008293|NCT00489255|559453550|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
155008294|NCT00489255|559453549|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
155008295|NCT00489255|559453550|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
155008296|NCT00489255|559453549|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
155008297|NCT00489255|559453550|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
155008298|NCT00489255|559453549|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
155008299|NCT00489255|559453550|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
155008300|NCT00489255|559453549|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
155008301|NCT00489255|559453550|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
155008302|NCT00489255|559453549|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
155008303|NCT00489255|559453550|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
155008304|NCT00489255|559453549|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
155008305|NCT00489255|559453550|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
155008306|NCT00489255|559453549|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
155008307|NCT00489255|559453550|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
155008308|NCT00489255|559453549|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
155008309|NCT00489255|559453550|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
155008310|NCT00489255|559453549|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
155008311|NCT00489255|559453550|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
155008312|NCT03485352|559453551|FG000|Overall Study|Lost to Follow-up|9|||
155008313|NCT00852202|559453562|FG000|Overall Study|Adverse Event|2|||
155008314|NCT00852202|559453563|FG001|Overall Study|Adverse Event|3|||
155008315|NCT00852202|559453564|FG002|Overall Study|Adverse Event|7|||
155008316|NCT00852202|559453562|FG000|Overall Study|Lack of Efficacy|4|||
155008317|NCT00852202|559453563|FG001|Overall Study|Lack of Efficacy|1|||
155008318|NCT00852202|559453564|FG002|Overall Study|Lack of Efficacy|2|||
155008319|NCT00852202|559453562|FG000|Overall Study|Protocol Violation|2|||
155008320|NCT00852202|559453563|FG001|Overall Study|Protocol Violation|2|||
155008321|NCT00852202|559453564|FG002|Overall Study|Protocol Violation|7|||
155008322|NCT00852202|559453562|FG000|Overall Study|Withdrawal by Subject|3|||
155008323|NCT00852202|559453563|FG001|Overall Study|Withdrawal by Subject|1|||
155008324|NCT00852202|559453564|FG002|Overall Study|Withdrawal by Subject|2|||
155008325|NCT00852202|559453562|FG000|Overall Study|Lost to Follow-up|5|||
155008326|NCT00852202|559453563|FG001|Overall Study|Lost to Follow-up|5|||
155008327|NCT00852202|559453564|FG002|Overall Study|Lost to Follow-up|6|||
155008328|NCT00852202|559453562|FG000|Overall Study|pregnancy,moving away and surgery|1|||
155008329|NCT00852202|559453563|FG001|Overall Study|pregnancy,moving away and surgery|0|||
155008330|NCT00852202|559453564|FG002|Overall Study|pregnancy,moving away and surgery|2|||
155008331|NCT00141778|559453569|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
155008332|NCT00141778|559453570|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
155008333|NCT00141778|559453571|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
155008334|NCT00141778|559453569|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
155008335|NCT00141778|559453570|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
155008336|NCT00141778|559453571|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
155008337|NCT00141778|559453569|FG000|Started Study Medication|Withdrawal by Subject|0|||
155008338|NCT00141778|559453570|FG001|Started Study Medication|Withdrawal by Subject|2|||
155008339|NCT00141778|559453571|FG002|Started Study Medication|Withdrawal by Subject|0|||
155008340|NCT00141778|559453569|FG000|Started Study Medication|Difficulty Swallowing|0|||
155008341|NCT00141778|559453570|FG001|Started Study Medication|Difficulty Swallowing|1|||
155008342|NCT00141778|559453571|FG002|Started Study Medication|Difficulty Swallowing|0|||
155008343|NCT00141778|559453569|FG000|Started Study Medication|Chest Discomfort|0|||
155008344|NCT00141778|559453570|FG001|Started Study Medication|Chest Discomfort|0|||
155008345|NCT00141778|559453571|FG002|Started Study Medication|Chest Discomfort|1|||
155008346|NCT00768248|559453572|FG000|Overall Study|Research coordinator didn't collect data|1|||
155008347|NCT00768248|559453573|FG001|Overall Study|Research coordinator didn't collect data|1|||
155008348|NCT01959295|559453576|FG000|Overall Study|Adverse Event|2|||
155008349|NCT01959295|559453577|FG001|Overall Study|Adverse Event|0|||
155008350|NCT01959295|559453576|FG000|Overall Study|Lost to Follow-up|0|||
155008351|NCT01959295|559453577|FG001|Overall Study|Lost to Follow-up|2|||
155008352|NCT01959295|559453576|FG000|Overall Study|Physician Decision|2|||
155008353|NCT01959295|559453577|FG001|Overall Study|Physician Decision|3|||
155008354|NCT01959295|559453576|FG000|Overall Study|Protocol Violation|16|||
155130566|NCT00549770|559909025|FG007|Overall Study|Lost to Follow-up|0|||
155008355|NCT01959295|559453577|FG001|Overall Study|Protocol Violation|5|||
155008356|NCT01959295|559453576|FG000|Overall Study|Withdrawal by Subject|3|||
155008357|NCT01959295|559453577|FG001|Overall Study|Withdrawal by Subject|1|||
155008358|NCT01959295|559453576|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
155130567|NCT00549770|559909018|FG000|Overall Study|Withdrawal by Subject|4|||
155130568|NCT00549770|559909019|FG001|Overall Study|Withdrawal by Subject|6|||
155008359|NCT01959295|559453577|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
155008360|NCT04467840|559455770|FG000|Overall Study|Death|35|||
155008361|NCT04467840|559455771|FG001|Overall Study|Death|39|||
155008362|NCT04467840|559455770|FG000|Overall Study|Withdrawal by Subject|8|||
155008363|NCT04467840|559455771|FG001|Overall Study|Withdrawal by Subject|4|||
155130569|NCT00549770|559909020|FG002|Overall Study|Withdrawal by Subject|4|||
155008364|NCT04467840|559455770|FG000|Overall Study|Adverse Event|2|||
155008365|NCT04467840|559455771|FG001|Overall Study|Adverse Event|0|||
155008366|NCT04467840|559455770|FG000|Overall Study|Lost to Follow-up|1|||
155008367|NCT04467840|559455771|FG001|Overall Study|Lost to Follow-up|3|||
155008368|NCT04467840|559455770|FG000|Overall Study|Physician Decision|1|||
155008369|NCT04467840|559455771|FG001|Overall Study|Physician Decision|0|||
155008370|NCT04467840|559455770|FG000|Overall Study|Other|1|||
155008371|NCT04467840|559455771|FG001|Overall Study|Other|5|||
155008372|NCT04467840|559455770|FG000|Overall Study|Missing study completion status|3|||
155008373|NCT04467840|559455771|FG001|Overall Study|Missing study completion status|1|||
155008374|NCT05126693|559455778|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
155008375|NCT05126693|559455779|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
155008376|NCT05126693|559455778|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
155130570|NCT00549770|559909021|FG003|Overall Study|Withdrawal by Subject|5|||
155130571|NCT00549770|559909022|FG004|Overall Study|Withdrawal by Subject|6|||
155130572|NCT00549770|559909023|FG005|Overall Study|Withdrawal by Subject|6|||
155130573|NCT00549770|559909024|FG006|Overall Study|Withdrawal by Subject|4|||
155130574|NCT00549770|559909025|FG007|Overall Study|Withdrawal by Subject|9|||
155130575|NCT00549770|559909018|FG000|Overall Study|Lack of Efficacy|1|||
155130576|NCT00549770|559909019|FG001|Overall Study|Lack of Efficacy|0|||
155130577|NCT00549770|559909020|FG002|Overall Study|Lack of Efficacy|2|||
155130578|NCT00549770|559909021|FG003|Overall Study|Lack of Efficacy|3|||
155130579|NCT00549770|559909022|FG004|Overall Study|Lack of Efficacy|5|||
155130580|NCT00549770|559909023|FG005|Overall Study|Lack of Efficacy|1|||
155130581|NCT00549770|559909024|FG006|Overall Study|Lack of Efficacy|3|||
155130582|NCT00549770|559909025|FG007|Overall Study|Lack of Efficacy|8|||
155130583|NCT00549770|559909018|FG000|Overall Study|Abnormal test procedure results|0|||
155130584|NCT00549770|559909019|FG001|Overall Study|Abnormal test procedure results|0|||
155130585|NCT00549770|559909020|FG002|Overall Study|Abnormal test procedure results|0|||
155130586|NCT00549770|559909021|FG003|Overall Study|Abnormal test procedure results|2|||
155130587|NCT00549770|559909022|FG004|Overall Study|Abnormal test procedure results|0|||
155130588|NCT00549770|559909023|FG005|Overall Study|Abnormal test procedure results|1|||
155130589|NCT00549770|559909024|FG006|Overall Study|Abnormal test procedure results|1|||
155130590|NCT00549770|559909025|FG007|Overall Study|Abnormal test procedure results|1|||
155130591|NCT00549770|559909018|FG000|Overall Study|Abnormal laboratory values|0|||
155130592|NCT00549770|559909019|FG001|Overall Study|Abnormal laboratory values|0|||
155130593|NCT00549770|559909020|FG002|Overall Study|Abnormal laboratory values|0|||
155130594|NCT00549770|559909021|FG003|Overall Study|Abnormal laboratory values|0|||
155130595|NCT00549770|559909022|FG004|Overall Study|Abnormal laboratory values|0|||
155130596|NCT00549770|559909023|FG005|Overall Study|Abnormal laboratory values|1|||
155130597|NCT00549770|559909024|FG006|Overall Study|Abnormal laboratory values|0|||
155130598|NCT00549770|559909025|FG007|Overall Study|Abnormal laboratory values|0|||
155130599|NCT00549770|559909018|FG000|Overall Study|Adverse Event|1|||
155130600|NCT00549770|559909019|FG001|Overall Study|Adverse Event|3|||
155130601|NCT00549770|559909020|FG002|Overall Study|Adverse Event|1|||
155130602|NCT00549770|559909021|FG003|Overall Study|Adverse Event|2|||
155130603|NCT00549770|559909022|FG004|Overall Study|Adverse Event|1|||
155130604|NCT00549770|559909023|FG005|Overall Study|Adverse Event|0|||
155130605|NCT00549770|559909024|FG006|Overall Study|Adverse Event|5|||
155130606|NCT00549770|559909025|FG007|Overall Study|Adverse Event|4|||
155130607|NCT00847015|559909026|FG000|Overall Study|Withdrawal by Subject|1|||
155130608|NCT00847015|559909026|FG000|Overall Study|declined any surgery|1|||
155130609|NCT00847015|559909026|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
155130610|NCT05026853|559909034|FG000|Overall Study|Cancelled appointment|1|||
155130611|NCT05026853|559909035|FG001|Overall Study|Cancelled appointment|0|||
155130612|NCT05026853|559909034|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
155130613|NCT05026853|559909035|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
155130614|NCT05026853|559909034|FG000|Overall Study|Did not complete 12-week survey|16|||
155130615|NCT05026853|559909035|FG001|Overall Study|Did not complete 12-week survey|16|||
155130616|NCT01353911|559909036|FG000|Overall Study|Lost to Follow-up|2|||
155008377|NCT05126693|559455779|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
155008378|NCT05126693|559455778|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
155008379|NCT05126693|559455779|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
155008380|NCT02848001|559455785|FG000|Overall Study|other reasons|0|||
155008381|NCT02848001|559455786|FG001|Overall Study|other reasons|0|||
155008382|NCT02848001|559455787|FG002|Overall Study|other reasons|1|||
155008383|NCT02848001|559455788|FG003|Overall Study|other reasons|0|||
155008384|NCT02848001|559455789|FG004|Overall Study|other reasons|4|||
155130617|NCT01353911|559909037|FG001|Overall Study|Lost to Follow-up|6|||
155130618|NCT01353911|559909038|FG002|Overall Study|Lost to Follow-up|4|||
155130619|NCT01353911|559909039|FG003|Overall Study|Lost to Follow-up|0|||
155130620|NCT01353911|559909040|FG004|Overall Study|Lost to Follow-up|4|||
155130621|NCT01353911|559909041|FG005|Overall Study|Lost to Follow-up|4|||
155130622|NCT01353911|559909042|FG006|Overall Study|Lost to Follow-up|3|||
155130623|NCT01353911|559909043|FG007|Overall Study|Lost to Follow-up|6|||
155130624|NCT01353911|559909036|FG000|Overall Study|Withdrawal by Subject|2|||
155130625|NCT01353911|559909037|FG001|Overall Study|Withdrawal by Subject|3|||
155151017|NCT02587520|559988163|FG003|Overall Study|Protocol Violation|2|||
155008385|NCT02848001|559455790|FG005|Overall Study|other reasons|1|||
155008386|NCT02848001|559455791|FG006|Overall Study|other reasons|0|||
155008387|NCT02848001|559455792|FG007|Overall Study|other reasons|2|||
155008388|NCT02848001|559455793|FG008|Overall Study|other reasons|2|||
155008389|NCT02848001|559455794|FG009|Overall Study|other reasons|3|||
155008390|NCT02848001|559455795|FG010|Overall Study|other reasons|0|||
155008391|NCT02848001|559455796|FG011|Overall Study|other reasons|1|||
155008392|NCT02848001|559455797|FG012|Overall Study|other reasons|1|||
155008393|NCT02848001|559455798|FG013|Overall Study|other reasons|0|||
155008394|NCT02848001|559455799|FG014|Overall Study|other reasons|0|||
155008395|NCT02848001|559455800|FG015|Overall Study|other reasons|2|||
155008396|NCT02848001|559455801|FG016|Overall Study|other reasons|1|||
155008397|NCT02848001|559455785|FG000|Overall Study|Lack of Efficacy|0|||
155008398|NCT02848001|559455786|FG001|Overall Study|Lack of Efficacy|1|||
155008399|NCT02848001|559455787|FG002|Overall Study|Lack of Efficacy|1|||
155008400|NCT02848001|559455788|FG003|Overall Study|Lack of Efficacy|2|||
155008401|NCT02848001|559455789|FG004|Overall Study|Lack of Efficacy|3|||
155008402|NCT02848001|559455790|FG005|Overall Study|Lack of Efficacy|0|||
155008403|NCT02848001|559455791|FG006|Overall Study|Lack of Efficacy|1|||
155008404|NCT02848001|559455792|FG007|Overall Study|Lack of Efficacy|0|||
155008405|NCT02848001|559455793|FG008|Overall Study|Lack of Efficacy|0|||
155008406|NCT02848001|559455794|FG009|Overall Study|Lack of Efficacy|1|||
155008407|NCT02848001|559455795|FG010|Overall Study|Lack of Efficacy|0|||
155008408|NCT02848001|559455796|FG011|Overall Study|Lack of Efficacy|2|||
155008409|NCT02848001|559455797|FG012|Overall Study|Lack of Efficacy|0|||
155008410|NCT02848001|559455798|FG013|Overall Study|Lack of Efficacy|2|||
155008411|NCT02848001|559455799|FG014|Overall Study|Lack of Efficacy|2|||
155008412|NCT02848001|559455800|FG015|Overall Study|Lack of Efficacy|0|||
155008413|NCT02848001|559455801|FG016|Overall Study|Lack of Efficacy|0|||
155008414|NCT02848001|559455785|FG000|Overall Study|Progressive Disease|2|||
155008415|NCT02848001|559455786|FG001|Overall Study|Progressive Disease|1|||
155008416|NCT02848001|559455787|FG002|Overall Study|Progressive Disease|0|||
155008417|NCT02848001|559455788|FG003|Overall Study|Progressive Disease|4|||
155008418|NCT02848001|559455789|FG004|Overall Study|Progressive Disease|3|||
155008419|NCT02848001|559455790|FG005|Overall Study|Progressive Disease|0|||
155008420|NCT02848001|559455791|FG006|Overall Study|Progressive Disease|4|||
155008421|NCT02848001|559455792|FG007|Overall Study|Progressive Disease|1|||
155008422|NCT02848001|559455793|FG008|Overall Study|Progressive Disease|0|||
155008423|NCT02848001|559455794|FG009|Overall Study|Progressive Disease|2|||
155008424|NCT02848001|559455795|FG010|Overall Study|Progressive Disease|3|||
155008425|NCT02848001|559455796|FG011|Overall Study|Progressive Disease|2|||
155008426|NCT02848001|559455797|FG012|Overall Study|Progressive Disease|1|||
155008427|NCT02848001|559455798|FG013|Overall Study|Progressive Disease|0|||
155008428|NCT02848001|559455799|FG014|Overall Study|Progressive Disease|2|||
155008429|NCT02848001|559455800|FG015|Overall Study|Progressive Disease|4|||
155008430|NCT02848001|559455801|FG016|Overall Study|Progressive Disease|0|||
155008431|NCT02848001|559455785|FG000|Overall Study|Adverse Event|0|||
155008432|NCT02848001|559455786|FG001|Overall Study|Adverse Event|0|||
155008433|NCT02848001|559455787|FG002|Overall Study|Adverse Event|0|||
155008434|NCT02848001|559455788|FG003|Overall Study|Adverse Event|0|||
155008435|NCT02848001|559455789|FG004|Overall Study|Adverse Event|2|||
155008436|NCT02848001|559455790|FG005|Overall Study|Adverse Event|0|||
155008437|NCT02848001|559455791|FG006|Overall Study|Adverse Event|0|||
155008438|NCT02848001|559455792|FG007|Overall Study|Adverse Event|0|||
155008439|NCT02848001|559455793|FG008|Overall Study|Adverse Event|0|||
155008440|NCT02848001|559455794|FG009|Overall Study|Adverse Event|1|||
155008441|NCT02848001|559455795|FG010|Overall Study|Adverse Event|0|||
155008442|NCT02848001|559455796|FG011|Overall Study|Adverse Event|1|||
155008443|NCT02848001|559455797|FG012|Overall Study|Adverse Event|1|||
155008444|NCT02848001|559455798|FG013|Overall Study|Adverse Event|0|||
155130626|NCT01353911|559909038|FG002|Overall Study|Withdrawal by Subject|4|||
155130627|NCT01353911|559909039|FG003|Overall Study|Withdrawal by Subject|2|||
155130628|NCT01353911|559909040|FG004|Overall Study|Withdrawal by Subject|2|||
155130629|NCT01353911|559909041|FG005|Overall Study|Withdrawal by Subject|3|||
155130630|NCT01353911|559909042|FG006|Overall Study|Withdrawal by Subject|3|||
155130631|NCT01353911|559909043|FG007|Overall Study|Withdrawal by Subject|9|||
155130632|NCT01353911|559909036|FG000|Overall Study|Status Not Recorded|4|||
155008445|NCT02848001|559455799|FG014|Overall Study|Adverse Event|2|||
155008446|NCT02848001|559455800|FG015|Overall Study|Adverse Event|0|||
155008447|NCT02848001|559455801|FG016|Overall Study|Adverse Event|0|||
155008448|NCT02848001|559455785|FG000|Overall Study|Death|0|||
155008449|NCT02848001|559455786|FG001|Overall Study|Death|0|||
155130633|NCT01353911|559909037|FG001|Overall Study|Status Not Recorded|0|||
155008450|NCT02848001|559455787|FG002|Overall Study|Death|0|||
155008451|NCT02848001|559455788|FG003|Overall Study|Death|1|||
155008452|NCT02848001|559455789|FG004|Overall Study|Death|3|||
155008453|NCT02848001|559455790|FG005|Overall Study|Death|1|||
155008454|NCT02848001|559455791|FG006|Overall Study|Death|2|||
155008455|NCT02848001|559455792|FG007|Overall Study|Death|3|||
155008456|NCT02848001|559455793|FG008|Overall Study|Death|4|||
155008457|NCT02848001|559455794|FG009|Overall Study|Death|1|||
155130634|NCT01353911|559909038|FG002|Overall Study|Status Not Recorded|1|||
155130635|NCT01353911|559909039|FG003|Overall Study|Status Not Recorded|0|||
155130636|NCT01353911|559909040|FG004|Overall Study|Status Not Recorded|0|||
155130637|NCT01353911|559909041|FG005|Overall Study|Status Not Recorded|0|||
155130638|NCT01353911|559909042|FG006|Overall Study|Status Not Recorded|0|||
155130639|NCT01353911|559909043|FG007|Overall Study|Status Not Recorded|0|||
155130640|NCT01732913|559909044|FG000|Overall Study|Study Terminated by Sponsor|105|||
155130641|NCT01732913|559909045|FG001|Overall Study|Study Terminated by Sponsor|55|||
155130642|NCT01732913|559909044|FG000|Overall Study|Withdrawal by Subject|27|||
155130643|NCT01732913|559909045|FG001|Overall Study|Withdrawal by Subject|4|||
155130644|NCT01732913|559909044|FG000|Overall Study|Physician Decision|14|||
155130645|NCT01732913|559909045|FG001|Overall Study|Physician Decision|7|||
155130646|NCT01732913|559909044|FG000|Overall Study|Other|7|||
155130647|NCT01732913|559909045|FG001|Overall Study|Other|1|||
155130648|NCT01732913|559909044|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
155130649|NCT01732913|559909045|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
155130650|NCT03233438|559909046|FG000|Overall Study|Lost to Follow-up|4|||
155130651|NCT03233438|559909047|FG001|Overall Study|Lost to Follow-up|9|||
155130652|NCT03233438|559909046|FG000|Overall Study|Withdrawal by Subject|2|||
155130653|NCT03233438|559909047|FG001|Overall Study|Withdrawal by Subject|1|||
155130654|NCT03233438|559909046|FG000|Overall Study|No recording of dalbavancin|0|||
155130655|NCT03233438|559909047|FG001|Overall Study|No recording of dalbavancin|1|||
155130656|NCT02345330|559909051|FG000|Overall Study|Death|1|||
155130657|NCT02345330|559909051|FG000|Overall Study|Progressive Disease|2|||
155130658|NCT03831945|559909054|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
155130659|NCT03831945|559909055|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
155130660|NCT03831945|559909054|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
155130661|NCT03831945|559909055|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
155130662|NCT03831945|559909054|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
155130663|NCT03831945|559909055|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
155130664|NCT00295932|559909056|FG000|Overall Study|Not Treated|0|||
155130665|NCT00295932|559909057|FG001|Overall Study|Not Treated|0|||
155130666|NCT00295932|559909058|FG002|Overall Study|Not Treated|0|||
155130667|NCT00295932|559909059|FG003|Overall Study|Not Treated|0|||
155130668|NCT00295932|559909060|FG004|Overall Study|Not Treated|0|||
155130669|NCT00295932|559909061|FG005|Overall Study|Not Treated|0|||
155130670|NCT00295932|559909062|FG006|Overall Study|Not Treated|0|||
155130671|NCT00295932|559909063|FG007|Overall Study|Not Treated|0|||
155130672|NCT00295932|559909064|FG008|Overall Study|Not Treated|0|||
155130673|NCT00295932|559909065|FG009|Overall Study|Not Treated|0|||
155130674|NCT00295932|559909066|FG010|Overall Study|Not Treated|1|||
155130675|NCT00454181|559909067|FG000|Overall Study|Adverse Event|1|||
155130676|NCT00454181|559909068|FG001|Overall Study|Adverse Event|1|||
155130677|NCT00454181|559909067|FG000|Overall Study|Lost to Follow-up|11|||
155130678|NCT00454181|559909068|FG001|Overall Study|Lost to Follow-up|1|||
155130679|NCT00454181|559909067|FG000|Overall Study|Protocol Violation|1|||
155130680|NCT00454181|559909068|FG001|Overall Study|Protocol Violation|1|||
155130681|NCT00454181|559909067|FG000|Overall Study|Withdrawal by Subject|2|||
155130682|NCT00454181|559909068|FG001|Overall Study|Withdrawal by Subject|0|||
155130683|NCT03729245|559909069|FG000|Overall Study|Lost to Follow-up|5|||
155130684|NCT03729245|559909070|FG001|Overall Study|Lost to Follow-up|6|||
155130685|NCT03729245|559909069|FG000|Overall Study|Withdrawal by Subject|16|||
155130686|NCT03729245|559909070|FG001|Overall Study|Withdrawal by Subject|19|||
155130687|NCT03729245|559909069|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
155130688|NCT03729245|559909070|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
155130689|NCT00884832|559909071|FG000|Overall Study|Withdrawal by Subject|0|||
155130690|NCT00884832|559909072|FG001|Overall Study|Withdrawal by Subject|1|||
155130691|NCT02096263|559909073|FG000|Overall Study|Adverse Event|1|||
155130692|NCT02096263|559909074|FG001|Overall Study|Adverse Event|0|||
155130693|NCT02096263|559909075|FG002|Overall Study|Adverse Event|1|||
155130694|NCT02096263|559909073|FG000|Overall Study|Lost to Follow-up|14|||
155130695|NCT02096263|559909074|FG001|Overall Study|Lost to Follow-up|18|||
155130696|NCT02096263|559909075|FG002|Overall Study|Lost to Follow-up|15|||
155130697|NCT02096263|559909073|FG000|Overall Study|Other|7|||
155130698|NCT02096263|559909074|FG001|Overall Study|Other|9|||
155130699|NCT02096263|559909075|FG002|Overall Study|Other|6|||
155130700|NCT02096263|559909073|FG000|Overall Study|Sponsor study termination|0|||
155008458|NCT02848001|559455795|FG010|Overall Study|Death|0|||
155130701|NCT02096263|559909074|FG001|Overall Study|Sponsor study termination|0|||
155130702|NCT02096263|559909075|FG002|Overall Study|Sponsor study termination|1|||
155130703|NCT02096263|559909073|FG000|Overall Study|Protocol Violation|7|||
155130704|NCT02096263|559909074|FG001|Overall Study|Protocol Violation|2|||
155130705|NCT02096263|559909075|FG002|Overall Study|Protocol Violation|8|||
155130706|NCT02096263|559909073|FG000|Overall Study|Withdrawal by Subject|5|||
155130707|NCT02096263|559909074|FG001|Overall Study|Withdrawal by Subject|7|||
155130708|NCT02096263|559909075|FG002|Overall Study|Withdrawal by Subject|8|||
155130709|NCT03178669|559909083|FG000|Overall Study|Adverse Event|4|||
155130710|NCT03178669|559909084|FG001|Overall Study|Adverse Event|1|||
155130711|NCT03178669|559909085|FG002|Overall Study|Adverse Event|4|||
155130712|NCT03178669|559909086|FG003|Overall Study|Adverse Event|2|||
155130713|NCT03178669|559909087|FG004|Overall Study|Adverse Event|2|||
155130714|NCT03178669|559909083|FG000|Overall Study|Lack of Efficacy|0|||
155130715|NCT03178669|559909084|FG001|Overall Study|Lack of Efficacy|0|||
155130716|NCT03178669|559909085|FG002|Overall Study|Lack of Efficacy|2|||
155130717|NCT03178669|559909086|FG003|Overall Study|Lack of Efficacy|0|||
155130718|NCT03178669|559909087|FG004|Overall Study|Lack of Efficacy|1|||
155130719|NCT03178669|559909083|FG000|Overall Study|Physician Decision|0|||
155130720|NCT03178669|559909084|FG001|Overall Study|Physician Decision|0|||
155130721|NCT03178669|559909085|FG002|Overall Study|Physician Decision|0|||
155130722|NCT03178669|559909086|FG003|Overall Study|Physician Decision|0|||
155130723|NCT03178669|559909087|FG004|Overall Study|Physician Decision|1|||
155130724|NCT03178669|559909083|FG000|Overall Study|Withdrawal by Subject|1|||
155130725|NCT03178669|559909084|FG001|Overall Study|Withdrawal by Subject|0|||
155130726|NCT03178669|559909085|FG002|Overall Study|Withdrawal by Subject|1|||
155130727|NCT03178669|559909086|FG003|Overall Study|Withdrawal by Subject|1|||
155130728|NCT03178669|559909087|FG004|Overall Study|Withdrawal by Subject|0|||
155130729|NCT03178669|559909083|FG000|Overall Study|Lost to Follow-up|0|||
155130730|NCT03178669|559909084|FG001|Overall Study|Lost to Follow-up|0|||
155130731|NCT03178669|559909085|FG002|Overall Study|Lost to Follow-up|0|||
155130732|NCT03178669|559909086|FG003|Overall Study|Lost to Follow-up|1|||
155130733|NCT03178669|559909087|FG004|Overall Study|Lost to Follow-up|0|||
155130734|NCT00079677|559909088|FG000|Overall Study|Adverse Event|5|||
155130735|NCT00079677|559909089|FG001|Overall Study|Adverse Event|6|||
155130736|NCT00079677|559909088|FG000|Overall Study|Lack of Efficacy|1|||
155130737|NCT00079677|559909089|FG001|Overall Study|Lack of Efficacy|0|||
155130738|NCT00079677|559909088|FG000|Overall Study|Lost to Follow-up|2|||
155130739|NCT00079677|559909089|FG001|Overall Study|Lost to Follow-up|2|||
155130740|NCT00079677|559909088|FG000|Overall Study|Physician Decision|3|||
155130741|NCT00079677|559909089|FG001|Overall Study|Physician Decision|0|||
155130742|NCT00079677|559909088|FG000|Overall Study|Protocol Violation|2|||
155130743|NCT00079677|559909089|FG001|Overall Study|Protocol Violation|3|||
155130744|NCT00079677|559909088|FG000|Overall Study|Withdrawal by Subject|5|||
155130745|NCT00079677|559909089|FG001|Overall Study|Withdrawal by Subject|3|||
155130746|NCT00079677|559909088|FG000|Overall Study|Miscellaneous|2|||
155130747|NCT00079677|559909089|FG001|Overall Study|Miscellaneous|0|||
155130748|NCT01300455|559909090|FG000|Washout|Withdrawal by Subject|1|||
155130749|NCT01300455|559909091|FG001|Washout|Withdrawal by Subject|0|||
155130750|NCT00565136|559909092|FG000|Overall Study|Lost to Follow-up|1|||
155130751|NCT00565136|559909092|FG000|Overall Study|Withdrawal by Subject|1|||
155130752|NCT00565136|559909092|FG000|Overall Study|Protocol Violation|1|||
155130753|NCT00694304|559909097|FG000|Overall Study|Adverse Event|42|||
155130754|NCT00694304|559909097|FG000|Overall Study|Lack of Efficacy|35|||
155130755|NCT00694304|559909097|FG000|Overall Study|Non-compliance With Study Product|16|||
155130756|NCT00694304|559909097|FG000|Overall Study|Protocol Violation|6|||
155130757|NCT00694304|559909097|FG000|Overall Study|Withdrawal of Consent|61|||
155130758|NCT00694304|559909097|FG000|Overall Study|Lost to Follow-up|15|||
155130759|NCT00694304|559909097|FG000|Overall Study|Administrative or Other Reasons|32|||
155130760|NCT00576576|559909098|FG000|Overall Study|Lost to Follow-up|6|||
155130761|NCT00576576|559909098|FG000|Overall Study|Protocol Violation|1|||
155130762|NCT02102399|559909101|FG000|Overall Study|Withdrawal by Subject|6|||
155130763|NCT02102399|559909102|FG001|Overall Study|Withdrawal by Subject|4|||
155130764|NCT02814175|559910903|FG000|Part 1|Adverse Event|2|||
155130765|NCT02814175|559910904|FG001|Part 1|Adverse Event|3|||
155130766|NCT02814175|559910905|FG002|Part 1|Adverse Event|0|||
155130767|NCT02814175|559910906|FG003|Part 1|Adverse Event|0|||
155130768|NCT02814175|559910907|FG004|Part 1|Adverse Event|0|||
155130769|NCT02814175|559910908|FG005|Part 1|Adverse Event|0|||
155130770|NCT02814175|559910903|FG000|Part 1|Withdrawal Consent|8|||
155130771|NCT02814175|559910904|FG001|Part 1|Withdrawal Consent|1|||
155130772|NCT02814175|559910905|FG002|Part 1|Withdrawal Consent|0|||
155130773|NCT02814175|559910906|FG003|Part 1|Withdrawal Consent|0|||
155130774|NCT02814175|559910907|FG004|Part 1|Withdrawal Consent|0|||
155130775|NCT02814175|559910908|FG005|Part 1|Withdrawal Consent|0|||
155130776|NCT02814175|559910903|FG000|Part 1|Lost to Follow-up|1|||
155008459|NCT02848001|559455796|FG011|Overall Study|Death|1|||
155008460|NCT02848001|559455797|FG012|Overall Study|Death|3|||
155130777|NCT02814175|559910904|FG001|Part 1|Lost to Follow-up|0|||
155130778|NCT02814175|559910905|FG002|Part 1|Lost to Follow-up|0|||
155130779|NCT02814175|559910906|FG003|Part 1|Lost to Follow-up|0|||
155130780|NCT02814175|559910907|FG004|Part 1|Lost to Follow-up|0|||
155130781|NCT02814175|559910908|FG005|Part 1|Lost to Follow-up|0|||
155130782|NCT02814175|559910903|FG000|Part 1|Lack of Efficacy|1|||
155130783|NCT02814175|559910904|FG001|Part 1|Lack of Efficacy|2|||
155130784|NCT02814175|559910905|FG002|Part 1|Lack of Efficacy|0|||
155130785|NCT02814175|559910906|FG003|Part 1|Lack of Efficacy|0|||
155130786|NCT02814175|559910907|FG004|Part 1|Lack of Efficacy|0|||
155130787|NCT02814175|559910908|FG005|Part 1|Lack of Efficacy|0|||
155130788|NCT02814175|559910903|FG000|Part 2|Adverse Event|0|||
155130789|NCT02814175|559910904|FG001|Part 2|Adverse Event|0|||
155130790|NCT02814175|559910905|FG002|Part 2|Adverse Event|0|||
155130791|NCT02814175|559910906|FG003|Part 2|Adverse Event|1|||
155130792|NCT02814175|559910907|FG004|Part 2|Adverse Event|1|||
155130793|NCT02814175|559910908|FG005|Part 2|Adverse Event|2|||
155130794|NCT02814175|559910903|FG000|Part 2|Withdrawal Consent|0|||
155130795|NCT02814175|559910904|FG001|Part 2|Withdrawal Consent|0|||
155130796|NCT02814175|559910905|FG002|Part 2|Withdrawal Consent|0|||
155130797|NCT02814175|559910906|FG003|Part 2|Withdrawal Consent|2|||
155130798|NCT02814175|559910907|FG004|Part 2|Withdrawal Consent|1|||
155130799|NCT02814175|559910908|FG005|Part 2|Withdrawal Consent|1|||
155130800|NCT02814175|559910903|FG000|Part 2|Lost to Follow-up|0|||
155130801|NCT02814175|559910904|FG001|Part 2|Lost to Follow-up|0|||
155130802|NCT02814175|559910905|FG002|Part 2|Lost to Follow-up|0|||
155130803|NCT02814175|559910906|FG003|Part 2|Lost to Follow-up|1|||
155130804|NCT02814175|559910907|FG004|Part 2|Lost to Follow-up|0|||
155130805|NCT02814175|559910908|FG005|Part 2|Lost to Follow-up|0|||
155130806|NCT02814175|559910903|FG000|Part 2|Lack of Efficacy|0|||
155130807|NCT02814175|559910904|FG001|Part 2|Lack of Efficacy|0|||
155130808|NCT02814175|559910905|FG002|Part 2|Lack of Efficacy|0|||
155130809|NCT02814175|559910906|FG003|Part 2|Lack of Efficacy|0|||
155130810|NCT02814175|559910907|FG004|Part 2|Lack of Efficacy|0|||
155130811|NCT02814175|559910908|FG005|Part 2|Lack of Efficacy|3|||
155130812|NCT01971008|559910913|FG000|Overall Study|Protocol Violation|2|||
155130813|NCT01971008|559910914|FG001|Overall Study|Protocol Violation|1|||
155130814|NCT03775512|559910915|FG000|Overall Study|Death|1|||
155130815|NCT03775512|559910916|FG001|Overall Study|Death|1|||
155130816|NCT03775512|559910915|FG000|Overall Study|Withdrawal by Subject|7|||
155130817|NCT03775512|559910916|FG001|Overall Study|Withdrawal by Subject|4|||
155130818|NCT03775512|559910915|FG000|Overall Study|Lost to Follow-up|5|||
155130819|NCT03775512|559910916|FG001|Overall Study|Lost to Follow-up|5|||
155130820|NCT03775512|559910915|FG000|Overall Study|Excluded before Catheter insertion|14|||
155130821|NCT03775512|559910916|FG001|Overall Study|Excluded before Catheter insertion|5|||
155130822|NCT03775512|559910915|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
155130823|NCT03775512|559910916|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
155130824|NCT03775512|559910915|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
155130825|NCT03775512|559910916|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
155130826|NCT03679624|559910917|FG000|Overall Study|Adverse Event|1|||
155130827|NCT03679624|559910918|FG001|Overall Study|Adverse Event|0|||
155130828|NCT02629822|559910919|FG000|Base Study|Lost to Follow-up|2|||
155130829|NCT02629822|559910919|FG000|Base Study|Non-Compliance With Study Drug|1|||
155130830|NCT02629822|559910919|FG000|Extension Study|Adverse Event|1|||
155130831|NCT02629822|559910919|FG000|Extension Study|Lost to Follow-up|1|||
155130832|NCT01610336|559910920|FG000|Overall Study|Progressive Disease|4|||
155130833|NCT01610336|559910921|FG001|Overall Study|Progressive Disease|6|||
155130834|NCT01610336|559910922|FG002|Overall Study|Progressive Disease|6|||
155130835|NCT01610336|559910923|FG003|Overall Study|Progressive Disease|5|||
155130836|NCT01610336|559910924|FG004|Overall Study|Progressive Disease|3|||
155130837|NCT01610336|559910925|FG005|Overall Study|Progressive Disease|10|||
155130838|NCT01610336|559910926|FG006|Overall Study|Progressive Disease|1|||
155130839|NCT01610336|559910927|FG007|Overall Study|Progressive Disease|6|||
155130840|NCT01610336|559910928|FG008|Overall Study|Progressive Disease|6|||
155130841|NCT01610336|559910929|FG009|Overall Study|Progressive Disease|40|||
155130842|NCT01610336|559910930|FG010|Overall Study|Progressive Disease|36|||
155130843|NCT01610336|559910920|FG000|Overall Study|Adverse Event|0|||
155130844|NCT01610336|559910921|FG001|Overall Study|Adverse Event|0|||
155130845|NCT01610336|559910922|FG002|Overall Study|Adverse Event|0|||
155130846|NCT01610336|559910923|FG003|Overall Study|Adverse Event|1|||
155130847|NCT01610336|559910924|FG004|Overall Study|Adverse Event|1|||
155130848|NCT01610336|559910925|FG005|Overall Study|Adverse Event|1|||
155130849|NCT01610336|559910926|FG006|Overall Study|Adverse Event|0|||
155130850|NCT01610336|559910927|FG007|Overall Study|Adverse Event|0|||
155130851|NCT01610336|559910928|FG008|Overall Study|Adverse Event|2|||
155130852|NCT01610336|559910929|FG009|Overall Study|Adverse Event|8|||
155130853|NCT01610336|559910930|FG010|Overall Study|Adverse Event|6|||
155130854|NCT01610336|559910920|FG000|Overall Study|Subject/Guardian decision|1|||
155130855|NCT01610336|559910921|FG001|Overall Study|Subject/Guardian decision|1|||
155130856|NCT01610336|559910922|FG002|Overall Study|Subject/Guardian decision|0|||
155130857|NCT01610336|559910923|FG003|Overall Study|Subject/Guardian decision|1|||
155130858|NCT01610336|559910924|FG004|Overall Study|Subject/Guardian decision|0|||
155130859|NCT01610336|559910925|FG005|Overall Study|Subject/Guardian decision|0|||
155130860|NCT01610336|559910926|FG006|Overall Study|Subject/Guardian decision|0|||
155130861|NCT01610336|559910927|FG007|Overall Study|Subject/Guardian decision|1|||
155130862|NCT01610336|559910928|FG008|Overall Study|Subject/Guardian decision|0|||
155130863|NCT01610336|559910929|FG009|Overall Study|Subject/Guardian decision|2|||
155130864|NCT01610336|559910930|FG010|Overall Study|Subject/Guardian decision|2|||
155130865|NCT01610336|559910920|FG000|Overall Study|Death|0|||
155130866|NCT01610336|559910921|FG001|Overall Study|Death|0|||
155130867|NCT01610336|559910922|FG002|Overall Study|Death|0|||
155130868|NCT01610336|559910923|FG003|Overall Study|Death|0|||
155130869|NCT01610336|559910924|FG004|Overall Study|Death|0|||
155130870|NCT01610336|559910925|FG005|Overall Study|Death|1|||
155130871|NCT01610336|559910926|FG006|Overall Study|Death|3|||
155130872|NCT01610336|559910927|FG007|Overall Study|Death|0|||
155130873|NCT01610336|559910928|FG008|Overall Study|Death|0|||
155130874|NCT01610336|559910929|FG009|Overall Study|Death|1|||
155130875|NCT01610336|559910930|FG010|Overall Study|Death|2|||
155130876|NCT01610336|559910920|FG000|Overall Study|Non-Compliance with study treatment|0|||
155130877|NCT01610336|559910921|FG001|Overall Study|Non-Compliance with study treatment|0|||
155130878|NCT01610336|559910922|FG002|Overall Study|Non-Compliance with study treatment|0|||
155130879|NCT01610336|559910923|FG003|Overall Study|Non-Compliance with study treatment|0|||
155130880|NCT01610336|559910924|FG004|Overall Study|Non-Compliance with study treatment|0|||
155130881|NCT01610336|559910925|FG005|Overall Study|Non-Compliance with study treatment|0|||
155130882|NCT01610336|559910926|FG006|Overall Study|Non-Compliance with study treatment|0|||
155130883|NCT01610336|559910927|FG007|Overall Study|Non-Compliance with study treatment|0|||
155130884|NCT01610336|559910928|FG008|Overall Study|Non-Compliance with study treatment|0|||
155130885|NCT01610336|559910929|FG009|Overall Study|Non-Compliance with study treatment|1|||
155130886|NCT01610336|559910930|FG010|Overall Study|Non-Compliance with study treatment|0|||
155130887|NCT01610336|559910920|FG000|Overall Study|Physician Decision|0|||
155130888|NCT01610336|559910921|FG001|Overall Study|Physician Decision|0|||
155130889|NCT01610336|559910922|FG002|Overall Study|Physician Decision|0|||
155130890|NCT01610336|559910923|FG003|Overall Study|Physician Decision|0|||
155130891|NCT01610336|559910924|FG004|Overall Study|Physician Decision|0|||
155130892|NCT01610336|559910925|FG005|Overall Study|Physician Decision|0|||
155130893|NCT01610336|559910926|FG006|Overall Study|Physician Decision|1|||
155130894|NCT01610336|559910927|FG007|Overall Study|Physician Decision|0|||
155130895|NCT01610336|559910928|FG008|Overall Study|Physician Decision|0|||
155130896|NCT01610336|559910929|FG009|Overall Study|Physician Decision|0|||
155130897|NCT01610336|559910930|FG010|Overall Study|Physician Decision|0|||
155130898|NCT01610336|559910920|FG000|Overall Study|Protocol Deviation|0|||
155130899|NCT01610336|559910921|FG001|Overall Study|Protocol Deviation|0|||
155008461|NCT02848001|559455798|FG013|Overall Study|Death|0|||
155008462|NCT02848001|559455799|FG014|Overall Study|Death|2|||
155008463|NCT02848001|559455800|FG015|Overall Study|Death|3|||
155008464|NCT02848001|559455801|FG016|Overall Study|Death|0|||
155008465|NCT02848001|559455785|FG000|Overall Study|Physician Decision|0|||
155008466|NCT02848001|559455786|FG001|Overall Study|Physician Decision|0|||
155008467|NCT02848001|559455787|FG002|Overall Study|Physician Decision|0|||
155008468|NCT02848001|559455788|FG003|Overall Study|Physician Decision|0|||
155008469|NCT02848001|559455789|FG004|Overall Study|Physician Decision|0|||
155008470|NCT02848001|559455790|FG005|Overall Study|Physician Decision|0|||
155008471|NCT02848001|559455791|FG006|Overall Study|Physician Decision|0|||
155008472|NCT02848001|559455792|FG007|Overall Study|Physician Decision|0|||
155008473|NCT02848001|559455793|FG008|Overall Study|Physician Decision|1|||
155008474|NCT02848001|559455794|FG009|Overall Study|Physician Decision|1|||
155008475|NCT02848001|559455795|FG010|Overall Study|Physician Decision|0|||
155008476|NCT02848001|559455796|FG011|Overall Study|Physician Decision|0|||
155008477|NCT02848001|559455797|FG012|Overall Study|Physician Decision|2|||
155008478|NCT02848001|559455798|FG013|Overall Study|Physician Decision|0|||
155008479|NCT02848001|559455799|FG014|Overall Study|Physician Decision|0|||
155008480|NCT02848001|559455800|FG015|Overall Study|Physician Decision|0|||
155008481|NCT02848001|559455801|FG016|Overall Study|Physician Decision|0|||
155008482|NCT02848001|559455785|FG000|Overall Study|Withdrawal by Subject|0|||
155008483|NCT02848001|559455786|FG001|Overall Study|Withdrawal by Subject|0|||
155008484|NCT02848001|559455787|FG002|Overall Study|Withdrawal by Subject|0|||
155008485|NCT02848001|559455788|FG003|Overall Study|Withdrawal by Subject|0|||
155008486|NCT02848001|559455789|FG004|Overall Study|Withdrawal by Subject|0|||
155008487|NCT02848001|559455790|FG005|Overall Study|Withdrawal by Subject|1|||
155008488|NCT02848001|559455791|FG006|Overall Study|Withdrawal by Subject|1|||
155008489|NCT02848001|559455792|FG007|Overall Study|Withdrawal by Subject|1|||
155008490|NCT02848001|559455793|FG008|Overall Study|Withdrawal by Subject|0|||
155008491|NCT02848001|559455794|FG009|Overall Study|Withdrawal by Subject|0|||
155008492|NCT02848001|559455795|FG010|Overall Study|Withdrawal by Subject|0|||
155008493|NCT02848001|559455796|FG011|Overall Study|Withdrawal by Subject|0|||
155130900|NCT01610336|559910922|FG002|Overall Study|Protocol Deviation|0|||
155130901|NCT01610336|559910923|FG003|Overall Study|Protocol Deviation|0|||
155130902|NCT01610336|559910924|FG004|Overall Study|Protocol Deviation|0|||
155130903|NCT01610336|559910925|FG005|Overall Study|Protocol Deviation|0|||
155130904|NCT01610336|559910926|FG006|Overall Study|Protocol Deviation|0|||
155130905|NCT01610336|559910927|FG007|Overall Study|Protocol Deviation|0|||
155008494|NCT02848001|559455797|FG012|Overall Study|Withdrawal by Subject|0|||
155008495|NCT02848001|559455798|FG013|Overall Study|Withdrawal by Subject|0|||
155130906|NCT01610336|559910928|FG008|Overall Study|Protocol Deviation|0|||
155008496|NCT02848001|559455799|FG014|Overall Study|Withdrawal by Subject|0|||
155008497|NCT02848001|559455800|FG015|Overall Study|Withdrawal by Subject|0|||
155008498|NCT02848001|559455801|FG016|Overall Study|Withdrawal by Subject|0|||
155008499|NCT03283566|559455802|FG000|Overall Study|Lost to Follow-up|1|||
155008500|NCT03283566|559455803|FG001|Overall Study|Lost to Follow-up|2|||
155130907|NCT01610336|559910929|FG009|Overall Study|Protocol Deviation|1|||
155008501|NCT04515147|559455804|FG000|Overall Study|Withdrawal by Subject|1|||
155008502|NCT04515147|559455805|FG001|Overall Study|Withdrawal by Subject|0|||
155008503|NCT04515147|559455806|FG002|Overall Study|Withdrawal by Subject|10|||
155008504|NCT04515147|559455807|FG003|Overall Study|Withdrawal by Subject|18|||
155008505|NCT04515147|559455808|FG004|Overall Study|Withdrawal by Subject|1|||
155008506|NCT04515147|559455809|FG005|Overall Study|Withdrawal by Subject|8|||
155008507|NCT04515147|559455804|FG000|Overall Study|Lost to Follow-up|0|||
155008508|NCT04515147|559455805|FG001|Overall Study|Lost to Follow-up|1|||
155008509|NCT04515147|559455806|FG002|Overall Study|Lost to Follow-up|5|||
155008510|NCT04515147|559455807|FG003|Overall Study|Lost to Follow-up|6|||
155008511|NCT04515147|559455808|FG004|Overall Study|Lost to Follow-up|2|||
155008512|NCT04515147|559455809|FG005|Overall Study|Lost to Follow-up|1|||
155008513|NCT04515147|559455804|FG000|Overall Study|Adverse Event|0|||
155008514|NCT04515147|559455805|FG001|Overall Study|Adverse Event|0|||
155008515|NCT04515147|559455806|FG002|Overall Study|Adverse Event|0|||
155008516|NCT04515147|559455807|FG003|Overall Study|Adverse Event|2|||
155008517|NCT04515147|559455808|FG004|Overall Study|Adverse Event|0|||
155008518|NCT04515147|559455809|FG005|Overall Study|Adverse Event|0|||
155008519|NCT04515147|559455804|FG000|Overall Study|Miscellaneous|0|||
155008520|NCT04515147|559455805|FG001|Overall Study|Miscellaneous|0|||
155008521|NCT04515147|559455806|FG002|Overall Study|Miscellaneous|0|||
155008522|NCT04515147|559455807|FG003|Overall Study|Miscellaneous|1|||
155008523|NCT04515147|559455808|FG004|Overall Study|Miscellaneous|0|||
155008524|NCT04515147|559455809|FG005|Overall Study|Miscellaneous|1|||
155008525|NCT01431079|559455817|FG000|Overall Study|Lost to Follow-up|35|||
155008526|NCT01431079|559455818|FG001|Overall Study|Lost to Follow-up|39|||
155008527|NCT01202175|559455819|FG000|Overall Study|Lost to Follow-up|2|||
155008528|NCT01202175|559455819|FG000|Overall Study|Withdrawal by Subject|1|||
155008529|NCT01202175|559455819|FG000|Overall Study|Adverse Event|2|||
155008530|NCT02790437|559455820|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
155008531|NCT02790437|559455821|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
155008532|NCT02790437|559455820|FG000|Overall Study|Adverse Event|1|||
155008533|NCT02790437|559455821|FG001|Overall Study|Adverse Event|0|||
155008534|NCT02790437|559455820|FG000|Overall Study|Withdrawal by Subject|1|||
155008535|NCT02790437|559455821|FG001|Overall Study|Withdrawal by Subject|0|||
155008536|NCT01626690|559455824|FG000|Overall Study|Protocol Violation|1|||
155008537|NCT01626690|559455825|FG001|Overall Study|Protocol Violation|0|||
155008538|NCT01626690|559455824|FG000|Overall Study|Adverse Event|1|||
155008539|NCT01626690|559455825|FG001|Overall Study|Adverse Event|0|||
155008540|NCT00942357|559455826|FG000|Overall Study|Ineligible|37|||
155008541|NCT00942357|559455827|FG001|Overall Study|Ineligible|40|||
155008542|NCT01321879|559455831|FG000|Overall Study|Lack of Efficacy|5|||
155008543|NCT01321879|559455831|FG000|Overall Study|Adverse Event|5|||
155008544|NCT01321879|559455831|FG000|Overall Study|Death|3|||
155008545|NCT01321879|559455831|FG000|Overall Study|Withdrawal by Subject|1|||
155008546|NCT01518322|559455838|FG000|Overall Study|FeNO measurement was missing|13|||
155008547|NCT00811733|559455848|FG000|Overall Study|Investigator Discretion|10|||
155008548|NCT00811733|559455849|FG001|Overall Study|Investigator Discretion|8|||
155008549|NCT00811733|559455848|FG000|Overall Study|Withdrawal by Subject|1|||
155008550|NCT00811733|559455849|FG001|Overall Study|Withdrawal by Subject|2|||
155008551|NCT04542057|559455852|FG000|Overall Study|Death|3|||
155008552|NCT04542057|559455853|FG001|Overall Study|Death|1|||
155008553|NCT04542057|559455852|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
155008554|NCT04542057|559455853|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
155008555|NCT04542057|559455852|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
155008556|NCT04542057|559455853|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
155008557|NCT04542057|559455852|FG000|Overall Study|Adverse Event|15|||
155008558|NCT04542057|559455853|FG001|Overall Study|Adverse Event|6|||
155008559|NCT04542057|559455852|FG000|Overall Study|COVID-19 adverse event|6|||
155008560|NCT04542057|559455853|FG001|Overall Study|COVID-19 adverse event|4|||
155008561|NCT04542057|559455852|FG000|Overall Study|Lack of Efficacy|2|||
155008562|NCT04542057|559455853|FG001|Overall Study|Lack of Efficacy|5|||
155008563|NCT04542057|559455852|FG000|Overall Study|Study terminated by sponsor|1|||
155008564|NCT04542057|559455853|FG001|Overall Study|Study terminated by sponsor|0|||
155008565|NCT04542057|559455852|FG000|Overall Study|Investigator discretion|2|||
155008566|NCT04542057|559455853|FG001|Overall Study|Investigator discretion|1|||
155008567|NCT04542057|559455852|FG000|Overall Study|Withdrawal by Subject|52|||
155008568|NCT04542057|559455853|FG001|Overall Study|Withdrawal by Subject|30|||
155008569|NCT04542057|559455852|FG000|Overall Study|Lost to Follow-up|8|||
155008570|NCT04542057|559455853|FG001|Overall Study|Lost to Follow-up|11|||
155008571|NCT04542057|559455852|FG000|Overall Study|Other|2|||
155008572|NCT04542057|559455853|FG001|Overall Study|Other|2|||
155008573|NCT02635984|559455858|FG000|Overall Study|Lost to Follow-up|2|||
155008574|NCT02635984|559455859|FG001|Overall Study|Lost to Follow-up|4|||
155008575|NCT02635984|559455858|FG000|Overall Study|Study Arm Closed|1|||
155008576|NCT02635984|559455859|FG001|Overall Study|Study Arm Closed|0|||
155008577|NCT01640249|559455860|FG000|Period 1|Withdrawal by Subject|1|||
155008578|NCT01640249|559455861|FG001|Period 1|Withdrawal by Subject|0|||
155008579|NCT01640249|559455862|FG002|Period 1|Withdrawal by Subject|0|||
155130908|NCT01610336|559910930|FG010|Overall Study|Protocol Deviation|0|||
155130909|NCT01610336|559910920|FG000|Overall Study|Transfer to another trial|0|||
155130910|NCT01610336|559910921|FG001|Overall Study|Transfer to another trial|0|||
155130911|NCT01610336|559910922|FG002|Overall Study|Transfer to another trial|0|||
155130912|NCT01610336|559910923|FG003|Overall Study|Transfer to another trial|0|||
155130913|NCT01610336|559910924|FG004|Overall Study|Transfer to another trial|0|||
155130914|NCT01610336|559910925|FG005|Overall Study|Transfer to another trial|0|||
155130915|NCT01610336|559910926|FG006|Overall Study|Transfer to another trial|0|||
155130916|NCT01610336|559910927|FG007|Overall Study|Transfer to another trial|0|||
155130917|NCT01610336|559910928|FG008|Overall Study|Transfer to another trial|0|||
155130918|NCT01610336|559910929|FG009|Overall Study|Transfer to another trial|0|||
155130919|NCT01610336|559910930|FG010|Overall Study|Transfer to another trial|1|||
155130920|NCT00741013|559910931|FG000|Overall Study|Adverse Event|1|||
155130921|NCT00741013|559910932|FG001|Overall Study|Adverse Event|0|||
155130922|NCT00741013|559910933|FG002|Overall Study|Adverse Event|0|||
155130923|NCT00741013|559910931|FG000|Overall Study|Withdrawal by Subject|0|||
155130924|NCT00741013|559910932|FG001|Overall Study|Withdrawal by Subject|0|||
155130925|NCT00741013|559910933|FG002|Overall Study|Withdrawal by Subject|1|||
155130926|NCT00741013|559910931|FG000|Overall Study|Discovered failed screen after enrolled|0|||
155130927|NCT00741013|559910932|FG001|Overall Study|Discovered failed screen after enrolled|2|||
155130928|NCT00741013|559910933|FG002|Overall Study|Discovered failed screen after enrolled|0|||
155130929|NCT00082407|559910934|FG000|Overall Study|Adverse Event|20|||
155130930|NCT00082407|559910935|FG001|Overall Study|Adverse Event|0|||
155130931|NCT00082407|559910934|FG000|Overall Study|Protocol Violation|14|||
155130932|NCT00082407|559910935|FG001|Overall Study|Protocol Violation|12|||
155130933|NCT00082407|559910934|FG000|Overall Study|Patient Decision|13|||
155130934|NCT00082407|559910935|FG001|Overall Study|Patient Decision|6|||
155130935|NCT00082407|559910934|FG000|Overall Study|Physician Decision|5|||
155130936|NCT00082407|559910935|FG001|Overall Study|Physician Decision|3|||
155130937|NCT00082407|559910934|FG000|Overall Study|Loss of Glucose Control|2|||
155130938|NCT00082407|559910935|FG001|Overall Study|Loss of Glucose Control|2|||
155130939|NCT00082407|559910934|FG000|Overall Study|Death|2|||
155130940|NCT00082407|559910935|FG001|Overall Study|Death|1|||
155130941|NCT00082407|559910934|FG000|Overall Study|Lost to Follow-up|0|||
155130942|NCT00082407|559910935|FG001|Overall Study|Lost to Follow-up|3|||
155130943|NCT03464019|559910936|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
155130944|NCT03464019|559910937|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
155130945|NCT03464019|559910938|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
155130946|NCT03464019|559910936|FG000|NODE-301 Part 1|Ablation|0|||
155130947|NCT03464019|559910937|FG001|NODE-301 Part 1|Ablation|0|||
155130948|NCT03464019|559910938|FG002|NODE-301 Part 1|Ablation|16|||
155130949|NCT03464019|559910936|FG000|NODE-301 Part 1|Test Dose Failure|0|||
155130950|NCT03464019|559910937|FG001|NODE-301 Part 1|Test Dose Failure|0|||
155130951|NCT03464019|559910938|FG002|NODE-301 Part 1|Test Dose Failure|8|||
155130952|NCT03464019|559910936|FG000|NODE-301 Part 1|Adverse Event|0|||
155130953|NCT03464019|559910937|FG001|NODE-301 Part 1|Adverse Event|0|||
155130954|NCT03464019|559910938|FG002|NODE-301 Part 1|Adverse Event|5|||
155130955|NCT03464019|559910936|FG000|NODE-301 Part 1|Physician Decision|0|||
155130956|NCT03464019|559910937|FG001|NODE-301 Part 1|Physician Decision|0|||
155130957|NCT03464019|559910938|FG002|NODE-301 Part 1|Physician Decision|4|||
155130958|NCT03464019|559910936|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
155130959|NCT03464019|559910937|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
155130960|NCT03464019|559910938|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
155130961|NCT03464019|559910936|FG000|NODE-301 Part 1|Protocol Violation|0|||
155130962|NCT03464019|559910937|FG001|NODE-301 Part 1|Protocol Violation|0|||
155130963|NCT03464019|559910938|FG002|NODE-301 Part 1|Protocol Violation|2|||
155130964|NCT03464019|559910936|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
155130965|NCT03464019|559910937|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
155008580|NCT01640249|559455863|FG003|Period 1|Withdrawal by Subject|0|||
155008581|NCT01640249|559455864|FG004|Period 1|Withdrawal by Subject|0|||
155008582|NCT01640249|559455865|FG005|Period 1|Withdrawal by Subject|1|||
155008583|NCT01640249|559455866|FG006|Period 1|Withdrawal by Subject|0|||
155008584|NCT01870778|559455868|FG000|Overall Study|Withdrawal by Subject|8|||
155130966|NCT03464019|559910938|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
155130967|NCT03464019|559910936|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
155130968|NCT03464019|559910937|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
155130969|NCT03464019|559910938|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
155130970|NCT03464019|559910936|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
155130971|NCT03464019|559910937|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
155130972|NCT03464019|559910938|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
155130973|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
155130974|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
155130975|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
155008585|NCT01870778|559455869|FG001|Overall Study|Withdrawal by Subject|7|||
155008586|NCT01870778|559455868|FG000|Overall Study|Lost to Follow-up|0|||
155008587|NCT01870778|559455869|FG001|Overall Study|Lost to Follow-up|2|||
155008588|NCT00312338|559455870|FG000|Overall Study|Adverse Event|7|||
155008589|NCT00312338|559455871|FG001|Overall Study|Adverse Event|2|||
155008590|NCT00312338|559455870|FG000|Overall Study|Lost to Follow-up|9|||
155008591|NCT00312338|559455871|FG001|Overall Study|Lost to Follow-up|1|||
155008592|NCT00312338|559455870|FG000|Overall Study|Withdrawal by Subject|4|||
155008593|NCT00312338|559455871|FG001|Overall Study|Withdrawal by Subject|0|||
155008594|NCT00312338|559455870|FG000|Overall Study|Subsequent infection|2|||
155008595|NCT00312338|559455871|FG001|Overall Study|Subsequent infection|0|||
155008596|NCT00100828|559455872|FG000|Overall Study|Physician Decision|6|||
155008597|NCT01215136|559455873|FG000|Overall Study|Adverse Event|2|||
155008598|NCT01215136|559455874|FG001|Overall Study|Adverse Event|9|||
155008599|NCT01215136|559455873|FG000|Overall Study|Disease Progression|3|||
155008600|NCT01215136|559455874|FG001|Overall Study|Disease Progression|14|||
155008601|NCT01215136|559455873|FG000|Overall Study|Symptomatic Deterioration|1|||
155008602|NCT01215136|559455874|FG001|Overall Study|Symptomatic Deterioration|1|||
155008603|NCT01215136|559455873|FG000|Overall Study|Death|0|||
155008604|NCT01215136|559455874|FG001|Overall Study|Death|2|||
155008605|NCT01215136|559455873|FG000|Overall Study|Withdrawal by Subject|0|||
155008606|NCT01215136|559455874|FG001|Overall Study|Withdrawal by Subject|1|||
155008607|NCT01125917|559455879|FG000|Overall Study|Adverse Event|43|||
155008608|NCT01125917|559455879|FG000|Overall Study|Lost to Follow-up|23|||
155008609|NCT01125917|559455879|FG000|Overall Study|Withdrawal by Subject|31|||
155008610|NCT01125917|559455879|FG000|Overall Study|Administrative|223|||
155008611|NCT01125917|559455879|FG000|Overall Study|Lack of Efficacy|19|||
155008612|NCT04421131|559455881|FG000|Overall Study|Lost to Follow-up|1|||
155008613|NCT04421131|559455881|FG000|Overall Study|Protocol Violation|2|||
155008614|NCT04421131|559455881|FG000|Overall Study|App crashed|5|||
155008615|NCT02308124|559455884|FG000|Overall Study|Lost to Follow-up|6|||
155008616|NCT02308124|559455885|FG001|Overall Study|Lost to Follow-up|6|||
155008617|NCT02308124|559455886|FG002|Overall Study|Lost to Follow-up|6|||
155008618|NCT02308124|559455884|FG000|Overall Study|Adverse Event|0|||
155008619|NCT02308124|559455885|FG001|Overall Study|Adverse Event|2|||
155008620|NCT02308124|559455886|FG002|Overall Study|Adverse Event|2|||
155008621|NCT02501928|559455891|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155008622|NCT02501928|559455892|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155008623|NCT02501928|559455893|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
155008624|NCT02501928|559455894|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
155008625|NCT02501928|559455895|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
155008626|NCT02501928|559455896|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
155008627|NCT01526057|559455898|FG000|Overall Study|Withdrawal by Subject|3|||
155008628|NCT01526057|559455899|FG001|Overall Study|Withdrawal by Subject|2|||
155008629|NCT01526057|559455900|FG002|Overall Study|Withdrawal by Subject|2|||
155008630|NCT01526057|559455898|FG000|Overall Study|Adverse Event|3|||
155008631|NCT01526057|559455899|FG001|Overall Study|Adverse Event|1|||
155008632|NCT01526057|559455900|FG002|Overall Study|Adverse Event|1|||
155008633|NCT01526057|559455898|FG000|Overall Study|Death|1|||
155008634|NCT01526057|559455899|FG001|Overall Study|Death|0|||
155008635|NCT01526057|559455900|FG002|Overall Study|Death|0|||
155008636|NCT01526057|559455898|FG000|Overall Study|Lost to Follow-up|1|||
155008637|NCT01526057|559455899|FG001|Overall Study|Lost to Follow-up|0|||
155008638|NCT01526057|559455900|FG002|Overall Study|Lost to Follow-up|1|||
155008639|NCT01526057|559455898|FG000|Overall Study|Other|1|||
155008640|NCT01526057|559455899|FG001|Overall Study|Other|0|||
155008641|NCT01526057|559455900|FG002|Overall Study|Other|1|||
155008642|NCT01526057|559455898|FG000|Overall Study|Protocol Violation|0|||
155008643|NCT01526057|559455899|FG001|Overall Study|Protocol Violation|0|||
155008644|NCT01526057|559455900|FG002|Overall Study|Protocol Violation|1|||
155008645|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
155008646|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
155008647|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
155008648|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
155008649|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
155008650|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
155008651|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
155008652|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
155008653|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
155008654|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
155008655|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
155008656|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
155008657|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
155008658|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
155008659|NCT04338022|559455903|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
155008660|NCT04338022|559455904|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
155008661|NCT04338022|559455903|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
155008662|NCT04338022|559455904|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
155008663|NCT04338022|559455903|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
155008664|NCT04338022|559455904|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
155008665|NCT04338022|559455903|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
155008666|NCT04338022|559455904|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
155008667|NCT04338022|559455903|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
155008668|NCT04338022|559455904|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
155130976|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
155130977|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
155130978|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
155130979|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
155130980|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
155130981|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
155130982|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
155130983|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
155130984|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
155130985|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
155130986|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
155130987|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
155130988|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
155130989|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
155130990|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
155130991|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
155130992|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
155130993|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
155130994|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
155130995|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
155130996|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
155130997|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
155130998|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
155130999|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
155131000|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
155131001|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
155131002|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
155131003|NCT03464019|559910936|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
155131004|NCT03464019|559910937|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
155131005|NCT03464019|559910938|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
155131006|NCT01754493|559910939|FG000|Overall Study|Adverse Event|1|||
155008669|NCT04338022|559455903|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
155008670|NCT04338022|559455904|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
155008671|NCT04338022|559455903|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
155008672|NCT04338022|559455904|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
155008673|NCT02553772|559455905|FG000|Overall Study|Adverse Event|2|||
155008674|NCT02553772|559455906|FG001|Overall Study|Adverse Event|3|||
155008675|NCT02553772|559455905|FG000|Overall Study|Lost to Follow-up|2|||
155008676|NCT02553772|559455906|FG001|Overall Study|Lost to Follow-up|1|||
155008677|NCT02553772|559455905|FG000|Overall Study|Withdrawal of Consent|1|||
155008678|NCT02553772|559455906|FG001|Overall Study|Withdrawal of Consent|1|||
155008679|NCT02553772|559455905|FG000|Overall Study|Lack of Efficacy|1|||
155008680|NCT02553772|559455906|FG001|Overall Study|Lack of Efficacy|0|||
155008681|NCT02553772|559455905|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155008682|NCT02553772|559455906|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155008683|NCT05724589|559455907|FG000|Overall Study|Lost to Follow-up|1|||
155008684|NCT02466321|559455908|FG000|Overall Study|Death|26|||
155008685|NCT02466321|559455908|FG000|Overall Study|Revision|6|||
155008686|NCT02466321|559455908|FG000|Overall Study|Lost to Follow-up|60|||
155008687|NCT02466321|559455908|FG000|Overall Study|Did not receive study device|1|||
155008688|NCT02189837|559455911|FG000|Overall Study|Withdrawal by Subject|2|||
155008689|NCT02189837|559455912|FG001|Overall Study|Withdrawal by Subject|1|||
155008690|NCT02189837|559455913|FG002|Overall Study|Withdrawal by Subject|3|||
155008691|NCT02189837|559455914|FG003|Overall Study|Withdrawal by Subject|1|||
155008692|NCT02189837|559455911|FG000|Overall Study|Sponsor Decision|0|||
155008693|NCT02189837|559455912|FG001|Overall Study|Sponsor Decision|0|||
155008694|NCT02189837|559455913|FG002|Overall Study|Sponsor Decision|0|||
155008695|NCT02189837|559455914|FG003|Overall Study|Sponsor Decision|1|||
155008696|NCT01808573|559455923|FG000|Overall Study|Death|212|||
155008697|NCT01808573|559455924|FG001|Overall Study|Death|240|||
155008698|NCT01808573|559455923|FG000|Overall Study|Withdrawal by Subject|12|||
155131007|NCT01754493|559910939|FG000|Overall Study|Lost to Follow-up|3|||
155151018|NCT02587520|559988164|FG004|Overall Study|Protocol Violation|0|||
155151019|NCT02587520|559988165|FG005|Overall Study|Protocol Violation|1|||
155151020|NCT02587520|559988166|FG006|Overall Study|Protocol Violation|1|||
155151021|NCT02587520|559988167|FG007|Overall Study|Protocol Violation|1|||
155131008|NCT01754493|559910939|FG000|Overall Study|Withdrawal by Subject|1|||
155131009|NCT01754493|559910939|FG000|Overall Study|Moved out of town|1|||
155131010|NCT01754493|559910939|FG000|Overall Study|Scheduling conflict|1|||
155131011|NCT00767806|559910940|FG000|Overall Study|Adverse Event|30|||
155131012|NCT00767806|559910941|FG001|Overall Study|Adverse Event|11|||
155131013|NCT00767806|559910940|FG000|Overall Study|Withdrawal by Subject|8|||
155131014|NCT00767806|559910941|FG001|Overall Study|Withdrawal by Subject|13|||
155131015|NCT00767806|559910940|FG000|Overall Study|Protocol Violation|6|||
155131016|NCT00767806|559910941|FG001|Overall Study|Protocol Violation|5|||
155131017|NCT00767806|559910940|FG000|Overall Study|Lack of Efficacy|1|||
155131018|NCT00767806|559910941|FG001|Overall Study|Lack of Efficacy|9|||
155131019|NCT00767806|559910940|FG000|Overall Study|Physician Decision|4|||
155131020|NCT00767806|559910941|FG001|Overall Study|Physician Decision|3|||
155131021|NCT00767806|559910940|FG000|Overall Study|Lost to Follow-up|1|||
155131022|NCT00767806|559910941|FG001|Overall Study|Lost to Follow-up|4|||
155131023|NCT00767806|559910940|FG000|Overall Study|Entry Criteria Not Met|1|||
155131024|NCT00767806|559910941|FG001|Overall Study|Entry Criteria Not Met|1|||
155131025|NCT00767806|559910940|FG000|Overall Study|Sponsor Decision|0|||
155131026|NCT00767806|559910941|FG001|Overall Study|Sponsor Decision|1|||
155131027|NCT02489942|559910942|FG000|Overall Study|Request by patient|602|||
155131028|NCT02489942|559910942|FG000|Overall Study|Improvement/remission|157|||
155131029|NCT02489942|559910942|FG000|Overall Study|No change/Progressive disease|263|||
155131030|NCT02489942|559910942|FG000|Overall Study|Adverse Event|522|||
155131031|NCT02489942|559910942|FG000|Overall Study|Other personal reasons|1218|||
155131032|NCT02489942|559910942|FG000|Overall Study|Lost to Follow-up|456|||
155131033|NCT02489942|559910942|FG000|Overall Study|Not continuously investigated|7|||
155131034|NCT02489942|559910942|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
155131035|NCT02489942|559910942|FG000|Overall Study|Multiple registration|1|||
155131036|NCT02489942|559910942|FG000|Overall Study|No patient visit after entry|100|||
155131037|NCT02489942|559910942|FG000|Overall Study|No treatment with Jardiance|2|||
155131038|NCT02489942|559910942|FG000|Overall Study|Patient received Jardiance before registration|1|||
155131039|NCT02489942|559910942|FG000|Overall Study|No CRF collected|86|||
155131040|NCT00567359|559910943|FG000|Overall Study|Withdrawal by Subject|1|||
155131041|NCT00679172|559910944|FG000|Overall Study|Non-compliance|1|||
155131042|NCT00679172|559910945|FG001|Overall Study|Non-compliance|1|||
155131043|NCT00679172|559910946|FG002|Overall Study|Non-compliance|0|||
155131044|NCT00679172|559910947|FG003|Overall Study|Non-compliance|1|||
155131045|NCT00679172|559910948|FG004|Overall Study|Non-compliance|0|||
155131046|NCT00679172|559910944|FG000|Overall Study|Other not specified|0|||
155131047|NCT00679172|559910945|FG001|Overall Study|Other not specified|0|||
155131048|NCT00679172|559910946|FG002|Overall Study|Other not specified|1|||
155131049|NCT00679172|559910947|FG003|Overall Study|Other not specified|0|||
155131050|NCT00679172|559910948|FG004|Overall Study|Other not specified|0|||
155131051|NCT04395690|559910950|FG000|Overall Study|Lost to Follow-up|1|||
155131052|NCT04395690|559910951|FG001|Overall Study|Lost to Follow-up|1|||
155131053|NCT00753454|559910954|FG000|Overall Study|Adverse Event|4|||
155131054|NCT00753454|559910954|FG000|Overall Study|Lack of Efficacy|1|||
155131055|NCT00753454|559910954|FG000|Overall Study|Lost to Follow-up|3|||
155131056|NCT00753454|559910954|FG000|Overall Study|Withdrawal by Subject|5|||
155131057|NCT00753454|559910954|FG000|Overall Study|Investigator Decision|1|||
155131058|NCT05249569|559910955|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
155131059|NCT04541628|559910956|FG000|Overall Study|Study Terminated|1|||
155131060|NCT04541628|559910957|FG001|Overall Study|Study Terminated|1|||
155131061|NCT04541628|559910958|FG002|Overall Study|Study Terminated|1|||
155131062|NCT02271945|559910962|FG000|Overall Study|Death|3|||
155131063|NCT02271945|559910963|FG001|Overall Study|Death|3|||
155131064|NCT02271945|559910962|FG000|Overall Study|Withdrawal by Subject|1|||
155131065|NCT02271945|559910963|FG001|Overall Study|Withdrawal by Subject|1|||
155131066|NCT02271945|559910962|FG000|Overall Study|Other|1|||
155131067|NCT02271945|559910963|FG001|Overall Study|Other|1|||
155178457|NCT00608569|560091498|FG001|Overall Study|Death|3|||
155178458|NCT00608569|560091497|FG000|Overall Study|Lost to Follow-up|4|||
155178459|NCT00608569|560091498|FG001|Overall Study|Lost to Follow-up|5|||
155131068|NCT01192412|559910964|FG000|Overall Study|Lost to Follow-up|2|||
155131069|NCT01192412|559910965|FG001|Overall Study|Lost to Follow-up|1|||
155131070|NCT01192412|559910964|FG000|Overall Study|Withdrawal by Subject|2|||
155131071|NCT01192412|559910965|FG001|Overall Study|Withdrawal by Subject|1|||
155178460|NCT00608569|560091497|FG000|Overall Study|Withdrawal by Subject|1|||
155131072|NCT00859937|559910966|FG000|Overall Study|Protocol Violation|1|||
155131073|NCT00859937|559910967|FG001|Overall Study|Protocol Violation|0|||
155131074|NCT00308074|559910970|FG000|Overall Study|Withdrawal by Subject|1|||
155131075|NCT01240200|559910971|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
155131076|NCT01240200|559910972|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
155131077|NCT01529034|559910975|FG000|Overall Study|Discontinued prior to study treatment|14|||
155131078|NCT01529034|559910975|FG000|Overall Study|Site closure|62|||
155131079|NCT01529034|559910975|FG000|Overall Study|Study termination|29|||
155131080|NCT01529034|559910975|FG000|Overall Study|Withdrawal by Subject|25|||
155178461|NCT00608569|560091498|FG001|Overall Study|Withdrawal by Subject|0|||
155131081|NCT01529034|559910975|FG000|Overall Study|No treated SCs within protocol window|13|||
155131082|NCT01529034|559910975|FG000|Overall Study|Noncompliance|8|||
155131083|NCT01529034|559910975|FG000|Overall Study|Caregiver no longer available|7|||
155131084|NCT01529034|559910975|FG000|Overall Study|Adverse Event|4|||
155131085|NCT01529034|559910975|FG000|Overall Study|Protocol Violation|4|||
155131086|NCT01529034|559910975|FG000|Overall Study|Lack of Efficacy|4|||
155131087|NCT01529034|559910975|FG000|Overall Study|Investigator no longer available|2|||
155131088|NCT01529034|559910975|FG000|Overall Study|Study drug not available|2|||
155131089|NCT02911142|559910976|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
155131090|NCT02911142|559910976|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
155131091|NCT02911142|559910976|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
155131092|NCT02911142|559910976|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
155131093|NCT01178099|559910977|FG000|Overall Study|Physician Decision|0|||
155131094|NCT01178099|559910978|FG001|Overall Study|Physician Decision|1|||
155131095|NCT03266172|559910979|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
155131096|NCT03266172|559910980|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
155131097|NCT03266172|559910981|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
155131098|NCT03266172|559910979|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
155131099|NCT03266172|559910980|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
155131100|NCT03266172|559910981|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
155131101|NCT03266172|559910979|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
155131102|NCT03266172|559910980|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
155131103|NCT03266172|559910981|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
155131104|NCT03266172|559910979|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
155131105|NCT03266172|559910980|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
155131106|NCT03266172|559910981|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
155131107|NCT03266172|559910979|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155131108|NCT03266172|559910980|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155131109|NCT03266172|559910981|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
155131110|NCT03266172|559910979|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155131111|NCT03266172|559910980|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
155131112|NCT03266172|559910981|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
155131113|NCT05222555|559910982|FG000|Overall Study|Ongoing|2|||
155131114|NCT05222555|559910983|FG001|Overall Study|Ongoing|18|||
155131115|NCT05222555|559910982|FG000|Overall Study|Adverse Event|1|||
155131116|NCT05222555|559910983|FG001|Overall Study|Adverse Event|1|||
155131117|NCT05222555|559910982|FG000|Overall Study|Death|0|||
155131118|NCT05222555|559910983|FG001|Overall Study|Death|6|||
155131119|NCT05222555|559910982|FG000|Overall Study|Withdrawal by Subject|0|||
155131120|NCT05222555|559910983|FG001|Overall Study|Withdrawal by Subject|11|||
155131121|NCT00300365|559910984|FG000|Overall Study|Lost to Follow-up|1|||
155131122|NCT00300365|559910985|FG001|Overall Study|Lost to Follow-up|0|||
155131123|NCT00300365|559910984|FG000|Overall Study|Physician Decision|2|||
155131124|NCT00300365|559910985|FG001|Overall Study|Physician Decision|0|||
155131125|NCT00300365|559910984|FG000|Overall Study|Withdrawal by Subject|1|||
155131126|NCT00300365|559910985|FG001|Overall Study|Withdrawal by Subject|0|||
155131127|NCT00300365|559910984|FG000|Overall Study|Adverse Event|0|||
155131128|NCT00300365|559910985|FG001|Overall Study|Adverse Event|2|||
155131129|NCT01422824|559910990|FG000|Overall Study|Case record form not evaluated|1|||
155131130|NCT01422824|559910990|FG000|Overall Study|Lost to Follow-up|37|||
155131131|NCT00902174|559910991|FG000|Overall Study|Adverse Event|27|||
155131132|NCT00902174|559910992|FG001|Overall Study|Adverse Event|7|||
155131133|NCT00902174|559910991|FG000|Overall Study|Lack of Efficacy|1|||
155131134|NCT00902174|559910992|FG001|Overall Study|Lack of Efficacy|5|||
155131135|NCT00902174|559910991|FG000|Overall Study|Death|2|||
155131136|NCT00902174|559910992|FG001|Overall Study|Death|2|||
155131137|NCT00902174|559910991|FG000|Overall Study|Withdrawal by Subject|2|||
155131138|NCT00902174|559910992|FG001|Overall Study|Withdrawal by Subject|1|||
155131139|NCT00902174|559910991|FG000|Overall Study|Abnormal labs|1|||
155131140|NCT00902174|559910992|FG001|Overall Study|Abnormal labs|1|||
155131141|NCT00902174|559910991|FG000|Overall Study|Protocol Violation|1|||
155131142|NCT00902174|559910992|FG001|Overall Study|Protocol Violation|1|||
155131143|NCT00902174|559910991|FG000|Overall Study|Administration problem|0|||
155131144|NCT00902174|559910992|FG001|Overall Study|Administration problem|1|||
155131145|NCT01641822|559910993|FG000|Run-in Phase|Noncompliance with study drug|1|||
155178462|NCT00608569|560091497|FG000|Overall Study|Adverse Event|1|||
155178463|NCT00608569|560091498|FG001|Overall Study|Adverse Event|0|||
155131146|NCT01641822|559910994|FG001|Run-in Phase|Noncompliance with study drug|0|||
155131147|NCT01641822|559910995|FG002|Run-in Phase|Noncompliance with study drug|0|||
155131148|NCT01641822|559910993|FG000|Run-in Phase|Adverse Event|3|||
155131149|NCT01641822|559910994|FG001|Run-in Phase|Adverse Event|0|||
155178464|NCT00608569|560091497|FG000|Overall Study|Unable to adhere with study requirements|0|||
155131150|NCT01641822|559910995|FG002|Run-in Phase|Adverse Event|0|||
155131151|NCT01641822|559910993|FG000|Run-in Phase|Withdrew consent|1|||
155131152|NCT01641822|559910994|FG001|Run-in Phase|Withdrew consent|0|||
155131153|NCT01641822|559910995|FG002|Run-in Phase|Withdrew consent|0|||
155131154|NCT01641822|559910993|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
155131155|NCT01641822|559910994|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
155131156|NCT01641822|559910995|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
155131157|NCT01641822|559910993|FG000|Comparative Phase|Noncompliance with study drug|0|||
155131158|NCT01641822|559910994|FG001|Comparative Phase|Noncompliance with study drug|1|||
155131159|NCT01641822|559910995|FG002|Comparative Phase|Noncompliance with study drug|0|||
155131160|NCT01641822|559910993|FG000|Comparative Phase|Investigator's discretion|0|||
155131161|NCT01641822|559910994|FG001|Comparative Phase|Investigator's discretion|0|||
155131162|NCT01641822|559910995|FG002|Comparative Phase|Investigator's discretion|1|||
155131163|NCT01641822|559910993|FG000|Comparative Phase|Pregnancy|0|||
155131164|NCT01641822|559910994|FG001|Comparative Phase|Pregnancy|0|||
155131165|NCT01641822|559910995|FG002|Comparative Phase|Pregnancy|1|||
155131166|NCT01641822|559910993|FG000|Comparative Phase|Adverse event, serious fatal|0|||
155131167|NCT01641822|559910994|FG001|Comparative Phase|Adverse event, serious fatal|1|||
155131168|NCT01641822|559910995|FG002|Comparative Phase|Adverse event, serious fatal|0|||
155131169|NCT01641822|559910993|FG000|Comparative Phase|Withdrew consent|0|||
155131170|NCT01641822|559910994|FG001|Comparative Phase|Withdrew consent|3|||
155131171|NCT01641822|559910995|FG002|Comparative Phase|Withdrew consent|7|||
155131172|NCT01641822|559910993|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
155131173|NCT01641822|559910994|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
155131174|NCT01641822|559910995|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
155131175|NCT00454584|559910996|FG000|Controlled Period|Adverse Event|5|||
155131176|NCT00454584|559910997|FG001|Controlled Period|Adverse Event|2|||
155131177|NCT00454584|559910998|FG002|Controlled Period|Adverse Event|1|||
155131178|NCT00454584|559910999|FG003|Controlled Period|Adverse Event|0|||
155131179|NCT00454584|559911000|FG004|Controlled Period|Adverse Event|0|||
155131180|NCT00454584|559911001|FG005|Controlled Period|Adverse Event|0|||
155131181|NCT00454584|559910996|FG000|Controlled Period|Lost to Follow-up|1|||
155131182|NCT00454584|559910997|FG001|Controlled Period|Lost to Follow-up|2|||
155131183|NCT00454584|559910998|FG002|Controlled Period|Lost to Follow-up|2|||
155131184|NCT00454584|559910999|FG003|Controlled Period|Lost to Follow-up|0|||
155131185|NCT00454584|559911000|FG004|Controlled Period|Lost to Follow-up|0|||
155131186|NCT00454584|559911001|FG005|Controlled Period|Lost to Follow-up|0|||
155131187|NCT00454584|559910996|FG000|Controlled Period|Other|5|||
155131188|NCT00454584|559910997|FG001|Controlled Period|Other|4|||
155131189|NCT00454584|559910998|FG002|Controlled Period|Other|2|||
155131190|NCT00454584|559910999|FG003|Controlled Period|Other|0|||
155131191|NCT00454584|559911000|FG004|Controlled Period|Other|0|||
155131192|NCT00454584|559911001|FG005|Controlled Period|Other|0|||
155131193|NCT00454584|559910996|FG000|After Controlled Period|Adverse Event|0|||
155131194|NCT00454584|559910997|FG001|After Controlled Period|Adverse Event|0|||
155131195|NCT00454584|559910998|FG002|After Controlled Period|Adverse Event|0|||
155131196|NCT00454584|559910999|FG003|After Controlled Period|Adverse Event|9|||
155131197|NCT00454584|559911000|FG004|After Controlled Period|Adverse Event|3|||
155131198|NCT00454584|559911001|FG005|After Controlled Period|Adverse Event|9|||
155131199|NCT00454584|559910996|FG000|After Controlled Period|Lack of Efficacy|0|||
155131200|NCT00454584|559910997|FG001|After Controlled Period|Lack of Efficacy|0|||
155131201|NCT00454584|559910998|FG002|After Controlled Period|Lack of Efficacy|0|||
155131202|NCT00454584|559910999|FG003|After Controlled Period|Lack of Efficacy|1|||
155131203|NCT00454584|559911000|FG004|After Controlled Period|Lack of Efficacy|0|||
155131204|NCT00454584|559911001|FG005|After Controlled Period|Lack of Efficacy|0|||
155131205|NCT00454584|559910996|FG000|After Controlled Period|Lost to Follow-up|0|||
155131206|NCT00454584|559910997|FG001|After Controlled Period|Lost to Follow-up|0|||
155131207|NCT00454584|559910998|FG002|After Controlled Period|Lost to Follow-up|0|||
155008699|NCT01808573|559455924|FG001|Overall Study|Withdrawal by Subject|10|||
155008700|NCT01808573|559455923|FG000|Overall Study|Lost to Follow-up|3|||
155178465|NCT00608569|560091498|FG001|Overall Study|Unable to adhere with study requirements|1|||
155008701|NCT01808573|559455924|FG001|Overall Study|Lost to Follow-up|0|||
155131208|NCT00454584|559910999|FG003|After Controlled Period|Lost to Follow-up|2|||
155131209|NCT00454584|559911000|FG004|After Controlled Period|Lost to Follow-up|4|||
155131210|NCT00454584|559911001|FG005|After Controlled Period|Lost to Follow-up|6|||
155131211|NCT00454584|559910996|FG000|After Controlled Period|Other|0|||
155131212|NCT00454584|559910997|FG001|After Controlled Period|Other|0|||
155131213|NCT00454584|559910998|FG002|After Controlled Period|Other|0|||
155131214|NCT00454584|559910999|FG003|After Controlled Period|Other|1|||
155131215|NCT00454584|559911000|FG004|After Controlled Period|Other|0|||
155008702|NCT01808573|559455923|FG000|Overall Study|Discontinuation of study by sponsor|79|||
155131216|NCT00454584|559911001|FG005|After Controlled Period|Other|0|||
155131217|NCT00454584|559910996|FG000|After Controlled Period|Other|0|||
155131218|NCT00454584|559910997|FG001|After Controlled Period|Other|0|||
155131219|NCT00454584|559910998|FG002|After Controlled Period|Other|0|||
155131220|NCT00454584|559910999|FG003|After Controlled Period|Other|13|||
155131221|NCT00454584|559911000|FG004|After Controlled Period|Other|5|||
155131222|NCT00454584|559911001|FG005|After Controlled Period|Other|17|||
155131223|NCT02760810|559911002|FG000|Overall Study|Protocol Violation|1|||
155131224|NCT02421601|559911003|FG000|Overall Study|Adverse Event|4|||
155131225|NCT02421601|559911003|FG000|Overall Study|Lack of Efficacy|5|||
155131226|NCT02421601|559911003|FG000|Overall Study|Physician Decision|1|||
155131227|NCT02421601|559911003|FG000|Overall Study|Withdrawal by Subject|31|||
155131228|NCT02421601|559911003|FG000|Overall Study|Others|41|||
155131229|NCT01581619|559911004|FG000|Overall Study|Withdrawal by Subject|1|||
155131230|NCT01581619|559911004|FG000|Overall Study|Lost to Follow-up|1|||
155131231|NCT02250664|559911005|FG000|Overall Study|Lost to Follow-up|18|||
155131232|NCT02250664|559911006|FG001|Overall Study|Lost to Follow-up|28|||
155131233|NCT02250664|559911007|FG002|Overall Study|Lost to Follow-up|33|||
155131234|NCT02250664|559911005|FG000|Overall Study|Personal Reasons|7|||
155131235|NCT02250664|559911006|FG001|Overall Study|Personal Reasons|8|||
155131236|NCT02250664|559911007|FG002|Overall Study|Personal Reasons|14|||
155131237|NCT02250664|559911005|FG000|Overall Study|Adverse Event|6|||
155131238|NCT02250664|559911006|FG001|Overall Study|Adverse Event|3|||
155131239|NCT02250664|559911007|FG002|Overall Study|Adverse Event|8|||
155131240|NCT02250664|559911005|FG000|Overall Study|Incarcerated|2|||
155131241|NCT02250664|559911006|FG001|Overall Study|Incarcerated|1|||
155131242|NCT02250664|559911007|FG002|Overall Study|Incarcerated|2|||
155131243|NCT02250664|559911005|FG000|Overall Study|Withdrawal by Subject|0|||
155131244|NCT02250664|559911006|FG001|Overall Study|Withdrawal by Subject|1|||
155131245|NCT02250664|559911007|FG002|Overall Study|Withdrawal by Subject|2|||
155131246|NCT02250664|559911005|FG000|Overall Study|Death|0|||
155131247|NCT02250664|559911006|FG001|Overall Study|Death|1|||
155131248|NCT02250664|559911007|FG002|Overall Study|Death|1|||
155131249|NCT02250664|559911005|FG000|Overall Study|Physician Decision|1|||
155131250|NCT02250664|559911006|FG001|Overall Study|Physician Decision|3|||
155131251|NCT02250664|559911007|FG002|Overall Study|Physician Decision|1|||
155131252|NCT02250664|559911005|FG000|Overall Study|Protocol Violation|1|||
155131253|NCT02250664|559911006|FG001|Overall Study|Protocol Violation|0|||
155131254|NCT02250664|559911007|FG002|Overall Study|Protocol Violation|1|||
155131255|NCT02250664|559911005|FG000|Overall Study|Reason unknown|1|||
155131256|NCT02250664|559911006|FG001|Overall Study|Reason unknown|0|||
155131257|NCT02250664|559911007|FG002|Overall Study|Reason unknown|0|||
155131258|NCT01716104|559911008|FG000|Overall Study|Do not meet inclusion criteria|6|||
155131259|NCT01716104|559911009|FG001|Overall Study|Do not meet inclusion criteria|7|||
155131260|NCT00117793|559911010|FG000|Overall Study|Withdrawal by Subject|12|||
155131261|NCT00975143|559911013|FG000|Overall Study|Adverse Event|19|||
155131262|NCT00975143|559911014|FG001|Overall Study|Adverse Event|15|||
155131263|NCT00975143|559911013|FG000|Overall Study|Withdrawal by Subject|15|||
155131264|NCT00975143|559911014|FG001|Overall Study|Withdrawal by Subject|15|||
155131265|NCT00975143|559911013|FG000|Overall Study|Lost to Follow-up|20|||
155131266|NCT00975143|559911014|FG001|Overall Study|Lost to Follow-up|16|||
155131267|NCT00975143|559911013|FG000|Overall Study|Non-compliance|5|||
155131268|NCT00975143|559911014|FG001|Overall Study|Non-compliance|8|||
155131269|NCT00975143|559911013|FG000|Overall Study|Physician Decision|1|||
155131270|NCT00975143|559911014|FG001|Overall Study|Physician Decision|2|||
155131271|NCT00975143|559911013|FG000|Overall Study|Details not available|10|||
155131272|NCT00975143|559911014|FG001|Overall Study|Details not available|4|||
155131273|NCT01753401|559911015|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
155131274|NCT01753401|559911016|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
155131275|NCT01753401|559911017|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
155131276|NCT01753401|559911018|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
155131277|NCT01753401|559911015|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
155131278|NCT01753401|559911016|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
155131279|NCT01753401|559911017|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
155131280|NCT01753401|559911018|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
155131281|NCT01753401|559911015|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
155131282|NCT01753401|559911016|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
155131283|NCT01753401|559911017|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
155131284|NCT01753401|559911018|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
155131285|NCT01753401|559911015|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
155131286|NCT01753401|559911016|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
155131287|NCT01753401|559911017|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
155131288|NCT01753401|559911018|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
155131289|NCT01753401|559911015|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
155131290|NCT01753401|559911016|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
155131291|NCT01753401|559911017|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
155131292|NCT01753401|559911018|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
155131293|NCT01753401|559911015|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
155131294|NCT01753401|559911016|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
155131295|NCT01753401|559911017|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
155131296|NCT01753401|559911018|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
155131297|NCT01753401|559911015|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
155131298|NCT01753401|559911016|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
155151022|NCT02587520|559988168|FG008|Overall Study|Protocol Violation|3|||
155008703|NCT01808573|559455924|FG001|Overall Study|Discontinuation of study by sponsor|64|||
155008704|NCT01808573|559455923|FG000|Overall Study|Randomized in Error|1|||
155008705|NCT01808573|559455924|FG001|Overall Study|Randomized in Error|0|||
155008706|NCT03953612|559455925|FG000|Overall Study|Randomized but did not start|1|||
155008707|NCT03953612|559455926|FG001|Overall Study|Randomized but did not start|1|||
155008708|NCT03953612|559455927|FG002|Overall Study|Randomized but did not start|1|||
155008709|NCT03953612|559455925|FG000|Overall Study|Withdrawal by Subject|2|||
155008710|NCT03953612|559455926|FG001|Overall Study|Withdrawal by Subject|1|||
155008711|NCT03953612|559455927|FG002|Overall Study|Withdrawal by Subject|0|||
155008712|NCT01682811|559455931|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155008713|NCT01682811|559455932|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155008714|NCT01682811|559455933|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155008715|NCT01682811|559455934|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155008716|NCT01682811|559455935|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
155008717|NCT01682811|559455936|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155008718|NCT01682811|559455937|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
155008719|NCT01682811|559455931|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
155008720|NCT01682811|559455932|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
155008721|NCT01682811|559455933|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
155008722|NCT01682811|559455934|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
155008723|NCT01682811|559455935|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
155008724|NCT01682811|559455936|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
155008725|NCT01682811|559455937|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
155008726|NCT01682811|559455931|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
155008727|NCT01682811|559455932|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
155008728|NCT01682811|559455933|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
155008729|NCT01682811|559455934|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
155008730|NCT01682811|559455935|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
155008731|NCT01682811|559455936|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
155008732|NCT01682811|559455937|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
155008733|NCT01682811|559455931|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
155008734|NCT01682811|559455932|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
155008735|NCT01682811|559455933|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
155008736|NCT01682811|559455934|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
155008737|NCT01682811|559455935|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
155008738|NCT01682811|559455936|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
155008739|NCT01682811|559455937|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
155008740|NCT04075487|559457599|FG000|Overall Study|Withdrawal by Subject|1|||
155008741|NCT05016960|559457602|FG000|Overall Study|Withdrawal by Subject|1|||
155008742|NCT05016960|559457603|FG001|Overall Study|Withdrawal by Subject|9|||
155008743|NCT04100018|559457606|FG000|Pre-Treatment Period|Not Reported|0|||
155008744|NCT04100018|559457607|FG001|Pre-Treatment Period|Not Reported|4|||
155008745|NCT04100018|559457606|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
155008746|NCT04100018|559457607|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
155008747|NCT04100018|559457606|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
155008748|NCT04100018|559457607|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
155008749|NCT04100018|559457606|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
155008750|NCT04100018|559457607|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
155008751|NCT04100018|559457606|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
155008752|NCT04100018|559457607|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
155008753|NCT04100018|559457606|FG000|Treatment Period|Ongoing Treatment|1|||
155008754|NCT04100018|559457607|FG001|Treatment Period|Ongoing Treatment|0|||
155008755|NCT04100018|559457606|FG000|Treatment Period|Other Reason|26|||
155008756|NCT04100018|559457607|FG001|Treatment Period|Other Reason|37|||
155008757|NCT04100018|559457606|FG000|Treatment Period|Completed treatment as per protocol|1|||
155008758|NCT04100018|559457607|FG001|Treatment Period|Completed treatment as per protocol|2|||
155008759|NCT04100018|559457606|FG000|Treatment Period|Maximum clinical benefit|3|||
155008760|NCT04100018|559457607|FG001|Treatment Period|Maximum clinical benefit|0|||
155008761|NCT04100018|559457606|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
155008762|NCT04100018|559457607|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
155008763|NCT04100018|559457606|FG000|Treatment Period|Study drug toxicity|67|||
155008764|NCT04100018|559457607|FG001|Treatment Period|Study drug toxicity|28|||
155008765|NCT04100018|559457606|FG000|Treatment Period|Disease Progression|284|||
155008766|NCT04100018|559457607|FG001|Treatment Period|Disease Progression|327|||
155008767|NCT04100018|559457606|FG000|Treatment Period|Administrative reasons by sponsor|16|||
155008768|NCT04100018|559457607|FG001|Treatment Period|Administrative reasons by sponsor|30|||
155008769|NCT04100018|559457606|FG000|Treatment Period|Poor/Non-Compliance|1|||
155008770|NCT04100018|559457607|FG001|Treatment Period|Poor/Non-Compliance|0|||
155008771|NCT04100018|559457606|FG000|Treatment Period|Lost to Follow-up|2|||
155008772|NCT04100018|559457607|FG001|Treatment Period|Lost to Follow-up|2|||
155008773|NCT04100018|559457606|FG000|Treatment Period|Death|16|||
155008774|NCT04100018|559457607|FG001|Treatment Period|Death|11|||
155008775|NCT04100018|559457606|FG000|Treatment Period|Participant withdrew consent|10|||
155151023|NCT02587520|559988169|FG009|Overall Study|Protocol Violation|3|||
155131299|NCT01753401|559911017|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
155131300|NCT01753401|559911018|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
155131301|NCT00581360|559911019|FG000|Overall Study|Withdrawal by Subject|1|||
155131302|NCT03129360|559911020|FG000|Overall Study|Did not meet entry criteria|0|||
155131303|NCT03129360|559911021|FG001|Overall Study|Did not meet entry criteria|2|||
155131304|NCT03129360|559911022|FG002|Overall Study|Did not meet entry criteria|1|||
155131305|NCT03129360|559911020|FG000|Overall Study|Excluded due to motion in scanner|1|||
155131306|NCT03129360|559911021|FG001|Overall Study|Excluded due to motion in scanner|0|||
155131307|NCT03129360|559911022|FG002|Overall Study|Excluded due to motion in scanner|0|||
155131308|NCT00599638|559911023|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
155131309|NCT00599638|559911024|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
155131310|NCT00599638|559911025|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
155131311|NCT00599638|559911026|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
155131312|NCT00599638|559911023|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
155131313|NCT00599638|559911024|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
155131314|NCT00599638|559911025|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
155008776|NCT04100018|559457607|FG001|Treatment Period|Participant withdrew consent|10|||
155008777|NCT04100018|559457606|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
155008778|NCT04100018|559457607|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
155008779|NCT04100018|559457606|FG000|Treatment Period|Adverse Event|14|||
155008780|NCT04100018|559457607|FG001|Treatment Period|Adverse Event|6|||
155008781|NCT04100018|559457606|FG000|Treatment Period|Lack of Efficacy|4|||
155008782|NCT04100018|559457607|FG001|Treatment Period|Lack of Efficacy|2|||
155008783|NCT04358081|559457608|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
155008784|NCT04358081|559457609|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
155008785|NCT04358081|559457610|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
155008786|NCT04358081|559457608|FG000|Treatment Phase of Study|Adverse Event|1|||
155008787|NCT04358081|559457609|FG001|Treatment Phase of Study|Adverse Event|0|||
155008788|NCT04358081|559457610|FG002|Treatment Phase of Study|Adverse Event|1|||
155008789|NCT04358081|559457608|FG000|Treatment Phase of Study|Physician Decision|2|||
155008790|NCT04358081|559457609|FG001|Treatment Phase of Study|Physician Decision|0|||
155008791|NCT04358081|559457610|FG002|Treatment Phase of Study|Physician Decision|1|||
155008792|NCT04358081|559457608|FG000|Treatment Phase of Study|Protocol Violation|1|||
155008793|NCT04358081|559457609|FG001|Treatment Phase of Study|Protocol Violation|0|||
155008794|NCT04358081|559457610|FG002|Treatment Phase of Study|Protocol Violation|0|||
155008795|NCT04358081|559457608|FG000|Study Completion Phase|Death|0|||
155008796|NCT04358081|559457609|FG001|Study Completion Phase|Death|0|||
155008797|NCT04358081|559457610|FG002|Study Completion Phase|Death|1|||
155008798|NCT04358081|559457608|FG000|Study Completion Phase|Lost to Follow-up|1|||
155008799|NCT04358081|559457609|FG001|Study Completion Phase|Lost to Follow-up|0|||
155008800|NCT04358081|559457610|FG002|Study Completion Phase|Lost to Follow-up|1|||
155008801|NCT00696423|559457614|FG000|Overall Study|Lost to Follow-up|0|||
155008802|NCT00696423|559457615|FG001|Overall Study|Lost to Follow-up|5|||
155008803|NCT03989102|559457616|FG000|Year 1|Withdrawal by Subject|6|||
155008804|NCT03989102|559457617|FG001|Year 1|Withdrawal by Subject|2|||
155008805|NCT03989102|559457618|FG002|Year 1|Withdrawal by Subject|7|||
155008806|NCT03989102|559457616|FG000|Year 1|Lost to Follow-up|5|||
155008807|NCT03989102|559457617|FG001|Year 1|Lost to Follow-up|2|||
155008808|NCT03989102|559457618|FG002|Year 1|Lost to Follow-up|5|||
155008809|NCT03989102|559457616|FG000|Year 1|Subject met withdrawal criteria|1|||
155008810|NCT03989102|559457617|FG001|Year 1|Subject met withdrawal criteria|0|||
155008811|NCT03989102|559457618|FG002|Year 1|Subject met withdrawal criteria|1|||
155008812|NCT03989102|559457616|FG000|Year 2|Lost to Follow-up|7|||
155008813|NCT03989102|559457617|FG001|Year 2|Lost to Follow-up|3|||
155008814|NCT03989102|559457618|FG002|Year 2|Lost to Follow-up|4|||
155008815|NCT03989102|559457616|FG000|Year 2|Withdrawal by Subject|3|||
155008816|NCT03989102|559457617|FG001|Year 2|Withdrawal by Subject|1|||
155008817|NCT03989102|559457618|FG002|Year 2|Withdrawal by Subject|2|||
155131315|NCT00599638|559911026|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
155131316|NCT00599638|559911023|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
155131317|NCT00599638|559911024|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
155131318|NCT00599638|559911025|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
155131319|NCT00599638|559911026|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
155008818|NCT03989102|559457616|FG000|Year 2|Subject non-compliant|3|||
155008819|NCT03989102|559457617|FG001|Year 2|Subject non-compliant|2|||
155008820|NCT03989102|559457618|FG002|Year 2|Subject non-compliant|0|||
155008821|NCT03989102|559457616|FG000|Year 2|Travel|1|||
155131320|NCT00599638|559911023|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
155131321|NCT00599638|559911024|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
155008822|NCT03989102|559457617|FG001|Year 2|Travel|0|||
155008823|NCT03989102|559457618|FG002|Year 2|Travel|1|||
155008824|NCT03989102|559457616|FG000|Year 2|P16 missing|4|||
155008825|NCT03989102|559457617|FG001|Year 2|P16 missing|2|||
155008826|NCT03989102|559457618|FG002|Year 2|P16 missing|1|||
155008827|NCT03989102|559457616|FG000|Year 2|P11 missing|1|||
155131322|NCT00599638|559911025|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
155131323|NCT00599638|559911026|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
155131324|NCT00599638|559911023|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
155131325|NCT00599638|559911024|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
155131326|NCT00599638|559911025|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
155131327|NCT00599638|559911026|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
155131328|NCT00599638|559911023|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
155131329|NCT00599638|559911024|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
155131330|NCT00599638|559911025|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
155131331|NCT00599638|559911026|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
155131332|NCT00599638|559911023|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
155131333|NCT00599638|559911024|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
155131334|NCT00599638|559911025|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
155131335|NCT00599638|559911026|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
155131336|NCT00599638|559911023|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
155131337|NCT00599638|559911024|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
155131338|NCT00599638|559911025|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
155131339|NCT00599638|559911026|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
155131340|NCT00599638|559911023|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
155131341|NCT00599638|559911024|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
155131342|NCT00599638|559911025|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
155131343|NCT00599638|559911026|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
155131344|NCT03006887|559911030|FG000|Overall Study|Adverse Event|1|||
155131345|NCT03836677|559911031|FG000|Period 1|Adverse Event|0|||
155131346|NCT03836677|559911032|FG001|Period 1|Adverse Event|1|||
155131347|NCT03836677|559911031|FG000|Period 2|Severe non-compliance to protocol|1|||
155131348|NCT03836677|559911032|FG001|Period 2|Severe non-compliance to protocol|0|||
155131349|NCT02895945|559911033|FG000|Overall Study|Physician Decision|2|||
155131350|NCT02895945|559911034|FG001|Overall Study|Physician Decision|1|||
155131351|NCT00462748|559911035|FG000|Overall Study|Adverse Event|7|||
155131352|NCT00462748|559911036|FG001|Overall Study|Adverse Event|5|||
155131353|NCT00462748|559911037|FG002|Overall Study|Adverse Event|9|||
155131354|NCT00462748|559911035|FG000|Overall Study|Protocol Violation|0|||
155131355|NCT00462748|559911036|FG001|Overall Study|Protocol Violation|2|||
155131356|NCT00462748|559911037|FG002|Overall Study|Protocol Violation|1|||
155131357|NCT00462748|559911035|FG000|Overall Study|Withdrew consent|3|||
155131358|NCT00462748|559911036|FG001|Overall Study|Withdrew consent|3|||
155131359|NCT00462748|559911037|FG002|Overall Study|Withdrew consent|0|||
155131360|NCT00462748|559911035|FG000|Overall Study|Lost to Follow-up|1|||
155131361|NCT00462748|559911036|FG001|Overall Study|Lost to Follow-up|1|||
155131362|NCT00462748|559911037|FG002|Overall Study|Lost to Follow-up|1|||
155131363|NCT00462748|559911035|FG000|Overall Study|Discontinued after 41 days Rx|1|||
155131364|NCT00462748|559911036|FG001|Overall Study|Discontinued after 41 days Rx|0|||
155131365|NCT00462748|559911037|FG002|Overall Study|Discontinued after 41 days Rx|0|||
155131366|NCT01818492|559911038|FG000|Overall Study|Adverse Event|2|||
155131367|NCT01818492|559911038|FG000|Overall Study|Death|3|||
155131368|NCT01818492|559911038|FG000|Overall Study|Withdrawal by Subject|1|||
155131369|NCT01818492|559911038|FG000|Overall Study|Additional therapy when not allowed PP|4|||
155131370|NCT00082381|559911039|FG000|Overall Study|Adverse Event|27|||
155131371|NCT00082381|559911040|FG001|Overall Study|Adverse Event|2|||
155131372|NCT00082381|559911039|FG000|Overall Study|Lost to Follow-up|5|||
155131373|NCT00082381|559911040|FG001|Overall Study|Lost to Follow-up|7|||
155131374|NCT00082381|559911039|FG000|Overall Study|Patient Decision|8|||
155131375|NCT00082381|559911040|FG001|Overall Study|Patient Decision|4|||
155131376|NCT00082381|559911039|FG000|Overall Study|Physician Decision|1|||
155131377|NCT00082381|559911040|FG001|Overall Study|Physician Decision|2|||
155131378|NCT00082381|559911039|FG000|Overall Study|Protocol Violation|10|||
155131379|NCT00082381|559911040|FG001|Overall Study|Protocol Violation|11|||
155131380|NCT00082381|559911039|FG000|Overall Study|Loss of Glucose Control|4|||
155131381|NCT00082381|559911040|FG001|Overall Study|Loss of Glucose Control|0|||
155131382|NCT01729208|559911041|FG000|Baseline|Physician Decision|5|||
155131383|NCT01729208|559911042|FG001|Baseline|Physician Decision|4|||
155131384|NCT01729208|559911041|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
155131385|NCT01729208|559911042|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
155131386|NCT01729208|559911041|FG000|12 Months Follow-up|Lost to Follow-up|3|||
155131387|NCT01729208|559911042|FG001|12 Months Follow-up|Lost to Follow-up|3|||
155131388|NCT01729208|559911041|FG000|24 Months Follow-up|Lost to Follow-up|3|||
155131389|NCT01729208|559911042|FG001|24 Months Follow-up|Lost to Follow-up|0|||
155131390|NCT01729208|559911041|FG000|36 Months Follow-up|Physician Decision|1|||
155131391|NCT01729208|559911042|FG001|36 Months Follow-up|Physician Decision|0|||
155178466|NCT03985878|560091506|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
155131392|NCT01729208|559911041|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
155131393|NCT01729208|559911042|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
155178467|NCT03985878|560091506|FG000|Overall Study|Study Terminated by Sponsor|12|||
155131394|NCT02428413|559911043|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
155131395|NCT02428413|559911044|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
155131396|NCT02428413|559911043|FG000|Overall Study|Protocol Violation|1|||
155131397|NCT02428413|559911044|FG001|Overall Study|Protocol Violation|2|||
155131398|NCT02428413|559911043|FG000|Overall Study|Case Cancelled|2|||
155008828|NCT03989102|559457617|FG001|Year 2|P11 missing|3|||
155008829|NCT03989102|559457618|FG002|Year 2|P11 missing|7|||
155008830|NCT03989102|559457616|FG000|Year 2|Definitive displacement outside the study site|0|||
155008831|NCT03989102|559457617|FG001|Year 2|Definitive displacement outside the study site|1|||
155008832|NCT03989102|559457618|FG002|Year 2|Definitive displacement outside the study site|0|||
155008833|NCT03989102|559457616|FG000|Year 2|Subject missed last study visit|0|||
155008834|NCT03989102|559457617|FG001|Year 2|Subject missed last study visit|1|||
155008835|NCT03989102|559457618|FG002|Year 2|Subject missed last study visit|0|||
155008836|NCT03989102|559457616|FG000|Year 2|Death|0|||
155008837|NCT03989102|559457617|FG001|Year 2|Death|1|||
155008838|NCT03989102|559457618|FG002|Year 2|Death|0|||
155008839|NCT03989102|559457616|FG000|Year 2|Subject not reachable|0|||
155008840|NCT03989102|559457617|FG001|Year 2|Subject not reachable|0|||
155008841|NCT03989102|559457618|FG002|Year 2|Subject not reachable|1|||
155008842|NCT03989102|559457616|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
155008843|NCT03989102|559457617|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
155008844|NCT03989102|559457618|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
155008845|NCT03989102|559457616|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
155008846|NCT03989102|559457617|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
155008847|NCT03989102|559457618|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
155008848|NCT03989102|559457616|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
155008849|NCT03989102|559457617|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
155008850|NCT03989102|559457618|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
155008851|NCT03989102|559457616|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
155008852|NCT03989102|559457617|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
155008853|NCT03989102|559457618|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
155008854|NCT03989102|559457616|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
155008855|NCT03989102|559457617|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
155008856|NCT03989102|559457618|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
155008857|NCT03989102|559457616|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
155008858|NCT03989102|559457617|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
155008859|NCT03989102|559457618|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
155008860|NCT01321749|559457619|FG000|Overall Study|Lost to Follow-up|4|||
155008861|NCT01321749|559457620|FG001|Overall Study|Lost to Follow-up|11|||
155008862|NCT01321749|559457619|FG000|Overall Study|Protocol Violation|4|||
155008863|NCT01321749|559457620|FG001|Overall Study|Protocol Violation|7|||
155008864|NCT01321749|559457619|FG000|Overall Study|Withdrawal by Subject|5|||
155008865|NCT01321749|559457620|FG001|Overall Study|Withdrawal by Subject|4|||
155008866|NCT04179838|559457621|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155008867|NCT04179838|559457622|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
155008868|NCT04179838|559457621|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
155008869|NCT04179838|559457622|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
155008870|NCT02760004|559457627|FG000|Overall Study|Lost to Follow-up|13|||
155008871|NCT02760004|559457628|FG001|Overall Study|Lost to Follow-up|22|||
155008872|NCT00970593|559457629|FG000|Overall Study|Adverse Event|1|||
155008873|NCT00970593|559457630|FG001|Overall Study|Adverse Event|1|||
155008874|NCT00970593|559457631|FG002|Overall Study|Adverse Event|0|||
155008875|NCT00970593|559457632|FG003|Overall Study|Adverse Event|0|||
155008876|NCT00970593|559457633|FG004|Overall Study|Adverse Event|0|||
155008877|NCT00970593|559457634|FG005|Overall Study|Adverse Event|0|||
155008878|NCT00970593|559457635|FG006|Overall Study|Adverse Event|0|||
155008879|NCT00970593|559457629|FG000|Overall Study|Discontinuation of study by sponsor|0|||
155008880|NCT00970593|559457630|FG001|Overall Study|Discontinuation of study by sponsor|0|||
155131399|NCT02428413|559911044|FG001|Overall Study|Case Cancelled|0|||
155131400|NCT02428413|559911043|FG000|Overall Study|Missed Cases|1|||
155131401|NCT02428413|559911044|FG001|Overall Study|Missed Cases|2|||
155131402|NCT02428413|559911043|FG000|Overall Study|Nurse Refusal|1|||
155008881|NCT00970593|559457631|FG002|Overall Study|Discontinuation of study by sponsor|5|||
155008882|NCT00970593|559457632|FG003|Overall Study|Discontinuation of study by sponsor|0|||
155008883|NCT00970593|559457633|FG004|Overall Study|Discontinuation of study by sponsor|0|||
155008884|NCT00970593|559457634|FG005|Overall Study|Discontinuation of study by sponsor|0|||
155008885|NCT00970593|559457635|FG006|Overall Study|Discontinuation of study by sponsor|2|||
155008886|NCT00970593|559457629|FG000|Overall Study|Withdrawal by Subject|0|||
155008887|NCT00970593|559457630|FG001|Overall Study|Withdrawal by Subject|0|||
155008888|NCT00970593|559457631|FG002|Overall Study|Withdrawal by Subject|1|||
155008889|NCT00970593|559457632|FG003|Overall Study|Withdrawal by Subject|0|||
155008890|NCT00970593|559457633|FG004|Overall Study|Withdrawal by Subject|0|||
155008891|NCT00970593|559457634|FG005|Overall Study|Withdrawal by Subject|0|||
155008892|NCT00970593|559457635|FG006|Overall Study|Withdrawal by Subject|0|||
155008893|NCT00470535|559457645|FG000|Overall Study|Disease Progression|13|||
155008894|NCT00470535|559457645|FG000|Overall Study|Withdrawal by Subject|1|||
155008895|NCT00470535|559457645|FG000|Overall Study|Adverse Event|1|||
155008896|NCT00470535|559457645|FG000|Overall Study|Death|1|||
155008897|NCT00470535|559457645|FG000|Overall Study|Other|2|||
155008898|NCT04123405|559457646|FG000|Overall Study|Adverse Event|1|||
155008899|NCT04123405|559457647|FG001|Overall Study|Adverse Event|2|||
155008900|NCT04123405|559457648|FG002|Overall Study|Adverse Event|3|||
155008901|NCT04123405|559457649|FG003|Overall Study|Adverse Event|3|||
155008902|NCT04123405|559457646|FG000|Overall Study|Exclusion criteria met|1|||
155008903|NCT04123405|559457647|FG001|Overall Study|Exclusion criteria met|2|||
155008904|NCT04123405|559457648|FG002|Overall Study|Exclusion criteria met|0|||
155008905|NCT04123405|559457649|FG003|Overall Study|Exclusion criteria met|2|||
155008906|NCT04123405|559457646|FG000|Overall Study|Withdrawal by Subject|1|||
155008907|NCT04123405|559457647|FG001|Overall Study|Withdrawal by Subject|3|||
155008908|NCT04123405|559457648|FG002|Overall Study|Withdrawal by Subject|0|||
155008909|NCT04123405|559457649|FG003|Overall Study|Withdrawal by Subject|2|||
155008910|NCT04123405|559457646|FG000|Overall Study|Contact to subject lost|0|||
155008911|NCT04123405|559457647|FG001|Overall Study|Contact to subject lost|0|||
155008912|NCT04123405|559457648|FG002|Overall Study|Contact to subject lost|0|||
155008913|NCT04123405|559457649|FG003|Overall Study|Contact to subject lost|1|||
155008914|NCT04123405|559457646|FG000|Overall Study|screening failure|1|||
155008915|NCT04123405|559457647|FG001|Overall Study|screening failure|0|||
155008916|NCT04123405|559457648|FG002|Overall Study|screening failure|0|||
155008917|NCT04123405|559457649|FG003|Overall Study|screening failure|0|||
155008918|NCT00545714|559457650|FG000|Induction Phase (6 Months)|Physician Decision|3|||
155008919|NCT00545714|559457650|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
155008920|NCT00545714|559457650|FG000|Induction Phase (6 Months)|Disease Progression|1|||
155008921|NCT00545714|559457650|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
155008922|NCT00545714|559457650|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
155008923|NCT00545714|559457650|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
155008924|NCT00545714|559457650|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
155008925|NCT00545714|559457650|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
155008926|NCT00545714|559457650|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
155008927|NCT00545714|559457650|FG000|Maintenance Phase (36 Months)|Death|2|||
155008928|NCT03889886|559457652|FG000|Overall Study|Other|0|||
155008929|NCT03889886|559457653|FG001|Overall Study|Other|1|||
155008930|NCT03889886|559457654|FG002|Overall Study|Other|0|||
155008931|NCT03889886|559457655|FG003|Overall Study|Other|1|||
155008932|NCT03889886|559457652|FG000|Overall Study|Withdrawal by Subject|0|||
155008933|NCT03889886|559457653|FG001|Overall Study|Withdrawal by Subject|0|||
155008934|NCT03889886|559457654|FG002|Overall Study|Withdrawal by Subject|1|||
155008935|NCT03889886|559457655|FG003|Overall Study|Withdrawal by Subject|0|||
155008936|NCT03889886|559457652|FG000|Overall Study|Adverse Event|0|||
155008937|NCT03889886|559457653|FG001|Overall Study|Adverse Event|0|||
155008938|NCT03889886|559457654|FG002|Overall Study|Adverse Event|0|||
155008939|NCT03889886|559457655|FG003|Overall Study|Adverse Event|6|||
155008940|NCT00276484|559457656|FG000|Overall Study|Adverse Event|4|||
155008941|NCT00276484|559457657|FG001|Overall Study|Adverse Event|7|||
155008942|NCT00276484|559457656|FG000|Overall Study|Lost to Follow-up|1|||
155008943|NCT00276484|559457657|FG001|Overall Study|Lost to Follow-up|1|||
155008944|NCT00276484|559457656|FG000|Overall Study|Protocol Violation|0|||
155008945|NCT00276484|559457657|FG001|Overall Study|Protocol Violation|1|||
155008946|NCT00276484|559457656|FG000|Overall Study|Withdrawal by Subject|4|||
155008947|NCT00276484|559457657|FG001|Overall Study|Withdrawal by Subject|3|||
155008948|NCT00276484|559457656|FG000|Overall Study|Could not take time off work|0|||
155008949|NCT00276484|559457657|FG001|Overall Study|Could not take time off work|1|||
155008950|NCT00116779|559457671|FG000|Overall Study|Adverse Event|4|||
155008951|NCT00116779|559457672|FG001|Overall Study|Adverse Event|2|||
155008952|NCT00116779|559457671|FG000|Overall Study|Protocol Violation|1|||
155008953|NCT00116779|559457672|FG001|Overall Study|Protocol Violation|4|||
155131403|NCT02428413|559911044|FG001|Overall Study|Nurse Refusal|0|||
155131404|NCT00109577|559911045|FG000|Overall Study|Withdrawal by Subject|3|||
155131405|NCT00109577|559911046|FG001|Overall Study|Withdrawal by Subject|3|||
155131406|NCT04891107|559911047|FG000|Overall Study|Physician Decision|1|||
155151024|NCT02587520|559988170|FG010|Overall Study|Protocol Violation|1|||
155008954|NCT00116779|559457671|FG000|Overall Study|Withdrawal by Subject|4|||
155008955|NCT00116779|559457672|FG001|Overall Study|Withdrawal by Subject|1|||
155008956|NCT00116779|559457671|FG000|Overall Study|Inadequate testosterone suppression|7|||
155008957|NCT00116779|559457672|FG001|Overall Study|Inadequate testosterone suppression|9|||
155008958|NCT00116779|559457671|FG000|Overall Study|Physician Decision|3|||
155008959|NCT00116779|559457672|FG001|Overall Study|Physician Decision|1|||
155008960|NCT00116779|559457671|FG000|Overall Study|Elevated PSA levels|2|||
155008961|NCT00116779|559457672|FG001|Overall Study|Elevated PSA levels|2|||
155008962|NCT00707239|559457673|FG000|Overall Study|Adverse Event|5|||
155008963|NCT00707239|559457674|FG001|Overall Study|Adverse Event|3|||
155008964|NCT00707239|559457675|FG002|Overall Study|Adverse Event|2|||
155008965|NCT00707239|559457673|FG000|Overall Study|Death|3|||
155008966|NCT00707239|559457674|FG001|Overall Study|Death|1|||
155008967|NCT00707239|559457675|FG002|Overall Study|Death|3|||
155008968|NCT00707239|559457673|FG000|Overall Study|Physician Decision|1|||
155008969|NCT00707239|559457674|FG001|Overall Study|Physician Decision|1|||
155008970|NCT00707239|559457675|FG002|Overall Study|Physician Decision|2|||
155008971|NCT00707239|559457673|FG000|Overall Study|Protocol Violation|0|||
155008972|NCT00707239|559457674|FG001|Overall Study|Protocol Violation|0|||
155008973|NCT00707239|559457675|FG002|Overall Study|Protocol Violation|1|||
155008974|NCT00707239|559457673|FG000|Overall Study|Lack of Efficacy|1|||
155008975|NCT00707239|559457674|FG001|Overall Study|Lack of Efficacy|2|||
155008976|NCT00707239|559457675|FG002|Overall Study|Lack of Efficacy|0|||
155008977|NCT00707239|559457673|FG000|Overall Study|Randomized, but not treated|1|||
155008978|NCT00707239|559457674|FG001|Overall Study|Randomized, but not treated|1|||
155008979|NCT00707239|559457675|FG002|Overall Study|Randomized, but not treated|1|||
155008980|NCT00707239|559457673|FG000|Overall Study|Other|8|||
155008981|NCT00707239|559457674|FG001|Overall Study|Other|3|||
155008982|NCT00707239|559457675|FG002|Overall Study|Other|5|||
155008983|NCT00711087|559457676|FG000|Overall Study|Lost to Follow-up|1|||
155008984|NCT00711087|559457677|FG001|Overall Study|Lost to Follow-up|0|||
155008985|NCT01958437|559457678|FG000|Overall Study|Incidental MRI findings|0|||
155008986|NCT01958437|559457679|FG001|Overall Study|Incidental MRI findings|0|||
155008987|NCT01958437|559457680|FG002|Overall Study|Incidental MRI findings|1|||
155008988|NCT01958437|559457681|FG003|Overall Study|Incidental MRI findings|1|||
155008989|NCT02394600|559457682|FG000|Overall Study|Adverse Event|3|||
155008990|NCT02394600|559457683|FG001|Overall Study|Adverse Event|0|||
155008991|NCT02394600|559457682|FG000|Overall Study|Lost to Follow-up|0|||
155008992|NCT02394600|559457683|FG001|Overall Study|Lost to Follow-up|1|||
155008993|NCT02394600|559457682|FG000|Overall Study|Withdrawal by Subject|0|||
155008994|NCT02394600|559457683|FG001|Overall Study|Withdrawal by Subject|1|||
155008995|NCT02394600|559457682|FG000|Overall Study|Protocol Violation|1|||
155008996|NCT02394600|559457683|FG001|Overall Study|Protocol Violation|0|||
155008997|NCT02569801|559457684|FG000|Overall Study|Withdrawal by Subject|9|||
155008998|NCT02569801|559457685|FG001|Overall Study|Withdrawal by Subject|9|||
155008999|NCT02569801|559457684|FG000|Overall Study|Sponsor Decision|13|||
155009000|NCT02569801|559457685|FG001|Overall Study|Sponsor Decision|14|||
155009001|NCT02569801|559457684|FG000|Overall Study|Progressive Disease|2|||
155009002|NCT02569801|559457685|FG001|Overall Study|Progressive Disease|7|||
155009003|NCT02569801|559457684|FG000|Overall Study|Lost to Follow-up|0|||
155009004|NCT02569801|559457685|FG001|Overall Study|Lost to Follow-up|1|||
155009005|NCT02569801|559457684|FG000|Overall Study|Death|12|||
155009006|NCT02569801|559457685|FG001|Overall Study|Death|4|||
155009007|NCT03442751|559457686|FG000|Overall Study|Withdrawal by Subject|3|||
155009008|NCT03442751|559457687|FG001|Overall Study|Withdrawal by Subject|1|||
155009009|NCT03442751|559457686|FG000|Overall Study|Lost to Follow-up|3|||
155009010|NCT03442751|559457687|FG001|Overall Study|Lost to Follow-up|0|||
155009011|NCT02603887|559457689|FG000|Stage 1|Adverse Event|4|||
155009012|NCT02603887|559457689|FG000|Stage 1|Disease progression|1|||
155009013|NCT02603887|559457689|FG000|Stage 2|FDA guidance|1|||
155009014|NCT01308424|559457692|FG000|Baseline Eligibility|Screen Failures|71|||
155009015|NCT01308424|559457693|FG001|Baseline Eligibility|Screen Failures|0|||
155009016|NCT01308424|559457694|FG002|Baseline Eligibility|Screen Failures|0|||
155009017|NCT01308424|559457692|FG000|Randomization|Adverse Event|0|||
155009018|NCT01308424|559457693|FG001|Randomization|Adverse Event|1|||
155009019|NCT01308424|559457694|FG002|Randomization|Adverse Event|1|||
155009020|NCT01308424|559457692|FG000|Randomization|Lost to Follow-up|0|||
155009021|NCT01308424|559457693|FG001|Randomization|Lost to Follow-up|1|||
155009022|NCT01308424|559457694|FG002|Randomization|Lost to Follow-up|0|||
155009023|NCT01308424|559457692|FG000|Randomization|Physician Decision|0|||
155009024|NCT01308424|559457693|FG001|Randomization|Physician Decision|1|||
155009025|NCT01308424|559457694|FG002|Randomization|Physician Decision|1|||
155009026|NCT00948155|559457695|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
155009027|NCT00948155|559457696|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
155009028|NCT00948155|559457695|FG000|Washout 14 Days|Lost to Follow-up|1|||
155009029|NCT00948155|559457696|FG001|Washout 14 Days|Lost to Follow-up|2|||
155009030|NCT04620746|559457697|FG000|Overall Study|Adverse Event|2|||
155009031|NCT04620746|559457698|FG001|Overall Study|Adverse Event|0|||
155009032|NCT04620746|559457697|FG000|Overall Study|Uniterpretable skin test|1|||
155009033|NCT04620746|559457698|FG001|Overall Study|Uniterpretable skin test|0|||
155009034|NCT04620746|559457697|FG000|Overall Study|Withdrawal by Subject|0|||
155009035|NCT04620746|559457698|FG001|Overall Study|Withdrawal by Subject|1|||
155009036|NCT05767905|559457701|FG000|Overall Study|Adverse Event|0|||
155009037|NCT05767905|559457702|FG001|Overall Study|Adverse Event|0|||
155009038|NCT05767905|559457703|FG002|Overall Study|Adverse Event|1|||
155009039|NCT03404674|559457705|FG000|Overall Study|Inability to Attend Future Visits|0|||
155131407|NCT04891107|559911047|FG000|Overall Study|Withdrawal by Subject|1|||
155009040|NCT03404674|559457706|FG001|Overall Study|Inability to Attend Future Visits|1|||
155009041|NCT03404674|559457707|FG002|Overall Study|Inability to Attend Future Visits|1|||
155009042|NCT03404674|559457708|FG003|Overall Study|Inability to Attend Future Visits|0|||
155009043|NCT03404674|559457709|FG004|Overall Study|Inability to Attend Future Visits|0|||
155009044|NCT03404674|559457710|FG005|Overall Study|Inability to Attend Future Visits|0|||
155009045|NCT03404674|559457705|FG000|Overall Study|Behavioral Problems|0|||
155009046|NCT03404674|559457706|FG001|Overall Study|Behavioral Problems|0|||
155009047|NCT03404674|559457707|FG002|Overall Study|Behavioral Problems|1|||
155009048|NCT03404674|559457708|FG003|Overall Study|Behavioral Problems|0|||
155009049|NCT03404674|559457709|FG004|Overall Study|Behavioral Problems|0|||
155009050|NCT03404674|559457710|FG005|Overall Study|Behavioral Problems|0|||
155009051|NCT03404674|559457705|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
155009052|NCT03404674|559457706|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
155009053|NCT03404674|559457707|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
155009054|NCT03404674|559457708|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
155009055|NCT03404674|559457709|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
155009056|NCT03404674|559457710|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
155009057|NCT03125798|559457712|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
155009058|NCT03125798|559457713|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
155009059|NCT03125798|559457712|FG000|Overall Study|Conversion to thoracotomy|7|||
155009060|NCT03125798|559457713|FG001|Overall Study|Conversion to thoracotomy|7|||
155009061|NCT01487525|559457714|FG000|Overall Study|Withdrawal by Subject|0|||
155009062|NCT01487525|559457715|FG001|Overall Study|Withdrawal by Subject|1|||
155009063|NCT00262028|559457719|FG000|Overall Study|Withdrawal by Subject|6|||
155009064|NCT00262028|559457720|FG001|Overall Study|Withdrawal by Subject|3|||
155009065|NCT00262028|559457721|FG002|Overall Study|Withdrawal by Subject|6|||
155009066|NCT00262028|559457722|FG003|Overall Study|Withdrawal by Subject|5|||
155009067|NCT00262028|559457723|FG004|Overall Study|Withdrawal by Subject|2|||
155009068|NCT00262028|559457724|FG005|Overall Study|Withdrawal by Subject|3|||
155009069|NCT00262028|559457725|FG006|Overall Study|Withdrawal by Subject|5|||
155009070|NCT00262028|559457726|FG007|Overall Study|Withdrawal by Subject|7|||
155009071|NCT00262028|559457727|FG008|Overall Study|Withdrawal by Subject|2|||
155009072|NCT00262028|559457719|FG000|Overall Study|Lost to Follow-up|7|||
155009073|NCT00262028|559457720|FG001|Overall Study|Lost to Follow-up|7|||
155009074|NCT00262028|559457721|FG002|Overall Study|Lost to Follow-up|5|||
155009075|NCT00262028|559457722|FG003|Overall Study|Lost to Follow-up|5|||
155009076|NCT00262028|559457723|FG004|Overall Study|Lost to Follow-up|4|||
155009077|NCT00262028|559457724|FG005|Overall Study|Lost to Follow-up|3|||
155009078|NCT00262028|559457725|FG006|Overall Study|Lost to Follow-up|3|||
155009079|NCT00262028|559457726|FG007|Overall Study|Lost to Follow-up|5|||
155009080|NCT00262028|559457727|FG008|Overall Study|Lost to Follow-up|6|||
155009081|NCT00262028|559457719|FG000|Overall Study|Administrative Reason|11|||
155009082|NCT00262028|559457720|FG001|Overall Study|Administrative Reason|14|||
155009083|NCT00262028|559457721|FG002|Overall Study|Administrative Reason|9|||
155009084|NCT00262028|559457722|FG003|Overall Study|Administrative Reason|12|||
155009085|NCT00262028|559457723|FG004|Overall Study|Administrative Reason|6|||
155009086|NCT00262028|559457724|FG005|Overall Study|Administrative Reason|7|||
155009087|NCT00262028|559457725|FG006|Overall Study|Administrative Reason|4|||
155009088|NCT00262028|559457726|FG007|Overall Study|Administrative Reason|6|||
155009089|NCT00262028|559457727|FG008|Overall Study|Administrative Reason|10|||
155009090|NCT00262028|559457719|FG000|Overall Study|Protocol Violation|0|||
155009091|NCT00262028|559457720|FG001|Overall Study|Protocol Violation|0|||
155009092|NCT00262028|559457721|FG002|Overall Study|Protocol Violation|0|||
155009093|NCT00262028|559457722|FG003|Overall Study|Protocol Violation|1|||
155009094|NCT00262028|559457723|FG004|Overall Study|Protocol Violation|0|||
155009095|NCT00262028|559457724|FG005|Overall Study|Protocol Violation|0|||
155009096|NCT00262028|559457725|FG006|Overall Study|Protocol Violation|0|||
155009097|NCT00262028|559457726|FG007|Overall Study|Protocol Violation|0|||
155009098|NCT00262028|559457727|FG008|Overall Study|Protocol Violation|0|||
155009099|NCT00262028|559457719|FG000|Overall Study|Unable to classify|0|||
155009100|NCT00262028|559457720|FG001|Overall Study|Unable to classify|3|||
155131408|NCT04891107|559911047|FG000|Overall Study|Screen failure after consent|1|||
155131409|NCT04566601|559912885|FG000|Overall Study|Other than listed|13|||
155131410|NCT04566601|559912886|FG001|Overall Study|Other than listed|4|||
155131411|NCT04566601|559912887|FG002|Overall Study|Other than listed|2|||
155131412|NCT04566601|559912888|FG003|Overall Study|Other than listed|1|||
155009101|NCT00262028|559457721|FG002|Overall Study|Unable to classify|0|||
155009102|NCT00262028|559457722|FG003|Overall Study|Unable to classify|0|||
155009103|NCT00262028|559457723|FG004|Overall Study|Unable to classify|0|||
155009104|NCT00262028|559457724|FG005|Overall Study|Unable to classify|0|||
155009105|NCT00262028|559457725|FG006|Overall Study|Unable to classify|0|||
155009106|NCT00262028|559457726|FG007|Overall Study|Unable to classify|0|||
155009107|NCT00262028|559457727|FG008|Overall Study|Unable to classify|1|||
155009108|NCT01515423|559457728|FG000|Open Label Phase|Adverse Event|57|||
155009109|NCT01515423|559457729|FG001|Open Label Phase|Adverse Event|0|||
155009110|NCT01515423|559457730|FG002|Open Label Phase|Adverse Event|0|||
155009111|NCT01515423|559457728|FG000|Open Label Phase|Death|2|||
155009112|NCT01515423|559457729|FG001|Open Label Phase|Death|0|||
155131413|NCT04566601|559912889|FG004|Overall Study|Other than listed|4|||
155131414|NCT04566601|559912885|FG000|Overall Study|Protocol deviation|3|||
155131415|NCT04566601|559912886|FG001|Overall Study|Protocol deviation|0|||
155131416|NCT04566601|559912887|FG002|Overall Study|Protocol deviation|1|||
155009113|NCT01515423|559457730|FG002|Open Label Phase|Death|0|||
155009114|NCT01515423|559457728|FG000|Open Label Phase|Lack of Efficacy|117|||
155009115|NCT01515423|559457729|FG001|Open Label Phase|Lack of Efficacy|0|||
155009116|NCT01515423|559457730|FG002|Open Label Phase|Lack of Efficacy|0|||
155009117|NCT01515423|559457728|FG000|Open Label Phase|Lost to Follow-up|21|||
155009118|NCT01515423|559457729|FG001|Open Label Phase|Lost to Follow-up|0|||
155009119|NCT01515423|559457730|FG002|Open Label Phase|Lost to Follow-up|0|||
155009120|NCT01515423|559457728|FG000|Open Label Phase|Withdrawal by Subject|118|||
155009121|NCT01515423|559457729|FG001|Open Label Phase|Withdrawal by Subject|0|||
155009122|NCT01515423|559457730|FG002|Open Label Phase|Withdrawal by Subject|0|||
155009123|NCT01515423|559457728|FG000|Open Label Phase|excluded from DB Phase|70|||
155009124|NCT01515423|559457729|FG001|Open Label Phase|excluded from DB Phase|0|||
155009125|NCT01515423|559457730|FG002|Open Label Phase|excluded from DB Phase|0|||
155009126|NCT01515423|559457728|FG000|Open Label Phase|Other|28|||
155009127|NCT01515423|559457729|FG001|Open Label Phase|Other|0|||
155009128|NCT01515423|559457730|FG002|Open Label Phase|Other|0|||
155009129|NCT01515423|559457728|FG000|DOUBLE BLIND|Adverse Event|0|||
155009130|NCT01515423|559457729|FG001|DOUBLE BLIND|Adverse Event|15|||
155009131|NCT01515423|559457730|FG002|DOUBLE BLIND|Adverse Event|13|||
155009132|NCT01515423|559457728|FG000|DOUBLE BLIND|Death|0|||
155009133|NCT01515423|559457729|FG001|DOUBLE BLIND|Death|1|||
155009134|NCT01515423|559457730|FG002|DOUBLE BLIND|Death|2|||
155009135|NCT01515423|559457728|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
155009136|NCT01515423|559457729|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
155009137|NCT01515423|559457730|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
155009138|NCT01515423|559457728|FG000|DOUBLE BLIND|Pregnancy|0|||
155009139|NCT01515423|559457729|FG001|DOUBLE BLIND|Pregnancy|2|||
155009140|NCT01515423|559457730|FG002|DOUBLE BLIND|Pregnancy|0|||
155009141|NCT01515423|559457728|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
155009142|NCT01515423|559457729|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
155009143|NCT01515423|559457730|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
155009144|NCT01515423|559457728|FG000|DOUBLE BLIND|Other|0|||
155009145|NCT01515423|559457729|FG001|DOUBLE BLIND|Other|6|||
155009146|NCT01515423|559457730|FG002|DOUBLE BLIND|Other|12|||
155009147|NCT01515423|559457728|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
155009148|NCT01515423|559457729|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
155009149|NCT01515423|559457730|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
155009150|NCT00613171|559457733|FG000|Overall Study|Adverse Event|7|||
155009151|NCT00613171|559457733|FG000|Overall Study|Withdrawal by Subject|3|||
155009152|NCT00613171|559457733|FG000|Overall Study|Reason not Specified|4|||
155009153|NCT01876446|559457743|FG000|Overall Study|Death|0|||
155009154|NCT01876446|559457744|FG001|Overall Study|Death|1|||
155009155|NCT01876446|559457743|FG000|Overall Study|Withdrawal by Subject|1|||
155009156|NCT01876446|559457744|FG001|Overall Study|Withdrawal by Subject|2|||
155009157|NCT01876446|559457743|FG000|Overall Study|Physician Decision|1|||
155009158|NCT01876446|559457744|FG001|Overall Study|Physician Decision|3|||
155009159|NCT03629184|559457751|FG000|Overall Study|Withdrawal by Subject|2|||
155009160|NCT03629184|559457752|FG001|Overall Study|Withdrawal by Subject|1|||
155009161|NCT03629184|559457751|FG000|Overall Study|Physician Decision|1|||
155009162|NCT03629184|559457752|FG001|Overall Study|Physician Decision|0|||
155009163|NCT01461538|559457753|FG000|Overall Study|Death|15|||
155009164|NCT01461538|559457754|FG001|Overall Study|Death|6|||
155009165|NCT01461538|559457755|FG002|Overall Study|Death|2|||
155009166|NCT01461538|559457753|FG000|Overall Study|Study Stopped by Sponsor|2|||
155009167|NCT01461538|559457754|FG001|Overall Study|Study Stopped by Sponsor|1|||
155009168|NCT01461538|559457755|FG002|Overall Study|Study Stopped by Sponsor|0|||
155009169|NCT01461538|559457753|FG000|Overall Study|Withdrawal by Subject|1|||
155009170|NCT01461538|559457754|FG001|Overall Study|Withdrawal by Subject|1|||
155009171|NCT01461538|559457755|FG002|Overall Study|Withdrawal by Subject|0|||
155009172|NCT01982955|559457756|FG000|Overall Study|Randomized but not treated|0|||
155009173|NCT01982955|559457757|FG001|Overall Study|Randomized but not treated|0|||
155009174|NCT01982955|559457758|FG002|Overall Study|Randomized but not treated|0|||
155009175|NCT01982955|559457759|FG003|Overall Study|Randomized but not treated|1|||
155009176|NCT01982955|559457760|FG004|Overall Study|Randomized but not treated|0|||
155009177|NCT05655546|559458938|FG000|Overall Study|Withdrawal by Subject|2|||
155131417|NCT04566601|559912888|FG003|Overall Study|Protocol deviation|1|||
155131418|NCT04566601|559912889|FG004|Overall Study|Protocol deviation|1|||
155009178|NCT05655546|559458939|FG001|Overall Study|Withdrawal by Subject|4|||
155009179|NCT03493685|559458940|FG000|Overall Study|Death|4|||
155009180|NCT03493685|559458941|FG001|Overall Study|Death|3|||
155009181|NCT03493685|559458940|FG000|Overall Study|Lost to Follow-up|3|||
155009182|NCT03493685|559458941|FG001|Overall Study|Lost to Follow-up|2|||
155009183|NCT03493685|559458940|FG000|Overall Study|Physician Decision|2|||
155009184|NCT03493685|559458941|FG001|Overall Study|Physician Decision|0|||
155009185|NCT03493685|559458940|FG000|Overall Study|Withdrawal by Subject|7|||
155009186|NCT03493685|559458941|FG001|Overall Study|Withdrawal by Subject|11|||
155009187|NCT04452669|559458942|FG000|Overall Study|Death|1|||
155131419|NCT04566601|559912885|FG000|Overall Study|Technical problems|0|||
155009188|NCT04452669|559458943|FG001|Overall Study|Death|4|||
155009189|NCT04576507|559458947|FG000|Overall Study|Adverse Event|4|||
155009190|NCT04576507|559458947|FG000|Overall Study|Withdrawal by Subject|1|||
155009191|NCT04653454|559458952|FG000|Overall Study|Withdrawal by Subject|1|||
155009192|NCT04653454|559458952|FG000|Overall Study|Physician Decision|40|||
155009193|NCT05525520|559458953|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
155009194|NCT05525520|559458954|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
155009195|NCT05525520|559458953|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
155009196|NCT05525520|559458954|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
155009197|NCT05878093|559458957|FG000|Overall Study|Withdrawal by Subject|3|||
155009198|NCT05878093|559458958|FG001|Overall Study|Withdrawal by Subject|1|||
155009199|NCT02721732|559458959|FG000|Overall Study|Adverse Event|2|||
155009200|NCT02721732|559458960|FG001|Overall Study|Adverse Event|0|||
155009201|NCT02721732|559458961|FG002|Overall Study|Adverse Event|2|||
155009202|NCT02721732|559458962|FG003|Overall Study|Adverse Event|0|||
155009203|NCT02721732|559458963|FG004|Overall Study|Adverse Event|1|||
155009204|NCT02721732|559458964|FG005|Overall Study|Adverse Event|0|||
155009205|NCT02721732|559458965|FG006|Overall Study|Adverse Event|1|||
155009206|NCT02721732|559458966|FG007|Overall Study|Adverse Event|0|||
155009207|NCT02721732|559458967|FG008|Overall Study|Adverse Event|1|||
155009208|NCT02721732|559458968|FG009|Overall Study|Adverse Event|1|||
155009209|NCT02721732|559458959|FG000|Overall Study|Death|0|||
155009210|NCT02721732|559458960|FG001|Overall Study|Death|0|||
155009211|NCT02721732|559458961|FG002|Overall Study|Death|0|||
155009212|NCT02721732|559458962|FG003|Overall Study|Death|0|||
155009213|NCT02721732|559458963|FG004|Overall Study|Death|1|||
155009214|NCT02721732|559458964|FG005|Overall Study|Death|0|||
155009215|NCT02721732|559458965|FG006|Overall Study|Death|1|||
155009216|NCT02721732|559458966|FG007|Overall Study|Death|0|||
155009217|NCT02721732|559458967|FG008|Overall Study|Death|0|||
155009218|NCT02721732|559458968|FG009|Overall Study|Death|1|||
155009219|NCT02721732|559458959|FG000|Overall Study|Lack of Efficacy|12|||
155009220|NCT02721732|559458960|FG001|Overall Study|Lack of Efficacy|11|||
155009221|NCT02721732|559458961|FG002|Overall Study|Lack of Efficacy|18|||
155009222|NCT02721732|559458962|FG003|Overall Study|Lack of Efficacy|5|||
155009223|NCT02721732|559458963|FG004|Overall Study|Lack of Efficacy|21|||
155009224|NCT02721732|559458964|FG005|Overall Study|Lack of Efficacy|2|||
155009225|NCT02721732|559458965|FG006|Overall Study|Lack of Efficacy|8|||
155009226|NCT02721732|559458966|FG007|Overall Study|Lack of Efficacy|11|||
155009227|NCT02721732|559458967|FG008|Overall Study|Lack of Efficacy|10|||
155009228|NCT02721732|559458968|FG009|Overall Study|Lack of Efficacy|20|||
155009229|NCT02721732|559458959|FG000|Overall Study|Physician Decision|0|||
155009230|NCT02721732|559458960|FG001|Overall Study|Physician Decision|0|||
155009231|NCT02721732|559458961|FG002|Overall Study|Physician Decision|1|||
155009232|NCT02721732|559458962|FG003|Overall Study|Physician Decision|0|||
155009233|NCT02721732|559458963|FG004|Overall Study|Physician Decision|0|||
155009234|NCT02721732|559458964|FG005|Overall Study|Physician Decision|0|||
155009235|NCT02721732|559458965|FG006|Overall Study|Physician Decision|0|||
155009236|NCT02721732|559458966|FG007|Overall Study|Physician Decision|0|||
155009237|NCT02721732|559458967|FG008|Overall Study|Physician Decision|0|||
155009238|NCT02721732|559458968|FG009|Overall Study|Physician Decision|0|||
155009239|NCT02721732|559458959|FG000|Overall Study|Withdrawal by Subject|1|||
155009240|NCT02721732|559458960|FG001|Overall Study|Withdrawal by Subject|0|||
155009241|NCT02721732|559458961|FG002|Overall Study|Withdrawal by Subject|0|||
155009242|NCT02721732|559458962|FG003|Overall Study|Withdrawal by Subject|0|||
155009243|NCT02721732|559458963|FG004|Overall Study|Withdrawal by Subject|3|||
155009244|NCT02721732|559458964|FG005|Overall Study|Withdrawal by Subject|0|||
155009245|NCT02721732|559458965|FG006|Overall Study|Withdrawal by Subject|1|||
155009246|NCT02721732|559458966|FG007|Overall Study|Withdrawal by Subject|1|||
155009247|NCT02721732|559458967|FG008|Overall Study|Withdrawal by Subject|0|||
155009248|NCT02721732|559458968|FG009|Overall Study|Withdrawal by Subject|1|||
155009249|NCT02721732|559458959|FG000|Overall Study|Participant Choice|1|||
155009250|NCT02721732|559458960|FG001|Overall Study|Participant Choice|0|||
155009251|NCT02721732|559458961|FG002|Overall Study|Participant Choice|0|||
155009252|NCT02721732|559458962|FG003|Overall Study|Participant Choice|0|||
155009253|NCT02721732|559458963|FG004|Overall Study|Participant Choice|0|||
155009254|NCT02721732|559458964|FG005|Overall Study|Participant Choice|0|||
155009255|NCT02721732|559458965|FG006|Overall Study|Participant Choice|0|||
155009256|NCT02721732|559458966|FG007|Overall Study|Participant Choice|0|||
155009257|NCT02721732|559458967|FG008|Overall Study|Participant Choice|0|||
155009258|NCT02721732|559458968|FG009|Overall Study|Participant Choice|1|||
155009259|NCT02721732|559458959|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009260|NCT02721732|559458960|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009261|NCT02721732|559458961|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
155009262|NCT02721732|559458962|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009263|NCT02721732|559458963|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009264|NCT02721732|559458964|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009265|NCT02721732|559458965|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155131420|NCT04566601|559912886|FG001|Overall Study|Technical problems|0|||
155009266|NCT02721732|559458966|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009267|NCT02721732|559458967|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009268|NCT02721732|559458968|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
155009269|NCT02721732|559458959|FG000|Overall Study|Progression and withdrew consent|1|||
155009270|NCT02721732|559458960|FG001|Overall Study|Progression and withdrew consent|1|||
155009271|NCT02721732|559458961|FG002|Overall Study|Progression and withdrew consent|0|||
155009272|NCT02721732|559458962|FG003|Overall Study|Progression and withdrew consent|0|||
155009273|NCT02721732|559458963|FG004|Overall Study|Progression and withdrew consent|0|||
155009274|NCT02721732|559458964|FG005|Overall Study|Progression and withdrew consent|0|||
155009275|NCT02721732|559458965|FG006|Overall Study|Progression and withdrew consent|0|||
155009276|NCT02721732|559458966|FG007|Overall Study|Progression and withdrew consent|0|||
155009277|NCT02721732|559458967|FG008|Overall Study|Progression and withdrew consent|0|||
155009278|NCT02721732|559458968|FG009|Overall Study|Progression and withdrew consent|1|||
155009279|NCT02721732|559458959|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
155009280|NCT02721732|559458960|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
155009281|NCT02721732|559458961|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
155009282|NCT02721732|559458962|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
155009283|NCT02721732|559458963|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
155009284|NCT02721732|559458964|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
155009285|NCT02721732|559458965|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
155009286|NCT02721732|559458966|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
155009287|NCT02721732|559458967|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
155009288|NCT02721732|559458968|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
155009289|NCT00725283|559458969|FG000|Overall Study|Missing Code|3|||
155009290|NCT00725283|559458969|FG000|Overall Study|Death|5|||
155009291|NCT00725283|559458969|FG000|Overall Study|Other|6|||
155009292|NCT00725283|559458969|FG000|Overall Study|Withdrawal by Subject|10|||
155009293|NCT00118157|559458970|FG000|Overall Study|Adverse Event|2|||
155009294|NCT00118157|559458970|FG000|Overall Study|Death|8|||
155009295|NCT00118157|559458970|FG000|Overall Study|Withdrawal by Subject|2|||
155009296|NCT02763046|559458977|FG000|Overall Study|Adverse Event|5|||
155009297|NCT02763046|559458978|FG001|Overall Study|Adverse Event|4|||
155131421|NCT04566601|559912887|FG002|Overall Study|Technical problems|1|||
155131422|NCT04566601|559912888|FG003|Overall Study|Technical problems|0|||
155131423|NCT04566601|559912889|FG004|Overall Study|Technical problems|0|||
155131424|NCT04566601|559912885|FG000|Overall Study|No reason available|3|||
155131425|NCT04566601|559912886|FG001|Overall Study|No reason available|2|||
155131426|NCT04566601|559912887|FG002|Overall Study|No reason available|7|||
155131427|NCT04566601|559912888|FG003|Overall Study|No reason available|1|||
155131428|NCT04566601|559912889|FG004|Overall Study|No reason available|5|||
155131429|NCT04566601|559912885|FG000|Overall Study|Burden of study procedures|3|||
155131430|NCT04566601|559912886|FG001|Overall Study|Burden of study procedures|0|||
155131431|NCT04566601|559912887|FG002|Overall Study|Burden of study procedures|0|||
155131432|NCT04566601|559912888|FG003|Overall Study|Burden of study procedures|3|||
155131433|NCT04566601|559912889|FG004|Overall Study|Burden of study procedures|1|||
155131434|NCT04566601|559912885|FG000|Overall Study|Change of residence|2|||
155131435|NCT04566601|559912886|FG001|Overall Study|Change of residence|2|||
155131436|NCT04566601|559912887|FG002|Overall Study|Change of residence|0|||
155131437|NCT04566601|559912888|FG003|Overall Study|Change of residence|1|||
155131438|NCT04566601|559912889|FG004|Overall Study|Change of residence|2|||
155131439|NCT04566601|559912885|FG000|Overall Study|Perceived lack of efficacy|2|||
155131440|NCT04566601|559912886|FG001|Overall Study|Perceived lack of efficacy|0|||
155131441|NCT04566601|559912887|FG002|Overall Study|Perceived lack of efficacy|1|||
155131442|NCT04566601|559912888|FG003|Overall Study|Perceived lack of efficacy|1|||
155131443|NCT04566601|559912889|FG004|Overall Study|Perceived lack of efficacy|2|||
155178468|NCT03985878|560091506|FG000|Overall Study|Withdrawal by Subject|1|||
155178469|NCT01606878|560091507|FG000|Overall Study|Adverse Event|1|||
155009298|NCT02763046|559458979|FG002|Overall Study|Adverse Event|0|||
155009299|NCT02763046|559458977|FG000|Overall Study|Lack of Efficacy|1|||
155009300|NCT02763046|559458978|FG001|Overall Study|Lack of Efficacy|1|||
155009301|NCT02763046|559458979|FG002|Overall Study|Lack of Efficacy|3|||
155009302|NCT02763046|559458977|FG000|Overall Study|Physician Decision|1|||
155009303|NCT02763046|559458978|FG001|Overall Study|Physician Decision|0|||
155131444|NCT04566601|559912885|FG000|Overall Study|Adverse Event|7|||
155178470|NCT01606878|560091508|FG001|Overall Study|Adverse Event|1|||
155178471|NCT01606878|560091509|FG002|Overall Study|Adverse Event|0|||
155009304|NCT02763046|559458979|FG002|Overall Study|Physician Decision|1|||
155009305|NCT02763046|559458977|FG000|Overall Study|Subject/guardian decision|2|||
155131445|NCT04566601|559912886|FG001|Overall Study|Adverse Event|4|||
155131446|NCT04566601|559912887|FG002|Overall Study|Adverse Event|6|||
155131447|NCT04566601|559912888|FG003|Overall Study|Adverse Event|5|||
155131448|NCT04566601|559912889|FG004|Overall Study|Adverse Event|12|||
155131449|NCT00495625|559912893|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
155178472|NCT01606878|560091510|FG003|Overall Study|Adverse Event|0|||
155009306|NCT02763046|559458978|FG001|Overall Study|Subject/guardian decision|0|||
155009307|NCT02763046|559458979|FG002|Overall Study|Subject/guardian decision|4|||
155009308|NCT00818766|559458982|FG000|Overall Study|Could not be Contacted on Day 28|11|||
155009309|NCT00818766|559458983|FG001|Overall Study|Could not be Contacted on Day 28|10|||
155009310|NCT00818766|559458982|FG000|Overall Study|Death|1|||
155009311|NCT00818766|559458983|FG001|Overall Study|Death|0|||
155009312|NCT00818766|559458982|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
155178473|NCT01606878|560091511|FG004|Overall Study|Adverse Event|0|||
155009313|NCT00818766|559458983|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
155009314|NCT00086684|559458984|FG000|Overall Study|Adverse Event|12|||
155009315|NCT00086684|559458985|FG001|Overall Study|Adverse Event|17|||
155009316|NCT00086684|559458986|FG002|Overall Study|Adverse Event|14|||
155009317|NCT00086684|559458984|FG000|Overall Study|Lack of Efficacy|6|||
155009318|NCT00086684|559458985|FG001|Overall Study|Lack of Efficacy|6|||
155009319|NCT00086684|559458986|FG002|Overall Study|Lack of Efficacy|5|||
155009320|NCT00086684|559458984|FG000|Overall Study|Lost to Follow-up|15|||
155009321|NCT00086684|559458985|FG001|Overall Study|Lost to Follow-up|8|||
155009322|NCT00086684|559458986|FG002|Overall Study|Lost to Follow-up|10|||
155009323|NCT00086684|559458984|FG000|Overall Study|Protocol Violation|8|||
155009324|NCT00086684|559458985|FG001|Overall Study|Protocol Violation|3|||
155009325|NCT00086684|559458986|FG002|Overall Study|Protocol Violation|0|||
155009326|NCT00086684|559458984|FG000|Overall Study|Withdrawal by Subject|0|||
155009327|NCT00086684|559458985|FG001|Overall Study|Withdrawal by Subject|4|||
155009328|NCT00086684|559458986|FG002|Overall Study|Withdrawal by Subject|10|||
155009329|NCT00086684|559458984|FG000|Overall Study|NONCOMPLIANCE|5|||
155009330|NCT00086684|559458985|FG001|Overall Study|NONCOMPLIANCE|7|||
155009331|NCT00086684|559458986|FG002|Overall Study|NONCOMPLIANCE|6|||
155009332|NCT00086684|559458984|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155009333|NCT00086684|559458985|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
155009334|NCT00086684|559458986|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
155009335|NCT00086684|559458984|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
155009336|NCT00086684|559458985|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
155009337|NCT00086684|559458986|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
155009338|NCT00086684|559458984|FG000|Overall Study|Other|4|||
155009339|NCT00086684|559458985|FG001|Overall Study|Other|2|||
155178474|NCT01606878|560091512|FG005|Overall Study|Adverse Event|0|||
155178475|NCT01606878|560091513|FG006|Overall Study|Adverse Event|1|||
155178476|NCT01606878|560091514|FG007|Overall Study|Adverse Event|0|||
155178477|NCT01606878|560091515|FG008|Overall Study|Adverse Event|1|||
155178478|NCT01606878|560091516|FG009|Overall Study|Adverse Event|3|||
155009340|NCT00086684|559458986|FG002|Overall Study|Other|3|||
155009341|NCT01103180|559458987|FG000|Overall Study|Withdrawal by Subject|8|||
155009342|NCT01103180|559458988|FG001|Overall Study|Withdrawal by Subject|13|||
155009343|NCT01103180|559458987|FG000|Overall Study|Lost to Follow-up|13|||
155009344|NCT01103180|559458988|FG001|Overall Study|Lost to Follow-up|7|||
155009345|NCT01103180|559458987|FG000|Overall Study|Physician Decision|1|||
155009346|NCT01103180|559458988|FG001|Overall Study|Physician Decision|0|||
155009347|NCT01103180|559458987|FG000|Overall Study|Protocol Violation|0|||
155009348|NCT01103180|559458988|FG001|Overall Study|Protocol Violation|1|||
155009349|NCT01067105|559458989|FG000|Overall Study|Adverse Event|14|||
155131450|NCT02397057|559912894|FG000|Overall Study|Withdrawal by Subject|6|||
155131451|NCT02397057|559912895|FG001|Overall Study|Withdrawal by Subject|7|||
155131452|NCT02397057|559912894|FG000|Overall Study|Lost to Follow-up|4|||
155131453|NCT02397057|559912895|FG001|Overall Study|Lost to Follow-up|3|||
155131454|NCT02397057|559912894|FG000|Overall Study|Death|1|||
155131455|NCT02397057|559912895|FG001|Overall Study|Death|0|||
155131456|NCT02397057|559912894|FG000|Overall Study|Adverse Event|0|||
155009350|NCT01067105|559458989|FG000|Overall Study|Protocol Violation|48|||
155009351|NCT01067105|559458989|FG000|Overall Study|Withdrawal by Subject|36|||
155009352|NCT01067105|559458989|FG000|Overall Study|Lost to Follow-up|6|||
155009353|NCT01067105|559458989|FG000|Overall Study|Physician Decision|6|||
155009354|NCT01067105|559458989|FG000|Overall Study|Other|31|||
155131457|NCT02397057|559912895|FG001|Overall Study|Adverse Event|1|||
155131458|NCT02397057|559912894|FG000|Overall Study|Physician Decision|0|||
155131459|NCT02397057|559912895|FG001|Overall Study|Physician Decision|1|||
155009355|NCT00853099|559458990|FG000|Double-blind Period|Adverse Event|7|||
155009356|NCT00853099|559458991|FG001|Double-blind Period|Adverse Event|9|||
155131460|NCT02397057|559912894|FG000|Overall Study|Subject did not receive study drug|0|||
155131461|NCT02397057|559912895|FG001|Overall Study|Subject did not receive study drug|1|||
155178479|NCT01606878|560091517|FG010|Overall Study|Adverse Event|0|||
155009357|NCT00853099|559458992|FG002|Double-blind Period|Adverse Event|13|||
155009358|NCT00853099|559458993|FG003|Double-blind Period|Adverse Event|0|||
155009359|NCT00853099|559458990|FG000|Double-blind Period|Withdrawal by Subject|2|||
155009360|NCT00853099|559458991|FG001|Double-blind Period|Withdrawal by Subject|3|||
155009361|NCT00853099|559458992|FG002|Double-blind Period|Withdrawal by Subject|0|||
155009362|NCT00853099|559458993|FG003|Double-blind Period|Withdrawal by Subject|0|||
155009363|NCT00853099|559458990|FG000|Double-blind Period|Lack of Efficacy|14|||
155131462|NCT02352753|559912896|FG000|6-Month Dosing Period|Decision by sponsor|2|||
155178480|NCT01606878|560091507|FG000|Overall Study|Lack of Efficacy|1|||
155009364|NCT00853099|559458991|FG001|Double-blind Period|Lack of Efficacy|17|||
155009365|NCT00853099|559458992|FG002|Double-blind Period|Lack of Efficacy|16|||
155009366|NCT00853099|559458993|FG003|Double-blind Period|Lack of Efficacy|0|||
155009367|NCT00853099|559458990|FG000|Double-blind Period|Other|0|||
155009368|NCT00853099|559458991|FG001|Double-blind Period|Other|0|||
155009369|NCT00853099|559458992|FG002|Double-blind Period|Other|1|||
155009370|NCT00853099|559458993|FG003|Double-blind Period|Other|0|||
155009371|NCT00853099|559458990|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
155009372|NCT00853099|559458991|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
155009373|NCT00853099|559458992|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
155009374|NCT00853099|559458993|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
155009375|NCT00853099|559458990|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
155009376|NCT00853099|559458991|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
155009377|NCT00853099|559458992|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
155009378|NCT00853099|559458993|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
155009379|NCT00853099|559458990|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
155009380|NCT00853099|559458991|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
155009381|NCT00853099|559458992|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
155009382|NCT00853099|559458993|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
155009383|NCT00853099|559458990|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
155009384|NCT00853099|559458991|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
155009385|NCT00853099|559458992|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
155009386|NCT00853099|559458993|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
155009387|NCT00853099|559458990|FG000|Double-blind + Open-label Periods|Other|0|||
155009388|NCT00853099|559458991|FG001|Double-blind + Open-label Periods|Other|0|||
155009389|NCT00853099|559458992|FG002|Double-blind + Open-label Periods|Other|0|||
155009390|NCT00853099|559458993|FG003|Double-blind + Open-label Periods|Other|6|||
155009391|NCT02203357|559458997|FG000|Overall Study|Lost to Follow-up|58|||
155009392|NCT02203357|559458998|FG001|Overall Study|Lost to Follow-up|66|||
155009393|NCT02203357|559458999|FG002|Overall Study|Lost to Follow-up|70|||
155009394|NCT02439216|559459000|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
155009395|NCT02439216|559459001|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009396|NCT02439216|559459002|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009397|NCT02439216|559459003|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009398|NCT02439216|559459004|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009399|NCT02439216|559459005|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009400|NCT02439216|559459006|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009401|NCT02439216|559459007|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009402|NCT02439216|559459008|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
155009403|NCT02439216|559459000|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009404|NCT02439216|559459001|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009405|NCT02439216|559459002|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009406|NCT02439216|559459003|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009407|NCT02439216|559459004|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009408|NCT02439216|559459005|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009409|NCT02439216|559459006|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009410|NCT02439216|559459007|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
155009411|NCT02439216|559459008|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
155009412|NCT02439216|559459000|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009413|NCT02439216|559459001|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009414|NCT02439216|559459002|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009415|NCT02439216|559459003|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009416|NCT02439216|559459004|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009417|NCT02439216|559459005|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009418|NCT02439216|559459006|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
155009419|NCT02439216|559459007|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
155009420|NCT02439216|559459008|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
155009421|NCT02439216|559459000|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009422|NCT02439216|559459001|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009423|NCT02439216|559459002|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009424|NCT02439216|559459003|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009425|NCT02439216|559459004|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009426|NCT02439216|559459005|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009427|NCT02439216|559459006|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009428|NCT02439216|559459007|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
155009429|NCT02439216|559459008|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
155009430|NCT02439216|559459000|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009431|NCT02439216|559459001|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009432|NCT02439216|559459002|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009433|NCT02439216|559459003|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009434|NCT02439216|559459004|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009435|NCT02439216|559459005|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009436|NCT02439216|559459006|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
155009437|NCT02439216|559459007|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
155009438|NCT02439216|559459008|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
155009439|NCT02094300|559459009|FG000|Overall Study|Death|7|||
155009440|NCT02094300|559459009|FG000|Overall Study|Lost to Follow-up|10|||
155009441|NCT02094300|559459009|FG000|Overall Study|Still be eligible for follow-up|3|||
155009442|NCT01050530|559459014|FG000|Overall Study|Adverse Event|6|||
155009443|NCT01050530|559459015|FG001|Overall Study|Adverse Event|3|||
155009444|NCT01050530|559459014|FG000|Overall Study|Lack of Efficacy|1|||
155009445|NCT01050530|559459015|FG001|Overall Study|Lack of Efficacy|4|||
155009446|NCT01050530|559459014|FG000|Overall Study|Withdrawal by Subject|0|||
155009447|NCT01050530|559459015|FG001|Overall Study|Withdrawal by Subject|3|||
155009448|NCT01050530|559459014|FG000|Overall Study|Protocol Violation|1|||
155009449|NCT01050530|559459015|FG001|Overall Study|Protocol Violation|0|||
155009450|NCT03347110|559459018|FG000|Overall Study|Other (Participant is incarcerated)|1|||
155009451|NCT03347110|559459018|FG000|Overall Study|Withdrawal by Subject|9|||
155009452|NCT03347110|559459018|FG000|Overall Study|Lost to Follow-up|1|||
155009453|NCT03347110|559459018|FG000|Overall Study|Lack of Efficacy|2|||
155009454|NCT03347110|559459018|FG000|Overall Study|Adverse Event, non-fatal|9|||
155009455|NCT01778530|559459019|FG000|Overall Study|Progression on study|1|||
155009456|NCT01778530|559459019|FG000|Overall Study|Adverse event/side effect|1|||
155009457|NCT03472014|559459020|FG000|Overall Study|Lost to Follow-up|4|||
155009458|NCT00428246|559459023|FG000|Overall Study|Withdrawal by Subject|0|||
155009459|NCT00428246|559459024|FG001|Overall Study|Withdrawal by Subject|0|||
155009460|NCT00428246|559459025|FG002|Overall Study|Withdrawal by Subject|1|||
155009461|NCT00428246|559459023|FG000|Overall Study|Adverse Event|1|||
155009462|NCT00428246|559459024|FG001|Overall Study|Adverse Event|0|||
155009463|NCT00428246|559459025|FG002|Overall Study|Adverse Event|0|||
155009464|NCT01841593|559459030|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
155009465|NCT01841593|559459031|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
155009466|NCT01841593|559459030|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
155009467|NCT01841593|559459031|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
155009468|NCT03518008|559459039|FG000|Period 2, Second Week of Wear|Family emergency|0|||
155009469|NCT03518008|559459040|FG001|Period 2, Second Week of Wear|Family emergency|1|||
155009470|NCT01169350|559459055|FG000|Overall Study|Physician Decision|3|||
155009471|NCT01169350|559459055|FG000|Overall Study|Lost to Follow-up|2|||
155009472|NCT04782076|559459057|FG000|Overall Study|Family Emergency|1|||
155009473|NCT01042093|559459058|FG000|Overall Study|Protocol Violation|2|||
155009474|NCT01042093|559459059|FG001|Overall Study|Protocol Violation|2|||
155009475|NCT01042093|559459060|FG002|Overall Study|Protocol Violation|2|||
155009476|NCT01042093|559459061|FG003|Overall Study|Protocol Violation|3|||
155009477|NCT01042093|559459058|FG000|Overall Study|Withdrawal by Subject|0|||
155009478|NCT01042093|559459059|FG001|Overall Study|Withdrawal by Subject|0|||
155009479|NCT01042093|559459060|FG002|Overall Study|Withdrawal by Subject|0|||
155009480|NCT01042093|559459061|FG003|Overall Study|Withdrawal by Subject|1|||
155009481|NCT02198963|559459065|FG000|Overall Study|Adverse Event|1|||
155009482|NCT02198963|559459065|FG000|Overall Study|Withdrawal by Subject|6|||
155009483|NCT00995774|559459066|FG000|Training Period 2|Withdrawal by Subject|2|||
155009484|NCT00995774|559459067|FG001|Training Period 2|Withdrawal by Subject|0|||
155009485|NCT00683657|559459068|FG000|Overall Study|Adverse Event|0|||
155009486|NCT00683657|559459069|FG001|Overall Study|Adverse Event|1|||
155009487|NCT00683657|559459068|FG000|Overall Study|Subject Withdrew Consent|1|||
155009488|NCT00683657|559459069|FG001|Overall Study|Subject Withdrew Consent|0|||
155009489|NCT04135937|559459070|FG000|Overall Study|Lost to Follow-up|2|||
155009490|NCT04135937|559459070|FG000|Overall Study|Withdrawal by Subject|1|||
155009491|NCT03657797|559461145|FG000|Overall Study|Lost to Follow-up|0|||
155009492|NCT03657797|559461146|FG001|Overall Study|Lost to Follow-up|1|||
155009493|NCT03657797|559461147|FG002|Overall Study|Lost to Follow-up|1|||
155009494|NCT03657797|559461148|FG003|Overall Study|Lost to Follow-up|0|||
155009495|NCT03657797|559461145|FG000|Overall Study|Physician Decision|0|||
155009496|NCT03657797|559461146|FG001|Overall Study|Physician Decision|1|||
155009497|NCT03657797|559461147|FG002|Overall Study|Physician Decision|0|||
155009498|NCT03657797|559461148|FG003|Overall Study|Physician Decision|0|||
155009499|NCT03657797|559461145|FG000|Overall Study|Withdrawal by Subject|0|||
155009500|NCT03657797|559461146|FG001|Overall Study|Withdrawal by Subject|1|||
155009501|NCT03657797|559461147|FG002|Overall Study|Withdrawal by Subject|2|||
155009502|NCT03657797|559461148|FG003|Overall Study|Withdrawal by Subject|0|||
155009503|NCT03657797|559461145|FG000|Overall Study|Adverse Event|0|||
155009504|NCT03657797|559461146|FG001|Overall Study|Adverse Event|0|||
155009505|NCT03657797|559461147|FG002|Overall Study|Adverse Event|2|||
155009506|NCT03657797|559461148|FG003|Overall Study|Adverse Event|0|||
155009507|NCT03103087|559461149|FG000|Overall Study|Did not receive any study drug|1|||
155009508|NCT03103087|559461150|FG001|Overall Study|Did not receive any study drug|0|||
155009509|NCT03103087|559461151|FG002|Overall Study|Did not receive any study drug|0|||
155009510|NCT03103087|559461149|FG000|Overall Study|Protocol Violation|1|||
155009511|NCT03103087|559461150|FG001|Overall Study|Protocol Violation|2|||
155009512|NCT03103087|559461151|FG002|Overall Study|Protocol Violation|1|||
155009513|NCT03103087|559461149|FG000|Overall Study|Lack of Efficacy|2|||
155009514|NCT03103087|559461150|FG001|Overall Study|Lack of Efficacy|1|||
155009515|NCT03103087|559461151|FG002|Overall Study|Lack of Efficacy|1|||
155009516|NCT03103087|559461149|FG000|Overall Study|Pregnancy|0|||
155009517|NCT03103087|559461150|FG001|Overall Study|Pregnancy|0|||
155009518|NCT03103087|559461151|FG002|Overall Study|Pregnancy|1|||
155009519|NCT03103087|559461149|FG000|Overall Study|Adverse Event|2|||
155009520|NCT03103087|559461150|FG001|Overall Study|Adverse Event|15|||
155009521|NCT03103087|559461151|FG002|Overall Study|Adverse Event|6|||
155009522|NCT03103087|559461149|FG000|Overall Study|Withdrawal by Subject|13|||
155009523|NCT03103087|559461150|FG001|Overall Study|Withdrawal by Subject|6|||
155009524|NCT03103087|559461151|FG002|Overall Study|Withdrawal by Subject|6|||
155009525|NCT03103087|559461149|FG000|Overall Study|Lost to Follow-up|4|||
155009526|NCT03103087|559461150|FG001|Overall Study|Lost to Follow-up|2|||
155009527|NCT03103087|559461151|FG002|Overall Study|Lost to Follow-up|7|||
155009528|NCT03103087|559461149|FG000|Overall Study|Other reason not reported|1|||
155009529|NCT03103087|559461150|FG001|Overall Study|Other reason not reported|3|||
155009530|NCT03103087|559461151|FG002|Overall Study|Other reason not reported|5|||
155009531|NCT00413699|559461152|FG000|Initial Period|Death|25|||
155009532|NCT00413699|559461153|FG001|Initial Period|Death|30|||
155009533|NCT00413699|559461154|FG002|Initial Period|Death|0|||
155009534|NCT00413699|559461152|FG000|Initial Period|Lack of Efficacy|59|||
155009535|NCT00413699|559461153|FG001|Initial Period|Lack of Efficacy|115|||
155009536|NCT00413699|559461154|FG002|Initial Period|Lack of Efficacy|0|||
155009537|NCT00413699|559461152|FG000|Initial Period|Lost to Follow-up|31|||
155009538|NCT00413699|559461153|FG001|Initial Period|Lost to Follow-up|101|||
155009539|NCT00413699|559461154|FG002|Initial Period|Lost to Follow-up|0|||
154923608|NCT03110107|559146280|FG003|Treatment Period|Study drug toxicity|2|||
154923609|NCT03110107|559146281|FG004|Treatment Period|Study drug toxicity|0|||
154923610|NCT03110107|559146282|FG005|Treatment Period|Study drug toxicity|3|||
154923611|NCT03110107|559146283|FG006|Treatment Period|Study drug toxicity|1|||
154923612|NCT03110107|559146284|FG007|Treatment Period|Study drug toxicity|1|||
154923613|NCT03110107|559146285|FG008|Treatment Period|Study drug toxicity|3|||
154923614|NCT03110107|559146286|FG009|Treatment Period|Study drug toxicity|2|||
154923615|NCT03110107|559146287|FG010|Treatment Period|Study drug toxicity|0|||
154923616|NCT03110107|559146288|FG011|Treatment Period|Study drug toxicity|2|||
154923617|NCT03110107|559146289|FG012|Treatment Period|Study drug toxicity|0|||
154923618|NCT03110107|559146290|FG013|Treatment Period|Study drug toxicity|0|||
154923619|NCT03110107|559146291|FG014|Treatment Period|Study drug toxicity|2|||
154923620|NCT03110107|559146292|FG015|Treatment Period|Study drug toxicity|3|||
154923621|NCT03110107|559146293|FG016|Treatment Period|Study drug toxicity|3|||
154923622|NCT03110107|559146294|FG017|Treatment Period|Study drug toxicity|3|||
154923623|NCT03110107|559146295|FG018|Treatment Period|Study drug toxicity|1|||
154923624|NCT03110107|559146296|FG019|Treatment Period|Study drug toxicity|2|||
154923625|NCT03110107|559146297|FG020|Treatment Period|Study drug toxicity|2|||
154923626|NCT03110107|559146298|FG021|Treatment Period|Study drug toxicity|0|||
154923627|NCT03110107|559146299|FG022|Treatment Period|Study drug toxicity|2|||
154923628|NCT03110107|559146300|FG023|Treatment Period|Study drug toxicity|6|||
154923629|NCT03110107|559146301|FG024|Treatment Period|Study drug toxicity|7|||
155009540|NCT00413699|559461152|FG000|Initial Period|Protocol Violation|38|||
155009541|NCT00413699|559461153|FG001|Initial Period|Protocol Violation|89|||
155009542|NCT00413699|559461154|FG002|Initial Period|Protocol Violation|0|||
155009543|NCT00413699|559461152|FG000|Initial Period|Pregnancy|10|||
155009544|NCT00413699|559461153|FG001|Initial Period|Pregnancy|8|||
155009545|NCT00413699|559461154|FG002|Initial Period|Pregnancy|0|||
155009546|NCT00413699|559461152|FG000|Initial Period|Did not meet entrance criteria|2|||
155009547|NCT00413699|559461153|FG001|Initial Period|Did not meet entrance criteria|2|||
155131463|NCT02352753|559912896|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
155131464|NCT02352753|559912896|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
155009548|NCT00413699|559461154|FG002|Initial Period|Did not meet entrance criteria|0|||
155009549|NCT00413699|559461152|FG000|Initial Period|Medication error without adverse event|0|||
155009550|NCT00413699|559461153|FG001|Initial Period|Medication error without adverse event|1|||
154923630|NCT03110107|559146302|FG025|Treatment Period|Study drug toxicity|6|||
154923631|NCT03110107|559146277|FG000|Treatment Period|Death|0|||
154923632|NCT03110107|559146278|FG001|Treatment Period|Death|0|||
154923633|NCT03110107|559146279|FG002|Treatment Period|Death|0|||
154923634|NCT03110107|559146280|FG003|Treatment Period|Death|0|||
155009551|NCT00413699|559461154|FG002|Initial Period|Medication error without adverse event|0|||
155009552|NCT00413699|559461152|FG000|Initial Period|Study terminated by Sponsor|0|||
154923635|NCT03110107|559146281|FG004|Treatment Period|Death|0|||
155009553|NCT00413699|559461153|FG001|Initial Period|Study terminated by Sponsor|1|||
155009554|NCT00413699|559461154|FG002|Initial Period|Study terminated by Sponsor|0|||
155009555|NCT00413699|559461152|FG000|Initial Period|Other|67|||
155009556|NCT00413699|559461153|FG001|Initial Period|Other|211|||
155009557|NCT00413699|559461154|FG002|Initial Period|Other|0|||
155009558|NCT00413699|559461152|FG000|Initial Period|Adverse event related to study drug|178|||
155009559|NCT00413699|559461153|FG001|Initial Period|Adverse event related to study drug|527|||
155009560|NCT00413699|559461154|FG002|Initial Period|Adverse event related to study drug|0|||
155009561|NCT00413699|559461152|FG000|Initial Period|Adverse event not related to study drug|113|||
155131465|NCT02352753|559912896|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
155131466|NCT02352753|559912896|FG000|3-Month Dosing Period|Decision by sponsor|14|||
155131467|NCT02352753|559912896|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
155131468|NCT00539305|559912897|FG000|Overall Study|Adverse Event|1|||
155131469|NCT00539305|559912898|FG001|Overall Study|Adverse Event|0|||
155131470|NCT00539305|559912897|FG000|Overall Study|Substance Use|0|||
155131471|NCT00539305|559912898|FG001|Overall Study|Substance Use|1|||
155131472|NCT00539305|559912897|FG000|Overall Study|Withdrawal by Subject|0|||
155131473|NCT00539305|559912898|FG001|Overall Study|Withdrawal by Subject|1|||
155131474|NCT00434642|559912904|FG000|Blinded Treatment Phase|Adverse Event|12|||
155131475|NCT00434642|559912905|FG001|Blinded Treatment Phase|Adverse Event|58|||
155131476|NCT00434642|559912904|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
155131477|NCT00434642|559912905|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
155131478|NCT00434642|559912904|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
155131479|NCT00434642|559912905|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
155131480|NCT00434642|559912904|FG000|Blinded Treatment Phase|Physician Decision|19|||
155131481|NCT00434642|559912905|FG001|Blinded Treatment Phase|Physician Decision|27|||
155131482|NCT00434642|559912904|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
155131483|NCT00434642|559912905|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
155009562|NCT00413699|559461153|FG001|Initial Period|Adverse event not related to study drug|248|||
155009563|NCT00413699|559461154|FG002|Initial Period|Adverse event not related to study drug|0|||
155009564|NCT00413699|559461152|FG000|Initial Period|Missing end of study page|0|||
155009565|NCT00413699|559461153|FG001|Initial Period|Missing end of study page|4|||
155009566|NCT00413699|559461154|FG002|Initial Period|Missing end of study page|0|||
155009567|NCT00413699|559461152|FG000|Initial Period|No longer willing to participate|116|||
155009568|NCT00413699|559461153|FG001|Initial Period|No longer willing to participate|368|||
155009569|NCT00413699|559461154|FG002|Initial Period|No longer willing to participate|0|||
155009570|NCT00413699|559461152|FG000|Extension Period|No Longer Willing to Participate|0|||
155009571|NCT00413699|559461153|FG001|Extension Period|No Longer Willing to Participate|0|||
155009572|NCT00413699|559461154|FG002|Extension Period|No Longer Willing to Participate|2|||
155009573|NCT00413699|559461152|FG000|Extension Period|Protocol Violation|0|||
155009574|NCT00413699|559461153|FG001|Extension Period|Protocol Violation|0|||
155009575|NCT00413699|559461154|FG002|Extension Period|Protocol Violation|1|||
155009576|NCT00413699|559461152|FG000|Extension Period|Adverse Event|0|||
155009577|NCT00413699|559461153|FG001|Extension Period|Adverse Event|0|||
155009578|NCT00413699|559461154|FG002|Extension Period|Adverse Event|2|||
155009579|NCT02115269|559461155|FG000|Overall Study|Lost to Follow-up|43|||
155009580|NCT02115269|559461155|FG000|Overall Study|Did not complete patient diary|3|||
155009581|NCT02115269|559461155|FG000|Overall Study|Moved to another city|7|||
155009582|NCT02115269|559461155|FG000|Overall Study|Withdrawal by Subject|2|||
155009583|NCT02115269|559461155|FG000|Overall Study|Didn't take study drug|2|||
155009584|NCT05989672|559461157|FG000|Overall Study|Adverse Event|3|||
155009585|NCT05989672|559461158|FG001|Overall Study|Adverse Event|0|||
155009586|NCT05989672|559461159|FG002|Overall Study|Adverse Event|0|||
155009587|NCT00711243|559461160|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
155009588|NCT00711243|559461161|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
155009589|NCT00711243|559461162|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
155009590|NCT00711243|559461163|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
155009591|NCT00711243|559461164|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
155009592|NCT00711243|559461165|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
155009593|NCT00711243|559461160|FG000|Reached First Response/4 Cycles|Death|0|||
155131484|NCT00434642|559912904|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
155131485|NCT00434642|559912905|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
155131486|NCT00434642|559912904|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
155131487|NCT00434642|559912905|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
155131488|NCT00434642|559912904|FG000|Open-label Treatment Phase|Adverse Event|0|||
155009594|NCT00711243|559461161|FG001|Reached First Response/4 Cycles|Death|0|||
155131489|NCT00434642|559912905|FG001|Open-label Treatment Phase|Adverse Event|5|||
155131490|NCT00434642|559912904|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
155009595|NCT00711243|559461162|FG002|Reached First Response/4 Cycles|Death|0|||
155009596|NCT00711243|559461163|FG003|Reached First Response/4 Cycles|Death|0|||
155131491|NCT00434642|559912905|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
155131492|NCT04512976|559912908|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155151025|NCT02587520|559988171|FG011|Overall Study|Protocol Violation|2|||
154923636|NCT03110107|559146282|FG005|Treatment Period|Death|0|||
154923637|NCT03110107|559146283|FG006|Treatment Period|Death|0|||
154923638|NCT03110107|559146284|FG007|Treatment Period|Death|0|||
154923639|NCT03110107|559146285|FG008|Treatment Period|Death|0|||
154923640|NCT03110107|559146286|FG009|Treatment Period|Death|0|||
154923641|NCT03110107|559146287|FG010|Treatment Period|Death|0|||
154923642|NCT03110107|559146288|FG011|Treatment Period|Death|0|||
154923643|NCT03110107|559146289|FG012|Treatment Period|Death|1|||
154923644|NCT03110107|559146290|FG013|Treatment Period|Death|0|||
154923645|NCT03110107|559146291|FG014|Treatment Period|Death|0|||
154923646|NCT03110107|559146292|FG015|Treatment Period|Death|0|||
154923647|NCT03110107|559146293|FG016|Treatment Period|Death|0|||
154923648|NCT03110107|559146294|FG017|Treatment Period|Death|0|||
154923649|NCT03110107|559146295|FG018|Treatment Period|Death|0|||
154923650|NCT03110107|559146296|FG019|Treatment Period|Death|0|||
154923651|NCT03110107|559146297|FG020|Treatment Period|Death|0|||
154923652|NCT03110107|559146298|FG021|Treatment Period|Death|0|||
154923653|NCT03110107|559146299|FG022|Treatment Period|Death|0|||
154923654|NCT03110107|559146300|FG023|Treatment Period|Death|0|||
154923655|NCT03110107|559146301|FG024|Treatment Period|Death|0|||
154923656|NCT03110107|559146302|FG025|Treatment Period|Death|0|||
154923657|NCT03110107|559146277|FG000|Treatment Period|Adverse Event|0|||
154923658|NCT03110107|559146278|FG001|Treatment Period|Adverse Event|0|||
154923659|NCT03110107|559146279|FG002|Treatment Period|Adverse Event|1|||
154923660|NCT03110107|559146280|FG003|Treatment Period|Adverse Event|0|||
154923661|NCT03110107|559146281|FG004|Treatment Period|Adverse Event|0|||
154923662|NCT03110107|559146282|FG005|Treatment Period|Adverse Event|2|||
154923663|NCT03110107|559146283|FG006|Treatment Period|Adverse Event|0|||
154923664|NCT03110107|559146284|FG007|Treatment Period|Adverse Event|2|||
154923665|NCT03110107|559146285|FG008|Treatment Period|Adverse Event|0|||
154923666|NCT03110107|559146286|FG009|Treatment Period|Adverse Event|1|||
154923667|NCT03110107|559146287|FG010|Treatment Period|Adverse Event|0|||
154923668|NCT03110107|559146288|FG011|Treatment Period|Adverse Event|0|||
154923669|NCT03110107|559146289|FG012|Treatment Period|Adverse Event|0|||
154923670|NCT03110107|559146290|FG013|Treatment Period|Adverse Event|0|||
154923671|NCT03110107|559146291|FG014|Treatment Period|Adverse Event|0|||
154923672|NCT03110107|559146292|FG015|Treatment Period|Adverse Event|2|||
154923673|NCT03110107|559146293|FG016|Treatment Period|Adverse Event|0|||
154923674|NCT03110107|559146294|FG017|Treatment Period|Adverse Event|1|||
154923675|NCT03110107|559146295|FG018|Treatment Period|Adverse Event|2|||
154923676|NCT03110107|559146296|FG019|Treatment Period|Adverse Event|1|||
154923677|NCT03110107|559146297|FG020|Treatment Period|Adverse Event|4|||
154923678|NCT03110107|559146298|FG021|Treatment Period|Adverse Event|2|||
154923679|NCT03110107|559146299|FG022|Treatment Period|Adverse Event|2|||
154923680|NCT03110107|559146300|FG023|Treatment Period|Adverse Event|2|||
154923681|NCT03110107|559146301|FG024|Treatment Period|Adverse Event|2|||
154923682|NCT03110107|559146302|FG025|Treatment Period|Adverse Event|4|||
154923683|NCT03110107|559146277|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
154923684|NCT03110107|559146278|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
154923685|NCT03110107|559146279|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
154923686|NCT03110107|559146280|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
154923687|NCT03110107|559146281|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
154923688|NCT03110107|559146282|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
154923689|NCT03110107|559146283|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
154923690|NCT03110107|559146284|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
154923691|NCT03110107|559146285|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
154923692|NCT03110107|559146286|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
154923693|NCT03110107|559146287|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
154923694|NCT03110107|559146288|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
154923695|NCT03110107|559146289|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
154923696|NCT03110107|559146290|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
154923697|NCT03110107|559146291|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
154923698|NCT03110107|559146292|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
154923699|NCT03110107|559146293|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
154923700|NCT03110107|559146294|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
154923701|NCT03110107|559146295|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
154923702|NCT03110107|559146296|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
154923703|NCT03110107|559146297|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
154923704|NCT03110107|559146298|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
154923705|NCT03110107|559146299|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
154923706|NCT03110107|559146300|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
155009597|NCT00711243|559461164|FG004|Reached First Response/4 Cycles|Death|0|||
154923707|NCT03110107|559146301|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
155009598|NCT00711243|559461165|FG005|Reached First Response/4 Cycles|Death|2|||
155009599|NCT00711243|559461160|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
155009600|NCT00711243|559461161|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
155009601|NCT00711243|559461162|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
155009602|NCT00711243|559461163|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
155009603|NCT00711243|559461164|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
155009604|NCT00711243|559461165|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
155009605|NCT00711243|559461160|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
155009606|NCT00711243|559461161|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
155009607|NCT00711243|559461162|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
155009608|NCT00711243|559461163|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
155009609|NCT00711243|559461164|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
155009610|NCT00711243|559461165|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
155009611|NCT00711243|559461160|FG000|Treated Cycle 5 After First Response|Death|0|||
155009612|NCT00711243|559461161|FG001|Treated Cycle 5 After First Response|Death|0|||
155009613|NCT00711243|559461162|FG002|Treated Cycle 5 After First Response|Death|0|||
155009614|NCT00711243|559461163|FG003|Treated Cycle 5 After First Response|Death|0|||
155009615|NCT00711243|559461164|FG004|Treated Cycle 5 After First Response|Death|0|||
155009616|NCT00711243|559461165|FG005|Treated Cycle 5 After First Response|Death|2|||
155009617|NCT00711243|559461160|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
155009618|NCT00711243|559461161|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
155009619|NCT00711243|559461162|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
155009620|NCT00711243|559461163|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
155009621|NCT00711243|559461164|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
155009622|NCT00711243|559461165|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
155009623|NCT00711243|559461160|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155009624|NCT00711243|559461161|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155009625|NCT00711243|559461162|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155009626|NCT00711243|559461163|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155009627|NCT00711243|559461164|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
155009628|NCT00711243|559461165|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
155009629|NCT03511105|559461166|FG000|Overall Study|Adverse Event|1|||
155009630|NCT03511105|559461167|FG001|Overall Study|Adverse Event|0|||
155009631|NCT03511105|559461166|FG000|Overall Study|Withdrew consent|1|||
155009632|NCT03511105|559461167|FG001|Overall Study|Withdrew consent|0|||
155009633|NCT02810457|559461168|FG000|Overall Study|Randomised but no treatment received|2|||
155009634|NCT02810457|559461169|FG001|Overall Study|Randomised but no treatment received|1|||
155009635|NCT02810457|559461168|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
155009636|NCT02810457|559461169|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
155009637|NCT02810457|559461168|FG000|Overall Study|Adverse Event|37|||
155009638|NCT02810457|559461169|FG001|Overall Study|Adverse Event|43|||
155009639|NCT02810457|559461168|FG000|Overall Study|Patient decision|31|||
155009640|NCT02810457|559461169|FG001|Overall Study|Patient decision|35|||
155009641|NCT02810457|559461168|FG000|Overall Study|Patient lost to follow-up|2|||
155009642|NCT02810457|559461169|FG001|Overall Study|Patient lost to follow-up|2|||
155009643|NCT02810457|559461168|FG000|Overall Study|Death|39|||
155009644|NCT02810457|559461169|FG001|Overall Study|Death|28|||
155009645|NCT02810457|559461168|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
155009646|NCT02810457|559461169|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
155009647|NCT02810457|559461168|FG000|Overall Study|Clinical progression|15|||
155009648|NCT02810457|559461169|FG001|Overall Study|Clinical progression|16|||
155009649|NCT02810457|559461168|FG000|Overall Study|Investigator decision|3|||
155009650|NCT02810457|559461169|FG001|Overall Study|Investigator decision|2|||
155009651|NCT02810457|559461168|FG000|Overall Study|Patient ineligibility|3|||
155009652|NCT02810457|559461169|FG001|Overall Study|Patient ineligibility|0|||
155009653|NCT02810457|559461168|FG000|Overall Study|Miscalculated PD|1|||
155009654|NCT02810457|559461169|FG001|Overall Study|Miscalculated PD|0|||
155009655|NCT02810457|559461168|FG000|Overall Study|Physician Decision|0|||
155009656|NCT02810457|559461169|FG001|Overall Study|Physician Decision|1|||
155009657|NCT01557504|559461172|FG000|Overall Study|Physician Decision|1|||
155009658|NCT01557504|559461173|FG001|Overall Study|Physician Decision|0|||
155009659|NCT01962103|559461176|FG000|Phase 1|Adverse Event|4|||
155009660|NCT01962103|559461177|FG001|Phase 1|Adverse Event|0|||
155009661|NCT01962103|559461178|FG002|Phase 1|Adverse Event|2|||
155009662|NCT01962103|559461179|FG003|Phase 1|Adverse Event|1|||
155009663|NCT01962103|559461180|FG004|Phase 1|Adverse Event|2|||
155009664|NCT01962103|559461181|FG005|Phase 1|Adverse Event|2|||
155009665|NCT01962103|559461182|FG006|Phase 1|Adverse Event|0|||
155009666|NCT01962103|559461183|FG007|Phase 1|Adverse Event|0|||
155009667|NCT01962103|559461184|FG008|Phase 1|Adverse Event|0|||
155009668|NCT01962103|559461176|FG000|Phase 1|Progressive Disease|8|||
155009669|NCT01962103|559461177|FG001|Phase 1|Progressive Disease|6|||
155009670|NCT01962103|559461178|FG002|Phase 1|Progressive Disease|8|||
155009671|NCT01962103|559461179|FG003|Phase 1|Progressive Disease|4|||
155009672|NCT01962103|559461180|FG004|Phase 1|Progressive Disease|5|||
155009673|NCT01962103|559461181|FG005|Phase 1|Progressive Disease|4|||
155009674|NCT01962103|559461182|FG006|Phase 1|Progressive Disease|0|||
155009675|NCT01962103|559461183|FG007|Phase 1|Progressive Disease|0|||
155009676|NCT01962103|559461184|FG008|Phase 1|Progressive Disease|0|||
155009677|NCT01962103|559461176|FG000|Phase 1|Withdrawal by Subject|0|||
155009678|NCT01962103|559461177|FG001|Phase 1|Withdrawal by Subject|0|||
155009679|NCT01962103|559461178|FG002|Phase 1|Withdrawal by Subject|0|||
155009680|NCT01962103|559461179|FG003|Phase 1|Withdrawal by Subject|2|||
155009681|NCT01962103|559461180|FG004|Phase 1|Withdrawal by Subject|0|||
155009682|NCT01962103|559461181|FG005|Phase 1|Withdrawal by Subject|0|||
155009683|NCT01962103|559461182|FG006|Phase 1|Withdrawal by Subject|0|||
155009684|NCT01962103|559461183|FG007|Phase 1|Withdrawal by Subject|0|||
155009685|NCT01962103|559461184|FG008|Phase 1|Withdrawal by Subject|0|||
155009686|NCT01962103|559461176|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
155009687|NCT01962103|559461177|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
155009688|NCT01962103|559461178|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
155009689|NCT01962103|559461179|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
155009690|NCT01962103|559461180|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
155009691|NCT01962103|559461181|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
155009692|NCT01962103|559461182|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
155009693|NCT01962103|559461183|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
155009694|NCT01962103|559461184|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
155009695|NCT01962103|559461176|FG000|Phase 1|Physician Decision|0|||
155009696|NCT01962103|559461177|FG001|Phase 1|Physician Decision|0|||
155009697|NCT01962103|559461178|FG002|Phase 1|Physician Decision|0|||
155009698|NCT01962103|559461179|FG003|Phase 1|Physician Decision|1|||
155009699|NCT01962103|559461180|FG004|Phase 1|Physician Decision|0|||
155009700|NCT01962103|559461181|FG005|Phase 1|Physician Decision|0|||
155009701|NCT01962103|559461182|FG006|Phase 1|Physician Decision|0|||
155009702|NCT01962103|559461183|FG007|Phase 1|Physician Decision|0|||
155009703|NCT01962103|559461184|FG008|Phase 1|Physician Decision|0|||
155009704|NCT01962103|559461176|FG000|Phase 1|Symptomatic Deterioration|3|||
155009705|NCT01962103|559461177|FG001|Phase 1|Symptomatic Deterioration|2|||
155009706|NCT01962103|559461178|FG002|Phase 1|Symptomatic Deterioration|2|||
155009707|NCT01962103|559461179|FG003|Phase 1|Symptomatic Deterioration|2|||
155009708|NCT01962103|559461180|FG004|Phase 1|Symptomatic Deterioration|1|||
155009709|NCT01962103|559461181|FG005|Phase 1|Symptomatic Deterioration|1|||
155009710|NCT01962103|559461182|FG006|Phase 1|Symptomatic Deterioration|0|||
155009711|NCT01962103|559461183|FG007|Phase 1|Symptomatic Deterioration|0|||
155009712|NCT01962103|559461184|FG008|Phase 1|Symptomatic Deterioration|0|||
155009713|NCT01962103|559461176|FG000|Phase 1|Miscellaneous|1|||
155009714|NCT01962103|559461177|FG001|Phase 1|Miscellaneous|0|||
155009715|NCT01962103|559461178|FG002|Phase 1|Miscellaneous|0|||
155009716|NCT01962103|559461179|FG003|Phase 1|Miscellaneous|0|||
155009717|NCT01962103|559461180|FG004|Phase 1|Miscellaneous|0|||
155009718|NCT01962103|559461181|FG005|Phase 1|Miscellaneous|0|||
155009719|NCT01962103|559461182|FG006|Phase 1|Miscellaneous|0|||
155009720|NCT01962103|559461183|FG007|Phase 1|Miscellaneous|0|||
155009721|NCT01962103|559461184|FG008|Phase 1|Miscellaneous|0|||
155009722|NCT01962103|559461176|FG000|Phase 2|Adverse Event|0|||
155009723|NCT01962103|559461177|FG001|Phase 2|Adverse Event|0|||
155009724|NCT01962103|559461178|FG002|Phase 2|Adverse Event|0|||
155009725|NCT01962103|559461179|FG003|Phase 2|Adverse Event|0|||
155009726|NCT01962103|559461180|FG004|Phase 2|Adverse Event|0|||
155009727|NCT01962103|559461181|FG005|Phase 2|Adverse Event|0|||
155009728|NCT01962103|559461182|FG006|Phase 2|Adverse Event|1|||
155009729|NCT01962103|559461183|FG007|Phase 2|Adverse Event|0|||
155009730|NCT01962103|559461184|FG008|Phase 2|Adverse Event|3|||
155009731|NCT01962103|559461176|FG000|Phase 2|Progressive Disease|0|||
155009732|NCT01962103|559461177|FG001|Phase 2|Progressive Disease|0|||
155009733|NCT01962103|559461178|FG002|Phase 2|Progressive Disease|0|||
155009734|NCT01962103|559461179|FG003|Phase 2|Progressive Disease|0|||
155009735|NCT01962103|559461180|FG004|Phase 2|Progressive Disease|0|||
155009736|NCT01962103|559461181|FG005|Phase 2|Progressive Disease|0|||
155009737|NCT01962103|559461182|FG006|Phase 2|Progressive Disease|11|||
155009738|NCT01962103|559461183|FG007|Phase 2|Progressive Disease|12|||
155009739|NCT01962103|559461184|FG008|Phase 2|Progressive Disease|11|||
155009740|NCT01962103|559461176|FG000|Phase 2|Symptomatic Deterioration|0|||
155009741|NCT01962103|559461177|FG001|Phase 2|Symptomatic Deterioration|0|||
155009742|NCT01962103|559461178|FG002|Phase 2|Symptomatic Deterioration|0|||
155009743|NCT01962103|559461179|FG003|Phase 2|Symptomatic Deterioration|0|||
155009744|NCT01962103|559461180|FG004|Phase 2|Symptomatic Deterioration|0|||
155009745|NCT01962103|559461181|FG005|Phase 2|Symptomatic Deterioration|0|||
155009746|NCT01962103|559461182|FG006|Phase 2|Symptomatic Deterioration|2|||
155009747|NCT01962103|559461183|FG007|Phase 2|Symptomatic Deterioration|2|||
155009748|NCT01962103|559461184|FG008|Phase 2|Symptomatic Deterioration|0|||
155009749|NCT02750618|559461185|FG000|Overall Study|Withdrawal by Subject|1|||
155009750|NCT02019472|559461192|FG000|Overall Study|Adverse Event|14|||
155009751|NCT02019472|559461193|FG001|Overall Study|Adverse Event|23|||
155009752|NCT02019472|559461194|FG002|Overall Study|Adverse Event|17|||
155009753|NCT02019472|559461192|FG000|Overall Study|Death|0|||
155009754|NCT02019472|559461193|FG001|Overall Study|Death|1|||
155009755|NCT02019472|559461194|FG002|Overall Study|Death|1|||
155009756|NCT02019472|559461192|FG000|Overall Study|Lack of Efficacy|7|||
155009757|NCT02019472|559461193|FG001|Overall Study|Lack of Efficacy|4|||
155009758|NCT02019472|559461194|FG002|Overall Study|Lack of Efficacy|4|||
155009759|NCT02019472|559461192|FG000|Overall Study|Lost to Follow-up|0|||
155009760|NCT02019472|559461193|FG001|Overall Study|Lost to Follow-up|2|||
155009761|NCT02019472|559461194|FG002|Overall Study|Lost to Follow-up|1|||
155009762|NCT02019472|559461192|FG000|Overall Study|Physician Decision|1|||
155009763|NCT02019472|559461193|FG001|Overall Study|Physician Decision|2|||
155009764|NCT02019472|559461194|FG002|Overall Study|Physician Decision|0|||
155009765|NCT02019472|559461192|FG000|Overall Study|Pregnancy|1|||
155009766|NCT02019472|559461193|FG001|Overall Study|Pregnancy|2|||
155009767|NCT02019472|559461194|FG002|Overall Study|Pregnancy|2|||
155009768|NCT02019472|559461192|FG000|Overall Study|Withdrawal by Subject|11|||
155009769|NCT02019472|559461193|FG001|Overall Study|Withdrawal by Subject|10|||
155009770|NCT02019472|559461194|FG002|Overall Study|Withdrawal by Subject|11|||
155009771|NCT02019472|559461192|FG000|Overall Study|Other|3|||
155009772|NCT02019472|559461193|FG001|Overall Study|Other|8|||
155009773|NCT02019472|559461194|FG002|Overall Study|Other|6|||
155009774|NCT00513695|559461195|FG000|Overall Study|Discontinued therapy|2|||
155009775|NCT00513695|559461195|FG000|Overall Study|Progression prior to surgery|3|||
155009776|NCT02157935|559461196|FG000|Overall Study|Withdrawal by Subject|25|||
155009777|NCT02157935|559461197|FG001|Overall Study|Withdrawal by Subject|39|||
155009778|NCT02157935|559461196|FG000|Overall Study|Screen failure|1|||
155009779|NCT02157935|559461197|FG001|Overall Study|Screen failure|2|||
155009780|NCT02157935|559461196|FG000|Overall Study|Protocol Violation|1|||
155009781|NCT02157935|559461197|FG001|Overall Study|Protocol Violation|0|||
155009782|NCT02157935|559461196|FG000|Overall Study|Progressive disease|0|||
155009783|NCT02157935|559461197|FG001|Overall Study|Progressive disease|2|||
155009784|NCT02157935|559461196|FG000|Overall Study|Other|5|||
155009785|NCT02157935|559461197|FG001|Overall Study|Other|12|||
155009786|NCT02157935|559461196|FG000|Overall Study|Lack of Efficacy|0|||
155009787|NCT02157935|559461197|FG001|Overall Study|Lack of Efficacy|1|||
155009788|NCT02157935|559461196|FG000|Overall Study|Death|4|||
155009789|NCT02157935|559461197|FG001|Overall Study|Death|4|||
155009790|NCT02157935|559461196|FG000|Overall Study|Adverse Event|3|||
155009791|NCT02157935|559461197|FG001|Overall Study|Adverse Event|5|||
155009792|NCT01866826|559461198|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
155009793|NCT01866826|559461199|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
155009794|NCT01866826|559461198|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
155009795|NCT01866826|559461199|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
155009796|NCT01866826|559461198|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
155009797|NCT01866826|559461199|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
155009798|NCT02493660|559461200|FG000|Overall Study|Physician Decision|0|||
155009799|NCT02493660|559461201|FG001|Overall Study|Physician Decision|1|||
155009800|NCT02493660|559461200|FG000|Overall Study|Adverse Event|4|||
155009801|NCT02493660|559461201|FG001|Overall Study|Adverse Event|2|||
155009802|NCT02493660|559461200|FG000|Overall Study|Withdrawal by Subject|2|||
155009803|NCT02493660|559461201|FG001|Overall Study|Withdrawal by Subject|3|||
155009804|NCT02493660|559461200|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
155009805|NCT02493660|559461201|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
155009806|NCT02493660|559461200|FG000|Overall Study|Protocol Violation|0|||
155009807|NCT02493660|559461201|FG001|Overall Study|Protocol Violation|1|||
155009808|NCT02493660|559461200|FG000|Overall Study|Death|0|||
155009809|NCT02493660|559461201|FG001|Overall Study|Death|1|||
155009810|NCT02493660|559461200|FG000|Overall Study|Lost to Follow-up|2|||
155009811|NCT02493660|559461201|FG001|Overall Study|Lost to Follow-up|4|||
155009812|NCT02288312|559461204|FG000|Overall Study|Pregnancy|1|||
155009813|NCT02288312|559461205|FG001|Overall Study|Pregnancy|0|||
155009814|NCT02288312|559461206|FG002|Overall Study|Pregnancy|0|||
155009815|NCT01276041|559461208|FG000|Overall Study|Adverse Event|2|||
155009816|NCT01276041|559461208|FG000|Overall Study|Protocol Violation|1|||
155009817|NCT00725491|559461209|FG000|Overall Study|Adverse Event|3|||
155009818|NCT00725491|559461210|FG001|Overall Study|Adverse Event|2|||
155009819|NCT00725491|559461209|FG000|Overall Study|Pregnancy|0|||
155009820|NCT00725491|559461210|FG001|Overall Study|Pregnancy|3|||
155009821|NCT00725491|559461209|FG000|Overall Study|Risk for hyperstimulation|2|||
155009822|NCT00725491|559461210|FG001|Overall Study|Risk for hyperstimulation|9|||
155009823|NCT00725491|559461209|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
155009824|NCT00725491|559461210|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
155009825|NCT00725491|559461209|FG000|Overall Study|Fertilization failure|0|||
155009826|NCT00725491|559461210|FG001|Overall Study|Fertilization failure|1|||
155009827|NCT00725491|559461209|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
155009828|NCT00725491|559461210|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
155009829|NCT01495000|559461213|FG000|Overall Study|Lost to Follow-up|2|||
155009830|NCT01495000|559461214|FG001|Overall Study|Lost to Follow-up|2|||
155009831|NCT01495000|559461213|FG000|Overall Study|Protocol Violation|1|||
155009832|NCT01495000|559461214|FG001|Overall Study|Protocol Violation|0|||
155009833|NCT01495000|559461213|FG000|Overall Study|Withdrawal by Subject|10|||
155009834|NCT01495000|559461214|FG001|Overall Study|Withdrawal by Subject|10|||
155009835|NCT02070965|559461215|FG000|Overall Study|Lost to Follow-up|0|||
155009836|NCT02070965|559461216|FG001|Overall Study|Lost to Follow-up|1|||
155009837|NCT02070965|559461217|FG002|Overall Study|Lost to Follow-up|0|||
155009838|NCT02070965|559461215|FG000|Overall Study|Withdrawal by Subject|1|||
155009839|NCT02070965|559461216|FG001|Overall Study|Withdrawal by Subject|1|||
155009840|NCT02070965|559461217|FG002|Overall Study|Withdrawal by Subject|1|||
155009841|NCT02070965|559461215|FG000|Overall Study|Subject moved|1|||
155009842|NCT02070965|559461216|FG001|Overall Study|Subject moved|0|||
155009843|NCT02070965|559461217|FG002|Overall Study|Subject moved|0|||
155009844|NCT02058069|559461218|FG000|Overall Study|Exclusion due to implant size|5|||
155009845|NCT02058069|559461218|FG000|Overall Study|Withdrawal by Subject|6|||
155009846|NCT02222922|559461219|FG000|Overall Study|Death|0|||
155009847|NCT02222922|559461220|FG001|Overall Study|Death|0|||
155009848|NCT02222922|559461221|FG002|Overall Study|Death|0|||
155009849|NCT02222922|559461222|FG003|Overall Study|Death|0|||
155009850|NCT02222922|559461223|FG004|Overall Study|Death|13|||
155009851|NCT02222922|559461224|FG005|Overall Study|Death|0|||
155009852|NCT02222922|559461225|FG006|Overall Study|Death|0|||
155009853|NCT02222922|559461226|FG007|Overall Study|Death|0|||
155009854|NCT02222922|559461227|FG008|Overall Study|Death|2|||
155009855|NCT02222922|559461219|FG000|Overall Study|Lost to Follow-up|0|||
155009856|NCT02222922|559461220|FG001|Overall Study|Lost to Follow-up|0|||
155009857|NCT02222922|559461221|FG002|Overall Study|Lost to Follow-up|1|||
155009858|NCT02222922|559461222|FG003|Overall Study|Lost to Follow-up|0|||
155009859|NCT02222922|559461223|FG004|Overall Study|Lost to Follow-up|9|||
155009860|NCT02222922|559461224|FG005|Overall Study|Lost to Follow-up|1|||
155009861|NCT02222922|559461225|FG006|Overall Study|Lost to Follow-up|0|||
155131493|NCT04512976|559912909|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155131494|NCT04512976|559912910|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155131495|NCT04512976|559912911|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155131496|NCT04512976|559912912|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
155131497|NCT04512976|559912913|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
155131498|NCT00615030|559912918|FG000|Period I|Administrative problem|0|||
155131499|NCT00615030|559912919|FG001|Period I|Administrative problem|0|||
155131500|NCT00615030|559912920|FG002|Period I|Administrative problem|0|||
155131501|NCT00615030|559912921|FG003|Period I|Administrative problem|0|||
155131502|NCT00615030|559912922|FG004|Period I|Administrative problem|1|||
155131503|NCT00615030|559912923|FG005|Period I|Administrative problem|0|||
155009862|NCT02222922|559461226|FG007|Overall Study|Lost to Follow-up|0|||
155009863|NCT02222922|559461227|FG008|Overall Study|Lost to Follow-up|0|||
155009864|NCT02222922|559461219|FG000|Overall Study|Other|0|||
155009865|NCT02222922|559461220|FG001|Overall Study|Other|0|||
155009866|NCT02222922|559461221|FG002|Overall Study|Other|0|||
155009867|NCT02222922|559461222|FG003|Overall Study|Other|2|||
155009868|NCT02222922|559461223|FG004|Overall Study|Other|10|||
155009869|NCT02222922|559461224|FG005|Overall Study|Other|2|||
155009870|NCT02222922|559461225|FG006|Overall Study|Other|2|||
155009871|NCT02222922|559461226|FG007|Overall Study|Other|4|||
155009872|NCT02222922|559461227|FG008|Overall Study|Other|1|||
155009873|NCT02222922|559461219|FG000|Overall Study|Participant refused further follow-up|1|||
155009874|NCT02222922|559461220|FG001|Overall Study|Participant refused further follow-up|0|||
155009875|NCT02222922|559461221|FG002|Overall Study|Participant refused further follow-up|0|||
155009876|NCT02222922|559461222|FG003|Overall Study|Participant refused further follow-up|1|||
155009877|NCT02222922|559461223|FG004|Overall Study|Participant refused further follow-up|6|||
155009878|NCT02222922|559461224|FG005|Overall Study|Participant refused further follow-up|0|||
155009879|NCT02222922|559461225|FG006|Overall Study|Participant refused further follow-up|0|||
155009880|NCT02222922|559461226|FG007|Overall Study|Participant refused further follow-up|0|||
155009881|NCT02222922|559461227|FG008|Overall Study|Participant refused further follow-up|3|||
155009882|NCT02687451|559461228|FG000|Overall Study|Withdrawal by Subject|1|||
155009883|NCT02687451|559461229|FG001|Overall Study|Withdrawal by Subject|0|||
155131504|NCT00615030|559912924|FG006|Period I|Administrative problem|0|||
155009884|NCT02687451|559461230|FG002|Overall Study|Withdrawal by Subject|0|||
155009885|NCT02687451|559461231|FG003|Overall Study|Withdrawal by Subject|0|||
155009886|NCT02687451|559461232|FG004|Overall Study|Withdrawal by Subject|0|||
155009887|NCT02687451|559461233|FG005|Overall Study|Withdrawal by Subject|1|||
155009888|NCT03652051|559461234|FG000|Stage 1|Adverse Event|0|||
155009889|NCT03652051|559461235|FG001|Stage 1|Adverse Event|5|||
155131505|NCT00615030|559912925|FG007|Period I|Administrative problem|0|||
155009890|NCT03652051|559461236|FG002|Stage 1|Adverse Event|7|||
155009891|NCT03652051|559461237|FG003|Stage 1|Adverse Event|1|||
155009892|NCT03652051|559461234|FG000|Stage 1|Withdrawal by Subject|0|||
155009893|NCT03652051|559461235|FG001|Stage 1|Withdrawal by Subject|0|||
155009894|NCT03652051|559461236|FG002|Stage 1|Withdrawal by Subject|1|||
155009895|NCT03652051|559461237|FG003|Stage 1|Withdrawal by Subject|0|||
155009896|NCT03652051|559461234|FG000|Stage 2|Adverse Event|0|||
155009897|NCT03652051|559461235|FG001|Stage 2|Adverse Event|2|||
155009898|NCT03652051|559461236|FG002|Stage 2|Adverse Event|1|||
155009899|NCT03652051|559461237|FG003|Stage 2|Adverse Event|0|||
155009900|NCT03652051|559461234|FG000|Stage 2|Protocol Violation|0|||
155009901|NCT03652051|559461235|FG001|Stage 2|Protocol Violation|1|||
155009902|NCT03652051|559461236|FG002|Stage 2|Protocol Violation|6|||
155009903|NCT03652051|559461237|FG003|Stage 2|Protocol Violation|0|||
155009904|NCT03652051|559461234|FG000|Stage 2|Lost to Follow-up|0|||
155009905|NCT03652051|559461235|FG001|Stage 2|Lost to Follow-up|2|||
155009906|NCT03652051|559461236|FG002|Stage 2|Lost to Follow-up|0|||
155009907|NCT03652051|559461237|FG003|Stage 2|Lost to Follow-up|3|||
155009908|NCT03652051|559461234|FG000|Stage 2|Withdrawal by Subject|0|||
155009909|NCT03652051|559461235|FG001|Stage 2|Withdrawal by Subject|11|||
155009910|NCT03652051|559461236|FG002|Stage 2|Withdrawal by Subject|9|||
155009911|NCT03652051|559461237|FG003|Stage 2|Withdrawal by Subject|3|||
155009912|NCT03473925|559461238|FG000|Overall Study|Death|48|||
155009913|NCT03473925|559461239|FG001|Overall Study|Death|44|||
155009914|NCT03473925|559461238|FG000|Overall Study|Sponsor Decision|2|||
155009915|NCT03473925|559461239|FG001|Overall Study|Sponsor Decision|7|||
155009916|NCT03473925|559461238|FG000|Overall Study|Withdrawal by Subject|1|||
155009917|NCT03473925|559461239|FG001|Overall Study|Withdrawal by Subject|3|||
155009918|NCT03473925|559461238|FG000|Overall Study|Not Treated|1|||
155009919|NCT03473925|559461239|FG001|Overall Study|Not Treated|1|||
155009920|NCT05198518|559461242|FG000|Screening Visit|Deemed unable to participate|58|||
155009921|NCT05198518|559461243|FG001|Screening Visit|Deemed unable to participate|0|||
155009922|NCT05198518|559461244|FG002|Screening Visit|Deemed unable to participate|0|||
155009923|NCT03645863|559461246|FG000|Overall Study|Withdrawal by Subject|1|||
155009924|NCT03645863|559461247|FG001|Overall Study|Withdrawal by Subject|0|||
155009925|NCT03645863|559461248|FG002|Overall Study|Withdrawal by Subject|0|||
155009926|NCT02756611|559461250|FG000|Overall Study|Death|70|||
155009927|NCT02756611|559461250|FG000|Overall Study|Withdrawal by Subject|2|||
155009928|NCT02756611|559461250|FG000|Overall Study|Lost to Follow-up|3|||
155009929|NCT02756611|559461250|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
155009930|NCT02756611|559461250|FG000|Overall Study|Other|10|||
155009931|NCT00124917|559461251|FG000|Overall Study|Physician Decision|3|||
155009932|NCT01422213|559461252|FG000|Overall Study|Adverse Event|8|||
155009933|NCT01422213|559461253|FG001|Overall Study|Adverse Event|7|||
155009934|NCT01422213|559461254|FG002|Overall Study|Adverse Event|11|||
155009935|NCT01422213|559461252|FG000|Overall Study|Lack of Efficacy|10|||
155009936|NCT01422213|559461253|FG001|Overall Study|Lack of Efficacy|2|||
155009937|NCT01422213|559461254|FG002|Overall Study|Lack of Efficacy|2|||
155009938|NCT01422213|559461252|FG000|Overall Study|Non-compliance with study drug|0|||
155009939|NCT01422213|559461253|FG001|Overall Study|Non-compliance with study drug|1|||
155009940|NCT01422213|559461254|FG002|Overall Study|Non-compliance with study drug|0|||
155009941|NCT01422213|559461252|FG000|Overall Study|Protocol Violation|0|||
155009942|NCT01422213|559461253|FG001|Overall Study|Protocol Violation|2|||
155009943|NCT01422213|559461254|FG002|Overall Study|Protocol Violation|4|||
155009944|NCT01422213|559461252|FG000|Overall Study|Withdrawal of Consent|7|||
155009945|NCT01422213|559461253|FG001|Overall Study|Withdrawal of Consent|3|||
155009946|NCT01422213|559461254|FG002|Overall Study|Withdrawal of Consent|5|||
155009947|NCT01422213|559461252|FG000|Overall Study|Lost to Follow-up|3|||
155009948|NCT01422213|559461253|FG001|Overall Study|Lost to Follow-up|3|||
155009949|NCT01422213|559461254|FG002|Overall Study|Lost to Follow-up|5|||
155009950|NCT01422213|559461252|FG000|Overall Study|Administrative or Other Reason(s)|5|||
155009951|NCT01422213|559461253|FG001|Overall Study|Administrative or Other Reason(s)|4|||
155009952|NCT01422213|559461254|FG002|Overall Study|Administrative or Other Reason(s)|2|||
155009953|NCT00951496|559461255|FG000|Overall Study|Did not initiate study treatment|10|||
155009954|NCT00951496|559461256|FG001|Overall Study|Did not initiate study treatment|8|||
155009955|NCT00951496|559461257|FG002|Overall Study|Did not initiate study treatment|13|||
155009956|NCT04870710|559461258|FG000|Overall Study|Lost to Follow-up|3|||
155009957|NCT00476190|559461259|FG000|Overall Study|Ineligible|1|||
155009958|NCT00476190|559461260|FG001|Overall Study|Ineligible|1|||
155009959|NCT00476190|559461259|FG000|Overall Study|Induction Death|2|||
155009960|NCT00476190|559461260|FG001|Overall Study|Induction Death|0|||
155009961|NCT00476190|559461259|FG000|Overall Study|Induction Failure|2|||
155009962|NCT00476190|559461260|FG001|Overall Study|Induction Failure|4|||
155009963|NCT00476190|559461259|FG000|Overall Study|Lost to Follow-up|1|||
155009964|NCT00476190|559461260|FG001|Overall Study|Lost to Follow-up|0|||
155009965|NCT00476190|559461259|FG000|Overall Study|Relapse/Progression|5|||
155009966|NCT00476190|559461260|FG001|Overall Study|Relapse/Progression|2|||
155009967|NCT00476190|559461259|FG000|Overall Study|Remission Death|0|||
155009968|NCT00476190|559461260|FG001|Overall Study|Remission Death|1|||
155009969|NCT00476190|559461259|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
155009970|NCT00476190|559461260|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
155009971|NCT00476190|559461259|FG000|Overall Study|Withdrawal by Subject|6|||
155009972|NCT00476190|559461260|FG001|Overall Study|Withdrawal by Subject|2|||
155009973|NCT00476190|559461259|FG000|Overall Study|Other|9|||
155009974|NCT00476190|559461260|FG001|Overall Study|Other|10|||
155009975|NCT02860546|559461261|FG000|Overall Study|Clinical Progression|6|||
155009976|NCT02860546|559461261|FG000|Overall Study|Radiological Progression|12|||
155009977|NCT01998841|559461272|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
155009978|NCT01998841|559461273|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
155009979|NCT01998841|559461274|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
155009980|NCT01998841|559461275|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155009981|NCT01998841|559461276|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155009982|NCT01998841|559461272|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155009983|NCT01998841|559461273|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155009984|NCT01998841|559461274|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
155009985|NCT01998841|559461275|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
155009986|NCT01998841|559461276|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
155009987|NCT00972595|559461277|FG000|Period 1|Adverse Event|1|||
155009988|NCT00972595|559461278|FG001|Period 1|Adverse Event|0|||
155009989|NCT03552380|559461280|FG000|Study Treatment|Disease Progression|3|||
155009990|NCT03552380|559461281|FG001|Study Treatment|Disease Progression|4|||
155009991|NCT03552380|559461280|FG000|Study Treatment|Adverse Event|2|||
155009992|NCT03552380|559461281|FG001|Study Treatment|Adverse Event|2|||
155009993|NCT03552380|559461280|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
155009994|NCT03552380|559461281|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
155009995|NCT03552380|559461280|FG000|Follow up|Death|3|||
155009996|NCT03552380|559461281|FG001|Follow up|Death|4|||
155009997|NCT03552380|559461280|FG000|Follow up|Site IRB terminated|0|||
155009998|NCT03552380|559461281|FG001|Follow up|Site IRB terminated|1|||
155009999|NCT03447743|559461282|FG000|Overall Study|Withdrawal by Subject|2|||
155010000|NCT03447743|559461282|FG000|Overall Study|Lost to Follow-up|3|||
155010001|NCT03447743|559461282|FG000|Overall Study|Adverse Event|1|||
155010002|NCT03447743|559461282|FG000|Overall Study|Did not meet criteria to continue|1|||
155010003|NCT02461160|559461283|FG000|Overall Study|Lost to Follow-up|0|||
155010004|NCT02461160|559461284|FG001|Overall Study|Lost to Follow-up|0|||
155010005|NCT02461160|559461285|FG002|Overall Study|Lost to Follow-up|0|||
155010006|NCT02461160|559461286|FG003|Overall Study|Lost to Follow-up|0|||
155010007|NCT02461160|559461287|FG004|Overall Study|Lost to Follow-up|0|||
155010008|NCT02461160|559461288|FG005|Overall Study|Lost to Follow-up|0|||
155010009|NCT02461160|559461289|FG006|Overall Study|Lost to Follow-up|0|||
155010010|NCT02461160|559461290|FG007|Overall Study|Lost to Follow-up|1|||
155010011|NCT02461160|559461291|FG008|Overall Study|Lost to Follow-up|0|||
155010012|NCT02461160|559461292|FG009|Overall Study|Lost to Follow-up|0|||
155010013|NCT02461160|559461293|FG010|Overall Study|Lost to Follow-up|0|||
155010014|NCT02461160|559461294|FG011|Overall Study|Lost to Follow-up|0|||
155010015|NCT02461160|559461295|FG012|Overall Study|Lost to Follow-up|0|||
155010016|NCT01112059|559461296|FG000|Overall Study|Withdrawal by Subject|1|||
155010017|NCT01112059|559461297|FG001|Overall Study|Withdrawal by Subject|0|||
155010018|NCT03567980|559461300|FG000|Overall Study|Adverse Event|1|||
155010019|NCT02575833|559461303|FG000|Overall Study|Withdrawal by Subject|0|||
155010020|NCT02575833|559461304|FG001|Overall Study|Withdrawal by Subject|1|||
155010021|NCT02575833|559461303|FG000|Overall Study|Lost to Follow-up|1|||
155010022|NCT02575833|559461304|FG001|Overall Study|Lost to Follow-up|0|||
155010023|NCT00967330|559461305|FG000|Overall Study|Protocol Violation|3|||
155010024|NCT00967330|559461306|FG001|Overall Study|Protocol Violation|4|||
155010025|NCT00967330|559461305|FG000|Overall Study|Regular|10|||
155010026|NCT00967330|559461306|FG001|Overall Study|Regular|3|||
155010027|NCT00967330|559461305|FG000|Overall Study|Withdrawal by Subject|6|||
155010028|NCT00967330|559461306|FG001|Overall Study|Withdrawal by Subject|0|||
155010029|NCT00967330|559461305|FG000|Overall Study|Lost to Follow-up|1|||
155010030|NCT00967330|559461306|FG001|Overall Study|Lost to Follow-up|1|||
155010031|NCT00967330|559461305|FG000|Overall Study|Death|102|||
155010032|NCT00967330|559461306|FG001|Overall Study|Death|51|||
155010033|NCT00967330|559461305|FG000|Overall Study|Severe protocol deviation|0|||
155010034|NCT00967330|559461306|FG001|Overall Study|Severe protocol deviation|1|||
155010035|NCT02698163|559461309|FG000|Overall Study|Lost to Follow-up|0|||
155010036|NCT02698163|559461310|FG001|Overall Study|Lost to Follow-up|1|||
155010037|NCT01133067|559461311|FG000|Overall Study|Death|136|||
155010038|NCT01133067|559461311|FG000|Overall Study|Lost to Follow-up|3|||
155010039|NCT00752128|559461315|FG000|Overall Study|Withdrawal by Subject|4|||
155010040|NCT00349973|559461316|FG000|Overall Study|Adverse Event|3|||
155010041|NCT00349973|559461317|FG001|Overall Study|Adverse Event|3|||
155010042|NCT00349973|559461316|FG000|Overall Study|Withdrawal by Subject|1|||
155010043|NCT00349973|559461317|FG001|Overall Study|Withdrawal by Subject|0|||
155010044|NCT02548143|559461318|FG000|Overall Study|Adverse Event|1|||
155010045|NCT02548143|559461319|FG001|Overall Study|Adverse Event|0|||
155010046|NCT02548143|559461318|FG000|Overall Study|Withdrawal by Subject|0|||
155010047|NCT02548143|559461319|FG001|Overall Study|Withdrawal by Subject|1|||
155010048|NCT05620082|559461320|FG000|Overall Study|Discharged before study end|1|||
155010049|NCT05620082|559461321|FG001|Overall Study|Discharged before study end|4|||
155010050|NCT05620082|559461322|FG002|Overall Study|Discharged before study end|0|||
155010051|NCT05620082|559461320|FG000|Overall Study|Moved to a different ward|1|||
155010052|NCT05620082|559461321|FG001|Overall Study|Moved to a different ward|0|||
155010053|NCT05620082|559461322|FG002|Overall Study|Moved to a different ward|0|||
155010054|NCT05620082|559461320|FG000|Overall Study|Feeling too unwell|1|||
155010055|NCT05620082|559461321|FG001|Overall Study|Feeling too unwell|0|||
155010056|NCT05620082|559461322|FG002|Overall Study|Feeling too unwell|0|||
155010057|NCT00625820|559461327|FG000|Overall Study|Withdrawal by Subject|1|||
155010058|NCT04796961|559463183|FG000|Overall Study|Lost to Follow-up|10|||
155010059|NCT04796961|559463183|FG000|Overall Study|Withdrawal by Subject|3|||
155010060|NCT04796961|559463183|FG000|Overall Study|Left Organization|10|||
155010061|NCT05201794|559463184|FG000|Overall Study|Withdrawal by Subject|13|||
155010062|NCT05201794|559463185|FG001|Overall Study|Withdrawal by Subject|12|||
155010063|NCT05201794|559463186|FG002|Overall Study|Withdrawal by Subject|14|||
155010064|NCT05201794|559463187|FG003|Overall Study|Withdrawal by Subject|0|||
155010065|NCT05201794|559463184|FG000|Overall Study|Adverse Event|5|||
155010066|NCT05201794|559463185|FG001|Overall Study|Adverse Event|5|||
155010067|NCT05201794|559463186|FG002|Overall Study|Adverse Event|4|||
155010068|NCT05201794|559463187|FG003|Overall Study|Adverse Event|0|||
155010069|NCT05201794|559463184|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
155010070|NCT05201794|559463185|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155010071|NCT05201794|559463186|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
155010072|NCT05201794|559463187|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155010073|NCT05201794|559463184|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155010074|NCT05201794|559463185|FG001|Overall Study|Non-Compliance With Study Drug|3|||
155010075|NCT05201794|559463186|FG002|Overall Study|Non-Compliance With Study Drug|3|||
155010076|NCT05201794|559463187|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155010077|NCT05201794|559463184|FG000|Overall Study|Physician Decision|1|||
155010078|NCT05201794|559463185|FG001|Overall Study|Physician Decision|3|||
155010079|NCT05201794|559463186|FG002|Overall Study|Physician Decision|2|||
155010080|NCT05201794|559463187|FG003|Overall Study|Physician Decision|0|||
155010081|NCT05201794|559463184|FG000|Overall Study|Lost to Follow-up|2|||
155010082|NCT05201794|559463185|FG001|Overall Study|Lost to Follow-up|2|||
155010083|NCT05201794|559463186|FG002|Overall Study|Lost to Follow-up|0|||
155010084|NCT05201794|559463187|FG003|Overall Study|Lost to Follow-up|0|||
155010085|NCT05201794|559463184|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
155010086|NCT05201794|559463185|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
155010087|NCT05201794|559463186|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
155010088|NCT05201794|559463187|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
155010089|NCT05201794|559463184|FG000|Overall Study|Protocol Violation|2|||
155010090|NCT05201794|559463185|FG001|Overall Study|Protocol Violation|0|||
155010091|NCT05201794|559463186|FG002|Overall Study|Protocol Violation|1|||
155010092|NCT05201794|559463187|FG003|Overall Study|Protocol Violation|0|||
155010093|NCT05201794|559463184|FG000|Overall Study|Death|1|||
155010094|NCT05201794|559463185|FG001|Overall Study|Death|0|||
155010095|NCT05201794|559463186|FG002|Overall Study|Death|0|||
155010096|NCT05201794|559463187|FG003|Overall Study|Death|0|||
155010097|NCT05201794|559463184|FG000|Overall Study|Site Terminated By Sponsor|0|||
155010098|NCT05201794|559463185|FG001|Overall Study|Site Terminated By Sponsor|1|||
155010099|NCT05201794|559463186|FG002|Overall Study|Site Terminated By Sponsor|0|||
155010100|NCT05201794|559463187|FG003|Overall Study|Site Terminated By Sponsor|0|||
155010101|NCT05201794|559463184|FG000|Overall Study|Other|3|||
155010102|NCT05201794|559463185|FG001|Overall Study|Other|3|||
155010103|NCT05201794|559463186|FG002|Overall Study|Other|3|||
155010104|NCT05201794|559463187|FG003|Overall Study|Other|0|||
155010105|NCT05201794|559463184|FG000|Overall Study|Randomized But Not Treated|1|||
155010106|NCT05201794|559463185|FG001|Overall Study|Randomized But Not Treated|2|||
155010107|NCT05201794|559463186|FG002|Overall Study|Randomized But Not Treated|1|||
155010108|NCT05201794|559463187|FG003|Overall Study|Randomized But Not Treated|0|||
155010109|NCT01490086|559463188|FG000|Overall Study|Consent withdrawn|4|||
155010110|NCT01490086|559463189|FG001|Overall Study|Consent withdrawn|4|||
155010111|NCT01490086|559463190|FG002|Overall Study|Consent withdrawn|3|||
155010112|NCT01490086|559463191|FG003|Overall Study|Consent withdrawn|0|||
155010113|NCT01490086|559463192|FG004|Overall Study|Consent withdrawn|1|||
155010114|NCT01490086|559463188|FG000|Overall Study|Non-compliance|0|||
155010115|NCT01490086|559463189|FG001|Overall Study|Non-compliance|1|||
155010116|NCT01490086|559463190|FG002|Overall Study|Non-compliance|0|||
155010117|NCT01490086|559463191|FG003|Overall Study|Non-compliance|0|||
155010118|NCT01490086|559463192|FG004|Overall Study|Non-compliance|0|||
155010119|NCT01490086|559463188|FG000|Overall Study|Abnormal laboratory findings|1|||
155010120|NCT01490086|559463189|FG001|Overall Study|Abnormal laboratory findings|0|||
155010121|NCT01490086|559463190|FG002|Overall Study|Abnormal laboratory findings|0|||
155010122|NCT01490086|559463191|FG003|Overall Study|Abnormal laboratory findings|0|||
155010123|NCT01490086|559463192|FG004|Overall Study|Abnormal laboratory findings|0|||
155010124|NCT01490086|559463188|FG000|Overall Study|Lost to Follow-up|0|||
155010125|NCT01490086|559463189|FG001|Overall Study|Lost to Follow-up|0|||
155010126|NCT01490086|559463190|FG002|Overall Study|Lost to Follow-up|0|||
155010127|NCT01490086|559463191|FG003|Overall Study|Lost to Follow-up|0|||
155010128|NCT01490086|559463192|FG004|Overall Study|Lost to Follow-up|1|||
155010129|NCT01490086|559463188|FG000|Overall Study|Physician Decision|3|||
155010130|NCT01490086|559463189|FG001|Overall Study|Physician Decision|4|||
155010131|NCT01490086|559463190|FG002|Overall Study|Physician Decision|2|||
155010132|NCT01490086|559463191|FG003|Overall Study|Physician Decision|3|||
155010133|NCT01490086|559463192|FG004|Overall Study|Physician Decision|1|||
155010134|NCT01490086|559463188|FG000|Overall Study|Adverse Event|0|||
155010135|NCT01490086|559463189|FG001|Overall Study|Adverse Event|0|||
155010136|NCT01490086|559463190|FG002|Overall Study|Adverse Event|1|||
155010137|NCT01490086|559463191|FG003|Overall Study|Adverse Event|2|||
155010138|NCT01490086|559463192|FG004|Overall Study|Adverse Event|0|||
155010139|NCT01490086|559463188|FG000|Overall Study|Lack of Efficacy|0|||
155010140|NCT01490086|559463189|FG001|Overall Study|Lack of Efficacy|3|||
155010141|NCT01490086|559463190|FG002|Overall Study|Lack of Efficacy|1|||
155010142|NCT01490086|559463191|FG003|Overall Study|Lack of Efficacy|0|||
155010143|NCT01490086|559463192|FG004|Overall Study|Lack of Efficacy|8|||
155010144|NCT01490086|559463188|FG000|Overall Study|Worsening of symptoms|0|||
155010145|NCT01490086|559463189|FG001|Overall Study|Worsening of symptoms|1|||
155010146|NCT01490086|559463190|FG002|Overall Study|Worsening of symptoms|0|||
155010147|NCT01490086|559463191|FG003|Overall Study|Worsening of symptoms|1|||
155010148|NCT01490086|559463192|FG004|Overall Study|Worsening of symptoms|0|||
155010149|NCT01490086|559463188|FG000|Overall Study|Subject uncontrollable and abusive|0|||
155010150|NCT01490086|559463189|FG001|Overall Study|Subject uncontrollable and abusive|1|||
155010151|NCT01490086|559463190|FG002|Overall Study|Subject uncontrollable and abusive|0|||
155010152|NCT01490086|559463191|FG003|Overall Study|Subject uncontrollable and abusive|0|||
155010153|NCT01490086|559463192|FG004|Overall Study|Subject uncontrollable and abusive|0|||
155010154|NCT01490086|559463188|FG000|Overall Study|Subject left hospital|0|||
155010155|NCT01490086|559463189|FG001|Overall Study|Subject left hospital|1|||
155010156|NCT01490086|559463190|FG002|Overall Study|Subject left hospital|0|||
155010157|NCT01490086|559463191|FG003|Overall Study|Subject left hospital|1|||
155010158|NCT01490086|559463192|FG004|Overall Study|Subject left hospital|0|||
155010159|NCT04510090|559463195|FG000|FE-HS|Withdrawal by Subject|0|||
155010160|NCT04510090|559463196|FG001|FE-HS|Withdrawal by Subject|0|||
155010161|NCT04510090|559463197|FG002|FE-HS|Withdrawal by Subject|0|||
155010162|NCT04510090|559463198|FG003|FE-HS|Withdrawal by Subject|0|||
155010163|NCT04510090|559463199|FG004|FE-HS|Withdrawal by Subject|1|||
155010164|NCT04510090|559463200|FG005|FE-HS|Withdrawal by Subject|0|||
155010165|NCT04510090|559463201|FG006|FE-HS|Withdrawal by Subject|0|||
155010166|NCT04510090|559463202|FG007|FE-HS|Withdrawal by Subject|0|||
155010167|NCT05825404|559463203|FG000|First Intervention (Weeks 2-5)|Death|0|||
155010168|NCT05825404|559463204|FG001|First Intervention (Weeks 2-5)|Death|1|||
155010169|NCT05825404|559463203|FG000|Second Intervention (Weeks 8-11)|Death|0|||
155010170|NCT05825404|559463204|FG001|Second Intervention (Weeks 8-11)|Death|1|||
155010171|NCT01127256|559463205|FG000|Overall Study|Adverse Event|13|||
155010172|NCT01127256|559463206|FG001|Overall Study|Adverse Event|13|||
155010173|NCT01127256|559463205|FG000|Overall Study|Lack of Efficacy|4|||
155010174|NCT01127256|559463206|FG001|Overall Study|Lack of Efficacy|0|||
155010175|NCT01127256|559463205|FG000|Overall Study|Lost to Follow-up|16|||
155010176|NCT01127256|559463206|FG001|Overall Study|Lost to Follow-up|17|||
155010177|NCT01127256|559463205|FG000|Overall Study|Withdrawal by Subject|5|||
155010178|NCT01127256|559463206|FG001|Overall Study|Withdrawal by Subject|9|||
155010179|NCT01127256|559463205|FG000|Overall Study|Protocol Violation|1|||
155010180|NCT01127256|559463206|FG001|Overall Study|Protocol Violation|0|||
155010181|NCT01749826|559463207|FG000|Overall Study|Study Terminated|20|||
155131506|NCT00615030|559912926|FG008|Period I|Administrative problem|0|||
155010182|NCT01749826|559463208|FG001|Overall Study|Study Terminated|0|||
155010183|NCT00679211|559463209|FG000|Overall Study|Progressive disease|82|||
155010184|NCT00679211|559463209|FG000|Overall Study|Adverse Event|7|||
155010185|NCT00679211|559463209|FG000|Overall Study|Withdrawal by Subject|2|||
155010186|NCT00679211|559463209|FG000|Overall Study|Physician Decision|5|||
155010187|NCT00679211|559463209|FG000|Overall Study|Refused to undergo protocol procedures|1|||
155010188|NCT00679211|559463209|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
155010189|NCT00679211|559463209|FG000|Overall Study|Other|1|||
155010190|NCT00931528|559463210|FG000|Overall Study|Protocol Violation|9|||
155010191|NCT00931528|559463211|FG001|Overall Study|Protocol Violation|12|||
155010192|NCT00931528|559463210|FG000|Overall Study|Withdrawal by Subject|4|||
155010193|NCT00931528|559463211|FG001|Overall Study|Withdrawal by Subject|12|||
155010194|NCT00931528|559463210|FG000|Overall Study|Lost to Follow-up|6|||
155010195|NCT00931528|559463211|FG001|Overall Study|Lost to Follow-up|13|||
155010196|NCT00931528|559463210|FG000|Overall Study|Assessment outside of Time Frame|22|||
155010197|NCT00931528|559463211|FG001|Overall Study|Assessment outside of Time Frame|23|||
155010198|NCT01470248|559463212|FG000|Overall Study|Withdrawal by Subject|1|||
155010199|NCT05085834|559463213|FG000|Overall Study|Lost to Follow-up|9|||
155010200|NCT05085834|559463214|FG001|Overall Study|Lost to Follow-up|2|||
155010201|NCT05085834|559463213|FG000|Overall Study|Adverse Event|6|||
155010202|NCT05085834|559463214|FG001|Overall Study|Adverse Event|0|||
155010203|NCT05085834|559463213|FG000|Overall Study|Death|1|||
155010204|NCT05085834|559463214|FG001|Overall Study|Death|0|||
155010205|NCT05085834|559463213|FG000|Overall Study|Inability to swallow the pill|0|||
155010206|NCT05085834|559463214|FG001|Overall Study|Inability to swallow the pill|1|||
155010207|NCT05842967|559463217|FG000|Period 1: SSA|Adverse Event|1|||
155010208|NCT05842967|559463218|FG001|Period 1: SSA|Adverse Event|1|||
155010209|NCT05842967|559463219|FG002|Period 1: SSA|Adverse Event|0|||
155010210|NCT05842967|559463220|FG003|Period 1: SSA|Adverse Event|0|||
155010211|NCT05842967|559463217|FG000|Period 1: SSA|Death|1|||
155010212|NCT05842967|559463218|FG001|Period 1: SSA|Death|0|||
155010213|NCT05842967|559463219|FG002|Period 1: SSA|Death|0|||
155010214|NCT05842967|559463220|FG003|Period 1: SSA|Death|0|||
155010215|NCT05842967|559463217|FG000|Period 1: SSA|Lost to Follow-up|16|||
155010216|NCT05842967|559463218|FG001|Period 1: SSA|Lost to Follow-up|4|||
155010217|NCT05842967|559463219|FG002|Period 1: SSA|Lost to Follow-up|0|||
155010218|NCT05842967|559463220|FG003|Period 1: SSA|Lost to Follow-up|0|||
155010219|NCT05842967|559463217|FG000|Period 1: SSA|Physician Decision|1|||
155010220|NCT05842967|559463218|FG001|Period 1: SSA|Physician Decision|0|||
155010221|NCT05842967|559463219|FG002|Period 1: SSA|Physician Decision|0|||
155010222|NCT05842967|559463220|FG003|Period 1: SSA|Physician Decision|0|||
155010223|NCT05842967|559463217|FG000|Period 1: SSA|Withdrawal by Subject|2|||
155010224|NCT05842967|559463218|FG001|Period 1: SSA|Withdrawal by Subject|2|||
155010225|NCT05842967|559463219|FG002|Period 1: SSA|Withdrawal by Subject|0|||
155010226|NCT05842967|559463220|FG003|Period 1: SSA|Withdrawal by Subject|0|||
155010227|NCT05842967|559463217|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
155010228|NCT05842967|559463218|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
155010229|NCT05842967|559463219|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
155010230|NCT05842967|559463220|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
155010231|NCT05842967|559463217|FG000|Period 2: SSB|Adverse Event|0|||
155010232|NCT05842967|559463218|FG001|Period 2: SSB|Adverse Event|0|||
155010233|NCT05842967|559463219|FG002|Period 2: SSB|Adverse Event|2|||
155010234|NCT05842967|559463220|FG003|Period 2: SSB|Adverse Event|0|||
155010235|NCT05842967|559463217|FG000|Period 2: SSB|Lost to Follow-up|0|||
155010236|NCT05842967|559463218|FG001|Period 2: SSB|Lost to Follow-up|0|||
155010237|NCT05842967|559463219|FG002|Period 2: SSB|Lost to Follow-up|4|||
155010238|NCT05842967|559463220|FG003|Period 2: SSB|Lost to Follow-up|3|||
155010239|NCT05842967|559463217|FG000|Period 2: SSB|Withdrawal by Subject|0|||
155010240|NCT05842967|559463218|FG001|Period 2: SSB|Withdrawal by Subject|0|||
155010241|NCT05842967|559463219|FG002|Period 2: SSB|Withdrawal by Subject|1|||
155010242|NCT05842967|559463220|FG003|Period 2: SSB|Withdrawal by Subject|0|||
155010243|NCT05842967|559463217|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
155010244|NCT05842967|559463218|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
155010245|NCT05842967|559463219|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
155010246|NCT05842967|559463220|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
155010247|NCT05842967|559463217|FG000|Period 2: SSB|Protocol Violation|0|||
155010248|NCT05842967|559463218|FG001|Period 2: SSB|Protocol Violation|0|||
155010249|NCT05842967|559463219|FG002|Period 2: SSB|Protocol Violation|0|||
155010250|NCT05842967|559463220|FG003|Period 2: SSB|Protocol Violation|1|||
155010251|NCT01402570|559463230|FG000|Overall Study|Adverse Event|1|||
155010252|NCT03642262|559463231|FG000|Period 1|Withdrawal by Subject|1|||
155010253|NCT03642262|559463232|FG001|Period 1|Withdrawal by Subject|1|||
155010254|NCT03642262|559463231|FG000|Period 1|Adverse Event|0|||
155010255|NCT03642262|559463232|FG001|Period 1|Adverse Event|1|||
155010256|NCT02302833|559463239|FG000|Overall Study|Lost to Follow-up|3|||
155010257|NCT04429503|559463240|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
155010258|NCT04429503|559463241|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
155010259|NCT04429503|559463242|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155010260|NCT04429503|559463243|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155010261|NCT04429503|559463244|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155010262|NCT04429503|559463245|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
155010263|NCT04429503|559463240|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
155010264|NCT04429503|559463241|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
155010265|NCT04429503|559463242|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
155010266|NCT04429503|559463243|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
155010267|NCT04429503|559463244|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
155010268|NCT04429503|559463245|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
155010269|NCT04429503|559463240|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
155010270|NCT04429503|559463241|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
155010271|NCT04429503|559463242|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
155010272|NCT04429503|559463243|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
155010273|NCT04429503|559463244|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
155010274|NCT04429503|559463245|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
155010275|NCT04429503|559463240|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
155010276|NCT04429503|559463241|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
155131507|NCT00615030|559912927|FG009|Period I|Administrative problem|0|||
155131508|NCT00615030|559912928|FG010|Period I|Administrative problem|0|||
155010277|NCT04429503|559463242|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
155010278|NCT04429503|559463243|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
155010279|NCT04429503|559463244|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
155010280|NCT04429503|559463245|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
155010281|NCT04429503|559463240|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
155010282|NCT04429503|559463241|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
155010283|NCT04429503|559463242|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
155010284|NCT04429503|559463243|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
155010285|NCT04429503|559463244|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
155010286|NCT04429503|559463245|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
155010287|NCT04429503|559463240|FG000|Main Study (Up to Wk 96)|Death|9|||
155010288|NCT04429503|559463241|FG001|Main Study (Up to Wk 96)|Death|18|||
155010289|NCT04429503|559463242|FG002|Main Study (Up to Wk 96)|Death|5|||
155010290|NCT04429503|559463243|FG003|Main Study (Up to Wk 96)|Death|0|||
155010291|NCT04429503|559463244|FG004|Main Study (Up to Wk 96)|Death|0|||
155010292|NCT04429503|559463245|FG005|Main Study (Up to Wk 96)|Death|0|||
155010293|NCT04429503|559463240|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155010294|NCT04429503|559463241|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155010295|NCT04429503|559463242|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155010296|NCT04429503|559463243|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
155010297|NCT04429503|559463244|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155010298|NCT04429503|559463245|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
155010299|NCT04429503|559463240|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
155010300|NCT04429503|559463241|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
155010301|NCT04429503|559463242|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
155010302|NCT04429503|559463243|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
155010303|NCT04429503|559463244|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
155010304|NCT04429503|559463245|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
155010305|NCT04429503|559463240|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155010306|NCT04429503|559463241|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155010307|NCT04429503|559463242|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155010308|NCT04429503|559463243|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
155010309|NCT04429503|559463244|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
155010310|NCT04429503|559463245|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
155010311|NCT04429503|559463240|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
155010312|NCT04429503|559463241|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
155010313|NCT04429503|559463242|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
155010314|NCT04429503|559463243|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
155010315|NCT04429503|559463244|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
155010316|NCT04429503|559463245|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
155010317|NCT04429503|559463240|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
155010318|NCT04429503|559463241|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
155010319|NCT04429503|559463242|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
155010320|NCT04429503|559463243|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
155010321|NCT04429503|559463244|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
155010322|NCT04429503|559463245|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
155010323|NCT04429503|559463240|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
155010324|NCT04429503|559463241|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
155010325|NCT04429503|559463242|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
155010326|NCT04429503|559463243|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
155010327|NCT04429503|559463244|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
155010328|NCT04429503|559463245|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
155010329|NCT05516108|559463246|FG000|Overall Study|Time Commitment|3|||
155010330|NCT05516108|559463247|FG001|Overall Study|Time Commitment|1|||
155010331|NCT05516108|559463246|FG000|Overall Study|Reason Unknown|2|||
155010332|NCT05516108|559463247|FG001|Overall Study|Reason Unknown|4|||
155010333|NCT02717507|559463248|FG000|Overall Study|Lost to Follow-up|5|||
155010334|NCT02717507|559463249|FG001|Overall Study|Lost to Follow-up|8|||
155010335|NCT02717507|559463248|FG000|Overall Study|Pregnancy|1|||
155010336|NCT02717507|559463249|FG001|Overall Study|Pregnancy|1|||
155010337|NCT02717507|559463248|FG000|Overall Study|Protocol Violation|2|||
155010338|NCT02717507|559463249|FG001|Overall Study|Protocol Violation|2|||
155010339|NCT02717507|559463248|FG000|Overall Study|Withdrawal by Subject|20|||
155178481|NCT01606878|560091508|FG001|Overall Study|Lack of Efficacy|1|||
155178482|NCT01606878|560091509|FG002|Overall Study|Lack of Efficacy|1|||
155010340|NCT02717507|559463249|FG001|Overall Study|Withdrawal by Subject|20|||
155010341|NCT02717507|559463248|FG000|Overall Study|Relapse|1|||
155010342|NCT02717507|559463249|FG001|Overall Study|Relapse|1|||
155010343|NCT02717507|559463248|FG000|Overall Study|Cardiac Event|2|||
155010344|NCT02717507|559463249|FG001|Overall Study|Cardiac Event|6|||
155010345|NCT05017246|559463250|FG000|Overall Study|Withdrawal by Subject|5|||
155178483|NCT01606878|560091510|FG003|Overall Study|Lack of Efficacy|2|||
155010346|NCT05017246|559463251|FG001|Overall Study|Withdrawal by Subject|3|||
155010347|NCT05017246|559463250|FG000|Overall Study|Determined to be ineligible|0|||
155010348|NCT05017246|559463251|FG001|Overall Study|Determined to be ineligible|1|||
155010349|NCT05017246|559463250|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
155010350|NCT05017246|559463251|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
155010351|NCT05017246|559463250|FG000|Overall Study|Technical failure|1|||
155010352|NCT05017246|559463251|FG001|Overall Study|Technical failure|3|||
155010353|NCT00709995|559463252|FG000|Overall Study|Adverse Event|4|||
155010354|NCT00709995|559463253|FG001|Overall Study|Adverse Event|2|||
155010355|NCT00709995|559463252|FG000|Overall Study|Withdrawal by Subject|1|||
155010356|NCT00709995|559463253|FG001|Overall Study|Withdrawal by Subject|3|||
155010357|NCT00882518|559463258|FG000|Overall Study|Adverse Event|9|||
155010358|NCT00882518|559463259|FG001|Overall Study|Adverse Event|18|||
155010359|NCT00882518|559463258|FG000|Overall Study|Withdrawal by Subject|9|||
155010360|NCT00882518|559463259|FG001|Overall Study|Withdrawal by Subject|13|||
155010361|NCT00882518|559463258|FG000|Overall Study|Lack of Efficacy|12|||
155010362|NCT00882518|559463259|FG001|Overall Study|Lack of Efficacy|9|||
155010363|NCT00882518|559463258|FG000|Overall Study|Severe non-compliance to protocol|3|||
155010364|NCT00882518|559463259|FG001|Overall Study|Severe non-compliance to protocol|1|||
155010365|NCT00882518|559463258|FG000|Overall Study|Incorrect enrolment|4|||
155010366|NCT00882518|559463259|FG001|Overall Study|Incorrect enrolment|2|||
155010367|NCT00882518|559463258|FG000|Overall Study|Central lab closure for National day|1|||
155010368|NCT00882518|559463259|FG001|Overall Study|Central lab closure for National day|0|||
155010369|NCT00882518|559463258|FG000|Overall Study|Allocating random number by mistake|0|||
155010370|NCT00882518|559463259|FG001|Overall Study|Allocating random number by mistake|1|||
155010371|NCT03238651|559463260|FG000|Overall Study|Other|0|||
155010372|NCT03238651|559463261|FG001|Overall Study|Other|0|||
155010373|NCT03238651|559463262|FG002|Overall Study|Other|0|||
155010374|NCT03238651|559463263|FG003|Overall Study|Other|0|||
155010375|NCT03238651|559463264|FG004|Overall Study|Other|1|||
155010376|NCT03238651|559463260|FG000|Overall Study|Progressive Disease|2|||
155010377|NCT03238651|559463261|FG001|Overall Study|Progressive Disease|2|||
155010378|NCT03238651|559463262|FG002|Overall Study|Progressive Disease|2|||
155010379|NCT03238651|559463263|FG003|Overall Study|Progressive Disease|2|||
155010380|NCT03238651|559463264|FG004|Overall Study|Progressive Disease|0|||
155010381|NCT03238651|559463260|FG000|Overall Study|Withdrawal by Subject|0|||
155010382|NCT03238651|559463261|FG001|Overall Study|Withdrawal by Subject|1|||
155010383|NCT03238651|559463262|FG002|Overall Study|Withdrawal by Subject|0|||
155010384|NCT03238651|559463263|FG003|Overall Study|Withdrawal by Subject|1|||
155010385|NCT03238651|559463264|FG004|Overall Study|Withdrawal by Subject|0|||
155010386|NCT03238651|559463260|FG000|Overall Study|Adverse Event|1|||
155010387|NCT03238651|559463261|FG001|Overall Study|Adverse Event|3|||
155010388|NCT03238651|559463262|FG002|Overall Study|Adverse Event|2|||
155010389|NCT03238651|559463263|FG003|Overall Study|Adverse Event|0|||
155010390|NCT03238651|559463264|FG004|Overall Study|Adverse Event|0|||
155010391|NCT03743051|559463265|FG000|Overall Study|Adverse Event|5|||
155010392|NCT03743051|559463266|FG001|Overall Study|Adverse Event|9|||
155010393|NCT03743051|559463265|FG000|Overall Study|Death|27|||
155010394|NCT03743051|559463266|FG001|Overall Study|Death|26|||
155010395|NCT03743051|559463265|FG000|Overall Study|Lost to Follow-up|4|||
155010396|NCT03743051|559463266|FG001|Overall Study|Lost to Follow-up|8|||
155010397|NCT03743051|559463265|FG000|Overall Study|Withdrawal by Subject|32|||
155010398|NCT03743051|559463266|FG001|Overall Study|Withdrawal by Subject|19|||
155010399|NCT03743051|559463265|FG000|Overall Study|Physician Decision|10|||
155010400|NCT03743051|559463266|FG001|Overall Study|Physician Decision|15|||
155010401|NCT03743051|559463265|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
155010402|NCT03743051|559463266|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
155010403|NCT01930162|559463269|FG000|Overall Study|Abnormal test procedure result(s)|4|||
155010404|NCT01930162|559463269|FG000|Overall Study|Death|1|||
155010405|NCT00840749|559463270|FG000|Overall Study|Death|1|||
155010406|NCT00840749|559463271|FG001|Overall Study|Death|2|||
155010407|NCT00840749|559463270|FG000|Overall Study|not treated on study arm|11|||
155010408|NCT00840749|559463271|FG001|Overall Study|not treated on study arm|11|||
155010409|NCT00840749|559463270|FG000|Overall Study|study closed|19|||
155010410|NCT00840749|559463271|FG001|Overall Study|study closed|14|||
155010411|NCT03411863|559463272|FG000|Overall Study|Withdrawal by Subject|3|||
155010412|NCT03411863|559463273|FG001|Overall Study|Withdrawal by Subject|1|||
155010413|NCT03411863|559463272|FG000|Overall Study|Physician Decision|0|||
155010414|NCT03411863|559463273|FG001|Overall Study|Physician Decision|1|||
155010415|NCT03535740|559463274|FG000|Overall Study|Death|44|||
155010416|NCT03535740|559463274|FG000|Overall Study|Lost to Follow-up|1|||
155010417|NCT03535740|559463274|FG000|Overall Study|Withdrawal by Subject|13|||
155010418|NCT03535740|559463274|FG000|Overall Study|Site terminated by Sponsor|45|||
155010419|NCT05317312|559463276|FG000|Overall Study|Withdrawal by Subject|0|||
155010420|NCT05317312|559463277|FG001|Overall Study|Withdrawal by Subject|1|||
155010421|NCT05317312|559463278|FG002|Overall Study|Withdrawal by Subject|0|||
155010422|NCT05317312|559463279|FG003|Overall Study|Withdrawal by Subject|0|||
155010423|NCT05317312|559463276|FG000|Overall Study|Lost to Follow-up|0|||
155010424|NCT05317312|559463277|FG001|Overall Study|Lost to Follow-up|0|||
155010425|NCT05317312|559463278|FG002|Overall Study|Lost to Follow-up|0|||
155010426|NCT05317312|559463279|FG003|Overall Study|Lost to Follow-up|1|||
155010427|NCT05317312|559463276|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
155010428|NCT05317312|559463277|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
155010429|NCT05317312|559463278|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
155010430|NCT05317312|559463279|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
155010431|NCT03164551|559463280|FG000|Overall Study|Imaging discontinued prior completion|8|||
155010432|NCT03164551|559463281|FG001|Overall Study|Imaging discontinued prior completion|0|||
155010433|NCT03164551|559463280|FG000|Overall Study|Participant was non-compliant|1|||
155010434|NCT03164551|559463281|FG001|Overall Study|Participant was non-compliant|0|||
155010435|NCT03164551|559463280|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
155010436|NCT03164551|559463281|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
155010437|NCT03164551|559463280|FG000|Overall Study|Other|8|||
155010438|NCT03164551|559463281|FG001|Overall Study|Other|2|||
155010439|NCT02857816|559463284|FG000|Overall Study|Screen Failure|33|||
155010440|NCT02857816|559463284|FG000|Overall Study|Withdrawal by Subject|4|||
155010441|NCT02857816|559463284|FG000|Overall Study|Lost to Follow-up|1|||
155010442|NCT00729937|559463295|FG000|Overall Study|Lost to Follow-up|49|||
155010443|NCT00729937|559463296|FG001|Overall Study|Lost to Follow-up|58|||
155010444|NCT00729937|559463297|FG002|Overall Study|Lost to Follow-up|18|||
155010445|NCT00729937|559463298|FG003|Overall Study|Lost to Follow-up|33|||
155010446|NCT00729937|559463299|FG004|Overall Study|Lost to Follow-up|18|||
155010447|NCT00729937|559463300|FG005|Overall Study|Lost to Follow-up|23|||
155010448|NCT00729937|559463295|FG000|Overall Study|Physician Decision|7|||
155010449|NCT00729937|559463296|FG001|Overall Study|Physician Decision|16|||
155010450|NCT00729937|559463297|FG002|Overall Study|Physician Decision|2|||
155010451|NCT00729937|559463298|FG003|Overall Study|Physician Decision|0|||
155010452|NCT00729937|559463299|FG004|Overall Study|Physician Decision|5|||
155010453|NCT00729937|559463300|FG005|Overall Study|Physician Decision|8|||
155010454|NCT00729937|559463295|FG000|Overall Study|Death|1|||
155010455|NCT00729937|559463296|FG001|Overall Study|Death|0|||
155010456|NCT00729937|559463297|FG002|Overall Study|Death|1|||
155010457|NCT00729937|559463298|FG003|Overall Study|Death|0|||
155010458|NCT00729937|559463299|FG004|Overall Study|Death|0|||
155010459|NCT00729937|559463300|FG005|Overall Study|Death|1|||
155010460|NCT00729937|559463295|FG000|Overall Study|Withdrawal by Subject|3|||
155010461|NCT00729937|559463296|FG001|Overall Study|Withdrawal by Subject|5|||
155010462|NCT00729937|559463297|FG002|Overall Study|Withdrawal by Subject|6|||
155010463|NCT00729937|559463298|FG003|Overall Study|Withdrawal by Subject|0|||
155010464|NCT00729937|559463299|FG004|Overall Study|Withdrawal by Subject|4|||
155010465|NCT00729937|559463300|FG005|Overall Study|Withdrawal by Subject|2|||
155010466|NCT00729937|559463295|FG000|Overall Study|Randomized but not treated|12|||
155010467|NCT00729937|559463296|FG001|Overall Study|Randomized but not treated|6|||
155010468|NCT00729937|559463297|FG002|Overall Study|Randomized but not treated|1|||
155010469|NCT00729937|559463298|FG003|Overall Study|Randomized but not treated|0|||
155010470|NCT00729937|559463299|FG004|Overall Study|Randomized but not treated|1|||
155010471|NCT00729937|559463300|FG005|Overall Study|Randomized but not treated|3|||
155010472|NCT00729937|559463295|FG000|Overall Study|Did not meet eligibility criteria|2|||
155010473|NCT00729937|559463296|FG001|Overall Study|Did not meet eligibility criteria|1|||
155010474|NCT00729937|559463297|FG002|Overall Study|Did not meet eligibility criteria|0|||
155010475|NCT00729937|559463298|FG003|Overall Study|Did not meet eligibility criteria|0|||
155010476|NCT00729937|559463299|FG004|Overall Study|Did not meet eligibility criteria|0|||
155010477|NCT00729937|559463300|FG005|Overall Study|Did not meet eligibility criteria|0|||
155010478|NCT00729937|559463295|FG000|Overall Study|Incarcerated|0|||
155010479|NCT00729937|559463296|FG001|Overall Study|Incarcerated|2|||
155010480|NCT00729937|559463297|FG002|Overall Study|Incarcerated|1|||
155010481|NCT00729937|559463298|FG003|Overall Study|Incarcerated|1|||
155010482|NCT00729937|559463299|FG004|Overall Study|Incarcerated|0|||
155010483|NCT00729937|559463300|FG005|Overall Study|Incarcerated|0|||
155010484|NCT00822692|559463301|FG000|Overall Study|Lost to Follow-up|17|||
155010485|NCT00822692|559463302|FG001|Overall Study|Lost to Follow-up|25|||
155131509|NCT00615030|559912929|FG011|Period I|Administrative problem|0|||
155131510|NCT00615030|559912918|FG000|Period I|Protocol deviation|1|||
155131511|NCT00615030|559912919|FG001|Period I|Protocol deviation|0|||
155131512|NCT00615030|559912920|FG002|Period I|Protocol deviation|0|||
155010486|NCT02208089|559463303|FG000|Overall Study|Withdrawal by Subject|1|||
155010487|NCT02208089|559463304|FG001|Overall Study|Withdrawal by Subject|0|||
155010488|NCT02208089|559463303|FG000|Overall Study|Lost to Follow-up|6|||
155010489|NCT02208089|559463304|FG001|Overall Study|Lost to Follow-up|0|||
155010490|NCT00456300|559463305|FG000|Overall Study|Adverse Event|1|||
155010491|NCT00456300|559463306|FG001|Overall Study|Adverse Event|0|||
155010492|NCT03200717|559463312|FG000|Overall Study|Progressive disease|24|||
155010493|NCT03200717|559463313|FG001|Overall Study|Progressive disease|5|||
155010494|NCT03200717|559463312|FG000|Overall Study|Adverse Event|11|||
155010495|NCT03200717|559463313|FG001|Overall Study|Adverse Event|8|||
155131513|NCT00615030|559912921|FG003|Period I|Protocol deviation|0|||
155010496|NCT03200717|559463312|FG000|Overall Study|Physician Decision|3|||
155010497|NCT03200717|559463313|FG001|Overall Study|Physician Decision|2|||
155010498|NCT03200717|559463312|FG000|Overall Study|Death|2|||
155010499|NCT03200717|559463313|FG001|Overall Study|Death|0|||
155010500|NCT03200717|559463312|FG000|Overall Study|Subject/Guardian Decision|1|||
155010501|NCT03200717|559463313|FG001|Overall Study|Subject/Guardian Decision|0|||
155010502|NCT02046603|559463314|FG000|Overall Study|Other|11|||
155010503|NCT02046603|559463315|FG001|Overall Study|Other|66|||
155010504|NCT02046603|559463314|FG000|Overall Study|Protocol Violation|0|||
155010505|NCT02046603|559463315|FG001|Overall Study|Protocol Violation|1|||
155010506|NCT02046603|559463314|FG000|Overall Study|Participant/legal guardian decision|1|||
155010507|NCT02046603|559463315|FG001|Overall Study|Participant/legal guardian decision|3|||
155010508|NCT02046603|559463314|FG000|Overall Study|Physician Decision|2|||
155010509|NCT02046603|559463315|FG001|Overall Study|Physician Decision|1|||
155010510|NCT02046603|559463314|FG000|Overall Study|Lost to Follow-up|1|||
155010511|NCT02046603|559463315|FG001|Overall Study|Lost to Follow-up|2|||
155010512|NCT02046603|559463314|FG000|Overall Study|Death|0|||
155010513|NCT02046603|559463315|FG001|Overall Study|Death|1|||
155010514|NCT02046603|559463314|FG000|Overall Study|Adverse Event|0|||
155010515|NCT02046603|559463315|FG001|Overall Study|Adverse Event|1|||
155010516|NCT02431364|559463316|FG000|Overall Study|Adverse Event|0|||
155010517|NCT02431364|559463317|FG001|Overall Study|Adverse Event|1|||
155010518|NCT02431364|559463318|FG002|Overall Study|Adverse Event|0|||
155010519|NCT02431364|559463319|FG003|Overall Study|Adverse Event|0|||
155010520|NCT02431364|559463320|FG004|Overall Study|Adverse Event|0|||
155010521|NCT02431364|559463316|FG000|Overall Study|Randomized but never treated|0|||
155010522|NCT02431364|559463317|FG001|Overall Study|Randomized but never treated|0|||
155131514|NCT00615030|559912922|FG004|Period I|Protocol deviation|0|||
155131515|NCT00615030|559912923|FG005|Period I|Protocol deviation|0|||
155131516|NCT00615030|559912924|FG006|Period I|Protocol deviation|0|||
155131517|NCT00615030|559912925|FG007|Period I|Protocol deviation|0|||
155131518|NCT00615030|559912926|FG008|Period I|Protocol deviation|0|||
155131519|NCT00615030|559912927|FG009|Period I|Protocol deviation|0|||
155131520|NCT00615030|559912928|FG010|Period I|Protocol deviation|0|||
155131521|NCT00615030|559912929|FG011|Period I|Protocol deviation|0|||
155131522|NCT00615030|559912918|FG000|Period I|Subject withdrew consent|0|||
155131523|NCT00615030|559912919|FG001|Period I|Subject withdrew consent|0|||
155131524|NCT00615030|559912920|FG002|Period I|Subject withdrew consent|0|||
155131525|NCT00615030|559912921|FG003|Period I|Subject withdrew consent|0|||
155131526|NCT00615030|559912922|FG004|Period I|Subject withdrew consent|0|||
155131527|NCT00615030|559912923|FG005|Period I|Subject withdrew consent|0|||
155131528|NCT00615030|559912924|FG006|Period I|Subject withdrew consent|0|||
155131529|NCT00615030|559912925|FG007|Period I|Subject withdrew consent|0|||
155131530|NCT00615030|559912926|FG008|Period I|Subject withdrew consent|1|||
155131531|NCT00615030|559912927|FG009|Period I|Subject withdrew consent|0|||
155131532|NCT00615030|559912928|FG010|Period I|Subject withdrew consent|1|||
155131533|NCT00615030|559912929|FG011|Period I|Subject withdrew consent|1|||
155131534|NCT00615030|559912918|FG000|Period I|Abnormal laboratory value(s)|0|||
155131535|NCT00615030|559912919|FG001|Period I|Abnormal laboratory value(s)|0|||
155131536|NCT00615030|559912920|FG002|Period I|Abnormal laboratory value(s)|0|||
155131537|NCT00615030|559912921|FG003|Period I|Abnormal laboratory value(s)|0|||
155131538|NCT00615030|559912922|FG004|Period I|Abnormal laboratory value(s)|0|||
155131539|NCT00615030|559912923|FG005|Period I|Abnormal laboratory value(s)|1|||
155131540|NCT00615030|559912924|FG006|Period I|Abnormal laboratory value(s)|0|||
155131541|NCT00615030|559912925|FG007|Period I|Abnormal laboratory value(s)|0|||
155131542|NCT00615030|559912926|FG008|Period I|Abnormal laboratory value(s)|0|||
155131543|NCT00615030|559912927|FG009|Period I|Abnormal laboratory value(s)|0|||
155131544|NCT00615030|559912928|FG010|Period I|Abnormal laboratory value(s)|0|||
155131545|NCT00615030|559912929|FG011|Period I|Abnormal laboratory value(s)|0|||
155131546|NCT00615030|559912918|FG000|Period II|Adverse Event|0|||
155131547|NCT00615030|559912919|FG001|Period II|Adverse Event|0|||
155131548|NCT00615030|559912920|FG002|Period II|Adverse Event|1|||
155131549|NCT00615030|559912921|FG003|Period II|Adverse Event|0|||
155131550|NCT00615030|559912922|FG004|Period II|Adverse Event|0|||
155131551|NCT00615030|559912923|FG005|Period II|Adverse Event|0|||
155131552|NCT00615030|559912924|FG006|Period II|Adverse Event|0|||
155131553|NCT00615030|559912925|FG007|Period II|Adverse Event|0|||
155131554|NCT00615030|559912926|FG008|Period II|Adverse Event|1|||
155131555|NCT00615030|559912927|FG009|Period II|Adverse Event|0|||
155131556|NCT00615030|559912928|FG010|Period II|Adverse Event|0|||
155131557|NCT00615030|559912929|FG011|Period II|Adverse Event|0|||
155131558|NCT00615030|559912918|FG000|Period II|Subject withdrew consent|0|||
155131559|NCT00615030|559912919|FG001|Period II|Subject withdrew consent|0|||
155131560|NCT00615030|559912920|FG002|Period II|Subject withdrew consent|0|||
155131561|NCT00615030|559912921|FG003|Period II|Subject withdrew consent|1|||
155010523|NCT02431364|559463318|FG002|Overall Study|Randomized but never treated|0|||
155010524|NCT02431364|559463319|FG003|Overall Study|Randomized but never treated|1|||
155010525|NCT02431364|559463320|FG004|Overall Study|Randomized but never treated|0|||
155010526|NCT00061932|559463321|FG000|Overall Study|Withdrawal by Subject|13|||
155131562|NCT00615030|559912922|FG004|Period II|Subject withdrew consent|0|||
155010527|NCT00061932|559463322|FG001|Overall Study|Withdrawal by Subject|4|||
155010528|NCT00916383|559463323|FG000|Overall Study|Adverse Event|1|||
155010529|NCT00916383|559463323|FG000|Overall Study|Death|1|||
155010530|NCT00916383|559463323|FG000|Overall Study|Protocol Violation|1|||
155010531|NCT02899962|559463324|FG000|Open-label Phase|Adverse Event|2|||
155010532|NCT02899962|559463325|FG001|Open-label Phase|Adverse Event|0|||
155010533|NCT02899962|559463326|FG002|Open-label Phase|Adverse Event|0|||
155010534|NCT02899962|559463324|FG000|Open-label Phase|Lost to Follow-up|9|||
155010535|NCT02899962|559463325|FG001|Open-label Phase|Lost to Follow-up|0|||
155010536|NCT02899962|559463326|FG002|Open-label Phase|Lost to Follow-up|0|||
155010537|NCT02899962|559463324|FG000|Open-label Phase|Other reasons|9|||
155010538|NCT02899962|559463325|FG001|Open-label Phase|Other reasons|0|||
155010539|NCT02899962|559463326|FG002|Open-label Phase|Other reasons|0|||
155010540|NCT02899962|559463324|FG000|Open-label Phase|Withdrawal by Subject|7|||
155010541|NCT02899962|559463325|FG001|Open-label Phase|Withdrawal by Subject|0|||
155010542|NCT02899962|559463326|FG002|Open-label Phase|Withdrawal by Subject|0|||
155010543|NCT02899962|559463324|FG000|Maintenance Phase|Adverse Event|0|||
155010544|NCT02899962|559463325|FG001|Maintenance Phase|Adverse Event|2|||
155010545|NCT02899962|559463326|FG002|Maintenance Phase|Adverse Event|1|||
155010546|NCT02899962|559463324|FG000|Maintenance Phase|Death|0|||
155010547|NCT02899962|559463325|FG001|Maintenance Phase|Death|0|||
155010548|NCT02899962|559463326|FG002|Maintenance Phase|Death|1|||
155010549|NCT02899962|559463324|FG000|Maintenance Phase|Lack of Efficacy|0|||
155010550|NCT02899962|559463325|FG001|Maintenance Phase|Lack of Efficacy|20|||
155010551|NCT02899962|559463326|FG002|Maintenance Phase|Lack of Efficacy|16|||
155010552|NCT02899962|559463324|FG000|Maintenance Phase|Lost to Follow-up|0|||
155010553|NCT02899962|559463325|FG001|Maintenance Phase|Lost to Follow-up|12|||
155010554|NCT02899962|559463326|FG002|Maintenance Phase|Lost to Follow-up|14|||
155010555|NCT02899962|559463324|FG000|Maintenance Phase|Other reasons|0|||
155010556|NCT02899962|559463325|FG001|Maintenance Phase|Other reasons|9|||
155010557|NCT02899962|559463326|FG002|Maintenance Phase|Other reasons|13|||
155010558|NCT02899962|559463324|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
155010559|NCT02899962|559463325|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
155010560|NCT02899962|559463326|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
155010561|NCT02899962|559463324|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
155010562|NCT02899962|559463325|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
155010563|NCT02899962|559463326|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
155010564|NCT02899962|559463324|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155010565|NCT02899962|559463325|FG001|Maintenance Phase|Withdrawal by Subject|30|||
155010566|NCT02899962|559463326|FG002|Maintenance Phase|Withdrawal by Subject|36|||
155010567|NCT00258960|559463327|FG000|Overall Study|Death|2|||
155010568|NCT00258960|559463327|FG000|Overall Study|Disease Progression|7|||
155010569|NCT00258960|559463327|FG000|Overall Study|Adverse Event|4|||
155010570|NCT00258960|559463327|FG000|Overall Study|Physician Decision|1|||
155010571|NCT00258960|559463327|FG000|Overall Study|Withdrawal by Subject|1|||
155010572|NCT00258960|559463327|FG000|Overall Study|Mistake|2|||
155010573|NCT03367819|559463330|FG000|Overall Study|Adverse Event|4|||
155010574|NCT03367819|559463331|FG001|Overall Study|Adverse Event|4|||
155010575|NCT03367819|559463330|FG000|Overall Study|Progressive Disease|15|||
155010576|NCT03367819|559463331|FG001|Overall Study|Progressive Disease|13|||
155010577|NCT03367819|559463330|FG000|Overall Study|Withdrawal by Subject|1|||
155010578|NCT03367819|559463331|FG001|Overall Study|Withdrawal by Subject|0|||
155010579|NCT03367819|559463330|FG000|Overall Study|Other|4|||
155010580|NCT03367819|559463331|FG001|Overall Study|Other|2|||
155010581|NCT02633787|559463332|FG000|Overall Study|Withdrawal by Subject|1|||
155010582|NCT00550459|559463333|FG000|Overall Study|Adverse Event|0|||
155010583|NCT00550459|559463334|FG001|Overall Study|Adverse Event|2|||
155010584|NCT00550459|559463333|FG000|Overall Study|Withdrawal by Subject|1|||
155010585|NCT00550459|559463334|FG001|Overall Study|Withdrawal by Subject|1|||
155010586|NCT02404805|559463335|FG000|Overall Study|Withdrawal by Subject|1|||
155010587|NCT02404805|559463336|FG001|Overall Study|Withdrawal by Subject|0|||
155010588|NCT02404805|559463337|FG002|Overall Study|Withdrawal by Subject|0|||
155131563|NCT00615030|559912923|FG005|Period II|Subject withdrew consent|0|||
155131564|NCT00615030|559912924|FG006|Period II|Subject withdrew consent|1|||
155010589|NCT02404805|559463338|FG003|Overall Study|Withdrawal by Subject|0|||
155010590|NCT02404805|559463339|FG004|Overall Study|Withdrawal by Subject|0|||
155010591|NCT02404805|559463340|FG005|Overall Study|Withdrawal by Subject|0|||
155010592|NCT01742897|559463341|FG000|Overall Study|Adverse Event|3|||
155010593|NCT01742897|559463341|FG000|Overall Study|Withdrawal by Subject|1|||
155010594|NCT01742897|559463341|FG000|Overall Study|Other|1|||
155010595|NCT04211831|559463344|FG000|Overall Study|Withdrawal by Subject|4|||
155010596|NCT04211831|559463345|FG001|Overall Study|Withdrawal by Subject|1|||
155010597|NCT04211831|559463346|FG002|Overall Study|Withdrawal by Subject|1|||
155010598|NCT04211831|559463344|FG000|Overall Study|Protocol Violation|0|||
155010599|NCT04211831|559463345|FG001|Overall Study|Protocol Violation|0|||
155010600|NCT04211831|559463346|FG002|Overall Study|Protocol Violation|1|||
155131565|NCT00615030|559912925|FG007|Period II|Subject withdrew consent|0|||
155010601|NCT04211831|559463344|FG000|Overall Study|Adverse Event|0|||
155010602|NCT04211831|559463345|FG001|Overall Study|Adverse Event|1|||
155010603|NCT04211831|559463346|FG002|Overall Study|Adverse Event|0|||
155010604|NCT04211831|559463344|FG000|Overall Study|Lack of Efficacy|0|||
155010605|NCT04211831|559463345|FG001|Overall Study|Lack of Efficacy|0|||
155010606|NCT04211831|559463346|FG002|Overall Study|Lack of Efficacy|1|||
155010607|NCT04211831|559463344|FG000|Overall Study|Lost to Follow-up|0|||
155010608|NCT04211831|559463345|FG001|Overall Study|Lost to Follow-up|0|||
155010609|NCT04211831|559463346|FG002|Overall Study|Lost to Follow-up|2|||
155010610|NCT04211831|559463344|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
155010611|NCT04211831|559463345|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
155010612|NCT04211831|559463346|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
155010613|NCT04211831|559463344|FG000|Overall Study|Other|0|||
155010614|NCT04211831|559463345|FG001|Overall Study|Other|1|||
155010615|NCT04211831|559463346|FG002|Overall Study|Other|0|||
155010616|NCT05373108|559463348|FG000|Overall Study|Withdrawal by Subject|2|||
155010617|NCT04871776|559463349|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
155010618|NCT04871776|559463350|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
155010619|NCT04871776|559463351|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
155010620|NCT04871776|559463349|FG000|Overall Study|Did not meet eligibility criteria|1|||
155010621|NCT04871776|559463350|FG001|Overall Study|Did not meet eligibility criteria|1|||
155010622|NCT04871776|559463351|FG002|Overall Study|Did not meet eligibility criteria|1|||
155131566|NCT00615030|559912926|FG008|Period II|Subject withdrew consent|0|||
155131567|NCT00615030|559912927|FG009|Period II|Subject withdrew consent|0|||
155131568|NCT00615030|559912928|FG010|Period II|Subject withdrew consent|0|||
155131569|NCT00615030|559912929|FG011|Period II|Subject withdrew consent|0|||
155131570|NCT00615030|559912918|FG000|Period III|Administrative problems|1|||
155131571|NCT00615030|559912919|FG001|Period III|Administrative problems|0|||
155131572|NCT00615030|559912920|FG002|Period III|Administrative problems|0|||
155131573|NCT00615030|559912921|FG003|Period III|Administrative problems|1|||
155131574|NCT00615030|559912922|FG004|Period III|Administrative problems|0|||
155131575|NCT00615030|559912923|FG005|Period III|Administrative problems|0|||
155131576|NCT00615030|559912924|FG006|Period III|Administrative problems|0|||
155131577|NCT00615030|559912925|FG007|Period III|Administrative problems|0|||
155131578|NCT00615030|559912926|FG008|Period III|Administrative problems|0|||
155131579|NCT00615030|559912927|FG009|Period III|Administrative problems|0|||
155131580|NCT00615030|559912928|FG010|Period III|Administrative problems|0|||
155131581|NCT00615030|559912929|FG011|Period III|Administrative problems|0|||
155131582|NCT00151476|559912930|FG000|FAP Identified Subjects|Protocol Violation|0|||
155131583|NCT00151476|559912931|FG001|FAP Identified Subjects|Protocol Violation|1|||
155131584|NCT00151476|559912930|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
155131585|NCT00151476|559912931|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
155131586|NCT00151476|559912930|FG000|FAP Analyzed Subjects|Other study participation|0|||
155131587|NCT00151476|559912931|FG001|FAP Analyzed Subjects|Other study participation|1|||
155131588|NCT03446456|559912932|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
155131589|NCT03446456|559912933|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
155131590|NCT03446456|559912932|FG000|Overall Study|Lost to Follow-up|1|||
155131591|NCT03446456|559912933|FG001|Overall Study|Lost to Follow-up|3|||
155131592|NCT03446456|559912932|FG000|Overall Study|Participant failed the toxicology test|1|||
155131593|NCT03446456|559912933|FG001|Overall Study|Participant failed the toxicology test|0|||
155131594|NCT03446456|559912932|FG000|Overall Study|Break down of the experimental equipment|1|||
155131595|NCT03446456|559912933|FG001|Overall Study|Break down of the experimental equipment|0|||
155131596|NCT03002311|559912946|FG000|Overall Study|Lost to Follow-up|13|||
155131597|NCT03002311|559912947|FG001|Overall Study|Lost to Follow-up|26|||
155131598|NCT03002311|559912946|FG000|Overall Study|Referral provider called to schedule app|3|||
155131599|NCT03002311|559912947|FG001|Overall Study|Referral provider called to schedule app|3|||
155131600|NCT03002311|559912946|FG000|Overall Study|Physician Decision|3|||
155131601|NCT03002311|559912947|FG001|Overall Study|Physician Decision|1|||
155131602|NCT01329939|559912951|FG000|Overall Study|Lost to Follow-up|3|||
155131603|NCT01329939|559912952|FG001|Overall Study|Lost to Follow-up|0|||
155131604|NCT01329939|559912953|FG002|Overall Study|Lost to Follow-up|1|||
155131605|NCT01329939|559912954|FG003|Overall Study|Lost to Follow-up|2|||
155131606|NCT01329939|559912951|FG000|Overall Study|Withdrawal by Subject|0|||
155131607|NCT01329939|559912952|FG001|Overall Study|Withdrawal by Subject|1|||
155131608|NCT01329939|559912953|FG002|Overall Study|Withdrawal by Subject|0|||
155131609|NCT01329939|559912954|FG003|Overall Study|Withdrawal by Subject|0|||
155131610|NCT01329939|559912951|FG000|Overall Study|Adverse Event|0|||
155131611|NCT01329939|559912952|FG001|Overall Study|Adverse Event|0|||
155131612|NCT01329939|559912953|FG002|Overall Study|Adverse Event|0|||
155131613|NCT01329939|559912954|FG003|Overall Study|Adverse Event|3|||
155131614|NCT03722524|559912955|FG000|Overall Study|Protocol Violation|86|||
155131615|NCT03722524|559912955|FG000|Overall Study|Adverse Event|7|||
155131616|NCT03722524|559912955|FG000|Overall Study|Lost to Follow-up|1|||
155010623|NCT00070564|559465615|FG000|Overall Study|Progression|2|||
155010624|NCT00070564|559465616|FG001|Overall Study|Progression|4|||
155010625|NCT00070564|559465617|FG002|Overall Study|Progression|7|||
155010626|NCT00070564|559465618|FG003|Overall Study|Progression|7|||
155010627|NCT00070564|559465619|FG004|Overall Study|Progression|1|||
155010628|NCT00070564|559465620|FG005|Overall Study|Progression|0|||
155010629|NCT00070564|559465615|FG000|Overall Study|Delinquent|1|||
155010630|NCT00070564|559465616|FG001|Overall Study|Delinquent|4|||
155010631|NCT00070564|559465617|FG002|Overall Study|Delinquent|2|||
155010632|NCT00070564|559465618|FG003|Overall Study|Delinquent|0|||
155010633|NCT00070564|559465619|FG004|Overall Study|Delinquent|0|||
155010634|NCT00070564|559465620|FG005|Overall Study|Delinquent|0|||
155010635|NCT00070564|559465615|FG000|Overall Study|Adverse Event|150|||
155010636|NCT00070564|559465616|FG001|Overall Study|Adverse Event|142|||
155010637|NCT00070564|559465617|FG002|Overall Study|Adverse Event|120|||
155010638|NCT00070564|559465618|FG003|Overall Study|Adverse Event|108|||
155010639|NCT00070564|559465619|FG004|Overall Study|Adverse Event|63|||
155010640|NCT00070564|559465620|FG005|Overall Study|Adverse Event|36|||
155010641|NCT00070564|559465615|FG000|Overall Study|Death|4|||
155010642|NCT00070564|559465616|FG001|Overall Study|Death|1|||
155010643|NCT00070564|559465617|FG002|Overall Study|Death|5|||
155010644|NCT00070564|559465618|FG003|Overall Study|Death|3|||
155010645|NCT00070564|559465619|FG004|Overall Study|Death|0|||
155010646|NCT00070564|559465620|FG005|Overall Study|Death|1|||
155131617|NCT03722524|559912955|FG000|Overall Study|Reason is not stated|1|||
155131618|NCT03722524|559912955|FG000|Overall Study|Physician Decision|1|||
155131619|NCT03722524|559912955|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
155131620|NCT00989963|559912957|FG000|Overall Study|Adverse Event|1|||
155131621|NCT00989963|559912958|FG001|Overall Study|Adverse Event|1|||
155131622|NCT00989963|559912959|FG002|Overall Study|Adverse Event|1|||
155131623|NCT04588389|559912966|FG000|Overall Study|Issues with anesthesia during surgery|2|||
155131624|NCT04588389|559912967|FG001|Overall Study|Issues with anesthesia during surgery|0|||
155131625|NCT04588389|559912968|FG002|Overall Study|Issues with anesthesia during surgery|0|||
155131626|NCT00719680|559912972|FG000|Overall Study|Adverse Event|1|||
155131627|NCT00719680|559912972|FG000|Overall Study|Lost to Follow-up|1|||
155131628|NCT00719680|559912972|FG000|Overall Study|Withdrawal by Subject|3|||
155131629|NCT00658814|559912973|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
155131630|NCT00658814|559912974|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
155131631|NCT00658814|559912973|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
155131632|NCT00658814|559912974|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
155131633|NCT00658814|559912973|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
155131634|NCT00658814|559912974|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
155131635|NCT00658814|559912973|FG000|Remission Induction Chemotherapy|Death|1|||
155131636|NCT00658814|559912974|FG001|Remission Induction Chemotherapy|Death|4|||
155131637|NCT00658814|559912973|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
155131638|NCT00658814|559912974|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
155131639|NCT00658814|559912973|FG000|Remission Induction Chemotherapy|Not eligible|1|||
155131640|NCT00658814|559912974|FG001|Remission Induction Chemotherapy|Not eligible|2|||
155131641|NCT00658814|559912973|FG000|Consolidation Therapy|Not protocol specified|0|||
155131642|NCT00658814|559912974|FG001|Consolidation Therapy|Not protocol specified|1|||
155131643|NCT00658814|559912973|FG000|Consolidation Therapy|Not eligible|2|||
155131644|NCT00658814|559912974|FG001|Consolidation Therapy|Not eligible|2|||
155131645|NCT00658814|559912973|FG000|Maintenance Therapy|Adverse Event|1|||
155131646|NCT00658814|559912974|FG001|Maintenance Therapy|Adverse Event|1|||
155131647|NCT00658814|559912973|FG000|Maintenance Therapy|Not protocol specified|1|||
155131648|NCT00658814|559912974|FG001|Maintenance Therapy|Not protocol specified|0|||
155131649|NCT00658814|559912973|FG000|Maintenance Therapy|Not eligible|1|||
155131650|NCT00658814|559912974|FG001|Maintenance Therapy|Not eligible|0|||
155131651|NCT04071158|559912975|FG000|Overall Study|Lost to Follow-up|1|||
155131652|NCT04071158|559912976|FG001|Overall Study|Lost to Follow-up|2|||
155131653|NCT04071158|559912977|FG002|Overall Study|Lost to Follow-up|3|||
155131654|NCT04071158|559912978|FG003|Overall Study|Lost to Follow-up|3|||
155131655|NCT04071158|559912979|FG004|Overall Study|Lost to Follow-up|5|||
155131656|NCT04071158|559912975|FG000|Overall Study|Randomized but not treated|2|||
155010647|NCT00070564|559465615|FG000|Overall Study|Other, not protocol specified|17|||
155010648|NCT00070564|559465616|FG001|Overall Study|Other, not protocol specified|15|||
155131657|NCT04071158|559912976|FG001|Overall Study|Randomized but not treated|2|||
155131658|NCT04071158|559912977|FG002|Overall Study|Randomized but not treated|0|||
155131659|NCT04071158|559912978|FG003|Overall Study|Randomized but not treated|0|||
155131660|NCT04071158|559912979|FG004|Overall Study|Randomized but not treated|0|||
155010649|NCT00070564|559465617|FG002|Overall Study|Other, not protocol specified|14|||
155010650|NCT00070564|559465618|FG003|Overall Study|Other, not protocol specified|19|||
155010651|NCT00070564|559465619|FG004|Overall Study|Other, not protocol specified|6|||
155010652|NCT00070564|559465620|FG005|Overall Study|Other, not protocol specified|7|||
155010653|NCT00070564|559465615|FG000|Overall Study|Withdrawal by Subject|26|||
155131661|NCT02678923|559912992|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
155010654|NCT00070564|559465616|FG001|Overall Study|Withdrawal by Subject|37|||
155178484|NCT01606878|560091511|FG004|Overall Study|Lack of Efficacy|1|||
155178485|NCT01606878|560091512|FG005|Overall Study|Lack of Efficacy|2|||
155178486|NCT01606878|560091513|FG006|Overall Study|Lack of Efficacy|1|||
155178487|NCT01606878|560091514|FG007|Overall Study|Lack of Efficacy|2|||
155010655|NCT00070564|559465617|FG002|Overall Study|Withdrawal by Subject|23|||
155010656|NCT00070564|559465618|FG003|Overall Study|Withdrawal by Subject|30|||
155010657|NCT00070564|559465619|FG004|Overall Study|Withdrawal by Subject|8|||
155010658|NCT00070564|559465620|FG005|Overall Study|Withdrawal by Subject|8|||
155010659|NCT00070564|559465615|FG000|Overall Study|Not reported|0|||
155010660|NCT00070564|559465616|FG001|Overall Study|Not reported|0|||
155010661|NCT00070564|559465617|FG002|Overall Study|Not reported|0|||
155010662|NCT00070564|559465618|FG003|Overall Study|Not reported|0|||
155010663|NCT00070564|559465619|FG004|Overall Study|Not reported|1|||
155010664|NCT00070564|559465620|FG005|Overall Study|Not reported|0|||
155010665|NCT01168232|559465621|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
155010666|NCT01168232|559465621|FG000|Overall Study|Ineligible- Wrong cell type|6|||
155010667|NCT01168232|559465621|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
155010668|NCT03018288|559465625|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
155010669|NCT03018288|559465626|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
155010670|NCT03018288|559465627|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
155010671|NCT03018288|559465628|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
155010672|NCT03018288|559465625|FG000|Overall Study|Participant withdrew consent.|0|||
155010673|NCT03018288|559465626|FG001|Overall Study|Participant withdrew consent.|0|||
155010674|NCT03018288|559465627|FG002|Overall Study|Participant withdrew consent.|1|||
155131662|NCT02678923|559912993|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
155131663|NCT02678923|559912992|FG000|Overall Study|Withdrawal by Subject|3|||
155131664|NCT02678923|559912993|FG001|Overall Study|Withdrawal by Subject|2|||
155131665|NCT02678923|559912992|FG000|Overall Study|Lost to Follow-up|1|||
155131666|NCT02678923|559912993|FG001|Overall Study|Lost to Follow-up|0|||
155131667|NCT02678923|559912992|FG000|Overall Study|Did Not Return for Study Visits|1|||
155131668|NCT02678923|559912993|FG001|Overall Study|Did Not Return for Study Visits|0|||
155131669|NCT00455143|559912994|FG000|Overall Study|Physician Decision|1|||
155131670|NCT00455143|559912994|FG000|Overall Study|Withdrawal by Subject|1|||
155131671|NCT00455143|559912994|FG000|Overall Study|Staff was not avail to follow patient|2|||
155131672|NCT00455143|559912994|FG000|Overall Study|No longer met Inclusion Criteria|1|||
155131673|NCT00455143|559912994|FG000|Overall Study|Surgical time, staff not available|1|||
155131674|NCT01966445|559912996|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155131675|NCT01966445|559912997|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155131676|NCT01966445|559912998|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155131677|NCT01966445|559912999|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
155131678|NCT01966445|559913000|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155131679|NCT01966445|559913001|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
155131680|NCT01966445|559913002|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
155131681|NCT01966445|559912996|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155131682|NCT01966445|559912997|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
155131683|NCT01966445|559912998|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155131684|NCT01966445|559912999|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
155131685|NCT01966445|559913000|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
155131686|NCT01966445|559913001|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155131687|NCT01966445|559913002|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
155131688|NCT01966445|559912996|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155131689|NCT01966445|559912997|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
155131690|NCT01966445|559912998|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
155131691|NCT01966445|559912999|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155131692|NCT01966445|559913000|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
155131693|NCT01966445|559913001|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155131694|NCT01966445|559913002|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
155131695|NCT01966445|559912996|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155131696|NCT01966445|559912997|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155131697|NCT01966445|559912998|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155131698|NCT01966445|559912999|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155131699|NCT01966445|559913000|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155131700|NCT01966445|559913001|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
155131701|NCT01966445|559913002|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
155131702|NCT01966445|559912996|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155131703|NCT01966445|559912997|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155131704|NCT01966445|559912998|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155131705|NCT01966445|559912999|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155178488|NCT01606878|560091515|FG008|Overall Study|Lack of Efficacy|2|||
155010675|NCT03018288|559465628|FG003|Overall Study|Participant withdrew consent.|0|||
155010676|NCT03018288|559465625|FG000|Overall Study|Switched to alternative treatment.|0|||
155010677|NCT03018288|559465626|FG001|Overall Study|Switched to alternative treatment.|0|||
155010678|NCT03018288|559465627|FG002|Overall Study|Switched to alternative treatment.|1|||
155010679|NCT03018288|559465628|FG003|Overall Study|Switched to alternative treatment.|0|||
155010680|NCT03018288|559465625|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
155010681|NCT03018288|559465626|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
155010682|NCT03018288|559465627|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
155010683|NCT03018288|559465628|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
155010684|NCT03018288|559465625|FG000|Overall Study|Screen failures|0|||
155010685|NCT03018288|559465626|FG001|Overall Study|Screen failures|0|||
155010686|NCT03018288|559465627|FG002|Overall Study|Screen failures|0|||
155010687|NCT03018288|559465628|FG003|Overall Study|Screen failures|51|||
155010688|NCT03018288|559465625|FG000|Overall Study|Chose treatment outside of UNC|0|||
155010689|NCT03018288|559465626|FG001|Overall Study|Chose treatment outside of UNC|0|||
155010690|NCT03018288|559465627|FG002|Overall Study|Chose treatment outside of UNC|0|||
155010691|NCT03018288|559465628|FG003|Overall Study|Chose treatment outside of UNC|1|||
155010692|NCT03018288|559465625|FG000|Overall Study|Unable to comply with protocol requirements|1|||
155010693|NCT03018288|559465626|FG001|Overall Study|Unable to comply with protocol requirements|1|||
155010694|NCT03018288|559465627|FG002|Overall Study|Unable to comply with protocol requirements|0|||
155010695|NCT03018288|559465628|FG003|Overall Study|Unable to comply with protocol requirements|1|||
155010696|NCT03018288|559465625|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
155010697|NCT03018288|559465626|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
155010698|NCT03018288|559465627|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
155010699|NCT03018288|559465628|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
155010700|NCT03018288|559465625|FG000|Overall Study|Physician Decision|0|||
155010701|NCT03018288|559465626|FG001|Overall Study|Physician Decision|0|||
155010702|NCT03018288|559465627|FG002|Overall Study|Physician Decision|0|||
155010703|NCT03018288|559465628|FG003|Overall Study|Physician Decision|1|||
155010704|NCT01922037|559465632|FG000|Overall Study|Withdrawal by Subject|2|||
155010705|NCT01922037|559465633|FG001|Overall Study|Withdrawal by Subject|44|||
155010706|NCT01922037|559465632|FG000|Overall Study|Adverse Event|1|||
155010707|NCT01922037|559465633|FG001|Overall Study|Adverse Event|7|||
155010708|NCT01922037|559465632|FG000|Overall Study|Death|0|||
155010709|NCT01922037|559465633|FG001|Overall Study|Death|5|||
155010710|NCT01922037|559465632|FG000|Overall Study|Pregnancy|0|||
155010711|NCT01922037|559465633|FG001|Overall Study|Pregnancy|2|||
155010712|NCT01922037|559465632|FG000|Overall Study|Participant non-compliance|4|||
155010713|NCT01922037|559465633|FG001|Overall Study|Participant non-compliance|46|||
155010714|NCT01922037|559465632|FG000|Overall Study|Investigator/Sponsor decision|1|||
155010715|NCT01922037|559465633|FG001|Overall Study|Investigator/Sponsor decision|4|||
155010716|NCT01922037|559465632|FG000|Overall Study|Other unspecified|2|||
155010717|NCT01922037|559465633|FG001|Overall Study|Other unspecified|66|||
155010718|NCT01730053|559465634|FG000|Overall Study|Participant moved|0|||
155010719|NCT01730053|559465635|FG001|Overall Study|Participant moved|0|||
155010720|NCT01730053|559465636|FG002|Overall Study|Participant moved|1|||
155010721|NCT01730053|559465637|FG003|Overall Study|Participant moved|0|||
155010722|NCT01730053|559465638|FG004|Overall Study|Participant moved|0|||
155131706|NCT01966445|559913000|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155131707|NCT01966445|559913001|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
155131708|NCT01966445|559913002|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
155131709|NCT01374178|559913003|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
155131710|NCT01374178|559913004|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
155010723|NCT01730053|559465639|FG005|Overall Study|Participant moved|0|||
155010724|NCT01730053|559465634|FG000|Overall Study|Physician Decision|0|||
155010725|NCT01730053|559465635|FG001|Overall Study|Physician Decision|0|||
155010726|NCT01730053|559465636|FG002|Overall Study|Physician Decision|0|||
155010727|NCT01730053|559465637|FG003|Overall Study|Physician Decision|1|||
155010728|NCT01730053|559465638|FG004|Overall Study|Physician Decision|0|||
155010729|NCT01730053|559465639|FG005|Overall Study|Physician Decision|0|||
155010730|NCT01730053|559465634|FG000|Overall Study|Adverse Event|2|||
155010731|NCT01730053|559465635|FG001|Overall Study|Adverse Event|6|||
155131711|NCT01374178|559913003|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
155131712|NCT01374178|559913004|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
155131713|NCT04856904|559913005|FG000|Overall Study|Physician Decision|1|||
155131714|NCT04856904|559913006|FG001|Overall Study|Physician Decision|1|||
155131715|NCT04856904|559913005|FG000|Overall Study|Withdrawal by Subject|13|||
155131716|NCT04856904|559913006|FG001|Overall Study|Withdrawal by Subject|13|||
155178489|NCT01606878|560091516|FG009|Overall Study|Lack of Efficacy|0|||
155010732|NCT01730053|559465636|FG002|Overall Study|Adverse Event|3|||
155010733|NCT01730053|559465637|FG003|Overall Study|Adverse Event|3|||
155010734|NCT01730053|559465638|FG004|Overall Study|Adverse Event|2|||
155178490|NCT01606878|560091517|FG010|Overall Study|Lack of Efficacy|1|||
155010735|NCT01730053|559465639|FG005|Overall Study|Adverse Event|2|||
155010736|NCT01730053|559465634|FG000|Overall Study|Poor compliance to protocol|1|||
155010737|NCT01730053|559465635|FG001|Overall Study|Poor compliance to protocol|2|||
155010738|NCT01730053|559465636|FG002|Overall Study|Poor compliance to protocol|2|||
155178491|NCT01606878|560091507|FG000|Overall Study|Physician Decision|1|||
155178492|NCT01606878|560091508|FG001|Overall Study|Physician Decision|0|||
155178493|NCT01606878|560091509|FG002|Overall Study|Physician Decision|2|||
155178494|NCT01606878|560091510|FG003|Overall Study|Physician Decision|1|||
155178495|NCT01606878|560091511|FG004|Overall Study|Physician Decision|1|||
155178496|NCT01606878|560091512|FG005|Overall Study|Physician Decision|1|||
155178497|NCT01606878|560091513|FG006|Overall Study|Physician Decision|2|||
155178498|NCT01606878|560091514|FG007|Overall Study|Physician Decision|0|||
155178499|NCT01606878|560091515|FG008|Overall Study|Physician Decision|1|||
155010739|NCT01730053|559465637|FG003|Overall Study|Poor compliance to protocol|0|||
155010740|NCT01730053|559465638|FG004|Overall Study|Poor compliance to protocol|0|||
155010741|NCT01730053|559465639|FG005|Overall Study|Poor compliance to protocol|2|||
155010742|NCT01730053|559465634|FG000|Overall Study|Other than specified|2|||
155010743|NCT01730053|559465635|FG001|Overall Study|Other than specified|6|||
155010744|NCT01730053|559465636|FG002|Overall Study|Other than specified|5|||
155010745|NCT01730053|559465637|FG003|Overall Study|Other than specified|4|||
155010746|NCT01730053|559465638|FG004|Overall Study|Other than specified|7|||
155010747|NCT01730053|559465639|FG005|Overall Study|Other than specified|9|||
155010748|NCT02572570|559465640|FG000|Overall Study|Study Terminated|27|||
155010749|NCT01173523|559465646|FG000|Overall Study|Clinical Progression|1|||
155010750|NCT01173523|559465647|FG001|Overall Study|Clinical Progression|1|||
155010751|NCT01173523|559465646|FG000|Overall Study|Progressive Disease|10|||
155010752|NCT01173523|559465647|FG001|Overall Study|Progressive Disease|8|||
155010753|NCT01173523|559465646|FG000|Overall Study|Other|2|||
155010754|NCT01173523|559465647|FG001|Overall Study|Other|3|||
155010755|NCT00742209|559465652|FG000|Overall Study|Adverse Event|11|||
155010756|NCT00742209|559465653|FG001|Overall Study|Adverse Event|4|||
155010757|NCT00742209|559465654|FG002|Overall Study|Adverse Event|17|||
155010758|NCT00742209|559465655|FG003|Overall Study|Adverse Event|16|||
155010759|NCT00742209|559465656|FG004|Overall Study|Adverse Event|13|||
155010760|NCT00742209|559465652|FG000|Overall Study|Participant Withdrew Consent|8|||
155010761|NCT00742209|559465653|FG001|Overall Study|Participant Withdrew Consent|4|||
155010762|NCT00742209|559465654|FG002|Overall Study|Participant Withdrew Consent|14|||
155010763|NCT00742209|559465655|FG003|Overall Study|Participant Withdrew Consent|7|||
155010764|NCT00742209|559465656|FG004|Overall Study|Participant Withdrew Consent|4|||
155010765|NCT00742209|559465652|FG000|Overall Study|Protocol Violation|6|||
155010766|NCT00742209|559465653|FG001|Overall Study|Protocol Violation|5|||
155010767|NCT00742209|559465654|FG002|Overall Study|Protocol Violation|4|||
155010768|NCT00742209|559465655|FG003|Overall Study|Protocol Violation|5|||
155010769|NCT00742209|559465656|FG004|Overall Study|Protocol Violation|3|||
155010770|NCT00742209|559465652|FG000|Overall Study|Lost to Follow-up|3|||
155010771|NCT00742209|559465653|FG001|Overall Study|Lost to Follow-up|4|||
155010772|NCT00742209|559465654|FG002|Overall Study|Lost to Follow-up|5|||
155010773|NCT00742209|559465655|FG003|Overall Study|Lost to Follow-up|5|||
155010774|NCT00742209|559465656|FG004|Overall Study|Lost to Follow-up|3|||
155010775|NCT00742209|559465652|FG000|Overall Study|Lack of Efficacy|6|||
155131717|NCT04856904|559913005|FG000|Overall Study|Adverse Event|1|||
155131718|NCT04856904|559913006|FG001|Overall Study|Adverse Event|1|||
155131719|NCT04856904|559913005|FG000|Overall Study|Non-compliance with study drug|1|||
155131720|NCT04856904|559913006|FG001|Overall Study|Non-compliance with study drug|1|||
155131721|NCT04856904|559913005|FG000|Overall Study|Lost to Follow-up|4|||
155131722|NCT04856904|559913006|FG001|Overall Study|Lost to Follow-up|4|||
155131723|NCT04856904|559913005|FG000|Overall Study|Withdrawal by Subject|1|||
155131724|NCT04856904|559913006|FG001|Overall Study|Withdrawal by Subject|1|||
155131725|NCT04856904|559913005|FG000|Overall Study|Protocol Violation|1|||
155131726|NCT04856904|559913006|FG001|Overall Study|Protocol Violation|1|||
155131727|NCT01375608|559913007|FG000|Overall Study|Withdrawal by Subject|2|||
155131728|NCT03429543|559913008|FG000|Overall Study|Adverse Event|1|||
155131729|NCT03429543|559913009|FG001|Overall Study|Adverse Event|1|||
155131730|NCT03429543|559913010|FG002|Overall Study|Adverse Event|0|||
155131731|NCT03429543|559913011|FG003|Overall Study|Adverse Event|0|||
155010776|NCT00742209|559465653|FG001|Overall Study|Lack of Efficacy|1|||
155010777|NCT00742209|559465654|FG002|Overall Study|Lack of Efficacy|1|||
155131732|NCT03429543|559913012|FG004|Overall Study|Adverse Event|0|||
155131733|NCT03429543|559913013|FG005|Overall Study|Adverse Event|2|||
155010778|NCT00742209|559465655|FG003|Overall Study|Lack of Efficacy|3|||
155010779|NCT00742209|559465656|FG004|Overall Study|Lack of Efficacy|1|||
155010780|NCT00742209|559465652|FG000|Overall Study|Investigator Discretion|0|||
155131734|NCT03429543|559913014|FG006|Overall Study|Adverse Event|0|||
155178500|NCT01606878|560091516|FG009|Overall Study|Physician Decision|0|||
155131735|NCT03429543|559913008|FG000|Overall Study|Lost to Follow-up|1|||
155131736|NCT03429543|559913009|FG001|Overall Study|Lost to Follow-up|0|||
155131737|NCT03429543|559913010|FG002|Overall Study|Lost to Follow-up|0|||
155178501|NCT01606878|560091517|FG010|Overall Study|Physician Decision|0|||
155178502|NCT01606878|560091507|FG000|Overall Study|Withdrawal by Subject|3|||
155010781|NCT00742209|559465653|FG001|Overall Study|Investigator Discretion|0|||
155010782|NCT00742209|559465654|FG002|Overall Study|Investigator Discretion|5|||
155010783|NCT00742209|559465655|FG003|Overall Study|Investigator Discretion|1|||
155010784|NCT00742209|559465656|FG004|Overall Study|Investigator Discretion|1|||
155010785|NCT00485264|559465657|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
155010786|NCT00485264|559465658|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
155010787|NCT00485264|559465659|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
155010788|NCT00485264|559465660|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
155010789|NCT00485264|559465661|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
155010790|NCT00485264|559465662|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
155010791|NCT00485264|559465657|FG000|Overall Study|Death|1|||
155010792|NCT00485264|559465658|FG001|Overall Study|Death|0|||
155010793|NCT00485264|559465659|FG002|Overall Study|Death|0|||
155010794|NCT00485264|559465660|FG003|Overall Study|Death|0|||
155010795|NCT00485264|559465661|FG004|Overall Study|Death|1|||
155010796|NCT00485264|559465662|FG005|Overall Study|Death|0|||
155010797|NCT00485264|559465657|FG000|Overall Study|Adverse Event|1|||
155010798|NCT00485264|559465658|FG001|Overall Study|Adverse Event|0|||
155010799|NCT00485264|559465659|FG002|Overall Study|Adverse Event|2|||
155010800|NCT00485264|559465660|FG003|Overall Study|Adverse Event|3|||
155010801|NCT00485264|559465661|FG004|Overall Study|Adverse Event|1|||
155010802|NCT00485264|559465662|FG005|Overall Study|Adverse Event|3|||
155010803|NCT00485264|559465657|FG000|Overall Study|Pregnancy|4|||
155131738|NCT03429543|559913011|FG003|Overall Study|Lost to Follow-up|0|||
155131739|NCT03429543|559913012|FG004|Overall Study|Lost to Follow-up|1|||
155131740|NCT03429543|559913013|FG005|Overall Study|Lost to Follow-up|0|||
155131741|NCT03429543|559913014|FG006|Overall Study|Lost to Follow-up|0|||
155131742|NCT03429543|559913008|FG000|Overall Study|Withdrawal by Subject|5|||
155131743|NCT03429543|559913009|FG001|Overall Study|Withdrawal by Subject|0|||
155131744|NCT03429543|559913010|FG002|Overall Study|Withdrawal by Subject|1|||
155131745|NCT03429543|559913011|FG003|Overall Study|Withdrawal by Subject|2|||
155131746|NCT03429543|559913012|FG004|Overall Study|Withdrawal by Subject|6|||
155131747|NCT03429543|559913013|FG005|Overall Study|Withdrawal by Subject|3|||
155131748|NCT03429543|559913014|FG006|Overall Study|Withdrawal by Subject|1|||
155131749|NCT03429543|559913008|FG000|Overall Study|Other reason than listed|0|||
155131750|NCT03429543|559913009|FG001|Overall Study|Other reason than listed|1|||
155131751|NCT03429543|559913010|FG002|Overall Study|Other reason than listed|0|||
155131752|NCT03429543|559913011|FG003|Overall Study|Other reason than listed|0|||
155131753|NCT03429543|559913012|FG004|Overall Study|Other reason than listed|4|||
155131754|NCT03429543|559913013|FG005|Overall Study|Other reason than listed|4|||
155131755|NCT03429543|559913014|FG006|Overall Study|Other reason than listed|0|||
155131756|NCT03429543|559913008|FG000|Overall Study|Not treated|0|||
155131757|NCT03429543|559913009|FG001|Overall Study|Not treated|0|||
155131758|NCT03429543|559913010|FG002|Overall Study|Not treated|0|||
155131759|NCT03429543|559913011|FG003|Overall Study|Not treated|0|||
155131760|NCT03429543|559913012|FG004|Overall Study|Not treated|1|||
155131761|NCT03429543|559913013|FG005|Overall Study|Not treated|0|||
155131762|NCT03429543|559913014|FG006|Overall Study|Not treated|0|||
155131763|NCT03322423|559913016|FG000|Period 1|Subject no longer eligible|0|||
155131764|NCT03322423|559913017|FG001|Period 1|Subject no longer eligible|1|||
155131765|NCT03322423|559913016|FG000|Period 1|Withdrawal by Subject|0|||
155131766|NCT03322423|559913017|FG001|Period 1|Withdrawal by Subject|1|||
155131767|NCT03322423|559913016|FG000|Period 1|Incorrect Lens Dispensed|1|||
155131768|NCT03322423|559913017|FG001|Period 1|Incorrect Lens Dispensed|0|||
155131769|NCT03322423|559913016|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
155131770|NCT03322423|559913017|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
155131771|NCT03322423|559913016|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
155131772|NCT03322423|559913017|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
155131773|NCT03322423|559913016|FG000|Period 2|Protocol Violation|1|||
155131774|NCT03322423|559913017|FG001|Period 2|Protocol Violation|0|||
155131775|NCT03322423|559913016|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
155131776|NCT03322423|559913017|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
155131777|NCT02453555|559913020|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
155131778|NCT02453555|559913021|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
155131779|NCT02453555|559913022|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
155131780|NCT02453555|559913023|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
155131781|NCT02453555|559913024|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
155131782|NCT02453555|559913025|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
155131783|NCT02453555|559913020|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
155131784|NCT02453555|559913021|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155131785|NCT02453555|559913022|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155010804|NCT00485264|559465658|FG001|Overall Study|Pregnancy|0|||
155010805|NCT00485264|559465659|FG002|Overall Study|Pregnancy|0|||
155010806|NCT00485264|559465660|FG003|Overall Study|Pregnancy|0|||
155131786|NCT02453555|559913023|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155131787|NCT02453555|559913024|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155151026|NCT02587520|559988172|FG012|Overall Study|Protocol Violation|0|||
155010807|NCT00485264|559465661|FG004|Overall Study|Pregnancy|0|||
155010808|NCT00485264|559465662|FG005|Overall Study|Pregnancy|0|||
155010809|NCT00485264|559465657|FG000|Overall Study|Disallowed Medication|0|||
155010810|NCT00485264|559465658|FG001|Overall Study|Disallowed Medication|0|||
155010811|NCT00485264|559465659|FG002|Overall Study|Disallowed Medication|0|||
155010812|NCT00485264|559465660|FG003|Overall Study|Disallowed Medication|0|||
155010813|NCT00485264|559465661|FG004|Overall Study|Disallowed Medication|0|||
155010814|NCT00485264|559465662|FG005|Overall Study|Disallowed Medication|1|||
155010815|NCT00485264|559465657|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
155010816|NCT00485264|559465658|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
155010817|NCT00485264|559465659|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
155010818|NCT00485264|559465660|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
155010819|NCT00485264|559465661|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
155010820|NCT00485264|559465662|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
155010821|NCT00485264|559465657|FG000|Overall Study|Lack of Efficacy|0|||
155010822|NCT00485264|559465658|FG001|Overall Study|Lack of Efficacy|1|||
155010823|NCT00485264|559465659|FG002|Overall Study|Lack of Efficacy|0|||
155010824|NCT00485264|559465660|FG003|Overall Study|Lack of Efficacy|0|||
155010825|NCT00485264|559465661|FG004|Overall Study|Lack of Efficacy|0|||
155010826|NCT00485264|559465662|FG005|Overall Study|Lack of Efficacy|0|||
155010827|NCT00485264|559465657|FG000|Overall Study|Guardian Consent Withdrawn|1|||
155010828|NCT00485264|559465658|FG001|Overall Study|Guardian Consent Withdrawn|0|||
155010829|NCT00485264|559465659|FG002|Overall Study|Guardian Consent Withdrawn|0|||
155010830|NCT00485264|559465660|FG003|Overall Study|Guardian Consent Withdrawn|0|||
155010831|NCT00485264|559465661|FG004|Overall Study|Guardian Consent Withdrawn|1|||
155010832|NCT00485264|559465662|FG005|Overall Study|Guardian Consent Withdrawn|0|||
155010833|NCT00485264|559465657|FG000|Overall Study|Physician Decision|0|||
155010834|NCT00485264|559465658|FG001|Overall Study|Physician Decision|2|||
155010835|NCT00485264|559465659|FG002|Overall Study|Physician Decision|0|||
155010836|NCT00485264|559465660|FG003|Overall Study|Physician Decision|0|||
155010837|NCT00485264|559465661|FG004|Overall Study|Physician Decision|0|||
155010838|NCT00485264|559465662|FG005|Overall Study|Physician Decision|0|||
155010839|NCT00485264|559465657|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155010840|NCT00485264|559465658|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155010841|NCT00485264|559465659|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
155010842|NCT00485264|559465660|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155010843|NCT00485264|559465661|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155010844|NCT00485264|559465662|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
155010845|NCT00485264|559465657|FG000|Overall Study|Not Able to Attend Clinic|5|||
155010846|NCT00485264|559465658|FG001|Overall Study|Not Able to Attend Clinic|0|||
155010847|NCT00485264|559465659|FG002|Overall Study|Not Able to Attend Clinic|0|||
155010848|NCT00485264|559465660|FG003|Overall Study|Not Able to Attend Clinic|1|||
155010849|NCT00485264|559465661|FG004|Overall Study|Not Able to Attend Clinic|1|||
155010850|NCT00485264|559465662|FG005|Overall Study|Not Able to Attend Clinic|2|||
155010851|NCT00485264|559465657|FG000|Overall Study|Non-Compliant|17|||
155010852|NCT00485264|559465658|FG001|Overall Study|Non-Compliant|2|||
155010853|NCT00485264|559465659|FG002|Overall Study|Non-Compliant|1|||
155010854|NCT00485264|559465660|FG003|Overall Study|Non-Compliant|0|||
155010855|NCT00485264|559465661|FG004|Overall Study|Non-Compliant|1|||
155010856|NCT00485264|559465662|FG005|Overall Study|Non-Compliant|0|||
155010857|NCT00485264|559465657|FG000|Overall Study|Lost to Follow-up|2|||
155010858|NCT00485264|559465658|FG001|Overall Study|Lost to Follow-up|1|||
155010859|NCT00485264|559465659|FG002|Overall Study|Lost to Follow-up|1|||
155010860|NCT00485264|559465660|FG003|Overall Study|Lost to Follow-up|0|||
155010861|NCT00485264|559465661|FG004|Overall Study|Lost to Follow-up|0|||
155010862|NCT00485264|559465662|FG005|Overall Study|Lost to Follow-up|1|||
155010863|NCT00485264|559465657|FG000|Overall Study|Other Reason|3|||
155131788|NCT02453555|559913025|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
155131789|NCT02453555|559913020|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
155131790|NCT02453555|559913021|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
155131791|NCT02453555|559913022|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155131792|NCT02453555|559913023|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155010864|NCT00485264|559465658|FG001|Overall Study|Other Reason|0|||
155010865|NCT00485264|559465659|FG002|Overall Study|Other Reason|0|||
155010866|NCT00485264|559465660|FG003|Overall Study|Other Reason|0|||
155010867|NCT00485264|559465661|FG004|Overall Study|Other Reason|0|||
155010868|NCT00485264|559465662|FG005|Overall Study|Other Reason|0|||
155010869|NCT01514461|559465663|FG000|Overall Study|Adverse Event|2|||
155010870|NCT01514461|559465664|FG001|Overall Study|Adverse Event|1|||
155010871|NCT01514461|559465665|FG002|Overall Study|Adverse Event|3|||
155010872|NCT01514461|559465663|FG000|Overall Study|Physician Decision|1|||
155010873|NCT01514461|559465664|FG001|Overall Study|Physician Decision|1|||
155010874|NCT01514461|559465665|FG002|Overall Study|Physician Decision|0|||
155010875|NCT01514461|559465663|FG000|Overall Study|Patient/guardian decision|1|||
155010876|NCT01514461|559465664|FG001|Overall Study|Patient/guardian decision|1|||
155010877|NCT01514461|559465665|FG002|Overall Study|Patient/guardian decision|1|||
155010878|NCT01514461|559465663|FG000|Overall Study|Death|1|||
155010879|NCT01514461|559465664|FG001|Overall Study|Death|0|||
155010880|NCT01514461|559465665|FG002|Overall Study|Death|0|||
155010881|NCT03565900|559465666|FG000|Overall Study|Disposition Unknown|4|||
155010882|NCT03565900|559465667|FG001|Overall Study|Disposition Unknown|1|||
155010883|NCT03565900|559465666|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155010884|NCT03565900|559465667|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
155010885|NCT03565900|559465666|FG000|Overall Study|Withdrawal by Subject|4|||
155010886|NCT03565900|559465667|FG001|Overall Study|Withdrawal by Subject|5|||
155010887|NCT03565900|559465666|FG000|Overall Study|Randomized By Mistake|0|||
155010888|NCT03565900|559465667|FG001|Overall Study|Randomized By Mistake|2|||
155010889|NCT03565900|559465666|FG000|Overall Study|Physician Decision|7|||
155010890|NCT03565900|559465667|FG001|Overall Study|Physician Decision|11|||
155010891|NCT03565900|559465666|FG000|Overall Study|Death|9|||
155010892|NCT03565900|559465667|FG001|Overall Study|Death|7|||
155010893|NCT02968576|559465668|FG000|Overall Study|Pregnancy|0|||
155010894|NCT02968576|559465669|FG001|Overall Study|Pregnancy|1|||
155010895|NCT02002221|559465673|FG000|Overall Study|Adverse Event|2|||
155010896|NCT02002221|559465674|FG001|Overall Study|Adverse Event|1|||
155010897|NCT02002221|559465673|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155010898|NCT02002221|559465674|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155010899|NCT02002221|559465673|FG000|Overall Study|Patient withdrew consent|0|||
155010900|NCT02002221|559465674|FG001|Overall Study|Patient withdrew consent|1|||
155010901|NCT01998919|559465675|FG000|Overall Study|Death|2|||
155010902|NCT01998919|559465676|FG001|Overall Study|Death|2|||
155010903|NCT01998919|559465675|FG000|Overall Study|Adverse Event|0|||
155010904|NCT01998919|559465676|FG001|Overall Study|Adverse Event|5|||
155010905|NCT01998919|559465675|FG000|Overall Study|Disease progression|31|||
155010906|NCT01998919|559465676|FG001|Overall Study|Disease progression|22|||
155010907|NCT01998919|559465675|FG000|Overall Study|Withdrawal by Subject|2|||
155010908|NCT01998919|559465676|FG001|Overall Study|Withdrawal by Subject|4|||
155010909|NCT01998919|559465675|FG000|Overall Study|Lost to Follow-up|2|||
155010910|NCT01998919|559465676|FG001|Overall Study|Lost to Follow-up|0|||
155010911|NCT01998919|559465675|FG000|Overall Study|Other|5|||
155010912|NCT01998919|559465676|FG001|Overall Study|Other|2|||
155010913|NCT01068860|559465677|FG000|Overall Study|Withdrawal by Subject|0|||
155010914|NCT01068860|559465678|FG001|Overall Study|Withdrawal by Subject|0|||
155010915|NCT01068860|559465679|FG002|Overall Study|Withdrawal by Subject|0|||
155010916|NCT01068860|559465680|FG003|Overall Study|Withdrawal by Subject|0|||
155010917|NCT01068860|559465681|FG004|Overall Study|Withdrawal by Subject|0|||
155010918|NCT01068860|559465682|FG005|Overall Study|Withdrawal by Subject|2|||
155010919|NCT01068860|559465683|FG006|Overall Study|Withdrawal by Subject|0|||
155010920|NCT01068860|559465684|FG007|Overall Study|Withdrawal by Subject|0|||
155010921|NCT01068860|559465685|FG008|Overall Study|Withdrawal by Subject|0|||
155010922|NCT01068860|559465686|FG009|Overall Study|Withdrawal by Subject|3|||
155010923|NCT01068860|559465677|FG000|Overall Study|Administrative problems; misrandomized|0|||
155010924|NCT01068860|559465678|FG001|Overall Study|Administrative problems; misrandomized|0|||
155010925|NCT01068860|559465679|FG002|Overall Study|Administrative problems; misrandomized|0|||
155010926|NCT01068860|559465680|FG003|Overall Study|Administrative problems; misrandomized|1|||
155010927|NCT01068860|559465681|FG004|Overall Study|Administrative problems; misrandomized|0|||
155010928|NCT01068860|559465682|FG005|Overall Study|Administrative problems; misrandomized|0|||
155010929|NCT01068860|559465683|FG006|Overall Study|Administrative problems; misrandomized|0|||
155010930|NCT01068860|559465684|FG007|Overall Study|Administrative problems; misrandomized|0|||
155010931|NCT01068860|559465685|FG008|Overall Study|Administrative problems; misrandomized|0|||
155010932|NCT01068860|559465686|FG009|Overall Study|Administrative problems; misrandomized|1|||
155010933|NCT01068860|559465677|FG000|Overall Study|Lost to Follow-up|0|||
155010934|NCT01068860|559465678|FG001|Overall Study|Lost to Follow-up|1|||
155010935|NCT01068860|559465679|FG002|Overall Study|Lost to Follow-up|0|||
155010936|NCT01068860|559465680|FG003|Overall Study|Lost to Follow-up|0|||
155010937|NCT01068860|559465681|FG004|Overall Study|Lost to Follow-up|0|||
155010938|NCT01068860|559465682|FG005|Overall Study|Lost to Follow-up|0|||
155010939|NCT01068860|559465683|FG006|Overall Study|Lost to Follow-up|0|||
155010940|NCT01068860|559465684|FG007|Overall Study|Lost to Follow-up|0|||
155010941|NCT01068860|559465685|FG008|Overall Study|Lost to Follow-up|0|||
155010942|NCT01068860|559465686|FG009|Overall Study|Lost to Follow-up|0|||
155010943|NCT00897715|559465690|FG000|Overall Study|Lost to Follow-up|0|||
155010944|NCT00897715|559465691|FG001|Overall Study|Lost to Follow-up|1|||
155010945|NCT00897715|559465690|FG000|Overall Study|Physician Decision|1|||
155010946|NCT00897715|559465691|FG001|Overall Study|Physician Decision|0|||
155010947|NCT00897715|559465690|FG000|Overall Study|increased risk of infection|1|||
155010948|NCT00897715|559465691|FG001|Overall Study|increased risk of infection|0|||
155010949|NCT00513240|559465693|FG000|Overall Study|Did not have intended surgery|3|||
155010950|NCT00513240|559465694|FG001|Overall Study|Did not have intended surgery|0|||
155010951|NCT00513240|559465693|FG000|Overall Study|Death|3|||
155010952|NCT00513240|559465694|FG001|Overall Study|Death|3|||
155010953|NCT00513240|559465693|FG000|Overall Study|Withdrawal by Subject|7|||
155010954|NCT00513240|559465694|FG001|Overall Study|Withdrawal by Subject|4|||
155010955|NCT02714218|559465695|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155010956|NCT02714218|559465696|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
155010957|NCT02714218|559465697|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
155010958|NCT02714218|559465695|FG000|Pre-Treatment Period|Other reasons|0|||
155010959|NCT02714218|559465696|FG001|Pre-Treatment Period|Other reasons|1|||
155010960|NCT02714218|559465697|FG002|Pre-Treatment Period|Other reasons|0|||
155010961|NCT02714218|559465695|FG000|Treatment Period|Disease Progression|55|||
155010962|NCT02714218|559465696|FG001|Treatment Period|Disease Progression|52|||
155010963|NCT02714218|559465697|FG002|Treatment Period|Disease Progression|14|||
155010964|NCT02714218|559465695|FG000|Treatment Period|Study drug toxicity|46|||
155010965|NCT02714218|559465696|FG001|Treatment Period|Study drug toxicity|70|||
155010966|NCT02714218|559465697|FG002|Treatment Period|Study drug toxicity|6|||
155010967|NCT02714218|559465695|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
155010968|NCT02714218|559465696|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
155010969|NCT02714218|559465697|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
155010970|NCT02714218|559465695|FG000|Treatment Period|Request to discontinue treatment|1|||
155010971|NCT02714218|559465696|FG001|Treatment Period|Request to discontinue treatment|4|||
155010972|NCT02714218|559465697|FG002|Treatment Period|Request to discontinue treatment|1|||
155010973|NCT02714218|559465695|FG000|Treatment Period|Participant withdrew consent|2|||
155010974|NCT02714218|559465696|FG001|Treatment Period|Participant withdrew consent|2|||
155010975|NCT02714218|559465697|FG002|Treatment Period|Participant withdrew consent|0|||
155010976|NCT02714218|559465695|FG000|Treatment Period|Maximum clinical benefit|4|||
155010977|NCT02714218|559465696|FG001|Treatment Period|Maximum clinical benefit|2|||
155010978|NCT02714218|559465697|FG002|Treatment Period|Maximum clinical benefit|0|||
155010979|NCT02714218|559465695|FG000|Treatment Period|Administrative reason by sponsor|2|||
155010980|NCT02714218|559465696|FG001|Treatment Period|Administrative reason by sponsor|1|||
155010981|NCT02714218|559465697|FG002|Treatment Period|Administrative reason by sponsor|0|||
155010982|NCT02714218|559465695|FG000|Treatment Period|Other reasons|6|||
155010983|NCT02714218|559465696|FG001|Treatment Period|Other reasons|6|||
155010984|NCT02714218|559465697|FG002|Treatment Period|Other reasons|0|||
155010985|NCT02714218|559465695|FG000|Treatment Period|Completed treatment as per protocol|36|||
155010986|NCT02714218|559465696|FG001|Treatment Period|Completed treatment as per protocol|27|||
155010987|NCT02714218|559465697|FG002|Treatment Period|Completed treatment as per protocol|3|||
155010988|NCT02714218|559465695|FG000|Treatment Period|Not reported|9|||
155010989|NCT02714218|559465696|FG001|Treatment Period|Not reported|6|||
155010990|NCT02714218|559465697|FG002|Treatment Period|Not reported|0|||
155010991|NCT02792517|559465705|FG000|Overall Study|Withdrawal by Subject|10|||
155010992|NCT02792517|559465705|FG000|Overall Study|Decision by Sponsor|7|||
155010993|NCT02792517|559465705|FG000|Overall Study|Lost to Follow-up|3|||
155010994|NCT03875508|559465706|FG000|Overall Study|Adverse Event|1|||
155010995|NCT03875508|559465706|FG000|Overall Study|Lost to Follow-up|8|||
155010996|NCT03875508|559465706|FG000|Overall Study|Lack of Efficacy|1|||
155010997|NCT03875508|559465706|FG000|Overall Study|Other, not specified|2|||
155010998|NCT02137252|559465707|FG000|Overall Study|trial terminated early|2|||
155010999|NCT02137252|559465708|FG001|Overall Study|trial terminated early|1|||
155011000|NCT02550561|559465710|FG000|Overall Study|Lost to Follow-up|5|||
155131793|NCT02453555|559913024|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155131794|NCT02453555|559913025|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155131795|NCT02453555|559913020|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
155131796|NCT02453555|559913021|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
155131797|NCT02453555|559913022|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
155131798|NCT02453555|559913023|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
155151027|NCT02587520|559988173|FG013|Overall Study|Protocol Violation|0|||
155011001|NCT02550561|559465710|FG000|Overall Study|Withdrawal by Subject|1|||
155011002|NCT01113892|559465715|FG000|Overall Study|Lost to Follow-up|2|||
155011003|NCT01113892|559465716|FG001|Overall Study|Lost to Follow-up|2|||
155011004|NCT01113892|559465715|FG000|Overall Study|Withdrawal by Subject|1|||
155011005|NCT01113892|559465716|FG001|Overall Study|Withdrawal by Subject|1|||
155011006|NCT01113892|559465715|FG000|Overall Study|Death|2|||
155011007|NCT01113892|559465716|FG001|Overall Study|Death|4|||
155011008|NCT01113892|559465715|FG000|Overall Study|Graft no longer evaluable|9|||
155011009|NCT01113892|559465716|FG001|Overall Study|Graft no longer evaluable|9|||
155011010|NCT02766335|559465721|FG000|Initial Registration|Adverse Event|6|||
155011011|NCT02766335|559465722|FG001|Initial Registration|Adverse Event|3|||
155011012|NCT02766335|559465723|FG002|Initial Registration|Adverse Event|0|||
155011013|NCT02766335|559465721|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
155011014|NCT02766335|559465722|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
155011015|NCT02766335|559465723|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
155011016|NCT02766335|559465721|FG000|Initial Registration|Progression/relapse|49|||
155011017|NCT02766335|559465722|FG001|Initial Registration|Progression/relapse|15|||
155011018|NCT02766335|559465723|FG002|Initial Registration|Progression/relapse|0|||
155011019|NCT02766335|559465721|FG000|Initial Registration|Death|1|||
155011020|NCT02766335|559465722|FG001|Initial Registration|Death|3|||
155011021|NCT02766335|559465723|FG002|Initial Registration|Death|0|||
155011022|NCT02766335|559465721|FG000|Initial Registration|not protocol specified|1|||
155011023|NCT02766335|559465722|FG001|Initial Registration|not protocol specified|9|||
155011024|NCT02766335|559465723|FG002|Initial Registration|not protocol specified|0|||
155011025|NCT02766335|559465721|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
155011026|NCT02766335|559465722|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
155011027|NCT02766335|559465723|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
155011028|NCT02766335|559465721|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
155011029|NCT02766335|559465722|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
155011030|NCT02766335|559465723|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
155011031|NCT00281957|559465724|FG000|Overall Study|Adverse Event|7|||
155011032|NCT00281957|559465725|FG001|Overall Study|Adverse Event|2|||
155011033|NCT00281957|559465724|FG000|Overall Study|Death|1|||
155011034|NCT00281957|559465725|FG001|Overall Study|Death|0|||
155011035|NCT00281957|559465724|FG000|Overall Study|Progression/relapse|47|||
155011036|NCT00281957|559465725|FG001|Overall Study|Progression/relapse|35|||
155011037|NCT00281957|559465724|FG000|Overall Study|Not protocol specified|8|||
155011038|NCT00281957|559465725|FG001|Overall Study|Not protocol specified|1|||
155011039|NCT00281957|559465724|FG000|Overall Study|Not eligible|1|||
155011040|NCT00281957|559465725|FG001|Overall Study|Not eligible|2|||
155011041|NCT00281957|559465724|FG000|Overall Study|Did not start treatment|3|||
155011042|NCT00281957|559465725|FG001|Overall Study|Did not start treatment|1|||
155011043|NCT00281957|559465724|FG000|Overall Study|Refusal unrelated to adverse events|0|||
155011044|NCT00281957|559465725|FG001|Overall Study|Refusal unrelated to adverse events|1|||
155011045|NCT03281876|559465733|FG000|Overall Study|Adverse Event|4|||
155011046|NCT03281876|559465734|FG001|Overall Study|Adverse Event|15|||
155011047|NCT03281876|559465733|FG000|Overall Study|Lost to Follow-up|1|||
155011048|NCT03281876|559465734|FG001|Overall Study|Lost to Follow-up|4|||
155011049|NCT03281876|559465733|FG000|Overall Study|Withdrawal by Subject|11|||
155011050|NCT03281876|559465734|FG001|Overall Study|Withdrawal by Subject|15|||
155011051|NCT03281876|559465733|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
155011052|NCT03281876|559465734|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155011053|NCT03281876|559465733|FG000|Overall Study|OTHER|5|||
155011054|NCT03281876|559465734|FG001|Overall Study|OTHER|5|||
155011055|NCT02443740|559465735|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011056|NCT02443740|559465736|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011057|NCT02443740|559465737|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011058|NCT02443740|559465738|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011059|NCT02443740|559465739|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011060|NCT02443740|559465740|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
155011061|NCT02443740|559465741|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011062|NCT02443740|559465742|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011063|NCT02443740|559465743|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011064|NCT02443740|559465744|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011065|NCT02443740|559465745|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
155011066|NCT02443740|559465735|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
155011067|NCT02443740|559465736|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011068|NCT02443740|559465737|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011069|NCT02443740|559465738|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011070|NCT02443740|559465739|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011071|NCT02443740|559465740|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011072|NCT02443740|559465741|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
155011073|NCT02443740|559465742|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011074|NCT02443740|559465743|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011075|NCT02443740|559465744|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011076|NCT02443740|559465745|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
155011077|NCT02443740|559465735|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011078|NCT02443740|559465736|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011079|NCT02443740|559465737|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011080|NCT02443740|559465738|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011081|NCT02443740|559465739|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011082|NCT02443740|559465740|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
155011083|NCT02443740|559465741|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011084|NCT02443740|559465742|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011085|NCT02443740|559465743|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011086|NCT02443740|559465744|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011087|NCT02443740|559465745|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
155011088|NCT02452476|559465747|FG000|Overall Study|Death|4|||
155011089|NCT02452476|559465748|FG001|Overall Study|Death|7|||
155011090|NCT02452476|559465747|FG000|Overall Study|Lost to Follow-up|1|||
155011091|NCT02452476|559465748|FG001|Overall Study|Lost to Follow-up|1|||
155011092|NCT02452476|559465747|FG000|Overall Study|Physician Decision|1|||
155011093|NCT02452476|559465748|FG001|Overall Study|Physician Decision|1|||
155011094|NCT02452476|559465747|FG000|Overall Study|Not treated|5|||
155011095|NCT02452476|559465748|FG001|Overall Study|Not treated|1|||
155011096|NCT01074944|559465751|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
155011097|NCT01074944|559465752|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155011098|NCT01074944|559465753|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155011099|NCT01074944|559465754|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155011100|NCT01074944|559465755|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
155011101|NCT01074944|559465751|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
155011102|NCT01074944|559465752|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155011103|NCT01074944|559465753|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155011104|NCT01074944|559465754|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155011105|NCT01074944|559465755|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
155011106|NCT01074944|559465751|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
155011107|NCT01074944|559465752|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155011108|NCT01074944|559465753|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155011109|NCT01074944|559465754|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155011110|NCT01074944|559465755|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
155011111|NCT01074944|559465751|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
155011112|NCT01074944|559465752|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155011113|NCT01074944|559465753|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155011114|NCT01074944|559465754|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155011115|NCT01074944|559465755|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
155011116|NCT01074944|559465751|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
155011117|NCT01074944|559465752|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
155011118|NCT01074944|559465753|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
155011119|NCT01074944|559465754|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
155011120|NCT01074944|559465755|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
155011121|NCT01074944|559465751|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
155011122|NCT01074944|559465752|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
155011123|NCT01074944|559465753|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
155011124|NCT01074944|559465754|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
155011125|NCT01074944|559465755|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
155011126|NCT01074944|559465751|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155011127|NCT01074944|559465752|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
155011128|NCT01074944|559465753|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
155011129|NCT01074944|559465754|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155011130|NCT01074944|559465755|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
155011131|NCT01074944|559465751|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155011132|NCT01074944|559465752|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
155011133|NCT01074944|559465753|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155011134|NCT01074944|559465754|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155011135|NCT01074944|559465755|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
155011136|NCT01074944|559465751|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
155011137|NCT01074944|559465752|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
155011138|NCT01074944|559465753|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
155011139|NCT01074944|559465754|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
155011140|NCT01074944|559465755|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
155011141|NCT01074944|559465751|FG000|Long Term Treatment|Adverse Event|0|||
155011142|NCT01074944|559465752|FG001|Long Term Treatment|Adverse Event|0|||
155011143|NCT01074944|559465753|FG002|Long Term Treatment|Adverse Event|0|||
155011144|NCT01074944|559465754|FG003|Long Term Treatment|Adverse Event|3|||
155011145|NCT01074944|559465755|FG004|Long Term Treatment|Adverse Event|0|||
155011146|NCT01074944|559465751|FG000|Long Term Treatment|Lost to Follow-up|0|||
155011147|NCT01074944|559465752|FG001|Long Term Treatment|Lost to Follow-up|0|||
155011148|NCT01074944|559465753|FG002|Long Term Treatment|Lost to Follow-up|0|||
155011149|NCT01074944|559465754|FG003|Long Term Treatment|Lost to Follow-up|2|||
155011150|NCT01074944|559465755|FG004|Long Term Treatment|Lost to Follow-up|0|||
155011151|NCT01074944|559465751|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155011152|NCT01074944|559465752|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155011153|NCT01074944|559465753|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155011154|NCT01074944|559465754|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
155011155|NCT01074944|559465755|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
155011156|NCT01074944|559465751|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
155011157|NCT01074944|559465752|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
155011158|NCT01074944|559465753|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
155178503|NCT01606878|560091508|FG001|Overall Study|Withdrawal by Subject|2|||
155011159|NCT01074944|559465754|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
155011160|NCT01074944|559465755|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
155131799|NCT02453555|559913024|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
155131800|NCT02453555|559913025|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
155131801|NCT02453555|559913020|FG000|Extension Period|Adverse Event|0|||
155131802|NCT02453555|559913021|FG001|Extension Period|Adverse Event|0|||
155131803|NCT02453555|559913022|FG002|Extension Period|Adverse Event|1|||
155131804|NCT02453555|559913023|FG003|Extension Period|Adverse Event|2|||
155131805|NCT02453555|559913024|FG004|Extension Period|Adverse Event|1|||
155131806|NCT02453555|559913025|FG005|Extension Period|Adverse Event|1|||
155131807|NCT02453555|559913020|FG000|Extension Period|Protocol Violation|0|||
155131808|NCT02453555|559913021|FG001|Extension Period|Protocol Violation|0|||
155131809|NCT02453555|559913022|FG002|Extension Period|Protocol Violation|1|||
155131810|NCT02453555|559913023|FG003|Extension Period|Protocol Violation|0|||
155131811|NCT02453555|559913024|FG004|Extension Period|Protocol Violation|0|||
155131812|NCT02453555|559913025|FG005|Extension Period|Protocol Violation|0|||
155131813|NCT02453555|559913020|FG000|Extension Period|Withdrawal by Subject|0|||
155131814|NCT02453555|559913021|FG001|Extension Period|Withdrawal by Subject|0|||
155131815|NCT02453555|559913022|FG002|Extension Period|Withdrawal by Subject|1|||
155131816|NCT02453555|559913023|FG003|Extension Period|Withdrawal by Subject|0|||
155131817|NCT02453555|559913024|FG004|Extension Period|Withdrawal by Subject|0|||
155131818|NCT02453555|559913025|FG005|Extension Period|Withdrawal by Subject|0|||
155131819|NCT03689855|559913030|FG000|Overall Study|Adverse Event|3|||
155131820|NCT03689855|559913030|FG000|Overall Study|Withdrawal by Subject|1|||
155131821|NCT02409719|559913031|FG000|Overall Study|Lost to Follow-up|3|||
155131822|NCT02409719|559913032|FG001|Overall Study|Lost to Follow-up|3|||
155131823|NCT00619099|559913036|FG000|Overall Study|Progressive Disease|7|||
155131824|NCT00619099|559913037|FG001|Overall Study|Progressive Disease|5|||
155131825|NCT00619099|559913036|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
155131826|NCT00619099|559913037|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
155131827|NCT00619099|559913036|FG000|Overall Study|Adverse Event|4|||
155131828|NCT00619099|559913037|FG001|Overall Study|Adverse Event|3|||
155131829|NCT00619099|559913036|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
155131830|NCT00619099|559913037|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
155131831|NCT00619099|559913036|FG000|Overall Study|Withdrawal by Subject|10|||
155131832|NCT00619099|559913037|FG001|Overall Study|Withdrawal by Subject|2|||
155131833|NCT00619099|559913036|FG000|Overall Study|Physician Decision|9|||
155131834|NCT00619099|559913037|FG001|Overall Study|Physician Decision|6|||
155131835|NCT00885482|559913038|FG000|Overall Study|Pregnancy|1|||
155131836|NCT00885482|559913038|FG000|Overall Study|Lack of Efficacy|1|||
155131837|NCT00885482|559913038|FG000|Overall Study|Death|1|||
155131838|NCT00885482|559913038|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
155131839|NCT00989781|559913039|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
155131840|NCT00989781|559913040|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
155131841|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
155131842|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
155131843|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
155131844|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
155131845|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
155131846|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
155131847|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
155131848|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
155131849|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
155131850|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
155131851|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
155131852|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
155131853|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
155131854|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
155131855|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
155131856|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
155131857|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
155131858|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
155131859|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
155131860|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
155131861|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
155131862|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
155131863|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
155131864|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
155131865|NCT01532869|559913041|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
155131866|NCT01532869|559913042|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
155131867|NCT01532869|559913041|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
155178504|NCT01606878|560091509|FG002|Overall Study|Withdrawal by Subject|2|||
155178505|NCT01606878|560091510|FG003|Overall Study|Withdrawal by Subject|0|||
155131868|NCT01532869|559913042|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
155131869|NCT01532869|559913041|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
155131870|NCT01532869|559913042|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
155178506|NCT01606878|560091511|FG004|Overall Study|Withdrawal by Subject|1|||
155178507|NCT01606878|560091512|FG005|Overall Study|Withdrawal by Subject|1|||
155178508|NCT01606878|560091513|FG006|Overall Study|Withdrawal by Subject|2|||
155178509|NCT01606878|560091514|FG007|Overall Study|Withdrawal by Subject|1|||
155178510|NCT01606878|560091515|FG008|Overall Study|Withdrawal by Subject|2|||
155178511|NCT01606878|560091516|FG009|Overall Study|Withdrawal by Subject|0|||
155178512|NCT01606878|560091517|FG010|Overall Study|Withdrawal by Subject|2|||
155131871|NCT01532869|559913041|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
155131872|NCT01532869|559913042|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
155131873|NCT01532869|559913041|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
155131874|NCT01532869|559913042|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
155131875|NCT02438813|559913043|FG000|Overall Study|Patient Decision|59|||
155131876|NCT02438813|559913043|FG000|Overall Study|Patient Lost to Follow-Up|137|||
155131877|NCT02438813|559913043|FG000|Overall Study|Study Ended by Sponsor|80|||
155131878|NCT02438813|559913043|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
155178513|NCT01007253|560091518|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
155178514|NCT01007253|560091519|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
155178515|NCT01007253|560091520|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
154923708|NCT03110107|559146302|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
154923709|NCT03110107|559146277|FG000|Treatment Period|Participant withdrew consent|0|||
154923710|NCT03110107|559146278|FG001|Treatment Period|Participant withdrew consent|0|||
154923711|NCT03110107|559146279|FG002|Treatment Period|Participant withdrew consent|1|||
154923712|NCT03110107|559146280|FG003|Treatment Period|Participant withdrew consent|0|||
154923713|NCT03110107|559146281|FG004|Treatment Period|Participant withdrew consent|4|||
154923714|NCT03110107|559146282|FG005|Treatment Period|Participant withdrew consent|3|||
154923715|NCT03110107|559146283|FG006|Treatment Period|Participant withdrew consent|0|||
154923716|NCT03110107|559146284|FG007|Treatment Period|Participant withdrew consent|0|||
154923717|NCT03110107|559146285|FG008|Treatment Period|Participant withdrew consent|0|||
154923718|NCT03110107|559146286|FG009|Treatment Period|Participant withdrew consent|1|||
154923719|NCT03110107|559146287|FG010|Treatment Period|Participant withdrew consent|0|||
154923720|NCT03110107|559146288|FG011|Treatment Period|Participant withdrew consent|0|||
154923721|NCT03110107|559146289|FG012|Treatment Period|Participant withdrew consent|0|||
154923722|NCT03110107|559146290|FG013|Treatment Period|Participant withdrew consent|0|||
154923723|NCT03110107|559146291|FG014|Treatment Period|Participant withdrew consent|0|||
154923724|NCT03110107|559146292|FG015|Treatment Period|Participant withdrew consent|0|||
154923725|NCT03110107|559146293|FG016|Treatment Period|Participant withdrew consent|0|||
154923726|NCT03110107|559146294|FG017|Treatment Period|Participant withdrew consent|0|||
154923727|NCT03110107|559146295|FG018|Treatment Period|Participant withdrew consent|0|||
154923728|NCT03110107|559146296|FG019|Treatment Period|Participant withdrew consent|1|||
154923729|NCT03110107|559146297|FG020|Treatment Period|Participant withdrew consent|0|||
154923730|NCT03110107|559146298|FG021|Treatment Period|Participant withdrew consent|2|||
154923731|NCT03110107|559146299|FG022|Treatment Period|Participant withdrew consent|0|||
154923732|NCT03110107|559146300|FG023|Treatment Period|Participant withdrew consent|0|||
154923733|NCT03110107|559146301|FG024|Treatment Period|Participant withdrew consent|0|||
154923734|NCT03110107|559146302|FG025|Treatment Period|Participant withdrew consent|2|||
154923735|NCT03110107|559146277|FG000|Treatment Period|Participants no longer meets study criteria|0|||
154923736|NCT03110107|559146278|FG001|Treatment Period|Participants no longer meets study criteria|0|||
154923737|NCT03110107|559146279|FG002|Treatment Period|Participants no longer meets study criteria|0|||
154923738|NCT03110107|559146280|FG003|Treatment Period|Participants no longer meets study criteria|0|||
154923739|NCT03110107|559146281|FG004|Treatment Period|Participants no longer meets study criteria|0|||
154923740|NCT03110107|559146282|FG005|Treatment Period|Participants no longer meets study criteria|0|||
154923741|NCT03110107|559146283|FG006|Treatment Period|Participants no longer meets study criteria|0|||
154923742|NCT03110107|559146284|FG007|Treatment Period|Participants no longer meets study criteria|0|||
154923743|NCT03110107|559146285|FG008|Treatment Period|Participants no longer meets study criteria|0|||
154923744|NCT03110107|559146286|FG009|Treatment Period|Participants no longer meets study criteria|0|||
154923745|NCT03110107|559146287|FG010|Treatment Period|Participants no longer meets study criteria|0|||
154923746|NCT03110107|559146288|FG011|Treatment Period|Participants no longer meets study criteria|0|||
154923747|NCT03110107|559146289|FG012|Treatment Period|Participants no longer meets study criteria|0|||
154923748|NCT03110107|559146290|FG013|Treatment Period|Participants no longer meets study criteria|0|||
155011161|NCT01074944|559465751|FG000|Long Term Treatment|Withdrawal by Subject|0|||
155131879|NCT00778895|559913044|FG000|Active Phase|Adverse Event|3|||
155178516|NCT01007253|560091521|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
155178517|NCT01159431|560091524|FG000|Overall Study|Adverse Event|1|||
155178518|NCT01159431|560091525|FG001|Overall Study|Adverse Event|2|||
155011162|NCT01074944|559465752|FG001|Long Term Treatment|Withdrawal by Subject|0|||
155011163|NCT01074944|559465753|FG002|Long Term Treatment|Withdrawal by Subject|0|||
155011164|NCT01074944|559465754|FG003|Long Term Treatment|Withdrawal by Subject|2|||
155011165|NCT01074944|559465755|FG004|Long Term Treatment|Withdrawal by Subject|0|||
155011166|NCT01074944|559465751|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155011167|NCT01074944|559465752|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155011168|NCT01074944|559465753|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155011169|NCT01074944|559465754|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
155011170|NCT01074944|559465755|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
155011171|NCT01074944|559465751|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155011172|NCT01074944|559465752|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155011173|NCT01074944|559465753|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155011174|NCT01074944|559465754|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
155011175|NCT01074944|559465755|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
155011176|NCT02348112|559465756|FG000|Overall Study|Withdrawal by Subject|32|||
155011177|NCT02348112|559465757|FG001|Overall Study|Withdrawal by Subject|29|||
155011178|NCT02348112|559465756|FG000|Overall Study|Lost to Follow-up|24|||
155011179|NCT02348112|559465757|FG001|Overall Study|Lost to Follow-up|20|||
155011180|NCT02348112|559465756|FG000|Overall Study|Physician Decision|17|||
155011181|NCT02348112|559465757|FG001|Overall Study|Physician Decision|15|||
155011182|NCT02348112|559465756|FG000|Overall Study|Site closed due to PI leaving|0|||
155011183|NCT02348112|559465757|FG001|Overall Study|Site closed due to PI leaving|30|||
155011184|NCT02348112|559465756|FG000|Overall Study|Sponsor withdrawal|0|||
155011185|NCT02348112|559465757|FG001|Overall Study|Sponsor withdrawal|7|||
155011186|NCT02348112|559465756|FG000|Overall Study|Death|0|||
155011187|NCT02348112|559465757|FG001|Overall Study|Death|1|||
155011188|NCT02586155|559465758|FG000|Overall Study|Adverse Event|2|||
155011189|NCT02586155|559465759|FG001|Overall Study|Adverse Event|3|||
155011190|NCT02586155|559465758|FG000|Overall Study|Withdrawal by Subject|31|||
155011191|NCT02586155|559465759|FG001|Overall Study|Withdrawal by Subject|24|||
155011192|NCT02586155|559465758|FG000|Overall Study|Lost to Follow-up|7|||
155011193|NCT02586155|559465759|FG001|Overall Study|Lost to Follow-up|13|||
155011194|NCT02586155|559465758|FG000|Overall Study|Death|61|||
155011195|NCT02586155|559465759|FG001|Overall Study|Death|72|||
155011196|NCT02586155|559465758|FG000|Overall Study|Other reasons|26|||
155011197|NCT02586155|559465759|FG001|Overall Study|Other reasons|15|||
155011198|NCT02072980|559465761|FG000|Period 2, Second Wear|Adverse Event|0|||
155011199|NCT02072980|559465762|FG001|Period 2, Second Wear|Adverse Event|1|||
155011200|NCT01757275|559465764|FG000|Overall Study|Lost to Follow-up|1|||
155011201|NCT01757275|559465765|FG001|Overall Study|Lost to Follow-up|2|||
155011202|NCT01757275|559465764|FG000|Overall Study|Adverse Event|3|||
155011203|NCT01757275|559465765|FG001|Overall Study|Adverse Event|3|||
155011204|NCT01757275|559465764|FG000|Overall Study|Withdrawal by Subject|2|||
155011205|NCT01757275|559465765|FG001|Overall Study|Withdrawal by Subject|4|||
155011206|NCT01757275|559465764|FG000|Overall Study|Not treated|3|||
155011207|NCT01757275|559465765|FG001|Overall Study|Not treated|4|||
155011208|NCT01401452|559465767|FG000|Overall Study|Adverse reaction|9|||
155011209|NCT01401452|559465767|FG000|Overall Study|Lost to Follow-up|12|||
155011210|NCT01401452|559465767|FG000|Overall Study|Lack of Efficacy|30|||
155011211|NCT01401452|559465767|FG000|Overall Study|Participant developed breast cancer|1|||
155011212|NCT01401452|559465767|FG000|Overall Study|Tx stopped due to financial reasons|1|||
155011213|NCT01401452|559465767|FG000|Overall Study|Tx stopped by psychiatrist|1|||
155011214|NCT01401452|559465767|FG000|Overall Study|No more visits within the 36 wk followup|4|||
155011215|NCT01401452|559465767|FG000|Overall Study|Subject did not come to follow up visits|2|||
155011216|NCT01401452|559465767|FG000|Overall Study|Subject didn't return for routine visits|1|||
155011217|NCT01401452|559465767|FG000|Overall Study|Subject moved to another city|1|||
155011218|NCT01401452|559465767|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
155011219|NCT01401452|559465767|FG000|Overall Study|Psoriatic arthritis|1|||
155011220|NCT01401452|559465767|FG000|Overall Study|Participant stopped Tx|2|||
155011221|NCT01401452|559465767|FG000|Overall Study|Discontinuation for personal reasons|1|||
155011222|NCT01401452|559465767|FG000|Overall Study|Treatment failure|1|||
155011223|NCT01401452|559465767|FG000|Overall Study|Unsatisfactory output|1|||
155011224|NCT01401452|559465767|FG000|Overall Study|Subject withdrew because of Tx success|1|||
155011225|NCT01401452|559465767|FG000|Overall Study|Subject chose to discontinue treatment|1|||
155011226|NCT01401452|559465767|FG000|Overall Study|Participant withdrew consent|1|||
155011227|NCT00584454|559465768|FG000|Overall Study|Adverse Event|1|||
155011228|NCT00584454|559465768|FG000|Overall Study|Relocation|1|||
155011229|NCT00584454|559465768|FG000|Overall Study|Clinical Hold|2|||
155011230|NCT01459783|559465770|FG000|Baseline to 6 Months|Death|1|||
155011231|NCT01459783|559465771|FG001|Baseline to 6 Months|Death|0|||
155011232|NCT01459783|559465770|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
155011233|NCT01459783|559465771|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
155011234|NCT01459783|559465770|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
155011235|NCT01459783|559465771|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
155011236|NCT01459783|559465770|FG000|6 Months to 12 Months|Death|0|||
155011237|NCT01459783|559465771|FG001|6 Months to 12 Months|Death|1|||
155011238|NCT01459783|559465770|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
155011239|NCT01459783|559465771|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
155011240|NCT01459783|559465770|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
155011241|NCT01459783|559465771|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
155011242|NCT01459783|559465770|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
155011243|NCT01459783|559465771|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
155011244|NCT02601014|559465772|FG000|Overall Study|Adverse Event|3|||
155011245|NCT02601014|559465773|FG001|Overall Study|Adverse Event|3|||
155011246|NCT02601014|559465772|FG000|Overall Study|Death|3|||
155011247|NCT02601014|559465773|FG001|Overall Study|Death|1|||
155011248|NCT02601014|559465772|FG000|Overall Study|Disease progression|4|||
155011249|NCT02601014|559465773|FG001|Overall Study|Disease progression|8|||
155011250|NCT00445146|559465776|FG000|Overall Study|Withdrew Consent|29|||
155011251|NCT00445146|559465776|FG000|Overall Study|Lack of Efficacy|28|||
155011252|NCT00445146|559465776|FG000|Overall Study|Investigator's Discretion|22|||
155011253|NCT00445146|559465776|FG000|Overall Study|Adverse Event|13|||
155011254|NCT00445146|559465776|FG000|Overall Study|Lost to Follow-up|13|||
155011255|NCT00445146|559465776|FG000|Overall Study|Death|9|||
155011256|NCT00445146|559465776|FG000|Overall Study|Protocol Violation|4|||
155011257|NCT00445146|559465776|FG000|Overall Study|Pregnancy|1|||
155011258|NCT02623725|559465777|FG000|Overall Study|Non compliance with protocol|9|||
155011259|NCT02623725|559465778|FG001|Overall Study|Non compliance with protocol|3|||
155011260|NCT02623725|559465777|FG000|Overall Study|Serious adverse event|0|||
155011261|NCT02623725|559465778|FG001|Overall Study|Serious adverse event|2|||
155011262|NCT02623725|559465777|FG000|Overall Study|Withdrawal by Subject|7|||
155011263|NCT02623725|559465778|FG001|Overall Study|Withdrawal by Subject|1|||
155011264|NCT03918629|559465779|FG000|Overall Study|Adverse Event|19|||
155011265|NCT03918629|559465780|FG001|Overall Study|Adverse Event|20|||
155011266|NCT03918629|559465779|FG000|Overall Study|Death|14|||
155011267|NCT03918629|559465780|FG001|Overall Study|Death|7|||
155011268|NCT03918629|559465779|FG000|Overall Study|Lost to Follow-up|36|||
155011269|NCT03918629|559465780|FG001|Overall Study|Lost to Follow-up|28|||
155011270|NCT03918629|559465779|FG000|Overall Study|Physician Decision|1|||
155011271|NCT03918629|559465780|FG001|Overall Study|Physician Decision|0|||
155011272|NCT03918629|559465779|FG000|Overall Study|Protocol Violation|7|||
155011273|NCT03918629|559465780|FG001|Overall Study|Protocol Violation|4|||
155011274|NCT03918629|559465779|FG000|Overall Study|Withdrawal by Subject|47|||
155011275|NCT03918629|559465780|FG001|Overall Study|Withdrawal by Subject|47|||
155011276|NCT03918629|559465779|FG000|Overall Study|Other|7|||
155011277|NCT03918629|559465780|FG001|Overall Study|Other|11|||
155011278|NCT03918629|559465779|FG000|Overall Study|Randomized but not vaccinated|2|||
155011279|NCT03918629|559465780|FG001|Overall Study|Randomized but not vaccinated|1|||
155011280|NCT02456740|559465781|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
155011281|NCT02456740|559465782|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
155011282|NCT02456740|559465783|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
155011283|NCT02456740|559465784|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155011284|NCT02456740|559465785|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155011285|NCT02456740|559465786|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155011286|NCT02456740|559465787|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155011287|NCT02456740|559465788|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155011288|NCT02456740|559465789|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
155011289|NCT02456740|559465781|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
155011290|NCT02456740|559465782|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
155011291|NCT02456740|559465783|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
155011292|NCT02456740|559465784|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155131880|NCT00778895|559913045|FG001|Active Phase|Adverse Event|1|||
155011293|NCT02456740|559465785|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155011294|NCT02456740|559465786|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155011295|NCT02456740|559465787|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155011296|NCT02456740|559465788|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155011297|NCT02456740|559465789|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
155011298|NCT02456740|559465781|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
155011299|NCT02456740|559465782|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
155011300|NCT02456740|559465783|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
155011301|NCT02456740|559465784|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155011302|NCT02456740|559465785|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155011303|NCT02456740|559465786|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155011304|NCT02456740|559465787|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155131881|NCT00778895|559913046|FG002|Active Phase|Adverse Event|0|||
155131882|NCT00778895|559913044|FG000|Active Phase|Withdrawal by Subject|1|||
155011305|NCT02456740|559465788|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155011306|NCT02456740|559465789|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
155011307|NCT02456740|559465781|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155011308|NCT02456740|559465782|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155011309|NCT02456740|559465783|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155011310|NCT02456740|559465784|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
155011311|NCT02456740|559465785|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
155011312|NCT02456740|559465786|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155011313|NCT02456740|559465787|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155011314|NCT02456740|559465788|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
155011315|NCT02456740|559465789|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
155011316|NCT02456740|559465781|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155011317|NCT02456740|559465782|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155011318|NCT02456740|559465783|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
155011319|NCT02456740|559465784|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
155011320|NCT02456740|559465785|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
155011321|NCT02456740|559465786|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
155011322|NCT02456740|559465787|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
155011323|NCT02456740|559465788|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
155011324|NCT02456740|559465789|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
155011325|NCT02456740|559465781|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011326|NCT02456740|559465782|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011327|NCT02456740|559465783|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011328|NCT02456740|559465784|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011329|NCT02456740|559465785|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011330|NCT02456740|559465786|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011331|NCT02456740|559465787|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011332|NCT02456740|559465788|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
155011333|NCT02456740|559465789|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
155011334|NCT02456740|559465781|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155011335|NCT02456740|559465782|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155011336|NCT02456740|559465783|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
155011337|NCT02456740|559465784|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
155011338|NCT02456740|559465785|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
155011339|NCT02456740|559465786|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
155011340|NCT02456740|559465787|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
155011341|NCT02456740|559465788|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
155011342|NCT02456740|559465789|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
155011343|NCT01891864|559465792|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
155011344|NCT01891864|559465793|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
155011345|NCT01891864|559465794|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155011346|NCT01891864|559465795|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155011347|NCT01891864|559465796|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155011348|NCT01891864|559465797|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
155011349|NCT01891864|559465792|FG000|Treatment Period 1|Physician Decision|0|||
155011350|NCT01891864|559465793|FG001|Treatment Period 1|Physician Decision|1|||
155011351|NCT01891864|559465794|FG002|Treatment Period 1|Physician Decision|0|||
155011352|NCT01891864|559465795|FG003|Treatment Period 1|Physician Decision|0|||
155011353|NCT01891864|559465796|FG004|Treatment Period 1|Physician Decision|0|||
155011354|NCT01891864|559465797|FG005|Treatment Period 1|Physician Decision|0|||
155011355|NCT01891864|559465792|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155011356|NCT01891864|559465793|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
155011357|NCT01891864|559465794|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155011358|NCT01891864|559465795|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155011359|NCT01891864|559465796|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155011360|NCT01891864|559465797|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
155011361|NCT01891864|559465792|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
155011362|NCT01891864|559465793|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
155011363|NCT01891864|559465794|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155011364|NCT01891864|559465795|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155011365|NCT01891864|559465796|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155011366|NCT01891864|559465797|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
155011367|NCT01891864|559465792|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155011368|NCT01891864|559465793|FG001|Treatment Period 1|Withdrawal by Subject|5|||
155178519|NCT01159431|560091524|FG000|Overall Study|non-compliance|1|||
155151028|NCT02587520|559988174|FG014|Overall Study|Protocol Violation|0|||
155151029|NCT02587520|559988175|FG015|Overall Study|Protocol Violation|0|||
155151030|NCT02587520|559988176|FG016|Overall Study|Protocol Violation|0|||
155151031|NCT02587520|559988177|FG017|Overall Study|Protocol Violation|0|||
155151032|NCT02587520|559988160|FG000|Overall Study|Adverse Event|0|||
155151033|NCT02587520|559988161|FG001|Overall Study|Adverse Event|0|||
155151034|NCT02587520|559988162|FG002|Overall Study|Adverse Event|0|||
155151035|NCT02587520|559988163|FG003|Overall Study|Adverse Event|0|||
155151036|NCT02587520|559988164|FG004|Overall Study|Adverse Event|0|||
155151037|NCT02587520|559988165|FG005|Overall Study|Adverse Event|0|||
155151038|NCT02587520|559988166|FG006|Overall Study|Adverse Event|0|||
155151039|NCT02587520|559988167|FG007|Overall Study|Adverse Event|0|||
155151040|NCT02587520|559988168|FG008|Overall Study|Adverse Event|0|||
155151041|NCT02587520|559988169|FG009|Overall Study|Adverse Event|0|||
155151042|NCT02587520|559988170|FG010|Overall Study|Adverse Event|0|||
155151043|NCT02587520|559988171|FG011|Overall Study|Adverse Event|1|||
155151044|NCT02587520|559988172|FG012|Overall Study|Adverse Event|0|||
155151045|NCT02587520|559988173|FG013|Overall Study|Adverse Event|0|||
155151046|NCT02587520|559988174|FG014|Overall Study|Adverse Event|0|||
155151047|NCT02587520|559988175|FG015|Overall Study|Adverse Event|0|||
155151048|NCT02587520|559988176|FG016|Overall Study|Adverse Event|0|||
155151049|NCT02587520|559988177|FG017|Overall Study|Adverse Event|0|||
155151050|NCT02587520|559988160|FG000|Overall Study|Withdrawal by Subject|0|||
155151051|NCT02587520|559988161|FG001|Overall Study|Withdrawal by Subject|0|||
155151052|NCT02587520|559988162|FG002|Overall Study|Withdrawal by Subject|1|||
155151053|NCT02587520|559988163|FG003|Overall Study|Withdrawal by Subject|1|||
155151054|NCT02587520|559988164|FG004|Overall Study|Withdrawal by Subject|0|||
155151055|NCT02587520|559988165|FG005|Overall Study|Withdrawal by Subject|1|||
155151056|NCT02587520|559988166|FG006|Overall Study|Withdrawal by Subject|1|||
155151057|NCT02587520|559988167|FG007|Overall Study|Withdrawal by Subject|0|||
155151058|NCT02587520|559988168|FG008|Overall Study|Withdrawal by Subject|0|||
155151059|NCT02587520|559988169|FG009|Overall Study|Withdrawal by Subject|0|||
155151060|NCT02587520|559988170|FG010|Overall Study|Withdrawal by Subject|0|||
155151061|NCT02587520|559988171|FG011|Overall Study|Withdrawal by Subject|0|||
155151062|NCT02587520|559988172|FG012|Overall Study|Withdrawal by Subject|0|||
155151063|NCT02587520|559988173|FG013|Overall Study|Withdrawal by Subject|1|||
155151064|NCT02587520|559988174|FG014|Overall Study|Withdrawal by Subject|0|||
155151065|NCT02587520|559988175|FG015|Overall Study|Withdrawal by Subject|0|||
155151066|NCT02587520|559988176|FG016|Overall Study|Withdrawal by Subject|0|||
155151067|NCT02587520|559988177|FG017|Overall Study|Withdrawal by Subject|0|||
155151068|NCT02587520|559988160|FG000|Overall Study|Lost to Follow-up|0|||
155151069|NCT02587520|559988161|FG001|Overall Study|Lost to Follow-up|2|||
155151070|NCT02587520|559988162|FG002|Overall Study|Lost to Follow-up|0|||
155151071|NCT02587520|559988163|FG003|Overall Study|Lost to Follow-up|2|||
155151072|NCT02587520|559988164|FG004|Overall Study|Lost to Follow-up|0|||
155151073|NCT02587520|559988165|FG005|Overall Study|Lost to Follow-up|1|||
155151074|NCT02587520|559988166|FG006|Overall Study|Lost to Follow-up|1|||
155151075|NCT02587520|559988167|FG007|Overall Study|Lost to Follow-up|1|||
155151076|NCT02587520|559988168|FG008|Overall Study|Lost to Follow-up|0|||
155151077|NCT02587520|559988169|FG009|Overall Study|Lost to Follow-up|2|||
155151078|NCT02587520|559988170|FG010|Overall Study|Lost to Follow-up|2|||
155151079|NCT02587520|559988171|FG011|Overall Study|Lost to Follow-up|1|||
155151080|NCT02587520|559988172|FG012|Overall Study|Lost to Follow-up|0|||
155151081|NCT02587520|559988173|FG013|Overall Study|Lost to Follow-up|0|||
155151082|NCT02587520|559988174|FG014|Overall Study|Lost to Follow-up|0|||
155151083|NCT02587520|559988175|FG015|Overall Study|Lost to Follow-up|0|||
155151084|NCT02587520|559988176|FG016|Overall Study|Lost to Follow-up|0|||
155151085|NCT02587520|559988177|FG017|Overall Study|Lost to Follow-up|0|||
155151086|NCT00672555|559988178|FG000|Overall Study|Lost to Follow-up|4|||
155151087|NCT00672555|559988178|FG000|Overall Study|Did not want to answer questionnaire|2|||
155151088|NCT04516746|559988181|FG000|Overall Study|Randomized but not Treated|51|||
155151089|NCT04516746|559988182|FG001|Overall Study|Randomized but not Treated|19|||
155151090|NCT04516746|559988181|FG000|Overall Study|Adverse Event|0|||
155151091|NCT04516746|559988182|FG001|Overall Study|Adverse Event|1|||
155151092|NCT04516746|559988181|FG000|Overall Study|Death|62|||
155151093|NCT04516746|559988182|FG001|Overall Study|Death|32|||
155151094|NCT04516746|559988181|FG000|Overall Study|Lost to Follow-up|3431|||
155151095|NCT04516746|559988182|FG001|Overall Study|Lost to Follow-up|1831|||
155151096|NCT04516746|559988181|FG000|Overall Study|Withdrawal by Subject|1946|||
155151097|NCT04516746|559988182|FG001|Overall Study|Withdrawal by Subject|1696|||
155151098|NCT04516746|559988181|FG000|Overall Study|Physician Decision|10|||
155151099|NCT04516746|559988182|FG001|Overall Study|Physician Decision|8|||
155151100|NCT04516746|559988181|FG000|Overall Study|Other|35|||
155151101|NCT04516746|559988182|FG001|Overall Study|Other|16|||
155151102|NCT00446849|559988184|FG000|Acute Phase|Lack of Efficacy|64|||
155151103|NCT00446849|559988184|FG000|Acute Phase|Protocol Violation|10|||
155011369|NCT01891864|559465794|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155011370|NCT01891864|559465795|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155011371|NCT01891864|559465796|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155011372|NCT01891864|559465797|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155011373|NCT01891864|559465792|FG000|Treatment Period 1|Lost to Follow-up|1|||
155011374|NCT01891864|559465793|FG001|Treatment Period 1|Lost to Follow-up|0|||
155011375|NCT01891864|559465794|FG002|Treatment Period 1|Lost to Follow-up|0|||
155011376|NCT01891864|559465795|FG003|Treatment Period 1|Lost to Follow-up|0|||
155011377|NCT01891864|559465796|FG004|Treatment Period 1|Lost to Follow-up|0|||
155011378|NCT01891864|559465797|FG005|Treatment Period 1|Lost to Follow-up|0|||
155011379|NCT01891864|559465792|FG000|Treatment Period 2|Protocol Violation|0|||
155011380|NCT01891864|559465793|FG001|Treatment Period 2|Protocol Violation|0|||
155011381|NCT01891864|559465794|FG002|Treatment Period 2|Protocol Violation|0|||
155011382|NCT01891864|559465795|FG003|Treatment Period 2|Protocol Violation|1|||
155011383|NCT01891864|559465796|FG004|Treatment Period 2|Protocol Violation|0|||
155011384|NCT01891864|559465797|FG005|Treatment Period 2|Protocol Violation|0|||
155011385|NCT01891864|559465792|FG000|Treatment Period 2|Physician Decision|0|||
155011386|NCT01891864|559465793|FG001|Treatment Period 2|Physician Decision|0|||
155011387|NCT01891864|559465794|FG002|Treatment Period 2|Physician Decision|1|||
155011388|NCT01891864|559465795|FG003|Treatment Period 2|Physician Decision|0|||
155011389|NCT01891864|559465796|FG004|Treatment Period 2|Physician Decision|0|||
155011390|NCT01891864|559465797|FG005|Treatment Period 2|Physician Decision|0|||
155011391|NCT01891864|559465792|FG000|Treatment Period 2|Site Termination|0|||
155011392|NCT01891864|559465793|FG001|Treatment Period 2|Site Termination|0|||
155011393|NCT01891864|559465794|FG002|Treatment Period 2|Site Termination|1|||
155011394|NCT01891864|559465795|FG003|Treatment Period 2|Site Termination|2|||
155011395|NCT01891864|559465796|FG004|Treatment Period 2|Site Termination|0|||
155011396|NCT01891864|559465797|FG005|Treatment Period 2|Site Termination|0|||
155011397|NCT01891864|559465792|FG000|Treatment Period 2|Lack of Efficacy|0|||
155011398|NCT01891864|559465793|FG001|Treatment Period 2|Lack of Efficacy|0|||
155011399|NCT01891864|559465794|FG002|Treatment Period 2|Lack of Efficacy|1|||
155011400|NCT01891864|559465795|FG003|Treatment Period 2|Lack of Efficacy|0|||
155011401|NCT01891864|559465796|FG004|Treatment Period 2|Lack of Efficacy|1|||
155011402|NCT01891864|559465797|FG005|Treatment Period 2|Lack of Efficacy|0|||
155011403|NCT01891864|559465792|FG000|Treatment Period 2|Adverse Event|0|||
155011404|NCT01891864|559465793|FG001|Treatment Period 2|Adverse Event|0|||
155011405|NCT01891864|559465794|FG002|Treatment Period 2|Adverse Event|1|||
155011406|NCT01891864|559465795|FG003|Treatment Period 2|Adverse Event|2|||
155011407|NCT01891864|559465796|FG004|Treatment Period 2|Adverse Event|0|||
155011408|NCT01891864|559465797|FG005|Treatment Period 2|Adverse Event|4|||
155011409|NCT01891864|559465792|FG000|Treatment Period 2|Termination of Site|0|||
155011410|NCT01891864|559465793|FG001|Treatment Period 2|Termination of Site|0|||
155011411|NCT01891864|559465794|FG002|Treatment Period 2|Termination of Site|0|||
155011412|NCT01891864|559465795|FG003|Treatment Period 2|Termination of Site|0|||
155011413|NCT01891864|559465796|FG004|Treatment Period 2|Termination of Site|2|||
155011414|NCT01891864|559465797|FG005|Treatment Period 2|Termination of Site|0|||
155011415|NCT01891864|559465792|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155011416|NCT01891864|559465793|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155011417|NCT01891864|559465794|FG002|Treatment Period 2|Withdrawal by Subject|3|||
155011418|NCT01891864|559465795|FG003|Treatment Period 2|Withdrawal by Subject|4|||
155011419|NCT01891864|559465796|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155011420|NCT01891864|559465797|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155011421|NCT01891864|559465792|FG000|Extension Period|Lack of Efficacy|0|||
155011422|NCT01891864|559465793|FG001|Extension Period|Lack of Efficacy|0|||
155011423|NCT01891864|559465794|FG002|Extension Period|Lack of Efficacy|0|||
155011424|NCT01891864|559465795|FG003|Extension Period|Lack of Efficacy|1|||
155011425|NCT01891864|559465796|FG004|Extension Period|Lack of Efficacy|1|||
155011426|NCT01891864|559465797|FG005|Extension Period|Lack of Efficacy|0|||
155011427|NCT01891864|559465792|FG000|Extension Period|Pregnancy|0|||
155011428|NCT01891864|559465793|FG001|Extension Period|Pregnancy|0|||
155011429|NCT01891864|559465794|FG002|Extension Period|Pregnancy|1|||
155011430|NCT01891864|559465795|FG003|Extension Period|Pregnancy|0|||
155011431|NCT01891864|559465796|FG004|Extension Period|Pregnancy|0|||
155011432|NCT01891864|559465797|FG005|Extension Period|Pregnancy|0|||
155011433|NCT01891864|559465792|FG000|Extension Period|Adverse Event|0|||
155011434|NCT01891864|559465793|FG001|Extension Period|Adverse Event|0|||
155011435|NCT01891864|559465794|FG002|Extension Period|Adverse Event|4|||
155011436|NCT01891864|559465795|FG003|Extension Period|Adverse Event|2|||
155011437|NCT01891864|559465796|FG004|Extension Period|Adverse Event|2|||
155011438|NCT01891864|559465797|FG005|Extension Period|Adverse Event|0|||
155011439|NCT01891864|559465792|FG000|Extension Period|Withdrawal by Subject|0|||
155011440|NCT01891864|559465793|FG001|Extension Period|Withdrawal by Subject|0|||
155011441|NCT01891864|559465794|FG002|Extension Period|Withdrawal by Subject|1|||
155011442|NCT01891864|559465795|FG003|Extension Period|Withdrawal by Subject|2|||
155011443|NCT01891864|559465796|FG004|Extension Period|Withdrawal by Subject|4|||
155011444|NCT01891864|559465797|FG005|Extension Period|Withdrawal by Subject|0|||
155011445|NCT01891864|559465792|FG000|Extension Period|Lost to Follow-up|0|||
155131883|NCT00778895|559913045|FG001|Active Phase|Withdrawal by Subject|4|||
155131884|NCT00778895|559913046|FG002|Active Phase|Withdrawal by Subject|0|||
155131885|NCT00778895|559913044|FG000|Active Phase|Lost to Follow-up|1|||
155131886|NCT00778895|559913045|FG001|Active Phase|Lost to Follow-up|1|||
155131887|NCT00778895|559913046|FG002|Active Phase|Lost to Follow-up|0|||
155131888|NCT00778895|559913044|FG000|Active Phase|Other|2|||
155131889|NCT00778895|559913045|FG001|Active Phase|Other|0|||
155131890|NCT00778895|559913046|FG002|Active Phase|Other|0|||
155131891|NCT00778895|559913044|FG000|ESFU Phase|Adverse Event|2|||
155131892|NCT00778895|559913045|FG001|ESFU Phase|Adverse Event|1|||
155131893|NCT00778895|559913046|FG002|ESFU Phase|Adverse Event|0|||
155131894|NCT00778895|559913044|FG000|ESFU Phase|Withdrawal by Subject|1|||
155131895|NCT00778895|559913045|FG001|ESFU Phase|Withdrawal by Subject|4|||
155131896|NCT00778895|559913046|FG002|ESFU Phase|Withdrawal by Subject|0|||
155131897|NCT00778895|559913044|FG000|ESFU Phase|Lost to Follow-up|6|||
155131898|NCT00778895|559913045|FG001|ESFU Phase|Lost to Follow-up|7|||
155131899|NCT00778895|559913046|FG002|ESFU Phase|Lost to Follow-up|2|||
155131900|NCT00778895|559913044|FG000|ESFU Phase|Other|2|||
155131901|NCT00778895|559913045|FG001|ESFU Phase|Other|0|||
155131902|NCT00778895|559913046|FG002|ESFU Phase|Other|0|||
155131903|NCT01805037|559913049|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
155131904|NCT01805037|559913050|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
155131905|NCT01805037|559913049|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
155131906|NCT01805037|559913050|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
155131907|NCT01805037|559913049|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
155131908|NCT01805037|559913050|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
155131909|NCT01805037|559913049|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
155131910|NCT01805037|559913050|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
155131911|NCT01805037|559913049|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
155131912|NCT01805037|559913050|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
155131913|NCT01805037|559913049|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
155131914|NCT01805037|559913050|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
155131915|NCT01805037|559913049|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
155131916|NCT01805037|559913050|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
155131917|NCT01805037|559913049|FG000|Follow Up (up to 3 Years)|Death|0|||
155131918|NCT01805037|559913050|FG001|Follow Up (up to 3 Years)|Death|2|||
155131919|NCT01805037|559913049|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
155131920|NCT01805037|559913050|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
155131921|NCT01805037|559913049|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
155131922|NCT01805037|559913050|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
155131923|NCT01270256|559913051|FG000|Overall Study|Withdrawal by Subject|1|||
155131924|NCT01270256|559913052|FG001|Overall Study|Withdrawal by Subject|0|||
155131925|NCT02879578|559913053|FG000|Overall Study|Adverse Event|1|||
155131926|NCT02879578|559913054|FG001|Overall Study|Adverse Event|2|||
155131927|NCT02879578|559913055|FG002|Overall Study|Adverse Event|14|||
155131928|NCT02879578|559913053|FG000|Overall Study|Protocol Violation|0|||
155131929|NCT02879578|559913054|FG001|Overall Study|Protocol Violation|1|||
155131930|NCT02879578|559913055|FG002|Overall Study|Protocol Violation|1|||
155131931|NCT02879578|559913053|FG000|Overall Study|Withdrawal by Subject|8|||
155131932|NCT02879578|559913054|FG001|Overall Study|Withdrawal by Subject|6|||
155131933|NCT02879578|559913055|FG002|Overall Study|Withdrawal by Subject|9|||
155131934|NCT02879578|559913053|FG000|Overall Study|Lost to Follow-up|1|||
155131935|NCT02879578|559913054|FG001|Overall Study|Lost to Follow-up|0|||
155131936|NCT02879578|559913055|FG002|Overall Study|Lost to Follow-up|4|||
155131937|NCT02879578|559913053|FG000|Overall Study|Physician Decision|0|||
155131938|NCT02879578|559913054|FG001|Overall Study|Physician Decision|0|||
154923749|NCT03110107|559146291|FG014|Treatment Period|Participants no longer meets study criteria|0|||
154923750|NCT03110107|559146292|FG015|Treatment Period|Participants no longer meets study criteria|0|||
154923751|NCT03110107|559146293|FG016|Treatment Period|Participants no longer meets study criteria|0|||
154923752|NCT03110107|559146294|FG017|Treatment Period|Participants no longer meets study criteria|0|||
154923753|NCT03110107|559146295|FG018|Treatment Period|Participants no longer meets study criteria|0|||
154923754|NCT03110107|559146296|FG019|Treatment Period|Participants no longer meets study criteria|0|||
154923755|NCT03110107|559146297|FG020|Treatment Period|Participants no longer meets study criteria|0|||
155131939|NCT02879578|559913055|FG002|Overall Study|Physician Decision|4|||
155131940|NCT03517566|559913059|FG000|Overall Study|Adverse Event|5|||
155131941|NCT03517566|559913060|FG001|Overall Study|Adverse Event|2|||
155131942|NCT03517566|559913061|FG002|Overall Study|Adverse Event|2|||
155131943|NCT03517566|559913062|FG003|Overall Study|Adverse Event|8|||
155131944|NCT03517566|559913063|FG004|Overall Study|Adverse Event|7|||
155131945|NCT03517566|559913059|FG000|Overall Study|Lack of Efficacy|3|||
155131946|NCT03517566|559913060|FG001|Overall Study|Lack of Efficacy|2|||
155131947|NCT03517566|559913061|FG002|Overall Study|Lack of Efficacy|1|||
155131948|NCT03517566|559913062|FG003|Overall Study|Lack of Efficacy|1|||
155131949|NCT03517566|559913063|FG004|Overall Study|Lack of Efficacy|4|||
155178520|NCT01159431|560091525|FG001|Overall Study|non-compliance|1|||
155131950|NCT03517566|559913059|FG000|Overall Study|Lost to Follow-up|3|||
155131951|NCT03517566|559913060|FG001|Overall Study|Lost to Follow-up|1|||
155131952|NCT03517566|559913061|FG002|Overall Study|Lost to Follow-up|1|||
155131953|NCT03517566|559913062|FG003|Overall Study|Lost to Follow-up|1|||
155131954|NCT03517566|559913063|FG004|Overall Study|Lost to Follow-up|0|||
155131955|NCT03517566|559913059|FG000|Overall Study|Physician Decision|1|||
155131956|NCT03517566|559913060|FG001|Overall Study|Physician Decision|1|||
155131957|NCT03517566|559913061|FG002|Overall Study|Physician Decision|0|||
155131958|NCT03517566|559913062|FG003|Overall Study|Physician Decision|1|||
155131959|NCT03517566|559913063|FG004|Overall Study|Physician Decision|0|||
155131960|NCT03517566|559913059|FG000|Overall Study|Pregnancy|0|||
155131961|NCT03517566|559913060|FG001|Overall Study|Pregnancy|1|||
155131962|NCT03517566|559913061|FG002|Overall Study|Pregnancy|0|||
155131963|NCT03517566|559913062|FG003|Overall Study|Pregnancy|0|||
155131964|NCT03517566|559913063|FG004|Overall Study|Pregnancy|0|||
155131965|NCT03517566|559913059|FG000|Overall Study|Protocol Deviation|0|||
155131966|NCT03517566|559913060|FG001|Overall Study|Protocol Deviation|1|||
155131967|NCT03517566|559913061|FG002|Overall Study|Protocol Deviation|0|||
155131968|NCT03517566|559913062|FG003|Overall Study|Protocol Deviation|1|||
155131969|NCT03517566|559913063|FG004|Overall Study|Protocol Deviation|1|||
155131970|NCT03517566|559913059|FG000|Overall Study|Study terminated by Sponsor|11|||
155131971|NCT03517566|559913060|FG001|Overall Study|Study terminated by Sponsor|5|||
155131972|NCT03517566|559913061|FG002|Overall Study|Study terminated by Sponsor|6|||
155131973|NCT03517566|559913062|FG003|Overall Study|Study terminated by Sponsor|14|||
155131974|NCT03517566|559913063|FG004|Overall Study|Study terminated by Sponsor|12|||
155131975|NCT03517566|559913059|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
155131976|NCT03517566|559913060|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
155131977|NCT03517566|559913061|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
155131978|NCT03517566|559913062|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
155131979|NCT03517566|559913063|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
155131980|NCT04566692|559913064|FG000|Overall Study|Adverse Event|2|||
155131981|NCT04566692|559913065|FG001|Overall Study|Adverse Event|0|||
155131982|NCT04566692|559913064|FG000|Overall Study|Withdrawal by Subject|1|||
155131983|NCT04566692|559913065|FG001|Overall Study|Withdrawal by Subject|1|||
155131984|NCT00671437|559913066|FG000|Overall Study|Progressive disease before C1 week 8|8|||
155131985|NCT00671437|559913066|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
155131986|NCT00671437|559913066|FG000|Overall Study|Adverse Event|3|||
155131987|NCT00671437|559913066|FG000|Overall Study|Ineligible post-hoc|1|||
155131988|NCT00590577|559913067|FG000|Overall Study|Lack of Efficacy|31|||
155131989|NCT00590577|559913068|FG001|Overall Study|Lack of Efficacy|28|||
155131990|NCT00590577|559913069|FG002|Overall Study|Lack of Efficacy|23|||
155131991|NCT00590577|559913070|FG003|Overall Study|Lack of Efficacy|45|||
155131992|NCT00590577|559913067|FG000|Overall Study|Withdrawal by Subject|23|||
155131993|NCT00590577|559913068|FG001|Overall Study|Withdrawal by Subject|28|||
155131994|NCT00590577|559913069|FG002|Overall Study|Withdrawal by Subject|30|||
154923756|NCT03110107|559146298|FG021|Treatment Period|Participants no longer meets study criteria|0|||
154923757|NCT03110107|559146299|FG022|Treatment Period|Participants no longer meets study criteria|0|||
154923758|NCT03110107|559146300|FG023|Treatment Period|Participants no longer meets study criteria|1|||
154923759|NCT03110107|559146301|FG024|Treatment Period|Participants no longer meets study criteria|0|||
154923760|NCT03110107|559146302|FG025|Treatment Period|Participants no longer meets study criteria|0|||
154923761|NCT03110107|559146277|FG000|Treatment Period|Other Reasons|0|||
154923762|NCT03110107|559146278|FG001|Treatment Period|Other Reasons|0|||
154923763|NCT03110107|559146279|FG002|Treatment Period|Other Reasons|1|||
154923764|NCT03110107|559146280|FG003|Treatment Period|Other Reasons|1|||
155011446|NCT01891864|559465793|FG001|Extension Period|Lost to Follow-up|0|||
155011447|NCT01891864|559465794|FG002|Extension Period|Lost to Follow-up|2|||
155011448|NCT01891864|559465795|FG003|Extension Period|Lost to Follow-up|0|||
155011449|NCT01891864|559465796|FG004|Extension Period|Lost to Follow-up|0|||
154923765|NCT03110107|559146281|FG004|Treatment Period|Other Reasons|0|||
154923766|NCT03110107|559146282|FG005|Treatment Period|Other Reasons|1|||
154923767|NCT03110107|559146283|FG006|Treatment Period|Other Reasons|0|||
154923768|NCT03110107|559146284|FG007|Treatment Period|Other Reasons|0|||
154923769|NCT03110107|559146285|FG008|Treatment Period|Other Reasons|0|||
154923770|NCT03110107|559146286|FG009|Treatment Period|Other Reasons|0|||
154923771|NCT03110107|559146287|FG010|Treatment Period|Other Reasons|0|||
154923772|NCT03110107|559146288|FG011|Treatment Period|Other Reasons|0|||
154923773|NCT03110107|559146289|FG012|Treatment Period|Other Reasons|0|||
154923774|NCT03110107|559146290|FG013|Treatment Period|Other Reasons|0|||
154923775|NCT03110107|559146291|FG014|Treatment Period|Other Reasons|0|||
154923776|NCT03110107|559146292|FG015|Treatment Period|Other Reasons|0|||
154923777|NCT03110107|559146293|FG016|Treatment Period|Other Reasons|0|||
155131995|NCT00590577|559913070|FG003|Overall Study|Withdrawal by Subject|26|||
155131996|NCT00590577|559913067|FG000|Overall Study|Adverse Event|10|||
155131997|NCT00590577|559913068|FG001|Overall Study|Adverse Event|10|||
155131998|NCT00590577|559913069|FG002|Overall Study|Adverse Event|13|||
154923778|NCT03110107|559146294|FG017|Treatment Period|Other Reasons|0|||
155131999|NCT00590577|559913070|FG003|Overall Study|Adverse Event|11|||
155132000|NCT00590577|559913067|FG000|Overall Study|Lost to Follow-up|12|||
155132001|NCT00590577|559913068|FG001|Overall Study|Lost to Follow-up|6|||
155011450|NCT01891864|559465797|FG005|Extension Period|Lost to Follow-up|0|||
155011451|NCT04720105|559465799|FG000|Overall Study|Lack of Efficacy|1|||
155011452|NCT04720105|559465799|FG000|Overall Study|Lost to Follow-up|1|||
155132002|NCT00590577|559913069|FG002|Overall Study|Lost to Follow-up|6|||
155132003|NCT00590577|559913070|FG003|Overall Study|Lost to Follow-up|9|||
155132004|NCT00590577|559913067|FG000|Overall Study|Pregnancy|0|||
155132005|NCT00590577|559913068|FG001|Overall Study|Pregnancy|1|||
155011453|NCT04720105|559465799|FG000|Overall Study|Withdrawal by Subject|3|||
155011454|NCT02892331|559465800|FG000|Overall Study|Withdrawal by Subject|0|||
155011455|NCT02892331|559465801|FG001|Overall Study|Withdrawal by Subject|1|||
155011456|NCT02892331|559465802|FG002|Overall Study|Withdrawal by Subject|1|||
155011457|NCT02892331|559465800|FG000|Overall Study|Sick family member|0|||
155011458|NCT02892331|559465801|FG001|Overall Study|Sick family member|0|||
155011459|NCT02892331|559465802|FG002|Overall Study|Sick family member|1|||
155011460|NCT02892331|559465800|FG000|Overall Study|Corona virus pandemic|1|||
155011461|NCT02892331|559465801|FG001|Overall Study|Corona virus pandemic|0|||
155011462|NCT02892331|559465802|FG002|Overall Study|Corona virus pandemic|1|||
155011463|NCT02892331|559465800|FG000|Overall Study|Lost to Follow-up|1|||
155011464|NCT02892331|559465801|FG001|Overall Study|Lost to Follow-up|0|||
155011465|NCT02892331|559465802|FG002|Overall Study|Lost to Follow-up|1|||
155011466|NCT02892331|559465800|FG000|Overall Study|Blood pressure was too elevated|0|||
155011467|NCT02892331|559465801|FG001|Overall Study|Blood pressure was too elevated|1|||
155011468|NCT02892331|559465802|FG002|Overall Study|Blood pressure was too elevated|0|||
155011469|NCT02892331|559465800|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
155011470|NCT02892331|559465801|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
155011471|NCT02892331|559465802|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
155011472|NCT04563754|559467922|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
155011473|NCT04563754|559467923|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
155011474|NCT04563754|559467924|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
155011475|NCT04563754|559467922|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
155011476|NCT04563754|559467923|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
155011477|NCT04563754|559467924|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
155011478|NCT04563754|559467922|FG000|Follow up|Lost to Follow-up|61|||
155011479|NCT04563754|559467923|FG001|Follow up|Lost to Follow-up|23|||
155011480|NCT04563754|559467924|FG002|Follow up|Lost to Follow-up|5|||
155011481|NCT04563754|559467922|FG000|Follow up|Death|0|||
155011482|NCT04563754|559467923|FG001|Follow up|Death|2|||
155011483|NCT04563754|559467924|FG002|Follow up|Death|0|||
155011484|NCT04563754|559467922|FG000|Follow up|Ongoing|0|||
155011485|NCT04563754|559467923|FG001|Follow up|Ongoing|28|||
155011486|NCT04563754|559467924|FG002|Follow up|Ongoing|0|||
155011487|NCT04023396|559467925|FG000|Overall Study|Adverse Event|16|||
155011488|NCT04023396|559467925|FG000|Overall Study|Death|1|||
155011489|NCT04023396|559467925|FG000|Overall Study|Lost to Follow-up|1|||
155011490|NCT04023396|559467925|FG000|Overall Study|Withdrawal by Subject|14|||
155011491|NCT04023396|559467925|FG000|Overall Study|Pregnancy|4|||
155011492|NCT04023396|559467925|FG000|Overall Study|Lack of Efficacy|3|||
155011493|NCT04023396|559467925|FG000|Overall Study|Physician Decision|4|||
155011494|NCT04023396|559467925|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
155011495|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
155011496|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
155011497|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
155011498|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
155011499|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
155011500|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
155011501|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
155011502|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
155011503|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
155132006|NCT00590577|559913069|FG002|Overall Study|Pregnancy|0|||
155132007|NCT00590577|559913070|FG003|Overall Study|Pregnancy|0|||
155132008|NCT00590577|559913067|FG000|Overall Study|Various reasons|1|||
155011504|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
155011505|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
155011506|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
155132009|NCT00590577|559913068|FG001|Overall Study|Various reasons|3|||
155011507|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
155011508|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
155132010|NCT00590577|559913069|FG002|Overall Study|Various reasons|1|||
155132011|NCT00590577|559913070|FG003|Overall Study|Various reasons|2|||
155132012|NCT01704456|559913074|FG000|Overall Study|Lost to Follow-up|8|||
155132013|NCT01704456|559913075|FG001|Overall Study|Lost to Follow-up|14|||
155132014|NCT03908970|559913078|FG000|Overall Study|Adverse Event|7|||
155011509|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
155011510|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
155011511|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
155011512|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
155011513|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
155011514|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
155011515|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
155011516|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
155011517|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
155011518|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
155011519|NCT02513160|559467926|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
155011520|NCT02513160|559467927|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
155011521|NCT02513160|559467928|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
155011522|NCT02513160|559467929|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
155011523|NCT02513160|559467926|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
155011524|NCT02513160|559467927|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
155011525|NCT02513160|559467928|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
155011526|NCT02513160|559467929|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
155011527|NCT02513160|559467926|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
155011528|NCT02513160|559467927|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
155011529|NCT02513160|559467928|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
155011530|NCT02513160|559467929|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
155011531|NCT02513160|559467926|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
155011532|NCT02513160|559467927|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
155011533|NCT02513160|559467928|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
155011534|NCT02513160|559467929|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
155011535|NCT02513160|559467926|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
155011536|NCT02513160|559467927|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
155011537|NCT02513160|559467928|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
155011538|NCT02513160|559467929|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
155011539|NCT02513160|559467926|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
155011540|NCT02513160|559467927|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
155011541|NCT02513160|559467928|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
155011542|NCT02513160|559467929|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
155011543|NCT02861586|559467933|FG000|Overall Study|Withdrawal by Subject|1|||
155011544|NCT02861586|559467934|FG001|Overall Study|Withdrawal by Subject|2|||
155011545|NCT02861586|559467935|FG002|Overall Study|Withdrawal by Subject|0|||
155011546|NCT02861586|559467936|FG003|Overall Study|Withdrawal by Subject|0|||
155011547|NCT02861586|559467937|FG004|Overall Study|Withdrawal by Subject|0|||
155011548|NCT02861586|559467938|FG005|Overall Study|Withdrawal by Subject|1|||
155011549|NCT02861586|559467939|FG006|Overall Study|Withdrawal by Subject|1|||
155011550|NCT02861586|559467940|FG007|Overall Study|Withdrawal by Subject|0|||
155011551|NCT02861586|559467933|FG000|Overall Study|Lost to Follow-up|3|||
155011552|NCT02861586|559467934|FG001|Overall Study|Lost to Follow-up|1|||
155011553|NCT02861586|559467935|FG002|Overall Study|Lost to Follow-up|1|||
155011554|NCT02861586|559467936|FG003|Overall Study|Lost to Follow-up|0|||
155011555|NCT02861586|559467937|FG004|Overall Study|Lost to Follow-up|0|||
155011556|NCT02861586|559467938|FG005|Overall Study|Lost to Follow-up|3|||
155011557|NCT02861586|559467939|FG006|Overall Study|Lost to Follow-up|0|||
155011558|NCT02861586|559467940|FG007|Overall Study|Lost to Follow-up|0|||
155011559|NCT02861586|559467933|FG000|Overall Study|Adverse Event|0|||
155011560|NCT02861586|559467934|FG001|Overall Study|Adverse Event|0|||
155011561|NCT02861586|559467935|FG002|Overall Study|Adverse Event|0|||
155011562|NCT02861586|559467936|FG003|Overall Study|Adverse Event|0|||
155011563|NCT02861586|559467937|FG004|Overall Study|Adverse Event|0|||
155011564|NCT02861586|559467938|FG005|Overall Study|Adverse Event|1|||
155011565|NCT02861586|559467939|FG006|Overall Study|Adverse Event|0|||
155011566|NCT02861586|559467940|FG007|Overall Study|Adverse Event|0|||
155011567|NCT02243605|559467942|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
155011568|NCT02243605|559467943|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
155011569|NCT02243605|559467942|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
155011570|NCT02243605|559467943|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
155011571|NCT02243605|559467942|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
155011572|NCT02243605|559467943|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
155011573|NCT02243605|559467942|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
155011574|NCT02243605|559467943|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
155011575|NCT02243605|559467942|FG000|Stage 2 - Final Analysis Population|Progression|0|||
155011576|NCT02243605|559467943|FG001|Stage 2 - Final Analysis Population|Progression|1|||
155011577|NCT04173507|559467944|FG000|Overall Study|On Treatment|3|||
155011578|NCT04173507|559467944|FG000|Overall Study|Adverse Event|3|||
155011579|NCT04173507|559467944|FG000|Overall Study|Progression/Relapse|34|||
155011580|NCT04173507|559467944|FG000|Overall Study|Death|2|||
155011581|NCT01823328|559467945|FG000|Overall Study|Withdrawal by Subject|8|||
155011582|NCT01823328|559467946|FG001|Overall Study|Withdrawal by Subject|6|||
155011583|NCT01417156|559467947|FG000|Overall Study|Adverse Event|12|||
155011584|NCT01417156|559467947|FG000|Overall Study|Protocol Violation|2|||
155011585|NCT03192488|559467948|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
155011586|NCT03192488|559467949|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
155011587|NCT03192488|559467950|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
155011588|NCT03192488|559467951|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
155011589|NCT03192488|559467952|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
155011590|NCT03192488|559467953|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
155011591|NCT03192488|559467948|FG000|Third Intervention (d1)|Adverse Event|0|||
155011592|NCT03192488|559467949|FG001|Third Intervention (d1)|Adverse Event|0|||
155011593|NCT03192488|559467950|FG002|Third Intervention (d1)|Adverse Event|0|||
155011594|NCT03192488|559467951|FG003|Third Intervention (d1)|Adverse Event|0|||
155011595|NCT03192488|559467952|FG004|Third Intervention (d1)|Adverse Event|1|||
155011596|NCT03192488|559467953|FG005|Third Intervention (d1)|Adverse Event|0|||
155011597|NCT03664232|559467964|FG000|Overall Study|Withdrawal by Subject|0|||
155011598|NCT03664232|559467965|FG001|Overall Study|Withdrawal by Subject|1|||
155011599|NCT03664232|559467966|FG002|Overall Study|Withdrawal by Subject|0|||
155011600|NCT03664232|559467967|FG003|Overall Study|Withdrawal by Subject|1|||
155011601|NCT03664232|559467964|FG000|Overall Study|Adverse Event|0|||
155011602|NCT03664232|559467965|FG001|Overall Study|Adverse Event|0|||
155011603|NCT03664232|559467966|FG002|Overall Study|Adverse Event|1|||
155011604|NCT03664232|559467967|FG003|Overall Study|Adverse Event|0|||
155011605|NCT03664232|559467964|FG000|Overall Study|Other-Non-compliance with study drug|0|||
155011606|NCT03664232|559467965|FG001|Overall Study|Other-Non-compliance with study drug|1|||
155011607|NCT03664232|559467966|FG002|Overall Study|Other-Non-compliance with study drug|0|||
155011608|NCT03664232|559467967|FG003|Overall Study|Other-Non-compliance with study drug|2|||
155011609|NCT03664232|559467964|FG000|Overall Study|Other-Unspecified|0|||
155011610|NCT03664232|559467965|FG001|Overall Study|Other-Unspecified|3|||
155011611|NCT03664232|559467966|FG002|Overall Study|Other-Unspecified|0|||
155011612|NCT03664232|559467967|FG003|Overall Study|Other-Unspecified|1|||
155011613|NCT03664232|559467964|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
155011614|NCT03664232|559467965|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
155011615|NCT03664232|559467966|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
155011616|NCT03664232|559467967|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
155011617|NCT01439802|559467968|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
155011618|NCT01439802|559467968|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
155011619|NCT02003209|559467972|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
155011620|NCT02003209|559467973|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
155011621|NCT00638508|559467974|FG000|Overall Study|Physician Decision|5|||
155011622|NCT00638508|559467975|FG001|Overall Study|Physician Decision|2|||
155011623|NCT03500198|559467978|FG000|Overall Study|Lost to Follow-up|0|||
155011624|NCT03500198|559467979|FG001|Overall Study|Lost to Follow-up|1|||
155011625|NCT00654095|559467980|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
155011626|NCT00654095|559467980|FG000|Overall Study|Elevated triglyceride level (2)|1|||
155011627|NCT00654095|559467980|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
155011628|NCT00654095|559467980|FG000|Overall Study|Adverse Event|11|||
155011629|NCT00654095|559467980|FG000|Overall Study|Withdrawal by Subject|5|||
155011630|NCT00654095|559467980|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
155011631|NCT00654095|559467980|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
155011632|NCT00654095|559467980|FG000|Overall Study|Did not meet inclusion criteria|1|||
155011633|NCT00595621|559467986|FG000|Open Label Run in|Adverse Event|1|||
155011634|NCT00595621|559467987|FG001|Open Label Run in|Adverse Event|0|||
155011635|NCT00595621|559467986|FG000|Open Label Run in|Physician Decision|1|||
155011636|NCT00595621|559467987|FG001|Open Label Run in|Physician Decision|0|||
155011637|NCT00595621|559467986|FG000|Open Label Run in|Withdrawal by Subject|1|||
155011638|NCT00595621|559467987|FG001|Open Label Run in|Withdrawal by Subject|0|||
155011639|NCT00595621|559467986|FG000|Randomization and Study|Adverse Event|2|||
155011640|NCT00595621|559467987|FG001|Randomization and Study|Adverse Event|0|||
155011641|NCT00595621|559467986|FG000|Randomization and Study|Withdrawal by Subject|0|||
155011642|NCT00595621|559467987|FG001|Randomization and Study|Withdrawal by Subject|1|||
155011643|NCT00324987|559467988|FG000|Overall Study|Adverse Event|2|||
155011644|NCT00324987|559467989|FG001|Overall Study|Adverse Event|1|||
155011645|NCT00324987|559467988|FG000|Overall Study|Withdrawal by Subject|1|||
155011646|NCT00324987|559467989|FG001|Overall Study|Withdrawal by Subject|1|||
155011647|NCT00324987|559467988|FG000|Overall Study|Progression|1|||
155011648|NCT00324987|559467989|FG001|Overall Study|Progression|1|||
155011649|NCT00324987|559467988|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
155011650|NCT00324987|559467989|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
155011651|NCT01254643|559467991|FG000|Overall Study|Withdrawal by Subject|1|||
155011652|NCT03359850|559467994|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
155011653|NCT03359850|559467995|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
155132015|NCT03908970|559913079|FG001|Overall Study|Adverse Event|21|||
155132016|NCT03908970|559913078|FG000|Overall Study|Physician Decision|1|||
155132017|NCT03908970|559913079|FG001|Overall Study|Physician Decision|4|||
155132018|NCT03908970|559913078|FG000|Overall Study|Withdrawal by Subject|9|||
155132019|NCT03908970|559913079|FG001|Overall Study|Withdrawal by Subject|22|||
155132020|NCT02126839|559913086|FG000|Overall Study|Adverse Event|0|||
155132021|NCT02126839|559913087|FG001|Overall Study|Adverse Event|1|||
155132022|NCT02126839|559913086|FG000|Overall Study|Withdrawal by Subject|1|||
155132023|NCT02126839|559913087|FG001|Overall Study|Withdrawal by Subject|0|||
155132024|NCT02126839|559913086|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155132025|NCT02126839|559913087|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155132026|NCT02126839|559913086|FG000|Overall Study|Protocol Violation|2|||
155132027|NCT02126839|559913087|FG001|Overall Study|Protocol Violation|3|||
154923779|NCT03110107|559146295|FG018|Treatment Period|Other Reasons|0|||
154923780|NCT03110107|559146296|FG019|Treatment Period|Other Reasons|0|||
154923781|NCT03110107|559146297|FG020|Treatment Period|Other Reasons|0|||
154923782|NCT03110107|559146298|FG021|Treatment Period|Other Reasons|0|||
154923783|NCT03110107|559146299|FG022|Treatment Period|Other Reasons|0|||
154923784|NCT03110107|559146300|FG023|Treatment Period|Other Reasons|0|||
154923785|NCT03110107|559146301|FG024|Treatment Period|Other Reasons|1|||
154923786|NCT03110107|559146302|FG025|Treatment Period|Other Reasons|0|||
154923787|NCT03927989|559146305|FG000|Overall Study|Withdrawal by Subject|0|||
154923788|NCT03927989|559146306|FG001|Overall Study|Withdrawal by Subject|1|||
154923789|NCT02593175|559146307|FG000|Overall Study|Adverse Event|5|||
154923790|NCT02593175|559146307|FG000|Overall Study|Disease progression|4|||
154923791|NCT03772574|559146311|FG000|Overall Study|Protocol Violation|2|||
154923792|NCT03772574|559146312|FG001|Overall Study|Protocol Violation|0|||
154923793|NCT03772574|559146313|FG002|Overall Study|Protocol Violation|0|||
154923794|NCT03772574|559146311|FG000|Overall Study|Discomfort|0|||
154923795|NCT03772574|559146312|FG001|Overall Study|Discomfort|5|||
154923796|NCT03772574|559146313|FG002|Overall Study|Discomfort|4|||
154923797|NCT03586427|559146316|FG000|Overall Study|Lost to Follow-up|0|||
154923798|NCT03586427|559146317|FG001|Overall Study|Lost to Follow-up|3|||
154923799|NCT03586427|559146318|FG002|Overall Study|Lost to Follow-up|1|||
154923800|NCT03586427|559146319|FG003|Overall Study|Lost to Follow-up|3|||
154923801|NCT03586427|559146320|FG004|Overall Study|Lost to Follow-up|3|||
154923802|NCT03586427|559146316|FG000|Overall Study|Withdrawal by Subject|0|||
154923803|NCT03586427|559146317|FG001|Overall Study|Withdrawal by Subject|1|||
154923804|NCT03586427|559146318|FG002|Overall Study|Withdrawal by Subject|2|||
154923805|NCT03586427|559146319|FG003|Overall Study|Withdrawal by Subject|1|||
154923806|NCT03586427|559146320|FG004|Overall Study|Withdrawal by Subject|1|||
154923807|NCT03586427|559146316|FG000|Overall Study|Adverse Event|0|||
154923808|NCT03586427|559146317|FG001|Overall Study|Adverse Event|0|||
154923809|NCT03586427|559146318|FG002|Overall Study|Adverse Event|1|||
154923810|NCT03586427|559146319|FG003|Overall Study|Adverse Event|0|||
154923811|NCT03586427|559146320|FG004|Overall Study|Adverse Event|0|||
154923812|NCT03586427|559146316|FG000|Overall Study|Protocol Violation|0|||
154923813|NCT03586427|559146317|FG001|Overall Study|Protocol Violation|0|||
154923814|NCT03586427|559146318|FG002|Overall Study|Protocol Violation|1|||
154923815|NCT03586427|559146319|FG003|Overall Study|Protocol Violation|0|||
154923816|NCT03586427|559146320|FG004|Overall Study|Protocol Violation|1|||
154923817|NCT03586427|559146316|FG000|Overall Study|Noncompliance with study drug|0|||
154923818|NCT03586427|559146317|FG001|Overall Study|Noncompliance with study drug|0|||
154923819|NCT03586427|559146318|FG002|Overall Study|Noncompliance with study drug|1|||
154923820|NCT03586427|559146319|FG003|Overall Study|Noncompliance with study drug|0|||
154923821|NCT03586427|559146320|FG004|Overall Study|Noncompliance with study drug|0|||
154923822|NCT03193996|559146321|FG000|Overall Study|Withdrawal by Subject|4|||
154923823|NCT03193996|559146321|FG000|Overall Study|Lost to Follow-up|4|||
154923824|NCT03193996|559146321|FG000|Overall Study|Physician Decision|2|||
154923825|NCT03193996|559146321|FG000|Overall Study|Pregnancy|1|||
154923826|NCT03193996|559146321|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
154923827|NCT03193996|559146321|FG000|Overall Study|Complicating disease|1|||
154923828|NCT00593385|559146324|FG000|Overall Study|Death|14|||
154923829|NCT00593385|559146324|FG000|Overall Study|Lost to Follow-up|17|||
154923830|NCT00593385|559146324|FG000|Overall Study|Withdrawal by Subject|9|||
154923831|NCT01471197|559146325|FG000|Overall Study|Disease Progression|4|||
154923832|NCT01471197|559146326|FG001|Overall Study|Disease Progression|2|||
154923833|NCT01471197|559146325|FG000|Overall Study|Death|1|||
154923834|NCT01471197|559146326|FG001|Overall Study|Death|0|||
154923835|NCT01471197|559146325|FG000|Overall Study|Study Drug Toxicity|1|||
154923836|NCT01471197|559146326|FG001|Overall Study|Study Drug Toxicity|0|||
154923837|NCT00924313|559146329|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
154923838|NCT01298362|559146333|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
154923839|NCT01298362|559146334|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
154923840|NCT01453296|559146338|FG000|Treatment Period 1|Adverse Event|0|||
154923841|NCT01453296|559146339|FG001|Treatment Period 1|Adverse Event|1|||
154923842|NCT01453296|559146338|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
155132028|NCT02126839|559913086|FG000|Overall Study|Sponsor request|0|||
155011654|NCT03359850|559467994|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
155011655|NCT03359850|559467995|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
155011656|NCT03359850|559467994|FG000|Extension Phase (Up to 28 Months)|Death|2|||
155011657|NCT03359850|559467995|FG001|Extension Phase (Up to 28 Months)|Death|4|||
155011658|NCT03359850|559467994|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
155011659|NCT03359850|559467995|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
155011660|NCT03359850|559467994|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
155011661|NCT03359850|559467995|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
155011662|NCT03817125|559468010|FG000|Overall Study|Adverse Event|1|||
155011663|NCT03817125|559468011|FG001|Overall Study|Adverse Event|0|||
155011664|NCT03817125|559468010|FG000|Overall Study|Physician Decision|0|||
155011665|NCT03817125|559468011|FG001|Overall Study|Physician Decision|1|||
155011666|NCT03817125|559468010|FG000|Overall Study|Lack of Efficacy|1|||
155011667|NCT03817125|559468011|FG001|Overall Study|Lack of Efficacy|5|||
155011668|NCT00942084|559468012|FG000|Overall Study|Death|2|||
155011669|NCT01062425|559468013|FG000|Overall Study|Protocol Violation|3|||
155011670|NCT01062425|559468014|FG001|Overall Study|Protocol Violation|6|||
155011671|NCT02383017|559468015|FG000|Overall Study|Injury Sustained Outside Study|1|||
155011672|NCT02383017|559468016|FG001|Overall Study|Injury Sustained Outside Study|0|||
155011673|NCT02383017|559468015|FG000|Overall Study|Compliance|3|||
155011674|NCT02383017|559468016|FG001|Overall Study|Compliance|2|||
155011675|NCT02383017|559468015|FG000|Overall Study|Found to be Hypogonadal|1|||
155011676|NCT02383017|559468016|FG001|Overall Study|Found to be Hypogonadal|0|||
155011677|NCT01037218|559468019|FG000|Overall Study|Adverse Event|4|||
155011678|NCT01037218|559468020|FG001|Overall Study|Adverse Event|2|||
155011679|NCT01037218|559468021|FG002|Overall Study|Adverse Event|2|||
155011680|NCT01037218|559468022|FG003|Overall Study|Adverse Event|1|||
155011681|NCT01037218|559468019|FG000|Overall Study|Lack of Efficacy|0|||
155011682|NCT01037218|559468020|FG001|Overall Study|Lack of Efficacy|2|||
155011683|NCT01037218|559468021|FG002|Overall Study|Lack of Efficacy|1|||
155011684|NCT01037218|559468022|FG003|Overall Study|Lack of Efficacy|5|||
155011685|NCT01037218|559468019|FG000|Overall Study|Lost to Follow-up|3|||
155011686|NCT01037218|559468020|FG001|Overall Study|Lost to Follow-up|5|||
155011687|NCT01037218|559468021|FG002|Overall Study|Lost to Follow-up|4|||
155011688|NCT01037218|559468022|FG003|Overall Study|Lost to Follow-up|2|||
155011689|NCT01037218|559468019|FG000|Overall Study|Withdrawal by Subject|6|||
155011690|NCT01037218|559468020|FG001|Overall Study|Withdrawal by Subject|7|||
155011691|NCT01037218|559468021|FG002|Overall Study|Withdrawal by Subject|7|||
155011692|NCT01037218|559468022|FG003|Overall Study|Withdrawal by Subject|4|||
155011693|NCT01037218|559468019|FG000|Overall Study|Partner Withdrew Consent|0|||
155011694|NCT01037218|559468020|FG001|Overall Study|Partner Withdrew Consent|3|||
155011695|NCT01037218|559468021|FG002|Overall Study|Partner Withdrew Consent|2|||
155011696|NCT01037218|559468022|FG003|Overall Study|Partner Withdrew Consent|1|||
155011697|NCT01037218|559468019|FG000|Overall Study|Protocol Violation|0|||
155011698|NCT01037218|559468020|FG001|Overall Study|Protocol Violation|0|||
155011699|NCT01037218|559468021|FG002|Overall Study|Protocol Violation|2|||
155011700|NCT01037218|559468022|FG003|Overall Study|Protocol Violation|2|||
155011701|NCT01037218|559468019|FG000|Overall Study|Various|3|||
155011702|NCT01037218|559468020|FG001|Overall Study|Various|2|||
155011703|NCT01037218|559468021|FG002|Overall Study|Various|3|||
155011704|NCT01037218|559468022|FG003|Overall Study|Various|1|||
155011705|NCT02568072|559468023|FG000|Overall Study|Unavailable for appointment|23|||
155011706|NCT02568072|559468023|FG000|Overall Study|Unable to contact|3|||
155011707|NCT02568072|559468023|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
155011708|NCT02568072|559468023|FG000|Overall Study|Withdrawal by Subject|1|||
155011709|NCT02568072|559468023|FG000|Overall Study|Sustained injury, marathon not run|24|||
155011710|NCT00927589|559468024|FG000|Overall Study|Death|1|||
155178521|NCT01159431|560091524|FG000|Overall Study|Lack of Efficacy|0|||
155011711|NCT00927589|559468024|FG000|Overall Study|Physician Decision|1|||
155011712|NCT00927589|559468024|FG000|Overall Study|Withdrawal by Subject|3|||
155011713|NCT00927589|559468024|FG000|Overall Study|Adverse Event|2|||
155011714|NCT00927589|559468024|FG000|Overall Study|Disease Progression|8|||
155011715|NCT00927589|559468024|FG000|Overall Study|Non-compliance|1|||
155011716|NCT05263908|559468026|FG000|Overall Study|No informed consent for publication of study results|397|||
155011717|NCT05263908|559468026|FG000|Overall Study|CRF not collected|1|||
155011718|NCT01641640|559468027|FG000|Overall Study|Enrolled but not treated|1|||
155011719|NCT01641640|559468027|FG000|Overall Study|Efficacy failure|29|||
155011720|NCT01641640|559468027|FG000|Overall Study|Lost to Follow-up|3|||
155011721|NCT01641640|559468027|FG000|Overall Study|Withdrawal by Subject|2|||
155011722|NCT01641640|559468027|FG000|Overall Study|Adverse Event|1|||
155011723|NCT01234350|559468029|FG000|Overall Study|Adverse Event|277|||
155011724|NCT01234350|559468030|FG001|Overall Study|Adverse Event|92|||
155011725|NCT01234350|559468029|FG000|Overall Study|Withdrawal by Subject|61|||
155011726|NCT01234350|559468030|FG001|Overall Study|Withdrawal by Subject|36|||
155011727|NCT01234350|559468029|FG000|Overall Study|Lost to Follow-up|115|||
155011728|NCT01234350|559468030|FG001|Overall Study|Lost to Follow-up|47|||
155178522|NCT01159431|560091525|FG001|Overall Study|Lack of Efficacy|3|||
155011729|NCT01234350|559468029|FG000|Overall Study|Covers a diverse set of reasons|234|||
155011730|NCT01234350|559468030|FG001|Overall Study|Covers a diverse set of reasons|92|||
155011731|NCT01199939|559468031|FG000|Overall Study|Adverse Event|4|||
155011732|NCT01199939|559468031|FG000|Overall Study|Protocol Violation|3|||
155011733|NCT01199939|559468031|FG000|Overall Study|Lost to Follow-up|2|||
155011734|NCT01199939|559468031|FG000|Overall Study|Reached a virologic endpoint|4|||
155011735|NCT01960413|559468032|FG000|Overall Study|Withdrawal by Subject|1|||
155011736|NCT01960413|559468033|FG001|Overall Study|Withdrawal by Subject|1|||
155011737|NCT01960413|559468032|FG000|Overall Study|Physician Decision|1|||
155011738|NCT01960413|559468033|FG001|Overall Study|Physician Decision|0|||
155011739|NCT01960413|559468032|FG000|Overall Study|Lost to Follow-up|2|||
155011740|NCT01960413|559468033|FG001|Overall Study|Lost to Follow-up|0|||
155011741|NCT00791778|559468034|FG000|Double-blind Treatment|Adverse Event|49|||
155011742|NCT00791778|559468035|FG001|Double-blind Treatment|Adverse Event|9|||
155011743|NCT00791778|559468034|FG000|Double-blind Treatment|Physician Decision|6|||
155011744|NCT00791778|559468035|FG001|Double-blind Treatment|Physician Decision|26|||
155011745|NCT00791778|559468034|FG000|Double-blind Treatment|Protocol Violation|0|||
155011746|NCT00791778|559468035|FG001|Double-blind Treatment|Protocol Violation|4|||
155011747|NCT00791778|559468034|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
155011748|NCT00791778|559468035|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
155011749|NCT00791778|559468034|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
155011750|NCT00791778|559468035|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
155011751|NCT00791778|559468034|FG000|Follow-up|Withdrawal by Subject|3|||
155011752|NCT00791778|559468035|FG001|Follow-up|Withdrawal by Subject|0|||
155011753|NCT00791778|559468034|FG000|Follow-up|Lost to Follow-up|2|||
155011754|NCT00791778|559468035|FG001|Follow-up|Lost to Follow-up|1|||
155011755|NCT03051100|559468036|FG000|Overall Study|Withdrawal by Subject|1|||
155011756|NCT03051100|559468037|FG001|Overall Study|Withdrawal by Subject|0|||
155011757|NCT03335475|559468038|FG000|Overall Study|Did not wear accelerometer|4|||
155011758|NCT03335475|559468039|FG001|Overall Study|Did not wear accelerometer|0|||
155011759|NCT03335475|559468038|FG000|Overall Study|Withdrawal by Subject|0|||
155011760|NCT03335475|559468039|FG001|Overall Study|Withdrawal by Subject|1|||
155011761|NCT04886596|559468040|FG000|Overall Study|Adverse Event|442|||
155011762|NCT04886596|559468041|FG001|Overall Study|Adverse Event|441|||
155011763|NCT04886596|559468040|FG000|Overall Study|Lost to Follow-up|448|||
155011764|NCT04886596|559468041|FG001|Overall Study|Lost to Follow-up|465|||
155011765|NCT04886596|559468040|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
155011766|NCT04886596|559468041|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
155011767|NCT04886596|559468040|FG000|Overall Study|Migrated/moved from the study area|201|||
155011768|NCT04886596|559468041|FG001|Overall Study|Migrated/moved from the study area|184|||
155011769|NCT04886596|559468040|FG000|Overall Study|Other|298|||
155011770|NCT04886596|559468041|FG001|Overall Study|Other|326|||
155011771|NCT02411656|559468042|FG000|Overall Study|Adverse Event|4|||
155011772|NCT02411656|559468042|FG000|Overall Study|Clinical Progression|33|||
155011773|NCT03305848|559468043|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
155011774|NCT03305848|559468043|FG000|Overall Study|Physician Decision|2|||
155011775|NCT00789854|559468044|FG000|Overall Study|Adverse Event|28|||
155011776|NCT00789854|559468045|FG001|Overall Study|Adverse Event|23|||
155011777|NCT00789854|559468046|FG002|Overall Study|Adverse Event|18|||
155011778|NCT00789854|559468044|FG000|Overall Study|Lost to Follow-up|1|||
155011779|NCT00789854|559468045|FG001|Overall Study|Lost to Follow-up|1|||
155011780|NCT00789854|559468046|FG002|Overall Study|Lost to Follow-up|4|||
155011781|NCT00789854|559468044|FG000|Overall Study|Withdrawal by Subject|9|||
155011782|NCT00789854|559468045|FG001|Overall Study|Withdrawal by Subject|6|||
155011783|NCT00789854|559468046|FG002|Overall Study|Withdrawal by Subject|17|||
155011784|NCT00789854|559468044|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155011785|NCT00789854|559468045|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
155011786|NCT00789854|559468046|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155011787|NCT00789854|559468044|FG000|Overall Study|Severe non-compliance to the protocol|3|||
155011788|NCT00789854|559468045|FG001|Overall Study|Severe non-compliance to the protocol|0|||
155011789|NCT00789854|559468046|FG002|Overall Study|Severe non-compliance to the protocol|0|||
155011790|NCT00789854|559468044|FG000|Overall Study|Safety reasons|0|||
155011791|NCT00789854|559468045|FG001|Overall Study|Safety reasons|0|||
155011792|NCT00789854|559468046|FG002|Overall Study|Safety reasons|2|||
155011793|NCT00789854|559468044|FG000|Overall Study|Other|6|||
155011794|NCT00789854|559468045|FG001|Overall Study|Other|0|||
155011795|NCT00789854|559468046|FG002|Overall Study|Other|5|||
155011796|NCT01949662|559468047|FG000|Overall Study|Death|9|||
155011797|NCT01949662|559468048|FG001|Overall Study|Death|7|||
155178523|NCT02232880|560091528|FG000|Overall Study|study stopped prior to randomization|1|||
155011798|NCT01949662|559468047|FG000|Overall Study|Discharged before an agitation event|8|||
155011799|NCT01949662|559468048|FG001|Overall Study|Discharged before an agitation event|3|||
155011800|NCT01949662|559468047|FG000|Overall Study|Dropped out|1|||
155011801|NCT01949662|559468048|FG001|Overall Study|Dropped out|3|||
155011802|NCT01949662|559468047|FG000|Overall Study|Ineligible|0|||
155011803|NCT01949662|559468048|FG001|Overall Study|Ineligible|1|||
155011804|NCT02291237|559468049|FG000|Overall Study|Study Terminated by Sponsor|72|||
155011805|NCT02291237|559468050|FG001|Overall Study|Study Terminated by Sponsor|67|||
155011806|NCT02291237|559468049|FG000|Overall Study|Adverse Event|1|||
155011807|NCT02291237|559468050|FG001|Overall Study|Adverse Event|3|||
155011808|NCT02291237|559468049|FG000|Overall Study|Investigator's Discretion|0|||
155011809|NCT02291237|559468050|FG001|Overall Study|Investigator's Discretion|3|||
155011810|NCT02291237|559468049|FG000|Overall Study|Withdrew Consent|11|||
155011811|NCT02291237|559468050|FG001|Overall Study|Withdrew Consent|11|||
155011812|NCT02291237|559468049|FG000|Overall Study|Lost to Follow-up|0|||
155011813|NCT02291237|559468050|FG001|Overall Study|Lost to Follow-up|2|||
155011814|NCT02291237|559468049|FG000|Overall Study|Subject Required Prohibited Medication|2|||
155011815|NCT02291237|559468050|FG001|Overall Study|Subject Required Prohibited Medication|0|||
155011816|NCT01478373|559468054|FG000|Treatment Phase|Protocol Violation|1|||
155011817|NCT01478373|559468054|FG000|Survival Phase|Adverse Event|8|||
155011818|NCT01478373|559468054|FG000|Survival Phase|Protocol Violation|1|||
155011819|NCT01478373|559468054|FG000|Survival Phase|crossover to another study|2|||
155011820|NCT01478373|559468054|FG000|Survival Phase|Progressive Disease|27|||
155011821|NCT01964976|559468055|FG000|Overall Study|Protocol Violation|31|||
155011822|NCT01408043|559468058|FG000|Overall Study|unable to collect cells|1|||
155011823|NCT02552121|559468061|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
155011824|NCT02552121|559468062|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011825|NCT02552121|559468063|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011826|NCT02552121|559468064|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011827|NCT02552121|559468065|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011828|NCT02552121|559468066|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011829|NCT02552121|559468067|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011830|NCT02552121|559468068|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
155011831|NCT02552121|559468061|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
155011832|NCT02552121|559468062|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011833|NCT02552121|559468063|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011834|NCT02552121|559468064|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011835|NCT02552121|559468065|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011836|NCT02552121|559468066|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011837|NCT02552121|559468067|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011838|NCT02552121|559468068|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
155011839|NCT02552121|559468061|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011840|NCT02552121|559468062|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
155011841|NCT02552121|559468063|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011842|NCT02552121|559468064|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011843|NCT02552121|559468065|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011844|NCT02552121|559468066|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011845|NCT02552121|559468067|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011846|NCT02552121|559468068|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
155011847|NCT02552121|559468061|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011848|NCT02552121|559468062|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
155011849|NCT02552121|559468063|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011850|NCT02552121|559468064|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011851|NCT02552121|559468065|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011852|NCT02552121|559468066|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011853|NCT02552121|559468067|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011854|NCT02552121|559468068|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
155011855|NCT02552121|559468061|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155011856|NCT02552121|559468062|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
155011857|NCT02552121|559468063|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155011858|NCT02552121|559468064|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155011859|NCT02552121|559468065|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155011860|NCT02552121|559468066|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155011861|NCT02552121|559468067|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155011862|NCT02552121|559468068|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
155132029|NCT02126839|559913087|FG001|Overall Study|Sponsor request|1|||
155132030|NCT02126839|559913086|FG000|Overall Study|Lost to Follow-up|1|||
155132031|NCT02126839|559913087|FG001|Overall Study|Lost to Follow-up|4|||
155132032|NCT02126839|559913086|FG000|Overall Study|Other|5|||
155132033|NCT02126839|559913087|FG001|Overall Study|Other|5|||
155011863|NCT02552121|559468061|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155011864|NCT02552121|559468062|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
155011865|NCT02552121|559468063|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155011866|NCT02552121|559468064|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155011867|NCT02552121|559468065|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155011868|NCT02552121|559468066|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155011869|NCT02552121|559468067|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155132034|NCT00411632|559913088|FG000|Overall Study|Death|1|||
155011870|NCT02552121|559468068|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
155011871|NCT02552121|559468061|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
155011872|NCT02552121|559468062|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
155011873|NCT02552121|559468063|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
155011874|NCT02552121|559468064|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
155011875|NCT02552121|559468065|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
155011876|NCT02552121|559468066|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
155011877|NCT02552121|559468067|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
155011878|NCT02552121|559468068|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
155011879|NCT02552121|559468061|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
155011880|NCT02552121|559468062|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
155011881|NCT02552121|559468063|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
155011882|NCT02552121|559468064|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
155011883|NCT02552121|559468065|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
155011884|NCT02552121|559468066|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
155011885|NCT02552121|559468067|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
155011886|NCT02552121|559468068|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
155011887|NCT02552121|559468061|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
155011888|NCT02552121|559468062|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
155011889|NCT02552121|559468063|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
155011890|NCT02552121|559468064|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
155011891|NCT02552121|559468065|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
155011892|NCT02552121|559468066|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
155011893|NCT02552121|559468067|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
155011894|NCT02552121|559468068|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
155011895|NCT02552121|559468061|FG000|Part 2: Cohort Expansion|Death|0|||
155011896|NCT02552121|559468062|FG001|Part 2: Cohort Expansion|Death|0|||
155011897|NCT02552121|559468063|FG002|Part 2: Cohort Expansion|Death|1|||
155011898|NCT02552121|559468064|FG003|Part 2: Cohort Expansion|Death|0|||
155011899|NCT02552121|559468065|FG004|Part 2: Cohort Expansion|Death|0|||
155011900|NCT02552121|559468066|FG005|Part 2: Cohort Expansion|Death|0|||
155011901|NCT02552121|559468067|FG006|Part 2: Cohort Expansion|Death|0|||
155011902|NCT02552121|559468068|FG007|Part 2: Cohort Expansion|Death|0|||
155011903|NCT01522456|559468069|FG000|Overall Study|Adverse Event|2|||
155011904|NCT01522456|559468069|FG000|Overall Study|Lost to Follow-up|2|||
155011905|NCT01522456|559468069|FG000|Overall Study|Withdrawal by Subject|2|||
155011906|NCT01522456|559468069|FG000|Overall Study|Pregnancy|1|||
155011907|NCT01522456|559468069|FG000|Overall Study|Tolerability Assessment|1|||
155011908|NCT01406574|559468070|FG000|Overall Study|Adverse Event|0|||
155011909|NCT01406574|559468071|FG001|Overall Study|Adverse Event|0|||
155011910|NCT01406574|559468072|FG002|Overall Study|Adverse Event|1|||
155011911|NCT01406574|559468073|FG003|Overall Study|Adverse Event|3|||
155011912|NCT01406574|559468070|FG000|Overall Study|Physician Decision|0|||
155011913|NCT01406574|559468071|FG001|Overall Study|Physician Decision|0|||
155011914|NCT01406574|559468072|FG002|Overall Study|Physician Decision|0|||
155011915|NCT01406574|559468073|FG003|Overall Study|Physician Decision|1|||
155011916|NCT01406574|559468070|FG000|Overall Study|Withdrawal by Subject|0|||
155011917|NCT01406574|559468071|FG001|Overall Study|Withdrawal by Subject|1|||
155011918|NCT01406574|559468072|FG002|Overall Study|Withdrawal by Subject|0|||
155011919|NCT01406574|559468073|FG003|Overall Study|Withdrawal by Subject|0|||
155011920|NCT01406574|559468070|FG000|Overall Study|Definite progression of primary disease|1|||
155011921|NCT01406574|559468071|FG001|Overall Study|Definite progression of primary disease|0|||
155011922|NCT01406574|559468072|FG002|Overall Study|Definite progression of primary disease|0|||
155011923|NCT01406574|559468073|FG003|Overall Study|Definite progression of primary disease|0|||
155011924|NCT04052620|559468074|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
155011925|NCT04052620|559468075|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
155011926|NCT04052620|559468074|FG000|Overall Study|Withdrawal by Subject|1|||
155011927|NCT04052620|559468075|FG001|Overall Study|Withdrawal by Subject|0|||
155011928|NCT04052620|559468074|FG000|Overall Study|Lost to Follow-up|1|||
155011929|NCT04052620|559468075|FG001|Overall Study|Lost to Follow-up|1|||
155011930|NCT04052620|559468074|FG000|Overall Study|Adverse Event|1|||
155011931|NCT04052620|559468075|FG001|Overall Study|Adverse Event|0|||
155178524|NCT00604214|560091529|FG000|Baseline to Day 28|Death|223|||
155178525|NCT00604214|560091530|FG001|Baseline to Day 28|Death|202|||
155178526|NCT00604214|560091529|FG000|Baseline to Day 28|Lost to Follow-up|2|||
155178527|NCT00604214|560091530|FG001|Baseline to Day 28|Lost to Follow-up|4|||
155011932|NCT04052620|559468074|FG000|Overall Study|Subject did not meet study Criteria|0|||
155011933|NCT04052620|559468075|FG001|Overall Study|Subject did not meet study Criteria|1|||
155011934|NCT04052620|559468074|FG000|Overall Study|Screened failure, randomized by mistake|0|||
155011935|NCT04052620|559468075|FG001|Overall Study|Screened failure, randomized by mistake|1|||
155011936|NCT04052620|559468074|FG000|Overall Study|Personal reasons|2|||
155011937|NCT04052620|559468075|FG001|Overall Study|Personal reasons|4|||
155011938|NCT04052620|559468074|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
155011939|NCT04052620|559468075|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
155132035|NCT03210961|559915674|FG000|Overall Study|Adverse Event|0|||
155132036|NCT03210961|559915675|FG001|Overall Study|Adverse Event|0|||
155132037|NCT03210961|559915676|FG002|Overall Study|Adverse Event|0|||
155132038|NCT03210961|559915677|FG003|Overall Study|Adverse Event|0|||
155132039|NCT03210961|559915678|FG004|Overall Study|Adverse Event|0|||
155132040|NCT03210961|559915679|FG005|Overall Study|Adverse Event|0|||
155132041|NCT03210961|559915680|FG006|Overall Study|Adverse Event|0|||
155132042|NCT03210961|559915681|FG007|Overall Study|Adverse Event|0|||
155132043|NCT03210961|559915682|FG008|Overall Study|Adverse Event|0|||
155132044|NCT03210961|559915683|FG009|Overall Study|Adverse Event|0|||
155132045|NCT03210961|559915684|FG010|Overall Study|Adverse Event|0|||
154923843|NCT01453296|559146339|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
154923844|NCT01453296|559146338|FG000|Treatment Period 2|Adverse Event|1|||
154923845|NCT01453296|559146339|FG001|Treatment Period 2|Adverse Event|0|||
154923846|NCT01453296|559146338|FG000|Treatment Period 2|Withdrawal by Subject|1|||
154923847|NCT01453296|559146339|FG001|Treatment Period 2|Withdrawal by Subject|0|||
154923848|NCT00620776|559146340|FG000|Overall Study|Did not receive treatment|3|||
154923849|NCT00620776|559146341|FG001|Overall Study|Did not receive treatment|5|||
154923850|NCT00620776|559146340|FG000|Overall Study|Adverse Event|2|||
154923851|NCT00620776|559146341|FG001|Overall Study|Adverse Event|3|||
154923852|NCT00620776|559146340|FG000|Overall Study|Lack of Efficacy|2|||
154923853|NCT00620776|559146341|FG001|Overall Study|Lack of Efficacy|1|||
154923854|NCT00620776|559146340|FG000|Overall Study|Lost to Follow-up|2|||
154923855|NCT00620776|559146341|FG001|Overall Study|Lost to Follow-up|5|||
154923856|NCT00620776|559146340|FG000|Overall Study|Withdrawal by Subject|3|||
154923857|NCT00620776|559146341|FG001|Overall Study|Withdrawal by Subject|2|||
154923858|NCT04983589|559146342|FG000|Overall Study|Withdrawal by Subject|0|||
154923859|NCT04983589|559146343|FG001|Overall Study|Withdrawal by Subject|3|||
154923860|NCT04983589|559146342|FG000|Overall Study|COVID-19 Infection|1|||
154923861|NCT04983589|559146343|FG001|Overall Study|COVID-19 Infection|0|||
154923862|NCT04983589|559146342|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
154923863|NCT04983589|559146343|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
154923864|NCT00761969|559146344|FG000|Overall Study|Death|112|||
154923865|NCT00761969|559146345|FG001|Overall Study|Death|47|||
154923866|NCT00761969|559146344|FG000|Overall Study|Lost to Follow-up|88|||
154923867|NCT00761969|559146345|FG001|Overall Study|Lost to Follow-up|93|||
154923868|NCT03155269|559146348|FG000|Overall Study|Withdrawal by Subject|4|||
154923869|NCT03155269|559146349|FG001|Overall Study|Withdrawal by Subject|5|||
154923870|NCT03155269|559146348|FG000|Overall Study|Lost to Follow-up|1|||
154923871|NCT03155269|559146349|FG001|Overall Study|Lost to Follow-up|2|||
154923872|NCT00455923|559146354|FG000|Overall Study|Pregnancy|0|||
154923873|NCT00455923|559146355|FG001|Overall Study|Pregnancy|2|||
154923874|NCT00455923|559146354|FG000|Overall Study|Other|3|||
154923875|NCT00455923|559146355|FG001|Overall Study|Other|1|||
154923876|NCT02686749|559146356|FG000|Overall Study|terminated for poor enrollment|2|||
154923877|NCT02686749|559146357|FG001|Overall Study|terminated for poor enrollment|2|||
154923878|NCT02319642|559146360|FG000|Overall Study|Adverse Event|2|||
154923879|NCT02319642|559146361|FG001|Overall Study|Adverse Event|4|||
154923880|NCT02319642|559146360|FG000|Overall Study|Lack of Efficacy|1|||
154923881|NCT02319642|559146361|FG001|Overall Study|Lack of Efficacy|1|||
154923882|NCT02319642|559146360|FG000|Overall Study|Withdrawal by Subject|1|||
154923883|NCT02319642|559146361|FG001|Overall Study|Withdrawal by Subject|1|||
154923884|NCT00483119|559146362|FG000|Overall Study|Adverse Event|0|||
154923885|NCT00483119|559146363|FG001|Overall Study|Adverse Event|1|||
154923886|NCT00483119|559146362|FG000|Overall Study|Physician Decision|1|||
154923887|NCT00483119|559146363|FG001|Overall Study|Physician Decision|0|||
154923888|NCT04409509|559146364|FG000|Overall Study|Failure to meet randomization requirement|1|||
154923889|NCT04409509|559146365|FG001|Overall Study|Failure to meet randomization requirement|0|||
154923890|NCT04409509|559146364|FG000|Overall Study|Adverse Event|0|||
154923891|NCT04409509|559146365|FG001|Overall Study|Adverse Event|1|||
154923892|NCT04409509|559146364|FG000|Overall Study|Death|11|||
154923893|NCT04409509|559146365|FG001|Overall Study|Death|10|||
154923894|NCT04409509|559146364|FG000|Overall Study|Non-compliance with study drug|0|||
154923895|NCT04409509|559146365|FG001|Overall Study|Non-compliance with study drug|1|||
154923896|NCT04409509|559146364|FG000|Overall Study|Lost to Follow-up|0|||
154923897|NCT04409509|559146365|FG001|Overall Study|Lost to Follow-up|3|||
154923898|NCT04409509|559146364|FG000|Overall Study|Withdrawal by Subject|0|||
154923899|NCT04409509|559146365|FG001|Overall Study|Withdrawal by Subject|3|||
154923900|NCT04409509|559146364|FG000|Overall Study|Randomized by mistake|0|||
155132046|NCT03210961|559915685|FG011|Overall Study|Adverse Event|0|||
155132047|NCT03210961|559915686|FG012|Overall Study|Adverse Event|0|||
155132048|NCT03210961|559915687|FG013|Overall Study|Adverse Event|1|||
155132049|NCT03210961|559915688|FG014|Overall Study|Adverse Event|0|||
154923901|NCT04409509|559146365|FG001|Overall Study|Randomized by mistake|1|||
154923902|NCT04409509|559146364|FG000|Overall Study|Other|1|||
154923903|NCT04409509|559146365|FG001|Overall Study|Other|1|||
154923904|NCT04668066|559146366|FG000|Part 1: Treatment Phase|Adverse Event|0|||
154923905|NCT04668066|559146367|FG001|Part 1: Treatment Phase|Adverse Event|0|||
155132050|NCT03210961|559915674|FG000|Overall Study|Lost to Follow-up|0|||
155011940|NCT02201784|559468077|FG000|Overall Study|Failure to achieve adequate block|2|||
155011941|NCT02201784|559468078|FG001|Overall Study|Failure to achieve adequate block|0|||
155011942|NCT00946920|559468079|FG000|Overall Study|Withdrawal by Subject|28|||
155011943|NCT00946920|559468080|FG001|Overall Study|Withdrawal by Subject|15|||
155011944|NCT00946920|559468079|FG000|Overall Study|Lost to Follow-up|2|||
155011945|NCT00946920|559468080|FG001|Overall Study|Lost to Follow-up|2|||
155011946|NCT00946920|559468079|FG000|Overall Study|Physician Decision|5|||
155011947|NCT00946920|559468080|FG001|Overall Study|Physician Decision|2|||
155011948|NCT00946920|559468079|FG000|Overall Study|Adverse Event|41|||
155011949|NCT00946920|559468080|FG001|Overall Study|Adverse Event|14|||
155011950|NCT00946920|559468079|FG000|Overall Study|Protocol Violation|16|||
155011951|NCT00946920|559468080|FG001|Overall Study|Protocol Violation|8|||
155011952|NCT00946920|559468079|FG000|Overall Study|Miscellaneous reasons|18|||
155011953|NCT00946920|559468080|FG001|Overall Study|Miscellaneous reasons|3|||
155011954|NCT00193050|559468081|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
155011955|NCT00193050|559468081|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
155011956|NCT00193050|559468081|FG000|Neoadjuvant Treatment|Physician Decision|2|||
155011957|NCT00193050|559468081|FG000|Neoadjuvant Treatment|Adverse Event|2|||
155011958|NCT00193050|559468081|FG000|Adjuvant|Physician Decision|5|||
155011959|NCT00193050|559468081|FG000|Adjuvant|Intercurrent Hospitalization|3|||
155011960|NCT00193050|559468081|FG000|Adjuvant|Lack of Efficacy|2|||
155011961|NCT00473590|559468082|FG000|Overall Study|Adverse Event|3|||
155011962|NCT00473590|559468083|FG001|Overall Study|Adverse Event|3|||
155011963|NCT00473590|559468082|FG000|Overall Study|Death|4|||
155011964|NCT00473590|559468083|FG001|Overall Study|Death|2|||
155011965|NCT00473590|559468082|FG000|Overall Study|Progression not resulting in death|24|||
155011966|NCT00473590|559468083|FG001|Overall Study|Progression not resulting in death|20|||
155011967|NCT00473590|559468082|FG000|Overall Study|Non-protocol-specified therapy|7|||
155011968|NCT00473590|559468083|FG001|Overall Study|Non-protocol-specified therapy|5|||
155011969|NCT00473590|559468082|FG000|Overall Study|Physician Decision|2|||
155011970|NCT00473590|559468083|FG001|Overall Study|Physician Decision|4|||
155011971|NCT00473590|559468082|FG000|Overall Study|Withdrawal by Subject|5|||
155011972|NCT00473590|559468083|FG001|Overall Study|Withdrawal by Subject|3|||
155011973|NCT00473590|559468082|FG000|Overall Study|Other|0|||
155011974|NCT00473590|559468083|FG001|Overall Study|Other|1|||
155011975|NCT01245283|559468086|FG000|Overall Study|Lost to Follow-up|14|||
155011976|NCT01245283|559468087|FG001|Overall Study|Lost to Follow-up|11|||
155011977|NCT01245283|559468088|FG002|Overall Study|Lost to Follow-up|11|||
155011978|NCT01610492|559468097|FG000|Overall Study|Adverse Event|1|||
155011979|NCT01610492|559468097|FG000|Overall Study|Lack of Efficacy|3|||
155011980|NCT01610492|559468097|FG000|Overall Study|Other: Reached stopping criteria|1|||
155011981|NCT01610492|559468097|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
155011982|NCT03093259|559468098|FG000|Overall Study|Adverse Event|1|||
155011983|NCT03093259|559468099|FG001|Overall Study|Adverse Event|0|||
155011984|NCT03093259|559468098|FG000|Overall Study|Withdrawal by Subject|1|||
155011985|NCT03093259|559468099|FG001|Overall Study|Withdrawal by Subject|0|||
155011986|NCT01821807|559468100|FG000|Overall Study|Lost to Follow-up|3|||
155011987|NCT01821807|559468101|FG001|Overall Study|Lost to Follow-up|1|||
155011988|NCT02325973|559469645|FG000|Overall Study|Death|5|||
155011989|NCT02325973|559469645|FG000|Overall Study|Withdrawal by subject or investigator|16|||
155011990|NCT03874117|559469649|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
155011991|NCT03874117|559469650|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
155011992|NCT03874117|559469649|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
155011993|NCT03874117|559469650|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
155011994|NCT03874117|559469649|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155011995|NCT03874117|559469650|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155011996|NCT03874117|559469649|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
155011997|NCT03874117|559469650|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
155011998|NCT03874117|559469649|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155011999|NCT03874117|559469650|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155012000|NCT05012098|559469651|FG000|Overall Study|Disease progression|5|||
155012001|NCT05012098|559469652|FG001|Overall Study|Disease progression|2|||
155012002|NCT05012098|559469651|FG000|Overall Study|Adverse Event|1|||
155012003|NCT05012098|559469652|FG001|Overall Study|Adverse Event|0|||
155012004|NCT05012098|559469651|FG000|Overall Study|Withdrawal by Subject|1|||
155012005|NCT05012098|559469652|FG001|Overall Study|Withdrawal by Subject|0|||
155012006|NCT05012098|559469651|FG000|Overall Study|Discontinuation per protocol|1|||
155012007|NCT05012098|559469652|FG001|Overall Study|Discontinuation per protocol|0|||
155012008|NCT04815083|559469653|FG000|Overall Study|Physician Decision|1|||
155012009|NCT04815083|559469653|FG000|Overall Study|Study pause|2|||
155012010|NCT04815083|559469653|FG000|Overall Study|Screening failure|4|||
155012011|NCT06025721|559469654|FG000|Overall Study|Physician Decision|1|||
155012012|NCT06025721|559469654|FG000|Overall Study|Protocol Violation|1|||
155012013|NCT06025721|559469654|FG000|Overall Study|Incarceration|1|||
155012014|NCT00075816|559469659|FG000|Overall Study|Did not undergo transplantation|14|||
155012015|NCT00075816|559469660|FG001|Overall Study|Did not undergo transplantation|11|||
155012016|NCT02832687|559469661|FG000|Overall Study|Adverse Event|0|||
155012017|NCT02832687|559469662|FG001|Overall Study|Adverse Event|2|||
155012018|NCT04231825|559469663|FG000|Overall Study|Protocol Violation|3|||
155012019|NCT04231825|559469664|FG001|Overall Study|Protocol Violation|3|||
155012020|NCT04231825|559469663|FG000|Overall Study|Lost to Follow-up|0|||
155012021|NCT04231825|559469664|FG001|Overall Study|Lost to Follow-up|1|||
155012022|NCT03588910|559469667|FG000|Overall Study|Withdrawal by Subject|1|||
155012023|NCT03588910|559469668|FG001|Overall Study|Withdrawal by Subject|0|||
155012024|NCT03588910|559469667|FG000|Overall Study|Allergy|2|||
155012025|NCT03588910|559469668|FG001|Overall Study|Allergy|0|||
155012026|NCT03588910|559469667|FG000|Overall Study|Protocol Violation|0|||
155012027|NCT03588910|559469668|FG001|Overall Study|Protocol Violation|3|||
155012028|NCT03588910|559469667|FG000|Overall Study|Did not complete Day 1 Survey|5|||
155012029|NCT03588910|559469668|FG001|Overall Study|Did not complete Day 1 Survey|10|||
155012030|NCT03588910|559469667|FG000|Overall Study|Did not complete Day 7 Survey|5|||
155012031|NCT03588910|559469668|FG001|Overall Study|Did not complete Day 7 Survey|2|||
155012032|NCT00611923|559469669|FG000|Overall Study|Withdrawal by Subject|2|||
155012033|NCT00611923|559469670|FG001|Overall Study|Withdrawal by Subject|2|||
155012034|NCT00471822|559469671|FG000|Overall Study|Protocol Violation|2|||
155012035|NCT03499067|559469672|FG000|First Intervention|Physician Decision|2|||
155012036|NCT03499067|559469673|FG001|First Intervention|Physician Decision|1|||
155012037|NCT03499067|559469672|FG000|First Intervention|Withdrawal by Subject|3|||
155012038|NCT03499067|559469673|FG001|First Intervention|Withdrawal by Subject|6|||
155012039|NCT02440464|559469674|FG000|Overall Study|Withdrawal by Subject|3|||
155012040|NCT02440464|559469675|FG001|Overall Study|Withdrawal by Subject|2|||
155012041|NCT02392481|559469676|FG000|Overall Study|Adverse Event|0|||
155012042|NCT02392481|559469677|FG001|Overall Study|Adverse Event|0|||
155012043|NCT02392481|559469678|FG002|Overall Study|Adverse Event|1|||
155012044|NCT02392481|559469679|FG003|Overall Study|Adverse Event|2|||
155012045|NCT02392481|559469676|FG000|Overall Study|Withdrawal by Subject|0|||
155012046|NCT02392481|559469677|FG001|Overall Study|Withdrawal by Subject|0|||
155012047|NCT02392481|559469678|FG002|Overall Study|Withdrawal by Subject|1|||
155012048|NCT02392481|559469679|FG003|Overall Study|Withdrawal by Subject|0|||
155012049|NCT02088177|559469689|FG000|Overall Study|Lost to Follow-up|3|||
155012050|NCT00289848|559469690|FG000|Overall Study|Adverse Event|6|||
155012051|NCT00289848|559469691|FG001|Overall Study|Adverse Event|4|||
155012052|NCT00289848|559469690|FG000|Overall Study|Death|1|||
155012053|NCT00289848|559469691|FG001|Overall Study|Death|0|||
155012054|NCT00289848|559469690|FG000|Overall Study|Lack of Efficacy|20|||
155012055|NCT00289848|559469691|FG001|Overall Study|Lack of Efficacy|24|||
155012056|NCT00289848|559469690|FG000|Overall Study|Lost to Follow-up|3|||
155012057|NCT00289848|559469691|FG001|Overall Study|Lost to Follow-up|1|||
155012058|NCT00289848|559469690|FG000|Overall Study|Protocol Violation|5|||
155012059|NCT00289848|559469691|FG001|Overall Study|Protocol Violation|2|||
155012060|NCT00289848|559469690|FG000|Overall Study|Withdrawal by Subject|5|||
155012061|NCT00289848|559469691|FG001|Overall Study|Withdrawal by Subject|11|||
155012062|NCT00289848|559469690|FG000|Overall Study|Patient Moved|6|||
155012063|NCT00289848|559469691|FG001|Overall Study|Patient Moved|2|||
155012064|NCT00289848|559469690|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
155012065|NCT00289848|559469691|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
155012066|NCT00063934|559469694|FG000|Overall Study|Ineligible|1|||
155012067|NCT00395629|559469695|FG000|Core Study|Adverse Event|0|||
155012068|NCT00395629|559469696|FG001|Core Study|Adverse Event|3|||
155012069|NCT00395629|559469697|FG002|Core Study|Adverse Event|4|||
155012070|NCT00395629|559469695|FG000|Core Study|Abnormal laboratory value(s)|0|||
155012071|NCT00395629|559469696|FG001|Core Study|Abnormal laboratory value(s)|0|||
155012072|NCT00395629|559469697|FG002|Core Study|Abnormal laboratory value(s)|1|||
155012073|NCT00395629|559469695|FG000|Core Study|Protocol Violation|1|||
155012074|NCT00395629|559469696|FG001|Core Study|Protocol Violation|0|||
155012075|NCT00395629|559469697|FG002|Core Study|Protocol Violation|0|||
155012076|NCT00395629|559469695|FG000|Core Study|Withdrawal by Subject|0|||
155012077|NCT00395629|559469696|FG001|Core Study|Withdrawal by Subject|1|||
155178528|NCT00604214|560091529|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
155178529|NCT00604214|560091530|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
155178530|NCT00604214|560091529|FG000|Day 29 to Day 90|Death|64|||
155012078|NCT00395629|559469697|FG002|Core Study|Withdrawal by Subject|1|||
155012079|NCT00395629|559469695|FG000|Core Study|Lost to Follow-up|0|||
155012080|NCT00395629|559469696|FG001|Core Study|Lost to Follow-up|0|||
155012081|NCT00395629|559469697|FG002|Core Study|Lost to Follow-up|1|||
155012082|NCT00395629|559469695|FG000|Extension Study|Adverse Event|0|||
155012083|NCT00395629|559469696|FG001|Extension Study|Adverse Event|0|||
155012084|NCT00395629|559469697|FG002|Extension Study|Adverse Event|2|||
155012085|NCT00395629|559469695|FG000|Extension Study|Administrative problems|0|||
155012086|NCT00395629|559469696|FG001|Extension Study|Administrative problems|0|||
155012087|NCT00395629|559469697|FG002|Extension Study|Administrative problems|1|||
155012088|NCT02570308|559469703|FG000|Overall Study|Death|1|||
155012089|NCT02570308|559469704|FG001|Overall Study|Death|5|||
155012090|NCT02570308|559469705|FG002|Overall Study|Death|4|||
155012091|NCT02570308|559469706|FG003|Overall Study|Death|4|||
155012092|NCT02570308|559469707|FG004|Overall Study|Death|69|||
155012093|NCT02570308|559469703|FG000|Overall Study|Lost to Follow-up|0|||
155012094|NCT02570308|559469704|FG001|Overall Study|Lost to Follow-up|0|||
155012095|NCT02570308|559469705|FG002|Overall Study|Lost to Follow-up|0|||
155012096|NCT02570308|559469706|FG003|Overall Study|Lost to Follow-up|0|||
155012097|NCT02570308|559469707|FG004|Overall Study|Lost to Follow-up|2|||
155012098|NCT02570308|559469703|FG000|Overall Study|Withdrawal by Subject|0|||
155012099|NCT02570308|559469704|FG001|Overall Study|Withdrawal by Subject|0|||
155012100|NCT02570308|559469705|FG002|Overall Study|Withdrawal by Subject|0|||
155012101|NCT02570308|559469706|FG003|Overall Study|Withdrawal by Subject|0|||
155012102|NCT02570308|559469707|FG004|Overall Study|Withdrawal by Subject|1|||
155012103|NCT02570308|559469703|FG000|Overall Study|Other|0|||
155012104|NCT02570308|559469704|FG001|Overall Study|Other|0|||
155012105|NCT02570308|559469705|FG002|Overall Study|Other|0|||
155012106|NCT02570308|559469706|FG003|Overall Study|Other|0|||
155012107|NCT02570308|559469707|FG004|Overall Study|Other|2|||
155012108|NCT01283464|559469709|FG000|Overall Study|Lost to Follow-up|0|||
155012109|NCT01283464|559469710|FG001|Overall Study|Lost to Follow-up|1|||
155012110|NCT01283464|559469709|FG000|Overall Study|Withdrawal by Subject|1|||
155012111|NCT01283464|559469710|FG001|Overall Study|Withdrawal by Subject|0|||
155012112|NCT01283464|559469709|FG000|Overall Study|Physician Decision|1|||
155012113|NCT01283464|559469710|FG001|Overall Study|Physician Decision|0|||
155012114|NCT05921903|559469711|FG000|Overall Study|Unsolicited non-SAE|0|||
155012115|NCT05921903|559469712|FG001|Overall Study|Unsolicited non-SAE|1|||
155012116|NCT05921903|559469713|FG002|Overall Study|Unsolicited non-SAE|0|||
155012117|NCT05921903|559469711|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
155012118|NCT05921903|559469712|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
155012119|NCT05921903|559469713|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
155012120|NCT05921903|559469711|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
155012121|NCT05921903|559469712|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
155012122|NCT05921903|559469713|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
155012123|NCT00923013|559469714|FG000|Overall Study|Refused further treatment|0|||
155012124|NCT00923013|559469715|FG001|Overall Study|Refused further treatment|1|||
155012125|NCT00923013|559469716|FG002|Overall Study|Refused further treatment|2|||
155012126|NCT00923013|559469717|FG003|Overall Study|Refused further treatment|0|||
155012127|NCT00923013|559469718|FG004|Overall Study|Refused further treatment|0|||
155012128|NCT00923013|559469719|FG005|Overall Study|Refused further treatment|0|||
155012129|NCT00923013|559469714|FG000|Overall Study|Switched to alternative treatment|0|||
155012130|NCT00923013|559469715|FG001|Overall Study|Switched to alternative treatment|1|||
155012131|NCT00923013|559469716|FG002|Overall Study|Switched to alternative treatment|0|||
155012132|NCT00923013|559469717|FG003|Overall Study|Switched to alternative treatment|0|||
155012133|NCT00923013|559469718|FG004|Overall Study|Switched to alternative treatment|0|||
155012134|NCT00923013|559469719|FG005|Overall Study|Switched to alternative treatment|0|||
155012135|NCT00923013|559469714|FG000|Overall Study|Death on study|2|||
155012136|NCT00923013|559469715|FG001|Overall Study|Death on study|2|||
155012137|NCT00923013|559469716|FG002|Overall Study|Death on study|0|||
155012138|NCT00923013|559469717|FG003|Overall Study|Death on study|1|||
155012139|NCT00923013|559469718|FG004|Overall Study|Death on study|0|||
155012140|NCT00923013|559469719|FG005|Overall Study|Death on study|0|||
155012141|NCT05366010|559469721|FG000|Overall Study|Withdrawal by Subject|1|||
155012142|NCT05366010|559469721|FG000|Overall Study|Protocol Violation|1|||
155132051|NCT03210961|559915675|FG001|Overall Study|Lost to Follow-up|0|||
155132052|NCT03210961|559915676|FG002|Overall Study|Lost to Follow-up|0|||
155132053|NCT03210961|559915677|FG003|Overall Study|Lost to Follow-up|0|||
155132054|NCT03210961|559915678|FG004|Overall Study|Lost to Follow-up|0|||
155132055|NCT03210961|559915679|FG005|Overall Study|Lost to Follow-up|0|||
155132056|NCT03210961|559915680|FG006|Overall Study|Lost to Follow-up|0|||
155012143|NCT05366010|559469721|FG000|Overall Study|Lost to Follow-up|2|||
155012144|NCT05366010|559469721|FG000|Overall Study|Screen Failure|2|||
155012145|NCT01108718|559469722|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
155012146|NCT01108718|559469723|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
155012147|NCT01060072|559469724|FG000|Overall Study|Adverse Event|1|||
155012148|NCT01060072|559469725|FG001|Overall Study|Adverse Event|1|||
155132057|NCT03210961|559915681|FG007|Overall Study|Lost to Follow-up|0|||
155132058|NCT03210961|559915682|FG008|Overall Study|Lost to Follow-up|0|||
155132059|NCT03210961|559915683|FG009|Overall Study|Lost to Follow-up|0|||
155132060|NCT03210961|559915684|FG010|Overall Study|Lost to Follow-up|0|||
155132061|NCT03210961|559915685|FG011|Overall Study|Lost to Follow-up|0|||
155132062|NCT03210961|559915686|FG012|Overall Study|Lost to Follow-up|0|||
155012149|NCT01060072|559469724|FG000|Overall Study|Physician Decision|0|||
155012150|NCT01060072|559469725|FG001|Overall Study|Physician Decision|2|||
155012151|NCT01060072|559469724|FG000|Overall Study|Protocol Violation|0|||
155012152|NCT01060072|559469725|FG001|Overall Study|Protocol Violation|1|||
155012153|NCT01060072|559469724|FG000|Overall Study|Acute cholecystitis|1|||
155012154|NCT01060072|559469725|FG001|Overall Study|Acute cholecystitis|0|||
155132063|NCT03210961|559915687|FG013|Overall Study|Lost to Follow-up|0|||
155132064|NCT03210961|559915688|FG014|Overall Study|Lost to Follow-up|1|||
155012155|NCT01060072|559469724|FG000|Overall Study|Excluded Medications|0|||
155012156|NCT01060072|559469725|FG001|Overall Study|Excluded Medications|1|||
155012157|NCT02301169|559469726|FG000|Overall Study|Adverse Event|1|||
155012158|NCT02301169|559469727|FG001|Overall Study|Adverse Event|0|||
155012159|NCT03762265|559469728|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
155012160|NCT03762265|559469729|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
155012161|NCT03762265|559469728|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
155012162|NCT03762265|559469729|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
155012163|NCT03762265|559469728|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
155012164|NCT03762265|559469729|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
155012165|NCT03762265|559469728|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
155012166|NCT03762265|559469729|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
155012167|NCT03762265|559469728|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
155012168|NCT03762265|559469729|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
155012169|NCT03762265|559469728|FG000|BT Period: Weeks 1 to 37|Other|0|||
155012170|NCT03762265|559469729|FG001|BT Period: Weeks 1 to 37|Other|1|||
155012171|NCT03762265|559469728|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
155012172|NCT03762265|559469729|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
155012173|NCT03762265|559469728|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
155012174|NCT03762265|559469729|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
155012175|NCT03762265|559469728|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
155012176|NCT03762265|559469729|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
155012177|NCT03762265|559469728|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
155012178|NCT03762265|559469729|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
155012179|NCT03762265|559469728|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
155012180|NCT03762265|559469729|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
155012181|NCT03762265|559469728|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
155012182|NCT03762265|559469729|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
155012183|NCT03762265|559469728|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
155012184|NCT03762265|559469729|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
155012185|NCT03762265|559469728|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
155012186|NCT03762265|559469729|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
155012187|NCT03762265|559469728|FG000|LTE Period: Weeks 61 to 109|Other|1|||
155012188|NCT03762265|559469729|FG001|LTE Period: Weeks 61 to 109|Other|0|||
155012189|NCT02289729|559469730|FG000|Overall Study|Lack of Efficacy|3|||
155012190|NCT02289729|559469730|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
155012191|NCT02289729|559469730|FG000|Overall Study|Withdrawal by Subject|1|||
155012192|NCT02289729|559469730|FG000|Overall Study|Death|1|||
155012193|NCT00470470|559469731|FG000|Overall Study|Adverse Event|2|||
155012194|NCT00470470|559469731|FG000|Overall Study|Death|2|||
155012195|NCT00470470|559469731|FG000|Overall Study|Not treated|1|||
155012196|NCT01149863|559469732|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
155012197|NCT03326193|559469733|FG000|Overall Study|Sponsor decision|35|||
155012198|NCT00640315|559469734|FG000|Overall Study|Withdrawal by Subject|0|||
155012199|NCT00640315|559469735|FG001|Overall Study|Withdrawal by Subject|1|||
155012200|NCT01256879|559469736|FG000|Overall Study|Withdrawal by Subject|1|||
155012201|NCT00397514|559469737|FG000|Overall Study|Withdrawal by Subject|1|||
155012202|NCT00397514|559469737|FG000|Overall Study|Pacing wire malfunction|1|||
155012203|NCT00397514|559469737|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
155012204|NCT00397514|559469737|FG000|Overall Study|early extubation|2|||
155132065|NCT03210961|559915674|FG000|Overall Study|Withdrawal by Subject|0|||
155132066|NCT03210961|559915675|FG001|Overall Study|Withdrawal by Subject|0|||
155132067|NCT03210961|559915676|FG002|Overall Study|Withdrawal by Subject|0|||
155132068|NCT03210961|559915677|FG003|Overall Study|Withdrawal by Subject|0|||
155012205|NCT00397514|559469737|FG000|Overall Study|poor echocardiographic windows|1|||
155012206|NCT00725920|559469738|FG000|Overall Study|Lack of Efficacy|3|||
155012207|NCT00725920|559469739|FG001|Overall Study|Lack of Efficacy|6|||
155012208|NCT02286713|559469742|FG000|One Week Follow-Up|Death|1|||
155012209|NCT02286713|559469743|FG001|One Week Follow-Up|Death|0|||
155012210|NCT02286713|559469742|FG000|One Week Follow-Up|Lost to Follow-up|17|||
155012211|NCT02286713|559469743|FG001|One Week Follow-Up|Lost to Follow-up|21|||
155012212|NCT02286713|559469742|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
155012213|NCT02286713|559469743|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
155132069|NCT03210961|559915678|FG004|Overall Study|Withdrawal by Subject|0|||
155132070|NCT03210961|559915679|FG005|Overall Study|Withdrawal by Subject|0|||
155012214|NCT02286713|559469742|FG000|Three Month Follow-Up|Death|1|||
155012215|NCT02286713|559469743|FG001|Three Month Follow-Up|Death|1|||
155012216|NCT02286713|559469742|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
155012217|NCT02286713|559469743|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
155012218|NCT02286713|559469742|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
155012219|NCT02286713|559469743|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
155012220|NCT02286713|559469742|FG000|Six Month Follow-Up|Death|2|||
155012221|NCT02286713|559469743|FG001|Six Month Follow-Up|Death|0|||
155012222|NCT02286713|559469742|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
155012223|NCT02286713|559469743|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
155178531|NCT00604214|560091530|FG001|Day 29 to Day 90|Death|67|||
155178532|NCT00604214|560091529|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
155178533|NCT00604214|560091530|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
155178534|NCT00604214|560091529|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
155178535|NCT00604214|560091530|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
155178536|NCT00604214|560091529|FG000|Day 91 to Day 180|Death|19|||
155178537|NCT00604214|560091530|FG001|Day 91 to Day 180|Death|23|||
155178538|NCT00604214|560091529|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
155178539|NCT00604214|560091530|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
155178540|NCT00604214|560091529|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
155178541|NCT00604214|560091530|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
155178542|NCT00534599|560091531|FG000|Overall Study|Adverse Event|25|||
155178543|NCT00534599|560091532|FG001|Overall Study|Adverse Event|4|||
155178544|NCT00534599|560091531|FG000|Overall Study|Incorrect enrollment|2|||
155178545|NCT00534599|560091532|FG001|Overall Study|Incorrect enrollment|1|||
155178546|NCT00534599|560091531|FG000|Overall Study|Mis-randomization|2|||
155178547|NCT00534599|560091532|FG001|Overall Study|Mis-randomization|2|||
155178548|NCT00534599|560091531|FG000|Overall Study|Developed study-specific d/c criteria|5|||
155178549|NCT00534599|560091532|FG001|Overall Study|Developed study-specific d/c criteria|0|||
155178550|NCT00534599|560091531|FG000|Overall Study|Lack of Efficacy|0|||
155178551|NCT00534599|560091532|FG001|Overall Study|Lack of Efficacy|1|||
155178552|NCT00534599|560091531|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
155178553|NCT00534599|560091532|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
155178554|NCT00534599|560091531|FG000|Overall Study|Protocol Violation|1|||
155178555|NCT00534599|560091532|FG001|Overall Study|Protocol Violation|3|||
155178556|NCT00534599|560091531|FG000|Overall Study|Lost to Follow-up|11|||
155132071|NCT03210961|559915680|FG006|Overall Study|Withdrawal by Subject|0|||
155132072|NCT03210961|559915681|FG007|Overall Study|Withdrawal by Subject|0|||
155132073|NCT03210961|559915682|FG008|Overall Study|Withdrawal by Subject|0|||
155132074|NCT03210961|559915683|FG009|Overall Study|Withdrawal by Subject|0|||
155132075|NCT03210961|559915684|FG010|Overall Study|Withdrawal by Subject|0|||
155132076|NCT03210961|559915685|FG011|Overall Study|Withdrawal by Subject|0|||
155132077|NCT03210961|559915686|FG012|Overall Study|Withdrawal by Subject|0|||
155132078|NCT03210961|559915687|FG013|Overall Study|Withdrawal by Subject|0|||
155132079|NCT03210961|559915688|FG014|Overall Study|Withdrawal by Subject|1|||
155132080|NCT03210961|559915674|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132081|NCT03210961|559915675|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132082|NCT03210961|559915676|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132083|NCT03210961|559915677|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132084|NCT03210961|559915678|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132085|NCT03210961|559915679|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132086|NCT03210961|559915680|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132087|NCT03210961|559915681|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132088|NCT03210961|559915682|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132089|NCT03210961|559915683|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132090|NCT03210961|559915684|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132091|NCT03210961|559915685|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132092|NCT03210961|559915686|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132093|NCT03210961|559915687|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
155132094|NCT03210961|559915688|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
155132095|NCT03210961|559915674|FG000|Overall Study|Other|0|||
155132096|NCT03210961|559915675|FG001|Overall Study|Other|0|||
155132097|NCT03210961|559915676|FG002|Overall Study|Other|0|||
155132098|NCT03210961|559915677|FG003|Overall Study|Other|1|||
155132099|NCT03210961|559915678|FG004|Overall Study|Other|0|||
155132100|NCT03210961|559915679|FG005|Overall Study|Other|0|||
155132101|NCT03210961|559915680|FG006|Overall Study|Other|1|||
155132102|NCT03210961|559915681|FG007|Overall Study|Other|0|||
155132103|NCT03210961|559915682|FG008|Overall Study|Other|0|||
155132104|NCT03210961|559915683|FG009|Overall Study|Other|0|||
155132105|NCT03210961|559915684|FG010|Overall Study|Other|1|||
155132106|NCT03210961|559915685|FG011|Overall Study|Other|0|||
155178557|NCT00534599|560091532|FG001|Overall Study|Lost to Follow-up|14|||
155132107|NCT03210961|559915686|FG012|Overall Study|Other|2|||
155178558|NCT00534599|560091531|FG000|Overall Study|Withdrawal by Subject|4|||
155178559|NCT00534599|560091532|FG001|Overall Study|Withdrawal by Subject|6|||
155178560|NCT00534599|560091531|FG000|Overall Study|Other|7|||
155178561|NCT00534599|560091532|FG001|Overall Study|Other|0|||
155132108|NCT03210961|559915687|FG013|Overall Study|Other|2|||
155132109|NCT03210961|559915688|FG014|Overall Study|Other|0|||
155132110|NCT02454478|559915694|FG000|Overall Study|Incomplete DLT Evaluation|1|||
155132111|NCT01732770|559915699|FG000|Overall Study|Lost to Follow-up|2|||
155132112|NCT01732770|559915700|FG001|Overall Study|Lost to Follow-up|3|||
155132113|NCT01732770|559915699|FG000|Overall Study|Withdrawal by Subject|5|||
155178562|NCT03645434|560091537|FG000|Period 1|Adverse Event|0|||
155178563|NCT03645434|560091538|FG001|Period 1|Adverse Event|0|||
155178564|NCT03645434|560091539|FG002|Period 1|Adverse Event|0|||
155178565|NCT03645434|560091540|FG003|Period 1|Adverse Event|1|||
155178566|NCT03645434|560091541|FG004|Period 1|Adverse Event|0|||
155178567|NCT03645434|560091542|FG005|Period 1|Adverse Event|0|||
155178568|NCT03645434|560091537|FG000|Period 1|COPD exacerbation|0|||
155012224|NCT02654054|559469744|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
155012225|NCT02654054|559469745|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
155012226|NCT02654054|559469746|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
155012227|NCT02654054|559469744|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155012228|NCT02654054|559469745|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
155012229|NCT02654054|559469746|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
155012230|NCT02654054|559469744|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
155012231|NCT02654054|559469745|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
155012232|NCT02654054|559469746|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
155012233|NCT02654054|559469744|FG000|Post-Treatment Follow-Up Period|Other|1|||
155012234|NCT02654054|559469745|FG001|Post-Treatment Follow-Up Period|Other|0|||
155012235|NCT02654054|559469746|FG002|Post-Treatment Follow-Up Period|Other|4|||
155012236|NCT02654054|559469744|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155012237|NCT02654054|559469745|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155012238|NCT02654054|559469746|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
155012239|NCT06018129|559469748|FG000|Overall Study|Death|1|||
155012240|NCT06018129|559469749|FG001|Overall Study|Death|1|||
155012241|NCT06018129|559469750|FG002|Overall Study|Death|2|||
155012242|NCT06018129|559469748|FG000|Overall Study|Sponsor Decision|2|||
155012243|NCT06018129|559469749|FG001|Overall Study|Sponsor Decision|2|||
155012244|NCT06018129|559469750|FG002|Overall Study|Sponsor Decision|1|||
155012245|NCT03832686|559469751|FG000|Overall Study|Lost to Follow-up|6|||
155012246|NCT03832686|559469752|FG001|Overall Study|Lost to Follow-up|9|||
155012247|NCT03832686|559469751|FG000|Overall Study|Discontinued Intervention|5|||
155012248|NCT03832686|559469752|FG001|Overall Study|Discontinued Intervention|4|||
155012249|NCT03323398|559469753|FG000|Overall Study|Other than Specified|0|||
155012250|NCT03323398|559469754|FG001|Overall Study|Other than Specified|1|||
155012251|NCT03323398|559469755|FG002|Overall Study|Other than Specified|2|||
155012252|NCT03323398|559469756|FG003|Overall Study|Other than Specified|0|||
155012253|NCT03323398|559469757|FG004|Overall Study|Other than Specified|0|||
155012254|NCT03323398|559469758|FG005|Overall Study|Other than Specified|0|||
155012255|NCT03323398|559469759|FG006|Overall Study|Other than Specified|1|||
155012256|NCT03323398|559469760|FG007|Overall Study|Other than Specified|0|||
155012257|NCT03323398|559469761|FG008|Overall Study|Other than Specified|2|||
155012258|NCT03323398|559469753|FG000|Overall Study|Lost to Follow-up|1|||
155012259|NCT03323398|559469754|FG001|Overall Study|Lost to Follow-up|2|||
155012260|NCT03323398|559469755|FG002|Overall Study|Lost to Follow-up|1|||
155012261|NCT03323398|559469756|FG003|Overall Study|Lost to Follow-up|0|||
155012262|NCT03323398|559469757|FG004|Overall Study|Lost to Follow-up|0|||
155012263|NCT03323398|559469758|FG005|Overall Study|Lost to Follow-up|0|||
155012264|NCT03323398|559469759|FG006|Overall Study|Lost to Follow-up|0|||
155012265|NCT03323398|559469760|FG007|Overall Study|Lost to Follow-up|0|||
155012266|NCT03323398|559469761|FG008|Overall Study|Lost to Follow-up|0|||
155012267|NCT03323398|559469753|FG000|Overall Study|Death|4|||
155012268|NCT03323398|559469754|FG001|Overall Study|Death|6|||
155012269|NCT03323398|559469755|FG002|Overall Study|Death|2|||
155012270|NCT03323398|559469756|FG003|Overall Study|Death|2|||
155012271|NCT03323398|559469757|FG004|Overall Study|Death|1|||
155012272|NCT03323398|559469758|FG005|Overall Study|Death|2|||
155012273|NCT03323398|559469759|FG006|Overall Study|Death|0|||
155012274|NCT03323398|559469760|FG007|Overall Study|Death|0|||
155012275|NCT03323398|559469761|FG008|Overall Study|Death|6|||
155012276|NCT03323398|559469753|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
155012277|NCT03323398|559469754|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
155012278|NCT03323398|559469755|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
155012279|NCT03323398|559469756|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
155012280|NCT03323398|559469757|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
155012281|NCT03323398|559469758|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
155012282|NCT03323398|559469759|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
155012283|NCT03323398|559469760|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
155012284|NCT03323398|559469761|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
155012285|NCT03323398|559469753|FG000|Overall Study|Withdrawal by Subject|2|||
155178569|NCT03645434|560091538|FG001|Period 1|COPD exacerbation|0|||
155178570|NCT03645434|560091539|FG002|Period 1|COPD exacerbation|0|||
155178571|NCT03645434|560091540|FG003|Period 1|COPD exacerbation|0|||
155012286|NCT03323398|559469754|FG001|Overall Study|Withdrawal by Subject|1|||
155012287|NCT03323398|559469755|FG002|Overall Study|Withdrawal by Subject|3|||
155012288|NCT03323398|559469756|FG003|Overall Study|Withdrawal by Subject|0|||
155012289|NCT03323398|559469757|FG004|Overall Study|Withdrawal by Subject|0|||
155012290|NCT03323398|559469758|FG005|Overall Study|Withdrawal by Subject|1|||
155012291|NCT03323398|559469759|FG006|Overall Study|Withdrawal by Subject|0|||
155178572|NCT03645434|560091541|FG004|Period 1|COPD exacerbation|1|||
155132114|NCT01732770|559915700|FG001|Overall Study|Withdrawal by Subject|3|||
155132115|NCT01732770|559915699|FG000|Overall Study|Decision by Sponsor|2|||
155132116|NCT01732770|559915700|FG001|Overall Study|Decision by Sponsor|2|||
155132117|NCT01732770|559915699|FG000|Overall Study|Death|1|||
155132118|NCT01732770|559915700|FG001|Overall Study|Death|0|||
155132119|NCT01959841|559915703|FG000|Overall Study|Adverse Event|1|||
155132120|NCT01959841|559915704|FG001|Overall Study|Adverse Event|3|||
155132121|NCT01959841|559915705|FG002|Overall Study|Adverse Event|2|||
155132122|NCT01959841|559915703|FG000|Overall Study|Lack of Efficacy|5|||
155132123|NCT01959841|559915704|FG001|Overall Study|Lack of Efficacy|0|||
155132124|NCT01959841|559915705|FG002|Overall Study|Lack of Efficacy|0|||
155132125|NCT01959841|559915703|FG000|Overall Study|Lost to Follow-up|1|||
155132126|NCT01959841|559915704|FG001|Overall Study|Lost to Follow-up|1|||
155132127|NCT01959841|559915705|FG002|Overall Study|Lost to Follow-up|0|||
155132128|NCT01959841|559915703|FG000|Overall Study|Physician Decision|0|||
155132129|NCT01959841|559915704|FG001|Overall Study|Physician Decision|2|||
155012292|NCT03323398|559469760|FG007|Overall Study|Withdrawal by Subject|0|||
155012293|NCT03323398|559469761|FG008|Overall Study|Withdrawal by Subject|0|||
155012294|NCT03323398|559469753|FG000|Overall Study|Participant was Put on Hospice|0|||
155012295|NCT03323398|559469754|FG001|Overall Study|Participant was Put on Hospice|0|||
155012296|NCT03323398|559469755|FG002|Overall Study|Participant was Put on Hospice|0|||
155012297|NCT03323398|559469756|FG003|Overall Study|Participant was Put on Hospice|0|||
155012298|NCT03323398|559469757|FG004|Overall Study|Participant was Put on Hospice|0|||
155012299|NCT03323398|559469758|FG005|Overall Study|Participant was Put on Hospice|0|||
155012300|NCT03323398|559469759|FG006|Overall Study|Participant was Put on Hospice|1|||
155012301|NCT03323398|559469760|FG007|Overall Study|Participant was Put on Hospice|0|||
155012302|NCT03323398|559469761|FG008|Overall Study|Participant was Put on Hospice|0|||
155012303|NCT03323398|559469753|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
155012304|NCT03323398|559469754|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
155012305|NCT03323398|559469755|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
155012306|NCT03323398|559469756|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
155012307|NCT03323398|559469757|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
155012308|NCT03323398|559469758|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
155012309|NCT03323398|559469759|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
155012310|NCT03323398|559469760|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
155012311|NCT03323398|559469761|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
155012312|NCT02235454|559469762|FG000|Overall Study|Withdrawal by Subject|2|||
155012313|NCT03641469|559469763|FG000|Overall Study|Ineligible|2|||
155012314|NCT03641469|559469763|FG000|Overall Study|Withdrawal by Subject|5|||
155012315|NCT03641469|559469763|FG000|Overall Study|Physician Decision|1|||
155012316|NCT03641469|559469763|FG000|Overall Study|Protocol Violation|1|||
155012317|NCT03641469|559469763|FG000|Overall Study|Lost to Follow-up|2|||
155012318|NCT06389487|559469764|FG000|Overall Study|Lost to Follow-up|9|||
155012319|NCT06389487|559469765|FG001|Overall Study|Lost to Follow-up|5|||
155012320|NCT06389487|559469766|FG002|Overall Study|Lost to Follow-up|13|||
155012321|NCT06389487|559469764|FG000|Overall Study|Protocol Violation|0|||
155012322|NCT06389487|559469765|FG001|Overall Study|Protocol Violation|0|||
155012323|NCT06389487|559469766|FG002|Overall Study|Protocol Violation|2|||
155012324|NCT06389487|559469764|FG000|Overall Study|Withdrawal by Subject|2|||
155012325|NCT06389487|559469765|FG001|Overall Study|Withdrawal by Subject|2|||
155012326|NCT06389487|559469766|FG002|Overall Study|Withdrawal by Subject|1|||
155012327|NCT06389487|559469764|FG000|Overall Study|Other|1|||
155012328|NCT06389487|559469765|FG001|Overall Study|Other|0|||
155012329|NCT06389487|559469766|FG002|Overall Study|Other|1|||
155012330|NCT05479435|559469767|FG000|Overall Study|Withdrawal by Subject|1|||
155012331|NCT05479435|559469768|FG001|Overall Study|Withdrawal by Subject|0|||
155012332|NCT05479435|559469769|FG002|Overall Study|Withdrawal by Subject|0|||
155012333|NCT05479435|559469767|FG000|Overall Study|Covid 19|0|||
155012334|NCT05479435|559469768|FG001|Overall Study|Covid 19|0|||
155012335|NCT05479435|559469769|FG002|Overall Study|Covid 19|2|||
155132130|NCT01959841|559915705|FG002|Overall Study|Physician Decision|3|||
155012336|NCT00955617|559469772|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
155132131|NCT01959841|559915703|FG000|Overall Study|Protocol Violation|16|||
155012337|NCT00955617|559469773|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
155012338|NCT00955617|559469772|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
155012339|NCT00955617|559469773|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
155012340|NCT00955617|559469772|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
155012341|NCT00955617|559469773|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
155132132|NCT01959841|559915704|FG001|Overall Study|Protocol Violation|23|||
155132133|NCT01959841|559915705|FG002|Overall Study|Protocol Violation|16|||
155132134|NCT01959841|559915703|FG000|Overall Study|Withdrawal by Subject|7|||
155132135|NCT01959841|559915704|FG001|Overall Study|Withdrawal by Subject|7|||
155012342|NCT00955617|559469772|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
155132136|NCT01959841|559915705|FG002|Overall Study|Withdrawal by Subject|5|||
155151104|NCT00446849|559988184|FG000|Acute Phase|Consent withdrawn|4|||
155012343|NCT00955617|559469773|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
155012344|NCT00982657|559469775|FG000|Overall Study|Death|1|||
155012345|NCT00982657|559469776|FG001|Overall Study|Death|0|||
155012346|NCT00982657|559469777|FG002|Overall Study|Death|1|||
155012347|NCT00982657|559469778|FG003|Overall Study|Death|1|||
155012348|NCT00982657|559469775|FG000|Overall Study|Withdrawal by Subject|0|||
155012349|NCT00982657|559469776|FG001|Overall Study|Withdrawal by Subject|0|||
155012350|NCT00982657|559469777|FG002|Overall Study|Withdrawal by Subject|1|||
155012351|NCT00982657|559469778|FG003|Overall Study|Withdrawal by Subject|3|||
155012352|NCT00982657|559469775|FG000|Overall Study|Other|0|||
155012353|NCT00982657|559469776|FG001|Overall Study|Other|0|||
155012354|NCT00982657|559469777|FG002|Overall Study|Other|0|||
155012355|NCT00982657|559469778|FG003|Overall Study|Other|4|||
155012356|NCT00982657|559469775|FG000|Overall Study|On going at date of cut-off|0|||
155012357|NCT00982657|559469776|FG001|Overall Study|On going at date of cut-off|0|||
155012358|NCT00982657|559469777|FG002|Overall Study|On going at date of cut-off|0|||
155012359|NCT00982657|559469778|FG003|Overall Study|On going at date of cut-off|1|||
155012360|NCT04199104|559471371|FG000|Overall Study|Death|148|||
155012361|NCT04199104|559471372|FG001|Overall Study|Death|134|||
155012362|NCT04199104|559471371|FG000|Overall Study|Lost to Follow-up|1|||
155012363|NCT04199104|559471372|FG001|Overall Study|Lost to Follow-up|1|||
155012364|NCT04199104|559471371|FG000|Overall Study|Withdrawal by Subject|4|||
155012365|NCT04199104|559471372|FG001|Overall Study|Withdrawal by Subject|4|||
155012366|NCT04199104|559471371|FG000|Overall Study|Participants Ongoing|103|||
155012367|NCT04199104|559471372|FG001|Overall Study|Participants Ongoing|116|||
155012368|NCT04075825|559471373|FG000|Overall Study|Withdrawal by Subject|6|||
155012369|NCT04075825|559471374|FG001|Overall Study|Withdrawal by Subject|8|||
155012370|NCT04075825|559471373|FG000|Overall Study|Physician Decision|3|||
155012371|NCT04075825|559471374|FG001|Overall Study|Physician Decision|1|||
155012372|NCT04075825|559471373|FG000|Overall Study|Lost to Follow-up|5|||
155012373|NCT04075825|559471374|FG001|Overall Study|Lost to Follow-up|1|||
155012374|NCT04075825|559471373|FG000|Overall Study|Participation in New Clinical Trial|1|||
155012375|NCT04075825|559471374|FG001|Overall Study|Participation in New Clinical Trial|1|||
155012376|NCT04075825|559471373|FG000|Overall Study|Reason Not Specified|2|||
155012377|NCT04075825|559471374|FG001|Overall Study|Reason Not Specified|2|||
155012378|NCT04581824|559471375|FG000|Overall Study|Lost to Follow-up|1|||
155012379|NCT04581824|559471376|FG001|Overall Study|Lost to Follow-up|0|||
155012380|NCT04581824|559471375|FG000|Overall Study|Withdrawal by Subject|2|||
155012381|NCT04581824|559471376|FG001|Overall Study|Withdrawal by Subject|7|||
155012382|NCT04581824|559471375|FG000|Overall Study|Study terminated by sponsor|37|||
155012383|NCT04581824|559471376|FG001|Overall Study|Study terminated by sponsor|23|||
155012384|NCT04796909|559471377|FG000|Overall Study|Withdrawal by Subject|1|||
155012385|NCT04796909|559471378|FG001|Overall Study|Withdrawal by Subject|1|||
155012386|NCT03879135|559471379|FG000|Overall Study|Physician Decision|0|||
155012387|NCT03879135|559471380|FG001|Overall Study|Physician Decision|0|||
155012388|NCT03879135|559471381|FG002|Overall Study|Physician Decision|0|||
155012389|NCT03879135|559471382|FG003|Overall Study|Physician Decision|1|||
155012390|NCT03879135|559471383|FG004|Overall Study|Physician Decision|0|||
155012391|NCT03879135|559471384|FG005|Overall Study|Physician Decision|0|||
155012392|NCT03879135|559471379|FG000|Overall Study|Withdrawal by Subject|0|||
155012393|NCT03879135|559471380|FG001|Overall Study|Withdrawal by Subject|0|||
155012394|NCT03879135|559471381|FG002|Overall Study|Withdrawal by Subject|0|||
155012395|NCT03879135|559471382|FG003|Overall Study|Withdrawal by Subject|0|||
155012396|NCT03879135|559471383|FG004|Overall Study|Withdrawal by Subject|0|||
155012397|NCT03879135|559471384|FG005|Overall Study|Withdrawal by Subject|1|||
155012398|NCT03879135|559471379|FG000|Overall Study|Site Closed by Sponsor|0|||
155012399|NCT03879135|559471380|FG001|Overall Study|Site Closed by Sponsor|0|||
155012400|NCT03879135|559471381|FG002|Overall Study|Site Closed by Sponsor|0|||
155012401|NCT03879135|559471382|FG003|Overall Study|Site Closed by Sponsor|1|||
155012402|NCT03879135|559471383|FG004|Overall Study|Site Closed by Sponsor|1|||
155012403|NCT03879135|559471384|FG005|Overall Study|Site Closed by Sponsor|0|||
155012404|NCT03428958|559471385|FG000|Overall Study|Adverse Event|0|||
155151105|NCT00446849|559988184|FG000|Acute Phase|Lost to Follow-up|2|||
155012405|NCT03428958|559471386|FG001|Overall Study|Adverse Event|0|||
155012406|NCT03428958|559471387|FG002|Overall Study|Adverse Event|0|||
155012407|NCT03428958|559471388|FG003|Overall Study|Adverse Event|1|||
155012408|NCT03428958|559471389|FG004|Overall Study|Adverse Event|0|||
155012409|NCT03428958|559471390|FG005|Overall Study|Adverse Event|2|||
155012410|NCT03428958|559471391|FG006|Overall Study|Adverse Event|1|||
155012411|NCT03428958|559471392|FG007|Overall Study|Adverse Event|0|||
155012412|NCT03428958|559471393|FG008|Overall Study|Adverse Event|0|||
155012413|NCT03428958|559471394|FG009|Overall Study|Adverse Event|0|||
155012414|NCT03428958|559471395|FG010|Overall Study|Adverse Event|0|||
155012415|NCT03428958|559471396|FG011|Overall Study|Adverse Event|0|||
155012416|NCT03428958|559471397|FG012|Overall Study|Adverse Event|0|||
155012417|NCT03428958|559471398|FG013|Overall Study|Adverse Event|0|||
155012418|NCT03428958|559471399|FG014|Overall Study|Adverse Event|0|||
155012419|NCT03428958|559471400|FG015|Overall Study|Adverse Event|0|||
155012420|NCT03428958|559471401|FG016|Overall Study|Adverse Event|0|||
155132137|NCT01959841|559915703|FG000|Overall Study|Clinical laboratory value|2|||
155132138|NCT01959841|559915704|FG001|Overall Study|Clinical laboratory value|6|||
155132139|NCT01959841|559915705|FG002|Overall Study|Clinical laboratory value|6|||
155132140|NCT01959841|559915703|FG000|Overall Study|Platelet count below on day1 or 4|11|||
155132141|NCT01959841|559915704|FG001|Overall Study|Platelet count below on day1 or 4|15|||
155132142|NCT01959841|559915705|FG002|Overall Study|Platelet count below on day1 or 4|11|||
155132143|NCT00780416|559915707|FG000|Overall Study|Physician Decision|3|||
155132144|NCT00780416|559915708|FG001|Overall Study|Physician Decision|3|||
155132145|NCT00780416|559915707|FG000|Overall Study|Protocol Violation|1|||
155132146|NCT00780416|559915708|FG001|Overall Study|Protocol Violation|0|||
155132147|NCT00780416|559915707|FG000|Overall Study|Withdrawal by Subject|8|||
155132148|NCT00780416|559915708|FG001|Overall Study|Withdrawal by Subject|6|||
155132149|NCT01450098|559915715|FG000|Period 3|Protocol Violation|0|||
155132150|NCT01450098|559915716|FG001|Period 3|Protocol Violation|1|||
155132151|NCT01450098|559915715|FG000|Period 3|Withdrawal by Subject|0|||
155132152|NCT01450098|559915716|FG001|Period 3|Withdrawal by Subject|2|||
155132153|NCT03828617|559915727|FG000|Overall Study|Lost to Follow-up|22|||
155132154|NCT03828617|559915728|FG001|Overall Study|Lost to Follow-up|12|||
155132155|NCT03828617|559915729|FG002|Overall Study|Lost to Follow-up|23|||
155132156|NCT03828617|559915730|FG003|Overall Study|Lost to Follow-up|7|||
155132157|NCT03828617|559915727|FG000|Overall Study|No longer met eligibility criteria|0|||
155132158|NCT03828617|559915728|FG001|Overall Study|No longer met eligibility criteria|1|||
155132159|NCT03828617|559915729|FG002|Overall Study|No longer met eligibility criteria|1|||
155132160|NCT03828617|559915730|FG003|Overall Study|No longer met eligibility criteria|3|||
155132161|NCT03828617|559915727|FG000|Overall Study|Protocol Violation|0|||
155132162|NCT03828617|559915728|FG001|Overall Study|Protocol Violation|2|||
155132163|NCT03828617|559915729|FG002|Overall Study|Protocol Violation|0|||
155132164|NCT03828617|559915730|FG003|Overall Study|Protocol Violation|0|||
155132165|NCT03828617|559915727|FG000|Overall Study|Withdrawal by Subject|2|||
155132166|NCT03828617|559915728|FG001|Overall Study|Withdrawal by Subject|0|||
155132167|NCT03828617|559915729|FG002|Overall Study|Withdrawal by Subject|2|||
155132168|NCT03828617|559915730|FG003|Overall Study|Withdrawal by Subject|0|||
155132169|NCT03354273|559915731|FG000|Overall Study|Adverse Event|5|||
155132170|NCT03354273|559915731|FG000|Overall Study|Screen Failure|21|||
155132171|NCT03354273|559915731|FG000|Overall Study|Withdrawal by Subject|34|||
155132172|NCT03354273|559915731|FG000|Overall Study|Technical Problems|30|||
155132173|NCT03354273|559915731|FG000|Overall Study|Lost to Follow-up|4|||
155132174|NCT03354273|559915731|FG000|Overall Study|Investigator Decision|3|||
155132175|NCT03354273|559915731|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
155132176|NCT03354273|559915731|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
155132177|NCT03354273|559915731|FG000|Overall Study|COVID-19 Restrictions|9|||
155132178|NCT03354273|559915731|FG000|Overall Study|Other|5|||
155132179|NCT03229109|559915734|FG000|Overall Study|Withdrawal by Subject|0|||
155132180|NCT03229109|559915735|FG001|Overall Study|Withdrawal by Subject|0|||
155132181|NCT03229109|559915736|FG002|Overall Study|Withdrawal by Subject|0|||
155132182|NCT03229109|559915737|FG003|Overall Study|Withdrawal by Subject|1|||
155132183|NCT04207749|559915740|FG000|Overall Study|Lost to Follow-up|0|||
155132184|NCT04207749|559915741|FG001|Overall Study|Lost to Follow-up|2|||
155132185|NCT04207749|559915740|FG000|Overall Study|Protocol Violation|0|||
155132186|NCT04207749|559915741|FG001|Overall Study|Protocol Violation|1|||
155132187|NCT04207749|559915740|FG000|Overall Study|Withdrawal by Subject|3|||
155132188|NCT04207749|559915741|FG001|Overall Study|Withdrawal by Subject|0|||
155132189|NCT04207749|559915740|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
155132190|NCT04207749|559915741|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
155132191|NCT00655629|559915742|FG000|Overall Study|Adverse Event|4|||
155132192|NCT00655629|559915743|FG001|Overall Study|Adverse Event|1|||
155132193|NCT00655629|559915742|FG000|Overall Study|Lack of Efficacy|2|||
155132194|NCT00655629|559915743|FG001|Overall Study|Lack of Efficacy|12|||
155132195|NCT00655629|559915742|FG000|Overall Study|Lost to Follow-up|4|||
155132196|NCT00655629|559915743|FG001|Overall Study|Lost to Follow-up|3|||
155132197|NCT00655629|559915742|FG000|Overall Study|Protocol Violation|5|||
155132198|NCT00655629|559915743|FG001|Overall Study|Protocol Violation|3|||
155132199|NCT00655629|559915742|FG000|Overall Study|consent withdrawn|6|||
155132200|NCT00655629|559915743|FG001|Overall Study|consent withdrawn|4|||
155132201|NCT03416127|559915744|FG000|Overall Study|Withdrawal by Subject|0|||
155132202|NCT03416127|559915745|FG001|Overall Study|Withdrawal by Subject|1|||
155132203|NCT03416127|559915746|FG002|Overall Study|Withdrawal by Subject|1|||
155132204|NCT03387020|559915750|FG000|Overall Study|Adverse Event|0|||
155132205|NCT03387020|559915751|FG001|Overall Study|Adverse Event|2|||
155132206|NCT03387020|559915752|FG002|Overall Study|Adverse Event|0|||
155132207|NCT03387020|559915750|FG000|Overall Study|Withdrawal by Subject|2|||
155132208|NCT03387020|559915751|FG001|Overall Study|Withdrawal by Subject|0|||
155132209|NCT03387020|559915752|FG002|Overall Study|Withdrawal by Subject|0|||
155132210|NCT01452919|559915753|FG000|Open-Label Treatment|Adverse Event|5|||
155132211|NCT01452919|559915754|FG001|Open-Label Treatment|Adverse Event|0|||
155132212|NCT01452919|559915755|FG002|Open-Label Treatment|Adverse Event|0|||
155012421|NCT03428958|559471385|FG000|Overall Study|Clinical Progression|2|||
155012422|NCT03428958|559471386|FG001|Overall Study|Clinical Progression|3|||
155012423|NCT03428958|559471387|FG002|Overall Study|Clinical Progression|2|||
155012424|NCT03428958|559471388|FG003|Overall Study|Clinical Progression|1|||
155012425|NCT03428958|559471389|FG004|Overall Study|Clinical Progression|0|||
155012426|NCT03428958|559471390|FG005|Overall Study|Clinical Progression|2|||
155012427|NCT03428958|559471391|FG006|Overall Study|Clinical Progression|0|||
155012428|NCT03428958|559471392|FG007|Overall Study|Clinical Progression|0|||
155012429|NCT03428958|559471393|FG008|Overall Study|Clinical Progression|0|||
155012430|NCT03428958|559471394|FG009|Overall Study|Clinical Progression|0|||
155012431|NCT03428958|559471395|FG010|Overall Study|Clinical Progression|0|||
155012432|NCT03428958|559471396|FG011|Overall Study|Clinical Progression|0|||
155012433|NCT03428958|559471397|FG012|Overall Study|Clinical Progression|0|||
155012434|NCT03428958|559471398|FG013|Overall Study|Clinical Progression|0|||
155012435|NCT03428958|559471399|FG014|Overall Study|Clinical Progression|0|||
155012436|NCT03428958|559471400|FG015|Overall Study|Clinical Progression|0|||
155012437|NCT03428958|559471401|FG016|Overall Study|Clinical Progression|0|||
155012438|NCT03428958|559471385|FG000|Overall Study|Progression per RECIST|6|||
155012439|NCT03428958|559471386|FG001|Overall Study|Progression per RECIST|6|||
155012440|NCT03428958|559471387|FG002|Overall Study|Progression per RECIST|7|||
155012441|NCT03428958|559471388|FG003|Overall Study|Progression per RECIST|4|||
155012442|NCT03428958|559471389|FG004|Overall Study|Progression per RECIST|0|||
155012443|NCT03428958|559471390|FG005|Overall Study|Progression per RECIST|7|||
155012444|NCT03428958|559471391|FG006|Overall Study|Progression per RECIST|8|||
155012445|NCT03428958|559471392|FG007|Overall Study|Progression per RECIST|0|||
155012446|NCT03428958|559471393|FG008|Overall Study|Progression per RECIST|0|||
155012447|NCT03428958|559471394|FG009|Overall Study|Progression per RECIST|0|||
155012448|NCT03428958|559471395|FG010|Overall Study|Progression per RECIST|0|||
155012449|NCT03428958|559471396|FG011|Overall Study|Progression per RECIST|0|||
155012450|NCT03428958|559471397|FG012|Overall Study|Progression per RECIST|1|||
155012451|NCT03428958|559471398|FG013|Overall Study|Progression per RECIST|0|||
155012452|NCT03428958|559471399|FG014|Overall Study|Progression per RECIST|0|||
155012453|NCT03428958|559471400|FG015|Overall Study|Progression per RECIST|0|||
155012454|NCT03428958|559471401|FG016|Overall Study|Progression per RECIST|0|||
155012455|NCT03428958|559471385|FG000|Overall Study|Death|2|||
155012456|NCT03428958|559471386|FG001|Overall Study|Death|2|||
155012457|NCT03428958|559471387|FG002|Overall Study|Death|0|||
155012458|NCT03428958|559471388|FG003|Overall Study|Death|0|||
155012459|NCT03428958|559471389|FG004|Overall Study|Death|0|||
155012460|NCT03428958|559471390|FG005|Overall Study|Death|7|||
155012461|NCT03428958|559471391|FG006|Overall Study|Death|9|||
155012462|NCT03428958|559471392|FG007|Overall Study|Death|6|||
155012463|NCT03428958|559471393|FG008|Overall Study|Death|0|||
155012464|NCT03428958|559471394|FG009|Overall Study|Death|0|||
155012465|NCT03428958|559471395|FG010|Overall Study|Death|3|||
155012466|NCT03428958|559471396|FG011|Overall Study|Death|0|||
155012467|NCT03428958|559471397|FG012|Overall Study|Death|4|||
155012468|NCT03428958|559471398|FG013|Overall Study|Death|0|||
155012469|NCT03428958|559471399|FG014|Overall Study|Death|0|||
155012470|NCT03428958|559471400|FG015|Overall Study|Death|0|||
155012471|NCT03428958|559471401|FG016|Overall Study|Death|0|||
155012472|NCT03428958|559471385|FG000|Overall Study|Lost to Follow-up|0|||
155012473|NCT03428958|559471386|FG001|Overall Study|Lost to Follow-up|0|||
155012474|NCT03428958|559471387|FG002|Overall Study|Lost to Follow-up|0|||
155012475|NCT03428958|559471388|FG003|Overall Study|Lost to Follow-up|0|||
155012476|NCT03428958|559471389|FG004|Overall Study|Lost to Follow-up|0|||
155012477|NCT03428958|559471390|FG005|Overall Study|Lost to Follow-up|1|||
155012478|NCT03428958|559471391|FG006|Overall Study|Lost to Follow-up|1|||
155012479|NCT03428958|559471392|FG007|Overall Study|Lost to Follow-up|0|||
155012480|NCT03428958|559471393|FG008|Overall Study|Lost to Follow-up|0|||
155012481|NCT03428958|559471394|FG009|Overall Study|Lost to Follow-up|0|||
155012482|NCT03428958|559471395|FG010|Overall Study|Lost to Follow-up|0|||
155012483|NCT03428958|559471396|FG011|Overall Study|Lost to Follow-up|0|||
155012484|NCT03428958|559471397|FG012|Overall Study|Lost to Follow-up|0|||
155012485|NCT03428958|559471398|FG013|Overall Study|Lost to Follow-up|0|||
155012486|NCT03428958|559471399|FG014|Overall Study|Lost to Follow-up|0|||
155012487|NCT03428958|559471400|FG015|Overall Study|Lost to Follow-up|0|||
155012488|NCT03428958|559471401|FG016|Overall Study|Lost to Follow-up|0|||
155012489|NCT03428958|559471385|FG000|Overall Study|Physician/Sponsor Decision|1|||
155012490|NCT03428958|559471386|FG001|Overall Study|Physician/Sponsor Decision|0|||
155012491|NCT03428958|559471387|FG002|Overall Study|Physician/Sponsor Decision|1|||
155012492|NCT03428958|559471388|FG003|Overall Study|Physician/Sponsor Decision|0|||
155012493|NCT03428958|559471389|FG004|Overall Study|Physician/Sponsor Decision|0|||
155012494|NCT03428958|559471390|FG005|Overall Study|Physician/Sponsor Decision|2|||
155012495|NCT03428958|559471391|FG006|Overall Study|Physician/Sponsor Decision|2|||
155012496|NCT03428958|559471392|FG007|Overall Study|Physician/Sponsor Decision|2|||
155012497|NCT03428958|559471393|FG008|Overall Study|Physician/Sponsor Decision|0|||
155012498|NCT03428958|559471394|FG009|Overall Study|Physician/Sponsor Decision|0|||
155012499|NCT03428958|559471395|FG010|Overall Study|Physician/Sponsor Decision|2|||
155012500|NCT03428958|559471396|FG011|Overall Study|Physician/Sponsor Decision|0|||
155012501|NCT03428958|559471397|FG012|Overall Study|Physician/Sponsor Decision|4|||
155012502|NCT03428958|559471398|FG013|Overall Study|Physician/Sponsor Decision|0|||
155012503|NCT03428958|559471399|FG014|Overall Study|Physician/Sponsor Decision|0|||
155012504|NCT03428958|559471400|FG015|Overall Study|Physician/Sponsor Decision|0|||
155012505|NCT03428958|559471401|FG016|Overall Study|Physician/Sponsor Decision|0|||
155012506|NCT03428958|559471385|FG000|Overall Study|Withdrawal by Subject|0|||
155012507|NCT03428958|559471386|FG001|Overall Study|Withdrawal by Subject|0|||
155012508|NCT03428958|559471387|FG002|Overall Study|Withdrawal by Subject|2|||
155012509|NCT03428958|559471388|FG003|Overall Study|Withdrawal by Subject|0|||
155012510|NCT03428958|559471389|FG004|Overall Study|Withdrawal by Subject|0|||
155012511|NCT03428958|559471390|FG005|Overall Study|Withdrawal by Subject|2|||
155012512|NCT03428958|559471391|FG006|Overall Study|Withdrawal by Subject|4|||
155012513|NCT03428958|559471392|FG007|Overall Study|Withdrawal by Subject|1|||
155012514|NCT03428958|559471393|FG008|Overall Study|Withdrawal by Subject|0|||
155012515|NCT03428958|559471394|FG009|Overall Study|Withdrawal by Subject|0|||
155012516|NCT03428958|559471395|FG010|Overall Study|Withdrawal by Subject|0|||
155012517|NCT03428958|559471396|FG011|Overall Study|Withdrawal by Subject|0|||
155012518|NCT03428958|559471397|FG012|Overall Study|Withdrawal by Subject|0|||
155012519|NCT03428958|559471398|FG013|Overall Study|Withdrawal by Subject|0|||
155012520|NCT03428958|559471399|FG014|Overall Study|Withdrawal by Subject|0|||
155012521|NCT03428958|559471400|FG015|Overall Study|Withdrawal by Subject|0|||
155012522|NCT03428958|559471401|FG016|Overall Study|Withdrawal by Subject|0|||
155012523|NCT03985800|559471402|FG000|Overall Study|Death|1|||
155012524|NCT03985800|559471403|FG001|Overall Study|Death|2|||
155012525|NCT03985800|559471402|FG000|Overall Study|Withdrawal by Subject|3|||
155012526|NCT03985800|559471403|FG001|Overall Study|Withdrawal by Subject|6|||
155012527|NCT03985800|559471402|FG000|Overall Study|Protocol Violation|2|||
155012528|NCT03985800|559471403|FG001|Overall Study|Protocol Violation|0|||
155012529|NCT05258773|559471404|FG000|Overall Study|Screen Failure|1|||
155012530|NCT05258773|559471405|FG001|Overall Study|Screen Failure|1|||
155012531|NCT05258773|559471404|FG000|Overall Study|Adverse Event|1|||
155012532|NCT05258773|559471405|FG001|Overall Study|Adverse Event|0|||
155012533|NCT05258773|559471404|FG000|Overall Study|Withdrawal by Subject|0|||
155012534|NCT05258773|559471405|FG001|Overall Study|Withdrawal by Subject|1|||
155012535|NCT01662635|559471408|FG000|Overall Study|scarce samples for evaluation|30|||
155012536|NCT00595920|559471409|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
155012537|NCT00351468|559471410|FG000|Overall Study|Adverse Event|42|||
155012538|NCT00351468|559471410|FG000|Overall Study|Withdrawal by Subject|39|||
155012539|NCT00351468|559471410|FG000|Overall Study|Various -follow up w clinical team|39|||
155012540|NCT00351468|559471410|FG000|Overall Study|Lack of Efficacy|32|||
155012541|NCT00351468|559471410|FG000|Overall Study|Non-compliance|8|||
155012542|NCT00351468|559471410|FG000|Overall Study|Lost to Follow-up|4|||
155012543|NCT00351468|559471410|FG000|Overall Study|Protocol Violation|3|||
155012544|NCT04565145|559471411|FG000|Overall Study|Withdrawal by Subject|1|||
155012545|NCT04565145|559471412|FG001|Overall Study|Withdrawal by Subject|1|||
155012546|NCT03096314|559471413|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
155012547|NCT03096314|559471414|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
155012548|NCT02502149|559471415|FG000|Intermediate|Discontinued prematurely|1|||
155012549|NCT02502149|559471416|FG001|Intermediate|Discontinued prematurely|0|||
155012550|NCT02502149|559471417|FG002|Intermediate|Discontinued prematurely|0|||
155012551|NCT02502149|559471418|FG003|Intermediate|Discontinued prematurely|0|||
155012552|NCT02502149|559471419|FG004|Intermediate|Discontinued prematurely|0|||
155012553|NCT02548832|559471420|FG000|Overall Study|Lost to Follow-up|2|||
155012554|NCT02548832|559471421|FG001|Overall Study|Lost to Follow-up|2|||
155012555|NCT02548832|559471422|FG002|Overall Study|Lost to Follow-up|2|||
155012556|NCT03428152|559471424|FG000|Overall Study|Physician Decision|4|||
155012557|NCT03428152|559471425|FG001|Overall Study|Physician Decision|2|||
155012558|NCT03428152|559471424|FG000|Overall Study|Protocol Violation|3|||
155012559|NCT03428152|559471425|FG001|Overall Study|Protocol Violation|5|||
155012560|NCT03428152|559471424|FG000|Overall Study|Lack of Efficacy|0|||
155012561|NCT03428152|559471425|FG001|Overall Study|Lack of Efficacy|4|||
155012562|NCT01686373|559471426|FG000|Overall Study|Lost to Follow-up|3|||
155012563|NCT01686373|559471427|FG001|Overall Study|Lost to Follow-up|0|||
155012564|NCT01686373|559471426|FG000|Overall Study|Withdrawal by Subject|0|||
155132213|NCT01452919|559915753|FG000|Open-Label Treatment|Lost to Follow-up|4|||
155012565|NCT01686373|559471427|FG001|Overall Study|Withdrawal by Subject|1|||
155012566|NCT01686373|559471426|FG000|Overall Study|Adverse Event|0|||
155012567|NCT01686373|559471427|FG001|Overall Study|Adverse Event|1|||
155012568|NCT01836471|559471434|FG000|Overall Study|Pregnancy|1|||
155012569|NCT01836471|559471435|FG001|Overall Study|Pregnancy|0|||
155012570|NCT01836471|559471436|FG002|Overall Study|Pregnancy|0|||
155012571|NCT01836471|559471437|FG003|Overall Study|Pregnancy|0|||
155012572|NCT01836471|559471438|FG004|Overall Study|Pregnancy|0|||
155012573|NCT01836471|559471434|FG000|Overall Study|Withdrawal by Subject|3|||
155012574|NCT01836471|559471435|FG001|Overall Study|Withdrawal by Subject|4|||
155012575|NCT01836471|559471436|FG002|Overall Study|Withdrawal by Subject|1|||
155132214|NCT01452919|559915754|FG001|Open-Label Treatment|Lost to Follow-up|0|||
155012576|NCT01836471|559471437|FG003|Overall Study|Withdrawal by Subject|0|||
155012577|NCT01836471|559471438|FG004|Overall Study|Withdrawal by Subject|2|||
155012578|NCT01836471|559471434|FG000|Overall Study|Physician Decision|0|||
155012579|NCT01836471|559471435|FG001|Overall Study|Physician Decision|1|||
155012580|NCT01836471|559471436|FG002|Overall Study|Physician Decision|0|||
155012581|NCT01836471|559471437|FG003|Overall Study|Physician Decision|0|||
155012582|NCT01836471|559471438|FG004|Overall Study|Physician Decision|0|||
155012583|NCT01836471|559471434|FG000|Overall Study|Lost to Follow-up|0|||
155012584|NCT01836471|559471435|FG001|Overall Study|Lost to Follow-up|0|||
155012585|NCT01836471|559471436|FG002|Overall Study|Lost to Follow-up|0|||
155012586|NCT01836471|559471437|FG003|Overall Study|Lost to Follow-up|1|||
155012587|NCT01836471|559471438|FG004|Overall Study|Lost to Follow-up|1|||
155012588|NCT01836471|559471434|FG000|Overall Study|Adverse Event|6|||
155012589|NCT01836471|559471435|FG001|Overall Study|Adverse Event|3|||
155012590|NCT01836471|559471436|FG002|Overall Study|Adverse Event|1|||
155012591|NCT01836471|559471437|FG003|Overall Study|Adverse Event|1|||
155012592|NCT01836471|559471438|FG004|Overall Study|Adverse Event|2|||
155012593|NCT01836471|559471434|FG000|Overall Study|Non compliance with tx|1|||
155012594|NCT01836471|559471435|FG001|Overall Study|Non compliance with tx|1|||
155012595|NCT01836471|559471436|FG002|Overall Study|Non compliance with tx|0|||
155012596|NCT01836471|559471437|FG003|Overall Study|Non compliance with tx|0|||
155012597|NCT01836471|559471438|FG004|Overall Study|Non compliance with tx|0|||
155012598|NCT00314340|559471439|FG000|Overall Study|lost interest|1|||
155012599|NCT02285361|559471440|FG000|Overall Study|Protocol Violation|43|||
155012600|NCT02285361|559471440|FG000|Overall Study|Lost to Follow-up|5|||
155012601|NCT02285361|559471440|FG000|Overall Study|Not taken GIOTRIF|2|||
155012602|NCT02285361|559471440|FG000|Overall Study|Consented prior to the contract date|1|||
155012603|NCT02059135|559471441|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
155012604|NCT02059135|559471442|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
155012605|NCT02059135|559471441|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
155012606|NCT02059135|559471442|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
155012607|NCT02059135|559471441|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
155012608|NCT02059135|559471442|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
155012609|NCT02059135|559471441|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
155012610|NCT02059135|559471442|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
155012611|NCT02059135|559471441|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
155012612|NCT02059135|559471442|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
155012613|NCT02059135|559471441|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
155012614|NCT02059135|559471442|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
155012615|NCT02059135|559471441|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
155012616|NCT02059135|559471442|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
155012617|NCT02059135|559471441|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
155012618|NCT02059135|559471442|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
155012619|NCT03776357|559471445|FG000|Overall Study|Lost to Follow-up|3|||
155012620|NCT06481709|559471448|FG000|Overall Study|Withdrawal by Subject|0|||
155012621|NCT06481709|559471449|FG001|Overall Study|Withdrawal by Subject|0|||
155012622|NCT06481709|559471450|FG002|Overall Study|Withdrawal by Subject|2|||
155012623|NCT06481709|559471451|FG003|Overall Study|Withdrawal by Subject|0|||
155012624|NCT03751098|559471452|FG000|Overall Study|Withdrawal by Subject|0|||
155012625|NCT03751098|559471453|FG001|Overall Study|Withdrawal by Subject|1|||
155012626|NCT02224157|559471455|FG000|Overall Study|Severe non-compliance to protocol|2|||
155012627|NCT02224157|559471456|FG001|Overall Study|Severe non-compliance to protocol|2|||
155012628|NCT02224157|559471455|FG000|Overall Study|Other|13|||
155012629|NCT02224157|559471456|FG001|Overall Study|Other|10|||
155012630|NCT02224157|559471455|FG000|Overall Study|Subject decision|58|||
155012631|NCT02224157|559471456|FG001|Overall Study|Subject decision|50|||
155012632|NCT02224157|559471455|FG000|Overall Study|Prematurely closed site|4|||
155012633|NCT02224157|559471456|FG001|Overall Study|Prematurely closed site|2|||
155012634|NCT02224157|559471455|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
155012635|NCT02224157|559471456|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
155012636|NCT02224157|559471455|FG000|Overall Study|Lost to Follow-up|27|||
155012637|NCT02224157|559471456|FG001|Overall Study|Lost to Follow-up|35|||
155132215|NCT01452919|559915755|FG002|Open-Label Treatment|Lost to Follow-up|0|||
155012638|NCT02224157|559471455|FG000|Overall Study|Death|1|||
155012639|NCT02224157|559471456|FG001|Overall Study|Death|1|||
155132216|NCT01452919|559915753|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
155012640|NCT02224157|559471455|FG000|Overall Study|Adverse Event|1|||
155132217|NCT01452919|559915754|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
155132218|NCT01452919|559915755|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
155012641|NCT02224157|559471456|FG001|Overall Study|Adverse Event|3|||
155012642|NCT05906628|559471457|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
155012643|NCT05906628|559471458|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
155012644|NCT05906628|559471457|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
155012645|NCT05906628|559471458|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
155132219|NCT01452919|559915753|FG000|Open-Label Treatment|Protocol Violation|4|||
155132220|NCT01452919|559915754|FG001|Open-Label Treatment|Protocol Violation|0|||
155132221|NCT01452919|559915755|FG002|Open-Label Treatment|Protocol Violation|0|||
155132222|NCT01452919|559915753|FG000|Open-Label Treatment|Sponsor Decision|1|||
155132223|NCT01452919|559915754|FG001|Open-Label Treatment|Sponsor Decision|0|||
155132224|NCT01452919|559915755|FG002|Open-Label Treatment|Sponsor Decision|0|||
155132225|NCT01452919|559915753|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
155132226|NCT01452919|559915754|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155132227|NCT01452919|559915755|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
155132228|NCT01452919|559915753|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
155132229|NCT01452919|559915754|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
155132230|NCT01452919|559915755|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
155132231|NCT01452919|559915753|FG000|Randomization Treatment|Adverse Event|0|||
155132232|NCT01452919|559915754|FG001|Randomization Treatment|Adverse Event|0|||
155132233|NCT01452919|559915755|FG002|Randomization Treatment|Adverse Event|2|||
155132234|NCT01452919|559915753|FG000|Randomization Treatment|Sponsor Decision|0|||
155132235|NCT01452919|559915754|FG001|Randomization Treatment|Sponsor Decision|1|||
155132236|NCT01452919|559915755|FG002|Randomization Treatment|Sponsor Decision|0|||
155132237|NCT01452919|559915753|FG000|Randomization Treatment|Withdrawal by Subject|0|||
155132238|NCT01452919|559915754|FG001|Randomization Treatment|Withdrawal by Subject|1|||
155132239|NCT01452919|559915755|FG002|Randomization Treatment|Withdrawal by Subject|0|||
155132240|NCT01452919|559915753|FG000|Randomization Treatment|Subject is moving or has moved|0|||
155132241|NCT01452919|559915754|FG001|Randomization Treatment|Subject is moving or has moved|1|||
155132242|NCT01452919|559915755|FG002|Randomization Treatment|Subject is moving or has moved|0|||
155132243|NCT02421588|559915756|FG000|Overall Study|Non-treatment-related AE|8|||
155132244|NCT02421588|559915757|FG001|Overall Study|Non-treatment-related AE|8|||
155132245|NCT02421588|559915756|FG000|Overall Study|Progressive disease|152|||
155132246|NCT02421588|559915757|FG001|Overall Study|Progressive disease|135|||
155132247|NCT02421588|559915756|FG000|Overall Study|Death|11|||
155132248|NCT02421588|559915757|FG001|Overall Study|Death|3|||
155132249|NCT02421588|559915756|FG000|Overall Study|Physician Decision|8|||
155132250|NCT02421588|559915757|FG001|Overall Study|Physician Decision|17|||
155132251|NCT02421588|559915756|FG000|Overall Study|Other reason not specified|3|||
155132252|NCT02421588|559915757|FG001|Overall Study|Other reason not specified|1|||
155132253|NCT02421588|559915756|FG000|Overall Study|Symptomatic deterioration|13|||
155132254|NCT02421588|559915757|FG001|Overall Study|Symptomatic deterioration|19|||
155132255|NCT02421588|559915756|FG000|Overall Study|Treatment-related AE|10|||
155132256|NCT02421588|559915757|FG001|Overall Study|Treatment-related AE|14|||
155132257|NCT02421588|559915756|FG000|Overall Study|Withdrawal by Subject|14|||
155132258|NCT02421588|559915757|FG001|Overall Study|Withdrawal by Subject|16|||
155132259|NCT02421588|559915756|FG000|Overall Study|Not treated|2|||
155132260|NCT02421588|559915757|FG001|Overall Study|Not treated|8|||
155132261|NCT01359943|559915758|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
155132262|NCT01359943|559915759|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
155132263|NCT01359943|559915760|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
155132264|NCT01359943|559915758|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
155132265|NCT01359943|559915759|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
155132266|NCT01359943|559915760|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
155132267|NCT01359943|559915758|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
155132268|NCT01359943|559915759|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
155132269|NCT01359943|559915760|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
155132270|NCT01359943|559915758|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
155132271|NCT01359943|559915759|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
155132272|NCT01359943|559915760|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
155132273|NCT01359943|559915758|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
155132274|NCT01359943|559915759|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
155132275|NCT01359943|559915760|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
155132276|NCT01359943|559915758|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
155132277|NCT01359943|559915759|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
155132278|NCT01359943|559915760|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
155132279|NCT01359943|559915758|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
155132280|NCT01359943|559915759|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
155132281|NCT01359943|559915760|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
155132282|NCT01359943|559915758|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
155132283|NCT01359943|559915759|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
155132284|NCT01359943|559915760|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
155132285|NCT01359943|559915758|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
155132286|NCT01359943|559915759|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
155132287|NCT01359943|559915760|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
155132288|NCT01359943|559915758|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
155132289|NCT01359943|559915759|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
155178573|NCT03645434|560091542|FG005|Period 1|COPD exacerbation|0|||
155178574|NCT00167778|560091543|FG000|Overall Study|Withdrawal by Subject|1|||
155178575|NCT02654717|560091544|FG000|Overall Study|Adverse Event|2|||
155178576|NCT02654717|560091545|FG001|Overall Study|Adverse Event|2|||
155178577|NCT02654717|560091544|FG000|Overall Study|Protocol Violation|1|||
155012646|NCT05906628|559471457|FG000|16-Week DBVC Period|Protocol Violation|4|||
155012647|NCT05906628|559471458|FG001|16-Week DBVC Period|Protocol Violation|2|||
155012648|NCT05906628|559471457|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
155012649|NCT05906628|559471458|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
155012650|NCT05906628|559471457|FG000|16-Week OLE Period|Death|1|||
155012651|NCT05906628|559471458|FG001|16-Week OLE Period|Death|0|||
155012652|NCT05906628|559471457|FG000|16-Week OLE Period|Lost to Follow-up|1|||
155012653|NCT05906628|559471458|FG001|16-Week OLE Period|Lost to Follow-up|1|||
155012654|NCT05906628|559471457|FG000|16-Week OLE Period|Protocol Violation|0|||
155012655|NCT05906628|559471458|FG001|16-Week OLE Period|Protocol Violation|1|||
155012656|NCT05906628|559471457|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
155012657|NCT05906628|559471458|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
155012658|NCT00837148|559471461|FG000|Overall Study|Adverse Event|1|||
155012659|NCT00837148|559471461|FG000|Overall Study|Death|1|||
155012660|NCT00931411|559471466|FG000|First Intervention - 42 Days|Adverse Event|2|||
155012661|NCT00931411|559471467|FG001|First Intervention - 42 Days|Adverse Event|3|||
155012662|NCT00931411|559471466|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
155012663|NCT00931411|559471467|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
155012664|NCT00931411|559471466|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
155012665|NCT00931411|559471467|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
155012666|NCT01306305|559471472|FG000|Overall Study|Lost to Follow-up|1|||
155012667|NCT01306305|559471473|FG001|Overall Study|Lost to Follow-up|0|||
155012668|NCT01306305|559471472|FG000|Overall Study|Withdrew consent|1|||
155012669|NCT01306305|559471473|FG001|Overall Study|Withdrew consent|0|||
155012670|NCT04030299|559471474|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
155012671|NCT04030299|559471474|FG000|Overall Study|Withdrawal by Subject|3|||
155012672|NCT00699998|559471475|FG000|Overall Study|Withdrawal by Subject|194|||
155012673|NCT00699998|559471476|FG001|Overall Study|Withdrawal by Subject|83|||
155012674|NCT00699998|559471477|FG002|Overall Study|Withdrawal by Subject|202|||
155012675|NCT00699998|559471478|FG003|Overall Study|Withdrawal by Subject|80|||
155012676|NCT00699998|559471475|FG000|Overall Study|Physician Decision|3|||
155012677|NCT00699998|559471476|FG001|Overall Study|Physician Decision|2|||
155012678|NCT00699998|559471477|FG002|Overall Study|Physician Decision|1|||
155012679|NCT00699998|559471478|FG003|Overall Study|Physician Decision|1|||
155012680|NCT00699998|559471475|FG000|Overall Study|Lost to Follow-up|2|||
155012681|NCT00699998|559471476|FG001|Overall Study|Lost to Follow-up|1|||
155012682|NCT00699998|559471477|FG002|Overall Study|Lost to Follow-up|3|||
155012683|NCT00699998|559471478|FG003|Overall Study|Lost to Follow-up|1|||
155012684|NCT04616612|559471483|FG000|Overall Study|Lost to Follow-up|6|||
155012685|NCT04616612|559471484|FG001|Overall Study|Lost to Follow-up|3|||
155012686|NCT04740918|559471486|FG000|Overall Study|Study Terminated by Sponsor|41|||
155012687|NCT04740918|559471487|FG001|Overall Study|Study Terminated by Sponsor|32|||
155012688|NCT04740918|559471486|FG000|Overall Study|Death|3|||
155012689|NCT04740918|559471487|FG001|Overall Study|Death|6|||
155012690|NCT04740918|559471486|FG000|Overall Study|Withdrawal by Subject|5|||
155012691|NCT04740918|559471487|FG001|Overall Study|Withdrawal by Subject|4|||
155012692|NCT04740918|559471486|FG000|Overall Study|Lost to Follow-up|1|||
155012693|NCT04740918|559471487|FG001|Overall Study|Lost to Follow-up|3|||
155012694|NCT04740918|559471486|FG000|Overall Study|Progressive disease|0|||
155012695|NCT04740918|559471487|FG001|Overall Study|Progressive disease|1|||
155012696|NCT01168427|559471488|FG000|Overall Study|Patient exited prior to implant|1|||
155012697|NCT02964247|559471490|FG000|Overall Study|Lost to Follow-up|2|||
155012698|NCT02964247|559471491|FG001|Overall Study|Lost to Follow-up|0|||
155012699|NCT02964247|559471490|FG000|Overall Study|Withdrawal by Subject|1|||
155012700|NCT02964247|559471491|FG001|Overall Study|Withdrawal by Subject|2|||
155012701|NCT03759392|559471492|FG000|Overall Study|Adverse Event|12|||
155012702|NCT03759392|559471493|FG001|Overall Study|Adverse Event|4|||
155012703|NCT03759392|559471492|FG000|Overall Study|Death|2|||
155012704|NCT03759392|559471493|FG001|Overall Study|Death|1|||
155012705|NCT03759392|559471492|FG000|Overall Study|Withdrawal by Subject|2|||
155012706|NCT03759392|559471493|FG001|Overall Study|Withdrawal by Subject|0|||
155012707|NCT03759392|559471492|FG000|Overall Study|Protocol Violation|2|||
155012708|NCT03759392|559471493|FG001|Overall Study|Protocol Violation|0|||
155012709|NCT03759392|559471492|FG000|Overall Study|Physician Decision|0|||
155012710|NCT03759392|559471493|FG001|Overall Study|Physician Decision|1|||
155012711|NCT03759392|559471492|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
155012712|NCT03759392|559471493|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
155178578|NCT02654717|560091545|FG001|Overall Study|Protocol Violation|2|||
155178579|NCT02654717|560091544|FG000|Overall Study|Withdrawal by Subject|0|||
155012713|NCT03759392|559471492|FG000|Overall Study|No longer able to take medicines|1|||
155012714|NCT03759392|559471493|FG001|Overall Study|No longer able to take medicines|0|||
155178580|NCT02654717|560091545|FG001|Overall Study|Withdrawal by Subject|1|||
155012715|NCT03759392|559471492|FG000|Overall Study|Stopped taking study drug|1|||
155012716|NCT03759392|559471493|FG001|Overall Study|Stopped taking study drug|0|||
155012717|NCT01288079|559471494|FG000|Overall Study|Withdrawal by Subject|2|||
155012718|NCT01288079|559471495|FG001|Overall Study|Withdrawal by Subject|4|||
155012719|NCT01288079|559471496|FG002|Overall Study|Withdrawal by Subject|1|||
155012720|NCT01288079|559471497|FG003|Overall Study|Withdrawal by Subject|0|||
155012721|NCT01288079|559471494|FG000|Overall Study|Adverse Event|2|||
155012722|NCT01288079|559471495|FG001|Overall Study|Adverse Event|1|||
155012723|NCT01288079|559471496|FG002|Overall Study|Adverse Event|2|||
155012724|NCT01288079|559471497|FG003|Overall Study|Adverse Event|3|||
155012725|NCT01288079|559471494|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
155012726|NCT01288079|559471495|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
155012727|NCT01288079|559471496|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
155012728|NCT01288079|559471497|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
155012729|NCT01288079|559471494|FG000|Overall Study|Condition under Investigation Worsened|0|||
155012730|NCT01288079|559471495|FG001|Overall Study|Condition under Investigation Worsened|0|||
155012731|NCT01288079|559471496|FG002|Overall Study|Condition under Investigation Worsened|0|||
155012732|NCT01288079|559471497|FG003|Overall Study|Condition under Investigation Worsened|1|||
155012733|NCT01288079|559471494|FG000|Overall Study|Lack of Efficacy|2|||
155012734|NCT01288079|559471495|FG001|Overall Study|Lack of Efficacy|2|||
155012735|NCT01288079|559471496|FG002|Overall Study|Lack of Efficacy|0|||
155012736|NCT01288079|559471497|FG003|Overall Study|Lack of Efficacy|2|||
155012737|NCT01288079|559471494|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
155012738|NCT01288079|559471495|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
155012739|NCT01288079|559471496|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
155012740|NCT01288079|559471497|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
155012741|NCT01288079|559471494|FG000|Overall Study|Lost to Follow-up|1|||
155012742|NCT01288079|559471495|FG001|Overall Study|Lost to Follow-up|1|||
155012743|NCT01288079|559471496|FG002|Overall Study|Lost to Follow-up|1|||
155012744|NCT01288079|559471497|FG003|Overall Study|Lost to Follow-up|0|||
155012745|NCT01288079|559471494|FG000|Overall Study|Other or Study Termination|11|||
155012746|NCT01288079|559471495|FG001|Overall Study|Other or Study Termination|15|||
155012747|NCT01288079|559471496|FG002|Overall Study|Other or Study Termination|14|||
155012748|NCT01288079|559471497|FG003|Overall Study|Other or Study Termination|8|||
155012749|NCT01530464|559471498|FG000|Washout (24h)|Withdrawal by Subject|1|||
155012750|NCT01530464|559471499|FG001|Washout (24h)|Withdrawal by Subject|0|||
155012751|NCT01530464|559471498|FG000|Washout (24h)|Withdrawal by Subject|0|||
155012752|NCT01530464|559471499|FG001|Washout (24h)|Withdrawal by Subject|1|||
155012753|NCT01709500|559471500|FG000|Overall Study|Randomized but not treated|0|||
155012754|NCT01709500|559471501|FG001|Overall Study|Randomized but not treated|1|||
155012755|NCT01709500|559471500|FG000|Overall Study|Adverse Event|5|||
155012756|NCT01709500|559471501|FG001|Overall Study|Adverse Event|1|||
155012757|NCT01709500|559471500|FG000|Overall Study|Poor compliance to protocol|2|||
155012758|NCT01709500|559471501|FG001|Overall Study|Poor compliance to protocol|1|||
155012759|NCT01709500|559471500|FG000|Overall Study|Other|3|||
155012760|NCT01709500|559471501|FG001|Overall Study|Other|1|||
155012761|NCT01709500|559471500|FG000|Overall Study|Related to IMP administration|1|||
155012762|NCT01709500|559471501|FG001|Overall Study|Related to IMP administration|0|||
155012763|NCT01709500|559471500|FG000|Overall Study|Treatment ongoing|156|||
155012764|NCT01709500|559471501|FG001|Overall Study|Treatment ongoing|78|||
155012765|NCT03539302|559471508|FG000|Overall Study|Spontaneous cardio version|0|||
155012766|NCT03539302|559471509|FG001|Overall Study|Spontaneous cardio version|0|||
155012767|NCT03539302|559471510|FG002|Overall Study|Spontaneous cardio version|0|||
155012768|NCT03539302|559471511|FG003|Overall Study|Spontaneous cardio version|0|||
155012769|NCT03539302|559471512|FG004|Overall Study|Spontaneous cardio version|0|||
155012770|NCT03539302|559471513|FG005|Overall Study|Spontaneous cardio version|1|||
155012771|NCT03539302|559471514|FG006|Overall Study|Spontaneous cardio version|1|||
155012772|NCT02107131|559471516|FG000|Overall Study|Lost to Follow-up|4|||
155012773|NCT02107131|559471517|FG001|Overall Study|Lost to Follow-up|4|||
155012774|NCT02107131|559471516|FG000|Overall Study|Physician Decision|1|||
155012775|NCT02107131|559471517|FG001|Overall Study|Physician Decision|0|||
155012776|NCT02107131|559471516|FG000|Overall Study|Withdrawal by Subject|2|||
155012777|NCT02107131|559471517|FG001|Overall Study|Withdrawal by Subject|0|||
155012778|NCT02107131|559471516|FG000|Overall Study|mental instability|1|||
155178581|NCT02654717|560091544|FG000|Overall Study|Non-permitted medication|3|||
155012779|NCT02107131|559471517|FG001|Overall Study|mental instability|0|||
155012780|NCT02107131|559471516|FG000|Overall Study|Death|0|||
155012781|NCT02107131|559471517|FG001|Overall Study|Death|1|||
155012782|NCT02107131|559471516|FG000|Overall Study|Protocol Violation|0|||
155012783|NCT02107131|559471517|FG001|Overall Study|Protocol Violation|4|||
155012784|NCT04314037|559471519|FG000|Treatment Period 2|Adverse Event|1|||
155012785|NCT04314037|559471520|FG001|Treatment Period 2|Adverse Event|0|||
155012786|NCT04314037|559471519|FG000|Treatment Period 3|Protocol Violation|1|||
155012787|NCT04314037|559471520|FG001|Treatment Period 3|Protocol Violation|0|||
155012788|NCT04314037|559471519|FG000|Treatment Period 3|Adverse Event|0|||
155012789|NCT04314037|559471520|FG001|Treatment Period 3|Adverse Event|1|||
155132290|NCT01359943|559915760|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
155132291|NCT01359943|559915758|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
155132292|NCT01359943|559915759|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
155132293|NCT01359943|559915760|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
155132294|NCT01359943|559915758|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
155132295|NCT01359943|559915759|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
155132296|NCT01359943|559915760|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
155132297|NCT01359943|559915758|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
155132298|NCT01359943|559915759|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
155132299|NCT01359943|559915760|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
155132300|NCT01359943|559915758|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
155132301|NCT01359943|559915759|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
155132302|NCT01359943|559915760|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
155132303|NCT01359943|559915758|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
155132304|NCT01359943|559915759|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
155132305|NCT01359943|559915760|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
155132306|NCT02516592|559915761|FG000|Overall Study|Patient withdrew consent|5|||
155132307|NCT02516592|559915762|FG001|Overall Study|Patient withdrew consent|2|||
155132308|NCT02516592|559915761|FG000|Overall Study|Protocol deviation|4|||
155132309|NCT02516592|559915762|FG001|Overall Study|Protocol deviation|4|||
155132310|NCT02516592|559915761|FG000|Overall Study|Lost to Follow-up|2|||
155132311|NCT02516592|559915762|FG001|Overall Study|Lost to Follow-up|3|||
155132312|NCT02516592|559915761|FG000|Overall Study|Patient/guardian decision|2|||
155132313|NCT02516592|559915762|FG001|Overall Study|Patient/guardian decision|1|||
155132314|NCT02516592|559915761|FG000|Overall Study|Adverse Event|1|||
155132315|NCT02516592|559915762|FG001|Overall Study|Adverse Event|2|||
155132316|NCT02516592|559915761|FG000|Overall Study|Abnormal test procedure result|1|||
155132317|NCT02516592|559915762|FG001|Overall Study|Abnormal test procedure result|0|||
155132318|NCT02516592|559915761|FG000|Overall Study|Death|1|||
155132319|NCT02516592|559915762|FG001|Overall Study|Death|1|||
155132320|NCT01110382|559915763|FG000|Overall Study|Withdrawal by Subject|0|||
155132321|NCT01110382|559915764|FG001|Overall Study|Withdrawal by Subject|1|||
155132322|NCT01110382|559915763|FG000|Overall Study|Protocol Violation|0|||
155132323|NCT01110382|559915764|FG001|Overall Study|Protocol Violation|1|||
155132324|NCT00098306|559915767|FG000|Double Blind|Randomized, not treated|9|||
155132325|NCT00098306|559915768|FG001|Double Blind|Randomized, not treated|5|||
155132326|NCT00098306|559915769|FG002|Double Blind|Randomized, not treated|2|||
155132327|NCT00098306|559915770|FG003|Double Blind|Randomized, not treated|0|||
155132328|NCT00098306|559915771|FG004|Double Blind|Randomized, not treated|0|||
155132329|NCT00098306|559915772|FG005|Double Blind|Randomized, not treated|0|||
155132330|NCT00098306|559915773|FG006|Double Blind|Randomized, not treated|0|||
155132331|NCT00098306|559915767|FG000|Double Blind|Ongoing at cut-off date|151|||
155132332|NCT00098306|559915768|FG001|Double Blind|Ongoing at cut-off date|166|||
155132333|NCT00098306|559915769|FG002|Double Blind|Ongoing at cut-off date|72|||
155132334|NCT00098306|559915770|FG003|Double Blind|Ongoing at cut-off date|0|||
155132335|NCT00098306|559915771|FG004|Double Blind|Ongoing at cut-off date|0|||
155132336|NCT00098306|559915772|FG005|Double Blind|Ongoing at cut-off date|0|||
155132337|NCT00098306|559915773|FG006|Double Blind|Ongoing at cut-off date|0|||
155132338|NCT00098306|559915767|FG000|Double Blind|Adverse Event|11|||
155132339|NCT00098306|559915768|FG001|Double Blind|Adverse Event|10|||
155132340|NCT00098306|559915769|FG002|Double Blind|Adverse Event|6|||
155132341|NCT00098306|559915770|FG003|Double Blind|Adverse Event|0|||
155132342|NCT00098306|559915771|FG004|Double Blind|Adverse Event|0|||
155132343|NCT00098306|559915772|FG005|Double Blind|Adverse Event|0|||
155132344|NCT00098306|559915773|FG006|Double Blind|Adverse Event|0|||
155132345|NCT00098306|559915767|FG000|Double Blind|Lack of Efficacy|43|||
155132346|NCT00098306|559915768|FG001|Double Blind|Lack of Efficacy|34|||
155132347|NCT00098306|559915769|FG002|Double Blind|Lack of Efficacy|17|||
155132348|NCT00098306|559915770|FG003|Double Blind|Lack of Efficacy|0|||
155012790|NCT00856492|559471523|FG000|Overall Study|Ineligible or withdrew consent|1|||
155132349|NCT00098306|559915771|FG004|Double Blind|Lack of Efficacy|0|||
155132350|NCT00098306|559915772|FG005|Double Blind|Lack of Efficacy|0|||
155132351|NCT00098306|559915773|FG006|Double Blind|Lack of Efficacy|0|||
155012791|NCT00856492|559471524|FG001|Overall Study|Ineligible or withdrew consent|1|||
155012792|NCT00856492|559471525|FG002|Overall Study|Ineligible or withdrew consent|2|||
155132352|NCT00098306|559915767|FG000|Double Blind|Death|1|||
155132353|NCT00098306|559915768|FG001|Double Blind|Death|4|||
155132354|NCT00098306|559915769|FG002|Double Blind|Death|1|||
155132355|NCT00098306|559915770|FG003|Double Blind|Death|0|||
155132356|NCT00098306|559915771|FG004|Double Blind|Death|0|||
155132357|NCT00098306|559915772|FG005|Double Blind|Death|0|||
155132358|NCT00098306|559915773|FG006|Double Blind|Death|0|||
155132359|NCT00098306|559915767|FG000|Double Blind|Participant defaulted|19|||
155132360|NCT00098306|559915768|FG001|Double Blind|Participant defaulted|18|||
155132361|NCT00098306|559915769|FG002|Double Blind|Participant defaulted|11|||
155132362|NCT00098306|559915770|FG003|Double Blind|Participant defaulted|0|||
155132363|NCT00098306|559915771|FG004|Double Blind|Participant defaulted|0|||
155132364|NCT00098306|559915772|FG005|Double Blind|Participant defaulted|0|||
155132365|NCT00098306|559915773|FG006|Double Blind|Participant defaulted|0|||
155132366|NCT00098306|559915767|FG000|Double Blind|Un-specified|7|||
155132367|NCT00098306|559915768|FG001|Double Blind|Un-specified|3|||
155132368|NCT00098306|559915769|FG002|Double Blind|Un-specified|11|||
155132369|NCT00098306|559915770|FG003|Double Blind|Un-specified|0|||
155132370|NCT00098306|559915771|FG004|Double Blind|Un-specified|0|||
155132371|NCT00098306|559915772|FG005|Double Blind|Un-specified|0|||
155132372|NCT00098306|559915773|FG006|Double Blind|Un-specified|0|||
155132373|NCT00098306|559915767|FG000|Open Label|Lack of Efficacy|0|||
155132374|NCT00098306|559915768|FG001|Open Label|Lack of Efficacy|0|||
155132375|NCT00098306|559915769|FG002|Open Label|Lack of Efficacy|0|||
155132376|NCT00098306|559915770|FG003|Open Label|Lack of Efficacy|13|||
155132377|NCT00098306|559915771|FG004|Open Label|Lack of Efficacy|0|||
155132378|NCT00098306|559915772|FG005|Open Label|Lack of Efficacy|0|||
155132379|NCT00098306|559915773|FG006|Open Label|Lack of Efficacy|0|||
155132380|NCT00098306|559915767|FG000|Open Label|Adverse Event|0|||
155132381|NCT00098306|559915768|FG001|Open Label|Adverse Event|0|||
155132382|NCT00098306|559915769|FG002|Open Label|Adverse Event|0|||
155132383|NCT00098306|559915770|FG003|Open Label|Adverse Event|2|||
155132384|NCT00098306|559915771|FG004|Open Label|Adverse Event|0|||
155132385|NCT00098306|559915772|FG005|Open Label|Adverse Event|0|||
155132386|NCT00098306|559915773|FG006|Open Label|Adverse Event|0|||
155132387|NCT00098306|559915767|FG000|Open Label|Death|0|||
155132388|NCT00098306|559915768|FG001|Open Label|Death|0|||
155132389|NCT00098306|559915769|FG002|Open Label|Death|0|||
155132390|NCT00098306|559915770|FG003|Open Label|Death|4|||
155132391|NCT00098306|559915771|FG004|Open Label|Death|0|||
155132392|NCT00098306|559915772|FG005|Open Label|Death|0|||
155132393|NCT00098306|559915773|FG006|Open Label|Death|0|||
155132394|NCT00098306|559915767|FG000|Open Label|Participant defaulted|0|||
154923906|NCT04668066|559146368|FG002|Part 1: Treatment Phase|Adverse Event|0|||
154923907|NCT04668066|559146369|FG003|Part 1: Treatment Phase|Adverse Event|0|||
154923908|NCT04668066|559146370|FG004|Part 1: Treatment Phase|Adverse Event|0|||
154923909|NCT04668066|559146371|FG005|Part 1: Treatment Phase|Adverse Event|0|||
154923910|NCT04668066|559146372|FG006|Part 1: Treatment Phase|Adverse Event|0|||
154923911|NCT04668066|559146373|FG007|Part 1: Treatment Phase|Adverse Event|0|||
154923912|NCT04668066|559146374|FG008|Part 1: Treatment Phase|Adverse Event|0|||
154923913|NCT04668066|559146375|FG009|Part 1: Treatment Phase|Adverse Event|0|||
154923914|NCT04668066|559146376|FG010|Part 1: Treatment Phase|Adverse Event|0|||
154923915|NCT04668066|559146377|FG011|Part 1: Treatment Phase|Adverse Event|1|||
154923916|NCT04668066|559146378|FG012|Part 1: Treatment Phase|Adverse Event|1|||
154923917|NCT04668066|559146379|FG013|Part 1: Treatment Phase|Adverse Event|0|||
154923918|NCT04668066|559146380|FG014|Part 1: Treatment Phase|Adverse Event|0|||
154923919|NCT04668066|559146381|FG015|Part 1: Treatment Phase|Adverse Event|0|||
154923920|NCT04668066|559146382|FG016|Part 1: Treatment Phase|Adverse Event|0|||
154923921|NCT04668066|559146383|FG017|Part 1: Treatment Phase|Adverse Event|0|||
154923922|NCT04668066|559146384|FG018|Part 1: Treatment Phase|Adverse Event|0|||
154923923|NCT04668066|559146366|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923924|NCT04668066|559146367|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923925|NCT04668066|559146368|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
154923926|NCT04668066|559146369|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923927|NCT04668066|559146370|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923928|NCT04668066|559146371|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
155012793|NCT00739882|559473348|FG000|Double-blind Period|Adverse Event|1|||
155012794|NCT00739882|559473349|FG001|Double-blind Period|Adverse Event|2|||
155012795|NCT00739882|559473348|FG000|Double-blind Period|Protocol Violation|1|||
155012796|NCT00739882|559473349|FG001|Double-blind Period|Protocol Violation|0|||
155012797|NCT00739882|559473348|FG000|Double-blind Period|Lack of Efficacy|1|||
155012798|NCT00739882|559473349|FG001|Double-blind Period|Lack of Efficacy|1|||
155012799|NCT00739882|559473348|FG000|Double-blind Period|Other|16|||
155012800|NCT00739882|559473349|FG001|Double-blind Period|Other|8|||
155012801|NCT00739882|559473348|FG000|Open-label Period|Adverse Event|1|||
154923929|NCT04668066|559146372|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923930|NCT04668066|559146373|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923931|NCT04668066|559146374|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
155012802|NCT00739882|559473349|FG001|Open-label Period|Adverse Event|0|||
155012803|NCT00739882|559473348|FG000|Open-label Period|Other|9|||
155132395|NCT00098306|559915768|FG001|Open Label|Participant defaulted|0|||
155012804|NCT00739882|559473349|FG001|Open-label Period|Other|5|||
155012805|NCT04021914|559473350|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
155132396|NCT00098306|559915769|FG002|Open Label|Participant defaulted|0|||
155132397|NCT00098306|559915770|FG003|Open Label|Participant defaulted|24|||
155132398|NCT00098306|559915771|FG004|Open Label|Participant defaulted|0|||
155132399|NCT00098306|559915772|FG005|Open Label|Participant defaulted|0|||
155132400|NCT00098306|559915773|FG006|Open Label|Participant defaulted|0|||
155132401|NCT00098306|559915767|FG000|Open Label|Un-specified|0|||
155132402|NCT00098306|559915768|FG001|Open Label|Un-specified|0|||
155132403|NCT00098306|559915769|FG002|Open Label|Un-specified|0|||
155132404|NCT00098306|559915770|FG003|Open Label|Un-specified|15|||
154923932|NCT04668066|559146375|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
155132405|NCT00098306|559915771|FG004|Open Label|Un-specified|0|||
155132406|NCT00098306|559915772|FG005|Open Label|Un-specified|0|||
155132407|NCT00098306|559915773|FG006|Open Label|Un-specified|0|||
155132408|NCT00098306|559915767|FG000|Open Label|Ongoing at cut-off date|0|||
155132409|NCT00098306|559915768|FG001|Open Label|Ongoing at cut-off date|0|||
155132410|NCT00098306|559915769|FG002|Open Label|Ongoing at cut-off date|0|||
155132411|NCT00098306|559915770|FG003|Open Label|Ongoing at cut-off date|269|||
155132412|NCT00098306|559915771|FG004|Open Label|Ongoing at cut-off date|62|||
155132413|NCT00098306|559915772|FG005|Open Label|Ongoing at cut-off date|0|||
155132414|NCT00098306|559915773|FG006|Open Label|Ongoing at cut-off date|0|||
155132415|NCT00098306|559915767|FG000|Observational Phase|Death|0|||
155132416|NCT00098306|559915768|FG001|Observational Phase|Death|0|||
155132417|NCT00098306|559915769|FG002|Observational Phase|Death|0|||
155132418|NCT00098306|559915770|FG003|Observational Phase|Death|0|||
155132419|NCT00098306|559915771|FG004|Observational Phase|Death|0|||
155132420|NCT00098306|559915772|FG005|Observational Phase|Death|5|||
155132421|NCT00098306|559915773|FG006|Observational Phase|Death|4|||
155132422|NCT00098306|559915767|FG000|Observational Phase|Participant defaulted|0|||
155132423|NCT00098306|559915768|FG001|Observational Phase|Participant defaulted|0|||
155132424|NCT00098306|559915769|FG002|Observational Phase|Participant defaulted|0|||
155132425|NCT00098306|559915770|FG003|Observational Phase|Participant defaulted|0|||
155132426|NCT00098306|559915771|FG004|Observational Phase|Participant defaulted|0|||
155132427|NCT00098306|559915772|FG005|Observational Phase|Participant defaulted|34|||
155132428|NCT00098306|559915773|FG006|Observational Phase|Participant defaulted|18|||
155132429|NCT00098306|559915767|FG000|Observational Phase|Un-specified|0|||
155132430|NCT00098306|559915768|FG001|Observational Phase|Un-specified|0|||
155132431|NCT00098306|559915769|FG002|Observational Phase|Un-specified|0|||
155132432|NCT00098306|559915770|FG003|Observational Phase|Un-specified|0|||
155132433|NCT00098306|559915771|FG004|Observational Phase|Un-specified|0|||
155132434|NCT00098306|559915772|FG005|Observational Phase|Un-specified|7|||
155132435|NCT00098306|559915773|FG006|Observational Phase|Un-specified|4|||
155132436|NCT00470418|559915774|FG000|Overall Study|Withdrawal by Subject|1|||
155132437|NCT00470418|559915775|FG001|Overall Study|Withdrawal by Subject|0|||
155132438|NCT03688100|559915778|FG000|Overall Study|Lost to Follow-up|21|||
155132439|NCT03688100|559915779|FG001|Overall Study|Lost to Follow-up|15|||
155132440|NCT03688100|559915780|FG002|Overall Study|Lost to Follow-up|15|||
155132441|NCT03688100|559915781|FG003|Overall Study|Lost to Follow-up|18|||
155132442|NCT03688100|559915778|FG000|Overall Study|Withdrawal by Subject|19|||
155132443|NCT03688100|559915779|FG001|Overall Study|Withdrawal by Subject|16|||
155132444|NCT03688100|559915780|FG002|Overall Study|Withdrawal by Subject|0|||
155132445|NCT03688100|559915781|FG003|Overall Study|Withdrawal by Subject|0|||
155132446|NCT03688100|559915778|FG000|Overall Study|Death|36|||
155132447|NCT03688100|559915779|FG001|Overall Study|Death|27|||
155132448|NCT03688100|559915780|FG002|Overall Study|Death|0|||
155132449|NCT03688100|559915781|FG003|Overall Study|Death|0|||
155132450|NCT01331291|559915787|FG000|Overall Study|Lack of Efficacy|2|||
155132451|NCT01331291|559915788|FG001|Overall Study|Lack of Efficacy|8|||
155132452|NCT01331291|559915787|FG000|Overall Study|Death|0|||
155132453|NCT01331291|559915788|FG001|Overall Study|Death|1|||
155132454|NCT01026220|559915789|FG000|Induction|Death|1|||
155132455|NCT01026220|559915790|FG001|Induction|Death|0|||
155132456|NCT01026220|559915791|FG002|Induction|Death|0|||
155132457|NCT01026220|559915789|FG000|Induction|Lack of Efficacy|2|||
155132458|NCT01026220|559915790|FG001|Induction|Lack of Efficacy|0|||
155132459|NCT01026220|559915791|FG002|Induction|Lack of Efficacy|0|||
155132460|NCT01026220|559915789|FG000|Induction|Physician Decision|12|||
155132461|NCT01026220|559915790|FG001|Induction|Physician Decision|0|||
155132462|NCT01026220|559915791|FG002|Induction|Physician Decision|0|||
155132463|NCT01026220|559915789|FG000|Induction|Withdrawal by Subject|9|||
154923933|NCT04668066|559146376|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923934|NCT04668066|559146377|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
155132464|NCT01026220|559915790|FG001|Induction|Withdrawal by Subject|0|||
155132465|NCT01026220|559915791|FG002|Induction|Withdrawal by Subject|0|||
155132466|NCT01026220|559915789|FG000|Induction|Ineligible|1|||
155132467|NCT01026220|559915790|FG001|Induction|Ineligible|0|||
155132468|NCT01026220|559915791|FG002|Induction|Ineligible|0|||
155132469|NCT01026220|559915789|FG000|Consolidation Maintenance|Death|0|||
155132470|NCT01026220|559915790|FG001|Consolidation Maintenance|Death|1|||
155132471|NCT01026220|559915791|FG002|Consolidation Maintenance|Death|0|||
155132472|NCT01026220|559915789|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
155132473|NCT01026220|559915790|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
155132474|NCT01026220|559915791|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
155132475|NCT01026220|559915789|FG000|Consolidation Maintenance|Physician Decision|0|||
155132476|NCT01026220|559915790|FG001|Consolidation Maintenance|Physician Decision|2|||
155132477|NCT01026220|559915791|FG002|Consolidation Maintenance|Physician Decision|7|||
155132478|NCT01026220|559915789|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
155132479|NCT01026220|559915790|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
155132480|NCT01026220|559915791|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
155132481|NCT00409344|559915793|FG000|Overall Study|no enrollment|0|||
155132482|NCT00409344|559915794|FG001|Overall Study|no enrollment|0|||
155132483|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
155132484|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
155132485|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
155132486|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
155132487|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
155132488|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
155132489|NCT01389323|559915800|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
155132490|NCT01389323|559915800|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
155132491|NCT01389323|559915800|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
155132492|NCT01389323|559915800|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
155132493|NCT01389323|559915800|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
155132494|NCT05096312|559915801|FG000|Overall Study|Lost to Follow-up|2|||
155132495|NCT05096312|559915802|FG001|Overall Study|Lost to Follow-up|4|||
155132496|NCT05096312|559915801|FG000|Overall Study|Adverse Event|1|||
155132497|NCT05096312|559915802|FG001|Overall Study|Adverse Event|0|||
155132498|NCT03135210|559915803|FG000|Overall Study|Death|0|||
155132499|NCT03135210|559915804|FG001|Overall Study|Death|1|||
155132500|NCT01183468|559915806|FG000|Overall Study|Lost to Follow-up|2|||
155132501|NCT01183468|559915807|FG001|Overall Study|Lost to Follow-up|1|||
155132502|NCT01183468|559915808|FG002|Overall Study|Lost to Follow-up|0|||
155132503|NCT01183468|559915809|FG003|Overall Study|Lost to Follow-up|0|||
155132504|NCT01183468|559915806|FG000|Overall Study|Physician Decision|1|||
155132505|NCT01183468|559915807|FG001|Overall Study|Physician Decision|0|||
155132506|NCT01183468|559915808|FG002|Overall Study|Physician Decision|0|||
155132507|NCT01183468|559915809|FG003|Overall Study|Physician Decision|0|||
155132508|NCT01183468|559915806|FG000|Overall Study|Withdrawal by Subject|0|||
155132509|NCT01183468|559915807|FG001|Overall Study|Withdrawal by Subject|1|||
155132510|NCT01183468|559915808|FG002|Overall Study|Withdrawal by Subject|0|||
155132511|NCT01183468|559915809|FG003|Overall Study|Withdrawal by Subject|0|||
155132512|NCT03927404|559915810|FG000|Overall Study|Withdrawal by Subject|1|||
155132513|NCT01229449|559915811|FG000|Overall Study|Withdrawal by Subject|0|||
155132514|NCT01229449|559915812|FG001|Overall Study|Withdrawal by Subject|3|||
155132515|NCT01229449|559915813|FG002|Overall Study|Withdrawal by Subject|0|||
155132516|NCT01229449|559915814|FG003|Overall Study|Withdrawal by Subject|1|||
155132517|NCT01229449|559915815|FG004|Overall Study|Withdrawal by Subject|1|||
155132518|NCT01229449|559915811|FG000|Overall Study|Lost to Follow-up|1|||
155132519|NCT01229449|559915812|FG001|Overall Study|Lost to Follow-up|1|||
155132520|NCT01229449|559915813|FG002|Overall Study|Lost to Follow-up|1|||
155132521|NCT01229449|559915814|FG003|Overall Study|Lost to Follow-up|0|||
155132522|NCT01229449|559915815|FG004|Overall Study|Lost to Follow-up|0|||
155132523|NCT01229449|559915811|FG000|Overall Study|Physician Decision|0|||
155132524|NCT01229449|559915812|FG001|Overall Study|Physician Decision|0|||
155132525|NCT01229449|559915813|FG002|Overall Study|Physician Decision|1|||
155132526|NCT01229449|559915814|FG003|Overall Study|Physician Decision|0|||
155132527|NCT01229449|559915815|FG004|Overall Study|Physician Decision|0|||
155132528|NCT03203291|559915819|FG000|Overall Study|Withdrawal by Subject|1|||
155132529|NCT01300260|559915820|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
155132530|NCT01300260|559915821|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
155132531|NCT01300260|559915820|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
155132532|NCT01300260|559915821|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
155132533|NCT01300260|559915820|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
155132534|NCT01300260|559915821|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
155132535|NCT05098509|559915825|FG000|Overall Study|Withdrawal by Subject|0|||
155132536|NCT05098509|559915826|FG001|Overall Study|Withdrawal by Subject|0|||
155132537|NCT05098509|559915827|FG002|Overall Study|Withdrawal by Subject|1|||
155132538|NCT05098509|559915828|FG003|Overall Study|Withdrawal by Subject|0|||
155132539|NCT05098509|559915825|FG000|Overall Study|Early study termination|1|||
155132540|NCT05098509|559915826|FG001|Overall Study|Early study termination|1|||
155132541|NCT05098509|559915827|FG002|Overall Study|Early study termination|1|||
155132542|NCT05098509|559915828|FG003|Overall Study|Early study termination|0|||
155132543|NCT04033068|559915829|FG000|Overall Study|Withdrawal by Subject|0|||
155132544|NCT04033068|559915830|FG001|Overall Study|Withdrawal by Subject|0|||
155132545|NCT04033068|559915831|FG002|Overall Study|Withdrawal by Subject|1|||
155132546|NCT04033068|559915832|FG003|Overall Study|Withdrawal by Subject|0|||
155132547|NCT04033068|559915829|FG000|Overall Study|Lost to Follow-up|0|||
155132548|NCT04033068|559915830|FG001|Overall Study|Lost to Follow-up|1|||
155132549|NCT04033068|559915831|FG002|Overall Study|Lost to Follow-up|0|||
155132550|NCT04033068|559915832|FG003|Overall Study|Lost to Follow-up|0|||
155132551|NCT04033068|559915829|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
155132552|NCT04033068|559915830|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
155132553|NCT04033068|559915831|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
155132554|NCT04033068|559915832|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
155132555|NCT03157037|559915833|FG000|Overall Study|Death|1|||
155012806|NCT00955409|559473351|FG000|Overall Study|Lack of Efficacy|1|||
155012807|NCT00955409|559473352|FG001|Overall Study|Lack of Efficacy|0|||
155012808|NCT00955409|559473353|FG002|Overall Study|Lack of Efficacy|0|||
155012809|NCT00955409|559473354|FG003|Overall Study|Lack of Efficacy|0|||
155012810|NCT00955409|559473355|FG004|Overall Study|Lack of Efficacy|0|||
155012811|NCT00955409|559473356|FG005|Overall Study|Lack of Efficacy|0|||
155012812|NCT00955409|559473357|FG006|Overall Study|Lack of Efficacy|0|||
155012813|NCT00955409|559473358|FG007|Overall Study|Lack of Efficacy|0|||
155012814|NCT00955409|559473359|FG008|Overall Study|Lack of Efficacy|0|||
155012815|NCT00955409|559473360|FG009|Overall Study|Lack of Efficacy|0|||
155012816|NCT00955409|559473351|FG000|Overall Study|Withdrawal by Subject|1|||
155012817|NCT00955409|559473352|FG001|Overall Study|Withdrawal by Subject|0|||
155012818|NCT00955409|559473353|FG002|Overall Study|Withdrawal by Subject|5|||
155012819|NCT00955409|559473354|FG003|Overall Study|Withdrawal by Subject|2|||
155012820|NCT00955409|559473355|FG004|Overall Study|Withdrawal by Subject|0|||
155012821|NCT00955409|559473356|FG005|Overall Study|Withdrawal by Subject|0|||
155012822|NCT00955409|559473357|FG006|Overall Study|Withdrawal by Subject|2|||
155012823|NCT00955409|559473358|FG007|Overall Study|Withdrawal by Subject|0|||
155012824|NCT00955409|559473359|FG008|Overall Study|Withdrawal by Subject|1|||
155012825|NCT00955409|559473360|FG009|Overall Study|Withdrawal by Subject|0|||
155012826|NCT00955409|559473351|FG000|Overall Study|Caregiver Request|2|||
155012827|NCT00955409|559473352|FG001|Overall Study|Caregiver Request|0|||
155012828|NCT00955409|559473353|FG002|Overall Study|Caregiver Request|6|||
155012829|NCT00955409|559473354|FG003|Overall Study|Caregiver Request|5|||
155012830|NCT00955409|559473355|FG004|Overall Study|Caregiver Request|0|||
155012831|NCT00955409|559473356|FG005|Overall Study|Caregiver Request|2|||
155012832|NCT00955409|559473357|FG006|Overall Study|Caregiver Request|3|||
155012833|NCT00955409|559473358|FG007|Overall Study|Caregiver Request|1|||
155012834|NCT00955409|559473359|FG008|Overall Study|Caregiver Request|3|||
155012835|NCT00955409|559473360|FG009|Overall Study|Caregiver Request|0|||
155012836|NCT00955409|559473351|FG000|Overall Study|Investigator Request|0|||
155012837|NCT00955409|559473352|FG001|Overall Study|Investigator Request|0|||
155012838|NCT00955409|559473353|FG002|Overall Study|Investigator Request|1|||
155012839|NCT00955409|559473354|FG003|Overall Study|Investigator Request|0|||
155012840|NCT00955409|559473355|FG004|Overall Study|Investigator Request|0|||
155012841|NCT00955409|559473356|FG005|Overall Study|Investigator Request|0|||
155012842|NCT00955409|559473357|FG006|Overall Study|Investigator Request|0|||
155012843|NCT00955409|559473358|FG007|Overall Study|Investigator Request|0|||
155012844|NCT00955409|559473359|FG008|Overall Study|Investigator Request|0|||
155012845|NCT00955409|559473360|FG009|Overall Study|Investigator Request|0|||
155012846|NCT00955409|559473351|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
155012847|NCT00955409|559473352|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155012848|NCT00955409|559473353|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
155012849|NCT00955409|559473354|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
155012850|NCT00955409|559473355|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
155012851|NCT00955409|559473356|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
155012852|NCT00955409|559473357|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
155012853|NCT00955409|559473358|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
155012854|NCT00955409|559473359|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
155012855|NCT00955409|559473360|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
155012856|NCT00955409|559473351|FG000|Overall Study|Lost to Follow-up|0|||
155012857|NCT00955409|559473352|FG001|Overall Study|Lost to Follow-up|0|||
155012858|NCT00955409|559473353|FG002|Overall Study|Lost to Follow-up|1|||
155012859|NCT00955409|559473354|FG003|Overall Study|Lost to Follow-up|0|||
155012860|NCT00955409|559473355|FG004|Overall Study|Lost to Follow-up|0|||
155012861|NCT00955409|559473356|FG005|Overall Study|Lost to Follow-up|0|||
155012862|NCT00955409|559473357|FG006|Overall Study|Lost to Follow-up|1|||
155012863|NCT00955409|559473358|FG007|Overall Study|Lost to Follow-up|0|||
155012864|NCT00955409|559473359|FG008|Overall Study|Lost to Follow-up|0|||
155012865|NCT00955409|559473360|FG009|Overall Study|Lost to Follow-up|0|||
155012866|NCT00955409|559473351|FG000|Overall Study|Failed to Return|2|||
155012867|NCT00955409|559473352|FG001|Overall Study|Failed to Return|0|||
155012868|NCT00955409|559473353|FG002|Overall Study|Failed to Return|0|||
155012869|NCT00955409|559473354|FG003|Overall Study|Failed to Return|0|||
155012870|NCT00955409|559473355|FG004|Overall Study|Failed to Return|0|||
155012871|NCT00955409|559473356|FG005|Overall Study|Failed to Return|0|||
155012872|NCT00955409|559473357|FG006|Overall Study|Failed to Return|0|||
155012873|NCT00955409|559473358|FG007|Overall Study|Failed to Return|2|||
155012874|NCT00955409|559473359|FG008|Overall Study|Failed to Return|0|||
155012875|NCT00955409|559473360|FG009|Overall Study|Failed to Return|0|||
155012876|NCT00955409|559473351|FG000|Overall Study|Adverse Event (AE)|2|||
155012877|NCT00955409|559473352|FG001|Overall Study|Adverse Event (AE)|0|||
155012878|NCT00955409|559473353|FG002|Overall Study|Adverse Event (AE)|0|||
155012879|NCT00955409|559473354|FG003|Overall Study|Adverse Event (AE)|0|||
155012880|NCT00955409|559473355|FG004|Overall Study|Adverse Event (AE)|0|||
155012881|NCT00955409|559473356|FG005|Overall Study|Adverse Event (AE)|1|||
155012882|NCT00955409|559473357|FG006|Overall Study|Adverse Event (AE)|2|||
155012883|NCT00955409|559473358|FG007|Overall Study|Adverse Event (AE)|0|||
155132556|NCT04349033|559915837|FG000|Overall Study|Lost to Follow-up|3|||
155132557|NCT04349033|559915838|FG001|Overall Study|Lost to Follow-up|1|||
155132558|NCT04349033|559915839|FG002|Overall Study|Lost to Follow-up|1|||
155132559|NCT00324233|559915840|FG000|First Period|unable to insert catheter|1|||
155132560|NCT00324233|559915841|FG001|First Period|unable to insert catheter|0|||
155132561|NCT00324233|559915840|FG000|Second Period|unable to insert catheter|1|||
155132562|NCT00324233|559915841|FG001|Second Period|unable to insert catheter|1|||
155132563|NCT00324233|559915840|FG000|Second Period|Protocol Violation|4|||
155132564|NCT00324233|559915841|FG001|Second Period|Protocol Violation|6|||
155132565|NCT04583956|559915844|FG000|Overall Study|Death|9|||
155132566|NCT04583956|559915845|FG001|Overall Study|Death|11|||
155132567|NCT04583956|559915844|FG000|Overall Study|Lost to Follow-up|7|||
155132568|NCT04583956|559915845|FG001|Overall Study|Lost to Follow-up|9|||
155132569|NCT04583956|559915844|FG000|Overall Study|Protocol Violation|2|||
155132570|NCT04583956|559915845|FG001|Overall Study|Protocol Violation|0|||
155132571|NCT04583956|559915844|FG000|Overall Study|Withdrawal by Subject|0|||
155132572|NCT04583956|559915845|FG001|Overall Study|Withdrawal by Subject|2|||
155132573|NCT04583956|559915844|FG000|Overall Study|Randomized but not dosed|2|||
155132574|NCT04583956|559915845|FG001|Overall Study|Randomized but not dosed|3|||
155132575|NCT04583956|559915844|FG000|Overall Study|Withdrawal of consent before product administration|1|||
155132576|NCT04583956|559915845|FG001|Overall Study|Withdrawal of consent before product administration|0|||
155132577|NCT01069705|559915846|FG000|Overall Study|Adverse Event|1|||
155132578|NCT01069705|559915846|FG000|Overall Study|Withdrawal by Subject|2|||
155132579|NCT00915551|559915847|FG000|Overall Study|Withdrawal by Subject|0|||
155132580|NCT00915551|559915848|FG001|Overall Study|Withdrawal by Subject|1|||
155132581|NCT00727558|559915849|FG000|Overall Study|Lens issue|0|||
155132582|NCT00727558|559915850|FG001|Overall Study|Lens issue|1|||
155132583|NCT00727558|559915849|FG000|Overall Study|Adverse Event|0|||
155132584|NCT00727558|559915850|FG001|Overall Study|Adverse Event|1|||
155132585|NCT00727558|559915849|FG000|Overall Study|Subject unable to return for follow-up|1|||
155132586|NCT00727558|559915850|FG001|Overall Study|Subject unable to return for follow-up|1|||
155132587|NCT00727558|559915849|FG000|Overall Study|Lost to Follow-up|1|||
155132588|NCT00727558|559915850|FG001|Overall Study|Lost to Follow-up|0|||
155132589|NCT01717326|559915851|FG000|Overall Study|Death|0|||
155132590|NCT01717326|559915852|FG001|Overall Study|Death|0|||
155132591|NCT01717326|559915853|FG002|Overall Study|Death|0|||
155132592|NCT01717326|559915854|FG003|Overall Study|Death|0|||
155132593|NCT01717326|559915855|FG004|Overall Study|Death|0|||
155132594|NCT01717326|559915856|FG005|Overall Study|Death|0|||
155132595|NCT01717326|559915857|FG006|Overall Study|Death|0|||
155132596|NCT01717326|559915858|FG007|Overall Study|Death|0|||
155132597|NCT01717326|559915859|FG008|Overall Study|Death|0|||
155132598|NCT01717326|559915860|FG009|Overall Study|Death|0|||
155132599|NCT01717326|559915861|FG010|Overall Study|Death|1|||
155132600|NCT01717326|559915862|FG011|Overall Study|Death|0|||
155132601|NCT01717326|559915863|FG012|Overall Study|Death|0|||
155132602|NCT01717326|559915864|FG013|Overall Study|Death|0|||
155132603|NCT01717326|559915865|FG014|Overall Study|Death|0|||
155132604|NCT01717326|559915866|FG015|Overall Study|Death|0|||
155132605|NCT01717326|559915867|FG016|Overall Study|Death|0|||
155132606|NCT01717326|559915868|FG017|Overall Study|Death|0|||
155132607|NCT01717326|559915869|FG018|Overall Study|Death|0|||
155132608|NCT01717326|559915870|FG019|Overall Study|Death|0|||
155132609|NCT01717326|559915851|FG000|Overall Study|Lost to Follow-up|3|||
155132610|NCT01717326|559915852|FG001|Overall Study|Lost to Follow-up|0|||
155132611|NCT01717326|559915853|FG002|Overall Study|Lost to Follow-up|0|||
155132612|NCT01717326|559915854|FG003|Overall Study|Lost to Follow-up|2|||
155132613|NCT01717326|559915855|FG004|Overall Study|Lost to Follow-up|1|||
155132614|NCT01717326|559915856|FG005|Overall Study|Lost to Follow-up|0|||
155132615|NCT01717326|559915857|FG006|Overall Study|Lost to Follow-up|1|||
155132616|NCT01717326|559915858|FG007|Overall Study|Lost to Follow-up|0|||
155012884|NCT00955409|559473359|FG008|Overall Study|Adverse Event (AE)|2|||
155012885|NCT00955409|559473360|FG009|Overall Study|Adverse Event (AE)|0|||
155012886|NCT00955409|559473351|FG000|Overall Study|Reason not Specified|2|||
155132617|NCT01717326|559915859|FG008|Overall Study|Lost to Follow-up|0|||
155132618|NCT01717326|559915860|FG009|Overall Study|Lost to Follow-up|0|||
155012887|NCT00955409|559473352|FG001|Overall Study|Reason not Specified|1|||
155012888|NCT00955409|559473353|FG002|Overall Study|Reason not Specified|13|||
155012889|NCT00955409|559473354|FG003|Overall Study|Reason not Specified|1|||
155012890|NCT00955409|559473355|FG004|Overall Study|Reason not Specified|2|||
155132619|NCT01717326|559915861|FG010|Overall Study|Lost to Follow-up|1|||
155132620|NCT01717326|559915862|FG011|Overall Study|Lost to Follow-up|0|||
155132621|NCT01717326|559915863|FG012|Overall Study|Lost to Follow-up|0|||
155132622|NCT01717326|559915864|FG013|Overall Study|Lost to Follow-up|0|||
155132623|NCT01717326|559915865|FG014|Overall Study|Lost to Follow-up|0|||
155132624|NCT01717326|559915866|FG015|Overall Study|Lost to Follow-up|2|||
155012891|NCT00955409|559473356|FG005|Overall Study|Reason not Specified|0|||
155132625|NCT01717326|559915867|FG016|Overall Study|Lost to Follow-up|1|||
155132626|NCT01717326|559915868|FG017|Overall Study|Lost to Follow-up|0|||
155132627|NCT01717326|559915869|FG018|Overall Study|Lost to Follow-up|2|||
155132628|NCT01717326|559915870|FG019|Overall Study|Lost to Follow-up|3|||
155012892|NCT00955409|559473357|FG006|Overall Study|Reason not Specified|16|||
155012893|NCT00955409|559473358|FG007|Overall Study|Reason not Specified|0|||
155012894|NCT00955409|559473359|FG008|Overall Study|Reason not Specified|8|||
155012895|NCT00955409|559473360|FG009|Overall Study|Reason not Specified|1|||
155012896|NCT00803790|559473361|FG000|Period 1|Adverse Event|0|||
155012897|NCT00803790|559473362|FG001|Period 1|Adverse Event|1|||
155012898|NCT00803790|559473363|FG002|Period 1|Adverse Event|0|||
155012899|NCT00803790|559473364|FG003|Period 1|Adverse Event|0|||
155012900|NCT00803790|559473361|FG000|Period 1|Lost to Follow-up|1|||
155012901|NCT00803790|559473362|FG001|Period 1|Lost to Follow-up|2|||
155012902|NCT00803790|559473363|FG002|Period 1|Lost to Follow-up|0|||
155012903|NCT00803790|559473364|FG003|Period 1|Lost to Follow-up|0|||
155012904|NCT00803790|559473361|FG000|Period 1|Withdrawal by Subject|8|||
155012905|NCT00803790|559473362|FG001|Period 1|Withdrawal by Subject|6|||
155012906|NCT00803790|559473363|FG002|Period 1|Withdrawal by Subject|0|||
155012907|NCT00803790|559473364|FG003|Period 1|Withdrawal by Subject|0|||
155012908|NCT00803790|559473361|FG000|Period 1|positive drug screen or personal reasons|0|||
155012909|NCT00803790|559473362|FG001|Period 1|positive drug screen or personal reasons|3|||
155012910|NCT00803790|559473363|FG002|Period 1|positive drug screen or personal reasons|0|||
155012911|NCT00803790|559473364|FG003|Period 1|positive drug screen or personal reasons|4|||
155012912|NCT00803790|559473361|FG000|Period 1|Protocol Violation|0|||
155012913|NCT00803790|559473362|FG001|Period 1|Protocol Violation|0|||
155012914|NCT00803790|559473363|FG002|Period 1|Protocol Violation|1|||
155012915|NCT00803790|559473364|FG003|Period 1|Protocol Violation|0|||
155012916|NCT00803790|559473361|FG000|Period 2|Adverse Event|0|||
155012917|NCT00803790|559473362|FG001|Period 2|Adverse Event|0|||
155012918|NCT00803790|559473363|FG002|Period 2|Adverse Event|1|||
155012919|NCT00803790|559473364|FG003|Period 2|Adverse Event|1|||
155012920|NCT00803790|559473361|FG000|Period 2|Withdrawal by Subject|1|||
155012921|NCT00803790|559473362|FG001|Period 2|Withdrawal by Subject|0|||
155012922|NCT00803790|559473363|FG002|Period 2|Withdrawal by Subject|0|||
155012923|NCT00803790|559473364|FG003|Period 2|Withdrawal by Subject|0|||
155012924|NCT00803790|559473361|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
155012925|NCT00803790|559473362|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
155012926|NCT00803790|559473363|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
155012927|NCT00803790|559473364|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
155012928|NCT04710576|559473365|FG000|Overall Study|Participants still in the study|73|||
155012929|NCT04710576|559473366|FG001|Overall Study|Participants still in the study|70|||
155012930|NCT04710576|559473367|FG002|Overall Study|Participants still in the study|60|||
155012931|NCT04710576|559473365|FG000|Overall Study|Death|2|||
155012932|NCT04710576|559473366|FG001|Overall Study|Death|7|||
155012933|NCT04710576|559473367|FG002|Overall Study|Death|12|||
155012934|NCT04710576|559473365|FG000|Overall Study|Withdrawal by Subject|4|||
155012935|NCT04710576|559473366|FG001|Overall Study|Withdrawal by Subject|3|||
155012936|NCT04710576|559473367|FG002|Overall Study|Withdrawal by Subject|7|||
155012937|NCT04710576|559473365|FG000|Overall Study|Sponsor decision|1|||
155012938|NCT04710576|559473366|FG001|Overall Study|Sponsor decision|0|||
155012939|NCT04710576|559473367|FG002|Overall Study|Sponsor decision|0|||
155012940|NCT04162847|559473368|FG000|Overall Study|Withdrawal by Subject|7|||
155012941|NCT04162847|559473369|FG001|Overall Study|Withdrawal by Subject|1|||
155012942|NCT05573464|559473370|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
155012943|NCT05573464|559473371|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
155012944|NCT05573464|559473370|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
155012945|NCT05573464|559473371|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
155012946|NCT05573464|559473370|FG000|12-week Treatment Period|Protocol Violation|3|||
155012947|NCT05573464|559473371|FG001|12-week Treatment Period|Protocol Violation|1|||
155012948|NCT05573464|559473370|FG000|12-week Treatment Period|Physician Decision|1|||
155012949|NCT05573464|559473371|FG001|12-week Treatment Period|Physician Decision|2|||
155012950|NCT05573464|559473370|FG000|12-week Treatment Period|Lost to Follow-up|2|||
155012951|NCT05573464|559473371|FG001|12-week Treatment Period|Lost to Follow-up|0|||
155012952|NCT05573464|559473370|FG000|12-week Treatment Period|Adverse Event|20|||
155012953|NCT05573464|559473371|FG001|12-week Treatment Period|Adverse Event|9|||
155012954|NCT05573464|559473370|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
155012955|NCT05573464|559473371|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
155012956|NCT05573464|559473370|FG000|12-week Treatment Period|Randomised, not treated|0|||
155012957|NCT05573464|559473371|FG001|12-week Treatment Period|Randomised, not treated|1|||
155012958|NCT05573464|559473370|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
155012959|NCT05573464|559473371|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
155012960|NCT05573464|559473370|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
155012961|NCT05573464|559473371|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
155012962|NCT05573464|559473370|FG000|52-week Treatment Period|Protocol Violation|1|||
155012963|NCT05573464|559473371|FG001|52-week Treatment Period|Protocol Violation|1|||
155012964|NCT05573464|559473370|FG000|52-week Treatment Period|Physician Decision|2|||
155012965|NCT05573464|559473371|FG001|52-week Treatment Period|Physician Decision|2|||
155012966|NCT05573464|559473370|FG000|52-week Treatment Period|Lost to Follow-up|1|||
155012967|NCT05573464|559473371|FG001|52-week Treatment Period|Lost to Follow-up|1|||
155012968|NCT05573464|559473370|FG000|52-week Treatment Period|Adverse Event|11|||
155012969|NCT05573464|559473371|FG001|52-week Treatment Period|Adverse Event|8|||
155012970|NCT05573464|559473370|FG000|52-week Treatment Period|Death|1|||
155012971|NCT05573464|559473371|FG001|52-week Treatment Period|Death|1|||
155012972|NCT05734157|559473372|FG000|Overall Study|Death|3|||
155012973|NCT05734157|559473372|FG000|Overall Study|Withdrawal by Subject|2|||
155012974|NCT05734157|559473372|FG000|Overall Study|Lost to Follow-up|1|||
155012975|NCT05734157|559473372|FG000|Overall Study|Telephone call|3|||
155012976|NCT01415518|559473373|FG000|Overall Study|Withdrawal by Subject|2|||
155012977|NCT01415518|559473374|FG001|Overall Study|Withdrawal by Subject|12|||
155012978|NCT01415518|559473373|FG000|Overall Study|Protocol Violation|6|||
155012979|NCT01415518|559473374|FG001|Overall Study|Protocol Violation|8|||
155012980|NCT01415518|559473373|FG000|Overall Study|Lost to Follow-up|3|||
155012981|NCT01415518|559473374|FG001|Overall Study|Lost to Follow-up|5|||
155012982|NCT01415518|559473373|FG000|Overall Study|Adverse Event|3|||
155012983|NCT01415518|559473374|FG001|Overall Study|Adverse Event|4|||
155012984|NCT01415518|559473373|FG000|Overall Study|Death|1|||
155012985|NCT01415518|559473374|FG001|Overall Study|Death|1|||
155012986|NCT01415518|559473373|FG000|Overall Study|Condition under Investigation Worsened|1|||
155012987|NCT01415518|559473374|FG001|Overall Study|Condition under Investigation Worsened|1|||
155012988|NCT02068508|559473378|FG000|Overall Study|Case report forms uncollected|27|||
155012989|NCT02068508|559473378|FG000|Overall Study|Patient did not visit the study site|1|||
155012990|NCT02068508|559473378|FG000|Overall Study|Protocol Violation|4|||
155012991|NCT00813150|559473379|FG000|Treatment Period|Adverse Event|16|||
155012992|NCT00813150|559473380|FG001|Treatment Period|Adverse Event|15|||
155012993|NCT00813150|559473379|FG000|Treatment Period|Death|2|||
155012994|NCT00813150|559473380|FG001|Treatment Period|Death|0|||
155012995|NCT00813150|559473379|FG000|Treatment Period|Progressive disease|1|||
155012996|NCT00813150|559473380|FG001|Treatment Period|Progressive disease|0|||
155012997|NCT00813150|559473379|FG000|Treatment Period|Complete response|0|||
155012998|NCT00813150|559473380|FG001|Treatment Period|Complete response|1|||
155012999|NCT00813150|559473379|FG000|Treatment Period|Stable disease|1|||
155013000|NCT00813150|559473380|FG001|Treatment Period|Stable disease|2|||
155013001|NCT00813150|559473379|FG000|Treatment Period|Protocol Violation|3|||
155013002|NCT00813150|559473380|FG001|Treatment Period|Protocol Violation|4|||
155013003|NCT00813150|559473379|FG000|Treatment Period|Withdrawal by Subject|5|||
155013004|NCT00813150|559473380|FG001|Treatment Period|Withdrawal by Subject|3|||
155013005|NCT00813150|559473379|FG000|Treatment Period|Non compliance|0|||
155013006|NCT00813150|559473380|FG001|Treatment Period|Non compliance|1|||
155013007|NCT00813150|559473379|FG000|Treatment Period|Reason not specified|3|||
155013008|NCT00813150|559473380|FG001|Treatment Period|Reason not specified|4|||
155013009|NCT00813150|559473379|FG000|Treatment Period|Data not available|1|||
155013010|NCT00813150|559473380|FG001|Treatment Period|Data not available|2|||
155013011|NCT00813150|559473379|FG000|Long Term Follow-up|Death|0|||
155013012|NCT00813150|559473380|FG001|Long Term Follow-up|Death|4|||
155013013|NCT00813150|559473379|FG000|Long Term Follow-up|Other|0|||
155013014|NCT00813150|559473380|FG001|Long Term Follow-up|Other|3|||
155013015|NCT00813150|559473379|FG000|Long Term Follow-up|Lost to Follow-up|2|||
155013016|NCT00813150|559473380|FG001|Long Term Follow-up|Lost to Follow-up|0|||
155013017|NCT00813150|559473379|FG000|Long Term Follow-up|Progression/Relapse|22|||
155013018|NCT00813150|559473380|FG001|Long Term Follow-up|Progression/Relapse|24|||
155013019|NCT00210210|559473381|FG000|Overall Study|Withdrawal by Subject|3|||
155013020|NCT00210210|559473382|FG001|Overall Study|Withdrawal by Subject|2|||
155013021|NCT00210210|559473381|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
155013022|NCT00210210|559473382|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
155013023|NCT02445248|559473383|FG000|Overall Study|Death|45|||
155013024|NCT02445248|559473384|FG001|Overall Study|Death|12|||
155013025|NCT02445248|559473383|FG000|Overall Study|Progressive disease|13|||
155013026|NCT02445248|559473384|FG001|Overall Study|Progressive disease|1|||
155013027|NCT02445248|559473383|FG000|Overall Study|Subject decision|8|||
155013028|NCT02445248|559473384|FG001|Overall Study|Subject decision|0|||
155013029|NCT02445248|559473383|FG000|Overall Study|Physician Decision|5|||
155013030|NCT02445248|559473384|FG001|Overall Study|Physician Decision|0|||
155013031|NCT02445248|559473383|FG000|Overall Study|Adverse Event|1|||
155013032|NCT02445248|559473384|FG001|Overall Study|Adverse Event|0|||
155013033|NCT02445248|559473383|FG000|Overall Study|Lost to Follow-up|1|||
155013034|NCT02445248|559473384|FG001|Overall Study|Lost to Follow-up|0|||
155013035|NCT01217112|559473385|FG000|Overall Study|Adverse Event|0|||
155013036|NCT01217112|559473386|FG001|Overall Study|Adverse Event|2|||
155013037|NCT01217112|559473387|FG002|Overall Study|Adverse Event|0|||
155013038|NCT01217112|559473388|FG003|Overall Study|Adverse Event|2|||
155013039|NCT01217112|559473389|FG004|Overall Study|Adverse Event|0|||
155013040|NCT01217112|559473385|FG000|Overall Study|Withdrawal by Subject|0|||
155013041|NCT01217112|559473386|FG001|Overall Study|Withdrawal by Subject|0|||
155013042|NCT01217112|559473387|FG002|Overall Study|Withdrawal by Subject|1|||
155132629|NCT01717326|559915851|FG000|Overall Study|Physician Decision|0|||
155132630|NCT01717326|559915852|FG001|Overall Study|Physician Decision|0|||
155132631|NCT01717326|559915853|FG002|Overall Study|Physician Decision|0|||
155132632|NCT01717326|559915854|FG003|Overall Study|Physician Decision|0|||
155132633|NCT01717326|559915855|FG004|Overall Study|Physician Decision|0|||
155132634|NCT01717326|559915856|FG005|Overall Study|Physician Decision|0|||
155132635|NCT01717326|559915857|FG006|Overall Study|Physician Decision|0|||
155132636|NCT01717326|559915858|FG007|Overall Study|Physician Decision|0|||
155132637|NCT01717326|559915859|FG008|Overall Study|Physician Decision|0|||
155132638|NCT01717326|559915860|FG009|Overall Study|Physician Decision|1|||
155132639|NCT01717326|559915861|FG010|Overall Study|Physician Decision|0|||
155132640|NCT01717326|559915862|FG011|Overall Study|Physician Decision|0|||
155132641|NCT01717326|559915863|FG012|Overall Study|Physician Decision|0|||
155132642|NCT01717326|559915864|FG013|Overall Study|Physician Decision|0|||
155132643|NCT01717326|559915865|FG014|Overall Study|Physician Decision|0|||
155132644|NCT01717326|559915866|FG015|Overall Study|Physician Decision|0|||
155132645|NCT01717326|559915867|FG016|Overall Study|Physician Decision|0|||
155132646|NCT01717326|559915868|FG017|Overall Study|Physician Decision|0|||
155132647|NCT01717326|559915869|FG018|Overall Study|Physician Decision|0|||
155132648|NCT01717326|559915870|FG019|Overall Study|Physician Decision|0|||
155132649|NCT01717326|559915851|FG000|Overall Study|Protocol Violation|0|||
155132650|NCT01717326|559915852|FG001|Overall Study|Protocol Violation|0|||
155132651|NCT01717326|559915853|FG002|Overall Study|Protocol Violation|0|||
155132652|NCT01717326|559915854|FG003|Overall Study|Protocol Violation|0|||
155132653|NCT01717326|559915855|FG004|Overall Study|Protocol Violation|1|||
155132654|NCT01717326|559915856|FG005|Overall Study|Protocol Violation|0|||
155132655|NCT01717326|559915857|FG006|Overall Study|Protocol Violation|0|||
155132656|NCT01717326|559915858|FG007|Overall Study|Protocol Violation|0|||
155132657|NCT01717326|559915859|FG008|Overall Study|Protocol Violation|0|||
155132658|NCT01717326|559915860|FG009|Overall Study|Protocol Violation|0|||
155132659|NCT01717326|559915861|FG010|Overall Study|Protocol Violation|0|||
155132660|NCT01717326|559915862|FG011|Overall Study|Protocol Violation|0|||
155132661|NCT01717326|559915863|FG012|Overall Study|Protocol Violation|0|||
155132662|NCT01717326|559915864|FG013|Overall Study|Protocol Violation|0|||
155132663|NCT01717326|559915865|FG014|Overall Study|Protocol Violation|0|||
155132664|NCT01717326|559915866|FG015|Overall Study|Protocol Violation|0|||
155132665|NCT01717326|559915867|FG016|Overall Study|Protocol Violation|0|||
155132666|NCT01717326|559915868|FG017|Overall Study|Protocol Violation|0|||
155132667|NCT01717326|559915869|FG018|Overall Study|Protocol Violation|0|||
155132668|NCT01717326|559915870|FG019|Overall Study|Protocol Violation|0|||
155132669|NCT01717326|559915851|FG000|Overall Study|Withdrawal by Subject|0|||
155132670|NCT01717326|559915852|FG001|Overall Study|Withdrawal by Subject|1|||
155132671|NCT01717326|559915853|FG002|Overall Study|Withdrawal by Subject|0|||
155132672|NCT01717326|559915854|FG003|Overall Study|Withdrawal by Subject|0|||
155132673|NCT01717326|559915855|FG004|Overall Study|Withdrawal by Subject|0|||
155132674|NCT01717326|559915856|FG005|Overall Study|Withdrawal by Subject|0|||
155132675|NCT01717326|559915857|FG006|Overall Study|Withdrawal by Subject|0|||
155132676|NCT01717326|559915858|FG007|Overall Study|Withdrawal by Subject|0|||
155132677|NCT01717326|559915859|FG008|Overall Study|Withdrawal by Subject|0|||
155132678|NCT01717326|559915860|FG009|Overall Study|Withdrawal by Subject|1|||
155132679|NCT01717326|559915861|FG010|Overall Study|Withdrawal by Subject|0|||
155132680|NCT01717326|559915862|FG011|Overall Study|Withdrawal by Subject|0|||
155132681|NCT01717326|559915863|FG012|Overall Study|Withdrawal by Subject|1|||
155132682|NCT01717326|559915864|FG013|Overall Study|Withdrawal by Subject|0|||
155132683|NCT01717326|559915865|FG014|Overall Study|Withdrawal by Subject|0|||
155132684|NCT01717326|559915866|FG015|Overall Study|Withdrawal by Subject|1|||
155132685|NCT01717326|559915867|FG016|Overall Study|Withdrawal by Subject|0|||
155132686|NCT01717326|559915868|FG017|Overall Study|Withdrawal by Subject|0|||
155132687|NCT01717326|559915869|FG018|Overall Study|Withdrawal by Subject|2|||
155132688|NCT01717326|559915870|FG019|Overall Study|Withdrawal by Subject|3|||
155132689|NCT01123707|559915872|FG000|Overall Study|Lost to Follow-up|3|||
155132690|NCT01123707|559915873|FG001|Overall Study|Lost to Follow-up|1|||
155132691|NCT01123707|559915874|FG002|Overall Study|Lost to Follow-up|3|||
155132692|NCT01123707|559915875|FG003|Overall Study|Lost to Follow-up|2|||
155132693|NCT01123707|559915872|FG000|Overall Study|Adverse Event|5|||
155132694|NCT01123707|559915873|FG001|Overall Study|Adverse Event|7|||
155132695|NCT01123707|559915874|FG002|Overall Study|Adverse Event|5|||
155132696|NCT01123707|559915875|FG003|Overall Study|Adverse Event|3|||
155132697|NCT01123707|559915872|FG000|Overall Study|Sponsor Discontinued Study|30|||
155132698|NCT01123707|559915873|FG001|Overall Study|Sponsor Discontinued Study|24|||
155132699|NCT01123707|559915874|FG002|Overall Study|Sponsor Discontinued Study|25|||
155132700|NCT01123707|559915875|FG003|Overall Study|Sponsor Discontinued Study|40|||
155132701|NCT01123707|559915872|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
155132702|NCT01123707|559915873|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
155132703|NCT01123707|559915874|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
155132704|NCT01123707|559915875|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
155151106|NCT00446849|559988184|FG000|Acute Phase|Physician Decision|1|||
155151107|NCT00446849|559988184|FG000|Acute Phase|noncompliance|1|||
155151108|NCT00446849|559988184|FG000|Maintenance Phase|Lack of Efficacy|40|||
155132705|NCT01123707|559915872|FG000|Overall Study|Investigator Withdrew Participant|0|||
155132706|NCT01123707|559915873|FG001|Overall Study|Investigator Withdrew Participant|1|||
155132707|NCT01123707|559915874|FG002|Overall Study|Investigator Withdrew Participant|1|||
155132708|NCT01123707|559915875|FG003|Overall Study|Investigator Withdrew Participant|1|||
155132709|NCT01123707|559915872|FG000|Overall Study|Subject Withdrew Consent|4|||
155132710|NCT01123707|559915873|FG001|Overall Study|Subject Withdrew Consent|5|||
155132711|NCT01123707|559915874|FG002|Overall Study|Subject Withdrew Consent|1|||
155132712|NCT01123707|559915875|FG003|Overall Study|Subject Withdrew Consent|2|||
155132713|NCT01123707|559915872|FG000|Overall Study|Lack of Efficacy|1|||
155132714|NCT01123707|559915873|FG001|Overall Study|Lack of Efficacy|2|||
155132715|NCT01123707|559915874|FG002|Overall Study|Lack of Efficacy|1|||
155132716|NCT01123707|559915875|FG003|Overall Study|Lack of Efficacy|0|||
155132717|NCT01123707|559915872|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
155132718|NCT01123707|559915873|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
155132719|NCT01123707|559915874|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
155132720|NCT01123707|559915875|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
155132721|NCT00488826|559915880|FG000|Overall Study|Withdrawal by Subject|40|||
155132722|NCT00488826|559915881|FG001|Overall Study|Withdrawal by Subject|35|||
155132723|NCT00488826|559915882|FG002|Overall Study|Withdrawal by Subject|19|||
155132724|NCT00488826|559915880|FG000|Overall Study|Protocol Violation|0|||
155132725|NCT00488826|559915881|FG001|Overall Study|Protocol Violation|0|||
155132726|NCT00488826|559915882|FG002|Overall Study|Protocol Violation|2|||
155132727|NCT00488826|559915880|FG000|Overall Study|Adverse Event|9|||
155132728|NCT00488826|559915881|FG001|Overall Study|Adverse Event|15|||
155132729|NCT00488826|559915882|FG002|Overall Study|Adverse Event|4|||
155132730|NCT00488826|559915880|FG000|Overall Study|Lost to Follow-up|5|||
155132731|NCT00488826|559915881|FG001|Overall Study|Lost to Follow-up|1|||
155132732|NCT00488826|559915882|FG002|Overall Study|Lost to Follow-up|0|||
155132733|NCT00488826|559915880|FG000|Overall Study|Protocol Deviations|2|||
155132734|NCT00488826|559915881|FG001|Overall Study|Protocol Deviations|1|||
155132735|NCT00488826|559915882|FG002|Overall Study|Protocol Deviations|1|||
155132736|NCT02292706|559915883|FG000|Overall Study|Lost to Follow-up|20|||
155132737|NCT02292706|559915884|FG001|Overall Study|Lost to Follow-up|44|||
155132738|NCT02292706|559915885|FG002|Overall Study|Lost to Follow-up|24|||
155132739|NCT02292706|559915886|FG003|Overall Study|Lost to Follow-up|61|||
155132740|NCT02292706|559915887|FG004|Overall Study|Lost to Follow-up|21|||
155132741|NCT02292706|559915888|FG005|Overall Study|Lost to Follow-up|52|||
155132742|NCT02292706|559915889|FG006|Overall Study|Lost to Follow-up|25|||
155132743|NCT02292706|559915890|FG007|Overall Study|Lost to Follow-up|0|||
155132744|NCT02292706|559915883|FG000|Overall Study|Withdrew consent|15|||
155132745|NCT02292706|559915884|FG001|Overall Study|Withdrew consent|56|||
155132746|NCT02292706|559915885|FG002|Overall Study|Withdrew consent|43|||
155132747|NCT02292706|559915886|FG003|Overall Study|Withdrew consent|36|||
155132748|NCT02292706|559915887|FG004|Overall Study|Withdrew consent|13|||
155132749|NCT02292706|559915888|FG005|Overall Study|Withdrew consent|51|||
155132750|NCT02292706|559915889|FG006|Overall Study|Withdrew consent|20|||
155132751|NCT02292706|559915890|FG007|Overall Study|Withdrew consent|0|||
155132752|NCT02292706|559915883|FG000|Overall Study|Death|3|||
155132753|NCT02292706|559915884|FG001|Overall Study|Death|11|||
155132754|NCT02292706|559915885|FG002|Overall Study|Death|16|||
155132755|NCT02292706|559915886|FG003|Overall Study|Death|22|||
155132756|NCT02292706|559915887|FG004|Overall Study|Death|8|||
155132757|NCT02292706|559915888|FG005|Overall Study|Death|17|||
155132758|NCT02292706|559915889|FG006|Overall Study|Death|3|||
155132759|NCT02292706|559915890|FG007|Overall Study|Death|0|||
155132760|NCT02292706|559915883|FG000|Overall Study|Study terminated by sponsor|0|||
155132761|NCT02292706|559915884|FG001|Overall Study|Study terminated by sponsor|9|||
155178582|NCT02654717|560091545|FG001|Overall Study|Non-permitted medication|0|||
155178583|NCT01879579|560093306|FG000|Overall Study|Phone incompatible with texting platform|3|||
155178584|NCT01879579|560093307|FG001|Overall Study|Phone incompatible with texting platform|0|||
155178585|NCT01879579|560093306|FG000|Overall Study|Did not enroll in texting platform|1|||
155178586|NCT01879579|560093307|FG001|Overall Study|Did not enroll in texting platform|0|||
155132762|NCT02292706|559915885|FG002|Overall Study|Study terminated by sponsor|4|||
155132763|NCT02292706|559915886|FG003|Overall Study|Study terminated by sponsor|21|||
155132764|NCT02292706|559915887|FG004|Overall Study|Study terminated by sponsor|11|||
155132765|NCT02292706|559915888|FG005|Overall Study|Study terminated by sponsor|13|||
155132766|NCT02292706|559915889|FG006|Overall Study|Study terminated by sponsor|3|||
155132767|NCT02292706|559915890|FG007|Overall Study|Study terminated by sponsor|0|||
155132768|NCT02292706|559915883|FG000|Overall Study|Investigator's discretion|4|||
155132769|NCT02292706|559915884|FG001|Overall Study|Investigator's discretion|9|||
155132770|NCT02292706|559915885|FG002|Overall Study|Investigator's discretion|7|||
155132771|NCT02292706|559915886|FG003|Overall Study|Investigator's discretion|11|||
155132772|NCT02292706|559915887|FG004|Overall Study|Investigator's discretion|4|||
155178587|NCT01879579|560093306|FG000|Overall Study|Did not initiate insulin treatment|1|||
155132773|NCT02292706|559915888|FG005|Overall Study|Investigator's discretion|10|||
155132774|NCT02292706|559915889|FG006|Overall Study|Investigator's discretion|1|||
155132775|NCT02292706|559915890|FG007|Overall Study|Investigator's discretion|0|||
155132776|NCT02292706|559915883|FG000|Overall Study|Liver transplant|1|||
155132777|NCT02292706|559915884|FG001|Overall Study|Liver transplant|1|||
155132778|NCT02292706|559915885|FG002|Overall Study|Liver transplant|11|||
155132779|NCT02292706|559915886|FG003|Overall Study|Liver transplant|16|||
155132780|NCT02292706|559915887|FG004|Overall Study|Liver transplant|5|||
155132781|NCT02292706|559915888|FG005|Overall Study|Liver transplant|6|||
155132782|NCT02292706|559915889|FG006|Overall Study|Liver transplant|5|||
155132783|NCT02292706|559915890|FG007|Overall Study|Liver transplant|0|||
155132784|NCT02292706|559915883|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
155132785|NCT02292706|559915884|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
155132786|NCT02292706|559915885|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
155132787|NCT02292706|559915886|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
155132788|NCT02292706|559915887|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
155132789|NCT02292706|559915888|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
155132790|NCT02292706|559915889|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
155132791|NCT02292706|559915890|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
155132792|NCT02292706|559915883|FG000|Overall Study|Subject terminated by sponsor|1|||
155132793|NCT02292706|559915884|FG001|Overall Study|Subject terminated by sponsor|0|||
155132794|NCT02292706|559915885|FG002|Overall Study|Subject terminated by sponsor|0|||
155132795|NCT02292706|559915886|FG003|Overall Study|Subject terminated by sponsor|2|||
155132796|NCT02292706|559915887|FG004|Overall Study|Subject terminated by sponsor|1|||
155132797|NCT02292706|559915888|FG005|Overall Study|Subject terminated by sponsor|0|||
155132798|NCT02292706|559915889|FG006|Overall Study|Subject terminated by sponsor|0|||
155132799|NCT02292706|559915890|FG007|Overall Study|Subject terminated by sponsor|0|||
155132800|NCT02292706|559915883|FG000|Overall Study|Missing|0|||
155132801|NCT02292706|559915884|FG001|Overall Study|Missing|0|||
155132802|NCT02292706|559915885|FG002|Overall Study|Missing|1|||
155132803|NCT02292706|559915886|FG003|Overall Study|Missing|1|||
155132804|NCT02292706|559915887|FG004|Overall Study|Missing|0|||
155132805|NCT02292706|559915888|FG005|Overall Study|Missing|1|||
155132806|NCT02292706|559915889|FG006|Overall Study|Missing|0|||
155132807|NCT02292706|559915890|FG007|Overall Study|Missing|0|||
155132808|NCT02292706|559915883|FG000|Overall Study|Virologic relapse or reinfection|1|||
155132809|NCT02292706|559915884|FG001|Overall Study|Virologic relapse or reinfection|0|||
155132810|NCT02292706|559915885|FG002|Overall Study|Virologic relapse or reinfection|0|||
155132811|NCT02292706|559915886|FG003|Overall Study|Virologic relapse or reinfection|1|||
155132812|NCT02292706|559915887|FG004|Overall Study|Virologic relapse or reinfection|0|||
155132813|NCT02292706|559915888|FG005|Overall Study|Virologic relapse or reinfection|1|||
155132814|NCT02292706|559915889|FG006|Overall Study|Virologic relapse or reinfection|0|||
155132815|NCT02292706|559915890|FG007|Overall Study|Virologic relapse or reinfection|0|||
155132816|NCT02725866|559915891|FG000|Overall Study|Failure to return|6|||
155132817|NCT02725866|559915891|FG000|Overall Study|Withdrew consent|3|||
155132818|NCT02725866|559915891|FG000|Overall Study|Insufficient virological response|1|||
155132819|NCT02725866|559915891|FG000|Overall Study|Other, not specified|4|||
155132820|NCT03208088|559915898|FG000|Period 2|Withdrawal by Subject|0|||
155132821|NCT03208088|559915899|FG001|Period 2|Withdrawal by Subject|0|||
155132822|NCT03208088|559915900|FG002|Period 2|Withdrawal by Subject|0|||
155132823|NCT03208088|559915901|FG003|Period 2|Withdrawal by Subject|0|||
155132824|NCT03208088|559915902|FG004|Period 2|Withdrawal by Subject|0|||
155132825|NCT03208088|559915903|FG005|Period 2|Withdrawal by Subject|0|||
155132826|NCT03208088|559915904|FG006|Period 2|Withdrawal by Subject|0|||
155132827|NCT03208088|559915905|FG007|Period 2|Withdrawal by Subject|0|||
155132828|NCT03208088|559915906|FG008|Period 2|Withdrawal by Subject|1|||
155132829|NCT03208088|559915907|FG009|Period 2|Withdrawal by Subject|0|||
155132830|NCT03208088|559915898|FG000|Period 3|Unsatisfactory Test Article|0|||
155132831|NCT03208088|559915899|FG001|Period 3|Unsatisfactory Test Article|0|||
155132832|NCT03208088|559915900|FG002|Period 3|Unsatisfactory Test Article|0|||
155132833|NCT03208088|559915901|FG003|Period 3|Unsatisfactory Test Article|1|||
155132834|NCT03208088|559915902|FG004|Period 3|Unsatisfactory Test Article|0|||
155132835|NCT03208088|559915903|FG005|Period 3|Unsatisfactory Test Article|0|||
155013043|NCT01217112|559473388|FG003|Overall Study|Withdrawal by Subject|0|||
155013044|NCT01217112|559473389|FG004|Overall Study|Withdrawal by Subject|0|||
155013045|NCT01217112|559473385|FG000|Overall Study|Physician Decision|0|||
155013046|NCT01217112|559473386|FG001|Overall Study|Physician Decision|0|||
155013047|NCT01217112|559473387|FG002|Overall Study|Physician Decision|0|||
155013048|NCT01217112|559473388|FG003|Overall Study|Physician Decision|0|||
155013049|NCT01217112|559473389|FG004|Overall Study|Physician Decision|1|||
155013050|NCT02596971|559473392|FG000|Overall Study|Death|5|||
155132836|NCT03208088|559915904|FG006|Period 3|Unsatisfactory Test Article|0|||
155132837|NCT03208088|559915905|FG007|Period 3|Unsatisfactory Test Article|0|||
155132838|NCT03208088|559915906|FG008|Period 3|Unsatisfactory Test Article|0|||
155132839|NCT03208088|559915907|FG009|Period 3|Unsatisfactory Test Article|0|||
155132840|NCT03208088|559915898|FG000|Period 4|Unsatisfactory Test Article|0|||
155132841|NCT03208088|559915899|FG001|Period 4|Unsatisfactory Test Article|0|||
155132842|NCT03208088|559915900|FG002|Period 4|Unsatisfactory Test Article|0|||
155132843|NCT03208088|559915901|FG003|Period 4|Unsatisfactory Test Article|1|||
155132844|NCT03208088|559915902|FG004|Period 4|Unsatisfactory Test Article|0|||
155132845|NCT03208088|559915903|FG005|Period 4|Unsatisfactory Test Article|0|||
155132846|NCT03208088|559915904|FG006|Period 4|Unsatisfactory Test Article|0|||
155132847|NCT03208088|559915905|FG007|Period 4|Unsatisfactory Test Article|0|||
155132848|NCT03208088|559915906|FG008|Period 4|Unsatisfactory Test Article|0|||
155132849|NCT03208088|559915907|FG009|Period 4|Unsatisfactory Test Article|0|||
155132850|NCT00605345|559915910|FG000|Overall Study|Withdrawal by Subject|1|||
155132851|NCT00605345|559915911|FG001|Overall Study|Withdrawal by Subject|0|||
155132852|NCT00605345|559915910|FG000|Overall Study|Adverse Event|0|||
155132853|NCT00605345|559915911|FG001|Overall Study|Adverse Event|1|||
155132854|NCT00605345|559915910|FG000|Overall Study|Protocol Violation|0|||
155132855|NCT00605345|559915911|FG001|Overall Study|Protocol Violation|2|||
155132856|NCT02577016|559915912|FG000|Overall Study|Adverse Event|2|||
155132857|NCT02577016|559915913|FG001|Overall Study|Adverse Event|1|||
155132858|NCT02577016|559915912|FG000|Overall Study|Physician Decision|0|||
155132859|NCT02577016|559915913|FG001|Overall Study|Physician Decision|1|||
155132860|NCT00812565|559915914|FG000|Overall Study|Did Not Receive Study Medication|1|||
155132861|NCT00812565|559915915|FG001|Overall Study|Did Not Receive Study Medication|1|||
155132862|NCT00812565|559915916|FG002|Overall Study|Did Not Receive Study Medication|0|||
155132863|NCT00812565|559915917|FG003|Overall Study|Did Not Receive Study Medication|0|||
155132864|NCT00812565|559915918|FG004|Overall Study|Did Not Receive Study Medication|0|||
155013051|NCT02596971|559473393|FG001|Overall Study|Death|1|||
155013052|NCT02596971|559473394|FG002|Overall Study|Death|5|||
155013053|NCT02596971|559473392|FG000|Overall Study|Withdrawal by Subject|5|||
155013054|NCT02596971|559473393|FG001|Overall Study|Withdrawal by Subject|1|||
155013055|NCT02596971|559473394|FG002|Overall Study|Withdrawal by Subject|4|||
155013056|NCT01401361|559473395|FG000|Overall Study|Withdrawal by Subject|16|||
155013057|NCT01401361|559473395|FG000|Overall Study|Lack of Efficacy|6|||
155013058|NCT01401361|559473395|FG000|Overall Study|Physician Decision|1|||
155013059|NCT01401361|559473395|FG000|Overall Study|Lost to Follow-up|3|||
155013060|NCT01401361|559473395|FG000|Overall Study|Subject/family decision post procedure|2|||
155013061|NCT02764762|559473398|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155013062|NCT02764762|559473398|FG000|Overall Study|Lost to Follow-up|4|||
155013063|NCT02764762|559473398|FG000|Overall Study|Voluntary Withdrawal|8|||
155013064|NCT02764762|559473398|FG000|Overall Study|Site Termination|1|||
155013065|NCT02764762|559473398|FG000|Overall Study|Lack of Efficacy|16|||
155013066|NCT02764762|559473398|FG000|Overall Study|Reason not Specified|1|||
155013067|NCT02547428|559473402|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
155013068|NCT02547428|559473403|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
155013069|NCT02547428|559473402|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
155013070|NCT02547428|559473403|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
155013071|NCT02547428|559473402|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
155013072|NCT02547428|559473403|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
155013073|NCT02547428|559473402|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
155013074|NCT02547428|559473403|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
155013075|NCT02547428|559473402|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
155013076|NCT02547428|559473403|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
155013077|NCT02547428|559473402|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
155013078|NCT02547428|559473403|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
155013079|NCT02547428|559473402|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
155013080|NCT02547428|559473403|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
155013081|NCT02547428|559473402|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
155013082|NCT02547428|559473403|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
155013083|NCT03318861|559473404|FG000|Overall Study|Death|2|||
155013084|NCT03318861|559473405|FG001|Overall Study|Death|3|||
155013085|NCT03318861|559473406|FG002|Overall Study|Death|3|||
155013086|NCT03318861|559473407|FG003|Overall Study|Death|2|||
155013087|NCT03318861|559473408|FG004|Overall Study|Death|2|||
155013088|NCT03318861|559473404|FG000|Overall Study|Enrolled But Never Treated|0|||
155013089|NCT03318861|559473405|FG001|Overall Study|Enrolled But Never Treated|1|||
155013090|NCT03318861|559473406|FG002|Overall Study|Enrolled But Never Treated|0|||
155132865|NCT00812565|559915919|FG005|Overall Study|Did Not Receive Study Medication|0|||
155132866|NCT00812565|559915920|FG006|Overall Study|Did Not Receive Study Medication|0|||
155132867|NCT00812565|559915921|FG007|Overall Study|Did Not Receive Study Medication|0|||
155013091|NCT03318861|559473407|FG003|Overall Study|Enrolled But Never Treated|1|||
155013092|NCT03318861|559473408|FG004|Overall Study|Enrolled But Never Treated|1|||
155013093|NCT03318861|559473404|FG000|Overall Study|Informed Consent Withdraw|0|||
155013094|NCT03318861|559473405|FG001|Overall Study|Informed Consent Withdraw|0|||
155013095|NCT03318861|559473406|FG002|Overall Study|Informed Consent Withdraw|0|||
155013096|NCT03318861|559473407|FG003|Overall Study|Informed Consent Withdraw|1|||
155013097|NCT03318861|559473408|FG004|Overall Study|Informed Consent Withdraw|0|||
155132868|NCT00812565|559915914|FG000|Overall Study|Adverse Event|0|||
155132869|NCT00812565|559915915|FG001|Overall Study|Adverse Event|0|||
155132870|NCT00812565|559915916|FG002|Overall Study|Adverse Event|0|||
155013098|NCT03318861|559473404|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
155013099|NCT03318861|559473405|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155013100|NCT03318861|559473406|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155013101|NCT03318861|559473407|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155013102|NCT03318861|559473408|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
155013103|NCT00917852|559473409|FG000|Overall Study|Death|6|||
155013104|NCT00471081|559473410|FG000|Active Phase|Protocol Violation|1|||
155013105|NCT00471081|559473411|FG001|Active Phase|Protocol Violation|1|||
155013106|NCT00471081|559473410|FG000|Active Phase|Withdrawal by Subject|0|||
155013107|NCT00471081|559473411|FG001|Active Phase|Withdrawal by Subject|3|||
155013108|NCT00471081|559473410|FG000|Active Phase|Lost to Follow-up|0|||
155013109|NCT00471081|559473411|FG001|Active Phase|Lost to Follow-up|1|||
155013110|NCT00471081|559473410|FG000|Active Phase|Lost health plan/insurance|1|||
155013111|NCT00471081|559473411|FG001|Active Phase|Lost health plan/insurance|8|||
155013112|NCT00471081|559473410|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
155013113|NCT00471081|559473411|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
155013114|NCT00471081|559473410|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
155013115|NCT00471081|559473411|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
155013116|NCT00471081|559473410|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
155013117|NCT00471081|559473411|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
155013118|NCT01479465|559473412|FG000|Overall Study|Disease Progression|9|||
155013119|NCT01479465|559473413|FG001|Overall Study|Disease Progression|61|||
155013120|NCT01479465|559473414|FG002|Overall Study|Disease Progression|65|||
155013121|NCT01479465|559473415|FG003|Overall Study|Disease Progression|70|||
155013122|NCT01479465|559473412|FG000|Overall Study|Study Discontinued by Sponsor|0|||
155013123|NCT01479465|559473413|FG001|Overall Study|Study Discontinued by Sponsor|7|||
155013124|NCT01479465|559473414|FG002|Overall Study|Study Discontinued by Sponsor|5|||
155013125|NCT01479465|559473415|FG003|Overall Study|Study Discontinued by Sponsor|3|||
155013126|NCT01479465|559473412|FG000|Overall Study|Adverse Event|0|||
155013127|NCT01479465|559473413|FG001|Overall Study|Adverse Event|3|||
155013128|NCT01479465|559473414|FG002|Overall Study|Adverse Event|6|||
155013129|NCT01479465|559473415|FG003|Overall Study|Adverse Event|4|||
155013130|NCT01479465|559473412|FG000|Overall Study|Investigator Discretion|1|||
155013131|NCT01479465|559473413|FG001|Overall Study|Investigator Discretion|4|||
155013132|NCT01479465|559473414|FG002|Overall Study|Investigator Discretion|2|||
155013133|NCT01479465|559473415|FG003|Overall Study|Investigator Discretion|4|||
155013134|NCT01479465|559473412|FG000|Overall Study|Subject Request|1|||
155013135|NCT01479465|559473413|FG001|Overall Study|Subject Request|3|||
155013136|NCT01479465|559473414|FG002|Overall Study|Subject Request|4|||
155013137|NCT01479465|559473415|FG003|Overall Study|Subject Request|2|||
155013138|NCT01479465|559473412|FG000|Overall Study|Subject Withdrew Consent|0|||
155013139|NCT01479465|559473413|FG001|Overall Study|Subject Withdrew Consent|5|||
155013140|NCT01479465|559473414|FG002|Overall Study|Subject Withdrew Consent|2|||
155013141|NCT01479465|559473415|FG003|Overall Study|Subject Withdrew Consent|1|||
155013142|NCT01479465|559473412|FG000|Overall Study|Protocol Violation|0|||
155013143|NCT01479465|559473413|FG001|Overall Study|Protocol Violation|1|||
155013144|NCT01479465|559473414|FG002|Overall Study|Protocol Violation|1|||
155013145|NCT01479465|559473415|FG003|Overall Study|Protocol Violation|0|||
155013146|NCT01479465|559473412|FG000|Overall Study|Death|0|||
155013147|NCT01479465|559473413|FG001|Overall Study|Death|0|||
155013148|NCT01479465|559473414|FG002|Overall Study|Death|0|||
155013149|NCT01479465|559473415|FG003|Overall Study|Death|1|||
155013150|NCT01479465|559473412|FG000|Overall Study|Lost to Follow-up|0|||
155013151|NCT01479465|559473413|FG001|Overall Study|Lost to Follow-up|0|||
155013152|NCT01479465|559473414|FG002|Overall Study|Lost to Follow-up|1|||
155013153|NCT01479465|559473415|FG003|Overall Study|Lost to Follow-up|0|||
155013154|NCT01892501|559473416|FG000|Overall Study|Protocol Violation|2|||
155013155|NCT01892501|559473416|FG000|Overall Study|Puncture not carried out|9|||
155013156|NCT01892501|559473416|FG000|Overall Study|Radiological monitoring not carried out|5|||
155013157|NCT01892501|559473416|FG000|Overall Study|Non-contributory histological result|12|||
155013158|NCT02393950|559473424|FG000|Overall Study|Adverse Event|1|||
155013159|NCT02393950|559473425|FG001|Overall Study|Adverse Event|0|||
155013160|NCT02393950|559473424|FG000|Overall Study|Withdrawal by Subject|0|||
155013161|NCT02393950|559473425|FG001|Overall Study|Withdrawal by Subject|1|||
155013162|NCT04335123|559473426|FG000|Overall Study|Withdrawal by Subject|2|||
155013163|NCT04335123|559473427|FG001|Overall Study|Withdrawal by Subject|0|||
155013164|NCT04335123|559473426|FG000|Overall Study|Physician Decision|2|||
155013165|NCT04335123|559473427|FG001|Overall Study|Physician Decision|0|||
155013166|NCT05486091|559473428|FG000|Overall Study|Withdrawal by Subject|1|||
155132871|NCT00812565|559915917|FG003|Overall Study|Adverse Event|2|||
155013167|NCT05486091|559473428|FG000|Overall Study|Lost to Follow-up|2|||
155013168|NCT00370552|559473429|FG000|Overall Study|Adverse Event|2|||
155013169|NCT00370552|559473430|FG001|Overall Study|Adverse Event|2|||
155013170|NCT00370552|559473431|FG002|Overall Study|Adverse Event|2|||
155013171|NCT00370552|559473429|FG000|Overall Study|Disease progression|23|||
155013172|NCT00370552|559473430|FG001|Overall Study|Disease progression|23|||
155132872|NCT00812565|559915918|FG004|Overall Study|Adverse Event|0|||
155132873|NCT00812565|559915919|FG005|Overall Study|Adverse Event|0|||
155132874|NCT00812565|559915920|FG006|Overall Study|Adverse Event|0|||
155132875|NCT00812565|559915921|FG007|Overall Study|Adverse Event|1|||
155132876|NCT00812565|559915914|FG000|Overall Study|Did Not Come to Study Visit|1|||
155132877|NCT00812565|559915915|FG001|Overall Study|Did Not Come to Study Visit|0|||
155132878|NCT00812565|559915916|FG002|Overall Study|Did Not Come to Study Visit|0|||
155132879|NCT00812565|559915917|FG003|Overall Study|Did Not Come to Study Visit|0|||
155132880|NCT00812565|559915918|FG004|Overall Study|Did Not Come to Study Visit|0|||
155132881|NCT00812565|559915919|FG005|Overall Study|Did Not Come to Study Visit|0|||
155132882|NCT00812565|559915920|FG006|Overall Study|Did Not Come to Study Visit|0|||
155132883|NCT00812565|559915921|FG007|Overall Study|Did Not Come to Study Visit|0|||
155132884|NCT00812565|559915914|FG000|Overall Study|Withdrawal of Consent|1|||
155132885|NCT00812565|559915915|FG001|Overall Study|Withdrawal of Consent|0|||
155132886|NCT00812565|559915916|FG002|Overall Study|Withdrawal of Consent|0|||
155132887|NCT00812565|559915917|FG003|Overall Study|Withdrawal of Consent|0|||
155132888|NCT00812565|559915918|FG004|Overall Study|Withdrawal of Consent|1|||
155132889|NCT00812565|559915919|FG005|Overall Study|Withdrawal of Consent|0|||
155132890|NCT00812565|559915920|FG006|Overall Study|Withdrawal of Consent|0|||
155132891|NCT00812565|559915921|FG007|Overall Study|Withdrawal of Consent|0|||
155132892|NCT00812565|559915914|FG000|Overall Study|Reason Not Specified|0|||
155132893|NCT00812565|559915915|FG001|Overall Study|Reason Not Specified|0|||
155132894|NCT00812565|559915916|FG002|Overall Study|Reason Not Specified|0|||
155132895|NCT00812565|559915917|FG003|Overall Study|Reason Not Specified|0|||
155132896|NCT00812565|559915918|FG004|Overall Study|Reason Not Specified|0|||
155132897|NCT00812565|559915919|FG005|Overall Study|Reason Not Specified|1|||
155132898|NCT00812565|559915920|FG006|Overall Study|Reason Not Specified|0|||
155132899|NCT00812565|559915921|FG007|Overall Study|Reason Not Specified|0|||
155132900|NCT00422383|559915924|FG000|Overall Study|Adverse Event|5|||
155132901|NCT00422383|559915925|FG001|Overall Study|Adverse Event|3|||
155132902|NCT00422383|559915926|FG002|Overall Study|Adverse Event|1|||
155132903|NCT00422383|559915927|FG003|Overall Study|Adverse Event|1|||
155132904|NCT00422383|559915928|FG004|Overall Study|Adverse Event|0|||
155132905|NCT00422383|559915924|FG000|Overall Study|Lack of Efficacy|4|||
155132906|NCT00422383|559915925|FG001|Overall Study|Lack of Efficacy|4|||
155132907|NCT00422383|559915926|FG002|Overall Study|Lack of Efficacy|2|||
155132908|NCT00422383|559915927|FG003|Overall Study|Lack of Efficacy|1|||
154923935|NCT04668066|559146378|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923936|NCT04668066|559146379|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923937|NCT04668066|559146380|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923938|NCT04668066|559146381|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923939|NCT04668066|559146382|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923940|NCT04668066|559146383|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923941|NCT04668066|559146384|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
154923942|NCT04668066|559146366|FG000|Part 1: Treatment Phase|Other|0|||
154923943|NCT04668066|559146367|FG001|Part 1: Treatment Phase|Other|0|||
154923944|NCT04668066|559146368|FG002|Part 1: Treatment Phase|Other|0|||
154923945|NCT04668066|559146369|FG003|Part 1: Treatment Phase|Other|0|||
154923946|NCT04668066|559146370|FG004|Part 1: Treatment Phase|Other|0|||
154923947|NCT04668066|559146371|FG005|Part 1: Treatment Phase|Other|0|||
154923948|NCT04668066|559146372|FG006|Part 1: Treatment Phase|Other|0|||
154923949|NCT04668066|559146373|FG007|Part 1: Treatment Phase|Other|0|||
154923950|NCT04668066|559146374|FG008|Part 1: Treatment Phase|Other|0|||
154923951|NCT04668066|559146375|FG009|Part 1: Treatment Phase|Other|0|||
154923952|NCT04668066|559146376|FG010|Part 1: Treatment Phase|Other|0|||
154923953|NCT04668066|559146377|FG011|Part 1: Treatment Phase|Other|1|||
154923954|NCT04668066|559146378|FG012|Part 1: Treatment Phase|Other|0|||
154923955|NCT04668066|559146379|FG013|Part 1: Treatment Phase|Other|0|||
154923956|NCT04668066|559146380|FG014|Part 1: Treatment Phase|Other|0|||
154923957|NCT04668066|559146381|FG015|Part 1: Treatment Phase|Other|0|||
154923958|NCT04668066|559146382|FG016|Part 1: Treatment Phase|Other|0|||
154923959|NCT04668066|559146383|FG017|Part 1: Treatment Phase|Other|0|||
154923960|NCT04668066|559146384|FG018|Part 1: Treatment Phase|Other|0|||
154923961|NCT04668066|559146366|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923962|NCT04668066|559146367|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923963|NCT04668066|559146368|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923964|NCT04668066|559146369|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923965|NCT04668066|559146370|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923966|NCT04668066|559146371|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923967|NCT04668066|559146372|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923968|NCT04668066|559146373|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155132909|NCT00422383|559915928|FG004|Overall Study|Lack of Efficacy|1|||
155132910|NCT00422383|559915924|FG000|Overall Study|Lost to Follow-up|0|||
155132911|NCT00422383|559915925|FG001|Overall Study|Lost to Follow-up|1|||
155132912|NCT00422383|559915926|FG002|Overall Study|Lost to Follow-up|0|||
155132913|NCT00422383|559915927|FG003|Overall Study|Lost to Follow-up|0|||
155132914|NCT00422383|559915928|FG004|Overall Study|Lost to Follow-up|1|||
155013173|NCT00370552|559473431|FG002|Overall Study|Disease progression|15|||
155013174|NCT00370552|559473429|FG000|Overall Study|Maximum clinical benefit|3|||
155013175|NCT00370552|559473430|FG001|Overall Study|Maximum clinical benefit|5|||
155013176|NCT00370552|559473431|FG002|Overall Study|Maximum clinical benefit|5|||
155013177|NCT00370552|559473429|FG000|Overall Study|Poor or noncompliance|0|||
155013178|NCT00370552|559473430|FG001|Overall Study|Poor or noncompliance|0|||
155013179|NCT00370552|559473431|FG002|Overall Study|Poor or noncompliance|1|||
155013180|NCT00370552|559473429|FG000|Overall Study|Study drug toxicity|11|||
155013181|NCT00370552|559473430|FG001|Overall Study|Study drug toxicity|8|||
155013182|NCT00370552|559473431|FG002|Overall Study|Study drug toxicity|6|||
155013183|NCT00370552|559473429|FG000|Overall Study|Withdrawal by Subject|2|||
155013184|NCT00370552|559473430|FG001|Overall Study|Withdrawal by Subject|0|||
155013185|NCT00370552|559473431|FG002|Overall Study|Withdrawal by Subject|1|||
155013186|NCT00370552|559473429|FG000|Overall Study|Still on treatment|1|||
155013187|NCT00370552|559473430|FG001|Overall Study|Still on treatment|3|||
155013188|NCT00370552|559473431|FG002|Overall Study|Still on treatment|2|||
155013189|NCT00370552|559473429|FG000|Overall Study|Never treated|1|||
155013190|NCT00370552|559473430|FG001|Overall Study|Never treated|0|||
155013191|NCT00370552|559473431|FG002|Overall Study|Never treated|0|||
155013192|NCT00370552|559473429|FG000|Overall Study|Physician Decision|1|||
155013193|NCT00370552|559473430|FG001|Overall Study|Physician Decision|1|||
155013194|NCT00370552|559473431|FG002|Overall Study|Physician Decision|0|||
155013195|NCT00370552|559473429|FG000|Overall Study|Investigator decision|2|||
155013196|NCT00370552|559473430|FG001|Overall Study|Investigator decision|1|||
155013197|NCT00370552|559473431|FG002|Overall Study|Investigator decision|0|||
155013198|NCT00370552|559473429|FG000|Overall Study|High risk of allergic reaction|0|||
155013199|NCT00370552|559473430|FG001|Overall Study|High risk of allergic reaction|1|||
155013200|NCT00370552|559473431|FG002|Overall Study|High risk of allergic reaction|0|||
155013201|NCT00370552|559473429|FG000|Overall Study|Planned radiation for palliation|0|||
155013202|NCT00370552|559473430|FG001|Overall Study|Planned radiation for palliation|1|||
155013203|NCT00370552|559473431|FG002|Overall Study|Planned radiation for palliation|0|||
155013204|NCT01651117|559473442|FG000|Overall Study|Death|2|||
155013205|NCT01651117|559473443|FG001|Overall Study|Death|3|||
155013206|NCT01651117|559473444|FG002|Overall Study|Death|2|||
155013207|NCT01651117|559473445|FG003|Overall Study|Death|2|||
155013208|NCT01894919|559473446|FG000|Overall Study|Withdrawal by Subject|1|||
155013209|NCT01894919|559473447|FG001|Overall Study|Withdrawal by Subject|0|||
155013210|NCT01894919|559473448|FG002|Overall Study|Withdrawal by Subject|0|||
155013211|NCT01894919|559473449|FG003|Overall Study|Withdrawal by Subject|0|||
155013212|NCT01894919|559473450|FG004|Overall Study|Withdrawal by Subject|1|||
155013213|NCT01894919|559473451|FG005|Overall Study|Withdrawal by Subject|0|||
155013214|NCT01894919|559473452|FG006|Overall Study|Withdrawal by Subject|0|||
155013215|NCT01894919|559473453|FG007|Overall Study|Withdrawal by Subject|0|||
155013216|NCT01894919|559473454|FG008|Overall Study|Withdrawal by Subject|0|||
155013217|NCT01894919|559473455|FG009|Overall Study|Withdrawal by Subject|1|||
155013218|NCT01894919|559473456|FG010|Overall Study|Withdrawal by Subject|1|||
155013219|NCT01894919|559473457|FG011|Overall Study|Withdrawal by Subject|0|||
155013220|NCT01894919|559473458|FG012|Overall Study|Withdrawal by Subject|0|||
155013221|NCT01894919|559473446|FG000|Overall Study|Adverse Event|0|||
155013222|NCT01894919|559473447|FG001|Overall Study|Adverse Event|0|||
155013223|NCT01894919|559473448|FG002|Overall Study|Adverse Event|0|||
155013224|NCT01894919|559473449|FG003|Overall Study|Adverse Event|0|||
155013225|NCT01894919|559473450|FG004|Overall Study|Adverse Event|0|||
155013226|NCT01894919|559473451|FG005|Overall Study|Adverse Event|0|||
155013227|NCT01894919|559473452|FG006|Overall Study|Adverse Event|0|||
155013228|NCT01894919|559473453|FG007|Overall Study|Adverse Event|0|||
155013229|NCT01894919|559473454|FG008|Overall Study|Adverse Event|0|||
155013230|NCT01894919|559473455|FG009|Overall Study|Adverse Event|0|||
155013231|NCT01894919|559473456|FG010|Overall Study|Adverse Event|1|||
155013232|NCT01894919|559473457|FG011|Overall Study|Adverse Event|0|||
155013233|NCT01894919|559473458|FG012|Overall Study|Adverse Event|0|||
155013234|NCT01894919|559473446|FG000|Overall Study|Other-Unspecified|1|||
155132915|NCT00422383|559915924|FG000|Overall Study|Protocol Violation|1|||
155132916|NCT00422383|559915925|FG001|Overall Study|Protocol Violation|1|||
155132917|NCT00422383|559915926|FG002|Overall Study|Protocol Violation|1|||
155132918|NCT00422383|559915927|FG003|Overall Study|Protocol Violation|0|||
155013235|NCT01894919|559473447|FG001|Overall Study|Other-Unspecified|0|||
155013236|NCT01894919|559473448|FG002|Overall Study|Other-Unspecified|0|||
155013237|NCT01894919|559473449|FG003|Overall Study|Other-Unspecified|0|||
155013238|NCT01894919|559473450|FG004|Overall Study|Other-Unspecified|0|||
155013239|NCT01894919|559473451|FG005|Overall Study|Other-Unspecified|0|||
155013240|NCT01894919|559473452|FG006|Overall Study|Other-Unspecified|0|||
155013241|NCT01894919|559473453|FG007|Overall Study|Other-Unspecified|0|||
155013242|NCT01894919|559473454|FG008|Overall Study|Other-Unspecified|0|||
155013243|NCT01894919|559473455|FG009|Overall Study|Other-Unspecified|0|||
155013244|NCT01894919|559473456|FG010|Overall Study|Other-Unspecified|0|||
155013245|NCT01894919|559473457|FG011|Overall Study|Other-Unspecified|0|||
155013246|NCT01894919|559473458|FG012|Overall Study|Other-Unspecified|0|||
155132919|NCT00422383|559915928|FG004|Overall Study|Protocol Violation|0|||
155132920|NCT00422383|559915924|FG000|Overall Study|Withdrawal by Subject|5|||
155132921|NCT00422383|559915925|FG001|Overall Study|Withdrawal by Subject|5|||
155132922|NCT00422383|559915926|FG002|Overall Study|Withdrawal by Subject|0|||
155132923|NCT00422383|559915927|FG003|Overall Study|Withdrawal by Subject|0|||
155132924|NCT00422383|559915928|FG004|Overall Study|Withdrawal by Subject|1|||
155132925|NCT01108523|559915929|FG000|Overall Study|Protocol Violation|4|||
155132926|NCT00761527|559915932|FG000|Overall Study|Adverse Event|3|||
155132927|NCT00761527|559915932|FG000|Overall Study|Poor Compliance|8|||
155132928|NCT00761527|559915932|FG000|Overall Study|Lost to Follow-up|9|||
155132929|NCT00761527|559915932|FG000|Overall Study|Unknown reason|2|||
155132930|NCT05066165|559917911|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
155132931|NCT05066165|559917912|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
155132932|NCT05066165|559917911|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
155132933|NCT05066165|559917912|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
155132934|NCT02467582|559917913|FG000|Allocation|Withdrawal by Subject|1|||
155132935|NCT02467582|559917914|FG001|Allocation|Withdrawal by Subject|0|||
155132936|NCT02467582|559917913|FG000|Follow-up|Death|5|||
155132937|NCT02467582|559917914|FG001|Follow-up|Death|4|||
155132938|NCT02467582|559917913|FG000|Follow-up|Lost to Follow-up|6|||
155132939|NCT02467582|559917914|FG001|Follow-up|Lost to Follow-up|5|||
155132940|NCT01370265|559917915|FG000|First Intervention|Adverse Event|1|||
155132941|NCT01370265|559917916|FG001|First Intervention|Adverse Event|1|||
155132942|NCT03343626|559917917|FG000|Overall Study|Lost to Follow-up|4|||
155132943|NCT03343626|559917918|FG001|Overall Study|Lost to Follow-up|3|||
155132944|NCT03343626|559917919|FG002|Overall Study|Lost to Follow-up|2|||
155132945|NCT03343626|559917920|FG003|Overall Study|Lost to Follow-up|5|||
155132946|NCT03343626|559917921|FG004|Overall Study|Lost to Follow-up|4|||
155132947|NCT03343626|559917922|FG005|Overall Study|Lost to Follow-up|4|||
155132948|NCT03343626|559917923|FG006|Overall Study|Lost to Follow-up|4|||
155132949|NCT03343626|559917924|FG007|Overall Study|Lost to Follow-up|7|||
155132950|NCT03343626|559917917|FG000|Overall Study|Withdrawal of Consent|2|||
155132951|NCT03343626|559917918|FG001|Overall Study|Withdrawal of Consent|1|||
155132952|NCT03343626|559917919|FG002|Overall Study|Withdrawal of Consent|0|||
155132953|NCT03343626|559917920|FG003|Overall Study|Withdrawal of Consent|3|||
155132954|NCT03343626|559917921|FG004|Overall Study|Withdrawal of Consent|3|||
155132955|NCT03343626|559917922|FG005|Overall Study|Withdrawal of Consent|1|||
155132956|NCT03343626|559917923|FG006|Overall Study|Withdrawal of Consent|1|||
155132957|NCT03343626|559917924|FG007|Overall Study|Withdrawal of Consent|2|||
155132958|NCT03343626|559917917|FG000|Overall Study|Reason not Specified|0|||
155132959|NCT03343626|559917918|FG001|Overall Study|Reason not Specified|1|||
155132960|NCT03343626|559917919|FG002|Overall Study|Reason not Specified|0|||
155132961|NCT03343626|559917920|FG003|Overall Study|Reason not Specified|0|||
155132962|NCT03343626|559917921|FG004|Overall Study|Reason not Specified|0|||
155132963|NCT03343626|559917922|FG005|Overall Study|Reason not Specified|0|||
155132964|NCT03343626|559917923|FG006|Overall Study|Reason not Specified|0|||
155132965|NCT03343626|559917924|FG007|Overall Study|Reason not Specified|1|||
155132966|NCT03343626|559917917|FG000|Overall Study|Data Entry Error|0|||
155132967|NCT03343626|559917918|FG001|Overall Study|Data Entry Error|0|||
155132968|NCT03343626|559917919|FG002|Overall Study|Data Entry Error|0|||
155132969|NCT03343626|559917920|FG003|Overall Study|Data Entry Error|0|||
155132970|NCT03343626|559917921|FG004|Overall Study|Data Entry Error|0|||
155132971|NCT03343626|559917922|FG005|Overall Study|Data Entry Error|0|||
155132972|NCT03343626|559917923|FG006|Overall Study|Data Entry Error|0|||
155132973|NCT03343626|559917924|FG007|Overall Study|Data Entry Error|1|||
155132974|NCT00703924|559917925|FG000|Overall Study|Withdrawal by Subject|1|||
155132975|NCT00703924|559917926|FG001|Overall Study|Withdrawal by Subject|1|||
155132976|NCT01031979|559917929|FG000|Overall Study|Lost to Follow-up|5|||
155132977|NCT01031979|559917930|FG001|Overall Study|Lost to Follow-up|4|||
155132978|NCT03592368|559917932|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
155132979|NCT03592368|559917933|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
155132980|NCT03592368|559917934|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
155132981|NCT03592368|559917935|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
155132982|NCT03592368|559917932|FG000|Overall Study|Adverse Event|0|||
155132983|NCT03592368|559917933|FG001|Overall Study|Adverse Event|0|||
155132984|NCT03592368|559917934|FG002|Overall Study|Adverse Event|0|||
155132985|NCT03592368|559917935|FG003|Overall Study|Adverse Event|1|||
155132986|NCT03592368|559917932|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
155013247|NCT01894919|559473446|FG000|Overall Study|Lost to Follow-up|0|||
155132987|NCT03592368|559917933|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
155132988|NCT03592368|559917934|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
155132989|NCT03592368|559917935|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
155132990|NCT03831100|559917936|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
155013248|NCT01894919|559473447|FG001|Overall Study|Lost to Follow-up|0|||
155013249|NCT01894919|559473448|FG002|Overall Study|Lost to Follow-up|0|||
155013250|NCT01894919|559473449|FG003|Overall Study|Lost to Follow-up|0|||
155013251|NCT01894919|559473450|FG004|Overall Study|Lost to Follow-up|2|||
155013252|NCT01894919|559473451|FG005|Overall Study|Lost to Follow-up|0|||
155013253|NCT01894919|559473452|FG006|Overall Study|Lost to Follow-up|0|||
155013254|NCT01894919|559473453|FG007|Overall Study|Lost to Follow-up|0|||
155013255|NCT01894919|559473454|FG008|Overall Study|Lost to Follow-up|0|||
155013256|NCT01894919|559473455|FG009|Overall Study|Lost to Follow-up|0|||
155013257|NCT01894919|559473456|FG010|Overall Study|Lost to Follow-up|0|||
155013258|NCT01894919|559473457|FG011|Overall Study|Lost to Follow-up|0|||
155013259|NCT01894919|559473458|FG012|Overall Study|Lost to Follow-up|0|||
155013260|NCT03711188|559473461|FG000|Overall Study|Disease progression|11|||
155013261|NCT03711188|559473461|FG000|Overall Study|Adverse Event|1|||
155013262|NCT01433471|559473464|FG000|Overall Study|Withdrawal by Subject|0|||
155013263|NCT01433471|559473465|FG001|Overall Study|Withdrawal by Subject|1|||
155013264|NCT04341363|559473466|FG000|Overall Study|Adverse Event|1|||
155013265|NCT04341363|559473466|FG000|Overall Study|Withdrawal by Subject|1|||
155013266|NCT03534687|559473468|FG000|Overall Study|Lost to Follow-up|7|||
155013267|NCT03534687|559473469|FG001|Overall Study|Lost to Follow-up|2|||
155013268|NCT02069015|559473470|FG000|Overall Study|Lost to Follow-up|39|||
155013269|NCT02069015|559473471|FG001|Overall Study|Lost to Follow-up|32|||
155013270|NCT02069015|559473470|FG000|Overall Study|Withdrawal by Subject|1|||
155013271|NCT02069015|559473471|FG001|Overall Study|Withdrawal by Subject|1|||
155013272|NCT00957801|559473472|FG000|Overall Study|Withdrawal by Subject|0|||
155013273|NCT00957801|559473473|FG001|Overall Study|Withdrawal by Subject|0|||
155013274|NCT00957801|559473474|FG002|Overall Study|Withdrawal by Subject|0|||
155013275|NCT00957801|559473475|FG003|Overall Study|Withdrawal by Subject|1|||
155013276|NCT01778855|559473476|FG000|Overall Study|Death|0|||
155013277|NCT01778855|559473477|FG001|Overall Study|Death|1|||
155013278|NCT00191477|559473479|FG000|Overall Study|Tumor Recurrence|49|||
155013279|NCT00191477|559473480|FG001|Overall Study|Tumor Recurrence|48|||
155013280|NCT00191477|559473479|FG000|Overall Study|Death, Study Disease|1|||
155013281|NCT00191477|559473480|FG001|Overall Study|Death, Study Disease|1|||
155013282|NCT00191477|559473479|FG000|Overall Study|Death, Other Cause|3|||
155013283|NCT00191477|559473480|FG001|Overall Study|Death, Other Cause|6|||
155013284|NCT00191477|559473479|FG000|Overall Study|Lost to Follow-up|23|||
155013285|NCT00191477|559473480|FG001|Overall Study|Lost to Follow-up|21|||
155013286|NCT00191477|559473479|FG000|Overall Study|Protocol Violation|1|||
155013287|NCT00191477|559473480|FG001|Overall Study|Protocol Violation|1|||
155013288|NCT00191477|559473479|FG000|Overall Study|Treatment Change|2|||
155013289|NCT00191477|559473480|FG001|Overall Study|Treatment Change|0|||
155013290|NCT00191477|559473479|FG000|Overall Study|Withdrawal by Subject|2|||
155013291|NCT00191477|559473480|FG001|Overall Study|Withdrawal by Subject|0|||
155013292|NCT00191477|559473479|FG000|Overall Study|Other|2|||
155013293|NCT00191477|559473480|FG001|Overall Study|Other|0|||
155013294|NCT00191477|559473479|FG000|Overall Study|Not Eligible|41|||
155013295|NCT00191477|559473480|FG001|Overall Study|Not Eligible|38|||
155013296|NCT00191477|559473479|FG000|Overall Study|Pathological Specimen Lost|1|||
155013297|NCT00191477|559473480|FG001|Overall Study|Pathological Specimen Lost|0|||
155013298|NCT00191477|559473479|FG000|Overall Study|Discontinued Prior to Instillation|13|||
155013299|NCT00191477|559473480|FG001|Overall Study|Discontinued Prior to Instillation|14|||
155013300|NCT01609790|559473497|FG000|Overall Study|Protocol Violation|1|||
155013301|NCT01609790|559473498|FG001|Overall Study|Protocol Violation|7|||
155013302|NCT01609790|559473499|FG002|Overall Study|Protocol Violation|8|||
155013303|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Adverse Event|7|||
155013304|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
155013305|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Non-compliance|3|||
155013306|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Other|17|||
155013307|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Physician Decision|2|||
155013308|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Pregnancy|1|||
155013309|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
155013310|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
155013311|NCT05207865|559474907|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
155013312|NCT05207865|559474907|FG000|Follow-up Phase|Lost to Follow-up|1|||
155013313|NCT05207865|559474907|FG000|Follow-up Phase|Non-compliance|1|||
155013314|NCT05207865|559474907|FG000|Follow-up Phase|Not reported|2|||
155013315|NCT05207865|559474907|FG000|Follow-up Phase|Not collected|11|||
155013316|NCT02141438|559474908|FG000|Overall Study|Death|1308|||
155013317|NCT02141438|559474908|FG000|Overall Study|Lost to Follow-up|84|||
155013318|NCT02141438|559474908|FG000|Overall Study|Withdrawal by Subject|52|||
155013319|NCT02141438|559474908|FG000|Overall Study|Physician Decision|1|||
155013320|NCT02141438|559474908|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
155013321|NCT02546986|559474909|FG000|Treatment Period|Progressive Disease|20|||
155013322|NCT02546986|559474910|FG001|Treatment Period|Progressive Disease|22|||
155013323|NCT02546986|559474909|FG000|Treatment Period|Adverse Event|14|||
155013324|NCT02546986|559474910|FG001|Treatment Period|Adverse Event|6|||
155013325|NCT02546986|559474909|FG000|Treatment Period|Symptomatic Deterioration|4|||
155132991|NCT03831100|559917937|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
155132992|NCT03047031|559917945|FG000|Overall Study|Other than listed|1|||
155132993|NCT03047031|559917946|FG001|Overall Study|Other than listed|0|||
155132994|NCT03047031|559917947|FG002|Overall Study|Other than listed|0|||
155132995|NCT03047031|559917945|FG000|Overall Study|Lost to Follow-up|4|||
155132996|NCT03047031|559917946|FG001|Overall Study|Lost to Follow-up|0|||
155132997|NCT03047031|559917947|FG002|Overall Study|Lost to Follow-up|0|||
155132998|NCT03047031|559917945|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
155132999|NCT03047031|559917946|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
155133000|NCT03047031|559917947|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
155133001|NCT03047031|559917945|FG000|Overall Study|Adverse Event|1|||
155133002|NCT03047031|559917946|FG001|Overall Study|Adverse Event|0|||
155133003|NCT03047031|559917947|FG002|Overall Study|Adverse Event|0|||
155133004|NCT03047031|559917945|FG000|Overall Study|Withdrawal by Subject|2|||
155133005|NCT03047031|559917946|FG001|Overall Study|Withdrawal by Subject|0|||
155133006|NCT03047031|559917947|FG002|Overall Study|Withdrawal by Subject|0|||
155133007|NCT03047031|559917945|FG000|Overall Study|Change to other medication|2|||
155133008|NCT03047031|559917946|FG001|Overall Study|Change to other medication|0|||
155133009|NCT03047031|559917947|FG002|Overall Study|Change to other medication|0|||
155133010|NCT03047031|559917945|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
155133011|NCT03047031|559917946|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
155133012|NCT03047031|559917947|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
155133013|NCT00666224|559917950|FG000|Double-Blind|Adverse Event|15|||
155133014|NCT00666224|559917951|FG001|Double-Blind|Adverse Event|5|||
155133015|NCT00666224|559917950|FG000|Double-Blind|Lost to Follow-up|2|||
155133016|NCT00666224|559917951|FG001|Double-Blind|Lost to Follow-up|2|||
155133017|NCT00666224|559917950|FG000|Double-Blind|Withdrawal by Subject|18|||
155133018|NCT00666224|559917951|FG001|Double-Blind|Withdrawal by Subject|14|||
155133019|NCT00666224|559917950|FG000|Double-Blind|Physician Decision|0|||
155133020|NCT00666224|559917951|FG001|Double-Blind|Physician Decision|3|||
155133021|NCT00666224|559917950|FG000|Double-Blind|Sponsor decision|1|||
155133022|NCT00666224|559917951|FG001|Double-Blind|Sponsor decision|0|||
155133023|NCT00666224|559917950|FG000|Double-Blind|Pregnancy|3|||
155133024|NCT00666224|559917951|FG001|Double-Blind|Pregnancy|2|||
155133025|NCT00666224|559917950|FG000|Double-Blind|Noncompliance|1|||
155133026|NCT00666224|559917951|FG001|Double-Blind|Noncompliance|0|||
155133027|NCT00666224|559917950|FG000|Double-Blind|Death|1|||
155133028|NCT00666224|559917951|FG001|Double-Blind|Death|0|||
155133029|NCT00666224|559917950|FG000|Double-Blind|Undefined/Unknown|4|||
155133030|NCT00666224|559917951|FG001|Double-Blind|Undefined/Unknown|1|||
155133031|NCT00666224|559917950|FG000|Open-Label|Adverse Event|8|||
155133032|NCT00666224|559917951|FG001|Open-Label|Adverse Event|43|||
155133033|NCT00666224|559917950|FG000|Open-Label|Lost to Follow-up|4|||
154923969|NCT04668066|559146374|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923970|NCT04668066|559146375|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923971|NCT04668066|559146376|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923972|NCT04668066|559146377|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923973|NCT04668066|559146378|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
154923974|NCT04668066|559146379|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923975|NCT04668066|559146380|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
155013326|NCT02546986|559474910|FG001|Treatment Period|Symptomatic Deterioration|3|||
155013327|NCT02546986|559474909|FG000|Treatment Period|Death|3|||
155013328|NCT02546986|559474910|FG001|Treatment Period|Death|4|||
155013329|NCT02546986|559474909|FG000|Treatment Period|Physician Decision|1|||
155013330|NCT02546986|559474910|FG001|Treatment Period|Physician Decision|2|||
155013331|NCT02546986|559474909|FG000|Treatment Period|Protocol Violation|1|||
155013332|NCT02546986|559474910|FG001|Treatment Period|Protocol Violation|0|||
155013333|NCT02546986|559474909|FG000|Treatment Period|Withdrawal by Subject|1|||
154923976|NCT04668066|559146381|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
154923977|NCT04668066|559146382|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923978|NCT04668066|559146383|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923979|NCT04668066|559146384|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
154923980|NCT04668066|559146366|FG000|Part 1: Follow-Up|Adverse Event|0|||
155013334|NCT02546986|559474910|FG001|Treatment Period|Withdrawal by Subject|1|||
155133034|NCT00666224|559917951|FG001|Open-Label|Lost to Follow-up|5|||
155133035|NCT00666224|559917950|FG000|Open-Label|Withdrawal by Subject|12|||
155133036|NCT00666224|559917951|FG001|Open-Label|Withdrawal by Subject|25|||
155133037|NCT00666224|559917950|FG000|Open-Label|Physician Decision|7|||
155133038|NCT00666224|559917951|FG001|Open-Label|Physician Decision|5|||
155133039|NCT00666224|559917950|FG000|Open-Label|Pregnancy|1|||
155133040|NCT00666224|559917951|FG001|Open-Label|Pregnancy|5|||
155133041|NCT00666224|559917950|FG000|Open-Label|Noncompliance|2|||
154923981|NCT04668066|559146367|FG001|Part 1: Follow-Up|Adverse Event|0|||
154923982|NCT04668066|559146368|FG002|Part 1: Follow-Up|Adverse Event|0|||
154923983|NCT04668066|559146369|FG003|Part 1: Follow-Up|Adverse Event|0|||
155013335|NCT02546986|559474909|FG000|Treatment Period|Non-compliance with Study Drug|0|||
155133042|NCT00666224|559917951|FG001|Open-Label|Noncompliance|1|||
155133043|NCT00666224|559917950|FG000|Open-Label|Undefined/Unknown|1|||
155133044|NCT00666224|559917951|FG001|Open-Label|Undefined/Unknown|1|||
155133045|NCT03521141|559917952|FG000|Overall Study|Death|1|||
155133046|NCT03521141|559917953|FG001|Overall Study|Death|0|||
155133047|NCT03521141|559917954|FG002|Overall Study|Death|1|||
155133048|NCT00705367|559917963|FG000|Long-term Extension Period|Adverse Event|2|||
155133049|NCT00705367|559917964|FG001|Long-term Extension Period|Adverse Event|0|||
155133050|NCT00705367|559917963|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
155133051|NCT00705367|559917964|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
155133052|NCT00705367|559917963|FG000|Long-term Extension Period|Lack of Efficacy|1|||
155133053|NCT00705367|559917964|FG001|Long-term Extension Period|Lack of Efficacy|0|||
155133054|NCT00705367|559917963|FG000|Long-term Extension Period|No longer met study criteria|1|||
155133055|NCT00705367|559917964|FG001|Long-term Extension Period|No longer met study criteria|0|||
155133056|NCT00705367|559917963|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
155133057|NCT00705367|559917964|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
155133058|NCT01959139|559917965|FG000|Phase II|Disease progression|0|||
155133059|NCT01959139|559917966|FG001|Phase II|Disease progression|0|||
155133060|NCT01959139|559917967|FG002|Phase II|Disease progression|26|||
155133061|NCT01959139|559917968|FG003|Phase II|Disease progression|34|||
155133062|NCT01959139|559917965|FG000|Phase II|Adverse Event|0|||
155133063|NCT01959139|559917966|FG001|Phase II|Adverse Event|0|||
155133064|NCT01959139|559917967|FG002|Phase II|Adverse Event|10|||
155133065|NCT01959139|559917968|FG003|Phase II|Adverse Event|11|||
155133066|NCT01959139|559917965|FG000|Phase II|Patient Refusal|0|||
155133067|NCT01959139|559917966|FG001|Phase II|Patient Refusal|0|||
155133068|NCT01959139|559917967|FG002|Phase II|Patient Refusal|5|||
155133069|NCT01959139|559917968|FG003|Phase II|Patient Refusal|4|||
155133070|NCT01959139|559917965|FG000|Phase II|Death|0|||
155133071|NCT01959139|559917966|FG001|Phase II|Death|0|||
155133072|NCT01959139|559917967|FG002|Phase II|Death|3|||
155133073|NCT01959139|559917968|FG003|Phase II|Death|1|||
155133074|NCT01959139|559917965|FG000|Phase II|Other/Unknown|0|||
155133075|NCT01959139|559917966|FG001|Phase II|Other/Unknown|0|||
155133076|NCT01959139|559917967|FG002|Phase II|Other/Unknown|8|||
155133077|NCT01959139|559917968|FG003|Phase II|Other/Unknown|5|||
155133078|NCT01959139|559917965|FG000|Phase II|On treatment|0|||
155133079|NCT01959139|559917966|FG001|Phase II|On treatment|0|||
155133080|NCT01959139|559917967|FG002|Phase II|On treatment|4|||
155133081|NCT01959139|559917968|FG003|Phase II|On treatment|0|||
155133082|NCT01378325|559917974|FG000|Overall Study|Protocol Violation|0|||
155133083|NCT01378325|559917975|FG001|Overall Study|Protocol Violation|1|||
155133084|NCT01559675|559917976|FG000|Overall Study|Protocol Violation|1|||
155133085|NCT01559675|559917977|FG001|Overall Study|Protocol Violation|2|||
155013336|NCT02546986|559474910|FG001|Treatment Period|Non-compliance with Study Drug|1|||
155013337|NCT02546986|559474909|FG000|Treatment Period|Study Terminated by Sponsor|0|||
155013338|NCT02546986|559474910|FG001|Treatment Period|Study Terminated by Sponsor|1|||
155013339|NCT02546986|559474909|FG000|Treatment Period|Miscellaneous|7|||
155013340|NCT02546986|559474910|FG001|Treatment Period|Miscellaneous|9|||
155013341|NCT02546986|559474909|FG000|Survival Follow-Up Phase|Missing Status|3|||
155013342|NCT02546986|559474910|FG001|Survival Follow-Up Phase|Missing Status|5|||
155013343|NCT02546986|559474909|FG000|Survival Follow-Up Phase|Death|18|||
155013344|NCT02546986|559474910|FG001|Survival Follow-Up Phase|Death|12|||
155013345|NCT02546986|559474909|FG000|Survival Follow-Up Phase|Alive|13|||
155013346|NCT02546986|559474910|FG001|Survival Follow-Up Phase|Alive|16|||
155013347|NCT02546986|559474909|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
155133086|NCT01559675|559917976|FG000|Overall Study|2nd operation on same patient excluded|14|||
155133087|NCT01559675|559917977|FG001|Overall Study|2nd operation on same patient excluded|12|||
155133088|NCT00077649|559917986|FG000|Overall Study|Adverse Event|5|||
155133089|NCT00077649|559917987|FG001|Overall Study|Adverse Event|1|||
155133090|NCT00077649|559917988|FG002|Overall Study|Adverse Event|7|||
155133091|NCT00077649|559917989|FG003|Overall Study|Adverse Event|9|||
155013348|NCT02546986|559474910|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
155133092|NCT00077649|559917986|FG000|Overall Study|Lack of Efficacy|5|||
155133093|NCT00077649|559917987|FG001|Overall Study|Lack of Efficacy|3|||
155133094|NCT00077649|559917988|FG002|Overall Study|Lack of Efficacy|3|||
155133095|NCT00077649|559917989|FG003|Overall Study|Lack of Efficacy|2|||
155133096|NCT00077649|559917986|FG000|Overall Study|Withdrawal by Subject|0|||
155133097|NCT00077649|559917987|FG001|Overall Study|Withdrawal by Subject|1|||
155133098|NCT00077649|559917988|FG002|Overall Study|Withdrawal by Subject|1|||
155133099|NCT00077649|559917989|FG003|Overall Study|Withdrawal by Subject|2|||
155133100|NCT00077649|559917986|FG000|Overall Study|Lost to Follow-up|2|||
155133101|NCT00077649|559917987|FG001|Overall Study|Lost to Follow-up|2|||
155133102|NCT00077649|559917988|FG002|Overall Study|Lost to Follow-up|3|||
155133103|NCT00077649|559917989|FG003|Overall Study|Lost to Follow-up|2|||
155133104|NCT00077649|559917986|FG000|Overall Study|Abnormality of Laboratory Test|1|||
155133105|NCT00077649|559917987|FG001|Overall Study|Abnormality of Laboratory Test|2|||
155133106|NCT00077649|559917988|FG002|Overall Study|Abnormality of Laboratory Test|1|||
155133107|NCT00077649|559917989|FG003|Overall Study|Abnormality of Laboratory Test|2|||
155013349|NCT02844543|559474911|FG000|Overall Study|Withdrawal by Subject|4|||
155013350|NCT02844543|559474911|FG000|Overall Study|Did not meet eligibility criteria|1|||
155013351|NCT03349060|559474912|FG000|Overall Study|Adverse Event|9|||
155013352|NCT03349060|559474913|FG001|Overall Study|Adverse Event|9|||
155013353|NCT03349060|559474914|FG002|Overall Study|Adverse Event|7|||
155013354|NCT03349060|559474912|FG000|Overall Study|Lack of Efficacy|1|||
155013355|NCT03349060|559474913|FG001|Overall Study|Lack of Efficacy|0|||
155013356|NCT03349060|559474914|FG002|Overall Study|Lack of Efficacy|2|||
155013357|NCT03349060|559474912|FG000|Overall Study|Lost to Follow-up|2|||
155013358|NCT03349060|559474913|FG001|Overall Study|Lost to Follow-up|1|||
155013359|NCT03349060|559474914|FG002|Overall Study|Lost to Follow-up|1|||
155013360|NCT03349060|559474912|FG000|Overall Study|Protocol Violation|2|||
155013361|NCT03349060|559474913|FG001|Overall Study|Protocol Violation|2|||
155013362|NCT03349060|559474914|FG002|Overall Study|Protocol Violation|1|||
155013363|NCT03349060|559474912|FG000|Overall Study|Withdrawal by Subject|5|||
155013364|NCT03349060|559474913|FG001|Overall Study|Withdrawal by Subject|3|||
155013365|NCT03349060|559474914|FG002|Overall Study|Withdrawal by Subject|4|||
155013366|NCT03349060|559474912|FG000|Overall Study|Medication error,no linked adverse event|0|||
155013367|NCT03349060|559474913|FG001|Overall Study|Medication error,no linked adverse event|0|||
155013368|NCT03349060|559474914|FG002|Overall Study|Medication error,no linked adverse event|1|||
155013369|NCT03349060|559474912|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155013370|NCT03349060|559474913|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
155013371|NCT03349060|559474914|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
155013372|NCT03349060|559474912|FG000|Overall Study|Other|2|||
155013373|NCT03349060|559474913|FG001|Overall Study|Other|1|||
155013374|NCT03349060|559474914|FG002|Overall Study|Other|0|||
155013375|NCT00485732|559474915|FG000|Overall Study|Protocol Violation|1|||
155013376|NCT00485732|559474916|FG001|Overall Study|Protocol Violation|3|||
155013377|NCT00485732|559474915|FG000|Overall Study|Withdrawal by Subject|5|||
155013378|NCT00485732|559474916|FG001|Overall Study|Withdrawal by Subject|4|||
155013379|NCT00485732|559474915|FG000|Overall Study|Lost to Follow-up|2|||
155013380|NCT00485732|559474916|FG001|Overall Study|Lost to Follow-up|2|||
155013381|NCT00437021|559474917|FG000|Overall Study|Adverse Event|0|||
155013382|NCT00437021|559474918|FG001|Overall Study|Adverse Event|0|||
155013383|NCT00437021|559474919|FG002|Overall Study|Adverse Event|0|||
155013384|NCT00437021|559474920|FG003|Overall Study|Adverse Event|0|||
155013385|NCT00437021|559474921|FG004|Overall Study|Adverse Event|0|||
155013386|NCT00437021|559474922|FG005|Overall Study|Adverse Event|0|||
155013387|NCT00437021|559474923|FG006|Overall Study|Adverse Event|1|||
155013388|NCT00437021|559474924|FG007|Overall Study|Adverse Event|0|||
155013389|NCT00437021|559474925|FG008|Overall Study|Adverse Event|0|||
155013390|NCT00437021|559474926|FG009|Overall Study|Adverse Event|0|||
155013391|NCT00437021|559474927|FG010|Overall Study|Adverse Event|0|||
155013392|NCT00437021|559474928|FG011|Overall Study|Adverse Event|0|||
155013393|NCT00437021|559474917|FG000|Overall Study|Lost to Follow-up|0|||
155013394|NCT00437021|559474918|FG001|Overall Study|Lost to Follow-up|3|||
155013395|NCT00437021|559474919|FG002|Overall Study|Lost to Follow-up|0|||
155013396|NCT00437021|559474920|FG003|Overall Study|Lost to Follow-up|0|||
155013397|NCT00437021|559474921|FG004|Overall Study|Lost to Follow-up|0|||
155013398|NCT00437021|559474922|FG005|Overall Study|Lost to Follow-up|2|||
155013399|NCT00437021|559474923|FG006|Overall Study|Lost to Follow-up|0|||
155013400|NCT00437021|559474924|FG007|Overall Study|Lost to Follow-up|1|||
155013401|NCT00437021|559474925|FG008|Overall Study|Lost to Follow-up|0|||
155013402|NCT00437021|559474926|FG009|Overall Study|Lost to Follow-up|0|||
155013403|NCT00437021|559474927|FG010|Overall Study|Lost to Follow-up|0|||
155013404|NCT00437021|559474928|FG011|Overall Study|Lost to Follow-up|0|||
155013405|NCT00437021|559474917|FG000|Overall Study|Withdrawal by Subject|2|||
155013406|NCT00437021|559474918|FG001|Overall Study|Withdrawal by Subject|1|||
155013407|NCT00437021|559474919|FG002|Overall Study|Withdrawal by Subject|0|||
155013408|NCT00437021|559474920|FG003|Overall Study|Withdrawal by Subject|0|||
155013409|NCT00437021|559474921|FG004|Overall Study|Withdrawal by Subject|0|||
155013410|NCT00437021|559474922|FG005|Overall Study|Withdrawal by Subject|0|||
155013411|NCT00437021|559474923|FG006|Overall Study|Withdrawal by Subject|0|||
155013412|NCT00437021|559474924|FG007|Overall Study|Withdrawal by Subject|0|||
155013413|NCT00437021|559474925|FG008|Overall Study|Withdrawal by Subject|0|||
155013414|NCT00437021|559474926|FG009|Overall Study|Withdrawal by Subject|0|||
155013415|NCT00437021|559474927|FG010|Overall Study|Withdrawal by Subject|0|||
155013416|NCT00437021|559474928|FG011|Overall Study|Withdrawal by Subject|0|||
155013417|NCT05423093|559474936|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
155013418|NCT05423093|559474936|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
155013419|NCT05423093|559474936|FG000|Attended Intervention Session|Lost to Follow-up|3|||
155013420|NCT05423093|559474936|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
155013421|NCT05423093|559474936|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
155013422|NCT05364931|559474937|FG000|Overall Study|Adverse Event|0|||
155013423|NCT05364931|559474938|FG001|Overall Study|Adverse Event|2|||
155013424|NCT05364931|559474939|FG002|Overall Study|Adverse Event|1|||
155013425|NCT05364931|559474940|FG003|Overall Study|Adverse Event|0|||
155133108|NCT00077649|559917986|FG000|Overall Study|Randomized but never dosed|1|||
155133109|NCT00077649|559917987|FG001|Overall Study|Randomized but never dosed|0|||
155133110|NCT00077649|559917988|FG002|Overall Study|Randomized but never dosed|0|||
155133111|NCT00077649|559917989|FG003|Overall Study|Randomized but never dosed|0|||
155133112|NCT02479139|559917990|FG000|Overall Study|Lost to Follow-up|2|||
155133113|NCT02479139|559917991|FG001|Overall Study|Lost to Follow-up|4|||
155133114|NCT02479139|559917992|FG002|Overall Study|Lost to Follow-up|4|||
155133115|NCT02479139|559917993|FG003|Overall Study|Lost to Follow-up|2|||
155133116|NCT02479139|559917994|FG004|Overall Study|Lost to Follow-up|3|||
155133117|NCT02479139|559917995|FG005|Overall Study|Lost to Follow-up|5|||
155133118|NCT02479139|559917990|FG000|Overall Study|Withdrew Consent|5|||
155133119|NCT02479139|559917991|FG001|Overall Study|Withdrew Consent|6|||
155133120|NCT02479139|559917992|FG002|Overall Study|Withdrew Consent|1|||
155133121|NCT02479139|559917993|FG003|Overall Study|Withdrew Consent|4|||
155133122|NCT02479139|559917994|FG004|Overall Study|Withdrew Consent|1|||
155133123|NCT02479139|559917995|FG005|Overall Study|Withdrew Consent|1|||
155133124|NCT02479139|559917990|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155133125|NCT02479139|559917991|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155133126|NCT02479139|559917992|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
155133127|NCT02479139|559917993|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155133128|NCT02479139|559917994|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155133129|NCT02479139|559917995|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
155133130|NCT02479139|559917990|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155133131|NCT02479139|559917991|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155133132|NCT02479139|559917992|FG002|Overall Study|Other Miscellaneous Reasons|1|||
155133133|NCT02479139|559917993|FG003|Overall Study|Other Miscellaneous Reasons|1|||
155133134|NCT02479139|559917994|FG004|Overall Study|Other Miscellaneous Reasons|1|||
155133135|NCT02479139|559917995|FG005|Overall Study|Other Miscellaneous Reasons|0|||
155133136|NCT00764673|559917996|FG000|Overall Study|Death|1|||
155133137|NCT00764673|559917996|FG000|Overall Study|Lost to Follow-up|3|||
155133138|NCT00764673|559917996|FG000|Overall Study|Withdrawal by Subject|6|||
155133139|NCT00764673|559917996|FG000|Overall Study|Revision of Device|2|||
155133140|NCT01438177|559917997|FG000|Overall Study|Withdrawal by Subject|1|||
155133141|NCT01438177|559917997|FG000|Overall Study|Initiation of new therapy|1|||
155133142|NCT01727336|559917998|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155133143|NCT01727336|559917999|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
155133144|NCT01727336|559918000|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
155133145|NCT01727336|559918001|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155133146|NCT01727336|559918002|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155133147|NCT01727336|559918003|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
155133148|NCT01727336|559917998|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
155133149|NCT01727336|559917999|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
155133150|NCT01727336|559918000|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
155133151|NCT01727336|559918001|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
155133152|NCT01727336|559918002|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
155133153|NCT01727336|559918003|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
155133154|NCT01727336|559917998|FG000|Part 2 Blinded|Death|0|||
155133155|NCT01727336|559917999|FG001|Part 2 Blinded|Death|0|||
155133156|NCT01727336|559918000|FG002|Part 2 Blinded|Death|0|||
155133157|NCT01727336|559918001|FG003|Part 2 Blinded|Death|0|||
155133158|NCT01727336|559918002|FG004|Part 2 Blinded|Death|20|||
155133159|NCT01727336|559918003|FG005|Part 2 Blinded|Death|16|||
155133160|NCT01727336|559917998|FG000|Part 2 Blinded|Lack of Efficacy|0|||
155133161|NCT01727336|559917999|FG001|Part 2 Blinded|Lack of Efficacy|0|||
155133162|NCT01727336|559918000|FG002|Part 2 Blinded|Lack of Efficacy|0|||
155133163|NCT01727336|559918001|FG003|Part 2 Blinded|Lack of Efficacy|0|||
155133164|NCT01727336|559918002|FG004|Part 2 Blinded|Lack of Efficacy|42|||
155133165|NCT01727336|559918003|FG005|Part 2 Blinded|Lack of Efficacy|44|||
155133166|NCT01727336|559917998|FG000|Part 2 Blinded|Lost to Follow-up|0|||
155133167|NCT01727336|559917999|FG001|Part 2 Blinded|Lost to Follow-up|0|||
155133168|NCT01727336|559918000|FG002|Part 2 Blinded|Lost to Follow-up|0|||
155133169|NCT01727336|559918001|FG003|Part 2 Blinded|Lost to Follow-up|0|||
155133170|NCT01727336|559918002|FG004|Part 2 Blinded|Lost to Follow-up|0|||
155133171|NCT01727336|559918003|FG005|Part 2 Blinded|Lost to Follow-up|1|||
155133172|NCT01727336|559917998|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
155133173|NCT01727336|559917999|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
155133174|NCT01727336|559918000|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
155133175|NCT01727336|559918001|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
155133176|NCT01727336|559918002|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
155133177|NCT01727336|559918003|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
155133178|NCT01727336|559917998|FG000|Part 2 Blinded|use of prohibited medications|0|||
155133179|NCT01727336|559917999|FG001|Part 2 Blinded|use of prohibited medications|0|||
155133180|NCT01727336|559918000|FG002|Part 2 Blinded|use of prohibited medications|0|||
155133181|NCT01727336|559918001|FG003|Part 2 Blinded|use of prohibited medications|0|||
155133182|NCT01727336|559918002|FG004|Part 2 Blinded|use of prohibited medications|1|||
155133183|NCT01727336|559918003|FG005|Part 2 Blinded|use of prohibited medications|3|||
155133184|NCT02772978|559918006|FG000|Overall Study|Withdrawal by Subject|1|||
155133185|NCT02772978|559918007|FG001|Overall Study|Withdrawal by Subject|1|||
155133186|NCT00820222|559918009|FG000|Overall Study|Lost to Follow-up|10|||
155133187|NCT00820222|559918010|FG001|Overall Study|Lost to Follow-up|9|||
155133188|NCT00820222|559918009|FG000|Overall Study|Withdrawal by Subject|19|||
155133189|NCT00820222|559918010|FG001|Overall Study|Withdrawal by Subject|21|||
155133190|NCT00820222|559918009|FG000|Overall Study|Physician Decision|93|||
155133191|NCT00820222|559918010|FG001|Overall Study|Physician Decision|88|||
155133192|NCT00820222|559918009|FG000|Overall Study|Sponsor Terminated Study|43|||
155133193|NCT00820222|559918010|FG001|Overall Study|Sponsor Terminated Study|65|||
155133194|NCT00820222|559918009|FG000|Overall Study|Unkown|11|||
155133195|NCT00820222|559918010|FG001|Overall Study|Unkown|7|||
155133196|NCT02690714|559918011|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
155133197|NCT02690714|559918011|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
155133198|NCT00293020|559918012|FG000|Overall Study|Withdrawal by Subject|34|||
155133199|NCT00293020|559918012|FG000|Overall Study|Adverse Event|30|||
155133200|NCT00293020|559918012|FG000|Overall Study|Death|32|||
155133201|NCT00293020|559918012|FG000|Overall Study|Lack of Efficacy|12|||
155133202|NCT00293020|559918012|FG000|Overall Study|Lost to Follow-up|4|||
155133203|NCT00293020|559918012|FG000|Overall Study|Protocol Violation|6|||
155133204|NCT00293020|559918012|FG000|Overall Study|Physician Decision|21|||
155133205|NCT00293020|559918012|FG000|Overall Study|Other Reason|22|||
155133206|NCT00293020|559918012|FG000|Overall Study|No dose taken|1|||
155133207|NCT01147848|559918013|FG000|Run-in Period|Screen Failure|623|||
155133208|NCT01147848|559918014|FG001|Run-in Period|Screen Failure|0|||
155133209|NCT01147848|559918015|FG002|Run-in Period|Screen Failure|0|||
155133210|NCT01147848|559918013|FG000|Run-in Period|Run-in Failure|135|||
155133211|NCT01147848|559918014|FG001|Run-in Period|Run-in Failure|0|||
155133212|NCT01147848|559918015|FG002|Run-in Period|Run-in Failure|0|||
155133213|NCT01147848|559918013|FG000|Randomized Phase|Adverse Event|0|||
155133214|NCT01147848|559918014|FG001|Randomized Phase|Adverse Event|6|||
155133215|NCT01147848|559918015|FG002|Randomized Phase|Adverse Event|8|||
155133216|NCT01147848|559918013|FG000|Randomized Phase|Lack of Efficacy|0|||
155133217|NCT01147848|559918014|FG001|Randomized Phase|Lack of Efficacy|20|||
155133218|NCT01147848|559918015|FG002|Randomized Phase|Lack of Efficacy|11|||
155133219|NCT01147848|559918013|FG000|Randomized Phase|Protocol Violation|0|||
155133220|NCT01147848|559918014|FG001|Randomized Phase|Protocol Violation|7|||
155133221|NCT01147848|559918015|FG002|Randomized Phase|Protocol Violation|10|||
155133222|NCT01147848|559918013|FG000|Randomized Phase|Lost to Follow-up|0|||
155133223|NCT01147848|559918014|FG001|Randomized Phase|Lost to Follow-up|5|||
155133224|NCT01147848|559918015|FG002|Randomized Phase|Lost to Follow-up|7|||
155133225|NCT01147848|559918013|FG000|Randomized Phase|Physician Decision|0|||
155133226|NCT01147848|559918014|FG001|Randomized Phase|Physician Decision|0|||
155133227|NCT01147848|559918015|FG002|Randomized Phase|Physician Decision|1|||
155133228|NCT01147848|559918013|FG000|Randomized Phase|Withdrawal by Subject|0|||
155133229|NCT01147848|559918014|FG001|Randomized Phase|Withdrawal by Subject|7|||
155133230|NCT01147848|559918015|FG002|Randomized Phase|Withdrawal by Subject|9|||
155133231|NCT02540265|559918016|FG000|Overall Study|Lost to Follow-up|0|||
155133232|NCT02540265|559918017|FG001|Overall Study|Lost to Follow-up|0|||
155133233|NCT02540265|559918018|FG002|Overall Study|Lost to Follow-up|1|||
155133234|NCT01972789|559918029|FG000|Overall Study|Adverse Event|11|||
155133235|NCT01972789|559918030|FG001|Overall Study|Adverse Event|4|||
155133236|NCT01972789|559918029|FG000|Overall Study|Subject withdrew consent|14|||
155133237|NCT01972789|559918030|FG001|Overall Study|Subject withdrew consent|12|||
155133238|NCT01972789|559918029|FG000|Overall Study|Lost to Follow-up|4|||
155133239|NCT01972789|559918030|FG001|Overall Study|Lost to Follow-up|7|||
155133240|NCT01972789|559918029|FG000|Overall Study|Death|7|||
155133241|NCT01972789|559918030|FG001|Overall Study|Death|5|||
155133242|NCT01972789|559918029|FG000|Overall Study|Protocol deviation|1|||
155133243|NCT01972789|559918030|FG001|Overall Study|Protocol deviation|0|||
155133244|NCT01972789|559918029|FG000|Overall Study|Physician Decision|3|||
155133245|NCT01972789|559918030|FG001|Overall Study|Physician Decision|2|||
155133246|NCT03596450|559918034|FG000|Overall Study|Death|9|||
155133247|NCT03596450|559918035|FG001|Overall Study|Death|9|||
155133248|NCT03596450|559918034|FG000|Overall Study|Protocol Violation|18|||
155133249|NCT03596450|559918035|FG001|Overall Study|Protocol Violation|26|||
155133250|NCT03596450|559918034|FG000|Overall Study|Lost to Follow-up|50|||
155133251|NCT03596450|559918035|FG001|Overall Study|Lost to Follow-up|56|||
155133252|NCT03596450|559918034|FG000|Overall Study|Adverse Event|14|||
155133253|NCT03596450|559918035|FG001|Overall Study|Adverse Event|7|||
155133254|NCT03596450|559918034|FG000|Overall Study|Withdrawal by Subject|38|||
155133255|NCT03596450|559918035|FG001|Overall Study|Withdrawal by Subject|36|||
155133256|NCT03596450|559918034|FG000|Overall Study|Accidentally Randomized|2|||
155133257|NCT03596450|559918035|FG001|Overall Study|Accidentally Randomized|0|||
155133258|NCT03596450|559918034|FG000|Overall Study|Other reasons|48|||
155133259|NCT03596450|559918035|FG001|Overall Study|Other reasons|53|||
155133260|NCT03596450|559918034|FG000|Overall Study|Pregnancy|2|||
155133261|NCT03596450|559918035|FG001|Overall Study|Pregnancy|0|||
155133262|NCT00498355|559918036|FG000|Overall Study|Lost to Follow-up|1|||
155013426|NCT05364931|559474937|FG000|Overall Study|Lost to Follow-up|1|||
155013427|NCT05364931|559474938|FG001|Overall Study|Lost to Follow-up|0|||
155013428|NCT05364931|559474939|FG002|Overall Study|Lost to Follow-up|0|||
155013429|NCT05364931|559474940|FG003|Overall Study|Lost to Follow-up|0|||
155013430|NCT05364931|559474937|FG000|Overall Study|Withdrawal by Subject|1|||
155013431|NCT05364931|559474938|FG001|Overall Study|Withdrawal by Subject|1|||
155013432|NCT05364931|559474939|FG002|Overall Study|Withdrawal by Subject|3|||
155013433|NCT05364931|559474940|FG003|Overall Study|Withdrawal by Subject|2|||
155013434|NCT05364931|559474937|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
155013435|NCT05364931|559474938|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
155013436|NCT05364931|559474939|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
155013437|NCT05364931|559474940|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
155013438|NCT05364931|559474937|FG000|Overall Study|Discontinued|1|||
155013439|NCT05364931|559474938|FG001|Overall Study|Discontinued|0|||
155013440|NCT05364931|559474939|FG002|Overall Study|Discontinued|0|||
155013441|NCT05364931|559474940|FG003|Overall Study|Discontinued|0|||
155013442|NCT03593525|559474941|FG000|Overall Study|Withdrawal by Subject|1|||
155013443|NCT03593525|559474942|FG001|Overall Study|Withdrawal by Subject|0|||
155013444|NCT03593525|559474941|FG000|Overall Study|Lost to Follow-up|7|||
155013445|NCT03593525|559474942|FG001|Overall Study|Lost to Follow-up|5|||
155013446|NCT04570670|559474950|FG000|Overall Study|Withdrawal by Subject|1|||
155013447|NCT04570670|559474951|FG001|Overall Study|Withdrawal by Subject|0|||
155013448|NCT02844933|559474952|FG000|Overall Study|Discontinued due to premature termination of study|3|||
155013449|NCT02844933|559474953|FG001|Overall Study|Discontinued due to premature termination of study|2|||
155013450|NCT04067050|559474954|FG000|One Month|Lost to Follow-up|4|||
155013451|NCT04067050|559474955|FG001|One Month|Lost to Follow-up|0|||
155013452|NCT04067050|559474954|FG000|Two Month|Lost to Follow-up|1|||
155013453|NCT04067050|559474955|FG001|Two Month|Lost to Follow-up|0|||
155013454|NCT04067050|559474954|FG000|Two Month|Adverse Event|1|||
155013455|NCT04067050|559474955|FG001|Two Month|Adverse Event|0|||
155013456|NCT00460603|559474962|FG000|Phase 1|Death|1|||
155013457|NCT00460603|559474963|FG001|Phase 1|Death|0|||
155013458|NCT00460603|559474964|FG002|Phase 1|Death|0|||
155013459|NCT00460603|559474965|FG003|Phase 1|Death|2|||
155013460|NCT00460603|559474966|FG004|Phase 1|Death|0|||
155013461|NCT00460603|559474967|FG005|Phase 1|Death|0|||
155013462|NCT00460603|559474968|FG006|Phase 1|Death|0|||
155013463|NCT00460603|559474969|FG007|Phase 1|Death|0|||
155013464|NCT00460603|559474970|FG008|Phase 1|Death|1|||
155013465|NCT00460603|559474971|FG009|Phase 1|Death|0|||
155013466|NCT00460603|559474972|FG010|Phase 1|Death|0|||
155013467|NCT00460603|559474973|FG011|Phase 1|Death|0|||
155013468|NCT00460603|559474962|FG000|Phase 1|Adverse Event|3|||
155013469|NCT00460603|559474963|FG001|Phase 1|Adverse Event|1|||
155013470|NCT00460603|559474964|FG002|Phase 1|Adverse Event|1|||
155013471|NCT00460603|559474965|FG003|Phase 1|Adverse Event|2|||
155013472|NCT00460603|559474966|FG004|Phase 1|Adverse Event|0|||
155013473|NCT00460603|559474967|FG005|Phase 1|Adverse Event|0|||
155013474|NCT00460603|559474968|FG006|Phase 1|Adverse Event|3|||
155013475|NCT00460603|559474969|FG007|Phase 1|Adverse Event|0|||
155013476|NCT00460603|559474970|FG008|Phase 1|Adverse Event|4|||
155013477|NCT00460603|559474971|FG009|Phase 1|Adverse Event|0|||
155013478|NCT00460603|559474972|FG010|Phase 1|Adverse Event|0|||
155013479|NCT00460603|559474973|FG011|Phase 1|Adverse Event|0|||
155013480|NCT00460603|559474962|FG000|Phase 1|Lack of Efficacy|1|||
155013481|NCT00460603|559474963|FG001|Phase 1|Lack of Efficacy|0|||
155013482|NCT00460603|559474964|FG002|Phase 1|Lack of Efficacy|1|||
155013483|NCT00460603|559474965|FG003|Phase 1|Lack of Efficacy|2|||
155013484|NCT00460603|559474966|FG004|Phase 1|Lack of Efficacy|2|||
155013485|NCT00460603|559474967|FG005|Phase 1|Lack of Efficacy|2|||
155013486|NCT00460603|559474968|FG006|Phase 1|Lack of Efficacy|2|||
155013487|NCT00460603|559474969|FG007|Phase 1|Lack of Efficacy|2|||
155013488|NCT00460603|559474970|FG008|Phase 1|Lack of Efficacy|11|||
155178588|NCT01879579|560093307|FG001|Overall Study|Did not initiate insulin treatment|0|||
155178589|NCT01879579|560093306|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
155178590|NCT01879579|560093307|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
155013489|NCT00460603|559474971|FG009|Phase 1|Lack of Efficacy|0|||
155013490|NCT00460603|559474972|FG010|Phase 1|Lack of Efficacy|0|||
155013491|NCT00460603|559474973|FG011|Phase 1|Lack of Efficacy|0|||
155013492|NCT00460603|559474962|FG000|Phase 1|Withdrawal by Subject|1|||
155013493|NCT00460603|559474963|FG001|Phase 1|Withdrawal by Subject|2|||
155013494|NCT00460603|559474964|FG002|Phase 1|Withdrawal by Subject|1|||
155013495|NCT00460603|559474965|FG003|Phase 1|Withdrawal by Subject|1|||
155013496|NCT00460603|559474966|FG004|Phase 1|Withdrawal by Subject|3|||
155013497|NCT00460603|559474967|FG005|Phase 1|Withdrawal by Subject|0|||
155013498|NCT00460603|559474968|FG006|Phase 1|Withdrawal by Subject|1|||
155013499|NCT00460603|559474969|FG007|Phase 1|Withdrawal by Subject|0|||
155013500|NCT00460603|559474970|FG008|Phase 1|Withdrawal by Subject|2|||
155013501|NCT00460603|559474971|FG009|Phase 1|Withdrawal by Subject|0|||
155013502|NCT00460603|559474972|FG010|Phase 1|Withdrawal by Subject|0|||
155133263|NCT04496453|559918037|FG000|Overall Study|Lost to Follow-up|6|||
155133264|NCT04058886|559918042|FG000|Overall Study|Withdrawal by Subject|4|||
155133265|NCT04058886|559918042|FG000|Overall Study|Inadequate deafness interpreter service|1|||
155133266|NCT04390841|559918045|FG000|Overall Study|Withdrawal by Subject|2|||
155133267|NCT02999633|559918046|FG000|Overall Study|Adverse Event|2|||
155133268|NCT02999633|559918046|FG000|Overall Study|Progressive disease|12|||
155133269|NCT03262441|559918047|FG000|Overall Study|Withdrawal by Subject|1|||
155133270|NCT02607228|559918048|FG000|Overall Study|Progressive Disease|4|||
155133271|NCT02607228|559918049|FG001|Overall Study|Progressive Disease|3|||
155133272|NCT02607228|559918050|FG002|Overall Study|Progressive Disease|1|||
155133273|NCT02607228|559918051|FG003|Overall Study|Progressive Disease|5|||
155133274|NCT02607228|559918052|FG004|Overall Study|Progressive Disease|4|||
155133275|NCT02607228|559918053|FG005|Overall Study|Progressive Disease|3|||
155133276|NCT02607228|559918054|FG006|Overall Study|Progressive Disease|1|||
155133277|NCT02607228|559918048|FG000|Overall Study|Adverse Event|1|||
155133278|NCT02607228|559918049|FG001|Overall Study|Adverse Event|0|||
155133279|NCT02607228|559918050|FG002|Overall Study|Adverse Event|1|||
155133280|NCT02607228|559918051|FG003|Overall Study|Adverse Event|0|||
155133281|NCT02607228|559918052|FG004|Overall Study|Adverse Event|1|||
155133282|NCT02607228|559918053|FG005|Overall Study|Adverse Event|1|||
155133283|NCT02607228|559918054|FG006|Overall Study|Adverse Event|1|||
155133284|NCT02607228|559918048|FG000|Overall Study|Investigator's Discretion|0|||
155133285|NCT02607228|559918049|FG001|Overall Study|Investigator's Discretion|0|||
155133286|NCT02607228|559918050|FG002|Overall Study|Investigator's Discretion|1|||
155133287|NCT02607228|559918051|FG003|Overall Study|Investigator's Discretion|0|||
155133288|NCT02607228|559918052|FG004|Overall Study|Investigator's Discretion|0|||
155133289|NCT02607228|559918053|FG005|Overall Study|Investigator's Discretion|1|||
155133290|NCT02607228|559918054|FG006|Overall Study|Investigator's Discretion|0|||
155133291|NCT02607228|559918048|FG000|Overall Study|Withdrew Consent|0|||
155133292|NCT02607228|559918049|FG001|Overall Study|Withdrew Consent|1|||
155133293|NCT02607228|559918050|FG002|Overall Study|Withdrew Consent|0|||
155133294|NCT02607228|559918051|FG003|Overall Study|Withdrew Consent|0|||
155133295|NCT02607228|559918052|FG004|Overall Study|Withdrew Consent|0|||
155133296|NCT02607228|559918053|FG005|Overall Study|Withdrew Consent|1|||
155133297|NCT02607228|559918054|FG006|Overall Study|Withdrew Consent|0|||
155133298|NCT02607228|559918048|FG000|Overall Study|Study Terminated by Sponsor|0|||
155133299|NCT02607228|559918049|FG001|Overall Study|Study Terminated by Sponsor|0|||
155133300|NCT02607228|559918050|FG002|Overall Study|Study Terminated by Sponsor|0|||
155133301|NCT02607228|559918051|FG003|Overall Study|Study Terminated by Sponsor|1|||
155133302|NCT02607228|559918052|FG004|Overall Study|Study Terminated by Sponsor|0|||
155133303|NCT02607228|559918053|FG005|Overall Study|Study Terminated by Sponsor|0|||
155133304|NCT02607228|559918054|FG006|Overall Study|Study Terminated by Sponsor|0|||
155133305|NCT04356040|559918055|FG000|Overall Study|Death|2|||
155133306|NCT04356040|559918056|FG001|Overall Study|Death|0|||
155133307|NCT04356040|559918055|FG000|Overall Study|Lost to Follow-up|1|||
155133308|NCT04356040|559918056|FG001|Overall Study|Lost to Follow-up|0|||
155133309|NCT04356040|559918055|FG000|Overall Study|Physician Decision|0|||
155133310|NCT04356040|559918056|FG001|Overall Study|Physician Decision|1|||
155133311|NCT04356040|559918055|FG000|Overall Study|Withdrawal by Subject|13|||
155133312|NCT04356040|559918056|FG001|Overall Study|Withdrawal by Subject|1|||
155133313|NCT04356040|559918055|FG000|Overall Study|Enrollment Pause|10|||
155133314|NCT04356040|559918056|FG001|Overall Study|Enrollment Pause|0|||
155133315|NCT04356040|559918055|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
155133316|NCT04356040|559918056|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
155133317|NCT04356040|559918055|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
155133318|NCT04356040|559918056|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
155133319|NCT04356040|559918055|FG000|Overall Study|PI left institution|3|||
155133320|NCT04356040|559918056|FG001|Overall Study|PI left institution|0|||
155133321|NCT04407234|559918057|FG000|Overall Study|Adverse Event|3|||
155133322|NCT04407234|559918058|FG001|Overall Study|Adverse Event|3|||
155133323|NCT00360568|559918064|FG000|Overall Study|Adverse Event|1|||
155133324|NCT00360568|559918065|FG001|Overall Study|Adverse Event|2|||
155133325|NCT00360568|559918064|FG000|Overall Study|Lack of Efficacy|1|||
155133326|NCT00360568|559918065|FG001|Overall Study|Lack of Efficacy|0|||
155133327|NCT00360568|559918064|FG000|Overall Study|Withdrawal by Subject|0|||
155133328|NCT00360568|559918065|FG001|Overall Study|Withdrawal by Subject|3|||
155133329|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
155133330|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
155133331|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
155133332|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
155133333|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
155133334|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
155133335|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
155133336|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
155133337|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Death|0|||
155133338|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Death|1|||
155178591|NCT01879579|560093306|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
155178592|NCT01879579|560093307|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
155178593|NCT03384693|560093308|FG000|Overall Study|Adverse Event|3|||
155178594|NCT05347147|560093309|FG000|Overall Study|Lost to Follow-up|0|||
155178595|NCT05347147|560093310|FG001|Overall Study|Lost to Follow-up|1|||
155178596|NCT05347147|560093309|FG000|Overall Study|Sponsor request|3|||
155178597|NCT05347147|560093310|FG001|Overall Study|Sponsor request|3|||
155178598|NCT05347147|560093309|FG000|Overall Study|Study termination|2|||
155178599|NCT05347147|560093310|FG001|Overall Study|Study termination|1|||
155178600|NCT01275339|560093315|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
155178601|NCT01275339|560093316|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
155178602|NCT01275339|560093317|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
155178603|NCT01275339|560093318|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
155178604|NCT01275339|560093315|FG000|Overall Study|Withdrawal by Subject|0|||
155178605|NCT01275339|560093316|FG001|Overall Study|Withdrawal by Subject|0|||
155178606|NCT01275339|560093317|FG002|Overall Study|Withdrawal by Subject|1|||
155178607|NCT01275339|560093318|FG003|Overall Study|Withdrawal by Subject|0|||
155178608|NCT00923364|560093322|FG000|Overall Study|Death|3|||
155178609|NCT00923364|560093323|FG001|Overall Study|Death|0|||
155178610|NCT00923364|560093322|FG000|Overall Study|Did not go to transplant|1|||
155013503|NCT00460603|559474973|FG011|Phase 1|Withdrawal by Subject|0|||
155013504|NCT00460603|559474962|FG000|Phase 1|Other|0|||
155013505|NCT00460603|559474963|FG001|Phase 1|Other|3|||
155013506|NCT00460603|559474964|FG002|Phase 1|Other|1|||
155013507|NCT00460603|559474965|FG003|Phase 1|Other|1|||
155013508|NCT00460603|559474966|FG004|Phase 1|Other|1|||
155013509|NCT00460603|559474967|FG005|Phase 1|Other|2|||
155013510|NCT00460603|559474968|FG006|Phase 1|Other|0|||
155013511|NCT00460603|559474969|FG007|Phase 1|Other|1|||
155013512|NCT00460603|559474970|FG008|Phase 1|Other|0|||
155013513|NCT00460603|559474971|FG009|Phase 1|Other|0|||
155013514|NCT00460603|559474972|FG010|Phase 1|Other|0|||
155013515|NCT00460603|559474973|FG011|Phase 1|Other|0|||
155013516|NCT00460603|559474962|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013517|NCT00460603|559474963|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013518|NCT00460603|559474964|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013519|NCT00460603|559474965|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013520|NCT00460603|559474966|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013521|NCT00460603|559474967|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013522|NCT00460603|559474968|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013523|NCT00460603|559474969|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013524|NCT00460603|559474970|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013525|NCT00460603|559474971|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
155013526|NCT00460603|559474972|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013527|NCT00460603|559474973|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
155013528|NCT00460603|559474962|FG000|Phase 2|Adverse Event|0|||
155013529|NCT00460603|559474963|FG001|Phase 2|Adverse Event|0|||
155013530|NCT00460603|559474964|FG002|Phase 2|Adverse Event|0|||
155013531|NCT00460603|559474965|FG003|Phase 2|Adverse Event|0|||
155013532|NCT00460603|559474966|FG004|Phase 2|Adverse Event|0|||
155013533|NCT00460603|559474967|FG005|Phase 2|Adverse Event|0|||
155013534|NCT00460603|559474968|FG006|Phase 2|Adverse Event|0|||
155013535|NCT00460603|559474969|FG007|Phase 2|Adverse Event|0|||
155013536|NCT00460603|559474970|FG008|Phase 2|Adverse Event|0|||
155013537|NCT00460603|559474971|FG009|Phase 2|Adverse Event|12|||
155013538|NCT00460603|559474972|FG010|Phase 2|Adverse Event|9|||
155013539|NCT00460603|559474973|FG011|Phase 2|Adverse Event|10|||
155013540|NCT00460603|559474962|FG000|Phase 2|Death|0|||
155013541|NCT00460603|559474963|FG001|Phase 2|Death|0|||
155013542|NCT00460603|559474964|FG002|Phase 2|Death|0|||
155013543|NCT00460603|559474965|FG003|Phase 2|Death|0|||
155013544|NCT00460603|559474966|FG004|Phase 2|Death|0|||
155013545|NCT00460603|559474967|FG005|Phase 2|Death|0|||
155013546|NCT00460603|559474968|FG006|Phase 2|Death|0|||
155013547|NCT00460603|559474969|FG007|Phase 2|Death|0|||
155013548|NCT00460603|559474970|FG008|Phase 2|Death|0|||
155013549|NCT00460603|559474971|FG009|Phase 2|Death|4|||
155013550|NCT00460603|559474972|FG010|Phase 2|Death|2|||
155013551|NCT00460603|559474973|FG011|Phase 2|Death|2|||
155013552|NCT00460603|559474962|FG000|Phase 2|Protocol Violation|0|||
155013553|NCT00460603|559474963|FG001|Phase 2|Protocol Violation|0|||
155013554|NCT00460603|559474964|FG002|Phase 2|Protocol Violation|0|||
155013555|NCT00460603|559474965|FG003|Phase 2|Protocol Violation|0|||
155178611|NCT00923364|560093323|FG001|Overall Study|Did not go to transplant|0|||
155013556|NCT00460603|559474966|FG004|Phase 2|Protocol Violation|0|||
155013557|NCT00460603|559474967|FG005|Phase 2|Protocol Violation|0|||
155013558|NCT00460603|559474968|FG006|Phase 2|Protocol Violation|0|||
155013559|NCT00460603|559474969|FG007|Phase 2|Protocol Violation|0|||
155013560|NCT00460603|559474970|FG008|Phase 2|Protocol Violation|0|||
155013561|NCT00460603|559474971|FG009|Phase 2|Protocol Violation|1|||
155013562|NCT00460603|559474972|FG010|Phase 2|Protocol Violation|1|||
155013563|NCT00460603|559474973|FG011|Phase 2|Protocol Violation|0|||
155013564|NCT00460603|559474962|FG000|Phase 2|Lost to Follow-up|0|||
155013565|NCT00460603|559474963|FG001|Phase 2|Lost to Follow-up|0|||
155133339|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
155133340|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
155133341|NCT03281304|559918066|FG000|Treatment Phase (up to 42 Months)|Other|0|||
155133342|NCT03281304|559918067|FG001|Treatment Phase (up to 42 Months)|Other|2|||
155133343|NCT03281304|559918066|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
155133344|NCT03281304|559918067|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
155133345|NCT01114438|559918070|FG000|Overall Study|Adverse Event|10|||
155133346|NCT01114438|559918070|FG000|Overall Study|concomitant medication|1|||
155133347|NCT01114438|559918070|FG000|Overall Study|Physician Decision|1|||
155133348|NCT01114438|559918070|FG000|Overall Study|Withdrawal by Subject|2|||
155133349|NCT00428844|559918075|FG000|Completed Study Drug Treatment|Adverse Event|2|||
155133350|NCT00428844|559918076|FG001|Completed Study Drug Treatment|Adverse Event|4|||
155133351|NCT00428844|559918077|FG002|Completed Study Drug Treatment|Adverse Event|4|||
155133352|NCT00428844|559918075|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
155133353|NCT00428844|559918076|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
155133354|NCT00428844|559918077|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
155133355|NCT00428844|559918075|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
155133356|NCT00428844|559918076|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
155133357|NCT00428844|559918077|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
155133358|NCT00428844|559918075|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
155133359|NCT00428844|559918076|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
155133360|NCT00428844|559918077|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
155133361|NCT00428844|559918075|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
155133362|NCT00428844|559918076|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
155133363|NCT00428844|559918077|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
155133364|NCT00428844|559918075|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
155133365|NCT00428844|559918076|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
155133366|NCT00428844|559918077|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
155133367|NCT00428844|559918075|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
155133368|NCT00428844|559918076|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
155133369|NCT00428844|559918077|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
155133370|NCT00428844|559918075|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
155133371|NCT00428844|559918076|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
155133372|NCT00428844|559918077|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
155133373|NCT00428844|559918075|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
155133374|NCT00428844|559918076|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
155133375|NCT00428844|559918077|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
155133376|NCT01990612|559918080|FG000|Overall Study|Lost to Follow-up|2|||
155133377|NCT01990612|559918081|FG001|Overall Study|Lost to Follow-up|1|||
155133378|NCT01990612|559918080|FG000|Overall Study|Withdrawal by Subject|5|||
155133379|NCT01990612|559918081|FG001|Overall Study|Withdrawal by Subject|2|||
155133380|NCT02188849|559918082|FG000|Overall Study|Lost to Follow-up|3|||
155133381|NCT02188849|559918083|FG001|Overall Study|Lost to Follow-up|8|||
155133382|NCT00566254|559918085|FG000|Overall Study|Adverse Event|3|||
155133383|NCT00566254|559918086|FG001|Overall Study|Adverse Event|1|||
155133384|NCT00566254|559918085|FG000|Overall Study|Protocol Violation|1|||
155133385|NCT00566254|559918086|FG001|Overall Study|Protocol Violation|3|||
155133386|NCT00566254|559918085|FG000|Overall Study|Withdrawal by Subject|1|||
155133387|NCT00566254|559918086|FG001|Overall Study|Withdrawal by Subject|2|||
155133388|NCT00566254|559918085|FG000|Overall Study|Lack of Efficacy|5|||
155133389|NCT00566254|559918086|FG001|Overall Study|Lack of Efficacy|6|||
155133390|NCT00566254|559918085|FG000|Overall Study|Other|0|||
155133391|NCT00566254|559918086|FG001|Overall Study|Other|2|||
155133392|NCT01793883|559918087|FG000|Overall Study|Withdrawal by Subject|3|||
155133393|NCT01793883|559918088|FG001|Overall Study|Withdrawal by Subject|7|||
155133394|NCT01793883|559918089|FG002|Overall Study|Withdrawal by Subject|3|||
155133395|NCT01793883|559918087|FG000|Overall Study|Subject noncompliance|0|||
155133396|NCT01793883|559918088|FG001|Overall Study|Subject noncompliance|1|||
155133397|NCT01793883|559918089|FG002|Overall Study|Subject noncompliance|1|||
155133398|NCT01793883|559918087|FG000|Overall Study|Lost to Follow-up|5|||
155133399|NCT01793883|559918088|FG001|Overall Study|Lost to Follow-up|1|||
155013566|NCT00460603|559474964|FG002|Phase 2|Lost to Follow-up|0|||
155133400|NCT01793883|559918089|FG002|Overall Study|Lost to Follow-up|3|||
155133401|NCT01793883|559918087|FG000|Overall Study|Randomized in error|1|||
155133402|NCT01793883|559918088|FG001|Overall Study|Randomized in error|0|||
155178612|NCT01397825|560093324|FG000|Overall Study|Progressive Disease|10|||
155178613|NCT01397825|560093325|FG001|Overall Study|Progressive Disease|3|||
155178614|NCT01397825|560093326|FG002|Overall Study|Progressive Disease|11|||
155133403|NCT01793883|559918089|FG002|Overall Study|Randomized in error|0|||
155133404|NCT01793883|559918087|FG000|Overall Study|Unable to complete spriometry|1|||
155178615|NCT01397825|560093327|FG003|Overall Study|Progressive Disease|1|||
155013567|NCT00460603|559474965|FG003|Phase 2|Lost to Follow-up|0|||
154923984|NCT04668066|559146370|FG004|Part 1: Follow-Up|Adverse Event|0|||
154923985|NCT04668066|559146371|FG005|Part 1: Follow-Up|Adverse Event|0|||
154923986|NCT04668066|559146372|FG006|Part 1: Follow-Up|Adverse Event|0|||
154923987|NCT04668066|559146373|FG007|Part 1: Follow-Up|Adverse Event|0|||
154923988|NCT04668066|559146374|FG008|Part 1: Follow-Up|Adverse Event|0|||
154923989|NCT04668066|559146375|FG009|Part 1: Follow-Up|Adverse Event|0|||
154923990|NCT04668066|559146376|FG010|Part 1: Follow-Up|Adverse Event|0|||
154923991|NCT04668066|559146377|FG011|Part 1: Follow-Up|Adverse Event|1|||
154923992|NCT04668066|559146378|FG012|Part 1: Follow-Up|Adverse Event|0|||
154923993|NCT04668066|559146379|FG013|Part 1: Follow-Up|Adverse Event|0|||
154923994|NCT04668066|559146380|FG014|Part 1: Follow-Up|Adverse Event|0|||
154923995|NCT04668066|559146381|FG015|Part 1: Follow-Up|Adverse Event|0|||
154923996|NCT04668066|559146382|FG016|Part 1: Follow-Up|Adverse Event|0|||
154923997|NCT04668066|559146383|FG017|Part 1: Follow-Up|Adverse Event|0|||
154923998|NCT04668066|559146384|FG018|Part 1: Follow-Up|Adverse Event|0|||
154923999|NCT04668066|559146366|FG000|Part 1: Follow-Up|Other|0|||
154924000|NCT04668066|559146367|FG001|Part 1: Follow-Up|Other|0|||
154924001|NCT04668066|559146368|FG002|Part 1: Follow-Up|Other|0|||
154924002|NCT04668066|559146369|FG003|Part 1: Follow-Up|Other|0|||
154924003|NCT04668066|559146370|FG004|Part 1: Follow-Up|Other|0|||
154924004|NCT04668066|559146371|FG005|Part 1: Follow-Up|Other|0|||
154924005|NCT04668066|559146372|FG006|Part 1: Follow-Up|Other|0|||
154924006|NCT04668066|559146373|FG007|Part 1: Follow-Up|Other|0|||
154924007|NCT04668066|559146374|FG008|Part 1: Follow-Up|Other|0|||
154924008|NCT04668066|559146375|FG009|Part 1: Follow-Up|Other|0|||
154924009|NCT04668066|559146376|FG010|Part 1: Follow-Up|Other|0|||
154924010|NCT04668066|559146377|FG011|Part 1: Follow-Up|Other|1|||
154924011|NCT04668066|559146378|FG012|Part 1: Follow-Up|Other|1|||
154924012|NCT04668066|559146379|FG013|Part 1: Follow-Up|Other|0|||
154924013|NCT04668066|559146380|FG014|Part 1: Follow-Up|Other|0|||
154924014|NCT04668066|559146381|FG015|Part 1: Follow-Up|Other|0|||
154924015|NCT04668066|559146382|FG016|Part 1: Follow-Up|Other|0|||
154924016|NCT04668066|559146383|FG017|Part 1: Follow-Up|Other|0|||
154924017|NCT04668066|559146384|FG018|Part 1: Follow-Up|Other|0|||
154924018|NCT04668066|559146366|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924019|NCT04668066|559146367|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924020|NCT04668066|559146368|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924021|NCT04668066|559146369|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924022|NCT04668066|559146370|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924023|NCT04668066|559146371|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924024|NCT04668066|559146372|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924025|NCT04668066|559146373|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924026|NCT04668066|559146374|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924027|NCT04668066|559146375|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924028|NCT04668066|559146376|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924029|NCT04668066|559146377|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924030|NCT04668066|559146378|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
154924031|NCT04668066|559146379|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924032|NCT04668066|559146380|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924033|NCT04668066|559146381|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
154924034|NCT04668066|559146382|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924035|NCT04668066|559146383|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924036|NCT04668066|559146384|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
154924037|NCT04668066|559146366|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924038|NCT04668066|559146367|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924039|NCT04668066|559146368|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924040|NCT04668066|559146369|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924041|NCT04668066|559146370|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924042|NCT04668066|559146371|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924043|NCT04668066|559146372|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924044|NCT04668066|559146373|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924045|NCT04668066|559146374|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924046|NCT04668066|559146375|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924047|NCT04668066|559146376|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924048|NCT04668066|559146377|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924049|NCT04668066|559146378|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924050|NCT04668066|559146379|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924051|NCT04668066|559146380|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924052|NCT04668066|559146381|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924053|NCT04668066|559146382|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924054|NCT04668066|559146383|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
154924055|NCT04668066|559146384|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
154924056|NCT04668066|559146366|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924057|NCT04668066|559146367|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924058|NCT04668066|559146368|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
155013568|NCT00460603|559474966|FG004|Phase 2|Lost to Follow-up|0|||
154924059|NCT04668066|559146369|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
154924060|NCT04668066|559146370|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
155133405|NCT01793883|559918088|FG001|Overall Study|Unable to complete spriometry|0|||
155133406|NCT01793883|559918089|FG002|Overall Study|Unable to complete spriometry|0|||
155133407|NCT01793883|559918087|FG000|Overall Study|Unable to complete measurements|1|||
155133408|NCT01793883|559918088|FG001|Overall Study|Unable to complete measurements|0|||
155133409|NCT01793883|559918089|FG002|Overall Study|Unable to complete measurements|0|||
155133410|NCT01793883|559918087|FG000|Overall Study|Met exclusion criteria|1|||
155133411|NCT01793883|559918088|FG001|Overall Study|Met exclusion criteria|0|||
155133412|NCT01793883|559918089|FG002|Overall Study|Met exclusion criteria|0|||
155133413|NCT01793883|559918087|FG000|Overall Study|Dosing error|0|||
155133414|NCT01793883|559918088|FG001|Overall Study|Dosing error|1|||
155133415|NCT01793883|559918089|FG002|Overall Study|Dosing error|0|||
155133416|NCT01793883|559918087|FG000|Overall Study|Respiratory distress during spirometry|0|||
155133417|NCT01793883|559918088|FG001|Overall Study|Respiratory distress during spirometry|0|||
155133418|NCT01793883|559918089|FG002|Overall Study|Respiratory distress during spirometry|1|||
155133419|NCT00687531|559918090|FG000|Overall Study|Did not meet protocol eligibility|104|||
155133420|NCT00687531|559918090|FG000|Overall Study|Adverse Event|5|||
155133421|NCT00687531|559918090|FG000|Overall Study|Lost to Follow-up|26|||
155133422|NCT02353728|559918091|FG000|Overall Study|Subject non-compliance|1|||
155133423|NCT00895310|559918092|FG000|Overall Study|Withdrawal by Subject|1|||
155133424|NCT00659230|559918093|FG000|Overall Study|Lost to Follow-up|2|||
155133425|NCT00659230|559918094|FG001|Overall Study|Lost to Follow-up|5|||
155133426|NCT00659230|559918093|FG000|Overall Study|Lost source documentation|5|||
155133427|NCT00659230|559918094|FG001|Overall Study|Lost source documentation|4|||
155133428|NCT00659230|559918093|FG000|Overall Study|Did not return post-randomization|2|||
155133429|NCT00659230|559918094|FG001|Overall Study|Did not return post-randomization|3|||
155133430|NCT00303485|559919717|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
155133431|NCT00303485|559919718|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
155133432|NCT00303485|559919717|FG000|Overall Study|Failure to return|0|||
155133433|NCT00303485|559919718|FG001|Overall Study|Failure to return|1|||
155133434|NCT00303485|559919717|FG000|Overall Study|Withdrawal by Subject|1|||
155133435|NCT00303485|559919718|FG001|Overall Study|Withdrawal by Subject|0|||
155133436|NCT01496469|559919719|FG000|Overall Study|Adverse Event|1|||
155133437|NCT01496469|559919720|FG001|Overall Study|Adverse Event|0|||
155133438|NCT01496469|559919719|FG000|Overall Study|Protocol Violation|2|||
155133439|NCT01496469|559919720|FG001|Overall Study|Protocol Violation|0|||
155133440|NCT01496469|559919719|FG000|Overall Study|Lost to Follow-up|1|||
155133441|NCT01496469|559919720|FG001|Overall Study|Lost to Follow-up|1|||
155133442|NCT01496469|559919719|FG000|Overall Study|Withdrawal by Subject|4|||
155133443|NCT01496469|559919720|FG001|Overall Study|Withdrawal by Subject|4|||
155133444|NCT01496469|559919719|FG000|Overall Study|BP exceeds protocol limits|1|||
155133445|NCT01496469|559919720|FG001|Overall Study|BP exceeds protocol limits|2|||
155133446|NCT01496469|559919719|FG000|Overall Study|Other|1|||
155133447|NCT01496469|559919720|FG001|Overall Study|Other|1|||
155133448|NCT00193180|559919724|FG000|Overall Study|Lack of Efficacy|1|||
155133449|NCT00193180|559919724|FG000|Overall Study|Adverse Event|8|||
155133450|NCT00193180|559919724|FG000|Overall Study|Protocol Violation|1|||
155133451|NCT00891228|559919726|FG000|Overall Study|Adverse Event|0|||
155133452|NCT00891228|559919727|FG001|Overall Study|Adverse Event|2|||
155133453|NCT00891228|559919728|FG002|Overall Study|Adverse Event|3|||
155133454|NCT00891228|559919726|FG000|Overall Study|Withdrawal by Subject|2|||
155133455|NCT00891228|559919727|FG001|Overall Study|Withdrawal by Subject|4|||
155133456|NCT00891228|559919728|FG002|Overall Study|Withdrawal by Subject|5|||
155133457|NCT00891228|559919726|FG000|Overall Study|Protocol Violation|3|||
155133458|NCT00891228|559919727|FG001|Overall Study|Protocol Violation|1|||
155133459|NCT00891228|559919728|FG002|Overall Study|Protocol Violation|2|||
155133460|NCT00891228|559919726|FG000|Overall Study|Physician Decision|2|||
155133461|NCT00891228|559919727|FG001|Overall Study|Physician Decision|1|||
155133462|NCT00891228|559919728|FG002|Overall Study|Physician Decision|0|||
155133463|NCT00891228|559919726|FG000|Overall Study|Lost to Follow-up|4|||
155133464|NCT00891228|559919727|FG001|Overall Study|Lost to Follow-up|4|||
155133465|NCT00891228|559919728|FG002|Overall Study|Lost to Follow-up|5|||
155133466|NCT00891228|559919726|FG000|Overall Study|Pregnancy|0|||
155133467|NCT00891228|559919727|FG001|Overall Study|Pregnancy|1|||
155133468|NCT00891228|559919728|FG002|Overall Study|Pregnancy|0|||
155133469|NCT02688985|559919737|FG000|Overall Study|Adverse Event|1|||
155133470|NCT02688985|559919738|FG001|Overall Study|Adverse Event|2|||
155133471|NCT02688985|559919739|FG002|Overall Study|Adverse Event|2|||
155133472|NCT02688985|559919740|FG003|Overall Study|Adverse Event|0|||
155133473|NCT02688985|559919741|FG004|Overall Study|Adverse Event|0|||
155133474|NCT02688985|559919737|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
155133475|NCT02688985|559919738|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
155133476|NCT02688985|559919739|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
155133477|NCT02688985|559919740|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
155133478|NCT02688985|559919741|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
155133479|NCT02688985|559919737|FG000|Overall Study|Death|0|||
155133480|NCT02688985|559919738|FG001|Overall Study|Death|0|||
155133481|NCT02688985|559919739|FG002|Overall Study|Death|0|||
155133482|NCT02688985|559919740|FG003|Overall Study|Death|0|||
155133483|NCT02688985|559919741|FG004|Overall Study|Death|1|||
155133484|NCT02688985|559919737|FG000|Overall Study|Lack of Efficacy|0|||
155133485|NCT02688985|559919738|FG001|Overall Study|Lack of Efficacy|0|||
155133486|NCT02688985|559919739|FG002|Overall Study|Lack of Efficacy|0|||
155133487|NCT02688985|559919740|FG003|Overall Study|Lack of Efficacy|0|||
155133488|NCT02688985|559919741|FG004|Overall Study|Lack of Efficacy|1|||
155133489|NCT02688985|559919737|FG000|Overall Study|Lost to Follow-up|2|||
155133490|NCT02688985|559919738|FG001|Overall Study|Lost to Follow-up|0|||
155133491|NCT02688985|559919739|FG002|Overall Study|Lost to Follow-up|1|||
155133492|NCT02688985|559919740|FG003|Overall Study|Lost to Follow-up|1|||
155133493|NCT02688985|559919741|FG004|Overall Study|Lost to Follow-up|1|||
155133494|NCT02688985|559919737|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155133495|NCT02688985|559919738|FG001|Overall Study|Non-Compliance With Study Drug|3|||
155133496|NCT02688985|559919739|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155133497|NCT02688985|559919740|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155133498|NCT02688985|559919741|FG004|Overall Study|Non-Compliance With Study Drug|1|||
155133499|NCT02688985|559919737|FG000|Overall Study|Other|3|||
155133500|NCT02688985|559919738|FG001|Overall Study|Other|4|||
155133501|NCT02688985|559919739|FG002|Overall Study|Other|1|||
155133502|NCT02688985|559919740|FG003|Overall Study|Other|0|||
155133503|NCT02688985|559919741|FG004|Overall Study|Other|0|||
155133504|NCT02688985|559919737|FG000|Overall Study|Physician Decision|2|||
155133505|NCT02688985|559919738|FG001|Overall Study|Physician Decision|2|||
155133506|NCT02688985|559919739|FG002|Overall Study|Physician Decision|0|||
155133507|NCT02688985|559919740|FG003|Overall Study|Physician Decision|0|||
155133508|NCT02688985|559919741|FG004|Overall Study|Physician Decision|1|||
155133509|NCT02688985|559919737|FG000|Overall Study|Pregnancy|0|||
155133510|NCT02688985|559919738|FG001|Overall Study|Pregnancy|0|||
155133511|NCT02688985|559919739|FG002|Overall Study|Pregnancy|2|||
155133512|NCT02688985|559919740|FG003|Overall Study|Pregnancy|1|||
155133513|NCT02688985|559919741|FG004|Overall Study|Pregnancy|0|||
155133514|NCT02688985|559919737|FG000|Overall Study|Study Terminated By Sponsor|0|||
155133515|NCT02688985|559919738|FG001|Overall Study|Study Terminated By Sponsor|0|||
155133516|NCT02688985|559919739|FG002|Overall Study|Study Terminated By Sponsor|0|||
155133517|NCT02688985|559919740|FG003|Overall Study|Study Terminated By Sponsor|1|||
155133518|NCT02688985|559919741|FG004|Overall Study|Study Terminated By Sponsor|0|||
155133519|NCT02688985|559919737|FG000|Overall Study|Withdrawal by Subject|2|||
155133520|NCT02688985|559919738|FG001|Overall Study|Withdrawal by Subject|8|||
155133521|NCT02688985|559919739|FG002|Overall Study|Withdrawal by Subject|7|||
155133522|NCT02688985|559919740|FG003|Overall Study|Withdrawal by Subject|1|||
155133523|NCT02688985|559919741|FG004|Overall Study|Withdrawal by Subject|4|||
155133524|NCT01964963|559919744|FG000|Overall Study|Case Report Forms Uncollected|888|||
155013569|NCT00460603|559474967|FG005|Phase 2|Lost to Follow-up|0|||
155013570|NCT00460603|559474968|FG006|Phase 2|Lost to Follow-up|0|||
155013571|NCT00460603|559474969|FG007|Phase 2|Lost to Follow-up|0|||
155013572|NCT00460603|559474970|FG008|Phase 2|Lost to Follow-up|0|||
155013573|NCT00460603|559474971|FG009|Phase 2|Lost to Follow-up|1|||
155013574|NCT00460603|559474972|FG010|Phase 2|Lost to Follow-up|0|||
155013575|NCT00460603|559474973|FG011|Phase 2|Lost to Follow-up|0|||
155013576|NCT00460603|559474962|FG000|Phase 2|Other|0|||
155013577|NCT00460603|559474963|FG001|Phase 2|Other|0|||
155013578|NCT00460603|559474964|FG002|Phase 2|Other|0|||
155013579|NCT00460603|559474965|FG003|Phase 2|Other|0|||
155013580|NCT00460603|559474966|FG004|Phase 2|Other|0|||
155013581|NCT00460603|559474967|FG005|Phase 2|Other|0|||
155013582|NCT00460603|559474968|FG006|Phase 2|Other|0|||
155013583|NCT00460603|559474969|FG007|Phase 2|Other|0|||
155013584|NCT00460603|559474970|FG008|Phase 2|Other|0|||
155013585|NCT00460603|559474971|FG009|Phase 2|Other|6|||
155013586|NCT00460603|559474972|FG010|Phase 2|Other|16|||
155013587|NCT00460603|559474973|FG011|Phase 2|Other|7|||
155013588|NCT00460603|559474962|FG000|Phase 2|Objective Progression or Relapse|0|||
155013589|NCT00460603|559474963|FG001|Phase 2|Objective Progression or Relapse|0|||
155013590|NCT00460603|559474964|FG002|Phase 2|Objective Progression or Relapse|0|||
155013591|NCT00460603|559474965|FG003|Phase 2|Objective Progression or Relapse|0|||
155013592|NCT00460603|559474966|FG004|Phase 2|Objective Progression or Relapse|0|||
155013593|NCT00460603|559474967|FG005|Phase 2|Objective Progression or Relapse|0|||
155013594|NCT00460603|559474968|FG006|Phase 2|Objective Progression or Relapse|0|||
155013595|NCT00460603|559474969|FG007|Phase 2|Objective Progression or Relapse|0|||
155013596|NCT00460603|559474970|FG008|Phase 2|Objective Progression or Relapse|0|||
155013597|NCT00460603|559474971|FG009|Phase 2|Objective Progression or Relapse|9|||
155013598|NCT00460603|559474972|FG010|Phase 2|Objective Progression or Relapse|10|||
155133525|NCT01964963|559919744|FG000|Overall Study|Protocol Deviation|50|||
155133526|NCT01964963|559919744|FG000|Overall Study|Data Reliability was not Assured|5|||
155133527|NCT00930553|559919745|FG000|Overall Study|Adverse Event|1|||
155133528|NCT00930553|559919745|FG000|Overall Study|Lack of Efficacy|7|||
155133529|NCT00930553|559919745|FG000|Overall Study|Physician Decision|39|||
155013599|NCT00460603|559474973|FG011|Phase 2|Objective Progression or Relapse|17|||
155013600|NCT00460603|559474962|FG000|Phase 2|Global Deterioration of Health Status|0|||
155013601|NCT00460603|559474963|FG001|Phase 2|Global Deterioration of Health Status|0|||
155133530|NCT00930553|559919745|FG000|Overall Study|Protocol Violation|1|||
155133531|NCT00930553|559919745|FG000|Overall Study|Pregnancy|1|||
155133532|NCT00930553|559919745|FG000|Overall Study|Withdrawal by Subject|88|||
155133533|NCT00930553|559919745|FG000|Overall Study|Lost to Follow-up|25|||
155133534|NCT00930553|559919745|FG000|Overall Study|Death|9|||
155133535|NCT00930553|559919745|FG000|Overall Study|Study terminated by sponsor|24|||
155013602|NCT00460603|559474964|FG002|Phase 2|Global Deterioration of Health Status|0|||
155013603|NCT00460603|559474965|FG003|Phase 2|Global Deterioration of Health Status|0|||
155013604|NCT00460603|559474966|FG004|Phase 2|Global Deterioration of Health Status|0|||
155013605|NCT00460603|559474967|FG005|Phase 2|Global Deterioration of Health Status|0|||
155013606|NCT00460603|559474968|FG006|Phase 2|Global Deterioration of Health Status|0|||
155013607|NCT00460603|559474969|FG007|Phase 2|Global Deterioration of Health Status|0|||
155013608|NCT00460603|559474970|FG008|Phase 2|Global Deterioration of Health Status|0|||
155013609|NCT00460603|559474971|FG009|Phase 2|Global Deterioration of Health Status|0|||
155013610|NCT00460603|559474972|FG010|Phase 2|Global Deterioration of Health Status|1|||
155013611|NCT00460603|559474973|FG011|Phase 2|Global Deterioration of Health Status|0|||
155013612|NCT00460603|559474962|FG000|Phase 2|Withdrawal by Subject|0|||
155013613|NCT00460603|559474963|FG001|Phase 2|Withdrawal by Subject|0|||
155013614|NCT00460603|559474964|FG002|Phase 2|Withdrawal by Subject|0|||
155013615|NCT00460603|559474965|FG003|Phase 2|Withdrawal by Subject|0|||
155013616|NCT00460603|559474966|FG004|Phase 2|Withdrawal by Subject|0|||
155013617|NCT00460603|559474967|FG005|Phase 2|Withdrawal by Subject|0|||
155013618|NCT00460603|559474968|FG006|Phase 2|Withdrawal by Subject|0|||
155013619|NCT00460603|559474969|FG007|Phase 2|Withdrawal by Subject|0|||
155013620|NCT00460603|559474970|FG008|Phase 2|Withdrawal by Subject|0|||
155013621|NCT00460603|559474971|FG009|Phase 2|Withdrawal by Subject|5|||
155013622|NCT00460603|559474972|FG010|Phase 2|Withdrawal by Subject|4|||
155013623|NCT00460603|559474973|FG011|Phase 2|Withdrawal by Subject|5|||
155013624|NCT00460603|559474962|FG000|Phase 2|Randomized, but not treated|0|||
155013625|NCT00460603|559474963|FG001|Phase 2|Randomized, but not treated|0|||
155013626|NCT00460603|559474964|FG002|Phase 2|Randomized, but not treated|0|||
155013627|NCT00460603|559474965|FG003|Phase 2|Randomized, but not treated|0|||
155013628|NCT00460603|559474966|FG004|Phase 2|Randomized, but not treated|0|||
155013629|NCT00460603|559474967|FG005|Phase 2|Randomized, but not treated|0|||
155013630|NCT00460603|559474968|FG006|Phase 2|Randomized, but not treated|0|||
155013631|NCT00460603|559474969|FG007|Phase 2|Randomized, but not treated|0|||
155013632|NCT00460603|559474970|FG008|Phase 2|Randomized, but not treated|0|||
155013633|NCT00460603|559474971|FG009|Phase 2|Randomized, but not treated|3|||
155013634|NCT00460603|559474972|FG010|Phase 2|Randomized, but not treated|0|||
155013635|NCT00460603|559474973|FG011|Phase 2|Randomized, but not treated|0|||
155013636|NCT03871543|559474974|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
155013637|NCT03871543|559474974|FG000|Period 1|Investigator Error|1|||
155013638|NCT03871543|559474974|FG000|Period 1|Protocol Violation|2|||
155013639|NCT03871543|559474974|FG000|Period 1|COVID-19 Related|1|||
155013640|NCT03871543|559474974|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
155013641|NCT03871543|559474974|FG000|Period 1|Withdrawal by Subject|10|||
155013642|NCT03871543|559474974|FG000|Period 2|Adverse Event|1|||
155013643|NCT03871543|559474974|FG000|Period 2|Withdrawal by Subject|1|||
155013644|NCT01082328|559474978|FG000|Overall Study|Adverse Event|1|||
155013645|NCT00031590|559474979|FG000|Overall Study|Adverse Event|1|||
155013646|NCT00031590|559474979|FG000|Overall Study|Withdrawal by parents|2|||
155013647|NCT05506046|559474982|FG000|Overall Study|Lost to Follow-up|89|||
155013648|NCT05506046|559474983|FG001|Overall Study|Lost to Follow-up|101|||
155013649|NCT05506046|559474984|FG002|Overall Study|Lost to Follow-up|102|||
155013650|NCT05506046|559474985|FG003|Overall Study|Lost to Follow-up|99|||
155013651|NCT01286467|559474988|FG000|Overall Study|Death|1|||
155013652|NCT01286467|559474989|FG001|Overall Study|Death|1|||
155013653|NCT01286467|559474990|FG002|Overall Study|Death|1|||
155013654|NCT01286467|559474991|FG003|Overall Study|Death|0|||
155013655|NCT01286467|559474988|FG000|Overall Study|Lost to Follow-up|0|||
155013656|NCT01286467|559474989|FG001|Overall Study|Lost to Follow-up|0|||
155013657|NCT01286467|559474990|FG002|Overall Study|Lost to Follow-up|0|||
155013658|NCT01286467|559474991|FG003|Overall Study|Lost to Follow-up|1|||
155013659|NCT01286467|559474988|FG000|Overall Study|Withdrawal by Subject|0|||
155013660|NCT01286467|559474989|FG001|Overall Study|Withdrawal by Subject|0|||
155013661|NCT01286467|559474990|FG002|Overall Study|Withdrawal by Subject|1|||
155133536|NCT00930553|559919745|FG000|Overall Study|Other than specified above|28|||
155133537|NCT01726582|559919746|FG000|Overall Study|Physician Decision|99|||
155013662|NCT01286467|559474991|FG003|Overall Study|Withdrawal by Subject|0|||
155013663|NCT01286467|559474988|FG000|Overall Study|Physician Decision|0|||
155013664|NCT01286467|559474989|FG001|Overall Study|Physician Decision|0|||
155013665|NCT01286467|559474990|FG002|Overall Study|Physician Decision|0|||
155013666|NCT01286467|559474991|FG003|Overall Study|Physician Decision|1|||
155013667|NCT01286467|559474988|FG000|Overall Study|Disease progression|3|||
155013668|NCT01286467|559474989|FG001|Overall Study|Disease progression|2|||
155013669|NCT01286467|559474990|FG002|Overall Study|Disease progression|2|||
155013670|NCT01286467|559474991|FG003|Overall Study|Disease progression|3|||
155013671|NCT01286467|559474988|FG000|Overall Study|Adverse Event|0|||
155133538|NCT01726582|559919746|FG000|Overall Study|Death|85|||
155133539|NCT01235234|559919747|FG000|Overall Study|Adverse Event|2|||
155133540|NCT01235234|559919748|FG001|Overall Study|Adverse Event|2|||
155133541|NCT01235234|559919749|FG002|Overall Study|Adverse Event|1|||
155133542|NCT02630472|559919750|FG000|Overall Study|Physician Decision|10|||
155133543|NCT02630472|559919751|FG001|Overall Study|Physician Decision|0|||
155133544|NCT01279616|559919752|FG000|Overall Study|donor could not be located|5|||
155133545|NCT01279616|559919752|FG000|Overall Study|no signs of sickle cell disease|2|||
155133546|NCT00183625|559919753|FG000|Overall Study|Withdrawal by Subject|18|||
155133547|NCT00183625|559919754|FG001|Overall Study|Withdrawal by Subject|18|||
155133548|NCT00183625|559919755|FG002|Overall Study|Withdrawal by Subject|19|||
155133549|NCT00183625|559919756|FG003|Overall Study|Withdrawal by Subject|14|||
155133550|NCT01369641|559919757|FG000|Overall Study|Withdrawal by Subject|1|||
155133551|NCT00842543|559919758|FG000|Overall Study|Withdrawal by Subject|2|||
155133552|NCT00842543|559919759|FG001|Overall Study|Withdrawal by Subject|0|||
155133553|NCT00842543|559919760|FG002|Overall Study|Withdrawal by Subject|3|||
155133554|NCT00842543|559919761|FG003|Overall Study|Withdrawal by Subject|4|||
155133555|NCT01483183|559919762|FG000|Overall Study|Physician Decision|0|||
155133556|NCT01483183|559919763|FG001|Overall Study|Physician Decision|0|||
155133557|NCT01483183|559919764|FG002|Overall Study|Physician Decision|0|||
155133558|NCT01483183|559919765|FG003|Overall Study|Physician Decision|0|||
155133559|NCT01483183|559919766|FG004|Overall Study|Physician Decision|0|||
155133560|NCT01483183|559919767|FG005|Overall Study|Physician Decision|0|||
155133561|NCT01483183|559919768|FG006|Overall Study|Physician Decision|2|||
155133562|NCT01483183|559919769|FG007|Overall Study|Physician Decision|0|||
155133563|NCT01483183|559919770|FG008|Overall Study|Physician Decision|0|||
155133564|NCT01483183|559919771|FG009|Overall Study|Physician Decision|0|||
155133565|NCT01483183|559919762|FG000|Overall Study|Withdrawal by Subject|0|||
155133566|NCT01483183|559919763|FG001|Overall Study|Withdrawal by Subject|0|||
155133567|NCT01483183|559919764|FG002|Overall Study|Withdrawal by Subject|0|||
155133568|NCT01483183|559919765|FG003|Overall Study|Withdrawal by Subject|0|||
155133569|NCT01483183|559919766|FG004|Overall Study|Withdrawal by Subject|0|||
155133570|NCT01483183|559919767|FG005|Overall Study|Withdrawal by Subject|0|||
155133571|NCT01483183|559919768|FG006|Overall Study|Withdrawal by Subject|0|||
155133572|NCT01483183|559919769|FG007|Overall Study|Withdrawal by Subject|0|||
155133573|NCT01483183|559919770|FG008|Overall Study|Withdrawal by Subject|0|||
155133574|NCT01483183|559919771|FG009|Overall Study|Withdrawal by Subject|1|||
155133575|NCT00239928|559919772|FG000|Overall Study|Lack of Efficacy|1|||
155133576|NCT00239928|559919772|FG000|Overall Study|Adverse Event|4|||
155133577|NCT00239928|559919772|FG000|Overall Study|Not need to continue study|3|||
155133578|NCT00239928|559919772|FG000|Overall Study|Withdrawal by Subject|2|||
155133579|NCT02718716|559919773|FG000|Overall Study|Lack of Efficacy|1|||
155133580|NCT02718716|559919774|FG001|Overall Study|Lack of Efficacy|0|||
155133581|NCT02718716|559919775|FG002|Overall Study|Lack of Efficacy|0|||
155133582|NCT02718716|559919776|FG003|Overall Study|Lack of Efficacy|0|||
155133583|NCT02718716|559919777|FG004|Overall Study|Lack of Efficacy|0|||
155133584|NCT02942485|559919778|FG000|Overall Study|Lost to Follow-up|1|||
155133585|NCT02942485|559919779|FG001|Overall Study|Lost to Follow-up|0|||
155133586|NCT00084656|559919782|FG000|Overall Study|Other reasons|0|||
155133587|NCT00084656|559919783|FG001|Overall Study|Other reasons|12|||
155133588|NCT00084656|559919784|FG002|Overall Study|Other reasons|11|||
155133589|NCT00084656|559919782|FG000|Overall Study|Withdrawal by Subject|15|||
155133590|NCT00084656|559919783|FG001|Overall Study|Withdrawal by Subject|4|||
155133591|NCT00084656|559919784|FG002|Overall Study|Withdrawal by Subject|4|||
155133592|NCT00084656|559919782|FG000|Overall Study|Disease relapse|0|||
155133593|NCT00084656|559919783|FG001|Overall Study|Disease relapse|9|||
155133594|NCT00084656|559919784|FG002|Overall Study|Disease relapse|10|||
155133595|NCT00084656|559919782|FG000|Overall Study|Disease progression|9|||
155133596|NCT00084656|559919783|FG001|Overall Study|Disease progression|0|||
155133597|NCT00084656|559919784|FG002|Overall Study|Disease progression|0|||
155133598|NCT00084656|559919782|FG000|Overall Study|Lost to Follow-up|1|||
155133599|NCT00084656|559919783|FG001|Overall Study|Lost to Follow-up|0|||
155133600|NCT00084656|559919784|FG002|Overall Study|Lost to Follow-up|1|||
155133601|NCT00666965|559919789|FG000|Overall Study|Adverse Event|0|||
155013672|NCT01286467|559474989|FG001|Overall Study|Adverse Event|1|||
155013673|NCT01286467|559474990|FG002|Overall Study|Adverse Event|2|||
155013674|NCT01286467|559474991|FG003|Overall Study|Adverse Event|3|||
155133602|NCT00666965|559919790|FG001|Overall Study|Adverse Event|2|||
155133603|NCT00666965|559919791|FG002|Overall Study|Adverse Event|1|||
155133604|NCT00666965|559919792|FG003|Overall Study|Adverse Event|9|||
155133605|NCT00666965|559919789|FG000|Overall Study|Lack of Efficacy|1|||
155133606|NCT00666965|559919790|FG001|Overall Study|Lack of Efficacy|1|||
155133607|NCT00666965|559919791|FG002|Overall Study|Lack of Efficacy|0|||
155178616|NCT01397825|560093328|FG004|Overall Study|Progressive Disease|0|||
155178617|NCT01397825|560093324|FG000|Overall Study|Symptomatic Deterioration|2|||
155133608|NCT00666965|559919792|FG003|Overall Study|Lack of Efficacy|0|||
155133609|NCT00666965|559919789|FG000|Overall Study|Protocol Violation|0|||
155133610|NCT00666965|559919790|FG001|Overall Study|Protocol Violation|0|||
155133611|NCT00666965|559919791|FG002|Overall Study|Protocol Violation|0|||
155013675|NCT01286467|559474988|FG000|Overall Study|Study drug stop longer than 14 days|0|||
155013676|NCT01286467|559474989|FG001|Overall Study|Study drug stop longer than 14 days|0|||
155013677|NCT01286467|559474990|FG002|Overall Study|Study drug stop longer than 14 days|1|||
155013678|NCT01286467|559474991|FG003|Overall Study|Study drug stop longer than 14 days|0|||
155013679|NCT00806403|559474992|FG000|Overall Study|Death|4|||
155013680|NCT00806403|559474993|FG001|Overall Study|Death|3|||
155013681|NCT00765102|559474994|FG000|Overall Study|Progressive disease|18|||
155013682|NCT00765102|559474994|FG000|Overall Study|Adverse Event|6|||
155013683|NCT00765102|559474994|FG000|Overall Study|Physician Decision|4|||
155013684|NCT00765102|559474994|FG000|Overall Study|Withdrawal by Subject|2|||
155013685|NCT00765102|559474994|FG000|Overall Study|Protocol Violation|1|||
155013686|NCT01320293|559474997|FG000|Overall Study|Lack of Efficacy|1|||
155013687|NCT01320293|559474997|FG000|Overall Study|Adverse Event|1|||
155013688|NCT01827111|559475000|FG000|Overall Study|Disease Progression|1|||
155013689|NCT01147068|559475001|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
155013690|NCT01147068|559475002|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155013691|NCT01147068|559475003|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155013692|NCT01147068|559475004|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155013693|NCT01147068|559475005|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155013694|NCT01147068|559475006|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
155013695|NCT01147068|559475007|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
155013696|NCT01147068|559475001|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
155013697|NCT01147068|559475002|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
155013698|NCT01147068|559475003|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
155013699|NCT01147068|559475004|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
155013700|NCT01147068|559475005|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
155013701|NCT01147068|559475006|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
155013702|NCT01147068|559475007|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
155013703|NCT01147068|559475001|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
155013704|NCT01147068|559475002|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
155013705|NCT01147068|559475003|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
155013706|NCT01147068|559475004|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
155013707|NCT01147068|559475005|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
155013708|NCT01147068|559475006|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
155013709|NCT01147068|559475007|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
155013710|NCT01147068|559475001|FG000|Subjects That Received 2nd Dose|Other|0|||
155013711|NCT01147068|559475002|FG001|Subjects That Received 2nd Dose|Other|3|||
155013712|NCT01147068|559475003|FG002|Subjects That Received 2nd Dose|Other|3|||
155013713|NCT01147068|559475004|FG003|Subjects That Received 2nd Dose|Other|0|||
155013714|NCT01147068|559475005|FG004|Subjects That Received 2nd Dose|Other|1|||
155013715|NCT01147068|559475006|FG005|Subjects That Received 2nd Dose|Other|0|||
155013716|NCT01147068|559475007|FG006|Subjects That Received 2nd Dose|Other|0|||
155013717|NCT01147068|559475001|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
155013718|NCT01147068|559475002|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155013719|NCT01147068|559475003|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155013720|NCT01147068|559475004|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155013721|NCT01147068|559475005|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
155013722|NCT01147068|559475006|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
155013723|NCT01147068|559475007|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
155013724|NCT01147068|559475001|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155013725|NCT01147068|559475002|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155013726|NCT01147068|559475003|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155013727|NCT01147068|559475004|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
155013728|NCT01147068|559475005|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155013729|NCT01147068|559475006|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155013730|NCT01147068|559475007|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
155013731|NCT01147068|559475001|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
155013732|NCT01147068|559475002|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
155013733|NCT01147068|559475003|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
155013734|NCT01147068|559475004|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
155013735|NCT01147068|559475005|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
155133612|NCT00666965|559919792|FG003|Overall Study|Protocol Violation|2|||
155133613|NCT00666965|559919789|FG000|Overall Study|Discontinuation criteria|2|||
155013736|NCT01147068|559475006|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
155013737|NCT01147068|559475007|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
155013738|NCT03181633|559475008|FG000|Overall Study|Withdrawal by Subject|1|||
155013739|NCT03181633|559475008|FG000|Overall Study|Missing follow-up visit|1|||
155013740|NCT04837196|559475013|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
155133614|NCT00666965|559919790|FG001|Overall Study|Discontinuation criteria|1|||
155133615|NCT00666965|559919791|FG002|Overall Study|Discontinuation criteria|1|||
155133616|NCT00666965|559919792|FG003|Overall Study|Discontinuation criteria|2|||
155133617|NCT00666965|559919789|FG000|Overall Study|Withdrawal by Subject|0|||
155133618|NCT00666965|559919790|FG001|Overall Study|Withdrawal by Subject|0|||
155133619|NCT00666965|559919791|FG002|Overall Study|Withdrawal by Subject|0|||
155133620|NCT00666965|559919792|FG003|Overall Study|Withdrawal by Subject|2|||
155133621|NCT03624127|559919793|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
155133622|NCT03624127|559919794|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
155133623|NCT03624127|559919795|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
155133624|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
155133625|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
155133626|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
155133627|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Death|0|||
155133628|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Death|1|||
155133629|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Death|0|||
155133630|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
155133631|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
155133632|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
155133633|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
155133634|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
155133635|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
155133636|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
155133637|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
155133638|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
155133639|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
155133640|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
155133641|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
155133642|NCT03624127|559919793|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
155133643|NCT03624127|559919794|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
155133644|NCT03624127|559919795|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
155133645|NCT03624127|559919793|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
155133646|NCT03624127|559919794|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
155133647|NCT03624127|559919795|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
155133648|NCT03624127|559919793|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
155133649|NCT03624127|559919794|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
155133650|NCT03624127|559919795|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
155133651|NCT03624127|559919793|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
155133652|NCT03624127|559919794|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
155133653|NCT03624127|559919795|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
155133654|NCT03624127|559919793|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
155133655|NCT03624127|559919794|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
155133656|NCT03624127|559919795|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
155133657|NCT03624127|559919793|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
155133658|NCT03624127|559919794|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
155133659|NCT03624127|559919795|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
155133660|NCT03624127|559919793|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
155133661|NCT03624127|559919794|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
155133662|NCT03624127|559919795|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
155133663|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
155133664|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
155133665|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
155133666|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
155133667|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
155133668|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
155133669|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
155133670|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
155133671|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
155133672|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
155133673|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
155133674|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
155133675|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
155133676|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
155133677|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
155133678|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
155133679|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
155133680|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
155133681|NCT03624127|559919793|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
155133682|NCT03624127|559919794|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
155133683|NCT03624127|559919795|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
155013741|NCT04837196|559475014|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
155133684|NCT03238924|559919809|FG000|Overall Study|Withdrawal by Subject|2|||
155133685|NCT03238924|559919810|FG001|Overall Study|Withdrawal by Subject|2|||
155133686|NCT03576716|559919811|FG000|Overall Study|Withdrawal by Subject|0|||
155133687|NCT03576716|559919812|FG001|Overall Study|Withdrawal by Subject|1|||
155133688|NCT00559988|559919813|FG000|Overall Study|Death|147|||
155133689|NCT00559988|559919814|FG001|Overall Study|Death|140|||
155133690|NCT00559988|559919813|FG000|Overall Study|Withdrawal by Subject|152|||
155133691|NCT00559988|559919814|FG001|Overall Study|Withdrawal by Subject|139|||
155133692|NCT00559988|559919813|FG000|Overall Study|Lost to Follow-up|42|||
155133693|NCT00559988|559919814|FG001|Overall Study|Lost to Follow-up|56|||
155133694|NCT00559988|559919813|FG000|Overall Study|ICD device explanted|10|||
155133695|NCT00559988|559919814|FG001|Overall Study|ICD device explanted|17|||
155133696|NCT02891382|559919815|FG000|Overall Study|Lost to Follow-up|3|||
155133697|NCT02891382|559919816|FG001|Overall Study|Lost to Follow-up|4|||
155133698|NCT02891382|559919817|FG002|Overall Study|Lost to Follow-up|5|||
155133699|NCT02891382|559919818|FG003|Overall Study|Lost to Follow-up|3|||
155133700|NCT02891382|559919819|FG004|Overall Study|Lost to Follow-up|4|||
155133701|NCT01455194|559919820|FG000|Overall Study|Screen Failure|20|||
155133702|NCT01455194|559919821|FG001|Overall Study|Screen Failure|0|||
155133703|NCT01455194|559919822|FG002|Overall Study|Screen Failure|0|||
155133704|NCT01455194|559919823|FG003|Overall Study|Screen Failure|0|||
155133705|NCT01455194|559919820|FG000|Overall Study|Randomisation Failure|90|||
155133706|NCT01455194|559919821|FG001|Overall Study|Randomisation Failure|0|||
155133707|NCT01455194|559919822|FG002|Overall Study|Randomisation Failure|0|||
155133708|NCT01455194|559919823|FG003|Overall Study|Randomisation Failure|0|||
155133709|NCT01455194|559919820|FG000|Overall Study|Deterioration in asthma|12|||
155133710|NCT01455194|559919821|FG001|Overall Study|Deterioration in asthma|6|||
155133711|NCT01455194|559919822|FG002|Overall Study|Deterioration in asthma|14|||
155133712|NCT01455194|559919823|FG003|Overall Study|Deterioration in asthma|9|||
155133713|NCT01455194|559919820|FG000|Overall Study|Adverse Event|1|||
155133714|NCT01455194|559919821|FG001|Overall Study|Adverse Event|1|||
155133715|NCT01455194|559919822|FG002|Overall Study|Adverse Event|1|||
155133716|NCT01455194|559919823|FG003|Overall Study|Adverse Event|3|||
155133717|NCT01455194|559919820|FG000|Overall Study|Withdrawal by Subject|21|||
155133718|NCT01455194|559919821|FG001|Overall Study|Withdrawal by Subject|16|||
155133719|NCT01455194|559919822|FG002|Overall Study|Withdrawal by Subject|12|||
155133720|NCT01455194|559919823|FG003|Overall Study|Withdrawal by Subject|9|||
155133721|NCT01455194|559919820|FG000|Overall Study|Lost to Follow-up|2|||
155133722|NCT01455194|559919821|FG001|Overall Study|Lost to Follow-up|0|||
155133723|NCT01455194|559919822|FG002|Overall Study|Lost to Follow-up|1|||
155133724|NCT01455194|559919823|FG003|Overall Study|Lost to Follow-up|1|||
155133725|NCT01455194|559919820|FG000|Overall Study|Pregnancy|0|||
155133726|NCT01455194|559919821|FG001|Overall Study|Pregnancy|1|||
155133727|NCT01455194|559919822|FG002|Overall Study|Pregnancy|1|||
155133728|NCT01455194|559919823|FG003|Overall Study|Pregnancy|0|||
155133729|NCT01455194|559919820|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
155133730|NCT01455194|559919821|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
155133731|NCT01455194|559919822|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
155133732|NCT01455194|559919823|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
155133733|NCT01455194|559919820|FG000|Overall Study|Miscellaneous|4|||
155133734|NCT01455194|559919821|FG001|Overall Study|Miscellaneous|5|||
155133735|NCT01455194|559919822|FG002|Overall Study|Miscellaneous|1|||
155133736|NCT01455194|559919823|FG003|Overall Study|Miscellaneous|4|||
155133737|NCT02249182|559919824|FG000|Treatment Phase|Lost to Follow-up|4|||
155133738|NCT02249182|559919825|FG001|Treatment Phase|Lost to Follow-up|0|||
155133739|NCT02249182|559919826|FG002|Treatment Phase|Lost to Follow-up|0|||
155133740|NCT02249182|559919827|FG003|Treatment Phase|Lost to Follow-up|0|||
155133741|NCT02249182|559919828|FG004|Treatment Phase|Lost to Follow-up|0|||
155133742|NCT02516228|559919829|FG000|Overall Study|Lost to Follow-up|1|||
155133743|NCT02516228|559919829|FG000|Overall Study|Withdrawal by Subject|1|||
155133744|NCT02516228|559919829|FG000|Overall Study|Physician Decision|1|||
155133745|NCT03916484|559919830|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155133746|NCT03916484|559919831|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
155133747|NCT03916484|559919832|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155133748|NCT03916484|559919833|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
155133749|NCT03916484|559919830|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
155133750|NCT03916484|559919831|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
155133751|NCT03916484|559919832|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
155133752|NCT03916484|559919833|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
155133753|NCT05090852|559919834|FG000|Overall Study|Physician Decision|5|||
155133754|NCT00504894|559919835|FG000|Overall Study|fMRI technical problems|1|||
155133755|NCT00504894|559919836|FG001|Overall Study|fMRI technical problems|1|||
155133756|NCT00504894|559919837|FG002|Overall Study|fMRI technical problems|0|||
155133757|NCT00504894|559919835|FG000|Overall Study|Withdrawal by Subject|0|||
155133758|NCT00504894|559919836|FG001|Overall Study|Withdrawal by Subject|1|||
155133759|NCT00504894|559919837|FG002|Overall Study|Withdrawal by Subject|0|||
155133760|NCT00504894|559919835|FG000|Overall Study|Infusion technical problems|0|||
155133761|NCT00504894|559919836|FG001|Overall Study|Infusion technical problems|1|||
155133762|NCT00504894|559919837|FG002|Overall Study|Infusion technical problems|0|||
155133763|NCT00504894|559919835|FG000|Overall Study|poor subject data|2|||
155133764|NCT00504894|559919836|FG001|Overall Study|poor subject data|0|||
155133765|NCT00504894|559919837|FG002|Overall Study|poor subject data|0|||
155133766|NCT01196416|559919838|FG000|Overall Study|Withdrawal by Subject|2|||
155133767|NCT00148941|559919839|FG000|Overall Study|Lost to Follow-up|17|||
155133768|NCT00148941|559919840|FG001|Overall Study|Lost to Follow-up|24|||
155133769|NCT00148941|559919841|FG002|Overall Study|Lost to Follow-up|18|||
155133770|NCT00148941|559919842|FG003|Overall Study|Lost to Follow-up|22|||
155133771|NCT00148941|559919839|FG000|Overall Study|Withdrawal by Subject|1|||
155133772|NCT00148941|559919840|FG001|Overall Study|Withdrawal by Subject|0|||
155133773|NCT00148941|559919841|FG002|Overall Study|Withdrawal by Subject|1|||
155133774|NCT00148941|559919842|FG003|Overall Study|Withdrawal by Subject|0|||
155133775|NCT00148941|559919839|FG000|Overall Study|Other|0|||
155133776|NCT00148941|559919840|FG001|Overall Study|Other|0|||
155133777|NCT00148941|559919841|FG002|Overall Study|Other|1|||
155133778|NCT00148941|559919842|FG003|Overall Study|Other|2|||
155133779|NCT01008904|559919845|FG000|Overall Study|Lost to Follow-up|1|||
155133780|NCT01008904|559919845|FG000|Overall Study|Adverse Event|2|||
155133781|NCT01008904|559919845|FG000|Overall Study|unexpected unrelated surgery|1|||
155133782|NCT00788710|559919846|FG000|Overall Study|Adverse Event|1|||
155133783|NCT00788710|559919847|FG001|Overall Study|Adverse Event|3|||
155133784|NCT00788710|559919848|FG002|Overall Study|Adverse Event|4|||
155133785|NCT00788710|559919846|FG000|Overall Study|Lack of Efficacy|0|||
155133786|NCT00788710|559919847|FG001|Overall Study|Lack of Efficacy|0|||
155133787|NCT00788710|559919848|FG002|Overall Study|Lack of Efficacy|1|||
155133788|NCT00788710|559919846|FG000|Overall Study|Lost to Follow-up|0|||
155133789|NCT00788710|559919847|FG001|Overall Study|Lost to Follow-up|1|||
155133790|NCT00788710|559919848|FG002|Overall Study|Lost to Follow-up|0|||
155133791|NCT00788710|559919846|FG000|Overall Study|Physician Decision|2|||
155133792|NCT00788710|559919847|FG001|Overall Study|Physician Decision|1|||
155133793|NCT00788710|559919848|FG002|Overall Study|Physician Decision|0|||
155133794|NCT00788710|559919846|FG000|Overall Study|Protocol Violation|0|||
155133795|NCT00788710|559919847|FG001|Overall Study|Protocol Violation|1|||
155133796|NCT00788710|559919848|FG002|Overall Study|Protocol Violation|1|||
155133797|NCT00788710|559919846|FG000|Overall Study|Withdrawal by Subject|2|||
155133798|NCT00788710|559919847|FG001|Overall Study|Withdrawal by Subject|2|||
155133799|NCT00788710|559919848|FG002|Overall Study|Withdrawal by Subject|0|||
155133800|NCT01008449|559919852|FG000|Overall Study|Lost to Follow-up|29|||
155133801|NCT01008449|559919853|FG001|Overall Study|Lost to Follow-up|19|||
155133802|NCT02262754|559919855|FG000|Overall Study|Adverse Event|3|||
155133803|NCT02262754|559919856|FG001|Overall Study|Adverse Event|4|||
155133804|NCT02262754|559919857|FG002|Overall Study|Adverse Event|0|||
155133805|NCT02262754|559919855|FG000|Overall Study|Lack of Efficacy|2|||
155133806|NCT02262754|559919856|FG001|Overall Study|Lack of Efficacy|0|||
155133807|NCT02262754|559919857|FG002|Overall Study|Lack of Efficacy|1|||
155133808|NCT02262754|559919855|FG000|Overall Study|Lost to Follow-up|0|||
155133809|NCT02262754|559919856|FG001|Overall Study|Lost to Follow-up|0|||
155133810|NCT02262754|559919857|FG002|Overall Study|Lost to Follow-up|1|||
155133811|NCT02262754|559919855|FG000|Overall Study|No longer meets eligibility criteria|0|||
155133812|NCT02262754|559919856|FG001|Overall Study|No longer meets eligibility criteria|1|||
155133813|NCT02262754|559919857|FG002|Overall Study|No longer meets eligibility criteria|0|||
155133814|NCT02262754|559919855|FG000|Overall Study|Study terminated by sponsor|5|||
155133815|NCT02262754|559919856|FG001|Overall Study|Study terminated by sponsor|4|||
155133816|NCT02262754|559919857|FG002|Overall Study|Study terminated by sponsor|4|||
155133817|NCT02262754|559919855|FG000|Overall Study|Protocol Violation|1|||
155133818|NCT02262754|559919856|FG001|Overall Study|Protocol Violation|0|||
155133819|NCT02262754|559919857|FG002|Overall Study|Protocol Violation|0|||
155133820|NCT02262754|559919855|FG000|Overall Study|Withdrawal by Subject|1|||
155133821|NCT02262754|559919856|FG001|Overall Study|Withdrawal by Subject|0|||
155133822|NCT02262754|559919857|FG002|Overall Study|Withdrawal by Subject|1|||
155133823|NCT02262754|559919855|FG000|Overall Study|Other|4|||
155133824|NCT02262754|559919856|FG001|Overall Study|Other|0|||
155133825|NCT02262754|559919857|FG002|Overall Study|Other|2|||
155133826|NCT01299116|559919858|FG000|Overall Study|Lost to Follow-up|65|||
155133827|NCT01299116|559919859|FG001|Overall Study|Lost to Follow-up|9|||
155133828|NCT01299116|559919860|FG002|Overall Study|Lost to Follow-up|11|||
155133829|NCT04079114|559919864|FG000|Overall Study|Study prematuely terminated.|166|||
155133830|NCT01364389|559919866|FG000|Overall Study|Withdrawal by Subject|0|||
155133831|NCT01364389|559919867|FG001|Overall Study|Withdrawal by Subject|1|||
155133832|NCT01364389|559919868|FG002|Overall Study|Withdrawal by Subject|0|||
155133833|NCT01364389|559919866|FG000|Overall Study|Protocol deviation|0|||
155133834|NCT01364389|559919867|FG001|Overall Study|Protocol deviation|0|||
155133835|NCT01364389|559919868|FG002|Overall Study|Protocol deviation|1|||
155133836|NCT01364389|559919866|FG000|Overall Study|Administrative problems|1|||
155133837|NCT01364389|559919867|FG001|Overall Study|Administrative problems|0|||
155133838|NCT01364389|559919868|FG002|Overall Study|Administrative problems|0|||
155133839|NCT01364389|559919866|FG000|Overall Study|Adverse Event|1|||
155133840|NCT01364389|559919867|FG001|Overall Study|Adverse Event|0|||
155133841|NCT01364389|559919868|FG002|Overall Study|Adverse Event|0|||
155133842|NCT01534195|559919869|FG000|Overall Study|Withdrawal by Subject|1|||
155133843|NCT01534195|559919870|FG001|Overall Study|Withdrawal by Subject|1|||
155133844|NCT00629798|559919873|FG000|Overall Study|Not Treated|4|||
155133845|NCT02554981|559919874|FG000|Overall Study|Adverse Event|1|||
155013742|NCT04837196|559475015|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
155013743|NCT04837196|559475016|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
155013744|NCT04837196|559475017|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
155013745|NCT04837196|559475013|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
155013746|NCT04837196|559475014|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
155013747|NCT04837196|559475015|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
155013748|NCT04837196|559475016|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
155013749|NCT04837196|559475017|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
155013750|NCT04837196|559475013|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155013751|NCT04837196|559475014|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
155013752|NCT04837196|559475015|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155013753|NCT04837196|559475016|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155013754|NCT04837196|559475017|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
155013755|NCT04837196|559475013|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155013756|NCT04837196|559475014|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155013757|NCT04837196|559475015|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
155013758|NCT04837196|559475016|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155013759|NCT04837196|559475017|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
155013760|NCT04837196|559475013|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155013761|NCT04837196|559475014|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155013762|NCT04837196|559475015|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
155013763|NCT04837196|559475016|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155013764|NCT04837196|559475017|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
155013765|NCT00858273|559475018|FG000|Overall Study|Protocol Violation|3|||
155013766|NCT00858273|559475019|FG001|Overall Study|Protocol Violation|5|||
155013767|NCT00350207|559477058|FG000|Overall Study|Adverse Event|5|||
155013768|NCT00350207|559477059|FG001|Overall Study|Adverse Event|2|||
155013769|NCT00350207|559477060|FG002|Overall Study|Adverse Event|2|||
155013770|NCT00350207|559477058|FG000|Overall Study|Lack of Efficacy|1|||
155013771|NCT00350207|559477059|FG001|Overall Study|Lack of Efficacy|0|||
155013772|NCT00350207|559477060|FG002|Overall Study|Lack of Efficacy|2|||
155013773|NCT00350207|559477058|FG000|Overall Study|Lost to Follow-up|1|||
155013774|NCT00350207|559477059|FG001|Overall Study|Lost to Follow-up|0|||
155013775|NCT00350207|559477060|FG002|Overall Study|Lost to Follow-up|1|||
155013776|NCT00350207|559477058|FG000|Overall Study|Withdrawal by Subject|0|||
155013777|NCT00350207|559477059|FG001|Overall Study|Withdrawal by Subject|1|||
155013778|NCT00350207|559477060|FG002|Overall Study|Withdrawal by Subject|1|||
155013779|NCT00350207|559477058|FG000|Overall Study|Other|1|||
155013780|NCT00350207|559477059|FG001|Overall Study|Other|3|||
155013781|NCT00350207|559477060|FG002|Overall Study|Other|1|||
155013782|NCT01293695|559477064|FG000|Overall Study|Withdrawal by Subject|7|||
155013783|NCT01293695|559477065|FG001|Overall Study|Withdrawal by Subject|1|||
155013784|NCT01293695|559477064|FG000|Overall Study|Lost to Follow-up|8|||
155013785|NCT01293695|559477065|FG001|Overall Study|Lost to Follow-up|6|||
155013786|NCT02626026|559477068|FG000|Overall Study|Randomized but Never Treated|0|||
155013787|NCT02626026|559477069|FG001|Overall Study|Randomized but Never Treated|0|||
155013788|NCT02626026|559477070|FG002|Overall Study|Randomized but Never Treated|0|||
155013789|NCT02626026|559477071|FG003|Overall Study|Randomized but Never Treated|0|||
155013790|NCT02626026|559477072|FG004|Overall Study|Randomized but Never Treated|1|||
155013791|NCT02626026|559477073|FG005|Overall Study|Randomized but Never Treated|0|||
155013792|NCT01568892|559477074|FG000|Open-label Phase|Adverse Event|2|||
155013793|NCT01568892|559477075|FG001|Open-label Phase|Adverse Event|0|||
155013794|NCT01568892|559477074|FG000|Open-label Phase|Lack of Efficacy|4|||
155013795|NCT01568892|559477075|FG001|Open-label Phase|Lack of Efficacy|2|||
155013796|NCT01568892|559477074|FG000|Open-label Phase|Lost to Follow-up|0|||
155013797|NCT01568892|559477075|FG001|Open-label Phase|Lost to Follow-up|1|||
155133846|NCT02554981|559919874|FG000|Overall Study|Administrative Reasons|1|||
155133847|NCT02554981|559919874|FG000|Overall Study|Other Miscellaneous Reasons|3|||
155133848|NCT03043651|559919880|FG000|Overall Study|Death|1|||
155133849|NCT03043651|559919880|FG000|Overall Study|Progressive Disease|2|||
155013798|NCT01058642|559477084|FG000|Treatment Period 1|Adverse Event|0|||
155013799|NCT01058642|559477085|FG001|Treatment Period 1|Adverse Event|1|||
155133850|NCT03043651|559919880|FG000|Overall Study|Adverse Event|2|||
155133851|NCT03043651|559919880|FG000|Overall Study|Withdrawal by Subject|4|||
155133852|NCT03043651|559919880|FG000|Overall Study|Study Terminated by Sponsor|39|||
155133853|NCT01630889|559919881|FG000|Overall Study|Death|2|||
155013800|NCT01058642|559477086|FG002|Treatment Period 1|Adverse Event|1|||
155133854|NCT01630889|559919881|FG000|Overall Study|Withdrawal by Subject|1|||
155133855|NCT01630889|559919881|FG000|Overall Study|Other than Specified|2|||
155133856|NCT01630889|559919881|FG000|Overall Study|Lost to Follow-up|4|||
155133857|NCT01630889|559919881|FG000|Overall Study|Other|1|||
155133858|NCT02980133|559919882|FG000|Overall Study|Other than specified|1|||
155133859|NCT02980133|559919883|FG001|Overall Study|Other than specified|1|||
155133860|NCT02980133|559919884|FG002|Overall Study|Other than specified|2|||
155133861|NCT02980133|559919885|FG003|Overall Study|Other than specified|2|||
155133862|NCT02980133|559919882|FG000|Overall Study|Lost to Follow-up|0|||
155133863|NCT02980133|559919883|FG001|Overall Study|Lost to Follow-up|0|||
155133864|NCT02980133|559919884|FG002|Overall Study|Lost to Follow-up|1|||
155133865|NCT02980133|559919885|FG003|Overall Study|Lost to Follow-up|3|||
155133866|NCT02980133|559919882|FG000|Overall Study|Protocol Violation|0|||
155133867|NCT02980133|559919883|FG001|Overall Study|Protocol Violation|1|||
155133868|NCT02980133|559919884|FG002|Overall Study|Protocol Violation|0|||
155133869|NCT02980133|559919885|FG003|Overall Study|Protocol Violation|0|||
155133870|NCT02980133|559919882|FG000|Overall Study|Withdrawal by parent/guardian|6|||
155133871|NCT02980133|559919883|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155133872|NCT02980133|559919884|FG002|Overall Study|Withdrawal by parent/guardian|3|||
155133873|NCT02980133|559919885|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155133874|NCT02980133|559919882|FG000|Overall Study|Withdrawal by Subject|0|||
155133875|NCT02980133|559919883|FG001|Overall Study|Withdrawal by Subject|0|||
155133876|NCT02980133|559919884|FG002|Overall Study|Withdrawal by Subject|1|||
155133877|NCT02980133|559919885|FG003|Overall Study|Withdrawal by Subject|0|||
155133878|NCT02974842|559919886|FG000|Overall Study|Withdrawal by Subject|4|||
155133879|NCT02974842|559919886|FG000|Overall Study|Screen failures|4|||
155133880|NCT00238238|559919896|FG000|Overall Study|Withdrawal by Subject|0|||
155133881|NCT00238238|559919897|FG001|Overall Study|Withdrawal by Subject|3|||
155133882|NCT00238238|559919898|FG002|Overall Study|Withdrawal by Subject|0|||
155133883|NCT01345669|559919899|FG000|Overall Study|Primary tumour recurrence|53|||
155133884|NCT01345669|559919900|FG001|Overall Study|Primary tumour recurrence|32|||
155133885|NCT01345669|559919899|FG000|Overall Study|Second primary tumour|4|||
155133886|NCT01345669|559919900|FG001|Overall Study|Second primary tumour|3|||
155133887|NCT01345669|559919899|FG000|Overall Study|Adverse Event|63|||
155133888|NCT01345669|559919900|FG001|Overall Study|Adverse Event|9|||
155133889|NCT01345669|559919899|FG000|Overall Study|Protocol Violation|3|||
155133890|NCT01345669|559919900|FG001|Overall Study|Protocol Violation|1|||
155133891|NCT01345669|559919899|FG000|Overall Study|Lost to Follow-up|1|||
155133892|NCT01345669|559919900|FG001|Overall Study|Lost to Follow-up|1|||
155133893|NCT01345669|559919899|FG000|Overall Study|Withdrawal by Subject|52|||
155133894|NCT01345669|559919900|FG001|Overall Study|Withdrawal by Subject|13|||
155133895|NCT01345669|559919899|FG000|Overall Study|Other Reasons|111|||
155133896|NCT01345669|559919900|FG001|Overall Study|Other Reasons|60|||
155133897|NCT02478255|559919902|FG000|Overall Study|Physician Decision|6|||
155133898|NCT02478255|559919903|FG001|Overall Study|Physician Decision|0|||
155133899|NCT02478255|559919902|FG000|Overall Study|Withdrawal by Subject|2|||
155133900|NCT02478255|559919903|FG001|Overall Study|Withdrawal by Subject|0|||
155133901|NCT03068767|559919904|FG000|Overall Study|Lost to Follow-up|7|||
155133902|NCT03068767|559919905|FG001|Overall Study|Lost to Follow-up|3|||
155133903|NCT03068767|559919904|FG000|Overall Study|Protocol Violation|3|||
155133904|NCT03068767|559919905|FG001|Overall Study|Protocol Violation|0|||
155133905|NCT01487265|559922756|FG000|Overall Study|Adverse Event|8|||
155133906|NCT01487265|559922756|FG000|Overall Study|Withdrawal by Subject|5|||
155133907|NCT01487265|559922756|FG000|Overall Study|Disease Progression|21|||
155133908|NCT01487265|559922756|FG000|Overall Study|Death|2|||
155133909|NCT01487265|559922756|FG000|Overall Study|Still on Treatment|1|||
155133910|NCT03499314|559922757|FG000|Overall Study|Time Commitment|1|||
155133911|NCT03499314|559922758|FG001|Overall Study|Time Commitment|2|||
155133912|NCT03499314|559922757|FG000|Overall Study|Medical issue unrelated to research study|1|||
155133913|NCT03499314|559922758|FG001|Overall Study|Medical issue unrelated to research study|1|||
155133914|NCT02291419|559922761|FG000|Overall Study|Early study termination|1|||
155133915|NCT02291419|559922762|FG001|Overall Study|Early study termination|5|||
155133916|NCT00931606|559922763|FG000|Overall Study|Death|1|||
155133917|NCT00931606|559922764|FG001|Overall Study|Death|3|||
155133918|NCT00931606|559922765|FG002|Overall Study|Death|2|||
155178618|NCT01397825|560093325|FG001|Overall Study|Symptomatic Deterioration|0|||
155178619|NCT01397825|560093326|FG002|Overall Study|Symptomatic Deterioration|4|||
155013801|NCT01058642|559477087|FG003|Treatment Period 1|Adverse Event|0|||
155013802|NCT01058642|559477084|FG000|Treatment Period 1|Physician Decision|0|||
155013803|NCT01058642|559477085|FG001|Treatment Period 1|Physician Decision|0|||
155013804|NCT01058642|559477086|FG002|Treatment Period 1|Physician Decision|1|||
155013805|NCT01058642|559477087|FG003|Treatment Period 1|Physician Decision|0|||
155133919|NCT00931606|559922766|FG003|Overall Study|Death|0|||
155133920|NCT00931606|559922763|FG000|Overall Study|Lost to Follow-up|0|||
155133921|NCT00931606|559922764|FG001|Overall Study|Lost to Follow-up|1|||
155133922|NCT00931606|559922765|FG002|Overall Study|Lost to Follow-up|0|||
155133923|NCT00931606|559922766|FG003|Overall Study|Lost to Follow-up|0|||
155133924|NCT00931606|559922763|FG000|Overall Study|Physician Decision|0|||
155013806|NCT01058642|559477084|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155013807|NCT01058642|559477085|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155013808|NCT01058642|559477086|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155013809|NCT01058642|559477087|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155013810|NCT01058642|559477084|FG000|Treatment Period 1|Lack of Efficacy|0|||
155013811|NCT01058642|559477085|FG001|Treatment Period 1|Lack of Efficacy|0|||
155013812|NCT01058642|559477086|FG002|Treatment Period 1|Lack of Efficacy|0|||
155013813|NCT01058642|559477087|FG003|Treatment Period 1|Lack of Efficacy|1|||
155013814|NCT01058642|559477084|FG000|Treatment Period 1|Protocol Violation|0|||
155013815|NCT01058642|559477085|FG001|Treatment Period 1|Protocol Violation|0|||
155013816|NCT01058642|559477086|FG002|Treatment Period 1|Protocol Violation|0|||
155013817|NCT01058642|559477087|FG003|Treatment Period 1|Protocol Violation|1|||
155013818|NCT01058642|559477084|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
155013819|NCT01058642|559477085|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
155013820|NCT01058642|559477086|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
155013821|NCT01058642|559477087|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
155013822|NCT02375971|559477088|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
155013823|NCT02375971|559477089|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
155013824|NCT02375971|559477090|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
155013825|NCT02375971|559477088|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
155013826|NCT02375971|559477089|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
155013827|NCT02375971|559477090|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
155013828|NCT02375971|559477088|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
155013829|NCT02375971|559477089|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
155013830|NCT02375971|559477090|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
155013831|NCT02375971|559477088|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
155013832|NCT02375971|559477089|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
155013833|NCT02375971|559477090|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
155013834|NCT02375971|559477088|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
155013835|NCT02375971|559477089|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
155013836|NCT02375971|559477090|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
155013837|NCT02375971|559477088|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
155013838|NCT02375971|559477089|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
155013839|NCT02375971|559477090|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
155013840|NCT02375971|559477088|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
155013841|NCT02375971|559477089|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
155013842|NCT02375971|559477090|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
155013843|NCT02375971|559477088|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
155013844|NCT02375971|559477089|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
155013845|NCT02375971|559477090|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
155013846|NCT02755103|559477092|FG000|Overall Study|Lost to Follow-up|17|||
155013847|NCT02755103|559477093|FG001|Overall Study|Lost to Follow-up|15|||
155013848|NCT02755103|559477092|FG000|Overall Study|Death|0|||
155013849|NCT02755103|559477093|FG001|Overall Study|Death|1|||
155013850|NCT02755103|559477092|FG000|Overall Study|Physician Decision|0|||
155013851|NCT02755103|559477093|FG001|Overall Study|Physician Decision|1|||
155013852|NCT02755103|559477092|FG000|Overall Study|Pregnancy|0|||
155013853|NCT02755103|559477093|FG001|Overall Study|Pregnancy|1|||
155013854|NCT02755103|559477092|FG000|Overall Study|Withdrawal by Subject|3|||
155013855|NCT02755103|559477093|FG001|Overall Study|Withdrawal by Subject|0|||
155013856|NCT01592786|559477098|FG000|Overall Study|Adverse Event|60|||
155013857|NCT01592786|559477098|FG000|Overall Study|Lack of Efficacy|19|||
155013858|NCT01592786|559477098|FG000|Overall Study|Protocol Violation|14|||
155013859|NCT01592786|559477098|FG000|Overall Study|Withdrawal by Subject|23|||
155013860|NCT01592786|559477098|FG000|Overall Study|Lost to Follow-up|19|||
155013861|NCT01592786|559477098|FG000|Overall Study|Other|3|||
155013862|NCT01909934|559477099|FG000|Overall Study|Withdrawal by Subject|3|||
155013863|NCT01909934|559477099|FG000|Overall Study|Lost to Follow-up|1|||
155013864|NCT01909934|559477099|FG000|Overall Study|Death|25|||
155013865|NCT01909934|559477099|FG000|Overall Study|Withdrawal of Informed Consent|1|||
155013866|NCT01909934|559477099|FG000|Overall Study|Reason Not Specified|1|||
155013867|NCT03810092|559477100|FG000|Overall Study|no ground support|17|||
155013868|NCT03810092|559477100|FG000|Overall Study|ADL not done at J0|16|||
155013869|NCT03810092|559477100|FG000|Overall Study|No hemoglobin measure at J5|27|||
155013870|NCT04578535|559477102|FG000|Overall Study|Lost to Follow-up|1|||
155013871|NCT04578535|559477103|FG001|Overall Study|Lost to Follow-up|0|||
155013872|NCT04578535|559477104|FG002|Overall Study|Lost to Follow-up|0|||
155013873|NCT04578535|559477105|FG003|Overall Study|Lost to Follow-up|1|||
155013874|NCT04578535|559477106|FG004|Overall Study|Lost to Follow-up|0|||
155013875|NCT04578535|559477107|FG005|Overall Study|Lost to Follow-up|2|||
155013876|NCT04578535|559477102|FG000|Overall Study|Pregnancy|1|||
155013877|NCT04578535|559477103|FG001|Overall Study|Pregnancy|0|||
155013878|NCT04578535|559477104|FG002|Overall Study|Pregnancy|0|||
155013879|NCT04578535|559477105|FG003|Overall Study|Pregnancy|0|||
155013880|NCT04578535|559477106|FG004|Overall Study|Pregnancy|0|||
155133925|NCT00931606|559922764|FG001|Overall Study|Physician Decision|0|||
155133926|NCT00931606|559922765|FG002|Overall Study|Physician Decision|3|||
155133927|NCT00931606|559922766|FG003|Overall Study|Physician Decision|0|||
155133928|NCT00931606|559922763|FG000|Overall Study|Sponsor Decision|1|||
155133929|NCT00931606|559922764|FG001|Overall Study|Sponsor Decision|4|||
155133930|NCT00931606|559922765|FG002|Overall Study|Sponsor Decision|0|||
155133931|NCT00931606|559922766|FG003|Overall Study|Sponsor Decision|2|||
155133932|NCT00931606|559922763|FG000|Overall Study|Withdrawal by Subject|3|||
155133933|NCT00931606|559922764|FG001|Overall Study|Withdrawal by Subject|1|||
155133934|NCT00931606|559922765|FG002|Overall Study|Withdrawal by Subject|1|||
155133935|NCT00931606|559922766|FG003|Overall Study|Withdrawal by Subject|1|||
155133936|NCT00871338|559922767|FG000|Prior to Booster|Withdrawal by Subject|1|||
155133937|NCT00871338|559922768|FG001|Prior to Booster|Withdrawal by Subject|3|||
155133938|NCT00871338|559922767|FG000|Prior to Booster|Lost to Follow-up|1|||
155133939|NCT00871338|559922768|FG001|Prior to Booster|Lost to Follow-up|0|||
155133940|NCT02391363|559922769|FG000|Overall Study|Lost to Follow-up|5|||
155133941|NCT02391363|559922770|FG001|Overall Study|Lost to Follow-up|5|||
155133942|NCT02391363|559922769|FG000|Overall Study|Withdrawal by Subject|6|||
155133943|NCT02391363|559922770|FG001|Overall Study|Withdrawal by Subject|3|||
155133944|NCT01016600|559922771|FG000|Overall Study|Did not start treatment|1|||
155133945|NCT01016600|559922772|FG001|Overall Study|Did not start treatment|0|||
155133946|NCT01016600|559922773|FG002|Overall Study|Did not start treatment|0|||
155133947|NCT01016600|559922774|FG003|Overall Study|Did not start treatment|0|||
155133948|NCT00872599|559922775|FG000|Second Washout Period|Adverse Event|1|||
155133949|NCT00872599|559922776|FG001|Second Washout Period|Adverse Event|1|||
155133950|NCT03826186|559922777|FG000|Overall Study|Protocol Violation|2|||
155133951|NCT03826186|559922778|FG001|Overall Study|Protocol Violation|0|||
155133952|NCT03826186|559922777|FG000|Overall Study|Withdrawal by Subject|1|||
155133953|NCT03826186|559922778|FG001|Overall Study|Withdrawal by Subject|0|||
155133954|NCT02737475|559922781|FG000|Overall Study|Other reasons|0|||
155133955|NCT02737475|559922782|FG001|Overall Study|Other reasons|0|||
155133956|NCT02737475|559922783|FG002|Overall Study|Other reasons|0|||
155133957|NCT02737475|559922784|FG003|Overall Study|Other reasons|0|||
155133958|NCT02737475|559922785|FG004|Overall Study|Other reasons|1|||
155133959|NCT02737475|559922786|FG005|Overall Study|Other reasons|1|||
155133960|NCT02737475|559922787|FG006|Overall Study|Other reasons|0|||
155133961|NCT02737475|559922788|FG007|Overall Study|Other reasons|0|||
155133962|NCT02737475|559922789|FG008|Overall Study|Other reasons|1|||
155133963|NCT02737475|559922790|FG009|Overall Study|Other reasons|0|||
155133964|NCT02737475|559922791|FG010|Overall Study|Other reasons|1|||
155133965|NCT02737475|559922792|FG011|Overall Study|Other reasons|0|||
155133966|NCT02737475|559922793|FG012|Overall Study|Other reasons|0|||
155133967|NCT02737475|559922794|FG013|Overall Study|Other reasons|0|||
155133968|NCT02737475|559922795|FG014|Overall Study|Other reasons|0|||
155133969|NCT02737475|559922796|FG015|Overall Study|Other reasons|0|||
155133970|NCT02737475|559922797|FG016|Overall Study|Other reasons|0|||
155133971|NCT02737475|559922798|FG017|Overall Study|Other reasons|0|||
155133972|NCT02737475|559922799|FG018|Overall Study|Other reasons|0|||
155133973|NCT02737475|559922800|FG019|Overall Study|Other reasons|0|||
155133974|NCT02737475|559922801|FG020|Overall Study|Other reasons|0|||
155133975|NCT02737475|559922802|FG021|Overall Study|Other reasons|1|||
155133976|NCT02737475|559922803|FG022|Overall Study|Other reasons|0|||
155133977|NCT02737475|559922804|FG023|Overall Study|Other reasons|1|||
155133978|NCT02737475|559922805|FG024|Overall Study|Other reasons|1|||
155133979|NCT02737475|559922806|FG025|Overall Study|Other reasons|1|||
155133980|NCT02737475|559922807|FG026|Overall Study|Other reasons|0|||
155133981|NCT02737475|559922781|FG000|Overall Study|Death|1|||
155133982|NCT02737475|559922782|FG001|Overall Study|Death|0|||
155133983|NCT02737475|559922783|FG002|Overall Study|Death|0|||
155133984|NCT02737475|559922784|FG003|Overall Study|Death|1|||
155133985|NCT02737475|559922785|FG004|Overall Study|Death|0|||
155133986|NCT02737475|559922786|FG005|Overall Study|Death|0|||
155133987|NCT02737475|559922787|FG006|Overall Study|Death|0|||
155133988|NCT02737475|559922788|FG007|Overall Study|Death|2|||
155133989|NCT02737475|559922789|FG008|Overall Study|Death|0|||
155133990|NCT02737475|559922790|FG009|Overall Study|Death|0|||
155133991|NCT02737475|559922791|FG010|Overall Study|Death|0|||
155133992|NCT02737475|559922792|FG011|Overall Study|Death|4|||
155133993|NCT02737475|559922793|FG012|Overall Study|Death|2|||
155133994|NCT02737475|559922794|FG013|Overall Study|Death|2|||
155013881|NCT04578535|559477107|FG005|Overall Study|Pregnancy|0|||
155013882|NCT04578535|559477102|FG000|Overall Study|Withdrawal by Subject|0|||
155133995|NCT02737475|559922795|FG014|Overall Study|Death|0|||
155133996|NCT02737475|559922796|FG015|Overall Study|Death|2|||
155133997|NCT02737475|559922797|FG016|Overall Study|Death|2|||
155133998|NCT02737475|559922798|FG017|Overall Study|Death|2|||
155133999|NCT02737475|559922799|FG018|Overall Study|Death|1|||
155134000|NCT02737475|559922800|FG019|Overall Study|Death|0|||
155134001|NCT02737475|559922801|FG020|Overall Study|Death|0|||
155134002|NCT02737475|559922802|FG021|Overall Study|Death|0|||
155134003|NCT02737475|559922803|FG022|Overall Study|Death|0|||
155134004|NCT02737475|559922804|FG023|Overall Study|Death|0|||
155134005|NCT02737475|559922805|FG024|Overall Study|Death|0|||
155013883|NCT04578535|559477103|FG001|Overall Study|Withdrawal by Subject|0|||
155013884|NCT04578535|559477104|FG002|Overall Study|Withdrawal by Subject|0|||
155013885|NCT04578535|559477105|FG003|Overall Study|Withdrawal by Subject|1|||
155013886|NCT04578535|559477106|FG004|Overall Study|Withdrawal by Subject|1|||
155013887|NCT04578535|559477107|FG005|Overall Study|Withdrawal by Subject|5|||
155013888|NCT04578535|559477102|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
155013889|NCT04578535|559477103|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
155013890|NCT04578535|559477104|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
155013891|NCT04578535|559477105|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
155013892|NCT04578535|559477106|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
155013893|NCT04578535|559477107|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
155013894|NCT00235755|559477108|FG000|4-Week Titration Phase|Adverse Event|6|||
155013895|NCT00235755|559477109|FG001|4-Week Titration Phase|Adverse Event|14|||
155013896|NCT00235755|559477110|FG002|4-Week Titration Phase|Adverse Event|20|||
155013897|NCT00235755|559477108|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
155013898|NCT00235755|559477109|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
155013899|NCT00235755|559477110|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
155013900|NCT00235755|559477108|FG000|4-Week Titration Phase|Protocol Violation|2|||
155013901|NCT00235755|559477109|FG001|4-Week Titration Phase|Protocol Violation|2|||
155013902|NCT00235755|559477110|FG002|4-Week Titration Phase|Protocol Violation|1|||
155013903|NCT00235755|559477108|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
155013904|NCT00235755|559477109|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
155013905|NCT00235755|559477110|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
155013906|NCT00235755|559477108|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
155013907|NCT00235755|559477109|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
155013908|NCT00235755|559477110|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
155013909|NCT00235755|559477108|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
155013910|NCT00235755|559477109|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
155013911|NCT00235755|559477110|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
155013912|NCT00235755|559477108|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
155013913|NCT00235755|559477109|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
155013914|NCT00235755|559477110|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
155013915|NCT00235755|559477108|FG000|12-Week Maintenance Phase|Adverse Event|8|||
155013916|NCT00235755|559477109|FG001|12-Week Maintenance Phase|Adverse Event|12|||
155013917|NCT00235755|559477110|FG002|12-Week Maintenance Phase|Adverse Event|26|||
155013918|NCT00235755|559477108|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
155013919|NCT00235755|559477109|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
155013920|NCT00235755|559477110|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
155013921|NCT00235755|559477108|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
155013922|NCT00235755|559477109|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
155013923|NCT00235755|559477110|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
155013924|NCT00235755|559477108|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
155013925|NCT00235755|559477109|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
155013926|NCT00235755|559477110|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
155013927|NCT00235755|559477108|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
155013928|NCT00235755|559477109|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
155013929|NCT00235755|559477110|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
155013930|NCT00235755|559477108|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
155013931|NCT00235755|559477109|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
155013932|NCT00235755|559477110|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
155013933|NCT01707290|559477113|FG000|Overall Study|Adverse event (AE)|1|||
155013934|NCT01707290|559477114|FG001|Overall Study|Adverse event (AE)|0|||
155013935|NCT01707290|559477113|FG000|Overall Study|Physician Decision|1|||
155013936|NCT01707290|559477114|FG001|Overall Study|Physician Decision|0|||
155013937|NCT01707290|559477113|FG000|Overall Study|Lost to Follow-up|3|||
155013938|NCT01707290|559477114|FG001|Overall Study|Lost to Follow-up|0|||
155013939|NCT01707290|559477113|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
155013940|NCT01707290|559477114|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
155013941|NCT01707290|559477113|FG000|Overall Study|Commercial drug available|60|||
155013942|NCT01707290|559477114|FG001|Overall Study|Commercial drug available|1|||
155013943|NCT01707290|559477113|FG000|Overall Study|Other unspecified|17|||
155013944|NCT01707290|559477114|FG001|Overall Study|Other unspecified|0|||
155013945|NCT01882985|559477117|FG000|Overall Study|Lost to Follow-up|1|||
155013946|NCT01882985|559477117|FG000|Overall Study|Withdrawal by Subject|1|||
155013947|NCT03193853|559477124|FG000|Overall Study|Death|6|||
155013948|NCT04129125|559477125|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
155013949|NCT04129125|559477125|FG000|Overall Study|Study device was not used|3|||
155013950|NCT01787292|559477131|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
155013951|NCT01787292|559477132|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
155134006|NCT02737475|559922806|FG025|Overall Study|Death|0|||
155134007|NCT02737475|559922807|FG026|Overall Study|Death|0|||
155134008|NCT02737475|559922781|FG000|Overall Study|Participant withdrew consent|0|||
155134009|NCT02737475|559922782|FG001|Overall Study|Participant withdrew consent|0|||
155134010|NCT02737475|559922783|FG002|Overall Study|Participant withdrew consent|0|||
155134011|NCT02737475|559922784|FG003|Overall Study|Participant withdrew consent|0|||
155134012|NCT02737475|559922785|FG004|Overall Study|Participant withdrew consent|0|||
155134013|NCT02737475|559922786|FG005|Overall Study|Participant withdrew consent|2|||
155134014|NCT02737475|559922787|FG006|Overall Study|Participant withdrew consent|0|||
155134015|NCT02737475|559922788|FG007|Overall Study|Participant withdrew consent|0|||
155134016|NCT02737475|559922789|FG008|Overall Study|Participant withdrew consent|0|||
155134017|NCT02737475|559922790|FG009|Overall Study|Participant withdrew consent|0|||
155134018|NCT02737475|559922791|FG010|Overall Study|Participant withdrew consent|0|||
155134019|NCT02737475|559922792|FG011|Overall Study|Participant withdrew consent|0|||
155134020|NCT02737475|559922793|FG012|Overall Study|Participant withdrew consent|0|||
155134021|NCT02737475|559922794|FG013|Overall Study|Participant withdrew consent|0|||
155134022|NCT02737475|559922795|FG014|Overall Study|Participant withdrew consent|1|||
155134023|NCT02737475|559922796|FG015|Overall Study|Participant withdrew consent|0|||
155134024|NCT02737475|559922797|FG016|Overall Study|Participant withdrew consent|0|||
155134025|NCT02737475|559922798|FG017|Overall Study|Participant withdrew consent|2|||
155134026|NCT02737475|559922799|FG018|Overall Study|Participant withdrew consent|1|||
155134027|NCT02737475|559922800|FG019|Overall Study|Participant withdrew consent|0|||
155134028|NCT02737475|559922801|FG020|Overall Study|Participant withdrew consent|2|||
155134029|NCT02737475|559922802|FG021|Overall Study|Participant withdrew consent|0|||
155134030|NCT02737475|559922803|FG022|Overall Study|Participant withdrew consent|0|||
155134031|NCT02737475|559922804|FG023|Overall Study|Participant withdrew consent|0|||
155134032|NCT02737475|559922805|FG024|Overall Study|Participant withdrew consent|0|||
155134033|NCT02737475|559922806|FG025|Overall Study|Participant withdrew consent|0|||
155134034|NCT02737475|559922807|FG026|Overall Study|Participant withdrew consent|0|||
155134035|NCT02737475|559922781|FG000|Overall Study|Lost to Follow-up|0|||
155134036|NCT02737475|559922782|FG001|Overall Study|Lost to Follow-up|0|||
155134037|NCT02737475|559922783|FG002|Overall Study|Lost to Follow-up|0|||
155134038|NCT02737475|559922784|FG003|Overall Study|Lost to Follow-up|0|||
155134039|NCT02737475|559922785|FG004|Overall Study|Lost to Follow-up|0|||
155134040|NCT02737475|559922786|FG005|Overall Study|Lost to Follow-up|0|||
155134041|NCT02737475|559922787|FG006|Overall Study|Lost to Follow-up|0|||
155134042|NCT02737475|559922788|FG007|Overall Study|Lost to Follow-up|0|||
155134043|NCT02737475|559922789|FG008|Overall Study|Lost to Follow-up|0|||
155134044|NCT02737475|559922790|FG009|Overall Study|Lost to Follow-up|0|||
155134045|NCT02737475|559922791|FG010|Overall Study|Lost to Follow-up|0|||
155134046|NCT02737475|559922792|FG011|Overall Study|Lost to Follow-up|0|||
155134047|NCT02737475|559922793|FG012|Overall Study|Lost to Follow-up|0|||
155134048|NCT02737475|559922794|FG013|Overall Study|Lost to Follow-up|0|||
155134049|NCT02737475|559922795|FG014|Overall Study|Lost to Follow-up|0|||
155134050|NCT02737475|559922796|FG015|Overall Study|Lost to Follow-up|1|||
155134051|NCT02737475|559922797|FG016|Overall Study|Lost to Follow-up|0|||
155134052|NCT02737475|559922798|FG017|Overall Study|Lost to Follow-up|0|||
155134053|NCT02737475|559922799|FG018|Overall Study|Lost to Follow-up|0|||
155134054|NCT02737475|559922800|FG019|Overall Study|Lost to Follow-up|0|||
155134055|NCT02737475|559922801|FG020|Overall Study|Lost to Follow-up|0|||
155134056|NCT02737475|559922802|FG021|Overall Study|Lost to Follow-up|0|||
155134057|NCT02737475|559922803|FG022|Overall Study|Lost to Follow-up|0|||
155134058|NCT02737475|559922804|FG023|Overall Study|Lost to Follow-up|0|||
155134059|NCT02737475|559922805|FG024|Overall Study|Lost to Follow-up|0|||
155134060|NCT02737475|559922806|FG025|Overall Study|Lost to Follow-up|0|||
155134061|NCT02737475|559922807|FG026|Overall Study|Lost to Follow-up|0|||
155134062|NCT02737475|559922781|FG000|Overall Study|Disease Progression|0|||
155013952|NCT01787292|559477131|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
155013953|NCT01787292|559477132|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
155013954|NCT01532934|559477133|FG000|Overall Study|Lost to Follow-up|11|||
155013955|NCT01532934|559477134|FG001|Overall Study|Lost to Follow-up|11|||
155013956|NCT01532934|559477133|FG000|Overall Study|In controlled environment|3|||
155013957|NCT01532934|559477134|FG001|Overall Study|In controlled environment|2|||
155013958|NCT02962648|559477136|FG000|Overall Study|Withdrawal by Subject|3|||
155013959|NCT02962648|559477136|FG000|Overall Study|Lost to Follow-up|3|||
155013960|NCT02962648|559477136|FG000|Overall Study|Physician Decision|1|||
155013961|NCT02962648|559477136|FG000|Overall Study|Subject had problems with transportation|2|||
155013962|NCT01597778|559477137|FG000|Overall Study|Death|7|||
155134063|NCT02737475|559922782|FG001|Overall Study|Disease Progression|0|||
155134064|NCT02737475|559922783|FG002|Overall Study|Disease Progression|0|||
155134065|NCT02737475|559922784|FG003|Overall Study|Disease Progression|0|||
155134066|NCT02737475|559922785|FG004|Overall Study|Disease Progression|0|||
155134067|NCT02737475|559922786|FG005|Overall Study|Disease Progression|0|||
155134068|NCT02737475|559922787|FG006|Overall Study|Disease Progression|0|||
155134069|NCT02737475|559922788|FG007|Overall Study|Disease Progression|0|||
155134070|NCT02737475|559922789|FG008|Overall Study|Disease Progression|0|||
155013963|NCT01597778|559477138|FG001|Overall Study|Death|10|||
155134071|NCT02737475|559922790|FG009|Overall Study|Disease Progression|0|||
155134072|NCT02737475|559922791|FG010|Overall Study|Disease Progression|0|||
155134073|NCT02737475|559922792|FG011|Overall Study|Disease Progression|0|||
155134074|NCT02737475|559922793|FG012|Overall Study|Disease Progression|0|||
155134075|NCT02737475|559922794|FG013|Overall Study|Disease Progression|0|||
155134076|NCT02737475|559922795|FG014|Overall Study|Disease Progression|0|||
155134077|NCT02737475|559922796|FG015|Overall Study|Disease Progression|0|||
155134078|NCT02737475|559922797|FG016|Overall Study|Disease Progression|0|||
155134079|NCT02737475|559922798|FG017|Overall Study|Disease Progression|0|||
155134080|NCT02737475|559922799|FG018|Overall Study|Disease Progression|0|||
155134081|NCT02737475|559922800|FG019|Overall Study|Disease Progression|0|||
155134082|NCT02737475|559922801|FG020|Overall Study|Disease Progression|0|||
155134083|NCT02737475|559922802|FG021|Overall Study|Disease Progression|0|||
155134084|NCT02737475|559922803|FG022|Overall Study|Disease Progression|0|||
155134085|NCT02737475|559922804|FG023|Overall Study|Disease Progression|0|||
155134086|NCT02737475|559922805|FG024|Overall Study|Disease Progression|0|||
155134087|NCT02737475|559922806|FG025|Overall Study|Disease Progression|0|||
155134088|NCT02737475|559922807|FG026|Overall Study|Disease Progression|1|||
155134089|NCT01363661|559922809|FG000|Overall Study|Adverse Event|9|||
155134090|NCT01363661|559922810|FG001|Overall Study|Adverse Event|2|||
155134091|NCT01363661|559922809|FG000|Overall Study|Withdrawal by Subject|1|||
155134092|NCT01363661|559922810|FG001|Overall Study|Withdrawal by Subject|1|||
155134093|NCT01363661|559922809|FG000|Overall Study|Protocol Violation|1|||
155134094|NCT01363661|559922810|FG001|Overall Study|Protocol Violation|0|||
155134095|NCT01363661|559922809|FG000|Overall Study|Lost to Follow-up|3|||
155134096|NCT01363661|559922810|FG001|Overall Study|Lost to Follow-up|1|||
155134097|NCT01835223|559922811|FG000|Overall Study|Adverse Event|1|||
155134098|NCT01835223|559922812|FG001|Overall Study|Adverse Event|0|||
155134099|NCT01835223|559922811|FG000|Overall Study|Withdrawal by Subject|2|||
155134100|NCT01835223|559922812|FG001|Overall Study|Withdrawal by Subject|0|||
155134101|NCT01835223|559922811|FG000|Overall Study|Disease progression|2|||
155134102|NCT01835223|559922812|FG001|Overall Study|Disease progression|1|||
155134103|NCT01835223|559922811|FG000|Overall Study|Became Inelligible|4|||
155134104|NCT01835223|559922812|FG001|Overall Study|Became Inelligible|0|||
155134105|NCT02219334|559922813|FG000|Overall Study|Withdrawal by Subject|1|||
155134106|NCT02219334|559922814|FG001|Overall Study|Withdrawal by Subject|0|||
155134107|NCT02219334|559922813|FG000|Overall Study|Protocol Violation|7|||
155134108|NCT02219334|559922814|FG001|Overall Study|Protocol Violation|3|||
155134109|NCT00711971|559922821|FG000|Overall Study|Lost to Follow-up|3|||
155134110|NCT00711971|559922822|FG001|Overall Study|Lost to Follow-up|4|||
155134111|NCT00711971|559922823|FG002|Overall Study|Lost to Follow-up|1|||
155134112|NCT03704688|559922828|FG000|Overall Study|Adverse Event|0|||
155134113|NCT03704688|559922829|FG001|Overall Study|Adverse Event|0|||
155134114|NCT03704688|559922830|FG002|Overall Study|Adverse Event|0|||
155134115|NCT03704688|559922831|FG003|Overall Study|Adverse Event|4|||
155134116|NCT03704688|559922832|FG004|Overall Study|Adverse Event|1|||
155134117|NCT03704688|559922833|FG005|Overall Study|Adverse Event|0|||
155134118|NCT03704688|559922828|FG000|Overall Study|Disease Progression|0|||
155134119|NCT03704688|559922829|FG001|Overall Study|Disease Progression|0|||
155134120|NCT03704688|559922830|FG002|Overall Study|Disease Progression|0|||
155134121|NCT03704688|559922831|FG003|Overall Study|Disease Progression|3|||
155134122|NCT03704688|559922832|FG004|Overall Study|Disease Progression|1|||
155134123|NCT03704688|559922833|FG005|Overall Study|Disease Progression|0|||
155134124|NCT03704688|559922828|FG000|Overall Study|Death|0|||
155134125|NCT03704688|559922829|FG001|Overall Study|Death|0|||
155134126|NCT03704688|559922830|FG002|Overall Study|Death|0|||
155134127|NCT03704688|559922831|FG003|Overall Study|Death|0|||
155134128|NCT03704688|559922832|FG004|Overall Study|Death|3|||
155134129|NCT03704688|559922833|FG005|Overall Study|Death|0|||
155134130|NCT04774926|559922835|FG000|Overall Study|Adverse Event|15|||
155134131|NCT04774926|559922835|FG000|Overall Study|Lost to Follow-up|3|||
155134132|NCT04774926|559922835|FG000|Overall Study|Physician Decision|6|||
155134133|NCT04774926|559922835|FG000|Overall Study|Withdrawal by Subject|3|||
155134134|NCT04774926|559922835|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
155013964|NCT01597778|559477137|FG000|Overall Study|Withdrawal by Subject|3|||
155013965|NCT01597778|559477138|FG001|Overall Study|Withdrawal by Subject|4|||
155134135|NCT01393639|559922836|FG000|Overall Study|Protocol Violation|0|||
155134136|NCT01393639|559922837|FG001|Overall Study|Protocol Violation|0|||
155134137|NCT01393639|559922838|FG002|Overall Study|Protocol Violation|0|||
155134138|NCT01393639|559922839|FG003|Overall Study|Protocol Violation|1|||
155134139|NCT01393639|559922840|FG004|Overall Study|Protocol Violation|0|||
155134140|NCT01393639|559922841|FG005|Overall Study|Protocol Violation|0|||
155134141|NCT01393639|559922842|FG006|Overall Study|Protocol Violation|0|||
155134142|NCT01393639|559922836|FG000|Overall Study|Other|0|||
155013966|NCT01597778|559477137|FG000|Overall Study|Adverse Event|1|||
155134143|NCT01393639|559922837|FG001|Overall Study|Other|2|||
155134144|NCT01393639|559922838|FG002|Overall Study|Other|0|||
155134145|NCT01393639|559922839|FG003|Overall Study|Other|2|||
155134146|NCT01393639|559922840|FG004|Overall Study|Other|1|||
155134147|NCT01393639|559922841|FG005|Overall Study|Other|0|||
155134148|NCT01393639|559922842|FG006|Overall Study|Other|1|||
155134149|NCT01393639|559922836|FG000|Overall Study|Withdrawal by Subject|1|||
155134150|NCT01393639|559922837|FG001|Overall Study|Withdrawal by Subject|1|||
155134151|NCT01393639|559922838|FG002|Overall Study|Withdrawal by Subject|0|||
155134152|NCT01393639|559922839|FG003|Overall Study|Withdrawal by Subject|0|||
155134153|NCT01393639|559922840|FG004|Overall Study|Withdrawal by Subject|0|||
155134154|NCT01393639|559922841|FG005|Overall Study|Withdrawal by Subject|0|||
155134155|NCT01393639|559922842|FG006|Overall Study|Withdrawal by Subject|1|||
155134156|NCT01393639|559922836|FG000|Overall Study|Medication error without associated AE|0|||
155134157|NCT01393639|559922837|FG001|Overall Study|Medication error without associated AE|0|||
155134158|NCT01393639|559922838|FG002|Overall Study|Medication error without associated AE|0|||
155134159|NCT01393639|559922839|FG003|Overall Study|Medication error without associated AE|0|||
155134160|NCT01393639|559922840|FG004|Overall Study|Medication error without associated AE|0|||
155134161|NCT01393639|559922841|FG005|Overall Study|Medication error without associated AE|0|||
155134162|NCT01393639|559922842|FG006|Overall Study|Medication error without associated AE|1|||
155134163|NCT01393639|559922836|FG000|Overall Study|Lost to Follow-up|0|||
155134164|NCT01393639|559922837|FG001|Overall Study|Lost to Follow-up|1|||
155134165|NCT01393639|559922838|FG002|Overall Study|Lost to Follow-up|0|||
155134166|NCT01393639|559922839|FG003|Overall Study|Lost to Follow-up|0|||
155134167|NCT01393639|559922840|FG004|Overall Study|Lost to Follow-up|0|||
155134168|NCT01393639|559922841|FG005|Overall Study|Lost to Follow-up|0|||
155134169|NCT01393639|559922842|FG006|Overall Study|Lost to Follow-up|1|||
155134170|NCT01393639|559922836|FG000|Overall Study|Lack of Efficacy|0|||
155134171|NCT01393639|559922837|FG001|Overall Study|Lack of Efficacy|0|||
155134172|NCT01393639|559922838|FG002|Overall Study|Lack of Efficacy|0|||
155134173|NCT01393639|559922839|FG003|Overall Study|Lack of Efficacy|0|||
155134174|NCT01393639|559922840|FG004|Overall Study|Lack of Efficacy|0|||
155134175|NCT01393639|559922841|FG005|Overall Study|Lack of Efficacy|0|||
155134176|NCT01393639|559922842|FG006|Overall Study|Lack of Efficacy|1|||
155134177|NCT01393639|559922836|FG000|Overall Study|Adverse Event|2|||
155134178|NCT01393639|559922837|FG001|Overall Study|Adverse Event|3|||
155134179|NCT01393639|559922838|FG002|Overall Study|Adverse Event|1|||
155134180|NCT01393639|559922839|FG003|Overall Study|Adverse Event|2|||
155134181|NCT01393639|559922840|FG004|Overall Study|Adverse Event|0|||
155134182|NCT01393639|559922841|FG005|Overall Study|Adverse Event|2|||
155134183|NCT01393639|559922842|FG006|Overall Study|Adverse Event|3|||
155134184|NCT03626545|559922843|FG000|Overall Study|Progressive disease|3|||
155134185|NCT03626545|559922844|FG001|Overall Study|Progressive disease|82|||
155134186|NCT03626545|559922845|FG002|Overall Study|Progressive disease|85|||
155134187|NCT03626545|559922843|FG000|Overall Study|Adverse Event|3|||
155134188|NCT03626545|559922844|FG001|Overall Study|Adverse Event|13|||
155134189|NCT03626545|559922845|FG002|Overall Study|Adverse Event|10|||
155134190|NCT03626545|559922843|FG000|Overall Study|Physician Decision|1|||
155134191|NCT03626545|559922844|FG001|Overall Study|Physician Decision|18|||
155134192|NCT03626545|559922845|FG002|Overall Study|Physician Decision|14|||
155134193|NCT03626545|559922843|FG000|Overall Study|Subject Decision|0|||
155134194|NCT03626545|559922844|FG001|Overall Study|Subject Decision|5|||
155134195|NCT03626545|559922845|FG002|Overall Study|Subject Decision|5|||
155134196|NCT03626545|559922843|FG000|Overall Study|Death|1|||
155134197|NCT03626545|559922844|FG001|Overall Study|Death|1|||
155134198|NCT03626545|559922845|FG002|Overall Study|Death|1|||
155134199|NCT03626545|559922843|FG000|Overall Study|Protocol Deviation|0|||
155134200|NCT03626545|559922844|FG001|Overall Study|Protocol Deviation|1|||
155134201|NCT03626545|559922845|FG002|Overall Study|Protocol Deviation|1|||
155134202|NCT03626545|559922843|FG000|Overall Study|Guardian Decision|0|||
155134203|NCT03626545|559922844|FG001|Overall Study|Guardian Decision|0|||
155134204|NCT03626545|559922845|FG002|Overall Study|Guardian Decision|1|||
155134205|NCT00793325|559922847|FG000|Overall Study|Protocol Violation|18|||
155134206|NCT00793325|559922847|FG000|Overall Study|Lost to Follow-up|1|||
155134207|NCT00787189|559922848|FG000|Overall Study|Lost to Follow-up|2|||
155134208|NCT00787189|559922849|FG001|Overall Study|Lost to Follow-up|2|||
155134209|NCT00413036|559922850|FG000|Overall Study|Adverse Event|44|||
155134210|NCT00413036|559922850|FG000|Overall Study|Lack of Efficacy|129|||
155134211|NCT00413036|559922850|FG000|Overall Study|Withdrawal by Subject|7|||
155134212|NCT00413036|559922850|FG000|Overall Study|Death|9|||
155134213|NCT00413036|559922850|FG000|Overall Study|Other|26|||
155134214|NCT00413036|559922850|FG000|Overall Study|Missing|2|||
155134215|NCT02524158|559922863|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
155134216|NCT02524158|559922864|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
155134217|NCT02524158|559922863|FG000|12-weeks Assessment|Lost to Follow-up|18|||
155134218|NCT02524158|559922864|FG001|12-weeks Assessment|Lost to Follow-up|12|||
155134219|NCT02524158|559922863|FG000|6-month Assessment|Withdrawal by Subject|1|||
155134220|NCT02524158|559922864|FG001|6-month Assessment|Withdrawal by Subject|1|||
155134221|NCT02524158|559922863|FG000|6-month Assessment|Lost to Follow-up|21|||
155134222|NCT02524158|559922864|FG001|6-month Assessment|Lost to Follow-up|20|||
155134223|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134224|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134225|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
155134226|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
155134227|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
155134228|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134229|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
155134230|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
155134231|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
155134232|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134233|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134234|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134235|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
155134236|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
155134237|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
155134238|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
155134239|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
155134240|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
155134241|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
155134242|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
155134243|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
155134244|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
155134245|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155134246|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155134247|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155134248|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
155134249|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134250|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155134251|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155134252|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134253|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134254|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155134255|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
155134256|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134257|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134258|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134259|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134260|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134261|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
155134262|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134263|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155134264|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155134265|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134266|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134267|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134268|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155134269|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134270|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
155134271|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134272|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134273|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134274|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
155134275|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134276|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134277|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134278|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
155134279|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134280|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134281|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134282|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
155134283|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134284|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134285|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134286|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134287|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
155134288|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134289|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134290|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134291|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
155134292|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134293|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134294|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
155134295|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134296|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134297|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134298|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134299|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134300|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
155134301|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134302|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
155134303|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134304|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134305|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134306|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134307|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134308|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134309|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134310|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134311|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134312|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134313|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
155134314|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
155134315|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134316|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134317|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134318|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134319|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134320|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134321|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134322|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134323|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134324|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134325|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155134326|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
155013967|NCT01597778|559477138|FG001|Overall Study|Adverse Event|1|||
155013968|NCT01597778|559477137|FG000|Overall Study|Protocol Violation|1|||
155013969|NCT01597778|559477138|FG001|Overall Study|Protocol Violation|11|||
155013970|NCT01597778|559477137|FG000|Overall Study|Transplanted off protocol|2|||
155013971|NCT01597778|559477138|FG001|Overall Study|Transplanted off protocol|3|||
155013972|NCT03267212|559477140|FG000|First Intervention|Lost to Follow-up|0|||
155013973|NCT03267212|559477141|FG001|First Intervention|Lost to Follow-up|2|||
155013974|NCT03267212|559477140|FG000|First Intervention|Withdrawal by Subject|1|||
155013975|NCT03267212|559477141|FG001|First Intervention|Withdrawal by Subject|1|||
155013976|NCT03267212|559477140|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
155013977|NCT03267212|559477141|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
155013978|NCT04383327|559477143|FG000|Overall Study|Lost to Follow-up|112|||
155013979|NCT04383327|559477144|FG001|Overall Study|Lost to Follow-up|14|||
155013980|NCT04383327|559477145|FG002|Overall Study|Lost to Follow-up|78|||
155013981|NCT04383327|559477146|FG003|Overall Study|Lost to Follow-up|13|||
155013982|NCT04383327|559477147|FG004|Overall Study|Lost to Follow-up|110|||
155013983|NCT04383327|559477148|FG005|Overall Study|Lost to Follow-up|13|||
155013984|NCT04383327|559477149|FG006|Overall Study|Lost to Follow-up|74|||
155013985|NCT04383327|559477150|FG007|Overall Study|Lost to Follow-up|13|||
155013986|NCT04383327|559477151|FG008|Overall Study|Lost to Follow-up|78|||
155013987|NCT04383327|559477152|FG009|Overall Study|Lost to Follow-up|10|||
155013988|NCT04383327|559477153|FG010|Overall Study|Lost to Follow-up|160|||
155013989|NCT04383327|559477154|FG011|Overall Study|Lost to Follow-up|13|||
155013990|NCT05691712|559477155|FG000|Overall Study|Adverse Event|0|||
155013991|NCT05691712|559477156|FG001|Overall Study|Adverse Event|1|||
155013992|NCT05691712|559477157|FG002|Overall Study|Adverse Event|2|||
155013993|NCT05691712|559477158|FG003|Overall Study|Adverse Event|1|||
155013994|NCT05691712|559477155|FG000|Overall Study|Withdrawal by Subject|2|||
155013995|NCT05691712|559477156|FG001|Overall Study|Withdrawal by Subject|3|||
155134327|NCT03100058|559922865|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134328|NCT03100058|559922866|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134329|NCT03100058|559922867|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134330|NCT03100058|559922868|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134331|NCT03100058|559922869|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134332|NCT03100058|559922870|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155013996|NCT05691712|559477157|FG002|Overall Study|Withdrawal by Subject|3|||
155013997|NCT05691712|559477158|FG003|Overall Study|Withdrawal by Subject|1|||
155013998|NCT05691712|559477155|FG000|Overall Study|Death|1|||
155013999|NCT05691712|559477156|FG001|Overall Study|Death|0|||
155014000|NCT05691712|559477157|FG002|Overall Study|Death|0|||
155134333|NCT03100058|559922871|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
155134334|NCT03100058|559922872|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134335|NCT03100058|559922873|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134336|NCT03100058|559922874|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134337|NCT03100058|559922875|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134338|NCT03100058|559922876|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134339|NCT03100058|559922877|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
155134340|NCT03100058|559922865|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134341|NCT03100058|559922866|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134342|NCT03100058|559922867|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134343|NCT03100058|559922868|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134344|NCT03100058|559922869|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134345|NCT03100058|559922870|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134346|NCT03100058|559922871|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134347|NCT03100058|559922872|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134348|NCT03100058|559922873|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134349|NCT03100058|559922874|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
155134350|NCT03100058|559922875|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
155134351|NCT03100058|559922876|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
155134352|NCT03100058|559922877|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
155134353|NCT03100058|559922865|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134354|NCT03100058|559922866|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134355|NCT03100058|559922867|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134356|NCT03100058|559922868|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134357|NCT03100058|559922869|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134358|NCT03100058|559922870|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155014001|NCT05691712|559477158|FG003|Overall Study|Death|0|||
155014002|NCT05691712|559477155|FG000|Overall Study|Pregnancy|0|||
155014003|NCT05691712|559477156|FG001|Overall Study|Pregnancy|1|||
155014004|NCT05691712|559477157|FG002|Overall Study|Pregnancy|0|||
155014005|NCT05691712|559477158|FG003|Overall Study|Pregnancy|0|||
155134359|NCT03100058|559922871|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134360|NCT03100058|559922872|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134361|NCT03100058|559922873|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134362|NCT03100058|559922874|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134363|NCT03100058|559922875|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
155134364|NCT03100058|559922876|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
155134365|NCT03100058|559922877|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
155134366|NCT03100058|559922865|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134367|NCT03100058|559922866|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134368|NCT03100058|559922867|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134369|NCT03100058|559922868|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134370|NCT03100058|559922869|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155014006|NCT05691712|559477155|FG000|Overall Study|Assigned Treatment by Mistake|1|||
155014007|NCT05691712|559477156|FG001|Overall Study|Assigned Treatment by Mistake|0|||
155014008|NCT05691712|559477157|FG002|Overall Study|Assigned Treatment by Mistake|0|||
155014009|NCT05691712|559477158|FG003|Overall Study|Assigned Treatment by Mistake|1|||
155014010|NCT05303194|559477159|FG000|Overall Study|Lost to Follow-up|1|||
155014011|NCT05303194|559477160|FG001|Overall Study|Lost to Follow-up|1|||
155134371|NCT03100058|559922870|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134372|NCT03100058|559922871|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134373|NCT03100058|559922872|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134374|NCT03100058|559922873|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134375|NCT03100058|559922874|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
155134376|NCT03100058|559922875|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
155134377|NCT03100058|559922876|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
155134378|NCT03100058|559922877|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
155134379|NCT03100058|559922865|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134380|NCT03100058|559922866|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134381|NCT03100058|559922867|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155178620|NCT01397825|560093327|FG003|Overall Study|Symptomatic Deterioration|0|||
155178621|NCT01397825|560093328|FG004|Overall Study|Symptomatic Deterioration|0|||
155178622|NCT01397825|560093324|FG000|Overall Study|Adverse Event|0|||
155178623|NCT01397825|560093325|FG001|Overall Study|Adverse Event|1|||
155014012|NCT05303194|559477159|FG000|Overall Study|Withdrawal by Subject|0|||
155014013|NCT05303194|559477160|FG001|Overall Study|Withdrawal by Subject|1|||
155014014|NCT01289678|559477170|FG000|Overall Study|Physician Decision|6|||
155014015|NCT00226499|559477171|FG000|Overall Study|Adverse Event|10|||
155014016|NCT00226499|559477172|FG001|Overall Study|Adverse Event|6|||
155014017|NCT00226499|559477173|FG002|Overall Study|Adverse Event|3|||
155014018|NCT00226499|559477171|FG000|Overall Study|Others|1064|||
155014019|NCT00226499|559477172|FG001|Overall Study|Others|1066|||
155014020|NCT00226499|559477173|FG002|Overall Study|Others|356|||
155014021|NCT00991887|559477174|FG000|Overall Study|Lost to Follow-up|2|||
155014022|NCT00991887|559477175|FG001|Overall Study|Lost to Follow-up|1|||
155014023|NCT02723344|559477178|FG000|Overall Study|Lost to Follow-up|0|||
155014024|NCT02723344|559477179|FG001|Overall Study|Lost to Follow-up|4|||
155014025|NCT02524847|559477181|FG000|Overall Study|Adverse Event|4|||
155014026|NCT02524847|559477181|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155014027|NCT02524847|559477181|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
155014028|NCT02524847|559477181|FG000|Overall Study|Death|1|||
155014029|NCT02524847|559477181|FG000|Overall Study|Reason not Specified|1|||
155014030|NCT04352101|559477182|FG000|Overall Study|Physician Decision|2|||
155014031|NCT04352101|559477183|FG001|Overall Study|Physician Decision|1|||
155014032|NCT02387840|559477190|FG000|Overall Study|Death|0|||
155014033|NCT02387840|559477191|FG001|Overall Study|Death|0|||
155014034|NCT02387840|559477192|FG002|Overall Study|Death|0|||
155014035|NCT02387840|559477193|FG003|Overall Study|Death|0|||
155014036|NCT02387840|559477194|FG004|Overall Study|Death|0|||
155014037|NCT02387840|559477195|FG005|Overall Study|Death|1|||
155014038|NCT03170544|559477196|FG000|Part 1|Lost to Follow-up|1|||
155014039|NCT03170544|559477197|FG001|Part 1|Lost to Follow-up|0|||
155014040|NCT03170544|559477198|FG002|Part 1|Lost to Follow-up|0|||
155014041|NCT03170544|559477199|FG003|Part 1|Lost to Follow-up|0|||
155014042|NCT03170544|559477200|FG004|Part 1|Lost to Follow-up|0|||
155014043|NCT03170544|559477201|FG005|Part 1|Lost to Follow-up|0|||
155014044|NCT03170544|559477202|FG006|Part 1|Lost to Follow-up|0|||
155014045|NCT03170544|559477203|FG007|Part 1|Lost to Follow-up|0|||
155014046|NCT03170544|559477204|FG008|Part 1|Lost to Follow-up|0|||
155014047|NCT03170544|559477205|FG009|Part 1|Lost to Follow-up|0|||
155014048|NCT03170544|559477206|FG010|Part 1|Lost to Follow-up|0|||
155014049|NCT03170544|559477207|FG011|Part 1|Lost to Follow-up|0|||
155014050|NCT03170544|559477196|FG000|Part 1|Not treated|0|||
155014051|NCT03170544|559477197|FG001|Part 1|Not treated|0|||
155014052|NCT03170544|559477198|FG002|Part 1|Not treated|0|||
155014053|NCT03170544|559477199|FG003|Part 1|Not treated|1|||
155014054|NCT03170544|559477200|FG004|Part 1|Not treated|0|||
155014055|NCT03170544|559477201|FG005|Part 1|Not treated|0|||
155014056|NCT03170544|559477202|FG006|Part 1|Not treated|0|||
155014057|NCT03170544|559477203|FG007|Part 1|Not treated|0|||
155014058|NCT03170544|559477204|FG008|Part 1|Not treated|0|||
155014059|NCT03170544|559477205|FG009|Part 1|Not treated|0|||
155014060|NCT03170544|559477206|FG010|Part 1|Not treated|0|||
155014061|NCT03170544|559477207|FG011|Part 1|Not treated|0|||
155014062|NCT01213966|559477208|FG000|Overall Study|Protocol Violation|1|||
155014063|NCT01213966|559477209|FG001|Overall Study|Protocol Violation|0|||
155014064|NCT01213966|559477210|FG002|Overall Study|Protocol Violation|3|||
155014065|NCT01213966|559477211|FG003|Overall Study|Protocol Violation|1|||
155014066|NCT04564092|559477216|FG000|Overall Study|Withdrawal by Subject|1|||
155014067|NCT00420420|559477224|FG000|Overall Study|Adverse Event|5|||
155014068|NCT00420420|559477225|FG001|Overall Study|Adverse Event|3|||
155014069|NCT00420420|559477224|FG000|Overall Study|Protocol Violation|1|||
155014070|NCT00420420|559477225|FG001|Overall Study|Protocol Violation|1|||
155014071|NCT00420420|559477224|FG000|Overall Study|Withdrawal by Subject|1|||
155014072|NCT00420420|559477225|FG001|Overall Study|Withdrawal by Subject|0|||
155014073|NCT00420420|559477224|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
155014074|NCT00420420|559477225|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
155014075|NCT00273182|559477226|FG000|Overall Study|Death|450|||
155014076|NCT00273182|559477226|FG000|Overall Study|Lost to Follow-up|88|||
155014077|NCT00273182|559477226|FG000|Overall Study|Withdrawal by Subject|257|||
155014078|NCT00273182|559477226|FG000|Overall Study|Device/System Explant|154|||
155014079|NCT00273182|559477226|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
155014080|NCT02362360|559477232|FG000|Period 1|Lack of Efficacy|1|||
155014081|NCT02362360|559477233|FG001|Period 1|Lack of Efficacy|0|||
155014082|NCT02362360|559477232|FG000|Period 1|Withdrawal by Subject|2|||
155014083|NCT02362360|559477233|FG001|Period 1|Withdrawal by Subject|1|||
155014084|NCT02208362|559477234|FG000|Overall Study|Participant did not complete treatment|0|||
155014085|NCT02208362|559477235|FG001|Overall Study|Participant did not complete treatment|1|||
155014086|NCT02208362|559477236|FG002|Overall Study|Participant did not complete treatment|0|||
155014087|NCT02208362|559477237|FG003|Overall Study|Participant did not complete treatment|0|||
155014088|NCT02208362|559477238|FG004|Overall Study|Participant did not complete treatment|0|||
155014089|NCT02208362|559477239|FG005|Overall Study|Participant did not complete treatment|0|||
155014090|NCT02208362|559477240|FG006|Overall Study|Participant did not complete treatment|1|||
155014091|NCT02208362|559477241|FG007|Overall Study|Participant did not complete treatment|1|||
155014092|NCT02208362|559477242|FG008|Overall Study|Participant did not complete treatment|2|||
155014093|NCT02208362|559477243|FG009|Overall Study|Participant did not complete treatment|0|||
155014094|NCT02208362|559477244|FG010|Overall Study|Participant did not complete treatment|1|||
155014095|NCT02208362|559477245|FG011|Overall Study|Participant did not complete treatment|0|||
155134382|NCT03100058|559922868|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134383|NCT03100058|559922869|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134384|NCT03100058|559922870|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134385|NCT03100058|559922871|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134386|NCT03100058|559922872|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134387|NCT03100058|559922873|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134388|NCT03100058|559922874|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134389|NCT03100058|559922875|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
155014096|NCT02208362|559477234|FG000|Overall Study|Participant received disallowed treatment|0|||
155134390|NCT03100058|559922876|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134391|NCT03100058|559922877|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
155134392|NCT03100058|559922865|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134393|NCT03100058|559922866|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134394|NCT03100058|559922867|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134395|NCT03100058|559922868|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134396|NCT03100058|559922869|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134397|NCT03100058|559922870|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134398|NCT03100058|559922871|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134399|NCT03100058|559922872|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134400|NCT03100058|559922873|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134401|NCT03100058|559922874|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134402|NCT03100058|559922875|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134403|NCT03100058|559922876|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
155134404|NCT03100058|559922877|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
155134405|NCT03100058|559922865|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134406|NCT03100058|559922866|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134407|NCT03100058|559922867|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134408|NCT03100058|559922868|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134409|NCT03100058|559922869|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134410|NCT03100058|559922870|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134411|NCT03100058|559922871|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134412|NCT03100058|559922872|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134413|NCT03100058|559922873|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134414|NCT03100058|559922874|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
155134415|NCT03100058|559922875|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134416|NCT03100058|559922876|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134417|NCT03100058|559922877|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
155134418|NCT03671304|559922878|FG000|Overall Study|study terminated|7|||
155134419|NCT00596830|559922885|FG000|Overall Study|Death|258|||
155134420|NCT00596830|559922886|FG001|Overall Study|Death|247|||
155134421|NCT00596830|559922885|FG000|Overall Study|Lost to Follow-up|7|||
155134422|NCT00596830|559922886|FG001|Overall Study|Lost to Follow-up|11|||
155134423|NCT00596830|559922885|FG000|Overall Study|Withdrawal by Subject|22|||
155134424|NCT00596830|559922886|FG001|Overall Study|Withdrawal by Subject|12|||
155134425|NCT00596830|559922885|FG000|Overall Study|Study terminated by sponsor|51|||
155134426|NCT00596830|559922886|FG001|Overall Study|Study terminated by sponsor|62|||
155134427|NCT00596830|559922885|FG000|Overall Study|Follow-up was discontinued|1|||
155134428|NCT00596830|559922886|FG001|Overall Study|Follow-up was discontinued|0|||
155134429|NCT00596830|559922885|FG000|Overall Study|Randomized but not treated|3|||
155134430|NCT00596830|559922886|FG001|Overall Study|Randomized but not treated|7|||
155134431|NCT00887926|559922887|FG000|Overall Study|Withdrawal by Subject|0|||
155134432|NCT00887926|559922888|FG001|Overall Study|Withdrawal by Subject|1|||
155134433|NCT00887926|559922889|FG002|Overall Study|Withdrawal by Subject|0|||
155014097|NCT02208362|559477235|FG001|Overall Study|Participant received disallowed treatment|0|||
155134434|NCT00887926|559922890|FG003|Overall Study|Withdrawal by Subject|0|||
155134435|NCT02097030|559922891|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
155134436|NCT02097030|559922892|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
155134437|NCT02097030|559922891|FG000|First Intervention (3 Days)|Visual Acuity|0|||
155134438|NCT02097030|559922892|FG001|First Intervention (3 Days)|Visual Acuity|1|||
155134439|NCT04869358|559922895|FG000|Overall Study|Wish to have children.|1|||
155134440|NCT04869358|559922896|FG001|Overall Study|Wish to have children.|0|||
155134441|NCT04869358|559922897|FG002|Overall Study|Wish to have children.|0|||
155134442|NCT04869358|559922898|FG003|Overall Study|Wish to have children.|0|||
155134443|NCT04302545|559922899|FG000|Overall Study|Lost to Follow-up|3|||
155134444|NCT04302545|559922900|FG001|Overall Study|Lost to Follow-up|4|||
155134445|NCT03550404|559922901|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
155134446|NCT03550404|559922902|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
155134447|NCT03550404|559922903|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
155178624|NCT01397825|560093326|FG002|Overall Study|Adverse Event|5|||
155014098|NCT02208362|559477236|FG002|Overall Study|Participant received disallowed treatment|0|||
155014099|NCT02208362|559477237|FG003|Overall Study|Participant received disallowed treatment|0|||
155014100|NCT02208362|559477238|FG004|Overall Study|Participant received disallowed treatment|0|||
155014101|NCT02208362|559477239|FG005|Overall Study|Participant received disallowed treatment|0|||
155014102|NCT02208362|559477240|FG006|Overall Study|Participant received disallowed treatment|0|||
155014103|NCT02208362|559477241|FG007|Overall Study|Participant received disallowed treatment|0|||
155014104|NCT02208362|559477242|FG008|Overall Study|Participant received disallowed treatment|1|||
155014105|NCT02208362|559477243|FG009|Overall Study|Participant received disallowed treatment|0|||
155014106|NCT02208362|559477244|FG010|Overall Study|Participant received disallowed treatment|0|||
155014107|NCT02208362|559477245|FG011|Overall Study|Participant received disallowed treatment|0|||
155014108|NCT00868530|559477248|FG000|Overall Study|Adverse Event|3|||
155014109|NCT00868530|559477248|FG000|Overall Study|Lost to Follow-up|1|||
155014110|NCT01880554|559478936|FG000|Overall Study|Protocol Violation|14|||
155014111|NCT01880554|559478936|FG000|Overall Study|Simon's design requirements|2|||
155014112|NCT03976362|559478940|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
155014113|NCT03976362|559478941|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155014114|NCT03976362|559478942|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155014115|NCT03976362|559478940|FG000|Induction Phase|Death|62|||
155014116|NCT03976362|559478941|FG001|Induction Phase|Death|0|||
155014117|NCT03976362|559478942|FG002|Induction Phase|Death|0|||
155014118|NCT03976362|559478940|FG000|Maintenance Phase|Participants Ongoing|0|||
155014119|NCT03976362|559478941|FG001|Maintenance Phase|Participants Ongoing|106|||
155014120|NCT03976362|559478942|FG002|Maintenance Phase|Participants Ongoing|103|||
155014121|NCT03976362|559478940|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155014122|NCT03976362|559478941|FG001|Maintenance Phase|Withdrawal by Subject|4|||
155014123|NCT03976362|559478942|FG002|Maintenance Phase|Withdrawal by Subject|4|||
155014124|NCT03976362|559478940|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
155014125|NCT03976362|559478941|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
155014126|NCT03976362|559478942|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
155014127|NCT03976362|559478940|FG000|Maintenance Phase|Death|0|||
155014128|NCT03976362|559478941|FG001|Maintenance Phase|Death|186|||
155014129|NCT03976362|559478942|FG002|Maintenance Phase|Death|187|||
155014130|NCT04846569|559478943|FG000|Overall Study|Withdrawal by Subject|3|||
155014131|NCT04846569|559478944|FG001|Overall Study|Withdrawal by Subject|1|||
155014132|NCT02512302|559478945|FG000|Period 1|Adverse Event|0|||
155014133|NCT02512302|559478946|FG001|Period 1|Adverse Event|1|||
155014134|NCT02512302|559478947|FG002|Period 1|Adverse Event|0|||
155014135|NCT02512302|559478948|FG003|Period 1|Adverse Event|0|||
155014136|NCT02512302|559478949|FG004|Period 1|Adverse Event|0|||
155014137|NCT02512302|559478950|FG005|Period 1|Adverse Event|0|||
155014138|NCT02512302|559478951|FG006|Period 1|Adverse Event|0|||
155014139|NCT02512302|559478952|FG007|Period 1|Adverse Event|0|||
155014140|NCT02512302|559478953|FG008|Period 1|Adverse Event|0|||
155014141|NCT02512302|559478954|FG009|Period 1|Adverse Event|0|||
155014142|NCT02512302|559478945|FG000|Period 2|Adverse Event|0|||
155014143|NCT02512302|559478946|FG001|Period 2|Adverse Event|0|||
155014144|NCT02512302|559478947|FG002|Period 2|Adverse Event|0|||
155014145|NCT02512302|559478948|FG003|Period 2|Adverse Event|0|||
155014146|NCT02512302|559478949|FG004|Period 2|Adverse Event|0|||
155014147|NCT02512302|559478950|FG005|Period 2|Adverse Event|0|||
155014148|NCT02512302|559478951|FG006|Period 2|Adverse Event|0|||
155014149|NCT02512302|559478952|FG007|Period 2|Adverse Event|0|||
155014150|NCT02512302|559478953|FG008|Period 2|Adverse Event|0|||
155014151|NCT02512302|559478954|FG009|Period 2|Adverse Event|1|||
155014152|NCT02512302|559478945|FG000|Period 3|Lost to Follow-up|0|||
155178625|NCT01397825|560093327|FG003|Overall Study|Adverse Event|1|||
155178626|NCT01397825|560093328|FG004|Overall Study|Adverse Event|0|||
155014153|NCT02512302|559478946|FG001|Period 3|Lost to Follow-up|0|||
155014154|NCT02512302|559478947|FG002|Period 3|Lost to Follow-up|1|||
155014155|NCT02512302|559478948|FG003|Period 3|Lost to Follow-up|0|||
155014156|NCT02512302|559478949|FG004|Period 3|Lost to Follow-up|0|||
155014157|NCT02512302|559478950|FG005|Period 3|Lost to Follow-up|0|||
155014158|NCT02512302|559478951|FG006|Period 3|Lost to Follow-up|0|||
155014159|NCT02512302|559478952|FG007|Period 3|Lost to Follow-up|0|||
155014160|NCT02512302|559478953|FG008|Period 3|Lost to Follow-up|0|||
155014161|NCT02512302|559478954|FG009|Period 3|Lost to Follow-up|0|||
155014162|NCT02512302|559478945|FG000|Period 4|Adverse Event|0|||
155014163|NCT02512302|559478946|FG001|Period 4|Adverse Event|0|||
155014164|NCT02512302|559478947|FG002|Period 4|Adverse Event|0|||
155014165|NCT02512302|559478948|FG003|Period 4|Adverse Event|0|||
155014166|NCT02512302|559478949|FG004|Period 4|Adverse Event|0|||
155014167|NCT02512302|559478950|FG005|Period 4|Adverse Event|0|||
155014168|NCT02512302|559478951|FG006|Period 4|Adverse Event|1|||
155178627|NCT01397825|560093324|FG000|Overall Study|Withdrawal by Subject|1|||
155014169|NCT02512302|559478952|FG007|Period 4|Adverse Event|0|||
155014170|NCT02512302|559478953|FG008|Period 4|Adverse Event|0|||
155014171|NCT02512302|559478954|FG009|Period 4|Adverse Event|0|||
155014172|NCT00683618|559478957|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
155014173|NCT00683618|559478958|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
155014174|NCT00683618|559478959|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
155014175|NCT00683618|559478957|FG000|Randomised Treatment Period|Protocol Violation|0|||
155014176|NCT00683618|559478958|FG001|Randomised Treatment Period|Protocol Violation|1|||
155014177|NCT00683618|559478959|FG002|Randomised Treatment Period|Protocol Violation|0|||
155014178|NCT00683618|559478957|FG000|Randomised Treatment Period|Adverse Event|2|||
155014179|NCT00683618|559478958|FG001|Randomised Treatment Period|Adverse Event|0|||
155014180|NCT00683618|559478959|FG002|Randomised Treatment Period|Adverse Event|2|||
155014181|NCT00683618|559478957|FG000|Randomised Treatment Period|Reason not provided|0|||
155014182|NCT00683618|559478958|FG001|Randomised Treatment Period|Reason not provided|0|||
155014183|NCT00683618|559478959|FG002|Randomised Treatment Period|Reason not provided|2|||
155014184|NCT00683618|559478957|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
155014185|NCT00683618|559478958|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155014186|NCT00683618|559478959|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
155014187|NCT00683618|559478957|FG000|Extension Treatment Period|Adverse Event|1|||
155014188|NCT00683618|559478958|FG001|Extension Treatment Period|Adverse Event|0|||
155014189|NCT00683618|559478959|FG002|Extension Treatment Period|Adverse Event|0|||
155014190|NCT00683618|559478957|FG000|Extension Treatment Period|Protocol Violation|1|||
155014191|NCT00683618|559478958|FG001|Extension Treatment Period|Protocol Violation|0|||
155014192|NCT00683618|559478959|FG002|Extension Treatment Period|Protocol Violation|0|||
155014193|NCT02954601|559478960|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
155014194|NCT02954601|559478961|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
155014195|NCT02954601|559478962|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
155014196|NCT02954601|559478963|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
155014197|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
155014198|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
155014199|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
155014200|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
155014201|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
155014202|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014203|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014204|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014205|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014206|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014207|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014208|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014209|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014210|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014211|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
155014212|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
155014213|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
155014214|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
155014215|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
155014216|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
155014217|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014218|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014219|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014220|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014221|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014222|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014223|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014224|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014225|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014226|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
155014227|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
155014228|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
155178628|NCT01397825|560093325|FG001|Overall Study|Withdrawal by Subject|0|||
155178629|NCT01397825|560093326|FG002|Overall Study|Withdrawal by Subject|5|||
155178630|NCT01397825|560093327|FG003|Overall Study|Withdrawal by Subject|1|||
155134448|NCT03550404|559922901|FG000|Phase 2|Vacated position|1|||
155134449|NCT03550404|559922902|FG001|Phase 2|Vacated position|0|||
155134450|NCT03550404|559922903|FG002|Phase 2|Vacated position|0|||
155134451|NCT01336023|559922905|FG000|Week 0 to Week 26|Adverse Event|8|||
155134452|NCT01336023|559922906|FG001|Week 0 to Week 26|Adverse Event|10|||
155134453|NCT01336023|559922907|FG002|Week 0 to Week 26|Adverse Event|24|||
155134454|NCT01336023|559922905|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
155134455|NCT01336023|559922906|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
155134456|NCT01336023|559922907|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
155134457|NCT01336023|559922905|FG000|Week 0 to Week 26|Protocol Violation|1|||
155134458|NCT01336023|559922906|FG001|Week 0 to Week 26|Protocol Violation|2|||
155134459|NCT01336023|559922907|FG002|Week 0 to Week 26|Protocol Violation|0|||
155134460|NCT01336023|559922905|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
155134461|NCT01336023|559922906|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
155134462|NCT01336023|559922907|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
155134463|NCT01336023|559922905|FG000|Week 0 to Week 26|Unclassified|5|||
155134464|NCT01336023|559922906|FG001|Week 0 to Week 26|Unclassified|16|||
155134465|NCT01336023|559922907|FG002|Week 0 to Week 26|Unclassified|9|||
155134466|NCT01336023|559922905|FG000|Week 27 to 52|Adverse Event|1|||
155134467|NCT01336023|559922906|FG001|Week 27 to 52|Adverse Event|5|||
155134468|NCT01336023|559922907|FG002|Week 27 to 52|Adverse Event|2|||
155134469|NCT01336023|559922905|FG000|Week 27 to 52|Protocol Violation|0|||
155134470|NCT01336023|559922906|FG001|Week 27 to 52|Protocol Violation|2|||
155134471|NCT01336023|559922907|FG002|Week 27 to 52|Protocol Violation|1|||
155134472|NCT01336023|559922905|FG000|Week 27 to 52|Withdrawal Criteria|14|||
155134473|NCT01336023|559922906|FG001|Week 27 to 52|Withdrawal Criteria|19|||
155134474|NCT01336023|559922907|FG002|Week 27 to 52|Withdrawal Criteria|16|||
155134475|NCT01336023|559922905|FG000|Week 27 to 52|Unclassified|13|||
155134476|NCT01336023|559922906|FG001|Week 27 to 52|Unclassified|18|||
155134477|NCT01336023|559922907|FG002|Week 27 to 52|Unclassified|9|||
155134478|NCT01894022|559922910|FG000|Overall Study|Death|1|||
155134479|NCT01894022|559922911|FG001|Overall Study|Death|0|||
155134480|NCT01894022|559922910|FG000|Overall Study|Adverse Event, non-fatal|1|||
155134481|NCT01894022|559922911|FG001|Overall Study|Adverse Event, non-fatal|0|||
155134482|NCT01894022|559922910|FG000|Overall Study|Study Closed/terminated|7|||
155134483|NCT01894022|559922911|FG001|Overall Study|Study Closed/terminated|10|||
155134484|NCT00235716|559922914|FG000|Overall Study|Death|26|||
155134485|NCT00235716|559922915|FG001|Overall Study|Death|39|||
155134486|NCT00235716|559922916|FG002|Overall Study|Death|32|||
155134487|NCT00235716|559922917|FG003|Overall Study|Death|31|||
155134488|NCT00235716|559922914|FG000|Overall Study|Withdrawal by Subject|23|||
155134489|NCT00235716|559922915|FG001|Overall Study|Withdrawal by Subject|19|||
155134490|NCT00235716|559922916|FG002|Overall Study|Withdrawal by Subject|17|||
155134491|NCT00235716|559922917|FG003|Overall Study|Withdrawal by Subject|18|||
155134492|NCT00235716|559922914|FG000|Overall Study|Lost to Follow-up|12|||
155134493|NCT00235716|559922915|FG001|Overall Study|Lost to Follow-up|7|||
155134494|NCT00235716|559922916|FG002|Overall Study|Lost to Follow-up|14|||
155134495|NCT00235716|559922917|FG003|Overall Study|Lost to Follow-up|10|||
155134496|NCT00235716|559922914|FG000|Overall Study|Adverse Event|1|||
155134497|NCT00235716|559922915|FG001|Overall Study|Adverse Event|1|||
155134498|NCT00235716|559922916|FG002|Overall Study|Adverse Event|1|||
155134499|NCT00235716|559922917|FG003|Overall Study|Adverse Event|0|||
155134500|NCT00235716|559922914|FG000|Overall Study|Physician Decision|0|||
155134501|NCT00235716|559922915|FG001|Overall Study|Physician Decision|1|||
155134502|NCT00235716|559922916|FG002|Overall Study|Physician Decision|1|||
155134503|NCT00235716|559922917|FG003|Overall Study|Physician Decision|3|||
155134504|NCT01545050|559922918|FG000|Overall Study|Lack of Efficacy|0|||
155134505|NCT01545050|559922919|FG001|Overall Study|Lack of Efficacy|0|||
155134506|NCT01545050|559922920|FG002|Overall Study|Lack of Efficacy|0|||
155134507|NCT01545050|559922921|FG003|Overall Study|Lack of Efficacy|3|||
155134508|NCT01545050|559922922|FG004|Overall Study|Lack of Efficacy|2|||
155134509|NCT01545050|559922918|FG000|Overall Study|Adverse Event|1|||
155134510|NCT01545050|559922919|FG001|Overall Study|Adverse Event|1|||
155134511|NCT01545050|559922920|FG002|Overall Study|Adverse Event|2|||
155134512|NCT01545050|559922921|FG003|Overall Study|Adverse Event|2|||
155134513|NCT01545050|559922922|FG004|Overall Study|Adverse Event|0|||
155134514|NCT01545050|559922918|FG000|Overall Study|Discontinued study treatment|1|||
155134515|NCT01545050|559922919|FG001|Overall Study|Discontinued study treatment|0|||
155134516|NCT01545050|559922920|FG002|Overall Study|Discontinued study treatment|0|||
155134517|NCT01545050|559922921|FG003|Overall Study|Discontinued study treatment|0|||
155134518|NCT01545050|559922922|FG004|Overall Study|Discontinued study treatment|0|||
155134519|NCT01545050|559922918|FG000|Overall Study|Withdrawal by Subject|1|||
155134520|NCT01545050|559922919|FG001|Overall Study|Withdrawal by Subject|0|||
155178631|NCT01397825|560093328|FG004|Overall Study|Withdrawal by Subject|0|||
155178632|NCT04352127|560093330|FG000|Overall Study|Unable to obtain readings|4|||
155134521|NCT01545050|559922920|FG002|Overall Study|Withdrawal by Subject|0|||
155134522|NCT01545050|559922921|FG003|Overall Study|Withdrawal by Subject|2|||
155134523|NCT01545050|559922922|FG004|Overall Study|Withdrawal by Subject|1|||
155134524|NCT01545050|559922918|FG000|Overall Study|Participant no longer meets study criteria|0|||
155134525|NCT01545050|559922919|FG001|Overall Study|Participant no longer meets study criteria|2|||
155134526|NCT01545050|559922920|FG002|Overall Study|Participant no longer meets study criteria|0|||
155134527|NCT01545050|559922921|FG003|Overall Study|Participant no longer meets study criteria|0|||
155134528|NCT01545050|559922922|FG004|Overall Study|Participant no longer meets study criteria|1|||
155134529|NCT01545050|559922918|FG000|Overall Study|Administrative reason by sponsor|4|||
155134530|NCT01545050|559922919|FG001|Overall Study|Administrative reason by sponsor|2|||
155134531|NCT01545050|559922920|FG002|Overall Study|Administrative reason by sponsor|3|||
155134532|NCT01545050|559922921|FG003|Overall Study|Administrative reason by sponsor|5|||
155134533|NCT01545050|559922922|FG004|Overall Study|Administrative reason by sponsor|5|||
155134534|NCT03235089|559922923|FG000|Overall Study|Lost to Follow-up|1|||
155134535|NCT03235089|559922924|FG001|Overall Study|Lost to Follow-up|1|||
155134536|NCT03235089|559922923|FG000|Overall Study|Physician Decision|2|||
155134537|NCT03235089|559922924|FG001|Overall Study|Physician Decision|2|||
155134538|NCT02673684|559922925|FG000|Overall Study|Study not completed d/t loss of funding|9|||
155134539|NCT02673684|559922926|FG001|Overall Study|Study not completed d/t loss of funding|8|||
155134540|NCT01092663|559922927|FG000|Overall Study|Withdrawal by Subject|3|||
155134541|NCT01092663|559922928|FG001|Overall Study|Withdrawal by Subject|2|||
155134542|NCT01092663|559922927|FG000|Overall Study|Glucose >300mg/dL|1|||
155134543|NCT01092663|559922928|FG001|Overall Study|Glucose >300mg/dL|0|||
155134544|NCT01092663|559922927|FG000|Overall Study|High fasting triglyceride|2|||
155134545|NCT01092663|559922928|FG001|Overall Study|High fasting triglyceride|0|||
155134546|NCT01092663|559922927|FG000|Overall Study|Adverse Event|1|||
155134547|NCT01092663|559922928|FG001|Overall Study|Adverse Event|1|||
155134548|NCT01092663|559922927|FG000|Overall Study|Protocol Violation|0|||
155134549|NCT01092663|559922928|FG001|Overall Study|Protocol Violation|1|||
155134550|NCT01220180|559922929|FG000|Overall Study|Lost to Follow-up|76|||
155134551|NCT01220180|559922929|FG000|Overall Study|Other|72|||
155134552|NCT01220180|559922929|FG000|Overall Study|Adverse Event|35|||
155134553|NCT01220180|559922929|FG000|Overall Study|Lack of Efficacy|22|||
155134554|NCT01220180|559922929|FG000|Overall Study|Death|1|||
155134555|NCT01220180|559922929|FG000|Overall Study|Randomized but not treated|1|||
155134556|NCT01068158|559922933|FG000|Overall Study|Withdrawal by Subject|1|||
155134557|NCT01068158|559922934|FG001|Overall Study|Withdrawal by Subject|2|||
155134558|NCT01068158|559922933|FG000|Overall Study|Lost to Follow-up|7|||
155134559|NCT01068158|559922934|FG001|Overall Study|Lost to Follow-up|0|||
155134560|NCT01068158|559922933|FG000|Overall Study|Protocol Violation|0|||
155134561|NCT01068158|559922934|FG001|Overall Study|Protocol Violation|2|||
155134562|NCT01959243|559922941|FG000|Overall Study|Investigator Decision|3|||
155134563|NCT01959243|559922942|FG001|Overall Study|Investigator Decision|0|||
155134564|NCT01959243|559922941|FG000|Overall Study|Adverse Event|5|||
155134565|NCT01959243|559922942|FG001|Overall Study|Adverse Event|2|||
155134566|NCT01959243|559922941|FG000|Overall Study|Administrative reasons|2|||
155134567|NCT01959243|559922942|FG001|Overall Study|Administrative reasons|1|||
155134568|NCT01959243|559922941|FG000|Overall Study|Lost to Follow-up|3|||
155134569|NCT01959243|559922942|FG001|Overall Study|Lost to Follow-up|1|||
155134570|NCT02596945|559922943|FG000|Overall Study|No documentation of study drug dosing|3|||
155134571|NCT02596945|559922943|FG000|Overall Study|Other|32|||
155134572|NCT02596945|559922943|FG000|Overall Study|Change to hemodialysis|15|||
155134573|NCT02596945|559922943|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
155134574|NCT02596945|559922943|FG000|Overall Study|Withdrawal by Subject|1|||
155134575|NCT02596945|559922943|FG000|Overall Study|Missing|1|||
155134576|NCT01368081|559922944|FG000|Overall Study|Adverse Event|4|||
155134577|NCT01368081|559922945|FG001|Overall Study|Adverse Event|4|||
155134578|NCT01368081|559922946|FG002|Overall Study|Adverse Event|3|||
155134579|NCT01368081|559922947|FG003|Overall Study|Adverse Event|2|||
155134580|NCT01368081|559922948|FG004|Overall Study|Adverse Event|2|||
155134581|NCT01368081|559922949|FG005|Overall Study|Adverse Event|5|||
155134582|NCT01368081|559922950|FG006|Overall Study|Adverse Event|6|||
155178633|NCT04352127|560093331|FG001|Overall Study|Unable to obtain readings|1|||
155178634|NCT03023046|560093332|FG000|Overall Study|Withdrawal by Subject|1|||
155178635|NCT00635024|560093335|FG000|Overall Study|Adverse Event|1|||
155178636|NCT01993836|560093336|FG000|Overall Study|Surgery Cancelled|3|||
155178637|NCT01993836|560093337|FG001|Overall Study|Surgery Cancelled|0|||
155178638|NCT01993836|560093338|FG002|Overall Study|Surgery Cancelled|0|||
155134583|NCT01368081|559922951|FG007|Overall Study|Adverse Event|2|||
155134584|NCT01368081|559922952|FG008|Overall Study|Adverse Event|3|||
155134585|NCT01368081|559922953|FG009|Overall Study|Adverse Event|5|||
155134586|NCT01368081|559922954|FG010|Overall Study|Adverse Event|6|||
155178639|NCT01993836|560093336|FG000|Overall Study|Physician Decision|2|||
155178640|NCT01993836|560093337|FG001|Overall Study|Physician Decision|1|||
155134587|NCT01368081|559922955|FG011|Overall Study|Adverse Event|1|||
155134588|NCT01368081|559922956|FG012|Overall Study|Adverse Event|3|||
155134589|NCT01368081|559922944|FG000|Overall Study|Lack of Efficacy|0|||
155134590|NCT01368081|559922945|FG001|Overall Study|Lack of Efficacy|1|||
155134591|NCT01368081|559922946|FG002|Overall Study|Lack of Efficacy|0|||
155134592|NCT01368081|559922947|FG003|Overall Study|Lack of Efficacy|1|||
155134593|NCT01368081|559922948|FG004|Overall Study|Lack of Efficacy|0|||
155134594|NCT01368081|559922949|FG005|Overall Study|Lack of Efficacy|0|||
155134595|NCT01368081|559922950|FG006|Overall Study|Lack of Efficacy|0|||
155134596|NCT01368081|559922951|FG007|Overall Study|Lack of Efficacy|2|||
155134597|NCT01368081|559922952|FG008|Overall Study|Lack of Efficacy|0|||
155134598|NCT01368081|559922953|FG009|Overall Study|Lack of Efficacy|0|||
155134599|NCT01368081|559922954|FG010|Overall Study|Lack of Efficacy|0|||
155134600|NCT01368081|559922955|FG011|Overall Study|Lack of Efficacy|0|||
155134601|NCT01368081|559922956|FG012|Overall Study|Lack of Efficacy|0|||
155134602|NCT01368081|559922944|FG000|Overall Study|Protocol Violation|0|||
155134603|NCT01368081|559922945|FG001|Overall Study|Protocol Violation|0|||
155134604|NCT01368081|559922946|FG002|Overall Study|Protocol Violation|0|||
155134605|NCT01368081|559922947|FG003|Overall Study|Protocol Violation|0|||
155134606|NCT01368081|559922948|FG004|Overall Study|Protocol Violation|0|||
155134607|NCT01368081|559922949|FG005|Overall Study|Protocol Violation|1|||
155134608|NCT01368081|559922950|FG006|Overall Study|Protocol Violation|0|||
155134609|NCT01368081|559922951|FG007|Overall Study|Protocol Violation|1|||
155134610|NCT01368081|559922952|FG008|Overall Study|Protocol Violation|0|||
155134611|NCT01368081|559922953|FG009|Overall Study|Protocol Violation|0|||
155134612|NCT01368081|559922954|FG010|Overall Study|Protocol Violation|0|||
155134613|NCT01368081|559922955|FG011|Overall Study|Protocol Violation|0|||
155134614|NCT01368081|559922956|FG012|Overall Study|Protocol Violation|0|||
155134615|NCT01368081|559922944|FG000|Overall Study|Lost to Follow-up|0|||
155134616|NCT01368081|559922945|FG001|Overall Study|Lost to Follow-up|0|||
155134617|NCT01368081|559922946|FG002|Overall Study|Lost to Follow-up|0|||
155134618|NCT01368081|559922947|FG003|Overall Study|Lost to Follow-up|0|||
155134619|NCT01368081|559922948|FG004|Overall Study|Lost to Follow-up|0|||
155134620|NCT01368081|559922949|FG005|Overall Study|Lost to Follow-up|0|||
155134621|NCT01368081|559922950|FG006|Overall Study|Lost to Follow-up|0|||
155134622|NCT01368081|559922951|FG007|Overall Study|Lost to Follow-up|0|||
155134623|NCT01368081|559922952|FG008|Overall Study|Lost to Follow-up|0|||
155134624|NCT01368081|559922953|FG009|Overall Study|Lost to Follow-up|0|||
155134625|NCT01368081|559922954|FG010|Overall Study|Lost to Follow-up|0|||
155134626|NCT01368081|559922955|FG011|Overall Study|Lost to Follow-up|0|||
155134627|NCT01368081|559922956|FG012|Overall Study|Lost to Follow-up|1|||
155134628|NCT01368081|559922944|FG000|Overall Study|Withdrawal by Subject|4|||
155134629|NCT01368081|559922945|FG001|Overall Study|Withdrawal by Subject|4|||
155134630|NCT01368081|559922946|FG002|Overall Study|Withdrawal by Subject|1|||
155134631|NCT01368081|559922947|FG003|Overall Study|Withdrawal by Subject|1|||
155134632|NCT01368081|559922948|FG004|Overall Study|Withdrawal by Subject|0|||
155134633|NCT01368081|559922949|FG005|Overall Study|Withdrawal by Subject|3|||
155134634|NCT01368081|559922950|FG006|Overall Study|Withdrawal by Subject|4|||
155134635|NCT01368081|559922951|FG007|Overall Study|Withdrawal by Subject|2|||
155134636|NCT01368081|559922952|FG008|Overall Study|Withdrawal by Subject|5|||
155134637|NCT01368081|559922953|FG009|Overall Study|Withdrawal by Subject|4|||
155134638|NCT01368081|559922954|FG010|Overall Study|Withdrawal by Subject|3|||
155134639|NCT01368081|559922955|FG011|Overall Study|Withdrawal by Subject|2|||
155134640|NCT01368081|559922956|FG012|Overall Study|Withdrawal by Subject|0|||
155134641|NCT01368081|559922944|FG000|Overall Study|Other reason not defined above|2|||
155134642|NCT01368081|559922945|FG001|Overall Study|Other reason not defined above|0|||
155134643|NCT01368081|559922946|FG002|Overall Study|Other reason not defined above|0|||
155178641|NCT01993836|560093338|FG002|Overall Study|Physician Decision|0|||
155178642|NCT01993836|560093336|FG000|Overall Study|Death|0|||
155014229|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
155014230|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
155014231|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
155014232|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014233|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014234|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014235|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014236|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014237|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014238|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014239|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155134644|NCT01368081|559922947|FG003|Overall Study|Other reason not defined above|1|||
155134645|NCT01368081|559922948|FG004|Overall Study|Other reason not defined above|0|||
155134646|NCT01368081|559922949|FG005|Overall Study|Other reason not defined above|1|||
155134647|NCT01368081|559922950|FG006|Overall Study|Other reason not defined above|2|||
155134648|NCT01368081|559922951|FG007|Overall Study|Other reason not defined above|0|||
155134649|NCT01368081|559922952|FG008|Overall Study|Other reason not defined above|0|||
155134650|NCT01368081|559922953|FG009|Overall Study|Other reason not defined above|1|||
155134651|NCT01368081|559922954|FG010|Overall Study|Other reason not defined above|0|||
155134652|NCT01368081|559922955|FG011|Overall Study|Other reason not defined above|0|||
155134653|NCT01368081|559922956|FG012|Overall Study|Other reason not defined above|3|||
155134654|NCT01007838|559922960|FG000|Overall Study|Withdrawal by Subject|1|||
155134655|NCT01007838|559922961|FG001|Overall Study|Withdrawal by Subject|0|||
155134656|NCT01007838|559922962|FG002|Overall Study|Withdrawal by Subject|0|||
155014240|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014241|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
155014242|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
155134657|NCT01007838|559922963|FG003|Overall Study|Withdrawal by Subject|0|||
155134658|NCT01007838|559922960|FG000|Overall Study|Physician Decision|1|||
155134659|NCT01007838|559922961|FG001|Overall Study|Physician Decision|0|||
155134660|NCT01007838|559922962|FG002|Overall Study|Physician Decision|0|||
155134661|NCT01007838|559922963|FG003|Overall Study|Physician Decision|0|||
155134662|NCT01007838|559922960|FG000|Overall Study|Started home haemodialysis|1|||
155134663|NCT01007838|559922961|FG001|Overall Study|Started home haemodialysis|0|||
155134664|NCT01007838|559922962|FG002|Overall Study|Started home haemodialysis|0|||
155134665|NCT01007838|559922963|FG003|Overall Study|Started home haemodialysis|0|||
155134666|NCT02277119|559922964|FG000|Overall Study|Lack of Efficacy|1|||
155134667|NCT02277119|559922965|FG001|Overall Study|Lack of Efficacy|1|||
155134668|NCT02277119|559922966|FG002|Overall Study|Lack of Efficacy|1|||
155134669|NCT02277119|559922964|FG000|Overall Study|Protocol Violation|2|||
155134670|NCT02277119|559922965|FG001|Overall Study|Protocol Violation|3|||
155134671|NCT02277119|559922966|FG002|Overall Study|Protocol Violation|7|||
155134672|NCT04699461|559922967|FG000|Overall Study|Withdrawal by Subject|1|||
155134673|NCT04699461|559922968|FG001|Overall Study|Withdrawal by Subject|0|||
155134674|NCT04699461|559922967|FG000|Overall Study|Study termination by sponsor|2|||
155134675|NCT04699461|559922968|FG001|Overall Study|Study termination by sponsor|1|||
155134676|NCT04699461|559922967|FG000|Overall Study|Death|1|||
155134677|NCT04699461|559922968|FG001|Overall Study|Death|0|||
155134678|NCT04699461|559922967|FG000|Overall Study|Radiographic progression|0|||
155134679|NCT04699461|559922968|FG001|Overall Study|Radiographic progression|1|||
155134680|NCT00061633|559922976|FG000|Overall Study|Adverse Event|1|||
155134681|NCT00061633|559922977|FG001|Overall Study|Adverse Event|2|||
155134682|NCT00061633|559922976|FG000|Overall Study|Withdrawal by Subject|2|||
155134683|NCT00061633|559922977|FG001|Overall Study|Withdrawal by Subject|2|||
155134684|NCT00061633|559922976|FG000|Overall Study|Lost to Follow-up|1|||
155134685|NCT00061633|559922977|FG001|Overall Study|Lost to Follow-up|4|||
155134686|NCT00061633|559922976|FG000|Overall Study|Other|1|||
155134687|NCT00061633|559922977|FG001|Overall Study|Other|1|||
155134688|NCT00061633|559922976|FG000|Overall Study|Never received study treatment|0|||
155134689|NCT00061633|559922977|FG001|Overall Study|Never received study treatment|2|||
155134690|NCT01431963|559922978|FG000|Overall Study|Adverse Event|18|||
155134691|NCT01431963|559922978|FG000|Overall Study|Lack of Efficacy|7|||
155134692|NCT01431963|559922978|FG000|Overall Study|Protocol Violation|1|||
155134693|NCT01431963|559922978|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
155134694|NCT01431963|559922978|FG000|Overall Study|Physician Decision|4|||
155134695|NCT01431963|559922978|FG000|Overall Study|Withdrawal by Subject|3|||
155134696|NCT02301624|559922983|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
155134697|NCT02301624|559922984|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
155134698|NCT02301624|559922983|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
155134699|NCT02301624|559922984|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
155134700|NCT02301624|559922983|FG000|Open-label Maintenance Phase|Adverse Event|2|||
155134701|NCT02301624|559922984|FG001|Open-label Maintenance Phase|Adverse Event|5|||
155014243|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
155014244|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
155014245|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
155014246|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
155014247|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014248|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014249|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014250|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014251|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014252|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014253|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014254|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014255|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014256|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
155014257|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
155014258|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014259|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
155134702|NCT02301624|559922983|FG000|Open-label Maintenance Phase|Physician Decision|3|||
155134703|NCT02301624|559922984|FG001|Open-label Maintenance Phase|Physician Decision|3|||
155134704|NCT02301624|559922983|FG000|Open-label Maintenance Phase|Death|2|||
155134705|NCT02301624|559922984|FG001|Open-label Maintenance Phase|Death|1|||
155134706|NCT02301624|559922983|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
155134707|NCT02301624|559922984|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
155134708|NCT00547521|559922985|FG000|Short Term Study (4 Months)|Adverse Event|1|||
155134709|NCT00547521|559922986|FG001|Short Term Study (4 Months)|Adverse Event|0|||
155134710|NCT00547521|559922985|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
155134711|NCT00547521|559922986|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
155134712|NCT00547521|559922985|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
155134713|NCT00547521|559922986|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
155134714|NCT00547521|559922985|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
155134715|NCT00547521|559922986|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
155134716|NCT00547521|559922985|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
155134717|NCT00547521|559922986|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
155134718|NCT00547521|559922985|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
155134719|NCT00547521|559922986|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
155134720|NCT00547521|559922985|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
155134721|NCT00547521|559922986|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
155134722|NCT00547521|559922985|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
155134723|NCT00547521|559922986|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
155134724|NCT00547521|559922985|FG000|Long Term Extension (LTE) Study|Other|0|||
155134725|NCT00547521|559922986|FG001|Long Term Extension (LTE) Study|Other|2|||
155014260|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
155014261|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
155014262|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014263|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014264|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014265|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014266|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014267|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014268|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014269|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014270|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014271|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
155014272|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014273|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014274|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014275|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
155014276|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014277|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014278|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014279|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014280|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014281|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014282|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014283|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014284|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014285|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014286|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
155014287|NCT03334435|559478977|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
155134726|NCT00547521|559922985|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
155134727|NCT00547521|559922986|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
155134728|NCT02611817|559925005|FG000|Open-label Induction Phase|Reason not Specified|9|||
155134729|NCT02611817|559925006|FG001|Open-label Induction Phase|Reason not Specified|0|||
155014288|NCT03334435|559478978|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
155014289|NCT03334435|559478979|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
155014290|NCT03334435|559478980|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
155014291|NCT03334435|559478981|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
155014292|NCT03334435|559478982|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014293|NCT03334435|559478983|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014294|NCT03334435|559478984|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014295|NCT03334435|559478985|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014296|NCT03334435|559478986|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014297|NCT03334435|559478987|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014298|NCT03334435|559478988|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014299|NCT03334435|559478989|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014300|NCT03334435|559478990|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014301|NCT03334435|559478991|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
155014302|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155014303|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155014304|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155014305|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155014306|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
155014307|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
155014308|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
155014309|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
155014310|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
155014311|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
155014312|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
155014313|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
155014314|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
155014315|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
155014316|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
155014317|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155014318|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155014319|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155014320|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155014321|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
155014322|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
155014323|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
155014324|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
155014325|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
155014326|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
155014327|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
155014328|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
155014329|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
155014330|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
155014331|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
155014332|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155014333|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155014334|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155014335|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155014336|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155014337|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
155014338|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
155014339|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
155014340|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
155014341|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
155014342|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
155014343|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
155014344|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
155014345|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
155014346|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
155014347|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155014348|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155014349|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155014350|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155014351|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
155014352|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
155014353|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
155014354|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
155014355|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
155014356|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
155014357|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
155014358|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
155134730|NCT02611817|559925007|FG002|Open-label Induction Phase|Reason not Specified|0|||
155134731|NCT02611817|559925005|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
155134732|NCT02611817|559925006|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
155134733|NCT02611817|559925007|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
155134734|NCT02611817|559925005|FG000|Open-label Induction Phase|Pregnancy|1|||
155134735|NCT02611817|559925006|FG001|Open-label Induction Phase|Pregnancy|0|||
155134736|NCT02611817|559925007|FG002|Open-label Induction Phase|Pregnancy|0|||
155134737|NCT02611817|559925005|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
155134738|NCT02611817|559925006|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
155134739|NCT02611817|559925007|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
155134740|NCT02611817|559925005|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
155134741|NCT02611817|559925006|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
155014359|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
155014360|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
155134742|NCT02611817|559925007|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
155134743|NCT02611817|559925005|FG000|Open-label Induction Phase|Protocol Violation|5|||
155134744|NCT02611817|559925006|FG001|Open-label Induction Phase|Protocol Violation|0|||
155134745|NCT02611817|559925007|FG002|Open-label Induction Phase|Protocol Violation|0|||
155134746|NCT02611817|559925005|FG000|Open-label Induction Phase|Adverse Event|16|||
155134747|NCT02611817|559925006|FG001|Open-label Induction Phase|Adverse Event|0|||
155134748|NCT02611817|559925007|FG002|Open-label Induction Phase|Adverse Event|0|||
155134749|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
155134750|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
155134751|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
155134752|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
155134753|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
155134754|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
155134755|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
155134756|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
155134757|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
155134758|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
155134759|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
155134760|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
155134761|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
155134762|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
155134763|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
155134764|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
155134765|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
155134766|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
155134767|NCT02611817|559925005|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
155134768|NCT02611817|559925006|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
155134769|NCT02611817|559925007|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
155134770|NCT03077919|559925008|FG000|Overall Study|Lost to Follow-up|4|||
155134771|NCT03077919|559925009|FG001|Overall Study|Lost to Follow-up|1|||
155134772|NCT03738618|559925010|FG000|Overall Study|Protocol deviation|23|||
155134773|NCT03738618|559925011|FG001|Overall Study|Protocol deviation|0|||
155134774|NCT03738618|559925010|FG000|Overall Study|Adverse Event|4|||
155134775|NCT03738618|559925011|FG001|Overall Study|Adverse Event|0|||
155134776|NCT03738618|559925010|FG000|Overall Study|Lost to Follow-up|2|||
155134777|NCT03738618|559925011|FG001|Overall Study|Lost to Follow-up|0|||
155134778|NCT03738618|559925010|FG000|Overall Study|Randomization failure|1|||
155134779|NCT03738618|559925011|FG001|Overall Study|Randomization failure|0|||
155134780|NCT03738618|559925010|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
155134781|NCT03738618|559925011|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
155134782|NCT03738618|559925010|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
155134783|NCT03738618|559925011|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
155134784|NCT00826618|559925012|FG000|Overall Study|Withdrawal by Subject|1|||
155134785|NCT01618695|559925017|FG000|Core Phase|Adverse Event|4|||
155134786|NCT01618695|559925018|FG001|Core Phase|Adverse Event|5|||
155134787|NCT01618695|559925019|FG002|Core Phase|Adverse Event|15|||
155134788|NCT01618695|559925020|FG003|Core Phase|Adverse Event|20|||
155134789|NCT01618695|559925017|FG000|Core Phase|Lost to Follow-up|0|||
155134790|NCT01618695|559925018|FG001|Core Phase|Lost to Follow-up|0|||
155134791|NCT01618695|559925019|FG002|Core Phase|Lost to Follow-up|1|||
155134792|NCT01618695|559925020|FG003|Core Phase|Lost to Follow-up|0|||
155134793|NCT01618695|559925017|FG000|Core Phase|Withdrawal by Subject|16|||
155134794|NCT01618695|559925018|FG001|Core Phase|Withdrawal by Subject|11|||
155134795|NCT01618695|559925019|FG002|Core Phase|Withdrawal by Subject|9|||
155134796|NCT01618695|559925020|FG003|Core Phase|Withdrawal by Subject|13|||
155134797|NCT01618695|559925017|FG000|Core Phase|Pregnancy|2|||
155134798|NCT01618695|559925018|FG001|Core Phase|Pregnancy|0|||
155134799|NCT01618695|559925019|FG002|Core Phase|Pregnancy|0|||
155134800|NCT01618695|559925020|FG003|Core Phase|Pregnancy|0|||
155014361|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
155014362|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155014363|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155134801|NCT01618695|559925017|FG000|Core Phase|Lack of Efficacy|1|||
155134802|NCT01618695|559925018|FG001|Core Phase|Lack of Efficacy|2|||
155134803|NCT01618695|559925019|FG002|Core Phase|Lack of Efficacy|1|||
155134804|NCT01618695|559925020|FG003|Core Phase|Lack of Efficacy|1|||
155134805|NCT01618695|559925017|FG000|Core Phase|Other than specified|1|||
155134806|NCT01618695|559925018|FG001|Core Phase|Other than specified|2|||
155134807|NCT01618695|559925019|FG002|Core Phase|Other than specified|2|||
155134808|NCT01618695|559925020|FG003|Core Phase|Other than specified|2|||
155134809|NCT01618695|559925017|FG000|Core Phase|Not treated|1|||
155014364|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155134810|NCT01618695|559925018|FG001|Core Phase|Not treated|0|||
155014365|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155014366|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155014367|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155014368|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
155014369|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
155014370|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
155014371|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
155014372|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
155014373|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
155014374|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
155014375|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
155014376|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
155014377|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014378|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014379|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014380|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014381|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014382|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014383|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014384|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014385|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014386|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014387|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014388|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
155014389|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014390|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
155014391|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
155014392|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014393|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014394|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014395|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014396|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014397|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
155014398|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014399|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014400|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014401|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014402|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014403|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014404|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014405|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
155014406|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
155014407|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014408|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014409|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014410|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014411|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014412|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155014413|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155014414|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155014415|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155014416|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
155014417|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155014418|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
155014419|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014420|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014421|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
155014422|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014423|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155134811|NCT01618695|559925019|FG002|Core Phase|Not treated|2|||
155134812|NCT01618695|559925020|FG003|Core Phase|Not treated|0|||
155134813|NCT01618695|559925017|FG000|Extension Phase|Lack of Efficacy|17|||
155134814|NCT01618695|559925018|FG001|Extension Phase|Lack of Efficacy|33|||
155134815|NCT01618695|559925019|FG002|Extension Phase|Lack of Efficacy|26|||
155134816|NCT01618695|559925020|FG003|Extension Phase|Lack of Efficacy|24|||
155134817|NCT01618695|559925017|FG000|Extension Phase|Pregnancy|2|||
155134818|NCT01618695|559925018|FG001|Extension Phase|Pregnancy|0|||
155134819|NCT01618695|559925019|FG002|Extension Phase|Pregnancy|1|||
155134820|NCT01618695|559925020|FG003|Extension Phase|Pregnancy|1|||
155134821|NCT01618695|559925017|FG000|Extension Phase|Withdrawal by Subject|43|||
155134822|NCT01618695|559925018|FG001|Extension Phase|Withdrawal by Subject|48|||
155134823|NCT01618695|559925019|FG002|Extension Phase|Withdrawal by Subject|42|||
155134824|NCT01618695|559925020|FG003|Extension Phase|Withdrawal by Subject|33|||
155134825|NCT01618695|559925017|FG000|Extension Phase|Adverse Event|18|||
155134826|NCT01618695|559925018|FG001|Extension Phase|Adverse Event|16|||
155134827|NCT01618695|559925019|FG002|Extension Phase|Adverse Event|9|||
155134828|NCT01618695|559925020|FG003|Extension Phase|Adverse Event|20|||
155134829|NCT01618695|559925017|FG000|Extension Phase|Lost to Follow-up|2|||
155134830|NCT01618695|559925018|FG001|Extension Phase|Lost to Follow-up|1|||
155134831|NCT01618695|559925019|FG002|Extension Phase|Lost to Follow-up|1|||
155134832|NCT01618695|559925020|FG003|Extension Phase|Lost to Follow-up|1|||
155134833|NCT01618695|559925017|FG000|Extension Phase|Other than specified|13|||
155134834|NCT01618695|559925018|FG001|Extension Phase|Other than specified|18|||
155134835|NCT01618695|559925019|FG002|Extension Phase|Other than specified|13|||
155134836|NCT01618695|559925020|FG003|Extension Phase|Other than specified|18|||
155134837|NCT02950480|559925030|FG000|Overall Study|Withdrawal by Subject|1|||
155134838|NCT02950480|559925031|FG001|Overall Study|Withdrawal by Subject|0|||
155134839|NCT01504841|559925034|FG000|Overall Study|Withdrawal by Subject|1|||
155134840|NCT01504841|559925035|FG001|Overall Study|Withdrawal by Subject|1|||
155134841|NCT01504841|559925036|FG002|Overall Study|Withdrawal by Subject|0|||
155134842|NCT04440813|559925041|FG000|Overall Study|Lost to Follow-up|5|||
155134843|NCT04440813|559925042|FG001|Overall Study|Lost to Follow-up|5|||
155134844|NCT02255461|559925043|FG000|Overall Study|Adverse Event|0|||
155134845|NCT02255461|559925044|FG001|Overall Study|Adverse Event|1|||
155134846|NCT02255461|559925045|FG002|Overall Study|Adverse Event|0|||
155134847|NCT02255461|559925046|FG003|Overall Study|Adverse Event|0|||
155134848|NCT02255461|559925047|FG004|Overall Study|Adverse Event|1|||
155134849|NCT02255461|559925043|FG000|Overall Study|Withdrawal by Subject|0|||
155134850|NCT02255461|559925044|FG001|Overall Study|Withdrawal by Subject|0|||
155134851|NCT02255461|559925045|FG002|Overall Study|Withdrawal by Subject|1|||
155134852|NCT02255461|559925046|FG003|Overall Study|Withdrawal by Subject|0|||
155134853|NCT02255461|559925047|FG004|Overall Study|Withdrawal by Subject|1|||
155134854|NCT02255461|559925043|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
155134855|NCT02255461|559925044|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
155134856|NCT02255461|559925045|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
155134857|NCT02255461|559925046|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
155134858|NCT02255461|559925047|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
155134859|NCT01440816|559925058|FG000|Overall Study|Disease Progression|0|||
155134860|NCT01440816|559925059|FG001|Overall Study|Disease Progression|9|||
155134861|NCT01440816|559925058|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
155134862|NCT01440816|559925059|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
155134863|NCT01832155|559925060|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
155134864|NCT01832155|559925061|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
155134865|NCT01832155|559925060|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
155134866|NCT01832155|559925061|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
155134867|NCT00847886|559925062|FG000|Overall Study|Adverse Event|0|||
155134868|NCT00847886|559925063|FG001|Overall Study|Adverse Event|1|||
155134869|NCT02462720|559925064|FG000|Part 2|Withdrawal by Subject|1|||
155134870|NCT02462720|559925065|FG001|Part 2|Withdrawal by Subject|0|||
155134871|NCT02462720|559925064|FG000|Part 2|Protocol Violation|0|||
155134872|NCT02462720|559925065|FG001|Part 2|Protocol Violation|1|||
155134873|NCT03250182|559925066|FG000|Overall Study|Withdrawal by Subject|1|||
155134874|NCT01858740|559925067|FG000|Overall Study|Death|4|||
155134875|NCT01068769|559925068|FG000|Overall Study|Ineligible|1|||
155134876|NCT04776317|559925071|FG000|Overall Study|Physician Decision|0|||
155134877|NCT04776317|559925072|FG001|Overall Study|Physician Decision|1|||
155134878|NCT04776317|559925073|FG002|Overall Study|Physician Decision|0|||
155134879|NCT04776317|559925074|FG003|Overall Study|Physician Decision|0|||
155134880|NCT04776317|559925075|FG004|Overall Study|Physician Decision|0|||
155134881|NCT04776317|559925076|FG005|Overall Study|Physician Decision|0|||
155134882|NCT04776317|559925077|FG006|Overall Study|Physician Decision|0|||
155134883|NCT04776317|559925078|FG007|Overall Study|Physician Decision|0|||
155134884|NCT04776317|559925079|FG008|Overall Study|Physician Decision|0|||
155134885|NCT04776317|559925080|FG009|Overall Study|Physician Decision|0|||
155134886|NCT04776317|559925081|FG010|Overall Study|Physician Decision|0|||
155134887|NCT04776317|559925082|FG011|Overall Study|Physician Decision|0|||
155134888|NCT04776317|559925083|FG012|Overall Study|Physician Decision|0|||
155134889|NCT04776317|559925084|FG013|Overall Study|Physician Decision|0|||
155134890|NCT04776317|559925085|FG014|Overall Study|Physician Decision|0|||
155014424|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014425|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014426|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014427|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155014428|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155014429|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014430|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014431|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014432|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
155014433|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155014434|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
155014435|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
155014436|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
155014437|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155134891|NCT04776317|559925071|FG000|Overall Study|Protocol Violation|0|||
155134892|NCT04776317|559925072|FG001|Overall Study|Protocol Violation|0|||
155134893|NCT04776317|559925073|FG002|Overall Study|Protocol Violation|1|||
155134894|NCT04776317|559925074|FG003|Overall Study|Protocol Violation|0|||
155134895|NCT04776317|559925075|FG004|Overall Study|Protocol Violation|0|||
155134896|NCT04776317|559925076|FG005|Overall Study|Protocol Violation|0|||
155134897|NCT04776317|559925077|FG006|Overall Study|Protocol Violation|0|||
155134898|NCT04776317|559925078|FG007|Overall Study|Protocol Violation|0|||
155134899|NCT04776317|559925079|FG008|Overall Study|Protocol Violation|0|||
155134900|NCT04776317|559925080|FG009|Overall Study|Protocol Violation|0|||
155134901|NCT04776317|559925081|FG010|Overall Study|Protocol Violation|0|||
155134902|NCT04776317|559925082|FG011|Overall Study|Protocol Violation|0|||
155134903|NCT04776317|559925083|FG012|Overall Study|Protocol Violation|0|||
155134904|NCT04776317|559925084|FG013|Overall Study|Protocol Violation|0|||
155134905|NCT04776317|559925085|FG014|Overall Study|Protocol Violation|0|||
155134906|NCT04776317|559925071|FG000|Overall Study|Withdrawal by Subject|0|||
155134907|NCT04776317|559925072|FG001|Overall Study|Withdrawal by Subject|0|||
155134908|NCT04776317|559925073|FG002|Overall Study|Withdrawal by Subject|0|||
155134909|NCT04776317|559925074|FG003|Overall Study|Withdrawal by Subject|0|||
155134910|NCT04776317|559925075|FG004|Overall Study|Withdrawal by Subject|1|||
155134911|NCT04776317|559925076|FG005|Overall Study|Withdrawal by Subject|0|||
155134912|NCT04776317|559925077|FG006|Overall Study|Withdrawal by Subject|0|||
155134913|NCT04776317|559925078|FG007|Overall Study|Withdrawal by Subject|0|||
155134914|NCT04776317|559925079|FG008|Overall Study|Withdrawal by Subject|0|||
155134915|NCT04776317|559925080|FG009|Overall Study|Withdrawal by Subject|0|||
155134916|NCT04776317|559925081|FG010|Overall Study|Withdrawal by Subject|0|||
155134917|NCT04776317|559925082|FG011|Overall Study|Withdrawal by Subject|0|||
155134918|NCT04776317|559925083|FG012|Overall Study|Withdrawal by Subject|0|||
155134919|NCT04776317|559925084|FG013|Overall Study|Withdrawal by Subject|0|||
155134920|NCT04776317|559925085|FG014|Overall Study|Withdrawal by Subject|0|||
155134921|NCT01067144|559925087|FG000|Treatment|Did not receive allocated intervention|4|||
155134922|NCT01067144|559925088|FG001|Treatment|Did not receive allocated intervention|7|||
155134923|NCT01067144|559925087|FG000|Follow-up|Lost to Follow-up|22|||
155134924|NCT01067144|559925088|FG001|Follow-up|Lost to Follow-up|12|||
155134925|NCT01067144|559925087|FG000|Follow-up|Censored owing to second surgery|19|||
155134926|NCT01067144|559925088|FG001|Follow-up|Censored owing to second surgery|28|||
155134927|NCT01067144|559925087|FG000|Follow-up|Withdrawal by Subject|18|||
155134928|NCT01067144|559925088|FG001|Follow-up|Withdrawal by Subject|14|||
155134929|NCT01067144|559925087|FG000|Follow-up|Surgery cancelled|0|||
155134930|NCT01067144|559925088|FG001|Follow-up|Surgery cancelled|1|||
155134931|NCT01067144|559925087|FG000|Follow-up|Death|0|||
155134932|NCT01067144|559925088|FG001|Follow-up|Death|1|||
155134933|NCT01843062|559925091|FG000|Overall Study|Protocol Violation|1|||
155134934|NCT01843062|559925092|FG001|Overall Study|Protocol Violation|0|||
155134935|NCT01843062|559925091|FG000|Overall Study|New treatment following progression|2|||
155134936|NCT01843062|559925092|FG001|Overall Study|New treatment following progression|0|||
155134937|NCT01843062|559925091|FG000|Overall Study|Pregnancy|1|||
155134938|NCT01843062|559925092|FG001|Overall Study|Pregnancy|0|||
155134939|NCT01843062|559925091|FG000|Overall Study|Adverse Event|2|||
155134940|NCT01843062|559925092|FG001|Overall Study|Adverse Event|0|||
155178643|NCT01993836|560093337|FG001|Overall Study|Death|2|||
155178644|NCT01993836|560093338|FG002|Overall Study|Death|0|||
155134941|NCT01843062|559925091|FG000|Overall Study|Incorrect randomisation|1|||
155134942|NCT01843062|559925092|FG001|Overall Study|Incorrect randomisation|0|||
155134943|NCT01843062|559925091|FG000|Overall Study|Withdrawal by Subject|12|||
155134944|NCT01843062|559925092|FG001|Overall Study|Withdrawal by Subject|3|||
155134945|NCT01843062|559925091|FG000|Overall Study|Death|1|||
155134946|NCT01843062|559925092|FG001|Overall Study|Death|2|||
155134947|NCT01843062|559925091|FG000|Overall Study|Lost to Follow-up|2|||
155134948|NCT01843062|559925092|FG001|Overall Study|Lost to Follow-up|4|||
155134949|NCT03194646|559925100|FG000|Overall Study|Adverse Event|24|||
155014438|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014439|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014440|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014441|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014442|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
155014443|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014444|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014445|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014446|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014447|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
155014448|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014449|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014450|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
155014451|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
155014452|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014453|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014454|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014455|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014456|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014457|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014458|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014459|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155014460|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155014461|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014462|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155014463|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
155014464|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
155014465|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014466|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
155014467|NCT03334435|559478977|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014468|NCT03334435|559478978|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014469|NCT03334435|559478979|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014470|NCT03334435|559478980|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014471|NCT03334435|559478981|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014472|NCT03334435|559478982|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014473|NCT03334435|559478983|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014474|NCT03334435|559478984|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014475|NCT03334435|559478985|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014476|NCT03334435|559478986|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014477|NCT03334435|559478987|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014478|NCT03334435|559478988|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
155014479|NCT03334435|559478989|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
155014480|NCT03334435|559478990|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
155014481|NCT03334435|559478991|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
155014482|NCT03922321|559478992|FG000|Overall Study|Participant Moved|1|||
155014483|NCT03922321|559478992|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
155014484|NCT02342678|559478996|FG000|Overall Study|Lost to Follow-up|0|||
155014485|NCT02342678|559478997|FG001|Overall Study|Lost to Follow-up|1|||
155014486|NCT02342678|559478996|FG000|Overall Study|Too busy to complete study|0|||
155014487|NCT02342678|559478997|FG001|Overall Study|Too busy to complete study|2|||
155014488|NCT02342678|559478996|FG000|Overall Study|Family illness/emergency|0|||
155014489|NCT02342678|559478997|FG001|Overall Study|Family illness/emergency|1|||
155014490|NCT02342678|559478996|FG000|Overall Study|Illness/medical reason|1|||
155014491|NCT02342678|559478997|FG001|Overall Study|Illness/medical reason|1|||
155014492|NCT03214224|559479002|FG000|Overall Study|Protocol Violation|1|||
155014493|NCT03214224|559479002|FG000|Overall Study|Withdrawal by Subject|2|||
155014494|NCT03214224|559479002|FG000|Overall Study|Practice controls or therapists|6|||
155014495|NCT03802825|559479003|FG000|Overall Study|Lost to follow-up for intervention|12|||
155014496|NCT03802825|559479004|FG001|Overall Study|Lost to follow-up for intervention|3|||
155014497|NCT03802825|559479003|FG000|Overall Study|Received only 1 component of intervention|0|||
155014498|NCT03802825|559479004|FG001|Overall Study|Received only 1 component of intervention|13|||
155014499|NCT01051960|559479008|FG000|Overall Study|Adverse Event|1|||
155014500|NCT00360282|559479009|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
155014501|NCT00360282|559479010|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
155014502|NCT00360282|559479011|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
155014503|NCT00360282|559479012|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
155014504|NCT00360282|559479009|FG000|Second Intervention|Adverse Event|0|||
155134950|NCT03194646|559925101|FG001|Overall Study|Adverse Event|25|||
155134951|NCT03194646|559925102|FG002|Overall Study|Adverse Event|14|||
155134952|NCT03194646|559925103|FG003|Overall Study|Adverse Event|17|||
155134953|NCT03194646|559925100|FG000|Overall Study|Lack of Efficacy|4|||
155134954|NCT03194646|559925101|FG001|Overall Study|Lack of Efficacy|2|||
155134955|NCT03194646|559925102|FG002|Overall Study|Lack of Efficacy|2|||
155134956|NCT03194646|559925103|FG003|Overall Study|Lack of Efficacy|12|||
155134957|NCT03194646|559925100|FG000|Overall Study|Lost to Follow-up|30|||
155134958|NCT03194646|559925101|FG001|Overall Study|Lost to Follow-up|22|||
155134959|NCT03194646|559925102|FG002|Overall Study|Lost to Follow-up|12|||
155134960|NCT03194646|559925103|FG003|Overall Study|Lost to Follow-up|35|||
155134961|NCT03194646|559925100|FG000|Overall Study|Non-compliance with study drug|4|||
155134962|NCT03194646|559925101|FG001|Overall Study|Non-compliance with study drug|0|||
155134963|NCT03194646|559925102|FG002|Overall Study|Non-compliance with study drug|1|||
155134964|NCT03194646|559925103|FG003|Overall Study|Non-compliance with study drug|1|||
155134965|NCT03194646|559925100|FG000|Overall Study|Other|89|||
155134966|NCT03194646|559925101|FG001|Overall Study|Other|68|||
155134967|NCT03194646|559925102|FG002|Overall Study|Other|34|||
155134968|NCT03194646|559925103|FG003|Overall Study|Other|31|||
155134969|NCT03194646|559925100|FG000|Overall Study|Physician Decision|7|||
155134970|NCT03194646|559925101|FG001|Overall Study|Physician Decision|9|||
155134971|NCT03194646|559925102|FG002|Overall Study|Physician Decision|5|||
155134972|NCT03194646|559925103|FG003|Overall Study|Physician Decision|4|||
155134973|NCT03194646|559925100|FG000|Overall Study|Pregnancy|4|||
155134974|NCT03194646|559925101|FG001|Overall Study|Pregnancy|5|||
155134975|NCT03194646|559925102|FG002|Overall Study|Pregnancy|1|||
155134976|NCT03194646|559925103|FG003|Overall Study|Pregnancy|2|||
155134977|NCT03194646|559925100|FG000|Overall Study|Protocol Violation|4|||
155134978|NCT03194646|559925101|FG001|Overall Study|Protocol Violation|2|||
155134979|NCT03194646|559925102|FG002|Overall Study|Protocol Violation|1|||
155134980|NCT03194646|559925103|FG003|Overall Study|Protocol Violation|1|||
155134981|NCT03194646|559925100|FG000|Overall Study|Site terminated by sponsor|0|||
155134982|NCT03194646|559925101|FG001|Overall Study|Site terminated by sponsor|0|||
155134983|NCT03194646|559925102|FG002|Overall Study|Site terminated by sponsor|2|||
155134984|NCT03194646|559925103|FG003|Overall Study|Site terminated by sponsor|0|||
155134985|NCT03194646|559925100|FG000|Overall Study|Study terminated by sponsor|62|||
155134986|NCT03194646|559925101|FG001|Overall Study|Study terminated by sponsor|61|||
155134987|NCT03194646|559925102|FG002|Overall Study|Study terminated by sponsor|30|||
155134988|NCT03194646|559925103|FG003|Overall Study|Study terminated by sponsor|34|||
155134989|NCT03194646|559925100|FG000|Overall Study|Withdrawal by Subject|75|||
155134990|NCT03194646|559925101|FG001|Overall Study|Withdrawal by Subject|74|||
155134991|NCT03194646|559925102|FG002|Overall Study|Withdrawal by Subject|36|||
155134992|NCT03194646|559925103|FG003|Overall Study|Withdrawal by Subject|131|||
155134993|NCT03194646|559925100|FG000|Overall Study|Missing|1|||
155134994|NCT03194646|559925101|FG001|Overall Study|Missing|0|||
155134995|NCT03194646|559925102|FG002|Overall Study|Missing|1|||
155134996|NCT03194646|559925103|FG003|Overall Study|Missing|12|||
155134997|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
155134998|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
155134999|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
155135000|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
155135001|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Death|2|||
155135002|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Death|2|||
155135003|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Death|0|||
155135004|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Death|0|||
155135005|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
155135006|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
155135007|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
155135008|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
155135009|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
155135010|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
155135011|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
155135012|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
155135013|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
155135014|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
155135015|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
155135016|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
155135017|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
155135018|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
155135019|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
155135020|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
155135021|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
155135022|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
155135023|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
155135024|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
155135025|NCT03068754|559925108|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
155135026|NCT03068754|559925109|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
155135027|NCT03068754|559925110|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
155135028|NCT03068754|559925111|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
155135029|NCT03068754|559925108|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
155135030|NCT03068754|559925109|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
155135031|NCT03068754|559925110|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
155135032|NCT03068754|559925111|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
155135033|NCT03068754|559925108|FG000|Open Label Extension Period (OLE)|Death|0|||
155135034|NCT03068754|559925109|FG001|Open Label Extension Period (OLE)|Death|0|||
155135035|NCT03068754|559925110|FG002|Open Label Extension Period (OLE)|Death|0|||
155135036|NCT03068754|559925111|FG003|Open Label Extension Period (OLE)|Death|1|||
155135037|NCT03068754|559925108|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
155135038|NCT03068754|559925109|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
155135039|NCT03068754|559925110|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
155135040|NCT03068754|559925111|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
155135041|NCT03068754|559925108|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
155135042|NCT03068754|559925109|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
155135043|NCT03068754|559925110|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
155135044|NCT03068754|559925111|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
155135045|NCT03068754|559925108|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
155135046|NCT03068754|559925109|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
155135047|NCT03068754|559925110|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
155135048|NCT03068754|559925111|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
155135049|NCT03068754|559925108|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
155135050|NCT03068754|559925109|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
155135051|NCT03068754|559925110|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
155135052|NCT03068754|559925111|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
155135053|NCT01361178|559925115|FG000|Overall Study|Death|13|||
155135054|NCT01361178|559925116|FG001|Overall Study|Death|0|||
155135055|NCT02726022|559925121|FG000|Overall Study|Adverse Event|14|||
155135056|NCT02726022|559925121|FG000|Overall Study|Treatment Failure|8|||
155135057|NCT02726022|559925121|FG000|Overall Study|Poor Compliance|13|||
155135058|NCT02726022|559925121|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
155135059|NCT00781859|559925126|FG000|Overall Study|Adverse Event|2|||
155135060|NCT00781859|559925127|FG001|Overall Study|Adverse Event|2|||
155135061|NCT00781859|559925126|FG000|Overall Study|Withdrawal by Subject|8|||
155135062|NCT00781859|559925127|FG001|Overall Study|Withdrawal by Subject|4|||
155135063|NCT00781859|559925126|FG000|Overall Study|Lost to Follow-up|6|||
155135064|NCT00781859|559925127|FG001|Overall Study|Lost to Follow-up|3|||
155135065|NCT00781859|559925126|FG000|Overall Study|Death|3|||
155135066|NCT00781859|559925127|FG001|Overall Study|Death|0|||
155135067|NCT01339897|559925128|FG000|Overall Study|Adverse Event|1|||
155135068|NCT01339897|559925129|FG001|Overall Study|Adverse Event|0|||
155135069|NCT01339897|559925130|FG002|Overall Study|Adverse Event|0|||
155135070|NCT01339897|559925131|FG003|Overall Study|Adverse Event|1|||
155135071|NCT01990859|559925132|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
155135072|NCT01990859|559925132|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
155135073|NCT00622388|559925135|FG000|Overall Study|Disease Progression|47|||
155135074|NCT00622388|559925135|FG000|Overall Study|Adverse Event|6|||
155135075|NCT00622388|559925135|FG000|Overall Study|Protocol Violation|3|||
155135076|NCT00622388|559925135|FG000|Overall Study|Participant Refusal|1|||
155135077|NCT00622388|559925135|FG000|Overall Study|Death|3|||
155135078|NCT00622388|559925135|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
155135079|NCT00622388|559925135|FG000|Overall Study|Took Prohibited Medication|2|||
155135080|NCT00622388|559925135|FG000|Overall Study|Withdrew Consent|1|||
155135081|NCT00622388|559925135|FG000|Overall Study|Insurance Expired|1|||
155135082|NCT00348309|559925136|FG000|Overall Study|Adverse Event|56|||
155135083|NCT00348309|559925137|FG001|Overall Study|Adverse Event|28|||
155135084|NCT00348309|559925138|FG002|Overall Study|Adverse Event|63|||
155135085|NCT00348309|559925136|FG000|Overall Study|Lost to Follow-up|6|||
155135086|NCT00348309|559925137|FG001|Overall Study|Lost to Follow-up|7|||
155135087|NCT00348309|559925138|FG002|Overall Study|Lost to Follow-up|4|||
155135088|NCT00348309|559925136|FG000|Overall Study|Protocol Violation|7|||
155135089|NCT00348309|559925137|FG001|Overall Study|Protocol Violation|12|||
155135090|NCT00348309|559925138|FG002|Overall Study|Protocol Violation|7|||
155135091|NCT00348309|559925136|FG000|Overall Study|Withdrawal by Subject|33|||
155135092|NCT00348309|559925137|FG001|Overall Study|Withdrawal by Subject|37|||
155135093|NCT00348309|559925138|FG002|Overall Study|Withdrawal by Subject|40|||
155135094|NCT00348309|559925136|FG000|Overall Study|Non-compliance|8|||
155178645|NCT01993836|560093336|FG000|Overall Study|Withdrawal by Subject|12|||
155135095|NCT00348309|559925137|FG001|Overall Study|Non-compliance|6|||
155135096|NCT00348309|559925138|FG002|Overall Study|Non-compliance|8|||
155135097|NCT00348309|559925136|FG000|Overall Study|Death of caregiver|1|||
155135098|NCT00348309|559925137|FG001|Overall Study|Death of caregiver|0|||
155135099|NCT00348309|559925138|FG002|Overall Study|Death of caregiver|1|||
155135100|NCT00348309|559925136|FG000|Overall Study|Lack of insight, dementia|1|||
155135101|NCT00348309|559925137|FG001|Overall Study|Lack of insight, dementia|0|||
155135102|NCT00348309|559925138|FG002|Overall Study|Lack of insight, dementia|0|||
155135103|NCT00348309|559925136|FG000|Overall Study|Wrong bottle allocated|1|||
155135104|NCT00348309|559925137|FG001|Overall Study|Wrong bottle allocated|0|||
155135105|NCT00348309|559925138|FG002|Overall Study|Wrong bottle allocated|0|||
155135106|NCT00348309|559925136|FG000|Overall Study|Caregiver sick|1|||
155135107|NCT00348309|559925137|FG001|Overall Study|Caregiver sick|0|||
155135108|NCT00348309|559925138|FG002|Overall Study|Caregiver sick|0|||
155135109|NCT00348309|559925136|FG000|Overall Study|Use of prohibited medication|5|||
155135110|NCT00348309|559925137|FG001|Overall Study|Use of prohibited medication|2|||
155135111|NCT00348309|559925138|FG002|Overall Study|Use of prohibited medication|2|||
155135112|NCT00348309|559925136|FG000|Overall Study|Caregiver withdrawal|3|||
155135113|NCT00348309|559925137|FG001|Overall Study|Caregiver withdrawal|0|||
155135114|NCT00348309|559925138|FG002|Overall Study|Caregiver withdrawal|7|||
155135115|NCT00348309|559925136|FG000|Overall Study|Unable to complete ET visit|1|||
155135116|NCT00348309|559925137|FG001|Overall Study|Unable to complete ET visit|0|||
155135117|NCT00348309|559925138|FG002|Overall Study|Unable to complete ET visit|0|||
155135118|NCT00348309|559925136|FG000|Overall Study|PI closing medical practice|1|||
155135119|NCT00348309|559925137|FG001|Overall Study|PI closing medical practice|0|||
155135120|NCT00348309|559925138|FG002|Overall Study|PI closing medical practice|0|||
155135121|NCT00348309|559925136|FG000|Overall Study|Principal investigator's decision|1|||
155135122|NCT00348309|559925137|FG001|Overall Study|Principal investigator's decision|0|||
155135123|NCT00348309|559925138|FG002|Overall Study|Principal investigator's decision|0|||
155135124|NCT00348309|559925136|FG000|Overall Study|No disponibility of medication|1|||
155135125|NCT00348309|559925137|FG001|Overall Study|No disponibility of medication|0|||
155135126|NCT00348309|559925138|FG002|Overall Study|No disponibility of medication|0|||
155014505|NCT00360282|559479010|FG001|Second Intervention|Adverse Event|1|||
155014506|NCT00360282|559479011|FG002|Second Intervention|Adverse Event|0|||
155014507|NCT00360282|559479012|FG003|Second Intervention|Adverse Event|0|||
155014508|NCT04537078|559479015|FG000|Overall Study|Protocol Violation|3|||
155014509|NCT04537078|559479016|FG001|Overall Study|Protocol Violation|2|||
155014510|NCT04537078|559479015|FG000|Overall Study|Lost to Follow-up|1|||
155014511|NCT04537078|559479016|FG001|Overall Study|Lost to Follow-up|0|||
155014512|NCT04537078|559479015|FG000|Overall Study|Withdrawal by Subject|0|||
155014513|NCT04537078|559479016|FG001|Overall Study|Withdrawal by Subject|1|||
155014514|NCT00444535|559479020|FG000|Overall Study|Withdrawal by Subject|5|||
155014515|NCT00444535|559479020|FG000|Overall Study|Physician Decision|5|||
155014516|NCT00444535|559479020|FG000|Overall Study|progressive disease|1|||
155014517|NCT00444535|559479020|FG000|Overall Study|Adverse Event|2|||
155014518|NCT01704495|559479022|FG000|Subjects Randomized|Other Reason|3|||
155014519|NCT01704495|559479023|FG001|Subjects Randomized|Other Reason|2|||
155014520|NCT01704495|559479024|FG002|Subjects Randomized|Other Reason|3|||
155014521|NCT01704495|559479025|FG003|Subjects Randomized|Other Reason|2|||
155014522|NCT01704495|559479022|FG000|Subjects Randomized|Discontinuation criteria met|4|||
155014523|NCT01704495|559479023|FG001|Subjects Randomized|Discontinuation criteria met|2|||
155014524|NCT01704495|559479024|FG002|Subjects Randomized|Discontinuation criteria met|2|||
155014525|NCT01704495|559479025|FG003|Subjects Randomized|Discontinuation criteria met|0|||
155014526|NCT01704495|559479022|FG000|Subjects Randomized|Adverse Event|8|||
155014527|NCT01704495|559479023|FG001|Subjects Randomized|Adverse Event|2|||
155014528|NCT01704495|559479024|FG002|Subjects Randomized|Adverse Event|0|||
155014529|NCT01704495|559479025|FG003|Subjects Randomized|Adverse Event|7|||
155014530|NCT01704495|559479022|FG000|Subjects Randomized|Withdrawal by Subject|5|||
155014531|NCT01704495|559479023|FG001|Subjects Randomized|Withdrawal by Subject|5|||
155014532|NCT01704495|559479024|FG002|Subjects Randomized|Withdrawal by Subject|5|||
155014533|NCT01704495|559479025|FG003|Subjects Randomized|Withdrawal by Subject|5|||
155014534|NCT01704495|559479022|FG000|Subjects Randomized|Protocol Violation|1|||
155014535|NCT01704495|559479023|FG001|Subjects Randomized|Protocol Violation|1|||
155014536|NCT01704495|559479024|FG002|Subjects Randomized|Protocol Violation|2|||
155014537|NCT01704495|559479025|FG003|Subjects Randomized|Protocol Violation|0|||
155014538|NCT01704495|559479022|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
155014539|NCT01704495|559479023|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
155014540|NCT01704495|559479024|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
155014541|NCT01704495|559479025|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
155014542|NCT01704495|559479022|FG000|Optional Safety Extension|Adverse Event|0|||
155014543|NCT01704495|559479023|FG001|Optional Safety Extension|Adverse Event|4|||
155014544|NCT01704495|559479024|FG002|Optional Safety Extension|Adverse Event|0|||
155135127|NCT00348309|559925136|FG000|Overall Study|Worsened neurodegenerative disease|1|||
155135128|NCT00348309|559925137|FG001|Overall Study|Worsened neurodegenerative disease|0|||
155135129|NCT00348309|559925138|FG002|Overall Study|Worsened neurodegenerative disease|0|||
155135130|NCT00348309|559925136|FG000|Overall Study|Cognitive and behaviour worsening|2|||
155135131|NCT00348309|559925137|FG001|Overall Study|Cognitive and behaviour worsening|0|||
155135132|NCT00348309|559925138|FG002|Overall Study|Cognitive and behaviour worsening|0|||
155014545|NCT01704495|559479025|FG003|Optional Safety Extension|Adverse Event|1|||
155014546|NCT01704495|559479022|FG000|Optional Safety Extension|Other reason|27|||
155014547|NCT01704495|559479023|FG001|Optional Safety Extension|Other reason|29|||
155014548|NCT01704495|559479024|FG002|Optional Safety Extension|Other reason|30|||
155014549|NCT01704495|559479025|FG003|Optional Safety Extension|Other reason|28|||
155014550|NCT01704495|559479022|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
155014551|NCT01704495|559479023|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
155014552|NCT01704495|559479024|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
155014553|NCT01704495|559479025|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
155014554|NCT01346059|559479031|FG000|Overall Study|Withdrawal by Subject|1|||
155014555|NCT01346059|559479032|FG001|Overall Study|Withdrawal by Subject|0|||
155014556|NCT02025725|559479033|FG000|Overall Study|Adverse Event|5|||
155014557|NCT02025725|559479034|FG001|Overall Study|Adverse Event|0|||
155014558|NCT02025725|559479033|FG000|Overall Study|Lost to Follow-up|2|||
155014559|NCT02025725|559479034|FG001|Overall Study|Lost to Follow-up|0|||
155014560|NCT02025725|559479033|FG000|Overall Study|Protocol Violation|1|||
155014561|NCT02025725|559479034|FG001|Overall Study|Protocol Violation|1|||
155014562|NCT02025725|559479033|FG000|Overall Study|Withdrawal by Subject|3|||
155014563|NCT02025725|559479034|FG001|Overall Study|Withdrawal by Subject|2|||
155014564|NCT02025725|559479033|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
155014565|NCT02025725|559479034|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
155014566|NCT00380874|559479040|FG000|Overall Study|Adverse Event|7|||
155014567|NCT00380874|559479041|FG001|Overall Study|Adverse Event|7|||
155014568|NCT00380874|559479040|FG000|Overall Study|Death|1|||
155014569|NCT00380874|559479041|FG001|Overall Study|Death|0|||
155014570|NCT00380874|559479040|FG000|Overall Study|Withdrawal by Subject|2|||
155014571|NCT00380874|559479041|FG001|Overall Study|Withdrawal by Subject|1|||
155014572|NCT00380874|559479040|FG000|Overall Study|Not related to study drug|3|||
155014573|NCT00380874|559479041|FG001|Overall Study|Not related to study drug|2|||
155014574|NCT03839628|559479042|FG000|Overall Study|Withdrawal by Subject|1|||
155014575|NCT02314026|559479043|FG000|Overall Study|Protocol Violation|28|||
155014576|NCT01139775|559479044|FG000|Overall Study|Adverse Event|0|||
155014577|NCT01139775|559479045|FG001|Overall Study|Adverse Event|6|||
155014578|NCT01139775|559479046|FG002|Overall Study|Adverse Event|2|||
155014579|NCT01139775|559479044|FG000|Overall Study|Protocol Violation|0|||
155014580|NCT01139775|559479045|FG001|Overall Study|Protocol Violation|5|||
155014581|NCT01139775|559479046|FG002|Overall Study|Protocol Violation|0|||
155014582|NCT01139775|559479044|FG000|Overall Study|Withdrawal by Subject|1|||
155014583|NCT01139775|559479045|FG001|Overall Study|Withdrawal by Subject|0|||
155014584|NCT01139775|559479046|FG002|Overall Study|Withdrawal by Subject|2|||
155014585|NCT01139775|559479044|FG000|Overall Study|Physician Decision|0|||
155014586|NCT01139775|559479045|FG001|Overall Study|Physician Decision|2|||
155014587|NCT01139775|559479046|FG002|Overall Study|Physician Decision|2|||
155014588|NCT00586703|559479047|FG000|Overall Study|Death|12|||
155014589|NCT02946463|559479048|FG000|Primary Evaluation Period|Physician Decision|0|||
155014590|NCT02946463|559479049|FG001|Primary Evaluation Period|Physician Decision|1|||
155014591|NCT02946463|559479050|FG002|Primary Evaluation Period|Physician Decision|0|||
155014592|NCT02946463|559479051|FG003|Primary Evaluation Period|Physician Decision|0|||
155014593|NCT02946463|559479048|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
155014594|NCT02946463|559479049|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
155014595|NCT02946463|559479050|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
155014596|NCT02946463|559479051|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
155014597|NCT02946463|559479048|FG000|Extension Period|Death|4|||
155014598|NCT02946463|559479049|FG001|Extension Period|Death|4|||
155014599|NCT02946463|559479050|FG002|Extension Period|Death|0|||
155014600|NCT02946463|559479051|FG003|Extension Period|Death|0|||
155014601|NCT02946463|559479048|FG000|Extension Period|Withdrawal by Subject|4|||
155014602|NCT02946463|559479049|FG001|Extension Period|Withdrawal by Subject|3|||
155014603|NCT02946463|559479050|FG002|Extension Period|Withdrawal by Subject|0|||
155014604|NCT02946463|559479051|FG003|Extension Period|Withdrawal by Subject|0|||
155014605|NCT02946463|559479048|FG000|Extension Period|Other than specified|2|||
155014606|NCT02946463|559479049|FG001|Extension Period|Other than specified|3|||
155014607|NCT02946463|559479050|FG002|Extension Period|Other than specified|2|||
155014608|NCT02946463|559479051|FG003|Extension Period|Other than specified|0|||
155014609|NCT02946463|559479048|FG000|Extension Period|Physician Decision|1|||
155014610|NCT02946463|559479049|FG001|Extension Period|Physician Decision|4|||
155014611|NCT02946463|559479050|FG002|Extension Period|Physician Decision|0|||
155014612|NCT02946463|559479051|FG003|Extension Period|Physician Decision|0|||
155014613|NCT02946463|559479048|FG000|Extension Period|Pregnancy|3|||
155014614|NCT02946463|559479049|FG001|Extension Period|Pregnancy|1|||
155014615|NCT02946463|559479050|FG002|Extension Period|Pregnancy|0|||
155014616|NCT02946463|559479051|FG003|Extension Period|Pregnancy|0|||
155014617|NCT02946463|559479048|FG000|Extension Period|Adverse Event|1|||
155014618|NCT02946463|559479049|FG001|Extension Period|Adverse Event|2|||
155014619|NCT02946463|559479050|FG002|Extension Period|Adverse Event|0|||
155014620|NCT02946463|559479051|FG003|Extension Period|Adverse Event|0|||
155014621|NCT02946463|559479048|FG000|Extension Period|Lost to Follow-up|1|||
155014622|NCT02946463|559479049|FG001|Extension Period|Lost to Follow-up|0|||
155014623|NCT02946463|559479050|FG002|Extension Period|Lost to Follow-up|0|||
155014624|NCT02946463|559479051|FG003|Extension Period|Lost to Follow-up|0|||
155014625|NCT05271175|559479053|FG000|One Week Follow up|Lost to Follow-up|10|||
155014626|NCT05271175|559479054|FG001|One Week Follow up|Lost to Follow-up|7|||
155014627|NCT05271175|559479055|FG002|One Week Follow up|Lost to Follow-up|5|||
155014628|NCT05271175|559479053|FG000|One Month Follow up|Lost to Follow-up|12|||
155014629|NCT05271175|559479054|FG001|One Month Follow up|Lost to Follow-up|7|||
155014630|NCT05271175|559479055|FG002|One Month Follow up|Lost to Follow-up|9|||
155014631|NCT05271175|559479053|FG000|Six Months Follow up|Lost to Follow-up|8|||
155014632|NCT05271175|559479054|FG001|Six Months Follow up|Lost to Follow-up|2|||
155014633|NCT05271175|559479055|FG002|Six Months Follow up|Lost to Follow-up|2|||
155014634|NCT00682786|559479056|FG000|Overall Study|Withdrawal by Subject|2|||
155014635|NCT00682786|559479057|FG001|Overall Study|Withdrawal by Subject|2|||
155014636|NCT00682786|559479056|FG000|Overall Study|Did not receive irinotecan|0|||
155014637|NCT00682786|559479057|FG001|Overall Study|Did not receive irinotecan|1|||
155014638|NCT00359424|559479058|FG000|Overall Study|Death|99|||
155014639|NCT00359424|559479059|FG001|Overall Study|Death|58|||
155014640|NCT00359424|559479058|FG000|Overall Study|Lost to Follow-up|19|||
155014641|NCT00359424|559479059|FG001|Overall Study|Lost to Follow-up|7|||
155014642|NCT00359424|559479058|FG000|Overall Study|Withdrawal by Subject|10|||
155014643|NCT00359424|559479059|FG001|Overall Study|Withdrawal by Subject|2|||
155014644|NCT00359424|559479058|FG000|Overall Study|follow up not conducted|2|||
155014645|NCT00359424|559479059|FG001|Overall Study|follow up not conducted|0|||
155014646|NCT04762160|559479060|FG000|Overall Study|Study terminated early due to business reasons|5|||
155014647|NCT01831635|559479062|FG000|Overall Study|Withdrawal by Subject|0|||
155014648|NCT01831635|559479063|FG001|Overall Study|Withdrawal by Subject|2|||
155014649|NCT01831635|559479064|FG002|Overall Study|Withdrawal by Subject|0|||
155014650|NCT02859337|559479065|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
155014651|NCT02859337|559479066|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
155014652|NCT02859337|559479067|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
155014653|NCT02859337|559479065|FG000|Overall Study|Withdrawal by Subject|3|||
155014654|NCT02859337|559479066|FG001|Overall Study|Withdrawal by Subject|1|||
155014655|NCT02859337|559479067|FG002|Overall Study|Withdrawal by Subject|0|||
155014656|NCT02859337|559479065|FG000|Overall Study|Lost to Follow-up|1|||
155014657|NCT02859337|559479066|FG001|Overall Study|Lost to Follow-up|0|||
155014658|NCT02859337|559479067|FG002|Overall Study|Lost to Follow-up|0|||
155014659|NCT04146012|559479068|FG000|Overall Study|Study Terminated|30|||
155014660|NCT04146012|559479069|FG001|Overall Study|Study Terminated|15|||
155014661|NCT03817190|559479070|FG000|Overall Study|Early Termination|13|||
155014662|NCT03817190|559479071|FG001|Overall Study|Early Termination|20|||
155014663|NCT03817190|559479070|FG000|Overall Study|Adverse Event|10|||
155014664|NCT03817190|559479071|FG001|Overall Study|Adverse Event|17|||
155014665|NCT03817190|559479070|FG000|Overall Study|Withdrawal by Subject|12|||
155014666|NCT03817190|559479071|FG001|Overall Study|Withdrawal by Subject|8|||
155014667|NCT03817190|559479070|FG000|Overall Study|Lost to Follow-up|11|||
155014668|NCT03817190|559479071|FG001|Overall Study|Lost to Follow-up|7|||
155014669|NCT03817190|559479070|FG000|Overall Study|Lack of Efficacy|7|||
155014670|NCT03817190|559479071|FG001|Overall Study|Lack of Efficacy|5|||
155014671|NCT03817190|559479070|FG000|Overall Study|Investigator Decision|5|||
155014672|NCT03817190|559479071|FG001|Overall Study|Investigator Decision|1|||
155014673|NCT03817190|559479070|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
155014674|NCT03817190|559479071|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
155014675|NCT03817190|559479070|FG000|Overall Study|Lack of Contact|1|||
155014676|NCT03817190|559479071|FG001|Overall Study|Lack of Contact|0|||
155014677|NCT03817190|559479070|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
155014678|NCT03817190|559479071|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
155014679|NCT01546025|559479072|FG000|Overall Study|Lost to Follow-up|0|||
155014680|NCT01546025|559479073|FG001|Overall Study|Lost to Follow-up|1|||
155014681|NCT02729025|559479077|FG000|Overall Study|Sponsor Decision|0|||
155014682|NCT02729025|559479078|FG001|Overall Study|Sponsor Decision|1|||
155014683|NCT05142722|559480436|FG000|Overall Study|Lost to Follow-up|16|||
155014684|NCT05142722|559480437|FG001|Overall Study|Lost to Follow-up|38|||
155014685|NCT05142722|559480436|FG000|Overall Study|Withdrawal by Subject|20|||
155014686|NCT05142722|559480437|FG001|Overall Study|Withdrawal by Subject|27|||
155014687|NCT05142722|559480436|FG000|Overall Study|Death|11|||
155014688|NCT05142722|559480437|FG001|Overall Study|Death|17|||
155135133|NCT00348309|559925136|FG000|Overall Study|Worsening of alzheimer|1|||
155135134|NCT00348309|559925137|FG001|Overall Study|Worsening of alzheimer|0|||
155014689|NCT05142722|559480436|FG000|Overall Study|Physician Decision|0|||
155014690|NCT05142722|559480437|FG001|Overall Study|Physician Decision|1|||
155014691|NCT05142722|559480436|FG000|Overall Study|Participant Moved Away|0|||
155014692|NCT05142722|559480437|FG001|Overall Study|Participant Moved Away|2|||
155014693|NCT05142722|559480436|FG000|Overall Study|Adverse Event|2|||
155014694|NCT05142722|559480437|FG001|Overall Study|Adverse Event|1|||
155135135|NCT00348309|559925138|FG002|Overall Study|Worsening of alzheimer|1|||
155135136|NCT00348309|559925136|FG000|Overall Study|Did not appear in time for Visit 3|1|||
155135137|NCT00348309|559925137|FG001|Overall Study|Did not appear in time for Visit 3|0|||
155135138|NCT00348309|559925138|FG002|Overall Study|Did not appear in time for Visit 3|0|||
155135139|NCT00348309|559925136|FG000|Overall Study|Participant died|2|||
155135140|NCT00348309|559925137|FG001|Overall Study|Participant died|1|||
155135141|NCT00348309|559925138|FG002|Overall Study|Participant died|1|||
155135142|NCT00348309|559925136|FG000|Overall Study|Decision of sponsor|1|||
155135143|NCT00348309|559925137|FG001|Overall Study|Decision of sponsor|0|||
155135144|NCT00348309|559925138|FG002|Overall Study|Decision of sponsor|0|||
155135145|NCT00348309|559925136|FG000|Overall Study|Ineffectiveness of treatment|0|||
155135146|NCT00348309|559925137|FG001|Overall Study|Ineffectiveness of treatment|1|||
155135147|NCT00348309|559925138|FG002|Overall Study|Ineffectiveness of treatment|0|||
155135148|NCT00348309|559925136|FG000|Overall Study|A foul of exclusion criteria|0|||
155135149|NCT00348309|559925137|FG001|Overall Study|A foul of exclusion criteria|1|||
155135150|NCT00348309|559925138|FG002|Overall Study|A foul of exclusion criteria|0|||
155135151|NCT00348309|559925136|FG000|Overall Study|Participant was hospitalized|0|||
155135152|NCT00348309|559925137|FG001|Overall Study|Participant was hospitalized|1|||
155135153|NCT00348309|559925138|FG002|Overall Study|Participant was hospitalized|0|||
155135154|NCT00348309|559925136|FG000|Overall Study|Sponsor refuseal|0|||
155135155|NCT00348309|559925137|FG001|Overall Study|Sponsor refuseal|1|||
155135156|NCT00348309|559925138|FG002|Overall Study|Sponsor refuseal|1|||
155135157|NCT00348309|559925136|FG000|Overall Study|Forgot often medication|0|||
155135158|NCT00348309|559925137|FG001|Overall Study|Forgot often medication|1|||
155135159|NCT00348309|559925138|FG002|Overall Study|Forgot often medication|0|||
155135160|NCT00348309|559925136|FG000|Overall Study|Medical Monitor decision|0|||
155135161|NCT00348309|559925137|FG001|Overall Study|Medical Monitor decision|0|||
155135162|NCT00348309|559925138|FG002|Overall Study|Medical Monitor decision|1|||
155135163|NCT00348309|559925136|FG000|Overall Study|Increased dose of Aricept|0|||
155135164|NCT00348309|559925137|FG001|Overall Study|Increased dose of Aricept|0|||
155135165|NCT00348309|559925138|FG002|Overall Study|Increased dose of Aricept|1|||
155135166|NCT00348309|559925136|FG000|Overall Study|Site closure|0|||
155135167|NCT00348309|559925137|FG001|Overall Study|Site closure|0|||
155135168|NCT00348309|559925138|FG002|Overall Study|Site closure|1|||
155135169|NCT00348309|559925136|FG000|Overall Study|Adverse event not attended|0|||
155135170|NCT00348309|559925137|FG001|Overall Study|Adverse event not attended|0|||
155135171|NCT00348309|559925138|FG002|Overall Study|Adverse event not attended|1|||
155135172|NCT00348309|559925136|FG000|Overall Study|ECG abnormal|0|||
155135173|NCT00348309|559925137|FG001|Overall Study|ECG abnormal|0|||
155135174|NCT00348309|559925138|FG002|Overall Study|ECG abnormal|2|||
155135175|NCT00348309|559925136|FG000|Overall Study|Cardiologist recommendations|0|||
155135176|NCT00348309|559925137|FG001|Overall Study|Cardiologist recommendations|0|||
155135177|NCT00348309|559925138|FG002|Overall Study|Cardiologist recommendations|1|||
155135178|NCT00348309|559925136|FG000|Overall Study|HCV career|0|||
155135179|NCT00348309|559925137|FG001|Overall Study|HCV career|0|||
155135180|NCT00348309|559925138|FG002|Overall Study|HCV career|1|||
155135181|NCT01894243|559925139|FG000|Overall Study|Adverse Event|0|||
155135182|NCT01894243|559925140|FG001|Overall Study|Adverse Event|1|||
155135183|NCT01894243|559925141|FG002|Overall Study|Adverse Event|2|||
155135184|NCT01894243|559925139|FG000|Overall Study|Death|0|||
155135185|NCT01894243|559925140|FG001|Overall Study|Death|0|||
155135186|NCT01894243|559925141|FG002|Overall Study|Death|3|||
155135187|NCT01894243|559925139|FG000|Overall Study|Lack of Efficacy|3|||
155135188|NCT01894243|559925140|FG001|Overall Study|Lack of Efficacy|3|||
155135189|NCT01894243|559925141|FG002|Overall Study|Lack of Efficacy|1|||
155135190|NCT01894243|559925139|FG000|Overall Study|Condition under investigation worsened|8|||
155135191|NCT01894243|559925140|FG001|Overall Study|Condition under investigation worsened|6|||
155135192|NCT01894243|559925141|FG002|Overall Study|Condition under investigation worsened|2|||
155135193|NCT01894243|559925139|FG000|Overall Study|Subject decision|1|||
155135194|NCT01894243|559925140|FG001|Overall Study|Subject decision|0|||
155135195|NCT01894243|559925141|FG002|Overall Study|Subject decision|0|||
155135196|NCT01894243|559925139|FG000|Overall Study|Other|1|||
155014695|NCT05086744|559480438|FG000|Part A|Adverse Event|0|||
155135197|NCT01894243|559925140|FG001|Overall Study|Other|0|||
155135198|NCT01894243|559925141|FG002|Overall Study|Other|0|||
155135199|NCT01743040|559925142|FG000|Overall Study|Death|1|||
155135200|NCT01743040|559925142|FG000|Overall Study|Lost to Follow-up|66|||
155135201|NCT01743040|559925142|FG000|Overall Study|Physician Decision|40|||
155135202|NCT01743040|559925142|FG000|Overall Study|Protocol Violation|1|||
155135203|NCT01743040|559925142|FG000|Overall Study|Withdrawal by Subject|121|||
155135204|NCT04006392|559925143|FG000|Overall Study|Lost to Follow-up|0|||
155135205|NCT04006392|559925144|FG001|Overall Study|Lost to Follow-up|1|||
155135206|NCT01067469|559925145|FG000|Overall Study|Withdrawal by Subject|0|||
155014696|NCT05086744|559480439|FG001|Part A|Adverse Event|1|||
155014697|NCT05086744|559480438|FG000|Part A|Lack of Efficacy|3|||
155135207|NCT01067469|559925146|FG001|Overall Study|Withdrawal by Subject|1|||
155135208|NCT01067469|559925145|FG000|Overall Study|Disease Progression|0|||
155135209|NCT01067469|559925146|FG001|Overall Study|Disease Progression|1|||
155135210|NCT02475278|559927234|FG000|Overall Study|Lost to Follow-up|1|||
155135211|NCT02475278|559927234|FG000|Overall Study|Reason Not Specified|1|||
155135212|NCT04794270|559927235|FG000|Period 1|Non Compliance|1|||
155135213|NCT04794270|559927236|FG001|Period 1|Non Compliance|0|||
155135214|NCT04794270|559927235|FG000|Period 1|Adverse Event|1|||
155135215|NCT04794270|559927236|FG001|Period 1|Adverse Event|0|||
155135216|NCT04794270|559927235|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
155135217|NCT04794270|559927236|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
155135218|NCT01271725|559927237|FG000|Part A|Progressive disease according to RECIST|8|||
155135219|NCT01271725|559927238|FG001|Part A|Progressive disease according to RECIST|0|||
155135220|NCT01271725|559927237|FG000|Part A|Clinical signs/symptoms of progression|2|||
155135221|NCT01271725|559927238|FG001|Part A|Clinical signs/symptoms of progression|0|||
155135222|NCT01271725|559927237|FG000|Part A|Other Adverse Event|8|||
155135223|NCT01271725|559927238|FG001|Part A|Other Adverse Event|0|||
155135224|NCT01271725|559927237|FG000|Part A|Lost to Follow-up|1|||
155135225|NCT01271725|559927238|FG001|Part A|Lost to Follow-up|0|||
155135226|NCT01271725|559927237|FG000|Part A|Withdrawal by Subject|12|||
155135227|NCT01271725|559927238|FG001|Part A|Withdrawal by Subject|0|||
155135228|NCT01271725|559927237|FG000|Part A|Other than specified|3|||
155135229|NCT01271725|559927238|FG001|Part A|Other than specified|0|||
155135230|NCT01271725|559927237|FG000|Part A|Protocol Violation|1|||
155135231|NCT01271725|559927238|FG001|Part A|Protocol Violation|0|||
155135232|NCT01271725|559927237|FG000|Part B|Other than specified|0|||
155135233|NCT01271725|559927238|FG001|Part B|Other than specified|2|||
155135234|NCT01271725|559927237|FG000|Part B|Clinical signs/symptoms of progression|0|||
155135235|NCT01271725|559927238|FG001|Part B|Clinical signs/symptoms of progression|2|||
155135236|NCT01271725|559927237|FG000|Part B|Other Adverse Event|0|||
155135237|NCT01271725|559927238|FG001|Part B|Other Adverse Event|1|||
155135238|NCT01271725|559927237|FG000|Part B|Protocol Violation|0|||
155135239|NCT01271725|559927238|FG001|Part B|Protocol Violation|1|||
155135240|NCT01271725|559927237|FG000|Part B|Withdrawal by Subject|0|||
155135241|NCT01271725|559927238|FG001|Part B|Withdrawal by Subject|6|||
155135242|NCT00801229|559927241|FG000|Signed Consent|Withdrawal by Subject|2|||
155135243|NCT00801229|559927242|FG001|Signed Consent|Withdrawal by Subject|2|||
155135244|NCT00801229|559927241|FG000|Signed Consent|Found Ineligible|1|||
155135245|NCT00801229|559927242|FG001|Signed Consent|Found Ineligible|1|||
155135246|NCT00801229|559927241|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
155135247|NCT00801229|559927242|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
155135248|NCT00801229|559927241|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
155135249|NCT00801229|559927242|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
155135250|NCT00801229|559927241|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
155135251|NCT00801229|559927242|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
155135252|NCT00801229|559927241|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
155135253|NCT00801229|559927242|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
155135254|NCT00801229|559927241|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
155135255|NCT00801229|559927242|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
155135256|NCT00801229|559927241|FG000|Received Study Drug/Placebo|Adverse Event|1|||
155135257|NCT00801229|559927242|FG001|Received Study Drug/Placebo|Adverse Event|1|||
155135258|NCT02300259|559927243|FG000|Period 1|Adverse Event|0|||
155135259|NCT02300259|559927244|FG001|Period 1|Adverse Event|0|||
155135260|NCT02300259|559927245|FG002|Period 1|Adverse Event|1|||
155135261|NCT02300259|559927243|FG000|Period 1|Withdrawal by Subject|0|||
155135262|NCT02300259|559927244|FG001|Period 1|Withdrawal by Subject|0|||
155135263|NCT02300259|559927245|FG002|Period 1|Withdrawal by Subject|1|||
155135264|NCT02300259|559927243|FG000|Period 2|Adverse Event|1|||
155135265|NCT02300259|559927244|FG001|Period 2|Adverse Event|0|||
155135266|NCT02300259|559927245|FG002|Period 2|Adverse Event|0|||
155135267|NCT02300259|559927243|FG000|Period 2|Withdrawal by Subject|0|||
155135268|NCT02300259|559927244|FG001|Period 2|Withdrawal by Subject|0|||
155135269|NCT02300259|559927245|FG002|Period 2|Withdrawal by Subject|1|||
155135270|NCT02510001|559927246|FG000|Overall Study|Early disease progression|0|||
155135271|NCT02510001|559927247|FG001|Overall Study|Early disease progression|0|||
155135272|NCT02510001|559927248|FG002|Overall Study|Early disease progression|0|||
155135273|NCT02510001|559927249|FG003|Overall Study|Early disease progression|1|||
155135274|NCT02510001|559927250|FG004|Overall Study|Early disease progression|1|||
155135275|NCT02510001|559927251|FG005|Overall Study|Early disease progression|1|||
155135276|NCT02510001|559927252|FG006|Overall Study|Early disease progression|0|||
155135277|NCT02510001|559927253|FG007|Overall Study|Early disease progression|0|||
155135278|NCT02510001|559927246|FG000|Overall Study|Adverse Event|0|||
155135279|NCT02510001|559927247|FG001|Overall Study|Adverse Event|0|||
155135280|NCT02510001|559927248|FG002|Overall Study|Adverse Event|0|||
155135281|NCT02510001|559927249|FG003|Overall Study|Adverse Event|1|||
155135282|NCT02510001|559927250|FG004|Overall Study|Adverse Event|2|||
155135283|NCT02510001|559927251|FG005|Overall Study|Adverse Event|1|||
155135284|NCT02510001|559927252|FG006|Overall Study|Adverse Event|2|||
155135285|NCT02510001|559927253|FG007|Overall Study|Adverse Event|5|||
155135286|NCT02510001|559927246|FG000|Overall Study|Physician Decision|0|||
155135287|NCT02510001|559927247|FG001|Overall Study|Physician Decision|0|||
155014698|NCT05086744|559480439|FG001|Part A|Lack of Efficacy|0|||
155014699|NCT05086744|559480438|FG000|Part A|Protocol deviation|1|||
155014700|NCT05086744|559480439|FG001|Part A|Protocol deviation|0|||
155014701|NCT05086744|559480438|FG000|Part A|Subject decision|1|||
155014702|NCT05086744|559480439|FG001|Part A|Subject decision|0|||
155014703|NCT05086744|559480438|FG000|Part B|Adverse Event|0|||
155014704|NCT05086744|559480439|FG001|Part B|Adverse Event|1|||
155014705|NCT05086744|559480438|FG000|Part B|Lack of Efficacy|0|||
155014706|NCT05086744|559480439|FG001|Part B|Lack of Efficacy|1|||
155014707|NCT05086744|559480438|FG000|Part B|Study terminated by sponsor|1|||
155014708|NCT05086744|559480439|FG001|Part B|Study terminated by sponsor|6|||
155014709|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
155014710|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155014711|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
155014712|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155014713|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
155014714|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155014715|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155014716|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
155014717|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155014718|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155014719|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
155014720|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155014721|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155014722|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
155014723|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155014724|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
155014725|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155014726|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155014727|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
155014728|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155014729|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155014730|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
155014731|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
155014732|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
155014733|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155014734|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155014735|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155014736|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155014737|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155014738|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
155014739|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155014740|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
155014741|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014742|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014743|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
155014744|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014745|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014746|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014747|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
155014748|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014749|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155014750|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155014751|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
155014752|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155014753|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155014754|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
155014755|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
155014756|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
155014757|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
155014758|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
155014759|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155014760|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155135288|NCT02510001|559927248|FG002|Overall Study|Physician Decision|0|||
155135289|NCT02510001|559927249|FG003|Overall Study|Physician Decision|0|||
155135290|NCT02510001|559927250|FG004|Overall Study|Physician Decision|1|||
155135291|NCT02510001|559927251|FG005|Overall Study|Physician Decision|0|||
155135292|NCT02510001|559927252|FG006|Overall Study|Physician Decision|0|||
155135293|NCT02510001|559927253|FG007|Overall Study|Physician Decision|0|||
155135294|NCT02510001|559927246|FG000|Overall Study|Withdrawal by Subject|0|||
155135295|NCT02510001|559927247|FG001|Overall Study|Withdrawal by Subject|0|||
155135296|NCT02510001|559927248|FG002|Overall Study|Withdrawal by Subject|0|||
155135297|NCT02510001|559927249|FG003|Overall Study|Withdrawal by Subject|0|||
155135298|NCT02510001|559927250|FG004|Overall Study|Withdrawal by Subject|0|||
155135299|NCT02510001|559927251|FG005|Overall Study|Withdrawal by Subject|0|||
155135300|NCT02510001|559927252|FG006|Overall Study|Withdrawal by Subject|0|||
155135301|NCT02510001|559927253|FG007|Overall Study|Withdrawal by Subject|2|||
155135302|NCT03149055|559927261|FG000|Overall Study|Not treated|4|||
155135303|NCT00291018|559927264|FG000|Overall Study|Not Consented or Declined PAS|12|||
155135304|NCT00291018|559927265|FG001|Overall Study|Not Consented or Declined PAS|15|||
155135305|NCT00291018|559927266|FG002|Overall Study|Not Consented or Declined PAS|15|||
155135306|NCT00291018|559927264|FG000|Overall Study|Death|3|||
155135307|NCT00291018|559927265|FG001|Overall Study|Death|3|||
155135308|NCT00291018|559927266|FG002|Overall Study|Death|4|||
155135309|NCT00291018|559927264|FG000|Overall Study|Withdrawal by Subject|2|||
155135310|NCT00291018|559927265|FG001|Overall Study|Withdrawal by Subject|8|||
155135311|NCT00291018|559927266|FG002|Overall Study|Withdrawal by Subject|1|||
155135312|NCT00291018|559927264|FG000|Overall Study|Failures|5|||
155135313|NCT00291018|559927265|FG001|Overall Study|Failures|12|||
155135314|NCT00291018|559927266|FG002|Overall Study|Failures|5|||
155135315|NCT00291018|559927264|FG000|Overall Study|Lost to Follow-up|3|||
155135316|NCT00291018|559927265|FG001|Overall Study|Lost to Follow-up|4|||
155135317|NCT00291018|559927266|FG002|Overall Study|Lost to Follow-up|18|||
155135318|NCT00630344|559927267|FG000|Overall Study|Adverse Event|5|||
155135319|NCT00630344|559927267|FG000|Overall Study|Progressive Disease|19|||
155135320|NCT00630344|559927267|FG000|Overall Study|Physician Decision|9|||
155135321|NCT00630344|559927267|FG000|Overall Study|Withdrawal by Subject|1|||
155135322|NCT00630344|559927267|FG000|Overall Study|Intercurrent Illness|1|||
155135323|NCT00630344|559927267|FG000|Overall Study|Other|1|||
155135324|NCT01357551|559927268|FG000|Overall Study|Withdrawal by Subject|6|||
155135325|NCT01357551|559927269|FG001|Overall Study|Withdrawal by Subject|4|||
155135326|NCT01357551|559927268|FG000|Overall Study|Death|0|||
155135327|NCT01357551|559927269|FG001|Overall Study|Death|1|||
155135328|NCT01357551|559927268|FG000|Overall Study|Lost to Follow-up|16|||
155135329|NCT01357551|559927269|FG001|Overall Study|Lost to Follow-up|6|||
155135330|NCT03668613|559927272|FG000|Overall Study|Adverse Event|1|||
155135331|NCT03668613|559927273|FG001|Overall Study|Adverse Event|2|||
155135332|NCT03668613|559927272|FG000|Overall Study|Lack of Efficacy|5|||
155135333|NCT03668613|559927273|FG001|Overall Study|Lack of Efficacy|1|||
155135334|NCT03668613|559927272|FG000|Overall Study|Pregnancy|0|||
155135335|NCT03668613|559927273|FG001|Overall Study|Pregnancy|2|||
155135336|NCT03668613|559927272|FG000|Overall Study|Protocol Violation|1|||
155135337|NCT03668613|559927273|FG001|Overall Study|Protocol Violation|0|||
155135338|NCT03668613|559927272|FG000|Overall Study|Physician Decision|1|||
155135339|NCT03668613|559927273|FG001|Overall Study|Physician Decision|0|||
155135340|NCT03668613|559927272|FG000|Overall Study|Withdrawal by Subject|2|||
155135341|NCT03668613|559927273|FG001|Overall Study|Withdrawal by Subject|1|||
155135342|NCT03668613|559927272|FG000|Overall Study|Guardian decision|1|||
155135343|NCT03668613|559927273|FG001|Overall Study|Guardian decision|0|||
155135344|NCT03386487|559927276|FG000|Overall Study|Lost to Follow-up|5|||
155135345|NCT03386487|559927277|FG001|Overall Study|Lost to Follow-up|6|||
155135346|NCT03386487|559927276|FG000|Overall Study|Withdrawal by Subject|11|||
155135347|NCT03386487|559927277|FG001|Overall Study|Withdrawal by Subject|7|||
155135348|NCT03386487|559927276|FG000|Overall Study|Physician Decision|11|||
155135349|NCT03386487|559927277|FG001|Overall Study|Physician Decision|8|||
155135350|NCT00894361|559927278|FG000|Overall Study|deaths and less than 2 years followup|24|||
155135351|NCT00894361|559927279|FG001|Overall Study|deaths and less than 2 years followup|64|||
155135352|NCT00286494|559927280|FG000|Overall Study|Hyperglycemic rescue|12|||
155135353|NCT00286494|559927281|FG001|Overall Study|Hyperglycemic rescue|19|||
155135354|NCT00286494|559927282|FG002|Overall Study|Hyperglycemic rescue|18|||
155135355|NCT00286494|559927280|FG000|Overall Study|Withdrawal by Subject|2|||
155135356|NCT00286494|559927281|FG001|Overall Study|Withdrawal by Subject|10|||
155135357|NCT00286494|559927282|FG002|Overall Study|Withdrawal by Subject|9|||
155135358|NCT00286494|559927280|FG000|Overall Study|Adverse Event|3|||
155135359|NCT00286494|559927281|FG001|Overall Study|Adverse Event|8|||
155135360|NCT00286494|559927282|FG002|Overall Study|Adverse Event|6|||
155135361|NCT00286494|559927280|FG000|Overall Study|Physician Decision|5|||
155135362|NCT00286494|559927281|FG001|Overall Study|Physician Decision|5|||
155135363|NCT00286494|559927282|FG002|Overall Study|Physician Decision|1|||
155178646|NCT01993836|560093337|FG001|Overall Study|Withdrawal by Subject|10|||
155135364|NCT00286494|559927280|FG000|Overall Study|Lost to Follow-up|3|||
155135365|NCT00286494|559927281|FG001|Overall Study|Lost to Follow-up|1|||
155135366|NCT00286494|559927282|FG002|Overall Study|Lost to Follow-up|3|||
155135367|NCT00286494|559927280|FG000|Overall Study|Protocol Violation|1|||
155135368|NCT00286494|559927281|FG001|Overall Study|Protocol Violation|1|||
155135369|NCT00286494|559927282|FG002|Overall Study|Protocol Violation|2|||
155135370|NCT04207060|559927283|FG000|Overall Study|Lost to Follow-up|2|||
155135371|NCT04207060|559927284|FG001|Overall Study|Lost to Follow-up|0|||
155135372|NCT01835158|559927288|FG000|Overall Study|Withdrawal by Subject|1|||
155135373|NCT01835158|559927289|FG001|Overall Study|Withdrawal by Subject|6|||
155135374|NCT00296140|559927290|FG000|Overall Study|Lost to Follow-up|1|||
155135375|NCT00296140|559927291|FG001|Overall Study|Lost to Follow-up|0|||
155135376|NCT00296140|559927290|FG000|Overall Study|Withdrawal by Subject|1|||
155135377|NCT00296140|559927291|FG001|Overall Study|Withdrawal by Subject|0|||
155135378|NCT00296140|559927290|FG000|Overall Study|Discharge to Nursing Home|1|||
155135379|NCT00296140|559927291|FG001|Overall Study|Discharge to Nursing Home|0|||
155135380|NCT00880191|559927298|FG000|Overall Study|Refused further treatment|4|||
155135381|NCT00880191|559927299|FG001|Overall Study|Refused further treatment|1|||
155135382|NCT00880191|559927298|FG000|Overall Study|Adverse Event|8|||
155135383|NCT00880191|559927299|FG001|Overall Study|Adverse Event|6|||
155135384|NCT00880191|559927298|FG000|Overall Study|Hospitalization/efficacy|1|||
155135385|NCT00880191|559927299|FG001|Overall Study|Hospitalization/efficacy|1|||
155135386|NCT00774800|559927303|FG000|Intervention 4|Withdrawal by Subject|1|||
155135387|NCT01919801|559927304|FG000|Overall Study|Withdrawal by Subject|1|||
155135388|NCT01919801|559927305|FG001|Overall Study|Withdrawal by Subject|0|||
155135389|NCT01919801|559927304|FG000|Overall Study|Physician Decision|0|||
155135390|NCT01919801|559927305|FG001|Overall Study|Physician Decision|1|||
155135391|NCT01919801|559927304|FG000|Overall Study|Lost to Follow-up|0|||
155135392|NCT01919801|559927305|FG001|Overall Study|Lost to Follow-up|1|||
155014761|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155014762|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155014763|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155135393|NCT01919801|559927304|FG000|Overall Study|Other|0|||
155135394|NCT01919801|559927305|FG001|Overall Study|Other|1|||
155135395|NCT01677858|559927306|FG000|Overall Study|Adverse Event|0|||
155135396|NCT01677858|559927307|FG001|Overall Study|Adverse Event|0|||
155135397|NCT01677858|559927308|FG002|Overall Study|Adverse Event|2|||
155135398|NCT01677858|559927309|FG003|Overall Study|Adverse Event|3|||
155135399|NCT01677858|559927310|FG004|Overall Study|Adverse Event|13|||
155135400|NCT01677858|559927306|FG000|Overall Study|Death|0|||
155135401|NCT01677858|559927307|FG001|Overall Study|Death|0|||
155135402|NCT01677858|559927308|FG002|Overall Study|Death|0|||
155135403|NCT01677858|559927309|FG003|Overall Study|Death|0|||
155135404|NCT01677858|559927310|FG004|Overall Study|Death|1|||
155135405|NCT01677858|559927306|FG000|Overall Study|Physician Decision|1|||
155135406|NCT01677858|559927307|FG001|Overall Study|Physician Decision|0|||
155135407|NCT01677858|559927308|FG002|Overall Study|Physician Decision|2|||
155135408|NCT01677858|559927309|FG003|Overall Study|Physician Decision|0|||
155135409|NCT01677858|559927310|FG004|Overall Study|Physician Decision|12|||
155135410|NCT01677858|559927306|FG000|Overall Study|Progressive Disease|2|||
155135411|NCT01677858|559927307|FG001|Overall Study|Progressive Disease|1|||
155135412|NCT01677858|559927308|FG002|Overall Study|Progressive Disease|9|||
155135413|NCT01677858|559927309|FG003|Overall Study|Progressive Disease|3|||
155135414|NCT01677858|559927310|FG004|Overall Study|Progressive Disease|43|||
155135415|NCT01677858|559927306|FG000|Overall Study|Withdrawal by Subject|0|||
155135416|NCT01677858|559927307|FG001|Overall Study|Withdrawal by Subject|1|||
155135417|NCT01677858|559927308|FG002|Overall Study|Withdrawal by Subject|1|||
155178647|NCT01993836|560093338|FG002|Overall Study|Withdrawal by Subject|5|||
155178648|NCT00686634|560093339|FG000|Overall Study|Protocol Violation|6|||
155014764|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
155014765|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155014766|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
155014767|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155014768|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155014769|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155014770|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155135418|NCT01677858|559927309|FG003|Overall Study|Withdrawal by Subject|0|||
155135419|NCT01677858|559927310|FG004|Overall Study|Withdrawal by Subject|15|||
155135420|NCT01677858|559927306|FG000|Overall Study|Lost to Follow-up|0|||
155135421|NCT01677858|559927307|FG001|Overall Study|Lost to Follow-up|0|||
155135422|NCT01677858|559927308|FG002|Overall Study|Lost to Follow-up|0|||
155135423|NCT01677858|559927309|FG003|Overall Study|Lost to Follow-up|0|||
155135424|NCT01677858|559927310|FG004|Overall Study|Lost to Follow-up|1|||
155135425|NCT01331109|559927311|FG000|Overall Study|Adverse Event|6|||
155178649|NCT02677324|560093342|FG000|Overall Study|Disease Progression|6|||
155135426|NCT01331109|559927311|FG000|Overall Study|Lack of Efficacy|2|||
155135427|NCT01331109|559927311|FG000|Overall Study|Protocol Violation|3|||
155135428|NCT01331109|559927311|FG000|Overall Study|Withdrawal by Subject|7|||
155135429|NCT01331109|559927311|FG000|Overall Study|Lost to Follow-up|1|||
155135430|NCT01331109|559927311|FG000|Overall Study|Study Terminated by Sponsor|38|||
155135431|NCT00988091|559927312|FG000|Double-blind Period|Withdrawal by Subject|15|||
155135432|NCT00988091|559927313|FG001|Double-blind Period|Withdrawal by Subject|13|||
155135433|NCT00988091|559927312|FG000|Double-blind Period|Lost to Follow-up|12|||
155135434|NCT00988091|559927313|FG001|Double-blind Period|Lost to Follow-up|14|||
155135435|NCT00988091|559927312|FG000|Double-blind Period|Other|8|||
155135436|NCT00988091|559927313|FG001|Double-blind Period|Other|8|||
155135437|NCT00988091|559927312|FG000|Double-blind Period|Adverse Event|6|||
155135438|NCT00988091|559927313|FG001|Double-blind Period|Adverse Event|9|||
155135439|NCT00988091|559927312|FG000|Double-blind Period|Use of exclusionary medication|2|||
155135440|NCT00988091|559927313|FG001|Double-blind Period|Use of exclusionary medication|3|||
155135441|NCT00988091|559927312|FG000|Open-label Period|Adverse Event|4|||
155135442|NCT00988091|559927313|FG001|Open-label Period|Adverse Event|7|||
155135443|NCT00988091|559927312|FG000|Open-label Period|Use of exclusionary medication|1|||
155135444|NCT00988091|559927313|FG001|Open-label Period|Use of exclusionary medication|1|||
155135445|NCT00988091|559927312|FG000|Open-label Period|Protocol Violation|1|||
155135446|NCT00988091|559927313|FG001|Open-label Period|Protocol Violation|1|||
155135447|NCT00988091|559927312|FG000|Open-label Period|Withdrawal by Subject|10|||
155135448|NCT00988091|559927313|FG001|Open-label Period|Withdrawal by Subject|16|||
155135449|NCT00988091|559927312|FG000|Open-label Period|Lost to Follow-up|3|||
155135450|NCT00988091|559927313|FG001|Open-label Period|Lost to Follow-up|5|||
155135451|NCT00988091|559927312|FG000|Open-label Period|Other|2|||
155135452|NCT00988091|559927313|FG001|Open-label Period|Other|3|||
155135453|NCT00773747|559927314|FG000|Overall Study|Lack of Efficacy|112|||
155135454|NCT00773747|559927315|FG001|Overall Study|Lack of Efficacy|144|||
155135455|NCT00773747|559927314|FG000|Overall Study|Physician Decision|26|||
155135456|NCT00773747|559927315|FG001|Overall Study|Physician Decision|18|||
155135457|NCT00773747|559927314|FG000|Overall Study|Lost to Follow-up|0|||
155135458|NCT00773747|559927315|FG001|Overall Study|Lost to Follow-up|1|||
155135459|NCT00773747|559927314|FG000|Overall Study|Protocol Violation|2|||
155135460|NCT00773747|559927315|FG001|Overall Study|Protocol Violation|2|||
155135461|NCT00773747|559927314|FG000|Overall Study|Withdrawal by Subject|89|||
155135462|NCT00773747|559927315|FG001|Overall Study|Withdrawal by Subject|61|||
155135463|NCT00773747|559927314|FG000|Overall Study|Adverse Event|61|||
155135464|NCT00773747|559927315|FG001|Overall Study|Adverse Event|62|||
155135465|NCT00773747|559927314|FG000|Overall Study|Death|5|||
155135466|NCT00773747|559927315|FG001|Overall Study|Death|8|||
155135467|NCT00773747|559927314|FG000|Overall Study|Not Treated|2|||
155135468|NCT00773747|559927315|FG001|Overall Study|Not Treated|0|||
155135469|NCT00994422|559927318|FG000|Overall Study|Lost to Follow-up|7|||
155135470|NCT00994422|559927319|FG001|Overall Study|Lost to Follow-up|1|||
155135471|NCT02669212|559927320|FG000|Overall Study|Lost to Follow-up|1|||
155135472|NCT02669212|559927321|FG001|Overall Study|Lost to Follow-up|0|||
155135473|NCT02669212|559927320|FG000|Overall Study|Medical Condition|3|||
155135474|NCT02669212|559927321|FG001|Overall Study|Medical Condition|4|||
155135475|NCT02669212|559927320|FG000|Overall Study|Withdrawal by Subject|0|||
155135476|NCT02669212|559927321|FG001|Overall Study|Withdrawal by Subject|2|||
155135477|NCT02669212|559927320|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
155135478|NCT02669212|559927321|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
155135479|NCT03549104|559927322|FG000|Overall Study|Withdrawal by Subject|5|||
155135480|NCT03549104|559927323|FG001|Overall Study|Withdrawal by Subject|2|||
155135481|NCT03549104|559927322|FG000|Overall Study|Covid shelter in place|1|||
155135482|NCT03549104|559927323|FG001|Overall Study|Covid shelter in place|2|||
155135483|NCT03078855|559927327|FG000|Overall Study|Lack of Efficacy|62|||
155135484|NCT03078855|559927328|FG001|Overall Study|Lack of Efficacy|31|||
155135485|NCT03078855|559927327|FG000|Overall Study|Death|1|||
155135486|NCT03078855|559927328|FG001|Overall Study|Death|0|||
155135487|NCT03078855|559927327|FG000|Overall Study|Withdrawal by Subject|12|||
155135488|NCT03078855|559927328|FG001|Overall Study|Withdrawal by Subject|6|||
155135489|NCT03078855|559927327|FG000|Overall Study|Physician Decision|3|||
155135490|NCT03078855|559927328|FG001|Overall Study|Physician Decision|2|||
155135491|NCT03078855|559927327|FG000|Overall Study|Second Malignancy|4|||
155135492|NCT03078855|559927328|FG001|Overall Study|Second Malignancy|0|||
155135493|NCT03078855|559927327|FG000|Overall Study|Ineligible|2|||
155135494|NCT03078855|559927328|FG001|Overall Study|Ineligible|0|||
155135495|NCT03078855|559927327|FG000|Overall Study|Withdrew before day 1 treatment|2|||
155135496|NCT03078855|559927328|FG001|Overall Study|Withdrew before day 1 treatment|1|||
155135497|NCT00391027|559927329|FG000|Overall Study|Adverse Event|8|||
155135498|NCT00391027|559927330|FG001|Overall Study|Adverse Event|8|||
155135499|NCT00391027|559927329|FG000|Overall Study|Lack of Efficacy|3|||
155135500|NCT00391027|559927330|FG001|Overall Study|Lack of Efficacy|0|||
155135501|NCT00391027|559927329|FG000|Overall Study|Withdrawal by Subject|10|||
155135502|NCT00391027|559927330|FG001|Overall Study|Withdrawal by Subject|1|||
155135503|NCT00391027|559927329|FG000|Overall Study|Other|4|||
155135504|NCT00391027|559927330|FG001|Overall Study|Other|3|||
155135505|NCT03422536|559927331|FG000|Randomized|Physician Decision|1|||
155135506|NCT03422536|559927332|FG001|Randomized|Physician Decision|1|||
155135507|NCT03422536|559927331|FG000|Allocation - Received Intervention|Disease progression|19|||
155014771|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155014772|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
155014773|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014774|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014775|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014776|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014777|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
155014778|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014779|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014780|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
155014781|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014782|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014783|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014784|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014785|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014786|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
155014787|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014788|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
155014789|NCT03896503|559480440|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155135508|NCT03422536|559927332|FG001|Allocation - Received Intervention|Disease progression|25|||
155014790|NCT03896503|559480441|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155014791|NCT03896503|559480442|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155014792|NCT03896503|559480443|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155014793|NCT03896503|559480444|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155014794|NCT03896503|559480445|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
155014795|NCT03896503|559480446|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
155014796|NCT03896503|559480447|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
155014797|NCT03055338|559480450|FG000|Overall Study|Lost to Follow-up|9|||
155014798|NCT03055338|559480451|FG001|Overall Study|Lost to Follow-up|2|||
155014799|NCT03055338|559480452|FG002|Overall Study|Lost to Follow-up|3|||
155014800|NCT03055338|559480450|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
155014801|NCT03055338|559480451|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
155014802|NCT03055338|559480452|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
155014803|NCT03055338|559480450|FG000|Overall Study|Physician Decision|0|||
155014804|NCT03055338|559480451|FG001|Overall Study|Physician Decision|0|||
155014805|NCT03055338|559480452|FG002|Overall Study|Physician Decision|2|||
155014806|NCT03055338|559480450|FG000|Overall Study|Withdrawal by Subject|9|||
155014807|NCT03055338|559480451|FG001|Overall Study|Withdrawal by Subject|8|||
155014808|NCT03055338|559480452|FG002|Overall Study|Withdrawal by Subject|7|||
155014809|NCT03058705|559480453|FG000|Overall Study|Withdrawal by Subject|2|||
155014810|NCT03058705|559480453|FG000|Overall Study|Physician Decision|2|||
155014811|NCT00824772|559480457|FG000|Overall Study|Withdrawal by Subject|8|||
155014812|NCT02075203|559480458|FG000|Overall Study|Withdrawal by Subject|1|||
155014813|NCT02075203|559480459|FG001|Overall Study|Withdrawal by Subject|0|||
155014814|NCT02075203|559480460|FG002|Overall Study|Withdrawal by Subject|1|||
155014815|NCT02075203|559480458|FG000|Overall Study|Adverse Event|1|||
155014816|NCT02075203|559480459|FG001|Overall Study|Adverse Event|0|||
155014817|NCT02075203|559480460|FG002|Overall Study|Adverse Event|0|||
155014818|NCT02075203|559480458|FG000|Overall Study|participant refused to use contraception|1|||
155014819|NCT02075203|559480459|FG001|Overall Study|participant refused to use contraception|0|||
155014820|NCT02075203|559480460|FG002|Overall Study|participant refused to use contraception|0|||
155014821|NCT00495391|559480461|FG000|Overall Study|Lack of Efficacy|34|||
155014822|NCT00495391|559480462|FG001|Overall Study|Lack of Efficacy|18|||
155014823|NCT00495391|559480461|FG000|Overall Study|Withdrawal by Subject|2|||
155014824|NCT00495391|559480462|FG001|Overall Study|Withdrawal by Subject|3|||
155014825|NCT02712320|559480471|FG000|Overall Study|Lost to Follow-up|1|||
155135509|NCT03422536|559927331|FG000|Allocation - Received Intervention|Death|1|||
155135510|NCT03422536|559927332|FG001|Allocation - Received Intervention|Death|3|||
155135511|NCT03422536|559927331|FG000|Allocation - Received Intervention|Adverse Event|1|||
155135512|NCT03422536|559927332|FG001|Allocation - Received Intervention|Adverse Event|0|||
155135513|NCT03422536|559927331|FG000|Allocation - Received Intervention|Physician Decision|1|||
155135514|NCT03422536|559927332|FG001|Allocation - Received Intervention|Physician Decision|1|||
155135515|NCT03422536|559927331|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
155135516|NCT03422536|559927332|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
155014826|NCT02712320|559480471|FG000|Overall Study|Withdrawal by Subject|1|||
155014827|NCT02712320|559480471|FG000|Overall Study|Transferred to another facility|1|||
155178650|NCT02677324|560093342|FG000|Overall Study|Inability to Swallow pills|1|||
155178651|NCT02677324|560093342|FG000|Overall Study|Non-compliance|1|||
155178652|NCT02677324|560093342|FG000|Overall Study|Lack of Efficacy|1|||
155178653|NCT02677324|560093342|FG000|Overall Study|Medical insurance coverage|1|||
155178654|NCT02677324|560093342|FG000|Overall Study|Adverse Event|1|||
155178655|NCT02677324|560093342|FG000|Overall Study|IgM Myeloma diagnosis|1|||
155178656|NCT03312751|560093343|FG000|Overall Study|Death|7|||
155178657|NCT03312751|560093344|FG001|Overall Study|Death|9|||
155178658|NCT03312751|560093343|FG000|Overall Study|Study discontinuation due to other reason|0|||
155178659|NCT03312751|560093344|FG001|Overall Study|Study discontinuation due to other reason|1|||
155178660|NCT00475423|560093345|FG000|Overall Study|Protocol Violation|5|||
155178661|NCT00475423|560093345|FG000|Overall Study|Adverse Event|4|||
155178662|NCT00475423|560093345|FG000|Overall Study|Withdrawal by Subject|6|||
155178663|NCT00475423|560093345|FG000|Overall Study|Lack of Efficacy|8|||
155178664|NCT00475423|560093345|FG000|Overall Study|Death|1|||
155178665|NCT00475423|560093345|FG000|Overall Study|Reason not specified|1|||
155178666|NCT00475423|560093345|FG000|Overall Study|Lost to Follow-up|7|||
155178667|NCT01214174|560093346|FG000|Overall Study|Withdrawal by Subject|0|||
155178668|NCT01214174|560093347|FG001|Overall Study|Withdrawal by Subject|0|||
155178669|NCT01214174|560093348|FG002|Overall Study|Withdrawal by Subject|1|||
155178670|NCT00290407|560093349|FG000|Overall Study|Physician Decision|2|||
155178671|NCT01925989|560093358|FG000|Period 1|Sponsor Decision|1|||
155178672|NCT01925989|560093359|FG001|Period 1|Sponsor Decision|1|||
155178673|NCT01925989|560093360|FG002|Period 1|Sponsor Decision|0|||
155178674|NCT01925989|560093358|FG000|Period 1|Withdrawal by Subject|0|||
155178675|NCT01925989|560093359|FG001|Period 1|Withdrawal by Subject|1|||
155178676|NCT01925989|560093360|FG002|Period 1|Withdrawal by Subject|0|||
155178677|NCT00868517|560093362|FG000|Overall Study|Withdrawal by Subject|3|||
155178678|NCT00868517|560093363|FG001|Overall Study|Withdrawal by Subject|3|||
155178679|NCT00868517|560093364|FG002|Overall Study|Withdrawal by Subject|2|||
155178680|NCT00868517|560093362|FG000|Overall Study|Protocol Violation|1|||
155178681|NCT00868517|560093363|FG001|Overall Study|Protocol Violation|1|||
155178682|NCT00868517|560093364|FG002|Overall Study|Protocol Violation|0|||
155178683|NCT02496676|560093366|FG000|Phase 1 - Period 1|Adverse Event|0|||
155178684|NCT02496676|560093367|FG001|Phase 1 - Period 1|Adverse Event|1|||
155178685|NCT02496676|560093366|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
155178686|NCT02496676|560093367|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
155178687|NCT05442775|560093368|FG000|Overall Study|Trial terminated|61|||
155178688|NCT05442775|560093368|FG000|Overall Study|Lack of Efficacy|4|||
155178689|NCT05442775|560093368|FG000|Overall Study|Withdrawal by Subject|4|||
155178690|NCT05442775|560093368|FG000|Overall Study|Death|1|||
155178691|NCT05442775|560093368|FG000|Overall Study|Participant removed at Sponsor request|1|||
155178692|NCT03459690|560093370|FG000|Overall Study|Lost to Follow-up|0|||
155178693|NCT03459690|560093371|FG001|Overall Study|Lost to Follow-up|1|||
155178694|NCT03459690|560093370|FG000|Overall Study|Withdrawal by Subject|1|||
155178695|NCT03459690|560093371|FG001|Overall Study|Withdrawal by Subject|1|||
155178696|NCT02963831|560093372|FG000|Overall Study|Progressive Disease|3|||
155178697|NCT02963831|560093373|FG001|Overall Study|Progressive Disease|3|||
155178698|NCT02963831|560093374|FG002|Overall Study|Progressive Disease|16|||
155178699|NCT02963831|560093375|FG003|Overall Study|Progressive Disease|27|||
155178700|NCT02963831|560093372|FG000|Overall Study|Withdrawal by Subject|1|||
155178701|NCT02963831|560093373|FG001|Overall Study|Withdrawal by Subject|0|||
155178702|NCT02963831|560093374|FG002|Overall Study|Withdrawal by Subject|2|||
155178703|NCT02963831|560093375|FG003|Overall Study|Withdrawal by Subject|4|||
155178704|NCT02963831|560093372|FG000|Overall Study|Adverse Event|0|||
155178705|NCT02963831|560093373|FG001|Overall Study|Adverse Event|1|||
155178706|NCT02963831|560093374|FG002|Overall Study|Adverse Event|1|||
155178707|NCT02963831|560093375|FG003|Overall Study|Adverse Event|2|||
155178708|NCT02963831|560093372|FG000|Overall Study|Death|0|||
155135517|NCT03422536|559927331|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
155135518|NCT03422536|559927332|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
155135519|NCT00532298|559927333|FG000|Overall Study|Adverse Event|1|||
155135520|NCT00532298|559927334|FG001|Overall Study|Adverse Event|0|||
155135521|NCT00532298|559927335|FG002|Overall Study|Adverse Event|0|||
155135522|NCT00532298|559927336|FG003|Overall Study|Adverse Event|0|||
155135523|NCT00532298|559927337|FG004|Overall Study|Adverse Event|1|||
155135524|NCT00532298|559927338|FG005|Overall Study|Adverse Event|1|||
155135525|NCT00532298|559927333|FG000|Overall Study|Lost to Follow-up|1|||
155178709|NCT02963831|560093373|FG001|Overall Study|Death|0|||
155178710|NCT02963831|560093374|FG002|Overall Study|Death|0|||
155178711|NCT02963831|560093375|FG003|Overall Study|Death|2|||
155135526|NCT00532298|559927334|FG001|Overall Study|Lost to Follow-up|1|||
155178712|NCT01966432|560093376|FG000|Overall Study|Lost to Follow-up|3|||
155178713|NCT01966432|560093377|FG001|Overall Study|Lost to Follow-up|2|||
155135527|NCT00532298|559927335|FG002|Overall Study|Lost to Follow-up|1|||
155178714|NCT01966432|560093378|FG002|Overall Study|Lost to Follow-up|5|||
155178715|NCT01966432|560093376|FG000|Overall Study|Withdrawal by Subject|1|||
155178716|NCT01966432|560093377|FG001|Overall Study|Withdrawal by Subject|3|||
155178717|NCT01966432|560093378|FG002|Overall Study|Withdrawal by Subject|0|||
155135528|NCT00532298|559927336|FG003|Overall Study|Lost to Follow-up|0|||
155135529|NCT00532298|559927337|FG004|Overall Study|Lost to Follow-up|0|||
155135530|NCT00532298|559927338|FG005|Overall Study|Lost to Follow-up|1|||
155135531|NCT00479856|559927339|FG000|Overall Study|Adverse Event|1|||
155135532|NCT00479856|559927339|FG000|Overall Study|Withdrawal by Subject|1|||
155135533|NCT00479856|559927339|FG000|Overall Study|Physician Decision|1|||
155135534|NCT01973998|559927340|FG000|Overall Study|Death|2|||
155135535|NCT01973998|559927341|FG001|Overall Study|Death|2|||
155135536|NCT04164732|559927342|FG000|Treatment run-in Period|Adverse Event|4|||
155135537|NCT04164732|559927343|FG001|Treatment run-in Period|Adverse Event|0|||
155135538|NCT04164732|559927344|FG002|Treatment run-in Period|Adverse Event|0|||
155135539|NCT04164732|559927342|FG000|Treatment run-in Period|Physician Decision|1|||
155135540|NCT04164732|559927343|FG001|Treatment run-in Period|Physician Decision|0|||
155135541|NCT04164732|559927344|FG002|Treatment run-in Period|Physician Decision|0|||
155135542|NCT04164732|559927342|FG000|Treatment run-in Period|Screen Failure|1|||
155135543|NCT04164732|559927343|FG001|Treatment run-in Period|Screen Failure|0|||
155135544|NCT04164732|559927344|FG002|Treatment run-in Period|Screen Failure|0|||
155135545|NCT04164732|559927342|FG000|Randomized Treatment Period|Adverse Event|0|||
155135546|NCT04164732|559927343|FG001|Randomized Treatment Period|Adverse Event|1|||
155135547|NCT04164732|559927344|FG002|Randomized Treatment Period|Adverse Event|0|||
155135548|NCT04164732|559927342|FG000|Randomized Treatment Period|Protocol Deviation|0|||
155135549|NCT04164732|559927343|FG001|Randomized Treatment Period|Protocol Deviation|1|||
155135550|NCT04164732|559927344|FG002|Randomized Treatment Period|Protocol Deviation|1|||
155135551|NCT04164732|559927342|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
155135552|NCT04164732|559927343|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
155135553|NCT04164732|559927344|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
155135554|NCT02141360|559927345|FG000|Overall Study|Withdrawal by Subject|6|||
155135555|NCT02141360|559927346|FG001|Overall Study|Withdrawal by Subject|0|||
155135556|NCT02141360|559927347|FG002|Overall Study|Withdrawal by Subject|0|||
155135557|NCT02141360|559927345|FG000|Overall Study|Study Terminated before Visit|1|||
155135558|NCT02141360|559927346|FG001|Overall Study|Study Terminated before Visit|0|||
155135559|NCT02141360|559927347|FG002|Overall Study|Study Terminated before Visit|0|||
155135560|NCT00129467|559927352|FG000|Received Intervention|Death|1|||
155135561|NCT00129467|559927353|FG001|Received Intervention|Death|1|||
155135562|NCT00129467|559927352|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
155135563|NCT00129467|559927353|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
155135564|NCT00129467|559927352|FG000|Received Intervention|Delirium|2|||
155135565|NCT00129467|559927353|FG001|Received Intervention|Delirium|0|||
155135566|NCT00129467|559927352|FG000|Received Intervention|Withdrawal by Subject|1|||
155135567|NCT00129467|559927353|FG001|Received Intervention|Withdrawal by Subject|0|||
155135568|NCT00129467|559927352|FG000|Received Intervention|Nausea|1|||
155135569|NCT00129467|559927353|FG001|Received Intervention|Nausea|0|||
155135570|NCT00129467|559927352|FG000|Received Intervention|Intolerance to citalopram|0|||
155135571|NCT00129467|559927353|FG001|Received Intervention|Intolerance to citalopram|1|||
155135572|NCT00129467|559927352|FG000|Received Intervention|Dizzyness, fatigue|0|||
155135573|NCT00129467|559927353|FG001|Received Intervention|Dizzyness, fatigue|1|||
155135574|NCT00129467|559927352|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
155135575|NCT00129467|559927353|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
155135576|NCT00129467|559927352|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
155135577|NCT00129467|559927353|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
155135578|NCT01009086|559927354|FG000|Overall Study|Lack of Efficacy|16|||
155135579|NCT01009086|559927355|FG001|Overall Study|Lack of Efficacy|15|||
155135580|NCT01009086|559927356|FG002|Overall Study|Lack of Efficacy|9|||
155135581|NCT01009086|559927354|FG000|Overall Study|Lost to Follow-up|4|||
155135582|NCT01009086|559927355|FG001|Overall Study|Lost to Follow-up|5|||
155135583|NCT01009086|559927356|FG002|Overall Study|Lost to Follow-up|3|||
155135584|NCT01009086|559927354|FG000|Overall Study|Adverse Event|12|||
155135585|NCT01009086|559927355|FG001|Overall Study|Adverse Event|11|||
155135586|NCT01009086|559927356|FG002|Overall Study|Adverse Event|8|||
155135587|NCT01009086|559927354|FG000|Overall Study|Withdrawal by Subject|9|||
155135588|NCT01009086|559927355|FG001|Overall Study|Withdrawal by Subject|11|||
155135589|NCT01009086|559927356|FG002|Overall Study|Withdrawal by Subject|13|||
155135590|NCT01009086|559927354|FG000|Overall Study|Other|3|||
155135591|NCT01009086|559927355|FG001|Overall Study|Other|5|||
155135592|NCT01009086|559927356|FG002|Overall Study|Other|1|||
155135593|NCT01424228|559927357|FG000|Overall Study|Withdrawal by Subject|27|||
155135594|NCT01424228|559927358|FG001|Overall Study|Withdrawal by Subject|11|||
155135595|NCT01424228|559927357|FG000|Overall Study|Adverse Event|10|||
155135596|NCT01424228|559927358|FG001|Overall Study|Adverse Event|14|||
155135597|NCT01424228|559927357|FG000|Overall Study|Sponsor's decision|9|||
155135598|NCT01424228|559927358|FG001|Overall Study|Sponsor's decision|12|||
155135599|NCT01424228|559927357|FG000|Overall Study|Lack of Efficacy|5|||
155135600|NCT01424228|559927358|FG001|Overall Study|Lack of Efficacy|7|||
155135601|NCT01424228|559927357|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
155135602|NCT01424228|559927358|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
155135603|NCT01424228|559927357|FG000|Overall Study|Non-compliance|2|||
155135604|NCT01424228|559927358|FG001|Overall Study|Non-compliance|0|||
155135605|NCT01424228|559927357|FG000|Overall Study|Worsening of symptoms|1|||
155135606|NCT01424228|559927358|FG001|Overall Study|Worsening of symptoms|0|||
155135607|NCT01424228|559927357|FG000|Overall Study|Unplanned journey|0|||
155135608|NCT01424228|559927358|FG001|Overall Study|Unplanned journey|1|||
155135609|NCT00932165|559927361|FG000|Overall Study|Lost to Follow-up|1|||
155135610|NCT00767819|559927362|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
155135611|NCT00767819|559927363|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
155135612|NCT00767819|559927364|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
155135613|NCT00767819|559927362|FG000|Overall Study|Withdrawal by Subject|1|||
155135614|NCT00767819|559927363|FG001|Overall Study|Withdrawal by Subject|1|||
155135615|NCT00767819|559927364|FG002|Overall Study|Withdrawal by Subject|0|||
155135616|NCT00767819|559927362|FG000|Overall Study|Administrative problems|0|||
155135617|NCT00767819|559927363|FG001|Overall Study|Administrative problems|1|||
155135618|NCT00767819|559927364|FG002|Overall Study|Administrative problems|0|||
155135619|NCT00767819|559927362|FG000|Overall Study|Death|2|||
155135620|NCT00767819|559927363|FG001|Overall Study|Death|3|||
155135621|NCT00767819|559927364|FG002|Overall Study|Death|0|||
155135622|NCT00767819|559927362|FG000|Overall Study|Adverse Event|2|||
155135623|NCT00767819|559927363|FG001|Overall Study|Adverse Event|0|||
155135624|NCT00767819|559927364|FG002|Overall Study|Adverse Event|0|||
155135625|NCT00767819|559927362|FG000|Overall Study|Abnormal lab values|1|||
155135626|NCT00767819|559927363|FG001|Overall Study|Abnormal lab values|0|||
155135627|NCT00767819|559927364|FG002|Overall Study|Abnormal lab values|0|||
155135628|NCT00767819|559927362|FG000|Overall Study|Lost to Follow-up|1|||
155135629|NCT00767819|559927363|FG001|Overall Study|Lost to Follow-up|0|||
155135630|NCT00767819|559927364|FG002|Overall Study|Lost to Follow-up|0|||
155135631|NCT05392803|559927366|FG000|Overall Study|Lost to Follow-up|0|||
155135632|NCT05392803|559927367|FG001|Overall Study|Lost to Follow-up|2|||
155135633|NCT00699335|559927372|FG000|Overall Study|Combination of multiple reasons|176|||
155135634|NCT00699335|559927372|FG000|Overall Study|Missing data|52|||
155135635|NCT01371305|559927373|FG000|Overall Study|Adverse Event|0|||
155135636|NCT01371305|559927374|FG001|Overall Study|Adverse Event|0|||
155135637|NCT01371305|559927375|FG002|Overall Study|Adverse Event|0|||
155135638|NCT01371305|559927376|FG003|Overall Study|Adverse Event|2|||
155135639|NCT01371305|559927377|FG004|Overall Study|Adverse Event|1|||
155135640|NCT01371305|559927378|FG005|Overall Study|Adverse Event|0|||
155135641|NCT01371305|559927373|FG000|Overall Study|Study terminated by sponsor|0|||
155135642|NCT01371305|559927374|FG001|Overall Study|Study terminated by sponsor|0|||
155135643|NCT01371305|559927375|FG002|Overall Study|Study terminated by sponsor|0|||
155135644|NCT01371305|559927376|FG003|Overall Study|Study terminated by sponsor|0|||
155135645|NCT01371305|559927377|FG004|Overall Study|Study terminated by sponsor|3|||
155135646|NCT01371305|559927378|FG005|Overall Study|Study terminated by sponsor|1|||
155135647|NCT01371305|559927373|FG000|Overall Study|Subject request|0|||
155135648|NCT01371305|559927374|FG001|Overall Study|Subject request|0|||
155135649|NCT01371305|559927375|FG002|Overall Study|Subject request|0|||
155135650|NCT01371305|559927376|FG003|Overall Study|Subject request|0|||
155135651|NCT01371305|559927377|FG004|Overall Study|Subject request|0|||
155135652|NCT01371305|559927378|FG005|Overall Study|Subject request|1|||
155135653|NCT04038567|559927379|FG000|Overall Study|Lost to Follow-up|6|||
155135654|NCT04038567|559927380|FG001|Overall Study|Lost to Follow-up|4|||
155135655|NCT04038567|559927381|FG002|Overall Study|Lost to Follow-up|5|||
155135656|NCT04038567|559927382|FG003|Overall Study|Lost to Follow-up|4|||
155135657|NCT04038567|559927383|FG004|Overall Study|Lost to Follow-up|6|||
155135658|NCT04038567|559927384|FG005|Overall Study|Lost to Follow-up|4|||
155135659|NCT04038567|559927385|FG006|Overall Study|Lost to Follow-up|4|||
155135660|NCT04038567|559927386|FG007|Overall Study|Lost to Follow-up|1|||
155135661|NCT04038567|559927379|FG000|Overall Study|Withdrawal by Subject|2|||
155135662|NCT04038567|559927380|FG001|Overall Study|Withdrawal by Subject|1|||
155135663|NCT04038567|559927381|FG002|Overall Study|Withdrawal by Subject|1|||
155135664|NCT04038567|559927382|FG003|Overall Study|Withdrawal by Subject|1|||
155135665|NCT04038567|559927383|FG004|Overall Study|Withdrawal by Subject|4|||
155014828|NCT02712320|559480471|FG000|Overall Study|Treating with the prohibited medications|2|||
155014829|NCT00568451|559480472|FG000|Overall Study|Disease Progression|0|||
155014830|NCT00568451|559480473|FG001|Overall Study|Disease Progression|0|||
155014831|NCT00568451|559480474|FG002|Overall Study|Disease Progression|2|||
155135666|NCT04038567|559927384|FG005|Overall Study|Withdrawal by Subject|1|||
155135667|NCT04038567|559927385|FG006|Overall Study|Withdrawal by Subject|1|||
155135668|NCT04038567|559927386|FG007|Overall Study|Withdrawal by Subject|1|||
155135669|NCT04038567|559927379|FG000|Overall Study|missed survey window|1|||
155135670|NCT04038567|559927380|FG001|Overall Study|missed survey window|2|||
155135671|NCT04038567|559927381|FG002|Overall Study|missed survey window|0|||
155135672|NCT04038567|559927382|FG003|Overall Study|missed survey window|0|||
155135673|NCT04038567|559927383|FG004|Overall Study|missed survey window|1|||
155135674|NCT04038567|559927384|FG005|Overall Study|missed survey window|1|||
155135675|NCT04038567|559927385|FG006|Overall Study|missed survey window|2|||
155135676|NCT04038567|559927386|FG007|Overall Study|missed survey window|2|||
155135677|NCT04038567|559927379|FG000|Overall Study|technical issues|0|||
155135678|NCT04038567|559927380|FG001|Overall Study|technical issues|0|||
155135679|NCT04038567|559927381|FG002|Overall Study|technical issues|0|||
155135680|NCT04038567|559927382|FG003|Overall Study|technical issues|0|||
155135681|NCT04038567|559927383|FG004|Overall Study|technical issues|0|||
155135682|NCT04038567|559927384|FG005|Overall Study|technical issues|0|||
155135683|NCT04038567|559927385|FG006|Overall Study|technical issues|1|||
155135684|NCT04038567|559927386|FG007|Overall Study|technical issues|0|||
155135685|NCT04038567|559927379|FG000|Overall Study|Medical issues (i.e., illness)|0|||
155135686|NCT04038567|559927380|FG001|Overall Study|Medical issues (i.e., illness)|1|||
155135687|NCT04038567|559927381|FG002|Overall Study|Medical issues (i.e., illness)|2|||
155135688|NCT04038567|559927382|FG003|Overall Study|Medical issues (i.e., illness)|1|||
155135689|NCT04038567|559927383|FG004|Overall Study|Medical issues (i.e., illness)|1|||
155135690|NCT04038567|559927384|FG005|Overall Study|Medical issues (i.e., illness)|1|||
155135691|NCT04038567|559927385|FG006|Overall Study|Medical issues (i.e., illness)|0|||
155135692|NCT04038567|559927386|FG007|Overall Study|Medical issues (i.e., illness)|0|||
155135693|NCT04038567|559927379|FG000|Overall Study|Death|0|||
155135694|NCT04038567|559927380|FG001|Overall Study|Death|0|||
155135695|NCT04038567|559927381|FG002|Overall Study|Death|0|||
155135696|NCT04038567|559927382|FG003|Overall Study|Death|1|||
155135697|NCT04038567|559927383|FG004|Overall Study|Death|1|||
155135698|NCT04038567|559927384|FG005|Overall Study|Death|0|||
155135699|NCT04038567|559927385|FG006|Overall Study|Death|0|||
155135700|NCT04038567|559927386|FG007|Overall Study|Death|1|||
155135701|NCT02456857|559927396|FG000|Overall Study|Disease Progression|4|||
155135702|NCT01138501|559927397|FG000|Overall Study|Protocol Violation|2|||
155135703|NCT01138501|559927397|FG000|Overall Study|Withdrawal by Subject|3|||
155135704|NCT00828750|559927398|FG000|Overall Study|Lack of Efficacy|3|||
155135705|NCT00828750|559927398|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
155135706|NCT01730586|559927399|FG000|Overall Study|Progressive Disease|2|||
155135707|NCT01730586|559927399|FG000|Overall Study|Inadequate Trial|8|||
155135708|NCT01730586|559927399|FG000|Overall Study|Adverse Event|2|||
155135709|NCT01730586|559927399|FG000|Overall Study|Hospice|1|||
155135710|NCT01946152|559928970|FG000|Overall Study|Adverse Event|1|||
155135711|NCT01946152|559928971|FG001|Overall Study|Adverse Event|0|||
155135712|NCT01946152|559928972|FG002|Overall Study|Adverse Event|0|||
155135713|NCT01946152|559928973|FG003|Overall Study|Adverse Event|0|||
155135714|NCT01946152|559928970|FG000|Overall Study|Withdrawal by Subject|0|||
155135715|NCT01946152|559928971|FG001|Overall Study|Withdrawal by Subject|2|||
155135716|NCT01946152|559928972|FG002|Overall Study|Withdrawal by Subject|0|||
155135717|NCT01946152|559928973|FG003|Overall Study|Withdrawal by Subject|0|||
155135718|NCT01946152|559928970|FG000|Overall Study|Progression|0|||
155135719|NCT01946152|559928971|FG001|Overall Study|Progression|1|||
155135720|NCT01946152|559928972|FG002|Overall Study|Progression|4|||
155135721|NCT01946152|559928973|FG003|Overall Study|Progression|7|||
155135722|NCT01946152|559928970|FG000|Overall Study|Physician Decision|0|||
155135723|NCT01946152|559928971|FG001|Overall Study|Physician Decision|0|||
155135724|NCT01946152|559928972|FG002|Overall Study|Physician Decision|1|||
155135725|NCT01946152|559928973|FG003|Overall Study|Physician Decision|0|||
155135726|NCT01946152|559928970|FG000|Overall Study|Second malignancy|0|||
155135727|NCT01946152|559928971|FG001|Overall Study|Second malignancy|0|||
155135728|NCT01946152|559928972|FG002|Overall Study|Second malignancy|1|||
155135729|NCT01946152|559928973|FG003|Overall Study|Second malignancy|0|||
155135730|NCT01946152|559928970|FG000|Overall Study|Adverse Event|0|||
155135731|NCT01946152|559928971|FG001|Overall Study|Adverse Event|0|||
155135732|NCT01946152|559928972|FG002|Overall Study|Adverse Event|0|||
155135733|NCT01946152|559928973|FG003|Overall Study|Adverse Event|1|||
155135734|NCT03712787|559928974|FG000|Overall Study|Adverse Event|2|||
155135735|NCT03712787|559928975|FG001|Overall Study|Adverse Event|3|||
155135736|NCT03712787|559928976|FG002|Overall Study|Adverse Event|0|||
155135737|NCT03712787|559928977|FG003|Overall Study|Adverse Event|4|||
155135738|NCT03712787|559928974|FG000|Overall Study|Withdrawal by Subject|4|||
155135739|NCT03712787|559928975|FG001|Overall Study|Withdrawal by Subject|14|||
155135740|NCT03712787|559928976|FG002|Overall Study|Withdrawal by Subject|12|||
155135741|NCT03712787|559928977|FG003|Overall Study|Withdrawal by Subject|8|||
155135742|NCT03712787|559928974|FG000|Overall Study|Lost to Follow-up|1|||
155135743|NCT03712787|559928975|FG001|Overall Study|Lost to Follow-up|1|||
155135744|NCT03712787|559928976|FG002|Overall Study|Lost to Follow-up|2|||
155135745|NCT03712787|559928977|FG003|Overall Study|Lost to Follow-up|1|||
155178718|NCT01966432|560093376|FG000|Overall Study|Subject Incarcerated|0|||
155178719|NCT01966432|560093377|FG001|Overall Study|Subject Incarcerated|0|||
155178720|NCT01966432|560093378|FG002|Overall Study|Subject Incarcerated|1|||
155135746|NCT03712787|559928974|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
155178721|NCT01966432|560093376|FG000|Overall Study|SBIRT program ended|1|||
155135747|NCT03712787|559928975|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
155135748|NCT03712787|559928976|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
155135749|NCT03712787|559928977|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
155135750|NCT03712787|559928974|FG000|Overall Study|COVID-19 Infection|0|||
155135751|NCT03712787|559928975|FG001|Overall Study|COVID-19 Infection|1|||
155135752|NCT03712787|559928976|FG002|Overall Study|COVID-19 Infection|0|||
155014832|NCT00568451|559480475|FG003|Overall Study|Disease Progression|7|||
155014833|NCT05266053|559480476|FG000|Overall Study|Withdrawal by Subject|8|||
155014834|NCT05266053|559480477|FG001|Overall Study|Withdrawal by Subject|4|||
155014835|NCT05344560|559480478|FG000|Period 1|Subject out of visit window|1|||
155014836|NCT05344560|559480479|FG001|Period 1|Subject out of visit window|1|||
155014837|NCT05344560|559480478|FG000|Period 2|Covid-19 Related|1|||
155014838|NCT05344560|559480479|FG001|Period 2|Covid-19 Related|0|||
155014839|NCT05344560|559480478|FG000|Period 2|Adverse Event|1|||
155014840|NCT05344560|559480479|FG001|Period 2|Adverse Event|0|||
155014841|NCT05344560|559480478|FG000|Period 2|Subject out of visit window|1|||
155014842|NCT05344560|559480479|FG001|Period 2|Subject out of visit window|1|||
155014843|NCT05344560|559480478|FG000|Period 3|Subject out of visit window|1|||
155014844|NCT05344560|559480479|FG001|Period 3|Subject out of visit window|0|||
155014845|NCT02996968|559480480|FG000|Overall Study|Withdrawal by Subject|1|||
155014846|NCT02996968|559480481|FG001|Overall Study|Withdrawal by Subject|0|||
155014847|NCT01620138|559480482|FG000|Overall Study|Withdrawal by Subject|3|||
155014848|NCT01620138|559480483|FG001|Overall Study|Withdrawal by Subject|0|||
155014849|NCT01620138|559480482|FG000|Overall Study|Lack of Efficacy|1|||
155014850|NCT01620138|559480483|FG001|Overall Study|Lack of Efficacy|0|||
155014851|NCT01620138|559480482|FG000|Overall Study|Adverse Event|2|||
155014852|NCT01620138|559480483|FG001|Overall Study|Adverse Event|0|||
155014853|NCT03922308|559480484|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
155014854|NCT03922308|559480485|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
155014855|NCT03922308|559480486|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
155014856|NCT03922308|559480484|FG000|Overall Study|Lost to Follow-up|1|||
155014857|NCT03922308|559480485|FG001|Overall Study|Lost to Follow-up|0|||
155014858|NCT03922308|559480486|FG002|Overall Study|Lost to Follow-up|0|||
155014859|NCT03922308|559480484|FG000|Overall Study|Reason not Specified|0|||
155014860|NCT03922308|559480485|FG001|Overall Study|Reason not Specified|2|||
155014861|NCT03922308|559480486|FG002|Overall Study|Reason not Specified|1|||
155014862|NCT05005507|559480487|FG000|Overall Study|Premature termination of study|1|||
155014863|NCT03313180|559480491|FG000|Overall Study|Adverse Event|120|||
155014864|NCT03313180|559480491|FG000|Overall Study|Lost to Follow-up|3|||
155014865|NCT03313180|559480491|FG000|Overall Study|Withdrawal by Subject|39|||
155014866|NCT03313180|559480491|FG000|Overall Study|Other than listed above|15|||
155014867|NCT03313180|559480491|FG000|Overall Study|Covid-19 related|2|||
155014868|NCT01697748|559480492|FG000|Overall Study|ineligible skin incision|1|||
155014869|NCT01697748|559480493|FG001|Overall Study|ineligible skin incision|2|||
155014870|NCT01697748|559480492|FG000|Overall Study|ineligible uterine incision|4|||
155014871|NCT01697748|559480493|FG001|Overall Study|ineligible uterine incision|1|||
155014872|NCT01697748|559480492|FG000|Overall Study|Lost to Follow-up|53|||
155014873|NCT01697748|559480493|FG001|Overall Study|Lost to Follow-up|65|||
155014874|NCT00832455|559480495|FG000|Overall Study|Adverse Event|13|||
155014875|NCT00832455|559480495|FG000|Overall Study|Lost to Follow-up|26|||
155014876|NCT00832455|559480495|FG000|Overall Study|Protocol Violation|4|||
155014877|NCT00832455|559480495|FG000|Overall Study|Withdrawal by Subject|17|||
155014878|NCT00832455|559480495|FG000|Overall Study|Screening Failure|2|||
155014879|NCT00832455|559480495|FG000|Overall Study|Stopped Medication|4|||
155014880|NCT00832455|559480495|FG000|Overall Study|Parent misunderstood study|1|||
155014881|NCT00832455|559480495|FG000|Overall Study|Parent dissatisfied|1|||
155014882|NCT00832455|559480495|FG000|Overall Study|No improvement|3|||
155014883|NCT00832455|559480495|FG000|Overall Study|Patient moved|1|||
155014884|NCT04177095|559480502|FG000|Overall Study|Withdrawal by Subject|3|||
155014885|NCT04177095|559480502|FG000|Overall Study|Screen Failure|3|||
155014886|NCT04177095|559480502|FG000|Overall Study|Problems with the Trugraf assay|1|||
155014887|NCT02275819|559480503|FG000|Overall Study|Adverse Event|0|||
155014888|NCT02275819|559480504|FG001|Overall Study|Adverse Event|1|||
155014889|NCT02556775|559480505|FG000|Overall Study|Withdrawal by Subject|1|||
155014890|NCT02556775|559480506|FG001|Overall Study|Withdrawal by Subject|0|||
155014891|NCT02556775|559480507|FG002|Overall Study|Withdrawal by Subject|1|||
155014892|NCT02556775|559480508|FG003|Overall Study|Withdrawal by Subject|0|||
155014893|NCT02556775|559480505|FG000|Overall Study|Lost to Follow-up|1|||
155014894|NCT02556775|559480506|FG001|Overall Study|Lost to Follow-up|0|||
155014895|NCT02556775|559480507|FG002|Overall Study|Lost to Follow-up|0|||
155014896|NCT02556775|559480508|FG003|Overall Study|Lost to Follow-up|0|||
155014897|NCT00777296|559480509|FG000|Overall Study|Adverse Event|0|||
155014898|NCT00777296|559480510|FG001|Overall Study|Adverse Event|1|||
155014899|NCT00777296|559480511|FG002|Overall Study|Adverse Event|0|||
155014900|NCT00777296|559480512|FG003|Overall Study|Adverse Event|1|||
155014901|NCT00777296|559480509|FG000|Overall Study|Withdrawal by Subject|1|||
155014902|NCT00777296|559480510|FG001|Overall Study|Withdrawal by Subject|0|||
155014903|NCT00777296|559480511|FG002|Overall Study|Withdrawal by Subject|0|||
155014904|NCT00777296|559480512|FG003|Overall Study|Withdrawal by Subject|0|||
155014905|NCT00777296|559480509|FG000|Overall Study|CRF form not completed|0|||
155014906|NCT00777296|559480510|FG001|Overall Study|CRF form not completed|0|||
155014907|NCT00777296|559480511|FG002|Overall Study|CRF form not completed|2|||
155014908|NCT00777296|559480512|FG003|Overall Study|CRF form not completed|0|||
155014909|NCT02211209|559480513|FG000|Overall Study|Investigator judgment|0|||
155014910|NCT02211209|559480514|FG001|Overall Study|Investigator judgment|1|||
155014911|NCT02211209|559480513|FG000|Overall Study|Voluntary withdrawal|1|||
155014912|NCT02211209|559480514|FG001|Overall Study|Voluntary withdrawal|4|||
155014913|NCT02211209|559480513|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
155135753|NCT03712787|559928977|FG003|Overall Study|COVID-19 Infection|0|||
155135754|NCT03712787|559928974|FG000|Overall Study|Other, Not Specified|79|||
155135755|NCT03712787|559928975|FG001|Overall Study|Other, Not Specified|77|||
155135756|NCT03712787|559928976|FG002|Overall Study|Other, Not Specified|74|||
155135757|NCT03712787|559928977|FG003|Overall Study|Other, Not Specified|78|||
155135758|NCT01865448|559928978|FG000|Overall Study|Adverse Event|1|||
155135759|NCT01865448|559928979|FG001|Overall Study|Adverse Event|1|||
155135760|NCT01865448|559928978|FG000|Overall Study|Pregnancy|0|||
155135761|NCT01865448|559928979|FG001|Overall Study|Pregnancy|1|||
155135762|NCT01865448|559928978|FG000|Overall Study|dropout unrelated to study|1|||
155135763|NCT01865448|559928979|FG001|Overall Study|dropout unrelated to study|1|||
155135764|NCT05111249|559928984|FG000|Overall Study|Lost to Follow-up|0|||
155135765|NCT05111249|559928985|FG001|Overall Study|Lost to Follow-up|2|||
155135766|NCT05111249|559928984|FG000|Overall Study|Physician Decision|0|||
155135767|NCT05111249|559928985|FG001|Overall Study|Physician Decision|1|||
155135768|NCT05111249|559928984|FG000|Overall Study|Participant decision|1|||
155135769|NCT05111249|559928985|FG001|Overall Study|Participant decision|5|||
155135770|NCT05128578|559928986|FG000|Overall Study|Withdrawal by Subject|9|||
155135771|NCT05128578|559928986|FG000|Overall Study|Lost to Follow-up|5|||
155135772|NCT00799266|559928987|FG000|Overall Study|Adverse Event|0|||
155135773|NCT00799266|559928988|FG001|Overall Study|Adverse Event|1|||
155135774|NCT00799266|559928987|FG000|Overall Study|Subject withdrew consent|3|||
155135775|NCT00799266|559928988|FG001|Overall Study|Subject withdrew consent|0|||
155135776|NCT00265317|559928990|FG000|Lead-In|Objective progression or relapse|6|||
155135777|NCT00265317|559928991|FG001|Lead-In|Objective progression or relapse|11|||
155135778|NCT00265317|559928992|FG002|Lead-In|Objective progression or relapse|0|||
155135779|NCT00265317|559928993|FG003|Lead-In|Objective progression or relapse|0|||
155135780|NCT00265317|559928990|FG000|Lead-In|Adverse Event|2|||
155135781|NCT00265317|559928991|FG001|Lead-In|Adverse Event|1|||
155135782|NCT00265317|559928992|FG002|Lead-In|Adverse Event|0|||
155135783|NCT00265317|559928993|FG003|Lead-In|Adverse Event|0|||
155135784|NCT00265317|559928990|FG000|Lead-In|Death|3|||
155135785|NCT00265317|559928991|FG001|Lead-In|Death|5|||
155135786|NCT00265317|559928992|FG002|Lead-In|Death|0|||
155135787|NCT00265317|559928993|FG003|Lead-In|Death|0|||
155135788|NCT00265317|559928990|FG000|Lead-In|Withdrawal/other than adverse event|1|||
155135789|NCT00265317|559928991|FG001|Lead-In|Withdrawal/other than adverse event|0|||
155135790|NCT00265317|559928992|FG002|Lead-In|Withdrawal/other than adverse event|0|||
155135791|NCT00265317|559928993|FG003|Lead-In|Withdrawal/other than adverse event|0|||
155135792|NCT00265317|559928990|FG000|Phase 2|Objective progression or relapse|0|||
155135793|NCT00265317|559928991|FG001|Phase 2|Objective progression or relapse|0|||
155135794|NCT00265317|559928992|FG002|Phase 2|Objective progression or relapse|37|||
155135795|NCT00265317|559928993|FG003|Phase 2|Objective progression or relapse|38|||
155135796|NCT00265317|559928990|FG000|Phase 2|Global deterioration of health status|0|||
155135797|NCT00265317|559928991|FG001|Phase 2|Global deterioration of health status|0|||
155135798|NCT00265317|559928992|FG002|Phase 2|Global deterioration of health status|3|||
155135799|NCT00265317|559928993|FG003|Phase 2|Global deterioration of health status|0|||
155135800|NCT00265317|559928990|FG000|Phase 2|Adverse Event|0|||
155135801|NCT00265317|559928991|FG001|Phase 2|Adverse Event|0|||
155135802|NCT00265317|559928992|FG002|Phase 2|Adverse Event|7|||
155135803|NCT00265317|559928993|FG003|Phase 2|Adverse Event|5|||
155135804|NCT00265317|559928990|FG000|Phase 2|Death|0|||
155135805|NCT00265317|559928991|FG001|Phase 2|Death|0|||
155135806|NCT00265317|559928992|FG002|Phase 2|Death|12|||
155135807|NCT00265317|559928993|FG003|Phase 2|Death|15|||
155014914|NCT02211209|559480514|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
155014915|NCT02211209|559480513|FG000|Overall Study|Reason Not Specified|1|||
155135808|NCT00265317|559928990|FG000|Phase 2|Protocol Violation|0|||
155135809|NCT00265317|559928991|FG001|Phase 2|Protocol Violation|0|||
155135810|NCT00265317|559928992|FG002|Phase 2|Protocol Violation|1|||
155014916|NCT02211209|559480514|FG001|Overall Study|Reason Not Specified|0|||
155014917|NCT00658723|559480518|FG000|Overall Study|Lost to Follow-up|0|||
155014918|NCT00658723|559480519|FG001|Overall Study|Lost to Follow-up|2|||
155135811|NCT00265317|559928993|FG003|Phase 2|Protocol Violation|4|||
155135812|NCT00265317|559928990|FG000|Phase 2|Lost to Follow-up|0|||
155014919|NCT00658723|559480520|FG002|Overall Study|Lost to Follow-up|2|||
155014920|NCT00658723|559480518|FG000|Overall Study|Death|2|||
155135813|NCT00265317|559928991|FG001|Phase 2|Lost to Follow-up|0|||
155135814|NCT00265317|559928992|FG002|Phase 2|Lost to Follow-up|0|||
155135815|NCT00265317|559928993|FG003|Phase 2|Lost to Follow-up|1|||
155135816|NCT00265317|559928990|FG000|Phase 2|Withdrawal/other than adverse event|0|||
155135817|NCT00265317|559928991|FG001|Phase 2|Withdrawal/other than adverse event|0|||
155135818|NCT00265317|559928992|FG002|Phase 2|Withdrawal/other than adverse event|2|||
155135819|NCT00265317|559928993|FG003|Phase 2|Withdrawal/other than adverse event|1|||
155135820|NCT00265317|559928990|FG000|Phase 2|Study terminated by sponsor|0|||
155135821|NCT00265317|559928991|FG001|Phase 2|Study terminated by sponsor|0|||
155135822|NCT00265317|559928992|FG002|Phase 2|Study terminated by sponsor|1|||
155135823|NCT00265317|559928993|FG003|Phase 2|Study terminated by sponsor|0|||
155135824|NCT00265317|559928990|FG000|Phase 2|Other|0|||
155135825|NCT00265317|559928991|FG001|Phase 2|Other|0|||
155135826|NCT00265317|559928992|FG002|Phase 2|Other|1|||
155135827|NCT00265317|559928993|FG003|Phase 2|Other|1|||
155135828|NCT00732875|559928996|FG000|Overall Study|Adverse Event|16|||
155135829|NCT00732875|559928996|FG000|Overall Study|Withdrawal by Subject|6|||
155135830|NCT00732875|559928996|FG000|Overall Study|Lack of Efficacy|13|||
155135831|NCT00660179|559928999|FG000|Overall Study|Death|44|||
155135832|NCT00660179|559929000|FG001|Overall Study|Death|47|||
155135833|NCT00660179|559929001|FG002|Overall Study|Death|34|||
155135834|NCT00660179|559928999|FG000|Overall Study|Withdrawal of consent|4|||
155135835|NCT00660179|559929000|FG001|Overall Study|Withdrawal of consent|6|||
155135836|NCT00660179|559929001|FG002|Overall Study|Withdrawal of consent|4|||
155135837|NCT00660179|559928999|FG000|Overall Study|Lost to Follow-up|7|||
155135838|NCT00660179|559929000|FG001|Overall Study|Lost to Follow-up|5|||
155135839|NCT00660179|559929001|FG002|Overall Study|Lost to Follow-up|2|||
155135840|NCT00660179|559928999|FG000|Overall Study|Administrative reason|0|||
155135841|NCT00660179|559929000|FG001|Overall Study|Administrative reason|0|||
155135842|NCT00660179|559929001|FG002|Overall Study|Administrative reason|1|||
155135843|NCT00660179|559928999|FG000|Overall Study|Incorrect randomization|1|||
155135844|NCT00660179|559929000|FG001|Overall Study|Incorrect randomization|0|||
155135845|NCT00660179|559929001|FG002|Overall Study|Incorrect randomization|0|||
155135846|NCT05362058|559929004|FG000|Treatment Period|Adverse Event|3|||
155135847|NCT05362058|559929005|FG001|Treatment Period|Adverse Event|3|||
155135848|NCT05362058|559929004|FG000|Treatment Period|Assigned treatment by mistake|3|||
155135849|NCT05362058|559929005|FG001|Treatment Period|Assigned treatment by mistake|4|||
155135850|NCT05362058|559929004|FG000|Treatment Period|Death|1|||
155135851|NCT05362058|559929005|FG001|Treatment Period|Death|1|||
155135852|NCT05362058|559929004|FG000|Treatment Period|Lost to Follow-up|6|||
155135853|NCT05362058|559929005|FG001|Treatment Period|Lost to Follow-up|3|||
155135854|NCT05362058|559929004|FG000|Treatment Period|Non-compliance with study drug|0|||
155135855|NCT05362058|559929005|FG001|Treatment Period|Non-compliance with study drug|1|||
155135856|NCT05362058|559929004|FG000|Treatment Period|Physician Decision|1|||
155135857|NCT05362058|559929005|FG001|Treatment Period|Physician Decision|0|||
155135858|NCT05362058|559929004|FG000|Treatment Period|Protocol deviation|1|||
155135859|NCT05362058|559929005|FG001|Treatment Period|Protocol deviation|0|||
155135860|NCT05362058|559929004|FG000|Treatment Period|Withdrawal by Subject|10|||
155135861|NCT05362058|559929005|FG001|Treatment Period|Withdrawal by Subject|11|||
155135862|NCT05362058|559929004|FG000|Follow-Up Period|Death|1|||
155135863|NCT05362058|559929005|FG001|Follow-Up Period|Death|0|||
155135864|NCT05362058|559929004|FG000|Follow-Up Period|Lost to Follow-up|2|||
155135865|NCT05362058|559929005|FG001|Follow-Up Period|Lost to Follow-up|1|||
155135866|NCT05362058|559929004|FG000|Follow-Up Period|Protocol deviation|1|||
155135867|NCT05362058|559929005|FG001|Follow-Up Period|Protocol deviation|1|||
155135868|NCT05362058|559929004|FG000|Follow-Up Period|Withdrawal by Subject|0|||
155135869|NCT05362058|559929005|FG001|Follow-Up Period|Withdrawal by Subject|3|||
155135870|NCT00398567|559929007|FG000|Overall Study|Disease Progression|3|||
155135871|NCT00398567|559929008|FG001|Overall Study|Disease Progression|4|||
155135872|NCT00398567|559929009|FG002|Overall Study|Disease Progression|27|||
155135873|NCT00398567|559929007|FG000|Overall Study|Withdrawal by Subject|1|||
155135874|NCT00398567|559929008|FG001|Overall Study|Withdrawal by Subject|0|||
155135875|NCT00398567|559929009|FG002|Overall Study|Withdrawal by Subject|4|||
155135876|NCT00398567|559929007|FG000|Overall Study|Adverse Event|0|||
155135877|NCT00398567|559929008|FG001|Overall Study|Adverse Event|0|||
155135878|NCT00398567|559929009|FG002|Overall Study|Adverse Event|2|||
155135879|NCT00398567|559929007|FG000|Overall Study|Protocol Violation|0|||
155135880|NCT00398567|559929008|FG001|Overall Study|Protocol Violation|0|||
155135881|NCT00398567|559929009|FG002|Overall Study|Protocol Violation|1|||
155135882|NCT04273893|559929012|FG000|Overall Study|Withdrawal by Subject|0|||
155135883|NCT04273893|559929013|FG001|Overall Study|Withdrawal by Subject|2|||
155135884|NCT04273893|559929012|FG000|Overall Study|Treatment of Disease Progression|0|||
155135885|NCT04273893|559929013|FG001|Overall Study|Treatment of Disease Progression|2|||
155135886|NCT04273893|559929012|FG000|Overall Study|Death|1|||
155135887|NCT04273893|559929013|FG001|Overall Study|Death|2|||
155135888|NCT04273893|559929012|FG000|Overall Study|Lost to Follow-up|0|||
155135889|NCT04273893|559929013|FG001|Overall Study|Lost to Follow-up|2|||
155135890|NCT04273893|559929012|FG000|Overall Study|Physician Decision|1|||
155135891|NCT04273893|559929013|FG001|Overall Study|Physician Decision|0|||
155135892|NCT01036321|559929018|FG000|Overall Study|Ineligible after randomization|0|||
155135893|NCT01036321|559929019|FG001|Overall Study|Ineligible after randomization|1|||
155135894|NCT01036321|559929018|FG000|Overall Study|Withdrawal by Subject|3|||
155135895|NCT01036321|559929019|FG001|Overall Study|Withdrawal by Subject|2|||
155135896|NCT01036321|559929018|FG000|Overall Study|Adverse Event|2|||
155135897|NCT01036321|559929019|FG001|Overall Study|Adverse Event|1|||
155178722|NCT01966432|560093377|FG001|Overall Study|SBIRT program ended|8|||
155135898|NCT05438576|559929024|FG000|Overall Study|Death|1|||
155135899|NCT05438576|559929025|FG001|Overall Study|Death|1|||
155135900|NCT05438576|559929024|FG000|Overall Study|Withdrawal by Subject|4|||
155135901|NCT05438576|559929025|FG001|Overall Study|Withdrawal by Subject|2|||
155135902|NCT05438576|559929024|FG000|Overall Study|Not Eligible|2|||
155135903|NCT05438576|559929025|FG001|Overall Study|Not Eligible|1|||
155135904|NCT05438576|559929024|FG000|Overall Study|Did not complete baseline testing|22|||
155135905|NCT05438576|559929025|FG001|Overall Study|Did not complete baseline testing|4|||
155135906|NCT02881762|559929026|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155135907|NCT02881762|559929027|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155135908|NCT01856582|559929030|FG000|Overall Study|Died prior to Boost infusion|1|||
155135909|NCT00646399|559929033|FG000|Overall Study|Death|63|||
155135910|NCT00646399|559929034|FG001|Overall Study|Death|53|||
155135911|NCT00646399|559929033|FG000|Overall Study|Withdrawal by Subject|9|||
155135912|NCT00646399|559929034|FG001|Overall Study|Withdrawal by Subject|10|||
155135913|NCT00646399|559929033|FG000|Overall Study|Other Reason|11|||
155135914|NCT00646399|559929034|FG001|Overall Study|Other Reason|11|||
155135915|NCT02160145|559929038|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
155135916|NCT02160145|559929039|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
155135917|NCT02160145|559929040|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
155135918|NCT02160145|559929038|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
155135919|NCT02160145|559929039|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
155135920|NCT02160145|559929040|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
155135921|NCT02160145|559929038|FG000|Randomized Double-blind Period|Subject decision|0|||
155135922|NCT02160145|559929039|FG001|Randomized Double-blind Period|Subject decision|21|||
155135923|NCT02160145|559929040|FG002|Randomized Double-blind Period|Subject decision|20|||
155135924|NCT02160145|559929038|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
155135925|NCT02160145|559929039|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
155135926|NCT02160145|559929040|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
155135927|NCT02160145|559929038|FG000|Randomized Double-blind Period|Physician Decision|0|||
155135928|NCT02160145|559929039|FG001|Randomized Double-blind Period|Physician Decision|7|||
155135929|NCT02160145|559929040|FG002|Randomized Double-blind Period|Physician Decision|5|||
155135930|NCT00395850|559929041|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
155135931|NCT00395850|559929042|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
155135932|NCT00395850|559929043|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
155135933|NCT00395850|559929044|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
155135934|NCT00395850|559929041|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
155135935|NCT00395850|559929042|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
155135936|NCT00395850|559929043|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
155135937|NCT00395850|559929044|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
155135938|NCT00395850|559929041|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
155135939|NCT00395850|559929042|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
155135940|NCT00395850|559929043|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
155135941|NCT00395850|559929044|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
155135942|NCT00395850|559929041|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
155135943|NCT00395850|559929042|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
155135944|NCT00395850|559929043|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
155135945|NCT00395850|559929044|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
155135946|NCT00395850|559929041|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
155135947|NCT00395850|559929042|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
155135948|NCT00395850|559929043|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
155135949|NCT00395850|559929044|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
155135950|NCT00395850|559929041|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
155135951|NCT00395850|559929042|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
155135952|NCT00395850|559929043|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
155135953|NCT00395850|559929044|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
155135954|NCT00395850|559929041|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
155135955|NCT00395850|559929042|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
155135956|NCT00395850|559929043|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
155135957|NCT00395850|559929044|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
155135958|NCT02540993|559929045|FG000|Overall Study|Lost to Follow-up|5|||
155135959|NCT02540993|559929046|FG001|Overall Study|Lost to Follow-up|3|||
155135960|NCT02540993|559929045|FG000|Overall Study|Withdrawal by Subject|4|||
155135961|NCT02540993|559929046|FG001|Overall Study|Withdrawal by Subject|6|||
155135962|NCT02540993|559929045|FG000|Overall Study|GCP violations|33|||
155135963|NCT02540993|559929046|FG001|Overall Study|GCP violations|27|||
155135964|NCT00844558|559929047|FG000|Overall Study|Withdrawal by Subject|9|||
155135965|NCT00844558|559929048|FG001|Overall Study|Withdrawal by Subject|2|||
155014921|NCT00658723|559480519|FG001|Overall Study|Death|1|||
155014922|NCT00658723|559480520|FG002|Overall Study|Death|4|||
155014923|NCT00658723|559480518|FG000|Overall Study|Scheduling Issue|1|||
155014924|NCT00658723|559480519|FG001|Overall Study|Scheduling Issue|1|||
155014925|NCT00658723|559480520|FG002|Overall Study|Scheduling Issue|0|||
155014926|NCT00658723|559480518|FG000|Overall Study|Withdrawal by Subject|1|||
155014927|NCT00658723|559480519|FG001|Overall Study|Withdrawal by Subject|0|||
155014928|NCT00658723|559480520|FG002|Overall Study|Withdrawal by Subject|1|||
155014929|NCT03876743|559480521|FG000|Overall Study|Lost to Follow-up|6|||
155014930|NCT03876743|559480522|FG001|Overall Study|Lost to Follow-up|4|||
155014931|NCT03876743|559480523|FG002|Overall Study|Lost to Follow-up|4|||
155014932|NCT03876743|559480524|FG003|Overall Study|Lost to Follow-up|7|||
155014933|NCT03889418|559480525|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
155014934|NCT03889418|559480526|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014935|NCT03889418|559480527|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014936|NCT03889418|559480528|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014937|NCT03889418|559480529|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014938|NCT03889418|559480530|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014939|NCT03889418|559480531|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014940|NCT03889418|559480532|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014941|NCT03889418|559480533|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014942|NCT03889418|559480534|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
155014943|NCT03889418|559480525|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014944|NCT03889418|559480526|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
155014945|NCT03889418|559480527|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
155014946|NCT03889418|559480528|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014947|NCT03889418|559480529|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014948|NCT03889418|559480530|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014949|NCT03889418|559480531|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014950|NCT03889418|559480532|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014951|NCT03889418|559480533|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014952|NCT03889418|559480534|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
155014953|NCT03889418|559480525|FG000|October-December 2019 (Month 7-9)|Death|0|||
155014954|NCT03889418|559480526|FG001|October-December 2019 (Month 7-9)|Death|0|||
155014955|NCT03889418|559480527|FG002|October-December 2019 (Month 7-9)|Death|0|||
155014956|NCT03889418|559480528|FG003|October-December 2019 (Month 7-9)|Death|0|||
155014957|NCT03889418|559480529|FG004|October-December 2019 (Month 7-9)|Death|0|||
155014958|NCT03889418|559480530|FG005|October-December 2019 (Month 7-9)|Death|0|||
155014959|NCT03889418|559480531|FG006|October-December 2019 (Month 7-9)|Death|0|||
155014960|NCT03889418|559480532|FG007|October-December 2019 (Month 7-9)|Death|0|||
155014961|NCT03889418|559480533|FG008|October-December 2019 (Month 7-9)|Death|1|||
155014962|NCT03889418|559480534|FG009|October-December 2019 (Month 7-9)|Death|0|||
155014963|NCT03889418|559480525|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014964|NCT03889418|559480526|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014965|NCT03889418|559480527|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014966|NCT03889418|559480528|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
155014967|NCT03889418|559480529|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014968|NCT03889418|559480530|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014969|NCT03889418|559480531|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014970|NCT03889418|559480532|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
155014971|NCT03889418|559480533|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014972|NCT03889418|559480534|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
155014973|NCT03889418|559480525|FG000|April - June 2020 (Month 13-15)|Death|0|||
155014974|NCT03889418|559480526|FG001|April - June 2020 (Month 13-15)|Death|1|||
155014975|NCT03889418|559480527|FG002|April - June 2020 (Month 13-15)|Death|0|||
155014976|NCT03889418|559480528|FG003|April - June 2020 (Month 13-15)|Death|0|||
155014977|NCT03889418|559480529|FG004|April - June 2020 (Month 13-15)|Death|0|||
155014978|NCT03889418|559480530|FG005|April - June 2020 (Month 13-15)|Death|0|||
155014979|NCT03889418|559480531|FG006|April - June 2020 (Month 13-15)|Death|0|||
155014980|NCT03889418|559480532|FG007|April - June 2020 (Month 13-15)|Death|0|||
155014981|NCT03889418|559480533|FG008|April - June 2020 (Month 13-15)|Death|0|||
155014982|NCT03889418|559480534|FG009|April - June 2020 (Month 13-15)|Death|0|||
155014983|NCT03889418|559480525|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014984|NCT03889418|559480526|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014985|NCT03889418|559480527|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014986|NCT03889418|559480528|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
155135966|NCT00844558|559929047|FG000|Overall Study|Death|1|||
155135967|NCT00844558|559929048|FG001|Overall Study|Death|0|||
155014987|NCT03889418|559480529|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014988|NCT03889418|559480530|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014989|NCT03889418|559480531|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155135968|NCT00844558|559929047|FG000|Overall Study|Protocol Violation|1|||
155135969|NCT00844558|559929048|FG001|Overall Study|Protocol Violation|1|||
155135970|NCT00844558|559929047|FG000|Overall Study|Lost to Follow-up|0|||
155135971|NCT00844558|559929048|FG001|Overall Study|Lost to Follow-up|1|||
155135972|NCT00844558|559929047|FG000|Overall Study|Physician Decision|1|||
155135973|NCT00844558|559929048|FG001|Overall Study|Physician Decision|0|||
155135974|NCT00588094|559929049|FG000|Overall Study|Adverse Event|3|||
155135975|NCT00588094|559929049|FG000|Overall Study|Progression of Disease|2|||
155135976|NCT02951429|559929056|FG000|Overall Study|Adverse Event|3|||
155135977|NCT02951429|559929057|FG001|Overall Study|Adverse Event|7|||
155135978|NCT02951429|559929056|FG000|Overall Study|Death|28|||
155135979|NCT02951429|559929057|FG001|Overall Study|Death|36|||
155135980|NCT02951429|559929056|FG000|Overall Study|Lack of Efficacy|0|||
155135981|NCT02951429|559929057|FG001|Overall Study|Lack of Efficacy|1|||
155135982|NCT02951429|559929056|FG000|Overall Study|Lost to Follow-up|0|||
155135983|NCT02951429|559929057|FG001|Overall Study|Lost to Follow-up|1|||
155135984|NCT02951429|559929056|FG000|Overall Study|Lung Transplantation|9|||
155135985|NCT02951429|559929057|FG001|Overall Study|Lung Transplantation|6|||
155135986|NCT02951429|559929056|FG000|Overall Study|Other|1|||
155135987|NCT02951429|559929057|FG001|Overall Study|Other|3|||
155135988|NCT02951429|559929056|FG000|Overall Study|Progressive Disease|1|||
155135989|NCT02951429|559929057|FG001|Overall Study|Progressive Disease|1|||
155135990|NCT02951429|559929056|FG000|Overall Study|Withdrawal by Subject|7|||
155135991|NCT02951429|559929057|FG001|Overall Study|Withdrawal by Subject|11|||
155135992|NCT02951429|559929056|FG000|Overall Study|Participant ongoing in the study|23|||
155135993|NCT02951429|559929057|FG001|Overall Study|Participant ongoing in the study|17|||
155135994|NCT02202538|559929060|FG000|Overall Study|Withdrawal by Subject|5|||
155135995|NCT02202538|559929060|FG000|Overall Study|Did not meet all inclusion criteria|2|||
155135996|NCT02202538|559929060|FG000|Overall Study|Investigator Decision|1|||
155135997|NCT01457846|559929061|FG000|Overall Study|Death before treatment|1|||
155135998|NCT01457846|559929062|FG001|Overall Study|Death before treatment|2|||
155135999|NCT01457846|559929061|FG000|Overall Study|Did not receive treatment|0|||
155136000|NCT01457846|559929062|FG001|Overall Study|Did not receive treatment|1|||
155136001|NCT01457846|559929061|FG000|Overall Study|Death|27|||
155136002|NCT01457846|559929062|FG001|Overall Study|Death|16|||
155136003|NCT01457846|559929061|FG000|Overall Study|Unclassified reason for not completed|11|||
155136004|NCT01457846|559929062|FG001|Overall Study|Unclassified reason for not completed|10|||
155136005|NCT01457846|559929061|FG000|Overall Study|Withdrawal by Subject|1|||
155136006|NCT01457846|559929062|FG001|Overall Study|Withdrawal by Subject|1|||
155136007|NCT01457846|559929061|FG000|Overall Study|Lost to Follow-up|1|||
155136008|NCT01457846|559929062|FG001|Overall Study|Lost to Follow-up|0|||
155136009|NCT01853878|559929063|FG000|Overall Study|Recurrence|2|||
155136010|NCT01853878|559929064|FG001|Overall Study|Recurrence|0|||
155136011|NCT01853878|559929063|FG000|Overall Study|Adverse Event|2|||
155136012|NCT01853878|559929064|FG001|Overall Study|Adverse Event|0|||
155136013|NCT01853878|559929063|FG000|Overall Study|Withdrawal by Subject|3|||
155136014|NCT01853878|559929064|FG001|Overall Study|Withdrawal by Subject|1|||
155136015|NCT01853878|559929063|FG000|Overall Study|Migrated/moved from the study area|1|||
155136016|NCT01853878|559929064|FG001|Overall Study|Migrated/moved from the study area|0|||
155136017|NCT01853878|559929063|FG000|Overall Study|Other|55|||
155136018|NCT01853878|559929064|FG001|Overall Study|Other|43|||
155136019|NCT01846741|559929065|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
155136020|NCT04294147|559929068|FG000|Overall Study|Protocol Violation|2|||
155136021|NCT04294147|559929069|FG001|Overall Study|Protocol Violation|0|||
155136022|NCT03916081|559929070|FG000|Overall Study|Adverse Event|1|||
155136023|NCT03916081|559929071|FG001|Overall Study|Adverse Event|0|||
155136024|NCT03916081|559929072|FG002|Overall Study|Adverse Event|0|||
155136025|NCT03916081|559929070|FG000|Overall Study|Physician Decision|0|||
155136026|NCT03916081|559929071|FG001|Overall Study|Physician Decision|0|||
155136027|NCT03916081|559929072|FG002|Overall Study|Physician Decision|1|||
155136028|NCT03916081|559929070|FG000|Overall Study|Lost to Follow-up|0|||
155136029|NCT03916081|559929071|FG001|Overall Study|Lost to Follow-up|1|||
155136030|NCT03916081|559929072|FG002|Overall Study|Lost to Follow-up|0|||
155136031|NCT03916081|559929070|FG000|Overall Study|Withdrawal by Subject|3|||
155136032|NCT03916081|559929071|FG001|Overall Study|Withdrawal by Subject|0|||
155136033|NCT03916081|559929072|FG002|Overall Study|Withdrawal by Subject|1|||
155136034|NCT03916081|559929070|FG000|Overall Study|Worsening of AD|0|||
155136035|NCT03916081|559929071|FG001|Overall Study|Worsening of AD|0|||
155136036|NCT03916081|559929072|FG002|Overall Study|Worsening of AD|1|||
155136037|NCT01240135|559929075|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
155178723|NCT01966432|560093378|FG002|Overall Study|SBIRT program ended|20|||
155136038|NCT01240135|559929076|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
155136039|NCT01240135|559929075|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
155136040|NCT01240135|559929076|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
155136041|NCT01817959|559929081|FG000|Overall Study|Graft loss|1|||
155136042|NCT01817959|559929082|FG001|Overall Study|Graft loss|1|||
155136043|NCT01817959|559929081|FG000|Overall Study|forbidden medication|1|||
155136044|NCT01817959|559929082|FG001|Overall Study|forbidden medication|1|||
155136045|NCT01817959|559929081|FG000|Overall Study|Adverse Event|1|||
155178724|NCT02536404|560093388|FG000|Overall Study|Adverse Event|5|||
155014990|NCT03889418|559480532|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014991|NCT03889418|559480533|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014992|NCT03889418|559480534|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
155014993|NCT03889418|559480525|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
155014994|NCT03889418|559480526|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
155014995|NCT03889418|559480527|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
155014996|NCT03889418|559480528|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
155014997|NCT03889418|559480529|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
155014998|NCT03889418|559480530|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
155014999|NCT03889418|559480531|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
155015000|NCT03889418|559480532|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
155015001|NCT03889418|559480533|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
155015002|NCT03889418|559480534|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
155015003|NCT03889418|559480525|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155015004|NCT03889418|559480526|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
155178725|NCT02536404|560093389|FG001|Overall Study|Adverse Event|0|||
155178726|NCT02536404|560093388|FG000|Overall Study|Withdrawal by Subject|4|||
155178727|NCT02536404|560093389|FG001|Overall Study|Withdrawal by Subject|1|||
155178728|NCT02536404|560093388|FG000|Overall Study|Physician Decision|10|||
155178729|NCT02536404|560093389|FG001|Overall Study|Physician Decision|0|||
155178730|NCT02536404|560093388|FG000|Overall Study|Sponsor decision|1|||
155178731|NCT02536404|560093389|FG001|Overall Study|Sponsor decision|0|||
155178732|NCT03915860|560093390|FG000|Overall Study|Adverse Event|3|||
155178733|NCT03915860|560093390|FG000|Overall Study|Withdrawal by Subject|6|||
155178734|NCT03915860|560093390|FG000|Overall Study|Lost to Follow-up|2|||
155178735|NCT03915860|560093390|FG000|Overall Study|Other than specified|3|||
155178736|NCT04559529|560093391|FG000|First Intervention (1 Day)|Adverse Event|0|||
155178737|NCT04559529|560093392|FG001|First Intervention (1 Day)|Adverse Event|0|||
155178738|NCT04559529|560093393|FG002|First Intervention (1 Day)|Adverse Event|0|||
155178739|NCT04559529|560093394|FG003|First Intervention (1 Day)|Adverse Event|1|||
155198473|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
155015005|NCT03889418|559480527|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
155015006|NCT03889418|559480528|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
155136046|NCT01817959|559929082|FG001|Overall Study|Adverse Event|0|||
155136047|NCT01817959|559929081|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
155136048|NCT01817959|559929082|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
155136049|NCT03244826|559929083|FG000|Overall Study|Withdrawal by Subject|2|||
155136050|NCT03244826|559929084|FG001|Overall Study|Withdrawal by Subject|0|||
155136051|NCT03244826|559929083|FG000|Overall Study|Transplant delayed or withdrawn|12|||
155136052|NCT03244826|559929084|FG001|Overall Study|Transplant delayed or withdrawn|10|||
155136053|NCT02828020|559929088|FG000|Treatment Period|Adverse Event|3|||
155136054|NCT02828020|559929089|FG001|Treatment Period|Adverse Event|1|||
155136055|NCT02828020|559929090|FG002|Treatment Period|Adverse Event|1|||
155136056|NCT02828020|559929088|FG000|Treatment Period|Withdrawal of Consent|10|||
155136057|NCT02828020|559929089|FG001|Treatment Period|Withdrawal of Consent|14|||
155136058|NCT02828020|559929090|FG002|Treatment Period|Withdrawal of Consent|9|||
155136059|NCT02828020|559929088|FG000|Treatment Period|Lost to Follow-up|21|||
155136060|NCT02828020|559929089|FG001|Treatment Period|Lost to Follow-up|24|||
155136061|NCT02828020|559929090|FG002|Treatment Period|Lost to Follow-up|18|||
155136062|NCT02828020|559929088|FG000|Treatment Period|Lack of Qualifying Event|44|||
155136063|NCT02828020|559929089|FG001|Treatment Period|Lack of Qualifying Event|53|||
155136064|NCT02828020|559929090|FG002|Treatment Period|Lack of Qualifying Event|43|||
155136065|NCT02828020|559929088|FG000|Treatment Period|Pregnancy|0|||
155136066|NCT02828020|559929089|FG001|Treatment Period|Pregnancy|2|||
155136067|NCT02828020|559929090|FG002|Treatment Period|Pregnancy|0|||
155136068|NCT02828020|559929088|FG000|Treatment Period|Protocol Violation|2|||
155136069|NCT02828020|559929089|FG001|Treatment Period|Protocol Violation|4|||
155136070|NCT02828020|559929090|FG002|Treatment Period|Protocol Violation|7|||
155136071|NCT02828020|559929088|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
155136072|NCT02828020|559929089|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
155136073|NCT02828020|559929090|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
155136074|NCT02828020|559929088|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
155136075|NCT02828020|559929089|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
155136076|NCT02828020|559929090|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
155015007|NCT03889418|559480529|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155015008|NCT03889418|559480530|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155015009|NCT03889418|559480531|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155015010|NCT03889418|559480532|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
155136077|NCT02828020|559929088|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
155136078|NCT02828020|559929089|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
155136079|NCT02828020|559929090|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
155136080|NCT02828020|559929088|FG000|Safety Follow-up Period|Protocol Violation|0|||
155136081|NCT02828020|559929089|FG001|Safety Follow-up Period|Protocol Violation|2|||
155136082|NCT02828020|559929090|FG002|Safety Follow-up Period|Protocol Violation|1|||
155136083|NCT02828020|559929088|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
155136084|NCT02828020|559929089|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
155136085|NCT02828020|559929090|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
155136086|NCT04356352|559929091|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
155136087|NCT04356352|559929092|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
155136088|NCT04356352|559929093|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
155136089|NCT04356352|559929091|FG000|Overall Study|Protocol Violation|0|||
155136090|NCT04356352|559929092|FG001|Overall Study|Protocol Violation|3|||
155136091|NCT04356352|559929093|FG002|Overall Study|Protocol Violation|1|||
155136092|NCT00416455|559929094|FG000|Overall Study|PET / CT not done|3|||
155136093|NCT00416455|559929095|FG001|Overall Study|PET / CT not done|5|||
155136094|NCT00416455|559929094|FG000|Overall Study|PET / CT poor quality|2|||
155136095|NCT00416455|559929095|FG001|Overall Study|PET / CT poor quality|1|||
155136096|NCT00416455|559929094|FG000|Overall Study|Inadequate pathology|11|||
155136097|NCT00416455|559929095|FG001|Overall Study|Inadequate pathology|2|||
155136098|NCT01183065|559929097|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
155136099|NCT01983774|559929101|FG000|Overall Study|Lung Transplant|0|||
155136100|NCT01983774|559929102|FG001|Overall Study|Lung Transplant|1|||
155136101|NCT01983774|559929101|FG000|Overall Study|Lost to Follow-up|1|||
155136102|NCT01983774|559929102|FG001|Overall Study|Lost to Follow-up|0|||
155136103|NCT03657095|559929104|FG000|Overall Study|Withdrawal by Subject|1|||
155136104|NCT03657095|559929105|FG001|Overall Study|Withdrawal by Subject|1|||
155136105|NCT03657095|559929104|FG000|Overall Study|Adverse Event|0|||
155136106|NCT03657095|559929105|FG001|Overall Study|Adverse Event|3|||
155136107|NCT03657095|559929104|FG000|Overall Study|Study Terminated by Sponsor|58|||
155136108|NCT03657095|559929105|FG001|Overall Study|Study Terminated by Sponsor|49|||
155136109|NCT00847197|559929106|FG000|Overall Study|Adverse Event|21|||
155136110|NCT00847197|559929107|FG001|Overall Study|Adverse Event|3|||
155136111|NCT00847197|559929106|FG000|Overall Study|Protocol Violation|0|||
155136112|NCT00847197|559929107|FG001|Overall Study|Protocol Violation|1|||
155136113|NCT00847197|559929106|FG000|Overall Study|Withdrawal by Subject|3|||
155136114|NCT00847197|559929107|FG001|Overall Study|Withdrawal by Subject|1|||
155136115|NCT04378114|559929110|FG000|Overall Study|Withdrawal by Subject|5|||
155136116|NCT00830180|559929111|FG000|Overall Study|Adverse Event|6|||
155136117|NCT00830180|559929111|FG000|Overall Study|Death|11|||
155136118|NCT00830180|559929111|FG000|Overall Study|Insufficient clinical response|1|||
155136119|NCT00830180|559929111|FG000|Overall Study|Withdrawal by Subject|5|||
155136120|NCT00830180|559929111|FG000|Overall Study|Progressive disease|2|||
155136121|NCT00830180|559929111|FG000|Overall Study|Other - Unspecified|1|||
155136122|NCT01832532|559929112|FG000|Overall Study|Withdrawal by Subject|5|||
155136123|NCT01832532|559929113|FG001|Overall Study|Withdrawal by Subject|2|||
155136124|NCT00392990|559929115|FG000|Treatment on Study|Adverse Event|3|||
155136125|NCT00392990|559929116|FG001|Treatment on Study|Adverse Event|1|||
155136126|NCT00392990|559929115|FG000|Follow up for 2 Years|Death|4|||
155136127|NCT00392990|559929116|FG001|Follow up for 2 Years|Death|0|||
155136128|NCT00825812|559929120|FG000|Overall Study|Never entered follow up|0|||
155136129|NCT00825812|559929121|FG001|Overall Study|Never entered follow up|0|||
155136130|NCT00825812|559929122|FG002|Overall Study|Never entered follow up|0|||
155136131|NCT00825812|559929123|FG003|Overall Study|Never entered follow up|1|||
155136132|NCT00825812|559929120|FG000|Overall Study|Adverse Event|0|||
155136133|NCT00825812|559929121|FG001|Overall Study|Adverse Event|0|||
155136134|NCT00825812|559929122|FG002|Overall Study|Adverse Event|0|||
155136135|NCT00825812|559929123|FG003|Overall Study|Adverse Event|1|||
155136136|NCT00825812|559929120|FG000|Overall Study|Subject withdrew consent|0|||
155136137|NCT00825812|559929121|FG001|Overall Study|Subject withdrew consent|0|||
155136138|NCT00825812|559929122|FG002|Overall Study|Subject withdrew consent|3|||
155136139|NCT00825812|559929123|FG003|Overall Study|Subject withdrew consent|2|||
155136140|NCT00825812|559929120|FG000|Overall Study|Non-compliance with protocol|0|||
155136141|NCT00825812|559929121|FG001|Overall Study|Non-compliance with protocol|0|||
155136142|NCT00825812|559929122|FG002|Overall Study|Non-compliance with protocol|0|||
155136143|NCT00825812|559929123|FG003|Overall Study|Non-compliance with protocol|1|||
155136144|NCT00825812|559929120|FG000|Overall Study|Administrative|0|||
155136145|NCT00825812|559929121|FG001|Overall Study|Administrative|1|||
155136146|NCT00825812|559929122|FG002|Overall Study|Administrative|3|||
155136147|NCT00825812|559929123|FG003|Overall Study|Administrative|5|||
155136148|NCT00991406|559929125|FG000|Overall Study|One participant did not respond to FES.|1|||
155136149|NCT00887549|559931198|FG000|Induction Therapy|Adverse Event|8|||
155136150|NCT00887549|559931198|FG000|Induction Therapy|Physician Decision|1|||
155136151|NCT00887549|559931198|FG000|Induction Therapy|Progressive Disease|13|||
155136152|NCT00887549|559931198|FG000|Induction Therapy|Death due to Study Disease|4|||
155136153|NCT00887549|559931198|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
155136154|NCT00887549|559931198|FG000|Maintenance Therapy|Adverse Event|16|||
155136155|NCT00887549|559931198|FG000|Maintenance Therapy|Physician Decision|1|||
155136156|NCT00887549|559931198|FG000|Maintenance Therapy|Progressive Disease|25|||
155136157|NCT00887549|559931198|FG000|Maintenance Therapy|Death due to adverse event|1|||
155136158|NCT00100789|559931199|FG000|Overall Study|Adverse Event|10|||
155136159|NCT00100789|559931199|FG000|Overall Study|Withdrawal by Subject|1|||
155136160|NCT00100789|559931199|FG000|Overall Study|Progression/relapse|42|||
155136161|NCT00100789|559931199|FG000|Overall Study|Death|2|||
155136162|NCT00100789|559931199|FG000|Overall Study|Not protocol specified|5|||
155136163|NCT00100789|559931199|FG000|Overall Study|Ineligible|3|||
155136164|NCT00100789|559931199|FG000|Overall Study|Never received treatment|1|||
155136165|NCT03472950|559931200|FG000|Overall Study|Lost to Follow-up|0|||
155136166|NCT03472950|559931201|FG001|Overall Study|Lost to Follow-up|1|||
155136167|NCT03472950|559931200|FG000|Overall Study|Adverse Event|0|||
155136168|NCT03472950|559931201|FG001|Overall Study|Adverse Event|3|||
155136169|NCT00377858|559931206|FG000|Overall Study|Withdrawal by Subject|12|||
155136170|NCT00377858|559931207|FG001|Overall Study|Withdrawal by Subject|11|||
155136171|NCT00377858|559931206|FG000|Overall Study|Lost to Follow-up|6|||
155136172|NCT00377858|559931207|FG001|Overall Study|Lost to Follow-up|1|||
155136173|NCT00377858|559931206|FG000|Overall Study|Physician Decision|5|||
155136174|NCT00377858|559931207|FG001|Overall Study|Physician Decision|5|||
155136175|NCT00377858|559931206|FG000|Overall Study|Protocol Violation|3|||
155136176|NCT00377858|559931207|FG001|Overall Study|Protocol Violation|4|||
155136177|NCT00377858|559931206|FG000|Overall Study|Adverse Event|2|||
155136178|NCT00377858|559931207|FG001|Overall Study|Adverse Event|1|||
155136179|NCT00377858|559931206|FG000|Overall Study|Entry Criteria Not Met|2|||
155136180|NCT00377858|559931207|FG001|Overall Study|Entry Criteria Not Met|0|||
155136181|NCT00377858|559931206|FG000|Overall Study|Sponsor Decision|1|||
155136182|NCT00377858|559931207|FG001|Overall Study|Sponsor Decision|2|||
155136183|NCT00377858|559931206|FG000|Overall Study|Death|0|||
155136184|NCT00377858|559931207|FG001|Overall Study|Death|3|||
155136185|NCT03534141|559931208|FG000|Overall Study|Enrolled in other clinical trial|1|||
155136186|NCT03534141|559931209|FG001|Overall Study|Enrolled in other clinical trial|0|||
155136187|NCT03534141|559931208|FG000|Overall Study|Liver transplant aborted after randomization|0|||
155136188|NCT03534141|559931209|FG001|Overall Study|Liver transplant aborted after randomization|2|||
155136189|NCT03534141|559931208|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
155136190|NCT03534141|559931209|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
155136191|NCT00517361|559931210|FG000|Overall Study|Death|6|||
155136192|NCT00517361|559931210|FG000|Overall Study|The study was terminated|5|||
155136193|NCT01824355|559931214|FG000|Overall Study|Adverse Event|2|||
155136194|NCT01824355|559931214|FG000|Overall Study|unevaluable reference method results per|1|||
155136195|NCT04124705|559931215|FG000|Titration Period|Adverse Event|9|||
155136196|NCT04124705|559931216|FG001|Titration Period|Adverse Event|5|||
155136197|NCT04124705|559931215|FG000|Titration Period|Withdrawal by Subject|6|||
155136198|NCT04124705|559931216|FG001|Titration Period|Withdrawal by Subject|3|||
155136199|NCT04124705|559931215|FG000|Titration Period|Lost to Follow-up|0|||
155136200|NCT04124705|559931216|FG001|Titration Period|Lost to Follow-up|1|||
155136201|NCT04124705|559931215|FG000|Titration Period|Death|1|||
155136202|NCT04124705|559931216|FG001|Titration Period|Death|1|||
155136203|NCT04124705|559931215|FG000|Titration Period|Lack of Efficacy|2|||
155136204|NCT04124705|559931216|FG001|Titration Period|Lack of Efficacy|0|||
155136205|NCT04124705|559931215|FG000|Titration Period|Physician Decision|2|||
155136206|NCT04124705|559931216|FG001|Titration Period|Physician Decision|0|||
155136207|NCT04124705|559931215|FG000|Titration Period|Non-compliance with Study Drug|2|||
155136208|NCT04124705|559931216|FG001|Titration Period|Non-compliance with Study Drug|0|||
155136209|NCT04124705|559931215|FG000|Titration Period|Other|4|||
155136210|NCT04124705|559931216|FG001|Titration Period|Other|9|||
155136211|NCT04124705|559931215|FG000|Stabilization Period|Adverse Event|4|||
155136212|NCT04124705|559931216|FG001|Stabilization Period|Adverse Event|2|||
155136213|NCT04124705|559931215|FG000|Stabilization Period|Withdrawal by Subject|1|||
155136214|NCT04124705|559931216|FG001|Stabilization Period|Withdrawal by Subject|1|||
155136215|NCT04124705|559931215|FG000|Stabilization Period|Lost to Follow-up|0|||
155136216|NCT04124705|559931216|FG001|Stabilization Period|Lost to Follow-up|1|||
155136217|NCT04124705|559931215|FG000|Stabilization Period|Lack of Efficacy|4|||
155136218|NCT04124705|559931216|FG001|Stabilization Period|Lack of Efficacy|2|||
155136219|NCT04124705|559931215|FG000|Stabilization Period|Protocol Deviation|0|||
155136220|NCT04124705|559931216|FG001|Stabilization Period|Protocol Deviation|2|||
155136221|NCT04124705|559931215|FG000|Stabilization Period|Other|2|||
155136222|NCT04124705|559931216|FG001|Stabilization Period|Other|2|||
155136223|NCT00661622|559931217|FG000|Overall Study|Protocol Violation|1|||
155136224|NCT00661622|559931218|FG001|Overall Study|Protocol Violation|0|||
155136225|NCT04765202|559931223|FG000|Overall Study|Lost to Follow-up|1|||
155136226|NCT04765202|559931224|FG001|Overall Study|Lost to Follow-up|1|||
155136227|NCT04765202|559931225|FG002|Overall Study|Lost to Follow-up|2|||
155136228|NCT04765202|559931226|FG003|Overall Study|Lost to Follow-up|2|||
155136229|NCT04765202|559931223|FG000|Overall Study|Physician Decision|0|||
155136230|NCT04765202|559931224|FG001|Overall Study|Physician Decision|0|||
155136231|NCT04765202|559931225|FG002|Overall Study|Physician Decision|1|||
155136232|NCT04765202|559931226|FG003|Overall Study|Physician Decision|1|||
155136233|NCT04929249|559931227|FG000|Overall Study|Adverse Event|2|||
155136234|NCT04929249|559931228|FG001|Overall Study|Adverse Event|1|||
155015011|NCT03889418|559480533|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
155015012|NCT03889418|559480534|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
155015013|NCT00092118|559480536|FG000|Overall Study|Adverse Event|35|||
155015014|NCT00092118|559480537|FG001|Overall Study|Adverse Event|32|||
155015015|NCT00092118|559480536|FG000|Overall Study|Lack of Efficacy|12|||
155015016|NCT00092118|559480537|FG001|Overall Study|Lack of Efficacy|14|||
155015017|NCT00092118|559480536|FG000|Overall Study|Lost to Follow-up|4|||
155015018|NCT00092118|559480537|FG001|Overall Study|Lost to Follow-up|3|||
155015019|NCT00092118|559480536|FG000|Overall Study|Protocol Violation|23|||
155015020|NCT00092118|559480537|FG001|Overall Study|Protocol Violation|25|||
155015021|NCT00092118|559480536|FG000|Overall Study|Withdrawal by Subject|4|||
155015022|NCT00092118|559480537|FG001|Overall Study|Withdrawal by Subject|10|||
155015023|NCT00092118|559480536|FG000|Overall Study|Other|6|||
155015024|NCT00092118|559480537|FG001|Overall Study|Other|5|||
155015025|NCT01139125|559480540|FG000|Overall Study|Withdrawal by Subject|1|||
155015026|NCT02172664|559480543|FG000|Overall Study|Lost to Follow-up|4|||
155015027|NCT02172664|559480544|FG001|Overall Study|Lost to Follow-up|4|||
155015028|NCT02172664|559480543|FG000|Overall Study|Death|1|||
155015029|NCT02172664|559480544|FG001|Overall Study|Death|1|||
155015030|NCT02172664|559480543|FG000|Overall Study|Moved out of area|1|||
155015031|NCT02172664|559480544|FG001|Overall Study|Moved out of area|1|||
155015032|NCT03380429|559480549|FG000|Overall Study|Physician Decision|0|||
155015033|NCT03380429|559480550|FG001|Overall Study|Physician Decision|1|||
155015034|NCT03380429|559480551|FG002|Overall Study|Physician Decision|0|||
155015035|NCT03380429|559480552|FG003|Overall Study|Physician Decision|1|||
155015036|NCT03380429|559480553|FG004|Overall Study|Physician Decision|1|||
155015037|NCT03380429|559480549|FG000|Overall Study|Withdrawal by Subject|3|||
155015038|NCT03380429|559480550|FG001|Overall Study|Withdrawal by Subject|3|||
155015039|NCT03380429|559480551|FG002|Overall Study|Withdrawal by Subject|5|||
155015040|NCT03380429|559480552|FG003|Overall Study|Withdrawal by Subject|2|||
155015041|NCT03380429|559480553|FG004|Overall Study|Withdrawal by Subject|1|||
155015042|NCT03380429|559480549|FG000|Overall Study|Lost to Follow-up|0|||
155015043|NCT03380429|559480550|FG001|Overall Study|Lost to Follow-up|2|||
155015044|NCT03380429|559480551|FG002|Overall Study|Lost to Follow-up|4|||
155015045|NCT03380429|559480552|FG003|Overall Study|Lost to Follow-up|3|||
155015046|NCT03380429|559480553|FG004|Overall Study|Lost to Follow-up|1|||
155015047|NCT03380429|559480549|FG000|Overall Study|Protocol Violation|1|||
155015048|NCT03380429|559480550|FG001|Overall Study|Protocol Violation|0|||
155015049|NCT03380429|559480551|FG002|Overall Study|Protocol Violation|1|||
155015050|NCT03380429|559480552|FG003|Overall Study|Protocol Violation|0|||
155015051|NCT03380429|559480553|FG004|Overall Study|Protocol Violation|1|||
155015052|NCT03380429|559480549|FG000|Overall Study|Lack of Efficacy|0|||
155015053|NCT03380429|559480550|FG001|Overall Study|Lack of Efficacy|0|||
155015054|NCT03380429|559480551|FG002|Overall Study|Lack of Efficacy|0|||
155015055|NCT03380429|559480552|FG003|Overall Study|Lack of Efficacy|2|||
155015056|NCT03380429|559480553|FG004|Overall Study|Lack of Efficacy|1|||
155015057|NCT03380429|559480549|FG000|Overall Study|Adverse Event|1|||
155015058|NCT03380429|559480550|FG001|Overall Study|Adverse Event|1|||
155015059|NCT03380429|559480551|FG002|Overall Study|Adverse Event|1|||
155015060|NCT03380429|559480552|FG003|Overall Study|Adverse Event|2|||
155015061|NCT03380429|559480553|FG004|Overall Study|Adverse Event|0|||
155015062|NCT01198470|559480558|FG000|Overall Study|Adverse Event|2|||
155015063|NCT02949973|559480559|FG000|Overall Study|Physician Decision|1|||
155015064|NCT04760626|559480560|FG000|Overall Study|Withdrawal by Subject|24|||
155015065|NCT04760626|559480561|FG001|Overall Study|Withdrawal by Subject|20|||
155015066|NCT04760626|559480560|FG000|Overall Study|Lost to Follow-up|14|||
155015067|NCT04760626|559480561|FG001|Overall Study|Lost to Follow-up|19|||
155015068|NCT04760626|559480560|FG000|Overall Study|Physician Decision|3|||
155015069|NCT04760626|559480561|FG001|Overall Study|Physician Decision|5|||
155015070|NCT04760626|559480560|FG000|Overall Study|Death|3|||
155015071|NCT04760626|559480561|FG001|Overall Study|Death|6|||
155015072|NCT04760626|559480560|FG000|Overall Study|Site closure|1|||
155015073|NCT04760626|559480561|FG001|Overall Study|Site closure|0|||
155015074|NCT01924689|559480564|FG000|Overall Study|Death|0|||
155015075|NCT01924689|559480565|FG001|Overall Study|Death|1|||
155015076|NCT01924689|559480566|FG002|Overall Study|Death|0|||
155015077|NCT01924689|559480567|FG003|Overall Study|Death|1|||
155015078|NCT01924689|559480568|FG004|Overall Study|Death|0|||
155015079|NCT01924689|559480569|FG005|Overall Study|Death|0|||
155015080|NCT01924689|559480564|FG000|Overall Study|Disease progression|0|||
155015081|NCT01924689|559480565|FG001|Overall Study|Disease progression|0|||
155015082|NCT01924689|559480566|FG002|Overall Study|Disease progression|2|||
155015083|NCT01924689|559480567|FG003|Overall Study|Disease progression|0|||
155015084|NCT01924689|559480568|FG004|Overall Study|Disease progression|3|||
155136235|NCT04929249|559931227|FG000|Overall Study|Death|2|||
155015085|NCT01924689|559480569|FG005|Overall Study|Disease progression|2|||
155136236|NCT04929249|559931228|FG001|Overall Study|Death|1|||
155015086|NCT01924689|559480564|FG000|Overall Study|New therapy or study|3|||
155015087|NCT01924689|559480565|FG001|Overall Study|New therapy or study|2|||
155015088|NCT01924689|559480566|FG002|Overall Study|New therapy or study|1|||
155136237|NCT04929249|559931227|FG000|Overall Study|Lost to Follow-up|3|||
155015089|NCT01924689|559480567|FG003|Overall Study|New therapy or study|4|||
155015090|NCT01924689|559480568|FG004|Overall Study|New therapy or study|2|||
155015091|NCT01924689|559480569|FG005|Overall Study|New therapy or study|0|||
155015092|NCT01924689|559480564|FG000|Overall Study|Withdrawal of consent|0|||
155015093|NCT01924689|559480565|FG001|Overall Study|Withdrawal of consent|0|||
155015094|NCT01924689|559480566|FG002|Overall Study|Withdrawal of consent|1|||
155015095|NCT01924689|559480567|FG003|Overall Study|Withdrawal of consent|1|||
155015096|NCT01924689|559480568|FG004|Overall Study|Withdrawal of consent|0|||
155015097|NCT01924689|559480569|FG005|Overall Study|Withdrawal of consent|0|||
155015098|NCT01924689|559480564|FG000|Overall Study|Other|0|||
155015099|NCT01924689|559480565|FG001|Overall Study|Other|0|||
155015100|NCT01924689|559480566|FG002|Overall Study|Other|0|||
155015101|NCT01924689|559480567|FG003|Overall Study|Other|0|||
155015102|NCT01924689|559480568|FG004|Overall Study|Other|1|||
155015103|NCT01924689|559480569|FG005|Overall Study|Other|0|||
155015104|NCT00468819|559480570|FG000|Overall Study|Withdrawal by Subject|4|||
155015105|NCT00468819|559480571|FG001|Overall Study|Withdrawal by Subject|0|||
155015106|NCT00468819|559480572|FG002|Overall Study|Withdrawal by Subject|1|||
155015107|NCT00468819|559480570|FG000|Overall Study|Lost to Follow-up|0|||
155015108|NCT00468819|559480571|FG001|Overall Study|Lost to Follow-up|0|||
155015109|NCT00468819|559480572|FG002|Overall Study|Lost to Follow-up|1|||
155015110|NCT00468819|559480570|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
155015111|NCT00468819|559480571|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
155015112|NCT00468819|559480572|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
155015113|NCT02492867|559480573|FG000|Overall Study|Alternate therapy|1|||
155015114|NCT02492867|559480573|FG000|Overall Study|Withdrawal by Subject|2|||
155015115|NCT02492867|559480573|FG000|Overall Study|Disease progression after treatment started|1|||
155015116|NCT02492867|559480573|FG000|Overall Study|Death|1|||
155015117|NCT03296527|559480574|FG000|Overall Study|Adverse Event|15|||
155015118|NCT03296527|559480575|FG001|Overall Study|Adverse Event|33|||
155015119|NCT03296527|559480574|FG000|Overall Study|Protocol Deviation|4|||
155015120|NCT03296527|559480575|FG001|Overall Study|Protocol Deviation|0|||
155015121|NCT03296527|559480574|FG000|Overall Study|Participant withdrew consent|3|||
155015122|NCT03296527|559480575|FG001|Overall Study|Participant withdrew consent|1|||
155015123|NCT03296527|559480574|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
155015124|NCT03296527|559480575|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
155015125|NCT03296527|559480574|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
155015126|NCT03296527|559480575|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
155015127|NCT03296527|559480574|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
155015128|NCT03296527|559480575|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
155015129|NCT03296527|559480574|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
155015130|NCT03296527|559480575|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
155015131|NCT03296527|559480574|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
155015132|NCT03296527|559480575|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
155015133|NCT01597973|559480576|FG000|Overall Study|Found ineligible before study medication started|4|||
155015134|NCT01597973|559480577|FG001|Overall Study|Found ineligible before study medication started|2|||
155015135|NCT01597973|559480576|FG000|Overall Study|Eligible pathogen not confirmed|14|||
155015136|NCT01597973|559480577|FG001|Overall Study|Eligible pathogen not confirmed|15|||
155015137|NCT01597973|559480576|FG000|Overall Study|LAR not authorized to consent|0|||
155015138|NCT01597973|559480577|FG001|Overall Study|LAR not authorized to consent|1|||
155015139|NCT01597973|559480576|FG000|Overall Study|Ineligible due to early seizures|1|||
155015140|NCT01597973|559480577|FG001|Overall Study|Ineligible due to early seizures|0|||
155015141|NCT01597973|559480576|FG000|Overall Study|Ineligible due to non-target infection|1|||
155015142|NCT01597973|559480577|FG001|Overall Study|Ineligible due to non-target infection|1|||
155015143|NCT01326845|559480578|FG000|Overall Study|Administrative Problems|5|||
155015144|NCT01326845|559480579|FG001|Overall Study|Administrative Problems|2|||
155015145|NCT01326845|559480578|FG000|Overall Study|Adverse Event|1|||
155015146|NCT01326845|559480579|FG001|Overall Study|Adverse Event|0|||
155136238|NCT04929249|559931228|FG001|Overall Study|Lost to Follow-up|11|||
155136239|NCT04929249|559931227|FG000|Overall Study|Technical problems|0|||
155136240|NCT04929249|559931228|FG001|Overall Study|Technical problems|1|||
155136241|NCT04929249|559931227|FG000|Overall Study|Subject decision|6|||
155136242|NCT04929249|559931228|FG001|Overall Study|Subject decision|8|||
155136243|NCT04929249|559931227|FG000|Overall Study|Withdrew consent|0|||
155015147|NCT01326845|559480578|FG000|Overall Study|Misisng|1|||
155136244|NCT04929249|559931228|FG001|Overall Study|Withdrew consent|8|||
155136245|NCT02332291|559931231|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
155015148|NCT01326845|559480579|FG001|Overall Study|Misisng|3|||
155015149|NCT00908544|559480580|FG000|Overall Study|Withdrawal by Subject|2|||
155015150|NCT00908544|559480581|FG001|Overall Study|Withdrawal by Subject|4|||
155015151|NCT00908544|559480580|FG000|Overall Study|Lack of Efficacy|0|||
155015152|NCT00908544|559480581|FG001|Overall Study|Lack of Efficacy|1|||
155015153|NCT00908544|559480580|FG000|Overall Study|Pregnancy|1|||
155136246|NCT02332291|559931232|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
155136247|NCT02332291|559931231|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
155136248|NCT02332291|559931232|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
155136249|NCT02332291|559931231|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
155136250|NCT02332291|559931232|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
155136251|NCT02332291|559931231|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
155136252|NCT02332291|559931232|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
155136253|NCT02332291|559931231|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
155136254|NCT02332291|559931232|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
155136255|NCT02332291|559931231|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
155136256|NCT02332291|559931232|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
155136257|NCT01620762|559931246|FG000|Overall Study|Protocol Violation|1|||
155136258|NCT01620762|559931247|FG001|Overall Study|Protocol Violation|1|||
155136259|NCT01620762|559931248|FG002|Overall Study|Protocol Violation|1|||
155136260|NCT01620762|559931246|FG000|Overall Study|Adverse Event|9|||
155136261|NCT01620762|559931247|FG001|Overall Study|Adverse Event|5|||
155136262|NCT01620762|559931248|FG002|Overall Study|Adverse Event|2|||
155136263|NCT01620762|559931246|FG000|Overall Study|Withdrawal by Subject|23|||
155136264|NCT01620762|559931247|FG001|Overall Study|Withdrawal by Subject|26|||
155136265|NCT01620762|559931248|FG002|Overall Study|Withdrawal by Subject|27|||
155136266|NCT01620762|559931246|FG000|Overall Study|Lost to Follow-up|11|||
155136267|NCT01620762|559931247|FG001|Overall Study|Lost to Follow-up|17|||
155136268|NCT01620762|559931248|FG002|Overall Study|Lost to Follow-up|10|||
155136269|NCT01620762|559931246|FG000|Overall Study|Protocol deviation|1|||
155136270|NCT01620762|559931247|FG001|Overall Study|Protocol deviation|1|||
155136271|NCT01620762|559931248|FG002|Overall Study|Protocol deviation|6|||
155136272|NCT01620762|559931246|FG000|Overall Study|Subject deterioration|0|||
155136273|NCT01620762|559931247|FG001|Overall Study|Subject deterioration|1|||
155136274|NCT01620762|559931248|FG002|Overall Study|Subject deterioration|1|||
155136275|NCT01620762|559931246|FG000|Overall Study|Non-specified|3|||
155136276|NCT01620762|559931247|FG001|Overall Study|Non-specified|6|||
155136277|NCT01620762|559931248|FG002|Overall Study|Non-specified|5|||
155136278|NCT01620762|559931246|FG000|Overall Study|Use of prohibted therapies|0|||
155136279|NCT01620762|559931247|FG001|Overall Study|Use of prohibted therapies|1|||
155136280|NCT01620762|559931248|FG002|Overall Study|Use of prohibted therapies|1|||
155136281|NCT00095173|559931253|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
155136282|NCT00095173|559931254|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155136283|NCT00095173|559931255|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155136284|NCT00095173|559931256|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155136285|NCT00095173|559931257|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155136286|NCT00095173|559931258|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
155136287|NCT00095173|559931253|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
155136288|NCT00095173|559931254|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155136289|NCT00095173|559931255|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155136290|NCT00095173|559931256|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155136291|NCT00095173|559931257|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155136292|NCT00095173|559931258|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
155136293|NCT00095173|559931253|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
155136294|NCT00095173|559931254|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155136295|NCT00095173|559931255|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155136296|NCT00095173|559931256|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155136297|NCT00095173|559931257|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155136298|NCT00095173|559931258|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
155136299|NCT00095173|559931253|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
155136300|NCT00095173|559931254|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
155136301|NCT00095173|559931255|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
155136302|NCT00095173|559931256|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
155136303|NCT00095173|559931257|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
155136304|NCT00095173|559931258|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
155136305|NCT00095173|559931253|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155136306|NCT00095173|559931254|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
155136307|NCT00095173|559931255|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
155136308|NCT00095173|559931256|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155136309|NCT00095173|559931257|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155136310|NCT00095173|559931258|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
155136311|NCT00095173|559931253|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155136312|NCT00095173|559931254|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
155136313|NCT00095173|559931255|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155136314|NCT00095173|559931256|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155136315|NCT00095173|559931257|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155178740|NCT04559529|560093391|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
155136316|NCT00095173|559931258|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
155136317|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Death|0|||
155136318|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Death|0|||
155136319|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Death|0|||
155136320|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Death|0|||
155136321|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Death|0|||
155136322|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Death|1|||
155136323|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
155136324|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
155136325|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
155136326|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
155136327|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
155136328|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
155136329|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
155136330|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
155136331|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
155136332|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
155136333|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
155136334|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
155136335|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
155136336|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
155136337|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
155136338|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
155136339|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
155136340|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
155136341|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155136342|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155136343|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155136344|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
155136345|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
155136346|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
155136347|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155136348|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155136349|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155136350|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
155136351|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
155136352|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
155136353|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155136354|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155136355|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155136356|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
155136357|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
155136358|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
155136359|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
155136360|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
155136361|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
155136362|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
155136363|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
155136364|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
155136365|NCT00095173|559931253|FG000|Open-Label Extension Phase (Period C)|Other|0|||
155136366|NCT00095173|559931254|FG001|Open-Label Extension Phase (Period C)|Other|0|||
155136367|NCT00095173|559931255|FG002|Open-Label Extension Phase (Period C)|Other|0|||
155136368|NCT00095173|559931256|FG003|Open-Label Extension Phase (Period C)|Other|4|||
155136369|NCT00095173|559931257|FG004|Open-Label Extension Phase (Period C)|Other|6|||
155136370|NCT00095173|559931258|FG005|Open-Label Extension Phase (Period C)|Other|8|||
155178741|NCT04559529|560093392|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
155136371|NCT01620528|559931259|FG000|Treatment Period|Did Not Receive Study Drug|0|||
155136372|NCT01620528|559931260|FG001|Treatment Period|Did Not Receive Study Drug|0|||
155178742|NCT04559529|560093393|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
155178743|NCT04559529|560093394|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
155015154|NCT00908544|559480581|FG001|Overall Study|Pregnancy|0|||
155015155|NCT00908544|559480580|FG000|Overall Study|Relocation abroad|1|||
155015156|NCT00908544|559480581|FG001|Overall Study|Relocation abroad|1|||
155015157|NCT00908544|559480580|FG000|Overall Study|Unable to visit sutdy center|1|||
155015158|NCT00908544|559480581|FG001|Overall Study|Unable to visit sutdy center|0|||
155015159|NCT00740636|559480584|FG000|Overall Study|Adverse Event|0|||
155015160|NCT00740636|559480585|FG001|Overall Study|Adverse Event|2|||
155015161|NCT00740636|559480584|FG000|Overall Study|Patient Ineligible|0|||
155015162|NCT00740636|559480585|FG001|Overall Study|Patient Ineligible|1|||
155015163|NCT00740636|559480584|FG000|Overall Study|Patient Not Treated|0|||
155015164|NCT00740636|559480585|FG001|Overall Study|Patient Not Treated|1|||
155015165|NCT00740636|559480584|FG000|Overall Study|Progressive Disease|1|||
155015166|NCT00740636|559480585|FG001|Overall Study|Progressive Disease|0|||
155015167|NCT00740636|559480584|FG000|Overall Study|Death|1|||
155015168|NCT00740636|559480585|FG001|Overall Study|Death|0|||
155015169|NCT02462603|559480590|FG000|Overall Study|Investigator Decision|1|||
155015170|NCT02462603|559480590|FG000|Overall Study|Non-Compliance|1|||
155015171|NCT02462603|559480590|FG000|Overall Study|Withdrawal by Subject|2|||
155015172|NCT03760744|559482303|FG000|Overall Study|Lost to Follow-up|3|||
155015173|NCT03760744|559482304|FG001|Overall Study|Lost to Follow-up|0|||
155015174|NCT05731700|559482305|FG000|Overall Study|Death|1|||
155015175|NCT05400655|559482306|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
155015176|NCT05400655|559482307|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
155015177|NCT05400655|559482308|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
155015178|NCT05400655|559482309|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
155015179|NCT05400655|559482310|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
155015180|NCT05400655|559482311|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
155015181|NCT05400655|559482312|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
155015182|NCT05400655|559482313|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
155015183|NCT05400655|559482314|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
155015184|NCT05400655|559482315|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
155015185|NCT05400655|559482316|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
155015186|NCT05400655|559482317|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
155015187|NCT05400655|559482318|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
155015188|NCT05400655|559482319|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
155015189|NCT05400655|559482320|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
155015190|NCT05400655|559482321|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
155015191|NCT05400655|559482322|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
155015192|NCT05400655|559482323|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
155015193|NCT05400655|559482324|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
155015194|NCT05400655|559482325|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
155015195|NCT05400655|559482326|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
155015196|NCT05400655|559482327|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
155015197|NCT05400655|559482306|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015198|NCT05400655|559482307|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015199|NCT05400655|559482308|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015200|NCT05400655|559482309|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015201|NCT05400655|559482310|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015202|NCT05400655|559482311|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015203|NCT05400655|559482312|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015204|NCT05400655|559482313|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015205|NCT05400655|559482314|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015206|NCT05400655|559482315|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015207|NCT05400655|559482316|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015208|NCT05400655|559482317|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015209|NCT05400655|559482318|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
155015210|NCT05400655|559482319|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015211|NCT05400655|559482320|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015212|NCT05400655|559482321|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015213|NCT05400655|559482322|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
155136373|NCT01620528|559931261|FG002|Treatment Period|Did Not Receive Study Drug|1|||
155136374|NCT01620528|559931259|FG000|Treatment Period|Withdrawal by Subject|35|||
155136375|NCT01620528|559931260|FG001|Treatment Period|Withdrawal by Subject|21|||
155136376|NCT01620528|559931261|FG002|Treatment Period|Withdrawal by Subject|16|||
155136377|NCT01620528|559931259|FG000|Treatment Period|Adverse Event|17|||
155136378|NCT01620528|559931260|FG001|Treatment Period|Adverse Event|13|||
155136379|NCT01620528|559931261|FG002|Treatment Period|Adverse Event|21|||
155136380|NCT01620528|559931259|FG000|Treatment Period|Lost to Follow-up|16|||
155136381|NCT01620528|559931260|FG001|Treatment Period|Lost to Follow-up|8|||
155015214|NCT05400655|559482323|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015215|NCT05400655|559482324|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
155015216|NCT05400655|559482325|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
155015217|NCT05400655|559482326|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015218|NCT05400655|559482327|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
155015219|NCT05400655|559482306|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015220|NCT05400655|559482307|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015221|NCT05400655|559482308|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015222|NCT05400655|559482309|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015223|NCT05400655|559482310|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015224|NCT05400655|559482311|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155136382|NCT01620528|559931261|FG002|Treatment Period|Lost to Follow-up|14|||
155015225|NCT05400655|559482312|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015226|NCT05400655|559482313|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015227|NCT05400655|559482314|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015228|NCT05400655|559482315|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015229|NCT05400655|559482316|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015230|NCT05400655|559482317|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015231|NCT05400655|559482318|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015232|NCT05400655|559482319|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
155015233|NCT05400655|559482320|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015234|NCT05400655|559482321|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015235|NCT05400655|559482322|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
155015236|NCT05400655|559482323|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015237|NCT05400655|559482324|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
155015238|NCT05400655|559482325|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015239|NCT05400655|559482326|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015240|NCT05400655|559482327|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
155015241|NCT05400655|559482306|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015242|NCT05400655|559482307|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015243|NCT05400655|559482308|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015244|NCT05400655|559482309|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015245|NCT05400655|559482310|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015246|NCT05400655|559482311|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015247|NCT05400655|559482312|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015248|NCT05400655|559482313|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015249|NCT05400655|559482314|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015250|NCT05400655|559482315|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015251|NCT05400655|559482316|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015252|NCT05400655|559482317|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015253|NCT05400655|559482318|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015254|NCT05400655|559482319|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015255|NCT05400655|559482320|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015256|NCT05400655|559482321|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015257|NCT05400655|559482322|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
155015258|NCT05400655|559482323|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
155015259|NCT05400655|559482324|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
155015260|NCT05400655|559482325|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
155015261|NCT05400655|559482326|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
155015262|NCT05400655|559482327|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
155015263|NCT05400655|559482306|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015264|NCT05400655|559482307|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015265|NCT05400655|559482308|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015266|NCT05400655|559482309|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015267|NCT05400655|559482310|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015268|NCT05400655|559482311|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015269|NCT05400655|559482312|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015270|NCT05400655|559482313|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015271|NCT05400655|559482314|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015272|NCT05400655|559482315|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015273|NCT05400655|559482316|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015274|NCT05400655|559482317|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015275|NCT05400655|559482318|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015276|NCT05400655|559482319|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015277|NCT05400655|559482320|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015278|NCT05400655|559482321|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015279|NCT05400655|559482322|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015280|NCT05400655|559482323|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
155015281|NCT05400655|559482324|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
155015282|NCT05400655|559482325|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015283|NCT05400655|559482326|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155136383|NCT01620528|559931259|FG000|Treatment Period|Other|9|||
155136384|NCT01620528|559931260|FG001|Treatment Period|Other|5|||
155136385|NCT01620528|559931261|FG002|Treatment Period|Other|7|||
155136386|NCT01620528|559931259|FG000|Treatment Period|Subject Noncompliant|11|||
155015284|NCT05400655|559482327|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
155015285|NCT05400655|559482306|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015286|NCT05400655|559482307|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015287|NCT05400655|559482308|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015288|NCT05400655|559482309|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015289|NCT05400655|559482310|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015290|NCT05400655|559482311|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015291|NCT05400655|559482312|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155136387|NCT01620528|559931260|FG001|Treatment Period|Subject Noncompliant|2|||
155136388|NCT01620528|559931261|FG002|Treatment Period|Subject Noncompliant|2|||
155015292|NCT05400655|559482313|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015293|NCT05400655|559482314|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015294|NCT05400655|559482315|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015295|NCT05400655|559482316|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015296|NCT05400655|559482317|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015297|NCT05400655|559482318|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015298|NCT05400655|559482319|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015299|NCT05400655|559482320|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015300|NCT05400655|559482321|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015301|NCT05400655|559482322|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
155015302|NCT05400655|559482323|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
155015303|NCT05400655|559482324|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
155015304|NCT05400655|559482325|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
155015305|NCT05400655|559482326|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
155015306|NCT05400655|559482327|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
155015307|NCT05161481|559482336|FG000|Overall Study|Withdrawal of consent|0|||
155015308|NCT05161481|559482337|FG001|Overall Study|Withdrawal of consent|1|||
155015309|NCT05161481|559482338|FG002|Overall Study|Withdrawal of consent|1|||
155015310|NCT05161481|559482336|FG000|Overall Study|Study terminated by sponsor|3|||
155015311|NCT05161481|559482337|FG001|Overall Study|Study terminated by sponsor|3|||
155015312|NCT05161481|559482338|FG002|Overall Study|Study terminated by sponsor|2|||
155015313|NCT05161481|559482336|FG000|Overall Study|Adverse Event|3|||
155015314|NCT05161481|559482337|FG001|Overall Study|Adverse Event|0|||
155015315|NCT05161481|559482338|FG002|Overall Study|Adverse Event|6|||
155015316|NCT05161481|559482336|FG000|Overall Study|Randomised in error and was not treated|1|||
155015317|NCT05161481|559482337|FG001|Overall Study|Randomised in error and was not treated|0|||
155015318|NCT05161481|559482338|FG002|Overall Study|Randomised in error and was not treated|0|||
155015319|NCT05161481|559482336|FG000|Overall Study|Subject decision|0|||
155015320|NCT05161481|559482337|FG001|Overall Study|Subject decision|0|||
155015321|NCT05161481|559482338|FG002|Overall Study|Subject decision|1|||
155015322|NCT04632927|559482341|FG000|Overall Study|Adverse Event|0|||
155015323|NCT04632927|559482342|FG001|Overall Study|Adverse Event|1|||
155015324|NCT04632927|559482341|FG000|Overall Study|Lack of Efficacy|0|||
155015325|NCT04632927|559482342|FG001|Overall Study|Lack of Efficacy|4|||
155015326|NCT04632927|559482341|FG000|Overall Study|Loss of efficacy|0|||
155015327|NCT04632927|559482342|FG001|Overall Study|Loss of efficacy|1|||
155015328|NCT04632927|559482341|FG000|Overall Study|Non-compliance with study drug|0|||
155015329|NCT04632927|559482342|FG001|Overall Study|Non-compliance with study drug|1|||
155015330|NCT04632927|559482341|FG000|Overall Study|Physician Decision|0|||
155015331|NCT04632927|559482342|FG001|Overall Study|Physician Decision|1|||
155015332|NCT04632927|559482341|FG000|Overall Study|Subject decision|0|||
155015333|NCT04632927|559482342|FG001|Overall Study|Subject decision|1|||
155015334|NCT04632927|559482341|FG000|Overall Study|Withdrawal by Subject|0|||
155015335|NCT04632927|559482342|FG001|Overall Study|Withdrawal by Subject|1|||
155015336|NCT03827291|559482343|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
155015337|NCT03827291|559482344|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
155015338|NCT01102257|559482349|FG000|Overall Study|Adverse Event|1|||
155015339|NCT01102257|559482350|FG001|Overall Study|Adverse Event|0|||
155015340|NCT01102257|559482349|FG000|Overall Study|Adverse Event|1|||
155015341|NCT01102257|559482350|FG001|Overall Study|Adverse Event|0|||
155015342|NCT03752970|559482351|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
155015343|NCT03752970|559482352|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
155015344|NCT03752970|559482353|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
155015345|NCT03752970|559482351|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
155015346|NCT03752970|559482352|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
155015347|NCT03752970|559482353|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
155015348|NCT03752970|559482351|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
155015349|NCT03752970|559482352|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
155136389|NCT01620528|559931259|FG000|Treatment Period|Pregnancy|7|||
155136390|NCT01620528|559931260|FG001|Treatment Period|Pregnancy|2|||
155136391|NCT01620528|559931261|FG002|Treatment Period|Pregnancy|2|||
155136392|NCT01620528|559931259|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
155136393|NCT01620528|559931260|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
155136394|NCT01620528|559931261|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
155015350|NCT03752970|559482353|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
155015351|NCT03752970|559482351|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
155015352|NCT03752970|559482352|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
155136395|NCT01620528|559931259|FG000|Treatment Period|Exclusionary Medication Received|0|||
155136396|NCT01620528|559931260|FG001|Treatment Period|Exclusionary Medication Received|1|||
155015353|NCT03752970|559482353|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
155015354|NCT03752970|559482351|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
155015355|NCT03752970|559482352|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
155015356|NCT03752970|559482353|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
155015357|NCT04767282|559482354|FG000|Overall Study|Refused or did not begin surveys|6|||
155015358|NCT04767282|559482355|FG001|Overall Study|Refused or did not begin surveys|2|||
155015359|NCT04767282|559482356|FG002|Overall Study|Refused or did not begin surveys|2|||
155015360|NCT04767282|559482354|FG000|Overall Study|Duplicate household previously enrolled|2|||
155015361|NCT04767282|559482355|FG001|Overall Study|Duplicate household previously enrolled|0|||
155015362|NCT04767282|559482356|FG002|Overall Study|Duplicate household previously enrolled|8|||
155015363|NCT04767282|559482354|FG000|Overall Study|Unable to confirm legal guardian|0|||
155015364|NCT04767282|559482355|FG001|Overall Study|Unable to confirm legal guardian|2|||
155015365|NCT04767282|559482356|FG002|Overall Study|Unable to confirm legal guardian|8|||
155015366|NCT04767282|559482354|FG000|Overall Study|Withdrawal by Subject|0|||
155015367|NCT04767282|559482355|FG001|Overall Study|Withdrawal by Subject|0|||
155015368|NCT04767282|559482356|FG002|Overall Study|Withdrawal by Subject|6|||
155015369|NCT04767282|559482354|FG000|Overall Study|Survey comprehension challenges|4|||
155015370|NCT04767282|559482355|FG001|Overall Study|Survey comprehension challenges|0|||
155015371|NCT04767282|559482356|FG002|Overall Study|Survey comprehension challenges|0|||
155015372|NCT01120184|559482362|FG000|Overall Study|Adverse Event|0|||
155015373|NCT01120184|559482363|FG001|Overall Study|Adverse Event|1|||
155015374|NCT01120184|559482364|FG002|Overall Study|Adverse Event|0|||
155015375|NCT01120184|559482362|FG000|Overall Study|Lost to Follow-up|13|||
155015376|NCT01120184|559482363|FG001|Overall Study|Lost to Follow-up|13|||
155015377|NCT01120184|559482364|FG002|Overall Study|Lost to Follow-up|11|||
155015378|NCT01120184|559482362|FG000|Overall Study|Physician Decision|9|||
155015379|NCT01120184|559482363|FG001|Overall Study|Physician Decision|1|||
155015380|NCT01120184|559482364|FG002|Overall Study|Physician Decision|3|||
155015381|NCT01120184|559482362|FG000|Overall Study|Reason not Specified|8|||
155015382|NCT01120184|559482363|FG001|Overall Study|Reason not Specified|3|||
155015383|NCT01120184|559482364|FG002|Overall Study|Reason not Specified|12|||
155015384|NCT01120184|559482362|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
155136397|NCT01620528|559931261|FG002|Treatment Period|Exclusionary Medication Received|0|||
155136398|NCT01620528|559931259|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
155136399|NCT01620528|559931260|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
155136400|NCT01620528|559931261|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
155136401|NCT01620528|559931259|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155136402|NCT01620528|559931260|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155136403|NCT01620528|559931261|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
155136404|NCT01620528|559931259|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
155136405|NCT01620528|559931260|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
155136406|NCT01620528|559931261|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
155136407|NCT01620528|559931259|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
155136408|NCT01620528|559931260|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
155136409|NCT01620528|559931261|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
155136410|NCT01620528|559931259|FG000|Post-Treatment Follow-Up Period|Other|6|||
155136411|NCT01620528|559931260|FG001|Post-Treatment Follow-Up Period|Other|4|||
155136412|NCT01620528|559931261|FG002|Post-Treatment Follow-Up Period|Other|2|||
155136413|NCT03997825|559931273|FG000|Overall Study|Death|3|||
155136414|NCT03997825|559931273|FG000|Overall Study|Lost to Follow-up|10|||
155136415|NCT03997825|559931273|FG000|Overall Study|Withdrawal by Subject|3|||
155136416|NCT03997825|559931273|FG000|Overall Study|Refused participation|1|||
155136417|NCT01153698|559931274|FG000|Overall Study|Adverse Event|12|||
155136418|NCT01153698|559931274|FG000|Overall Study|Lost to Follow-up|4|||
155136419|NCT01153698|559931274|FG000|Overall Study|Withdrawal by Subject|2|||
155136420|NCT01153698|559931274|FG000|Overall Study|Switch to other anticoagulants|4|||
155136421|NCT01153698|559931274|FG000|Overall Study|Other|2|||
155136422|NCT01153698|559931274|FG000|Overall Study|Not treated with Pradaxa|5|||
155136423|NCT00465647|559931275|FG000|Overall Study|Administrative|2|||
155136424|NCT00465647|559931276|FG001|Overall Study|Administrative|2|||
155136425|NCT00465647|559931277|FG002|Overall Study|Administrative|3|||
155136426|NCT00465647|559931278|FG003|Overall Study|Administrative|2|||
155136427|NCT00465647|559931275|FG000|Overall Study|Adverse Event|2|||
155136428|NCT00465647|559931276|FG001|Overall Study|Adverse Event|0|||
155015385|NCT01120184|559482363|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
155015386|NCT01120184|559482364|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
155015387|NCT01120184|559482362|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
155015388|NCT01120184|559482363|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
155015389|NCT01120184|559482364|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
155136429|NCT00465647|559931277|FG002|Overall Study|Adverse Event|3|||
155136430|NCT00465647|559931278|FG003|Overall Study|Adverse Event|2|||
155136431|NCT00465647|559931275|FG000|Overall Study|Withdrawal by Subject|1|||
155136432|NCT00465647|559931276|FG001|Overall Study|Withdrawal by Subject|2|||
155136433|NCT00465647|559931277|FG002|Overall Study|Withdrawal by Subject|2|||
155136434|NCT00465647|559931278|FG003|Overall Study|Withdrawal by Subject|7|||
155136435|NCT00465647|559931275|FG000|Overall Study|"The other reasons included loss of IV"|8|||
155136436|NCT00465647|559931276|FG001|Overall Study|"The other reasons included loss of IV"|4|||
155136437|NCT00465647|559931277|FG002|Overall Study|"The other reasons included loss of IV"|3|||
155136438|NCT00465647|559931278|FG003|Overall Study|"The other reasons included loss of IV"|2|||
155136439|NCT02220712|559931279|FG000|Overall Study|Adverse Event|1|||
155136440|NCT02220712|559931279|FG000|Overall Study|Withdrawal by Subject|2|||
155136441|NCT02220712|559931279|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
155136442|NCT00760838|559931280|FG000|Overall Study|Adverse Event|1|||
155136443|NCT00760838|559931281|FG001|Overall Study|Adverse Event|1|||
155136444|NCT00760838|559931280|FG000|Overall Study|Lack of Efficacy|1|||
155136445|NCT00760838|559931281|FG001|Overall Study|Lack of Efficacy|0|||
155136446|NCT00760838|559931280|FG000|Overall Study|Lost to Follow-up|2|||
155136447|NCT00760838|559931281|FG001|Overall Study|Lost to Follow-up|0|||
155136448|NCT00760838|559931280|FG000|Overall Study|Withdrawal by Subject|1|||
155136449|NCT00760838|559931281|FG001|Overall Study|Withdrawal by Subject|1|||
155136450|NCT01628965|559931284|FG000|Overall Study|Adverse Event|30|||
155136451|NCT01628965|559931284|FG000|Overall Study|Lack of Efficacy|7|||
155136452|NCT01628965|559931284|FG000|Overall Study|Withdrawal by Subject|3|||
155136453|NCT01628965|559931284|FG000|Overall Study|Lost to Follow-up|1|||
155136454|NCT01628965|559931284|FG000|Overall Study|Discontinuation criteria|8|||
155136455|NCT03688620|559931287|FG000|Overall Study|Other|0|||
155136456|NCT03688620|559931288|FG001|Overall Study|Other|0|||
155136457|NCT03688620|559931289|FG002|Overall Study|Other|1|||
155136458|NCT03688620|559931287|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
155136459|NCT03688620|559931288|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
155136460|NCT03688620|559931289|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
155136461|NCT03688620|559931287|FG000|Overall Study|Lost to Follow-up|16|||
155136462|NCT03688620|559931288|FG001|Overall Study|Lost to Follow-up|0|||
155136463|NCT03688620|559931289|FG002|Overall Study|Lost to Follow-up|1|||
155136464|NCT03688620|559931287|FG000|Overall Study|Withdrawal by Subject|0|||
155136465|NCT03688620|559931288|FG001|Overall Study|Withdrawal by Subject|0|||
155136466|NCT03688620|559931289|FG002|Overall Study|Withdrawal by Subject|6|||
155136467|NCT00330681|559931290|FG000|Overall Study|Adverse Event|3|||
155136468|NCT00330681|559931291|FG001|Overall Study|Adverse Event|6|||
155136469|NCT00330681|559931290|FG000|Overall Study|Protocol Violation|0|||
155136470|NCT00330681|559931291|FG001|Overall Study|Protocol Violation|1|||
155136471|NCT00330681|559931290|FG000|Overall Study|Withdrawal by Subject|5|||
155136472|NCT00330681|559931291|FG001|Overall Study|Withdrawal by Subject|5|||
155136473|NCT00330681|559931290|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
155136474|NCT00330681|559931291|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
155136475|NCT02578186|559931292|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
155136476|NCT02578186|559931293|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
155136477|NCT02578186|559931292|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
155136478|NCT02578186|559931293|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
155136479|NCT03824587|559931294|FG000|Run-in Period|Screen Failure|0|||
155136480|NCT03824587|559931295|FG001|Run-in Period|Screen Failure|275|||
155136481|NCT03824587|559931294|FG000|Treatment Period|Adverse Event|4|||
155136482|NCT03824587|559931295|FG001|Treatment Period|Adverse Event|1|||
155136483|NCT03824587|559931294|FG000|Treatment Period|Withdrawal by Subject|0|||
155136484|NCT03824587|559931295|FG001|Treatment Period|Withdrawal by Subject|1|||
155136485|NCT03824587|559931294|FG000|Treatment Period|Kidney Transplant|1|||
155136486|NCT03824587|559931295|FG001|Treatment Period|Kidney Transplant|1|||
155136487|NCT00986362|559931296|FG000|Overall Study|Death|2|||
155136488|NCT00986362|559931297|FG001|Overall Study|Death|0|||
155136489|NCT00986362|559931296|FG000|Overall Study|Lost to Follow-up|0|||
155136490|NCT00986362|559931297|FG001|Overall Study|Lost to Follow-up|1|||
155136491|NCT01300572|559931298|FG000|Overall Study|HAMA + post dosimetry|1|||
155136492|NCT03597061|559931299|FG000|Overall Study|Lost to Follow-up|1|||
155136493|NCT03597061|559931300|FG001|Overall Study|Lost to Follow-up|0|||
155136494|NCT03597061|559931299|FG000|Overall Study|Protocol Violation|0|||
155136495|NCT03597061|559931300|FG001|Overall Study|Protocol Violation|1|||
155136496|NCT02006979|559931301|FG000|Overall Study|Withdrawal by Subject|1|||
155136497|NCT02006979|559931302|FG001|Overall Study|Withdrawal by Subject|1|||
155015390|NCT01120184|559482362|FG000|Overall Study|Death|170|||
155136498|NCT02006979|559931301|FG000|Overall Study|Protocol Violation|0|||
155136499|NCT02006979|559931302|FG001|Overall Study|Protocol Violation|1|||
155136500|NCT02038075|559931303|FG000|Overall Study|Withdrawal by Subject|3|||
155136501|NCT02038075|559931304|FG001|Overall Study|Withdrawal by Subject|0|||
155136502|NCT03477838|559931305|FG000|Overall Study|Lost to Follow-up|14|||
155136503|NCT02519595|559931307|FG000|Overall Study|Protocol Violation|8|||
155136504|NCT02519595|559931308|FG001|Overall Study|Protocol Violation|22|||
155136505|NCT02519595|559931309|FG002|Overall Study|Protocol Violation|16|||
155136506|NCT00850538|559931312|FG000|Overall Study|unable/unwilling to complete MRI|13|||
155136507|NCT00850538|559931312|FG000|Overall Study|specimen missed due to scheduling error|14|||
155136508|NCT00850538|559931312|FG000|Overall Study|specimen unusable|7|||
155136509|NCT00850538|559931312|FG000|Overall Study|Withdrawal by Subject|3|||
155136510|NCT00850538|559931312|FG000|Overall Study|radiology error|2|||
155136511|NCT00850538|559931312|FG000|Overall Study|Protocol Violation|2|||
155136512|NCT03188510|559931313|FG000|Overall Study|Inappropriate behavior with site staff|0|||
155136513|NCT03188510|559931314|FG001|Overall Study|Inappropriate behavior with site staff|1|||
155136514|NCT03188510|559931315|FG002|Overall Study|Inappropriate behavior with site staff|0|||
155136515|NCT01736618|559931318|FG000|Overall Study|Death|294|||
155136516|NCT01736618|559931318|FG000|Overall Study|Lost to Follow-up|193|||
155136517|NCT01736618|559931318|FG000|Overall Study|Withdrawal by Subject|54|||
155136518|NCT01736618|559931318|FG000|Overall Study|Subject unable to be followed at study location|223|||
155136519|NCT01736618|559931318|FG000|Overall Study|Physician Decision|33|||
155136520|NCT01736618|559931318|FG000|Overall Study|Transplant or removal of target organ|19|||
155136521|NCT01736618|559931318|FG000|Overall Study|Change in indication or condition|78|||
155136522|NCT01736618|559931318|FG000|Overall Study|Study device explant|103|||
155136523|NCT01736618|559931318|FG000|Overall Study|Unable to complete implant|2|||
155136524|NCT04167137|559931319|FG000|Overall Study|Disease progression|1|||
155136525|NCT04167137|559931320|FG001|Overall Study|Disease progression|1|||
155136526|NCT04167137|559931321|FG002|Overall Study|Disease progression|3|||
155136527|NCT04167137|559931322|FG003|Overall Study|Disease progression|3|||
155136528|NCT04167137|559931323|FG004|Overall Study|Disease progression|2|||
155136529|NCT04167137|559931324|FG005|Overall Study|Disease progression|3|||
155136530|NCT04167137|559931325|FG006|Overall Study|Disease progression|2|||
155136531|NCT04167137|559931326|FG007|Overall Study|Disease progression|2|||
155136532|NCT04167137|559931319|FG000|Overall Study|Withdrawal by Subject|1|||
155136533|NCT04167137|559931320|FG001|Overall Study|Withdrawal by Subject|0|||
155136534|NCT04167137|559931321|FG002|Overall Study|Withdrawal by Subject|0|||
155136535|NCT04167137|559931322|FG003|Overall Study|Withdrawal by Subject|1|||
155136536|NCT04167137|559931323|FG004|Overall Study|Withdrawal by Subject|0|||
155136537|NCT04167137|559931324|FG005|Overall Study|Withdrawal by Subject|2|||
155136538|NCT04167137|559931325|FG006|Overall Study|Withdrawal by Subject|1|||
155136539|NCT04167137|559931326|FG007|Overall Study|Withdrawal by Subject|0|||
155136540|NCT04167137|559931319|FG000|Overall Study|Adverse Event|0|||
155136541|NCT04167137|559931320|FG001|Overall Study|Adverse Event|0|||
155136542|NCT04167137|559931321|FG002|Overall Study|Adverse Event|0|||
155136543|NCT04167137|559931322|FG003|Overall Study|Adverse Event|0|||
155136544|NCT04167137|559931323|FG004|Overall Study|Adverse Event|0|||
155136545|NCT04167137|559931324|FG005|Overall Study|Adverse Event|1|||
155136546|NCT04167137|559931325|FG006|Overall Study|Adverse Event|0|||
155136547|NCT04167137|559931326|FG007|Overall Study|Adverse Event|1|||
155136548|NCT04167137|559931319|FG000|Overall Study|Physician Decision|0|||
155136549|NCT04167137|559931320|FG001|Overall Study|Physician Decision|0|||
155136550|NCT04167137|559931321|FG002|Overall Study|Physician Decision|0|||
155136551|NCT04167137|559931322|FG003|Overall Study|Physician Decision|1|||
155136552|NCT04167137|559931323|FG004|Overall Study|Physician Decision|0|||
155136553|NCT04167137|559931324|FG005|Overall Study|Physician Decision|0|||
155136554|NCT04167137|559931325|FG006|Overall Study|Physician Decision|1|||
155136555|NCT04167137|559931326|FG007|Overall Study|Physician Decision|0|||
155136556|NCT04167137|559931319|FG000|Overall Study|Death|0|||
155136557|NCT04167137|559931320|FG001|Overall Study|Death|1|||
155136558|NCT04167137|559931321|FG002|Overall Study|Death|0|||
155136559|NCT04167137|559931322|FG003|Overall Study|Death|0|||
155136560|NCT04167137|559931323|FG004|Overall Study|Death|0|||
155136561|NCT04167137|559931324|FG005|Overall Study|Death|0|||
155136562|NCT04167137|559931325|FG006|Overall Study|Death|0|||
155136563|NCT04167137|559931326|FG007|Overall Study|Death|0|||
155136564|NCT04167137|559931319|FG000|Overall Study|Study terminated by Sponsor|0|||
155136565|NCT04167137|559931320|FG001|Overall Study|Study terminated by Sponsor|0|||
155136566|NCT04167137|559931321|FG002|Overall Study|Study terminated by Sponsor|0|||
155136567|NCT04167137|559931322|FG003|Overall Study|Study terminated by Sponsor|0|||
155136568|NCT04167137|559931323|FG004|Overall Study|Study terminated by Sponsor|0|||
155136569|NCT04167137|559931324|FG005|Overall Study|Study terminated by Sponsor|0|||
155136570|NCT04167137|559931325|FG006|Overall Study|Study terminated by Sponsor|0|||
155136571|NCT04167137|559931326|FG007|Overall Study|Study terminated by Sponsor|1|||
155136572|NCT02461745|559931333|FG000|Overall Study|Lack of Efficacy|9|||
155136573|NCT02461745|559931334|FG001|Overall Study|Lack of Efficacy|1|||
155136574|NCT02461745|559931333|FG000|Overall Study|Lost to Follow-up|2|||
155136575|NCT02461745|559931334|FG001|Overall Study|Lost to Follow-up|2|||
155136576|NCT02461745|559931333|FG000|Overall Study|Withdrawal by Subject|3|||
155136577|NCT02461745|559931334|FG001|Overall Study|Withdrawal by Subject|1|||
155015391|NCT01120184|559482363|FG001|Overall Study|Death|176|||
155136578|NCT02921087|559931335|FG000|Overall Study|Withdrawal by Subject|0|||
155136579|NCT02921087|559931336|FG001|Overall Study|Withdrawal by Subject|1|||
155136580|NCT00211887|559931337|FG000|Overall Study|Adverse Event|8|||
155136581|NCT00211887|559931338|FG001|Overall Study|Adverse Event|4|||
155136582|NCT00211887|559931339|FG002|Overall Study|Adverse Event|6|||
155136583|NCT00211887|559931337|FG000|Overall Study|Death|1|||
155136584|NCT00211887|559931338|FG001|Overall Study|Death|1|||
155136585|NCT00211887|559931339|FG002|Overall Study|Death|1|||
155136586|NCT00211887|559931337|FG000|Overall Study|Lost to Follow-up|28|||
155136587|NCT00211887|559931338|FG001|Overall Study|Lost to Follow-up|13|||
155136588|NCT00211887|559931339|FG002|Overall Study|Lost to Follow-up|9|||
155136589|NCT00211887|559931337|FG000|Overall Study|Non-medical reason|31|||
155136590|NCT00211887|559931338|FG001|Overall Study|Non-medical reason|14|||
155136591|NCT00211887|559931339|FG002|Overall Study|Non-medical reason|8|||
155136592|NCT00211887|559931337|FG000|Overall Study|Other medical reason|15|||
155136593|NCT00211887|559931338|FG001|Overall Study|Other medical reason|11|||
155136594|NCT00211887|559931339|FG002|Overall Study|Other medical reason|7|||
155136595|NCT00211887|559931337|FG000|Overall Study|Side effects|19|||
155136596|NCT00211887|559931338|FG001|Overall Study|Side effects|13|||
155136597|NCT00211887|559931339|FG002|Overall Study|Side effects|5|||
155136598|NCT03058692|559932874|FG000|Overall Study|Lost to Follow-up|2|||
155136599|NCT03058692|559932875|FG001|Overall Study|Lost to Follow-up|1|||
155136600|NCT03058692|559932874|FG000|Overall Study|Withdrawal by Subject|1|||
155136601|NCT03058692|559932875|FG001|Overall Study|Withdrawal by Subject|1|||
155136602|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
155136603|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
155136604|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
155136605|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
155136606|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
155136607|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
155136608|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
155136609|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
155136610|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
155136611|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
155136612|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
155136613|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
155136614|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
155136615|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
155136616|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
155136617|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
155136618|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
155136619|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
155136620|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
155136621|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
155136622|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
155136623|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
155136624|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
155136625|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
155136626|NCT03777059|559932878|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
155136627|NCT03777059|559932879|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
155136628|NCT03777059|559932880|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
155136629|NCT03777059|559932881|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
155136630|NCT03777059|559932878|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
155136631|NCT03777059|559932879|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
155136632|NCT03777059|559932880|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
155136633|NCT03777059|559932881|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
155136634|NCT03777059|559932878|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
155136635|NCT03777059|559932879|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
155136636|NCT03777059|559932880|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
155136637|NCT03777059|559932881|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
155136638|NCT03777059|559932878|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
155136639|NCT03777059|559932879|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
155136640|NCT03777059|559932880|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
155136641|NCT03777059|559932881|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
155136642|NCT03777059|559932878|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
155136643|NCT03777059|559932879|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
155136644|NCT03777059|559932880|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
155136645|NCT03777059|559932881|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
155136646|NCT02813889|559932882|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
155136647|NCT02813889|559932883|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
155136648|NCT01702025|559932888|FG000|Overall Study|Equipment failure|1|||
155136649|NCT01702025|559932889|FG001|Overall Study|Equipment failure|0|||
155136650|NCT01702025|559932890|FG002|Overall Study|Equipment failure|0|||
155136651|NCT01702025|559932891|FG003|Overall Study|Equipment failure|0|||
155136652|NCT01702025|559932888|FG000|Overall Study|Adverse Event|1|||
155136653|NCT01702025|559932889|FG001|Overall Study|Adverse Event|1|||
155015392|NCT01120184|559482364|FG002|Overall Study|Death|169|||
155015393|NCT02525783|559482366|FG000|Overall Study|Lost to Follow-up|10|||
155015394|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
155015395|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
155015396|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
155015397|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
155015398|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
155015399|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
155015400|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
155015401|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
155136654|NCT01702025|559932890|FG002|Overall Study|Adverse Event|1|||
155136655|NCT01702025|559932891|FG003|Overall Study|Adverse Event|0|||
155136656|NCT04737278|559932892|FG000|Overall Study|Lost to Follow-up|1|||
155136657|NCT04737278|559932893|FG001|Overall Study|Lost to Follow-up|1|||
155015402|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
155015403|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
155015404|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
155015405|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
155015406|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155015407|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155015408|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
155015409|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
155015410|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
155015411|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
155015412|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
155015413|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
155015414|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
155015415|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
155015416|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
155015417|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
155015418|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
155015419|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
155015420|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
155015421|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
155015422|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
155015423|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
155015424|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
155015425|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
155015426|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
155015427|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
155015428|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
155015429|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
155015430|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
155015431|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
155015432|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
155015433|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
155015434|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
155015435|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
155015436|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
155015437|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
155015438|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
155015439|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
155015440|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
155015441|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
155015442|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
155015443|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
155015444|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
155015445|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
155015446|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Site closed|0|||
155015447|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Site closed|0|||
155015448|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Site closed|1|||
155015449|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Site closed|0|||
155015450|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
155015451|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
155136658|NCT04737278|559932892|FG000|Overall Study|Withdrawal by Subject|1|||
155015452|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
155136659|NCT04737278|559932893|FG001|Overall Study|Withdrawal by Subject|0|||
155136660|NCT04737278|559932892|FG000|Overall Study|Protocol Violation|1|||
155136661|NCT04737278|559932893|FG001|Overall Study|Protocol Violation|1|||
155136662|NCT04737278|559932892|FG000|Overall Study|failure to complete questionnaire|1|||
155136663|NCT04737278|559932893|FG001|Overall Study|failure to complete questionnaire|1|||
155136664|NCT00546000|559932896|FG000|Overall Study|Adverse Event|1|||
155136665|NCT00546000|559932896|FG000|Overall Study|Lost to Follow-up|1|||
155136666|NCT00546000|559932896|FG000|Overall Study|Baseline HPA Axis Supression|2|||
155136667|NCT01362608|559932901|FG000|Overall Study|Protocol Violation|0|||
155136668|NCT01362608|559932902|FG001|Overall Study|Protocol Violation|1|||
155136669|NCT01362608|559932901|FG000|Overall Study|Lost to Follow-up|3|||
155136670|NCT01362608|559932902|FG001|Overall Study|Lost to Follow-up|1|||
155136671|NCT01362608|559932901|FG000|Overall Study|Withdrawal by Subject|1|||
155136672|NCT01362608|559932902|FG001|Overall Study|Withdrawal by Subject|2|||
155136673|NCT01362608|559932901|FG000|Overall Study|Lack of Efficacy|0|||
155136674|NCT01362608|559932902|FG001|Overall Study|Lack of Efficacy|2|||
155136675|NCT01362608|559932901|FG000|Overall Study|Adverse Event|0|||
155136676|NCT01362608|559932902|FG001|Overall Study|Adverse Event|2|||
155136677|NCT03056339|559932914|FG000|Overall Study|Failed Requirements|0|||
155136678|NCT03056339|559932915|FG001|Overall Study|Failed Requirements|2|||
155136679|NCT03056339|559932916|FG002|Overall Study|Failed Requirements|7|||
155136680|NCT03056339|559932917|FG003|Overall Study|Failed Requirements|1|||
155136681|NCT01504412|559932920|FG000|Overall Study|Adverse Event|1|||
155136682|NCT01504412|559932921|FG001|Overall Study|Adverse Event|8|||
155136683|NCT01504412|559932922|FG002|Overall Study|Adverse Event|1|||
155136684|NCT01504412|559932923|FG003|Overall Study|Adverse Event|7|||
155136685|NCT01504412|559932924|FG004|Overall Study|Adverse Event|10|||
155136686|NCT01504412|559932920|FG000|Overall Study|Withdrawal by Subject|2|||
155136687|NCT01504412|559932921|FG001|Overall Study|Withdrawal by Subject|1|||
155136688|NCT01504412|559932922|FG002|Overall Study|Withdrawal by Subject|1|||
155136689|NCT01504412|559932923|FG003|Overall Study|Withdrawal by Subject|5|||
155136690|NCT01504412|559932924|FG004|Overall Study|Withdrawal by Subject|1|||
155136691|NCT01504412|559932920|FG000|Overall Study|Other|2|||
155136692|NCT01504412|559932921|FG001|Overall Study|Other|1|||
155136693|NCT01504412|559932922|FG002|Overall Study|Other|1|||
155136694|NCT01504412|559932923|FG003|Overall Study|Other|6|||
155136695|NCT01504412|559932924|FG004|Overall Study|Other|1|||
155136696|NCT01504412|559932920|FG000|Overall Study|Lost to Follow-up|0|||
155136697|NCT01504412|559932921|FG001|Overall Study|Lost to Follow-up|2|||
155136698|NCT01504412|559932922|FG002|Overall Study|Lost to Follow-up|0|||
155136699|NCT01504412|559932923|FG003|Overall Study|Lost to Follow-up|0|||
155136700|NCT01504412|559932924|FG004|Overall Study|Lost to Follow-up|0|||
155136701|NCT01504412|559932920|FG000|Overall Study|Lack of Efficacy|0|||
155136702|NCT01504412|559932921|FG001|Overall Study|Lack of Efficacy|0|||
155136703|NCT01504412|559932922|FG002|Overall Study|Lack of Efficacy|1|||
155136704|NCT01504412|559932923|FG003|Overall Study|Lack of Efficacy|0|||
155136705|NCT01504412|559932924|FG004|Overall Study|Lack of Efficacy|1|||
155136706|NCT01504412|559932920|FG000|Overall Study|Death|0|||
155136707|NCT01504412|559932921|FG001|Overall Study|Death|0|||
155136708|NCT01504412|559932922|FG002|Overall Study|Death|0|||
155136709|NCT01504412|559932923|FG003|Overall Study|Death|1|||
155136710|NCT01504412|559932924|FG004|Overall Study|Death|0|||
155136711|NCT02837029|559932929|FG000|Screening|Failed to meet screening requirements.|7|||
155136712|NCT02837029|559932930|FG001|Screening|Failed to meet screening requirements.|3|||
155136713|NCT02837029|559932931|FG002|Screening|Failed to meet screening requirements.|0|||
155136714|NCT02837029|559932929|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
155136715|NCT02837029|559932930|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
155136716|NCT02837029|559932931|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
155136717|NCT02837029|559932929|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
155136718|NCT02837029|559932930|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
155136719|NCT02837029|559932931|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
155136720|NCT02837029|559932929|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
155136721|NCT02837029|559932930|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
155136722|NCT02837029|559932931|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
155136723|NCT02837029|559932929|FG000|Cycle 2 and Beyond|Adverse Event|1|||
155136724|NCT02837029|559932930|FG001|Cycle 2 and Beyond|Adverse Event|0|||
155136725|NCT02837029|559932931|FG002|Cycle 2 and Beyond|Adverse Event|0|||
155136726|NCT02837029|559932929|FG000|2 Year Follow-up|Death|6|||
155136727|NCT02837029|559932930|FG001|2 Year Follow-up|Death|7|||
155136728|NCT02837029|559932931|FG002|2 Year Follow-up|Death|0|||
155136729|NCT03437577|559932934|FG000|Pre-Randomization|Withdrawal by Subject|0|||
155136730|NCT03437577|559932935|FG001|Pre-Randomization|Withdrawal by Subject|0|||
155136731|NCT03437577|559932936|FG002|Pre-Randomization|Withdrawal by Subject|10|||
155136732|NCT03437577|559932934|FG000|Post-Randomization|Physician Decision|0|||
155136733|NCT03437577|559932935|FG001|Post-Randomization|Physician Decision|2|||
155136734|NCT03437577|559932936|FG002|Post-Randomization|Physician Decision|0|||
155136735|NCT00381693|559932941|FG000|Overall Study|Death|1|||
155136736|NCT00381693|559932941|FG000|Overall Study|Adverse Event|4|||
155136737|NCT00381693|559932941|FG000|Overall Study|Patient Choice|1|||
155136738|NCT00381693|559932941|FG000|Overall Study|Progression|2|||
155136739|NCT01687101|559932942|FG000|Overall Study|Lost to Follow-up|7|||
155136740|NCT02598297|559932946|FG000|Overall Study|Study terminated by Sponsor|21|||
155136741|NCT02598297|559932947|FG001|Overall Study|Study terminated by Sponsor|23|||
155136742|NCT02598297|559932946|FG000|Overall Study|Adverse Event|1|||
155136743|NCT02598297|559932947|FG001|Overall Study|Adverse Event|1|||
155136744|NCT02598297|559932946|FG000|Overall Study|Physician Decision|1|||
155136745|NCT02598297|559932947|FG001|Overall Study|Physician Decision|0|||
155136746|NCT02598297|559932946|FG000|Overall Study|Subject/guardian decision|1|||
155136747|NCT02598297|559932947|FG001|Overall Study|Subject/guardian decision|0|||
155136748|NCT02598297|559932946|FG000|Overall Study|Followed for survival|1|||
155136749|NCT02598297|559932947|FG001|Overall Study|Followed for survival|0|||
155136750|NCT05274269|559932951|FG000|Overall Study|Adverse Event|0|||
155136751|NCT05274269|559932952|FG001|Overall Study|Adverse Event|3|||
155136752|NCT05274269|559932951|FG000|Overall Study|Death|0|||
155136753|NCT05274269|559932952|FG001|Overall Study|Death|1|||
155136754|NCT05274269|559932951|FG000|Overall Study|Other|0|||
155136755|NCT05274269|559932952|FG001|Overall Study|Other|2|||
155136756|NCT05274269|559932951|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155136757|NCT05274269|559932952|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155136758|NCT02206035|559932953|FG000|Overall Study|Physician Decision|10|||
155136759|NCT02206035|559932954|FG001|Overall Study|Physician Decision|0|||
155136760|NCT02206035|559932955|FG002|Overall Study|Physician Decision|175|||
155136761|NCT05173012|559932956|FG000|Overall Study|Adverse Event|2|||
155136762|NCT05173012|559932957|FG001|Overall Study|Adverse Event|3|||
155136763|NCT05173012|559932958|FG002|Overall Study|Adverse Event|4|||
155136764|NCT05173012|559932959|FG003|Overall Study|Adverse Event|13|||
155136765|NCT05173012|559932960|FG004|Overall Study|Adverse Event|0|||
155136766|NCT05173012|559932961|FG005|Overall Study|Adverse Event|0|||
155136767|NCT05173012|559932962|FG006|Overall Study|Adverse Event|2|||
155136768|NCT05173012|559932963|FG007|Overall Study|Adverse Event|4|||
155136769|NCT05173012|559932956|FG000|Overall Study|Lost to Follow-up|0|||
155136770|NCT05173012|559932957|FG001|Overall Study|Lost to Follow-up|0|||
155136771|NCT05173012|559932958|FG002|Overall Study|Lost to Follow-up|0|||
155136772|NCT05173012|559932959|FG003|Overall Study|Lost to Follow-up|1|||
155136773|NCT05173012|559932960|FG004|Overall Study|Lost to Follow-up|0|||
155136774|NCT05173012|559932961|FG005|Overall Study|Lost to Follow-up|0|||
155136775|NCT05173012|559932962|FG006|Overall Study|Lost to Follow-up|0|||
155136776|NCT05173012|559932963|FG007|Overall Study|Lost to Follow-up|0|||
155136777|NCT05173012|559932956|FG000|Overall Study|Withdrawal by Subject|1|||
155136778|NCT05173012|559932957|FG001|Overall Study|Withdrawal by Subject|0|||
155136779|NCT05173012|559932958|FG002|Overall Study|Withdrawal by Subject|1|||
155136780|NCT05173012|559932959|FG003|Overall Study|Withdrawal by Subject|3|||
155136781|NCT05173012|559932960|FG004|Overall Study|Withdrawal by Subject|1|||
155136782|NCT05173012|559932961|FG005|Overall Study|Withdrawal by Subject|0|||
155136783|NCT05173012|559932962|FG006|Overall Study|Withdrawal by Subject|1|||
155136784|NCT05173012|559932963|FG007|Overall Study|Withdrawal by Subject|0|||
155136785|NCT05173012|559932956|FG000|Overall Study|Protocol Deviation|0|||
155136786|NCT05173012|559932957|FG001|Overall Study|Protocol Deviation|0|||
155136787|NCT05173012|559932958|FG002|Overall Study|Protocol Deviation|0|||
155136788|NCT05173012|559932959|FG003|Overall Study|Protocol Deviation|1|||
155136789|NCT05173012|559932960|FG004|Overall Study|Protocol Deviation|0|||
155136790|NCT05173012|559932961|FG005|Overall Study|Protocol Deviation|0|||
155136791|NCT05173012|559932962|FG006|Overall Study|Protocol Deviation|0|||
155136792|NCT05173012|559932963|FG007|Overall Study|Protocol Deviation|0|||
155136793|NCT05173012|559932956|FG000|Overall Study|Other|0|||
155136794|NCT05173012|559932957|FG001|Overall Study|Other|0|||
155136795|NCT05173012|559932958|FG002|Overall Study|Other|0|||
155136796|NCT05173012|559932959|FG003|Overall Study|Other|2|||
155136797|NCT05173012|559932960|FG004|Overall Study|Other|0|||
155136798|NCT05173012|559932961|FG005|Overall Study|Other|0|||
155136799|NCT05173012|559932962|FG006|Overall Study|Other|0|||
155136800|NCT05173012|559932963|FG007|Overall Study|Other|0|||
155136801|NCT02936843|559932964|FG000|Overall Study|Lost to Follow-up|3|||
155136802|NCT02936843|559932965|FG001|Overall Study|Lost to Follow-up|1|||
155136803|NCT02936843|559932964|FG000|Overall Study|Withdrawal by Subject|1|||
155136804|NCT02936843|559932965|FG001|Overall Study|Withdrawal by Subject|1|||
155136805|NCT01393821|559932966|FG000|Overall Study|Cancel|1|||
155136806|NCT01393821|559932967|FG001|Overall Study|Cancel|1|||
155136807|NCT01393821|559932966|FG000|Overall Study|not evaluable for primary endpoint|4|||
155136808|NCT01393821|559932967|FG001|Overall Study|not evaluable for primary endpoint|2|||
155136809|NCT01685697|559932975|FG000|Overall Study|Protocol Violation|3|||
155136810|NCT01685697|559932976|FG001|Overall Study|Protocol Violation|3|||
155136811|NCT01948063|559932978|FG000|Overall Study|Boston MCI halted research protocol|0|||
155136812|NCT01948063|559932979|FG001|Overall Study|Boston MCI halted research protocol|1|||
155136813|NCT01948063|559932978|FG000|Overall Study|Discovered an enrollment in other study|0|||
155136814|NCT01948063|559932979|FG001|Overall Study|Discovered an enrollment in other study|1|||
155136815|NCT01948063|559932978|FG000|Overall Study|Blood samples were accidentally thawed|1|||
155136816|NCT01948063|559932979|FG001|Overall Study|Blood samples were accidentally thawed|0|||
155136817|NCT04427072|559932988|FG000|Randomized Treatment Phase|Progressive disease|9|||
155136818|NCT04427072|559932989|FG001|Randomized Treatment Phase|Progressive disease|4|||
155136819|NCT04427072|559932988|FG000|Randomized Treatment Phase|Adverse Event|3|||
155136820|NCT04427072|559932989|FG001|Randomized Treatment Phase|Adverse Event|1|||
155136821|NCT04427072|559932988|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
155136822|NCT04427072|559932989|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
155136823|NCT04427072|559932988|FG000|Randomized Treatment Phase|Death|0|||
155136824|NCT04427072|559932989|FG001|Randomized Treatment Phase|Death|1|||
155136825|NCT04427072|559932988|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
155136826|NCT04427072|559932989|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
155136827|NCT04427072|559932988|FG000|Extension Treatment Phase|Progressive disease|0|||
155136828|NCT04427072|559932989|FG001|Extension Treatment Phase|Progressive disease|5|||
155136829|NCT05232864|559932990|FG000|Overall Study|Adverse Event|0|||
155136830|NCT05232864|559932991|FG001|Overall Study|Adverse Event|1|||
155136831|NCT05232864|559932990|FG000|Overall Study|Study terminated by sponsor|16|||
155136832|NCT05232864|559932991|FG001|Overall Study|Study terminated by sponsor|14|||
155136833|NCT01636986|559932992|FG000|Overall Study|Withdrawal by Subject|0|||
155136834|NCT01636986|559932993|FG001|Overall Study|Withdrawal by Subject|1|||
155136835|NCT01636986|559932992|FG000|Overall Study|Corneal Staining|0|||
155136836|NCT01636986|559932993|FG001|Overall Study|Corneal Staining|1|||
155136837|NCT00705146|559932994|FG000|Overall Study|Lost to Follow-up|1|||
155136838|NCT00705146|559932995|FG001|Overall Study|Lost to Follow-up|1|||
155136839|NCT03664765|559932997|FG000|Overall Study|Withdrawal by Subject|4|||
155136840|NCT03664765|559932998|FG001|Overall Study|Withdrawal by Subject|1|||
155136841|NCT03664765|559932997|FG000|Overall Study|Lost to Follow-up|0|||
155136842|NCT03664765|559932998|FG001|Overall Study|Lost to Follow-up|1|||
155136843|NCT00383162|559932999|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
155136844|NCT00383162|559933000|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
155136845|NCT00383162|559932999|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
155136846|NCT00383162|559933000|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
155136847|NCT00383162|559932999|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
155136848|NCT00383162|559933000|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
155136849|NCT00383162|559932999|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
155136850|NCT00383162|559933000|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
155136851|NCT00383162|559932999|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
155136852|NCT00383162|559933000|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
155136853|NCT00383162|559932999|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
155136854|NCT00383162|559933000|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
155136855|NCT00383162|559932999|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
155136856|NCT00383162|559933000|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
155136857|NCT00383162|559932999|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
155136858|NCT00383162|559933000|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
155136859|NCT00383162|559932999|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
155136860|NCT00383162|559933000|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
155136861|NCT01496846|559933004|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
155136862|NCT01496846|559933005|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
155136863|NCT01496846|559933006|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155136864|NCT01496846|559933007|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155136865|NCT01496846|559933008|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155136866|NCT01496846|559933009|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
155136867|NCT01772576|559933010|FG000|Overall Study|Death|15|||
155136868|NCT01772576|559933010|FG000|Overall Study|Protocol Violation|1|||
155136869|NCT01772576|559933010|FG000|Overall Study|Lost to Follow-up|3|||
155136870|NCT01772576|559933010|FG000|Overall Study|Study device not used|3|||
155136871|NCT01772576|559933010|FG000|Overall Study|Adverse Event|6|||
155136872|NCT01772576|559933010|FG000|Overall Study|Withdrawal by Subject|6|||
155136873|NCT00923845|559933011|FG000|Induction Therapy|Poor performance status|0|||
155136874|NCT00923845|559933012|FG001|Induction Therapy|Poor performance status|2|||
155136875|NCT02873338|559933021|FG000|Overall Study|Adverse Event|0|||
155136876|NCT02873338|559933022|FG001|Overall Study|Adverse Event|2|||
155136877|NCT02873338|559933023|FG002|Overall Study|Adverse Event|1|||
155136878|NCT02873338|559933021|FG000|Overall Study|Death|2|||
155136879|NCT02873338|559933022|FG001|Overall Study|Death|1|||
155136880|NCT02873338|559933023|FG002|Overall Study|Death|1|||
155136881|NCT02873338|559933021|FG000|Overall Study|Withdrawal by Subject|2|||
155136882|NCT02873338|559933022|FG001|Overall Study|Withdrawal by Subject|1|||
155136883|NCT02873338|559933023|FG002|Overall Study|Withdrawal by Subject|3|||
155136884|NCT02873338|559933021|FG000|Overall Study|Lack of Efficacy|0|||
155136885|NCT02873338|559933022|FG001|Overall Study|Lack of Efficacy|2|||
155136886|NCT02873338|559933023|FG002|Overall Study|Lack of Efficacy|0|||
155136887|NCT02873338|559933021|FG000|Overall Study|Other or Missing|14|||
155136888|NCT02873338|559933022|FG001|Overall Study|Other or Missing|15|||
155136889|NCT02873338|559933023|FG002|Overall Study|Other or Missing|13|||
155015453|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
155015454|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
155015455|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
155015456|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
155015457|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
155015458|NCT00838903|559482367|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
155015459|NCT00838903|559482368|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
155015460|NCT00838903|559482369|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
155015461|NCT00838903|559482370|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
155015462|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
155015463|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
155015464|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
155015465|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
155015466|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
155015467|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
155015468|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
155015469|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
155015470|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
155015471|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
155015472|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
155015473|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
155015474|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
155015475|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
155015476|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
155015477|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
155015478|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
155015479|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
155015480|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
155015481|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
155015482|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
155015483|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
155015484|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
155015485|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
155015486|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
155015487|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
155015488|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
155015489|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
155015490|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
155015491|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
155015492|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
155015493|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
155015494|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
155015495|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
155015496|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
155015497|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
155015498|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
155015499|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
155015500|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
155015501|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
155015502|NCT00838903|559482367|FG000|Follow-up Period (8 Weeks)|Missing|1|||
155015503|NCT00838903|559482368|FG001|Follow-up Period (8 Weeks)|Missing|2|||
155015504|NCT00838903|559482369|FG002|Follow-up Period (8 Weeks)|Missing|1|||
155015505|NCT00838903|559482370|FG003|Follow-up Period (8 Weeks)|Missing|1|||
155015506|NCT01894841|559482371|FG000|Overall Study|Withdrawal by Subject|9|||
155015507|NCT01894841|559482372|FG001|Overall Study|Withdrawal by Subject|4|||
155015508|NCT01894841|559482371|FG000|Overall Study|Withdrawn by investigator|2|||
155015509|NCT01894841|559482372|FG001|Overall Study|Withdrawn by investigator|2|||
155015510|NCT01894841|559482371|FG000|Overall Study|Lost to Follow-up|7|||
155136890|NCT01620944|559933024|FG000|Overall Study|Early termination of Study|2|||
155136891|NCT01620944|559933025|FG001|Overall Study|Early termination of Study|1|||
155136892|NCT00375518|559933026|FG000|Overall Study|Withdrawal by Subject|2|||
155136893|NCT00375518|559933027|FG001|Overall Study|Withdrawal by Subject|10|||
155136894|NCT00375518|559933026|FG000|Overall Study|Patient Not Treated|6|||
155015511|NCT01894841|559482372|FG001|Overall Study|Lost to Follow-up|3|||
155015512|NCT01100086|559482373|FG000|Period 1|Withdrawal by Subject|1|||
155015513|NCT01100086|559482374|FG001|Period 1|Withdrawal by Subject|0|||
155015514|NCT01002989|559482380|FG000|Overall Study|exclusion criteria, no consent|5|||
155015515|NCT00318474|559482381|FG000|Overall Study|Adverse Event|1|||
155136895|NCT00375518|559933027|FG001|Overall Study|Patient Not Treated|6|||
155136896|NCT00375518|559933026|FG000|Overall Study|Death|0|||
155136897|NCT00375518|559933027|FG001|Overall Study|Death|1|||
155136898|NCT03170193|559933028|FG000|Overall Study|Withdrawal by Subject|0|||
155136899|NCT03170193|559933029|FG001|Overall Study|Withdrawal by Subject|0|||
155136900|NCT03170193|559933030|FG002|Overall Study|Withdrawal by Subject|0|||
155136901|NCT03170193|559933031|FG003|Overall Study|Withdrawal by Subject|1|||
155136902|NCT03170193|559933032|FG004|Overall Study|Withdrawal by Subject|0|||
155136903|NCT03170193|559933033|FG005|Overall Study|Withdrawal by Subject|0|||
155136904|NCT03170193|559933034|FG006|Overall Study|Withdrawal by Subject|0|||
155136905|NCT03170193|559933028|FG000|Overall Study|Lost to Follow-up|1|||
155136906|NCT03170193|559933029|FG001|Overall Study|Lost to Follow-up|1|||
155136907|NCT03170193|559933030|FG002|Overall Study|Lost to Follow-up|0|||
155136908|NCT03170193|559933031|FG003|Overall Study|Lost to Follow-up|0|||
155136909|NCT03170193|559933032|FG004|Overall Study|Lost to Follow-up|0|||
155136910|NCT03170193|559933033|FG005|Overall Study|Lost to Follow-up|0|||
155136911|NCT03170193|559933034|FG006|Overall Study|Lost to Follow-up|0|||
155136912|NCT03052816|559933039|FG000|Overall Study|Withdrawal by Subject|1|||
155136913|NCT03052816|559933040|FG001|Overall Study|Withdrawal by Subject|0|||
155136914|NCT03052816|559933039|FG000|Overall Study|Desired opioids|2|||
155136915|NCT03052816|559933040|FG001|Overall Study|Desired opioids|0|||
155136916|NCT03755661|559933041|FG000|Overall Study|Lost to Follow-up|1|||
155136917|NCT03755661|559933042|FG001|Overall Study|Lost to Follow-up|0|||
155136918|NCT04000581|559933043|FG000|Overall Study|Withdrawal by Subject|0|||
155136919|NCT04000581|559933044|FG001|Overall Study|Withdrawal by Subject|1|||
155136920|NCT00895453|559933045|FG000|Overall Study|Lost to Follow-up|25|||
155136921|NCT00895453|559933046|FG001|Overall Study|Lost to Follow-up|25|||
155136922|NCT00895453|559933047|FG002|Overall Study|Lost to Follow-up|23|||
155136923|NCT01748825|559933051|FG000|Dose Escalation|Refused further treatment|2|||
155136924|NCT01748825|559933052|FG001|Dose Escalation|Refused further treatment|2|||
155136925|NCT01748825|559933053|FG002|Dose Escalation|Refused further treatment|0|||
155136926|NCT01748825|559933054|FG003|Dose Escalation|Refused further treatment|0|||
155136927|NCT01748825|559933055|FG004|Dose Escalation|Refused further treatment|1|||
155136928|NCT01748825|559933056|FG005|Dose Escalation|Refused further treatment|2|||
155136929|NCT01748825|559933057|FG006|Dose Escalation|Refused further treatment|0|||
155136930|NCT01748825|559933058|FG007|Dose Escalation|Refused further treatment|0|||
155136931|NCT01748825|559933059|FG008|Dose Escalation|Refused further treatment|0|||
155136932|NCT01748825|559933060|FG009|Dose Escalation|Refused further treatment|0|||
155015516|NCT00318474|559482382|FG001|Overall Study|Adverse Event|1|||
155015517|NCT00318474|559482381|FG000|Overall Study|Lost to Follow-up|0|||
155015518|NCT00318474|559482382|FG001|Overall Study|Lost to Follow-up|1|||
155015519|NCT00318474|559482381|FG000|Overall Study|Pregnancy|0|||
155015520|NCT00318474|559482382|FG001|Overall Study|Pregnancy|2|||
155015521|NCT00318474|559482381|FG000|Overall Study|Protocol Violation|1|||
155015522|NCT00318474|559482382|FG001|Overall Study|Protocol Violation|0|||
155136933|NCT01748825|559933051|FG000|Dose Escalation|Switched to alternative treatment|0|||
155136934|NCT01748825|559933052|FG001|Dose Escalation|Switched to alternative treatment|0|||
155136935|NCT01748825|559933053|FG002|Dose Escalation|Switched to alternative treatment|0|||
155136936|NCT01748825|559933054|FG003|Dose Escalation|Switched to alternative treatment|1|||
155136937|NCT01748825|559933055|FG004|Dose Escalation|Switched to alternative treatment|0|||
155136938|NCT01748825|559933056|FG005|Dose Escalation|Switched to alternative treatment|0|||
155136939|NCT01748825|559933057|FG006|Dose Escalation|Switched to alternative treatment|0|||
155136940|NCT01748825|559933058|FG007|Dose Escalation|Switched to alternative treatment|0|||
155136941|NCT01748825|559933059|FG008|Dose Escalation|Switched to alternative treatment|0|||
155136942|NCT01748825|559933060|FG009|Dose Escalation|Switched to alternative treatment|0|||
155136943|NCT01748825|559933051|FG000|Dose Escalation|Adverse Event|0|||
155136944|NCT01748825|559933052|FG001|Dose Escalation|Adverse Event|0|||
155136945|NCT01748825|559933053|FG002|Dose Escalation|Adverse Event|0|||
155136946|NCT01748825|559933054|FG003|Dose Escalation|Adverse Event|0|||
155136947|NCT01748825|559933055|FG004|Dose Escalation|Adverse Event|0|||
155136948|NCT01748825|559933056|FG005|Dose Escalation|Adverse Event|0|||
155136949|NCT01748825|559933057|FG006|Dose Escalation|Adverse Event|1|||
155136950|NCT01748825|559933058|FG007|Dose Escalation|Adverse Event|0|||
155136951|NCT01748825|559933059|FG008|Dose Escalation|Adverse Event|0|||
155136952|NCT01748825|559933060|FG009|Dose Escalation|Adverse Event|0|||
155136953|NCT01748825|559933051|FG000|Dose Expansion|Refused further treatment|0|||
155136954|NCT01748825|559933052|FG001|Dose Expansion|Refused further treatment|0|||
155136955|NCT01748825|559933053|FG002|Dose Expansion|Refused further treatment|0|||
155136956|NCT01748825|559933054|FG003|Dose Expansion|Refused further treatment|0|||
155136957|NCT01748825|559933055|FG004|Dose Expansion|Refused further treatment|0|||
155136958|NCT01748825|559933056|FG005|Dose Expansion|Refused further treatment|0|||
155136959|NCT01748825|559933057|FG006|Dose Expansion|Refused further treatment|0|||
155136960|NCT01748825|559933058|FG007|Dose Expansion|Refused further treatment|0|||
155015523|NCT00318474|559482381|FG000|Overall Study|Withdrawal by Subject|3|||
155015524|NCT00318474|559482382|FG001|Overall Study|Withdrawal by Subject|2|||
155136961|NCT01748825|559933059|FG008|Dose Expansion|Refused further treatment|1|||
155136962|NCT01748825|559933060|FG009|Dose Expansion|Refused further treatment|1|||
155136963|NCT01748825|559933051|FG000|Dose Expansion|Switched to alternative treatment|0|||
155136964|NCT01748825|559933052|FG001|Dose Expansion|Switched to alternative treatment|0|||
155136965|NCT01748825|559933053|FG002|Dose Expansion|Switched to alternative treatment|0|||
155136966|NCT01748825|559933054|FG003|Dose Expansion|Switched to alternative treatment|0|||
155136967|NCT01748825|559933055|FG004|Dose Expansion|Switched to alternative treatment|0|||
155136968|NCT01748825|559933056|FG005|Dose Expansion|Switched to alternative treatment|0|||
155136969|NCT01748825|559933057|FG006|Dose Expansion|Switched to alternative treatment|0|||
155136970|NCT01748825|559933058|FG007|Dose Expansion|Switched to alternative treatment|0|||
155136971|NCT01748825|559933059|FG008|Dose Expansion|Switched to alternative treatment|0|||
155136972|NCT01748825|559933060|FG009|Dose Expansion|Switched to alternative treatment|1|||
155136973|NCT01748825|559933051|FG000|Dose Expansion|Adverse Event|0|||
155136974|NCT01748825|559933052|FG001|Dose Expansion|Adverse Event|0|||
155136975|NCT01748825|559933053|FG002|Dose Expansion|Adverse Event|0|||
155136976|NCT01748825|559933054|FG003|Dose Expansion|Adverse Event|0|||
155136977|NCT01748825|559933055|FG004|Dose Expansion|Adverse Event|0|||
155136978|NCT01748825|559933056|FG005|Dose Expansion|Adverse Event|0|||
155136979|NCT01748825|559933057|FG006|Dose Expansion|Adverse Event|0|||
155136980|NCT01748825|559933058|FG007|Dose Expansion|Adverse Event|0|||
155136981|NCT01748825|559933059|FG008|Dose Expansion|Adverse Event|0|||
155136982|NCT01748825|559933060|FG009|Dose Expansion|Adverse Event|3|||
155136983|NCT01748825|559933051|FG000|Dose Expansion|Physician Decision|0|||
155136984|NCT01748825|559933052|FG001|Dose Expansion|Physician Decision|0|||
155136985|NCT01748825|559933053|FG002|Dose Expansion|Physician Decision|0|||
155136986|NCT01748825|559933054|FG003|Dose Expansion|Physician Decision|0|||
155136987|NCT01748825|559933055|FG004|Dose Expansion|Physician Decision|0|||
155136988|NCT01748825|559933056|FG005|Dose Expansion|Physician Decision|0|||
155136989|NCT01748825|559933057|FG006|Dose Expansion|Physician Decision|0|||
155136990|NCT01748825|559933058|FG007|Dose Expansion|Physician Decision|0|||
155136991|NCT01748825|559933059|FG008|Dose Expansion|Physician Decision|1|||
155136992|NCT01748825|559933060|FG009|Dose Expansion|Physician Decision|0|||
155136993|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Adverse Event|33|||
155136994|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
155136995|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
155136996|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
155136997|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Physician Decision|6|||
155136998|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
155136999|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
155137000|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
155137001|NCT00965419|559933061|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
155137002|NCT00965419|559933061|FG000|Follow-up Phase|Adverse Event|9|||
155137003|NCT00965419|559933061|FG000|Follow-up Phase|Protocol Violation|4|||
155137004|NCT00965419|559933061|FG000|Follow-up Phase|Withdrawal by Subject|8|||
155137005|NCT00965419|559933061|FG000|Follow-up Phase|Physician Decision|4|||
155137006|NCT00965419|559933061|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
155137007|NCT00965419|559933061|FG000|Follow-up Phase|Lack of Efficacy|28|||
155137008|NCT02679755|559934947|FG000|Overall Study|Death|0|||
155137009|NCT02679755|559934948|FG001|Overall Study|Death|3|||
155137010|NCT02679755|559934947|FG000|Overall Study|Global deterioration of health status|1|||
155137011|NCT02679755|559934948|FG001|Overall Study|Global deterioration of health status|8|||
155137012|NCT02679755|559934947|FG000|Overall Study|Lost to Follow-up|1|||
155137013|NCT02679755|559934948|FG001|Overall Study|Lost to Follow-up|0|||
155137014|NCT02679755|559934947|FG000|Overall Study|Objective progression or relapse|24|||
155137015|NCT02679755|559934948|FG001|Overall Study|Objective progression or relapse|83|||
155137016|NCT02679755|559934947|FG000|Overall Study|Not defined|0|||
155137017|NCT02679755|559934948|FG001|Overall Study|Not defined|2|||
155137018|NCT02679755|559934947|FG000|Overall Study|Withdrawal by participant|6|||
155137019|NCT02679755|559934948|FG001|Overall Study|Withdrawal by participant|3|||
155137020|NCT02679755|559934947|FG000|Overall Study|Adverse Event|1|||
155137021|NCT02679755|559934948|FG001|Overall Study|Adverse Event|4|||
155137022|NCT02679755|559934947|FG000|Overall Study|Adverse events not related to study drug|1|||
155137023|NCT02679755|559934948|FG001|Overall Study|Adverse events not related to study drug|2|||
155137024|NCT01061359|559934949|FG000|Overall Study|Death|32|||
155137025|NCT01061359|559934949|FG000|Overall Study|Lost to Follow-up|1072|||
155137026|NCT01061359|559934949|FG000|Overall Study|Relapse|187|||
155137027|NCT01061359|559934949|FG000|Overall Study|Secondary neoplasm|11|||
155178744|NCT04559529|560093391|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
155137028|NCT02610777|559934950|FG000|Overall Study|Lost to Follow-up|1|||
155137029|NCT02610777|559934951|FG001|Overall Study|Lost to Follow-up|0|||
155137030|NCT02610777|559934950|FG000|Overall Study|Site Terminated by Sponsor|9|||
155137031|NCT02610777|559934951|FG001|Overall Study|Site Terminated by Sponsor|8|||
155137032|NCT02610777|559934950|FG000|Overall Study|Withdrawal by Subject|2|||
155137033|NCT02610777|559934951|FG001|Overall Study|Withdrawal by Subject|2|||
155137034|NCT02610777|559934950|FG000|Overall Study|Reason not Specified|0|||
155137035|NCT02610777|559934951|FG001|Overall Study|Reason not Specified|1|||
155137036|NCT02610777|559934950|FG000|Overall Study|Death|50|||
155137037|NCT02610777|559934951|FG001|Overall Study|Death|47|||
155137038|NCT00411671|559934954|FG000|Overall Study|Adverse Event|15|||
155137039|NCT00411671|559934954|FG000|Overall Study|Death|2|||
155137040|NCT00411671|559934954|FG000|Overall Study|Lost to Follow-up|3|||
155137041|NCT03688074|559934957|FG000|Overall Study|Adverse Event|0|||
155137042|NCT03688074|559934958|FG001|Overall Study|Adverse Event|1|||
155137043|NCT03688074|559934957|FG000|Overall Study|Other|1|||
155137044|NCT03688074|559934958|FG001|Overall Study|Other|0|||
155137045|NCT04171219|559934962|FG000|Overall Study|Adverse Event|1|||
155137046|NCT04171219|559934963|FG001|Overall Study|Adverse Event|0|||
155178745|NCT04559529|560093392|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
155137047|NCT04171219|559934962|FG000|Overall Study|Death|0|||
155137048|NCT04171219|559934963|FG001|Overall Study|Death|1|||
155137049|NCT04171219|559934962|FG000|Overall Study|Lack of Efficacy|9|||
155137050|NCT04171219|559934963|FG001|Overall Study|Lack of Efficacy|13|||
155137051|NCT04171219|559934962|FG000|Overall Study|Withdrawal by Subject|1|||
155137052|NCT04171219|559934963|FG001|Overall Study|Withdrawal by Subject|2|||
155137053|NCT04171219|559934962|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
155137054|NCT04171219|559934963|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
155137055|NCT04171219|559934962|FG000|Overall Study|Clinical PD/Patient choice|1|||
155137056|NCT04171219|559934963|FG001|Overall Study|Clinical PD/Patient choice|0|||
155137057|NCT04171219|559934962|FG000|Overall Study|Toxicity/ Patient choice|1|||
155137058|NCT04171219|559934963|FG001|Overall Study|Toxicity/ Patient choice|0|||
155137059|NCT04809285|559934966|FG000|Phase 1|Lost to Follow-up|6|||
155137060|NCT04809285|559934966|FG000|Phase 1|Protocol Violation|2|||
155137061|NCT04809285|559934966|FG000|Phase 1|Physician Decision|3|||
155137062|NCT04809285|559934966|FG000|Phase 1|Withdrawal by Subject|29|||
155137063|NCT04809285|559934966|FG000|Phase 2|Protocol Violation|3|||
155137064|NCT04809285|559934966|FG000|Phase 2|Withdrawal by Subject|4|||
155137065|NCT02974257|559934967|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
155137066|NCT02974257|559934968|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
155137067|NCT02974257|559934967|FG000|Overall Study|Clinical indication for thiamine|1|||
155137068|NCT02974257|559934968|FG001|Overall Study|Clinical indication for thiamine|0|||
155137069|NCT02974257|559934967|FG000|Overall Study|Already on thiamine|1|||
155137070|NCT02974257|559934968|FG001|Overall Study|Already on thiamine|0|||
155137071|NCT02974257|559934967|FG000|Overall Study|Extubated prior to study drug|0|||
155137072|NCT02974257|559934968|FG001|Overall Study|Extubated prior to study drug|1|||
155137073|NCT02974257|559934967|FG000|Overall Study|Death|0|||
155137074|NCT02974257|559934968|FG001|Overall Study|Death|1|||
155137075|NCT03526146|559934969|FG000|Overall Study|Lost to Follow-up|5|||
155137076|NCT03526146|559934969|FG000|Overall Study|Withdrawal by Subject|6|||
155137077|NCT03526146|559934969|FG000|Overall Study|class canceled due to COVID-19|4|||
155137078|NCT02644343|559934970|FG000|Overall Study|Withdrawal by Subject|1|||
155137079|NCT02034877|559934971|FG000|Overall Study|Lost to Follow-up|0|||
155137080|NCT02034877|559934972|FG001|Overall Study|Lost to Follow-up|3|||
155137081|NCT02034877|559934971|FG000|Overall Study|No Longer Willing to Participate|0|||
155137082|NCT02034877|559934972|FG001|Overall Study|No Longer Willing to Participate|3|||
155137083|NCT00536471|559934973|FG000|Overall Study|Lost to Follow-up|48|||
155137084|NCT00536471|559934974|FG001|Overall Study|Lost to Follow-up|23|||
155137085|NCT00536471|559934975|FG002|Overall Study|Lost to Follow-up|48|||
155137086|NCT00536471|559934976|FG003|Overall Study|Lost to Follow-up|22|||
155137087|NCT00536471|559934973|FG000|Overall Study|Adverse Event|32|||
155137088|NCT00536471|559934974|FG001|Overall Study|Adverse Event|16|||
155137089|NCT00536471|559934975|FG002|Overall Study|Adverse Event|28|||
155137090|NCT00536471|559934976|FG003|Overall Study|Adverse Event|13|||
155137091|NCT00536471|559934973|FG000|Overall Study|Withdrawal by Subject|40|||
155137092|NCT00536471|559934974|FG001|Overall Study|Withdrawal by Subject|24|||
155137093|NCT00536471|559934975|FG002|Overall Study|Withdrawal by Subject|43|||
155137094|NCT00536471|559934976|FG003|Overall Study|Withdrawal by Subject|21|||
155137095|NCT00536471|559934973|FG000|Overall Study|Lack of Efficacy|17|||
155137096|NCT00536471|559934974|FG001|Overall Study|Lack of Efficacy|18|||
155137097|NCT00536471|559934975|FG002|Overall Study|Lack of Efficacy|11|||
155137098|NCT00536471|559934976|FG003|Overall Study|Lack of Efficacy|9|||
155137099|NCT00536471|559934973|FG000|Overall Study|Protocol Violation|8|||
155137100|NCT00536471|559934974|FG001|Overall Study|Protocol Violation|1|||
155137101|NCT00536471|559934975|FG002|Overall Study|Protocol Violation|2|||
155178746|NCT04559529|560093393|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
155137102|NCT00536471|559934976|FG003|Overall Study|Protocol Violation|3|||
155137103|NCT00536471|559934973|FG000|Overall Study|Physician Decision|11|||
155137104|NCT00536471|559934974|FG001|Overall Study|Physician Decision|1|||
155137105|NCT00536471|559934975|FG002|Overall Study|Physician Decision|3|||
155137106|NCT00536471|559934976|FG003|Overall Study|Physician Decision|2|||
155137107|NCT00536471|559934973|FG000|Overall Study|Death|0|||
155137108|NCT00536471|559934974|FG001|Overall Study|Death|0|||
155137109|NCT00536471|559934975|FG002|Overall Study|Death|1|||
155137110|NCT00536471|559934976|FG003|Overall Study|Death|2|||
155137111|NCT00536471|559934973|FG000|Overall Study|Sponsor Decision|0|||
155137112|NCT00536471|559934974|FG001|Overall Study|Sponsor Decision|1|||
155137113|NCT00536471|559934975|FG002|Overall Study|Sponsor Decision|3|||
155137114|NCT00536471|559934976|FG003|Overall Study|Sponsor Decision|2|||
155137115|NCT04878211|559934982|FG000|Overall Study|Lost to Follow-up|0|||
155137116|NCT04878211|559934983|FG001|Overall Study|Lost to Follow-up|0|||
155137117|NCT04878211|559934984|FG002|Overall Study|Lost to Follow-up|0|||
155137118|NCT04878211|559934985|FG003|Overall Study|Lost to Follow-up|1|||
155137119|NCT04878211|559934986|FG004|Overall Study|Lost to Follow-up|0|||
155137120|NCT04878211|559934987|FG005|Overall Study|Lost to Follow-up|1|||
155137121|NCT04878211|559934982|FG000|Overall Study|Protocol deviation|1|||
155137122|NCT04878211|559934983|FG001|Overall Study|Protocol deviation|0|||
155137123|NCT04878211|559934984|FG002|Overall Study|Protocol deviation|0|||
155137124|NCT04878211|559934985|FG003|Overall Study|Protocol deviation|0|||
155137125|NCT04878211|559934986|FG004|Overall Study|Protocol deviation|0|||
155137126|NCT04878211|559934987|FG005|Overall Study|Protocol deviation|0|||
155137127|NCT04878211|559934982|FG000|Overall Study|Study terminated by sponsor|0|||
155137128|NCT04878211|559934983|FG001|Overall Study|Study terminated by sponsor|0|||
155137129|NCT04878211|559934984|FG002|Overall Study|Study terminated by sponsor|0|||
155137130|NCT04878211|559934985|FG003|Overall Study|Study terminated by sponsor|0|||
155137131|NCT04878211|559934986|FG004|Overall Study|Study terminated by sponsor|9|||
155137132|NCT04878211|559934987|FG005|Overall Study|Study terminated by sponsor|4|||
155137133|NCT04878211|559934982|FG000|Overall Study|Subject decision|0|||
155137134|NCT04878211|559934983|FG001|Overall Study|Subject decision|0|||
155137135|NCT04878211|559934984|FG002|Overall Study|Subject decision|0|||
155137136|NCT04878211|559934985|FG003|Overall Study|Subject decision|0|||
155137137|NCT04878211|559934986|FG004|Overall Study|Subject decision|1|||
155137138|NCT04878211|559934987|FG005|Overall Study|Subject decision|0|||
155137139|NCT03574779|559934994|FG000|Overall Study|Screening failure|13|||
155137140|NCT03574779|559934995|FG001|Overall Study|Screening failure|83|||
155137141|NCT02783599|559934996|FG000|Overall Study|Progressive disease|23|||
155137142|NCT02783599|559934996|FG000|Overall Study|Surgical Resection|10|||
155137143|NCT02783599|559934996|FG000|Overall Study|Adverse Event|4|||
155137144|NCT02783599|559934996|FG000|Overall Study|Physician Decision|2|||
155137145|NCT02783599|559934996|FG000|Overall Study|Death|1|||
155137146|NCT00856544|559935004|FG000|Overall Study|Randomized but not treated|3|||
155137147|NCT00856544|559935005|FG001|Overall Study|Randomized but not treated|0|||
155137148|NCT00856544|559935006|FG002|Overall Study|Randomized but not treated|0|||
155137149|NCT00856544|559935007|FG003|Overall Study|Randomized but not treated|0|||
155137150|NCT00856544|559935004|FG000|Overall Study|Death|0|||
155137151|NCT00856544|559935005|FG001|Overall Study|Death|2|||
155137152|NCT00856544|559935006|FG002|Overall Study|Death|0|||
155137153|NCT00856544|559935007|FG003|Overall Study|Death|0|||
155137154|NCT00856544|559935004|FG000|Overall Study|Adverse Event|20|||
155137155|NCT00856544|559935005|FG001|Overall Study|Adverse Event|29|||
155137156|NCT00856544|559935006|FG002|Overall Study|Adverse Event|2|||
155137157|NCT00856544|559935007|FG003|Overall Study|Adverse Event|3|||
155137158|NCT00856544|559935004|FG000|Overall Study|Lack of Efficacy|16|||
155137159|NCT00856544|559935005|FG001|Overall Study|Lack of Efficacy|12|||
155137160|NCT00856544|559935006|FG002|Overall Study|Lack of Efficacy|3|||
155137161|NCT00856544|559935007|FG003|Overall Study|Lack of Efficacy|3|||
155137162|NCT00856544|559935004|FG000|Overall Study|Other|9|||
155137163|NCT00856544|559935005|FG001|Overall Study|Other|16|||
155137164|NCT00856544|559935006|FG002|Overall Study|Other|1|||
155137165|NCT00856544|559935007|FG003|Overall Study|Other|6|||
155137166|NCT00856544|559935004|FG000|Overall Study|Lost to Follow-up|1|||
155137167|NCT00856544|559935005|FG001|Overall Study|Lost to Follow-up|2|||
155137168|NCT00856544|559935006|FG002|Overall Study|Lost to Follow-up|2|||
155137169|NCT00856544|559935007|FG003|Overall Study|Lost to Follow-up|0|||
155137170|NCT00856544|559935004|FG000|Overall Study|Withdrawal by Subject|8|||
155137171|NCT00856544|559935005|FG001|Overall Study|Withdrawal by Subject|5|||
155137172|NCT00856544|559935006|FG002|Overall Study|Withdrawal by Subject|0|||
155137173|NCT00856544|559935007|FG003|Overall Study|Withdrawal by Subject|1|||
155137174|NCT01564732|559935008|FG000|Overall Study|Early termination by the study sponsor|6|||
155137175|NCT01564732|559935009|FG001|Overall Study|Early termination by the study sponsor|5|||
155137176|NCT00394706|559935014|FG000|Overall Study|Withdrawal by Subject|2|||
155137177|NCT00394706|559935015|FG001|Overall Study|Withdrawal by Subject|0|||
155137178|NCT00394706|559935016|FG002|Overall Study|Withdrawal by Subject|1|||
155137179|NCT00394706|559935017|FG003|Overall Study|Withdrawal by Subject|0|||
155137180|NCT00394706|559935018|FG004|Overall Study|Withdrawal by Subject|0|||
155137181|NCT00394706|559935019|FG005|Overall Study|Withdrawal by Subject|2|||
155137182|NCT00394706|559935020|FG006|Overall Study|Withdrawal by Subject|1|||
155137183|NCT00394706|559935021|FG007|Overall Study|Withdrawal by Subject|0|||
155137184|NCT00394706|559935014|FG000|Overall Study|Lost to Follow-up|2|||
155137185|NCT00394706|559935015|FG001|Overall Study|Lost to Follow-up|2|||
155137186|NCT00394706|559935016|FG002|Overall Study|Lost to Follow-up|8|||
155137187|NCT00394706|559935017|FG003|Overall Study|Lost to Follow-up|1|||
155137188|NCT00394706|559935018|FG004|Overall Study|Lost to Follow-up|2|||
155137189|NCT00394706|559935019|FG005|Overall Study|Lost to Follow-up|5|||
155137190|NCT00394706|559935020|FG006|Overall Study|Lost to Follow-up|2|||
155137191|NCT00394706|559935021|FG007|Overall Study|Lost to Follow-up|0|||
155137192|NCT02003534|559935026|FG000|Overall Study|Lost to Follow-up|47|||
155137193|NCT03920254|559935027|FG000|Overall Study|Adverse Event|1|||
155137194|NCT03920254|559935028|FG001|Overall Study|Adverse Event|0|||
155137195|NCT03920254|559935029|FG002|Overall Study|Adverse Event|0|||
155137196|NCT03920254|559935027|FG000|Overall Study|Physician Decision|0|||
155137197|NCT03920254|559935028|FG001|Overall Study|Physician Decision|1|||
155137198|NCT03920254|559935029|FG002|Overall Study|Physician Decision|2|||
155137199|NCT03920254|559935027|FG000|Overall Study|Study Terminated By Sponsor|12|||
155137200|NCT03920254|559935028|FG001|Overall Study|Study Terminated By Sponsor|17|||
155137201|NCT03920254|559935029|FG002|Overall Study|Study Terminated By Sponsor|12|||
155137202|NCT03920254|559935027|FG000|Overall Study|Withdrawal by Subject|0|||
155137203|NCT03920254|559935028|FG001|Overall Study|Withdrawal by Subject|0|||
155137204|NCT03920254|559935029|FG002|Overall Study|Withdrawal by Subject|1|||
155137205|NCT03040674|559935030|FG000|Overall Study|Lost to Follow-up|225|||
155137206|NCT03040674|559935030|FG000|Overall Study|Death|23|||
155137207|NCT01934010|559935031|FG000|Overall Study|Adverse Event|1|||
155137208|NCT01934010|559935032|FG001|Overall Study|Adverse Event|1|||
155137209|NCT01934010|559935033|FG002|Overall Study|Adverse Event|0|||
155137210|NCT01934010|559935031|FG000|Overall Study|Withdrawal by Subject|15|||
155137211|NCT01934010|559935032|FG001|Overall Study|Withdrawal by Subject|6|||
155137212|NCT01934010|559935033|FG002|Overall Study|Withdrawal by Subject|2|||
155137213|NCT01934010|559935031|FG000|Overall Study|Lost to Follow-up|7|||
155137214|NCT01934010|559935032|FG001|Overall Study|Lost to Follow-up|4|||
155137215|NCT01934010|559935033|FG002|Overall Study|Lost to Follow-up|0|||
155137216|NCT04112303|559935034|FG000|Overall Study|Death|1|||
155137217|NCT02506192|559935035|FG000|Overall Study|Withdrawal by Subject|1|||
155137218|NCT02506192|559935036|FG001|Overall Study|Withdrawal by Subject|1|||
155137219|NCT00709618|559935037|FG000|Overall Study|Withdrawal by Subject|4|||
155137220|NCT00709618|559935037|FG000|Overall Study|Lost to Follow-up|1|||
155137221|NCT00709618|559935037|FG000|Overall Study|Study Closed/Terminated|25|||
155137222|NCT02703324|559935038|FG000|Period Two|Withdrawal by Subject|0|||
155137223|NCT02703324|559935039|FG001|Period Two|Withdrawal by Subject|0|||
155137224|NCT02703324|559935040|FG002|Period Two|Withdrawal by Subject|1|||
155137225|NCT02703324|559935041|FG003|Period Two|Withdrawal by Subject|0|||
155137226|NCT02703324|559935042|FG004|Period Two|Withdrawal by Subject|0|||
155137227|NCT02703324|559935043|FG005|Period Two|Withdrawal by Subject|0|||
155137228|NCT04042909|559935044|FG000|Overall Study|Withdrawal by Subject|1|||
155137229|NCT04042909|559935045|FG001|Overall Study|Withdrawal by Subject|0|||
155137230|NCT04042909|559935046|FG002|Overall Study|Withdrawal by Subject|0|||
155137231|NCT04042909|559935044|FG000|Overall Study|duplicate cases|2|||
155137232|NCT04042909|559935045|FG001|Overall Study|duplicate cases|0|||
155137233|NCT04042909|559935046|FG002|Overall Study|duplicate cases|0|||
155137234|NCT04042909|559935044|FG000|Overall Study|technical problem|0|||
155137235|NCT04042909|559935045|FG001|Overall Study|technical problem|1|||
155137236|NCT04042909|559935046|FG002|Overall Study|technical problem|0|||
155137237|NCT04303572|559935047|FG000|Overall Study|Study closed due to poor enrollment|1|||
155137238|NCT06312592|559935048|FG000|Overall Study|Lost to Follow-up|29|||
155137239|NCT06312592|559935049|FG001|Overall Study|Lost to Follow-up|13|||
155137240|NCT03785405|559935052|FG000|Overall Study|Adverse Event|16|||
155137241|NCT03785405|559935053|FG001|Overall Study|Adverse Event|1|||
155137242|NCT03785405|559935052|FG000|Overall Study|Death|6|||
155137243|NCT03785405|559935053|FG001|Overall Study|Death|4|||
155137244|NCT03785405|559935052|FG000|Overall Study|Guardian decision|4|||
155137245|NCT03785405|559935053|FG001|Overall Study|Guardian decision|1|||
155137246|NCT03785405|559935052|FG000|Overall Study|Lost to Follow-up|1|||
155137247|NCT03785405|559935053|FG001|Overall Study|Lost to Follow-up|0|||
155137248|NCT03785405|559935052|FG000|Overall Study|Physician Decision|8|||
155137249|NCT03785405|559935053|FG001|Overall Study|Physician Decision|5|||
155137250|NCT03785405|559935052|FG000|Overall Study|Participant decision|2|||
155137251|NCT03785405|559935053|FG001|Overall Study|Participant decision|0|||
155137252|NCT03785405|559935052|FG000|Overall Study|Other|1|||
155137253|NCT03785405|559935053|FG001|Overall Study|Other|0|||
155137254|NCT03785405|559935052|FG000|Overall Study|No treatment was received|0|||
155137255|NCT03785405|559935053|FG001|Overall Study|No treatment was received|1|||
155137256|NCT03705559|559935054|FG000|Overall Study|COVID Shut down|1|||
155137257|NCT01858766|559935055|FG000|Overall Study|Randomized but Never Treated|0|||
155137258|NCT01858766|559935056|FG001|Overall Study|Randomized but Never Treated|0|||
155137259|NCT01858766|559935057|FG002|Overall Study|Randomized but Never Treated|0|||
155137260|NCT01858766|559935058|FG003|Overall Study|Randomized but Never Treated|0|||
155137261|NCT01858766|559935059|FG004|Overall Study|Randomized but Never Treated|0|||
155137262|NCT01858766|559935060|FG005|Overall Study|Randomized but Never Treated|1|||
155137263|NCT01858766|559935061|FG006|Overall Study|Randomized but Never Treated|0|||
155137264|NCT01858766|559935062|FG007|Overall Study|Randomized but Never Treated|0|||
155137265|NCT01858766|559935063|FG008|Overall Study|Randomized but Never Treated|0|||
155137266|NCT01858766|559935064|FG009|Overall Study|Randomized but Never Treated|0|||
155137267|NCT01858766|559935065|FG010|Overall Study|Randomized but Never Treated|0|||
155137268|NCT01858766|559935066|FG011|Overall Study|Randomized but Never Treated|0|||
155137269|NCT01858766|559935067|FG012|Overall Study|Randomized but Never Treated|0|||
155137270|NCT01858766|559935068|FG013|Overall Study|Randomized but Never Treated|0|||
155015525|NCT00318474|559482381|FG000|Overall Study|Fall in GFR|3|||
155015526|NCT00318474|559482382|FG001|Overall Study|Fall in GFR|3|||
155015527|NCT00318474|559482381|FG000|Overall Study|Post-therapy hyperflycemia|0|||
155015528|NCT00318474|559482382|FG001|Overall Study|Post-therapy hyperflycemia|1|||
155015529|NCT00318474|559482381|FG000|Overall Study|Trial terminated|10|||
155015530|NCT00318474|559482382|FG001|Overall Study|Trial terminated|7|||
155015531|NCT01611935|559482383|FG000|Overall Study|Family Declined Participation|1|||
155015532|NCT01611935|559482384|FG001|Overall Study|Family Declined Participation|0|||
155015533|NCT01735916|559482385|FG000|Overall Study|Subject not eligible to be randomized|11|||
155015534|NCT01735916|559482386|FG001|Overall Study|Subject not eligible to be randomized|0|||
155015535|NCT01735916|559482387|FG002|Overall Study|Subject not eligible to be randomized|0|||
155015536|NCT01735916|559482385|FG000|Overall Study|Early termination of study by sponsor|4|||
155015537|NCT01735916|559482386|FG001|Overall Study|Early termination of study by sponsor|19|||
155015538|NCT01735916|559482387|FG002|Overall Study|Early termination of study by sponsor|7|||
155015539|NCT01735916|559482385|FG000|Overall Study|Withdrawal by Subject|3|||
155015540|NCT01735916|559482386|FG001|Overall Study|Withdrawal by Subject|0|||
155015541|NCT01735916|559482387|FG002|Overall Study|Withdrawal by Subject|0|||
155015542|NCT04227197|559482388|FG000|Randomization|Protocol Violation|1|||
155015543|NCT04227197|559482389|FG001|Randomization|Protocol Violation|0|||
155015544|NCT04227197|559482388|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
155015545|NCT04227197|559482389|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
155015546|NCT04227197|559482388|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
155015547|NCT04227197|559482389|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
155015548|NCT04227197|559482388|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
155015549|NCT04227197|559482389|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
155015550|NCT04227197|559482388|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
155015551|NCT04227197|559482389|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
155015552|NCT04227197|559482388|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
155015553|NCT04227197|559482389|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
155015554|NCT04227197|559482388|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
155015555|NCT04227197|559482389|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
155015556|NCT05177484|559482392|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
155015557|NCT05177484|559482393|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
155015558|NCT05177484|559482392|FG000|Overall Study|Inadvertently withdrawn|3|||
155015559|NCT05177484|559482393|FG001|Overall Study|Inadvertently withdrawn|1|||
155015560|NCT05177484|559482392|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
155015561|NCT05177484|559482393|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
155015562|NCT02549859|559482396|FG000|Long-term 60 Hz DBS|Study Closed|1|||
155015563|NCT01379768|559482397|FG000|Overall Study|Adverse Event|1|||
155015564|NCT01379768|559482398|FG001|Overall Study|Adverse Event|1|||
155015565|NCT01379768|559482399|FG002|Overall Study|Adverse Event|0|||
155015566|NCT01379768|559482397|FG000|Overall Study|Lost to Follow-up|2|||
155015567|NCT01379768|559482398|FG001|Overall Study|Lost to Follow-up|0|||
155015568|NCT01379768|559482399|FG002|Overall Study|Lost to Follow-up|0|||
155015569|NCT01209949|559482407|FG000|Overall Study|Lost to Follow-up|3|||
155015570|NCT00729612|559482412|FG000|Overall Study|Non evaluable for response|10|||
155015571|NCT00708552|559482413|FG000|Overall Study|Adverse Event|10|||
155015572|NCT00708552|559482414|FG001|Overall Study|Adverse Event|3|||
155015573|NCT00708552|559482415|FG002|Overall Study|Adverse Event|4|||
155015574|NCT00708552|559482416|FG003|Overall Study|Adverse Event|6|||
155015575|NCT00708552|559482413|FG000|Overall Study|Lack of Efficacy|0|||
155015576|NCT00708552|559482414|FG001|Overall Study|Lack of Efficacy|4|||
155015577|NCT00708552|559482415|FG002|Overall Study|Lack of Efficacy|1|||
155015578|NCT00708552|559482416|FG003|Overall Study|Lack of Efficacy|0|||
155015579|NCT00708552|559482413|FG000|Overall Study|Protocol Violation|0|||
155015580|NCT00708552|559482414|FG001|Overall Study|Protocol Violation|0|||
155015581|NCT00708552|559482415|FG002|Overall Study|Protocol Violation|2|||
155015582|NCT00708552|559482416|FG003|Overall Study|Protocol Violation|4|||
155015583|NCT00708552|559482413|FG000|Overall Study|Lost to Follow-up|4|||
155015584|NCT00708552|559482414|FG001|Overall Study|Lost to Follow-up|2|||
155015585|NCT00708552|559482415|FG002|Overall Study|Lost to Follow-up|0|||
155015586|NCT00708552|559482416|FG003|Overall Study|Lost to Follow-up|1|||
155015587|NCT00708552|559482413|FG000|Overall Study|Physician Decision|1|||
155015588|NCT00708552|559482414|FG001|Overall Study|Physician Decision|2|||
155015589|NCT00708552|559482415|FG002|Overall Study|Physician Decision|0|||
155015590|NCT00708552|559482416|FG003|Overall Study|Physician Decision|0|||
155015591|NCT00708552|559482413|FG000|Overall Study|Withdrawal by Subject|12|||
155015592|NCT00708552|559482414|FG001|Overall Study|Withdrawal by Subject|7|||
155015593|NCT00708552|559482415|FG002|Overall Study|Withdrawal by Subject|8|||
155015594|NCT00708552|559482416|FG003|Overall Study|Withdrawal by Subject|10|||
155015595|NCT03971071|559482418|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155015596|NCT03971071|559482419|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
155015597|NCT03971071|559482420|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155137271|NCT01858766|559935069|FG014|Overall Study|Randomized but Never Treated|0|||
155137272|NCT01858766|559935070|FG015|Overall Study|Randomized but Never Treated|0|||
155137273|NCT01858766|559935071|FG016|Overall Study|Randomized but Never Treated|0|||
155137274|NCT01858766|559935072|FG017|Overall Study|Randomized but Never Treated|1|||
155137275|NCT01858766|559935073|FG018|Overall Study|Randomized but Never Treated|0|||
155137276|NCT01858766|559935055|FG000|Overall Study|Death|0|||
155137277|NCT01858766|559935056|FG001|Overall Study|Death|0|||
155137278|NCT01858766|559935057|FG002|Overall Study|Death|1|||
155137279|NCT01858766|559935058|FG003|Overall Study|Death|0|||
155137280|NCT01858766|559935059|FG004|Overall Study|Death|0|||
155137281|NCT01858766|559935060|FG005|Overall Study|Death|0|||
155137282|NCT01858766|559935061|FG006|Overall Study|Death|0|||
155137283|NCT01858766|559935062|FG007|Overall Study|Death|0|||
155137284|NCT01858766|559935063|FG008|Overall Study|Death|0|||
155137285|NCT01858766|559935064|FG009|Overall Study|Death|0|||
155137286|NCT01858766|559935065|FG010|Overall Study|Death|0|||
155137287|NCT01858766|559935066|FG011|Overall Study|Death|0|||
155137288|NCT01858766|559935067|FG012|Overall Study|Death|0|||
155137289|NCT01858766|559935068|FG013|Overall Study|Death|0|||
155137290|NCT01858766|559935069|FG014|Overall Study|Death|0|||
155137291|NCT01858766|559935070|FG015|Overall Study|Death|0|||
155137292|NCT01858766|559935071|FG016|Overall Study|Death|0|||
155137293|NCT01858766|559935072|FG017|Overall Study|Death|0|||
155137294|NCT01858766|559935073|FG018|Overall Study|Death|0|||
155137295|NCT01858766|559935055|FG000|Overall Study|Lack of Efficacy|1|||
155137296|NCT01858766|559935056|FG001|Overall Study|Lack of Efficacy|0|||
155137297|NCT01858766|559935057|FG002|Overall Study|Lack of Efficacy|0|||
155137298|NCT01858766|559935058|FG003|Overall Study|Lack of Efficacy|0|||
155137299|NCT01858766|559935059|FG004|Overall Study|Lack of Efficacy|1|||
155137300|NCT01858766|559935060|FG005|Overall Study|Lack of Efficacy|2|||
155137301|NCT01858766|559935061|FG006|Overall Study|Lack of Efficacy|0|||
155137302|NCT01858766|559935062|FG007|Overall Study|Lack of Efficacy|0|||
155137303|NCT01858766|559935063|FG008|Overall Study|Lack of Efficacy|0|||
155137304|NCT01858766|559935064|FG009|Overall Study|Lack of Efficacy|0|||
155137305|NCT01858766|559935065|FG010|Overall Study|Lack of Efficacy|0|||
155137306|NCT01858766|559935066|FG011|Overall Study|Lack of Efficacy|3|||
155137307|NCT01858766|559935067|FG012|Overall Study|Lack of Efficacy|5|||
155137308|NCT01858766|559935068|FG013|Overall Study|Lack of Efficacy|3|||
155137309|NCT01858766|559935069|FG014|Overall Study|Lack of Efficacy|5|||
155137310|NCT01858766|559935070|FG015|Overall Study|Lack of Efficacy|5|||
155137311|NCT01858766|559935071|FG016|Overall Study|Lack of Efficacy|2|||
155137312|NCT01858766|559935072|FG017|Overall Study|Lack of Efficacy|3|||
155137313|NCT01858766|559935073|FG018|Overall Study|Lack of Efficacy|3|||
155137314|NCT01858766|559935055|FG000|Overall Study|Lost to Follow-up|0|||
155137315|NCT01858766|559935056|FG001|Overall Study|Lost to Follow-up|0|||
155137316|NCT01858766|559935057|FG002|Overall Study|Lost to Follow-up|0|||
155137317|NCT01858766|559935058|FG003|Overall Study|Lost to Follow-up|0|||
155137318|NCT01858766|559935059|FG004|Overall Study|Lost to Follow-up|0|||
155137319|NCT01858766|559935060|FG005|Overall Study|Lost to Follow-up|1|||
155137320|NCT01858766|559935061|FG006|Overall Study|Lost to Follow-up|0|||
155137321|NCT01858766|559935062|FG007|Overall Study|Lost to Follow-up|2|||
155137322|NCT01858766|559935063|FG008|Overall Study|Lost to Follow-up|0|||
155137323|NCT01858766|559935064|FG009|Overall Study|Lost to Follow-up|0|||
155137324|NCT01858766|559935065|FG010|Overall Study|Lost to Follow-up|0|||
155137325|NCT01858766|559935066|FG011|Overall Study|Lost to Follow-up|1|||
155137326|NCT01858766|559935067|FG012|Overall Study|Lost to Follow-up|0|||
155137327|NCT01858766|559935068|FG013|Overall Study|Lost to Follow-up|0|||
155137328|NCT01858766|559935069|FG014|Overall Study|Lost to Follow-up|3|||
155137329|NCT01858766|559935070|FG015|Overall Study|Lost to Follow-up|1|||
155137330|NCT01858766|559935071|FG016|Overall Study|Lost to Follow-up|1|||
155137331|NCT01858766|559935072|FG017|Overall Study|Lost to Follow-up|0|||
155137332|NCT01858766|559935073|FG018|Overall Study|Lost to Follow-up|1|||
155137333|NCT01858766|559935055|FG000|Overall Study|Withdrew Consent|0|||
155015598|NCT03971071|559482421|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155015599|NCT03971071|559482422|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
155137334|NCT01858766|559935056|FG001|Overall Study|Withdrew Consent|0|||
155137335|NCT01858766|559935057|FG002|Overall Study|Withdrew Consent|0|||
155137336|NCT01858766|559935058|FG003|Overall Study|Withdrew Consent|0|||
155137337|NCT01858766|559935059|FG004|Overall Study|Withdrew Consent|0|||
155137338|NCT01858766|559935060|FG005|Overall Study|Withdrew Consent|0|||
155137339|NCT01858766|559935061|FG006|Overall Study|Withdrew Consent|0|||
155137340|NCT01858766|559935062|FG007|Overall Study|Withdrew Consent|0|||
155137341|NCT01858766|559935063|FG008|Overall Study|Withdrew Consent|0|||
155137342|NCT01858766|559935064|FG009|Overall Study|Withdrew Consent|0|||
155137343|NCT01858766|559935065|FG010|Overall Study|Withdrew Consent|0|||
155137344|NCT01858766|559935066|FG011|Overall Study|Withdrew Consent|1|||
155137345|NCT01858766|559935067|FG012|Overall Study|Withdrew Consent|0|||
155137346|NCT01858766|559935068|FG013|Overall Study|Withdrew Consent|0|||
155137347|NCT01858766|559935069|FG014|Overall Study|Withdrew Consent|0|||
155137348|NCT01858766|559935070|FG015|Overall Study|Withdrew Consent|0|||
155137349|NCT01858766|559935071|FG016|Overall Study|Withdrew Consent|0|||
155015600|NCT03971071|559482418|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
155015601|NCT03971071|559482419|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
155015602|NCT03971071|559482420|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
155015603|NCT03971071|559482421|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155015604|NCT03971071|559482422|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
155015605|NCT03971071|559482418|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
155137350|NCT01858766|559935072|FG017|Overall Study|Withdrew Consent|0|||
155137351|NCT01858766|559935073|FG018|Overall Study|Withdrew Consent|0|||
155137352|NCT03517228|559935074|FG000|Overall Study|Withdrawal by Subject|2|||
155137353|NCT03517228|559935074|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
155137354|NCT03517228|559935074|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
155137355|NCT03517228|559935074|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
155137356|NCT03517228|559935074|FG000|Overall Study|Canceled due to device being updated|1|||
155137357|NCT03517228|559935074|FG000|Overall Study|No V Cares in stock|1|||
155137358|NCT03517228|559935074|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
155137359|NCT01979952|559935075|FG000|Overall Study|Adverse Event|4|||
155137360|NCT01979952|559935076|FG001|Overall Study|Adverse Event|5|||
155137361|NCT01979952|559935075|FG000|Overall Study|Protocol Violation|1|||
155137362|NCT01979952|559935076|FG001|Overall Study|Protocol Violation|0|||
155137363|NCT01979952|559935075|FG000|Overall Study|Withdrawal by Subject|2|||
155137364|NCT01979952|559935076|FG001|Overall Study|Withdrawal by Subject|1|||
155137365|NCT01979952|559935075|FG000|Overall Study|Other than specified above|1|||
155137366|NCT01979952|559935076|FG001|Overall Study|Other than specified above|0|||
155137367|NCT03781414|559935077|FG000|Overall Study|Study terminated by sponsor|39|||
155137368|NCT03781414|559935078|FG001|Overall Study|Study terminated by sponsor|34|||
155137369|NCT03781414|559935079|FG002|Overall Study|Study terminated by sponsor|25|||
155137370|NCT03781414|559935077|FG000|Overall Study|Adverse Event|3|||
155137371|NCT03781414|559935078|FG001|Overall Study|Adverse Event|6|||
155137372|NCT03781414|559935079|FG002|Overall Study|Adverse Event|3|||
155137373|NCT03781414|559935077|FG000|Overall Study|Physician Decision|2|||
155137374|NCT03781414|559935078|FG001|Overall Study|Physician Decision|0|||
155137375|NCT03781414|559935079|FG002|Overall Study|Physician Decision|1|||
155137376|NCT03781414|559935077|FG000|Overall Study|Withdrawal by Subject|2|||
155137377|NCT03781414|559935078|FG001|Overall Study|Withdrawal by Subject|3|||
155137378|NCT03781414|559935079|FG002|Overall Study|Withdrawal by Subject|3|||
155137379|NCT03781414|559935077|FG000|Overall Study|Death|1|||
155137380|NCT03781414|559935078|FG001|Overall Study|Death|4|||
155137381|NCT03781414|559935079|FG002|Overall Study|Death|0|||
155137382|NCT03781414|559935077|FG000|Overall Study|Lost to Follow-up|1|||
155137383|NCT03781414|559935078|FG001|Overall Study|Lost to Follow-up|1|||
155137384|NCT03781414|559935079|FG002|Overall Study|Lost to Follow-up|0|||
155137385|NCT00719355|559935082|FG000|Overall Study|Death|0|||
155137386|NCT00719355|559935083|FG001|Overall Study|Death|1|||
155137387|NCT00719355|559935082|FG000|Overall Study|Medical|14|||
155137388|NCT00719355|559935083|FG001|Overall Study|Medical|5|||
155137389|NCT00719355|559935082|FG000|Overall Study|Compliance|4|||
155137390|NCT00719355|559935083|FG001|Overall Study|Compliance|6|||
155137391|NCT00719355|559935082|FG000|Overall Study|Moved|0|||
155137392|NCT00719355|559935083|FG001|Overall Study|Moved|1|||
155137393|NCT02161757|559935089|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
155137394|NCT02161757|559935090|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
155137395|NCT02161757|559935091|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
155137396|NCT02161757|559935089|FG000|Treatment Through Study Completion|Adverse Event|1|||
155137397|NCT02161757|559935090|FG001|Treatment Through Study Completion|Adverse Event|1|||
155137398|NCT02161757|559935091|FG002|Treatment Through Study Completion|Adverse Event|0|||
155137399|NCT02161757|559935089|FG000|Treatment Through Study Completion|Protocol Violation|0|||
155137400|NCT02161757|559935090|FG001|Treatment Through Study Completion|Protocol Violation|1|||
155137401|NCT02161757|559935091|FG002|Treatment Through Study Completion|Protocol Violation|2|||
155137402|NCT02161757|559935089|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
155137403|NCT02161757|559935090|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
155137404|NCT02161757|559935091|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
155137405|NCT02161757|559935089|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
155137406|NCT02161757|559935090|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
155137407|NCT02161757|559935091|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
155137408|NCT02161757|559935089|FG000|Treatment Through Study Completion|Other|20|||
155137409|NCT02161757|559935090|FG001|Treatment Through Study Completion|Other|19|||
155137410|NCT02161757|559935091|FG002|Treatment Through Study Completion|Other|12|||
155137411|NCT02161757|559935089|FG000|Treatment Through Study Completion|Death|2|||
155137412|NCT02161757|559935090|FG001|Treatment Through Study Completion|Death|1|||
155137413|NCT02161757|559935091|FG002|Treatment Through Study Completion|Death|1|||
155137414|NCT00391625|559935092|FG000|Month 14|Withdrawal by Subject|1|||
155015606|NCT03971071|559482419|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
155015607|NCT03971071|559482420|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
155015608|NCT03971071|559482421|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
155015609|NCT03971071|559482422|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
155015610|NCT03971071|559482418|FG000|Open-label Treatment Period|Sponsor decision|0|||
155015611|NCT03971071|559482419|FG001|Open-label Treatment Period|Sponsor decision|0|||
155015612|NCT03971071|559482420|FG002|Open-label Treatment Period|Sponsor decision|0|||
155015613|NCT03971071|559482421|FG003|Open-label Treatment Period|Sponsor decision|0|||
155015614|NCT03971071|559482422|FG004|Open-label Treatment Period|Sponsor decision|1|||
155015615|NCT03971071|559482418|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
155015616|NCT03971071|559482419|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155015617|NCT03971071|559482420|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
155015618|NCT03971071|559482421|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
155015619|NCT03971071|559482422|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
155015620|NCT03971071|559482418|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
155015621|NCT03971071|559482419|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155015622|NCT03971071|559482420|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
155015623|NCT03971071|559482421|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
155015624|NCT03971071|559482422|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
155015625|NCT00391768|559482423|FG000|Overall Study|Withdrawal by Subject|0|||
155015626|NCT00391768|559482424|FG001|Overall Study|Withdrawal by Subject|0|||
155015627|NCT00391768|559482425|FG002|Overall Study|Withdrawal by Subject|1|||
155015628|NCT00391768|559482426|FG003|Overall Study|Withdrawal by Subject|0|||
155015629|NCT00391768|559482427|FG004|Overall Study|Withdrawal by Subject|0|||
155015630|NCT00391768|559482428|FG005|Overall Study|Withdrawal by Subject|1|||
155015631|NCT00391768|559482429|FG006|Overall Study|Withdrawal by Subject|1|||
155015632|NCT00391768|559482423|FG000|Overall Study|Lost to Follow-up|0|||
155015633|NCT00391768|559482424|FG001|Overall Study|Lost to Follow-up|0|||
155015634|NCT00391768|559482425|FG002|Overall Study|Lost to Follow-up|0|||
155015635|NCT00391768|559482426|FG003|Overall Study|Lost to Follow-up|1|||
155015636|NCT00391768|559482427|FG004|Overall Study|Lost to Follow-up|2|||
155015637|NCT00391768|559482428|FG005|Overall Study|Lost to Follow-up|2|||
155015638|NCT00391768|559482429|FG006|Overall Study|Lost to Follow-up|3|||
155015639|NCT00891020|559482430|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
155015640|NCT00891020|559482431|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
155015641|NCT00891020|559482432|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
155015642|NCT00891020|559482430|FG000|24 Week Treatment Period|Death|0|||
155015643|NCT00891020|559482431|FG001|24 Week Treatment Period|Death|2|||
155015644|NCT00891020|559482432|FG002|24 Week Treatment Period|Death|0|||
155015645|NCT00891020|559482430|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
155015646|NCT00891020|559482431|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
155015647|NCT00891020|559482432|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
155015648|NCT00891020|559482430|FG000|24 Week Treatment Period|Failure to return|4|||
155015649|NCT00891020|559482431|FG001|24 Week Treatment Period|Failure to return|5|||
155015650|NCT00891020|559482432|FG002|24 Week Treatment Period|Failure to return|5|||
155015651|NCT00891020|559482430|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
155015652|NCT00891020|559482431|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
155015653|NCT00891020|559482432|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
155015654|NCT00891020|559482430|FG000|24 Week Treatment Period|Other protocol violation|1|||
155015655|NCT00891020|559482431|FG001|24 Week Treatment Period|Other protocol violation|1|||
155015656|NCT00891020|559482432|FG002|24 Week Treatment Period|Other protocol violation|2|||
155015657|NCT00891020|559482430|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
155015658|NCT00891020|559482431|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
155137415|NCT00391625|559935092|FG000|Month 50|Physician Decision|1|||
155137416|NCT00379912|559935096|FG000|Overall Study|Lack of Efficacy|1|||
155137417|NCT00379912|559935097|FG001|Overall Study|Lack of Efficacy|0|||
155137418|NCT04405076|559935098|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
155137419|NCT04405076|559935099|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
155137420|NCT04405076|559935100|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
155137421|NCT04405076|559935101|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
155137422|NCT04405076|559935102|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
155137423|NCT04405076|559935103|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
155137424|NCT04405076|559935104|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
155137425|NCT04405076|559935105|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
155137426|NCT04405076|559935106|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
155015659|NCT00891020|559482432|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
155015660|NCT00891020|559482430|FG000|24 Week Treatment Period|Withdrew consent|6|||
155015661|NCT00891020|559482431|FG001|24 Week Treatment Period|Withdrew consent|3|||
155015662|NCT00891020|559482432|FG002|24 Week Treatment Period|Withdrew consent|15|||
155137427|NCT04405076|559935098|FG000|Part A (Blinded Phase)|Physician Decision|1|||
155137428|NCT04405076|559935099|FG001|Part A (Blinded Phase)|Physician Decision|2|||
155137429|NCT04405076|559935100|FG002|Part A (Blinded Phase)|Physician Decision|0|||
155137430|NCT04405076|559935101|FG003|Part A (Blinded Phase)|Physician Decision|0|||
155137431|NCT04405076|559935102|FG004|Part A (Blinded Phase)|Physician Decision|0|||
155137432|NCT04405076|559935103|FG005|Part A (Blinded Phase)|Physician Decision|0|||
155137433|NCT04405076|559935104|FG006|Part A (Blinded Phase)|Physician Decision|0|||
155137434|NCT04405076|559935105|FG007|Part A (Blinded Phase)|Physician Decision|0|||
155137435|NCT04405076|559935106|FG008|Part A (Blinded Phase)|Physician Decision|0|||
155137436|NCT04405076|559935098|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
155137437|NCT04405076|559935099|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
155137438|NCT04405076|559935100|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
155137439|NCT04405076|559935101|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
155137440|NCT04405076|559935102|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
155137441|NCT04405076|559935103|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
155137442|NCT04405076|559935104|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
155137443|NCT04405076|559935105|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
155137444|NCT04405076|559935106|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
155137445|NCT04405076|559935098|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
155137446|NCT04405076|559935099|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137447|NCT04405076|559935100|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137448|NCT04405076|559935101|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137449|NCT04405076|559935102|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137450|NCT04405076|559935103|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137451|NCT04405076|559935104|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137452|NCT04405076|559935105|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137453|NCT04405076|559935106|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
155137454|NCT04405076|559935098|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
155137455|NCT04405076|559935099|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
155137456|NCT04405076|559935100|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137457|NCT04405076|559935101|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137458|NCT04405076|559935102|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137459|NCT04405076|559935103|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137460|NCT04405076|559935104|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137461|NCT04405076|559935105|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137462|NCT04405076|559935106|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
155137463|NCT04405076|559935098|FG000|Part A (Blinded Phase)|Other than Specified|0|||
155137464|NCT04405076|559935099|FG001|Part A (Blinded Phase)|Other than Specified|0|||
155137465|NCT04405076|559935100|FG002|Part A (Blinded Phase)|Other than Specified|3|||
155137466|NCT04405076|559935101|FG003|Part A (Blinded Phase)|Other than Specified|0|||
155137467|NCT04405076|559935102|FG004|Part A (Blinded Phase)|Other than Specified|0|||
155137468|NCT04405076|559935103|FG005|Part A (Blinded Phase)|Other than Specified|0|||
155137469|NCT04405076|559935104|FG006|Part A (Blinded Phase)|Other than Specified|0|||
155137470|NCT04405076|559935105|FG007|Part A (Blinded Phase)|Other than Specified|0|||
155137471|NCT04405076|559935106|FG008|Part A (Blinded Phase)|Other than Specified|0|||
155137472|NCT04405076|559935098|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155137473|NCT04405076|559935099|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155137474|NCT04405076|559935100|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155137475|NCT04405076|559935101|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
155137476|NCT04405076|559935102|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
155137477|NCT04405076|559935103|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
155137478|NCT04405076|559935104|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155137479|NCT04405076|559935105|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155137480|NCT04405076|559935106|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
155137481|NCT04405076|559935098|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137482|NCT04405076|559935099|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137483|NCT04405076|559935100|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137484|NCT04405076|559935101|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137485|NCT04405076|559935102|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
155137486|NCT04405076|559935103|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137487|NCT04405076|559935104|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137488|NCT04405076|559935105|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137489|NCT04405076|559935106|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
155137490|NCT04405076|559935098|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155137491|NCT04405076|559935099|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155137492|NCT04405076|559935100|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155137493|NCT04405076|559935101|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
155137494|NCT04405076|559935102|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
155178747|NCT04559529|560093394|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
155178748|NCT01009281|560093395|FG000|Overall Study|Administrative problems|7|||
155178749|NCT03901456|560093398|FG000|Overall Study|Withdrawal by Subject|0|||
155178750|NCT03901456|560093399|FG001|Overall Study|Withdrawal by Subject|0|||
155178751|NCT03901456|560093400|FG002|Overall Study|Withdrawal by Subject|1|||
155178752|NCT03901456|560093398|FG000|Overall Study|Lost to Follow-up|0|||
155178753|NCT03901456|560093399|FG001|Overall Study|Lost to Follow-up|1|||
155178754|NCT03901456|560093400|FG002|Overall Study|Lost to Follow-up|0|||
155178755|NCT02217527|560093401|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
155178756|NCT02217527|560093402|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
155178757|NCT02217527|560093401|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
155178758|NCT02217527|560093402|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
155178759|NCT01203852|560093403|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
155178760|NCT01203852|560093403|FG000|Washout 2 Weeks|Physician Decision|46|||
155178761|NCT02582684|560093404|FG000|Overall Study|Unable to contact subject/parent|4|||
155178762|NCT02582684|560093404|FG000|Overall Study|Subject not able to get to clinic|10|||
155178763|NCT02582684|560093404|FG000|Overall Study|Subject withdrew consent|1|||
155178764|NCT02582684|560093404|FG000|Overall Study|Found to be ineligible after enrollment|2|||
155015663|NCT00891020|559482430|FG000|24 Week Treatment Period|Administrative/Other|5|||
155015664|NCT00891020|559482431|FG001|24 Week Treatment Period|Administrative/Other|6|||
155015665|NCT00891020|559482432|FG002|24 Week Treatment Period|Administrative/Other|1|||
155015666|NCT00891020|559482430|FG000|Long-term Extension Period|Adverse Event|1|||
155015667|NCT00891020|559482431|FG001|Long-term Extension Period|Adverse Event|11|||
155015668|NCT00891020|559482432|FG002|Long-term Extension Period|Adverse Event|10|||
155015669|NCT00891020|559482430|FG000|Long-term Extension Period|Death|0|||
155015670|NCT00891020|559482431|FG001|Long-term Extension Period|Death|0|||
155015671|NCT00891020|559482432|FG002|Long-term Extension Period|Death|1|||
155015672|NCT00891020|559482430|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
155015673|NCT00891020|559482431|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
155015674|NCT00891020|559482432|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
155015675|NCT00891020|559482430|FG000|Long-term Extension Period|Protocol Violation|0|||
155015676|NCT00891020|559482431|FG001|Long-term Extension Period|Protocol Violation|1|||
155015677|NCT00891020|559482432|FG002|Long-term Extension Period|Protocol Violation|1|||
155015678|NCT00891020|559482430|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
155015679|NCT00891020|559482431|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
155015680|NCT00891020|559482432|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
155015681|NCT00891020|559482430|FG000|Long-term Extension Period|Failure to return|0|||
155015682|NCT00891020|559482431|FG001|Long-term Extension Period|Failure to return|2|||
155015683|NCT00891020|559482432|FG002|Long-term Extension Period|Failure to return|3|||
155015684|NCT00891020|559482430|FG000|Long-term Extension Period|Administrative|1|||
155015685|NCT00891020|559482431|FG001|Long-term Extension Period|Administrative|2|||
155015686|NCT00891020|559482432|FG002|Long-term Extension Period|Administrative|2|||
155015687|NCT00320710|559482433|FG000|Overall Study|Disease progression|24|||
155015688|NCT00320710|559482434|FG001|Overall Study|Disease progression|19|||
155015689|NCT00320710|559482435|FG002|Overall Study|Disease progression|2|||
155137495|NCT04405076|559935103|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
155137496|NCT04405076|559935104|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155137497|NCT04405076|559935105|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155137498|NCT04405076|559935106|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
155137499|NCT04405076|559935098|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137500|NCT04405076|559935099|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137501|NCT04405076|559935100|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137502|NCT04405076|559935101|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137503|NCT04405076|559935102|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137504|NCT04405076|559935103|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137505|NCT04405076|559935104|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
155137506|NCT04405076|559935105|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
155137507|NCT04405076|559935106|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
155137508|NCT04405076|559935098|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137509|NCT04405076|559935099|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137510|NCT04405076|559935100|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137511|NCT04405076|559935101|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137512|NCT04405076|559935102|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137513|NCT04405076|559935103|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137514|NCT04405076|559935104|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
155137515|NCT04405076|559935105|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155137516|NCT04405076|559935106|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
155178765|NCT01878149|560093405|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
155137517|NCT04310566|559935107|FG000|Period 1|Study Termination due to COVID-19|15|||
155137518|NCT04310566|559935108|FG001|Period 1|Study Termination due to COVID-19|17|||
155137519|NCT04310566|559935107|FG000|Period 1|Protocol Violation|0|||
155137520|NCT04310566|559935108|FG001|Period 1|Protocol Violation|1|||
155137521|NCT04310566|559935107|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
155137522|NCT04310566|559935108|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
155137523|NCT04310566|559935107|FG000|Period 1|Lost to Follow-up|1|||
155137524|NCT04310566|559935108|FG001|Period 1|Lost to Follow-up|0|||
155137525|NCT04310566|559935107|FG000|Period 1|Withdrawal by Subject|0|||
155137526|NCT04310566|559935108|FG001|Period 1|Withdrawal by Subject|1|||
155137527|NCT04310566|559935107|FG000|Period 2|Study Termination|7|||
155137528|NCT04310566|559935108|FG001|Period 2|Study Termination|5|||
155137529|NCT02560012|559935116|FG000|Overall Study|Study Terminated|2|||
155137530|NCT02218008|559935117|FG000|Stage 1 (S1)|Adverse Event|6|||
155137531|NCT02218008|559935118|FG001|Stage 1 (S1)|Adverse Event|5|||
155137532|NCT02218008|559935119|FG002|Stage 1 (S1)|Adverse Event|11|||
155137533|NCT02218008|559935120|FG003|Stage 1 (S1)|Adverse Event|0|||
155137534|NCT02218008|559935121|FG004|Stage 1 (S1)|Adverse Event|0|||
155137535|NCT02218008|559935122|FG005|Stage 1 (S1)|Adverse Event|0|||
155137536|NCT02218008|559935117|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
155137537|NCT02218008|559935118|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
155137538|NCT02218008|559935119|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
155137539|NCT02218008|559935120|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
155137540|NCT02218008|559935121|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
155137541|NCT02218008|559935122|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
155137542|NCT02218008|559935117|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
155137543|NCT02218008|559935118|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
155137544|NCT02218008|559935119|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
155137545|NCT02218008|559935120|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
155137546|NCT02218008|559935121|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
155137547|NCT02218008|559935122|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
155137548|NCT02218008|559935117|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
155137549|NCT02218008|559935118|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
155137550|NCT02218008|559935119|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
155137551|NCT02218008|559935120|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
155137552|NCT02218008|559935121|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
155137553|NCT02218008|559935122|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
155137554|NCT02218008|559935117|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
155137555|NCT02218008|559935118|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
155137556|NCT02218008|559935119|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155137557|NCT02218008|559935120|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155137558|NCT02218008|559935121|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155137559|NCT02218008|559935122|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
155137560|NCT02218008|559935117|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
155137561|NCT02218008|559935118|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
155137562|NCT02218008|559935119|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
155137563|NCT02218008|559935120|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
155137564|NCT02218008|559935121|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
155137565|NCT02218008|559935122|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
155137566|NCT02218008|559935117|FG000|Stage 1 (S1)|Pregnancy|0|||
155137567|NCT02218008|559935118|FG001|Stage 1 (S1)|Pregnancy|0|||
155137568|NCT02218008|559935119|FG002|Stage 1 (S1)|Pregnancy|1|||
155137569|NCT02218008|559935120|FG003|Stage 1 (S1)|Pregnancy|0|||
155137570|NCT02218008|559935121|FG004|Stage 1 (S1)|Pregnancy|0|||
155137571|NCT02218008|559935122|FG005|Stage 1 (S1)|Pregnancy|0|||
155137572|NCT02218008|559935117|FG000|Stage 1 (S1)|Protocol Violation|0|||
155137573|NCT02218008|559935118|FG001|Stage 1 (S1)|Protocol Violation|0|||
155137574|NCT02218008|559935119|FG002|Stage 1 (S1)|Protocol Violation|1|||
155137575|NCT02218008|559935120|FG003|Stage 1 (S1)|Protocol Violation|0|||
155137576|NCT02218008|559935121|FG004|Stage 1 (S1)|Protocol Violation|0|||
155137577|NCT02218008|559935122|FG005|Stage 1 (S1)|Protocol Violation|0|||
155137578|NCT02218008|559935117|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
155137579|NCT02218008|559935118|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155137580|NCT02218008|559935119|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155137581|NCT02218008|559935120|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155137582|NCT02218008|559935121|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155137583|NCT02218008|559935122|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
155137584|NCT02218008|559935117|FG000|Stage 2 (S2)|Adverse Event|0|||
155137585|NCT02218008|559935118|FG001|Stage 2 (S2)|Adverse Event|0|||
155137586|NCT02218008|559935119|FG002|Stage 2 (S2)|Adverse Event|0|||
155137587|NCT02218008|559935120|FG003|Stage 2 (S2)|Adverse Event|2|||
155137588|NCT02218008|559935121|FG004|Stage 2 (S2)|Adverse Event|3|||
155137589|NCT02218008|559935122|FG005|Stage 2 (S2)|Adverse Event|3|||
155137590|NCT02218008|559935117|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
155137591|NCT02218008|559935118|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
155137592|NCT02218008|559935119|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
155137593|NCT02218008|559935120|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
155137594|NCT02218008|559935121|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
155178766|NCT01878149|560093406|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
155178767|NCT06390839|560093411|FG000|Overall Study|Ineligible|2|||
155178768|NCT06390839|560093411|FG000|Overall Study|Never start protocol therapy|3|||
155178769|NCT06390839|560093411|FG000|Overall Study|Adverse Event|1|||
155178770|NCT06390839|560093411|FG000|Overall Study|Alternative therapy|2|||
155178771|NCT06390839|560093411|FG000|Overall Study|Death|3|||
155178772|NCT06390839|560093411|FG000|Overall Study|Disease progression|28|||
155178773|NCT06390839|560093411|FG000|Overall Study|Withdrawal by Subject|2|||
155178774|NCT06390839|560093411|FG000|Overall Study|Complicating disease|1|||
155178775|NCT06390839|560093411|FG000|Overall Study|Noncompliance|1|||
155178776|NCT01587898|560093416|FG000|Overall Study|Adverse Event|1|||
155178777|NCT01587898|560093417|FG001|Overall Study|Adverse Event|1|||
155178778|NCT01587898|560093418|FG002|Overall Study|Adverse Event|0|||
155178779|NCT01587898|560093419|FG003|Overall Study|Adverse Event|0|||
155178780|NCT01587898|560093416|FG000|Overall Study|Protocol Violation|0|||
155178781|NCT01587898|560093417|FG001|Overall Study|Protocol Violation|2|||
155178782|NCT01587898|560093418|FG002|Overall Study|Protocol Violation|1|||
155178783|NCT01587898|560093419|FG003|Overall Study|Protocol Violation|1|||
155178784|NCT01587898|560093416|FG000|Overall Study|Lost to Follow-up|0|||
155178785|NCT01587898|560093417|FG001|Overall Study|Lost to Follow-up|0|||
155178786|NCT01587898|560093418|FG002|Overall Study|Lost to Follow-up|0|||
155178787|NCT01587898|560093419|FG003|Overall Study|Lost to Follow-up|1|||
155178788|NCT01587898|560093416|FG000|Overall Study|Withdrawal by Subject|2|||
155178789|NCT01587898|560093417|FG001|Overall Study|Withdrawal by Subject|1|||
155178790|NCT01587898|560093418|FG002|Overall Study|Withdrawal by Subject|0|||
155178791|NCT01587898|560093419|FG003|Overall Study|Withdrawal by Subject|0|||
155178792|NCT01587898|560093416|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
155178793|NCT01587898|560093417|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
155178794|NCT01587898|560093418|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
155178795|NCT01587898|560093419|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
155178796|NCT01738477|560093420|FG000|Overall Study|Lost to Follow-up|1|||
155178797|NCT01738477|560093421|FG001|Overall Study|Lost to Follow-up|4|||
155178798|NCT00502203|560093422|FG000|Overall Study|Inevaluable|1|||
155178799|NCT02720094|560093423|FG000|Overall Study|Ongoing|2210|||
155178800|NCT02720094|560093424|FG001|Overall Study|Ongoing|2203|||
155178801|NCT02720094|560093423|FG000|Overall Study|Scheduled exit visit/end of study|2|||
155178802|NCT02720094|560093424|FG001|Overall Study|Scheduled exit visit/end of study|1|||
155178803|NCT02720094|560093423|FG000|Overall Study|Death|4|||
155178804|NCT02720094|560093424|FG001|Overall Study|Death|7|||
155178805|NCT02720094|560093423|FG000|Overall Study|Withdrawal by Subject|55|||
155015690|NCT00320710|559482433|FG000|Overall Study|Death|10|||
155015691|NCT00320710|559482434|FG001|Overall Study|Death|7|||
155015692|NCT00320710|559482435|FG002|Overall Study|Death|1|||
155137595|NCT02218008|559935122|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
155137596|NCT02218008|559935117|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
155137597|NCT02218008|559935118|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
155137598|NCT02218008|559935119|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
155137599|NCT02218008|559935120|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
155137600|NCT02218008|559935121|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
155137601|NCT02218008|559935122|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
155137602|NCT02218008|559935117|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155137603|NCT02218008|559935118|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155137604|NCT02218008|559935119|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155137605|NCT02218008|559935120|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
155137606|NCT02218008|559935121|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155137607|NCT02218008|559935122|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
155137608|NCT02218008|559935117|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
155137609|NCT02218008|559935118|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
155137610|NCT02218008|559935119|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
155137611|NCT02218008|559935120|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
155137612|NCT02218008|559935121|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
155137613|NCT02218008|559935122|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
155137614|NCT00408434|559935123|FG000|Overall Study|Adverse Event|0|||
155137615|NCT00408434|559935124|FG001|Overall Study|Adverse Event|0|||
155137616|NCT00408434|559935125|FG002|Overall Study|Adverse Event|1|||
155137617|NCT00408434|559935126|FG003|Overall Study|Adverse Event|0|||
155137618|NCT00408434|559935127|FG004|Overall Study|Adverse Event|0|||
155137619|NCT00408434|559935128|FG005|Overall Study|Adverse Event|0|||
155178806|NCT02720094|560093424|FG001|Overall Study|Withdrawal by Subject|56|||
155178807|NCT02720094|560093423|FG000|Overall Study|Lost to Follow-up|2|||
155178808|NCT02720094|560093424|FG001|Overall Study|Lost to Follow-up|7|||
155178809|NCT02720094|560093423|FG000|Overall Study|Physician Decision|1|||
155178810|NCT02720094|560093424|FG001|Overall Study|Physician Decision|3|||
155137620|NCT00408434|559935129|FG006|Overall Study|Adverse Event|0|||
155137621|NCT00408434|559935123|FG000|Overall Study|Progressive disease|6|||
155137622|NCT00408434|559935124|FG001|Overall Study|Progressive disease|3|||
155137623|NCT00408434|559935125|FG002|Overall Study|Progressive disease|4|||
155178811|NCT02720094|560093423|FG000|Overall Study|Inappropriate enrollment|1|||
155178812|NCT02720094|560093424|FG001|Overall Study|Inappropriate enrollment|3|||
155137624|NCT00408434|559935126|FG003|Overall Study|Progressive disease|3|||
155137625|NCT00408434|559935127|FG004|Overall Study|Progressive disease|3|||
155137626|NCT00408434|559935128|FG005|Overall Study|Progressive disease|1|||
155137627|NCT00408434|559935129|FG006|Overall Study|Progressive disease|4|||
155137628|NCT00408434|559935123|FG000|Overall Study|Other|0|||
155137629|NCT00408434|559935124|FG001|Overall Study|Other|0|||
155137630|NCT00408434|559935125|FG002|Overall Study|Other|1|||
155137631|NCT00408434|559935126|FG003|Overall Study|Other|0|||
155137632|NCT00408434|559935127|FG004|Overall Study|Other|2|||
155137633|NCT00408434|559935128|FG005|Overall Study|Other|1|||
155137634|NCT00408434|559935129|FG006|Overall Study|Other|0|||
155137635|NCT00408434|559935123|FG000|Overall Study|Terminated by Investigator|0|||
155137636|NCT00408434|559935124|FG001|Overall Study|Terminated by Investigator|0|||
155137637|NCT00408434|559935125|FG002|Overall Study|Terminated by Investigator|0|||
155137638|NCT00408434|559935126|FG003|Overall Study|Terminated by Investigator|0|||
155137639|NCT00408434|559935127|FG004|Overall Study|Terminated by Investigator|1|||
155137640|NCT00408434|559935128|FG005|Overall Study|Terminated by Investigator|1|||
155137641|NCT00408434|559935129|FG006|Overall Study|Terminated by Investigator|0|||
155137642|NCT01088399|559935135|FG000|Overall Study|Adverse Event|211|||
155137643|NCT01088399|559935136|FG001|Overall Study|Adverse Event|16|||
155137644|NCT01088399|559935137|FG002|Overall Study|Adverse Event|0|||
155137645|NCT01088399|559935135|FG000|Overall Study|Death|204|||
155137646|NCT01088399|559935136|FG001|Overall Study|Death|45|||
155137647|NCT01088399|559935137|FG002|Overall Study|Death|0|||
155137648|NCT01088399|559935135|FG000|Overall Study|Lack of Efficacy|298|||
155137649|NCT01088399|559935136|FG001|Overall Study|Lack of Efficacy|7|||
155137650|NCT01088399|559935137|FG002|Overall Study|Lack of Efficacy|5|||
155137651|NCT01088399|559935135|FG000|Overall Study|Lost to Follow-up|1070|||
155137652|NCT01088399|559935136|FG001|Overall Study|Lost to Follow-up|278|||
155137653|NCT01088399|559935137|FG002|Overall Study|Lost to Follow-up|58|||
155137654|NCT01088399|559935135|FG000|Overall Study|Physician Decision|531|||
155137655|NCT01088399|559935136|FG001|Overall Study|Physician Decision|88|||
155137656|NCT01088399|559935137|FG002|Overall Study|Physician Decision|16|||
155137657|NCT01088399|559935135|FG000|Overall Study|Withdrawal by Subject|544|||
155137658|NCT01088399|559935136|FG001|Overall Study|Withdrawal by Subject|195|||
155137659|NCT01088399|559935137|FG002|Overall Study|Withdrawal by Subject|33|||
155137660|NCT01088399|559935135|FG000|Overall Study|Change to or start of somatropin therapy|234|||
155137661|NCT01088399|559935136|FG001|Overall Study|Change to or start of somatropin therapy|17|||
155137662|NCT01088399|559935137|FG002|Overall Study|Change to or start of somatropin therapy|12|||
155137663|NCT01088399|559935135|FG000|Overall Study|Sponsor decision|1573|||
155137664|NCT01088399|559935136|FG001|Overall Study|Sponsor decision|298|||
155137665|NCT01088399|559935137|FG002|Overall Study|Sponsor decision|7|||
155137666|NCT01088399|559935135|FG000|Overall Study|Protocol Violation|10|||
155137667|NCT01088399|559935136|FG001|Overall Study|Protocol Violation|1|||
155137668|NCT01088399|559935137|FG002|Overall Study|Protocol Violation|0|||
155137669|NCT01088399|559935135|FG000|Overall Study|Enrollment criteria not met|48|||
155137670|NCT01088399|559935136|FG001|Overall Study|Enrollment criteria not met|119|||
155137671|NCT01088399|559935137|FG002|Overall Study|Enrollment criteria not met|70|||
155137672|NCT01088399|559935135|FG000|Overall Study|Study summary visit not completed|2398|||
155137673|NCT01088399|559935136|FG001|Overall Study|Study summary visit not completed|283|||
155137674|NCT01088399|559935137|FG002|Overall Study|Study summary visit not completed|80|||
155137675|NCT00118430|559935140|FG000|Overall Study|Withdrawal by Subject|6|||
155137676|NCT00118430|559935141|FG001|Overall Study|Withdrawal by Subject|2|||
155137677|NCT00118430|559935142|FG002|Overall Study|Withdrawal by Subject|0|||
155137678|NCT00118430|559935140|FG000|Overall Study|Lost to Follow-up|15|||
155137679|NCT00118430|559935141|FG001|Overall Study|Lost to Follow-up|22|||
155137680|NCT00118430|559935142|FG002|Overall Study|Lost to Follow-up|28|||
155137681|NCT02147288|559935143|FG000|Overall Study|post-operative hematoma|1|||
155137682|NCT02147288|559935144|FG001|Overall Study|post-operative hematoma|1|||
155137683|NCT02147288|559935145|FG002|Overall Study|post-operative hematoma|0|||
155137684|NCT02147288|559935146|FG003|Overall Study|post-operative hematoma|0|||
155137685|NCT02147288|559935147|FG004|Overall Study|post-operative hematoma|0|||
155137686|NCT02147288|559935148|FG005|Overall Study|post-operative hematoma|0|||
155137687|NCT02147288|559935149|FG006|Overall Study|post-operative hematoma|0|||
155137688|NCT02147288|559935150|FG007|Overall Study|post-operative hematoma|0|||
155137689|NCT02147288|559935151|FG008|Overall Study|post-operative hematoma|0|||
155137690|NCT02147288|559935152|FG009|Overall Study|post-operative hematoma|0|||
155137691|NCT02147288|559935143|FG000|Overall Study|complications from concurrent hernia rep|0|||
155137692|NCT02147288|559935144|FG001|Overall Study|complications from concurrent hernia rep|1|||
155137693|NCT02147288|559935145|FG002|Overall Study|complications from concurrent hernia rep|0|||
155137694|NCT02147288|559935146|FG003|Overall Study|complications from concurrent hernia rep|0|||
155137695|NCT02147288|559935147|FG004|Overall Study|complications from concurrent hernia rep|0|||
155137696|NCT02147288|559935148|FG005|Overall Study|complications from concurrent hernia rep|0|||
155137697|NCT02147288|559935149|FG006|Overall Study|complications from concurrent hernia rep|0|||
155137698|NCT02147288|559935150|FG007|Overall Study|complications from concurrent hernia rep|0|||
155137699|NCT02147288|559935151|FG008|Overall Study|complications from concurrent hernia rep|0|||
155178813|NCT02720094|560093423|FG000|Overall Study|Relocation|1|||
155137700|NCT02147288|559935152|FG009|Overall Study|complications from concurrent hernia rep|0|||
155137701|NCT02069392|559935153|FG000|Overall Study|Withdrawal by Subject|4|||
155137702|NCT02069392|559935154|FG001|Overall Study|Withdrawal by Subject|2|||
155137703|NCT00269633|559935155|FG000|Overall Study|Withdrawal by Subject|1|||
155137704|NCT00269633|559935156|FG001|Overall Study|Withdrawal by Subject|0|||
155137705|NCT04412707|559935157|FG000|Cycle 1|Death|0|||
155137706|NCT04412707|559935158|FG001|Cycle 1|Death|3|||
155137707|NCT04412707|559935157|FG000|Cycle 1|Disease progression|1|||
155137708|NCT04412707|559935158|FG001|Cycle 1|Disease progression|2|||
155137709|NCT04412707|559935157|FG000|Cycle 2|Death|0|||
155137710|NCT04412707|559935158|FG001|Cycle 2|Death|1|||
155137711|NCT04412707|559935157|FG000|Cycle 2|Disease progression|3|||
155137712|NCT04412707|559935158|FG001|Cycle 2|Disease progression|0|||
155137713|NCT04412707|559935157|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
155137714|NCT04412707|559935158|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
155137715|NCT04412707|559935157|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
155137716|NCT04412707|559935158|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
155137717|NCT04412707|559935157|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
155137718|NCT04412707|559935158|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
155137719|NCT04412707|559935157|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
155137720|NCT04412707|559935158|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
155137721|NCT00615017|559937298|FG000|Overall Study|Adverse Event|0|||
155137722|NCT00615017|559937299|FG001|Overall Study|Adverse Event|1|||
155137723|NCT00615017|559937300|FG002|Overall Study|Adverse Event|2|||
155137724|NCT00615017|559937301|FG003|Overall Study|Adverse Event|0|||
155137725|NCT00615017|559937302|FG004|Overall Study|Adverse Event|0|||
155137726|NCT00615017|559937303|FG005|Overall Study|Adverse Event|1|||
155137727|NCT00615017|559937298|FG000|Overall Study|Death|0|||
155137728|NCT00615017|559937299|FG001|Overall Study|Death|0|||
155137729|NCT00615017|559937300|FG002|Overall Study|Death|2|||
155137730|NCT00615017|559937301|FG003|Overall Study|Death|0|||
155137731|NCT00615017|559937302|FG004|Overall Study|Death|1|||
155137732|NCT00615017|559937303|FG005|Overall Study|Death|1|||
155137733|NCT00615017|559937298|FG000|Overall Study|Sepsis resolved|0|||
155137734|NCT00615017|559937299|FG001|Overall Study|Sepsis resolved|0|||
155137735|NCT00615017|559937300|FG002|Overall Study|Sepsis resolved|1|||
155137736|NCT00615017|559937301|FG003|Overall Study|Sepsis resolved|0|||
155137737|NCT00615017|559937302|FG004|Overall Study|Sepsis resolved|0|||
155137738|NCT00615017|559937303|FG005|Overall Study|Sepsis resolved|0|||
155137739|NCT00615017|559937298|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
155137740|NCT00615017|559937299|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
155137741|NCT00615017|559937300|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
155137742|NCT00615017|559937301|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
155137743|NCT00615017|559937302|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
155137744|NCT00615017|559937303|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
155137745|NCT00615017|559937298|FG000|Overall Study|Physician discontinued drug|0|||
155137746|NCT00615017|559937299|FG001|Overall Study|Physician discontinued drug|0|||
155137747|NCT00615017|559937300|FG002|Overall Study|Physician discontinued drug|0|||
155137748|NCT00615017|559937301|FG003|Overall Study|Physician discontinued drug|0|||
155137749|NCT00615017|559937302|FG004|Overall Study|Physician discontinued drug|0|||
155137750|NCT00615017|559937303|FG005|Overall Study|Physician discontinued drug|1|||
155137751|NCT04775953|559937305|FG000|Overall Study|Lost to Follow-up|6|||
155137752|NCT04775953|559937306|FG001|Overall Study|Lost to Follow-up|11|||
155137753|NCT04775953|559937305|FG000|Overall Study|Death|5|||
155137754|NCT04775953|559937306|FG001|Overall Study|Death|4|||
155137755|NCT04775953|559937305|FG000|Overall Study|Withdrawal by Subject|3|||
155137756|NCT04775953|559937306|FG001|Overall Study|Withdrawal by Subject|3|||
155137757|NCT04775953|559937305|FG000|Overall Study|Protocol Violation|2|||
155137758|NCT04775953|559937306|FG001|Overall Study|Protocol Violation|0|||
155137759|NCT04775953|559937305|FG000|Overall Study|Participant non-compliance|0|||
155137760|NCT04775953|559937306|FG001|Overall Study|Participant non-compliance|1|||
155137761|NCT01698814|559937307|FG000|Overall Study|Adverse Event|0|||
155137762|NCT01698814|559937308|FG001|Overall Study|Adverse Event|2|||
155137763|NCT01698814|559937307|FG000|Overall Study|Lost to Follow-up|0|||
155137764|NCT01698814|559937308|FG001|Overall Study|Lost to Follow-up|1|||
155137765|NCT01698814|559937307|FG000|Overall Study|Pregnancy|1|||
155137766|NCT01698814|559937308|FG001|Overall Study|Pregnancy|0|||
155137767|NCT01698814|559937307|FG000|Overall Study|Randomized in error|1|||
155137768|NCT01698814|559937308|FG001|Overall Study|Randomized in error|0|||
155137769|NCT00855959|559937309|FG000|Overall Study|Adverse Event|2|||
155137770|NCT00855959|559937309|FG000|Overall Study|Lost to Follow-up|2|||
155137771|NCT00855959|559937309|FG000|Overall Study|Withdrawal by Subject|3|||
155137772|NCT00855959|559937309|FG000|Overall Study|Pregnancy|1|||
155137773|NCT00855959|559937309|FG000|Overall Study|Incorrect enrolment|1|||
155137774|NCT00368641|559937312|FG000|Overall Study|Adverse Event|2|||
155137775|NCT00368641|559937313|FG001|Overall Study|Adverse Event|1|||
155137776|NCT00368641|559937312|FG000|Overall Study|Death|1|||
155137777|NCT00368641|559937313|FG001|Overall Study|Death|0|||
155178814|NCT02720094|560093424|FG001|Overall Study|Relocation|1|||
155015693|NCT00320710|559482433|FG000|Overall Study|Administrative problems|1|||
155015694|NCT00320710|559482434|FG001|Overall Study|Administrative problems|2|||
155015695|NCT00320710|559482435|FG002|Overall Study|Administrative problems|0|||
155015696|NCT00320710|559482433|FG000|Overall Study|Withdrawal by Subject|20|||
155015697|NCT00320710|559482434|FG001|Overall Study|Withdrawal by Subject|26|||
155015698|NCT00320710|559482435|FG002|Overall Study|Withdrawal by Subject|1|||
155015699|NCT00320710|559482433|FG000|Overall Study|Protocol Violation|6|||
155015700|NCT00320710|559482434|FG001|Overall Study|Protocol Violation|5|||
155015701|NCT00320710|559482435|FG002|Overall Study|Protocol Violation|0|||
155015702|NCT00320710|559482433|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155015703|NCT00320710|559482434|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155015704|NCT00320710|559482435|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155015705|NCT00320710|559482433|FG000|Overall Study|Abnormal laboratory value(s)|12|||
155015706|NCT00320710|559482434|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155015707|NCT00320710|559482435|FG002|Overall Study|Abnormal laboratory value(s)|0|||
155015708|NCT00320710|559482433|FG000|Overall Study|Adverse Event|18|||
155015709|NCT00320710|559482434|FG001|Overall Study|Adverse Event|14|||
155015710|NCT00320710|559482435|FG002|Overall Study|Adverse Event|1|||
155015711|NCT00320710|559482433|FG000|Overall Study|Lost to Follow-up|1|||
155015712|NCT00320710|559482434|FG001|Overall Study|Lost to Follow-up|0|||
155015713|NCT00320710|559482435|FG002|Overall Study|Lost to Follow-up|0|||
155015714|NCT04578457|559482436|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
155015715|NCT04578457|559482436|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
155015716|NCT04578457|559482436|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
155015717|NCT04578457|559482436|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
155015718|NCT03809663|559482444|FG000|Overall Study|Decision by sponsor|24|||
155015719|NCT03809663|559482445|FG001|Overall Study|Decision by sponsor|18|||
155015720|NCT03809663|559482446|FG002|Overall Study|Decision by sponsor|20|||
155015721|NCT03809663|559482447|FG003|Overall Study|Decision by sponsor|20|||
155015722|NCT03809663|559482448|FG004|Overall Study|Decision by sponsor|0|||
155015723|NCT03809663|559482449|FG005|Overall Study|Decision by sponsor|0|||
155015724|NCT03809663|559482444|FG000|Overall Study|Withdrawal by Subject|26|||
155015725|NCT03809663|559482445|FG001|Overall Study|Withdrawal by Subject|22|||
155015726|NCT03809663|559482446|FG002|Overall Study|Withdrawal by Subject|27|||
155015727|NCT03809663|559482447|FG003|Overall Study|Withdrawal by Subject|26|||
155015728|NCT03809663|559482448|FG004|Overall Study|Withdrawal by Subject|0|||
155015729|NCT03809663|559482449|FG005|Overall Study|Withdrawal by Subject|0|||
155015730|NCT03809663|559482444|FG000|Overall Study|Lost to Follow-up|1|||
155015731|NCT03809663|559482445|FG001|Overall Study|Lost to Follow-up|4|||
155015732|NCT03809663|559482446|FG002|Overall Study|Lost to Follow-up|1|||
155015733|NCT03809663|559482447|FG003|Overall Study|Lost to Follow-up|1|||
155015734|NCT03809663|559482448|FG004|Overall Study|Lost to Follow-up|0|||
155015735|NCT03809663|559482449|FG005|Overall Study|Lost to Follow-up|0|||
155015736|NCT03376789|559482452|FG000|Overall Study|Withdrawal by Subject|3|||
155015737|NCT03376789|559482453|FG001|Overall Study|Withdrawal by Subject|5|||
155015738|NCT03376789|559482452|FG000|Overall Study|Protocol Violation|0|||
155015739|NCT03376789|559482453|FG001|Overall Study|Protocol Violation|1|||
155015740|NCT03376789|559482452|FG000|Overall Study|Adverse Event|0|||
155015741|NCT03376789|559482453|FG001|Overall Study|Adverse Event|1|||
155015742|NCT03376789|559482452|FG000|Overall Study|Lost to Follow-up|1|||
155015743|NCT03376789|559482453|FG001|Overall Study|Lost to Follow-up|1|||
155015744|NCT03376789|559482452|FG000|Overall Study|Per sponsor due to noncompliance|1|||
155015745|NCT03376789|559482453|FG001|Overall Study|Per sponsor due to noncompliance|0|||
155015746|NCT03376789|559482452|FG000|Overall Study|Subject off study medication|0|||
155137778|NCT00368641|559937312|FG000|Overall Study|Withdrawal by Subject|1|||
155137779|NCT00368641|559937313|FG001|Overall Study|Withdrawal by Subject|0|||
155137780|NCT00368641|559937312|FG000|Overall Study|Sponsor decision to terminate study|2|||
155137781|NCT00368641|559937313|FG001|Overall Study|Sponsor decision to terminate study|5|||
155015747|NCT03376789|559482453|FG001|Overall Study|Subject off study medication|1|||
155015748|NCT01703260|559482454|FG000|Overall Study|Adverse Event|1|||
155015749|NCT01703260|559482455|FG001|Overall Study|Adverse Event|2|||
155015750|NCT01703260|559482456|FG002|Overall Study|Adverse Event|2|||
155015751|NCT01703260|559482454|FG000|Overall Study|Lost to Follow-up|1|||
155015752|NCT01703260|559482455|FG001|Overall Study|Lost to Follow-up|0|||
155015753|NCT01703260|559482456|FG002|Overall Study|Lost to Follow-up|0|||
155015754|NCT01703260|559482454|FG000|Overall Study|Withdrawal by Subject|0|||
155015755|NCT01703260|559482455|FG001|Overall Study|Withdrawal by Subject|0|||
155015756|NCT01703260|559482456|FG002|Overall Study|Withdrawal by Subject|1|||
155015757|NCT01703260|559482454|FG000|Overall Study|Study Termination|1|||
155015758|NCT01703260|559482455|FG001|Overall Study|Study Termination|2|||
155015759|NCT01703260|559482456|FG002|Overall Study|Study Termination|0|||
155015760|NCT01464424|559482463|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
155015761|NCT01464424|559482464|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
155015762|NCT00739661|559482465|FG000|Overall Study|Adverse Event|2|||
155015763|NCT00739661|559482466|FG001|Overall Study|Adverse Event|0|||
155015764|NCT00739661|559482465|FG000|Overall Study|Physician decision to withdraw patient|1|||
155137782|NCT04014062|559937314|FG000|Period I: Dosing|Medical Grounds|4|||
155137783|NCT04014062|559937315|FG001|Period I: Dosing|Medical Grounds|5|||
155137784|NCT04014062|559937314|FG000|Period I: Dosing|Withdrawal by Subject|3|||
155137785|NCT04014062|559937315|FG001|Period I: Dosing|Withdrawal by Subject|1|||
155137786|NCT03038126|559937317|FG000|Overall Study|Death|1|||
155137787|NCT03038126|559937318|FG001|Overall Study|Death|1|||
155137788|NCT03038126|559937317|FG000|Overall Study|Withdrawal by Subject|5|||
155137789|NCT03038126|559937318|FG001|Overall Study|Withdrawal by Subject|0|||
155137790|NCT03038126|559937317|FG000|Overall Study|Lost to Follow-up|0|||
155137791|NCT03038126|559937318|FG001|Overall Study|Lost to Follow-up|1|||
155137792|NCT03038126|559937317|FG000|Overall Study|Long Term Hospitalization|2|||
155137793|NCT03038126|559937318|FG001|Overall Study|Long Term Hospitalization|0|||
155137794|NCT03038126|559937317|FG000|Overall Study|Too Ill to Participate|1|||
155137795|NCT03038126|559937318|FG001|Overall Study|Too Ill to Participate|2|||
155137796|NCT01724866|559937319|FG000|Overall Study|Adverse Event|0|||
155137797|NCT01724866|559937320|FG001|Overall Study|Adverse Event|0|||
155137798|NCT01724866|559937321|FG002|Overall Study|Adverse Event|1|||
155137799|NCT01724866|559937322|FG003|Overall Study|Adverse Event|1|||
155137800|NCT01724866|559937319|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
155137801|NCT01724866|559937320|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
155137802|NCT01724866|559937321|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
155137803|NCT01724866|559937322|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
155137804|NCT01724866|559937319|FG000|Overall Study|Investigator's Discretion|0|||
155137805|NCT01724866|559937320|FG001|Overall Study|Investigator's Discretion|1|||
155137806|NCT01724866|559937321|FG002|Overall Study|Investigator's Discretion|1|||
155137807|NCT01724866|559937322|FG003|Overall Study|Investigator's Discretion|0|||
155137808|NCT01724866|559937319|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
155137809|NCT01724866|559937320|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
155137810|NCT01724866|559937321|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
155137811|NCT01724866|559937322|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
155137812|NCT01724866|559937319|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
155137813|NCT01724866|559937320|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
155137814|NCT01724866|559937321|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
155137815|NCT01724866|559937322|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
155137816|NCT01424501|559937325|FG000|Overall Study|Withdrawal by Subject|1|||
155137817|NCT01424501|559937326|FG001|Overall Study|Withdrawal by Subject|0|||
155137818|NCT01424501|559937327|FG002|Overall Study|Withdrawal by Subject|1|||
155137819|NCT01424501|559937328|FG003|Overall Study|Withdrawal by Subject|0|||
155137820|NCT01424501|559937329|FG004|Overall Study|Withdrawal by Subject|0|||
155137821|NCT01424501|559937330|FG005|Overall Study|Withdrawal by Subject|0|||
155137822|NCT01424501|559937325|FG000|Overall Study|Lost to Follow-up|0|||
155137823|NCT01424501|559937326|FG001|Overall Study|Lost to Follow-up|1|||
155137824|NCT01424501|559937327|FG002|Overall Study|Lost to Follow-up|1|||
155137825|NCT01424501|559937328|FG003|Overall Study|Lost to Follow-up|0|||
155137826|NCT01424501|559937329|FG004|Overall Study|Lost to Follow-up|0|||
155137827|NCT01424501|559937330|FG005|Overall Study|Lost to Follow-up|0|||
155137828|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
155137829|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155137830|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155137831|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155137832|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
155137833|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
155137834|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155137835|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155137836|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155137837|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
155137838|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
155137839|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155137840|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155137841|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155137842|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
155137843|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
155137844|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155137845|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155137846|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155137847|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
155137848|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
155137849|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155137850|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155178815|NCT02437110|560093429|FG000|Screening|Lost to Follow-up|3|||
155178816|NCT02437110|560093429|FG000|Screening|Physician Decision|1|||
155178817|NCT02437110|560093429|FG000|ART|Adverse Event|3|||
155178818|NCT02437110|560093429|FG000|ART|Protocol Violation|3|||
155178819|NCT02437110|560093429|FG000|ART|Withdrawal by Subject|4|||
155178820|NCT02437110|560093429|FG000|ART|Lost to follow-up prior to start of intervention|1|||
155178821|NCT02437110|560093429|FG000|ART|Physician decision prior to start of intervention|2|||
155178822|NCT02437110|560093429|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
155178823|NCT02437110|560093429|FG000|Post-ART|Lost to Follow-up|3|||
155178824|NCT02437110|560093429|FG000|Post-ART|Protocol Violation|4|||
155178825|NCT02437110|560093429|FG000|Post-ART|Withdrawal by Subject|3|||
155178826|NCT03735238|560093430|FG000|Overall Study|Did not want to participate in research|3|||
155178827|NCT03735238|560093430|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
155178828|NCT01431638|560093431|FG000|Overall Study|Adverse Event|1|||
155178829|NCT01431638|560093432|FG001|Overall Study|Adverse Event|3|||
155178830|NCT01431638|560093433|FG002|Overall Study|Adverse Event|1|||
155178831|NCT01431638|560093431|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155178832|NCT01431638|560093432|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
155178833|NCT01431638|560093433|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
155178834|NCT01431638|560093431|FG000|Overall Study|Participants condition no longer requires study drug|0|||
155178835|NCT01431638|560093432|FG001|Overall Study|Participants condition no longer requires study drug|1|||
155178836|NCT01431638|560093433|FG002|Overall Study|Participants condition no longer requires study drug|0|||
155178837|NCT01431638|560093431|FG000|Overall Study|Participant withdrew consent|14|||
155178838|NCT01431638|560093432|FG001|Overall Study|Participant withdrew consent|5|||
155178839|NCT01431638|560093433|FG002|Overall Study|Participant withdrew consent|8|||
155178840|NCT01431638|560093431|FG000|Overall Study|Lost to Follow-up|7|||
155178841|NCT01431638|560093432|FG001|Overall Study|Lost to Follow-up|9|||
155178842|NCT01431638|560093433|FG002|Overall Study|Lost to Follow-up|7|||
155178843|NCT01431638|560093431|FG000|Overall Study|Administrative problems|1|||
155178844|NCT01431638|560093432|FG001|Overall Study|Administrative problems|4|||
155178845|NCT01431638|560093433|FG002|Overall Study|Administrative problems|6|||
155178846|NCT01431638|560093431|FG000|Overall Study|Death|1|||
155178847|NCT01431638|560093432|FG001|Overall Study|Death|0|||
155178848|NCT01431638|560093433|FG002|Overall Study|Death|0|||
155178849|NCT01431638|560093431|FG000|Overall Study|Protocol deviation|1|||
155178850|NCT01431638|560093432|FG001|Overall Study|Protocol deviation|1|||
155178851|NCT01431638|560093433|FG002|Overall Study|Protocol deviation|4|||
155178852|NCT01431638|560093431|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
155178853|NCT01431638|560093432|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
155178854|NCT01431638|560093433|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
155178855|NCT01261780|560093434|FG000|Overall Study|Withdrawal by Subject|1|||
155178856|NCT01261780|560093435|FG001|Overall Study|Withdrawal by Subject|0|||
155178857|NCT01261780|560093434|FG000|Overall Study|Event not related to subject|1|||
155178858|NCT01261780|560093435|FG001|Overall Study|Event not related to subject|2|||
155178859|NCT03836001|560093436|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
155178860|NCT03836001|560093437|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
155178861|NCT03836001|560093438|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
155178862|NCT03836001|560093436|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
155178863|NCT03836001|560093437|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
155178864|NCT03836001|560093438|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
155178865|NCT03836001|560093436|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
155178866|NCT03836001|560093437|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
155178867|NCT03836001|560093438|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
155178868|NCT03836001|560093436|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
155178869|NCT03836001|560093437|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
155178870|NCT03836001|560093438|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
155178871|NCT01381562|560093439|FG000|Overall Study|Adverse Event|0|||
155178872|NCT01381562|560093440|FG001|Overall Study|Adverse Event|1|||
155178873|NCT01381562|560093441|FG002|Overall Study|Adverse Event|0|||
155015765|NCT00739661|559482466|FG001|Overall Study|Physician decision to withdraw patient|0|||
155015766|NCT00739661|559482465|FG000|Overall Study|Patient decision to withdraw|9|||
155015767|NCT00739661|559482466|FG001|Overall Study|Patient decision to withdraw|4|||
155015768|NCT00739661|559482465|FG000|Overall Study|Disease progression, radiographic|33|||
155015769|NCT00739661|559482466|FG001|Overall Study|Disease progression, radiographic|37|||
155015770|NCT00739661|559482465|FG000|Overall Study|Reason for discontinuation not available|1|||
155178874|NCT00308581|560093445|FG000|Induction Phase|Adverse Event|0|||
155178875|NCT00308581|560093446|FG001|Induction Phase|Adverse Event|0|||
155178876|NCT00308581|560093447|FG002|Induction Phase|Adverse Event|37|||
155178877|NCT00308581|560093445|FG000|Induction Phase|Lack of Efficacy|0|||
155178878|NCT00308581|560093446|FG001|Induction Phase|Lack of Efficacy|0|||
155178879|NCT00308581|560093447|FG002|Induction Phase|Lack of Efficacy|121|||
155015771|NCT00739661|559482466|FG001|Overall Study|Reason for discontinuation not available|1|||
155137851|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155137852|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
155137853|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
155137854|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155137855|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155137856|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155137857|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
155137858|NCT01173601|559937331|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
155137859|NCT01173601|559937332|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155137860|NCT01173601|559937333|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155137861|NCT01173601|559937334|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155137862|NCT01173601|559937335|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
155137863|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
155137864|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
155137865|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
155137866|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
155137867|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
155137868|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
155137869|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
155137870|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
155137871|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
155137872|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
155137873|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155137874|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
155137875|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
155137876|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
155137877|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
155137878|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155137879|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
155137880|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
155137881|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
155137882|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
155137883|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
155137884|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
155137885|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155137886|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
155137887|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
155137888|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
155137889|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
155137890|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
155137891|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
155137892|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
155137893|NCT01173601|559937331|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155137894|NCT01173601|559937332|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155137895|NCT01173601|559937333|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
155137896|NCT01173601|559937334|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
155137897|NCT01173601|559937335|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
155137898|NCT01980095|559937336|FG000|Overall Study|Lost to Follow-up|6|||
155137899|NCT01980095|559937337|FG001|Overall Study|Lost to Follow-up|7|||
155137900|NCT01980095|559937336|FG000|Overall Study|Withdrawal by Subject|2|||
155137901|NCT01980095|559937337|FG001|Overall Study|Withdrawal by Subject|3|||
155137902|NCT01980095|559937336|FG000|Overall Study|Poor compliance|5|||
155137903|NCT01980095|559937337|FG001|Overall Study|Poor compliance|0|||
155137904|NCT01980095|559937336|FG000|Overall Study|Safety issue|0|||
155137905|NCT01980095|559937337|FG001|Overall Study|Safety issue|1|||
155137906|NCT01980095|559937336|FG000|Overall Study|Study drug discontinued|1|||
155137907|NCT01980095|559937337|FG001|Overall Study|Study drug discontinued|0|||
155137908|NCT01980095|559937336|FG000|Overall Study|Randomized by mistake|1|||
155137909|NCT01980095|559937337|FG001|Overall Study|Randomized by mistake|0|||
155137910|NCT01128244|559937339|FG000|Overall Study|Adverse Event|1|||
155137911|NCT01128244|559937339|FG000|Overall Study|Scheduling conflict|2|||
155137912|NCT04506502|559937343|FG000|Overall Study|Withdrawal by Subject|1|||
155137913|NCT04506502|559937343|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
155137914|NCT01449006|559937344|FG000|Overall Study|Lost to Follow-up|1|||
155137915|NCT01449006|559937345|FG001|Overall Study|Lost to Follow-up|0|||
155137916|NCT01449006|559937344|FG000|Overall Study|Withdrawal by Subject|1|||
155137917|NCT01449006|559937345|FG001|Overall Study|Withdrawal by Subject|0|||
155137918|NCT01449006|559937344|FG000|Overall Study|Protocol Violation|1|||
155137919|NCT01449006|559937345|FG001|Overall Study|Protocol Violation|0|||
155137920|NCT03350815|559937346|FG000|Period 1|Adverse Event|10|||
155137921|NCT03350815|559937347|FG001|Period 1|Adverse Event|0|||
155137922|NCT03350815|559937348|FG002|Period 1|Adverse Event|0|||
155137923|NCT03350815|559937349|FG003|Period 1|Adverse Event|0|||
155137924|NCT03350815|559937346|FG000|Period 1|Technical problems|1|||
155137925|NCT03350815|559937347|FG001|Period 1|Technical problems|0|||
155137926|NCT03350815|559937348|FG002|Period 1|Technical problems|0|||
155137927|NCT03350815|559937349|FG003|Period 1|Technical problems|0|||
155137928|NCT03350815|559937346|FG000|Period 1|Lost to Follow-up|3|||
155137929|NCT03350815|559937347|FG001|Period 1|Lost to Follow-up|0|||
155137930|NCT03350815|559937348|FG002|Period 1|Lost to Follow-up|0|||
155137931|NCT03350815|559937349|FG003|Period 1|Lost to Follow-up|0|||
155137932|NCT03350815|559937346|FG000|Period 1|Physician Decision|1|||
155137933|NCT03350815|559937347|FG001|Period 1|Physician Decision|0|||
155137934|NCT03350815|559937348|FG002|Period 1|Physician Decision|0|||
155137935|NCT03350815|559937349|FG003|Period 1|Physician Decision|0|||
155137936|NCT03350815|559937346|FG000|Period 1|Withdrawal by Subject|8|||
155137937|NCT03350815|559937347|FG001|Period 1|Withdrawal by Subject|0|||
155137938|NCT03350815|559937348|FG002|Period 1|Withdrawal by Subject|0|||
155137939|NCT03350815|559937349|FG003|Period 1|Withdrawal by Subject|0|||
155137940|NCT03350815|559937346|FG000|Period 1|Lack of Efficacy|15|||
155137941|NCT03350815|559937347|FG001|Period 1|Lack of Efficacy|0|||
155137942|NCT03350815|559937348|FG002|Period 1|Lack of Efficacy|0|||
155137943|NCT03350815|559937349|FG003|Period 1|Lack of Efficacy|0|||
155137944|NCT03350815|559937346|FG000|Period 1|Non-compliance with study treatment|2|||
155137945|NCT03350815|559937347|FG001|Period 1|Non-compliance with study treatment|0|||
155137946|NCT03350815|559937348|FG002|Period 1|Non-compliance with study treatment|0|||
155137947|NCT03350815|559937349|FG003|Period 1|Non-compliance with study treatment|0|||
155137948|NCT03350815|559937346|FG000|Period 1|Protocol Violation|3|||
155137949|NCT03350815|559937347|FG001|Period 1|Protocol Violation|0|||
155137950|NCT03350815|559937348|FG002|Period 1|Protocol Violation|0|||
155137951|NCT03350815|559937349|FG003|Period 1|Protocol Violation|0|||
155137952|NCT03350815|559937346|FG000|Period 2|Adverse Event|0|||
155137953|NCT03350815|559937347|FG001|Period 2|Adverse Event|3|||
155137954|NCT03350815|559937348|FG002|Period 2|Adverse Event|5|||
155137955|NCT03350815|559937349|FG003|Period 2|Adverse Event|0|||
155137956|NCT03350815|559937346|FG000|Period 2|Technical problem|0|||
155137957|NCT03350815|559937347|FG001|Period 2|Technical problem|1|||
155137958|NCT03350815|559937348|FG002|Period 2|Technical problem|0|||
155137959|NCT03350815|559937349|FG003|Period 2|Technical problem|0|||
155137960|NCT03350815|559937346|FG000|Period 2|Lost to Follow-up|0|||
155137961|NCT03350815|559937347|FG001|Period 2|Lost to Follow-up|3|||
155137962|NCT03350815|559937348|FG002|Period 2|Lost to Follow-up|3|||
155137963|NCT03350815|559937349|FG003|Period 2|Lost to Follow-up|0|||
155137964|NCT03350815|559937346|FG000|Period 2|Physician Decision|0|||
155137965|NCT03350815|559937347|FG001|Period 2|Physician Decision|0|||
155137966|NCT03350815|559937348|FG002|Period 2|Physician Decision|1|||
155137967|NCT03350815|559937349|FG003|Period 2|Physician Decision|0|||
155137968|NCT03350815|559937346|FG000|Period 2|Withdrawal by Subject|0|||
155137969|NCT03350815|559937347|FG001|Period 2|Withdrawal by Subject|3|||
155137970|NCT03350815|559937348|FG002|Period 2|Withdrawal by Subject|4|||
155137971|NCT03350815|559937349|FG003|Period 2|Withdrawal by Subject|0|||
155137972|NCT03350815|559937346|FG000|Period 2|Lack of Efficacy|0|||
155137973|NCT03350815|559937347|FG001|Period 2|Lack of Efficacy|6|||
155137974|NCT03350815|559937348|FG002|Period 2|Lack of Efficacy|2|||
155137975|NCT03350815|559937349|FG003|Period 2|Lack of Efficacy|0|||
155137976|NCT03350815|559937346|FG000|Period 2|Protocol Violation|0|||
155137977|NCT03350815|559937347|FG001|Period 2|Protocol Violation|0|||
155137978|NCT03350815|559937348|FG002|Period 2|Protocol Violation|1|||
155137979|NCT03350815|559937349|FG003|Period 2|Protocol Violation|0|||
155137980|NCT03350815|559937346|FG000|Period 2|New therapy for study indication|0|||
155137981|NCT03350815|559937347|FG001|Period 2|New therapy for study indication|0|||
155137982|NCT03350815|559937348|FG002|Period 2|New therapy for study indication|1|||
155137983|NCT03350815|559937349|FG003|Period 2|New therapy for study indication|0|||
155137984|NCT02517541|559937354|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
155137985|NCT02517541|559937354|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
155137986|NCT02517541|559937354|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
155137987|NCT02517541|559937354|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
155137988|NCT02517541|559937354|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
155137989|NCT02517541|559937354|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
155178880|NCT00308581|560093445|FG000|Induction Phase|Withdrawal by Subject|0|||
155015772|NCT05600283|559482467|FG000|Overall Study|Withdrawal by Subject|3|||
155137990|NCT00699608|559937355|FG000|First Intervention|Withdrawal by Subject|0|||
155137991|NCT00699608|559937356|FG001|First Intervention|Withdrawal by Subject|0|||
155015773|NCT05600283|559482468|FG001|Overall Study|Withdrawal by Subject|8|||
155137992|NCT00699608|559937357|FG002|First Intervention|Withdrawal by Subject|1|||
155137993|NCT00699608|559937358|FG003|First Intervention|Withdrawal by Subject|0|||
155137994|NCT00699608|559937359|FG004|First Intervention|Withdrawal by Subject|0|||
155137995|NCT00699608|559937360|FG005|First Intervention|Withdrawal by Subject|0|||
155137996|NCT00699608|559937355|FG000|First Intervention|Protocol Violation|0|||
155137997|NCT00699608|559937356|FG001|First Intervention|Protocol Violation|0|||
155137998|NCT00699608|559937357|FG002|First Intervention|Protocol Violation|0|||
155137999|NCT00699608|559937358|FG003|First Intervention|Protocol Violation|0|||
155138000|NCT00699608|559937359|FG004|First Intervention|Protocol Violation|1|||
155138001|NCT00699608|559937360|FG005|First Intervention|Protocol Violation|0|||
155138002|NCT00699608|559937355|FG000|Second Intervention|Adverse Event|0|||
155138003|NCT00699608|559937356|FG001|Second Intervention|Adverse Event|0|||
155138004|NCT00699608|559937357|FG002|Second Intervention|Adverse Event|1|||
155138005|NCT00699608|559937358|FG003|Second Intervention|Adverse Event|0|||
155138006|NCT00699608|559937359|FG004|Second Intervention|Adverse Event|0|||
155138007|NCT00699608|559937360|FG005|Second Intervention|Adverse Event|0|||
155138008|NCT00699608|559937355|FG000|Second Intervention|Withdrawal by Subject|0|||
155138009|NCT00699608|559937356|FG001|Second Intervention|Withdrawal by Subject|0|||
155138010|NCT00699608|559937357|FG002|Second Intervention|Withdrawal by Subject|0|||
155138011|NCT00699608|559937358|FG003|Second Intervention|Withdrawal by Subject|1|||
155138012|NCT00699608|559937359|FG004|Second Intervention|Withdrawal by Subject|0|||
155138013|NCT00699608|559937360|FG005|Second Intervention|Withdrawal by Subject|0|||
155138014|NCT02828436|559937361|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
155138015|NCT02828436|559937362|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
155138016|NCT02828436|559937361|FG000|Period 1|Lost to Follow-up|0|||
155138017|NCT02828436|559937362|FG001|Period 1|Lost to Follow-up|1|||
155138018|NCT02828436|559937361|FG000|Period 2|Withdrawal by Subject|4|||
155138019|NCT02828436|559937362|FG001|Period 2|Withdrawal by Subject|0|||
155138020|NCT02828436|559937361|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
155138021|NCT02828436|559937362|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
155138022|NCT02828436|559937361|FG000|Period 2|Lost to Follow-up|1|||
155138023|NCT02828436|559937362|FG001|Period 2|Lost to Follow-up|0|||
155138024|NCT01363908|559937367|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
155138025|NCT01363908|559937368|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
155138026|NCT01363908|559937367|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
155138027|NCT01363908|559937368|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
155138028|NCT01363908|559937367|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
155138029|NCT01363908|559937368|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
155138030|NCT01363908|559937367|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
155138031|NCT01363908|559937368|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
155138032|NCT05258149|559937369|FG000|Period 1|Protocol Deviation|1|||
155138033|NCT05258149|559937370|FG001|Period 1|Protocol Deviation|0|||
155138034|NCT05258149|559937369|FG000|Period 1|Adverse Event|0|||
155138035|NCT05258149|559937370|FG001|Period 1|Adverse Event|1|||
155138036|NCT05258149|559937369|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
155138037|NCT05258149|559937370|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
155138038|NCT05258149|559937369|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
155138039|NCT05258149|559937370|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
155138040|NCT05258149|559937369|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
155138041|NCT05258149|559937370|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
155138042|NCT01442714|559937374|FG000|Overall Study|Death|11|||
155138043|NCT01442714|559937374|FG000|Overall Study|Withdrawal by Subject|1|||
155138044|NCT00245037|559937388|FG000|Overall Study|Death|17|||
155138045|NCT00203424|559937390|FG000|Treatment Period|Withdrawal by Subject|4|||
155138046|NCT00203424|559937390|FG000|Treatment Period|Adverse Event|5|||
155138047|NCT00203424|559937390|FG000|Treatment Period|progressive disease|2|||
155178881|NCT00308581|560093446|FG001|Induction Phase|Withdrawal by Subject|0|||
155138048|NCT00203424|559937390|FG000|Follow-up Period|Withdrawal by Subject|1|||
155138049|NCT00203424|559937390|FG000|Follow-up Period|progressive disease|4|||
155138050|NCT00203424|559937390|FG000|Follow-up Period|Lost to Follow-up|1|||
155138051|NCT01053988|559937391|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
155138052|NCT01053988|559937392|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155138053|NCT01053988|559937393|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155138054|NCT01053988|559937394|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155138055|NCT01053988|559937395|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155138056|NCT01053988|559937396|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
155138057|NCT01053988|559937391|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
155138058|NCT01053988|559937392|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155138059|NCT01053988|559937393|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155138060|NCT01053988|559937394|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155138061|NCT01053988|559937395|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155138062|NCT01053988|559937396|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
155138063|NCT01053988|559937391|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
155138064|NCT01053988|559937392|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155015774|NCT05600283|559482467|FG000|Overall Study|invalid individual swab|1|||
155138065|NCT01053988|559937393|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155138066|NCT01053988|559937394|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155138067|NCT01053988|559937395|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155138068|NCT01053988|559937396|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
155138069|NCT01053988|559937391|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
155138070|NCT01053988|559937392|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
155138071|NCT01053988|559937393|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
155138072|NCT01053988|559937394|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
155138073|NCT01053988|559937395|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
155138074|NCT01053988|559937396|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
155138075|NCT01053988|559937391|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
155138076|NCT01053988|559937392|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
155138077|NCT01053988|559937393|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
155138078|NCT01053988|559937394|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
155138079|NCT01053988|559937395|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
155138080|NCT01053988|559937396|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
155138081|NCT01053988|559937391|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
155138082|NCT01053988|559937392|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155138083|NCT01053988|559937393|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155138084|NCT01053988|559937394|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155138085|NCT01053988|559937395|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155138086|NCT01053988|559937396|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
155138087|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
155138088|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
155138089|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
155138090|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
155138091|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
155138092|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
155138093|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155138094|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
155138095|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
155138096|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
155138097|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
155138098|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
155138099|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
155138100|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
155138101|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
155138102|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
155138103|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
155138104|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
155138105|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
155138106|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
155138107|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155138108|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
155138109|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
155138110|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
155138111|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
155138112|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
155138113|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
155138114|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
155138115|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
155138116|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
155138117|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155138118|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
155138119|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
155138120|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
155138121|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
155138122|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
155138123|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
155015775|NCT05600283|559482468|FG001|Overall Study|invalid individual swab|0|||
155015776|NCT05600283|559482467|FG000|Overall Study|missing clinician collection|3|||
155015777|NCT05600283|559482468|FG001|Overall Study|missing clinician collection|0|||
155138124|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
155138125|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
155138126|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
155138127|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
155138128|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
155138129|NCT01053988|559937391|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
155138130|NCT01053988|559937392|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
155138131|NCT01053988|559937393|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155138132|NCT01053988|559937394|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
155138133|NCT01053988|559937395|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
155138134|NCT01053988|559937396|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
155138135|NCT01922271|559937397|FG000|WASHOUT Period|Withdrawal by Subject|1|||
155138136|NCT01922271|559937398|FG001|WASHOUT Period|Withdrawal by Subject|0|||
155138137|NCT01415401|559937403|FG000|Overall Study|Adverse Event|5|||
155138138|NCT01415401|559937403|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
155138139|NCT01415401|559937403|FG000|Overall Study|Terminated by Sponsor|1|||
155138140|NCT00836186|559937404|FG000|Overall Study|Blood could not be drawn|1|||
155138141|NCT04079816|559937405|FG000|Overall Study|Request of Subject|2|||
155138142|NCT04079816|559937405|FG000|Overall Study|Unable to draw samples|1|||
155138143|NCT03724890|559937406|FG000|Overall Study|Death|2|||
155138144|NCT03724890|559937407|FG001|Overall Study|Death|6|||
155138145|NCT03724890|559937408|FG002|Overall Study|Death|3|||
155138146|NCT03724890|559937409|FG003|Overall Study|Death|5|||
155138147|NCT03724890|559937410|FG004|Overall Study|Death|2|||
155138148|NCT03724890|559937411|FG005|Overall Study|Death|0|||
155138149|NCT03724890|559937412|FG006|Overall Study|Death|2|||
155138150|NCT03724890|559937413|FG007|Overall Study|Death|3|||
155138151|NCT03724890|559937414|FG008|Overall Study|Death|4|||
155138152|NCT03724890|559937415|FG009|Overall Study|Death|2|||
155138153|NCT03724890|559937416|FG010|Overall Study|Death|2|||
155138154|NCT03724890|559937406|FG000|Overall Study|Lost to Follow-up|0|||
155138155|NCT03724890|559937407|FG001|Overall Study|Lost to Follow-up|3|||
155138156|NCT03724890|559937408|FG002|Overall Study|Lost to Follow-up|0|||
155138157|NCT03724890|559937409|FG003|Overall Study|Lost to Follow-up|1|||
155138158|NCT03724890|559937410|FG004|Overall Study|Lost to Follow-up|2|||
155138159|NCT03724890|559937411|FG005|Overall Study|Lost to Follow-up|2|||
155138160|NCT03724890|559937412|FG006|Overall Study|Lost to Follow-up|1|||
155138161|NCT03724890|559937413|FG007|Overall Study|Lost to Follow-up|0|||
155138162|NCT03724890|559937414|FG008|Overall Study|Lost to Follow-up|2|||
155138163|NCT03724890|559937415|FG009|Overall Study|Lost to Follow-up|0|||
155138164|NCT03724890|559937416|FG010|Overall Study|Lost to Follow-up|0|||
155138165|NCT03724890|559937406|FG000|Overall Study|Withdrawal by Subject|1|||
155138166|NCT03724890|559937407|FG001|Overall Study|Withdrawal by Subject|2|||
155138167|NCT03724890|559937408|FG002|Overall Study|Withdrawal by Subject|1|||
155138168|NCT03724890|559937409|FG003|Overall Study|Withdrawal by Subject|0|||
155138169|NCT03724890|559937410|FG004|Overall Study|Withdrawal by Subject|0|||
155138170|NCT03724890|559937411|FG005|Overall Study|Withdrawal by Subject|1|||
155138171|NCT03724890|559937412|FG006|Overall Study|Withdrawal by Subject|0|||
155138172|NCT03724890|559937413|FG007|Overall Study|Withdrawal by Subject|0|||
155138173|NCT03724890|559937414|FG008|Overall Study|Withdrawal by Subject|2|||
155138174|NCT03724890|559937415|FG009|Overall Study|Withdrawal by Subject|2|||
155138175|NCT03724890|559937416|FG010|Overall Study|Withdrawal by Subject|1|||
155138176|NCT03724890|559937406|FG000|Overall Study|Other|1|||
155138177|NCT03724890|559937407|FG001|Overall Study|Other|0|||
155138178|NCT03724890|559937408|FG002|Overall Study|Other|0|||
155138179|NCT03724890|559937409|FG003|Overall Study|Other|0|||
155138180|NCT03724890|559937410|FG004|Overall Study|Other|0|||
155138181|NCT03724890|559937411|FG005|Overall Study|Other|0|||
155138182|NCT03724890|559937412|FG006|Overall Study|Other|0|||
155138183|NCT03724890|559937413|FG007|Overall Study|Other|1|||
155138184|NCT03724890|559937414|FG008|Overall Study|Other|1|||
155138185|NCT03724890|559937415|FG009|Overall Study|Other|0|||
155138186|NCT03724890|559937416|FG010|Overall Study|Other|2|||
155138187|NCT01844778|559937417|FG000|Overall Study|Protocol deviation|0|||
155138188|NCT01844778|559937418|FG001|Overall Study|Protocol deviation|1|||
155138189|NCT01844778|559937419|FG002|Overall Study|Protocol deviation|2|||
155138190|NCT01844778|559937417|FG000|Overall Study|Withdrawal by Subject|2|||
155138191|NCT01844778|559937418|FG001|Overall Study|Withdrawal by Subject|0|||
155138192|NCT01844778|559937419|FG002|Overall Study|Withdrawal by Subject|0|||
155138193|NCT01844778|559937417|FG000|Overall Study|Adverse Event|0|||
155138194|NCT01844778|559937418|FG001|Overall Study|Adverse Event|2|||
155138195|NCT01844778|559937419|FG002|Overall Study|Adverse Event|2|||
155138196|NCT02106403|559937423|FG000|Follow-Up Visit 3|Other Reason|0|||
155138197|NCT02106403|559937424|FG001|Follow-Up Visit 3|Other Reason|0|||
155178882|NCT00308581|560093447|FG002|Induction Phase|Withdrawal by Subject|5|||
155138198|NCT02106403|559937425|FG002|Follow-Up Visit 3|Other Reason|0|||
155138199|NCT02106403|559937426|FG003|Follow-Up Visit 3|Other Reason|0|||
155138200|NCT02106403|559937427|FG004|Follow-Up Visit 3|Other Reason|0|||
155178883|NCT00308581|560093445|FG000|Induction Phase|Unknown reason|0|||
155178884|NCT00308581|560093446|FG001|Induction Phase|Unknown reason|0|||
155178885|NCT00308581|560093447|FG002|Induction Phase|Unknown reason|3|||
155178886|NCT00308581|560093445|FG000|Randomized Maintenance Phase|Adverse Event|10|||
155178887|NCT00308581|560093446|FG001|Randomized Maintenance Phase|Adverse Event|17|||
155178888|NCT00308581|560093447|FG002|Randomized Maintenance Phase|Adverse Event|0|||
155178889|NCT00308581|560093445|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
155178890|NCT00308581|560093446|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
155178891|NCT00308581|560093447|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
155178892|NCT00308581|560093445|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
155178893|NCT00308581|560093446|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
155178894|NCT00308581|560093447|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
155178895|NCT00308581|560093445|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
155178896|NCT00308581|560093446|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
155178897|NCT00308581|560093447|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
155178898|NCT00308581|560093445|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
155178899|NCT00308581|560093446|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
155178900|NCT00308581|560093447|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
155178901|NCT00308581|560093445|FG000|Randomized Maintenance Phase|Unknown reason|3|||
155178902|NCT00308581|560093446|FG001|Randomized Maintenance Phase|Unknown reason|0|||
155178903|NCT00308581|560093447|FG002|Randomized Maintenance Phase|Unknown reason|0|||
155178904|NCT00899353|560093450|FG000|Overall Study|Adverse Event|2|||
155178905|NCT00899353|560093450|FG000|Overall Study|Lost to Follow-up|1|||
155178906|NCT00899353|560093450|FG000|Overall Study|Withdrawal by Subject|2|||
155178907|NCT00952380|560093458|FG000|Overall Study|Other|0|||
155138201|NCT02106403|559937428|FG005|Follow-Up Visit 3|Other Reason|1|||
155138202|NCT01128946|559937432|FG000|Period I|Protocol Violation|0|||
155138203|NCT01128946|559937433|FG001|Period I|Protocol Violation|1|||
155138204|NCT01128946|559937434|FG002|Period I|Protocol Violation|0|||
155138205|NCT01128946|559937435|FG003|Period I|Protocol Violation|0|||
155138206|NCT01128946|559937432|FG000|Period I|Withdrawal by Subject|0|||
155138207|NCT01128946|559937433|FG001|Period I|Withdrawal by Subject|0|||
155138208|NCT01128946|559937434|FG002|Period I|Withdrawal by Subject|1|||
155138209|NCT01128946|559937435|FG003|Period I|Withdrawal by Subject|1|||
155138210|NCT01128946|559937432|FG000|Period II|Protocol Violation|0|||
155138211|NCT01128946|559937433|FG001|Period II|Protocol Violation|1|||
155138212|NCT01128946|559937434|FG002|Period II|Protocol Violation|0|||
155138213|NCT01128946|559937435|FG003|Period II|Protocol Violation|0|||
155138214|NCT01128946|559937432|FG000|Period II|Withdrawal by Subject|0|||
155138215|NCT01128946|559937433|FG001|Period II|Withdrawal by Subject|0|||
155138216|NCT01128946|559937434|FG002|Period II|Withdrawal by Subject|0|||
155138217|NCT01128946|559937435|FG003|Period II|Withdrawal by Subject|1|||
155138218|NCT01128946|559937432|FG000|Period III|Protocol Violation|1|||
155138219|NCT01128946|559937433|FG001|Period III|Protocol Violation|0|||
155138220|NCT01128946|559937434|FG002|Period III|Protocol Violation|0|||
155138221|NCT01128946|559937435|FG003|Period III|Protocol Violation|0|||
155138222|NCT00145574|559937436|FG000|Double Blind|Adverse Event|0|||
155138223|NCT00145574|559937437|FG001|Double Blind|Adverse Event|3|||
155138224|NCT00145574|559937438|FG002|Double Blind|Adverse Event|1|||
155138225|NCT00145574|559937436|FG000|Double Blind|Withdrawal by Subject|1|||
155138226|NCT00145574|559937437|FG001|Double Blind|Withdrawal by Subject|1|||
155138227|NCT00145574|559937438|FG002|Double Blind|Withdrawal by Subject|1|||
155138228|NCT00145574|559937436|FG000|Double Blind|required restricted medicine|0|||
155138229|NCT00145574|559937437|FG001|Double Blind|required restricted medicine|1|||
155138230|NCT00145574|559937438|FG002|Double Blind|required restricted medicine|0|||
155178908|NCT00952380|560093459|FG001|Overall Study|Other|0|||
155178909|NCT00952380|560093460|FG002|Overall Study|Other|0|||
155178910|NCT00952380|560093461|FG003|Overall Study|Other|0|||
155178911|NCT00952380|560093462|FG004|Overall Study|Other|1|||
155178912|NCT00952380|560093458|FG000|Overall Study|Withdrawal by Subject|0|||
155178913|NCT00952380|560093459|FG001|Overall Study|Withdrawal by Subject|0|||
155178914|NCT00952380|560093460|FG002|Overall Study|Withdrawal by Subject|1|||
155178915|NCT00952380|560093461|FG003|Overall Study|Withdrawal by Subject|0|||
155138231|NCT00145574|559937436|FG000|Open Label Long-term Extension|Adverse Event|0|||
155178916|NCT00952380|560093462|FG004|Overall Study|Withdrawal by Subject|2|||
155138232|NCT00145574|559937437|FG001|Open Label Long-term Extension|Adverse Event|0|||
155138233|NCT00145574|559937438|FG002|Open Label Long-term Extension|Adverse Event|5|||
155138234|NCT00145574|559937436|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
155138235|NCT00145574|559937437|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
155138236|NCT00145574|559937438|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
155138237|NCT00145574|559937436|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
155138238|NCT00145574|559937437|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
155178917|NCT00952380|560093458|FG000|Overall Study|Adverse Event|0|||
155138239|NCT00145574|559937438|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
155015778|NCT05600283|559482467|FG000|Overall Study|screening failure|0|||
155138240|NCT00145574|559937436|FG000|Open Label Long-term Extension|required restricted medicine|0|||
155138241|NCT00145574|559937437|FG001|Open Label Long-term Extension|required restricted medicine|0|||
155138242|NCT00145574|559937438|FG002|Open Label Long-term Extension|required restricted medicine|1|||
155138243|NCT00621140|559937439|FG000|Overall Study|Adverse Event|4|||
155138244|NCT00621140|559937440|FG001|Overall Study|Adverse Event|5|||
155138245|NCT00621140|559937439|FG000|Overall Study|Lost to Follow-up|1|||
155138246|NCT00621140|559937440|FG001|Overall Study|Lost to Follow-up|2|||
155138247|NCT00621140|559937439|FG000|Overall Study|Withdrawal by Subject|4|||
155138248|NCT00621140|559937440|FG001|Overall Study|Withdrawal by Subject|6|||
155138249|NCT00621140|559937439|FG000|Overall Study|Other incl. lack of efficacy|6|||
155138250|NCT00621140|559937440|FG001|Overall Study|Other incl. lack of efficacy|5|||
155138251|NCT00527904|559937441|FG000|Overall Study|Adverse Event|45|||
155138252|NCT00527904|559937441|FG000|Overall Study|Withdrawal by Subject|21|||
155138253|NCT00527904|559937441|FG000|Overall Study|Lost to Follow-up|8|||
155138254|NCT00527904|559937441|FG000|Overall Study|misc|22|||
155138255|NCT00766051|559937443|FG000|Overall Study|Withdrawal by Subject|2|||
155138256|NCT00766051|559937444|FG001|Overall Study|Withdrawal by Subject|0|||
155138257|NCT02669121|559937445|FG000|Overall Study|Adverse Event|4|||
155138258|NCT02669121|559937446|FG001|Overall Study|Adverse Event|5|||
155138259|NCT02669121|559937445|FG000|Overall Study|Lost to Follow-up|15|||
155138260|NCT02669121|559937446|FG001|Overall Study|Lost to Follow-up|27|||
155138261|NCT02669121|559937445|FG000|Overall Study|Withdrawal by Subject|132|||
155138262|NCT02669121|559937446|FG001|Overall Study|Withdrawal by Subject|140|||
155138263|NCT02669121|559937445|FG000|Overall Study|Pregnancy|0|||
155138264|NCT02669121|559937446|FG001|Overall Study|Pregnancy|1|||
155138265|NCT02669121|559937445|FG000|Overall Study|Discharged from US Military Active Service|117|||
155138266|NCT02669121|559937446|FG001|Overall Study|Discharged from US Military Active Service|91|||
155138267|NCT02669121|559937445|FG000|Overall Study|Reason not Specified|22|||
155138268|NCT02669121|559937446|FG001|Overall Study|Reason not Specified|18|||
155138269|NCT02708355|559937447|FG000|Overall Study|Adverse Event|1|||
155138270|NCT02708355|559937448|FG001|Overall Study|Adverse Event|0|||
155138271|NCT02708355|559937449|FG002|Overall Study|Adverse Event|0|||
155138272|NCT03216746|559937450|FG000|Overall Study|Lost to Follow-up|6|||
155138273|NCT03216746|559937451|FG001|Overall Study|Lost to Follow-up|8|||
155138274|NCT03216746|559937452|FG002|Overall Study|Lost to Follow-up|5|||
155138275|NCT03216746|559937453|FG003|Overall Study|Lost to Follow-up|6|||
155138276|NCT01320202|559937454|FG000|Overall Study|Adverse Event|5|||
155138277|NCT01320202|559937455|FG001|Overall Study|Adverse Event|5|||
155138278|NCT01320202|559937454|FG000|Overall Study|Death|5|||
155138279|NCT01320202|559937455|FG001|Overall Study|Death|3|||
155138280|NCT01320202|559937454|FG000|Overall Study|Lost to Follow-up|1|||
155138281|NCT01320202|559937455|FG001|Overall Study|Lost to Follow-up|0|||
155138282|NCT01320202|559937454|FG000|Overall Study|Physician Decision|3|||
155138283|NCT01320202|559937455|FG001|Overall Study|Physician Decision|1|||
155138284|NCT01320202|559937454|FG000|Overall Study|Protocol Violation|2|||
155138285|NCT01320202|559937455|FG001|Overall Study|Protocol Violation|1|||
155138286|NCT01320202|559937454|FG000|Overall Study|Withdrawal by Subject|10|||
155138287|NCT01320202|559937455|FG001|Overall Study|Withdrawal by Subject|3|||
155138288|NCT01320202|559937454|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
155138289|NCT01320202|559937455|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
155138290|NCT01320202|559937454|FG000|Overall Study|kidney transplant|1|||
155138291|NCT01320202|559937455|FG001|Overall Study|kidney transplant|2|||
155138292|NCT01320202|559937454|FG000|Overall Study|blood transfusion|1|||
155138293|NCT01320202|559937455|FG001|Overall Study|blood transfusion|7|||
155138294|NCT01320202|559937454|FG000|Overall Study|moved/changed dialysis|5|||
155178918|NCT00952380|560093459|FG001|Overall Study|Adverse Event|1|||
155138295|NCT01320202|559937455|FG001|Overall Study|moved/changed dialysis|2|||
155138296|NCT01320202|559937454|FG000|Overall Study|sponsor request|2|||
155138297|NCT01320202|559937455|FG001|Overall Study|sponsor request|0|||
155138298|NCT01320202|559937454|FG000|Overall Study|ineligible|3|||
155138299|NCT01320202|559937455|FG001|Overall Study|ineligible|0|||
155138300|NCT01320202|559937454|FG000|Overall Study|regained renal function|1|||
155138301|NCT01320202|559937455|FG001|Overall Study|regained renal function|0|||
155138302|NCT00635882|559937456|FG000|Overall Study|Protocol Violation|1|||
155138303|NCT00635882|559937457|FG001|Overall Study|Protocol Violation|0|||
155138304|NCT00635882|559937458|FG002|Overall Study|Protocol Violation|0|||
155138305|NCT00635882|559937459|FG003|Overall Study|Protocol Violation|0|||
155138306|NCT00635882|559937460|FG004|Overall Study|Protocol Violation|0|||
155138307|NCT00635882|559937461|FG005|Overall Study|Protocol Violation|0|||
155138308|NCT00835341|559937462|FG000|Overall Study|Lost to Follow-up|3|||
155138309|NCT00835341|559937463|FG001|Overall Study|Lost to Follow-up|12|||
155138310|NCT02513472|559937464|FG000|Overall Study|Radiological Disease Progression|45|||
155178919|NCT00952380|560093460|FG002|Overall Study|Adverse Event|0|||
155178920|NCT00952380|560093461|FG003|Overall Study|Adverse Event|0|||
155138311|NCT02513472|559937465|FG001|Overall Study|Radiological Disease Progression|57|||
155138312|NCT02513472|559937464|FG000|Overall Study|Clinical Disease Progression|5|||
155138313|NCT02513472|559937465|FG001|Overall Study|Clinical Disease Progression|13|||
155178921|NCT00952380|560093462|FG004|Overall Study|Adverse Event|3|||
155015779|NCT05600283|559482468|FG001|Overall Study|screening failure|2|||
155015780|NCT02883062|559482469|FG000|Overall Study|Withdrawal by Subject|6|||
155015781|NCT02883062|559482470|FG001|Overall Study|Withdrawal by Subject|0|||
155015782|NCT02174627|559482475|FG000|Overall Study|Missing|0|||
155015783|NCT02174627|559482476|FG001|Overall Study|Missing|1|||
155015784|NCT02174627|559482475|FG000|Overall Study|Incorrect enrolment before randomization|0|||
155015785|NCT02174627|559482476|FG001|Overall Study|Incorrect enrolment before randomization|1|||
155015786|NCT02174627|559482475|FG000|Overall Study|Participant decision|84|||
155138314|NCT02513472|559937464|FG000|Overall Study|Adverse Event|8|||
155138315|NCT02513472|559937465|FG001|Overall Study|Adverse Event|11|||
155138316|NCT02513472|559937464|FG000|Overall Study|Withdrawal by Subject|0|||
155138317|NCT02513472|559937465|FG001|Overall Study|Withdrawal by Subject|4|||
155138318|NCT02513472|559937464|FG000|Overall Study|Subject Choice|2|||
155138319|NCT02513472|559937465|FG001|Overall Study|Subject Choice|7|||
155138320|NCT02513472|559937464|FG000|Overall Study|Treatment Completed as per Protocol|3|||
155138321|NCT02513472|559937465|FG001|Overall Study|Treatment Completed as per Protocol|3|||
155138322|NCT02513472|559937464|FG000|Overall Study|Other|3|||
155138323|NCT02513472|559937465|FG001|Overall Study|Other|6|||
155138324|NCT00400569|559937472|FG000|Overall Study|Death|1|||
155138325|NCT00620113|559937473|FG000|Overall Study|Adverse Event|3|||
155138326|NCT00620113|559937474|FG001|Overall Study|Adverse Event|2|||
155138327|NCT00620113|559937475|FG002|Overall Study|Adverse Event|2|||
155138328|NCT00620113|559937476|FG003|Overall Study|Adverse Event|1|||
155138329|NCT00620113|559937473|FG000|Overall Study|Lack of Efficacy|2|||
155138330|NCT00620113|559937474|FG001|Overall Study|Lack of Efficacy|3|||
155138331|NCT00620113|559937475|FG002|Overall Study|Lack of Efficacy|0|||
155138332|NCT00620113|559937476|FG003|Overall Study|Lack of Efficacy|2|||
155138333|NCT00620113|559937473|FG000|Overall Study|Physician Decision|1|||
155138334|NCT00620113|559937474|FG001|Overall Study|Physician Decision|0|||
155138335|NCT00620113|559937475|FG002|Overall Study|Physician Decision|0|||
155138336|NCT00620113|559937476|FG003|Overall Study|Physician Decision|2|||
155138337|NCT00620113|559937473|FG000|Overall Study|Protocol Violation|2|||
155138338|NCT00620113|559937474|FG001|Overall Study|Protocol Violation|1|||
155138339|NCT00620113|559937475|FG002|Overall Study|Protocol Violation|0|||
155138340|NCT00620113|559937476|FG003|Overall Study|Protocol Violation|0|||
155138341|NCT00620113|559937473|FG000|Overall Study|Withdrawal by Subject|5|||
155138342|NCT00620113|559937474|FG001|Overall Study|Withdrawal by Subject|1|||
155138343|NCT00620113|559937475|FG002|Overall Study|Withdrawal by Subject|3|||
155138344|NCT00620113|559937476|FG003|Overall Study|Withdrawal by Subject|5|||
155138345|NCT00852241|559937477|FG000|Overall Study|Physician Decision|18|||
155138346|NCT03848949|559937478|FG000|Overall Study|Lost to Follow-up|5|||
155138347|NCT03848949|559937479|FG001|Overall Study|Lost to Follow-up|7|||
155138348|NCT00619307|559937480|FG000|Overall Study|Adverse Event|0|||
155138349|NCT00619307|559937481|FG001|Overall Study|Adverse Event|1|||
155138350|NCT00619307|559937480|FG000|Overall Study|Lost to Follow-up|0|||
155138351|NCT00619307|559937481|FG001|Overall Study|Lost to Follow-up|1|||
155138352|NCT00619307|559937480|FG000|Overall Study|Protocol Violation|3|||
155138353|NCT00619307|559937481|FG001|Overall Study|Protocol Violation|0|||
155138354|NCT00619307|559937480|FG000|Overall Study|Withdrew consent|1|||
155138355|NCT00619307|559937481|FG001|Overall Study|Withdrew consent|0|||
155138356|NCT00619307|559937480|FG000|Overall Study|Severe migraine|0|||
155138357|NCT00619307|559937481|FG001|Overall Study|Severe migraine|1|||
155138358|NCT00619307|559937480|FG000|Overall Study|MS attack plus steroids|0|||
155138359|NCT00619307|559937481|FG001|Overall Study|MS attack plus steroids|1|||
155138360|NCT02476006|559937490|FG000|Overall Study|Death|4|||
155138361|NCT02476006|559937490|FG000|Overall Study|Lack of treatment efficacy|2|||
155138362|NCT02476006|559937490|FG000|Overall Study|Pregnancy|1|||
155138363|NCT02476006|559937490|FG000|Overall Study|Participant did not wish to continue|39|||
155138364|NCT02476006|559937490|FG000|Overall Study|Adverse Event|41|||
155138365|NCT02476006|559937490|FG000|Overall Study|Poor compliance to study protocol|3|||
155138366|NCT02476006|559937490|FG000|Overall Study|Sponsor decision|6|||
155138367|NCT02476006|559937490|FG000|Overall Study|Lost to Follow-up|5|||
155138368|NCT02476006|559937490|FG000|Overall Study|Physician Decision|5|||
155138369|NCT02476006|559937490|FG000|Overall Study|Study ended treatment not available|4|||
155138370|NCT02476006|559937490|FG000|Overall Study|Switched to commercial drug|4|||
155138371|NCT02476006|559937490|FG000|Overall Study|Excluded from study|1|||
155138372|NCT02476006|559937490|FG000|Overall Study|Protocol Violation|1|||
155138373|NCT02476006|559937490|FG000|Overall Study|Enrolled but not treated|4|||
155015787|NCT02174627|559482476|FG001|Overall Study|Participant decision|128|||
155015788|NCT00848718|559482479|FG000|Overall Study|Adverse Event|2|||
155138374|NCT04306510|559939139|FG000|Overall Study|Voluntarily withdrawal|1|||
155138375|NCT04306510|559939139|FG000|Overall Study|Enrolled but Not Treated|1|||
155138376|NCT04720417|559939142|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
155138377|NCT03329092|559939143|FG000|Overall Study|Other|2|||
155138378|NCT03329092|559939144|FG001|Overall Study|Other|2|||
155138379|NCT03329092|559939143|FG000|Overall Study|Withdrawal by Subject|16|||
155138380|NCT03329092|559939144|FG001|Overall Study|Withdrawal by Subject|3|||
155138381|NCT03329092|559939143|FG000|Overall Study|Physician Decision|1|||
155138382|NCT03329092|559939144|FG001|Overall Study|Physician Decision|0|||
155138383|NCT03329092|559939143|FG000|Overall Study|Death|17|||
155138384|NCT03329092|559939144|FG001|Overall Study|Death|11|||
155138385|NCT03329092|559939143|FG000|Overall Study|Adverse Event|3|||
155138386|NCT03329092|559939144|FG001|Overall Study|Adverse Event|1|||
155138387|NCT03329092|559939143|FG000|Overall Study|Lost to Follow-up|1|||
155138388|NCT03329092|559939144|FG001|Overall Study|Lost to Follow-up|1|||
155138389|NCT03314987|559939145|FG000|Overall Study|Lost to Follow-up|13|||
155138390|NCT03314987|559939146|FG001|Overall Study|Lost to Follow-up|13|||
155138391|NCT03755882|559939147|FG000|Period 1|Protocol Violation|1|||
155138392|NCT03755882|559939148|FG001|Period 1|Protocol Violation|0|||
155138393|NCT03755882|559939147|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
155138394|NCT03755882|559939148|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
155138395|NCT05636852|559939149|FG000|Overall Study|Withdrawal by Subject|1|||
155138396|NCT05636852|559939149|FG000|Overall Study|Other than specified|1|||
155138397|NCT02221674|559939152|FG000|Overall Study|Lost to Follow-up|1|||
155138398|NCT02221674|559939153|FG001|Overall Study|Lost to Follow-up|0|||
155138399|NCT02221674|559939154|FG002|Overall Study|Lost to Follow-up|0|||
155138400|NCT02557542|559939155|FG000|Overall Study|Poor recruitment|3|||
155138401|NCT02557542|559939156|FG001|Overall Study|Poor recruitment|0|||
155138402|NCT04390880|559939157|FG000|Overall Study|Withdrawal by Subject|1|||
155138403|NCT00195091|559939158|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
155138404|NCT00475709|559939164|FG000|Overall Study|Did not meet eligibility criteria|8|||
155138405|NCT00475709|559939164|FG000|Overall Study|Death|41|||
155138406|NCT00475709|559939164|FG000|Overall Study|Device Explant|6|||
155138407|NCT00475709|559939164|FG000|Overall Study|Lost to Follow-up|21|||
155138408|NCT04752358|559939165|FG000|Overall Study|Death|2|||
155138409|NCT04752358|559939166|FG001|Overall Study|Death|1|||
155138410|NCT00555672|559939169|FG000|Overall Study|Death|0|||
155138411|NCT00555672|559939170|FG001|Overall Study|Death|2|||
155138412|NCT00555672|559939169|FG000|Overall Study|Adverse Event|8|||
155138413|NCT00555672|559939170|FG001|Overall Study|Adverse Event|2|||
155138414|NCT00555672|559939169|FG000|Overall Study|Objective progression or relapse|11|||
155138415|NCT00555672|559939170|FG001|Overall Study|Objective progression or relapse|5|||
155138416|NCT00555672|559939169|FG000|Overall Study|Other|3|||
155138417|NCT00555672|559939170|FG001|Overall Study|Other|1|||
155138418|NCT00555672|559939169|FG000|Overall Study|Participant refused|2|||
155138419|NCT00555672|559939170|FG001|Overall Study|Participant refused|0|||
155138420|NCT06041919|559939171|FG000|Overall Study|Lost to Follow-up|1|||
155138421|NCT06041919|559939172|FG001|Overall Study|Lost to Follow-up|0|||
155138422|NCT06041919|559939173|FG002|Overall Study|Lost to Follow-up|0|||
155138423|NCT06041919|559939174|FG003|Overall Study|Lost to Follow-up|0|||
155138424|NCT06041919|559939175|FG004|Overall Study|Lost to Follow-up|0|||
155138425|NCT06041919|559939171|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
155138426|NCT06041919|559939172|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
155138427|NCT06041919|559939173|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
155138428|NCT06041919|559939174|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
155138429|NCT06041919|559939175|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
155138430|NCT02023996|559939182|FG000|Overall Study|Protocol Violation|6|||
155138431|NCT03400176|559939183|FG000|Dose Escalation|Progressive disease|1|||
155138432|NCT03400176|559939184|FG001|Dose Escalation|Progressive disease|1|||
155138433|NCT03400176|559939185|FG002|Dose Escalation|Progressive disease|0|||
155138434|NCT03400176|559939186|FG003|Dose Escalation|Progressive disease|0|||
155138435|NCT03400176|559939187|FG004|Dose Escalation|Progressive disease|1|||
155138436|NCT03400176|559939183|FG000|Dose Escalation|Patient decision|0|||
155138437|NCT03400176|559939184|FG001|Dose Escalation|Patient decision|0|||
155138438|NCT03400176|559939185|FG002|Dose Escalation|Patient decision|0|||
155138439|NCT03400176|559939186|FG003|Dose Escalation|Patient decision|0|||
155138440|NCT03400176|559939187|FG004|Dose Escalation|Patient decision|1|||
155138441|NCT03400176|559939183|FG000|Dose Expansion|Patient decision|0|||
155138442|NCT03400176|559939184|FG001|Dose Expansion|Patient decision|0|||
155138443|NCT03400176|559939185|FG002|Dose Expansion|Patient decision|0|||
155138444|NCT03400176|559939186|FG003|Dose Expansion|Patient decision|1|||
155138445|NCT03400176|559939187|FG004|Dose Expansion|Patient decision|0|||
155138446|NCT03400176|559939183|FG000|Dose Expansion|Adverse Event|0|||
155138447|NCT03400176|559939184|FG001|Dose Expansion|Adverse Event|0|||
155138448|NCT03400176|559939185|FG002|Dose Expansion|Adverse Event|0|||
155138449|NCT03400176|559939186|FG003|Dose Expansion|Adverse Event|1|||
155138450|NCT03400176|559939187|FG004|Dose Expansion|Adverse Event|0|||
155138451|NCT03400176|559939183|FG000|Dose Expansion|Physician Decision|0|||
155015789|NCT00848718|559482480|FG001|Overall Study|Adverse Event|2|||
155138452|NCT03400176|559939184|FG001|Dose Expansion|Physician Decision|0|||
155138453|NCT03400176|559939185|FG002|Dose Expansion|Physician Decision|0|||
155138454|NCT03400176|559939186|FG003|Dose Expansion|Physician Decision|1|||
155138455|NCT03400176|559939187|FG004|Dose Expansion|Physician Decision|0|||
155138456|NCT03400176|559939183|FG000|Dose Expansion|Progressive disease|0|||
155138457|NCT03400176|559939184|FG001|Dose Expansion|Progressive disease|0|||
155138458|NCT03400176|559939185|FG002|Dose Expansion|Progressive disease|1|||
155138459|NCT03400176|559939186|FG003|Dose Expansion|Progressive disease|1|||
155138460|NCT03400176|559939187|FG004|Dose Expansion|Progressive disease|0|||
155138461|NCT01090063|559939193|FG000|Screen|Screen Failed|4|||
155138462|NCT01090063|559939193|FG000|Treatment|Withdrawal by Subject|4|||
155138463|NCT00874848|559939194|FG000|Overall Study|Adverse Event|13|||
155138464|NCT00874848|559939195|FG001|Overall Study|Adverse Event|2|||
155138465|NCT00874848|559939194|FG000|Overall Study|Progressive neoplastic disease|38|||
155138466|NCT00874848|559939195|FG001|Overall Study|Progressive neoplastic disease|18|||
155138467|NCT00874848|559939194|FG000|Overall Study|Withdrawal by Subject|7|||
155138468|NCT00874848|559939195|FG001|Overall Study|Withdrawal by Subject|4|||
155138469|NCT00874848|559939194|FG000|Overall Study|Noncompliance|1|||
155138470|NCT00874848|559939195|FG001|Overall Study|Noncompliance|1|||
155138471|NCT00874848|559939194|FG000|Overall Study|Failure to comply with protocol|0|||
155138472|NCT00874848|559939195|FG001|Overall Study|Failure to comply with protocol|1|||
155138473|NCT00874848|559939194|FG000|Overall Study|Physician Decision|0|||
155138474|NCT00874848|559939195|FG001|Overall Study|Physician Decision|2|||
155138475|NCT04698993|559939202|FG000|Overall Study|PCR results not accessible|2|||
155138476|NCT04698993|559939203|FG001|Overall Study|PCR results not accessible|7|||
155138477|NCT04698993|559939202|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
155138478|NCT04698993|559939203|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
155138479|NCT01371734|559939204|FG000|Overall Study|Other|2|||
155138480|NCT01371734|559939205|FG001|Overall Study|Other|1|||
155138481|NCT01371734|559939206|FG002|Overall Study|Other|2|||
155138482|NCT01371734|559939204|FG000|Overall Study|Withdrawal by Subject|3|||
155138483|NCT01371734|559939205|FG001|Overall Study|Withdrawal by Subject|4|||
155138484|NCT01371734|559939206|FG002|Overall Study|Withdrawal by Subject|9|||
155138485|NCT01371734|559939204|FG000|Overall Study|Lost to Follow-up|5|||
155138486|NCT01371734|559939205|FG001|Overall Study|Lost to Follow-up|3|||
155138487|NCT01371734|559939206|FG002|Overall Study|Lost to Follow-up|1|||
155138488|NCT01371734|559939204|FG000|Overall Study|Protocol Violation|3|||
155138489|NCT01371734|559939205|FG001|Overall Study|Protocol Violation|1|||
155138490|NCT01371734|559939206|FG002|Overall Study|Protocol Violation|2|||
155138491|NCT01371734|559939204|FG000|Overall Study|Adverse Event|8|||
155138492|NCT01371734|559939205|FG001|Overall Study|Adverse Event|8|||
155138493|NCT01371734|559939206|FG002|Overall Study|Adverse Event|3|||
155138494|NCT01371734|559939204|FG000|Overall Study|Lack of Efficacy|2|||
155138495|NCT01371734|559939205|FG001|Overall Study|Lack of Efficacy|2|||
155138496|NCT01371734|559939206|FG002|Overall Study|Lack of Efficacy|0|||
155138497|NCT00206440|559939207|FG000|Overall Study|Protocol Violation|1|||
155138498|NCT00206440|559939208|FG001|Overall Study|Protocol Violation|2|||
155138499|NCT00206440|559939207|FG000|Overall Study|Adverse Event|4|||
155138500|NCT00206440|559939208|FG001|Overall Study|Adverse Event|2|||
155138501|NCT00958165|559939209|FG000|Overall Study|Lost to Follow-up|5|||
155138502|NCT00958165|559939209|FG000|Overall Study|Not eligible|9|||
155138503|NCT01298765|559939210|FG000|Titration Period|Adverse Event|26|||
155138504|NCT01298765|559939210|FG000|Titration Period|Death|1|||
155138505|NCT01298765|559939210|FG000|Titration Period|Lack of Efficacy|21|||
155138506|NCT01298765|559939210|FG000|Titration Period|Lost to Follow-up|9|||
155138507|NCT01298765|559939210|FG000|Titration Period|Physician Decision|1|||
155138508|NCT01298765|559939210|FG000|Titration Period|Withdrawal by Subject|10|||
155138509|NCT01298765|559939210|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
155138510|NCT01298765|559939210|FG000|Long-Term Treatment Period|Adverse Event|19|||
155138511|NCT01298765|559939210|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
155138512|NCT01298765|559939210|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
155138513|NCT01298765|559939210|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
155138514|NCT01298765|559939210|FG000|Long-Term Treatment Period|Physician Decision|1|||
155138515|NCT01298765|559939210|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
155138516|NCT03565237|559939211|FG000|Overall Study|Non-compliance of Investigational Product|1|||
155138517|NCT03565237|559939211|FG000|Overall Study|Physician Decision|1|||
155138518|NCT01140061|559939215|FG000|Part I|Adverse Event|1|||
155138519|NCT01140061|559939216|FG001|Part I|Adverse Event|0|||
155138520|NCT01140061|559939217|FG002|Part I|Adverse Event|0|||
155138521|NCT01140061|559939218|FG003|Part I|Adverse Event|0|||
155138522|NCT01140061|559939219|FG004|Part I|Adverse Event|0|||
155138523|NCT01140061|559939220|FG005|Part I|Adverse Event|0|||
155138524|NCT01140061|559939221|FG006|Part I|Adverse Event|0|||
155138525|NCT01140061|559939222|FG007|Part I|Adverse Event|0|||
155138526|NCT01140061|559939223|FG008|Part I|Adverse Event|0|||
155138527|NCT01140061|559939224|FG009|Part I|Adverse Event|0|||
155138528|NCT01140061|559939215|FG000|Extension|Laboratory Adverse Event|0|||
155138529|NCT01140061|559939216|FG001|Extension|Laboratory Adverse Event|0|||
155138530|NCT01140061|559939217|FG002|Extension|Laboratory Adverse Event|0|||
155138531|NCT01140061|559939218|FG003|Extension|Laboratory Adverse Event|0|||
155138532|NCT01140061|559939219|FG004|Extension|Laboratory Adverse Event|0|||
155138533|NCT01140061|559939220|FG005|Extension|Laboratory Adverse Event|0|||
155138534|NCT01140061|559939221|FG006|Extension|Laboratory Adverse Event|0|||
155138535|NCT01140061|559939222|FG007|Extension|Laboratory Adverse Event|0|||
155138536|NCT01140061|559939223|FG008|Extension|Laboratory Adverse Event|0|||
155015790|NCT00848718|559482481|FG002|Overall Study|Adverse Event|1|||
155015791|NCT00848718|559482482|FG003|Overall Study|Adverse Event|1|||
155015792|NCT00848718|559482483|FG004|Overall Study|Adverse Event|1|||
155015793|NCT00848718|559482484|FG005|Overall Study|Adverse Event|0|||
155015794|NCT00848718|559482485|FG006|Overall Study|Adverse Event|0|||
155015795|NCT00848718|559482486|FG007|Overall Study|Adverse Event|1|||
155015796|NCT00848718|559482487|FG008|Overall Study|Adverse Event|1|||
155015797|NCT00848718|559482488|FG009|Overall Study|Adverse Event|0|||
155015798|NCT00848718|559482489|FG010|Overall Study|Adverse Event|0|||
155015799|NCT00848718|559482490|FG011|Overall Study|Adverse Event|0|||
155015800|NCT00848718|559482491|FG012|Overall Study|Adverse Event|2|||
155015801|NCT00848718|559482479|FG000|Overall Study|Lack of Efficacy|0|||
155015802|NCT00848718|559482480|FG001|Overall Study|Lack of Efficacy|0|||
155015803|NCT00848718|559482481|FG002|Overall Study|Lack of Efficacy|1|||
155015804|NCT00848718|559482482|FG003|Overall Study|Lack of Efficacy|0|||
155015805|NCT00848718|559482483|FG004|Overall Study|Lack of Efficacy|0|||
155015806|NCT00848718|559482484|FG005|Overall Study|Lack of Efficacy|0|||
155015807|NCT00848718|559482485|FG006|Overall Study|Lack of Efficacy|1|||
155015808|NCT00848718|559482486|FG007|Overall Study|Lack of Efficacy|0|||
155015809|NCT00848718|559482487|FG008|Overall Study|Lack of Efficacy|0|||
155015810|NCT00848718|559482488|FG009|Overall Study|Lack of Efficacy|0|||
155015811|NCT00848718|559482489|FG010|Overall Study|Lack of Efficacy|0|||
155015812|NCT00848718|559482490|FG011|Overall Study|Lack of Efficacy|0|||
155015813|NCT00848718|559482491|FG012|Overall Study|Lack of Efficacy|0|||
155015814|NCT00848718|559482479|FG000|Overall Study|Physician Decision|0|||
155015815|NCT00848718|559482480|FG001|Overall Study|Physician Decision|1|||
155015816|NCT00848718|559482481|FG002|Overall Study|Physician Decision|0|||
155015817|NCT00848718|559482482|FG003|Overall Study|Physician Decision|0|||
155015818|NCT00848718|559482483|FG004|Overall Study|Physician Decision|1|||
155015819|NCT00848718|559482484|FG005|Overall Study|Physician Decision|1|||
155015820|NCT00848718|559482485|FG006|Overall Study|Physician Decision|0|||
155015821|NCT00848718|559482486|FG007|Overall Study|Physician Decision|0|||
155015822|NCT00848718|559482487|FG008|Overall Study|Physician Decision|1|||
155015823|NCT00848718|559482488|FG009|Overall Study|Physician Decision|2|||
155015824|NCT00848718|559482489|FG010|Overall Study|Physician Decision|0|||
155015825|NCT00848718|559482490|FG011|Overall Study|Physician Decision|0|||
155015826|NCT00848718|559482491|FG012|Overall Study|Physician Decision|1|||
155015827|NCT00848718|559482479|FG000|Overall Study|Progressive disease before treatment|1|||
155015828|NCT00848718|559482480|FG001|Overall Study|Progressive disease before treatment|5|||
155015829|NCT00848718|559482481|FG002|Overall Study|Progressive disease before treatment|1|||
155015830|NCT00848718|559482482|FG003|Overall Study|Progressive disease before treatment|3|||
155015831|NCT00848718|559482483|FG004|Overall Study|Progressive disease before treatment|4|||
155015832|NCT00848718|559482484|FG005|Overall Study|Progressive disease before treatment|4|||
155015833|NCT00848718|559482485|FG006|Overall Study|Progressive disease before treatment|2|||
155015834|NCT00848718|559482486|FG007|Overall Study|Progressive disease before treatment|1|||
155015835|NCT00848718|559482487|FG008|Overall Study|Progressive disease before treatment|2|||
155015836|NCT00848718|559482488|FG009|Overall Study|Progressive disease before treatment|7|||
155015837|NCT00848718|559482489|FG010|Overall Study|Progressive disease before treatment|3|||
155015838|NCT00848718|559482490|FG011|Overall Study|Progressive disease before treatment|6|||
155015839|NCT00848718|559482491|FG012|Overall Study|Progressive disease before treatment|2|||
155015840|NCT00848718|559482479|FG000|Overall Study|Protocol Violation|0|||
155015841|NCT00848718|559482480|FG001|Overall Study|Protocol Violation|1|||
155015842|NCT00848718|559482481|FG002|Overall Study|Protocol Violation|0|||
155015843|NCT00848718|559482482|FG003|Overall Study|Protocol Violation|0|||
155015844|NCT00848718|559482483|FG004|Overall Study|Protocol Violation|0|||
155015845|NCT00848718|559482484|FG005|Overall Study|Protocol Violation|0|||
155015846|NCT00848718|559482485|FG006|Overall Study|Protocol Violation|0|||
155015847|NCT00848718|559482486|FG007|Overall Study|Protocol Violation|1|||
155015848|NCT00848718|559482487|FG008|Overall Study|Protocol Violation|0|||
155015849|NCT00848718|559482488|FG009|Overall Study|Protocol Violation|0|||
155015850|NCT00848718|559482489|FG010|Overall Study|Protocol Violation|0|||
155015851|NCT00848718|559482490|FG011|Overall Study|Protocol Violation|0|||
155015852|NCT00848718|559482491|FG012|Overall Study|Protocol Violation|1|||
155015853|NCT00848718|559482479|FG000|Overall Study|Withdrawal by Subject|1|||
155015854|NCT00848718|559482480|FG001|Overall Study|Withdrawal by Subject|0|||
155015855|NCT00848718|559482481|FG002|Overall Study|Withdrawal by Subject|0|||
155015856|NCT00848718|559482482|FG003|Overall Study|Withdrawal by Subject|1|||
155015857|NCT00848718|559482483|FG004|Overall Study|Withdrawal by Subject|0|||
155015858|NCT00848718|559482484|FG005|Overall Study|Withdrawal by Subject|0|||
155178922|NCT00952380|560093458|FG000|Overall Study|Physician Decision|0|||
155015859|NCT00848718|559482485|FG006|Overall Study|Withdrawal by Subject|0|||
155015860|NCT00848718|559482486|FG007|Overall Study|Withdrawal by Subject|0|||
155015861|NCT00848718|559482487|FG008|Overall Study|Withdrawal by Subject|0|||
155015862|NCT00848718|559482488|FG009|Overall Study|Withdrawal by Subject|0|||
155015863|NCT00848718|559482489|FG010|Overall Study|Withdrawal by Subject|1|||
155015864|NCT00848718|559482490|FG011|Overall Study|Withdrawal by Subject|0|||
155015865|NCT00848718|559482491|FG012|Overall Study|Withdrawal by Subject|0|||
155015866|NCT00848718|559482479|FG000|Overall Study|Progressive disease during treatment|3|||
155015867|NCT00848718|559482480|FG001|Overall Study|Progressive disease during treatment|0|||
155015868|NCT00848718|559482481|FG002|Overall Study|Progressive disease during treatment|3|||
155015869|NCT00848718|559482482|FG003|Overall Study|Progressive disease during treatment|0|||
155015870|NCT00848718|559482483|FG004|Overall Study|Progressive disease during treatment|0|||
155015871|NCT00848718|559482484|FG005|Overall Study|Progressive disease during treatment|0|||
155015872|NCT00848718|559482485|FG006|Overall Study|Progressive disease during treatment|0|||
155015873|NCT00848718|559482486|FG007|Overall Study|Progressive disease during treatment|2|||
155015874|NCT00848718|559482487|FG008|Overall Study|Progressive disease during treatment|0|||
155015875|NCT00848718|559482488|FG009|Overall Study|Progressive disease during treatment|0|||
155015876|NCT00848718|559482489|FG010|Overall Study|Progressive disease during treatment|0|||
155138537|NCT01140061|559939224|FG009|Extension|Laboratory Adverse Event|1|||
155138538|NCT00428389|559939226|FG000|Core Phase|Adverse Event|6|||
155138539|NCT00428389|559939227|FG001|Core Phase|Adverse Event|4|||
155138540|NCT00428389|559939226|FG000|Core Phase|Lack of Efficacy|2|||
155138541|NCT00428389|559939227|FG001|Core Phase|Lack of Efficacy|0|||
155138542|NCT00428389|559939226|FG000|Core Phase|Abnormal test procedure result(s)|0|||
155138543|NCT00428389|559939227|FG001|Core Phase|Abnormal test procedure result(s)|1|||
155138544|NCT00428389|559939226|FG000|Core Phase|Withdrawal by Subject|3|||
155138545|NCT00428389|559939227|FG001|Core Phase|Withdrawal by Subject|4|||
155138546|NCT00428389|559939226|FG000|Core Phase|Protocol deviation|0|||
155138547|NCT00428389|559939227|FG001|Core Phase|Protocol deviation|2|||
155138548|NCT00428389|559939226|FG000|Extension Phase|Adverse Event|17|||
155138549|NCT00428389|559939227|FG001|Extension Phase|Adverse Event|11|||
155138550|NCT00428389|559939226|FG000|Extension Phase|Lack of Efficacy|4|||
155138551|NCT00428389|559939227|FG001|Extension Phase|Lack of Efficacy|3|||
155138552|NCT00428389|559939226|FG000|Extension Phase|Withdrawal by Subject|6|||
155138553|NCT00428389|559939227|FG001|Extension Phase|Withdrawal by Subject|6|||
155138554|NCT00428389|559939226|FG000|Extension Phase|Lost to Follow-up|0|||
155138555|NCT00428389|559939227|FG001|Extension Phase|Lost to Follow-up|3|||
155138556|NCT00428389|559939226|FG000|Extension Phase|Death|1|||
155138557|NCT00428389|559939227|FG001|Extension Phase|Death|0|||
155138558|NCT00428389|559939226|FG000|Extension Phase|Protocol Violation|3|||
155138559|NCT00428389|559939227|FG001|Extension Phase|Protocol Violation|2|||
155138560|NCT00428389|559939226|FG000|Extension Phase|Administrative problems|1|||
155138561|NCT00428389|559939227|FG001|Extension Phase|Administrative problems|1|||
155138562|NCT04090242|559939228|FG000|Overall Study|Withdrawal by Subject|1|||
155138563|NCT04090242|559939229|FG001|Overall Study|Withdrawal by Subject|0|||
155138564|NCT02687581|559939230|FG000|Overall Study|Withdrawal by Subject|1|||
155138565|NCT02687581|559939231|FG001|Overall Study|Withdrawal by Subject|0|||
155138566|NCT02687581|559939232|FG002|Overall Study|Withdrawal by Subject|0|||
155138567|NCT02687581|559939233|FG003|Overall Study|Withdrawal by Subject|1|||
155138568|NCT02687581|559939230|FG000|Overall Study|Lost to Follow-up|2|||
155138569|NCT02687581|559939231|FG001|Overall Study|Lost to Follow-up|2|||
155138570|NCT02687581|559939232|FG002|Overall Study|Lost to Follow-up|0|||
155138571|NCT02687581|559939233|FG003|Overall Study|Lost to Follow-up|0|||
155138572|NCT02687581|559939230|FG000|Overall Study|the device is too small for the patient.|1|||
155138573|NCT02687581|559939231|FG001|Overall Study|the device is too small for the patient.|0|||
155138574|NCT02687581|559939232|FG002|Overall Study|the device is too small for the patient.|0|||
155138575|NCT02687581|559939233|FG003|Overall Study|the device is too small for the patient.|0|||
155138576|NCT01019369|559939235|FG000|Overall Study|Lost to Follow-up|10|||
155138577|NCT01019369|559939236|FG001|Overall Study|Lost to Follow-up|6|||
155138578|NCT01019369|559939235|FG000|Overall Study|Withdrawal by Subject|0|||
155138579|NCT01019369|559939236|FG001|Overall Study|Withdrawal by Subject|1|||
155138580|NCT01098305|559939237|FG000|Overall Study|Lost to Follow-up|31|||
155138581|NCT01098305|559939238|FG001|Overall Study|Lost to Follow-up|33|||
155138582|NCT01711645|559939239|FG000|Overall Study|Withdrawal by Subject|8|||
155138583|NCT01711645|559939239|FG000|Overall Study|Lost to Follow-up|6|||
155138584|NCT01711645|559939239|FG000|Overall Study|Physician Decision|5|||
155138585|NCT01746173|559939244|FG000|Overall Study|Disease Progression|2|||
155138586|NCT00172042|559939245|FG000|Overall Study|Adverse Event|27|||
155138587|NCT00172042|559939246|FG001|Overall Study|Adverse Event|13|||
155138588|NCT00172042|559939245|FG000|Overall Study|Abnormal laboratory value(s)|5|||
155138589|NCT00172042|559939246|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155138590|NCT00172042|559939245|FG000|Overall Study|Abnormal test procedure(s)|0|||
155138591|NCT00172042|559939246|FG001|Overall Study|Abnormal test procedure(s)|3|||
155138592|NCT00172042|559939245|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
155138593|NCT00172042|559939246|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
155138594|NCT00172042|559939245|FG000|Overall Study|Patient no longer requires study drug|10|||
155138595|NCT00172042|559939246|FG001|Overall Study|Patient no longer requires study drug|8|||
155138596|NCT00172042|559939245|FG000|Overall Study|Protocol Violation|8|||
155138597|NCT00172042|559939246|FG001|Overall Study|Protocol Violation|7|||
155138598|NCT00172042|559939245|FG000|Overall Study|Withdrawal by Subject|37|||
155138599|NCT00172042|559939246|FG001|Overall Study|Withdrawal by Subject|25|||
155138600|NCT00172042|559939245|FG000|Overall Study|Lost to Follow-up|3|||
155178923|NCT00952380|560093459|FG001|Overall Study|Physician Decision|0|||
155178924|NCT00952380|560093460|FG002|Overall Study|Physician Decision|1|||
155178925|NCT00952380|560093461|FG003|Overall Study|Physician Decision|2|||
155178926|NCT00952380|560093462|FG004|Overall Study|Physician Decision|0|||
155178927|NCT00952380|560093458|FG000|Overall Study|Non-compliant to protocol|0|||
155178928|NCT00952380|560093459|FG001|Overall Study|Non-compliant to protocol|0|||
155178929|NCT00952380|560093460|FG002|Overall Study|Non-compliant to protocol|0|||
155178930|NCT00952380|560093461|FG003|Overall Study|Non-compliant to protocol|1|||
155178931|NCT00952380|560093462|FG004|Overall Study|Non-compliant to protocol|0|||
155178932|NCT00492063|560093464|FG000|Overall Study|Death|0|||
155178933|NCT00492063|560093465|FG001|Overall Study|Death|0|||
155178934|NCT00492063|560093466|FG002|Overall Study|Death|1|||
155178935|NCT00492063|560093467|FG003|Overall Study|Death|2|||
155178936|NCT00492063|560093464|FG000|Overall Study|Withdrawal by Subject|4|||
155178937|NCT00492063|560093465|FG001|Overall Study|Withdrawal by Subject|3|||
155015877|NCT00848718|559482490|FG011|Overall Study|Progressive disease during treatment|0|||
155138601|NCT00172042|559939246|FG001|Overall Study|Lost to Follow-up|5|||
155138602|NCT00172042|559939245|FG000|Overall Study|Administrative problems|13|||
155138603|NCT00172042|559939246|FG001|Overall Study|Administrative problems|10|||
155138604|NCT00172042|559939245|FG000|Overall Study|Death|42|||
155138605|NCT00172042|559939246|FG001|Overall Study|Death|42|||
155138606|NCT01278797|559939247|FG000|Period 1|Adverse Event|0|||
155138607|NCT01278797|559939248|FG001|Period 1|Adverse Event|1|||
155138608|NCT01278797|559939247|FG000|Period 1|Protocol Violation|1|||
155138609|NCT01278797|559939248|FG001|Period 1|Protocol Violation|0|||
155138610|NCT00588354|559939249|FG000|Baseline to 2 Weeks|Adverse Event|1|||
155138611|NCT00588354|559939250|FG001|Baseline to 2 Weeks|Adverse Event|0|||
155138612|NCT00588354|559939249|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
155138613|NCT00588354|559939250|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
155138614|NCT00588354|559939249|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
155138615|NCT00588354|559939250|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
155138616|NCT04522141|559939251|FG000|Overall Study|Withdrawal by Subject|1|||
155138617|NCT04522141|559939252|FG001|Overall Study|Withdrawal by Subject|0|||
155138618|NCT03052049|559939253|FG000|Overall Study|Withdrawal by Subject|2|||
155138619|NCT02328027|559939254|FG000|Overall Study|Withdrawal by Subject|0|||
155138620|NCT02328027|559939255|FG001|Overall Study|Withdrawal by Subject|1|||
155138621|NCT03304873|559939256|FG000|Overall Study|Lost to Follow-up|1|||
155138622|NCT03304873|559939257|FG001|Overall Study|Lost to Follow-up|8|||
155138623|NCT03319212|559939258|FG000|Overall Study|Discontinued as moving out of local area|0|||
155138624|NCT03319212|559939259|FG001|Overall Study|Discontinued as moving out of local area|1|||
155138625|NCT03319212|559939258|FG000|Overall Study|Adverse Event|2|||
155138626|NCT03319212|559939259|FG001|Overall Study|Adverse Event|2|||
155138627|NCT03319212|559939258|FG000|Overall Study|Withdrawal by Subject|0|||
155138628|NCT03319212|559939259|FG001|Overall Study|Withdrawal by Subject|1|||
155138629|NCT03319212|559939258|FG000|Overall Study|Lost to Follow-up|0|||
155138630|NCT03319212|559939259|FG001|Overall Study|Lost to Follow-up|1|||
155138631|NCT03319212|559939258|FG000|Overall Study|Physician Decision|1|||
155138632|NCT03319212|559939259|FG001|Overall Study|Physician Decision|0|||
155138633|NCT04230213|559939268|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
155138634|NCT04230213|559939269|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
155138635|NCT04230213|559939270|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
155138636|NCT04230213|559939268|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
155138637|NCT04230213|559939269|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
155138638|NCT04230213|559939270|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
155138639|NCT04230213|559939268|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
155138640|NCT04230213|559939269|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
155138641|NCT04230213|559939270|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
155138642|NCT04230213|559939268|FG000|TP2: Week 10 to Week 16|Other|0|||
155138643|NCT04230213|559939269|FG001|TP2: Week 10 to Week 16|Other|2|||
155138644|NCT04230213|559939270|FG002|TP2: Week 10 to Week 16|Other|1|||
155138645|NCT04230213|559939268|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
155138646|NCT04230213|559939269|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
155138647|NCT04230213|559939270|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
155138648|NCT04230213|559939268|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
155138649|NCT04230213|559939269|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
155138650|NCT04230213|559939270|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
155138651|NCT04230213|559939268|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
155138652|NCT04230213|559939269|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
155138653|NCT04230213|559939270|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
155138654|NCT04230213|559939268|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
155138655|NCT04230213|559939269|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
155138656|NCT04230213|559939270|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
155138657|NCT04230213|559939268|FG000|TP3: Week 16 to Week 22|Other|0|||
155138658|NCT04230213|559939269|FG001|TP3: Week 16 to Week 22|Other|1|||
155178938|NCT00492063|560093466|FG002|Overall Study|Withdrawal by Subject|5|||
155178939|NCT00492063|560093467|FG003|Overall Study|Withdrawal by Subject|4|||
155178940|NCT00492063|560093464|FG000|Overall Study|Lost to Follow-up|6|||
155178941|NCT00492063|560093465|FG001|Overall Study|Lost to Follow-up|11|||
155178942|NCT00492063|560093466|FG002|Overall Study|Lost to Follow-up|5|||
155178943|NCT00492063|560093467|FG003|Overall Study|Lost to Follow-up|3|||
155178944|NCT00492063|560093464|FG000|Overall Study|Protocol Violation|0|||
155178945|NCT00492063|560093465|FG001|Overall Study|Protocol Violation|0|||
155178946|NCT00492063|560093466|FG002|Overall Study|Protocol Violation|0|||
155178947|NCT00492063|560093467|FG003|Overall Study|Protocol Violation|1|||
155178948|NCT04085367|560094936|FG000|Overall Study|Adverse Event|1|||
155178949|NCT04085367|560094937|FG001|Overall Study|Adverse Event|1|||
155178950|NCT04085367|560094936|FG000|Overall Study|Withdrawal by Subject|13|||
155178951|NCT04085367|560094937|FG001|Overall Study|Withdrawal by Subject|4|||
155178952|NCT04085367|560094936|FG000|Overall Study|Lost to Follow-up|3|||
155178953|NCT04085367|560094937|FG001|Overall Study|Lost to Follow-up|1|||
155178954|NCT04085367|560094936|FG000|Overall Study|Other unspecified|2|||
155178955|NCT04085367|560094937|FG001|Overall Study|Other unspecified|1|||
155178956|NCT04085367|560094936|FG000|Overall Study|Status Unknown|1|||
155178957|NCT04085367|560094937|FG001|Overall Study|Status Unknown|1|||
155178958|NCT00130442|560094938|FG000|Overall Study|Withdrawal by Subject|0|||
155178959|NCT00130442|560094939|FG001|Overall Study|Withdrawal by Subject|1|||
155178960|NCT00130442|560094938|FG000|Overall Study|did not meet criteria|1|||
155178961|NCT00130442|560094939|FG001|Overall Study|did not meet criteria|1|||
155178962|NCT00814333|560094940|FG000|Enrollment|Lost to Follow-up|1|||
155178963|NCT00814333|560094941|FG001|Enrollment|Lost to Follow-up|0|||
155178964|NCT02233946|560094942|FG000|Baseline|Withdrawal by Subject|2|||
155178965|NCT02233946|560094943|FG001|Baseline|Withdrawal by Subject|0|||
155178966|NCT02233946|560094942|FG000|3-months Follow-up|Lost to Follow-up|53|||
155178967|NCT02233946|560094943|FG001|3-months Follow-up|Lost to Follow-up|29|||
155178968|NCT02233946|560094942|FG000|6-months Follow-up|Lost to Follow-up|21|||
155178969|NCT02233946|560094943|FG001|6-months Follow-up|Lost to Follow-up|2|||
155178970|NCT02233946|560094942|FG000|9-month Follow-up|Lost to Follow-up|20|||
155178971|NCT02233946|560094943|FG001|9-month Follow-up|Lost to Follow-up|11|||
155178972|NCT02233946|560094942|FG000|12-month Follow-up|Lost to Follow-up|28|||
155178973|NCT02233946|560094943|FG001|12-month Follow-up|Lost to Follow-up|11|||
155178974|NCT00910247|560094944|FG000|Overall Study|Adverse Event|15|||
155178975|NCT00910247|560094944|FG000|Overall Study|Death|2|||
155178976|NCT00910247|560094944|FG000|Overall Study|Lost to Follow-up|10|||
155178977|NCT00910247|560094944|FG000|Overall Study|Physician Decision|3|||
155178978|NCT00910247|560094944|FG000|Overall Study|Protocol Violation|10|||
155178979|NCT00910247|560094944|FG000|Overall Study|Withdrawal by Subject|25|||
155178980|NCT00910247|560094944|FG000|Overall Study|Not collected|4|||
155178981|NCT02927067|560094945|FG000|Overall Study|Withdrawn Consent|20|||
155178982|NCT02927067|560094946|FG001|Overall Study|Withdrawn Consent|12|||
155178983|NCT02927067|560094945|FG000|Overall Study|Death|18|||
155178984|NCT02927067|560094946|FG001|Overall Study|Death|31|||
155178985|NCT02927067|560094945|FG000|Overall Study|Adverse Event|13|||
155178986|NCT02927067|560094946|FG001|Overall Study|Adverse Event|10|||
155178987|NCT02927067|560094945|FG000|Overall Study|Noncompliance|5|||
155178988|NCT02927067|560094946|FG001|Overall Study|Noncompliance|2|||
155178989|NCT02927067|560094945|FG000|Overall Study|Reason not Specified|4|||
155178990|NCT02927067|560094946|FG001|Overall Study|Reason not Specified|6|||
155178991|NCT02292784|560094949|FG000|Overall Study|Lost to Follow-up|1|||
155178992|NCT02292784|560094950|FG001|Overall Study|Lost to Follow-up|17|||
155178993|NCT02292784|560094951|FG002|Overall Study|Lost to Follow-up|18|||
155178994|NCT02292784|560094949|FG000|Overall Study|Withdrawal by Subject|0|||
155178995|NCT02292784|560094950|FG001|Overall Study|Withdrawal by Subject|3|||
155178996|NCT02292784|560094951|FG002|Overall Study|Withdrawal by Subject|3|||
155178997|NCT00622739|560094952|FG000|Overall Study|Physician Decision|1|||
155178998|NCT00622739|560094953|FG001|Overall Study|Physician Decision|0|||
155178999|NCT00622739|560094952|FG000|Overall Study|Adverse Event|1|||
155179000|NCT00622739|560094953|FG001|Overall Study|Adverse Event|2|||
155179001|NCT00622739|560094952|FG000|Overall Study|Lack of Efficacy|0|||
155179002|NCT00622739|560094953|FG001|Overall Study|Lack of Efficacy|2|||
155179003|NCT00622739|560094952|FG000|Overall Study|Withdrawal by Subject|0|||
155179004|NCT00622739|560094953|FG001|Overall Study|Withdrawal by Subject|1|||
155179005|NCT00622739|560094952|FG000|Overall Study|Lost to Follow-up|0|||
155179006|NCT00622739|560094953|FG001|Overall Study|Lost to Follow-up|1|||
155179007|NCT00134784|560094954|FG000|Overall Study|Withdrawal by Subject|2|||
155179008|NCT00134784|560094955|FG001|Overall Study|Withdrawal by Subject|2|||
155179009|NCT00134784|560094956|FG002|Overall Study|Withdrawal by Subject|2|||
155179010|NCT00134784|560094957|FG003|Overall Study|Withdrawal by Subject|1|||
155179011|NCT02519855|560094958|FG000|Overall Study|Adverse Event|0|||
155179012|NCT02519855|560094959|FG001|Overall Study|Adverse Event|1|||
155179013|NCT02519855|560094958|FG000|Overall Study|Lost to Follow-up|3|||
155179014|NCT02519855|560094959|FG001|Overall Study|Lost to Follow-up|3|||
155179015|NCT01099709|560094962|FG000|Period 1|Withdrawal by Subject|0|||
155179016|NCT01099709|560094963|FG001|Period 1|Withdrawal by Subject|1|||
155138659|NCT04230213|559939270|FG002|TP3: Week 16 to Week 22|Other|3|||
155138660|NCT04230213|559939268|FG000|TP4: Week 22 to Week 32|Other|0|||
155138661|NCT04230213|559939269|FG001|TP4: Week 22 to Week 32|Other|5|||
155138662|NCT04230213|559939270|FG002|TP4: Week 22 to Week 32|Other|5|||
155138663|NCT04230213|559939268|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
155138664|NCT04230213|559939269|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
155138665|NCT04230213|559939270|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
155138666|NCT04230213|559939268|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
155138667|NCT04230213|559939269|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
155138668|NCT04230213|559939270|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
155138669|NCT04230213|559939268|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
155138670|NCT04230213|559939269|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
155138671|NCT04230213|559939270|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
155138672|NCT04230213|559939268|FG000|Follow up: Week 32 to Week 36|Other|0|||
155138673|NCT04230213|559939269|FG001|Follow up: Week 32 to Week 36|Other|1|||
155138674|NCT04230213|559939270|FG002|Follow up: Week 32 to Week 36|Other|1|||
155138675|NCT00534976|559939290|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
155138676|NCT00534976|559939291|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
155138677|NCT00534976|559939290|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
155138678|NCT00534976|559939291|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
155138679|NCT00534976|559939290|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
155138680|NCT00534976|559939291|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
155138681|NCT00861471|559939292|FG000|Overall Study|Withdrawal by Subject|1|||
155138682|NCT00861471|559939292|FG000|Overall Study|Adverse Event|2|||
155138683|NCT00861471|559939292|FG000|Overall Study|Lack of Efficacy|3|||
155138684|NCT00861471|559939292|FG000|Overall Study|treatment for lumbar laminectomy|1|||
155138685|NCT00861471|559939292|FG000|Overall Study|Physician Decision|2|||
155138686|NCT02092025|559939293|FG000|Overall Study|Case Report Forms Uncollected|44|||
155138687|NCT02092025|559939293|FG000|Overall Study|Protocol Deviation|24|||
155138688|NCT02927938|559939294|FG000|Overall Study|Death|0|||
155138689|NCT02927938|559939295|FG001|Overall Study|Death|1|||
155138690|NCT02927938|559939296|FG002|Overall Study|Death|0|||
155138691|NCT02927938|559939297|FG003|Overall Study|Death|4|||
155138692|NCT02927938|559939294|FG000|Overall Study|Early Study Termination|1|||
155138693|NCT02927938|559939295|FG001|Overall Study|Early Study Termination|5|||
155138694|NCT02927938|559939296|FG002|Overall Study|Early Study Termination|4|||
155138695|NCT02927938|559939297|FG003|Overall Study|Early Study Termination|3|||
155138696|NCT00806988|559940506|FG000|Overall Study|Death|15|||
155138697|NCT00806988|559940507|FG001|Overall Study|Death|16|||
155138698|NCT00806988|559940506|FG000|Overall Study|Withdrawal by Subject|8|||
155138699|NCT00806988|559940507|FG001|Overall Study|Withdrawal by Subject|8|||
155138700|NCT00806988|559940506|FG000|Overall Study|Lost to Follow-up|4|||
155138701|NCT00806988|559940507|FG001|Overall Study|Lost to Follow-up|19|||
155138702|NCT00108862|559940515|FG000|Overall Study|Death|31|||
155138703|NCT00108862|559940516|FG001|Overall Study|Death|37|||
155138704|NCT00108862|559940515|FG000|Overall Study|Withdrawal by Subject|10|||
155138705|NCT00108862|559940516|FG001|Overall Study|Withdrawal by Subject|6|||
155138706|NCT00108862|559940515|FG000|Overall Study|Lost to Follow-up|27|||
155138707|NCT00108862|559940516|FG001|Overall Study|Lost to Follow-up|19|||
155138708|NCT01746368|559940518|FG000|Overall Study|Lost to Follow-up|2|||
155138709|NCT01746368|559940519|FG001|Overall Study|Lost to Follow-up|0|||
155138710|NCT01746368|559940518|FG000|Overall Study|Withdrawal by Subject|0|||
155138711|NCT01746368|559940519|FG001|Overall Study|Withdrawal by Subject|1|||
155138712|NCT01076036|559940520|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
155138713|NCT01147055|559940521|FG000|First Intervention Period|Lost to Follow-up|1|||
155138714|NCT01147055|559940522|FG001|First Intervention Period|Lost to Follow-up|0|||
155138715|NCT02576795|559940525|FG000|Overall Study|Lost to Follow-up|0|||
155138716|NCT02576795|559940526|FG001|Overall Study|Lost to Follow-up|0|||
155138717|NCT02576795|559940527|FG002|Overall Study|Lost to Follow-up|1|||
155138718|NCT02576795|559940528|FG003|Overall Study|Lost to Follow-up|0|||
155138719|NCT01702246|559940529|FG000|Overall Study|Lost to Follow-up|2|||
155138720|NCT01702246|559940529|FG000|Overall Study|Withdrawal by Subject|2|||
155138721|NCT01702246|559940529|FG000|Overall Study|Physician Decision|1|||
155138722|NCT01518374|559940530|FG000|Overall Study|Withdrawal by Subject|2|||
155138723|NCT01518374|559940530|FG000|Overall Study|Protocol Violation|3|||
155138724|NCT01518374|559940530|FG000|Overall Study|Lost to Follow-up|2|||
155138725|NCT02123823|559940531|FG000|Overall Study|Lack of Efficacy|0|||
155138726|NCT02123823|559940532|FG001|Overall Study|Lack of Efficacy|2|||
155138727|NCT02123823|559940533|FG002|Overall Study|Lack of Efficacy|8|||
155138728|NCT02123823|559940534|FG003|Overall Study|Lack of Efficacy|10|||
155138729|NCT02123823|559940531|FG000|Overall Study|Progressive disease|3|||
155138730|NCT02123823|559940532|FG001|Overall Study|Progressive disease|19|||
155138731|NCT02123823|559940533|FG002|Overall Study|Progressive disease|52|||
155138732|NCT02123823|559940534|FG003|Overall Study|Progressive disease|53|||
155138733|NCT02123823|559940531|FG000|Overall Study|Withdrawal by Subject|0|||
155138734|NCT02123823|559940532|FG001|Overall Study|Withdrawal by Subject|0|||
155015878|NCT00848718|559482491|FG012|Overall Study|Progressive disease during treatment|2|||
155015879|NCT03668119|559484798|FG000|Pre-treatment|Disease Progression|1|||
155015880|NCT03668119|559484799|FG001|Pre-treatment|Disease Progression|0|||
155015881|NCT03668119|559484798|FG000|Treatment|Disease Progression|76|||
155015882|NCT03668119|559484799|FG001|Treatment|Disease Progression|57|||
155015883|NCT03668119|559484798|FG000|Treatment|Study drug toxicity|19|||
155015884|NCT03668119|559484799|FG001|Treatment|Study drug toxicity|1|||
155015885|NCT03668119|559484798|FG000|Treatment|Death|3|||
155015886|NCT03668119|559484799|FG001|Treatment|Death|0|||
155015887|NCT03668119|559484798|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
155015888|NCT03668119|559484799|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
155015889|NCT03668119|559484798|FG000|Treatment|Withdrawal by Subject|1|||
155138735|NCT02123823|559940533|FG002|Overall Study|Withdrawal by Subject|7|||
155138736|NCT02123823|559940534|FG003|Overall Study|Withdrawal by Subject|2|||
155138737|NCT02123823|559940531|FG000|Overall Study|Adverse Event|0|||
155138738|NCT02123823|559940532|FG001|Overall Study|Adverse Event|0|||
155138739|NCT02123823|559940533|FG002|Overall Study|Adverse Event|3|||
155138740|NCT02123823|559940534|FG003|Overall Study|Adverse Event|5|||
155138741|NCT00465452|559940544|FG000|Overall Study|Adverse Event|1|||
155138742|NCT01635855|559940578|FG000|Overall Study|Withdrawal by Subject|4|||
155138743|NCT04677504|559940588|FG000|Overall Study|Death|51|||
155138744|NCT04677504|559940589|FG001|Overall Study|Death|49|||
155138745|NCT04677504|559940588|FG000|Overall Study|Progressive Disease|1|||
155138746|NCT04677504|559940589|FG001|Overall Study|Progressive Disease|0|||
155138747|NCT04677504|559940588|FG000|Overall Study|Symptomatic Deterioration|1|||
155138748|NCT04677504|559940589|FG001|Overall Study|Symptomatic Deterioration|0|||
155138749|NCT04677504|559940588|FG000|Overall Study|Withdrawal by Subject|2|||
155138750|NCT04677504|559940589|FG001|Overall Study|Withdrawal by Subject|5|||
155138751|NCT04677504|559940588|FG000|Overall Study|Study Terminated By Sponsor|28|||
155138752|NCT04677504|559940589|FG001|Overall Study|Study Terminated By Sponsor|24|||
155138753|NCT04677504|559940588|FG000|Overall Study|Adverse Event|0|||
155138754|NCT04677504|559940589|FG001|Overall Study|Adverse Event|1|||
155138755|NCT03182907|559940590|FG000|Overall Study|Death|3|||
155138756|NCT03182907|559940591|FG001|Overall Study|Death|0|||
155138757|NCT03182907|559940590|FG000|Overall Study|Protocol Violation|4|||
155138758|NCT03182907|559940591|FG001|Overall Study|Protocol Violation|0|||
155138759|NCT03182907|559940590|FG000|Overall Study|Lost to Follow-up|1|||
155138760|NCT03182907|559940591|FG001|Overall Study|Lost to Follow-up|0|||
155138761|NCT03182907|559940590|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155138762|NCT03182907|559940591|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
155138763|NCT00384332|559940594|FG000|Overall Study|Lost to Follow-up|4|||
155138764|NCT00384332|559940595|FG001|Overall Study|Lost to Follow-up|0|||
155138765|NCT01771250|559940596|FG000|Period 1|Met exclusion criteria|1|||
155138766|NCT01771250|559940597|FG001|Period 1|Met exclusion criteria|0|||
155138767|NCT02058563|559940598|FG000|Overall Study|Lost to Follow-up|26|||
155138768|NCT02058563|559940599|FG001|Overall Study|Lost to Follow-up|22|||
155138769|NCT02058563|559940598|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
155138770|NCT02058563|559940599|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
155138771|NCT02058563|559940598|FG000|Overall Study|Consent Withdrawal|1|||
155138772|NCT02058563|559940599|FG001|Overall Study|Consent Withdrawal|1|||
155138773|NCT02058563|559940598|FG000|Overall Study|Other (patient incarcerated)|0|||
155138774|NCT02058563|559940599|FG001|Overall Study|Other (patient incarcerated)|1|||
155138775|NCT04039217|559940602|FG000|Overall Study|Lost to Follow-up|1|||
155138776|NCT00106353|559940603|FG000|Part 1|Disease progression|3|||
155138777|NCT00106353|559940604|FG001|Part 1|Disease progression|4|||
155138778|NCT00106353|559940605|FG002|Part 1|Disease progression|1|||
155138779|NCT00106353|559940606|FG003|Part 1|Disease progression|3|||
155138780|NCT00106353|559940607|FG004|Part 1|Disease progression|0|||
155138781|NCT00106353|559940608|FG005|Part 1|Disease progression|0|||
155138782|NCT00106353|559940609|FG006|Part 1|Disease progression|0|||
155138783|NCT00106353|559940603|FG000|Part 1|Withdrawal by Subject|0|||
155138784|NCT00106353|559940604|FG001|Part 1|Withdrawal by Subject|0|||
155138785|NCT00106353|559940605|FG002|Part 1|Withdrawal by Subject|1|||
155138786|NCT00106353|559940606|FG003|Part 1|Withdrawal by Subject|2|||
155138787|NCT00106353|559940607|FG004|Part 1|Withdrawal by Subject|0|||
155015890|NCT03668119|559484799|FG001|Treatment|Withdrawal by Subject|1|||
155015891|NCT03668119|559484798|FG000|Treatment|Participant request to discontinue study treatment|3|||
155015892|NCT03668119|559484799|FG001|Treatment|Participant request to discontinue study treatment|1|||
155015893|NCT03668119|559484798|FG000|Treatment|Maximum Clinical Benefit|0|||
155138788|NCT00106353|559940608|FG005|Part 1|Withdrawal by Subject|0|||
155138789|NCT00106353|559940609|FG006|Part 1|Withdrawal by Subject|0|||
155138790|NCT00106353|559940603|FG000|Part 1|Symptomatic deterioration|0|||
155138791|NCT00106353|559940604|FG001|Part 1|Symptomatic deterioration|0|||
155138792|NCT00106353|559940605|FG002|Part 1|Symptomatic deterioration|1|||
155138793|NCT00106353|559940606|FG003|Part 1|Symptomatic deterioration|0|||
155138794|NCT00106353|559940607|FG004|Part 1|Symptomatic deterioration|0|||
155138795|NCT00106353|559940608|FG005|Part 1|Symptomatic deterioration|0|||
155138796|NCT00106353|559940609|FG006|Part 1|Symptomatic deterioration|0|||
155138797|NCT00106353|559940603|FG000|Part 1|Entered follow-up phase|1|||
155179017|NCT01099709|560094962|FG000|Period 1|Positive cotinine test|0|||
155179018|NCT01099709|560094963|FG001|Period 1|Positive cotinine test|1|||
155179019|NCT01099709|560094962|FG000|Period 1|Adverse Event|1|||
155179020|NCT01099709|560094963|FG001|Period 1|Adverse Event|0|||
155179021|NCT00706849|560094970|FG000|Treatment Period|Adverse Event|0|||
155179022|NCT00706849|560094971|FG001|Treatment Period|Adverse Event|9|||
155179023|NCT00706849|560094970|FG000|Treatment Period|Other|0|||
155179024|NCT00706849|560094971|FG001|Treatment Period|Other|1|||
155179025|NCT00706849|560094970|FG000|Follow-up Period|Withdrawal by Subject|0|||
155179026|NCT00706849|560094971|FG001|Follow-up Period|Withdrawal by Subject|2|||
155179027|NCT00706849|560094970|FG000|Follow-up Period|Protocol non-compliance|0|||
155179028|NCT00706849|560094971|FG001|Follow-up Period|Protocol non-compliance|1|||
155179029|NCT01611454|560094972|FG000|Overall Study|Lack of Efficacy|18|||
155179030|NCT01611454|560094973|FG001|Overall Study|Lack of Efficacy|10|||
155179031|NCT00920907|560094975|FG000|Induction Period|Adverse Event|0|||
155179032|NCT00920907|560094976|FG001|Induction Period|Adverse Event|2|||
155179033|NCT00920907|560094975|FG000|Induction Period|Death|1|||
155179034|NCT00920907|560094976|FG001|Induction Period|Death|1|||
155179035|NCT00920907|560094975|FG000|Induction Period|Disease Progression|12|||
155179036|NCT00920907|560094976|FG001|Induction Period|Disease Progression|11|||
155179037|NCT00920907|560094975|FG000|Induction Period|Study Drug Toxicity|8|||
155179038|NCT00920907|560094976|FG001|Induction Period|Study Drug Toxicity|6|||
155179039|NCT00920907|560094975|FG000|Induction Period|No longer meets study criteria|0|||
155179040|NCT00920907|560094976|FG001|Induction Period|No longer meets study criteria|1|||
155179041|NCT00920907|560094975|FG000|Induction Period|Withdrawal by Subject|1|||
155179042|NCT00920907|560094976|FG001|Induction Period|Withdrawal by Subject|1|||
155179043|NCT00920907|560094975|FG000|Maintenance Period|Disease Progression|3|||
155179044|NCT00920907|560094976|FG001|Maintenance Period|Disease Progression|7|||
155179045|NCT00920907|560094975|FG000|Maintenance Period|Administrative (study closure)|7|||
155179046|NCT00920907|560094976|FG001|Maintenance Period|Administrative (study closure)|2|||
155179047|NCT00920907|560094975|FG000|Maintenance Period|Study Drug Toxicity|0|||
155179048|NCT00920907|560094976|FG001|Maintenance Period|Study Drug Toxicity|2|||
155179049|NCT00920907|560094975|FG000|Maintenance Period|Death|1|||
155179050|NCT00920907|560094976|FG001|Maintenance Period|Death|1|||
155179051|NCT00920907|560094975|FG000|Maintenance Period|Withdrawal by Subject|1|||
155179052|NCT00920907|560094976|FG001|Maintenance Period|Withdrawal by Subject|0|||
155179053|NCT00920907|560094975|FG000|Maintenance Period|Adverse Event|0|||
155179054|NCT00920907|560094976|FG001|Maintenance Period|Adverse Event|1|||
155179055|NCT02616601|560094977|FG000|Overall Study|Withdrawal by Subject|4|||
155179056|NCT02616601|560094978|FG001|Overall Study|Withdrawal by Subject|4|||
155179057|NCT02616601|560094979|FG002|Overall Study|Withdrawal by Subject|3|||
155179058|NCT02616601|560094977|FG000|Overall Study|Adverse Event|2|||
155179059|NCT02616601|560094978|FG001|Overall Study|Adverse Event|0|||
155179060|NCT02616601|560094979|FG002|Overall Study|Adverse Event|2|||
155179061|NCT02616601|560094977|FG000|Overall Study|Death|1|||
155179062|NCT02616601|560094978|FG001|Overall Study|Death|0|||
155179063|NCT02616601|560094979|FG002|Overall Study|Death|0|||
155179064|NCT02616601|560094977|FG000|Overall Study|Lost to Follow-up|1|||
155179065|NCT02616601|560094978|FG001|Overall Study|Lost to Follow-up|0|||
155179066|NCT02616601|560094979|FG002|Overall Study|Lost to Follow-up|1|||
155179067|NCT02616601|560094977|FG000|Overall Study|Non-Compliance with Test Article|1|||
155179068|NCT02616601|560094978|FG001|Overall Study|Non-Compliance with Test Article|0|||
155179069|NCT02616601|560094979|FG002|Overall Study|Non-Compliance with Test Article|1|||
155179070|NCT03718299|560094982|FG000|Overall Study|Adverse Event|1|||
155179071|NCT03718299|560094982|FG000|Overall Study|Withdrawal by Subject|6|||
155179072|NCT03718299|560094982|FG000|Overall Study|Physician Decision|2|||
155179073|NCT03718299|560094982|FG000|Overall Study|Lost to Follow-up|1|||
155179074|NCT04389970|560094983|FG000|Overall Study|Lost to Follow-up|1|||
155179075|NCT03123185|560094984|FG000|Overall Study|Withdrawal by Subject|0|||
155179076|NCT03123185|560094985|FG001|Overall Study|Withdrawal by Subject|0|||
155179077|NCT03123185|560094986|FG002|Overall Study|Withdrawal by Subject|0|||
155179078|NCT03123185|560094987|FG003|Overall Study|Withdrawal by Subject|0|||
155179079|NCT03123185|560094988|FG004|Overall Study|Withdrawal by Subject|0|||
155179080|NCT03123185|560094989|FG005|Overall Study|Withdrawal by Subject|0|||
155179081|NCT03123185|560094990|FG006|Overall Study|Withdrawal by Subject|0|||
155179082|NCT03123185|560094991|FG007|Overall Study|Withdrawal by Subject|0|||
155179083|NCT03123185|560094992|FG008|Overall Study|Withdrawal by Subject|0|||
155179084|NCT03123185|560094993|FG009|Overall Study|Withdrawal by Subject|0|||
155179085|NCT03123185|560094994|FG010|Overall Study|Withdrawal by Subject|0|||
155179086|NCT03123185|560094995|FG011|Overall Study|Withdrawal by Subject|0|||
155179087|NCT03123185|560094996|FG012|Overall Study|Withdrawal by Subject|1|||
155179088|NCT03123185|560094997|FG013|Overall Study|Withdrawal by Subject|0|||
155179089|NCT00718081|560095000|FG000|Overall Study|Adverse Event|0|||
155179090|NCT00718081|560095001|FG001|Overall Study|Adverse Event|1|||
155179091|NCT00718081|560095002|FG002|Overall Study|Adverse Event|0|||
155179092|NCT00718081|560095000|FG000|Overall Study|Lack of Efficacy|7|||
155179093|NCT00718081|560095001|FG001|Overall Study|Lack of Efficacy|3|||
155179094|NCT00718081|560095002|FG002|Overall Study|Lack of Efficacy|21|||
155015894|NCT03668119|559484799|FG001|Treatment|Maximum Clinical Benefit|1|||
155015895|NCT03668119|559484798|FG000|Treatment|Participants completed treatment|27|||
155015896|NCT03668119|559484799|FG001|Treatment|Participants completed treatment|11|||
155015897|NCT03668119|559484798|FG000|Treatment|Other reasons|2|||
155015898|NCT03668119|559484799|FG001|Treatment|Other reasons|1|||
155015899|NCT03769168|559484800|FG000|Overall Study|Adverse Event|0|||
155015900|NCT03769168|559484801|FG001|Overall Study|Adverse Event|1|||
155015901|NCT03769168|559484800|FG000|Overall Study|Lack of Efficacy|2|||
155015902|NCT03769168|559484801|FG001|Overall Study|Lack of Efficacy|4|||
155015903|NCT03769168|559484800|FG000|Overall Study|Post study access to treatment|3|||
155015904|NCT03769168|559484801|FG001|Overall Study|Post study access to treatment|11|||
155015905|NCT03769168|559484800|FG000|Overall Study|Physician Decision|1|||
155015906|NCT03769168|559484801|FG001|Overall Study|Physician Decision|4|||
155015907|NCT03769168|559484800|FG000|Overall Study|Subject Decision|2|||
155015908|NCT03769168|559484801|FG001|Overall Study|Subject Decision|4|||
155015909|NCT03769168|559484800|FG000|Overall Study|Guardian decision|1|||
155015910|NCT03769168|559484801|FG001|Overall Study|Guardian decision|0|||
155015911|NCT05336227|559484802|FG000|Overall Study|Adverse Event|1|||
155015912|NCT05336227|559484803|FG001|Overall Study|Adverse Event|0|||
155015913|NCT05336227|559484802|FG000|Overall Study|Lost to Follow-up|2|||
155015914|NCT05336227|559484803|FG001|Overall Study|Lost to Follow-up|0|||
155015915|NCT05336227|559484802|FG000|Overall Study|Withdrawal by Subject|1|||
155015916|NCT05336227|559484803|FG001|Overall Study|Withdrawal by Subject|0|||
155015917|NCT04050462|559484804|FG000|Overall Study|Withdrawal by Subject|1|||
155015918|NCT04050462|559484805|FG001|Overall Study|Withdrawal by Subject|0|||
155015919|NCT04050462|559484806|FG002|Overall Study|Withdrawal by Subject|0|||
155015920|NCT05151744|559484809|FG000|Overall Study|Adverse Event|6|||
155015921|NCT05151744|559484810|FG001|Overall Study|Adverse Event|2|||
155015922|NCT05151744|559484809|FG000|Overall Study|Death|1|||
155015923|NCT05151744|559484810|FG001|Overall Study|Death|2|||
155015924|NCT05151744|559484809|FG000|Overall Study|Lack of Efficacy|1|||
155015925|NCT05151744|559484810|FG001|Overall Study|Lack of Efficacy|1|||
155015926|NCT05151744|559484809|FG000|Overall Study|Lost to Follow-up|2|||
155015927|NCT05151744|559484810|FG001|Overall Study|Lost to Follow-up|2|||
155015928|NCT05151744|559484809|FG000|Overall Study|Need for Rescue Treatment|0|||
155015929|NCT05151744|559484810|FG001|Overall Study|Need for Rescue Treatment|1|||
155015930|NCT05151744|559484809|FG000|Overall Study|Non-compliance with Study Drug|0|||
155015931|NCT05151744|559484810|FG001|Overall Study|Non-compliance with Study Drug|1|||
155015932|NCT05151744|559484809|FG000|Overall Study|Reason not Specified|10|||
155015933|NCT05151744|559484810|FG001|Overall Study|Reason not Specified|0|||
155015934|NCT05151744|559484809|FG000|Overall Study|Physician Decision|2|||
155015935|NCT05151744|559484810|FG001|Overall Study|Physician Decision|1|||
155015936|NCT05151744|559484809|FG000|Overall Study|Protocol Violation|1|||
155015937|NCT05151744|559484810|FG001|Overall Study|Protocol Violation|0|||
155015938|NCT05151744|559484809|FG000|Overall Study|Withdrawal by Subject|6|||
155015939|NCT05151744|559484810|FG001|Overall Study|Withdrawal by Subject|3|||
155015940|NCT05228470|559484811|FG000|Overall Study|Death|6|||
155015941|NCT05228470|559484812|FG001|Overall Study|Death|11|||
155015942|NCT05228470|559484811|FG000|Overall Study|Withdrawal by Subject|1|||
155015943|NCT05228470|559484812|FG001|Overall Study|Withdrawal by Subject|8|||
155015944|NCT05228470|559484811|FG000|Overall Study|Ongoing|1|||
155015945|NCT05228470|559484812|FG001|Overall Study|Ongoing|11|||
155015946|NCT04053868|559484813|FG000|Overall Study|Withdrawal by Subject|1|||
155015947|NCT04053868|559484814|FG001|Overall Study|Withdrawal by Subject|0|||
155015948|NCT01068678|559484817|FG000|Overall Study|Lack of Efficacy|3|||
155015949|NCT01068678|559484818|FG001|Overall Study|Lack of Efficacy|2|||
155179095|NCT01931670|560095005|FG000|Treatment Period|Exclusionary Medication Received|1|||
155179096|NCT01931670|560095006|FG001|Treatment Period|Exclusionary Medication Received|1|||
155179097|NCT01931670|560095007|FG002|Treatment Period|Exclusionary Medication Received|1|||
155179098|NCT01931670|560095005|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
155179099|NCT01931670|560095006|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
155015950|NCT01068678|559484817|FG000|Overall Study|Protocol Violation|5|||
155015951|NCT01068678|559484818|FG001|Overall Study|Protocol Violation|1|||
155015952|NCT01068678|559484817|FG000|Overall Study|Withdrawal criteria|12|||
155015953|NCT01068678|559484818|FG001|Overall Study|Withdrawal criteria|6|||
155015954|NCT01068678|559484817|FG000|Overall Study|Unclassified|18|||
155015955|NCT01068678|559484818|FG001|Overall Study|Unclassified|15|||
155015956|NCT05468164|559484829|FG000|Treatment Period 4|Adverse Event|0|||
155015957|NCT05468164|559484830|FG001|Treatment Period 4|Adverse Event|0|||
155015958|NCT05468164|559484831|FG002|Treatment Period 4|Adverse Event|0|||
155015959|NCT05468164|559484832|FG003|Treatment Period 4|Adverse Event|1|||
155015960|NCT04795466|559484833|FG000|Overall Study|Adverse Event|3|||
155015961|NCT04795466|559484834|FG001|Overall Study|Adverse Event|1|||
155015962|NCT04795466|559484833|FG000|Overall Study|Physician Decision|1|||
155015963|NCT04795466|559484834|FG001|Overall Study|Physician Decision|0|||
155015964|NCT04795466|559484833|FG000|Overall Study|Withdrawal by Subject|2|||
155015965|NCT04795466|559484834|FG001|Overall Study|Withdrawal by Subject|1|||
155015966|NCT04652726|559484835|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
155015967|NCT04652726|559484836|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
155015968|NCT04652726|559484837|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
155015969|NCT04652726|559484835|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
155015970|NCT04652726|559484836|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
155015971|NCT04652726|559484837|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
155015972|NCT04066244|559484847|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
155015973|NCT04066244|559484848|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
155015974|NCT04066244|559484849|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
155015975|NCT04066244|559484850|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
155015976|NCT04066244|559484851|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
155015977|NCT04066244|559484852|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
155015978|NCT04066244|559484847|FG000|Part 2 (Cohort 5)|Death|0|||
155015979|NCT04066244|559484848|FG001|Part 2 (Cohort 5)|Death|0|||
155015980|NCT04066244|559484849|FG002|Part 2 (Cohort 5)|Death|0|||
155015981|NCT04066244|559484850|FG003|Part 2 (Cohort 5)|Death|0|||
155015982|NCT04066244|559484851|FG004|Part 2 (Cohort 5)|Death|0|||
155015983|NCT04066244|559484852|FG005|Part 2 (Cohort 5)|Death|2|||
155015984|NCT04066244|559484847|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155015985|NCT04066244|559484848|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155015986|NCT04066244|559484849|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155015987|NCT04066244|559484850|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155015988|NCT04066244|559484851|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
155015989|NCT04066244|559484852|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
155015990|NCT04066244|559484847|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155015991|NCT04066244|559484848|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155015992|NCT04066244|559484849|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155015993|NCT04066244|559484850|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155015994|NCT04066244|559484851|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
155015995|NCT04066244|559484852|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
155015996|NCT01467713|559484853|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
155015997|NCT01467713|559484854|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
155015998|NCT01467713|559484855|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
155015999|NCT01467713|559484856|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
155016000|NCT01467713|559484853|FG000|Overall Study|Major Protocol Deviation|2|||
155016001|NCT01467713|559484854|FG001|Overall Study|Major Protocol Deviation|4|||
155016002|NCT01467713|559484855|FG002|Overall Study|Major Protocol Deviation|4|||
155016003|NCT01467713|559484856|FG003|Overall Study|Major Protocol Deviation|1|||
155016004|NCT01467713|559484853|FG000|Overall Study|Lost to Follow-up|9|||
155016005|NCT01467713|559484854|FG001|Overall Study|Lost to Follow-up|12|||
155016006|NCT01467713|559484855|FG002|Overall Study|Lost to Follow-up|6|||
155016007|NCT01467713|559484856|FG003|Overall Study|Lost to Follow-up|9|||
155016008|NCT01467713|559484853|FG000|Overall Study|Voluntary Withdrawal|18|||
155016009|NCT01467713|559484854|FG001|Overall Study|Voluntary Withdrawal|14|||
155016010|NCT01467713|559484855|FG002|Overall Study|Voluntary Withdrawal|21|||
155016011|NCT01467713|559484856|FG003|Overall Study|Voluntary Withdrawal|20|||
155016012|NCT01467713|559484853|FG000|Overall Study|Study Termination|23|||
155016013|NCT01467713|559484854|FG001|Overall Study|Study Termination|33|||
155016014|NCT01467713|559484855|FG002|Overall Study|Study Termination|28|||
155016015|NCT01467713|559484856|FG003|Overall Study|Study Termination|29|||
155016016|NCT01467713|559484853|FG000|Overall Study|Pregnancy|0|||
155016017|NCT01467713|559484854|FG001|Overall Study|Pregnancy|1|||
155016018|NCT01467713|559484855|FG002|Overall Study|Pregnancy|1|||
155016019|NCT01467713|559484856|FG003|Overall Study|Pregnancy|3|||
155016020|NCT01467713|559484853|FG000|Overall Study|Relapse|35|||
155016021|NCT01467713|559484854|FG001|Overall Study|Relapse|25|||
155016022|NCT01467713|559484855|FG002|Overall Study|Relapse|28|||
155016023|NCT01467713|559484856|FG003|Overall Study|Relapse|35|||
155016024|NCT01467713|559484853|FG000|Overall Study|Reason not Specified|6|||
155016025|NCT01467713|559484854|FG001|Overall Study|Reason not Specified|11|||
155016026|NCT01467713|559484855|FG002|Overall Study|Reason not Specified|8|||
155016027|NCT01467713|559484856|FG003|Overall Study|Reason not Specified|7|||
155016028|NCT00866281|559484859|FG000|Overall Study|Adverse Event|1|||
155016029|NCT00866281|559484860|FG001|Overall Study|Adverse Event|0|||
155016030|NCT00866281|559484859|FG000|Overall Study|Withdrawal by participants|3|||
155138798|NCT00106353|559940604|FG001|Part 1|Entered follow-up phase|1|||
155016031|NCT00866281|559484860|FG001|Overall Study|Withdrawal by participants|0|||
155016032|NCT00866281|559484859|FG000|Overall Study|Disease progression|3|||
155016033|NCT00866281|559484860|FG001|Overall Study|Disease progression|11|||
155016034|NCT00866281|559484859|FG000|Overall Study|New cancer therapy|0|||
155016035|NCT00866281|559484860|FG001|Overall Study|New cancer therapy|4|||
155016036|NCT04225715|559484861|FG000|Overall Study|Reason not Specified|1|||
155016037|NCT04225715|559484862|FG001|Overall Study|Reason not Specified|0|||
155016038|NCT04225715|559484863|FG002|Overall Study|Reason not Specified|0|||
155016039|NCT04225715|559484864|FG003|Overall Study|Reason not Specified|0|||
155016040|NCT04225715|559484865|FG004|Overall Study|Reason not Specified|0|||
155016041|NCT04225715|559484866|FG005|Overall Study|Reason not Specified|0|||
155016042|NCT04225715|559484867|FG006|Overall Study|Reason not Specified|0|||
155016043|NCT04225715|559484868|FG007|Overall Study|Reason not Specified|0|||
155016044|NCT04225715|559484869|FG008|Overall Study|Reason not Specified|0|||
155016045|NCT04225715|559484861|FG000|Overall Study|Protocol Violation|1|||
155016046|NCT04225715|559484862|FG001|Overall Study|Protocol Violation|0|||
155016047|NCT04225715|559484863|FG002|Overall Study|Protocol Violation|0|||
155016048|NCT04225715|559484864|FG003|Overall Study|Protocol Violation|0|||
155016049|NCT04225715|559484865|FG004|Overall Study|Protocol Violation|0|||
155016050|NCT04225715|559484866|FG005|Overall Study|Protocol Violation|9|||
155016051|NCT04225715|559484867|FG006|Overall Study|Protocol Violation|0|||
155016052|NCT04225715|559484868|FG007|Overall Study|Protocol Violation|0|||
155016053|NCT04225715|559484869|FG008|Overall Study|Protocol Violation|0|||
155016054|NCT04225715|559484861|FG000|Overall Study|Withdrawal by Subject|4|||
155016055|NCT04225715|559484862|FG001|Overall Study|Withdrawal by Subject|1|||
155016056|NCT04225715|559484863|FG002|Overall Study|Withdrawal by Subject|1|||
155016057|NCT04225715|559484864|FG003|Overall Study|Withdrawal by Subject|0|||
155016058|NCT04225715|559484865|FG004|Overall Study|Withdrawal by Subject|3|||
155016059|NCT04225715|559484866|FG005|Overall Study|Withdrawal by Subject|1|||
155016060|NCT04225715|559484867|FG006|Overall Study|Withdrawal by Subject|1|||
155016061|NCT04225715|559484868|FG007|Overall Study|Withdrawal by Subject|1|||
155016062|NCT04225715|559484869|FG008|Overall Study|Withdrawal by Subject|0|||
155016063|NCT04225715|559484861|FG000|Overall Study|Adverse Event|0|||
155016064|NCT04225715|559484862|FG001|Overall Study|Adverse Event|0|||
155016065|NCT04225715|559484863|FG002|Overall Study|Adverse Event|0|||
155016066|NCT04225715|559484864|FG003|Overall Study|Adverse Event|0|||
155016067|NCT04225715|559484865|FG004|Overall Study|Adverse Event|0|||
155016068|NCT04225715|559484866|FG005|Overall Study|Adverse Event|0|||
155016069|NCT04225715|559484867|FG006|Overall Study|Adverse Event|0|||
155016070|NCT04225715|559484868|FG007|Overall Study|Adverse Event|0|||
155016071|NCT04225715|559484869|FG008|Overall Study|Adverse Event|1|||
155016072|NCT04225715|559484861|FG000|Overall Study|Arm Terminated By Sponsor|0|||
155138799|NCT00106353|559940605|FG002|Part 1|Entered follow-up phase|0|||
155138800|NCT00106353|559940606|FG003|Part 1|Entered follow-up phase|1|||
155138801|NCT00106353|559940607|FG004|Part 1|Entered follow-up phase|0|||
155138802|NCT00106353|559940608|FG005|Part 1|Entered follow-up phase|0|||
155138803|NCT00106353|559940609|FG006|Part 1|Entered follow-up phase|0|||
155138804|NCT00106353|559940603|FG000|Part 1|Adverse Event|0|||
155138805|NCT00106353|559940604|FG001|Part 1|Adverse Event|0|||
155138806|NCT00106353|559940605|FG002|Part 1|Adverse Event|0|||
155138807|NCT00106353|559940606|FG003|Part 1|Adverse Event|1|||
155138808|NCT00106353|559940607|FG004|Part 1|Adverse Event|0|||
155138809|NCT00106353|559940608|FG005|Part 1|Adverse Event|0|||
155138810|NCT00106353|559940609|FG006|Part 1|Adverse Event|0|||
155138811|NCT00106353|559940603|FG000|Part 2|Disease progression|0|||
155138812|NCT00106353|559940604|FG001|Part 2|Disease progression|0|||
155138813|NCT00106353|559940605|FG002|Part 2|Disease progression|0|||
155138814|NCT00106353|559940606|FG003|Part 2|Disease progression|0|||
155138815|NCT00106353|559940607|FG004|Part 2|Disease progression|8|||
155138816|NCT00106353|559940608|FG005|Part 2|Disease progression|14|||
155138817|NCT00106353|559940609|FG006|Part 2|Disease progression|13|||
155138818|NCT00106353|559940603|FG000|Part 2|Death|0|||
155138819|NCT00106353|559940604|FG001|Part 2|Death|0|||
155138820|NCT00106353|559940605|FG002|Part 2|Death|0|||
155138821|NCT00106353|559940606|FG003|Part 2|Death|0|||
155138822|NCT00106353|559940607|FG004|Part 2|Death|3|||
155138823|NCT00106353|559940608|FG005|Part 2|Death|0|||
155138824|NCT00106353|559940609|FG006|Part 2|Death|1|||
155138825|NCT00106353|559940603|FG000|Part 2|Symptomatic deterioration|0|||
155138826|NCT00106353|559940604|FG001|Part 2|Symptomatic deterioration|0|||
155138827|NCT00106353|559940605|FG002|Part 2|Symptomatic deterioration|0|||
155138828|NCT00106353|559940606|FG003|Part 2|Symptomatic deterioration|0|||
155138829|NCT00106353|559940607|FG004|Part 2|Symptomatic deterioration|3|||
155138830|NCT00106353|559940608|FG005|Part 2|Symptomatic deterioration|0|||
155138831|NCT00106353|559940609|FG006|Part 2|Symptomatic deterioration|0|||
155138832|NCT00106353|559940603|FG000|Part 2|Adverse Event|0|||
155138833|NCT00106353|559940604|FG001|Part 2|Adverse Event|0|||
155138834|NCT00106353|559940605|FG002|Part 2|Adverse Event|0|||
155138835|NCT00106353|559940606|FG003|Part 2|Adverse Event|0|||
155138836|NCT00106353|559940607|FG004|Part 2|Adverse Event|0|||
155138837|NCT00106353|559940608|FG005|Part 2|Adverse Event|2|||
155138838|NCT00106353|559940609|FG006|Part 2|Adverse Event|1|||
155138839|NCT00106353|559940603|FG000|Part 2|Other|0|||
155138840|NCT00106353|559940604|FG001|Part 2|Other|0|||
155138841|NCT00106353|559940605|FG002|Part 2|Other|0|||
155179100|NCT01931670|560095007|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
155016073|NCT04225715|559484862|FG001|Overall Study|Arm Terminated By Sponsor|0|||
155016074|NCT04225715|559484863|FG002|Overall Study|Arm Terminated By Sponsor|0|||
155016075|NCT04225715|559484864|FG003|Overall Study|Arm Terminated By Sponsor|0|||
155016076|NCT04225715|559484865|FG004|Overall Study|Arm Terminated By Sponsor|0|||
155016077|NCT04225715|559484866|FG005|Overall Study|Arm Terminated By Sponsor|0|||
155138842|NCT00106353|559940606|FG003|Part 2|Other|0|||
155138843|NCT00106353|559940607|FG004|Part 2|Other|1|||
155138844|NCT00106353|559940608|FG005|Part 2|Other|1|||
155138845|NCT00106353|559940609|FG006|Part 2|Other|1|||
155016078|NCT04225715|559484867|FG006|Overall Study|Arm Terminated By Sponsor|0|||
155016079|NCT04225715|559484868|FG007|Overall Study|Arm Terminated By Sponsor|17|||
155016080|NCT04225715|559484869|FG008|Overall Study|Arm Terminated By Sponsor|18|||
155016081|NCT02275546|559484872|FG000|Treatment Period 2|Withdrawal by Subject|2|||
155016082|NCT02275546|559484873|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155016083|NCT02275546|559484872|FG000|Treatment Period 2|Protocol Violation|0|||
155016084|NCT02275546|559484873|FG001|Treatment Period 2|Protocol Violation|1|||
155016085|NCT02955355|559484882|FG000|Overall Study|Adverse Event|4|||
155016086|NCT02955355|559484882|FG000|Overall Study|Death|1|||
155016087|NCT02955355|559484882|FG000|Overall Study|Physician Decision|21|||
155016088|NCT02955355|559484882|FG000|Overall Study|Site Terminated by Sponsor|35|||
155016089|NCT02955355|559484882|FG000|Overall Study|Withdrawal by Subject|19|||
155016090|NCT02955355|559484882|FG000|Overall Study|Reason Not Specified|5|||
155016091|NCT02612623|559484883|FG000|Overall Study|Withdrawal by Subject|0|||
155016092|NCT02612623|559484884|FG001|Overall Study|Withdrawal by Subject|1|||
155016093|NCT02612623|559484885|FG002|Overall Study|Withdrawal by Subject|0|||
155016094|NCT02612623|559484886|FG003|Overall Study|Withdrawal by Subject|0|||
155016095|NCT02612623|559484883|FG000|Overall Study|Adverse Event|1|||
155016096|NCT02612623|559484884|FG001|Overall Study|Adverse Event|0|||
155016097|NCT02612623|559484885|FG002|Overall Study|Adverse Event|1|||
155016098|NCT02612623|559484886|FG003|Overall Study|Adverse Event|0|||
155016099|NCT00570141|559484891|FG000|Overall Study|Adverse Event|1|||
155016100|NCT00570141|559484891|FG000|Overall Study|Missed visits|1|||
155016101|NCT00570141|559484891|FG000|Overall Study|Lost to Follow-up|1|||
155016102|NCT04878432|559484894|FG000|Overall Study|Adverse Event|1|||
155016103|NCT04878432|559484894|FG000|Overall Study|Death|2|||
155016104|NCT04878432|559484894|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
155016105|NCT04878432|559484894|FG000|Overall Study|Withdrawal by Subject|6|||
155016106|NCT04878432|559484894|FG000|Overall Study|Progressive Disease|7|||
155016107|NCT04878432|559484894|FG000|Overall Study|New Therapy for Study Indication|7|||
155016108|NCT04878432|559484894|FG000|Overall Study|Physician Decision|11|||
155016109|NCT03817853|559484895|FG000|Induction Phase|Adverse Event|5|||
155016110|NCT03817853|559484896|FG001|Induction Phase|Adverse Event|0|||
155016111|NCT03817853|559484897|FG002|Induction Phase|Adverse Event|0|||
155016112|NCT03817853|559484895|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
155016113|NCT03817853|559484896|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
155016114|NCT03817853|559484897|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
155016115|NCT03817853|559484895|FG000|Induction Phase|Physician Decision|2|||
155016116|NCT03817853|559484896|FG001|Induction Phase|Physician Decision|0|||
155016117|NCT03817853|559484897|FG002|Induction Phase|Physician Decision|0|||
155016118|NCT03817853|559484895|FG000|Induction Phase|Progressive Disease|6|||
155016119|NCT03817853|559484896|FG001|Induction Phase|Progressive Disease|0|||
155016120|NCT03817853|559484897|FG002|Induction Phase|Progressive Disease|0|||
155016121|NCT03817853|559484895|FG000|Induction Phase|Withdrawal by Subject|4|||
155016122|NCT03817853|559484896|FG001|Induction Phase|Withdrawal by Subject|0|||
155016123|NCT03817853|559484897|FG002|Induction Phase|Withdrawal by Subject|0|||
155016124|NCT03817853|559484895|FG000|Maintenance Phase|Adverse Event|0|||
155016125|NCT03817853|559484896|FG001|Maintenance Phase|Adverse Event|8|||
155016126|NCT03817853|559484897|FG002|Maintenance Phase|Adverse Event|0|||
155016127|NCT03817853|559484895|FG000|Maintenance Phase|Death|0|||
155016128|NCT03817853|559484896|FG001|Maintenance Phase|Death|5|||
155016129|NCT03817853|559484897|FG002|Maintenance Phase|Death|0|||
155016130|NCT03817853|559484895|FG000|Maintenance Phase|Progressive Disease|0|||
155016131|NCT03817853|559484896|FG001|Maintenance Phase|Progressive Disease|7|||
155016132|NCT03817853|559484897|FG002|Maintenance Phase|Progressive Disease|0|||
155016133|NCT03817853|559484895|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155016134|NCT03817853|559484896|FG001|Maintenance Phase|Withdrawal by Subject|2|||
155016135|NCT03817853|559484897|FG002|Maintenance Phase|Withdrawal by Subject|0|||
155016136|NCT03817853|559484895|FG000|Maintenance Phase|Physician Decision|0|||
155016137|NCT03817853|559484896|FG001|Maintenance Phase|Physician Decision|1|||
155016138|NCT03817853|559484897|FG002|Maintenance Phase|Physician Decision|0|||
155016139|NCT03817853|559484895|FG000|Maintenance Phase|Various reasons|0|||
155016140|NCT03817853|559484896|FG001|Maintenance Phase|Various reasons|4|||
155016141|NCT03817853|559484897|FG002|Maintenance Phase|Various reasons|0|||
155016142|NCT03817853|559484895|FG000|Maintenance Phase|Protocol Deviation|0|||
155016143|NCT03817853|559484896|FG001|Maintenance Phase|Protocol Deviation|1|||
155138846|NCT00106353|559940603|FG000|Part 2|Withdrawal by Subject|0|||
155016144|NCT03817853|559484897|FG002|Maintenance Phase|Protocol Deviation|0|||
155016145|NCT03817853|559484895|FG000|Follow-up Phase|Adverse Event|0|||
155016146|NCT03817853|559484896|FG001|Follow-up Phase|Adverse Event|0|||
155016147|NCT03817853|559484897|FG002|Follow-up Phase|Adverse Event|2|||
155016148|NCT03817853|559484895|FG000|Follow-up Phase|Death|0|||
155016149|NCT03817853|559484896|FG001|Follow-up Phase|Death|0|||
155016150|NCT03817853|559484897|FG002|Follow-up Phase|Death|1|||
155016151|NCT03817853|559484895|FG000|Follow-up Phase|Progressive Disease|0|||
155138847|NCT00106353|559940604|FG001|Part 2|Withdrawal by Subject|0|||
155016152|NCT03817853|559484896|FG001|Follow-up Phase|Progressive Disease|0|||
155016153|NCT03817853|559484897|FG002|Follow-up Phase|Progressive Disease|3|||
155179101|NCT01931670|560095005|FG000|Treatment Period|Subject Noncompliant|4|||
155179102|NCT01931670|560095006|FG001|Treatment Period|Subject Noncompliant|9|||
155179103|NCT01931670|560095007|FG002|Treatment Period|Subject Noncompliant|5|||
155179104|NCT01931670|560095005|FG000|Treatment Period|Adverse Event|19|||
155179105|NCT01931670|560095006|FG001|Treatment Period|Adverse Event|8|||
155179106|NCT01931670|560095007|FG002|Treatment Period|Adverse Event|21|||
155179107|NCT01931670|560095005|FG000|Treatment Period|Lack of Efficacy|11|||
155179108|NCT01931670|560095006|FG001|Treatment Period|Lack of Efficacy|2|||
155179109|NCT01931670|560095007|FG002|Treatment Period|Lack of Efficacy|2|||
155179110|NCT01931670|560095005|FG000|Treatment Period|Pregnancy|7|||
155179111|NCT01931670|560095006|FG001|Treatment Period|Pregnancy|2|||
155179112|NCT01931670|560095007|FG002|Treatment Period|Pregnancy|0|||
155179113|NCT01931670|560095005|FG000|Treatment Period|Other|8|||
155179114|NCT01931670|560095006|FG001|Treatment Period|Other|7|||
155179115|NCT01931670|560095007|FG002|Treatment Period|Other|2|||
155179116|NCT01931670|560095005|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
155179117|NCT01931670|560095006|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
155179118|NCT01931670|560095007|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
155179119|NCT01931670|560095005|FG000|Treatment Period|Lost to Follow-up|19|||
155016154|NCT03817853|559484895|FG000|Follow-up Phase|Withdrawal by Subject|0|||
155016155|NCT03817853|559484896|FG001|Follow-up Phase|Withdrawal by Subject|0|||
155016156|NCT03817853|559484897|FG002|Follow-up Phase|Withdrawal by Subject|1|||
155016157|NCT01256450|559484900|FG000|Open-label Titration|Adverse Event|39|||
155016158|NCT01256450|559484901|FG001|Open-label Titration|Adverse Event|0|||
155016159|NCT01256450|559484902|FG002|Open-label Titration|Adverse Event|0|||
155016160|NCT01256450|559484900|FG000|Open-label Titration|Lost to Follow-up|7|||
155016161|NCT01256450|559484901|FG001|Open-label Titration|Lost to Follow-up|0|||
155016162|NCT01256450|559484902|FG002|Open-label Titration|Lost to Follow-up|0|||
155016163|NCT01256450|559484900|FG000|Open-label Titration|Lack of analgesic effect|30|||
155016164|NCT01256450|559484901|FG001|Open-label Titration|Lack of analgesic effect|0|||
155016165|NCT01256450|559484902|FG002|Open-label Titration|Lack of analgesic effect|0|||
155016166|NCT01256450|559484900|FG000|Open-label Titration|Non-compliance|9|||
155016167|NCT01256450|559484901|FG001|Open-label Titration|Non-compliance|0|||
155016168|NCT01256450|559484902|FG002|Open-label Titration|Non-compliance|0|||
155016169|NCT01256450|559484900|FG000|Open-label Titration|Screen failure|1|||
155016170|NCT01256450|559484901|FG001|Open-label Titration|Screen failure|0|||
155016171|NCT01256450|559484902|FG002|Open-label Titration|Screen failure|0|||
155016172|NCT01256450|559484900|FG000|Open-label Titration|Other|13|||
155016173|NCT01256450|559484901|FG001|Open-label Titration|Other|0|||
155016174|NCT01256450|559484902|FG002|Open-label Titration|Other|0|||
155016175|NCT01256450|559484900|FG000|Double-blind Treatment|Adverse Event|0|||
155016176|NCT01256450|559484901|FG001|Double-blind Treatment|Adverse Event|8|||
155016177|NCT01256450|559484902|FG002|Double-blind Treatment|Adverse Event|6|||
155016178|NCT01256450|559484900|FG000|Double-blind Treatment|Lost to Follow-up|0|||
155016179|NCT01256450|559484901|FG001|Double-blind Treatment|Lost to Follow-up|1|||
155016180|NCT01256450|559484902|FG002|Double-blind Treatment|Lost to Follow-up|7|||
155016181|NCT01256450|559484900|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
155016182|NCT01256450|559484901|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
155016183|NCT01256450|559484902|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
155016184|NCT01256450|559484900|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
155179120|NCT01931670|560095006|FG001|Treatment Period|Lost to Follow-up|5|||
155179121|NCT01931670|560095007|FG002|Treatment Period|Lost to Follow-up|7|||
155179122|NCT01931670|560095005|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
155179123|NCT01931670|560095006|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
155179124|NCT01931670|560095007|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
155179125|NCT01931670|560095005|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
155179126|NCT01931670|560095006|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
155179127|NCT01931670|560095007|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
155179128|NCT01931670|560095005|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
155179129|NCT01931670|560095006|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
155179130|NCT01931670|560095007|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
155179131|NCT01931670|560095005|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
155179132|NCT01931670|560095006|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
155179133|NCT01931670|560095007|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
155179134|NCT01931670|560095005|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
155016185|NCT01256450|559484901|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
155016186|NCT01256450|559484902|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
155016187|NCT01256450|559484900|FG000|Double-blind Treatment|Non-compliance|0|||
155016188|NCT01256450|559484901|FG001|Double-blind Treatment|Non-compliance|5|||
155016189|NCT01256450|559484902|FG002|Double-blind Treatment|Non-compliance|4|||
155016190|NCT01256450|559484900|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
155016191|NCT01256450|559484901|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
155016192|NCT01256450|559484902|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
155016193|NCT01256450|559484900|FG000|Double-blind Treatment|Other|0|||
155016194|NCT01256450|559484901|FG001|Double-blind Treatment|Other|9|||
155016195|NCT01256450|559484902|FG002|Double-blind Treatment|Other|12|||
155016196|NCT03866512|559484905|FG000|Overall Study|Lost to Follow-up|1|||
155016197|NCT03866512|559484906|FG001|Overall Study|Lost to Follow-up|2|||
155016198|NCT03866512|559484907|FG002|Overall Study|Lost to Follow-up|1|||
155016199|NCT03866512|559484905|FG000|Overall Study|Cannulation issues|0|||
155016200|NCT03866512|559484906|FG001|Overall Study|Cannulation issues|1|||
155016201|NCT03866512|559484907|FG002|Overall Study|Cannulation issues|2|||
155016202|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
155016203|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155016204|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155016205|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155016206|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
155016207|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
155016208|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
155016209|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
155016210|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
155016211|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
155016212|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
155016213|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
155016214|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
155016215|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155016216|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155016217|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155016218|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
155016219|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155016220|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155016221|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155016222|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
155016223|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155016224|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155016225|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155016226|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
155016227|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
155016228|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
155016229|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
155016230|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
155016231|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
155016232|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
155016233|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
155016234|NCT00506415|559484909|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
155016235|NCT00506415|559484910|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155016236|NCT00506415|559484911|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155016237|NCT00506415|559484912|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155016238|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
155016239|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
155016240|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
155016241|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
155016242|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
155016243|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
155016244|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
155016245|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
155016246|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
155016247|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
155016248|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
155016249|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
155016250|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
155016251|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
155016252|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
155016253|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
155138848|NCT00106353|559940605|FG002|Part 2|Withdrawal by Subject|0|||
155138849|NCT00106353|559940606|FG003|Part 2|Withdrawal by Subject|0|||
155138850|NCT00106353|559940607|FG004|Part 2|Withdrawal by Subject|1|||
155179135|NCT01931670|560095006|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
155179136|NCT01931670|560095007|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
155179137|NCT01931670|560095005|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
155179138|NCT01931670|560095006|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
155016254|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
155016255|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
155016256|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
155016257|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
155016258|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
155016259|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
155016260|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
155016261|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
155016262|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
155016263|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
155016264|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
155016265|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
155016266|NCT00506415|559484909|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
155016267|NCT00506415|559484910|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
155016268|NCT00506415|559484911|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
155016269|NCT00506415|559484912|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
155016270|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
155016271|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
155016272|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
155016273|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
155016274|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155016275|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155016276|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
155016277|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
155016278|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155016279|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155016280|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
155016281|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
155016282|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155016283|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155016284|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
155016285|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
155016286|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155016287|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155016288|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
155016289|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
155016290|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155016291|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155016292|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
155016293|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
155016294|NCT00506415|559484909|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
155016295|NCT00506415|559484910|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
155016296|NCT00506415|559484911|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
155016297|NCT00506415|559484912|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
155016298|NCT00997373|559484913|FG000|Overall Study|Withdrawal by Subject|5|||
155016299|NCT00997373|559484914|FG001|Overall Study|Withdrawal by Subject|0|||
155016300|NCT00997373|559484913|FG000|Overall Study|wrong tumor type|4|||
155016301|NCT00997373|559484914|FG001|Overall Study|wrong tumor type|0|||
155016302|NCT00997373|559484913|FG000|Overall Study|could not have hysterectomy|6|||
155016303|NCT00997373|559484914|FG001|Overall Study|could not have hysterectomy|0|||
155016304|NCT02841995|559484915|FG000|Overall Study|Disease progression|5|||
155016305|NCT02841995|559484916|FG001|Overall Study|Disease progression|11|||
155016306|NCT02841995|559484917|FG002|Overall Study|Disease progression|8|||
155016307|NCT02841995|559484915|FG000|Overall Study|Withdrawal by Subject|2|||
155016308|NCT02841995|559484916|FG001|Overall Study|Withdrawal by Subject|4|||
155016309|NCT02841995|559484917|FG002|Overall Study|Withdrawal by Subject|4|||
155016310|NCT02841995|559484915|FG000|Overall Study|Adverse Event|2|||
155016311|NCT02841995|559484916|FG001|Overall Study|Adverse Event|0|||
155016312|NCT02841995|559484917|FG002|Overall Study|Adverse Event|1|||
155179139|NCT01931670|560095007|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
155179140|NCT00815516|560095008|FG000|Overall Study|Death|3|||
155179141|NCT00815516|560095009|FG001|Overall Study|Death|1|||
155016313|NCT02841995|559484915|FG000|Overall Study|Investigator decision|2|||
155016314|NCT02841995|559484916|FG001|Overall Study|Investigator decision|0|||
155016315|NCT02841995|559484917|FG002|Overall Study|Investigator decision|1|||
155016316|NCT02841995|559484915|FG000|Overall Study|Death|0|||
155016317|NCT02841995|559484916|FG001|Overall Study|Death|0|||
155016318|NCT02841995|559484917|FG002|Overall Study|Death|2|||
155016319|NCT02841995|559484915|FG000|Overall Study|Noncompliance to protocol|1|||
155016320|NCT02841995|559484916|FG001|Overall Study|Noncompliance to protocol|0|||
155016321|NCT02841995|559484917|FG002|Overall Study|Noncompliance to protocol|0|||
155016322|NCT02841995|559484915|FG000|Overall Study|Sponsor decision|1|||
155016323|NCT02841995|559484916|FG001|Overall Study|Sponsor decision|0|||
155016324|NCT02841995|559484917|FG002|Overall Study|Sponsor decision|0|||
155016325|NCT02841995|559484915|FG000|Overall Study|Other|4|||
155016326|NCT02841995|559484916|FG001|Overall Study|Other|1|||
155016327|NCT02841995|559484917|FG002|Overall Study|Other|5|||
155016328|NCT02042014|559484918|FG000|Overall Study|Adverse Event|1|||
155016329|NCT02042014|559484918|FG000|Overall Study|Physician Decision|7|||
155016330|NCT02792062|559484919|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
155016331|NCT02792062|559484920|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155016332|NCT02792062|559484921|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155016333|NCT02792062|559484922|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155016334|NCT02792062|559484923|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155016335|NCT02792062|559484924|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
155016336|NCT02632409|559484925|FG000|Randomized|AE unrelated to study Drug|0|||
155016337|NCT02632409|559484926|FG001|Randomized|AE unrelated to study Drug|1|||
155016338|NCT02632409|559484925|FG000|Randomized|Participant withdrew consent|2|||
155016339|NCT02632409|559484926|FG001|Randomized|Participant withdrew consent|1|||
155016340|NCT02632409|559484925|FG000|Randomized|No Longer meets study criteria|5|||
155016341|NCT02632409|559484926|FG001|Randomized|No Longer meets study criteria|0|||
155016342|NCT02632409|559484925|FG000|Randomized|other reasons|1|||
155016343|NCT02632409|559484926|FG001|Randomized|other reasons|0|||
155016344|NCT02632409|559484925|FG000|Treatment Period|Ongoing Treatment|20|||
155016345|NCT02632409|559484926|FG001|Treatment Period|Ongoing Treatment|21|||
155016346|NCT02632409|559484925|FG000|Treatment Period|Disease Recurrence|147|||
155016347|NCT02632409|559484926|FG001|Treatment Period|Disease Recurrence|90|||
155016348|NCT02632409|559484925|FG000|Treatment Period|Study Drug Toxicity|8|||
155016349|NCT02632409|559484926|FG001|Treatment Period|Study Drug Toxicity|49|||
155016350|NCT02632409|559484925|FG000|Treatment Period|Death|1|||
155016351|NCT02632409|559484926|FG001|Treatment Period|Death|0|||
155016352|NCT02632409|559484925|FG000|Treatment Period|AE unrelated to study drug|15|||
155016353|NCT02632409|559484926|FG001|Treatment Period|AE unrelated to study drug|16|||
155016354|NCT02632409|559484925|FG000|Treatment Period|Request to discontinue treatment|4|||
155016355|NCT02632409|559484926|FG001|Treatment Period|Request to discontinue treatment|19|||
155016356|NCT02632409|559484925|FG000|Treatment Period|Participant withdrew consent|7|||
155016357|NCT02632409|559484926|FG001|Treatment Period|Participant withdrew consent|5|||
155016358|NCT02632409|559484925|FG000|Treatment Period|Lost to Follow-up|0|||
155016359|NCT02632409|559484926|FG001|Treatment Period|Lost to Follow-up|1|||
155016360|NCT02632409|559484925|FG000|Treatment Period|Maximum clinical benefit|1|||
155016361|NCT02632409|559484926|FG001|Treatment Period|Maximum clinical benefit|0|||
155016362|NCT02632409|559484925|FG000|Treatment Period|No longer meets study criteria|3|||
155016363|NCT02632409|559484926|FG001|Treatment Period|No longer meets study criteria|0|||
155016364|NCT02632409|559484925|FG000|Treatment Period|Administrative Reason by sponsor|0|||
155016365|NCT02632409|559484926|FG001|Treatment Period|Administrative Reason by sponsor|1|||
155016366|NCT02632409|559484925|FG000|Treatment Period|Other Reasons|10|||
155016367|NCT02632409|559484926|FG001|Treatment Period|Other Reasons|6|||
155016368|NCT04426006|559484927|FG000|Inclusion|Protocol Violation|1|||
155016369|NCT04426006|559484927|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
155016370|NCT04426006|559484927|FG000|Inclusion|Blood sample at inclusion not done|1|||
155016371|NCT04426006|559484927|FG000|3 Months|Lost to Follow-up|17|||
155016372|NCT04426006|559484927|FG000|12 Months|Lost to Follow-up|38|||
155016373|NCT01262872|559484928|FG000|Step 2|Death|0|||
155138851|NCT00106353|559940608|FG005|Part 2|Withdrawal by Subject|0|||
155138852|NCT00106353|559940609|FG006|Part 2|Withdrawal by Subject|0|||
155138853|NCT00106353|559940603|FG000|Part 2|Physician Decision|0|||
155016374|NCT01262872|559484929|FG001|Step 2|Death|0|||
155138854|NCT00106353|559940604|FG001|Part 2|Physician Decision|0|||
155138855|NCT00106353|559940605|FG002|Part 2|Physician Decision|0|||
155138856|NCT00106353|559940606|FG003|Part 2|Physician Decision|0|||
155138857|NCT00106353|559940607|FG004|Part 2|Physician Decision|0|||
155016375|NCT01262872|559484930|FG002|Step 2|Death|0|||
155016376|NCT01262872|559484931|FG003|Step 2|Death|1|||
155016377|NCT01262872|559484932|FG004|Step 2|Death|0|||
155016378|NCT01262872|559484933|FG005|Step 2|Death|2|||
155016379|NCT01262872|559484934|FG006|Step 2|Death|2|||
155016380|NCT01262872|559484935|FG007|Step 2|Death|1|||
155016381|NCT01262872|559484928|FG000|Step 2|Protocol Violation|0|||
155016382|NCT01262872|559484929|FG001|Step 2|Protocol Violation|0|||
155016383|NCT01262872|559484930|FG002|Step 2|Protocol Violation|1|||
155016384|NCT01262872|559484931|FG003|Step 2|Protocol Violation|0|||
155138858|NCT00106353|559940608|FG005|Part 2|Physician Decision|1|||
155016385|NCT01262872|559484932|FG004|Step 2|Protocol Violation|0|||
155016386|NCT01262872|559484933|FG005|Step 2|Protocol Violation|0|||
155016387|NCT01262872|559484934|FG006|Step 2|Protocol Violation|3|||
155016388|NCT01262872|559484935|FG007|Step 2|Protocol Violation|1|||
155016389|NCT01262872|559484928|FG000|Step 2|Withdrawal by Subject|0|||
155016390|NCT01262872|559484929|FG001|Step 2|Withdrawal by Subject|0|||
155016391|NCT01262872|559484930|FG002|Step 2|Withdrawal by Subject|4|||
155016392|NCT01262872|559484931|FG003|Step 2|Withdrawal by Subject|6|||
155016393|NCT01262872|559484932|FG004|Step 2|Withdrawal by Subject|3|||
155016394|NCT01262872|559484933|FG005|Step 2|Withdrawal by Subject|1|||
155016395|NCT01262872|559484934|FG006|Step 2|Withdrawal by Subject|2|||
155016396|NCT01262872|559484935|FG007|Step 2|Withdrawal by Subject|1|||
155016397|NCT01262872|559484928|FG000|Step 2|Migrated/moved from study area|0|||
155016398|NCT01262872|559484929|FG001|Step 2|Migrated/moved from study area|0|||
155016399|NCT01262872|559484930|FG002|Step 2|Migrated/moved from study area|4|||
155016400|NCT01262872|559484931|FG003|Step 2|Migrated/moved from study area|3|||
155016401|NCT01262872|559484932|FG004|Step 2|Migrated/moved from study area|2|||
155016402|NCT01262872|559484933|FG005|Step 2|Migrated/moved from study area|6|||
155016403|NCT01262872|559484934|FG006|Step 2|Migrated/moved from study area|2|||
155016404|NCT01262872|559484935|FG007|Step 2|Migrated/moved from study area|3|||
155016405|NCT01000155|559484936|FG000|Overall Study|Withdrawal by Subject|1|||
155016406|NCT01000155|559484936|FG000|Overall Study|Adverse Event|1|||
155016407|NCT00720213|559484937|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
155016408|NCT00720213|559484938|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
155016409|NCT00720213|559484939|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
155016410|NCT01252095|559484944|FG000|Overall Study|Disease progression|1|||
155016411|NCT01252095|559484945|FG001|Overall Study|Disease progression|0|||
155016412|NCT00745901|559484946|FG000|Overall Study|Adverse Event|3|||
155016413|NCT00745901|559484947|FG001|Overall Study|Adverse Event|4|||
155016414|NCT00745901|559484946|FG000|Overall Study|Protocol Violation|0|||
155016415|NCT00745901|559484947|FG001|Overall Study|Protocol Violation|1|||
155016416|NCT00745901|559484946|FG000|Overall Study|Withdrawal by Subject|1|||
155016417|NCT00745901|559484947|FG001|Overall Study|Withdrawal by Subject|0|||
155016418|NCT00745901|559484946|FG000|Overall Study|Lost to Follow-up|7|||
155016419|NCT00745901|559484947|FG001|Overall Study|Lost to Follow-up|4|||
155016420|NCT00745901|559484946|FG000|Overall Study|Pregnancy|2|||
155016421|NCT00745901|559484947|FG001|Overall Study|Pregnancy|4|||
155016422|NCT00745901|559484946|FG000|Overall Study|Lack of compliance|2|||
155016423|NCT00745901|559484947|FG001|Overall Study|Lack of compliance|2|||
155016424|NCT00745901|559484946|FG000|Overall Study|Patient's next menses did not start with|1|||
155016425|NCT00745901|559484947|FG001|Overall Study|Patient's next menses did not start with|0|||
155016426|NCT00745901|559484946|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
155016427|NCT00745901|559484947|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
155016428|NCT00745901|559484946|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
155016429|NCT00745901|559484947|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
155016430|NCT00745901|559484946|FG000|Overall Study|Patient didn't take any study medication|7|||
155016431|NCT00745901|559484947|FG001|Overall Study|Patient didn't take any study medication|3|||
155016432|NCT02022202|559484950|FG000|Overall Study|Withdrawal by Subject|2|||
155016433|NCT02022202|559484950|FG000|Overall Study|Disease Progression|3|||
155016434|NCT02022202|559484950|FG000|Overall Study|Desire go to immediately to surgery|3|||
155016435|NCT01956773|559484956|FG000|Overall Study|Lost to Follow-up|628|||
155016436|NCT01956773|559484957|FG001|Overall Study|Lost to Follow-up|1|||
155016437|NCT01662492|559484960|FG000|Overall Study|Other miscellaneous reasons.|1|||
155016438|NCT01662492|559484961|FG001|Overall Study|Other miscellaneous reasons.|0|||
155016439|NCT01662492|559484962|FG002|Overall Study|Other miscellaneous reasons.|1|||
155016440|NCT01662492|559484960|FG000|Overall Study|Withdrawal by Subject|0|||
155016441|NCT01662492|559484961|FG001|Overall Study|Withdrawal by Subject|0|||
155016442|NCT01662492|559484962|FG002|Overall Study|Withdrawal by Subject|1|||
155016443|NCT01662492|559484960|FG000|Overall Study|Protocol Violation|1|||
155138859|NCT00106353|559940609|FG006|Part 2|Physician Decision|0|||
155138860|NCT00615992|559940610|FG000|Overall Study|Protocol Violation|67|||
155138861|NCT01868477|559940612|FG000|Overall Study|Adverse Event|2|||
155016444|NCT01662492|559484961|FG001|Overall Study|Protocol Violation|0|||
155016445|NCT01662492|559484962|FG002|Overall Study|Protocol Violation|0|||
155138862|NCT01868477|559940613|FG001|Overall Study|Adverse Event|4|||
155016446|NCT01662492|559484960|FG000|Overall Study|Lost to Follow-up|0|||
155016447|NCT01662492|559484961|FG001|Overall Study|Lost to Follow-up|0|||
155016448|NCT01662492|559484962|FG002|Overall Study|Lost to Follow-up|2|||
155016449|NCT01662492|559484960|FG000|Overall Study|Lack of Efficacy|1|||
155016450|NCT01662492|559484961|FG001|Overall Study|Lack of Efficacy|1|||
155016451|NCT01662492|559484962|FG002|Overall Study|Lack of Efficacy|2|||
155016452|NCT01591096|559484963|FG000|Overall Study|Adverse Event|1|||
155016453|NCT01167140|559484969|FG000|Overall Study|Withdrawal by Subject|1|||
155016454|NCT03805412|559484972|FG000|Overall Study|Lost to Follow-up|0|||
155016455|NCT03805412|559484973|FG001|Overall Study|Lost to Follow-up|1|||
155016456|NCT02389829|559484979|FG000|Overall Study|Lost to Follow-up|0|||
155016457|NCT02389829|559484980|FG001|Overall Study|Lost to Follow-up|1|||
155016458|NCT00571727|559484981|FG000|Overall Study|Did not enter in this study|1|||
155016459|NCT00571727|559484981|FG000|Overall Study|Non-compliance|4|||
155016460|NCT00571727|559484981|FG000|Overall Study|Lost to Follow-up|30|||
155016461|NCT00571727|559484981|FG000|Overall Study|Poor growth|1|||
155016462|NCT00571727|559484981|FG000|Overall Study|Parent/patient decision|2|||
155016463|NCT00571727|559484981|FG000|Overall Study|Participant transferred to commercial drug|14|||
155016464|NCT00571727|559484981|FG000|Overall Study|Unable to provide study drug|6|||
155016465|NCT00571727|559484981|FG000|Overall Study|On-treatment at end of study|8|||
155016466|NCT05514873|559484984|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
155016467|NCT05514873|559484984|FG000|Main Treatment Period|Adverse Event|2|||
155016468|NCT05514873|559484984|FG000|Extension Treatment Period|Lost to Follow-up|3|||
155016469|NCT03525678|559484987|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
155016470|NCT03525678|559484988|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
155016471|NCT03525678|559484989|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
155016472|NCT03525678|559484990|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
155016473|NCT03525678|559484991|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
155016474|NCT03525678|559484987|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
155016475|NCT03525678|559484988|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
155179142|NCT00815516|560095008|FG000|Overall Study|Physician Decision|1|||
155179143|NCT00815516|560095009|FG001|Overall Study|Physician Decision|0|||
155179144|NCT00976508|560095019|FG000|Overall Study|Death|7|||
155179145|NCT00976508|560095020|FG001|Overall Study|Death|1|||
155179146|NCT00976508|560095019|FG000|Overall Study|Lost to Follow-up|1|||
155179147|NCT00976508|560095020|FG001|Overall Study|Lost to Follow-up|0|||
155179148|NCT00976508|560095019|FG000|Overall Study|Withdrawal by Subject|1|||
155179149|NCT00976508|560095020|FG001|Overall Study|Withdrawal by Subject|0|||
155179150|NCT00976508|560095019|FG000|Overall Study|Disease Progression|4|||
155179151|NCT00976508|560095020|FG001|Overall Study|Disease Progression|4|||
155179152|NCT00976508|560095019|FG000|Overall Study|Subject Enrolled in Hospice|1|||
155179153|NCT00976508|560095020|FG001|Overall Study|Subject Enrolled in Hospice|0|||
155179154|NCT00976508|560095019|FG000|Overall Study|Terminated by the Sponsor|0|||
155179155|NCT00976508|560095020|FG001|Overall Study|Terminated by the Sponsor|1|||
155179156|NCT00329901|560095022|FG000|Overall Study|Withdrawal by Subject|4|||
155179157|NCT00329901|560095023|FG001|Overall Study|Withdrawal by Subject|3|||
155179158|NCT00329901|560095024|FG002|Overall Study|Withdrawal by Subject|2|||
155179159|NCT00329901|560095022|FG000|Overall Study|Lost to Follow-up|2|||
155179160|NCT00329901|560095023|FG001|Overall Study|Lost to Follow-up|0|||
155179161|NCT00329901|560095024|FG002|Overall Study|Lost to Follow-up|1|||
155179162|NCT00329901|560095022|FG000|Overall Study|Protocol Violation|1|||
155179163|NCT00329901|560095023|FG001|Overall Study|Protocol Violation|0|||
155179164|NCT00329901|560095024|FG002|Overall Study|Protocol Violation|1|||
155179165|NCT00329901|560095022|FG000|Overall Study|Unable to classify|2|||
155179166|NCT00329901|560095023|FG001|Overall Study|Unable to classify|2|||
155179167|NCT00329901|560095024|FG002|Overall Study|Unable to classify|0|||
155179168|NCT05028361|560095025|FG000|Overall Study|Withdrawal by Subject|1|||
155179169|NCT05028361|560095026|FG001|Overall Study|Withdrawal by Subject|0|||
155179170|NCT02195687|560095027|FG000|Overall Study|Personal Reasons|1|||
155179171|NCT02195687|560095028|FG001|Overall Study|Personal Reasons|1|||
155179172|NCT02195687|560095027|FG000|Overall Study|Lost to Follow-up|4|||
155179173|NCT02195687|560095028|FG001|Overall Study|Lost to Follow-up|1|||
155179174|NCT02296138|560095031|FG000|Overall Study|Adverse Event|348|||
155179175|NCT02296138|560095032|FG001|Overall Study|Adverse Event|259|||
155179176|NCT02296138|560095031|FG000|Overall Study|Lack of Efficacy|59|||
155179177|NCT02296138|560095032|FG001|Overall Study|Lack of Efficacy|37|||
155179178|NCT02296138|560095031|FG000|Overall Study|Protocol Violation|35|||
155179179|NCT02296138|560095032|FG001|Overall Study|Protocol Violation|36|||
155179180|NCT02296138|560095031|FG000|Overall Study|Lost to Follow-up|9|||
155179181|NCT02296138|560095032|FG001|Overall Study|Lost to Follow-up|12|||
155179182|NCT02296138|560095031|FG000|Overall Study|Withdrawal by Subject|184|||
155179183|NCT02296138|560095032|FG001|Overall Study|Withdrawal by Subject|131|||
155179184|NCT02296138|560095031|FG000|Overall Study|Not Treated|1|||
155179185|NCT02296138|560095032|FG001|Overall Study|Not Treated|1|||
155179186|NCT02296138|560095031|FG000|Overall Study|Patients with data irregularities|10|||
155179187|NCT02296138|560095032|FG001|Overall Study|Patients with data irregularities|11|||
155179188|NCT02296138|560095031|FG000|Overall Study|Other than specified|15|||
155179189|NCT02296138|560095032|FG001|Overall Study|Other than specified|13|||
155179190|NCT04369924|560095033|FG000|Overall Study|Lost to Follow-up|302|||
155179191|NCT04369924|560095034|FG001|Overall Study|Lost to Follow-up|339|||
155179192|NCT01653132|560095035|FG000|First Intervention|Protocol Violation|1|||
155179193|NCT01653132|560095036|FG001|First Intervention|Protocol Violation|0|||
155179194|NCT03828370|560095037|FG000|3 Month Follow-up|Lost to Follow-up|4|||
155179195|NCT03828370|560095038|FG001|3 Month Follow-up|Lost to Follow-up|12|||
155179196|NCT03828370|560095037|FG000|9 Month Follow up|Lost to Follow-up|12|||
155016476|NCT03525678|559484989|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
155016477|NCT03525678|559484990|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
155179197|NCT03828370|560095038|FG001|9 Month Follow up|Lost to Follow-up|20|||
155016478|NCT03525678|559484991|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
155016479|NCT03525678|559484987|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
155016480|NCT03525678|559484988|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
155016481|NCT03525678|559484989|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
155016482|NCT03525678|559484990|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
155016483|NCT03525678|559484991|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
155016484|NCT03525678|559484987|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
155016485|NCT03525678|559484988|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
155016486|NCT03525678|559484989|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
155016487|NCT03525678|559484990|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
155016488|NCT03525678|559484991|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
155016489|NCT03525678|559484987|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
155016490|NCT03525678|559484988|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
155016491|NCT03525678|559484989|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
155016492|NCT03525678|559484990|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
155016493|NCT03525678|559484991|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
155016494|NCT03525678|559484987|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
155016495|NCT03525678|559484988|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
155016496|NCT03525678|559484989|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
155016497|NCT03525678|559484990|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
155016498|NCT03525678|559484991|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
155016499|NCT04955691|559486822|FG000|Period 2|Discontinued intervention|1|||
155016500|NCT04955691|559486823|FG001|Period 2|Discontinued intervention|2|||
155016501|NCT05795153|559486824|FG000|Overall Study|Adverse Event|2|||
155016502|NCT05795153|559486824|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155016503|NCT05795153|559486824|FG000|Overall Study|Lost to Follow-up|1|||
155016504|NCT05795153|559486824|FG000|Overall Study|Subject decision|2|||
155016505|NCT00975611|559486825|FG000|Overall Study|Screen Fail|16|||
155016506|NCT00975611|559486825|FG000|Overall Study|Physician Decision|1|||
155016507|NCT03123120|559486826|FG000|Overall Study|Lost to Follow-up|0|||
155016508|NCT03123120|559486827|FG001|Overall Study|Lost to Follow-up|1|||
155016509|NCT03123120|559486826|FG000|Overall Study|Withdrawal by Subject|0|||
155016510|NCT03123120|559486827|FG001|Overall Study|Withdrawal by Subject|1|||
155016511|NCT02632175|559486828|FG000|Overall Study|Withdrawal by Subject|6|||
155016512|NCT02632175|559486828|FG000|Overall Study|Lost to Follow-up|1|||
155016513|NCT02632175|559486828|FG000|Overall Study|Lack of Efficacy|18|||
155016514|NCT02632175|559486828|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
155016515|NCT02632175|559486828|FG000|Overall Study|Subject noncompliance|3|||
155016516|NCT02632175|559486828|FG000|Overall Study|other|2|||
155016517|NCT02088554|559486829|FG000|Overall Study|Exited before procedure|130|||
155016518|NCT02088554|559486829|FG000|Overall Study|Attempted but not implanted|31|||
155016519|NCT02088554|559486829|FG000|Overall Study|Implant not attempted|19|||
155016520|NCT02088554|559486829|FG000|Overall Study|Pending next visit|532|||
155016521|NCT02088554|559486829|FG000|Overall Study|Death|170|||
155016522|NCT02088554|559486829|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
155016523|NCT02088554|559486829|FG000|Overall Study|Lost to Follow-up|23|||
155016524|NCT02088554|559486829|FG000|Overall Study|Explanted|32|||
155016525|NCT02088554|559486829|FG000|Overall Study|Any other reason not covered by previous categories|11|||
155016526|NCT00536939|559486830|FG000|Overall Study|Withdrawal by Subject|1|||
155016527|NCT00536939|559486831|FG001|Overall Study|Withdrawal by Subject|0|||
155016528|NCT00536939|559486830|FG000|Overall Study|Other Complicating Disease|1|||
155016529|NCT00536939|559486831|FG001|Overall Study|Other Complicating Disease|0|||
155016530|NCT00529087|559486834|FG000|Overall Study|Adverse Event|10|||
155016531|NCT00529087|559486835|FG001|Overall Study|Adverse Event|13|||
155016532|NCT00529087|559486836|FG002|Overall Study|Adverse Event|4|||
155016533|NCT00529087|559486834|FG000|Overall Study|Lost to Follow-up|6|||
155016534|NCT00529087|559486835|FG001|Overall Study|Lost to Follow-up|4|||
155016535|NCT00529087|559486836|FG002|Overall Study|Lost to Follow-up|1|||
155016536|NCT00529087|559486834|FG000|Overall Study|Protocol Violation|8|||
155016537|NCT00529087|559486835|FG001|Overall Study|Protocol Violation|7|||
155016538|NCT00529087|559486836|FG002|Overall Study|Protocol Violation|6|||
155016539|NCT00529087|559486834|FG000|Overall Study|Withdrawal by Subject|3|||
155016540|NCT00529087|559486835|FG001|Overall Study|Withdrawal by Subject|3|||
155016541|NCT00529087|559486836|FG002|Overall Study|Withdrawal by Subject|3|||
155016542|NCT00529087|559486834|FG000|Overall Study|Protocol deviation|1|||
155016543|NCT00529087|559486835|FG001|Overall Study|Protocol deviation|1|||
155016544|NCT00529087|559486836|FG002|Overall Study|Protocol deviation|2|||
155016545|NCT02309411|559486841|FG000|Overall Study|Physician Decision|1|||
155016546|NCT02309411|559486842|FG001|Overall Study|Physician Decision|0|||
155016547|NCT02309411|559486843|FG002|Overall Study|Physician Decision|0|||
155016548|NCT02309411|559486841|FG000|Overall Study|Withdrawal by Subject|1|||
155016549|NCT02309411|559486842|FG001|Overall Study|Withdrawal by Subject|1|||
155016550|NCT02309411|559486843|FG002|Overall Study|Withdrawal by Subject|0|||
155138863|NCT01868477|559940612|FG000|Overall Study|Disease progression|1|||
155138864|NCT01868477|559940613|FG001|Overall Study|Disease progression|1|||
155016551|NCT00925704|559486847|FG000|First Intervention|Withdrew consent|0|||
155016552|NCT00925704|559486848|FG001|First Intervention|Withdrew consent|0|||
155016553|NCT00925704|559486849|FG002|First Intervention|Withdrew consent|0|||
155016554|NCT00925704|559486850|FG003|First Intervention|Withdrew consent|1|||
155016555|NCT00925704|559486851|FG004|First Intervention|Withdrew consent|1|||
155016556|NCT00925704|559486852|FG005|First Intervention|Withdrew consent|0|||
155016557|NCT00925704|559486847|FG000|Second Intervention|Withdrawal by Subject|1|||
155016558|NCT00925704|559486848|FG001|Second Intervention|Withdrawal by Subject|0|||
155016559|NCT00925704|559486849|FG002|Second Intervention|Withdrawal by Subject|0|||
155016560|NCT00925704|559486850|FG003|Second Intervention|Withdrawal by Subject|0|||
155016561|NCT00925704|559486851|FG004|Second Intervention|Withdrawal by Subject|1|||
155016562|NCT00925704|559486852|FG005|Second Intervention|Withdrawal by Subject|0|||
155016563|NCT00925704|559486847|FG000|Third Intervention|Withdrew consent|0|||
155016564|NCT00925704|559486848|FG001|Third Intervention|Withdrew consent|0|||
155016565|NCT00925704|559486849|FG002|Third Intervention|Withdrew consent|0|||
155016566|NCT00925704|559486850|FG003|Third Intervention|Withdrew consent|0|||
155016567|NCT00925704|559486851|FG004|Third Intervention|Withdrew consent|0|||
155016568|NCT00925704|559486852|FG005|Third Intervention|Withdrew consent|1|||
155016569|NCT03207815|559486858|FG000|Overall Study|Protocol Violation|3|||
155016570|NCT03207815|559486859|FG001|Overall Study|Protocol Violation|1|||
155016571|NCT03207815|559486858|FG000|Overall Study|Adverse Event|1|||
155016572|NCT03207815|559486859|FG001|Overall Study|Adverse Event|2|||
155016573|NCT03207815|559486858|FG000|Overall Study|Lost to Follow-up|1|||
155016574|NCT03207815|559486859|FG001|Overall Study|Lost to Follow-up|2|||
155016575|NCT03207815|559486858|FG000|Overall Study|Investigator's Discretion|1|||
155016576|NCT03207815|559486859|FG001|Overall Study|Investigator's Discretion|1|||
155138865|NCT01868477|559940612|FG000|Overall Study|Withdrawal by Subject|1|||
155138866|NCT01868477|559940613|FG001|Overall Study|Withdrawal by Subject|0|||
155138867|NCT01811186|559940615|FG000|Overall Study|Adverse Event|54|||
155138868|NCT01811186|559940616|FG001|Overall Study|Adverse Event|38|||
155138869|NCT01811186|559940615|FG000|Overall Study|Protocol Violation|5|||
155138870|NCT01811186|559940616|FG001|Overall Study|Protocol Violation|6|||
155138871|NCT01811186|559940615|FG000|Overall Study|Withdrawal by Subject|5|||
155138872|NCT01811186|559940616|FG001|Overall Study|Withdrawal by Subject|10|||
155138873|NCT01811186|559940615|FG000|Overall Study|Lack of Efficacy|3|||
155138874|NCT01811186|559940616|FG001|Overall Study|Lack of Efficacy|6|||
155138875|NCT01811186|559940615|FG000|Overall Study|Lost to Follow-up|4|||
155138876|NCT01811186|559940616|FG001|Overall Study|Lost to Follow-up|2|||
155138877|NCT02465203|559940617|FG000|Overall Study|Protocol Violation|1|||
155138878|NCT02465203|559940618|FG001|Overall Study|Protocol Violation|1|||
155138879|NCT02465203|559940619|FG002|Overall Study|Protocol Violation|1|||
155138880|NCT02465203|559940617|FG000|Overall Study|Study terminated by sponsor|50|||
155138881|NCT02465203|559940618|FG001|Overall Study|Study terminated by sponsor|34|||
155138882|NCT02465203|559940619|FG002|Overall Study|Study terminated by sponsor|11|||
155138883|NCT02465203|559940617|FG000|Overall Study|New therapy for study indication|4|||
155138884|NCT02465203|559940618|FG001|Overall Study|New therapy for study indication|0|||
155138885|NCT02465203|559940619|FG002|Overall Study|New therapy for study indication|0|||
155138886|NCT02465203|559940617|FG000|Overall Study|Patient/guardian decision|1|||
155138887|NCT02465203|559940618|FG001|Overall Study|Patient/guardian decision|1|||
155138888|NCT02465203|559940619|FG002|Overall Study|Patient/guardian decision|1|||
155138889|NCT00042991|559940626|FG000|Overall Study|Adverse Event|1|||
155138890|NCT00042991|559940627|FG001|Overall Study|Adverse Event|4|||
155138891|NCT00042991|559940628|FG002|Overall Study|Adverse Event|2|||
155138892|NCT00042991|559940629|FG003|Overall Study|Adverse Event|0|||
155138893|NCT00042991|559940630|FG004|Overall Study|Adverse Event|0|||
155138894|NCT00042991|559940631|FG005|Overall Study|Adverse Event|1|||
155138895|NCT00042991|559940632|FG006|Overall Study|Adverse Event|0|||
155138896|NCT00042991|559940626|FG000|Overall Study|Withdrawal by Subject|0|||
155138897|NCT00042991|559940627|FG001|Overall Study|Withdrawal by Subject|7|||
155138898|NCT00042991|559940628|FG002|Overall Study|Withdrawal by Subject|2|||
155138899|NCT00042991|559940629|FG003|Overall Study|Withdrawal by Subject|0|||
155138900|NCT00042991|559940630|FG004|Overall Study|Withdrawal by Subject|1|||
155138901|NCT00042991|559940631|FG005|Overall Study|Withdrawal by Subject|0|||
155138902|NCT00042991|559940632|FG006|Overall Study|Withdrawal by Subject|0|||
155138903|NCT00042991|559940626|FG000|Overall Study|Disease Progression|5|||
155138904|NCT00042991|559940627|FG001|Overall Study|Disease Progression|29|||
155138905|NCT00042991|559940628|FG002|Overall Study|Disease Progression|2|||
155138906|NCT00042991|559940629|FG003|Overall Study|Disease Progression|2|||
155138907|NCT00042991|559940630|FG004|Overall Study|Disease Progression|1|||
155138908|NCT00042991|559940631|FG005|Overall Study|Disease Progression|4|||
155016577|NCT03207815|559486858|FG000|Overall Study|Lack of Efficacy|0|||
155016578|NCT03207815|559486859|FG001|Overall Study|Lack of Efficacy|1|||
155016579|NCT03207815|559486858|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
155016580|NCT03207815|559486859|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
155016581|NCT03207815|559486858|FG000|Overall Study|Withdrew Consent|1|||
155016582|NCT03207815|559486859|FG001|Overall Study|Withdrew Consent|0|||
155016583|NCT01671007|559486860|FG000|Overall Study|Other reasons than listed|166|||
155138909|NCT00042991|559940632|FG006|Overall Study|Disease Progression|2|||
155016584|NCT01671007|559486861|FG001|Overall Study|Other reasons than listed|373|||
155016585|NCT01671007|559486862|FG002|Overall Study|Other reasons than listed|197|||
155016586|NCT01671007|559486863|FG003|Overall Study|Other reasons than listed|228|||
155016587|NCT01671007|559486864|FG004|Overall Study|Other reasons than listed|14|||
155016588|NCT01671007|559486865|FG005|Overall Study|Other reasons than listed|71|||
155016589|NCT01671007|559486866|FG006|Overall Study|Other reasons than listed|17|||
155016590|NCT01671007|559486867|FG007|Overall Study|Other reasons than listed|66|||
155016591|NCT01671007|559486868|FG008|Overall Study|Other reasons than listed|0|||
155016592|NCT01671007|559486860|FG000|Overall Study|Withdrawal by Subject|36|||
155016593|NCT01671007|559486861|FG001|Overall Study|Withdrawal by Subject|59|||
155016594|NCT01671007|559486862|FG002|Overall Study|Withdrawal by Subject|53|||
155016595|NCT01671007|559486863|FG003|Overall Study|Withdrawal by Subject|58|||
155016596|NCT01671007|559486864|FG004|Overall Study|Withdrawal by Subject|4|||
155016597|NCT01671007|559486865|FG005|Overall Study|Withdrawal by Subject|15|||
155016598|NCT01671007|559486866|FG006|Overall Study|Withdrawal by Subject|1|||
155016599|NCT01671007|559486867|FG007|Overall Study|Withdrawal by Subject|19|||
155016600|NCT01671007|559486868|FG008|Overall Study|Withdrawal by Subject|0|||
155016601|NCT01671007|559486860|FG000|Overall Study|Lost to Follow-up|93|||
155016602|NCT01671007|559486861|FG001|Overall Study|Lost to Follow-up|142|||
155016603|NCT01671007|559486862|FG002|Overall Study|Lost to Follow-up|91|||
155016604|NCT01671007|559486863|FG003|Overall Study|Lost to Follow-up|63|||
155016605|NCT01671007|559486864|FG004|Overall Study|Lost to Follow-up|7|||
155016606|NCT01671007|559486865|FG005|Overall Study|Lost to Follow-up|20|||
155016607|NCT01671007|559486866|FG006|Overall Study|Lost to Follow-up|2|||
155016608|NCT01671007|559486867|FG007|Overall Study|Lost to Follow-up|28|||
155016609|NCT01671007|559486868|FG008|Overall Study|Lost to Follow-up|0|||
155016610|NCT01671007|559486860|FG000|Overall Study|No end of study case report form|3|||
155016611|NCT01671007|559486861|FG001|Overall Study|No end of study case report form|1|||
155016612|NCT01671007|559486862|FG002|Overall Study|No end of study case report form|0|||
155016613|NCT01671007|559486863|FG003|Overall Study|No end of study case report form|2|||
155016614|NCT01671007|559486864|FG004|Overall Study|No end of study case report form|0|||
155016615|NCT01671007|559486865|FG005|Overall Study|No end of study case report form|0|||
155016616|NCT01671007|559486866|FG006|Overall Study|No end of study case report form|0|||
155016617|NCT01671007|559486867|FG007|Overall Study|No end of study case report form|0|||
155016618|NCT01671007|559486868|FG008|Overall Study|No end of study case report form|0|||
155016619|NCT01671007|559486860|FG000|Overall Study|Not eligible|23|||
155016620|NCT01671007|559486861|FG001|Overall Study|Not eligible|76|||
155016621|NCT01671007|559486862|FG002|Overall Study|Not eligible|25|||
155016622|NCT01671007|559486863|FG003|Overall Study|Not eligible|17|||
155016623|NCT01671007|559486864|FG004|Overall Study|Not eligible|0|||
155016624|NCT01671007|559486865|FG005|Overall Study|Not eligible|6|||
155016625|NCT01671007|559486866|FG006|Overall Study|Not eligible|1|||
155016626|NCT01671007|559486867|FG007|Overall Study|Not eligible|19|||
155016627|NCT01671007|559486868|FG008|Overall Study|Not eligible|0|||
155016628|NCT03877068|559486869|FG000|Overall Study|Physician Decision|9|||
155016629|NCT03877068|559486870|FG001|Overall Study|Physician Decision|3|||
155016630|NCT00406367|559486871|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
155016631|NCT00406367|559486872|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
155016632|NCT00406367|559486871|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
155016633|NCT00406367|559486872|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
155016634|NCT00406367|559486871|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
155016635|NCT00406367|559486872|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
155016636|NCT00406367|559486871|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
155016637|NCT00406367|559486872|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
155016638|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
155016639|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
155016640|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
155016641|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
155016642|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
155016643|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
155016644|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
155016645|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
155016646|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
155016647|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
155016648|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
155016649|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
155016650|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
155016651|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
155016652|NCT00406367|559486871|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
155016653|NCT00406367|559486872|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
155016654|NCT03187301|559486875|FG000|Titration Period|Adverse Event|0|||
155016655|NCT03187301|559486876|FG001|Titration Period|Adverse Event|0|||
155016656|NCT03187301|559486877|FG002|Titration Period|Adverse Event|0|||
155016657|NCT03187301|559486878|FG003|Titration Period|Adverse Event|0|||
155016658|NCT03187301|559486879|FG004|Titration Period|Adverse Event|0|||
155016659|NCT03187301|559486880|FG005|Titration Period|Adverse Event|0|||
155016660|NCT03187301|559486881|FG006|Titration Period|Adverse Event|5|||
155016661|NCT03187301|559486875|FG000|Titration Period|Withdrawal by Subject|0|||
155016662|NCT03187301|559486876|FG001|Titration Period|Withdrawal by Subject|0|||
155016663|NCT03187301|559486877|FG002|Titration Period|Withdrawal by Subject|0|||
155016664|NCT03187301|559486878|FG003|Titration Period|Withdrawal by Subject|0|||
155016665|NCT03187301|559486879|FG004|Titration Period|Withdrawal by Subject|0|||
155016666|NCT03187301|559486880|FG005|Titration Period|Withdrawal by Subject|0|||
155016667|NCT03187301|559486881|FG006|Titration Period|Withdrawal by Subject|1|||
155016668|NCT03187301|559486875|FG000|Titration Period|Exclusion Criteria Met|0|||
155138910|NCT00042991|559940626|FG000|Overall Study|Alternative Therapy|0|||
155138911|NCT00042991|559940627|FG001|Overall Study|Alternative Therapy|0|||
155138912|NCT00042991|559940628|FG002|Overall Study|Alternative Therapy|0|||
155138913|NCT00042991|559940629|FG003|Overall Study|Alternative Therapy|0|||
155138914|NCT00042991|559940630|FG004|Overall Study|Alternative Therapy|1|||
155138915|NCT00042991|559940631|FG005|Overall Study|Alternative Therapy|0|||
155138916|NCT00042991|559940632|FG006|Overall Study|Alternative Therapy|0|||
155138917|NCT03369236|559940635|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
155138918|NCT03369236|559940636|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
155138919|NCT03369236|559940635|FG000|Open-label Extension Period|Lack of Efficacy|2|||
155138920|NCT03369236|559940636|FG001|Open-label Extension Period|Lack of Efficacy|1|||
155138921|NCT03369236|559940635|FG000|Open-label Extension Period|Adverse Event|0|||
155138922|NCT03369236|559940636|FG001|Open-label Extension Period|Adverse Event|1|||
155138923|NCT03369236|559940635|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
155138924|NCT03369236|559940636|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
155138925|NCT01153724|559940641|FG000|Treatment Period 1|Withdrawal by Subject|1|||
155138926|NCT01153724|559940641|FG000|Treatment Period 2|Adverse Event|1|||
155138927|NCT01153724|559940641|FG000|Treatment Period 2|Other reason not defined above|1|||
155138928|NCT02697435|559940642|FG000|Overall Study|Withdrawal by Subject|1|||
155138929|NCT02697435|559940643|FG001|Overall Study|Withdrawal by Subject|0|||
155138930|NCT02697435|559940642|FG000|Overall Study|Physician Decision|0|||
155138931|NCT02697435|559940643|FG001|Overall Study|Physician Decision|4|||
155138932|NCT02508428|559940647|FG000|Overall Study|Death|32|||
155138933|NCT02508428|559940648|FG001|Overall Study|Death|33|||
155138934|NCT02508428|559940647|FG000|Overall Study|Liner revised|3|||
155138935|NCT02508428|559940648|FG001|Overall Study|Liner revised|19|||
155138936|NCT02508428|559940647|FG000|Overall Study|Incomplete follow-up|17|||
155138937|NCT02508428|559940648|FG001|Overall Study|Incomplete follow-up|15|||
155138938|NCT04371666|559940651|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
155138939|NCT04371666|559940652|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
155138940|NCT04371666|559940651|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
155138941|NCT04371666|559940652|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
155138942|NCT04371666|559940651|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
155138943|NCT04371666|559940652|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
155138944|NCT04371666|559940651|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
155138945|NCT04371666|559940652|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
155138946|NCT04371666|559940651|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
155138947|NCT04371666|559940652|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
155138948|NCT04371666|559940651|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
155138949|NCT04371666|559940652|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
155138950|NCT00264537|559940653|FG000|Overall Study|Death|0|||
155138951|NCT00264537|559940654|FG001|Overall Study|Death|3|||
155138952|NCT00264537|559940655|FG002|Overall Study|Death|3|||
155138953|NCT00264537|559940656|FG003|Overall Study|Death|2|||
155138954|NCT00264537|559940653|FG000|Overall Study|Lost to Follow-up|3|||
155138955|NCT00264537|559940654|FG001|Overall Study|Lost to Follow-up|4|||
155138956|NCT00264537|559940655|FG002|Overall Study|Lost to Follow-up|7|||
155138957|NCT00264537|559940656|FG003|Overall Study|Lost to Follow-up|6|||
155138958|NCT00264537|559940653|FG000|Overall Study|Adverse Event|21|||
155138959|NCT00264537|559940654|FG001|Overall Study|Adverse Event|32|||
155016669|NCT03187301|559486876|FG001|Titration Period|Exclusion Criteria Met|0|||
155016670|NCT03187301|559486877|FG002|Titration Period|Exclusion Criteria Met|0|||
155138960|NCT00264537|559940655|FG002|Overall Study|Adverse Event|24|||
155138961|NCT00264537|559940656|FG003|Overall Study|Adverse Event|34|||
155138962|NCT00264537|559940653|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
155138963|NCT00264537|559940654|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155016671|NCT03187301|559486878|FG003|Titration Period|Exclusion Criteria Met|0|||
155016672|NCT03187301|559486879|FG004|Titration Period|Exclusion Criteria Met|0|||
155016673|NCT03187301|559486880|FG005|Titration Period|Exclusion Criteria Met|0|||
155016674|NCT03187301|559486881|FG006|Titration Period|Exclusion Criteria Met|1|||
155016675|NCT03187301|559486875|FG000|Pre-Intervention|Withdrawal by Subject|1|||
155179198|NCT00761150|560095041|FG000|Open-label Period|Adverse Event|36|||
155179199|NCT00761150|560095042|FG001|Open-label Period|Adverse Event|0|||
155016676|NCT03187301|559486876|FG001|Pre-Intervention|Withdrawal by Subject|0|||
155016677|NCT03187301|559486877|FG002|Pre-Intervention|Withdrawal by Subject|0|||
155016678|NCT03187301|559486878|FG003|Pre-Intervention|Withdrawal by Subject|0|||
155016679|NCT03187301|559486879|FG004|Pre-Intervention|Withdrawal by Subject|0|||
155016680|NCT03187301|559486880|FG005|Pre-Intervention|Withdrawal by Subject|0|||
155016681|NCT03187301|559486881|FG006|Pre-Intervention|Withdrawal by Subject|0|||
155016682|NCT01966120|559486882|FG000|Overall Study|Withdrawal by Subject|0|||
155016683|NCT01966120|559486883|FG001|Overall Study|Withdrawal by Subject|5|||
155016684|NCT01966120|559486882|FG000|Overall Study|Lost to Follow-up|1|||
155016685|NCT01966120|559486883|FG001|Overall Study|Lost to Follow-up|1|||
155016686|NCT00461630|559486884|FG000|Overall Study|Death|798|||
155016687|NCT00461630|559486885|FG001|Overall Study|Death|732|||
155016688|NCT00461630|559486884|FG000|Overall Study|Lost to Follow-up|108|||
155016689|NCT00461630|559486885|FG001|Overall Study|Lost to Follow-up|95|||
155016690|NCT02588612|559486892|FG000|Overall Study|Physician Decision|1|||
155016691|NCT02588612|559486892|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
155016692|NCT02588612|559486892|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
155016693|NCT02588612|559486892|FG000|Overall Study|Death prior to T-cell infusion|1|||
155016694|NCT03123393|559486895|FG000|Overall Study|Study Terminated by Sponsor|6|||
155016695|NCT03123393|559486896|FG001|Overall Study|Study Terminated by Sponsor|9|||
155016696|NCT03123393|559486895|FG000|Overall Study|Withdrawal by Subject|2|||
155016697|NCT03123393|559486896|FG001|Overall Study|Withdrawal by Subject|1|||
155016698|NCT03123393|559486895|FG000|Overall Study|Reason not Specified|13|||
155016699|NCT03123393|559486896|FG001|Overall Study|Reason not Specified|13|||
155016700|NCT00558701|559486898|FG000|Overall Study|Protocol Deviations|1|||
155016701|NCT00558701|559486899|FG001|Overall Study|Protocol Deviations|4|||
155016702|NCT00427648|559486900|FG000|Overall Study|Protocol Violation|1|||
155016703|NCT00427648|559486901|FG001|Overall Study|Protocol Violation|2|||
155016704|NCT00427648|559486900|FG000|Overall Study|Adverse Event|0|||
155016705|NCT00427648|559486901|FG001|Overall Study|Adverse Event|1|||
155016706|NCT02230904|559486902|FG000|Overall Study|Safety follow up could not take place|0|||
155016707|NCT02230904|559486903|FG001|Overall Study|Safety follow up could not take place|1|||
155016708|NCT01681212|559486904|FG000|Overall Study|No longer met study criteria|5|||
155016709|NCT01681212|559486904|FG000|Overall Study|Administrative reason by sponsor|1|||
155016710|NCT01464333|559486906|FG000|Overall Study|Adverse Event|34|||
155016711|NCT01464333|559486906|FG000|Overall Study|Lack of Efficacy|72|||
155016712|NCT01464333|559486906|FG000|Overall Study|Withdrawal by Subject|11|||
155016713|NCT01464333|559486906|FG000|Overall Study|Other|4|||
155016714|NCT01464333|559486906|FG000|Overall Study|No Hospital Visit|42|||
155016715|NCT05047211|559486909|FG000|Overall Study|Lost to Follow-up|8|||
155016716|NCT05047211|559486910|FG001|Overall Study|Lost to Follow-up|5|||
155016717|NCT00561392|559486911|FG000|Overall Study|Adverse Event|38|||
155179200|NCT00761150|560095043|FG002|Open-label Period|Adverse Event|0|||
155179201|NCT00761150|560095041|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
155179202|NCT00761150|560095042|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
155179203|NCT00761150|560095043|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
155179204|NCT00761150|560095041|FG000|Open-label Period|Lost to Follow-up|7|||
155179205|NCT00761150|560095042|FG001|Open-label Period|Lost to Follow-up|0|||
155179206|NCT00761150|560095043|FG002|Open-label Period|Lost to Follow-up|0|||
155179207|NCT00761150|560095041|FG000|Open-label Period|Lack of Efficacy|4|||
155179208|NCT00761150|560095042|FG001|Open-label Period|Lack of Efficacy|0|||
155179209|NCT00761150|560095043|FG002|Open-label Period|Lack of Efficacy|0|||
155179210|NCT00761150|560095041|FG000|Open-label Period|Withdrawal by Subject|5|||
155016718|NCT00561392|559486911|FG000|Overall Study|Lack of Efficacy|2|||
155016719|NCT00561392|559486911|FG000|Overall Study|Protocol Violation|1|||
155016720|NCT00561392|559486911|FG000|Overall Study|Withdrawal by Subject|8|||
155016721|NCT00561392|559486911|FG000|Overall Study|Administrative problems|4|||
155179211|NCT00761150|560095042|FG001|Open-label Period|Withdrawal by Subject|0|||
155179212|NCT00761150|560095043|FG002|Open-label Period|Withdrawal by Subject|0|||
155179213|NCT00761150|560095041|FG000|Open-label Period|Noncompliance|2|||
155179214|NCT00761150|560095042|FG001|Open-label Period|Noncompliance|0|||
155179215|NCT00761150|560095043|FG002|Open-label Period|Noncompliance|0|||
155179216|NCT00761150|560095041|FG000|Open-label Period|Other|5|||
155016722|NCT03321968|559486912|FG000|Overall Study|Withdrawal by Subject|1|||
155016723|NCT03321968|559486913|FG001|Overall Study|Withdrawal by Subject|2|||
155016724|NCT03321968|559486914|FG002|Overall Study|Withdrawal by Subject|1|||
155016725|NCT03321968|559486912|FG000|Overall Study|Lost to Follow-up|2|||
155016726|NCT03321968|559486913|FG001|Overall Study|Lost to Follow-up|0|||
155016727|NCT03321968|559486914|FG002|Overall Study|Lost to Follow-up|1|||
155179217|NCT00761150|560095042|FG001|Open-label Period|Other|0|||
155179218|NCT00761150|560095043|FG002|Open-label Period|Other|0|||
155179219|NCT00761150|560095041|FG000|Double-blind Period|Lack of Efficacy|0|||
155179220|NCT00761150|560095042|FG001|Double-blind Period|Lack of Efficacy|2|||
155016728|NCT03321968|559486912|FG000|Overall Study|Other than specified|0|||
155016729|NCT03321968|559486913|FG001|Overall Study|Other than specified|0|||
155016730|NCT03321968|559486914|FG002|Overall Study|Other than specified|1|||
155016731|NCT03822468|559486915|FG000|Treatment Period|Progressive disease|98|||
155016732|NCT03822468|559486916|FG001|Treatment Period|Progressive disease|94|||
155016733|NCT03822468|559486915|FG000|Treatment Period|Adverse Event|21|||
155016734|NCT03822468|559486916|FG001|Treatment Period|Adverse Event|24|||
155016735|NCT03822468|559486915|FG000|Treatment Period|Withdrawal by Subject|9|||
155016736|NCT03822468|559486916|FG001|Treatment Period|Withdrawal by Subject|5|||
155016737|NCT03822468|559486915|FG000|Treatment Period|Physician Decision|9|||
155016738|NCT03822468|559486916|FG001|Treatment Period|Physician Decision|7|||
155016739|NCT03822468|559486915|FG000|Treatment Period|Protocol Violation|2|||
155016740|NCT03822468|559486916|FG001|Treatment Period|Protocol Violation|1|||
155016741|NCT03822468|559486915|FG000|Treatment Period|Death|2|||
155016742|NCT03822468|559486916|FG001|Treatment Period|Death|3|||
155016743|NCT03822468|559486915|FG000|Treatment Period|Lost to Follow-up|1|||
155016744|NCT03822468|559486916|FG001|Treatment Period|Lost to Follow-up|1|||
155016745|NCT03822468|559486915|FG000|Treatment Period|Sponsor decision|46|||
155016746|NCT03822468|559486916|FG001|Treatment Period|Sponsor decision|53|||
155016747|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
155016748|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
155016749|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
155016750|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
155016751|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Death|1|||
155016752|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Death|0|||
155016753|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155016754|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155016755|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155016756|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155016757|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
155016758|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155016759|NCT03822468|559486915|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
155016760|NCT03822468|559486916|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
155016761|NCT02198664|559486917|FG000|Overall Study|Adverse Event|2|||
155016762|NCT02198664|559486918|FG001|Overall Study|Adverse Event|0|||
155016763|NCT02198664|559486917|FG000|Overall Study|Withdrawal by Subject|11|||
155016764|NCT02198664|559486918|FG001|Overall Study|Withdrawal by Subject|8|||
155016765|NCT02198664|559486917|FG000|Overall Study|Failure to tolerate|2|||
155016766|NCT02198664|559486918|FG001|Overall Study|Failure to tolerate|0|||
155016767|NCT02198664|559486917|FG000|Overall Study|Not stated|1|||
155016768|NCT02198664|559486918|FG001|Overall Study|Not stated|0|||
155016769|NCT00529308|559486919|FG000|Overall Study|Withdrawal by Subject|1|||
155016770|NCT00529308|559486920|FG001|Overall Study|Withdrawal by Subject|1|||
155016771|NCT03331796|559486921|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
155016772|NCT03331796|559486922|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
155016773|NCT03331796|559486923|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
155016774|NCT03331796|559486921|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
155016775|NCT03331796|559486922|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
155016776|NCT03331796|559486923|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
155016777|NCT03331796|559486921|FG000|Extended Follow-up|Adverse Event|1|||
155016778|NCT03331796|559486922|FG001|Extended Follow-up|Adverse Event|0|||
155016779|NCT03331796|559486923|FG002|Extended Follow-up|Adverse Event|1|||
155016780|NCT03331796|559486921|FG000|Extended Follow-up|Lost to Follow-up|0|||
155016781|NCT03331796|559486922|FG001|Extended Follow-up|Lost to Follow-up|0|||
155016782|NCT03331796|559486923|FG002|Extended Follow-up|Lost to Follow-up|1|||
155016783|NCT03331796|559486921|FG000|Extended Follow-up|Withdrawal by Subject|1|||
155016784|NCT03331796|559486922|FG001|Extended Follow-up|Withdrawal by Subject|0|||
155016785|NCT03331796|559486923|FG002|Extended Follow-up|Withdrawal by Subject|0|||
155016786|NCT03331796|559486921|FG000|Extended Follow-up|Termination of Funding|0|||
155138964|NCT00264537|559940655|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
155138965|NCT00264537|559940656|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
155138966|NCT00264537|559940653|FG000|Overall Study|Other|21|||
155138967|NCT00264537|559940654|FG001|Overall Study|Other|11|||
155138968|NCT00264537|559940655|FG002|Overall Study|Other|10|||
155138969|NCT00264537|559940656|FG003|Overall Study|Other|11|||
155138970|NCT00264537|559940653|FG000|Overall Study|Not treated|0|||
155016787|NCT03331796|559486922|FG001|Extended Follow-up|Termination of Funding|1|||
155016788|NCT03331796|559486923|FG002|Extended Follow-up|Termination of Funding|0|||
155016789|NCT01808066|559486926|FG000|Overall Study|Withdrawal by Subject|15|||
155016790|NCT01420068|559486932|FG000|Overall Study|Administrative problems|1|||
155016791|NCT01420068|559486933|FG001|Overall Study|Administrative problems|3|||
155016792|NCT01420068|559486932|FG000|Overall Study|Withdrawal by Subject|1|||
155016793|NCT01420068|559486933|FG001|Overall Study|Withdrawal by Subject|2|||
155016794|NCT00365794|559486934|FG000|Overall Study|Withdrawal by Subject|2|||
155016795|NCT02554682|559486935|FG000|Overall Study|Lost to Follow-up|11|||
155138971|NCT00264537|559940654|FG001|Overall Study|Not treated|2|||
155016796|NCT02554682|559486936|FG001|Overall Study|Lost to Follow-up|9|||
155016797|NCT02554682|559486937|FG002|Overall Study|Lost to Follow-up|4|||
155016798|NCT02554682|559486938|FG003|Overall Study|Lost to Follow-up|3|||
155016799|NCT02554682|559486939|FG004|Overall Study|Lost to Follow-up|2|||
155016800|NCT02554682|559486940|FG005|Overall Study|Lost to Follow-up|1|||
155016801|NCT02554682|559486941|FG006|Overall Study|Lost to Follow-up|6|||
155016802|NCT02554682|559486942|FG007|Overall Study|Lost to Follow-up|6|||
155016803|NCT02554682|559486943|FG008|Overall Study|Lost to Follow-up|2|||
155016804|NCT02554682|559486944|FG009|Overall Study|Lost to Follow-up|2|||
155016805|NCT02554682|559486935|FG000|Overall Study|Withdrawal by Subject|2|||
155016806|NCT02554682|559486936|FG001|Overall Study|Withdrawal by Subject|1|||
155016807|NCT02554682|559486937|FG002|Overall Study|Withdrawal by Subject|0|||
155016808|NCT02554682|559486938|FG003|Overall Study|Withdrawal by Subject|0|||
155016809|NCT02554682|559486939|FG004|Overall Study|Withdrawal by Subject|0|||
155016810|NCT02554682|559486940|FG005|Overall Study|Withdrawal by Subject|0|||
155016811|NCT02554682|559486941|FG006|Overall Study|Withdrawal by Subject|0|||
155016812|NCT02554682|559486942|FG007|Overall Study|Withdrawal by Subject|0|||
155016813|NCT02554682|559486943|FG008|Overall Study|Withdrawal by Subject|0|||
155016814|NCT02554682|559486944|FG009|Overall Study|Withdrawal by Subject|0|||
155016815|NCT02554682|559486935|FG000|Overall Study|Physician Decision|2|||
155016816|NCT02554682|559486936|FG001|Overall Study|Physician Decision|2|||
155016817|NCT02554682|559486937|FG002|Overall Study|Physician Decision|0|||
155016818|NCT02554682|559486938|FG003|Overall Study|Physician Decision|0|||
155016819|NCT02554682|559486939|FG004|Overall Study|Physician Decision|0|||
155016820|NCT02554682|559486940|FG005|Overall Study|Physician Decision|0|||
155016821|NCT02554682|559486941|FG006|Overall Study|Physician Decision|0|||
155016822|NCT02554682|559486942|FG007|Overall Study|Physician Decision|0|||
155016823|NCT02554682|559486943|FG008|Overall Study|Physician Decision|0|||
155016824|NCT02554682|559486944|FG009|Overall Study|Physician Decision|0|||
155016825|NCT00884117|559486945|FG000|Overall Study|Adverse Event|2|||
155016826|NCT00884117|559486945|FG000|Overall Study|Withdrawal by Subject|89|||
155016827|NCT00884117|559486945|FG000|Overall Study|Death|3|||
155016828|NCT00884117|559486945|FG000|Overall Study|Lost to Follow-up|143|||
155016829|NCT00884117|559486945|FG000|Overall Study|Other|12|||
155016830|NCT01753310|559486946|FG000|Overall Study|Entered into open label extension study|25|||
155016831|NCT01753310|559486947|FG001|Overall Study|Entered into open label extension study|22|||
155016832|NCT01753310|559486946|FG000|Overall Study|Adverse Event|1|||
155016833|NCT01753310|559486947|FG001|Overall Study|Adverse Event|0|||
155016834|NCT01753310|559486946|FG000|Overall Study|Lost to Follow-up|2|||
155016835|NCT01753310|559486947|FG001|Overall Study|Lost to Follow-up|0|||
155016836|NCT01753310|559486946|FG000|Overall Study|Subject decision|2|||
155016837|NCT01753310|559486947|FG001|Overall Study|Subject decision|2|||
155016838|NCT01753310|559486946|FG000|Overall Study|Sponsor decision|1|||
155016839|NCT01753310|559486947|FG001|Overall Study|Sponsor decision|0|||
155016840|NCT01753310|559486946|FG000|Overall Study|Withdrawal by Subject|1|||
155016841|NCT01753310|559486947|FG001|Overall Study|Withdrawal by Subject|0|||
155016842|NCT01580670|559486948|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
155016843|NCT01580670|559486948|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
155016844|NCT05581641|559486949|FG000|Overall Study|Withdrawal by Subject|0|||
155016845|NCT05581641|559486950|FG001|Overall Study|Withdrawal by Subject|1|||
155016846|NCT05581641|559486951|FG002|Overall Study|Withdrawal by Subject|3|||
155016847|NCT05581641|559486952|FG003|Overall Study|Withdrawal by Subject|1|||
155016848|NCT05581641|559486949|FG000|Overall Study|Lost to Follow-up|0|||
155016849|NCT05581641|559486950|FG001|Overall Study|Lost to Follow-up|1|||
155016850|NCT05581641|559486951|FG002|Overall Study|Lost to Follow-up|0|||
155016851|NCT05581641|559486952|FG003|Overall Study|Lost to Follow-up|1|||
155016852|NCT05581641|559486949|FG000|Overall Study|Protocol Violation|1|||
155016853|NCT05581641|559486950|FG001|Overall Study|Protocol Violation|0|||
155016854|NCT05581641|559486951|FG002|Overall Study|Protocol Violation|0|||
155016855|NCT05581641|559486952|FG003|Overall Study|Protocol Violation|0|||
155016856|NCT05581641|559486949|FG000|Overall Study|Other|1|||
155016857|NCT05581641|559486950|FG001|Overall Study|Other|0|||
155016858|NCT05581641|559486951|FG002|Overall Study|Other|2|||
155016859|NCT05581641|559486952|FG003|Overall Study|Other|1|||
155016860|NCT04390763|559486953|FG000|Safety run-in Part|Adverse Event|4|||
155016861|NCT04390763|559486954|FG001|Safety run-in Part|Adverse Event|0|||
155016862|NCT04390763|559486955|FG002|Safety run-in Part|Adverse Event|0|||
155016863|NCT04390763|559486956|FG003|Safety run-in Part|Adverse Event|0|||
155016864|NCT04390763|559486953|FG000|Safety run-in Part|Physician Decision|1|||
155016865|NCT04390763|559486954|FG001|Safety run-in Part|Physician Decision|0|||
155016866|NCT04390763|559486955|FG002|Safety run-in Part|Physician Decision|0|||
155016867|NCT04390763|559486956|FG003|Safety run-in Part|Physician Decision|0|||
155016868|NCT04390763|559486953|FG000|Safety run-in Part|Progressive Disease|6|||
155016869|NCT04390763|559486954|FG001|Safety run-in Part|Progressive Disease|0|||
155016870|NCT04390763|559486955|FG002|Safety run-in Part|Progressive Disease|0|||
155016871|NCT04390763|559486956|FG003|Safety run-in Part|Progressive Disease|0|||
155016872|NCT04390763|559486953|FG000|Randomized Part|Adverse Event|0|||
155016873|NCT04390763|559486954|FG001|Randomized Part|Adverse Event|11|||
155016874|NCT04390763|559486955|FG002|Randomized Part|Adverse Event|5|||
155016875|NCT04390763|559486956|FG003|Randomized Part|Adverse Event|5|||
155016876|NCT04390763|559486953|FG000|Randomized Part|Death|0|||
155016877|NCT04390763|559486954|FG001|Randomized Part|Death|3|||
155016878|NCT04390763|559486955|FG002|Randomized Part|Death|4|||
155016879|NCT04390763|559486956|FG003|Randomized Part|Death|2|||
155016880|NCT04390763|559486953|FG000|Randomized Part|Physician Decision|0|||
155016881|NCT04390763|559486954|FG001|Randomized Part|Physician Decision|2|||
155016882|NCT04390763|559486955|FG002|Randomized Part|Physician Decision|2|||
155016883|NCT04390763|559486956|FG003|Randomized Part|Physician Decision|9|||
155016884|NCT04390763|559486953|FG000|Randomized Part|Progressive Disease|0|||
155016885|NCT04390763|559486954|FG001|Randomized Part|Progressive Disease|24|||
155016886|NCT04390763|559486955|FG002|Randomized Part|Progressive Disease|31|||
155016887|NCT04390763|559486956|FG003|Randomized Part|Progressive Disease|23|||
155016888|NCT04390763|559486953|FG000|Randomized Part|Study terminated by sponsor|0|||
155016889|NCT04390763|559486954|FG001|Randomized Part|Study terminated by sponsor|1|||
155016890|NCT04390763|559486955|FG002|Randomized Part|Study terminated by sponsor|0|||
155016891|NCT04390763|559486956|FG003|Randomized Part|Study terminated by sponsor|0|||
155016892|NCT04390763|559486953|FG000|Randomized Part|Participant Decision|0|||
155016893|NCT04390763|559486954|FG001|Randomized Part|Participant Decision|5|||
155016894|NCT04390763|559486955|FG002|Randomized Part|Participant Decision|7|||
155016895|NCT04390763|559486956|FG003|Randomized Part|Participant Decision|6|||
155016896|NCT04390763|559486953|FG000|Randomized Part|Not treated|0|||
155016897|NCT04390763|559486954|FG001|Randomized Part|Not treated|4|||
155016898|NCT04390763|559486955|FG002|Randomized Part|Not treated|2|||
155016899|NCT04390763|559486956|FG003|Randomized Part|Not treated|7|||
155016900|NCT01383174|559486959|FG000|3 Month Assessment|Death|0|||
155016901|NCT01383174|559486960|FG001|3 Month Assessment|Death|1|||
155016902|NCT01383174|559486959|FG000|3 Month Assessment|Lost to Follow-up|2|||
155016903|NCT01383174|559486960|FG001|3 Month Assessment|Lost to Follow-up|0|||
155016904|NCT01383174|559486959|FG000|3 Month Assessment|Refused to complete|4|||
155016905|NCT01383174|559486960|FG001|3 Month Assessment|Refused to complete|0|||
155016906|NCT01383174|559486959|FG000|6 Month Assessment|Lost to Follow-up|1|||
155016907|NCT01383174|559486960|FG001|6 Month Assessment|Lost to Follow-up|1|||
155016908|NCT01383174|559486959|FG000|6 Month Assessment|Refused to complete|4|||
155016909|NCT01383174|559486960|FG001|6 Month Assessment|Refused to complete|0|||
155016910|NCT01153815|559486961|FG000|Overall Study|Adverse Event|3|||
155016911|NCT01153815|559486962|FG001|Overall Study|Adverse Event|1|||
155016912|NCT01153815|559486961|FG000|Overall Study|Withdrawal by Subject|6|||
155016913|NCT01153815|559486962|FG001|Overall Study|Withdrawal by Subject|4|||
155016914|NCT01786993|559486965|FG000|Overall Study|Death|6|||
155016915|NCT01786993|559486966|FG001|Overall Study|Death|7|||
155016916|NCT01786993|559486965|FG000|Overall Study|Withdrawal by Subject|3|||
155016917|NCT01786993|559486966|FG001|Overall Study|Withdrawal by Subject|2|||
155016918|NCT01786993|559486965|FG000|Overall Study|Lost to Follow-up|0|||
155016919|NCT01786993|559486966|FG001|Overall Study|Lost to Follow-up|1|||
155138972|NCT00264537|559940655|FG002|Overall Study|Not treated|1|||
155138973|NCT00264537|559940656|FG003|Overall Study|Not treated|0|||
155138974|NCT02834247|559940657|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
155138975|NCT02834247|559940658|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
155138976|NCT02834247|559940659|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
155138977|NCT02834247|559940660|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
155138978|NCT02834247|559940657|FG000|Dose Escalation Phase|Death|5|||
155138979|NCT02834247|559940658|FG001|Dose Escalation Phase|Death|6|||
155138980|NCT02834247|559940659|FG002|Dose Escalation Phase|Death|5|||
155138981|NCT02834247|559940660|FG003|Dose Escalation Phase|Death|0|||
155138982|NCT02834247|559940657|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
155138983|NCT02834247|559940658|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
155138984|NCT02834247|559940659|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
155138985|NCT02834247|559940660|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
155138986|NCT02834247|559940657|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
155138987|NCT02834247|559940658|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
155138988|NCT02834247|559940659|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155138989|NCT02834247|559940660|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155138990|NCT02834247|559940657|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
155138991|NCT02834247|559940658|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
155138992|NCT02834247|559940659|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
155016920|NCT01786993|559486965|FG000|Overall Study|Subject Non-Compliance|1|||
155016921|NCT01786993|559486966|FG001|Overall Study|Subject Non-Compliance|0|||
155016922|NCT01786993|559486965|FG000|Overall Study|System Explant|1|||
155016923|NCT01786993|559486966|FG001|Overall Study|System Explant|0|||
155016924|NCT01786993|559486965|FG000|Overall Study|Hospice Admission|1|||
155138993|NCT02834247|559940660|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
155016925|NCT01786993|559486966|FG001|Overall Study|Hospice Admission|0|||
155016926|NCT00450437|559486967|FG000|Overall Study|Withdrawal by Subject|10|||
155016927|NCT00450437|559486968|FG001|Overall Study|Withdrawal by Subject|2|||
155016928|NCT00450437|559486969|FG002|Overall Study|Withdrawal by Subject|0|||
155016929|NCT00450437|559486970|FG003|Overall Study|Withdrawal by Subject|1|||
155016930|NCT00450437|559486967|FG000|Overall Study|Lost to Follow-up|31|||
155016931|NCT00450437|559486968|FG001|Overall Study|Lost to Follow-up|12|||
155016932|NCT00450437|559486969|FG002|Overall Study|Lost to Follow-up|19|||
155016933|NCT00450437|559486970|FG003|Overall Study|Lost to Follow-up|9|||
155016934|NCT00450437|559486967|FG000|Overall Study|Protocol Violation|0|||
155016935|NCT00450437|559486968|FG001|Overall Study|Protocol Violation|1|||
155016936|NCT00450437|559486969|FG002|Overall Study|Protocol Violation|0|||
155016937|NCT00450437|559486970|FG003|Overall Study|Protocol Violation|1|||
155016938|NCT00450437|559486967|FG000|Overall Study|Inappropriate enrollment|4|||
155016939|NCT00450437|559486968|FG001|Overall Study|Inappropriate enrollment|1|||
155016940|NCT00450437|559486969|FG002|Overall Study|Inappropriate enrollment|3|||
155016941|NCT00450437|559486970|FG003|Overall Study|Inappropriate enrollment|0|||
155016942|NCT00450437|559486967|FG000|Overall Study|Administrative reason|0|||
155016943|NCT00450437|559486968|FG001|Overall Study|Administrative reason|0|||
155016944|NCT00450437|559486969|FG002|Overall Study|Administrative reason|1|||
155016945|NCT00450437|559486970|FG003|Overall Study|Administrative reason|0|||
155016946|NCT00450437|559486967|FG000|Overall Study|Unable to Classify|1|||
155016947|NCT00450437|559486968|FG001|Overall Study|Unable to Classify|0|||
155016948|NCT00450437|559486969|FG002|Overall Study|Unable to Classify|1|||
155016949|NCT00450437|559486970|FG003|Overall Study|Unable to Classify|0|||
155016950|NCT01890122|559486971|FG000|Overall Study|Adverse Event|1|||
155016951|NCT01890122|559486972|FG001|Overall Study|Adverse Event|1|||
155016952|NCT01890122|559486973|FG002|Overall Study|Adverse Event|1|||
155016953|NCT01890122|559486974|FG003|Overall Study|Adverse Event|2|||
155016954|NCT01890122|559486971|FG000|Overall Study|Major Protocol Deviation|3|||
155016955|NCT01890122|559486972|FG001|Overall Study|Major Protocol Deviation|1|||
155016956|NCT01890122|559486973|FG002|Overall Study|Major Protocol Deviation|0|||
155016957|NCT01890122|559486974|FG003|Overall Study|Major Protocol Deviation|1|||
155016958|NCT01890122|559486971|FG000|Overall Study|Lost to Follow-up|0|||
155016959|NCT01890122|559486972|FG001|Overall Study|Lost to Follow-up|1|||
155016960|NCT01890122|559486973|FG002|Overall Study|Lost to Follow-up|2|||
155016961|NCT01890122|559486974|FG003|Overall Study|Lost to Follow-up|2|||
155016962|NCT01890122|559486971|FG000|Overall Study|Voluntary Withdrawal|8|||
155016963|NCT01890122|559486972|FG001|Overall Study|Voluntary Withdrawal|8|||
155016964|NCT01890122|559486973|FG002|Overall Study|Voluntary Withdrawal|2|||
155016965|NCT01890122|559486974|FG003|Overall Study|Voluntary Withdrawal|11|||
155016966|NCT01890122|559486971|FG000|Overall Study|Lack of Efficacy|14|||
155016967|NCT01890122|559486972|FG001|Overall Study|Lack of Efficacy|24|||
155016968|NCT01890122|559486973|FG002|Overall Study|Lack of Efficacy|7|||
155016969|NCT01890122|559486974|FG003|Overall Study|Lack of Efficacy|41|||
155016970|NCT01890122|559486971|FG000|Overall Study|Reason not Specified|0|||
155016971|NCT01890122|559486972|FG001|Overall Study|Reason not Specified|1|||
155016972|NCT01890122|559486973|FG002|Overall Study|Reason not Specified|1|||
155016973|NCT01890122|559486974|FG003|Overall Study|Reason not Specified|2|||
155016974|NCT01890122|559486971|FG000|Overall Study|Randomized but not Treated|1|||
155016975|NCT01890122|559486972|FG001|Overall Study|Randomized but not Treated|1|||
155016976|NCT01890122|559486973|FG002|Overall Study|Randomized but not Treated|0|||
155016977|NCT01890122|559486974|FG003|Overall Study|Randomized but not Treated|0|||
155016978|NCT01565889|559486975|FG000|Part A|Withdrawal by Subject|1|||
155016979|NCT01565889|559486976|FG001|Part A|Withdrawal by Subject|0|||
155016980|NCT01565889|559486977|FG002|Part A|Withdrawal by Subject|0|||
155016981|NCT01565889|559486978|FG003|Part A|Withdrawal by Subject|0|||
155016982|NCT01565889|559486979|FG004|Part A|Withdrawal by Subject|0|||
155016983|NCT01565889|559486980|FG005|Part A|Withdrawal by Subject|0|||
155016984|NCT01565889|559486975|FG000|Part B|Withdrawal by Subject|0|||
155016985|NCT01565889|559486976|FG001|Part B|Withdrawal by Subject|0|||
155016986|NCT01565889|559486977|FG002|Part B|Withdrawal by Subject|0|||
155016987|NCT01565889|559486978|FG003|Part B|Withdrawal by Subject|0|||
155016988|NCT01565889|559486979|FG004|Part B|Withdrawal by Subject|0|||
155016989|NCT01565889|559486980|FG005|Part B|Withdrawal by Subject|1|||
155016990|NCT01565889|559486975|FG000|Part B|Lack of Efficacy|0|||
155016991|NCT01565889|559486976|FG001|Part B|Lack of Efficacy|0|||
155016992|NCT01565889|559486977|FG002|Part B|Lack of Efficacy|0|||
155016993|NCT01565889|559486978|FG003|Part B|Lack of Efficacy|0|||
155016994|NCT01565889|559486979|FG004|Part B|Lack of Efficacy|0|||
155016995|NCT01565889|559486980|FG005|Part B|Lack of Efficacy|2|||
155016996|NCT01565889|559486975|FG000|Part B|Lost to Follow-up|0|||
155016997|NCT01565889|559486976|FG001|Part B|Lost to Follow-up|0|||
155016998|NCT01565889|559486977|FG002|Part B|Lost to Follow-up|0|||
155016999|NCT01565889|559486978|FG003|Part B|Lost to Follow-up|0|||
155017000|NCT01565889|559486979|FG004|Part B|Lost to Follow-up|0|||
155017001|NCT01565889|559486980|FG005|Part B|Lost to Follow-up|1|||
155017002|NCT00122382|559486981|FG000|Double-Blind Study|Adverse Event|9|||
155017003|NCT00122382|559486982|FG001|Double-Blind Study|Adverse Event|11|||
155017004|NCT00122382|559486983|FG002|Double-Blind Study|Adverse Event|0|||
155017005|NCT00122382|559486981|FG000|Double-Blind Study|Death|2|||
155017006|NCT00122382|559486982|FG001|Double-Blind Study|Death|2|||
155017007|NCT00122382|559486983|FG002|Double-Blind Study|Death|0|||
155017008|NCT00122382|559486981|FG000|Double-Blind Study|Lack of Efficacy|0|||
155017009|NCT00122382|559486982|FG001|Double-Blind Study|Lack of Efficacy|8|||
155017010|NCT00122382|559486983|FG002|Double-Blind Study|Lack of Efficacy|0|||
155017011|NCT00122382|559486981|FG000|Double-Blind Study|Lost to Follow-up|2|||
155017012|NCT00122382|559486982|FG001|Double-Blind Study|Lost to Follow-up|1|||
155017013|NCT00122382|559486983|FG002|Double-Blind Study|Lost to Follow-up|0|||
155017014|NCT00122382|559486981|FG000|Double-Blind Study|Pregnancy|2|||
155017015|NCT00122382|559486982|FG001|Double-Blind Study|Pregnancy|0|||
155017016|NCT00122382|559486983|FG002|Double-Blind Study|Pregnancy|0|||
155017017|NCT00122382|559486981|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
155017018|NCT00122382|559486982|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
155017019|NCT00122382|559486983|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
155017020|NCT00122382|559486981|FG000|Double-Blind Study|Withdrawal of Consent|7|||
155017021|NCT00122382|559486982|FG001|Double-Blind Study|Withdrawal of Consent|3|||
155017022|NCT00122382|559486983|FG002|Double-Blind Study|Withdrawal of Consent|0|||
155017023|NCT00122382|559486981|FG000|Double-Blind Study|Protocol Violation|1|||
155017024|NCT00122382|559486982|FG001|Double-Blind Study|Protocol Violation|0|||
155017025|NCT00122382|559486983|FG002|Double-Blind Study|Protocol Violation|0|||
155017026|NCT00122382|559486981|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
155017027|NCT00122382|559486982|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
155017028|NCT00122382|559486983|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
155017029|NCT00122382|559486981|FG000|Double-Blind Study|Randomized but not treated|0|||
155017030|NCT00122382|559486982|FG001|Double-Blind Study|Randomized but not treated|2|||
155017031|NCT00122382|559486983|FG002|Double-Blind Study|Randomized but not treated|0|||
155017032|NCT00122382|559486981|FG000|Open-Label Study|Adverse Event|0|||
155017033|NCT00122382|559486982|FG001|Open-Label Study|Adverse Event|0|||
155017034|NCT00122382|559486983|FG002|Open-Label Study|Adverse Event|11|||
155017035|NCT00122382|559486981|FG000|Open-Label Study|Death|0|||
155017036|NCT00122382|559486982|FG001|Open-Label Study|Death|0|||
155017037|NCT00122382|559486983|FG002|Open-Label Study|Death|2|||
155017038|NCT00122382|559486981|FG000|Open-Label Study|Lack of Efficacy|0|||
155017039|NCT00122382|559486982|FG001|Open-Label Study|Lack of Efficacy|0|||
155017040|NCT00122382|559486983|FG002|Open-Label Study|Lack of Efficacy|3|||
155017041|NCT00122382|559486981|FG000|Open-Label Study|Lost to Follow-up|0|||
155017042|NCT00122382|559486982|FG001|Open-Label Study|Lost to Follow-up|0|||
155017043|NCT00122382|559486983|FG002|Open-Label Study|Lost to Follow-up|3|||
155017044|NCT00122382|559486981|FG000|Open-Label Study|Pregnancy|0|||
155017045|NCT00122382|559486982|FG001|Open-Label Study|Pregnancy|0|||
155017046|NCT00122382|559486983|FG002|Open-Label Study|Pregnancy|2|||
155017047|NCT00122382|559486981|FG000|Open-Label Study|Poor/Non-Compliance|0|||
155017048|NCT00122382|559486982|FG001|Open-Label Study|Poor/Non-Compliance|0|||
155017049|NCT00122382|559486983|FG002|Open-Label Study|Poor/Non-Compliance|1|||
155017050|NCT00122382|559486981|FG000|Open-Label Study|Withdrawal of Consent|0|||
155017051|NCT00122382|559486982|FG001|Open-Label Study|Withdrawal of Consent|0|||
155017052|NCT00122382|559486983|FG002|Open-Label Study|Withdrawal of Consent|4|||
155017053|NCT02040805|559486984|FG000|Overall Study|Lost to Follow-up|14|||
155017054|NCT02040805|559486985|FG001|Overall Study|Lost to Follow-up|9|||
155017055|NCT02040805|559486984|FG000|Overall Study|Withdrawal by Subject|28|||
155017056|NCT02040805|559486985|FG001|Overall Study|Withdrawal by Subject|41|||
155017057|NCT03591874|559486986|FG000|Overall Study|Adverse Event|4|||
155017058|NCT03591874|559486987|FG001|Overall Study|Adverse Event|0|||
155017059|NCT03591874|559486986|FG000|Overall Study|Withdrawal by Subject|2|||
155017060|NCT03591874|559486987|FG001|Overall Study|Withdrawal by Subject|1|||
155017061|NCT03591874|559486986|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
155017062|NCT03591874|559486987|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
155017063|NCT03591874|559486986|FG000|Overall Study|On Study at Time of Study Termination|12|||
155017064|NCT03591874|559486987|FG001|Overall Study|On Study at Time of Study Termination|6|||
155017065|NCT00071110|559486988|FG000|Overall Study|Protocol Violation|0|||
155017066|NCT00071110|559486989|FG001|Overall Study|Protocol Violation|4|||
155017067|NCT02166333|559486993|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
155017068|NCT02166333|559486994|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
155017069|NCT02166333|559486995|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
155138994|NCT02834247|559940657|FG000|Dose Expansion Phase|Death|0|||
155017070|NCT02166333|559486996|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
155017071|NCT02166333|559486997|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
155017072|NCT02166333|559486998|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
155017073|NCT02166333|559486993|FG000|Stage 1|Death|4|||
155017074|NCT02166333|559486994|FG001|Stage 1|Death|0|||
155017075|NCT02166333|559486995|FG002|Stage 1|Death|2|||
155017076|NCT02166333|559486996|FG003|Stage 1|Death|0|||
155017077|NCT02166333|559486997|FG004|Stage 1|Death|3|||
155017078|NCT02166333|559486998|FG005|Stage 1|Death|2|||
155017079|NCT02166333|559486993|FG000|Stage 1|Lost to Follow-up|12|||
155017080|NCT02166333|559486994|FG001|Stage 1|Lost to Follow-up|0|||
155017081|NCT02166333|559486995|FG002|Stage 1|Lost to Follow-up|6|||
155017082|NCT02166333|559486996|FG003|Stage 1|Lost to Follow-up|0|||
155017083|NCT02166333|559486997|FG004|Stage 1|Lost to Follow-up|3|||
155017084|NCT02166333|559486998|FG005|Stage 1|Lost to Follow-up|3|||
155017085|NCT02166333|559486993|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
155017086|NCT02166333|559486994|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
155017087|NCT02166333|559486995|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
155017088|NCT02166333|559486996|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
155017089|NCT02166333|559486997|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
155017090|NCT02166333|559486998|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
155017091|NCT02166333|559486993|FG000|Stage 2|Death|4|||
155017092|NCT02166333|559486994|FG001|Stage 2|Death|2|||
155017093|NCT02166333|559486995|FG002|Stage 2|Death|1|||
155017094|NCT02166333|559486996|FG003|Stage 2|Death|0|||
155017095|NCT02166333|559486997|FG004|Stage 2|Death|0|||
155017096|NCT02166333|559486998|FG005|Stage 2|Death|1|||
155017097|NCT02166333|559486993|FG000|Stage 2|Lost to Follow-up|23|||
155017098|NCT02166333|559486994|FG001|Stage 2|Lost to Follow-up|4|||
155017099|NCT02166333|559486995|FG002|Stage 2|Lost to Follow-up|11|||
155017100|NCT02166333|559486996|FG003|Stage 2|Lost to Follow-up|9|||
155017101|NCT02166333|559486997|FG004|Stage 2|Lost to Follow-up|3|||
155017102|NCT02166333|559486998|FG005|Stage 2|Lost to Follow-up|6|||
155017103|NCT02269098|559486999|FG000|Overall Study|Lost to Follow-up|14|||
155017104|NCT02269098|559487000|FG001|Overall Study|Lost to Follow-up|9|||
155017105|NCT03644342|559487005|FG000|Overall Study|Adverse Event|2|||
155017106|NCT03644342|559487006|FG001|Overall Study|Adverse Event|0|||
155017107|NCT03644342|559487005|FG000|Overall Study|Protocol Violation|0|||
155017108|NCT03644342|559487006|FG001|Overall Study|Protocol Violation|1|||
155017109|NCT03655405|559487007|FG000|Overall Study|Death after initial data collection|4|||
155017110|NCT03655405|559487008|FG001|Overall Study|Death after initial data collection|2|||
155017111|NCT03655405|559487007|FG000|Overall Study|Died before initial data collection|1|||
155017112|NCT03655405|559487008|FG001|Overall Study|Died before initial data collection|2|||
155017113|NCT03655405|559487007|FG000|Overall Study|Protocol Violation|0|||
155017114|NCT03655405|559487008|FG001|Overall Study|Protocol Violation|1|||
155017115|NCT01991743|559487009|FG000|Overall Study|external cephalic version not performed|0|||
155017116|NCT01991743|559487010|FG001|Overall Study|external cephalic version not performed|0|||
155017117|NCT01991743|559487011|FG002|Overall Study|external cephalic version not performed|1|||
155017118|NCT01991743|559487012|FG003|Overall Study|external cephalic version not performed|0|||
155017119|NCT04390113|559487013|FG000|Overall Study|Not Treated|0|||
155017120|NCT04390113|559487014|FG001|Overall Study|Not Treated|1|||
155017121|NCT04390113|559487013|FG000|Overall Study|Adverse Event|1|||
155017122|NCT04390113|559487014|FG001|Overall Study|Adverse Event|0|||
155017123|NCT04390113|559487013|FG000|Overall Study|Death|2|||
155017124|NCT04390113|559487014|FG001|Overall Study|Death|1|||
155017125|NCT04390113|559487013|FG000|Overall Study|Physician Decision|1|||
155017126|NCT04390113|559487014|FG001|Overall Study|Physician Decision|3|||
155017127|NCT04390113|559487013|FG000|Overall Study|Study Terminated by Sponsor|5|||
155017128|NCT04390113|559487014|FG001|Overall Study|Study Terminated by Sponsor|3|||
155017129|NCT04390113|559487013|FG000|Overall Study|Withdrawal by Subject|10|||
155017130|NCT04390113|559487014|FG001|Overall Study|Withdrawal by Subject|5|||
155017131|NCT04390113|559487013|FG000|Overall Study|Other|1|||
155017132|NCT04390113|559487014|FG001|Overall Study|Other|0|||
155017133|NCT04390113|559487013|FG000|Overall Study|Missing|0|||
155017134|NCT04390113|559487014|FG001|Overall Study|Missing|1|||
155017135|NCT01682226|559488136|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
155017136|NCT01682226|559488136|FG000|Overall Study|Participants did not receive treatment|2|||
155017137|NCT01682226|559488136|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
155017138|NCT03771898|559488137|FG000|Overall Study|Adverse Event|1|||
155017139|NCT03771898|559488138|FG001|Overall Study|Adverse Event|0|||
155017140|NCT03771898|559488139|FG002|Overall Study|Adverse Event|0|||
155017141|NCT03771898|559488140|FG003|Overall Study|Adverse Event|0|||
155017142|NCT03771898|559488141|FG004|Overall Study|Adverse Event|0|||
155017143|NCT03771898|559488137|FG000|Overall Study|Lost to Follow-up|1|||
155179221|NCT00761150|560095043|FG002|Double-blind Period|Lack of Efficacy|19|||
155179222|NCT00761150|560095041|FG000|Double-blind Period|Adverse Event|0|||
155017144|NCT03771898|559488138|FG001|Overall Study|Lost to Follow-up|1|||
155017145|NCT03771898|559488139|FG002|Overall Study|Lost to Follow-up|1|||
155017146|NCT03771898|559488140|FG003|Overall Study|Lost to Follow-up|0|||
155017147|NCT03771898|559488141|FG004|Overall Study|Lost to Follow-up|0|||
155017148|NCT03771898|559488137|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155017149|NCT03771898|559488138|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155017150|NCT03771898|559488139|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155017151|NCT03771898|559488140|FG003|Overall Study|Withdrawal by parent/guardian|0|||
155017152|NCT03771898|559488141|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155017153|NCT03771898|559488137|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155017154|NCT03771898|559488138|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155017155|NCT03771898|559488139|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155017156|NCT03771898|559488140|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
155017157|NCT03771898|559488141|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
155017158|NCT03135548|559488142|FG000|Overall Study|Lost to Follow-up|3|||
155017159|NCT03135548|559488143|FG001|Overall Study|Lost to Follow-up|0|||
155017160|NCT03135548|559488144|FG002|Overall Study|Lost to Follow-up|0|||
155017161|NCT03135548|559488142|FG000|Overall Study|Withdrawal by Subject|2|||
155017162|NCT03135548|559488143|FG001|Overall Study|Withdrawal by Subject|2|||
155017163|NCT03135548|559488144|FG002|Overall Study|Withdrawal by Subject|1|||
155017164|NCT03135548|559488142|FG000|Overall Study|Other than listed|0|||
155017165|NCT03135548|559488143|FG001|Overall Study|Other than listed|2|||
155017166|NCT03135548|559488144|FG002|Overall Study|Other than listed|2|||
155017167|NCT04623216|559488145|FG000|Overall Study|Death|5|||
155017168|NCT04623216|559488146|FG001|Overall Study|Death|2|||
155017169|NCT04623216|559488147|FG002|Overall Study|Death|0|||
155017170|NCT04623216|559488148|FG003|Overall Study|Death|0|||
155017171|NCT04623216|559488145|FG000|Overall Study|Terminated by Sponsor|3|||
155017172|NCT04623216|559488146|FG001|Overall Study|Terminated by Sponsor|2|||
155017173|NCT04623216|559488147|FG002|Overall Study|Terminated by Sponsor|2|||
155017174|NCT04623216|559488148|FG003|Overall Study|Terminated by Sponsor|0|||
155017175|NCT04623216|559488145|FG000|Overall Study|Physician Decision|1|||
155017176|NCT04623216|559488146|FG001|Overall Study|Physician Decision|0|||
155017177|NCT04623216|559488147|FG002|Overall Study|Physician Decision|0|||
155017178|NCT04623216|559488148|FG003|Overall Study|Physician Decision|0|||
155017179|NCT03521154|559488151|FG000|Overall Study|Ongoing study at data cut-off|111|||
155017180|NCT03521154|559488152|FG001|Overall Study|Ongoing study at data cut-off|52|||
155017181|NCT05386680|559488153|FG000|Overall Study|Guardian decision|2|||
155017182|NCT04168112|559488156|FG000|Overall Study|Lost to Follow-up|1|||
155017183|NCT04168112|559488157|FG001|Overall Study|Lost to Follow-up|0|||
155017184|NCT04168112|559488156|FG000|Overall Study|Withdrawal by Subject|1|||
155017185|NCT04168112|559488157|FG001|Overall Study|Withdrawal by Subject|0|||
155017186|NCT00455403|559488158|FG000|Overall Study|Lost to Follow-up|2|||
155017187|NCT00455403|559488159|FG001|Overall Study|Lost to Follow-up|1|||
155017188|NCT00455403|559488158|FG000|Overall Study|Withdrawal by Subject|1|||
155017189|NCT00455403|559488159|FG001|Overall Study|Withdrawal by Subject|3|||
155017190|NCT00455403|559488158|FG000|Overall Study|Protocol Violation|0|||
155017191|NCT00455403|559488159|FG001|Overall Study|Protocol Violation|2|||
155017192|NCT00449865|559488160|FG000|Overall Study|Withdrawal by Subject|110|||
155017193|NCT00449865|559488161|FG001|Overall Study|Withdrawal by Subject|110|||
155017194|NCT00449865|559488160|FG000|Overall Study|Lost to Follow-up|36|||
155017195|NCT00449865|559488161|FG001|Overall Study|Lost to Follow-up|37|||
155017196|NCT00449865|559488160|FG000|Overall Study|Physician Decision|13|||
155017197|NCT00449865|559488161|FG001|Overall Study|Physician Decision|12|||
155017198|NCT00449865|559488160|FG000|Overall Study|Death|31|||
155017199|NCT00449865|559488161|FG001|Overall Study|Death|40|||
155017200|NCT00449865|559488160|FG000|Overall Study|Protocol Violation|8|||
155017201|NCT00449865|559488161|FG001|Overall Study|Protocol Violation|7|||
155017202|NCT00449865|559488160|FG000|Overall Study|Study was stopped|324|||
155017203|NCT00449865|559488161|FG001|Overall Study|Study was stopped|328|||
155017204|NCT00171210|559488162|FG000|Overall Study|Adverse Event|16|||
155017205|NCT00171210|559488163|FG001|Overall Study|Adverse Event|27|||
155017206|NCT00171210|559488162|FG000|Overall Study|Abnormal laboratory value(s)|6|||
155017207|NCT00171210|559488163|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155017208|NCT00171210|559488162|FG000|Overall Study|Abnormal test procedure result(s)|0|||
155017209|NCT00171210|559488163|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155017210|NCT00171210|559488162|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
155017211|NCT00171210|559488163|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
155138995|NCT02834247|559940658|FG001|Dose Expansion Phase|Death|0|||
155138996|NCT02834247|559940659|FG002|Dose Expansion Phase|Death|0|||
155138997|NCT02834247|559940660|FG003|Dose Expansion Phase|Death|8|||
155138998|NCT02834247|559940657|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
155138999|NCT02834247|559940658|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
155139000|NCT02834247|559940659|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
155017212|NCT00171210|559488162|FG000|Overall Study|Protocol Violation|0|||
155017213|NCT00171210|559488163|FG001|Overall Study|Protocol Violation|2|||
155017214|NCT00171210|559488162|FG000|Overall Study|Withdrawal by Subject|32|||
155017215|NCT00171210|559488163|FG001|Overall Study|Withdrawal by Subject|30|||
155017216|NCT00171210|559488162|FG000|Overall Study|Lost to Follow-up|1|||
155139001|NCT02834247|559940660|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
155017217|NCT00171210|559488163|FG001|Overall Study|Lost to Follow-up|0|||
155017218|NCT00171210|559488162|FG000|Overall Study|Administrative problems|1|||
155017219|NCT00171210|559488163|FG001|Overall Study|Administrative problems|1|||
155017220|NCT00171210|559488162|FG000|Overall Study|Death|2|||
155017221|NCT00171210|559488163|FG001|Overall Study|Death|3|||
155017222|NCT00171210|559488162|FG000|Overall Study|Stopped at end of core|0|||
155139002|NCT02834247|559940657|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
155139003|NCT02834247|559940658|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
155017223|NCT00171210|559488163|FG001|Overall Study|Stopped at end of core|32|||
155017224|NCT00171210|559488162|FG000|Overall Study|Stopped at end of extension 1|0|||
155017225|NCT00171210|559488163|FG001|Overall Study|Stopped at end of extension 1|1|||
155017226|NCT03252535|559488165|FG000|Overall Study|Withdrawal by Subject|1|||
155017227|NCT03252535|559488166|FG001|Overall Study|Withdrawal by Subject|0|||
155017228|NCT03252535|559488167|FG002|Overall Study|Withdrawal by Subject|0|||
155017229|NCT03252535|559488165|FG000|Overall Study|Physician Decision|0|||
155017230|NCT03252535|559488166|FG001|Overall Study|Physician Decision|1|||
155017231|NCT03252535|559488167|FG002|Overall Study|Physician Decision|0|||
155017232|NCT03252535|559488165|FG000|Overall Study|Met discontinuation criteria|0|||
155017233|NCT03252535|559488166|FG001|Overall Study|Met discontinuation criteria|1|||
155017234|NCT03252535|559488167|FG002|Overall Study|Met discontinuation criteria|0|||
155017235|NCT00442897|559488176|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
155017236|NCT00442897|559488177|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
155017237|NCT00442897|559488176|FG000|Base Study (12 Week Follow-up)|Death|0|||
155017238|NCT00442897|559488177|FG001|Base Study (12 Week Follow-up)|Death|1|||
155017239|NCT00442897|559488176|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
155017240|NCT00442897|559488177|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
155017241|NCT00442897|559488176|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
155017242|NCT00442897|559488177|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
155017243|NCT00442897|559488176|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
155017244|NCT00442897|559488177|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
155017245|NCT00442897|559488176|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
155017246|NCT00442897|559488177|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
155017247|NCT00442897|559488176|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
155017248|NCT00442897|559488177|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
155017249|NCT00442897|559488176|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
155017250|NCT00442897|559488177|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
155017251|NCT04498182|559488178|FG000|Overall Study|Adverse Event|2|||
155017252|NCT04498182|559488179|FG001|Overall Study|Adverse Event|3|||
155017253|NCT04498182|559488180|FG002|Overall Study|Adverse Event|2|||
155017254|NCT04498182|559488178|FG000|Overall Study|Withdrawal of Consent|3|||
155017255|NCT04498182|559488179|FG001|Overall Study|Withdrawal of Consent|4|||
155017256|NCT04498182|559488180|FG002|Overall Study|Withdrawal of Consent|3|||
155017257|NCT04498182|559488178|FG000|Overall Study|Non-Compliant|1|||
155017258|NCT04498182|559488179|FG001|Overall Study|Non-Compliant|0|||
155017259|NCT04498182|559488180|FG002|Overall Study|Non-Compliant|1|||
155017260|NCT04498182|559488178|FG000|Overall Study|Lost to Follow-up|0|||
155017261|NCT04498182|559488179|FG001|Overall Study|Lost to Follow-up|0|||
155017262|NCT04498182|559488180|FG002|Overall Study|Lost to Follow-up|1|||
155017263|NCT04498182|559488178|FG000|Overall Study|Investigator Decision|0|||
155017264|NCT04498182|559488179|FG001|Overall Study|Investigator Decision|0|||
155017265|NCT04498182|559488180|FG002|Overall Study|Investigator Decision|1|||
155017266|NCT04498182|559488178|FG000|Overall Study|Protocol Violation|1|||
155017267|NCT04498182|559488179|FG001|Overall Study|Protocol Violation|0|||
155017268|NCT04498182|559488180|FG002|Overall Study|Protocol Violation|2|||
155017269|NCT02182843|559488182|FG000|Overall Study|Withdrawal by Subject|7|||
155017270|NCT02182843|559488182|FG000|Overall Study|Lost to Follow-up|2|||
155017271|NCT02182843|559488182|FG000|Overall Study|Adverse Event|1|||
155017272|NCT00503698|559488189|FG000|Overall Study|Protocol Violation|5|||
155017273|NCT00503698|559488190|FG001|Overall Study|Protocol Violation|6|||
155017274|NCT00503698|559488189|FG000|Overall Study|Adverse Event|52|||
155017275|NCT00503698|559488190|FG001|Overall Study|Adverse Event|41|||
155017276|NCT00503698|559488189|FG000|Overall Study|Death|1|||
155017277|NCT00503698|559488190|FG001|Overall Study|Death|0|||
155017278|NCT00503698|559488189|FG000|Overall Study|Lack of Efficacy|3|||
155017279|NCT00503698|559488190|FG001|Overall Study|Lack of Efficacy|4|||
155017280|NCT00503698|559488189|FG000|Overall Study|Trial terminated|216|||
155017281|NCT00503698|559488190|FG001|Overall Study|Trial terminated|253|||
155017282|NCT00503698|559488189|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
155017283|NCT00503698|559488190|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
155017284|NCT00503698|559488189|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
155017285|NCT00503698|559488190|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
155017286|NCT00503698|559488189|FG000|Overall Study|Any condition in exclusion criteria|4|||
155017287|NCT00503698|559488190|FG001|Overall Study|Any condition in exclusion criteria|6|||
155017288|NCT00503698|559488189|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
155017289|NCT00503698|559488190|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
155017290|NCT00503698|559488189|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
155017291|NCT00503698|559488190|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
155017292|NCT00503698|559488189|FG000|Overall Study|Critically ill|2|||
155017293|NCT00503698|559488190|FG001|Overall Study|Critically ill|0|||
155017294|NCT00503698|559488189|FG000|Overall Study|Unclassified|48|||
155017295|NCT00503698|559488190|FG001|Overall Study|Unclassified|32|||
155017296|NCT00503698|559488189|FG000|Overall Study|Not exposed to trial drug|11|||
155017297|NCT00503698|559488190|FG001|Overall Study|Not exposed to trial drug|6|||
155017298|NCT02259010|559488193|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
155017299|NCT02712554|559488194|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
155017300|NCT02712554|559488195|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
155017301|NCT02712554|559488194|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
155017302|NCT02712554|559488195|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
155017303|NCT02712554|559488194|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
155017304|NCT02712554|559488195|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
155017305|NCT02712554|559488194|FG000|Part B: Qualification Phase|Adverse Event|0|||
155017306|NCT02712554|559488195|FG001|Part B: Qualification Phase|Adverse Event|1|||
155017307|NCT02712554|559488194|FG000|Part B: Treatment Phase|Adverse Event|0|||
155017308|NCT02712554|559488195|FG001|Part B: Treatment Phase|Adverse Event|1|||
155017309|NCT02712554|559488194|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
155017310|NCT02712554|559488195|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
155017311|NCT02712554|559488194|FG000|Part B: Treatment Phase|Other|0|||
155017312|NCT02712554|559488195|FG001|Part B: Treatment Phase|Other|1|||
155017313|NCT01445730|559488197|FG000|Overall Study|Adverse Event|1|||
155017314|NCT01445730|559488197|FG000|Overall Study|For the advice of a dentist|1|||
155017315|NCT01445730|559488197|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
155017316|NCT03711786|559488198|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
155017317|NCT03711786|559488199|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
155017318|NCT03711786|559488198|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
155017319|NCT03711786|559488199|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
155017320|NCT03711786|559488198|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
155017321|NCT03711786|559488199|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
155017322|NCT03711786|559488198|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
155017323|NCT03711786|559488199|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
155017324|NCT03711786|559488198|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
155017325|NCT03711786|559488199|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
155017326|NCT03711786|559488198|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
155017327|NCT03711786|559488199|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
155017328|NCT01611883|559488201|FG000|Overall Study|Adverse Event|1|||
155017329|NCT01611883|559488202|FG001|Overall Study|Adverse Event|1|||
155017330|NCT00030901|559488205|FG000|Initial Registration|Ineligible|167|||
155017331|NCT00030901|559488206|FG001|Initial Registration|Ineligible|0|||
155017332|NCT00030901|559488207|FG002|Initial Registration|Ineligible|0|||
155017333|NCT00030901|559488205|FG000|Randomization|Adverse Event|0|||
155017334|NCT00030901|559488206|FG001|Randomization|Adverse Event|11|||
155017335|NCT00030901|559488207|FG002|Randomization|Adverse Event|7|||
155017336|NCT00030901|559488205|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
155017337|NCT00030901|559488206|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
155017338|NCT00030901|559488207|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
155017339|NCT00030901|559488205|FG000|Randomization|Progression/Relapse|0|||
155017340|NCT00030901|559488206|FG001|Randomization|Progression/Relapse|22|||
155017341|NCT00030901|559488207|FG002|Randomization|Progression/Relapse|21|||
155017342|NCT00030901|559488205|FG000|Randomization|Death|0|||
155139004|NCT02834247|559940659|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
155139005|NCT02834247|559940660|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
155139006|NCT00811174|559940661|FG000|Overall Study|Protocol Violation|2|||
155139007|NCT00811174|559940661|FG000|Overall Study|Sponsors Decision|1|||
155139008|NCT01392547|559942625|FG000|Overall Study|Adverse Event|2|||
155139009|NCT01392547|559942625|FG000|Overall Study|Non-compliance|2|||
155139010|NCT01392547|559942625|FG000|Overall Study|Withdrawal criteria|3|||
155139011|NCT01392547|559942625|FG000|Overall Study|Unclassified|1|||
155139012|NCT04404556|559942626|FG000|Intervention|Withdrawal by Subject|15|||
155139013|NCT04404556|559942627|FG001|Intervention|Withdrawal by Subject|3|||
155139014|NCT04404556|559942626|FG000|Intervention|Did not complete all intervention sessions|2|||
155139015|NCT04404556|559942627|FG001|Intervention|Did not complete all intervention sessions|1|||
155139016|NCT04404556|559942626|FG000|Post-Intervention|Missing Data|1|||
155139017|NCT04404556|559942627|FG001|Post-Intervention|Missing Data|2|||
155139018|NCT04404556|559942626|FG000|Follow-up 1|Withdrawal by Subject|5|||
155139019|NCT04404556|559942627|FG001|Follow-up 1|Withdrawal by Subject|1|||
155139020|NCT04404556|559942626|FG000|Follow-up 1|Missing Data|4|||
155139021|NCT04404556|559942627|FG001|Follow-up 1|Missing Data|7|||
155139022|NCT04404556|559942626|FG000|Follow-up 2|Withdrawal by Subject|1|||
155139023|NCT04404556|559942627|FG001|Follow-up 2|Withdrawal by Subject|1|||
155139024|NCT04404556|559942626|FG000|Follow-up 2|Missing Data|6|||
155179223|NCT00761150|560095042|FG001|Double-blind Period|Adverse Event|3|||
155017343|NCT00030901|559488206|FG001|Randomization|Death|1|||
155017344|NCT00030901|559488207|FG002|Randomization|Death|3|||
155139025|NCT04404556|559942627|FG001|Follow-up 2|Missing Data|5|||
155139026|NCT02451917|559942628|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
155139027|NCT02451917|559942629|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
155139028|NCT02451917|559942628|FG000|First Intervention (24 Weeks)|Death|0|||
155139029|NCT02451917|559942629|FG001|First Intervention (24 Weeks)|Death|1|||
155017345|NCT00030901|559488205|FG000|Randomization|Other|0|||
155017346|NCT00030901|559488206|FG001|Randomization|Other|36|||
155017347|NCT00030901|559488207|FG002|Randomization|Other|33|||
155017348|NCT00030901|559488205|FG000|Randomization|Ineligible|0|||
155017349|NCT00030901|559488206|FG001|Randomization|Ineligible|15|||
155017350|NCT00030901|559488207|FG002|Randomization|Ineligible|14|||
155017351|NCT01806051|559488210|FG000|Overall Study|Withdrawal by Subject|6|||
155017352|NCT02576847|559488211|FG000|Overall Study|Adverse Event|27|||
155017353|NCT02576847|559488211|FG000|Overall Study|Lost to Follow-up|22|||
155017354|NCT02576847|559488211|FG000|Overall Study|Physician Decision|1|||
155017355|NCT02576847|559488211|FG000|Overall Study|Pregnancy|1|||
155017356|NCT02576847|559488211|FG000|Overall Study|Protocol Violation|3|||
155017357|NCT02576847|559488211|FG000|Overall Study|Withdrawal by Subject|78|||
155017358|NCT02576847|559488211|FG000|Overall Study|Other|5|||
155017359|NCT02418182|559488212|FG000|Overall Study|Unable to re-consent|18|||
155017360|NCT02418182|559488213|FG001|Overall Study|Unable to re-consent|15|||
155017361|NCT02418182|559488212|FG000|Overall Study|Lost to Follow-up|0|||
155017362|NCT02418182|559488213|FG001|Overall Study|Lost to Follow-up|2|||
155017363|NCT00734994|559488214|FG000|Overall Study|Withdrawal by Subject|1|||
155017364|NCT04031846|559488217|FG000|Overall Study|Lost to Follow-up|4|||
155017365|NCT04031846|559488218|FG001|Overall Study|Lost to Follow-up|4|||
155017366|NCT04031846|559488217|FG000|Overall Study|Physician Decision|0|||
155017367|NCT04031846|559488218|FG001|Overall Study|Physician Decision|1|||
155017368|NCT04031846|559488217|FG000|Overall Study|Protocol Violation|1|||
155017369|NCT04031846|559488218|FG001|Overall Study|Protocol Violation|1|||
155017370|NCT04031846|559488217|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
155017371|NCT04031846|559488218|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
155017372|NCT02431676|559488219|FG000|Overall Study|no lab obtained|0|||
155017373|NCT02431676|559488220|FG001|Overall Study|no lab obtained|1|||
155017374|NCT02431676|559488221|FG002|Overall Study|no lab obtained|2|||
155017375|NCT01622673|559488222|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155017376|NCT01622673|559488223|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155017377|NCT01622673|559488224|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155017378|NCT01622673|559488225|FG003|Treatment Period 1|Withdrawal by Subject|1|||
155017379|NCT01622673|559488226|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155017380|NCT01622673|559488227|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155017381|NCT01622673|559488222|FG000|Treatment Period 1|Protocol Violation|0|||
155017382|NCT01622673|559488223|FG001|Treatment Period 1|Protocol Violation|1|||
155017383|NCT01622673|559488224|FG002|Treatment Period 1|Protocol Violation|0|||
155017384|NCT01622673|559488225|FG003|Treatment Period 1|Protocol Violation|0|||
155017385|NCT01622673|559488226|FG004|Treatment Period 1|Protocol Violation|0|||
155017386|NCT01622673|559488227|FG005|Treatment Period 1|Protocol Violation|0|||
155017387|NCT01622673|559488222|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155017388|NCT01622673|559488223|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155017389|NCT01622673|559488224|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155017390|NCT01622673|559488225|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155017391|NCT01622673|559488226|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155017392|NCT01622673|559488227|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155017393|NCT01622673|559488222|FG000|Treatment Period 3|Protocol Violation|0|||
155017394|NCT01622673|559488223|FG001|Treatment Period 3|Protocol Violation|1|||
155017395|NCT01622673|559488224|FG002|Treatment Period 3|Protocol Violation|0|||
155017396|NCT01622673|559488225|FG003|Treatment Period 3|Protocol Violation|0|||
155017397|NCT01622673|559488226|FG004|Treatment Period 3|Protocol Violation|0|||
155017398|NCT01622673|559488227|FG005|Treatment Period 3|Protocol Violation|0|||
155017399|NCT05966584|559488233|FG000|Overall Study|Lost to Follow-up|1|||
155017400|NCT00570687|559489961|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017401|NCT00570687|559489962|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017402|NCT00570687|559489963|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017403|NCT00570687|559489964|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017404|NCT00570687|559489965|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155017405|NCT00570687|559489966|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155017406|NCT00570687|559489967|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
155017407|NCT00570687|559489968|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155017408|NCT00570687|559489969|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
155017409|NCT00570687|559489970|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
155017410|NCT00570687|559489961|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017411|NCT00570687|559489962|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017412|NCT00570687|559489963|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017413|NCT00570687|559489964|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017414|NCT00570687|559489965|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017415|NCT00570687|559489966|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017416|NCT00570687|559489967|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017417|NCT00570687|559489968|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017418|NCT00570687|559489969|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
155179224|NCT00761150|560095043|FG002|Double-blind Period|Adverse Event|3|||
155017419|NCT00570687|559489970|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017420|NCT00570687|559489961|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017421|NCT00570687|559489962|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017422|NCT00570687|559489963|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017423|NCT00570687|559489964|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017424|NCT00570687|559489965|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017425|NCT00570687|559489966|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017426|NCT00570687|559489967|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
155017427|NCT00570687|559489968|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017428|NCT00570687|559489969|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017429|NCT00570687|559489970|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
155017430|NCT05343000|559489971|FG000|Overall Study|Physician Decision|2|||
155017431|NCT05271370|559489972|FG000|Overall Study|Study early termination|8|||
155017432|NCT05271370|559489973|FG001|Overall Study|Study early termination|16|||
155017433|NCT05271370|559489974|FG002|Overall Study|Study early termination|29|||
155017434|NCT00333983|559489980|FG000|Overall Study|Lost to Follow-up|2|||
155017435|NCT00333983|559489981|FG001|Overall Study|Lost to Follow-up|1|||
155017436|NCT00333983|559489982|FG002|Overall Study|Lost to Follow-up|0|||
155017437|NCT00333983|559489980|FG000|Overall Study|Adverse Event|1|||
155017438|NCT00333983|559489981|FG001|Overall Study|Adverse Event|1|||
155017439|NCT00333983|559489982|FG002|Overall Study|Adverse Event|1|||
155017440|NCT00333983|559489980|FG000|Overall Study|Withdrawal by Subject|0|||
155017441|NCT00333983|559489981|FG001|Overall Study|Withdrawal by Subject|3|||
155017442|NCT00333983|559489982|FG002|Overall Study|Withdrawal by Subject|1|||
155017443|NCT00833105|559489983|FG000|Overall Study|Withdrawal by Subject|1|||
155017444|NCT00833105|559489983|FG000|Overall Study|Adverse Event|2|||
155017445|NCT03656068|559489984|FG000|Overall Study|Withdrawal by Subject|4|||
155017446|NCT03656068|559489984|FG000|Overall Study|Adverse Event|1|||
155017447|NCT00154284|559489985|FG000|Overall Study|Adverse Event|6|||
155017448|NCT00154284|559489986|FG001|Overall Study|Adverse Event|9|||
155017449|NCT00154284|559489985|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155017450|NCT00154284|559489986|FG001|Overall Study|Abnormal laboratory value(s)|1|||
155017451|NCT00154284|559489985|FG000|Overall Study|Lack of Efficacy|1|||
155017452|NCT00154284|559489986|FG001|Overall Study|Lack of Efficacy|2|||
155017453|NCT00154284|559489985|FG000|Overall Study|Protocol Violation|0|||
155017454|NCT00154284|559489986|FG001|Overall Study|Protocol Violation|1|||
155017455|NCT01780038|559489995|FG000|Overall Study|Lost to Follow-up|4|||
155017456|NCT01780038|559489996|FG001|Overall Study|Lost to Follow-up|1|||
155017457|NCT03168711|559489997|FG000|Overall Study|Adverse Event|2|||
155017458|NCT03168711|559489998|FG001|Overall Study|Adverse Event|0|||
155017459|NCT03168711|559489997|FG000|Overall Study|Withdrawal by Subject|0|||
155017460|NCT03168711|559489998|FG001|Overall Study|Withdrawal by Subject|1|||
155017461|NCT03168711|559489997|FG000|Overall Study|Death|0|||
155017462|NCT03168711|559489998|FG001|Overall Study|Death|1|||
155017463|NCT03270657|559490000|FG000|Overall Study|Withdrawal by Subject|1|||
155017464|NCT00162981|559490001|FG000|Overall Study|Adverse Event|2|||
155017465|NCT00162981|559490002|FG001|Overall Study|Adverse Event|5|||
155017466|NCT00162981|559490001|FG000|Overall Study|Withdrawal by Subject|1|||
155017467|NCT00162981|559490002|FG001|Overall Study|Withdrawal by Subject|1|||
155017468|NCT00162981|559490001|FG000|Overall Study|Physician Decision|1|||
155017469|NCT00162981|559490002|FG001|Overall Study|Physician Decision|0|||
155017470|NCT01343043|559490005|FG000|Overall Study|Disease progression before treatment|1|||
155017471|NCT01343043|559490006|FG001|Overall Study|Disease progression before treatment|0|||
155017472|NCT01343043|559490007|FG002|Overall Study|Disease progression before treatment|0|||
155017473|NCT01343043|559490008|FG003|Overall Study|Disease progression before treatment|0|||
155017474|NCT01343043|559490005|FG000|Overall Study|Withdrawal by Subject|1|||
155017475|NCT01343043|559490006|FG001|Overall Study|Withdrawal by Subject|0|||
155139030|NCT02451917|559942628|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
155139031|NCT02451917|559942629|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
155139032|NCT02871635|559942630|FG000|Overall Study|Primary lack of efficacy|4|||
155139033|NCT02871635|559942631|FG001|Overall Study|Primary lack of efficacy|4|||
155139034|NCT02871635|559942630|FG000|Overall Study|Protocol Violation|3|||
155139035|NCT02871635|559942631|FG001|Overall Study|Protocol Violation|1|||
155017476|NCT01343043|559490007|FG002|Overall Study|Withdrawal by Subject|0|||
155017477|NCT01343043|559490008|FG003|Overall Study|Withdrawal by Subject|0|||
155017478|NCT01343043|559490005|FG000|Overall Study|Death|1|||
155017479|NCT01343043|559490006|FG001|Overall Study|Death|1|||
155017480|NCT01343043|559490007|FG002|Overall Study|Death|0|||
155017481|NCT01343043|559490008|FG003|Overall Study|Death|1|||
155139036|NCT02871635|559942630|FG000|Overall Study|Lost to Follow-up|1|||
155017482|NCT00502242|559490011|FG000|Overall Study|Lack of Efficacy|1|||
155017483|NCT00502242|559490012|FG001|Overall Study|Lack of Efficacy|11|||
155017484|NCT00502242|559490011|FG000|Overall Study|Adverse Event|31|||
155139037|NCT02871635|559942631|FG001|Overall Study|Lost to Follow-up|2|||
155179225|NCT00761150|560095041|FG000|Double-blind Period|Withdrawal by Subject|0|||
155017485|NCT00502242|559490012|FG001|Overall Study|Adverse Event|20|||
155017486|NCT00502242|559490011|FG000|Overall Study|Physician Decision|2|||
155017487|NCT00502242|559490012|FG001|Overall Study|Physician Decision|3|||
155017488|NCT00502242|559490011|FG000|Overall Study|Other - Unspecified|8|||
155017489|NCT00502242|559490012|FG001|Overall Study|Other - Unspecified|14|||
155017490|NCT00502242|559490011|FG000|Overall Study|Protocol Violation|3|||
155017491|NCT00502242|559490012|FG001|Overall Study|Protocol Violation|1|||
155017492|NCT00502242|559490011|FG000|Overall Study|Withdrawal by Subject|6|||
155017493|NCT00502242|559490012|FG001|Overall Study|Withdrawal by Subject|7|||
155017494|NCT01812109|559490013|FG000|Overall Study|research personnel delay|16|||
155017495|NCT01812109|559490013|FG000|Overall Study|NIRS Unattainable|17|||
155017496|NCT01346696|559490014|FG000|Overall Study|Death|1|||
155017497|NCT04630002|559490015|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
155017498|NCT04630002|559490016|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155017499|NCT04630002|559490017|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155017500|NCT04630002|559490015|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
155017501|NCT04630002|559490016|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155017502|NCT04630002|559490017|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155017503|NCT04630002|559490015|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
155017504|NCT04630002|559490016|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155017505|NCT04630002|559490017|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155017506|NCT04630002|559490015|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155017507|NCT04630002|559490016|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
155017508|NCT04630002|559490017|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
155017509|NCT04630002|559490015|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155017510|NCT04630002|559490016|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
155017511|NCT04630002|559490017|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
155017512|NCT04630002|559490015|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155017513|NCT04630002|559490016|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
155017514|NCT04630002|559490017|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
155017515|NCT04630002|559490015|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
155017516|NCT04630002|559490016|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
155017517|NCT04630002|559490017|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
155017518|NCT04630002|559490015|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
155017519|NCT04630002|559490016|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
155017520|NCT04630002|559490017|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
155017521|NCT04548193|559490031|FG000|Overall Study|Lost to Follow-up|0|||
155017522|NCT04548193|559490032|FG001|Overall Study|Lost to Follow-up|1|||
155017523|NCT04548193|559490031|FG000|Overall Study|Death|0|||
155017524|NCT04548193|559490032|FG001|Overall Study|Death|1|||
155017525|NCT04548193|559490031|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
155017526|NCT04548193|559490032|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
155017527|NCT04548193|559490031|FG000|Overall Study|Withdrawal by Subject|2|||
155017528|NCT04548193|559490032|FG001|Overall Study|Withdrawal by Subject|2|||
155017529|NCT00630825|559490033|FG000|Overall Study|Adverse Event|4|||
155017530|NCT00630825|559490034|FG001|Overall Study|Adverse Event|4|||
155017531|NCT00630825|559490035|FG002|Overall Study|Adverse Event|3|||
155139038|NCT02871635|559942630|FG000|Overall Study|Pregnancy|0|||
155139039|NCT02871635|559942631|FG001|Overall Study|Pregnancy|2|||
155139040|NCT02871635|559942630|FG000|Overall Study|Physician Decision|1|||
155139041|NCT02871635|559942631|FG001|Overall Study|Physician Decision|1|||
155139042|NCT02871635|559942630|FG000|Overall Study|Withdrawal by Subject|3|||
155139043|NCT02871635|559942631|FG001|Overall Study|Withdrawal by Subject|4|||
155139044|NCT02871635|559942630|FG000|Overall Study|Adverse Event|4|||
155139045|NCT02871635|559942631|FG001|Overall Study|Adverse Event|4|||
155139046|NCT02871635|559942630|FG000|Overall Study|Secondary lack of efficacy|2|||
155139047|NCT02871635|559942631|FG001|Overall Study|Secondary lack of efficacy|1|||
155139048|NCT00502671|559942632|FG000|Overall Study|Disease Progression|13|||
155139049|NCT00502671|559942632|FG000|Overall Study|Personal Reasons|22|||
155139050|NCT00502671|559942632|FG000|Overall Study|Lost to Follow-up|7|||
155139051|NCT00502671|559942632|FG000|Overall Study|Protocol Violation|16|||
155139052|NCT00502671|559942632|FG000|Overall Study|Adverse Event|19|||
155139053|NCT00853151|559942634|FG000|Overall Study|Adverse Event|1|||
155139054|NCT00853151|559942635|FG001|Overall Study|Adverse Event|4|||
155139055|NCT00853151|559942636|FG002|Overall Study|Adverse Event|2|||
155017532|NCT00630825|559490036|FG003|Overall Study|Adverse Event|1|||
155017533|NCT00630825|559490033|FG000|Overall Study|Entry Criteria Not Met|1|||
155017534|NCT00630825|559490034|FG001|Overall Study|Entry Criteria Not Met|0|||
155139056|NCT00853151|559942637|FG003|Overall Study|Adverse Event|0|||
155139057|NCT00853151|559942634|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
155139058|NCT00853151|559942635|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155139059|NCT00853151|559942636|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155139060|NCT00853151|559942637|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155017535|NCT00630825|559490035|FG002|Overall Study|Entry Criteria Not Met|2|||
155017536|NCT00630825|559490036|FG003|Overall Study|Entry Criteria Not Met|1|||
155017537|NCT00630825|559490033|FG000|Overall Study|Lost to Follow-up|1|||
155017538|NCT00630825|559490034|FG001|Overall Study|Lost to Follow-up|1|||
155017539|NCT00630825|559490035|FG002|Overall Study|Lost to Follow-up|1|||
155017540|NCT00630825|559490036|FG003|Overall Study|Lost to Follow-up|1|||
155017541|NCT00630825|559490033|FG000|Overall Study|Physician Decision|1|||
155017542|NCT00630825|559490034|FG001|Overall Study|Physician Decision|0|||
155017543|NCT00630825|559490035|FG002|Overall Study|Physician Decision|0|||
155017544|NCT00630825|559490036|FG003|Overall Study|Physician Decision|0|||
155017545|NCT00630825|559490033|FG000|Overall Study|Withdrawal by Subject|2|||
155017546|NCT00630825|559490034|FG001|Overall Study|Withdrawal by Subject|2|||
155017547|NCT00630825|559490035|FG002|Overall Study|Withdrawal by Subject|2|||
155017548|NCT00630825|559490036|FG003|Overall Study|Withdrawal by Subject|3|||
155017549|NCT02187198|559490043|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
155017550|NCT02187198|559490044|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
155017551|NCT02187198|559490043|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
155017552|NCT02187198|559490044|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
155017553|NCT01532518|559490045|FG000|Overall Study|Withdrawal by Subject|0|||
155017554|NCT01532518|559490046|FG001|Overall Study|Withdrawal by Subject|0|||
155017555|NCT01532518|559490047|FG002|Overall Study|Withdrawal by Subject|1|||
155017556|NCT06509438|559490050|FG000|Overall Study|Adverse Event|1|||
155017557|NCT06509438|559490050|FG000|Overall Study|Lost to Follow-up|3|||
155017558|NCT00952068|559490053|FG000|Overall Study|Adverse Event|3|||
155017559|NCT00952068|559490053|FG000|Overall Study|Withdrawal by Subject|4|||
155017560|NCT00488644|559490054|FG000|Overall Study|Not Eligible|1|||
155017561|NCT00488644|559490054|FG000|Overall Study|Not Evaluable|1|||
155017562|NCT02169271|559490055|FG000|Overall Study|Protocol Violation|1|||
155017563|NCT02169271|559490056|FG001|Overall Study|Protocol Violation|2|||
155017564|NCT04926831|559490057|FG000|Overall Study|Withdrawal by Subject|2|||
155017565|NCT04926831|559490057|FG000|Overall Study|Adverse Event|2|||
155017566|NCT04025879|559490058|FG000|Randomization|Participant withdrew consent|0|||
155017567|NCT04025879|559490059|FG001|Randomization|Participant withdrew consent|1|||
155017568|NCT04025879|559490058|FG000|Randomization|Participant no longer met study criteria|1|||
155017569|NCT04025879|559490059|FG001|Randomization|Participant no longer met study criteria|1|||
155017570|NCT04025879|559490058|FG000|Treatment|Ongoing treatment|10|||
155017571|NCT04025879|559490059|FG001|Treatment|Ongoing treatment|8|||
155017572|NCT04025879|559490058|FG000|Treatment|Disease progression/recurrence|36|||
155017573|NCT04025879|559490059|FG001|Treatment|Disease progression/recurrence|72|||
155017574|NCT04025879|559490058|FG000|Treatment|Study drug toxicity|36|||
155017575|NCT04025879|559490059|FG001|Treatment|Study drug toxicity|13|||
155017576|NCT04025879|559490058|FG000|Treatment|Death|2|||
155017577|NCT04025879|559490059|FG001|Treatment|Death|0|||
155017578|NCT04025879|559490058|FG000|Treatment|Adverse event unrelated to study drug|21|||
155017579|NCT04025879|559490059|FG001|Treatment|Adverse event unrelated to study drug|14|||
155017580|NCT04025879|559490058|FG000|Treatment|Participant request to discontinue study treatment|16|||
155017581|NCT04025879|559490059|FG001|Treatment|Participant request to discontinue study treatment|8|||
155017582|NCT04025879|559490058|FG000|Treatment|Participant withdrew consent|1|||
155017583|NCT04025879|559490059|FG001|Treatment|Participant withdrew consent|3|||
155017584|NCT04025879|559490058|FG000|Treatment|Participant no longer meets study criteria|3|||
155017585|NCT04025879|559490059|FG001|Treatment|Participant no longer meets study criteria|2|||
155017586|NCT04025879|559490058|FG000|Treatment|Lost to Follow-up|1|||
155017587|NCT04025879|559490059|FG001|Treatment|Lost to Follow-up|0|||
155017588|NCT04025879|559490058|FG000|Treatment|Other reasons|15|||
155017589|NCT04025879|559490059|FG001|Treatment|Other reasons|17|||
155017590|NCT04025879|559490058|FG000|Treatment|Administrative reason by sponsor|0|||
155017591|NCT04025879|559490059|FG001|Treatment|Administrative reason by sponsor|1|||
155017592|NCT04025879|559490058|FG000|Treatment|Not reported|2|||
155017593|NCT04025879|559490059|FG001|Treatment|Not reported|0|||
155017594|NCT03194542|559490068|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
155017595|NCT03194542|559490069|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
155017596|NCT03194542|559490070|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
155017597|NCT03194542|559490071|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
155017598|NCT03194542|559490068|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
155017599|NCT03194542|559490069|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
155017600|NCT03194542|559490070|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
155017601|NCT03194542|559490071|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
155017602|NCT03194542|559490068|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
155017603|NCT03194542|559490069|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
155017604|NCT03194542|559490070|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
155017605|NCT03194542|559490071|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
155179226|NCT00761150|560095042|FG001|Double-blind Period|Withdrawal by Subject|3|||
155017606|NCT03194542|559490068|FG000|Overall Study|Loss of Response|4|||
155017607|NCT03194542|559490069|FG001|Overall Study|Loss of Response|2|||
155017608|NCT03194542|559490070|FG002|Overall Study|Loss of Response|3|||
155017609|NCT03194542|559490071|FG003|Overall Study|Loss of Response|4|||
155017610|NCT03194542|559490068|FG000|Overall Study|Physician Decision|0|||
155017611|NCT03194542|559490069|FG001|Overall Study|Physician Decision|1|||
155017612|NCT03194542|559490070|FG002|Overall Study|Physician Decision|0|||
155017613|NCT03194542|559490071|FG003|Overall Study|Physician Decision|0|||
155017614|NCT03194542|559490068|FG000|Overall Study|Lack of Efficacy|2|||
155017615|NCT03194542|559490069|FG001|Overall Study|Lack of Efficacy|2|||
155017616|NCT03194542|559490070|FG002|Overall Study|Lack of Efficacy|2|||
155017617|NCT03194542|559490071|FG003|Overall Study|Lack of Efficacy|6|||
155017618|NCT03194542|559490068|FG000|Overall Study|Withdrawal by Subject|2|||
155017619|NCT03194542|559490069|FG001|Overall Study|Withdrawal by Subject|1|||
155017620|NCT03194542|559490070|FG002|Overall Study|Withdrawal by Subject|5|||
155017621|NCT03194542|559490071|FG003|Overall Study|Withdrawal by Subject|4|||
155017622|NCT03194542|559490068|FG000|Overall Study|Progressive Disease|1|||
155017623|NCT03194542|559490069|FG001|Overall Study|Progressive Disease|0|||
155017624|NCT03194542|559490070|FG002|Overall Study|Progressive Disease|1|||
155017625|NCT03194542|559490071|FG003|Overall Study|Progressive Disease|1|||
155017626|NCT03194542|559490068|FG000|Overall Study|Adverse Event|1|||
155017627|NCT03194542|559490069|FG001|Overall Study|Adverse Event|2|||
155017628|NCT03194542|559490070|FG002|Overall Study|Adverse Event|0|||
155017629|NCT03194542|559490071|FG003|Overall Study|Adverse Event|5|||
155017630|NCT03194542|559490068|FG000|Overall Study|Death|1|||
155017631|NCT03194542|559490069|FG001|Overall Study|Death|2|||
155017632|NCT03194542|559490070|FG002|Overall Study|Death|0|||
155017633|NCT03194542|559490071|FG003|Overall Study|Death|5|||
155017634|NCT03194542|559490068|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
155017635|NCT03194542|559490069|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
155017636|NCT03194542|559490070|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
155017637|NCT03194542|559490071|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
155017638|NCT02503540|559490075|FG000|Overall Study|Death|2|||
155017639|NCT02503540|559490075|FG000|Overall Study|Withdrawal by Subject|1|||
155017640|NCT00979654|559490078|FG000|Overall Study|Lost to Follow-up|1|||
155017641|NCT00979654|559490078|FG000|Overall Study|Withdrawal by Subject|22|||
155017642|NCT00979654|559490078|FG000|Overall Study|Death|1|||
155017643|NCT00979654|559490078|FG000|Overall Study|Lack of Efficacy|6|||
155017644|NCT00979654|559490078|FG000|Overall Study|Adverse Event|1|||
155017645|NCT00979654|559490078|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
155017646|NCT00979654|559490078|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
155017647|NCT00979654|559490078|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
155017648|NCT00979654|559490078|FG000|Overall Study|Serious Adverse Event|1|||
155017649|NCT00979654|559490078|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
155017650|NCT01804946|559490081|FG000|Overall Study|Protocol Violation|1|||
155017651|NCT01804946|559490082|FG001|Overall Study|Protocol Violation|0|||
155017652|NCT01804946|559490081|FG000|Overall Study|Adverse Event|0|||
155017653|NCT01804946|559490082|FG001|Overall Study|Adverse Event|1|||
155017654|NCT01804946|559490081|FG000|Overall Study|Insufficient data available|0|||
155017655|NCT01804946|559490082|FG001|Overall Study|Insufficient data available|1|||
155017656|NCT01804946|559490081|FG000|Overall Study|Do not meet inclusion criteria|1|||
155017657|NCT01804946|559490082|FG001|Overall Study|Do not meet inclusion criteria|2|||
155017658|NCT00722137|559490084|FG000|Overall Study|Overt Disease Progression|5|||
155017659|NCT00722137|559490085|FG001|Overall Study|Overt Disease Progression|4|||
155017660|NCT00722137|559490084|FG000|Overall Study|Adverse Event|17|||
155017661|NCT00722137|559490085|FG001|Overall Study|Adverse Event|21|||
155017662|NCT00722137|559490084|FG000|Overall Study|Death|12|||
155017663|NCT00722137|559490085|FG001|Overall Study|Death|7|||
155017664|NCT00722137|559490084|FG000|Overall Study|Withdrawal by Subject|6|||
155017665|NCT00722137|559490085|FG001|Overall Study|Withdrawal by Subject|9|||
155017666|NCT00722137|559490084|FG000|Overall Study|Other Reason Unknown|3|||
155017667|NCT00722137|559490085|FG001|Overall Study|Other Reason Unknown|4|||
155017668|NCT00722137|559490084|FG000|Overall Study|Randomized But Not Treated|2|||
155017669|NCT00722137|559490085|FG001|Overall Study|Randomized But Not Treated|3|||
155017670|NCT03830333|559490086|FG000|Overall Study|Death|0|||
155017671|NCT03830333|559490087|FG001|Overall Study|Death|1|||
155017672|NCT03830333|559490086|FG000|Overall Study|Withdrawal by Subject|5|||
155017673|NCT03830333|559490087|FG001|Overall Study|Withdrawal by Subject|1|||
155017674|NCT03830333|559490086|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
155017675|NCT03830333|559490087|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
155017676|NCT01129557|559490088|FG000|Overall Study|Adverse Event|1|||
155017677|NCT01129557|559490089|FG001|Overall Study|Adverse Event|2|||
155017678|NCT01129557|559490090|FG002|Overall Study|Adverse Event|2|||
155017679|NCT01129557|559490088|FG000|Overall Study|Novartis terminated study early|3|||
155017680|NCT01129557|559490089|FG001|Overall Study|Novartis terminated study early|3|||
155017681|NCT01129557|559490090|FG002|Overall Study|Novartis terminated study early|2|||
155139061|NCT00853151|559942634|FG000|Overall Study|Lost to Follow-up|2|||
155139062|NCT00853151|559942635|FG001|Overall Study|Lost to Follow-up|0|||
155139063|NCT00853151|559942636|FG002|Overall Study|Lost to Follow-up|3|||
155139064|NCT00853151|559942637|FG003|Overall Study|Lost to Follow-up|0|||
155139065|NCT00853151|559942634|FG000|Overall Study|Death|1|||
155139066|NCT00853151|559942635|FG001|Overall Study|Death|0|||
155017682|NCT01486446|559490091|FG000|Overall Study|Adverse Event|1|||
155017683|NCT01486446|559490092|FG001|Overall Study|Adverse Event|0|||
155017684|NCT01367886|559490095|FG000|Overall Study|Lost to Follow-up|4|||
155017685|NCT01367886|559490095|FG000|Overall Study|Lack of Efficacy|2|||
155017686|NCT01367886|559490095|FG000|Overall Study|Death|1|||
155017687|NCT00985504|559490100|FG000|Acute Treatment Period|Adverse Event|3|||
155017688|NCT00985504|559490101|FG001|Acute Treatment Period|Adverse Event|4|||
155017689|NCT00985504|559490100|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
155017690|NCT00985504|559490101|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
155017691|NCT00985504|559490100|FG000|Acute Treatment Period|Protocol Violation|2|||
155017692|NCT00985504|559490101|FG001|Acute Treatment Period|Protocol Violation|0|||
155017693|NCT00985504|559490100|FG000|Acute Treatment Period|Sponsor Decision|0|||
155017694|NCT00985504|559490101|FG001|Acute Treatment Period|Sponsor Decision|1|||
155017695|NCT00985504|559490100|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
155017696|NCT00985504|559490101|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
155017697|NCT00985504|559490100|FG000|Optimization Period|Adverse Event|7|||
155017698|NCT00985504|559490101|FG001|Optimization Period|Adverse Event|9|||
155017699|NCT00985504|559490100|FG000|Optimization Period|Death|0|||
155017700|NCT00985504|559490101|FG001|Optimization Period|Death|1|||
155017701|NCT00985504|559490100|FG000|Optimization Period|Lack of Efficacy|5|||
155017702|NCT00985504|559490101|FG001|Optimization Period|Lack of Efficacy|3|||
155017703|NCT00985504|559490100|FG000|Optimization Period|Lost to Follow-up|0|||
155017704|NCT00985504|559490101|FG001|Optimization Period|Lost to Follow-up|1|||
155017705|NCT00985504|559490100|FG000|Optimization Period|Physician Decision|1|||
155017706|NCT00985504|559490101|FG001|Optimization Period|Physician Decision|0|||
155017707|NCT00985504|559490100|FG000|Optimization Period|Protocol Violation|3|||
155017708|NCT00985504|559490101|FG001|Optimization Period|Protocol Violation|1|||
155017709|NCT00985504|559490100|FG000|Optimization Period|Withdrawal by Subject|10|||
155017710|NCT00985504|559490101|FG001|Optimization Period|Withdrawal by Subject|8|||
155017711|NCT03379727|559490105|FG000|Overall Study|Lack of Efficacy|73|||
155017712|NCT03379727|559490105|FG000|Overall Study|Adverse Event|32|||
155017713|NCT03379727|559490105|FG000|Overall Study|Death|18|||
155017714|NCT03379727|559490105|FG000|Overall Study|Patient/guardian decision|17|||
155017715|NCT03379727|559490105|FG000|Overall Study|Physician Decision|104|||
155017716|NCT03379727|559490105|FG000|Overall Study|Protocol Violation|4|||
155017717|NCT03379727|559490105|FG000|Overall Study|Lost to Follow-up|1|||
155017718|NCT01205776|559490106|FG000|Overall Study|Lost to Follow-up|53|||
155017719|NCT01205776|559490107|FG001|Overall Study|Lost to Follow-up|61|||
155017720|NCT01205776|559490106|FG000|Overall Study|Withdrawal by Subject|11|||
155017721|NCT01205776|559490107|FG001|Overall Study|Withdrawal by Subject|34|||
155017722|NCT02747108|559490110|FG000|Overall Study|Death|2|||
155017723|NCT02747108|559490111|FG001|Overall Study|Death|2|||
155017724|NCT02747108|559490110|FG000|Overall Study|Withdrawal by Subject|1|||
155017725|NCT02747108|559490111|FG001|Overall Study|Withdrawal by Subject|0|||
155017726|NCT02747108|559490110|FG000|Overall Study|Protocol Violation|2|||
155017727|NCT02747108|559490111|FG001|Overall Study|Protocol Violation|0|||
155017728|NCT02283268|559491828|FG000|Overall Study|Withdrawal by Subject|1|||
155017729|NCT02898597|559491829|FG000|Overall Study|Protocol Violation|4|||
155017730|NCT02898597|559491830|FG001|Overall Study|Protocol Violation|2|||
155017731|NCT02898597|559491829|FG000|Overall Study|Lost to Follow-up|0|||
155017732|NCT02898597|559491830|FG001|Overall Study|Lost to Follow-up|9|||
155017733|NCT02898597|559491829|FG000|Overall Study|Death|0|||
155017734|NCT02898597|559491830|FG001|Overall Study|Death|1|||
155017735|NCT00326716|559491831|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
155017736|NCT00326716|559491832|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
155017737|NCT00326716|559491833|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
155017738|NCT00326716|559491834|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
155017739|NCT00684411|559491835|FG000|Overall Study|New Primary Cancer|1|||
155017740|NCT00684411|559491835|FG000|Overall Study|Disease Progression|10|||
155017741|NCT00684411|559491835|FG000|Overall Study|Adverse Event|1|||
155017742|NCT05253573|559491836|FG000|Overall Study|Death|1|||
155017743|NCT05253573|559491837|FG001|Overall Study|Death|0|||
155017744|NCT01344824|559491838|FG000|Overall Study|Adverse Event|15|||
155017745|NCT01344824|559491838|FG000|Overall Study|Withdrawal by Subject|6|||
155017746|NCT01344824|559491838|FG000|Overall Study|Other complicating disease|1|||
155017747|NCT01344824|559491838|FG000|Overall Study|Progression|15|||
155017748|NCT01295671|559491841|FG000|Overall Study|Lost to Follow-up|4|||
155017749|NCT01295671|559491842|FG001|Overall Study|Lost to Follow-up|6|||
155017750|NCT01295671|559491843|FG002|Overall Study|Lost to Follow-up|3|||
155017751|NCT01295671|559491841|FG000|Overall Study|Withdrawal by Subject|3|||
155017752|NCT01295671|559491842|FG001|Overall Study|Withdrawal by Subject|1|||
155139067|NCT00853151|559942636|FG002|Overall Study|Death|0|||
155139068|NCT00853151|559942637|FG003|Overall Study|Death|1|||
155017753|NCT01295671|559491843|FG002|Overall Study|Withdrawal by Subject|0|||
155017754|NCT01436370|559491846|FG000|Overall Study|Lost to Follow-up|0|||
155017755|NCT01436370|559491847|FG001|Overall Study|Lost to Follow-up|0|||
155017756|NCT01436370|559491848|FG002|Overall Study|Lost to Follow-up|0|||
155017757|NCT01436370|559491849|FG003|Overall Study|Lost to Follow-up|0|||
155017758|NCT01436370|559491850|FG004|Overall Study|Lost to Follow-up|1|||
155017759|NCT01436370|559491851|FG005|Overall Study|Lost to Follow-up|0|||
155017760|NCT01436370|559491852|FG006|Overall Study|Lost to Follow-up|0|||
155017761|NCT01436370|559491853|FG007|Overall Study|Lost to Follow-up|0|||
155017762|NCT02395848|559491854|FG000|Overall Study|Lost to Follow-up|2|||
155017763|NCT02276560|559491855|FG000|Overall Study|Adverse Event|1|||
155017764|NCT02276560|559491856|FG001|Overall Study|Adverse Event|0|||
155017765|NCT02276560|559491857|FG002|Overall Study|Adverse Event|0|||
155017766|NCT01754129|559491858|FG000|Overall Study|Death|13|||
155017767|NCT01754129|559491858|FG000|Overall Study|Duodopa discontinuation|9|||
155017768|NCT01754129|559491858|FG000|Overall Study|Lost to Follow-up|7|||
155017769|NCT01754129|559491858|FG000|Overall Study|Withdrew consent|1|||
155017770|NCT01754129|559491858|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
155017771|NCT02126579|559491860|FG000|Overall Study|disease progression|0|||
155017772|NCT02126579|559491861|FG001|Overall Study|disease progression|0|||
155017773|NCT02126579|559491862|FG002|Overall Study|disease progression|0|||
155017774|NCT02126579|559491863|FG003|Overall Study|disease progression|1|||
155017775|NCT02126579|559491864|FG004|Overall Study|disease progression|0|||
155017776|NCT02126579|559491865|FG005|Overall Study|disease progression|0|||
155017777|NCT02126579|559491866|FG006|Overall Study|disease progression|1|||
155017778|NCT02366637|559491867|FG000|First Intervention Period|Adverse Event|0|||
155017779|NCT02366637|559491868|FG001|First Intervention Period|Adverse Event|1|||
155017780|NCT02366637|559491867|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
155017781|NCT02366637|559491868|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
155017782|NCT02366637|559491867|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
155017783|NCT02366637|559491868|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
155017784|NCT03691207|559491869|FG000|Overall Study|Death|41|||
155017785|NCT03691207|559491870|FG001|Overall Study|Death|26|||
155017786|NCT03691207|559491869|FG000|Overall Study|Lost to Follow-up|1|||
155017787|NCT03691207|559491870|FG001|Overall Study|Lost to Follow-up|1|||
155017788|NCT03691207|559491869|FG000|Overall Study|Withdrawal by Subject|2|||
155017789|NCT03691207|559491870|FG001|Overall Study|Withdrawal by Subject|8|||
155017790|NCT03691207|559491869|FG000|Overall Study|Sponsor decision|1|||
155017791|NCT03691207|559491870|FG001|Overall Study|Sponsor decision|7|||
155017792|NCT01609010|559491873|FG000|Overall Study|Stable disease (SD)|22|||
155017793|NCT01609010|559491874|FG001|Overall Study|Stable disease (SD)|16|||
155017794|NCT01609010|559491873|FG000|Overall Study|Progressive disease (PD)|8|||
155017795|NCT01609010|559491874|FG001|Overall Study|Progressive disease (PD)|10|||
155017796|NCT01609010|559491873|FG000|Overall Study|Adverse Event|3|||
155017797|NCT01609010|559491874|FG001|Overall Study|Adverse Event|6|||
155017798|NCT01609010|559491873|FG000|Overall Study|Withdrawal by Subject|2|||
155017799|NCT01609010|559491874|FG001|Overall Study|Withdrawal by Subject|2|||
155017800|NCT01609010|559491873|FG000|Overall Study|Other|2|||
155017801|NCT01609010|559491874|FG001|Overall Study|Other|0|||
155017802|NCT01609010|559491873|FG000|Overall Study|Other malignancy|1|||
155017803|NCT01609010|559491874|FG001|Overall Study|Other malignancy|0|||
155017804|NCT01609010|559491873|FG000|Overall Study|Pathology review|2|||
155017805|NCT01609010|559491874|FG001|Overall Study|Pathology review|1|||
155017806|NCT01609010|559491873|FG000|Overall Study|Protocol Violation|1|||
155017807|NCT01609010|559491874|FG001|Overall Study|Protocol Violation|1|||
155017808|NCT01609010|559491873|FG000|Overall Study|New cancer|1|||
155017809|NCT01609010|559491874|FG001|Overall Study|New cancer|0|||
155017810|NCT01609010|559491873|FG000|Overall Study|Lost to Follow-up|1|||
155017811|NCT01609010|559491874|FG001|Overall Study|Lost to Follow-up|1|||
155017812|NCT01134107|559491875|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
155017813|NCT01134107|559491876|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
155017814|NCT01134107|559491875|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
155017815|NCT01134107|559491876|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
155017816|NCT01134107|559491875|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
155017817|NCT01134107|559491876|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
155017818|NCT01134107|559491875|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
155017819|NCT01134107|559491876|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
155017820|NCT01134107|559491875|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
155017821|NCT01134107|559491876|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
155017822|NCT01134107|559491875|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
155017823|NCT01134107|559491876|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
155017824|NCT01134107|559491875|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
155017825|NCT01134107|559491876|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
155017826|NCT02027545|559491879|FG000|Overall Study|Failed to sign HIPAA|0|||
155017827|NCT02027545|559491880|FG001|Overall Study|Failed to sign HIPAA|2|||
155017828|NCT02027545|559491879|FG000|Overall Study|Failed to attend study visit|2|||
155017829|NCT02027545|559491880|FG001|Overall Study|Failed to attend study visit|0|||
155017830|NCT02027545|559491879|FG000|Overall Study|Protocol Violation|1|||
155017831|NCT02027545|559491880|FG001|Overall Study|Protocol Violation|0|||
155017832|NCT04541589|559491885|FG000|Treatment Period|Adverse Event|8|||
155017833|NCT04541589|559491886|FG001|Treatment Period|Adverse Event|2|||
155017834|NCT04541589|559491885|FG000|Treatment Period|Physician Decision|3|||
155017835|NCT04541589|559491886|FG001|Treatment Period|Physician Decision|1|||
155017836|NCT04541589|559491885|FG000|Treatment Period|Subject decision|7|||
155017837|NCT04541589|559491886|FG001|Treatment Period|Subject decision|4|||
155017838|NCT04541589|559491885|FG000|Treatment Period|Withdrawal by Subject|1|||
155017839|NCT04541589|559491886|FG001|Treatment Period|Withdrawal by Subject|0|||
155017840|NCT04541589|559491885|FG000|Safety Follow-up Period|Adverse Event|2|||
155017841|NCT04541589|559491886|FG001|Safety Follow-up Period|Adverse Event|1|||
155017842|NCT04541589|559491885|FG000|Safety Follow-up Period|Physician Decision|1|||
155017843|NCT04541589|559491886|FG001|Safety Follow-up Period|Physician Decision|0|||
155017844|NCT04541589|559491885|FG000|Safety Follow-up Period|Subject decision|5|||
155017845|NCT04541589|559491886|FG001|Safety Follow-up Period|Subject decision|3|||
155017846|NCT04541589|559491885|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
155017847|NCT04541589|559491886|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
155017848|NCT02770170|559491887|FG000|Overall Study|Withdrawal by Subject|0|||
155017849|NCT02770170|559491888|FG001|Overall Study|Withdrawal by Subject|0|||
155017850|NCT02770170|559491889|FG002|Overall Study|Withdrawal by Subject|0|||
155017851|NCT02770170|559491890|FG003|Overall Study|Withdrawal by Subject|2|||
155017852|NCT02770170|559491887|FG000|Overall Study|due to pregnancy|1|||
155017853|NCT02770170|559491888|FG001|Overall Study|due to pregnancy|0|||
155017854|NCT02770170|559491889|FG002|Overall Study|due to pregnancy|0|||
155017855|NCT02770170|559491890|FG003|Overall Study|due to pregnancy|0|||
155017856|NCT02770170|559491887|FG000|Overall Study|Lack of Efficacy|2|||
155017857|NCT02770170|559491888|FG001|Overall Study|Lack of Efficacy|0|||
155017858|NCT02770170|559491889|FG002|Overall Study|Lack of Efficacy|0|||
155017859|NCT02770170|559491890|FG003|Overall Study|Lack of Efficacy|1|||
155017860|NCT02770170|559491887|FG000|Overall Study|Adverse Event|4|||
155017861|NCT02770170|559491888|FG001|Overall Study|Adverse Event|3|||
155017862|NCT02770170|559491889|FG002|Overall Study|Adverse Event|5|||
155017863|NCT02770170|559491890|FG003|Overall Study|Adverse Event|3|||
155017864|NCT02770170|559491887|FG000|Overall Study|due to disease worsening|0|||
155017865|NCT02770170|559491888|FG001|Overall Study|due to disease worsening|0|||
155017866|NCT02770170|559491889|FG002|Overall Study|due to disease worsening|0|||
155017867|NCT02770170|559491890|FG003|Overall Study|due to disease worsening|1|||
155017868|NCT04195685|559491893|FG000|Overall Study|Withdrawal by Subject|6|||
155017869|NCT04195685|559491894|FG001|Overall Study|Withdrawal by Subject|2|||
155017870|NCT04195685|559491893|FG000|Overall Study|Lost to Follow-up|1|||
155017871|NCT04195685|559491894|FG001|Overall Study|Lost to Follow-up|4|||
155017872|NCT04509076|559491901|FG000|Overall Study|Withdrawal by Subject|1|||
155017873|NCT04509076|559491902|FG001|Overall Study|Withdrawal by Subject|2|||
155017874|NCT04509076|559491901|FG000|Overall Study|Lost to Follow-up|1|||
155017875|NCT04509076|559491902|FG001|Overall Study|Lost to Follow-up|2|||
155017876|NCT03351608|559491903|FG000|Overall Study|Lost to Follow-up|0|||
155017877|NCT03351608|559491904|FG001|Overall Study|Lost to Follow-up|1|||
155017878|NCT03351608|559491905|FG002|Overall Study|Lost to Follow-up|1|||
155017879|NCT03351608|559491906|FG003|Overall Study|Lost to Follow-up|1|||
155017880|NCT03351608|559491907|FG004|Overall Study|Lost to Follow-up|1|||
155017881|NCT03351608|559491903|FG000|Overall Study|Physician Decision|1|||
155017882|NCT03351608|559491904|FG001|Overall Study|Physician Decision|0|||
155017883|NCT03351608|559491905|FG002|Overall Study|Physician Decision|0|||
155017884|NCT03351608|559491906|FG003|Overall Study|Physician Decision|2|||
155017885|NCT03351608|559491907|FG004|Overall Study|Physician Decision|1|||
155017886|NCT03351608|559491903|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
155017887|NCT03351608|559491904|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
155017888|NCT03351608|559491905|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
155017889|NCT03351608|559491906|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
155017890|NCT03351608|559491907|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
155017891|NCT03351608|559491903|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155179227|NCT00761150|560095043|FG002|Double-blind Period|Withdrawal by Subject|2|||
155017892|NCT03351608|559491904|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155017893|NCT03351608|559491905|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155017894|NCT03351608|559491906|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155017895|NCT03351608|559491907|FG004|Overall Study|Withdrawal by parent/guardian|0|||
155017896|NCT03351608|559491903|FG000|Overall Study|Other|0|||
155017897|NCT03351608|559491904|FG001|Overall Study|Other|1|||
155017898|NCT03351608|559491905|FG002|Overall Study|Other|1|||
155017899|NCT03351608|559491906|FG003|Overall Study|Other|3|||
155017900|NCT03351608|559491907|FG004|Overall Study|Other|0|||
155017901|NCT02877004|559491908|FG000|Overall Study|Pregnancy|0|||
155017902|NCT02877004|559491909|FG001|Overall Study|Pregnancy|0|||
155017903|NCT02877004|559491910|FG002|Overall Study|Pregnancy|1|||
155017904|NCT02727478|559491911|FG000|Overall Study|Withdrawal by Subject|8|||
155017905|NCT02727478|559491912|FG001|Overall Study|Withdrawal by Subject|10|||
155017906|NCT02356588|559491913|FG000|Overall Study|Lack of Efficacy|4|||
155017907|NCT02356588|559491914|FG001|Overall Study|Lack of Efficacy|10|||
155017908|NCT02356588|559491913|FG000|Overall Study|Adverse Event|0|||
155017909|NCT02356588|559491914|FG001|Overall Study|Adverse Event|2|||
155017910|NCT02356588|559491913|FG000|Overall Study|Withdrawal by Subject|1|||
155017911|NCT02356588|559491914|FG001|Overall Study|Withdrawal by Subject|0|||
155017912|NCT02356588|559491913|FG000|Overall Study|Protocol Violation|0|||
155017913|NCT02356588|559491914|FG001|Overall Study|Protocol Violation|1|||
155017914|NCT01418378|559491915|FG000|Overall Study|Death|1|||
155017915|NCT01418378|559491916|FG001|Overall Study|Death|2|||
155017916|NCT01418378|559491915|FG000|Overall Study|Physician Decision|0|||
155017917|NCT01418378|559491916|FG001|Overall Study|Physician Decision|1|||
155017918|NCT01418378|559491915|FG000|Overall Study|ligament imbalance|0|||
155017919|NCT01418378|559491916|FG001|Overall Study|ligament imbalance|1|||
155017920|NCT01418378|559491915|FG000|Overall Study|developed chronic myopathy|0|||
155017921|NCT01418378|559491916|FG001|Overall Study|developed chronic myopathy|1|||
155017922|NCT01051791|559491919|FG000|Overall Study|Failed screening|3|||
155017923|NCT01051791|559491919|FG000|Overall Study|Withdrawal by Subject|1|||
155017924|NCT00288626|559491920|FG000|Overall Study|Death|3|||
155017925|NCT00288626|559491920|FG000|Overall Study|Withdrawal by Subject|4|||
155017926|NCT01372618|559491923|FG000|Overall Study|PI Died. Study Terminated|9|||
155017927|NCT04610346|559491925|FG000|Overall Study|Withdrawal by Subject|1|||
155017928|NCT04610346|559491926|FG001|Overall Study|Withdrawal by Subject|1|||
155017929|NCT04610346|559491925|FG000|Overall Study|did not complete shelter onboarding|2|||
155017930|NCT04610346|559491926|FG001|Overall Study|did not complete shelter onboarding|1|||
155017931|NCT01081769|559491927|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
155017932|NCT01081769|559491928|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
155017933|NCT01081769|559491927|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
155017934|NCT01081769|559491928|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
155017935|NCT01081769|559491927|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
155017936|NCT01081769|559491928|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
155017937|NCT01081769|559491927|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
155017938|NCT01081769|559491928|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
155017939|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Adverse Event|14|||
155017940|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Adverse Event|11|||
155017941|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Death|1|||
155017942|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Death|1|||
155017943|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
155017944|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
155017945|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
155017946|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
155017947|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Pregnancy|1|||
155017948|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Pregnancy|0|||
155017949|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
155017950|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
155017951|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
155017952|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
155017953|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Other|0|||
155017954|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Other|1|||
155017955|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Ineligibility|3|||
155017956|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Ineligibility|4|||
155017957|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
155017958|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
155017959|NCT01081769|559491927|FG000|CORE Intent-To-Treat|Patient Moved|2|||
155017960|NCT01081769|559491928|FG001|CORE Intent-To-Treat|Patient Moved|2|||
155017961|NCT03309943|559491929|FG000|Overall Study|Withdrawal by Subject|0|||
155017962|NCT03309943|559491930|FG001|Overall Study|Withdrawal by Subject|1|||
155017963|NCT03309943|559491929|FG000|Overall Study|Inappropriate behavior towards staff|0|||
155017964|NCT03309943|559491930|FG001|Overall Study|Inappropriate behavior towards staff|1|||
155139069|NCT00853151|559942634|FG000|Overall Study|Protocol Violation|0|||
155139070|NCT00853151|559942635|FG001|Overall Study|Protocol Violation|0|||
155139071|NCT00853151|559942636|FG002|Overall Study|Protocol Violation|0|||
155017965|NCT02019264|559491933|FG000|Overall Study|Not treated|6|||
155017966|NCT02019264|559491934|FG001|Overall Study|Not treated|4|||
155017967|NCT02019264|559491933|FG000|Overall Study|Lost to Follow-up|50|||
155139072|NCT00853151|559942637|FG003|Overall Study|Protocol Violation|1|||
155017968|NCT02019264|559491934|FG001|Overall Study|Lost to Follow-up|47|||
155017969|NCT02019264|559491933|FG000|Overall Study|Withdrawal by Subject|142|||
155017970|NCT02019264|559491934|FG001|Overall Study|Withdrawal by Subject|117|||
155017971|NCT02019264|559491933|FG000|Overall Study|Administrative reason|36|||
155017972|NCT02019264|559491934|FG001|Overall Study|Administrative reason|28|||
155017973|NCT02019264|559491933|FG000|Overall Study|Missing|14|||
155017974|NCT02019264|559491934|FG001|Overall Study|Missing|11|||
155179228|NCT00761150|560095041|FG000|Double-blind Period|Lost to Follow-up|0|||
155179229|NCT00761150|560095042|FG001|Double-blind Period|Lost to Follow-up|2|||
155179230|NCT00761150|560095043|FG002|Double-blind Period|Lost to Follow-up|1|||
155179231|NCT00761150|560095041|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
155179232|NCT00761150|560095042|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
155179233|NCT00761150|560095043|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
155179234|NCT00761150|560095041|FG000|Double-blind Period|Noncompliance|0|||
155179235|NCT00761150|560095042|FG001|Double-blind Period|Noncompliance|1|||
155179236|NCT00761150|560095043|FG002|Double-blind Period|Noncompliance|0|||
155179237|NCT00761150|560095041|FG000|Double-blind Period|Other|0|||
155179238|NCT00761150|560095042|FG001|Double-blind Period|Other|3|||
155179239|NCT00761150|560095043|FG002|Double-blind Period|Other|3|||
155179240|NCT02106923|560095045|FG000|Overall Study|Protocol Violation|0|||
155179241|NCT02106923|560095046|FG001|Overall Study|Protocol Violation|0|||
155179242|NCT02106923|560095047|FG002|Overall Study|Protocol Violation|0|||
155179243|NCT02106923|560095048|FG003|Overall Study|Protocol Violation|0|||
155179244|NCT02106923|560095049|FG004|Overall Study|Protocol Violation|0|||
155179245|NCT02106923|560095050|FG005|Overall Study|Protocol Violation|1|||
155179246|NCT01107379|560095054|FG000|Overall Study|Withdrawal by Subject|18|||
155179247|NCT01107379|560095054|FG000|Overall Study|Lost to Follow-up|3|||
155179248|NCT00548405|560095055|FG000|Overall Study|Adverse Event|6|||
155179249|NCT00548405|560095056|FG001|Overall Study|Adverse Event|2|||
155179250|NCT00548405|560095057|FG002|Overall Study|Adverse Event|0|||
155179251|NCT00548405|560095055|FG000|Overall Study|Lack of Efficacy|6|||
155179252|NCT00548405|560095056|FG001|Overall Study|Lack of Efficacy|0|||
155179253|NCT00548405|560095057|FG002|Overall Study|Lack of Efficacy|0|||
155179254|NCT00548405|560095055|FG000|Overall Study|Physician Decision|3|||
155179255|NCT00548405|560095056|FG001|Overall Study|Physician Decision|4|||
155179256|NCT00548405|560095057|FG002|Overall Study|Physician Decision|1|||
155179257|NCT00548405|560095055|FG000|Overall Study|Pregnancy|1|||
155179258|NCT00548405|560095056|FG001|Overall Study|Pregnancy|0|||
155179259|NCT00548405|560095057|FG002|Overall Study|Pregnancy|0|||
155179260|NCT00548405|560095055|FG000|Overall Study|Protocol Violation|1|||
155179261|NCT00548405|560095056|FG001|Overall Study|Protocol Violation|0|||
155179262|NCT00548405|560095057|FG002|Overall Study|Protocol Violation|0|||
155179263|NCT00548405|560095055|FG000|Overall Study|Withdrawal by Subject|36|||
155179264|NCT00548405|560095056|FG001|Overall Study|Withdrawal by Subject|12|||
155179265|NCT00548405|560095057|FG002|Overall Study|Withdrawal by Subject|5|||
155179266|NCT00548405|560095055|FG000|Overall Study|Lost to Follow-up|1|||
155179267|NCT00548405|560095056|FG001|Overall Study|Lost to Follow-up|1|||
155179268|NCT00548405|560095057|FG002|Overall Study|Lost to Follow-up|2|||
155179269|NCT00548405|560095055|FG000|Overall Study|Death|0|||
155179270|NCT00548405|560095056|FG001|Overall Study|Death|1|||
155179271|NCT00548405|560095057|FG002|Overall Study|Death|1|||
155179272|NCT00548405|560095055|FG000|Overall Study|Sponsor decision|1|||
155179273|NCT00548405|560095056|FG001|Overall Study|Sponsor decision|0|||
155179274|NCT00548405|560095057|FG002|Overall Study|Sponsor decision|0|||
155179275|NCT00548405|560095055|FG000|Overall Study|Randomized but not treated|1|||
155179276|NCT00548405|560095056|FG001|Overall Study|Randomized but not treated|0|||
155179277|NCT00548405|560095057|FG002|Overall Study|Randomized but not treated|0|||
155179278|NCT00924170|560095058|FG000|Overall Study|Refused further treatment|0|||
155179279|NCT00924170|560095059|FG001|Overall Study|Refused further treatment|1|||
155179280|NCT00924170|560095058|FG000|Overall Study|Physician Decision|0|||
155179281|NCT00924170|560095059|FG001|Overall Study|Physician Decision|1|||
155179282|NCT00924170|560095058|FG000|Overall Study|Progressive disease|3|||
155179283|NCT00924170|560095059|FG001|Overall Study|Progressive disease|6|||
155179284|NCT00924170|560095058|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
155179285|NCT00924170|560095059|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
155179286|NCT00924170|560095058|FG000|Overall Study|Death|1|||
155179287|NCT00924170|560095059|FG001|Overall Study|Death|0|||
155179288|NCT04672252|560095060|FG000|Overall Study|Protocol Violation|1|||
155179289|NCT04672252|560095061|FG001|Overall Study|Protocol Violation|0|||
155179290|NCT00899392|560095062|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
155179291|NCT00899392|560095063|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
155179292|NCT01903252|560095064|FG000|Double-Blind Induction|Adverse Event|20|||
155179293|NCT01903252|560095065|FG001|Double-Blind Induction|Adverse Event|18|||
155179294|NCT01903252|560095066|FG002|Double-Blind Induction|Adverse Event|0|||
155179295|NCT01903252|560095067|FG003|Double-Blind Induction|Adverse Event|0|||
155179296|NCT01903252|560095068|FG004|Double-Blind Induction|Adverse Event|0|||
155179297|NCT01903252|560095069|FG005|Double-Blind Induction|Adverse Event|0|||
155179298|NCT01903252|560095064|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
155179299|NCT01903252|560095065|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
155179300|NCT01903252|560095066|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
155179301|NCT01903252|560095067|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
155179302|NCT01903252|560095068|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
155179303|NCT01903252|560095069|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
155179304|NCT01903252|560095064|FG000|Double-Blind Induction|Physician Decision|2|||
155179305|NCT01903252|560095065|FG001|Double-Blind Induction|Physician Decision|3|||
155017975|NCT02155283|559491940|FG000|Overall Study|Lost to Follow-up|3|||
155017976|NCT02155283|559491940|FG000|Overall Study|Withdrawal by Subject|1|||
155017977|NCT02155283|559491940|FG000|Overall Study|Protocol Violation|3|||
155017978|NCT02282813|559491942|FG000|Overall Study|Withdrawal by Subject|4|||
155017979|NCT02282813|559491943|FG001|Overall Study|Withdrawal by Subject|5|||
155017980|NCT02282813|559491944|FG002|Overall Study|Withdrawal by Subject|0|||
155017981|NCT02282813|559491942|FG000|Overall Study|Adverse Event|3|||
155017982|NCT02282813|559491943|FG001|Overall Study|Adverse Event|10|||
155017983|NCT02282813|559491944|FG002|Overall Study|Adverse Event|1|||
155017984|NCT02282813|559491942|FG000|Overall Study|Subject non-compliance|1|||
155017985|NCT02282813|559491943|FG001|Overall Study|Subject non-compliance|4|||
155017986|NCT02282813|559491944|FG002|Overall Study|Subject non-compliance|0|||
155017987|NCT02282813|559491942|FG000|Overall Study|Physician Decision|0|||
155017988|NCT02282813|559491943|FG001|Overall Study|Physician Decision|3|||
155017989|NCT02282813|559491944|FG002|Overall Study|Physician Decision|1|||
155017990|NCT02282813|559491942|FG000|Overall Study|Lost to Follow-up|2|||
155017991|NCT02282813|559491943|FG001|Overall Study|Lost to Follow-up|0|||
155017992|NCT02282813|559491944|FG002|Overall Study|Lost to Follow-up|1|||
155017993|NCT02282813|559491942|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
155017994|NCT02282813|559491943|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
155017995|NCT02282813|559491944|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
155017996|NCT02282813|559491942|FG000|Overall Study|Lack of Efficacy|1|||
155017997|NCT02282813|559491943|FG001|Overall Study|Lack of Efficacy|0|||
155017998|NCT02282813|559491944|FG002|Overall Study|Lack of Efficacy|0|||
155017999|NCT02282813|559491942|FG000|Overall Study|Administrative reasons|0|||
155018000|NCT02282813|559491943|FG001|Overall Study|Administrative reasons|1|||
155018001|NCT02282813|559491944|FG002|Overall Study|Administrative reasons|0|||
155018002|NCT05000164|559491947|FG000|Overall Study|Adverse Event|1|||
155018003|NCT05000164|559491947|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155018004|NCT05000164|559491947|FG000|Overall Study|Lens Discomfort|3|||
155018005|NCT05000164|559491947|FG000|Overall Study|Withdrew Consent during Study|2|||
155018006|NCT05000164|559491947|FG000|Overall Study|Subject Withdrawn by PI|2|||
155018007|NCT05000164|559491947|FG000|Overall Study|Other Fractured Test Article|1|||
155018008|NCT04278417|559491950|FG000|Overall Study|Withdrawal by Subject|20|||
155018009|NCT04278417|559491951|FG001|Overall Study|Withdrawal by Subject|20|||
155018010|NCT04278417|559491950|FG000|Overall Study|Progressive disease|0|||
155018011|NCT04278417|559491951|FG001|Overall Study|Progressive disease|2|||
155018012|NCT04278417|559491950|FG000|Overall Study|Physician Decision|4|||
155018013|NCT04278417|559491951|FG001|Overall Study|Physician Decision|6|||
155018014|NCT04278417|559491950|FG000|Overall Study|Lost to Follow-up|11|||
155018015|NCT04278417|559491951|FG001|Overall Study|Lost to Follow-up|13|||
155018016|NCT04278417|559491950|FG000|Overall Study|Death|8|||
155018017|NCT04278417|559491951|FG001|Overall Study|Death|9|||
155018018|NCT04278417|559491950|FG000|Overall Study|Adverse Event|3|||
155018019|NCT04278417|559491951|FG001|Overall Study|Adverse Event|5|||
155018020|NCT04830969|559491955|FG000|Overall Study|Withdrawal by Subject|6|||
155018021|NCT04830969|559491956|FG001|Overall Study|Withdrawal by Subject|2|||
155018022|NCT04830969|559491955|FG000|Overall Study|Protocol Violation|3|||
155018023|NCT04830969|559491956|FG001|Overall Study|Protocol Violation|9|||
155018024|NCT04830969|559491955|FG000|Overall Study|Lost to Follow-up|4|||
155018025|NCT04830969|559491956|FG001|Overall Study|Lost to Follow-up|4|||
155018026|NCT00996125|559491957|FG000|Overall Study|Adverse Event|0|||
155018027|NCT00996125|559491958|FG001|Overall Study|Adverse Event|2|||
155018028|NCT00996125|559491957|FG000|Overall Study|Lost to Follow-up|1|||
155018029|NCT00996125|559491958|FG001|Overall Study|Lost to Follow-up|6|||
155018030|NCT00996125|559491957|FG000|Overall Study|Withdrawal by Subject|4|||
155018031|NCT00996125|559491958|FG001|Overall Study|Withdrawal by Subject|3|||
155018032|NCT04495829|559491959|FG000|Overall Study|Lost to Follow-up|2|||
155018033|NCT04495829|559491959|FG000|Overall Study|Inclusion criterion not met|3|||
155018034|NCT03859427|559491960|FG000|Overall Study|Withdrawal by Subject|4|||
155018035|NCT03859427|559491961|FG001|Overall Study|Withdrawal by Subject|7|||
155018036|NCT03859427|559491960|FG000|Overall Study|Decision by sponsor|0|||
155018037|NCT03859427|559491961|FG001|Overall Study|Decision by sponsor|3|||
155018038|NCT03859427|559491960|FG000|Overall Study|Lost to Follow-up|3|||
155018039|NCT03859427|559491961|FG001|Overall Study|Lost to Follow-up|2|||
155018040|NCT03859427|559491960|FG000|Overall Study|Death|22|||
155018041|NCT03859427|559491961|FG001|Overall Study|Death|25|||
155018042|NCT00564850|559491962|FG000|Overall Study|Protocol Violation|2|||
155018043|NCT02640664|559491963|FG000|Epoch 1|Withdrawal of informed consent|1|||
155018044|NCT02640664|559491964|FG001|Epoch 1|Withdrawal of informed consent|0|||
155018045|NCT02640664|559491965|FG002|Epoch 1|Withdrawal of informed consent|0|||
155018046|NCT02640664|559491963|FG000|Epoch 1|Death|0|||
155018047|NCT02640664|559491964|FG001|Epoch 1|Death|0|||
155139073|NCT00853151|559942634|FG000|Overall Study|Withdrawal by Subject|5|||
155018048|NCT02640664|559491965|FG002|Epoch 1|Death|1|||
155018049|NCT02640664|559491963|FG000|Epoch 2|Withdrawal of informed consent|3|||
155018050|NCT02640664|559491964|FG001|Epoch 2|Withdrawal of informed consent|4|||
155018051|NCT02640664|559491965|FG002|Epoch 2|Withdrawal of informed consent|2|||
155018052|NCT02640664|559491963|FG000|Epoch 2|Subject/guardian decision|0|||
155179306|NCT01903252|560095066|FG002|Double-Blind Induction|Physician Decision|0|||
155179307|NCT01903252|560095067|FG003|Double-Blind Induction|Physician Decision|0|||
155179308|NCT01903252|560095068|FG004|Double-Blind Induction|Physician Decision|0|||
155179309|NCT01903252|560095069|FG005|Double-Blind Induction|Physician Decision|0|||
155179310|NCT01903252|560095064|FG000|Double-Blind Induction|non-compliance,|7|||
155179311|NCT01903252|560095065|FG001|Double-Blind Induction|non-compliance,|7|||
155179312|NCT01903252|560095066|FG002|Double-Blind Induction|non-compliance,|0|||
155179313|NCT01903252|560095067|FG003|Double-Blind Induction|non-compliance,|0|||
155179314|NCT01903252|560095068|FG004|Double-Blind Induction|non-compliance,|0|||
155179315|NCT01903252|560095069|FG005|Double-Blind Induction|non-compliance,|0|||
155179316|NCT01903252|560095064|FG000|Extended Induction, Open-Label|Adverse Event|0|||
155179317|NCT01903252|560095065|FG001|Extended Induction, Open-Label|Adverse Event|0|||
155179318|NCT01903252|560095066|FG002|Extended Induction, Open-Label|Adverse Event|17|||
155179319|NCT01903252|560095067|FG003|Extended Induction, Open-Label|Adverse Event|0|||
155179320|NCT01903252|560095068|FG004|Extended Induction, Open-Label|Adverse Event|0|||
155179321|NCT01903252|560095069|FG005|Extended Induction, Open-Label|Adverse Event|0|||
155179322|NCT01903252|560095064|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155179323|NCT01903252|560095065|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155179324|NCT01903252|560095066|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
155179325|NCT01903252|560095067|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155179326|NCT01903252|560095068|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155179327|NCT01903252|560095069|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
155179328|NCT01903252|560095064|FG000|Extended Induction, Open-Label|Physician Decision|0|||
155179329|NCT01903252|560095065|FG001|Extended Induction, Open-Label|Physician Decision|0|||
155179330|NCT01903252|560095066|FG002|Extended Induction, Open-Label|Physician Decision|1|||
155179331|NCT01903252|560095067|FG003|Extended Induction, Open-Label|Physician Decision|0|||
155179332|NCT01903252|560095068|FG004|Extended Induction, Open-Label|Physician Decision|0|||
155179333|NCT01903252|560095069|FG005|Extended Induction, Open-Label|Physician Decision|0|||
155179334|NCT01903252|560095064|FG000|Maintenance, Open-Label|Adverse Event|0|||
155179335|NCT01903252|560095065|FG001|Maintenance, Open-Label|Adverse Event|0|||
155179336|NCT01903252|560095066|FG002|Maintenance, Open-Label|Adverse Event|0|||
155179337|NCT01903252|560095067|FG003|Maintenance, Open-Label|Adverse Event|3|||
155179338|NCT01903252|560095068|FG004|Maintenance, Open-Label|Adverse Event|9|||
155179339|NCT01903252|560095069|FG005|Maintenance, Open-Label|Adverse Event|14|||
155179340|NCT01903252|560095064|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
155179341|NCT01903252|560095065|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
155179342|NCT01903252|560095066|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
155018053|NCT02640664|559491964|FG001|Epoch 2|Subject/guardian decision|2|||
155018054|NCT02640664|559491965|FG002|Epoch 2|Subject/guardian decision|2|||
155018055|NCT02640664|559491963|FG000|Epoch 2|Lost to Follow-up|3|||
155018056|NCT02640664|559491964|FG001|Epoch 2|Lost to Follow-up|4|||
155018057|NCT02640664|559491965|FG002|Epoch 2|Lost to Follow-up|1|||
155018058|NCT02640664|559491963|FG000|Epoch 2|Death|0|||
155018059|NCT02640664|559491964|FG001|Epoch 2|Death|0|||
155018060|NCT02640664|559491965|FG002|Epoch 2|Death|1|||
155018061|NCT05678959|559494101|FG000|Overall Study|Study Terminated by Sponsor|76|||
155018062|NCT05678959|559494102|FG001|Overall Study|Study Terminated by Sponsor|76|||
155018063|NCT05678959|559494101|FG000|Overall Study|Physician Decision|2|||
155018064|NCT05678959|559494102|FG001|Overall Study|Physician Decision|3|||
155018065|NCT05678959|559494101|FG000|Overall Study|Adverse Event|1|||
155018066|NCT05678959|559494102|FG001|Overall Study|Adverse Event|1|||
155018067|NCT05678959|559494101|FG000|Overall Study|Guardian Decision|1|||
155018068|NCT05678959|559494102|FG001|Overall Study|Guardian Decision|0|||
155018069|NCT05678959|559494101|FG000|Overall Study|Protocol Deviation|0|||
155018070|NCT05678959|559494102|FG001|Overall Study|Protocol Deviation|1|||
155018071|NCT05678959|559494101|FG000|Overall Study|Subject Decision|1|||
155018072|NCT05678959|559494102|FG001|Overall Study|Subject Decision|0|||
155018073|NCT05678959|559494101|FG000|Overall Study|Technical Problem|0|||
155018074|NCT05678959|559494102|FG001|Overall Study|Technical Problem|1|||
155018075|NCT06360588|559494103|FG000|Overall Study|Adverse Event|3|||
155018076|NCT06360588|559494103|FG000|Overall Study|Death|2|||
155018077|NCT06360588|559494103|FG000|Overall Study|Disease Progression|14|||
155018078|NCT06360588|559494103|FG000|Overall Study|Withdrawal by Subject|1|||
155018079|NCT06360588|559494103|FG000|Overall Study|Lack of Efficacy|1|||
155179343|NCT01903252|560095067|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
155018080|NCT06360588|559494103|FG000|Overall Study|Ineligible|1|||
155018081|NCT04010240|559494104|FG000|Overall Study|IHC not performed|2299|||
155018082|NCT03263936|559494105|FG000|Overall Study|Adverse Event|0|||
155018083|NCT03263936|559494106|FG001|Overall Study|Adverse Event|1|||
155179344|NCT01903252|560095068|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
155179345|NCT01903252|560095069|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
155179346|NCT01903252|560095064|FG000|Maintenance, Open-Label|Other|0|||
155018084|NCT03263936|559494107|FG002|Overall Study|Adverse Event|0|||
155018085|NCT03263936|559494105|FG000|Overall Study|Death|0|||
155018086|NCT03263936|559494106|FG001|Overall Study|Death|1|||
155018087|NCT03263936|559494107|FG002|Overall Study|Death|0|||
155018088|NCT04432831|559494108|FG000|Overall Study|Withdrawal by Subject|24|||
155018089|NCT04432831|559494109|FG001|Overall Study|Withdrawal by Subject|28|||
155018090|NCT04432831|559494110|FG002|Overall Study|Withdrawal by Subject|21|||
155018091|NCT04432831|559494108|FG000|Overall Study|Death|23|||
155018092|NCT04432831|559494109|FG001|Overall Study|Death|23|||
155018093|NCT04432831|559494110|FG002|Overall Study|Death|17|||
155018094|NCT04432831|559494108|FG000|Overall Study|Lost to Follow-up|15|||
155018095|NCT04432831|559494109|FG001|Overall Study|Lost to Follow-up|15|||
155018096|NCT04432831|559494110|FG002|Overall Study|Lost to Follow-up|12|||
155018097|NCT04432831|559494108|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
155018098|NCT04432831|559494109|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
155018099|NCT04432831|559494110|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
155018100|NCT04432831|559494108|FG000|Overall Study|Reason Not Specified|7|||
155018101|NCT04432831|559494109|FG001|Overall Study|Reason Not Specified|11|||
155018102|NCT04432831|559494110|FG002|Overall Study|Reason Not Specified|9|||
155018103|NCT04432831|559494108|FG000|Overall Study|Adverse Event|7|||
155018104|NCT04432831|559494109|FG001|Overall Study|Adverse Event|7|||
155018105|NCT04432831|559494110|FG002|Overall Study|Adverse Event|7|||
155018106|NCT04432831|559494108|FG000|Overall Study|Physician Decision|1|||
155018107|NCT04432831|559494109|FG001|Overall Study|Physician Decision|3|||
155018108|NCT04432831|559494110|FG002|Overall Study|Physician Decision|6|||
155018109|NCT04432831|559494108|FG000|Overall Study|Protocol Violation|1|||
155018110|NCT04432831|559494109|FG001|Overall Study|Protocol Violation|0|||
155018111|NCT04432831|559494110|FG002|Overall Study|Protocol Violation|2|||
155018112|NCT04432831|559494108|FG000|Overall Study|Pregnancy|0|||
155018113|NCT04432831|559494109|FG001|Overall Study|Pregnancy|1|||
155018114|NCT04432831|559494110|FG002|Overall Study|Pregnancy|0|||
155018115|NCT04432831|559494108|FG000|Overall Study|Lack of Efficacy|0|||
155018116|NCT04432831|559494109|FG001|Overall Study|Lack of Efficacy|0|||
155018117|NCT04432831|559494110|FG002|Overall Study|Lack of Efficacy|2|||
155018118|NCT03782792|559494111|FG000|Overall Study|Patient left the country|0|||
155018119|NCT03782792|559494112|FG001|Overall Study|Patient left the country|1|||
155018120|NCT03782792|559494111|FG000|Overall Study|Withdrawal by Subject|1|||
155018121|NCT03782792|559494112|FG001|Overall Study|Withdrawal by Subject|2|||
155018122|NCT01540487|559494115|FG000|Overall Study|Protocol Violation|1|||
155018123|NCT01540487|559494116|FG001|Overall Study|Protocol Violation|0|||
155018124|NCT00617890|559494117|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
155018125|NCT00617890|559494118|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
155018126|NCT00617890|559494119|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
155018127|NCT00617890|559494120|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
155018128|NCT00617890|559494117|FG000|Overall Study|Lack of Efficacy|23|||
155018129|NCT00617890|559494118|FG001|Overall Study|Lack of Efficacy|26|||
155018130|NCT00617890|559494119|FG002|Overall Study|Lack of Efficacy|30|||
155018131|NCT00617890|559494120|FG003|Overall Study|Lack of Efficacy|97|||
155018132|NCT00617890|559494117|FG000|Overall Study|Lost to Follow-up|0|||
155018133|NCT00617890|559494118|FG001|Overall Study|Lost to Follow-up|0|||
155018134|NCT00617890|559494119|FG002|Overall Study|Lost to Follow-up|1|||
155018135|NCT00617890|559494120|FG003|Overall Study|Lost to Follow-up|2|||
155018136|NCT00617890|559494117|FG000|Overall Study|Withdrawal by Subject|4|||
155018137|NCT00617890|559494118|FG001|Overall Study|Withdrawal by Subject|1|||
155018138|NCT00617890|559494119|FG002|Overall Study|Withdrawal by Subject|0|||
155139074|NCT00853151|559942635|FG001|Overall Study|Withdrawal by Subject|4|||
155139075|NCT00853151|559942636|FG002|Overall Study|Withdrawal by Subject|2|||
155139076|NCT00853151|559942637|FG003|Overall Study|Withdrawal by Subject|1|||
155018139|NCT00617890|559494120|FG003|Overall Study|Withdrawal by Subject|2|||
155018140|NCT00617890|559494117|FG000|Overall Study|Protocol Violation|2|||
155018141|NCT00617890|559494118|FG001|Overall Study|Protocol Violation|1|||
155018142|NCT00617890|559494119|FG002|Overall Study|Protocol Violation|0|||
155018143|NCT00617890|559494120|FG003|Overall Study|Protocol Violation|0|||
155018144|NCT00617890|559494117|FG000|Overall Study|Adverse Event|1|||
155018145|NCT00617890|559494118|FG001|Overall Study|Adverse Event|0|||
155018146|NCT00617890|559494119|FG002|Overall Study|Adverse Event|3|||
155018147|NCT00617890|559494120|FG003|Overall Study|Adverse Event|8|||
155018148|NCT00617890|559494117|FG000|Overall Study|Not treated|1|||
155018149|NCT00617890|559494118|FG001|Overall Study|Not treated|0|||
155018150|NCT00617890|559494119|FG002|Overall Study|Not treated|1|||
155018151|NCT00617890|559494120|FG003|Overall Study|Not treated|1|||
155018152|NCT03503370|559494121|FG000|Overall Study|Death|3|||
155018153|NCT03503370|559494122|FG001|Overall Study|Death|1|||
155018154|NCT04545489|559494123|FG000|Overall Study|Withdrawal by Subject|12|||
155018155|NCT04545489|559494124|FG001|Overall Study|Withdrawal by Subject|4|||
155018156|NCT04545489|559494123|FG000|Overall Study|Lost to Follow-up|17|||
155018157|NCT04545489|559494124|FG001|Overall Study|Lost to Follow-up|18|||
155018158|NCT04545489|559494123|FG000|Overall Study|12month BP not collected|4|||
155139077|NCT00853151|559942634|FG000|Overall Study|Physician Decision|0|||
155018159|NCT04545489|559494124|FG001|Overall Study|12month BP not collected|4|||
155018160|NCT00457002|559494128|FG000|Overall Study|Death|40|||
155018161|NCT00457002|559494129|FG001|Overall Study|Death|47|||
155018162|NCT00457002|559494128|FG000|Overall Study|Adverse Event|284|||
155018163|NCT00457002|559494129|FG001|Overall Study|Adverse Event|260|||
155018164|NCT00457002|559494128|FG000|Overall Study|Withdrawal by Subject|299|||
155018165|NCT00457002|559494129|FG001|Overall Study|Withdrawal by Subject|271|||
155018166|NCT00457002|559494128|FG000|Overall Study|Lost to Follow-up|72|||
155018167|NCT00457002|559494129|FG001|Overall Study|Lost to Follow-up|71|||
155018168|NCT00457002|559494128|FG000|Overall Study|Poor/Non-compliance|46|||
155018169|NCT00457002|559494129|FG001|Overall Study|Poor/Non-compliance|33|||
155018170|NCT00457002|559494128|FG000|Overall Study|No longer met criteria|41|||
155018171|NCT00457002|559494129|FG001|Overall Study|No longer met criteria|37|||
155018172|NCT00457002|559494128|FG000|Overall Study|Administrative reason by Sponsor|1|||
155018173|NCT00457002|559494129|FG001|Overall Study|Administrative reason by Sponsor|0|||
155018174|NCT00457002|559494128|FG000|Overall Study|non-specified|29|||
155018175|NCT00457002|559494129|FG001|Overall Study|non-specified|38|||
155018176|NCT00457002|559494128|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
155018177|NCT00457002|559494129|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
155018178|NCT01623310|559494130|FG000|Overall Study|Adverse Event|21|||
155018179|NCT01623310|559494130|FG000|Overall Study|Lost to Follow-up|18|||
155018180|NCT01623310|559494130|FG000|Overall Study|Lack of Efficacy|6|||
155018181|NCT01623310|559494130|FG000|Overall Study|Protocol Violation|6|||
155018182|NCT01623310|559494130|FG000|Overall Study|Withdrawal by Subject|25|||
155018183|NCT01623310|559494130|FG000|Overall Study|Became potentially child-bearing|1|||
155018184|NCT01623310|559494130|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
155018185|NCT01623310|559494130|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
155018186|NCT00454246|559494131|FG000|Overall Study|Adverse Event|2|||
155018187|NCT00454246|559494132|FG001|Overall Study|Adverse Event|2|||
155018188|NCT00454246|559494133|FG002|Overall Study|Adverse Event|0|||
155018189|NCT00454246|559494131|FG000|Overall Study|Violation of selection criteria at entry|6|||
155018190|NCT00454246|559494132|FG001|Overall Study|Violation of selection criteria at entry|0|||
155018191|NCT00454246|559494133|FG002|Overall Study|Violation of selection criteria at entry|0|||
155018192|NCT00454246|559494131|FG000|Overall Study|Protocol Violation|1|||
155018193|NCT00454246|559494132|FG001|Overall Study|Protocol Violation|0|||
155018194|NCT00454246|559494133|FG002|Overall Study|Protocol Violation|0|||
155018195|NCT00454246|559494131|FG000|Overall Study|Refused Treatment|1|||
155018196|NCT00454246|559494132|FG001|Overall Study|Refused Treatment|1|||
155018197|NCT00454246|559494133|FG002|Overall Study|Refused Treatment|0|||
155018198|NCT00454246|559494131|FG000|Overall Study|Failure to return|1|||
155018199|NCT00454246|559494132|FG001|Overall Study|Failure to return|0|||
155018200|NCT00454246|559494133|FG002|Overall Study|Failure to return|0|||
155018201|NCT00454246|559494131|FG000|Overall Study|Early termination of study|62|||
155018202|NCT00454246|559494132|FG001|Overall Study|Early termination of study|26|||
155018203|NCT00454246|559494133|FG002|Overall Study|Early termination of study|9|||
155018204|NCT02058537|559494135|FG000|Overall Study|Withdrawal by Subject|1|||
155018205|NCT01085630|559494136|FG000|Overall Study|Insufficient data|1|||
155018206|NCT01085630|559494137|FG001|Overall Study|Insufficient data|0|||
155018207|NCT01085630|559494136|FG000|Overall Study|Ineligible|3|||
155018208|NCT01085630|559494137|FG001|Overall Study|Ineligible|0|||
155018209|NCT00651261|559494148|FG000|Overall Study|Adverse Event|32|||
155018210|NCT00651261|559494149|FG001|Overall Study|Adverse Event|22|||
155018211|NCT00651261|559494148|FG000|Overall Study|Death|18|||
155018212|NCT00651261|559494149|FG001|Overall Study|Death|18|||
155018213|NCT00651261|559494148|FG000|Overall Study|Withdrawal by Subject|22|||
155018214|NCT00651261|559494149|FG001|Overall Study|Withdrawal by Subject|40|||
155018215|NCT00651261|559494148|FG000|Overall Study|Induction failure|24|||
155018216|NCT00651261|559494149|FG001|Overall Study|Induction failure|35|||
155018217|NCT00651261|559494148|FG000|Overall Study|Disease progression|58|||
155018218|NCT00651261|559494149|FG001|Overall Study|Disease progression|58|||
155018219|NCT00651261|559494148|FG000|Overall Study|Alternative therapy|109|||
155018220|NCT00651261|559494149|FG001|Overall Study|Alternative therapy|107|||
155018221|NCT00651261|559494148|FG000|Overall Study|Other disease or participant decisions|23|||
155018222|NCT00651261|559494149|FG001|Overall Study|Other disease or participant decisions|23|||
155018223|NCT00651261|559494148|FG000|Overall Study|Never treated|5|||
155179347|NCT01903252|560095065|FG001|Maintenance, Open-Label|Other|0|||
155018224|NCT00651261|559494149|FG001|Overall Study|Never treated|3|||
155018225|NCT03581123|559494150|FG000|2-month Follow-up|Withdrawal by Subject|5|||
155018226|NCT03581123|559494151|FG001|2-month Follow-up|Withdrawal by Subject|4|||
155018227|NCT03581123|559494152|FG002|2-month Follow-up|Withdrawal by Subject|6|||
155018228|NCT03581123|559494153|FG003|2-month Follow-up|Withdrawal by Subject|4|||
155018229|NCT03581123|559494150|FG000|2-month Follow-up|Lost to Follow-up|8|||
155018230|NCT03581123|559494151|FG001|2-month Follow-up|Lost to Follow-up|1|||
155018231|NCT03581123|559494152|FG002|2-month Follow-up|Lost to Follow-up|2|||
155018232|NCT03581123|559494153|FG003|2-month Follow-up|Lost to Follow-up|2|||
155018233|NCT03581123|559494150|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
155018234|NCT03581123|559494151|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
155018235|NCT03581123|559494152|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
155018236|NCT03581123|559494153|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
155018237|NCT03581123|559494150|FG000|6-Month Follow-up|Lost to Follow-up|3|||
155018238|NCT03581123|559494151|FG001|6-Month Follow-up|Lost to Follow-up|3|||
155018239|NCT03581123|559494152|FG002|6-Month Follow-up|Lost to Follow-up|1|||
155018240|NCT03581123|559494153|FG003|6-Month Follow-up|Lost to Follow-up|1|||
155018241|NCT03581123|559494150|FG000|12-Month Follow-up|Lost to Follow-up|4|||
155018242|NCT03581123|559494151|FG001|12-Month Follow-up|Lost to Follow-up|3|||
155018243|NCT03581123|559494152|FG002|12-Month Follow-up|Lost to Follow-up|4|||
155018244|NCT03581123|559494153|FG003|12-Month Follow-up|Lost to Follow-up|5|||
155018245|NCT02633293|559494154|FG000|Overall Study|Death|56|||
155018246|NCT02633293|559494154|FG000|Overall Study|Progressive Disease|12|||
155018247|NCT02633293|559494154|FG000|Overall Study|Adverse Event|29|||
155018248|NCT02633293|559494154|FG000|Overall Study|Withdrawal by Subject|41|||
155018249|NCT02633293|559494154|FG000|Overall Study|Protocol Violation|1|||
155018250|NCT02633293|559494154|FG000|Overall Study|Lost to Follow-up|1|||
155018251|NCT02633293|559494154|FG000|Overall Study|Study Terminated by Sponsor|24|||
155018252|NCT02633293|559494154|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
155018253|NCT02633293|559494154|FG000|Overall Study|Lung Transplant|5|||
155018254|NCT02633293|559494154|FG000|Overall Study|Lack of Efficacy|2|||
155018255|NCT02633293|559494154|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
155018256|NCT00808210|559494155|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
155018257|NCT00808210|559494156|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
155018258|NCT00808210|559494155|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
155018259|NCT00808210|559494156|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
155018260|NCT00808210|559494155|FG000|Double-Blind TX Period|Adverse Event|0|||
155018261|NCT00808210|559494156|FG001|Double-Blind TX Period|Adverse Event|1|||
155018262|NCT00808210|559494155|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
155018263|NCT00808210|559494156|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
155018264|NCT00808210|559494155|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
155018265|NCT00808210|559494156|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
155018266|NCT00808210|559494155|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
155018267|NCT00808210|559494156|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
155018268|NCT02044302|559494157|FG000|Overall Study|study terminated|2|||
155018269|NCT02044302|559494158|FG001|Overall Study|study terminated|0|||
155018270|NCT01790984|559494160|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
155018271|NCT01790984|559494161|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
155018272|NCT01790984|559494162|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
155018273|NCT01790984|559494163|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
155018274|NCT03448419|559494166|FG000|Overall Study|Adverse Event|10|||
155018275|NCT03448419|559494167|FG001|Overall Study|Adverse Event|9|||
155018276|NCT03448419|559494166|FG000|Overall Study|Lost to Follow-up|0|||
155018277|NCT03448419|559494167|FG001|Overall Study|Lost to Follow-up|2|||
155018278|NCT03448419|559494166|FG000|Overall Study|Withdrawal by Subject|3|||
155018279|NCT03448419|559494167|FG001|Overall Study|Withdrawal by Subject|1|||
155018280|NCT03448419|559494166|FG000|Overall Study|Not treated|0|||
155018281|NCT03448419|559494167|FG001|Overall Study|Not treated|1|||
155018282|NCT03448419|559494166|FG000|Overall Study|Patient did not attend all visits|0|||
155018283|NCT03448419|559494167|FG001|Overall Study|Patient did not attend all visits|2|||
155018284|NCT03448419|559494166|FG000|Overall Study|Withdrawn by Sponsor|0|||
155018285|NCT03448419|559494167|FG001|Overall Study|Withdrawn by Sponsor|1|||
155018286|NCT00558467|559494168|FG000|Overall Study|Adverse Event|1|||
155018287|NCT00558467|559494169|FG001|Overall Study|Adverse Event|2|||
155018288|NCT00558467|559494168|FG000|Overall Study|Lack of Efficacy|0|||
155018289|NCT00558467|559494169|FG001|Overall Study|Lack of Efficacy|1|||
155018290|NCT00558467|559494168|FG000|Overall Study|Patient moving out of state|0|||
155018291|NCT00558467|559494169|FG001|Overall Study|Patient moving out of state|1|||
155018292|NCT00507455|559494170|FG000|Overall Study|Adverse Event|3|||
155018293|NCT00507455|559494171|FG001|Overall Study|Adverse Event|3|||
155018294|NCT00507455|559494172|FG002|Overall Study|Adverse Event|6|||
155018295|NCT00507455|559494170|FG000|Overall Study|Withdrawal by Subject|2|||
155018296|NCT00507455|559494171|FG001|Overall Study|Withdrawal by Subject|1|||
155018297|NCT00507455|559494172|FG002|Overall Study|Withdrawal by Subject|2|||
155018298|NCT00507455|559494170|FG000|Overall Study|Protocol Violation|4|||
155018299|NCT00507455|559494171|FG001|Overall Study|Protocol Violation|1|||
155018300|NCT00507455|559494172|FG002|Overall Study|Protocol Violation|1|||
155018301|NCT00507455|559494170|FG000|Overall Study|Lost to Follow-up|2|||
155018302|NCT00507455|559494171|FG001|Overall Study|Lost to Follow-up|0|||
155018303|NCT00507455|559494172|FG002|Overall Study|Lost to Follow-up|2|||
155018304|NCT00507455|559494170|FG000|Overall Study|Lack of Efficacy|0|||
155018305|NCT00507455|559494171|FG001|Overall Study|Lack of Efficacy|1|||
155018306|NCT00507455|559494172|FG002|Overall Study|Lack of Efficacy|0|||
155018307|NCT00507455|559494170|FG000|Overall Study|Other - miscellaneous reason|1|||
155018308|NCT00507455|559494171|FG001|Overall Study|Other - miscellaneous reason|0|||
155018309|NCT00507455|559494172|FG002|Overall Study|Other - miscellaneous reason|1|||
155018310|NCT00931255|559494173|FG000|Overall Study|Follow up biopsy not done|2|||
155018311|NCT00931255|559494174|FG001|Overall Study|Follow up biopsy not done|3|||
155018312|NCT00546377|559494184|FG000|Overall Study|Deemed ineligible|1|||
155018313|NCT00546377|559494184|FG000|Overall Study|Adverse Event|6|||
155018314|NCT01684423|559494185|FG000|Overall Study|Withdrawal by Subject|0|||
155018315|NCT01684423|559494186|FG001|Overall Study|Withdrawal by Subject|0|||
155018316|NCT01684423|559494187|FG002|Overall Study|Withdrawal by Subject|1|||
155018317|NCT01684423|559494188|FG003|Overall Study|Withdrawal by Subject|0|||
155018318|NCT01684423|559494189|FG004|Overall Study|Withdrawal by Subject|0|||
155018319|NCT01575834|559494190|FG000|Overall Study|Withdrawal by Subject|352|||
155018320|NCT01575834|559494191|FG001|Overall Study|Withdrawal by Subject|390|||
155018321|NCT01575834|559494190|FG000|Overall Study|Death|81|||
155018322|NCT01575834|559494191|FG001|Overall Study|Death|74|||
155018323|NCT01575834|559494190|FG000|Overall Study|Other|70|||
155018324|NCT01575834|559494191|FG001|Overall Study|Other|70|||
155018325|NCT01575834|559494190|FG000|Overall Study|Adverse Event|63|||
155018326|NCT01575834|559494191|FG001|Overall Study|Adverse Event|61|||
155018327|NCT01575834|559494190|FG000|Overall Study|Lost to Follow-up|55|||
155018328|NCT01575834|559494191|FG001|Overall Study|Lost to Follow-up|68|||
155018329|NCT01575834|559494190|FG000|Overall Study|Noncompliance|52|||
155018330|NCT01575834|559494191|FG001|Overall Study|Noncompliance|27|||
155018331|NCT01575834|559494190|FG000|Overall Study|Administrative decision|15|||
155018332|NCT01575834|559494191|FG001|Overall Study|Administrative decision|33|||
155018333|NCT01575834|559494190|FG000|Overall Study|Ineligibility Determined|5|||
155018334|NCT01575834|559494191|FG001|Overall Study|Ineligibility Determined|8|||
155018335|NCT01575834|559494190|FG000|Overall Study|Protocol Deviation|4|||
155018336|NCT01575834|559494191|FG001|Overall Study|Protocol Deviation|3|||
155018337|NCT01575834|559494190|FG000|Overall Study|Requirement for Alternative Therapy|2|||
155018338|NCT01575834|559494191|FG001|Overall Study|Requirement for Alternative Therapy|4|||
155018339|NCT01741688|559494193|FG000|Overall Study|Lack of insurance coverage|2|||
155018340|NCT01741688|559494193|FG000|Overall Study|Withdrawal by Subject|1|||
155018341|NCT00463047|559494197|FG000|Titration Period 1|Adverse Event|10|||
155018342|NCT00463047|559494198|FG001|Titration Period 1|Adverse Event|8|||
155018343|NCT00463047|559494197|FG000|Titration Period 1|Lack of Efficacy|10|||
155018344|NCT00463047|559494198|FG001|Titration Period 1|Lack of Efficacy|4|||
155018345|NCT00463047|559494197|FG000|Titration Period 1|Lost to Follow-up|2|||
155018346|NCT00463047|559494198|FG001|Titration Period 1|Lost to Follow-up|0|||
155018347|NCT00463047|559494197|FG000|Titration Period 1|Non-compliance with study medication|3|||
155018348|NCT00463047|559494198|FG001|Titration Period 1|Non-compliance with study medication|5|||
155018349|NCT00463047|559494197|FG000|Titration Period 1|Protocol Violation|5|||
155018350|NCT00463047|559494198|FG001|Titration Period 1|Protocol Violation|5|||
155018351|NCT00463047|559494197|FG000|Titration Period 1|Withdrawal by Subject|3|||
155018352|NCT00463047|559494198|FG001|Titration Period 1|Withdrawal by Subject|5|||
155018353|NCT00463047|559494197|FG000|Titration Period 1|Non-compliance procedures|4|||
155018354|NCT00463047|559494198|FG001|Titration Period 1|Non-compliance procedures|10|||
155018355|NCT00463047|559494197|FG000|Titration Period 1|Other|0|||
155018356|NCT00463047|559494198|FG001|Titration Period 1|Other|2|||
155018357|NCT00463047|559494197|FG000|Titration Period 2|Adverse Event|9|||
155018358|NCT00463047|559494198|FG001|Titration Period 2|Adverse Event|9|||
155018359|NCT00463047|559494197|FG000|Titration Period 2|Lack of Efficacy|6|||
155018360|NCT00463047|559494198|FG001|Titration Period 2|Lack of Efficacy|4|||
155018361|NCT00463047|559494197|FG000|Titration Period 2|Withdrawal by Subject|1|||
155018362|NCT00463047|559494198|FG001|Titration Period 2|Withdrawal by Subject|0|||
155018363|NCT00463047|559494197|FG000|Titration Period 2|Protocol Violation|2|||
155018364|NCT00463047|559494198|FG001|Titration Period 2|Protocol Violation|3|||
155018365|NCT00463047|559494197|FG000|Titration Period 2|Lost to Follow-up|1|||
155018366|NCT00463047|559494198|FG001|Titration Period 2|Lost to Follow-up|2|||
155018367|NCT00463047|559494197|FG000|Titration Period 2|Non-compliance study medication|4|||
155018368|NCT00463047|559494198|FG001|Titration Period 2|Non-compliance study medication|2|||
155018369|NCT00463047|559494197|FG000|Titration Period 2|Non-compliance procedures|4|||
155018370|NCT00463047|559494198|FG001|Titration Period 2|Non-compliance procedures|1|||
155018371|NCT00463047|559494197|FG000|Titration Period 2|Other|3|||
155018372|NCT00463047|559494198|FG001|Titration Period 2|Other|2|||
155018373|NCT00463047|559494197|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
155018374|NCT00463047|559494198|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
155018375|NCT00463047|559494197|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
155018376|NCT00463047|559494198|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
155018377|NCT00463047|559494197|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
155018378|NCT00463047|559494198|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
155018379|NCT00463047|559494197|FG000|Double-Blind Treatment Period 1|Other|1|||
155018380|NCT00463047|559494198|FG001|Double-Blind Treatment Period 1|Other|0|||
155018381|NCT00463047|559494197|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
155018382|NCT00463047|559494198|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
155018383|NCT00463047|559494197|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
155018384|NCT00463047|559494198|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
155018385|NCT00463047|559494197|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
155018386|NCT00463047|559494198|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
155018387|NCT02220764|559494204|FG000|Overall Study|Lost to Follow-up|3|||
155018388|NCT02220764|559494205|FG001|Overall Study|Lost to Follow-up|1|||
155018389|NCT02220764|559494204|FG000|Overall Study|Death|1|||
155018390|NCT02220764|559494205|FG001|Overall Study|Death|0|||
155018391|NCT03020992|559494206|FG000|Overall Study|Adverse Event|5|||
155018392|NCT03020992|559494206|FG000|Overall Study|Withdrawal by Subject|1|||
155018393|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
155018394|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
155018395|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
155018396|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
155018397|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Pregnancy|0|||
155018398|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Pregnancy|1|||
155018399|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
155018400|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
155018401|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
155018402|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
155018403|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
155018404|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
155018405|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Other|3|||
155018406|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Other|0|||
155018407|NCT01006122|559494207|FG000|First Double-blind Intervention Period|Adverse Event|0|||
155018408|NCT01006122|559494208|FG001|First Double-blind Intervention Period|Adverse Event|4|||
155018409|NCT01006122|559494207|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
155018410|NCT01006122|559494208|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
155018411|NCT01006122|559494207|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
155018412|NCT01006122|559494208|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
155018413|NCT01006122|559494207|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
155018414|NCT01006122|559494208|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
155018415|NCT01006122|559494207|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
155018416|NCT01006122|559494208|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
155018417|NCT01006122|559494207|FG000|Second Double-blind Intervention Period|Death|0|||
155018418|NCT01006122|559494208|FG001|Second Double-blind Intervention Period|Death|1|||
155018419|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
155018420|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
155018421|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
155018422|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
155018423|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
155018424|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
155018425|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
155018426|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
155018427|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
155018428|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
155018429|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
155018430|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
155018431|NCT03493854|559494209|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
155018432|NCT03493854|559494210|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
155018433|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
155018434|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
155018435|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
155018436|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
155018437|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
155018438|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
155018439|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
155018440|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
155018441|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
155018442|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
155018443|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
155179348|NCT01903252|560095066|FG002|Maintenance, Open-Label|Other|0|||
155179349|NCT01903252|560095067|FG003|Maintenance, Open-Label|Other|2|||
155179350|NCT01903252|560095068|FG004|Maintenance, Open-Label|Other|6|||
155179351|NCT01903252|560095069|FG005|Maintenance, Open-Label|Other|2|||
155179352|NCT02660138|560095071|FG000|Overall Study|Adverse Event|0|||
155179353|NCT02660138|560095072|FG001|Overall Study|Adverse Event|3|||
155018444|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
155018445|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
155179354|NCT02660138|560095073|FG002|Overall Study|Adverse Event|2|||
155179355|NCT02660138|560095071|FG000|Overall Study|Lack of Efficacy|1|||
155179356|NCT02660138|560095072|FG001|Overall Study|Lack of Efficacy|2|||
155018446|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
155018447|NCT03493854|559494209|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
155018448|NCT03493854|559494210|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
155018449|NCT03493854|559494209|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
155018450|NCT03493854|559494210|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
155018451|NCT03493854|559494209|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
155018452|NCT03493854|559494210|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
155018453|NCT03493854|559494209|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
155018454|NCT03493854|559494210|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
155018455|NCT00410813|559494211|FG000|Overall Study|Adverse Event|6|||
155018456|NCT00410813|559494212|FG001|Overall Study|Adverse Event|11|||
155018457|NCT00410813|559494211|FG000|Overall Study|Progression|32|||
155018458|NCT00410813|559494212|FG001|Overall Study|Progression|21|||
155018459|NCT00410813|559494211|FG000|Overall Study|Not protocol specified|3|||
155018460|NCT00410813|559494212|FG001|Overall Study|Not protocol specified|4|||
155018461|NCT00410813|559494211|FG000|Overall Study|Ineligible|2|||
155018462|NCT00410813|559494212|FG001|Overall Study|Ineligible|4|||
155018463|NCT00410813|559494211|FG000|Overall Study|Death|0|||
155018464|NCT00410813|559494212|FG001|Overall Study|Death|2|||
155018465|NCT03926117|559494223|FG000|Overall Study|Unclassified|1|||
155018466|NCT03926117|559494224|FG001|Overall Study|Unclassified|4|||
155018467|NCT03926117|559494225|FG002|Overall Study|Unclassified|1|||
155018468|NCT03926117|559494226|FG003|Overall Study|Unclassified|4|||
155018469|NCT03926117|559494223|FG000|Overall Study|Withdrawal by Subject|3|||
155018470|NCT03926117|559494224|FG001|Overall Study|Withdrawal by Subject|0|||
155018471|NCT03926117|559494225|FG002|Overall Study|Withdrawal by Subject|1|||
155018472|NCT03926117|559494226|FG003|Overall Study|Withdrawal by Subject|1|||
155018473|NCT03926117|559494223|FG000|Overall Study|Lost to Follow-up|0|||
155018474|NCT03926117|559494224|FG001|Overall Study|Lost to Follow-up|2|||
155018475|NCT03926117|559494225|FG002|Overall Study|Lost to Follow-up|1|||
155018476|NCT03926117|559494226|FG003|Overall Study|Lost to Follow-up|0|||
155018477|NCT03926117|559494223|FG000|Overall Study|Adverse Event|1|||
155018478|NCT03926117|559494224|FG001|Overall Study|Adverse Event|2|||
155018479|NCT03926117|559494225|FG002|Overall Study|Adverse Event|3|||
155018480|NCT03926117|559494226|FG003|Overall Study|Adverse Event|1|||
155018481|NCT03926117|559494223|FG000|Overall Study|Randomized but not treated|1|||
155018482|NCT03926117|559494224|FG001|Overall Study|Randomized but not treated|1|||
155018483|NCT03926117|559494225|FG002|Overall Study|Randomized but not treated|0|||
155018484|NCT03926117|559494226|FG003|Overall Study|Randomized but not treated|1|||
155018485|NCT02203721|559494229|FG000|Overall Study|Lost to Follow-up|1|||
155018486|NCT02203721|559494230|FG001|Overall Study|Lost to Follow-up|0|||
155018487|NCT02203721|559494229|FG000|Overall Study|Death|0|||
155018488|NCT02203721|559494230|FG001|Overall Study|Death|2|||
155018489|NCT02203721|559494229|FG000|Overall Study|Illness|0|||
155018490|NCT02203721|559494230|FG001|Overall Study|Illness|1|||
155018491|NCT01796392|559494231|FG000|Overall Study|Withdrawal by Subject|2|||
155018492|NCT01796392|559494232|FG001|Overall Study|Withdrawal by Subject|0|||
155018493|NCT01796392|559494231|FG000|Overall Study|Death|5|||
155018494|NCT01796392|559494232|FG001|Overall Study|Death|1|||
155018495|NCT01796392|559494231|FG000|Overall Study|Excluded for medical reasons|1|||
155018496|NCT01796392|559494232|FG001|Overall Study|Excluded for medical reasons|2|||
155018497|NCT01796392|559494231|FG000|Overall Study|Lost to Follow-up|1|||
155139078|NCT00853151|559942635|FG001|Overall Study|Physician Decision|2|||
155139079|NCT00853151|559942636|FG002|Overall Study|Physician Decision|1|||
155139080|NCT00853151|559942637|FG003|Overall Study|Physician Decision|0|||
155139081|NCT00853151|559942634|FG000|Overall Study|Sponsor Decision|0|||
155139082|NCT00853151|559942635|FG001|Overall Study|Sponsor Decision|3|||
155139083|NCT00853151|559942636|FG002|Overall Study|Sponsor Decision|0|||
155139084|NCT00853151|559942637|FG003|Overall Study|Sponsor Decision|0|||
155139085|NCT01510158|559942638|FG000|Overall Study|Adverse Event|7|||
155139086|NCT01510158|559942639|FG001|Overall Study|Adverse Event|8|||
155139087|NCT01510158|559942640|FG002|Overall Study|Adverse Event|5|||
155139088|NCT01510158|559942638|FG000|Overall Study|Gout flare|1|||
155179357|NCT02660138|560095073|FG002|Overall Study|Lack of Efficacy|1|||
155018498|NCT01796392|559494232|FG001|Overall Study|Lost to Follow-up|0|||
155018499|NCT04639219|559494233|FG000|Overall Study|Withdrawal by Subject|8|||
155018500|NCT04639219|559494233|FG000|Overall Study|Lost to Follow-up|6|||
155018501|NCT04639219|559494233|FG000|Overall Study|Death|55|||
155018502|NCT04681066|559494234|FG000|Overall Study|Lost to Follow-up|3|||
155018503|NCT04681066|559494235|FG001|Overall Study|Lost to Follow-up|1|||
155018504|NCT04681066|559494236|FG002|Overall Study|Lost to Follow-up|2|||
155018505|NCT04681066|559494237|FG003|Overall Study|Lost to Follow-up|1|||
155018506|NCT04681066|559494234|FG000|Overall Study|Withdrawal by Subject|2|||
155018507|NCT04681066|559494235|FG001|Overall Study|Withdrawal by Subject|1|||
155018508|NCT04681066|559494236|FG002|Overall Study|Withdrawal by Subject|0|||
155018509|NCT04681066|559494237|FG003|Overall Study|Withdrawal by Subject|3|||
155139089|NCT01510158|559942639|FG001|Overall Study|Gout flare|0|||
155139090|NCT01510158|559942640|FG002|Overall Study|Gout flare|0|||
155018510|NCT04681066|559494234|FG000|Overall Study|Death|0|||
155018511|NCT04681066|559494235|FG001|Overall Study|Death|1|||
155018512|NCT04681066|559494236|FG002|Overall Study|Death|0|||
155018513|NCT04681066|559494237|FG003|Overall Study|Death|0|||
155018514|NCT01205269|559494242|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155018515|NCT01205269|559494243|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155018516|NCT01205269|559494244|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155018517|NCT01205269|559494245|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
155018518|NCT01205269|559494246|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155018519|NCT01205269|559494247|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
155018520|NCT00987337|559494248|FG000|Overall Study|Adverse Event|10|||
155018521|NCT00987337|559494249|FG001|Overall Study|Adverse Event|9|||
155018522|NCT00987337|559494250|FG002|Overall Study|Adverse Event|8|||
155018523|NCT00987337|559494248|FG000|Overall Study|Insufficient Virologic Response|10|||
155018524|NCT00987337|559494249|FG001|Overall Study|Insufficient Virologic Response|7|||
155018525|NCT00987337|559494250|FG002|Overall Study|Insufficient Virologic Response|12|||
155018526|NCT00987337|559494248|FG000|Overall Study|Virologic Breakthrough|2|||
155018527|NCT00987337|559494249|FG001|Overall Study|Virologic Breakthrough|2|||
155018528|NCT00987337|559494250|FG002|Overall Study|Virologic Breakthrough|8|||
155018529|NCT00987337|559494248|FG000|Overall Study|Lost to Follow-up|10|||
155018530|NCT00987337|559494249|FG001|Overall Study|Lost to Follow-up|6|||
155018531|NCT00987337|559494250|FG002|Overall Study|Lost to Follow-up|2|||
155018532|NCT00987337|559494248|FG000|Overall Study|Withdrawal by Subject|6|||
155018533|NCT00987337|559494249|FG001|Overall Study|Withdrawal by Subject|9|||
155018534|NCT00987337|559494250|FG002|Overall Study|Withdrawal by Subject|9|||
155018535|NCT00987337|559494248|FG000|Overall Study|Other|0|||
155018536|NCT00987337|559494249|FG001|Overall Study|Other|2|||
155018537|NCT00987337|559494250|FG002|Overall Study|Other|5|||
155018538|NCT00987337|559494248|FG000|Overall Study|Protocol Violation|1|||
155018539|NCT00987337|559494249|FG001|Overall Study|Protocol Violation|0|||
155018540|NCT00987337|559494250|FG002|Overall Study|Protocol Violation|2|||
155018541|NCT00987337|559494248|FG000|Overall Study|Participant Relapsed|18|||
155018542|NCT00987337|559494249|FG001|Overall Study|Participant Relapsed|20|||
155018543|NCT00987337|559494250|FG002|Overall Study|Participant Relapsed|5|||
155018544|NCT00669669|559494252|FG000|Overall Study|To late to start treatment|1|||
155018545|NCT03103152|559494254|FG000|Overall Study|Physician Decision|5|||
155018546|NCT03103152|559494255|FG001|Overall Study|Physician Decision|2|||
155018547|NCT03103152|559494256|FG002|Overall Study|Physician Decision|6|||
155018548|NCT03103152|559494257|FG003|Overall Study|Physician Decision|3|||
155018549|NCT03103152|559494258|FG004|Overall Study|Physician Decision|3|||
155018550|NCT03103152|559494259|FG005|Overall Study|Physician Decision|1|||
155018551|NCT03103152|559494254|FG000|Overall Study|Protocol Violation|2|||
155018552|NCT03103152|559494255|FG001|Overall Study|Protocol Violation|2|||
155018553|NCT03103152|559494256|FG002|Overall Study|Protocol Violation|1|||
155018554|NCT03103152|559494257|FG003|Overall Study|Protocol Violation|2|||
155018555|NCT03103152|559494258|FG004|Overall Study|Protocol Violation|1|||
155018556|NCT03103152|559494259|FG005|Overall Study|Protocol Violation|1|||
155018557|NCT03103152|559494254|FG000|Overall Study|Inter-current illness|0|||
155018558|NCT03103152|559494255|FG001|Overall Study|Inter-current illness|0|||
155018559|NCT03103152|559494256|FG002|Overall Study|Inter-current illness|1|||
155018560|NCT03103152|559494257|FG003|Overall Study|Inter-current illness|0|||
155018561|NCT03103152|559494258|FG004|Overall Study|Inter-current illness|0|||
155018562|NCT03103152|559494259|FG005|Overall Study|Inter-current illness|0|||
155018563|NCT03103152|559494254|FG000|Overall Study|Death|0|||
155018564|NCT03103152|559494255|FG001|Overall Study|Death|1|||
155018565|NCT03103152|559494256|FG002|Overall Study|Death|0|||
155018566|NCT03103152|559494257|FG003|Overall Study|Death|0|||
155018567|NCT03103152|559494258|FG004|Overall Study|Death|0|||
155018568|NCT03103152|559494259|FG005|Overall Study|Death|0|||
155018569|NCT03103152|559494254|FG000|Overall Study|Adverse Event|0|||
155018570|NCT03103152|559494255|FG001|Overall Study|Adverse Event|0|||
155018571|NCT03103152|559494256|FG002|Overall Study|Adverse Event|1|||
155018572|NCT03103152|559494257|FG003|Overall Study|Adverse Event|0|||
155018573|NCT03103152|559494258|FG004|Overall Study|Adverse Event|0|||
155018574|NCT03103152|559494259|FG005|Overall Study|Adverse Event|1|||
155018575|NCT03103152|559494254|FG000|Overall Study|Withdrawal by Subject|1|||
155018576|NCT03103152|559494255|FG001|Overall Study|Withdrawal by Subject|0|||
155018577|NCT03103152|559494256|FG002|Overall Study|Withdrawal by Subject|1|||
155139091|NCT01510158|559942638|FG000|Overall Study|Protocol Violation|17|||
155139092|NCT01510158|559942639|FG001|Overall Study|Protocol Violation|16|||
155139093|NCT01510158|559942640|FG002|Overall Study|Protocol Violation|24|||
155139094|NCT01510158|559942638|FG000|Overall Study|Sponsor terminated study.|2|||
155018578|NCT03103152|559494257|FG003|Overall Study|Withdrawal by Subject|1|||
155018579|NCT03103152|559494258|FG004|Overall Study|Withdrawal by Subject|1|||
155018580|NCT03103152|559494259|FG005|Overall Study|Withdrawal by Subject|1|||
155018581|NCT03103152|559494254|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
155018582|NCT03103152|559494255|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
155139095|NCT01510158|559942639|FG001|Overall Study|Sponsor terminated study.|0|||
155018583|NCT03103152|559494256|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
155018584|NCT03103152|559494257|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
155018585|NCT03103152|559494258|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
155018586|NCT03103152|559494259|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
155018587|NCT03103152|559494254|FG000|Overall Study|Unacceptable side effects|0|||
155018588|NCT03103152|559494255|FG001|Overall Study|Unacceptable side effects|0|||
155018589|NCT03103152|559494256|FG002|Overall Study|Unacceptable side effects|0|||
155018590|NCT03103152|559494257|FG003|Overall Study|Unacceptable side effects|0|||
155018591|NCT03103152|559494258|FG004|Overall Study|Unacceptable side effects|0|||
155018592|NCT03103152|559494259|FG005|Overall Study|Unacceptable side effects|1|||
155018593|NCT03103152|559494254|FG000|Overall Study|Lost to Follow-up|0|||
155018594|NCT03103152|559494255|FG001|Overall Study|Lost to Follow-up|1|||
155018595|NCT03103152|559494256|FG002|Overall Study|Lost to Follow-up|0|||
155018596|NCT03103152|559494257|FG003|Overall Study|Lost to Follow-up|1|||
155018597|NCT03103152|559494258|FG004|Overall Study|Lost to Follow-up|0|||
155018598|NCT03103152|559494259|FG005|Overall Study|Lost to Follow-up|1|||
155018599|NCT03103152|559494254|FG000|Overall Study|Testicular pain|0|||
155018600|NCT03103152|559494255|FG001|Overall Study|Testicular pain|0|||
155018601|NCT03103152|559494256|FG002|Overall Study|Testicular pain|0|||
155018602|NCT03103152|559494257|FG003|Overall Study|Testicular pain|1|||
155018603|NCT03103152|559494258|FG004|Overall Study|Testicular pain|0|||
155018604|NCT03103152|559494259|FG005|Overall Study|Testicular pain|0|||
155018605|NCT03474965|559494260|FG000|Overall Study|Pregnancy|1|||
155018606|NCT03474965|559494261|FG001|Overall Study|Pregnancy|0|||
155018607|NCT03474965|559494262|FG002|Overall Study|Pregnancy|0|||
155018608|NCT03474965|559494263|FG003|Overall Study|Pregnancy|0|||
155018609|NCT03474965|559494260|FG000|Overall Study|Lost to Follow-up|0|||
155018610|NCT03474965|559494261|FG001|Overall Study|Lost to Follow-up|0|||
155018611|NCT03474965|559494262|FG002|Overall Study|Lost to Follow-up|1|||
155018612|NCT03474965|559494263|FG003|Overall Study|Lost to Follow-up|0|||
155018613|NCT03474965|559494260|FG000|Overall Study|Death|1|||
155018614|NCT03474965|559494261|FG001|Overall Study|Death|0|||
155018615|NCT03474965|559494262|FG002|Overall Study|Death|0|||
155018616|NCT03474965|559494263|FG003|Overall Study|Death|0|||
155018617|NCT03474965|559494260|FG000|Overall Study|Adverse Event|1|||
155018618|NCT03474965|559494261|FG001|Overall Study|Adverse Event|0|||
155018619|NCT03474965|559494262|FG002|Overall Study|Adverse Event|0|||
155018620|NCT03474965|559494263|FG003|Overall Study|Adverse Event|1|||
155018621|NCT03474965|559494260|FG000|Overall Study|Physician Decision|3|||
155018622|NCT03474965|559494261|FG001|Overall Study|Physician Decision|1|||
155018623|NCT03474965|559494262|FG002|Overall Study|Physician Decision|2|||
155018624|NCT03474965|559494263|FG003|Overall Study|Physician Decision|0|||
155018625|NCT03474965|559494260|FG000|Overall Study|Participant Decision|7|||
155018626|NCT03474965|559494261|FG001|Overall Study|Participant Decision|0|||
155018627|NCT03474965|559494262|FG002|Overall Study|Participant Decision|1|||
155018628|NCT03474965|559494263|FG003|Overall Study|Participant Decision|0|||
155018629|NCT03474965|559494260|FG000|Overall Study|Guardian Decision|4|||
155018630|NCT03474965|559494261|FG001|Overall Study|Guardian Decision|2|||
155018631|NCT03474965|559494262|FG002|Overall Study|Guardian Decision|7|||
155018632|NCT03474965|559494263|FG003|Overall Study|Guardian Decision|2|||
155018633|NCT03100903|559496072|FG000|Overall Study|Withdrawal by Subject|0|||
155018634|NCT03100903|559496073|FG001|Overall Study|Withdrawal by Subject|0|||
155018635|NCT03100903|559496074|FG002|Overall Study|Withdrawal by Subject|1|||
155139096|NCT01510158|559942640|FG002|Overall Study|Sponsor terminated study.|2|||
155139097|NCT01510158|559942638|FG000|Overall Study|Lost to Follow-up|13|||
155139098|NCT01510158|559942639|FG001|Overall Study|Lost to Follow-up|16|||
155139099|NCT01510158|559942640|FG002|Overall Study|Lost to Follow-up|9|||
155139100|NCT01510158|559942638|FG000|Overall Study|Withdrawal by Subject|10|||
155139101|NCT01510158|559942639|FG001|Overall Study|Withdrawal by Subject|13|||
155018636|NCT04659993|559496075|FG000|Overall Study|Withdrawal by Subject|2|||
155018637|NCT04659993|559496075|FG000|Overall Study|Lost to Follow-up|2|||
155018638|NCT00754234|559496078|FG000|Overall Study|Withdrawal by Subject|3|||
155018639|NCT03483961|559496079|FG000|Overall Study|Lost to Follow-up|7|||
155018640|NCT03483961|559496080|FG001|Overall Study|Lost to Follow-up|6|||
155018641|NCT03483961|559496081|FG002|Overall Study|Lost to Follow-up|6|||
155018642|NCT03483961|559496082|FG003|Overall Study|Lost to Follow-up|6|||
155139102|NCT01510158|559942640|FG002|Overall Study|Withdrawal by Subject|10|||
155139103|NCT01510158|559942638|FG000|Overall Study|Death|1|||
155018643|NCT03483961|559496083|FG004|Overall Study|Lost to Follow-up|6|||
155018644|NCT03483961|559496084|FG005|Overall Study|Lost to Follow-up|4|||
155018645|NCT03483961|559496085|FG006|Overall Study|Lost to Follow-up|4|||
155018646|NCT03483961|559496086|FG007|Overall Study|Lost to Follow-up|11|||
155018647|NCT03483961|559496087|FG008|Overall Study|Lost to Follow-up|1|||
155018648|NCT03483961|559496088|FG009|Overall Study|Lost to Follow-up|0|||
155018649|NCT03483961|559496079|FG000|Overall Study|Withdrawal by Subject|3|||
155018650|NCT03483961|559496080|FG001|Overall Study|Withdrawal by Subject|4|||
155018651|NCT03483961|559496081|FG002|Overall Study|Withdrawal by Subject|5|||
155018652|NCT03483961|559496082|FG003|Overall Study|Withdrawal by Subject|3|||
155139104|NCT01510158|559942639|FG001|Overall Study|Death|0|||
155018653|NCT03483961|559496083|FG004|Overall Study|Withdrawal by Subject|4|||
155018654|NCT03483961|559496084|FG005|Overall Study|Withdrawal by Subject|2|||
155018655|NCT03483961|559496085|FG006|Overall Study|Withdrawal by Subject|1|||
155018656|NCT03483961|559496086|FG007|Overall Study|Withdrawal by Subject|2|||
155018657|NCT03483961|559496087|FG008|Overall Study|Withdrawal by Subject|1|||
155018658|NCT03483961|559496088|FG009|Overall Study|Withdrawal by Subject|0|||
155018659|NCT03483961|559496079|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
155018660|NCT03483961|559496080|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018661|NCT03483961|559496081|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018662|NCT03483961|559496082|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018663|NCT03483961|559496083|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018664|NCT03483961|559496084|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018665|NCT03483961|559496085|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018666|NCT03483961|559496086|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018667|NCT03483961|559496087|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018668|NCT03483961|559496088|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
155018669|NCT03483961|559496079|FG000|Overall Study|Adverse Event|0|||
155018670|NCT03483961|559496080|FG001|Overall Study|Adverse Event|0|||
155018671|NCT03483961|559496081|FG002|Overall Study|Adverse Event|1|||
155018672|NCT03483961|559496082|FG003|Overall Study|Adverse Event|0|||
155018673|NCT03483961|559496083|FG004|Overall Study|Adverse Event|0|||
155018674|NCT03483961|559496084|FG005|Overall Study|Adverse Event|0|||
155018675|NCT03483961|559496085|FG006|Overall Study|Adverse Event|0|||
155018676|NCT03483961|559496086|FG007|Overall Study|Adverse Event|0|||
155018677|NCT03483961|559496087|FG008|Overall Study|Adverse Event|0|||
155018678|NCT03483961|559496088|FG009|Overall Study|Adverse Event|0|||
155018679|NCT04003636|559496089|FG000|Overall Study|Death|409|||
155018680|NCT04003636|559496090|FG001|Overall Study|Death|443|||
155018681|NCT04003636|559496089|FG000|Overall Study|Lost to Follow-up|0|||
155018682|NCT04003636|559496090|FG001|Overall Study|Lost to Follow-up|1|||
155018683|NCT04003636|559496089|FG000|Overall Study|Withdrawal by Subject|5|||
155018684|NCT04003636|559496090|FG001|Overall Study|Withdrawal by Subject|2|||
155018685|NCT04003636|559496089|FG000|Overall Study|Participant On-going|119|||
155018686|NCT04003636|559496090|FG001|Overall Study|Participant On-going|90|||
155018687|NCT03048747|559496091|FG000|Overall Study|Adverse Event|2|||
155018688|NCT03048747|559496091|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
155018689|NCT03048747|559496091|FG000|Overall Study|Physician Decision|1|||
155018690|NCT00298272|559496092|FG000|Double-blind Phase|Adverse Event|2|||
155018691|NCT00298272|559496093|FG001|Double-blind Phase|Adverse Event|0|||
155018692|NCT00298272|559496092|FG000|Double-blind Phase|Failure to Return|2|||
155018693|NCT00298272|559496093|FG001|Double-blind Phase|Failure to Return|0|||
155018694|NCT00298272|559496092|FG000|Double-blind Phase|Protocol Violation|2|||
155018695|NCT00298272|559496093|FG001|Double-blind Phase|Protocol Violation|0|||
155018696|NCT00298272|559496092|FG000|Double-blind Phase|Withdrawal by Subject|2|||
155018697|NCT00298272|559496093|FG001|Double-blind Phase|Withdrawal by Subject|0|||
155018698|NCT00298272|559496092|FG000|Open Label Retreatment Phase|Adverse Event|1|||
155018699|NCT00298272|559496093|FG001|Open Label Retreatment Phase|Adverse Event|2|||
155018700|NCT00298272|559496092|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
155018701|NCT00298272|559496093|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
155018702|NCT00298272|559496092|FG000|Open Label Retreatment Phase|Failure to Return|1|||
155018703|NCT00298272|559496093|FG001|Open Label Retreatment Phase|Failure to Return|0|||
155018704|NCT00298272|559496092|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
155018705|NCT00298272|559496093|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
155018706|NCT00298272|559496092|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
155018707|NCT00298272|559496093|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
155018708|NCT00298272|559496092|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
155018709|NCT00298272|559496093|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
155018710|NCT00298272|559496092|FG000|Safety Follow-up Phase|Failure to Return|1|||
155018711|NCT00298272|559496093|FG001|Safety Follow-up Phase|Failure to Return|1|||
155018712|NCT00298272|559496092|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
155179358|NCT02660138|560095071|FG000|Overall Study|Withdrawal by Subject|7|||
155179359|NCT02660138|560095072|FG001|Overall Study|Withdrawal by Subject|6|||
155018713|NCT00298272|559496093|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
155018714|NCT00298272|559496092|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
155018715|NCT00298272|559496093|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
155018716|NCT00915018|559496094|FG000|Overall Study|Death|75|||
155018717|NCT00915018|559496095|FG001|Overall Study|Death|70|||
155018718|NCT00915018|559496094|FG000|Overall Study|Lost to Follow-up|10|||
155018719|NCT00915018|559496095|FG001|Overall Study|Lost to Follow-up|5|||
155018720|NCT00915018|559496094|FG000|Overall Study|Withdrawal by Subject|38|||
155018721|NCT00915018|559496095|FG001|Overall Study|Withdrawal by Subject|27|||
155018722|NCT00915018|559496094|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
155018723|NCT00915018|559496095|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
155018724|NCT05326529|559496096|FG000|Overall Study|Lack of Efficacy|0|||
155018725|NCT05326529|559496097|FG001|Overall Study|Lack of Efficacy|1|||
155018726|NCT05326529|559496098|FG002|Overall Study|Lack of Efficacy|0|||
155018727|NCT05326529|559496096|FG000|Overall Study|Physician Decision|0|||
155018728|NCT05326529|559496097|FG001|Overall Study|Physician Decision|0|||
155018729|NCT05326529|559496098|FG002|Overall Study|Physician Decision|2|||
155018730|NCT00734162|559496099|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
155018731|NCT00734162|559496100|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
155018732|NCT00734162|559496101|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
155018733|NCT00734162|559496102|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
155018734|NCT00734162|559496099|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
155018735|NCT00734162|559496100|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
155018736|NCT00734162|559496101|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
155018737|NCT00734162|559496102|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
155018738|NCT00734162|559496099|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
155018739|NCT00734162|559496100|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
155018740|NCT00734162|559496101|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
155018741|NCT00734162|559496102|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
155018742|NCT00734162|559496099|FG000|Open-Label Phase|Withdrew Consent|1|||
155018743|NCT00734162|559496100|FG001|Open-Label Phase|Withdrew Consent|0|||
155018744|NCT00734162|559496101|FG002|Open-Label Phase|Withdrew Consent|1|||
155018745|NCT00734162|559496102|FG003|Open-Label Phase|Withdrew Consent|1|||
155018746|NCT00734162|559496099|FG000|Open-Label Phase|Lost to Follow-up|1|||
155018747|NCT00734162|559496100|FG001|Open-Label Phase|Lost to Follow-up|2|||
155018748|NCT00734162|559496101|FG002|Open-Label Phase|Lost to Follow-up|0|||
155018749|NCT00734162|559496102|FG003|Open-Label Phase|Lost to Follow-up|1|||
155018750|NCT00734162|559496099|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155018751|NCT00734162|559496100|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155018752|NCT00734162|559496101|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
155018753|NCT00734162|559496102|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
155018754|NCT00566020|559496103|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
155018755|NCT00566020|559496104|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
155018756|NCT00566020|559496103|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
155018757|NCT00566020|559496104|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
155018758|NCT00566020|559496103|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
155018759|NCT00566020|559496104|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
155018760|NCT00566020|559496103|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
155018761|NCT00566020|559496104|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
155018762|NCT00566020|559496103|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
155018763|NCT00566020|559496104|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
155018764|NCT00566020|559496103|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
155018765|NCT00566020|559496104|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
155018766|NCT02609607|559496105|FG000|Overall Study|Lost to Follow-up|0|||
155018767|NCT02609607|559496106|FG001|Overall Study|Lost to Follow-up|1|||
155018768|NCT00687271|559496107|FG000|Overall Study|Adverse Event|1|||
155018769|NCT00687271|559496108|FG001|Overall Study|Adverse Event|3|||
155018770|NCT00687271|559496109|FG002|Overall Study|Adverse Event|1|||
155018771|NCT00687271|559496110|FG003|Overall Study|Adverse Event|0|||
155018772|NCT00687271|559496107|FG000|Overall Study|Lost to Follow-up|0|||
155018773|NCT00687271|559496108|FG001|Overall Study|Lost to Follow-up|1|||
155179360|NCT02660138|560095073|FG002|Overall Study|Withdrawal by Subject|6|||
155179361|NCT02660138|560095071|FG000|Overall Study|Lost to Follow-up|4|||
155179362|NCT02660138|560095072|FG001|Overall Study|Lost to Follow-up|4|||
155179363|NCT02660138|560095073|FG002|Overall Study|Lost to Follow-up|1|||
155179364|NCT02660138|560095071|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
155018774|NCT00687271|559496109|FG002|Overall Study|Lost to Follow-up|0|||
155018775|NCT00687271|559496110|FG003|Overall Study|Lost to Follow-up|0|||
155018776|NCT00687271|559496107|FG000|Overall Study|Protocol Violation|2|||
155018777|NCT00687271|559496108|FG001|Overall Study|Protocol Violation|1|||
155018778|NCT00687271|559496109|FG002|Overall Study|Protocol Violation|1|||
155018779|NCT00687271|559496110|FG003|Overall Study|Protocol Violation|0|||
155018780|NCT00687271|559496107|FG000|Overall Study|Withdrawal by Subject|0|||
155018781|NCT00687271|559496108|FG001|Overall Study|Withdrawal by Subject|1|||
155018782|NCT00687271|559496109|FG002|Overall Study|Withdrawal by Subject|3|||
155018783|NCT00687271|559496110|FG003|Overall Study|Withdrawal by Subject|0|||
155018784|NCT00778817|559496117|FG000|Overall Study|Adverse Event|2|||
155018785|NCT00778817|559496117|FG000|Overall Study|Withdrawal by Subject|2|||
155018786|NCT03150719|559496118|FG000|Overall Study|Adverse Event|0|||
155018787|NCT03150719|559496119|FG001|Overall Study|Adverse Event|1|||
155018788|NCT03150719|559496118|FG000|Overall Study|Death|0|||
155018789|NCT03150719|559496119|FG001|Overall Study|Death|1|||
155018790|NCT03150719|559496118|FG000|Overall Study|Other|1|||
155018791|NCT03150719|559496119|FG001|Overall Study|Other|0|||
155018792|NCT01372995|559496124|FG000|Overall Study|Spouse withdrew participant from study|0|||
155018793|NCT01372995|559496125|FG001|Overall Study|Spouse withdrew participant from study|1|||
155018794|NCT01372995|559496126|FG002|Overall Study|Spouse withdrew participant from study|0|||
155018795|NCT01372995|559496124|FG000|Overall Study|Physician Decision|0|||
155018796|NCT01372995|559496125|FG001|Overall Study|Physician Decision|0|||
155018797|NCT01372995|559496126|FG002|Overall Study|Physician Decision|1|||
155018798|NCT01609296|559496127|FG000|Overall Study|Death|253|||
155018799|NCT01609296|559496127|FG000|Overall Study|Withdrawal by Subject|151|||
155018800|NCT01609296|559496127|FG000|Overall Study|Lost to Follow-up|21|||
155018801|NCT01609296|559496127|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
155018802|NCT01609296|559496127|FG000|Overall Study|missed visit but known to be alive|28|||
155018803|NCT02914613|559496128|FG000|Overall Study|Withdrawal by Subject|1|||
155018804|NCT02914613|559496129|FG001|Overall Study|Withdrawal by Subject|2|||
155018805|NCT02914613|559496128|FG000|Overall Study|Adverse Event|1|||
155018806|NCT02914613|559496129|FG001|Overall Study|Adverse Event|0|||
155018807|NCT01964222|559496134|FG000|Overall Study|Lost to Follow-up|7|||
155018808|NCT01964222|559496135|FG001|Overall Study|Lost to Follow-up|5|||
155018809|NCT01964222|559496134|FG000|Overall Study|Withdrawal by Subject|6|||
155018810|NCT01964222|559496135|FG001|Overall Study|Withdrawal by Subject|6|||
155018811|NCT01964222|559496134|FG000|Overall Study|Screening Failure|2|||
155018812|NCT01964222|559496135|FG001|Overall Study|Screening Failure|0|||
155018813|NCT03850496|559496142|FG000|Overall Study|Withdrawal by Subject|1|||
155018814|NCT03850496|559496143|FG001|Overall Study|Withdrawal by Subject|0|||
155018815|NCT03850496|559496144|FG002|Overall Study|Withdrawal by Subject|0|||
155018816|NCT03850496|559496142|FG000|Overall Study|Lost to Follow-up|0|||
155018817|NCT03850496|559496143|FG001|Overall Study|Lost to Follow-up|1|||
155018818|NCT03850496|559496144|FG002|Overall Study|Lost to Follow-up|4|||
155018819|NCT00869999|559496151|FG000|Overall Study|Withdrawal by Subject|1|||
155018820|NCT00869999|559496151|FG000|Overall Study|removed prior to starting therapy|1|||
155018821|NCT03674112|559496154|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
155018822|NCT03674112|559496155|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
155018823|NCT03674112|559496154|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
155018824|NCT03674112|559496155|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
155018825|NCT03674112|559496154|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
155018826|NCT03674112|559496155|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
155018827|NCT03674112|559496154|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
155018828|NCT03674112|559496155|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
155018829|NCT03674112|559496154|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
155018830|NCT03674112|559496155|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
155018831|NCT03674112|559496154|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
155018832|NCT03674112|559496155|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
155018833|NCT03674112|559496154|FG000|Follow-Up Period (≥3 Years)|Death|2|||
155018834|NCT03674112|559496155|FG001|Follow-Up Period (≥3 Years)|Death|0|||
155018835|NCT03674112|559496154|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
155018836|NCT03674112|559496155|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
155018837|NCT03363776|559496156|FG000|Overall Study|Progressive disease|2|||
155018838|NCT03363776|559496157|FG001|Overall Study|Progressive disease|3|||
155018839|NCT03363776|559496158|FG002|Overall Study|Progressive disease|1|||
155018840|NCT03363776|559496156|FG000|Overall Study|Study drug toxicity|0|||
155018841|NCT03363776|559496157|FG001|Overall Study|Study drug toxicity|0|||
155018842|NCT03363776|559496158|FG002|Overall Study|Study drug toxicity|1|||
155018843|NCT03363776|559496156|FG000|Overall Study|Death|1|||
155018844|NCT03363776|559496157|FG001|Overall Study|Death|0|||
155018845|NCT03363776|559496158|FG002|Overall Study|Death|0|||
155018846|NCT02861807|559496159|FG000|Overall Study|Lost to Follow-up|7|||
155018847|NCT02861807|559496160|FG001|Overall Study|Lost to Follow-up|6|||
155018848|NCT02861807|559496159|FG000|Overall Study|Withdrawal by Subject|5|||
155018849|NCT02861807|559496160|FG001|Overall Study|Withdrawal by Subject|8|||
155018850|NCT02268916|559496169|FG000|Overall Study|Lost to Follow-up|1|||
155018851|NCT02268916|559496170|FG001|Overall Study|Lost to Follow-up|1|||
155139105|NCT01510158|559942640|FG002|Overall Study|Death|0|||
155139106|NCT03078556|559942641|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
155139107|NCT03078556|559942642|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
155139108|NCT03078556|559942643|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
155018852|NCT02268916|559496169|FG000|Overall Study|Withdrawal by Subject|6|||
155018853|NCT02268916|559496170|FG001|Overall Study|Withdrawal by Subject|5|||
155018854|NCT02268916|559496169|FG000|Overall Study|Participant did not have diabetes|1|||
155018855|NCT02268916|559496170|FG001|Overall Study|Participant did not have diabetes|0|||
155018856|NCT02268916|559496169|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
155018857|NCT02268916|559496170|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
155018858|NCT04526288|559496174|FG000|Overall Study|Disease Progression|1|||
155018859|NCT04526288|559496175|FG001|Overall Study|Disease Progression|0|||
155018860|NCT00594165|559496178|FG000|Overall Study|Major protocol violation|1|||
155018861|NCT00594165|559496178|FG000|Overall Study|Lack of Efficacy|12|||
155018862|NCT00594165|559496178|FG000|Overall Study|Adverse Event|52|||
155018863|NCT00594165|559496178|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
155018864|NCT00594165|559496178|FG000|Overall Study|Subject withdrew consent|27|||
155018865|NCT00594165|559496178|FG000|Overall Study|Study ended per sponsor|102|||
155018866|NCT00594165|559496178|FG000|Overall Study|Lost to Follow-up|4|||
155018867|NCT00594165|559496178|FG000|Overall Study|Other: PI discretion|5|||
155018868|NCT00594165|559496178|FG000|Overall Study|Other: Subject moving|3|||
155018869|NCT00594165|559496178|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
155018870|NCT00594165|559496178|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
155018871|NCT00594165|559496178|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
155018872|NCT00594165|559496178|FG000|Overall Study|Other: Site terminated participation|2|||
155018873|NCT01422889|559496179|FG000|Overall Study|No Data Entered for Study Stent|9|||
155018874|NCT02748356|559496184|FG000|Overall Study|Withdrawal by Subject|1|||
155018875|NCT01732458|559496185|FG000|Overall Study|Lost to Follow-up|0|||
155018876|NCT01732458|559496186|FG001|Overall Study|Lost to Follow-up|2|||
155018877|NCT01732458|559496187|FG002|Overall Study|Lost to Follow-up|0|||
155018878|NCT01732458|559496188|FG003|Overall Study|Lost to Follow-up|0|||
155018879|NCT01732458|559496185|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155018880|NCT01732458|559496186|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155018881|NCT01732458|559496187|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155018882|NCT01732458|559496188|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155018883|NCT01732458|559496185|FG000|Overall Study|Physician Decision|1|||
155018884|NCT01732458|559496186|FG001|Overall Study|Physician Decision|2|||
155018885|NCT01732458|559496187|FG002|Overall Study|Physician Decision|2|||
155018886|NCT01732458|559496188|FG003|Overall Study|Physician Decision|0|||
155018887|NCT01732458|559496185|FG000|Overall Study|Protocol Violation|2|||
155018888|NCT01732458|559496186|FG001|Overall Study|Protocol Violation|0|||
155018889|NCT01732458|559496187|FG002|Overall Study|Protocol Violation|0|||
155018890|NCT01732458|559496188|FG003|Overall Study|Protocol Violation|2|||
155018891|NCT01732458|559496185|FG000|Overall Study|Screen Failure|0|||
155018892|NCT01732458|559496186|FG001|Overall Study|Screen Failure|1|||
155018893|NCT01732458|559496187|FG002|Overall Study|Screen Failure|0|||
155018894|NCT01732458|559496188|FG003|Overall Study|Screen Failure|0|||
155018895|NCT05107492|559496190|FG000|Overall Study|Lost to Follow-up|1|||
155018896|NCT05107492|559496191|FG001|Overall Study|Lost to Follow-up|0|||
155018897|NCT04331067|559496192|FG000|Overall Study|Adverse Event|1|||
155018898|NCT04331067|559496193|FG001|Overall Study|Adverse Event|3|||
155018899|NCT04331067|559496194|FG002|Overall Study|Adverse Event|1|||
155018900|NCT04331067|559496192|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
155179365|NCT02660138|560095072|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
155179366|NCT02660138|560095073|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
155179367|NCT02660138|560095071|FG000|Overall Study|Other|1|||
155179368|NCT02660138|560095072|FG001|Overall Study|Other|1|||
155179369|NCT02660138|560095073|FG002|Overall Study|Other|0|||
155179370|NCT02660138|560095071|FG000|Overall Study|Not treated|0|||
155179371|NCT02660138|560095072|FG001|Overall Study|Not treated|1|||
155179372|NCT02660138|560095073|FG002|Overall Study|Not treated|0|||
155179373|NCT01642732|560095074|FG000|Overall Study|Withdrawal by Subject|1|||
155179374|NCT04604132|560095077|FG000|Overall Study|Adverse Event|2|||
155179375|NCT04604132|560095078|FG001|Overall Study|Adverse Event|0|||
155179376|NCT04604132|560095079|FG002|Overall Study|Adverse Event|0|||
155179377|NCT04604132|560095080|FG003|Overall Study|Adverse Event|1|||
155179378|NCT04604132|560095081|FG004|Overall Study|Adverse Event|2|||
155179379|NCT04604132|560095077|FG000|Overall Study|Study terminated by sponsor|0|||
155179380|NCT04604132|560095078|FG001|Overall Study|Study terminated by sponsor|0|||
155179381|NCT04604132|560095079|FG002|Overall Study|Study terminated by sponsor|0|||
155179382|NCT04604132|560095080|FG003|Overall Study|Study terminated by sponsor|0|||
155018901|NCT04331067|559496193|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
155018902|NCT04331067|559496194|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
155018903|NCT05236764|559496195|FG000|Overall Study|In follow up (ongoing)|1|||
155018904|NCT05236764|559496195|FG000|Overall Study|Taken off study - secondary graft failure|1|||
155018905|NCT05236764|559496195|FG000|Overall Study|Death|1|||
155018906|NCT00703157|559496197|FG000|Overall Study|Lost to Follow-up|0|||
155018907|NCT00703157|559496198|FG001|Overall Study|Lost to Follow-up|1|||
155018908|NCT00703157|559496197|FG000|Overall Study|source data permanently lost/ other|4|||
155018909|NCT00703157|559496198|FG001|Overall Study|source data permanently lost/ other|1|||
155179383|NCT04604132|560095081|FG004|Overall Study|Study terminated by sponsor|1|||
155018910|NCT00347009|559496199|FG000|Overall Study|Death|1|||
155179384|NCT04604132|560095077|FG000|Overall Study|Progressive disease: Clinical progression|0|||
155018911|NCT00347009|559496199|FG000|Overall Study|Adverse Event|6|||
155179385|NCT04604132|560095078|FG001|Overall Study|Progressive disease: Clinical progression|0|||
155018912|NCT00347009|559496199|FG000|Overall Study|Withdrawal by Subject|3|||
155018913|NCT00347009|559496199|FG000|Overall Study|Physician Decision|5|||
155018914|NCT00347009|559496199|FG000|Overall Study|Lost to Follow-up|4|||
155018915|NCT00347009|559496199|FG000|Overall Study|Protocol Violation|2|||
155018916|NCT00347009|559496199|FG000|Overall Study|Adverse Laboratory Experience|1|||
155018917|NCT00347009|559496199|FG000|Overall Study|Insufficient Viral Suppression|3|||
155018918|NCT00347009|559496199|FG000|Overall Study|Increased ALT/HBV DNA|1|||
155018919|NCT00347009|559496199|FG000|Overall Study|Serious Adverse Event|1|||
155018920|NCT02522884|559496202|FG000|Overall Study|Withdrawal by Subject|6|||
155018921|NCT02522884|559496202|FG000|Overall Study|Death|3|||
155018922|NCT02522884|559496202|FG000|Overall Study|Missed 12-month Follow-up|9|||
155018923|NCT04495751|559496203|FG000|Overall Study|Withdrawal by Subject|1|||
155018924|NCT04495751|559496204|FG001|Overall Study|Withdrawal by Subject|0|||
155018925|NCT04495751|559496203|FG000|Overall Study|Lost to Follow-up|1|||
155018926|NCT04495751|559496204|FG001|Overall Study|Lost to Follow-up|0|||
155018927|NCT03289754|559496205|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
155018928|NCT04873934|559496206|FG000|Overall Study|Adverse Event|0|||
155018929|NCT04873934|559496207|FG001|Overall Study|Adverse Event|1|||
155018930|NCT04873934|559496206|FG000|Overall Study|Death|0|||
155018931|NCT04873934|559496207|FG001|Overall Study|Death|2|||
155018932|NCT04873934|559496206|FG000|Overall Study|Lost to Follow-up|13|||
155018933|NCT04873934|559496207|FG001|Overall Study|Lost to Follow-up|9|||
155018934|NCT04873934|559496206|FG000|Overall Study|Physician Decision|1|||
155018935|NCT04873934|559496207|FG001|Overall Study|Physician Decision|1|||
155018936|NCT04873934|559496206|FG000|Overall Study|Protocol deviation|2|||
155018937|NCT04873934|559496207|FG001|Overall Study|Protocol deviation|1|||
155018938|NCT04873934|559496206|FG000|Overall Study|Subject decision|1|||
155018939|NCT04873934|559496207|FG001|Overall Study|Subject decision|8|||
155018940|NCT04873934|559496206|FG000|Overall Study|Withdrew consent|0|||
155018941|NCT04873934|559496207|FG001|Overall Study|Withdrew consent|4|||
155018942|NCT04873934|559496206|FG000|Overall Study|Missing|1|||
155018943|NCT04873934|559496207|FG001|Overall Study|Missing|0|||
155018944|NCT02907177|559496209|FG000|Overall Study|Death|0|||
155018945|NCT02907177|559496210|FG001|Overall Study|Death|1|||
155018946|NCT02907177|559496209|FG000|Overall Study|Physician Decision|3|||
155018947|NCT02907177|559496210|FG001|Overall Study|Physician Decision|3|||
155018948|NCT02907177|559496209|FG000|Overall Study|Withdrawal by Subject|15|||
155018949|NCT02907177|559496210|FG001|Overall Study|Withdrawal by Subject|7|||
155018950|NCT02907177|559496209|FG000|Overall Study|Sponsor's Decision|50|||
155018951|NCT02907177|559496210|FG001|Overall Study|Sponsor's Decision|57|||
155018952|NCT03482635|559496211|FG000|Overall Study|Lack of Efficacy|0|||
155018953|NCT03482635|559496212|FG001|Overall Study|Lack of Efficacy|0|||
155018954|NCT03482635|559496213|FG002|Overall Study|Lack of Efficacy|1|||
155018955|NCT03482635|559496214|FG003|Overall Study|Lack of Efficacy|3|||
155018956|NCT03482635|559496211|FG000|Overall Study|Adverse Event|2|||
155018957|NCT03482635|559496212|FG001|Overall Study|Adverse Event|2|||
155018958|NCT03482635|559496213|FG002|Overall Study|Adverse Event|0|||
155018959|NCT03482635|559496214|FG003|Overall Study|Adverse Event|3|||
155018960|NCT03482635|559496211|FG000|Overall Study|Withdrawal by Subject|2|||
155018961|NCT03482635|559496212|FG001|Overall Study|Withdrawal by Subject|1|||
155018962|NCT03482635|559496213|FG002|Overall Study|Withdrawal by Subject|0|||
155018963|NCT03482635|559496214|FG003|Overall Study|Withdrawal by Subject|1|||
155018964|NCT03482635|559496211|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
155018965|NCT03482635|559496212|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
155018966|NCT03482635|559496213|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
155018967|NCT03482635|559496214|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
155018968|NCT03482635|559496211|FG000|Overall Study|Not treated|0|||
155018969|NCT03482635|559496212|FG001|Overall Study|Not treated|0|||
155018970|NCT03482635|559496213|FG002|Overall Study|Not treated|0|||
155018971|NCT03482635|559496214|FG003|Overall Study|Not treated|1|||
155018972|NCT02640950|559497581|FG000|Overall Study|Adverse Event|1|||
155139109|NCT03078556|559942644|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
155018973|NCT02640950|559497581|FG000|Overall Study|Withdrawal by Subject|1|||
155018974|NCT00652626|559497582|FG000|Initial Treatment Phase|Adverse Event|0|||
155018975|NCT00652626|559497583|FG001|Initial Treatment Phase|Adverse Event|0|||
155018976|NCT00652626|559497584|FG002|Initial Treatment Phase|Adverse Event|0|||
155018977|NCT00652626|559497585|FG003|Initial Treatment Phase|Adverse Event|0|||
155139110|NCT03078556|559942641|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
155139111|NCT03078556|559942642|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
155018978|NCT00652626|559497586|FG004|Initial Treatment Phase|Adverse Event|1|||
155018979|NCT00652626|559497587|FG005|Initial Treatment Phase|Adverse Event|0|||
155018980|NCT00652626|559497588|FG006|Initial Treatment Phase|Adverse Event|0|||
155018981|NCT00652626|559497582|FG000|Initial Treatment Phase|Protocol Violation|0|||
155018982|NCT00652626|559497583|FG001|Initial Treatment Phase|Protocol Violation|0|||
155018983|NCT00652626|559497584|FG002|Initial Treatment Phase|Protocol Violation|0|||
155018984|NCT00652626|559497585|FG003|Initial Treatment Phase|Protocol Violation|1|||
155018985|NCT00652626|559497586|FG004|Initial Treatment Phase|Protocol Violation|0|||
155018986|NCT00652626|559497587|FG005|Initial Treatment Phase|Protocol Violation|0|||
155018987|NCT00652626|559497588|FG006|Initial Treatment Phase|Protocol Violation|0|||
155018988|NCT00652626|559497582|FG000|Initial Treatment Phase|Physician Decision|0|||
155018989|NCT00652626|559497583|FG001|Initial Treatment Phase|Physician Decision|0|||
155018990|NCT00652626|559497584|FG002|Initial Treatment Phase|Physician Decision|0|||
155018991|NCT00652626|559497585|FG003|Initial Treatment Phase|Physician Decision|0|||
155018992|NCT00652626|559497586|FG004|Initial Treatment Phase|Physician Decision|1|||
155018993|NCT00652626|559497587|FG005|Initial Treatment Phase|Physician Decision|0|||
155018994|NCT00652626|559497588|FG006|Initial Treatment Phase|Physician Decision|0|||
155018995|NCT00652626|559497582|FG000|Initial Treatment Phase|Sponsor Request|0|||
155018996|NCT00652626|559497583|FG001|Initial Treatment Phase|Sponsor Request|0|||
155018997|NCT00652626|559497584|FG002|Initial Treatment Phase|Sponsor Request|1|||
155018998|NCT00652626|559497585|FG003|Initial Treatment Phase|Sponsor Request|0|||
155018999|NCT00652626|559497586|FG004|Initial Treatment Phase|Sponsor Request|0|||
155019000|NCT00652626|559497587|FG005|Initial Treatment Phase|Sponsor Request|0|||
155019001|NCT00652626|559497588|FG006|Initial Treatment Phase|Sponsor Request|0|||
155019002|NCT00652626|559497582|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
155019003|NCT00652626|559497583|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
155019004|NCT00652626|559497584|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
155019005|NCT00652626|559497585|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
155019006|NCT00652626|559497586|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
155019007|NCT00652626|559497587|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
155019008|NCT00652626|559497588|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
155019009|NCT00652626|559497582|FG000|Extension Phase|Withdrawal by Subject|0|||
155019010|NCT00652626|559497583|FG001|Extension Phase|Withdrawal by Subject|0|||
155019011|NCT00652626|559497584|FG002|Extension Phase|Withdrawal by Subject|0|||
155019012|NCT00652626|559497585|FG003|Extension Phase|Withdrawal by Subject|0|||
155019013|NCT00652626|559497586|FG004|Extension Phase|Withdrawal by Subject|0|||
155019014|NCT00652626|559497587|FG005|Extension Phase|Withdrawal by Subject|2|||
155019015|NCT00652626|559497588|FG006|Extension Phase|Withdrawal by Subject|0|||
155019016|NCT00652626|559497582|FG000|Extension Phase|Adverse Event|0|||
155019017|NCT00652626|559497583|FG001|Extension Phase|Adverse Event|0|||
155019018|NCT00652626|559497584|FG002|Extension Phase|Adverse Event|0|||
155019019|NCT00652626|559497585|FG003|Extension Phase|Adverse Event|0|||
155019020|NCT00652626|559497586|FG004|Extension Phase|Adverse Event|0|||
155019021|NCT00652626|559497587|FG005|Extension Phase|Adverse Event|2|||
155019022|NCT00652626|559497588|FG006|Extension Phase|Adverse Event|1|||
155019023|NCT00652626|559497582|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155019024|NCT00652626|559497583|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155019025|NCT00652626|559497584|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155019026|NCT00652626|559497585|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155019027|NCT00652626|559497586|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155019028|NCT00652626|559497587|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
155019029|NCT00652626|559497588|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
155019030|NCT00652626|559497582|FG000|Extension Phase|Physician Decision|0|||
155019031|NCT00652626|559497583|FG001|Extension Phase|Physician Decision|0|||
155019032|NCT00652626|559497584|FG002|Extension Phase|Physician Decision|0|||
155019033|NCT00652626|559497585|FG003|Extension Phase|Physician Decision|0|||
155019034|NCT00652626|559497586|FG004|Extension Phase|Physician Decision|0|||
155019035|NCT00652626|559497587|FG005|Extension Phase|Physician Decision|1|||
155019036|NCT00652626|559497588|FG006|Extension Phase|Physician Decision|1|||
155019037|NCT00652626|559497582|FG000|Extension Phase|Death|0|||
155019038|NCT00652626|559497583|FG001|Extension Phase|Death|0|||
155019039|NCT00652626|559497584|FG002|Extension Phase|Death|0|||
155019040|NCT00652626|559497585|FG003|Extension Phase|Death|0|||
155019041|NCT00652626|559497586|FG004|Extension Phase|Death|0|||
155019042|NCT00652626|559497587|FG005|Extension Phase|Death|1|||
155019043|NCT00652626|559497588|FG006|Extension Phase|Death|1|||
155019044|NCT00356603|559497591|FG000|Overall Study|Other|6|||
155019045|NCT00356603|559497592|FG001|Overall Study|Other|3|||
155019046|NCT02582242|559497593|FG000|Overall Study|Adverse Event|4|||
155019047|NCT02582242|559497594|FG001|Overall Study|Adverse Event|3|||
155019048|NCT02582242|559497593|FG000|Overall Study|Protocol Violation|3|||
155139112|NCT03078556|559942643|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
155139113|NCT03078556|559942644|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
155019049|NCT02582242|559497594|FG001|Overall Study|Protocol Violation|1|||
155019050|NCT02582242|559497593|FG000|Overall Study|Lost to Follow-up|0|||
155019051|NCT02582242|559497594|FG001|Overall Study|Lost to Follow-up|1|||
155019052|NCT02582242|559497593|FG000|Overall Study|Withdrawal by Subject|11|||
155019053|NCT02582242|559497594|FG001|Overall Study|Withdrawal by Subject|11|||
155019054|NCT02582242|559497593|FG000|Overall Study|Unclassified|2|||
155019055|NCT02582242|559497594|FG001|Overall Study|Unclassified|1|||
155019056|NCT00638404|559497595|FG000|Overall Study|Physician Decision|8|||
155019057|NCT00638404|559497596|FG001|Overall Study|Physician Decision|0|||
155019058|NCT02101736|559497600|FG000|Overall Study|Protocol Violation|3|||
155019059|NCT02101736|559497601|FG001|Overall Study|Protocol Violation|0|||
155139114|NCT03078556|559942641|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
155019060|NCT02101736|559497600|FG000|Overall Study|Withdrawal by Subject|1|||
155019061|NCT02101736|559497601|FG001|Overall Study|Withdrawal by Subject|1|||
155019062|NCT02282631|559497602|FG000|Overall Study|Lost to Follow-up|2|||
155019063|NCT02282631|559497603|FG001|Overall Study|Lost to Follow-up|0|||
155019064|NCT05483686|559497604|FG000|Overall Study|Lost to Follow-up|5|||
155019065|NCT05483686|559497605|FG001|Overall Study|Lost to Follow-up|7|||
155019066|NCT05780983|559497606|FG000|Overall Study|Withdrawal by Subject|1|||
155019067|NCT01017874|559497607|FG000|Overall Study|Withdrawal by Subject|23|||
155019068|NCT01017874|559497608|FG001|Overall Study|Withdrawal by Subject|20|||
155019069|NCT01017874|559497607|FG000|Overall Study|Sponsor decision|3|||
155019070|NCT01017874|559497608|FG001|Overall Study|Sponsor decision|1|||
155019071|NCT01017874|559497607|FG000|Overall Study|Lost to Follow-up|3|||
155019072|NCT01017874|559497608|FG001|Overall Study|Lost to Follow-up|2|||
155019073|NCT01017874|559497607|FG000|Overall Study|Physician Decision|1|||
155019074|NCT01017874|559497608|FG001|Overall Study|Physician Decision|3|||
155019075|NCT06110494|559497614|FG000|Overall Study|Protocol Violation|2|||
155019076|NCT06110494|559497615|FG001|Overall Study|Protocol Violation|0|||
155019077|NCT06110494|559497616|FG002|Overall Study|Protocol Violation|1|||
155019078|NCT06110494|559497614|FG000|Overall Study|Dixon's test for outlier analysis|1|||
155019079|NCT06110494|559497615|FG001|Overall Study|Dixon's test for outlier analysis|1|||
155019080|NCT06110494|559497616|FG002|Overall Study|Dixon's test for outlier analysis|0|||
155019081|NCT00105079|559497617|FG000|Overall Study|Adverse Event|5|||
155019082|NCT00105079|559497618|FG001|Overall Study|Adverse Event|12|||
155019083|NCT00105079|559497617|FG000|Overall Study|Death|3|||
155019084|NCT00105079|559497618|FG001|Overall Study|Death|1|||
155019085|NCT00105079|559497617|FG000|Overall Study|Lost to Follow-up|12|||
155019086|NCT00105079|559497618|FG001|Overall Study|Lost to Follow-up|12|||
155019087|NCT00105079|559497617|FG000|Overall Study|Lack of Efficacy|9|||
155019088|NCT00105079|559497618|FG001|Overall Study|Lack of Efficacy|3|||
155019089|NCT00105079|559497617|FG000|Overall Study|Refused treatment|6|||
155019090|NCT00105079|559497618|FG001|Overall Study|Refused treatment|4|||
155019091|NCT00105079|559497617|FG000|Overall Study|Violation of selection criteria at entry|0|||
155019092|NCT00105079|559497618|FG001|Overall Study|Violation of selection criteria at entry|2|||
155019093|NCT00105079|559497617|FG000|Overall Study|Protocol Violation|1|||
155019094|NCT00105079|559497618|FG001|Overall Study|Protocol Violation|0|||
155019095|NCT00105079|559497617|FG000|Overall Study|Other|3|||
155019096|NCT00105079|559497618|FG001|Overall Study|Other|1|||
155019097|NCT01464593|559497621|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
155019098|NCT01297517|559497622|FG000|Overall Study|Adverse Event|21|||
155019099|NCT01297517|559497623|FG001|Overall Study|Adverse Event|7|||
155019100|NCT01297517|559497624|FG002|Overall Study|Adverse Event|16|||
155019101|NCT01297517|559497622|FG000|Overall Study|Lost to Follow-up|1|||
155019102|NCT01297517|559497623|FG001|Overall Study|Lost to Follow-up|0|||
155019103|NCT01297517|559497624|FG002|Overall Study|Lost to Follow-up|1|||
155019104|NCT01297517|559497622|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
155019105|NCT01297517|559497623|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
155019106|NCT01297517|559497624|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
155019107|NCT01297517|559497622|FG000|Overall Study|Noncompliance|1|||
155019108|NCT01297517|559497623|FG001|Overall Study|Noncompliance|0|||
155019109|NCT01297517|559497624|FG002|Overall Study|Noncompliance|0|||
155019110|NCT01297517|559497622|FG000|Overall Study|Protocol Violation|1|||
155019111|NCT01297517|559497623|FG001|Overall Study|Protocol Violation|1|||
155019112|NCT01297517|559497624|FG002|Overall Study|Protocol Violation|1|||
155019113|NCT01297517|559497622|FG000|Overall Study|Inadequate Control of IOP|1|||
155019114|NCT01297517|559497623|FG001|Overall Study|Inadequate Control of IOP|1|||
155179386|NCT04604132|560095079|FG002|Overall Study|Progressive disease: Clinical progression|1|||
155019115|NCT01297517|559497624|FG002|Overall Study|Inadequate Control of IOP|2|||
155019116|NCT00386360|559497627|FG000|Overall Study|Adverse Event|4|||
155019117|NCT00386360|559497628|FG001|Overall Study|Adverse Event|2|||
155019118|NCT00386360|559497627|FG000|Overall Study|Physician Decision|2|||
155019119|NCT00386360|559497628|FG001|Overall Study|Physician Decision|2|||
155019120|NCT00386360|559497627|FG000|Overall Study|Lost to Follow-up|0|||
155019121|NCT00386360|559497628|FG001|Overall Study|Lost to Follow-up|2|||
155019122|NCT00386360|559497627|FG000|Overall Study|Protocol Violation|0|||
155019123|NCT00386360|559497628|FG001|Overall Study|Protocol Violation|3|||
155019124|NCT00386360|559497627|FG000|Overall Study|Withdrawal by Subject|3|||
155019125|NCT00386360|559497628|FG001|Overall Study|Withdrawal by Subject|6|||
155019126|NCT00386360|559497627|FG000|Overall Study|Did not take any study medication|0|||
155019127|NCT00386360|559497628|FG001|Overall Study|Did not take any study medication|2|||
155019128|NCT01163851|559497629|FG000|Overall Study|Site Closure|0|||
155019129|NCT01163851|559497630|FG001|Overall Study|Site Closure|1|||
155019130|NCT01163851|559497629|FG000|Overall Study|Enrolled but not treated|1|||
155019131|NCT01163851|559497630|FG001|Overall Study|Enrolled but not treated|0|||
155019132|NCT00789373|559497631|FG000|Induction|Adverse Event|64|||
155019133|NCT00789373|559497632|FG001|Induction|Adverse Event|0|||
155019134|NCT00789373|559497633|FG002|Induction|Adverse Event|0|||
155019135|NCT00789373|559497631|FG000|Induction|Death Due to study disease|24|||
155019136|NCT00789373|559497632|FG001|Induction|Death Due to study disease|0|||
155019137|NCT00789373|559497633|FG002|Induction|Death Due to study disease|0|||
155019138|NCT00789373|559497631|FG000|Induction|Death due to adverse event|19|||
155019139|NCT00789373|559497632|FG001|Induction|Death due to adverse event|0|||
155019140|NCT00789373|559497633|FG002|Induction|Death due to adverse event|0|||
155019141|NCT00789373|559497631|FG000|Induction|Death due to toxicity|11|||
155019142|NCT00789373|559497632|FG001|Induction|Death due to toxicity|0|||
155019143|NCT00789373|559497633|FG002|Induction|Death due to toxicity|0|||
155019144|NCT00789373|559497631|FG000|Induction|Death due to procedure|1|||
155019145|NCT00789373|559497632|FG001|Induction|Death due to procedure|0|||
155019146|NCT00789373|559497633|FG002|Induction|Death due to procedure|0|||
155019147|NCT00789373|559497631|FG000|Induction|Investigator decision|7|||
155019148|NCT00789373|559497632|FG001|Induction|Investigator decision|0|||
155019149|NCT00789373|559497633|FG002|Induction|Investigator decision|0|||
155019150|NCT00789373|559497631|FG000|Induction|Protocol entry criteria not met|9|||
155019151|NCT00789373|559497632|FG001|Induction|Protocol entry criteria not met|0|||
155019152|NCT00789373|559497633|FG002|Induction|Protocol entry criteria not met|0|||
155019153|NCT00789373|559497631|FG000|Induction|Lost to Follow-up|6|||
155019154|NCT00789373|559497632|FG001|Induction|Lost to Follow-up|0|||
155019155|NCT00789373|559497633|FG002|Induction|Lost to Follow-up|0|||
155019156|NCT00789373|559497631|FG000|Induction|Protocol Violation|1|||
155019157|NCT00789373|559497632|FG001|Induction|Protocol Violation|0|||
155019158|NCT00789373|559497633|FG002|Induction|Protocol Violation|0|||
155019159|NCT00789373|559497631|FG000|Induction|Progressive Disease|220|||
155019160|NCT00789373|559497632|FG001|Induction|Progressive Disease|0|||
155019161|NCT00789373|559497633|FG002|Induction|Progressive Disease|0|||
155019162|NCT00789373|559497631|FG000|Induction|Withdrawal by Subject|37|||
155019163|NCT00789373|559497632|FG001|Induction|Withdrawal by Subject|0|||
155019164|NCT00789373|559497633|FG002|Induction|Withdrawal by Subject|0|||
155179387|NCT04604132|560095080|FG003|Overall Study|Progressive disease: Clinical progression|0|||
155179388|NCT04604132|560095081|FG004|Overall Study|Progressive disease: Clinical progression|0|||
155179389|NCT04604132|560095077|FG000|Overall Study|Progressive disease: Radiological progression|8|||
155179390|NCT04604132|560095078|FG001|Overall Study|Progressive disease: Radiological progression|7|||
155179391|NCT04604132|560095079|FG002|Overall Study|Progressive disease: Radiological progression|10|||
155179392|NCT04604132|560095080|FG003|Overall Study|Progressive disease: Radiological progression|4|||
155179393|NCT04604132|560095081|FG004|Overall Study|Progressive disease: Radiological progression|3|||
155179394|NCT04604132|560095077|FG000|Overall Study|Death|3|||
155179395|NCT04604132|560095078|FG001|Overall Study|Death|1|||
155179396|NCT04604132|560095079|FG002|Overall Study|Death|2|||
155179397|NCT04604132|560095080|FG003|Overall Study|Death|1|||
155179398|NCT04604132|560095081|FG004|Overall Study|Death|0|||
155179399|NCT03044574|560095082|FG000|Overall Study|Lost to Follow-up|37|||
155179400|NCT03044574|560095083|FG001|Overall Study|Lost to Follow-up|45|||
155179401|NCT00053898|560095084|FG000|Overall Study|No follow-up data from any source|9|||
155179402|NCT00053898|560095085|FG001|Overall Study|No follow-up data from any source|12|||
155179403|NCT00053898|560095084|FG000|Overall Study|Follow-up from telephone contact only|5|||
155179404|NCT00053898|560095085|FG001|Overall Study|Follow-up from telephone contact only|1|||
155179405|NCT01077375|560095092|FG000|Overall Study|Adverse Event|2|||
155179406|NCT01077375|560095093|FG001|Overall Study|Adverse Event|15|||
155179407|NCT01077375|560095092|FG000|Overall Study|Lack of Efficacy|6|||
155179408|NCT01077375|560095093|FG001|Overall Study|Lack of Efficacy|8|||
155179409|NCT01077375|560095092|FG000|Overall Study|Withdrawal by Subject|0|||
155179410|NCT01077375|560095093|FG001|Overall Study|Withdrawal by Subject|6|||
155179411|NCT01077375|560095092|FG000|Overall Study|Lost to Follow-up|2|||
155179412|NCT01077375|560095093|FG001|Overall Study|Lost to Follow-up|5|||
155179413|NCT01077375|560095092|FG000|Overall Study|Other Reason|0|||
155179414|NCT01077375|560095093|FG001|Overall Study|Other Reason|1|||
155179415|NCT01924429|560095094|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
155179416|NCT01924429|560095095|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
155179417|NCT00884377|560096298|FG000|Overall Study|Withdrawal by Subject|1|||
155179418|NCT00884377|560096299|FG001|Overall Study|Withdrawal by Subject|0|||
155179419|NCT00884377|560096298|FG000|Overall Study|Could not confirm diagnosis|1|||
155179420|NCT00884377|560096299|FG001|Overall Study|Could not confirm diagnosis|0|||
155179421|NCT00884377|560096298|FG000|Overall Study|Physician Decision|0|||
155179422|NCT00884377|560096299|FG001|Overall Study|Physician Decision|1|||
155179423|NCT01527357|560096304|FG000|Overall Study|Death|8|||
155179424|NCT01527357|560096305|FG001|Overall Study|Death|2|||
155019165|NCT00789373|559497631|FG000|Maintenance|Adverse Event|0|||
155019166|NCT00789373|559497632|FG001|Maintenance|Adverse Event|65|||
155179425|NCT01527357|560096304|FG000|Overall Study|Lost to Follow-up|6|||
155179426|NCT01527357|560096305|FG001|Overall Study|Lost to Follow-up|4|||
155179427|NCT01527357|560096304|FG000|Overall Study|Withdrew Consent|1|||
155019167|NCT00789373|559497633|FG002|Maintenance|Adverse Event|12|||
155019168|NCT00789373|559497631|FG000|Maintenance|Death due to study disease|0|||
155019169|NCT00789373|559497632|FG001|Maintenance|Death due to study disease|3|||
155019170|NCT00789373|559497633|FG002|Maintenance|Death due to study disease|1|||
155019171|NCT00789373|559497631|FG000|Maintenance|Death due to adverse event|0|||
155019172|NCT00789373|559497632|FG001|Maintenance|Death due to adverse event|4|||
155139115|NCT03078556|559942642|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
155139116|NCT03078556|559942643|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
155139117|NCT03078556|559942644|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
155019173|NCT00789373|559497633|FG002|Maintenance|Death due to adverse event|1|||
155019174|NCT00789373|559497631|FG000|Maintenance|Death due to toxicity|0|||
155019175|NCT00789373|559497632|FG001|Maintenance|Death due to toxicity|1|||
155019176|NCT00789373|559497633|FG002|Maintenance|Death due to toxicity|2|||
155019177|NCT00789373|559497631|FG000|Maintenance|Investigator Decision|0|||
155019178|NCT00789373|559497632|FG001|Maintenance|Investigator Decision|4|||
155019179|NCT00789373|559497633|FG002|Maintenance|Investigator Decision|2|||
155019180|NCT00789373|559497631|FG000|Maintenance|Protocol entry criteria not met|0|||
155019181|NCT00789373|559497632|FG001|Maintenance|Protocol entry criteria not met|2|||
155019182|NCT00789373|559497633|FG002|Maintenance|Protocol entry criteria not met|0|||
155019183|NCT00789373|559497631|FG000|Maintenance|Lost to Follow-up|0|||
155019184|NCT00789373|559497632|FG001|Maintenance|Lost to Follow-up|2|||
155019185|NCT00789373|559497633|FG002|Maintenance|Lost to Follow-up|0|||
155019186|NCT00789373|559497631|FG000|Maintenance|Progressive Disease|0|||
155019187|NCT00789373|559497632|FG001|Maintenance|Progressive Disease|253|||
155019188|NCT00789373|559497633|FG002|Maintenance|Progressive Disease|152|||
155019189|NCT00789373|559497631|FG000|Maintenance|Withdrawal by Subject|0|||
155019190|NCT00789373|559497632|FG001|Maintenance|Withdrawal by Subject|21|||
155019191|NCT00789373|559497633|FG002|Maintenance|Withdrawal by Subject|8|||
155019192|NCT00789373|559497631|FG000|Maintenance|Sponsor Decision|0|||
155019193|NCT00789373|559497632|FG001|Maintenance|Sponsor Decision|0|||
155019194|NCT00789373|559497633|FG002|Maintenance|Sponsor Decision|2|||
155019195|NCT00789373|559497631|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
155019196|NCT00789373|559497632|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
155019197|NCT00789373|559497633|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
155019198|NCT04938180|559497637|FG000|Overall Study|Adverse Event|1|||
155019199|NCT04157348|559497644|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
155019200|NCT04157348|559497645|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
155019201|NCT04157348|559497644|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155019202|NCT04157348|559497645|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
155019203|NCT04157348|559497644|FG000|Double-blind Treatment Period|Adverse Event|0|||
155019204|NCT04157348|559497645|FG001|Double-blind Treatment Period|Adverse Event|1|||
155019205|NCT04157348|559497644|FG000|Open-label Extension Period|Adverse Event|1|||
155019206|NCT04157348|559497645|FG001|Open-label Extension Period|Adverse Event|1|||
155019207|NCT04157348|559497644|FG000|Open-label Extension Period|Death|0|||
155019208|NCT04157348|559497645|FG001|Open-label Extension Period|Death|1|||
155019209|NCT04157348|559497644|FG000|Open-label Extension Period|Lack of Efficacy|2|||
155019210|NCT04157348|559497645|FG001|Open-label Extension Period|Lack of Efficacy|2|||
155019211|NCT04157348|559497644|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
155019212|NCT04157348|559497645|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
155019213|NCT04157348|559497644|FG000|Open-label Extension Period|Ongoing|60|||
155019214|NCT04157348|559497645|FG001|Open-label Extension Period|Ongoing|57|||
155019215|NCT04157348|559497644|FG000|Open-label Extension Period|other reasons|1|||
155019216|NCT04157348|559497645|FG001|Open-label Extension Period|other reasons|1|||
155019217|NCT02527434|559497646|FG000|Overall Study|Lost to Follow-up|2|||
155019218|NCT02527434|559497647|FG001|Overall Study|Lost to Follow-up|2|||
155019219|NCT02527434|559497648|FG002|Overall Study|Lost to Follow-up|0|||
155019220|NCT02527434|559497646|FG000|Overall Study|Death|19|||
155019221|NCT02527434|559497647|FG001|Overall Study|Death|6|||
155019222|NCT02527434|559497648|FG002|Overall Study|Death|17|||
155019223|NCT02527434|559497646|FG000|Overall Study|Withdrawal by Subject|5|||
155019224|NCT02527434|559497647|FG001|Overall Study|Withdrawal by Subject|3|||
155019225|NCT02527434|559497648|FG002|Overall Study|Withdrawal by Subject|3|||
155019226|NCT02527434|559497646|FG000|Overall Study|Reason Not Specified|1|||
155019227|NCT02527434|559497647|FG001|Overall Study|Reason Not Specified|0|||
155019228|NCT02527434|559497648|FG002|Overall Study|Reason Not Specified|0|||
155019229|NCT02527434|559497646|FG000|Overall Study|Site closure|1|||
155019230|NCT02527434|559497647|FG001|Overall Study|Site closure|0|||
155019231|NCT02527434|559497648|FG002|Overall Study|Site closure|0|||
155019232|NCT00568061|559497651|FG000|Overall Study|Inclusion / exclusion criteria|5|||
155019233|NCT00568061|559497652|FG001|Overall Study|Inclusion / exclusion criteria|1|||
155019234|NCT00568061|559497651|FG000|Overall Study|Adverse Event|0|||
155019235|NCT00568061|559497652|FG001|Overall Study|Adverse Event|1|||
155019236|NCT05027451|559497653|FG000|Overall Study|Lost to Follow-up|1|||
155019237|NCT05027451|559497654|FG001|Overall Study|Lost to Follow-up|1|||
155019238|NCT02693002|559497656|FG000|Overall Study|Withdrawal by Subject|1|||
155019239|NCT02693002|559497657|FG001|Overall Study|Withdrawal by Subject|0|||
155019240|NCT05343364|559497661|FG000|Overall Study|Miscellaneous|0|||
155019241|NCT05343364|559497662|FG001|Overall Study|Miscellaneous|1|||
155019242|NCT01753570|559497663|FG000|Overall Study|Adverse Event|1|||
155019243|NCT01753570|559497664|FG001|Overall Study|Adverse Event|0|||
155019244|NCT01753570|559497665|FG002|Overall Study|Adverse Event|1|||
155019245|NCT01753570|559497663|FG000|Overall Study|Physician Decision|0|||
155179428|NCT01527357|560096305|FG001|Overall Study|Withdrew Consent|1|||
155019246|NCT01753570|559497664|FG001|Overall Study|Physician Decision|1|||
155019247|NCT01753570|559497665|FG002|Overall Study|Physician Decision|0|||
155019248|NCT01753570|559497663|FG000|Overall Study|Withdrawal by Subject|1|||
155019249|NCT01753570|559497664|FG001|Overall Study|Withdrawal by Subject|4|||
155019250|NCT01753570|559497665|FG002|Overall Study|Withdrawal by Subject|0|||
155019251|NCT01791894|559497666|FG000|Overall Study|Adverse Event|1|||
155019252|NCT05870371|559497667|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
155019253|NCT05870371|559497668|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
155019254|NCT02062450|559497673|FG000|Overall Study|No follow-up visit|124|||
155019255|NCT02589639|559497677|FG000|Overall Study|Lost to Follow-up|1|||
155019256|NCT02589639|559497678|FG001|Overall Study|Lost to Follow-up|0|||
155019257|NCT02589639|559497679|FG002|Overall Study|Lost to Follow-up|0|||
155019258|NCT02589639|559497677|FG000|Overall Study|Protocol Violation|1|||
155019259|NCT02589639|559497678|FG001|Overall Study|Protocol Violation|0|||
155019260|NCT02589639|559497679|FG002|Overall Study|Protocol Violation|0|||
155019261|NCT02589639|559497677|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
155019262|NCT02589639|559497678|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
155019263|NCT02589639|559497679|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
155019264|NCT02589639|559497677|FG000|Overall Study|Adverse Event|4|||
155019265|NCT02589639|559497678|FG001|Overall Study|Adverse Event|5|||
155019266|NCT02589639|559497679|FG002|Overall Study|Adverse Event|3|||
155019267|NCT02589639|559497677|FG000|Overall Study|Other reason than specified above|1|||
155019268|NCT02589639|559497678|FG001|Overall Study|Other reason than specified above|2|||
155019269|NCT02589639|559497679|FG002|Overall Study|Other reason than specified above|1|||
155019270|NCT02589639|559497677|FG000|Overall Study|Not Treated|0|||
155019271|NCT02589639|559497678|FG001|Overall Study|Not Treated|3|||
155019272|NCT02589639|559497679|FG002|Overall Study|Not Treated|0|||
155019273|NCT00708461|559497682|FG000|Overall Study|Lost to Follow-up|18|||
155019274|NCT00708461|559497683|FG001|Overall Study|Lost to Follow-up|11|||
155019275|NCT00708461|559497682|FG000|Overall Study|Withdrawal by Subject|8|||
155019276|NCT00708461|559497683|FG001|Overall Study|Withdrawal by Subject|9|||
155019277|NCT00708461|559497682|FG000|Overall Study|left workforce|115|||
155019278|NCT00708461|559497683|FG001|Overall Study|left workforce|180|||
155019279|NCT03584854|559497684|FG000|Overall Study|Primary outcome not measured|1|||
155019280|NCT03584854|559497685|FG001|Overall Study|Primary outcome not measured|2|||
155019281|NCT02968173|559497686|FG000|Overall Study|Withdrawal by Subject|1|||
155019282|NCT00153179|559497693|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
155019283|NCT00153179|559497694|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
155019284|NCT00153179|559497695|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
155019285|NCT00153179|559497696|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
155019286|NCT00314327|559497701|FG000|Overall Study|Withdrawal by Subject|1|||
155019287|NCT01408303|559497702|FG000|Overall Study|Adverse Event|3|||
155019288|NCT01408303|559497703|FG001|Overall Study|Adverse Event|7|||
155019289|NCT01408303|559497704|FG002|Overall Study|Adverse Event|2|||
155019290|NCT01408303|559497702|FG000|Overall Study|Lost to Follow-up|0|||
155019291|NCT01408303|559497703|FG001|Overall Study|Lost to Follow-up|1|||
155019292|NCT01408303|559497704|FG002|Overall Study|Lost to Follow-up|2|||
155019293|NCT01408303|559497702|FG000|Overall Study|Withdrawal by Subject|2|||
155019294|NCT01408303|559497703|FG001|Overall Study|Withdrawal by Subject|3|||
155019295|NCT01408303|559497704|FG002|Overall Study|Withdrawal by Subject|1|||
155019296|NCT01408303|559497702|FG000|Overall Study|Protocol Violation|0|||
155019297|NCT01408303|559497703|FG001|Overall Study|Protocol Violation|1|||
155019298|NCT01408303|559497704|FG002|Overall Study|Protocol Violation|0|||
155019299|NCT01408303|559497702|FG000|Overall Study|Noncompliance|1|||
155019300|NCT01408303|559497703|FG001|Overall Study|Noncompliance|0|||
155019301|NCT01408303|559497704|FG002|Overall Study|Noncompliance|1|||
155019302|NCT01207687|559497705|FG000|Overall Study|Adverse Event|1|||
155019303|NCT01207687|559497705|FG000|Overall Study|Withdrawal by Subject|1|||
155019304|NCT01801865|559497706|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
155019305|NCT01801865|559497706|FG000|Overall Study|Physician Decision|7|||
155019306|NCT02134015|559497709|FG000|Overall Study|Protocol Violation|0|||
155019307|NCT02134015|559497710|FG001|Overall Study|Protocol Violation|1|||
155019308|NCT02134015|559497709|FG000|Overall Study|Death|2|||
155019309|NCT02134015|559497710|FG001|Overall Study|Death|1|||
155019310|NCT02134015|559497709|FG000|Overall Study|Reason not provided|1|||
155019311|NCT02134015|559497710|FG001|Overall Study|Reason not provided|2|||
155019312|NCT02134015|559497709|FG000|Overall Study|Clinical progression|14|||
155019313|NCT02134015|559497710|FG001|Overall Study|Clinical progression|7|||
155019314|NCT02134015|559497709|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
155019315|NCT02134015|559497710|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
155019316|NCT02134015|559497709|FG000|Overall Study|Study terminated by sponsor|2|||
155019317|NCT02134015|559497710|FG001|Overall Study|Study terminated by sponsor|3|||
155019318|NCT02134015|559497709|FG000|Overall Study|Adverse Event|9|||
155019319|NCT02134015|559497710|FG001|Overall Study|Adverse Event|10|||
155019320|NCT02134015|559497709|FG000|Overall Study|Withdrawal by Subject|3|||
155019321|NCT02134015|559497710|FG001|Overall Study|Withdrawal by Subject|7|||
155019322|NCT03867201|559497711|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
155019323|NCT03867201|559497712|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
155019324|NCT03867201|559497711|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
155019325|NCT03867201|559497712|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
155019326|NCT03867201|559497711|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
155019327|NCT03867201|559497712|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
155019328|NCT03867201|559497711|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
155139118|NCT03078556|559942641|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
155139119|NCT03078556|559942642|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
155139120|NCT03078556|559942643|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
155139121|NCT03078556|559942644|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
155139122|NCT00832416|559942645|FG000|Overall Study|Lack of Efficacy|17|||
155139123|NCT00832416|559942646|FG001|Overall Study|Lack of Efficacy|15|||
155139124|NCT00832416|559942647|FG002|Overall Study|Lack of Efficacy|13|||
155139125|NCT00832416|559942648|FG003|Overall Study|Lack of Efficacy|52|||
155139126|NCT00832416|559942645|FG000|Overall Study|Withdrawal by Subject|5|||
155139127|NCT00832416|559942646|FG001|Overall Study|Withdrawal by Subject|7|||
155139128|NCT00832416|559942647|FG002|Overall Study|Withdrawal by Subject|2|||
155139129|NCT00832416|559942648|FG003|Overall Study|Withdrawal by Subject|10|||
155139130|NCT00832416|559942645|FG000|Overall Study|Physician Decision|2|||
155139131|NCT00832416|559942646|FG001|Overall Study|Physician Decision|12|||
155139132|NCT00832416|559942647|FG002|Overall Study|Physician Decision|5|||
155139133|NCT00832416|559942648|FG003|Overall Study|Physician Decision|10|||
155139134|NCT00832416|559942645|FG000|Overall Study|Administrative|0|||
155019329|NCT03867201|559497712|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
155019330|NCT03867201|559497711|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
155019331|NCT03867201|559497712|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
155019332|NCT03867201|559497711|FG000|Open-Label Period From Week 12|Adverse Event|5|||
155019333|NCT03867201|559497712|FG001|Open-Label Period From Week 12|Adverse Event|11|||
155019334|NCT03867201|559497711|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
155019335|NCT03867201|559497712|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
155019336|NCT03867201|559497711|FG000|Open-Label Period From Week 12|Physician Decision|6|||
155019337|NCT03867201|559497712|FG001|Open-Label Period From Week 12|Physician Decision|3|||
155019338|NCT03867201|559497711|FG000|Open-Label Period From Week 12|Pregnancy|2|||
155019339|NCT03867201|559497712|FG001|Open-Label Period From Week 12|Pregnancy|2|||
155019340|NCT03867201|559497711|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
155019341|NCT03867201|559497712|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
155019342|NCT03867201|559497711|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
155019343|NCT03867201|559497712|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
155019344|NCT03867201|559497711|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
155019345|NCT03867201|559497712|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
155019346|NCT03867201|559497711|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
155019347|NCT03867201|559497712|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
155019348|NCT05763875|559497717|FG000|Overall Study|Subject decision|5|||
155019349|NCT05763875|559497718|FG001|Overall Study|Subject decision|2|||
155019350|NCT05763875|559497719|FG002|Overall Study|Subject decision|1|||
155019351|NCT05763875|559497717|FG000|Overall Study|Lost to Follow-up|4|||
155019352|NCT05763875|559497718|FG001|Overall Study|Lost to Follow-up|1|||
155019353|NCT05763875|559497719|FG002|Overall Study|Lost to Follow-up|2|||
155019354|NCT05763875|559497717|FG000|Overall Study|Adverse Event|1|||
155019355|NCT05763875|559497718|FG001|Overall Study|Adverse Event|0|||
155019356|NCT05763875|559497719|FG002|Overall Study|Adverse Event|0|||
155019357|NCT01481766|559499624|FG000|4 months|Lost to Follow-up|3|||
155019358|NCT01481766|559499625|FG001|4 months|Lost to Follow-up|2|||
155019359|NCT01481766|559499626|FG002|4 months|Lost to Follow-up|1|||
155019360|NCT01481766|559499627|FG003|4 months|Lost to Follow-up|5|||
155019361|NCT01481766|559499624|FG000|12 months|Lost to Follow-up|7|||
155019362|NCT01481766|559499625|FG001|12 months|Lost to Follow-up|8|||
155019363|NCT01481766|559499626|FG002|12 months|Lost to Follow-up|5|||
155019364|NCT01481766|559499627|FG003|12 months|Lost to Follow-up|3|||
155019365|NCT00347958|559499628|FG000|Overall Study|Adverse Event|1|||
155019366|NCT00347958|559499628|FG000|Overall Study|Protocol Violation|2|||
155019367|NCT00347958|559499628|FG000|Overall Study|Withdrawal by Subject|1|||
155019368|NCT03868930|559499629|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
155019369|NCT03868930|559499630|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
155019370|NCT03868930|559499629|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
155019371|NCT03868930|559499630|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
155019372|NCT03868930|559499629|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
155019373|NCT03868930|559499630|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
155139135|NCT00832416|559942646|FG001|Overall Study|Administrative|0|||
155139136|NCT00832416|559942647|FG002|Overall Study|Administrative|0|||
155139137|NCT00832416|559942648|FG003|Overall Study|Administrative|1|||
155139138|NCT00832416|559942645|FG000|Overall Study|Adverse Event|21|||
155139139|NCT00832416|559942646|FG001|Overall Study|Adverse Event|19|||
155019374|NCT03868930|559499629|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
155019375|NCT03868930|559499630|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
155019376|NCT03868930|559499629|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
155179429|NCT01527357|560096304|FG000|Overall Study|Non-compliance|0|||
155179430|NCT01527357|560096305|FG001|Overall Study|Non-compliance|1|||
155179431|NCT01527357|560096304|FG000|Overall Study|No Day 29 Visit|0|||
155179432|NCT01527357|560096305|FG001|Overall Study|No Day 29 Visit|1|||
155179433|NCT01527357|560096304|FG000|Overall Study|Did Not Receive Treatment|2|||
155179434|NCT01527357|560096305|FG001|Overall Study|Did Not Receive Treatment|0|||
155179435|NCT02919969|560096306|FG000|Overall Study|Lack of Efficacy|22|||
155179436|NCT02919969|560096306|FG000|Overall Study|Death|4|||
155179437|NCT02919969|560096306|FG000|Overall Study|Physician Decision|3|||
155179438|NCT02919969|560096306|FG000|Overall Study|Withdrawal by Subject|2|||
155179439|NCT03621475|560096307|FG000|Overall Study|No longer required restraints at initiation|0|||
155179440|NCT03621475|560096308|FG001|Overall Study|No longer required restraints at initiation|1|||
155179441|NCT02093351|560096312|FG000|Part A|Adverse Event|0|||
155179442|NCT02093351|560096313|FG001|Part A|Adverse Event|1|||
155179443|NCT02093351|560096314|FG002|Part A|Adverse Event|1|||
155179444|NCT02093351|560096315|FG003|Part A|Adverse Event|0|||
155179445|NCT02093351|560096312|FG000|Part A|Condition under investigation worsened|2|||
155179446|NCT02093351|560096313|FG001|Part A|Condition under investigation worsened|0|||
155179447|NCT02093351|560096314|FG002|Part A|Condition under investigation worsened|2|||
155179448|NCT02093351|560096315|FG003|Part A|Condition under investigation worsened|0|||
155179449|NCT02093351|560096312|FG000|Part A|Death|0|||
155179450|NCT02093351|560096313|FG001|Part A|Death|1|||
155179451|NCT02093351|560096314|FG002|Part A|Death|0|||
155179452|NCT02093351|560096315|FG003|Part A|Death|0|||
155179453|NCT02093351|560096312|FG000|Part B|Patient decision|0|||
155179454|NCT02093351|560096313|FG001|Part B|Patient decision|0|||
155179455|NCT02093351|560096314|FG002|Part B|Patient decision|0|||
155179456|NCT02093351|560096315|FG003|Part B|Patient decision|3|||
155179457|NCT02093351|560096312|FG000|Part B|Disease progression|0|||
155179458|NCT02093351|560096313|FG001|Part B|Disease progression|0|||
155179459|NCT02093351|560096314|FG002|Part B|Disease progression|0|||
155179460|NCT02093351|560096315|FG003|Part B|Disease progression|4|||
155179461|NCT02093351|560096312|FG000|Part B|Complete response|0|||
155179462|NCT02093351|560096313|FG001|Part B|Complete response|0|||
155179463|NCT02093351|560096314|FG002|Part B|Complete response|0|||
155179464|NCT02093351|560096315|FG003|Part B|Complete response|1|||
155179465|NCT02093351|560096312|FG000|Part B|Adverse event + disease progression|0|||
155179466|NCT02093351|560096313|FG001|Part B|Adverse event + disease progression|0|||
155179467|NCT02093351|560096314|FG002|Part B|Adverse event + disease progression|0|||
155179468|NCT02093351|560096315|FG003|Part B|Adverse event + disease progression|1|||
155179469|NCT02093351|560096312|FG000|Part B|Lack of therapeutic response|0|||
155179470|NCT02093351|560096313|FG001|Part B|Lack of therapeutic response|0|||
155179471|NCT02093351|560096314|FG002|Part B|Lack of therapeutic response|0|||
155179472|NCT02093351|560096315|FG003|Part B|Lack of therapeutic response|12|||
155179473|NCT02093351|560096312|FG000|Part B|Condition under investigation worsened|0|||
155179474|NCT02093351|560096313|FG001|Part B|Condition under investigation worsened|0|||
155179475|NCT02093351|560096314|FG002|Part B|Condition under investigation worsened|0|||
155179476|NCT02093351|560096315|FG003|Part B|Condition under investigation worsened|39|||
155179477|NCT02093351|560096312|FG000|Part B|Adverse Event|0|||
155179478|NCT02093351|560096313|FG001|Part B|Adverse Event|0|||
155179479|NCT02093351|560096314|FG002|Part B|Adverse Event|0|||
155139140|NCT00832416|559942647|FG002|Overall Study|Adverse Event|41|||
155139141|NCT00832416|559942648|FG003|Overall Study|Adverse Event|10|||
155139142|NCT00832416|559942645|FG000|Overall Study|Death|1|||
155139143|NCT00832416|559942646|FG001|Overall Study|Death|0|||
155139144|NCT00832416|559942647|FG002|Overall Study|Death|0|||
155139145|NCT00832416|559942648|FG003|Overall Study|Death|0|||
155139146|NCT02114606|559942649|FG000|Overall Study|Unable to swallow Cytosponge|6|||
155139147|NCT04421482|559942656|FG000|Overall Study|Physician Decision|1|||
155139148|NCT03010319|559942659|FG000|Overall Study|Adverse Event|15|||
155139149|NCT03010319|559942660|FG001|Overall Study|Adverse Event|9|||
155139150|NCT03010319|559942659|FG000|Overall Study|Withdrawal by Subject|1|||
155139151|NCT03010319|559942660|FG001|Overall Study|Withdrawal by Subject|6|||
155139152|NCT03010319|559942659|FG000|Overall Study|Physician Decision|2|||
155139153|NCT03010319|559942660|FG001|Overall Study|Physician Decision|4|||
155139154|NCT03010319|559942659|FG000|Overall Study|Sponsor requested withdrawal|2|||
155139155|NCT03010319|559942660|FG001|Overall Study|Sponsor requested withdrawal|2|||
155139156|NCT03010319|559942659|FG000|Overall Study|Death|1|||
155139157|NCT03010319|559942660|FG001|Overall Study|Death|0|||
155139158|NCT03010319|559942659|FG000|Overall Study|Lost to Follow-up|0|||
155139159|NCT03010319|559942660|FG001|Overall Study|Lost to Follow-up|1|||
155139160|NCT03010319|559942659|FG000|Overall Study|Other Reason|5|||
155139161|NCT03010319|559942660|FG001|Overall Study|Other Reason|7|||
155139162|NCT02128724|559942661|FG000|Overall Study|Death|1|||
155139163|NCT02128724|559942662|FG001|Overall Study|Death|0|||
155139164|NCT02128724|559942663|FG002|Overall Study|Death|0|||
155019377|NCT03868930|559499630|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
155019378|NCT02151851|559499633|FG000|Overall Study|Lack of Efficacy|67|||
155019379|NCT02151851|559499634|FG001|Overall Study|Lack of Efficacy|94|||
155019380|NCT02151851|559499633|FG000|Overall Study|Protocol Violation|0|||
155019381|NCT02151851|559499634|FG001|Overall Study|Protocol Violation|1|||
155019382|NCT02151851|559499633|FG000|Overall Study|Withdrawal by Subject|2|||
155019383|NCT02151851|559499634|FG001|Overall Study|Withdrawal by Subject|5|||
155019384|NCT02151851|559499633|FG000|Overall Study|Medical impairment|1|||
155019385|NCT02151851|559499634|FG001|Overall Study|Medical impairment|0|||
155019386|NCT02151851|559499633|FG000|Overall Study|Low compliance to study visits|0|||
155019387|NCT02151851|559499634|FG001|Overall Study|Low compliance to study visits|1|||
155019388|NCT02151851|559499633|FG000|Overall Study|Subject entered into study in error|0|||
155019389|NCT02151851|559499634|FG001|Overall Study|Subject entered into study in error|1|||
155019390|NCT02151851|559499633|FG000|Overall Study|Adverse Event|6|||
155019391|NCT02151851|559499634|FG001|Overall Study|Adverse Event|28|||
155019392|NCT00932373|559499635|FG000|Overall Study|Progressive disease|3|||
155019393|NCT00932373|559499636|FG001|Overall Study|Progressive disease|1|||
155019394|NCT00932373|559499637|FG002|Overall Study|Progressive disease|0|||
155019395|NCT00932373|559499638|FG003|Overall Study|Progressive disease|0|||
155019396|NCT00932373|559499639|FG004|Overall Study|Progressive disease|10|||
155019397|NCT00932373|559499640|FG005|Overall Study|Progressive disease|1|||
155019398|NCT00932373|559499641|FG006|Overall Study|Progressive disease|0|||
155019399|NCT00932373|559499642|FG007|Overall Study|Progressive disease|2|||
155019400|NCT00932373|559499643|FG008|Overall Study|Progressive disease|1|||
155019401|NCT00932373|559499644|FG009|Overall Study|Progressive disease|9|||
155019402|NCT00932373|559499645|FG010|Overall Study|Progressive disease|2|||
155019403|NCT00932373|559499635|FG000|Overall Study|Adverse Event|0|||
155019404|NCT00932373|559499636|FG001|Overall Study|Adverse Event|0|||
155019405|NCT00932373|559499637|FG002|Overall Study|Adverse Event|0|||
155019406|NCT00932373|559499638|FG003|Overall Study|Adverse Event|0|||
155019407|NCT00932373|559499639|FG004|Overall Study|Adverse Event|2|||
155019408|NCT00932373|559499640|FG005|Overall Study|Adverse Event|1|||
155019409|NCT00932373|559499641|FG006|Overall Study|Adverse Event|0|||
155019410|NCT00932373|559499642|FG007|Overall Study|Adverse Event|1|||
155019411|NCT00932373|559499643|FG008|Overall Study|Adverse Event|0|||
155019412|NCT00932373|559499644|FG009|Overall Study|Adverse Event|2|||
155019413|NCT00932373|559499645|FG010|Overall Study|Adverse Event|1|||
155019414|NCT00932373|559499635|FG000|Overall Study|Physician Decision|0|||
155019415|NCT00932373|559499636|FG001|Overall Study|Physician Decision|0|||
155019416|NCT00932373|559499637|FG002|Overall Study|Physician Decision|1|||
155019417|NCT00932373|559499638|FG003|Overall Study|Physician Decision|0|||
155019418|NCT00932373|559499639|FG004|Overall Study|Physician Decision|2|||
155019419|NCT00932373|559499640|FG005|Overall Study|Physician Decision|0|||
155019420|NCT00932373|559499641|FG006|Overall Study|Physician Decision|0|||
155019421|NCT00932373|559499642|FG007|Overall Study|Physician Decision|0|||
155019422|NCT00932373|559499643|FG008|Overall Study|Physician Decision|0|||
155019423|NCT00932373|559499644|FG009|Overall Study|Physician Decision|1|||
155019424|NCT00932373|559499645|FG010|Overall Study|Physician Decision|0|||
155019425|NCT00932373|559499635|FG000|Overall Study|Dose limiting toxicity|0|||
155019426|NCT00932373|559499636|FG001|Overall Study|Dose limiting toxicity|0|||
155019427|NCT00932373|559499637|FG002|Overall Study|Dose limiting toxicity|0|||
155019428|NCT00932373|559499638|FG003|Overall Study|Dose limiting toxicity|0|||
155019429|NCT00932373|559499639|FG004|Overall Study|Dose limiting toxicity|0|||
155019430|NCT00932373|559499640|FG005|Overall Study|Dose limiting toxicity|1|||
155019431|NCT00932373|559499641|FG006|Overall Study|Dose limiting toxicity|0|||
155019432|NCT00932373|559499642|FG007|Overall Study|Dose limiting toxicity|0|||
155019433|NCT00932373|559499643|FG008|Overall Study|Dose limiting toxicity|0|||
155019434|NCT00932373|559499644|FG009|Overall Study|Dose limiting toxicity|0|||
155019435|NCT00932373|559499645|FG010|Overall Study|Dose limiting toxicity|0|||
155019436|NCT00932373|559499635|FG000|Overall Study|Withdrawal by Subject|0|||
155019437|NCT00932373|559499636|FG001|Overall Study|Withdrawal by Subject|0|||
155019438|NCT00932373|559499637|FG002|Overall Study|Withdrawal by Subject|0|||
155019439|NCT00932373|559499638|FG003|Overall Study|Withdrawal by Subject|0|||
155019440|NCT00932373|559499639|FG004|Overall Study|Withdrawal by Subject|0|||
155019441|NCT00932373|559499640|FG005|Overall Study|Withdrawal by Subject|0|||
155019442|NCT00932373|559499641|FG006|Overall Study|Withdrawal by Subject|0|||
155019443|NCT00932373|559499642|FG007|Overall Study|Withdrawal by Subject|0|||
155019444|NCT00932373|559499643|FG008|Overall Study|Withdrawal by Subject|1|||
155019445|NCT00932373|559499644|FG009|Overall Study|Withdrawal by Subject|0|||
155019446|NCT00932373|559499645|FG010|Overall Study|Withdrawal by Subject|0|||
155019447|NCT00932373|559499635|FG000|Overall Study|Clinical progression|0|||
155019448|NCT00932373|559499636|FG001|Overall Study|Clinical progression|0|||
155019449|NCT00932373|559499637|FG002|Overall Study|Clinical progression|0|||
155019450|NCT00932373|559499638|FG003|Overall Study|Clinical progression|0|||
155019451|NCT00932373|559499639|FG004|Overall Study|Clinical progression|0|||
155019452|NCT00932373|559499640|FG005|Overall Study|Clinical progression|0|||
155019453|NCT00932373|559499641|FG006|Overall Study|Clinical progression|1|||
155019454|NCT00932373|559499642|FG007|Overall Study|Clinical progression|0|||
155179480|NCT02093351|560096315|FG003|Part B|Adverse Event|2|||
155179481|NCT02093351|560096312|FG000|Part B|Death|0|||
155179482|NCT02093351|560096313|FG001|Part B|Death|0|||
155179483|NCT02093351|560096314|FG002|Part B|Death|0|||
155179484|NCT02093351|560096315|FG003|Part B|Death|1|||
155179485|NCT03565367|560096316|FG000|Overall Study|No scan due to technical issues|4|||
155179486|NCT03565367|560096317|FG001|Overall Study|No scan due to technical issues|0|||
155179487|NCT01992159|560096318|FG000|Overall Study|Withdrawal by Subject|4|||
155019455|NCT00932373|559499643|FG008|Overall Study|Clinical progression|0|||
155019456|NCT00932373|559499644|FG009|Overall Study|Clinical progression|0|||
155019457|NCT00932373|559499645|FG010|Overall Study|Clinical progression|0|||
155019458|NCT00932373|559499635|FG000|Overall Study|Lack of Efficacy|0|||
155019459|NCT00932373|559499636|FG001|Overall Study|Lack of Efficacy|0|||
155019460|NCT00932373|559499637|FG002|Overall Study|Lack of Efficacy|0|||
155019461|NCT00932373|559499638|FG003|Overall Study|Lack of Efficacy|0|||
155019462|NCT00932373|559499639|FG004|Overall Study|Lack of Efficacy|0|||
155019463|NCT00932373|559499640|FG005|Overall Study|Lack of Efficacy|0|||
155019464|NCT00932373|559499641|FG006|Overall Study|Lack of Efficacy|0|||
155019465|NCT00932373|559499642|FG007|Overall Study|Lack of Efficacy|0|||
155019466|NCT00932373|559499643|FG008|Overall Study|Lack of Efficacy|0|||
155019467|NCT00932373|559499644|FG009|Overall Study|Lack of Efficacy|1|||
155019468|NCT00932373|559499645|FG010|Overall Study|Lack of Efficacy|0|||
155019469|NCT04134767|559499648|FG000|Overall Study|Death|0|||
155019470|NCT04134767|559499649|FG001|Overall Study|Death|1|||
155019471|NCT04134767|559499648|FG000|Overall Study|Removed for harassing staff|0|||
155019472|NCT04134767|559499649|FG001|Overall Study|Removed for harassing staff|1|||
155019473|NCT04134767|559499648|FG000|Overall Study|Lost to Follow-up|44|||
155019474|NCT04134767|559499649|FG001|Overall Study|Lost to Follow-up|40|||
155019475|NCT00459290|559499650|FG000|Overall Study|Adverse Event|3|||
155019476|NCT00459290|559499650|FG000|Overall Study|Ineligible|2|||
155019477|NCT02453334|559499651|FG000|Overall Study|Death|15|||
155019478|NCT02453334|559499652|FG001|Overall Study|Death|13|||
155019479|NCT02453334|559499651|FG000|Overall Study|Adverse Event|2|||
155019480|NCT02453334|559499652|FG001|Overall Study|Adverse Event|1|||
155019481|NCT02453334|559499651|FG000|Overall Study|Lost to Follow-up|5|||
155019482|NCT02453334|559499652|FG001|Overall Study|Lost to Follow-up|9|||
155019483|NCT02453334|559499651|FG000|Overall Study|Physician Decision|1|||
155019484|NCT02453334|559499652|FG001|Overall Study|Physician Decision|0|||
155019485|NCT02453334|559499651|FG000|Overall Study|Withdrawal by Subject|17|||
155019486|NCT02453334|559499652|FG001|Overall Study|Withdrawal by Subject|13|||
155019487|NCT02453334|559499651|FG000|Overall Study|Other reason|1|||
155019488|NCT02453334|559499652|FG001|Overall Study|Other reason|4|||
155019489|NCT01841762|559499653|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
155019490|NCT01841762|559499653|FG000|Treatment Period|Adverse Event|16|||
155019491|NCT01841762|559499653|FG000|Treatment Period|Death|1|||
155019492|NCT01841762|559499653|FG000|Treatment Period|Withdrawal by Subject|7|||
155019493|NCT01841762|559499653|FG000|Treatment Period|Lost to Follow-up|1|||
155019494|NCT01841762|559499653|FG000|Treatment Period|Physician Decision|2|||
155019495|NCT01841762|559499653|FG000|Treatment Period|Other, including non-compliance|5|||
155019496|NCT01841762|559499653|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
155019497|NCT01841762|559499653|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
155019498|NCT01841762|559499653|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
155019499|NCT01841762|559499653|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
155019500|NCT06152224|559499660|FG000|Overall Study|Withdrawal by Subject|1|||
155019501|NCT06152224|559499661|FG001|Overall Study|Withdrawal by Subject|0|||
155019502|NCT06152224|559499660|FG000|Overall Study|Lost to Follow-up|0|||
155019503|NCT06152224|559499661|FG001|Overall Study|Lost to Follow-up|1|||
155019504|NCT06152224|559499660|FG000|Overall Study|On Follow Up|18|||
155019505|NCT06152224|559499661|FG001|Overall Study|On Follow Up|18|||
155019506|NCT06028438|559499662|FG000|Overall Study|Adverse Event|3|||
155019507|NCT06028438|559499663|FG001|Overall Study|Adverse Event|9|||
155019508|NCT06028438|559499662|FG000|Overall Study|Lack of Efficacy|1|||
155019509|NCT06028438|559499663|FG001|Overall Study|Lack of Efficacy|1|||
155019510|NCT06028438|559499662|FG000|Overall Study|Lost to Follow-up|1|||
155019511|NCT06028438|559499663|FG001|Overall Study|Lost to Follow-up|0|||
155019512|NCT06028438|559499662|FG000|Overall Study|Withdrawal by Subject|1|||
155019513|NCT06028438|559499663|FG001|Overall Study|Withdrawal by Subject|0|||
155019514|NCT06028438|559499662|FG000|Overall Study|Other|3|||
155019515|NCT06028438|559499663|FG001|Overall Study|Other|3|||
155019516|NCT05625802|559499664|FG000|Overall Study|Lost to Follow-up|1|||
155019517|NCT05625802|559499665|FG001|Overall Study|Lost to Follow-up|0|||
155019518|NCT02509507|559499666|FG000|Overall Study|Death|21|||
155019519|NCT02509507|559499667|FG001|Overall Study|Death|3|||
155019520|NCT02509507|559499668|FG002|Overall Study|Death|22|||
155019521|NCT02509507|559499669|FG003|Overall Study|Death|14|||
155019522|NCT02509507|559499670|FG004|Overall Study|Death|8|||
155019523|NCT02509507|559499671|FG005|Overall Study|Death|12|||
155019524|NCT02509507|559499672|FG006|Overall Study|Death|5|||
155179488|NCT01992159|560096319|FG001|Overall Study|Withdrawal by Subject|7|||
155179489|NCT01992159|560096320|FG002|Overall Study|Withdrawal by Subject|0|||
155179490|NCT01992159|560096321|FG003|Overall Study|Withdrawal by Subject|3|||
155019525|NCT02509507|559499673|FG007|Overall Study|Death|4|||
155019526|NCT02509507|559499674|FG008|Overall Study|Death|8|||
155019527|NCT02509507|559499666|FG000|Overall Study|Lost to Follow-up|0|||
155019528|NCT02509507|559499667|FG001|Overall Study|Lost to Follow-up|1|||
155019529|NCT02509507|559499668|FG002|Overall Study|Lost to Follow-up|0|||
155019530|NCT02509507|559499669|FG003|Overall Study|Lost to Follow-up|0|||
155019531|NCT02509507|559499670|FG004|Overall Study|Lost to Follow-up|0|||
155019532|NCT02509507|559499671|FG005|Overall Study|Lost to Follow-up|2|||
155019533|NCT02509507|559499672|FG006|Overall Study|Lost to Follow-up|0|||
155019534|NCT02509507|559499673|FG007|Overall Study|Lost to Follow-up|0|||
155019535|NCT02509507|559499674|FG008|Overall Study|Lost to Follow-up|0|||
155019536|NCT02509507|559499666|FG000|Overall Study|Withdrawal by Subject|2|||
155019537|NCT02509507|559499667|FG001|Overall Study|Withdrawal by Subject|0|||
155019538|NCT02509507|559499668|FG002|Overall Study|Withdrawal by Subject|1|||
155019539|NCT02509507|559499669|FG003|Overall Study|Withdrawal by Subject|4|||
155019540|NCT02509507|559499670|FG004|Overall Study|Withdrawal by Subject|1|||
155019541|NCT02509507|559499671|FG005|Overall Study|Withdrawal by Subject|3|||
155019542|NCT02509507|559499672|FG006|Overall Study|Withdrawal by Subject|4|||
155019543|NCT02509507|559499673|FG007|Overall Study|Withdrawal by Subject|0|||
155019544|NCT02509507|559499674|FG008|Overall Study|Withdrawal by Subject|1|||
155019545|NCT01954056|559499677|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
155019546|NCT01954056|559499678|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
155019547|NCT03337113|559499690|FG000|Overall Study|Adverse Event|1|||
155019548|NCT03337113|559499691|FG001|Overall Study|Adverse Event|1|||
155019549|NCT03337113|559499692|FG002|Overall Study|Adverse Event|0|||
155019550|NCT03337113|559499693|FG003|Overall Study|Adverse Event|1|||
155019551|NCT03337113|559499690|FG000|Overall Study|Physician Decision|0|||
155019552|NCT03337113|559499691|FG001|Overall Study|Physician Decision|2|||
155019553|NCT03337113|559499692|FG002|Overall Study|Physician Decision|0|||
155019554|NCT03337113|559499693|FG003|Overall Study|Physician Decision|1|||
155019555|NCT03337113|559499690|FG000|Overall Study|Withdrawal by Subject|0|||
155019556|NCT03337113|559499691|FG001|Overall Study|Withdrawal by Subject|0|||
155019557|NCT03337113|559499692|FG002|Overall Study|Withdrawal by Subject|1|||
155019558|NCT03337113|559499693|FG003|Overall Study|Withdrawal by Subject|0|||
155019559|NCT00628212|559499698|FG000|Overall Study|Adverse Event|2|||
155019560|NCT00628212|559499699|FG001|Overall Study|Adverse Event|0|||
155019561|NCT00628212|559499700|FG002|Overall Study|Adverse Event|1|||
155019562|NCT00628212|559499701|FG003|Overall Study|Adverse Event|2|||
155019563|NCT00628212|559499698|FG000|Overall Study|Physician Decision|1|||
155019564|NCT00628212|559499699|FG001|Overall Study|Physician Decision|1|||
155019565|NCT00628212|559499700|FG002|Overall Study|Physician Decision|2|||
155019566|NCT00628212|559499701|FG003|Overall Study|Physician Decision|3|||
155019567|NCT02490371|559499702|FG000|Overall Study|Lost to Follow-up|1|||
155019568|NCT02490371|559499703|FG001|Overall Study|Lost to Follow-up|1|||
155019569|NCT01073605|559499704|FG000|Overall Study|Ongoing at Cutoff Date|1|||
155019570|NCT01073605|559499705|FG001|Overall Study|Ongoing at Cutoff Date|1|||
155019571|NCT01073605|559499706|FG002|Overall Study|Ongoing at Cutoff Date|0|||
155019572|NCT01073605|559499704|FG000|Overall Study|Adverse Event|2|||
155019573|NCT01073605|559499705|FG001|Overall Study|Adverse Event|1|||
155019574|NCT01073605|559499706|FG002|Overall Study|Adverse Event|0|||
155019575|NCT01073605|559499704|FG000|Overall Study|Lost to Follow-up|3|||
155019576|NCT01073605|559499705|FG001|Overall Study|Lost to Follow-up|4|||
155019577|NCT01073605|559499706|FG002|Overall Study|Lost to Follow-up|9|||
155019578|NCT01073605|559499704|FG000|Overall Study|Other|25|||
155019579|NCT01073605|559499705|FG001|Overall Study|Other|21|||
155019580|NCT01073605|559499706|FG002|Overall Study|Other|29|||
155019581|NCT01073605|559499704|FG000|Overall Study|Withdrawal by Subject|31|||
155019582|NCT01073605|559499705|FG001|Overall Study|Withdrawal by Subject|39|||
155019583|NCT01073605|559499706|FG002|Overall Study|Withdrawal by Subject|22|||
155019584|NCT01073605|559499704|FG000|Overall Study|Randomized But Not Treated|0|||
155019585|NCT01073605|559499705|FG001|Overall Study|Randomized But Not Treated|1|||
155019586|NCT01073605|559499706|FG002|Overall Study|Randomized But Not Treated|1|||
155019587|NCT03018080|559499707|FG000|Overall Study|Death|12|||
155019588|NCT03018080|559499708|FG001|Overall Study|Death|19|||
155019589|NCT03491462|559499709|FG000|Overall Study|Lost to Follow-up|2|||
155019590|NCT03491462|559499710|FG001|Overall Study|Lost to Follow-up|0|||
155019591|NCT03491462|559499709|FG000|Overall Study|Adverse Event|11|||
155019592|NCT03491462|559499710|FG001|Overall Study|Adverse Event|1|||
155019593|NCT03491462|559499709|FG000|Overall Study|Physician Decision|3|||
155019594|NCT03491462|559499710|FG001|Overall Study|Physician Decision|0|||
155019595|NCT03491462|559499709|FG000|Overall Study|Withdrawal by Subject|22|||
155019596|NCT03491462|559499710|FG001|Overall Study|Withdrawal by Subject|15|||
155019597|NCT00740792|559499711|FG000|Overall Study|Adverse Event|3|||
155019598|NCT00740792|559499712|FG001|Overall Study|Adverse Event|1|||
155019599|NCT00740792|559499713|FG002|Overall Study|Adverse Event|1|||
155019600|NCT00740792|559499714|FG003|Overall Study|Adverse Event|3|||
155019601|NCT00740792|559499711|FG000|Overall Study|Lack of Efficacy|1|||
155019602|NCT00740792|559499712|FG001|Overall Study|Lack of Efficacy|1|||
155019603|NCT00740792|559499713|FG002|Overall Study|Lack of Efficacy|0|||
155019604|NCT00740792|559499714|FG003|Overall Study|Lack of Efficacy|3|||
155019605|NCT00740792|559499711|FG000|Overall Study|Lost to Follow-up|2|||
155019606|NCT00740792|559499712|FG001|Overall Study|Lost to Follow-up|1|||
155019607|NCT00740792|559499713|FG002|Overall Study|Lost to Follow-up|0|||
155019608|NCT00740792|559499714|FG003|Overall Study|Lost to Follow-up|0|||
155019609|NCT00740792|559499711|FG000|Overall Study|Protocol Violation|0|||
155019610|NCT00740792|559499712|FG001|Overall Study|Protocol Violation|1|||
155019611|NCT00740792|559499713|FG002|Overall Study|Protocol Violation|0|||
155019612|NCT00740792|559499714|FG003|Overall Study|Protocol Violation|2|||
155019613|NCT00740792|559499711|FG000|Overall Study|Withdrawal by Subject|1|||
155019614|NCT00740792|559499712|FG001|Overall Study|Withdrawal by Subject|1|||
155019615|NCT00740792|559499713|FG002|Overall Study|Withdrawal by Subject|0|||
155019616|NCT00740792|559499714|FG003|Overall Study|Withdrawal by Subject|0|||
155019617|NCT00740792|559499711|FG000|Overall Study|administrative|3|||
155019618|NCT00740792|559499712|FG001|Overall Study|administrative|3|||
155139165|NCT02128724|559942664|FG003|Overall Study|Death|0|||
155139166|NCT02128724|559942661|FG000|Overall Study|Adverse Event|0|||
155139167|NCT02128724|559942662|FG001|Overall Study|Adverse Event|1|||
155139168|NCT02128724|559942663|FG002|Overall Study|Adverse Event|0|||
155139169|NCT02128724|559942664|FG003|Overall Study|Adverse Event|0|||
155139170|NCT02128724|559942661|FG000|Overall Study|Physician Decision|0|||
155139171|NCT02128724|559942662|FG001|Overall Study|Physician Decision|0|||
155139172|NCT02128724|559942663|FG002|Overall Study|Physician Decision|0|||
155139173|NCT02128724|559942664|FG003|Overall Study|Physician Decision|2|||
155139174|NCT02128724|559942661|FG000|Overall Study|Withdrawal by Subject|0|||
155139175|NCT02128724|559942662|FG001|Overall Study|Withdrawal by Subject|0|||
155139176|NCT02128724|559942663|FG002|Overall Study|Withdrawal by Subject|0|||
155139177|NCT02128724|559942664|FG003|Overall Study|Withdrawal by Subject|1|||
155139178|NCT02751580|559942666|FG000|Overall Study|Lost to Follow-up|4|||
155139179|NCT02751580|559942666|FG000|Overall Study|Death|2|||
155139180|NCT02588261|559942667|FG000|Overall Study|Study Terminated by Sponsor|157|||
155139181|NCT02588261|559942668|FG001|Overall Study|Study Terminated by Sponsor|142|||
155139182|NCT02588261|559942667|FG000|Overall Study|Protocol Deviation|1|||
155139183|NCT02588261|559942668|FG001|Overall Study|Protocol Deviation|0|||
155139184|NCT02588261|559942667|FG000|Overall Study|Death|1|||
155139185|NCT02588261|559942668|FG001|Overall Study|Death|2|||
155139186|NCT02588261|559942667|FG000|Overall Study|Withdrawal by Subject|12|||
155139187|NCT02588261|559942668|FG001|Overall Study|Withdrawal by Subject|8|||
155139188|NCT02588261|559942667|FG000|Overall Study|Noncompliance with Study Drug|0|||
155139189|NCT02588261|559942668|FG001|Overall Study|Noncompliance with Study Drug|1|||
155139190|NCT02588261|559942667|FG000|Overall Study|Miscellaneous|5|||
155139191|NCT02588261|559942668|FG001|Overall Study|Miscellaneous|4|||
155139192|NCT02588261|559942667|FG000|Overall Study|Progressive Disease|61|||
155139193|NCT02588261|559942668|FG001|Overall Study|Progressive Disease|82|||
155139194|NCT02588261|559942667|FG000|Overall Study|Adverse Event|29|||
155139195|NCT02588261|559942668|FG001|Overall Study|Adverse Event|24|||
155139196|NCT02588261|559942667|FG000|Overall Study|Lost to Follow-up|1|||
155139197|NCT02588261|559942668|FG001|Overall Study|Lost to Follow-up|0|||
155139198|NCT04829916|559942669|FG000|Overall Study|Withdrawal by Subject|1|||
155139199|NCT04829916|559942670|FG001|Overall Study|Withdrawal by Subject|0|||
155139200|NCT02287467|559942671|FG000|Overall Study|Protocol Violation|12|||
155139201|NCT02287467|559942672|FG001|Overall Study|Protocol Violation|9|||
155139202|NCT04343755|559942673|FG000|Overall Study|Death|11|||
155139203|NCT04343755|559942673|FG000|Overall Study|Screen Failure|1|||
155139204|NCT02292446|559942674|FG000|Overall Study|Adverse Event|12|||
155139205|NCT02292446|559942674|FG000|Overall Study|Death|1|||
155139206|NCT02292446|559942674|FG000|Overall Study|Disease progression|2|||
155139207|NCT02292446|559942674|FG000|Overall Study|Subject/guardian decision|2|||
155139208|NCT02292446|559942674|FG000|Overall Study|Withdrawal by Subject|3|||
155139209|NCT05292131|559942676|FG000|Overall Study|Lost to Follow-up|1|||
155139210|NCT05292131|559942677|FG001|Overall Study|Lost to Follow-up|1|||
155139211|NCT05292131|559942676|FG000|Overall Study|Withdrawal by Subject|0|||
155139212|NCT05292131|559942677|FG001|Overall Study|Withdrawal by Subject|1|||
155139213|NCT01345188|559942678|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
155019619|NCT00740792|559499713|FG002|Overall Study|administrative|8|||
155019620|NCT00740792|559499714|FG003|Overall Study|administrative|2|||
155019621|NCT01019694|559499721|FG000|Overall Study|Adverse Event|12|||
155139214|NCT01345188|559942678|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
155139215|NCT04526145|559942679|FG000|Overall Study|Withdrawal by Subject|5|||
155139216|NCT03364738|559942686|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
155139217|NCT03364738|559942686|FG000|Overall Study|Withdrawal by Subject|1|||
155139218|NCT03364738|559942686|FG000|Overall Study|Adverse Event|1|||
155139219|NCT03245398|559942687|FG000|Overall Study|Travelled to another island|1|||
155139220|NCT03245398|559942688|FG001|Overall Study|Travelled to another island|0|||
155139221|NCT02735343|559942689|FG000|Overall Study|screen fail|0|||
155139222|NCT02735343|559942690|FG001|Overall Study|screen fail|2|||
155139223|NCT01625000|559942695|FG000|Overall Study|Physician Decision|15|||
155019622|NCT01019694|559499722|FG001|Overall Study|Adverse Event|16|||
155019623|NCT01019694|559499723|FG002|Overall Study|Adverse Event|19|||
155019624|NCT01019694|559499721|FG000|Overall Study|Protocol Violation|2|||
155019625|NCT01019694|559499722|FG001|Overall Study|Protocol Violation|6|||
155019626|NCT01019694|559499723|FG002|Overall Study|Protocol Violation|4|||
155019627|NCT01019694|559499721|FG000|Overall Study|Lost to Follow-up|5|||
155019628|NCT01019694|559499722|FG001|Overall Study|Lost to Follow-up|3|||
155019629|NCT01019694|559499723|FG002|Overall Study|Lost to Follow-up|3|||
155019630|NCT01019694|559499721|FG000|Overall Study|Withdrawal by Subject|4|||
155019631|NCT01019694|559499722|FG001|Overall Study|Withdrawal by Subject|6|||
155019632|NCT01019694|559499723|FG002|Overall Study|Withdrawal by Subject|12|||
155019633|NCT01019694|559499721|FG000|Overall Study|Not treated|0|||
155019634|NCT01019694|559499722|FG001|Overall Study|Not treated|2|||
155019635|NCT01019694|559499723|FG002|Overall Study|Not treated|3|||
155019636|NCT01019694|559499721|FG000|Overall Study|Other reason (not specified)|1|||
155019637|NCT01019694|559499722|FG001|Overall Study|Other reason (not specified)|5|||
155019638|NCT01019694|559499723|FG002|Overall Study|Other reason (not specified)|6|||
155019639|NCT00026494|559499726|FG000|Overall Study|Withdrawal by Subject|1|||
155019640|NCT00026494|559499727|FG001|Overall Study|Withdrawal by Subject|0|||
155019641|NCT00026494|559499728|FG002|Overall Study|Withdrawal by Subject|1|||
155019642|NCT00026494|559499729|FG003|Overall Study|Withdrawal by Subject|0|||
155019643|NCT00026494|559499726|FG000|Overall Study|Patient non-compliance|1|||
155019644|NCT00026494|559499727|FG001|Overall Study|Patient non-compliance|0|||
155019645|NCT00026494|559499728|FG002|Overall Study|Patient non-compliance|0|||
155019646|NCT00026494|559499729|FG003|Overall Study|Patient non-compliance|0|||
155019647|NCT00026494|559499726|FG000|Overall Study|Patient not treated|0|||
155019648|NCT00026494|559499727|FG001|Overall Study|Patient not treated|0|||
155019649|NCT00026494|559499728|FG002|Overall Study|Patient not treated|2|||
155019650|NCT00026494|559499729|FG003|Overall Study|Patient not treated|0|||
155019651|NCT00026494|559499726|FG000|Overall Study|Clinical progression|0|||
155019652|NCT00026494|559499727|FG001|Overall Study|Clinical progression|0|||
155019653|NCT00026494|559499728|FG002|Overall Study|Clinical progression|3|||
155019654|NCT00026494|559499729|FG003|Overall Study|Clinical progression|0|||
155019655|NCT00441129|559499730|FG000|Overall Study|Withdrawal by Subject|6|||
155019656|NCT00441129|559499731|FG001|Overall Study|Withdrawal by Subject|14|||
155019657|NCT01455597|559499732|FG000|Overall Study|Adverse Event|7|||
155019658|NCT01455597|559499733|FG001|Overall Study|Adverse Event|0|||
155019659|NCT01455597|559499734|FG002|Overall Study|Adverse Event|5|||
155019660|NCT01455597|559499735|FG003|Overall Study|Adverse Event|1|||
155019661|NCT01455597|559499732|FG000|Overall Study|Lack of Efficacy|0|||
155019662|NCT01455597|559499733|FG001|Overall Study|Lack of Efficacy|1|||
155139224|NCT01625000|559942696|FG001|Overall Study|Physician Decision|7|||
155139225|NCT01625000|559942697|FG002|Overall Study|Physician Decision|7|||
155139226|NCT01625000|559942698|FG003|Overall Study|Physician Decision|2|||
155139227|NCT01625000|559942699|FG004|Overall Study|Physician Decision|15|||
155139228|NCT01625000|559942695|FG000|Overall Study|Protocol Violation|3|||
155139229|NCT01625000|559942696|FG001|Overall Study|Protocol Violation|10|||
155139230|NCT01625000|559942697|FG002|Overall Study|Protocol Violation|4|||
155139231|NCT01625000|559942698|FG003|Overall Study|Protocol Violation|1|||
155139232|NCT01625000|559942699|FG004|Overall Study|Protocol Violation|2|||
155139233|NCT01625000|559942695|FG000|Overall Study|Withdrawal by Subject|19|||
155139234|NCT01625000|559942696|FG001|Overall Study|Withdrawal by Subject|16|||
155139235|NCT01625000|559942697|FG002|Overall Study|Withdrawal by Subject|11|||
155139236|NCT01625000|559942698|FG003|Overall Study|Withdrawal by Subject|9|||
155139237|NCT01625000|559942699|FG004|Overall Study|Withdrawal by Subject|17|||
155139238|NCT01625000|559942695|FG000|Overall Study|Adverse Event (including Death)|15|||
155139239|NCT01625000|559942696|FG001|Overall Study|Adverse Event (including Death)|19|||
155139240|NCT01625000|559942697|FG002|Overall Study|Adverse Event (including Death)|11|||
155139241|NCT01625000|559942698|FG003|Overall Study|Adverse Event (including Death)|7|||
155139242|NCT01625000|559942699|FG004|Overall Study|Adverse Event (including Death)|21|||
155139243|NCT00566852|559942700|FG000|Overall Study|Protocol Violation|22|||
155139244|NCT00566852|559942701|FG001|Overall Study|Protocol Violation|24|||
155139245|NCT00566852|559942700|FG000|Overall Study|Death|95|||
155139246|NCT00566852|559942701|FG001|Overall Study|Death|78|||
155139247|NCT00566852|559942700|FG000|Overall Study|Withdrawal by Subject|30|||
155139248|NCT00566852|559942701|FG001|Overall Study|Withdrawal by Subject|25|||
155139249|NCT00566852|559942700|FG000|Overall Study|Patient refusal|37|||
155139250|NCT00566852|559942701|FG001|Overall Study|Patient refusal|37|||
155139251|NCT00566852|559942700|FG000|Overall Study|Not tested due to disability|6|||
155139252|NCT00566852|559942701|FG001|Overall Study|Not tested due to disability|12|||
155139253|NCT00566852|559942700|FG000|Overall Study|Missing reason not specified|1|||
155139254|NCT00566852|559942701|FG001|Overall Study|Missing reason not specified|2|||
155139255|NCT00566852|559942700|FG000|Overall Study|Missing reason not reported|16|||
155139256|NCT00566852|559942701|FG001|Overall Study|Missing reason not reported|20|||
155139257|NCT00132808|559942702|FG000|Stratum I|Adverse Event|2|||
155139258|NCT00132808|559942703|FG001|Stratum I|Adverse Event|1|||
155139259|NCT00132808|559942704|FG002|Stratum I|Adverse Event|0|||
155139260|NCT00132808|559942702|FG000|Stratum I|Lost to Follow-up|3|||
155019663|NCT01455597|559499734|FG002|Overall Study|Lack of Efficacy|2|||
155019664|NCT01455597|559499735|FG003|Overall Study|Lack of Efficacy|0|||
155019665|NCT01455597|559499732|FG000|Overall Study|Lost to Follow-up|3|||
155019666|NCT01455597|559499733|FG001|Overall Study|Lost to Follow-up|0|||
155019667|NCT01455597|559499734|FG002|Overall Study|Lost to Follow-up|2|||
155019668|NCT01455597|559499735|FG003|Overall Study|Lost to Follow-up|1|||
155019669|NCT01455597|559499732|FG000|Overall Study|Withdrew Consent|6|||
155019670|NCT01455597|559499733|FG001|Overall Study|Withdrew Consent|5|||
155019671|NCT01455597|559499734|FG002|Overall Study|Withdrew Consent|8|||
155019672|NCT01455597|559499735|FG003|Overall Study|Withdrew Consent|5|||
155019673|NCT01455597|559499732|FG000|Overall Study|Reason not Specified|1|||
155019674|NCT01455597|559499733|FG001|Overall Study|Reason not Specified|2|||
155019675|NCT01455597|559499734|FG002|Overall Study|Reason not Specified|3|||
155019676|NCT01455597|559499735|FG003|Overall Study|Reason not Specified|3|||
155019677|NCT01737710|559499737|FG000|Overall Study|Lost to Follow-up|0|||
155019678|NCT01737710|559499738|FG001|Overall Study|Lost to Follow-up|2|||
155019679|NCT01737710|559499739|FG002|Overall Study|Lost to Follow-up|2|||
155019680|NCT01737710|559499740|FG003|Overall Study|Lost to Follow-up|0|||
155019681|NCT01737710|559499741|FG004|Overall Study|Lost to Follow-up|0|||
155019682|NCT01737710|559499737|FG000|Overall Study|Withdrawal by Subject|1|||
155019683|NCT01737710|559499738|FG001|Overall Study|Withdrawal by Subject|1|||
155019684|NCT01737710|559499739|FG002|Overall Study|Withdrawal by Subject|1|||
155019685|NCT01737710|559499740|FG003|Overall Study|Withdrawal by Subject|0|||
155019686|NCT01737710|559499741|FG004|Overall Study|Withdrawal by Subject|0|||
155019687|NCT01737710|559499737|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
155019688|NCT01737710|559499738|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
155019689|NCT01737710|559499739|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
155019690|NCT01737710|559499740|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
155019691|NCT01737710|559499741|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
155019692|NCT03412734|559499745|FG000|Overall Study|Incorrect labeling of samples|2|||
155019693|NCT03412734|559499746|FG001|Overall Study|Incorrect labeling of samples|0|||
155019694|NCT03412734|559499745|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
155019695|NCT03412734|559499746|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
155019696|NCT00423332|559499747|FG000|Overall Study|Adverse Event|6|||
155019697|NCT00423332|559499748|FG001|Overall Study|Adverse Event|2|||
155019698|NCT00423332|559499747|FG000|Overall Study|Withdrawal by Subject|1|||
155019699|NCT00423332|559499748|FG001|Overall Study|Withdrawal by Subject|0|||
155019700|NCT00423332|559499747|FG000|Overall Study|Condition under investigation worsened|1|||
155019701|NCT00423332|559499748|FG001|Overall Study|Condition under investigation worsened|1|||
155019702|NCT00423332|559499747|FG000|Overall Study|Progressive at Week 6|0|||
155019703|NCT00423332|559499748|FG001|Overall Study|Progressive at Week 6|1|||
155019704|NCT00423332|559499747|FG000|Overall Study|Unblinded before 12 weeks|1|||
155019705|NCT00423332|559499748|FG001|Overall Study|Unblinded before 12 weeks|3|||
155019706|NCT03777436|559499752|FG000|Placebo-controlled Phase|Adverse Event|8|||
155019707|NCT03777436|559499753|FG001|Placebo-controlled Phase|Adverse Event|10|||
155019708|NCT03777436|559499754|FG002|Placebo-controlled Phase|Adverse Event|0|||
155019709|NCT03777436|559499752|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
155019710|NCT03777436|559499753|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
155019711|NCT03777436|559499754|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
155019712|NCT03777436|559499752|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
155019713|NCT03777436|559499753|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
155019714|NCT03777436|559499754|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
155019715|NCT03777436|559499752|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
155019716|NCT03777436|559499753|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
155019717|NCT03777436|559499754|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
155019718|NCT03777436|559499752|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
155019719|NCT03777436|559499753|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
155019720|NCT03777436|559499754|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
155019721|NCT03777436|559499752|FG000|Placebo-controlled Phase|Physician Decision|0|||
155019722|NCT03777436|559499753|FG001|Placebo-controlled Phase|Physician Decision|1|||
155019723|NCT03777436|559499754|FG002|Placebo-controlled Phase|Physician Decision|0|||
155019724|NCT03777436|559499752|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
155139261|NCT00132808|559942703|FG001|Stratum I|Lost to Follow-up|4|||
155139262|NCT00132808|559942704|FG002|Stratum I|Lost to Follow-up|1|||
155139263|NCT00132808|559942702|FG000|Stratum I|Withdrawal by Subject|4|||
155139264|NCT00132808|559942703|FG001|Stratum I|Withdrawal by Subject|7|||
155019725|NCT03777436|559499753|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
155019726|NCT03777436|559499754|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
155019727|NCT03777436|559499752|FG000|Apremilast Extension Phase|Adverse Event|0|||
155019728|NCT03777436|559499753|FG001|Apremilast Extension Phase|Adverse Event|0|||
155019729|NCT03777436|559499754|FG002|Apremilast Extension Phase|Adverse Event|6|||
155019730|NCT03777436|559499752|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
155019731|NCT03777436|559499753|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
155139265|NCT00132808|559942704|FG002|Stratum I|Withdrawal by Subject|3|||
155019732|NCT03777436|559499754|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
155019733|NCT03777436|559499752|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
155019734|NCT03777436|559499753|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
155019735|NCT03777436|559499754|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
155019736|NCT03777436|559499752|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
155019737|NCT03777436|559499753|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
155019738|NCT03777436|559499754|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
155019739|NCT03777436|559499752|FG000|Apremilast Extension Phase|Miscellaneous|0|||
155019740|NCT03777436|559499753|FG001|Apremilast Extension Phase|Miscellaneous|0|||
155019741|NCT03777436|559499754|FG002|Apremilast Extension Phase|Miscellaneous|1|||
155019742|NCT02035202|559499755|FG000|Overall Study|Lost to Follow-up|8|||
155019743|NCT02035202|559499756|FG001|Overall Study|Lost to Follow-up|16|||
155019744|NCT02035202|559499757|FG002|Overall Study|Lost to Follow-up|2|||
155019745|NCT00685399|559499759|FG000|Treatment Period 1|Withdrawal by Subject|2|||
155019746|NCT00685399|559499760|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155019747|NCT00685399|559499761|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155019748|NCT00685399|559499762|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155019749|NCT00685399|559499763|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155019750|NCT00685399|559499764|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155019751|NCT00685399|559499765|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155019752|NCT00685399|559499766|FG007|Treatment Period 1|Withdrawal by Subject|0|||
155019753|NCT00685399|559499759|FG000|Treatment Period 1|Protocol Violation|1|||
155019754|NCT00685399|559499760|FG001|Treatment Period 1|Protocol Violation|0|||
155019755|NCT00685399|559499761|FG002|Treatment Period 1|Protocol Violation|0|||
155019756|NCT00685399|559499762|FG003|Treatment Period 1|Protocol Violation|0|||
155019757|NCT00685399|559499763|FG004|Treatment Period 1|Protocol Violation|0|||
155019758|NCT00685399|559499764|FG005|Treatment Period 1|Protocol Violation|0|||
155019759|NCT00685399|559499765|FG006|Treatment Period 1|Protocol Violation|0|||
155019760|NCT00685399|559499766|FG007|Treatment Period 1|Protocol Violation|0|||
155019761|NCT00685399|559499759|FG000|Treatment Period 1|Administrative|2|||
155019762|NCT00685399|559499760|FG001|Treatment Period 1|Administrative|0|||
155019763|NCT00685399|559499761|FG002|Treatment Period 1|Administrative|0|||
155019764|NCT00685399|559499762|FG003|Treatment Period 1|Administrative|0|||
155019765|NCT00685399|559499763|FG004|Treatment Period 1|Administrative|0|||
155019766|NCT00685399|559499764|FG005|Treatment Period 1|Administrative|0|||
155019767|NCT00685399|559499765|FG006|Treatment Period 1|Administrative|0|||
155019768|NCT00685399|559499766|FG007|Treatment Period 1|Administrative|0|||
155019769|NCT00685399|559499759|FG000|Treatment Period 1|Lack of Efficacy|1|||
155019770|NCT00685399|559499760|FG001|Treatment Period 1|Lack of Efficacy|0|||
155019771|NCT00685399|559499761|FG002|Treatment Period 1|Lack of Efficacy|0|||
155019772|NCT00685399|559499762|FG003|Treatment Period 1|Lack of Efficacy|0|||
155019773|NCT00685399|559499763|FG004|Treatment Period 1|Lack of Efficacy|0|||
155019774|NCT00685399|559499764|FG005|Treatment Period 1|Lack of Efficacy|0|||
155019775|NCT00685399|559499765|FG006|Treatment Period 1|Lack of Efficacy|0|||
155019776|NCT00685399|559499766|FG007|Treatment Period 1|Lack of Efficacy|0|||
155019777|NCT00685399|559499759|FG000|Treatment Period 2|Administrative Problems|0|||
155019778|NCT00685399|559499760|FG001|Treatment Period 2|Administrative Problems|2|||
155019779|NCT00685399|559499761|FG002|Treatment Period 2|Administrative Problems|1|||
155019780|NCT00685399|559499762|FG003|Treatment Period 2|Administrative Problems|0|||
155019781|NCT00685399|559499763|FG004|Treatment Period 2|Administrative Problems|0|||
155019782|NCT00685399|559499764|FG005|Treatment Period 2|Administrative Problems|0|||
155019783|NCT00685399|559499765|FG006|Treatment Period 2|Administrative Problems|0|||
155019784|NCT00685399|559499766|FG007|Treatment Period 2|Administrative Problems|0|||
155019785|NCT00685399|559499759|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155019786|NCT00685399|559499760|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155019787|NCT00685399|559499761|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155019788|NCT00685399|559499762|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155019789|NCT00685399|559499763|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155019790|NCT00685399|559499764|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155019791|NCT00685399|559499765|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155019792|NCT00685399|559499766|FG007|Treatment Period 2|Withdrawal by Subject|2|||
155019793|NCT00685399|559499759|FG000|Treatment Period 2|Adverse Event|0|||
155019794|NCT00685399|559499760|FG001|Treatment Period 2|Adverse Event|0|||
155019795|NCT00685399|559499761|FG002|Treatment Period 2|Adverse Event|0|||
155019796|NCT00685399|559499762|FG003|Treatment Period 2|Adverse Event|0|||
155019797|NCT00685399|559499763|FG004|Treatment Period 2|Adverse Event|0|||
155019798|NCT00685399|559499764|FG005|Treatment Period 2|Adverse Event|1|||
155019799|NCT00685399|559499765|FG006|Treatment Period 2|Adverse Event|0|||
155019800|NCT00685399|559499766|FG007|Treatment Period 2|Adverse Event|0|||
155019801|NCT00685399|559499759|FG000|Treatment Period 2|Lack of Efficacy|0|||
155019802|NCT00685399|559499760|FG001|Treatment Period 2|Lack of Efficacy|10|||
155019803|NCT00685399|559499761|FG002|Treatment Period 2|Lack of Efficacy|2|||
155019804|NCT00685399|559499762|FG003|Treatment Period 2|Lack of Efficacy|0|||
155019805|NCT00685399|559499763|FG004|Treatment Period 2|Lack of Efficacy|0|||
155019806|NCT00685399|559499764|FG005|Treatment Period 2|Lack of Efficacy|1|||
155179491|NCT01992159|560096318|FG000|Overall Study|Adverse Event|0|||
155019807|NCT00685399|559499765|FG006|Treatment Period 2|Lack of Efficacy|0|||
155019808|NCT00685399|559499766|FG007|Treatment Period 2|Lack of Efficacy|0|||
155019809|NCT00685399|559499759|FG000|Extension|Administrative Issues|0|||
155019810|NCT00685399|559499760|FG001|Extension|Administrative Issues|0|||
155019811|NCT00685399|559499761|FG002|Extension|Administrative Issues|0|||
155019812|NCT00685399|559499762|FG003|Extension|Administrative Issues|1|||
155019813|NCT00685399|559499763|FG004|Extension|Administrative Issues|0|||
155019814|NCT00685399|559499764|FG005|Extension|Administrative Issues|0|||
155019815|NCT00685399|559499765|FG006|Extension|Administrative Issues|0|||
155019816|NCT00685399|559499766|FG007|Extension|Administrative Issues|0|||
155019817|NCT00685399|559499759|FG000|Extension|Withdrawal by Subject|0|||
155019818|NCT00685399|559499760|FG001|Extension|Withdrawal by Subject|0|||
155019819|NCT00685399|559499761|FG002|Extension|Withdrawal by Subject|0|||
155019820|NCT00685399|559499762|FG003|Extension|Withdrawal by Subject|1|||
155019821|NCT00685399|559499763|FG004|Extension|Withdrawal by Subject|0|||
155019822|NCT00685399|559499764|FG005|Extension|Withdrawal by Subject|0|||
155019823|NCT00685399|559499765|FG006|Extension|Withdrawal by Subject|0|||
155019824|NCT00685399|559499766|FG007|Extension|Withdrawal by Subject|0|||
155019825|NCT00685399|559499759|FG000|Extension|Protocol Violation|0|||
155019826|NCT00685399|559499760|FG001|Extension|Protocol Violation|0|||
155019827|NCT00685399|559499761|FG002|Extension|Protocol Violation|0|||
155019828|NCT00685399|559499762|FG003|Extension|Protocol Violation|1|||
155019829|NCT00685399|559499763|FG004|Extension|Protocol Violation|0|||
155019830|NCT00685399|559499764|FG005|Extension|Protocol Violation|0|||
155019831|NCT00685399|559499765|FG006|Extension|Protocol Violation|0|||
155019832|NCT00685399|559499766|FG007|Extension|Protocol Violation|0|||
155019833|NCT00685399|559499759|FG000|Extension|Lack of Efficacy|0|||
155019834|NCT00685399|559499760|FG001|Extension|Lack of Efficacy|0|||
155019835|NCT00685399|559499761|FG002|Extension|Lack of Efficacy|0|||
155019836|NCT00685399|559499762|FG003|Extension|Lack of Efficacy|2|||
155019837|NCT00685399|559499763|FG004|Extension|Lack of Efficacy|0|||
155019838|NCT00685399|559499764|FG005|Extension|Lack of Efficacy|0|||
155019839|NCT00685399|559499765|FG006|Extension|Lack of Efficacy|0|||
155019840|NCT00685399|559499766|FG007|Extension|Lack of Efficacy|0|||
155019841|NCT00685399|559499759|FG000|Extension|Adverse Event|0|||
155019842|NCT00685399|559499760|FG001|Extension|Adverse Event|0|||
155019843|NCT00685399|559499761|FG002|Extension|Adverse Event|0|||
155019844|NCT00685399|559499762|FG003|Extension|Adverse Event|2|||
155019845|NCT00685399|559499763|FG004|Extension|Adverse Event|0|||
155019846|NCT00685399|559499764|FG005|Extension|Adverse Event|0|||
155019847|NCT00685399|559499765|FG006|Extension|Adverse Event|0|||
155019848|NCT00685399|559499766|FG007|Extension|Adverse Event|0|||
155019849|NCT00758485|559499767|FG000|Overall Study|Lost to Follow-up|0|||
155019850|NCT00758485|559499768|FG001|Overall Study|Lost to Follow-up|1|||
155019851|NCT00758485|559499767|FG000|Overall Study|Not Treated|1|||
155019852|NCT00758485|559499768|FG001|Overall Study|Not Treated|2|||
155019853|NCT00656292|559499769|FG000|Overall Study|Withdrawal by Subject|2|||
155019854|NCT00656292|559499770|FG001|Overall Study|Withdrawal by Subject|3|||
155019855|NCT00656292|559499769|FG000|Overall Study|Screen failure|1|||
155019856|NCT00656292|559499770|FG001|Overall Study|Screen failure|2|||
155019857|NCT00921557|559499771|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
155019858|NCT00921557|559499772|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
155019859|NCT00921557|559499773|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
155019860|NCT00921557|559499771|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
155019861|NCT00921557|559499772|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
155019862|NCT00921557|559499773|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
155019863|NCT00921557|559499771|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
155019864|NCT00921557|559499772|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
155019865|NCT00921557|559499773|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
155019866|NCT00921557|559499771|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
155019867|NCT00921557|559499772|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
155019868|NCT00921557|559499773|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
155179492|NCT01992159|560096319|FG001|Overall Study|Adverse Event|1|||
155019869|NCT00921557|559499771|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
155019870|NCT00921557|559499772|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
155019871|NCT00921557|559499773|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
155019872|NCT03259425|559499774|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
155019873|NCT00812981|559499780|FG000|Overall Study|Other|0|||
155019874|NCT00812981|559499781|FG001|Overall Study|Other|1|||
155019875|NCT04666259|559499784|FG000|Treatment Phase|Physician Decision|9|||
155019876|NCT04666259|559499785|FG001|Treatment Phase|Physician Decision|3|||
155179493|NCT01992159|560096320|FG002|Overall Study|Adverse Event|0|||
155019877|NCT04666259|559499786|FG002|Treatment Phase|Physician Decision|3|||
155019878|NCT04666259|559499784|FG000|Treatment Phase|Adverse Event|3|||
155019879|NCT04666259|559499785|FG001|Treatment Phase|Adverse Event|1|||
155019880|NCT04666259|559499786|FG002|Treatment Phase|Adverse Event|0|||
155019881|NCT04666259|559499784|FG000|Treatment Phase|Subject decision|1|||
155019882|NCT04666259|559499785|FG001|Treatment Phase|Subject decision|2|||
155019883|NCT04666259|559499786|FG002|Treatment Phase|Subject decision|0|||
155019884|NCT04666259|559499784|FG000|Treatment Phase|Progressive disease|0|||
155019885|NCT04666259|559499785|FG001|Treatment Phase|Progressive disease|1|||
155019886|NCT04666259|559499786|FG002|Treatment Phase|Progressive disease|0|||
155019887|NCT04666259|559499784|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
155019888|NCT04666259|559499785|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
155019889|NCT04666259|559499786|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
155019890|NCT04666259|559499784|FG000|Safety Follow-up Phase|Physician Decision|2|||
155019891|NCT04666259|559499785|FG001|Safety Follow-up Phase|Physician Decision|0|||
155019892|NCT04666259|559499786|FG002|Safety Follow-up Phase|Physician Decision|0|||
155019893|NCT04666259|559499784|FG000|Safety Follow-up Phase|Subject decision|1|||
155019894|NCT04666259|559499785|FG001|Safety Follow-up Phase|Subject decision|0|||
155019895|NCT04666259|559499786|FG002|Safety Follow-up Phase|Subject decision|0|||
155019896|NCT04666259|559499784|FG000|Safety Follow-up Phase|Death|0|||
155019897|NCT04666259|559499785|FG001|Safety Follow-up Phase|Death|1|||
155019898|NCT04666259|559499786|FG002|Safety Follow-up Phase|Death|0|||
155019899|NCT04178122|559499787|FG000|Overall Study|Withdrawal by Subject|1|||
155019900|NCT04178122|559499788|FG001|Overall Study|Withdrawal by Subject|1|||
155019901|NCT04178122|559499787|FG000|Overall Study|Death|2|||
155019902|NCT04178122|559499788|FG001|Overall Study|Death|0|||
155019903|NCT04178122|559499787|FG000|Overall Study|Did not complete testing|3|||
155019904|NCT04178122|559499788|FG001|Overall Study|Did not complete testing|13|||
155019905|NCT02684097|559499789|FG000|Overall Study|Lack of Efficacy|13|||
155019906|NCT02684097|559499790|FG001|Overall Study|Lack of Efficacy|6|||
155019907|NCT00462709|559499791|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
155019908|NCT00462709|559499791|FG000|Overall Study|Lost to Follow-up|10|||
155019909|NCT00462709|559499791|FG000|Overall Study|Withdrawal by Subject|8|||
155019910|NCT00462709|559499791|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
155019911|NCT00462709|559499791|FG000|Overall Study|Death|2|||
155019912|NCT00462709|559499791|FG000|Overall Study|Logistical reasons|2|||
155019913|NCT00462709|559499791|FG000|Overall Study|Physician Decision|1|||
155019914|NCT00462709|559499791|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
155019915|NCT00425750|559499792|FG000|Overall Study|Death|1|||
155019916|NCT00425750|559499792|FG000|Overall Study|Withdrawal by Subject|3|||
155019917|NCT00425750|559499792|FG000|Overall Study|Adverse Event|3|||
155019918|NCT00425750|559499792|FG000|Overall Study|Progression of disease|18|||
155019919|NCT04339062|559499793|FG000|Overall Study|Death|0|||
155019920|NCT04339062|559499794|FG001|Overall Study|Death|1|||
155019921|NCT01197534|559499795|FG000|Overall Study|Not reported|16|||
155019922|NCT01197534|559499796|FG001|Overall Study|Not reported|10|||
155019923|NCT01197534|559499797|FG002|Overall Study|Not reported|16|||
155019924|NCT01197534|559499795|FG000|Overall Study|Enrolment in long term extension|57|||
155019925|NCT01197534|559499796|FG001|Overall Study|Enrolment in long term extension|66|||
155019926|NCT01197534|559499797|FG002|Overall Study|Enrolment in long term extension|119|||
155019927|NCT01197534|559499795|FG000|Overall Study|Severe non-compliance to protocol|3|||
155019928|NCT01197534|559499796|FG001|Overall Study|Severe non-compliance to protocol|4|||
155019929|NCT01197534|559499797|FG002|Overall Study|Severe non-compliance to protocol|1|||
155019930|NCT01197534|559499795|FG000|Overall Study|Lack of therapeutic response|9|||
155019931|NCT01197534|559499796|FG001|Overall Study|Lack of therapeutic response|4|||
155019932|NCT01197534|559499797|FG002|Overall Study|Lack of therapeutic response|9|||
155019933|NCT01197534|559499795|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
155019934|NCT01197534|559499796|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
155019935|NCT01197534|559499797|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
155019936|NCT01197534|559499795|FG000|Overall Study|Lost to Follow-up|1|||
155019937|NCT01197534|559499796|FG001|Overall Study|Lost to Follow-up|4|||
155019938|NCT01197534|559499797|FG002|Overall Study|Lost to Follow-up|2|||
155019939|NCT01197534|559499795|FG000|Overall Study|Adverse Event|35|||
155019940|NCT01197534|559499796|FG001|Overall Study|Adverse Event|36|||
155019941|NCT01197534|559499797|FG002|Overall Study|Adverse Event|24|||
155019942|NCT01276756|559499800|FG000|Overall Study|Lost to Follow-up|2|||
155019943|NCT01276756|559499801|FG001|Overall Study|Lost to Follow-up|0|||
155139266|NCT00132808|559942702|FG000|Stratum I|Abnormal test procedure result (s)|0|||
155139267|NCT00132808|559942703|FG001|Stratum I|Abnormal test procedure result (s)|0|||
155019944|NCT01276756|559499800|FG000|Overall Study|Adverse Event|3|||
155019945|NCT01276756|559499801|FG001|Overall Study|Adverse Event|2|||
155019946|NCT04586244|559499808|FG000|Overall Study|Lost to Follow-up|1|||
155019947|NCT04586244|559499809|FG001|Overall Study|Lost to Follow-up|0|||
155019948|NCT04586244|559499810|FG002|Overall Study|Lost to Follow-up|0|||
155019949|NCT04586244|559499811|FG003|Overall Study|Lost to Follow-up|1|||
155019950|NCT04586244|559499812|FG004|Overall Study|Lost to Follow-up|0|||
155019951|NCT04586244|559499808|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155179494|NCT01992159|560096321|FG003|Overall Study|Adverse Event|1|||
155019952|NCT04586244|559499809|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
155019953|NCT04586244|559499810|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155019954|NCT04586244|559499811|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155019955|NCT04586244|559499812|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
155019956|NCT02670525|559499813|FG000|Overall Study|Death|94|||
155019957|NCT02670525|559499814|FG001|Overall Study|Death|14|||
155019958|NCT02670525|559499813|FG000|Overall Study|Lost to Follow-up|4|||
155019959|NCT02670525|559499814|FG001|Overall Study|Lost to Follow-up|1|||
155019960|NCT02670525|559499813|FG000|Overall Study|Subject withdrew consent|1|||
155019961|NCT02670525|559499814|FG001|Overall Study|Subject withdrew consent|0|||
155019962|NCT02670525|559499813|FG000|Overall Study|Unknown, data entry delayed|123|||
155019963|NCT02670525|559499814|FG001|Overall Study|Unknown, data entry delayed|78|||
155019964|NCT02505217|559499815|FG000|Overall Study|Withdrawal by Subject|1|||
155019965|NCT02505217|559499816|FG001|Overall Study|Withdrawal by Subject|2|||
155019966|NCT00550745|559499817|FG000|Overall Study|Death|20|||
155019967|NCT00550745|559499818|FG001|Overall Study|Death|16|||
155019968|NCT00550745|559499817|FG000|Overall Study|Lost to Follow-up|45|||
155019969|NCT00550745|559499818|FG001|Overall Study|Lost to Follow-up|30|||
155019970|NCT00550745|559499817|FG000|Overall Study|Physician Decision|0|||
155019971|NCT00550745|559499818|FG001|Overall Study|Physician Decision|2|||
155019972|NCT00550745|559499817|FG000|Overall Study|Protocol Violation|4|||
155019973|NCT00550745|559499818|FG001|Overall Study|Protocol Violation|2|||
155019974|NCT00550745|559499817|FG000|Overall Study|Withdrawal by Subject|17|||
155019975|NCT00550745|559499818|FG001|Overall Study|Withdrawal by Subject|10|||
155019976|NCT00550745|559499817|FG000|Overall Study|Screen failure|1|||
155019977|NCT00550745|559499818|FG001|Overall Study|Screen failure|0|||
155019978|NCT00764660|559499819|FG000|Overall Study|Adverse Event|6|||
155019979|NCT00764660|559499820|FG001|Overall Study|Adverse Event|3|||
155019980|NCT00764660|559499819|FG000|Overall Study|Lost to Follow-up|3|||
155019981|NCT00764660|559499820|FG001|Overall Study|Lost to Follow-up|4|||
155019982|NCT00764660|559499819|FG000|Overall Study|Withdrawal by Subject|7|||
155019983|NCT00764660|559499820|FG001|Overall Study|Withdrawal by Subject|3|||
155019984|NCT00764660|559499819|FG000|Overall Study|Noncompliance With Protocol|5|||
155019985|NCT00764660|559499820|FG001|Overall Study|Noncompliance With Protocol|1|||
155019986|NCT00764660|559499819|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
155019987|NCT00764660|559499820|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
155019988|NCT02186873|559501598|FG000|Overall Study|Adverse Event|1|||
155019989|NCT02186873|559501599|FG001|Overall Study|Adverse Event|3|||
155019990|NCT02186873|559501598|FG000|Overall Study|Lack of Efficacy|0|||
155019991|NCT02186873|559501599|FG001|Overall Study|Lack of Efficacy|1|||
155019992|NCT02186873|559501598|FG000|Overall Study|Lost to Follow-up|1|||
155019993|NCT02186873|559501599|FG001|Overall Study|Lost to Follow-up|2|||
155019994|NCT02186873|559501598|FG000|Overall Study|Withdrawal by Subject|7|||
155019995|NCT02186873|559501599|FG001|Overall Study|Withdrawal by Subject|2|||
155019996|NCT03694002|559501600|FG000|Overall Study|Progression|4|||
155019997|NCT03694002|559501601|FG001|Overall Study|Progression|2|||
155019998|NCT03694002|559501600|FG000|Overall Study|Adverse Event|2|||
155019999|NCT03694002|559501601|FG001|Overall Study|Adverse Event|0|||
155020000|NCT03694002|559501600|FG000|Overall Study|Other not protocol specified|1|||
155020001|NCT03694002|559501601|FG001|Overall Study|Other not protocol specified|0|||
155020002|NCT03694002|559501600|FG000|Overall Study|Ineligible|0|||
155020003|NCT03694002|559501601|FG001|Overall Study|Ineligible|1|||
155020004|NCT03694002|559501600|FG000|Overall Study|Withdrew consent before starting treatment|0|||
155020005|NCT03694002|559501601|FG001|Overall Study|Withdrew consent before starting treatment|3|||
155020006|NCT02159053|559501602|FG000|Overall Study|Death|2|||
155020007|NCT02159053|559501603|FG001|Overall Study|Death|0|||
155020008|NCT02159053|559501604|FG002|Overall Study|Death|1|||
155020009|NCT02159053|559501602|FG000|Overall Study|Physician Decision|0|||
155020010|NCT02159053|559501603|FG001|Overall Study|Physician Decision|1|||
155020011|NCT02159053|559501604|FG002|Overall Study|Physician Decision|1|||
155020012|NCT02159053|559501602|FG000|Overall Study|Lack of Efficacy|3|||
155020013|NCT02159053|559501603|FG001|Overall Study|Lack of Efficacy|4|||
155020014|NCT02159053|559501604|FG002|Overall Study|Lack of Efficacy|7|||
155139268|NCT00132808|559942704|FG002|Stratum I|Abnormal test procedure result (s)|1|||
155020015|NCT02159053|559501602|FG000|Overall Study|Adverse Event|7|||
155020016|NCT02159053|559501603|FG001|Overall Study|Adverse Event|6|||
155020017|NCT02159053|559501604|FG002|Overall Study|Adverse Event|5|||
155139269|NCT00132808|559942702|FG000|Stratum II|Adverse Event|1|||
155139270|NCT00132808|559942703|FG001|Stratum II|Adverse Event|2|||
155020018|NCT02159053|559501602|FG000|Overall Study|Participants/guardian decision|8|||
155020019|NCT02159053|559501603|FG001|Overall Study|Participants/guardian decision|10|||
155020020|NCT02159053|559501604|FG002|Overall Study|Participants/guardian decision|6|||
155020021|NCT00596687|559501605|FG000|Overall Study|< 24 hours of insulin treatment|8|||
155020022|NCT00596687|559501606|FG001|Overall Study|< 24 hours of insulin treatment|6|||
155020023|NCT00596687|559501605|FG000|Overall Study|continuous insulin infusion during TPN|2|||
155020024|NCT00596687|559501606|FG001|Overall Study|continuous insulin infusion during TPN|1|||
155020025|NCT00596687|559501605|FG000|Overall Study|Withdrawal by Subject|3|||
155020026|NCT00596687|559501606|FG001|Overall Study|Withdrawal by Subject|1|||
155020027|NCT00596687|559501605|FG000|Overall Study|cancelled surgery|1|||
155020028|NCT00596687|559501606|FG001|Overall Study|cancelled surgery|1|||
155020029|NCT01262287|559501607|FG000|Overall Study|Lost to Follow-up|2|||
155020030|NCT01262287|559501608|FG001|Overall Study|Lost to Follow-up|1|||
155020031|NCT06098339|559501609|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
155020032|NCT06098339|559501610|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
155020033|NCT06098339|559501609|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
155020034|NCT06098339|559501610|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
155020035|NCT00300885|559501611|FG000|Treatment|Adverse Event|134|||
155020036|NCT00300885|559501612|FG001|Treatment|Adverse Event|82|||
155020037|NCT00300885|559501611|FG000|Treatment|Death|20|||
155020038|NCT00300885|559501612|FG001|Treatment|Death|7|||
155020039|NCT00300885|559501611|FG000|Treatment|Lack of Efficacy|1|||
155020040|NCT00300885|559501612|FG001|Treatment|Lack of Efficacy|1|||
155020041|NCT00300885|559501611|FG000|Treatment|Lost to Follow-up|3|||
155020042|NCT00300885|559501612|FG001|Treatment|Lost to Follow-up|2|||
155020043|NCT00300885|559501611|FG000|Treatment|Physician Decision|4|||
155020044|NCT00300885|559501612|FG001|Treatment|Physician Decision|5|||
155020045|NCT00300885|559501611|FG000|Treatment|Protocol Violation|11|||
155020046|NCT00300885|559501612|FG001|Treatment|Protocol Violation|11|||
155020047|NCT00300885|559501611|FG000|Treatment|Withdrawal by Subject|26|||
155020048|NCT00300885|559501612|FG001|Treatment|Withdrawal by Subject|23|||
155020049|NCT00300885|559501611|FG000|Treatment|Disease progression|171|||
155020050|NCT00300885|559501612|FG001|Treatment|Disease progression|238|||
155020051|NCT00300885|559501611|FG000|Treatment|Random code broken (subject died)|0|||
155020052|NCT00300885|559501612|FG001|Treatment|Random code broken (subject died)|1|||
155020053|NCT00300885|559501611|FG000|Treatment|Non-compliant with study medication|3|||
155020054|NCT00300885|559501612|FG001|Treatment|Non-compliant with study medication|4|||
155020055|NCT00300885|559501611|FG000|Follow-up|Death|141|||
155020056|NCT00300885|559501612|FG001|Follow-up|Death|163|||
155020057|NCT00300885|559501611|FG000|Follow-up|Lost to Follow-up|11|||
155020058|NCT00300885|559501612|FG001|Follow-up|Lost to Follow-up|7|||
155020059|NCT00300885|559501611|FG000|Follow-up|Withdrawal by Subject|26|||
155020060|NCT00300885|559501612|FG001|Follow-up|Withdrawal by Subject|25|||
155020061|NCT01637922|559501613|FG000|Overall Study|Adverse Event|0|||
155020062|NCT01637922|559501614|FG001|Overall Study|Adverse Event|1|||
155020063|NCT01637922|559501613|FG000|Overall Study|Protocol Violation|0|||
155020064|NCT01637922|559501614|FG001|Overall Study|Protocol Violation|1|||
155020065|NCT01637922|559501613|FG000|Overall Study|Withdrawal by Subject|0|||
155020066|NCT01637922|559501614|FG001|Overall Study|Withdrawal by Subject|3|||
155020067|NCT01637922|559501613|FG000|Overall Study|Lost to Follow-up|2|||
155020068|NCT01637922|559501614|FG001|Overall Study|Lost to Follow-up|0|||
155020069|NCT02492984|559501615|FG000|Overall Study|Adverse Event|1|||
155020070|NCT02492984|559501616|FG001|Overall Study|Adverse Event|0|||
155020071|NCT02492984|559501615|FG000|Overall Study|Protocol Violation|1|||
155020072|NCT02492984|559501616|FG001|Overall Study|Protocol Violation|0|||
155020073|NCT02492984|559501615|FG000|Overall Study|Withdrawal by Subject|1|||
155020074|NCT02492984|559501616|FG001|Overall Study|Withdrawal by Subject|0|||
155020075|NCT03981900|559501617|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
155020076|NCT03981900|559501617|FG000|Overall Study|Adverse Event|5|||
155020077|NCT03981900|559501617|FG000|Overall Study|Protocol Violation|1|||
155020078|NCT03981900|559501617|FG000|Overall Study|Withdrawal by Subject|7|||
155020079|NCT03981900|559501617|FG000|Overall Study|Lost to Follow-up|46|||
155020080|NCT03981900|559501617|FG000|Overall Study|Decision of the researcher|3|||
155020081|NCT03981900|559501617|FG000|Overall Study|Death|3|||
155020082|NCT03981900|559501617|FG000|Overall Study|Other|5|||
155020083|NCT02510664|559501635|FG000|Overall Study|Transferred Care|9|||
155020084|NCT02510664|559501636|FG001|Overall Study|Transferred Care|9|||
155020085|NCT02510664|559501637|FG002|Overall Study|Transferred Care|0|||
155020086|NCT02510664|559501635|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
155020087|NCT02510664|559501636|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
155020088|NCT02510664|559501637|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
155020089|NCT02510664|559501635|FG000|Overall Study|Time Constraints|1|||
155020090|NCT02510664|559501636|FG001|Overall Study|Time Constraints|1|||
155020091|NCT02510664|559501637|FG002|Overall Study|Time Constraints|0|||
155020092|NCT04090060|559501638|FG000|Overall Study|Lost to Follow-up|76|||
155139271|NCT00132808|559942704|FG002|Stratum II|Adverse Event|1|||
155139272|NCT00132808|559942702|FG000|Stratum II|Death|1|||
155020093|NCT04090060|559501639|FG001|Overall Study|Lost to Follow-up|77|||
155139273|NCT00132808|559942703|FG001|Stratum II|Death|0|||
155139274|NCT00132808|559942704|FG002|Stratum II|Death|0|||
155020094|NCT02176655|559501640|FG000|Overall Study|Subjects did not treat|6|||
155020095|NCT01718535|559501648|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
155020096|NCT01718535|559501649|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
155020097|NCT01718535|559501650|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
155139275|NCT00132808|559942702|FG000|Stratum II|Lost to Follow-up|2|||
155020098|NCT01718535|559501651|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
155139276|NCT00132808|559942703|FG001|Stratum II|Lost to Follow-up|2|||
155020099|NCT01718535|559501652|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
155020100|NCT01718535|559501653|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
155020101|NCT01718535|559501654|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
155020102|NCT01718535|559501655|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
155020103|NCT01718535|559501656|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
155020104|NCT01718535|559501657|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
155020105|NCT04747886|559501660|FG000|Overall Study|Withdrawal by Subject|1|||
155020106|NCT04747886|559501661|FG001|Overall Study|Withdrawal by Subject|4|||
155020107|NCT00179660|559501670|FG000|Overall Study|Adverse Event|7|||
155020108|NCT00179660|559501670|FG000|Overall Study|Lack of therapeutic effect|28|||
155020109|NCT00179660|559501670|FG000|Overall Study|Withdrawal by Subject|2|||
155020110|NCT00179660|559501670|FG000|Overall Study|Lost to Follow-up|1|||
155020111|NCT00179660|559501670|FG000|Overall Study|Death|3|||
155020112|NCT00179660|559501670|FG000|Overall Study|Other - Unspecified|9|||
155020113|NCT01282372|559501676|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
155020114|NCT01282372|559501676|FG000|Overall Study|Lost to Follow-up|23|||
155020115|NCT01282372|559501676|FG000|Overall Study|Withdrawal by Subject|11|||
155020116|NCT01282372|559501676|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
155020117|NCT01282372|559501676|FG000|Overall Study|Death|1|||
155020118|NCT01282372|559501676|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
155020119|NCT01282372|559501676|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
155020120|NCT01282372|559501676|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
155020121|NCT01282372|559501676|FG000|Overall Study|Adverse Event|12|||
155020122|NCT02993250|559501677|FG000|Overall Study|Lost to Follow-up|0|||
155020123|NCT02993250|559501678|FG001|Overall Study|Lost to Follow-up|1|||
155020124|NCT02737930|559501682|FG000|Overall Study|Withdrawal by Subject|0|||
155020125|NCT02737930|559501683|FG001|Overall Study|Withdrawal by Subject|1|||
155020126|NCT02105987|559501684|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
155020127|NCT02105987|559501685|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155020128|NCT02105987|559501686|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155020129|NCT02105987|559501687|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155020130|NCT02105987|559501688|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155020131|NCT02105987|559501689|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
155020132|NCT02105987|559501684|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
155020133|NCT02105987|559501685|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
155020134|NCT02105987|559501686|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155020135|NCT02105987|559501687|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155020136|NCT02105987|559501688|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155020137|NCT02105987|559501689|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
155020138|NCT02105987|559501684|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
155020139|NCT02105987|559501685|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
155020140|NCT02105987|559501686|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020141|NCT02105987|559501687|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020142|NCT02105987|559501688|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020143|NCT02105987|559501689|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020144|NCT02105987|559501684|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
155020145|NCT02105987|559501685|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
155020146|NCT02105987|559501686|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020147|NCT02105987|559501687|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020148|NCT02105987|559501688|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020149|NCT02105987|559501689|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020150|NCT02105987|559501684|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
155020151|NCT02105987|559501685|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
155020152|NCT02105987|559501686|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155020153|NCT02105987|559501687|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155020154|NCT02105987|559501688|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155020155|NCT02105987|559501689|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
155020156|NCT02105987|559501684|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155020157|NCT02105987|559501685|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
155020158|NCT02105987|559501686|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155020159|NCT02105987|559501687|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155020160|NCT02105987|559501688|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155020161|NCT02105987|559501689|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
155020162|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155020163|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155020164|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
155020165|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
155020166|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155020167|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
155020168|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155020169|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155020170|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
155020171|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
155020172|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155020173|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
155020174|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020175|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020176|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
155020177|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
155020178|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020179|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
155020180|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020181|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020182|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
155020183|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
155020184|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020185|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
155020186|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155020187|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155020188|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
155020189|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155020190|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155020191|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
155020192|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155020193|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155020194|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155020195|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
155020196|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155020197|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
155020198|NCT02105987|559501684|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155020199|NCT02105987|559501685|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155020200|NCT02105987|559501686|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
155020201|NCT02105987|559501687|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155020202|NCT02105987|559501688|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155020203|NCT02105987|559501689|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
155020204|NCT02105987|559501684|FG000|Continuation Phase|Protocol Violation|0|||
155020205|NCT02105987|559501685|FG001|Continuation Phase|Protocol Violation|0|||
155020206|NCT02105987|559501686|FG002|Continuation Phase|Protocol Violation|0|||
155020207|NCT02105987|559501687|FG003|Continuation Phase|Protocol Violation|0|||
155020208|NCT02105987|559501688|FG004|Continuation Phase|Protocol Violation|1|||
155020209|NCT02105987|559501689|FG005|Continuation Phase|Protocol Violation|0|||
155020210|NCT00984542|559501702|FG000|Overall Study|disease progression|19|||
155020211|NCT00984542|559501702|FG000|Overall Study|toxicity|7|||
155020212|NCT00984542|559501702|FG000|Overall Study|Death|7|||
155020213|NCT00984542|559501702|FG000|Overall Study|complicating disease|3|||
155020214|NCT00984542|559501702|FG000|Overall Study|Withdrawal by Subject|3|||
155020215|NCT00984542|559501702|FG000|Overall Study|clinical deterioration|2|||
155020216|NCT02097745|559501703|FG000|Overall Study|Adverse Event|25|||
155020217|NCT02097745|559501703|FG000|Overall Study|Death|16|||
155020218|NCT02097745|559501703|FG000|Overall Study|Failure to Return|14|||
155020219|NCT02097745|559501703|FG000|Overall Study|Administrative/Other|27|||
155020220|NCT02097745|559501703|FG000|Overall Study|Reason Not Specified|96|||
155020221|NCT02064816|559501704|FG000|Overall Study|Adverse Event|3|||
155020222|NCT02064816|559501705|FG001|Overall Study|Adverse Event|2|||
155020223|NCT02064816|559501704|FG000|Overall Study|Withdrawal by Subject|2|||
155020224|NCT02064816|559501705|FG001|Overall Study|Withdrawal by Subject|1|||
155020225|NCT02064816|559501704|FG000|Overall Study|Lost to Follow-up|2|||
155020226|NCT02064816|559501705|FG001|Overall Study|Lost to Follow-up|1|||
155020227|NCT02064816|559501704|FG000|Overall Study|Therapeutic failure|0|||
155020228|NCT02064816|559501705|FG001|Overall Study|Therapeutic failure|1|||
155020229|NCT02064816|559501704|FG000|Overall Study|Other|1|||
155020230|NCT02064816|559501705|FG001|Overall Study|Other|3|||
155139277|NCT00132808|559942704|FG002|Stratum II|Lost to Follow-up|1|||
155139278|NCT00132808|559942702|FG000|Stratum II|Protocol Violation|0|||
155139279|NCT00132808|559942703|FG001|Stratum II|Protocol Violation|2|||
155139280|NCT00132808|559942704|FG002|Stratum II|Protocol Violation|1|||
155020231|NCT01757184|559501708|FG000|Double-blind Period|Adverse Event|1|||
155020232|NCT01757184|559501709|FG001|Double-blind Period|Adverse Event|0|||
155020233|NCT01757184|559501710|FG002|Double-blind Period|Adverse Event|0|||
155020234|NCT01757184|559501711|FG003|Double-blind Period|Adverse Event|0|||
155020235|NCT01757184|559501708|FG000|Open-label Period|Lost to Follow-up|0|||
155139281|NCT00132808|559942702|FG000|Stratum II|Withdrawal by Subject|4|||
155139282|NCT00132808|559942703|FG001|Stratum II|Withdrawal by Subject|9|||
155020236|NCT01757184|559501709|FG001|Open-label Period|Lost to Follow-up|0|||
155020237|NCT01757184|559501710|FG002|Open-label Period|Lost to Follow-up|2|||
155020238|NCT01757184|559501711|FG003|Open-label Period|Lost to Follow-up|0|||
155020239|NCT01757184|559501708|FG000|Open-label Period|Withdrawal by Subject|0|||
155020240|NCT01757184|559501709|FG001|Open-label Period|Withdrawal by Subject|0|||
155020241|NCT01757184|559501710|FG002|Open-label Period|Withdrawal by Subject|1|||
155020242|NCT01757184|559501711|FG003|Open-label Period|Withdrawal by Subject|1|||
155020243|NCT01757184|559501708|FG000|Open-label Period|Discontinued by Sponsor|0|||
155020244|NCT01757184|559501709|FG001|Open-label Period|Discontinued by Sponsor|0|||
155020245|NCT01757184|559501710|FG002|Open-label Period|Discontinued by Sponsor|1|||
155020246|NCT01757184|559501711|FG003|Open-label Period|Discontinued by Sponsor|2|||
155020247|NCT04468347|559501714|FG000|Overall Study|Withdrawal by Subject|0|||
155020248|NCT04468347|559501715|FG001|Overall Study|Withdrawal by Subject|1|||
155020249|NCT04468347|559501716|FG002|Overall Study|Withdrawal by Subject|3|||
155020250|NCT04468347|559501717|FG003|Overall Study|Withdrawal by Subject|3|||
155020251|NCT04468347|559501714|FG000|Overall Study|Lost to Follow-up|0|||
155020252|NCT04468347|559501715|FG001|Overall Study|Lost to Follow-up|0|||
155020253|NCT04468347|559501716|FG002|Overall Study|Lost to Follow-up|1|||
155020254|NCT04468347|559501717|FG003|Overall Study|Lost to Follow-up|1|||
155020255|NCT04468347|559501714|FG000|Overall Study|Physician Decision|1|||
155020256|NCT04468347|559501715|FG001|Overall Study|Physician Decision|0|||
155020257|NCT04468347|559501716|FG002|Overall Study|Physician Decision|2|||
155020258|NCT04468347|559501717|FG003|Overall Study|Physician Decision|0|||
155020259|NCT04468347|559501714|FG000|Overall Study|Protocol Violation|1|||
155020260|NCT04468347|559501715|FG001|Overall Study|Protocol Violation|0|||
155020261|NCT04468347|559501716|FG002|Overall Study|Protocol Violation|0|||
155020262|NCT04468347|559501717|FG003|Overall Study|Protocol Violation|0|||
155020263|NCT03515811|559501718|FG000|Overall Study|Lost to Follow-up|2|||
155020264|NCT03515811|559501719|FG001|Overall Study|Lost to Follow-up|1|||
155020265|NCT03515811|559501718|FG000|Overall Study|Protocol Violation|1|||
155020266|NCT03515811|559501719|FG001|Overall Study|Protocol Violation|1|||
155139283|NCT00132808|559942704|FG002|Stratum II|Withdrawal by Subject|6|||
155139284|NCT00577824|559942706|FG000|Overall Study|Adverse Event|6|||
155139285|NCT00577824|559942707|FG001|Overall Study|Adverse Event|18|||
155139286|NCT00577824|559942708|FG002|Overall Study|Adverse Event|1|||
155139287|NCT00577824|559942706|FG000|Overall Study|Patient decision|0|||
155139288|NCT00577824|559942707|FG001|Overall Study|Patient decision|1|||
155139289|NCT00577824|559942708|FG002|Overall Study|Patient decision|1|||
155139290|NCT00577824|559942706|FG000|Overall Study|Protocol Violation|1|||
155139291|NCT00577824|559942707|FG001|Overall Study|Protocol Violation|1|||
155139292|NCT00577824|559942708|FG002|Overall Study|Protocol Violation|0|||
155139293|NCT04531241|559942709|FG000|Period 1|Withdrawal by Subject|2|||
155139294|NCT04531241|559942710|FG001|Period 1|Withdrawal by Subject|0|||
155139295|NCT04531241|559942709|FG000|Period 1|Dispesed incorrect lens power|1|||
155139296|NCT04531241|559942710|FG001|Period 1|Dispesed incorrect lens power|0|||
155139297|NCT04531241|559942709|FG000|Period 1|Protocol Violation|1|||
155139298|NCT04531241|559942710|FG001|Period 1|Protocol Violation|0|||
155139299|NCT04531241|559942709|FG000|Period 1|No longer eligible|0|||
155139300|NCT04531241|559942710|FG001|Period 1|No longer eligible|1|||
155139301|NCT04531241|559942709|FG000|Period 1|Lens Discomfort|0|||
155139302|NCT04531241|559942710|FG001|Period 1|Lens Discomfort|1|||
155139303|NCT04531241|559942709|FG000|Period 2|Covid-19 Related|1|||
155139304|NCT04531241|559942710|FG001|Period 2|Covid-19 Related|1|||
155139305|NCT02362464|559942711|FG000|Overall Study|Switched to alternative therapy|1|||
155139306|NCT02362464|559942711|FG000|Overall Study|Refused further treatment|1|||
155139307|NCT02362464|559942711|FG000|Overall Study|Physician Decision|4|||
155139308|NCT03828019|559942713|FG000|Overall Study|Withdrawal by Subject|3|||
155139309|NCT03828019|559942714|FG001|Overall Study|Withdrawal by Subject|8|||
155139310|NCT03828019|559942713|FG000|Overall Study|Lost to Follow-up|1|||
155139311|NCT03828019|559942714|FG001|Overall Study|Lost to Follow-up|6|||
155139312|NCT03828019|559942713|FG000|Overall Study|Incarcerated|1|||
155139313|NCT03828019|559942714|FG001|Overall Study|Incarcerated|0|||
155139314|NCT03828019|559942713|FG000|Overall Study|Adverse Event|0|||
155139315|NCT03828019|559942714|FG001|Overall Study|Adverse Event|1|||
155139316|NCT05715242|559942715|FG000|Overall Study|Lost to Follow-up|0|||
155139317|NCT05715242|559942716|FG001|Overall Study|Lost to Follow-up|0|||
155020267|NCT03515811|559501718|FG000|Overall Study|Death|1|||
155020268|NCT03515811|559501719|FG001|Overall Study|Death|1|||
155020269|NCT03515811|559501718|FG000|Overall Study|Withdrawal by Subject|0|||
155020270|NCT03515811|559501719|FG001|Overall Study|Withdrawal by Subject|2|||
155020271|NCT03515811|559501718|FG000|Overall Study|Technical Problems|1|||
155020272|NCT03515811|559501719|FG001|Overall Study|Technical Problems|0|||
155020273|NCT03515811|559501718|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
155020274|NCT03515811|559501719|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
155139318|NCT05715242|559942717|FG002|Overall Study|Lost to Follow-up|1|||
155139319|NCT05715242|559942718|FG003|Overall Study|Lost to Follow-up|0|||
155139320|NCT05715242|559942719|FG004|Overall Study|Lost to Follow-up|0|||
155139321|NCT05715242|559942720|FG005|Overall Study|Lost to Follow-up|1|||
155139322|NCT05715242|559942721|FG006|Overall Study|Lost to Follow-up|0|||
155020275|NCT03515811|559501718|FG000|Overall Study|COVID-19|0|||
155020276|NCT03515811|559501719|FG001|Overall Study|COVID-19|1|||
155020277|NCT00237458|559501720|FG000|Overall Study|Lack of Efficacy|1|||
155020278|NCT00237458|559501720|FG000|Overall Study|Adverse Event|1|||
155020279|NCT00237458|559501720|FG000|Overall Study|Withdrawal by Subject|1|||
155020280|NCT03218826|559501721|FG000|Overall Study|Non-compliance with protocol|1|||
155020281|NCT03218826|559501722|FG001|Overall Study|Non-compliance with protocol|0|||
155020282|NCT03218826|559501723|FG002|Overall Study|Non-compliance with protocol|2|||
155020283|NCT03218826|559501724|FG003|Overall Study|Non-compliance with protocol|1|||
155020284|NCT03218826|559501725|FG004|Overall Study|Non-compliance with protocol|1|||
155020285|NCT05868577|559501726|FG000|Overall Study|Lost to Follow-up|5|||
155020286|NCT05868577|559501727|FG001|Overall Study|Lost to Follow-up|5|||
155020287|NCT02630251|559501728|FG000|Overall Study|Physician Decision|0|||
155020288|NCT02630251|559501729|FG001|Overall Study|Physician Decision|0|||
155020289|NCT02630251|559501730|FG002|Overall Study|Physician Decision|1|||
155020290|NCT02630251|559501731|FG003|Overall Study|Physician Decision|0|||
155020291|NCT00634036|559501734|FG000|Overall Study|Lost to Follow-up|1|||
155020292|NCT00634036|559501735|FG001|Overall Study|Lost to Follow-up|1|||
155020293|NCT00634036|559501734|FG000|Overall Study|Withdrawal by Subject|1|||
155020294|NCT00634036|559501735|FG001|Overall Study|Withdrawal by Subject|1|||
155020295|NCT03517540|559501736|FG000|Overall Study|Protocol Violation|2|||
155020296|NCT03517540|559501737|FG001|Overall Study|Protocol Violation|0|||
155020297|NCT03517540|559501738|FG002|Overall Study|Protocol Violation|0|||
155020298|NCT03517540|559501739|FG003|Overall Study|Protocol Violation|1|||
155020299|NCT03517540|559501736|FG000|Overall Study|Adverse Event|9|||
155020300|NCT03517540|559501737|FG001|Overall Study|Adverse Event|3|||
155020301|NCT03517540|559501738|FG002|Overall Study|Adverse Event|8|||
155020302|NCT03517540|559501739|FG003|Overall Study|Adverse Event|1|||
155020303|NCT03517540|559501736|FG000|Overall Study|Withdrawal by Subject|3|||
155020304|NCT03517540|559501737|FG001|Overall Study|Withdrawal by Subject|4|||
155020305|NCT03517540|559501738|FG002|Overall Study|Withdrawal by Subject|1|||
155020306|NCT03517540|559501739|FG003|Overall Study|Withdrawal by Subject|3|||
155020307|NCT03896022|559501744|FG000|Overall Study|Withdrawal by Subject|1|||
155020308|NCT03896022|559501745|FG001|Overall Study|Withdrawal by Subject|0|||
155020309|NCT03896022|559501746|FG002|Overall Study|Withdrawal by Subject|0|||
155020310|NCT03896022|559501744|FG000|Overall Study|Did not have procedure|3|||
155020311|NCT03896022|559501745|FG001|Overall Study|Did not have procedure|0|||
155020312|NCT03896022|559501746|FG002|Overall Study|Did not have procedure|0|||
155020313|NCT00615550|559501747|FG000|Overall Study|Lost to Follow-up|6|||
155020314|NCT00615550|559501748|FG001|Overall Study|Lost to Follow-up|1|||
155020315|NCT00961350|559501749|FG000|Overall Study|Adverse Event|18|||
155020316|NCT00961350|559501750|FG001|Overall Study|Adverse Event|33|||
155020317|NCT00961350|559501749|FG000|Overall Study|Withdrawal by Subject|10|||
155020318|NCT00961350|559501750|FG001|Overall Study|Withdrawal by Subject|10|||
155020319|NCT00961350|559501749|FG000|Overall Study|Lost to Follow-up|3|||
155020320|NCT00961350|559501750|FG001|Overall Study|Lost to Follow-up|3|||
155020321|NCT00961350|559501749|FG000|Overall Study|Misc|16|||
155020322|NCT00961350|559501750|FG001|Overall Study|Misc|21|||
155020323|NCT06868654|559501753|FG000|Overall Study|Death|4|||
155020324|NCT06868654|559501754|FG001|Overall Study|Death|14|||
155020325|NCT06868654|559501753|FG000|Overall Study|Lost to Follow-up|0|||
155020326|NCT06868654|559501754|FG001|Overall Study|Lost to Follow-up|1|||
155020327|NCT06868654|559501753|FG000|Overall Study|Withdrawal by Subject|5|||
155020328|NCT06868654|559501754|FG001|Overall Study|Withdrawal by Subject|3|||
155020329|NCT06868654|559501753|FG000|Overall Study|Physician Decision|0|||
155020330|NCT06868654|559501754|FG001|Overall Study|Physician Decision|1|||
155020331|NCT06868654|559501753|FG000|Overall Study|Ongoing|23|||
155020332|NCT06868654|559501754|FG001|Overall Study|Ongoing|21|||
155020333|NCT01777282|559501755|FG000|Overall Study|Persistent Hyperglycemia|0|||
155020334|NCT01777282|559501756|FG001|Overall Study|Persistent Hyperglycemia|0|||
155020335|NCT01777282|559501757|FG002|Overall Study|Persistent Hyperglycemia|1|||
155020336|NCT01777282|559501758|FG003|Overall Study|Persistent Hyperglycemia|0|||
155020337|NCT01777282|559501759|FG004|Overall Study|Persistent Hyperglycemia|0|||
155020338|NCT01777282|559501755|FG000|Overall Study|New Antidiabetic Medication|0|||
155020339|NCT01777282|559501756|FG001|Overall Study|New Antidiabetic Medication|0|||
155020340|NCT01777282|559501757|FG002|Overall Study|New Antidiabetic Medication|1|||
155020341|NCT01777282|559501758|FG003|Overall Study|New Antidiabetic Medication|0|||
155139323|NCT05715242|559942722|FG007|Overall Study|Lost to Follow-up|0|||
155020342|NCT01777282|559501759|FG004|Overall Study|New Antidiabetic Medication|0|||
155020343|NCT01777282|559501755|FG000|Overall Study|Adverse Event|4|||
155020344|NCT01777282|559501756|FG001|Overall Study|Adverse Event|4|||
155020345|NCT01777282|559501757|FG002|Overall Study|Adverse Event|2|||
155020346|NCT01777282|559501758|FG003|Overall Study|Adverse Event|1|||
155020347|NCT01777282|559501759|FG004|Overall Study|Adverse Event|3|||
155020348|NCT01777282|559501755|FG000|Overall Study|Withdrawal by Subject|4|||
155020349|NCT01777282|559501756|FG001|Overall Study|Withdrawal by Subject|0|||
155020350|NCT01777282|559501757|FG002|Overall Study|Withdrawal by Subject|0|||
155020351|NCT01777282|559501758|FG003|Overall Study|Withdrawal by Subject|1|||
155139324|NCT05715242|559942723|FG008|Overall Study|Lost to Follow-up|0|||
155020352|NCT01777282|559501759|FG004|Overall Study|Withdrawal by Subject|2|||
155020353|NCT01777282|559501755|FG000|Overall Study|Protocol Violation|2|||
155020354|NCT01777282|559501756|FG001|Overall Study|Protocol Violation|0|||
155020355|NCT01777282|559501757|FG002|Overall Study|Protocol Violation|1|||
155020356|NCT01777282|559501758|FG003|Overall Study|Protocol Violation|0|||
155020357|NCT01777282|559501759|FG004|Overall Study|Protocol Violation|2|||
155020358|NCT01777282|559501755|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
155020359|NCT01777282|559501756|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
155020360|NCT01777282|559501757|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
155020361|NCT01777282|559501758|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
155020362|NCT01777282|559501759|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
155020363|NCT04015518|559501760|FG000|Overall Study|Adverse Event|6|||
155020364|NCT04015518|559501761|FG001|Overall Study|Adverse Event|1|||
155020365|NCT04015518|559501762|FG002|Overall Study|Adverse Event|1|||
155020366|NCT04015518|559501763|FG003|Overall Study|Adverse Event|3|||
155020367|NCT04015518|559501764|FG004|Overall Study|Adverse Event|3|||
155020368|NCT04015518|559501760|FG000|Overall Study|Lack of Efficacy|1|||
155020369|NCT04015518|559501761|FG001|Overall Study|Lack of Efficacy|0|||
155020370|NCT04015518|559501762|FG002|Overall Study|Lack of Efficacy|1|||
155020371|NCT04015518|559501763|FG003|Overall Study|Lack of Efficacy|0|||
155020372|NCT04015518|559501764|FG004|Overall Study|Lack of Efficacy|4|||
155020373|NCT04015518|559501760|FG000|Overall Study|Lost to Follow-up|0|||
155020374|NCT04015518|559501761|FG001|Overall Study|Lost to Follow-up|0|||
155020375|NCT04015518|559501762|FG002|Overall Study|Lost to Follow-up|0|||
155020376|NCT04015518|559501763|FG003|Overall Study|Lost to Follow-up|0|||
155020377|NCT04015518|559501764|FG004|Overall Study|Lost to Follow-up|1|||
155020378|NCT04015518|559501760|FG000|Overall Study|Withdrawal by Subject|0|||
155020379|NCT04015518|559501761|FG001|Overall Study|Withdrawal by Subject|1|||
155020380|NCT04015518|559501762|FG002|Overall Study|Withdrawal by Subject|0|||
155020381|NCT04015518|559501763|FG003|Overall Study|Withdrawal by Subject|1|||
155020382|NCT04015518|559501764|FG004|Overall Study|Withdrawal by Subject|1|||
155020383|NCT04015518|559501760|FG000|Overall Study|Patient did not come for consecutive visits|0|||
155020384|NCT04015518|559501761|FG001|Overall Study|Patient did not come for consecutive visits|1|||
155020385|NCT04015518|559501762|FG002|Overall Study|Patient did not come for consecutive visits|0|||
155020386|NCT04015518|559501763|FG003|Overall Study|Patient did not come for consecutive visits|0|||
155020387|NCT04015518|559501764|FG004|Overall Study|Patient did not come for consecutive visits|0|||
155020388|NCT04015518|559501760|FG000|Overall Study|not willing to travel due to Covid-19|0|||
155020389|NCT04015518|559501761|FG001|Overall Study|not willing to travel due to Covid-19|0|||
155020390|NCT04015518|559501762|FG002|Overall Study|not willing to travel due to Covid-19|1|||
155020391|NCT04015518|559501763|FG003|Overall Study|not willing to travel due to Covid-19|0|||
155020392|NCT04015518|559501764|FG004|Overall Study|not willing to travel due to Covid-19|0|||
155020393|NCT04015518|559501760|FG000|Overall Study|Patient wants to discontinue treatment|0|||
155020394|NCT04015518|559501761|FG001|Overall Study|Patient wants to discontinue treatment|0|||
155020395|NCT04015518|559501762|FG002|Overall Study|Patient wants to discontinue treatment|0|||
155020396|NCT04015518|559501763|FG003|Overall Study|Patient wants to discontinue treatment|1|||
155020397|NCT04015518|559501764|FG004|Overall Study|Patient wants to discontinue treatment|0|||
155020398|NCT04015518|559501760|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
155020399|NCT04015518|559501761|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
155020400|NCT04015518|559501762|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
155020401|NCT04015518|559501763|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
155020402|NCT04015518|559501764|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
155020403|NCT04015518|559501760|FG000|Overall Study|Pregnancy|0|||
155020404|NCT04015518|559501761|FG001|Overall Study|Pregnancy|0|||
155020405|NCT04015518|559501762|FG002|Overall Study|Pregnancy|0|||
155020406|NCT04015518|559501763|FG003|Overall Study|Pregnancy|0|||
155020407|NCT04015518|559501764|FG004|Overall Study|Pregnancy|1|||
155020408|NCT04015518|559501760|FG000|Overall Study|Personal reasons|1|||
155020409|NCT04015518|559501761|FG001|Overall Study|Personal reasons|0|||
155139325|NCT05715242|559942724|FG009|Overall Study|Lost to Follow-up|0|||
155139326|NCT05715242|559942725|FG010|Overall Study|Lost to Follow-up|0|||
155020410|NCT04015518|559501762|FG002|Overall Study|Personal reasons|0|||
155020411|NCT04015518|559501763|FG003|Overall Study|Personal reasons|0|||
155020412|NCT04015518|559501764|FG004|Overall Study|Personal reasons|1|||
155020413|NCT04015518|559501760|FG000|Overall Study|Withdrew consent|1|||
155020414|NCT04015518|559501761|FG001|Overall Study|Withdrew consent|0|||
155020415|NCT04015518|559501762|FG002|Overall Study|Withdrew consent|0|||
155020416|NCT04015518|559501763|FG003|Overall Study|Withdrew consent|0|||
155020417|NCT04015518|559501764|FG004|Overall Study|Withdrew consent|0|||
155020418|NCT04015518|559501760|FG000|Overall Study|Prostate carcinoma|1|||
155020419|NCT04015518|559501761|FG001|Overall Study|Prostate carcinoma|0|||
155020420|NCT04015518|559501762|FG002|Overall Study|Prostate carcinoma|0|||
155020421|NCT04015518|559501763|FG003|Overall Study|Prostate carcinoma|0|||
155020422|NCT04015518|559501764|FG004|Overall Study|Prostate carcinoma|0|||
155020423|NCT04015518|559501760|FG000|Overall Study|Could not keep appointments due to work|1|||
155020424|NCT04015518|559501761|FG001|Overall Study|Could not keep appointments due to work|0|||
155020425|NCT04015518|559501762|FG002|Overall Study|Could not keep appointments due to work|0|||
155020426|NCT04015518|559501763|FG003|Overall Study|Could not keep appointments due to work|0|||
155020427|NCT04015518|559501764|FG004|Overall Study|Could not keep appointments due to work|0|||
155020428|NCT01131455|559501765|FG000|Overall Study|Death of PI|6|||
155020429|NCT01131455|559501766|FG001|Overall Study|Death of PI|4|||
155020430|NCT01131455|559501767|FG002|Overall Study|Death of PI|0|||
155020431|NCT01760655|559503286|FG000|Overall Study|Death|18|||
155020432|NCT01760655|559503286|FG000|Overall Study|Physician Decision|1|||
155020433|NCT03056638|559503291|FG000|Overall Study|Death|1|||
155020434|NCT03056638|559503292|FG001|Overall Study|Death|0|||
155020435|NCT02530125|559503293|FG000|Completed Treatment|Early termination of study|1|||
155020436|NCT02530125|559503293|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
155020437|NCT00468481|559503294|FG000|Overall Study|Adverse Event|13|||
155020438|NCT00468481|559503295|FG001|Overall Study|Adverse Event|3|||
155020439|NCT00468481|559503294|FG000|Overall Study|Lost to Follow-up|25|||
155020440|NCT00468481|559503295|FG001|Overall Study|Lost to Follow-up|8|||
155020441|NCT00468481|559503294|FG000|Overall Study|Pregnancy|2|||
155020442|NCT00468481|559503295|FG001|Overall Study|Pregnancy|0|||
155020443|NCT00468481|559503294|FG000|Overall Study|Protocol Violation|18|||
155020444|NCT00468481|559503295|FG001|Overall Study|Protocol Violation|8|||
155020445|NCT00468481|559503294|FG000|Overall Study|Withdrawal by Subject|12|||
155020446|NCT00468481|559503295|FG001|Overall Study|Withdrawal by Subject|3|||
155020447|NCT00468481|559503294|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
155020448|NCT00468481|559503295|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
155020449|NCT00468481|559503294|FG000|Overall Study|Prohibited Medication|1|||
155020450|NCT00468481|559503295|FG001|Overall Study|Prohibited Medication|1|||
155020451|NCT00468481|559503294|FG000|Overall Study|Egg Donor|1|||
155020452|NCT00468481|559503295|FG001|Overall Study|Egg Donor|0|||
155020453|NCT00468481|559503294|FG000|Overall Study|Moved out of area|4|||
155020454|NCT00468481|559503295|FG001|Overall Study|Moved out of area|1|||
155020455|NCT00468481|559503294|FG000|Overall Study|Non-Compliance|5|||
155020456|NCT00468481|559503295|FG001|Overall Study|Non-Compliance|0|||
155020457|NCT00468481|559503294|FG000|Overall Study|Other|6|||
155020458|NCT00468481|559503295|FG001|Overall Study|Other|0|||
155020459|NCT01568034|559503297|FG000|Overall Study|Withdrawal by Subject|1|||
155020460|NCT01568034|559503298|FG001|Overall Study|Withdrawal by Subject|0|||
155020461|NCT01568034|559503299|FG002|Overall Study|Withdrawal by Subject|0|||
155020462|NCT01568034|559503300|FG003|Overall Study|Withdrawal by Subject|0|||
155020463|NCT00728468|559503301|FG000|Overall Study|Enrolled but not treated|1|||
155020464|NCT00728468|559503301|FG000|Overall Study|Death|1|||
155020465|NCT00728468|559503301|FG000|Overall Study|Protocol Violation|4|||
155020466|NCT00728468|559503301|FG000|Overall Study|Objective progression or relapse|9|||
155020467|NCT00728468|559503301|FG000|Overall Study|Study terminated by sponsor|1|||
155020468|NCT03831113|559503302|FG000|Overall Study|Withdrawal by Subject|0|||
155020469|NCT03831113|559503303|FG001|Overall Study|Withdrawal by Subject|2|||
155020470|NCT03831113|559503302|FG000|Overall Study|Protocol Violation|0|||
155020471|NCT03831113|559503303|FG001|Overall Study|Protocol Violation|9|||
155020472|NCT01515865|559503305|FG000|Part A (Open-label)|Other|3|||
155020473|NCT01515865|559503306|FG001|Part A (Open-label)|Other|0|||
155020474|NCT01515865|559503307|FG002|Part A (Open-label)|Other|0|||
155139327|NCT05715242|559942726|FG011|Overall Study|Lost to Follow-up|0|||
155139328|NCT05715242|559942727|FG012|Overall Study|Lost to Follow-up|0|||
155139329|NCT05715242|559942728|FG013|Overall Study|Lost to Follow-up|0|||
155139330|NCT05715242|559942729|FG014|Overall Study|Lost to Follow-up|0|||
155020475|NCT01515865|559503305|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
155020476|NCT01515865|559503306|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
155020477|NCT01515865|559503307|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
155020478|NCT01515865|559503305|FG000|Part B (Open-label)|Other|1|||
155020479|NCT01515865|559503306|FG001|Part B (Open-label)|Other|0|||
155020480|NCT01515865|559503307|FG002|Part B (Open-label)|Other|0|||
155020481|NCT02498444|559503310|FG000|Overall Study|Withdrawal by Subject|3|||
155020482|NCT02498444|559503311|FG001|Overall Study|Withdrawal by Subject|0|||
155020483|NCT02498444|559503310|FG000|Overall Study|Physician Decision|1|||
155020484|NCT02498444|559503311|FG001|Overall Study|Physician Decision|0|||
155139331|NCT05715242|559942730|FG015|Overall Study|Lost to Follow-up|0|||
155020485|NCT03656692|559503312|FG000|Overall Study|Worsening of disease activity|2|||
155020486|NCT03656692|559503312|FG000|Overall Study|Physician Decision|1|||
155020487|NCT02693106|559503314|FG000|Overall Study|No time|3|||
155020488|NCT04478695|559503319|FG000|Overall Study|Death|1|||
155020489|NCT04478695|559503320|FG001|Overall Study|Death|0|||
155020490|NCT00644917|559503321|FG000|Overall Study|Withdrawal by Subject|2|||
155020491|NCT00402688|559503322|FG000|Overall Study|Adverse Event|12|||
155020492|NCT00402688|559503323|FG001|Overall Study|Adverse Event|9|||
155020493|NCT00402688|559503324|FG002|Overall Study|Adverse Event|3|||
155020494|NCT00402688|559503322|FG000|Overall Study|Withdrawal by Subject|3|||
155020495|NCT00402688|559503323|FG001|Overall Study|Withdrawal by Subject|1|||
155020496|NCT00402688|559503324|FG002|Overall Study|Withdrawal by Subject|1|||
155020497|NCT00402688|559503322|FG000|Overall Study|Physician Decision|0|||
155020498|NCT00402688|559503323|FG001|Overall Study|Physician Decision|0|||
155020499|NCT00402688|559503324|FG002|Overall Study|Physician Decision|1|||
155020500|NCT00402688|559503322|FG000|Overall Study|Lack of Efficacy|4|||
155020501|NCT00402688|559503323|FG001|Overall Study|Lack of Efficacy|4|||
155020502|NCT00402688|559503324|FG002|Overall Study|Lack of Efficacy|5|||
155020503|NCT00402688|559503322|FG000|Overall Study|Protocol Violation|1|||
155020504|NCT00402688|559503323|FG001|Overall Study|Protocol Violation|1|||
155020505|NCT00402688|559503324|FG002|Overall Study|Protocol Violation|1|||
155020506|NCT00402688|559503322|FG000|Overall Study|Lost to Follow-up|1|||
155020507|NCT00402688|559503323|FG001|Overall Study|Lost to Follow-up|0|||
155020508|NCT00402688|559503324|FG002|Overall Study|Lost to Follow-up|2|||
155020509|NCT00402688|559503322|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
155020510|NCT00402688|559503323|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
155020511|NCT00402688|559503324|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
155020512|NCT00402688|559503322|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
155020513|NCT00402688|559503323|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
155020514|NCT00402688|559503324|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
155020515|NCT00402688|559503322|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
155020516|NCT00402688|559503323|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
155020517|NCT00402688|559503324|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
155020518|NCT00927862|559503325|FG000|Overall Study|Missing data needed for endpt analyses|27|||
155020519|NCT00927862|559503326|FG001|Overall Study|Missing data needed for endpt analyses|45|||
155020520|NCT02088905|559503342|FG000|Overall Study|Withdrawal by Subject|5|||
155020521|NCT02088905|559503343|FG001|Overall Study|Withdrawal by Subject|1|||
155020522|NCT01562782|559503346|FG000|Overall Study|Withdrawal by Subject|3|||
155020523|NCT01562782|559503347|FG001|Overall Study|Withdrawal by Subject|3|||
155020524|NCT01562782|559503346|FG000|Overall Study|screen failure|1|||
155020525|NCT01562782|559503347|FG001|Overall Study|screen failure|2|||
155020526|NCT02097238|559503351|FG000|Overall Study|Death|1|||
155020527|NCT02097238|559503351|FG000|Overall Study|Physician Decision|1|||
155020528|NCT02097238|559503351|FG000|Overall Study|Progressive Disease|17|||
155020529|NCT01106911|559503352|FG000|Overall Study|Physician Decision|2|||
155020530|NCT01106911|559503352|FG000|Overall Study|deemed ineligible after screening|3|||
155020531|NCT01814696|559503354|FG000|Overall Study|Withdrawal by Subject|1|||
155020532|NCT01814696|559503355|FG001|Overall Study|Withdrawal by Subject|0|||
155020533|NCT01814696|559503354|FG000|Overall Study|Randomized to wrong group|1|||
155020534|NCT01814696|559503355|FG001|Overall Study|Randomized to wrong group|0|||
155020535|NCT00356148|559503358|FG000|Overall Study|Reoperation within 30 days|2|||
155020536|NCT00356148|559503359|FG001|Overall Study|Reoperation within 30 days|1|||
155020537|NCT02484456|559503360|FG000|Washout Period|Withdrawal by Subject|0|||
155020538|NCT02484456|559503361|FG001|Washout Period|Withdrawal by Subject|1|||
155020539|NCT02484456|559503360|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
155020540|NCT02484456|559503361|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
155020541|NCT02484456|559503360|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
155020542|NCT02484456|559503361|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
155020543|NCT02484456|559503360|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
155020544|NCT02484456|559503361|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
155020545|NCT00708214|559503362|FG000|Overall Study|Other Adverse Event|3|||
155179495|NCT01992159|560096318|FG000|Overall Study|Death|0|||
155179496|NCT01992159|560096319|FG001|Overall Study|Death|0|||
155179497|NCT01992159|560096320|FG002|Overall Study|Death|1|||
155179498|NCT01992159|560096321|FG003|Overall Study|Death|0|||
155179499|NCT00470158|560096329|FG000|Overall Study|Death|0|||
155179500|NCT00470158|560096330|FG001|Overall Study|Death|0|||
155179501|NCT00470158|560096331|FG002|Overall Study|Death|0|||
155179502|NCT00470158|560096332|FG003|Overall Study|Death|0|||
155020546|NCT00708214|559503363|FG001|Overall Study|Other Adverse Event|6|||
155020547|NCT00708214|559503364|FG002|Overall Study|Other Adverse Event|2|||
155020548|NCT00708214|559503362|FG000|Overall Study|Other|0|||
155020549|NCT00708214|559503363|FG001|Overall Study|Other|1|||
155020550|NCT00708214|559503364|FG002|Overall Study|Other|1|||
155020551|NCT00708214|559503362|FG000|Overall Study|Progressive Disease|4|||
155020552|NCT00708214|559503363|FG001|Overall Study|Progressive Disease|6|||
155020553|NCT00708214|559503364|FG002|Overall Study|Progressive Disease|5|||
155179503|NCT00470158|560096333|FG004|Overall Study|Death|2|||
155179504|NCT00470158|560096329|FG000|Overall Study|Lost to Follow-up|7|||
155179505|NCT00470158|560096330|FG001|Overall Study|Lost to Follow-up|8|||
155179506|NCT00470158|560096331|FG002|Overall Study|Lost to Follow-up|8|||
155179507|NCT00470158|560096332|FG003|Overall Study|Lost to Follow-up|5|||
155179508|NCT00470158|560096333|FG004|Overall Study|Lost to Follow-up|4|||
155020554|NCT02199795|559503365|FG000|Overall Study|no longer met inclusion criteria|1|||
155020555|NCT02199795|559503366|FG001|Overall Study|no longer met inclusion criteria|0|||
155179509|NCT00470158|560096329|FG000|Overall Study|Protocol Violation|1|||
155020556|NCT02199795|559503365|FG000|Overall Study|withdrew due to shoulder pain|1|||
155020557|NCT02199795|559503366|FG001|Overall Study|withdrew due to shoulder pain|0|||
155179510|NCT00470158|560096330|FG001|Overall Study|Protocol Violation|0|||
155179511|NCT00470158|560096331|FG002|Overall Study|Protocol Violation|0|||
155020558|NCT02677922|559503375|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
155020559|NCT02677922|559503376|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
155020560|NCT02677922|559503377|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
155020561|NCT02677922|559503378|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
155020562|NCT02677922|559503379|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
155020563|NCT02677922|559503380|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
155020564|NCT02677922|559503375|FG000|Treatment Period|Adverse Event|0|||
155020565|NCT02677922|559503376|FG001|Treatment Period|Adverse Event|0|||
155020566|NCT02677922|559503377|FG002|Treatment Period|Adverse Event|1|||
155020567|NCT02677922|559503378|FG003|Treatment Period|Adverse Event|3|||
155020568|NCT02677922|559503379|FG004|Treatment Period|Adverse Event|5|||
155020569|NCT02677922|559503380|FG005|Treatment Period|Adverse Event|2|||
155020570|NCT02677922|559503375|FG000|Treatment Period|Progressive Disease|1|||
155020571|NCT02677922|559503376|FG001|Treatment Period|Progressive Disease|1|||
155020572|NCT02677922|559503377|FG002|Treatment Period|Progressive Disease|0|||
155020573|NCT02677922|559503378|FG003|Treatment Period|Progressive Disease|0|||
155020574|NCT02677922|559503379|FG004|Treatment Period|Progressive Disease|8|||
155139332|NCT02104947|559942731|FG000|Overall Study|Withdrawal by Subject|10|||
155139333|NCT02104947|559942732|FG001|Overall Study|Withdrawal by Subject|3|||
155139334|NCT02104947|559942731|FG000|Overall Study|Lost to Follow-up|4|||
155139335|NCT02104947|559942732|FG001|Overall Study|Lost to Follow-up|4|||
155139336|NCT02104947|559942731|FG000|Overall Study|Protocol Violation|6|||
155139337|NCT02104947|559942732|FG001|Overall Study|Protocol Violation|8|||
155139338|NCT02104947|559942731|FG000|Overall Study|Adverse Event|57|||
155139339|NCT02104947|559942732|FG001|Overall Study|Adverse Event|38|||
155139340|NCT02104947|559942731|FG000|Overall Study|Other than stated above|2|||
155139341|NCT02104947|559942732|FG001|Overall Study|Other than stated above|3|||
155139342|NCT04384523|559942733|FG000|Overall Study|Lost to Follow-up|0|||
155139343|NCT04384523|559942734|FG001|Overall Study|Lost to Follow-up|0|||
155139344|NCT04384523|559942735|FG002|Overall Study|Lost to Follow-up|0|||
155139345|NCT04384523|559942736|FG003|Overall Study|Lost to Follow-up|0|||
155139346|NCT04384523|559942737|FG004|Overall Study|Lost to Follow-up|0|||
155139347|NCT04384523|559942738|FG005|Overall Study|Lost to Follow-up|1|||
155139348|NCT04384523|559942733|FG000|Overall Study|Protocol Violation|0|||
155139349|NCT04384523|559942734|FG001|Overall Study|Protocol Violation|1|||
155139350|NCT04384523|559942735|FG002|Overall Study|Protocol Violation|0|||
155139351|NCT04384523|559942736|FG003|Overall Study|Protocol Violation|0|||
155139352|NCT04384523|559942737|FG004|Overall Study|Protocol Violation|0|||
155139353|NCT04384523|559942738|FG005|Overall Study|Protocol Violation|0|||
155139354|NCT04384523|559942733|FG000|Overall Study|Withdrawal by Subject|1|||
155139355|NCT04384523|559942734|FG001|Overall Study|Withdrawal by Subject|0|||
155139356|NCT04384523|559942735|FG002|Overall Study|Withdrawal by Subject|0|||
155139357|NCT04384523|559942736|FG003|Overall Study|Withdrawal by Subject|0|||
155139358|NCT04384523|559942737|FG004|Overall Study|Withdrawal by Subject|0|||
155139359|NCT04384523|559942738|FG005|Overall Study|Withdrawal by Subject|0|||
155139360|NCT02305238|559942739|FG000|Overall Study|Death|2|||
155139361|NCT02305238|559942740|FG001|Overall Study|Death|1|||
155139362|NCT02305238|559942741|FG002|Overall Study|Death|0|||
155139363|NCT02305238|559942739|FG000|Overall Study|Progressive disease|4|||
155139364|NCT02305238|559942740|FG001|Overall Study|Progressive disease|4|||
155139365|NCT02305238|559942741|FG002|Overall Study|Progressive disease|0|||
155139366|NCT02305238|559942739|FG000|Overall Study|Logistical difficulties|1|||
155139367|NCT02305238|559942740|FG001|Overall Study|Logistical difficulties|3|||
155139368|NCT02305238|559942741|FG002|Overall Study|Logistical difficulties|0|||
155139369|NCT02305238|559942739|FG000|Overall Study|Protocol Violation|0|||
155139370|NCT02305238|559942740|FG001|Overall Study|Protocol Violation|3|||
155139371|NCT02305238|559942741|FG002|Overall Study|Protocol Violation|0|||
155139372|NCT02305238|559942739|FG000|Overall Study|Physician Decision|2|||
155139373|NCT02305238|559942740|FG001|Overall Study|Physician Decision|1|||
155139374|NCT02305238|559942741|FG002|Overall Study|Physician Decision|0|||
155139375|NCT02305238|559942739|FG000|Overall Study|Adverse Event|4|||
155139376|NCT02305238|559942740|FG001|Overall Study|Adverse Event|2|||
155139377|NCT02305238|559942741|FG002|Overall Study|Adverse Event|0|||
155139378|NCT02305238|559942739|FG000|Overall Study|Withdrawal by Subject|3|||
155139379|NCT02305238|559942740|FG001|Overall Study|Withdrawal by Subject|4|||
155139380|NCT02305238|559942741|FG002|Overall Study|Withdrawal by Subject|0|||
155139381|NCT02305238|559942739|FG000|Overall Study|Randomized failure|0|||
155020575|NCT02677922|559503380|FG005|Treatment Period|Progressive Disease|7|||
155020576|NCT02677922|559503375|FG000|Treatment Period|Lack of Efficacy|0|||
155139382|NCT02305238|559942740|FG001|Overall Study|Randomized failure|0|||
155020577|NCT02677922|559503376|FG001|Treatment Period|Lack of Efficacy|0|||
155020578|NCT02677922|559503377|FG002|Treatment Period|Lack of Efficacy|0|||
155139383|NCT02305238|559942741|FG002|Overall Study|Randomized failure|8|||
155139384|NCT02305238|559942739|FG000|Overall Study|Required procedure failed|0|||
155139385|NCT02305238|559942740|FG001|Overall Study|Required procedure failed|1|||
155020579|NCT02677922|559503378|FG003|Treatment Period|Lack of Efficacy|1|||
155139386|NCT02305238|559942741|FG002|Overall Study|Required procedure failed|0|||
155020580|NCT02677922|559503379|FG004|Treatment Period|Lack of Efficacy|1|||
155020581|NCT02677922|559503380|FG005|Treatment Period|Lack of Efficacy|6|||
155020582|NCT02677922|559503375|FG000|Treatment Period|Withdrawal by Subject|0|||
155020583|NCT02677922|559503376|FG001|Treatment Period|Withdrawal by Subject|0|||
155020584|NCT02677922|559503377|FG002|Treatment Period|Withdrawal by Subject|1|||
155020585|NCT02677922|559503378|FG003|Treatment Period|Withdrawal by Subject|3|||
155020586|NCT02677922|559503379|FG004|Treatment Period|Withdrawal by Subject|5|||
155020587|NCT02677922|559503380|FG005|Treatment Period|Withdrawal by Subject|5|||
155020588|NCT02677922|559503375|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
155020589|NCT02677922|559503376|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
155020590|NCT02677922|559503377|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
155020591|NCT02677922|559503378|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
155020592|NCT02677922|559503379|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
155020593|NCT02677922|559503380|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
155020594|NCT02677922|559503375|FG000|Treatment Period|Disease Relapse|0|||
155020595|NCT02677922|559503376|FG001|Treatment Period|Disease Relapse|0|||
155020596|NCT02677922|559503377|FG002|Treatment Period|Disease Relapse|0|||
155020597|NCT02677922|559503378|FG003|Treatment Period|Disease Relapse|3|||
155020598|NCT02677922|559503379|FG004|Treatment Period|Disease Relapse|6|||
155020599|NCT02677922|559503380|FG005|Treatment Period|Disease Relapse|1|||
155020600|NCT02677922|559503375|FG000|Treatment Period|Allogeneic HSCT|1|||
155020601|NCT02677922|559503376|FG001|Treatment Period|Allogeneic HSCT|0|||
155020602|NCT02677922|559503377|FG002|Treatment Period|Allogeneic HSCT|0|||
155020603|NCT02677922|559503378|FG003|Treatment Period|Allogeneic HSCT|1|||
155020604|NCT02677922|559503379|FG004|Treatment Period|Allogeneic HSCT|4|||
155020605|NCT02677922|559503380|FG005|Treatment Period|Allogeneic HSCT|1|||
155020606|NCT02677922|559503375|FG000|Treatment Period|Other Reasons|0|||
155020607|NCT02677922|559503376|FG001|Treatment Period|Other Reasons|0|||
155020608|NCT02677922|559503377|FG002|Treatment Period|Other Reasons|0|||
155020609|NCT02677922|559503378|FG003|Treatment Period|Other Reasons|1|||
155020610|NCT02677922|559503379|FG004|Treatment Period|Other Reasons|3|||
155020611|NCT02677922|559503380|FG005|Treatment Period|Other Reasons|5|||
155020612|NCT02677922|559503375|FG000|Treatment Period|Death|0|||
155020613|NCT02677922|559503376|FG001|Treatment Period|Death|0|||
155020614|NCT02677922|559503377|FG002|Treatment Period|Death|0|||
155020615|NCT02677922|559503378|FG003|Treatment Period|Death|0|||
155020616|NCT02677922|559503379|FG004|Treatment Period|Death|12|||
155020617|NCT02677922|559503380|FG005|Treatment Period|Death|1|||
155020618|NCT02677922|559503375|FG000|Treatment Period|Non-compliance with Study Drug|0|||
155020619|NCT02677922|559503376|FG001|Treatment Period|Non-compliance with Study Drug|0|||
155020620|NCT02677922|559503377|FG002|Treatment Period|Non-compliance with Study Drug|0|||
155020621|NCT02677922|559503378|FG003|Treatment Period|Non-compliance with Study Drug|0|||
155020622|NCT02677922|559503379|FG004|Treatment Period|Non-compliance with Study Drug|1|||
155020623|NCT02677922|559503380|FG005|Treatment Period|Non-compliance with Study Drug|0|||
155020624|NCT02677922|559503375|FG000|Treatment Period|Physician Decision|0|||
155020625|NCT02677922|559503376|FG001|Treatment Period|Physician Decision|0|||
155020626|NCT02677922|559503377|FG002|Treatment Period|Physician Decision|0|||
155020627|NCT02677922|559503378|FG003|Treatment Period|Physician Decision|0|||
155020628|NCT02677922|559503379|FG004|Treatment Period|Physician Decision|0|||
155020629|NCT02677922|559503380|FG005|Treatment Period|Physician Decision|1|||
155020630|NCT02677922|559503375|FG000|Treatment Period|Symptomatic Deterioration|0|||
155020631|NCT02677922|559503376|FG001|Treatment Period|Symptomatic Deterioration|0|||
155020632|NCT02677922|559503377|FG002|Treatment Period|Symptomatic Deterioration|0|||
155020633|NCT02677922|559503378|FG003|Treatment Period|Symptomatic Deterioration|0|||
155020634|NCT02677922|559503379|FG004|Treatment Period|Symptomatic Deterioration|1|||
155020635|NCT02677922|559503380|FG005|Treatment Period|Symptomatic Deterioration|0|||
155020636|NCT04481789|559503381|FG000|Period 1|Withdrawal by Subject|1|||
155020637|NCT04481789|559503382|FG001|Period 1|Withdrawal by Subject|0|||
155020638|NCT04481789|559503383|FG002|Period 1|Withdrawal by Subject|0|||
155020639|NCT04481789|559503384|FG003|Period 1|Withdrawal by Subject|0|||
155139387|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
155139388|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
155139389|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
155020640|NCT04481789|559503385|FG004|Period 1|Withdrawal by Subject|0|||
155020641|NCT04481789|559503386|FG005|Period 1|Withdrawal by Subject|0|||
155020642|NCT03124407|559503391|FG000|Overall Study|Lost to Follow-up|1|||
155020643|NCT03124407|559503392|FG001|Overall Study|Lost to Follow-up|0|||
155020644|NCT03124407|559503393|FG002|Overall Study|Lost to Follow-up|0|||
155020645|NCT03124407|559503394|FG003|Overall Study|Lost to Follow-up|0|||
155020646|NCT03124407|559503391|FG000|Overall Study|Adverse Event|0|||
155020647|NCT03124407|559503392|FG001|Overall Study|Adverse Event|0|||
155020648|NCT03124407|559503393|FG002|Overall Study|Adverse Event|1|||
155020649|NCT03124407|559503394|FG003|Overall Study|Adverse Event|0|||
155020650|NCT05708976|559503400|FG000|Overall Study|Withdrawal by Subject|0|||
155020651|NCT05708976|559503401|FG001|Overall Study|Withdrawal by Subject|1|||
155020652|NCT01303172|559503404|FG000|Overall Study|Physician Decision|9|||
155020653|NCT01303172|559503405|FG001|Overall Study|Physician Decision|6|||
155020654|NCT01303172|559503404|FG000|Overall Study|Adverse Event|5|||
155020655|NCT01303172|559503405|FG001|Overall Study|Adverse Event|2|||
155020656|NCT01303172|559503404|FG000|Overall Study|Withdrawal by Subject|4|||
155020657|NCT01303172|559503405|FG001|Overall Study|Withdrawal by Subject|2|||
155020658|NCT01303172|559503404|FG000|Overall Study|Death|20|||
155020659|NCT01303172|559503405|FG001|Overall Study|Death|7|||
155020660|NCT01303172|559503404|FG000|Overall Study|Lack of Efficacy|25|||
155020661|NCT01303172|559503405|FG001|Overall Study|Lack of Efficacy|17|||
155020662|NCT03564119|559503413|FG000|Overall Study|Adverse Event|4|||
155020663|NCT03564119|559503414|FG001|Overall Study|Adverse Event|0|||
155020664|NCT03564119|559503413|FG000|Overall Study|Lost to Follow-up|1|||
155020665|NCT03564119|559503414|FG001|Overall Study|Lost to Follow-up|4|||
155020666|NCT03564119|559503413|FG000|Overall Study|Protocol Violation|1|||
155020667|NCT03564119|559503414|FG001|Overall Study|Protocol Violation|0|||
155020668|NCT03564119|559503413|FG000|Overall Study|Withdrawal by Subject|9|||
155020669|NCT03564119|559503414|FG001|Overall Study|Withdrawal by Subject|4|||
155020670|NCT03564119|559503413|FG000|Overall Study|Other Than Specified|0|||
155020671|NCT03564119|559503414|FG001|Overall Study|Other Than Specified|1|||
155020672|NCT03627546|559503415|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
155020673|NCT03627546|559503416|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
155020674|NCT03627546|559503417|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
155020675|NCT03627546|559503415|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
155020676|NCT03627546|559503416|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
155020677|NCT03627546|559503417|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
155020678|NCT01537042|559503420|FG000|Overall Study|Adverse Event|0|||
155020679|NCT01537042|559503421|FG001|Overall Study|Adverse Event|2|||
155020680|NCT01537042|559503420|FG000|Overall Study|Lack of Efficacy|0|||
155020681|NCT01537042|559503421|FG001|Overall Study|Lack of Efficacy|1|||
155020682|NCT01537042|559503420|FG000|Overall Study|Protocol Violation|0|||
155020683|NCT01537042|559503421|FG001|Overall Study|Protocol Violation|1|||
155020684|NCT01537042|559503420|FG000|Overall Study|Other|0|||
155020685|NCT01537042|559503421|FG001|Overall Study|Other|1|||
155020686|NCT02741076|559503422|FG000|Overall Study|Adverse Event|0|||
155020687|NCT02741076|559503423|FG001|Overall Study|Adverse Event|1|||
155020688|NCT02741076|559503424|FG002|Overall Study|Adverse Event|1|||
155020689|NCT02741076|559503425|FG003|Overall Study|Adverse Event|0|||
155020690|NCT02741076|559503422|FG000|Overall Study|Lack of Efficacy|1|||
155020691|NCT02741076|559503423|FG001|Overall Study|Lack of Efficacy|0|||
155020692|NCT02741076|559503424|FG002|Overall Study|Lack of Efficacy|0|||
155020693|NCT02741076|559503425|FG003|Overall Study|Lack of Efficacy|0|||
155020694|NCT02741076|559503422|FG000|Overall Study|Withdrawal by Subject|0|||
155020695|NCT02741076|559503423|FG001|Overall Study|Withdrawal by Subject|1|||
155020696|NCT02741076|559503424|FG002|Overall Study|Withdrawal by Subject|0|||
155020697|NCT02741076|559503425|FG003|Overall Study|Withdrawal by Subject|0|||
155020698|NCT02741076|559503422|FG000|Overall Study|Sponsor Request|2|||
155020699|NCT02741076|559503423|FG001|Overall Study|Sponsor Request|3|||
155020700|NCT02741076|559503424|FG002|Overall Study|Sponsor Request|0|||
155020701|NCT02741076|559503425|FG003|Overall Study|Sponsor Request|1|||
155020702|NCT02741076|559503422|FG000|Overall Study|No additional information available|0|||
155020703|NCT02741076|559503423|FG001|Overall Study|No additional information available|0|||
155020704|NCT02741076|559503424|FG002|Overall Study|No additional information available|1|||
155020705|NCT02741076|559503425|FG003|Overall Study|No additional information available|1|||
155020706|NCT01779440|559503428|FG000|Overall Study|Withdrawal by Subject|3|||
155020707|NCT01779440|559503429|FG001|Overall Study|Withdrawal by Subject|5|||
155020708|NCT02965573|559503430|FG000|Overall Study|Lack of Efficacy|1|||
155020709|NCT02965573|559503431|FG001|Overall Study|Lack of Efficacy|0|||
155020710|NCT00086619|559503433|FG000|Overall Study|Withdrawal by Subject|6|||
155020711|NCT00086619|559503434|FG001|Overall Study|Withdrawal by Subject|6|||
155020712|NCT00086619|559503433|FG000|Overall Study|Adverse Event|8|||
155020713|NCT00086619|559503434|FG001|Overall Study|Adverse Event|10|||
155020714|NCT00086619|559503433|FG000|Overall Study|Protocol Violation|1|||
155020715|NCT00086619|559503434|FG001|Overall Study|Protocol Violation|1|||
155139390|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Death|0|||
155139391|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Death|2|||
155139392|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Death|0|||
155139393|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
155139394|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
155020716|NCT02644668|559503435|FG000|Overall Study|Adverse Event|2|||
155020717|NCT02644668|559503436|FG001|Overall Study|Adverse Event|0|||
155020718|NCT02644668|559503437|FG002|Overall Study|Adverse Event|1|||
155020719|NCT02644668|559503435|FG000|Overall Study|Protocol Violation|0|||
155020720|NCT02644668|559503436|FG001|Overall Study|Protocol Violation|0|||
155020721|NCT02644668|559503437|FG002|Overall Study|Protocol Violation|1|||
155020722|NCT02644668|559503435|FG000|Overall Study|Withdrawal by Subject|0|||
155020723|NCT02644668|559503436|FG001|Overall Study|Withdrawal by Subject|0|||
155020724|NCT02644668|559503437|FG002|Overall Study|Withdrawal by Subject|1|||
155020725|NCT01209520|559503438|FG000|Overall Study|Withdrawal by Subject|3|||
155179512|NCT00470158|560096332|FG003|Overall Study|Protocol Violation|0|||
155179513|NCT00470158|560096333|FG004|Overall Study|Protocol Violation|0|||
155179514|NCT00880685|560096334|FG000|Memantine 10mg|Lost to Follow-up|2|||
155179515|NCT00880685|560096334|FG000|Memantine 20mg|Withdrawal by Subject|1|||
155179516|NCT04179890|560096335|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
155179517|NCT04179890|560096336|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
155179518|NCT04179890|560096335|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
155179519|NCT04179890|560096336|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
155179520|NCT04179890|560096335|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
155179521|NCT04179890|560096336|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
155179522|NCT04179890|560096335|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
155179523|NCT04179890|560096336|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
155179524|NCT04179890|560096335|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
155179525|NCT04179890|560096336|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
155179526|NCT04179890|560096335|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
155179527|NCT04179890|560096336|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
155179528|NCT04179890|560096335|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
155179529|NCT04179890|560096336|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
155179530|NCT04179890|560096335|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
155179531|NCT04179890|560096336|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
155179532|NCT04179890|560096335|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
155179533|NCT04179890|560096336|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
155179534|NCT01236118|560096337|FG000|Overall Study|Adverse Event|2|||
155179535|NCT01236118|560096338|FG001|Overall Study|Adverse Event|0|||
155179536|NCT01236118|560096339|FG002|Overall Study|Adverse Event|2|||
155179537|NCT01236118|560096337|FG000|Overall Study|Physician Decision|0|||
155179538|NCT01236118|560096338|FG001|Overall Study|Physician Decision|1|||
155179539|NCT01236118|560096339|FG002|Overall Study|Physician Decision|0|||
155179540|NCT01236118|560096337|FG000|Overall Study|Withdrawal by Subject|0|||
155179541|NCT01236118|560096338|FG001|Overall Study|Withdrawal by Subject|0|||
155179542|NCT01236118|560096339|FG002|Overall Study|Withdrawal by Subject|1|||
155179543|NCT04535167|560096340|FG000|Treatment|Adverse Event|0|||
155179544|NCT04535167|560096341|FG001|Treatment|Adverse Event|0|||
155179545|NCT04535167|560096342|FG002|Treatment|Adverse Event|0|||
155179546|NCT04535167|560096343|FG003|Treatment|Adverse Event|0|||
155179547|NCT04535167|560096344|FG004|Treatment|Adverse Event|0|||
155179548|NCT04535167|560096345|FG005|Treatment|Adverse Event|0|||
155179549|NCT04535167|560096346|FG006|Treatment|Adverse Event|1|||
155179550|NCT04535167|560096340|FG000|Follow-Up|Death|0|||
155179551|NCT04535167|560096341|FG001|Follow-Up|Death|0|||
155179552|NCT04535167|560096342|FG002|Follow-Up|Death|0|||
155179553|NCT04535167|560096343|FG003|Follow-Up|Death|0|||
155179554|NCT04535167|560096344|FG004|Follow-Up|Death|0|||
155179555|NCT04535167|560096345|FG005|Follow-Up|Death|0|||
155179556|NCT04535167|560096346|FG006|Follow-Up|Death|1|||
155179557|NCT04535167|560096340|FG000|Follow-Up|Lost to Follow-up|0|||
155179558|NCT04535167|560096341|FG001|Follow-Up|Lost to Follow-up|0|||
155179559|NCT04535167|560096342|FG002|Follow-Up|Lost to Follow-up|0|||
155179560|NCT04535167|560096343|FG003|Follow-Up|Lost to Follow-up|1|||
155179561|NCT04535167|560096344|FG004|Follow-Up|Lost to Follow-up|0|||
155179562|NCT04535167|560096345|FG005|Follow-Up|Lost to Follow-up|0|||
155179563|NCT04535167|560096346|FG006|Follow-Up|Lost to Follow-up|0|||
155179564|NCT00978432|560096347|FG000|Overall Study|Withdrawal by Subject|0|||
155179565|NCT00978432|560096348|FG001|Overall Study|Withdrawal by Subject|0|||
155179566|NCT00978432|560096349|FG002|Overall Study|Withdrawal by Subject|1|||
155179567|NCT00978432|560096347|FG000|Overall Study|Lack of Efficacy|1|||
155179568|NCT00978432|560096348|FG001|Overall Study|Lack of Efficacy|1|||
155179569|NCT00978432|560096349|FG002|Overall Study|Lack of Efficacy|3|||
155179570|NCT00978432|560096347|FG000|Overall Study|Adverse Event|2|||
155179571|NCT00978432|560096348|FG001|Overall Study|Adverse Event|0|||
155179572|NCT00978432|560096349|FG002|Overall Study|Adverse Event|1|||
155179573|NCT03404960|560096351|FG000|Overall Study|Adverse Event|0|||
155179574|NCT03404960|560096352|FG001|Overall Study|Adverse Event|2|||
155179575|NCT03404960|560096351|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
155179576|NCT03404960|560096352|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
155179577|NCT03404960|560096351|FG000|Overall Study|Bowel obstruction|0|||
155179578|NCT03404960|560096352|FG001|Overall Study|Bowel obstruction|1|||
155179579|NCT03404960|560096351|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
155179580|NCT03404960|560096352|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
155179581|NCT00246571|560096353|FG000|Overall Study|Adverse Event|7|||
155020726|NCT01500382|559503440|FG000|Washout Period|Study site went out of business|0|||
155020727|NCT01500382|559503441|FG001|Washout Period|Study site went out of business|0|||
155020728|NCT01500382|559503442|FG002|Washout Period|Study site went out of business|1|||
155020729|NCT01500382|559503443|FG003|Washout Period|Study site went out of business|0|||
155020730|NCT03291431|559503444|FG000|Overall Study|Protocol Violation|2|||
155020731|NCT03291431|559503445|FG001|Overall Study|Protocol Violation|1|||
155020732|NCT03291431|559503444|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
155020733|NCT03291431|559503445|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
155020734|NCT03291431|559503444|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
155020735|NCT03291431|559503445|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
155020736|NCT04725812|559505064|FG000|Overall Study|Withdrawal by Subject|1|||
155020737|NCT00839800|559505067|FG000|Overall Study|Adverse Event|8|||
155020738|NCT00839800|559505068|FG001|Overall Study|Adverse Event|12|||
155020739|NCT00839800|559505067|FG000|Overall Study|Lost to Follow-up|31|||
155020740|NCT00839800|559505068|FG001|Overall Study|Lost to Follow-up|26|||
155020741|NCT00839800|559505067|FG000|Overall Study|Withdrawal by Subject|28|||
155020742|NCT00839800|559505068|FG001|Overall Study|Withdrawal by Subject|34|||
155020743|NCT00839800|559505067|FG000|Overall Study|Incorrect Enrolment|3|||
155020744|NCT00839800|559505068|FG001|Overall Study|Incorrect Enrolment|3|||
155020745|NCT00839800|559505067|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
155020746|NCT00839800|559505068|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
155020747|NCT00839800|559505067|FG000|Overall Study|Safety Reasons|2|||
155020748|NCT00839800|559505068|FG001|Overall Study|Safety Reasons|1|||
155020749|NCT00839800|559505067|FG000|Overall Study|Other|8|||
155020750|NCT00839800|559505068|FG001|Overall Study|Other|14|||
155020751|NCT00839800|559505067|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
155020752|NCT00839800|559505068|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
155020753|NCT02801617|559505070|FG000|Overall Study|Protocol Violation|2|||
155020754|NCT02801617|559505071|FG001|Overall Study|Protocol Violation|6|||
155020755|NCT01164579|559505072|FG000|Overall Study|Lack of Efficacy|0|||
155020756|NCT01164579|559505073|FG001|Overall Study|Lack of Efficacy|0|||
155020757|NCT01164579|559505074|FG002|Overall Study|Lack of Efficacy|6|||
155020758|NCT01164579|559505072|FG000|Overall Study|Lost to Follow-up|1|||
155020759|NCT01164579|559505073|FG001|Overall Study|Lost to Follow-up|1|||
155020760|NCT01164579|559505074|FG002|Overall Study|Lost to Follow-up|0|||
155020761|NCT01164579|559505072|FG000|Overall Study|Withdrawal by Subject|2|||
155020762|NCT01164579|559505073|FG001|Overall Study|Withdrawal by Subject|5|||
155020763|NCT01164579|559505074|FG002|Overall Study|Withdrawal by Subject|3|||
155020764|NCT01164579|559505072|FG000|Overall Study|Protocol Violation|0|||
155020765|NCT01164579|559505073|FG001|Overall Study|Protocol Violation|1|||
155020766|NCT01164579|559505074|FG002|Overall Study|Protocol Violation|2|||
155020767|NCT01164579|559505072|FG000|Overall Study|Adverse Event|4|||
155020768|NCT01164579|559505073|FG001|Overall Study|Adverse Event|2|||
155020769|NCT01164579|559505074|FG002|Overall Study|Adverse Event|5|||
155020770|NCT01164579|559505072|FG000|Overall Study|Reason not specified|1|||
155020771|NCT01164579|559505073|FG001|Overall Study|Reason not specified|0|||
155020772|NCT01164579|559505074|FG002|Overall Study|Reason not specified|0|||
155020773|NCT02476578|559505078|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
155020774|NCT02476578|559505079|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
155020775|NCT02476578|559505078|FG000|Overall Study|Lost to Follow-up|6|||
155020776|NCT02476578|559505079|FG001|Overall Study|Lost to Follow-up|13|||
155020777|NCT02237196|559505082|FG000|Overall Study|Adverse Event|0|||
155020778|NCT02237196|559505083|FG001|Overall Study|Adverse Event|1|||
155020779|NCT02237196|559505084|FG002|Overall Study|Adverse Event|1|||
155020780|NCT02237196|559505085|FG003|Overall Study|Adverse Event|0|||
155020781|NCT02237196|559505082|FG000|Overall Study|Lost to Follow-up|4|||
155020782|NCT02237196|559505083|FG001|Overall Study|Lost to Follow-up|2|||
155020783|NCT02237196|559505084|FG002|Overall Study|Lost to Follow-up|4|||
155020784|NCT02237196|559505085|FG003|Overall Study|Lost to Follow-up|6|||
155139395|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
155139396|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
155139397|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
155020785|NCT02237196|559505082|FG000|Overall Study|Physician Decision|2|||
155020786|NCT02237196|559505083|FG001|Overall Study|Physician Decision|0|||
155020787|NCT02237196|559505084|FG002|Overall Study|Physician Decision|0|||
155020788|NCT02237196|559505085|FG003|Overall Study|Physician Decision|1|||
155020789|NCT02237196|559505082|FG000|Overall Study|Pregnancy|0|||
155139398|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
155139399|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
155020790|NCT02237196|559505083|FG001|Overall Study|Pregnancy|0|||
155020791|NCT02237196|559505084|FG002|Overall Study|Pregnancy|1|||
155020792|NCT02237196|559505085|FG003|Overall Study|Pregnancy|1|||
155020793|NCT02237196|559505082|FG000|Overall Study|Withdrawal by Subject|1|||
155020794|NCT02237196|559505083|FG001|Overall Study|Withdrawal by Subject|1|||
155020795|NCT02237196|559505084|FG002|Overall Study|Withdrawal by Subject|4|||
155020796|NCT02237196|559505085|FG003|Overall Study|Withdrawal by Subject|1|||
155020797|NCT02237196|559505082|FG000|Overall Study|Site Error|1|||
155020798|NCT02237196|559505083|FG001|Overall Study|Site Error|2|||
155020799|NCT02237196|559505084|FG002|Overall Study|Site Error|0|||
155020800|NCT02237196|559505085|FG003|Overall Study|Site Error|2|||
155020801|NCT04157296|559505086|FG000|Overall Study|Withdrawal by Subject|0|||
155020802|NCT04157296|559505087|FG001|Overall Study|Withdrawal by Subject|1|||
155179582|NCT00246571|560096354|FG001|Overall Study|Adverse Event|0|||
155179583|NCT00246571|560096353|FG000|Overall Study|Protocol Violation|0|||
155179584|NCT00246571|560096354|FG001|Overall Study|Protocol Violation|1|||
155179585|NCT00246571|560096353|FG000|Overall Study|Withdrawal by Subject|2|||
155179586|NCT00246571|560096354|FG001|Overall Study|Withdrawal by Subject|3|||
155179587|NCT00246571|560096353|FG000|Overall Study|Lack of Efficacy|84|||
155179588|NCT00246571|560096354|FG001|Overall Study|Lack of Efficacy|21|||
155179589|NCT00246571|560096353|FG000|Overall Study|Death|17|||
155179590|NCT00246571|560096354|FG001|Overall Study|Death|3|||
155179591|NCT00246571|560096353|FG000|Overall Study|Sponsor|0|||
155179592|NCT00246571|560096354|FG001|Overall Study|Sponsor|1|||
155179593|NCT00246571|560096353|FG000|Overall Study|Did not meet entrance criteria|2|||
155179594|NCT00246571|560096354|FG001|Overall Study|Did not meet entrance criteria|1|||
155179595|NCT00246571|560096353|FG000|Overall Study|Laboratory abnormalities|1|||
155179596|NCT00246571|560096354|FG001|Overall Study|Laboratory abnormalities|0|||
155179597|NCT00246571|560096353|FG000|Overall Study|Crossover participants|0|||
155179598|NCT00246571|560096354|FG001|Overall Study|Crossover participants|74|||
155179599|NCT05247398|560096358|FG000|Overall Study|Withdrawal by Subject|1|||
155179600|NCT04251156|560096359|FG000|Overall Study|Lost to Follow-up|1|||
155179601|NCT04251156|560096360|FG001|Overall Study|Lost to Follow-up|1|||
155179602|NCT04251156|560096359|FG000|Overall Study|Withdrawal by Subject|4|||
155179603|NCT04251156|560096360|FG001|Overall Study|Withdrawal by Subject|4|||
155179604|NCT04656275|560096361|FG000|Overall Study|Study terminated by sponsor|2|||
155179605|NCT04656275|560096362|FG001|Overall Study|Study terminated by sponsor|4|||
155179606|NCT05954143|560096365|FG000|Overall Study|Progressive Disease|1|||
155179607|NCT05954143|560096366|FG001|Overall Study|Progressive Disease|0|||
155179608|NCT05954143|560096365|FG000|Overall Study|Physician Decision|1|||
155179609|NCT05954143|560096366|FG001|Overall Study|Physician Decision|0|||
155179610|NCT05954143|560096365|FG000|Overall Study|Study Terminated by Sponsor|2|||
155179611|NCT05954143|560096366|FG001|Overall Study|Study Terminated by Sponsor|4|||
155179612|NCT05954143|560096365|FG000|Overall Study|Death|1|||
155179613|NCT05954143|560096366|FG001|Overall Study|Death|0|||
155179614|NCT05954143|560096365|FG000|Overall Study|Withdrawal by Subject|0|||
155179615|NCT05954143|560096366|FG001|Overall Study|Withdrawal by Subject|1|||
155179616|NCT05954143|560096365|FG000|Overall Study|Other|1|||
155179617|NCT05954143|560096366|FG001|Overall Study|Other|0|||
155179618|NCT01129024|560096369|FG000|Overall Study|Physician Decision|5|||
155179619|NCT01129024|560096369|FG000|Overall Study|Study Terminated by Sponsor|8|||
155179620|NCT01129024|560096369|FG000|Overall Study|Withdrawal by Subject|2|||
155179621|NCT01129024|560096369|FG000|Overall Study|Lack of Efficacy|3|||
155179622|NCT01129024|560096369|FG000|Overall Study|Needed a Platelet Transfusion|1|||
155179623|NCT00708201|560096377|FG000|Overall Study|Adverse Event|4|||
155179624|NCT00708201|560096378|FG001|Overall Study|Adverse Event|4|||
155179625|NCT00708201|560096377|FG000|Overall Study|Withdrawal by Subject|1|||
155179626|NCT00708201|560096378|FG001|Overall Study|Withdrawal by Subject|1|||
155179627|NCT00708201|560096377|FG000|Overall Study|Lost to Follow-up|2|||
155179628|NCT00708201|560096378|FG001|Overall Study|Lost to Follow-up|0|||
155179629|NCT00708201|560096377|FG000|Overall Study|Protocol Violation|0|||
155179630|NCT00708201|560096378|FG001|Overall Study|Protocol Violation|1|||
155179631|NCT00723203|560096379|FG000|Overall Study|Withdrawal by Subject|3|||
155179632|NCT01055496|560096380|FG000|Overall Study|Withdrawal by Subject|2|||
155179633|NCT01055496|560096381|FG001|Overall Study|Withdrawal by Subject|4|||
155179634|NCT01055496|560096380|FG000|Overall Study|Death|13|||
155179635|NCT01055496|560096381|FG001|Overall Study|Death|23|||
155179636|NCT01055496|560096380|FG000|Overall Study|Lost to Follow-up|0|||
155179637|NCT01055496|560096381|FG001|Overall Study|Lost to Follow-up|2|||
155179638|NCT01055496|560096380|FG000|Overall Study|Other - Unspecified|0|||
155179639|NCT01055496|560096381|FG001|Overall Study|Other - Unspecified|1|||
155179640|NCT00584740|560096382|FG000|Overall Study|Adverse Event|1|||
155020803|NCT04157296|559505086|FG000|Overall Study|Did not obtain second fMRI.|0|||
155179641|NCT00584740|560096383|FG001|Overall Study|Adverse Event|1|||
155179642|NCT00584740|560096382|FG000|Overall Study|Lack of Efficacy|8|||
155179643|NCT00584740|560096383|FG001|Overall Study|Lack of Efficacy|2|||
155179644|NCT00584740|560096382|FG000|Overall Study|Withdrawal by Subject|3|||
155020804|NCT04157296|559505087|FG001|Overall Study|Did not obtain second fMRI.|1|||
155020805|NCT04157296|559505086|FG000|Overall Study|MRI failed/no second fMRI|0|||
155179645|NCT00584740|560096383|FG001|Overall Study|Withdrawal by Subject|2|||
155179646|NCT00584740|560096382|FG000|Overall Study|Lost to Follow-up|0|||
155179647|NCT00584740|560096383|FG001|Overall Study|Lost to Follow-up|1|||
155179648|NCT03485495|560096386|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
155179649|NCT03485495|560096387|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
155020806|NCT04157296|559505087|FG001|Overall Study|MRI failed/no second fMRI|1|||
155020807|NCT01057810|559505088|FG000|Overall Study|Disease progression|156|||
155020808|NCT01057810|559505089|FG001|Overall Study|Disease progression|197|||
155020809|NCT01057810|559505088|FG000|Overall Study|Study drug toxicity|5|||
155020810|NCT01057810|559505089|FG001|Overall Study|Study drug toxicity|114|||
155020811|NCT01057810|559505088|FG000|Overall Study|Adverse event unrelated to study drug|13|||
155020812|NCT01057810|559505089|FG001|Overall Study|Adverse event unrelated to study drug|29|||
155020813|NCT01057810|559505088|FG000|Overall Study|Withdrawal by Subject|10|||
155020814|NCT01057810|559505089|FG001|Overall Study|Withdrawal by Subject|25|||
155020815|NCT01057810|559505088|FG000|Overall Study|Death|2|||
155020816|NCT01057810|559505089|FG001|Overall Study|Death|12|||
155020817|NCT01057810|559505088|FG000|Overall Study|Maximum clinical benefit|5|||
155020818|NCT01057810|559505089|FG001|Overall Study|Maximum clinical benefit|5|||
155020819|NCT01057810|559505088|FG000|Overall Study|Poor/non-compliance|0|||
155020820|NCT01057810|559505089|FG001|Overall Study|Poor/non-compliance|1|||
155020821|NCT01057810|559505088|FG000|Overall Study|No longer met study criteria|0|||
155020822|NCT01057810|559505089|FG001|Overall Study|No longer met study criteria|1|||
155020823|NCT01057810|559505088|FG000|Overall Study|Other|7|||
155020824|NCT01057810|559505089|FG001|Overall Study|Other|14|||
155020825|NCT00267969|559505090|FG000|Controlled Period|Adverse Event|6|||
155020826|NCT00267969|559505091|FG001|Controlled Period|Adverse Event|0|||
155020827|NCT00267969|559505092|FG002|Controlled Period|Adverse Event|2|||
155020828|NCT00267969|559505093|FG003|Controlled Period|Adverse Event|0|||
155020829|NCT00267969|559505094|FG004|Controlled Period|Adverse Event|0|||
155020830|NCT00267969|559505095|FG005|Controlled Period|Adverse Event|0|||
155020831|NCT00267969|559505096|FG006|Controlled Period|Adverse Event|0|||
155020832|NCT00267969|559505090|FG000|Controlled Period|Lack of Efficacy|3|||
155020833|NCT00267969|559505091|FG001|Controlled Period|Lack of Efficacy|0|||
155020834|NCT00267969|559505092|FG002|Controlled Period|Lack of Efficacy|1|||
155020835|NCT00267969|559505093|FG003|Controlled Period|Lack of Efficacy|0|||
155020836|NCT00267969|559505094|FG004|Controlled Period|Lack of Efficacy|0|||
155020837|NCT00267969|559505095|FG005|Controlled Period|Lack of Efficacy|0|||
155020838|NCT00267969|559505096|FG006|Controlled Period|Lack of Efficacy|0|||
155020839|NCT00267969|559505090|FG000|Controlled Period|Lost to Follow-up|1|||
155020840|NCT00267969|559505091|FG001|Controlled Period|Lost to Follow-up|0|||
155020841|NCT00267969|559505092|FG002|Controlled Period|Lost to Follow-up|1|||
155020842|NCT00267969|559505093|FG003|Controlled Period|Lost to Follow-up|0|||
155020843|NCT00267969|559505094|FG004|Controlled Period|Lost to Follow-up|0|||
155020844|NCT00267969|559505095|FG005|Controlled Period|Lost to Follow-up|0|||
155020845|NCT00267969|559505096|FG006|Controlled Period|Lost to Follow-up|0|||
155020846|NCT00267969|559505090|FG000|Controlled Period|Randomized but not treated|0|||
155020847|NCT00267969|559505091|FG001|Controlled Period|Randomized but not treated|0|||
155020848|NCT00267969|559505092|FG002|Controlled Period|Randomized but not treated|1|||
155020849|NCT00267969|559505093|FG003|Controlled Period|Randomized but not treated|0|||
155020850|NCT00267969|559505094|FG004|Controlled Period|Randomized but not treated|0|||
155020851|NCT00267969|559505095|FG005|Controlled Period|Randomized but not treated|0|||
155020852|NCT00267969|559505096|FG006|Controlled Period|Randomized but not treated|0|||
155020853|NCT00267969|559505090|FG000|Controlled Period|Other|2|||
155020854|NCT00267969|559505091|FG001|Controlled Period|Other|1|||
155020855|NCT00267969|559505092|FG002|Controlled Period|Other|6|||
155020856|NCT00267969|559505093|FG003|Controlled Period|Other|0|||
155020857|NCT00267969|559505094|FG004|Controlled Period|Other|0|||
155020858|NCT00267969|559505095|FG005|Controlled Period|Other|0|||
155020859|NCT00267969|559505096|FG006|Controlled Period|Other|0|||
155020860|NCT00267969|559505090|FG000|After Controlled Period|Adverse Event|0|||
155020861|NCT00267969|559505091|FG001|After Controlled Period|Adverse Event|0|||
155020862|NCT00267969|559505092|FG002|After Controlled Period|Adverse Event|0|||
155020863|NCT00267969|559505093|FG003|After Controlled Period|Adverse Event|7|||
155020864|NCT00267969|559505094|FG004|After Controlled Period|Adverse Event|8|||
155020865|NCT00267969|559505095|FG005|After Controlled Period|Adverse Event|23|||
155020866|NCT00267969|559505096|FG006|After Controlled Period|Adverse Event|21|||
155020867|NCT00267969|559505090|FG000|After Controlled Period|Death|0|||
155020868|NCT00267969|559505091|FG001|After Controlled Period|Death|0|||
155020869|NCT00267969|559505092|FG002|After Controlled Period|Death|0|||
155020870|NCT00267969|559505093|FG003|After Controlled Period|Death|1|||
155020871|NCT00267969|559505094|FG004|After Controlled Period|Death|2|||
155139400|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
155139401|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
155139402|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
155139403|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
155139404|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
155139405|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
155139406|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
155179650|NCT05318183|560096388|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
155020872|NCT00267969|559505095|FG005|After Controlled Period|Death|0|||
155020873|NCT00267969|559505096|FG006|After Controlled Period|Death|1|||
155020874|NCT00267969|559505090|FG000|After Controlled Period|Lack of Efficacy|0|||
155020875|NCT00267969|559505091|FG001|After Controlled Period|Lack of Efficacy|0|||
155020876|NCT00267969|559505092|FG002|After Controlled Period|Lack of Efficacy|0|||
155020877|NCT00267969|559505093|FG003|After Controlled Period|Lack of Efficacy|10|||
155020878|NCT00267969|559505094|FG004|After Controlled Period|Lack of Efficacy|6|||
155020879|NCT00267969|559505095|FG005|After Controlled Period|Lack of Efficacy|28|||
155020880|NCT00267969|559505096|FG006|After Controlled Period|Lack of Efficacy|15|||
155020881|NCT00267969|559505090|FG000|After Controlled Period|Lost to Follow-up|0|||
155020882|NCT00267969|559505091|FG001|After Controlled Period|Lost to Follow-up|0|||
155020883|NCT00267969|559505092|FG002|After Controlled Period|Lost to Follow-up|0|||
155020884|NCT00267969|559505093|FG003|After Controlled Period|Lost to Follow-up|5|||
155020885|NCT00267969|559505094|FG004|After Controlled Period|Lost to Follow-up|8|||
155020886|NCT00267969|559505095|FG005|After Controlled Period|Lost to Follow-up|9|||
155020887|NCT00267969|559505096|FG006|After Controlled Period|Lost to Follow-up|10|||
155020888|NCT00267969|559505090|FG000|After Controlled Period|Other|0|||
155020889|NCT00267969|559505091|FG001|After Controlled Period|Other|0|||
155020890|NCT00267969|559505092|FG002|After Controlled Period|Other|0|||
155020891|NCT00267969|559505093|FG003|After Controlled Period|Other|13|||
155020892|NCT00267969|559505094|FG004|After Controlled Period|Other|11|||
155020893|NCT00267969|559505095|FG005|After Controlled Period|Other|22|||
155020894|NCT00267969|559505096|FG006|After Controlled Period|Other|25|||
155020895|NCT00862823|559505097|FG000|First Intervention|Withdrawal by Subject|1|||
155020896|NCT00862823|559505098|FG001|First Intervention|Withdrawal by Subject|1|||
155020897|NCT00887315|559505099|FG000|Overall Study|Study termination|7|||
155020898|NCT00887315|559505100|FG001|Overall Study|Study termination|4|||
155020899|NCT00619892|559505101|FG000|Overall Study|Adverse Event|3|||
155020900|NCT00619892|559505102|FG001|Overall Study|Adverse Event|0|||
155020901|NCT00619892|559505101|FG000|Overall Study|Lost to Follow-up|0|||
155020902|NCT00619892|559505102|FG001|Overall Study|Lost to Follow-up|1|||
155020903|NCT00619892|559505101|FG000|Overall Study|Intercurrent illness|0|||
155020904|NCT00619892|559505102|FG001|Overall Study|Intercurrent illness|1|||
155020905|NCT02308540|559505112|FG000|Overall Study|Lost to Follow-up|0|||
155020906|NCT02308540|559505113|FG001|Overall Study|Lost to Follow-up|0|||
155020907|NCT02308540|559505114|FG002|Overall Study|Lost to Follow-up|0|||
155020908|NCT02308540|559505115|FG003|Overall Study|Lost to Follow-up|0|||
155020909|NCT02308540|559505116|FG004|Overall Study|Lost to Follow-up|0|||
155020910|NCT02308540|559505117|FG005|Overall Study|Lost to Follow-up|1|||
155020911|NCT01091662|559505118|FG000|Overall Study|Adverse Event|1|||
155020912|NCT01091662|559505119|FG001|Overall Study|Adverse Event|9|||
155139407|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
155139408|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Recovery|1|||
155139409|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Recovery|0|||
155139410|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Recovery|1|||
155139411|NCT00195663|559942742|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
155139412|NCT00195663|559942743|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
155139413|NCT00195663|559942744|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
155139414|NCT00195663|559942742|FG000|Open-Label Extension Period|Adverse Event|21|||
155139415|NCT00195663|559942743|FG001|Open-Label Extension Period|Adverse Event|32|||
155139416|NCT00195663|559942744|FG002|Open-Label Extension Period|Adverse Event|36|||
155139417|NCT00195663|559942742|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
155139418|NCT00195663|559942743|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
155139419|NCT00195663|559942744|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
155139420|NCT00195663|559942742|FG000|Open-Label Extension Period|Recovery|0|||
155139421|NCT00195663|559942743|FG001|Open-Label Extension Period|Recovery|2|||
155139422|NCT00195663|559942744|FG002|Open-Label Extension Period|Recovery|2|||
155139423|NCT00195663|559942742|FG000|Open-Label Extension Period|Protocol Violation|3|||
155139424|NCT00195663|559942743|FG001|Open-Label Extension Period|Protocol Violation|4|||
155139425|NCT00195663|559942744|FG002|Open-Label Extension Period|Protocol Violation|4|||
155139426|NCT00195663|559942742|FG000|Open-Label Extension Period|Death|2|||
155139427|NCT00195663|559942743|FG001|Open-Label Extension Period|Death|2|||
155139428|NCT00195663|559942744|FG002|Open-Label Extension Period|Death|2|||
155139429|NCT00195663|559942742|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
155139430|NCT00195663|559942743|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
155139431|NCT00195663|559942744|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
155139432|NCT00195663|559942742|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
155139433|NCT00195663|559942743|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
155139434|NCT00195663|559942744|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
155179651|NCT05318183|560096389|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
155020913|NCT01091662|559505118|FG000|Overall Study|Physician Decision|1|||
155020914|NCT01091662|559505119|FG001|Overall Study|Physician Decision|1|||
155020915|NCT01091662|559505118|FG000|Overall Study|Withdrawal by Subject|7|||
155020916|NCT01091662|559505119|FG001|Overall Study|Withdrawal by Subject|6|||
155020917|NCT01091662|559505118|FG000|Overall Study|met exit criteria|7|||
155020918|NCT01091662|559505119|FG001|Overall Study|met exit criteria|13|||
155020919|NCT01091662|559505118|FG000|Overall Study|met exclusion criteria|1|||
155020920|NCT01091662|559505119|FG001|Overall Study|met exclusion criteria|0|||
155020921|NCT01091662|559505118|FG000|Overall Study|Lost to Follow-up|0|||
155020922|NCT01091662|559505119|FG001|Overall Study|Lost to Follow-up|1|||
155020923|NCT01091662|559505118|FG000|Overall Study|Pregnancy|0|||
155020924|NCT01091662|559505119|FG001|Overall Study|Pregnancy|1|||
155020925|NCT01091662|559505118|FG000|Overall Study|Protocol Violation|0|||
155020926|NCT01091662|559505119|FG001|Overall Study|Protocol Violation|2|||
155020927|NCT01091662|559505118|FG000|Overall Study|unable to swallow capsule|0|||
155020928|NCT01091662|559505119|FG001|Overall Study|unable to swallow capsule|1|||
155020929|NCT04109391|559505120|FG000|Overall Study|Adverse Event|2|||
155020930|NCT04109391|559505121|FG001|Overall Study|Adverse Event|2|||
155020931|NCT04109391|559505122|FG002|Overall Study|Adverse Event|0|||
155020932|NCT04109391|559505120|FG000|Overall Study|Withdrawal by Subject|2|||
155020933|NCT04109391|559505121|FG001|Overall Study|Withdrawal by Subject|0|||
155020934|NCT04109391|559505122|FG002|Overall Study|Withdrawal by Subject|0|||
155020935|NCT04109391|559505120|FG000|Overall Study|Pregnancy|1|||
155020936|NCT04109391|559505121|FG001|Overall Study|Pregnancy|0|||
155020937|NCT04109391|559505122|FG002|Overall Study|Pregnancy|0|||
155020938|NCT04109391|559505120|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
155020939|NCT04109391|559505121|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
155020940|NCT04109391|559505122|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
155020941|NCT04109391|559505120|FG000|Overall Study|Lost to Follow-up|0|||
155020942|NCT04109391|559505121|FG001|Overall Study|Lost to Follow-up|0|||
155020943|NCT04109391|559505122|FG002|Overall Study|Lost to Follow-up|1|||
155020944|NCT04109391|559505120|FG000|Overall Study|Lack of Efficacy|2|||
155020945|NCT04109391|559505121|FG001|Overall Study|Lack of Efficacy|2|||
155020946|NCT04109391|559505122|FG002|Overall Study|Lack of Efficacy|3|||
155020947|NCT00443079|559505127|FG000|Overall Study|Lost to Follow-up|0|||
155020948|NCT00443079|559505128|FG001|Overall Study|Lost to Follow-up|1|||
155020949|NCT02649439|559505129|FG000|Overall Study|Switched to alternative treatment|6|||
155020950|NCT02649439|559505130|FG001|Overall Study|Switched to alternative treatment|4|||
155020951|NCT02649439|559505129|FG000|Overall Study|Patient decision|1|||
155020952|NCT02649439|559505130|FG001|Overall Study|Patient decision|0|||
155020953|NCT02649439|559505129|FG000|Overall Study|Patient going out of country|1|||
155020954|NCT02649439|559505130|FG001|Overall Study|Patient going out of country|0|||
155020955|NCT02649439|559505129|FG000|Overall Study|To start finasteride|1|||
155020956|NCT02649439|559505130|FG001|Overall Study|To start finasteride|0|||
155020957|NCT02649439|559505129|FG000|Overall Study|Physician Decision|1|||
155020958|NCT02649439|559505130|FG001|Overall Study|Physician Decision|0|||
155020959|NCT02649439|559505129|FG000|Overall Study|Disease progression on study|12|||
155020960|NCT02649439|559505130|FG001|Overall Study|Disease progression on study|13|||
155020961|NCT02649439|559505129|FG000|Overall Study|Refused further treatment|1|||
155020962|NCT02649439|559505130|FG001|Overall Study|Refused further treatment|0|||
155020963|NCT02649439|559505129|FG000|Overall Study|Refused further follow up|2|||
155020964|NCT02649439|559505130|FG001|Overall Study|Refused further follow up|7|||
155020965|NCT02649439|559505129|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
155020966|NCT02649439|559505130|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
155020967|NCT02649439|559505129|FG000|Overall Study|No treatment, per protocol|1|||
155020968|NCT02649439|559505130|FG001|Overall Study|No treatment, per protocol|0|||
155020969|NCT02649439|559505129|FG000|Overall Study|PSA DT makes ineligible|0|||
155020970|NCT02649439|559505130|FG001|Overall Study|PSA DT makes ineligible|1|||
155020971|NCT02649439|559505129|FG000|Overall Study|Rising PSA No Mets|0|||
155020972|NCT02649439|559505130|FG001|Overall Study|Rising PSA No Mets|1|||
155020973|NCT02649439|559505129|FG000|Overall Study|Rising PSA|0|||
155020974|NCT02649439|559505130|FG001|Overall Study|Rising PSA|1|||
155020975|NCT02649439|559505129|FG000|Overall Study|Signed follow up protocol|0|||
155020976|NCT02649439|559505130|FG001|Overall Study|Signed follow up protocol|1|||
155020977|NCT02049814|559505131|FG000|Overall Study|Reason not Specified|4|||
155020978|NCT02049814|559505132|FG001|Overall Study|Reason not Specified|3|||
155020979|NCT02049814|559505131|FG000|Overall Study|Pregnancy|1|||
155139435|NCT00195663|559942742|FG000|Open-Label Extension Period|Administrative reasons|11|||
155020980|NCT02049814|559505132|FG001|Overall Study|Pregnancy|0|||
155020981|NCT02049814|559505131|FG000|Overall Study|Lost to Follow-up|2|||
155020982|NCT02049814|559505132|FG001|Overall Study|Lost to Follow-up|3|||
155020983|NCT02049814|559505131|FG000|Overall Study|Serious Protocol Violation|5|||
155020984|NCT02049814|559505132|FG001|Overall Study|Serious Protocol Violation|7|||
155020985|NCT02049814|559505131|FG000|Overall Study|Study Termination|0|||
155020986|NCT02049814|559505132|FG001|Overall Study|Study Termination|1|||
155139436|NCT00195663|559942743|FG001|Open-Label Extension Period|Administrative reasons|11|||
155139437|NCT00195663|559942744|FG002|Open-Label Extension Period|Administrative reasons|13|||
155020987|NCT02049814|559505131|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
155020988|NCT02049814|559505132|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
155020989|NCT02049814|559505131|FG000|Overall Study|Voluntary withdrawal|9|||
155020990|NCT02049814|559505132|FG001|Overall Study|Voluntary withdrawal|8|||
155020991|NCT00713258|559505141|FG000|Overall Study|Adverse Event|2|||
155020992|NCT00713258|559505142|FG001|Overall Study|Adverse Event|4|||
155020993|NCT00713258|559505141|FG000|Overall Study|Non-Compliance|2|||
155020994|NCT00713258|559505142|FG001|Overall Study|Non-Compliance|1|||
155020995|NCT00713258|559505141|FG000|Overall Study|Other|1|||
155020996|NCT00713258|559505142|FG001|Overall Study|Other|1|||
155020997|NCT03852264|559505145|FG000|Third Research Visit|Lost to Follow-up|1|||
155020998|NCT03852264|559505146|FG001|Third Research Visit|Lost to Follow-up|0|||
155020999|NCT02477826|559505167|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
155021000|NCT02477826|559505168|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
155021001|NCT02477826|559505169|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
155021002|NCT02477826|559505170|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
155021003|NCT02477826|559505171|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
155021004|NCT02477826|559505172|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
155021005|NCT02477826|559505173|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
155021006|NCT02477826|559505174|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
155021007|NCT02477826|559505175|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
155021008|NCT02477826|559505176|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
155021009|NCT02477826|559505167|FG000|Pre-Treatment|Other reasons|4|||
155021010|NCT02477826|559505168|FG001|Pre-Treatment|Other reasons|1|||
155021011|NCT02477826|559505169|FG002|Pre-Treatment|Other reasons|4|||
155021012|NCT02477826|559505170|FG003|Pre-Treatment|Other reasons|1|||
155021013|NCT02477826|559505171|FG004|Pre-Treatment|Other reasons|4|||
155021014|NCT02477826|559505172|FG005|Pre-Treatment|Other reasons|2|||
155021015|NCT02477826|559505173|FG006|Pre-Treatment|Other reasons|0|||
155021016|NCT02477826|559505174|FG007|Pre-Treatment|Other reasons|0|||
155021017|NCT02477826|559505175|FG008|Pre-Treatment|Other reasons|0|||
155021018|NCT02477826|559505176|FG009|Pre-Treatment|Other reasons|0|||
155021019|NCT02477826|559505167|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
155021020|NCT02477826|559505168|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
155021021|NCT02477826|559505169|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
155021022|NCT02477826|559505170|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
155021023|NCT02477826|559505171|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
155021024|NCT02477826|559505172|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
155021025|NCT02477826|559505173|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
155021026|NCT02477826|559505174|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
155021027|NCT02477826|559505175|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
155021028|NCT02477826|559505176|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
155021029|NCT02477826|559505167|FG000|Pre-Treatment|Subject withdrew consent|0|||
155021030|NCT02477826|559505168|FG001|Pre-Treatment|Subject withdrew consent|0|||
155021031|NCT02477826|559505169|FG002|Pre-Treatment|Subject withdrew consent|3|||
155021032|NCT02477826|559505170|FG003|Pre-Treatment|Subject withdrew consent|0|||
155021033|NCT02477826|559505171|FG004|Pre-Treatment|Subject withdrew consent|0|||
155021034|NCT02477826|559505172|FG005|Pre-Treatment|Subject withdrew consent|1|||
155021035|NCT02477826|559505173|FG006|Pre-Treatment|Subject withdrew consent|0|||
155021036|NCT02477826|559505174|FG007|Pre-Treatment|Subject withdrew consent|1|||
155021037|NCT02477826|559505175|FG008|Pre-Treatment|Subject withdrew consent|0|||
155021038|NCT02477826|559505176|FG009|Pre-Treatment|Subject withdrew consent|3|||
155021039|NCT02477826|559505167|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021040|NCT02477826|559505168|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
155021041|NCT02477826|559505169|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021042|NCT02477826|559505170|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021043|NCT02477826|559505171|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021044|NCT02477826|559505172|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021045|NCT02477826|559505173|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021046|NCT02477826|559505174|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021047|NCT02477826|559505175|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
155021048|NCT02477826|559505176|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
155021049|NCT02477826|559505167|FG000|Pre-Treatment|Death|0|||
155021050|NCT02477826|559505168|FG001|Pre-Treatment|Death|0|||
155021051|NCT02477826|559505169|FG002|Pre-Treatment|Death|0|||
155021052|NCT02477826|559505170|FG003|Pre-Treatment|Death|0|||
155021053|NCT02477826|559505171|FG004|Pre-Treatment|Death|0|||
155021054|NCT02477826|559505172|FG005|Pre-Treatment|Death|0|||
155021055|NCT02477826|559505173|FG006|Pre-Treatment|Death|1|||
155021056|NCT02477826|559505174|FG007|Pre-Treatment|Death|0|||
155021057|NCT02477826|559505175|FG008|Pre-Treatment|Death|0|||
155021058|NCT02477826|559505176|FG009|Pre-Treatment|Death|0|||
155021059|NCT02477826|559505167|FG000|Treatment Period|Not reported|8|||
155021060|NCT02477826|559505168|FG001|Treatment Period|Not reported|6|||
155021061|NCT02477826|559505169|FG002|Treatment Period|Not reported|4|||
155021062|NCT02477826|559505170|FG003|Treatment Period|Not reported|4|||
155021063|NCT02477826|559505171|FG004|Treatment Period|Not reported|2|||
155021064|NCT02477826|559505172|FG005|Treatment Period|Not reported|1|||
155021065|NCT02477826|559505173|FG006|Treatment Period|Not reported|14|||
155021066|NCT02477826|559505174|FG007|Treatment Period|Not reported|8|||
155021067|NCT02477826|559505175|FG008|Treatment Period|Not reported|5|||
155021068|NCT02477826|559505176|FG009|Treatment Period|Not reported|2|||
155021069|NCT02477826|559505167|FG000|Treatment Period|Other reasons|5|||
155021070|NCT02477826|559505168|FG001|Treatment Period|Other reasons|6|||
155021071|NCT02477826|559505169|FG002|Treatment Period|Other reasons|12|||
155021072|NCT02477826|559505170|FG003|Treatment Period|Other reasons|7|||
155021073|NCT02477826|559505171|FG004|Treatment Period|Other reasons|5|||
155021074|NCT02477826|559505172|FG005|Treatment Period|Other reasons|1|||
155021075|NCT02477826|559505173|FG006|Treatment Period|Other reasons|8|||
155021076|NCT02477826|559505174|FG007|Treatment Period|Other reasons|8|||
155021077|NCT02477826|559505175|FG008|Treatment Period|Other reasons|21|||
155021078|NCT02477826|559505176|FG009|Treatment Period|Other reasons|1|||
155021079|NCT02477826|559505167|FG000|Treatment Period|Administrative reason by sponsor|0|||
155021080|NCT02477826|559505168|FG001|Treatment Period|Administrative reason by sponsor|3|||
155021081|NCT02477826|559505169|FG002|Treatment Period|Administrative reason by sponsor|0|||
155021082|NCT02477826|559505170|FG003|Treatment Period|Administrative reason by sponsor|0|||
155021083|NCT02477826|559505171|FG004|Treatment Period|Administrative reason by sponsor|0|||
155021084|NCT02477826|559505172|FG005|Treatment Period|Administrative reason by sponsor|0|||
155021085|NCT02477826|559505173|FG006|Treatment Period|Administrative reason by sponsor|0|||
155021086|NCT02477826|559505174|FG007|Treatment Period|Administrative reason by sponsor|0|||
155021087|NCT02477826|559505175|FG008|Treatment Period|Administrative reason by sponsor|0|||
155021088|NCT02477826|559505176|FG009|Treatment Period|Administrative reason by sponsor|0|||
155021089|NCT02477826|559505167|FG000|Treatment Period|Participant meet no longer study criteria|1|||
155021090|NCT02477826|559505168|FG001|Treatment Period|Participant meet no longer study criteria|1|||
155021091|NCT02477826|559505169|FG002|Treatment Period|Participant meet no longer study criteria|0|||
155021092|NCT02477826|559505170|FG003|Treatment Period|Participant meet no longer study criteria|0|||
155021093|NCT02477826|559505171|FG004|Treatment Period|Participant meet no longer study criteria|1|||
155021094|NCT02477826|559505172|FG005|Treatment Period|Participant meet no longer study criteria|1|||
155021095|NCT02477826|559505173|FG006|Treatment Period|Participant meet no longer study criteria|0|||
155021096|NCT02477826|559505174|FG007|Treatment Period|Participant meet no longer study criteria|1|||
155021097|NCT02477826|559505175|FG008|Treatment Period|Participant meet no longer study criteria|0|||
155021098|NCT02477826|559505176|FG009|Treatment Period|Participant meet no longer study criteria|0|||
155021099|NCT02477826|559505167|FG000|Treatment Period|Poor/Non Compliance|1|||
155021100|NCT02477826|559505168|FG001|Treatment Period|Poor/Non Compliance|0|||
155021101|NCT02477826|559505169|FG002|Treatment Period|Poor/Non Compliance|2|||
155021102|NCT02477826|559505170|FG003|Treatment Period|Poor/Non Compliance|0|||
155021103|NCT02477826|559505171|FG004|Treatment Period|Poor/Non Compliance|0|||
155021104|NCT02477826|559505172|FG005|Treatment Period|Poor/Non Compliance|1|||
155021105|NCT02477826|559505173|FG006|Treatment Period|Poor/Non Compliance|1|||
155021106|NCT02477826|559505174|FG007|Treatment Period|Poor/Non Compliance|0|||
155021107|NCT02477826|559505175|FG008|Treatment Period|Poor/Non Compliance|0|||
155021108|NCT02477826|559505176|FG009|Treatment Period|Poor/Non Compliance|1|||
155021109|NCT02477826|559505167|FG000|Treatment Period|Maximum Clinical Benefit|3|||
155021110|NCT02477826|559505168|FG001|Treatment Period|Maximum Clinical Benefit|3|||
155021111|NCT02477826|559505169|FG002|Treatment Period|Maximum Clinical Benefit|1|||
155021112|NCT02477826|559505170|FG003|Treatment Period|Maximum Clinical Benefit|1|||
155021113|NCT02477826|559505171|FG004|Treatment Period|Maximum Clinical Benefit|3|||
155021114|NCT02477826|559505172|FG005|Treatment Period|Maximum Clinical Benefit|0|||
155021115|NCT02477826|559505173|FG006|Treatment Period|Maximum Clinical Benefit|3|||
155021116|NCT02477826|559505174|FG007|Treatment Period|Maximum Clinical Benefit|2|||
155021117|NCT02477826|559505175|FG008|Treatment Period|Maximum Clinical Benefit|2|||
155021118|NCT02477826|559505176|FG009|Treatment Period|Maximum Clinical Benefit|2|||
155021119|NCT02477826|559505167|FG000|Treatment Period|Lost to Follow-up|0|||
155021120|NCT02477826|559505168|FG001|Treatment Period|Lost to Follow-up|0|||
155021121|NCT02477826|559505169|FG002|Treatment Period|Lost to Follow-up|1|||
155021122|NCT02477826|559505170|FG003|Treatment Period|Lost to Follow-up|1|||
155139438|NCT01380834|559942745|FG000|Overall Study|Physician Decision|1|||
155139439|NCT01380834|559942746|FG001|Overall Study|Physician Decision|0|||
155139440|NCT03214406|559942747|FG000|Overall Study|did not meet enrollment criteria|9|||
155139441|NCT03214406|559942748|FG001|Overall Study|did not meet enrollment criteria|13|||
155139442|NCT03214406|559942747|FG000|Overall Study|Withdrawal by Subject|1|||
155021123|NCT02477826|559505171|FG004|Treatment Period|Lost to Follow-up|0|||
155021124|NCT02477826|559505172|FG005|Treatment Period|Lost to Follow-up|0|||
155021125|NCT02477826|559505173|FG006|Treatment Period|Lost to Follow-up|2|||
155021126|NCT02477826|559505174|FG007|Treatment Period|Lost to Follow-up|2|||
155021127|NCT02477826|559505175|FG008|Treatment Period|Lost to Follow-up|0|||
155021128|NCT02477826|559505176|FG009|Treatment Period|Lost to Follow-up|0|||
155021129|NCT02477826|559505167|FG000|Treatment Period|Participant withdrew Consent|5|||
155021130|NCT02477826|559505168|FG001|Treatment Period|Participant withdrew Consent|5|||
155139443|NCT03214406|559942748|FG001|Overall Study|Withdrawal by Subject|0|||
155139444|NCT03214406|559942747|FG000|Overall Study|Lost to Follow-up|0|||
155021131|NCT02477826|559505169|FG002|Treatment Period|Participant withdrew Consent|3|||
155021132|NCT02477826|559505170|FG003|Treatment Period|Participant withdrew Consent|3|||
155021133|NCT02477826|559505171|FG004|Treatment Period|Participant withdrew Consent|1|||
155021134|NCT02477826|559505172|FG005|Treatment Period|Participant withdrew Consent|3|||
155021135|NCT02477826|559505173|FG006|Treatment Period|Participant withdrew Consent|3|||
155021136|NCT02477826|559505174|FG007|Treatment Period|Participant withdrew Consent|3|||
155021137|NCT02477826|559505175|FG008|Treatment Period|Participant withdrew Consent|2|||
155021138|NCT02477826|559505176|FG009|Treatment Period|Participant withdrew Consent|3|||
155021139|NCT02477826|559505167|FG000|Treatment Period|Participant request to discontinue treatment|5|||
155021140|NCT02477826|559505168|FG001|Treatment Period|Participant request to discontinue treatment|3|||
155021141|NCT02477826|559505169|FG002|Treatment Period|Participant request to discontinue treatment|15|||
155021142|NCT02477826|559505170|FG003|Treatment Period|Participant request to discontinue treatment|5|||
155021143|NCT02477826|559505171|FG004|Treatment Period|Participant request to discontinue treatment|3|||
155021144|NCT02477826|559505172|FG005|Treatment Period|Participant request to discontinue treatment|6|||
155021145|NCT02477826|559505173|FG006|Treatment Period|Participant request to discontinue treatment|13|||
155021146|NCT02477826|559505174|FG007|Treatment Period|Participant request to discontinue treatment|15|||
155021147|NCT02477826|559505175|FG008|Treatment Period|Participant request to discontinue treatment|4|||
155021148|NCT02477826|559505176|FG009|Treatment Period|Participant request to discontinue treatment|18|||
155021149|NCT02477826|559505167|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
155021150|NCT02477826|559505168|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
155021151|NCT02477826|559505169|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
155021152|NCT02477826|559505170|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
155021153|NCT02477826|559505171|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
155021154|NCT02477826|559505172|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
155021155|NCT02477826|559505173|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
155021156|NCT02477826|559505174|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
155021157|NCT02477826|559505175|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
155021158|NCT02477826|559505176|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
155021159|NCT02477826|559505167|FG000|Treatment Period|Death|4|||
155021160|NCT02477826|559505168|FG001|Treatment Period|Death|7|||
155021161|NCT02477826|559505169|FG002|Treatment Period|Death|0|||
155021162|NCT02477826|559505170|FG003|Treatment Period|Death|0|||
155021163|NCT02477826|559505171|FG004|Treatment Period|Death|1|||
155021164|NCT02477826|559505172|FG005|Treatment Period|Death|2|||
155021165|NCT02477826|559505173|FG006|Treatment Period|Death|6|||
155021166|NCT02477826|559505174|FG007|Treatment Period|Death|5|||
155021167|NCT02477826|559505175|FG008|Treatment Period|Death|9|||
155021168|NCT02477826|559505176|FG009|Treatment Period|Death|0|||
155021169|NCT02477826|559505167|FG000|Treatment Period|Study Drug Toxicity|79|||
155021170|NCT02477826|559505168|FG001|Treatment Period|Study Drug Toxicity|51|||
155021171|NCT02477826|559505169|FG002|Treatment Period|Study Drug Toxicity|31|||
155021172|NCT02477826|559505170|FG003|Treatment Period|Study Drug Toxicity|39|||
155021173|NCT02477826|559505171|FG004|Treatment Period|Study Drug Toxicity|12|||
155021174|NCT02477826|559505172|FG005|Treatment Period|Study Drug Toxicity|25|||
155021175|NCT02477826|559505173|FG006|Treatment Period|Study Drug Toxicity|52|||
155021176|NCT02477826|559505174|FG007|Treatment Period|Study Drug Toxicity|30|||
155021177|NCT02477826|559505175|FG008|Treatment Period|Study Drug Toxicity|20|||
155021178|NCT02477826|559505176|FG009|Treatment Period|Study Drug Toxicity|9|||
155021179|NCT02477826|559505167|FG000|Treatment Period|Disease progression|212|||
155021180|NCT02477826|559505168|FG001|Treatment Period|Disease progression|240|||
155021181|NCT02477826|559505169|FG002|Treatment Period|Disease progression|202|||
155021182|NCT02477826|559505170|FG003|Treatment Period|Disease progression|93|||
155021183|NCT02477826|559505171|FG004|Treatment Period|Disease progression|113|||
155021184|NCT02477826|559505172|FG005|Treatment Period|Disease progression|96|||
155021185|NCT02477826|559505173|FG006|Treatment Period|Disease progression|208|||
155021186|NCT02477826|559505174|FG007|Treatment Period|Disease progression|195|||
155021187|NCT02477826|559505175|FG008|Treatment Period|Disease progression|59|||
155021188|NCT02477826|559505176|FG009|Treatment Period|Disease progression|46|||
155021189|NCT02477826|559505167|FG000|Treatment Period|Pregnancy|0|||
155021190|NCT02477826|559505168|FG001|Treatment Period|Pregnancy|0|||
155139445|NCT03214406|559942748|FG001|Overall Study|Lost to Follow-up|2|||
155139446|NCT00604695|559942749|FG000|Overall Study|Did not receive first bolus.|0|||
155139447|NCT00604695|559942750|FG001|Overall Study|Did not receive first bolus.|4|||
155139448|NCT04565951|559942758|FG000|Overall Study|Lost to Follow-up|66|||
155139449|NCT04565951|559942759|FG001|Overall Study|Lost to Follow-up|38|||
155021191|NCT02477826|559505169|FG002|Treatment Period|Pregnancy|0|||
155021192|NCT02477826|559505170|FG003|Treatment Period|Pregnancy|0|||
155021193|NCT02477826|559505171|FG004|Treatment Period|Pregnancy|0|||
155021194|NCT02477826|559505172|FG005|Treatment Period|Pregnancy|0|||
155021195|NCT02477826|559505173|FG006|Treatment Period|Pregnancy|0|||
155021196|NCT02477826|559505174|FG007|Treatment Period|Pregnancy|0|||
155021197|NCT02477826|559505175|FG008|Treatment Period|Pregnancy|0|||
155139450|NCT04565951|559942758|FG000|Overall Study|Withdrawal by Subject|14|||
155021198|NCT02477826|559505176|FG009|Treatment Period|Pregnancy|1|||
155021199|NCT02477826|559505167|FG000|Treatment Period|Other|0|||
155021200|NCT02477826|559505168|FG001|Treatment Period|Other|0|||
155021201|NCT02477826|559505169|FG002|Treatment Period|Other|0|||
155021202|NCT02477826|559505170|FG003|Treatment Period|Other|0|||
155021203|NCT02477826|559505171|FG004|Treatment Period|Other|0|||
155021204|NCT02477826|559505172|FG005|Treatment Period|Other|0|||
155021205|NCT02477826|559505173|FG006|Treatment Period|Other|0|||
155021206|NCT02477826|559505174|FG007|Treatment Period|Other|0|||
155021207|NCT02477826|559505175|FG008|Treatment Period|Other|0|||
155021208|NCT02477826|559505176|FG009|Treatment Period|Other|1|||
155021209|NCT00183885|559505179|FG000|Overall Study|Adverse Event|11|||
155021210|NCT00183885|559505179|FG000|Overall Study|Death|1|||
155021211|NCT00183885|559505179|FG000|Overall Study|Lost to Follow-up|3|||
155021212|NCT00183885|559505179|FG000|Overall Study|Physician Decision|6|||
155021213|NCT00183885|559505179|FG000|Overall Study|Withdrawal by Subject|5|||
155021214|NCT00183885|559505179|FG000|Overall Study|Switched to alternative treatment|8|||
155021215|NCT00183885|559505179|FG000|Overall Study|Treatment delayed too long|4|||
155021216|NCT00183885|559505179|FG000|Overall Study|Developed second malignancy|1|||
155021217|NCT05310071|559505193|FG000|Overall Study|Death|0|||
155021218|NCT05310071|559505194|FG001|Overall Study|Death|3|||
155021219|NCT05310071|559505193|FG000|Overall Study|Adverse Event|4|||
155021220|NCT05310071|559505194|FG001|Overall Study|Adverse Event|31|||
155021221|NCT05310071|559505193|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
155021222|NCT05310071|559505194|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
155021223|NCT05310071|559505193|FG000|Overall Study|Protocol Deviation|2|||
155021224|NCT05310071|559505194|FG001|Overall Study|Protocol Deviation|0|||
155021225|NCT05310071|559505193|FG000|Overall Study|Randomized by Mistake|0|||
155021226|NCT05310071|559505194|FG001|Overall Study|Randomized by Mistake|1|||
155179652|NCT05318183|560096388|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
155179653|NCT05318183|560096389|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
155179654|NCT05318183|560096388|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
155179655|NCT05318183|560096389|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
155179656|NCT05318183|560096388|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
155179657|NCT05318183|560096389|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
155179658|NCT06400251|560096390|FG000|Overall Study|Never Start Protocol Therapy|1|||
155179659|NCT06400251|560096390|FG000|Overall Study|Ineligible|2|||
155179660|NCT06400251|560096390|FG000|Overall Study|Mutation Status Not Confirmed|3|||
155179661|NCT06400251|560096390|FG000|Overall Study|Disease Progression|25|||
155179662|NCT06400251|560096390|FG000|Overall Study|Adverse Event|1|||
155179663|NCT06400251|560096390|FG000|Overall Study|Complicating Disease|1|||
155179664|NCT06400251|560096390|FG000|Overall Study|Physician Decision|2|||
155179665|NCT04658940|560096398|FG000|Overall Study|Withdrawal by Subject|1|||
155179666|NCT03579602|560096399|FG000|Overall Study|Subject unable to receive study drug|0|||
155179667|NCT03579602|560096400|FG001|Overall Study|Subject unable to receive study drug|2|||
155179668|NCT03579602|560096399|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
155179669|NCT03579602|560096400|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
155179670|NCT00266877|560096401|FG000|Overall Study|Death|1|||
155179671|NCT00266877|560096402|FG001|Overall Study|Death|1|||
155179672|NCT00266877|560096403|FG002|Overall Study|Death|1|||
155179673|NCT00266877|560096401|FG000|Overall Study|Adverse Event|6|||
155179674|NCT00266877|560096402|FG001|Overall Study|Adverse Event|4|||
155179675|NCT00266877|560096403|FG002|Overall Study|Adverse Event|1|||
155179676|NCT00266877|560096401|FG000|Overall Study|Physician Decision|2|||
155179677|NCT00266877|560096402|FG001|Overall Study|Physician Decision|1|||
155179678|NCT00266877|560096403|FG002|Overall Study|Physician Decision|1|||
155179679|NCT00266877|560096401|FG000|Overall Study|Withdrawal by Subject|3|||
155179680|NCT00266877|560096402|FG001|Overall Study|Withdrawal by Subject|1|||
155179681|NCT00266877|560096403|FG002|Overall Study|Withdrawal by Subject|1|||
155179682|NCT00266877|560096401|FG000|Overall Study|Disease Progression|72|||
155021227|NCT05310071|559505193|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
155021228|NCT05310071|559505194|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
155021229|NCT05310071|559505193|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
155021230|NCT05310071|559505194|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
155179683|NCT00266877|560096402|FG001|Overall Study|Disease Progression|37|||
155179684|NCT00266877|560096403|FG002|Overall Study|Disease Progression|23|||
155021231|NCT05310071|559505193|FG000|Overall Study|Site Terminated by Sponsor|0|||
155021232|NCT05310071|559505194|FG001|Overall Study|Site Terminated by Sponsor|2|||
155179685|NCT00266877|560096401|FG000|Overall Study|Symptomatic Deterioration|6|||
155179686|NCT00266877|560096402|FG001|Overall Study|Symptomatic Deterioration|3|||
155179687|NCT00266877|560096403|FG002|Overall Study|Symptomatic Deterioration|1|||
155179688|NCT00266877|560096401|FG000|Overall Study|Hospitalization|1|||
155179689|NCT00266877|560096402|FG001|Overall Study|Hospitalization|0|||
155021233|NCT05310071|559505193|FG000|Overall Study|Study Terminated by Sponsor|282|||
155021234|NCT05310071|559505194|FG001|Overall Study|Study Terminated by Sponsor|559|||
155021235|NCT05310071|559505193|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
155021236|NCT05310071|559505194|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
155021237|NCT05310071|559505193|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
155021238|NCT05310071|559505194|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
155021239|NCT05310071|559505193|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
155021240|NCT05310071|559505194|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
155021241|NCT05310071|559505193|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
155021242|NCT05310071|559505194|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
155021243|NCT05310071|559505193|FG000|Overall Study|Withdrawal by Participant - Other|25|||
155021244|NCT05310071|559505194|FG001|Overall Study|Withdrawal by Participant - Other|30|||
155021245|NCT05310071|559505193|FG000|Overall Study|Lost to Follow-up|2|||
155021246|NCT05310071|559505194|FG001|Overall Study|Lost to Follow-up|4|||
155021247|NCT05310071|559505193|FG000|Overall Study|Reason Not Specified|1|||
155021248|NCT05310071|559505194|FG001|Overall Study|Reason Not Specified|3|||
155021249|NCT02418949|559505195|FG000|Overall Study|Withdrawal by Subject|1|||
155021250|NCT02418949|559505196|FG001|Overall Study|Withdrawal by Subject|0|||
155021251|NCT02418949|559505197|FG002|Overall Study|Withdrawal by Subject|1|||
155021252|NCT02418949|559505198|FG003|Overall Study|Withdrawal by Subject|1|||
155021253|NCT02418949|559505195|FG000|Overall Study|Lost to Follow-up|1|||
155021254|NCT02418949|559505196|FG001|Overall Study|Lost to Follow-up|0|||
155021255|NCT02418949|559505197|FG002|Overall Study|Lost to Follow-up|1|||
155021256|NCT02418949|559505198|FG003|Overall Study|Lost to Follow-up|0|||
155021257|NCT02418949|559505195|FG000|Overall Study|Physician Decision|1|||
155021258|NCT02418949|559505196|FG001|Overall Study|Physician Decision|1|||
155021259|NCT02418949|559505197|FG002|Overall Study|Physician Decision|1|||
155021260|NCT02418949|559505198|FG003|Overall Study|Physician Decision|0|||
155021261|NCT00014495|559505199|FG000|Overall Study|Death|0|||
155021262|NCT00014495|559505200|FG001|Overall Study|Death|0|||
155021263|NCT00014495|559505201|FG002|Overall Study|Death|1|||
155021264|NCT00014495|559505202|FG003|Overall Study|Death|0|||
155021265|NCT00014495|559505199|FG000|Overall Study|Clinical deterioration|0|||
155021266|NCT00014495|559505200|FG001|Overall Study|Clinical deterioration|0|||
155021267|NCT00014495|559505201|FG002|Overall Study|Clinical deterioration|0|||
155021268|NCT00014495|559505202|FG003|Overall Study|Clinical deterioration|1|||
155021269|NCT00828568|559505203|FG000|Randomized|Withdrawal by Subject|1|||
155021270|NCT00828568|559505204|FG001|Randomized|Withdrawal by Subject|0|||
155021271|NCT00828568|559505205|FG002|Randomized|Withdrawal by Subject|2|||
155021272|NCT00828568|559505203|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
155021273|NCT00828568|559505204|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
155021274|NCT00828568|559505205|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
155021275|NCT00828568|559505203|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
155021276|NCT00828568|559505204|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
155021277|NCT00828568|559505205|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
155021278|NCT00828568|559505203|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
155021279|NCT00828568|559505204|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
155021280|NCT00828568|559505205|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
155021281|NCT00828568|559505203|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
155021282|NCT00828568|559505204|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
155021283|NCT00828568|559505205|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
155021284|NCT00403481|559505240|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
155021285|NCT00403481|559505240|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
155021286|NCT00403481|559505240|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
155021287|NCT00403481|559505240|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
155021288|NCT00403481|559505240|FG000|Olm 40 mg|Adverse Event|2|||
155021289|NCT00403481|559505240|FG000|Olm 40 mg|Protocol Violation|1|||
155021290|NCT00403481|559505240|FG000|Olm 40 mg|Withdrawal by Subject|1|||
155179690|NCT00266877|560096403|FG002|Overall Study|Hospitalization|0|||
155179691|NCT00266877|560096401|FG000|Overall Study|Concomitant Radiotherapy|0|||
155179692|NCT00266877|560096402|FG001|Overall Study|Concomitant Radiotherapy|1|||
155179693|NCT00266877|560096403|FG002|Overall Study|Concomitant Radiotherapy|0|||
155179694|NCT02889562|560096407|FG000|Overall Study|Physician Decision|0|||
155179695|NCT02889562|560096408|FG001|Overall Study|Physician Decision|1|||
155179696|NCT02889562|560096407|FG000|Overall Study|Withdrawal by Subject|0|||
155021291|NCT00403481|559505240|FG000|Olm 40 mg|Other|1|||
155021292|NCT00403481|559505240|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
155021293|NCT00403481|559505240|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
155021294|NCT00403481|559505240|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
155021295|NCT00403481|559505240|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
155021296|NCT00403481|559505240|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
155021297|NCT00403481|559505240|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
155179697|NCT02889562|560096408|FG001|Overall Study|Withdrawal by Subject|1|||
155179698|NCT00217464|560096412|FG000|Overall Study|Progression|15|||
155179699|NCT00217464|560096412|FG000|Overall Study|Other|2|||
155179700|NCT00278915|560096415|FG000|Overall Study|Disease progression|1|||
155179701|NCT05214573|560096416|FG000|Overall Study|Physician Decision|5924|||
155179702|NCT05214573|560096417|FG001|Overall Study|Physician Decision|0|||
155179703|NCT02520089|560096418|FG000|Overall Study|Lost to Follow-up|3|||
155179704|NCT02520089|560096419|FG001|Overall Study|Lost to Follow-up|4|||
155179705|NCT04268823|560096420|FG000|Overall Study|Adverse Event|1|||
155179706|NCT04268823|560096421|FG001|Overall Study|Adverse Event|0|||
155179707|NCT04268823|560096420|FG000|Overall Study|Participant Decision|1|||
155179708|NCT04268823|560096421|FG001|Overall Study|Participant Decision|0|||
155179709|NCT02579928|560098204|FG000|Overall Study|Withdrawal by Subject|1|||
155179710|NCT02579928|560098205|FG001|Overall Study|Withdrawal by Subject|0|||
155179711|NCT00075270|560098210|FG000|Overall Study|Withdrawal by Subject|28|||
155179712|NCT00075270|560098211|FG001|Overall Study|Withdrawal by Subject|21|||
155179713|NCT00075270|560098210|FG000|Overall Study|Lost to Follow-up|25|||
155179714|NCT00075270|560098211|FG001|Overall Study|Lost to Follow-up|28|||
155179715|NCT00075270|560098210|FG000|Overall Study|Protocol Violation|0|||
155179716|NCT00075270|560098211|FG001|Overall Study|Protocol Violation|2|||
155179717|NCT00075270|560098210|FG000|Overall Study|Death|198|||
155179718|NCT00075270|560098211|FG001|Overall Study|Death|215|||
155179719|NCT00075270|560098210|FG000|Overall Study|Other/Unknown|9|||
155179720|NCT00075270|560098211|FG001|Overall Study|Other/Unknown|5|||
155179721|NCT00075270|560098210|FG000|Overall Study|Missing|26|||
155179722|NCT00075270|560098211|FG001|Overall Study|Missing|13|||
155179723|NCT02455557|560098212|FG000|Overall Study|Withdrawal by Subject|2|||
155179724|NCT00761748|560098214|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
155179725|NCT00761748|560098215|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
155179726|NCT00761748|560098214|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
155179727|NCT00761748|560098215|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
155179728|NCT01857310|560098216|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
155179729|NCT01857310|560098217|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
155179730|NCT02554279|560098218|FG000|Overall Study|Adverse Event|2|||
155179731|NCT02554279|560098219|FG001|Overall Study|Adverse Event|5|||
155179732|NCT02554279|560098218|FG000|Overall Study|Lost to Follow-up|3|||
155179733|NCT02554279|560098219|FG001|Overall Study|Lost to Follow-up|2|||
155179734|NCT02554279|560098218|FG000|Overall Study|Withdrawal by Subject|6|||
155179735|NCT02554279|560098219|FG001|Overall Study|Withdrawal by Subject|4|||
155179736|NCT02554279|560098218|FG000|Overall Study|Protocol Violation|2|||
155179737|NCT02554279|560098219|FG001|Overall Study|Protocol Violation|1|||
155179738|NCT02554279|560098218|FG000|Overall Study|Other reason|19|||
155179739|NCT02554279|560098219|FG001|Overall Study|Other reason|6|||
155179740|NCT00812487|560098220|FG000|Overall Study|Lost to Follow-up|2|||
155179741|NCT00812487|560098221|FG001|Overall Study|Lost to Follow-up|0|||
155179742|NCT00812487|560098220|FG000|Overall Study|Withdrawal by Subject|3|||
155179743|NCT00812487|560098221|FG001|Overall Study|Withdrawal by Subject|2|||
155179744|NCT00812487|560098220|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
155179745|NCT00812487|560098221|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
155179746|NCT00812487|560098220|FG000|Overall Study|Protocol Violation|0|||
155179747|NCT00812487|560098221|FG001|Overall Study|Protocol Violation|1|||
155179748|NCT00998764|560098222|FG000|Overall Study|Lack of Efficacy|3|||
155179749|NCT00998764|560098223|FG001|Overall Study|Lack of Efficacy|6|||
155179750|NCT00998764|560098222|FG000|Overall Study|Adverse Event|17|||
155179751|NCT00998764|560098223|FG001|Overall Study|Adverse Event|12|||
155179752|NCT00998764|560098222|FG000|Overall Study|Withdrawal by Subject|19|||
155179753|NCT00998764|560098223|FG001|Overall Study|Withdrawal by Subject|25|||
155179754|NCT00998764|560098222|FG000|Overall Study|Physician Decision|3|||
155179755|NCT00998764|560098223|FG001|Overall Study|Physician Decision|3|||
155179756|NCT00998764|560098222|FG000|Overall Study|Death|3|||
155179757|NCT00998764|560098223|FG001|Overall Study|Death|1|||
155179758|NCT00998764|560098222|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
155179759|NCT00998764|560098223|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
155179760|NCT00998764|560098222|FG000|Overall Study|Protocol Violation|0|||
155179761|NCT00998764|560098223|FG001|Overall Study|Protocol Violation|1|||
155179762|NCT00998764|560098222|FG000|Overall Study|Failed to Return|1|||
155179763|NCT00998764|560098223|FG001|Overall Study|Failed to Return|1|||
155179764|NCT00998764|560098222|FG000|Overall Study|Lost to Follow-up|1|||
155179765|NCT00998764|560098223|FG001|Overall Study|Lost to Follow-up|1|||
155179766|NCT00998764|560098222|FG000|Overall Study|Loss of Caregiver|0|||
155179767|NCT00998764|560098223|FG001|Overall Study|Loss of Caregiver|3|||
155021298|NCT02929589|559505241|FG000|Overall Study|Withdrawal by Subject|1|||
155021299|NCT02929589|559505242|FG001|Overall Study|Withdrawal by Subject|0|||
155179768|NCT00998764|560098222|FG000|Overall Study|Other|4|||
155179769|NCT00998764|560098223|FG001|Overall Study|Other|4|||
155179770|NCT00998764|560098222|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
155179771|NCT00998764|560098223|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
155179772|NCT04761627|560098226|FG000|Run-in Period|Death|1|||
155179773|NCT04761627|560098227|FG001|Run-in Period|Death|0|||
155179774|NCT04761627|560098228|FG002|Run-in Period|Death|0|||
155021300|NCT02929589|559505243|FG002|Overall Study|Withdrawal by Subject|0|||
155021301|NCT02929589|559505244|FG003|Overall Study|Withdrawal by Subject|0|||
155021302|NCT02929589|559505241|FG000|Overall Study|Physician Decision|2|||
155021303|NCT02929589|559505242|FG001|Overall Study|Physician Decision|0|||
155021304|NCT02929589|559505243|FG002|Overall Study|Physician Decision|0|||
155021305|NCT02929589|559505244|FG003|Overall Study|Physician Decision|0|||
155021306|NCT00396656|559505246|FG000|First Treatment Period|Withdrawal by Subject|0|||
155021307|NCT00396656|559505247|FG001|First Treatment Period|Withdrawal by Subject|2|||
155021308|NCT00396656|559505246|FG000|Second Treatment Period|Adverse Event|0|||
155021309|NCT00396656|559505247|FG001|Second Treatment Period|Adverse Event|1|||
155021310|NCT02091089|559505248|FG000|Overall Study|Lost to Follow-up|2|||
155021311|NCT02343939|559505251|FG000|Overall Study|Death|0|||
155021312|NCT02343939|559505252|FG001|Overall Study|Death|15|||
155021313|NCT02343939|559505253|FG002|Overall Study|Death|4|||
155021314|NCT02343939|559505254|FG003|Overall Study|Death|2|||
155021315|NCT02343939|559505255|FG004|Overall Study|Death|5|||
155021316|NCT02343939|559505256|FG005|Overall Study|Death|11|||
155021317|NCT02343939|559505257|FG006|Overall Study|Death|8|||
155021318|NCT02343939|559505258|FG007|Overall Study|Death|22|||
155021319|NCT02343939|559505259|FG008|Overall Study|Death|1|||
155021320|NCT02343939|559505251|FG000|Overall Study|Study terminated by sponsor|0|||
155021321|NCT02343939|559505252|FG001|Overall Study|Study terminated by sponsor|27|||
155021322|NCT02343939|559505253|FG002|Overall Study|Study terminated by sponsor|0|||
155179775|NCT04761627|560098226|FG000|Run-in Period|Required alternative therapy|2|||
155179776|NCT04761627|560098227|FG001|Run-in Period|Required alternative therapy|0|||
155179777|NCT04761627|560098228|FG002|Run-in Period|Required alternative therapy|0|||
155179778|NCT04761627|560098226|FG000|Run-in Period|Lost to Follow-up|2|||
155179779|NCT04761627|560098227|FG001|Run-in Period|Lost to Follow-up|0|||
155179780|NCT04761627|560098228|FG002|Run-in Period|Lost to Follow-up|0|||
155179781|NCT04761627|560098226|FG000|Run-in Period|Protocol Violation|3|||
155179782|NCT04761627|560098227|FG001|Run-in Period|Protocol Violation|0|||
155179783|NCT04761627|560098228|FG002|Run-in Period|Protocol Violation|0|||
155179784|NCT04761627|560098226|FG000|Run-in Period|Abnormal liver function|1|||
155179785|NCT04761627|560098227|FG001|Run-in Period|Abnormal liver function|0|||
155179786|NCT04761627|560098228|FG002|Run-in Period|Abnormal liver function|0|||
155179787|NCT04761627|560098226|FG000|Run-in Period|Adverse Event|6|||
155179788|NCT04761627|560098227|FG001|Run-in Period|Adverse Event|0|||
155179789|NCT04761627|560098228|FG002|Run-in Period|Adverse Event|0|||
155179790|NCT04761627|560098226|FG000|Run-in Period|Withdrawal by Subject|7|||
155179791|NCT04761627|560098227|FG001|Run-in Period|Withdrawal by Subject|0|||
155179792|NCT04761627|560098228|FG002|Run-in Period|Withdrawal by Subject|0|||
155179793|NCT04761627|560098226|FG000|Run-in Period|Did not meet PASI 50|15|||
155179794|NCT04761627|560098227|FG001|Run-in Period|Did not meet PASI 50|0|||
155179795|NCT04761627|560098228|FG002|Run-in Period|Did not meet PASI 50|0|||
155179796|NCT04761627|560098226|FG000|Run-in Period|Study site closure|2|||
155179797|NCT04761627|560098227|FG001|Run-in Period|Study site closure|0|||
155179798|NCT04761627|560098228|FG002|Run-in Period|Study site closure|0|||
155179799|NCT04761627|560098226|FG000|Run-in Period|Pregnancy|2|||
155179800|NCT04761627|560098227|FG001|Run-in Period|Pregnancy|0|||
155179801|NCT04761627|560098228|FG002|Run-in Period|Pregnancy|0|||
155179802|NCT04761627|560098226|FG000|Post-randomization Period|Military service|0|||
155179803|NCT04761627|560098227|FG001|Post-randomization Period|Military service|1|||
155179804|NCT04761627|560098228|FG002|Post-randomization Period|Military service|0|||
155179805|NCT04761627|560098226|FG000|Post-randomization Period|Adverse Event|0|||
155179806|NCT04761627|560098227|FG001|Post-randomization Period|Adverse Event|4|||
155179807|NCT04761627|560098228|FG002|Post-randomization Period|Adverse Event|2|||
155179808|NCT04761627|560098226|FG000|Post-randomization Period|Lost to Follow-up|0|||
155179809|NCT04761627|560098227|FG001|Post-randomization Period|Lost to Follow-up|6|||
155179810|NCT04761627|560098228|FG002|Post-randomization Period|Lost to Follow-up|6|||
155179811|NCT04761627|560098226|FG000|Post-randomization Period|Withdrawal by Subject|0|||
155021323|NCT02343939|559505254|FG003|Overall Study|Study terminated by sponsor|1|||
155021324|NCT02343939|559505255|FG004|Overall Study|Study terminated by sponsor|1|||
155021325|NCT02343939|559505256|FG005|Overall Study|Study terminated by sponsor|5|||
155021326|NCT02343939|559505257|FG006|Overall Study|Study terminated by sponsor|3|||
155021327|NCT02343939|559505258|FG007|Overall Study|Study terminated by sponsor|4|||
155021328|NCT02343939|559505259|FG008|Overall Study|Study terminated by sponsor|0|||
155021329|NCT02343939|559505251|FG000|Overall Study|Withdrew consent|3|||
155021330|NCT02343939|559505252|FG001|Overall Study|Withdrew consent|6|||
155021331|NCT02343939|559505253|FG002|Overall Study|Withdrew consent|1|||
155021332|NCT02343939|559505254|FG003|Overall Study|Withdrew consent|2|||
155021333|NCT02343939|559505255|FG004|Overall Study|Withdrew consent|2|||
155179812|NCT04761627|560098227|FG001|Post-randomization Period|Withdrawal by Subject|7|||
155179813|NCT04761627|560098228|FG002|Post-randomization Period|Withdrawal by Subject|6|||
155179814|NCT04761627|560098226|FG000|Post-randomization Period|Pregnancy|0|||
155179815|NCT04761627|560098227|FG001|Post-randomization Period|Pregnancy|0|||
155179816|NCT04761627|560098228|FG002|Post-randomization Period|Pregnancy|1|||
155179817|NCT04761627|560098226|FG000|Post-randomization Period|Study site closure|0|||
155179818|NCT04761627|560098227|FG001|Post-randomization Period|Study site closure|0|||
155179819|NCT04761627|560098228|FG002|Post-randomization Period|Study site closure|1|||
155179820|NCT04761627|560098226|FG000|Post-randomization Period|Family planning|0|||
155179821|NCT04761627|560098227|FG001|Post-randomization Period|Family planning|1|||
155179822|NCT04761627|560098228|FG002|Post-randomization Period|Family planning|0|||
155179823|NCT01933789|560098229|FG000|Overall Study|Death|0|||
155179824|NCT01933789|560098230|FG001|Overall Study|Death|0|||
155179825|NCT01933789|560098231|FG002|Overall Study|Death|0|||
155179826|NCT01933789|560098232|FG003|Overall Study|Death|0|||
155179827|NCT01933789|560098233|FG004|Overall Study|Death|21|||
155179828|NCT01933789|560098234|FG005|Overall Study|Death|32|||
155179829|NCT01933789|560098235|FG006|Overall Study|Death|0|||
155179830|NCT01933789|560098236|FG007|Overall Study|Death|0|||
155179831|NCT01933789|560098237|FG008|Overall Study|Death|0|||
155179832|NCT01933789|560098229|FG000|Overall Study|Lost to Follow-up|0|||
155179833|NCT01933789|560098230|FG001|Overall Study|Lost to Follow-up|0|||
155179834|NCT01933789|560098231|FG002|Overall Study|Lost to Follow-up|0|||
155179835|NCT01933789|560098232|FG003|Overall Study|Lost to Follow-up|1|||
155179836|NCT01933789|560098233|FG004|Overall Study|Lost to Follow-up|8|||
155179837|NCT01933789|560098234|FG005|Overall Study|Lost to Follow-up|9|||
155179838|NCT01933789|560098235|FG006|Overall Study|Lost to Follow-up|1|||
155179839|NCT01933789|560098236|FG007|Overall Study|Lost to Follow-up|4|||
155179840|NCT01933789|560098237|FG008|Overall Study|Lost to Follow-up|0|||
155179841|NCT01933789|560098229|FG000|Overall Study|Withdrawal by Subject|2|||
155179842|NCT01933789|560098230|FG001|Overall Study|Withdrawal by Subject|1|||
155179843|NCT01933789|560098231|FG002|Overall Study|Withdrawal by Subject|0|||
155179844|NCT01933789|560098232|FG003|Overall Study|Withdrawal by Subject|0|||
155179845|NCT01933789|560098233|FG004|Overall Study|Withdrawal by Subject|17|||
155179846|NCT01933789|560098234|FG005|Overall Study|Withdrawal by Subject|16|||
155179847|NCT01933789|560098235|FG006|Overall Study|Withdrawal by Subject|1|||
155179848|NCT01933789|560098236|FG007|Overall Study|Withdrawal by Subject|4|||
155179849|NCT01933789|560098237|FG008|Overall Study|Withdrawal by Subject|0|||
155179850|NCT01933789|560098229|FG000|Overall Study|Became Ineligible|4|||
155179851|NCT01933789|560098230|FG001|Overall Study|Became Ineligible|0|||
155179852|NCT01933789|560098231|FG002|Overall Study|Became Ineligible|0|||
155179853|NCT01933789|560098232|FG003|Overall Study|Became Ineligible|0|||
155179854|NCT01933789|560098233|FG004|Overall Study|Became Ineligible|13|||
155179855|NCT01933789|560098234|FG005|Overall Study|Became Ineligible|10|||
155179856|NCT01933789|560098235|FG006|Overall Study|Became Ineligible|13|||
155179857|NCT01933789|560098236|FG007|Overall Study|Became Ineligible|6|||
155179858|NCT01933789|560098237|FG008|Overall Study|Became Ineligible|0|||
155179859|NCT00274924|560098242|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
155179860|NCT00274924|560098243|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
155179861|NCT00274924|560098244|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
155179862|NCT00274924|560098242|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
155179863|NCT00274924|560098243|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
155179864|NCT00274924|560098244|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
155179865|NCT00274924|560098242|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
155179866|NCT00274924|560098243|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
155179867|NCT00274924|560098244|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
155179868|NCT00274924|560098242|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
155179869|NCT00274924|560098243|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
155179870|NCT00274924|560098244|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
155179871|NCT00274924|560098242|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
155179872|NCT00274924|560098243|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
155179873|NCT00274924|560098244|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
155179874|NCT00274924|560098242|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
155179875|NCT00274924|560098243|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
155179876|NCT00274924|560098244|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
155179877|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
155179878|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
155179879|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
155179880|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
155179881|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
155179882|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
155179883|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
155179884|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
155179885|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
155179886|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
155179887|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
155179888|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
155179889|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
155179890|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
155179891|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
155139451|NCT04565951|559942759|FG001|Overall Study|Withdrawal by Subject|7|||
155139452|NCT04565951|559942758|FG000|Overall Study|Death|0|||
155139453|NCT04565951|559942759|FG001|Overall Study|Death|1|||
155139454|NCT01180296|559942762|FG000|Overall Study|Protocol Violation|1|||
155139455|NCT01180296|559942763|FG001|Overall Study|Protocol Violation|2|||
155139456|NCT00483938|559942764|FG000|Overall Study|Protocol Violation|0|||
155139457|NCT00483938|559942765|FG001|Overall Study|Protocol Violation|0|||
155139458|NCT00483938|559942766|FG002|Overall Study|Protocol Violation|0|||
155139459|NCT00483938|559942767|FG003|Overall Study|Protocol Violation|0|||
155139460|NCT00483938|559942768|FG004|Overall Study|Protocol Violation|0|||
155139461|NCT00483938|559942769|FG005|Overall Study|Protocol Violation|0|||
155139462|NCT00483938|559942770|FG006|Overall Study|Protocol Violation|3|||
155139463|NCT00483938|559942764|FG000|Overall Study|Withdrawal by Subject|1|||
155139464|NCT00483938|559942765|FG001|Overall Study|Withdrawal by Subject|6|||
155139465|NCT00483938|559942766|FG002|Overall Study|Withdrawal by Subject|0|||
155139466|NCT00483938|559942767|FG003|Overall Study|Withdrawal by Subject|0|||
155139467|NCT00483938|559942768|FG004|Overall Study|Withdrawal by Subject|1|||
155139468|NCT00483938|559942769|FG005|Overall Study|Withdrawal by Subject|3|||
155139469|NCT00483938|559942770|FG006|Overall Study|Withdrawal by Subject|2|||
155139470|NCT00483938|559942764|FG000|Overall Study|Lost to Follow-up|1|||
155139471|NCT00483938|559942765|FG001|Overall Study|Lost to Follow-up|2|||
155139472|NCT00483938|559942766|FG002|Overall Study|Lost to Follow-up|0|||
155139473|NCT00483938|559942767|FG003|Overall Study|Lost to Follow-up|2|||
155139474|NCT00483938|559942768|FG004|Overall Study|Lost to Follow-up|1|||
155139475|NCT00483938|559942769|FG005|Overall Study|Lost to Follow-up|1|||
155139476|NCT00483938|559942770|FG006|Overall Study|Lost to Follow-up|3|||
155139477|NCT00483938|559942764|FG000|Overall Study|Death|0|||
155139478|NCT00483938|559942765|FG001|Overall Study|Death|2|||
155139479|NCT00483938|559942766|FG002|Overall Study|Death|0|||
155139480|NCT00483938|559942767|FG003|Overall Study|Death|0|||
155139481|NCT00483938|559942768|FG004|Overall Study|Death|0|||
155139482|NCT00483938|559942769|FG005|Overall Study|Death|0|||
155139483|NCT00483938|559942770|FG006|Overall Study|Death|0|||
155139484|NCT00483938|559942764|FG000|Overall Study|Other|3|||
155139485|NCT00483938|559942765|FG001|Overall Study|Other|9|||
155139486|NCT00483938|559942766|FG002|Overall Study|Other|0|||
155139487|NCT00483938|559942767|FG003|Overall Study|Other|4|||
155139488|NCT00483938|559942768|FG004|Overall Study|Other|0|||
155139489|NCT00483938|559942769|FG005|Overall Study|Other|4|||
155139490|NCT00483938|559942770|FG006|Overall Study|Other|32|||
155139491|NCT03364309|559942773|FG000|Induction Period|Adverse Event|4|||
155139492|NCT03364309|559942774|FG001|Induction Period|Adverse Event|0|||
155139493|NCT03364309|559942775|FG002|Induction Period|Adverse Event|1|||
155139494|NCT03364309|559942776|FG003|Induction Period|Adverse Event|0|||
155139495|NCT03364309|559942777|FG004|Induction Period|Adverse Event|0|||
155139496|NCT03364309|559942778|FG005|Induction Period|Adverse Event|0|||
155139497|NCT03364309|559942779|FG006|Induction Period|Adverse Event|0|||
155139498|NCT03364309|559942780|FG007|Induction Period|Adverse Event|0|||
155139499|NCT03364309|559942781|FG008|Induction Period|Adverse Event|0|||
155139500|NCT03364309|559942782|FG009|Induction Period|Adverse Event|0|||
155139501|NCT03364309|559942783|FG010|Induction Period|Adverse Event|0|||
155139502|NCT03364309|559942784|FG011|Induction Period|Adverse Event|0|||
155139503|NCT03364309|559942785|FG012|Induction Period|Adverse Event|0|||
155139504|NCT03364309|559942786|FG013|Induction Period|Adverse Event|0|||
155139505|NCT03364309|559942787|FG014|Induction Period|Adverse Event|0|||
155139506|NCT03364309|559942788|FG015|Induction Period|Adverse Event|0|||
155139507|NCT03364309|559942789|FG016|Induction Period|Adverse Event|0|||
155139508|NCT03364309|559942790|FG017|Induction Period|Adverse Event|0|||
155139509|NCT03364309|559942791|FG018|Induction Period|Adverse Event|0|||
155139510|NCT03364309|559942773|FG000|Induction Period|Withdrawal by Subject|1|||
155139511|NCT03364309|559942774|FG001|Induction Period|Withdrawal by Subject|3|||
155139512|NCT03364309|559942775|FG002|Induction Period|Withdrawal by Subject|0|||
155139513|NCT03364309|559942776|FG003|Induction Period|Withdrawal by Subject|0|||
155139514|NCT03364309|559942777|FG004|Induction Period|Withdrawal by Subject|0|||
155139515|NCT03364309|559942778|FG005|Induction Period|Withdrawal by Subject|0|||
155139516|NCT03364309|559942779|FG006|Induction Period|Withdrawal by Subject|0|||
155139517|NCT03364309|559942780|FG007|Induction Period|Withdrawal by Subject|0|||
155139518|NCT03364309|559942781|FG008|Induction Period|Withdrawal by Subject|0|||
155139519|NCT03364309|559942782|FG009|Induction Period|Withdrawal by Subject|0|||
155139520|NCT03364309|559942783|FG010|Induction Period|Withdrawal by Subject|0|||
155139521|NCT03364309|559942784|FG011|Induction Period|Withdrawal by Subject|0|||
155139522|NCT03364309|559942785|FG012|Induction Period|Withdrawal by Subject|0|||
155139523|NCT03364309|559942786|FG013|Induction Period|Withdrawal by Subject|0|||
155139524|NCT03364309|559942787|FG014|Induction Period|Withdrawal by Subject|0|||
155139525|NCT03364309|559942788|FG015|Induction Period|Withdrawal by Subject|0|||
155139526|NCT03364309|559942789|FG016|Induction Period|Withdrawal by Subject|0|||
155139527|NCT03364309|559942790|FG017|Induction Period|Withdrawal by Subject|0|||
155139528|NCT03364309|559942791|FG018|Induction Period|Withdrawal by Subject|0|||
155139529|NCT03364309|559942773|FG000|Induction Period|Lost to Follow-up|1|||
155139530|NCT03364309|559942774|FG001|Induction Period|Lost to Follow-up|0|||
155021334|NCT02343939|559505256|FG005|Overall Study|Withdrew consent|0|||
155021335|NCT02343939|559505257|FG006|Overall Study|Withdrew consent|0|||
155021336|NCT02343939|559505258|FG007|Overall Study|Withdrew consent|8|||
155021337|NCT02343939|559505259|FG008|Overall Study|Withdrew consent|6|||
155021338|NCT02343939|559505251|FG000|Overall Study|Treatment failure|0|||
155021339|NCT02343939|559505252|FG001|Overall Study|Treatment failure|0|||
155021340|NCT02343939|559505253|FG002|Overall Study|Treatment failure|0|||
155021341|NCT02343939|559505254|FG003|Overall Study|Treatment failure|0|||
155021342|NCT02343939|559505255|FG004|Overall Study|Treatment failure|0|||
155021343|NCT02343939|559505256|FG005|Overall Study|Treatment failure|0|||
155021344|NCT02343939|559505257|FG006|Overall Study|Treatment failure|2|||
155021345|NCT02343939|559505258|FG007|Overall Study|Treatment failure|1|||
155021346|NCT02343939|559505259|FG008|Overall Study|Treatment failure|0|||
155021347|NCT02343939|559505251|FG000|Overall Study|Investigator's discretion|0|||
155021348|NCT02343939|559505252|FG001|Overall Study|Investigator's discretion|0|||
155021349|NCT02343939|559505253|FG002|Overall Study|Investigator's discretion|0|||
155021350|NCT02343939|559505254|FG003|Overall Study|Investigator's discretion|1|||
155021351|NCT02343939|559505255|FG004|Overall Study|Investigator's discretion|0|||
155021352|NCT02343939|559505256|FG005|Overall Study|Investigator's discretion|0|||
155021353|NCT02343939|559505257|FG006|Overall Study|Investigator's discretion|1|||
155021354|NCT02343939|559505258|FG007|Overall Study|Investigator's discretion|0|||
155021355|NCT02343939|559505259|FG008|Overall Study|Investigator's discretion|0|||
155021356|NCT02343939|559505251|FG000|Overall Study|Adverse Event|0|||
155021357|NCT02343939|559505252|FG001|Overall Study|Adverse Event|0|||
155021358|NCT02343939|559505253|FG002|Overall Study|Adverse Event|0|||
155021359|NCT02343939|559505254|FG003|Overall Study|Adverse Event|0|||
155021360|NCT02343939|559505255|FG004|Overall Study|Adverse Event|0|||
155139531|NCT03364309|559942775|FG002|Induction Period|Lost to Follow-up|0|||
155139532|NCT03364309|559942776|FG003|Induction Period|Lost to Follow-up|0|||
155139533|NCT03364309|559942777|FG004|Induction Period|Lost to Follow-up|0|||
155139534|NCT03364309|559942778|FG005|Induction Period|Lost to Follow-up|0|||
155139535|NCT03364309|559942779|FG006|Induction Period|Lost to Follow-up|0|||
155139536|NCT03364309|559942780|FG007|Induction Period|Lost to Follow-up|0|||
155139537|NCT03364309|559942781|FG008|Induction Period|Lost to Follow-up|0|||
155139538|NCT03364309|559942782|FG009|Induction Period|Lost to Follow-up|0|||
155139539|NCT03364309|559942783|FG010|Induction Period|Lost to Follow-up|0|||
155139540|NCT03364309|559942784|FG011|Induction Period|Lost to Follow-up|0|||
155139541|NCT03364309|559942785|FG012|Induction Period|Lost to Follow-up|0|||
155139542|NCT03364309|559942786|FG013|Induction Period|Lost to Follow-up|0|||
155139543|NCT03364309|559942787|FG014|Induction Period|Lost to Follow-up|0|||
155139544|NCT03364309|559942788|FG015|Induction Period|Lost to Follow-up|0|||
155139545|NCT03364309|559942789|FG016|Induction Period|Lost to Follow-up|0|||
155139546|NCT03364309|559942790|FG017|Induction Period|Lost to Follow-up|0|||
155139547|NCT03364309|559942791|FG018|Induction Period|Lost to Follow-up|0|||
155139548|NCT03364309|559942773|FG000|Induction Period|Physician Decision|0|||
155139549|NCT03364309|559942774|FG001|Induction Period|Physician Decision|1|||
155139550|NCT03364309|559942775|FG002|Induction Period|Physician Decision|0|||
155139551|NCT03364309|559942776|FG003|Induction Period|Physician Decision|0|||
155139552|NCT03364309|559942777|FG004|Induction Period|Physician Decision|0|||
155139553|NCT03364309|559942778|FG005|Induction Period|Physician Decision|0|||
155139554|NCT03364309|559942779|FG006|Induction Period|Physician Decision|0|||
155139555|NCT03364309|559942780|FG007|Induction Period|Physician Decision|0|||
155139556|NCT03364309|559942781|FG008|Induction Period|Physician Decision|0|||
155139557|NCT03364309|559942782|FG009|Induction Period|Physician Decision|0|||
155139558|NCT03364309|559942783|FG010|Induction Period|Physician Decision|0|||
155139559|NCT03364309|559942784|FG011|Induction Period|Physician Decision|0|||
155139560|NCT03364309|559942785|FG012|Induction Period|Physician Decision|0|||
155139561|NCT03364309|559942786|FG013|Induction Period|Physician Decision|0|||
155139562|NCT03364309|559942787|FG014|Induction Period|Physician Decision|0|||
155139563|NCT03364309|559942788|FG015|Induction Period|Physician Decision|0|||
155139564|NCT03364309|559942789|FG016|Induction Period|Physician Decision|0|||
155139565|NCT03364309|559942790|FG017|Induction Period|Physician Decision|0|||
155139566|NCT03364309|559942791|FG018|Induction Period|Physician Decision|0|||
155139567|NCT03364309|559942773|FG000|Maintenance Period|Withdrawal by Subject|0|||
155139568|NCT03364309|559942774|FG001|Maintenance Period|Withdrawal by Subject|0|||
155139569|NCT03364309|559942775|FG002|Maintenance Period|Withdrawal by Subject|0|||
155139570|NCT03364309|559942776|FG003|Maintenance Period|Withdrawal by Subject|1|||
155139571|NCT03364309|559942777|FG004|Maintenance Period|Withdrawal by Subject|3|||
155139572|NCT03364309|559942778|FG005|Maintenance Period|Withdrawal by Subject|1|||
155021361|NCT02343939|559505256|FG005|Overall Study|Adverse Event|1|||
155021362|NCT02343939|559505257|FG006|Overall Study|Adverse Event|0|||
155021363|NCT02343939|559505258|FG007|Overall Study|Adverse Event|0|||
155139573|NCT03364309|559942779|FG006|Maintenance Period|Withdrawal by Subject|3|||
155021364|NCT02343939|559505259|FG008|Overall Study|Adverse Event|0|||
155139574|NCT03364309|559942780|FG007|Maintenance Period|Withdrawal by Subject|0|||
155021365|NCT02343939|559505251|FG000|Overall Study|Never Treated With ENTO|0|||
155021366|NCT02343939|559505252|FG001|Overall Study|Never Treated With ENTO|0|||
155179892|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
155179893|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
155179894|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
155179895|NCT00274924|560098242|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
155179896|NCT00274924|560098243|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
155179897|NCT00274924|560098244|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
155179898|NCT02915874|560098246|FG000|Overall Study|Lost to Follow-up|5|||
155179899|NCT02915874|560098247|FG001|Overall Study|Lost to Follow-up|4|||
155179900|NCT02915874|560098246|FG000|Overall Study|Withdrawal by Subject|1|||
155179901|NCT02915874|560098247|FG001|Overall Study|Withdrawal by Subject|1|||
155179902|NCT02915874|560098246|FG000|Overall Study|Started New Anxiety Medication|0|||
155179903|NCT02915874|560098247|FG001|Overall Study|Started New Anxiety Medication|1|||
155179904|NCT02518464|560098253|FG000|Overall Study|Adverse Event|2|||
155179905|NCT03021564|560098259|FG000|Overall Study|Death|84|||
155179906|NCT03021564|560098260|FG001|Overall Study|Death|466|||
155179907|NCT03021564|560098259|FG000|Overall Study|Lost to Follow-up|0|||
155179908|NCT03021564|560098260|FG001|Overall Study|Lost to Follow-up|2|||
155179909|NCT00969280|560098261|FG000|Overall Study|Protocol Violation|2|||
155179910|NCT00969280|560098262|FG001|Overall Study|Protocol Violation|1|||
155021367|NCT02343939|559505253|FG002|Overall Study|Never Treated With ENTO|0|||
155021368|NCT02343939|559505254|FG003|Overall Study|Never Treated With ENTO|0|||
155021369|NCT02343939|559505255|FG004|Overall Study|Never Treated With ENTO|0|||
155021370|NCT02343939|559505256|FG005|Overall Study|Never Treated With ENTO|0|||
155021371|NCT02343939|559505257|FG006|Overall Study|Never Treated With ENTO|1|||
155021372|NCT02343939|559505258|FG007|Overall Study|Never Treated With ENTO|2|||
155021373|NCT02343939|559505259|FG008|Overall Study|Never Treated With ENTO|0|||
155021374|NCT00460811|559505262|FG000|Overall Study|Adverse Event|4|||
155021375|NCT00460811|559505263|FG001|Overall Study|Adverse Event|6|||
155021376|NCT00460811|559505264|FG002|Overall Study|Adverse Event|3|||
155021377|NCT00460811|559505265|FG003|Overall Study|Adverse Event|10|||
155021378|NCT00460811|559505266|FG004|Overall Study|Adverse Event|2|||
155021379|NCT00460811|559505262|FG000|Overall Study|Noncompliance|1|||
155021380|NCT00460811|559505263|FG001|Overall Study|Noncompliance|0|||
155021381|NCT00460811|559505264|FG002|Overall Study|Noncompliance|0|||
155021382|NCT00460811|559505265|FG003|Overall Study|Noncompliance|2|||
155179911|NCT00969280|560098261|FG000|Overall Study|Withdrawal by Subject|0|||
155179912|NCT00969280|560098262|FG001|Overall Study|Withdrawal by Subject|1|||
155179913|NCT00969280|560098261|FG000|Overall Study|infection of influenza A(H1N1)|0|||
155179914|NCT00969280|560098262|FG001|Overall Study|infection of influenza A(H1N1)|1|||
155179915|NCT00821327|560098263|FG000|Overall Study|Adverse Event|13|||
155179916|NCT00821327|560098263|FG000|Overall Study|Patient Request|1|||
155021383|NCT00460811|559505266|FG004|Overall Study|Noncompliance|1|||
155021384|NCT00460811|559505262|FG000|Overall Study|Withdrawal by Subject|7|||
155021385|NCT00460811|559505263|FG001|Overall Study|Withdrawal by Subject|7|||
155021386|NCT00460811|559505264|FG002|Overall Study|Withdrawal by Subject|6|||
155021387|NCT00460811|559505265|FG003|Overall Study|Withdrawal by Subject|3|||
155021388|NCT00460811|559505266|FG004|Overall Study|Withdrawal by Subject|11|||
155021389|NCT00460811|559505262|FG000|Overall Study|Physician Decision|1|||
155021390|NCT00460811|559505263|FG001|Overall Study|Physician Decision|0|||
155021391|NCT00460811|559505264|FG002|Overall Study|Physician Decision|0|||
155021392|NCT00460811|559505265|FG003|Overall Study|Physician Decision|0|||
155021393|NCT00460811|559505266|FG004|Overall Study|Physician Decision|0|||
155021394|NCT00460811|559505262|FG000|Overall Study|Lost to Follow-up|3|||
155021395|NCT00460811|559505263|FG001|Overall Study|Lost to Follow-up|2|||
155021396|NCT00460811|559505264|FG002|Overall Study|Lost to Follow-up|5|||
155179917|NCT00821327|560098263|FG000|Overall Study|Investigator Request|2|||
155179918|NCT00821327|560098263|FG000|Overall Study|Sponsor Request|1|||
155179919|NCT00821327|560098263|FG000|Overall Study|Disease Progression|13|||
155179920|NCT00821327|560098263|FG000|Overall Study|Other/Unknown|5|||
155179921|NCT00459979|560098264|FG000|Overall Study|Withdrawal by Subject|1|||
155179922|NCT00459979|560098264|FG000|Overall Study|Protocol Violation|1|||
155179923|NCT00989573|560098265|FG000|Overall Study|Adverse Event|8|||
155179924|NCT00989573|560098266|FG001|Overall Study|Adverse Event|12|||
155179925|NCT00989573|560098267|FG002|Overall Study|Adverse Event|4|||
155021397|NCT00460811|559505265|FG003|Overall Study|Lost to Follow-up|3|||
155021398|NCT00460811|559505266|FG004|Overall Study|Lost to Follow-up|6|||
155021399|NCT02821754|559505267|FG000|Overall Study|Procedure not required prior to amendment change|13|||
155021400|NCT02821754|559505268|FG001|Overall Study|Procedure not required prior to amendment change|11|||
155021401|NCT02821754|559505269|FG002|Overall Study|Procedure not required prior to amendment change|0|||
155021402|NCT02821754|559505267|FG000|Overall Study|Participant's Clinical status|2|||
155179926|NCT00989573|560098265|FG000|Overall Study|Physician Decision|0|||
155179927|NCT00989573|560098266|FG001|Overall Study|Physician Decision|2|||
155179928|NCT00989573|560098267|FG002|Overall Study|Physician Decision|0|||
155179929|NCT00989573|560098265|FG000|Overall Study|Protocol Violation|1|||
155179930|NCT00989573|560098266|FG001|Overall Study|Protocol Violation|1|||
155179931|NCT00989573|560098267|FG002|Overall Study|Protocol Violation|1|||
155179932|NCT00989573|560098265|FG000|Overall Study|Withdrawal by Subject|4|||
155179933|NCT00989573|560098266|FG001|Overall Study|Withdrawal by Subject|7|||
155179934|NCT00989573|560098267|FG002|Overall Study|Withdrawal by Subject|3|||
155179935|NCT00814801|560098268|FG000|Overall Study|Adverse Event|15|||
155179936|NCT00814801|560098269|FG001|Overall Study|Adverse Event|16|||
155179937|NCT00814801|560098270|FG002|Overall Study|Adverse Event|19|||
155179938|NCT00814801|560098268|FG000|Overall Study|Withdrawal by Subject|9|||
155179939|NCT00814801|560098269|FG001|Overall Study|Withdrawal by Subject|11|||
155179940|NCT00814801|560098270|FG002|Overall Study|Withdrawal by Subject|14|||
155179941|NCT00814801|560098268|FG000|Overall Study|Inappropriate as a subject|1|||
155179942|NCT00814801|560098269|FG001|Overall Study|Inappropriate as a subject|1|||
155179943|NCT00814801|560098270|FG002|Overall Study|Inappropriate as a subject|1|||
155179944|NCT00814801|560098268|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
155179945|NCT00814801|560098269|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
155021403|NCT02821754|559505268|FG001|Overall Study|Participant's Clinical status|0|||
155021404|NCT02821754|559505269|FG002|Overall Study|Participant's Clinical status|0|||
155021405|NCT02821754|559505267|FG000|Overall Study|Participant removed for noncompliance|1|||
155021406|NCT02821754|559505268|FG001|Overall Study|Participant removed for noncompliance|0|||
155021407|NCT02821754|559505269|FG002|Overall Study|Participant removed for noncompliance|0|||
155021408|NCT02821754|559505267|FG000|Overall Study|Drug not available.|0|||
155021409|NCT02821754|559505268|FG001|Overall Study|Drug not available.|0|||
155021410|NCT02821754|559505269|FG002|Overall Study|Drug not available.|1|||
155021411|NCT02821754|559505267|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
155021412|NCT02821754|559505268|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
155021413|NCT02821754|559505269|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
155179946|NCT00814801|560098270|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
155179947|NCT00814801|560098268|FG000|Overall Study|Missing or change of caregiver|6|||
155179948|NCT00814801|560098269|FG001|Overall Study|Missing or change of caregiver|2|||
155179949|NCT00814801|560098270|FG002|Overall Study|Missing or change of caregiver|4|||
155179950|NCT00814801|560098268|FG000|Overall Study|Non-compliance|0|||
155179951|NCT00814801|560098269|FG001|Overall Study|Non-compliance|1|||
155179952|NCT00814801|560098270|FG002|Overall Study|Non-compliance|1|||
155179953|NCT00814801|560098268|FG000|Overall Study|Other|2|||
155179954|NCT00814801|560098269|FG001|Overall Study|Other|6|||
155179955|NCT00814801|560098270|FG002|Overall Study|Other|4|||
155021414|NCT02099110|559505273|FG000|Overall Study|Protocol Violation|2|||
155021415|NCT02099110|559505274|FG001|Overall Study|Protocol Violation|1|||
155021416|NCT02099110|559505275|FG002|Overall Study|Protocol Violation|0|||
155021417|NCT02099110|559505276|FG003|Overall Study|Protocol Violation|3|||
155021418|NCT02099110|559505277|FG004|Overall Study|Protocol Violation|1|||
155021419|NCT02099110|559505273|FG000|Overall Study|Participant moved|1|||
155021420|NCT02099110|559505274|FG001|Overall Study|Participant moved|1|||
155021421|NCT02099110|559505275|FG002|Overall Study|Participant moved|1|||
155021422|NCT02099110|559505276|FG003|Overall Study|Participant moved|0|||
155021423|NCT02099110|559505277|FG004|Overall Study|Participant moved|2|||
155021424|NCT02099110|559505273|FG000|Overall Study|Withdrawal by Subject|7|||
155021425|NCT02099110|559505274|FG001|Overall Study|Withdrawal by Subject|11|||
155021426|NCT02099110|559505275|FG002|Overall Study|Withdrawal by Subject|13|||
155021427|NCT02099110|559505276|FG003|Overall Study|Withdrawal by Subject|9|||
155021428|NCT02099110|559505277|FG004|Overall Study|Withdrawal by Subject|13|||
155021429|NCT02099110|559505273|FG000|Overall Study|Adverse Event|3|||
155021430|NCT02099110|559505274|FG001|Overall Study|Adverse Event|5|||
155021431|NCT02099110|559505275|FG002|Overall Study|Adverse Event|2|||
155021432|NCT02099110|559505276|FG003|Overall Study|Adverse Event|3|||
155021433|NCT02099110|559505277|FG004|Overall Study|Adverse Event|2|||
155021434|NCT02099110|559505273|FG000|Overall Study|Lost to Follow-up|6|||
155021435|NCT02099110|559505274|FG001|Overall Study|Lost to Follow-up|12|||
155021436|NCT02099110|559505275|FG002|Overall Study|Lost to Follow-up|11|||
155021437|NCT02099110|559505276|FG003|Overall Study|Lost to Follow-up|5|||
155021438|NCT02099110|559505277|FG004|Overall Study|Lost to Follow-up|6|||
155021439|NCT02099110|559505273|FG000|Overall Study|Death|0|||
155021440|NCT02099110|559505274|FG001|Overall Study|Death|1|||
155021441|NCT02099110|559505275|FG002|Overall Study|Death|0|||
155021442|NCT02099110|559505276|FG003|Overall Study|Death|0|||
155021443|NCT02099110|559505277|FG004|Overall Study|Death|0|||
155021444|NCT02099110|559505273|FG000|Overall Study|Screen failure|0|||
155021445|NCT02099110|559505274|FG001|Overall Study|Screen failure|0|||
155021446|NCT02099110|559505275|FG002|Overall Study|Screen failure|0|||
155021447|NCT02099110|559505276|FG003|Overall Study|Screen failure|0|||
155021448|NCT02099110|559505277|FG004|Overall Study|Screen failure|1|||
155179956|NCT02486718|560098273|FG000|Enrollment Phase|Death|19|||
155179957|NCT02486718|560098274|FG001|Enrollment Phase|Death|0|||
155179958|NCT02486718|560098275|FG002|Enrollment Phase|Death|0|||
155179959|NCT02486718|560098273|FG000|Enrollment Phase|Symptomatic deterioration|1|||
155179960|NCT02486718|560098274|FG001|Enrollment Phase|Symptomatic deterioration|0|||
155021449|NCT02099110|559505273|FG000|Overall Study|Non-compliance with study drug|2|||
155179961|NCT02486718|560098275|FG002|Enrollment Phase|Symptomatic deterioration|0|||
155021450|NCT02099110|559505274|FG001|Overall Study|Non-compliance with study drug|0|||
155021451|NCT02099110|559505275|FG002|Overall Study|Non-compliance with study drug|0|||
155021452|NCT02099110|559505276|FG003|Overall Study|Non-compliance with study drug|0|||
155021453|NCT02099110|559505277|FG004|Overall Study|Non-compliance with study drug|1|||
155021454|NCT02099110|559505273|FG000|Overall Study|Physician Decision|3|||
155021455|NCT02099110|559505274|FG001|Overall Study|Physician Decision|0|||
155021456|NCT02099110|559505275|FG002|Overall Study|Physician Decision|1|||
155021457|NCT02099110|559505276|FG003|Overall Study|Physician Decision|2|||
155021458|NCT02099110|559505277|FG004|Overall Study|Physician Decision|1|||
155021459|NCT00994461|559505282|FG000|Overall Study|Adverse Event|2|||
155021460|NCT00994461|559505283|FG001|Overall Study|Adverse Event|1|||
155021461|NCT00994461|559505284|FG002|Overall Study|Adverse Event|0|||
155021462|NCT02977572|559505285|FG000|Overall Study|Exclusion criterion|2|||
155021463|NCT02977572|559505286|FG001|Overall Study|Exclusion criterion|2|||
155021464|NCT00454363|559505291|FG000|Overall Study|Adverse Event|1|||
155021465|NCT00454363|559505292|FG001|Overall Study|Adverse Event|2|||
155021466|NCT00454363|559505291|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
155021467|NCT00454363|559505292|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
155021468|NCT01863667|559505294|FG000|Overall Study|Adverse Event|1|||
155021469|NCT01863667|559505295|FG001|Overall Study|Adverse Event|0|||
155021470|NCT01863667|559505294|FG000|Overall Study|Study terminated by Sponsor|30|||
155021471|NCT01863667|559505295|FG001|Overall Study|Study terminated by Sponsor|30|||
155021472|NCT01863667|559505294|FG000|Overall Study|Withdrawal by Subject|2|||
155021473|NCT01863667|559505295|FG001|Overall Study|Withdrawal by Subject|2|||
155021474|NCT02837731|559505297|FG000|Allocation|Admitted to General Floor|3|||
155021475|NCT02837731|559505298|FG001|Allocation|Admitted to General Floor|4|||
155021476|NCT02837731|559505297|FG000|Allocation|Immediate surgery/withdrew|2|||
155021477|NCT02837731|559505298|FG001|Allocation|Immediate surgery/withdrew|0|||
155021478|NCT02837731|559505297|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
155021479|NCT02837731|559505298|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
155021480|NCT02837731|559505297|FG000|Allocation|Withdrawal by Subject|2|||
155021481|NCT02837731|559505298|FG001|Allocation|Withdrawal by Subject|0|||
155021482|NCT02837731|559505297|FG000|Allocation|Device not available|1|||
155021483|NCT02837731|559505298|FG001|Allocation|Device not available|0|||
155021484|NCT02837731|559505297|FG000|Allocation|Protocol not implemented|7|||
155021485|NCT02837731|559505298|FG001|Allocation|Protocol not implemented|0|||
155021486|NCT02837731|559505297|FG000|Allocation|Moribund/Do not resuscitate|2|||
155021487|NCT02837731|559505298|FG001|Allocation|Moribund/Do not resuscitate|0|||
155021488|NCT02837731|559505297|FG000|Allocation|Did not meet sepsis criteria|1|||
155021489|NCT02837731|559505298|FG001|Allocation|Did not meet sepsis criteria|2|||
155021490|NCT02837731|559505297|FG000|Allocation|Known aortic abnormalities|0|||
155021491|NCT02837731|559505298|FG001|Allocation|Known aortic abnormalities|1|||
155021492|NCT00315458|559505299|FG000|Overall Study|Administrative|0|||
155021493|NCT00315458|559505300|FG001|Overall Study|Administrative|3|||
155021494|NCT00315458|559505301|FG002|Overall Study|Administrative|8|||
155021495|NCT00315458|559505302|FG003|Overall Study|Administrative|21|||
155021496|NCT00315458|559505299|FG000|Overall Study|Adverse Event|2|||
155021497|NCT00315458|559505300|FG001|Overall Study|Adverse Event|4|||
155021498|NCT00315458|559505301|FG002|Overall Study|Adverse Event|23|||
155021499|NCT00315458|559505302|FG003|Overall Study|Adverse Event|3|||
155021500|NCT00315458|559505299|FG000|Overall Study|Lost to Follow-up|1|||
155021501|NCT00315458|559505300|FG001|Overall Study|Lost to Follow-up|2|||
155021502|NCT00315458|559505301|FG002|Overall Study|Lost to Follow-up|0|||
155021503|NCT00315458|559505302|FG003|Overall Study|Lost to Follow-up|2|||
155021504|NCT00315458|559505299|FG000|Overall Study|Withdrawal by Subject|0|||
155021505|NCT00315458|559505300|FG001|Overall Study|Withdrawal by Subject|3|||
155021506|NCT00315458|559505301|FG002|Overall Study|Withdrawal by Subject|0|||
155021507|NCT00315458|559505302|FG003|Overall Study|Withdrawal by Subject|2|||
155021508|NCT00315458|559505299|FG000|Overall Study|Lack of Efficacy|0|||
155021509|NCT00315458|559505300|FG001|Overall Study|Lack of Efficacy|0|||
155021510|NCT00315458|559505301|FG002|Overall Study|Lack of Efficacy|20|||
155021511|NCT00315458|559505302|FG003|Overall Study|Lack of Efficacy|1|||
155021512|NCT00315458|559505299|FG000|Overall Study|Did not qualify|0|||
155021513|NCT00315458|559505300|FG001|Overall Study|Did not qualify|0|||
155021514|NCT00315458|559505301|FG002|Overall Study|Did not qualify|1|||
155021515|NCT00315458|559505302|FG003|Overall Study|Did not qualify|0|||
155021516|NCT00523848|559505304|FG000|Overall Study|Adverse Event|11|||
155021517|NCT00523848|559505304|FG000|Overall Study|Withdrawal by Subject|2|||
155021518|NCT00523848|559505304|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
155021519|NCT00523848|559505304|FG000|Overall Study|Disease Progression|5|||
155021520|NCT00523848|559505304|FG000|Overall Study|Other, unspecified|4|||
155021521|NCT00489918|559505306|FG000|Overall Study|Withdrawal by Subject|2|||
155021522|NCT00489918|559505307|FG001|Overall Study|Withdrawal by Subject|1|||
155021523|NCT00489918|559505308|FG002|Overall Study|Withdrawal by Subject|1|||
155021524|NCT00489918|559505309|FG003|Overall Study|Withdrawal by Subject|0|||
155021525|NCT00489918|559505310|FG004|Overall Study|Withdrawal by Subject|1|||
155021526|NCT00489918|559505306|FG000|Overall Study|Adverse Event|0|||
155021527|NCT00489918|559505307|FG001|Overall Study|Adverse Event|1|||
155021528|NCT00489918|559505308|FG002|Overall Study|Adverse Event|1|||
155139575|NCT03364309|559942781|FG008|Maintenance Period|Withdrawal by Subject|1|||
155139576|NCT03364309|559942782|FG009|Maintenance Period|Withdrawal by Subject|1|||
155139577|NCT03364309|559942783|FG010|Maintenance Period|Withdrawal by Subject|2|||
155139578|NCT03364309|559942784|FG011|Maintenance Period|Withdrawal by Subject|0|||
155139579|NCT03364309|559942785|FG012|Maintenance Period|Withdrawal by Subject|0|||
155139580|NCT03364309|559942786|FG013|Maintenance Period|Withdrawal by Subject|0|||
155139581|NCT03364309|559942787|FG014|Maintenance Period|Withdrawal by Subject|0|||
155139582|NCT03364309|559942788|FG015|Maintenance Period|Withdrawal by Subject|0|||
155139583|NCT03364309|559942789|FG016|Maintenance Period|Withdrawal by Subject|0|||
155139584|NCT03364309|559942790|FG017|Maintenance Period|Withdrawal by Subject|0|||
155139585|NCT03364309|559942791|FG018|Maintenance Period|Withdrawal by Subject|0|||
155139586|NCT03364309|559942773|FG000|Maintenance Period|Adverse Event|0|||
155139587|NCT03364309|559942774|FG001|Maintenance Period|Adverse Event|0|||
155139588|NCT03364309|559942775|FG002|Maintenance Period|Adverse Event|0|||
155139589|NCT03364309|559942776|FG003|Maintenance Period|Adverse Event|0|||
155139590|NCT03364309|559942777|FG004|Maintenance Period|Adverse Event|2|||
155139591|NCT03364309|559942778|FG005|Maintenance Period|Adverse Event|0|||
155139592|NCT03364309|559942779|FG006|Maintenance Period|Adverse Event|3|||
155139593|NCT03364309|559942780|FG007|Maintenance Period|Adverse Event|0|||
155139594|NCT03364309|559942781|FG008|Maintenance Period|Adverse Event|1|||
155139595|NCT03364309|559942782|FG009|Maintenance Period|Adverse Event|0|||
155139596|NCT03364309|559942783|FG010|Maintenance Period|Adverse Event|2|||
155139597|NCT03364309|559942784|FG011|Maintenance Period|Adverse Event|0|||
155139598|NCT03364309|559942785|FG012|Maintenance Period|Adverse Event|0|||
155139599|NCT03364309|559942786|FG013|Maintenance Period|Adverse Event|0|||
155139600|NCT03364309|559942787|FG014|Maintenance Period|Adverse Event|0|||
155139601|NCT03364309|559942788|FG015|Maintenance Period|Adverse Event|0|||
155139602|NCT03364309|559942789|FG016|Maintenance Period|Adverse Event|0|||
155139603|NCT03364309|559942790|FG017|Maintenance Period|Adverse Event|0|||
155139604|NCT03364309|559942791|FG018|Maintenance Period|Adverse Event|0|||
155139605|NCT03364309|559942773|FG000|Maintenance Period|Relapsed|0|||
155139606|NCT03364309|559942774|FG001|Maintenance Period|Relapsed|0|||
155139607|NCT03364309|559942775|FG002|Maintenance Period|Relapsed|0|||
155139608|NCT03364309|559942776|FG003|Maintenance Period|Relapsed|43|||
155139609|NCT03364309|559942777|FG004|Maintenance Period|Relapsed|7|||
155139610|NCT03364309|559942778|FG005|Maintenance Period|Relapsed|45|||
155139611|NCT03364309|559942779|FG006|Maintenance Period|Relapsed|10|||
155139612|NCT03364309|559942780|FG007|Maintenance Period|Relapsed|2|||
155139613|NCT03364309|559942781|FG008|Maintenance Period|Relapsed|0|||
155139614|NCT03364309|559942782|FG009|Maintenance Period|Relapsed|0|||
155139615|NCT03364309|559942783|FG010|Maintenance Period|Relapsed|0|||
155139616|NCT03364309|559942784|FG011|Maintenance Period|Relapsed|0|||
155139617|NCT03364309|559942785|FG012|Maintenance Period|Relapsed|0|||
155139618|NCT03364309|559942786|FG013|Maintenance Period|Relapsed|0|||
155139619|NCT03364309|559942787|FG014|Maintenance Period|Relapsed|0|||
155139620|NCT03364309|559942788|FG015|Maintenance Period|Relapsed|0|||
155139621|NCT03364309|559942789|FG016|Maintenance Period|Relapsed|0|||
155139622|NCT03364309|559942790|FG017|Maintenance Period|Relapsed|0|||
155139623|NCT03364309|559942791|FG018|Maintenance Period|Relapsed|0|||
155139624|NCT03364309|559942773|FG000|Maintenance Period|Lack of Efficacy|0|||
155139625|NCT03364309|559942774|FG001|Maintenance Period|Lack of Efficacy|0|||
155139626|NCT03364309|559942775|FG002|Maintenance Period|Lack of Efficacy|0|||
155139627|NCT03364309|559942776|FG003|Maintenance Period|Lack of Efficacy|0|||
155139628|NCT03364309|559942777|FG004|Maintenance Period|Lack of Efficacy|0|||
155139629|NCT03364309|559942778|FG005|Maintenance Period|Lack of Efficacy|0|||
155139630|NCT03364309|559942779|FG006|Maintenance Period|Lack of Efficacy|0|||
155139631|NCT03364309|559942780|FG007|Maintenance Period|Lack of Efficacy|0|||
155139632|NCT03364309|559942781|FG008|Maintenance Period|Lack of Efficacy|1|||
155139633|NCT03364309|559942782|FG009|Maintenance Period|Lack of Efficacy|3|||
155139634|NCT03364309|559942783|FG010|Maintenance Period|Lack of Efficacy|2|||
155139635|NCT03364309|559942784|FG011|Maintenance Period|Lack of Efficacy|0|||
155139636|NCT03364309|559942785|FG012|Maintenance Period|Lack of Efficacy|0|||
155139637|NCT03364309|559942786|FG013|Maintenance Period|Lack of Efficacy|0|||
155139638|NCT03364309|559942787|FG014|Maintenance Period|Lack of Efficacy|0|||
155139639|NCT03364309|559942788|FG015|Maintenance Period|Lack of Efficacy|0|||
155139640|NCT03364309|559942789|FG016|Maintenance Period|Lack of Efficacy|0|||
155139641|NCT03364309|559942790|FG017|Maintenance Period|Lack of Efficacy|0|||
155139642|NCT03364309|559942791|FG018|Maintenance Period|Lack of Efficacy|0|||
155139643|NCT03364309|559942773|FG000|Maintenance Period|Death|0|||
155139644|NCT03364309|559942774|FG001|Maintenance Period|Death|0|||
155139645|NCT03364309|559942775|FG002|Maintenance Period|Death|0|||
155139646|NCT03364309|559942776|FG003|Maintenance Period|Death|0|||
155139647|NCT03364309|559942777|FG004|Maintenance Period|Death|0|||
155139648|NCT03364309|559942778|FG005|Maintenance Period|Death|0|||
155139649|NCT03364309|559942779|FG006|Maintenance Period|Death|0|||
155139650|NCT03364309|559942780|FG007|Maintenance Period|Death|0|||
155139651|NCT03364309|559942781|FG008|Maintenance Period|Death|1|||
155139652|NCT03364309|559942782|FG009|Maintenance Period|Death|0|||
155139653|NCT03364309|559942783|FG010|Maintenance Period|Death|0|||
155021529|NCT00489918|559505309|FG003|Overall Study|Adverse Event|0|||
155021530|NCT00489918|559505310|FG004|Overall Study|Adverse Event|0|||
155021531|NCT00489918|559505306|FG000|Overall Study|Lost to Follow-up|0|||
155021532|NCT00489918|559505307|FG001|Overall Study|Lost to Follow-up|0|||
155021533|NCT00489918|559505308|FG002|Overall Study|Lost to Follow-up|1|||
155021534|NCT00489918|559505309|FG003|Overall Study|Lost to Follow-up|1|||
155021535|NCT00489918|559505310|FG004|Overall Study|Lost to Follow-up|0|||
155021536|NCT00489918|559505306|FG000|Overall Study|Physician Decision|0|||
155021537|NCT00489918|559505307|FG001|Overall Study|Physician Decision|0|||
155021538|NCT00489918|559505308|FG002|Overall Study|Physician Decision|1|||
155021539|NCT00489918|559505309|FG003|Overall Study|Physician Decision|0|||
155021540|NCT00489918|559505310|FG004|Overall Study|Physician Decision|0|||
155021541|NCT02748213|559505311|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
155021542|NCT02748213|559505312|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
155021543|NCT02748213|559505311|FG000|Overall Study|Abnormal Laboratory Test|1|||
155021544|NCT02748213|559505312|FG001|Overall Study|Abnormal Laboratory Test|0|||
155021545|NCT02748213|559505311|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
155021546|NCT02748213|559505312|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
155021547|NCT02748213|559505311|FG000|Overall Study|Death|5|||
155021548|NCT02748213|559505312|FG001|Overall Study|Death|3|||
155179962|NCT02486718|560098273|FG000|Enrollment Phase|Withdrawal by Subject|86|||
155021549|NCT02748213|559505311|FG000|Overall Study|Insufficient Therapeutic Response|56|||
155021550|NCT02748213|559505312|FG001|Overall Study|Insufficient Therapeutic Response|57|||
155021551|NCT02748213|559505311|FG000|Overall Study|Violation of Selection Criteria|2|||
155021552|NCT02748213|559505312|FG001|Overall Study|Violation of Selection Criteria|0|||
155021553|NCT02748213|559505311|FG000|Overall Study|Protocol Violation|6|||
155021554|NCT02748213|559505312|FG001|Overall Study|Protocol Violation|4|||
155021555|NCT02748213|559505311|FG000|Overall Study|Refused Treatment*|6|||
155021556|NCT02748213|559505312|FG001|Overall Study|Refused Treatment*|6|||
155021557|NCT02748213|559505311|FG000|Overall Study|Failure to Return|1|||
155021558|NCT02748213|559505312|FG001|Overall Study|Failure to Return|0|||
155021559|NCT02748213|559505311|FG000|Overall Study|Other|30|||
155021560|NCT02748213|559505312|FG001|Overall Study|Other|29|||
155021561|NCT01190410|559506823|FG000|Overall Study|Adverse Event|0|||
155021562|NCT01190410|559506824|FG001|Overall Study|Adverse Event|3|||
155021563|NCT01190410|559506823|FG000|Overall Study|Lack of Efficacy|0|||
155021564|NCT01190410|559506824|FG001|Overall Study|Lack of Efficacy|2|||
155021565|NCT01190410|559506823|FG000|Overall Study|Withdrawal by Subject|0|||
155021566|NCT01190410|559506824|FG001|Overall Study|Withdrawal by Subject|2|||
155021567|NCT01190410|559506823|FG000|Overall Study|Administrative decision|1|||
155021568|NCT01190410|559506824|FG001|Overall Study|Administrative decision|0|||
155021569|NCT01190410|559506823|FG000|Overall Study|PI discretion|0|||
155021570|NCT01190410|559506824|FG001|Overall Study|PI discretion|2|||
155021571|NCT01399047|559506825|FG000|Overall Study|Withdrawal by Subject|0|||
155021572|NCT01399047|559506826|FG001|Overall Study|Withdrawal by Subject|1|||
155021573|NCT03300505|559506840|FG000|Overall Study|Death|0|||
155021574|NCT03300505|559506841|FG001|Overall Study|Death|1|||
155021575|NCT03300505|559506842|FG002|Overall Study|Death|0|||
155021576|NCT03300505|559506840|FG000|Overall Study|Withdrawal by Subject|0|||
155021577|NCT03300505|559506841|FG001|Overall Study|Withdrawal by Subject|1|||
155021578|NCT03300505|559506842|FG002|Overall Study|Withdrawal by Subject|1|||
155021579|NCT03300505|559506840|FG000|Overall Study|Sponsor Termination|0|||
155021580|NCT03300505|559506841|FG001|Overall Study|Sponsor Termination|1|||
155021581|NCT03300505|559506842|FG002|Overall Study|Sponsor Termination|0|||
155021582|NCT03300505|559506840|FG000|Overall Study|Adverse Event|0|||
155021583|NCT03300505|559506841|FG001|Overall Study|Adverse Event|0|||
155021584|NCT03300505|559506842|FG002|Overall Study|Adverse Event|2|||
155021585|NCT01108341|559506843|FG000|Overall Study|Death|2|||
155139654|NCT03364309|559942784|FG011|Maintenance Period|Death|0|||
155139655|NCT03364309|559942785|FG012|Maintenance Period|Death|0|||
155139656|NCT03364309|559942786|FG013|Maintenance Period|Death|0|||
155139657|NCT03364309|559942787|FG014|Maintenance Period|Death|0|||
155139658|NCT03364309|559942788|FG015|Maintenance Period|Death|0|||
155139659|NCT03364309|559942789|FG016|Maintenance Period|Death|0|||
155139660|NCT03364309|559942790|FG017|Maintenance Period|Death|0|||
155139661|NCT03364309|559942791|FG018|Maintenance Period|Death|0|||
155139662|NCT03364309|559942773|FG000|Maintenance Period|Lost to Follow-up|0|||
155139663|NCT03364309|559942774|FG001|Maintenance Period|Lost to Follow-up|0|||
155139664|NCT03364309|559942775|FG002|Maintenance Period|Lost to Follow-up|0|||
155139665|NCT03364309|559942776|FG003|Maintenance Period|Lost to Follow-up|0|||
155139666|NCT03364309|559942777|FG004|Maintenance Period|Lost to Follow-up|0|||
155139667|NCT03364309|559942778|FG005|Maintenance Period|Lost to Follow-up|0|||
155139668|NCT03364309|559942779|FG006|Maintenance Period|Lost to Follow-up|0|||
155139669|NCT03364309|559942780|FG007|Maintenance Period|Lost to Follow-up|0|||
155179963|NCT02486718|560098274|FG001|Enrollment Phase|Withdrawal by Subject|0|||
155021586|NCT01108341|559506843|FG000|Overall Study|Withdrawal by Subject|1|||
155021587|NCT01108341|559506843|FG000|Overall Study|Lost to Follow-up|1|||
155021588|NCT01108341|559506843|FG000|Overall Study|Other|1|||
155139670|NCT03364309|559942781|FG008|Maintenance Period|Lost to Follow-up|1|||
155139671|NCT03364309|559942782|FG009|Maintenance Period|Lost to Follow-up|0|||
155139672|NCT03364309|559942783|FG010|Maintenance Period|Lost to Follow-up|0|||
155139673|NCT03364309|559942784|FG011|Maintenance Period|Lost to Follow-up|0|||
155139674|NCT03364309|559942785|FG012|Maintenance Period|Lost to Follow-up|0|||
155139675|NCT03364309|559942786|FG013|Maintenance Period|Lost to Follow-up|0|||
155139676|NCT03364309|559942787|FG014|Maintenance Period|Lost to Follow-up|0|||
155139677|NCT03364309|559942788|FG015|Maintenance Period|Lost to Follow-up|0|||
155139678|NCT03364309|559942789|FG016|Maintenance Period|Lost to Follow-up|0|||
155139679|NCT03364309|559942790|FG017|Maintenance Period|Lost to Follow-up|0|||
155139680|NCT03364309|559942791|FG018|Maintenance Period|Lost to Follow-up|0|||
155139681|NCT03364309|559942773|FG000|Maintenance Period|Miscellaneous|0|||
155139682|NCT03364309|559942774|FG001|Maintenance Period|Miscellaneous|0|||
155139683|NCT03364309|559942775|FG002|Maintenance Period|Miscellaneous|0|||
155139684|NCT03364309|559942776|FG003|Maintenance Period|Miscellaneous|0|||
155139685|NCT03364309|559942777|FG004|Maintenance Period|Miscellaneous|0|||
155139686|NCT03364309|559942778|FG005|Maintenance Period|Miscellaneous|0|||
155139687|NCT03364309|559942779|FG006|Maintenance Period|Miscellaneous|0|||
155139688|NCT03364309|559942780|FG007|Maintenance Period|Miscellaneous|0|||
155139689|NCT03364309|559942781|FG008|Maintenance Period|Miscellaneous|1|||
155139690|NCT03364309|559942782|FG009|Maintenance Period|Miscellaneous|0|||
155139691|NCT03364309|559942783|FG010|Maintenance Period|Miscellaneous|0|||
155139692|NCT03364309|559942784|FG011|Maintenance Period|Miscellaneous|0|||
155139693|NCT03364309|559942785|FG012|Maintenance Period|Miscellaneous|0|||
155139694|NCT03364309|559942786|FG013|Maintenance Period|Miscellaneous|0|||
155139695|NCT03364309|559942787|FG014|Maintenance Period|Miscellaneous|0|||
155139696|NCT03364309|559942788|FG015|Maintenance Period|Miscellaneous|0|||
155139697|NCT03364309|559942789|FG016|Maintenance Period|Miscellaneous|0|||
155139698|NCT03364309|559942790|FG017|Maintenance Period|Miscellaneous|0|||
155139699|NCT03364309|559942791|FG018|Maintenance Period|Miscellaneous|0|||
155139700|NCT03364309|559942773|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139701|NCT03364309|559942774|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139702|NCT03364309|559942775|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139703|NCT03364309|559942776|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139704|NCT03364309|559942777|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139705|NCT03364309|559942778|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139706|NCT03364309|559942779|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139707|NCT03364309|559942780|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139708|NCT03364309|559942781|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139709|NCT03364309|559942782|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139710|NCT03364309|559942783|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139711|NCT03364309|559942784|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139712|NCT03364309|559942785|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139713|NCT03364309|559942786|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
155139714|NCT03364309|559942787|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
155139715|NCT03364309|559942788|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
155139716|NCT03364309|559942789|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139717|NCT03364309|559942790|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139718|NCT03364309|559942791|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
155139719|NCT03364309|559942773|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139720|NCT03364309|559942774|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139721|NCT03364309|559942775|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139722|NCT03364309|559942776|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139723|NCT03364309|559942777|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139724|NCT03364309|559942778|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139725|NCT03364309|559942779|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139726|NCT03364309|559942780|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139727|NCT03364309|559942781|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139728|NCT03364309|559942782|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139729|NCT03364309|559942783|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
155021589|NCT03467217|559506846|FG000|Overall Study|Trial stopped early|5|||
155021590|NCT03467217|559506847|FG001|Overall Study|Trial stopped early|2|||
155021591|NCT03467217|559506846|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
155021592|NCT03467217|559506847|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
155021593|NCT03467217|559506846|FG000|Overall Study|Lost to Follow-up|0|||
155021594|NCT03467217|559506847|FG001|Overall Study|Lost to Follow-up|2|||
155021595|NCT00769067|559506848|FG000|Overall Study|Death|89|||
155021596|NCT00769067|559506849|FG001|Overall Study|Death|86|||
155021597|NCT00769067|559506848|FG000|Overall Study|Lost to Follow-up|3|||
155021598|NCT00769067|559506849|FG001|Overall Study|Lost to Follow-up|1|||
155021599|NCT00769067|559506848|FG000|Overall Study|Study terminated by sponsor|1|||
155021600|NCT00769067|559506849|FG001|Overall Study|Study terminated by sponsor|3|||
155021601|NCT00769067|559506848|FG000|Overall Study|Other|1|||
155021602|NCT00769067|559506849|FG001|Overall Study|Other|3|||
155021603|NCT00769067|559506848|FG000|Overall Study|Withdrawal by Subject|0|||
155179964|NCT02486718|560098275|FG002|Enrollment Phase|Withdrawal by Subject|0|||
155179965|NCT02486718|560098273|FG000|Enrollment Phase|Protocol Violation|18|||
155179966|NCT02486718|560098274|FG001|Enrollment Phase|Protocol Violation|0|||
155179967|NCT02486718|560098275|FG002|Enrollment Phase|Protocol Violation|0|||
155179968|NCT02486718|560098273|FG000|Enrollment Phase|Physician Decision|18|||
155179969|NCT02486718|560098274|FG001|Enrollment Phase|Physician Decision|0|||
155179970|NCT02486718|560098275|FG002|Enrollment Phase|Physician Decision|0|||
155179971|NCT02486718|560098273|FG000|Enrollment Phase|Reason not provided|41|||
155179972|NCT02486718|560098274|FG001|Enrollment Phase|Reason not provided|0|||
155179973|NCT02486718|560098275|FG002|Enrollment Phase|Reason not provided|0|||
155179974|NCT02486718|560098273|FG000|Enrollment Phase|Disease relapse|54|||
155179975|NCT02486718|560098274|FG001|Enrollment Phase|Disease relapse|0|||
155179976|NCT02486718|560098275|FG002|Enrollment Phase|Disease relapse|0|||
155179977|NCT02486718|560098273|FG000|Enrollment Phase|Lost to Follow-up|4|||
155179978|NCT02486718|560098274|FG001|Enrollment Phase|Lost to Follow-up|0|||
155179979|NCT02486718|560098275|FG002|Enrollment Phase|Lost to Follow-up|0|||
155179980|NCT02486718|560098273|FG000|Enrollment Phase|Adverse Event|34|||
155179981|NCT02486718|560098274|FG001|Enrollment Phase|Adverse Event|0|||
155179982|NCT02486718|560098275|FG002|Enrollment Phase|Adverse Event|0|||
155179983|NCT02486718|560098273|FG000|Randomized Phase|Withdrawal by Subject|0|||
155179984|NCT02486718|560098274|FG001|Randomized Phase|Withdrawal by Subject|44|||
155179985|NCT02486718|560098275|FG002|Randomized Phase|Withdrawal by Subject|47|||
155179986|NCT02486718|560098273|FG000|Randomized Phase|Protocol Violation|0|||
155179987|NCT02486718|560098274|FG001|Randomized Phase|Protocol Violation|2|||
155179988|NCT02486718|560098275|FG002|Randomized Phase|Protocol Violation|0|||
155179989|NCT02486718|560098273|FG000|Randomized Phase|Physician Decision|0|||
155179990|NCT02486718|560098274|FG001|Randomized Phase|Physician Decision|0|||
155179991|NCT02486718|560098275|FG002|Randomized Phase|Physician Decision|3|||
155179992|NCT02486718|560098273|FG000|Randomized Phase|Lost to Follow-up|0|||
155179993|NCT02486718|560098274|FG001|Randomized Phase|Lost to Follow-up|5|||
155179994|NCT02486718|560098275|FG002|Randomized Phase|Lost to Follow-up|11|||
155179995|NCT02486718|560098273|FG000|Randomized Phase|Disease Relapse|0|||
155179996|NCT02486718|560098274|FG001|Randomized Phase|Disease Relapse|1|||
155179997|NCT02486718|560098275|FG002|Randomized Phase|Disease Relapse|0|||
155179998|NCT02486718|560098273|FG000|Randomized Phase|Death|0|||
155179999|NCT02486718|560098274|FG001|Randomized Phase|Death|154|||
155180000|NCT02486718|560098275|FG002|Randomized Phase|Death|155|||
155180001|NCT02486718|560098273|FG000|Randomized Phase|Ongoing|0|||
155180002|NCT02486718|560098274|FG001|Randomized Phase|Ongoing|301|||
155180003|NCT02486718|560098275|FG002|Randomized Phase|Ongoing|282|||
155180004|NCT01037088|560098278|FG000|Overall Study|Withdrawal by Subject|3|||
155180005|NCT02216812|560098281|FG000|Overall Study|Lost to Follow-up|10|||
155180006|NCT02216812|560098282|FG001|Overall Study|Lost to Follow-up|5|||
155180007|NCT00527488|560098287|FG000|Overall Study|Withdrawn prior to dosing|0|||
155180008|NCT00527488|560098288|FG001|Overall Study|Withdrawn prior to dosing|1|||
155180009|NCT00527488|560098289|FG002|Overall Study|Withdrawn prior to dosing|1|||
155180010|NCT00527488|560098290|FG003|Overall Study|Withdrawn prior to dosing|0|||
155180011|NCT01958827|560098291|FG000|Overall Study|Adverse Event|3|||
155180012|NCT01958827|560098291|FG000|Overall Study|Lack of Efficacy|6|||
155180013|NCT01958827|560098291|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
155180014|NCT03036800|560098292|FG000|Overall Study|Protocol Violation|1|||
155180015|NCT03036800|560098293|FG001|Overall Study|Protocol Violation|0|||
155180016|NCT03036800|560098292|FG000|Overall Study|Non-compliance|1|||
155180017|NCT03036800|560098293|FG001|Overall Study|Non-compliance|0|||
155180018|NCT03036800|560098292|FG000|Overall Study|Lost to Follow-up|1|||
155180019|NCT03036800|560098293|FG001|Overall Study|Lost to Follow-up|0|||
155180020|NCT03036800|560098292|FG000|Overall Study|Death|1|||
155180021|NCT03036800|560098293|FG001|Overall Study|Death|0|||
155180022|NCT03036800|560098292|FG000|Overall Study|Tolerance|5|||
155180023|NCT03036800|560098293|FG001|Overall Study|Tolerance|0|||
155180024|NCT03036800|560098292|FG000|Overall Study|Unknown/no reason given|50|||
155021604|NCT00769067|559506849|FG001|Overall Study|Withdrawal by Subject|1|||
155021605|NCT01270464|559506850|FG000|Overall Study|Protocol Violation|4|||
155021606|NCT01270464|559506851|FG001|Overall Study|Protocol Violation|3|||
155021607|NCT01270464|559506852|FG002|Overall Study|Protocol Violation|2|||
155180025|NCT03036800|560098293|FG001|Overall Study|Unknown/no reason given|39|||
155180026|NCT01986933|560098294|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
155180027|NCT01986933|560098295|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
155180028|NCT01986933|560098296|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
155180029|NCT01986933|560098297|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
155180030|NCT01986933|560098298|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
155180031|NCT01986933|560098294|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
155180032|NCT01986933|560098295|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
155180033|NCT01986933|560098296|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
155180034|NCT01986933|560098297|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
155180035|NCT01986933|560098298|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
155180036|NCT01986933|560098294|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
155180037|NCT01986933|560098295|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
155180038|NCT01986933|560098296|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
155180039|NCT01986933|560098297|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
155180040|NCT01986933|560098298|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
155180041|NCT01986933|560098294|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
155180042|NCT01986933|560098295|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
155180043|NCT01986933|560098296|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
155180044|NCT01986933|560098297|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
155180045|NCT01986933|560098298|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
155180046|NCT01986933|560098294|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155180047|NCT01986933|560098295|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155180048|NCT01986933|560098296|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155180049|NCT01986933|560098297|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
155180050|NCT01986933|560098298|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
155180051|NCT01986933|560098294|FG000|Active-to-active (Part B)|Adverse Event|0|||
155180052|NCT01986933|560098295|FG001|Active-to-active (Part B)|Adverse Event|2|||
155180053|NCT01986933|560098296|FG002|Active-to-active (Part B)|Adverse Event|0|||
155180054|NCT01986933|560098297|FG003|Active-to-active (Part B)|Adverse Event|1|||
155180055|NCT01986933|560098298|FG004|Active-to-active (Part B)|Adverse Event|3|||
155180056|NCT01986933|560098294|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
155180057|NCT01986933|560098295|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
155180058|NCT01986933|560098296|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
155180059|NCT01986933|560098297|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
155180060|NCT01986933|560098298|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
155180061|NCT01986933|560098294|FG000|Active-to-active (Part B)|Pregnancy|0|||
155180062|NCT01986933|560098295|FG001|Active-to-active (Part B)|Pregnancy|0|||
155180063|NCT01986933|560098296|FG002|Active-to-active (Part B)|Pregnancy|0|||
155180064|NCT01986933|560098297|FG003|Active-to-active (Part B)|Pregnancy|0|||
155180065|NCT01986933|560098298|FG004|Active-to-active (Part B)|Pregnancy|1|||
155180066|NCT01986933|560098294|FG000|Active-to-active (Part B)|Physician Decision|0|||
155180067|NCT01986933|560098295|FG001|Active-to-active (Part B)|Physician Decision|0|||
155180068|NCT01986933|560098296|FG002|Active-to-active (Part B)|Physician Decision|1|||
155180069|NCT01986933|560098297|FG003|Active-to-active (Part B)|Physician Decision|1|||
155180070|NCT01986933|560098298|FG004|Active-to-active (Part B)|Physician Decision|0|||
155180071|NCT01986933|560098294|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
155180072|NCT01986933|560098295|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
155180073|NCT01986933|560098296|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
155180074|NCT01986933|560098297|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
155180075|NCT01986933|560098298|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
155180076|NCT01986933|560098294|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
155180077|NCT01986933|560098295|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
155180078|NCT01986933|560098296|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
155180079|NCT01986933|560098297|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
155180080|NCT01986933|560098298|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
155180081|NCT01986933|560098294|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
155180082|NCT01986933|560098295|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
155180083|NCT01986933|560098296|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
155180084|NCT01986933|560098297|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
155180085|NCT01986933|560098298|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
155180086|NCT01986933|560098294|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
155180087|NCT01986933|560098295|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
155180088|NCT01986933|560098296|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
155180089|NCT01986933|560098297|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
155180090|NCT01986933|560098298|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
155180091|NCT01986933|560098294|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155180092|NCT01986933|560098295|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155180093|NCT01986933|560098296|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155180094|NCT01986933|560098297|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
155180095|NCT01986933|560098298|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
155180096|NCT01986933|560098294|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
155180097|NCT01986933|560098295|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
155180098|NCT01986933|560098296|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
155180099|NCT01986933|560098297|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
155021608|NCT01270464|559506850|FG000|Overall Study|Lack of Efficacy|2|||
155180100|NCT01986933|560098298|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
155180101|NCT01986933|560098294|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
155180102|NCT01986933|560098295|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
155180103|NCT01986933|560098296|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
155180104|NCT01986933|560098297|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
155180105|NCT01986933|560098298|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
155180106|NCT01986933|560098294|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155180107|NCT01986933|560098295|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
155180108|NCT01986933|560098296|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155180109|NCT01986933|560098297|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155180110|NCT01986933|560098298|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
155180111|NCT01077154|560098299|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
155180112|NCT01077154|560098300|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
155180113|NCT01077154|560098299|FG000|Overall Study|Withdrawal by Subject|369|||
155180114|NCT01077154|560098300|FG001|Overall Study|Withdrawal by Subject|385|||
155180115|NCT01077154|560098299|FG000|Overall Study|Death|215|||
155180116|NCT01077154|560098300|FG001|Overall Study|Death|214|||
155180117|NCT01077154|560098299|FG000|Overall Study|Lost to Follow-up|43|||
155180118|NCT01077154|560098300|FG001|Overall Study|Lost to Follow-up|35|||
155180119|NCT01077154|560098299|FG000|Overall Study|Noncompliance|22|||
155180120|NCT01077154|560098300|FG001|Overall Study|Noncompliance|20|||
155180121|NCT01077154|560098299|FG000|Overall Study|Disease Progression|18|||
155180122|NCT01077154|560098300|FG001|Overall Study|Disease Progression|20|||
155180123|NCT01077154|560098299|FG000|Overall Study|Ineligibility Determined|10|||
155180124|NCT01077154|560098300|FG001|Overall Study|Ineligibility Determined|14|||
155180125|NCT01077154|560098299|FG000|Overall Study|Other|14|||
155180126|NCT01077154|560098300|FG001|Overall Study|Other|11|||
155180127|NCT01077154|560098299|FG000|Overall Study|Adverse Event|9|||
155180128|NCT01077154|560098300|FG001|Overall Study|Adverse Event|9|||
155180129|NCT01077154|560098299|FG000|Overall Study|Administrative Decision|1|||
155180130|NCT01077154|560098300|FG001|Overall Study|Administrative Decision|6|||
155180131|NCT01077154|560098299|FG000|Overall Study|Protocol Deviation|1|||
155180132|NCT01077154|560098300|FG001|Overall Study|Protocol Deviation|0|||
155180133|NCT04030026|560098301|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
155180134|NCT04030026|560098302|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
155180135|NCT04030026|560098301|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
155180136|NCT04030026|560098302|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
155180137|NCT04030026|560098301|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
155180138|NCT04030026|560098302|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
155180139|NCT04030026|560098301|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
155180140|NCT04030026|560098302|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
155180141|NCT04030026|560098301|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
155180142|NCT04030026|560098302|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
155180143|NCT04030026|560098301|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
155180144|NCT04030026|560098302|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
155180145|NCT04030026|560098301|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
155180146|NCT04030026|560098302|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
155180147|NCT02207946|560098303|FG000|Overall Study|Lost to Follow-up|1|||
155180148|NCT02207946|560098304|FG001|Overall Study|Lost to Follow-up|0|||
155180149|NCT02207946|560098303|FG000|Overall Study|Adverse Event|0|||
155180150|NCT02207946|560098304|FG001|Overall Study|Adverse Event|1|||
155180151|NCT02545543|560098305|FG000|Overall Study|Lost to Follow-up|67|||
155180152|NCT02545543|560098306|FG001|Overall Study|Lost to Follow-up|25|||
155180153|NCT02545543|560098305|FG000|Overall Study|Physician Decision|3|||
155180154|NCT02545543|560098306|FG001|Overall Study|Physician Decision|0|||
155180155|NCT02545543|560098305|FG000|Overall Study|Withdrawal by Subject|9|||
155180156|NCT02545543|560098306|FG001|Overall Study|Withdrawal by Subject|8|||
155180157|NCT02545543|560098305|FG000|Overall Study|Noncomplaince|1|||
155180158|NCT02545543|560098306|FG001|Overall Study|Noncomplaince|0|||
155180159|NCT02545543|560098305|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
155180160|NCT02545543|560098306|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
155180161|NCT02829944|560098314|FG000|Overall Study|Physician Decision|0|||
155180162|NCT02829944|560098315|FG001|Overall Study|Physician Decision|1|||
155180163|NCT02829944|560098314|FG000|Overall Study|Screen Failure|2|||
155180164|NCT02829944|560098315|FG001|Overall Study|Screen Failure|2|||
155180165|NCT02829944|560098314|FG000|Overall Study|Inadequate Neuraxial Block|1|||
155180166|NCT02829944|560098315|FG001|Overall Study|Inadequate Neuraxial Block|1|||
155180167|NCT02829944|560098314|FG000|Overall Study|Withdrawal by Subject|2|||
155021609|NCT01270464|559506851|FG001|Overall Study|Lack of Efficacy|3|||
155021610|NCT01270464|559506852|FG002|Overall Study|Lack of Efficacy|1|||
155021611|NCT01270464|559506850|FG000|Overall Study|Adverse Event|9|||
155021612|NCT01270464|559506851|FG001|Overall Study|Adverse Event|1|||
155021613|NCT01270464|559506852|FG002|Overall Study|Adverse Event|7|||
155180168|NCT02829944|560098315|FG001|Overall Study|Withdrawal by Subject|1|||
155180169|NCT02829944|560098314|FG000|Overall Study|Catheter Displacement|1|||
155180170|NCT02829944|560098315|FG001|Overall Study|Catheter Displacement|0|||
155180171|NCT02829944|560098314|FG000|Overall Study|Catheter broke|0|||
155180172|NCT02829944|560098315|FG001|Overall Study|Catheter broke|1|||
155180173|NCT02829944|560098314|FG000|Overall Study|Staff unavailable|0|||
155180174|NCT02829944|560098315|FG001|Overall Study|Staff unavailable|1|||
155180175|NCT04675151|560098319|FG000|Overall Study|Protocol Violation|1|||
155180176|NCT04675151|560098320|FG001|Overall Study|Protocol Violation|0|||
155180177|NCT04675151|560098321|FG002|Overall Study|Protocol Violation|0|||
155180178|NCT04675151|560098322|FG003|Overall Study|Protocol Violation|1|||
155180179|NCT01730937|560098323|FG000|Overall Study|Protocol Violation|5|||
155180180|NCT01730937|560098324|FG001|Overall Study|Protocol Violation|11|||
155180181|NCT03947684|560098325|FG000|Overall Study|Lost to Follow-up|13|||
155180182|NCT03947684|560098326|FG001|Overall Study|Lost to Follow-up|5|||
155180183|NCT03947684|560098327|FG002|Overall Study|Lost to Follow-up|1|||
155180184|NCT03947684|560098325|FG000|Overall Study|Withdrawal by Subject|11|||
155180185|NCT03947684|560098326|FG001|Overall Study|Withdrawal by Subject|4|||
155180186|NCT03947684|560098327|FG002|Overall Study|Withdrawal by Subject|0|||
155180187|NCT03947684|560098325|FG000|Overall Study|Physician Decision|1|||
155180188|NCT03947684|560098326|FG001|Overall Study|Physician Decision|0|||
155180189|NCT03947684|560098327|FG002|Overall Study|Physician Decision|0|||
155180190|NCT03947684|560098325|FG000|Overall Study|Lack of adherence to study protocol|2|||
155180191|NCT03947684|560098326|FG001|Overall Study|Lack of adherence to study protocol|0|||
155180192|NCT03947684|560098327|FG002|Overall Study|Lack of adherence to study protocol|0|||
155180193|NCT03875235|560098329|FG000|Overall Study|Ongoing study treatment|63|||
155180194|NCT03875235|560098330|FG001|Overall Study|Ongoing study treatment|20|||
155180195|NCT03875235|560098329|FG000|Overall Study|Off treatment|77|||
155180196|NCT03875235|560098330|FG001|Overall Study|Off treatment|91|||
155180197|NCT03875235|560098329|FG000|Overall Study|Withdrawal by Subject|3|||
155180198|NCT03875235|560098330|FG001|Overall Study|Withdrawal by Subject|10|||
155180199|NCT03875235|560098329|FG000|Overall Study|Death|198|||
155180200|NCT03875235|560098330|FG001|Overall Study|Death|223|||
155180201|NCT01395784|560098340|FG000|Overall Study|Lost to Follow-up|7|||
155180202|NCT01395784|560098340|FG000|Overall Study|Withdrawal by Subject|3|||
155180203|NCT01395784|560098340|FG000|Overall Study|Physician Decision|5|||
155180204|NCT05772702|560098341|FG000|Overall Study|Adverse Event|1|||
155180205|NCT04153149|560098342|FG000|Double Blind Period|Death|63|||
155180206|NCT04153149|560098343|FG001|Double Blind Period|Death|49|||
155180207|NCT04153149|560098344|FG002|Double Blind Period|Death|0|||
155180208|NCT04153149|560098345|FG003|Double Blind Period|Death|0|||
155180209|NCT04153149|560098342|FG000|Double Blind Period|Withdrawal by Subject|16|||
155180210|NCT04153149|560098343|FG001|Double Blind Period|Withdrawal by Subject|11|||
155180211|NCT04153149|560098344|FG002|Double Blind Period|Withdrawal by Subject|0|||
155180212|NCT04153149|560098345|FG003|Double Blind Period|Withdrawal by Subject|0|||
155180213|NCT04153149|560098342|FG000|Double Blind Period|Adverse Event|6|||
155180214|NCT04153149|560098343|FG001|Double Blind Period|Adverse Event|2|||
155180215|NCT04153149|560098344|FG002|Double Blind Period|Adverse Event|0|||
155180216|NCT04153149|560098345|FG003|Double Blind Period|Adverse Event|0|||
155180217|NCT04153149|560098342|FG000|Double Blind Period|Lost to Follow-up|2|||
155180218|NCT04153149|560098343|FG001|Double Blind Period|Lost to Follow-up|1|||
155180219|NCT04153149|560098344|FG002|Double Blind Period|Lost to Follow-up|0|||
155180220|NCT04153149|560098345|FG003|Double Blind Period|Lost to Follow-up|0|||
155180221|NCT04153149|560098342|FG000|Double Blind Period|Withdrawal by guardian|0|||
155021614|NCT01270464|559506850|FG000|Overall Study|Withdrawal by Subject|2|||
155021615|NCT01270464|559506851|FG001|Overall Study|Withdrawal by Subject|1|||
155021616|NCT01270464|559506852|FG002|Overall Study|Withdrawal by Subject|4|||
155021617|NCT01270464|559506850|FG000|Overall Study|Lost to Follow-up|2|||
155021618|NCT01270464|559506851|FG001|Overall Study|Lost to Follow-up|3|||
155021619|NCT01270464|559506852|FG002|Overall Study|Lost to Follow-up|1|||
155180222|NCT04153149|560098343|FG001|Double Blind Period|Withdrawal by guardian|2|||
155180223|NCT04153149|560098344|FG002|Double Blind Period|Withdrawal by guardian|0|||
155180224|NCT04153149|560098345|FG003|Double Blind Period|Withdrawal by guardian|0|||
155021620|NCT01270464|559506850|FG000|Overall Study|Other|1|||
155021621|NCT01270464|559506851|FG001|Overall Study|Other|1|||
155021622|NCT01270464|559506852|FG002|Overall Study|Other|3|||
155021623|NCT02448537|559506853|FG000|Overall Study|Withdrawal by Subject|1|||
155021624|NCT02448537|559506854|FG001|Overall Study|Withdrawal by Subject|1|||
155021625|NCT02448537|559506855|FG002|Overall Study|Withdrawal by Subject|1|||
155021626|NCT05656534|559506856|FG000|Overall Study|Withdrawal by Subject|1|||
155021627|NCT05656534|559506857|FG001|Overall Study|Withdrawal by Subject|1|||
155021628|NCT05656534|559506858|FG002|Overall Study|Withdrawal by Subject|0|||
155021629|NCT05656534|559506859|FG003|Overall Study|Withdrawal by Subject|0|||
155021630|NCT05656534|559506856|FG000|Overall Study|Physician Decision|1|||
155021631|NCT05656534|559506857|FG001|Overall Study|Physician Decision|1|||
155021632|NCT05656534|559506858|FG002|Overall Study|Physician Decision|0|||
155021633|NCT05656534|559506859|FG003|Overall Study|Physician Decision|0|||
155021634|NCT01288937|559506860|FG000|Overall Study|Adverse Event|1|||
155021635|NCT01288937|559506861|FG001|Overall Study|Adverse Event|0|||
155021636|NCT00912743|559506866|FG000|Overall Study|Adverse Event|3|||
155180225|NCT04153149|560098342|FG000|Double Blind Period|Reason Not Specified|5|||
155180226|NCT04153149|560098343|FG001|Double Blind Period|Reason Not Specified|4|||
155180227|NCT04153149|560098344|FG002|Double Blind Period|Reason Not Specified|0|||
155021637|NCT00912743|559506867|FG001|Overall Study|Adverse Event|1|||
155021638|NCT00912743|559506866|FG000|Overall Study|Lack of Efficacy|9|||
155021639|NCT00912743|559506867|FG001|Overall Study|Lack of Efficacy|18|||
155021640|NCT00912743|559506866|FG000|Overall Study|Toxicity|0|||
155021641|NCT00912743|559506867|FG001|Overall Study|Toxicity|1|||
155139730|NCT03364309|559942784|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139731|NCT03364309|559942785|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139732|NCT03364309|559942786|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139733|NCT03364309|559942787|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
155139734|NCT03364309|559942788|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139735|NCT03364309|559942789|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139736|NCT03364309|559942790|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139737|NCT03364309|559942791|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
155139738|NCT03364309|559942773|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
155139739|NCT03364309|559942774|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
155139740|NCT03364309|559942775|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
155139741|NCT03364309|559942776|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
155139742|NCT03364309|559942777|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
155139743|NCT03364309|559942778|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
155139744|NCT03364309|559942779|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
155139745|NCT03364309|559942780|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
155139746|NCT03364309|559942781|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
155139747|NCT03364309|559942782|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
155139748|NCT03364309|559942783|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
155139749|NCT03364309|559942784|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
155139750|NCT03364309|559942785|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
155139751|NCT03364309|559942786|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
155139752|NCT03364309|559942787|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
155139753|NCT03364309|559942788|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
155139754|NCT03364309|559942789|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
155139755|NCT03364309|559942790|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
155139756|NCT03364309|559942791|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
155139757|NCT03364309|559942773|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139758|NCT03364309|559942774|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139759|NCT03364309|559942775|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139760|NCT03364309|559942776|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139761|NCT03364309|559942777|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139762|NCT03364309|559942778|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139763|NCT03364309|559942779|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139764|NCT03364309|559942780|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139765|NCT03364309|559942781|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139766|NCT03364309|559942782|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139767|NCT03364309|559942783|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139768|NCT03364309|559942784|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139769|NCT03364309|559942785|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139770|NCT03364309|559942786|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139771|NCT03364309|559942787|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139772|NCT03364309|559942788|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155139773|NCT03364309|559942789|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
155139774|NCT03364309|559942790|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
155139775|NCT03364309|559942791|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
155139776|NCT03364309|559942773|FG000|Post-Treatment Followup Period|Adverse Event|0|||
155139777|NCT03364309|559942774|FG001|Post-Treatment Followup Period|Adverse Event|0|||
155139778|NCT03364309|559942775|FG002|Post-Treatment Followup Period|Adverse Event|0|||
155139779|NCT03364309|559942776|FG003|Post-Treatment Followup Period|Adverse Event|0|||
155139780|NCT03364309|559942777|FG004|Post-Treatment Followup Period|Adverse Event|0|||
155139781|NCT03364309|559942778|FG005|Post-Treatment Followup Period|Adverse Event|0|||
155139782|NCT03364309|559942779|FG006|Post-Treatment Followup Period|Adverse Event|0|||
155139783|NCT03364309|559942780|FG007|Post-Treatment Followup Period|Adverse Event|0|||
155139784|NCT03364309|559942781|FG008|Post-Treatment Followup Period|Adverse Event|0|||
155139785|NCT03364309|559942782|FG009|Post-Treatment Followup Period|Adverse Event|0|||
155139786|NCT03364309|559942783|FG010|Post-Treatment Followup Period|Adverse Event|0|||
155139787|NCT03364309|559942784|FG011|Post-Treatment Followup Period|Adverse Event|0|||
155139788|NCT03364309|559942785|FG012|Post-Treatment Followup Period|Adverse Event|0|||
155139789|NCT03364309|559942786|FG013|Post-Treatment Followup Period|Adverse Event|0|||
155139790|NCT03364309|559942787|FG014|Post-Treatment Followup Period|Adverse Event|0|||
155139791|NCT03364309|559942788|FG015|Post-Treatment Followup Period|Adverse Event|0|||
155139792|NCT03364309|559942789|FG016|Post-Treatment Followup Period|Adverse Event|2|||
155139793|NCT03364309|559942790|FG017|Post-Treatment Followup Period|Adverse Event|6|||
155139794|NCT03364309|559942791|FG018|Post-Treatment Followup Period|Adverse Event|1|||
155139795|NCT03364309|559942773|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139796|NCT03364309|559942774|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139797|NCT03364309|559942775|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139798|NCT03364309|559942776|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139799|NCT03364309|559942777|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
155021642|NCT00912743|559506866|FG000|Overall Study|End of treatment form was not collected|1|||
155021643|NCT00912743|559506867|FG001|Overall Study|End of treatment form was not collected|0|||
155021644|NCT01136356|559506871|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
155021645|NCT01136356|559506872|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
155021646|NCT01136356|559506871|FG000|First 18-day Withdrawal|Physician Decision|1|||
155021647|NCT01136356|559506872|FG001|First 18-day Withdrawal|Physician Decision|0|||
155021648|NCT01136356|559506871|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
155021649|NCT01136356|559506872|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
155021650|NCT00178685|559506873|FG000|Overall Study|Death|3|||
155021651|NCT00178685|559506874|FG001|Overall Study|Death|3|||
155021652|NCT00178685|559506875|FG002|Overall Study|Death|6|||
155021653|NCT00178685|559506873|FG000|Overall Study|Lost to Follow-up|100|||
155021654|NCT00178685|559506874|FG001|Overall Study|Lost to Follow-up|187|||
155021655|NCT00178685|559506875|FG002|Overall Study|Lost to Follow-up|183|||
155021656|NCT00178685|559506873|FG000|Overall Study|Withdrawal by Subject|8|||
155021657|NCT00178685|559506874|FG001|Overall Study|Withdrawal by Subject|14|||
155021658|NCT00178685|559506875|FG002|Overall Study|Withdrawal by Subject|7|||
155021659|NCT00820248|559506876|FG000|Overall Study|No treated|4|||
155021660|NCT00820248|559506877|FG001|Overall Study|No treated|1|||
155021661|NCT01750697|559506878|FG000|Overall Study|Transferred Back to Local Hospital|1|||
155021662|NCT01750697|559506878|FG000|Overall Study|Physician and Family Decision|1|||
155021663|NCT01750697|559506878|FG000|Overall Study|Transferred to Adult Services|5|||
155021664|NCT01750697|559506878|FG000|Overall Study|Physician Decision|1|||
155021665|NCT01750697|559506878|FG000|Overall Study|Withdrawal by Subject|1|||
155021666|NCT00857896|559506881|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
155021667|NCT01431716|559506883|FG000|Overall Study|Withdrawal of consent|1|||
155021668|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
155021669|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
155021670|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
155021671|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
155021672|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
155021673|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
155021674|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
155021675|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
155021676|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
155021677|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
155021678|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
155021679|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
155021680|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
155021681|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
155021682|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155021683|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155021684|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155021685|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
155021686|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
155021687|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
155021688|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
155021689|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
155021690|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
155021691|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
155021692|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
155021693|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
155021694|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
155021695|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
155021696|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
155021697|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
155021698|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
155021699|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
155021700|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155021701|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155021702|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155021703|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
155021704|NCT02016105|559506884|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
155021705|NCT02016105|559506885|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
155021706|NCT02016105|559506886|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155021707|NCT02016105|559506887|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155021708|NCT02016105|559506888|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155139800|NCT03364309|559942778|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139801|NCT03364309|559942779|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
155021709|NCT02016105|559506889|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
155021710|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
155021711|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
155021712|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
155021713|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
155021714|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
155021715|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
155021716|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
155021717|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
155021718|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
155021719|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
155021720|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
155021721|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
155021722|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
155021723|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
155021724|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
155021725|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
155021726|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
155021727|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
155021728|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Death|0|||
155021729|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Death|0|||
155021730|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Death|0|||
155021731|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Death|0|||
155021732|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Death|0|||
155021733|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Death|1|||
155021734|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
155021735|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
155021736|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
155021737|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
155021738|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
155021739|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
155021740|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
155021741|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
155021742|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
155021743|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
155021744|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
155021745|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
155021746|NCT02016105|559506884|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155021747|NCT02016105|559506885|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155021748|NCT02016105|559506886|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
155021749|NCT02016105|559506887|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155021750|NCT02016105|559506888|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
155021751|NCT02016105|559506889|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
155021752|NCT02016105|559506884|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
155021753|NCT02016105|559506885|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
155021754|NCT02016105|559506886|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
155021755|NCT02016105|559506887|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
155021756|NCT02016105|559506888|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
155021757|NCT02016105|559506889|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
155021758|NCT02016105|559506884|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
155021759|NCT02016105|559506885|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
155021760|NCT02016105|559506886|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
155021761|NCT02016105|559506887|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
155021762|NCT02016105|559506888|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
155021763|NCT02016105|559506889|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
155021764|NCT02016105|559506884|FG000|EXTENSION PERIOD|Adverse Event|0|||
155021765|NCT02016105|559506885|FG001|EXTENSION PERIOD|Adverse Event|0|||
155021766|NCT02016105|559506886|FG002|EXTENSION PERIOD|Adverse Event|2|||
155021767|NCT02016105|559506887|FG003|EXTENSION PERIOD|Adverse Event|0|||
155021768|NCT02016105|559506888|FG004|EXTENSION PERIOD|Adverse Event|1|||
155021769|NCT02016105|559506889|FG005|EXTENSION PERIOD|Adverse Event|0|||
155021770|NCT02016105|559506884|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
155021771|NCT02016105|559506885|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
155021772|NCT02016105|559506886|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
155021773|NCT02016105|559506887|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
155021774|NCT02016105|559506888|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
155021775|NCT02016105|559506889|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
155021776|NCT02016105|559506884|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
155021777|NCT02016105|559506885|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
155021778|NCT02016105|559506886|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
155021779|NCT02016105|559506887|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
155021780|NCT02016105|559506888|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
155021781|NCT02016105|559506889|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
155021782|NCT02016105|559506884|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
155021783|NCT02016105|559506885|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
155021784|NCT02016105|559506886|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
155021785|NCT02016105|559506887|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
155021786|NCT02016105|559506888|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
155021787|NCT02016105|559506889|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
155021788|NCT01908829|559506893|FG000|Overall Study|Adverse Event|13|||
155021789|NCT01908829|559506894|FG001|Overall Study|Adverse Event|11|||
155021790|NCT01908829|559506895|FG002|Overall Study|Adverse Event|13|||
155021791|NCT01908829|559506893|FG000|Overall Study|Lost to Follow-up|4|||
155021792|NCT01908829|559506894|FG001|Overall Study|Lost to Follow-up|2|||
155021793|NCT01908829|559506895|FG002|Overall Study|Lost to Follow-up|1|||
155021794|NCT01908829|559506893|FG000|Overall Study|Randomized no double-blind drug received|1|||
155021795|NCT01908829|559506894|FG001|Overall Study|Randomized no double-blind drug received|0|||
155021796|NCT01908829|559506895|FG002|Overall Study|Randomized no double-blind drug received|1|||
155021797|NCT01908829|559506893|FG000|Overall Study|Discontinued (no EoT page)|2|||
155021798|NCT01908829|559506894|FG001|Overall Study|Discontinued (no EoT page)|0|||
155021799|NCT01908829|559506895|FG002|Overall Study|Discontinued (no EoT page)|0|||
155021800|NCT01908829|559506893|FG000|Overall Study|Miscellaneous|0|||
155021801|NCT01908829|559506894|FG001|Overall Study|Miscellaneous|2|||
155021802|NCT01908829|559506895|FG002|Overall Study|Miscellaneous|0|||
155021803|NCT01908829|559506893|FG000|Overall Study|Protocol Violation|2|||
155021804|NCT01908829|559506894|FG001|Overall Study|Protocol Violation|2|||
155021805|NCT01908829|559506895|FG002|Overall Study|Protocol Violation|0|||
155021806|NCT01908829|559506893|FG000|Overall Study|Lack of Efficacy|1|||
155021807|NCT01908829|559506894|FG001|Overall Study|Lack of Efficacy|3|||
155021808|NCT01908829|559506895|FG002|Overall Study|Lack of Efficacy|2|||
155021809|NCT01908829|559506893|FG000|Overall Study|Withdrawal by Subject|26|||
155021810|NCT01908829|559506894|FG001|Overall Study|Withdrawal by Subject|29|||
155021811|NCT01908829|559506895|FG002|Overall Study|Withdrawal by Subject|22|||
155021812|NCT02865499|559506896|FG000|Baseline|Adverse Event|1|||
155021813|NCT02865499|559506896|FG000|Baseline|Withdrawal by Subject|1|||
155021814|NCT02792192|559506897|FG000|Overall Study|Death|1|||
155021815|NCT02792192|559506898|FG001|Overall Study|Death|0|||
155021816|NCT02792192|559506899|FG002|Overall Study|Death|0|||
155021817|NCT02792192|559506900|FG003|Overall Study|Death|0|||
155021818|NCT02792192|559506897|FG000|Overall Study|Informed Consent Withdrawn|4|||
155021819|NCT02792192|559506898|FG001|Overall Study|Informed Consent Withdrawn|0|||
155021820|NCT02792192|559506899|FG002|Overall Study|Informed Consent Withdrawn|0|||
155021821|NCT02792192|559506900|FG003|Overall Study|Informed Consent Withdrawn|0|||
155021822|NCT02792192|559506897|FG000|Overall Study|Physician Decision|1|||
155021823|NCT02792192|559506898|FG001|Overall Study|Physician Decision|0|||
155021824|NCT02792192|559506899|FG002|Overall Study|Physician Decision|0|||
155021825|NCT02792192|559506900|FG003|Overall Study|Physician Decision|0|||
155021826|NCT02792192|559506897|FG000|Overall Study|Progressive Disease|0|||
155021827|NCT02792192|559506898|FG001|Overall Study|Progressive Disease|1|||
155021828|NCT02792192|559506899|FG002|Overall Study|Progressive Disease|0|||
155021829|NCT02792192|559506900|FG003|Overall Study|Progressive Disease|0|||
155021830|NCT02792192|559506897|FG000|Overall Study|Study Terminated By Sponsor|6|||
155021831|NCT02792192|559506898|FG001|Overall Study|Study Terminated By Sponsor|10|||
155021832|NCT02792192|559506899|FG002|Overall Study|Study Terminated By Sponsor|0|||
155021833|NCT02792192|559506900|FG003|Overall Study|Study Terminated By Sponsor|0|||
155021834|NCT02320058|559506901|FG000|Overall Study|Death|25|||
155021835|NCT02320058|559506902|FG001|Overall Study|Death|10|||
155021836|NCT02320058|559506901|FG000|Overall Study|Lost to Follow-up|4|||
155021837|NCT02320058|559506902|FG001|Overall Study|Lost to Follow-up|0|||
155021838|NCT02320058|559506901|FG000|Overall Study|Other reasons|4|||
155021839|NCT02320058|559506902|FG001|Overall Study|Other reasons|1|||
155021840|NCT02320058|559506901|FG000|Overall Study|Withdrawal by Subject|8|||
155021841|NCT02320058|559506902|FG001|Overall Study|Withdrawal by Subject|2|||
155021842|NCT02320058|559506901|FG000|Overall Study|Not reported|1|||
155021843|NCT02320058|559506902|FG001|Overall Study|Not reported|0|||
155021844|NCT01339923|559506903|FG000|Overall Study|Adverse Event|1|||
155021845|NCT01339923|559506904|FG001|Overall Study|Adverse Event|1|||
155021846|NCT01339923|559506905|FG002|Overall Study|Adverse Event|1|||
155021847|NCT01339923|559506906|FG003|Overall Study|Adverse Event|0|||
155021848|NCT01339923|559506907|FG004|Overall Study|Adverse Event|0|||
155021849|NCT01339923|559506908|FG005|Overall Study|Adverse Event|0|||
155021850|NCT01339923|559506909|FG006|Overall Study|Adverse Event|1|||
155021851|NCT01339923|559506903|FG000|Overall Study|Inappropriate Enrollment|1|||
155021852|NCT01339923|559506904|FG001|Overall Study|Inappropriate Enrollment|0|||
155021853|NCT01339923|559506905|FG002|Overall Study|Inappropriate Enrollment|0|||
155021854|NCT01339923|559506906|FG003|Overall Study|Inappropriate Enrollment|0|||
155021855|NCT01339923|559506907|FG004|Overall Study|Inappropriate Enrollment|0|||
155021856|NCT01339923|559506908|FG005|Overall Study|Inappropriate Enrollment|1|||
155021857|NCT01339923|559506909|FG006|Overall Study|Inappropriate Enrollment|0|||
155021858|NCT01339923|559506903|FG000|Overall Study|Lost to Follow-up|4|||
155021859|NCT01339923|559506904|FG001|Overall Study|Lost to Follow-up|4|||
155139802|NCT03364309|559942780|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
155021860|NCT01339923|559506905|FG002|Overall Study|Lost to Follow-up|0|||
155021861|NCT01339923|559506906|FG003|Overall Study|Lost to Follow-up|3|||
155021862|NCT01339923|559506907|FG004|Overall Study|Lost to Follow-up|1|||
155021863|NCT01339923|559506908|FG005|Overall Study|Lost to Follow-up|1|||
155021864|NCT01339923|559506909|FG006|Overall Study|Lost to Follow-up|5|||
155021865|NCT01339923|559506903|FG000|Overall Study|Protocol Violation|0|||
155021866|NCT01339923|559506904|FG001|Overall Study|Protocol Violation|0|||
155021867|NCT01339923|559506905|FG002|Overall Study|Protocol Violation|0|||
155021868|NCT01339923|559506906|FG003|Overall Study|Protocol Violation|0|||
155021869|NCT01339923|559506907|FG004|Overall Study|Protocol Violation|0|||
155021870|NCT01339923|559506908|FG005|Overall Study|Protocol Violation|3|||
155021871|NCT01339923|559506909|FG006|Overall Study|Protocol Violation|1|||
155021872|NCT01339923|559506903|FG000|Overall Study|Unable to Classify|1|||
155021873|NCT01339923|559506904|FG001|Overall Study|Unable to Classify|0|||
155021874|NCT01339923|559506905|FG002|Overall Study|Unable to Classify|1|||
155021875|NCT01339923|559506906|FG003|Overall Study|Unable to Classify|0|||
155021876|NCT01339923|559506907|FG004|Overall Study|Unable to Classify|0|||
155021877|NCT01339923|559506908|FG005|Overall Study|Unable to Classify|1|||
155021878|NCT01339923|559506909|FG006|Overall Study|Unable to Classify|5|||
155021879|NCT01339923|559506903|FG000|Overall Study|Withdrawal by Subject|7|||
155021880|NCT01339923|559506904|FG001|Overall Study|Withdrawal by Subject|11|||
155021881|NCT01339923|559506905|FG002|Overall Study|Withdrawal by Subject|6|||
155021882|NCT01339923|559506906|FG003|Overall Study|Withdrawal by Subject|1|||
155021883|NCT01339923|559506907|FG004|Overall Study|Withdrawal by Subject|4|||
155021884|NCT01339923|559506908|FG005|Overall Study|Withdrawal by Subject|3|||
155021885|NCT01339923|559506909|FG006|Overall Study|Withdrawal by Subject|2|||
155021886|NCT01430403|559506910|FG000|Overall Study|Lost to Follow-up|5|||
155021887|NCT01430403|559506911|FG001|Overall Study|Lost to Follow-up|5|||
155021888|NCT01430403|559506912|FG002|Overall Study|Lost to Follow-up|3|||
155021889|NCT01430403|559506910|FG000|Overall Study|Physician Decision|1|||
155021890|NCT01430403|559506911|FG001|Overall Study|Physician Decision|0|||
155021891|NCT01430403|559506912|FG002|Overall Study|Physician Decision|0|||
155021892|NCT01430403|559506910|FG000|Overall Study|Protocol Violation|2|||
155021893|NCT01430403|559506911|FG001|Overall Study|Protocol Violation|3|||
155021894|NCT01430403|559506912|FG002|Overall Study|Protocol Violation|2|||
155021895|NCT01430403|559506910|FG000|Overall Study|Withdrawal by Subject|9|||
155021896|NCT01430403|559506911|FG001|Overall Study|Withdrawal by Subject|1|||
155021897|NCT01430403|559506912|FG002|Overall Study|Withdrawal by Subject|3|||
155021898|NCT01166438|559506917|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
155021899|NCT01166438|559506918|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
155021900|NCT01166438|559506917|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
155021901|NCT01166438|559506918|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
155021902|NCT01166438|559506917|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
155021903|NCT01166438|559506918|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
155021904|NCT01166438|559506917|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
155021905|NCT01166438|559506918|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
155021906|NCT01166438|559506917|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
155021907|NCT01166438|559506918|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
155021908|NCT01166438|559506917|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
155021909|NCT01166438|559506918|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
155021910|NCT01075256|559506919|FG000|Overall Study|Withdrawal by Subject|1|||
155021911|NCT01075256|559506920|FG001|Overall Study|Withdrawal by Subject|0|||
155021912|NCT01075256|559506921|FG002|Overall Study|Withdrawal by Subject|0|||
155021913|NCT03502070|559506922|FG000|Overall Study|Withdrawal by Subject|1|||
155021914|NCT03502070|559506922|FG000|Overall Study|Screen Failure|1|||
155021915|NCT00591565|559506935|FG000|Overall Study|lost follow up, withdrawn|5|||
155021916|NCT03850483|559506938|FG000|Treatment for Stage 1|Adverse Event|1|||
155021917|NCT03850483|559506939|FG001|Treatment for Stage 1|Adverse Event|1|||
155021918|NCT03850483|559506940|FG002|Treatment for Stage 1|Adverse Event|3|||
155021919|NCT03850483|559506941|FG003|Treatment for Stage 1|Adverse Event|0|||
155021920|NCT03850483|559506942|FG004|Treatment for Stage 1|Adverse Event|2|||
155021921|NCT03850483|559506943|FG005|Treatment for Stage 1|Adverse Event|0|||
155021922|NCT03850483|559506944|FG006|Treatment for Stage 1|Adverse Event|2|||
155021923|NCT03850483|559506945|FG007|Treatment for Stage 1|Adverse Event|2|||
155021924|NCT03850483|559506946|FG008|Treatment for Stage 1|Adverse Event|0|||
155021925|NCT03850483|559506947|FG009|Treatment for Stage 1|Adverse Event|0|||
155021926|NCT03850483|559506938|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
155021927|NCT03850483|559506939|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
155021928|NCT03850483|559506940|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
155021929|NCT03850483|559506941|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
155021930|NCT03850483|559506942|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
155021931|NCT03850483|559506943|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
155021932|NCT03850483|559506944|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
155021933|NCT03850483|559506945|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
155021934|NCT03850483|559506946|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
155021935|NCT03850483|559506947|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
155021936|NCT03850483|559506938|FG000|Treatment for Stage 1|Protocol Violation|1|||
155021937|NCT03850483|559506939|FG001|Treatment for Stage 1|Protocol Violation|0|||
155021938|NCT03850483|559506940|FG002|Treatment for Stage 1|Protocol Violation|0|||
155021939|NCT03850483|559506941|FG003|Treatment for Stage 1|Protocol Violation|0|||
155021940|NCT03850483|559506942|FG004|Treatment for Stage 1|Protocol Violation|0|||
155021941|NCT03850483|559506943|FG005|Treatment for Stage 1|Protocol Violation|0|||
155021942|NCT03850483|559506944|FG006|Treatment for Stage 1|Protocol Violation|1|||
155021943|NCT03850483|559506945|FG007|Treatment for Stage 1|Protocol Violation|0|||
155021944|NCT03850483|559506946|FG008|Treatment for Stage 1|Protocol Violation|0|||
155021945|NCT03850483|559506947|FG009|Treatment for Stage 1|Protocol Violation|0|||
155021946|NCT03850483|559506938|FG000|Treatment for Stage 1|Physician Decision|0|||
155021947|NCT03850483|559506939|FG001|Treatment for Stage 1|Physician Decision|0|||
155021948|NCT03850483|559506940|FG002|Treatment for Stage 1|Physician Decision|0|||
155021949|NCT03850483|559506941|FG003|Treatment for Stage 1|Physician Decision|0|||
155021950|NCT03850483|559506942|FG004|Treatment for Stage 1|Physician Decision|0|||
155021951|NCT03850483|559506943|FG005|Treatment for Stage 1|Physician Decision|1|||
155021952|NCT03850483|559506944|FG006|Treatment for Stage 1|Physician Decision|0|||
155021953|NCT03850483|559506945|FG007|Treatment for Stage 1|Physician Decision|0|||
155021954|NCT03850483|559506946|FG008|Treatment for Stage 1|Physician Decision|0|||
155021955|NCT03850483|559506947|FG009|Treatment for Stage 1|Physician Decision|0|||
155021956|NCT03850483|559506938|FG000|Treatment for Stage 1|Other|0|||
155021957|NCT03850483|559506939|FG001|Treatment for Stage 1|Other|0|||
155021958|NCT03850483|559506940|FG002|Treatment for Stage 1|Other|0|||
155021959|NCT03850483|559506941|FG003|Treatment for Stage 1|Other|0|||
155021960|NCT03850483|559506942|FG004|Treatment for Stage 1|Other|2|||
155021961|NCT03850483|559506943|FG005|Treatment for Stage 1|Other|1|||
155021962|NCT03850483|559506944|FG006|Treatment for Stage 1|Other|0|||
155021963|NCT03850483|559506945|FG007|Treatment for Stage 1|Other|0|||
155021964|NCT03850483|559506946|FG008|Treatment for Stage 1|Other|0|||
155021965|NCT03850483|559506947|FG009|Treatment for Stage 1|Other|0|||
155021966|NCT03850483|559506938|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021967|NCT03850483|559506939|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021968|NCT03850483|559506940|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
155021969|NCT03850483|559506941|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021970|NCT03850483|559506942|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021971|NCT03850483|559506943|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021972|NCT03850483|559506944|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021973|NCT03850483|559506945|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021974|NCT03850483|559506946|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021975|NCT03850483|559506947|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
155021976|NCT03850483|559506938|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021977|NCT03850483|559506939|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021978|NCT03850483|559506940|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021979|NCT03850483|559506941|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021980|NCT03850483|559506942|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021981|NCT03850483|559506943|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
155021982|NCT03850483|559506944|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021983|NCT03850483|559506945|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021984|NCT03850483|559506946|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021985|NCT03850483|559506947|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
155021986|NCT03850483|559506938|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
155021987|NCT03850483|559506939|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
155021988|NCT03850483|559506940|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
155021989|NCT03850483|559506941|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
155021990|NCT03850483|559506942|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
155021991|NCT03850483|559506943|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
155021992|NCT03850483|559506944|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
155021993|NCT03850483|559506945|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
155021994|NCT03850483|559506946|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
155021995|NCT03850483|559506947|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
155021996|NCT03850483|559506938|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
155021997|NCT03850483|559506939|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
155021998|NCT03850483|559506940|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
155021999|NCT03850483|559506941|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
155022000|NCT03850483|559506942|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
155022001|NCT03850483|559506943|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
155022002|NCT03850483|559506944|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
155022003|NCT03850483|559506945|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
155022004|NCT03850483|559506946|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
155022005|NCT03850483|559506947|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
155022006|NCT03850483|559506938|FG000|Treatment for Stage 1|Death|0|||
155022007|NCT03850483|559506939|FG001|Treatment for Stage 1|Death|0|||
155022008|NCT03850483|559506940|FG002|Treatment for Stage 1|Death|0|||
155022009|NCT03850483|559506941|FG003|Treatment for Stage 1|Death|0|||
155022010|NCT03850483|559506942|FG004|Treatment for Stage 1|Death|0|||
155022011|NCT03850483|559506943|FG005|Treatment for Stage 1|Death|1|||
155022012|NCT03850483|559506944|FG006|Treatment for Stage 1|Death|0|||
155022013|NCT03850483|559506945|FG007|Treatment for Stage 1|Death|0|||
155022014|NCT03850483|559506946|FG008|Treatment for Stage 1|Death|0|||
155022015|NCT03850483|559506947|FG009|Treatment for Stage 1|Death|0|||
155022016|NCT03850483|559506938|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
155022017|NCT03850483|559506939|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
155022018|NCT03850483|559506940|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
155022019|NCT03850483|559506941|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
155022020|NCT03850483|559506942|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
155022021|NCT03850483|559506943|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
155022022|NCT03850483|559506944|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
155022023|NCT03850483|559506945|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
155022024|NCT03850483|559506946|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
155022025|NCT03850483|559506947|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
155022026|NCT03850483|559506938|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
155022027|NCT03850483|559506939|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
155022028|NCT03850483|559506940|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
155022029|NCT03850483|559506941|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
155022030|NCT03850483|559506942|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
155022031|NCT03850483|559506943|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
155022032|NCT03850483|559506944|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
155022033|NCT03850483|559506945|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
155022034|NCT03850483|559506946|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
155022035|NCT03850483|559506947|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
155022036|NCT03850483|559506938|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022037|NCT03850483|559506939|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022038|NCT03850483|559506940|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022039|NCT03850483|559506941|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022040|NCT03850483|559506942|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022041|NCT03850483|559506943|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022042|NCT03850483|559506944|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
155022043|NCT03850483|559506945|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
155022044|NCT03850483|559506946|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022045|NCT03850483|559506947|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
155022046|NCT03850483|559506938|FG000|Follow-up for Stage 1|Physician Decision|0|||
155022047|NCT03850483|559506939|FG001|Follow-up for Stage 1|Physician Decision|0|||
155022048|NCT03850483|559506940|FG002|Follow-up for Stage 1|Physician Decision|0|||
155022049|NCT03850483|559506941|FG003|Follow-up for Stage 1|Physician Decision|0|||
155022050|NCT03850483|559506942|FG004|Follow-up for Stage 1|Physician Decision|1|||
155022051|NCT03850483|559506943|FG005|Follow-up for Stage 1|Physician Decision|0|||
155022052|NCT03850483|559506944|FG006|Follow-up for Stage 1|Physician Decision|1|||
155022053|NCT03850483|559506945|FG007|Follow-up for Stage 1|Physician Decision|0|||
155022054|NCT03850483|559506946|FG008|Follow-up for Stage 1|Physician Decision|0|||
155022055|NCT03850483|559506947|FG009|Follow-up for Stage 1|Physician Decision|0|||
155022056|NCT03850483|559506938|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
155022057|NCT03850483|559506939|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
155022058|NCT03850483|559506940|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
155022059|NCT03850483|559506941|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
155022060|NCT03850483|559506942|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
155022061|NCT03850483|559506943|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
155022062|NCT03850483|559506944|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
155022063|NCT03850483|559506945|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
155022064|NCT03850483|559506946|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
155022065|NCT03850483|559506947|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
155022066|NCT03850483|559506938|FG000|Follow-up for Stage 1|Adverse Event|0|||
155022067|NCT03850483|559506939|FG001|Follow-up for Stage 1|Adverse Event|0|||
155022068|NCT03850483|559506940|FG002|Follow-up for Stage 1|Adverse Event|1|||
155022069|NCT03850483|559506941|FG003|Follow-up for Stage 1|Adverse Event|0|||
155022070|NCT03850483|559506942|FG004|Follow-up for Stage 1|Adverse Event|0|||
155022071|NCT03850483|559506943|FG005|Follow-up for Stage 1|Adverse Event|1|||
155022072|NCT03850483|559506944|FG006|Follow-up for Stage 1|Adverse Event|0|||
155022073|NCT03850483|559506945|FG007|Follow-up for Stage 1|Adverse Event|0|||
155022074|NCT03850483|559506946|FG008|Follow-up for Stage 1|Adverse Event|0|||
155022075|NCT03850483|559506947|FG009|Follow-up for Stage 1|Adverse Event|0|||
155022076|NCT03850483|559506938|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022077|NCT03850483|559506939|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
155022078|NCT03850483|559506940|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022079|NCT03850483|559506941|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022080|NCT03850483|559506942|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
155022081|NCT03850483|559506943|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
155022082|NCT03850483|559506944|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022083|NCT03850483|559506945|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022084|NCT03850483|559506946|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022085|NCT03850483|559506947|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
155022086|NCT03850483|559506938|FG000|Follow-up for Stage 1|Other|0|||
155022087|NCT03850483|559506939|FG001|Follow-up for Stage 1|Other|2|||
155022088|NCT03850483|559506940|FG002|Follow-up for Stage 1|Other|0|||
155022089|NCT03850483|559506941|FG003|Follow-up for Stage 1|Other|2|||
155022090|NCT03850483|559506942|FG004|Follow-up for Stage 1|Other|0|||
155022091|NCT03850483|559506943|FG005|Follow-up for Stage 1|Other|1|||
155022092|NCT03850483|559506944|FG006|Follow-up for Stage 1|Other|0|||
155022093|NCT03850483|559506945|FG007|Follow-up for Stage 1|Other|0|||
155022094|NCT03850483|559506946|FG008|Follow-up for Stage 1|Other|0|||
155022095|NCT03850483|559506947|FG009|Follow-up for Stage 1|Other|0|||
155022096|NCT03850483|559506938|FG000|Treatment for Stage 2|Adverse Event|0|||
155022097|NCT03850483|559506939|FG001|Treatment for Stage 2|Adverse Event|0|||
155022098|NCT03850483|559506940|FG002|Treatment for Stage 2|Adverse Event|0|||
155022099|NCT03850483|559506941|FG003|Treatment for Stage 2|Adverse Event|0|||
155022100|NCT03850483|559506942|FG004|Treatment for Stage 2|Adverse Event|0|||
155022101|NCT03850483|559506943|FG005|Treatment for Stage 2|Adverse Event|0|||
155022102|NCT03850483|559506944|FG006|Treatment for Stage 2|Adverse Event|0|||
155022103|NCT03850483|559506945|FG007|Treatment for Stage 2|Adverse Event|0|||
155022104|NCT03850483|559506946|FG008|Treatment for Stage 2|Adverse Event|0|||
155022105|NCT03850483|559506947|FG009|Treatment for Stage 2|Adverse Event|1|||
155022106|NCT03850483|559506938|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
155022107|NCT03850483|559506939|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
155022108|NCT03850483|559506940|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
155022109|NCT03850483|559506941|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
155022110|NCT03850483|559506942|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
155022111|NCT03850483|559506943|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
155022112|NCT03850483|559506944|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
155022113|NCT03850483|559506945|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
155022114|NCT03850483|559506946|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
155022115|NCT03850483|559506947|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
155022116|NCT03850483|559506938|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
155022117|NCT03850483|559506939|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
155022118|NCT03850483|559506940|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
155022119|NCT03850483|559506941|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
155022120|NCT03850483|559506942|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
155022121|NCT03850483|559506943|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
155022122|NCT03850483|559506944|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
155022123|NCT03850483|559506945|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
155022124|NCT03850483|559506946|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
155022125|NCT03850483|559506947|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
155022126|NCT03850483|559506938|FG000|Treatment for Stage 2|Physician Decision|0|||
155022127|NCT03850483|559506939|FG001|Treatment for Stage 2|Physician Decision|0|||
155022128|NCT03850483|559506940|FG002|Treatment for Stage 2|Physician Decision|0|||
155022129|NCT03850483|559506941|FG003|Treatment for Stage 2|Physician Decision|0|||
155022130|NCT03850483|559506942|FG004|Treatment for Stage 2|Physician Decision|0|||
155022131|NCT03850483|559506943|FG005|Treatment for Stage 2|Physician Decision|0|||
155022132|NCT03850483|559506944|FG006|Treatment for Stage 2|Physician Decision|0|||
155022133|NCT03850483|559506945|FG007|Treatment for Stage 2|Physician Decision|0|||
155022134|NCT03850483|559506946|FG008|Treatment for Stage 2|Physician Decision|0|||
155022135|NCT03850483|559506947|FG009|Treatment for Stage 2|Physician Decision|1|||
155022136|NCT03850483|559506938|FG000|Treatment for Stage 2|Protocol Violation|0|||
155022137|NCT03850483|559506939|FG001|Treatment for Stage 2|Protocol Violation|0|||
155022138|NCT03850483|559506940|FG002|Treatment for Stage 2|Protocol Violation|0|||
155022139|NCT03850483|559506941|FG003|Treatment for Stage 2|Protocol Violation|0|||
155022140|NCT03850483|559506942|FG004|Treatment for Stage 2|Protocol Violation|0|||
155022141|NCT03850483|559506943|FG005|Treatment for Stage 2|Protocol Violation|0|||
155022142|NCT03850483|559506944|FG006|Treatment for Stage 2|Protocol Violation|0|||
155022143|NCT03850483|559506945|FG007|Treatment for Stage 2|Protocol Violation|0|||
155022144|NCT03850483|559506946|FG008|Treatment for Stage 2|Protocol Violation|1|||
155022145|NCT03850483|559506947|FG009|Treatment for Stage 2|Protocol Violation|0|||
155022146|NCT03850483|559506938|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
155022147|NCT03850483|559506939|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
155022148|NCT03850483|559506940|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
155022149|NCT03850483|559506941|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
155022150|NCT03850483|559506942|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
155022151|NCT03850483|559506943|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
155022152|NCT03850483|559506944|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
155022153|NCT03850483|559506945|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
155022154|NCT03850483|559506946|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
155022155|NCT03850483|559506947|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
155022156|NCT03850483|559506938|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022157|NCT03850483|559506939|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022158|NCT03850483|559506940|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022159|NCT03850483|559506941|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155180228|NCT04153149|560098345|FG003|Double Blind Period|Reason Not Specified|0|||
155180229|NCT04153149|560098342|FG000|Double Blind Period|Physician Decision|2|||
155022160|NCT03850483|559506942|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022161|NCT03850483|559506943|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022162|NCT03850483|559506944|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022163|NCT03850483|559506945|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022164|NCT03850483|559506946|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
155022165|NCT03850483|559506947|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
155022166|NCT03850483|559506938|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
155022167|NCT03850483|559506939|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
155022168|NCT03850483|559506940|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
155022169|NCT03850483|559506941|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
155022170|NCT03850483|559506942|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
155022171|NCT03850483|559506943|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
155022172|NCT03850483|559506944|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
155022173|NCT03850483|559506945|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
155022174|NCT03850483|559506946|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
155022175|NCT03850483|559506947|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
155022176|NCT03850483|559506938|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
155022177|NCT03850483|559506939|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
155022178|NCT03850483|559506940|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
155022179|NCT03850483|559506941|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
155022180|NCT03850483|559506942|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
155022181|NCT03850483|559506943|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
155022182|NCT03850483|559506944|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
155022183|NCT03850483|559506945|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
155022184|NCT03850483|559506946|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
155022185|NCT03850483|559506947|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
155022186|NCT03850483|559506938|FG000|Follow-up For Stage 2|Other|0|||
155022187|NCT03850483|559506939|FG001|Follow-up For Stage 2|Other|0|||
155022188|NCT03850483|559506940|FG002|Follow-up For Stage 2|Other|0|||
155022189|NCT03850483|559506941|FG003|Follow-up For Stage 2|Other|0|||
155022190|NCT03850483|559506942|FG004|Follow-up For Stage 2|Other|0|||
155022191|NCT03850483|559506943|FG005|Follow-up For Stage 2|Other|0|||
155022192|NCT03850483|559506944|FG006|Follow-up For Stage 2|Other|0|||
155022193|NCT03850483|559506945|FG007|Follow-up For Stage 2|Other|0|||
155022194|NCT03850483|559506946|FG008|Follow-up For Stage 2|Other|0|||
155022195|NCT03850483|559506947|FG009|Follow-up For Stage 2|Other|1|||
155022196|NCT03232931|559508379|FG000|Overall Study|Physician Decision|1|||
155022197|NCT03232931|559508380|FG001|Overall Study|Physician Decision|1|||
155022198|NCT03232931|559508379|FG000|Overall Study|Withdrawal by Subject|6|||
155022199|NCT03232931|559508380|FG001|Overall Study|Withdrawal by Subject|0|||
155022200|NCT03232931|559508379|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
155022201|NCT03232931|559508380|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
155022202|NCT03232931|559508379|FG000|Overall Study|Parent did not record voice|1|||
155022203|NCT03232931|559508380|FG001|Overall Study|Parent did not record voice|2|||
155022204|NCT03232931|559508379|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
155022205|NCT03232931|559508380|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
155022206|NCT04925557|559508381|FG000|Overall Study|Study closed|5|||
155022207|NCT04925557|559508382|FG001|Overall Study|Study closed|3|||
155022208|NCT05488470|559508383|FG000|Overall Study|Physician Decision|2|||
155022209|NCT05488470|559508383|FG000|Overall Study|Withdrawal by Subject|1|||
155022210|NCT05488470|559508383|FG000|Overall Study|Death|1|||
155022211|NCT00068393|559508384|FG000|Overall Study|Adverse Event|2|||
155022212|NCT00068393|559508384|FG000|Overall Study|Death|3|||
155022213|NCT00068393|559508384|FG000|Overall Study|Withdrawal by Subject|3|||
155022214|NCT00068393|559508384|FG000|Overall Study|Alternative treatment|1|||
155022215|NCT00068393|559508384|FG000|Overall Study|Quality of life worsening|1|||
155022216|NCT05119595|559508391|FG000|Overall Study|Death|1|||
155022217|NCT05119595|559508391|FG000|Overall Study|Lost to Follow-up|7|||
155022218|NCT01806961|559508392|FG000|Overall Study|sponsor decision|16|||
155022219|NCT01283334|559508397|FG000|Overall Study|Withdrawal by Subject|1|||
155022220|NCT01283334|559508397|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
155022221|NCT01283334|559508397|FG000|Overall Study|Adverse Event|4|||
155022222|NCT01283334|559508397|FG000|Overall Study|Physician Decision|1|||
155022223|NCT04981470|559508400|FG000|Overall Study|Device failure in all 4 patients|4|||
155022224|NCT04402138|559508401|FG000|Overall Study|Progressive Disease|2|||
155022225|NCT04402138|559508401|FG000|Overall Study|Adverse Event|1|||
155022226|NCT00784238|559508402|FG000|Overall Study|Adverse Event|14|||
155022227|NCT00784238|559508402|FG000|Overall Study|Death|2|||
155022228|NCT00784238|559508402|FG000|Overall Study|Lack of Efficacy|33|||
155022229|NCT00784238|559508402|FG000|Overall Study|Lost to Follow-up|29|||
155022230|NCT00784238|559508402|FG000|Overall Study|Pregnancy|1|||
155022231|NCT00784238|559508402|FG000|Overall Study|Withdrawal by Subject|26|||
155022232|NCT00784238|559508402|FG000|Overall Study|Other|14|||
155022233|NCT04390503|559508404|FG000|Overall Study|Physician Decision|2|||
155022234|NCT04390503|559508405|FG001|Overall Study|Physician Decision|1|||
155022235|NCT04390503|559508404|FG000|Overall Study|Adverse Event|1|||
155022236|NCT04390503|559508405|FG001|Overall Study|Adverse Event|0|||
155022237|NCT00078767|559508406|FG000|Overall Study|Withdrawal by Subject|1|||
155022238|NCT00078767|559508407|FG001|Overall Study|Withdrawal by Subject|1|||
155022239|NCT03508726|559508408|FG000|Overall Study|Withdrawal by Subject|0|||
155022240|NCT03508726|559508409|FG001|Overall Study|Withdrawal by Subject|1|||
155022241|NCT01068730|559508410|FG000|Period 3|Personal reason|1|||
155022242|NCT01068730|559508411|FG001|Period 3|Personal reason|0|||
155022243|NCT01068730|559508412|FG002|Period 3|Personal reason|0|||
155022244|NCT01068730|559508413|FG003|Period 3|Personal reason|0|||
155022245|NCT01068730|559508410|FG000|Period 4|Family emergency|0|||
155022246|NCT01068730|559508411|FG001|Period 4|Family emergency|1|||
155022247|NCT01068730|559508412|FG002|Period 4|Family emergency|0|||
155022248|NCT01068730|559508413|FG003|Period 4|Family emergency|0|||
155022249|NCT03260244|559508421|FG000|Overall Study|Death|19|||
155022250|NCT03260244|559508421|FG000|Overall Study|Lost to Follow-up|60|||
155022251|NCT03260244|559508421|FG000|Overall Study|Withdrawal by Subject|48|||
155022252|NCT03260244|559508421|FG000|Overall Study|Procedure Not Performed|21|||
155022253|NCT03260244|559508421|FG000|Overall Study|Enrollment Criteria Not Met|31|||
155022254|NCT03260244|559508421|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
155022255|NCT03260244|559508421|FG000|Overall Study|Subject Noncompliance|6|||
155022256|NCT03260244|559508421|FG000|Overall Study|No inducible Arrhythmia|2|||
155022257|NCT03260244|559508421|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
155022258|NCT03260244|559508421|FG000|Overall Study|Screen Failure|2|||
155022259|NCT03260244|559508421|FG000|Overall Study|Treated Off Label|69|||
155022260|NCT03260244|559508421|FG000|Overall Study|No Radiofrequency Ablation|14|||
155022261|NCT03233529|559508422|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
155022262|NCT03233529|559508422|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
155022263|NCT01177293|559508423|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
155022264|NCT01177293|559508424|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
155022265|NCT00594100|559508427|FG000|Procedure|Technical Failure|9|||
155022266|NCT00594100|559508427|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
155139803|NCT03364309|559942781|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139804|NCT03364309|559942782|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139805|NCT03364309|559942783|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139806|NCT03364309|559942784|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139807|NCT03364309|559942785|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139808|NCT03364309|559942786|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139809|NCT03364309|559942787|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139810|NCT03364309|559942788|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139811|NCT03364309|559942789|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139812|NCT03364309|559942790|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
155139813|NCT03364309|559942791|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
155139814|NCT03364309|559942773|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
155139815|NCT03364309|559942774|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
155139816|NCT03364309|559942775|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
155139817|NCT03364309|559942776|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
155139818|NCT03364309|559942777|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
155139819|NCT03364309|559942778|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
155139820|NCT03364309|559942779|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
155139821|NCT03364309|559942780|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
155139822|NCT03364309|559942781|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
155139823|NCT03364309|559942782|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
155139824|NCT03364309|559942783|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
155139825|NCT03364309|559942784|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
155139826|NCT03364309|559942785|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
155139827|NCT03364309|559942786|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
155139828|NCT03364309|559942787|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
155139829|NCT03364309|559942788|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
155139830|NCT03364309|559942789|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
155139831|NCT03364309|559942790|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
155139832|NCT03364309|559942791|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
155139833|NCT01371552|559942792|FG000|Part 1, First 3 Days|Inconvenience|0|||
155139834|NCT01371552|559942793|FG001|Part 1, First 3 Days|Inconvenience|0|||
155022267|NCT00594100|559508427|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
155022268|NCT00594100|559508427|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
155022269|NCT03528369|559508430|FG000|Overall Study|Withdrawal by Subject|2|||
155022270|NCT03528369|559508431|FG001|Overall Study|Withdrawal by Subject|0|||
155180230|NCT04153149|560098343|FG001|Double Blind Period|Physician Decision|0|||
155180231|NCT04153149|560098344|FG002|Double Blind Period|Physician Decision|0|||
155022271|NCT03528369|559508432|FG002|Overall Study|Withdrawal by Subject|0|||
155022272|NCT03528369|559508430|FG000|Overall Study|Lost to Follow-up|1|||
155022273|NCT03528369|559508431|FG001|Overall Study|Lost to Follow-up|0|||
155022274|NCT03528369|559508432|FG002|Overall Study|Lost to Follow-up|0|||
155022275|NCT03528369|559508430|FG000|Overall Study|Adverse Event|0|||
155022276|NCT03528369|559508431|FG001|Overall Study|Adverse Event|1|||
155022277|NCT03528369|559508432|FG002|Overall Study|Adverse Event|0|||
155022278|NCT00302328|559508433|FG000|Overall Study|Physician Decision|0|||
155022279|NCT00302328|559508434|FG001|Overall Study|Physician Decision|1|||
155022280|NCT00302328|559508435|FG002|Overall Study|Physician Decision|0|||
155022281|NCT02875613|559508438|FG000|Overall Study|Withdrawal by Subject|1|||
155022282|NCT02875613|559508438|FG000|Overall Study|Screen Failure|1|||
155022283|NCT02347774|559508439|FG000|Study Participation|Lost to Follow-up|3|||
155022284|NCT02347774|559508440|FG001|Study Participation|Lost to Follow-up|6|||
155022285|NCT02347774|559508441|FG002|Study Participation|Lost to Follow-up|2|||
155022286|NCT02347774|559508439|FG000|Study Participation|Withdrawal by Subject|8|||
155022287|NCT02347774|559508440|FG001|Study Participation|Withdrawal by Subject|9|||
155022288|NCT02347774|559508441|FG002|Study Participation|Withdrawal by Subject|15|||
155022289|NCT02347774|559508439|FG000|Study Participation|Adverse Event|1|||
155022290|NCT02347774|559508440|FG001|Study Participation|Adverse Event|4|||
155022291|NCT02347774|559508441|FG002|Study Participation|Adverse Event|6|||
155022292|NCT02347774|559508439|FG000|Study Participation|withdrew consent|1|||
155022293|NCT02347774|559508440|FG001|Study Participation|withdrew consent|1|||
155022294|NCT02347774|559508441|FG002|Study Participation|withdrew consent|1|||
155022295|NCT02347774|559508439|FG000|Study Participation|Met Prolonged QT criteria|1|||
155022296|NCT02347774|559508440|FG001|Study Participation|Met Prolonged QT criteria|0|||
155022297|NCT02347774|559508441|FG002|Study Participation|Met Prolonged QT criteria|0|||
155022298|NCT02347774|559508439|FG000|Study Participation|non-compliance with study drug|0|||
155022299|NCT02347774|559508440|FG001|Study Participation|non-compliance with study drug|1|||
155022300|NCT02347774|559508441|FG002|Study Participation|non-compliance with study drug|0|||
155022301|NCT02347774|559508439|FG000|Study Participation|incarceration|1|||
155022302|NCT02347774|559508440|FG001|Study Participation|incarceration|0|||
155022303|NCT02347774|559508441|FG002|Study Participation|incarceration|0|||
155022304|NCT02347774|559508439|FG000|Study Participation|randomized in error|0|||
155022305|NCT02347774|559508440|FG001|Study Participation|randomized in error|0|||
155022306|NCT02347774|559508441|FG002|Study Participation|randomized in error|1|||
155022307|NCT02347774|559508439|FG000|On Study Treatment|Adverse Event|9|||
155022308|NCT02347774|559508440|FG001|On Study Treatment|Adverse Event|15|||
155022309|NCT02347774|559508441|FG002|On Study Treatment|Adverse Event|19|||
155022310|NCT02347774|559508439|FG000|On Study Treatment|Lack of Efficacy|3|||
155022311|NCT02347774|559508440|FG001|On Study Treatment|Lack of Efficacy|0|||
155022312|NCT02347774|559508441|FG002|On Study Treatment|Lack of Efficacy|2|||
155022313|NCT02347774|559508439|FG000|On Study Treatment|non-complicance with study medication|0|||
155022314|NCT02347774|559508440|FG001|On Study Treatment|non-complicance with study medication|2|||
155022315|NCT02347774|559508441|FG002|On Study Treatment|non-complicance with study medication|0|||
155022316|NCT02347774|559508439|FG000|On Study Treatment|Protocol Violation|0|||
155022317|NCT02347774|559508440|FG001|On Study Treatment|Protocol Violation|0|||
155022318|NCT02347774|559508441|FG002|On Study Treatment|Protocol Violation|1|||
155022319|NCT02347774|559508439|FG000|On Study Treatment|withdrew consent|9|||
155022320|NCT02347774|559508440|FG001|On Study Treatment|withdrew consent|8|||
155022321|NCT02347774|559508441|FG002|On Study Treatment|withdrew consent|12|||
155022322|NCT02347774|559508439|FG000|On Study Treatment|Lost to Follow-up|2|||
155022323|NCT02347774|559508440|FG001|On Study Treatment|Lost to Follow-up|6|||
155022324|NCT02347774|559508441|FG002|On Study Treatment|Lost to Follow-up|1|||
155022325|NCT02347774|559508439|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
155022326|NCT02347774|559508440|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
155022327|NCT02347774|559508441|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
155022328|NCT02347774|559508439|FG000|On Study Treatment|ranomized in error|0|||
155139835|NCT01371552|559942794|FG002|Part 1, First 3 Days|Inconvenience|1|||
155139836|NCT01371552|559942795|FG003|Part 1, First 3 Days|Inconvenience|0|||
155139837|NCT01371552|559942796|FG004|Part 1, First 3 Days|Inconvenience|0|||
155139838|NCT01371552|559942797|FG005|Part 1, First 3 Days|Inconvenience|0|||
155139839|NCT00167310|559942798|FG000|Overall Study|Protocol Violation|5|||
155139840|NCT00167310|559942799|FG001|Overall Study|Protocol Violation|3|||
155139841|NCT00167310|559942798|FG000|Overall Study|Withdrawal by Subject|3|||
155139842|NCT00167310|559942799|FG001|Overall Study|Withdrawal by Subject|7|||
155139843|NCT04072887|559942800|FG000|Overall Study|Withdrawal by Subject|3|||
155139844|NCT04072887|559942801|FG001|Overall Study|Withdrawal by Subject|8|||
155022329|NCT02347774|559508440|FG001|On Study Treatment|ranomized in error|0|||
155022330|NCT02347774|559508441|FG002|On Study Treatment|ranomized in error|1|||
155022331|NCT04112043|559508443|FG000|Overall Study|Withdrawal by Subject|1|||
155022332|NCT04112043|559508444|FG001|Overall Study|Withdrawal by Subject|1|||
155022333|NCT04112043|559508445|FG002|Overall Study|Withdrawal by Subject|1|||
155022334|NCT04112043|559508443|FG000|Overall Study|Taking NR supplement|1|||
155022335|NCT04112043|559508444|FG001|Overall Study|Taking NR supplement|0|||
155022336|NCT04112043|559508445|FG002|Overall Study|Taking NR supplement|0|||
155022337|NCT04112043|559508443|FG000|Overall Study|Adverse Event|0|||
155022338|NCT04112043|559508444|FG001|Overall Study|Adverse Event|1|||
155022339|NCT04112043|559508445|FG002|Overall Study|Adverse Event|0|||
155022340|NCT02285166|559508448|FG000|Overall Study|Case Report Forms Uncollected|564|||
155022341|NCT02285166|559508448|FG000|Overall Study|Protocol Deviation|402|||
155022342|NCT00384839|559508453|FG000|Overall Study|Adverse Event|4|||
155022343|NCT00384839|559508453|FG000|Overall Study|Investigator Request|1|||
155022344|NCT00384839|559508453|FG000|Overall Study|Patient Request|1|||
155022345|NCT00384839|559508453|FG000|Overall Study|Ineligible|2|||
155022346|NCT01421225|559508456|FG000|Overall Study|Withdrawal by Subject|0|||
155022347|NCT01421225|559508457|FG001|Overall Study|Withdrawal by Subject|1|||
155022348|NCT02714595|559508458|FG000|Overall Study|Lost to Follow-up|1|||
155022349|NCT02714595|559508459|FG001|Overall Study|Lost to Follow-up|0|||
155022350|NCT02714595|559508458|FG000|Overall Study|Withdrawal by Subject|1|||
155022351|NCT02714595|559508459|FG001|Overall Study|Withdrawal by Subject|2|||
155022352|NCT02714595|559508458|FG000|Overall Study|Lack of Efficacy|0|||
155022353|NCT02714595|559508459|FG001|Overall Study|Lack of Efficacy|1|||
155022354|NCT02714595|559508458|FG000|Overall Study|Death|30|||
155022355|NCT02714595|559508459|FG001|Overall Study|Death|9|||
155022356|NCT02714595|559508458|FG000|Overall Study|Other-Miscellaneous|0|||
155022357|NCT02714595|559508459|FG001|Overall Study|Other-Miscellaneous|1|||
155022358|NCT01322490|559508460|FG000|Treatment Period|Adverse Event|12|||
155022359|NCT01322490|559508461|FG001|Treatment Period|Adverse Event|18|||
155022360|NCT01322490|559508462|FG002|Treatment Period|Adverse Event|15|||
155022361|NCT01322490|559508460|FG000|Treatment Period|Death|5|||
155022362|NCT01322490|559508461|FG001|Treatment Period|Death|7|||
155022363|NCT01322490|559508462|FG002|Treatment Period|Death|3|||
155022364|NCT01322490|559508460|FG000|Treatment Period|Lack of Efficacy|89|||
155022365|NCT01322490|559508461|FG001|Treatment Period|Lack of Efficacy|100|||
155022366|NCT01322490|559508462|FG002|Treatment Period|Lack of Efficacy|112|||
155022367|NCT01322490|559508460|FG000|Treatment Period|Physician Decision|0|||
155022368|NCT01322490|559508461|FG001|Treatment Period|Physician Decision|2|||
155022369|NCT01322490|559508462|FG002|Treatment Period|Physician Decision|1|||
155022370|NCT01322490|559508460|FG000|Treatment Period|Protocol Violation|7|||
155022371|NCT01322490|559508461|FG001|Treatment Period|Protocol Violation|5|||
155022372|NCT01322490|559508462|FG002|Treatment Period|Protocol Violation|4|||
155022373|NCT01322490|559508460|FG000|Treatment Period|Withdrawal by Subject|14|||
155022374|NCT01322490|559508461|FG001|Treatment Period|Withdrawal by Subject|16|||
155022375|NCT01322490|559508462|FG002|Treatment Period|Withdrawal by Subject|11|||
155022376|NCT01322490|559508460|FG000|Treatment Period|Non-compliance with study drug|0|||
155022377|NCT01322490|559508461|FG001|Treatment Period|Non-compliance with study drug|0|||
155022378|NCT01322490|559508462|FG002|Treatment Period|Non-compliance with study drug|1|||
155022379|NCT01322490|559508460|FG000|Treatment Period|Other per report|2|||
155022380|NCT01322490|559508461|FG001|Treatment Period|Other per report|2|||
155022381|NCT01322490|559508462|FG002|Treatment Period|Other per report|1|||
155022382|NCT01322490|559508460|FG000|Treatment Period|Randomized but Not Treated|3|||
155022383|NCT01322490|559508461|FG001|Treatment Period|Randomized but Not Treated|3|||
155022384|NCT01322490|559508462|FG002|Treatment Period|Randomized but Not Treated|5|||
155022385|NCT01322490|559508460|FG000|Long Term Follow-up Period|Death|235|||
155022386|NCT01322490|559508461|FG001|Long Term Follow-up Period|Death|239|||
155022387|NCT01322490|559508462|FG002|Long Term Follow-up Period|Death|236|||
155022388|NCT01322490|559508460|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
155022389|NCT01322490|559508461|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
155022390|NCT01322490|559508462|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
155139845|NCT04072887|559942802|FG002|Overall Study|Withdrawal by Subject|1|||
155139846|NCT04072887|559942803|FG003|Overall Study|Withdrawal by Subject|3|||
155139847|NCT04072887|559942804|FG004|Overall Study|Withdrawal by Subject|3|||
155139848|NCT04072887|559942805|FG005|Overall Study|Withdrawal by Subject|13|||
155139849|NCT04072887|559942800|FG000|Overall Study|Adverse Event|2|||
155139850|NCT04072887|559942801|FG001|Overall Study|Adverse Event|4|||
155139851|NCT04072887|559942802|FG002|Overall Study|Adverse Event|1|||
155139852|NCT04072887|559942803|FG003|Overall Study|Adverse Event|4|||
155139853|NCT04072887|559942804|FG004|Overall Study|Adverse Event|0|||
155139854|NCT04072887|559942805|FG005|Overall Study|Adverse Event|1|||
155139855|NCT04072887|559942800|FG000|Overall Study|Physician Decision|2|||
155139856|NCT04072887|559942801|FG001|Overall Study|Physician Decision|0|||
155139857|NCT04072887|559942802|FG002|Overall Study|Physician Decision|0|||
155139858|NCT04072887|559942803|FG003|Overall Study|Physician Decision|0|||
155139859|NCT04072887|559942804|FG004|Overall Study|Physician Decision|0|||
155139860|NCT04072887|559942805|FG005|Overall Study|Physician Decision|1|||
155022391|NCT01322490|559508460|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
155022392|NCT01322490|559508461|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
155022393|NCT01322490|559508462|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
155022394|NCT01322490|559508460|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
155022395|NCT01322490|559508461|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
155022396|NCT01322490|559508462|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
155022397|NCT01322490|559508460|FG000|Long Term Follow-up Period|Other per report|3|||
155022398|NCT01322490|559508461|FG001|Long Term Follow-up Period|Other per report|2|||
155022399|NCT01322490|559508462|FG002|Long Term Follow-up Period|Other per report|2|||
155022400|NCT01322490|559508460|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
155022401|NCT01322490|559508461|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
155022402|NCT01322490|559508462|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
155022403|NCT02257489|559508463|FG000|Overall Study|Withdrawal by Subject|0|||
155022404|NCT02257489|559508464|FG001|Overall Study|Withdrawal by Subject|0|||
155022405|NCT02257489|559508465|FG002|Overall Study|Withdrawal by Subject|0|||
155022406|NCT02257489|559508466|FG003|Overall Study|Withdrawal by Subject|1|||
155022407|NCT02257489|559508467|FG004|Overall Study|Withdrawal by Subject|0|||
155022408|NCT02257489|559508468|FG005|Overall Study|Withdrawal by Subject|0|||
155022409|NCT02257489|559508469|FG006|Overall Study|Withdrawal by Subject|0|||
155022410|NCT02257489|559508470|FG007|Overall Study|Withdrawal by Subject|0|||
155022411|NCT02257489|559508471|FG008|Overall Study|Withdrawal by Subject|0|||
155022412|NCT01896128|559508472|FG000|Overall Study|Withdrawal by Subject|3|||
155022413|NCT01896128|559508473|FG001|Overall Study|Withdrawal by Subject|3|||
155022414|NCT01996254|559508477|FG000|Overall Study|Change in Eligibility|0|||
155022415|NCT01996254|559508478|FG001|Overall Study|Change in Eligibility|2|||
155022416|NCT01996254|559508479|FG002|Overall Study|Change in Eligibility|0|||
155022417|NCT01996254|559508477|FG000|Overall Study|Withdrawal by Subject|0|||
155022418|NCT01996254|559508478|FG001|Overall Study|Withdrawal by Subject|3|||
155022419|NCT01996254|559508479|FG002|Overall Study|Withdrawal by Subject|4|||
155022420|NCT01996254|559508477|FG000|Overall Study|Lost to Follow-up|1|||
155022421|NCT01996254|559508478|FG001|Overall Study|Lost to Follow-up|0|||
155022422|NCT01996254|559508479|FG002|Overall Study|Lost to Follow-up|4|||
155022423|NCT02411396|559508483|FG000|Overall Study|Lost to Follow-up|31|||
155022424|NCT02411396|559508483|FG000|Overall Study|Death|10|||
155022425|NCT02071706|559508488|FG000|Overall Study|Adverse Event|1|||
155022426|NCT02071706|559508488|FG000|Overall Study|Withdrawal by Subject|2|||
155022427|NCT02247440|559508491|FG000|Overall Study|Withdrawal by Subject|1|||
155022428|NCT02247440|559508491|FG000|Overall Study|Lack of Efficacy|3|||
155022429|NCT00661609|559508492|FG000|Overall Study|Adverse Event|4|||
155022430|NCT00661609|559508492|FG000|Overall Study|Death|20|||
155022431|NCT00661609|559508492|FG000|Overall Study|Withdrawal by Subject|2|||
155022432|NCT00661609|559508492|FG000|Overall Study|PI Decision|1|||
155022433|NCT00661609|559508492|FG000|Overall Study|Survival follow up stage discontinued|11|||
155022434|NCT00661609|559508492|FG000|Overall Study|Disease progression|3|||
155022435|NCT00637000|559508493|FG000|Overall Study|Withdrawal by Subject|4|||
155022436|NCT00637000|559508494|FG001|Overall Study|Withdrawal by Subject|3|||
155022437|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
155022438|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
155022439|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
155022440|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
155022441|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
155022442|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
155022443|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
155022444|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
155022445|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
155022446|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
155022447|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
155022448|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
155022449|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
155022450|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
155022451|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
155022452|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
155022453|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
155022454|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
155022455|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
155022456|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
155022457|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
155022458|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
155022459|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
155022460|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
155022461|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
155022462|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
155022463|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
155022464|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
155022465|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
155022466|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
155022467|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
155022468|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
155022469|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
155139861|NCT04072887|559942800|FG000|Overall Study|Lost to Follow-up|1|||
155022470|NCT00839527|559508495|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
155022471|NCT00839527|559508496|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
155022472|NCT00839527|559508497|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
155022473|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
155022474|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
155022475|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
155022476|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
155022477|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
155022478|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
155022479|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
155022480|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
155022481|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
155022482|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
155022483|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
155022484|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
155022485|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
155022486|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
155022487|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
155022488|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
155022489|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
155022490|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
155022491|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
155022492|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
155022493|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
155022494|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
155022495|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
155022496|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
155022497|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
155022498|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
155022499|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
155022500|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
155022501|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
155022502|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
155022503|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
155022504|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
155022505|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
155022506|NCT00839527|559508495|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
155022507|NCT00839527|559508496|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
155022508|NCT00839527|559508497|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
155022509|NCT01855243|559508498|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
155022510|NCT01855243|559508499|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
155022511|NCT01855243|559508500|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
155022512|NCT01931995|559508501|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
155022513|NCT01931995|559508502|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
155022514|NCT01931995|559508501|FG000|First Intervention (1 Day)|Physician Decision|1|||
155022515|NCT01931995|559508502|FG001|First Intervention (1 Day)|Physician Decision|1|||
155022516|NCT01931995|559508501|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
155022517|NCT01931995|559508502|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
155022518|NCT02477332|559508505|FG000|Overall Study|Adverse Event|0|||
155022519|NCT02477332|559508506|FG001|Overall Study|Adverse Event|1|||
155022520|NCT02477332|559508507|FG002|Overall Study|Adverse Event|1|||
155022521|NCT02477332|559508508|FG003|Overall Study|Adverse Event|2|||
155022522|NCT02477332|559508509|FG004|Overall Study|Adverse Event|1|||
155022523|NCT02477332|559508510|FG005|Overall Study|Adverse Event|2|||
155022524|NCT02477332|559508505|FG000|Overall Study|Lack of Efficacy|1|||
155022525|NCT02477332|559508506|FG001|Overall Study|Lack of Efficacy|2|||
155022526|NCT02477332|559508507|FG002|Overall Study|Lack of Efficacy|1|||
155022527|NCT02477332|559508508|FG003|Overall Study|Lack of Efficacy|2|||
155022528|NCT02477332|559508509|FG004|Overall Study|Lack of Efficacy|1|||
155022529|NCT02477332|559508510|FG005|Overall Study|Lack of Efficacy|1|||
155022530|NCT02477332|559508505|FG000|Overall Study|Non-compliance with study treatment|0|||
155022531|NCT02477332|559508506|FG001|Overall Study|Non-compliance with study treatment|1|||
155180232|NCT04153149|560098345|FG003|Double Blind Period|Physician Decision|0|||
155022532|NCT02477332|559508507|FG002|Overall Study|Non-compliance with study treatment|2|||
155022533|NCT02477332|559508508|FG003|Overall Study|Non-compliance with study treatment|0|||
155022534|NCT02477332|559508509|FG004|Overall Study|Non-compliance with study treatment|0|||
155022535|NCT02477332|559508510|FG005|Overall Study|Non-compliance with study treatment|0|||
155022536|NCT02477332|559508505|FG000|Overall Study|Pregnancy|0|||
155022537|NCT02477332|559508506|FG001|Overall Study|Pregnancy|0|||
155022538|NCT02477332|559508507|FG002|Overall Study|Pregnancy|0|||
155022539|NCT02477332|559508508|FG003|Overall Study|Pregnancy|1|||
155022540|NCT02477332|559508509|FG004|Overall Study|Pregnancy|0|||
155022541|NCT02477332|559508510|FG005|Overall Study|Pregnancy|0|||
155022542|NCT02477332|559508505|FG000|Overall Study|Protocol Violation|2|||
155022543|NCT02477332|559508506|FG001|Overall Study|Protocol Violation|0|||
155022544|NCT02477332|559508507|FG002|Overall Study|Protocol Violation|3|||
155022545|NCT02477332|559508508|FG003|Overall Study|Protocol Violation|3|||
155022546|NCT02477332|559508509|FG004|Overall Study|Protocol Violation|1|||
155022547|NCT02477332|559508510|FG005|Overall Study|Protocol Violation|1|||
155022548|NCT02477332|559508505|FG000|Overall Study|Technical problems|0|||
155022549|NCT02477332|559508506|FG001|Overall Study|Technical problems|0|||
155022550|NCT02477332|559508507|FG002|Overall Study|Technical problems|1|||
155022551|NCT02477332|559508508|FG003|Overall Study|Technical problems|0|||
155022552|NCT02477332|559508509|FG004|Overall Study|Technical problems|0|||
155022553|NCT02477332|559508510|FG005|Overall Study|Technical problems|0|||
155022554|NCT02477332|559508505|FG000|Overall Study|Lost to Follow-up|0|||
155022555|NCT02477332|559508506|FG001|Overall Study|Lost to Follow-up|0|||
155022556|NCT02477332|559508507|FG002|Overall Study|Lost to Follow-up|2|||
155022557|NCT02477332|559508508|FG003|Overall Study|Lost to Follow-up|0|||
155022558|NCT02477332|559508509|FG004|Overall Study|Lost to Follow-up|0|||
155022559|NCT02477332|559508510|FG005|Overall Study|Lost to Follow-up|0|||
155022560|NCT02477332|559508505|FG000|Overall Study|Physician Decision|0|||
155022561|NCT02477332|559508506|FG001|Overall Study|Physician Decision|0|||
155022562|NCT02477332|559508507|FG002|Overall Study|Physician Decision|1|||
155022563|NCT02477332|559508508|FG003|Overall Study|Physician Decision|3|||
155022564|NCT02477332|559508509|FG004|Overall Study|Physician Decision|0|||
155022565|NCT02477332|559508510|FG005|Overall Study|Physician Decision|1|||
155022566|NCT02477332|559508505|FG000|Overall Study|Withdrawal by Subject|0|||
155022567|NCT02477332|559508506|FG001|Overall Study|Withdrawal by Subject|3|||
155022568|NCT02477332|559508507|FG002|Overall Study|Withdrawal by Subject|1|||
155022569|NCT02477332|559508508|FG003|Overall Study|Withdrawal by Subject|2|||
155022570|NCT02477332|559508509|FG004|Overall Study|Withdrawal by Subject|1|||
155022571|NCT02477332|559508510|FG005|Overall Study|Withdrawal by Subject|0|||
155022572|NCT04657198|559508511|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
155022573|NCT04657198|559508512|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
155022574|NCT04657198|559508513|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
155022575|NCT03793842|559508514|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
155022576|NCT03793842|559508515|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
155022577|NCT03793842|559508514|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
155022578|NCT03793842|559508515|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
155022579|NCT02549287|559508516|FG000|Overall Study|Lost to Follow-up|65|||
155022580|NCT02549287|559508517|FG001|Overall Study|Lost to Follow-up|26|||
155022581|NCT02549287|559508516|FG000|Overall Study|Withdrawal by Subject|15|||
155022582|NCT02549287|559508517|FG001|Overall Study|Withdrawal by Subject|6|||
155022583|NCT03806933|559510070|FG000|Main Period|Physician Decision|0|||
155022584|NCT03806933|559510071|FG001|Main Period|Physician Decision|0|||
155022585|NCT03806933|559510072|FG002|Main Period|Physician Decision|0|||
155022586|NCT03806933|559510073|FG003|Main Period|Physician Decision|1|||
155022587|NCT03806933|559510070|FG000|Main Period|Pregnancy|0|||
155022588|NCT03806933|559510071|FG001|Main Period|Pregnancy|0|||
155022589|NCT03806933|559510072|FG002|Main Period|Pregnancy|1|||
155022590|NCT03806933|559510073|FG003|Main Period|Pregnancy|0|||
155022591|NCT03806933|559510070|FG000|Main Period|Withdrawal by Subject|2|||
155022592|NCT03806933|559510071|FG001|Main Period|Withdrawal by Subject|1|||
155022593|NCT03806933|559510072|FG002|Main Period|Withdrawal by Subject|1|||
155022594|NCT03806933|559510073|FG003|Main Period|Withdrawal by Subject|2|||
155022595|NCT03806933|559510070|FG000|Main Period|Lost to Follow-up|2|||
155022596|NCT03806933|559510071|FG001|Main Period|Lost to Follow-up|2|||
155022597|NCT03806933|559510072|FG002|Main Period|Lost to Follow-up|0|||
155022598|NCT03806933|559510073|FG003|Main Period|Lost to Follow-up|0|||
155022599|NCT03806933|559510070|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
155022600|NCT03806933|559510071|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
155022601|NCT03806933|559510072|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
155022602|NCT03806933|559510073|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
155022603|NCT04606394|559510074|FG000|Overall Study|Withdrawal by Subject|3|||
155022604|NCT04606394|559510074|FG000|Overall Study|Exclusion criteria screen failure|12|||
155022605|NCT00954941|559510075|FG000|Overall Study|Received treatment at home|1|||
155022606|NCT00954941|559510076|FG001|Overall Study|Received treatment at home|0|||
155022607|NCT00954941|559510075|FG000|Overall Study|Withdrawal by Subject|1|||
155022608|NCT00954941|559510076|FG001|Overall Study|Withdrawal by Subject|0|||
155022609|NCT00954941|559510075|FG000|Overall Study|Insurance Denial|2|||
155022610|NCT00954941|559510076|FG001|Overall Study|Insurance Denial|2|||
155022611|NCT00954941|559510075|FG000|Overall Study|Physician Decision|2|||
155022612|NCT00954941|559510076|FG001|Overall Study|Physician Decision|2|||
155022613|NCT00954941|559510075|FG000|Overall Study|Ineligible|2|||
155022614|NCT00954941|559510076|FG001|Overall Study|Ineligible|2|||
155022615|NCT00954941|559510075|FG000|Overall Study|Adverse Event|0|||
155022616|NCT00954941|559510076|FG001|Overall Study|Adverse Event|1|||
155022617|NCT02920008|559510077|FG000|Overall Study|Death|117|||
155022618|NCT02920008|559510078|FG001|Overall Study|Death|127|||
155022619|NCT02920008|559510077|FG000|Overall Study|Withdrawal by Subject|3|||
155022620|NCT02920008|559510078|FG001|Overall Study|Withdrawal by Subject|6|||
155022621|NCT02920008|559510077|FG000|Overall Study|Lost to Follow-up|0|||
155022622|NCT02920008|559510078|FG001|Overall Study|Lost to Follow-up|1|||
155022623|NCT01053663|559510079|FG000|Overall Study|Death|2|||
155022624|NCT01053663|559510079|FG000|Overall Study|Lost to Follow-up|1|||
155022625|NCT01053663|559510079|FG000|Overall Study|Poor IV Access|1|||
155022626|NCT01053663|559510079|FG000|Overall Study|Transferred to Another Hospital|1|||
155022627|NCT01053663|559510079|FG000|Overall Study|Negative Influenza Diagnosis|1|||
155022628|NCT01862250|559510080|FG000|Overall Study|Adverse Event|4|||
155022629|NCT00090493|559510083|FG000|Overall Study|Physician Decision|2|||
155022630|NCT00562302|559510084|FG000|Overall Study|Lost to Follow-up|3|||
155022631|NCT00562302|559510085|FG001|Overall Study|Lost to Follow-up|3|||
155022632|NCT00562302|559510084|FG000|Overall Study|Adverse Event|0|||
155022633|NCT00562302|559510085|FG001|Overall Study|Adverse Event|6|||
155022634|NCT00562302|559510084|FG000|Overall Study|Non-compliance|1|||
155022635|NCT00562302|559510085|FG001|Overall Study|Non-compliance|2|||
155022636|NCT00562302|559510084|FG000|Overall Study|Withdrawal by Subject|7|||
155022637|NCT00562302|559510085|FG001|Overall Study|Withdrawal by Subject|8|||
155022638|NCT00562302|559510084|FG000|Overall Study|Death|1|||
155022639|NCT00562302|559510085|FG001|Overall Study|Death|2|||
155022640|NCT00562302|559510084|FG000|Overall Study|Lung resection prior to study completion|7|||
155022641|NCT00562302|559510085|FG001|Overall Study|Lung resection prior to study completion|7|||
155022642|NCT00562302|559510084|FG000|Overall Study|Not stated|1|||
155022643|NCT00562302|559510085|FG001|Overall Study|Not stated|4|||
155022644|NCT03615144|559510086|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
155022645|NCT03615144|559510087|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
155022646|NCT01860040|559510090|FG000|Overall Study|Withdrawal by Subject|1|||
155022647|NCT01860040|559510091|FG001|Overall Study|Withdrawal by Subject|0|||
155022648|NCT00679289|559510092|FG000|Overall Study|Progressive disease|4|||
155022649|NCT00679289|559510093|FG001|Overall Study|Progressive disease|5|||
155022650|NCT00679289|559510094|FG002|Overall Study|Progressive disease|18|||
155022651|NCT00679289|559510092|FG000|Overall Study|Withdrawal by Subject|0|||
155022652|NCT00679289|559510093|FG001|Overall Study|Withdrawal by Subject|1|||
155022653|NCT00679289|559510094|FG002|Overall Study|Withdrawal by Subject|1|||
155022654|NCT00679289|559510092|FG000|Overall Study|Adverse Event|0|||
155022655|NCT00679289|559510093|FG001|Overall Study|Adverse Event|0|||
155022656|NCT00679289|559510094|FG002|Overall Study|Adverse Event|3|||
155022657|NCT00679289|559510092|FG000|Overall Study|Physician Decision|1|||
155022658|NCT00679289|559510093|FG001|Overall Study|Physician Decision|0|||
155022659|NCT00679289|559510094|FG002|Overall Study|Physician Decision|1|||
155022660|NCT00937040|559510095|FG000|Overall Study|Adverse Event|5|||
155022661|NCT00937040|559510096|FG001|Overall Study|Adverse Event|8|||
155022662|NCT00937040|559510095|FG000|Overall Study|Lost to Follow-up|12|||
155022663|NCT00937040|559510096|FG001|Overall Study|Lost to Follow-up|12|||
155022664|NCT00937040|559510095|FG000|Overall Study|Protocol Violation|3|||
155022665|NCT00937040|559510096|FG001|Overall Study|Protocol Violation|0|||
155022666|NCT00937040|559510095|FG000|Overall Study|Withdrawal by Subject|13|||
155022667|NCT00937040|559510096|FG001|Overall Study|Withdrawal by Subject|7|||
155022668|NCT00937040|559510095|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
155022669|NCT00937040|559510096|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
155022670|NCT00937040|559510095|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
155022671|NCT00937040|559510096|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
155022672|NCT00554515|559510099|FG000|Overall Study|Withdrawal by Subject|3|||
155022673|NCT00554515|559510099|FG000|Overall Study|Disease progression|52|||
155022674|NCT00554515|559510099|FG000|Overall Study|Physician Decision|18|||
155022675|NCT00554515|559510099|FG000|Overall Study|Withdrawal by Subject|11|||
155022676|NCT00554515|559510099|FG000|Overall Study|Adverse Event|9|||
155022677|NCT00554515|559510099|FG000|Overall Study|Death|2|||
155022678|NCT00554515|559510099|FG000|Overall Study|Achieved Stable Disease|7|||
155022679|NCT00554515|559510099|FG000|Overall Study|Other|1|||
155022680|NCT00554515|559510099|FG000|Overall Study|Misc|15|||
155022681|NCT00427921|559510103|FG000|Overall Study|Adverse Event|26|||
155022682|NCT00427921|559510103|FG000|Overall Study|Withdrawal by Subject|4|||
155022683|NCT00427921|559510103|FG000|Overall Study|Lost to Follow-up|2|||
155022684|NCT00427921|559510103|FG000|Overall Study|Other reason not specified|10|||
155139862|NCT04072887|559942801|FG001|Overall Study|Lost to Follow-up|3|||
155022685|NCT00427921|559510103|FG000|Overall Study|Adverse Event + Hospitalization|1|||
155022686|NCT00427921|559510103|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
155022687|NCT00427921|559510103|FG000|Overall Study|Adverse Event + No Response|1|||
155022688|NCT00427921|559510103|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
155022689|NCT00427921|559510103|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
155139863|NCT04072887|559942802|FG002|Overall Study|Lost to Follow-up|0|||
155022690|NCT00427921|559510103|FG000|Overall Study|Adverse Event + Lost Response|1|||
155022691|NCT00427921|559510103|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
155022692|NCT00427921|559510103|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
155022693|NCT00520533|559510104|FG000|Overall Study|Death|1|||
155022694|NCT00520533|559510104|FG000|Overall Study|Suspension of the study for safety reasons|1|||
155022695|NCT00520533|559510104|FG000|Overall Study|Withdrawal by Subject|1|||
155022696|NCT00520533|559510104|FG000|Overall Study|Physician Decision|1|||
155022697|NCT00900159|559510105|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
155022698|NCT00900159|559510106|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
155022699|NCT02593097|559510114|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
155022700|NCT02593097|559510115|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
155022701|NCT02593097|559510114|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155022702|NCT02593097|559510115|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155022703|NCT02593097|559510114|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
155022704|NCT02593097|559510115|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
155022705|NCT02593097|559510114|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
155022706|NCT02593097|559510115|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
155022707|NCT02593097|559510114|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
155022708|NCT02593097|559510115|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
155022709|NCT02858583|559510116|FG000|Overall Study|Declined consent|1|||
155022710|NCT02858583|559510117|FG001|Overall Study|Declined consent|1|||
155022711|NCT03759587|559510118|FG000|Overall Study|Adverse Event|5|||
155022712|NCT03759587|559510118|FG000|Overall Study|Progressive Disease|10|||
155022713|NCT03759587|559510118|FG000|Overall Study|Site Terminated by Sponsor|3|||
155022714|NCT03759587|559510118|FG000|Overall Study|Withdrawal by Subject|1|||
155022715|NCT01218087|559510120|FG000|Overall Study|Death|2|||
155022716|NCT01218087|559510121|FG001|Overall Study|Death|1|||
155022717|NCT01218087|559510120|FG000|Overall Study|Withdrawal by Subject|5|||
155022718|NCT01218087|559510121|FG001|Overall Study|Withdrawal by Subject|0|||
155022719|NCT01218087|559510120|FG000|Overall Study|Transferred|8|||
155022720|NCT01218087|559510121|FG001|Overall Study|Transferred|5|||
155022721|NCT03170362|559510122|FG000|Overall Study|Death|2|||
155022722|NCT03170362|559510123|FG001|Overall Study|Death|2|||
155022723|NCT03170362|559510122|FG000|Overall Study|Withdrawal by Subject|23|||
155022724|NCT03170362|559510123|FG001|Overall Study|Withdrawal by Subject|22|||
155022725|NCT03170362|559510122|FG000|Overall Study|Lost to Follow-up|187|||
155022726|NCT03170362|559510123|FG001|Overall Study|Lost to Follow-up|167|||
155022727|NCT00665431|559510124|FG000|Overall Study|Adverse Event|16|||
155022728|NCT00665431|559510125|FG001|Overall Study|Adverse Event|22|||
155022729|NCT00665431|559510126|FG002|Overall Study|Adverse Event|6|||
155022730|NCT00665431|559510124|FG000|Overall Study|Withdrawal by Subject|17|||
155022731|NCT00665431|559510125|FG001|Overall Study|Withdrawal by Subject|25|||
155022732|NCT00665431|559510126|FG002|Overall Study|Withdrawal by Subject|15|||
155022733|NCT00665431|559510124|FG000|Overall Study|Lost to Follow-up|3|||
155022734|NCT00665431|559510125|FG001|Overall Study|Lost to Follow-up|3|||
155022735|NCT00665431|559510126|FG002|Overall Study|Lost to Follow-up|1|||
155022736|NCT00665431|559510124|FG000|Overall Study|Other|4|||
155022737|NCT00665431|559510125|FG001|Overall Study|Other|7|||
155022738|NCT00665431|559510126|FG002|Overall Study|Other|2|||
155022739|NCT03340454|559510127|FG000|Overall Study|Lost to Follow-up|0|||
155022740|NCT03340454|559510128|FG001|Overall Study|Lost to Follow-up|4|||
155022741|NCT02568189|559510134|FG000|Overall Study|Protocol Violation|0|||
155022742|NCT02568189|559510135|FG001|Overall Study|Protocol Violation|0|||
155022743|NCT02568189|559510136|FG002|Overall Study|Protocol Violation|19|||
155022744|NCT02568189|559510137|FG003|Overall Study|Protocol Violation|18|||
155022745|NCT01052480|559510138|FG000|Overall Study|Lost to Follow-up|3|||
155022746|NCT01052480|559510139|FG001|Overall Study|Lost to Follow-up|3|||
155022747|NCT01052480|559510138|FG000|Overall Study|Protocol Violation|1|||
155022748|NCT01052480|559510139|FG001|Overall Study|Protocol Violation|0|||
155022749|NCT01052480|559510138|FG000|Overall Study|Withdrawal by Subject|3|||
155022750|NCT01052480|559510139|FG001|Overall Study|Withdrawal by Subject|7|||
155022751|NCT01052480|559510138|FG000|Overall Study|Physician Decision|0|||
155022752|NCT01052480|559510139|FG001|Overall Study|Physician Decision|2|||
155022753|NCT01052480|559510138|FG000|Overall Study|Death|1|||
155022754|NCT01052480|559510139|FG001|Overall Study|Death|5|||
155022755|NCT00529373|559510146|FG000|Base Study|Adverse Event|525|||
155022756|NCT00529373|559510147|FG001|Base Study|Adverse Event|470|||
155022757|NCT00529373|559510146|FG000|Base Study|Lack of Efficacy|16|||
155022758|NCT00529373|559510147|FG001|Base Study|Lack of Efficacy|75|||
155022759|NCT00529373|559510146|FG000|Base Study|Lost to Follow-up|221|||
155022760|NCT00529373|559510147|FG001|Base Study|Lost to Follow-up|208|||
155022761|NCT00529373|559510146|FG000|Base Study|Other Protocol Specified Criteria|19|||
155022762|NCT00529373|559510147|FG001|Base Study|Other Protocol Specified Criteria|20|||
155022763|NCT00529373|559510146|FG000|Base Study|Physician Decision|60|||
155022764|NCT00529373|559510147|FG001|Base Study|Physician Decision|52|||
155022765|NCT00529373|559510146|FG000|Base Study|Protocol Violation|48|||
155022766|NCT00529373|559510147|FG001|Base Study|Protocol Violation|38|||
155022767|NCT00529373|559510146|FG000|Base Study|Withdrawal by Subject|1062|||
155180233|NCT04153149|560098342|FG000|Open Label Extension Period|Death|0|||
155180234|NCT04153149|560098343|FG001|Open Label Extension Period|Death|0|||
155180235|NCT04153149|560098344|FG002|Open Label Extension Period|Death|7|||
155180236|NCT04153149|560098345|FG003|Open Label Extension Period|Death|3|||
155180237|NCT04153149|560098342|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
155022768|NCT00529373|559510147|FG001|Base Study|Withdrawal by Subject|967|||
155022769|NCT00529373|559510146|FG000|Base Study|Did not continue into Extension|1795|||
155022770|NCT00529373|559510147|FG001|Base Study|Did not continue into Extension|2238|||
155022771|NCT00529373|559510146|FG000|First Extension Study|Adverse Event|162|||
155022772|NCT00529373|559510147|FG001|First Extension Study|Adverse Event|142|||
155022773|NCT00529373|559510146|FG000|First Extension Study|Lack of Efficacy|65|||
155180238|NCT04153149|560098343|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
155180239|NCT04153149|560098344|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
155180240|NCT04153149|560098345|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
155180241|NCT04153149|560098342|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
155180242|NCT04153149|560098343|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
155180243|NCT04153149|560098344|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
155022774|NCT00529373|559510147|FG001|First Extension Study|Lack of Efficacy|427|||
155022775|NCT00529373|559510146|FG000|First Extension Study|Lost to Follow-up|41|||
155022776|NCT00529373|559510147|FG001|First Extension Study|Lost to Follow-up|37|||
155022777|NCT00529373|559510146|FG000|First Extension Study|Other|27|||
155022778|NCT00529373|559510147|FG001|First Extension Study|Other|47|||
155022779|NCT00529373|559510146|FG000|First Extension Study|Physician Decision|50|||
155022780|NCT00529373|559510147|FG001|First Extension Study|Physician Decision|45|||
155022781|NCT00529373|559510146|FG000|First Extension Study|Protocol Violation|16|||
155022782|NCT00529373|559510147|FG001|First Extension Study|Protocol Violation|13|||
155022783|NCT00529373|559510146|FG000|First Extension Study|Withdrawal by Subject|296|||
155022784|NCT00529373|559510147|FG001|First Extension Study|Withdrawal by Subject|287|||
155022785|NCT00529373|559510146|FG000|First Extension Study|Disposition record non-existing|0|||
155022786|NCT00529373|559510147|FG001|First Extension Study|Disposition record non-existing|1|||
155022787|NCT00529373|559510146|FG000|First Extension Study|Discontinued after 5 years completion|208|||
155022788|NCT00529373|559510147|FG001|First Extension Study|Discontinued after 5 years completion|346|||
155022789|NCT00529373|559510146|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
155022790|NCT00529373|559510147|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
155022791|NCT00529373|559510146|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
155022792|NCT00529373|559510147|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
155022793|NCT00529373|559510146|FG000|Second Extension Study|Adverse Event|101|||
155022794|NCT00529373|559510147|FG001|Second Extension Study|Adverse Event|51|||
155022795|NCT00529373|559510146|FG000|Second Extension Study|Lack of Efficacy|7|||
155022796|NCT00529373|559510147|FG001|Second Extension Study|Lack of Efficacy|15|||
155022797|NCT00529373|559510146|FG000|Second Extension Study|Lost to Follow-up|18|||
155022798|NCT00529373|559510147|FG001|Second Extension Study|Lost to Follow-up|12|||
155022799|NCT00529373|559510146|FG000|Second Extension Study|Other|7|||
155022800|NCT00529373|559510147|FG001|Second Extension Study|Other|12|||
155022801|NCT00529373|559510146|FG000|Second Extension Study|Physician Decision|63|||
155022802|NCT00529373|559510147|FG001|Second Extension Study|Physician Decision|26|||
155022803|NCT00529373|559510146|FG000|Second Extension Study|Protocol Violation|2|||
155022804|NCT00529373|559510147|FG001|Second Extension Study|Protocol Violation|1|||
155022805|NCT00529373|559510146|FG000|Second Extension Study|Withdrawal by Subject|97|||
155022806|NCT00529373|559510147|FG001|Second Extension Study|Withdrawal by Subject|75|||
155022807|NCT00529373|559510146|FG000|Second Extension Study|Status Missing|5|||
155022808|NCT00529373|559510147|FG001|Second Extension Study|Status Missing|5|||
155022809|NCT01074268|559510148|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
155022810|NCT01074268|559510149|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
155022811|NCT01074268|559510148|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
155022812|NCT01074268|559510149|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
155022813|NCT01074268|559510148|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
155022814|NCT01074268|559510149|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
155022815|NCT01074268|559510148|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
155022816|NCT01074268|559510149|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
155022817|NCT01074268|559510148|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
155022818|NCT01074268|559510149|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
155022819|NCT01074268|559510148|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
155022820|NCT01074268|559510149|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
155022821|NCT01074268|559510148|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
155022822|NCT01074268|559510149|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
155022823|NCT01074268|559510148|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
155022824|NCT01074268|559510149|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
155022825|NCT01074268|559510148|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
155180244|NCT04153149|560098345|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
155180245|NCT04153149|560098342|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
155180246|NCT04153149|560098343|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
155180247|NCT04153149|560098344|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
155180248|NCT04153149|560098345|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
155180249|NCT00625742|560099605|FG000|Overall Study|Disease Progression|2|||
155180250|NCT00625742|560099605|FG000|Overall Study|Withdrawal by Subject|1|||
155180251|NCT00625742|560099605|FG000|Overall Study|Adverse Event|4|||
155022826|NCT01074268|559510149|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
155022827|NCT01578239|559510150|FG000|Treatment Period|Progressive Disease|19|||
155022828|NCT01578239|559510151|FG001|Treatment Period|Progressive Disease|64|||
155022829|NCT01578239|559510150|FG000|Treatment Period|Physician Decision|17|||
155022830|NCT01578239|559510151|FG001|Treatment Period|Physician Decision|17|||
155022831|NCT01578239|559510150|FG000|Treatment Period|Adverse Event|13|||
155022832|NCT01578239|559510151|FG001|Treatment Period|Adverse Event|10|||
155022833|NCT01578239|559510150|FG000|Treatment Period|Non-compliance|2|||
155022834|NCT01578239|559510151|FG001|Treatment Period|Non-compliance|0|||
155022835|NCT01578239|559510150|FG000|Treatment Period|Withdrawal by Subject|10|||
155022836|NCT01578239|559510151|FG001|Treatment Period|Withdrawal by Subject|9|||
155022837|NCT01578239|559510150|FG000|Treatment Period|Other|6|||
155022838|NCT01578239|559510151|FG001|Treatment Period|Other|1|||
155022839|NCT01578239|559510150|FG000|Long-term Follow-Up Period|Death|69|||
155022840|NCT01578239|559510151|FG001|Long-term Follow-Up Period|Death|64|||
155022841|NCT01578239|559510150|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
155022842|NCT01578239|559510151|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
155022843|NCT01578239|559510150|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
155022844|NCT01578239|559510151|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
155022845|NCT01578239|559510150|FG000|Long-term Follow-Up Period|Other|2|||
155022846|NCT01578239|559510151|FG001|Long-term Follow-Up Period|Other|2|||
155022847|NCT01119859|559510156|FG000|Overall Study|Adverse Event|9|||
155022848|NCT01119859|559510157|FG001|Overall Study|Adverse Event|10|||
155022849|NCT01119859|559510156|FG000|Overall Study|Death|2|||
155022850|NCT01119859|559510157|FG001|Overall Study|Death|0|||
155022851|NCT01119859|559510156|FG000|Overall Study|Insufficient therapeutic response|7|||
155022852|NCT01119859|559510157|FG001|Overall Study|Insufficient therapeutic response|14|||
155022853|NCT01119859|559510156|FG000|Overall Study|Refused treatment|3|||
155022854|NCT01119859|559510157|FG001|Overall Study|Refused treatment|6|||
155022855|NCT01119859|559510156|FG000|Overall Study|Failure to return|3|||
155022856|NCT01119859|559510157|FG001|Overall Study|Failure to return|0|||
155022857|NCT01134939|559510161|FG000|Overall Study|Adverse Event|9|||
155022858|NCT01134939|559510162|FG001|Overall Study|Adverse Event|3|||
155022859|NCT01134939|559510163|FG002|Overall Study|Adverse Event|4|||
155022860|NCT01134939|559510164|FG003|Overall Study|Adverse Event|5|||
155022861|NCT01134939|559510165|FG004|Overall Study|Adverse Event|5|||
155022862|NCT01134939|559510166|FG005|Overall Study|Adverse Event|5|||
155022863|NCT01134939|559510167|FG006|Overall Study|Adverse Event|1|||
155022864|NCT01134939|559510168|FG007|Overall Study|Adverse Event|0|||
155022865|NCT01134939|559510161|FG000|Overall Study|Lack of Efficacy|2|||
155022866|NCT01134939|559510162|FG001|Overall Study|Lack of Efficacy|5|||
155022867|NCT01134939|559510163|FG002|Overall Study|Lack of Efficacy|1|||
155022868|NCT01134939|559510164|FG003|Overall Study|Lack of Efficacy|0|||
155022869|NCT01134939|559510165|FG004|Overall Study|Lack of Efficacy|3|||
155022870|NCT01134939|559510166|FG005|Overall Study|Lack of Efficacy|0|||
155022871|NCT01134939|559510167|FG006|Overall Study|Lack of Efficacy|1|||
155022872|NCT01134939|559510168|FG007|Overall Study|Lack of Efficacy|0|||
155022873|NCT01134939|559510161|FG000|Overall Study|Lost to Follow-up|2|||
155022874|NCT01134939|559510162|FG001|Overall Study|Lost to Follow-up|3|||
155022875|NCT01134939|559510163|FG002|Overall Study|Lost to Follow-up|0|||
155022876|NCT01134939|559510164|FG003|Overall Study|Lost to Follow-up|1|||
155022877|NCT01134939|559510165|FG004|Overall Study|Lost to Follow-up|2|||
155022878|NCT01134939|559510166|FG005|Overall Study|Lost to Follow-up|1|||
155022879|NCT01134939|559510167|FG006|Overall Study|Lost to Follow-up|0|||
155022880|NCT01134939|559510168|FG007|Overall Study|Lost to Follow-up|0|||
155022881|NCT01134939|559510161|FG000|Overall Study|Death|0|||
155022882|NCT01134939|559510162|FG001|Overall Study|Death|1|||
155022883|NCT01134939|559510163|FG002|Overall Study|Death|0|||
155022884|NCT01134939|559510164|FG003|Overall Study|Death|0|||
155022885|NCT01134939|559510165|FG004|Overall Study|Death|0|||
155022886|NCT01134939|559510166|FG005|Overall Study|Death|0|||
155022887|NCT01134939|559510167|FG006|Overall Study|Death|0|||
155022888|NCT01134939|559510168|FG007|Overall Study|Death|0|||
155022889|NCT01134939|559510161|FG000|Overall Study|Termination page not available|4|||
155022890|NCT01134939|559510162|FG001|Overall Study|Termination page not available|6|||
155022891|NCT01134939|559510163|FG002|Overall Study|Termination page not available|5|||
155022892|NCT01134939|559510164|FG003|Overall Study|Termination page not available|8|||
155022893|NCT01134939|559510165|FG004|Overall Study|Termination page not available|0|||
155022894|NCT01134939|559510166|FG005|Overall Study|Termination page not available|3|||
155022895|NCT01134939|559510167|FG006|Overall Study|Termination page not available|7|||
155022896|NCT01134939|559510168|FG007|Overall Study|Termination page not available|0|||
155022897|NCT00733421|559510169|FG000|Overall Study|Withdrawal by Subject|1|||
155022898|NCT00733421|559510170|FG001|Overall Study|Withdrawal by Subject|1|||
155022899|NCT03817229|559510171|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
155022900|NCT03817229|559510172|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
155022901|NCT03817229|559510173|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
155022902|NCT03817229|559510174|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
155022903|NCT03817229|559510171|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
155022904|NCT03817229|559510172|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
155022905|NCT03817229|559510173|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
155022906|NCT03817229|559510174|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
155022907|NCT03817229|559510171|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
155022908|NCT03817229|559510172|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
155022909|NCT03817229|559510173|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
155022910|NCT03817229|559510174|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
155022911|NCT03817229|559510171|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
155022912|NCT03817229|559510172|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
155022913|NCT03817229|559510173|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
155022914|NCT03817229|559510174|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
155022915|NCT03817229|559510171|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
155022916|NCT03817229|559510172|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
155022917|NCT03817229|559510173|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
155022918|NCT03817229|559510174|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
155022919|NCT03817229|559510171|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
155022920|NCT03817229|559510172|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
155022921|NCT03817229|559510173|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
155022922|NCT03817229|559510174|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
155022923|NCT03817229|559510171|FG000|Post-Intervention|Withdrawal by Subject|6|||
155022924|NCT03817229|559510172|FG001|Post-Intervention|Withdrawal by Subject|0|||
155022925|NCT03817229|559510173|FG002|Post-Intervention|Withdrawal by Subject|2|||
155022926|NCT03817229|559510174|FG003|Post-Intervention|Withdrawal by Subject|2|||
155022927|NCT03817229|559510171|FG000|Post-Intervention|Withdrawal by Study Team|3|||
155022928|NCT03817229|559510172|FG001|Post-Intervention|Withdrawal by Study Team|1|||
155022929|NCT03817229|559510173|FG002|Post-Intervention|Withdrawal by Study Team|1|||
155022930|NCT03817229|559510174|FG003|Post-Intervention|Withdrawal by Study Team|4|||
155022931|NCT03817229|559510171|FG000|Post-Intervention|Weaned from medication|3|||
155022932|NCT03817229|559510172|FG001|Post-Intervention|Weaned from medication|0|||
155022933|NCT03817229|559510173|FG002|Post-Intervention|Weaned from medication|2|||
155022934|NCT03817229|559510174|FG003|Post-Intervention|Weaned from medication|1|||
155022935|NCT03817229|559510171|FG000|Post-Intervention|Transferred care to another institution|1|||
155022936|NCT03817229|559510172|FG001|Post-Intervention|Transferred care to another institution|0|||
155022937|NCT03817229|559510173|FG002|Post-Intervention|Transferred care to another institution|0|||
155022938|NCT03817229|559510174|FG003|Post-Intervention|Transferred care to another institution|0|||
155022939|NCT03817229|559510171|FG000|Post-Intervention|Change in parental guardianship|0|||
155022940|NCT03817229|559510172|FG001|Post-Intervention|Change in parental guardianship|0|||
155022941|NCT03817229|559510173|FG002|Post-Intervention|Change in parental guardianship|1|||
155022942|NCT03817229|559510174|FG003|Post-Intervention|Change in parental guardianship|0|||
155022943|NCT03817229|559510171|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
155022944|NCT03817229|559510172|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
155022945|NCT03817229|559510173|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
155022946|NCT03817229|559510174|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
155022947|NCT03817229|559510171|FG000|Follow-up 1|Withdrawal by Subject|1|||
155022948|NCT03817229|559510172|FG001|Follow-up 1|Withdrawal by Subject|2|||
155022949|NCT03817229|559510173|FG002|Follow-up 1|Withdrawal by Subject|0|||
155022950|NCT03817229|559510174|FG003|Follow-up 1|Withdrawal by Subject|0|||
155022951|NCT03817229|559510171|FG000|Follow-up 1|Withdrawal by Study Team|3|||
155022952|NCT03817229|559510172|FG001|Follow-up 1|Withdrawal by Study Team|1|||
155022953|NCT03817229|559510173|FG002|Follow-up 1|Withdrawal by Study Team|0|||
155022954|NCT03817229|559510174|FG003|Follow-up 1|Withdrawal by Study Team|0|||
155022955|NCT03817229|559510171|FG000|Follow-up 1|Wean from medication|3|||
155022956|NCT03817229|559510172|FG001|Follow-up 1|Wean from medication|4|||
155022957|NCT03817229|559510173|FG002|Follow-up 1|Wean from medication|0|||
155022958|NCT03817229|559510174|FG003|Follow-up 1|Wean from medication|1|||
155022959|NCT03817229|559510171|FG000|Follow-up 1|Transferred care to another hospital|1|||
155022960|NCT03817229|559510172|FG001|Follow-up 1|Transferred care to another hospital|0|||
155022961|NCT03817229|559510173|FG002|Follow-up 1|Transferred care to another hospital|0|||
155022962|NCT03817229|559510174|FG003|Follow-up 1|Transferred care to another hospital|0|||
155022963|NCT03817229|559510171|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
155022964|NCT03817229|559510172|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
155139864|NCT04072887|559942803|FG003|Overall Study|Lost to Follow-up|0|||
155180252|NCT00625742|560099605|FG000|Overall Study|Lost to Follow-up|4|||
155180253|NCT00625742|560099605|FG000|Overall Study|Ineligible|1|||
155180254|NCT02316548|560099606|FG000|Overall Study|Protocol Violation|0|||
155022965|NCT03817229|559510173|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
155022966|NCT03817229|559510174|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
155022967|NCT03817229|559510171|FG000|Follow-up 2|Withdrawal by Subject|2|||
155022968|NCT03817229|559510172|FG001|Follow-up 2|Withdrawal by Subject|0|||
155022969|NCT03817229|559510173|FG002|Follow-up 2|Withdrawal by Subject|1|||
155180255|NCT02316548|560099607|FG001|Overall Study|Protocol Violation|1|||
155180256|NCT01842633|560099608|FG000|Overall Study|Screen Failure|1|||
155180257|NCT01842633|560099609|FG001|Overall Study|Screen Failure|0|||
155180258|NCT01842633|560099610|FG002|Overall Study|Screen Failure|0|||
155180259|NCT01842633|560099608|FG000|Overall Study|Adverse Event|1|||
155180260|NCT01842633|560099609|FG001|Overall Study|Adverse Event|1|||
155180261|NCT01842633|560099610|FG002|Overall Study|Adverse Event|0|||
155180262|NCT01842633|560099608|FG000|Overall Study|Withdrawal by Subject|0|||
155180263|NCT01842633|560099609|FG001|Overall Study|Withdrawal by Subject|1|||
155180264|NCT01842633|560099610|FG002|Overall Study|Withdrawal by Subject|0|||
155180265|NCT01842633|560099608|FG000|Overall Study|Technical issues|1|||
155180266|NCT01842633|560099609|FG001|Overall Study|Technical issues|0|||
155180267|NCT01842633|560099610|FG002|Overall Study|Technical issues|0|||
155180268|NCT00371761|560099611|FG000|Overall Study|Adverse Event|1|||
155180269|NCT00371761|560099612|FG001|Overall Study|Adverse Event|1|||
155022970|NCT03817229|559510174|FG003|Follow-up 2|Withdrawal by Subject|1|||
155022971|NCT03817229|559510171|FG000|Follow-up 2|Withdrawal by Study Team|2|||
155022972|NCT03817229|559510172|FG001|Follow-up 2|Withdrawal by Study Team|0|||
155022973|NCT03817229|559510173|FG002|Follow-up 2|Withdrawal by Study Team|1|||
155022974|NCT03817229|559510174|FG003|Follow-up 2|Withdrawal by Study Team|0|||
155022975|NCT03817229|559510171|FG000|Follow-up 2|Wean from medication|1|||
155022976|NCT03817229|559510172|FG001|Follow-up 2|Wean from medication|0|||
155022977|NCT03817229|559510173|FG002|Follow-up 2|Wean from medication|0|||
155022978|NCT03817229|559510174|FG003|Follow-up 2|Wean from medication|0|||
155022979|NCT03817229|559510171|FG000|Follow-up 2|Transferred care|0|||
155022980|NCT03817229|559510172|FG001|Follow-up 2|Transferred care|0|||
155022981|NCT03817229|559510173|FG002|Follow-up 2|Transferred care|1|||
155022982|NCT03817229|559510174|FG003|Follow-up 2|Transferred care|0|||
155022983|NCT04185220|559510175|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
155022984|NCT04185220|559510176|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
155022985|NCT04185220|559510175|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
155022986|NCT04185220|559510176|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
155022987|NCT01031680|559510177|FG000|Overall Study|Adverse Event|8|||
155022988|NCT01031680|559510178|FG001|Overall Study|Adverse Event|3|||
155022989|NCT01031680|559510177|FG000|Overall Study|Lost to Follow-up|2|||
155022990|NCT01031680|559510178|FG001|Overall Study|Lost to Follow-up|10|||
155022991|NCT01031680|559510177|FG000|Overall Study|Withdrawal by Subject|12|||
155022992|NCT01031680|559510178|FG001|Overall Study|Withdrawal by Subject|16|||
155022993|NCT01031680|559510177|FG000|Overall Study|Death|2|||
155022994|NCT01031680|559510178|FG001|Overall Study|Death|1|||
155022995|NCT01031680|559510177|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
155022996|NCT01031680|559510178|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
155022997|NCT01031680|559510177|FG000|Overall Study|Poor/Non-compliance|5|||
155022998|NCT01031680|559510178|FG001|Overall Study|Poor/Non-compliance|6|||
155022999|NCT01031680|559510177|FG000|Overall Study|Safety|1|||
155023000|NCT01031680|559510178|FG001|Overall Study|Safety|0|||
155023001|NCT01031680|559510177|FG000|Overall Study|Incorrect Enrolment|1|||
155023002|NCT01031680|559510178|FG001|Overall Study|Incorrect Enrolment|2|||
155023003|NCT01031680|559510177|FG000|Overall Study|Administrative Reason by Sponsor|0|||
155023004|NCT01031680|559510178|FG001|Overall Study|Administrative Reason by Sponsor|1|||
155023005|NCT01031680|559510177|FG000|Overall Study|Various|0|||
155023006|NCT01031680|559510178|FG001|Overall Study|Various|2|||
155023007|NCT01029782|559510181|FG000|Overall Study|Lost to Follow-up|2|||
155023008|NCT01029782|559510182|FG001|Overall Study|Lost to Follow-up|2|||
155023009|NCT01029782|559510181|FG000|Overall Study|Diagnosis changed|1|||
155023010|NCT01029782|559510182|FG001|Overall Study|Diagnosis changed|1|||
155023011|NCT01029782|559510181|FG000|Overall Study|Adverse Event|0|||
155023012|NCT01029782|559510182|FG001|Overall Study|Adverse Event|1|||
155023013|NCT01029782|559510181|FG000|Overall Study|Physician Decision|0|||
155023014|NCT01029782|559510182|FG001|Overall Study|Physician Decision|1|||
155023015|NCT01029782|559510181|FG000|Overall Study|Protocol Violation|0|||
155023016|NCT01029782|559510182|FG001|Overall Study|Protocol Violation|2|||
155023017|NCT01029782|559510181|FG000|Overall Study|Withdrawal by Subject|0|||
155023018|NCT01029782|559510182|FG001|Overall Study|Withdrawal by Subject|1|||
155023019|NCT03319732|559510189|FG000|Overall Study|Adverse Event|40|||
155023020|NCT03319732|559510189|FG000|Overall Study|Withdrawal by Subject|50|||
155180270|NCT00371761|560099611|FG000|Overall Study|Withdrawal by Subject|1|||
155180271|NCT00371761|560099612|FG001|Overall Study|Withdrawal by Subject|3|||
155180272|NCT00371761|560099611|FG000|Overall Study|Investigator Judgment|2|||
155180273|NCT00371761|560099612|FG001|Overall Study|Investigator Judgment|3|||
155180274|NCT00371761|560099611|FG000|Overall Study|Study termination|4|||
155180275|NCT00371761|560099612|FG001|Overall Study|Study termination|3|||
155180276|NCT01343823|560099614|FG000|Overall Study|Study Terminated|1|||
155180277|NCT01343823|560099615|FG001|Overall Study|Study Terminated|0|||
155180278|NCT01343823|560099616|FG002|Overall Study|Study Terminated|0|||
155180279|NCT01343823|560099617|FG003|Overall Study|Study Terminated|1|||
155180280|NCT01343823|560099614|FG000|Overall Study|Withdrawal by Subject|1|||
155180281|NCT01343823|560099615|FG001|Overall Study|Withdrawal by Subject|0|||
155180282|NCT01343823|560099616|FG002|Overall Study|Withdrawal by Subject|0|||
155180283|NCT01343823|560099617|FG003|Overall Study|Withdrawal by Subject|0|||
155180284|NCT03468543|560099618|FG000|Overall Study|Protocol stopping rules met|3|||
155180285|NCT01249118|560099619|FG000|First Washout Period|Physician Decision|0|||
155180286|NCT01249118|560099620|FG001|First Washout Period|Physician Decision|1|||
155023021|NCT03319732|559510189|FG000|Overall Study|MS relapse|10|||
155023022|NCT03319732|559510189|FG000|Overall Study|reason not specified|5|||
155180287|NCT01249118|560099621|FG002|First Washout Period|Physician Decision|0|||
155180288|NCT04300751|560099622|FG000|Overall Study|Withdrawal by Subject|1|||
155180289|NCT02311582|560099625|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
155023023|NCT00757042|559510190|FG000|Overall Study|Lost to Follow-up|0|||
155023024|NCT00757042|559510191|FG001|Overall Study|Lost to Follow-up|0|||
155023025|NCT00757042|559510192|FG002|Overall Study|Lost to Follow-up|0|||
155023026|NCT00757042|559510193|FG003|Overall Study|Lost to Follow-up|0|||
155180290|NCT02311582|560099626|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
155180291|NCT02311582|560099627|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
155180292|NCT02311582|560099628|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
155180293|NCT02311582|560099629|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
155180294|NCT04972630|560099632|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
155180295|NCT04972630|560099633|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
155180296|NCT04972630|560099634|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
155180297|NCT03422627|560099637|FG000|Overall Study|Protocol-specified Criteria|1|||
155023027|NCT00757042|559510194|FG004|Overall Study|Lost to Follow-up|0|||
155023028|NCT00757042|559510195|FG005|Overall Study|Lost to Follow-up|0|||
155023029|NCT00757042|559510196|FG006|Overall Study|Lost to Follow-up|0|||
155023030|NCT00757042|559510197|FG007|Overall Study|Lost to Follow-up|0|||
155023031|NCT00757042|559510198|FG008|Overall Study|Lost to Follow-up|1|||
155023032|NCT00757042|559510199|FG009|Overall Study|Lost to Follow-up|0|||
155023033|NCT00757042|559510200|FG010|Overall Study|Lost to Follow-up|0|||
155023034|NCT00757042|559510190|FG000|Overall Study|Ineligibility Determined|0|||
155023035|NCT00757042|559510191|FG001|Overall Study|Ineligibility Determined|0|||
155023036|NCT00757042|559510192|FG002|Overall Study|Ineligibility Determined|0|||
155023037|NCT00757042|559510193|FG003|Overall Study|Ineligibility Determined|0|||
155023038|NCT00757042|559510194|FG004|Overall Study|Ineligibility Determined|0|||
155023039|NCT00757042|559510195|FG005|Overall Study|Ineligibility Determined|0|||
155023040|NCT00757042|559510196|FG006|Overall Study|Ineligibility Determined|0|||
155023041|NCT00757042|559510197|FG007|Overall Study|Ineligibility Determined|0|||
155023042|NCT00757042|559510198|FG008|Overall Study|Ineligibility Determined|0|||
155023043|NCT00757042|559510199|FG009|Overall Study|Ineligibility Determined|0|||
155023044|NCT00757042|559510200|FG010|Overall Study|Ineligibility Determined|1|||
155023045|NCT00757042|559510190|FG000|Overall Study|Withdrawal by Subject|0|||
155023046|NCT00757042|559510191|FG001|Overall Study|Withdrawal by Subject|0|||
155023047|NCT00757042|559510192|FG002|Overall Study|Withdrawal by Subject|0|||
155023048|NCT00757042|559510193|FG003|Overall Study|Withdrawal by Subject|0|||
155023049|NCT00757042|559510194|FG004|Overall Study|Withdrawal by Subject|0|||
155023050|NCT00757042|559510195|FG005|Overall Study|Withdrawal by Subject|0|||
155023051|NCT00757042|559510196|FG006|Overall Study|Withdrawal by Subject|0|||
155023052|NCT00757042|559510197|FG007|Overall Study|Withdrawal by Subject|0|||
155023053|NCT00757042|559510198|FG008|Overall Study|Withdrawal by Subject|0|||
155023054|NCT00757042|559510199|FG009|Overall Study|Withdrawal by Subject|1|||
155023055|NCT00757042|559510200|FG010|Overall Study|Withdrawal by Subject|0|||
155023056|NCT02702388|559510206|FG000|Overall Study|Disease Progression|18|||
155023057|NCT02702388|559510207|FG001|Overall Study|Disease Progression|25|||
155023058|NCT02702388|559510206|FG000|Overall Study|Withdrawal by Subject|9|||
155023059|NCT02702388|559510207|FG001|Overall Study|Withdrawal by Subject|7|||
155023060|NCT02702388|559510206|FG000|Overall Study|Adverse Event|11|||
155180298|NCT03422627|560099638|FG001|Overall Study|Protocol-specified Criteria|1|||
155180299|NCT03422627|560099639|FG002|Overall Study|Protocol-specified Criteria|0|||
155180300|NCT03422627|560099640|FG003|Overall Study|Protocol-specified Criteria|0|||
155180301|NCT03422627|560099641|FG004|Overall Study|Protocol-specified Criteria|2|||
155023061|NCT02702388|559510207|FG001|Overall Study|Adverse Event|15|||
155023062|NCT02702388|559510206|FG000|Overall Study|Other|2|||
155023063|NCT02702388|559510207|FG001|Overall Study|Other|4|||
155023064|NCT02729051|559510208|FG000|Overall Study|Adverse Event|21|||
155023065|NCT02729051|559510209|FG001|Overall Study|Adverse Event|11|||
155023066|NCT02729051|559510208|FG000|Overall Study|Lack of Efficacy|1|||
155023067|NCT02729051|559510209|FG001|Overall Study|Lack of Efficacy|1|||
155023068|NCT02729051|559510208|FG000|Overall Study|Lost to Follow-up|1|||
155023069|NCT02729051|559510209|FG001|Overall Study|Lost to Follow-up|2|||
155023070|NCT02729051|559510208|FG000|Overall Study|Physician Decision|1|||
155023071|NCT02729051|559510209|FG001|Overall Study|Physician Decision|1|||
155023072|NCT02729051|559510208|FG000|Overall Study|Withdrawal by Subject|6|||
155023073|NCT02729051|559510209|FG001|Overall Study|Withdrawal by Subject|17|||
155023074|NCT03652636|559511604|FG000|Overall Study|Withdrawal by Subject|7|||
155023075|NCT01736397|559511607|FG000|Overall Study|Lack of Efficacy|1|||
155023076|NCT01736397|559511608|FG001|Overall Study|Lack of Efficacy|11|||
155023077|NCT01736397|559511607|FG000|Overall Study|Withdrawal by Subject|6|||
155023078|NCT01736397|559511608|FG001|Overall Study|Withdrawal by Subject|5|||
155023079|NCT01736397|559511607|FG000|Overall Study|Lost to Follow-up|0|||
155023080|NCT01736397|559511608|FG001|Overall Study|Lost to Follow-up|1|||
155023081|NCT01736397|559511607|FG000|Overall Study|Adverse Event|6|||
155023082|NCT01736397|559511608|FG001|Overall Study|Adverse Event|3|||
155023083|NCT01736397|559511607|FG000|Overall Study|Not stated|1|||
155023084|NCT01736397|559511608|FG001|Overall Study|Not stated|4|||
155023085|NCT05088603|559511609|FG000|Overall Study|Protocol Violation|6|||
155023086|NCT05088603|559511610|FG001|Overall Study|Protocol Violation|1|||
155023087|NCT01868438|559511611|FG000|First Intervention|Withdrawal by Subject|5|||
155023088|NCT01868438|559511612|FG001|First Intervention|Withdrawal by Subject|1|||
155023089|NCT01868438|559511611|FG000|First Intervention|Lost to Follow-up|2|||
155023090|NCT01868438|559511612|FG001|First Intervention|Lost to Follow-up|3|||
155023091|NCT01868438|559511611|FG000|First Intervention|Meeting the non-redosing criteria|0|||
155023092|NCT01868438|559511612|FG001|First Intervention|Meeting the non-redosing criteria|1|||
155023093|NCT01868438|559511611|FG000|Second Intervention|Adverse Event|3|||
155023094|NCT01868438|559511612|FG001|Second Intervention|Adverse Event|3|||
155023095|NCT03555565|559511615|FG000|Overall Study|Case Report Forms Uncollected|2|||
155023096|NCT03555565|559511615|FG000|Overall Study|Protocol Deviation|13|||
155023097|NCT00076752|559511616|FG000|Overall Study|Death|2|||
155023098|NCT00076752|559511616|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
155023099|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
155023100|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
155023101|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
155023102|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
155023103|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
155023104|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
155023105|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
155023106|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
155023107|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Death|0|||
155023108|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Death|1|||
155023109|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
155023110|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
155023111|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
155023112|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
155023113|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
155023114|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
155023115|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
155023116|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
155023117|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
155023118|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
155023119|NCT00394836|559511619|FG000|Teatment or Follow-up Phase|Non compliance|0|||
155023120|NCT00394836|559511620|FG001|Teatment or Follow-up Phase|Non compliance|1|||
155023121|NCT00394836|559511619|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
155023122|NCT00394836|559511620|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
155023123|NCT00394836|559511619|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
155023124|NCT00394836|559511620|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
155023125|NCT00394836|559511619|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
155023126|NCT00394836|559511620|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
155023127|NCT00394836|559511619|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
155023128|NCT00394836|559511620|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
155023129|NCT01560234|559511621|FG000|Overall Study|Lost to Follow-up|3|||
155023130|NCT01560234|559511622|FG001|Overall Study|Lost to Follow-up|0|||
155023131|NCT01560234|559511623|FG002|Overall Study|Lost to Follow-up|1|||
155023132|NCT01560234|559511624|FG003|Overall Study|Lost to Follow-up|0|||
155023133|NCT01560234|559511625|FG004|Overall Study|Lost to Follow-up|0|||
155023134|NCT01560234|559511626|FG005|Overall Study|Lost to Follow-up|2|||
155023135|NCT01560234|559511627|FG006|Overall Study|Lost to Follow-up|0|||
155023136|NCT01560234|559511628|FG007|Overall Study|Lost to Follow-up|2|||
155023137|NCT02028767|559511629|FG000|Treatment Period 2|Non compliant with protocol|1|||
155023138|NCT02028767|559511630|FG001|Treatment Period 2|Non compliant with protocol|0|||
155023139|NCT02028767|559511629|FG000|Treatment Period 2|Reason other than those specified above|1|||
155023140|NCT02028767|559511630|FG001|Treatment Period 2|Reason other than those specified above|0|||
155023141|NCT01284348|559511631|FG000|Overall Study|Death|1|||
155023142|NCT01284348|559511632|FG001|Overall Study|Death|1|||
155023143|NCT01284348|559511631|FG000|Overall Study|Withdrew consent|0|||
155023144|NCT01284348|559511632|FG001|Overall Study|Withdrew consent|1|||
155023145|NCT01284348|559511631|FG000|Overall Study|Status not recorded|9|||
155023146|NCT01284348|559511632|FG001|Overall Study|Status not recorded|10|||
155023147|NCT00892151|559511635|FG000|Overall Study|Protocol Violation|1|||
155023148|NCT04075682|559511638|FG000|Overall Study|Lost to Follow-up|5|||
155023149|NCT04075682|559511639|FG001|Overall Study|Lost to Follow-up|5|||
155023150|NCT04075682|559511640|FG002|Overall Study|Lost to Follow-up|2|||
155023151|NCT04075682|559511641|FG003|Overall Study|Lost to Follow-up|2|||
155023152|NCT04075682|559511638|FG000|Overall Study|Withdrawal by Subject|1|||
155023153|NCT04075682|559511639|FG001|Overall Study|Withdrawal by Subject|0|||
155023154|NCT04075682|559511640|FG002|Overall Study|Withdrawal by Subject|1|||
155023155|NCT04075682|559511641|FG003|Overall Study|Withdrawal by Subject|0|||
155023156|NCT04075682|559511638|FG000|Overall Study|Protocol Violation|0|||
155023157|NCT04075682|559511639|FG001|Overall Study|Protocol Violation|1|||
155023158|NCT04075682|559511640|FG002|Overall Study|Protocol Violation|1|||
155023159|NCT04075682|559511641|FG003|Overall Study|Protocol Violation|0|||
155023160|NCT04075682|559511638|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
155023161|NCT04075682|559511639|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
155023162|NCT04075682|559511640|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
155023163|NCT04075682|559511641|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
155023164|NCT04075682|559511638|FG000|Overall Study|Lost study phone the first day of study participation|0|||
155023165|NCT04075682|559511639|FG001|Overall Study|Lost study phone the first day of study participation|1|||
155023166|NCT04075682|559511640|FG002|Overall Study|Lost study phone the first day of study participation|0|||
155023167|NCT04075682|559511641|FG003|Overall Study|Lost study phone the first day of study participation|0|||
155023168|NCT01222520|559511644|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
155023169|NCT01222520|559511645|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
155023170|NCT01222520|559511644|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
155023171|NCT01222520|559511645|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
155023172|NCT01222520|559511644|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
155023173|NCT01222520|559511645|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
155023174|NCT01222520|559511644|FG000|Double-blind Period|Adverse Event|0|||
155023175|NCT01222520|559511645|FG001|Double-blind Period|Adverse Event|1|||
155023176|NCT01222520|559511644|FG000|Double-blind Period|Lack of Efficacy|0|||
155023177|NCT01222520|559511645|FG001|Double-blind Period|Lack of Efficacy|1|||
155023178|NCT01222520|559511644|FG000|Double-blind Period|Study medication stolen|1|||
155023179|NCT01222520|559511645|FG001|Double-blind Period|Study medication stolen|0|||
155023180|NCT03423173|559511650|FG000|Overall Study|Randomized but not vaccinated|1|||
155023181|NCT03423173|559511651|FG001|Overall Study|Randomized but not vaccinated|0|||
155023182|NCT03423173|559511652|FG002|Overall Study|Randomized but not vaccinated|2|||
155023183|NCT03423173|559511653|FG003|Overall Study|Randomized but not vaccinated|1|||
155023184|NCT03423173|559511650|FG000|Overall Study|Adverse Event|1|||
155023185|NCT03423173|559511651|FG001|Overall Study|Adverse Event|1|||
155023186|NCT03423173|559511652|FG002|Overall Study|Adverse Event|1|||
155023187|NCT03423173|559511653|FG003|Overall Study|Adverse Event|1|||
155023188|NCT03423173|559511650|FG000|Overall Study|Lost to Follow-up|10|||
155023189|NCT03423173|559511651|FG001|Overall Study|Lost to Follow-up|19|||
155023190|NCT03423173|559511652|FG002|Overall Study|Lost to Follow-up|17|||
155023191|NCT03423173|559511653|FG003|Overall Study|Lost to Follow-up|22|||
155023192|NCT03423173|559511650|FG000|Overall Study|Withdrawal of consent|4|||
155023193|NCT03423173|559511651|FG001|Overall Study|Withdrawal of consent|10|||
155023194|NCT03423173|559511652|FG002|Overall Study|Withdrawal of consent|4|||
155023195|NCT03423173|559511653|FG003|Overall Study|Withdrawal of consent|5|||
155023196|NCT03423173|559511650|FG000|Overall Study|Death|1|||
155023197|NCT03423173|559511651|FG001|Overall Study|Death|0|||
155023198|NCT03423173|559511652|FG002|Overall Study|Death|0|||
155023199|NCT03423173|559511653|FG003|Overall Study|Death|0|||
155023200|NCT03423173|559511650|FG000|Overall Study|Reason not Specified|2|||
155023201|NCT03423173|559511651|FG001|Overall Study|Reason not Specified|5|||
155023202|NCT03423173|559511652|FG002|Overall Study|Reason not Specified|3|||
155023203|NCT03423173|559511653|FG003|Overall Study|Reason not Specified|1|||
155023204|NCT03348930|559511654|FG000|Washout (1 Week)|Lost to Follow-up|1|||
155023205|NCT03348930|559511655|FG001|Washout (1 Week)|Lost to Follow-up|1|||
155023206|NCT03533114|559511656|FG000|Overall|Adverse Event|16|||
155023207|NCT03533114|559511657|FG001|Overall|Adverse Event|11|||
155023208|NCT03533114|559511656|FG000|Overall|Consent Withdrawal by Participant|7|||
155023209|NCT03533114|559511657|FG001|Overall|Consent Withdrawal by Participant|6|||
155023210|NCT03533114|559511656|FG000|Overall|Lack of Efficacy|5|||
155023211|NCT03533114|559511657|FG001|Overall|Lack of Efficacy|3|||
155023212|NCT03533114|559511656|FG000|Overall|Lost to Follow-up|1|||
155023213|NCT03533114|559511657|FG001|Overall|Lost to Follow-up|1|||
155023214|NCT03533114|559511656|FG000|Overall|Physician Decision|0|||
155023215|NCT03533114|559511657|FG001|Overall|Physician Decision|2|||
155023216|NCT03533114|559511656|FG000|Overall|Protocol deviation|1|||
155023217|NCT03533114|559511657|FG001|Overall|Protocol deviation|1|||
155023218|NCT03533114|559511656|FG000|Overall|Failure to meet randomization criteria|1|||
155023219|NCT03533114|559511657|FG001|Overall|Failure to meet randomization criteria|2|||
155023220|NCT03533114|559511656|FG000|Overall|Non-Compliance with study drug|0|||
155023221|NCT03533114|559511657|FG001|Overall|Non-Compliance with study drug|1|||
155023222|NCT03533114|559511656|FG000|Overall|Other|0|||
155023223|NCT03533114|559511657|FG001|Overall|Other|1|||
155023224|NCT03533114|559511656|FG000|Open Label Titration and Optimization|Adverse Event|11|||
155023225|NCT03533114|559511657|FG001|Open Label Titration and Optimization|Adverse Event|8|||
155023226|NCT03533114|559511656|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
155023227|NCT03533114|559511657|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
155023228|NCT03533114|559511656|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
155023229|NCT03533114|559511657|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
155023230|NCT03533114|559511656|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
155023231|NCT03533114|559511657|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
155023232|NCT03533114|559511656|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
155023233|NCT03533114|559511657|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
155023234|NCT03533114|559511656|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
155023235|NCT03533114|559511657|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
155023236|NCT03533114|559511656|FG000|Stable Dose|Adverse Event|0|||
155023237|NCT03533114|559511657|FG001|Stable Dose|Adverse Event|2|||
155023238|NCT03533114|559511656|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
155023239|NCT03533114|559511657|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
155023240|NCT03533114|559511656|FG000|Stable Dose|Lack of Efficacy|1|||
155023241|NCT03533114|559511657|FG001|Stable Dose|Lack of Efficacy|0|||
155023242|NCT03533114|559511656|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
155023243|NCT03533114|559511657|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
155023244|NCT03533114|559511656|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
155023245|NCT03533114|559511657|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
155023246|NCT03533114|559511656|FG000|Open-Label Safety Extension|Adverse Event|3|||
155023247|NCT03533114|559511657|FG001|Open-Label Safety Extension|Adverse Event|0|||
155023248|NCT03533114|559511656|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
155023249|NCT03533114|559511657|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
155023250|NCT03533114|559511656|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
155023251|NCT03533114|559511657|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
155023252|NCT03533114|559511656|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
155023253|NCT03533114|559511657|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
155023254|NCT03533114|559511656|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
155023255|NCT03533114|559511657|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
155023256|NCT01062113|559511658|FG000|Overall Study|Adverse Event|1|||
155023257|NCT01062113|559511659|FG001|Overall Study|Adverse Event|0|||
155023258|NCT01062113|559511660|FG002|Overall Study|Adverse Event|0|||
155023259|NCT01062113|559511658|FG000|Overall Study|Lack of Efficacy|38|||
155023260|NCT01062113|559511659|FG001|Overall Study|Lack of Efficacy|22|||
155023261|NCT01062113|559511660|FG002|Overall Study|Lack of Efficacy|31|||
155023262|NCT01062113|559511658|FG000|Overall Study|Withdrawal by Subject|1|||
155023263|NCT01062113|559511659|FG001|Overall Study|Withdrawal by Subject|0|||
155023264|NCT01062113|559511660|FG002|Overall Study|Withdrawal by Subject|0|||
155023265|NCT01769508|559511666|FG000|Overall Study|Death|3|||
155023266|NCT01769508|559511666|FG000|Overall Study|Withdrawal by Subject|1|||
155023267|NCT01769508|559511666|FG000|Overall Study|Adverse Event|1|||
155023268|NCT01769508|559511666|FG000|Overall Study|Lost to Follow-up|1|||
155023269|NCT02751450|559511669|FG000|Overall Study|Adverse Event|1|||
155023270|NCT02751450|559511670|FG001|Overall Study|Adverse Event|0|||
155023271|NCT02587598|559511671|FG000|Overall Study|Death|4|||
155023272|NCT02587598|559511672|FG001|Overall Study|Death|8|||
155023273|NCT02587598|559511673|FG002|Overall Study|Death|4|||
155023274|NCT02587598|559511674|FG003|Overall Study|Death|16|||
155023275|NCT02587598|559511675|FG004|Overall Study|Death|9|||
155023276|NCT02587598|559511676|FG005|Overall Study|Death|4|||
155023277|NCT02587598|559511677|FG006|Overall Study|Death|6|||
155023278|NCT02587598|559511678|FG007|Overall Study|Death|7|||
155023279|NCT02587598|559511679|FG008|Overall Study|Death|9|||
155023280|NCT02587598|559511680|FG009|Overall Study|Death|1|||
155023281|NCT02587598|559511681|FG010|Overall Study|Death|3|||
155023282|NCT02587598|559511671|FG000|Overall Study|Study Terminated by the Sponsor|0|||
155023283|NCT02587598|559511672|FG001|Overall Study|Study Terminated by the Sponsor|1|||
155023284|NCT02587598|559511673|FG002|Overall Study|Study Terminated by the Sponsor|0|||
155023285|NCT02587598|559511674|FG003|Overall Study|Study Terminated by the Sponsor|3|||
155023286|NCT02587598|559511675|FG004|Overall Study|Study Terminated by the Sponsor|0|||
155023287|NCT02587598|559511676|FG005|Overall Study|Study Terminated by the Sponsor|1|||
155023288|NCT02587598|559511677|FG006|Overall Study|Study Terminated by the Sponsor|0|||
155023289|NCT02587598|559511678|FG007|Overall Study|Study Terminated by the Sponsor|0|||
155023290|NCT02587598|559511679|FG008|Overall Study|Study Terminated by the Sponsor|0|||
155023291|NCT02587598|559511680|FG009|Overall Study|Study Terminated by the Sponsor|1|||
155180302|NCT03422627|560099637|FG000|Overall Study|Requirement for Alternative Therapy|1|||
155180303|NCT03422627|560099638|FG001|Overall Study|Requirement for Alternative Therapy|1|||
155180304|NCT03422627|560099639|FG002|Overall Study|Requirement for Alternative Therapy|2|||
155180305|NCT03422627|560099640|FG003|Overall Study|Requirement for Alternative Therapy|0|||
155180306|NCT03422627|560099641|FG004|Overall Study|Requirement for Alternative Therapy|0|||
155180307|NCT03422627|560099637|FG000|Overall Study|Disease Progression|1|||
155180308|NCT03422627|560099638|FG001|Overall Study|Disease Progression|0|||
155180309|NCT03422627|560099639|FG002|Overall Study|Disease Progression|1|||
155180310|NCT03422627|560099640|FG003|Overall Study|Disease Progression|2|||
155180311|NCT03422627|560099641|FG004|Overall Study|Disease Progression|0|||
155180312|NCT03422627|560099637|FG000|Overall Study|Adverse Event|2|||
155023292|NCT02587598|559511681|FG010|Overall Study|Study Terminated by the Sponsor|6|||
155023293|NCT02587598|559511671|FG000|Overall Study|Reason for study withdrawal not specified|0|||
155023294|NCT02587598|559511672|FG001|Overall Study|Reason for study withdrawal not specified|1|||
155023295|NCT02587598|559511673|FG002|Overall Study|Reason for study withdrawal not specified|0|||
155023296|NCT02587598|559511674|FG003|Overall Study|Reason for study withdrawal not specified|0|||
155023297|NCT02587598|559511675|FG004|Overall Study|Reason for study withdrawal not specified|0|||
155023298|NCT02587598|559511676|FG005|Overall Study|Reason for study withdrawal not specified|0|||
155023299|NCT02587598|559511677|FG006|Overall Study|Reason for study withdrawal not specified|0|||
155023300|NCT02587598|559511678|FG007|Overall Study|Reason for study withdrawal not specified|0|||
155023301|NCT02587598|559511679|FG008|Overall Study|Reason for study withdrawal not specified|0|||
155023302|NCT02587598|559511680|FG009|Overall Study|Reason for study withdrawal not specified|0|||
155023303|NCT02587598|559511681|FG010|Overall Study|Reason for study withdrawal not specified|0|||
155023304|NCT02587598|559511671|FG000|Overall Study|Withdrawal by Subject|0|||
155180313|NCT03422627|560099638|FG001|Overall Study|Adverse Event|1|||
155180314|NCT03422627|560099639|FG002|Overall Study|Adverse Event|0|||
155023305|NCT02587598|559511672|FG001|Overall Study|Withdrawal by Subject|1|||
155023306|NCT02587598|559511673|FG002|Overall Study|Withdrawal by Subject|0|||
155023307|NCT02587598|559511674|FG003|Overall Study|Withdrawal by Subject|2|||
155023308|NCT02587598|559511675|FG004|Overall Study|Withdrawal by Subject|3|||
155023309|NCT02587598|559511676|FG005|Overall Study|Withdrawal by Subject|1|||
155023310|NCT02587598|559511677|FG006|Overall Study|Withdrawal by Subject|0|||
155023311|NCT02587598|559511678|FG007|Overall Study|Withdrawal by Subject|0|||
155023312|NCT02587598|559511679|FG008|Overall Study|Withdrawal by Subject|0|||
155023313|NCT02587598|559511680|FG009|Overall Study|Withdrawal by Subject|1|||
155023314|NCT02587598|559511681|FG010|Overall Study|Withdrawal by Subject|2|||
155023315|NCT02587598|559511671|FG000|Overall Study|Physician Decision|0|||
155023316|NCT02587598|559511672|FG001|Overall Study|Physician Decision|0|||
155023317|NCT02587598|559511673|FG002|Overall Study|Physician Decision|0|||
155023318|NCT02587598|559511674|FG003|Overall Study|Physician Decision|0|||
155023319|NCT02587598|559511675|FG004|Overall Study|Physician Decision|0|||
155023320|NCT02587598|559511676|FG005|Overall Study|Physician Decision|0|||
155023321|NCT02587598|559511677|FG006|Overall Study|Physician Decision|0|||
155023322|NCT02587598|559511678|FG007|Overall Study|Physician Decision|0|||
155023323|NCT02587598|559511679|FG008|Overall Study|Physician Decision|0|||
155023324|NCT02587598|559511680|FG009|Overall Study|Physician Decision|0|||
155023325|NCT02587598|559511681|FG010|Overall Study|Physician Decision|3|||
155023326|NCT01704651|559511682|FG000|Overall Study|Pre-op withdrawal by subject|1|||
155023327|NCT01704651|559511683|FG001|Overall Study|Pre-op withdrawal by subject|1|||
155023328|NCT01704651|559511682|FG000|Overall Study|Pre-op change in treatment plan|1|||
155023329|NCT01704651|559511683|FG001|Overall Study|Pre-op change in treatment plan|4|||
155023330|NCT01704651|559511682|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
155023331|NCT01704651|559511683|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
155023332|NCT01704651|559511682|FG000|Overall Study|Post-op did not have laparotomy|2|||
155023333|NCT01704651|559511683|FG001|Overall Study|Post-op did not have laparotomy|1|||
155023334|NCT00791661|559511684|FG000|7 Day Wash-out|Adverse Event|0|||
155023335|NCT00791661|559511685|FG001|7 Day Wash-out|Adverse Event|0|||
155023336|NCT00791661|559511686|FG002|7 Day Wash-out|Adverse Event|1|||
155023337|NCT00791661|559511684|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
155023338|NCT00791661|559511685|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
155023339|NCT00791661|559511686|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
155023340|NCT00634803|559511689|FG000|Overall Study|Lost to Follow-up|6|||
155023341|NCT00634803|559511690|FG001|Overall Study|Lost to Follow-up|7|||
155023342|NCT00634803|559511691|FG002|Overall Study|Lost to Follow-up|7|||
155023343|NCT00766636|559511694|FG000|Overall Study|Withdrawal by Subject|1|||
155023344|NCT00766636|559511695|FG001|Overall Study|Withdrawal by Subject|1|||
155023345|NCT00766636|559511694|FG000|Overall Study|Incomplete Treatment|0|||
155180315|NCT03422627|560099640|FG003|Overall Study|Adverse Event|0|||
155023346|NCT00766636|559511695|FG001|Overall Study|Incomplete Treatment|1|||
155180316|NCT03422627|560099641|FG004|Overall Study|Adverse Event|2|||
155180317|NCT03422627|560099637|FG000|Overall Study|Ineligibility Determined|0|||
155023347|NCT00766636|559511694|FG000|Overall Study|Adverse Event|1|||
155023348|NCT00766636|559511695|FG001|Overall Study|Adverse Event|0|||
155023349|NCT00766636|559511694|FG000|Overall Study|Disease Progression|1|||
155023350|NCT00766636|559511695|FG001|Overall Study|Disease Progression|0|||
155023351|NCT04087720|559511700|FG000|Overall Study|Withdrawal by Subject|2|||
155023352|NCT04087720|559511700|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
155023353|NCT00478777|559511703|FG000|Overall Study|Adverse Event|29|||
155023354|NCT00478777|559511703|FG000|Overall Study|Lack of Efficacy|23|||
155023355|NCT00478777|559511703|FG000|Overall Study|Withdrawal by Subject|4|||
155023356|NCT00478777|559511703|FG000|Overall Study|Death|3|||
155023357|NCT00478777|559511703|FG000|Overall Study|Protocol Violation|3|||
155023358|NCT00478777|559511703|FG000|Overall Study|Lost to Follow-up|3|||
155023359|NCT00478777|559511703|FG000|Overall Study|Physician Decision|1|||
155023360|NCT00478777|559511703|FG000|Overall Study|Intolerance of therapy|1|||
155023361|NCT00478777|559511703|FG000|Overall Study|Lack of compliance|1|||
155023362|NCT00478777|559511703|FG000|Overall Study|Lymphocytes infusion|1|||
155023363|NCT00478777|559511703|FG000|Overall Study|End of therapy|2|||
155023364|NCT00478777|559511703|FG000|Overall Study|Not treated with lenalidomide|6|||
155023365|NCT01377922|559511709|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
155023366|NCT01377922|559511710|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
155023367|NCT00552396|559511712|FG000|Overall Study|protocol withdrawal criteria|3|||
155023368|NCT00552396|559511713|FG001|Overall Study|protocol withdrawal criteria|3|||
155023369|NCT00552396|559511714|FG002|Overall Study|protocol withdrawal criteria|3|||
155023370|NCT00552396|559511715|FG003|Overall Study|protocol withdrawal criteria|6|||
155023371|NCT00552396|559511716|FG004|Overall Study|protocol withdrawal criteria|3|||
155180318|NCT03422627|560099638|FG001|Overall Study|Ineligibility Determined|1|||
155180319|NCT03422627|560099639|FG002|Overall Study|Ineligibility Determined|0|||
155180320|NCT03422627|560099640|FG003|Overall Study|Ineligibility Determined|0|||
155180321|NCT03422627|560099641|FG004|Overall Study|Ineligibility Determined|0|||
155180322|NCT03422627|560099637|FG000|Overall Study|Death|0|||
155180323|NCT03422627|560099638|FG001|Overall Study|Death|1|||
155180324|NCT03422627|560099639|FG002|Overall Study|Death|1|||
155023372|NCT00552396|559511717|FG005|Overall Study|protocol withdrawal criteria|3|||
155023373|NCT00552396|559511718|FG006|Overall Study|protocol withdrawal criteria|9|||
155023374|NCT04615403|559511719|FG000|Overall Study|Death|1|||
155023375|NCT01582178|559511720|FG000|Overall Study|Physician Decision|6|||
155023376|NCT01582178|559511721|FG001|Overall Study|Physician Decision|5|||
155023377|NCT02347813|559511722|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
155023378|NCT02347813|559511723|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
155180325|NCT03422627|560099640|FG003|Overall Study|Death|0|||
155180326|NCT03422627|560099641|FG004|Overall Study|Death|0|||
155023379|NCT02347813|559511722|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
155023380|NCT02347813|559511723|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
155180327|NCT03422627|560099637|FG000|Overall Study|Withdrawal by Subject|0|||
155180328|NCT03422627|560099638|FG001|Overall Study|Withdrawal by Subject|0|||
155180329|NCT03422627|560099639|FG002|Overall Study|Withdrawal by Subject|0|||
155180330|NCT03422627|560099640|FG003|Overall Study|Withdrawal by Subject|1|||
155180331|NCT03422627|560099641|FG004|Overall Study|Withdrawal by Subject|0|||
155180332|NCT05171816|560099642|FG000|Overall Study|Death|18|||
155023381|NCT00603473|559511724|FG000|Overall Study|Adverse Event|4|||
155023382|NCT00603473|559511724|FG000|Overall Study|Lack of Efficacy|4|||
155023383|NCT00603473|559511724|FG000|Overall Study|Protocol Violation|1|||
155023384|NCT02887183|559511725|FG000|Overall Study|Adverse Event|44|||
155023385|NCT02887183|559511725|FG000|Overall Study|Death|30|||
155023386|NCT02887183|559511725|FG000|Overall Study|Pregnancy|1|||
155023387|NCT02887183|559511725|FG000|Overall Study|Protocol Violation|6|||
155023388|NCT02887183|559511725|FG000|Overall Study|Technical Problems|2|||
155023389|NCT02887183|559511725|FG000|Overall Study|Lost to Follow-up|13|||
155023390|NCT02887183|559511725|FG000|Overall Study|Physician Decision|10|||
155180333|NCT05171816|560099643|FG001|Overall Study|Death|16|||
155180334|NCT04214288|560099644|FG000|Overall Study|Ongoing in the study|41|||
155180335|NCT04214288|560099645|FG001|Overall Study|Ongoing in the study|51|||
155180336|NCT04214288|560099646|FG002|Overall Study|Ongoing in the study|12|||
155180337|NCT04214288|560099647|FG003|Overall Study|Ongoing in the study|39|||
155180338|NCT04214288|560099644|FG000|Overall Study|Adverse Event|1|||
155180339|NCT04214288|560099645|FG001|Overall Study|Adverse Event|0|||
155180340|NCT04214288|560099646|FG002|Overall Study|Adverse Event|0|||
155180341|NCT04214288|560099647|FG003|Overall Study|Adverse Event|0|||
155180342|NCT04214288|560099644|FG000|Overall Study|Death|22|||
155023391|NCT02887183|559511725|FG000|Overall Study|Withdrawal by Subject|35|||
155180343|NCT04214288|560099645|FG001|Overall Study|Death|13|||
155180344|NCT04214288|560099646|FG002|Overall Study|Death|7|||
155180345|NCT04214288|560099647|FG003|Overall Study|Death|19|||
155023392|NCT01186692|559511728|FG000|Overall Study|Not Catheterized|11|||
155180346|NCT04214288|560099644|FG000|Overall Study|Lost to Follow-up|1|||
155180347|NCT04214288|560099645|FG001|Overall Study|Lost to Follow-up|2|||
155180348|NCT04214288|560099646|FG002|Overall Study|Lost to Follow-up|1|||
155180349|NCT04214288|560099647|FG003|Overall Study|Lost to Follow-up|0|||
155180350|NCT04214288|560099644|FG000|Overall Study|Other|1|||
155180351|NCT04214288|560099645|FG001|Overall Study|Other|2|||
155180352|NCT04214288|560099646|FG002|Overall Study|Other|0|||
155180353|NCT04214288|560099647|FG003|Overall Study|Other|6|||
155180354|NCT04214288|560099644|FG000|Overall Study|Protocol Violation|0|||
155180355|NCT04214288|560099645|FG001|Overall Study|Protocol Violation|1|||
155180356|NCT04214288|560099646|FG002|Overall Study|Protocol Violation|0|||
155180357|NCT04214288|560099647|FG003|Overall Study|Protocol Violation|0|||
155180358|NCT04214288|560099644|FG000|Overall Study|Withdrawal by Subject|8|||
155180359|NCT04214288|560099645|FG001|Overall Study|Withdrawal by Subject|4|||
155180360|NCT04214288|560099646|FG002|Overall Study|Withdrawal by Subject|0|||
155180361|NCT04214288|560099647|FG003|Overall Study|Withdrawal by Subject|9|||
155180362|NCT03675321|560099648|FG000|Overall Study|Lack of Efficacy|2|||
155180363|NCT03675321|560099649|FG001|Overall Study|Lack of Efficacy|2|||
155180364|NCT03675321|560099648|FG000|Overall Study|Withdrawal by Subject|1|||
155180365|NCT03675321|560099649|FG001|Overall Study|Withdrawal by Subject|3|||
155180366|NCT03997383|560099650|FG000|Double-blind Treatment Period|Adverse Event|4|||
155180367|NCT03997383|560099651|FG001|Double-blind Treatment Period|Adverse Event|3|||
155180368|NCT03997383|560099650|FG000|Double-blind Treatment Period|Death|4|||
155180369|NCT03997383|560099651|FG001|Double-blind Treatment Period|Death|4|||
155180370|NCT03997383|560099650|FG000|Double-blind Treatment Period|Physician Decision|2|||
155180371|NCT03997383|560099651|FG001|Double-blind Treatment Period|Physician Decision|0|||
155180372|NCT03997383|560099650|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
155180373|NCT03997383|560099651|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
155180374|NCT03997383|560099650|FG000|Open-label Extension Period|Ongoing|148|||
155180375|NCT03997383|560099651|FG001|Open-label Extension Period|Ongoing|151|||
155180376|NCT03997383|560099650|FG000|Open-label Extension Period|Adverse Event|4|||
155180377|NCT03997383|560099651|FG001|Open-label Extension Period|Adverse Event|1|||
155180378|NCT03997383|560099650|FG000|Open-label Extension Period|Death|8|||
155180379|NCT03997383|560099651|FG001|Open-label Extension Period|Death|9|||
155180380|NCT03997383|560099650|FG000|Open-label Extension Period|Physician Decision|1|||
155180381|NCT03997383|560099651|FG001|Open-label Extension Period|Physician Decision|1|||
155180382|NCT03997383|560099650|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
155180383|NCT03997383|560099651|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
155180384|NCT03997383|560099650|FG000|Open-label Extension Period|Reason Not Specified|2|||
155180385|NCT03997383|560099651|FG001|Open-label Extension Period|Reason Not Specified|0|||
155180386|NCT02278341|560099652|FG000|Overall Study|Randomized but never received study drug|1|||
155180387|NCT02278341|560099653|FG001|Overall Study|Randomized but never received study drug|1|||
155180388|NCT02278341|560099652|FG000|Overall Study|Adverse Event|3|||
155180389|NCT02278341|560099653|FG001|Overall Study|Adverse Event|0|||
155180390|NCT02278341|560099652|FG000|Overall Study|Death|68|||
155180391|NCT02278341|560099653|FG001|Overall Study|Death|56|||
155180392|NCT02278341|560099652|FG000|Overall Study|Withdrawal by Subject|30|||
155180393|NCT02278341|560099653|FG001|Overall Study|Withdrawal by Subject|19|||
155180394|NCT02278341|560099652|FG000|Overall Study|Lost to Follow-up|0|||
155180395|NCT02278341|560099653|FG001|Overall Study|Lost to Follow-up|1|||
155180396|NCT02278341|560099652|FG000|Overall Study|Physician Decision|1|||
155180397|NCT02278341|560099653|FG001|Overall Study|Physician Decision|1|||
155180398|NCT02278341|560099652|FG000|Overall Study|Miscellaneous|15|||
155180399|NCT02278341|560099653|FG001|Overall Study|Miscellaneous|14|||
155180400|NCT04902326|560099656|FG000|Overall Study|Withdrawal by Subject|1|||
155180401|NCT04902326|560099657|FG001|Overall Study|Withdrawal by Subject|3|||
155180402|NCT04902326|560099658|FG002|Overall Study|Withdrawal by Subject|0|||
155180403|NCT04902326|560099659|FG003|Overall Study|Withdrawal by Subject|1|||
155180404|NCT04902326|560099656|FG000|Overall Study|Lost to Follow-up|14|||
155180405|NCT04902326|560099657|FG001|Overall Study|Lost to Follow-up|14|||
155180406|NCT04902326|560099658|FG002|Overall Study|Lost to Follow-up|14|||
155180407|NCT04902326|560099659|FG003|Overall Study|Lost to Follow-up|6|||
155180408|NCT00934648|560099661|FG000|Overall Study|Failure to return|8|||
155180409|NCT00934648|560099661|FG000|Overall Study|Withdrawal by Subject|1|||
155180410|NCT02361580|560099662|FG000|Overall Study|Lost to Follow-up|6|||
155180411|NCT02361580|560099663|FG001|Overall Study|Lost to Follow-up|3|||
155180412|NCT02047318|560099664|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
155023393|NCT01186692|559511728|FG000|Overall Study|Futher testing contraindicated implant|19|||
155180413|NCT02047318|560099664|FG000|Core Study Period|Adverse Event|1|||
155180414|NCT02047318|560099664|FG000|Core Study Period|Withdrawal by caregiver|3|||
155180415|NCT02047318|560099664|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
155180416|NCT00924781|560099665|FG000|Overall Study|Study terminated by sponsor|12|||
155180417|NCT00924781|560099666|FG001|Overall Study|Study terminated by sponsor|10|||
155180418|NCT01487577|560099667|FG000|Overall Study|Became ineligible after signing consent|1|||
155180419|NCT01479985|560099670|FG000|Overall Study|Tablet malfunction, no data saved|1|||
155180420|NCT01479985|560099671|FG001|Overall Study|Tablet malfunction, no data saved|1|||
155180421|NCT01479985|560099670|FG000|Overall Study|No decisional conflict scale responses|0|||
155180422|NCT01479985|560099671|FG001|Overall Study|No decisional conflict scale responses|2|||
155180423|NCT01479985|560099670|FG000|Overall Study|No post-visit survey|5|||
155180424|NCT01479985|560099671|FG001|Overall Study|No post-visit survey|3|||
155180425|NCT01653782|560099672|FG000|Overall Study|Withdrawal by Subject|9|||
155180426|NCT01653782|560099673|FG001|Overall Study|Withdrawal by Subject|15|||
155180427|NCT01653782|560099674|FG002|Overall Study|Withdrawal by Subject|4|||
155180428|NCT01653782|560099672|FG000|Overall Study|Lost to Follow-up|7|||
155180429|NCT01653782|560099673|FG001|Overall Study|Lost to Follow-up|3|||
155180430|NCT01653782|560099674|FG002|Overall Study|Lost to Follow-up|2|||
155180431|NCT01155479|560099680|FG000|Part I|Adverse Event|13|||
155180432|NCT01155479|560099681|FG001|Part I|Adverse Event|8|||
155180433|NCT01155479|560099682|FG002|Part I|Adverse Event|18|||
155180434|NCT01155479|560099683|FG003|Part I|Adverse Event|7|||
155180435|NCT01155479|560099684|FG004|Part I|Adverse Event|6|||
155180436|NCT01155479|560099680|FG000|Part I|Administrative|2|||
155180437|NCT01155479|560099681|FG001|Part I|Administrative|2|||
155180438|NCT01155479|560099682|FG002|Part I|Administrative|2|||
155180439|NCT01155479|560099683|FG003|Part I|Administrative|0|||
155180440|NCT01155479|560099684|FG004|Part I|Administrative|0|||
155180441|NCT01155479|560099680|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
155180442|NCT01155479|560099681|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
155180443|NCT01155479|560099682|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
155180444|NCT01155479|560099683|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
155180445|NCT01155479|560099684|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
155180446|NCT01155479|560099680|FG000|Part I|Withdrawal by Subject|11|||
155180447|NCT01155479|560099681|FG001|Part I|Withdrawal by Subject|13|||
155180448|NCT01155479|560099682|FG002|Part I|Withdrawal by Subject|8|||
155180449|NCT01155479|560099683|FG003|Part I|Withdrawal by Subject|8|||
155180450|NCT01155479|560099684|FG004|Part I|Withdrawal by Subject|9|||
155180451|NCT01155479|560099680|FG000|Part I|Lost to Follow-up|0|||
155180452|NCT01155479|560099681|FG001|Part I|Lost to Follow-up|0|||
155180453|NCT01155479|560099682|FG002|Part I|Lost to Follow-up|1|||
155180454|NCT01155479|560099683|FG003|Part I|Lost to Follow-up|1|||
155180455|NCT01155479|560099684|FG004|Part I|Lost to Follow-up|0|||
155180456|NCT01155479|560099680|FG000|Part I|Treatment Failure|3|||
155180457|NCT01155479|560099681|FG001|Part I|Treatment Failure|0|||
155180458|NCT01155479|560099682|FG002|Part I|Treatment Failure|3|||
155180459|NCT01155479|560099683|FG003|Part I|Treatment Failure|1|||
155180460|NCT01155479|560099684|FG004|Part I|Treatment Failure|2|||
155180461|NCT01155479|560099680|FG000|Part I|Did Not Receive Treatment|4|||
155180462|NCT01155479|560099681|FG001|Part I|Did Not Receive Treatment|2|||
155180463|NCT01155479|560099682|FG002|Part I|Did Not Receive Treatment|2|||
155180464|NCT01155479|560099683|FG003|Part I|Did Not Receive Treatment|6|||
155180465|NCT01155479|560099684|FG004|Part I|Did Not Receive Treatment|1|||
155180466|NCT01155479|560099680|FG000|Part I|Non-Compliance with Protocol|2|||
155180467|NCT01155479|560099681|FG001|Part I|Non-Compliance with Protocol|1|||
155180468|NCT01155479|560099682|FG002|Part I|Non-Compliance with Protocol|3|||
155180469|NCT01155479|560099683|FG003|Part I|Non-Compliance with Protocol|3|||
155180470|NCT01155479|560099684|FG004|Part I|Non-Compliance with Protocol|2|||
155180471|NCT01155479|560099680|FG000|Part II|Adverse Event|7|||
155180472|NCT01155479|560099681|FG001|Part II|Adverse Event|6|||
155180473|NCT01155479|560099682|FG002|Part II|Adverse Event|8|||
155180474|NCT01155479|560099683|FG003|Part II|Adverse Event|3|||
155180475|NCT01155479|560099684|FG004|Part II|Adverse Event|4|||
155180476|NCT01155479|560099680|FG000|Part II|Administrative|43|||
155180477|NCT01155479|560099681|FG001|Part II|Administrative|49|||
155180478|NCT01155479|560099682|FG002|Part II|Administrative|36|||
155180479|NCT01155479|560099683|FG003|Part II|Administrative|38|||
155180480|NCT01155479|560099684|FG004|Part II|Administrative|46|||
155180481|NCT01155479|560099680|FG000|Part II|Withdrawal by Subject|8|||
155180482|NCT01155479|560099681|FG001|Part II|Withdrawal by Subject|4|||
155180483|NCT01155479|560099682|FG002|Part II|Withdrawal by Subject|12|||
155180484|NCT01155479|560099683|FG003|Part II|Withdrawal by Subject|7|||
155180485|NCT01155479|560099684|FG004|Part II|Withdrawal by Subject|3|||
155180486|NCT01155479|560099680|FG000|Part II|Lost to Follow-up|1|||
155180487|NCT01155479|560099681|FG001|Part II|Lost to Follow-up|0|||
155180488|NCT01155479|560099682|FG002|Part II|Lost to Follow-up|0|||
155180489|NCT01155479|560099683|FG003|Part II|Lost to Follow-up|0|||
155180490|NCT01155479|560099684|FG004|Part II|Lost to Follow-up|1|||
155180491|NCT01155479|560099680|FG000|Part II|Treatment Failure|0|||
155023394|NCT01186692|559511728|FG000|Overall Study|Adverse Event|2|||
155023395|NCT02195869|559511729|FG000|Overall Study|cGVHD Progression|5|||
155180492|NCT01155479|560099681|FG001|Part II|Treatment Failure|1|||
155180493|NCT01155479|560099682|FG002|Part II|Treatment Failure|2|||
155180494|NCT01155479|560099683|FG003|Part II|Treatment Failure|0|||
155180495|NCT01155479|560099684|FG004|Part II|Treatment Failure|1|||
155180496|NCT01155479|560099680|FG000|Part II|Non-Compliance with Protocol|0|||
155180497|NCT01155479|560099681|FG001|Part II|Non-Compliance with Protocol|1|||
155180498|NCT01155479|560099682|FG002|Part II|Non-Compliance with Protocol|0|||
155180499|NCT01155479|560099683|FG003|Part II|Non-Compliance with Protocol|2|||
155180500|NCT01155479|560099684|FG004|Part II|Non-Compliance with Protocol|0|||
155023396|NCT02195869|559511729|FG000|Overall Study|Malignancy Progression/relapse|2|||
155023397|NCT02195869|559511729|FG000|Overall Study|Adverse Event|15|||
155023398|NCT02195869|559511729|FG000|Overall Study|Withdrawal by Subject|7|||
155023399|NCT02195869|559511729|FG000|Overall Study|Physician Decision|4|||
155023400|NCT02195869|559511729|FG000|Overall Study|Study Terminated by Sponsor|7|||
155023401|NCT02195869|559511729|FG000|Overall Study|Noncompliance with study drug|2|||
155023402|NCT02654977|559511730|FG000|Overall Study|Death|1|||
155023403|NCT02654977|559511730|FG000|Overall Study|Lost to Follow-up|1|||
155023404|NCT02654977|559511730|FG000|Overall Study|Adverse Event|1|||
155023405|NCT02654977|559511730|FG000|Overall Study|Withdrawal by Subject|1|||
155023406|NCT02654977|559511730|FG000|Overall Study|Lack of Efficacy|3|||
155023407|NCT01921101|559511732|FG000|Overall Study|Death|16|||
155023408|NCT01921101|559511733|FG001|Overall Study|Death|6|||
155023409|NCT01266291|559511734|FG000|Overall Study|Adverse Event|1|||
155023410|NCT03225105|559511736|FG000|Overall Study|Withdrawal by Subject|1|||
155023411|NCT03225105|559511737|FG001|Overall Study|Withdrawal by Subject|0|||
155023412|NCT03225105|559511738|FG002|Overall Study|Withdrawal by Subject|0|||
155023413|NCT03225105|559511739|FG003|Overall Study|Withdrawal by Subject|0|||
155023414|NCT03225105|559511736|FG000|Overall Study|Death|0|||
155023415|NCT03225105|559511737|FG001|Overall Study|Death|4|||
155023416|NCT03225105|559511738|FG002|Overall Study|Death|2|||
155023417|NCT03225105|559511739|FG003|Overall Study|Death|0|||
155023418|NCT03225105|559511736|FG000|Overall Study|Study termination per Sponsor Decision|2|||
155023419|NCT03225105|559511737|FG001|Overall Study|Study termination per Sponsor Decision|0|||
155023420|NCT03225105|559511738|FG002|Overall Study|Study termination per Sponsor Decision|3|||
155023421|NCT03225105|559511739|FG003|Overall Study|Study termination per Sponsor Decision|3|||
155023422|NCT00679029|559513295|FG000|Overall Study|Adverse Event|3|||
155023423|NCT00679029|559513295|FG000|Overall Study|Withdrawal by Subject|1|||
155023424|NCT00679029|559513295|FG000|Overall Study|Lost to Follow-up|1|||
155023425|NCT00160706|559513298|FG000|Overall Study|Adverse Event|53|||
155023426|NCT00160706|559513298|FG000|Overall Study|Adverse Event and Other Reason|105|||
155023427|NCT00160706|559513298|FG000|Overall Study|Protocol Violation|3|||
155023428|NCT00160706|559513298|FG000|Overall Study|Withdrawal by Subject|41|||
155023429|NCT00160706|559513298|FG000|Overall Study|Withdrawal by Subject and Other|12|||
155139865|NCT04072887|559942804|FG004|Overall Study|Lost to Follow-up|0|||
155139866|NCT04072887|559942805|FG005|Overall Study|Lost to Follow-up|0|||
155139867|NCT04072887|559942800|FG000|Overall Study|Death|0|||
155139868|NCT04072887|559942801|FG001|Overall Study|Death|2|||
155139869|NCT04072887|559942802|FG002|Overall Study|Death|0|||
155139870|NCT04072887|559942803|FG003|Overall Study|Death|2|||
155139871|NCT04072887|559942804|FG004|Overall Study|Death|3|||
155139872|NCT04072887|559942805|FG005|Overall Study|Death|0|||
155139873|NCT03193736|559942806|FG000|Overall Study|Death|2|||
155139874|NCT03193736|559942806|FG000|Overall Study|Withdrawal by Subject|1|||
155139875|NCT03193736|559942806|FG000|Overall Study|Lost to Follow-up|1|||
155139876|NCT03193736|559942806|FG000|Overall Study|implant not received|1|||
155139877|NCT00856297|559942807|FG000|Overall Study|Unable to classify|2|||
155139878|NCT00856297|559942808|FG001|Overall Study|Unable to classify|0|||
155139879|NCT00856297|559942809|FG002|Overall Study|Unable to classify|0|||
155139880|NCT00856297|559942810|FG003|Overall Study|Unable to classify|0|||
155139881|NCT00856297|559942811|FG004|Overall Study|Unable to classify|0|||
155139882|NCT00423449|559942816|FG000|Overall Study|Clinical Adverse Event|1|||
155139883|NCT00423449|559942817|FG001|Overall Study|Clinical Adverse Event|0|||
155139884|NCT00423449|559942818|FG002|Overall Study|Clinical Adverse Event|1|||
155139885|NCT00423449|559942819|FG003|Overall Study|Clinical Adverse Event|8|||
155139886|NCT00423449|559942820|FG004|Overall Study|Clinical Adverse Event|2|||
155139887|NCT00423449|559942816|FG000|Overall Study|Death|1|||
155139888|NCT00423449|559942817|FG001|Overall Study|Death|0|||
155139889|NCT00423449|559942818|FG002|Overall Study|Death|2|||
155139890|NCT00423449|559942819|FG003|Overall Study|Death|1|||
155139891|NCT00423449|559942820|FG004|Overall Study|Death|1|||
155139892|NCT00423449|559942816|FG000|Overall Study|Progressive Disease|1|||
155139893|NCT00423449|559942817|FG001|Overall Study|Progressive Disease|3|||
155139894|NCT00423449|559942818|FG002|Overall Study|Progressive Disease|8|||
155139895|NCT00423449|559942819|FG003|Overall Study|Progressive Disease|11|||
155139896|NCT00423449|559942820|FG004|Overall Study|Progressive Disease|4|||
155139897|NCT00423449|559942816|FG000|Overall Study|Laboratory Adverse Event|0|||
155139898|NCT00423449|559942817|FG001|Overall Study|Laboratory Adverse Event|1|||
155139899|NCT00423449|559942818|FG002|Overall Study|Laboratory Adverse Event|2|||
155139900|NCT00423449|559942819|FG003|Overall Study|Laboratory Adverse Event|0|||
155139901|NCT00423449|559942820|FG004|Overall Study|Laboratory Adverse Event|0|||
155180501|NCT02360605|560099685|FG000|Overall Study|Withdrawal by Subject|4|||
155023430|NCT00160706|559513298|FG000|Overall Study|Physician Decision|10|||
155023431|NCT00160706|559513298|FG000|Overall Study|Physician Decision and Other|3|||
155139902|NCT00423449|559942816|FG000|Overall Study|Other|0|||
155139903|NCT00423449|559942817|FG001|Overall Study|Other|0|||
155139904|NCT00423449|559942818|FG002|Overall Study|Other|0|||
155139905|NCT00423449|559942819|FG003|Overall Study|Other|1|||
155139906|NCT00423449|559942820|FG004|Overall Study|Other|0|||
155180502|NCT02360605|560099686|FG001|Overall Study|Withdrawal by Subject|9|||
155023432|NCT00160706|559513298|FG000|Overall Study|Lost to Follow-up|4|||
155023433|NCT00160706|559513298|FG000|Overall Study|Lost to Follow-up and Other|1|||
155023434|NCT00160706|559513298|FG000|Overall Study|Lack of Efficacy|42|||
155023435|NCT00160706|559513298|FG000|Overall Study|Lack of Efficacy and Other|1|||
155023436|NCT00160706|559513298|FG000|Overall Study|Other Reason|11|||
155023437|NCT00379080|559513299|FG000|Overall Study|Withdrawal by Subject|0|||
155023438|NCT00379080|559513300|FG001|Overall Study|Withdrawal by Subject|4|||
155023439|NCT00379080|559513301|FG002|Overall Study|Withdrawal by Subject|0|||
155023440|NCT01089608|559513302|FG000|Overall Study|Adverse Event|0|||
155023441|NCT01089608|559513303|FG001|Overall Study|Adverse Event|4|||
155023442|NCT01089608|559513302|FG000|Overall Study|Lost to Follow-up|0|||
155023443|NCT01089608|559513303|FG001|Overall Study|Lost to Follow-up|2|||
155023444|NCT04292912|559513304|FG000|Overall Study|Physician Decision|1|||
155023445|NCT04292912|559513304|FG000|Overall Study|Protocol Violation|6|||
155023446|NCT00955955|559513305|FG000|Overall Study|Lost to Follow-up|2|||
155023447|NCT00955955|559513306|FG001|Overall Study|Lost to Follow-up|0|||
155023448|NCT00955955|559513307|FG002|Overall Study|Lost to Follow-up|0|||
155023449|NCT03575793|559513308|FG000|Overall Study|Withdrawal by Subject|0|||
155023450|NCT03575793|559513309|FG001|Overall Study|Withdrawal by Subject|1|||
155023451|NCT03575793|559513308|FG000|Overall Study|Never Treated|0|||
155023452|NCT03575793|559513309|FG001|Overall Study|Never Treated|2|||
155023453|NCT01250873|559513310|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
155023454|NCT01250873|559513310|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
155023455|NCT01127451|559513314|FG000|Overall Study|Other|2|||
155023456|NCT01127451|559513315|FG001|Overall Study|Other|1|||
155023457|NCT01127451|559513314|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
155023458|NCT01127451|559513315|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
155023459|NCT01127451|559513314|FG000|Overall Study|Death|22|||
155023460|NCT01127451|559513315|FG001|Overall Study|Death|17|||
155023461|NCT01127451|559513314|FG000|Overall Study|Lost to Follow-up|3|||
155023462|NCT01127451|559513315|FG001|Overall Study|Lost to Follow-up|0|||
155023463|NCT01127451|559513314|FG000|Overall Study|Administrative Reason by Sponsor|2|||
155023464|NCT01127451|559513315|FG001|Overall Study|Administrative Reason by Sponsor|2|||
155023465|NCT02429778|559513317|FG000|Overall Study|Lost to Follow-up|2|||
155023466|NCT02429778|559513318|FG001|Overall Study|Lost to Follow-up|0|||
155023467|NCT02429778|559513317|FG000|Overall Study|Withdrawal by Subject|5|||
155023468|NCT02429778|559513318|FG001|Overall Study|Withdrawal by Subject|0|||
155023469|NCT03521115|559513319|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
155023470|NCT03521115|559513320|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
155023471|NCT03521115|559513319|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
155023472|NCT03521115|559513320|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
155023473|NCT02295020|559513327|FG000|Overall Study|Adverse Event|0|||
155023474|NCT02295020|559513328|FG001|Overall Study|Adverse Event|1|||
155023475|NCT02295020|559513327|FG000|Overall Study|Withdrawal by Subject|3|||
155023476|NCT02295020|559513328|FG001|Overall Study|Withdrawal by Subject|2|||
155023477|NCT01290679|559513329|FG000|Overall Study|Adverse Event|2|||
155023478|NCT01290679|559513330|FG001|Overall Study|Adverse Event|0|||
155023479|NCT01290679|559513329|FG000|Overall Study|Lost to Follow-up|8|||
155023480|NCT01290679|559513330|FG001|Overall Study|Lost to Follow-up|10|||
155023481|NCT01290679|559513329|FG000|Overall Study|Protocol Violation|0|||
155023482|NCT01290679|559513330|FG001|Overall Study|Protocol Violation|1|||
155023483|NCT01290679|559513329|FG000|Overall Study|Withdrawal by Subject|6|||
155023484|NCT01290679|559513330|FG001|Overall Study|Withdrawal by Subject|5|||
155023485|NCT01290679|559513329|FG000|Overall Study|Subject Entered Another Trial|0|||
155023486|NCT01290679|559513330|FG001|Overall Study|Subject Entered Another Trial|5|||
155023487|NCT01598090|559513331|FG000|Treatment Period|Poor/non-compliance|0|||
155023488|NCT01598090|559513332|FG001|Treatment Period|Poor/non-compliance|2|||
155023489|NCT01598090|559513333|FG002|Treatment Period|Poor/non-compliance|0|||
155180503|NCT02360605|560099685|FG000|Overall Study|Lost to Follow-up|7|||
155180504|NCT02360605|560099686|FG001|Overall Study|Lost to Follow-up|8|||
155180505|NCT02360605|560099685|FG000|Overall Study|Death|0|||
155180506|NCT02360605|560099686|FG001|Overall Study|Death|1|||
155180507|NCT01117792|560099689|FG000|Overall Study|Death|1|||
155180508|NCT01117792|560099689|FG000|Overall Study|Adverse Event|3|||
155180509|NCT05867342|560099690|FG000|Overall Study|Investigator Decision|3|||
155023490|NCT01598090|559513331|FG000|Treatment Period|No longer meet study criteria|0|||
155023491|NCT01598090|559513332|FG001|Treatment Period|No longer meet study criteria|1|||
155023492|NCT01598090|559513333|FG002|Treatment Period|No longer meet study criteria|0|||
155023493|NCT01598090|559513331|FG000|Treatment Period|Lack of Efficacy|5|||
155023494|NCT01598090|559513332|FG001|Treatment Period|Lack of Efficacy|14|||
155180510|NCT05867342|560099691|FG001|Overall Study|Investigator Decision|3|||
155180511|NCT01721577|560099692|FG000|Overall Study|Lack of Efficacy|1|||
155023495|NCT01598090|559513333|FG002|Treatment Period|Lack of Efficacy|6|||
155023496|NCT01598090|559513331|FG000|Treatment Period|Adverse Event|2|||
155023497|NCT01598090|559513332|FG001|Treatment Period|Adverse Event|33|||
155180512|NCT01721577|560099693|FG001|Overall Study|Lack of Efficacy|0|||
155180513|NCT01721577|560099692|FG000|Overall Study|Death|1|||
155023498|NCT01598090|559513333|FG002|Treatment Period|Adverse Event|17|||
155023499|NCT01598090|559513331|FG000|Treatment Period|Other reasons|0|||
155023500|NCT01598090|559513332|FG001|Treatment Period|Other reasons|4|||
155023501|NCT01598090|559513333|FG002|Treatment Period|Other reasons|1|||
155023502|NCT01598090|559513331|FG000|Treatment Period|Withdrawal by Subject|3|||
155023503|NCT01598090|559513332|FG001|Treatment Period|Withdrawal by Subject|13|||
155023504|NCT01598090|559513333|FG002|Treatment Period|Withdrawal by Subject|10|||
155023505|NCT01598090|559513331|FG000|Treatment Period|Lost to Follow-up|1|||
155023506|NCT01598090|559513332|FG001|Treatment Period|Lost to Follow-up|5|||
155023507|NCT01598090|559513333|FG002|Treatment Period|Lost to Follow-up|1|||
155023508|NCT01598090|559513331|FG000|Follow-up Period|Death|0|||
155023509|NCT01598090|559513332|FG001|Follow-up Period|Death|1|||
155023510|NCT01598090|559513333|FG002|Follow-up Period|Death|0|||
155023511|NCT01598090|559513331|FG000|Follow-up Period|No longer required per protocol|1|||
155023512|NCT01598090|559513332|FG001|Follow-up Period|No longer required per protocol|3|||
155023513|NCT01598090|559513333|FG002|Follow-up Period|No longer required per protocol|2|||
155023514|NCT01598090|559513331|FG000|Follow-up Period|Not reported|0|||
155023515|NCT01598090|559513332|FG001|Follow-up Period|Not reported|10|||
155023516|NCT01598090|559513333|FG002|Follow-up Period|Not reported|4|||
155023517|NCT01598090|559513331|FG000|Follow-up Period|Withdrawal by Subject|0|||
155023518|NCT01598090|559513332|FG001|Follow-up Period|Withdrawal by Subject|3|||
155023519|NCT01598090|559513333|FG002|Follow-up Period|Withdrawal by Subject|2|||
155023520|NCT01598090|559513331|FG000|Follow-up Period|Other reasons|2|||
155023521|NCT01598090|559513332|FG001|Follow-up Period|Other reasons|8|||
155023522|NCT01598090|559513333|FG002|Follow-up Period|Other reasons|8|||
155023523|NCT01598090|559513331|FG000|Follow-up Period|Lost to Follow-up|2|||
155023524|NCT01598090|559513332|FG001|Follow-up Period|Lost to Follow-up|10|||
155023525|NCT01598090|559513333|FG002|Follow-up Period|Lost to Follow-up|12|||
155023526|NCT04791319|559513334|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
155023527|NCT04791319|559513335|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
155023528|NCT04791319|559513336|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
155023529|NCT04791319|559513337|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
155023530|NCT04791319|559513338|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023531|NCT04791319|559513339|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023532|NCT04791319|559513340|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023533|NCT04791319|559513341|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023534|NCT04791319|559513342|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023535|NCT04791319|559513343|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023536|NCT04791319|559513344|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
155023537|NCT04791319|559513334|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
155023538|NCT04791319|559513335|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023539|NCT04791319|559513336|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
155023540|NCT04791319|559513337|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
155023541|NCT04791319|559513338|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023542|NCT04791319|559513339|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023543|NCT04791319|559513340|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023544|NCT04791319|559513341|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023545|NCT04791319|559513342|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023546|NCT04791319|559513343|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023547|NCT04791319|559513344|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
155023548|NCT04791319|559513334|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
155023549|NCT04791319|559513335|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
155023550|NCT04791319|559513336|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
155023551|NCT04791319|559513337|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
155023552|NCT04791319|559513338|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023553|NCT04791319|559513339|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023554|NCT04791319|559513340|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023555|NCT04791319|559513341|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023556|NCT04791319|559513342|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023557|NCT04791319|559513343|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023558|NCT04791319|559513344|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
155023559|NCT04791319|559513334|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
155023560|NCT04791319|559513335|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
155023561|NCT04791319|559513336|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
155023562|NCT04791319|559513337|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
155023563|NCT04791319|559513338|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155023564|NCT04791319|559513339|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155139907|NCT00423449|559942816|FG000|Overall Study|Protocol Violation|0|||
155023565|NCT04791319|559513340|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155023566|NCT04791319|559513341|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155023567|NCT04791319|559513342|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155023568|NCT04791319|559513343|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155023569|NCT04791319|559513344|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
155023570|NCT04791319|559513334|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023571|NCT04791319|559513335|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023572|NCT04791319|559513336|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023573|NCT04791319|559513337|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
155023574|NCT04791319|559513338|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023575|NCT04791319|559513339|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023576|NCT04791319|559513340|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023577|NCT04791319|559513341|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023578|NCT04791319|559513342|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023579|NCT04791319|559513343|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023580|NCT04791319|559513344|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
155023581|NCT04791319|559513334|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023582|NCT04791319|559513335|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023583|NCT04791319|559513336|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023584|NCT04791319|559513337|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023585|NCT04791319|559513338|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
155023586|NCT04791319|559513339|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
155023587|NCT04791319|559513340|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
155023588|NCT04791319|559513341|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023589|NCT04791319|559513342|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023590|NCT04791319|559513343|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
155023591|NCT04791319|559513344|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
155023592|NCT04791319|559513334|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023593|NCT04791319|559513335|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023594|NCT04791319|559513336|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023595|NCT04791319|559513337|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023596|NCT04791319|559513338|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023597|NCT04791319|559513339|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023598|NCT04791319|559513340|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023599|NCT04791319|559513341|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023600|NCT04791319|559513342|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023601|NCT04791319|559513343|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
155023602|NCT04791319|559513344|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
155023603|NCT04791319|559513334|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155023604|NCT04791319|559513335|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155023605|NCT04791319|559513336|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155023606|NCT04791319|559513337|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155023607|NCT04791319|559513338|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
155023608|NCT04791319|559513339|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
155023609|NCT04791319|559513340|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
155023610|NCT04791319|559513341|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
155023611|NCT04791319|559513342|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
155023612|NCT04791319|559513343|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
155023613|NCT04791319|559513344|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
155023614|NCT04791319|559513334|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155023615|NCT04791319|559513335|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155023616|NCT04791319|559513336|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155023617|NCT04791319|559513337|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
155023618|NCT04791319|559513338|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
155023619|NCT04791319|559513339|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
155023620|NCT04791319|559513340|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
155023621|NCT04791319|559513341|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
155023622|NCT04791319|559513342|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
155023623|NCT04791319|559513343|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
155023624|NCT04791319|559513344|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
155023625|NCT00355147|559513353|FG000|Overall Study|Lost to Follow-up|10|||
155023626|NCT00355147|559513354|FG001|Overall Study|Lost to Follow-up|8|||
155023627|NCT00355147|559513353|FG000|Overall Study|Withdrawal by Subject|8|||
155023628|NCT00355147|559513354|FG001|Overall Study|Withdrawal by Subject|12|||
155023629|NCT03557931|559513361|FG000|Overall Study|Adverse Event|4|||
155023630|NCT03557931|559513362|FG001|Overall Study|Adverse Event|6|||
155023631|NCT03557931|559513363|FG002|Overall Study|Adverse Event|1|||
155023632|NCT03557931|559513361|FG000|Overall Study|Lost to Follow-up|4|||
155023633|NCT03557931|559513362|FG001|Overall Study|Lost to Follow-up|4|||
155023634|NCT03557931|559513363|FG002|Overall Study|Lost to Follow-up|1|||
155023635|NCT03557931|559513361|FG000|Overall Study|Protocol Violation|1|||
155023636|NCT03557931|559513362|FG001|Overall Study|Protocol Violation|4|||
155023637|NCT03557931|559513363|FG002|Overall Study|Protocol Violation|1|||
155023638|NCT03557931|559513361|FG000|Overall Study|Withdrawal by Subject|14|||
155180514|NCT01721577|560099693|FG001|Overall Study|Death|0|||
155180515|NCT01721577|560099692|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
155023639|NCT03557931|559513362|FG001|Overall Study|Withdrawal by Subject|0|||
155023640|NCT03557931|559513363|FG002|Overall Study|Withdrawal by Subject|7|||
155023641|NCT03557931|559513361|FG000|Overall Study|Miscellaneous|8|||
155023642|NCT03557931|559513362|FG001|Overall Study|Miscellaneous|5|||
155023643|NCT03557931|559513363|FG002|Overall Study|Miscellaneous|3|||
155023644|NCT02394340|559513366|FG000|Overall Study|Failed drug screen test|1|||
155023645|NCT02394340|559513366|FG000|Overall Study|Adverse Event|1|||
155023646|NCT03605862|559513367|FG000|Overall Study|Withdrawal by Subject|12|||
155023647|NCT03605862|559513368|FG001|Overall Study|Withdrawal by Subject|9|||
155023648|NCT03605862|559513367|FG000|Overall Study|Adverse Event|2|||
155023649|NCT03605862|559513368|FG001|Overall Study|Adverse Event|1|||
155023650|NCT03605862|559513367|FG000|Overall Study|Physician Decision|3|||
155023651|NCT03605862|559513368|FG001|Overall Study|Physician Decision|1|||
155023652|NCT03605862|559513367|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
155023653|NCT03605862|559513368|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
155023654|NCT00364923|559513369|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
155023655|NCT00364923|559513369|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
155023656|NCT01355575|559513377|FG000|Overall Study|Withdrawal by Subject|2|||
155023657|NCT00765336|559513380|FG000|Overall Study|Protocol Violation|4|||
155023658|NCT00765336|559513381|FG001|Overall Study|Protocol Violation|2|||
155023659|NCT00765336|559513380|FG000|Overall Study|Withdrawal by Subject|6|||
155023660|NCT00765336|559513381|FG001|Overall Study|Withdrawal by Subject|4|||
155023661|NCT00765336|559513380|FG000|Overall Study|Lost to Follow-up|7|||
155023662|NCT00765336|559513381|FG001|Overall Study|Lost to Follow-up|9|||
155023663|NCT00765336|559513380|FG000|Overall Study|Adverse Event|2|||
155023664|NCT00765336|559513381|FG001|Overall Study|Adverse Event|1|||
155023665|NCT02553499|559513384|FG000|Overall Study|Adverse Event|0|||
155023666|NCT02553499|559513385|FG001|Overall Study|Adverse Event|0|||
155023667|NCT02553499|559513386|FG002|Overall Study|Adverse Event|0|||
155023668|NCT02553499|559513387|FG003|Overall Study|Adverse Event|0|||
155023669|NCT02553499|559513388|FG004|Overall Study|Adverse Event|0|||
155023670|NCT02553499|559513389|FG005|Overall Study|Adverse Event|0|||
155023671|NCT02553499|559513390|FG006|Overall Study|Adverse Event|1|||
155023672|NCT02553499|559513391|FG007|Overall Study|Adverse Event|1|||
155023673|NCT02553499|559513392|FG008|Overall Study|Adverse Event|0|||
155023674|NCT02553499|559513393|FG009|Overall Study|Adverse Event|0|||
155023675|NCT02553499|559513394|FG010|Overall Study|Adverse Event|0|||
155023676|NCT02553499|559513395|FG011|Overall Study|Adverse Event|0|||
155023677|NCT02553499|559513396|FG012|Overall Study|Adverse Event|0|||
155023678|NCT02553499|559513397|FG013|Overall Study|Adverse Event|1|||
155023679|NCT02553499|559513384|FG000|Overall Study|Death|0|||
155023680|NCT02553499|559513385|FG001|Overall Study|Death|1|||
155023681|NCT02553499|559513386|FG002|Overall Study|Death|1|||
155023682|NCT02553499|559513387|FG003|Overall Study|Death|0|||
155023683|NCT02553499|559513388|FG004|Overall Study|Death|1|||
155023684|NCT02553499|559513389|FG005|Overall Study|Death|2|||
155023685|NCT02553499|559513390|FG006|Overall Study|Death|0|||
155023686|NCT02553499|559513391|FG007|Overall Study|Death|0|||
155023687|NCT02553499|559513392|FG008|Overall Study|Death|0|||
155023688|NCT02553499|559513393|FG009|Overall Study|Death|0|||
155023689|NCT02553499|559513394|FG010|Overall Study|Death|1|||
155023690|NCT02553499|559513395|FG011|Overall Study|Death|0|||
155023691|NCT02553499|559513396|FG012|Overall Study|Death|0|||
155023692|NCT02553499|559513397|FG013|Overall Study|Death|0|||
155023693|NCT02553499|559513384|FG000|Overall Study|Lost to Follow-up|0|||
155023694|NCT02553499|559513385|FG001|Overall Study|Lost to Follow-up|0|||
155023695|NCT02553499|559513386|FG002|Overall Study|Lost to Follow-up|0|||
155180516|NCT01721577|560099693|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
155023696|NCT02553499|559513387|FG003|Overall Study|Lost to Follow-up|0|||
155023697|NCT02553499|559513388|FG004|Overall Study|Lost to Follow-up|0|||
155023698|NCT02553499|559513389|FG005|Overall Study|Lost to Follow-up|0|||
155023699|NCT02553499|559513390|FG006|Overall Study|Lost to Follow-up|1|||
155023700|NCT02553499|559513391|FG007|Overall Study|Lost to Follow-up|0|||
155023701|NCT02553499|559513392|FG008|Overall Study|Lost to Follow-up|0|||
155023702|NCT02553499|559513393|FG009|Overall Study|Lost to Follow-up|0|||
155023703|NCT02553499|559513394|FG010|Overall Study|Lost to Follow-up|0|||
155023704|NCT02553499|559513395|FG011|Overall Study|Lost to Follow-up|0|||
155023705|NCT02553499|559513396|FG012|Overall Study|Lost to Follow-up|0|||
155023706|NCT02553499|559513397|FG013|Overall Study|Lost to Follow-up|0|||
155023707|NCT02553499|559513384|FG000|Overall Study|Physician Decision|0|||
155023708|NCT02553499|559513385|FG001|Overall Study|Physician Decision|1|||
155023709|NCT02553499|559513386|FG002|Overall Study|Physician Decision|1|||
155023710|NCT02553499|559513387|FG003|Overall Study|Physician Decision|0|||
155023711|NCT02553499|559513388|FG004|Overall Study|Physician Decision|1|||
155023712|NCT02553499|559513389|FG005|Overall Study|Physician Decision|0|||
155023713|NCT02553499|559513390|FG006|Overall Study|Physician Decision|0|||
155023714|NCT02553499|559513391|FG007|Overall Study|Physician Decision|1|||
155023715|NCT02553499|559513392|FG008|Overall Study|Physician Decision|1|||
155023716|NCT02553499|559513393|FG009|Overall Study|Physician Decision|2|||
155023717|NCT02553499|559513394|FG010|Overall Study|Physician Decision|1|||
155023718|NCT02553499|559513395|FG011|Overall Study|Physician Decision|3|||
155023719|NCT02553499|559513396|FG012|Overall Study|Physician Decision|1|||
155023720|NCT02553499|559513397|FG013|Overall Study|Physician Decision|0|||
155023721|NCT02553499|559513384|FG000|Overall Study|Progressive Disease|0|||
155023722|NCT02553499|559513385|FG001|Overall Study|Progressive Disease|0|||
155023723|NCT02553499|559513386|FG002|Overall Study|Progressive Disease|0|||
155023724|NCT02553499|559513387|FG003|Overall Study|Progressive Disease|2|||
155023725|NCT02553499|559513388|FG004|Overall Study|Progressive Disease|1|||
155023726|NCT02553499|559513389|FG005|Overall Study|Progressive Disease|1|||
155023727|NCT02553499|559513390|FG006|Overall Study|Progressive Disease|1|||
155023728|NCT02553499|559513391|FG007|Overall Study|Progressive Disease|0|||
155023729|NCT02553499|559513392|FG008|Overall Study|Progressive Disease|0|||
155023730|NCT02553499|559513393|FG009|Overall Study|Progressive Disease|1|||
155023731|NCT02553499|559513394|FG010|Overall Study|Progressive Disease|0|||
155023732|NCT02553499|559513395|FG011|Overall Study|Progressive Disease|0|||
155023733|NCT02553499|559513396|FG012|Overall Study|Progressive Disease|2|||
155023734|NCT02553499|559513397|FG013|Overall Study|Progressive Disease|1|||
155023735|NCT02553499|559513384|FG000|Overall Study|Study Terminated by Sponsor|0|||
155023736|NCT02553499|559513385|FG001|Overall Study|Study Terminated by Sponsor|0|||
155023737|NCT02553499|559513386|FG002|Overall Study|Study Terminated by Sponsor|0|||
155023738|NCT02553499|559513387|FG003|Overall Study|Study Terminated by Sponsor|0|||
155023739|NCT02553499|559513388|FG004|Overall Study|Study Terminated by Sponsor|0|||
155023740|NCT02553499|559513389|FG005|Overall Study|Study Terminated by Sponsor|0|||
155023741|NCT02553499|559513390|FG006|Overall Study|Study Terminated by Sponsor|0|||
155023742|NCT02553499|559513391|FG007|Overall Study|Study Terminated by Sponsor|0|||
155023743|NCT02553499|559513392|FG008|Overall Study|Study Terminated by Sponsor|1|||
155023744|NCT02553499|559513393|FG009|Overall Study|Study Terminated by Sponsor|0|||
155023745|NCT02553499|559513394|FG010|Overall Study|Study Terminated by Sponsor|0|||
155023746|NCT02553499|559513395|FG011|Overall Study|Study Terminated by Sponsor|0|||
155023747|NCT02553499|559513396|FG012|Overall Study|Study Terminated by Sponsor|0|||
155023748|NCT02553499|559513397|FG013|Overall Study|Study Terminated by Sponsor|0|||
155023749|NCT02553499|559513384|FG000|Overall Study|Withdrawal by Subject|2|||
155023750|NCT02553499|559513385|FG001|Overall Study|Withdrawal by Subject|0|||
155023751|NCT02553499|559513386|FG002|Overall Study|Withdrawal by Subject|0|||
155023752|NCT02553499|559513387|FG003|Overall Study|Withdrawal by Subject|0|||
155023753|NCT02553499|559513388|FG004|Overall Study|Withdrawal by Subject|0|||
155023754|NCT02553499|559513389|FG005|Overall Study|Withdrawal by Subject|0|||
155023755|NCT02553499|559513390|FG006|Overall Study|Withdrawal by Subject|0|||
155023756|NCT02553499|559513391|FG007|Overall Study|Withdrawal by Subject|1|||
155023757|NCT02553499|559513392|FG008|Overall Study|Withdrawal by Subject|1|||
155023758|NCT02553499|559513393|FG009|Overall Study|Withdrawal by Subject|0|||
155023759|NCT02553499|559513394|FG010|Overall Study|Withdrawal by Subject|1|||
155023760|NCT02553499|559513395|FG011|Overall Study|Withdrawal by Subject|0|||
155023761|NCT02553499|559513396|FG012|Overall Study|Withdrawal by Subject|0|||
155023762|NCT02553499|559513397|FG013|Overall Study|Withdrawal by Subject|0|||
155023763|NCT01726270|559513400|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
155023764|NCT01726270|559513400|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
155023765|NCT01726270|559513400|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
155023766|NCT01726270|559513400|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
155023767|NCT01726270|559513400|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
155023768|NCT01726270|559513400|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
155023769|NCT01323387|559513401|FG000|Overall Study|Withdrawal by Subject|41|||
155023770|NCT01323387|559513401|FG000|Overall Study|Radiographic Data Unavailable|1|||
155023771|NCT01323387|559513401|FG000|Overall Study|Revision|14|||
155023772|NCT01323387|559513401|FG000|Overall Study|Protocol Violation|12|||
155023773|NCT01323387|559513401|FG000|Overall Study|Randomized but Never Treated|16|||
155023774|NCT01464164|559513403|FG000|Overall Study|Screen failure|0|||
155023775|NCT01464164|559513404|FG001|Overall Study|Screen failure|1|||
155023776|NCT01464164|559513405|FG002|Overall Study|Screen failure|2|||
155023777|NCT01464164|559513406|FG003|Overall Study|Screen failure|0|||
155023778|NCT01464164|559513407|FG004|Overall Study|Screen failure|0|||
155023779|NCT01464164|559513408|FG005|Overall Study|Screen failure|0|||
155023780|NCT01464164|559513409|FG006|Overall Study|Screen failure|0|||
155023781|NCT01464164|559513403|FG000|Overall Study|Physician Decision|0|||
155023782|NCT01464164|559513404|FG001|Overall Study|Physician Decision|1|||
155023783|NCT01464164|559513405|FG002|Overall Study|Physician Decision|0|||
155023784|NCT01464164|559513406|FG003|Overall Study|Physician Decision|0|||
155023785|NCT01464164|559513407|FG004|Overall Study|Physician Decision|0|||
155023786|NCT01464164|559513408|FG005|Overall Study|Physician Decision|0|||
155023787|NCT01464164|559513409|FG006|Overall Study|Physician Decision|2|||
155023788|NCT01972438|559513410|FG000|Baseline-Month 3 Crossover Period|Death|1|||
155023789|NCT01972438|559513411|FG001|Baseline-Month 3 Crossover Period|Death|0|||
155023790|NCT01972438|559513410|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
155023791|NCT01972438|559513411|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
155023792|NCT01972438|559513410|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
155023793|NCT01972438|559513411|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
155023794|NCT01972438|559513410|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
155023795|NCT01972438|559513411|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
155023796|NCT01972438|559513410|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
155023797|NCT01972438|559513411|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
155023798|NCT01972438|559513410|FG000|Months 6-12 Study Period|Death|1|||
155023799|NCT01972438|559513411|FG001|Months 6-12 Study Period|Death|0|||
155023800|NCT01972438|559513410|FG000|Months 6-12 Study Period|Early Study Closure|2|||
155023801|NCT01972438|559513411|FG001|Months 6-12 Study Period|Early Study Closure|2|||
155023802|NCT01972438|559513410|FG000|Post Month 12 Study Period|Early Study Closure|3|||
155023803|NCT01972438|559513411|FG001|Post Month 12 Study Period|Early Study Closure|4|||
155023804|NCT00570063|559513414|FG000|Overall Study|Adverse Event|4|||
155023805|NCT00570063|559513415|FG001|Overall Study|Adverse Event|1|||
155180517|NCT01721577|560099692|FG000|Overall Study|Adverse Event|0|||
155180518|NCT01721577|560099693|FG001|Overall Study|Adverse Event|2|||
155180519|NCT01673282|560099694|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
155180520|NCT01673282|560099695|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
155180521|NCT01673282|560099694|FG000|Overall Study|Lack of Efficacy|9|||
155180522|NCT01673282|560099695|FG001|Overall Study|Lack of Efficacy|2|||
155180523|NCT01673282|560099694|FG000|Overall Study|Lost to Follow-up|11|||
155180524|NCT01673282|560099695|FG001|Overall Study|Lost to Follow-up|10|||
155180525|NCT01673282|560099694|FG000|Overall Study|Withdrawal by Subject|3|||
155180526|NCT01673282|560099695|FG001|Overall Study|Withdrawal by Subject|3|||
155180527|NCT01673282|560099694|FG000|Overall Study|Other|1|||
155180528|NCT01673282|560099695|FG001|Overall Study|Other|6|||
155180529|NCT04391569|560099698|FG000|Overall Study|Death|15|||
155180530|NCT04391569|560099699|FG001|Overall Study|Death|10|||
155180531|NCT04391569|560099698|FG000|Overall Study|Withdrawal by Subject|1|||
155180532|NCT04391569|560099699|FG001|Overall Study|Withdrawal by Subject|0|||
155180533|NCT04391569|560099698|FG000|Overall Study|Lost to Follow-up|3|||
155180534|NCT04391569|560099699|FG001|Overall Study|Lost to Follow-up|2|||
155180535|NCT04391569|560099698|FG000|Overall Study|Lack of Efficacy|0|||
155180536|NCT04391569|560099699|FG001|Overall Study|Lack of Efficacy|1|||
155023806|NCT00570063|559513414|FG000|Overall Study|Lack of Efficacy|0|||
155023807|NCT00570063|559513415|FG001|Overall Study|Lack of Efficacy|1|||
155023808|NCT00570063|559513414|FG000|Overall Study|Withdrawal by Subject|4|||
155023809|NCT00570063|559513415|FG001|Overall Study|Withdrawal by Subject|3|||
155023810|NCT00570063|559513414|FG000|Overall Study|Sponsor's Decision|7|||
155023811|NCT00570063|559513415|FG001|Overall Study|Sponsor's Decision|3|||
155023812|NCT00697463|559513416|FG000|Overall Study|Withdrawal by Subject|1|||
155023813|NCT03307252|559513417|FG000|Part 2, Period 1|Treatment not received|0|||
155023814|NCT03307252|559513418|FG001|Part 2, Period 1|Treatment not received|0|||
155023815|NCT03307252|559513419|FG002|Part 2, Period 1|Treatment not received|0|||
155023816|NCT03307252|559513420|FG003|Part 2, Period 1|Treatment not received|0|||
155023817|NCT03307252|559513421|FG004|Part 2, Period 1|Treatment not received|0|||
155023818|NCT03307252|559513422|FG005|Part 2, Period 1|Treatment not received|1|||
155023819|NCT03307252|559513423|FG006|Part 2, Period 1|Treatment not received|0|||
155023820|NCT03307252|559513424|FG007|Part 2, Period 1|Treatment not received|0|||
155023821|NCT03307252|559513425|FG008|Part 2, Period 1|Treatment not received|0|||
155180537|NCT04391569|560099698|FG000|Overall Study|Participant discharged to hospice facility|0|||
155180538|NCT04391569|560099699|FG001|Overall Study|Participant discharged to hospice facility|1|||
155180539|NCT04391569|560099698|FG000|Overall Study|Participant family decision|1|||
155023822|NCT03307252|559513426|FG009|Part 2, Period 1|Treatment not received|0|||
155023823|NCT03307252|559513427|FG010|Part 2, Period 1|Treatment not received|0|||
155023824|NCT03307252|559513417|FG000|Part 2, Period 3|Other than listed|0|||
155023825|NCT03307252|559513418|FG001|Part 2, Period 3|Other than listed|0|||
155023826|NCT03307252|559513419|FG002|Part 2, Period 3|Other than listed|0|||
155023827|NCT03307252|559513420|FG003|Part 2, Period 3|Other than listed|0|||
155023828|NCT03307252|559513421|FG004|Part 2, Period 3|Other than listed|1|||
155023829|NCT03307252|559513422|FG005|Part 2, Period 3|Other than listed|0|||
155023830|NCT03307252|559513423|FG006|Part 2, Period 3|Other than listed|0|||
155023831|NCT03307252|559513424|FG007|Part 2, Period 3|Other than listed|0|||
155023832|NCT03307252|559513425|FG008|Part 2, Period 3|Other than listed|0|||
155023833|NCT03307252|559513426|FG009|Part 2, Period 3|Other than listed|0|||
155023834|NCT03307252|559513427|FG010|Part 2, Period 3|Other than listed|0|||
155023835|NCT03307252|559513417|FG000|Part 2, Period 4|Other than listed|0|||
155023836|NCT03307252|559513418|FG001|Part 2, Period 4|Other than listed|0|||
155023837|NCT03307252|559513419|FG002|Part 2, Period 4|Other than listed|0|||
155023838|NCT03307252|559513420|FG003|Part 2, Period 4|Other than listed|0|||
155180540|NCT04391569|560099699|FG001|Overall Study|Participant family decision|0|||
155180541|NCT04391569|560099698|FG000|Overall Study|Participant discharged prematurely|1|||
155180542|NCT04391569|560099699|FG001|Overall Study|Participant discharged prematurely|0|||
155180543|NCT00732940|560099725|FG000|Overall Study|Withdrawal by Subject|1|||
155180544|NCT00732940|560099726|FG001|Overall Study|Withdrawal by Subject|2|||
155180545|NCT00732940|560099725|FG000|Overall Study|Adverse Event|0|||
155180546|NCT00732940|560099726|FG001|Overall Study|Adverse Event|1|||
155180547|NCT00732940|560099725|FG000|Overall Study|Lost to Follow-up|1|||
155180548|NCT00732940|560099726|FG001|Overall Study|Lost to Follow-up|0|||
155180549|NCT03562767|560099727|FG000|Overall Study|Physician Decision|2|||
155023839|NCT03307252|559513421|FG004|Part 2, Period 4|Other than listed|0|||
155023840|NCT03307252|559513422|FG005|Part 2, Period 4|Other than listed|0|||
155023841|NCT03307252|559513423|FG006|Part 2, Period 4|Other than listed|1|||
155023842|NCT03307252|559513424|FG007|Part 2, Period 4|Other than listed|0|||
155023843|NCT03307252|559513425|FG008|Part 2, Period 4|Other than listed|0|||
155023844|NCT03307252|559513426|FG009|Part 2, Period 4|Other than listed|0|||
155180550|NCT03562767|560099728|FG001|Overall Study|Physician Decision|0|||
155180551|NCT03562767|560099729|FG002|Overall Study|Physician Decision|0|||
155180552|NCT03562767|560099727|FG000|Overall Study|Logistic Reason|1|||
155180553|NCT03562767|560099728|FG001|Overall Study|Logistic Reason|3|||
155180554|NCT03562767|560099729|FG002|Overall Study|Logistic Reason|0|||
155180555|NCT01589770|560099730|FG000|Overall Study|EGFR <60ml/min|6|||
155180556|NCT01589770|560099731|FG001|Overall Study|EGFR <60ml/min|4|||
155180557|NCT01589770|560099730|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
155180558|NCT01589770|560099731|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
155180559|NCT00938886|560099734|FG000|Overall Study|Death|0|||
155180560|NCT00938886|560099735|FG001|Overall Study|Death|1|||
155180561|NCT00938886|560099734|FG000|Overall Study|Withdrawal by Subject|4|||
155180562|NCT00938886|560099735|FG001|Overall Study|Withdrawal by Subject|7|||
155180563|NCT00938886|560099734|FG000|Overall Study|Lost to Follow-up|3|||
155180564|NCT00938886|560099735|FG001|Overall Study|Lost to Follow-up|2|||
155023845|NCT03307252|559513427|FG010|Part 2, Period 4|Other than listed|0|||
155023846|NCT03307252|559513417|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023847|NCT03307252|559513418|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023848|NCT03307252|559513419|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023849|NCT03307252|559513420|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023850|NCT03307252|559513421|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155180565|NCT01120067|560099736|FG000|Overall Study|Lost to Follow-up|3|||
155180566|NCT01120067|560099737|FG001|Overall Study|Lost to Follow-up|1|||
155180567|NCT01120067|560099736|FG000|Overall Study|fail to engage >3 sessions|2|||
155180568|NCT01120067|560099737|FG001|Overall Study|fail to engage >3 sessions|0|||
155180569|NCT03761797|560099738|FG000|Overall Study|Changing hospital|11|||
155180570|NCT03761797|560099738|FG000|Overall Study|Improvement/remission|6|||
155180571|NCT03761797|560099738|FG000|Overall Study|Withdrawal by Subject|19|||
155180572|NCT03761797|560099738|FG000|Overall Study|Lost to Follow-up|33|||
155180573|NCT03761797|560099738|FG000|Overall Study|Adverse Event|37|||
155180574|NCT03761797|560099738|FG000|Overall Study|Case report form (CRF) not collected|5|||
155180575|NCT03761797|560099738|FG000|Overall Study|No patient visit after entry|13|||
155180576|NCT03761797|560099738|FG000|Overall Study|Switch to other diabetes medication|10|||
155180577|NCT03761797|560099738|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
155023851|NCT03307252|559513422|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023852|NCT03307252|559513423|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023853|NCT03307252|559513424|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023854|NCT03307252|559513425|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023855|NCT03307252|559513426|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
155023856|NCT03307252|559513427|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
155180578|NCT03761797|560099738|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
155180579|NCT03761797|560099738|FG000|Overall Study|Insufficient effectives|2|||
155180580|NCT03761797|560099738|FG000|Overall Study|Excessive alcohol intake|1|||
155180581|NCT01150474|560099739|FG000|Overall Study|Withdrawal by Subject|5|||
155180582|NCT01150474|560099740|FG001|Overall Study|Withdrawal by Subject|2|||
155180583|NCT01150474|560099739|FG000|Overall Study|Cancer found|1|||
155180584|NCT01150474|560099740|FG001|Overall Study|Cancer found|0|||
155180585|NCT01150474|560099739|FG000|Overall Study|Multiple Studies|0|||
155023857|NCT01554527|559513428|FG000|Overall Study|Withdrawal by Subject|1|||
155023858|NCT01554527|559513429|FG001|Overall Study|Withdrawal by Subject|0|||
155023859|NCT01554527|559513430|FG002|Overall Study|Withdrawal by Subject|3|||
155023860|NCT01554527|559513428|FG000|Overall Study|Lost to Follow-up|0|||
155023861|NCT01554527|559513429|FG001|Overall Study|Lost to Follow-up|0|||
155023862|NCT01554527|559513430|FG002|Overall Study|Lost to Follow-up|4|||
155023863|NCT01554527|559513428|FG000|Overall Study|Physician Decision|0|||
155023864|NCT01554527|559513429|FG001|Overall Study|Physician Decision|0|||
155023865|NCT01554527|559513430|FG002|Overall Study|Physician Decision|1|||
155023866|NCT02157376|559513431|FG000|Overall Study|Death|10|||
155023867|NCT02157376|559513432|FG001|Overall Study|Death|4|||
155023868|NCT02157376|559513431|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155023869|NCT02157376|559513432|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155023870|NCT02157376|559513431|FG000|Overall Study|Withdrawal by Subject|3|||
155023871|NCT02157376|559513432|FG001|Overall Study|Withdrawal by Subject|8|||
155023872|NCT02157376|559513431|FG000|Overall Study|Not treated|8|||
155023873|NCT02157376|559513432|FG001|Overall Study|Not treated|3|||
155023874|NCT02157376|559513431|FG000|Overall Study|Investigator's misjudgement|1|||
155023875|NCT02157376|559513432|FG001|Overall Study|Investigator's misjudgement|2|||
155023876|NCT04200651|559513435|FG000|Overall Study|Moved to another country during follow-up|2|||
155023877|NCT04200651|559513436|FG001|Overall Study|Moved to another country during follow-up|2|||
155023878|NCT04200651|559513435|FG000|Overall Study|Lost to Follow-up|1|||
155023879|NCT04200651|559513436|FG001|Overall Study|Lost to Follow-up|3|||
155023880|NCT02547220|559513437|FG000|Overall Study|Withdrawal by Subject|1|||
155023881|NCT02547220|559513438|FG001|Overall Study|Withdrawal by Subject|0|||
155023882|NCT02547220|559513437|FG000|Overall Study|Study terminated by sponsor|18|||
155023883|NCT02547220|559513438|FG001|Overall Study|Study terminated by sponsor|20|||
155023884|NCT04250350|559514582|FG000|Overall Study|Withdrawal by Subject|13|||
155023885|NCT04250350|559514582|FG000|Overall Study|Lost to Follow-up|8|||
155023886|NCT04250350|559514582|FG000|Overall Study|Adverse Event|5|||
155023887|NCT04250350|559514582|FG000|Overall Study|Lack of Efficacy|4|||
155023888|NCT04250350|559514582|FG000|Overall Study|Physician Decision|1|||
155023889|NCT04250350|559514582|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
155023890|NCT00378508|559514587|FG000|Overall Study|Withdrawal by Subject|1|||
155023891|NCT00378508|559514588|FG001|Overall Study|Withdrawal by Subject|3|||
155023892|NCT00378508|559514587|FG000|Overall Study|Lost to Follow-up|1|||
155023893|NCT00378508|559514588|FG001|Overall Study|Lost to Follow-up|0|||
155023894|NCT00956592|559514591|FG000|Overall Study|Protocol Violation|1|||
155023895|NCT00956592|559514592|FG001|Overall Study|Protocol Violation|3|||
155023896|NCT02162719|559514593|FG000|Overall Study|Death|41|||
155023897|NCT02162719|559514594|FG001|Overall Study|Death|46|||
155023898|NCT02162719|559514593|FG000|Overall Study|Lost to Follow-up|1|||
155023899|NCT02162719|559514594|FG001|Overall Study|Lost to Follow-up|3|||
155023900|NCT02162719|559514593|FG000|Overall Study|Disease Progression|2|||
155023901|NCT02162719|559514594|FG001|Overall Study|Disease Progression|1|||
155023902|NCT02162719|559514593|FG000|Overall Study|Withdrawal by Subject|8|||
155023903|NCT02162719|559514594|FG001|Overall Study|Withdrawal by Subject|2|||
155023904|NCT02162719|559514593|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
155023905|NCT02162719|559514594|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
155023906|NCT03214380|559514595|FG000|Lead-in|Adverse Event|3|||
155023907|NCT03214380|559514596|FG001|Lead-in|Adverse Event|0|||
155023908|NCT03214380|559514597|FG002|Lead-in|Adverse Event|0|||
155023909|NCT03214380|559514598|FG003|Lead-in|Adverse Event|1|||
155023910|NCT03214380|559514599|FG004|Lead-in|Adverse Event|0|||
155023911|NCT03214380|559514600|FG005|Lead-in|Adverse Event|0|||
155023912|NCT03214380|559514595|FG000|Lead-in|Lost to Follow-up|4|||
155023913|NCT03214380|559514596|FG001|Lead-in|Lost to Follow-up|0|||
155023914|NCT03214380|559514597|FG002|Lead-in|Lost to Follow-up|0|||
155023915|NCT03214380|559514598|FG003|Lead-in|Lost to Follow-up|1|||
155023916|NCT03214380|559514599|FG004|Lead-in|Lost to Follow-up|0|||
155023917|NCT03214380|559514600|FG005|Lead-in|Lost to Follow-up|0|||
155023918|NCT03214380|559514595|FG000|Lead-in|Eligibility Criteria|3|||
155023919|NCT03214380|559514596|FG001|Lead-in|Eligibility Criteria|0|||
155023920|NCT03214380|559514597|FG002|Lead-in|Eligibility Criteria|0|||
155023921|NCT03214380|559514598|FG003|Lead-in|Eligibility Criteria|0|||
155023922|NCT03214380|559514599|FG004|Lead-in|Eligibility Criteria|0|||
155023923|NCT03214380|559514600|FG005|Lead-in|Eligibility Criteria|0|||
155023924|NCT03214380|559514595|FG000|Lead-in|Physician Decision|6|||
155023925|NCT03214380|559514596|FG001|Lead-in|Physician Decision|0|||
155180586|NCT01150474|560099740|FG001|Overall Study|Multiple Studies|1|||
155180587|NCT01150474|560099739|FG000|Overall Study|Rectotomy|1|||
155180588|NCT01150474|560099740|FG001|Overall Study|Rectotomy|0|||
155180589|NCT01150474|560099739|FG000|Overall Study|Drug did not arrive in time|1|||
155023926|NCT03214380|559514597|FG002|Lead-in|Physician Decision|0|||
155023927|NCT03214380|559514598|FG003|Lead-in|Physician Decision|0|||
155180590|NCT01150474|560099740|FG001|Overall Study|Drug did not arrive in time|0|||
155023928|NCT03214380|559514599|FG004|Lead-in|Physician Decision|0|||
155023929|NCT03214380|559514600|FG005|Lead-in|Physician Decision|0|||
155023930|NCT03214380|559514595|FG000|Lead-in|Protocol Deviation|7|||
155180591|NCT01150474|560099739|FG000|Overall Study|Drug not administered|1|||
155180592|NCT01150474|560099740|FG001|Overall Study|Drug not administered|0|||
155180593|NCT01150474|560099739|FG000|Overall Study|Surgery Changed|1|||
155180594|NCT01150474|560099740|FG001|Overall Study|Surgery Changed|0|||
155180595|NCT01470989|560099741|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
155180596|NCT01470989|560099742|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
155023931|NCT03214380|559514596|FG001|Lead-in|Protocol Deviation|0|||
155023932|NCT03214380|559514597|FG002|Lead-in|Protocol Deviation|0|||
155180597|NCT01470989|560099741|FG000|Overall Study|Adverse Event|2|||
155180598|NCT01470989|560099742|FG001|Overall Study|Adverse Event|5|||
155180599|NCT01470989|560099741|FG000|Overall Study|Abnormal laboratory value|1|||
155180600|NCT01470989|560099742|FG001|Overall Study|Abnormal laboratory value|1|||
155023933|NCT03214380|559514598|FG003|Lead-in|Protocol Deviation|3|||
155023934|NCT03214380|559514599|FG004|Lead-in|Protocol Deviation|0|||
155023935|NCT03214380|559514600|FG005|Lead-in|Protocol Deviation|0|||
155023936|NCT03214380|559514595|FG000|Lead-in|Withdrawal by Subject|41|||
155023937|NCT03214380|559514596|FG001|Lead-in|Withdrawal by Subject|0|||
155023938|NCT03214380|559514597|FG002|Lead-in|Withdrawal by Subject|0|||
155023939|NCT03214380|559514598|FG003|Lead-in|Withdrawal by Subject|14|||
155023940|NCT03214380|559514599|FG004|Lead-in|Withdrawal by Subject|0|||
155023941|NCT03214380|559514600|FG005|Lead-in|Withdrawal by Subject|0|||
155023942|NCT03214380|559514595|FG000|Lead-in|Family Emergency|1|||
155023943|NCT03214380|559514596|FG001|Lead-in|Family Emergency|0|||
155023944|NCT03214380|559514597|FG002|Lead-in|Family Emergency|0|||
155023945|NCT03214380|559514598|FG003|Lead-in|Family Emergency|0|||
155023946|NCT03214380|559514599|FG004|Lead-in|Family Emergency|0|||
155023947|NCT03214380|559514600|FG005|Lead-in|Family Emergency|0|||
155023948|NCT03214380|559514595|FG000|Lead-in|Natural Disaster|9|||
155023949|NCT03214380|559514596|FG001|Lead-in|Natural Disaster|0|||
155023950|NCT03214380|559514597|FG002|Lead-in|Natural Disaster|0|||
155023951|NCT03214380|559514598|FG003|Lead-in|Natural Disaster|0|||
155023952|NCT03214380|559514599|FG004|Lead-in|Natural Disaster|0|||
155023953|NCT03214380|559514600|FG005|Lead-in|Natural Disaster|0|||
155023954|NCT03214380|559514595|FG000|Lead-in|Non Compliance|1|||
155023955|NCT03214380|559514596|FG001|Lead-in|Non Compliance|0|||
155023956|NCT03214380|559514597|FG002|Lead-in|Non Compliance|0|||
155023957|NCT03214380|559514598|FG003|Lead-in|Non Compliance|0|||
155023958|NCT03214380|559514599|FG004|Lead-in|Non Compliance|0|||
155023959|NCT03214380|559514600|FG005|Lead-in|Non Compliance|0|||
155023960|NCT03214380|559514595|FG000|Lead-in|Participant Schedule|2|||
155023961|NCT03214380|559514596|FG001|Lead-in|Participant Schedule|0|||
155023962|NCT03214380|559514597|FG002|Lead-in|Participant Schedule|0|||
155023963|NCT03214380|559514598|FG003|Lead-in|Participant Schedule|0|||
155180601|NCT01470989|560099741|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155180602|NCT01470989|560099742|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
155180603|NCT01470989|560099741|FG000|Overall Study|Withdrawal by Subject|19|||
155180604|NCT01470989|560099742|FG001|Overall Study|Withdrawal by Subject|17|||
155023964|NCT03214380|559514599|FG004|Lead-in|Participant Schedule|0|||
155023965|NCT03214380|559514600|FG005|Lead-in|Participant Schedule|0|||
155023966|NCT03214380|559514595|FG000|Treatment Period|Adverse Event|0|||
155023967|NCT03214380|559514596|FG001|Treatment Period|Adverse Event|1|||
155023968|NCT03214380|559514597|FG002|Treatment Period|Adverse Event|1|||
155023969|NCT03214380|559514598|FG003|Treatment Period|Adverse Event|0|||
155023970|NCT03214380|559514599|FG004|Treatment Period|Adverse Event|1|||
155023971|NCT03214380|559514600|FG005|Treatment Period|Adverse Event|0|||
155023972|NCT03214380|559514595|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
155023973|NCT03214380|559514596|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
155180605|NCT01470989|560099741|FG000|Overall Study|Lost to Follow-up|18|||
155180606|NCT01470989|560099742|FG001|Overall Study|Lost to Follow-up|13|||
155023974|NCT03214380|559514597|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
155023975|NCT03214380|559514598|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
155023976|NCT03214380|559514599|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
155023977|NCT03214380|559514600|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
155023978|NCT03214380|559514595|FG000|Treatment Period|Withdrawal by Subject|0|||
155023979|NCT03214380|559514596|FG001|Treatment Period|Withdrawal by Subject|10|||
155023980|NCT03214380|559514597|FG002|Treatment Period|Withdrawal by Subject|8|||
155023981|NCT03214380|559514598|FG003|Treatment Period|Withdrawal by Subject|0|||
155023982|NCT03214380|559514599|FG004|Treatment Period|Withdrawal by Subject|7|||
155023983|NCT03214380|559514600|FG005|Treatment Period|Withdrawal by Subject|11|||
155023984|NCT03214380|559514595|FG000|Treatment Period|Death|0|||
155180607|NCT01470989|560099741|FG000|Overall Study|Administrative problems|2|||
155023985|NCT03214380|559514596|FG001|Treatment Period|Death|1|||
155023986|NCT03214380|559514597|FG002|Treatment Period|Death|2|||
155023987|NCT03214380|559514598|FG003|Treatment Period|Death|0|||
155023988|NCT03214380|559514599|FG004|Treatment Period|Death|0|||
155023989|NCT03214380|559514600|FG005|Treatment Period|Death|0|||
155180608|NCT01470989|560099742|FG001|Overall Study|Administrative problems|4|||
155180609|NCT01470989|560099741|FG000|Overall Study|Death|2|||
155023990|NCT03214380|559514595|FG000|Treatment Period|Lost to Follow-up|0|||
155023991|NCT03214380|559514596|FG001|Treatment Period|Lost to Follow-up|6|||
155023992|NCT03214380|559514597|FG002|Treatment Period|Lost to Follow-up|3|||
155023993|NCT03214380|559514598|FG003|Treatment Period|Lost to Follow-up|0|||
155023994|NCT03214380|559514599|FG004|Treatment Period|Lost to Follow-up|0|||
155023995|NCT03214380|559514600|FG005|Treatment Period|Lost to Follow-up|0|||
155023996|NCT03214380|559514595|FG000|Treatment Period|Participant schedule|0|||
155023997|NCT03214380|559514596|FG001|Treatment Period|Participant schedule|0|||
155023998|NCT03214380|559514597|FG002|Treatment Period|Participant schedule|1|||
155023999|NCT03214380|559514598|FG003|Treatment Period|Participant schedule|0|||
155024000|NCT03214380|559514599|FG004|Treatment Period|Participant schedule|0|||
155024001|NCT03214380|559514600|FG005|Treatment Period|Participant schedule|0|||
155024002|NCT03214380|559514595|FG000|Treatment Period|Treatment Interruption|0|||
155024003|NCT03214380|559514596|FG001|Treatment Period|Treatment Interruption|0|||
155024004|NCT03214380|559514597|FG002|Treatment Period|Treatment Interruption|1|||
155024005|NCT03214380|559514598|FG003|Treatment Period|Treatment Interruption|0|||
155180610|NCT01470989|560099742|FG001|Overall Study|Death|2|||
155180611|NCT01470989|560099741|FG000|Overall Study|Protocol deviation|1|||
155180612|NCT01470989|560099742|FG001|Overall Study|Protocol deviation|2|||
155180613|NCT02119676|560099743|FG000|Overall Study|Adverse Event|9|||
155180614|NCT02119676|560099744|FG001|Overall Study|Adverse Event|17|||
155180615|NCT02119676|560099745|FG002|Overall Study|Adverse Event|10|||
155024006|NCT03214380|559514599|FG004|Treatment Period|Treatment Interruption|0|||
155024007|NCT03214380|559514600|FG005|Treatment Period|Treatment Interruption|0|||
155024008|NCT01905553|559514604|FG000|Period 2|Adverse Event|1|||
155024009|NCT01905553|559514605|FG001|Period 2|Adverse Event|0|||
155024010|NCT03692325|559514609|FG000|Overall Study|Adverse Event|2|||
155024011|NCT03692325|559514609|FG000|Overall Study|Progression/Recurrence|2|||
155024012|NCT02817516|559514610|FG000|Overall Study|Other|0|||
155024013|NCT02817516|559514611|FG001|Overall Study|Other|0|||
155024014|NCT02817516|559514612|FG002|Overall Study|Other|1|||
155024015|NCT02817516|559514613|FG003|Overall Study|Other|0|||
155024016|NCT01920958|559514615|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
155024017|NCT00610155|559514616|FG000|Period 1|Withdrawal by Subject|0|||
155024018|NCT00610155|559514617|FG001|Period 1|Withdrawal by Subject|0|||
155024019|NCT00610155|559514618|FG002|Period 1|Withdrawal by Subject|1|||
155024020|NCT00610155|559514619|FG003|Period 1|Withdrawal by Subject|0|||
155024021|NCT00610155|559514620|FG004|Period 1|Withdrawal by Subject|0|||
155024022|NCT00610155|559514621|FG005|Period 1|Withdrawal by Subject|0|||
155024023|NCT00610155|559514616|FG000|Period 3|Adverse Event|1|||
155024024|NCT00610155|559514617|FG001|Period 3|Adverse Event|0|||
155024025|NCT00610155|559514618|FG002|Period 3|Adverse Event|0|||
155024026|NCT00610155|559514619|FG003|Period 3|Adverse Event|0|||
155024027|NCT00610155|559514620|FG004|Period 3|Adverse Event|0|||
155024028|NCT00610155|559514621|FG005|Period 3|Adverse Event|0|||
155024029|NCT03192306|559514626|FG000|Overall Study|Did not treat cold sore during study|149|||
155024030|NCT03192306|559514627|FG001|Overall Study|Did not treat cold sore during study|143|||
155024031|NCT03192306|559514626|FG000|Overall Study|Withdrawal by Subject|1|||
155024032|NCT03192306|559514627|FG001|Overall Study|Withdrawal by Subject|1|||
155024033|NCT03192306|559514626|FG000|Overall Study|Lost to Follow-up|1|||
155024034|NCT03192306|559514627|FG001|Overall Study|Lost to Follow-up|0|||
155024035|NCT03192306|559514626|FG000|Overall Study|Protocol Violation|1|||
155024036|NCT03192306|559514627|FG001|Overall Study|Protocol Violation|1|||
155024037|NCT00083759|559514635|FG000|Overall Study|Adverse Event|5|||
155024038|NCT00083759|559514636|FG001|Overall Study|Adverse Event|3|||
155024039|NCT00083759|559514635|FG000|Overall Study|Lost to Follow-up|1|||
155024040|NCT00083759|559514636|FG001|Overall Study|Lost to Follow-up|0|||
155024041|NCT00083759|559514635|FG000|Overall Study|Death|1|||
155024042|NCT00083759|559514636|FG001|Overall Study|Death|1|||
155024043|NCT00083759|559514635|FG000|Overall Study|Inadequate Therapeutic Response|32|||
155024044|NCT00083759|559514636|FG001|Overall Study|Inadequate Therapeutic Response|35|||
155024045|NCT00083759|559514635|FG000|Overall Study|Subject Withdrew Consent|2|||
155024046|NCT00083759|559514636|FG001|Overall Study|Subject Withdrew Consent|2|||
155024047|NCT00083759|559514635|FG000|Overall Study|Non-Compliance|1|||
155024048|NCT00083759|559514636|FG001|Overall Study|Non-Compliance|0|||
155024049|NCT00083759|559514635|FG000|Overall Study|Sponsor's Discretion|28|||
155180616|NCT02119676|560099746|FG003|Overall Study|Adverse Event|10|||
155180617|NCT02119676|560099743|FG000|Overall Study|Disease progression|53|||
155024050|NCT00083759|559514636|FG001|Overall Study|Sponsor's Discretion|29|||
155024051|NCT00083759|559514635|FG000|Overall Study|Other|14|||
155024052|NCT00083759|559514636|FG001|Overall Study|Other|13|||
155024053|NCT00280397|559514639|FG000|Overall Study|Adverse Event|1|||
155024054|NCT01028014|559514647|FG000|Overall Study|Lost to Follow-up|1|||
155024055|NCT01028014|559514648|FG001|Overall Study|Lost to Follow-up|2|||
155024056|NCT01028014|559514649|FG002|Overall Study|Lost to Follow-up|0|||
155024057|NCT01028014|559514650|FG003|Overall Study|Lost to Follow-up|1|||
155024058|NCT01028014|559514651|FG004|Overall Study|Lost to Follow-up|1|||
155024059|NCT01028014|559514652|FG005|Overall Study|Lost to Follow-up|2|||
155024060|NCT05338502|559514653|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
155024061|NCT05338502|559514654|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
155024062|NCT05338502|559514655|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
155024063|NCT05338502|559514653|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
155024064|NCT05338502|559514654|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
155024065|NCT05338502|559514655|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
155024066|NCT01940887|559514662|FG000|Year 1|Protocol Violation|0|||
155024067|NCT01940887|559514663|FG001|Year 1|Protocol Violation|1|||
155024068|NCT01940887|559514662|FG000|Year 1|Physician Decision|7|||
155024069|NCT01940887|559514663|FG001|Year 1|Physician Decision|3|||
155024070|NCT01940887|559514662|FG000|Year 1|Death|5|||
155024071|NCT01940887|559514663|FG001|Year 1|Death|3|||
155024072|NCT01940887|559514662|FG000|Year 1|Adverse Event|7|||
155024073|NCT01940887|559514663|FG001|Year 1|Adverse Event|6|||
155024074|NCT01940887|559514662|FG000|Year 1|Withdrawal by Subject|18|||
155024075|NCT01940887|559514663|FG001|Year 1|Withdrawal by Subject|9|||
155024076|NCT01940887|559514662|FG000|Year 1|Lost to Follow-up|2|||
155024077|NCT01940887|559514663|FG001|Year 1|Lost to Follow-up|1|||
155024078|NCT01940887|559514662|FG000|Year 2|Physician Decision|8|||
155024079|NCT01940887|559514663|FG001|Year 2|Physician Decision|1|||
155024080|NCT01940887|559514662|FG000|Year 2|Death|0|||
155024081|NCT01940887|559514663|FG001|Year 2|Death|2|||
155024082|NCT01940887|559514662|FG000|Year 2|Sponsor Decision, early termination|192|||
155024083|NCT01940887|559514663|FG001|Year 2|Sponsor Decision, early termination|203|||
155024084|NCT01940887|559514662|FG000|Year 2|Adverse Event|8|||
155024085|NCT01940887|559514663|FG001|Year 2|Adverse Event|2|||
155024086|NCT01940887|559514662|FG000|Year 2|Withdrawal by Subject|8|||
155024087|NCT01940887|559514663|FG001|Year 2|Withdrawal by Subject|8|||
155024088|NCT01940887|559514662|FG000|Year 2|Lost to Follow-up|1|||
155024089|NCT01940887|559514663|FG001|Year 2|Lost to Follow-up|6|||
155024090|NCT04590586|559514664|FG000|Overall Study|Death|7|||
155024091|NCT04590586|559514665|FG001|Overall Study|Death|1|||
155024092|NCT04590586|559514666|FG002|Overall Study|Death|37|||
155024093|NCT04590586|559514667|FG003|Overall Study|Death|34|||
155024094|NCT04590586|559514668|FG004|Overall Study|Death|19|||
155024095|NCT04590586|559514669|FG005|Overall Study|Death|3|||
155024096|NCT04590586|559514664|FG000|Overall Study|Lost to Follow-up|3|||
155024097|NCT04590586|559514665|FG001|Overall Study|Lost to Follow-up|0|||
155024098|NCT04590586|559514666|FG002|Overall Study|Lost to Follow-up|11|||
155024099|NCT04590586|559514667|FG003|Overall Study|Lost to Follow-up|11|||
155024100|NCT04590586|559514668|FG004|Overall Study|Lost to Follow-up|6|||
155024101|NCT04590586|559514669|FG005|Overall Study|Lost to Follow-up|0|||
155024102|NCT04590586|559514664|FG000|Overall Study|Withdrawal by Subject|0|||
155024103|NCT04590586|559514665|FG001|Overall Study|Withdrawal by Subject|0|||
155024104|NCT04590586|559514666|FG002|Overall Study|Withdrawal by Subject|6|||
155024105|NCT04590586|559514667|FG003|Overall Study|Withdrawal by Subject|0|||
155024106|NCT04590586|559514668|FG004|Overall Study|Withdrawal by Subject|3|||
155024107|NCT04590586|559514669|FG005|Overall Study|Withdrawal by Subject|0|||
155024108|NCT04590586|559514664|FG000|Overall Study|Other|3|||
155024109|NCT04590586|559514665|FG001|Overall Study|Other|0|||
155024110|NCT04590586|559514666|FG002|Overall Study|Other|1|||
155024111|NCT04590586|559514667|FG003|Overall Study|Other|1|||
155024112|NCT04590586|559514668|FG004|Overall Study|Other|2|||
155024113|NCT04590586|559514669|FG005|Overall Study|Other|1|||
155024114|NCT03063086|559514670|FG000|Overall Study|technical problems|1|||
155024115|NCT03063086|559514671|FG001|Overall Study|technical problems|0|||
155024116|NCT03063086|559514672|FG002|Overall Study|technical problems|0|||
155024117|NCT03063086|559514673|FG003|Overall Study|technical problems|0|||
155024118|NCT03063086|559514674|FG004|Overall Study|technical problems|0|||
155024119|NCT03063086|559514675|FG005|Overall Study|technical problems|0|||
155024120|NCT03063086|559514670|FG000|Overall Study|Adverse Event|1|||
155024121|NCT03063086|559514671|FG001|Overall Study|Adverse Event|1|||
155024122|NCT03063086|559514672|FG002|Overall Study|Adverse Event|1|||
155024123|NCT03063086|559514673|FG003|Overall Study|Adverse Event|1|||
155024124|NCT03063086|559514674|FG004|Overall Study|Adverse Event|0|||
155024125|NCT03063086|559514675|FG005|Overall Study|Adverse Event|0|||
155024126|NCT03063086|559514670|FG000|Overall Study|subject/guardian decision|1|||
155024127|NCT03063086|559514671|FG001|Overall Study|subject/guardian decision|0|||
155024128|NCT03063086|559514672|FG002|Overall Study|subject/guardian decision|0|||
155024129|NCT03063086|559514673|FG003|Overall Study|subject/guardian decision|0|||
155024130|NCT03063086|559514674|FG004|Overall Study|subject/guardian decision|0|||
155024131|NCT03063086|559514675|FG005|Overall Study|subject/guardian decision|0|||
155024132|NCT03063086|559514670|FG000|Overall Study|Non-compliance with study treatment|0|||
155024133|NCT03063086|559514671|FG001|Overall Study|Non-compliance with study treatment|0|||
155024134|NCT03063086|559514672|FG002|Overall Study|Non-compliance with study treatment|0|||
155024135|NCT03063086|559514673|FG003|Overall Study|Non-compliance with study treatment|1|||
155024136|NCT03063086|559514674|FG004|Overall Study|Non-compliance with study treatment|0|||
155024137|NCT03063086|559514675|FG005|Overall Study|Non-compliance with study treatment|1|||
155024138|NCT03063086|559514670|FG000|Overall Study|Physician Decision|0|||
155024139|NCT03063086|559514671|FG001|Overall Study|Physician Decision|0|||
155024140|NCT03063086|559514672|FG002|Overall Study|Physician Decision|0|||
155024141|NCT03063086|559514673|FG003|Overall Study|Physician Decision|1|||
155024142|NCT03063086|559514674|FG004|Overall Study|Physician Decision|0|||
155024143|NCT03063086|559514675|FG005|Overall Study|Physician Decision|0|||
155024144|NCT01893281|559514676|FG000|Overall Study|Adverse Event|1|||
155024145|NCT01893281|559514676|FG000|Overall Study|Protocol Violation|1|||
155024146|NCT01893281|559514676|FG000|Overall Study|Withdrawal by Subject|1|||
155024147|NCT05481125|559514677|FG000|Overall Study|Adverse Event|1|||
155024148|NCT05481125|559514678|FG001|Overall Study|Adverse Event|0|||
155180618|NCT02119676|560099744|FG001|Overall Study|Disease progression|55|||
155180619|NCT02119676|560099745|FG002|Overall Study|Disease progression|68|||
155180620|NCT02119676|560099746|FG003|Overall Study|Disease progression|73|||
155180621|NCT02119676|560099743|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
155180622|NCT02119676|560099744|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
155180623|NCT02119676|560099745|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
155180624|NCT02119676|560099746|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
155180625|NCT02119676|560099743|FG000|Overall Study|Physician Decision|4|||
155180626|NCT02119676|560099744|FG001|Overall Study|Physician Decision|2|||
155180627|NCT02119676|560099745|FG002|Overall Study|Physician Decision|3|||
155180628|NCT02119676|560099746|FG003|Overall Study|Physician Decision|2|||
155180629|NCT02119676|560099743|FG000|Overall Study|Death|9|||
155180630|NCT02119676|560099744|FG001|Overall Study|Death|3|||
155180631|NCT02119676|560099745|FG002|Overall Study|Death|2|||
155180632|NCT02119676|560099746|FG003|Overall Study|Death|1|||
155180633|NCT02119676|560099743|FG000|Overall Study|Noncompliance|0|||
155180634|NCT02119676|560099744|FG001|Overall Study|Noncompliance|1|||
155180635|NCT02119676|560099745|FG002|Overall Study|Noncompliance|0|||
155180636|NCT02119676|560099746|FG003|Overall Study|Noncompliance|0|||
155180637|NCT02119676|560099743|FG000|Overall Study|Lost to Follow-up|0|||
155180638|NCT02119676|560099744|FG001|Overall Study|Lost to Follow-up|0|||
155180639|NCT02119676|560099745|FG002|Overall Study|Lost to Follow-up|1|||
155180640|NCT02119676|560099746|FG003|Overall Study|Lost to Follow-up|0|||
155180641|NCT02119676|560099743|FG000|Overall Study|Protocol deviation|0|||
155180642|NCT02119676|560099744|FG001|Overall Study|Protocol deviation|0|||
155180643|NCT02119676|560099745|FG002|Overall Study|Protocol deviation|1|||
155180644|NCT02119676|560099746|FG003|Overall Study|Protocol deviation|0|||
155180645|NCT02119676|560099743|FG000|Overall Study|Other, unspecified|2|||
155180646|NCT02119676|560099744|FG001|Overall Study|Other, unspecified|1|||
155180647|NCT02119676|560099745|FG002|Overall Study|Other, unspecified|3|||
155180648|NCT02119676|560099746|FG003|Overall Study|Other, unspecified|4|||
155180649|NCT02119676|560099743|FG000|Overall Study|Did not receive study med|2|||
155180650|NCT02119676|560099744|FG001|Overall Study|Did not receive study med|2|||
155180651|NCT02119676|560099745|FG002|Overall Study|Did not receive study med|4|||
155180652|NCT02119676|560099746|FG003|Overall Study|Did not receive study med|5|||
155180653|NCT00219544|560099747|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
155180654|NCT00219544|560099748|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
155180655|NCT00219544|560099747|FG000|Single Blind Treatment Period|Adverse Event|9|||
155180656|NCT00219544|560099748|FG001|Single Blind Treatment Period|Adverse Event|0|||
155180657|NCT00219544|560099747|FG000|Single Blind Treatment Period|Protocol Violation|4|||
155180658|NCT00219544|560099748|FG001|Single Blind Treatment Period|Protocol Violation|0|||
155180659|NCT00219544|560099747|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
155180660|NCT00219544|560099748|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
155180661|NCT00219544|560099747|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
155180662|NCT00219544|560099748|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
155180663|NCT00219544|560099747|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
155180664|NCT00219544|560099748|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
155180665|NCT00811642|560099749|FG000|Overall Study|Adverse Event|3|||
155180666|NCT00811642|560099749|FG000|Overall Study|Protocol Violation|1|||
155180667|NCT00811642|560099749|FG000|Overall Study|Death|2|||
155180668|NCT00811642|560099749|FG000|Overall Study|Withdrawal by Subject|7|||
155180669|NCT00811642|560099749|FG000|Overall Study|Cumulative use of antifungal agent|2|||
155180670|NCT02186301|560100728|FG000|Overall Study|Progressive Disease|7|||
155180671|NCT02186301|560100729|FG001|Overall Study|Progressive Disease|22|||
155180672|NCT02186301|560100730|FG002|Overall Study|Progressive Disease|27|||
155180673|NCT02186301|560100728|FG000|Overall Study|Adverse Event|5|||
155180674|NCT02186301|560100729|FG001|Overall Study|Adverse Event|5|||
155180675|NCT02186301|560100730|FG002|Overall Study|Adverse Event|5|||
155180676|NCT02186301|560100728|FG000|Overall Study|Death|1|||
155180677|NCT02186301|560100729|FG001|Overall Study|Death|0|||
155180678|NCT02186301|560100730|FG002|Overall Study|Death|0|||
155024149|NCT05481125|559514677|FG000|Overall Study|Lost to Follow-up|0|||
155024150|NCT05481125|559514678|FG001|Overall Study|Lost to Follow-up|1|||
155180679|NCT02186301|560100728|FG000|Overall Study|Withdrawal by Subject|5|||
155180680|NCT02186301|560100729|FG001|Overall Study|Withdrawal by Subject|1|||
155180681|NCT02186301|560100730|FG002|Overall Study|Withdrawal by Subject|3|||
155180682|NCT02186301|560100728|FG000|Overall Study|Physician Decision|1|||
155180683|NCT02186301|560100729|FG001|Overall Study|Physician Decision|0|||
155180684|NCT02186301|560100730|FG002|Overall Study|Physician Decision|1|||
155180685|NCT02186301|560100728|FG000|Overall Study|Study Terminated by Sponsor|1|||
155180686|NCT02186301|560100729|FG001|Overall Study|Study Terminated by Sponsor|0|||
155024151|NCT05481125|559514677|FG000|Overall Study|Withdrawal by Subject|0|||
155180687|NCT02186301|560100730|FG002|Overall Study|Study Terminated by Sponsor|11|||
155180688|NCT02186301|560100728|FG000|Overall Study|Protocol Deviation|0|||
155180689|NCT02186301|560100729|FG001|Overall Study|Protocol Deviation|2|||
155024152|NCT05481125|559514678|FG001|Overall Study|Withdrawal by Subject|1|||
155024153|NCT02244463|559514681|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
155024154|NCT02244463|559514682|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155024155|NCT02244463|559514683|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155024156|NCT02244463|559514684|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155024157|NCT02244463|559514685|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155024158|NCT02244463|559514686|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
155024159|NCT02244463|559514681|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
155139908|NCT00423449|559942817|FG001|Overall Study|Protocol Violation|0|||
155139909|NCT00423449|559942818|FG002|Overall Study|Protocol Violation|2|||
155139910|NCT00423449|559942819|FG003|Overall Study|Protocol Violation|1|||
155139911|NCT00423449|559942820|FG004|Overall Study|Protocol Violation|0|||
155139912|NCT01574651|559942821|FG000|Overall Study|Lost to Follow-up|2|||
155139913|NCT01574651|559942822|FG001|Overall Study|Lost to Follow-up|4|||
155139914|NCT01574651|559942821|FG000|Overall Study|Administrative problems|0|||
155139915|NCT01574651|559942822|FG001|Overall Study|Administrative problems|1|||
155139916|NCT01574651|559942821|FG000|Overall Study|Death|3|||
155139917|NCT01574651|559942822|FG001|Overall Study|Death|3|||
155139918|NCT01574651|559942821|FG000|Overall Study|Patient's inability to use the device|0|||
155139919|NCT01574651|559942822|FG001|Overall Study|Patient's inability to use the device|1|||
155139920|NCT01574651|559942821|FG000|Overall Study|Adverse Event|36|||
155139921|NCT01574651|559942822|FG001|Overall Study|Adverse Event|27|||
155024160|NCT02244463|559514682|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
155024161|NCT02244463|559514683|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
155024162|NCT02244463|559514684|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
155024163|NCT02244463|559514685|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
155024164|NCT02244463|559514686|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
155024165|NCT02244463|559514681|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155024166|NCT02244463|559514682|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
155024167|NCT02244463|559514683|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155024168|NCT02244463|559514684|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155024169|NCT02244463|559514685|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155024170|NCT02244463|559514686|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
155024171|NCT02244463|559514681|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155139922|NCT01574651|559942821|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155139923|NCT01574651|559942822|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155139924|NCT01574651|559942821|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155139925|NCT01574651|559942822|FG001|Overall Study|Abnormal test procedure result(s)|1|||
155139926|NCT01574651|559942821|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155139927|NCT01574651|559942822|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155139928|NCT01574651|559942821|FG000|Overall Study|Protocol Violation|3|||
155139929|NCT01574651|559942822|FG001|Overall Study|Protocol Violation|5|||
155139930|NCT01574651|559942821|FG000|Overall Study|Withdrawal by Subject|9|||
155139931|NCT01574651|559942822|FG001|Overall Study|Withdrawal by Subject|10|||
155139932|NCT00445770|559942823|FG000|Overall Study|Adverse Event|9|||
155139933|NCT00445770|559942824|FG001|Overall Study|Adverse Event|15|||
155139934|NCT00445770|559942825|FG002|Overall Study|Adverse Event|19|||
155139935|NCT00445770|559942823|FG000|Overall Study|Lack of Efficacy|38|||
155139936|NCT00445770|559942824|FG001|Overall Study|Lack of Efficacy|13|||
155139937|NCT00445770|559942825|FG002|Overall Study|Lack of Efficacy|6|||
155139938|NCT00445770|559942823|FG000|Overall Study|Lost to Follow-up|0|||
155139939|NCT00445770|559942824|FG001|Overall Study|Lost to Follow-up|2|||
155139940|NCT00445770|559942825|FG002|Overall Study|Lost to Follow-up|0|||
155139941|NCT00445770|559942823|FG000|Overall Study|Other|6|||
155139942|NCT00445770|559942824|FG001|Overall Study|Other|5|||
155139943|NCT00445770|559942825|FG002|Overall Study|Other|6|||
155139944|NCT02487030|559942826|FG000|Overall Study|Lack of Efficacy|2|||
155139945|NCT02487030|559942827|FG001|Overall Study|Lack of Efficacy|4|||
155139946|NCT02487030|559942828|FG002|Overall Study|Lack of Efficacy|1|||
155139947|NCT02487030|559942829|FG003|Overall Study|Lack of Efficacy|0|||
155139948|NCT02487030|559942830|FG004|Overall Study|Lack of Efficacy|1|||
155180690|NCT02186301|560100730|FG002|Overall Study|Protocol Deviation|0|||
155180691|NCT02186301|560100728|FG000|Overall Study|Missing|0|||
155024172|NCT02244463|559514682|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155139949|NCT02487030|559942831|FG005|Overall Study|Lack of Efficacy|0|||
155139950|NCT02487030|559942832|FG006|Overall Study|Lack of Efficacy|0|||
155139951|NCT02487030|559942826|FG000|Overall Study|Lost to Follow-up|0|||
155139952|NCT02487030|559942827|FG001|Overall Study|Lost to Follow-up|0|||
155139953|NCT02487030|559942828|FG002|Overall Study|Lost to Follow-up|1|||
155139954|NCT02487030|559942829|FG003|Overall Study|Lost to Follow-up|1|||
155139955|NCT02487030|559942830|FG004|Overall Study|Lost to Follow-up|0|||
155139956|NCT02487030|559942831|FG005|Overall Study|Lost to Follow-up|1|||
155139957|NCT02487030|559942832|FG006|Overall Study|Lost to Follow-up|0|||
155024173|NCT02244463|559514683|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
155024174|NCT02244463|559514684|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155024175|NCT02244463|559514685|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155024176|NCT02244463|559514686|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
155024177|NCT02244463|559514681|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155024178|NCT02244463|559514682|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155024179|NCT02244463|559514683|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155024180|NCT02244463|559514684|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
155024181|NCT02244463|559514685|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155024182|NCT02244463|559514686|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
155024183|NCT02244463|559514681|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155024184|NCT02244463|559514682|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155024185|NCT02244463|559514683|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155024186|NCT02244463|559514684|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
155024187|NCT02244463|559514685|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155024188|NCT02244463|559514686|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
155024189|NCT02244463|559514681|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155024190|NCT02244463|559514682|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155024191|NCT02244463|559514683|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155024192|NCT02244463|559514684|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
155024193|NCT02244463|559514685|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155024194|NCT02244463|559514686|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
155024195|NCT02244463|559514681|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155024196|NCT02244463|559514682|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155024197|NCT02244463|559514683|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155024198|NCT02244463|559514684|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
155024199|NCT02244463|559514685|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155024200|NCT02244463|559514686|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
155024201|NCT02244463|559514681|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155024202|NCT02244463|559514682|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155024203|NCT02244463|559514683|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155024204|NCT02244463|559514684|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
155024205|NCT02244463|559514685|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155024206|NCT02244463|559514686|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
155024207|NCT02244463|559514681|FG000|Period 5: Phase II|Disease Progression|0|||
155024208|NCT02244463|559514682|FG001|Period 5: Phase II|Disease Progression|0|||
155024209|NCT02244463|559514683|FG002|Period 5: Phase II|Disease Progression|0|||
155024210|NCT02244463|559514684|FG003|Period 5: Phase II|Disease Progression|0|||
155024211|NCT02244463|559514685|FG004|Period 5: Phase II|Disease Progression|10|||
155024212|NCT02244463|559514686|FG005|Period 5: Phase II|Disease Progression|11|||
155024213|NCT02244463|559514681|FG000|Period 5: Phase II|Physician Decision|0|||
155024214|NCT02244463|559514682|FG001|Period 5: Phase II|Physician Decision|0|||
155024215|NCT02244463|559514683|FG002|Period 5: Phase II|Physician Decision|0|||
155024216|NCT02244463|559514684|FG003|Period 5: Phase II|Physician Decision|0|||
155024217|NCT02244463|559514685|FG004|Period 5: Phase II|Physician Decision|3|||
155024218|NCT02244463|559514686|FG005|Period 5: Phase II|Physician Decision|2|||
155024219|NCT02244463|559514681|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
155024220|NCT02244463|559514682|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
155024221|NCT02244463|559514683|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
155024222|NCT02244463|559514684|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
155024223|NCT02244463|559514685|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
155024224|NCT02244463|559514686|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
155024225|NCT02244463|559514681|FG000|Period 5: Phase II|Intercurrent Illness|0|||
155024226|NCT02244463|559514682|FG001|Period 5: Phase II|Intercurrent Illness|0|||
155024227|NCT02244463|559514683|FG002|Period 5: Phase II|Intercurrent Illness|0|||
155024228|NCT02244463|559514684|FG003|Period 5: Phase II|Intercurrent Illness|0|||
155024229|NCT02244463|559514685|FG004|Period 5: Phase II|Intercurrent Illness|2|||
155024230|NCT02244463|559514686|FG005|Period 5: Phase II|Intercurrent Illness|0|||
155024231|NCT02244463|559514681|FG000|Period 5: Phase II|Adverse Event|0|||
155024232|NCT02244463|559514682|FG001|Period 5: Phase II|Adverse Event|0|||
155024233|NCT02244463|559514683|FG002|Period 5: Phase II|Adverse Event|0|||
155024234|NCT02244463|559514684|FG003|Period 5: Phase II|Adverse Event|0|||
155024235|NCT02244463|559514685|FG004|Period 5: Phase II|Adverse Event|0|||
155024236|NCT02244463|559514686|FG005|Period 5: Phase II|Adverse Event|2|||
155024237|NCT02244463|559514681|FG000|Period 5: Phase II|Still On treatment|0|||
155024238|NCT02244463|559514682|FG001|Period 5: Phase II|Still On treatment|0|||
155024239|NCT02244463|559514683|FG002|Period 5: Phase II|Still On treatment|0|||
155024240|NCT02244463|559514684|FG003|Period 5: Phase II|Still On treatment|0|||
155024241|NCT02244463|559514685|FG004|Period 5: Phase II|Still On treatment|0|||
155024242|NCT02244463|559514686|FG005|Period 5: Phase II|Still On treatment|3|||
155024243|NCT03702010|559514689|FG000|Follow-up (30days)|Lack of Efficacy|2|||
155024244|NCT03702010|559514690|FG001|Follow-up (30days)|Lack of Efficacy|2|||
155024245|NCT03474731|559514697|FG000|Overall Study|Withdrawal by Subject|36|||
155024246|NCT03474731|559514698|FG001|Overall Study|Withdrawal by Subject|29|||
155024247|NCT03474731|559514699|FG002|Overall Study|Withdrawal by Subject|11|||
155024248|NCT03474731|559514700|FG003|Overall Study|Withdrawal by Subject|27|||
155024249|NCT03474731|559514697|FG000|Overall Study|COVID|0|||
155024250|NCT03474731|559514698|FG001|Overall Study|COVID|23|||
155024251|NCT03474731|559514699|FG002|Overall Study|COVID|0|||
155024252|NCT03474731|559514700|FG003|Overall Study|COVID|0|||
155024253|NCT03474731|559514697|FG000|Overall Study|Participant moved from area|1|||
155024254|NCT03474731|559514698|FG001|Overall Study|Participant moved from area|0|||
155024255|NCT03474731|559514699|FG002|Overall Study|Participant moved from area|0|||
155024256|NCT03474731|559514700|FG003|Overall Study|Participant moved from area|0|||
155024257|NCT03474731|559514697|FG000|Overall Study|Lost to Follow-up|11|||
155024258|NCT03474731|559514698|FG001|Overall Study|Lost to Follow-up|3|||
155024259|NCT03474731|559514699|FG002|Overall Study|Lost to Follow-up|18|||
155024260|NCT03474731|559514700|FG003|Overall Study|Lost to Follow-up|17|||
155024261|NCT03474731|559514697|FG000|Overall Study|Death|0|||
155024262|NCT03474731|559514698|FG001|Overall Study|Death|1|||
155024263|NCT03474731|559514699|FG002|Overall Study|Death|0|||
155024264|NCT03474731|559514700|FG003|Overall Study|Death|0|||
155024265|NCT03474731|559514697|FG000|Overall Study|Participant Removed|0|||
155024266|NCT03474731|559514698|FG001|Overall Study|Participant Removed|0|||
155024267|NCT03474731|559514699|FG002|Overall Study|Participant Removed|0|||
155024268|NCT03474731|559514700|FG003|Overall Study|Participant Removed|1|||
155024269|NCT00675428|559514702|FG000|Overall Study|Disease Progression|2|||
155024270|NCT00675428|559514703|FG001|Overall Study|Disease Progression|2|||
155024271|NCT00675428|559514702|FG000|Overall Study|No Disease Response After Cycle 6|0|||
155024272|NCT00675428|559514703|FG001|Overall Study|No Disease Response After Cycle 6|1|||
155024273|NCT00675428|559514702|FG000|Overall Study|Physician Decision|1|||
155024274|NCT00675428|559514703|FG001|Overall Study|Physician Decision|0|||
155024275|NCT04105218|559514705|FG000|Overall Study|Withdrawal by Subject|3|||
155024276|NCT04105218|559514706|FG001|Overall Study|Withdrawal by Subject|2|||
155024277|NCT04105218|559514705|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
155024278|NCT04105218|559514706|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
155024279|NCT04105218|559514705|FG000|Overall Study|Failed screening tests|2|||
155024280|NCT04105218|559514706|FG001|Overall Study|Failed screening tests|1|||
155024281|NCT00582608|559514709|FG000|Overall Study|Not Treated|7|||
155024282|NCT00582608|559514709|FG000|Overall Study|Patient Ineligible|1|||
155024283|NCT00582608|559514709|FG000|Overall Study|Lack of accrual|4|||
155024284|NCT00550043|559514713|FG000|Overall Study|Adverse Event|0|||
155024285|NCT00550043|559514714|FG001|Overall Study|Adverse Event|0|||
155024286|NCT00550043|559514715|FG002|Overall Study|Adverse Event|0|||
155024287|NCT00550043|559514716|FG003|Overall Study|Adverse Event|1|||
155024288|NCT00550043|559514717|FG004|Overall Study|Adverse Event|1|||
155024289|NCT00550043|559514713|FG000|Overall Study|Subject Withdrew Consent|0|||
155024290|NCT00550043|559514714|FG001|Overall Study|Subject Withdrew Consent|2|||
155024291|NCT00550043|559514715|FG002|Overall Study|Subject Withdrew Consent|1|||
155024292|NCT00550043|559514716|FG003|Overall Study|Subject Withdrew Consent|0|||
155024293|NCT00550043|559514717|FG004|Overall Study|Subject Withdrew Consent|0|||
155024294|NCT00550043|559514713|FG000|Overall Study|Other Reasons- Unspecified|0|||
155024295|NCT00550043|559514714|FG001|Overall Study|Other Reasons- Unspecified|1|||
155024296|NCT00550043|559514715|FG002|Overall Study|Other Reasons- Unspecified|0|||
155024297|NCT00550043|559514716|FG003|Overall Study|Other Reasons- Unspecified|1|||
155024298|NCT00550043|559514717|FG004|Overall Study|Other Reasons- Unspecified|0|||
155024299|NCT00789698|559514718|FG000|Overall Study|Lack of Efficacy|10|||
155024300|NCT00789698|559514719|FG001|Overall Study|Lack of Efficacy|4|||
155024301|NCT00789698|559514720|FG002|Overall Study|Lack of Efficacy|5|||
155024302|NCT00789698|559514721|FG003|Overall Study|Lack of Efficacy|18|||
155024303|NCT00789698|559514718|FG000|Overall Study|Adverse Event|5|||
155024304|NCT00789698|559514719|FG001|Overall Study|Adverse Event|5|||
155024305|NCT00789698|559514720|FG002|Overall Study|Adverse Event|3|||
155024306|NCT00789698|559514721|FG003|Overall Study|Adverse Event|4|||
155024307|NCT00789698|559514718|FG000|Overall Study|Lost to Follow-up|5|||
155024308|NCT00789698|559514719|FG001|Overall Study|Lost to Follow-up|5|||
155024309|NCT00789698|559514720|FG002|Overall Study|Lost to Follow-up|2|||
155024310|NCT00789698|559514721|FG003|Overall Study|Lost to Follow-up|9|||
155024311|NCT00789698|559514718|FG000|Overall Study|Protocol Violation|6|||
155024312|NCT00789698|559514719|FG001|Overall Study|Protocol Violation|1|||
155024313|NCT00789698|559514720|FG002|Overall Study|Protocol Violation|2|||
155024314|NCT00789698|559514721|FG003|Overall Study|Protocol Violation|1|||
155024315|NCT00789698|559514718|FG000|Overall Study|Withdrawal by Subject|14|||
155024316|NCT00789698|559514719|FG001|Overall Study|Withdrawal by Subject|15|||
155024317|NCT00789698|559514720|FG002|Overall Study|Withdrawal by Subject|12|||
155024318|NCT00789698|559514721|FG003|Overall Study|Withdrawal by Subject|19|||
155024319|NCT00789698|559514718|FG000|Overall Study|Administrative|0|||
155024320|NCT00789698|559514719|FG001|Overall Study|Administrative|3|||
155024321|NCT00789698|559514720|FG002|Overall Study|Administrative|3|||
155024322|NCT00789698|559514721|FG003|Overall Study|Administrative|1|||
155024323|NCT01870973|559514722|FG000|Overall Study|Lost to Follow-up|10|||
155024324|NCT01870973|559514723|FG001|Overall Study|Lost to Follow-up|3|||
155024325|NCT02981082|559514725|FG000|Overall Study|Withdrawal by Subject|2|||
155024326|NCT02981082|559514726|FG001|Overall Study|Withdrawal by Subject|0|||
155024327|NCT02981082|559514725|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
155024328|NCT02981082|559514726|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
155024329|NCT02981082|559514725|FG000|Overall Study|Adverse Event|0|||
155024330|NCT02981082|559514726|FG001|Overall Study|Adverse Event|1|||
155024331|NCT00596817|559514727|FG000|Open-label Period|Adverse Event|0|||
155024332|NCT00596817|559514728|FG001|Open-label Period|Adverse Event|49|||
155180692|NCT02186301|560100729|FG001|Overall Study|Missing|0|||
155180693|NCT02186301|560100730|FG002|Overall Study|Missing|2|||
155024333|NCT00596817|559514727|FG000|Open-label Period|Lack of Efficacy|0|||
155180694|NCT02186301|560100728|FG000|Overall Study|Other|0|||
155180695|NCT02186301|560100729|FG001|Overall Study|Other|0|||
155180696|NCT02186301|560100730|FG002|Overall Study|Other|1|||
155180697|NCT00997438|560100731|FG000|Overall Study|Blood draw difficulty|2|||
155180698|NCT00997438|560100732|FG001|Overall Study|Blood draw difficulty|0|||
155180699|NCT00997438|560100733|FG002|Overall Study|Blood draw difficulty|1|||
155180700|NCT00997438|560100731|FG000|Overall Study|Withdrawal by Subject|1|||
155180701|NCT00997438|560100732|FG001|Overall Study|Withdrawal by Subject|1|||
155180702|NCT00997438|560100733|FG002|Overall Study|Withdrawal by Subject|0|||
155180703|NCT00997438|560100731|FG000|Overall Study|Exclusion criteria at visit 1|2|||
155180704|NCT00997438|560100732|FG001|Overall Study|Exclusion criteria at visit 1|2|||
155180705|NCT00997438|560100733|FG002|Overall Study|Exclusion criteria at visit 1|3|||
155180706|NCT00095238|560100734|FG000|Overall Study|Lack of Efficacy|9|||
155180707|NCT00095238|560100735|FG001|Overall Study|Lack of Efficacy|9|||
155180708|NCT00095238|560100734|FG000|Overall Study|Adverse Event|331|||
155180709|NCT00095238|560100735|FG001|Overall Study|Adverse Event|287|||
155180710|NCT00095238|560100734|FG000|Overall Study|Subject Withdrew Consent|208|||
155180711|NCT00095238|560100735|FG001|Overall Study|Subject Withdrew Consent|223|||
155180712|NCT00095238|560100734|FG000|Overall Study|Death|154|||
155180713|NCT00095238|560100735|FG001|Overall Study|Death|170|||
155180714|NCT00095238|560100734|FG000|Overall Study|Lost to Follow-up|19|||
155180715|NCT00095238|560100735|FG001|Overall Study|Lost to Follow-up|24|||
155180716|NCT00095238|560100734|FG000|Overall Study|Noncompliance|44|||
155180717|NCT00095238|560100735|FG001|Overall Study|Noncompliance|45|||
155180718|NCT00095238|560100734|FG000|Overall Study|No longer met study criteria|4|||
155180719|NCT00095238|560100735|FG001|Overall Study|No longer met study criteria|5|||
155180720|NCT00095238|560100734|FG000|Overall Study|Study terminated by sponsor|0|||
155180721|NCT00095238|560100735|FG001|Overall Study|Study terminated by sponsor|1|||
155180722|NCT00095238|560100734|FG000|Overall Study|Missing|1|||
155180723|NCT00095238|560100735|FG001|Overall Study|Missing|0|||
155024334|NCT00596817|559514728|FG001|Open-label Period|Lack of Efficacy|33|||
155024335|NCT00596817|559514727|FG000|Open-label Period|Other Reasons|0|||
155024336|NCT00596817|559514728|FG001|Open-label Period|Other Reasons|65|||
155024337|NCT00596817|559514727|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
155024338|NCT00596817|559514728|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
155024339|NCT00596817|559514727|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
155024340|NCT00596817|559514728|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
155024341|NCT00596817|559514727|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
155024342|NCT00596817|559514728|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
155024343|NCT00596817|559514727|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
155024344|NCT00596817|559514728|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
155024345|NCT00596817|559514727|FG000|Double-blind Period|Adverse Event|5|||
155024346|NCT00596817|559514728|FG001|Double-blind Period|Adverse Event|16|||
155024347|NCT00596817|559514727|FG000|Double-blind Period|Lack of Efficacy|52|||
155024348|NCT00596817|559514728|FG001|Double-blind Period|Lack of Efficacy|28|||
155024349|NCT00596817|559514727|FG000|Double-blind Period|Non-compliance With Study Product|3|||
155024350|NCT00596817|559514728|FG001|Double-blind Period|Non-compliance With Study Product|4|||
155024351|NCT00596817|559514727|FG000|Double-blind Period|Protocol Violation|11|||
155024352|NCT00596817|559514728|FG001|Double-blind Period|Protocol Violation|8|||
155024353|NCT00596817|559514727|FG000|Double-blind Period|Withdrawal of Consent|7|||
155024354|NCT00596817|559514728|FG001|Double-blind Period|Withdrawal of Consent|3|||
155024355|NCT00596817|559514727|FG000|Double-blind Period|Lost to Follow-up|0|||
155180724|NCT00095238|560100734|FG000|Overall Study|Other Reasons|87|||
155024356|NCT00596817|559514728|FG001|Double-blind Period|Lost to Follow-up|2|||
155024357|NCT00596817|559514727|FG000|Double-blind Period|Other Reasons|10|||
155024358|NCT00596817|559514728|FG001|Double-blind Period|Other Reasons|18|||
155024359|NCT00199797|559517019|FG000|Overall Study|Progressive Disease|1|||
155024360|NCT00199797|559517019|FG000|Overall Study|Adverse Event|1|||
155024361|NCT00199797|559517019|FG000|Overall Study|Physician Decision|1|||
155180725|NCT00095238|560100735|FG001|Overall Study|Other Reasons|88|||
155180726|NCT02937571|560100736|FG000|Overall Study|Adverse Event|0|||
155180727|NCT02937571|560100737|FG001|Overall Study|Adverse Event|0|||
155180728|NCT02937571|560100738|FG002|Overall Study|Adverse Event|4|||
155024362|NCT00504725|559517020|FG000|Overall Study|Protocol Violation|1|||
155024363|NCT00504725|559517021|FG001|Overall Study|Protocol Violation|0|||
155024364|NCT01435018|559517022|FG000|Overall Study|Death|37|||
155024365|NCT01435018|559517023|FG001|Overall Study|Death|18|||
155024366|NCT01435018|559517024|FG002|Overall Study|Death|25|||
155024367|NCT01435018|559517022|FG000|Overall Study|Site is closing|4|||
155024368|NCT01435018|559517023|FG001|Overall Study|Site is closing|9|||
155024369|NCT01435018|559517024|FG002|Overall Study|Site is closing|7|||
155024370|NCT01435018|559517022|FG000|Overall Study|Withdrew consent|0|||
155024371|NCT01435018|559517023|FG001|Overall Study|Withdrew consent|3|||
155024372|NCT01435018|559517024|FG002|Overall Study|Withdrew consent|1|||
155024373|NCT01435018|559517022|FG000|Overall Study|Not willing to adhere to requirements|0|||
155024374|NCT01435018|559517023|FG001|Overall Study|Not willing to adhere to requirements|2|||
155024375|NCT01435018|559517024|FG002|Overall Study|Not willing to adhere to requirements|3|||
155024376|NCT01435018|559517022|FG000|Overall Study|Not able to get to clinic|2|||
155024377|NCT01435018|559517023|FG001|Overall Study|Not able to get to clinic|0|||
155024378|NCT01435018|559517024|FG002|Overall Study|Not able to get to clinic|2|||
155024379|NCT01435018|559517022|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155024380|NCT01435018|559517023|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155024381|NCT01435018|559517024|FG002|Overall Study|Severe debilitation, unable to continue|1|||
155024382|NCT01435018|559517022|FG000|Overall Study|Unable to contact participant/parent|1|||
155024383|NCT01435018|559517023|FG001|Overall Study|Unable to contact participant/parent|1|||
155024384|NCT01435018|559517024|FG002|Overall Study|Unable to contact participant/parent|1|||
155024385|NCT01435018|559517022|FG000|Overall Study|Enrollment Violation|0|||
155024386|NCT01435018|559517023|FG001|Overall Study|Enrollment Violation|1|||
155024387|NCT01435018|559517024|FG002|Overall Study|Enrollment Violation|0|||
155024388|NCT01435018|559517022|FG000|Overall Study|Never started chemotherapy|3|||
155024389|NCT01435018|559517023|FG001|Overall Study|Never started chemotherapy|0|||
155024390|NCT01435018|559517024|FG002|Overall Study|Never started chemotherapy|1|||
155024391|NCT03205761|559517025|FG000|Overall Study|Withdrawal by Subject|1|||
155024392|NCT03205761|559517025|FG000|Overall Study|Progressive Disease|10|||
155024393|NCT00636194|559517026|FG000|Overall Study|Study related symptoms and complaints|1|||
155024394|NCT00636194|559517027|FG001|Overall Study|Study related symptoms and complaints|0|||
155024395|NCT00636194|559517026|FG000|Overall Study|Protocol Violation|2|||
155024396|NCT00636194|559517027|FG001|Overall Study|Protocol Violation|0|||
155024397|NCT00972816|559517029|FG000|Overall Study|Adverse Event|0|||
155024398|NCT00972816|559517030|FG001|Overall Study|Adverse Event|0|||
155024399|NCT00972816|559517031|FG002|Overall Study|Adverse Event|1|||
155024400|NCT00972816|559517032|FG003|Overall Study|Adverse Event|0|||
155024401|NCT00972816|559517033|FG004|Overall Study|Adverse Event|0|||
155024402|NCT00972816|559517034|FG005|Overall Study|Adverse Event|0|||
155024403|NCT00972816|559517035|FG006|Overall Study|Adverse Event|0|||
155024404|NCT00972816|559517036|FG007|Overall Study|Adverse Event|0|||
155024405|NCT00972816|559517029|FG000|Overall Study|Withdrawal by Subject|4|||
155024406|NCT00972816|559517030|FG001|Overall Study|Withdrawal by Subject|2|||
155024407|NCT00972816|559517031|FG002|Overall Study|Withdrawal by Subject|1|||
155024408|NCT00972816|559517032|FG003|Overall Study|Withdrawal by Subject|3|||
155024409|NCT00972816|559517033|FG004|Overall Study|Withdrawal by Subject|0|||
155024410|NCT00972816|559517034|FG005|Overall Study|Withdrawal by Subject|1|||
155024411|NCT00972816|559517035|FG006|Overall Study|Withdrawal by Subject|1|||
155024412|NCT00972816|559517036|FG007|Overall Study|Withdrawal by Subject|2|||
155024413|NCT00972816|559517029|FG000|Overall Study|Lost to Follow-up|11|||
155024414|NCT00972816|559517030|FG001|Overall Study|Lost to Follow-up|9|||
155024415|NCT00972816|559517031|FG002|Overall Study|Lost to Follow-up|7|||
155024416|NCT00972816|559517032|FG003|Overall Study|Lost to Follow-up|5|||
155024417|NCT00972816|559517033|FG004|Overall Study|Lost to Follow-up|11|||
155024418|NCT00972816|559517034|FG005|Overall Study|Lost to Follow-up|10|||
155024419|NCT00972816|559517035|FG006|Overall Study|Lost to Follow-up|7|||
155024420|NCT00972816|559517036|FG007|Overall Study|Lost to Follow-up|7|||
155024421|NCT00972816|559517029|FG000|Overall Study|Inappropriate enrolment|0|||
155024422|NCT00972816|559517030|FG001|Overall Study|Inappropriate enrolment|0|||
155139958|NCT02487030|559942826|FG000|Overall Study|Adverse Event|0|||
155139959|NCT02487030|559942827|FG001|Overall Study|Adverse Event|0|||
155024423|NCT00972816|559517031|FG002|Overall Study|Inappropriate enrolment|0|||
155024424|NCT00972816|559517032|FG003|Overall Study|Inappropriate enrolment|0|||
155024425|NCT00972816|559517033|FG004|Overall Study|Inappropriate enrolment|0|||
155024426|NCT00972816|559517034|FG005|Overall Study|Inappropriate enrolment|0|||
155024427|NCT00972816|559517035|FG006|Overall Study|Inappropriate enrolment|2|||
155024428|NCT00972816|559517036|FG007|Overall Study|Inappropriate enrolment|0|||
155024429|NCT00972816|559517029|FG000|Overall Study|Unable to classify|2|||
155024430|NCT00972816|559517030|FG001|Overall Study|Unable to classify|0|||
155024431|NCT00972816|559517031|FG002|Overall Study|Unable to classify|0|||
155024432|NCT00972816|559517032|FG003|Overall Study|Unable to classify|0|||
155024433|NCT00972816|559517033|FG004|Overall Study|Unable to classify|1|||
155024434|NCT00972816|559517034|FG005|Overall Study|Unable to classify|0|||
155024435|NCT00972816|559517035|FG006|Overall Study|Unable to classify|0|||
155139960|NCT02487030|559942828|FG002|Overall Study|Adverse Event|0|||
155024436|NCT00972816|559517036|FG007|Overall Study|Unable to classify|0|||
155024437|NCT02163226|559517037|FG000|Overall Study|Death|2|||
155024438|NCT02163226|559517038|FG001|Overall Study|Death|1|||
155024439|NCT02163226|559517037|FG000|Overall Study|Withdrawal by Subject|5|||
155024440|NCT02163226|559517038|FG001|Overall Study|Withdrawal by Subject|2|||
155024441|NCT02163226|559517037|FG000|Overall Study|Returned home, local radiotherapy|3|||
155024442|NCT02163226|559517038|FG001|Overall Study|Returned home, local radiotherapy|0|||
155024443|NCT02163226|559517037|FG000|Overall Study|Repeat imaging showed no disease|2|||
155024444|NCT02163226|559517038|FG001|Overall Study|Repeat imaging showed no disease|0|||
155024445|NCT02163226|559517037|FG000|Overall Study|Incomplete radiotherapy|3|||
155024446|NCT02163226|559517038|FG001|Overall Study|Incomplete radiotherapy|0|||
155024447|NCT02163226|559517037|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
155024448|NCT02163226|559517038|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
155024449|NCT02163226|559517037|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
155024450|NCT02163226|559517038|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
155024451|NCT02163226|559517037|FG000|Overall Study|ineligible|0|||
155024452|NCT02163226|559517038|FG001|Overall Study|ineligible|3|||
155024453|NCT00593684|559517041|FG000|Overall Study|Death|2|||
155180729|NCT02937571|560100736|FG000|Overall Study|Withdrawal by Subject|0|||
155180730|NCT02937571|560100737|FG001|Overall Study|Withdrawal by Subject|0|||
155180731|NCT02937571|560100738|FG002|Overall Study|Withdrawal by Subject|3|||
155180732|NCT00807027|560100739|FG000|Overall Study|Withdrawal by Subject|13|||
155180733|NCT00807027|560100740|FG001|Overall Study|Withdrawal by Subject|14|||
155180734|NCT00807027|560100739|FG000|Overall Study|Protocol Violation|1|||
155180735|NCT00807027|560100740|FG001|Overall Study|Protocol Violation|1|||
155180736|NCT00807027|560100739|FG000|Overall Study|Adverse Event|2|||
155024454|NCT00593684|559517042|FG001|Overall Study|Death|1|||
155024455|NCT03625466|559517043|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
155024456|NCT03625466|559517044|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
155024457|NCT03625466|559517045|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
155024458|NCT03625466|559517043|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155024459|NCT03625466|559517044|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
155024460|NCT03625466|559517045|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155024461|NCT03625466|559517043|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155024462|NCT03625466|559517044|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
155024463|NCT03625466|559517045|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
155024464|NCT00664859|559517046|FG000|Overall Study|Adverse Event|2|||
155024465|NCT00664859|559517047|FG001|Overall Study|Adverse Event|1|||
155024466|NCT00664859|559517048|FG002|Overall Study|Adverse Event|3|||
155024467|NCT00664859|559517046|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
155024468|NCT00664859|559517047|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
155024469|NCT00664859|559517048|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
155024470|NCT00664859|559517046|FG000|Overall Study|Noncompliance with protocol|1|||
155024471|NCT00664859|559517047|FG001|Overall Study|Noncompliance with protocol|0|||
155024472|NCT00664859|559517048|FG002|Overall Study|Noncompliance with protocol|4|||
155024473|NCT00664859|559517046|FG000|Overall Study|Laboratory abnormality|2|||
155024474|NCT00664859|559517047|FG001|Overall Study|Laboratory abnormality|1|||
155024475|NCT00664859|559517048|FG002|Overall Study|Laboratory abnormality|4|||
155024476|NCT00664859|559517046|FG000|Overall Study|Withdrawal by Subject|4|||
155024477|NCT00664859|559517047|FG001|Overall Study|Withdrawal by Subject|1|||
155024478|NCT00664859|559517048|FG002|Overall Study|Withdrawal by Subject|3|||
155024479|NCT00664859|559517046|FG000|Overall Study|Lost to Follow-up|2|||
155024480|NCT00664859|559517047|FG001|Overall Study|Lost to Follow-up|2|||
155024481|NCT00664859|559517048|FG002|Overall Study|Lost to Follow-up|1|||
155024482|NCT00664859|559517046|FG000|Overall Study|Other|0|||
155024483|NCT00664859|559517047|FG001|Overall Study|Other|1|||
155024484|NCT00664859|559517048|FG002|Overall Study|Other|2|||
155024485|NCT00748189|559517049|FG000|Overall Study|Death|99|||
155024486|NCT00748189|559517050|FG001|Overall Study|Death|84|||
155024487|NCT00748189|559517049|FG000|Overall Study|Withdrawal by Subject|23|||
155024488|NCT00748189|559517050|FG001|Overall Study|Withdrawal by Subject|29|||
155024489|NCT00748189|559517049|FG000|Overall Study|Physician Decision|16|||
155024490|NCT00748189|559517050|FG001|Overall Study|Physician Decision|5|||
155024491|NCT00748189|559517049|FG000|Overall Study|Lost to Follow-up|8|||
155024492|NCT00748189|559517050|FG001|Overall Study|Lost to Follow-up|15|||
155024493|NCT00748189|559517049|FG000|Overall Study|Study terminated by Sponsor|70|||
155024494|NCT00748189|559517050|FG001|Overall Study|Study terminated by Sponsor|79|||
155024495|NCT04481191|559517057|FG000|Overall Study|Withdrawn by parent/guardian|15|||
155024496|NCT04481191|559517058|FG001|Overall Study|Withdrawn by parent/guardian|10|||
155024497|NCT00546117|559517063|FG000|Overall Study|Withdrawal by Subject|3|||
155024498|NCT00546117|559517064|FG001|Overall Study|Withdrawal by Subject|0|||
155024499|NCT00546117|559517063|FG000|Overall Study|Inability to schedule follow-up visit|1|||
155024500|NCT00546117|559517064|FG001|Overall Study|Inability to schedule follow-up visit|0|||
155180737|NCT00807027|560100740|FG001|Overall Study|Adverse Event|2|||
155024501|NCT04696055|559517070|FG000|Overall Study|Adverse Event|10|||
155024502|NCT04696055|559517071|FG001|Overall Study|Adverse Event|2|||
155024503|NCT04696055|559517070|FG000|Overall Study|Death|4|||
155024504|NCT04696055|559517071|FG001|Overall Study|Death|0|||
155024505|NCT04696055|559517070|FG000|Overall Study|Other|7|||
155024506|NCT04696055|559517071|FG001|Overall Study|Other|2|||
155024507|NCT04696055|559517070|FG000|Overall Study|Physician Decision|3|||
155024508|NCT04696055|559517071|FG001|Overall Study|Physician Decision|0|||
155024509|NCT04696055|559517070|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
155024510|NCT04696055|559517071|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
155024511|NCT04696055|559517070|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
155024512|NCT04696055|559517071|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
155024513|NCT04696055|559517070|FG000|Overall Study|Subject Decision|1|||
155024514|NCT04696055|559517071|FG001|Overall Study|Subject Decision|2|||
155024515|NCT03969901|559517072|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155024516|NCT03969901|559517073|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155024517|NCT03969901|559517074|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155024518|NCT03969901|559517075|FG003|Overall Study|Withdrawal by parent/guardian|0|||
155024519|NCT03969901|559517076|FG004|Overall Study|Withdrawal by parent/guardian|1|||
155024520|NCT03969901|559517077|FG005|Overall Study|Withdrawal by parent/guardian|0|||
155024521|NCT03969901|559517078|FG006|Overall Study|Withdrawal by parent/guardian|0|||
155024522|NCT03969901|559517079|FG007|Overall Study|Withdrawal by parent/guardian|1|||
155024523|NCT03969901|559517080|FG008|Overall Study|Withdrawal by parent/guardian|1|||
155024524|NCT03969901|559517081|FG009|Overall Study|Withdrawal by parent/guardian|0|||
155024525|NCT00348595|559517082|FG000|Overall Study|Adverse Event|5|||
155024526|NCT00348595|559517083|FG001|Overall Study|Adverse Event|8|||
155024527|NCT02589626|559517084|FG000|Overall Study|Other than the reason specified|1|||
155024528|NCT02589626|559517085|FG001|Overall Study|Other than the reason specified|0|||
155024529|NCT02589626|559517084|FG000|Overall Study|Withdrawal by Subject|1|||
155024530|NCT02589626|559517085|FG001|Overall Study|Withdrawal by Subject|1|||
155024531|NCT02589626|559517084|FG000|Overall Study|Adverse Event|1|||
155024532|NCT02589626|559517085|FG001|Overall Study|Adverse Event|1|||
155024533|NCT03645395|559517086|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
155024534|NCT03645395|559517087|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
155024535|NCT03645395|559517088|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
155024536|NCT03645395|559517089|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
155024537|NCT03645395|559517086|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
155024538|NCT03645395|559517087|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
155024539|NCT03645395|559517088|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
155024540|NCT03645395|559517089|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
155024541|NCT03645395|559517086|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
155024542|NCT03645395|559517087|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
155024543|NCT03645395|559517088|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
155024544|NCT03645395|559517089|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
155024545|NCT03645395|559517086|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
155024546|NCT03645395|559517087|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
155024547|NCT03645395|559517088|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
155024548|NCT03645395|559517089|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
155024549|NCT02564900|559517090|FG000|Dose Escalation|Progressive disease per RECIST|2|||
155024550|NCT02564900|559517091|FG001|Dose Escalation|Progressive disease per RECIST|3|||
155024551|NCT02564900|559517092|FG002|Dose Escalation|Progressive disease per RECIST|3|||
155024552|NCT02564900|559517093|FG003|Dose Escalation|Progressive disease per RECIST|3|||
155024553|NCT02564900|559517094|FG004|Dose Escalation|Progressive disease per RECIST|3|||
155024554|NCT02564900|559517095|FG005|Dose Escalation|Progressive disease per RECIST|1|||
155024555|NCT02564900|559517096|FG006|Dose Escalation|Progressive disease per RECIST|0|||
155024556|NCT02564900|559517097|FG007|Dose Escalation|Progressive disease per RECIST|0|||
155024557|NCT02564900|559517098|FG008|Dose Escalation|Progressive disease per RECIST|0|||
155024558|NCT02564900|559517099|FG009|Dose Escalation|Progressive disease per RECIST|0|||
155024559|NCT02564900|559517100|FG010|Dose Escalation|Progressive disease per RECIST|0|||
155024560|NCT02564900|559517101|FG011|Dose Escalation|Progressive disease per RECIST|0|||
155024561|NCT02564900|559517102|FG012|Dose Escalation|Progressive disease per RECIST|0|||
155024562|NCT02564900|559517103|FG013|Dose Escalation|Progressive disease per RECIST|0|||
155024563|NCT02564900|559517104|FG014|Dose Escalation|Progressive disease per RECIST|0|||
155024564|NCT02564900|559517090|FG000|Dose Escalation|Ongoing|1|||
155024565|NCT02564900|559517091|FG001|Dose Escalation|Ongoing|0|||
155024566|NCT02564900|559517092|FG002|Dose Escalation|Ongoing|0|||
155024567|NCT02564900|559517093|FG003|Dose Escalation|Ongoing|2|||
155024568|NCT02564900|559517094|FG004|Dose Escalation|Ongoing|2|||
155024569|NCT02564900|559517095|FG005|Dose Escalation|Ongoing|2|||
155024570|NCT02564900|559517096|FG006|Dose Escalation|Ongoing|0|||
155024571|NCT02564900|559517097|FG007|Dose Escalation|Ongoing|0|||
155024572|NCT02564900|559517098|FG008|Dose Escalation|Ongoing|0|||
155024573|NCT02564900|559517099|FG009|Dose Escalation|Ongoing|0|||
155024574|NCT02564900|559517100|FG010|Dose Escalation|Ongoing|0|||
155024575|NCT02564900|559517101|FG011|Dose Escalation|Ongoing|0|||
155024576|NCT02564900|559517102|FG012|Dose Escalation|Ongoing|0|||
155024577|NCT02564900|559517103|FG013|Dose Escalation|Ongoing|0|||
155024578|NCT02564900|559517104|FG014|Dose Escalation|Ongoing|0|||
155024579|NCT02564900|559517090|FG000|Dose Escalation|Adverse Event|0|||
155024580|NCT02564900|559517091|FG001|Dose Escalation|Adverse Event|0|||
155024581|NCT02564900|559517092|FG002|Dose Escalation|Adverse Event|0|||
155024582|NCT02564900|559517093|FG003|Dose Escalation|Adverse Event|1|||
155024583|NCT02564900|559517094|FG004|Dose Escalation|Adverse Event|1|||
155024584|NCT02564900|559517095|FG005|Dose Escalation|Adverse Event|3|||
155024585|NCT02564900|559517096|FG006|Dose Escalation|Adverse Event|0|||
155024586|NCT02564900|559517097|FG007|Dose Escalation|Adverse Event|0|||
155024587|NCT02564900|559517098|FG008|Dose Escalation|Adverse Event|0|||
155024588|NCT02564900|559517099|FG009|Dose Escalation|Adverse Event|0|||
155024589|NCT02564900|559517100|FG010|Dose Escalation|Adverse Event|0|||
155024590|NCT02564900|559517101|FG011|Dose Escalation|Adverse Event|0|||
155024591|NCT02564900|559517102|FG012|Dose Escalation|Adverse Event|0|||
155024592|NCT02564900|559517103|FG013|Dose Escalation|Adverse Event|0|||
155024593|NCT02564900|559517104|FG014|Dose Escalation|Adverse Event|0|||
155024594|NCT02564900|559517090|FG000|Dose Expansion|Progressive disease per RECIST|0|||
155024595|NCT02564900|559517091|FG001|Dose Expansion|Progressive disease per RECIST|0|||
155024596|NCT02564900|559517092|FG002|Dose Expansion|Progressive disease per RECIST|0|||
155024597|NCT02564900|559517093|FG003|Dose Expansion|Progressive disease per RECIST|0|||
155024598|NCT02564900|559517094|FG004|Dose Expansion|Progressive disease per RECIST|0|||
155024599|NCT02564900|559517095|FG005|Dose Expansion|Progressive disease per RECIST|0|||
155024600|NCT02564900|559517096|FG006|Dose Expansion|Progressive disease per RECIST|19|||
155024601|NCT02564900|559517097|FG007|Dose Expansion|Progressive disease per RECIST|17|||
155024602|NCT02564900|559517098|FG008|Dose Expansion|Progressive disease per RECIST|8|||
155024603|NCT02564900|559517099|FG009|Dose Expansion|Progressive disease per RECIST|16|||
155024604|NCT02564900|559517100|FG010|Dose Expansion|Progressive disease per RECIST|13|||
155024605|NCT02564900|559517101|FG011|Dose Expansion|Progressive disease per RECIST|19|||
155024606|NCT02564900|559517102|FG012|Dose Expansion|Progressive disease per RECIST|10|||
155024607|NCT02564900|559517103|FG013|Dose Expansion|Progressive disease per RECIST|13|||
155024608|NCT02564900|559517104|FG014|Dose Expansion|Progressive disease per RECIST|11|||
155024609|NCT02564900|559517090|FG000|Dose Expansion|Clinical progression|0|||
155024610|NCT02564900|559517091|FG001|Dose Expansion|Clinical progression|0|||
155024611|NCT02564900|559517092|FG002|Dose Expansion|Clinical progression|0|||
155024612|NCT02564900|559517093|FG003|Dose Expansion|Clinical progression|0|||
155024613|NCT02564900|559517094|FG004|Dose Expansion|Clinical progression|0|||
155024614|NCT02564900|559517095|FG005|Dose Expansion|Clinical progression|0|||
155024615|NCT02564900|559517096|FG006|Dose Expansion|Clinical progression|5|||
155024616|NCT02564900|559517097|FG007|Dose Expansion|Clinical progression|12|||
155024617|NCT02564900|559517098|FG008|Dose Expansion|Clinical progression|0|||
155024618|NCT02564900|559517099|FG009|Dose Expansion|Clinical progression|3|||
155024619|NCT02564900|559517100|FG010|Dose Expansion|Clinical progression|2|||
155024620|NCT02564900|559517101|FG011|Dose Expansion|Clinical progression|0|||
155024621|NCT02564900|559517102|FG012|Dose Expansion|Clinical progression|1|||
155024622|NCT02564900|559517103|FG013|Dose Expansion|Clinical progression|3|||
155024623|NCT02564900|559517104|FG014|Dose Expansion|Clinical progression|1|||
155024624|NCT02564900|559517090|FG000|Dose Expansion|Adverse Event|0|||
155024625|NCT02564900|559517091|FG001|Dose Expansion|Adverse Event|0|||
155024626|NCT02564900|559517092|FG002|Dose Expansion|Adverse Event|0|||
155024627|NCT02564900|559517093|FG003|Dose Expansion|Adverse Event|0|||
155024628|NCT02564900|559517094|FG004|Dose Expansion|Adverse Event|0|||
155024629|NCT02564900|559517095|FG005|Dose Expansion|Adverse Event|0|||
155024630|NCT02564900|559517096|FG006|Dose Expansion|Adverse Event|9|||
155024631|NCT02564900|559517097|FG007|Dose Expansion|Adverse Event|22|||
155024632|NCT02564900|559517098|FG008|Dose Expansion|Adverse Event|0|||
155024633|NCT02564900|559517099|FG009|Dose Expansion|Adverse Event|11|||
155024634|NCT02564900|559517100|FG010|Dose Expansion|Adverse Event|0|||
155024635|NCT02564900|559517101|FG011|Dose Expansion|Adverse Event|5|||
155024636|NCT02564900|559517102|FG012|Dose Expansion|Adverse Event|2|||
155024637|NCT02564900|559517103|FG013|Dose Expansion|Adverse Event|2|||
155024638|NCT02564900|559517104|FG014|Dose Expansion|Adverse Event|1|||
155024639|NCT02564900|559517090|FG000|Dose Expansion|Ongoing|0|||
155024640|NCT02564900|559517091|FG001|Dose Expansion|Ongoing|0|||
155024641|NCT02564900|559517092|FG002|Dose Expansion|Ongoing|0|||
155024642|NCT02564900|559517093|FG003|Dose Expansion|Ongoing|0|||
155024643|NCT02564900|559517094|FG004|Dose Expansion|Ongoing|0|||
155024644|NCT02564900|559517095|FG005|Dose Expansion|Ongoing|0|||
155024645|NCT02564900|559517096|FG006|Dose Expansion|Ongoing|9|||
155024646|NCT02564900|559517097|FG007|Dose Expansion|Ongoing|10|||
155024647|NCT02564900|559517098|FG008|Dose Expansion|Ongoing|11|||
155024648|NCT02564900|559517099|FG009|Dose Expansion|Ongoing|3|||
155024649|NCT02564900|559517100|FG010|Dose Expansion|Ongoing|0|||
155024650|NCT02564900|559517101|FG011|Dose Expansion|Ongoing|0|||
155024651|NCT02564900|559517102|FG012|Dose Expansion|Ongoing|4|||
155024652|NCT02564900|559517103|FG013|Dose Expansion|Ongoing|0|||
155024653|NCT02564900|559517104|FG014|Dose Expansion|Ongoing|6|||
155024654|NCT02564900|559517090|FG000|Dose Expansion|Death|0|||
155024655|NCT02564900|559517091|FG001|Dose Expansion|Death|0|||
155024656|NCT02564900|559517092|FG002|Dose Expansion|Death|0|||
155024657|NCT02564900|559517093|FG003|Dose Expansion|Death|0|||
155024658|NCT02564900|559517094|FG004|Dose Expansion|Death|0|||
155024659|NCT02564900|559517095|FG005|Dose Expansion|Death|0|||
155024660|NCT02564900|559517096|FG006|Dose Expansion|Death|1|||
155024661|NCT02564900|559517097|FG007|Dose Expansion|Death|0|||
155024662|NCT02564900|559517098|FG008|Dose Expansion|Death|0|||
155024663|NCT02564900|559517099|FG009|Dose Expansion|Death|0|||
155024664|NCT02564900|559517100|FG010|Dose Expansion|Death|1|||
155024665|NCT02564900|559517101|FG011|Dose Expansion|Death|0|||
155024666|NCT02564900|559517102|FG012|Dose Expansion|Death|1|||
155024667|NCT02564900|559517103|FG013|Dose Expansion|Death|1|||
155024668|NCT02564900|559517104|FG014|Dose Expansion|Death|0|||
155024669|NCT02564900|559517090|FG000|Dose Expansion|Withdrawal by Subject|0|||
155024670|NCT02564900|559517091|FG001|Dose Expansion|Withdrawal by Subject|0|||
155024671|NCT02564900|559517092|FG002|Dose Expansion|Withdrawal by Subject|0|||
155024672|NCT02564900|559517093|FG003|Dose Expansion|Withdrawal by Subject|0|||
155024673|NCT02564900|559517094|FG004|Dose Expansion|Withdrawal by Subject|0|||
155024674|NCT02564900|559517095|FG005|Dose Expansion|Withdrawal by Subject|0|||
155024675|NCT02564900|559517096|FG006|Dose Expansion|Withdrawal by Subject|4|||
155024676|NCT02564900|559517097|FG007|Dose Expansion|Withdrawal by Subject|0|||
155024677|NCT02564900|559517098|FG008|Dose Expansion|Withdrawal by Subject|0|||
155024678|NCT02564900|559517099|FG009|Dose Expansion|Withdrawal by Subject|0|||
155024679|NCT02564900|559517100|FG010|Dose Expansion|Withdrawal by Subject|1|||
155024680|NCT02564900|559517101|FG011|Dose Expansion|Withdrawal by Subject|0|||
155024681|NCT02564900|559517102|FG012|Dose Expansion|Withdrawal by Subject|0|||
155024682|NCT02564900|559517103|FG013|Dose Expansion|Withdrawal by Subject|1|||
155024683|NCT02564900|559517104|FG014|Dose Expansion|Withdrawal by Subject|1|||
155024684|NCT02564900|559517090|FG000|Dose Expansion|Other|0|||
155024685|NCT02564900|559517091|FG001|Dose Expansion|Other|0|||
155024686|NCT02564900|559517092|FG002|Dose Expansion|Other|0|||
155024687|NCT02564900|559517093|FG003|Dose Expansion|Other|0|||
155024688|NCT02564900|559517094|FG004|Dose Expansion|Other|0|||
155024689|NCT02564900|559517095|FG005|Dose Expansion|Other|0|||
155024690|NCT02564900|559517096|FG006|Dose Expansion|Other|1|||
155024691|NCT02564900|559517097|FG007|Dose Expansion|Other|0|||
155024692|NCT02564900|559517098|FG008|Dose Expansion|Other|1|||
155024693|NCT02564900|559517099|FG009|Dose Expansion|Other|0|||
155024694|NCT02564900|559517100|FG010|Dose Expansion|Other|0|||
155024695|NCT02564900|559517101|FG011|Dose Expansion|Other|0|||
155024696|NCT02564900|559517102|FG012|Dose Expansion|Other|0|||
155024697|NCT02564900|559517103|FG013|Dose Expansion|Other|0|||
155024698|NCT02564900|559517104|FG014|Dose Expansion|Other|1|||
155024699|NCT02564900|559517090|FG000|Dose Expansion|Did not receive treatment|0|||
155024700|NCT02564900|559517091|FG001|Dose Expansion|Did not receive treatment|0|||
155024701|NCT02564900|559517092|FG002|Dose Expansion|Did not receive treatment|0|||
155024702|NCT02564900|559517093|FG003|Dose Expansion|Did not receive treatment|0|||
155024703|NCT02564900|559517094|FG004|Dose Expansion|Did not receive treatment|0|||
155024704|NCT02564900|559517095|FG005|Dose Expansion|Did not receive treatment|0|||
155024705|NCT02564900|559517096|FG006|Dose Expansion|Did not receive treatment|1|||
155024706|NCT02564900|559517097|FG007|Dose Expansion|Did not receive treatment|1|||
155024707|NCT02564900|559517098|FG008|Dose Expansion|Did not receive treatment|0|||
155024708|NCT02564900|559517099|FG009|Dose Expansion|Did not receive treatment|0|||
155024709|NCT02564900|559517100|FG010|Dose Expansion|Did not receive treatment|0|||
155024710|NCT02564900|559517101|FG011|Dose Expansion|Did not receive treatment|0|||
155024711|NCT02564900|559517102|FG012|Dose Expansion|Did not receive treatment|0|||
155024712|NCT02564900|559517103|FG013|Dose Expansion|Did not receive treatment|0|||
155024713|NCT02564900|559517104|FG014|Dose Expansion|Did not receive treatment|1|||
155024714|NCT02423343|559517106|FG000|Overall Study|Withdrawal by Subject|0|||
155024715|NCT02423343|559517107|FG001|Overall Study|Withdrawal by Subject|1|||
155024716|NCT02423343|559517108|FG002|Overall Study|Withdrawal by Subject|0|||
155024717|NCT02423343|559517109|FG003|Overall Study|Withdrawal by Subject|0|||
155024718|NCT02423343|559517110|FG004|Overall Study|Withdrawal by Subject|0|||
155139961|NCT02487030|559942829|FG003|Overall Study|Adverse Event|1|||
155024719|NCT02423343|559517111|FG005|Overall Study|Withdrawal by Subject|0|||
155024720|NCT02423343|559517106|FG000|Overall Study|Progressive Disease|0|||
155024721|NCT02423343|559517107|FG001|Overall Study|Progressive Disease|0|||
155024722|NCT02423343|559517108|FG002|Overall Study|Progressive Disease|0|||
155024723|NCT02423343|559517109|FG003|Overall Study|Progressive Disease|0|||
155024724|NCT02423343|559517110|FG004|Overall Study|Progressive Disease|2|||
155024725|NCT02423343|559517111|FG005|Overall Study|Progressive Disease|0|||
155024726|NCT02423343|559517106|FG000|Overall Study|Adverse Event|0|||
155024727|NCT02423343|559517107|FG001|Overall Study|Adverse Event|0|||
155024728|NCT02423343|559517108|FG002|Overall Study|Adverse Event|0|||
155024729|NCT02423343|559517109|FG003|Overall Study|Adverse Event|0|||
155024730|NCT02423343|559517110|FG004|Overall Study|Adverse Event|2|||
155139962|NCT02487030|559942830|FG004|Overall Study|Adverse Event|0|||
155139963|NCT02487030|559942831|FG005|Overall Study|Adverse Event|0|||
155139964|NCT02487030|559942832|FG006|Overall Study|Adverse Event|0|||
155024731|NCT02423343|559517111|FG005|Overall Study|Adverse Event|0|||
155024732|NCT02423343|559517106|FG000|Overall Study|Death|0|||
155024733|NCT02423343|559517107|FG001|Overall Study|Death|0|||
155024734|NCT02423343|559517108|FG002|Overall Study|Death|0|||
155024735|NCT02423343|559517109|FG003|Overall Study|Death|0|||
155024736|NCT02423343|559517110|FG004|Overall Study|Death|1|||
155024737|NCT02423343|559517111|FG005|Overall Study|Death|0|||
155024738|NCT02111577|559517112|FG000|Overall Study|Protocol Violation|2|||
155024739|NCT02111577|559517113|FG001|Overall Study|Protocol Violation|0|||
155024740|NCT02111577|559517112|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
155024741|NCT02111577|559517113|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
155024742|NCT02111577|559517112|FG000|Overall Study|Failure to produce study treatment|6|||
155024743|NCT02111577|559517113|FG001|Overall Study|Failure to produce study treatment|0|||
155024744|NCT02111577|559517112|FG000|Overall Study|Death|518|||
155024745|NCT02111577|559517113|FG001|Overall Study|Death|254|||
155024746|NCT02111577|559517112|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
155024747|NCT02111577|559517113|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
155024748|NCT02111577|559517112|FG000|Overall Study|Adverse Event|1|||
155024749|NCT02111577|559517113|FG001|Overall Study|Adverse Event|1|||
155024750|NCT02111577|559517112|FG000|Overall Study|Withdrawal by Subject|51|||
155024751|NCT02111577|559517113|FG001|Overall Study|Withdrawal by Subject|23|||
155024752|NCT02111577|559517112|FG000|Overall Study|Disease progression|0|||
155024753|NCT02111577|559517113|FG001|Overall Study|Disease progression|1|||
155024754|NCT02111577|559517112|FG000|Overall Study|Lost to Follow-up|19|||
155024755|NCT02111577|559517113|FG001|Overall Study|Lost to Follow-up|10|||
155024756|NCT04967885|559517114|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
155024757|NCT04967885|559517115|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
155024758|NCT04967885|559517114|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
155024759|NCT04967885|559517115|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
155024760|NCT04967885|559517114|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
155024761|NCT04967885|559517115|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
155024762|NCT04967885|559517114|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
155024763|NCT04967885|559517115|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
155024764|NCT04967885|559517114|FG000|EMI-II Intervention|Lost to Follow-up|14|||
155024765|NCT04967885|559517115|FG001|EMI-II Intervention|Lost to Follow-up|10|||
155024766|NCT00654875|559517116|FG000|Overall Study|Adverse Event|5|||
155024767|NCT00654875|559517117|FG001|Overall Study|Adverse Event|5|||
155024768|NCT00654875|559517116|FG000|Overall Study|Withdrawal by Subject|4|||
155024769|NCT00654875|559517117|FG001|Overall Study|Withdrawal by Subject|4|||
155024770|NCT00654875|559517116|FG000|Overall Study|Protocol Violation|3|||
155024771|NCT00654875|559517117|FG001|Overall Study|Protocol Violation|3|||
155024772|NCT00654875|559517116|FG000|Overall Study|Lack of Efficacy|2|||
155024773|NCT00654875|559517117|FG001|Overall Study|Lack of Efficacy|2|||
155024774|NCT00654875|559517116|FG000|Overall Study|Lost to Follow-up|1|||
155024775|NCT00654875|559517117|FG001|Overall Study|Lost to Follow-up|3|||
155024776|NCT00654875|559517116|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155024777|NCT00654875|559517117|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155024778|NCT00654875|559517116|FG000|Overall Study|Administrative Problems|1|||
155024779|NCT00654875|559517117|FG001|Overall Study|Administrative Problems|0|||
155024780|NCT01011465|559517118|FG000|Overall Study|Withdrawal by Subject|2|||
155024781|NCT01011465|559517119|FG001|Overall Study|Withdrawal by Subject|1|||
155024782|NCT01011465|559517120|FG002|Overall Study|Withdrawal by Subject|0|||
155024783|NCT01011465|559517121|FG003|Overall Study|Withdrawal by Subject|0|||
155024784|NCT01011465|559517122|FG004|Overall Study|Withdrawal by Subject|1|||
155024785|NCT01011465|559517123|FG005|Overall Study|Withdrawal by Subject|0|||
155024786|NCT01011465|559517124|FG006|Overall Study|Withdrawal by Subject|1|||
155024787|NCT01011465|559517125|FG007|Overall Study|Withdrawal by Subject|0|||
155024788|NCT02042950|559517128|FG000|Overall Study|Progressive Disease|4|||
155024789|NCT00723008|559517129|FG000|Enrollment|Lost to Follow-up|1|||
155024790|NCT00723008|559517130|FG001|Enrollment|Lost to Follow-up|0|||
155024791|NCT00723008|559517129|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
155024792|NCT00723008|559517130|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
155024793|NCT00723008|559517129|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
155180738|NCT02497976|560100742|FG000|Overall Study|Withdrawal by Subject|2|||
155180739|NCT02497976|560100743|FG001|Overall Study|Withdrawal by Subject|0|||
155024794|NCT00723008|559517130|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
155024795|NCT00723008|559517129|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
155024796|NCT00723008|559517130|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
155024797|NCT00723008|559517129|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
155024798|NCT00723008|559517130|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
155024799|NCT00723008|559517129|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
155024800|NCT00723008|559517130|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
155024801|NCT01014988|559517133|FG000|Overall Study|Adverse Event|20|||
155024802|NCT01014988|559517134|FG001|Overall Study|Adverse Event|0|||
155024803|NCT01014988|559517135|FG002|Overall Study|Adverse Event|1|||
155024804|NCT01014988|559517136|FG003|Overall Study|Adverse Event|0|||
155024805|NCT01014988|559517137|FG004|Overall Study|Adverse Event|1|||
155024806|NCT01014988|559517138|FG005|Overall Study|Adverse Event|3|||
155024807|NCT01014988|559517133|FG000|Overall Study|Lost to Follow-up|1|||
155024808|NCT01014988|559517134|FG001|Overall Study|Lost to Follow-up|0|||
155024809|NCT01014988|559517135|FG002|Overall Study|Lost to Follow-up|1|||
155024810|NCT01014988|559517136|FG003|Overall Study|Lost to Follow-up|0|||
155024811|NCT01014988|559517137|FG004|Overall Study|Lost to Follow-up|0|||
155024812|NCT01014988|559517138|FG005|Overall Study|Lost to Follow-up|0|||
155024813|NCT01014988|559517133|FG000|Overall Study|Physician Decision|1|||
155024814|NCT01014988|559517134|FG001|Overall Study|Physician Decision|0|||
155024815|NCT01014988|559517135|FG002|Overall Study|Physician Decision|0|||
155024816|NCT01014988|559517136|FG003|Overall Study|Physician Decision|0|||
155024817|NCT01014988|559517137|FG004|Overall Study|Physician Decision|0|||
155024818|NCT01014988|559517138|FG005|Overall Study|Physician Decision|0|||
155024819|NCT01014988|559517133|FG000|Overall Study|Withdrawal by Subject|1|||
155024820|NCT01014988|559517134|FG001|Overall Study|Withdrawal by Subject|0|||
155024821|NCT01014988|559517135|FG002|Overall Study|Withdrawal by Subject|0|||
155024822|NCT01014988|559517136|FG003|Overall Study|Withdrawal by Subject|0|||
155024823|NCT01014988|559517137|FG004|Overall Study|Withdrawal by Subject|0|||
155024824|NCT01014988|559517138|FG005|Overall Study|Withdrawal by Subject|0|||
155024825|NCT00729157|559517141|FG000|Overall Study|Withdrawal by Subject|1|||
155024826|NCT01683266|559517142|FG000|Overall Study|Adverse Event|5|||
155024827|NCT01683266|559517143|FG001|Overall Study|Adverse Event|4|||
155024828|NCT01683266|559517142|FG000|Overall Study|Lack of Efficacy|5|||
155024829|NCT01683266|559517143|FG001|Overall Study|Lack of Efficacy|2|||
155024830|NCT01683266|559517142|FG000|Overall Study|Protocol Violation|13|||
155024831|NCT01683266|559517143|FG001|Overall Study|Protocol Violation|6|||
155024832|NCT01683266|559517142|FG000|Overall Study|Personal Reason|17|||
155024833|NCT01683266|559517143|FG001|Overall Study|Personal Reason|25|||
155024834|NCT01683266|559517142|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
155024835|NCT01683266|559517143|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
155024836|NCT01683266|559517142|FG000|Overall Study|Lost to Follow-up|5|||
155024837|NCT01683266|559517143|FG001|Overall Study|Lost to Follow-up|0|||
155024838|NCT01683266|559517142|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
155024839|NCT01683266|559517143|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
155024840|NCT01683266|559517142|FG000|Overall Study|Nonserious Hypoglycemia|0|||
155024841|NCT01683266|559517143|FG001|Overall Study|Nonserious Hypoglycemia|3|||
155024842|NCT01683266|559517142|FG000|Overall Study|Perceived Lack of Efficacy|1|||
155024843|NCT01683266|559517143|FG001|Overall Study|Perceived Lack of Efficacy|1|||
155024844|NCT01683266|559517142|FG000|Overall Study|Possibly Hypoglycemia|1|||
155024845|NCT01683266|559517143|FG001|Overall Study|Possibly Hypoglycemia|0|||
155024846|NCT01683266|559517142|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
155024847|NCT01683266|559517143|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
155024848|NCT02217410|559517146|FG000|Overall Study|Graft Loss|0|||
155024849|NCT02217410|559517147|FG001|Overall Study|Graft Loss|0|||
155024850|NCT02217410|559517148|FG002|Overall Study|Graft Loss|2|||
155024851|NCT02217410|559517146|FG000|Overall Study|Withdrawal by Subject|0|||
155024852|NCT02217410|559517147|FG001|Overall Study|Withdrawal by Subject|0|||
155024853|NCT02217410|559517148|FG002|Overall Study|Withdrawal by Subject|2|||
155024854|NCT02217410|559517146|FG000|Overall Study|Lost to Follow-up|0|||
155024855|NCT02217410|559517147|FG001|Overall Study|Lost to Follow-up|0|||
155024856|NCT02217410|559517148|FG002|Overall Study|Lost to Follow-up|1|||
155024857|NCT02217410|559517146|FG000|Overall Study|Lack of Efficacy|0|||
155024858|NCT02217410|559517147|FG001|Overall Study|Lack of Efficacy|1|||
155024859|NCT02217410|559517148|FG002|Overall Study|Lack of Efficacy|0|||
155024860|NCT02217410|559517146|FG000|Overall Study|Physician Decision|1|||
155024861|NCT02217410|559517147|FG001|Overall Study|Physician Decision|3|||
155024862|NCT02217410|559517148|FG002|Overall Study|Physician Decision|0|||
155024863|NCT00090220|559517156|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
155024864|NCT00090220|559517157|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
155024865|NCT00090220|559517158|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155024866|NCT00090220|559517159|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155024867|NCT00090220|559517160|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155024868|NCT00090220|559517161|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
155024869|NCT00090220|559517156|FG000|Base Study Vaccination Period|Adverse Event|6|||
155024870|NCT00090220|559517157|FG001|Base Study Vaccination Period|Adverse Event|1|||
155024871|NCT00090220|559517158|FG002|Base Study Vaccination Period|Adverse Event|0|||
155024872|NCT00090220|559517159|FG003|Base Study Vaccination Period|Adverse Event|0|||
155024873|NCT00090220|559517160|FG004|Base Study Vaccination Period|Adverse Event|0|||
155024874|NCT00090220|559517161|FG005|Base Study Vaccination Period|Adverse Event|0|||
155024875|NCT00090220|559517156|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
155139965|NCT02487030|559942826|FG000|Overall Study|Death|0|||
155139966|NCT02487030|559942827|FG001|Overall Study|Death|0|||
155024876|NCT00090220|559517157|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
155024877|NCT00090220|559517158|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
155024878|NCT00090220|559517159|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
155139967|NCT02487030|559942828|FG002|Overall Study|Death|0|||
155024879|NCT00090220|559517160|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
155024880|NCT00090220|559517161|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
155024881|NCT00090220|559517156|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
155024882|NCT00090220|559517157|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
155024883|NCT00090220|559517158|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
155024884|NCT00090220|559517159|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
155024885|NCT00090220|559517160|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
155024886|NCT00090220|559517161|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
155024887|NCT00090220|559517156|FG000|Base Study Vaccination Period|Patient Moved|6|||
155024888|NCT00090220|559517157|FG001|Base Study Vaccination Period|Patient Moved|2|||
155024889|NCT00090220|559517158|FG002|Base Study Vaccination Period|Patient Moved|0|||
155024890|NCT00090220|559517159|FG003|Base Study Vaccination Period|Patient Moved|0|||
155024891|NCT00090220|559517160|FG004|Base Study Vaccination Period|Patient Moved|0|||
155024892|NCT00090220|559517161|FG005|Base Study Vaccination Period|Patient Moved|0|||
155024893|NCT00090220|559517156|FG000|Base Study Vaccination Period|Other|4|||
155024894|NCT00090220|559517157|FG001|Base Study Vaccination Period|Other|4|||
155024895|NCT00090220|559517158|FG002|Base Study Vaccination Period|Other|0|||
155024896|NCT00090220|559517159|FG003|Base Study Vaccination Period|Other|0|||
155024897|NCT00090220|559517160|FG004|Base Study Vaccination Period|Other|0|||
155024898|NCT00090220|559517161|FG005|Base Study Vaccination Period|Other|0|||
155024899|NCT00090220|559517156|FG000|Base Study Follow-up Period|Adverse Event|6|||
155024900|NCT00090220|559517157|FG001|Base Study Follow-up Period|Adverse Event|1|||
155024901|NCT00090220|559517158|FG002|Base Study Follow-up Period|Adverse Event|0|||
155024902|NCT00090220|559517159|FG003|Base Study Follow-up Period|Adverse Event|0|||
155024903|NCT00090220|559517160|FG004|Base Study Follow-up Period|Adverse Event|0|||
155024904|NCT00090220|559517161|FG005|Base Study Follow-up Period|Adverse Event|0|||
155024905|NCT00090220|559517156|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
155024906|NCT00090220|559517157|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
155024907|NCT00090220|559517158|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
155024908|NCT00090220|559517159|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
155024909|NCT00090220|559517160|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
155024910|NCT00090220|559517161|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
155024911|NCT00090220|559517156|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
155024912|NCT00090220|559517157|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
155024913|NCT00090220|559517158|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
155024914|NCT00090220|559517159|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
155024915|NCT00090220|559517160|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
155024916|NCT00090220|559517161|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
155024917|NCT00090220|559517156|FG000|Base Study Follow-up Period|Patient Moved|20|||
155024918|NCT00090220|559517157|FG001|Base Study Follow-up Period|Patient Moved|28|||
155024919|NCT00090220|559517158|FG002|Base Study Follow-up Period|Patient Moved|0|||
155024920|NCT00090220|559517159|FG003|Base Study Follow-up Period|Patient Moved|0|||
155024921|NCT00090220|559517160|FG004|Base Study Follow-up Period|Patient Moved|0|||
155024922|NCT00090220|559517161|FG005|Base Study Follow-up Period|Patient Moved|0|||
155024923|NCT00090220|559517156|FG000|Base Study Follow-up Period|Other|19|||
155024924|NCT00090220|559517157|FG001|Base Study Follow-up Period|Other|21|||
155024925|NCT00090220|559517158|FG002|Base Study Follow-up Period|Other|0|||
155024926|NCT00090220|559517159|FG003|Base Study Follow-up Period|Other|0|||
155024927|NCT00090220|559517160|FG004|Base Study Follow-up Period|Other|0|||
155024928|NCT00090220|559517161|FG005|Base Study Follow-up Period|Other|0|||
155024929|NCT00090220|559517156|FG000|Extension 1 (EXT1)|Adverse Event|0|||
155024930|NCT00090220|559517157|FG001|Extension 1 (EXT1)|Adverse Event|0|||
155024931|NCT00090220|559517158|FG002|Extension 1 (EXT1)|Adverse Event|4|||
155024932|NCT00090220|559517159|FG003|Extension 1 (EXT1)|Adverse Event|0|||
155024933|NCT00090220|559517160|FG004|Extension 1 (EXT1)|Adverse Event|0|||
155024934|NCT00090220|559517161|FG005|Extension 1 (EXT1)|Adverse Event|0|||
155024935|NCT00090220|559517156|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
155024936|NCT00090220|559517157|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
155024937|NCT00090220|559517158|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
155024938|NCT00090220|559517159|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
155024939|NCT00090220|559517160|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
155024940|NCT00090220|559517161|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
155024941|NCT00090220|559517156|FG000|Extension 1 (EXT1)|Moved|0|||
155024942|NCT00090220|559517157|FG001|Extension 1 (EXT1)|Moved|0|||
155024943|NCT00090220|559517158|FG002|Extension 1 (EXT1)|Moved|2|||
155024944|NCT00090220|559517159|FG003|Extension 1 (EXT1)|Moved|1|||
155024945|NCT00090220|559517160|FG004|Extension 1 (EXT1)|Moved|0|||
155024946|NCT00090220|559517161|FG005|Extension 1 (EXT1)|Moved|0|||
155024947|NCT00090220|559517156|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155024948|NCT00090220|559517157|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155024949|NCT00090220|559517158|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
155024950|NCT00090220|559517159|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155024951|NCT00090220|559517160|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155024952|NCT00090220|559517161|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
155024953|NCT00090220|559517156|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
155024954|NCT00090220|559517157|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
155024955|NCT00090220|559517158|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
155024956|NCT00090220|559517159|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
155024957|NCT00090220|559517160|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
155024958|NCT00090220|559517161|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
155024959|NCT00090220|559517156|FG000|Extension 1 (EXT1)|Other reason|0|||
155024960|NCT00090220|559517157|FG001|Extension 1 (EXT1)|Other reason|0|||
155024961|NCT00090220|559517158|FG002|Extension 1 (EXT1)|Other reason|2|||
155024962|NCT00090220|559517159|FG003|Extension 1 (EXT1)|Other reason|0|||
155024963|NCT00090220|559517160|FG004|Extension 1 (EXT1)|Other reason|0|||
155024964|NCT00090220|559517161|FG005|Extension 1 (EXT1)|Other reason|0|||
155024965|NCT00090220|559517156|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155024966|NCT00090220|559517157|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155024967|NCT00090220|559517158|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155024968|NCT00090220|559517159|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
155024969|NCT00090220|559517160|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
155024970|NCT00090220|559517161|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
155024971|NCT00090220|559517156|FG000|Long-term Follow-up (EXT2)|Death|0|||
155024972|NCT00090220|559517157|FG001|Long-term Follow-up (EXT2)|Death|0|||
155024973|NCT00090220|559517158|FG002|Long-term Follow-up (EXT2)|Death|0|||
155024974|NCT00090220|559517159|FG003|Long-term Follow-up (EXT2)|Death|0|||
155024975|NCT00090220|559517160|FG004|Long-term Follow-up (EXT2)|Death|1|||
155024976|NCT00090220|559517161|FG005|Long-term Follow-up (EXT2)|Death|1|||
155024977|NCT00090220|559517156|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155024978|NCT00090220|559517157|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155024979|NCT00090220|559517158|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155024980|NCT00090220|559517159|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
155024981|NCT00090220|559517160|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
155024982|NCT00090220|559517161|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
155024983|NCT00090220|559517156|FG000|Long-term Follow-up (EXT2)|Other|0|||
155024984|NCT00090220|559517157|FG001|Long-term Follow-up (EXT2)|Other|0|||
155024985|NCT00090220|559517158|FG002|Long-term Follow-up (EXT2)|Other|0|||
155024986|NCT00090220|559517159|FG003|Long-term Follow-up (EXT2)|Other|0|||
155024987|NCT00090220|559517160|FG004|Long-term Follow-up (EXT2)|Other|1|||
155024988|NCT00090220|559517161|FG005|Long-term Follow-up (EXT2)|Other|0|||
155024989|NCT02475265|559517162|FG000|Overall Study|Physician Decision|1|||
155024990|NCT02475265|559517162|FG000|Overall Study|Withdrawal by Subject|2|||
155024991|NCT03499899|559517163|FG000|Overall Study|Adverse Event|2|||
155024992|NCT03499899|559517164|FG001|Overall Study|Adverse Event|3|||
155024993|NCT03499899|559517165|FG002|Overall Study|Adverse Event|3|||
155024994|NCT03499899|559517163|FG000|Overall Study|Death|0|||
155024995|NCT03499899|559517164|FG001|Overall Study|Death|0|||
155024996|NCT03499899|559517165|FG002|Overall Study|Death|1|||
155024997|NCT03499899|559517163|FG000|Overall Study|Physician Decision|3|||
155024998|NCT03499899|559517164|FG001|Overall Study|Physician Decision|6|||
155024999|NCT03499899|559517165|FG002|Overall Study|Physician Decision|6|||
155025000|NCT03499899|559517163|FG000|Overall Study|Progressive disease|15|||
155025001|NCT03499899|559517164|FG001|Overall Study|Progressive disease|23|||
155025002|NCT03499899|559517165|FG002|Overall Study|Progressive disease|23|||
155025003|NCT03499899|559517163|FG000|Overall Study|Patient decision|0|||
155025004|NCT03499899|559517164|FG001|Overall Study|Patient decision|1|||
155025005|NCT03499899|559517165|FG002|Overall Study|Patient decision|1|||
155025006|NCT03499899|559517163|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
155025007|NCT03499899|559517164|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
155025008|NCT03499899|559517165|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
155025009|NCT03655470|559517170|FG000|Overall Study|Lost to Follow-up|6|||
155025010|NCT03655470|559517171|FG001|Overall Study|Lost to Follow-up|7|||
155025011|NCT01254318|559517172|FG000|Overall Study|Lost to Follow-up|5|||
155025012|NCT01254318|559517172|FG000|Overall Study|Death|47|||
155025013|NCT01137110|559517179|FG000|Overall Study|Protocol Violation|1|||
155025014|NCT01137110|559517180|FG001|Overall Study|Protocol Violation|0|||
155025015|NCT00886743|559517184|FG000|Overall Study|Adverse Event|3|||
155025016|NCT00886743|559517184|FG000|Overall Study|Other|1|||
155025017|NCT03482453|559517193|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155139968|NCT02487030|559942829|FG003|Overall Study|Death|0|||
155025018|NCT03482453|559517194|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025019|NCT03482453|559517195|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025020|NCT03482453|559517196|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025021|NCT03482453|559517197|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025022|NCT03482453|559517198|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025023|NCT03482453|559517199|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025024|NCT03482453|559517200|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025025|NCT03482453|559517201|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025026|NCT03482453|559517202|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025027|NCT03482453|559517203|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
155139969|NCT02487030|559942830|FG004|Overall Study|Death|1|||
155025028|NCT03482453|559517204|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
155025029|NCT03478644|559517207|FG000|Phase 2|Withdrawal by Subject|2|||
155025030|NCT03478644|559517208|FG001|Phase 2|Withdrawal by Subject|1|||
155025031|NCT03478644|559517207|FG000|Phase 2|Lost to Follow-up|1|||
155025032|NCT03478644|559517208|FG001|Phase 2|Lost to Follow-up|0|||
155025033|NCT00767455|559517209|FG000|Overall Study|Investigator error|19|||
155025034|NCT01314872|559517219|FG000|Treatment Period 1|Protocol Violation|2|||
155025035|NCT01314872|559517220|FG001|Treatment Period 1|Protocol Violation|1|||
155025036|NCT01314872|559517221|FG002|Treatment Period 1|Protocol Violation|1|||
155025037|NCT01314872|559517222|FG003|Treatment Period 1|Protocol Violation|0|||
155025038|NCT01314872|559517223|FG004|Treatment Period 1|Protocol Violation|1|||
155025039|NCT01314872|559517224|FG005|Treatment Period 1|Protocol Violation|0|||
155025040|NCT01314872|559517225|FG006|Treatment Period 1|Protocol Violation|0|||
155025041|NCT01314872|559517226|FG007|Treatment Period 1|Protocol Violation|0|||
155025042|NCT01314872|559517227|FG008|Treatment Period 1|Protocol Violation|0|||
155025043|NCT01314872|559517228|FG009|Treatment Period 1|Protocol Violation|1|||
155025044|NCT01314872|559517229|FG010|Treatment Period 1|Protocol Violation|1|||
155025045|NCT01314872|559517230|FG011|Treatment Period 1|Protocol Violation|0|||
155025046|NCT01314872|559517231|FG012|Treatment Period 1|Protocol Violation|0|||
155025047|NCT01314872|559517232|FG013|Treatment Period 1|Protocol Violation|0|||
155025048|NCT01314872|559517233|FG014|Treatment Period 1|Protocol Violation|0|||
155025049|NCT01314872|559517219|FG000|Treatment Period 1|Physician Decision|0|||
155025050|NCT01314872|559517220|FG001|Treatment Period 1|Physician Decision|1|||
155025051|NCT01314872|559517221|FG002|Treatment Period 1|Physician Decision|0|||
155025052|NCT01314872|559517222|FG003|Treatment Period 1|Physician Decision|1|||
155025053|NCT01314872|559517223|FG004|Treatment Period 1|Physician Decision|0|||
155025054|NCT01314872|559517224|FG005|Treatment Period 1|Physician Decision|0|||
155025055|NCT01314872|559517225|FG006|Treatment Period 1|Physician Decision|0|||
155025056|NCT01314872|559517226|FG007|Treatment Period 1|Physician Decision|0|||
155025057|NCT01314872|559517227|FG008|Treatment Period 1|Physician Decision|0|||
155025058|NCT01314872|559517228|FG009|Treatment Period 1|Physician Decision|1|||
155025059|NCT01314872|559517229|FG010|Treatment Period 1|Physician Decision|0|||
155025060|NCT01314872|559517230|FG011|Treatment Period 1|Physician Decision|0|||
155025061|NCT01314872|559517231|FG012|Treatment Period 1|Physician Decision|0|||
155025062|NCT01314872|559517232|FG013|Treatment Period 1|Physician Decision|0|||
155025063|NCT01314872|559517233|FG014|Treatment Period 1|Physician Decision|0|||
155025064|NCT01314872|559517219|FG000|Treatment Period 1|Lack of Efficacy|1|||
155025065|NCT01314872|559517220|FG001|Treatment Period 1|Lack of Efficacy|0|||
155025066|NCT01314872|559517221|FG002|Treatment Period 1|Lack of Efficacy|0|||
155025067|NCT01314872|559517222|FG003|Treatment Period 1|Lack of Efficacy|0|||
155025068|NCT01314872|559517223|FG004|Treatment Period 1|Lack of Efficacy|0|||
155025069|NCT01314872|559517224|FG005|Treatment Period 1|Lack of Efficacy|1|||
155025070|NCT01314872|559517225|FG006|Treatment Period 1|Lack of Efficacy|0|||
155025071|NCT01314872|559517226|FG007|Treatment Period 1|Lack of Efficacy|2|||
155025072|NCT01314872|559517227|FG008|Treatment Period 1|Lack of Efficacy|0|||
155025073|NCT01314872|559517228|FG009|Treatment Period 1|Lack of Efficacy|0|||
155025074|NCT01314872|559517229|FG010|Treatment Period 1|Lack of Efficacy|0|||
155025075|NCT01314872|559517230|FG011|Treatment Period 1|Lack of Efficacy|0|||
155025076|NCT01314872|559517231|FG012|Treatment Period 1|Lack of Efficacy|0|||
155025077|NCT01314872|559517232|FG013|Treatment Period 1|Lack of Efficacy|0|||
155025078|NCT01314872|559517233|FG014|Treatment Period 1|Lack of Efficacy|0|||
155025079|NCT01314872|559517219|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
155025080|NCT01314872|559517220|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
155180740|NCT02497976|560100742|FG000|Overall Study|Moved out of area|0|||
155180741|NCT02497976|560100743|FG001|Overall Study|Moved out of area|1|||
155180742|NCT00058539|560100747|FG000|Overall Study|Disease progression|24|||
155180743|NCT00058539|560100747|FG000|Overall Study|Adverse Event|3|||
155180744|NCT00058539|560100747|FG000|Overall Study|Withdrawal by Subject|5|||
155025081|NCT01314872|559517221|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
155025082|NCT01314872|559517222|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
155025083|NCT01314872|559517223|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
155025084|NCT01314872|559517224|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
155025085|NCT01314872|559517225|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
155025086|NCT01314872|559517226|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
155025087|NCT01314872|559517227|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
155025088|NCT01314872|559517228|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
155025089|NCT01314872|559517229|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
155025090|NCT01314872|559517230|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
155025091|NCT01314872|559517231|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
155025092|NCT01314872|559517232|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
155025093|NCT01314872|559517233|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
155025094|NCT01314872|559517219|FG000|Treatment Period 1|Withdrawal by Subject|3|||
155025095|NCT01314872|559517220|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155025096|NCT01314872|559517221|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155180745|NCT00058539|560100747|FG000|Overall Study|Physician Decision|9|||
155025097|NCT01314872|559517222|FG003|Treatment Period 1|Withdrawal by Subject|2|||
155025098|NCT01314872|559517223|FG004|Treatment Period 1|Withdrawal by Subject|3|||
155025099|NCT01314872|559517224|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155025100|NCT01314872|559517225|FG006|Treatment Period 1|Withdrawal by Subject|3|||
155025101|NCT01314872|559517226|FG007|Treatment Period 1|Withdrawal by Subject|2|||
155025102|NCT01314872|559517227|FG008|Treatment Period 1|Withdrawal by Subject|2|||
155025103|NCT01314872|559517228|FG009|Treatment Period 1|Withdrawal by Subject|2|||
155025104|NCT01314872|559517229|FG010|Treatment Period 1|Withdrawal by Subject|1|||
155025105|NCT01314872|559517230|FG011|Treatment Period 1|Withdrawal by Subject|0|||
155025106|NCT01314872|559517231|FG012|Treatment Period 1|Withdrawal by Subject|0|||
155025107|NCT01314872|559517232|FG013|Treatment Period 1|Withdrawal by Subject|0|||
155025108|NCT01314872|559517233|FG014|Treatment Period 1|Withdrawal by Subject|0|||
155025109|NCT01314872|559517219|FG000|Treatment Period 1|Lost to Follow-up|0|||
155025110|NCT01314872|559517220|FG001|Treatment Period 1|Lost to Follow-up|1|||
155025111|NCT01314872|559517221|FG002|Treatment Period 1|Lost to Follow-up|2|||
155025112|NCT01314872|559517222|FG003|Treatment Period 1|Lost to Follow-up|2|||
155025113|NCT01314872|559517223|FG004|Treatment Period 1|Lost to Follow-up|1|||
155025114|NCT01314872|559517224|FG005|Treatment Period 1|Lost to Follow-up|1|||
155025115|NCT01314872|559517225|FG006|Treatment Period 1|Lost to Follow-up|1|||
155025116|NCT01314872|559517226|FG007|Treatment Period 1|Lost to Follow-up|1|||
155025117|NCT01314872|559517227|FG008|Treatment Period 1|Lost to Follow-up|1|||
155025118|NCT01314872|559517228|FG009|Treatment Period 1|Lost to Follow-up|0|||
155025119|NCT01314872|559517229|FG010|Treatment Period 1|Lost to Follow-up|0|||
155025120|NCT01314872|559517230|FG011|Treatment Period 1|Lost to Follow-up|0|||
155025121|NCT01314872|559517231|FG012|Treatment Period 1|Lost to Follow-up|0|||
155025122|NCT01314872|559517232|FG013|Treatment Period 1|Lost to Follow-up|0|||
155025123|NCT01314872|559517233|FG014|Treatment Period 1|Lost to Follow-up|0|||
155025124|NCT01314872|559517219|FG000|Period 2|Protocol Violation|0|||
155025125|NCT01314872|559517220|FG001|Period 2|Protocol Violation|0|||
155025126|NCT01314872|559517221|FG002|Period 2|Protocol Violation|0|||
155025127|NCT01314872|559517222|FG003|Period 2|Protocol Violation|0|||
155025128|NCT01314872|559517223|FG004|Period 2|Protocol Violation|0|||
155025129|NCT01314872|559517224|FG005|Period 2|Protocol Violation|0|||
155025130|NCT01314872|559517225|FG006|Period 2|Protocol Violation|0|||
155025131|NCT01314872|559517226|FG007|Period 2|Protocol Violation|0|||
155025132|NCT01314872|559517227|FG008|Period 2|Protocol Violation|0|||
155025133|NCT01314872|559517228|FG009|Period 2|Protocol Violation|0|||
155025134|NCT01314872|559517229|FG010|Period 2|Protocol Violation|0|||
155025135|NCT01314872|559517230|FG011|Period 2|Protocol Violation|3|||
155025136|NCT01314872|559517231|FG012|Period 2|Protocol Violation|3|||
155025137|NCT01314872|559517232|FG013|Period 2|Protocol Violation|2|||
155025138|NCT01314872|559517233|FG014|Period 2|Protocol Violation|0|||
155025139|NCT01314872|559517219|FG000|Period 2|Non-compliance with study drug|0|||
155025140|NCT01314872|559517220|FG001|Period 2|Non-compliance with study drug|0|||
155025141|NCT01314872|559517221|FG002|Period 2|Non-compliance with study drug|0|||
155025142|NCT01314872|559517222|FG003|Period 2|Non-compliance with study drug|0|||
155025143|NCT01314872|559517223|FG004|Period 2|Non-compliance with study drug|0|||
155025144|NCT01314872|559517224|FG005|Period 2|Non-compliance with study drug|0|||
155025145|NCT01314872|559517225|FG006|Period 2|Non-compliance with study drug|0|||
155025146|NCT01314872|559517226|FG007|Period 2|Non-compliance with study drug|0|||
155025147|NCT01314872|559517227|FG008|Period 2|Non-compliance with study drug|0|||
155025148|NCT01314872|559517228|FG009|Period 2|Non-compliance with study drug|0|||
155025149|NCT01314872|559517229|FG010|Period 2|Non-compliance with study drug|0|||
155025150|NCT01314872|559517230|FG011|Period 2|Non-compliance with study drug|3|||
155025151|NCT01314872|559517231|FG012|Period 2|Non-compliance with study drug|3|||
155025152|NCT01314872|559517232|FG013|Period 2|Non-compliance with study drug|1|||
155025153|NCT01314872|559517233|FG014|Period 2|Non-compliance with study drug|2|||
155025154|NCT01314872|559517219|FG000|Period 2|Lack of Efficacy|0|||
155025155|NCT01314872|559517220|FG001|Period 2|Lack of Efficacy|0|||
155025156|NCT01314872|559517221|FG002|Period 2|Lack of Efficacy|0|||
155025157|NCT01314872|559517222|FG003|Period 2|Lack of Efficacy|0|||
155025158|NCT01314872|559517223|FG004|Period 2|Lack of Efficacy|0|||
155025159|NCT01314872|559517224|FG005|Period 2|Lack of Efficacy|0|||
155025160|NCT01314872|559517225|FG006|Period 2|Lack of Efficacy|0|||
155025161|NCT01314872|559517226|FG007|Period 2|Lack of Efficacy|0|||
155025162|NCT01314872|559517227|FG008|Period 2|Lack of Efficacy|0|||
155025163|NCT01314872|559517228|FG009|Period 2|Lack of Efficacy|0|||
155025164|NCT01314872|559517229|FG010|Period 2|Lack of Efficacy|0|||
155025165|NCT01314872|559517230|FG011|Period 2|Lack of Efficacy|7|||
155025166|NCT01314872|559517231|FG012|Period 2|Lack of Efficacy|12|||
155025167|NCT01314872|559517232|FG013|Period 2|Lack of Efficacy|9|||
155025168|NCT01314872|559517233|FG014|Period 2|Lack of Efficacy|2|||
155025169|NCT01314872|559517219|FG000|Period 2|Pregnancy|0|||
155025170|NCT01314872|559517220|FG001|Period 2|Pregnancy|0|||
155025171|NCT01314872|559517221|FG002|Period 2|Pregnancy|0|||
155025172|NCT01314872|559517222|FG003|Period 2|Pregnancy|0|||
155025173|NCT01314872|559517223|FG004|Period 2|Pregnancy|0|||
155025174|NCT01314872|559517224|FG005|Period 2|Pregnancy|0|||
155025175|NCT01314872|559517225|FG006|Period 2|Pregnancy|0|||
155025176|NCT01314872|559517226|FG007|Period 2|Pregnancy|0|||
155025177|NCT01314872|559517227|FG008|Period 2|Pregnancy|0|||
155025178|NCT01314872|559517228|FG009|Period 2|Pregnancy|0|||
155025179|NCT01314872|559517229|FG010|Period 2|Pregnancy|0|||
155025180|NCT01314872|559517230|FG011|Period 2|Pregnancy|0|||
155025181|NCT01314872|559517231|FG012|Period 2|Pregnancy|0|||
155025182|NCT01314872|559517232|FG013|Period 2|Pregnancy|0|||
155025183|NCT01314872|559517233|FG014|Period 2|Pregnancy|1|||
155025184|NCT01314872|559517219|FG000|Period 2|Study terminated by Sponsor|0|||
155025185|NCT01314872|559517220|FG001|Period 2|Study terminated by Sponsor|0|||
155025186|NCT01314872|559517221|FG002|Period 2|Study terminated by Sponsor|0|||
155025187|NCT01314872|559517222|FG003|Period 2|Study terminated by Sponsor|0|||
155025188|NCT01314872|559517223|FG004|Period 2|Study terminated by Sponsor|0|||
155025189|NCT01314872|559517224|FG005|Period 2|Study terminated by Sponsor|0|||
155025190|NCT01314872|559517225|FG006|Period 2|Study terminated by Sponsor|0|||
155025191|NCT01314872|559517226|FG007|Period 2|Study terminated by Sponsor|0|||
155025192|NCT01314872|559517227|FG008|Period 2|Study terminated by Sponsor|0|||
155025193|NCT01314872|559517228|FG009|Period 2|Study terminated by Sponsor|0|||
155025194|NCT01314872|559517229|FG010|Period 2|Study terminated by Sponsor|0|||
155025195|NCT01314872|559517230|FG011|Period 2|Study terminated by Sponsor|2|||
155025196|NCT01314872|559517231|FG012|Period 2|Study terminated by Sponsor|2|||
155025197|NCT01314872|559517232|FG013|Period 2|Study terminated by Sponsor|3|||
155025198|NCT01314872|559517233|FG014|Period 2|Study terminated by Sponsor|0|||
155025199|NCT01314872|559517219|FG000|Period 2|Adverse event, non-fatal|0|||
155025200|NCT01314872|559517220|FG001|Period 2|Adverse event, non-fatal|0|||
155025201|NCT01314872|559517221|FG002|Period 2|Adverse event, non-fatal|0|||
155025202|NCT01314872|559517222|FG003|Period 2|Adverse event, non-fatal|0|||
155025203|NCT01314872|559517223|FG004|Period 2|Adverse event, non-fatal|0|||
155025204|NCT01314872|559517224|FG005|Period 2|Adverse event, non-fatal|0|||
155025205|NCT01314872|559517225|FG006|Period 2|Adverse event, non-fatal|0|||
155025206|NCT01314872|559517226|FG007|Period 2|Adverse event, non-fatal|0|||
155025207|NCT01314872|559517227|FG008|Period 2|Adverse event, non-fatal|0|||
155025208|NCT01314872|559517228|FG009|Period 2|Adverse event, non-fatal|0|||
155025209|NCT01314872|559517229|FG010|Period 2|Adverse event, non-fatal|0|||
155025210|NCT01314872|559517230|FG011|Period 2|Adverse event, non-fatal|13|||
155025211|NCT01314872|559517231|FG012|Period 2|Adverse event, non-fatal|16|||
155025212|NCT01314872|559517232|FG013|Period 2|Adverse event, non-fatal|24|||
155025213|NCT01314872|559517233|FG014|Period 2|Adverse event, non-fatal|9|||
155025214|NCT01314872|559517219|FG000|Period 2|Withdrawal by Subject|0|||
155025215|NCT01314872|559517220|FG001|Period 2|Withdrawal by Subject|0|||
155025216|NCT01314872|559517221|FG002|Period 2|Withdrawal by Subject|0|||
155025217|NCT01314872|559517222|FG003|Period 2|Withdrawal by Subject|0|||
155025218|NCT01314872|559517223|FG004|Period 2|Withdrawal by Subject|0|||
155025219|NCT01314872|559517224|FG005|Period 2|Withdrawal by Subject|0|||
155025220|NCT01314872|559517225|FG006|Period 2|Withdrawal by Subject|0|||
155025221|NCT01314872|559517226|FG007|Period 2|Withdrawal by Subject|0|||
155025222|NCT01314872|559517227|FG008|Period 2|Withdrawal by Subject|0|||
155025223|NCT01314872|559517228|FG009|Period 2|Withdrawal by Subject|0|||
155025224|NCT01314872|559517229|FG010|Period 2|Withdrawal by Subject|0|||
155025225|NCT01314872|559517230|FG011|Period 2|Withdrawal by Subject|14|||
155025226|NCT01314872|559517231|FG012|Period 2|Withdrawal by Subject|17|||
155025227|NCT01314872|559517232|FG013|Period 2|Withdrawal by Subject|12|||
155025228|NCT01314872|559517233|FG014|Period 2|Withdrawal by Subject|4|||
155025229|NCT01314872|559517219|FG000|Period 2|Lost to Follow-up|0|||
155025230|NCT01314872|559517220|FG001|Period 2|Lost to Follow-up|0|||
155025231|NCT01314872|559517221|FG002|Period 2|Lost to Follow-up|0|||
155025232|NCT01314872|559517222|FG003|Period 2|Lost to Follow-up|0|||
155025233|NCT01314872|559517223|FG004|Period 2|Lost to Follow-up|0|||
155025234|NCT01314872|559517224|FG005|Period 2|Lost to Follow-up|0|||
155025235|NCT01314872|559517225|FG006|Period 2|Lost to Follow-up|0|||
155025236|NCT01314872|559517226|FG007|Period 2|Lost to Follow-up|0|||
155025237|NCT01314872|559517227|FG008|Period 2|Lost to Follow-up|0|||
155025238|NCT01314872|559517228|FG009|Period 2|Lost to Follow-up|0|||
155025239|NCT01314872|559517229|FG010|Period 2|Lost to Follow-up|0|||
155025240|NCT01314872|559517230|FG011|Period 2|Lost to Follow-up|6|||
155025241|NCT01314872|559517231|FG012|Period 2|Lost to Follow-up|7|||
155025242|NCT01314872|559517232|FG013|Period 2|Lost to Follow-up|2|||
155025243|NCT01314872|559517233|FG014|Period 2|Lost to Follow-up|6|||
155025244|NCT03634033|559519066|FG000|Overall Study|Did not have a post-assessment|384|||
155025245|NCT03634033|559519067|FG001|Overall Study|Did not have a post-assessment|291|||
155025246|NCT03634033|559519068|FG002|Overall Study|Did not have a post-assessment|114|||
155025247|NCT03634033|559519069|FG003|Overall Study|Did not have a post-assessment|161|||
155025248|NCT03634033|559519070|FG004|Overall Study|Did not have a post-assessment|5|||
155025249|NCT03634033|559519071|FG005|Overall Study|Did not have a post-assessment|0|||
155025250|NCT03634033|559519072|FG006|Overall Study|Did not have a post-assessment|0|||
155025251|NCT03634033|559519066|FG000|Overall Study|Death|0|||
155025252|NCT03634033|559519067|FG001|Overall Study|Death|0|||
155025253|NCT03634033|559519068|FG002|Overall Study|Death|0|||
155025254|NCT03634033|559519069|FG003|Overall Study|Death|0|||
155025255|NCT03634033|559519070|FG004|Overall Study|Death|0|||
155025256|NCT03634033|559519071|FG005|Overall Study|Death|7|||
155025257|NCT03634033|559519072|FG006|Overall Study|Death|7|||
155025258|NCT03634033|559519066|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155025259|NCT03634033|559519067|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155025260|NCT03634033|559519068|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155025261|NCT03634033|559519069|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155025262|NCT03634033|559519070|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
155025263|NCT03634033|559519071|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
155025264|NCT03634033|559519072|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
155025265|NCT03634033|559519066|FG000|Overall Study|Lost to Follow-up|0|||
155025266|NCT03634033|559519067|FG001|Overall Study|Lost to Follow-up|0|||
155025267|NCT03634033|559519068|FG002|Overall Study|Lost to Follow-up|0|||
155025268|NCT03634033|559519069|FG003|Overall Study|Lost to Follow-up|0|||
155025269|NCT03634033|559519070|FG004|Overall Study|Lost to Follow-up|0|||
155025270|NCT03634033|559519071|FG005|Overall Study|Lost to Follow-up|1|||
155025271|NCT03634033|559519072|FG006|Overall Study|Lost to Follow-up|2|||
155025272|NCT03634033|559519066|FG000|Overall Study|Withdrawal by Subject|0|||
155025273|NCT03634033|559519067|FG001|Overall Study|Withdrawal by Subject|0|||
155025274|NCT03634033|559519068|FG002|Overall Study|Withdrawal by Subject|0|||
155025275|NCT03634033|559519069|FG003|Overall Study|Withdrawal by Subject|0|||
155025276|NCT03634033|559519070|FG004|Overall Study|Withdrawal by Subject|0|||
155025277|NCT03634033|559519071|FG005|Overall Study|Withdrawal by Subject|0|||
155025278|NCT03634033|559519072|FG006|Overall Study|Withdrawal by Subject|1|||
155025279|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
155025280|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
155025281|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
155025282|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
155025283|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Death|0|||
155025284|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Death|0|||
155025285|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Death|1|||
155025286|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Death|0|||
155025287|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
155025288|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
155025289|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
155025290|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
155025291|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
155025292|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
155025293|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
155025294|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
155025295|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
155025296|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
155025297|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
155025298|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
155025299|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
155025300|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
155025301|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
155025302|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
155025303|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
155025304|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
155025305|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
155025306|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
155025307|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
155025308|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
155025309|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
155025310|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
155025311|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
155025312|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
155025313|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155025314|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
155025315|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
155025316|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
155025317|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
155025318|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
155025319|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
155025320|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
155025321|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
155025322|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
155025323|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Other|8|||
155025324|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Other|14|||
155025325|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Other|8|||
155025326|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Other|23|||
155025327|NCT01106677|559519074|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
155025328|NCT01106677|559519075|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
155025329|NCT01106677|559519076|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
155025330|NCT01106677|559519077|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
155025331|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155025332|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
155025333|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
155025334|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
155025335|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Death|0|||
155025336|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Death|0|||
155025337|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Death|0|||
155025338|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Death|1|||
155025339|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
155025340|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
155025341|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
155025342|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
155025343|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
155025344|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155025345|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155025346|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
155025347|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155025348|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
155025349|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
155025350|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
155025351|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
155025352|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155025353|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155025354|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
155025355|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155025356|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
155025357|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
155025358|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
155025359|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
155025360|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
155025361|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
155025362|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
155025363|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155025364|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155025365|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
155025366|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
155025367|NCT01106677|559519074|FG000|Extension Period: Week 26 to Week 52|Other|6|||
155025368|NCT01106677|559519075|FG001|Extension Period: Week 26 to Week 52|Other|5|||
155025369|NCT01106677|559519076|FG002|Extension Period: Week 26 to Week 52|Other|8|||
155025370|NCT01106677|559519077|FG003|Extension Period: Week 26 to Week 52|Other|5|||
155025371|NCT03937908|559519078|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
155025372|NCT03937908|559519079|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
155025373|NCT03875092|559519080|FG000|Overall Study|Adverse Event|2|||
155025374|NCT03875092|559519081|FG001|Overall Study|Adverse Event|5|||
155025375|NCT03875092|559519080|FG000|Overall Study|Death|44|||
155025376|NCT03875092|559519081|FG001|Overall Study|Death|51|||
155025377|NCT03875092|559519080|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
155025378|NCT03875092|559519081|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
155025379|NCT04114357|559519082|FG000|Baseline-Randomization|Adverse Event|2|||
155025380|NCT04114357|559519083|FG001|Baseline-Randomization|Adverse Event|1|||
155025381|NCT04114357|559519082|FG000|Baseline-Randomization|Lost to Follow-up|1|||
155025382|NCT04114357|559519083|FG001|Baseline-Randomization|Lost to Follow-up|1|||
155139970|NCT02487030|559942831|FG005|Overall Study|Death|0|||
155139971|NCT02487030|559942832|FG006|Overall Study|Death|0|||
155139972|NCT00947115|559942833|FG000|Overall Study|Missed reporting interval|3|||
155139973|NCT00947115|559942834|FG001|Overall Study|Missed reporting interval|4|||
155139974|NCT00947115|559942835|FG002|Overall Study|Missed reporting interval|2|||
155139975|NCT00947115|559942833|FG000|Overall Study|Physician Decision|0|||
155139976|NCT00947115|559942834|FG001|Overall Study|Physician Decision|2|||
155139977|NCT00947115|559942835|FG002|Overall Study|Physician Decision|0|||
155139978|NCT00947115|559942833|FG000|Overall Study|Death|0|||
155139979|NCT00947115|559942834|FG001|Overall Study|Death|1|||
155025383|NCT04114357|559519082|FG000|Cross-over|Adverse Event|0|||
155025384|NCT04114357|559519083|FG001|Cross-over|Adverse Event|1|||
155180746|NCT00058539|560100747|FG000|Overall Study|Death|1|||
155180747|NCT04365257|560100748|FG000|Overall Study|Physician Decision|1|||
155180748|NCT04365257|560100749|FG001|Overall Study|Physician Decision|0|||
155180749|NCT04365257|560100748|FG000|Overall Study|Patient Noncompliance|1|||
155180750|NCT04365257|560100749|FG001|Overall Study|Patient Noncompliance|0|||
155180751|NCT04365257|560100748|FG000|Overall Study|Withdrawal by Subject|0|||
155180752|NCT04365257|560100749|FG001|Overall Study|Withdrawal by Subject|1|||
155180753|NCT02129777|560100752|FG000|Double-Blind Period|Adverse Event|0|||
155180754|NCT02129777|560100753|FG001|Double-Blind Period|Adverse Event|0|||
155180755|NCT02129777|560100754|FG002|Double-Blind Period|Adverse Event|0|||
155180756|NCT02129777|560100755|FG003|Double-Blind Period|Adverse Event|0|||
155180757|NCT02129777|560100756|FG004|Double-Blind Period|Adverse Event|1|||
155180758|NCT02129777|560100757|FG005|Double-Blind Period|Adverse Event|0|||
155180759|NCT02129777|560100758|FG006|Double-Blind Period|Adverse Event|0|||
155180760|NCT02129777|560100752|FG000|Double-Blind Period|Lost to Follow-up|1|||
155180761|NCT02129777|560100753|FG001|Double-Blind Period|Lost to Follow-up|1|||
155180762|NCT02129777|560100754|FG002|Double-Blind Period|Lost to Follow-up|1|||
155180763|NCT02129777|560100755|FG003|Double-Blind Period|Lost to Follow-up|2|||
155180764|NCT02129777|560100756|FG004|Double-Blind Period|Lost to Follow-up|0|||
155180765|NCT02129777|560100757|FG005|Double-Blind Period|Lost to Follow-up|0|||
155180766|NCT02129777|560100758|FG006|Double-Blind Period|Lost to Follow-up|0|||
155180767|NCT02129777|560100752|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155180768|NCT02129777|560100753|FG001|Double-Blind Period|Withdrawal by Subject|4|||
155025385|NCT03693612|559519087|FG000|Overall Study|Lost to Follow-up|0|||
155025386|NCT03693612|559519088|FG001|Overall Study|Lost to Follow-up|0|||
155025387|NCT03693612|559519089|FG002|Overall Study|Lost to Follow-up|0|||
155025388|NCT03693612|559519090|FG003|Overall Study|Lost to Follow-up|0|||
155025389|NCT03693612|559519091|FG004|Overall Study|Lost to Follow-up|1|||
155025390|NCT03693612|559519092|FG005|Overall Study|Lost to Follow-up|0|||
155025391|NCT03693612|559519093|FG006|Overall Study|Lost to Follow-up|0|||
155025392|NCT03693612|559519087|FG000|Overall Study|Withdrawal by Subject|0|||
155025393|NCT03693612|559519088|FG001|Overall Study|Withdrawal by Subject|0|||
155025394|NCT03693612|559519089|FG002|Overall Study|Withdrawal by Subject|1|||
155025395|NCT03693612|559519090|FG003|Overall Study|Withdrawal by Subject|0|||
155025396|NCT03693612|559519091|FG004|Overall Study|Withdrawal by Subject|2|||
155025397|NCT03693612|559519092|FG005|Overall Study|Withdrawal by Subject|0|||
155180769|NCT02129777|560100754|FG002|Double-Blind Period|Withdrawal by Subject|3|||
155180770|NCT02129777|560100755|FG003|Double-Blind Period|Withdrawal by Subject|2|||
155180771|NCT02129777|560100756|FG004|Double-Blind Period|Withdrawal by Subject|3|||
155180772|NCT02129777|560100757|FG005|Double-Blind Period|Withdrawal by Subject|0|||
155180773|NCT02129777|560100758|FG006|Double-Blind Period|Withdrawal by Subject|0|||
155180774|NCT02129777|560100752|FG000|Double-Blind Period|Pregnancy|0|||
155180775|NCT02129777|560100753|FG001|Double-Blind Period|Pregnancy|0|||
155180776|NCT02129777|560100754|FG002|Double-Blind Period|Pregnancy|0|||
155180777|NCT02129777|560100755|FG003|Double-Blind Period|Pregnancy|0|||
155180778|NCT02129777|560100756|FG004|Double-Blind Period|Pregnancy|1|||
155180779|NCT02129777|560100757|FG005|Double-Blind Period|Pregnancy|0|||
155180780|NCT02129777|560100758|FG006|Double-Blind Period|Pregnancy|0|||
155025398|NCT03693612|559519093|FG006|Overall Study|Withdrawal by Subject|0|||
155025399|NCT03693612|559519087|FG000|Overall Study|Study Terminated by Sponsor|0|||
155025400|NCT03693612|559519088|FG001|Overall Study|Study Terminated by Sponsor|1|||
155025401|NCT03693612|559519089|FG002|Overall Study|Study Terminated by Sponsor|0|||
155025402|NCT03693612|559519090|FG003|Overall Study|Study Terminated by Sponsor|0|||
155025403|NCT03693612|559519091|FG004|Overall Study|Study Terminated by Sponsor|3|||
155025404|NCT03693612|559519092|FG005|Overall Study|Study Terminated by Sponsor|0|||
155025405|NCT03693612|559519093|FG006|Overall Study|Study Terminated by Sponsor|0|||
155025406|NCT00809471|559519095|FG000|Overall Study|Protocol non-compliance|15|||
155025407|NCT00809471|559519096|FG001|Overall Study|Protocol non-compliance|15|||
155025408|NCT00809471|559519097|FG002|Overall Study|Protocol non-compliance|6|||
155025409|NCT00809471|559519095|FG000|Overall Study|Lost to Follow-up|4|||
155025410|NCT00809471|559519096|FG001|Overall Study|Lost to Follow-up|2|||
155025411|NCT00809471|559519097|FG002|Overall Study|Lost to Follow-up|9|||
155025412|NCT00809471|559519095|FG000|Overall Study|Adverse Event|0|||
155025413|NCT00809471|559519096|FG001|Overall Study|Adverse Event|2|||
155025414|NCT00809471|559519097|FG002|Overall Study|Adverse Event|2|||
155025415|NCT00809471|559519095|FG000|Overall Study|Requirement for restricted medication|1|||
155025416|NCT00809471|559519096|FG001|Overall Study|Requirement for restricted medication|1|||
155180781|NCT02129777|560100752|FG000|Double-Blind Period|Lack of Efficacy|3|||
155180782|NCT02129777|560100753|FG001|Double-Blind Period|Lack of Efficacy|1|||
155180783|NCT02129777|560100754|FG002|Double-Blind Period|Lack of Efficacy|0|||
155025417|NCT00809471|559519097|FG002|Overall Study|Requirement for restricted medication|0|||
155025418|NCT05318092|559519100|FG000|Overall Study|Lost to Follow-up|3|||
155025419|NCT05318092|559519100|FG000|Overall Study|Withdrawal by Subject|1|||
155025420|NCT01669174|559519108|FG000|Overall Study|Subject withdrew consent|2|||
155180784|NCT02129777|560100755|FG003|Double-Blind Period|Lack of Efficacy|3|||
155025421|NCT01669174|559519109|FG001|Overall Study|Subject withdrew consent|2|||
155025422|NCT01669174|559519108|FG000|Overall Study|Lost to Follow-up|1|||
155025423|NCT01669174|559519109|FG001|Overall Study|Lost to Follow-up|0|||
155025424|NCT01669174|559519108|FG000|Overall Study|Adverse Event|2|||
155025425|NCT01669174|559519109|FG001|Overall Study|Adverse Event|2|||
155025426|NCT01669174|559519108|FG000|Overall Study|Administrative problems|1|||
155025427|NCT01669174|559519109|FG001|Overall Study|Administrative problems|2|||
155025428|NCT01953601|559519114|FG000|Part 1 (Base Study)|Adverse Event|24|||
155025429|NCT01953601|559519115|FG001|Part 1 (Base Study)|Adverse Event|37|||
155025430|NCT01953601|559519116|FG002|Part 1 (Base Study)|Adverse Event|15|||
155025431|NCT01953601|559519114|FG000|Part 1 (Base Study)|Death|2|||
155025432|NCT01953601|559519115|FG001|Part 1 (Base Study)|Death|0|||
155025433|NCT01953601|559519116|FG002|Part 1 (Base Study)|Death|3|||
155025434|NCT01953601|559519114|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
155025435|NCT01953601|559519115|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
155025436|NCT01953601|559519116|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
155025437|NCT01953601|559519114|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
155025438|NCT01953601|559519115|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
155025439|NCT01953601|559519116|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
155025440|NCT01953601|559519114|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
155025441|NCT01953601|559519115|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
155025442|NCT01953601|559519116|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
155025443|NCT01953601|559519114|FG000|Part 1 (Base Study)|Physician Decision|3|||
155025444|NCT01953601|559519115|FG001|Part 1 (Base Study)|Physician Decision|7|||
155025445|NCT01953601|559519116|FG002|Part 1 (Base Study)|Physician Decision|4|||
155025446|NCT01953601|559519114|FG000|Part 1 (Base Study)|Screen failure|1|||
155025447|NCT01953601|559519115|FG001|Part 1 (Base Study)|Screen failure|0|||
155025448|NCT01953601|559519116|FG002|Part 1 (Base Study)|Screen failure|1|||
155025449|NCT01953601|559519114|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
155025450|NCT01953601|559519115|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
155025451|NCT01953601|559519116|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
155025452|NCT01953601|559519114|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
155025453|NCT01953601|559519115|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
155025454|NCT01953601|559519116|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
155025455|NCT01953601|559519114|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
155025456|NCT01953601|559519115|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
155025457|NCT01953601|559519116|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
155025458|NCT01953601|559519114|FG000|Part 1 (Base Study)|Subject moved|2|||
155025459|NCT01953601|559519115|FG001|Part 1 (Base Study)|Subject moved|2|||
155025460|NCT01953601|559519116|FG002|Part 1 (Base Study)|Subject moved|1|||
155025461|NCT01953601|559519114|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
155025462|NCT01953601|559519115|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
155025463|NCT01953601|559519116|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
155025464|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Adverse Event|1|||
155025465|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Adverse Event|1|||
155025466|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Adverse Event|10|||
155025467|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Death|0|||
155025468|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Death|3|||
155025469|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Death|0|||
155025470|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
155025471|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
155025472|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
155025473|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
155025474|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
155025475|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
155025476|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Physician Decision|2|||
155025477|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Physician Decision|0|||
155025478|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Physician Decision|2|||
155025479|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
155025480|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
155025481|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
155025482|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
155025483|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
155025484|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
155025485|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
155025486|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
155025487|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
155139980|NCT00947115|559942835|FG002|Overall Study|Death|1|||
155139981|NCT00947115|559942833|FG000|Overall Study|Migrated from study area|2|||
155025488|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Subject moved|0|||
155025489|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Subject moved|0|||
155025490|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Subject moved|1|||
155139982|NCT00947115|559942834|FG001|Overall Study|Migrated from study area|0|||
155025491|NCT01953601|559519114|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
155025492|NCT01953601|559519115|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
155025493|NCT01953601|559519116|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
155025494|NCT04310397|559519123|FG000|Overall Study|Lack of Efficacy|3|||
155025495|NCT04310397|559519123|FG000|Overall Study|Withdrawal by Subject|1|||
155025496|NCT00614523|559519126|FG000|Overall Study|Adverse Event|4|||
155025497|NCT00614523|559519127|FG001|Overall Study|Adverse Event|20|||
155025498|NCT00614523|559519126|FG000|Overall Study|Death|5|||
155025499|NCT00614523|559519127|FG001|Overall Study|Death|8|||
155025500|NCT00614523|559519126|FG000|Overall Study|Lack of Efficacy|9|||
155025501|NCT00614523|559519127|FG001|Overall Study|Lack of Efficacy|11|||
155025502|NCT00614523|559519126|FG000|Overall Study|Lost to Follow-up|0|||
155025503|NCT00614523|559519127|FG001|Overall Study|Lost to Follow-up|1|||
155025504|NCT00614523|559519126|FG000|Overall Study|Protocol Violation|3|||
155025505|NCT00614523|559519127|FG001|Overall Study|Protocol Violation|2|||
155025506|NCT00614523|559519126|FG000|Overall Study|Withdrawal by Subject|12|||
155025507|NCT00614523|559519127|FG001|Overall Study|Withdrawal by Subject|22|||
155025508|NCT00614523|559519126|FG000|Overall Study|Other|6|||
155025509|NCT00614523|559519127|FG001|Overall Study|Other|11|||
155025510|NCT00614523|559519126|FG000|Overall Study|Ineligibility Determined|1|||
155025511|NCT00614523|559519127|FG001|Overall Study|Ineligibility Determined|2|||
155025512|NCT00614523|559519126|FG000|Overall Study|Disease Progression|0|||
155025513|NCT00614523|559519127|FG001|Overall Study|Disease Progression|8|||
155025514|NCT00614523|559519126|FG000|Overall Study|Administrative Decision|23|||
155025515|NCT00614523|559519127|FG001|Overall Study|Administrative Decision|46|||
155025516|NCT00723255|559519130|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
155025517|NCT00723255|559519130|FG000|Overall Study|Ineligible: Second primary|1|||
155025518|NCT00723255|559519130|FG000|Overall Study|Ineligible: Wrong Primary|2|||
155025519|NCT03962790|559519131|FG000|Period 1|Adverse Event|0|||
155025520|NCT03962790|559519132|FG001|Period 1|Adverse Event|1|||
155025521|NCT03962790|559519131|FG000|Period 1|Failed to meet all eligibility criteria|1|||
155025522|NCT03962790|559519132|FG001|Period 1|Failed to meet all eligibility criteria|1|||
155025523|NCT03962790|559519131|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
155025524|NCT03962790|559519132|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
155025525|NCT03962790|559519131|FG000|Period 1|Withdrawal by Subject|1|||
155025526|NCT03962790|559519132|FG001|Period 1|Withdrawal by Subject|0|||
155025527|NCT03854370|559519142|FG000|Overall Study|samples not collected|1|||
155025528|NCT03854370|559519143|FG001|Overall Study|samples not collected|1|||
155025529|NCT03854370|559519144|FG002|Overall Study|samples not collected|1|||
155025530|NCT03854370|559519145|FG003|Overall Study|samples not collected|1|||
155025531|NCT00452673|559519149|FG000|Dose Escalation Period|Disease Progression|6|||
155025532|NCT00452673|559519150|FG001|Dose Escalation Period|Disease Progression|6|||
155025533|NCT00452673|559519151|FG002|Dose Escalation Period|Disease Progression|2|||
155025534|NCT00452673|559519152|FG003|Dose Escalation Period|Disease Progression|6|||
155025535|NCT00452673|559519153|FG004|Dose Escalation Period|Disease Progression|0|||
155025536|NCT00452673|559519149|FG000|Dose Escalation Period|study drug toxicity|1|||
155025537|NCT00452673|559519150|FG001|Dose Escalation Period|study drug toxicity|3|||
155025538|NCT00452673|559519151|FG002|Dose Escalation Period|study drug toxicity|3|||
155025539|NCT00452673|559519152|FG003|Dose Escalation Period|study drug toxicity|1|||
155025540|NCT00452673|559519153|FG004|Dose Escalation Period|study drug toxicity|0|||
155025541|NCT00452673|559519149|FG000|Dose Escalation Period|Other|0|||
155025542|NCT00452673|559519150|FG001|Dose Escalation Period|Other|0|||
155025543|NCT00452673|559519151|FG002|Dose Escalation Period|Other|1|||
155025544|NCT00452673|559519152|FG003|Dose Escalation Period|Other|0|||
155025545|NCT00452673|559519153|FG004|Dose Escalation Period|Other|0|||
155025546|NCT00452673|559519149|FG000|Dose Escalation Period|Adverse Event|0|||
155025547|NCT00452673|559519150|FG001|Dose Escalation Period|Adverse Event|0|||
155025548|NCT00452673|559519151|FG002|Dose Escalation Period|Adverse Event|0|||
155025549|NCT00452673|559519152|FG003|Dose Escalation Period|Adverse Event|1|||
155025550|NCT00452673|559519153|FG004|Dose Escalation Period|Adverse Event|0|||
155025551|NCT00452673|559519149|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
155025552|NCT00452673|559519150|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
155025553|NCT00452673|559519151|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
155025554|NCT00452673|559519152|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
155025555|NCT00452673|559519153|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
155025556|NCT00452673|559519149|FG000|Dose Expansion Period|Disease Progression|0|||
155025557|NCT00452673|559519150|FG001|Dose Expansion Period|Disease Progression|0|||
155025558|NCT00452673|559519151|FG002|Dose Expansion Period|Disease Progression|0|||
155025559|NCT00452673|559519152|FG003|Dose Expansion Period|Disease Progression|0|||
155025560|NCT00452673|559519153|FG004|Dose Expansion Period|Disease Progression|19|||
155025561|NCT00452673|559519149|FG000|Dose Expansion Period|Other|0|||
155025562|NCT00452673|559519150|FG001|Dose Expansion Period|Other|0|||
155139983|NCT00947115|559942835|FG002|Overall Study|Migrated from study area|0|||
155025563|NCT00452673|559519151|FG002|Dose Expansion Period|Other|0|||
155025564|NCT00452673|559519152|FG003|Dose Expansion Period|Other|0|||
155025565|NCT00452673|559519153|FG004|Dose Expansion Period|Other|2|||
155025566|NCT02656290|559519154|FG000|Overall Study|Lost to Follow-up|1|||
155025567|NCT02656290|559519154|FG000|Overall Study|Reintervention|3|||
155025568|NCT01608087|559519157|FG000|Overall Study|Lost to Follow-up|0|||
155025569|NCT01608087|559519158|FG001|Overall Study|Lost to Follow-up|1|||
155025570|NCT01608087|559519159|FG002|Overall Study|Lost to Follow-up|0|||
155025571|NCT01608087|559519157|FG000|Overall Study|Other Reason|0|||
155025572|NCT01608087|559519158|FG001|Overall Study|Other Reason|1|||
155025573|NCT01608087|559519159|FG002|Overall Study|Other Reason|0|||
155025574|NCT00401544|559519162|FG000|Overall Study|Adverse Event|5|||
155025575|NCT00401544|559519163|FG001|Overall Study|Adverse Event|1|||
155025576|NCT00401544|559519164|FG002|Overall Study|Adverse Event|1|||
155025577|NCT00401544|559519165|FG003|Overall Study|Adverse Event|1|||
155025578|NCT00401544|559519162|FG000|Overall Study|Death|3|||
155025579|NCT00401544|559519163|FG001|Overall Study|Death|6|||
155025580|NCT00401544|559519164|FG002|Overall Study|Death|2|||
155025581|NCT00401544|559519165|FG003|Overall Study|Death|5|||
155025582|NCT00401544|559519162|FG000|Overall Study|Lost to Follow-up|2|||
155025583|NCT00401544|559519163|FG001|Overall Study|Lost to Follow-up|0|||
155025584|NCT00401544|559519164|FG002|Overall Study|Lost to Follow-up|1|||
155025585|NCT00401544|559519165|FG003|Overall Study|Lost to Follow-up|1|||
155025586|NCT00401544|559519162|FG000|Overall Study|Withdrawal by Subject|7|||
155025587|NCT00401544|559519163|FG001|Overall Study|Withdrawal by Subject|6|||
155025588|NCT00401544|559519164|FG002|Overall Study|Withdrawal by Subject|6|||
155025589|NCT00401544|559519165|FG003|Overall Study|Withdrawal by Subject|5|||
155025590|NCT00401544|559519162|FG000|Overall Study|Physician Decision|1|||
155025591|NCT00401544|559519163|FG001|Overall Study|Physician Decision|3|||
155025592|NCT00401544|559519164|FG002|Overall Study|Physician Decision|0|||
155025593|NCT00401544|559519165|FG003|Overall Study|Physician Decision|0|||
155025594|NCT00401544|559519162|FG000|Overall Study|Ineligibility determined|0|||
155025595|NCT00401544|559519163|FG001|Overall Study|Ineligibility determined|1|||
155025596|NCT00401544|559519164|FG002|Overall Study|Ineligibility determined|0|||
155025597|NCT00401544|559519165|FG003|Overall Study|Ineligibility determined|2|||
155025598|NCT00401544|559519162|FG000|Overall Study|Disease progression|0|||
155025599|NCT00401544|559519163|FG001|Overall Study|Disease progression|1|||
155025600|NCT00401544|559519164|FG002|Overall Study|Disease progression|0|||
155025601|NCT00401544|559519165|FG003|Overall Study|Disease progression|0|||
155025602|NCT00401544|559519162|FG000|Overall Study|Other|0|||
155025603|NCT00401544|559519163|FG001|Overall Study|Other|0|||
155025604|NCT00401544|559519164|FG002|Overall Study|Other|2|||
155025605|NCT00401544|559519165|FG003|Overall Study|Other|2|||
155025606|NCT04984278|559519166|FG000|Period 1|Withdrawal by Subject|1|||
155025607|NCT04984278|559519167|FG001|Period 1|Withdrawal by Subject|0|||
155025608|NCT04984278|559519166|FG000|Period 1|Other|0|||
155025609|NCT04984278|559519167|FG001|Period 1|Other|1|||
155025610|NCT04984278|559519166|FG000|Period 2|Adverse Event|1|||
155025611|NCT04984278|559519167|FG001|Period 2|Adverse Event|0|||
155025612|NCT04984278|559519166|FG000|Period 2|Other|0|||
155025613|NCT04984278|559519167|FG001|Period 2|Other|1|||
155025614|NCT04411810|559519168|FG000|Overall Study|Screen failure|1|||
155025615|NCT04411810|559519168|FG000|Overall Study|Withdrawal by Subject|1|||
155025616|NCT01289639|559519171|FG000|Overall Study|Lost to Follow-up|1|||
155025617|NCT01289639|559519172|FG001|Overall Study|Lost to Follow-up|0|||
155025618|NCT01289639|559519173|FG002|Overall Study|Lost to Follow-up|0|||
155025619|NCT02780713|559519174|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155025620|NCT02780713|559519175|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155025621|NCT02780713|559519176|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
155025622|NCT02780713|559519177|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155025623|NCT02780713|559519178|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
155025624|NCT01931475|559519179|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
155025625|NCT01931475|559519180|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
155025626|NCT01931475|559519179|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
155025627|NCT01931475|559519180|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
155025628|NCT01931475|559519179|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
155025629|NCT01931475|559519180|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
155025630|NCT01931475|559519179|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
155025631|NCT01931475|559519180|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
155025632|NCT01931475|559519179|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
155025633|NCT01931475|559519180|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
155025634|NCT01931475|559519179|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
155025635|NCT01931475|559519180|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
155025636|NCT01931475|559519179|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
155025637|NCT01931475|559519180|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
155025638|NCT01931475|559519179|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
155025639|NCT01931475|559519180|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
155025640|NCT01931475|559519179|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
155025641|NCT01931475|559519180|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
155025642|NCT01931475|559519179|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
155025643|NCT01931475|559519180|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
155025644|NCT01931475|559519179|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
155025645|NCT01931475|559519180|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
155025646|NCT03991299|559519183|FG000|Overall Study|Study closed, sponsor decision|3|||
155025647|NCT03991299|559519183|FG000|Overall Study|Withdrawal by Subject|1|||
155025648|NCT04304235|559519184|FG000|Overall Study|incomplete triage data|0|||
155025649|NCT04304235|559519185|FG001|Overall Study|incomplete triage data|69|||
155025650|NCT04304235|559519186|FG002|Overall Study|incomplete triage data|0|||
155025651|NCT04304235|559519187|FG003|Overall Study|incomplete triage data|0|||
155025652|NCT04304235|559519188|FG004|Overall Study|incomplete triage data|289|||
155025653|NCT04304235|559519189|FG005|Overall Study|incomplete triage data|123|||
155025654|NCT04304235|559519190|FG006|Overall Study|incomplete triage data|65|||
155025655|NCT02278939|559519193|FG000|Overall Study|lack of time|1|||
155025656|NCT02278939|559519194|FG001|Overall Study|lack of time|0|||
155025657|NCT02278939|559519193|FG000|Overall Study|Lost to Follow-up|1|||
155025658|NCT02278939|559519194|FG001|Overall Study|Lost to Follow-up|1|||
155025659|NCT02278939|559519193|FG000|Overall Study|death in family|1|||
155025660|NCT02278939|559519194|FG001|Overall Study|death in family|0|||
155025661|NCT02278939|559519193|FG000|Overall Study|family emergency unable to commit|2|||
155025662|NCT02278939|559519194|FG001|Overall Study|family emergency unable to commit|0|||
155025663|NCT00930774|559519195|FG000|Overall Study|Withdrawal by Subject|1|||
155025664|NCT00930774|559519196|FG001|Overall Study|Withdrawal by Subject|9|||
155025665|NCT00930774|559519197|FG002|Overall Study|Withdrawal by Subject|2|||
155025666|NCT00930774|559519198|FG003|Overall Study|Withdrawal by Subject|0|||
155025667|NCT03200704|559519199|FG000|Overall Study|Withdrawal by Subject|1|||
155025668|NCT00425061|559519200|FG000|Overall Study|Adverse Event|1|||
155025669|NCT00425061|559519201|FG001|Overall Study|Adverse Event|0|||
155025670|NCT00425061|559519202|FG002|Overall Study|Adverse Event|0|||
155025671|NCT00425061|559519203|FG003|Overall Study|Adverse Event|2|||
155025672|NCT00425061|559519204|FG004|Overall Study|Adverse Event|2|||
155025673|NCT00425061|559519205|FG005|Overall Study|Adverse Event|0|||
155025674|NCT00425061|559519206|FG006|Overall Study|Adverse Event|0|||
155025675|NCT00425061|559519200|FG000|Overall Study|Lost to Follow-up|0|||
155025676|NCT00425061|559519201|FG001|Overall Study|Lost to Follow-up|1|||
155025677|NCT00425061|559519202|FG002|Overall Study|Lost to Follow-up|0|||
155025678|NCT00425061|559519203|FG003|Overall Study|Lost to Follow-up|0|||
155025679|NCT00425061|559519204|FG004|Overall Study|Lost to Follow-up|0|||
155025680|NCT00425061|559519205|FG005|Overall Study|Lost to Follow-up|0|||
155025681|NCT00425061|559519206|FG006|Overall Study|Lost to Follow-up|0|||
155025682|NCT00425061|559519200|FG000|Overall Study|Protocol Violation|1|||
155025683|NCT00425061|559519201|FG001|Overall Study|Protocol Violation|0|||
155025684|NCT00425061|559519202|FG002|Overall Study|Protocol Violation|0|||
155025685|NCT00425061|559519203|FG003|Overall Study|Protocol Violation|0|||
155025686|NCT00425061|559519204|FG004|Overall Study|Protocol Violation|0|||
155025687|NCT00425061|559519205|FG005|Overall Study|Protocol Violation|0|||
155025688|NCT00425061|559519206|FG006|Overall Study|Protocol Violation|0|||
155025689|NCT00425061|559519200|FG000|Overall Study|Withdrawal by Subject|0|||
155025690|NCT00425061|559519201|FG001|Overall Study|Withdrawal by Subject|1|||
155025691|NCT00425061|559519202|FG002|Overall Study|Withdrawal by Subject|0|||
155025692|NCT00425061|559519203|FG003|Overall Study|Withdrawal by Subject|0|||
155025693|NCT00425061|559519204|FG004|Overall Study|Withdrawal by Subject|1|||
155025694|NCT00425061|559519205|FG005|Overall Study|Withdrawal by Subject|0|||
155025695|NCT00425061|559519206|FG006|Overall Study|Withdrawal by Subject|3|||
155025696|NCT00425061|559519200|FG000|Overall Study|Sponsor's request|0|||
155025697|NCT00425061|559519201|FG001|Overall Study|Sponsor's request|0|||
155025698|NCT00425061|559519202|FG002|Overall Study|Sponsor's request|0|||
155025699|NCT00425061|559519203|FG003|Overall Study|Sponsor's request|0|||
155025700|NCT00425061|559519204|FG004|Overall Study|Sponsor's request|19|||
155025701|NCT00425061|559519205|FG005|Overall Study|Sponsor's request|4|||
155025702|NCT00425061|559519206|FG006|Overall Study|Sponsor's request|15|||
155025703|NCT00425061|559519200|FG000|Overall Study|Physician Decision|0|||
155025704|NCT00425061|559519201|FG001|Overall Study|Physician Decision|0|||
155025705|NCT00425061|559519202|FG002|Overall Study|Physician Decision|0|||
155025706|NCT00425061|559519203|FG003|Overall Study|Physician Decision|0|||
155025707|NCT00425061|559519204|FG004|Overall Study|Physician Decision|1|||
155025708|NCT00425061|559519205|FG005|Overall Study|Physician Decision|0|||
155139984|NCT00947115|559942833|FG000|Overall Study|Withdrawal by Subject|1|||
155139985|NCT00947115|559942834|FG001|Overall Study|Withdrawal by Subject|3|||
155139986|NCT00947115|559942835|FG002|Overall Study|Withdrawal by Subject|4|||
155025709|NCT00425061|559519206|FG006|Overall Study|Physician Decision|0|||
155025710|NCT00425061|559519200|FG000|Overall Study|Other|0|||
155025711|NCT00425061|559519201|FG001|Overall Study|Other|0|||
155025712|NCT00425061|559519202|FG002|Overall Study|Other|0|||
155025713|NCT00425061|559519203|FG003|Overall Study|Other|0|||
155025714|NCT00425061|559519204|FG004|Overall Study|Other|3|||
155025715|NCT00425061|559519205|FG005|Overall Study|Other|0|||
155025716|NCT00425061|559519206|FG006|Overall Study|Other|1|||
155025717|NCT03436693|559519207|FG000|Overall Study|Adverse Event|22|||
155025718|NCT03436693|559519208|FG001|Overall Study|Adverse Event|10|||
155025719|NCT03436693|559519207|FG000|Overall Study|Physician Decision|3|||
155025720|NCT03436693|559519208|FG001|Overall Study|Physician Decision|3|||
155025721|NCT03436693|559519207|FG000|Overall Study|Withdrawal by Subject|4|||
155025722|NCT03436693|559519208|FG001|Overall Study|Withdrawal by Subject|13|||
155025723|NCT03436693|559519207|FG000|Overall Study|Progressive Disease|1|||
155025724|NCT03436693|559519208|FG001|Overall Study|Progressive Disease|1|||
155025725|NCT00626821|559519211|FG000|Overall Study|Adverse Event|44|||
155025726|NCT00626821|559519211|FG000|Overall Study|Protocol Violation|33|||
155025727|NCT00626821|559519211|FG000|Overall Study|Withdrawal by Subject|10|||
155025728|NCT00626821|559519211|FG000|Overall Study|Physician Decision|9|||
155025729|NCT00626821|559519211|FG000|Overall Study|Product dysfunction|21|||
155025730|NCT00626821|559519211|FG000|Overall Study|other/unknown reason|104|||
155025731|NCT01471340|559519212|FG000|Overall Study|Death|5|||
155025732|NCT01471340|559519213|FG001|Overall Study|Death|4|||
155025733|NCT01471340|559519212|FG000|Overall Study|Lost to Follow-up|0|||
155025734|NCT01471340|559519213|FG001|Overall Study|Lost to Follow-up|1|||
155025735|NCT01471340|559519212|FG000|Overall Study|Investigational site closure|0|||
155025736|NCT01471340|559519213|FG001|Overall Study|Investigational site closure|1|||
155025737|NCT01471340|559519212|FG000|Overall Study|Invalid informed consent|1|||
155025738|NCT01471340|559519213|FG001|Overall Study|Invalid informed consent|0|||
155025739|NCT01981954|559519214|FG000|Titration Period|Protocol Deviation|1|||
155025740|NCT01981954|559519214|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
155025741|NCT01609543|559519224|FG000|Overall Study|Disease Progression|28|||
155025742|NCT01609543|559519224|FG000|Overall Study|Adverse Event|5|||
155025743|NCT01609543|559519224|FG000|Overall Study|Withdrawal by Subject|1|||
155025744|NCT01609543|559519224|FG000|Overall Study|Protocol Violation|1|||
155025745|NCT01609543|559519224|FG000|Overall Study|Death|7|||
155025746|NCT00586820|559519225|FG000|Overall Study|Unsuccessful PCI|1|||
155025747|NCT00586820|559519226|FG001|Overall Study|Unsuccessful PCI|0|||
155025748|NCT01483027|559519227|FG000|Overall Study|Administrative Reasons|2|||
155025749|NCT01483027|559519228|FG001|Overall Study|Administrative Reasons|1|||
155025750|NCT01483027|559519227|FG000|Overall Study|Withdrawal by Subject|21|||
155025751|NCT01483027|559519228|FG001|Overall Study|Withdrawal by Subject|32|||
155025752|NCT01483027|559519227|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
155025753|NCT01483027|559519228|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
155025754|NCT01483027|559519227|FG000|Overall Study|Lost to Follow-up|1|||
155025755|NCT01483027|559519228|FG001|Overall Study|Lost to Follow-up|1|||
155025756|NCT01483027|559519227|FG000|Overall Study|Adverse Event|0|||
155025757|NCT01483027|559519228|FG001|Overall Study|Adverse Event|1|||
155025758|NCT01483027|559519227|FG000|Overall Study|Withdrawal by Subject|0|||
155025759|NCT01483027|559519228|FG001|Overall Study|Withdrawal by Subject|1|||
155025760|NCT06366087|559521610|FG000|Overall Study|Withdrawal by Subject|0|||
155025761|NCT06366087|559521611|FG001|Overall Study|Withdrawal by Subject|1|||
155025762|NCT01397786|559521614|FG000|Phase A|Lost to Follow-up|0|||
155025763|NCT01397786|559521615|FG001|Phase A|Lost to Follow-up|0|||
155025764|NCT01397786|559521616|FG002|Phase A|Lost to Follow-up|6|||
155025765|NCT01397786|559521614|FG000|Phase A|Adverse Event|0|||
155025766|NCT01397786|559521615|FG001|Phase A|Adverse Event|0|||
155025767|NCT01397786|559521616|FG002|Phase A|Adverse Event|8|||
155025768|NCT01397786|559521614|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
155025769|NCT01397786|559521615|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
155025770|NCT01397786|559521616|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
155025771|NCT01397786|559521614|FG000|Phase A|Physician Decision|0|||
155025772|NCT01397786|559521615|FG001|Phase A|Physician Decision|0|||
155025773|NCT01397786|559521616|FG002|Phase A|Physician Decision|1|||
155025774|NCT01397786|559521614|FG000|Phase A|Withdrawal by Subject|0|||
155025775|NCT01397786|559521615|FG001|Phase A|Withdrawal by Subject|0|||
155025776|NCT01397786|559521616|FG002|Phase A|Withdrawal by Subject|5|||
155025777|NCT01397786|559521614|FG000|Phase A|Lack of Efficacy|0|||
155025778|NCT01397786|559521615|FG001|Phase A|Lack of Efficacy|0|||
155025779|NCT01397786|559521616|FG002|Phase A|Lack of Efficacy|1|||
155025780|NCT01397786|559521614|FG000|Phase B|Lost to Follow-up|22|||
155025781|NCT01397786|559521615|FG001|Phase B|Lost to Follow-up|12|||
155025782|NCT01397786|559521616|FG002|Phase B|Lost to Follow-up|22|||
155025783|NCT01397786|559521614|FG000|Phase B|Adverse Event|109|||
155025784|NCT01397786|559521615|FG001|Phase B|Adverse Event|23|||
155025785|NCT01397786|559521616|FG002|Phase B|Adverse Event|27|||
155025786|NCT01397786|559521614|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
155025787|NCT01397786|559521615|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
155025788|NCT01397786|559521616|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
155025789|NCT01397786|559521614|FG000|Phase B|Physician Decision|9|||
155025790|NCT01397786|559521615|FG001|Phase B|Physician Decision|1|||
155025791|NCT01397786|559521616|FG002|Phase B|Physician Decision|3|||
155025792|NCT01397786|559521614|FG000|Phase B|Withdrawal by Subject|102|||
155025793|NCT01397786|559521615|FG001|Phase B|Withdrawal by Subject|45|||
155025794|NCT01397786|559521616|FG002|Phase B|Withdrawal by Subject|30|||
155025795|NCT01397786|559521614|FG000|Phase B|Protocol Deviation|1|||
155025796|NCT01397786|559521615|FG001|Phase B|Protocol Deviation|2|||
155025797|NCT01397786|559521616|FG002|Phase B|Protocol Deviation|4|||
155025798|NCT01397786|559521614|FG000|Phase B|Lack of Efficacy|22|||
155025799|NCT01397786|559521615|FG001|Phase B|Lack of Efficacy|7|||
155025800|NCT01397786|559521616|FG002|Phase B|Lack of Efficacy|14|||
155025801|NCT02836236|559521623|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
155025802|NCT02836236|559521624|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
155025803|NCT02836236|559521625|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
155025804|NCT02836236|559521626|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
155025805|NCT02836236|559521623|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
155025806|NCT02836236|559521624|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
155025807|NCT02836236|559521625|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
155025808|NCT02836236|559521626|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
155025809|NCT02836236|559521623|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155025810|NCT02836236|559521624|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
155025811|NCT02836236|559521625|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155025812|NCT02836236|559521626|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155025813|NCT02836236|559521623|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
155025814|NCT02836236|559521624|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155025815|NCT02836236|559521625|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155025816|NCT02836236|559521626|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
155025817|NCT02836236|559521623|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155025818|NCT02836236|559521624|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
155025819|NCT02836236|559521625|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
155025820|NCT02836236|559521626|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
155025821|NCT02836236|559521623|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155025822|NCT02836236|559521624|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
155025823|NCT02836236|559521625|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
155025824|NCT02836236|559521626|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
155025825|NCT02836236|559521623|FG000|Open-Label TAF Treatment Phase|Death|0|||
155025826|NCT02836236|559521624|FG001|Open-Label TAF Treatment Phase|Death|0|||
155025827|NCT02836236|559521625|FG002|Open-Label TAF Treatment Phase|Death|1|||
155025828|NCT02836236|559521626|FG003|Open-Label TAF Treatment Phase|Death|1|||
155025829|NCT02836236|559521623|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
155025830|NCT02836236|559521624|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
155025831|NCT02836236|559521625|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
155025832|NCT02836236|559521626|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
155025833|NCT00831311|559521627|FG000|Overall Study|Definitive Contraindication|3|||
155025834|NCT00831311|559521628|FG001|Overall Study|Definitive Contraindication|3|||
155025835|NCT00831311|559521627|FG000|Overall Study|Lost to Follow-up|3|||
155025836|NCT00831311|559521628|FG001|Overall Study|Lost to Follow-up|0|||
155025837|NCT00831311|559521627|FG000|Overall Study|Physician Decision|0|||
155025838|NCT00831311|559521628|FG001|Overall Study|Physician Decision|1|||
155025839|NCT00831311|559521627|FG000|Overall Study|Withdrawal by Subject|6|||
155025840|NCT00831311|559521628|FG001|Overall Study|Withdrawal by Subject|4|||
155025841|NCT01300338|559521635|FG000|Overall Study|Lost to Follow-up|5|||
155025842|NCT01300338|559521636|FG001|Overall Study|Lost to Follow-up|0|||
155025843|NCT02461524|559521638|FG000|Overall Study|Death|16|||
155025844|NCT02461524|559521638|FG000|Overall Study|Withdrawal by Subject|4|||
155025845|NCT02461524|559521638|FG000|Overall Study|Device Explanted|5|||
155025846|NCT02461524|559521638|FG000|Overall Study|Missed Visit|6|||
155025847|NCT01943851|559521639|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025848|NCT01943851|559521640|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025849|NCT01943851|559521641|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025850|NCT01943851|559521642|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155025851|NCT01943851|559521643|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025852|NCT01943851|559521644|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025853|NCT01943851|559521645|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155025854|NCT01943851|559521646|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155025855|NCT01943851|559521647|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
155025856|NCT01943851|559521648|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025857|NCT01943851|559521649|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025858|NCT01943851|559521650|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025859|NCT01943851|559521651|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025860|NCT01943851|559521652|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025861|NCT01943851|559521653|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025862|NCT01943851|559521654|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025863|NCT01943851|559521655|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025864|NCT01943851|559521656|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
155025865|NCT01943851|559521639|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025866|NCT01943851|559521640|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025867|NCT01943851|559521641|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025868|NCT01943851|559521642|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025869|NCT01943851|559521643|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
155025870|NCT01943851|559521644|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025871|NCT01943851|559521645|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025872|NCT01943851|559521646|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
155025873|NCT01943851|559521647|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025874|NCT01943851|559521648|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025875|NCT01943851|559521649|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025876|NCT01943851|559521650|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025877|NCT01943851|559521651|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025878|NCT01943851|559521652|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025879|NCT01943851|559521653|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025880|NCT01943851|559521654|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025881|NCT01943851|559521655|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025882|NCT01943851|559521656|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
155025883|NCT01943851|559521639|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025884|NCT01943851|559521640|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025885|NCT01943851|559521641|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025886|NCT01943851|559521642|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025887|NCT01943851|559521643|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025888|NCT01943851|559521644|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025889|NCT01943851|559521645|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025890|NCT01943851|559521646|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025891|NCT01943851|559521647|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025892|NCT01943851|559521648|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025893|NCT01943851|559521649|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025894|NCT01943851|559521650|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025895|NCT01943851|559521651|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025896|NCT01943851|559521652|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
155025897|NCT01943851|559521653|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025898|NCT01943851|559521654|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025899|NCT01943851|559521655|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025900|NCT01943851|559521656|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
155025901|NCT01943851|559521639|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025902|NCT01943851|559521640|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025903|NCT01943851|559521641|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025904|NCT01943851|559521642|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025905|NCT01943851|559521643|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025906|NCT01943851|559521644|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025907|NCT01943851|559521645|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025908|NCT01943851|559521646|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025909|NCT01943851|559521647|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025910|NCT01943851|559521648|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025911|NCT01943851|559521649|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025912|NCT01943851|559521650|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025913|NCT01943851|559521651|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025914|NCT01943851|559521652|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025915|NCT01943851|559521653|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025916|NCT01943851|559521654|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
155025917|NCT01943851|559521655|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025918|NCT01943851|559521656|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
155025919|NCT01943851|559521639|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025920|NCT01943851|559521640|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025921|NCT01943851|559521641|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025922|NCT01943851|559521642|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025923|NCT01943851|559521643|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025924|NCT01943851|559521644|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025925|NCT01943851|559521645|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025926|NCT01943851|559521646|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025927|NCT01943851|559521647|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025928|NCT01943851|559521648|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025929|NCT01943851|559521649|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025930|NCT01943851|559521650|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025931|NCT01943851|559521651|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025932|NCT01943851|559521652|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025933|NCT01943851|559521653|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
155025934|NCT01943851|559521654|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
155025935|NCT01943851|559521655|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
155025936|NCT01943851|559521656|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
155025937|NCT00381238|559521661|FG000|Overall Study|Adverse Event|3|||
155025938|NCT00381238|559521661|FG000|Overall Study|Protocol Violation|1|||
155025939|NCT00381238|559521661|FG000|Overall Study|Withdrawal by Subject|4|||
155025940|NCT00381238|559521661|FG000|Overall Study|Lack of Efficacy|2|||
155025941|NCT00381238|559521661|FG000|Overall Study|Withdrew by physician|1|||
155025942|NCT00381238|559521661|FG000|Overall Study|Disease progression|1|||
155025943|NCT00843037|559521665|FG000|Overall Study|Lost to Follow-up|1|||
155025944|NCT03535194|559521666|FG000|Induction Period|Adverse Event|2|||
155025945|NCT03535194|559521667|FG001|Induction Period|Adverse Event|2|||
155025946|NCT03535194|559521668|FG002|Induction Period|Adverse Event|1|||
155025947|NCT03535194|559521669|FG003|Induction Period|Adverse Event|3|||
155025948|NCT03535194|559521670|FG004|Induction Period|Adverse Event|0|||
155025949|NCT03535194|559521666|FG000|Induction Period|Death|0|||
155025950|NCT03535194|559521667|FG001|Induction Period|Death|1|||
155025951|NCT03535194|559521668|FG002|Induction Period|Death|0|||
155025952|NCT03535194|559521669|FG003|Induction Period|Death|0|||
155025953|NCT03535194|559521670|FG004|Induction Period|Death|0|||
155025954|NCT03535194|559521666|FG000|Induction Period|Lack of Efficacy|1|||
155025955|NCT03535194|559521667|FG001|Induction Period|Lack of Efficacy|3|||
155025956|NCT03535194|559521668|FG002|Induction Period|Lack of Efficacy|2|||
155025957|NCT03535194|559521669|FG003|Induction Period|Lack of Efficacy|2|||
155025958|NCT03535194|559521670|FG004|Induction Period|Lack of Efficacy|0|||
155025959|NCT03535194|559521666|FG000|Induction Period|Lost to Follow-up|3|||
155025960|NCT03535194|559521667|FG001|Induction Period|Lost to Follow-up|5|||
155025961|NCT03535194|559521668|FG002|Induction Period|Lost to Follow-up|2|||
155025962|NCT03535194|559521669|FG003|Induction Period|Lost to Follow-up|3|||
155025963|NCT03535194|559521670|FG004|Induction Period|Lost to Follow-up|0|||
155025964|NCT03535194|559521666|FG000|Induction Period|Physician Decision|1|||
155025965|NCT03535194|559521667|FG001|Induction Period|Physician Decision|1|||
155025966|NCT03535194|559521668|FG002|Induction Period|Physician Decision|0|||
155025967|NCT03535194|559521669|FG003|Induction Period|Physician Decision|0|||
155025968|NCT03535194|559521670|FG004|Induction Period|Physician Decision|0|||
155025969|NCT03535194|559521666|FG000|Induction Period|Protocol Violation|1|||
155025970|NCT03535194|559521667|FG001|Induction Period|Protocol Violation|0|||
155025971|NCT03535194|559521668|FG002|Induction Period|Protocol Violation|0|||
155025972|NCT03535194|559521669|FG003|Induction Period|Protocol Violation|1|||
155025973|NCT03535194|559521670|FG004|Induction Period|Protocol Violation|0|||
155025974|NCT03535194|559521666|FG000|Induction Period|Screen Failure|0|||
155025975|NCT03535194|559521667|FG001|Induction Period|Screen Failure|1|||
155025976|NCT03535194|559521668|FG002|Induction Period|Screen Failure|0|||
155025977|NCT03535194|559521669|FG003|Induction Period|Screen Failure|0|||
155025978|NCT03535194|559521670|FG004|Induction Period|Screen Failure|0|||
155025979|NCT03535194|559521666|FG000|Induction Period|Withdrawal by Subject|3|||
155025980|NCT03535194|559521667|FG001|Induction Period|Withdrawal by Subject|4|||
155025981|NCT03535194|559521668|FG002|Induction Period|Withdrawal by Subject|3|||
155025982|NCT03535194|559521669|FG003|Induction Period|Withdrawal by Subject|2|||
155025983|NCT03535194|559521670|FG004|Induction Period|Withdrawal by Subject|0|||
155025984|NCT03535194|559521666|FG000|Maintenance Period|Adverse Event|6|||
155025985|NCT03535194|559521667|FG001|Maintenance Period|Adverse Event|5|||
155025986|NCT03535194|559521668|FG002|Maintenance Period|Adverse Event|1|||
155025987|NCT03535194|559521669|FG003|Maintenance Period|Adverse Event|11|||
155025988|NCT03535194|559521670|FG004|Maintenance Period|Adverse Event|4|||
155025989|NCT03535194|559521666|FG000|Maintenance Period|Lack of Efficacy|3|||
155025990|NCT03535194|559521667|FG001|Maintenance Period|Lack of Efficacy|2|||
155025991|NCT03535194|559521668|FG002|Maintenance Period|Lack of Efficacy|5|||
155025992|NCT03535194|559521669|FG003|Maintenance Period|Lack of Efficacy|9|||
155025993|NCT03535194|559521670|FG004|Maintenance Period|Lack of Efficacy|0|||
155025994|NCT03535194|559521666|FG000|Maintenance Period|Lost to Follow-up|4|||
155025995|NCT03535194|559521667|FG001|Maintenance Period|Lost to Follow-up|2|||
155025996|NCT03535194|559521668|FG002|Maintenance Period|Lost to Follow-up|1|||
155025997|NCT03535194|559521669|FG003|Maintenance Period|Lost to Follow-up|5|||
155025998|NCT03535194|559521670|FG004|Maintenance Period|Lost to Follow-up|2|||
155025999|NCT03535194|559521666|FG000|Maintenance Period|Other|1|||
155026000|NCT03535194|559521667|FG001|Maintenance Period|Other|2|||
155026001|NCT03535194|559521668|FG002|Maintenance Period|Other|0|||
155026002|NCT03535194|559521669|FG003|Maintenance Period|Other|0|||
155026003|NCT03535194|559521670|FG004|Maintenance Period|Other|0|||
155026004|NCT03535194|559521666|FG000|Maintenance Period|Physician Decision|1|||
155026005|NCT03535194|559521667|FG001|Maintenance Period|Physician Decision|2|||
155026006|NCT03535194|559521668|FG002|Maintenance Period|Physician Decision|0|||
155026007|NCT03535194|559521669|FG003|Maintenance Period|Physician Decision|2|||
155026008|NCT03535194|559521670|FG004|Maintenance Period|Physician Decision|0|||
155026009|NCT03535194|559521666|FG000|Maintenance Period|Pregnancy|0|||
155026010|NCT03535194|559521667|FG001|Maintenance Period|Pregnancy|0|||
155026011|NCT03535194|559521668|FG002|Maintenance Period|Pregnancy|0|||
155026012|NCT03535194|559521669|FG003|Maintenance Period|Pregnancy|2|||
155026013|NCT03535194|559521670|FG004|Maintenance Period|Pregnancy|0|||
155026014|NCT03535194|559521666|FG000|Maintenance Period|Protocol Violation|0|||
155026015|NCT03535194|559521667|FG001|Maintenance Period|Protocol Violation|1|||
155026016|NCT03535194|559521668|FG002|Maintenance Period|Protocol Violation|0|||
155026017|NCT03535194|559521669|FG003|Maintenance Period|Protocol Violation|0|||
155026018|NCT03535194|559521670|FG004|Maintenance Period|Protocol Violation|0|||
155026019|NCT03535194|559521666|FG000|Maintenance Period|Withdrawal by Subject|7|||
155026020|NCT03535194|559521667|FG001|Maintenance Period|Withdrawal by Subject|2|||
155026021|NCT03535194|559521668|FG002|Maintenance Period|Withdrawal by Subject|1|||
155026022|NCT03535194|559521669|FG003|Maintenance Period|Withdrawal by Subject|8|||
155026023|NCT03535194|559521670|FG004|Maintenance Period|Withdrawal by Subject|0|||
155026024|NCT03535194|559521666|FG000|Post-Treatment Followup Period|Adverse Event|4|||
155026025|NCT03535194|559521667|FG001|Post-Treatment Followup Period|Adverse Event|5|||
155026026|NCT03535194|559521668|FG002|Post-Treatment Followup Period|Adverse Event|1|||
155026027|NCT03535194|559521669|FG003|Post-Treatment Followup Period|Adverse Event|8|||
155026028|NCT03535194|559521670|FG004|Post-Treatment Followup Period|Adverse Event|0|||
155026029|NCT03535194|559521666|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
155026030|NCT03535194|559521667|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
155026031|NCT03535194|559521668|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
155026032|NCT03535194|559521669|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
155026033|NCT03535194|559521670|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
155026034|NCT03535194|559521666|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
155026035|NCT03535194|559521667|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
155026036|NCT03535194|559521668|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
155026037|NCT03535194|559521669|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
155026038|NCT03535194|559521670|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
155026039|NCT03535194|559521666|FG000|Post-Treatment Followup Period|Other|1|||
155026040|NCT03535194|559521667|FG001|Post-Treatment Followup Period|Other|0|||
155026041|NCT03535194|559521668|FG002|Post-Treatment Followup Period|Other|0|||
155026042|NCT03535194|559521669|FG003|Post-Treatment Followup Period|Other|5|||
155026043|NCT03535194|559521670|FG004|Post-Treatment Followup Period|Other|0|||
155026044|NCT03535194|559521666|FG000|Post-Treatment Followup Period|Physician Decision|0|||
155026045|NCT03535194|559521667|FG001|Post-Treatment Followup Period|Physician Decision|2|||
155026046|NCT03535194|559521668|FG002|Post-Treatment Followup Period|Physician Decision|1|||
155026047|NCT03535194|559521669|FG003|Post-Treatment Followup Period|Physician Decision|1|||
155026048|NCT03535194|559521670|FG004|Post-Treatment Followup Period|Physician Decision|0|||
155026049|NCT03535194|559521666|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
155026050|NCT03535194|559521667|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
155026051|NCT03535194|559521668|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
155026052|NCT03535194|559521669|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
155026053|NCT03535194|559521670|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
155026054|NCT04429555|559521679|FG000|Overall Study|Death|0|||
155026055|NCT04429555|559521680|FG001|Overall Study|Death|2|||
155026056|NCT04429555|559521679|FG000|Overall Study|Other|2|||
155026057|NCT04429555|559521680|FG001|Overall Study|Other|0|||
155026058|NCT02703272|559521681|FG000|Overall Study|Death|4|||
155026059|NCT02703272|559521682|FG001|Overall Study|Death|9|||
155026060|NCT02703272|559521683|FG002|Overall Study|Death|19|||
155026061|NCT02703272|559521684|FG003|Overall Study|Death|10|||
155026062|NCT02703272|559521681|FG000|Overall Study|Withdrawal by Subject|0|||
155026063|NCT02703272|559521682|FG001|Overall Study|Withdrawal by Subject|0|||
155026064|NCT02703272|559521683|FG002|Overall Study|Withdrawal by Subject|4|||
155026065|NCT02703272|559521684|FG003|Overall Study|Withdrawal by Subject|2|||
155026066|NCT02703272|559521681|FG000|Overall Study|Study Terminated by Sponsor|6|||
155026067|NCT02703272|559521682|FG001|Overall Study|Study Terminated by Sponsor|1|||
155026068|NCT02703272|559521683|FG002|Overall Study|Study Terminated by Sponsor|12|||
155026069|NCT02703272|559521684|FG003|Overall Study|Study Terminated by Sponsor|4|||
155026070|NCT02703272|559521681|FG000|Overall Study|Other|1|||
155026071|NCT02703272|559521682|FG001|Overall Study|Other|0|||
155026072|NCT02703272|559521683|FG002|Overall Study|Other|0|||
155026073|NCT02703272|559521684|FG003|Overall Study|Other|0|||
155026074|NCT04470544|559521685|FG000|Overall Study|Withdrawal by Subject|4|||
155026075|NCT04470544|559521686|FG001|Overall Study|Withdrawal by Subject|6|||
155026076|NCT01680861|559521687|FG000|Early Post-transplant Period|Protocol Violation|1|||
155026077|NCT01680861|559521688|FG001|Early Post-transplant Period|Protocol Violation|1|||
155026078|NCT05835011|559521691|FG000|Overall Study|Study Terminated by the Sponsor|1|||
155026079|NCT05835011|559521691|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
155026080|NCT02218736|559521699|FG000|Overall Study|Withdrawal by Subject|10|||
155026081|NCT02218736|559521700|FG001|Overall Study|Withdrawal by Subject|9|||
155026082|NCT02218736|559521699|FG000|Overall Study|Protocol Violation|2|||
155026083|NCT02218736|559521700|FG001|Overall Study|Protocol Violation|0|||
155026084|NCT00747474|559521703|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026085|NCT00747474|559521704|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026086|NCT00747474|559521705|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026087|NCT00747474|559521706|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026088|NCT00747474|559521707|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026089|NCT00747474|559521708|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155180785|NCT02129777|560100756|FG004|Double-Blind Period|Lack of Efficacy|2|||
155026090|NCT00747474|559521709|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026091|NCT00747474|559521710|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
155026092|NCT00747474|559521711|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026093|NCT00747474|559521712|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026094|NCT00747474|559521713|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026095|NCT00747474|559521714|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
155026096|NCT03514485|559521715|FG000|Overall Study|Lost to Follow-up|5|||
155026097|NCT03514485|559521716|FG001|Overall Study|Lost to Follow-up|3|||
155026098|NCT03514485|559521717|FG002|Overall Study|Lost to Follow-up|2|||
155026099|NCT03514485|559521718|FG003|Overall Study|Lost to Follow-up|0|||
155026100|NCT03514485|559521719|FG004|Overall Study|Lost to Follow-up|1|||
155026101|NCT03514485|559521720|FG005|Overall Study|Lost to Follow-up|4|||
155026102|NCT03514485|559521715|FG000|Overall Study|Withdrawal by Subject|0|||
155026103|NCT03514485|559521716|FG001|Overall Study|Withdrawal by Subject|1|||
155026104|NCT03514485|559521717|FG002|Overall Study|Withdrawal by Subject|3|||
155026105|NCT03514485|559521718|FG003|Overall Study|Withdrawal by Subject|1|||
155026106|NCT03514485|559521719|FG004|Overall Study|Withdrawal by Subject|2|||
155026107|NCT03514485|559521720|FG005|Overall Study|Withdrawal by Subject|1|||
155026108|NCT03075891|559521721|FG000|Overall Study|Withdrawal by Subject|3|||
155026109|NCT03075891|559521722|FG001|Overall Study|Withdrawal by Subject|6|||
155026110|NCT03075891|559521721|FG000|Overall Study|Lost to Follow-up|1|||
155026111|NCT03075891|559521722|FG001|Overall Study|Lost to Follow-up|0|||
155026112|NCT03075891|559521721|FG000|Overall Study|Pregnancy|3|||
155026113|NCT03075891|559521722|FG001|Overall Study|Pregnancy|1|||
155026114|NCT03075891|559521721|FG000|Overall Study|visits not performed (no time)|1|||
155026115|NCT03075891|559521722|FG001|Overall Study|visits not performed (no time)|0|||
155026116|NCT03075891|559521721|FG000|Overall Study|Drug abuse relapse issue|0|||
155026117|NCT03075891|559521722|FG001|Overall Study|Drug abuse relapse issue|1|||
155026118|NCT03075891|559521721|FG000|Overall Study|Participant requiring study withdrawal|0|||
155026119|NCT03075891|559521722|FG001|Overall Study|Participant requiring study withdrawal|1|||
155026120|NCT03075891|559521721|FG000|Overall Study|Adverse event, non-fatal|1|||
155026121|NCT03075891|559521722|FG001|Overall Study|Adverse event, non-fatal|4|||
155026122|NCT00179673|559521726|FG000|Overall Study|Adverse Event|7|||
155026123|NCT00179673|559521726|FG000|Overall Study|Lack of Efficacy|15|||
155026124|NCT00179673|559521726|FG000|Overall Study|Withdrawal by Subject|3|||
155026125|NCT00179673|559521726|FG000|Overall Study|Death|4|||
155139987|NCT00947115|559942833|FG000|Overall Study|Lost to Follow-up|11|||
155139988|NCT00947115|559942834|FG001|Overall Study|Lost to Follow-up|12|||
155139989|NCT00947115|559942835|FG002|Overall Study|Lost to Follow-up|8|||
155139990|NCT00934128|559942839|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
155139991|NCT00934128|559942840|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
155139992|NCT00934128|559942839|FG000|First Intervention (2 Hours)|Adverse Event|4|||
155139993|NCT00934128|559942840|FG001|First Intervention (2 Hours)|Adverse Event|1|||
155139994|NCT00934128|559942839|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
155139995|NCT00934128|559942840|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
155139996|NCT00934128|559942839|FG000|Washout Period (1 Hour)|Patient preference|1|||
155139997|NCT00934128|559942840|FG001|Washout Period (1 Hour)|Patient preference|3|||
155139998|NCT00934128|559942839|FG000|Washout Period (1 Hour)|Pain|1|||
155139999|NCT00934128|559942840|FG001|Washout Period (1 Hour)|Pain|0|||
155140000|NCT00934128|559942839|FG000|Washout Period (1 Hour)|Too tired|1|||
155140001|NCT00934128|559942840|FG001|Washout Period (1 Hour)|Too tired|0|||
155140002|NCT00934128|559942839|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
155140003|NCT00934128|559942840|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
155140004|NCT00934128|559942839|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
155140005|NCT00934128|559942840|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
155140006|NCT03228212|559942841|FG000|Period 1|Adverse Event|1|||
155140007|NCT03228212|559942842|FG001|Period 1|Adverse Event|0|||
155140008|NCT03228212|559942841|FG000|Period 1|no longer meets eligibility criteria|0|||
155140009|NCT03228212|559942842|FG001|Period 1|no longer meets eligibility criteria|1|||
155140010|NCT03228212|559942841|FG000|Period 2|Lost to Follow-up|1|||
155140011|NCT03228212|559942842|FG001|Period 2|Lost to Follow-up|0|||
155140012|NCT01807299|559942846|FG000|Overall Study|Protocol Violation|3|||
155140013|NCT01807299|559942847|FG001|Overall Study|Protocol Violation|1|||
155140014|NCT01807299|559942848|FG002|Overall Study|Protocol Violation|0|||
155140015|NCT01807299|559942849|FG003|Overall Study|Protocol Violation|2|||
155140016|NCT02936635|559944354|FG000|Overall Study|Adverse Event|43|||
155140017|NCT02936635|559944355|FG001|Overall Study|Adverse Event|25|||
155140018|NCT02936635|559944354|FG000|Overall Study|Progressive Disease|10|||
155140019|NCT02936635|559944355|FG001|Overall Study|Progressive Disease|18|||
155140020|NCT02936635|559944354|FG000|Overall Study|Sponsor Discretion|10|||
155140021|NCT02936635|559944355|FG001|Overall Study|Sponsor Discretion|16|||
155140022|NCT02936635|559944354|FG000|Overall Study|Death|9|||
155140023|NCT02936635|559944355|FG001|Overall Study|Death|15|||
155140024|NCT02936635|559944354|FG000|Overall Study|Withdrawal by Subject|8|||
155140025|NCT02936635|559944355|FG001|Overall Study|Withdrawal by Subject|15|||
155026126|NCT00179673|559521726|FG000|Overall Study|Other Observations and options|14|||
155026127|NCT00492648|559521727|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
155026128|NCT00492648|559521728|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
155026129|NCT00282113|559521729|FG000|Overall Study|Removed at parents request|1|||
155026130|NCT00282113|559521730|FG001|Overall Study|Removed at parents request|0|||
155026131|NCT00282113|559521731|FG002|Overall Study|Removed at parents request|0|||
155026132|NCT02387957|559521732|FG000|Overall Study|The study was discontinued|21|||
155026133|NCT02387957|559521733|FG001|Overall Study|The study was discontinued|21|||
155026134|NCT02387957|559521734|FG002|Overall Study|The study was discontinued|20|||
155026135|NCT02887248|559521735|FG000|Overall Study|Withdrawal by Subject|1|||
155026136|NCT02887248|559521735|FG000|Overall Study|Adverse Event|1|||
155026137|NCT02887248|559521735|FG000|Overall Study|Progressive Disease|1|||
155026138|NCT02294396|559521736|FG000|Overall Study|Adverse Event|26|||
155026139|NCT02294396|559521737|FG001|Overall Study|Adverse Event|25|||
155026140|NCT02294396|559521738|FG002|Overall Study|Adverse Event|21|||
155026141|NCT02294396|559521739|FG003|Overall Study|Adverse Event|24|||
155026142|NCT02294396|559521736|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
155026143|NCT02294396|559521737|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
155026144|NCT02294396|559521738|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
155026145|NCT02294396|559521739|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
155026146|NCT02294396|559521736|FG000|Overall Study|Withdrawal by Subject|8|||
155026147|NCT02294396|559521737|FG001|Overall Study|Withdrawal by Subject|6|||
155026148|NCT02294396|559521738|FG002|Overall Study|Withdrawal by Subject|6|||
155026149|NCT02294396|559521739|FG003|Overall Study|Withdrawal by Subject|8|||
155026150|NCT02294396|559521736|FG000|Overall Study|Lost to Follow-up|0|||
155026151|NCT02294396|559521737|FG001|Overall Study|Lost to Follow-up|0|||
155026152|NCT02294396|559521738|FG002|Overall Study|Lost to Follow-up|1|||
155180786|NCT02129777|560100757|FG005|Double-Blind Period|Lack of Efficacy|0|||
155180787|NCT02129777|560100758|FG006|Double-Blind Period|Lack of Efficacy|0|||
155180788|NCT02129777|560100752|FG000|Double-Blind Period|Other|1|||
155180789|NCT02129777|560100753|FG001|Double-Blind Period|Other|2|||
155180790|NCT02129777|560100754|FG002|Double-Blind Period|Other|0|||
155180791|NCT02129777|560100755|FG003|Double-Blind Period|Other|0|||
155180792|NCT02129777|560100756|FG004|Double-Blind Period|Other|0|||
155180793|NCT02129777|560100757|FG005|Double-Blind Period|Other|0|||
155180794|NCT02129777|560100758|FG006|Double-Blind Period|Other|0|||
155180795|NCT02129777|560100752|FG000|Open-Label Period|Lack of Efficacy|0|||
155180796|NCT02129777|560100753|FG001|Open-Label Period|Lack of Efficacy|0|||
155180797|NCT02129777|560100754|FG002|Open-Label Period|Lack of Efficacy|0|||
155180798|NCT02129777|560100755|FG003|Open-Label Period|Lack of Efficacy|0|||
155026153|NCT02294396|559521739|FG003|Overall Study|Lost to Follow-up|1|||
155026154|NCT02294396|559521736|FG000|Overall Study|Protocol Deviation|3|||
155026155|NCT02294396|559521737|FG001|Overall Study|Protocol Deviation|2|||
155026156|NCT02294396|559521738|FG002|Overall Study|Protocol Deviation|2|||
155026157|NCT02294396|559521739|FG003|Overall Study|Protocol Deviation|1|||
155026158|NCT02294396|559521736|FG000|Overall Study|Miscellaneous|2|||
155026159|NCT02294396|559521737|FG001|Overall Study|Miscellaneous|0|||
155026160|NCT02294396|559521738|FG002|Overall Study|Miscellaneous|5|||
155026161|NCT02294396|559521739|FG003|Overall Study|Miscellaneous|2|||
155026162|NCT02120833|559521740|FG000|Overall Study|Adverse Event|1|||
155026163|NCT02120833|559521741|FG001|Overall Study|Adverse Event|0|||
155026164|NCT02120833|559521740|FG000|Overall Study|Withdrawal by Subject|2|||
155026165|NCT02120833|559521741|FG001|Overall Study|Withdrawal by Subject|0|||
155026166|NCT02120833|559521740|FG000|Overall Study|Lost to Follow-up|1|||
155026167|NCT02120833|559521741|FG001|Overall Study|Lost to Follow-up|1|||
155026168|NCT02438826|559521744|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
155026169|NCT02438826|559521745|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
155026170|NCT02438826|559521746|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
155180799|NCT02129777|560100756|FG004|Open-Label Period|Lack of Efficacy|0|||
155026171|NCT02438826|559521747|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
155026172|NCT02438826|559521744|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
155180800|NCT02129777|560100757|FG005|Open-Label Period|Lack of Efficacy|0|||
155180801|NCT02129777|560100758|FG006|Open-Label Period|Lack of Efficacy|5|||
155026173|NCT02438826|559521745|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155026174|NCT02438826|559521746|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155026175|NCT02438826|559521747|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
155026176|NCT02438826|559521744|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
155026177|NCT02438826|559521745|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
155026178|NCT02438826|559521746|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155026179|NCT02438826|559521747|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
155026180|NCT02438826|559521744|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
155026181|NCT02438826|559521745|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
155180802|NCT02129777|560100752|FG000|Open-Label Period|Lost to Follow-up|0|||
155180803|NCT02129777|560100753|FG001|Open-Label Period|Lost to Follow-up|0|||
155180804|NCT02129777|560100754|FG002|Open-Label Period|Lost to Follow-up|0|||
155180805|NCT02129777|560100755|FG003|Open-Label Period|Lost to Follow-up|0|||
155026182|NCT02438826|559521746|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
155026183|NCT02438826|559521747|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
155026184|NCT02438826|559521744|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
155026185|NCT02438826|559521745|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
155026186|NCT02438826|559521746|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
155026187|NCT02438826|559521747|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
155026188|NCT02438826|559521744|FG000|Open-Label Treatment Phase|Adverse Event|11|||
155026189|NCT02438826|559521745|FG001|Open-Label Treatment Phase|Adverse Event|6|||
155026190|NCT02438826|559521746|FG002|Open-Label Treatment Phase|Adverse Event|0|||
155026191|NCT02438826|559521747|FG003|Open-Label Treatment Phase|Adverse Event|0|||
155026192|NCT02438826|559521744|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
155026193|NCT02438826|559521745|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
155026194|NCT02438826|559521746|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
155026195|NCT02438826|559521747|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
155026196|NCT02438826|559521744|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
155026197|NCT02438826|559521745|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
155026198|NCT02438826|559521746|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
155026199|NCT02438826|559521747|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
155026200|NCT02438826|559521744|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
155026201|NCT02438826|559521745|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
155026202|NCT02438826|559521746|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
155026203|NCT02438826|559521747|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
155026204|NCT02438826|559521744|FG000|Post-Treatment Phase|Adverse Event|3|||
155026205|NCT02438826|559521745|FG001|Post-Treatment Phase|Adverse Event|0|||
155026206|NCT02438826|559521746|FG002|Post-Treatment Phase|Adverse Event|0|||
155026207|NCT02438826|559521747|FG003|Post-Treatment Phase|Adverse Event|0|||
155026208|NCT02438826|559521744|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
155026209|NCT02438826|559521745|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
155026210|NCT02438826|559521746|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
155026211|NCT02438826|559521747|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
155026212|NCT02438826|559521744|FG000|Post-Treatment Phase|Physician Decision|1|||
155026213|NCT02438826|559521745|FG001|Post-Treatment Phase|Physician Decision|0|||
155026214|NCT02438826|559521746|FG002|Post-Treatment Phase|Physician Decision|0|||
155026215|NCT02438826|559521747|FG003|Post-Treatment Phase|Physician Decision|0|||
155026216|NCT02438826|559521744|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
155026217|NCT02438826|559521745|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
155026218|NCT02438826|559521746|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
155026219|NCT02438826|559521747|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
155026220|NCT01500187|559521748|FG000|Overall Study|Lost to Follow-up|6|||
155026221|NCT01500187|559521749|FG001|Overall Study|Lost to Follow-up|0|||
155026222|NCT04152837|559521771|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
155026223|NCT04152837|559521771|FG000|Maintenance Period|Adverse Event|1|||
155026224|NCT04152837|559521771|FG000|Maintenance Period|Withdrawal by Subject|1|||
155026225|NCT04152837|559521771|FG000|Maintenance Period|Sponsor Termination of Study|2|||
155026226|NCT02073929|559521772|FG000|Overall Study|Lost to Follow-up|2|||
155026227|NCT02073929|559521773|FG001|Overall Study|Lost to Follow-up|1|||
155026228|NCT02073929|559521772|FG000|Overall Study|Adverse Event|2|||
155026229|NCT02073929|559521773|FG001|Overall Study|Adverse Event|1|||
155026230|NCT02073929|559521772|FG000|Overall Study|Withdrawal by Subject|0|||
155026231|NCT02073929|559521773|FG001|Overall Study|Withdrawal by Subject|1|||
155026232|NCT02504827|559521776|FG000|Overall Study|Could not produce sputum|1|||
155026233|NCT00686829|559521777|FG000|Overall Study|Adverse Event|5|||
155026234|NCT00686829|559521777|FG000|Overall Study|Lack of Efficacy|6|||
155026235|NCT00686829|559521777|FG000|Overall Study|Lost to Follow-up|4|||
155026236|NCT00686829|559521777|FG000|Overall Study|Withdrawal by Subject|14|||
155026237|NCT00686829|559521777|FG000|Overall Study|Protocol Violation|3|||
155026238|NCT00686829|559521777|FG000|Overall Study|Sponsor discontinued VCV|47|||
155026239|NCT01732640|559521779|FG000|Overall Study|Adverse Event|0|||
155026240|NCT01732640|559521780|FG001|Overall Study|Adverse Event|1|||
155026241|NCT01732640|559521779|FG000|Overall Study|Death|0|||
155026242|NCT01732640|559521780|FG001|Overall Study|Death|1|||
155026243|NCT03070002|559521783|FG000|Follow up for 2 Years|Death|1|||
155026244|NCT00712543|559521786|FG000|Day 8-14|Lost to Follow-up|0|||
155026245|NCT00712543|559521787|FG001|Day 8-14|Lost to Follow-up|2|||
155026246|NCT04740827|559521788|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
155026247|NCT04740827|559521789|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
155026248|NCT04740827|559521788|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
155026249|NCT04740827|559521789|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
155026250|NCT04740827|559521788|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
155026251|NCT04740827|559521789|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
155026252|NCT04740827|559521788|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
155026253|NCT04740827|559521789|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
155026254|NCT04740827|559521788|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
155140026|NCT02936635|559944354|FG000|Overall Study|Physician Decision|2|||
155026255|NCT04740827|559521789|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
155026256|NCT04740827|559521788|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
155026257|NCT04740827|559521789|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
155026258|NCT02147158|559521790|FG000|Treatment Course 1|Adverse Event|1|||
155026259|NCT02147158|559521791|FG001|Treatment Course 1|Adverse Event|4|||
155026260|NCT02147158|559521792|FG002|Treatment Course 1|Adverse Event|3|||
155026261|NCT02147158|559521793|FG003|Treatment Course 1|Adverse Event|4|||
155026262|NCT02147158|559521794|FG004|Treatment Course 1|Adverse Event|1|||
155026263|NCT02147158|559521795|FG005|Treatment Course 1|Adverse Event|2|||
155026264|NCT02147158|559521790|FG000|Treatment Course 1|Lost to Follow-up|2|||
155026265|NCT02147158|559521791|FG001|Treatment Course 1|Lost to Follow-up|4|||
155026266|NCT02147158|559521792|FG002|Treatment Course 1|Lost to Follow-up|3|||
155026267|NCT02147158|559521793|FG003|Treatment Course 1|Lost to Follow-up|3|||
155026268|NCT02147158|559521794|FG004|Treatment Course 1|Lost to Follow-up|2|||
155026269|NCT02147158|559521795|FG005|Treatment Course 1|Lost to Follow-up|4|||
155026270|NCT02147158|559521790|FG000|Treatment Course 1|Protocol Violation|0|||
155026271|NCT02147158|559521791|FG001|Treatment Course 1|Protocol Violation|0|||
155026272|NCT02147158|559521792|FG002|Treatment Course 1|Protocol Violation|1|||
155026273|NCT02147158|559521793|FG003|Treatment Course 1|Protocol Violation|1|||
155026274|NCT02147158|559521794|FG004|Treatment Course 1|Protocol Violation|0|||
155026275|NCT02147158|559521795|FG005|Treatment Course 1|Protocol Violation|0|||
155026276|NCT02147158|559521790|FG000|Treatment Course 1|Withdrawal of Consent|1|||
155026277|NCT02147158|559521791|FG001|Treatment Course 1|Withdrawal of Consent|1|||
155026278|NCT02147158|559521792|FG002|Treatment Course 1|Withdrawal of Consent|1|||
155026279|NCT02147158|559521793|FG003|Treatment Course 1|Withdrawal of Consent|5|||
155026280|NCT02147158|559521794|FG004|Treatment Course 1|Withdrawal of Consent|3|||
155026281|NCT02147158|559521795|FG005|Treatment Course 1|Withdrawal of Consent|2|||
155026282|NCT02147158|559521790|FG000|Off-Treatment Interval 1|Adverse Event|1|||
155026283|NCT02147158|559521791|FG001|Off-Treatment Interval 1|Adverse Event|0|||
155026284|NCT02147158|559521792|FG002|Off-Treatment Interval 1|Adverse Event|0|||
155026285|NCT02147158|559521793|FG003|Off-Treatment Interval 1|Adverse Event|1|||
155026286|NCT02147158|559521794|FG004|Off-Treatment Interval 1|Adverse Event|0|||
155026287|NCT02147158|559521795|FG005|Off-Treatment Interval 1|Adverse Event|0|||
155026288|NCT02147158|559521790|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
155026289|NCT02147158|559521791|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
155026290|NCT02147158|559521792|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
155026291|NCT02147158|559521793|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
155026292|NCT02147158|559521794|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
155026293|NCT02147158|559521795|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
155026294|NCT02147158|559521790|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
155026295|NCT02147158|559521791|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
155026296|NCT02147158|559521792|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
155026297|NCT02147158|559521793|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
155026298|NCT02147158|559521794|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
155026299|NCT02147158|559521795|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
155026300|NCT02147158|559521790|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
155026301|NCT02147158|559521791|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
155026302|NCT02147158|559521792|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
155026303|NCT02147158|559521793|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
155026304|NCT02147158|559521794|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
155026305|NCT02147158|559521795|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
155026306|NCT02147158|559521790|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
155026307|NCT02147158|559521791|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
155026308|NCT02147158|559521792|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
155026309|NCT02147158|559521793|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
155026310|NCT02147158|559521794|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
155026311|NCT02147158|559521795|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
155026312|NCT02147158|559521790|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
155026313|NCT02147158|559521791|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
155026314|NCT02147158|559521792|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
155026315|NCT02147158|559521793|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
155026316|NCT02147158|559521794|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
155026317|NCT02147158|559521795|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
155026318|NCT02147158|559521790|FG000|Treatment Course 2|Adverse Event|0|||
155026319|NCT02147158|559521791|FG001|Treatment Course 2|Adverse Event|4|||
155026320|NCT02147158|559521792|FG002|Treatment Course 2|Adverse Event|2|||
155026321|NCT02147158|559521793|FG003|Treatment Course 2|Adverse Event|1|||
155026322|NCT02147158|559521794|FG004|Treatment Course 2|Adverse Event|0|||
155026323|NCT02147158|559521795|FG005|Treatment Course 2|Adverse Event|1|||
155026324|NCT02147158|559521790|FG000|Treatment Course 2|Withdrawal of Consent|0|||
155140027|NCT02936635|559944355|FG001|Overall Study|Physician Decision|9|||
155140028|NCT02936635|559944354|FG000|Overall Study|Lost to Follow-up|1|||
155140029|NCT02936635|559944355|FG001|Overall Study|Lost to Follow-up|2|||
155140030|NCT02936635|559944354|FG000|Overall Study|Protocol Violation|1|||
155026325|NCT02147158|559521791|FG001|Treatment Course 2|Withdrawal of Consent|1|||
155026326|NCT02147158|559521792|FG002|Treatment Course 2|Withdrawal of Consent|2|||
155026327|NCT02147158|559521793|FG003|Treatment Course 2|Withdrawal of Consent|3|||
155026328|NCT02147158|559521794|FG004|Treatment Course 2|Withdrawal of Consent|0|||
155026329|NCT02147158|559521795|FG005|Treatment Course 2|Withdrawal of Consent|0|||
155026330|NCT02147158|559521790|FG000|Treatment Course 2|Lost to Follow-up|1|||
155026331|NCT02147158|559521791|FG001|Treatment Course 2|Lost to Follow-up|0|||
155026332|NCT02147158|559521792|FG002|Treatment Course 2|Lost to Follow-up|1|||
155026333|NCT02147158|559521793|FG003|Treatment Course 2|Lost to Follow-up|1|||
155026334|NCT02147158|559521794|FG004|Treatment Course 2|Lost to Follow-up|0|||
155026335|NCT02147158|559521795|FG005|Treatment Course 2|Lost to Follow-up|1|||
155026336|NCT02147158|559521790|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
155026337|NCT02147158|559521791|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
155026338|NCT02147158|559521792|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
155026339|NCT02147158|559521793|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
155026340|NCT02147158|559521794|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
155026341|NCT02147158|559521795|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
155026342|NCT02147158|559521790|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
155026343|NCT02147158|559521791|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
155026344|NCT02147158|559521792|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
155026345|NCT02147158|559521793|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
155026346|NCT02147158|559521794|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
155026347|NCT02147158|559521795|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
155026348|NCT02147158|559521790|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
155026349|NCT02147158|559521791|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
155026350|NCT02147158|559521792|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
155026351|NCT02147158|559521793|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
155026352|NCT02147158|559521794|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
155026353|NCT02147158|559521795|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
155026354|NCT02147158|559521790|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
155026355|NCT02147158|559521791|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
155026356|NCT02147158|559521792|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
155026357|NCT02147158|559521793|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
155026358|NCT02147158|559521794|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
155026359|NCT02147158|559521795|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
155026360|NCT02147158|559521790|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
155026361|NCT02147158|559521791|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
155026362|NCT02147158|559521792|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
155026363|NCT02147158|559521793|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
155026364|NCT02147158|559521794|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
155026365|NCT02147158|559521795|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
155026366|NCT00940823|559521796|FG000|Overall Study|Death|8|||
155026367|NCT00940823|559521797|FG001|Overall Study|Death|12|||
155026368|NCT00940823|559521796|FG000|Overall Study|Lost to Follow-up|27|||
155026369|NCT00940823|559521797|FG001|Overall Study|Lost to Follow-up|20|||
155026370|NCT04520997|559521798|FG000|Overall Study|Lost to Follow-up|1|||
155026371|NCT04520997|559521799|FG001|Overall Study|Lost to Follow-up|1|||
155026372|NCT04520997|559521798|FG000|Overall Study|Withdrawal by Subject|1|||
155026373|NCT04520997|559521799|FG001|Overall Study|Withdrawal by Subject|0|||
155026374|NCT04520997|559521798|FG000|Overall Study|Not Treated|0|||
155026375|NCT04520997|559521799|FG001|Overall Study|Not Treated|1|||
155026376|NCT03689374|559521802|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
155026377|NCT03689374|559521803|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
155026378|NCT03689374|559521804|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
155026379|NCT03689374|559521802|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
155026380|NCT03689374|559521803|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
155026381|NCT03689374|559521804|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
155026382|NCT03689374|559521802|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
155026383|NCT03689374|559521803|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
155026384|NCT03689374|559521804|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
155026385|NCT03689374|559521802|FG000|Treatment Period (Week 0 to 52)|Death|0|||
155026386|NCT03689374|559521803|FG001|Treatment Period (Week 0 to 52)|Death|11|||
155026387|NCT03689374|559521804|FG002|Treatment Period (Week 0 to 52)|Death|1|||
155026388|NCT00601172|559524452|FG000|Overall Study|Adverse Event|43|||
155026389|NCT00601172|559524453|FG001|Overall Study|Adverse Event|32|||
155026390|NCT00601172|559524452|FG000|Overall Study|Lack of Efficacy|11|||
155026391|NCT00601172|559524453|FG001|Overall Study|Lack of Efficacy|12|||
155026392|NCT00601172|559524452|FG000|Overall Study|Protocol Violation|2|||
155026393|NCT00601172|559524453|FG001|Overall Study|Protocol Violation|5|||
155026394|NCT00601172|559524452|FG000|Overall Study|Lost to Follow-up|4|||
155026395|NCT00601172|559524453|FG001|Overall Study|Lost to Follow-up|3|||
155026396|NCT00601172|559524452|FG000|Overall Study|Physician Decision|27|||
155026397|NCT00601172|559524453|FG001|Overall Study|Physician Decision|28|||
155026398|NCT00601172|559524452|FG000|Overall Study|Withdrawal by Subject|35|||
155026399|NCT00601172|559524453|FG001|Overall Study|Withdrawal by Subject|27|||
155026400|NCT00601172|559524452|FG000|Overall Study|Did not meet continuation criteria|19|||
155026401|NCT00601172|559524453|FG001|Overall Study|Did not meet continuation criteria|20|||
155026402|NCT00712881|559524462|FG000|Overall Study|Adverse Event|3|||
155026403|NCT00712881|559524463|FG001|Overall Study|Adverse Event|3|||
155026404|NCT00712881|559524462|FG000|Overall Study|Withdrawal by Subject|1|||
155026405|NCT00712881|559524463|FG001|Overall Study|Withdrawal by Subject|1|||
155180806|NCT02129777|560100756|FG004|Open-Label Period|Lost to Follow-up|0|||
155180807|NCT02129777|560100757|FG005|Open-Label Period|Lost to Follow-up|1|||
155180808|NCT02129777|560100758|FG006|Open-Label Period|Lost to Follow-up|1|||
155180809|NCT02129777|560100752|FG000|Open-Label Period|Withdrawal by Subject|0|||
155180810|NCT02129777|560100753|FG001|Open-Label Period|Withdrawal by Subject|0|||
155180811|NCT02129777|560100754|FG002|Open-Label Period|Withdrawal by Subject|0|||
155180812|NCT02129777|560100755|FG003|Open-Label Period|Withdrawal by Subject|0|||
155026406|NCT00712881|559524462|FG000|Overall Study|Disease Progression|2|||
155026407|NCT00712881|559524463|FG001|Overall Study|Disease Progression|1|||
155026408|NCT00712881|559524462|FG000|Overall Study|Lost to Follow-up|1|||
155026409|NCT00712881|559524463|FG001|Overall Study|Lost to Follow-up|1|||
155026410|NCT00712881|559524462|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
155026411|NCT00712881|559524463|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
155026412|NCT00712881|559524462|FG000|Overall Study|Protocol Violation|1|||
155026413|NCT00712881|559524463|FG001|Overall Study|Protocol Violation|1|||
155026414|NCT00712881|559524462|FG000|Overall Study|Randomized but not treated|1|||
155026415|NCT00712881|559524463|FG001|Overall Study|Randomized but not treated|0|||
155026416|NCT04720911|559524464|FG000|Overall Study|Withdrawal by Subject|0|||
155026417|NCT04720911|559524465|FG001|Overall Study|Withdrawal by Subject|1|||
155026418|NCT04720911|559524466|FG002|Overall Study|Withdrawal by Subject|0|||
155026419|NCT00941863|559524468|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
155026420|NCT00941863|559524469|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
155026421|NCT00941863|559524470|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
155026422|NCT00941863|559524471|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
155026423|NCT00941863|559524472|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
155026424|NCT00941863|559524468|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
155026425|NCT00941863|559524469|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
155026426|NCT00941863|559524470|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
155026427|NCT00941863|559524471|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
155026428|NCT00941863|559524472|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
155026429|NCT00941863|559524468|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
155026430|NCT00941863|559524469|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
155026431|NCT00941863|559524470|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
155026432|NCT00941863|559524471|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
155026433|NCT00941863|559524472|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
155026434|NCT00941863|559524468|FG000|Until Primary Completion Date (PCD)|Death|0|||
155026435|NCT00941863|559524469|FG001|Until Primary Completion Date (PCD)|Death|0|||
155026436|NCT00941863|559524470|FG002|Until Primary Completion Date (PCD)|Death|1|||
155026437|NCT00941863|559524471|FG003|Until Primary Completion Date (PCD)|Death|2|||
155026438|NCT00941863|559524472|FG004|Until Primary Completion Date (PCD)|Death|7|||
155026439|NCT00941863|559524468|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
155026440|NCT00941863|559524469|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
155026441|NCT00941863|559524470|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
155026442|NCT00941863|559524471|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
155026443|NCT00941863|559524472|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
155026444|NCT00941863|559524468|FG000|Continued After PCD|Withdrawal by Subject|0|||
155026445|NCT00941863|559524469|FG001|Continued After PCD|Withdrawal by Subject|0|||
155026446|NCT00941863|559524470|FG002|Continued After PCD|Withdrawal by Subject|0|||
155026447|NCT00941863|559524471|FG003|Continued After PCD|Withdrawal by Subject|0|||
155026448|NCT00941863|559524472|FG004|Continued After PCD|Withdrawal by Subject|1|||
155026449|NCT00941863|559524468|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
155026450|NCT00941863|559524469|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
155026451|NCT00941863|559524470|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
155026452|NCT00941863|559524471|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
155026453|NCT00941863|559524472|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
155026454|NCT00537316|559524473|FG000|Part 1|Adverse Event|7|||
155180813|NCT02129777|560100756|FG004|Open-Label Period|Withdrawal by Subject|0|||
155026455|NCT00537316|559524474|FG001|Part 1|Adverse Event|11|||
155180814|NCT02129777|560100757|FG005|Open-Label Period|Withdrawal by Subject|1|||
155026456|NCT00537316|559524475|FG002|Part 1|Adverse Event|8|||
155026457|NCT00537316|559524476|FG003|Part 1|Adverse Event|0|||
155026458|NCT00537316|559524477|FG004|Part 1|Adverse Event|0|||
155026459|NCT00537316|559524478|FG005|Part 1|Adverse Event|0|||
155026460|NCT00537316|559524479|FG006|Part 1|Adverse Event|0|||
155026461|NCT00537316|559524473|FG000|Part 1|Protocol defined clinical event|1|||
155180815|NCT02129777|560100758|FG006|Open-Label Period|Withdrawal by Subject|3|||
155026462|NCT00537316|559524474|FG001|Part 1|Protocol defined clinical event|0|||
155026463|NCT00537316|559524475|FG002|Part 1|Protocol defined clinical event|0|||
155026464|NCT00537316|559524476|FG003|Part 1|Protocol defined clinical event|0|||
155026465|NCT00537316|559524477|FG004|Part 1|Protocol defined clinical event|0|||
155026466|NCT00537316|559524478|FG005|Part 1|Protocol defined clinical event|0|||
155026467|NCT00537316|559524479|FG006|Part 1|Protocol defined clinical event|0|||
155026468|NCT00537316|559524473|FG000|Part 1|Lost to Follow-up|1|||
155026469|NCT00537316|559524474|FG001|Part 1|Lost to Follow-up|0|||
155026470|NCT00537316|559524475|FG002|Part 1|Lost to Follow-up|0|||
155026471|NCT00537316|559524476|FG003|Part 1|Lost to Follow-up|0|||
155026472|NCT00537316|559524477|FG004|Part 1|Lost to Follow-up|0|||
155026473|NCT00537316|559524478|FG005|Part 1|Lost to Follow-up|0|||
155026474|NCT00537316|559524479|FG006|Part 1|Lost to Follow-up|0|||
155026475|NCT00537316|559524473|FG000|Part 1|Withdrawal by Subject|3|||
155026476|NCT00537316|559524474|FG001|Part 1|Withdrawal by Subject|8|||
155026477|NCT00537316|559524475|FG002|Part 1|Withdrawal by Subject|4|||
155026478|NCT00537316|559524476|FG003|Part 1|Withdrawal by Subject|0|||
155026479|NCT00537316|559524477|FG004|Part 1|Withdrawal by Subject|0|||
155026480|NCT00537316|559524478|FG005|Part 1|Withdrawal by Subject|0|||
155026481|NCT00537316|559524479|FG006|Part 1|Withdrawal by Subject|0|||
155026482|NCT00537316|559524473|FG000|Part 1|Protocol Violation|1|||
155026483|NCT00537316|559524474|FG001|Part 1|Protocol Violation|5|||
155026484|NCT00537316|559524475|FG002|Part 1|Protocol Violation|1|||
155026485|NCT00537316|559524476|FG003|Part 1|Protocol Violation|0|||
155026486|NCT00537316|559524477|FG004|Part 1|Protocol Violation|0|||
155026487|NCT00537316|559524478|FG005|Part 1|Protocol Violation|0|||
155026488|NCT00537316|559524479|FG006|Part 1|Protocol Violation|0|||
155026489|NCT00537316|559524473|FG000|Part 1|Did not meet protocol eligibility|1|||
155026490|NCT00537316|559524474|FG001|Part 1|Did not meet protocol eligibility|3|||
155026491|NCT00537316|559524475|FG002|Part 1|Did not meet protocol eligibility|2|||
155026492|NCT00537316|559524476|FG003|Part 1|Did not meet protocol eligibility|0|||
155026493|NCT00537316|559524477|FG004|Part 1|Did not meet protocol eligibility|0|||
155026494|NCT00537316|559524478|FG005|Part 1|Did not meet protocol eligibility|0|||
155026495|NCT00537316|559524479|FG006|Part 1|Did not meet protocol eligibility|0|||
155026496|NCT00537316|559524473|FG000|Part 1|Administrative|0|||
155026497|NCT00537316|559524474|FG001|Part 1|Administrative|0|||
155026498|NCT00537316|559524475|FG002|Part 1|Administrative|2|||
155026499|NCT00537316|559524476|FG003|Part 1|Administrative|0|||
155026500|NCT00537316|559524477|FG004|Part 1|Administrative|0|||
155026501|NCT00537316|559524478|FG005|Part 1|Administrative|0|||
155026502|NCT00537316|559524479|FG006|Part 1|Administrative|0|||
155026503|NCT00537316|559524473|FG000|Part 2|Never entered follow-up|0|||
155026504|NCT00537316|559524474|FG001|Part 2|Never entered follow-up|0|||
155026505|NCT00537316|559524475|FG002|Part 2|Never entered follow-up|0|||
155026506|NCT00537316|559524476|FG003|Part 2|Never entered follow-up|0|||
155026507|NCT00537316|559524477|FG004|Part 2|Never entered follow-up|0|||
155026508|NCT00537316|559524478|FG005|Part 2|Never entered follow-up|0|||
155026509|NCT00537316|559524479|FG006|Part 2|Never entered follow-up|1|||
155026510|NCT00537316|559524473|FG000|Part 2|Adverse Event|4|||
155180816|NCT02129777|560100752|FG000|Open-Label Period|Study Termination|0|||
155180817|NCT02129777|560100753|FG001|Open-Label Period|Study Termination|0|||
155180818|NCT02129777|560100754|FG002|Open-Label Period|Study Termination|0|||
155026511|NCT00537316|559524474|FG001|Part 2|Adverse Event|0|||
155026512|NCT00537316|559524475|FG002|Part 2|Adverse Event|2|||
155026513|NCT00537316|559524476|FG003|Part 2|Adverse Event|0|||
155026514|NCT00537316|559524477|FG004|Part 2|Adverse Event|0|||
155026515|NCT00537316|559524478|FG005|Part 2|Adverse Event|0|||
155026516|NCT00537316|559524479|FG006|Part 2|Adverse Event|0|||
155026517|NCT00537316|559524473|FG000|Part 2|Lost to Follow-up|1|||
155026518|NCT00537316|559524474|FG001|Part 2|Lost to Follow-up|0|||
155026519|NCT00537316|559524475|FG002|Part 2|Lost to Follow-up|2|||
155180819|NCT02129777|560100755|FG003|Open-Label Period|Study Termination|0|||
155026520|NCT00537316|559524476|FG003|Part 2|Lost to Follow-up|0|||
155026521|NCT00537316|559524477|FG004|Part 2|Lost to Follow-up|0|||
155026522|NCT00537316|559524478|FG005|Part 2|Lost to Follow-up|0|||
155026523|NCT00537316|559524479|FG006|Part 2|Lost to Follow-up|0|||
155026524|NCT00537316|559524473|FG000|Part 2|Withdrawal by Subject|5|||
155026525|NCT00537316|559524474|FG001|Part 2|Withdrawal by Subject|1|||
155026526|NCT00537316|559524475|FG002|Part 2|Withdrawal by Subject|4|||
155026527|NCT00537316|559524476|FG003|Part 2|Withdrawal by Subject|0|||
155026528|NCT00537316|559524477|FG004|Part 2|Withdrawal by Subject|0|||
155026529|NCT00537316|559524478|FG005|Part 2|Withdrawal by Subject|0|||
155026530|NCT00537316|559524479|FG006|Part 2|Withdrawal by Subject|0|||
155026531|NCT00537316|559524473|FG000|Part 2|Administrative|16|||
155026532|NCT00537316|559524474|FG001|Part 2|Administrative|8|||
155026533|NCT00537316|559524475|FG002|Part 2|Administrative|24|||
155026534|NCT00537316|559524476|FG003|Part 2|Administrative|3|||
155026535|NCT00537316|559524477|FG004|Part 2|Administrative|1|||
155026536|NCT00537316|559524478|FG005|Part 2|Administrative|4|||
155026537|NCT00537316|559524479|FG006|Part 2|Administrative|1|||
155026538|NCT02651155|559524480|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155026539|NCT02651155|559524481|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155026540|NCT02651155|559524480|FG000|Overall Study|Voluntary Withdrawal|5|||
155026541|NCT02651155|559524481|FG001|Overall Study|Voluntary Withdrawal|0|||
155026542|NCT01867710|559524482|FG000|Overall Study|Death|25|||
155026543|NCT01867710|559524483|FG001|Overall Study|Death|15|||
155026544|NCT01867710|559524484|FG002|Overall Study|Death|27|||
155026545|NCT01867710|559524485|FG003|Overall Study|Death|20|||
155026546|NCT01867710|559524482|FG000|Overall Study|Lost to Follow-up|3|||
155026547|NCT01867710|559524483|FG001|Overall Study|Lost to Follow-up|4|||
155026548|NCT01867710|559524484|FG002|Overall Study|Lost to Follow-up|3|||
155026549|NCT01867710|559524485|FG003|Overall Study|Lost to Follow-up|2|||
155180820|NCT02129777|560100756|FG004|Open-Label Period|Study Termination|0|||
155180821|NCT02129777|560100757|FG005|Open-Label Period|Study Termination|10|||
155180822|NCT02129777|560100758|FG006|Open-Label Period|Study Termination|39|||
155180823|NCT01323920|560100759|FG000|Overall Study|Death|5|||
155180824|NCT01323920|560100759|FG000|Overall Study|Withdrawal by Subject|1|||
155180825|NCT01609478|560100766|FG000|Overall Study|Adverse Event|3|||
155180826|NCT01609478|560100767|FG001|Overall Study|Adverse Event|1|||
155180827|NCT01609478|560100768|FG002|Overall Study|Adverse Event|5|||
155180828|NCT01609478|560100766|FG000|Overall Study|Protocol Deviation|0|||
155180829|NCT01609478|560100767|FG001|Overall Study|Protocol Deviation|1|||
155180830|NCT01609478|560100768|FG002|Overall Study|Protocol Deviation|1|||
155180831|NCT01609478|560100766|FG000|Overall Study|Non-Compliance with study treatment|1|||
155180832|NCT01609478|560100767|FG001|Overall Study|Non-Compliance with study treatment|0|||
155180833|NCT01609478|560100768|FG002|Overall Study|Non-Compliance with study treatment|0|||
155180834|NCT01609478|560100766|FG000|Overall Study|Physician Decision|1|||
155180835|NCT01609478|560100767|FG001|Overall Study|Physician Decision|0|||
155180836|NCT01609478|560100768|FG002|Overall Study|Physician Decision|1|||
155180837|NCT01609478|560100766|FG000|Overall Study|Withdrawal by Subject|2|||
155180838|NCT01609478|560100767|FG001|Overall Study|Withdrawal by Subject|0|||
155180839|NCT01609478|560100768|FG002|Overall Study|Withdrawal by Subject|2|||
155180840|NCT05040971|560100769|FG000|Overall Study|Withdrawal by Subject|0|||
155180841|NCT05040971|560100770|FG001|Overall Study|Withdrawal by Subject|2|||
155180842|NCT05040971|560100769|FG000|Overall Study|Lost to Follow-up|8|||
155180843|NCT05040971|560100770|FG001|Overall Study|Lost to Follow-up|3|||
155180844|NCT05040971|560100769|FG000|Overall Study|Death|2|||
155180845|NCT05040971|560100770|FG001|Overall Study|Death|0|||
155180846|NCT01101191|560100776|FG000|Period 1|Withdrawal by Subject|1|||
155180847|NCT01101191|560100777|FG001|Period 1|Withdrawal by Subject|0|||
155180848|NCT01101191|560100776|FG000|Period 1|Adverse Event|1|||
155180849|NCT01101191|560100777|FG001|Period 1|Adverse Event|2|||
155180850|NCT02751931|560100779|FG000|Overall Study|Adverse Event|3|||
155180851|NCT02751931|560100780|FG001|Overall Study|Adverse Event|0|||
155180852|NCT02751931|560100779|FG000|Overall Study|Other: Miscelleneous|10|||
155180853|NCT02751931|560100780|FG001|Overall Study|Other: Miscelleneous|8|||
155180854|NCT03473548|560100781|FG000|Overall Study|Did not attempt HST testing|3|||
155140031|NCT02936635|559944355|FG001|Overall Study|Protocol Violation|0|||
155140032|NCT02936635|559944354|FG000|Overall Study|Lack of effect/Entry into other study|31|||
155140033|NCT02936635|559944355|FG001|Overall Study|Lack of effect/Entry into other study|65|||
155140034|NCT00447226|559944356|FG000|12-Week Open-label Phase|Adverse Event|0|||
155140035|NCT00447226|559944357|FG001|12-Week Open-label Phase|Adverse Event|3|||
155140036|NCT00447226|559944356|FG000|12-Week Open-label Phase|Protocol Violation|0|||
155140037|NCT00447226|559944357|FG001|12-Week Open-label Phase|Protocol Violation|1|||
155140038|NCT00447226|559944356|FG000|12-Week Open-label Phase|Disease Progression|0|||
155140039|NCT00447226|559944357|FG001|12-Week Open-label Phase|Disease Progression|20|||
155140040|NCT00447226|559944356|FG000|12-Week Open-label Phase|Physician Decision|0|||
155140041|NCT00447226|559944357|FG001|12-Week Open-label Phase|Physician Decision|1|||
155140042|NCT00447226|559944356|FG000|Double-blind Phase|Disease Progression|4|||
155140043|NCT00447226|559944357|FG001|Double-blind Phase|Disease Progression|3|||
155140044|NCT01402817|559944363|FG000|Overall Study|Withdrawal by Subject|3|||
155140045|NCT01402817|559944363|FG000|Overall Study|Study Suspended by FDA|8|||
155140046|NCT00681629|559944364|FG000|Overall Study|Study termination|4|||
155140047|NCT00681629|559944365|FG001|Overall Study|Study termination|2|||
155140048|NCT00681629|559944364|FG000|Overall Study|Adverse Event|1|||
155140049|NCT00681629|559944365|FG001|Overall Study|Adverse Event|0|||
155140050|NCT00412893|559944366|FG000|Overall Study|Adverse Event|31|||
155140051|NCT00412893|559944367|FG001|Overall Study|Adverse Event|53|||
155140052|NCT00412893|559944366|FG000|Overall Study|Death|17|||
155140053|NCT00412893|559944367|FG001|Overall Study|Death|21|||
155140054|NCT00412893|559944366|FG000|Overall Study|Insufficient Therapeutic Response|39|||
155140055|NCT00412893|559944367|FG001|Overall Study|Insufficient Therapeutic Response|23|||
155180855|NCT03473548|560100782|FG001|Overall Study|Did not attempt HST testing|0|||
155180856|NCT05856760|560100793|FG000|Overall Study|Adverse Event|2|||
155180857|NCT05856760|560100793|FG000|Overall Study|Physician Decision|1|||
155026550|NCT01867710|559524482|FG000|Overall Study|Withdrawal of consent|2|||
155026551|NCT01867710|559524483|FG001|Overall Study|Withdrawal of consent|5|||
155140056|NCT00412893|559944366|FG000|Overall Study|Lost to Follow-up|2|||
155026552|NCT01867710|559524484|FG002|Overall Study|Withdrawal of consent|1|||
155026553|NCT01867710|559524485|FG003|Overall Study|Withdrawal of consent|2|||
155180858|NCT05856760|560100793|FG000|Overall Study|Protocol Violation|1|||
155180859|NCT05856760|560100793|FG000|Overall Study|Withdrawal by Subject|3|||
155180860|NCT04035486|560100794|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
155180861|NCT04035486|560100795|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
155180862|NCT04035486|560100796|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
155180863|NCT04035486|560100797|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
155180864|NCT04035486|560100794|FG000|Overall Study|Death|6|||
155180865|NCT04035486|560100795|FG001|Overall Study|Death|3|||
155180866|NCT04035486|560100796|FG002|Overall Study|Death|70|||
155180867|NCT04035486|560100797|FG003|Overall Study|Death|77|||
155180868|NCT04035486|560100794|FG000|Overall Study|Screen Failure|0|||
155180869|NCT04035486|560100795|FG001|Overall Study|Screen Failure|0|||
155180870|NCT04035486|560100796|FG002|Overall Study|Screen Failure|1|||
155180871|NCT04035486|560100797|FG003|Overall Study|Screen Failure|1|||
155180872|NCT04035486|560100794|FG000|Overall Study|Withdrawal by Subject|1|||
155180873|NCT04035486|560100795|FG001|Overall Study|Withdrawal by Subject|1|||
155180874|NCT04035486|560100796|FG002|Overall Study|Withdrawal by Subject|11|||
155180875|NCT04035486|560100797|FG003|Overall Study|Withdrawal by Subject|9|||
155180876|NCT01006603|560100798|FG000|Overall Study|Withdrawal by Subject|17|||
155180877|NCT01006603|560100799|FG001|Overall Study|Withdrawal by Subject|19|||
155180878|NCT01006603|560100798|FG000|Overall Study|Lost to Follow-up|0|||
155180879|NCT01006603|560100799|FG001|Overall Study|Lost to Follow-up|1|||
155180880|NCT01006603|560100798|FG000|Overall Study|Safety reason|1|||
155180881|NCT01006603|560100799|FG001|Overall Study|Safety reason|1|||
155180882|NCT01006603|560100798|FG000|Overall Study|Protocol Violation|1|||
155180883|NCT01006603|560100799|FG001|Overall Study|Protocol Violation|3|||
155180884|NCT01006603|560100798|FG000|Overall Study|Incorrect enrolment|0|||
155180885|NCT01006603|560100799|FG001|Overall Study|Incorrect enrolment|2|||
155180886|NCT01006603|560100798|FG000|Overall Study|Adverse Event|15|||
155180887|NCT01006603|560100799|FG001|Overall Study|Adverse Event|7|||
155180888|NCT01006603|560100798|FG000|Overall Study|Death|1|||
155180889|NCT01006603|560100799|FG001|Overall Study|Death|1|||
155180890|NCT01006603|560100798|FG000|Overall Study|Study specific discontinuation criteria|33|||
155180891|NCT01006603|560100799|FG001|Overall Study|Study specific discontinuation criteria|34|||
155180892|NCT01006603|560100798|FG000|Overall Study|Other|3|||
155180893|NCT01006603|560100799|FG001|Overall Study|Other|7|||
155180894|NCT02477696|560100802|FG000|Overall Study|Death|89|||
155180895|NCT02477696|560100803|FG001|Overall Study|Death|106|||
155180896|NCT02477696|560100802|FG000|Overall Study|Lost to Follow-up|7|||
155180897|NCT02477696|560100803|FG001|Overall Study|Lost to Follow-up|5|||
155180898|NCT02477696|560100802|FG000|Overall Study|Withdrawal by Subject|37|||
155180899|NCT02477696|560100803|FG001|Overall Study|Withdrawal by Subject|34|||
155180900|NCT02477696|560100802|FG000|Overall Study|Physician Decision|7|||
155180901|NCT02477696|560100803|FG001|Overall Study|Physician Decision|9|||
155180902|NCT02477696|560100802|FG000|Overall Study|Study terminated by sponsor|103|||
155180903|NCT02477696|560100803|FG001|Overall Study|Study terminated by sponsor|99|||
155180904|NCT02477696|560100802|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
155180905|NCT02477696|560100803|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
155180906|NCT02477696|560100802|FG000|Overall Study|Missing/Unknown|2|||
155180907|NCT02477696|560100803|FG001|Overall Study|Missing/Unknown|0|||
155180908|NCT03587727|560100804|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
155180909|NCT03587727|560100804|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
155180910|NCT02003365|560102003|FG000|Overall Study|Lost to Follow-up|0|||
155180911|NCT02003365|560102004|FG001|Overall Study|Lost to Follow-up|0|||
155180912|NCT02003365|560102005|FG002|Overall Study|Lost to Follow-up|1|||
155180913|NCT00562627|560102006|FG000|Overall Study|Protocol Violation|1|||
155180914|NCT00562627|560102007|FG001|Overall Study|Protocol Violation|1|||
155180915|NCT00562627|560102008|FG002|Overall Study|Protocol Violation|1|||
155180916|NCT03387150|560102013|FG000|Overall Study|Withdrawal by Subject|3|||
155180917|NCT03387150|560102014|FG001|Overall Study|Withdrawal by Subject|0|||
155180918|NCT03387150|560102015|FG002|Overall Study|Withdrawal by Subject|3|||
155180919|NCT03387150|560102016|FG003|Overall Study|Withdrawal by Subject|4|||
155180920|NCT03387150|560102017|FG004|Overall Study|Withdrawal by Subject|1|||
155180921|NCT03387150|560102018|FG005|Overall Study|Withdrawal by Subject|2|||
155180922|NCT03387150|560102019|FG006|Overall Study|Withdrawal by Subject|0|||
155180923|NCT03387150|560102013|FG000|Overall Study|Lost to Follow-up|3|||
155180924|NCT03387150|560102014|FG001|Overall Study|Lost to Follow-up|2|||
155180925|NCT03387150|560102015|FG002|Overall Study|Lost to Follow-up|2|||
155180926|NCT03387150|560102016|FG003|Overall Study|Lost to Follow-up|3|||
155180927|NCT03387150|560102017|FG004|Overall Study|Lost to Follow-up|3|||
155180928|NCT03387150|560102018|FG005|Overall Study|Lost to Follow-up|3|||
155180929|NCT03387150|560102019|FG006|Overall Study|Lost to Follow-up|0|||
155180930|NCT03387150|560102013|FG000|Overall Study|Participant unable to adhere to visit|0|||
155180931|NCT03387150|560102014|FG001|Overall Study|Participant unable to adhere to visit|1|||
155180932|NCT03387150|560102015|FG002|Overall Study|Participant unable to adhere to visit|0|||
155180933|NCT03387150|560102016|FG003|Overall Study|Participant unable to adhere to visit|0|||
155180934|NCT03387150|560102017|FG004|Overall Study|Participant unable to adhere to visit|2|||
155180935|NCT03387150|560102018|FG005|Overall Study|Participant unable to adhere to visit|2|||
155180936|NCT03387150|560102019|FG006|Overall Study|Participant unable to adhere to visit|0|||
155180937|NCT04078178|560102020|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
155180938|NCT04078178|560102021|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
155180939|NCT04078178|560102020|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
155180940|NCT04078178|560102021|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
155180941|NCT04078178|560102020|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
155180942|NCT04078178|560102021|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
155180943|NCT04078178|560102020|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
155180944|NCT04078178|560102021|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
155180945|NCT04078178|560102020|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
155180946|NCT04078178|560102021|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
155180947|NCT04006119|560102022|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
155180948|NCT04006119|560102022|FG000|End of Treatment Veledimex|Adverse Event|2|||
155180949|NCT04006119|560102022|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
155180950|NCT04006119|560102022|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
155180951|NCT04006119|560102022|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
155180952|NCT04006119|560102022|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
155180953|NCT03269552|560102023|FG000|Overall Study|Adverse Event|2|||
155180954|NCT06460493|560102028|FG000|Overall Study|Withdrawal by Subject|2|||
155180955|NCT05128929|560102029|FG000|Overall Study|Adverse Event|0|||
155180956|NCT05128929|560102030|FG001|Overall Study|Adverse Event|1|||
155180957|NCT03707184|560102033|FG000|Overall Study|Withdrawal by Subject|2|||
155180958|NCT04704154|560102034|FG000|Overall Study|Adverse Event|3|||
155180959|NCT04704154|560102035|FG001|Overall Study|Adverse Event|2|||
155180960|NCT04704154|560102036|FG002|Overall Study|Adverse Event|4|||
155180961|NCT04704154|560102037|FG003|Overall Study|Adverse Event|2|||
155180962|NCT04704154|560102038|FG004|Overall Study|Adverse Event|3|||
155180963|NCT04704154|560102039|FG005|Overall Study|Adverse Event|0|||
155180964|NCT04704154|560102034|FG000|Overall Study|Death|3|||
155180965|NCT04704154|560102035|FG001|Overall Study|Death|0|||
155180966|NCT04704154|560102036|FG002|Overall Study|Death|0|||
155180967|NCT04704154|560102037|FG003|Overall Study|Death|0|||
155180968|NCT04704154|560102038|FG004|Overall Study|Death|3|||
155180969|NCT04704154|560102039|FG005|Overall Study|Death|0|||
155180970|NCT04704154|560102034|FG000|Overall Study|Physician Decision|1|||
155180971|NCT04704154|560102035|FG001|Overall Study|Physician Decision|0|||
155180972|NCT04704154|560102036|FG002|Overall Study|Physician Decision|1|||
155180973|NCT04704154|560102037|FG003|Overall Study|Physician Decision|0|||
155180974|NCT04704154|560102038|FG004|Overall Study|Physician Decision|2|||
155180975|NCT04704154|560102039|FG005|Overall Study|Physician Decision|0|||
155180976|NCT04704154|560102034|FG000|Overall Study|Participant Decision|1|||
155180977|NCT04704154|560102035|FG001|Overall Study|Participant Decision|1|||
155180978|NCT04704154|560102036|FG002|Overall Study|Participant Decision|0|||
155180979|NCT04704154|560102037|FG003|Overall Study|Participant Decision|0|||
155180980|NCT04704154|560102038|FG004|Overall Study|Participant Decision|0|||
155180981|NCT04704154|560102039|FG005|Overall Study|Participant Decision|0|||
155180982|NCT04704154|560102034|FG000|Overall Study|Progressive Disease|19|||
155180983|NCT04704154|560102035|FG001|Overall Study|Progressive Disease|17|||
155180984|NCT04704154|560102036|FG002|Overall Study|Progressive Disease|20|||
155180985|NCT04704154|560102037|FG003|Overall Study|Progressive Disease|18|||
155180986|NCT04704154|560102038|FG004|Overall Study|Progressive Disease|36|||
155180987|NCT04704154|560102039|FG005|Overall Study|Progressive Disease|30|||
155180988|NCT04704154|560102034|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
155180989|NCT04704154|560102035|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
155180990|NCT04704154|560102036|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
155180991|NCT04704154|560102037|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
155180992|NCT04704154|560102038|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
155180993|NCT04704154|560102039|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
155180994|NCT04704154|560102034|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
155180995|NCT04704154|560102035|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
155180996|NCT04704154|560102036|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
155180997|NCT04704154|560102037|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
155180998|NCT04704154|560102038|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
155180999|NCT04704154|560102039|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
155181000|NCT04950608|560102040|FG000|Overall Study|Withdrawal by Subject|2|||
155181001|NCT04950608|560102040|FG000|Overall Study|Physician Decision|3|||
155181002|NCT01634178|560102041|FG000|Treatment Period 1|Adverse Event|0|||
155181003|NCT01634178|560102042|FG001|Treatment Period 1|Adverse Event|1|||
155181004|NCT01634178|560102041|FG000|Treatment Period 2|Adverse Event|1|||
155181005|NCT01634178|560102042|FG001|Treatment Period 2|Adverse Event|0|||
155181006|NCT01903525|560102047|FG000|Overall Study|Lost to Follow-up|5|||
155181007|NCT01903525|560102048|FG001|Overall Study|Lost to Follow-up|9|||
155181008|NCT01903525|560102047|FG000|Overall Study|Adverse Event|0|||
155181009|NCT01903525|560102048|FG001|Overall Study|Adverse Event|1|||
155181010|NCT03977454|560102049|FG000|Overall Study|immediate postoperative revision|2|||
155181011|NCT03977454|560102050|FG001|Overall Study|immediate postoperative revision|2|||
155181012|NCT02483533|560102053|FG000|Overall Study|Lack of Efficacy|50|||
155181013|NCT02483533|560102054|FG001|Overall Study|Lack of Efficacy|50|||
155181014|NCT02283177|560102057|FG000|Overall Study|Withdrawal by Subject|1|||
155181015|NCT02283177|560102058|FG001|Overall Study|Withdrawal by Subject|1|||
155181016|NCT00879879|560102065|FG000|Overall Study|Death|1|||
155181017|NCT00879879|560102065|FG000|Overall Study|Withdrawal by Subject|1|||
155181018|NCT00879879|560102065|FG000|Overall Study|Physician Decision|1|||
155181019|NCT00645788|560102066|FG000|Overall Study|Did not receive study drug|1|||
155181020|NCT00645788|560102067|FG001|Overall Study|Did not receive study drug|1|||
155181021|NCT00645788|560102068|FG002|Overall Study|Did not receive study drug|0|||
155181022|NCT00645788|560102069|FG003|Overall Study|Did not receive study drug|0|||
155181023|NCT00645788|560102066|FG000|Overall Study|Adverse Event|4|||
155181024|NCT00645788|560102067|FG001|Overall Study|Adverse Event|9|||
155181025|NCT00645788|560102068|FG002|Overall Study|Adverse Event|5|||
155181026|NCT00645788|560102069|FG003|Overall Study|Adverse Event|3|||
155181027|NCT00645788|560102066|FG000|Overall Study|Lost to Follow-up|1|||
155181028|NCT00645788|560102067|FG001|Overall Study|Lost to Follow-up|0|||
155181029|NCT00645788|560102068|FG002|Overall Study|Lost to Follow-up|0|||
155181030|NCT00645788|560102069|FG003|Overall Study|Lost to Follow-up|0|||
155181031|NCT00645788|560102066|FG000|Overall Study|Protocol Violation|1|||
155181032|NCT00645788|560102067|FG001|Overall Study|Protocol Violation|0|||
155181033|NCT00645788|560102068|FG002|Overall Study|Protocol Violation|2|||
155181034|NCT00645788|560102069|FG003|Overall Study|Protocol Violation|0|||
155181035|NCT00645788|560102066|FG000|Overall Study|Withdrawal by Subject|0|||
155181036|NCT00645788|560102067|FG001|Overall Study|Withdrawal by Subject|1|||
155181037|NCT00645788|560102068|FG002|Overall Study|Withdrawal by Subject|0|||
155181038|NCT00645788|560102069|FG003|Overall Study|Withdrawal by Subject|2|||
155181039|NCT00645788|560102066|FG000|Overall Study|Pulmonary exacerbation|13|||
155181040|NCT00645788|560102067|FG001|Overall Study|Pulmonary exacerbation|16|||
155181041|NCT00645788|560102068|FG002|Overall Study|Pulmonary exacerbation|11|||
155181042|NCT00645788|560102069|FG003|Overall Study|Pulmonary exacerbation|9|||
155181043|NCT00327470|560102073|FG000|Overall Study|Randomized, but not treated|0|||
155181044|NCT00327470|560102074|FG001|Overall Study|Randomized, but not treated|2|||
155181045|NCT00327470|560102073|FG000|Overall Study|Adverse Event|9|||
155181046|NCT00327470|560102074|FG001|Overall Study|Adverse Event|14|||
155181047|NCT00327470|560102073|FG000|Overall Study|Lack of Efficacy|7|||
155181048|NCT00327470|560102074|FG001|Overall Study|Lack of Efficacy|19|||
155181049|NCT00327470|560102073|FG000|Overall Study|Other|5|||
155181050|NCT00327470|560102074|FG001|Overall Study|Other|9|||
155181051|NCT00327470|560102073|FG000|Overall Study|Lost to Follow-up|1|||
155181052|NCT00327470|560102074|FG001|Overall Study|Lost to Follow-up|3|||
155181053|NCT00327470|560102073|FG000|Overall Study|Withdrawal by Subject|6|||
155181054|NCT00327470|560102074|FG001|Overall Study|Withdrawal by Subject|12|||
155181055|NCT00327470|560102073|FG000|Overall Study|Death|1|||
155181056|NCT00327470|560102074|FG001|Overall Study|Death|4|||
155181057|NCT04231981|560102075|FG000|Overall Study|Adverse Event|1|||
155181058|NCT04231981|560102075|FG000|Overall Study|Death|16|||
155181059|NCT04231981|560102075|FG000|Overall Study|Lost to Follow-up|1|||
155181060|NCT02581943|560102076|FG000|Overall Study|Death|5|||
155181061|NCT02581943|560102077|FG001|Overall Study|Death|2|||
155181062|NCT02581943|560102076|FG000|Overall Study|Disease Progression|12|||
155181063|NCT02581943|560102077|FG001|Overall Study|Disease Progression|15|||
155181064|NCT02581943|560102076|FG000|Overall Study|Withdrawal by Subject|1|||
155181065|NCT02581943|560102077|FG001|Overall Study|Withdrawal by Subject|2|||
155181066|NCT01233687|560102078|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
155181067|NCT01233687|560102078|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
155181068|NCT01233687|560102078|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
155181069|NCT02197234|560102081|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
155181070|NCT02197234|560102081|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
155181071|NCT02197234|560102081|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
155181072|NCT02197234|560102081|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
155181073|NCT02197234|560102081|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
155181074|NCT02197234|560102081|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
155181075|NCT03783702|560102082|FG000|Overall Study|Lost to Follow-up|6|||
155181076|NCT03783702|560102083|FG001|Overall Study|Lost to Follow-up|8|||
155181077|NCT03783702|560102082|FG000|Overall Study|Protocol Violation|1|||
155181078|NCT03783702|560102083|FG001|Overall Study|Protocol Violation|3|||
155181079|NCT00745615|560102084|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
155181080|NCT00745615|560102085|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
155181081|NCT00745615|560102086|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
155181082|NCT00745615|560102087|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
155181083|NCT00745615|560102088|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
155181084|NCT00745615|560102089|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
155181085|NCT00745615|560102084|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155181086|NCT00745615|560102085|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
155181087|NCT00745615|560102086|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155181088|NCT00745615|560102087|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155181089|NCT00745615|560102088|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155181090|NCT00745615|560102089|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
155181091|NCT00745615|560102084|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
155181092|NCT00745615|560102085|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
155181093|NCT00745615|560102086|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
155181094|NCT00745615|560102087|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
155181095|NCT00745615|560102088|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
155181096|NCT00745615|560102089|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
155181097|NCT00745615|560102084|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155181098|NCT00745615|560102085|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
155181099|NCT00745615|560102086|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155181100|NCT00745615|560102087|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155181101|NCT00745615|560102088|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155181102|NCT00745615|560102089|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
155181103|NCT00745615|560102084|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155181104|NCT00745615|560102085|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
155181105|NCT00745615|560102086|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155181106|NCT00745615|560102087|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155181107|NCT00745615|560102088|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155181108|NCT00745615|560102089|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
155181109|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155181110|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155181111|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155181112|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
155181113|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
155181114|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
155181115|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155140057|NCT00412893|559944367|FG001|Overall Study|Lost to Follow-up|1|||
155140058|NCT00412893|559944366|FG000|Overall Study|Violation of Selection at Entry|17|||
155140059|NCT00412893|559944367|FG001|Overall Study|Violation of Selection at Entry|10|||
155140060|NCT00412893|559944366|FG000|Overall Study|Other Protocol Violation|10|||
155140061|NCT00412893|559944367|FG001|Overall Study|Other Protocol Violation|6|||
155140062|NCT00412893|559944366|FG000|Overall Study|Did Not Cooperate|12|||
155140063|NCT00412893|559944367|FG001|Overall Study|Did Not Cooperate|9|||
155140064|NCT00412893|559944366|FG000|Overall Study|Administrative Reason|12|||
155140065|NCT00412893|559944367|FG001|Overall Study|Administrative Reason|15|||
155140066|NCT00412893|559944366|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
155140067|NCT00412893|559944367|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
155140068|NCT01751984|559944368|FG000|Overall Study|Adverse Event|5|||
155140069|NCT01751984|559944369|FG001|Overall Study|Adverse Event|3|||
155140070|NCT01751984|559944368|FG000|Overall Study|Withdrawal by Subject|0|||
155140071|NCT01751984|559944369|FG001|Overall Study|Withdrawal by Subject|1|||
155140072|NCT01751984|559944368|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
155140073|NCT01751984|559944369|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
155140074|NCT00587158|559944370|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
155140075|NCT00587158|559944371|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
155140076|NCT00587158|559944370|FG000|Overall Study|Physician Decision|0|||
155140077|NCT00587158|559944371|FG001|Overall Study|Physician Decision|1|||
155140078|NCT00587158|559944370|FG000|Overall Study|Lost to Follow-up|1|||
155140079|NCT00587158|559944371|FG001|Overall Study|Lost to Follow-up|2|||
155140080|NCT00587158|559944370|FG000|Overall Study|Death|0|||
155140081|NCT00587158|559944371|FG001|Overall Study|Death|1|||
155140082|NCT00587158|559944370|FG000|Overall Study|Subject did not want to take study med|0|||
155140083|NCT00587158|559944371|FG001|Overall Study|Subject did not want to take study med|1|||
155140084|NCT01136408|559944372|FG000|Overall Study|Adverse Event|4|||
155140085|NCT01136408|559944373|FG001|Overall Study|Adverse Event|8|||
155140086|NCT01136408|559944374|FG002|Overall Study|Adverse Event|4|||
155140087|NCT01136408|559944372|FG000|Overall Study|Protocol Violation|1|||
155140088|NCT01136408|559944373|FG001|Overall Study|Protocol Violation|1|||
155140089|NCT01136408|559944374|FG002|Overall Study|Protocol Violation|1|||
155140090|NCT02274792|559944375|FG000|Overall Study|Withdrawal by Subject|13|||
155140091|NCT02274792|559944375|FG000|Overall Study|Lost to Follow-up|8|||
155140092|NCT02274792|559944375|FG000|Overall Study|Protocol Specified Criteria|2|||
155140093|NCT02274792|559944375|FG000|Overall Study|Sponsor Decision|2|||
155181116|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155181117|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155181118|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
155181119|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
155181120|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
155026554|NCT01867710|559524482|FG000|Overall Study|Study Terminated by Sponsor|9|||
155181121|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155181122|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155181123|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155181124|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
155181125|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
155181126|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
155181127|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155181128|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155181129|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155181130|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
155181131|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
155181132|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
155181133|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155181134|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155181135|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155181136|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
155181137|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
155181138|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
155181139|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155181140|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155181141|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155181142|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
155181143|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
155181144|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
155181145|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155181146|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155181147|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155181148|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155181149|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
155181150|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
155181151|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
155181152|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
155181153|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
155181154|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
155181155|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
155181156|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
155181157|NCT00745615|560102084|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155181158|NCT00745615|560102085|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155181159|NCT00745615|560102086|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155181160|NCT00745615|560102087|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
155181161|NCT00745615|560102088|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
155181162|NCT00745615|560102089|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
155181163|NCT01076075|560102090|FG000|Overall Study|Adverse Event|3|||
155181164|NCT01076075|560102091|FG001|Overall Study|Adverse Event|9|||
155181165|NCT01076075|560102090|FG000|Overall Study|Lack of Efficacy|5|||
155181166|NCT01076075|560102091|FG001|Overall Study|Lack of Efficacy|4|||
155181167|NCT01076075|560102090|FG000|Overall Study|Lost to Follow-up|6|||
155181168|NCT01076075|560102091|FG001|Overall Study|Lost to Follow-up|5|||
155181169|NCT01076075|560102090|FG000|Overall Study|other|19|||
155181170|NCT01076075|560102091|FG001|Overall Study|other|9|||
155181171|NCT01076075|560102090|FG000|Overall Study|Protocol Violation|0|||
155181172|NCT01076075|560102091|FG001|Overall Study|Protocol Violation|1|||
155181173|NCT01076075|560102090|FG000|Overall Study|Withdrawal by Subject|8|||
155181174|NCT01076075|560102091|FG001|Overall Study|Withdrawal by Subject|19|||
155181175|NCT01445886|560102097|FG000|Overall Study|Lost to Follow-up|2|||
155181176|NCT01445886|560102097|FG000|Overall Study|Protocol Violation|3|||
155181177|NCT01163032|560102098|FG000|Randomization Phase|Withdrawal by Subject|2|||
155181178|NCT01163032|560102099|FG001|Randomization Phase|Withdrawal by Subject|3|||
155026555|NCT01867710|559524483|FG001|Overall Study|Study Terminated by Sponsor|13|||
155026556|NCT01867710|559524484|FG002|Overall Study|Study Terminated by Sponsor|8|||
155026557|NCT01867710|559524485|FG003|Overall Study|Study Terminated by Sponsor|16|||
155181179|NCT01163032|560102100|FG002|Randomization Phase|Withdrawal by Subject|0|||
155026558|NCT01867710|559524482|FG000|Overall Study|Biochemical progression|0|||
155026559|NCT01867710|559524483|FG001|Overall Study|Biochemical progression|1|||
155026560|NCT01867710|559524484|FG002|Overall Study|Biochemical progression|0|||
155026561|NCT01867710|559524485|FG003|Overall Study|Biochemical progression|0|||
155026562|NCT01867710|559524482|FG000|Overall Study|Clinical progression|0|||
155026563|NCT01867710|559524483|FG001|Overall Study|Clinical progression|0|||
155026564|NCT01867710|559524484|FG002|Overall Study|Clinical progression|1|||
155026565|NCT01867710|559524485|FG003|Overall Study|Clinical progression|0|||
155026566|NCT01867710|559524482|FG000|Overall Study|Disease progression|1|||
155026567|NCT01867710|559524483|FG001|Overall Study|Disease progression|0|||
155026568|NCT01867710|559524484|FG002|Overall Study|Disease progression|0|||
155026569|NCT01867710|559524485|FG003|Overall Study|Disease progression|0|||
155026570|NCT01867710|559524482|FG000|Overall Study|Patient decision|0|||
155026571|NCT01867710|559524483|FG001|Overall Study|Patient decision|0|||
155026572|NCT01867710|559524484|FG002|Overall Study|Patient decision|0|||
155026573|NCT01867710|559524485|FG003|Overall Study|Patient decision|1|||
155026574|NCT01867710|559524482|FG000|Overall Study|Patient to follow subsequent treatment|0|||
155026575|NCT01867710|559524483|FG001|Overall Study|Patient to follow subsequent treatment|1|||
155026576|NCT01867710|559524484|FG002|Overall Study|Patient to follow subsequent treatment|0|||
155026577|NCT01867710|559524485|FG003|Overall Study|Patient to follow subsequent treatment|0|||
155026578|NCT01867710|559524482|FG000|Overall Study|Progressive disease|1|||
155026579|NCT01867710|559524483|FG001|Overall Study|Progressive disease|0|||
155026580|NCT01867710|559524484|FG002|Overall Study|Progressive disease|0|||
155026581|NCT01867710|559524485|FG003|Overall Study|Progressive disease|0|||
155026582|NCT01867710|559524482|FG000|Overall Study|Protocol Violation|0|||
155026583|NCT01867710|559524483|FG001|Overall Study|Protocol Violation|0|||
155026584|NCT01867710|559524484|FG002|Overall Study|Protocol Violation|0|||
155026585|NCT01867710|559524485|FG003|Overall Study|Protocol Violation|1|||
155026586|NCT01867710|559524482|FG000|Overall Study|PSA-progression|0|||
155026587|NCT01867710|559524483|FG001|Overall Study|PSA-progression|1|||
155026588|NCT01867710|559524484|FG002|Overall Study|PSA-progression|0|||
155026589|NCT01867710|559524485|FG003|Overall Study|PSA-progression|0|||
155026590|NCT01867710|559524482|FG000|Overall Study|Study medication no longer effective|0|||
155026591|NCT01867710|559524483|FG001|Overall Study|Study medication no longer effective|1|||
155026592|NCT01867710|559524484|FG002|Overall Study|Study medication no longer effective|0|||
155026593|NCT01867710|559524485|FG003|Overall Study|Study medication no longer effective|0|||
155026594|NCT02048826|559524489|FG000|Overall Study|Withdrawal by Subject|1|||
155026595|NCT02048826|559524490|FG001|Overall Study|Withdrawal by Subject|0|||
155026596|NCT00526669|559524491|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
155026597|NCT00526669|559524492|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
155026598|NCT00526669|559524491|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
155026599|NCT00526669|559524492|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
155026600|NCT00526669|559524491|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
155026601|NCT00526669|559524492|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
155026602|NCT00526669|559524491|FG000|Combined Treatment Phase|Death|0|||
155026603|NCT00526669|559524492|FG001|Combined Treatment Phase|Death|2|||
155026604|NCT03452488|559524499|FG000|Overall Study|Adverse Event|4|||
155026605|NCT03452488|559524500|FG001|Overall Study|Adverse Event|6|||
155026606|NCT03452488|559524501|FG002|Overall Study|Adverse Event|1|||
155026607|NCT03452488|559524499|FG000|Overall Study|Death|0|||
155026608|NCT03452488|559524500|FG001|Overall Study|Death|0|||
155026609|NCT03452488|559524501|FG002|Overall Study|Death|1|||
155026610|NCT03452488|559524499|FG000|Overall Study|Lost to Follow-up|1|||
155026611|NCT03452488|559524500|FG001|Overall Study|Lost to Follow-up|2|||
155026612|NCT03452488|559524501|FG002|Overall Study|Lost to Follow-up|0|||
155026613|NCT03452488|559524499|FG000|Overall Study|PI Decision|1|||
155026614|NCT03452488|559524500|FG001|Overall Study|PI Decision|0|||
155026615|NCT03452488|559524501|FG002|Overall Study|PI Decision|0|||
155026616|NCT03452488|559524499|FG000|Overall Study|Withdrew consent|4|||
155026617|NCT03452488|559524500|FG001|Overall Study|Withdrew consent|2|||
155026618|NCT03452488|559524501|FG002|Overall Study|Withdrew consent|2|||
155026619|NCT03452488|559524499|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
155026620|NCT03452488|559524500|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
155026621|NCT03452488|559524501|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
155026622|NCT03452488|559524499|FG000|Overall Study|Other|0|||
155026623|NCT03452488|559524500|FG001|Overall Study|Other|2|||
155026624|NCT03452488|559524501|FG002|Overall Study|Other|2|||
155026625|NCT04016779|559524502|FG000|Overall Study|Adverse Event|9|||
155026626|NCT04016779|559524503|FG001|Overall Study|Adverse Event|17|||
155026627|NCT04016779|559524502|FG000|Overall Study|Lack of Efficacy|4|||
155026628|NCT04016779|559524503|FG001|Overall Study|Lack of Efficacy|1|||
155026629|NCT04016779|559524502|FG000|Overall Study|Lost to Follow-up|5|||
155026630|NCT04016779|559524503|FG001|Overall Study|Lost to Follow-up|14|||
155026631|NCT04016779|559524502|FG000|Overall Study|Physician Decision|1|||
155026632|NCT04016779|559524503|FG001|Overall Study|Physician Decision|3|||
155026633|NCT04016779|559524502|FG000|Overall Study|Withdrawal by Subject|6|||
155181180|NCT01163032|560102098|FG000|Randomization Phase|Adverse Event|3|||
155181181|NCT01163032|560102099|FG001|Randomization Phase|Adverse Event|3|||
155181182|NCT01163032|560102100|FG002|Randomization Phase|Adverse Event|0|||
155181183|NCT01163032|560102098|FG000|Randomization Phase|Protocol Violation|0|||
155181184|NCT01163032|560102099|FG001|Randomization Phase|Protocol Violation|1|||
155181185|NCT01163032|560102100|FG002|Randomization Phase|Protocol Violation|0|||
155181186|NCT01163032|560102098|FG000|Randomization Phase|Various*|5|||
155181187|NCT01163032|560102099|FG001|Randomization Phase|Various*|4|||
155026634|NCT04016779|559524503|FG001|Overall Study|Withdrawal by Subject|8|||
155026635|NCT04016779|559524502|FG000|Overall Study|Non-compliance with Study Drug|2|||
155026636|NCT04016779|559524503|FG001|Overall Study|Non-compliance with Study Drug|3|||
155181188|NCT01163032|560102100|FG002|Randomization Phase|Various*|0|||
155181189|NCT01163032|560102098|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
155026637|NCT04016779|559524502|FG000|Overall Study|Other, Multiple categories|17|||
155026638|NCT04016779|559524503|FG001|Overall Study|Other, Multiple categories|17|||
155026639|NCT00623935|559524504|FG000|Overall Study|Death|1|||
155026640|NCT00623935|559524504|FG000|Overall Study|Patient Declined Transplant|1|||
155026641|NCT03315286|559524505|FG000|Overall Study|Lost to Follow-up|0|||
155026642|NCT03315286|559524506|FG001|Overall Study|Lost to Follow-up|3|||
155026643|NCT03315286|559524505|FG000|Overall Study|Withdrawal by Subject|1|||
155026644|NCT03315286|559524506|FG001|Overall Study|Withdrawal by Subject|0|||
155026645|NCT03315286|559524505|FG000|Overall Study|Protocol Violation|0|||
155026646|NCT03315286|559524506|FG001|Overall Study|Protocol Violation|1|||
155026647|NCT02828124|559524507|FG000|Overall Study|Disease Progression|1|||
155026648|NCT02828124|559524508|FG001|Overall Study|Disease Progression|2|||
155026649|NCT02828124|559524509|FG002|Overall Study|Disease Progression|1|||
155026650|NCT02828124|559524510|FG003|Overall Study|Disease Progression|4|||
155026651|NCT02828124|559524507|FG000|Overall Study|AE Unrelated to Study Drug|0|||
155026652|NCT02828124|559524508|FG001|Overall Study|AE Unrelated to Study Drug|0|||
155026653|NCT02828124|559524509|FG002|Overall Study|AE Unrelated to Study Drug|0|||
155026654|NCT02828124|559524510|FG003|Overall Study|AE Unrelated to Study Drug|1|||
155026655|NCT02828124|559524507|FG000|Overall Study|Subject Withdrew Consent|0|||
155026656|NCT02828124|559524508|FG001|Overall Study|Subject Withdrew Consent|0|||
155026657|NCT02828124|559524509|FG002|Overall Study|Subject Withdrew Consent|0|||
155026658|NCT02828124|559524510|FG003|Overall Study|Subject Withdrew Consent|1|||
155026659|NCT02829723|559524512|FG000|Overall Study|Adverse Event|0|||
155026660|NCT02829723|559524513|FG001|Overall Study|Adverse Event|0|||
155026661|NCT02829723|559524514|FG002|Overall Study|Adverse Event|1|||
155026662|NCT02829723|559524515|FG003|Overall Study|Adverse Event|1|||
155026663|NCT02829723|559524516|FG004|Overall Study|Adverse Event|0|||
155026664|NCT02829723|559524517|FG005|Overall Study|Adverse Event|0|||
155026665|NCT02829723|559524518|FG006|Overall Study|Adverse Event|0|||
155026666|NCT02829723|559524519|FG007|Overall Study|Adverse Event|1|||
155026667|NCT02829723|559524520|FG008|Overall Study|Adverse Event|0|||
155026668|NCT02829723|559524521|FG009|Overall Study|Adverse Event|0|||
155026669|NCT02829723|559524522|FG010|Overall Study|Adverse Event|0|||
155026670|NCT02829723|559524523|FG011|Overall Study|Adverse Event|0|||
155026671|NCT02829723|559524524|FG012|Overall Study|Adverse Event|0|||
155026672|NCT02829723|559524525|FG013|Overall Study|Adverse Event|0|||
155026673|NCT02829723|559524526|FG014|Overall Study|Adverse Event|1|||
155026674|NCT02829723|559524527|FG015|Overall Study|Adverse Event|1|||
155026675|NCT02829723|559524528|FG016|Overall Study|Adverse Event|1|||
155026676|NCT02829723|559524529|FG017|Overall Study|Adverse Event|2|||
155026677|NCT02829723|559524530|FG018|Overall Study|Adverse Event|1|||
155026678|NCT02829723|559524531|FG019|Overall Study|Adverse Event|1|||
155026679|NCT02829723|559524532|FG020|Overall Study|Adverse Event|3|||
155026680|NCT02829723|559524533|FG021|Overall Study|Adverse Event|0|||
155026681|NCT02829723|559524534|FG022|Overall Study|Adverse Event|0|||
155026682|NCT02829723|559524535|FG023|Overall Study|Adverse Event|1|||
155026683|NCT02829723|559524536|FG024|Overall Study|Adverse Event|1|||
155026684|NCT02829723|559524537|FG025|Overall Study|Adverse Event|3|||
155026685|NCT02829723|559524538|FG026|Overall Study|Adverse Event|5|||
155026686|NCT02829723|559524512|FG000|Overall Study|Death|1|||
155026687|NCT02829723|559524513|FG001|Overall Study|Death|0|||
155026688|NCT02829723|559524514|FG002|Overall Study|Death|1|||
155026689|NCT02829723|559524515|FG003|Overall Study|Death|1|||
155026690|NCT02829723|559524516|FG004|Overall Study|Death|0|||
155026691|NCT02829723|559524517|FG005|Overall Study|Death|0|||
155026692|NCT02829723|559524518|FG006|Overall Study|Death|2|||
155026693|NCT02829723|559524519|FG007|Overall Study|Death|0|||
155026694|NCT02829723|559524520|FG008|Overall Study|Death|1|||
155026695|NCT02829723|559524521|FG009|Overall Study|Death|0|||
155026696|NCT02829723|559524522|FG010|Overall Study|Death|0|||
155026697|NCT02829723|559524523|FG011|Overall Study|Death|0|||
155026698|NCT02829723|559524524|FG012|Overall Study|Death|2|||
155026699|NCT02829723|559524525|FG013|Overall Study|Death|1|||
155026700|NCT02829723|559524526|FG014|Overall Study|Death|0|||
155026701|NCT02829723|559524527|FG015|Overall Study|Death|0|||
155181190|NCT01163032|560102099|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
155181191|NCT01163032|560102100|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
155181192|NCT01163032|560102098|FG000|Open Label Extension Phase|Adverse Event|0|||
155181193|NCT01163032|560102099|FG001|Open Label Extension Phase|Adverse Event|0|||
155181194|NCT01163032|560102100|FG002|Open Label Extension Phase|Adverse Event|3|||
155181195|NCT01163032|560102098|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
155181196|NCT01163032|560102099|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
155181197|NCT01163032|560102100|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
155181198|NCT01163032|560102098|FG000|Open Label Extension Phase|Protocol Violation|0|||
155181199|NCT01163032|560102099|FG001|Open Label Extension Phase|Protocol Violation|0|||
155181200|NCT01163032|560102100|FG002|Open Label Extension Phase|Protocol Violation|1|||
155181201|NCT01163032|560102098|FG000|Open Label Extension Phase|Study Termination|0|||
155181202|NCT01163032|560102099|FG001|Open Label Extension Phase|Study Termination|0|||
155181203|NCT01163032|560102100|FG002|Open Label Extension Phase|Study Termination|7|||
155181204|NCT01163032|560102098|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
155181205|NCT01163032|560102099|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
155181206|NCT01163032|560102100|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
155181207|NCT03326206|560102106|FG000|Overall Study - 24 months|Unable to match cases with controls|17|||
155181208|NCT03326206|560102107|FG001|Overall Study - 24 months|Unable to match cases with controls|22721|||
155181209|NCT03326206|560102106|FG000|Overall Study - 24 months|Death|8|||
155181210|NCT03326206|560102107|FG001|Overall Study - 24 months|Death|92|||
155181211|NCT03326206|560102106|FG000|Overall Study - 24 months|Observational data not available|43|||
155181212|NCT03326206|560102107|FG001|Overall Study - 24 months|Observational data not available|2879|||
155181213|NCT03326206|560102106|FG000|12 months|Unable to match cases with controls|17|||
155181214|NCT03326206|560102107|FG001|12 months|Unable to match cases with controls|22721|||
155181215|NCT03326206|560102106|FG000|12 months|Death|2|||
155181216|NCT03326206|560102107|FG001|12 months|Death|50|||
155181217|NCT03326206|560102106|FG000|12 months|Observational data not available|49|||
155181218|NCT03326206|560102107|FG001|12 months|Observational data not available|2921|||
155181219|NCT04090411|560102108|FG000|Induction Period|Adverse Event|3|||
155181220|NCT04090411|560102109|FG001|Induction Period|Adverse Event|1|||
155181221|NCT04090411|560102110|FG002|Induction Period|Adverse Event|1|||
155181222|NCT04090411|560102111|FG003|Induction Period|Adverse Event|1|||
155181223|NCT04090411|560102112|FG004|Induction Period|Adverse Event|0|||
155181224|NCT04090411|560102113|FG005|Induction Period|Adverse Event|0|||
155181225|NCT04090411|560102114|FG006|Induction Period|Adverse Event|0|||
155181226|NCT04090411|560102115|FG007|Induction Period|Adverse Event|0|||
155181227|NCT04090411|560102116|FG008|Induction Period|Adverse Event|0|||
155181228|NCT04090411|560102117|FG009|Induction Period|Adverse Event|0|||
155181229|NCT04090411|560102118|FG010|Induction Period|Adverse Event|0|||
155181230|NCT04090411|560102119|FG011|Induction Period|Adverse Event|0|||
155181231|NCT04090411|560102120|FG012|Induction Period|Adverse Event|0|||
155181232|NCT04090411|560102108|FG000|Induction Period|Lack of Efficacy|0|||
155181233|NCT04090411|560102109|FG001|Induction Period|Lack of Efficacy|0|||
155181234|NCT04090411|560102110|FG002|Induction Period|Lack of Efficacy|1|||
155181235|NCT04090411|560102111|FG003|Induction Period|Lack of Efficacy|1|||
155181236|NCT04090411|560102112|FG004|Induction Period|Lack of Efficacy|0|||
155181237|NCT04090411|560102113|FG005|Induction Period|Lack of Efficacy|0|||
155181238|NCT04090411|560102114|FG006|Induction Period|Lack of Efficacy|0|||
155181239|NCT04090411|560102115|FG007|Induction Period|Lack of Efficacy|0|||
155181240|NCT04090411|560102116|FG008|Induction Period|Lack of Efficacy|0|||
155181241|NCT04090411|560102117|FG009|Induction Period|Lack of Efficacy|0|||
155181242|NCT04090411|560102118|FG010|Induction Period|Lack of Efficacy|0|||
155181243|NCT04090411|560102119|FG011|Induction Period|Lack of Efficacy|0|||
155181244|NCT04090411|560102120|FG012|Induction Period|Lack of Efficacy|0|||
155181245|NCT04090411|560102108|FG000|Induction Period|Physician Decision|0|||
155181246|NCT04090411|560102109|FG001|Induction Period|Physician Decision|0|||
155181247|NCT04090411|560102110|FG002|Induction Period|Physician Decision|1|||
155181248|NCT04090411|560102111|FG003|Induction Period|Physician Decision|0|||
155181249|NCT04090411|560102112|FG004|Induction Period|Physician Decision|0|||
155181250|NCT04090411|560102113|FG005|Induction Period|Physician Decision|0|||
155181251|NCT04090411|560102114|FG006|Induction Period|Physician Decision|0|||
155181252|NCT04090411|560102115|FG007|Induction Period|Physician Decision|0|||
155181253|NCT04090411|560102116|FG008|Induction Period|Physician Decision|0|||
155026702|NCT02829723|559524528|FG016|Overall Study|Death|0|||
155026703|NCT02829723|559524529|FG017|Overall Study|Death|0|||
155026704|NCT02829723|559524530|FG018|Overall Study|Death|0|||
155181254|NCT04090411|560102117|FG009|Induction Period|Physician Decision|0|||
155181255|NCT04090411|560102118|FG010|Induction Period|Physician Decision|0|||
155181256|NCT04090411|560102119|FG011|Induction Period|Physician Decision|0|||
155181257|NCT04090411|560102120|FG012|Induction Period|Physician Decision|0|||
155181258|NCT04090411|560102108|FG000|Induction Period|Protocol Violation|0|||
155181259|NCT04090411|560102109|FG001|Induction Period|Protocol Violation|0|||
155026705|NCT02829723|559524531|FG019|Overall Study|Death|0|||
155026706|NCT02829723|559524532|FG020|Overall Study|Death|0|||
155181260|NCT04090411|560102110|FG002|Induction Period|Protocol Violation|0|||
155181261|NCT04090411|560102111|FG003|Induction Period|Protocol Violation|1|||
155181262|NCT04090411|560102112|FG004|Induction Period|Protocol Violation|0|||
155181263|NCT04090411|560102113|FG005|Induction Period|Protocol Violation|0|||
155181264|NCT04090411|560102114|FG006|Induction Period|Protocol Violation|0|||
155181265|NCT04090411|560102115|FG007|Induction Period|Protocol Violation|0|||
155181266|NCT04090411|560102116|FG008|Induction Period|Protocol Violation|0|||
155181267|NCT04090411|560102117|FG009|Induction Period|Protocol Violation|0|||
155181268|NCT04090411|560102118|FG010|Induction Period|Protocol Violation|0|||
155181269|NCT04090411|560102119|FG011|Induction Period|Protocol Violation|0|||
155181270|NCT04090411|560102120|FG012|Induction Period|Protocol Violation|0|||
155181271|NCT04090411|560102108|FG000|Induction Period|Withdrawal by Subject|2|||
155181272|NCT04090411|560102109|FG001|Induction Period|Withdrawal by Subject|0|||
155181273|NCT04090411|560102110|FG002|Induction Period|Withdrawal by Subject|1|||
155181274|NCT04090411|560102111|FG003|Induction Period|Withdrawal by Subject|5|||
155181275|NCT04090411|560102112|FG004|Induction Period|Withdrawal by Subject|0|||
155181276|NCT04090411|560102113|FG005|Induction Period|Withdrawal by Subject|0|||
155181277|NCT04090411|560102114|FG006|Induction Period|Withdrawal by Subject|0|||
155181278|NCT04090411|560102115|FG007|Induction Period|Withdrawal by Subject|0|||
155181279|NCT04090411|560102116|FG008|Induction Period|Withdrawal by Subject|0|||
155181280|NCT04090411|560102117|FG009|Induction Period|Withdrawal by Subject|0|||
155181281|NCT04090411|560102118|FG010|Induction Period|Withdrawal by Subject|0|||
155181282|NCT04090411|560102119|FG011|Induction Period|Withdrawal by Subject|0|||
155181283|NCT04090411|560102120|FG012|Induction Period|Withdrawal by Subject|0|||
155181284|NCT04090411|560102108|FG000|Chronic Period|Adverse Event|0|||
155181285|NCT04090411|560102109|FG001|Chronic Period|Adverse Event|0|||
155181286|NCT04090411|560102110|FG002|Chronic Period|Adverse Event|0|||
155181287|NCT04090411|560102111|FG003|Chronic Period|Adverse Event|0|||
155181288|NCT04090411|560102112|FG004|Chronic Period|Adverse Event|0|||
155181289|NCT04090411|560102113|FG005|Chronic Period|Adverse Event|1|||
155181290|NCT04090411|560102114|FG006|Chronic Period|Adverse Event|0|||
155181291|NCT04090411|560102115|FG007|Chronic Period|Adverse Event|3|||
155181292|NCT04090411|560102116|FG008|Chronic Period|Adverse Event|0|||
155181293|NCT04090411|560102117|FG009|Chronic Period|Adverse Event|0|||
155181294|NCT04090411|560102118|FG010|Chronic Period|Adverse Event|5|||
155181295|NCT04090411|560102119|FG011|Chronic Period|Adverse Event|1|||
155181296|NCT04090411|560102120|FG012|Chronic Period|Adverse Event|1|||
155181297|NCT04090411|560102108|FG000|Chronic Period|Lack of Efficacy|0|||
155181298|NCT04090411|560102109|FG001|Chronic Period|Lack of Efficacy|0|||
155181299|NCT04090411|560102110|FG002|Chronic Period|Lack of Efficacy|0|||
155181300|NCT04090411|560102111|FG003|Chronic Period|Lack of Efficacy|0|||
155181301|NCT04090411|560102112|FG004|Chronic Period|Lack of Efficacy|0|||
155181302|NCT04090411|560102113|FG005|Chronic Period|Lack of Efficacy|0|||
155181303|NCT04090411|560102114|FG006|Chronic Period|Lack of Efficacy|1|||
155181304|NCT04090411|560102115|FG007|Chronic Period|Lack of Efficacy|4|||
155181305|NCT04090411|560102116|FG008|Chronic Period|Lack of Efficacy|2|||
155181306|NCT04090411|560102117|FG009|Chronic Period|Lack of Efficacy|2|||
155181307|NCT04090411|560102118|FG010|Chronic Period|Lack of Efficacy|2|||
155181308|NCT04090411|560102119|FG011|Chronic Period|Lack of Efficacy|1|||
155181309|NCT04090411|560102120|FG012|Chronic Period|Lack of Efficacy|2|||
155181310|NCT04090411|560102108|FG000|Chronic Period|Relocation|0|||
155181311|NCT04090411|560102109|FG001|Chronic Period|Relocation|0|||
155181312|NCT04090411|560102110|FG002|Chronic Period|Relocation|0|||
155181313|NCT04090411|560102111|FG003|Chronic Period|Relocation|0|||
155181314|NCT04090411|560102112|FG004|Chronic Period|Relocation|0|||
155181315|NCT04090411|560102113|FG005|Chronic Period|Relocation|0|||
155181316|NCT04090411|560102114|FG006|Chronic Period|Relocation|0|||
155181317|NCT04090411|560102115|FG007|Chronic Period|Relocation|1|||
155181318|NCT04090411|560102116|FG008|Chronic Period|Relocation|0|||
155181319|NCT04090411|560102117|FG009|Chronic Period|Relocation|0|||
155181320|NCT04090411|560102118|FG010|Chronic Period|Relocation|0|||
155181321|NCT04090411|560102119|FG011|Chronic Period|Relocation|0|||
155181322|NCT04090411|560102120|FG012|Chronic Period|Relocation|0|||
155181323|NCT04090411|560102108|FG000|Chronic Period|Physician Decision|0|||
155181324|NCT04090411|560102109|FG001|Chronic Period|Physician Decision|0|||
155181325|NCT04090411|560102110|FG002|Chronic Period|Physician Decision|0|||
155181326|NCT04090411|560102111|FG003|Chronic Period|Physician Decision|0|||
155181327|NCT04090411|560102112|FG004|Chronic Period|Physician Decision|1|||
155181328|NCT04090411|560102113|FG005|Chronic Period|Physician Decision|0|||
155181329|NCT04090411|560102114|FG006|Chronic Period|Physician Decision|0|||
155181330|NCT04090411|560102115|FG007|Chronic Period|Physician Decision|1|||
155181331|NCT04090411|560102116|FG008|Chronic Period|Physician Decision|0|||
155181332|NCT04090411|560102117|FG009|Chronic Period|Physician Decision|0|||
155181333|NCT04090411|560102118|FG010|Chronic Period|Physician Decision|0|||
155181334|NCT04090411|560102119|FG011|Chronic Period|Physician Decision|1|||
155181335|NCT04090411|560102120|FG012|Chronic Period|Physician Decision|1|||
155181336|NCT04090411|560102108|FG000|Chronic Period|Protocol Violation|0|||
155181337|NCT04090411|560102109|FG001|Chronic Period|Protocol Violation|0|||
155181338|NCT04090411|560102110|FG002|Chronic Period|Protocol Violation|0|||
155181339|NCT04090411|560102111|FG003|Chronic Period|Protocol Violation|0|||
155181340|NCT04090411|560102112|FG004|Chronic Period|Protocol Violation|0|||
155181341|NCT04090411|560102113|FG005|Chronic Period|Protocol Violation|0|||
155181342|NCT04090411|560102114|FG006|Chronic Period|Protocol Violation|0|||
155181343|NCT04090411|560102115|FG007|Chronic Period|Protocol Violation|0|||
155181344|NCT04090411|560102116|FG008|Chronic Period|Protocol Violation|0|||
155181345|NCT04090411|560102117|FG009|Chronic Period|Protocol Violation|0|||
155181346|NCT04090411|560102118|FG010|Chronic Period|Protocol Violation|0|||
155181347|NCT04090411|560102119|FG011|Chronic Period|Protocol Violation|0|||
155181348|NCT04090411|560102120|FG012|Chronic Period|Protocol Violation|1|||
155181349|NCT04090411|560102108|FG000|Chronic Period|Withdrawal by Subject|0|||
155181350|NCT04090411|560102109|FG001|Chronic Period|Withdrawal by Subject|0|||
155181351|NCT04090411|560102110|FG002|Chronic Period|Withdrawal by Subject|0|||
155181352|NCT04090411|560102111|FG003|Chronic Period|Withdrawal by Subject|0|||
155181353|NCT04090411|560102112|FG004|Chronic Period|Withdrawal by Subject|0|||
155181354|NCT04090411|560102113|FG005|Chronic Period|Withdrawal by Subject|1|||
155181355|NCT04090411|560102114|FG006|Chronic Period|Withdrawal by Subject|1|||
155181356|NCT04090411|560102115|FG007|Chronic Period|Withdrawal by Subject|3|||
155181357|NCT04090411|560102116|FG008|Chronic Period|Withdrawal by Subject|3|||
155181358|NCT04090411|560102117|FG009|Chronic Period|Withdrawal by Subject|3|||
155181359|NCT04090411|560102118|FG010|Chronic Period|Withdrawal by Subject|1|||
155181360|NCT04090411|560102119|FG011|Chronic Period|Withdrawal by Subject|3|||
155181361|NCT04090411|560102120|FG012|Chronic Period|Withdrawal by Subject|0|||
155181362|NCT01615029|560102124|FG000|Overall Study|Adverse Event|1|||
155181363|NCT01615029|560102125|FG001|Overall Study|Adverse Event|0|||
155181364|NCT01615029|560102126|FG002|Overall Study|Adverse Event|3|||
155181365|NCT01615029|560102127|FG003|Overall Study|Adverse Event|0|||
155181366|NCT01615029|560102128|FG004|Overall Study|Adverse Event|4|||
155181367|NCT01615029|560102124|FG000|Overall Study|Progressive disease|1|||
155181368|NCT01615029|560102125|FG001|Overall Study|Progressive disease|1|||
155181369|NCT01615029|560102126|FG002|Overall Study|Progressive disease|1|||
155181370|NCT01615029|560102127|FG003|Overall Study|Progressive disease|1|||
155181371|NCT01615029|560102128|FG004|Overall Study|Progressive disease|10|||
155181372|NCT01615029|560102124|FG000|Overall Study|Physician Decision|0|||
155181373|NCT01615029|560102125|FG001|Overall Study|Physician Decision|0|||
155181374|NCT01615029|560102126|FG002|Overall Study|Physician Decision|0|||
155181375|NCT01615029|560102127|FG003|Overall Study|Physician Decision|0|||
155181376|NCT01615029|560102128|FG004|Overall Study|Physician Decision|2|||
155181377|NCT03764033|560102130|FG000|Treatment Phase|Withdrawal by Subject|8|||
155181378|NCT03764033|560102131|FG001|Treatment Phase|Withdrawal by Subject|3|||
155181379|NCT03764033|560102130|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
155181380|NCT03764033|560102131|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
155181381|NCT03764033|560102130|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
155181382|NCT03764033|560102131|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
155181383|NCT01163318|560102132|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
155181384|NCT01163318|560102132|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
155181385|NCT01163318|560102132|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
155181386|NCT01163318|560102132|FG000|Overall Study|Participants Without Case Report Form|7|||
155181387|NCT01163318|560102132|FG000|Overall Study|Multiple Reasons Per Participant|224|||
155181388|NCT01892722|560102133|FG000|Overall Study|Protocol deviation|0|||
155181389|NCT01892722|560102134|FG001|Overall Study|Protocol deviation|1|||
155181390|NCT01892722|560102133|FG000|Overall Study|Administrative problems|0|||
155181391|NCT01892722|560102134|FG001|Overall Study|Administrative problems|1|||
155181392|NCT01892722|560102133|FG000|Overall Study|Patient/guardian decision|0|||
155181393|NCT01892722|560102134|FG001|Overall Study|Patient/guardian decision|2|||
155181394|NCT01892722|560102133|FG000|Overall Study|Physician Decision|1|||
155181395|NCT01892722|560102134|FG001|Overall Study|Physician Decision|2|||
155181396|NCT01892722|560102133|FG000|Overall Study|Adverse Event|3|||
155181397|NCT01892722|560102134|FG001|Overall Study|Adverse Event|2|||
155181398|NCT01892722|560102133|FG000|Overall Study|Lack of Efficacy|0|||
155181399|NCT01892722|560102134|FG001|Overall Study|Lack of Efficacy|7|||
155181400|NCT01892722|560102133|FG000|Overall Study|Withdrawal by Subject|3|||
155181401|NCT01892722|560102134|FG001|Overall Study|Withdrawal by Subject|5|||
155181402|NCT05710185|560103061|FG000|Overall Study|Adverse Event|1|||
155181403|NCT05710185|560103061|FG000|Overall Study|Lack of Efficacy|1|||
155181404|NCT04617795|560103064|FG000|Main Study|Lost to Follow-up|1|||
155181405|NCT04617795|560103065|FG001|Main Study|Lost to Follow-up|0|||
155181406|NCT00472459|560103066|FG000|Overall Study|Adverse Event|13|||
155181407|NCT00472459|560103067|FG001|Overall Study|Adverse Event|13|||
155181408|NCT00472459|560103066|FG000|Overall Study|Withdrawal by Subject|5|||
155181409|NCT00472459|560103067|FG001|Overall Study|Withdrawal by Subject|5|||
155181410|NCT00472459|560103066|FG000|Overall Study|Protocol Violation|3|||
155181411|NCT00472459|560103067|FG001|Overall Study|Protocol Violation|3|||
155181412|NCT00472459|560103066|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
155181413|NCT00472459|560103067|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
155181414|NCT00472459|560103066|FG000|Overall Study|Lost to Follow-up|1|||
155181415|NCT00472459|560103067|FG001|Overall Study|Lost to Follow-up|1|||
155181416|NCT04850313|560103068|FG000|Overall Study|Withdrawal by Subject|0|||
155181417|NCT04850313|560103069|FG001|Overall Study|Withdrawal by Subject|1|||
155181418|NCT05313009|560103070|FG000|Overall Study|Death|1|||
155181419|NCT05313009|560103071|FG001|Overall Study|Death|0|||
155181420|NCT03505671|560103074|FG000|Overall Study|Withdrawal by Subject|2|||
155181421|NCT03505671|560103075|FG001|Overall Study|Withdrawal by Subject|1|||
155181422|NCT03505671|560103074|FG000|Overall Study|Lost to Follow-up|1|||
155181423|NCT03505671|560103075|FG001|Overall Study|Lost to Follow-up|0|||
155181424|NCT02038829|560103078|FG000|Washout Period 1|Death|0|||
155026707|NCT02829723|559524533|FG021|Overall Study|Death|2|||
155026708|NCT02829723|559524534|FG022|Overall Study|Death|0|||
155026709|NCT02829723|559524535|FG023|Overall Study|Death|0|||
155026710|NCT02829723|559524536|FG024|Overall Study|Death|0|||
155026711|NCT02829723|559524537|FG025|Overall Study|Death|1|||
155026712|NCT02829723|559524538|FG026|Overall Study|Death|2|||
155026713|NCT02829723|559524512|FG000|Overall Study|Physician Decision|0|||
155026714|NCT02829723|559524513|FG001|Overall Study|Physician Decision|0|||
155026715|NCT02829723|559524514|FG002|Overall Study|Physician Decision|0|||
155026716|NCT02829723|559524515|FG003|Overall Study|Physician Decision|0|||
155026717|NCT02829723|559524516|FG004|Overall Study|Physician Decision|0|||
155026718|NCT02829723|559524517|FG005|Overall Study|Physician Decision|0|||
155026719|NCT02829723|559524518|FG006|Overall Study|Physician Decision|0|||
155026720|NCT02829723|559524519|FG007|Overall Study|Physician Decision|0|||
155026721|NCT02829723|559524520|FG008|Overall Study|Physician Decision|0|||
155026722|NCT02829723|559524521|FG009|Overall Study|Physician Decision|1|||
155026723|NCT02829723|559524522|FG010|Overall Study|Physician Decision|1|||
155026724|NCT02829723|559524523|FG011|Overall Study|Physician Decision|0|||
155026725|NCT02829723|559524524|FG012|Overall Study|Physician Decision|0|||
155026726|NCT02829723|559524525|FG013|Overall Study|Physician Decision|1|||
155026727|NCT02829723|559524526|FG014|Overall Study|Physician Decision|0|||
155026728|NCT02829723|559524527|FG015|Overall Study|Physician Decision|0|||
155026729|NCT02829723|559524528|FG016|Overall Study|Physician Decision|2|||
155026730|NCT02829723|559524529|FG017|Overall Study|Physician Decision|0|||
155026731|NCT02829723|559524530|FG018|Overall Study|Physician Decision|0|||
155026732|NCT02829723|559524531|FG019|Overall Study|Physician Decision|0|||
155026733|NCT02829723|559524532|FG020|Overall Study|Physician Decision|0|||
155026734|NCT02829723|559524533|FG021|Overall Study|Physician Decision|0|||
155026735|NCT02829723|559524534|FG022|Overall Study|Physician Decision|1|||
155026736|NCT02829723|559524535|FG023|Overall Study|Physician Decision|1|||
155026737|NCT02829723|559524536|FG024|Overall Study|Physician Decision|1|||
155026738|NCT02829723|559524537|FG025|Overall Study|Physician Decision|1|||
155026739|NCT02829723|559524538|FG026|Overall Study|Physician Decision|3|||
155026740|NCT02829723|559524512|FG000|Overall Study|Progressive disease|4|||
155026741|NCT02829723|559524513|FG001|Overall Study|Progressive disease|6|||
155026742|NCT02829723|559524514|FG002|Overall Study|Progressive disease|3|||
155026743|NCT02829723|559524515|FG003|Overall Study|Progressive disease|3|||
155026744|NCT02829723|559524516|FG004|Overall Study|Progressive disease|3|||
155026745|NCT02829723|559524517|FG005|Overall Study|Progressive disease|5|||
155026746|NCT02829723|559524518|FG006|Overall Study|Progressive disease|4|||
155026747|NCT02829723|559524519|FG007|Overall Study|Progressive disease|6|||
155026748|NCT02829723|559524520|FG008|Overall Study|Progressive disease|8|||
155026749|NCT02829723|559524521|FG009|Overall Study|Progressive disease|4|||
155026750|NCT02829723|559524522|FG010|Overall Study|Progressive disease|9|||
155026751|NCT02829723|559524523|FG011|Overall Study|Progressive disease|0|||
155026752|NCT02829723|559524524|FG012|Overall Study|Progressive disease|3|||
155026753|NCT02829723|559524525|FG013|Overall Study|Progressive disease|4|||
155026754|NCT02829723|559524526|FG014|Overall Study|Progressive disease|2|||
155026755|NCT02829723|559524527|FG015|Overall Study|Progressive disease|4|||
155026756|NCT02829723|559524528|FG016|Overall Study|Progressive disease|5|||
155026757|NCT02829723|559524529|FG017|Overall Study|Progressive disease|3|||
155026758|NCT02829723|559524530|FG018|Overall Study|Progressive disease|4|||
155026759|NCT02829723|559524531|FG019|Overall Study|Progressive disease|4|||
155026760|NCT02829723|559524532|FG020|Overall Study|Progressive disease|7|||
155026761|NCT02829723|559524533|FG021|Overall Study|Progressive disease|6|||
155026762|NCT02829723|559524534|FG022|Overall Study|Progressive disease|3|||
155026763|NCT02829723|559524535|FG023|Overall Study|Progressive disease|3|||
155026764|NCT02829723|559524536|FG024|Overall Study|Progressive disease|3|||
155026765|NCT02829723|559524537|FG025|Overall Study|Progressive disease|16|||
155026766|NCT02829723|559524538|FG026|Overall Study|Progressive disease|10|||
155026767|NCT02829723|559524512|FG000|Overall Study|Subject/guardian decision|0|||
155026768|NCT02829723|559524513|FG001|Overall Study|Subject/guardian decision|1|||
155026769|NCT02829723|559524514|FG002|Overall Study|Subject/guardian decision|0|||
155026770|NCT02829723|559524515|FG003|Overall Study|Subject/guardian decision|1|||
155026771|NCT02829723|559524516|FG004|Overall Study|Subject/guardian decision|0|||
155026772|NCT02829723|559524517|FG005|Overall Study|Subject/guardian decision|0|||
155026773|NCT02829723|559524518|FG006|Overall Study|Subject/guardian decision|0|||
155026774|NCT02829723|559524519|FG007|Overall Study|Subject/guardian decision|1|||
155026775|NCT02829723|559524520|FG008|Overall Study|Subject/guardian decision|0|||
155026776|NCT02829723|559524521|FG009|Overall Study|Subject/guardian decision|0|||
155026777|NCT02829723|559524522|FG010|Overall Study|Subject/guardian decision|0|||
155181425|NCT02038829|560103079|FG001|Washout Period 1|Death|0|||
155026778|NCT02829723|559524523|FG011|Overall Study|Subject/guardian decision|0|||
155026779|NCT02829723|559524524|FG012|Overall Study|Subject/guardian decision|0|||
155026780|NCT02829723|559524525|FG013|Overall Study|Subject/guardian decision|0|||
155026781|NCT02829723|559524526|FG014|Overall Study|Subject/guardian decision|1|||
155026782|NCT02829723|559524527|FG015|Overall Study|Subject/guardian decision|0|||
155026783|NCT02829723|559524528|FG016|Overall Study|Subject/guardian decision|1|||
155026784|NCT02829723|559524529|FG017|Overall Study|Subject/guardian decision|0|||
155026785|NCT02829723|559524530|FG018|Overall Study|Subject/guardian decision|1|||
155026786|NCT02829723|559524531|FG019|Overall Study|Subject/guardian decision|0|||
155026787|NCT02829723|559524532|FG020|Overall Study|Subject/guardian decision|1|||
155026788|NCT02829723|559524533|FG021|Overall Study|Subject/guardian decision|0|||
155026789|NCT02829723|559524534|FG022|Overall Study|Subject/guardian decision|0|||
155026790|NCT02829723|559524535|FG023|Overall Study|Subject/guardian decision|1|||
155026791|NCT02829723|559524536|FG024|Overall Study|Subject/guardian decision|0|||
155026792|NCT02829723|559524537|FG025|Overall Study|Subject/guardian decision|1|||
155026793|NCT02829723|559524538|FG026|Overall Study|Subject/guardian decision|1|||
155026794|NCT02829723|559524512|FG000|Overall Study|Study terminated by sponsor|0|||
155026795|NCT02829723|559524513|FG001|Overall Study|Study terminated by sponsor|0|||
155026796|NCT02829723|559524514|FG002|Overall Study|Study terminated by sponsor|0|||
155026797|NCT02829723|559524515|FG003|Overall Study|Study terminated by sponsor|0|||
155026798|NCT02829723|559524516|FG004|Overall Study|Study terminated by sponsor|0|||
155026799|NCT02829723|559524517|FG005|Overall Study|Study terminated by sponsor|0|||
155026800|NCT02829723|559524518|FG006|Overall Study|Study terminated by sponsor|0|||
155026801|NCT02829723|559524519|FG007|Overall Study|Study terminated by sponsor|0|||
155026802|NCT02829723|559524520|FG008|Overall Study|Study terminated by sponsor|0|||
155026803|NCT02829723|559524521|FG009|Overall Study|Study terminated by sponsor|0|||
155026804|NCT02829723|559524522|FG010|Overall Study|Study terminated by sponsor|0|||
155026805|NCT02829723|559524523|FG011|Overall Study|Study terminated by sponsor|0|||
155026806|NCT02829723|559524524|FG012|Overall Study|Study terminated by sponsor|0|||
155026807|NCT02829723|559524525|FG013|Overall Study|Study terminated by sponsor|0|||
155026808|NCT02829723|559524526|FG014|Overall Study|Study terminated by sponsor|0|||
155026809|NCT02829723|559524527|FG015|Overall Study|Study terminated by sponsor|0|||
155026810|NCT02829723|559524528|FG016|Overall Study|Study terminated by sponsor|0|||
155026811|NCT02829723|559524529|FG017|Overall Study|Study terminated by sponsor|0|||
155026812|NCT02829723|559524530|FG018|Overall Study|Study terminated by sponsor|0|||
155026813|NCT02829723|559524531|FG019|Overall Study|Study terminated by sponsor|0|||
155026814|NCT02829723|559524532|FG020|Overall Study|Study terminated by sponsor|0|||
155026815|NCT02829723|559524533|FG021|Overall Study|Study terminated by sponsor|1|||
155026816|NCT02829723|559524534|FG022|Overall Study|Study terminated by sponsor|0|||
155026817|NCT02829723|559524535|FG023|Overall Study|Study terminated by sponsor|0|||
155026818|NCT02829723|559524536|FG024|Overall Study|Study terminated by sponsor|0|||
155026819|NCT02829723|559524537|FG025|Overall Study|Study terminated by sponsor|0|||
155026820|NCT02829723|559524538|FG026|Overall Study|Study terminated by sponsor|0|||
155026821|NCT02989649|559524539|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
155026822|NCT02989649|559524539|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
155026823|NCT02989649|559524539|FG000|Overall Study|Lost For Observation During Study|3|||
155026824|NCT02989649|559524539|FG000|Overall Study|Reason Not Specified|13|||
155026825|NCT00330343|559524540|FG000|Overall Study|Lost to Follow-up|5|||
155026826|NCT00256854|559524541|FG000|Overall Study|Withdrawal by Subject|2|||
155026827|NCT00256854|559524542|FG001|Overall Study|Withdrawal by Subject|3|||
155026828|NCT00256854|559524543|FG002|Overall Study|Withdrawal by Subject|0|||
155026829|NCT00256854|559524544|FG003|Overall Study|Withdrawal by Subject|0|||
155026830|NCT00256854|559524545|FG004|Overall Study|Withdrawal by Subject|0|||
155026831|NCT00256854|559524546|FG005|Overall Study|Withdrawal by Subject|0|||
155026832|NCT00256854|559524541|FG000|Overall Study|Lack of Efficacy|1|||
155026833|NCT00256854|559524542|FG001|Overall Study|Lack of Efficacy|0|||
155026834|NCT00256854|559524543|FG002|Overall Study|Lack of Efficacy|0|||
155026835|NCT00256854|559524544|FG003|Overall Study|Lack of Efficacy|0|||
155026836|NCT00256854|559524545|FG004|Overall Study|Lack of Efficacy|0|||
155026837|NCT00256854|559524546|FG005|Overall Study|Lack of Efficacy|0|||
155026838|NCT00256854|559524541|FG000|Overall Study|Protocol Violation|0|||
155026839|NCT00256854|559524542|FG001|Overall Study|Protocol Violation|1|||
155026840|NCT00256854|559524543|FG002|Overall Study|Protocol Violation|1|||
155026841|NCT00256854|559524544|FG003|Overall Study|Protocol Violation|1|||
155026842|NCT00256854|559524545|FG004|Overall Study|Protocol Violation|0|||
155026843|NCT00256854|559524546|FG005|Overall Study|Protocol Violation|0|||
155026844|NCT00256854|559524541|FG000|Overall Study|Adverse Event|0|||
155026845|NCT00256854|559524542|FG001|Overall Study|Adverse Event|0|||
155026846|NCT00256854|559524543|FG002|Overall Study|Adverse Event|2|||
155026847|NCT00256854|559524544|FG003|Overall Study|Adverse Event|2|||
155026848|NCT00256854|559524545|FG004|Overall Study|Adverse Event|0|||
155026849|NCT00256854|559524546|FG005|Overall Study|Adverse Event|1|||
155026850|NCT00256854|559524541|FG000|Overall Study|Not compliant with the study drug|0|||
155026851|NCT00256854|559524542|FG001|Overall Study|Not compliant with the study drug|0|||
155026852|NCT00256854|559524543|FG002|Overall Study|Not compliant with the study drug|0|||
155026853|NCT00256854|559524544|FG003|Overall Study|Not compliant with the study drug|0|||
155026854|NCT00256854|559524545|FG004|Overall Study|Not compliant with the study drug|1|||
155026855|NCT00256854|559524546|FG005|Overall Study|Not compliant with the study drug|0|||
155026856|NCT06586788|559524547|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
155026857|NCT03990571|559524548|FG000|Overall Study|Withdrawal by Subject|1|||
155026858|NCT03990571|559524548|FG000|Overall Study|Insurance Issues|3|||
155026859|NCT03990571|559524548|FG000|Overall Study|Covid Restrictions|2|||
155026860|NCT03047720|559524551|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
155026861|NCT03047720|559524552|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
155026862|NCT01475851|559524553|FG000|Overall Study|Protocol defined stopping criteria|1|||
155026863|NCT01475851|559524554|FG001|Overall Study|Protocol defined stopping criteria|0|||
155026864|NCT04603482|559524555|FG000|Overall Study|Lost to Follow-up|15|||
155026865|NCT04603482|559524556|FG001|Overall Study|Lost to Follow-up|15|||
155026866|NCT04603482|559524557|FG002|Overall Study|Lost to Follow-up|15|||
155026867|NCT00732758|559524558|FG000|Overall Study|Lost to Follow-up|8|||
155026868|NCT00732758|559524559|FG001|Overall Study|Lost to Follow-up|16|||
155026869|NCT00373958|559524560|FG000|Infant Series|Withdrawal by Subject|13|||
155026870|NCT00373958|559524561|FG001|Infant Series|Withdrawal by Subject|15|||
155026871|NCT00373958|559524560|FG000|Infant Series|Failed to return|8|||
155026872|NCT00373958|559524561|FG001|Infant Series|Failed to return|13|||
155026873|NCT00373958|559524560|FG000|Infant Series|Lost to Follow-up|6|||
155026874|NCT00373958|559524561|FG001|Infant Series|Lost to Follow-up|5|||
155026875|NCT00373958|559524560|FG000|Infant Series|Protocol Violation|3|||
155026876|NCT00373958|559524561|FG001|Infant Series|Protocol Violation|7|||
155026877|NCT00373958|559524560|FG000|Infant Series|Lost Kaiser coverage|4|||
155026878|NCT00373958|559524561|FG001|Infant Series|Lost Kaiser coverage|0|||
155026879|NCT00373958|559524560|FG000|Infant Series|Child relocated|1|||
155026880|NCT00373958|559524561|FG001|Infant Series|Child relocated|0|||
155026881|NCT00373958|559524560|FG000|Infant Series|Consent was not received|1|||
155026882|NCT00373958|559524561|FG001|Infant Series|Consent was not received|0|||
155026883|NCT00373958|559524560|FG000|Infant Series|Adverse Event|3|||
155026884|NCT00373958|559524561|FG001|Infant Series|Adverse Event|1|||
155026885|NCT00373958|559524560|FG000|Infant Series|Physician Decision|1|||
155026886|NCT00373958|559524561|FG001|Infant Series|Physician Decision|1|||
155026887|NCT00373958|559524560|FG000|Toddler Dose|Lost to Follow-up|5|||
155026888|NCT00373958|559524561|FG001|Toddler Dose|Lost to Follow-up|8|||
155026889|NCT00373958|559524560|FG000|Toddler Dose|Withdrawal by Subject|2|||
155026890|NCT00373958|559524561|FG001|Toddler Dose|Withdrawal by Subject|2|||
155026891|NCT00373958|559524560|FG000|Toddler Dose|Failed to return|1|||
155026892|NCT00373958|559524561|FG001|Toddler Dose|Failed to return|2|||
155026893|NCT00373958|559524560|FG000|Toddler Dose|Protocol Violation|0|||
155026894|NCT00373958|559524561|FG001|Toddler Dose|Protocol Violation|1|||
155026895|NCT00373958|559524560|FG000|Toddler Dose|Withdrawn after infant series|22|||
155026896|NCT00373958|559524561|FG001|Toddler Dose|Withdrawn after infant series|25|||
155026897|NCT03382834|559524564|FG000|Step 1|Lost to Follow-up|0|||
155026898|NCT03382834|559524565|FG001|Step 1|Lost to Follow-up|1|||
155026899|NCT03382834|559524564|FG000|Step 2|Death|1|||
155026900|NCT03382834|559524565|FG001|Step 2|Death|0|||
155026901|NCT03382834|559524564|FG000|Step 2|Lost to Follow-up|2|||
155026902|NCT03382834|559524565|FG001|Step 2|Lost to Follow-up|2|||
155026903|NCT03382834|559524564|FG000|Step 2|Site Terminated by Sponsor|1|||
155026904|NCT03382834|559524565|FG001|Step 2|Site Terminated by Sponsor|0|||
155026905|NCT02949843|559524566|FG000|Overall Study|Withdrawal by Subject|0|||
155026906|NCT02949843|559524567|FG001|Overall Study|Withdrawal by Subject|1|||
155026907|NCT02949843|559524568|FG002|Overall Study|Withdrawal by Subject|1|||
155026908|NCT03613649|559524569|FG000|Second Treatment|Lost to Follow-up|0|||
155026909|NCT03613649|559524570|FG001|Second Treatment|Lost to Follow-up|0|||
155026910|NCT03613649|559524571|FG002|Second Treatment|Lost to Follow-up|1|||
155026911|NCT03613649|559524572|FG003|Second Treatment|Lost to Follow-up|0|||
155026912|NCT03613649|559524573|FG004|Second Treatment|Lost to Follow-up|0|||
155026913|NCT03613649|559524574|FG005|Second Treatment|Lost to Follow-up|0|||
155026914|NCT03613649|559524575|FG006|Second Treatment|Lost to Follow-up|0|||
155026915|NCT03613649|559524576|FG007|Second Treatment|Lost to Follow-up|0|||
155026916|NCT03613649|559524577|FG008|Second Treatment|Lost to Follow-up|0|||
155026917|NCT03613649|559524578|FG009|Second Treatment|Lost to Follow-up|0|||
155026918|NCT03613649|559524579|FG010|Second Treatment|Lost to Follow-up|0|||
155026919|NCT03613649|559524580|FG011|Second Treatment|Lost to Follow-up|0|||
155026920|NCT03613649|559524569|FG000|Second Treatment|Withdrawal by Subject|0|||
155026921|NCT03613649|559524570|FG001|Second Treatment|Withdrawal by Subject|0|||
155026922|NCT03613649|559524571|FG002|Second Treatment|Withdrawal by Subject|0|||
155026923|NCT03613649|559524572|FG003|Second Treatment|Withdrawal by Subject|0|||
155026924|NCT03613649|559524573|FG004|Second Treatment|Withdrawal by Subject|1|||
155026925|NCT03613649|559524574|FG005|Second Treatment|Withdrawal by Subject|0|||
155026926|NCT03613649|559524575|FG006|Second Treatment|Withdrawal by Subject|0|||
155026927|NCT03613649|559524576|FG007|Second Treatment|Withdrawal by Subject|0|||
155026928|NCT03613649|559524577|FG008|Second Treatment|Withdrawal by Subject|0|||
155026929|NCT03613649|559524578|FG009|Second Treatment|Withdrawal by Subject|0|||
155026930|NCT03613649|559524579|FG010|Second Treatment|Withdrawal by Subject|0|||
155026931|NCT03613649|559524580|FG011|Second Treatment|Withdrawal by Subject|0|||
155026932|NCT03613649|559524569|FG000|Third Treatment|Lost to Follow-up|0|||
155026933|NCT03613649|559524570|FG001|Third Treatment|Lost to Follow-up|0|||
155026934|NCT03613649|559524571|FG002|Third Treatment|Lost to Follow-up|0|||
155026935|NCT03613649|559524572|FG003|Third Treatment|Lost to Follow-up|0|||
155026936|NCT03613649|559524573|FG004|Third Treatment|Lost to Follow-up|1|||
155026937|NCT03613649|559524574|FG005|Third Treatment|Lost to Follow-up|0|||
155026938|NCT03613649|559524575|FG006|Third Treatment|Lost to Follow-up|0|||
155026939|NCT03613649|559524576|FG007|Third Treatment|Lost to Follow-up|0|||
155026940|NCT03613649|559524577|FG008|Third Treatment|Lost to Follow-up|0|||
155026941|NCT03613649|559524578|FG009|Third Treatment|Lost to Follow-up|0|||
155026942|NCT03613649|559524579|FG010|Third Treatment|Lost to Follow-up|0|||
155026943|NCT03613649|559524580|FG011|Third Treatment|Lost to Follow-up|1|||
155026944|NCT03613649|559524569|FG000|Third Treatment|Protocol Violation|0|||
155026945|NCT03613649|559524570|FG001|Third Treatment|Protocol Violation|0|||
155026946|NCT03613649|559524571|FG002|Third Treatment|Protocol Violation|0|||
155026947|NCT03613649|559524572|FG003|Third Treatment|Protocol Violation|0|||
155026948|NCT03613649|559524573|FG004|Third Treatment|Protocol Violation|0|||
155026949|NCT03613649|559524574|FG005|Third Treatment|Protocol Violation|0|||
155026950|NCT03613649|559524575|FG006|Third Treatment|Protocol Violation|1|||
155026951|NCT03613649|559524576|FG007|Third Treatment|Protocol Violation|0|||
155026952|NCT03613649|559524577|FG008|Third Treatment|Protocol Violation|0|||
155026953|NCT03613649|559524578|FG009|Third Treatment|Protocol Violation|0|||
155026954|NCT03613649|559524579|FG010|Third Treatment|Protocol Violation|0|||
155026955|NCT03613649|559524580|FG011|Third Treatment|Protocol Violation|1|||
155026956|NCT03613649|559524569|FG000|Fourth Treatment|Protocol Violation|1|||
155026957|NCT03613649|559524570|FG001|Fourth Treatment|Protocol Violation|0|||
155026958|NCT03613649|559524571|FG002|Fourth Treatment|Protocol Violation|0|||
155026959|NCT03613649|559524572|FG003|Fourth Treatment|Protocol Violation|0|||
155026960|NCT03613649|559524573|FG004|Fourth Treatment|Protocol Violation|1|||
155026961|NCT03613649|559524574|FG005|Fourth Treatment|Protocol Violation|0|||
155026962|NCT03613649|559524575|FG006|Fourth Treatment|Protocol Violation|0|||
155026963|NCT03613649|559524576|FG007|Fourth Treatment|Protocol Violation|0|||
155026964|NCT03613649|559524577|FG008|Fourth Treatment|Protocol Violation|0|||
155026965|NCT03613649|559524578|FG009|Fourth Treatment|Protocol Violation|0|||
155026966|NCT03613649|559524579|FG010|Fourth Treatment|Protocol Violation|0|||
155026967|NCT03613649|559524580|FG011|Fourth Treatment|Protocol Violation|0|||
155026968|NCT03613649|559524569|FG000|Fourth Treatment|Physician Decision|0|||
155026969|NCT03613649|559524570|FG001|Fourth Treatment|Physician Decision|0|||
155026970|NCT03613649|559524571|FG002|Fourth Treatment|Physician Decision|0|||
155026971|NCT03613649|559524572|FG003|Fourth Treatment|Physician Decision|0|||
155026972|NCT03613649|559524573|FG004|Fourth Treatment|Physician Decision|0|||
155026973|NCT03613649|559524574|FG005|Fourth Treatment|Physician Decision|0|||
155026974|NCT03613649|559524575|FG006|Fourth Treatment|Physician Decision|1|||
155026975|NCT03613649|559524576|FG007|Fourth Treatment|Physician Decision|0|||
155026976|NCT03613649|559524577|FG008|Fourth Treatment|Physician Decision|0|||
155026977|NCT03613649|559524578|FG009|Fourth Treatment|Physician Decision|0|||
155026978|NCT03613649|559524579|FG010|Fourth Treatment|Physician Decision|0|||
155026979|NCT03613649|559524580|FG011|Fourth Treatment|Physician Decision|0|||
155026980|NCT02693171|559524582|FG000|Overall Study|Adverse Event|1|||
155026981|NCT02693171|559524582|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
155026982|NCT00319592|559524583|FG000|Overall Study|Protocol Violation|1|||
155026983|NCT00319592|559524584|FG001|Overall Study|Protocol Violation|0|||
155026984|NCT00319592|559524583|FG000|Overall Study|Physician Decision|0|||
155026985|NCT00319592|559524584|FG001|Overall Study|Physician Decision|1|||
155026986|NCT03429244|559524585|FG000|Overall Study|Withdrawal by Subject|2|||
155026987|NCT03429244|559524586|FG001|Overall Study|Withdrawal by Subject|1|||
155026988|NCT03429244|559524587|FG002|Overall Study|Withdrawal by Subject|1|||
155026989|NCT00750139|559524590|FG000|Overall Study|Adverse Event|1|||
155026990|NCT00750139|559524591|FG001|Overall Study|Adverse Event|2|||
155026991|NCT00750139|559524592|FG002|Overall Study|Adverse Event|0|||
155026992|NCT00750139|559524593|FG003|Overall Study|Adverse Event|1|||
155026993|NCT00750139|559524590|FG000|Overall Study|Lost to Follow-up|17|||
155181426|NCT02038829|560103080|FG002|Washout Period 1|Death|0|||
155181427|NCT02038829|560103081|FG003|Washout Period 1|Death|0|||
155181428|NCT02038829|560103082|FG004|Washout Period 1|Death|1|||
155026994|NCT00750139|559524591|FG001|Overall Study|Lost to Follow-up|12|||
155026995|NCT00750139|559524592|FG002|Overall Study|Lost to Follow-up|15|||
155026996|NCT00750139|559524593|FG003|Overall Study|Lost to Follow-up|6|||
155026997|NCT00750139|559524590|FG000|Overall Study|Withdrawal by Subject|3|||
155026998|NCT00750139|559524591|FG001|Overall Study|Withdrawal by Subject|2|||
155026999|NCT00750139|559524592|FG002|Overall Study|Withdrawal by Subject|6|||
155027000|NCT00750139|559524593|FG003|Overall Study|Withdrawal by Subject|2|||
155027001|NCT00750139|559524590|FG000|Overall Study|Physician Decision|1|||
155027002|NCT00750139|559524591|FG001|Overall Study|Physician Decision|1|||
155027003|NCT00750139|559524592|FG002|Overall Study|Physician Decision|0|||
155027004|NCT00750139|559524593|FG003|Overall Study|Physician Decision|0|||
155181429|NCT02038829|560103083|FG005|Washout Period 1|Death|0|||
155027005|NCT00750139|559524590|FG000|Overall Study|Non-compliance|1|||
155027006|NCT00750139|559524591|FG001|Overall Study|Non-compliance|0|||
155027007|NCT00750139|559524592|FG002|Overall Study|Non-compliance|1|||
155027008|NCT00750139|559524593|FG003|Overall Study|Non-compliance|3|||
155027009|NCT00750139|559524590|FG000|Overall Study|Termination by sponsor|4|||
155027010|NCT00750139|559524591|FG001|Overall Study|Termination by sponsor|0|||
155027011|NCT00750139|559524592|FG002|Overall Study|Termination by sponsor|0|||
155027012|NCT00750139|559524593|FG003|Overall Study|Termination by sponsor|1|||
155027013|NCT00750139|559524590|FG000|Overall Study|Non-specific|62|||
155027014|NCT00750139|559524591|FG001|Overall Study|Non-specific|42|||
155027015|NCT00750139|559524592|FG002|Overall Study|Non-specific|79|||
155027016|NCT00750139|559524593|FG003|Overall Study|Non-specific|33|||
155027017|NCT00658775|559524594|FG000|Overall Study|Adverse Event|4|||
155027018|NCT00658775|559524595|FG001|Overall Study|Adverse Event|6|||
155027019|NCT00658775|559524594|FG000|Overall Study|Lost to Follow-up|17|||
155027020|NCT00658775|559524595|FG001|Overall Study|Lost to Follow-up|18|||
155027021|NCT00658775|559524594|FG000|Overall Study|Withdrawal by Subject|6|||
155027022|NCT00658775|559524595|FG001|Overall Study|Withdrawal by Subject|4|||
155027023|NCT00658775|559524594|FG000|Overall Study|Withdrawal of consent|8|||
155027024|NCT00658775|559524595|FG001|Overall Study|Withdrawal of consent|7|||
155027025|NCT00658775|559524594|FG000|Overall Study|Other|7|||
155027026|NCT00658775|559524595|FG001|Overall Study|Other|8|||
155027027|NCT01992653|559524598|FG000|Overall Study|Death|0|||
155027028|NCT01992653|559524599|FG001|Overall Study|Death|0|||
155027029|NCT01992653|559524600|FG002|Overall Study|Death|1|||
155027030|NCT01992653|559524601|FG003|Overall Study|Death|0|||
155027031|NCT01992653|559524602|FG004|Overall Study|Death|1|||
155027032|NCT01992653|559524603|FG005|Overall Study|Death|0|||
155027033|NCT01992653|559524604|FG006|Overall Study|Death|4|||
155027034|NCT01992653|559524605|FG007|Overall Study|Death|2|||
155027035|NCT01992653|559524598|FG000|Overall Study|Lost to Follow-up|0|||
155027036|NCT01992653|559524599|FG001|Overall Study|Lost to Follow-up|0|||
155027037|NCT01992653|559524600|FG002|Overall Study|Lost to Follow-up|0|||
155027038|NCT01992653|559524601|FG003|Overall Study|Lost to Follow-up|0|||
155027039|NCT01992653|559524602|FG004|Overall Study|Lost to Follow-up|0|||
155027040|NCT01992653|559524603|FG005|Overall Study|Lost to Follow-up|0|||
155027041|NCT01992653|559524604|FG006|Overall Study|Lost to Follow-up|0|||
155027042|NCT01992653|559524605|FG007|Overall Study|Lost to Follow-up|1|||
155027043|NCT01992653|559524598|FG000|Overall Study|Study Completed|0|||
155027044|NCT01992653|559524599|FG001|Overall Study|Study Completed|0|||
155027045|NCT01992653|559524600|FG002|Overall Study|Study Completed|0|||
155027046|NCT01992653|559524601|FG003|Overall Study|Study Completed|0|||
155027047|NCT01992653|559524602|FG004|Overall Study|Study Completed|0|||
155027048|NCT01992653|559524603|FG005|Overall Study|Study Completed|0|||
155027049|NCT01992653|559524604|FG006|Overall Study|Study Completed|0|||
155027050|NCT01992653|559524605|FG007|Overall Study|Study Completed|1|||
155027051|NCT01992653|559524598|FG000|Overall Study|Disease Progression|0|||
155027052|NCT01992653|559524599|FG001|Overall Study|Disease Progression|0|||
155027053|NCT01992653|559524600|FG002|Overall Study|Disease Progression|0|||
155027054|NCT01992653|559524601|FG003|Overall Study|Disease Progression|0|||
155027055|NCT01992653|559524602|FG004|Overall Study|Disease Progression|0|||
155027056|NCT01992653|559524603|FG005|Overall Study|Disease Progression|0|||
155027057|NCT01992653|559524604|FG006|Overall Study|Disease Progression|4|||
155027058|NCT01992653|559524605|FG007|Overall Study|Disease Progression|0|||
155027059|NCT01435460|559524606|FG000|Overall Study|Adverse Event|2|||
155027060|NCT01435460|559524607|FG001|Overall Study|Adverse Event|1|||
155027061|NCT01435460|559524606|FG000|Overall Study|Lost to Follow-up|6|||
155027062|NCT01435460|559524607|FG001|Overall Study|Lost to Follow-up|1|||
155027063|NCT01435460|559524606|FG000|Overall Study|Withdrawal by Subject|1|||
155027064|NCT01435460|559524607|FG001|Overall Study|Withdrawal by Subject|3|||
155027065|NCT01435460|559524606|FG000|Overall Study|Protocol Violation|0|||
155027066|NCT01435460|559524607|FG001|Overall Study|Protocol Violation|1|||
155027067|NCT01435460|559524606|FG000|Overall Study|Did not meet eligibility criteria|2|||
155027068|NCT01435460|559524607|FG001|Overall Study|Did not meet eligibility criteria|0|||
155027069|NCT01706939|559524608|FG000|Pre Randomization|Screen Failure|1|||
155027070|NCT01706939|559524609|FG001|Pre Randomization|Screen Failure|0|||
155027071|NCT01706939|559524610|FG002|Pre Randomization|Screen Failure|0|||
155027072|NCT01706939|559524608|FG000|Pre Randomization|Ineligible for Randomization|1|||
155027073|NCT01706939|559524609|FG001|Pre Randomization|Ineligible for Randomization|0|||
155027074|NCT01706939|559524610|FG002|Pre Randomization|Ineligible for Randomization|0|||
155027075|NCT01706939|559524608|FG000|Pre Randomization|Withdrawal by Subject|1|||
155027076|NCT01706939|559524609|FG001|Pre Randomization|Withdrawal by Subject|0|||
155027077|NCT01706939|559524610|FG002|Pre Randomization|Withdrawal by Subject|0|||
155027078|NCT01706939|559524608|FG000|Randomization|Insufficient QoL survey compliance|0|||
155027079|NCT01706939|559524609|FG001|Randomization|Insufficient QoL survey compliance|1|||
155027080|NCT01706939|559524610|FG002|Randomization|Insufficient QoL survey compliance|1|||
155027081|NCT01706939|559524608|FG000|Randomization|Progression of disease|0|||
155027082|NCT01706939|559524609|FG001|Randomization|Progression of disease|2|||
155027083|NCT01706939|559524610|FG002|Randomization|Progression of disease|1|||
155027084|NCT01046903|559524611|FG000|Overall Study|Lost to Follow-up|16|||
155027085|NCT01046903|559524611|FG000|Overall Study|Adverse Event|4|||
155027086|NCT01046903|559524611|FG000|Overall Study|Withdrawal by Subject|3|||
155027087|NCT01046903|559524611|FG000|Overall Study|Other|5|||
155027088|NCT04013672|559524615|FG000|Overall Study|Withdrawal by Subject|3|||
155027089|NCT04013672|559524616|FG001|Overall Study|Withdrawal by Subject|0|||
155027090|NCT04013672|559524615|FG000|Overall Study|Death|1|||
155027091|NCT04013672|559524616|FG001|Overall Study|Death|0|||
155027092|NCT04013672|559524615|FG000|Overall Study|Physician Decision|5|||
155027093|NCT04013672|559524616|FG001|Overall Study|Physician Decision|0|||
155027094|NCT00556933|559524617|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
155027095|NCT00556933|559524618|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
155027096|NCT00556933|559524619|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
155027097|NCT00556933|559524620|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
155027098|NCT00556933|559524617|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
155027099|NCT00556933|559524618|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
155027100|NCT00556933|559524619|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
155027101|NCT00556933|559524620|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
155027102|NCT00556933|559524617|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
155027103|NCT00556933|559524618|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
155027104|NCT00556933|559524619|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
155027105|NCT00556933|559524620|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
155027106|NCT00556933|559524617|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
155027107|NCT00556933|559524618|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
155027108|NCT00556933|559524619|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
155027109|NCT00556933|559524620|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
155027110|NCT00556933|559524617|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
155027111|NCT00556933|559524618|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
155027112|NCT00556933|559524619|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
155027113|NCT00556933|559524620|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
155027114|NCT00556933|559524617|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
155027115|NCT00556933|559524618|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
155027116|NCT00556933|559524619|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
155027117|NCT00556933|559524620|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
155027118|NCT00556933|559524617|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
155027119|NCT00556933|559524618|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
155027120|NCT00556933|559524619|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
155027121|NCT00556933|559524620|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
155027122|NCT00556933|559524617|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
155027123|NCT00556933|559524618|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
155027124|NCT00556933|559524619|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
155027125|NCT00556933|559524620|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
155027126|NCT00556933|559524617|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
155027127|NCT00556933|559524618|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
155027128|NCT00556933|559524619|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
155027129|NCT00556933|559524620|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
155027130|NCT00556933|559524617|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
155027131|NCT00556933|559524618|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
155027132|NCT00556933|559524619|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
155027133|NCT00556933|559524620|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
155027134|NCT00556933|559524617|FG000|CNI Withdrawal vs. Minimization|Death|0|||
155027135|NCT00556933|559524618|FG001|CNI Withdrawal vs. Minimization|Death|0|||
155027136|NCT00556933|559524619|FG002|CNI Withdrawal vs. Minimization|Death|0|||
155027137|NCT00556933|559524620|FG003|CNI Withdrawal vs. Minimization|Death|1|||
155027138|NCT03887442|559524621|FG000|Overall Study|Adverse Event|1|||
155027139|NCT03887442|559524622|FG001|Overall Study|Adverse Event|0|||
155027140|NCT04463251|559524627|FG000|Overall Study|Death|1|||
155027141|NCT04463251|559524628|FG001|Overall Study|Death|0|||
155027142|NCT04463251|559524629|FG002|Overall Study|Death|1|||
155027143|NCT04463251|559524627|FG000|Overall Study|Adverse Event|0|||
155027144|NCT04463251|559524628|FG001|Overall Study|Adverse Event|1|||
155027145|NCT04463251|559524629|FG002|Overall Study|Adverse Event|0|||
155027146|NCT04463251|559524627|FG000|Overall Study|Lost to Follow-up|0|||
155027147|NCT04463251|559524628|FG001|Overall Study|Lost to Follow-up|1|||
155027148|NCT04463251|559524629|FG002|Overall Study|Lost to Follow-up|0|||
155027149|NCT04463251|559524627|FG000|Overall Study|Withdrawal by Subject|0|||
155027150|NCT04463251|559524628|FG001|Overall Study|Withdrawal by Subject|2|||
155027151|NCT04463251|559524629|FG002|Overall Study|Withdrawal by Subject|2|||
155027152|NCT01628198|559524631|FG000|Overall Study|Lost to Follow-up|7|||
155027153|NCT01628198|559524631|FG000|Overall Study|Withdrawal by Subject|10|||
155027154|NCT01628198|559524631|FG000|Overall Study|Screen failure|1|||
155027155|NCT01743560|559524632|FG000|Overall Study|Disease progression|26|||
155027156|NCT01743560|559524632|FG000|Overall Study|Adverse Event|8|||
155027157|NCT01743560|559524632|FG000|Overall Study|Death|3|||
155027158|NCT01743560|559524632|FG000|Overall Study|Withdrawal by Subject|2|||
155027159|NCT01743560|559524632|FG000|Overall Study|Protocol Violation|1|||
155027160|NCT01743560|559524632|FG000|Overall Study|>1 dose of study drug|3|||
155027161|NCT01827267|559524638|FG000|Overall Study|Did not receive study drug|1|||
155027162|NCT01827267|559524639|FG001|Overall Study|Did not receive study drug|1|||
155027163|NCT01827267|559524638|FG000|Overall Study|Physician Decision|1|||
155027164|NCT01827267|559524639|FG001|Overall Study|Physician Decision|0|||
155027165|NCT01827267|559524638|FG000|Overall Study|Disease Progression|1|||
155027166|NCT01827267|559524639|FG001|Overall Study|Disease Progression|1|||
155027167|NCT01827267|559524638|FG000|Overall Study|Sponsor Discontinued Study|2|||
155027168|NCT01827267|559524639|FG001|Overall Study|Sponsor Discontinued Study|8|||
155027169|NCT01827267|559524638|FG000|Overall Study|Still on study|0|||
155027170|NCT01827267|559524639|FG001|Overall Study|Still on study|2|||
155027171|NCT05367973|559524640|FG000|Overall Study|Adverse Event|0|||
155027172|NCT05367973|559524641|FG001|Overall Study|Adverse Event|2|||
155027173|NCT04999163|559524642|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
155027174|NCT04999163|559524643|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
155027175|NCT04999163|559524642|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
155027176|NCT04999163|559524643|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
155027177|NCT04999163|559524642|FG000|Overall Study|Withdrawal by Subject|1|||
155027178|NCT04999163|559524643|FG001|Overall Study|Withdrawal by Subject|0|||
155027179|NCT00860249|559526829|FG000|Overall Study|trial was terminated prior to completion|21|||
155027180|NCT00860249|559526830|FG001|Overall Study|trial was terminated prior to completion|18|||
155027181|NCT00860249|559526831|FG002|Overall Study|trial was terminated prior to completion|21|||
155027182|NCT00743288|559526832|FG000|Overall Study|Adverse Event|1|||
155027183|NCT00743288|559526833|FG001|Overall Study|Adverse Event|1|||
155027184|NCT00743288|559526834|FG002|Overall Study|Adverse Event|2|||
155027185|NCT00743288|559526835|FG003|Overall Study|Adverse Event|2|||
155027186|NCT00743288|559526836|FG004|Overall Study|Adverse Event|1|||
155027187|NCT00743288|559526837|FG005|Overall Study|Adverse Event|1|||
155027188|NCT00743288|559526838|FG006|Overall Study|Adverse Event|2|||
155027189|NCT00743288|559526832|FG000|Overall Study|Withdrawal by Subject|0|||
155027190|NCT00743288|559526833|FG001|Overall Study|Withdrawal by Subject|0|||
155027191|NCT00743288|559526834|FG002|Overall Study|Withdrawal by Subject|1|||
155027192|NCT00743288|559526835|FG003|Overall Study|Withdrawal by Subject|0|||
155027193|NCT00743288|559526836|FG004|Overall Study|Withdrawal by Subject|0|||
155027194|NCT00743288|559526837|FG005|Overall Study|Withdrawal by Subject|1|||
155027195|NCT00743288|559526838|FG006|Overall Study|Withdrawal by Subject|1|||
155027196|NCT00743288|559526832|FG000|Overall Study|Progressive disease (PD)|2|||
155027197|NCT00743288|559526833|FG001|Overall Study|Progressive disease (PD)|0|||
155027198|NCT00743288|559526834|FG002|Overall Study|Progressive disease (PD)|1|||
155027199|NCT00743288|559526835|FG003|Overall Study|Progressive disease (PD)|4|||
155027200|NCT00743288|559526836|FG004|Overall Study|Progressive disease (PD)|5|||
155027201|NCT00743288|559526837|FG005|Overall Study|Progressive disease (PD)|3|||
155027202|NCT00743288|559526838|FG006|Overall Study|Progressive disease (PD)|6|||
155027203|NCT00743288|559526832|FG000|Overall Study|Worsening of condition (Not PD)|0|||
155027204|NCT00743288|559526833|FG001|Overall Study|Worsening of condition (Not PD)|2|||
155027205|NCT00743288|559526834|FG002|Overall Study|Worsening of condition (Not PD)|1|||
155027206|NCT00743288|559526835|FG003|Overall Study|Worsening of condition (Not PD)|1|||
155027207|NCT00743288|559526836|FG004|Overall Study|Worsening of condition (Not PD)|0|||
155027208|NCT00743288|559526837|FG005|Overall Study|Worsening of condition (Not PD)|0|||
155027209|NCT00743288|559526838|FG006|Overall Study|Worsening of condition (Not PD)|0|||
155027210|NCT00519428|559526839|FG000|Overall Study|Adverse Event|5|||
155027211|NCT00519428|559526840|FG001|Overall Study|Adverse Event|2|||
155027212|NCT00519428|559526841|FG002|Overall Study|Adverse Event|10|||
155027213|NCT00519428|559526839|FG000|Overall Study|Lost to Follow-up|7|||
155027214|NCT00519428|559526840|FG001|Overall Study|Lost to Follow-up|7|||
155027215|NCT00519428|559526841|FG002|Overall Study|Lost to Follow-up|6|||
155027216|NCT00519428|559526839|FG000|Overall Study|Withdrawal by Subject|8|||
155027217|NCT00519428|559526840|FG001|Overall Study|Withdrawal by Subject|3|||
155027218|NCT00519428|559526841|FG002|Overall Study|Withdrawal by Subject|7|||
155027219|NCT00519428|559526839|FG000|Overall Study|unstated|1|||
155027220|NCT00519428|559526840|FG001|Overall Study|unstated|3|||
155027221|NCT00519428|559526841|FG002|Overall Study|unstated|2|||
155027222|NCT00688701|559526842|FG000|Overall Study|Adverse Event|1|||
155027223|NCT00688701|559526843|FG001|Overall Study|Adverse Event|0|||
155027224|NCT00688701|559526844|FG002|Overall Study|Adverse Event|5|||
155027225|NCT00688701|559526845|FG003|Overall Study|Adverse Event|3|||
155027226|NCT00688701|559526842|FG000|Overall Study|Lack of Efficacy|0|||
155027227|NCT00688701|559526843|FG001|Overall Study|Lack of Efficacy|1|||
155027228|NCT00688701|559526844|FG002|Overall Study|Lack of Efficacy|0|||
155027229|NCT00688701|559526845|FG003|Overall Study|Lack of Efficacy|0|||
155027230|NCT00688701|559526842|FG000|Overall Study|Withdrawal by Subject|3|||
155027231|NCT00688701|559526843|FG001|Overall Study|Withdrawal by Subject|3|||
155027232|NCT00688701|559526844|FG002|Overall Study|Withdrawal by Subject|4|||
155027233|NCT00688701|559526845|FG003|Overall Study|Withdrawal by Subject|8|||
155027234|NCT00688701|559526842|FG000|Overall Study|Poor compliance to protocol|0|||
155027235|NCT00688701|559526843|FG001|Overall Study|Poor compliance to protocol|1|||
155027236|NCT00688701|559526844|FG002|Overall Study|Poor compliance to protocol|1|||
155027237|NCT00688701|559526845|FG003|Overall Study|Poor compliance to protocol|0|||
155027238|NCT01275755|559526853|FG000|Double-blind Treatment Period|Adverse Event|0|||
155027239|NCT01275755|559526854|FG001|Double-blind Treatment Period|Adverse Event|2|||
155027240|NCT01275755|559526853|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
155027241|NCT01275755|559526854|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
155027242|NCT01275755|559526853|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
155027243|NCT01275755|559526854|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155027244|NCT01275755|559526853|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
155027245|NCT01275755|559526854|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
155027246|NCT04420585|559526859|FG000|Overall Study|Adverse Event|1|||
155027247|NCT04420585|559526859|FG000|Overall Study|Never initiated medication|2|||
155027248|NCT00477750|559526861|FG000|Overall Study|Currently Receiving Treatment|11|||
155027249|NCT04434469|559526862|FG000|Overall Study|Death|2|||
155027250|NCT04434469|559526863|FG001|Overall Study|Death|3|||
155027251|NCT04434469|559526864|FG002|Overall Study|Death|2|||
155027252|NCT04434469|559526865|FG003|Overall Study|Death|2|||
155027253|NCT04434469|559526866|FG004|Overall Study|Death|2|||
155027254|NCT04434469|559526867|FG005|Overall Study|Death|0|||
155027255|NCT04434469|559526862|FG000|Overall Study|Lost to Follow-up|0|||
155027256|NCT04434469|559526863|FG001|Overall Study|Lost to Follow-up|0|||
155027257|NCT04434469|559526864|FG002|Overall Study|Lost to Follow-up|0|||
155027258|NCT04434469|559526865|FG003|Overall Study|Lost to Follow-up|1|||
155027259|NCT04434469|559526866|FG004|Overall Study|Lost to Follow-up|1|||
155027260|NCT04434469|559526867|FG005|Overall Study|Lost to Follow-up|0|||
155027261|NCT04434469|559526862|FG000|Overall Study|Study terminated by sponsor|1|||
155027262|NCT04434469|559526863|FG001|Overall Study|Study terminated by sponsor|1|||
155027263|NCT04434469|559526864|FG002|Overall Study|Study terminated by sponsor|1|||
155027264|NCT04434469|559526865|FG003|Overall Study|Study terminated by sponsor|2|||
155027265|NCT04434469|559526866|FG004|Overall Study|Study terminated by sponsor|3|||
155027266|NCT04434469|559526867|FG005|Overall Study|Study terminated by sponsor|3|||
155027267|NCT04434469|559526862|FG000|Overall Study|Withdrawal by Subject|0|||
155027268|NCT04434469|559526863|FG001|Overall Study|Withdrawal by Subject|0|||
155027269|NCT04434469|559526864|FG002|Overall Study|Withdrawal by Subject|1|||
155027270|NCT04434469|559526865|FG003|Overall Study|Withdrawal by Subject|0|||
155027271|NCT04434469|559526866|FG004|Overall Study|Withdrawal by Subject|0|||
155027272|NCT04434469|559526867|FG005|Overall Study|Withdrawal by Subject|0|||
155027273|NCT01346189|559526870|FG000|Overall Study|Withdrawal by Subject|7|||
155027274|NCT01346189|559526871|FG001|Overall Study|Withdrawal by Subject|5|||
155027275|NCT01346189|559526872|FG002|Overall Study|Withdrawal by Subject|3|||
155027276|NCT01346189|559526873|FG003|Overall Study|Withdrawal by Subject|5|||
155027277|NCT01346189|559526870|FG000|Overall Study|Physician Decision|4|||
155027278|NCT01346189|559526871|FG001|Overall Study|Physician Decision|0|||
155027279|NCT01346189|559526872|FG002|Overall Study|Physician Decision|0|||
155027280|NCT01346189|559526873|FG003|Overall Study|Physician Decision|0|||
155027281|NCT01346189|559526870|FG000|Overall Study|Moved|3|||
155027282|NCT01346189|559526871|FG001|Overall Study|Moved|0|||
155027283|NCT01346189|559526872|FG002|Overall Study|Moved|4|||
155027284|NCT01346189|559526873|FG003|Overall Study|Moved|0|||
155027285|NCT01346189|559526870|FG000|Overall Study|Other|2|||
155027286|NCT01346189|559526871|FG001|Overall Study|Other|4|||
155027287|NCT01346189|559526872|FG002|Overall Study|Other|7|||
155027288|NCT01346189|559526873|FG003|Overall Study|Other|3|||
155027289|NCT01346189|559526870|FG000|Overall Study|Death|0|||
155027290|NCT01346189|559526871|FG001|Overall Study|Death|3|||
155027291|NCT01346189|559526872|FG002|Overall Study|Death|0|||
155140094|NCT00981461|559944382|FG000|Overall Study|Lost to Follow-up|5|||
155140095|NCT00981461|559944383|FG001|Overall Study|Lost to Follow-up|2|||
155140096|NCT05786508|559944384|FG000|Overall Study|Withdrawal by Subject|2|||
155027292|NCT01346189|559526873|FG003|Overall Study|Death|0|||
155027293|NCT01346189|559526870|FG000|Overall Study|Non-health system primary care physician|0|||
155027294|NCT01346189|559526871|FG001|Overall Study|Non-health system primary care physician|5|||
155027295|NCT01346189|559526872|FG002|Overall Study|Non-health system primary care physician|0|||
155027296|NCT01346189|559526873|FG003|Overall Study|Non-health system primary care physician|0|||
155027297|NCT01346189|559526870|FG000|Overall Study|Travel|0|||
155027298|NCT01346189|559526871|FG001|Overall Study|Travel|0|||
155027299|NCT01346189|559526872|FG002|Overall Study|Travel|0|||
155027300|NCT01346189|559526873|FG003|Overall Study|Travel|3|||
155027301|NCT00900757|559526874|FG000|Overall Study|screen failure|19|||
155027302|NCT05113979|559526877|FG000|Overall Study|Death|2|||
155027303|NCT05113979|559526877|FG000|Overall Study|Lost to Follow-up|1|||
155027304|NCT00976820|559526878|FG000|Overall Study|Lost to Follow-up|5|||
155027305|NCT00976820|559526879|FG001|Overall Study|Lost to Follow-up|16|||
155140097|NCT05786508|559944385|FG001|Overall Study|Withdrawal by Subject|0|||
155027306|NCT00976820|559526880|FG002|Overall Study|Lost to Follow-up|2|||
155027307|NCT00976820|559526881|FG003|Overall Study|Lost to Follow-up|3|||
155027308|NCT00976820|559526878|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
155027309|NCT00976820|559526879|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
155027310|NCT00976820|559526880|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
155027311|NCT00976820|559526881|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
155027312|NCT00976820|559526878|FG000|Overall Study|Withdrawal by Subject|2|||
155027313|NCT00976820|559526879|FG001|Overall Study|Withdrawal by Subject|4|||
155027314|NCT00976820|559526880|FG002|Overall Study|Withdrawal by Subject|1|||
155027315|NCT00976820|559526881|FG003|Overall Study|Withdrawal by Subject|4|||
155027316|NCT00968981|559526882|FG000|Overall Study|Adverse Event|2|||
155027317|NCT00968981|559526883|FG001|Overall Study|Adverse Event|0|||
155027318|NCT00968981|559526884|FG002|Overall Study|Adverse Event|0|||
155027319|NCT00968981|559526882|FG000|Overall Study|Disease Progression|14|||
155027320|NCT00968981|559526883|FG001|Overall Study|Disease Progression|16|||
155027321|NCT00968981|559526884|FG002|Overall Study|Disease Progression|13|||
155027322|NCT00968981|559526882|FG000|Overall Study|Lost to Follow-up|0|||
155027323|NCT00968981|559526883|FG001|Overall Study|Lost to Follow-up|0|||
155027324|NCT00968981|559526884|FG002|Overall Study|Lost to Follow-up|1|||
155027325|NCT00968981|559526882|FG000|Overall Study|Physician Decision|5|||
155027326|NCT00968981|559526883|FG001|Overall Study|Physician Decision|3|||
155027327|NCT00968981|559526884|FG002|Overall Study|Physician Decision|5|||
155027328|NCT00968981|559526882|FG000|Overall Study|Withdrawal by Subject|1|||
155027329|NCT00968981|559526883|FG001|Overall Study|Withdrawal by Subject|3|||
155027330|NCT00968981|559526884|FG002|Overall Study|Withdrawal by Subject|3|||
155027331|NCT01489254|559526885|FG000|Double-blind Part|Adverse Event|7|||
155027332|NCT01489254|559526886|FG001|Double-blind Part|Adverse Event|2|||
155027333|NCT01489254|559526887|FG002|Double-blind Part|Adverse Event|2|||
155027334|NCT01489254|559526888|FG003|Double-blind Part|Adverse Event|0|||
155027335|NCT01489254|559526885|FG000|Double-blind Part|Pregnancy|1|||
155027336|NCT01489254|559526886|FG001|Double-blind Part|Pregnancy|3|||
155027337|NCT01489254|559526887|FG002|Double-blind Part|Pregnancy|0|||
155027338|NCT01489254|559526888|FG003|Double-blind Part|Pregnancy|0|||
155027339|NCT01489254|559526885|FG000|Double-blind Part|Withdrawal by Subject|12|||
155027340|NCT01489254|559526886|FG001|Double-blind Part|Withdrawal by Subject|20|||
155027341|NCT01489254|559526887|FG002|Double-blind Part|Withdrawal by Subject|1|||
155027342|NCT01489254|559526888|FG003|Double-blind Part|Withdrawal by Subject|0|||
155027343|NCT01489254|559526885|FG000|Double-blind Part|Lost to Follow-up|1|||
155027344|NCT01489254|559526886|FG001|Double-blind Part|Lost to Follow-up|2|||
155027345|NCT01489254|559526887|FG002|Double-blind Part|Lost to Follow-up|0|||
155027346|NCT01489254|559526888|FG003|Double-blind Part|Lost to Follow-up|0|||
155027347|NCT01489254|559526885|FG000|Double-blind Part|Other reasons for not completing study|4|||
155027348|NCT01489254|559526886|FG001|Double-blind Part|Other reasons for not completing study|6|||
155027349|NCT01489254|559526887|FG002|Double-blind Part|Other reasons for not completing study|0|||
155027350|NCT01489254|559526888|FG003|Double-blind Part|Other reasons for not completing study|0|||
155027351|NCT01489254|559526885|FG000|Open-label Extension Part|Adverse Event|0|||
155027352|NCT01489254|559526886|FG001|Open-label Extension Part|Adverse Event|0|||
155027353|NCT01489254|559526887|FG002|Open-label Extension Part|Adverse Event|0|||
155027354|NCT01489254|559526888|FG003|Open-label Extension Part|Adverse Event|10|||
155027355|NCT01489254|559526885|FG000|Open-label Extension Part|Pregnancy|0|||
155027356|NCT01489254|559526886|FG001|Open-label Extension Part|Pregnancy|0|||
155027357|NCT01489254|559526887|FG002|Open-label Extension Part|Pregnancy|0|||
155027358|NCT01489254|559526888|FG003|Open-label Extension Part|Pregnancy|3|||
155027359|NCT01489254|559526885|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
155027360|NCT01489254|559526886|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
155027361|NCT01489254|559526887|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
155027362|NCT01489254|559526888|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
155027363|NCT01489254|559526885|FG000|Open-label Extension Part|Protocol Violation|0|||
155027364|NCT01489254|559526886|FG001|Open-label Extension Part|Protocol Violation|0|||
155027365|NCT01489254|559526887|FG002|Open-label Extension Part|Protocol Violation|0|||
155027366|NCT01489254|559526888|FG003|Open-label Extension Part|Protocol Violation|1|||
155027367|NCT01489254|559526885|FG000|Open-label Extension Part|Lost to Follow-up|0|||
155027368|NCT01489254|559526886|FG001|Open-label Extension Part|Lost to Follow-up|0|||
155181430|NCT02038829|560103084|FG006|Washout Period 1|Death|0|||
155181431|NCT02038829|560103085|FG007|Washout Period 1|Death|0|||
155181432|NCT02038829|560103086|FG008|Washout Period 1|Death|0|||
155181433|NCT02038829|560103087|FG009|Washout Period 1|Death|0|||
155027369|NCT01489254|559526887|FG002|Open-label Extension Part|Lost to Follow-up|0|||
155027370|NCT01489254|559526888|FG003|Open-label Extension Part|Lost to Follow-up|9|||
155027371|NCT01489254|559526885|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
155027372|NCT01489254|559526886|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
155027373|NCT01489254|559526887|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
155027374|NCT01489254|559526888|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
155027375|NCT00281632|559526889|FG000|Overall Study|Adverse Event|7|||
155181434|NCT02038829|560103088|FG010|Washout Period 1|Death|0|||
155027376|NCT00281632|559526889|FG000|Overall Study|Withdrawal by Subject|2|||
155027377|NCT00281632|559526889|FG000|Overall Study|Disease Progression|22|||
155027378|NCT00281632|559526889|FG000|Overall Study|Death|1|||
155027379|NCT00281632|559526889|FG000|Overall Study|Physician Decision|1|||
155027380|NCT00281632|559526889|FG000|Overall Study|Ongoing|3|||
155027381|NCT02691936|559526895|FG000|Overall Study|Withdrawal by Subject|2|||
155027382|NCT02691936|559526896|FG001|Overall Study|Withdrawal by Subject|5|||
155027383|NCT01878084|559526897|FG000|Overall Study|Physician Decision|2|||
155027384|NCT00749684|559526898|FG000|Overall Study|Death|1|||
155027385|NCT00749684|559526898|FG000|Overall Study|Adverse Event|27|||
155027386|NCT00749684|559526898|FG000|Overall Study|Participant's Wish|10|||
155027387|NCT00749684|559526898|FG000|Overall Study|Not Documented|1|||
155027388|NCT00749684|559526898|FG000|Overall Study|Progressive Desease|31|||
155027389|NCT00749684|559526898|FG000|Overall Study|Therapy according to protocol + AE|2|||
155027390|NCT00749684|559526898|FG000|Overall Study|AE+discontinuation on participants wish|1|||
155027391|NCT00749684|559526898|FG000|Overall Study|Missing|9|||
155027392|NCT03696108|559526899|FG000|Overall Study|Physician Decision|1|||
155027393|NCT03696108|559526900|FG001|Overall Study|Physician Decision|0|||
155027394|NCT03696108|559526899|FG000|Overall Study|Withdrawal by Subject|3|||
155027395|NCT03696108|559526900|FG001|Overall Study|Withdrawal by Subject|6|||
155027396|NCT03891862|559526902|FG000|Open-label Period|Adverse Event|2|||
155027397|NCT03891862|559526903|FG001|Open-label Period|Adverse Event|0|||
155027398|NCT03891862|559526904|FG002|Open-label Period|Adverse Event|0|||
155027399|NCT03891862|559526902|FG000|Open-label Period|Protocol Violation|5|||
155027400|NCT03891862|559526903|FG001|Open-label Period|Protocol Violation|0|||
155027401|NCT03891862|559526904|FG002|Open-label Period|Protocol Violation|0|||
155027402|NCT03891862|559526902|FG000|Open-label Period|Withdrawal by Subject|6|||
155027403|NCT03891862|559526903|FG001|Open-label Period|Withdrawal by Subject|0|||
155027404|NCT03891862|559526904|FG002|Open-label Period|Withdrawal by Subject|0|||
155027405|NCT03891862|559526902|FG000|Open-label Period|Death|1|||
155027406|NCT03891862|559526903|FG001|Open-label Period|Death|0|||
155027407|NCT03891862|559526904|FG002|Open-label Period|Death|0|||
155027408|NCT03891862|559526902|FG000|Open-label Period|Lost to Follow-up|2|||
155027409|NCT03891862|559526903|FG001|Open-label Period|Lost to Follow-up|0|||
155027410|NCT03891862|559526904|FG002|Open-label Period|Lost to Follow-up|0|||
155027411|NCT03891862|559526902|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
155027412|NCT03891862|559526903|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
155027413|NCT03891862|559526904|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
155027414|NCT03891862|559526902|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
155027415|NCT03891862|559526903|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
155027416|NCT03891862|559526904|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
155027417|NCT03891862|559526902|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
155027418|NCT03891862|559526903|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
155027419|NCT03891862|559526904|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
155027420|NCT03891862|559526902|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
155027421|NCT03891862|559526903|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
155027422|NCT03891862|559526904|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
155027423|NCT01053962|559526905|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
155027424|NCT01053962|559526906|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
155027425|NCT01053962|559526907|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
155027426|NCT01053962|559526908|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
155027427|NCT01053962|559526909|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
155027428|NCT01053962|559526905|FG000|Pretreatment Period|Venipuncture Failure|0|||
155027429|NCT01053962|559526906|FG001|Pretreatment Period|Venipuncture Failure|0|||
155027430|NCT01053962|559526907|FG002|Pretreatment Period|Venipuncture Failure|1|||
155027431|NCT01053962|559526908|FG003|Pretreatment Period|Venipuncture Failure|0|||
155027432|NCT01053962|559526909|FG004|Pretreatment Period|Venipuncture Failure|0|||
155027433|NCT01053962|559526905|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155027434|NCT01053962|559526906|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
155027435|NCT01053962|559526907|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155027436|NCT01053962|559526908|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155027437|NCT01053962|559526909|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
155027438|NCT01053962|559526905|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155027439|NCT01053962|559526906|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155027440|NCT01053962|559526907|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155027441|NCT01053962|559526908|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
155027442|NCT01053962|559526909|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
155027443|NCT01053962|559526905|FG000|Treatment Period|Lack of Efficacy|0|||
155027444|NCT01053962|559526906|FG001|Treatment Period|Lack of Efficacy|0|||
155027445|NCT01053962|559526907|FG002|Treatment Period|Lack of Efficacy|0|||
155027446|NCT01053962|559526908|FG003|Treatment Period|Lack of Efficacy|0|||
155027447|NCT01053962|559526909|FG004|Treatment Period|Lack of Efficacy|1|||
155027448|NCT01053962|559526905|FG000|Treatment Period|Adverse Event|0|||
155027449|NCT01053962|559526906|FG001|Treatment Period|Adverse Event|0|||
155027450|NCT01053962|559526907|FG002|Treatment Period|Adverse Event|0|||
155027451|NCT01053962|559526908|FG003|Treatment Period|Adverse Event|0|||
155027452|NCT01053962|559526909|FG004|Treatment Period|Adverse Event|1|||
155027453|NCT01053962|559526905|FG000|Treatment Period|Withdrawal by Subject|0|||
155027454|NCT01053962|559526906|FG001|Treatment Period|Withdrawal by Subject|0|||
155027455|NCT01053962|559526907|FG002|Treatment Period|Withdrawal by Subject|0|||
155027456|NCT01053962|559526908|FG003|Treatment Period|Withdrawal by Subject|0|||
155027457|NCT01053962|559526909|FG004|Treatment Period|Withdrawal by Subject|1|||
155027458|NCT01053962|559526905|FG000|Treatment Period|Noncompliance with protocol|1|||
155027459|NCT01053962|559526906|FG001|Treatment Period|Noncompliance with protocol|0|||
155027460|NCT01053962|559526907|FG002|Treatment Period|Noncompliance with protocol|0|||
155027461|NCT01053962|559526908|FG003|Treatment Period|Noncompliance with protocol|0|||
155027462|NCT01053962|559526909|FG004|Treatment Period|Noncompliance with protocol|0|||
155027463|NCT04143594|559526910|FG000|Overall Study|Withdrew consent|3|||
155027464|NCT04143594|559526911|FG001|Overall Study|Withdrew consent|10|||
155027465|NCT04143594|559526912|FG002|Overall Study|Withdrew consent|3|||
155027466|NCT04143594|559526913|FG003|Overall Study|Withdrew consent|1|||
155027467|NCT04143594|559526910|FG000|Overall Study|Lost to Follow-up|3|||
155027468|NCT04143594|559526911|FG001|Overall Study|Lost to Follow-up|5|||
155027469|NCT04143594|559526912|FG002|Overall Study|Lost to Follow-up|11|||
155027470|NCT04143594|559526913|FG003|Overall Study|Lost to Follow-up|0|||
155027471|NCT04143594|559526910|FG000|Overall Study|Investigator's discretion|2|||
155027472|NCT04143594|559526911|FG001|Overall Study|Investigator's discretion|2|||
155027473|NCT04143594|559526912|FG002|Overall Study|Investigator's discretion|0|||
155027474|NCT04143594|559526913|FG003|Overall Study|Investigator's discretion|0|||
155027475|NCT04143594|559526910|FG000|Overall Study|Randomized but never treated|0|||
155027476|NCT04143594|559526911|FG001|Overall Study|Randomized but never treated|0|||
155027477|NCT04143594|559526912|FG002|Overall Study|Randomized but never treated|0|||
155027478|NCT04143594|559526913|FG003|Overall Study|Randomized but never treated|1|||
155027479|NCT04143594|559526910|FG000|Overall Study|Death|1|||
155027480|NCT04143594|559526911|FG001|Overall Study|Death|0|||
155027481|NCT04143594|559526912|FG002|Overall Study|Death|1|||
155027482|NCT04143594|559526913|FG003|Overall Study|Death|0|||
155027483|NCT04143594|559526910|FG000|Overall Study|Adverse Event|1|||
155027484|NCT04143594|559526911|FG001|Overall Study|Adverse Event|0|||
155027485|NCT04143594|559526912|FG002|Overall Study|Adverse Event|0|||
155027486|NCT04143594|559526913|FG003|Overall Study|Adverse Event|0|||
155027487|NCT04143594|559526910|FG000|Overall Study|Pregnancy|0|||
155027488|NCT04143594|559526911|FG001|Overall Study|Pregnancy|0|||
155027489|NCT04143594|559526912|FG002|Overall Study|Pregnancy|1|||
155027490|NCT04143594|559526913|FG003|Overall Study|Pregnancy|0|||
155027491|NCT04143594|559526910|FG000|Overall Study|Lack of Efficacy|1|||
155027492|NCT04143594|559526911|FG001|Overall Study|Lack of Efficacy|1|||
155027493|NCT04143594|559526912|FG002|Overall Study|Lack of Efficacy|0|||
155027494|NCT04143594|559526913|FG003|Overall Study|Lack of Efficacy|0|||
155027495|NCT03089697|559526914|FG000|Overall Study|Adverse Event|1|||
155027496|NCT03089697|559526915|FG001|Overall Study|Adverse Event|2|||
155027497|NCT03089697|559526914|FG000|Overall Study|Withdrawal by Subject|1|||
155027498|NCT03089697|559526915|FG001|Overall Study|Withdrawal by Subject|0|||
155027499|NCT00638443|559526916|FG000|First Intervention|Adverse Event|2|||
155027500|NCT00638443|559526917|FG001|First Intervention|Adverse Event|1|||
155027501|NCT01044290|559526918|FG000|Follow-up 1|Death|3|||
155027502|NCT01044290|559526919|FG001|Follow-up 1|Death|3|||
155027503|NCT01044290|559526920|FG002|Follow-up 1|Death|1|||
155027504|NCT01044290|559526918|FG000|Follow-up 1|Withdrawal by Subject|2|||
155027505|NCT01044290|559526919|FG001|Follow-up 1|Withdrawal by Subject|2|||
155027506|NCT01044290|559526920|FG002|Follow-up 1|Withdrawal by Subject|0|||
155027507|NCT01044290|559526918|FG000|Follow-Up 2|Death|0|||
155027508|NCT01044290|559526919|FG001|Follow-Up 2|Death|1|||
155027509|NCT01044290|559526920|FG002|Follow-Up 2|Death|1|||
155027510|NCT01044290|559526918|FG000|Follow-Up 2|Withdrawal by Subject|0|||
155027511|NCT01044290|559526919|FG001|Follow-Up 2|Withdrawal by Subject|1|||
155181435|NCT02038829|560103089|FG011|Washout Period 1|Death|0|||
155181436|NCT02038829|560103078|FG000|Treatment Period 2|Adverse Event|0|||
155181437|NCT02038829|560103079|FG001|Treatment Period 2|Adverse Event|0|||
155181438|NCT02038829|560103080|FG002|Treatment Period 2|Adverse Event|0|||
155027512|NCT01044290|559526920|FG002|Follow-Up 2|Withdrawal by Subject|1|||
155027513|NCT01967706|559526925|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
155027514|NCT01967706|559526926|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
155027515|NCT01967706|559526927|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155027516|NCT01967706|559526928|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
155027517|NCT00614120|559526932|FG000|Overall Study|Adverse Event|9|||
155027518|NCT00614120|559526933|FG001|Overall Study|Adverse Event|22|||
155181439|NCT02038829|560103081|FG003|Treatment Period 2|Adverse Event|0|||
155181440|NCT02038829|560103082|FG004|Treatment Period 2|Adverse Event|0|||
155181441|NCT02038829|560103083|FG005|Treatment Period 2|Adverse Event|0|||
155027519|NCT00614120|559526934|FG002|Overall Study|Adverse Event|30|||
155027520|NCT00614120|559526935|FG003|Overall Study|Adverse Event|3|||
155027521|NCT00614120|559526932|FG000|Overall Study|Lack of Efficacy|3|||
155027522|NCT00614120|559526933|FG001|Overall Study|Lack of Efficacy|3|||
155027523|NCT00614120|559526934|FG002|Overall Study|Lack of Efficacy|2|||
155027524|NCT00614120|559526935|FG003|Overall Study|Lack of Efficacy|2|||
155027525|NCT00614120|559526932|FG000|Overall Study|Protocol Violation|2|||
155027526|NCT00614120|559526933|FG001|Overall Study|Protocol Violation|5|||
155027527|NCT00614120|559526934|FG002|Overall Study|Protocol Violation|3|||
155027528|NCT00614120|559526935|FG003|Overall Study|Protocol Violation|1|||
155027529|NCT00614120|559526932|FG000|Overall Study|Withdrawal criteria|1|||
155027530|NCT00614120|559526933|FG001|Overall Study|Withdrawal criteria|0|||
155027531|NCT00614120|559526934|FG002|Overall Study|Withdrawal criteria|0|||
155027532|NCT00614120|559526935|FG003|Overall Study|Withdrawal criteria|0|||
155027533|NCT00614120|559526932|FG000|Overall Study|Withdrawal by Subject|9|||
155027534|NCT00614120|559526933|FG001|Overall Study|Withdrawal by Subject|10|||
155027535|NCT00614120|559526934|FG002|Overall Study|Withdrawal by Subject|16|||
155027536|NCT00614120|559526935|FG003|Overall Study|Withdrawal by Subject|3|||
155027537|NCT00614120|559526932|FG000|Overall Study|Did not meet trial criteria|0|||
155027538|NCT00614120|559526933|FG001|Overall Study|Did not meet trial criteria|1|||
155027539|NCT00614120|559526934|FG002|Overall Study|Did not meet trial criteria|1|||
155027540|NCT00614120|559526935|FG003|Overall Study|Did not meet trial criteria|1|||
155027541|NCT00614120|559526932|FG000|Overall Study|hCG positive (not pregnant)|0|||
155027542|NCT00614120|559526933|FG001|Overall Study|hCG positive (not pregnant)|0|||
155027543|NCT00614120|559526934|FG002|Overall Study|hCG positive (not pregnant)|1|||
155027544|NCT00614120|559526935|FG003|Overall Study|hCG positive (not pregnant)|0|||
155027545|NCT00614120|559526932|FG000|Overall Study|Hypoglycaemia|0|||
155027546|NCT00614120|559526933|FG001|Overall Study|Hypoglycaemia|0|||
155027547|NCT00614120|559526934|FG002|Overall Study|Hypoglycaemia|0|||
155027548|NCT00614120|559526935|FG003|Overall Study|Hypoglycaemia|1|||
155027549|NCT00614120|559526932|FG000|Overall Study|Lack of trial product|3|||
155027550|NCT00614120|559526933|FG001|Overall Study|Lack of trial product|3|||
155027551|NCT00614120|559526934|FG002|Overall Study|Lack of trial product|2|||
155027552|NCT00614120|559526935|FG003|Overall Study|Lack of trial product|0|||
155027553|NCT00614120|559526932|FG000|Overall Study|Late syphilis, latent|1|||
155027554|NCT00614120|559526933|FG001|Overall Study|Late syphilis, latent|0|||
155027555|NCT00614120|559526934|FG002|Overall Study|Late syphilis, latent|0|||
155027556|NCT00614120|559526935|FG003|Overall Study|Late syphilis, latent|0|||
155027557|NCT00614120|559526932|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
155027558|NCT00614120|559526933|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
155027559|NCT00614120|559526934|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
155027560|NCT00614120|559526935|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
155027561|NCT00614120|559526932|FG000|Overall Study|Lost to Follow-up|1|||
155027562|NCT00614120|559526933|FG001|Overall Study|Lost to Follow-up|2|||
155027563|NCT00614120|559526934|FG002|Overall Study|Lost to Follow-up|3|||
155027564|NCT00614120|559526935|FG003|Overall Study|Lost to Follow-up|4|||
155027565|NCT01552915|559526947|FG000|Overall Study|Adverse Event|3|||
155027566|NCT01552915|559526948|FG001|Overall Study|Adverse Event|14|||
155027567|NCT01552915|559526949|FG002|Overall Study|Adverse Event|3|||
155027568|NCT01552915|559526947|FG000|Overall Study|Lost to Follow-up|4|||
155027569|NCT01552915|559526948|FG001|Overall Study|Lost to Follow-up|6|||
155027570|NCT01552915|559526949|FG002|Overall Study|Lost to Follow-up|5|||
155027571|NCT01552915|559526947|FG000|Overall Study|Withdrawal by Subject|6|||
155027572|NCT01552915|559526948|FG001|Overall Study|Withdrawal by Subject|4|||
155027573|NCT01552915|559526949|FG002|Overall Study|Withdrawal by Subject|5|||
155027574|NCT01552915|559526947|FG000|Overall Study|Protocol Violation|0|||
155027575|NCT01552915|559526948|FG001|Overall Study|Protocol Violation|4|||
155027576|NCT01552915|559526949|FG002|Overall Study|Protocol Violation|4|||
155027577|NCT01552915|559526947|FG000|Overall Study|Lack of Efficacy|8|||
155027578|NCT01552915|559526948|FG001|Overall Study|Lack of Efficacy|1|||
155027579|NCT01552915|559526949|FG002|Overall Study|Lack of Efficacy|4|||
155027580|NCT01552915|559526947|FG000|Overall Study|Other|2|||
155027581|NCT01552915|559526948|FG001|Overall Study|Other|0|||
155027582|NCT01552915|559526949|FG002|Overall Study|Other|6|||
155027583|NCT01054196|559526950|FG000|Overall Study|Physician Decision|0|||
155027584|NCT01054196|559526951|FG001|Overall Study|Physician Decision|0|||
155027585|NCT01054196|559526952|FG002|Overall Study|Physician Decision|0|||
155027586|NCT01054196|559526953|FG003|Overall Study|Physician Decision|1|||
155027587|NCT01054196|559526954|FG004|Overall Study|Physician Decision|0|||
155027588|NCT01054196|559526955|FG005|Overall Study|Physician Decision|0|||
155027589|NCT01054196|559526956|FG006|Overall Study|Physician Decision|1|||
155027590|NCT01820572|559526967|FG000|Randomization|Not Treated|2|||
155027591|NCT01820572|559526968|FG001|Randomization|Not Treated|1|||
155027592|NCT01820572|559526967|FG000|Treatment Period|Adverse Event|12|||
155027593|NCT01820572|559526968|FG001|Treatment Period|Adverse Event|7|||
155027594|NCT01820572|559526967|FG000|Treatment Period|Death|3|||
155027595|NCT01820572|559526968|FG001|Treatment Period|Death|3|||
155027596|NCT01820572|559526967|FG000|Treatment Period|Lack of Efficacy|1|||
155027597|NCT01820572|559526968|FG001|Treatment Period|Lack of Efficacy|0|||
155027598|NCT01820572|559526967|FG000|Treatment Period|poor/non compliance|0|||
155027599|NCT01820572|559526968|FG001|Treatment Period|poor/non compliance|3|||
155027600|NCT01820572|559526967|FG000|Treatment Period|request to discontinue|6|||
155027601|NCT01820572|559526968|FG001|Treatment Period|request to discontinue|11|||
155027602|NCT01820572|559526967|FG000|Treatment Period|No longer meets study criteria|3|||
155027603|NCT01820572|559526968|FG001|Treatment Period|No longer meets study criteria|10|||
155027604|NCT01820572|559526967|FG000|Treatment Period|withdrew consent|1|||
155027605|NCT01820572|559526968|FG001|Treatment Period|withdrew consent|2|||
155027606|NCT00595517|559526969|FG000|Overall Study|Adverse Event|6|||
155027607|NCT00595517|559526969|FG000|Overall Study|Withdrawal by Subject|4|||
155027608|NCT00595517|559526969|FG000|Overall Study|Protocol Violation|2|||
155027609|NCT00595517|559526969|FG000|Overall Study|Recurrence of ulcer|5|||
155027610|NCT00595517|559526969|FG000|Overall Study|usage of prohibited treatment|1|||
155027611|NCT00595517|559526969|FG000|Overall Study|No intention to attend regularly|1|||
155027612|NCT01167881|559526970|FG000|Overall Study|Adverse Event|47|||
155027613|NCT01167881|559526971|FG001|Overall Study|Adverse Event|51|||
155027614|NCT01167881|559526970|FG000|Overall Study|Lack of Efficacy|4|||
155027615|NCT01167881|559526971|FG001|Overall Study|Lack of Efficacy|7|||
155027616|NCT01167881|559526970|FG000|Overall Study|Non compliant with protocol|9|||
155027617|NCT01167881|559526971|FG001|Overall Study|Non compliant with protocol|18|||
155027618|NCT01167881|559526970|FG000|Overall Study|Lost to Follow-up|19|||
155027619|NCT01167881|559526971|FG001|Overall Study|Lost to Follow-up|20|||
155027620|NCT01167881|559526970|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
155027621|NCT01167881|559526971|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
155027622|NCT01167881|559526970|FG000|Overall Study|Not treated|4|||
155027623|NCT01167881|559526971|FG001|Overall Study|Not treated|0|||
155027624|NCT01167881|559526970|FG000|Overall Study|Other not defined above|31|||
155027625|NCT01167881|559526971|FG001|Overall Study|Other not defined above|55|||
155027626|NCT02107859|559526972|FG000|Overall Study|Withdrawal by Subject|14|||
155027627|NCT02107859|559526972|FG000|Overall Study|Adverse Event|3|||
155027628|NCT02107859|559526972|FG000|Overall Study|Study closure|41|||
155027629|NCT02107859|559526972|FG000|Overall Study|Other than specified|3|||
155027630|NCT00977314|559526973|FG000|Overall Study|Withdrawal by Subject|1|||
155027631|NCT00977314|559526974|FG001|Overall Study|Withdrawal by Subject|0|||
155027632|NCT00977314|559526973|FG000|Overall Study|Physician Decision|1|||
155027633|NCT00977314|559526974|FG001|Overall Study|Physician Decision|0|||
155027634|NCT01343277|559526975|FG000|Overall Study|Other|3|||
155027635|NCT01343277|559526976|FG001|Overall Study|Other|3|||
155027636|NCT01343277|559526975|FG000|Overall Study|Withdrawal by Subject|18|||
155027637|NCT01343277|559526976|FG001|Overall Study|Withdrawal by Subject|13|||
155027638|NCT01343277|559526975|FG000|Overall Study|Physician Decision|1|||
155027639|NCT01343277|559526976|FG001|Overall Study|Physician Decision|2|||
155027640|NCT01343277|559526975|FG000|Overall Study|Death|10|||
155027641|NCT01343277|559526976|FG001|Overall Study|Death|1|||
155027642|NCT01343277|559526975|FG000|Overall Study|Adverse Event|67|||
155027643|NCT01343277|559526976|FG001|Overall Study|Adverse Event|13|||
155027644|NCT01343277|559526975|FG000|Overall Study|Disease progression|270|||
155027645|NCT01343277|559526976|FG001|Overall Study|Disease progression|138|||
155027646|NCT01343277|559526975|FG000|Overall Study|Randomized not treated|6|||
155027647|NCT01343277|559526976|FG001|Overall Study|Randomized not treated|21|||
155027648|NCT01343277|559526975|FG000|Overall Study|Treatment ongoing|8|||
155027649|NCT01343277|559526976|FG001|Overall Study|Treatment ongoing|2|||
155027650|NCT01343277|559526975|FG000|Overall Study|Subsequent anticancer therapy|1|||
155027651|NCT01343277|559526976|FG001|Overall Study|Subsequent anticancer therapy|0|||
155027652|NCT01894100|559526979|FG000|Overall Study|Lost to Follow-up|0|||
155027653|NCT01894100|559526980|FG001|Overall Study|Lost to Follow-up|1|||
155027654|NCT01894100|559526979|FG000|Overall Study|Withdrawal by Subject|3|||
155027655|NCT01894100|559526980|FG001|Overall Study|Withdrawal by Subject|0|||
155027656|NCT01094301|559526983|FG000|Trial Stage|Withdrawal by Subject|1|||
155027657|NCT01094301|559526983|FG000|Implant Stage|Adverse Event|1|||
155027658|NCT01094301|559526983|FG000|Implant Stage|Protocol Violation|1|||
155027659|NCT01094301|559526983|FG000|Implant Stage|Withdrawal by Subject|2|||
155027660|NCT01094301|559526983|FG000|Implant Stage|No return of pain|4|||
155027661|NCT00135512|559526984|FG000|Overall Study|Adverse Event|56|||
155027662|NCT00135512|559526984|FG000|Overall Study|Lack of Efficacy|25|||
155027663|NCT00135512|559526984|FG000|Overall Study|Other|42|||
155027664|NCT04439214|559526988|FG000|Overall Study|Adverse Event|13|||
155027665|NCT04439214|559526988|FG000|Overall Study|Disease progression|16|||
155027666|NCT04439214|559526988|FG000|Overall Study|Death|1|||
155027667|NCT04439214|559526988|FG000|Overall Study|Withdrawal by Subject|2|||
155027668|NCT04439214|559526988|FG000|Overall Study|Declining health|1|||
155027669|NCT04439214|559526988|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
155027670|NCT04439214|559526988|FG000|Overall Study|Ineligible|5|||
155181442|NCT02038829|560103084|FG006|Treatment Period 2|Adverse Event|0|||
155027671|NCT02235077|559526989|FG000|Overall Study|Death|5|||
155027672|NCT02235077|559526990|FG001|Overall Study|Death|7|||
155027673|NCT02235077|559526989|FG000|Overall Study|Lost to Follow-up|5|||
155027674|NCT02235077|559526990|FG001|Overall Study|Lost to Follow-up|6|||
155027675|NCT02235077|559526989|FG000|Overall Study|Withdrawal by Subject|8|||
155027676|NCT02235077|559526990|FG001|Overall Study|Withdrawal by Subject|5|||
155027677|NCT02235077|559526989|FG000|Overall Study|Physician Decision|0|||
155027678|NCT02235077|559526990|FG001|Overall Study|Physician Decision|1|||
155027679|NCT03852628|559526991|FG000|Overall Study|Lost to Follow-up|7|||
155027680|NCT03852628|559526992|FG001|Overall Study|Lost to Follow-up|6|||
155027681|NCT03852628|559526991|FG000|Overall Study|Lack of Efficacy|6|||
155027682|NCT03852628|559526992|FG001|Overall Study|Lack of Efficacy|6|||
155027683|NCT02964208|559526993|FG000|Overall Study|Death|103|||
155027684|NCT02964208|559526993|FG000|Overall Study|Withdrawal by Subject|6|||
155027685|NCT02964208|559526993|FG000|Overall Study|Lost to Follow-up|6|||
155027686|NCT02964208|559526993|FG000|Overall Study|Unsuccessful Procedure|5|||
155027687|NCT02964208|559526993|FG000|Overall Study|Device Explant|1|||
155027688|NCT02964208|559526993|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
155027689|NCT00430573|559526996|FG000|Overall Study|Withdrawal by Subject|5|||
155027690|NCT05020665|559526999|FG000|Overall Study|Study terminated by Sponsor|5|||
155027691|NCT05020665|559527000|FG001|Overall Study|Study terminated by Sponsor|4|||
155027692|NCT05020665|559526999|FG000|Overall Study|Death|2|||
155027693|NCT05020665|559527000|FG001|Overall Study|Death|1|||
155027694|NCT05020665|559526999|FG000|Overall Study|Physician Decision|0|||
155027695|NCT05020665|559527000|FG001|Overall Study|Physician Decision|1|||
155027696|NCT05020665|559526999|FG000|Overall Study|Withdrawal by Subject|0|||
155027697|NCT05020665|559527000|FG001|Overall Study|Withdrawal by Subject|1|||
155027698|NCT05020665|559526999|FG000|Overall Study|Reason not specified|1|||
155027699|NCT05020665|559527000|FG001|Overall Study|Reason not specified|0|||
155027700|NCT00101166|559527001|FG000|Overall Study|progressive disease|10|||
155027701|NCT01868022|559527002|FG000|Overall Study|Withdrawal by Subject|0|||
155027702|NCT01868022|559527003|FG001|Overall Study|Withdrawal by Subject|0|||
155027703|NCT01868022|559527004|FG002|Overall Study|Withdrawal by Subject|1|||
155027704|NCT01868022|559527005|FG003|Overall Study|Withdrawal by Subject|1|||
155027705|NCT01868022|559527006|FG004|Overall Study|Withdrawal by Subject|0|||
155027706|NCT01868022|559527007|FG005|Overall Study|Withdrawal by Subject|0|||
155027707|NCT01868022|559527008|FG006|Overall Study|Withdrawal by Subject|0|||
155027708|NCT01868022|559527009|FG007|Overall Study|Withdrawal by Subject|1|||
155027709|NCT01868022|559527010|FG008|Overall Study|Withdrawal by Subject|0|||
155027710|NCT01868022|559527002|FG000|Overall Study|Adverse Event|0|||
155027711|NCT01868022|559527003|FG001|Overall Study|Adverse Event|0|||
155027712|NCT01868022|559527004|FG002|Overall Study|Adverse Event|0|||
155027713|NCT01868022|559527005|FG003|Overall Study|Adverse Event|0|||
155027714|NCT01868022|559527006|FG004|Overall Study|Adverse Event|2|||
155027715|NCT01868022|559527007|FG005|Overall Study|Adverse Event|0|||
155027716|NCT01868022|559527008|FG006|Overall Study|Adverse Event|0|||
155027717|NCT01868022|559527009|FG007|Overall Study|Adverse Event|2|||
155027718|NCT01868022|559527010|FG008|Overall Study|Adverse Event|2|||
155027719|NCT01868022|559527002|FG000|Overall Study|Physician Decision|0|||
155027720|NCT01868022|559527003|FG001|Overall Study|Physician Decision|0|||
155027721|NCT01868022|559527004|FG002|Overall Study|Physician Decision|0|||
155027722|NCT01868022|559527005|FG003|Overall Study|Physician Decision|0|||
155027723|NCT01868022|559527006|FG004|Overall Study|Physician Decision|0|||
155027724|NCT01868022|559527007|FG005|Overall Study|Physician Decision|1|||
155027725|NCT01868022|559527008|FG006|Overall Study|Physician Decision|0|||
155027726|NCT01868022|559527009|FG007|Overall Study|Physician Decision|2|||
155027727|NCT01868022|559527010|FG008|Overall Study|Physician Decision|0|||
155027728|NCT01868022|559527002|FG000|Overall Study|Study closed/terminated|0|||
155027729|NCT01868022|559527003|FG001|Overall Study|Study closed/terminated|0|||
155027730|NCT01868022|559527004|FG002|Overall Study|Study closed/terminated|0|||
155027731|NCT01868022|559527005|FG003|Overall Study|Study closed/terminated|0|||
155027732|NCT01868022|559527006|FG004|Overall Study|Study closed/terminated|0|||
155027733|NCT01868022|559527007|FG005|Overall Study|Study closed/terminated|0|||
155027734|NCT01868022|559527008|FG006|Overall Study|Study closed/terminated|0|||
155027735|NCT01868022|559527009|FG007|Overall Study|Study closed/terminated|1|||
155027736|NCT01868022|559527010|FG008|Overall Study|Study closed/terminated|0|||
155027737|NCT01868022|559527002|FG000|Overall Study|Ongoing|0|||
155027738|NCT01868022|559527003|FG001|Overall Study|Ongoing|0|||
155027739|NCT01868022|559527004|FG002|Overall Study|Ongoing|0|||
155027740|NCT01868022|559527005|FG003|Overall Study|Ongoing|0|||
155027741|NCT01868022|559527006|FG004|Overall Study|Ongoing|0|||
155027742|NCT01868022|559527007|FG005|Overall Study|Ongoing|0|||
155181443|NCT02038829|560103085|FG007|Treatment Period 2|Adverse Event|0|||
155181444|NCT02038829|560103086|FG008|Treatment Period 2|Adverse Event|0|||
155027743|NCT01868022|559527008|FG006|Overall Study|Ongoing|0|||
155027744|NCT01868022|559527009|FG007|Overall Study|Ongoing|3|||
155027745|NCT01868022|559527010|FG008|Overall Study|Ongoing|0|||
155027746|NCT03386994|559527014|FG000|Overall Study|Lung transplant|1|||
155027747|NCT03386994|559527014|FG000|Overall Study|Adverse Event|14|||
155027748|NCT03386994|559527014|FG000|Overall Study|Lost to Follow-up|4|||
155027749|NCT03386994|559527014|FG000|Overall Study|Withdrawal by Subject|3|||
155027750|NCT03386994|559527014|FG000|Overall Study|Death|16|||
155027751|NCT00877487|559527015|FG000|Open-label Treatment Phase|Adverse Event|1|||
155027752|NCT00877487|559527016|FG001|Open-label Treatment Phase|Adverse Event|0|||
155181445|NCT02038829|560103087|FG009|Treatment Period 2|Adverse Event|0|||
155027753|NCT00877487|559527015|FG000|Open-label Treatment Phase|Protocol Violation|3|||
155027754|NCT00877487|559527016|FG001|Open-label Treatment Phase|Protocol Violation|0|||
155181446|NCT02038829|560103088|FG010|Treatment Period 2|Adverse Event|1|||
155027755|NCT00877487|559527015|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
155027756|NCT00877487|559527016|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
155027757|NCT00877487|559527015|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
155027758|NCT00877487|559527016|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
155027759|NCT00877487|559527015|FG000|Open-label Treatment Phase|Out of country for business|1|||
155027760|NCT00877487|559527016|FG001|Open-label Treatment Phase|Out of country for business|0|||
155027761|NCT00877487|559527015|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
155027762|NCT00877487|559527016|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
155027763|NCT00877487|559527015|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
155027764|NCT00877487|559527016|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
155027765|NCT00877487|559527015|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
155027766|NCT00877487|559527016|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
155027767|NCT00877487|559527015|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
155027768|NCT00877487|559527016|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
155027769|NCT03425396|559527017|FG000|Overall Study|Lost to Follow-up|2|||
155027770|NCT03425396|559527018|FG001|Overall Study|Lost to Follow-up|5|||
155027771|NCT03425396|559527019|FG002|Overall Study|Lost to Follow-up|2|||
155027772|NCT03425396|559527020|FG003|Overall Study|Lost to Follow-up|0|||
155027773|NCT03425396|559527021|FG004|Overall Study|Lost to Follow-up|0|||
155027774|NCT03425396|559527017|FG000|Overall Study|Withdrawal by Subject|0|||
155027775|NCT03425396|559527018|FG001|Overall Study|Withdrawal by Subject|1|||
155027776|NCT03425396|559527019|FG002|Overall Study|Withdrawal by Subject|0|||
155027777|NCT03425396|559527020|FG003|Overall Study|Withdrawal by Subject|1|||
155027778|NCT03425396|559527021|FG004|Overall Study|Withdrawal by Subject|0|||
155027779|NCT03425396|559527017|FG000|Overall Study|Other|0|||
155027780|NCT03425396|559527018|FG001|Overall Study|Other|1|||
155027781|NCT03425396|559527019|FG002|Overall Study|Other|1|||
155027782|NCT03425396|559527020|FG003|Overall Study|Other|0|||
155027783|NCT03425396|559527021|FG004|Overall Study|Other|1|||
155027784|NCT03033602|559527022|FG000|Overall Study|Withdrawal by Subject|11|||
155027785|NCT03033602|559527023|FG001|Overall Study|Withdrawal by Subject|21|||
155027786|NCT03033602|559527022|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
155027787|NCT03033602|559527023|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
155027788|NCT01441765|559527024|FG000|Overall Study|Death|1|||
155027789|NCT01441765|559527025|FG001|Overall Study|Death|0|||
155027790|NCT04445714|559527026|FG000|Overall Study|Discontinuation of the study|14|||
155027791|NCT04445714|559527026|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
155027792|NCT04445714|559527026|FG000|Overall Study|Withdrawal of Informed Consent|8|||
155027793|NCT02122887|559527032|FG000|Overall Study|Withdrawal by Subject|20|||
155027794|NCT02122887|559527033|FG001|Overall Study|Withdrawal by Subject|2|||
155027795|NCT01082211|559527034|FG000|Overall Study|Protocol Violation|4|||
155027796|NCT01082211|559527034|FG000|Overall Study|No protocol treatment received|3|||
155027797|NCT03725761|559527035|FG000|Overall Study|still on study|1|||
155027798|NCT00784550|559528591|FG000|Overall Study|Adverse Event|12|||
155027799|NCT00784550|559528592|FG001|Overall Study|Adverse Event|10|||
155027800|NCT00784550|559528591|FG000|Overall Study|Lack of Efficacy|0|||
155027801|NCT00784550|559528592|FG001|Overall Study|Lack of Efficacy|1|||
155027802|NCT00784550|559528591|FG000|Overall Study|Protocol Violation|10|||
155027803|NCT00784550|559528592|FG001|Overall Study|Protocol Violation|10|||
155181447|NCT02038829|560103089|FG011|Treatment Period 2|Adverse Event|0|||
155027804|NCT00784550|559528591|FG000|Overall Study|Lost to Follow-up|8|||
155027805|NCT00784550|559528592|FG001|Overall Study|Lost to Follow-up|5|||
155027806|NCT00784550|559528591|FG000|Overall Study|Physician Decision|2|||
155027807|NCT00784550|559528592|FG001|Overall Study|Physician Decision|3|||
155027808|NCT00784550|559528591|FG000|Overall Study|Withdrawal by Subject|4|||
155027809|NCT00784550|559528592|FG001|Overall Study|Withdrawal by Subject|13|||
155027810|NCT05903924|559528593|FG000|Overall Study|Lost to Follow-up|1|||
155027811|NCT05903924|559528594|FG001|Overall Study|Lost to Follow-up|0|||
155027812|NCT05903924|559528595|FG002|Overall Study|Lost to Follow-up|0|||
155027813|NCT00174967|559528596|FG000|Overall Study|Adverse Event|1|||
155027814|NCT00174967|559528597|FG001|Overall Study|Adverse Event|2|||
155027815|NCT00174967|559528598|FG002|Overall Study|Adverse Event|2|||
155027816|NCT00174967|559528599|FG003|Overall Study|Adverse Event|1|||
155027817|NCT00174967|559528596|FG000|Overall Study|Gout Flare|0|||
155027818|NCT00174967|559528597|FG001|Overall Study|Gout Flare|0|||
155027819|NCT00174967|559528598|FG002|Overall Study|Gout Flare|0|||
155181448|NCT02038829|560103078|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155027820|NCT00174967|559528599|FG003|Overall Study|Gout Flare|1|||
155027821|NCT00174967|559528596|FG000|Overall Study|Other|0|||
155027822|NCT00174967|559528597|FG001|Overall Study|Other|1|||
155027823|NCT00174967|559528598|FG002|Overall Study|Other|0|||
155027824|NCT00174967|559528599|FG003|Overall Study|Other|0|||
155027825|NCT03558152|559528600|FG000|Overall Study|Adverse Event|0|||
155027826|NCT03558152|559528601|FG001|Overall Study|Adverse Event|0|||
155027827|NCT03558152|559528602|FG002|Overall Study|Adverse Event|1|||
155027828|NCT03558152|559528603|FG003|Overall Study|Adverse Event|1|||
155027829|NCT03558152|559528604|FG004|Overall Study|Adverse Event|2|||
155027830|NCT03558152|559528605|FG005|Overall Study|Adverse Event|1|||
155027831|NCT03558152|559528606|FG006|Overall Study|Adverse Event|1|||
155027832|NCT03558152|559528607|FG007|Overall Study|Adverse Event|0|||
155027833|NCT03558152|559528600|FG000|Overall Study|Death|0|||
155027834|NCT03558152|559528601|FG001|Overall Study|Death|0|||
155027835|NCT03558152|559528602|FG002|Overall Study|Death|0|||
155027836|NCT03558152|559528603|FG003|Overall Study|Death|0|||
155027837|NCT03558152|559528604|FG004|Overall Study|Death|1|||
155027838|NCT03558152|559528605|FG005|Overall Study|Death|0|||
155027839|NCT03558152|559528606|FG006|Overall Study|Death|0|||
155027840|NCT03558152|559528607|FG007|Overall Study|Death|0|||
155027841|NCT03558152|559528600|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
155027842|NCT03558152|559528601|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027843|NCT03558152|559528602|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027844|NCT03558152|559528603|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027845|NCT03558152|559528604|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027846|NCT03558152|559528605|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027847|NCT03558152|559528606|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027848|NCT03558152|559528607|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
155027849|NCT03558152|559528600|FG000|Overall Study|Miscalculation in mmcs|0|||
155027850|NCT03558152|559528601|FG001|Overall Study|Miscalculation in mmcs|0|||
155027851|NCT03558152|559528602|FG002|Overall Study|Miscalculation in mmcs|0|||
155027852|NCT03558152|559528603|FG003|Overall Study|Miscalculation in mmcs|0|||
155027853|NCT03558152|559528604|FG004|Overall Study|Miscalculation in mmcs|0|||
155027854|NCT03558152|559528605|FG005|Overall Study|Miscalculation in mmcs|0|||
155027855|NCT03558152|559528606|FG006|Overall Study|Miscalculation in mmcs|1|||
155027856|NCT03558152|559528607|FG007|Overall Study|Miscalculation in mmcs|0|||
155027857|NCT03558152|559528600|FG000|Overall Study|Mistake in calculation|0|||
155027858|NCT03558152|559528601|FG001|Overall Study|Mistake in calculation|0|||
155027859|NCT03558152|559528602|FG002|Overall Study|Mistake in calculation|0|||
155027860|NCT03558152|559528603|FG003|Overall Study|Mistake in calculation|1|||
155027861|NCT03558152|559528604|FG004|Overall Study|Mistake in calculation|0|||
155027862|NCT03558152|559528605|FG005|Overall Study|Mistake in calculation|0|||
155027863|NCT03558152|559528606|FG006|Overall Study|Mistake in calculation|0|||
155027864|NCT03558152|559528607|FG007|Overall Study|Mistake in calculation|0|||
155027865|NCT03558152|559528600|FG000|Overall Study|Mistake in evaluation of disease status|0|||
155027866|NCT03558152|559528601|FG001|Overall Study|Mistake in evaluation of disease status|0|||
155027867|NCT03558152|559528602|FG002|Overall Study|Mistake in evaluation of disease status|0|||
155027868|NCT03558152|559528603|FG003|Overall Study|Mistake in evaluation of disease status|0|||
155027869|NCT03558152|559528604|FG004|Overall Study|Mistake in evaluation of disease status|0|||
155027870|NCT03558152|559528605|FG005|Overall Study|Mistake in evaluation of disease status|0|||
155027871|NCT03558152|559528606|FG006|Overall Study|Mistake in evaluation of disease status|0|||
155027872|NCT03558152|559528607|FG007|Overall Study|Mistake in evaluation of disease status|1|||
155027873|NCT03558152|559528600|FG000|Overall Study|Physician Decision|0|||
155027874|NCT03558152|559528601|FG001|Overall Study|Physician Decision|0|||
155027875|NCT03558152|559528602|FG002|Overall Study|Physician Decision|0|||
155027876|NCT03558152|559528603|FG003|Overall Study|Physician Decision|0|||
155027877|NCT03558152|559528604|FG004|Overall Study|Physician Decision|0|||
155027878|NCT03558152|559528605|FG005|Overall Study|Physician Decision|0|||
155027879|NCT03558152|559528606|FG006|Overall Study|Physician Decision|1|||
155027880|NCT03558152|559528607|FG007|Overall Study|Physician Decision|0|||
155027881|NCT03558152|559528600|FG000|Overall Study|Withdrawal by Subject|2|||
155027882|NCT03558152|559528601|FG001|Overall Study|Withdrawal by Subject|3|||
155027883|NCT03558152|559528602|FG002|Overall Study|Withdrawal by Subject|2|||
155027884|NCT03558152|559528603|FG003|Overall Study|Withdrawal by Subject|1|||
155181449|NCT02038829|560103079|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155181450|NCT02038829|560103080|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155181451|NCT02038829|560103081|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155181452|NCT02038829|560103082|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155181453|NCT02038829|560103083|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155181454|NCT02038829|560103084|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155027885|NCT03558152|559528604|FG004|Overall Study|Withdrawal by Subject|1|||
155027886|NCT03558152|559528605|FG005|Overall Study|Withdrawal by Subject|1|||
155027887|NCT03558152|559528606|FG006|Overall Study|Withdrawal by Subject|3|||
155027888|NCT03558152|559528607|FG007|Overall Study|Withdrawal by Subject|2|||
155027889|NCT03558152|559528600|FG000|Overall Study|Lack of Efficacy|11|||
155027890|NCT03558152|559528601|FG001|Overall Study|Lack of Efficacy|11|||
155027891|NCT03558152|559528602|FG002|Overall Study|Lack of Efficacy|10|||
155027892|NCT03558152|559528603|FG003|Overall Study|Lack of Efficacy|11|||
155027893|NCT03558152|559528604|FG004|Overall Study|Lack of Efficacy|14|||
155027894|NCT03558152|559528605|FG005|Overall Study|Lack of Efficacy|12|||
155027895|NCT03558152|559528606|FG006|Overall Study|Lack of Efficacy|14|||
155027896|NCT03558152|559528607|FG007|Overall Study|Lack of Efficacy|13|||
155181455|NCT02038829|560103085|FG007|Treatment Period 2|Withdrawal by Subject|0|||
155027897|NCT03558152|559528600|FG000|Overall Study|Protocol Violation|1|||
155027898|NCT03558152|559528601|FG001|Overall Study|Protocol Violation|1|||
155027899|NCT03558152|559528602|FG002|Overall Study|Protocol Violation|0|||
155027900|NCT03558152|559528603|FG003|Overall Study|Protocol Violation|1|||
155027901|NCT03558152|559528604|FG004|Overall Study|Protocol Violation|1|||
155027902|NCT03558152|559528605|FG005|Overall Study|Protocol Violation|0|||
155027903|NCT03558152|559528606|FG006|Overall Study|Protocol Violation|2|||
155027904|NCT03558152|559528607|FG007|Overall Study|Protocol Violation|0|||
155027905|NCT04166591|559528608|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155027906|NCT04166591|559528609|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155027907|NCT04166591|559528610|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155027908|NCT04166591|559528611|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155027909|NCT04166591|559528608|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
155027910|NCT04166591|559528609|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
155027911|NCT04166591|559528610|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155027912|NCT04166591|559528611|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
155027913|NCT03960021|559528612|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
155027914|NCT01936181|559528616|FG000|Randomised, Double-blind|Adverse Event|27|||
155027915|NCT01936181|559528617|FG001|Randomised, Double-blind|Adverse Event|21|||
155027916|NCT01936181|559528618|FG002|Randomised, Double-blind|Adverse Event|0|||
155027917|NCT01936181|559528619|FG003|Randomised, Double-blind|Adverse Event|0|||
155027918|NCT01936181|559528616|FG000|Randomised, Double-blind|Protocol Violation|1|||
155027919|NCT01936181|559528617|FG001|Randomised, Double-blind|Protocol Violation|5|||
155027920|NCT01936181|559528618|FG002|Randomised, Double-blind|Protocol Violation|0|||
155027921|NCT01936181|559528619|FG003|Randomised, Double-blind|Protocol Violation|0|||
155027922|NCT01936181|559528616|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
155027923|NCT01936181|559528617|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
155027924|NCT01936181|559528618|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
155027925|NCT01936181|559528619|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
155027926|NCT01936181|559528616|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
155027927|NCT01936181|559528617|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
155027928|NCT01936181|559528618|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
155027929|NCT01936181|559528619|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
155027930|NCT01936181|559528616|FG000|Randomised, Double-blind|Pregnancy|0|||
155027931|NCT01936181|559528617|FG001|Randomised, Double-blind|Pregnancy|1|||
155027932|NCT01936181|559528618|FG002|Randomised, Double-blind|Pregnancy|0|||
155027933|NCT01936181|559528619|FG003|Randomised, Double-blind|Pregnancy|0|||
155027934|NCT01936181|559528616|FG000|Randomised, Double-blind|Physician Decision|4|||
155027935|NCT01936181|559528617|FG001|Randomised, Double-blind|Physician Decision|4|||
155027936|NCT01936181|559528618|FG002|Randomised, Double-blind|Physician Decision|0|||
155027937|NCT01936181|559528619|FG003|Randomised, Double-blind|Physician Decision|0|||
155027938|NCT01936181|559528616|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
155027939|NCT01936181|559528617|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
155027940|NCT01936181|559528618|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
155027941|NCT01936181|559528619|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
155027942|NCT01936181|559528616|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
155027943|NCT01936181|559528617|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
155027944|NCT01936181|559528618|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
155027945|NCT01936181|559528619|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
155027946|NCT01936181|559528616|FG000|Transition-extension|Adverse Event|3|||
155027947|NCT01936181|559528617|FG001|Transition-extension|Adverse Event|0|||
155027948|NCT01936181|559528618|FG002|Transition-extension|Adverse Event|3|||
155027949|NCT01936181|559528619|FG003|Transition-extension|Adverse Event|1|||
155027950|NCT01936181|559528616|FG000|Transition-extension|Lost to Follow-up|3|||
155027951|NCT01936181|559528617|FG001|Transition-extension|Lost to Follow-up|0|||
155027952|NCT01936181|559528618|FG002|Transition-extension|Lost to Follow-up|1|||
155027953|NCT01936181|559528619|FG003|Transition-extension|Lost to Follow-up|2|||
155027954|NCT01936181|559528616|FG000|Transition-extension|Physician Decision|2|||
155027955|NCT01936181|559528617|FG001|Transition-extension|Physician Decision|0|||
155027956|NCT01936181|559528618|FG002|Transition-extension|Physician Decision|0|||
155027957|NCT01936181|559528619|FG003|Transition-extension|Physician Decision|1|||
155027958|NCT01936181|559528616|FG000|Transition-extension|Withdrawal by Subject|7|||
155027959|NCT01936181|559528617|FG001|Transition-extension|Withdrawal by Subject|0|||
155027960|NCT01936181|559528618|FG002|Transition-extension|Withdrawal by Subject|2|||
155027961|NCT01936181|559528619|FG003|Transition-extension|Withdrawal by Subject|1|||
155027962|NCT02086448|559528622|FG000|Overall Study|Withdrawal by Subject|1|||
155027963|NCT02086448|559528623|FG001|Overall Study|Withdrawal by Subject|0|||
155027964|NCT02086448|559528624|FG002|Overall Study|Withdrawal by Subject|0|||
155027965|NCT02086448|559528625|FG003|Overall Study|Withdrawal by Subject|2|||
155027966|NCT01730534|559528629|FG000|Overall Study|Withdrawal by Subject|97|||
155027967|NCT01730534|559528630|FG001|Overall Study|Withdrawal by Subject|127|||
155027968|NCT01730534|559528629|FG000|Overall Study|Lost to Follow-up|12|||
155027969|NCT01730534|559528630|FG001|Overall Study|Lost to Follow-up|18|||
155027970|NCT02980341|559528631|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
155027971|NCT02980341|559528632|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
155027972|NCT02980341|559528633|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
155027973|NCT02980341|559528634|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
155027974|NCT02980341|559528635|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
155027975|NCT02980341|559528636|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155027976|NCT02980341|559528637|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155027977|NCT02980341|559528638|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155027978|NCT02980341|559528639|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155027979|NCT02980341|559528640|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155027980|NCT02980341|559528641|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
155027981|NCT02980341|559528631|FG000|Dose Escalation|Clinical progression|0|||
155027982|NCT02980341|559528632|FG001|Dose Escalation|Clinical progression|0|||
155027983|NCT02980341|559528633|FG002|Dose Escalation|Clinical progression|2|||
155027984|NCT02980341|559528634|FG003|Dose Escalation|Clinical progression|1|||
155027985|NCT02980341|559528635|FG004|Dose Escalation|Clinical progression|0|||
155027986|NCT02980341|559528636|FG005|Dose Escalation|Clinical progression|0|||
155027987|NCT02980341|559528637|FG006|Dose Escalation|Clinical progression|0|||
155027988|NCT02980341|559528638|FG007|Dose Escalation|Clinical progression|0|||
155027989|NCT02980341|559528639|FG008|Dose Escalation|Clinical progression|0|||
155027990|NCT02980341|559528640|FG009|Dose Escalation|Clinical progression|0|||
155027991|NCT02980341|559528641|FG010|Dose Escalation|Clinical progression|0|||
155027992|NCT02980341|559528631|FG000|Dose Escalation|Adverse Event|0|||
155027993|NCT02980341|559528632|FG001|Dose Escalation|Adverse Event|0|||
155027994|NCT02980341|559528633|FG002|Dose Escalation|Adverse Event|1|||
155027995|NCT02980341|559528634|FG003|Dose Escalation|Adverse Event|2|||
155027996|NCT02980341|559528635|FG004|Dose Escalation|Adverse Event|2|||
155027997|NCT02980341|559528636|FG005|Dose Escalation|Adverse Event|0|||
155027998|NCT02980341|559528637|FG006|Dose Escalation|Adverse Event|0|||
155027999|NCT02980341|559528638|FG007|Dose Escalation|Adverse Event|0|||
155028000|NCT02980341|559528639|FG008|Dose Escalation|Adverse Event|0|||
155028001|NCT02980341|559528640|FG009|Dose Escalation|Adverse Event|0|||
155028002|NCT02980341|559528641|FG010|Dose Escalation|Adverse Event|0|||
155028003|NCT02980341|559528631|FG000|Dose Escalation|Withdrawal by Subject|0|||
155028004|NCT02980341|559528632|FG001|Dose Escalation|Withdrawal by Subject|0|||
155028005|NCT02980341|559528633|FG002|Dose Escalation|Withdrawal by Subject|1|||
155028006|NCT02980341|559528634|FG003|Dose Escalation|Withdrawal by Subject|0|||
155028007|NCT02980341|559528635|FG004|Dose Escalation|Withdrawal by Subject|0|||
155028008|NCT02980341|559528636|FG005|Dose Escalation|Withdrawal by Subject|0|||
155028009|NCT02980341|559528637|FG006|Dose Escalation|Withdrawal by Subject|0|||
155028010|NCT02980341|559528638|FG007|Dose Escalation|Withdrawal by Subject|0|||
155028011|NCT02980341|559528639|FG008|Dose Escalation|Withdrawal by Subject|0|||
155028012|NCT02980341|559528640|FG009|Dose Escalation|Withdrawal by Subject|0|||
155028013|NCT02980341|559528641|FG010|Dose Escalation|Withdrawal by Subject|0|||
155028014|NCT02980341|559528631|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028015|NCT02980341|559528632|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028016|NCT02980341|559528633|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028017|NCT02980341|559528634|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
155028018|NCT02980341|559528635|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028019|NCT02980341|559528636|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028020|NCT02980341|559528637|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028021|NCT02980341|559528638|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028022|NCT02980341|559528639|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028023|NCT02980341|559528640|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028024|NCT02980341|559528641|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
155028025|NCT02980341|559528631|FG000|Dose Escalation|Due to investigator's decision|0|||
155028026|NCT02980341|559528632|FG001|Dose Escalation|Due to investigator's decision|0|||
155028027|NCT02980341|559528633|FG002|Dose Escalation|Due to investigator's decision|0|||
155028028|NCT02980341|559528634|FG003|Dose Escalation|Due to investigator's decision|0|||
155028029|NCT02980341|559528635|FG004|Dose Escalation|Due to investigator's decision|1|||
155028030|NCT02980341|559528636|FG005|Dose Escalation|Due to investigator's decision|0|||
155028031|NCT02980341|559528637|FG006|Dose Escalation|Due to investigator's decision|0|||
155028032|NCT02980341|559528638|FG007|Dose Escalation|Due to investigator's decision|0|||
155028033|NCT02980341|559528639|FG008|Dose Escalation|Due to investigator's decision|0|||
155028034|NCT02980341|559528640|FG009|Dose Escalation|Due to investigator's decision|0|||
155028035|NCT02980341|559528641|FG010|Dose Escalation|Due to investigator's decision|0|||
155028036|NCT02980341|559528631|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028037|NCT02980341|559528632|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028038|NCT02980341|559528633|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028039|NCT02980341|559528634|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028040|NCT02980341|559528635|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028041|NCT02980341|559528636|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
155028042|NCT02980341|559528637|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
155028043|NCT02980341|559528638|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028044|NCT02980341|559528639|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028045|NCT02980341|559528640|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028046|NCT02980341|559528641|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
155028047|NCT02980341|559528631|FG000|Dose Finding|Adverse Event|0|||
155028048|NCT02980341|559528632|FG001|Dose Finding|Adverse Event|0|||
155028049|NCT02980341|559528633|FG002|Dose Finding|Adverse Event|0|||
155028050|NCT02980341|559528634|FG003|Dose Finding|Adverse Event|0|||
155028051|NCT02980341|559528635|FG004|Dose Finding|Adverse Event|0|||
155028052|NCT02980341|559528636|FG005|Dose Finding|Adverse Event|3|||
155028053|NCT02980341|559528637|FG006|Dose Finding|Adverse Event|0|||
155028054|NCT02980341|559528638|FG007|Dose Finding|Adverse Event|0|||
155028055|NCT02980341|559528639|FG008|Dose Finding|Adverse Event|0|||
155028056|NCT02980341|559528640|FG009|Dose Finding|Adverse Event|0|||
155028057|NCT02980341|559528641|FG010|Dose Finding|Adverse Event|0|||
155028058|NCT02980341|559528631|FG000|Dose Finding|Withdrawal by Subject|0|||
155028059|NCT02980341|559528632|FG001|Dose Finding|Withdrawal by Subject|0|||
155028060|NCT02980341|559528633|FG002|Dose Finding|Withdrawal by Subject|0|||
155028061|NCT02980341|559528634|FG003|Dose Finding|Withdrawal by Subject|0|||
155028062|NCT02980341|559528635|FG004|Dose Finding|Withdrawal by Subject|0|||
155028063|NCT02980341|559528636|FG005|Dose Finding|Withdrawal by Subject|1|||
155028064|NCT02980341|559528637|FG006|Dose Finding|Withdrawal by Subject|1|||
155028065|NCT02980341|559528638|FG007|Dose Finding|Withdrawal by Subject|0|||
155028066|NCT02980341|559528639|FG008|Dose Finding|Withdrawal by Subject|0|||
155028067|NCT02980341|559528640|FG009|Dose Finding|Withdrawal by Subject|0|||
155028068|NCT02980341|559528641|FG010|Dose Finding|Withdrawal by Subject|0|||
155028069|NCT02980341|559528631|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028070|NCT02980341|559528632|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028071|NCT02980341|559528633|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028072|NCT02980341|559528634|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028073|NCT02980341|559528635|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028074|NCT02980341|559528636|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028075|NCT02980341|559528637|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
155028076|NCT02980341|559528638|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
155028077|NCT02980341|559528639|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
155028078|NCT02980341|559528640|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
155028079|NCT02980341|559528641|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
155028080|NCT02980341|559528631|FG000|Dose Expansion|Clinical progression|0|||
155028081|NCT02980341|559528632|FG001|Dose Expansion|Clinical progression|0|||
155028082|NCT02980341|559528633|FG002|Dose Expansion|Clinical progression|0|||
155028083|NCT02980341|559528634|FG003|Dose Expansion|Clinical progression|0|||
155028084|NCT02980341|559528635|FG004|Dose Expansion|Clinical progression|0|||
155028085|NCT02980341|559528636|FG005|Dose Expansion|Clinical progression|0|||
155028086|NCT02980341|559528637|FG006|Dose Expansion|Clinical progression|0|||
155028087|NCT02980341|559528638|FG007|Dose Expansion|Clinical progression|4|||
155028088|NCT02980341|559528639|FG008|Dose Expansion|Clinical progression|3|||
155028089|NCT02980341|559528640|FG009|Dose Expansion|Clinical progression|1|||
155028090|NCT02980341|559528641|FG010|Dose Expansion|Clinical progression|4|||
155028091|NCT02980341|559528631|FG000|Dose Expansion|Adverse Event|0|||
155028092|NCT02980341|559528632|FG001|Dose Expansion|Adverse Event|0|||
155028093|NCT02980341|559528633|FG002|Dose Expansion|Adverse Event|0|||
155028094|NCT02980341|559528634|FG003|Dose Expansion|Adverse Event|0|||
155028095|NCT02980341|559528635|FG004|Dose Expansion|Adverse Event|0|||
155028096|NCT02980341|559528636|FG005|Dose Expansion|Adverse Event|0|||
155028097|NCT02980341|559528637|FG006|Dose Expansion|Adverse Event|0|||
155028098|NCT02980341|559528638|FG007|Dose Expansion|Adverse Event|3|||
155028099|NCT02980341|559528639|FG008|Dose Expansion|Adverse Event|0|||
155028100|NCT02980341|559528640|FG009|Dose Expansion|Adverse Event|1|||
155028101|NCT02980341|559528641|FG010|Dose Expansion|Adverse Event|3|||
155028102|NCT02980341|559528631|FG000|Dose Expansion|Death|0|||
155028103|NCT02980341|559528632|FG001|Dose Expansion|Death|0|||
155028104|NCT02980341|559528633|FG002|Dose Expansion|Death|0|||
155140098|NCT03781778|559944387|FG000|Overall Study|Withdrawal by Subject|2|||
155140099|NCT03781778|559944388|FG001|Overall Study|Withdrawal by Subject|2|||
155028105|NCT02980341|559528634|FG003|Dose Expansion|Death|0|||
155028106|NCT02980341|559528635|FG004|Dose Expansion|Death|0|||
155028107|NCT02980341|559528636|FG005|Dose Expansion|Death|0|||
155028108|NCT02980341|559528637|FG006|Dose Expansion|Death|0|||
155028109|NCT02980341|559528638|FG007|Dose Expansion|Death|0|||
155028110|NCT02980341|559528639|FG008|Dose Expansion|Death|2|||
155028111|NCT02980341|559528640|FG009|Dose Expansion|Death|1|||
155028112|NCT02980341|559528641|FG010|Dose Expansion|Death|0|||
155028113|NCT02980341|559528631|FG000|Dose Expansion|Withdrawal by Subject|0|||
155028114|NCT02980341|559528632|FG001|Dose Expansion|Withdrawal by Subject|0|||
155028115|NCT02980341|559528633|FG002|Dose Expansion|Withdrawal by Subject|0|||
155028116|NCT02980341|559528634|FG003|Dose Expansion|Withdrawal by Subject|0|||
155028117|NCT02980341|559528635|FG004|Dose Expansion|Withdrawal by Subject|0|||
155028118|NCT02980341|559528636|FG005|Dose Expansion|Withdrawal by Subject|0|||
155028119|NCT02980341|559528637|FG006|Dose Expansion|Withdrawal by Subject|0|||
155028120|NCT02980341|559528638|FG007|Dose Expansion|Withdrawal by Subject|2|||
155028121|NCT02980341|559528639|FG008|Dose Expansion|Withdrawal by Subject|0|||
155028122|NCT02980341|559528640|FG009|Dose Expansion|Withdrawal by Subject|1|||
155028123|NCT02980341|559528641|FG010|Dose Expansion|Withdrawal by Subject|0|||
155028124|NCT02980341|559528631|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028125|NCT02980341|559528632|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028126|NCT02980341|559528633|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028127|NCT02980341|559528634|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028128|NCT02980341|559528635|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028129|NCT02980341|559528636|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028130|NCT02980341|559528637|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028131|NCT02980341|559528638|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
155028132|NCT02980341|559528639|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028133|NCT02980341|559528640|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028134|NCT02980341|559528641|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
155028135|NCT02980341|559528631|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028136|NCT02980341|559528632|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028137|NCT02980341|559528633|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028138|NCT02980341|559528634|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028139|NCT02980341|559528635|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028140|NCT02980341|559528636|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028141|NCT02980341|559528637|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028142|NCT02980341|559528638|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028143|NCT02980341|559528639|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
155028144|NCT02980341|559528640|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028145|NCT02980341|559528641|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
155028146|NCT02980341|559528631|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028147|NCT02980341|559528632|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028148|NCT02980341|559528633|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028149|NCT02980341|559528634|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028150|NCT02980341|559528635|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028151|NCT02980341|559528636|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028152|NCT02980341|559528637|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028153|NCT02980341|559528638|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028154|NCT02980341|559528639|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
155028155|NCT02980341|559528640|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028156|NCT02980341|559528641|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
155028157|NCT02980341|559528631|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028158|NCT02980341|559528632|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028159|NCT02980341|559528633|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028160|NCT02980341|559528634|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028161|NCT02980341|559528635|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028162|NCT02980341|559528636|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028163|NCT02980341|559528637|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028164|NCT02980341|559528638|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028165|NCT02980341|559528639|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028166|NCT02980341|559528640|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
155028167|NCT02980341|559528641|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
155028168|NCT02004886|559528642|FG000|Overall Study|Adverse Event|0|||
155028169|NCT02004886|559528643|FG001|Overall Study|Adverse Event|1|||
155181456|NCT02038829|560103086|FG008|Treatment Period 2|Withdrawal by Subject|0|||
155181457|NCT02038829|560103087|FG009|Treatment Period 2|Withdrawal by Subject|0|||
155028170|NCT02004886|559528644|FG002|Overall Study|Adverse Event|0|||
155028171|NCT02004886|559528645|FG003|Overall Study|Adverse Event|0|||
155028172|NCT02004886|559528642|FG000|Overall Study|Unable to attend future visits|1|||
155028173|NCT02004886|559528643|FG001|Overall Study|Unable to attend future visits|0|||
155028174|NCT02004886|559528644|FG002|Overall Study|Unable to attend future visits|0|||
155028175|NCT02004886|559528645|FG003|Overall Study|Unable to attend future visits|0|||
155028176|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
155028177|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
155028178|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
155028179|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
155028180|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
155028181|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
155028182|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
155028183|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
155028184|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
155028185|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
155028186|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Death|1|||
155028187|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Death|0|||
155028188|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
155028189|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
155028190|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
155028191|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
155028192|NCT01876784|559528647|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
155028193|NCT01876784|559528648|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
155028194|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
155028195|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
155028196|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Adverse Event|2|||
155028197|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Adverse Event|6|||
155028198|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
155028199|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
155028200|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Progressive disease|4|||
155028201|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Progressive disease|35|||
155028202|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
155028203|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
155028204|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
155028205|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
155028206|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Death|0|||
155028207|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Death|1|||
155028208|NCT01876784|559528647|FG000|Open-label Period (31 Months)|Other than specified above|9|||
155028209|NCT01876784|559528648|FG001|Open-label Period (31 Months)|Other than specified above|18|||
155028210|NCT03505593|559528649|FG000|Overall Study|Withdrawal by Subject|1|||
155028211|NCT03505593|559528649|FG000|Overall Study|Died before procedure|1|||
155028212|NCT03505593|559528649|FG000|Overall Study|Anatomical abnormality|1|||
155028213|NCT03505593|559528649|FG000|Overall Study|Unable to pass through esophagus|1|||
155028214|NCT03505593|559528649|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
155028215|NCT05239494|559528650|FG000|Overall Study|Lost to Follow-up|1|||
155028216|NCT01194531|559528651|FG000|Overall Study|Withdrawal by Subject|1|||
155028217|NCT01194531|559528652|FG001|Overall Study|Withdrawal by Subject|0|||
155028218|NCT01194531|559528651|FG000|Overall Study|Protocol Violation|4|||
155028219|NCT01194531|559528652|FG001|Overall Study|Protocol Violation|1|||
155028220|NCT01194531|559528651|FG000|Overall Study|Physician Decision|0|||
155028221|NCT01194531|559528652|FG001|Overall Study|Physician Decision|2|||
155028222|NCT02822573|559528653|FG000|Overall Study|Lost to Follow-up|5|||
155028223|NCT02822573|559528654|FG001|Overall Study|Lost to Follow-up|3|||
155028224|NCT02822573|559528653|FG000|Overall Study|Physician Decision|1|||
155028225|NCT02822573|559528654|FG001|Overall Study|Physician Decision|1|||
155028226|NCT02822573|559528653|FG000|Overall Study|Withdrawal by Subject|9|||
155028227|NCT02822573|559528654|FG001|Overall Study|Withdrawal by Subject|5|||
155028228|NCT02822573|559528653|FG000|Overall Study|Protocol Violation|6|||
155028229|NCT02822573|559528654|FG001|Overall Study|Protocol Violation|4|||
155028230|NCT02822573|559528653|FG000|Overall Study|Too sick or ill|2|||
155028231|NCT02822573|559528654|FG001|Overall Study|Too sick or ill|1|||
155028232|NCT02822573|559528653|FG000|Overall Study|Disease Progression|1|||
155028233|NCT02822573|559528654|FG001|Overall Study|Disease Progression|1|||
155028234|NCT02822573|559528653|FG000|Overall Study|No reason given|6|||
155140100|NCT02652156|559944393|FG000|Overall Study|Physician Decision|1|||
155140101|NCT02652156|559944394|FG001|Overall Study|Physician Decision|0|||
155028235|NCT02822573|559528654|FG001|Overall Study|No reason given|4|||
155028236|NCT02892422|559528657|FG000|Overall Study|Enrolled not treated|4|||
155140102|NCT02652156|559944395|FG002|Overall Study|Physician Decision|0|||
155028237|NCT02892422|559528657|FG000|Overall Study|Adverse Event|38|||
155028238|NCT02892422|559528657|FG000|Overall Study|Lack of Efficacy|32|||
155028239|NCT02892422|559528657|FG000|Overall Study|Non-compliance with study drug|11|||
155028240|NCT02892422|559528657|FG000|Overall Study|Protocol Violation|4|||
155028241|NCT02892422|559528657|FG000|Overall Study|Withdrawal by Subject|56|||
155028242|NCT02892422|559528657|FG000|Overall Study|Lost to Follow-up|5|||
155028243|NCT02892422|559528657|FG000|Overall Study|sponsor information 16159A results|21|||
155028244|NCT02892422|559528657|FG000|Overall Study|withdrawal of consent|13|||
155028245|NCT02892422|559528657|FG000|Overall Study|exclusion criteria met|3|||
155028246|NCT02892422|559528657|FG000|Overall Study|moving elsewhere|4|||
155028247|NCT02892422|559528657|FG000|Overall Study|non-compliance|10|||
155028248|NCT02892422|559528657|FG000|Overall Study|patient legally incapable|1|||
155028249|NCT02892422|559528657|FG000|Overall Study|patient decision|7|||
155028250|NCT02892422|559528657|FG000|Overall Study|Investigator decision|1|||
155028251|NCT02855359|559528660|FG000|Overall Study|Death|2|||
155028252|NCT02855359|559528661|FG001|Overall Study|Death|2|||
155028253|NCT02855359|559528662|FG002|Overall Study|Death|0|||
155028254|NCT02855359|559528663|FG003|Overall Study|Death|0|||
155028255|NCT02855359|559528660|FG000|Overall Study|Study Termination by Sponsor|9|||
155028256|NCT02855359|559528661|FG001|Overall Study|Study Termination by Sponsor|11|||
155028257|NCT02855359|559528662|FG002|Overall Study|Study Termination by Sponsor|0|||
155028258|NCT02855359|559528663|FG003|Overall Study|Study Termination by Sponsor|0|||
155028259|NCT01023256|559528664|FG000|Overall Study|Protocol Violation|2|||
155028260|NCT01023256|559528665|FG001|Overall Study|Protocol Violation|3|||
155028261|NCT01023256|559528666|FG002|Overall Study|Protocol Violation|0|||
155028262|NCT01023256|559528667|FG003|Overall Study|Protocol Violation|0|||
155028263|NCT01023256|559528664|FG000|Overall Study|Randomized but not treated|1|||
155028264|NCT01023256|559528665|FG001|Overall Study|Randomized but not treated|0|||
155028265|NCT01023256|559528666|FG002|Overall Study|Randomized but not treated|1|||
155028266|NCT01023256|559528667|FG003|Overall Study|Randomized but not treated|0|||
155028267|NCT01023256|559528664|FG000|Overall Study|Other|1|||
155028268|NCT01023256|559528665|FG001|Overall Study|Other|0|||
155028269|NCT01023256|559528666|FG002|Overall Study|Other|0|||
155028270|NCT01023256|559528667|FG003|Overall Study|Other|2|||
155028271|NCT01023256|559528664|FG000|Overall Study|Adverse Event|0|||
155028272|NCT01023256|559528665|FG001|Overall Study|Adverse Event|0|||
155028273|NCT01023256|559528666|FG002|Overall Study|Adverse Event|0|||
155028274|NCT01023256|559528667|FG003|Overall Study|Adverse Event|1|||
155028275|NCT01023256|559528664|FG000|Overall Study|Withdrawal by Subject|0|||
155028276|NCT01023256|559528665|FG001|Overall Study|Withdrawal by Subject|0|||
155028277|NCT01023256|559528666|FG002|Overall Study|Withdrawal by Subject|0|||
155028278|NCT01023256|559528667|FG003|Overall Study|Withdrawal by Subject|2|||
155028279|NCT01646021|559528668|FG000|Overall Study|Death|77|||
155028280|NCT01646021|559528669|FG001|Overall Study|Death|83|||
155028281|NCT01646021|559528668|FG000|Overall Study|Study Terminated by Sponsor|50|||
155028282|NCT01646021|559528669|FG001|Overall Study|Study Terminated by Sponsor|41|||
155028283|NCT01646021|559528668|FG000|Overall Study|Lost to Follow-up|2|||
155028284|NCT01646021|559528669|FG001|Overall Study|Lost to Follow-up|2|||
155028285|NCT01646021|559528668|FG000|Overall Study|Withdrawal by Subject|10|||
155028286|NCT01646021|559528669|FG001|Overall Study|Withdrawal by Subject|15|||
155028287|NCT00725608|559528672|FG000|Overall Study|Lost to Follow-up|60|||
155028288|NCT00725608|559528672|FG000|Overall Study|Adverse Event|14|||
155028289|NCT00725608|559528672|FG000|Overall Study|Individual reasons|86|||
155028290|NCT00725608|559528672|FG000|Overall Study|Other|7|||
155028291|NCT01154088|559528673|FG000|Overall Study|Lost to Follow-up|4|||
155028292|NCT01154088|559528674|FG001|Overall Study|Lost to Follow-up|6|||
155028293|NCT01154088|559528675|FG002|Overall Study|Lost to Follow-up|7|||
155028294|NCT05129137|559528676|FG000|Second Period|Adverse Event|1|||
155028295|NCT05129137|559528677|FG001|Second Period|Adverse Event|0|||
155028296|NCT05129137|559528678|FG002|Second Period|Adverse Event|0|||
155028297|NCT05129137|559528679|FG003|Second Period|Adverse Event|0|||
155028298|NCT05129137|559528676|FG000|Second Period|Protocol Violation|0|||
155028299|NCT05129137|559528677|FG001|Second Period|Protocol Violation|0|||
155028300|NCT05129137|559528678|FG002|Second Period|Protocol Violation|0|||
155028301|NCT05129137|559528679|FG003|Second Period|Protocol Violation|1|||
155028302|NCT05129137|559528676|FG000|Third Period|Protocol Violation|0|||
155028303|NCT05129137|559528677|FG001|Third Period|Protocol Violation|0|||
155028304|NCT05129137|559528678|FG002|Third Period|Protocol Violation|0|||
155028305|NCT05129137|559528679|FG003|Third Period|Protocol Violation|1|||
155028306|NCT05129137|559528676|FG000|Forth Period|Protocol Violation|0|||
155028307|NCT05129137|559528677|FG001|Forth Period|Protocol Violation|1|||
155028308|NCT05129137|559528678|FG002|Forth Period|Protocol Violation|0|||
155028309|NCT05129137|559528679|FG003|Forth Period|Protocol Violation|0|||
155028310|NCT05129137|559528676|FG000|Forth Period|Withdrawal by Subject|0|||
155028311|NCT05129137|559528677|FG001|Forth Period|Withdrawal by Subject|0|||
155028312|NCT05129137|559528678|FG002|Forth Period|Withdrawal by Subject|1|||
155028313|NCT05129137|559528679|FG003|Forth Period|Withdrawal by Subject|0|||
155028314|NCT02447497|559528680|FG000|Overall Study|Did not meet treatment day baseline.|6|||
155028315|NCT02447497|559528681|FG001|Overall Study|Did not meet treatment day baseline.|5|||
155028316|NCT02447497|559528682|FG002|Overall Study|Did not meet treatment day baseline.|2|||
155028317|NCT02447497|559528683|FG003|Overall Study|Did not meet treatment day baseline.|2|||
155028318|NCT02447497|559528680|FG000|Overall Study|Dressing was compromised|0|||
155028319|NCT02447497|559528681|FG001|Overall Study|Dressing was compromised|1|||
155028320|NCT02447497|559528682|FG002|Overall Study|Dressing was compromised|0|||
155028321|NCT02447497|559528683|FG003|Overall Study|Dressing was compromised|0|||
155028322|NCT00979420|559528684|FG000|Overall Study|Adverse Event|1|||
155028323|NCT00979420|559528685|FG001|Overall Study|Adverse Event|0|||
155028324|NCT00979420|559528686|FG002|Overall Study|Adverse Event|0|||
155028325|NCT00979420|559528687|FG003|Overall Study|Adverse Event|0|||
155028326|NCT00979420|559528684|FG000|Overall Study|Lack of Efficacy|3|||
155028327|NCT00979420|559528685|FG001|Overall Study|Lack of Efficacy|0|||
155028328|NCT00979420|559528686|FG002|Overall Study|Lack of Efficacy|1|||
155028329|NCT00979420|559528687|FG003|Overall Study|Lack of Efficacy|1|||
155028330|NCT00979420|559528684|FG000|Overall Study|Other reasons not related to Viramune|3|||
155028331|NCT00979420|559528685|FG001|Overall Study|Other reasons not related to Viramune|0|||
155028332|NCT00979420|559528686|FG002|Overall Study|Other reasons not related to Viramune|0|||
155028333|NCT00979420|559528687|FG003|Overall Study|Other reasons not related to Viramune|1|||
155028334|NCT01668173|559528700|FG000|Overall Study|Adverse Event|3|||
155028335|NCT01668173|559528700|FG000|Overall Study|Trial suspension|4|||
155028336|NCT01295827|559528703|FG000|Overall Study|Adverse Event|1|||
155028337|NCT01295827|559528704|FG001|Overall Study|Adverse Event|2|||
155028338|NCT01295827|559528705|FG002|Overall Study|Adverse Event|2|||
155028339|NCT01295827|559528706|FG003|Overall Study|Adverse Event|1|||
155028340|NCT01295827|559528707|FG004|Overall Study|Adverse Event|1|||
155028341|NCT01295827|559528708|FG005|Overall Study|Adverse Event|4|||
155028342|NCT01295827|559528709|FG006|Overall Study|Adverse Event|15|||
155028343|NCT01295827|559528710|FG007|Overall Study|Adverse Event|49|||
155028344|NCT01295827|559528711|FG008|Overall Study|Adverse Event|22|||
155028345|NCT01295827|559528712|FG009|Overall Study|Adverse Event|7|||
155028346|NCT01295827|559528713|FG010|Overall Study|Adverse Event|50|||
155028347|NCT01295827|559528714|FG011|Overall Study|Adverse Event|21|||
155028348|NCT01295827|559528715|FG012|Overall Study|Adverse Event|0|||
155028349|NCT01295827|559528716|FG013|Overall Study|Adverse Event|0|||
155028350|NCT01295827|559528717|FG014|Overall Study|Adverse Event|0|||
155028351|NCT01295827|559528703|FG000|Overall Study|Lost to Follow-up|0|||
155028352|NCT01295827|559528704|FG001|Overall Study|Lost to Follow-up|0|||
155028353|NCT01295827|559528705|FG002|Overall Study|Lost to Follow-up|3|||
155028354|NCT01295827|559528706|FG003|Overall Study|Lost to Follow-up|0|||
155028355|NCT01295827|559528707|FG004|Overall Study|Lost to Follow-up|1|||
155028356|NCT01295827|559528708|FG005|Overall Study|Lost to Follow-up|0|||
155028357|NCT01295827|559528709|FG006|Overall Study|Lost to Follow-up|4|||
155028358|NCT01295827|559528710|FG007|Overall Study|Lost to Follow-up|8|||
155028359|NCT01295827|559528711|FG008|Overall Study|Lost to Follow-up|7|||
155028360|NCT01295827|559528712|FG009|Overall Study|Lost to Follow-up|4|||
155028361|NCT01295827|559528713|FG010|Overall Study|Lost to Follow-up|7|||
155028362|NCT01295827|559528714|FG011|Overall Study|Lost to Follow-up|3|||
155028363|NCT01295827|559528715|FG012|Overall Study|Lost to Follow-up|0|||
155028364|NCT01295827|559528716|FG013|Overall Study|Lost to Follow-up|0|||
155028365|NCT01295827|559528717|FG014|Overall Study|Lost to Follow-up|0|||
155028366|NCT01295827|559528703|FG000|Overall Study|Not Reported|0|||
155028367|NCT01295827|559528704|FG001|Overall Study|Not Reported|0|||
155028368|NCT01295827|559528705|FG002|Overall Study|Not Reported|0|||
155028369|NCT01295827|559528706|FG003|Overall Study|Not Reported|1|||
155028370|NCT01295827|559528707|FG004|Overall Study|Not Reported|0|||
155028371|NCT01295827|559528708|FG005|Overall Study|Not Reported|0|||
155028372|NCT01295827|559528709|FG006|Overall Study|Not Reported|24|||
155028373|NCT01295827|559528710|FG007|Overall Study|Not Reported|58|||
155028374|NCT01295827|559528711|FG008|Overall Study|Not Reported|41|||
155028375|NCT01295827|559528712|FG009|Overall Study|Not Reported|2|||
155028376|NCT01295827|559528713|FG010|Overall Study|Not Reported|23|||
155181458|NCT02038829|560103088|FG010|Treatment Period 2|Withdrawal by Subject|0|||
155028377|NCT01295827|559528714|FG011|Overall Study|Not Reported|13|||
155028378|NCT01295827|559528715|FG012|Overall Study|Not Reported|0|||
155028379|NCT01295827|559528716|FG013|Overall Study|Not Reported|0|||
155028380|NCT01295827|559528717|FG014|Overall Study|Not Reported|0|||
155028381|NCT01295827|559528703|FG000|Overall Study|Progressive Disease|2|||
155028382|NCT01295827|559528704|FG001|Overall Study|Progressive Disease|1|||
155181459|NCT02038829|560103089|FG011|Treatment Period 2|Withdrawal by Subject|0|||
155028383|NCT01295827|559528705|FG002|Overall Study|Progressive Disease|5|||
155028384|NCT01295827|559528706|FG003|Overall Study|Progressive Disease|2|||
155028385|NCT01295827|559528707|FG004|Overall Study|Progressive Disease|0|||
155028386|NCT01295827|559528708|FG005|Overall Study|Progressive Disease|1|||
155028387|NCT01295827|559528709|FG006|Overall Study|Progressive Disease|87|||
155028388|NCT01295827|559528710|FG007|Overall Study|Progressive Disease|144|||
155028389|NCT01295827|559528711|FG008|Overall Study|Progressive Disease|85|||
155028390|NCT01295827|559528712|FG009|Overall Study|Progressive Disease|40|||
155028391|NCT01295827|559528713|FG010|Overall Study|Progressive Disease|175|||
155028392|NCT01295827|559528714|FG011|Overall Study|Progressive Disease|136|||
155028393|NCT01295827|559528715|FG012|Overall Study|Progressive Disease|0|||
155028394|NCT01295827|559528716|FG013|Overall Study|Progressive Disease|0|||
155028395|NCT01295827|559528717|FG014|Overall Study|Progressive Disease|0|||
155028396|NCT01295827|559528703|FG000|Overall Study|Screen Failure|0|||
155028397|NCT01295827|559528704|FG001|Overall Study|Screen Failure|0|||
155028398|NCT01295827|559528705|FG002|Overall Study|Screen Failure|0|||
155028399|NCT01295827|559528706|FG003|Overall Study|Screen Failure|0|||
155028400|NCT01295827|559528707|FG004|Overall Study|Screen Failure|0|||
155028401|NCT01295827|559528708|FG005|Overall Study|Screen Failure|0|||
155028402|NCT01295827|559528709|FG006|Overall Study|Screen Failure|2|||
155028403|NCT01295827|559528710|FG007|Overall Study|Screen Failure|2|||
155028404|NCT01295827|559528711|FG008|Overall Study|Screen Failure|2|||
155028405|NCT01295827|559528712|FG009|Overall Study|Screen Failure|0|||
155028406|NCT01295827|559528713|FG010|Overall Study|Screen Failure|1|||
155028407|NCT01295827|559528714|FG011|Overall Study|Screen Failure|0|||
155028408|NCT01295827|559528715|FG012|Overall Study|Screen Failure|0|||
155028409|NCT01295827|559528716|FG013|Overall Study|Screen Failure|0|||
155028410|NCT01295827|559528717|FG014|Overall Study|Screen Failure|0|||
155028411|NCT01295827|559528703|FG000|Overall Study|Withdrawal by Subject|1|||
155028412|NCT01295827|559528704|FG001|Overall Study|Withdrawal by Subject|0|||
155028413|NCT01295827|559528705|FG002|Overall Study|Withdrawal by Subject|2|||
155028414|NCT01295827|559528706|FG003|Overall Study|Withdrawal by Subject|0|||
155028415|NCT01295827|559528707|FG004|Overall Study|Withdrawal by Subject|0|||
155028416|NCT01295827|559528708|FG005|Overall Study|Withdrawal by Subject|1|||
155028417|NCT01295827|559528709|FG006|Overall Study|Withdrawal by Subject|13|||
155028418|NCT01295827|559528710|FG007|Overall Study|Withdrawal by Subject|35|||
155028419|NCT01295827|559528711|FG008|Overall Study|Withdrawal by Subject|11|||
155028420|NCT01295827|559528712|FG009|Overall Study|Withdrawal by Subject|2|||
155028421|NCT01295827|559528713|FG010|Overall Study|Withdrawal by Subject|18|||
155028422|NCT01295827|559528714|FG011|Overall Study|Withdrawal by Subject|13|||
155028423|NCT01295827|559528715|FG012|Overall Study|Withdrawal by Subject|0|||
155028424|NCT01295827|559528716|FG013|Overall Study|Withdrawal by Subject|0|||
155028425|NCT01295827|559528717|FG014|Overall Study|Withdrawal by Subject|0|||
155028426|NCT01295827|559528703|FG000|Overall Study|Other|0|||
155028427|NCT01295827|559528704|FG001|Overall Study|Other|0|||
155028428|NCT01295827|559528705|FG002|Overall Study|Other|0|||
155028429|NCT01295827|559528706|FG003|Overall Study|Other|0|||
155028430|NCT01295827|559528707|FG004|Overall Study|Other|0|||
155028431|NCT01295827|559528708|FG005|Overall Study|Other|0|||
155028432|NCT01295827|559528709|FG006|Overall Study|Other|1|||
155028433|NCT01295827|559528710|FG007|Overall Study|Other|1|||
155028434|NCT01295827|559528711|FG008|Overall Study|Other|1|||
155028435|NCT01295827|559528712|FG009|Overall Study|Other|0|||
155028436|NCT01295827|559528713|FG010|Overall Study|Other|2|||
155028437|NCT01295827|559528714|FG011|Overall Study|Other|0|||
155028438|NCT01295827|559528715|FG012|Overall Study|Other|0|||
155028439|NCT01295827|559528716|FG013|Overall Study|Other|0|||
155028440|NCT01295827|559528717|FG014|Overall Study|Other|0|||
155028441|NCT00746564|559528718|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
155028442|NCT00022698|559528719|FG000|Overall Study|Adverse Event|5|||
155028443|NCT00022698|559528720|FG001|Overall Study|Adverse Event|9|||
155028444|NCT00022698|559528719|FG000|Overall Study|Death|0|||
155028445|NCT00022698|559528720|FG001|Overall Study|Death|2|||
155028446|NCT00022698|559528719|FG000|Overall Study|Failure to return|0|||
155028447|NCT00022698|559528720|FG001|Overall Study|Failure to return|1|||
155028448|NCT00022698|559528719|FG000|Overall Study|Refused treatment|0|||
155028449|NCT00022698|559528720|FG001|Overall Study|Refused treatment|2|||
155028450|NCT00022698|559528719|FG000|Overall Study|Insufficient therapeutic response|2|||
155028451|NCT00022698|559528720|FG001|Overall Study|Insufficient therapeutic response|14|||
155028452|NCT00022698|559528719|FG000|Overall Study|Administrative /other|1|||
155028453|NCT00022698|559528720|FG001|Overall Study|Administrative /other|7|||
155028454|NCT01217476|559528727|FG000|Overall Study|Adverse Event|6|||
155028455|NCT01217476|559528728|FG001|Overall Study|Adverse Event|1|||
155028456|NCT01217476|559528727|FG000|Overall Study|Physician Decision|0|||
155028457|NCT01217476|559528728|FG001|Overall Study|Physician Decision|1|||
155028458|NCT01217476|559528727|FG000|Overall Study|Withdrawal by Subject|3|||
155028459|NCT01217476|559528728|FG001|Overall Study|Withdrawal by Subject|3|||
155028460|NCT01217476|559528727|FG000|Overall Study|Surgery on the Target Limb|0|||
155028461|NCT01217476|559528728|FG001|Overall Study|Surgery on the Target Limb|2|||
155028462|NCT01217476|559528727|FG000|Overall Study|Protocol Deviation|1|||
155028463|NCT01217476|559528728|FG001|Overall Study|Protocol Deviation|0|||
155028464|NCT01217476|559528727|FG000|Overall Study|Other|2|||
155028465|NCT01217476|559528728|FG001|Overall Study|Other|0|||
155028466|NCT00813813|559528733|FG000|Overall Study|Withdrawal by Subject|1|||
155028467|NCT00813813|559528734|FG001|Overall Study|Withdrawal by Subject|1|||
155181460|NCT02038829|560103078|FG000|Washout Period 2|Adverse Event|0|||
155028468|NCT00813813|559528733|FG000|Overall Study|Lost to Follow-up|2|||
155028469|NCT00813813|559528734|FG001|Overall Study|Lost to Follow-up|7|||
155028470|NCT00813813|559528733|FG000|Overall Study|Other|0|||
155028471|NCT00813813|559528734|FG001|Overall Study|Other|1|||
155028472|NCT00986921|559528735|FG000|Overall Study|Physician Decision|1|||
155028473|NCT00986921|559528736|FG001|Overall Study|Physician Decision|0|||
155028474|NCT01758731|559528737|FG000|Overall Study|Physician Decision|1|||
155028475|NCT03030989|559530601|FG000|Overall Study|Fever|2|||
155028476|NCT03030989|559530602|FG001|Overall Study|Fever|2|||
155028477|NCT03030989|559530601|FG000|Overall Study|Rash|2|||
155028478|NCT03030989|559530602|FG001|Overall Study|Rash|1|||
155028479|NCT03030989|559530601|FG000|Overall Study|Fatigue/Overwhelmed|1|||
155028480|NCT03030989|559530602|FG001|Overall Study|Fatigue/Overwhelmed|5|||
155028481|NCT03030989|559530601|FG000|Overall Study|Positive Blood Cultures|2|||
155028482|NCT03030989|559530602|FG001|Overall Study|Positive Blood Cultures|1|||
155028483|NCT03030989|559530601|FG000|Overall Study|Line Removed|0|||
155028484|NCT03030989|559530602|FG001|Overall Study|Line Removed|2|||
155028485|NCT03030989|559530601|FG000|Overall Study|No longer interested|5|||
155028486|NCT03030989|559530602|FG001|Overall Study|No longer interested|3|||
155028487|NCT02730377|559530603|FG000|Overall Study|Other|5|||
155028488|NCT02730377|559530604|FG001|Overall Study|Other|4|||
155028489|NCT02730377|559530603|FG000|Overall Study|Death|1|||
155028490|NCT02730377|559530604|FG001|Overall Study|Death|8|||
155028491|NCT02730377|559530603|FG000|Overall Study|Inadequate glycaemic control|368|||
155028492|NCT02730377|559530604|FG001|Overall Study|Inadequate glycaemic control|473|||
155028493|NCT02730377|559530603|FG000|Overall Study|Adverse Event|79|||
155028494|NCT02730377|559530604|FG001|Overall Study|Adverse Event|41|||
155028495|NCT02730377|559530603|FG000|Overall Study|Protocol Violation|23|||
155028496|NCT02730377|559530604|FG001|Overall Study|Protocol Violation|30|||
155028497|NCT02730377|559530603|FG000|Overall Study|Lack of Efficacy|4|||
155028498|NCT02730377|559530604|FG001|Overall Study|Lack of Efficacy|13|||
155028499|NCT02730377|559530603|FG000|Overall Study|Pregnancy|0|||
155028500|NCT02730377|559530604|FG001|Overall Study|Pregnancy|1|||
155028501|NCT02730377|559530603|FG000|Overall Study|Withdrawal by Subject|45|||
155028502|NCT02730377|559530604|FG001|Overall Study|Withdrawal by Subject|42|||
155028503|NCT02730377|559530603|FG000|Overall Study|Lost to Follow-up|25|||
155028504|NCT02730377|559530604|FG001|Overall Study|Lost to Follow-up|21|||
155028505|NCT03917472|559530605|FG000|Overall Study|Physician Decision|4|||
155028506|NCT03917472|559530606|FG001|Overall Study|Physician Decision|0|||
155028507|NCT03917472|559530605|FG000|Overall Study|Adverse Event|3|||
155028508|NCT03917472|559530606|FG001|Overall Study|Adverse Event|1|||
155028509|NCT03917472|559530605|FG000|Overall Study|Death|7|||
155028510|NCT03917472|559530606|FG001|Overall Study|Death|5|||
155028511|NCT03917472|559530605|FG000|Overall Study|Withdrawal by Subject|11|||
155028512|NCT03917472|559530606|FG001|Overall Study|Withdrawal by Subject|4|||
155028513|NCT03917472|559530605|FG000|Overall Study|Lost to Follow-up|10|||
155028514|NCT03917472|559530606|FG001|Overall Study|Lost to Follow-up|5|||
155028515|NCT02706886|559530607|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
155028516|NCT02706886|559530608|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
155028517|NCT02706886|559530609|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
155028518|NCT02706886|559530610|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
155028519|NCT02706886|559530611|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
155028520|NCT02706886|559530612|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
155028521|NCT02706886|559530613|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
155028522|NCT02706886|559530614|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
155028523|NCT02706886|559530615|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
155028524|NCT01154296|559530616|FG000|Randomization and Intervention|Decided to decline|1|||
155028525|NCT01154296|559530617|FG001|Randomization and Intervention|Decided to decline|1|||
155028526|NCT01154296|559530616|FG000|Randomization and Intervention|Declined by staff|1|||
155028527|NCT01154296|559530617|FG001|Randomization and Intervention|Declined by staff|0|||
155028528|NCT01154296|559530616|FG000|Randomization and Intervention|Did not return|1|||
155028529|NCT01154296|559530617|FG001|Randomization and Intervention|Did not return|0|||
155028530|NCT01154296|559530616|FG000|Randomization and Intervention|Left before test|0|||
155028531|NCT01154296|559530617|FG001|Randomization and Intervention|Left before test|1|||
155028532|NCT01154296|559530616|FG000|Randomization and Intervention|Left clinic early|2|||
155028533|NCT01154296|559530617|FG001|Randomization and Intervention|Left clinic early|0|||
155028534|NCT01154296|559530616|FG000|6-month Follow-up|Lost contact|269|||
155028535|NCT01154296|559530617|FG001|6-month Follow-up|Lost contact|275|||
155028536|NCT01154296|559530616|FG000|6-month Follow-up|Incarcerated|37|||
155028537|NCT01154296|559530617|FG001|6-month Follow-up|Incarcerated|32|||
155028538|NCT01154296|559530616|FG000|6-month Follow-up|Withdrew consent|14|||
155028539|NCT01154296|559530617|FG001|6-month Follow-up|Withdrew consent|15|||
155140103|NCT00496080|559944400|FG000|Overall Study|Lost to Follow-up|9|||
155140104|NCT00496080|559944400|FG000|Overall Study|Surgical re-intervention|7|||
155028540|NCT01154296|559530616|FG000|6-month Follow-up|Death|3|||
155028541|NCT01154296|559530617|FG001|6-month Follow-up|Death|2|||
155028542|NCT01154296|559530616|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
155028543|NCT01154296|559530617|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
155028544|NCT02203851|559530618|FG000|Overall Study|Lost to Follow-up|4|||
155028545|NCT02203851|559530618|FG000|Overall Study|Withdrawal by Subject|6|||
155028546|NCT02203851|559530618|FG000|Overall Study|Other|1|||
155028547|NCT04934189|559530619|FG000|Overall Study|Lost to Follow-up|4|||
155028548|NCT04934189|559530619|FG000|Overall Study|Withdrawal by Subject|17|||
155028549|NCT03320850|559530622|FG000|Overall Study|Lost to Follow-up|0|||
155028550|NCT03320850|559530623|FG001|Overall Study|Lost to Follow-up|0|||
155028551|NCT03320850|559530624|FG002|Overall Study|Lost to Follow-up|0|||
155028552|NCT03320850|559530625|FG003|Overall Study|Lost to Follow-up|0|||
155028553|NCT03320850|559530626|FG004|Overall Study|Lost to Follow-up|1|||
155028554|NCT03320850|559530627|FG005|Overall Study|Lost to Follow-up|2|||
155028555|NCT03320850|559530628|FG006|Overall Study|Lost to Follow-up|2|||
155028556|NCT03320850|559530629|FG007|Overall Study|Lost to Follow-up|0|||
155028557|NCT03320850|559530630|FG008|Overall Study|Lost to Follow-up|6|||
155028558|NCT03320850|559530631|FG009|Overall Study|Lost to Follow-up|4|||
155028559|NCT03320850|559530622|FG000|Overall Study|Withdrawal by Subject|0|||
155028560|NCT03320850|559530623|FG001|Overall Study|Withdrawal by Subject|0|||
155028561|NCT03320850|559530624|FG002|Overall Study|Withdrawal by Subject|0|||
155028562|NCT03320850|559530625|FG003|Overall Study|Withdrawal by Subject|0|||
155028563|NCT03320850|559530626|FG004|Overall Study|Withdrawal by Subject|1|||
155028564|NCT03320850|559530627|FG005|Overall Study|Withdrawal by Subject|2|||
155028565|NCT03320850|559530628|FG006|Overall Study|Withdrawal by Subject|4|||
155028566|NCT03320850|559530629|FG007|Overall Study|Withdrawal by Subject|5|||
155028567|NCT03320850|559530630|FG008|Overall Study|Withdrawal by Subject|2|||
155028568|NCT03320850|559530631|FG009|Overall Study|Withdrawal by Subject|1|||
155028569|NCT03320850|559530622|FG000|Overall Study|Lack of Efficacy|0|||
155181461|NCT02038829|560103079|FG001|Washout Period 2|Adverse Event|0|||
155181462|NCT02038829|560103080|FG002|Washout Period 2|Adverse Event|0|||
155181463|NCT02038829|560103081|FG003|Washout Period 2|Adverse Event|0|||
155181464|NCT02038829|560103082|FG004|Washout Period 2|Adverse Event|0|||
155028570|NCT03320850|559530623|FG001|Overall Study|Lack of Efficacy|0|||
155028571|NCT03320850|559530624|FG002|Overall Study|Lack of Efficacy|0|||
155028572|NCT03320850|559530625|FG003|Overall Study|Lack of Efficacy|1|||
155028573|NCT03320850|559530626|FG004|Overall Study|Lack of Efficacy|0|||
155028574|NCT03320850|559530627|FG005|Overall Study|Lack of Efficacy|1|||
155028575|NCT03320850|559530628|FG006|Overall Study|Lack of Efficacy|0|||
155028576|NCT03320850|559530629|FG007|Overall Study|Lack of Efficacy|2|||
155028577|NCT03320850|559530630|FG008|Overall Study|Lack of Efficacy|0|||
155028578|NCT03320850|559530631|FG009|Overall Study|Lack of Efficacy|3|||
155028579|NCT03320850|559530622|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
155028580|NCT03320850|559530623|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
155028581|NCT03320850|559530624|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
155028582|NCT03320850|559530625|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
155028583|NCT03320850|559530626|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
155028584|NCT03320850|559530627|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
155028585|NCT03320850|559530628|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
155028586|NCT03320850|559530629|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
155028587|NCT03320850|559530630|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
155028588|NCT03320850|559530631|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
155028589|NCT03320850|559530622|FG000|Overall Study|Adverse Event|0|||
155028590|NCT03320850|559530623|FG001|Overall Study|Adverse Event|0|||
155028591|NCT03320850|559530624|FG002|Overall Study|Adverse Event|0|||
155028592|NCT03320850|559530625|FG003|Overall Study|Adverse Event|0|||
155028593|NCT03320850|559530626|FG004|Overall Study|Adverse Event|0|||
155028594|NCT03320850|559530627|FG005|Overall Study|Adverse Event|2|||
155028595|NCT03320850|559530628|FG006|Overall Study|Adverse Event|1|||
155028596|NCT03320850|559530629|FG007|Overall Study|Adverse Event|0|||
155028597|NCT03320850|559530630|FG008|Overall Study|Adverse Event|2|||
155028598|NCT03320850|559530631|FG009|Overall Study|Adverse Event|0|||
155028599|NCT03320850|559530622|FG000|Overall Study|Reason Not Specified|0|||
155028600|NCT03320850|559530623|FG001|Overall Study|Reason Not Specified|0|||
155028601|NCT03320850|559530624|FG002|Overall Study|Reason Not Specified|0|||
155028602|NCT03320850|559530625|FG003|Overall Study|Reason Not Specified|0|||
155028603|NCT03320850|559530626|FG004|Overall Study|Reason Not Specified|0|||
155028604|NCT03320850|559530627|FG005|Overall Study|Reason Not Specified|1|||
155028605|NCT03320850|559530628|FG006|Overall Study|Reason Not Specified|0|||
155028606|NCT03320850|559530629|FG007|Overall Study|Reason Not Specified|0|||
155028607|NCT03320850|559530630|FG008|Overall Study|Reason Not Specified|0|||
155028608|NCT03320850|559530631|FG009|Overall Study|Reason Not Specified|1|||
155028609|NCT01871402|559530641|FG000|Overall Study|Lost to Follow-up|1|||
155028610|NCT01871402|559530642|FG001|Overall Study|Lost to Follow-up|0|||
155028611|NCT01871402|559530641|FG000|Overall Study|Withdrawal by Subject|0|||
155028612|NCT01871402|559530642|FG001|Overall Study|Withdrawal by Subject|2|||
155181465|NCT02038829|560103083|FG005|Washout Period 2|Adverse Event|0|||
155181466|NCT02038829|560103084|FG006|Washout Period 2|Adverse Event|0|||
155181467|NCT02038829|560103085|FG007|Washout Period 2|Adverse Event|0|||
155028613|NCT01871402|559530641|FG000|Overall Study|Non-compliance|0|||
155028614|NCT01871402|559530642|FG001|Overall Study|Non-compliance|1|||
155028615|NCT04594941|559530643|FG000|Overall Study|Other|0|||
155028616|NCT04594941|559530644|FG001|Overall Study|Other|3|||
155028617|NCT04594941|559530645|FG002|Overall Study|Other|1|||
155028618|NCT04594941|559530646|FG003|Overall Study|Other|0|||
155028619|NCT00231114|559530647|FG000|Randomized|Withdrawal by Subject|6|||
155028620|NCT00231114|559530648|FG001|Randomized|Withdrawal by Subject|3|||
155028621|NCT00231114|559530647|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
155028622|NCT00231114|559530648|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
155028623|NCT00231114|559530647|FG000|Post-Treatment Period|Lost to Follow-up|6|||
155028624|NCT00231114|559530648|FG001|Post-Treatment Period|Lost to Follow-up|1|||
155028625|NCT00231114|559530647|FG000|Post-Treatment Period|Physician Decision|1|||
155028626|NCT00231114|559530648|FG001|Post-Treatment Period|Physician Decision|0|||
155028627|NCT00231114|559530647|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
155028628|NCT00231114|559530648|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
155028629|NCT02031640|559530650|FG000|Screening Period|Adverse Event|1|||
155028630|NCT02031640|559530651|FG001|Screening Period|Adverse Event|0|||
155028631|NCT02031640|559530652|FG002|Screening Period|Adverse Event|0|||
155028632|NCT02031640|559530653|FG003|Screening Period|Adverse Event|0|||
155028633|NCT02031640|559530654|FG004|Screening Period|Adverse Event|0|||
155028634|NCT02031640|559530655|FG005|Screening Period|Adverse Event|0|||
155028635|NCT02031640|559530650|FG000|Screening Period|Withdrawal by Subject|29|||
155028636|NCT02031640|559530651|FG001|Screening Period|Withdrawal by Subject|0|||
155028637|NCT02031640|559530652|FG002|Screening Period|Withdrawal by Subject|0|||
155028638|NCT02031640|559530653|FG003|Screening Period|Withdrawal by Subject|0|||
155028639|NCT02031640|559530654|FG004|Screening Period|Withdrawal by Subject|0|||
155028640|NCT02031640|559530655|FG005|Screening Period|Withdrawal by Subject|0|||
155028641|NCT02031640|559530650|FG000|Screening Period|Inclusion criteria not met|312|||
155028642|NCT02031640|559530651|FG001|Screening Period|Inclusion criteria not met|0|||
155028643|NCT02031640|559530652|FG002|Screening Period|Inclusion criteria not met|0|||
155028644|NCT02031640|559530653|FG003|Screening Period|Inclusion criteria not met|0|||
155028645|NCT02031640|559530654|FG004|Screening Period|Inclusion criteria not met|0|||
155028646|NCT02031640|559530655|FG005|Screening Period|Inclusion criteria not met|0|||
155028647|NCT02031640|559530650|FG000|Screening Period|Exclusion criteria met|30|||
155028648|NCT02031640|559530651|FG001|Screening Period|Exclusion criteria met|0|||
155028649|NCT02031640|559530652|FG002|Screening Period|Exclusion criteria met|0|||
155028650|NCT02031640|559530653|FG003|Screening Period|Exclusion criteria met|0|||
155028651|NCT02031640|559530654|FG004|Screening Period|Exclusion criteria met|0|||
155028652|NCT02031640|559530655|FG005|Screening Period|Exclusion criteria met|0|||
155028653|NCT02031640|559530650|FG000|Screening Period|Lost to Follow-up|14|||
155028654|NCT02031640|559530651|FG001|Screening Period|Lost to Follow-up|0|||
155028655|NCT02031640|559530652|FG002|Screening Period|Lost to Follow-up|0|||
155028656|NCT02031640|559530653|FG003|Screening Period|Lost to Follow-up|0|||
155028657|NCT02031640|559530654|FG004|Screening Period|Lost to Follow-up|0|||
155028658|NCT02031640|559530655|FG005|Screening Period|Lost to Follow-up|0|||
155028659|NCT02031640|559530650|FG000|Screening Period|Enrollment closed|26|||
155028660|NCT02031640|559530651|FG001|Screening Period|Enrollment closed|0|||
155028661|NCT02031640|559530652|FG002|Screening Period|Enrollment closed|0|||
155028662|NCT02031640|559530653|FG003|Screening Period|Enrollment closed|0|||
155028663|NCT02031640|559530654|FG004|Screening Period|Enrollment closed|0|||
155028664|NCT02031640|559530655|FG005|Screening Period|Enrollment closed|0|||
155028665|NCT02031640|559530650|FG000|Run-In Period|Adverse Event|4|||
155028666|NCT02031640|559530651|FG001|Run-In Period|Adverse Event|0|||
155028667|NCT02031640|559530652|FG002|Run-In Period|Adverse Event|0|||
155028668|NCT02031640|559530653|FG003|Run-In Period|Adverse Event|0|||
155028669|NCT02031640|559530654|FG004|Run-In Period|Adverse Event|0|||
155028670|NCT02031640|559530655|FG005|Run-In Period|Adverse Event|0|||
155028671|NCT02031640|559530650|FG000|Run-In Period|Withdrawal by Subject|17|||
155028672|NCT02031640|559530651|FG001|Run-In Period|Withdrawal by Subject|0|||
155028673|NCT02031640|559530652|FG002|Run-In Period|Withdrawal by Subject|0|||
155028674|NCT02031640|559530653|FG003|Run-In Period|Withdrawal by Subject|0|||
155028675|NCT02031640|559530654|FG004|Run-In Period|Withdrawal by Subject|0|||
155028676|NCT02031640|559530655|FG005|Run-In Period|Withdrawal by Subject|0|||
155028677|NCT02031640|559530650|FG000|Run-In Period|Inclusion criteria not met|38|||
155028678|NCT02031640|559530651|FG001|Run-In Period|Inclusion criteria not met|0|||
155028679|NCT02031640|559530652|FG002|Run-In Period|Inclusion criteria not met|0|||
155028680|NCT02031640|559530653|FG003|Run-In Period|Inclusion criteria not met|0|||
155028681|NCT02031640|559530654|FG004|Run-In Period|Inclusion criteria not met|0|||
155028682|NCT02031640|559530655|FG005|Run-In Period|Inclusion criteria not met|0|||
155028683|NCT02031640|559530650|FG000|Run-In Period|Exclusion criteria met|8|||
155028684|NCT02031640|559530651|FG001|Run-In Period|Exclusion criteria met|0|||
155028685|NCT02031640|559530652|FG002|Run-In Period|Exclusion criteria met|0|||
155028686|NCT02031640|559530653|FG003|Run-In Period|Exclusion criteria met|0|||
155028687|NCT02031640|559530654|FG004|Run-In Period|Exclusion criteria met|0|||
155028688|NCT02031640|559530655|FG005|Run-In Period|Exclusion criteria met|0|||
155028689|NCT02031640|559530650|FG000|Run-In Period|Randomization criteria not met|85|||
155028690|NCT02031640|559530651|FG001|Run-In Period|Randomization criteria not met|0|||
155028691|NCT02031640|559530652|FG002|Run-In Period|Randomization criteria not met|0|||
155028692|NCT02031640|559530653|FG003|Run-In Period|Randomization criteria not met|0|||
155028693|NCT02031640|559530654|FG004|Run-In Period|Randomization criteria not met|0|||
155028694|NCT02031640|559530655|FG005|Run-In Period|Randomization criteria not met|0|||
155028695|NCT02031640|559530650|FG000|Run-In Period|Various administrative reasons|17|||
155028696|NCT02031640|559530651|FG001|Run-In Period|Various administrative reasons|0|||
155028697|NCT02031640|559530652|FG002|Run-In Period|Various administrative reasons|0|||
155028698|NCT02031640|559530653|FG003|Run-In Period|Various administrative reasons|0|||
155028699|NCT02031640|559530654|FG004|Run-In Period|Various administrative reasons|0|||
155028700|NCT02031640|559530655|FG005|Run-In Period|Various administrative reasons|0|||
155028701|NCT02031640|559530650|FG000|Double-blind Treatment Period|Protocol deviation|0|||
155028702|NCT02031640|559530651|FG001|Double-blind Treatment Period|Protocol deviation|2|||
155028703|NCT02031640|559530652|FG002|Double-blind Treatment Period|Protocol deviation|0|||
155028704|NCT02031640|559530653|FG003|Double-blind Treatment Period|Protocol deviation|1|||
155028705|NCT02031640|559530654|FG004|Double-blind Treatment Period|Protocol deviation|3|||
155028706|NCT02031640|559530655|FG005|Double-blind Treatment Period|Protocol deviation|1|||
155028707|NCT02031640|559530650|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
155028708|NCT02031640|559530651|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
155028709|NCT02031640|559530652|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
155028710|NCT02031640|559530653|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
155028711|NCT02031640|559530654|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
155028712|NCT02031640|559530655|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
155028713|NCT02031640|559530650|FG000|Double-blind Treatment Period|Non-compliance|0|||
155028714|NCT02031640|559530651|FG001|Double-blind Treatment Period|Non-compliance|1|||
155028715|NCT02031640|559530652|FG002|Double-blind Treatment Period|Non-compliance|0|||
155028716|NCT02031640|559530653|FG003|Double-blind Treatment Period|Non-compliance|1|||
155028717|NCT02031640|559530654|FG004|Double-blind Treatment Period|Non-compliance|1|||
155028718|NCT02031640|559530655|FG005|Double-blind Treatment Period|Non-compliance|0|||
155028719|NCT02031640|559530650|FG000|Double-blind Treatment Period|Adverse Event|0|||
155028720|NCT02031640|559530651|FG001|Double-blind Treatment Period|Adverse Event|0|||
155028721|NCT02031640|559530652|FG002|Double-blind Treatment Period|Adverse Event|0|||
155028722|NCT02031640|559530653|FG003|Double-blind Treatment Period|Adverse Event|2|||
155028723|NCT02031640|559530654|FG004|Double-blind Treatment Period|Adverse Event|0|||
155028724|NCT02031640|559530655|FG005|Double-blind Treatment Period|Adverse Event|0|||
155028725|NCT02031640|559530650|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
155028726|NCT02031640|559530651|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
155028727|NCT02031640|559530652|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
155028728|NCT02031640|559530653|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
155028729|NCT02031640|559530654|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
155028730|NCT02031640|559530655|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
155028731|NCT02031640|559530650|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
155028732|NCT02031640|559530651|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
155028733|NCT02031640|559530652|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
155028734|NCT02031640|559530653|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
155028735|NCT02031640|559530654|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
155028736|NCT02031640|559530655|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
155028737|NCT02005692|559530658|FG000|Overall Study|Protocol Violation|1|||
155028738|NCT02005692|559530658|FG000|Overall Study|Withdrawal by Subject|1|||
155028739|NCT02005692|559530658|FG000|Overall Study|Discharged earlier than anticipated|5|||
155028740|NCT01895270|559530659|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
155028741|NCT01895270|559530660|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
155028742|NCT01895270|559530659|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
155028743|NCT01895270|559530660|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
155028744|NCT01895270|559530659|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
155028745|NCT01895270|559530660|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
155028746|NCT01895270|559530659|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
155028747|NCT01895270|559530660|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
155028748|NCT01895270|559530659|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
155028749|NCT01895270|559530660|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
155028750|NCT01895270|559530659|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
155028751|NCT01895270|559530660|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
155028752|NCT01895270|559530659|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
155028753|NCT01895270|559530660|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
155028754|NCT01194999|559530661|FG000|Overall Study|Lost to Follow-up|17|||
155028755|NCT02091375|559530664|FG000|Overall Study|Adverse Event|8|||
155028756|NCT02091375|559530665|FG001|Overall Study|Adverse Event|1|||
155028757|NCT02091375|559530664|FG000|Overall Study|Lost to Follow-up|0|||
155028758|NCT02091375|559530665|FG001|Overall Study|Lost to Follow-up|1|||
155028759|NCT02091375|559530664|FG000|Overall Study|Withdrawal by Subject|0|||
155028760|NCT02091375|559530665|FG001|Overall Study|Withdrawal by Subject|1|||
155140105|NCT00496080|559944400|FG000|Overall Study|Withdrawal by Subject|5|||
155140106|NCT00496080|559944400|FG000|Overall Study|Physician Decision|6|||
155028761|NCT02091375|559530664|FG000|Overall Study|Withdrawn by the investigator|1|||
155028762|NCT02091375|559530665|FG001|Overall Study|Withdrawn by the investigator|0|||
155028763|NCT02682823|559530667|FG000|Overall Study|Withdrawal by Subject|0|||
155028764|NCT02682823|559530668|FG001|Overall Study|Withdrawal by Subject|0|||
155028765|NCT02682823|559530669|FG002|Overall Study|Withdrawal by Subject|1|||
155028766|NCT02682823|559530670|FG003|Overall Study|Withdrawal by Subject|0|||
155028767|NCT02682823|559530671|FG004|Overall Study|Withdrawal by Subject|1|||
155028768|NCT02682823|559530667|FG000|Overall Study|Protocol Deviation|0|||
155028769|NCT02682823|559530668|FG001|Overall Study|Protocol Deviation|1|||
155028770|NCT02682823|559530669|FG002|Overall Study|Protocol Deviation|0|||
155028771|NCT02682823|559530670|FG003|Overall Study|Protocol Deviation|0|||
155028772|NCT02682823|559530671|FG004|Overall Study|Protocol Deviation|0|||
155028773|NCT02682823|559530667|FG000|Overall Study|Adverse Event|0|||
155028774|NCT02682823|559530668|FG001|Overall Study|Adverse Event|0|||
155028775|NCT02682823|559530669|FG002|Overall Study|Adverse Event|0|||
155028776|NCT02682823|559530670|FG003|Overall Study|Adverse Event|1|||
155028777|NCT02682823|559530671|FG004|Overall Study|Adverse Event|0|||
155028778|NCT05896527|559530672|FG000|Overall Study|Withdrawal by Subject|11|||
155028779|NCT05896527|559530673|FG001|Overall Study|Withdrawal by Subject|10|||
155028780|NCT05896527|559530674|FG002|Overall Study|Withdrawal by Subject|4|||
155028781|NCT05896527|559530675|FG003|Overall Study|Withdrawal by Subject|3|||
155028782|NCT05896527|559530676|FG004|Overall Study|Withdrawal by Subject|2|||
155028783|NCT05896527|559530672|FG000|Overall Study|Lost to Follow-up|0|||
155028784|NCT05896527|559530673|FG001|Overall Study|Lost to Follow-up|2|||
155028785|NCT05896527|559530674|FG002|Overall Study|Lost to Follow-up|2|||
155028786|NCT05896527|559530675|FG003|Overall Study|Lost to Follow-up|2|||
155028787|NCT05896527|559530676|FG004|Overall Study|Lost to Follow-up|1|||
155028788|NCT05896527|559530672|FG000|Overall Study|Significant protocol noncompliance|0|||
155028789|NCT05896527|559530673|FG001|Overall Study|Significant protocol noncompliance|1|||
155028790|NCT05896527|559530674|FG002|Overall Study|Significant protocol noncompliance|0|||
155028791|NCT05896527|559530675|FG003|Overall Study|Significant protocol noncompliance|0|||
155028792|NCT05896527|559530676|FG004|Overall Study|Significant protocol noncompliance|0|||
155028793|NCT05896527|559530672|FG000|Overall Study|Eligibility criteria not met|1|||
155028794|NCT05896527|559530673|FG001|Overall Study|Eligibility criteria not met|0|||
155028795|NCT05896527|559530674|FG002|Overall Study|Eligibility criteria not met|0|||
155028796|NCT05896527|559530675|FG003|Overall Study|Eligibility criteria not met|0|||
155028797|NCT05896527|559530676|FG004|Overall Study|Eligibility criteria not met|0|||
155028798|NCT05896527|559530672|FG000|Overall Study|Sponsor's decision|0|||
155028799|NCT05896527|559530673|FG001|Overall Study|Sponsor's decision|0|||
155028800|NCT05896527|559530674|FG002|Overall Study|Sponsor's decision|0|||
155028801|NCT05896527|559530675|FG003|Overall Study|Sponsor's decision|1|||
155028802|NCT05896527|559530676|FG004|Overall Study|Sponsor's decision|0|||
155028803|NCT05896527|559530672|FG000|Overall Study|Investigator's decision|0|||
155028804|NCT05896527|559530673|FG001|Overall Study|Investigator's decision|1|||
155028805|NCT05896527|559530674|FG002|Overall Study|Investigator's decision|0|||
155028806|NCT05896527|559530675|FG003|Overall Study|Investigator's decision|0|||
155028807|NCT05896527|559530676|FG004|Overall Study|Investigator's decision|0|||
155028808|NCT05896527|559530672|FG000|Overall Study|Pregnancy of his partner|0|||
155028809|NCT05896527|559530673|FG001|Overall Study|Pregnancy of his partner|0|||
155028810|NCT05896527|559530674|FG002|Overall Study|Pregnancy of his partner|0|||
155028811|NCT05896527|559530675|FG003|Overall Study|Pregnancy of his partner|1|||
155028812|NCT05896527|559530676|FG004|Overall Study|Pregnancy of his partner|0|||
155028813|NCT01279070|559530678|FG000|Overall Study|Withdrawal by Subject|2|||
155028814|NCT01279070|559530679|FG001|Overall Study|Withdrawal by Subject|3|||
155028815|NCT01279070|559530678|FG000|Overall Study|Acute exacerbation|3|||
155028816|NCT01279070|559530679|FG001|Overall Study|Acute exacerbation|1|||
155028817|NCT03781583|559530680|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
155028818|NCT03781583|559530681|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
155028819|NCT03781583|559530682|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
155028820|NCT03781583|559530683|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
155028821|NCT03781583|559530680|FG000|Overall Study|Technology did not work for that person in that environment|1|||
155028822|NCT03781583|559530681|FG001|Overall Study|Technology did not work for that person in that environment|0|||
155028823|NCT03781583|559530682|FG002|Overall Study|Technology did not work for that person in that environment|0|||
155028824|NCT03781583|559530683|FG003|Overall Study|Technology did not work for that person in that environment|0|||
155028825|NCT03781583|559530680|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
155028826|NCT03781583|559530681|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
155028827|NCT03781583|559530682|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
155028828|NCT03781583|559530683|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
155028829|NCT03781583|559530680|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
155028830|NCT03781583|559530681|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
155140107|NCT04098809|559944401|FG000|Overall Study|Withdrawal by Subject|1|||
155028831|NCT03781583|559530682|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
155028832|NCT03781583|559530683|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
155028833|NCT02222545|559530684|FG000|Overall Study|Adverse Event|1|||
155028834|NCT02222545|559530685|FG001|Overall Study|Adverse Event|0|||
155028835|NCT02222545|559530686|FG002|Overall Study|Adverse Event|2|||
155028836|NCT02222545|559530684|FG000|Overall Study|Death|0|||
155028837|NCT02222545|559530685|FG001|Overall Study|Death|0|||
155028838|NCT02222545|559530686|FG002|Overall Study|Death|9|||
155028839|NCT02222545|559530684|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
155028840|NCT02222545|559530685|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
155028841|NCT02222545|559530686|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
155028842|NCT02222545|559530684|FG000|Overall Study|Withdrawal by Subject|0|||
155028843|NCT02222545|559530685|FG001|Overall Study|Withdrawal by Subject|0|||
155028844|NCT02222545|559530686|FG002|Overall Study|Withdrawal by Subject|3|||
155028845|NCT02222545|559530684|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
155028846|NCT02222545|559530685|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
155028847|NCT02222545|559530686|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
155028848|NCT01938430|559530687|FG000|Overall Study|Randomized but Not Treated|0|||
155028849|NCT01938430|559530688|FG001|Overall Study|Randomized but Not Treated|0|||
155028850|NCT01938430|559530689|FG002|Overall Study|Randomized but Not Treated|0|||
155028851|NCT01938430|559530690|FG003|Overall Study|Randomized but Not Treated|0|||
155028852|NCT01938430|559530691|FG004|Overall Study|Randomized but Not Treated|0|||
155028853|NCT01938430|559530692|FG005|Overall Study|Randomized but Not Treated|0|||
155028854|NCT01938430|559530693|FG006|Overall Study|Randomized but Not Treated|0|||
155028855|NCT01938430|559530694|FG007|Overall Study|Randomized but Not Treated|0|||
155028856|NCT01938430|559530695|FG008|Overall Study|Randomized but Not Treated|0|||
155028857|NCT01938430|559530696|FG009|Overall Study|Randomized but Not Treated|0|||
155028858|NCT01938430|559530697|FG010|Overall Study|Randomized but Not Treated|1|||
155028859|NCT01938430|559530698|FG011|Overall Study|Randomized but Not Treated|0|||
155028860|NCT01938430|559530699|FG012|Overall Study|Randomized but Not Treated|0|||
155028861|NCT01938430|559530700|FG013|Overall Study|Randomized but Not Treated|1|||
155028862|NCT01938430|559530687|FG000|Overall Study|Adverse Event|0|||
155028863|NCT01938430|559530688|FG001|Overall Study|Adverse Event|0|||
155028864|NCT01938430|559530689|FG002|Overall Study|Adverse Event|0|||
155028865|NCT01938430|559530690|FG003|Overall Study|Adverse Event|0|||
155028866|NCT01938430|559530691|FG004|Overall Study|Adverse Event|0|||
155028867|NCT01938430|559530692|FG005|Overall Study|Adverse Event|0|||
155028868|NCT01938430|559530693|FG006|Overall Study|Adverse Event|1|||
155028869|NCT01938430|559530694|FG007|Overall Study|Adverse Event|0|||
155028870|NCT01938430|559530695|FG008|Overall Study|Adverse Event|0|||
155028871|NCT01938430|559530696|FG009|Overall Study|Adverse Event|0|||
155028872|NCT01938430|559530697|FG010|Overall Study|Adverse Event|0|||
155028873|NCT01938430|559530698|FG011|Overall Study|Adverse Event|0|||
155028874|NCT01938430|559530699|FG012|Overall Study|Adverse Event|0|||
155028875|NCT01938430|559530700|FG013|Overall Study|Adverse Event|0|||
155028876|NCT01938430|559530687|FG000|Overall Study|Death|1|||
155028877|NCT01938430|559530688|FG001|Overall Study|Death|2|||
155028878|NCT01938430|559530689|FG002|Overall Study|Death|2|||
155028879|NCT01938430|559530690|FG003|Overall Study|Death|1|||
155028880|NCT01938430|559530691|FG004|Overall Study|Death|0|||
155028881|NCT01938430|559530692|FG005|Overall Study|Death|0|||
155028882|NCT01938430|559530693|FG006|Overall Study|Death|1|||
155028883|NCT01938430|559530694|FG007|Overall Study|Death|1|||
155028884|NCT01938430|559530695|FG008|Overall Study|Death|2|||
155028885|NCT01938430|559530696|FG009|Overall Study|Death|3|||
155028886|NCT01938430|559530697|FG010|Overall Study|Death|0|||
155028887|NCT01938430|559530698|FG011|Overall Study|Death|0|||
155028888|NCT01938430|559530699|FG012|Overall Study|Death|0|||
155028889|NCT01938430|559530700|FG013|Overall Study|Death|0|||
155028890|NCT01938430|559530687|FG000|Overall Study|Investigator's Discretion|0|||
155028891|NCT01938430|559530688|FG001|Overall Study|Investigator's Discretion|0|||
155028892|NCT01938430|559530689|FG002|Overall Study|Investigator's Discretion|1|||
155028893|NCT01938430|559530690|FG003|Overall Study|Investigator's Discretion|0|||
155028894|NCT01938430|559530691|FG004|Overall Study|Investigator's Discretion|0|||
155028895|NCT01938430|559530692|FG005|Overall Study|Investigator's Discretion|0|||
155028896|NCT01938430|559530693|FG006|Overall Study|Investigator's Discretion|0|||
155028897|NCT01938430|559530694|FG007|Overall Study|Investigator's Discretion|0|||
155028898|NCT01938430|559530695|FG008|Overall Study|Investigator's Discretion|0|||
155028899|NCT01938430|559530696|FG009|Overall Study|Investigator's Discretion|0|||
155028900|NCT01938430|559530697|FG010|Overall Study|Investigator's Discretion|0|||
155028901|NCT01938430|559530698|FG011|Overall Study|Investigator's Discretion|0|||
155028902|NCT01938430|559530699|FG012|Overall Study|Investigator's Discretion|0|||
155028903|NCT01938430|559530700|FG013|Overall Study|Investigator's Discretion|0|||
155028904|NCT01938430|559530687|FG000|Overall Study|Lack of Efficacy|3|||
155028905|NCT01938430|559530688|FG001|Overall Study|Lack of Efficacy|1|||
155028906|NCT01938430|559530689|FG002|Overall Study|Lack of Efficacy|1|||
155028907|NCT01938430|559530690|FG003|Overall Study|Lack of Efficacy|1|||
155028908|NCT01938430|559530691|FG004|Overall Study|Lack of Efficacy|0|||
155028909|NCT01938430|559530692|FG005|Overall Study|Lack of Efficacy|0|||
155028910|NCT01938430|559530693|FG006|Overall Study|Lack of Efficacy|0|||
155028911|NCT01938430|559530694|FG007|Overall Study|Lack of Efficacy|0|||
155028912|NCT01938430|559530695|FG008|Overall Study|Lack of Efficacy|1|||
155028913|NCT01938430|559530696|FG009|Overall Study|Lack of Efficacy|0|||
155028914|NCT01938430|559530697|FG010|Overall Study|Lack of Efficacy|2|||
155028915|NCT01938430|559530698|FG011|Overall Study|Lack of Efficacy|1|||
155028916|NCT01938430|559530699|FG012|Overall Study|Lack of Efficacy|0|||
155028917|NCT01938430|559530700|FG013|Overall Study|Lack of Efficacy|0|||
155028918|NCT01938430|559530687|FG000|Overall Study|Lost to Follow-up|0|||
155028919|NCT01938430|559530688|FG001|Overall Study|Lost to Follow-up|0|||
155028920|NCT01938430|559530689|FG002|Overall Study|Lost to Follow-up|1|||
155028921|NCT01938430|559530690|FG003|Overall Study|Lost to Follow-up|0|||
155028922|NCT01938430|559530691|FG004|Overall Study|Lost to Follow-up|0|||
155028923|NCT01938430|559530692|FG005|Overall Study|Lost to Follow-up|1|||
155028924|NCT01938430|559530693|FG006|Overall Study|Lost to Follow-up|0|||
155028925|NCT01938430|559530694|FG007|Overall Study|Lost to Follow-up|0|||
155028926|NCT01938430|559530695|FG008|Overall Study|Lost to Follow-up|0|||
155028927|NCT01938430|559530696|FG009|Overall Study|Lost to Follow-up|0|||
155028928|NCT01938430|559530697|FG010|Overall Study|Lost to Follow-up|0|||
155028929|NCT01938430|559530698|FG011|Overall Study|Lost to Follow-up|0|||
155028930|NCT01938430|559530699|FG012|Overall Study|Lost to Follow-up|0|||
155028931|NCT01938430|559530700|FG013|Overall Study|Lost to Follow-up|0|||
155028932|NCT01938430|559530687|FG000|Overall Study|Withdrew Consent|0|||
155028933|NCT01938430|559530688|FG001|Overall Study|Withdrew Consent|0|||
155028934|NCT01938430|559530689|FG002|Overall Study|Withdrew Consent|0|||
155028935|NCT01938430|559530690|FG003|Overall Study|Withdrew Consent|0|||
155028936|NCT01938430|559530691|FG004|Overall Study|Withdrew Consent|0|||
155028937|NCT01938430|559530692|FG005|Overall Study|Withdrew Consent|0|||
155028938|NCT01938430|559530693|FG006|Overall Study|Withdrew Consent|0|||
155028939|NCT01938430|559530694|FG007|Overall Study|Withdrew Consent|0|||
155028940|NCT01938430|559530695|FG008|Overall Study|Withdrew Consent|1|||
155028941|NCT01938430|559530696|FG009|Overall Study|Withdrew Consent|0|||
155028942|NCT01938430|559530697|FG010|Overall Study|Withdrew Consent|0|||
155028943|NCT01938430|559530698|FG011|Overall Study|Withdrew Consent|0|||
155028944|NCT01938430|559530699|FG012|Overall Study|Withdrew Consent|0|||
155028945|NCT01938430|559530700|FG013|Overall Study|Withdrew Consent|0|||
155028946|NCT04533412|559530701|FG000|Overall Study|Withdrawal by Subject|1|||
155028947|NCT04533412|559530702|FG001|Overall Study|Withdrawal by Subject|1|||
155028948|NCT04533412|559530701|FG000|Overall Study|Lost to Follow-up|1|||
155028949|NCT04533412|559530702|FG001|Overall Study|Lost to Follow-up|4|||
155028950|NCT02353442|559530707|FG000|Overall Study|Withdrawal by Subject|3|||
155028951|NCT02353442|559530708|FG001|Overall Study|Withdrawal by Subject|4|||
155028952|NCT00782184|559530709|FG000|Overall Study|Adverse Event|1|||
155028953|NCT00782184|559530710|FG001|Overall Study|Adverse Event|2|||
155028954|NCT00782184|559530709|FG000|Overall Study|Protocol Violation|0|||
155028955|NCT00782184|559530710|FG001|Overall Study|Protocol Violation|1|||
155028956|NCT00782184|559530709|FG000|Overall Study|Withdrawal by Subject|3|||
155028957|NCT00782184|559530710|FG001|Overall Study|Withdrawal by Subject|2|||
155028958|NCT00890084|559530711|FG000|Overall Study|Adverse Event|16|||
155028959|NCT00890084|559530711|FG000|Overall Study|Lost to Follow-up|126|||
155028960|NCT02738879|559530712|FG000|Overall Study|Adverse Event|1|||
155028961|NCT02738879|559530713|FG001|Overall Study|Adverse Event|1|||
155028962|NCT02738879|559530712|FG000|Overall Study|Death|0|||
155028963|NCT02738879|559530713|FG001|Overall Study|Death|2|||
155028964|NCT02738879|559530712|FG000|Overall Study|Lost to Follow-up|1|||
155028965|NCT02738879|559530713|FG001|Overall Study|Lost to Follow-up|5|||
155028966|NCT02738879|559530712|FG000|Overall Study|Protocol Violation|1|||
155028967|NCT02738879|559530713|FG001|Overall Study|Protocol Violation|3|||
155028968|NCT02738879|559530712|FG000|Overall Study|Physician Decision|3|||
155028969|NCT02738879|559530713|FG001|Overall Study|Physician Decision|4|||
155028970|NCT02738879|559530712|FG000|Overall Study|Pregnancy|0|||
155028971|NCT02738879|559530713|FG001|Overall Study|Pregnancy|1|||
155028972|NCT02738879|559530712|FG000|Overall Study|Screen Failure|1|||
155028973|NCT02738879|559530713|FG001|Overall Study|Screen Failure|2|||
155028974|NCT02738879|559530712|FG000|Overall Study|Site Discontinued Study Participation|1|||
155028975|NCT02738879|559530713|FG001|Overall Study|Site Discontinued Study Participation|0|||
155028976|NCT02738879|559530712|FG000|Overall Study|Withdrawal by Subject|5|||
155028977|NCT02738879|559530713|FG001|Overall Study|Withdrawal by Subject|7|||
155028978|NCT01438294|559530714|FG000|Overall Study|Lost to Follow-up|3|||
155028979|NCT01438294|559530715|FG001|Overall Study|Lost to Follow-up|7|||
155028980|NCT01075646|559530718|FG000|Overall Study|Lost to Follow-up|4|||
155028981|NCT01075646|559530719|FG001|Overall Study|Lost to Follow-up|3|||
155028982|NCT01075646|559530720|FG002|Overall Study|Lost to Follow-up|1|||
155028983|NCT01075646|559530721|FG003|Overall Study|Lost to Follow-up|2|||
155028984|NCT01647516|559530725|FG000|Induction Period (IP)|Physician Decision|2|||
155028985|NCT01647516|559530726|FG001|Induction Period (IP)|Physician Decision|0|||
155028986|NCT01647516|559530727|FG002|Induction Period (IP)|Physician Decision|0|||
155028987|NCT01647516|559530728|FG003|Induction Period (IP)|Physician Decision|0|||
155028988|NCT01647516|559530729|FG004|Induction Period (IP)|Physician Decision|0|||
155028989|NCT01647516|559530730|FG005|Induction Period (IP)|Physician Decision|0|||
155028990|NCT01647516|559530725|FG000|Induction Period (IP)|Adverse Event|1|||
155028991|NCT01647516|559530726|FG001|Induction Period (IP)|Adverse Event|2|||
155028992|NCT01647516|559530727|FG002|Induction Period (IP)|Adverse Event|0|||
155028993|NCT01647516|559530728|FG003|Induction Period (IP)|Adverse Event|0|||
155028994|NCT01647516|559530729|FG004|Induction Period (IP)|Adverse Event|0|||
155028995|NCT01647516|559530730|FG005|Induction Period (IP)|Adverse Event|0|||
155028996|NCT01647516|559530725|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
155028997|NCT01647516|559530726|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
155028998|NCT01647516|559530727|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
155028999|NCT01647516|559530728|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
155029000|NCT01647516|559530729|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
155029001|NCT01647516|559530730|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
155029002|NCT01647516|559530725|FG000|Induction Period (IP)|Participant Choice|0|||
155029003|NCT01647516|559530726|FG001|Induction Period (IP)|Participant Choice|0|||
155029004|NCT01647516|559530727|FG002|Induction Period (IP)|Participant Choice|1|||
155029005|NCT01647516|559530728|FG003|Induction Period (IP)|Participant Choice|0|||
155029006|NCT01647516|559530729|FG004|Induction Period (IP)|Participant Choice|0|||
155029007|NCT01647516|559530730|FG005|Induction Period (IP)|Participant Choice|0|||
155029008|NCT01647516|559530725|FG000|Induction Period (IP)|Lack of Efficacy|1|||
155029009|NCT01647516|559530726|FG001|Induction Period (IP)|Lack of Efficacy|0|||
155029010|NCT01647516|559530727|FG002|Induction Period (IP)|Lack of Efficacy|0|||
155029011|NCT01647516|559530728|FG003|Induction Period (IP)|Lack of Efficacy|0|||
155029012|NCT01647516|559530729|FG004|Induction Period (IP)|Lack of Efficacy|0|||
155029013|NCT01647516|559530730|FG005|Induction Period (IP)|Lack of Efficacy|0|||
155029014|NCT01647516|559530725|FG000|Induction Period (IP)|No study drug received|1|||
155029015|NCT01647516|559530726|FG001|Induction Period (IP)|No study drug received|1|||
155029016|NCT01647516|559530727|FG002|Induction Period (IP)|No study drug received|0|||
155029017|NCT01647516|559530728|FG003|Induction Period (IP)|No study drug received|0|||
155029018|NCT01647516|559530729|FG004|Induction Period (IP)|No study drug received|0|||
155029019|NCT01647516|559530730|FG005|Induction Period (IP)|No study drug received|0|||
155029020|NCT01647516|559530725|FG000|Maintenance Period (MP)|Adverse Event|2|||
155029021|NCT01647516|559530726|FG001|Maintenance Period (MP)|Adverse Event|1|||
155029022|NCT01647516|559530727|FG002|Maintenance Period (MP)|Adverse Event|0|||
155029023|NCT01647516|559530728|FG003|Maintenance Period (MP)|Adverse Event|0|||
155029024|NCT01647516|559530729|FG004|Maintenance Period (MP)|Adverse Event|0|||
155029025|NCT01647516|559530730|FG005|Maintenance Period (MP)|Adverse Event|0|||
155029026|NCT01647516|559530725|FG000|Maintenance Period (MP)|Non-compliance|1|||
155029027|NCT01647516|559530726|FG001|Maintenance Period (MP)|Non-compliance|0|||
155029028|NCT01647516|559530727|FG002|Maintenance Period (MP)|Non-compliance|0|||
155029029|NCT01647516|559530728|FG003|Maintenance Period (MP)|Non-compliance|0|||
155029030|NCT01647516|559530729|FG004|Maintenance Period (MP)|Non-compliance|0|||
155029031|NCT01647516|559530730|FG005|Maintenance Period (MP)|Non-compliance|0|||
155029032|NCT01647516|559530725|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
155029033|NCT01647516|559530726|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
155029034|NCT01647516|559530727|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
155029035|NCT01647516|559530728|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
155029036|NCT01647516|559530729|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
155029037|NCT01647516|559530730|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
155029038|NCT01647516|559530725|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
155029039|NCT01647516|559530726|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
155029040|NCT01647516|559530727|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
155029041|NCT01647516|559530728|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
155029042|NCT01647516|559530729|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
155029043|NCT01647516|559530730|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
155029044|NCT01647516|559530725|FG000|Open-Label Period|Adverse Event|0|||
155029045|NCT01647516|559530726|FG001|Open-Label Period|Adverse Event|0|||
155029046|NCT01647516|559530727|FG002|Open-Label Period|Adverse Event|0|||
155029047|NCT01647516|559530728|FG003|Open-Label Period|Adverse Event|5|||
155029048|NCT01647516|559530729|FG004|Open-Label Period|Adverse Event|6|||
155029049|NCT01647516|559530730|FG005|Open-Label Period|Adverse Event|3|||
155029050|NCT01647516|559530725|FG000|Open-Label Period|Pregnancy|0|||
155140108|NCT04098809|559944402|FG001|Overall Study|Withdrawal by Subject|3|||
155029051|NCT01647516|559530726|FG001|Open-Label Period|Pregnancy|0|||
155029052|NCT01647516|559530727|FG002|Open-Label Period|Pregnancy|0|||
155029053|NCT01647516|559530728|FG003|Open-Label Period|Pregnancy|0|||
155029054|NCT01647516|559530729|FG004|Open-Label Period|Pregnancy|0|||
155029055|NCT01647516|559530730|FG005|Open-Label Period|Pregnancy|1|||
155029056|NCT01647516|559530725|FG000|Open-Label Period|Non-compliance|0|||
155029057|NCT01647516|559530726|FG001|Open-Label Period|Non-compliance|0|||
155029058|NCT01647516|559530727|FG002|Open-Label Period|Non-compliance|0|||
155029059|NCT01647516|559530728|FG003|Open-Label Period|Non-compliance|1|||
155029060|NCT01647516|559530729|FG004|Open-Label Period|Non-compliance|0|||
155029061|NCT01647516|559530730|FG005|Open-Label Period|Non-compliance|1|||
155029062|NCT01647516|559530725|FG000|Open-Label Period|Physician Decision|0|||
155029063|NCT01647516|559530726|FG001|Open-Label Period|Physician Decision|0|||
155029064|NCT01647516|559530727|FG002|Open-Label Period|Physician Decision|0|||
155029065|NCT01647516|559530728|FG003|Open-Label Period|Physician Decision|1|||
155029066|NCT01647516|559530729|FG004|Open-Label Period|Physician Decision|1|||
155029067|NCT01647516|559530730|FG005|Open-Label Period|Physician Decision|0|||
155029068|NCT01647516|559530725|FG000|Open-Label Period|Withdrawal by Subject|0|||
155029069|NCT01647516|559530726|FG001|Open-Label Period|Withdrawal by Subject|0|||
155029070|NCT01647516|559530727|FG002|Open-Label Period|Withdrawal by Subject|0|||
155029071|NCT01647516|559530728|FG003|Open-Label Period|Withdrawal by Subject|9|||
155029072|NCT01647516|559530729|FG004|Open-Label Period|Withdrawal by Subject|11|||
155029073|NCT01647516|559530730|FG005|Open-Label Period|Withdrawal by Subject|6|||
155029074|NCT01647516|559530725|FG000|Open-Label Period|Lost to Follow-up|0|||
155029075|NCT01647516|559530726|FG001|Open-Label Period|Lost to Follow-up|0|||
155029076|NCT01647516|559530727|FG002|Open-Label Period|Lost to Follow-up|0|||
155029077|NCT01647516|559530728|FG003|Open-Label Period|Lost to Follow-up|1|||
155029078|NCT01647516|559530729|FG004|Open-Label Period|Lost to Follow-up|0|||
155029079|NCT01647516|559530730|FG005|Open-Label Period|Lost to Follow-up|1|||
155029080|NCT01647516|559530725|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
155029081|NCT01647516|559530726|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
155029082|NCT01647516|559530727|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
155029083|NCT01647516|559530728|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
155029084|NCT01647516|559530729|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
155029085|NCT01647516|559530730|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
155029086|NCT01647516|559530725|FG000|Open-Label Period|Lack of Efficacy|0|||
155029087|NCT01647516|559530726|FG001|Open-Label Period|Lack of Efficacy|0|||
155029088|NCT01647516|559530727|FG002|Open-Label Period|Lack of Efficacy|0|||
155029089|NCT01647516|559530728|FG003|Open-Label Period|Lack of Efficacy|7|||
155029090|NCT01647516|559530729|FG004|Open-Label Period|Lack of Efficacy|9|||
155029091|NCT01647516|559530730|FG005|Open-Label Period|Lack of Efficacy|10|||
155029092|NCT01647516|559530725|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
155029093|NCT01647516|559530726|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
155029094|NCT01647516|559530727|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
155029095|NCT01647516|559530728|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
155029096|NCT01647516|559530729|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
155029097|NCT01647516|559530730|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
155029098|NCT01647516|559530725|FG000|Open-Label Period|No completion / discontinuation visit|0|||
155029099|NCT01647516|559530726|FG001|Open-Label Period|No completion / discontinuation visit|0|||
155029100|NCT01647516|559530727|FG002|Open-Label Period|No completion / discontinuation visit|0|||
155029101|NCT01647516|559530728|FG003|Open-Label Period|No completion / discontinuation visit|0|||
155029102|NCT01647516|559530729|FG004|Open-Label Period|No completion / discontinuation visit|2|||
155029103|NCT01647516|559530730|FG005|Open-Label Period|No completion / discontinuation visit|1|||
155029104|NCT01613222|559530735|FG000|Overall Study|Physician Decision|1|||
155029105|NCT01613222|559530735|FG000|Overall Study|Unable to place arterial line|1|||
155029106|NCT01613222|559530735|FG000|Overall Study|Reused disposable sensors|10|||
155029107|NCT01895608|559530736|FG000|Overall Study|change in health status|0|||
155029108|NCT01895608|559530737|FG001|Overall Study|change in health status|1|||
155029109|NCT01895608|559530738|FG002|Overall Study|change in health status|1|||
155029110|NCT01895608|559530739|FG003|Overall Study|change in health status|0|||
155029111|NCT01895608|559530736|FG000|Overall Study|Withdrawal by Subject|0|||
155029112|NCT01895608|559530737|FG001|Overall Study|Withdrawal by Subject|0|||
155029113|NCT01895608|559530738|FG002|Overall Study|Withdrawal by Subject|2|||
155029114|NCT01895608|559530739|FG003|Overall Study|Withdrawal by Subject|0|||
155029115|NCT00089778|559530741|FG000|Overall Study|Protocol Violation|0|||
155029116|NCT00089778|559530742|FG001|Overall Study|Protocol Violation|0|||
155029117|NCT00089778|559530743|FG002|Overall Study|Protocol Violation|1|||
155029118|NCT01084668|559530746|FG000|Overall Study|Lack of Efficacy|5|||
155029119|NCT01084668|559530746|FG000|Overall Study|Withdrawal by Subject|2|||
155029120|NCT01084668|559530746|FG000|Overall Study|Pregnancy|1|||
155029121|NCT01084668|559530746|FG000|Overall Study|Non-compliance|1|||
155029122|NCT04240457|559530750|FG000|Overall Study|Lost to Follow-up|5|||
155029123|NCT04240457|559530751|FG001|Overall Study|Lost to Follow-up|1|||
155029124|NCT00985959|559530752|FG000|Overall Study|Adverse Event|0|||
155029125|NCT00985959|559530753|FG001|Overall Study|Adverse Event|0|||
155029126|NCT00985959|559530754|FG002|Overall Study|Adverse Event|19|||
155029127|NCT00985959|559530752|FG000|Overall Study|Withdrawal by Subject|0|||
155029128|NCT00985959|559530753|FG001|Overall Study|Withdrawal by Subject|0|||
155029129|NCT00985959|559530754|FG002|Overall Study|Withdrawal by Subject|8|||
155029130|NCT00985959|559530752|FG000|Overall Study|Progressive disease|1|||
155029131|NCT00985959|559530753|FG001|Overall Study|Progressive disease|2|||
155029132|NCT00985959|559530754|FG002|Overall Study|Progressive disease|8|||
155029133|NCT00985959|559530752|FG000|Overall Study|Unrecovered toxicity|0|||
155029134|NCT00985959|559530753|FG001|Overall Study|Unrecovered toxicity|0|||
155029135|NCT00985959|559530754|FG002|Overall Study|Unrecovered toxicity|7|||
155029136|NCT00985959|559530752|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
155029137|NCT00985959|559530753|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
155029138|NCT00985959|559530754|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
155029139|NCT00985959|559530752|FG000|Overall Study|Complete response observed over 2 cycles|0|||
155029140|NCT00985959|559530753|FG001|Overall Study|Complete response observed over 2 cycles|1|||
155029141|NCT00985959|559530754|FG002|Overall Study|Complete response observed over 2 cycles|4|||
155029142|NCT00985959|559530752|FG000|Overall Study|Other|0|||
155029143|NCT00985959|559530753|FG001|Overall Study|Other|0|||
155029144|NCT00985959|559530754|FG002|Overall Study|Other|11|||
155029145|NCT02858180|559530755|FG000|Overall Study|Lost to Follow-up|0|||
155029146|NCT02858180|559530756|FG001|Overall Study|Lost to Follow-up|2|||
155029147|NCT00844480|559530757|FG000|Overall Study|Withdrawal by Subject|2|||
155029148|NCT00844480|559530758|FG001|Overall Study|Withdrawal by Subject|3|||
155029149|NCT01516008|559530765|FG000|Overall Study|Adverse Event|0|||
155029150|NCT01516008|559530766|FG001|Overall Study|Adverse Event|2|||
155029151|NCT01516008|559530767|FG002|Overall Study|Adverse Event|7|||
155029152|NCT01516008|559530765|FG000|Overall Study|Lack of Efficacy|44|||
155029153|NCT01516008|559530766|FG001|Overall Study|Lack of Efficacy|14|||
155029154|NCT01516008|559530767|FG002|Overall Study|Lack of Efficacy|10|||
155029155|NCT01516008|559530765|FG000|Overall Study|Protocol Violation|1|||
155029156|NCT01516008|559530766|FG001|Overall Study|Protocol Violation|0|||
155029157|NCT01516008|559530767|FG002|Overall Study|Protocol Violation|0|||
155029158|NCT01516008|559530765|FG000|Overall Study|Reason not specified|0|||
155029159|NCT01516008|559530766|FG001|Overall Study|Reason not specified|0|||
155029160|NCT01516008|559530767|FG002|Overall Study|Reason not specified|1|||
155029161|NCT02805660|559530768|FG000|Overall Study|Death|5|||
155029162|NCT02805660|559530769|FG001|Overall Study|Death|2|||
155029163|NCT02805660|559530770|FG002|Overall Study|Death|9|||
155029164|NCT02805660|559530771|FG003|Overall Study|Death|5|||
155029165|NCT02805660|559530772|FG004|Overall Study|Death|0|||
155029166|NCT02805660|559530773|FG005|Overall Study|Death|14|||
155029167|NCT02805660|559530774|FG006|Overall Study|Death|12|||
155029168|NCT02805660|559530768|FG000|Overall Study|Lost to Follow-up|0|||
155029169|NCT02805660|559530769|FG001|Overall Study|Lost to Follow-up|1|||
155029170|NCT02805660|559530770|FG002|Overall Study|Lost to Follow-up|1|||
155029171|NCT02805660|559530771|FG003|Overall Study|Lost to Follow-up|2|||
155029172|NCT02805660|559530772|FG004|Overall Study|Lost to Follow-up|0|||
155029173|NCT02805660|559530773|FG005|Overall Study|Lost to Follow-up|0|||
155029174|NCT02805660|559530774|FG006|Overall Study|Lost to Follow-up|0|||
155029175|NCT02805660|559530768|FG000|Overall Study|Withdrawal by Subject|0|||
155029176|NCT02805660|559530769|FG001|Overall Study|Withdrawal by Subject|0|||
155029177|NCT02805660|559530770|FG002|Overall Study|Withdrawal by Subject|0|||
155029178|NCT02805660|559530771|FG003|Overall Study|Withdrawal by Subject|3|||
155029179|NCT02805660|559530772|FG004|Overall Study|Withdrawal by Subject|1|||
155029180|NCT02805660|559530773|FG005|Overall Study|Withdrawal by Subject|0|||
155029181|NCT02805660|559530774|FG006|Overall Study|Withdrawal by Subject|2|||
155029182|NCT02805660|559530768|FG000|Overall Study|Study terminated by Sponsor|0|||
155029183|NCT02805660|559530769|FG001|Overall Study|Study terminated by Sponsor|0|||
155029184|NCT02805660|559530770|FG002|Overall Study|Study terminated by Sponsor|1|||
155029185|NCT02805660|559530771|FG003|Overall Study|Study terminated by Sponsor|4|||
155029186|NCT02805660|559530772|FG004|Overall Study|Study terminated by Sponsor|2|||
155029187|NCT02805660|559530773|FG005|Overall Study|Study terminated by Sponsor|3|||
155029188|NCT02805660|559530774|FG006|Overall Study|Study terminated by Sponsor|1|||
155029189|NCT02805660|559530768|FG000|Overall Study|Miscellaneous|0|||
155029190|NCT02805660|559530769|FG001|Overall Study|Miscellaneous|1|||
155029191|NCT02805660|559530770|FG002|Overall Study|Miscellaneous|0|||
155029192|NCT02805660|559530771|FG003|Overall Study|Miscellaneous|4|||
155029193|NCT02805660|559530772|FG004|Overall Study|Miscellaneous|0|||
155029194|NCT02805660|559530773|FG005|Overall Study|Miscellaneous|6|||
155029195|NCT02805660|559530774|FG006|Overall Study|Miscellaneous|4|||
155029196|NCT02572076|559530776|FG000|Overall Study|Protocol Violation|1|||
155029197|NCT02396420|559530779|FG000|Overall Study|Death|1|||
155029198|NCT01273623|559530785|FG000|Overall Study|did not meet IVUS criteria|29|||
155029199|NCT01493284|559530786|FG000|Overall Study|Death|29|||
155029200|NCT01493284|559530786|FG000|Overall Study|Withdrawal by Subject|32|||
155029201|NCT03489707|559530789|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
155029202|NCT03489707|559530790|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
155029203|NCT03489707|559530789|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
155029204|NCT03489707|559530790|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
155029205|NCT00325156|559530791|FG000|Overall Study|Protocol Violation|8|||
155029206|NCT00325156|559530791|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
155140109|NCT04098809|559944401|FG000|Overall Study|Physician Decision|2|||
155140110|NCT04098809|559944402|FG001|Overall Study|Physician Decision|1|||
155029207|NCT00325156|559530791|FG000|Overall Study|Migrated/moved from study area|12|||
155029208|NCT00325156|559530791|FG000|Overall Study|Adverse event, non-fatal|3|||
155029209|NCT00325156|559530791|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
155029210|NCT00325156|559530791|FG000|Overall Study|Other|1|||
155029211|NCT00325156|559530791|FG000|Overall Study|Withdrawal by Subject|31|||
155029212|NCT04064411|559530792|FG000|Overall Study|Adverse Event|29|||
155029213|NCT04064411|559530793|FG001|Overall Study|Adverse Event|19|||
155029214|NCT04064411|559530792|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
155029215|NCT04064411|559530793|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
155029216|NCT04064411|559530792|FG000|Overall Study|Protocol Deviation|0|||
155029217|NCT04064411|559530793|FG001|Overall Study|Protocol Deviation|2|||
155029218|NCT04064411|559530792|FG000|Overall Study|Withdrawal by Subject|25|||
155029219|NCT04064411|559530793|FG001|Overall Study|Withdrawal by Subject|29|||
155029220|NCT04064411|559530792|FG000|Overall Study|Lost to Follow-up|5|||
155029221|NCT04064411|559530793|FG001|Overall Study|Lost to Follow-up|2|||
155029222|NCT04064411|559530792|FG000|Overall Study|Other than Specified|4|||
155029223|NCT04064411|559530793|FG001|Overall Study|Other than Specified|1|||
155029224|NCT04064411|559530792|FG000|Overall Study|Death|1|||
155029225|NCT04064411|559530793|FG001|Overall Study|Death|0|||
155029226|NCT03512210|559530799|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
155029227|NCT03512210|559530799|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
155029228|NCT03512210|559530799|FG000|Step 2:Post-MINMON|Death|2|||
155029229|NCT03512210|559530799|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
155029230|NCT03512210|559530799|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
155029231|NCT01286168|559532290|FG000|Overall Study|Withdrawal by Subject|1|||
155029232|NCT01286168|559532290|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
155029233|NCT01424514|559532291|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
155029234|NCT01424514|559532292|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
155029235|NCT01424514|559532291|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
155029236|NCT01424514|559532292|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
155029237|NCT02653170|559532295|FG000|Overall Study|Withdrawal by Subject|3|||
155029238|NCT02653170|559532296|FG001|Overall Study|Withdrawal by Subject|8|||
155029239|NCT02653170|559532297|FG002|Overall Study|Withdrawal by Subject|3|||
155029240|NCT02653170|559532295|FG000|Overall Study|withdrawn by study team|2|||
155029241|NCT02653170|559532296|FG001|Overall Study|withdrawn by study team|4|||
155029242|NCT02653170|559532297|FG002|Overall Study|withdrawn by study team|5|||
155029243|NCT02653170|559532295|FG000|Overall Study|Lost to Follow-up|12|||
155029244|NCT02653170|559532296|FG001|Overall Study|Lost to Follow-up|4|||
155029245|NCT02653170|559532297|FG002|Overall Study|Lost to Follow-up|10|||
155029246|NCT02002533|559532298|FG000|Overall Study|Withdrawal by Subject|6|||
155029247|NCT02002533|559532299|FG001|Overall Study|Withdrawal by Subject|13|||
155029248|NCT02002533|559532298|FG000|Overall Study|Protocol Violation|0|||
155029249|NCT02002533|559532299|FG001|Overall Study|Protocol Violation|1|||
155029250|NCT02002533|559532298|FG000|Overall Study|Adverse Event|0|||
155029251|NCT02002533|559532299|FG001|Overall Study|Adverse Event|3|||
155029252|NCT02002533|559532298|FG000|Overall Study|Lost to Follow-up|0|||
155029253|NCT02002533|559532299|FG001|Overall Study|Lost to Follow-up|1|||
155029254|NCT01482065|559532302|FG000|Overall Study|Withdrawal by Subject|0|||
155029255|NCT01482065|559532303|FG001|Overall Study|Withdrawal by Subject|1|||
155029256|NCT01942486|559532304|FG000|Overall Study|Lost to Follow-up|27|||
155029257|NCT03728426|559532305|FG000|Overall Study|Death|3|||
155029258|NCT02424630|559532308|FG000|Overall Study|No rotator cuff tear|1|||
155029259|NCT02424630|559532309|FG001|Overall Study|No rotator cuff tear|2|||
155029260|NCT02424630|559532308|FG000|Overall Study|Open procedure|0|||
155029261|NCT02424630|559532309|FG001|Overall Study|Open procedure|1|||
155029262|NCT01741792|559532310|FG000|Overall Study|Death|6|||
155029263|NCT01741792|559532311|FG001|Overall Study|Death|1|||
155029264|NCT01741792|559532312|FG002|Overall Study|Death|12|||
155029265|NCT05139303|559532313|FG000|Overall Study|Lost to Follow-up|3|||
155029266|NCT05139303|559532314|FG001|Overall Study|Lost to Follow-up|0|||
155029267|NCT05139303|559532313|FG000|Overall Study|Adverse Event|1|||
155029268|NCT05139303|559532314|FG001|Overall Study|Adverse Event|0|||
155029269|NCT03261674|559532316|FG000|Overall Study|Lost to Follow-up|6|||
155029270|NCT03261674|559532317|FG001|Overall Study|Lost to Follow-up|7|||
155029271|NCT03261674|559532316|FG000|Overall Study|Protocol Violation|1|||
155029272|NCT03261674|559532317|FG001|Overall Study|Protocol Violation|4|||
155029273|NCT03261674|559532316|FG000|Overall Study|Withdrawal by Subject|1|||
155181468|NCT02038829|560103086|FG008|Washout Period 2|Adverse Event|1|||
155029274|NCT03261674|559532317|FG001|Overall Study|Withdrawal by Subject|4|||
155029275|NCT03261674|559532316|FG000|Overall Study|Physician Decision|1|||
155029276|NCT03261674|559532317|FG001|Overall Study|Physician Decision|0|||
155029277|NCT04964544|559532330|FG000|Overall Study|Screen failure or other uncategorised|10|||
155029278|NCT04964544|559532330|FG000|Overall Study|Physician Decision|4|||
155029279|NCT04964544|559532330|FG000|Overall Study|Lost to Follow-up|9|||
155029280|NCT04964544|559532330|FG000|Overall Study|Withdrawal by Subject|18|||
155029281|NCT04964544|559532330|FG000|Overall Study|Death|1|||
155029282|NCT03155178|559532334|FG000|Overall Study|Did not meet treatment day baseline|7|||
155029283|NCT03155178|559532335|FG001|Overall Study|Did not meet treatment day baseline|7|||
155029284|NCT03155178|559532336|FG002|Overall Study|Did not meet treatment day baseline|7|||
155029285|NCT03155178|559532337|FG003|Overall Study|Did not meet treatment day baseline|7|||
155029286|NCT02833844|559532338|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155029287|NCT02833844|559532339|FG001|Double-Blind Period|Withdrawal by Subject|3|||
155029288|NCT02833844|559532338|FG000|Double-Blind Period|Protocol Violation|0|||
155029289|NCT02833844|559532339|FG001|Double-Blind Period|Protocol Violation|4|||
155029290|NCT02833844|559532338|FG000|Open-Label Period|Death|0|||
155029291|NCT02833844|559532339|FG001|Open-Label Period|Death|2|||
155029292|NCT02833844|559532338|FG000|Open-Label Period|Lost to Follow-up|1|||
155029293|NCT02833844|559532339|FG001|Open-Label Period|Lost to Follow-up|0|||
155029294|NCT02833844|559532338|FG000|Open-Label Period|Withdrawal by Subject|1|||
155029295|NCT02833844|559532339|FG001|Open-Label Period|Withdrawal by Subject|0|||
155029296|NCT00308087|559532340|FG000|Overall Study|Progressive Disease|19|||
155029297|NCT00308087|559532341|FG001|Overall Study|Progressive Disease|21|||
155029298|NCT00308087|559532340|FG000|Overall Study|Study Closure|11|||
155029299|NCT00308087|559532341|FG001|Overall Study|Study Closure|12|||
155029300|NCT00308087|559532340|FG000|Overall Study|Withdrawal by Subject|2|||
155029301|NCT00308087|559532341|FG001|Overall Study|Withdrawal by Subject|1|||
155029302|NCT00308087|559532340|FG000|Overall Study|Other|4|||
155029303|NCT00308087|559532341|FG001|Overall Study|Other|3|||
155029304|NCT04323306|559532343|FG000|Overall Study|Physician Decision|1|||
155029305|NCT04323306|559532344|FG001|Overall Study|Physician Decision|0|||
155029306|NCT04323306|559532345|FG002|Overall Study|Physician Decision|0|||
155029307|NCT04323306|559532346|FG003|Overall Study|Physician Decision|0|||
155029308|NCT04323306|559532347|FG004|Overall Study|Physician Decision|0|||
155029309|NCT04323306|559532348|FG005|Overall Study|Physician Decision|0|||
155029310|NCT04323306|559532349|FG006|Overall Study|Physician Decision|0|||
155029311|NCT04323306|559532350|FG007|Overall Study|Physician Decision|0|||
155029312|NCT04323306|559532351|FG008|Overall Study|Physician Decision|0|||
155029313|NCT04323306|559532343|FG000|Overall Study|Withdrawal by Subject|0|||
155029314|NCT04323306|559532344|FG001|Overall Study|Withdrawal by Subject|0|||
155029315|NCT04323306|559532345|FG002|Overall Study|Withdrawal by Subject|0|||
155029316|NCT04323306|559532346|FG003|Overall Study|Withdrawal by Subject|0|||
155029317|NCT04323306|559532347|FG004|Overall Study|Withdrawal by Subject|0|||
155029318|NCT04323306|559532348|FG005|Overall Study|Withdrawal by Subject|1|||
155029319|NCT04323306|559532349|FG006|Overall Study|Withdrawal by Subject|3|||
155029320|NCT04323306|559532350|FG007|Overall Study|Withdrawal by Subject|0|||
155029321|NCT04323306|559532351|FG008|Overall Study|Withdrawal by Subject|1|||
155029322|NCT04712019|559532352|FG000|Overall Study|Withdrawal by Subject|2|||
155029323|NCT04712019|559532353|FG001|Overall Study|Withdrawal by Subject|2|||
155029324|NCT04712019|559532352|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
155029325|NCT04712019|559532353|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
155029326|NCT03729570|559532361|FG000|Overall Study|Lost to Follow-up|16|||
155029327|NCT03729570|559532362|FG001|Overall Study|Lost to Follow-up|20|||
155029328|NCT03729570|559532361|FG000|Overall Study|Seroconversion|5|||
155029329|NCT03729570|559532362|FG001|Overall Study|Seroconversion|0|||
155029330|NCT03729570|559532361|FG000|Overall Study|Moved out of the city|1|||
155029331|NCT03729570|559532362|FG001|Overall Study|Moved out of the city|0|||
155029332|NCT03729570|559532361|FG000|Overall Study|Time Conflict|1|||
155029333|NCT03729570|559532362|FG001|Overall Study|Time Conflict|0|||
155029334|NCT03729570|559532361|FG000|Overall Study|Time Commitment|2|||
155029335|NCT03729570|559532362|FG001|Overall Study|Time Commitment|0|||
155029336|NCT03729570|559532361|FG000|Overall Study|Bad Experience|0|||
155029337|NCT03729570|559532362|FG001|Overall Study|Bad Experience|1|||
155029338|NCT03729570|559532361|FG000|Overall Study|No reason provided|2|||
155029339|NCT03729570|559532362|FG001|Overall Study|No reason provided|1|||
155029340|NCT03729570|559532361|FG000|Overall Study|Family Conflict|0|||
155029341|NCT03729570|559532362|FG001|Overall Study|Family Conflict|1|||
155029342|NCT03729570|559532361|FG000|Overall Study|Did not want to continue taking medications|0|||
155029343|NCT03729570|559532362|FG001|Overall Study|Did not want to continue taking medications|1|||
155029344|NCT03729570|559532361|FG000|Overall Study|Found another PrEP provider|1|||
155029345|NCT03729570|559532362|FG001|Overall Study|Found another PrEP provider|0|||
155029346|NCT03729570|559532361|FG000|Overall Study|Did not enjoy being in the control group|0|||
155140111|NCT00570310|559944407|FG000|Overall Study|Adverse Event|1|||
155029347|NCT03729570|559532362|FG001|Overall Study|Did not enjoy being in the control group|1|||
155029348|NCT01867294|559532365|FG000|Overall Study|Withdrawal by Subject|1|||
155029349|NCT01867294|559532366|FG001|Overall Study|Withdrawal by Subject|1|||
155029350|NCT01867294|559532367|FG002|Overall Study|Withdrawal by Subject|0|||
155029351|NCT01867294|559532368|FG003|Overall Study|Withdrawal by Subject|0|||
155029352|NCT00631410|559532371|FG000|Overall Study|Adverse Event|1|||
155029353|NCT00631410|559532372|FG001|Overall Study|Adverse Event|3|||
155029354|NCT00631410|559532371|FG000|Overall Study|Objective Progression or Relapse|4|||
155140112|NCT00570310|559944408|FG001|Overall Study|Adverse Event|2|||
155029355|NCT00631410|559532372|FG001|Overall Study|Objective Progression or Relapse|3|||
155029356|NCT00631410|559532371|FG000|Overall Study|Surgery|1|||
155029357|NCT00631410|559532372|FG001|Overall Study|Surgery|0|||
155029358|NCT01322035|559532374|FG000|Overall Study|Lost to Follow-up|8|||
155029359|NCT01322035|559532375|FG001|Overall Study|Lost to Follow-up|3|||
155029360|NCT00727844|559532376|FG000|Initial Randomization|Physician Decision|2|||
155029361|NCT00727844|559532377|FG001|Initial Randomization|Physician Decision|0|||
155029362|NCT00727844|559532378|FG002|Initial Randomization|Physician Decision|0|||
155029363|NCT00727844|559532379|FG003|Initial Randomization|Physician Decision|0|||
155029364|NCT04569968|559532380|FG000|Overall Study|Lost to Follow-up|2|||
155029365|NCT04569968|559532381|FG001|Overall Study|Lost to Follow-up|5|||
155029366|NCT04569968|559532380|FG000|Overall Study|Story of head and/or neck surgery|2|||
155029367|NCT04569968|559532381|FG001|Overall Study|Story of head and/or neck surgery|2|||
155029368|NCT04569968|559532380|FG000|Overall Study|Time of stroke onset|8|||
155029369|NCT04569968|559532381|FG001|Overall Study|Time of stroke onset|7|||
155029370|NCT04569968|559532380|FG000|Overall Study|Type of strokr|12|||
155029371|NCT04569968|559532381|FG001|Overall Study|Type of strokr|8|||
155029372|NCT04569968|559532380|FG000|Overall Study|Cooperation|8|||
155029373|NCT04569968|559532381|FG001|Overall Study|Cooperation|8|||
155029374|NCT04569968|559532380|FG000|Overall Study|Age interval|17|||
155029375|NCT04569968|559532381|FG001|Overall Study|Age interval|6|||
155029376|NCT04569968|559532380|FG000|Overall Study|Denial of participation to the study|0|||
155029377|NCT04569968|559532381|FG001|Overall Study|Denial of participation to the study|3|||
155029378|NCT04569968|559532380|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
155029379|NCT04569968|559532381|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
155029380|NCT04569968|559532380|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
155029381|NCT04569968|559532381|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
155029382|NCT04569968|559532380|FG000|Overall Study|Quarantine|1|||
155029383|NCT04569968|559532381|FG001|Overall Study|Quarantine|0|||
155029384|NCT04569968|559532380|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
155029385|NCT04569968|559532381|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
155029386|NCT04569968|559532380|FG000|Overall Study|Repetitive stroke|8|||
155029387|NCT04569968|559532381|FG001|Overall Study|Repetitive stroke|0|||
155029388|NCT04569968|559532380|FG000|Overall Study|Insufficient mastication|1|||
155029389|NCT04569968|559532381|FG001|Overall Study|Insufficient mastication|0|||
155029390|NCT04569968|559532380|FG000|Overall Study|Infection|1|||
155029391|NCT04569968|559532381|FG001|Overall Study|Infection|0|||
155029392|NCT03843632|559532397|FG000|Overall Study|Withdrawal by Subject|1|||
155029393|NCT03843632|559532398|FG001|Overall Study|Withdrawal by Subject|0|||
155029394|NCT03843632|559532399|FG002|Overall Study|Withdrawal by Subject|0|||
155029395|NCT03843632|559532400|FG003|Overall Study|Withdrawal by Subject|0|||
155029396|NCT03085238|559532401|FG000|Overall Study|Adverse Event|2|||
155029397|NCT03085238|559532401|FG000|Overall Study|Death|2|||
155029398|NCT02847494|559532405|FG000|Overall Study|Lost to Follow-up|8|||
155029399|NCT02847494|559532406|FG001|Overall Study|Lost to Follow-up|5|||
155029400|NCT03226769|559532407|FG000|Overall Study|Withdrawal by Subject|0|||
155029401|NCT03226769|559532408|FG001|Overall Study|Withdrawal by Subject|1|||
155029402|NCT02640677|559532409|FG000|Overall Study|Lost to Follow-up|1|||
155029403|NCT02640677|559532409|FG000|Overall Study|Withdrawal by Subject|1|||
155029404|NCT01684943|559532411|FG000|Overall Study|Inadequate Venous Access|3|||
155029405|NCT01684943|559532412|FG001|Overall Study|Inadequate Venous Access|0|||
155029406|NCT01684943|559532413|FG002|Overall Study|Inadequate Venous Access|0|||
155029407|NCT01684943|559532411|FG000|Overall Study|Principal Investigator Determination|1|||
155029408|NCT01684943|559532412|FG001|Overall Study|Principal Investigator Determination|0|||
155029409|NCT01684943|559532413|FG002|Overall Study|Principal Investigator Determination|0|||
155029410|NCT01684943|559532411|FG000|Overall Study|Excluded from Analysis|1|||
155029411|NCT01684943|559532412|FG001|Overall Study|Excluded from Analysis|1|||
155029412|NCT01684943|559532413|FG002|Overall Study|Excluded from Analysis|1|||
155029413|NCT01684943|559532411|FG000|Overall Study|Lost to Follow-up|3|||
155029414|NCT01684943|559532412|FG001|Overall Study|Lost to Follow-up|0|||
155029415|NCT01684943|559532413|FG002|Overall Study|Lost to Follow-up|0|||
155029416|NCT01684943|559532411|FG000|Overall Study|Planning Pregnancy|1|||
155029417|NCT01684943|559532412|FG001|Overall Study|Planning Pregnancy|0|||
155029418|NCT01684943|559532413|FG002|Overall Study|Planning Pregnancy|0|||
155029419|NCT03395184|559532414|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
155029420|NCT03395184|559532415|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
155029421|NCT03395184|559532416|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
155029422|NCT03395184|559532417|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155029423|NCT03395184|559532418|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155029424|NCT03395184|559532419|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155029425|NCT03395184|559532420|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
155029426|NCT03395184|559532414|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155029427|NCT03395184|559532415|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
155029428|NCT03395184|559532416|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
155029429|NCT03395184|559532417|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155029430|NCT03395184|559532418|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155140113|NCT00570310|559944407|FG000|Overall Study|Lack of Efficacy|1|||
155029431|NCT03395184|559532419|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155029432|NCT03395184|559532420|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
155029433|NCT03395184|559532414|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
155029434|NCT03395184|559532415|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
155029435|NCT03395184|559532416|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155029436|NCT03395184|559532417|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155029437|NCT03395184|559532418|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155029438|NCT03395184|559532419|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155029439|NCT03395184|559532420|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
155029440|NCT03395184|559532414|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155029441|NCT03395184|559532415|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
155029442|NCT03395184|559532416|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155029443|NCT03395184|559532417|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155029444|NCT03395184|559532418|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155029445|NCT03395184|559532419|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155029446|NCT03395184|559532420|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
155029447|NCT03395184|559532414|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
155029448|NCT03395184|559532415|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155029449|NCT03395184|559532416|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
155029450|NCT03395184|559532417|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155029451|NCT03395184|559532418|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155029452|NCT03395184|559532419|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155029453|NCT03395184|559532420|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
155029454|NCT03395184|559532414|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
155029455|NCT03395184|559532415|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
155029456|NCT03395184|559532416|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
155029457|NCT03395184|559532417|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
155029458|NCT03395184|559532418|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
155029459|NCT03395184|559532419|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
155029460|NCT03395184|559532420|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
155029461|NCT03395184|559532414|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
155029462|NCT03395184|559532415|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
155029463|NCT03395184|559532416|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
155029464|NCT03395184|559532417|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
155029465|NCT03395184|559532418|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
155029466|NCT03395184|559532419|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
155029467|NCT03395184|559532420|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
155029468|NCT03395184|559532414|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
155029469|NCT03395184|559532415|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
155029470|NCT03395184|559532416|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
155029471|NCT03395184|559532417|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
155029472|NCT03395184|559532418|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
155029473|NCT03395184|559532419|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
155029474|NCT03395184|559532420|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
155029475|NCT03395184|559532414|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155029476|NCT03395184|559532415|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155029477|NCT03395184|559532416|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155029478|NCT03395184|559532417|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155029479|NCT03395184|559532418|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
155029480|NCT03395184|559532419|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155029481|NCT03395184|559532420|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
155029482|NCT03395184|559532414|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
155029483|NCT03395184|559532415|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
155029484|NCT03395184|559532416|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
155029485|NCT03395184|559532417|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
155029486|NCT03395184|559532418|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
155029487|NCT03395184|559532419|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
155029488|NCT03395184|559532420|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
155029489|NCT03395184|559532414|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155029490|NCT03395184|559532415|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155029491|NCT03395184|559532416|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155029492|NCT03395184|559532417|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
155029493|NCT03395184|559532418|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155029494|NCT03395184|559532419|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
155029495|NCT03395184|559532420|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
155029496|NCT03395184|559532414|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
155029497|NCT03395184|559532415|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
155029498|NCT03395184|559532416|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
155140114|NCT00570310|559944408|FG001|Overall Study|Lack of Efficacy|4|||
155029499|NCT03395184|559532417|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
155029500|NCT03395184|559532418|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
155029501|NCT03395184|559532419|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
155029502|NCT03395184|559532420|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
155029503|NCT01817582|559532424|FG000|Overall Study|Withdrawal by Subject|0|||
155029504|NCT01817582|559532425|FG001|Overall Study|Withdrawal by Subject|1|||
155029505|NCT01817582|559532426|FG002|Overall Study|Withdrawal by Subject|0|||
155029506|NCT01817582|559532424|FG000|Overall Study|Participant revealed masked treatment|1|||
155029507|NCT01817582|559532425|FG001|Overall Study|Participant revealed masked treatment|0|||
155029508|NCT01817582|559532426|FG002|Overall Study|Participant revealed masked treatment|0|||
155029509|NCT01817582|559532424|FG000|Overall Study|Randomized but exclusion criteria met|1|||
155029510|NCT01817582|559532425|FG001|Overall Study|Randomized but exclusion criteria met|0|||
155029511|NCT01817582|559532426|FG002|Overall Study|Randomized but exclusion criteria met|0|||
155029512|NCT03053063|559532427|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
155029513|NCT03053063|559532428|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
155029514|NCT03053063|559532429|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
155029515|NCT03053063|559532430|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
155029516|NCT03053063|559532427|FG000|Randomized Phase|Withdrew consent|8|||
155029517|NCT03053063|559532428|FG001|Randomized Phase|Withdrew consent|11|||
155029518|NCT03053063|559532429|FG002|Randomized Phase|Withdrew consent|5|||
155029519|NCT03053063|559532430|FG003|Randomized Phase|Withdrew consent|0|||
155029520|NCT03053063|559532427|FG000|Randomized Phase|Investigator's Discretion|8|||
155029521|NCT03053063|559532428|FG001|Randomized Phase|Investigator's Discretion|6|||
155029522|NCT03053063|559532429|FG002|Randomized Phase|Investigator's Discretion|2|||
155029523|NCT03053063|559532430|FG003|Randomized Phase|Investigator's Discretion|0|||
155029524|NCT03053063|559532427|FG000|Randomized Phase|Lost to Follow-up|3|||
155029525|NCT03053063|559532428|FG001|Randomized Phase|Lost to Follow-up|5|||
155029526|NCT03053063|559532429|FG002|Randomized Phase|Lost to Follow-up|1|||
155029527|NCT03053063|559532430|FG003|Randomized Phase|Lost to Follow-up|0|||
155029528|NCT03053063|559532427|FG000|Randomized Phase|Adverse Event|0|||
155029529|NCT03053063|559532428|FG001|Randomized Phase|Adverse Event|1|||
155029530|NCT03053063|559532429|FG002|Randomized Phase|Adverse Event|0|||
155029531|NCT03053063|559532430|FG003|Randomized Phase|Adverse Event|0|||
155029532|NCT03053063|559532427|FG000|Randomized Phase|Randomized but Never Treated|1|||
155029533|NCT03053063|559532428|FG001|Randomized Phase|Randomized but Never Treated|3|||
155029534|NCT03053063|559532429|FG002|Randomized Phase|Randomized but Never Treated|2|||
155029535|NCT03053063|559532430|FG003|Randomized Phase|Randomized but Never Treated|0|||
155029536|NCT03053063|559532427|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
155029537|NCT03053063|559532428|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
155029538|NCT03053063|559532429|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
155029539|NCT03053063|559532430|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
155029540|NCT03053063|559532427|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
155029541|NCT03053063|559532428|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
155029542|NCT03053063|559532429|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
155029543|NCT03053063|559532430|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
155029544|NCT03053063|559532427|FG000|Open-Label Phase|Death|0|||
155029545|NCT03053063|559532428|FG001|Open-Label Phase|Death|0|||
155029546|NCT03053063|559532429|FG002|Open-Label Phase|Death|0|||
155029547|NCT03053063|559532430|FG003|Open-Label Phase|Death|2|||
155029548|NCT03053063|559532427|FG000|Open-Label Phase|Investigator's discretion|0|||
155029549|NCT03053063|559532428|FG001|Open-Label Phase|Investigator's discretion|0|||
155029550|NCT03053063|559532429|FG002|Open-Label Phase|Investigator's discretion|0|||
155029551|NCT03053063|559532430|FG003|Open-Label Phase|Investigator's discretion|2|||
155029552|NCT02600845|559532431|FG000|Overall Study|Reason Not Specified|3|||
155029553|NCT02600845|559532431|FG000|Overall Study|Non-compliance with Study Procedures|10|||
155029554|NCT02600845|559532431|FG000|Overall Study|Consent Withdrawal|5|||
155029555|NCT03963232|559532434|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
155029556|NCT03963232|559532435|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
155029557|NCT03963232|559532434|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
155029558|NCT03963232|559532435|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
155029559|NCT03963232|559532434|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
155029560|NCT03963232|559532435|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
155029561|NCT03963232|559532434|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
155029562|NCT03963232|559532435|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
155029563|NCT03963232|559532434|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
155029564|NCT03963232|559532435|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
155029565|NCT03963232|559532434|FG000|Open-Label Treatment Phase|Adverse Event|1|||
155029566|NCT03963232|559532435|FG001|Open-Label Treatment Phase|Adverse Event|2|||
155029567|NCT03963232|559532434|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
155140115|NCT00479336|559944410|FG000|Overall Study|Adverse Event|1|||
155140116|NCT00479336|559944411|FG001|Overall Study|Adverse Event|1|||
155140117|NCT00479336|559944412|FG002|Overall Study|Adverse Event|1|||
155140118|NCT00479336|559944413|FG003|Overall Study|Adverse Event|3|||
155029568|NCT03963232|559532435|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
155029569|NCT03963232|559532434|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
155029570|NCT03963232|559532435|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
155029571|NCT03963232|559532434|FG000|Open-Label Treatment Phase|Pregnancy|1|||
155029572|NCT03963232|559532435|FG001|Open-Label Treatment Phase|Pregnancy|0|||
155029573|NCT03963232|559532434|FG000|Follow-up Phase|Withdrawal by Subject|7|||
155029574|NCT03963232|559532435|FG001|Follow-up Phase|Withdrawal by Subject|5|||
155029575|NCT03963232|559532434|FG000|Follow-up Phase|Protocol Violation|0|||
155029576|NCT03963232|559532435|FG001|Follow-up Phase|Protocol Violation|2|||
155029577|NCT03963232|559532434|FG000|Follow-up Phase|Adverse Event|0|||
155029578|NCT03963232|559532435|FG001|Follow-up Phase|Adverse Event|1|||
155029579|NCT03963232|559532434|FG000|Follow-up Phase|Lost to Follow-up|0|||
155029580|NCT03963232|559532435|FG001|Follow-up Phase|Lost to Follow-up|1|||
155029581|NCT03617770|559532436|FG000|Overall Study|Lost to Follow-up|1|||
155029582|NCT03617770|559532437|FG001|Overall Study|Lost to Follow-up|0|||
155029583|NCT01672710|559532438|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
155029584|NCT01672710|559532439|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
155029585|NCT01672710|559532438|FG000|3 Month Follow up|Lost to Follow-up|2|||
155029586|NCT01672710|559532439|FG001|3 Month Follow up|Lost to Follow-up|3|||
155029587|NCT01672710|559532438|FG000|3 Month Follow up|follow up due after termination date|4|||
155029588|NCT01672710|559532439|FG001|3 Month Follow up|follow up due after termination date|1|||
155029589|NCT05033262|559532440|FG000|Overall Study|Lost to Follow-up|1|||
155029590|NCT05033262|559532441|FG001|Overall Study|Lost to Follow-up|0|||
155029591|NCT05033262|559532442|FG002|Overall Study|Lost to Follow-up|0|||
155029592|NCT05033262|559532443|FG003|Overall Study|Lost to Follow-up|1|||
155029593|NCT03055494|559534918|FG000|Overall Study|Lost to Follow-up|6|||
155029594|NCT03055494|559534919|FG001|Overall Study|Lost to Follow-up|0|||
155029595|NCT03055494|559534918|FG000|Overall Study|Physician Decision|2|||
155029596|NCT03055494|559534919|FG001|Overall Study|Physician Decision|0|||
155029597|NCT03055494|559534918|FG000|Overall Study|Withdrawal by Subject|1|||
155029598|NCT03055494|559534919|FG001|Overall Study|Withdrawal by Subject|0|||
155029599|NCT03055494|559534918|FG000|Overall Study|Adverse Event|0|||
155029600|NCT03055494|559534919|FG001|Overall Study|Adverse Event|1|||
155029601|NCT03055494|559534918|FG000|Overall Study|Non-compliance with study treatment|1|||
155029602|NCT03055494|559534919|FG001|Overall Study|Non-compliance with study treatment|0|||
155029603|NCT03666533|559534920|FG000|Overall Study|Lost to Follow-up|2|||
155029604|NCT03666533|559534921|FG001|Overall Study|Lost to Follow-up|2|||
155029605|NCT02017717|559534922|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029606|NCT02017717|559534923|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029607|NCT02017717|559534924|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029608|NCT02017717|559534925|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029609|NCT02017717|559534926|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029610|NCT02017717|559534927|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029611|NCT02017717|559534928|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029612|NCT02017717|559534929|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
155029613|NCT02017717|559534930|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
155029614|NCT02017717|559534922|FG000|Before Treatment Period|Participant request to stop therapy|0|||
155029615|NCT02017717|559534923|FG001|Before Treatment Period|Participant request to stop therapy|0|||
155029616|NCT02017717|559534924|FG002|Before Treatment Period|Participant request to stop therapy|0|||
155029617|NCT02017717|559534925|FG003|Before Treatment Period|Participant request to stop therapy|0|||
155029618|NCT02017717|559534926|FG004|Before Treatment Period|Participant request to stop therapy|0|||
155029619|NCT02017717|559534927|FG005|Before Treatment Period|Participant request to stop therapy|0|||
155029620|NCT02017717|559534928|FG006|Before Treatment Period|Participant request to stop therapy|0|||
155029621|NCT02017717|559534929|FG007|Before Treatment Period|Participant request to stop therapy|0|||
155029622|NCT02017717|559534930|FG008|Before Treatment Period|Participant request to stop therapy|5|||
155029623|NCT02017717|559534922|FG000|Before Treatment Period|Participant withdrew consent|0|||
155029624|NCT02017717|559534923|FG001|Before Treatment Period|Participant withdrew consent|0|||
155029625|NCT02017717|559534924|FG002|Before Treatment Period|Participant withdrew consent|0|||
155029626|NCT02017717|559534925|FG003|Before Treatment Period|Participant withdrew consent|0|||
155029627|NCT02017717|559534926|FG004|Before Treatment Period|Participant withdrew consent|0|||
155029628|NCT02017717|559534927|FG005|Before Treatment Period|Participant withdrew consent|0|||
155029629|NCT02017717|559534928|FG006|Before Treatment Period|Participant withdrew consent|2|||
155029630|NCT02017717|559534929|FG007|Before Treatment Period|Participant withdrew consent|0|||
155029631|NCT02017717|559534930|FG008|Before Treatment Period|Participant withdrew consent|11|||
155029632|NCT02017717|559534922|FG000|Before Treatment Period|Lost to Follow-up|0|||
155029633|NCT02017717|559534923|FG001|Before Treatment Period|Lost to Follow-up|0|||
155029634|NCT02017717|559534924|FG002|Before Treatment Period|Lost to Follow-up|0|||
155029635|NCT02017717|559534925|FG003|Before Treatment Period|Lost to Follow-up|0|||
155029636|NCT02017717|559534926|FG004|Before Treatment Period|Lost to Follow-up|0|||
155029637|NCT02017717|559534927|FG005|Before Treatment Period|Lost to Follow-up|0|||
155029638|NCT02017717|559534928|FG006|Before Treatment Period|Lost to Follow-up|0|||
155029639|NCT02017717|559534929|FG007|Before Treatment Period|Lost to Follow-up|0|||
155029640|NCT02017717|559534930|FG008|Before Treatment Period|Lost to Follow-up|1|||
155029641|NCT02017717|559534922|FG000|Before Treatment Period|Participant no longer met criteria|0|||
155029642|NCT02017717|559534923|FG001|Before Treatment Period|Participant no longer met criteria|0|||
155029643|NCT02017717|559534924|FG002|Before Treatment Period|Participant no longer met criteria|0|||
155029644|NCT02017717|559534925|FG003|Before Treatment Period|Participant no longer met criteria|0|||
155029645|NCT02017717|559534926|FG004|Before Treatment Period|Participant no longer met criteria|0|||
155029646|NCT02017717|559534927|FG005|Before Treatment Period|Participant no longer met criteria|1|||
155029647|NCT02017717|559534928|FG006|Before Treatment Period|Participant no longer met criteria|0|||
155029648|NCT02017717|559534929|FG007|Before Treatment Period|Participant no longer met criteria|1|||
155029649|NCT02017717|559534930|FG008|Before Treatment Period|Participant no longer met criteria|2|||
155029650|NCT02017717|559534922|FG000|Before Treatment Period|other reason|0|||
155029651|NCT02017717|559534923|FG001|Before Treatment Period|other reason|0|||
155029652|NCT02017717|559534924|FG002|Before Treatment Period|other reason|0|||
155029653|NCT02017717|559534925|FG003|Before Treatment Period|other reason|0|||
155029654|NCT02017717|559534926|FG004|Before Treatment Period|other reason|0|||
155029655|NCT02017717|559534927|FG005|Before Treatment Period|other reason|0|||
155029656|NCT02017717|559534928|FG006|Before Treatment Period|other reason|0|||
155029657|NCT02017717|559534929|FG007|Before Treatment Period|other reason|0|||
155029658|NCT02017717|559534930|FG008|Before Treatment Period|other reason|1|||
155029659|NCT02017717|559534922|FG000|Treatment Period|Disease progression|7|||
155029660|NCT02017717|559534923|FG001|Treatment Period|Disease progression|9|||
155029661|NCT02017717|559534924|FG002|Treatment Period|Disease progression|12|||
155029662|NCT02017717|559534925|FG003|Treatment Period|Disease progression|20|||
155029663|NCT02017717|559534926|FG004|Treatment Period|Disease progression|26|||
155029664|NCT02017717|559534927|FG005|Treatment Period|Disease progression|16|||
155029665|NCT02017717|559534928|FG006|Treatment Period|Disease progression|22|||
155029666|NCT02017717|559534929|FG007|Treatment Period|Disease progression|165|||
155029667|NCT02017717|559534930|FG008|Treatment Period|Disease progression|135|||
155029668|NCT02017717|559534922|FG000|Treatment Period|Study drug toxicity|3|||
155029669|NCT02017717|559534923|FG001|Treatment Period|Study drug toxicity|0|||
155029670|NCT02017717|559534924|FG002|Treatment Period|Study drug toxicity|1|||
155029671|NCT02017717|559534925|FG003|Treatment Period|Study drug toxicity|4|||
155029672|NCT02017717|559534926|FG004|Treatment Period|Study drug toxicity|4|||
155029673|NCT02017717|559534927|FG005|Treatment Period|Study drug toxicity|5|||
155029674|NCT02017717|559534928|FG006|Treatment Period|Study drug toxicity|3|||
155029675|NCT02017717|559534929|FG007|Treatment Period|Study drug toxicity|7|||
155029676|NCT02017717|559534930|FG008|Treatment Period|Study drug toxicity|11|||
155029677|NCT02017717|559534922|FG000|Treatment Period|Death|0|||
155029678|NCT02017717|559534923|FG001|Treatment Period|Death|0|||
155029679|NCT02017717|559534924|FG002|Treatment Period|Death|1|||
155029680|NCT02017717|559534925|FG003|Treatment Period|Death|0|||
155029681|NCT02017717|559534926|FG004|Treatment Period|Death|0|||
155029682|NCT02017717|559534927|FG005|Treatment Period|Death|2|||
155029683|NCT02017717|559534928|FG006|Treatment Period|Death|0|||
155029684|NCT02017717|559534929|FG007|Treatment Period|Death|0|||
155029685|NCT02017717|559534930|FG008|Treatment Period|Death|0|||
155029686|NCT02017717|559534922|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
155029687|NCT02017717|559534923|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
155029688|NCT02017717|559534924|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
155029689|NCT02017717|559534925|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
155029690|NCT02017717|559534926|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
155029691|NCT02017717|559534927|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
155029692|NCT02017717|559534928|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
155029693|NCT02017717|559534929|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
155029694|NCT02017717|559534930|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
155029695|NCT02017717|559534922|FG000|Treatment Period|Participant request to stop therapy|0|||
155029696|NCT02017717|559534923|FG001|Treatment Period|Participant request to stop therapy|0|||
155029697|NCT02017717|559534924|FG002|Treatment Period|Participant request to stop therapy|3|||
155029698|NCT02017717|559534925|FG003|Treatment Period|Participant request to stop therapy|6|||
155029699|NCT02017717|559534926|FG004|Treatment Period|Participant request to stop therapy|0|||
155029700|NCT02017717|559534927|FG005|Treatment Period|Participant request to stop therapy|2|||
155029701|NCT02017717|559534928|FG006|Treatment Period|Participant request to stop therapy|1|||
155029702|NCT02017717|559534929|FG007|Treatment Period|Participant request to stop therapy|4|||
155029703|NCT02017717|559534930|FG008|Treatment Period|Participant request to stop therapy|7|||
155029704|NCT02017717|559534922|FG000|Treatment Period|Participant withdrew consent|0|||
155029705|NCT02017717|559534923|FG001|Treatment Period|Participant withdrew consent|0|||
155029706|NCT02017717|559534924|FG002|Treatment Period|Participant withdrew consent|1|||
155029707|NCT02017717|559534925|FG003|Treatment Period|Participant withdrew consent|0|||
155029708|NCT02017717|559534926|FG004|Treatment Period|Participant withdrew consent|0|||
155140119|NCT00479336|559944410|FG000|Overall Study|Lack of Efficacy|1|||
155029709|NCT02017717|559534927|FG005|Treatment Period|Participant withdrew consent|2|||
155029710|NCT02017717|559534928|FG006|Treatment Period|Participant withdrew consent|0|||
155029711|NCT02017717|559534929|FG007|Treatment Period|Participant withdrew consent|1|||
155029712|NCT02017717|559534930|FG008|Treatment Period|Participant withdrew consent|4|||
155029713|NCT02017717|559534922|FG000|Treatment Period|Participant no longer met criteria|0|||
155029714|NCT02017717|559534923|FG001|Treatment Period|Participant no longer met criteria|0|||
155029715|NCT02017717|559534924|FG002|Treatment Period|Participant no longer met criteria|0|||
155029716|NCT02017717|559534925|FG003|Treatment Period|Participant no longer met criteria|0|||
155029717|NCT02017717|559534926|FG004|Treatment Period|Participant no longer met criteria|0|||
155029718|NCT02017717|559534927|FG005|Treatment Period|Participant no longer met criteria|0|||
155029719|NCT02017717|559534928|FG006|Treatment Period|Participant no longer met criteria|0|||
155029720|NCT02017717|559534929|FG007|Treatment Period|Participant no longer met criteria|0|||
155029721|NCT02017717|559534930|FG008|Treatment Period|Participant no longer met criteria|1|||
155029722|NCT02017717|559534922|FG000|Treatment Period|Other reasons|0|||
155029723|NCT02017717|559534923|FG001|Treatment Period|Other reasons|0|||
155029724|NCT02017717|559534924|FG002|Treatment Period|Other reasons|0|||
155029725|NCT02017717|559534925|FG003|Treatment Period|Other reasons|1|||
155029726|NCT02017717|559534926|FG004|Treatment Period|Other reasons|0|||
155029727|NCT02017717|559534927|FG005|Treatment Period|Other reasons|1|||
155029728|NCT02017717|559534928|FG006|Treatment Period|Other reasons|1|||
155029729|NCT02017717|559534929|FG007|Treatment Period|Other reasons|1|||
155029730|NCT02017717|559534930|FG008|Treatment Period|Other reasons|1|||
155029731|NCT02017717|559534922|FG000|Treatment Period|Maximum clinical benefit|0|||
155029732|NCT02017717|559534923|FG001|Treatment Period|Maximum clinical benefit|0|||
155029733|NCT02017717|559534924|FG002|Treatment Period|Maximum clinical benefit|0|||
155029734|NCT02017717|559534925|FG003|Treatment Period|Maximum clinical benefit|0|||
155029735|NCT02017717|559534926|FG004|Treatment Period|Maximum clinical benefit|0|||
155029736|NCT02017717|559534927|FG005|Treatment Period|Maximum clinical benefit|0|||
155029737|NCT02017717|559534928|FG006|Treatment Period|Maximum clinical benefit|0|||
155029738|NCT02017717|559534929|FG007|Treatment Period|Maximum clinical benefit|0|||
155029739|NCT02017717|559534930|FG008|Treatment Period|Maximum clinical benefit|1|||
155029740|NCT02017717|559534922|FG000|Treatment Period|Not reported|0|||
155029741|NCT02017717|559534923|FG001|Treatment Period|Not reported|1|||
155029742|NCT02017717|559534924|FG002|Treatment Period|Not reported|0|||
155029743|NCT02017717|559534925|FG003|Treatment Period|Not reported|0|||
155029744|NCT02017717|559534926|FG004|Treatment Period|Not reported|0|||
155029745|NCT02017717|559534927|FG005|Treatment Period|Not reported|0|||
155029746|NCT02017717|559534928|FG006|Treatment Period|Not reported|0|||
155029747|NCT02017717|559534929|FG007|Treatment Period|Not reported|0|||
155029748|NCT02017717|559534930|FG008|Treatment Period|Not reported|0|||
155029749|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
155029750|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
155029751|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
155029752|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
155029753|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
155029754|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
155029755|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
155029756|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
155029757|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
155029758|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
155029759|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
155029760|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
155029761|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
155029762|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
155029763|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
155029764|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
155029765|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
155029766|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
155029767|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
155029768|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
155029769|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
155029770|NCT04488419|559534931|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
155029771|NCT04488419|559534932|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
155029772|NCT04488419|559534933|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
155140120|NCT00479336|559944411|FG001|Overall Study|Lack of Efficacy|0|||
155140121|NCT00479336|559944412|FG002|Overall Study|Lack of Efficacy|0|||
155140122|NCT00479336|559944413|FG003|Overall Study|Lack of Efficacy|0|||
155140123|NCT00479336|559944410|FG000|Overall Study|Protocol Violation|0|||
155140124|NCT00479336|559944411|FG001|Overall Study|Protocol Violation|1|||
155140125|NCT00479336|559944412|FG002|Overall Study|Protocol Violation|0|||
155140126|NCT00479336|559944413|FG003|Overall Study|Protocol Violation|0|||
155029773|NCT04488419|559534931|FG000|Primary Analysis Population|Adverse Event|6|||
155029774|NCT04488419|559534932|FG001|Primary Analysis Population|Adverse Event|9|||
155029775|NCT04488419|559534933|FG002|Primary Analysis Population|Adverse Event|0|||
155029776|NCT04488419|559534931|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
155029777|NCT04488419|559534932|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
155029778|NCT04488419|559534933|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
155029779|NCT04488419|559534931|FG000|Primary Analysis Population|Protocol Violation|1|||
155029780|NCT04488419|559534932|FG001|Primary Analysis Population|Protocol Violation|1|||
155029781|NCT04488419|559534933|FG002|Primary Analysis Population|Protocol Violation|0|||
155029782|NCT04488419|559534931|FG000|Primary Analysis Population|Undetermined|7|||
155029783|NCT04488419|559534932|FG001|Primary Analysis Population|Undetermined|3|||
155029784|NCT04488419|559534933|FG002|Primary Analysis Population|Undetermined|0|||
155029785|NCT04488419|559534931|FG000|Primary Analysis Population|>1 Reason|2|||
155029786|NCT04488419|559534932|FG001|Primary Analysis Population|>1 Reason|4|||
155029787|NCT04488419|559534933|FG002|Primary Analysis Population|>1 Reason|0|||
155029788|NCT04338269|559534938|FG000|Overall Study|Death|86|||
155029789|NCT04338269|559534939|FG001|Overall Study|Death|89|||
155029790|NCT04338269|559534938|FG000|Overall Study|Lost to Follow-up|1|||
155029791|NCT04338269|559534939|FG001|Overall Study|Lost to Follow-up|2|||
155029792|NCT04338269|559534938|FG000|Overall Study|Physician Decision|1|||
155029793|NCT04338269|559534939|FG001|Overall Study|Physician Decision|0|||
155029794|NCT04338269|559534938|FG000|Overall Study|Withdrawal by Subject|14|||
155029795|NCT04338269|559534939|FG001|Overall Study|Withdrawal by Subject|11|||
155029796|NCT00970632|559534940|FG000|Overall Study|Adverse Event|2|||
155029797|NCT00970632|559534941|FG001|Overall Study|Adverse Event|2|||
155029798|NCT00970632|559534942|FG002|Overall Study|Adverse Event|1|||
155029799|NCT00970632|559534940|FG000|Overall Study|Lack of Efficacy|3|||
155029800|NCT00970632|559534941|FG001|Overall Study|Lack of Efficacy|0|||
155029801|NCT00970632|559534942|FG002|Overall Study|Lack of Efficacy|0|||
155029802|NCT00970632|559534940|FG000|Overall Study|Lost to Follow-up|3|||
155029803|NCT00970632|559534941|FG001|Overall Study|Lost to Follow-up|0|||
155029804|NCT00970632|559534942|FG002|Overall Study|Lost to Follow-up|2|||
155029805|NCT00970632|559534940|FG000|Overall Study|Protocol Violation|8|||
155029806|NCT00970632|559534941|FG001|Overall Study|Protocol Violation|5|||
155029807|NCT00970632|559534942|FG002|Overall Study|Protocol Violation|8|||
155029808|NCT00970632|559534940|FG000|Overall Study|Withdrawal by Subject|7|||
155029809|NCT00970632|559534941|FG001|Overall Study|Withdrawal by Subject|6|||
155029810|NCT00970632|559534942|FG002|Overall Study|Withdrawal by Subject|4|||
155029811|NCT00970632|559534940|FG000|Overall Study|Entry criteria not met|0|||
155029812|NCT00970632|559534941|FG001|Overall Study|Entry criteria not met|2|||
155029813|NCT00970632|559534942|FG002|Overall Study|Entry criteria not met|2|||
155029814|NCT00970632|559534940|FG000|Overall Study|Sponsor decision|1|||
155029815|NCT00970632|559534941|FG001|Overall Study|Sponsor decision|0|||
155029816|NCT00970632|559534942|FG002|Overall Study|Sponsor decision|1|||
155029817|NCT02487771|559534947|FG000|Overall Study|Lost to Follow-up|2|||
155029818|NCT02487771|559534948|FG001|Overall Study|Lost to Follow-up|3|||
155029819|NCT02487771|559534947|FG000|Overall Study|Moved out of area|5|||
155029820|NCT02487771|559534948|FG001|Overall Study|Moved out of area|6|||
155029821|NCT02487771|559534947|FG000|Overall Study|Withdrawal by Subject|3|||
155029822|NCT02487771|559534948|FG001|Overall Study|Withdrawal by Subject|5|||
155029823|NCT03875482|559534955|FG000|Overall Study|Adverse Event|0|||
155029824|NCT03875482|559534956|FG001|Overall Study|Adverse Event|1|||
155029825|NCT03875482|559534955|FG000|Overall Study|Withdrew consent|5|||
155029826|NCT03875482|559534956|FG001|Overall Study|Withdrew consent|6|||
155029827|NCT03875482|559534955|FG000|Overall Study|Lost to Follow-up|8|||
155029828|NCT03875482|559534956|FG001|Overall Study|Lost to Follow-up|2|||
155029829|NCT03875482|559534955|FG000|Overall Study|Lack of Efficacy|0|||
155029830|NCT03875482|559534956|FG001|Overall Study|Lack of Efficacy|11|||
155029831|NCT00507819|559534959|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
155029832|NCT00507819|559534960|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
155029833|NCT04507256|559534965|FG000|Overall Study|Withdrawal by Subject|1|||
155029834|NCT04507256|559534966|FG001|Overall Study|Withdrawal by Subject|0|||
155029835|NCT04507256|559534967|FG002|Overall Study|Withdrawal by Subject|0|||
155029836|NCT04507256|559534968|FG003|Overall Study|Withdrawal by Subject|1|||
155029837|NCT04507256|559534969|FG004|Overall Study|Withdrawal by Subject|0|||
155029838|NCT04507256|559534970|FG005|Overall Study|Withdrawal by Subject|0|||
155029839|NCT01676896|559534973|FG000|Overall Study|Withdrawal by Subject|12|||
155029840|NCT01676896|559534974|FG001|Overall Study|Withdrawal by Subject|7|||
155029841|NCT01676896|559534975|FG002|Overall Study|Withdrawal by Subject|19|||
155029842|NCT02256982|559534976|FG000|Overall Study|Disease Progression|0|||
155029843|NCT02256982|559534977|FG001|Overall Study|Disease Progression|1|||
155029844|NCT03614078|559534978|FG000|Overall Study|Withdrawal by Subject|2|||
155029845|NCT03614078|559534979|FG001|Overall Study|Withdrawal by Subject|2|||
155029846|NCT03614078|559534980|FG002|Overall Study|Withdrawal by Subject|3|||
155029847|NCT03614078|559534978|FG000|Overall Study|Participant Did Not Return for Visit|0|||
155029848|NCT03614078|559534979|FG001|Overall Study|Participant Did Not Return for Visit|1|||
155029849|NCT03614078|559534980|FG002|Overall Study|Participant Did Not Return for Visit|0|||
155029850|NCT03614078|559534978|FG000|Overall Study|High Neutrophils|0|||
155029851|NCT03614078|559534979|FG001|Overall Study|High Neutrophils|0|||
155029852|NCT03614078|559534980|FG002|Overall Study|High Neutrophils|2|||
155029853|NCT03614078|559534978|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
155029854|NCT03614078|559534979|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
155029855|NCT03614078|559534980|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
155029856|NCT03614078|559534978|FG000|Overall Study|Exacerbation of Psoriasis|0|||
155029857|NCT03614078|559534979|FG001|Overall Study|Exacerbation of Psoriasis|1|||
155029858|NCT03614078|559534980|FG002|Overall Study|Exacerbation of Psoriasis|0|||
155029859|NCT03614078|559534978|FG000|Overall Study|Adverse Event|0|||
155029860|NCT03614078|559534979|FG001|Overall Study|Adverse Event|2|||
155029861|NCT03614078|559534980|FG002|Overall Study|Adverse Event|0|||
155029862|NCT03614078|559534978|FG000|Overall Study|Dizziness and Rash|0|||
155029863|NCT03614078|559534979|FG001|Overall Study|Dizziness and Rash|1|||
155029864|NCT03614078|559534980|FG002|Overall Study|Dizziness and Rash|0|||
155029865|NCT02777970|559534983|FG000|Overall Study|Lost to Follow-up|0|||
155029866|NCT02777970|559534984|FG001|Overall Study|Lost to Follow-up|1|||
155029867|NCT02777970|559534985|FG002|Overall Study|Lost to Follow-up|0|||
155029868|NCT02777970|559534983|FG000|Overall Study|Protocol Violation|1|||
155029869|NCT02777970|559534984|FG001|Overall Study|Protocol Violation|0|||
155029870|NCT02777970|559534985|FG002|Overall Study|Protocol Violation|0|||
155029871|NCT02347891|559534989|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
155029872|NCT02347891|559534990|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
155029873|NCT02347891|559534989|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
155029874|NCT02347891|559534990|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
155029875|NCT02541669|559534991|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
155029876|NCT02541669|559534992|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
155029877|NCT02541669|559534993|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
155029878|NCT02541669|559534994|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
155029879|NCT02541669|559534995|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
155029880|NCT04739722|559534998|FG000|Overall Study|Lost to Follow-up|5301|||
155029881|NCT04739722|559534998|FG000|Overall Study|Withdrawal by Subject|42|||
155029882|NCT04739722|559534998|FG000|Overall Study|Non Average-risk|1157|||
155029883|NCT00834639|559534999|FG000|Second Intervention|Physician Decision|0|||
155029884|NCT00834639|559535000|FG001|Second Intervention|Physician Decision|2|||
155029885|NCT01869699|559535001|FG000|Overall Study|Withdrawal by Subject|1|||
155029886|NCT01869699|559535002|FG001|Overall Study|Withdrawal by Subject|0|||
155029887|NCT01083186|559535003|FG000|Overall Study|Lost to Follow-up|48|||
155029888|NCT01083186|559535003|FG000|Overall Study|Consent Withdrawal|7|||
155029889|NCT01083186|559535003|FG000|Overall Study|Death|3|||
155029890|NCT01083186|559535003|FG000|Overall Study|Adverse Event|3|||
155029891|NCT01083186|559535003|FG000|Overall Study|Lack of Efficacy|2|||
155029892|NCT01083186|559535003|FG000|Overall Study|Hemodialysis Initiation|28|||
155029893|NCT01083186|559535003|FG000|Overall Study|Administrative Reasons|2|||
155029894|NCT01083186|559535003|FG000|Overall Study|Non-compliance to Study Treatment|1|||
155029895|NCT03419598|559535010|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
155029896|NCT00380081|559535011|FG000|Overall Study|Withdrawal by Subject|0|||
155029897|NCT00380081|559535012|FG001|Overall Study|Withdrawal by Subject|0|||
155029898|NCT00380081|559535013|FG002|Overall Study|Withdrawal by Subject|0|||
155029899|NCT00380081|559535014|FG003|Overall Study|Withdrawal by Subject|0|||
155029900|NCT00380081|559535015|FG004|Overall Study|Withdrawal by Subject|1|||
155029901|NCT00380081|559535016|FG005|Overall Study|Withdrawal by Subject|0|||
155029902|NCT00380081|559535011|FG000|Overall Study|Family Emergency|0|||
155029903|NCT00380081|559535012|FG001|Overall Study|Family Emergency|0|||
155029904|NCT00380081|559535013|FG002|Overall Study|Family Emergency|0|||
155029905|NCT00380081|559535014|FG003|Overall Study|Family Emergency|0|||
155029906|NCT00380081|559535015|FG004|Overall Study|Family Emergency|0|||
155029907|NCT00380081|559535016|FG005|Overall Study|Family Emergency|1|||
155029908|NCT00189306|559535017|FG000|Treatment Period|Withdrawal by Subject|2|||
155029909|NCT00189306|559535017|FG000|Treatment Period|Adverse Event|2|||
155029910|NCT00189306|559535017|FG000|Treatment Period|Protocol Violation|1|||
155029911|NCT00189306|559535017|FG000|Posttreatment Period|Death|1|||
155029912|NCT00189306|559535017|FG000|Posttreatment Period|Withdrawal by Subject|2|||
155029913|NCT00189306|559535017|FG000|Posttreatment Period|Noncompliance|1|||
155029914|NCT00189306|559535017|FG000|Posttreatment Period|Target lesion excised|1|||
155181469|NCT02038829|560103087|FG009|Washout Period 2|Adverse Event|0|||
155181470|NCT02038829|560103088|FG010|Washout Period 2|Adverse Event|0|||
155029915|NCT00189306|559535017|FG000|Posttreatment Period|Protocol Violation|1|||
155029916|NCT00189306|559535017|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
155029917|NCT00189306|559535017|FG000|Posttreatment Period|Local skin reaction/sign|1|||
155029918|NCT00189306|559535017|FG000|Long-Term Follow-up|Adverse Event|2|||
155029919|NCT00189306|559535017|FG000|Long-Term Follow-up|Death|4|||
155181471|NCT02038829|560103089|FG011|Washout Period 2|Adverse Event|0|||
155029920|NCT00189306|559535017|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
155029921|NCT00189306|559535017|FG000|Long-Term Follow-up|Intercurrent disease|2|||
155029922|NCT00189306|559535017|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
155029923|NCT00189306|559535017|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
155029924|NCT00459706|559535018|FG000|Overall Study|Adverse Event|19|||
155029925|NCT00459706|559535019|FG001|Overall Study|Adverse Event|13|||
155029926|NCT00459706|559535018|FG000|Overall Study|Withdrawal by Subject|1|||
155029927|NCT00459706|559535019|FG001|Overall Study|Withdrawal by Subject|6|||
155029928|NCT00459706|559535018|FG000|Overall Study|Physician Decision|2|||
155029929|NCT00459706|559535019|FG001|Overall Study|Physician Decision|0|||
155029930|NCT00459706|559535018|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
155029931|NCT00459706|559535019|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155029932|NCT00459706|559535018|FG000|Overall Study|Protocol Violation|2|||
155029933|NCT00459706|559535019|FG001|Overall Study|Protocol Violation|1|||
155029934|NCT00459706|559535018|FG000|Overall Study|Failed to Return|1|||
155029935|NCT00459706|559535019|FG001|Overall Study|Failed to Return|0|||
155029936|NCT00459706|559535018|FG000|Overall Study|Other|0|||
155029937|NCT00459706|559535019|FG001|Overall Study|Other|1|||
155029938|NCT02017912|559535020|FG000|Overall Study|Withdrawal by Subject|2|||
155029939|NCT02017912|559535021|FG001|Overall Study|Withdrawal by Subject|1|||
155029940|NCT02017912|559535020|FG000|Overall Study|miscellaneous|1|||
155029941|NCT02017912|559535021|FG001|Overall Study|miscellaneous|1|||
155029942|NCT03640481|559535022|FG000|Overall Study|Death|14|||
155029943|NCT03640481|559535023|FG001|Overall Study|Death|14|||
155029944|NCT03640481|559535024|FG002|Overall Study|Death|0|||
155029945|NCT03640481|559535025|FG003|Overall Study|Death|0|||
155029946|NCT03640481|559535022|FG000|Overall Study|Lost to Follow-up|2|||
155029947|NCT03640481|559535023|FG001|Overall Study|Lost to Follow-up|0|||
155029948|NCT03640481|559535024|FG002|Overall Study|Lost to Follow-up|0|||
155029949|NCT03640481|559535025|FG003|Overall Study|Lost to Follow-up|0|||
155029950|NCT03640481|559535022|FG000|Overall Study|Site terminated by sponsor|1|||
155029951|NCT03640481|559535023|FG001|Overall Study|Site terminated by sponsor|3|||
155029952|NCT03640481|559535024|FG002|Overall Study|Site terminated by sponsor|0|||
155029953|NCT03640481|559535025|FG003|Overall Study|Site terminated by sponsor|0|||
155029954|NCT03640481|559535022|FG000|Overall Study|Study terminated by sponsor|29|||
155029955|NCT03640481|559535023|FG001|Overall Study|Study terminated by sponsor|42|||
155029956|NCT03640481|559535024|FG002|Overall Study|Study terminated by sponsor|1|||
155029957|NCT03640481|559535025|FG003|Overall Study|Study terminated by sponsor|0|||
155029958|NCT03640481|559535022|FG000|Overall Study|Withdrawal by Subject|5|||
155029959|NCT03640481|559535023|FG001|Overall Study|Withdrawal by Subject|4|||
155029960|NCT03640481|559535024|FG002|Overall Study|Withdrawal by Subject|0|||
155029961|NCT03640481|559535025|FG003|Overall Study|Withdrawal by Subject|1|||
155029962|NCT03640481|559535022|FG000|Overall Study|Other|26|||
155029963|NCT03640481|559535023|FG001|Overall Study|Other|12|||
155029964|NCT03640481|559535024|FG002|Overall Study|Other|1|||
155029965|NCT03640481|559535025|FG003|Overall Study|Other|0|||
155029966|NCT03640481|559535022|FG000|Overall Study|Randomized, but not treated|1|||
155029967|NCT03640481|559535023|FG001|Overall Study|Randomized, but not treated|3|||
155029968|NCT03640481|559535024|FG002|Overall Study|Randomized, but not treated|0|||
155029969|NCT03640481|559535025|FG003|Overall Study|Randomized, but not treated|0|||
155029970|NCT00535847|559535026|FG000|Overall Study|Adverse Event|5|||
155029971|NCT00535847|559535027|FG001|Overall Study|Adverse Event|3|||
155029972|NCT00535847|559535028|FG002|Overall Study|Adverse Event|2|||
155029973|NCT00535847|559535026|FG000|Overall Study|Non compliance|1|||
155029974|NCT00535847|559535027|FG001|Overall Study|Non compliance|1|||
155029975|NCT00535847|559535028|FG002|Overall Study|Non compliance|0|||
155029976|NCT00535847|559535026|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
155029977|NCT00535847|559535027|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
155029978|NCT00535847|559535028|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
155029979|NCT03197870|559535037|FG000|Overall Study|Adverse Event|9|||
155029980|NCT03197870|559535038|FG001|Overall Study|Adverse Event|4|||
155029981|NCT03197870|559535039|FG002|Overall Study|Adverse Event|6|||
155029982|NCT03197870|559535037|FG000|Overall Study|Withdrawal by Subject|2|||
155029983|NCT03197870|559535038|FG001|Overall Study|Withdrawal by Subject|3|||
155029984|NCT03197870|559535039|FG002|Overall Study|Withdrawal by Subject|0|||
155029985|NCT03197870|559535037|FG000|Overall Study|Lost to Follow-up|2|||
155029986|NCT03197870|559535038|FG001|Overall Study|Lost to Follow-up|2|||
155029987|NCT03197870|559535039|FG002|Overall Study|Lost to Follow-up|0|||
155029988|NCT03197870|559535037|FG000|Overall Study|data not available|1|||
155029989|NCT03197870|559535038|FG001|Overall Study|data not available|1|||
155029990|NCT03197870|559535039|FG002|Overall Study|data not available|0|||
155029991|NCT01618019|559535040|FG000|Overall Study|Withdrawal by Subject|14|||
155029992|NCT01618019|559535041|FG001|Overall Study|Withdrawal by Subject|14|||
155029993|NCT01508130|559535045|FG000|Overall Study|Adverse Event|81|||
155029994|NCT01508130|559535046|FG001|Overall Study|Adverse Event|28|||
155029995|NCT01508130|559535045|FG000|Overall Study|Death|3|||
155029996|NCT01508130|559535046|FG001|Overall Study|Death|1|||
155029997|NCT01508130|559535045|FG000|Overall Study|Protocol Violation|2|||
155029998|NCT01508130|559535046|FG001|Overall Study|Protocol Violation|0|||
155029999|NCT01508130|559535045|FG000|Overall Study|Lost to Follow-up|25|||
155030000|NCT01508130|559535046|FG001|Overall Study|Lost to Follow-up|2|||
155030001|NCT01508130|559535045|FG000|Overall Study|Withdrawal by Subject|3|||
155030002|NCT01508130|559535046|FG001|Overall Study|Withdrawal by Subject|3|||
155030003|NCT01508130|559535045|FG000|Overall Study|Subject's substantial non-compliance|25|||
155030004|NCT01508130|559535046|FG001|Overall Study|Subject's substantial non-compliance|9|||
155030005|NCT01508130|559535045|FG000|Overall Study|Insufficient therapeutic response|74|||
155030006|NCT01508130|559535046|FG001|Overall Study|Insufficient therapeutic response|23|||
155030007|NCT01508130|559535045|FG000|Overall Study|Administrative|14|||
155030008|NCT01508130|559535046|FG001|Overall Study|Administrative|3|||
155030009|NCT01680159|559535047|FG000|Screening Period|Not meet criteria for dose-up period|7|||
155030010|NCT01680159|559535047|FG000|Increased Dose Period|Adverse Event|6|||
155030011|NCT01680159|559535047|FG000|Increased Dose Period|Withdrawal by Subject|2|||
155030012|NCT02783729|559535051|FG000|Overall Study|Lack of Efficacy|1|||
155030013|NCT02783729|559535052|FG001|Overall Study|Lack of Efficacy|0|||
155030014|NCT02783729|559535053|FG002|Overall Study|Lack of Efficacy|0|||
155030015|NCT02783729|559535054|FG003|Overall Study|Lack of Efficacy|0|||
155030016|NCT02783729|559535051|FG000|Overall Study|Adverse Event|2|||
155030017|NCT02783729|559535052|FG001|Overall Study|Adverse Event|6|||
155030018|NCT02783729|559535053|FG002|Overall Study|Adverse Event|2|||
155030019|NCT02783729|559535054|FG003|Overall Study|Adverse Event|3|||
155030020|NCT02783729|559535051|FG000|Overall Study|Other|1|||
155030021|NCT02783729|559535052|FG001|Overall Study|Other|6|||
155030022|NCT02783729|559535053|FG002|Overall Study|Other|2|||
155030023|NCT02783729|559535054|FG003|Overall Study|Other|3|||
155030024|NCT02783729|559535051|FG000|Overall Study|Withdrawal by Subject|2|||
155030025|NCT02783729|559535052|FG001|Overall Study|Withdrawal by Subject|3|||
155030026|NCT02783729|559535053|FG002|Overall Study|Withdrawal by Subject|1|||
155030027|NCT02783729|559535054|FG003|Overall Study|Withdrawal by Subject|2|||
155030028|NCT02783729|559535051|FG000|Overall Study|Participant's choice|2|||
155030029|NCT02783729|559535052|FG001|Overall Study|Participant's choice|1|||
155030030|NCT02783729|559535053|FG002|Overall Study|Participant's choice|2|||
155030031|NCT02783729|559535054|FG003|Overall Study|Participant's choice|1|||
155030032|NCT02783729|559535051|FG000|Overall Study|Lost to Follow-up|2|||
155030033|NCT02783729|559535052|FG001|Overall Study|Lost to Follow-up|1|||
155030034|NCT02783729|559535053|FG002|Overall Study|Lost to Follow-up|1|||
155030035|NCT02783729|559535054|FG003|Overall Study|Lost to Follow-up|0|||
155030036|NCT02288091|559535056|FG000|Overall Study|Lost to Follow-up|1|||
155030037|NCT02288091|559535056|FG000|Overall Study|Screen fail|7|||
155030038|NCT03403751|559535057|FG000|Overall Study|Death|5|||
155030039|NCT03403751|559535058|FG001|Overall Study|Death|6|||
155030040|NCT03403751|559535057|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
155030041|NCT03403751|559535058|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
155030042|NCT00387010|559535062|FG000|Dose Titration Period|Adverse Event|12|||
155030043|NCT00387010|559535062|FG000|Dose Titration Period|Lack of Efficacy|5|||
155030044|NCT00387010|559535062|FG000|Dose Titration Period|Withdrawal by Subject|3|||
155030045|NCT00387010|559535062|FG000|Dose Titration Period|Protocol Violation|1|||
155030046|NCT00387010|559535062|FG000|Dose Titration Period|Lost to Follow-up|2|||
155030047|NCT00387010|559535062|FG000|Dose Titration Period|Noncompliance with study medication|8|||
155030048|NCT00387010|559535062|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
155030049|NCT00387010|559535062|FG000|Treatment Period|Adverse Event|4|||
155030050|NCT00387010|559535062|FG000|Treatment Period|Withdrawal by Subject|1|||
155030051|NCT00387010|559535062|FG000|Treatment Period|Noncompliance with study medication|2|||
155030052|NCT00387010|559535062|FG000|Treatment Period|Noncompliance with study procedures|3|||
155030053|NCT00387010|559535062|FG000|Treatment Period|Participant reported study drug stolen|1|||
155030054|NCT00520481|559535063|FG000|Overall Study|Adverse Event|4|||
155030055|NCT00520481|559535064|FG001|Overall Study|Adverse Event|1|||
155030056|NCT00520481|559535063|FG000|Overall Study|Withdrawal by Subject|3|||
155030057|NCT00520481|559535064|FG001|Overall Study|Withdrawal by Subject|0|||
155030058|NCT00471718|559535074|FG000|Overall Study|Adverse Event|3|||
155030059|NCT00471718|559535074|FG000|Overall Study|other complicating disease|1|||
155030060|NCT00471718|559535074|FG000|Overall Study|disease progression|22|||
155181472|NCT02038829|560103078|FG000|Washout Period 2|Withdrawal by Subject|0|||
155181473|NCT02038829|560103079|FG001|Washout Period 2|Withdrawal by Subject|0|||
155181474|NCT02038829|560103080|FG002|Washout Period 2|Withdrawal by Subject|0|||
155181475|NCT02038829|560103081|FG003|Washout Period 2|Withdrawal by Subject|0|||
155181476|NCT02038829|560103082|FG004|Washout Period 2|Withdrawal by Subject|0|||
155030061|NCT00471718|559535074|FG000|Overall Study|Withdrawal by Subject|1|||
155030062|NCT01931956|559535075|FG000|Overall Study|Death|42|||
155030063|NCT01931956|559535076|FG001|Overall Study|Death|7|||
155030064|NCT01931956|559535077|FG002|Overall Study|Death|379|||
155030065|NCT01931956|559535078|FG003|Overall Study|Death|96|||
155030066|NCT01931956|559535075|FG000|Overall Study|Withdrawal by Subject|5|||
155030067|NCT01931956|559535076|FG001|Overall Study|Withdrawal by Subject|0|||
155030068|NCT01931956|559535077|FG002|Overall Study|Withdrawal by Subject|70|||
155030069|NCT01931956|559535078|FG003|Overall Study|Withdrawal by Subject|30|||
155030070|NCT01931956|559535075|FG000|Overall Study|Lost to Follow-up|2|||
155030071|NCT01931956|559535076|FG001|Overall Study|Lost to Follow-up|0|||
155030072|NCT01931956|559535077|FG002|Overall Study|Lost to Follow-up|11|||
155030073|NCT01931956|559535078|FG003|Overall Study|Lost to Follow-up|7|||
155030074|NCT01931956|559535075|FG000|Overall Study|Expected|2|||
155030075|NCT01931956|559535076|FG001|Overall Study|Expected|0|||
155030076|NCT01931956|559535077|FG002|Overall Study|Expected|6|||
155030077|NCT01931956|559535078|FG003|Overall Study|Expected|0|||
155030078|NCT01931956|559535075|FG000|Overall Study|Not due|0|||
155030079|NCT01931956|559535076|FG001|Overall Study|Not due|0|||
155030080|NCT01931956|559535077|FG002|Overall Study|Not due|21|||
155030081|NCT01931956|559535078|FG003|Overall Study|Not due|0|||
155030082|NCT02294175|559535079|FG000|Overall Study|Withdrawal by Subject|1|||
155030083|NCT02294175|559535080|FG001|Overall Study|Withdrawal by Subject|2|||
155030084|NCT02294175|559535079|FG000|Overall Study|pt taking excluded medication|3|||
155030085|NCT02294175|559535080|FG001|Overall Study|pt taking excluded medication|1|||
155030086|NCT02294175|559535079|FG000|Overall Study|Protocol Violation|1|||
155030087|NCT02294175|559535080|FG001|Overall Study|Protocol Violation|0|||
155030088|NCT02294175|559535079|FG000|Overall Study|Lost to Follow-up|0|||
155030089|NCT02294175|559535080|FG001|Overall Study|Lost to Follow-up|1|||
155030090|NCT02294175|559535079|FG000|Overall Study|wound healed|0|||
155030091|NCT02294175|559535080|FG001|Overall Study|wound healed|2|||
155030092|NCT01901653|559535081|FG000|Overall Study|Death|2|||
155030093|NCT01901653|559535082|FG001|Overall Study|Death|1|||
155030094|NCT01901653|559535083|FG002|Overall Study|Death|8|||
155030095|NCT01901653|559535084|FG003|Overall Study|Death|3|||
155030096|NCT01901653|559535085|FG004|Overall Study|Death|2|||
155030097|NCT01901653|559535086|FG005|Overall Study|Death|2|||
155030098|NCT01901653|559535087|FG006|Overall Study|Death|6|||
155030099|NCT01901653|559535088|FG007|Overall Study|Death|9|||
155030100|NCT01901653|559535089|FG008|Overall Study|Death|1|||
155030101|NCT01901653|559535090|FG009|Overall Study|Death|16|||
155030102|NCT01901653|559535091|FG010|Overall Study|Death|2|||
155030103|NCT01901653|559535092|FG011|Overall Study|Death|15|||
155030104|NCT01901653|559535093|FG012|Overall Study|Death|4|||
155030105|NCT01901653|559535081|FG000|Overall Study|Lost to Follow-up|1|||
155030106|NCT01901653|559535082|FG001|Overall Study|Lost to Follow-up|0|||
155030107|NCT01901653|559535083|FG002|Overall Study|Lost to Follow-up|2|||
155030108|NCT01901653|559535084|FG003|Overall Study|Lost to Follow-up|0|||
155030109|NCT01901653|559535085|FG004|Overall Study|Lost to Follow-up|0|||
155030110|NCT01901653|559535086|FG005|Overall Study|Lost to Follow-up|1|||
155030111|NCT01901653|559535087|FG006|Overall Study|Lost to Follow-up|0|||
155030112|NCT01901653|559535088|FG007|Overall Study|Lost to Follow-up|1|||
155030113|NCT01901653|559535089|FG008|Overall Study|Lost to Follow-up|0|||
155030114|NCT01901653|559535090|FG009|Overall Study|Lost to Follow-up|0|||
155030115|NCT01901653|559535091|FG010|Overall Study|Lost to Follow-up|0|||
155030116|NCT01901653|559535092|FG011|Overall Study|Lost to Follow-up|0|||
155030117|NCT01901653|559535093|FG012|Overall Study|Lost to Follow-up|0|||
155030118|NCT01901653|559535081|FG000|Overall Study|Withdrawal by Subject|0|||
155030119|NCT01901653|559535082|FG001|Overall Study|Withdrawal by Subject|0|||
155030120|NCT01901653|559535083|FG002|Overall Study|Withdrawal by Subject|0|||
155030121|NCT01901653|559535084|FG003|Overall Study|Withdrawal by Subject|0|||
155030122|NCT01901653|559535085|FG004|Overall Study|Withdrawal by Subject|0|||
155030123|NCT01901653|559535086|FG005|Overall Study|Withdrawal by Subject|0|||
155030124|NCT01901653|559535087|FG006|Overall Study|Withdrawal by Subject|1|||
155030125|NCT01901653|559535088|FG007|Overall Study|Withdrawal by Subject|0|||
155030126|NCT01901653|559535089|FG008|Overall Study|Withdrawal by Subject|0|||
155030127|NCT01901653|559535090|FG009|Overall Study|Withdrawal by Subject|0|||
155030128|NCT01901653|559535091|FG010|Overall Study|Withdrawal by Subject|0|||
155030129|NCT01901653|559535092|FG011|Overall Study|Withdrawal by Subject|0|||
155030130|NCT01901653|559535093|FG012|Overall Study|Withdrawal by Subject|0|||
155030131|NCT01901653|559535081|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
155030132|NCT01901653|559535082|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
155030133|NCT01901653|559535083|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
155030134|NCT01901653|559535084|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
155030135|NCT01901653|559535085|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
155030136|NCT01901653|559535086|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
155030137|NCT01901653|559535087|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
155030138|NCT01901653|559535088|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
155030139|NCT01901653|559535089|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
155030140|NCT01901653|559535090|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
155181477|NCT02038829|560103083|FG005|Washout Period 2|Withdrawal by Subject|1|||
155030141|NCT01901653|559535091|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
155030142|NCT01901653|559535092|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
155030143|NCT01901653|559535093|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
155030144|NCT02548351|559535094|FG000|Overall Study|Withdrawal by Subject|149|||
155030145|NCT02548351|559535095|FG001|Overall Study|Withdrawal by Subject|154|||
155030146|NCT02548351|559535096|FG002|Overall Study|Withdrawal by Subject|152|||
155030147|NCT02548351|559535094|FG000|Overall Study|Death|11|||
155030148|NCT02548351|559535095|FG001|Overall Study|Death|15|||
155030149|NCT02548351|559535096|FG002|Overall Study|Death|12|||
155030150|NCT02548351|559535094|FG000|Overall Study|Adverse Event|22|||
155030151|NCT02548351|559535095|FG001|Overall Study|Adverse Event|56|||
155030152|NCT02548351|559535096|FG002|Overall Study|Adverse Event|36|||
155030153|NCT02548351|559535094|FG000|Overall Study|Study Terminated by Sponsor|549|||
155030154|NCT02548351|559535095|FG001|Overall Study|Study Terminated by Sponsor|509|||
155030155|NCT02548351|559535096|FG002|Overall Study|Study Terminated by Sponsor|528|||
155030156|NCT02548351|559535094|FG000|Overall Study|Site Closure|14|||
155030157|NCT02548351|559535095|FG001|Overall Study|Site Closure|5|||
155030158|NCT02548351|559535096|FG002|Overall Study|Site Closure|7|||
155030159|NCT02548351|559535094|FG000|Overall Study|Non-compliance with Study Drug|4|||
155030160|NCT02548351|559535095|FG001|Overall Study|Non-compliance with Study Drug|2|||
155030161|NCT02548351|559535096|FG002|Overall Study|Non-compliance with Study Drug|0|||
155030162|NCT02548351|559535094|FG000|Overall Study|Protocol Violation|2|||
155030163|NCT02548351|559535095|FG001|Overall Study|Protocol Violation|1|||
155030164|NCT02548351|559535096|FG002|Overall Study|Protocol Violation|2|||
155030165|NCT02548351|559535094|FG000|Overall Study|Physician Decision|11|||
155030166|NCT02548351|559535095|FG001|Overall Study|Physician Decision|18|||
155030167|NCT02548351|559535096|FG002|Overall Study|Physician Decision|11|||
155030168|NCT02548351|559535094|FG000|Overall Study|Lost to Follow-up|43|||
155030169|NCT02548351|559535095|FG001|Overall Study|Lost to Follow-up|50|||
155030170|NCT02548351|559535096|FG002|Overall Study|Lost to Follow-up|57|||
155030171|NCT02548351|559535094|FG000|Overall Study|Other|19|||
155030172|NCT02548351|559535095|FG001|Overall Study|Other|16|||
155030173|NCT02548351|559535096|FG002|Overall Study|Other|20|||
155030174|NCT02548351|559535094|FG000|Overall Study|Missing|1|||
155030175|NCT02548351|559535095|FG001|Overall Study|Missing|1|||
155030176|NCT02548351|559535096|FG002|Overall Study|Missing|0|||
155030177|NCT04553471|559535102|FG000|Overall Study|Did not start treatment on protocol|3|||
155030178|NCT04553471|559535102|FG000|Overall Study|Death|1|||
155030179|NCT02778074|559535103|FG000|Overall Study|Lost to Follow-up|7|||
155030180|NCT02778074|559535104|FG001|Overall Study|Lost to Follow-up|10|||
155030181|NCT00356135|559535116|FG000|Overall Study|Protocol Violation|1|||
155030182|NCT00356135|559535117|FG001|Overall Study|Protocol Violation|0|||
155030183|NCT00356135|559535118|FG002|Overall Study|Protocol Violation|0|||
155030184|NCT00356135|559535116|FG000|Overall Study|Adverse Event|1|||
155030185|NCT00356135|559535117|FG001|Overall Study|Adverse Event|0|||
155030186|NCT00356135|559535118|FG002|Overall Study|Adverse Event|0|||
155030187|NCT00356135|559535116|FG000|Overall Study|Lost to Follow-up|0|||
155030188|NCT00356135|559535117|FG001|Overall Study|Lost to Follow-up|0|||
155030189|NCT00356135|559535118|FG002|Overall Study|Lost to Follow-up|1|||
155030190|NCT00356135|559535116|FG000|Overall Study|Physician Decision|1|||
155030191|NCT00356135|559535117|FG001|Overall Study|Physician Decision|1|||
155030192|NCT00356135|559535118|FG002|Overall Study|Physician Decision|1|||
155030193|NCT00356135|559535116|FG000|Overall Study|Subject non-compliance|1|||
155030194|NCT00356135|559535117|FG001|Overall Study|Subject non-compliance|1|||
155030195|NCT00356135|559535118|FG002|Overall Study|Subject non-compliance|3|||
155030196|NCT05270395|559535124|FG000|Overall Study|Lost to Follow-up|2|||
155030197|NCT05270395|559535125|FG001|Overall Study|Lost to Follow-up|2|||
155030198|NCT05270395|559535124|FG000|Overall Study|Death|1|||
155030199|NCT05270395|559535125|FG001|Overall Study|Death|2|||
155030200|NCT05270395|559535124|FG000|Overall Study|Study Team Withdrew|1|||
155030201|NCT05270395|559535125|FG001|Overall Study|Study Team Withdrew|0|||
155030202|NCT03197467|559536721|FG000|Overall Study|Withdrawal by Subject|1|||
155030203|NCT04743804|559536723|FG000|Overall Study|Other|1|||
155030204|NCT04743804|559536724|FG001|Overall Study|Other|0|||
155030205|NCT04743804|559536723|FG000|Overall Study|Withdrawal by Subject|0|||
155030206|NCT04743804|559536724|FG001|Overall Study|Withdrawal by Subject|1|||
155030207|NCT04743804|559536723|FG000|Overall Study|Study Terminated by Sponsor|1|||
155030208|NCT04743804|559536724|FG001|Overall Study|Study Terminated by Sponsor|4|||
155030209|NCT04743804|559536723|FG000|Overall Study|Physician Decision|0|||
155030210|NCT04743804|559536724|FG001|Overall Study|Physician Decision|1|||
155030211|NCT04743804|559536723|FG000|Overall Study|Death|3|||
155030212|NCT04743804|559536724|FG001|Overall Study|Death|0|||
155030213|NCT02759055|559536726|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
155030214|NCT02759055|559536727|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
155030215|NCT02515994|559536728|FG000|Overall Study|Protocol Violation|3|||
155030216|NCT02515994|559536729|FG001|Overall Study|Protocol Violation|5|||
155030217|NCT02515994|559536728|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
155030218|NCT02515994|559536729|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
155030219|NCT02515994|559536728|FG000|Overall Study|Adverse Event|3|||
155030220|NCT02515994|559536729|FG001|Overall Study|Adverse Event|1|||
155030221|NCT02515994|559536728|FG000|Overall Study|Withdrawal by Subject|2|||
155030222|NCT02515994|559536729|FG001|Overall Study|Withdrawal by Subject|0|||
155030223|NCT04045132|559536732|FG000|Overall Study|Lost to Follow-up|3|||
155030224|NCT04045132|559536733|FG001|Overall Study|Lost to Follow-up|6|||
155030225|NCT04598451|559536734|FG000|Overall Study|Adverse Event|3|||
155030226|NCT04598451|559536735|FG001|Overall Study|Adverse Event|2|||
155030227|NCT04598451|559536734|FG000|Overall Study|Withdrawal by Subject|3|||
155030228|NCT04598451|559536735|FG001|Overall Study|Withdrawal by Subject|7|||
155030229|NCT04598451|559536734|FG000|Overall Study|Lost to Follow-up|2|||
155030230|NCT04598451|559536735|FG001|Overall Study|Lost to Follow-up|0|||
155030231|NCT04598451|559536734|FG000|Overall Study|Physician Decision|4|||
155030232|NCT04598451|559536735|FG001|Overall Study|Physician Decision|1|||
155030233|NCT04598451|559536734|FG000|Overall Study|Requires Prohibited Medication|1|||
155030234|NCT04598451|559536735|FG001|Overall Study|Requires Prohibited Medication|0|||
155030235|NCT04598451|559536734|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
155030236|NCT04598451|559536735|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
155030237|NCT01632150|559536738|FG000|Overall Study|Disease progression|27|||
155030238|NCT01632150|559536738|FG000|Overall Study|Study drug toxicity|1|||
155030239|NCT01632150|559536738|FG000|Overall Study|Unrelated adverse event|7|||
155030240|NCT01632150|559536738|FG000|Overall Study|Withdrawal by Subject|2|||
155030241|NCT01632150|559536738|FG000|Overall Study|Patient underwent autologous transplant|1|||
155030242|NCT01632150|559536738|FG000|Overall Study|Moved to compassionate program|2|||
155030243|NCT03408444|559536741|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
155030244|NCT03408444|559536742|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155030245|NCT03408444|559536743|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155030246|NCT03408444|559536744|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
155030247|NCT03408444|559536741|FG000|Overall Study|Lens Discomfort|0|||
155030248|NCT03408444|559536742|FG001|Overall Study|Lens Discomfort|1|||
155030249|NCT03408444|559536743|FG002|Overall Study|Lens Discomfort|0|||
155030250|NCT03408444|559536744|FG003|Overall Study|Lens Discomfort|0|||
155030251|NCT03408444|559536741|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
155030252|NCT03408444|559536742|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
155030253|NCT03408444|559536743|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
155030254|NCT03408444|559536744|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
155030255|NCT03408444|559536741|FG000|Overall Study|Withdrawal by Subject|0|||
155030256|NCT03408444|559536742|FG001|Overall Study|Withdrawal by Subject|2|||
155030257|NCT03408444|559536743|FG002|Overall Study|Withdrawal by Subject|3|||
155030258|NCT03408444|559536744|FG003|Overall Study|Withdrawal by Subject|0|||
155030259|NCT03408444|559536741|FG000|Overall Study|Lost to Follow-up|0|||
155030260|NCT03408444|559536742|FG001|Overall Study|Lost to Follow-up|0|||
155030261|NCT03408444|559536743|FG002|Overall Study|Lost to Follow-up|1|||
155030262|NCT03408444|559536744|FG003|Overall Study|Lost to Follow-up|0|||
155030263|NCT03408444|559536741|FG000|Overall Study|Adverse Event|0|||
155030264|NCT03408444|559536742|FG001|Overall Study|Adverse Event|0|||
155030265|NCT03408444|559536743|FG002|Overall Study|Adverse Event|0|||
155030266|NCT03408444|559536744|FG003|Overall Study|Adverse Event|1|||
155030267|NCT03408444|559536741|FG000|Overall Study|Lens Handling Difficulties|0|||
155030268|NCT03408444|559536742|FG001|Overall Study|Lens Handling Difficulties|0|||
155030269|NCT03408444|559536743|FG002|Overall Study|Lens Handling Difficulties|1|||
155030270|NCT03408444|559536744|FG003|Overall Study|Lens Handling Difficulties|0|||
155030271|NCT03408444|559536741|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
155030272|NCT03408444|559536742|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
155030273|NCT03408444|559536743|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
155030274|NCT03408444|559536744|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
155030275|NCT02091960|559536745|FG000|Overall Study|Death|7|||
155030276|NCT02091960|559536745|FG000|Overall Study|Withdrawal by Subject|1|||
155030277|NCT02091960|559536745|FG000|Overall Study|Miscellaneous Reasons|37|||
155030278|NCT02637895|559536759|FG000|Overall Study|Lost to Follow-up|4|||
155030279|NCT02637895|559536760|FG001|Overall Study|Lost to Follow-up|0|||
155030280|NCT02637895|559536759|FG000|Overall Study|Protocol Violation|0|||
155030281|NCT02637895|559536760|FG001|Overall Study|Protocol Violation|1|||
155030282|NCT02637895|559536759|FG000|Overall Study|Lack of Efficacy|1|||
155030283|NCT02637895|559536760|FG001|Overall Study|Lack of Efficacy|0|||
155030284|NCT02637895|559536759|FG000|Overall Study|Withdrawal by Subject|1|||
155030285|NCT02637895|559536760|FG001|Overall Study|Withdrawal by Subject|1|||
155030286|NCT02637895|559536759|FG000|Overall Study|Abnormal baseline lab|0|||
155030287|NCT02637895|559536760|FG001|Overall Study|Abnormal baseline lab|1|||
155030288|NCT01995175|559536763|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
155030289|NCT01995175|559536763|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
155030290|NCT01995175|559536763|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
155030291|NCT01995175|559536763|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
155030292|NCT01995175|559536763|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
155030293|NCT01995175|559536763|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
155030294|NCT01995175|559536763|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
155030295|NCT01995175|559536763|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
155030296|NCT01995175|559536763|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
155030297|NCT00984061|559536764|FG000|Clarithromycin Alone|Protocol Violation|1|||
155030298|NCT00761280|559536765|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
155030299|NCT00761280|559536766|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
155030300|NCT00761280|559536765|FG000|Randomization to First Dose|Sponsor decision|1|||
155030301|NCT00761280|559536766|FG001|Randomization to First Dose|Sponsor decision|0|||
155030302|NCT00761280|559536765|FG000|Randomization to First Dose|Other|1|||
155030303|NCT00761280|559536766|FG001|Randomization to First Dose|Other|0|||
155030304|NCT00761280|559536765|FG000|First Dose to End of Study|End of trial|5|||
155030305|NCT00761280|559536766|FG001|First Dose to End of Study|End of trial|5|||
155030306|NCT00761280|559536765|FG000|First Dose to End of Study|Progressive disease|5|||
155030307|NCT00761280|559536766|FG001|First Dose to End of Study|Progressive disease|3|||
155030308|NCT00761280|559536765|FG000|First Dose to End of Study|Sponsor decision|1|||
155030309|NCT00761280|559536766|FG001|First Dose to End of Study|Sponsor decision|2|||
155030310|NCT00761280|559536765|FG000|First Dose to End of Study|Death|1|||
155030311|NCT00761280|559536766|FG001|First Dose to End of Study|Death|0|||
155030312|NCT00761280|559536765|FG000|First Dose to End of Study|Lost to Follow-up|0|||
155030313|NCT00761280|559536766|FG001|First Dose to End of Study|Lost to Follow-up|1|||
155030314|NCT04777201|559536770|FG000|Main Study|Withdrawal by Subject|19|||
155030315|NCT04777201|559536771|FG001|Main Study|Withdrawal by Subject|27|||
155030316|NCT04777201|559536772|FG002|Main Study|Withdrawal by Subject|0|||
155030317|NCT04777201|559536770|FG000|Main Study|Death|13|||
155030318|NCT04777201|559536771|FG001|Main Study|Death|27|||
155030319|NCT04777201|559536772|FG002|Main Study|Death|0|||
155030320|NCT04777201|559536770|FG000|Main Study|Subject missed the safety follow-up visit|9|||
155030321|NCT04777201|559536771|FG001|Main Study|Subject missed the safety follow-up visit|10|||
155030322|NCT04777201|559536772|FG002|Main Study|Subject missed the safety follow-up visit|0|||
155030323|NCT04777201|559536770|FG000|Main Study|Physician Decision|8|||
155030324|NCT04777201|559536771|FG001|Main Study|Physician Decision|10|||
155030325|NCT04777201|559536772|FG002|Main Study|Physician Decision|0|||
155030326|NCT04777201|559536770|FG000|Main Study|Adverse Event|8|||
155030327|NCT04777201|559536771|FG001|Main Study|Adverse Event|8|||
155030328|NCT04777201|559536772|FG002|Main Study|Adverse Event|0|||
155030329|NCT04777201|559536770|FG000|Main Study|Lost to Follow-up|9|||
155030330|NCT04777201|559536771|FG001|Main Study|Lost to Follow-up|4|||
155030331|NCT04777201|559536772|FG002|Main Study|Lost to Follow-up|0|||
155030332|NCT04777201|559536770|FG000|Main Study|Reason not specified|3|||
155030333|NCT04777201|559536771|FG001|Main Study|Reason not specified|3|||
155030334|NCT04777201|559536772|FG002|Main Study|Reason not specified|0|||
155030335|NCT04777201|559536770|FG000|Main Study|Lack of Efficacy|1|||
155030336|NCT04777201|559536771|FG001|Main Study|Lack of Efficacy|1|||
155030337|NCT04777201|559536772|FG002|Main Study|Lack of Efficacy|0|||
155030338|NCT04777201|559536770|FG000|Main Study|Protocol Violation|1|||
155030339|NCT04777201|559536771|FG001|Main Study|Protocol Violation|0|||
155030340|NCT04777201|559536772|FG002|Main Study|Protocol Violation|0|||
155030341|NCT04777201|559536770|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
155030342|NCT04777201|559536771|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
155030343|NCT04777201|559536772|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
155030344|NCT04777201|559536770|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
155030345|NCT04777201|559536771|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
155030346|NCT04777201|559536772|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
155030347|NCT04777201|559536770|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
155030348|NCT04777201|559536771|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
155030349|NCT04777201|559536772|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
155030350|NCT04777201|559536770|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
155030351|NCT04777201|559536771|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
155030352|NCT04777201|559536772|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
155030353|NCT04777201|559536770|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
155030354|NCT04777201|559536771|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
155030355|NCT04777201|559536772|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
155030356|NCT04777201|559536770|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
155030357|NCT04777201|559536771|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
155030358|NCT04777201|559536772|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
155030359|NCT02045862|559536773|FG000|Overall Study|Death|0|||
155030360|NCT02045862|559536774|FG001|Overall Study|Death|0|||
155030361|NCT02045862|559536775|FG002|Overall Study|Death|1|||
155030362|NCT02045862|559536773|FG000|Overall Study|Miscellaneous|5|||
155030363|NCT02045862|559536774|FG001|Overall Study|Miscellaneous|0|||
155030364|NCT02045862|559536775|FG002|Overall Study|Miscellaneous|8|||
155030365|NCT02045862|559536773|FG000|Overall Study|Withdrawal by Patient|18|||
155030366|NCT02045862|559536774|FG001|Overall Study|Withdrawal by Patient|27|||
155030367|NCT02045862|559536775|FG002|Overall Study|Withdrawal by Patient|57|||
155030368|NCT02045862|559536773|FG000|Overall Study|Protocol Violation|0|||
155030369|NCT02045862|559536774|FG001|Overall Study|Protocol Violation|0|||
155030370|NCT02045862|559536775|FG002|Overall Study|Protocol Violation|6|||
155030371|NCT02045862|559536773|FG000|Overall Study|Lack of Efficacy|8|||
155030372|NCT02045862|559536774|FG001|Overall Study|Lack of Efficacy|4|||
155030373|NCT02045862|559536775|FG002|Overall Study|Lack of Efficacy|13|||
155030374|NCT02045862|559536773|FG000|Overall Study|Randomized but not Received Study Drug|0|||
155030375|NCT02045862|559536774|FG001|Overall Study|Randomized but not Received Study Drug|2|||
155030376|NCT02045862|559536775|FG002|Overall Study|Randomized but not Received Study Drug|8|||
155030377|NCT02045862|559536773|FG000|Overall Study|Adverse Event|7|||
155030378|NCT02045862|559536774|FG001|Overall Study|Adverse Event|5|||
155030379|NCT02045862|559536775|FG002|Overall Study|Adverse Event|27|||
155030380|NCT02045862|559536773|FG000|Overall Study|Lost to Follow-up|1|||
155030381|NCT02045862|559536774|FG001|Overall Study|Lost to Follow-up|2|||
155030382|NCT02045862|559536775|FG002|Overall Study|Lost to Follow-up|6|||
155030383|NCT02691013|559536778|FG000|Overall Study|Withdrawal by Subject|3|||
155030384|NCT02691013|559536779|FG001|Overall Study|Withdrawal by Subject|0|||
155030385|NCT02111785|559536781|FG000|Overall Study|Death|0|||
155030386|NCT02111785|559536782|FG001|Overall Study|Death|1|||
155030387|NCT02111785|559536783|FG002|Overall Study|Death|0|||
155030388|NCT02111785|559536784|FG003|Overall Study|Death|0|||
155030389|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Adverse Event|6|||
155030390|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Adverse Event|14|||
155030391|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Death|3|||
155030392|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Death|1|||
155030393|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
155030394|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
155030395|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
155030396|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
155181478|NCT02038829|560103084|FG006|Washout Period 2|Withdrawal by Subject|0|||
155181479|NCT02038829|560103085|FG007|Washout Period 2|Withdrawal by Subject|0|||
155181480|NCT02038829|560103086|FG008|Washout Period 2|Withdrawal by Subject|0|||
155181481|NCT02038829|560103087|FG009|Washout Period 2|Withdrawal by Subject|0|||
155181482|NCT02038829|560103088|FG010|Washout Period 2|Withdrawal by Subject|0|||
155181483|NCT02038829|560103089|FG011|Washout Period 2|Withdrawal by Subject|0|||
155181484|NCT02038829|560103078|FG000|Treatment Period 4|Adverse Event|0|||
155181485|NCT02038829|560103079|FG001|Treatment Period 4|Adverse Event|1|||
155181486|NCT02038829|560103080|FG002|Treatment Period 4|Adverse Event|0|||
155181487|NCT02038829|560103081|FG003|Treatment Period 4|Adverse Event|0|||
155181488|NCT02038829|560103082|FG004|Treatment Period 4|Adverse Event|0|||
155181489|NCT02038829|560103083|FG005|Treatment Period 4|Adverse Event|0|||
155181490|NCT02038829|560103084|FG006|Treatment Period 4|Adverse Event|0|||
155181491|NCT02038829|560103085|FG007|Treatment Period 4|Adverse Event|0|||
155181492|NCT02038829|560103086|FG008|Treatment Period 4|Adverse Event|0|||
155181493|NCT02038829|560103087|FG009|Treatment Period 4|Adverse Event|0|||
155181494|NCT02038829|560103088|FG010|Treatment Period 4|Adverse Event|0|||
155181495|NCT02038829|560103089|FG011|Treatment Period 4|Adverse Event|0|||
155181496|NCT02038829|560103078|FG000|Washout Period 4|Adverse Event|0|||
155030397|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
155030398|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
155030399|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
155030400|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
155030401|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
155030402|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
155030403|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Physician Decision|2|||
155030404|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Physician Decision|4|||
155030405|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Pregnancy|2|||
155030406|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Pregnancy|1|||
155030407|NCT02275780|559536785|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
155030408|NCT02275780|559536786|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
155030409|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
155030410|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
155030411|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
155030412|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
155030413|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
155030414|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
155030415|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
155030416|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
155030417|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
155181497|NCT02038829|560103079|FG001|Washout Period 4|Adverse Event|0|||
155181498|NCT02038829|560103080|FG002|Washout Period 4|Adverse Event|0|||
155030418|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
155030419|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
155030420|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
155030421|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
155030422|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
155181499|NCT02038829|560103081|FG003|Washout Period 4|Adverse Event|0|||
155181500|NCT02038829|560103082|FG004|Washout Period 4|Adverse Event|0|||
155181501|NCT02038829|560103083|FG005|Washout Period 4|Adverse Event|0|||
155140127|NCT00479336|559944410|FG000|Overall Study|Withdrawal by Subject|1|||
155140128|NCT00479336|559944411|FG001|Overall Study|Withdrawal by Subject|2|||
155140129|NCT00479336|559944412|FG002|Overall Study|Withdrawal by Subject|0|||
155140130|NCT00479336|559944413|FG003|Overall Study|Withdrawal by Subject|0|||
155140131|NCT00479336|559944410|FG000|Overall Study|Physician Decision|0|||
155140132|NCT00479336|559944411|FG001|Overall Study|Physician Decision|1|||
155140133|NCT00479336|559944412|FG002|Overall Study|Physician Decision|0|||
155140134|NCT00479336|559944413|FG003|Overall Study|Physician Decision|2|||
155140135|NCT00479336|559944410|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
155140136|NCT00479336|559944411|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
155140137|NCT00479336|559944412|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
155140138|NCT00479336|559944413|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
155140139|NCT02741596|559944414|FG000|Overall Study|Adverse Event|1|||
155140140|NCT02741596|559944415|FG001|Overall Study|Adverse Event|5|||
155140141|NCT02741596|559944414|FG000|Overall Study|Lost to Follow-up|1|||
155140142|NCT02741596|559944415|FG001|Overall Study|Lost to Follow-up|1|||
155140143|NCT02741596|559944414|FG000|Overall Study|Physician Decision|2|||
155140144|NCT02741596|559944415|FG001|Overall Study|Physician Decision|1|||
155140145|NCT02741596|559944414|FG000|Overall Study|Pregnancy|3|||
155140146|NCT02741596|559944415|FG001|Overall Study|Pregnancy|1|||
155140147|NCT02741596|559944414|FG000|Overall Study|Other (Unspecified)|0|||
155140148|NCT02741596|559944415|FG001|Overall Study|Other (Unspecified)|3|||
155140149|NCT02741596|559944414|FG000|Overall Study|Subject withdrawn-Other|17|||
155140150|NCT02741596|559944415|FG001|Overall Study|Subject withdrawn-Other|4|||
155140151|NCT02741596|559944414|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
155140152|NCT02741596|559944415|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
155140153|NCT03329846|559944416|FG000|Overall Study|Disease progression|4|||
155140154|NCT03329846|559944417|FG001|Overall Study|Disease progression|6|||
155140155|NCT03329846|559944416|FG000|Overall Study|Study drug toxicity|1|||
155140156|NCT03329846|559944417|FG001|Overall Study|Study drug toxicity|0|||
155140157|NCT03329846|559944416|FG000|Overall Study|Participant request to discontinue treatment|0|||
155140158|NCT03329846|559944417|FG001|Overall Study|Participant request to discontinue treatment|1|||
155140159|NCT03329846|559944416|FG000|Overall Study|Participant withdrew consent|1|||
155140160|NCT03329846|559944417|FG001|Overall Study|Participant withdrew consent|0|||
155140161|NCT03329846|559944416|FG000|Overall Study|Other reasons|2|||
155140162|NCT03329846|559944417|FG001|Overall Study|Other reasons|2|||
155140163|NCT03066193|559944418|FG000|Overall Study|Withdrawal by Subject|1|||
155140164|NCT04854551|559944423|FG000|Overall Study|Withdrawal by Subject|1|||
155140165|NCT04854551|559944424|FG001|Overall Study|Withdrawal by Subject|1|||
155140166|NCT02859246|559944426|FG000|Overall Study|Screen fails|3|||
155140167|NCT02859246|559944426|FG000|Overall Study|Adverse Event|1|||
155140168|NCT02859246|559944426|FG000|Overall Study|Withdrawal by Subject|1|||
155140169|NCT05280717|559944427|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
155140170|NCT05280717|559944428|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
155140171|NCT05280717|559944429|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
155140172|NCT05280717|559944430|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155140173|NCT05280717|559944431|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155140174|NCT05280717|559944432|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155140175|NCT05280717|559944433|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
155140176|NCT05280717|559944427|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
155140177|NCT05280717|559944428|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155140178|NCT05280717|559944429|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155140179|NCT05280717|559944430|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155140180|NCT05280717|559944431|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155140181|NCT05280717|559944432|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155140182|NCT05280717|559944433|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
155140183|NCT05280717|559944427|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155140184|NCT05280717|559944428|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
155140185|NCT05280717|559944429|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155140186|NCT05280717|559944430|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155140187|NCT05280717|559944431|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155140188|NCT05280717|559944432|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155140189|NCT05280717|559944433|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
155140190|NCT05280717|559944427|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155140191|NCT05280717|559944428|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155140192|NCT05280717|559944429|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
155140193|NCT05280717|559944430|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155181502|NCT02038829|560103084|FG006|Washout Period 4|Adverse Event|1|||
155181503|NCT02038829|560103085|FG007|Washout Period 4|Adverse Event|0|||
155181504|NCT02038829|560103086|FG008|Washout Period 4|Adverse Event|0|||
155030423|NCT02275780|559536785|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
155030424|NCT02275780|559536786|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
155030425|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
155030426|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
155030427|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
155030428|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
155030429|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
155030430|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
155030431|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
155030432|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
155030433|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
155030434|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
155030435|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
155030436|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
155030437|NCT02275780|559536785|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
155030438|NCT02275780|559536786|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
155030439|NCT02275780|559536785|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
155030440|NCT02275780|559536786|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
155030441|NCT02275780|559536785|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
155030442|NCT02275780|559536786|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
155030443|NCT02275780|559536785|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
155030444|NCT02275780|559536786|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
155030445|NCT02275780|559536785|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
155030446|NCT02275780|559536786|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
155030447|NCT02275780|559536785|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
155030448|NCT02275780|559536786|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
155030449|NCT02275780|559536785|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
155030450|NCT02275780|559536786|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
155030451|NCT01899742|559536789|FG000|Overall Study|Adverse Event|5|||
155030452|NCT01899742|559536790|FG001|Overall Study|Adverse Event|4|||
155030453|NCT01899742|559536789|FG000|Overall Study|Lack of Efficacy|1|||
155030454|NCT01899742|559536790|FG001|Overall Study|Lack of Efficacy|5|||
155030455|NCT01899742|559536789|FG000|Overall Study|Protocol Violation|2|||
155030456|NCT01899742|559536790|FG001|Overall Study|Protocol Violation|2|||
155030457|NCT01899742|559536789|FG000|Overall Study|Withdrawal by Subject|9|||
155030458|NCT01899742|559536790|FG001|Overall Study|Withdrawal by Subject|5|||
155030459|NCT00759785|559536795|FG000|Overall Study|Participant sample not evaluable|11|||
155030460|NCT00759785|559536796|FG001|Overall Study|Participant sample not evaluable|2|||
155030461|NCT00759785|559536795|FG000|Overall Study|Participant sample lost|0|||
155030462|NCT00759785|559536796|FG001|Overall Study|Participant sample lost|1|||
155030463|NCT00759785|559536795|FG000|Overall Study|Protocol Violation|1|||
155030464|NCT00759785|559536796|FG001|Overall Study|Protocol Violation|0|||
155030465|NCT00759785|559536795|FG000|Overall Study|Physician Decision|0|||
155030466|NCT00759785|559536796|FG001|Overall Study|Physician Decision|1|||
155030467|NCT00759785|559536795|FG000|Overall Study|Withdrawal by Subject|0|||
155030468|NCT00759785|559536796|FG001|Overall Study|Withdrawal by Subject|1|||
155030469|NCT00177307|559536797|FG000|Overall Study|Withdrawal by Subject|1|||
155030470|NCT02677038|559536799|FG000|Overall Study|Physician Decision|1|||
155030471|NCT02677038|559536799|FG000|Overall Study|Withdrawal by Subject|1|||
155030472|NCT00278148|559536800|FG000|Phase II - Expansion Phase|Disease progression|0|||
155030473|NCT00278148|559536801|FG001|Phase II - Expansion Phase|Disease progression|0|||
155030474|NCT00278148|559536802|FG002|Phase II - Expansion Phase|Disease progression|4|||
155030475|NCT00278148|559536800|FG000|Phase II - Expansion Phase|Adverse Event|0|||
155030476|NCT00278148|559536801|FG001|Phase II - Expansion Phase|Adverse Event|0|||
155030477|NCT00278148|559536802|FG002|Phase II - Expansion Phase|Adverse Event|2|||
155030478|NCT01546168|559536803|FG000|Overall Study|Lost to Follow-up|1|||
155030479|NCT01546168|559536804|FG001|Overall Study|Lost to Follow-up|0|||
155030480|NCT01546168|559536803|FG000|Overall Study|Withdrawal by Subject|1|||
155030481|NCT01546168|559536804|FG001|Overall Study|Withdrawal by Subject|0|||
155030482|NCT01546168|559536803|FG000|Overall Study|ineligible after signing consent|2|||
155030483|NCT01546168|559536804|FG001|Overall Study|ineligible after signing consent|0|||
155030484|NCT02850016|559536807|FG000|Overall Study|Withdrawal by Subject|1|||
155030485|NCT02850016|559536808|FG001|Overall Study|Withdrawal by Subject|2|||
155030486|NCT00070018|559536809|FG000|Overall Study|Adverse Event|2|||
155030487|NCT00070018|559536809|FG000|Overall Study|Lack of Efficacy|1|||
155030488|NCT00070018|559536809|FG000|Overall Study|Withdrawal by Subject|1|||
155030489|NCT01446237|559536812|FG000|Overall Study|Adverse Event|1|||
155030490|NCT01446237|559536812|FG000|Overall Study|Lost to Follow-up|2|||
155030491|NCT01446237|559536812|FG000|Overall Study|Withdrawal by Subject|7|||
155030492|NCT01744184|559536826|FG000|Overall Study|Adverse Event|1|||
155030493|NCT01744184|559536827|FG001|Overall Study|Adverse Event|0|||
155030494|NCT01744184|559536826|FG000|Overall Study|Withdrawal by Subject|0|||
155030495|NCT01744184|559536827|FG001|Overall Study|Withdrawal by Subject|1|||
155030496|NCT00072280|559536828|FG000|Treatment|Found ineligible|1|||
155030497|NCT00072280|559536829|FG001|Treatment|Found ineligible|2|||
155140194|NCT05280717|559944431|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155140195|NCT05280717|559944432|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155140196|NCT05280717|559944433|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
155140197|NCT05280717|559944427|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155140198|NCT05280717|559944428|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155140199|NCT05280717|559944429|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155140200|NCT05280717|559944430|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155140201|NCT05280717|559944431|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155140202|NCT05280717|559944432|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
155140203|NCT05280717|559944433|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
155140204|NCT05280717|559944427|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155140205|NCT05280717|559944428|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155140206|NCT05280717|559944429|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155140207|NCT05280717|559944430|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155140208|NCT05280717|559944431|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155140209|NCT05280717|559944432|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
155140210|NCT05280717|559944433|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
155140211|NCT00080301|559944434|FG000|Overall Study|Randomized but Never Treated|5|||
155140212|NCT00080301|559944435|FG001|Overall Study|Randomized but Never Treated|10|||
155140213|NCT00080301|559944434|FG000|Overall Study|Still on Treatment as of CSR date|0|||
155140214|NCT00080301|559944435|FG001|Overall Study|Still on Treatment as of CSR date|1|||
155140215|NCT01514201|559944442|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
155140216|NCT01514201|559944443|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155140217|NCT01514201|559944444|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155140218|NCT01514201|559944445|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155140219|NCT01514201|559944442|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155140220|NCT01514201|559944443|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
155140221|NCT01514201|559944444|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
155140222|NCT01514201|559944445|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155140223|NCT01514201|559944442|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
155140224|NCT01514201|559944443|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
155140225|NCT01514201|559944444|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
155140226|NCT01514201|559944445|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155140227|NCT01514201|559944442|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
155140228|NCT01514201|559944443|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
155140229|NCT01514201|559944444|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155140230|NCT01514201|559944445|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155140231|NCT01514201|559944442|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
155140232|NCT01514201|559944443|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
155140233|NCT01514201|559944444|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
155140234|NCT01514201|559944445|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
155140235|NCT01514201|559944442|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
155140236|NCT01514201|559944443|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
155140237|NCT01514201|559944444|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
155140238|NCT01514201|559944445|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
155140239|NCT01514201|559944442|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
155140240|NCT01514201|559944443|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
155140241|NCT01514201|559944444|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
155140242|NCT01514201|559944445|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
155140243|NCT01514201|559944442|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155140244|NCT01514201|559944443|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155140245|NCT01514201|559944444|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
155140246|NCT01514201|559944445|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
155181505|NCT02038829|560103087|FG009|Washout Period 4|Adverse Event|0|||
155181506|NCT02038829|560103088|FG010|Washout Period 4|Adverse Event|0|||
155030498|NCT00072280|559536828|FG000|Follow-up|Early termination of study|2|||
155030499|NCT00072280|559536829|FG001|Follow-up|Early termination of study|2|||
155030500|NCT02841280|559536830|FG000|Overall Study|Adverse Event|2|||
155030501|NCT02841280|559536831|FG001|Overall Study|Adverse Event|1|||
155030502|NCT02841280|559536830|FG000|Overall Study|Death|1|||
155030503|NCT02841280|559536831|FG001|Overall Study|Death|0|||
155030504|NCT02841280|559536830|FG000|Overall Study|Lost to Follow-up|2|||
155030505|NCT02841280|559536831|FG001|Overall Study|Lost to Follow-up|2|||
155030506|NCT02841280|559536830|FG000|Overall Study|Withdrawal by Subject|7|||
155030507|NCT02841280|559536831|FG001|Overall Study|Withdrawal by Subject|3|||
155030508|NCT02841280|559536830|FG000|Overall Study|Stop Point: BP above threshold|2|||
155030509|NCT02841280|559536831|FG001|Overall Study|Stop Point: BP above threshold|0|||
155030510|NCT00957268|559536832|FG000|Overall Study|Voluntary Withdrawal|0|||
155030511|NCT00957268|559536833|FG001|Overall Study|Voluntary Withdrawal|0|||
155030512|NCT00957268|559536834|FG002|Overall Study|Voluntary Withdrawal|1|||
155030513|NCT00957268|559536835|FG003|Overall Study|Voluntary Withdrawal|0|||
155030514|NCT00957268|559536836|FG004|Overall Study|Voluntary Withdrawal|0|||
155030515|NCT01340027|559536838|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
155030516|NCT01340027|559536839|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
155181507|NCT02038829|560103089|FG011|Washout Period 4|Adverse Event|0|||
155181508|NCT02038829|560103078|FG000|Treatment Period 6|Adverse Event|0|||
155181509|NCT02038829|560103079|FG001|Treatment Period 6|Adverse Event|0|||
155181510|NCT02038829|560103080|FG002|Treatment Period 6|Adverse Event|1|||
155181511|NCT02038829|560103081|FG003|Treatment Period 6|Adverse Event|0|||
155181512|NCT02038829|560103082|FG004|Treatment Period 6|Adverse Event|0|||
155181513|NCT02038829|560103083|FG005|Treatment Period 6|Adverse Event|0|||
155181514|NCT02038829|560103084|FG006|Treatment Period 6|Adverse Event|0|||
155181515|NCT02038829|560103085|FG007|Treatment Period 6|Adverse Event|0|||
155181516|NCT02038829|560103086|FG008|Treatment Period 6|Adverse Event|0|||
155181517|NCT02038829|560103087|FG009|Treatment Period 6|Adverse Event|0|||
155181518|NCT02038829|560103088|FG010|Treatment Period 6|Adverse Event|0|||
155181519|NCT02038829|560103089|FG011|Treatment Period 6|Adverse Event|0|||
155181520|NCT00749580|560103090|FG000|Overall Study|Lost to Follow-up|4|||
155181521|NCT00749580|560103091|FG001|Overall Study|Lost to Follow-up|8|||
155181522|NCT00749580|560103090|FG000|Overall Study|Adverse Event|0|||
155181523|NCT00749580|560103091|FG001|Overall Study|Adverse Event|1|||
155181524|NCT04393298|560103092|FG000|Overall Study|Adverse Event|0|||
155181525|NCT04393298|560103093|FG001|Overall Study|Adverse Event|0|||
155181526|NCT04393298|560103094|FG002|Overall Study|Adverse Event|0|||
155181527|NCT04393298|560103095|FG003|Overall Study|Adverse Event|0|||
155181528|NCT04393298|560103096|FG004|Overall Study|Adverse Event|1|||
155181529|NCT04393298|560103097|FG005|Overall Study|Adverse Event|0|||
155181530|NCT04393298|560103098|FG006|Overall Study|Adverse Event|0|||
155181531|NCT04393298|560103099|FG007|Overall Study|Adverse Event|0|||
155181532|NCT04393298|560103100|FG008|Overall Study|Adverse Event|2|||
155181533|NCT04393298|560103101|FG009|Overall Study|Adverse Event|0|||
155181534|NCT04393298|560103102|FG010|Overall Study|Adverse Event|0|||
155181535|NCT04393298|560103103|FG011|Overall Study|Adverse Event|0|||
155181536|NCT04393298|560103104|FG012|Overall Study|Adverse Event|1|||
155181537|NCT04393298|560103105|FG013|Overall Study|Adverse Event|1|||
155181538|NCT04393298|560103106|FG014|Overall Study|Adverse Event|0|||
155181539|NCT04393298|560103092|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181540|NCT04393298|560103093|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181541|NCT04393298|560103094|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
155181542|NCT04393298|560103095|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181543|NCT04393298|560103096|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181544|NCT04393298|560103097|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181545|NCT04393298|560103098|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181546|NCT04393298|560103099|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181547|NCT04393298|560103100|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155030517|NCT01340027|559536840|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
155030518|NCT01340027|559536841|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
155030519|NCT01340027|559536842|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
155181548|NCT04393298|560103101|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181549|NCT04393298|560103102|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181550|NCT04393298|560103103|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181551|NCT04393298|560103104|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181552|NCT04393298|560103105|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
155181553|NCT04393298|560103106|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
155181554|NCT04393298|560103092|FG000|Overall Study|Lack of Efficacy|0|||
155181555|NCT04393298|560103093|FG001|Overall Study|Lack of Efficacy|0|||
155030520|NCT01340027|559536843|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
155181556|NCT04393298|560103094|FG002|Overall Study|Lack of Efficacy|0|||
155181557|NCT04393298|560103095|FG003|Overall Study|Lack of Efficacy|0|||
155181558|NCT04393298|560103096|FG004|Overall Study|Lack of Efficacy|0|||
155181559|NCT04393298|560103097|FG005|Overall Study|Lack of Efficacy|0|||
155181560|NCT04393298|560103098|FG006|Overall Study|Lack of Efficacy|0|||
155181561|NCT04393298|560103099|FG007|Overall Study|Lack of Efficacy|0|||
155181562|NCT04393298|560103100|FG008|Overall Study|Lack of Efficacy|0|||
155181563|NCT04393298|560103101|FG009|Overall Study|Lack of Efficacy|0|||
155181564|NCT04393298|560103102|FG010|Overall Study|Lack of Efficacy|0|||
155181565|NCT04393298|560103103|FG011|Overall Study|Lack of Efficacy|0|||
155181566|NCT04393298|560103104|FG012|Overall Study|Lack of Efficacy|0|||
155181567|NCT04393298|560103105|FG013|Overall Study|Lack of Efficacy|0|||
155181568|NCT04393298|560103106|FG014|Overall Study|Lack of Efficacy|1|||
155181569|NCT04393298|560103092|FG000|Overall Study|Progression|1|||
155181570|NCT04393298|560103093|FG001|Overall Study|Progression|0|||
155181571|NCT04393298|560103094|FG002|Overall Study|Progression|0|||
155181572|NCT04393298|560103095|FG003|Overall Study|Progression|0|||
155181573|NCT04393298|560103096|FG004|Overall Study|Progression|0|||
155181574|NCT04393298|560103097|FG005|Overall Study|Progression|0|||
155181575|NCT04393298|560103098|FG006|Overall Study|Progression|0|||
155181576|NCT04393298|560103099|FG007|Overall Study|Progression|0|||
155181577|NCT04393298|560103100|FG008|Overall Study|Progression|0|||
155181578|NCT04393298|560103101|FG009|Overall Study|Progression|0|||
155181579|NCT04393298|560103102|FG010|Overall Study|Progression|1|||
155181580|NCT04393298|560103103|FG011|Overall Study|Progression|1|||
155181581|NCT04393298|560103104|FG012|Overall Study|Progression|0|||
155181582|NCT04393298|560103105|FG013|Overall Study|Progression|0|||
155181583|NCT04393298|560103106|FG014|Overall Study|Progression|0|||
155181584|NCT04393298|560103092|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
155181585|NCT04393298|560103093|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181586|NCT04393298|560103094|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181587|NCT04393298|560103095|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181588|NCT04393298|560103096|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181589|NCT04393298|560103097|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181590|NCT04393298|560103098|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181591|NCT04393298|560103099|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181592|NCT04393298|560103100|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181593|NCT04393298|560103101|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181594|NCT04393298|560103102|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181595|NCT04393298|560103103|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181596|NCT04393298|560103104|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181597|NCT04393298|560103105|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181598|NCT04393298|560103106|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
155181599|NCT04393298|560103092|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181600|NCT04393298|560103093|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
155181601|NCT04393298|560103094|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181602|NCT04393298|560103095|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181603|NCT04393298|560103096|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181604|NCT04393298|560103097|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181605|NCT04393298|560103098|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181606|NCT04393298|560103099|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181607|NCT04393298|560103100|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181608|NCT04393298|560103101|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181609|NCT04393298|560103102|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181610|NCT04393298|560103103|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181611|NCT04393298|560103104|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181612|NCT04393298|560103105|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181613|NCT04393298|560103106|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
155181614|NCT04393298|560103092|FG000|Overall Study|Clinical Progression|0|||
155181615|NCT04393298|560103093|FG001|Overall Study|Clinical Progression|2|||
155181616|NCT04393298|560103094|FG002|Overall Study|Clinical Progression|0|||
155181617|NCT04393298|560103095|FG003|Overall Study|Clinical Progression|0|||
155181618|NCT04393298|560103096|FG004|Overall Study|Clinical Progression|0|||
155181619|NCT04393298|560103097|FG005|Overall Study|Clinical Progression|0|||
155181620|NCT04393298|560103098|FG006|Overall Study|Clinical Progression|0|||
155181621|NCT04393298|560103099|FG007|Overall Study|Clinical Progression|0|||
155181622|NCT04393298|560103100|FG008|Overall Study|Clinical Progression|0|||
155181623|NCT04393298|560103101|FG009|Overall Study|Clinical Progression|0|||
155181624|NCT04393298|560103102|FG010|Overall Study|Clinical Progression|0|||
155181625|NCT04393298|560103103|FG011|Overall Study|Clinical Progression|0|||
155181626|NCT04393298|560103104|FG012|Overall Study|Clinical Progression|0|||
155181627|NCT04393298|560103105|FG013|Overall Study|Clinical Progression|0|||
155030521|NCT01340027|559536844|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
155181628|NCT04393298|560103106|FG014|Overall Study|Clinical Progression|0|||
155181629|NCT04393298|560103092|FG000|Overall Study|Disease Progression|0|||
155181630|NCT04393298|560103093|FG001|Overall Study|Disease Progression|1|||
155181631|NCT04393298|560103094|FG002|Overall Study|Disease Progression|0|||
155181632|NCT04393298|560103095|FG003|Overall Study|Disease Progression|0|||
155181633|NCT04393298|560103096|FG004|Overall Study|Disease Progression|0|||
155181634|NCT04393298|560103097|FG005|Overall Study|Disease Progression|3|||
155181635|NCT04393298|560103098|FG006|Overall Study|Disease Progression|2|||
155181636|NCT04393298|560103099|FG007|Overall Study|Disease Progression|1|||
155181637|NCT04393298|560103100|FG008|Overall Study|Disease Progression|2|||
155181638|NCT04393298|560103101|FG009|Overall Study|Disease Progression|1|||
155181639|NCT04393298|560103102|FG010|Overall Study|Disease Progression|0|||
155181640|NCT04393298|560103103|FG011|Overall Study|Disease Progression|3|||
155181641|NCT04393298|560103104|FG012|Overall Study|Disease Progression|0|||
155181642|NCT04393298|560103105|FG013|Overall Study|Disease Progression|0|||
155030522|NCT01340027|559536845|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
155030523|NCT01340027|559536846|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
155030524|NCT01340027|559536847|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
155030525|NCT01340027|559536848|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
155030526|NCT01340027|559536849|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
155030527|NCT01340027|559536838|FG000|Overall Study|Adverse Event|0|||
155030528|NCT01340027|559536839|FG001|Overall Study|Adverse Event|1|||
155030529|NCT01340027|559536840|FG002|Overall Study|Adverse Event|2|||
155030530|NCT01340027|559536841|FG003|Overall Study|Adverse Event|0|||
155030531|NCT01340027|559536842|FG004|Overall Study|Adverse Event|1|||
155030532|NCT01340027|559536843|FG005|Overall Study|Adverse Event|2|||
155030533|NCT01340027|559536844|FG006|Overall Study|Adverse Event|2|||
155030534|NCT01340027|559536845|FG007|Overall Study|Adverse Event|1|||
155030535|NCT01340027|559536846|FG008|Overall Study|Adverse Event|4|||
155030536|NCT01340027|559536847|FG009|Overall Study|Adverse Event|1|||
155030537|NCT01340027|559536848|FG010|Overall Study|Adverse Event|1|||
155030538|NCT01340027|559536849|FG011|Overall Study|Adverse Event|3|||
155030539|NCT01340027|559536838|FG000|Overall Study|Lack of Efficacy|0|||
155030540|NCT01340027|559536839|FG001|Overall Study|Lack of Efficacy|0|||
155030541|NCT01340027|559536840|FG002|Overall Study|Lack of Efficacy|0|||
155030542|NCT01340027|559536841|FG003|Overall Study|Lack of Efficacy|0|||
155030543|NCT01340027|559536842|FG004|Overall Study|Lack of Efficacy|0|||
155030544|NCT01340027|559536843|FG005|Overall Study|Lack of Efficacy|0|||
155030545|NCT01340027|559536844|FG006|Overall Study|Lack of Efficacy|1|||
155030546|NCT01340027|559536845|FG007|Overall Study|Lack of Efficacy|1|||
155030547|NCT01340027|559536846|FG008|Overall Study|Lack of Efficacy|1|||
155030548|NCT01340027|559536847|FG009|Overall Study|Lack of Efficacy|0|||
155030549|NCT01340027|559536848|FG010|Overall Study|Lack of Efficacy|0|||
155030550|NCT01340027|559536849|FG011|Overall Study|Lack of Efficacy|0|||
155030551|NCT01340027|559536838|FG000|Overall Study|Lost to Follow-up|0|||
155030552|NCT01340027|559536839|FG001|Overall Study|Lost to Follow-up|1|||
155030553|NCT01340027|559536840|FG002|Overall Study|Lost to Follow-up|0|||
155030554|NCT01340027|559536841|FG003|Overall Study|Lost to Follow-up|0|||
155030555|NCT01340027|559536842|FG004|Overall Study|Lost to Follow-up|0|||
155030556|NCT01340027|559536843|FG005|Overall Study|Lost to Follow-up|0|||
155030557|NCT01340027|559536844|FG006|Overall Study|Lost to Follow-up|1|||
155030558|NCT01340027|559536845|FG007|Overall Study|Lost to Follow-up|0|||
155030559|NCT01340027|559536846|FG008|Overall Study|Lost to Follow-up|0|||
155030560|NCT01340027|559536847|FG009|Overall Study|Lost to Follow-up|1|||
155030561|NCT01340027|559536848|FG010|Overall Study|Lost to Follow-up|0|||
155030562|NCT01340027|559536849|FG011|Overall Study|Lost to Follow-up|0|||
155030563|NCT01340027|559536838|FG000|Overall Study|Protocol Violation|1|||
155030564|NCT01340027|559536839|FG001|Overall Study|Protocol Violation|2|||
155030565|NCT01340027|559536840|FG002|Overall Study|Protocol Violation|0|||
155030566|NCT01340027|559536841|FG003|Overall Study|Protocol Violation|0|||
155030567|NCT01340027|559536842|FG004|Overall Study|Protocol Violation|6|||
155030568|NCT01340027|559536843|FG005|Overall Study|Protocol Violation|0|||
155030569|NCT01340027|559536844|FG006|Overall Study|Protocol Violation|0|||
155030570|NCT01340027|559536845|FG007|Overall Study|Protocol Violation|1|||
155030571|NCT01340027|559536846|FG008|Overall Study|Protocol Violation|2|||
155030572|NCT01340027|559536847|FG009|Overall Study|Protocol Violation|2|||
155030573|NCT01340027|559536848|FG010|Overall Study|Protocol Violation|0|||
155030574|NCT01340027|559536849|FG011|Overall Study|Protocol Violation|0|||
155030575|NCT01340027|559536838|FG000|Overall Study|Withdrawal by Subject|4|||
155030576|NCT01340027|559536839|FG001|Overall Study|Withdrawal by Subject|3|||
155030577|NCT01340027|559536840|FG002|Overall Study|Withdrawal by Subject|1|||
155030578|NCT01340027|559536841|FG003|Overall Study|Withdrawal by Subject|3|||
155030579|NCT01340027|559536842|FG004|Overall Study|Withdrawal by Subject|3|||
155030580|NCT01340027|559536843|FG005|Overall Study|Withdrawal by Subject|2|||
155030581|NCT01340027|559536844|FG006|Overall Study|Withdrawal by Subject|3|||
155140247|NCT01514201|559944442|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
155140248|NCT01514201|559944443|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
155140249|NCT01514201|559944444|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
155140250|NCT01514201|559944445|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
155140251|NCT01514201|559944442|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155140252|NCT01514201|559944443|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155030582|NCT01340027|559536845|FG007|Overall Study|Withdrawal by Subject|4|||
155030583|NCT01340027|559536846|FG008|Overall Study|Withdrawal by Subject|1|||
155030584|NCT01340027|559536847|FG009|Overall Study|Withdrawal by Subject|2|||
155181643|NCT04393298|560103106|FG014|Overall Study|Disease Progression|1|||
155181644|NCT04393298|560103092|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181645|NCT04393298|560103093|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181646|NCT04393298|560103094|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
155181647|NCT04393298|560103095|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181648|NCT04393298|560103096|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181649|NCT04393298|560103097|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181650|NCT04393298|560103098|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181651|NCT04393298|560103099|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181652|NCT04393298|560103100|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181653|NCT04393298|560103101|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181654|NCT04393298|560103102|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181655|NCT04393298|560103103|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181656|NCT04393298|560103104|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181657|NCT04393298|560103105|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181658|NCT04393298|560103106|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
155181659|NCT04393298|560103092|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181660|NCT04393298|560103093|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181661|NCT04393298|560103094|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
155181662|NCT04393298|560103095|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181663|NCT04393298|560103096|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181664|NCT04393298|560103097|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181665|NCT04393298|560103098|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181666|NCT04393298|560103099|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181667|NCT04393298|560103100|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181668|NCT04393298|560103101|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181669|NCT04393298|560103102|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181670|NCT04393298|560103103|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181671|NCT04393298|560103104|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181672|NCT04393298|560103105|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181673|NCT04393298|560103106|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
155181674|NCT04393298|560103092|FG000|Overall Study|Progressive Disease (PD)|0|||
155181675|NCT04393298|560103093|FG001|Overall Study|Progressive Disease (PD)|0|||
155181676|NCT04393298|560103094|FG002|Overall Study|Progressive Disease (PD)|0|||
155181677|NCT04393298|560103095|FG003|Overall Study|Progressive Disease (PD)|3|||
155181678|NCT04393298|560103096|FG004|Overall Study|Progressive Disease (PD)|0|||
155181679|NCT04393298|560103097|FG005|Overall Study|Progressive Disease (PD)|0|||
155181680|NCT04393298|560103098|FG006|Overall Study|Progressive Disease (PD)|0|||
155181681|NCT04393298|560103099|FG007|Overall Study|Progressive Disease (PD)|0|||
155181682|NCT04393298|560103100|FG008|Overall Study|Progressive Disease (PD)|0|||
155181683|NCT04393298|560103101|FG009|Overall Study|Progressive Disease (PD)|0|||
155181684|NCT04393298|560103102|FG010|Overall Study|Progressive Disease (PD)|0|||
155181685|NCT04393298|560103103|FG011|Overall Study|Progressive Disease (PD)|0|||
155181686|NCT04393298|560103104|FG012|Overall Study|Progressive Disease (PD)|0|||
155181687|NCT04393298|560103105|FG013|Overall Study|Progressive Disease (PD)|0|||
155181688|NCT04393298|560103106|FG014|Overall Study|Progressive Disease (PD)|0|||
155181689|NCT04393298|560103092|FG000|Overall Study|Started a New Cancer Treatment|0|||
155181690|NCT04393298|560103093|FG001|Overall Study|Started a New Cancer Treatment|0|||
155181691|NCT04393298|560103094|FG002|Overall Study|Started a New Cancer Treatment|0|||
155181692|NCT04393298|560103095|FG003|Overall Study|Started a New Cancer Treatment|0|||
155181693|NCT04393298|560103096|FG004|Overall Study|Started a New Cancer Treatment|1|||
155181694|NCT04393298|560103097|FG005|Overall Study|Started a New Cancer Treatment|0|||
155030585|NCT01340027|559536848|FG010|Overall Study|Withdrawal by Subject|0|||
155030586|NCT01340027|559536849|FG011|Overall Study|Withdrawal by Subject|1|||
155030587|NCT01340027|559536838|FG000|Overall Study|Miscellaneous|0|||
155181695|NCT04393298|560103098|FG006|Overall Study|Started a New Cancer Treatment|0|||
155181696|NCT04393298|560103099|FG007|Overall Study|Started a New Cancer Treatment|0|||
155181697|NCT04393298|560103100|FG008|Overall Study|Started a New Cancer Treatment|0|||
155181698|NCT04393298|560103101|FG009|Overall Study|Started a New Cancer Treatment|0|||
155181699|NCT04393298|560103102|FG010|Overall Study|Started a New Cancer Treatment|0|||
155181700|NCT04393298|560103103|FG011|Overall Study|Started a New Cancer Treatment|0|||
155181701|NCT04393298|560103104|FG012|Overall Study|Started a New Cancer Treatment|0|||
155181702|NCT04393298|560103105|FG013|Overall Study|Started a New Cancer Treatment|0|||
155181703|NCT04393298|560103106|FG014|Overall Study|Started a New Cancer Treatment|0|||
155181704|NCT04393298|560103092|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155030588|NCT01340027|559536839|FG001|Overall Study|Miscellaneous|0|||
155030589|NCT01340027|559536840|FG002|Overall Study|Miscellaneous|0|||
155181705|NCT04393298|560103093|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181706|NCT04393298|560103094|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181707|NCT04393298|560103095|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181708|NCT04393298|560103096|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
155181709|NCT04393298|560103097|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181710|NCT04393298|560103098|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181711|NCT04393298|560103099|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181712|NCT04393298|560103100|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181713|NCT04393298|560103101|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181714|NCT04393298|560103102|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181715|NCT04393298|560103103|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181716|NCT04393298|560103104|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181717|NCT04393298|560103105|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181718|NCT04393298|560103106|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
155181719|NCT04393298|560103092|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181720|NCT04393298|560103093|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181721|NCT04393298|560103094|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181722|NCT04393298|560103095|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181723|NCT04393298|560103096|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181724|NCT04393298|560103097|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
155181725|NCT04393298|560103098|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181726|NCT04393298|560103099|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181727|NCT04393298|560103100|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181728|NCT04393298|560103101|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181729|NCT04393298|560103102|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181730|NCT04393298|560103103|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181731|NCT04393298|560103104|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181732|NCT04393298|560103105|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181733|NCT04393298|560103106|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
155181734|NCT04393298|560103092|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181735|NCT04393298|560103093|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181736|NCT04393298|560103094|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181737|NCT04393298|560103095|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181738|NCT04393298|560103096|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181739|NCT04393298|560103097|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
155181740|NCT04393298|560103098|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181741|NCT04393298|560103099|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181742|NCT04393298|560103100|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181743|NCT04393298|560103101|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181744|NCT04393298|560103102|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181745|NCT04393298|560103103|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181746|NCT04393298|560103104|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181747|NCT04393298|560103105|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
155181748|NCT04393298|560103106|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
155181749|NCT04393298|560103092|FG000|Overall Study|Death|0|||
155181750|NCT04393298|560103093|FG001|Overall Study|Death|0|||
155181751|NCT04393298|560103094|FG002|Overall Study|Death|0|||
155181752|NCT04393298|560103095|FG003|Overall Study|Death|0|||
155181753|NCT04393298|560103096|FG004|Overall Study|Death|0|||
155181754|NCT04393298|560103097|FG005|Overall Study|Death|1|||
155181755|NCT04393298|560103098|FG006|Overall Study|Death|1|||
155181756|NCT04393298|560103099|FG007|Overall Study|Death|0|||
155181757|NCT04393298|560103100|FG008|Overall Study|Death|1|||
155181758|NCT04393298|560103101|FG009|Overall Study|Death|1|||
155181759|NCT04393298|560103102|FG010|Overall Study|Death|0|||
155181760|NCT04393298|560103103|FG011|Overall Study|Death|1|||
155181761|NCT04393298|560103104|FG012|Overall Study|Death|1|||
155181762|NCT04393298|560103105|FG013|Overall Study|Death|0|||
155181763|NCT04393298|560103106|FG014|Overall Study|Death|1|||
155181764|NCT04393298|560103092|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181765|NCT04393298|560103093|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181766|NCT04393298|560103094|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181767|NCT04393298|560103095|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181768|NCT04393298|560103096|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181769|NCT04393298|560103097|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
155181770|NCT04393298|560103098|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181771|NCT04393298|560103099|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155030590|NCT01340027|559536841|FG003|Overall Study|Miscellaneous|1|||
155181772|NCT04393298|560103100|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181773|NCT04393298|560103101|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181774|NCT04393298|560103102|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181775|NCT04393298|560103103|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181776|NCT04393298|560103104|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181777|NCT04393298|560103105|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181778|NCT04393298|560103106|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
155181779|NCT04393298|560103092|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
155181780|NCT04393298|560103093|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
155181781|NCT04393298|560103094|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
155181782|NCT04393298|560103095|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
155181783|NCT04393298|560103096|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
155181784|NCT04393298|560103097|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
155181785|NCT04393298|560103098|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
155181786|NCT04393298|560103099|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
155181787|NCT04393298|560103100|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
155181788|NCT04393298|560103101|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
155181789|NCT04393298|560103102|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
155181790|NCT04393298|560103103|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
155181791|NCT04393298|560103104|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
155181792|NCT04393298|560103105|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
155181793|NCT04393298|560103106|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
155181794|NCT04393298|560103092|FG000|Overall Study|Patient Passed Away|0|||
155181795|NCT04393298|560103093|FG001|Overall Study|Patient Passed Away|0|||
155181796|NCT04393298|560103094|FG002|Overall Study|Patient Passed Away|0|||
155181797|NCT04393298|560103095|FG003|Overall Study|Patient Passed Away|0|||
155181798|NCT04393298|560103096|FG004|Overall Study|Patient Passed Away|0|||
155181799|NCT04393298|560103097|FG005|Overall Study|Patient Passed Away|0|||
155181800|NCT04393298|560103098|FG006|Overall Study|Patient Passed Away|0|||
155181801|NCT04393298|560103099|FG007|Overall Study|Patient Passed Away|1|||
155181802|NCT04393298|560103100|FG008|Overall Study|Patient Passed Away|0|||
155181803|NCT04393298|560103101|FG009|Overall Study|Patient Passed Away|0|||
155181804|NCT04393298|560103102|FG010|Overall Study|Patient Passed Away|0|||
155181805|NCT04393298|560103103|FG011|Overall Study|Patient Passed Away|0|||
155181806|NCT04393298|560103104|FG012|Overall Study|Patient Passed Away|0|||
155181807|NCT04393298|560103105|FG013|Overall Study|Patient Passed Away|0|||
155181808|NCT04393298|560103106|FG014|Overall Study|Patient Passed Away|0|||
155181809|NCT04393298|560103092|FG000|Overall Study|Patient Deceased|0|||
155181810|NCT04393298|560103093|FG001|Overall Study|Patient Deceased|0|||
155181811|NCT04393298|560103094|FG002|Overall Study|Patient Deceased|0|||
155181812|NCT04393298|560103095|FG003|Overall Study|Patient Deceased|0|||
155181813|NCT04393298|560103096|FG004|Overall Study|Patient Deceased|0|||
155181814|NCT04393298|560103097|FG005|Overall Study|Patient Deceased|0|||
155181815|NCT04393298|560103098|FG006|Overall Study|Patient Deceased|0|||
155181816|NCT04393298|560103099|FG007|Overall Study|Patient Deceased|1|||
155181817|NCT04393298|560103100|FG008|Overall Study|Patient Deceased|0|||
155181818|NCT04393298|560103101|FG009|Overall Study|Patient Deceased|0|||
155181819|NCT04393298|560103102|FG010|Overall Study|Patient Deceased|0|||
155181820|NCT04393298|560103103|FG011|Overall Study|Patient Deceased|0|||
155181821|NCT04393298|560103104|FG012|Overall Study|Patient Deceased|0|||
155181822|NCT04393298|560103105|FG013|Overall Study|Patient Deceased|0|||
155181823|NCT04393298|560103106|FG014|Overall Study|Patient Deceased|0|||
155181824|NCT04393298|560103092|FG000|Overall Study|Patient Discharged to Hospice|0|||
155181825|NCT04393298|560103093|FG001|Overall Study|Patient Discharged to Hospice|0|||
155181826|NCT04393298|560103094|FG002|Overall Study|Patient Discharged to Hospice|0|||
155181827|NCT04393298|560103095|FG003|Overall Study|Patient Discharged to Hospice|0|||
155030591|NCT01340027|559536842|FG004|Overall Study|Miscellaneous|0|||
155030592|NCT01340027|559536843|FG005|Overall Study|Miscellaneous|0|||
155181828|NCT04393298|560103096|FG004|Overall Study|Patient Discharged to Hospice|0|||
155181829|NCT04393298|560103097|FG005|Overall Study|Patient Discharged to Hospice|0|||
155181830|NCT04393298|560103098|FG006|Overall Study|Patient Discharged to Hospice|0|||
155181831|NCT04393298|560103099|FG007|Overall Study|Patient Discharged to Hospice|0|||
155181832|NCT04393298|560103100|FG008|Overall Study|Patient Discharged to Hospice|1|||
155181833|NCT04393298|560103101|FG009|Overall Study|Patient Discharged to Hospice|0|||
155181834|NCT04393298|560103102|FG010|Overall Study|Patient Discharged to Hospice|0|||
155181835|NCT04393298|560103103|FG011|Overall Study|Patient Discharged to Hospice|0|||
155181836|NCT04393298|560103104|FG012|Overall Study|Patient Discharged to Hospice|0|||
155181837|NCT04393298|560103105|FG013|Overall Study|Patient Discharged to Hospice|0|||
155181838|NCT04393298|560103106|FG014|Overall Study|Patient Discharged to Hospice|0|||
155181839|NCT04393298|560103092|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181840|NCT04393298|560103093|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155030593|NCT01340027|559536844|FG006|Overall Study|Miscellaneous|0|||
155140253|NCT01514201|559944444|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
155140254|NCT01514201|559944445|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
155140255|NCT01514201|559944442|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155140256|NCT01514201|559944443|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155140257|NCT01514201|559944444|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
155140258|NCT01514201|559944445|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
155140259|NCT01514201|559944442|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155140260|NCT01514201|559944443|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155140261|NCT01514201|559944444|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
155140262|NCT01514201|559944445|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
155140263|NCT00637416|559944450|FG000|Overall Study|Lost to Follow-up|1|||
155140264|NCT00637416|559944451|FG001|Overall Study|Lost to Follow-up|1|||
155140265|NCT00637416|559944450|FG000|Overall Study|Unable to take study drug|0|||
155140266|NCT00637416|559944451|FG001|Overall Study|Unable to take study drug|1|||
155140267|NCT02715609|559944463|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
155140268|NCT02715609|559944464|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
155140269|NCT02715609|559944465|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
155140270|NCT02715609|559944463|FG000|Overall Study|Withdrawal by Subject|0|||
155140271|NCT02715609|559944464|FG001|Overall Study|Withdrawal by Subject|0|||
155140272|NCT02715609|559944465|FG002|Overall Study|Withdrawal by Subject|1|||
155140273|NCT00310817|559944466|FG000|Overall Study|AE or Death|3|||
155140274|NCT00310817|559944467|FG001|Overall Study|AE or Death|1|||
155140275|NCT00310817|559944468|FG002|Overall Study|AE or Death|0|||
155140276|NCT00310817|559944469|FG003|Overall Study|AE or Death|0|||
155140277|NCT00310817|559944466|FG000|Overall Study|Withdrawal by Subject|1|||
155140278|NCT00310817|559944467|FG001|Overall Study|Withdrawal by Subject|4|||
155140279|NCT00310817|559944468|FG002|Overall Study|Withdrawal by Subject|6|||
155140280|NCT00310817|559944469|FG003|Overall Study|Withdrawal by Subject|7|||
155140281|NCT00310817|559944466|FG000|Overall Study|Lost to Follow-up|2|||
155140282|NCT00310817|559944467|FG001|Overall Study|Lost to Follow-up|1|||
155140283|NCT00310817|559944468|FG002|Overall Study|Lost to Follow-up|0|||
155140284|NCT00310817|559944469|FG003|Overall Study|Lost to Follow-up|0|||
155140285|NCT00310817|559944466|FG000|Overall Study|Inappropriate Enrollment|1|||
155140286|NCT00310817|559944467|FG001|Overall Study|Inappropriate Enrollment|0|||
155140287|NCT00310817|559944468|FG002|Overall Study|Inappropriate Enrollment|1|||
155140288|NCT00310817|559944469|FG003|Overall Study|Inappropriate Enrollment|0|||
155140289|NCT00310817|559944466|FG000|Overall Study|Protocol Violation|1|||
155140290|NCT00310817|559944467|FG001|Overall Study|Protocol Violation|1|||
155140291|NCT00310817|559944468|FG002|Overall Study|Protocol Violation|1|||
155140292|NCT00310817|559944469|FG003|Overall Study|Protocol Violation|1|||
155140293|NCT00310817|559944466|FG000|Overall Study|Unable to classify|3|||
155140294|NCT00310817|559944467|FG001|Overall Study|Unable to classify|1|||
155140295|NCT00310817|559944468|FG002|Overall Study|Unable to classify|0|||
155140296|NCT00310817|559944469|FG003|Overall Study|Unable to classify|0|||
155140297|NCT04300309|559944475|FG000|Overall Study|Lost to Follow-up|1|||
155140298|NCT04300309|559944476|FG001|Overall Study|Lost to Follow-up|0|||
155140299|NCT04607837|559944478|FG000|Overall Study|Adverse Event|8|||
155140300|NCT04607837|559944479|FG001|Overall Study|Adverse Event|2|||
155140301|NCT04607837|559944478|FG000|Overall Study|Withdrawal by Subject|8|||
155140302|NCT04607837|559944479|FG001|Overall Study|Withdrawal by Subject|7|||
155140303|NCT04607837|559944478|FG000|Overall Study|Physician Decision|2|||
155140304|NCT04607837|559944479|FG001|Overall Study|Physician Decision|0|||
155140305|NCT04607837|559944478|FG000|Overall Study|Lack of Efficacy|2|||
155140306|NCT04607837|559944479|FG001|Overall Study|Lack of Efficacy|0|||
155140307|NCT04607837|559944478|FG000|Overall Study|Participant terminated by sponsor|1|||
155140308|NCT04607837|559944479|FG001|Overall Study|Participant terminated by sponsor|0|||
155140309|NCT04607837|559944478|FG000|Overall Study|Disease worsening|36|||
155030594|NCT01340027|559536845|FG007|Overall Study|Miscellaneous|0|||
155030595|NCT01340027|559536846|FG008|Overall Study|Miscellaneous|0|||
155030596|NCT01340027|559536847|FG009|Overall Study|Miscellaneous|0|||
155030597|NCT01340027|559536848|FG010|Overall Study|Miscellaneous|1|||
155030598|NCT01340027|559536849|FG011|Overall Study|Miscellaneous|0|||
155030599|NCT00833482|559536850|FG000|Days 11-20|Adverse Event|0|||
155030600|NCT00833482|559536851|FG001|Days 11-20|Adverse Event|2|||
155030601|NCT00833482|559536852|FG002|Days 11-20|Adverse Event|0|||
155030602|NCT00833482|559536853|FG003|Days 11-20|Adverse Event|0|||
155140310|NCT04607837|559944479|FG001|Overall Study|Disease worsening|36|||
155030603|NCT00833482|559536854|FG004|Days 11-20|Adverse Event|0|||
155140311|NCT04607837|559944478|FG000|Overall Study|Other|1|||
155030604|NCT00833482|559536855|FG005|Days 11-20|Adverse Event|0|||
155030605|NCT00833482|559536850|FG000|Days 11-20|Withdrawal by Subject|0|||
155140312|NCT04607837|559944479|FG001|Overall Study|Other|0|||
155140313|NCT00367835|559944480|FG000|Overall Study|Adverse Event|14|||
155140314|NCT00367835|559944481|FG001|Overall Study|Adverse Event|1|||
155140315|NCT00367835|559944480|FG000|Overall Study|Protocol Violation|1|||
155140316|NCT00367835|559944481|FG001|Overall Study|Protocol Violation|7|||
155181841|NCT04393298|560103094|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181842|NCT04393298|560103095|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181843|NCT04393298|560103096|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181844|NCT04393298|560103097|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181845|NCT04393298|560103098|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181846|NCT04393298|560103099|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181847|NCT04393298|560103100|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181848|NCT04393298|560103101|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
155181849|NCT04393298|560103102|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181850|NCT04393298|560103103|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181851|NCT04393298|560103104|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181852|NCT04393298|560103105|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181853|NCT04393298|560103106|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
155181854|NCT04393298|560103092|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
155181855|NCT04393298|560103093|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
155181856|NCT04393298|560103094|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
155181857|NCT04393298|560103095|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
155181858|NCT04393298|560103096|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
155181859|NCT04393298|560103097|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
155181860|NCT04393298|560103098|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
155181861|NCT04393298|560103099|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
155181862|NCT04393298|560103100|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
155181863|NCT04393298|560103101|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
155181864|NCT04393298|560103102|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
155181865|NCT04393298|560103103|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
155181866|NCT04393298|560103104|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
155181867|NCT04393298|560103105|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
155181868|NCT04393298|560103106|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
155181869|NCT03754972|560103109|FG000|Overall Study|Protocol Violation|25|||
155181870|NCT02987660|560103111|FG000|Overall Study|Study terminated by sponsor|10|||
155181871|NCT02987660|560103112|FG001|Overall Study|Study terminated by sponsor|10|||
155181872|NCT03553836|560103113|FG000|Overall Study|Ongoing in Study|460|||
155181873|NCT03553836|560103114|FG001|Overall Study|Ongoing in Study|459|||
155181874|NCT03553836|560103113|FG000|Overall Study|Withdrawal by Subject|9|||
155181875|NCT03553836|560103114|FG001|Overall Study|Withdrawal by Subject|10|||
155181876|NCT03553836|560103113|FG000|Overall Study|Lost to Follow-up|1|||
155181877|NCT03553836|560103114|FG001|Overall Study|Lost to Follow-up|3|||
155181878|NCT03553836|560103113|FG000|Overall Study|Death|17|||
155181879|NCT03553836|560103114|FG001|Overall Study|Death|17|||
155181880|NCT03220438|560103115|FG000|Overall Study|Lost to Follow-up|0|||
155181881|NCT03220438|560103116|FG001|Overall Study|Lost to Follow-up|0|||
155181882|NCT03220438|560103117|FG002|Overall Study|Lost to Follow-up|1|||
155181883|NCT03220438|560103118|FG003|Overall Study|Lost to Follow-up|0|||
155181884|NCT04190680|560103119|FG000|Overall Study|Not meeting criteria for data analysis|1|||
155181885|NCT04190680|560103120|FG001|Overall Study|Not meeting criteria for data analysis|15|||
155181886|NCT04190680|560103119|FG000|Overall Study|Administrative error|0|||
155181887|NCT04190680|560103120|FG001|Overall Study|Administrative error|18|||
155181888|NCT05660850|560103122|FG000|Treatment Period 2|Study Terminated by Sponsor|1|||
155181889|NCT05660850|560103123|FG001|Treatment Period 2|Study Terminated by Sponsor|0|||
155030606|NCT00833482|559536851|FG001|Days 11-20|Withdrawal by Subject|1|||
155181890|NCT05660850|560103124|FG002|Treatment Period 2|Study Terminated by Sponsor|0|||
155181891|NCT05660850|560103125|FG003|Treatment Period 2|Study Terminated by Sponsor|0|||
155181892|NCT02604017|560103126|FG000|Overall Study|Withdrew Consent|0|||
155181893|NCT02604017|560103127|FG001|Overall Study|Withdrew Consent|2|||
155181894|NCT02604017|560103126|FG000|Overall Study|Lost to Follow-up|5|||
155181895|NCT02604017|560103127|FG001|Overall Study|Lost to Follow-up|6|||
155181896|NCT02604017|560103126|FG000|Overall Study|Other|1|||
155181897|NCT02604017|560103127|FG001|Overall Study|Other|0|||
155181898|NCT04104438|560103128|FG000|Overall Study|Death|2|||
155181899|NCT04104438|560103129|FG001|Overall Study|Death|1|||
155181900|NCT04104438|560103130|FG002|Overall Study|Death|2|||
155181901|NCT04104438|560103128|FG000|Overall Study|Adverse Event|0|||
155181902|NCT04104438|560103129|FG001|Overall Study|Adverse Event|3|||
155181903|NCT04104438|560103130|FG002|Overall Study|Adverse Event|0|||
155181904|NCT04104438|560103128|FG000|Overall Study|Withdrawal by Subject|0|||
155181905|NCT04104438|560103129|FG001|Overall Study|Withdrawal by Subject|1|||
155181906|NCT04104438|560103130|FG002|Overall Study|Withdrawal by Subject|0|||
155181907|NCT04104438|560103128|FG000|Overall Study|Disenrolled due to noncompliance|0|||
155181908|NCT04104438|560103129|FG001|Overall Study|Disenrolled due to noncompliance|1|||
155181909|NCT04104438|560103130|FG002|Overall Study|Disenrolled due to noncompliance|0|||
155181910|NCT04104438|560103128|FG000|Overall Study|stopped due to possible operation|0|||
155181911|NCT04104438|560103129|FG001|Overall Study|stopped due to possible operation|1|||
155181912|NCT04104438|560103130|FG002|Overall Study|stopped due to possible operation|0|||
155030607|NCT00833482|559536852|FG002|Days 11-20|Withdrawal by Subject|0|||
155030608|NCT00833482|559536853|FG003|Days 11-20|Withdrawal by Subject|0|||
155030609|NCT00833482|559536854|FG004|Days 11-20|Withdrawal by Subject|0|||
155030610|NCT00833482|559536855|FG005|Days 11-20|Withdrawal by Subject|0|||
155030611|NCT00833482|559536850|FG000|Days 21-30|Adverse Event|0|||
155030612|NCT00833482|559536851|FG001|Days 21-30|Adverse Event|0|||
155030613|NCT00833482|559536852|FG002|Days 21-30|Adverse Event|1|||
155030614|NCT00833482|559536853|FG003|Days 21-30|Adverse Event|0|||
155030615|NCT00833482|559536854|FG004|Days 21-30|Adverse Event|0|||
155030616|NCT00833482|559536855|FG005|Days 21-30|Adverse Event|0|||
155030617|NCT00833482|559536850|FG000|Days 21-30|Withdrawal by Subject|0|||
155030618|NCT00833482|559536851|FG001|Days 21-30|Withdrawal by Subject|0|||
155030619|NCT00833482|559536852|FG002|Days 21-30|Withdrawal by Subject|0|||
155030620|NCT00833482|559536853|FG003|Days 21-30|Withdrawal by Subject|0|||
155030621|NCT00833482|559536854|FG004|Days 21-30|Withdrawal by Subject|1|||
155030622|NCT00833482|559536855|FG005|Days 21-30|Withdrawal by Subject|0|||
155030623|NCT02496091|559536856|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155030624|NCT02234596|559536858|FG000|Overall Study|Participant not treated|2|||
155030625|NCT04240886|559538587|FG000|Treatment Phase|Death|4|||
155030626|NCT04240886|559538587|FG000|Treatment Phase|Discontinuation by Subject|1|||
155030627|NCT04240886|559538587|FG000|Treatment Phase|Adverse Event|5|||
155030628|NCT04240886|559538587|FG000|Follow-up Phase|Withdrawal by Subject|1|||
155030629|NCT04240886|559538587|FG000|Follow-up Phase|Discontinuation by Subject|1|||
155030630|NCT04240886|559538587|FG000|Follow-up Phase|Death|2|||
155030631|NCT04161079|559538592|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
155030632|NCT04327661|559538595|FG000|Overall Study|Withdrawal by Subject|1|||
155030633|NCT04327661|559538596|FG001|Overall Study|Withdrawal by Subject|0|||
155030634|NCT04327661|559538597|FG002|Overall Study|Withdrawal by Subject|0|||
155030635|NCT01473394|559538598|FG000|Overall Study|Adverse Event|13|||
155030636|NCT01473394|559538599|FG001|Overall Study|Adverse Event|16|||
155030637|NCT01473394|559538598|FG000|Overall Study|Insufficient Therapeutic Response|4|||
155030638|NCT01473394|559538599|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155030639|NCT01473394|559538598|FG000|Overall Study|Protocol Violation|7|||
155030640|NCT01473394|559538599|FG001|Overall Study|Protocol Violation|5|||
155030641|NCT01473394|559538598|FG000|Overall Study|Withdrew Consent|12|||
155030642|NCT01473394|559538599|FG001|Overall Study|Withdrew Consent|10|||
155030643|NCT01473394|559538598|FG000|Overall Study|Lost to Follow-up|9|||
155030644|NCT01473394|559538599|FG001|Overall Study|Lost to Follow-up|11|||
155030645|NCT03391232|559538600|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
155030646|NCT03391232|559538601|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
155030647|NCT03391232|559538600|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
155030648|NCT03391232|559538601|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
155030649|NCT02662764|559538606|FG000|Overall Study|Adverse Event|6|||
155030650|NCT02662764|559538606|FG000|Overall Study|Lack of Efficacy|8|||
155030651|NCT02662764|559538606|FG000|Overall Study|Protocol Violation|1|||
155030652|NCT02662764|559538606|FG000|Overall Study|Withdrawal by Subject|5|||
155030653|NCT02662764|559538606|FG000|Overall Study|Device failure|4|||
155030654|NCT02662764|559538606|FG000|Overall Study|Patient changed treatment|1|||
155030655|NCT02662764|559538606|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
155030656|NCT04521621|559538610|FG000|Overall Study|Death|17|||
155030657|NCT04521621|559538611|FG001|Overall Study|Death|8|||
155030658|NCT04521621|559538612|FG002|Overall Study|Death|8|||
155030659|NCT04521621|559538613|FG003|Overall Study|Death|5|||
155030660|NCT04521621|559538614|FG004|Overall Study|Death|2|||
155030661|NCT04521621|559538615|FG005|Overall Study|Death|7|||
155030662|NCT04521621|559538616|FG006|Overall Study|Death|0|||
155030663|NCT04521621|559538617|FG007|Overall Study|Death|0|||
155030664|NCT04521621|559538610|FG000|Overall Study|Study Terminated by Sponsor|4|||
155030665|NCT04521621|559538611|FG001|Overall Study|Study Terminated by Sponsor|6|||
155030666|NCT04521621|559538612|FG002|Overall Study|Study Terminated by Sponsor|8|||
155030667|NCT04521621|559538613|FG003|Overall Study|Study Terminated by Sponsor|0|||
155030668|NCT04521621|559538614|FG004|Overall Study|Study Terminated by Sponsor|1|||
155030669|NCT04521621|559538615|FG005|Overall Study|Study Terminated by Sponsor|7|||
155030670|NCT04521621|559538616|FG006|Overall Study|Study Terminated by Sponsor|0|||
155030671|NCT04521621|559538617|FG007|Overall Study|Study Terminated by Sponsor|0|||
155030672|NCT04521621|559538610|FG000|Overall Study|Withdrawal by Subject|0|||
155030673|NCT04521621|559538611|FG001|Overall Study|Withdrawal by Subject|0|||
155030674|NCT04521621|559538612|FG002|Overall Study|Withdrawal by Subject|1|||
155030675|NCT04521621|559538613|FG003|Overall Study|Withdrawal by Subject|1|||
155030676|NCT04521621|559538614|FG004|Overall Study|Withdrawal by Subject|0|||
155030677|NCT04521621|559538615|FG005|Overall Study|Withdrawal by Subject|0|||
155030678|NCT04521621|559538616|FG006|Overall Study|Withdrawal by Subject|0|||
155030679|NCT04521621|559538617|FG007|Overall Study|Withdrawal by Subject|0|||
155030680|NCT04521621|559538610|FG000|Overall Study|Allocated in error without study intervention|1|||
155030681|NCT04521621|559538611|FG001|Overall Study|Allocated in error without study intervention|0|||
155181913|NCT04104438|560103128|FG000|Overall Study|everolimus not started due to bile duct injury|0|||
155181914|NCT04104438|560103129|FG001|Overall Study|everolimus not started due to bile duct injury|1|||
155181915|NCT04104438|560103130|FG002|Overall Study|everolimus not started due to bile duct injury|0|||
155181916|NCT03116347|560103135|FG000|Overall Study|Withdrawal by Subject|1|||
155181917|NCT03116347|560103136|FG001|Overall Study|Withdrawal by Subject|2|||
155181918|NCT04193410|560103137|FG000|Overall Study|Lost to Follow-up|7|||
155181919|NCT04193410|560103138|FG001|Overall Study|Lost to Follow-up|6|||
155181920|NCT04973137|560103139|FG000|Double Blind Phase|Adverse Event|4|||
155181921|NCT04973137|560103140|FG001|Double Blind Phase|Adverse Event|0|||
155181922|NCT04973137|560103139|FG000|Double Blind Phase|Death|25|||
155181923|NCT04973137|560103140|FG001|Double Blind Phase|Death|15|||
155181924|NCT04973137|560103139|FG000|Double Blind Phase|Physician Decision|5|||
155181925|NCT04973137|560103140|FG001|Double Blind Phase|Physician Decision|1|||
155181926|NCT04973137|560103139|FG000|Double Blind Phase|Withdrawal by Subject|6|||
155181927|NCT04973137|560103140|FG001|Double Blind Phase|Withdrawal by Subject|1|||
155181928|NCT04973137|560103139|FG000|Double Blind Phase|Other|2|||
155181929|NCT04973137|560103140|FG001|Double Blind Phase|Other|2|||
155181930|NCT04973137|560103139|FG000|Open Label Extension Phase|Death|3|||
155181931|NCT04973137|560103140|FG001|Open Label Extension Phase|Death|0|||
155181932|NCT04973137|560103139|FG000|Open Label Extension Phase|Physician Decision|0|||
155181933|NCT04973137|560103140|FG001|Open Label Extension Phase|Physician Decision|1|||
155181934|NCT04973137|560103139|FG000|Open Label Extension Phase|Withdrawal by Subject|1|||
155181935|NCT04973137|560103140|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
155181936|NCT04973137|560103139|FG000|Open Label Extension Phase|Study Terminated by Sponsor|83|||
155181937|NCT04973137|560103140|FG001|Open Label Extension Phase|Study Terminated by Sponsor|43|||
155181938|NCT04973137|560103139|FG000|Open Label Extension Phase|Site Terminated by Sponsor|5|||
155181939|NCT04973137|560103140|FG001|Open Label Extension Phase|Site Terminated by Sponsor|0|||
155181940|NCT01302834|560103141|FG000|Overall Study|Protocol Violation|17|||
155181941|NCT01302834|560103142|FG001|Overall Study|Protocol Violation|23|||
155181942|NCT01302834|560103141|FG000|Overall Study|HIV positive|1|||
155181943|NCT01302834|560103142|FG001|Overall Study|HIV positive|3|||
155181944|NCT04779216|560103143|FG000|Overall Study|Lost to Follow-up|1|||
155181945|NCT04779216|560103144|FG001|Overall Study|Lost to Follow-up|0|||
155181946|NCT04779216|560103143|FG000|Overall Study|Withdrawal by Subject|1|||
155181947|NCT04779216|560103144|FG001|Overall Study|Withdrawal by Subject|0|||
155181948|NCT02274038|560103149|FG000|Overall Study|Death|1|||
155181949|NCT00570232|560103150|FG000|Overall Study|Adverse Event|10|||
155181950|NCT00570232|560103150|FG000|Overall Study|discontinued due to medical condition|3|||
155181951|NCT00570232|560103150|FG000|Overall Study|discontinued due to recurrence|8|||
155181952|NCT00570232|560103150|FG000|Overall Study|discontinued due to noncompliance|2|||
155181953|NCT04594369|560103152|FG000|Overall Study|Adverse Event|10|||
155181954|NCT04594369|560103153|FG001|Overall Study|Adverse Event|10|||
155181955|NCT04594369|560103154|FG002|Overall Study|Adverse Event|9|||
155181956|NCT04594369|560103152|FG000|Overall Study|Death|2|||
155181957|NCT04594369|560103153|FG001|Overall Study|Death|4|||
155181958|NCT04594369|560103154|FG002|Overall Study|Death|8|||
155181959|NCT04594369|560103152|FG000|Overall Study|Lost to Follow-up|10|||
155181960|NCT04594369|560103153|FG001|Overall Study|Lost to Follow-up|2|||
155181961|NCT04594369|560103154|FG002|Overall Study|Lost to Follow-up|4|||
155181962|NCT04594369|560103152|FG000|Overall Study|Physician Decision|2|||
155181963|NCT04594369|560103153|FG001|Overall Study|Physician Decision|2|||
155181964|NCT04594369|560103154|FG002|Overall Study|Physician Decision|3|||
155181965|NCT04594369|560103152|FG000|Overall Study|Protocol deviation|1|||
155181966|NCT04594369|560103153|FG001|Overall Study|Protocol deviation|3|||
155181967|NCT04594369|560103154|FG002|Overall Study|Protocol deviation|2|||
155181968|NCT04594369|560103152|FG000|Overall Study|Withdrawal by Subject|40|||
155181969|NCT04594369|560103153|FG001|Overall Study|Withdrawal by Subject|32|||
155181970|NCT04594369|560103154|FG002|Overall Study|Withdrawal by Subject|37|||
155181971|NCT04594369|560103152|FG000|Overall Study|Reason not specified|60|||
155181972|NCT04594369|560103153|FG001|Overall Study|Reason not specified|56|||
155181973|NCT04594369|560103154|FG002|Overall Study|Reason not specified|43|||
155198474|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
155198475|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
155198476|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
155198477|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
155198478|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
155198479|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
155198480|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
155198481|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
155198482|NCT00787891|560164974|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
155198483|NCT00787891|560164975|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
155198484|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
155198485|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
155198486|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
155181974|NCT04626310|560103861|FG000|Overall Study|4-miss from treatment|6|||
155030682|NCT04521621|559538612|FG002|Overall Study|Allocated in error without study intervention|0|||
155030683|NCT04521621|559538613|FG003|Overall Study|Allocated in error without study intervention|0|||
155181975|NCT04626310|560103862|FG001|Overall Study|4-miss from treatment|5|||
155181976|NCT04626310|560103863|FG002|Overall Study|4-miss from treatment|5|||
155181977|NCT04626310|560103861|FG000|Overall Study|Withdrawal by Subject|1|||
155181978|NCT04626310|560103862|FG001|Overall Study|Withdrawal by Subject|0|||
155181979|NCT04626310|560103863|FG002|Overall Study|Withdrawal by Subject|3|||
155181980|NCT01315236|560103864|FG000|Double-blind Phase|Death|1|||
155181981|NCT01315236|560103865|FG001|Double-blind Phase|Death|0|||
155181982|NCT01315236|560103864|FG000|Double-blind Phase|Adverse Event|1|||
155181983|NCT01315236|560103865|FG001|Double-blind Phase|Adverse Event|0|||
155181984|NCT01315236|560103864|FG000|Double-blind Phase|Withdrawal of Consent|1|||
155181985|NCT01315236|560103865|FG001|Double-blind Phase|Withdrawal of Consent|0|||
155181986|NCT01315236|560103864|FG000|Double-blind Phase|Lost to Follow-up|1|||
155181987|NCT01315236|560103865|FG001|Double-blind Phase|Lost to Follow-up|0|||
155181988|NCT01315236|560103864|FG000|Open-label Phase|Death|1|||
155181989|NCT01315236|560103865|FG001|Open-label Phase|Death|0|||
155030684|NCT04521621|559538614|FG004|Overall Study|Allocated in error without study intervention|0|||
155030685|NCT04521621|559538615|FG005|Overall Study|Allocated in error without study intervention|0|||
155030686|NCT04521621|559538616|FG006|Overall Study|Allocated in error without study intervention|0|||
155030687|NCT04521621|559538617|FG007|Overall Study|Allocated in error without study intervention|0|||
155030688|NCT01282164|559538618|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
155030689|NCT01282164|559538619|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
155030690|NCT03671564|559538620|FG000|Overall Study|Progressive Disease|3|||
155030691|NCT03671564|559538621|FG001|Overall Study|Progressive Disease|5|||
155030692|NCT03671564|559538622|FG002|Overall Study|Progressive Disease|3|||
155030693|NCT03671564|559538620|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
155030694|NCT03671564|559538621|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
155030695|NCT03671564|559538622|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
155030696|NCT03671564|559538620|FG000|Overall Study|Withdrawal by Subject|1|||
155030697|NCT03671564|559538621|FG001|Overall Study|Withdrawal by Subject|1|||
155030698|NCT03671564|559538622|FG002|Overall Study|Withdrawal by Subject|0|||
155030699|NCT05845567|559538630|FG000|Overall Study|Withdrawal by Subject|1|||
155030700|NCT01968707|559538636|FG000|Overall Study|Did not meet treatment day baseline|49|||
155030701|NCT01968707|559538637|FG001|Overall Study|Did not meet treatment day baseline|12|||
155030702|NCT01968707|559538638|FG002|Overall Study|Did not meet treatment day baseline|41|||
155030703|NCT01968707|559538639|FG003|Overall Study|Did not meet treatment day baseline|44|||
155030704|NCT01968707|559538640|FG004|Overall Study|Did not meet treatment day baseline|36|||
155030705|NCT01968707|559538641|FG005|Overall Study|Did not meet treatment day baseline|11|||
155030706|NCT01968707|559538642|FG006|Overall Study|Did not meet treatment day baseline|34|||
155030707|NCT01968707|559538643|FG007|Overall Study|Did not meet treatment day baseline|35|||
155030708|NCT01104246|559538648|FG000|Overall Study|Withdrawal by Subject|1|||
155030709|NCT01104246|559538648|FG000|Overall Study|did not meet inclusion criteria|4|||
155030710|NCT05178641|559538649|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
155030711|NCT05178641|559538650|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
155030712|NCT05178641|559538649|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
155030713|NCT05178641|559538650|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
155030714|NCT02083185|559538659|FG000|Overall Study|Lost to Follow-up|0|||
155030715|NCT02083185|559538660|FG001|Overall Study|Lost to Follow-up|3|||
155030716|NCT02083185|559538661|FG002|Overall Study|Lost to Follow-up|0|||
155030717|NCT02083185|559538659|FG000|Overall Study|Withdrawal by Subject|9|||
155030718|NCT02083185|559538660|FG001|Overall Study|Withdrawal by Subject|15|||
155030719|NCT02083185|559538661|FG002|Overall Study|Withdrawal by Subject|1|||
155030720|NCT02083185|559538659|FG000|Overall Study|Death|2|||
155030721|NCT02083185|559538660|FG001|Overall Study|Death|2|||
155030722|NCT02083185|559538661|FG002|Overall Study|Death|1|||
155030723|NCT02083185|559538659|FG000|Overall Study|Reason not Specified|9|||
155030724|NCT02083185|559538660|FG001|Overall Study|Reason not Specified|6|||
155030725|NCT02083185|559538661|FG002|Overall Study|Reason not Specified|5|||
155030726|NCT02083185|559538659|FG000|Overall Study|Study Terminated by Sponsor|0|||
155030727|NCT02083185|559538660|FG001|Overall Study|Study Terminated by Sponsor|1|||
155030728|NCT02083185|559538661|FG002|Overall Study|Study Terminated by Sponsor|0|||
155030729|NCT02083185|559538659|FG000|Overall Study|Did not Receive Study Drug|0|||
155030730|NCT02083185|559538660|FG001|Overall Study|Did not Receive Study Drug|2|||
155030731|NCT02083185|559538661|FG002|Overall Study|Did not Receive Study Drug|0|||
155030732|NCT01740128|559538662|FG000|Overall Study|Pregnancy|0|||
155030733|NCT01740128|559538663|FG001|Overall Study|Pregnancy|1|||
155030734|NCT01740128|559538662|FG000|Overall Study|Protocol Violation|1|||
155030735|NCT01740128|559538663|FG001|Overall Study|Protocol Violation|2|||
155181990|NCT01315236|560103864|FG000|Open-label Phase|Adverse Event|0|||
155181991|NCT01315236|560103865|FG001|Open-label Phase|Adverse Event|1|||
155181992|NCT01315236|560103864|FG000|Open-label Phase|Other|0|||
155181993|NCT01315236|560103865|FG001|Open-label Phase|Other|1|||
155181994|NCT01315236|560103864|FG000|12-Month Follow-up Period|Death|0|||
155181995|NCT01315236|560103865|FG001|12-Month Follow-up Period|Death|1|||
155181996|NCT01315236|560103864|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
155181997|NCT01315236|560103865|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
155181998|NCT01293799|560103866|FG000|Overall Study|Kidney transplantation|109|||
155181999|NCT01293799|560103867|FG001|Overall Study|Kidney transplantation|96|||
155182000|NCT01293799|560103866|FG000|Overall Study|Transfer to hemodialysis|70|||
155182001|NCT01293799|560103867|FG001|Overall Study|Transfer to hemodialysis|90|||
155182002|NCT01293799|560103866|FG000|Overall Study|Death|27|||
155182003|NCT01293799|560103867|FG001|Overall Study|Death|29|||
155182004|NCT01293799|560103866|FG000|Overall Study|Transfer to assisted PD|24|||
155182005|NCT01293799|560103867|FG001|Overall Study|Transfer to assisted PD|18|||
155182006|NCT01293799|560103866|FG000|Overall Study|Withdrawal by Subject|26|||
155182007|NCT01293799|560103867|FG001|Overall Study|Withdrawal by Subject|0|||
155182008|NCT01293799|560103866|FG000|Overall Study|Investigator decision|5|||
155182009|NCT01293799|560103867|FG001|Overall Study|Investigator decision|2|||
155182010|NCT01293799|560103866|FG000|Overall Study|Kidney function improved|6|||
155182011|NCT01293799|560103867|FG001|Overall Study|Kidney function improved|7|||
155182012|NCT01293799|560103866|FG000|Overall Study|Other causes|6|||
155182013|NCT01293799|560103867|FG001|Overall Study|Other causes|3|||
155182014|NCT02674854|560103876|FG000|Overall Study|Adverse Event|17|||
155182015|NCT02674854|560103877|FG001|Overall Study|Adverse Event|15|||
155182016|NCT02674854|560103878|FG002|Overall Study|Adverse Event|5|||
155182017|NCT02674854|560103876|FG000|Overall Study|Withdrawal by Subject|1|||
155182018|NCT02674854|560103877|FG001|Overall Study|Withdrawal by Subject|5|||
155182019|NCT02674854|560103878|FG002|Overall Study|Withdrawal by Subject|4|||
155182020|NCT02674854|560103876|FG000|Overall Study|No-compliant subject|1|||
155182021|NCT02674854|560103877|FG001|Overall Study|No-compliant subject|0|||
155182022|NCT02674854|560103878|FG002|Overall Study|No-compliant subject|1|||
155182023|NCT02674854|560103876|FG000|Overall Study|Lost to Follow-up|1|||
155182024|NCT02674854|560103877|FG001|Overall Study|Lost to Follow-up|0|||
155182025|NCT02674854|560103878|FG002|Overall Study|Lost to Follow-up|2|||
155182026|NCT02674854|560103876|FG000|Overall Study|Lack of Efficacy|0|||
155182027|NCT02674854|560103877|FG001|Overall Study|Lack of Efficacy|3|||
155182028|NCT02674854|560103878|FG002|Overall Study|Lack of Efficacy|0|||
155182029|NCT02674854|560103876|FG000|Overall Study|Disallowed Concurrent Medication|2|||
155182030|NCT02674854|560103877|FG001|Overall Study|Disallowed Concurrent Medication|2|||
155182031|NCT02674854|560103878|FG002|Overall Study|Disallowed Concurrent Medication|0|||
155182032|NCT02674854|560103876|FG000|Overall Study|Protocol Violation|1|||
155182033|NCT02674854|560103877|FG001|Overall Study|Protocol Violation|1|||
155182034|NCT02674854|560103878|FG002|Overall Study|Protocol Violation|2|||
155182035|NCT02674854|560103876|FG000|Overall Study|Death|0|||
155182036|NCT02674854|560103877|FG001|Overall Study|Death|1|||
155182037|NCT02674854|560103878|FG002|Overall Study|Death|0|||
155182038|NCT02674854|560103876|FG000|Overall Study|Subject missed V6.2|1|||
155182039|NCT02674854|560103877|FG001|Overall Study|Subject missed V6.2|0|||
155182040|NCT02674854|560103878|FG002|Overall Study|Subject missed V6.2|0|||
155182041|NCT01602666|560103879|FG000|Induction Chemotherapy|Death|2|||
155182042|NCT01602666|560103880|FG001|Induction Chemotherapy|Death|1|||
155182043|NCT01602666|560103879|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
155182044|NCT01602666|560103880|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
155182045|NCT01602666|560103879|FG000|Induction Chemotherapy|Physician Decision|12|||
155030736|NCT01740128|559538662|FG000|Overall Study|Lost to Follow-up|2|||
155030737|NCT01740128|559538663|FG001|Overall Study|Lost to Follow-up|2|||
155182046|NCT01602666|560103880|FG001|Induction Chemotherapy|Physician Decision|5|||
155182047|NCT01602666|560103879|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
155182048|NCT01602666|560103880|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
155182049|NCT01602666|560103879|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
155182050|NCT01602666|560103880|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
155182051|NCT01602666|560103879|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
155182052|NCT01602666|560103880|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
155182053|NCT01602666|560103879|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
155182054|NCT01602666|560103880|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
155182055|NCT01602666|560103879|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
155182056|NCT01602666|560103880|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
155182057|NCT01602666|560103879|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
155182058|NCT01602666|560103880|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
155182059|NCT01602666|560103879|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
155182060|NCT01602666|560103880|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
155182061|NCT01602666|560103879|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
155182062|NCT01602666|560103880|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
155182063|NCT05458648|560103881|FG000|Overall Study|Physician Decision|1|||
155182064|NCT05458648|560103881|FG000|Overall Study|Patient presented in atrial flutter|1|||
155182065|NCT03610555|560103885|FG000|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
155182066|NCT03610555|560103886|FG001|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
155182067|NCT03610555|560103887|FG002|Crossover to 2nd Website and Question|Withdrawal by Subject|1|||
155182068|NCT03610555|560103888|FG003|Crossover to 2nd Website and Question|Withdrawal by Subject|0|||
155182069|NCT05217927|560103891|FG000|DBT Phase|Adverse Event|7|||
155182070|NCT05217927|560103892|FG001|DBT Phase|Adverse Event|2|||
155182071|NCT05217927|560103893|FG002|DBT Phase|Adverse Event|5|||
155182072|NCT05217927|560103891|FG000|DBT Phase|Lack of Efficacy|1|||
155182073|NCT05217927|560103892|FG001|DBT Phase|Lack of Efficacy|0|||
155182074|NCT05217927|560103893|FG002|DBT Phase|Lack of Efficacy|0|||
155182075|NCT05217927|560103891|FG000|DBT Phase|Lost to Follow-up|0|||
155182076|NCT05217927|560103892|FG001|DBT Phase|Lost to Follow-up|2|||
155182077|NCT05217927|560103893|FG002|DBT Phase|Lost to Follow-up|0|||
155182078|NCT05217927|560103891|FG000|DBT Phase|Non-compliance|1|||
155182079|NCT05217927|560103892|FG001|DBT Phase|Non-compliance|0|||
155182080|NCT05217927|560103893|FG002|DBT Phase|Non-compliance|0|||
155182081|NCT05217927|560103891|FG000|DBT Phase|Pregnancy|0|||
155182082|NCT05217927|560103892|FG001|DBT Phase|Pregnancy|0|||
155182083|NCT05217927|560103893|FG002|DBT Phase|Pregnancy|1|||
155182084|NCT05217927|560103891|FG000|DBT Phase|Protocol Violation|0|||
155182085|NCT05217927|560103892|FG001|DBT Phase|Protocol Violation|2|||
155182086|NCT05217927|560103893|FG002|DBT Phase|Protocol Violation|1|||
155182087|NCT05217927|560103891|FG000|DBT Phase|Protocol-specified withdrawal criterion met|4|||
155182088|NCT05217927|560103892|FG001|DBT Phase|Protocol-specified withdrawal criterion met|6|||
155182089|NCT05217927|560103893|FG002|DBT Phase|Protocol-specified withdrawal criterion met|5|||
155182090|NCT05217927|560103891|FG000|DBT Phase|Withdrawal of consent|8|||
155182091|NCT05217927|560103892|FG001|DBT Phase|Withdrawal of consent|5|||
155182092|NCT05217927|560103893|FG002|DBT Phase|Withdrawal of consent|7|||
155182093|NCT05217927|560103891|FG000|DBT Phase|Other|7|||
155182094|NCT05217927|560103892|FG001|DBT Phase|Other|3|||
155182095|NCT05217927|560103893|FG002|DBT Phase|Other|4|||
155182096|NCT05217927|560103891|FG000|DBT Phase|Randomized, not treated|2|||
155030738|NCT01740128|559538662|FG000|Overall Study|Withdrawal by Subject|1|||
155030739|NCT01740128|559538663|FG001|Overall Study|Withdrawal by Subject|0|||
155030740|NCT01740128|559538662|FG000|Overall Study|Insufficient protocol compliance|2|||
155030741|NCT01740128|559538663|FG001|Overall Study|Insufficient protocol compliance|2|||
155030742|NCT02474589|559538664|FG000|Overall Study|Adverse Event|6|||
155030743|NCT02474589|559538665|FG001|Overall Study|Adverse Event|2|||
155030744|NCT02474589|559538664|FG000|Overall Study|Lost to Follow-up|6|||
155030745|NCT02474589|559538665|FG001|Overall Study|Lost to Follow-up|1|||
155030746|NCT02474589|559538664|FG000|Overall Study|Protocol Violation|4|||
155030747|NCT02474589|559538665|FG001|Overall Study|Protocol Violation|1|||
155030748|NCT02474589|559538664|FG000|Overall Study|Withdrawal by Subject|4|||
155030749|NCT02474589|559538665|FG001|Overall Study|Withdrawal by Subject|0|||
155030750|NCT02474589|559538664|FG000|Overall Study|Inability to complete study procedures|5|||
155030751|NCT02474589|559538665|FG001|Overall Study|Inability to complete study procedures|1|||
155030752|NCT02231879|559538668|FG000|Overall Study|Adverse Event|2|||
155030753|NCT02231879|559538669|FG001|Overall Study|Adverse Event|1|||
155030754|NCT02231879|559538668|FG000|Overall Study|Lack of Efficacy|0|||
155030755|NCT02231879|559538669|FG001|Overall Study|Lack of Efficacy|1|||
155030756|NCT05007041|559538670|FG000|Overall Study|Missing Diary Entries|0|||
155030757|NCT05007041|559538671|FG001|Overall Study|Missing Diary Entries|1|||
155030758|NCT00423189|559538673|FG000|Overall Study|Death|0|||
155030759|NCT00423189|559538674|FG001|Overall Study|Death|1|||
155030760|NCT00423189|559538675|FG002|Overall Study|Death|0|||
155030761|NCT01459718|559538682|FG000|Overall Study|Physician Decision|1|||
155030762|NCT01459718|559538682|FG000|Overall Study|Lost to Follow-up|1|||
155030763|NCT01459718|559538682|FG000|Overall Study|Adverse Event|1|||
155030764|NCT02939716|559538685|FG000|Overall Study|scanner failure|0|||
155030765|NCT02939716|559538686|FG001|Overall Study|scanner failure|0|||
155030766|NCT02939716|559538687|FG002|Overall Study|scanner failure|0|||
155030767|NCT02939716|559538688|FG003|Overall Study|scanner failure|1|||
155030768|NCT02939716|559538689|FG004|Overall Study|scanner failure|1|||
155030769|NCT02939716|559538690|FG005|Overall Study|scanner failure|1|||
155030770|NCT00574249|559538694|FG000|Overall Study|Adverse Event|6|||
155182097|NCT05217927|560103892|FG001|DBT Phase|Randomized, not treated|3|||
155182098|NCT05217927|560103893|FG002|DBT Phase|Randomized, not treated|2|||
155182099|NCT05217927|560103891|FG000|OLE Phase|Adverse Event|4|||
155182100|NCT05217927|560103892|FG001|OLE Phase|Adverse Event|1|||
155182101|NCT05217927|560103893|FG002|OLE Phase|Adverse Event|1|||
155030771|NCT00574249|559538695|FG001|Overall Study|Adverse Event|18|||
155030772|NCT00574249|559538694|FG000|Overall Study|Lack of Efficacy|5|||
155182102|NCT05217927|560103891|FG000|OLE Phase|Extension phase eligibility failure|1|||
155182103|NCT05217927|560103892|FG001|OLE Phase|Extension phase eligibility failure|0|||
155182104|NCT05217927|560103893|FG002|OLE Phase|Extension phase eligibility failure|0|||
155182105|NCT05217927|560103891|FG000|OLE Phase|Lost to Follow-up|1|||
155182106|NCT05217927|560103892|FG001|OLE Phase|Lost to Follow-up|2|||
155182107|NCT05217927|560103893|FG002|OLE Phase|Lost to Follow-up|1|||
155182108|NCT05217927|560103891|FG000|OLE Phase|Non-compliance|0|||
155182109|NCT05217927|560103892|FG001|OLE Phase|Non-compliance|0|||
155182110|NCT05217927|560103893|FG002|OLE Phase|Non-compliance|1|||
155030773|NCT00574249|559538695|FG001|Overall Study|Lack of Efficacy|3|||
155030774|NCT00574249|559538694|FG000|Overall Study|Lost to Follow-up|4|||
155030775|NCT00574249|559538695|FG001|Overall Study|Lost to Follow-up|3|||
155030776|NCT00574249|559538694|FG000|Overall Study|Protocol Violation|5|||
155030777|NCT00574249|559538695|FG001|Overall Study|Protocol Violation|2|||
155030778|NCT00574249|559538694|FG000|Overall Study|History of carcinoma|1|||
155030779|NCT00574249|559538695|FG001|Overall Study|History of carcinoma|0|||
155030780|NCT00574249|559538694|FG000|Overall Study|Withdrawal by Subject|3|||
155030781|NCT00574249|559538695|FG001|Overall Study|Withdrawal by Subject|0|||
155030782|NCT00574249|559538694|FG000|Overall Study|Physician Decision|1|||
155030783|NCT00574249|559538695|FG001|Overall Study|Physician Decision|0|||
155030784|NCT00574249|559538694|FG000|Overall Study|Pregnancy|1|||
155030785|NCT00574249|559538695|FG001|Overall Study|Pregnancy|0|||
155030786|NCT00574249|559538694|FG000|Overall Study|Excluded by company|0|||
155030787|NCT00574249|559538695|FG001|Overall Study|Excluded by company|1|||
155030788|NCT00574249|559538694|FG000|Overall Study|PPD test taken twice|0|||
155030789|NCT00574249|559538695|FG001|Overall Study|PPD test taken twice|1|||
155030790|NCT01542034|559538696|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
155030791|NCT01542034|559538697|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
155030792|NCT01542034|559538696|FG000|Overall Study|Administrative decision|0|||
155030793|NCT01542034|559538697|FG001|Overall Study|Administrative decision|3|||
155030794|NCT01542034|559538696|FG000|Overall Study|Subject Noncompliance|1|||
155030795|NCT01542034|559538697|FG001|Overall Study|Subject Noncompliance|0|||
155030796|NCT01542034|559538696|FG000|Overall Study|Adverse Event|2|||
155030797|NCT01542034|559538697|FG001|Overall Study|Adverse Event|2|||
155030798|NCT01542034|559538696|FG000|Overall Study|Lost to Follow-up|7|||
155030799|NCT01542034|559538697|FG001|Overall Study|Lost to Follow-up|6|||
155030800|NCT01546571|559538698|FG000|Overall Study|Adverse Event|1|||
155030801|NCT01546571|559538699|FG001|Overall Study|Adverse Event|0|||
155030802|NCT01546571|559538700|FG002|Overall Study|Adverse Event|0|||
155030803|NCT01546571|559538701|FG003|Overall Study|Adverse Event|1|||
155030804|NCT01546571|559538702|FG004|Overall Study|Adverse Event|0|||
155030805|NCT01546571|559538698|FG000|Overall Study|assigned placebo in Part A|0|||
155030806|NCT01546571|559538699|FG001|Overall Study|assigned placebo in Part A|0|||
155030807|NCT01546571|559538700|FG002|Overall Study|assigned placebo in Part A|22|||
155030808|NCT01546571|559538701|FG003|Overall Study|assigned placebo in Part A|0|||
155030809|NCT01546571|559538702|FG004|Overall Study|assigned placebo in Part A|0|||
155030810|NCT01546571|559538698|FG000|Overall Study|Death|0|||
155030811|NCT01546571|559538699|FG001|Overall Study|Death|1|||
155030812|NCT01546571|559538700|FG002|Overall Study|Death|0|||
155140317|NCT00367835|559944480|FG000|Overall Study|Withdrawal by Subject|7|||
155140318|NCT00367835|559944481|FG001|Overall Study|Withdrawal by Subject|6|||
155140319|NCT00367835|559944480|FG000|Overall Study|Lost to Follow-up|1|||
155140320|NCT00367835|559944481|FG001|Overall Study|Lost to Follow-up|4|||
155140321|NCT00367835|559944480|FG000|Overall Study|Lack of Efficacy|3|||
155140322|NCT00367835|559944481|FG001|Overall Study|Lack of Efficacy|12|||
155140323|NCT00367835|559944480|FG000|Overall Study|Subject in juvenile detention center|1|||
155140324|NCT00367835|559944481|FG001|Overall Study|Subject in juvenile detention center|0|||
155140325|NCT00367835|559944480|FG000|Overall Study|refused blood collection|1|||
155140326|NCT00367835|559944481|FG001|Overall Study|refused blood collection|0|||
155140327|NCT00367835|559944480|FG000|Overall Study|Did not respond to calls|1|||
155140328|NCT00367835|559944481|FG001|Overall Study|Did not respond to calls|0|||
155140329|NCT00367835|559944480|FG000|Overall Study|History of lead poisoning|0|||
155140330|NCT00367835|559944481|FG001|Overall Study|History of lead poisoning|1|||
155140331|NCT04346654|559944482|FG000|Overall Study|Adverse Event|2|||
155140332|NCT04346654|559944483|FG001|Overall Study|Adverse Event|0|||
155140333|NCT04346654|559944482|FG000|Overall Study|Non-response|1|||
155140334|NCT04346654|559944483|FG001|Overall Study|Non-response|1|||
155140335|NCT04346654|559944482|FG000|Overall Study|Withdrawal by Subject|2|||
155030813|NCT01546571|559538701|FG003|Overall Study|Death|0|||
155030814|NCT01546571|559538702|FG004|Overall Study|Death|0|||
155030815|NCT01546571|559538698|FG000|Overall Study|Lost to Follow-up|0|||
155030816|NCT01546571|559538699|FG001|Overall Study|Lost to Follow-up|0|||
155030817|NCT01546571|559538700|FG002|Overall Study|Lost to Follow-up|2|||
155030818|NCT01546571|559538701|FG003|Overall Study|Lost to Follow-up|2|||
155030819|NCT01546571|559538702|FG004|Overall Study|Lost to Follow-up|3|||
155030820|NCT01546571|559538698|FG000|Overall Study|Pregnancy|0|||
155030821|NCT01546571|559538699|FG001|Overall Study|Pregnancy|0|||
155030822|NCT01546571|559538700|FG002|Overall Study|Pregnancy|0|||
155030823|NCT01546571|559538701|FG003|Overall Study|Pregnancy|1|||
155140336|NCT04346654|559944483|FG001|Overall Study|Withdrawal by Subject|0|||
155140337|NCT04346654|559944482|FG000|Overall Study|Lost to Follow-up|0|||
155030824|NCT01546571|559538702|FG004|Overall Study|Pregnancy|0|||
155030825|NCT01546571|559538698|FG000|Overall Study|Disease Progression|20|||
155030826|NCT01546571|559538699|FG001|Overall Study|Disease Progression|18|||
155030827|NCT01546571|559538700|FG002|Overall Study|Disease Progression|15|||
155030828|NCT01546571|559538701|FG003|Overall Study|Disease Progression|73|||
155140338|NCT04346654|559944483|FG001|Overall Study|Lost to Follow-up|1|||
155140339|NCT04346654|559944482|FG000|Overall Study|Pregnancy|0|||
155030829|NCT01546571|559538702|FG004|Overall Study|Disease Progression|37|||
155030830|NCT01546571|559538698|FG000|Overall Study|Withdrawal by Subject|1|||
155030831|NCT01546571|559538699|FG001|Overall Study|Withdrawal by Subject|2|||
155030832|NCT01546571|559538700|FG002|Overall Study|Withdrawal by Subject|4|||
155030833|NCT01546571|559538701|FG003|Overall Study|Withdrawal by Subject|9|||
155030834|NCT01546571|559538702|FG004|Overall Study|Withdrawal by Subject|2|||
155030835|NCT01546571|559538698|FG000|Overall Study|Intercurrent Illness|1|||
155030836|NCT01546571|559538699|FG001|Overall Study|Intercurrent Illness|2|||
155030837|NCT01546571|559538700|FG002|Overall Study|Intercurrent Illness|0|||
155140340|NCT04346654|559944483|FG001|Overall Study|Pregnancy|1|||
155140341|NCT04209205|559944490|FG000|Overall Study|Adverse Event|2|||
155140342|NCT04209205|559944491|FG001|Overall Study|Adverse Event|3|||
155140343|NCT04209205|559944490|FG000|Overall Study|Lost to Follow-up|3|||
155140344|NCT04209205|559944491|FG001|Overall Study|Lost to Follow-up|1|||
155140345|NCT04209205|559944490|FG000|Overall Study|Physician Decision|1|||
155140346|NCT04209205|559944491|FG001|Overall Study|Physician Decision|1|||
155140347|NCT04209205|559944490|FG000|Overall Study|Subject decision|10|||
155140348|NCT04209205|559944491|FG001|Overall Study|Subject decision|10|||
155140349|NCT04209205|559944490|FG000|Overall Study|Progressive disease|1|||
155140350|NCT04209205|559944491|FG001|Overall Study|Progressive disease|0|||
155140351|NCT04209205|559944490|FG000|Overall Study|Protocol deviation|0|||
155140352|NCT04209205|559944491|FG001|Overall Study|Protocol deviation|1|||
155140353|NCT04209205|559944490|FG000|Overall Study|New therapy for study indication|1|||
155140354|NCT04209205|559944491|FG001|Overall Study|New therapy for study indication|0|||
155140355|NCT04209205|559944490|FG000|Overall Study|Adverse event - placebo not switched|0|||
155140356|NCT04209205|559944491|FG001|Overall Study|Adverse event - placebo not switched|1|||
155140357|NCT04209205|559944490|FG000|Overall Study|Subject decision - placebo not switched|0|||
155140358|NCT04209205|559944491|FG001|Overall Study|Subject decision - placebo not switched|5|||
155140359|NCT04209205|559944490|FG000|Overall Study|Death - placebo not switched|0|||
155140360|NCT04209205|559944491|FG001|Overall Study|Death - placebo not switched|1|||
155140361|NCT05870865|559944492|FG000|Randomized|Did not receive study treatment|2|||
155140362|NCT05870865|559944493|FG001|Randomized|Did not receive study treatment|4|||
155140363|NCT05870865|559944494|FG002|Randomized|Did not receive study treatment|4|||
155140364|NCT05870865|559944495|FG003|Randomized|Did not receive study treatment|3|||
155140365|NCT05870865|559944492|FG000|Treatment Period|Adverse Event|1|||
155140366|NCT05870865|559944493|FG001|Treatment Period|Adverse Event|1|||
155140367|NCT05870865|559944494|FG002|Treatment Period|Adverse Event|1|||
155140368|NCT05870865|559944495|FG003|Treatment Period|Adverse Event|1|||
155140369|NCT05870865|559944492|FG000|Treatment Period|Lost to Follow-up|0|||
155140370|NCT05870865|559944493|FG001|Treatment Period|Lost to Follow-up|1|||
155140371|NCT05870865|559944494|FG002|Treatment Period|Lost to Follow-up|2|||
155140372|NCT05870865|559944495|FG003|Treatment Period|Lost to Follow-up|0|||
155140373|NCT05870865|559944492|FG000|Treatment Period|Protocol Violation|0|||
155140374|NCT05870865|559944493|FG001|Treatment Period|Protocol Violation|0|||
155140375|NCT05870865|559944494|FG002|Treatment Period|Protocol Violation|0|||
155140376|NCT05870865|559944495|FG003|Treatment Period|Protocol Violation|1|||
155140377|NCT05870865|559944492|FG000|Treatment Period|Withdrawal by Subject|0|||
155140378|NCT05870865|559944493|FG001|Treatment Period|Withdrawal by Subject|1|||
155140379|NCT05870865|559944494|FG002|Treatment Period|Withdrawal by Subject|1|||
155140380|NCT05870865|559944495|FG003|Treatment Period|Withdrawal by Subject|1|||
155140381|NCT00548145|559944496|FG000|Overall Study|Death|0|||
155140382|NCT00548145|559944497|FG001|Overall Study|Death|1|||
155140383|NCT00548145|559944496|FG000|Overall Study|Withdrawal by Subject|0|||
155140384|NCT00548145|559944497|FG001|Overall Study|Withdrawal by Subject|2|||
155140385|NCT00548145|559944496|FG000|Overall Study|Physician Decision|1|||
155140386|NCT00548145|559944497|FG001|Overall Study|Physician Decision|1|||
155140387|NCT02863328|559944500|FG000|Overall Study|Lost to Follow-up|4|||
155140388|NCT02863328|559944501|FG001|Overall Study|Lost to Follow-up|10|||
155140389|NCT02863328|559944500|FG000|Overall Study|Withdrawal by Subject|7|||
155140390|NCT02863328|559944501|FG001|Overall Study|Withdrawal by Subject|12|||
155140391|NCT02863328|559944500|FG000|Overall Study|Died|0|||
155140392|NCT02863328|559944501|FG001|Overall Study|Died|1|||
155140393|NCT03301350|559944503|FG000|Overall Study|Withdrawal by Subject|4|||
155140394|NCT03301350|559944503|FG000|Overall Study|Adverse Event|1|||
155140395|NCT03301350|559944503|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
155140396|NCT03301350|559944503|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
155140397|NCT03301350|559944503|FG000|Overall Study|no detail provided|1|||
155140398|NCT00858637|559944504|FG000|Active Comparison Phase|Adverse Event|14|||
155140399|NCT00858637|559944505|FG001|Active Comparison Phase|Adverse Event|0|||
155140400|NCT00858637|559944506|FG002|Active Comparison Phase|Adverse Event|0|||
155030838|NCT01546571|559538701|FG003|Overall Study|Intercurrent Illness|0|||
155030839|NCT01546571|559538702|FG004|Overall Study|Intercurrent Illness|0|||
155140401|NCT00858637|559944507|FG003|Active Comparison Phase|Adverse Event|9|||
155140402|NCT00858637|559944508|FG004|Active Comparison Phase|Adverse Event|0|||
155140403|NCT00858637|559944509|FG005|Active Comparison Phase|Adverse Event|0|||
155182111|NCT05217927|560103891|FG000|OLE Phase|Other|3|||
155030840|NCT01546571|559538698|FG000|Overall Study|Other Cancers|0|||
155030841|NCT01546571|559538699|FG001|Overall Study|Other Cancers|0|||
155030842|NCT01546571|559538700|FG002|Overall Study|Other Cancers|0|||
155030843|NCT01546571|559538701|FG003|Overall Study|Other Cancers|3|||
155030844|NCT01546571|559538702|FG004|Overall Study|Other Cancers|1|||
155030845|NCT01546571|559538698|FG000|Overall Study|Other|0|||
155030846|NCT01546571|559538699|FG001|Overall Study|Other|0|||
155030847|NCT01546571|559538700|FG002|Overall Study|Other|3|||
155030848|NCT01546571|559538701|FG003|Overall Study|Other|0|||
155030849|NCT01546571|559538702|FG004|Overall Study|Other|0|||
155030850|NCT04021121|559538707|FG000|Overall Study|Death|3|||
155030851|NCT04021121|559538708|FG001|Overall Study|Death|3|||
155030852|NCT04021121|559538709|FG002|Overall Study|Death|5|||
155030853|NCT04021121|559538710|FG003|Overall Study|Death|4|||
155030854|NCT00978250|559538711|FG000|Overall Study|Late determination of ineligibility|0|||
155030855|NCT00978250|559538712|FG001|Overall Study|Late determination of ineligibility|1|||
155030856|NCT00978250|559538713|FG002|Overall Study|Late determination of ineligibility|0|||
155030857|NCT00978250|559538714|FG003|Overall Study|Late determination of ineligibility|1|||
155030858|NCT02029989|559538720|FG000|Overall Study|Withdrawal by Subject|1|||
155030859|NCT02029989|559538721|FG001|Overall Study|Withdrawal by Subject|0|||
155030860|NCT02029989|559538720|FG000|Overall Study|Withdrawal: Fear of needles|1|||
155030861|NCT02029989|559538721|FG001|Overall Study|Withdrawal: Fear of needles|0|||
155030862|NCT02029989|559538720|FG000|Overall Study|Change of location|2|||
155030863|NCT02029989|559538721|FG001|Overall Study|Change of location|3|||
155030864|NCT02029989|559538720|FG000|Overall Study|Physician Decision|2|||
155030865|NCT02029989|559538721|FG001|Overall Study|Physician Decision|0|||
155030866|NCT02029989|559538720|FG000|Overall Study|Lost to Follow-up|9|||
155030867|NCT02029989|559538721|FG001|Overall Study|Lost to Follow-up|7|||
155030868|NCT02029989|559538720|FG000|Overall Study|Death|0|||
155030869|NCT02029989|559538721|FG001|Overall Study|Death|1|||
155030870|NCT02029989|559538720|FG000|Overall Study|Protocol Violation|1|||
155030871|NCT02029989|559538721|FG001|Overall Study|Protocol Violation|0|||
155030872|NCT05036668|559538722|FG000|Overall Study|lost to follow Up|0|||
155030873|NCT05036668|559538723|FG001|Overall Study|lost to follow Up|0|||
155030874|NCT05036668|559538724|FG002|Overall Study|lost to follow Up|1|||
155030875|NCT04601103|559538725|FG000|Overall Study|Needed crown & cleaning|0|||
155030876|NCT04601103|559538726|FG001|Overall Study|Needed crown & cleaning|0|||
155030877|NCT04601103|559538727|FG002|Overall Study|Needed crown & cleaning|1|||
155030878|NCT04601103|559538725|FG000|Overall Study|study was terminated|18|||
155030879|NCT04601103|559538726|FG001|Overall Study|study was terminated|18|||
155030880|NCT04601103|559538727|FG002|Overall Study|study was terminated|16|||
155030881|NCT04442269|559538732|FG000|Overall Study|Adverse Event|1|||
155030882|NCT04442269|559538733|FG001|Overall Study|Adverse Event|0|||
155030883|NCT04442269|559538732|FG000|Overall Study|Death|0|||
155030884|NCT04442269|559538733|FG001|Overall Study|Death|1|||
155030885|NCT04442269|559538732|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
155030886|NCT04442269|559538733|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
155030887|NCT04442269|559538732|FG000|Overall Study|Lost to Follow-up|1|||
155030888|NCT04442269|559538733|FG001|Overall Study|Lost to Follow-up|0|||
155030889|NCT04442269|559538732|FG000|Overall Study|Withdrawal by Subject|3|||
155030890|NCT04442269|559538733|FG001|Overall Study|Withdrawal by Subject|2|||
155030891|NCT04442269|559538732|FG000|Overall Study|Protocol Deviation|0|||
155030892|NCT04442269|559538733|FG001|Overall Study|Protocol Deviation|1|||
155030893|NCT04442269|559538732|FG000|Overall Study|Travel Limitations|1|||
155030894|NCT04442269|559538733|FG001|Overall Study|Travel Limitations|1|||
155030895|NCT03802565|559538734|FG000|Overall Study|Adverse Event|0|||
155030896|NCT03802565|559538735|FG001|Overall Study|Adverse Event|1|||
155030897|NCT03802565|559538736|FG002|Overall Study|Adverse Event|2|||
155030898|NCT03802565|559538737|FG003|Overall Study|Adverse Event|1|||
155030899|NCT03802565|559538738|FG004|Overall Study|Adverse Event|1|||
155030900|NCT03802565|559538734|FG000|Overall Study|Withdrawal by Subject|2|||
155030901|NCT03802565|559538735|FG001|Overall Study|Withdrawal by Subject|2|||
155030902|NCT03802565|559538736|FG002|Overall Study|Withdrawal by Subject|2|||
155030903|NCT03802565|559538737|FG003|Overall Study|Withdrawal by Subject|0|||
155030904|NCT03802565|559538738|FG004|Overall Study|Withdrawal by Subject|1|||
155030905|NCT03802565|559538734|FG000|Overall Study|Protocol Violation|2|||
155030906|NCT03802565|559538735|FG001|Overall Study|Protocol Violation|1|||
155030907|NCT03802565|559538736|FG002|Overall Study|Protocol Violation|4|||
155030908|NCT03802565|559538737|FG003|Overall Study|Protocol Violation|5|||
155030909|NCT03802565|559538738|FG004|Overall Study|Protocol Violation|1|||
155030910|NCT03802565|559538734|FG000|Overall Study|Lost to Follow-up|0|||
155030911|NCT03802565|559538735|FG001|Overall Study|Lost to Follow-up|0|||
155030912|NCT03802565|559538736|FG002|Overall Study|Lost to Follow-up|1|||
155030913|NCT03802565|559538737|FG003|Overall Study|Lost to Follow-up|0|||
155030914|NCT03802565|559538738|FG004|Overall Study|Lost to Follow-up|0|||
155030915|NCT03802565|559538734|FG000|Overall Study|Subjects Related to Each Other|1|||
155030916|NCT03802565|559538735|FG001|Overall Study|Subjects Related to Each Other|0|||
155030917|NCT03802565|559538736|FG002|Overall Study|Subjects Related to Each Other|0|||
155030918|NCT03802565|559538737|FG003|Overall Study|Subjects Related to Each Other|2|||
155182112|NCT05217927|560103892|FG001|OLE Phase|Other|5|||
155182113|NCT05217927|560103893|FG002|OLE Phase|Other|4|||
155182114|NCT05217927|560103891|FG000|OLE Phase|Withdrawal of consent|3|||
155182115|NCT05217927|560103892|FG001|OLE Phase|Withdrawal of consent|1|||
155182116|NCT05217927|560103893|FG002|OLE Phase|Withdrawal of consent|5|||
155182117|NCT06785857|560103896|FG000|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|2|||
155182118|NCT06785857|560103897|FG001|Overall Study|Death of the Care recipient (Patients with Dementia and TDM2)|3|||
155182119|NCT03576274|560103899|FG000|Overall Study|Lost to Follow-up|3|||
155182120|NCT03576274|560103900|FG001|Overall Study|Lost to Follow-up|2|||
155182121|NCT03576274|560103901|FG002|Overall Study|Lost to Follow-up|3|||
155182122|NCT03576274|560103902|FG003|Overall Study|Lost to Follow-up|1|||
155182123|NCT03576274|560103903|FG004|Overall Study|Lost to Follow-up|3|||
155182124|NCT03576274|560103899|FG000|Overall Study|Withdrawal by Subject|5|||
155182125|NCT03576274|560103900|FG001|Overall Study|Withdrawal by Subject|3|||
155182126|NCT03576274|560103901|FG002|Overall Study|Withdrawal by Subject|2|||
155182127|NCT03576274|560103902|FG003|Overall Study|Withdrawal by Subject|8|||
155182128|NCT03576274|560103903|FG004|Overall Study|Withdrawal by Subject|6|||
155182129|NCT05952401|560103912|FG000|Overall Study|Lost to Follow-up|4|||
155182130|NCT05952401|560103913|FG001|Overall Study|Lost to Follow-up|1|||
155182131|NCT04285580|560105234|FG000|Overall Study|Protocol Violation|0|||
155182132|NCT04285580|560105235|FG001|Overall Study|Protocol Violation|1|||
155182133|NCT02582255|560105236|FG000|Overall Study|Protocol Violation|0|||
155182134|NCT02582255|560105237|FG001|Overall Study|Protocol Violation|3|||
155182135|NCT01709578|560105239|FG000|Overall Study|Rescued and entered in long term safety|63|||
155182136|NCT01709578|560105240|FG001|Overall Study|Rescued and entered in long term safety|25|||
155182137|NCT01709578|560105241|FG002|Overall Study|Rescued and entered in long term safety|26|||
155182138|NCT01709578|560105239|FG000|Overall Study|Adverse Event|9|||
155182139|NCT01709578|560105240|FG001|Overall Study|Adverse Event|18|||
155182140|NCT01709578|560105241|FG002|Overall Study|Adverse Event|17|||
155182141|NCT01709578|560105239|FG000|Overall Study|Lack of Efficacy|5|||
155182142|NCT01709578|560105240|FG001|Overall Study|Lack of Efficacy|4|||
155182143|NCT01709578|560105241|FG002|Overall Study|Lack of Efficacy|2|||
155182144|NCT01709578|560105239|FG000|Overall Study|Poor compliance to protocol|1|||
155182145|NCT01709578|560105240|FG001|Overall Study|Poor compliance to protocol|2|||
155182146|NCT01709578|560105241|FG002|Overall Study|Poor compliance to protocol|1|||
155182147|NCT01709578|560105239|FG000|Overall Study|Other, not related to safety or efficacy|2|||
155182148|NCT01709578|560105240|FG001|Overall Study|Other, not related to safety or efficacy|7|||
155182149|NCT01709578|560105241|FG002|Overall Study|Other, not related to safety or efficacy|5|||
155182150|NCT04050371|560105242|FG000|Overall Study|Withdrawal by Subject|1|||
155182151|NCT04050371|560105243|FG001|Overall Study|Withdrawal by Subject|0|||
155182152|NCT00597701|560105244|FG000|Overall Study|Withdrawal by Subject|5|||
155182153|NCT00597701|560105245|FG001|Overall Study|Withdrawal by Subject|5|||
155182154|NCT00597701|560105244|FG000|Overall Study|Death|0|||
155182155|NCT00597701|560105245|FG001|Overall Study|Death|1|||
155182156|NCT00597701|560105244|FG000|Overall Study|Physician Decision|2|||
155182157|NCT00597701|560105245|FG001|Overall Study|Physician Decision|0|||
155182158|NCT00597701|560105244|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
155182159|NCT00597701|560105245|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
155182160|NCT01107418|560105246|FG000|Overall Study|Disease Progression|45|||
155182161|NCT01107418|560105246|FG000|Overall Study|Adverse Event|3|||
155182162|NCT01107418|560105246|FG000|Overall Study|Withdrawal by Subject|1|||
155182163|NCT01107418|560105246|FG000|Overall Study|Study Closing|1|||
155182164|NCT01107418|560105246|FG000|Overall Study|Started Other Therapy|1|||
155182165|NCT01107418|560105246|FG000|Overall Study|Entered Extension Study|1|||
155182166|NCT01741012|560105248|FG000|Overall Study|Lost to Follow-up|1|||
155182167|NCT01741012|560105248|FG000|Overall Study|Withdrawal by Subject|2|||
155182168|NCT01282203|560105256|FG000|Overall Study|Adverse Event|1|||
155182169|NCT00518973|560105257|FG000|Overall Study|Withdrawal by Subject|3|||
155182170|NCT00518973|560105258|FG001|Overall Study|Withdrawal by Subject|2|||
155182171|NCT01565499|560105259|FG000|Overall Study|Physician Decision|1|||
155182172|NCT01565499|560105259|FG000|Overall Study|Adverse Event|5|||
155182173|NCT01565499|560105259|FG000|Overall Study|Withdrawal by Subject|2|||
155182174|NCT01923168|560105260|FG000|Overall Study|Protocol Violation|1|||
155182175|NCT01923168|560105261|FG001|Overall Study|Protocol Violation|1|||
155182176|NCT01923168|560105262|FG002|Overall Study|Protocol Violation|0|||
155182177|NCT01923168|560105260|FG000|Overall Study|Subject/guardian decision|14|||
155182178|NCT01923168|560105261|FG001|Overall Study|Subject/guardian decision|14|||
155182179|NCT01923168|560105262|FG002|Overall Study|Subject/guardian decision|4|||
155182180|NCT01923168|560105260|FG000|Overall Study|Adverse Event|12|||
155182181|NCT01923168|560105261|FG001|Overall Study|Adverse Event|12|||
155182182|NCT01923168|560105262|FG002|Overall Study|Adverse Event|0|||
155182183|NCT01923168|560105260|FG000|Overall Study|Physician Decision|6|||
155182184|NCT01923168|560105261|FG001|Overall Study|Physician Decision|9|||
155182185|NCT01923168|560105262|FG002|Overall Study|Physician Decision|5|||
155182186|NCT01923168|560105260|FG000|Overall Study|Progressive disease|4|||
155182187|NCT01923168|560105261|FG001|Overall Study|Progressive disease|3|||
155182188|NCT01923168|560105262|FG002|Overall Study|Progressive disease|7|||
155182189|NCT01923168|560105260|FG000|Overall Study|Death|0|||
155182190|NCT01923168|560105261|FG001|Overall Study|Death|0|||
155182191|NCT01923168|560105262|FG002|Overall Study|Death|1|||
155182192|NCT01255787|560105263|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
155182193|NCT01255787|560105264|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
155182194|NCT01255787|560105265|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
155182195|NCT01255787|560105266|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
155182196|NCT01255787|560105263|FG000|Overall Study|Major Protocol Deviation|1|||
155182197|NCT01255787|560105264|FG001|Overall Study|Major Protocol Deviation|1|||
155182198|NCT01255787|560105265|FG002|Overall Study|Major Protocol Deviation|0|||
155182199|NCT01255787|560105266|FG003|Overall Study|Major Protocol Deviation|4|||
155182200|NCT01255787|560105263|FG000|Overall Study|Lost to Follow-up|1|||
155182201|NCT01255787|560105264|FG001|Overall Study|Lost to Follow-up|2|||
155182202|NCT01255787|560105265|FG002|Overall Study|Lost to Follow-up|4|||
155182203|NCT01255787|560105266|FG003|Overall Study|Lost to Follow-up|2|||
155182204|NCT01255787|560105263|FG000|Overall Study|Withdrawal of Consent|3|||
155182205|NCT01255787|560105264|FG001|Overall Study|Withdrawal of Consent|9|||
155182206|NCT01255787|560105265|FG002|Overall Study|Withdrawal of Consent|3|||
155182207|NCT01255787|560105266|FG003|Overall Study|Withdrawal of Consent|4|||
155182208|NCT01255787|560105263|FG000|Overall Study|Pregnancy|0|||
155182209|NCT01255787|560105264|FG001|Overall Study|Pregnancy|0|||
155182210|NCT01255787|560105265|FG002|Overall Study|Pregnancy|0|||
155182211|NCT01255787|560105266|FG003|Overall Study|Pregnancy|1|||
155182212|NCT01255787|560105263|FG000|Overall Study|Lack of Efficacy|2|||
155030919|NCT03802565|559538738|FG004|Overall Study|Subjects Related to Each Other|1|||
155030920|NCT03802565|559538734|FG000|Overall Study|Elevated Enzymes|0|||
155030921|NCT03802565|559538735|FG001|Overall Study|Elevated Enzymes|0|||
155182213|NCT01255787|560105264|FG001|Overall Study|Lack of Efficacy|2|||
155182214|NCT01255787|560105265|FG002|Overall Study|Lack of Efficacy|2|||
155182215|NCT01255787|560105266|FG003|Overall Study|Lack of Efficacy|2|||
155182216|NCT01255787|560105263|FG000|Overall Study|Noncompliance with Study Drug|3|||
155182217|NCT01255787|560105264|FG001|Overall Study|Noncompliance with Study Drug|1|||
155182218|NCT01255787|560105265|FG002|Overall Study|Noncompliance with Study Drug|0|||
155182219|NCT01255787|560105266|FG003|Overall Study|Noncompliance with Study Drug|0|||
155182220|NCT00476047|560105267|FG000|Overall Study|Lost to Follow-up|1|||
155182221|NCT00768469|560105268|FG000|Overall Study|Adverse Event|0|||
155182222|NCT00768469|560105269|FG001|Overall Study|Adverse Event|2|||
155182223|NCT00768469|560105268|FG000|Overall Study|Disease Progression|3|||
155182224|NCT00768469|560105269|FG001|Overall Study|Disease Progression|4|||
155182225|NCT00768469|560105268|FG000|Overall Study|Withdrawal by Subject|0|||
155182226|NCT00768469|560105269|FG001|Overall Study|Withdrawal by Subject|1|||
155182227|NCT04966741|560105270|FG000|Overall Study|Lost to Follow-up|1|||
155182228|NCT04966741|560105271|FG001|Overall Study|Lost to Follow-up|0|||
155182229|NCT02241889|560105274|FG000|Overall Study|device issues|0|||
155182230|NCT02241889|560105275|FG001|Overall Study|device issues|0|||
155182231|NCT02241889|560105276|FG002|Overall Study|device issues|1|||
155182232|NCT02241889|560105277|FG003|Overall Study|device issues|0|||
155182233|NCT02241889|560105278|FG004|Overall Study|device issues|0|||
155182234|NCT02241889|560105279|FG005|Overall Study|device issues|0|||
155182235|NCT02241889|560105274|FG000|Overall Study|Withdrawal by Subject|0|||
155182236|NCT02241889|560105275|FG001|Overall Study|Withdrawal by Subject|0|||
155182237|NCT02241889|560105276|FG002|Overall Study|Withdrawal by Subject|0|||
155182238|NCT02241889|560105277|FG003|Overall Study|Withdrawal by Subject|0|||
155182239|NCT02241889|560105278|FG004|Overall Study|Withdrawal by Subject|0|||
155182240|NCT02241889|560105279|FG005|Overall Study|Withdrawal by Subject|1|||
155182241|NCT00773838|560105280|FG000|Overall Study|Adverse Event|29|||
155030922|NCT03802565|559538736|FG002|Overall Study|Elevated Enzymes|0|||
155182242|NCT00773838|560105280|FG000|Overall Study|Lost to Follow-up|1|||
155182243|NCT00773838|560105280|FG000|Overall Study|Physician Decision|8|||
155182244|NCT00773838|560105280|FG000|Overall Study|Progressive Disease|82|||
155182245|NCT00773838|560105280|FG000|Overall Study|Protocol Violation|2|||
155030923|NCT03802565|559538737|FG003|Overall Study|Elevated Enzymes|0|||
155030924|NCT03802565|559538738|FG004|Overall Study|Elevated Enzymes|2|||
155182246|NCT00773838|560105280|FG000|Overall Study|Withdrawal by Subject|21|||
155182247|NCT00459056|560105282|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
155182248|NCT00459056|560105283|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
155182249|NCT00509262|560105284|FG000|Overall Study|Adverse Event|16|||
155182250|NCT00509262|560105285|FG001|Overall Study|Adverse Event|18|||
155182251|NCT00509262|560105284|FG000|Overall Study|Other|2|||
155182252|NCT00509262|560105285|FG001|Overall Study|Other|2|||
155182253|NCT00509262|560105284|FG000|Overall Study|Lack of Efficacy|1|||
155182254|NCT00509262|560105285|FG001|Overall Study|Lack of Efficacy|0|||
155182255|NCT00509262|560105284|FG000|Overall Study|Lost to Follow-up|1|||
155182256|NCT00509262|560105285|FG001|Overall Study|Lost to Follow-up|6|||
155182257|NCT00509262|560105284|FG000|Overall Study|Physician Decision|1|||
155182258|NCT00509262|560105285|FG001|Overall Study|Physician Decision|3|||
155182259|NCT00509262|560105284|FG000|Overall Study|Protocol Violation|2|||
155182260|NCT00509262|560105285|FG001|Overall Study|Protocol Violation|2|||
155030925|NCT00430352|559538742|FG000|Overall Study|Disease progression|58|||
155030926|NCT00430352|559538742|FG000|Overall Study|Withdrawal by Subject|11|||
155030927|NCT00430352|559538742|FG000|Overall Study|Adverse Event|16|||
155030928|NCT00430352|559538742|FG000|Overall Study|Death|5|||
155030929|NCT00430352|559538742|FG000|Overall Study|Other|48|||
155030930|NCT03099694|559538743|FG000|Overall Study|Withdrawal by Subject|11|||
155030931|NCT03099694|559538744|FG001|Overall Study|Withdrawal by Subject|13|||
155030932|NCT03099694|559538743|FG000|Overall Study|Lost to Follow-up|9|||
155030933|NCT03099694|559538744|FG001|Overall Study|Lost to Follow-up|5|||
155030934|NCT04326439|559538745|FG000|Overall Study|Withdrawal by Subject|1|||
155030935|NCT04326439|559538746|FG001|Overall Study|Withdrawal by Subject|0|||
155030936|NCT04326439|559538745|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
155030937|NCT04326439|559538746|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
155030938|NCT04326439|559538745|FG000|Overall Study|Relapse after Induction 2|0|||
155030939|NCT04326439|559538746|FG001|Overall Study|Relapse after Induction 2|1|||
155030940|NCT04326439|559538745|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
155030941|NCT04326439|559538746|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
155030942|NCT00381043|559538747|FG000|Overall Study|Lost to Follow-up|8|||
155030943|NCT00381043|559538748|FG001|Overall Study|Lost to Follow-up|6|||
155030944|NCT00381043|559538747|FG000|Overall Study|Withdrawal by Subject|3|||
155030945|NCT00381043|559538748|FG001|Overall Study|Withdrawal by Subject|1|||
155030946|NCT00381043|559538747|FG000|Overall Study|wanted more care|0|||
155030947|NCT00381043|559538748|FG001|Overall Study|wanted more care|1|||
155030948|NCT00381043|559538747|FG000|Overall Study|incarcerated|1|||
155030949|NCT00381043|559538748|FG001|Overall Study|incarcerated|0|||
155030950|NCT02880865|559538749|FG000|Overall Study|Adverse Event|1|||
155030951|NCT02880865|559538750|FG001|Overall Study|Adverse Event|0|||
155030952|NCT02880865|559538749|FG000|Overall Study|Withdrawal by Subject|0|||
155030953|NCT02880865|559538750|FG001|Overall Study|Withdrawal by Subject|2|||
155030954|NCT02880865|559538749|FG000|Overall Study|Physician Decision|0|||
155030955|NCT02880865|559538750|FG001|Overall Study|Physician Decision|1|||
155030956|NCT00125242|559538755|FG000|Overall Study|did not qualify|7|||
155030957|NCT00125242|559538756|FG001|Overall Study|did not qualify|2|||
155030958|NCT01664949|559538757|FG000|Overall Study|Adverse Event|11|||
155030959|NCT01664949|559538758|FG001|Overall Study|Adverse Event|12|||
155030960|NCT01664949|559538757|FG000|Overall Study|Lack of Efficacy|1|||
155030961|NCT01664949|559538758|FG001|Overall Study|Lack of Efficacy|1|||
155030962|NCT01664949|559538757|FG000|Overall Study|Lost to Follow-up|1|||
155030963|NCT01664949|559538758|FG001|Overall Study|Lost to Follow-up|2|||
155030964|NCT01664949|559538757|FG000|Overall Study|Personal Reasons|3|||
155030965|NCT01664949|559538758|FG001|Overall Study|Personal Reasons|4|||
155030966|NCT01664949|559538757|FG000|Overall Study|Protocol Violation|5|||
155030967|NCT01664949|559538758|FG001|Overall Study|Protocol Violation|5|||
155030968|NCT01664949|559538757|FG000|Overall Study|Other Miscellaneous Reasons|3|||
155030969|NCT01664949|559538758|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155030970|NCT02727777|559538760|FG000|Overall Study|Screen Failure|2|||
155030971|NCT02727777|559538761|FG001|Overall Study|Screen Failure|0|||
155030972|NCT02727777|559538762|FG002|Overall Study|Screen Failure|0|||
155030973|NCT02727777|559538760|FG000|Overall Study|Progressive disease|2|||
155030974|NCT02727777|559538761|FG001|Overall Study|Progressive disease|0|||
155030975|NCT02727777|559538762|FG002|Overall Study|Progressive disease|0|||
155030976|NCT01738503|559538763|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
155030977|NCT01738503|559538764|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
155030978|NCT01738503|559538765|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
155030979|NCT01738503|559538766|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
155030980|NCT01738503|559538767|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
155030981|NCT01738503|559538768|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
155030982|NCT01738503|559538769|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
155030983|NCT01738503|559538763|FG000|Treatment Period|Adverse Event|0|||
155030984|NCT01738503|559538764|FG001|Treatment Period|Adverse Event|1|||
155030985|NCT01738503|559538765|FG002|Treatment Period|Adverse Event|0|||
155030986|NCT01738503|559538766|FG003|Treatment Period|Adverse Event|1|||
155030987|NCT01738503|559538767|FG004|Treatment Period|Adverse Event|2|||
155030988|NCT01738503|559538768|FG005|Treatment Period|Adverse Event|2|||
155030989|NCT01738503|559538769|FG006|Treatment Period|Adverse Event|2|||
155030990|NCT01738503|559538763|FG000|Treatment Period|Lost to Follow-up|0|||
155030991|NCT01738503|559538764|FG001|Treatment Period|Lost to Follow-up|0|||
155030992|NCT01738503|559538765|FG002|Treatment Period|Lost to Follow-up|3|||
155030993|NCT01738503|559538766|FG003|Treatment Period|Lost to Follow-up|4|||
155030994|NCT01738503|559538767|FG004|Treatment Period|Lost to Follow-up|1|||
155030995|NCT01738503|559538768|FG005|Treatment Period|Lost to Follow-up|1|||
155030996|NCT01738503|559538769|FG006|Treatment Period|Lost to Follow-up|5|||
155030997|NCT01738503|559538763|FG000|Treatment Period|Withdrawal by Subject|0|||
155030998|NCT01738503|559538764|FG001|Treatment Period|Withdrawal by Subject|1|||
155030999|NCT01738503|559538765|FG002|Treatment Period|Withdrawal by Subject|0|||
155031000|NCT01738503|559538766|FG003|Treatment Period|Withdrawal by Subject|1|||
155031001|NCT01738503|559538767|FG004|Treatment Period|Withdrawal by Subject|1|||
155182261|NCT00509262|560105284|FG000|Overall Study|Withdrawal by Subject|24|||
155182262|NCT00509262|560105285|FG001|Overall Study|Withdrawal by Subject|11|||
155182263|NCT00725842|560105286|FG000|Overall Study|Lost to Follow-up|19|||
155182264|NCT00725842|560105286|FG000|Overall Study|Death|1|||
155182265|NCT00725842|560105286|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
155182266|NCT00725842|560105286|FG000|Overall Study|Consent date prior to study start date|5|||
155182267|NCT00725842|560105286|FG000|Overall Study|Inclusion criterion not met|1|||
155182268|NCT00725842|560105286|FG000|Overall Study|No Visit 1 data|1|||
155182269|NCT01853618|560105287|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
155182270|NCT01853618|560105288|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
155182271|NCT01853618|560105289|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
155182272|NCT01853618|560105290|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
155182273|NCT01853618|560105291|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
155182274|NCT01853618|560105287|FG000|Overall Study|Progressive disease|1|||
155182275|NCT01853618|560105288|FG001|Overall Study|Progressive disease|1|||
155182276|NCT01853618|560105289|FG002|Overall Study|Progressive disease|1|||
155182277|NCT01853618|560105290|FG003|Overall Study|Progressive disease|1|||
155182278|NCT01853618|560105291|FG004|Overall Study|Progressive disease|2|||
155182279|NCT01853618|560105287|FG000|Overall Study|Physician Decision|0|||
155182280|NCT01853618|560105288|FG001|Overall Study|Physician Decision|1|||
155182281|NCT01853618|560105289|FG002|Overall Study|Physician Decision|1|||
155182282|NCT01853618|560105290|FG003|Overall Study|Physician Decision|0|||
155182283|NCT01853618|560105291|FG004|Overall Study|Physician Decision|0|||
155182284|NCT01853618|560105287|FG000|Overall Study|Refused further treatment|0|||
155031002|NCT01738503|559538768|FG005|Treatment Period|Withdrawal by Subject|1|||
155031003|NCT01738503|559538769|FG006|Treatment Period|Withdrawal by Subject|1|||
155031004|NCT01738503|559538763|FG000|Treatment Period|Protocol Violation|0|||
155031005|NCT01738503|559538764|FG001|Treatment Period|Protocol Violation|3|||
155031006|NCT01738503|559538765|FG002|Treatment Period|Protocol Violation|1|||
155031007|NCT01738503|559538766|FG003|Treatment Period|Protocol Violation|0|||
155031008|NCT01738503|559538767|FG004|Treatment Period|Protocol Violation|4|||
155031009|NCT01738503|559538768|FG005|Treatment Period|Protocol Violation|2|||
155031010|NCT01738503|559538769|FG006|Treatment Period|Protocol Violation|0|||
155031011|NCT01738503|559538763|FG000|Treatment Period|Other|0|||
155031012|NCT01738503|559538764|FG001|Treatment Period|Other|0|||
155031013|NCT01738503|559538765|FG002|Treatment Period|Other|1|||
155031014|NCT01738503|559538766|FG003|Treatment Period|Other|0|||
155031015|NCT01738503|559538767|FG004|Treatment Period|Other|0|||
155031016|NCT01738503|559538768|FG005|Treatment Period|Other|0|||
155031017|NCT01738503|559538769|FG006|Treatment Period|Other|0|||
155031018|NCT01738503|559538763|FG000|PET Imaging Sub-study|Adverse Event|0|||
155031019|NCT01738503|559538764|FG001|PET Imaging Sub-study|Adverse Event|0|||
155031020|NCT01738503|559538765|FG002|PET Imaging Sub-study|Adverse Event|0|||
155031021|NCT01738503|559538766|FG003|PET Imaging Sub-study|Adverse Event|0|||
155031022|NCT01738503|559538767|FG004|PET Imaging Sub-study|Adverse Event|0|||
155031023|NCT01738503|559538768|FG005|PET Imaging Sub-study|Adverse Event|1|||
155031024|NCT01738503|559538769|FG006|PET Imaging Sub-study|Adverse Event|0|||
155031025|NCT01738503|559538763|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155031026|NCT01738503|559538764|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155031027|NCT01738503|559538765|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155140404|NCT00858637|559944504|FG000|Active Comparison Phase|Death|1|||
155140405|NCT00858637|559944505|FG001|Active Comparison Phase|Death|0|||
155140406|NCT00858637|559944506|FG002|Active Comparison Phase|Death|0|||
155140407|NCT00858637|559944507|FG003|Active Comparison Phase|Death|1|||
155140408|NCT00858637|559944508|FG004|Active Comparison Phase|Death|0|||
155140409|NCT00858637|559944509|FG005|Active Comparison Phase|Death|0|||
155140410|NCT00858637|559944504|FG000|Active Comparison Phase|Physician Decision|1|||
155140411|NCT00858637|559944505|FG001|Active Comparison Phase|Physician Decision|0|||
155140412|NCT00858637|559944506|FG002|Active Comparison Phase|Physician Decision|0|||
155140413|NCT00858637|559944507|FG003|Active Comparison Phase|Physician Decision|1|||
155140414|NCT00858637|559944508|FG004|Active Comparison Phase|Physician Decision|0|||
155140415|NCT00858637|559944509|FG005|Active Comparison Phase|Physician Decision|0|||
155140416|NCT00858637|559944504|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
155140417|NCT00858637|559944505|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
155140418|NCT00858637|559944506|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
155140419|NCT00858637|559944507|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
155140420|NCT00858637|559944508|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
155140421|NCT00858637|559944509|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
155140422|NCT00858637|559944504|FG000|Active Comparison Phase|Other Reasons|1|||
155140423|NCT00858637|559944505|FG001|Active Comparison Phase|Other Reasons|0|||
155140424|NCT00858637|559944506|FG002|Active Comparison Phase|Other Reasons|0|||
155140425|NCT00858637|559944507|FG003|Active Comparison Phase|Other Reasons|1|||
155140426|NCT00858637|559944508|FG004|Active Comparison Phase|Other Reasons|0|||
155140427|NCT00858637|559944509|FG005|Active Comparison Phase|Other Reasons|0|||
155031028|NCT01738503|559538766|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155031029|NCT01738503|559538767|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
155031030|NCT01738503|559538768|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
155182285|NCT01853618|560105288|FG001|Overall Study|Refused further treatment|0|||
155182286|NCT01853618|560105289|FG002|Overall Study|Refused further treatment|0|||
155182287|NCT01853618|560105290|FG003|Overall Study|Refused further treatment|0|||
155182288|NCT01853618|560105291|FG004|Overall Study|Refused further treatment|1|||
155182289|NCT01658813|560105292|FG000|Overall Study|Disease progression|3|||
155182290|NCT02398227|560105297|FG000|Overall Study|Lost to Follow-up|21|||
155182291|NCT02398227|560105298|FG001|Overall Study|Lost to Follow-up|12|||
155182292|NCT02398227|560105297|FG000|Overall Study|Withdrawal by Subject|5|||
155182293|NCT02398227|560105298|FG001|Overall Study|Withdrawal by Subject|6|||
155182294|NCT02398227|560105297|FG000|Overall Study|Removed from treatment and dropped out|1|||
155182295|NCT02398227|560105298|FG001|Overall Study|Removed from treatment and dropped out|0|||
155182296|NCT01715129|560105299|FG000|Overall Study|Adverse Event, fatal|1|||
155182297|NCT01715129|560105299|FG000|Overall Study|Lack of Efficacy|3|||
155182298|NCT01715129|560105299|FG000|Overall Study|Protocol Violation|1|||
155182299|NCT01715129|560105299|FG000|Overall Study|Consent Withdrawn|2|||
155182300|NCT01715129|560105299|FG000|Overall Study|Lost to Follow-up|1|||
155182301|NCT01715129|560105299|FG000|Overall Study|Other|1|||
155182302|NCT00722371|560105300|FG000|Overall Study|Adverse Event|6|||
155182303|NCT00722371|560105301|FG001|Overall Study|Adverse Event|13|||
155182304|NCT00722371|560105302|FG002|Overall Study|Adverse Event|9|||
155182305|NCT00722371|560105303|FG003|Overall Study|Adverse Event|10|||
155182306|NCT00722371|560105304|FG004|Overall Study|Adverse Event|6|||
155182307|NCT00722371|560105305|FG005|Overall Study|Adverse Event|8|||
155182308|NCT00722371|560105306|FG006|Overall Study|Adverse Event|4|||
155031031|NCT01738503|559538769|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
155031032|NCT04687072|559538770|FG000|Overall Study|Adverse Event|2|||
155031033|NCT04687072|559538771|FG001|Overall Study|Adverse Event|0|||
155031034|NCT04687072|559538770|FG000|Overall Study|Death|1|||
155031035|NCT04687072|559538771|FG001|Overall Study|Death|0|||
155140428|NCT00858637|559944504|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
155140429|NCT00858637|559944505|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
155140430|NCT00858637|559944506|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
155140431|NCT00858637|559944507|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
155140432|NCT00858637|559944508|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
155140433|NCT00858637|559944509|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
155140434|NCT00858637|559944504|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155140435|NCT00858637|559944505|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155140436|NCT00858637|559944506|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155140437|NCT00858637|559944507|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155140438|NCT00858637|559944508|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
155140439|NCT00858637|559944509|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
155140440|NCT00429169|559944512|FG000|Overall Study|Lost to Follow-up|0|||
155140441|NCT00429169|559944513|FG001|Overall Study|Lost to Follow-up|1|||
155140442|NCT00429169|559944512|FG000|Overall Study|Ineligibility discovered after entry|2|||
155140443|NCT00429169|559944513|FG001|Overall Study|Ineligibility discovered after entry|1|||
155140444|NCT00166439|559944514|FG000|Overall Study|Ineligible|5|||
155140445|NCT03887221|559944515|FG000|Overall Study|Protocol Violation|1|||
155140446|NCT03887221|559944516|FG001|Overall Study|Protocol Violation|0|||
155140447|NCT02123576|559944517|FG000|Overall Study|Adverse Event|1|||
155140448|NCT02123576|559944518|FG001|Overall Study|Adverse Event|0|||
155140449|NCT00999544|559946425|FG000|Overall Study|Withdrawal by Subject|1|||
155140450|NCT02407223|559946427|FG000|Overall Study|Adverse Event|1|||
155140451|NCT02407223|559946428|FG001|Overall Study|Adverse Event|0|||
155140452|NCT02407223|559946429|FG002|Overall Study|Adverse Event|1|||
155140453|NCT02407223|559946427|FG000|Overall Study|Lack of Efficacy|6|||
155140454|NCT02407223|559946428|FG001|Overall Study|Lack of Efficacy|6|||
155140455|NCT02407223|559946429|FG002|Overall Study|Lack of Efficacy|4|||
155140456|NCT02407223|559946427|FG000|Overall Study|Lost to Follow-up|1|||
155140457|NCT02407223|559946428|FG001|Overall Study|Lost to Follow-up|0|||
155140458|NCT02407223|559946429|FG002|Overall Study|Lost to Follow-up|2|||
155140459|NCT02407223|559946427|FG000|Overall Study|Withdrawal by Subject|2|||
155140460|NCT02407223|559946428|FG001|Overall Study|Withdrawal by Subject|4|||
155140461|NCT02407223|559946429|FG002|Overall Study|Withdrawal by Subject|4|||
155140462|NCT02407223|559946427|FG000|Overall Study|Study Terminated by Sponsor|77|||
155182309|NCT00722371|560105300|FG000|Overall Study|Contraindication|0|||
155182310|NCT00722371|560105301|FG001|Overall Study|Contraindication|0|||
155182311|NCT00722371|560105302|FG002|Overall Study|Contraindication|1|||
155182312|NCT00722371|560105303|FG003|Overall Study|Contraindication|0|||
155182313|NCT00722371|560105304|FG004|Overall Study|Contraindication|0|||
155182314|NCT00722371|560105305|FG005|Overall Study|Contraindication|0|||
155182315|NCT00722371|560105306|FG006|Overall Study|Contraindication|0|||
155182316|NCT00722371|560105300|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
155182317|NCT00722371|560105301|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
155031036|NCT04687072|559538770|FG000|Overall Study|Lack of Efficacy|2|||
155031037|NCT04687072|559538771|FG001|Overall Study|Lack of Efficacy|1|||
155031038|NCT04687072|559538770|FG000|Overall Study|Physician Decision|1|||
155031039|NCT04687072|559538771|FG001|Overall Study|Physician Decision|0|||
155031040|NCT04687072|559538770|FG000|Overall Study|Pregnancy|1|||
155031041|NCT04687072|559538771|FG001|Overall Study|Pregnancy|0|||
155031042|NCT04687072|559538770|FG000|Overall Study|Requires Prohibited Medication|2|||
155031043|NCT04687072|559538771|FG001|Overall Study|Requires Prohibited Medication|0|||
155031044|NCT04687072|559538770|FG000|Overall Study|Withdrawal of Consent|11|||
155031045|NCT04687072|559538771|FG001|Overall Study|Withdrawal of Consent|6|||
155031046|NCT04687072|559538770|FG000|Overall Study|Miscellaneous|4|||
155031047|NCT04687072|559538771|FG001|Overall Study|Miscellaneous|1|||
155031048|NCT02272842|559538772|FG000|Overall Study|Lost to Follow-up|8|||
155031049|NCT02272842|559538773|FG001|Overall Study|Lost to Follow-up|8|||
155031050|NCT02272842|559538772|FG000|Overall Study|Withdrawal by Subject|8|||
155031051|NCT02272842|559538773|FG001|Overall Study|Withdrawal by Subject|2|||
155031052|NCT00197002|559540773|FG000|Overall Study|Adverse Event|0|||
155031053|NCT00197002|559540774|FG001|Overall Study|Adverse Event|1|||
155031054|NCT00197002|559540775|FG002|Overall Study|Adverse Event|0|||
155031055|NCT00197002|559540773|FG000|Overall Study|Protocol Violation|1|||
155031056|NCT00197002|559540774|FG001|Overall Study|Protocol Violation|0|||
155031057|NCT00197002|559540775|FG002|Overall Study|Protocol Violation|2|||
155031058|NCT00197002|559540773|FG000|Overall Study|Withdrawal by Subject|9|||
155031059|NCT00197002|559540774|FG001|Overall Study|Withdrawal by Subject|5|||
155031060|NCT00197002|559540775|FG002|Overall Study|Withdrawal by Subject|7|||
155031061|NCT00197002|559540773|FG000|Overall Study|Migrated/moved from study area|3|||
155031062|NCT00197002|559540774|FG001|Overall Study|Migrated/moved from study area|5|||
155031063|NCT00197002|559540775|FG002|Overall Study|Migrated/moved from study area|1|||
155031064|NCT00197002|559540773|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
155031065|NCT00197002|559540774|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
155031066|NCT00197002|559540775|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
155031067|NCT00197002|559540773|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
155031068|NCT00197002|559540774|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
155031069|NCT00197002|559540775|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
155031070|NCT00197002|559540773|FG000|Overall Study|Others|3|||
155031071|NCT00197002|559540774|FG001|Overall Study|Others|1|||
155031072|NCT00197002|559540775|FG002|Overall Study|Others|1|||
155031073|NCT05072106|559540778|FG000|Overall Study|Progressive disease|3|||
155031074|NCT05072106|559540779|FG001|Overall Study|Progressive disease|3|||
155031075|NCT05072106|559540778|FG000|Overall Study|Compassionate use|3|||
155031076|NCT05072106|559540779|FG001|Overall Study|Compassionate use|1|||
155031077|NCT05072106|559540778|FG000|Overall Study|Withdrawal by Subject|1|||
155140463|NCT02407223|559946428|FG001|Overall Study|Study Terminated by Sponsor|80|||
155140464|NCT02407223|559946429|FG002|Overall Study|Study Terminated by Sponsor|86|||
155140465|NCT02407223|559946427|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
155140466|NCT02407223|559946428|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
155140467|NCT02407223|559946429|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
155140468|NCT02407223|559946427|FG000|Overall Study|Other|29|||
155140469|NCT02407223|559946428|FG001|Overall Study|Other|27|||
155140470|NCT02407223|559946429|FG002|Overall Study|Other|25|||
155140471|NCT04864639|559946431|FG000|Overall Study|Death|1|||
155140472|NCT04864639|559946431|FG000|Overall Study|Lost to Follow-up|1|||
155140473|NCT03449758|559946434|FG000|Overall Study|Major protocol deviation|1|||
155140474|NCT03449758|559946434|FG000|Overall Study|Treatment inefficacy|5|||
155140475|NCT03449758|559946434|FG000|Overall Study|Adverse Event|9|||
155140476|NCT03449758|559946434|FG000|Overall Study|Consent withdrawal|1|||
155140477|NCT03449758|559946434|FG000|Overall Study|Other unspecified reason|3|||
155140478|NCT01478971|559946441|FG000|Standard of Care Period|Adverse Event|1|||
155140479|NCT01478971|559946441|FG000|Standard of Care Period|Withdrawal by Subject|3|||
155140480|NCT01478971|559946441|FG000|Standard of Care Period|Death|8|||
155140481|NCT01478971|559946441|FG000|Standard of Care Period|Lost to Follow-up|9|||
155140482|NCT01478971|559946441|FG000|Standard of Care Period|Other|4|||
155140483|NCT01478971|559946441|FG000|Peginesatide Treatment Period|Adverse Event|1|||
155140484|NCT01478971|559946441|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
155140485|NCT01478971|559946441|FG000|Peginesatide Treatment Period|Death|4|||
155140486|NCT01478971|559946441|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
155140487|NCT01478971|559946441|FG000|Peginesatide Treatment Period|Other|4|||
155140488|NCT00584012|559946442|FG000|Overall Study|Withdrawal by Subject|1|||
155140489|NCT03937713|559946446|FG000|Overall Study|Withdrawal by Subject|3|||
155140490|NCT03937713|559946447|FG001|Overall Study|Withdrawal by Subject|6|||
155140491|NCT03937713|559946446|FG000|Overall Study|Lost to Follow-up|1|||
155031078|NCT05072106|559540779|FG001|Overall Study|Withdrawal by Subject|0|||
155140492|NCT03937713|559946447|FG001|Overall Study|Lost to Follow-up|0|||
155031079|NCT03839459|559540780|FG000|Overall Study|Withdrawal by Subject|2|||
155031080|NCT03839459|559540780|FG000|Overall Study|progression of disease|3|||
155031081|NCT01632904|559540781|FG000|Overall Study|Adverse Event|4|||
155182318|NCT00722371|560105302|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
155182319|NCT00722371|560105303|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
155182320|NCT00722371|560105304|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
155182321|NCT00722371|560105305|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
155182322|NCT00722371|560105306|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
155182323|NCT00722371|560105300|FG000|Overall Study|Excluded medication|0|||
155182324|NCT00722371|560105301|FG001|Overall Study|Excluded medication|1|||
155182325|NCT00722371|560105302|FG002|Overall Study|Excluded medication|1|||
155182326|NCT00722371|560105303|FG003|Overall Study|Excluded medication|0|||
155182327|NCT00722371|560105304|FG004|Overall Study|Excluded medication|0|||
155182328|NCT00722371|560105305|FG005|Overall Study|Excluded medication|0|||
155182329|NCT00722371|560105306|FG006|Overall Study|Excluded medication|1|||
155182330|NCT00722371|560105300|FG000|Overall Study|Hyperglycemia|2|||
155182331|NCT00722371|560105301|FG001|Overall Study|Hyperglycemia|6|||
155182332|NCT00722371|560105302|FG002|Overall Study|Hyperglycemia|4|||
155182333|NCT00722371|560105303|FG003|Overall Study|Hyperglycemia|2|||
155182334|NCT00722371|560105304|FG004|Overall Study|Hyperglycemia|5|||
155182335|NCT00722371|560105305|FG005|Overall Study|Hyperglycemia|1|||
155182336|NCT00722371|560105306|FG006|Overall Study|Hyperglycemia|1|||
155182337|NCT00722371|560105300|FG000|Overall Study|Hypoglycemia|1|||
155182338|NCT00722371|560105301|FG001|Overall Study|Hypoglycemia|0|||
155182339|NCT00722371|560105302|FG002|Overall Study|Hypoglycemia|0|||
155182340|NCT00722371|560105303|FG003|Overall Study|Hypoglycemia|0|||
155182341|NCT00722371|560105304|FG004|Overall Study|Hypoglycemia|0|||
155182342|NCT00722371|560105305|FG005|Overall Study|Hypoglycemia|0|||
155182343|NCT00722371|560105306|FG006|Overall Study|Hypoglycemia|0|||
155182344|NCT00722371|560105300|FG000|Overall Study|Lack of Efficacy|4|||
155182345|NCT00722371|560105301|FG001|Overall Study|Lack of Efficacy|6|||
155182346|NCT00722371|560105302|FG002|Overall Study|Lack of Efficacy|6|||
155182347|NCT00722371|560105303|FG003|Overall Study|Lack of Efficacy|6|||
155182348|NCT00722371|560105304|FG004|Overall Study|Lack of Efficacy|2|||
155182349|NCT00722371|560105305|FG005|Overall Study|Lack of Efficacy|3|||
155182350|NCT00722371|560105306|FG006|Overall Study|Lack of Efficacy|0|||
155182351|NCT00722371|560105300|FG000|Overall Study|Lost to Follow-up|11|||
155182352|NCT00722371|560105301|FG001|Overall Study|Lost to Follow-up|14|||
155182353|NCT00722371|560105302|FG002|Overall Study|Lost to Follow-up|21|||
155182354|NCT00722371|560105303|FG003|Overall Study|Lost to Follow-up|13|||
155182355|NCT00722371|560105304|FG004|Overall Study|Lost to Follow-up|8|||
155182356|NCT00722371|560105305|FG005|Overall Study|Lost to Follow-up|16|||
155182357|NCT00722371|560105306|FG006|Overall Study|Lost to Follow-up|13|||
155182358|NCT00722371|560105300|FG000|Overall Study|Physician Decision|5|||
155182359|NCT00722371|560105301|FG001|Overall Study|Physician Decision|2|||
155182360|NCT00722371|560105302|FG002|Overall Study|Physician Decision|2|||
155182361|NCT00722371|560105303|FG003|Overall Study|Physician Decision|5|||
155182362|NCT00722371|560105304|FG004|Overall Study|Physician Decision|2|||
155182363|NCT00722371|560105305|FG005|Overall Study|Physician Decision|3|||
155182364|NCT00722371|560105306|FG006|Overall Study|Physician Decision|4|||
155182365|NCT00722371|560105300|FG000|Overall Study|Pregnancy|1|||
155182366|NCT00722371|560105301|FG001|Overall Study|Pregnancy|1|||
155182367|NCT00722371|560105302|FG002|Overall Study|Pregnancy|0|||
155182368|NCT00722371|560105303|FG003|Overall Study|Pregnancy|0|||
155182369|NCT00722371|560105304|FG004|Overall Study|Pregnancy|0|||
155182370|NCT00722371|560105305|FG005|Overall Study|Pregnancy|1|||
155182371|NCT00722371|560105306|FG006|Overall Study|Pregnancy|0|||
155182372|NCT00722371|560105300|FG000|Overall Study|Protocol Violation|6|||
155182373|NCT00722371|560105301|FG001|Overall Study|Protocol Violation|1|||
155182374|NCT00722371|560105302|FG002|Overall Study|Protocol Violation|0|||
155182375|NCT00722371|560105303|FG003|Overall Study|Protocol Violation|1|||
155182376|NCT00722371|560105304|FG004|Overall Study|Protocol Violation|4|||
155182377|NCT00722371|560105305|FG005|Overall Study|Protocol Violation|2|||
155182378|NCT00722371|560105306|FG006|Overall Study|Protocol Violation|1|||
155182379|NCT00722371|560105300|FG000|Overall Study|Withdrawal by Subject|18|||
155182380|NCT00722371|560105301|FG001|Overall Study|Withdrawal by Subject|27|||
155182381|NCT00722371|560105302|FG002|Overall Study|Withdrawal by Subject|19|||
155182382|NCT00722371|560105303|FG003|Overall Study|Withdrawal by Subject|23|||
155182383|NCT00722371|560105304|FG004|Overall Study|Withdrawal by Subject|19|||
155182384|NCT00722371|560105305|FG005|Overall Study|Withdrawal by Subject|18|||
155182385|NCT00722371|560105306|FG006|Overall Study|Withdrawal by Subject|26|||
155182386|NCT01075191|560105307|FG000|Overall Study|Death|1|||
155182387|NCT01075191|560105307|FG000|Overall Study|Intensification|3|||
155182388|NCT01075191|560105307|FG000|Overall Study|Co-morbidities|1|||
155182389|NCT01075191|560105307|FG000|Overall Study|Adverse Event|4|||
155182390|NCT01075191|560105307|FG000|Overall Study|Noncompliance|3|||
155182391|NCT01075191|560105307|FG000|Overall Study|Therapy Break|3|||
155182392|NCT01075191|560105307|FG000|Overall Study|Patient's Wish|2|||
155182393|NCT01075191|560105307|FG000|Overall Study|Unknown Reasons|1|||
155182394|NCT00718237|560105312|FG000|Overall Study|Adverse Event|1|||
155182395|NCT00718237|560105313|FG001|Overall Study|Adverse Event|3|||
155182396|NCT00718237|560105312|FG000|Overall Study|Lost to Follow-up|2|||
155182397|NCT00718237|560105313|FG001|Overall Study|Lost to Follow-up|2|||
155031082|NCT01632904|559540782|FG001|Overall Study|Adverse Event|1|||
155031083|NCT01632904|559540781|FG000|Overall Study|Physician Decision|0|||
155031084|NCT01632904|559540782|FG001|Overall Study|Physician Decision|1|||
155140493|NCT00763386|559946453|FG000|Overall Study|Adverse Event|43|||
155140494|NCT00763386|559946454|FG001|Overall Study|Adverse Event|33|||
155140495|NCT00763386|559946453|FG000|Overall Study|Death|1|||
155140496|NCT00763386|559946454|FG001|Overall Study|Death|2|||
155140497|NCT00763386|559946453|FG000|Overall Study|Lost to Follow-up|3|||
155140498|NCT00763386|559946454|FG001|Overall Study|Lost to Follow-up|3|||
155140499|NCT00763386|559946453|FG000|Overall Study|Withdrawal by Subject|0|||
155140500|NCT00763386|559946454|FG001|Overall Study|Withdrawal by Subject|1|||
155140501|NCT00763386|559946453|FG000|Overall Study|CRF missing|0|||
155140502|NCT00763386|559946454|FG001|Overall Study|CRF missing|1|||
155140503|NCT00763386|559946453|FG000|Overall Study|Study Prosthesis Removed|1|||
155140504|NCT00763386|559946454|FG001|Overall Study|Study Prosthesis Removed|0|||
155140505|NCT01217944|559946455|FG000|Overall Study|Protocol Violation|1|||
155140506|NCT01217944|559946456|FG001|Overall Study|Protocol Violation|1|||
155140507|NCT01217944|559946457|FG002|Overall Study|Protocol Violation|0|||
155140508|NCT01217944|559946455|FG000|Overall Study|Lost to Follow-up|3|||
155140509|NCT01217944|559946456|FG001|Overall Study|Lost to Follow-up|1|||
155140510|NCT01217944|559946457|FG002|Overall Study|Lost to Follow-up|0|||
155140511|NCT01217944|559946455|FG000|Overall Study|Withdrawal by Subject|1|||
155140512|NCT01217944|559946456|FG001|Overall Study|Withdrawal by Subject|2|||
155140513|NCT01217944|559946457|FG002|Overall Study|Withdrawal by Subject|0|||
155140514|NCT01217944|559946455|FG000|Overall Study|Lack of Efficacy|1|||
155140515|NCT01217944|559946456|FG001|Overall Study|Lack of Efficacy|0|||
155140516|NCT01217944|559946457|FG002|Overall Study|Lack of Efficacy|0|||
155140517|NCT00950846|559946458|FG000|Overall Study|Death|6|||
155140518|NCT00950846|559946458|FG000|Overall Study|Lost to Follow-up|3|||
155140519|NCT00950846|559946458|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
155140520|NCT00483405|559946461|FG000|Overall Study|Adverse Event|8|||
155140521|NCT00483405|559946461|FG000|Overall Study|Lack of Efficacy|14|||
155140522|NCT00483405|559946461|FG000|Overall Study|Death|3|||
155140523|NCT00483405|559946461|FG000|Overall Study|Withdrawal by Subject|2|||
155140524|NCT00483405|559946461|FG000|Overall Study|Other complicating disease|1|||
155140525|NCT00571038|559946462|FG000|Overall Study|Lost to Follow-up|1|||
155031085|NCT01632904|559540781|FG000|Overall Study|Subject decision|3|||
155031086|NCT01632904|559540782|FG001|Overall Study|Subject decision|2|||
155031087|NCT01632904|559540781|FG000|Overall Study|Disease Progression|0|||
155031088|NCT01632904|559540782|FG001|Overall Study|Disease Progression|1|||
155031089|NCT01632904|559540781|FG000|Overall Study|Reason for discontinuation not available|0|||
155031090|NCT01632904|559540782|FG001|Overall Study|Reason for discontinuation not available|1|||
155031091|NCT01944670|559540783|FG000|Overall Study|Lost to Follow-up|2|||
155031092|NCT03339726|559540785|FG000|Overall Study|Withdrawal by Subject|1|||
155031093|NCT03339726|559540786|FG001|Overall Study|Withdrawal by Subject|0|||
155031094|NCT03339726|559540787|FG002|Overall Study|Withdrawal by Subject|0|||
155031095|NCT03339726|559540785|FG000|Overall Study|Lost to Follow-up|0|||
155031096|NCT03339726|559540786|FG001|Overall Study|Lost to Follow-up|1|||
155031097|NCT03339726|559540787|FG002|Overall Study|Lost to Follow-up|0|||
155031098|NCT04542499|559540793|FG000|Overall Study|Adverse Event|23|||
155031099|NCT04542499|559540794|FG001|Overall Study|Adverse Event|43|||
155031100|NCT04542499|559540793|FG000|Overall Study|Lack of Efficacy|5|||
155031101|NCT04542499|559540794|FG001|Overall Study|Lack of Efficacy|2|||
155031102|NCT04542499|559540793|FG000|Overall Study|Lost to Follow-up|3|||
155031103|NCT04542499|559540794|FG001|Overall Study|Lost to Follow-up|4|||
155031104|NCT04542499|559540793|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
155031105|NCT04542499|559540794|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
155031106|NCT04542499|559540793|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
155031107|NCT04542499|559540794|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
155031108|NCT04542499|559540793|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155031109|NCT04542499|559540794|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155031110|NCT04542499|559540793|FG000|Overall Study|Physician Decision|0|||
155031111|NCT04542499|559540794|FG001|Overall Study|Physician Decision|1|||
155031112|NCT04542499|559540793|FG000|Overall Study|Site Terminated by Sponsor|3|||
155031113|NCT04542499|559540794|FG001|Overall Study|Site Terminated by Sponsor|5|||
155031114|NCT04542499|559540793|FG000|Overall Study|Withdrawal by Subject|12|||
155031115|NCT04542499|559540794|FG001|Overall Study|Withdrawal by Subject|33|||
155031116|NCT04542499|559540793|FG000|Overall Study|Other|2|||
155031117|NCT04542499|559540794|FG001|Overall Study|Other|2|||
155031118|NCT04035434|559540800|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031119|NCT04035434|559540801|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155031120|NCT04035434|559540802|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031121|NCT04035434|559540803|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
155140526|NCT00571038|559946463|FG001|Overall Study|Lost to Follow-up|4|||
155140527|NCT00571038|559946462|FG000|Overall Study|Death|7|||
155140528|NCT00571038|559946463|FG001|Overall Study|Death|5|||
155140529|NCT00571038|559946462|FG000|Overall Study|Withdrawal by Subject|1|||
155031122|NCT04035434|559540804|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155031123|NCT04035434|559540805|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031124|NCT04035434|559540806|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031125|NCT04035434|559540807|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031126|NCT04035434|559540808|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031127|NCT04035434|559540809|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031128|NCT04035434|559540810|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155031129|NCT04035434|559540811|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155031130|NCT04035434|559540812|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031131|NCT04035434|559540800|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155031132|NCT04035434|559540801|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
155031133|NCT04035434|559540802|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
155031134|NCT04035434|559540803|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155031135|NCT04035434|559540804|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
155031136|NCT04035434|559540805|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155031137|NCT04035434|559540806|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
155031138|NCT04035434|559540807|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
155031139|NCT04035434|559540808|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155031140|NCT04035434|559540809|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
155031141|NCT04035434|559540810|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
155031142|NCT04035434|559540811|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
155031143|NCT04035434|559540812|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
155031144|NCT04035434|559540800|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031145|NCT04035434|559540801|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155031146|NCT04035434|559540802|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
155031147|NCT04035434|559540803|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031148|NCT04035434|559540804|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155031149|NCT04035434|559540805|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155031150|NCT04035434|559540806|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031151|NCT04035434|559540807|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031152|NCT04035434|559540808|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
155031153|NCT04035434|559540809|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
155031154|NCT04035434|559540810|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031155|NCT04035434|559540811|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
155031156|NCT04035434|559540812|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
155031157|NCT04035434|559540800|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031158|NCT04035434|559540801|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031159|NCT04035434|559540802|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031160|NCT04035434|559540803|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
155031161|NCT04035434|559540804|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031162|NCT04035434|559540805|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031163|NCT04035434|559540806|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031164|NCT04035434|559540807|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031165|NCT04035434|559540808|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031166|NCT04035434|559540809|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031167|NCT04035434|559540810|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031168|NCT04035434|559540811|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031169|NCT04035434|559540812|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
155031170|NCT04035434|559540800|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031171|NCT04035434|559540801|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031172|NCT04035434|559540802|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031173|NCT04035434|559540803|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031174|NCT04035434|559540804|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031175|NCT04035434|559540805|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
155031176|NCT04035434|559540806|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
155031177|NCT04035434|559540807|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031178|NCT04035434|559540808|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031179|NCT04035434|559540809|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031180|NCT04035434|559540810|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031181|NCT04035434|559540811|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031182|NCT04035434|559540812|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
155031183|NCT04035434|559540800|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031184|NCT04035434|559540801|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031185|NCT04035434|559540802|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031186|NCT04035434|559540803|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155182398|NCT00718237|560105312|FG000|Overall Study|Physician Decision|1|||
155182399|NCT00718237|560105313|FG001|Overall Study|Physician Decision|0|||
155182400|NCT00718237|560105312|FG000|Overall Study|Withdrawal by Subject|9|||
155182401|NCT00718237|560105313|FG001|Overall Study|Withdrawal by Subject|10|||
155182402|NCT03149848|560105316|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
155182403|NCT03149848|560105316|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
155182404|NCT04738318|560105319|FG000|Overall Study|Protocol Violation|1|||
155182405|NCT04738318|560105320|FG001|Overall Study|Protocol Violation|0|||
155182406|NCT01226121|560105321|FG000|Overall Study|Lost to Follow-up|2|||
155182407|NCT01226121|560105322|FG001|Overall Study|Lost to Follow-up|0|||
155182408|NCT01226121|560105323|FG002|Overall Study|Lost to Follow-up|1|||
155182409|NCT00378079|560105324|FG000|Overall Study|Lost to Follow-up|6|||
155182410|NCT00378079|560105325|FG001|Overall Study|Lost to Follow-up|1|||
155182411|NCT00378079|560105326|FG002|Overall Study|Lost to Follow-up|0|||
155182412|NCT04473482|560105327|FG000|Overall Study|Death|0|||
155182413|NCT04473482|560105328|FG001|Overall Study|Death|3|||
155182414|NCT04473482|560105327|FG000|Overall Study|Lost to Follow-up|9|||
155182415|NCT04473482|560105328|FG001|Overall Study|Lost to Follow-up|7|||
155182416|NCT04473482|560105327|FG000|Overall Study|Withdrawal by Subject|2|||
155182417|NCT04473482|560105328|FG001|Overall Study|Withdrawal by Subject|1|||
155182418|NCT00586664|560105336|FG000|Overall Study|Withdrawal by Subject|3|||
155182419|NCT00586664|560105337|FG001|Overall Study|Withdrawal by Subject|7|||
155182420|NCT00586664|560105338|FG002|Overall Study|Withdrawal by Subject|1|||
155182421|NCT00586664|560105336|FG000|Overall Study|Exclusion criteria met|2|||
155182422|NCT00586664|560105337|FG001|Overall Study|Exclusion criteria met|0|||
155182423|NCT00586664|560105338|FG002|Overall Study|Exclusion criteria met|0|||
155182424|NCT00686998|560105342|FG000|Overall Study|Adverse Event|3|||
155182425|NCT00686998|560105343|FG001|Overall Study|Adverse Event|2|||
155182426|NCT00686998|560105344|FG002|Overall Study|Adverse Event|1|||
155182427|NCT00686998|560105342|FG000|Overall Study|Withdrawal by Subject|2|||
155182428|NCT00686998|560105343|FG001|Overall Study|Withdrawal by Subject|1|||
155182429|NCT00686998|560105344|FG002|Overall Study|Withdrawal by Subject|2|||
155182430|NCT00686998|560105342|FG000|Overall Study|Lack of Efficacy|7|||
155182431|NCT00686998|560105343|FG001|Overall Study|Lack of Efficacy|5|||
155182432|NCT00686998|560105344|FG002|Overall Study|Lack of Efficacy|0|||
155182433|NCT00686998|560105342|FG000|Overall Study|Other|0|||
155182434|NCT00686998|560105343|FG001|Overall Study|Other|0|||
155182435|NCT00686998|560105344|FG002|Overall Study|Other|1|||
155182436|NCT00686998|560105342|FG000|Overall Study|Safety Reasons|1|||
155182437|NCT00686998|560105343|FG001|Overall Study|Safety Reasons|0|||
155182438|NCT00686998|560105344|FG002|Overall Study|Safety Reasons|0|||
155182439|NCT02361346|560105345|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182440|NCT02361346|560105346|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182441|NCT02361346|560105347|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182442|NCT02361346|560105348|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
155182443|NCT02361346|560105349|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182444|NCT02361346|560105350|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182445|NCT02361346|560105351|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182446|NCT02361346|560105352|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182447|NCT02361346|560105353|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
155182448|NCT02361346|560105345|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182449|NCT02361346|560105346|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182450|NCT02361346|560105347|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182451|NCT02361346|560105348|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182452|NCT02361346|560105349|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
155182453|NCT02361346|560105350|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182454|NCT02361346|560105351|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182455|NCT02361346|560105352|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182456|NCT02361346|560105353|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
155182457|NCT02361346|560105345|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
155182458|NCT02361346|560105346|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
155182459|NCT02361346|560105347|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
155182460|NCT02361346|560105348|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
155182461|NCT02361346|560105349|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
155182462|NCT02361346|560105350|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
155182463|NCT02361346|560105351|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
155182464|NCT02361346|560105352|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
155182465|NCT02361346|560105353|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
155182466|NCT02361346|560105345|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155182467|NCT02361346|560105346|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155031187|NCT04035434|559540804|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155182468|NCT02361346|560105347|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155182469|NCT02361346|560105348|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155182470|NCT02361346|560105349|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155182471|NCT02361346|560105350|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155182472|NCT02361346|560105351|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155031188|NCT04035434|559540805|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155031189|NCT04035434|559540806|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
155031190|NCT04035434|559540807|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031191|NCT04035434|559540808|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031192|NCT04035434|559540809|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031193|NCT04035434|559540810|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155140530|NCT00571038|559946463|FG001|Overall Study|Withdrawal by Subject|3|||
155140531|NCT00571038|559946462|FG000|Overall Study|Moved out of state|2|||
155140532|NCT00571038|559946463|FG001|Overall Study|Moved out of state|2|||
155140533|NCT04426318|559946464|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
155140534|NCT04426318|559946465|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
155140535|NCT02152761|559946468|FG000|Epoch: Treatment Epoch|Technical problems|0|||
155140536|NCT02152761|559946469|FG001|Epoch: Treatment Epoch|Technical problems|0|||
155140537|NCT02152761|559946470|FG002|Epoch: Treatment Epoch|Technical problems|0|||
155140538|NCT02152761|559946471|FG003|Epoch: Treatment Epoch|Technical problems|1|||
155140539|NCT02152761|559946468|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
155140540|NCT02152761|559946469|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
155140541|NCT02152761|559946470|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
155140542|NCT02152761|559946471|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
155140543|NCT02152761|559946468|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
155140544|NCT02152761|559946469|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
155140545|NCT02152761|559946470|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
155140546|NCT02152761|559946471|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
155140547|NCT02152761|559946468|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
155140548|NCT02152761|559946469|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
155140549|NCT02152761|559946470|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
155140550|NCT02152761|559946471|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
155140551|NCT02152761|559946468|FG000|Epoch: Treatment Epoch|Death|0|||
155140552|NCT02152761|559946469|FG001|Epoch: Treatment Epoch|Death|3|||
155140553|NCT02152761|559946470|FG002|Epoch: Treatment Epoch|Death|1|||
155140554|NCT02152761|559946471|FG003|Epoch: Treatment Epoch|Death|0|||
155140555|NCT02152761|559946468|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
155140556|NCT02152761|559946469|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
155140557|NCT02152761|559946470|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
155140558|NCT02152761|559946471|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
155140559|NCT02152761|559946468|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
155140560|NCT02152761|559946469|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
155140561|NCT02152761|559946470|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
155140562|NCT02152761|559946471|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
155140563|NCT02152761|559946468|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
155140564|NCT02152761|559946469|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
155140565|NCT02152761|559946470|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
155140566|NCT02152761|559946471|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
155140567|NCT02152761|559946468|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
155140568|NCT02152761|559946469|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
155140569|NCT02152761|559946470|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
155140570|NCT02152761|559946471|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
155140571|NCT02152761|559946468|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
155140572|NCT02152761|559946469|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
155140573|NCT02152761|559946470|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
155140574|NCT02152761|559946471|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
155140575|NCT01957202|559946472|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140576|NCT01957202|559946473|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
155140577|NCT01957202|559946474|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140578|NCT01957202|559946475|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140579|NCT01957202|559946476|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140580|NCT01957202|559946477|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140581|NCT01957202|559946478|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140582|NCT01957202|559946479|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155031194|NCT04035434|559540811|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155140583|NCT01957202|559946480|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140584|NCT01957202|559946481|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140585|NCT01957202|559946482|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140586|NCT01957202|559946483|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140587|NCT01957202|559946484|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140588|NCT01957202|559946485|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140589|NCT01957202|559946486|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140590|NCT01957202|559946487|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140591|NCT01957202|559946488|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
155031195|NCT04035434|559540812|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
155031196|NCT04035434|559540800|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031197|NCT04035434|559540801|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031198|NCT04035434|559540802|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031199|NCT04035434|559540803|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031200|NCT04035434|559540804|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155140592|NCT01957202|559946489|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
155140593|NCT01957202|559946472|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140594|NCT01957202|559946473|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140595|NCT01957202|559946474|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140596|NCT01957202|559946475|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140597|NCT01957202|559946476|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140598|NCT01957202|559946477|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140599|NCT01957202|559946478|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140600|NCT01957202|559946479|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140601|NCT01957202|559946480|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140602|NCT01957202|559946481|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140603|NCT01957202|559946482|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140604|NCT01957202|559946483|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140605|NCT01957202|559946484|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140606|NCT01957202|559946485|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140607|NCT01957202|559946486|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140608|NCT01957202|559946487|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140609|NCT01957202|559946488|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
155140610|NCT01957202|559946489|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
155140611|NCT01456169|559946490|FG000|Overall Study|Adverse Event|1|||
155140612|NCT01456169|559946491|FG001|Overall Study|Adverse Event|2|||
155140613|NCT01456169|559946492|FG002|Overall Study|Adverse Event|7|||
155140614|NCT01456169|559946490|FG000|Overall Study|Major Protocol Deviation|3|||
155140615|NCT01456169|559946491|FG001|Overall Study|Major Protocol Deviation|2|||
155140616|NCT01456169|559946492|FG002|Overall Study|Major Protocol Deviation|3|||
155140617|NCT01456169|559946490|FG000|Overall Study|Voluntary Withdrawal|3|||
155140618|NCT01456169|559946491|FG001|Overall Study|Voluntary Withdrawal|0|||
155140619|NCT01456169|559946492|FG002|Overall Study|Voluntary Withdrawal|2|||
155140620|NCT01456169|559946490|FG000|Overall Study|Lack of Efficacy|2|||
155140621|NCT01456169|559946491|FG001|Overall Study|Lack of Efficacy|0|||
155140622|NCT01456169|559946492|FG002|Overall Study|Lack of Efficacy|0|||
155140623|NCT01456169|559946490|FG000|Overall Study|Other|1|||
155140624|NCT01456169|559946491|FG001|Overall Study|Other|1|||
155140625|NCT01456169|559946492|FG002|Overall Study|Other|0|||
155140626|NCT01290757|559946493|FG000|Overall Study|Adverse Event|1|||
155140627|NCT01290757|559946494|FG001|Overall Study|Adverse Event|0|||
155140628|NCT01290757|559946493|FG000|Overall Study|Protocol Violation|1|||
155140629|NCT01290757|559946494|FG001|Overall Study|Protocol Violation|1|||
155140630|NCT01290757|559946493|FG000|Overall Study|Other|0|||
155140631|NCT01290757|559946494|FG001|Overall Study|Other|1|||
155140632|NCT02021643|559946496|FG000|Overall Study|Enrolled but Never Treated|1|||
155140633|NCT02021643|559946497|FG001|Overall Study|Enrolled but Never Treated|0|||
155140634|NCT02021643|559946498|FG002|Overall Study|Enrolled but Never Treated|0|||
155140635|NCT02021643|559946499|FG003|Overall Study|Enrolled but Never Treated|0|||
155140636|NCT02021643|559946496|FG000|Overall Study|Adverse Event|0|||
155140637|NCT02021643|559946497|FG001|Overall Study|Adverse Event|1|||
155140638|NCT02021643|559946498|FG002|Overall Study|Adverse Event|0|||
155140639|NCT02021643|559946499|FG003|Overall Study|Adverse Event|0|||
155140640|NCT02021643|559946496|FG000|Overall Study|Death|0|||
155140641|NCT02021643|559946497|FG001|Overall Study|Death|1|||
155140642|NCT02021643|559946498|FG002|Overall Study|Death|0|||
155140643|NCT02021643|559946499|FG003|Overall Study|Death|0|||
155140644|NCT02021643|559946496|FG000|Overall Study|Investigator's Discretion|1|||
155140645|NCT02021643|559946497|FG001|Overall Study|Investigator's Discretion|0|||
155140646|NCT02021643|559946498|FG002|Overall Study|Investigator's Discretion|0|||
155140647|NCT02021643|559946499|FG003|Overall Study|Investigator's Discretion|0|||
155140648|NCT02021643|559946496|FG000|Overall Study|Lack of Efficacy|7|||
155140649|NCT02021643|559946497|FG001|Overall Study|Lack of Efficacy|6|||
155140650|NCT02021643|559946498|FG002|Overall Study|Lack of Efficacy|0|||
155140651|NCT02021643|559946499|FG003|Overall Study|Lack of Efficacy|12|||
155140652|NCT02021643|559946496|FG000|Overall Study|Lost to Follow-up|0|||
155140653|NCT02021643|559946497|FG001|Overall Study|Lost to Follow-up|1|||
155140654|NCT02021643|559946498|FG002|Overall Study|Lost to Follow-up|0|||
155140655|NCT02021643|559946499|FG003|Overall Study|Lost to Follow-up|0|||
155140656|NCT02021643|559946496|FG000|Overall Study|Withdrew Consent|0|||
155182473|NCT02361346|560105352|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
155182474|NCT02361346|560105353|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
155140657|NCT02021643|559946497|FG001|Overall Study|Withdrew Consent|1|||
155140658|NCT02021643|559946498|FG002|Overall Study|Withdrew Consent|0|||
155140659|NCT02021643|559946499|FG003|Overall Study|Withdrew Consent|0|||
155140660|NCT02631551|559946500|FG000|Overall Study|Adverse Event|1|||
155031201|NCT04035434|559540805|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
155031202|NCT04035434|559540806|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
155031203|NCT04035434|559540807|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031204|NCT04035434|559540808|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031205|NCT04035434|559540809|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031206|NCT04035434|559540810|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031207|NCT04035434|559540811|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031208|NCT04035434|559540812|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
155031209|NCT02879994|559540814|FG000|Overall Study|off treatment early|7|||
155031210|NCT02879994|559540814|FG000|Overall Study|Adverse Event|2|||
155031211|NCT02879994|559540814|FG000|Overall Study|Death|2|||
155031212|NCT02143791|559540815|FG000|Enrolled|Withdrawal by Subject|4|||
155031213|NCT02143791|559540815|FG000|Trial Stimulation|Lack of Efficacy|21|||
155031214|NCT02143791|559540815|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
155031215|NCT02143791|559540815|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
155031216|NCT02143791|559540815|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
155031217|NCT02143791|559540815|FG000|Any Programming (3-6 Months)|Missing Data|1|||
155031218|NCT02143791|559540815|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
155031219|NCT04984681|559540821|FG000|Overall Study|Lost to Follow-up|3|||
155031220|NCT04984681|559540822|FG001|Overall Study|Lost to Follow-up|1|||
155031221|NCT01214252|559540823|FG000|Overall Study|Not eligible per protocol|82|||
155031222|NCT00552032|559540825|FG000|Overall Study|Withdrawal by Subject|2|||
155031223|NCT00552032|559540826|FG001|Overall Study|Withdrawal by Subject|2|||
155031224|NCT00552032|559540825|FG000|Overall Study|Protocol Violation|7|||
155182475|NCT02361346|560105345|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182476|NCT02361346|560105346|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182477|NCT02361346|560105347|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182478|NCT02361346|560105348|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182479|NCT02361346|560105349|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182480|NCT02361346|560105350|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182481|NCT02361346|560105351|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182482|NCT02361346|560105352|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
155182483|NCT02361346|560105353|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
155182484|NCT02361346|560105345|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182485|NCT02361346|560105346|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182486|NCT02361346|560105347|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182487|NCT02361346|560105348|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182488|NCT02361346|560105349|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182489|NCT02361346|560105350|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182490|NCT02361346|560105351|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182491|NCT02361346|560105352|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
155182492|NCT02361346|560105353|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
155182493|NCT02275910|560105354|FG000|Overall Study|Subject Choice|0|||
155182494|NCT02275910|560105355|FG001|Overall Study|Subject Choice|0|||
155182495|NCT02275910|560105356|FG002|Overall Study|Subject Choice|0|||
155182496|NCT02275910|560105357|FG003|Overall Study|Subject Choice|0|||
155182497|NCT02275910|560105358|FG004|Overall Study|Subject Choice|0|||
155182498|NCT02275910|560105359|FG005|Overall Study|Subject Choice|0|||
155182499|NCT02275910|560105360|FG006|Overall Study|Subject Choice|0|||
155182500|NCT02275910|560105361|FG007|Overall Study|Subject Choice|0|||
155182501|NCT02275910|560105362|FG008|Overall Study|Subject Choice|1|||
155182502|NCT02275910|560105363|FG009|Overall Study|Subject Choice|0|||
155182503|NCT02275910|560105364|FG010|Overall Study|Subject Choice|0|||
155182504|NCT02275910|560105365|FG011|Overall Study|Subject Choice|0|||
155182505|NCT02275910|560105354|FG000|Overall Study|Radiological Disease Progression|0|||
155182506|NCT02275910|560105355|FG001|Overall Study|Radiological Disease Progression|0|||
155182507|NCT02275910|560105356|FG002|Overall Study|Radiological Disease Progression|0|||
155182508|NCT02275910|560105357|FG003|Overall Study|Radiological Disease Progression|0|||
155182509|NCT02275910|560105358|FG004|Overall Study|Radiological Disease Progression|0|||
155182510|NCT02275910|560105359|FG005|Overall Study|Radiological Disease Progression|0|||
155182511|NCT02275910|560105360|FG006|Overall Study|Radiological Disease Progression|1|||
155182512|NCT02275910|560105361|FG007|Overall Study|Radiological Disease Progression|1|||
155182513|NCT02275910|560105362|FG008|Overall Study|Radiological Disease Progression|0|||
155031225|NCT00552032|559540826|FG001|Overall Study|Protocol Violation|12|||
155182514|NCT02275910|560105363|FG009|Overall Study|Radiological Disease Progression|1|||
155182515|NCT02275910|560105364|FG010|Overall Study|Radiological Disease Progression|0|||
155182516|NCT02275910|560105365|FG011|Overall Study|Radiological Disease Progression|0|||
155182517|NCT00076024|560106628|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
155031226|NCT00552032|559540825|FG000|Overall Study|Lost to Follow-up|8|||
155182518|NCT00076024|560106629|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
155182519|NCT00076024|560106630|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
155182520|NCT00076024|560106631|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
155182521|NCT00076024|560106628|FG000|Phase 1, Lead-in|Adverse Event|1|||
155182522|NCT00076024|560106629|FG001|Phase 1, Lead-in|Adverse Event|0|||
155182523|NCT00076024|560106630|FG002|Phase 1, Lead-in|Adverse Event|0|||
155182524|NCT00076024|560106631|FG003|Phase 1, Lead-in|Adverse Event|0|||
155182525|NCT00076024|560106628|FG000|Phase 1, Lead-in|Clinical progression|1|||
155182526|NCT00076024|560106629|FG001|Phase 1, Lead-in|Clinical progression|0|||
155182527|NCT00076024|560106630|FG002|Phase 1, Lead-in|Clinical progression|0|||
155182528|NCT00076024|560106631|FG003|Phase 1, Lead-in|Clinical progression|0|||
155182529|NCT00076024|560106628|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
155182530|NCT00076024|560106629|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
155182531|NCT00076024|560106630|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
155182532|NCT00076024|560106631|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
155182533|NCT00076024|560106628|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
155182534|NCT00076024|560106629|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
155182535|NCT00076024|560106630|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
155182536|NCT00076024|560106631|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
155182537|NCT00076024|560106628|FG000|Phase 2, Double-blind|Adverse Event|0|||
155182538|NCT00076024|560106629|FG001|Phase 2, Double-blind|Adverse Event|25|||
155182539|NCT00076024|560106630|FG002|Phase 2, Double-blind|Adverse Event|6|||
155182540|NCT00076024|560106631|FG003|Phase 2, Double-blind|Adverse Event|0|||
155182541|NCT00076024|560106628|FG000|Phase 2, Double-blind|Un-specified|0|||
155182542|NCT00076024|560106629|FG001|Phase 2, Double-blind|Un-specified|14|||
155182543|NCT00076024|560106630|FG002|Phase 2, Double-blind|Un-specified|6|||
155182544|NCT00076024|560106631|FG003|Phase 2, Double-blind|Un-specified|0|||
155182545|NCT00076024|560106628|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
155182546|NCT00076024|560106629|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
155182547|NCT00076024|560106630|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
155182548|NCT00076024|560106631|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
155182549|NCT00076024|560106628|FG000|Phase 2, Open-label|Adverse Event|0|||
155182550|NCT00076024|560106629|FG001|Phase 2, Open-label|Adverse Event|0|||
155182551|NCT00076024|560106630|FG002|Phase 2, Open-label|Adverse Event|0|||
155182552|NCT00076024|560106631|FG003|Phase 2, Open-label|Adverse Event|2|||
155182553|NCT00076024|560106628|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
155182554|NCT00076024|560106629|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
155182555|NCT00076024|560106630|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
155182556|NCT00076024|560106631|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
155182557|NCT00076024|560106628|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
155182558|NCT00076024|560106629|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
155182559|NCT00076024|560106630|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
155182560|NCT00076024|560106631|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
155182561|NCT00076024|560106628|FG000|Phase 2, Open-label|Other|0|||
155182562|NCT00076024|560106629|FG001|Phase 2, Open-label|Other|0|||
155182563|NCT00076024|560106630|FG002|Phase 2, Open-label|Other|0|||
155182564|NCT00076024|560106631|FG003|Phase 2, Open-label|Other|2|||
155182565|NCT01155219|560106638|FG000|Overall Study|Adverse Event|3|||
155182566|NCT01155219|560106639|FG001|Overall Study|Adverse Event|1|||
155182567|NCT01155219|560106638|FG000|Overall Study|non-medical reason|1|||
155182568|NCT01155219|560106639|FG001|Overall Study|non-medical reason|2|||
155182569|NCT03150485|560106641|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155182570|NCT03150485|560106642|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155182571|NCT03150485|560106643|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
155182572|NCT03150485|560106644|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
155182573|NCT03150485|560106645|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
155182574|NCT03150485|560106646|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
155182575|NCT01394718|560106648|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
155031227|NCT00552032|559540826|FG001|Overall Study|Lost to Follow-up|5|||
155031228|NCT01054300|559540831|FG000|Period 1|Adverse Event|1|||
155182576|NCT01394718|560106649|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
155031229|NCT01054300|559540832|FG001|Period 1|Adverse Event|0|||
155031230|NCT01054300|559540833|FG002|Period 1|Adverse Event|0|||
155031231|NCT01054300|559540834|FG003|Period 1|Adverse Event|0|||
155182577|NCT00096954|560106652|FG000|Overall Study|Adverse Event|3|||
155182578|NCT00096954|560106653|FG001|Overall Study|Adverse Event|1|||
155182579|NCT00096954|560106652|FG000|Overall Study|Withdrawal by Subject|9|||
155182580|NCT00096954|560106653|FG001|Overall Study|Withdrawal by Subject|8|||
155182581|NCT00096954|560106652|FG000|Overall Study|Physician Decision|1|||
155182582|NCT00096954|560106653|FG001|Overall Study|Physician Decision|1|||
155182583|NCT00096954|560106652|FG000|Overall Study|Sponsors Decision|1|||
155182584|NCT00096954|560106653|FG001|Overall Study|Sponsors Decision|1|||
155182585|NCT00096954|560106652|FG000|Overall Study|Pregnancy|1|||
155182586|NCT00096954|560106653|FG001|Overall Study|Pregnancy|1|||
155182587|NCT00096954|560106652|FG000|Overall Study|Initiation of immunotherapy|1|||
155031232|NCT01054300|559540831|FG000|Period 2|Withdrawal by Subject|0|||
155031233|NCT01054300|559540832|FG001|Period 2|Withdrawal by Subject|0|||
155182588|NCT00096954|560106653|FG001|Overall Study|Initiation of immunotherapy|0|||
155182589|NCT00096954|560106652|FG000|Overall Study|Non-compliance|0|||
155182590|NCT00096954|560106653|FG001|Overall Study|Non-compliance|3|||
155182591|NCT00096954|560106652|FG000|Overall Study|Lost to Follow-up|8|||
155182592|NCT00096954|560106653|FG001|Overall Study|Lost to Follow-up|5|||
155182593|NCT04478123|560106654|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
155182594|NCT04478123|560106654|FG000|Overall Study|NE|1|||
155182595|NCT01547780|560106655|FG000|Baseline PET Scan|Physician Decision|1|||
155182596|NCT01547780|560106656|FG001|Baseline PET Scan|Physician Decision|0|||
155182597|NCT01547780|560106657|FG002|Baseline PET Scan|Physician Decision|1|||
155182598|NCT01547780|560106658|FG003|Baseline PET Scan|Physician Decision|0|||
155182599|NCT01547780|560106655|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
155182600|NCT01547780|560106656|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
155182601|NCT01547780|560106657|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
155182602|NCT01547780|560106658|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
155182603|NCT00814879|560106659|FG000|By Week 24|Cancer Diagnosis|1|||
155182604|NCT00814879|560106660|FG001|By Week 24|Cancer Diagnosis|0|||
155182605|NCT00814879|560106659|FG000|By Week 24|Incarceration|0|||
155182606|NCT00814879|560106660|FG001|By Week 24|Incarceration|1|||
155182607|NCT00814879|560106659|FG000|By Week 48|Lost to Follow-up|2|||
155182608|NCT00814879|560106660|FG001|By Week 48|Lost to Follow-up|2|||
155182609|NCT00814879|560106659|FG000|By Week 48|Death|0|||
155182610|NCT00814879|560106660|FG001|By Week 48|Death|1|||
155182611|NCT00588952|560106661|FG000|Overall Study|Adverse Event|0|||
155182612|NCT00588952|560106662|FG001|Overall Study|Adverse Event|2|||
155182613|NCT00588952|560106661|FG000|Overall Study|Withdrawal by Subject|3|||
155182614|NCT00588952|560106662|FG001|Overall Study|Withdrawal by Subject|5|||
155182615|NCT01461057|560106663|FG000|Overall Study|Death|10|||
155182616|NCT01461057|560106664|FG001|Overall Study|Death|9|||
155182617|NCT01461057|560106663|FG000|Overall Study|Withdrawal by Subject|2|||
155182618|NCT01461057|560106664|FG001|Overall Study|Withdrawal by Subject|3|||
155182619|NCT01461057|560106663|FG000|Overall Study|Physician Decision|0|||
155182620|NCT01461057|560106664|FG001|Overall Study|Physician Decision|2|||
155182621|NCT01461057|560106663|FG000|Overall Study|Adverse Event|0|||
155182622|NCT01461057|560106664|FG001|Overall Study|Adverse Event|1|||
155182623|NCT01461057|560106663|FG000|Overall Study|Progression of Disease|1|||
155182624|NCT01461057|560106664|FG001|Overall Study|Progression of Disease|0|||
155182625|NCT01461057|560106663|FG000|Overall Study|Study Terminated by Sponsor|2|||
155182626|NCT01461057|560106664|FG001|Overall Study|Study Terminated by Sponsor|0|||
155182627|NCT01288976|560106665|FG000|Overall Study|Withdrawal by Subject|58|||
155182628|NCT01288976|560106666|FG001|Overall Study|Withdrawal by Subject|12|||
155182629|NCT01288976|560106667|FG002|Overall Study|Withdrawal by Subject|9|||
155182630|NCT01288976|560106665|FG000|Overall Study|Death|98|||
155182631|NCT01288976|560106666|FG001|Overall Study|Death|6|||
155182632|NCT01288976|560106667|FG002|Overall Study|Death|4|||
155182633|NCT01288976|560106665|FG000|Overall Study|Data unavailable|22|||
155182634|NCT01288976|560106666|FG001|Overall Study|Data unavailable|9|||
155182635|NCT01288976|560106667|FG002|Overall Study|Data unavailable|7|||
155182636|NCT03560739|560106669|FG000|Overall Study|Adverse Event|0|||
155182637|NCT03560739|560106670|FG001|Overall Study|Adverse Event|1|||
155182638|NCT03560739|560106671|FG002|Overall Study|Adverse Event|0|||
155182639|NCT03560739|560106672|FG003|Overall Study|Adverse Event|0|||
155182640|NCT01362595|560106673|FG000|Overall Study|Screen failure|10|||
155182641|NCT01362595|560106673|FG000|Overall Study|Withdrawal by Subject|2|||
155182642|NCT00959374|560106674|FG000|Overall Study|Withdrawal by Subject|2|||
155182643|NCT00959374|560106674|FG000|Overall Study|Lost to Follow-up|14|||
155182644|NCT00959374|560106674|FG000|Overall Study|Death|1|||
155182645|NCT00959374|560106674|FG000|Overall Study|Protocol Violation|1|||
155182646|NCT00959374|560106674|FG000|Overall Study|Implant Removed/Not Replaced|4|||
155182647|NCT00959374|560106674|FG000|Overall Study|Physician Decision|1|||
155182648|NCT02448680|560106675|FG000|Overall Study|Physician Decision|1|||
155182649|NCT02448680|560106676|FG001|Overall Study|Physician Decision|1|||
155182650|NCT02448680|560106675|FG000|Overall Study|Withdrawal by Subject|0|||
155182651|NCT02448680|560106676|FG001|Overall Study|Withdrawal by Subject|2|||
155182652|NCT01736657|560106677|FG000|Overall Study|insufficient vascular access|1|||
155182653|NCT03350984|560106678|FG000|Overall Study|Death|1|||
155182654|NCT03350984|560106679|FG001|Overall Study|Death|0|||
155182655|NCT03350984|560106678|FG000|Overall Study|Lost to Follow-up|5|||
155182656|NCT03350984|560106679|FG001|Overall Study|Lost to Follow-up|6|||
155182657|NCT03350984|560106678|FG000|Overall Study|Protocol Violation|1|||
155182658|NCT03350984|560106679|FG001|Overall Study|Protocol Violation|2|||
155182659|NCT03350984|560106678|FG000|Overall Study|Physician Decision|1|||
155182660|NCT03350984|560106679|FG001|Overall Study|Physician Decision|0|||
155182661|NCT04533880|560106680|FG000|Overall Study|Lost to Follow-up|0|||
155182662|NCT04533880|560106681|FG001|Overall Study|Lost to Follow-up|1|||
155182663|NCT04533880|560106682|FG002|Overall Study|Lost to Follow-up|1|||
155182664|NCT02284178|560106683|FG000|Overall Study|Met exclusion criteria|49|||
155182665|NCT02284178|560106684|FG001|Overall Study|Met exclusion criteria|54|||
155182666|NCT04123665|560106685|FG000|Overall Study|Withdrawal by Subject|7|||
155182667|NCT04123665|560106686|FG001|Overall Study|Withdrawal by Subject|0|||
155182668|NCT04123665|560106685|FG000|Overall Study|Lost to Follow-up|1|||
155182669|NCT04123665|560106686|FG001|Overall Study|Lost to Follow-up|0|||
155182670|NCT01711879|560106690|FG000|Overall Study|Death|1|||
155182671|NCT01711879|560106691|FG001|Overall Study|Death|0|||
155182672|NCT00958789|560106695|FG000|Overall Study|Death|5|||
155182673|NCT00958789|560106695|FG000|Overall Study|Lost to Follow-up|14|||
155182674|NCT00958789|560106695|FG000|Overall Study|Withdrawal by Subject|17|||
155182675|NCT00958789|560106695|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
155182676|NCT00958789|560106695|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
155182677|NCT00958789|560106695|FG000|Overall Study|Subject terminated|2|||
155182678|NCT00958789|560106695|FG000|Overall Study|Revision|7|||
155182679|NCT01466179|560106696|FG000|Overall Study|Ongoing in core study|2|||
155182680|NCT01466179|560106696|FG000|Overall Study|Physician Decision|46|||
155182681|NCT01466179|560106696|FG000|Overall Study|Progressive disease|43|||
155182682|NCT01466179|560106696|FG000|Overall Study|Adverse Event|32|||
155182683|NCT01466179|560106696|FG000|Overall Study|Disease relapse|23|||
155182684|NCT01466179|560106696|FG000|Overall Study|Lack of Efficacy|14|||
155182685|NCT01466179|560106696|FG000|Overall Study|Death|7|||
155182686|NCT01466179|560106696|FG000|Overall Study|Withdrawal by Subject|7|||
155182687|NCT01466179|560106696|FG000|Overall Study|Protocol Violation|2|||
155182688|NCT01466179|560106696|FG000|Overall Study|Other|3|||
155182689|NCT01083173|560106699|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
155182690|NCT01083173|560106700|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
155182691|NCT01083173|560106699|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
155182692|NCT01083173|560106700|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
155182693|NCT01083173|560106699|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
155182694|NCT01083173|560106700|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
155182695|NCT01083173|560106699|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
155182696|NCT01083173|560106700|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
155182697|NCT01083173|560106699|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
155182698|NCT01083173|560106700|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
155182699|NCT01083173|560106699|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
155182700|NCT01083173|560106700|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
155182701|NCT01083173|560106699|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
155182702|NCT01083173|560106700|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
155182703|NCT01083173|560106699|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
155182704|NCT01083173|560106700|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
155182705|NCT01083173|560106699|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
155182706|NCT01083173|560106700|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
155182707|NCT01083173|560106699|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
155182708|NCT01083173|560106700|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
155182709|NCT01083173|560106699|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
155182710|NCT01083173|560106700|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
155182711|NCT04062123|560106703|FG000|Overall Study|Withdrawal by Subject|0|||
155182712|NCT04062123|560106704|FG001|Overall Study|Withdrawal by Subject|1|||
155182713|NCT04062123|560106705|FG002|Overall Study|Withdrawal by Subject|0|||
155182714|NCT00367770|560106708|FG000|Overall Study|Adverse Event|1|||
155182715|NCT00367770|560106708|FG000|Overall Study|Withdrawal by Subject|1|||
155182716|NCT03282565|560106711|FG000|Overall Study|COVID-19 Research Shutdown|0|||
155182717|NCT03282565|560106712|FG001|Overall Study|COVID-19 Research Shutdown|2|||
155182718|NCT03282565|560106713|FG002|Overall Study|COVID-19 Research Shutdown|2|||
155182719|NCT00740051|560106714|FG000|Overall Study|Lack of Efficacy|2|||
155182720|NCT00740051|560106715|FG001|Overall Study|Lack of Efficacy|5|||
155182721|NCT00740051|560106714|FG000|Overall Study|Adverse Event|1|||
155182722|NCT00740051|560106715|FG001|Overall Study|Adverse Event|4|||
155182723|NCT00740051|560106714|FG000|Overall Study|Protocol Violation|2|||
155182724|NCT00740051|560106715|FG001|Overall Study|Protocol Violation|6|||
155182725|NCT00740051|560106714|FG000|Overall Study|Lost to Follow-up|3|||
155182726|NCT00740051|560106715|FG001|Overall Study|Lost to Follow-up|8|||
155182727|NCT00740051|560106714|FG000|Overall Study|Withdrawal by Subject|6|||
155182728|NCT00740051|560106715|FG001|Overall Study|Withdrawal by Subject|8|||
155182729|NCT00740051|560106714|FG000|Overall Study|Other reason (not specified)|4|||
155182730|NCT00740051|560106715|FG001|Overall Study|Other reason (not specified)|1|||
155182731|NCT02011893|560106716|FG000|Enrollment to Randomization|Adverse Event|2|||
155182732|NCT02011893|560106717|FG001|Enrollment to Randomization|Adverse Event|0|||
155182733|NCT02011893|560106718|FG002|Enrollment to Randomization|Adverse Event|0|||
155182734|NCT02011893|560106716|FG000|Enrollment to Randomization|Physician Decision|10|||
155182735|NCT02011893|560106717|FG001|Enrollment to Randomization|Physician Decision|0|||
155182736|NCT02011893|560106718|FG002|Enrollment to Randomization|Physician Decision|0|||
155182737|NCT02011893|560106716|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
155182738|NCT02011893|560106717|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
155182739|NCT02011893|560106718|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
155182740|NCT02011893|560106716|FG000|Enrollment to Randomization|Screening Failure|29|||
155182741|NCT02011893|560106717|FG001|Enrollment to Randomization|Screening Failure|0|||
155182742|NCT02011893|560106718|FG002|Enrollment to Randomization|Screening Failure|0|||
155182743|NCT02011893|560106716|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
155182744|NCT02011893|560106717|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
155182745|NCT02011893|560106718|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
155182746|NCT02011893|560106716|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
155182747|NCT02011893|560106717|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
155182748|NCT02011893|560106718|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
155182749|NCT02011893|560106716|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
155182750|NCT02011893|560106717|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
155182751|NCT02011893|560106718|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
155182752|NCT02011893|560106716|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
155182753|NCT02011893|560106717|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
155182754|NCT02011893|560106718|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
155182755|NCT02011893|560106716|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
155182756|NCT02011893|560106717|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
155182757|NCT02011893|560106718|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
155182758|NCT00930982|560106719|FG000|Overall Study|Adverse Event|19|||
155182759|NCT00930982|560106720|FG001|Overall Study|Adverse Event|23|||
155182760|NCT00930982|560106719|FG000|Overall Study|Protocol Violation|1|||
155182761|NCT00930982|560106720|FG001|Overall Study|Protocol Violation|5|||
155182762|NCT00930982|560106719|FG000|Overall Study|Withdrawal by Subject|1|||
155182763|NCT00930982|560106720|FG001|Overall Study|Withdrawal by Subject|1|||
155182764|NCT00991952|560106721|FG000|Overall Study|Adverse Event|0|||
155182765|NCT00991952|560106722|FG001|Overall Study|Adverse Event|1|||
155182766|NCT03452527|560106723|FG000|Overall Study|Withdrawal by Subject|1|||
155182767|NCT03452527|560106724|FG001|Overall Study|Withdrawal by Subject|1|||
155182768|NCT03452527|560106723|FG000|Overall Study|Study Terminated|2|||
155182769|NCT03452527|560106724|FG001|Overall Study|Study Terminated|3|||
155182770|NCT00582816|560106725|FG000|Overall Study|Engraftment Failure|3|||
155182771|NCT02522871|560106728|FG000|Overall Study|Protocol Violation|1|||
155182772|NCT02522871|560106729|FG001|Overall Study|Protocol Violation|4|||
155182773|NCT02522871|560106728|FG000|Overall Study|Treated without randomization|1|||
155182774|NCT02522871|560106729|FG001|Overall Study|Treated without randomization|0|||
155182775|NCT02522871|560106728|FG000|Overall Study|Death|9|||
155182776|NCT02522871|560106729|FG001|Overall Study|Death|9|||
155182777|NCT02522871|560106728|FG000|Overall Study|Died in operating room prior to transplant|0|||
155182778|NCT02522871|560106729|FG001|Overall Study|Died in operating room prior to transplant|1|||
155182779|NCT02009384|560106733|FG000|Overall Study|Death|2|||
155182780|NCT01146860|560106734|FG000|Overall Study|Withdrawal by Subject|0|||
155182781|NCT01146860|560106735|FG001|Overall Study|Withdrawal by Subject|1|||
155182782|NCT01092832|560106736|FG000|Overall Study|Other|1|||
155182783|NCT01092832|560106737|FG001|Overall Study|Other|0|||
155182784|NCT02635646|560106738|FG000|Overall Study|Lost to Follow-up|24|||
155182785|NCT02635646|560106739|FG001|Overall Study|Lost to Follow-up|25|||
155182786|NCT02635646|560106738|FG000|Overall Study|Pregnancy|1|||
155182787|NCT02635646|560106739|FG001|Overall Study|Pregnancy|1|||
155182788|NCT01244490|560106740|FG000|Overall Study|Lack of Efficacy|14|||
155182789|NCT01244490|560106741|FG001|Overall Study|Lack of Efficacy|5|||
155182790|NCT01244490|560106742|FG002|Overall Study|Lack of Efficacy|5|||
155182791|NCT01244490|560106740|FG000|Overall Study|Withdrawal by Subject|4|||
155182792|NCT01244490|560106741|FG001|Overall Study|Withdrawal by Subject|4|||
155182793|NCT01244490|560106742|FG002|Overall Study|Withdrawal by Subject|9|||
155182794|NCT01244490|560106740|FG000|Overall Study|Adverse Event|1|||
155182795|NCT01244490|560106741|FG001|Overall Study|Adverse Event|9|||
155182796|NCT01244490|560106742|FG002|Overall Study|Adverse Event|5|||
155182797|NCT01244490|560106740|FG000|Overall Study|Lost to Follow-up|0|||
155182798|NCT01244490|560106741|FG001|Overall Study|Lost to Follow-up|6|||
155182799|NCT01244490|560106742|FG002|Overall Study|Lost to Follow-up|3|||
155182800|NCT01244490|560106740|FG000|Overall Study|Other|0|||
155182801|NCT01244490|560106741|FG001|Overall Study|Other|0|||
155182802|NCT01244490|560106742|FG002|Overall Study|Other|1|||
155182803|NCT00400153|560106745|FG000|Overall Study|AE due to study disease worsening|14|||
155182804|NCT00400153|560106746|FG001|Overall Study|AE due to study disease worsening|19|||
155182805|NCT00400153|560106747|FG002|Overall Study|AE due to study disease worsening|20|||
155182806|NCT00400153|560106745|FG000|Overall Study|AE due to other disease worsening|2|||
155182807|NCT00400153|560106746|FG001|Overall Study|AE due to other disease worsening|1|||
155182808|NCT00400153|560106747|FG002|Overall Study|AE due to other disease worsening|0|||
155182809|NCT00400153|560106745|FG000|Overall Study|AE due to other condition|3|||
155182810|NCT00400153|560106746|FG001|Overall Study|AE due to other condition|14|||
155182811|NCT00400153|560106747|FG002|Overall Study|AE due to other condition|15|||
155140661|NCT02631551|559946501|FG001|Overall Study|Adverse Event|2|||
155140662|NCT02631551|559946502|FG002|Overall Study|Adverse Event|4|||
155140663|NCT02631551|559946503|FG003|Overall Study|Adverse Event|0|||
155140664|NCT02631551|559946500|FG000|Overall Study|Lack of Efficacy|0|||
155140665|NCT02631551|559946501|FG001|Overall Study|Lack of Efficacy|0|||
155140666|NCT02631551|559946502|FG002|Overall Study|Lack of Efficacy|1|||
155140667|NCT02631551|559946503|FG003|Overall Study|Lack of Efficacy|0|||
155140668|NCT02631551|559946500|FG000|Overall Study|Lost to Follow-up|1|||
155140669|NCT02631551|559946501|FG001|Overall Study|Lost to Follow-up|2|||
155140670|NCT02631551|559946502|FG002|Overall Study|Lost to Follow-up|0|||
155140671|NCT02631551|559946503|FG003|Overall Study|Lost to Follow-up|3|||
155140672|NCT02631551|559946500|FG000|Overall Study|Withdrawal by Subject|2|||
155140673|NCT02631551|559946501|FG001|Overall Study|Withdrawal by Subject|2|||
155140674|NCT02631551|559946502|FG002|Overall Study|Withdrawal by Subject|0|||
155140675|NCT02631551|559946503|FG003|Overall Study|Withdrawal by Subject|5|||
155140676|NCT02631551|559946500|FG000|Overall Study|Protocol deviation|3|||
155140677|NCT02631551|559946501|FG001|Overall Study|Protocol deviation|6|||
155140678|NCT02631551|559946502|FG002|Overall Study|Protocol deviation|3|||
155140679|NCT02631551|559946503|FG003|Overall Study|Protocol deviation|0|||
155140680|NCT02631551|559946500|FG000|Overall Study|Non-compliance with study procedures|0|||
155140681|NCT02631551|559946501|FG001|Overall Study|Non-compliance with study procedures|0|||
155140682|NCT02631551|559946502|FG002|Overall Study|Non-compliance with study procedures|1|||
155140683|NCT02631551|559946503|FG003|Overall Study|Non-compliance with study procedures|1|||
155140684|NCT02631551|559946500|FG000|Overall Study|Non-compliance with study drug|1|||
155140685|NCT02631551|559946501|FG001|Overall Study|Non-compliance with study drug|0|||
155140686|NCT02631551|559946502|FG002|Overall Study|Non-compliance with study drug|0|||
155140687|NCT02631551|559946503|FG003|Overall Study|Non-compliance with study drug|0|||
155140688|NCT02631551|559946500|FG000|Overall Study|Other, specific reasons not collected|5|||
155140689|NCT02631551|559946501|FG001|Overall Study|Other, specific reasons not collected|7|||
155140690|NCT02631551|559946502|FG002|Overall Study|Other, specific reasons not collected|2|||
155140691|NCT02631551|559946503|FG003|Overall Study|Other, specific reasons not collected|2|||
155140692|NCT04390243|559946509|FG000|Overall Study|Death|1|||
155140693|NCT04390243|559946509|FG000|Overall Study|Disease Progression|4|||
155140694|NCT04390243|559946509|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
155140695|NCT01521507|559946516|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
155140696|NCT01521507|559946517|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
155140697|NCT01521507|559946516|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
155140698|NCT01521507|559946517|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
155140699|NCT01521507|559946516|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
155140700|NCT01521507|559946517|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
155140701|NCT01521507|559946516|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
155140702|NCT01521507|559946517|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
155140703|NCT01521507|559946516|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
155140704|NCT01521507|559946517|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
155140705|NCT01521507|559946516|FG000|Stage 2: Observational Design|Physician Decision|1|||
155140706|NCT01521507|559946517|FG001|Stage 2: Observational Design|Physician Decision|0|||
155140707|NCT01196026|559946518|FG000|Overall Study|Withdrawal by Subject|1|||
155140708|NCT01196026|559946519|FG001|Overall Study|Withdrawal by Subject|4|||
155140709|NCT01196026|559946520|FG002|Overall Study|Withdrawal by Subject|0|||
155140710|NCT01196026|559946521|FG003|Overall Study|Withdrawal by Subject|0|||
155140711|NCT01196026|559946522|FG004|Overall Study|Withdrawal by Subject|0|||
155140712|NCT01196026|559946523|FG005|Overall Study|Withdrawal by Subject|0|||
155140713|NCT01196026|559946518|FG000|Overall Study|Lost to Follow-up|0|||
155140714|NCT01196026|559946519|FG001|Overall Study|Lost to Follow-up|3|||
155140715|NCT01196026|559946520|FG002|Overall Study|Lost to Follow-up|0|||
155140716|NCT01196026|559946521|FG003|Overall Study|Lost to Follow-up|0|||
155140717|NCT01196026|559946522|FG004|Overall Study|Lost to Follow-up|1|||
155140718|NCT01196026|559946523|FG005|Overall Study|Lost to Follow-up|0|||
155140719|NCT01196026|559946518|FG000|Overall Study|Other|0|||
155140720|NCT01196026|559946519|FG001|Overall Study|Other|1|||
155140721|NCT01196026|559946520|FG002|Overall Study|Other|0|||
155140722|NCT01196026|559946521|FG003|Overall Study|Other|0|||
155140723|NCT01196026|559946522|FG004|Overall Study|Other|0|||
155140724|NCT01196026|559946523|FG005|Overall Study|Other|0|||
155140725|NCT04034004|559946524|FG000|Overall Study|Withdrawal by Subject|1|||
155140726|NCT04034004|559946525|FG001|Overall Study|Withdrawal by Subject|2|||
155140727|NCT04034004|559946526|FG002|Overall Study|Withdrawal by Subject|2|||
155140728|NCT04034004|559946527|FG003|Overall Study|Withdrawal by Subject|3|||
155140729|NCT04034004|559946524|FG000|Overall Study|could not find vein to administer IV|2|||
155140730|NCT04034004|559946525|FG001|Overall Study|could not find vein to administer IV|1|||
155140731|NCT04034004|559946526|FG002|Overall Study|could not find vein to administer IV|0|||
155140732|NCT04034004|559946527|FG003|Overall Study|could not find vein to administer IV|0|||
155140733|NCT04034004|559946524|FG000|Overall Study|nurse accidentally unblinded subject|0|||
155140734|NCT04034004|559946525|FG001|Overall Study|nurse accidentally unblinded subject|0|||
155140735|NCT04034004|559946526|FG002|Overall Study|nurse accidentally unblinded subject|0|||
155140736|NCT04034004|559946527|FG003|Overall Study|nurse accidentally unblinded subject|1|||
155140737|NCT04317040|559946528|FG000|Overall Study|Lost to Follow-up|2|||
155140738|NCT04317040|559946529|FG001|Overall Study|Lost to Follow-up|0|||
155140739|NCT04317040|559946528|FG000|Overall Study|Death|16|||
155140740|NCT04317040|559946529|FG001|Overall Study|Death|18|||
155140741|NCT04317040|559946528|FG000|Overall Study|Withdrawal by Subject|0|||
155140742|NCT04317040|559946529|FG001|Overall Study|Withdrawal by Subject|1|||
155140743|NCT04317040|559946528|FG000|Overall Study|Incomplete assessments|0|||
155140744|NCT04317040|559946529|FG001|Overall Study|Incomplete assessments|1|||
155140745|NCT02518971|559946530|FG000|Overall Study|Lost to Follow-up|0|||
155140746|NCT02518971|559946531|FG001|Overall Study|Lost to Follow-up|1|||
155140747|NCT02518971|559946530|FG000|Overall Study|Physician Decision|6|||
155140748|NCT02518971|559946531|FG001|Overall Study|Physician Decision|6|||
155140749|NCT02518971|559946530|FG000|Overall Study|Protocol Violation|6|||
155140750|NCT02518971|559946531|FG001|Overall Study|Protocol Violation|4|||
155140751|NCT02518971|559946530|FG000|Overall Study|Withdrawal by Subject|4|||
155140752|NCT02518971|559946531|FG001|Overall Study|Withdrawal by Subject|5|||
155140753|NCT02518971|559946530|FG000|Overall Study|Side effects|1|||
155140754|NCT02518971|559946531|FG001|Overall Study|Side effects|0|||
155140755|NCT02518971|559946530|FG000|Overall Study|medication lost in mail|0|||
155140756|NCT02518971|559946531|FG001|Overall Study|medication lost in mail|1|||
155140757|NCT02518971|559946530|FG000|Overall Study|eligibility criteria no longer met|6|||
155140758|NCT02518971|559946531|FG001|Overall Study|eligibility criteria no longer met|3|||
155140759|NCT00757237|559946532|FG000|Overall Study|Lost to Follow-up|0|||
155140760|NCT00757237|559946533|FG001|Overall Study|Lost to Follow-up|1|||
155140761|NCT00757237|559946532|FG000|Overall Study|Protocol Violation|0|||
155140762|NCT00757237|559946533|FG001|Overall Study|Protocol Violation|2|||
155140763|NCT00757237|559946532|FG000|Overall Study|Physician Decision|2|||
155140764|NCT00757237|559946533|FG001|Overall Study|Physician Decision|3|||
155140765|NCT00757237|559946532|FG000|Overall Study|Withdrawal by Subject|8|||
155140766|NCT00757237|559946533|FG001|Overall Study|Withdrawal by Subject|12|||
155140767|NCT00757237|559946532|FG000|Overall Study|Safety or Tolerability|3|||
155140768|NCT00757237|559946533|FG001|Overall Study|Safety or Tolerability|5|||
155140769|NCT00757237|559946532|FG000|Overall Study|Other|0|||
155140770|NCT00757237|559946533|FG001|Overall Study|Other|2|||
155140771|NCT05150990|559946534|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
155140772|NCT05150990|559946535|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
155140773|NCT05150990|559946534|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
155140774|NCT05150990|559946535|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
155140775|NCT05150990|559946534|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
155140776|NCT05150990|559946535|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
155140777|NCT05150990|559946534|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
155140778|NCT05150990|559946535|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
155140779|NCT05150990|559946534|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
155140780|NCT05150990|559946535|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
155140781|NCT05150990|559946534|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
155140782|NCT05150990|559946535|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
155140783|NCT05150990|559946534|FG000|Overall Study|Death (unrelated to the intervention)|1|||
155140784|NCT05150990|559946535|FG001|Overall Study|Death (unrelated to the intervention)|2|||
155140785|NCT01397461|559946537|FG000|Overall Study|Withdrawal by Subject|2|||
155140786|NCT01397461|559946538|FG001|Overall Study|Withdrawal by Subject|1|||
155140787|NCT01397461|559946539|FG002|Overall Study|Withdrawal by Subject|0|||
155140788|NCT01397461|559946537|FG000|Overall Study|Lost to Follow-up|0|||
155140789|NCT01397461|559946538|FG001|Overall Study|Lost to Follow-up|2|||
155140790|NCT01397461|559946539|FG002|Overall Study|Lost to Follow-up|1|||
155140791|NCT01397461|559946537|FG000|Overall Study|Lack of Efficacy|0|||
155140792|NCT01397461|559946538|FG001|Overall Study|Lack of Efficacy|3|||
155140793|NCT01397461|559946539|FG002|Overall Study|Lack of Efficacy|0|||
155140794|NCT01397461|559946537|FG000|Overall Study|Not treated|0|||
155140795|NCT01397461|559946538|FG001|Overall Study|Not treated|0|||
155140796|NCT01397461|559946539|FG002|Overall Study|Not treated|1|||
155140797|NCT04980612|559946556|FG000|Overall Study|Withdrawal by Subject|7|||
155140798|NCT04980612|559946557|FG001|Overall Study|Withdrawal by Subject|5|||
155140799|NCT01502228|559946558|FG000|Overall Study|Death|1|||
155140800|NCT05730387|559946559|FG000|Overall Study|Stillbirth|0|||
155140801|NCT05730387|559946560|FG001|Overall Study|Stillbirth|262|||
155140802|NCT05730387|559946559|FG000|Overall Study|Died during or after delivery|2|||
155140803|NCT05730387|559946560|FG001|Overall Study|Died during or after delivery|85|||
155140804|NCT05730387|559946559|FG000|Overall Study|Died after being admitted|0|||
155140805|NCT05730387|559946560|FG001|Overall Study|Died after being admitted|44|||
155182812|NCT00400153|560106745|FG000|Overall Study|Protocol Violation|7|||
155182813|NCT00400153|560106746|FG001|Overall Study|Protocol Violation|4|||
155182814|NCT00400153|560106747|FG002|Overall Study|Protocol Violation|9|||
155182815|NCT00400153|560106745|FG000|Overall Study|Lost to Follow-up|2|||
155182816|NCT00400153|560106746|FG001|Overall Study|Lost to Follow-up|1|||
155182817|NCT00400153|560106747|FG002|Overall Study|Lost to Follow-up|4|||
155182818|NCT00400153|560106745|FG000|Overall Study|Withdrawal by Subject|12|||
155182819|NCT00400153|560106746|FG001|Overall Study|Withdrawal by Subject|11|||
155182820|NCT00400153|560106747|FG002|Overall Study|Withdrawal by Subject|10|||
155182821|NCT00400153|560106745|FG000|Overall Study|Other reasons - not mentioned above|8|||
155182822|NCT00400153|560106746|FG001|Overall Study|Other reasons - not mentioned above|5|||
155182823|NCT00400153|560106747|FG002|Overall Study|Other reasons - not mentioned above|3|||
155182824|NCT01423604|560106749|FG000|Safety Run-In|Adverse Event|3|||
155182825|NCT01423604|560106750|FG001|Safety Run-In|Adverse Event|0|||
155182826|NCT01423604|560106749|FG000|Safety Run-In|Death|1|||
155182827|NCT01423604|560106750|FG001|Safety Run-In|Death|0|||
155182828|NCT01423604|560106749|FG000|Safety Run-In|Physician Decision|1|||
155182829|NCT01423604|560106750|FG001|Safety Run-In|Physician Decision|0|||
155182830|NCT01423604|560106749|FG000|Safety Run-In|Disease progression|3|||
155182831|NCT01423604|560106750|FG001|Safety Run-In|Disease progression|0|||
155182832|NCT01423604|560106749|FG000|Safety Run-In|Patient decision|1|||
155182833|NCT01423604|560106750|FG001|Safety Run-In|Patient decision|0|||
155182834|NCT01423604|560106749|FG000|Randomized|Adverse Event|4|||
155182835|NCT01423604|560106750|FG001|Randomized|Adverse Event|10|||
155182836|NCT01423604|560106749|FG000|Randomized|Death|1|||
155182837|NCT01423604|560106750|FG001|Randomized|Death|0|||
155182838|NCT01423604|560106749|FG000|Randomized|Physician Decision|16|||
155182839|NCT01423604|560106750|FG001|Randomized|Physician Decision|13|||
155182840|NCT01423604|560106749|FG000|Randomized|Other - unspecified|37|||
155182841|NCT01423604|560106750|FG001|Randomized|Other - unspecified|31|||
155182842|NCT01423604|560106749|FG000|Randomized|Patient decision|5|||
155182843|NCT01423604|560106750|FG001|Randomized|Patient decision|9|||
155182844|NCT02290431|560106751|FG000|Overall Study|Adverse Event|20|||
155182845|NCT02290431|560106751|FG000|Overall Study|Progressive disease|4|||
155182846|NCT02290431|560106751|FG000|Overall Study|Study terminated by Sponsor|1|||
155182847|NCT02290431|560106751|FG000|Overall Study|Physician Decision|2|||
155182848|NCT03324581|560106753|FG000|Overall Study|Adverse Event|18|||
155182849|NCT03324581|560106754|FG001|Overall Study|Adverse Event|11|||
155182850|NCT03324581|560106755|FG002|Overall Study|Adverse Event|7|||
155182851|NCT03324581|560106753|FG000|Overall Study|Lack of Efficacy|0|||
155182852|NCT03324581|560106754|FG001|Overall Study|Lack of Efficacy|1|||
155182853|NCT03324581|560106755|FG002|Overall Study|Lack of Efficacy|0|||
155182854|NCT03324581|560106753|FG000|Overall Study|Lost to Follow-up|5|||
155182855|NCT03324581|560106754|FG001|Overall Study|Lost to Follow-up|3|||
155182856|NCT03324581|560106755|FG002|Overall Study|Lost to Follow-up|6|||
155182857|NCT03324581|560106753|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
155182858|NCT03324581|560106754|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
155182859|NCT03324581|560106755|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
155182860|NCT03324581|560106753|FG000|Overall Study|Physician Decision|0|||
155182861|NCT03324581|560106754|FG001|Overall Study|Physician Decision|1|||
155182862|NCT03324581|560106755|FG002|Overall Study|Physician Decision|2|||
155182863|NCT03324581|560106753|FG000|Overall Study|Protocol Deviation|8|||
155182864|NCT03324581|560106754|FG001|Overall Study|Protocol Deviation|9|||
155182865|NCT03324581|560106755|FG002|Overall Study|Protocol Deviation|4|||
155182866|NCT03324581|560106753|FG000|Overall Study|Withdrawal by Subject|6|||
155182867|NCT03324581|560106754|FG001|Overall Study|Withdrawal by Subject|8|||
155182868|NCT03324581|560106755|FG002|Overall Study|Withdrawal by Subject|6|||
155182869|NCT03324581|560106753|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
155182870|NCT03324581|560106754|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
155182871|NCT03324581|560106755|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
155182872|NCT00321893|560106756|FG000|Overall Study|Non-Compliance/Refusal|16|||
155182873|NCT00321893|560106757|FG001|Overall Study|Non-Compliance/Refusal|10|||
155031234|NCT01054300|559540833|FG002|Period 2|Withdrawal by Subject|1|||
155031235|NCT01054300|559540834|FG003|Period 2|Withdrawal by Subject|0|||
155031236|NCT00738881|559540840|FG000|Overall Study|Withdrawal by Subject|0|||
155182874|NCT00321893|560106756|FG000|Overall Study|Lost to Follow-up|2|||
155182875|NCT00321893|560106757|FG001|Overall Study|Lost to Follow-up|1|||
155182876|NCT00321893|560106756|FG000|Overall Study|Adverse Event|6|||
155182877|NCT00321893|560106757|FG001|Overall Study|Adverse Event|3|||
155182878|NCT03455764|560106758|FG000|Overall Study|Adverse Event|1|||
155182879|NCT03455764|560106759|FG001|Overall Study|Adverse Event|0|||
155031237|NCT00738881|559540841|FG001|Overall Study|Withdrawal by Subject|2|||
155182880|NCT03455764|560106760|FG002|Overall Study|Adverse Event|0|||
155182881|NCT03455764|560106761|FG003|Overall Study|Adverse Event|0|||
155182882|NCT03455764|560106762|FG004|Overall Study|Adverse Event|0|||
155182883|NCT03455764|560106758|FG000|Overall Study|Disease Progression|4|||
155182884|NCT03455764|560106759|FG001|Overall Study|Disease Progression|0|||
155182885|NCT03455764|560106760|FG002|Overall Study|Disease Progression|0|||
155031238|NCT02062944|559540844|FG000|Overall Study|Lost to Follow-up|1|||
155182886|NCT03455764|560106761|FG003|Overall Study|Disease Progression|0|||
155182887|NCT03455764|560106762|FG004|Overall Study|Disease Progression|0|||
155182888|NCT03455764|560106758|FG000|Overall Study|On Treatment|1|||
155182889|NCT03455764|560106759|FG001|Overall Study|On Treatment|0|||
155182890|NCT03455764|560106760|FG002|Overall Study|On Treatment|0|||
155182891|NCT03455764|560106761|FG003|Overall Study|On Treatment|0|||
155182892|NCT03455764|560106762|FG004|Overall Study|On Treatment|0|||
155182893|NCT01585584|560106763|FG000|Overall Study|Lack of Efficacy|1|||
155182894|NCT01585584|560106763|FG000|Overall Study|Withdrawal by Subject|1|||
155182895|NCT01585584|560106763|FG000|Overall Study|Physician Decision|2|||
155182896|NCT04854642|560108358|FG000|Overall Study|Adverse Event|1|||
155182897|NCT04854642|560108359|FG001|Overall Study|Adverse Event|2|||
155182898|NCT04854642|560108358|FG000|Overall Study|Withdrawal by Subject|0|||
155182899|NCT04854642|560108359|FG001|Overall Study|Withdrawal by Subject|1|||
155182900|NCT03052764|560108361|FG000|Double-Blind Treatment Period|Adverse Event|2|||
155182901|NCT03052764|560108362|FG001|Double-Blind Treatment Period|Adverse Event|0|||
155182902|NCT03052764|560108361|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
155182903|NCT03052764|560108362|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
155182904|NCT03052764|560108361|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
155182905|NCT03052764|560108362|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
155182906|NCT03052764|560108361|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
155182907|NCT03052764|560108362|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155182908|NCT03052764|560108361|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
155182909|NCT03052764|560108362|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
155182910|NCT01314911|560108363|FG000|Overall Study|Lost to Follow-up|3|||
155182911|NCT01314911|560108364|FG001|Overall Study|Lost to Follow-up|2|||
155182912|NCT01314911|560108363|FG000|Overall Study|Withdrawal by Subject|1|||
155182913|NCT01314911|560108364|FG001|Overall Study|Withdrawal by Subject|3|||
155182914|NCT01314911|560108363|FG000|Overall Study|Received Non-randomized Study Drug|0|||
155182915|NCT01314911|560108364|FG001|Overall Study|Received Non-randomized Study Drug|1|||
155182916|NCT01314911|560108363|FG000|Overall Study|Never Started Treatment|1|||
155182917|NCT01314911|560108364|FG001|Overall Study|Never Started Treatment|0|||
155182918|NCT02395016|560108368|FG000|Overall Study|Adverse Event|4|||
155182919|NCT02395016|560108369|FG001|Overall Study|Adverse Event|3|||
155182920|NCT02395016|560108368|FG000|Overall Study|Withdrawal by Subject|9|||
155182921|NCT02395016|560108369|FG001|Overall Study|Withdrawal by Subject|6|||
155182922|NCT02395016|560108368|FG000|Overall Study|Protocol Violation|2|||
155182923|NCT02395016|560108369|FG001|Overall Study|Protocol Violation|3|||
155182924|NCT01739400|560108371|FG000|Overall Study|Physician Decision|3|||
155182925|NCT01739400|560108372|FG001|Overall Study|Physician Decision|0|||
155182926|NCT01739400|560108371|FG000|Overall Study|Lost to Follow-up|2|||
155182927|NCT01739400|560108372|FG001|Overall Study|Lost to Follow-up|0|||
155182928|NCT01739400|560108371|FG000|Overall Study|Death|5|||
155182929|NCT01739400|560108372|FG001|Overall Study|Death|2|||
155182930|NCT01739400|560108371|FG000|Overall Study|Withdrawal by Subject|7|||
155182931|NCT01739400|560108372|FG001|Overall Study|Withdrawal by Subject|7|||
155182932|NCT00642473|560108381|FG000|Overall Study|Withdrawal by Subject|0|||
155182933|NCT00642473|560108382|FG001|Overall Study|Withdrawal by Subject|5|||
155182934|NCT00642473|560108381|FG000|Overall Study|Progression or death|2|||
155182935|NCT00642473|560108382|FG001|Overall Study|Progression or death|4|||
155182936|NCT00642473|560108381|FG000|Overall Study|Other|2|||
155182937|NCT00642473|560108382|FG001|Overall Study|Other|2|||
155182938|NCT00478881|560108386|FG000|Overall Study|Adverse Event|31|||
155182939|NCT00478881|560108387|FG001|Overall Study|Adverse Event|12|||
155182940|NCT00478881|560108386|FG000|Overall Study|Lack of Efficacy|0|||
155182941|NCT00478881|560108387|FG001|Overall Study|Lack of Efficacy|3|||
155182942|NCT00478881|560108386|FG000|Overall Study|Lost to Follow-up|0|||
155182943|NCT00478881|560108387|FG001|Overall Study|Lost to Follow-up|1|||
155182944|NCT00478881|560108386|FG000|Overall Study|Protocol Violation|2|||
155182945|NCT00478881|560108387|FG001|Overall Study|Protocol Violation|2|||
155182946|NCT00478881|560108386|FG000|Overall Study|Withdrawal by Subject|6|||
155182947|NCT00478881|560108387|FG001|Overall Study|Withdrawal by Subject|2|||
155182948|NCT00478881|560108386|FG000|Overall Study|Non-Compliance with Study Medication|0|||
155182949|NCT00478881|560108387|FG001|Overall Study|Non-Compliance with Study Medication|2|||
155182950|NCT03410823|560108388|FG000|Overall Study|Death|1|||
155182951|NCT03410823|560108388|FG000|Overall Study|Withdrawal by Subject|2|||
155182952|NCT03410823|560108388|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
155182953|NCT05007717|560108390|FG000|Overall Study|Death|3|||
155182954|NCT05007717|560108391|FG001|Overall Study|Death|2|||
155182955|NCT04565236|560108392|FG000|Overall Study|Patient/Guardian Decision|0|||
155182956|NCT04565236|560108393|FG001|Overall Study|Patient/Guardian Decision|0|||
155182957|NCT04565236|560108394|FG002|Overall Study|Patient/Guardian Decision|1|||
155182958|NCT04565236|560108395|FG003|Overall Study|Patient/Guardian Decision|0|||
155182959|NCT00740246|560108396|FG000|Overall Study|Received Blood Transfusion|0|||
155182960|NCT00740246|560108397|FG001|Overall Study|Received Blood Transfusion|1|||
155182961|NCT00740246|560108396|FG000|Overall Study|Adverse Event|1|||
155182962|NCT00740246|560108397|FG001|Overall Study|Adverse Event|2|||
155031239|NCT02062944|559540844|FG000|Overall Study|New hemotological disorder identified|1|||
155031240|NCT02062944|559540844|FG000|Overall Study|Uncontrolled Hypertension|1|||
155031241|NCT02062944|559540844|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
155031242|NCT02035748|559540845|FG000|Overall Study|Adverse Event|5|||
155031243|NCT02035748|559540845|FG000|Overall Study|Death|3|||
155031244|NCT02035748|559540845|FG000|Overall Study|Lost to Follow-up|2|||
155031245|NCT02035748|559540845|FG000|Overall Study|Physician Decision|3|||
155031246|NCT02035748|559540845|FG000|Overall Study|Withdrawal by Subject|6|||
155031247|NCT02035748|559540845|FG000|Overall Study|Progressive Disease|1|||
155031248|NCT00705718|559540846|FG000|Overall Study|Death|6|||
155031249|NCT00705718|559540847|FG001|Overall Study|Death|6|||
155140806|NCT05730387|559946559|FG000|Overall Study|Lost to Follow-up|69|||
155140807|NCT05730387|559946560|FG001|Overall Study|Lost to Follow-up|77|||
155140808|NCT02728089|559946561|FG000|Overall Study|Physician Decision|2|||
155140809|NCT02728089|559946561|FG000|Overall Study|Withdrawal by Subject|1|||
155140810|NCT01221350|559946564|FG000|Overall Study|Discontinued intervention (GERD)|1|||
155140811|NCT01221350|559946565|FG001|Overall Study|Discontinued intervention (GERD)|0|||
155140812|NCT01221350|559946564|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
155140813|NCT01221350|559946565|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
155140814|NCT01221350|559946564|FG000|Overall Study|Withdrawal by Subject|4|||
155140815|NCT01221350|559946565|FG001|Overall Study|Withdrawal by Subject|2|||
155140816|NCT05888181|559946567|FG000|Overall Study|Lost to Follow-up|1|||
155140817|NCT05888181|559946568|FG001|Overall Study|Lost to Follow-up|1|||
155140818|NCT05888181|559946569|FG002|Overall Study|Lost to Follow-up|0|||
155140819|NCT04137731|559946572|FG000|Overall Study|Surgery Cancellation|1|||
155140820|NCT04137731|559946573|FG001|Overall Study|Surgery Cancellation|2|||
155140821|NCT04137731|559946572|FG000|Overall Study|Withdrawal by Subject|2|||
155140822|NCT04137731|559946573|FG001|Overall Study|Withdrawal by Subject|0|||
155140823|NCT04137731|559946572|FG000|Overall Study|Protocol Violation|0|||
155140824|NCT04137731|559946573|FG001|Overall Study|Protocol Violation|1|||
155140825|NCT02204072|559946574|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
155140826|NCT02204072|559946575|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
155140827|NCT02204072|559946576|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
155140828|NCT02204072|559946577|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
155140829|NCT02204072|559946578|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
155140830|NCT02204072|559946574|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
155140831|NCT02204072|559946575|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
155140832|NCT02204072|559946576|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
155140833|NCT02204072|559946577|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
155140834|NCT02204072|559946578|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
155140835|NCT02204072|559946574|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
155140836|NCT02204072|559946575|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
155140837|NCT02204072|559946576|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
155140838|NCT02204072|559946577|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
155140839|NCT02204072|559946578|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
155140840|NCT02204072|559946574|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155140841|NCT02204072|559946575|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155140842|NCT02204072|559946576|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
155140843|NCT02204072|559946577|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155140844|NCT02204072|559946578|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
155140845|NCT03983304|559946579|FG000|Overall Study|Withdrawal by Subject|5|||
155140846|NCT03983304|559946579|FG000|Overall Study|Lost to Follow-up|2|||
155140847|NCT01587040|559946580|FG000|Overall Study|Protocol Violation|0|||
155140848|NCT01587040|559946581|FG001|Overall Study|Protocol Violation|0|||
155140849|NCT01587040|559946582|FG002|Overall Study|Protocol Violation|1|||
155140850|NCT01587040|559946583|FG003|Overall Study|Protocol Violation|0|||
155140851|NCT01587040|559946580|FG000|Overall Study|Adverse Event|0|||
155140852|NCT01587040|559946581|FG001|Overall Study|Adverse Event|1|||
155140853|NCT01587040|559946582|FG002|Overall Study|Adverse Event|10|||
155140854|NCT01587040|559946583|FG003|Overall Study|Adverse Event|0|||
155140855|NCT01587040|559946580|FG000|Overall Study|Disease progression|12|||
155140856|NCT01587040|559946581|FG001|Overall Study|Disease progression|1|||
155140857|NCT01587040|559946582|FG002|Overall Study|Disease progression|15|||
155140858|NCT01587040|559946583|FG003|Overall Study|Disease progression|3|||
155140859|NCT01587040|559946580|FG000|Overall Study|Other than specified|5|||
155140860|NCT01587040|559946581|FG001|Overall Study|Other than specified|1|||
155140861|NCT01587040|559946582|FG002|Overall Study|Other than specified|11|||
155140862|NCT01587040|559946583|FG003|Overall Study|Other than specified|1|||
155031250|NCT00705718|559540846|FG000|Overall Study|Not due for Visit|0|||
155031251|NCT00705718|559540847|FG001|Overall Study|Not due for Visit|12|||
155031252|NCT00705718|559540846|FG000|Overall Study|Follow up not done|1|||
155140863|NCT05236257|559946593|FG000|Overall Study|Ongoing with study treatment|29|||
155140864|NCT05236257|559946594|FG001|Overall Study|Ongoing with study treatment|1|||
155140865|NCT05236257|559946593|FG000|Overall Study|Discontinued study treatment|22|||
155140866|NCT05236257|559946594|FG001|Overall Study|Discontinued study treatment|41|||
155140867|NCT00048347|559946598|FG000|Overall Study|Screen failure|2|||
155140868|NCT02343406|559946599|FG000|Overall Study|Progressive disease|72|||
155140869|NCT02343406|559946600|FG001|Overall Study|Progressive disease|70|||
155140870|NCT02343406|559946601|FG002|Overall Study|Progressive disease|43|||
155140871|NCT02343406|559946602|FG003|Overall Study|Progressive disease|15|||
155140872|NCT02343406|559946603|FG004|Overall Study|Progressive disease|5|||
155140873|NCT02343406|559946599|FG000|Overall Study|Adverse Event|6|||
155140874|NCT02343406|559946600|FG001|Overall Study|Adverse Event|8|||
155140875|NCT02343406|559946601|FG002|Overall Study|Adverse Event|6|||
155140876|NCT02343406|559946602|FG003|Overall Study|Adverse Event|3|||
155140877|NCT02343406|559946603|FG004|Overall Study|Adverse Event|0|||
155140878|NCT02343406|559946599|FG000|Overall Study|Withdrawal by Subject|6|||
155140879|NCT02343406|559946600|FG001|Overall Study|Withdrawal by Subject|4|||
155140880|NCT02343406|559946601|FG002|Overall Study|Withdrawal by Subject|8|||
155140881|NCT02343406|559946602|FG003|Overall Study|Withdrawal by Subject|3|||
155140882|NCT02343406|559946603|FG004|Overall Study|Withdrawal by Subject|0|||
155140883|NCT02343406|559946599|FG000|Overall Study|Death|2|||
155140884|NCT02343406|559946600|FG001|Overall Study|Death|1|||
155140885|NCT02343406|559946601|FG002|Overall Study|Death|0|||
155140886|NCT02343406|559946602|FG003|Overall Study|Death|0|||
155140887|NCT02343406|559946603|FG004|Overall Study|Death|0|||
155140888|NCT02343406|559946599|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
155140889|NCT02343406|559946600|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
155140890|NCT02343406|559946601|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
155140891|NCT02343406|559946602|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
155140892|NCT02343406|559946603|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
155140893|NCT02343406|559946599|FG000|Overall Study|Other primary malignancy|0|||
155140894|NCT02343406|559946600|FG001|Overall Study|Other primary malignancy|1|||
155140895|NCT02343406|559946601|FG002|Overall Study|Other primary malignancy|0|||
155140896|NCT02343406|559946602|FG003|Overall Study|Other primary malignancy|0|||
155140897|NCT02343406|559946603|FG004|Overall Study|Other primary malignancy|0|||
155140898|NCT02343406|559946599|FG000|Overall Study|Other, not specified|2|||
155140899|NCT02343406|559946600|FG001|Overall Study|Other, not specified|1|||
155140900|NCT02343406|559946601|FG002|Overall Study|Other, not specified|1|||
155140901|NCT02343406|559946602|FG003|Overall Study|Other, not specified|4|||
155140902|NCT02343406|559946603|FG004|Overall Study|Other, not specified|0|||
155140903|NCT03508609|559946605|FG000|Overall Study|Withdrawal by Subject|1|||
155140904|NCT00999518|559946606|FG000|Overall Study|Adverse Event|1|||
155140905|NCT00999518|559946607|FG001|Overall Study|Adverse Event|6|||
155140906|NCT00999518|559946608|FG002|Overall Study|Adverse Event|3|||
155140907|NCT00999518|559946609|FG003|Overall Study|Adverse Event|1|||
155140908|NCT00999518|559946610|FG004|Overall Study|Adverse Event|2|||
155140909|NCT00999518|559946606|FG000|Overall Study|Lack of Efficacy|2|||
155140910|NCT00999518|559946607|FG001|Overall Study|Lack of Efficacy|0|||
155140911|NCT00999518|559946608|FG002|Overall Study|Lack of Efficacy|0|||
155140912|NCT00999518|559946609|FG003|Overall Study|Lack of Efficacy|2|||
155140913|NCT00999518|559946610|FG004|Overall Study|Lack of Efficacy|2|||
155140914|NCT00999518|559946606|FG000|Overall Study|Lost to Follow-up|0|||
155140915|NCT00999518|559946607|FG001|Overall Study|Lost to Follow-up|0|||
155140916|NCT00999518|559946608|FG002|Overall Study|Lost to Follow-up|0|||
155140917|NCT00999518|559946609|FG003|Overall Study|Lost to Follow-up|4|||
155140918|NCT00999518|559946610|FG004|Overall Study|Lost to Follow-up|1|||
155140919|NCT00999518|559946606|FG000|Overall Study|Did not meet entrance criteria|0|||
155140920|NCT00999518|559946607|FG001|Overall Study|Did not meet entrance criteria|0|||
155140921|NCT00999518|559946608|FG002|Overall Study|Did not meet entrance criteria|0|||
155140922|NCT00999518|559946609|FG003|Overall Study|Did not meet entrance criteria|0|||
155140923|NCT00999518|559946610|FG004|Overall Study|Did not meet entrance criteria|1|||
155140924|NCT00999518|559946606|FG000|Overall Study|Study terminated by sponsor|10|||
155140925|NCT00999518|559946607|FG001|Overall Study|Study terminated by sponsor|6|||
155140926|NCT00999518|559946608|FG002|Overall Study|Study terminated by sponsor|5|||
155140927|NCT00999518|559946609|FG003|Overall Study|Study terminated by sponsor|5|||
155140928|NCT00999518|559946610|FG004|Overall Study|Study terminated by sponsor|9|||
155140929|NCT00999518|559946606|FG000|Overall Study|Pregnancy|0|||
155140930|NCT00999518|559946607|FG001|Overall Study|Pregnancy|0|||
155140931|NCT00999518|559946608|FG002|Overall Study|Pregnancy|1|||
155140932|NCT00999518|559946609|FG003|Overall Study|Pregnancy|0|||
155140933|NCT00999518|559946610|FG004|Overall Study|Pregnancy|0|||
155140934|NCT00999518|559946606|FG000|Overall Study|Protocol Violation|0|||
155140935|NCT00999518|559946607|FG001|Overall Study|Protocol Violation|1|||
155140936|NCT00999518|559946608|FG002|Overall Study|Protocol Violation|0|||
155140937|NCT00999518|559946609|FG003|Overall Study|Protocol Violation|0|||
155140938|NCT00999518|559946610|FG004|Overall Study|Protocol Violation|2|||
155140939|NCT00999518|559946606|FG000|Overall Study|Withdrawal by Subject|5|||
155140940|NCT00999518|559946607|FG001|Overall Study|Withdrawal by Subject|4|||
155182963|NCT00740246|560108396|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
155182964|NCT00740246|560108397|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
155182965|NCT00740246|560108396|FG000|Overall Study|Lost to Follow-up|2|||
155182966|NCT00740246|560108397|FG001|Overall Study|Lost to Follow-up|2|||
155182967|NCT00740246|560108396|FG000|Overall Study|Withdrawal by Subject|4|||
155182968|NCT00740246|560108397|FG001|Overall Study|Withdrawal by Subject|3|||
155182969|NCT00740246|560108396|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
155182970|NCT00740246|560108397|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
155182971|NCT00740246|560108396|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
155182972|NCT00740246|560108397|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
155182973|NCT00740246|560108396|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
155182974|NCT00740246|560108397|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
155182975|NCT00740246|560108396|FG000|Overall Study|Unable To Comply With Study Visits|2|||
155182976|NCT00740246|560108397|FG001|Overall Study|Unable To Comply With Study Visits|0|||
155182977|NCT00740246|560108396|FG000|Overall Study|Unable to Access Vein|0|||
155182978|NCT00740246|560108397|FG001|Overall Study|Unable to Access Vein|2|||
155182979|NCT00740246|560108396|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
155182980|NCT00740246|560108397|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
155182981|NCT01041495|560108398|FG000|Overall Study|Withdrawal by Subject|2|||
155182982|NCT01041495|560108399|FG001|Overall Study|Withdrawal by Subject|5|||
155182983|NCT01041495|560108398|FG000|Overall Study|Adverse Event|2|||
155182984|NCT01041495|560108399|FG001|Overall Study|Adverse Event|1|||
155182985|NCT01041495|560108398|FG000|Overall Study|Lost to Follow-up|0|||
155182986|NCT01041495|560108399|FG001|Overall Study|Lost to Follow-up|1|||
155182987|NCT03584373|560108400|FG000|Overall Study|Lost to Follow-up|7|||
155182988|NCT03584373|560108401|FG001|Overall Study|Lost to Follow-up|8|||
155182989|NCT03780400|560108403|FG000|Overall Study|Lost to Follow-up|5|||
155182990|NCT03780400|560108403|FG000|Overall Study|Withdrawal by Subject|2|||
155182991|NCT00662532|560108404|FG000|Overall Study|Adverse Event|0|||
155182992|NCT00662532|560108405|FG001|Overall Study|Adverse Event|1|||
155182993|NCT00662532|560108404|FG000|Overall Study|Lost to Follow-up|0|||
155182994|NCT00662532|560108405|FG001|Overall Study|Lost to Follow-up|1|||
155182995|NCT01850602|560108406|FG000|Overall Study|Adverse Event|7|||
155182996|NCT01850602|560108407|FG001|Overall Study|Adverse Event|10|||
155182997|NCT01850602|560108406|FG000|Overall Study|Physician Decision|2|||
155182998|NCT01850602|560108407|FG001|Overall Study|Physician Decision|1|||
155182999|NCT01850602|560108406|FG000|Overall Study|Withdrawal by Subject|2|||
155183000|NCT01850602|560108407|FG001|Overall Study|Withdrawal by Subject|4|||
155183001|NCT01850602|560108406|FG000|Overall Study|Decrease in serum calcium|2|||
155183002|NCT01850602|560108407|FG001|Overall Study|Decrease in serum calcium|3|||
155183003|NCT01850602|560108406|FG000|Overall Study|Increase in serum ferritin|1|||
155183004|NCT01850602|560108407|FG001|Overall Study|Increase in serum ferritin|0|||
155183005|NCT00366340|560108408|FG000|Infant Series|Protocol Violation|3|||
155183006|NCT00366340|560108409|FG001|Infant Series|Protocol Violation|4|||
155183007|NCT00366340|560108408|FG000|Infant Series|Withdrawal by Subject|3|||
155183008|NCT00366340|560108409|FG001|Infant Series|Withdrawal by Subject|3|||
155183009|NCT00366340|560108408|FG000|Infant Series|Adverse Event|0|||
155183010|NCT00366340|560108409|FG001|Infant Series|Adverse Event|2|||
155183011|NCT00366340|560108408|FG000|Infant Series|Lost to Follow-up|1|||
155183012|NCT00366340|560108409|FG001|Infant Series|Lost to Follow-up|1|||
155183013|NCT00366340|560108408|FG000|Infant Series|Failure to return|1|||
155183014|NCT00366340|560108409|FG001|Infant Series|Failure to return|0|||
155183015|NCT00366340|560108408|FG000|After the Infant Series|Parent/legal guardian request|1|||
155183016|NCT00366340|560108409|FG001|After the Infant Series|Parent/legal guardian request|1|||
155183017|NCT00366340|560108408|FG000|After the Infant Series|Failed to return|0|||
155183018|NCT00366340|560108409|FG001|After the Infant Series|Failed to return|1|||
155183019|NCT00366340|560108408|FG000|After the Infant Series|Protocol Violation|2|||
155183020|NCT00366340|560108409|FG001|After the Infant Series|Protocol Violation|2|||
155183021|NCT00366340|560108408|FG000|After the Infant Series|Adverse Event|0|||
155031253|NCT00705718|559540847|FG001|Overall Study|Follow up not done|4|||
155183022|NCT00366340|560108409|FG001|After the Infant Series|Adverse Event|1|||
155183023|NCT00366340|560108408|FG000|After the Infant Series|Lost to Follow-up|0|||
155183024|NCT00366340|560108409|FG001|After the Infant Series|Lost to Follow-up|1|||
155183025|NCT00366340|560108408|FG000|Toddler Dose|Failed to return|1|||
155183026|NCT00366340|560108409|FG001|Toddler Dose|Failed to return|0|||
155183027|NCT00366340|560108408|FG000|Toddler Dose|Parent/legal guardian request|0|||
155183028|NCT00366340|560108409|FG001|Toddler Dose|Parent/legal guardian request|1|||
155183029|NCT00442468|560108413|FG000|Overall Study|Adverse Event|4|||
155183030|NCT00442468|560108413|FG000|Overall Study|Withdrawal by Subject|91|||
155183031|NCT00442468|560108413|FG000|Overall Study|Did not complete all study procedures|88|||
155183032|NCT00589784|560108414|FG000|Overall Study|Withdrawal by Subject|0|||
155183033|NCT00589784|560108415|FG001|Overall Study|Withdrawal by Subject|6|||
155183034|NCT00589784|560108414|FG000|Overall Study|Patient inevaluable|1|||
155031254|NCT01258075|559540848|FG000|Overall Study|Adverse Event|8|||
155183035|NCT00589784|560108415|FG001|Overall Study|Patient inevaluable|0|||
155183036|NCT00589784|560108414|FG000|Overall Study|Adverse Event|0|||
155183037|NCT00589784|560108415|FG001|Overall Study|Adverse Event|4|||
155183038|NCT00287079|560108417|FG000|Overall Study|Qualifying relapse|12|||
155183039|NCT00287079|560108418|FG001|Overall Study|Qualifying relapse|1|||
155183040|NCT00287079|560108417|FG000|Overall Study|Non-qualifying relapse|1|||
155183041|NCT00287079|560108418|FG001|Overall Study|Non-qualifying relapse|0|||
155183042|NCT00287079|560108417|FG000|Overall Study|Adverse Event|5|||
155183043|NCT00287079|560108418|FG001|Overall Study|Adverse Event|0|||
155183044|NCT00287079|560108417|FG000|Overall Study|Protocol Violation|1|||
155183045|NCT00287079|560108418|FG001|Overall Study|Protocol Violation|0|||
155183046|NCT00287079|560108417|FG000|Overall Study|Other|3|||
155183047|NCT00287079|560108418|FG001|Overall Study|Other|0|||
155183048|NCT00470184|560108419|FG000|Overall Study|Not Treated(became ineligible)|4|||
155183049|NCT00470184|560108419|FG000|Overall Study|Not treated (other)|1|||
155183050|NCT00470184|560108419|FG000|Overall Study|disease Progression|4|||
155183051|NCT00470184|560108419|FG000|Overall Study|Adverse Event|3|||
155183052|NCT00470184|560108419|FG000|Overall Study|Withdrawal by Subject|4|||
155183053|NCT00470184|560108419|FG000|Overall Study|other|5|||
155183054|NCT00470184|560108419|FG000|Overall Study|recurrence|1|||
155183055|NCT01001299|560108423|FG000|Overall Study|Insufficient Therapeutic Response|20|||
155031255|NCT01258075|559540849|FG001|Overall Study|Adverse Event|3|||
155031256|NCT01258075|559540848|FG000|Overall Study|Lost to Follow-up|11|||
155031257|NCT01258075|559540849|FG001|Overall Study|Lost to Follow-up|6|||
155031258|NCT01258075|559540848|FG000|Overall Study|Withdrawal by Subject|10|||
155031259|NCT01258075|559540849|FG001|Overall Study|Withdrawal by Subject|7|||
155031260|NCT01258075|559540848|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
155140941|NCT00999518|559946608|FG002|Overall Study|Withdrawal by Subject|10|||
155140942|NCT00999518|559946609|FG003|Overall Study|Withdrawal by Subject|6|||
155140943|NCT00999518|559946610|FG004|Overall Study|Withdrawal by Subject|1|||
155140944|NCT00999518|559946606|FG000|Overall Study|Other|5|||
155140945|NCT00999518|559946607|FG001|Overall Study|Other|7|||
155140946|NCT00999518|559946608|FG002|Overall Study|Other|1|||
155140947|NCT00999518|559946609|FG003|Overall Study|Other|4|||
155140948|NCT00999518|559946610|FG004|Overall Study|Other|5|||
155140949|NCT00999518|559946606|FG000|Overall Study|Randomized but not Treated|1|||
155140950|NCT00999518|559946607|FG001|Overall Study|Randomized but not Treated|1|||
155140951|NCT00999518|559946608|FG002|Overall Study|Randomized but not Treated|2|||
155140952|NCT00999518|559946609|FG003|Overall Study|Randomized but not Treated|0|||
155140953|NCT00999518|559946610|FG004|Overall Study|Randomized but not Treated|1|||
155140954|NCT01445080|559946616|FG000|Overall Study|Adverse Event|5|||
155140955|NCT01445080|559946617|FG001|Overall Study|Adverse Event|3|||
155140956|NCT01445080|559946618|FG002|Overall Study|Adverse Event|11|||
155140957|NCT01445080|559946619|FG003|Overall Study|Adverse Event|6|||
155140958|NCT01445080|559946620|FG004|Overall Study|Adverse Event|2|||
155140959|NCT01445080|559946621|FG005|Overall Study|Adverse Event|3|||
155140960|NCT01445080|559946622|FG006|Overall Study|Adverse Event|0|||
155140961|NCT01445080|559946623|FG007|Overall Study|Adverse Event|3|||
155140962|NCT01445080|559946624|FG008|Overall Study|Adverse Event|10|||
155140963|NCT01445080|559946616|FG000|Overall Study|Physician Decision|0|||
155140964|NCT01445080|559946617|FG001|Overall Study|Physician Decision|0|||
155140965|NCT01445080|559946618|FG002|Overall Study|Physician Decision|1|||
155140966|NCT01445080|559946619|FG003|Overall Study|Physician Decision|0|||
155140967|NCT01445080|559946620|FG004|Overall Study|Physician Decision|0|||
155140968|NCT01445080|559946621|FG005|Overall Study|Physician Decision|3|||
155140969|NCT01445080|559946622|FG006|Overall Study|Physician Decision|2|||
155140970|NCT01445080|559946623|FG007|Overall Study|Physician Decision|2|||
155140971|NCT01445080|559946624|FG008|Overall Study|Physician Decision|0|||
155140972|NCT01445080|559946616|FG000|Overall Study|Withdrawal by Subject|1|||
155140973|NCT01445080|559946617|FG001|Overall Study|Withdrawal by Subject|0|||
155140974|NCT01445080|559946618|FG002|Overall Study|Withdrawal by Subject|0|||
155140975|NCT01445080|559946619|FG003|Overall Study|Withdrawal by Subject|1|||
155140976|NCT01445080|559946620|FG004|Overall Study|Withdrawal by Subject|0|||
155140977|NCT01445080|559946621|FG005|Overall Study|Withdrawal by Subject|0|||
155140978|NCT01445080|559946622|FG006|Overall Study|Withdrawal by Subject|0|||
155140979|NCT01445080|559946623|FG007|Overall Study|Withdrawal by Subject|0|||
155140980|NCT01445080|559946624|FG008|Overall Study|Withdrawal by Subject|2|||
155140981|NCT01445080|559946616|FG000|Overall Study|Ineligible/Inevaluable|1|||
155140982|NCT01445080|559946617|FG001|Overall Study|Ineligible/Inevaluable|2|||
155183056|NCT01001299|560108423|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
155183057|NCT01001299|560108423|FG000|Overall Study|Death|1|||
155031261|NCT01258075|559540849|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
155031262|NCT01258075|559540848|FG000|Overall Study|Other|12|||
155140983|NCT01445080|559946618|FG002|Overall Study|Ineligible/Inevaluable|0|||
155140984|NCT01445080|559946619|FG003|Overall Study|Ineligible/Inevaluable|1|||
155183058|NCT01001299|560108423|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
155031263|NCT01258075|559540849|FG001|Overall Study|Other|5|||
155031264|NCT00976209|559540850|FG000|Treatment Period 1|Protocol Violation|1|||
155140985|NCT01445080|559946620|FG004|Overall Study|Ineligible/Inevaluable|2|||
155140986|NCT01445080|559946621|FG005|Overall Study|Ineligible/Inevaluable|3|||
155140987|NCT01445080|559946622|FG006|Overall Study|Ineligible/Inevaluable|0|||
155140988|NCT01445080|559946623|FG007|Overall Study|Ineligible/Inevaluable|0|||
155140989|NCT01445080|559946624|FG008|Overall Study|Ineligible/Inevaluable|6|||
155140990|NCT01594931|559948348|FG000|Overall Study|Adverse Event|3|||
155140991|NCT01594931|559948349|FG001|Overall Study|Adverse Event|1|||
155140992|NCT01594931|559948350|FG002|Overall Study|Adverse Event|1|||
155140993|NCT01594931|559948348|FG000|Overall Study|Withdrawal by Subject|2|||
155140994|NCT01594931|559948349|FG001|Overall Study|Withdrawal by Subject|1|||
155140995|NCT01594931|559948350|FG002|Overall Study|Withdrawal by Subject|1|||
155140996|NCT01594931|559948348|FG000|Overall Study|Lack of Efficacy|7|||
155140997|NCT01594931|559948349|FG001|Overall Study|Lack of Efficacy|2|||
155140998|NCT01594931|559948350|FG002|Overall Study|Lack of Efficacy|2|||
155140999|NCT01594931|559948348|FG000|Overall Study|Lost to Follow-up|4|||
155141000|NCT01594931|559948349|FG001|Overall Study|Lost to Follow-up|3|||
155141001|NCT01594931|559948350|FG002|Overall Study|Lost to Follow-up|3|||
155141002|NCT01594931|559948348|FG000|Overall Study|Protocol Violation|2|||
155141003|NCT01594931|559948349|FG001|Overall Study|Protocol Violation|1|||
155141004|NCT01594931|559948350|FG002|Overall Study|Protocol Violation|0|||
155141005|NCT01594931|559948348|FG000|Overall Study|No defiined|11|||
155141006|NCT01594931|559948349|FG001|Overall Study|No defiined|4|||
155141007|NCT01594931|559948350|FG002|Overall Study|No defiined|7|||
155141008|NCT02451943|559948356|FG000|Overall Study|Withdrawal by Subject|13|||
155141009|NCT02451943|559948357|FG001|Overall Study|Withdrawal by Subject|16|||
155141010|NCT02451943|559948356|FG000|Overall Study|Lost to Follow-up|3|||
155141011|NCT02451943|559948357|FG001|Overall Study|Lost to Follow-up|4|||
155141012|NCT02451943|559948356|FG000|Overall Study|Sponsor Decision|0|||
155141013|NCT02451943|559948357|FG001|Overall Study|Sponsor Decision|4|||
155141014|NCT00922623|559948359|FG000|Overall Study|Other|4|||
155141015|NCT00922623|559948359|FG000|Overall Study|Lost to Follow-up|1|||
155141016|NCT01410890|559948363|FG000|Overall Study|Withdrawal by Subject|0|||
155141017|NCT01410890|559948364|FG001|Overall Study|Withdrawal by Subject|1|||
155141018|NCT00217425|559948365|FG000|Overall Study|Never started treatment|2|||
155141019|NCT00217425|559948365|FG000|Overall Study|Patient ineligible|5|||
155141020|NCT00217425|559948365|FG000|Overall Study|Lack of Efficacy|13|||
155141021|NCT00217425|559948365|FG000|Overall Study|Adverse Event|8|||
155141022|NCT00217425|559948365|FG000|Overall Study|Withdrawal by Subject|4|||
155141023|NCT00217425|559948365|FG000|Overall Study|Other complicating disease|1|||
155141024|NCT00217425|559948365|FG000|Overall Study|Other|4|||
155141025|NCT00671034|559948366|FG000|Overall Study|Adverse Event|5|||
155141026|NCT00671034|559948367|FG001|Overall Study|Adverse Event|7|||
155141027|NCT00671034|559948368|FG002|Overall Study|Adverse Event|1|||
155141028|NCT00671034|559948366|FG000|Overall Study|Death|3|||
155141029|NCT00671034|559948367|FG001|Overall Study|Death|2|||
155141030|NCT00671034|559948368|FG002|Overall Study|Death|1|||
155141031|NCT00671034|559948366|FG000|Overall Study|Physician Decision|12|||
155141032|NCT00671034|559948367|FG001|Overall Study|Physician Decision|4|||
155141033|NCT00671034|559948368|FG002|Overall Study|Physician Decision|5|||
155141034|NCT00671034|559948366|FG000|Overall Study|VHR ALL feature|8|||
155141035|NCT00671034|559948367|FG001|Overall Study|VHR ALL feature|3|||
155141036|NCT00671034|559948368|FG002|Overall Study|VHR ALL feature|5|||
155141037|NCT00671034|559948366|FG000|Overall Study|Refusal|5|||
155141038|NCT00671034|559948367|FG001|Overall Study|Refusal|3|||
155141039|NCT00671034|559948368|FG002|Overall Study|Refusal|5|||
155141040|NCT00671034|559948366|FG000|Overall Study|includes Alternative therapy, etc.|6|||
155141041|NCT00671034|559948367|FG001|Overall Study|includes Alternative therapy, etc.|1|||
155141042|NCT00671034|559948368|FG002|Overall Study|includes Alternative therapy, etc.|7|||
155141043|NCT00713544|559948374|FG000|Overall Study|Adverse Event|5|||
155141044|NCT00713544|559948375|FG001|Overall Study|Adverse Event|3|||
155141045|NCT00713544|559948376|FG002|Overall Study|Adverse Event|7|||
155141046|NCT00713544|559948377|FG003|Overall Study|Adverse Event|7|||
155141047|NCT00713544|559948378|FG004|Overall Study|Adverse Event|3|||
155141048|NCT00713544|559948379|FG005|Overall Study|Adverse Event|5|||
155141049|NCT00713544|559948374|FG000|Overall Study|Withdrawal by Subject|2|||
155141050|NCT00713544|559948375|FG001|Overall Study|Withdrawal by Subject|0|||
155141051|NCT00713544|559948376|FG002|Overall Study|Withdrawal by Subject|3|||
155141052|NCT00713544|559948377|FG003|Overall Study|Withdrawal by Subject|2|||
155141053|NCT00713544|559948378|FG004|Overall Study|Withdrawal by Subject|3|||
155141054|NCT00713544|559948379|FG005|Overall Study|Withdrawal by Subject|1|||
155141055|NCT00713544|559948374|FG000|Overall Study|Protocol Violation|0|||
155141056|NCT00713544|559948375|FG001|Overall Study|Protocol Violation|0|||
155141057|NCT00713544|559948376|FG002|Overall Study|Protocol Violation|0|||
155141058|NCT00713544|559948377|FG003|Overall Study|Protocol Violation|0|||
155141059|NCT00713544|559948378|FG004|Overall Study|Protocol Violation|0|||
155141060|NCT00713544|559948379|FG005|Overall Study|Protocol Violation|1|||
155141061|NCT00713544|559948374|FG000|Overall Study|Physician Decision|0|||
155141062|NCT00713544|559948375|FG001|Overall Study|Physician Decision|0|||
155141063|NCT00713544|559948376|FG002|Overall Study|Physician Decision|0|||
155141064|NCT00713544|559948377|FG003|Overall Study|Physician Decision|0|||
155141065|NCT00713544|559948378|FG004|Overall Study|Physician Decision|0|||
155141066|NCT00713544|559948379|FG005|Overall Study|Physician Decision|2|||
155141067|NCT00713544|559948374|FG000|Overall Study|Lack of Efficacy|0|||
155141068|NCT00713544|559948375|FG001|Overall Study|Lack of Efficacy|1|||
155141069|NCT00713544|559948376|FG002|Overall Study|Lack of Efficacy|0|||
155141070|NCT00713544|559948377|FG003|Overall Study|Lack of Efficacy|1|||
155141071|NCT00713544|559948378|FG004|Overall Study|Lack of Efficacy|1|||
155141072|NCT00713544|559948379|FG005|Overall Study|Lack of Efficacy|0|||
155141073|NCT00713544|559948374|FG000|Overall Study|Lost to Follow-up|0|||
155141074|NCT00713544|559948375|FG001|Overall Study|Lost to Follow-up|0|||
155141075|NCT00713544|559948376|FG002|Overall Study|Lost to Follow-up|1|||
155141076|NCT00713544|559948377|FG003|Overall Study|Lost to Follow-up|0|||
155141077|NCT00713544|559948378|FG004|Overall Study|Lost to Follow-up|0|||
155141078|NCT00713544|559948379|FG005|Overall Study|Lost to Follow-up|0|||
155141079|NCT00713544|559948374|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155141080|NCT00713544|559948375|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
155141081|NCT00713544|559948376|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155141082|NCT00713544|559948377|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155141083|NCT00713544|559948378|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155141084|NCT00713544|559948379|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
155141085|NCT00713544|559948374|FG000|Overall Study|Incorrect enrollment|0|||
155141086|NCT00713544|559948375|FG001|Overall Study|Incorrect enrollment|1|||
155141087|NCT00713544|559948376|FG002|Overall Study|Incorrect enrollment|0|||
155141088|NCT00713544|559948377|FG003|Overall Study|Incorrect enrollment|0|||
155141089|NCT00713544|559948378|FG004|Overall Study|Incorrect enrollment|0|||
155141090|NCT00713544|559948379|FG005|Overall Study|Incorrect enrollment|0|||
155141091|NCT00713544|559948374|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
155141092|NCT00713544|559948375|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
155141093|NCT00713544|559948376|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
155141094|NCT00713544|559948377|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
155141095|NCT00713544|559948378|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
155141096|NCT00713544|559948379|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
155141097|NCT00786799|559948382|FG000|Overall Study|Lost to Follow-up|1|||
155141098|NCT00786799|559948383|FG001|Overall Study|Lost to Follow-up|1|||
155141099|NCT02544503|559948384|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
155141100|NCT02544503|559948385|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
155141101|NCT02544503|559948384|FG000|Overall Study|Lost to Follow-up|9|||
155141102|NCT02544503|559948385|FG001|Overall Study|Lost to Follow-up|0|||
155141103|NCT02544503|559948384|FG000|Overall Study|Withdrawal by Subject|1|||
155141104|NCT02544503|559948385|FG001|Overall Study|Withdrawal by Subject|0|||
155141105|NCT02380287|559948386|FG000|Overall Study|Adverse Event|0|||
155141106|NCT02380287|559948387|FG001|Overall Study|Adverse Event|0|||
155141107|NCT02380287|559948388|FG002|Overall Study|Adverse Event|1|||
155141108|NCT02380287|559948389|FG003|Overall Study|Adverse Event|0|||
155141109|NCT02380287|559948390|FG004|Overall Study|Adverse Event|0|||
155141110|NCT02380287|559948391|FG005|Overall Study|Adverse Event|0|||
155141111|NCT02380287|559948392|FG006|Overall Study|Adverse Event|0|||
155141112|NCT02380287|559948393|FG007|Overall Study|Adverse Event|0|||
155141113|NCT04473963|559948394|FG000|Overall Study|Withdrawal by Subject|1|||
155141114|NCT04473963|559948395|FG001|Overall Study|Withdrawal by Subject|1|||
155141115|NCT04473963|559948396|FG002|Overall Study|Withdrawal by Subject|0|||
155141116|NCT04473963|559948394|FG000|Overall Study|Not inducible in AF|0|||
155141117|NCT04473963|559948395|FG001|Overall Study|Not inducible in AF|0|||
155141118|NCT04473963|559948396|FG002|Overall Study|Not inducible in AF|2|||
155141119|NCT04640311|559948397|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
155141120|NCT04640311|559948398|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141121|NCT04640311|559948399|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141122|NCT04640311|559948400|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141123|NCT04640311|559948401|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141124|NCT04640311|559948402|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141125|NCT04640311|559948403|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141126|NCT04640311|559948404|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141127|NCT04640311|559948405|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155183059|NCT01001299|560108423|FG000|Overall Study|Withdrew Consent|1|||
155141128|NCT04640311|559948406|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141129|NCT04640311|559948407|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141130|NCT04640311|559948408|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141131|NCT04640311|559948409|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141132|NCT04640311|559948397|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141133|NCT04640311|559948398|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
155141134|NCT04640311|559948399|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141135|NCT04640311|559948400|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155183060|NCT02195011|560108424|FG000|Overall Study|Adverse Event|4|||
155183061|NCT02195011|560108425|FG001|Overall Study|Adverse Event|0|||
155183062|NCT02195011|560108424|FG000|Overall Study|Progressive Disease|18|||
155183063|NCT02195011|560108425|FG001|Overall Study|Progressive Disease|1|||
155183064|NCT02195011|560108424|FG000|Overall Study|Withdrawal by Subject|3|||
155183065|NCT02195011|560108425|FG001|Overall Study|Withdrawal by Subject|0|||
155183066|NCT03418571|560108426|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
155141136|NCT04640311|559948401|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141137|NCT04640311|559948402|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141138|NCT04640311|559948403|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141139|NCT04640311|559948404|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141140|NCT04640311|559948405|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141141|NCT04640311|559948406|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141142|NCT04640311|559948407|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141143|NCT04640311|559948408|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141144|NCT04640311|559948409|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
155141145|NCT04640311|559948397|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141146|NCT04640311|559948398|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
155141147|NCT04640311|559948399|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141148|NCT04640311|559948400|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141149|NCT04640311|559948401|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141150|NCT04640311|559948402|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141151|NCT04640311|559948403|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141152|NCT04640311|559948404|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141153|NCT04640311|559948405|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141154|NCT04640311|559948406|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141155|NCT04640311|559948407|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141156|NCT04640311|559948408|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141157|NCT04640311|559948409|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141158|NCT04640311|559948397|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
155141159|NCT04640311|559948398|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
155141160|NCT04640311|559948399|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
155141161|NCT04640311|559948400|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141162|NCT04640311|559948401|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141163|NCT04640311|559948402|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141164|NCT04640311|559948403|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141165|NCT04640311|559948404|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141166|NCT04640311|559948405|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141167|NCT04640311|559948406|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141168|NCT04640311|559948407|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141169|NCT04640311|559948408|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141170|NCT04640311|559948409|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
155141171|NCT04640311|559948397|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141172|NCT04640311|559948398|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141173|NCT04640311|559948399|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
155141174|NCT04640311|559948400|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141175|NCT04640311|559948401|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141176|NCT04640311|559948402|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141177|NCT04640311|559948403|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141178|NCT04640311|559948404|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155183067|NCT03418571|560108427|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
155183068|NCT03170232|560108428|FG000|Overall Study|Adverse Event|0|||
155183069|NCT03170232|560108429|FG001|Overall Study|Adverse Event|1|||
155183070|NCT03170232|560108428|FG000|Overall Study|Protocol Violation|0|||
155183071|NCT03170232|560108429|FG001|Overall Study|Protocol Violation|1|||
155183072|NCT03170232|560108428|FG000|Overall Study|Lack of Efficacy|0|||
155183073|NCT03170232|560108429|FG001|Overall Study|Lack of Efficacy|1|||
155183074|NCT03170232|560108428|FG000|Overall Study|Study closed/terminated|26|||
155183075|NCT03170232|560108429|FG001|Overall Study|Study closed/terminated|23|||
155183076|NCT03170232|560108428|FG000|Overall Study|Lost to Follow-up|1|||
155183077|NCT03170232|560108429|FG001|Overall Study|Lost to Follow-up|0|||
155183078|NCT03170232|560108428|FG000|Overall Study|Withdrawal by Subject|0|||
155183079|NCT03170232|560108429|FG001|Overall Study|Withdrawal by Subject|1|||
155183080|NCT03882008|560108430|FG000|Overall Study|Withdrawal by Subject|1|||
155183081|NCT03882008|560108430|FG000|Overall Study|Lost to Follow-up|1|||
155183082|NCT01222403|560108433|FG000|Overall Study|Inappropriate enrollment|0|||
155183083|NCT01222403|560108434|FG001|Overall Study|Inappropriate enrollment|2|||
155183084|NCT02793622|560108435|FG000|Overall Study|Lost to Follow-up|31|||
155183085|NCT02793622|560108436|FG001|Overall Study|Lost to Follow-up|19|||
155183086|NCT02793622|560108435|FG000|Overall Study|Withdrawal by Subject|21|||
155183087|NCT02793622|560108436|FG001|Overall Study|Withdrawal by Subject|17|||
155183088|NCT02793622|560108435|FG000|Overall Study|Adverse Event|0|||
155183089|NCT02793622|560108436|FG001|Overall Study|Adverse Event|1|||
155183090|NCT02793622|560108435|FG000|Overall Study|Protocol Violation|1|||
155183091|NCT02793622|560108436|FG001|Overall Study|Protocol Violation|5|||
155183092|NCT02068768|560108437|FG000|Overall Study|Lost to Follow-up|5|||
155183093|NCT02068768|560108437|FG000|Overall Study|Early Termination by Sponsor|2|||
155183094|NCT01262352|560108438|FG000|Period 1|Illness after randomization|1|||
155183095|NCT01262352|560108439|FG001|Period 1|Illness after randomization|0|||
155183096|NCT01262352|560108438|FG000|Washout|Adverse Event|1|||
155183097|NCT01262352|560108439|FG001|Washout|Adverse Event|1|||
155183098|NCT01262352|560108438|FG000|Washout|Extended Washout|0|||
155183099|NCT01262352|560108439|FG001|Washout|Extended Washout|1|||
155183100|NCT01185834|560108440|FG000|Overall Study|Lost to Follow-up|2|||
155183101|NCT01185834|560108440|FG000|Overall Study|Discomfort|4|||
155183102|NCT01185834|560108440|FG000|Overall Study|Biomicroscopy|4|||
155183103|NCT01185834|560108440|FG000|Overall Study|Time/Job Conflict|2|||
155183104|NCT01185834|560108440|FG000|Overall Study|Early exit - Site error|2|||
155183105|NCT01401959|560108441|FG000|Enrolled|Withdrawal by Subject|1|||
155183106|NCT01401959|560108442|FG001|Enrolled|Withdrawal by Subject|0|||
155183107|NCT01401959|560108443|FG002|Enrolled|Withdrawal by Subject|0|||
155141179|NCT04640311|559948405|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141180|NCT04640311|559948406|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141181|NCT04640311|559948407|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141182|NCT04640311|559948408|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141183|NCT04640311|559948409|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
155141184|NCT04640311|559948397|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141185|NCT04640311|559948398|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141186|NCT04640311|559948399|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141187|NCT04640311|559948400|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
155141188|NCT04640311|559948401|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141189|NCT04640311|559948402|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141190|NCT04640311|559948403|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
155141191|NCT04640311|559948404|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141192|NCT04640311|559948405|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141193|NCT04640311|559948406|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141194|NCT04640311|559948407|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141195|NCT04640311|559948408|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141196|NCT04640311|559948409|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
155141197|NCT04640311|559948397|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141198|NCT04640311|559948398|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141199|NCT04640311|559948399|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141200|NCT04640311|559948400|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141201|NCT04640311|559948401|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141202|NCT04640311|559948402|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
155141203|NCT04640311|559948403|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141204|NCT04640311|559948404|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141205|NCT04640311|559948405|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
155141206|NCT04640311|559948406|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141207|NCT04640311|559948407|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141208|NCT04640311|559948408|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141209|NCT04640311|559948409|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
155141210|NCT04640311|559948397|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141211|NCT04640311|559948398|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141212|NCT04640311|559948399|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141213|NCT04640311|559948400|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141214|NCT04640311|559948401|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155031265|NCT00976209|559540851|FG001|Treatment Period 1|Protocol Violation|0|||
155031266|NCT00976209|559540850|FG000|Treatment Period 1|Lost to Follow-up|2|||
155031267|NCT00976209|559540851|FG001|Treatment Period 1|Lost to Follow-up|0|||
155031268|NCT00976209|559540850|FG000|Treatment Period 1|Other|0|||
155031269|NCT00976209|559540851|FG001|Treatment Period 1|Other|1|||
155031270|NCT00976209|559540850|FG000|Wash-out Period|Adverse Event|1|||
155031271|NCT00976209|559540851|FG001|Wash-out Period|Adverse Event|2|||
155031272|NCT00976209|559540850|FG000|Wash-out Period|Lost to Follow-up|1|||
155031273|NCT00976209|559540851|FG001|Wash-out Period|Lost to Follow-up|0|||
155031274|NCT00976209|559540850|FG000|Wash-out Period|Protocol Violation|1|||
155031275|NCT00976209|559540851|FG001|Wash-out Period|Protocol Violation|0|||
155031276|NCT00976209|559540850|FG000|Wash-out Period|Other|1|||
155031277|NCT00976209|559540851|FG001|Wash-out Period|Other|0|||
155031278|NCT00976209|559540850|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155031279|NCT00976209|559540851|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155141215|NCT04640311|559948402|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141216|NCT04640311|559948403|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
155141217|NCT04640311|559948404|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141218|NCT04640311|559948405|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141219|NCT04640311|559948406|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141220|NCT04640311|559948407|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
155141221|NCT04640311|559948408|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141222|NCT04640311|559948409|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
155141223|NCT04640311|559948397|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141224|NCT04640311|559948398|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141225|NCT04640311|559948399|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141226|NCT04640311|559948400|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141227|NCT04640311|559948401|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141228|NCT04640311|559948402|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141229|NCT04640311|559948403|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141230|NCT04640311|559948404|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141231|NCT04640311|559948405|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141232|NCT04640311|559948406|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141233|NCT04640311|559948407|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141234|NCT04640311|559948408|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
155141235|NCT04640311|559948409|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
155141236|NCT01799226|559948410|FG000|Overall Study|Withdrawal by Subject|1|||
155141237|NCT01799226|559948411|FG001|Overall Study|Withdrawal by Subject|0|||
155141238|NCT01799226|559948410|FG000|Overall Study|Disqualified at Day 14|1|||
155141239|NCT01799226|559948411|FG001|Overall Study|Disqualified at Day 14|0|||
155141240|NCT02178995|559948412|FG000|Double Blind|Adverse Event|0|||
155141241|NCT02178995|559948413|FG001|Double Blind|Adverse Event|0|||
155141242|NCT02178995|559948414|FG002|Double Blind|Adverse Event|0|||
155141243|NCT02178995|559948415|FG003|Double Blind|Adverse Event|0|||
155141244|NCT02178995|559948416|FG004|Double Blind|Adverse Event|0|||
155141245|NCT02178995|559948417|FG005|Double Blind|Adverse Event|1|||
155141246|NCT02178995|559948418|FG006|Double Blind|Adverse Event|0|||
155141247|NCT02178995|559948419|FG007|Double Blind|Adverse Event|1|||
155141248|NCT02178995|559948420|FG008|Double Blind|Adverse Event|1|||
155141249|NCT02178995|559948412|FG000|Double Blind|Lost to Follow-up|0|||
155141250|NCT02178995|559948413|FG001|Double Blind|Lost to Follow-up|1|||
155141251|NCT02178995|559948414|FG002|Double Blind|Lost to Follow-up|0|||
155141252|NCT02178995|559948415|FG003|Double Blind|Lost to Follow-up|0|||
155141253|NCT02178995|559948416|FG004|Double Blind|Lost to Follow-up|0|||
155141254|NCT02178995|559948417|FG005|Double Blind|Lost to Follow-up|0|||
155141255|NCT02178995|559948418|FG006|Double Blind|Lost to Follow-up|0|||
155141256|NCT02178995|559948419|FG007|Double Blind|Lost to Follow-up|1|||
155141257|NCT02178995|559948420|FG008|Double Blind|Lost to Follow-up|0|||
155141258|NCT02178995|559948412|FG000|Open Label|Adverse Event|2|||
155141259|NCT02178995|559948413|FG001|Open Label|Adverse Event|0|||
155141260|NCT02178995|559948414|FG002|Open Label|Adverse Event|0|||
155141261|NCT02178995|559948415|FG003|Open Label|Adverse Event|0|||
155183108|NCT01401959|560108441|FG000|Treated|Disease Progression|2|||
155183109|NCT01401959|560108442|FG001|Treated|Disease Progression|2|||
155183110|NCT01401959|560108443|FG002|Treated|Disease Progression|1|||
155031280|NCT00976209|559540850|FG000|Treatment Period 2|Lost to Follow-up|0|||
155031281|NCT00976209|559540851|FG001|Treatment Period 2|Lost to Follow-up|1|||
155031282|NCT02612610|559540852|FG000|Overall Study|Withdrawal by Subject|1|||
155031283|NCT02612610|559540853|FG001|Overall Study|Withdrawal by Subject|1|||
155031284|NCT02612610|559540854|FG002|Overall Study|Withdrawal by Subject|0|||
155031285|NCT02612610|559540855|FG003|Overall Study|Withdrawal by Subject|2|||
155031286|NCT02612610|559540852|FG000|Overall Study|Adverse Event|2|||
155031287|NCT02612610|559540853|FG001|Overall Study|Adverse Event|2|||
155031288|NCT02612610|559540854|FG002|Overall Study|Adverse Event|3|||
155183111|NCT01401959|560108441|FG000|Treated|Adverse Event|4|||
155183112|NCT01401959|560108442|FG001|Treated|Adverse Event|3|||
155183113|NCT01401959|560108443|FG002|Treated|Adverse Event|2|||
155183114|NCT01401959|560108441|FG000|Treated|Withdrawal by Subject|1|||
155183115|NCT01401959|560108442|FG001|Treated|Withdrawal by Subject|2|||
155183116|NCT01401959|560108443|FG002|Treated|Withdrawal by Subject|2|||
155183117|NCT01401959|560108441|FG000|Treated|Protocol Violation|0|||
155183118|NCT01401959|560108442|FG001|Treated|Protocol Violation|1|||
155183119|NCT01401959|560108443|FG002|Treated|Protocol Violation|0|||
155183120|NCT02694718|560108448|FG000|Overall Study|Death|1|||
155183121|NCT02694718|560108448|FG000|Overall Study|Withdrawal by Subject|1|||
155183122|NCT02925793|560108449|FG000|Overall Study|Adverse Event|3|||
155183123|NCT02925793|560108450|FG001|Overall Study|Adverse Event|3|||
155183124|NCT02925793|560108451|FG002|Overall Study|Adverse Event|6|||
155183125|NCT02925793|560108449|FG000|Overall Study|Withdrawal by Subject|16|||
155183126|NCT02925793|560108450|FG001|Overall Study|Withdrawal by Subject|15|||
155183127|NCT02925793|560108451|FG002|Overall Study|Withdrawal by Subject|13|||
155183128|NCT02925793|560108449|FG000|Overall Study|Investigator Discretion|0|||
155183129|NCT02925793|560108450|FG001|Overall Study|Investigator Discretion|1|||
155183130|NCT02925793|560108451|FG002|Overall Study|Investigator Discretion|1|||
155183131|NCT02925793|560108449|FG000|Overall Study|Lost to Follow-up|2|||
155183132|NCT02925793|560108450|FG001|Overall Study|Lost to Follow-up|3|||
155183133|NCT02925793|560108451|FG002|Overall Study|Lost to Follow-up|1|||
155183134|NCT02925793|560108449|FG000|Overall Study|Lack of Efficacy|2|||
155183135|NCT02925793|560108450|FG001|Overall Study|Lack of Efficacy|6|||
155183136|NCT02925793|560108451|FG002|Overall Study|Lack of Efficacy|4|||
155183137|NCT02925793|560108449|FG000|Overall Study|Other:|2|||
155183138|NCT02925793|560108450|FG001|Overall Study|Other:|1|||
155183139|NCT02925793|560108451|FG002|Overall Study|Other:|3|||
155183140|NCT00393042|560108452|FG000|First Intervention|Withdrawal by Subject|1|||
155183141|NCT00393042|560108453|FG001|First Intervention|Withdrawal by Subject|2|||
155183142|NCT00393042|560108452|FG000|First Intervention|Lost to Follow-up|3|||
155183143|NCT00393042|560108453|FG001|First Intervention|Lost to Follow-up|3|||
155183144|NCT00393042|560108452|FG000|First Intervention|Protocol Violation|1|||
155183145|NCT00393042|560108453|FG001|First Intervention|Protocol Violation|0|||
155183146|NCT00393042|560108452|FG000|First Intervention|Adverse Event|0|||
155183147|NCT00393042|560108453|FG001|First Intervention|Adverse Event|1|||
155183148|NCT00393042|560108452|FG000|Second Intervetion|Adverse Event|0|||
155183149|NCT00393042|560108453|FG001|Second Intervetion|Adverse Event|3|||
155183150|NCT00393042|560108452|FG000|Second Intervetion|Withdrawal by Subject|0|||
155183151|NCT00393042|560108453|FG001|Second Intervetion|Withdrawal by Subject|2|||
155183152|NCT00393042|560108452|FG000|Second Intervetion|Lack of Efficacy|1|||
155183153|NCT00393042|560108453|FG001|Second Intervetion|Lack of Efficacy|0|||
155183154|NCT00393042|560108452|FG000|Second Intervetion|Lost to Follow-up|0|||
155183155|NCT00393042|560108453|FG001|Second Intervetion|Lost to Follow-up|2|||
155183156|NCT00393042|560108452|FG000|Second Intervetion|Protocol Violation|1|||
155031289|NCT02612610|559540855|FG003|Overall Study|Adverse Event|10|||
155031290|NCT02612610|559540852|FG000|Overall Study|Lost to Follow-up|0|||
155031291|NCT02612610|559540853|FG001|Overall Study|Lost to Follow-up|1|||
155031292|NCT02612610|559540854|FG002|Overall Study|Lost to Follow-up|0|||
155031293|NCT02612610|559540855|FG003|Overall Study|Lost to Follow-up|0|||
155031294|NCT02612610|559540852|FG000|Overall Study|Protocol Violation|0|||
155031295|NCT02612610|559540853|FG001|Overall Study|Protocol Violation|1|||
155031296|NCT02612610|559540854|FG002|Overall Study|Protocol Violation|1|||
155031297|NCT02612610|559540855|FG003|Overall Study|Protocol Violation|0|||
155031298|NCT02612610|559540852|FG000|Overall Study|Lack of Efficacy|1|||
155031299|NCT02612610|559540853|FG001|Overall Study|Lack of Efficacy|2|||
155031300|NCT02612610|559540854|FG002|Overall Study|Lack of Efficacy|0|||
155031301|NCT02612610|559540855|FG003|Overall Study|Lack of Efficacy|1|||
155031302|NCT02612610|559540852|FG000|Overall Study|Physician Decision|0|||
155031303|NCT02612610|559540853|FG001|Overall Study|Physician Decision|1|||
155031304|NCT02612610|559540854|FG002|Overall Study|Physician Decision|0|||
155031305|NCT02612610|559540855|FG003|Overall Study|Physician Decision|0|||
155031306|NCT02612610|559540852|FG000|Overall Study|Noncompliance|1|||
155031307|NCT02612610|559540853|FG001|Overall Study|Noncompliance|0|||
155031308|NCT02612610|559540854|FG002|Overall Study|Noncompliance|0|||
155031309|NCT02612610|559540855|FG003|Overall Study|Noncompliance|0|||
155031310|NCT02612610|559540852|FG000|Overall Study|Cough Improvement|0|||
155183157|NCT00393042|560108453|FG001|Second Intervetion|Protocol Violation|1|||
155183158|NCT00322153|560108458|FG000|Overall Study|Adverse Event|21|||
155183159|NCT00322153|560108459|FG001|Overall Study|Adverse Event|34|||
155183160|NCT00322153|560108458|FG000|Overall Study|Protocol Violation|6|||
155183161|NCT00322153|560108459|FG001|Overall Study|Protocol Violation|14|||
155183162|NCT00322153|560108458|FG000|Overall Study|Withdrawal by Subject|18|||
155183163|NCT00322153|560108459|FG001|Overall Study|Withdrawal by Subject|10|||
155183164|NCT00322153|560108458|FG000|Overall Study|Lack of Efficacy|8|||
155183165|NCT00322153|560108459|FG001|Overall Study|Lack of Efficacy|3|||
155031311|NCT02612610|559540853|FG001|Overall Study|Cough Improvement|0|||
155183166|NCT00322153|560108458|FG000|Overall Study|Lost to Follow-up|5|||
155183167|NCT00322153|560108459|FG001|Overall Study|Lost to Follow-up|4|||
155183168|NCT00322153|560108458|FG000|Overall Study|Withdrawn for other reasons|5|||
155183169|NCT00322153|560108459|FG001|Overall Study|Withdrawn for other reasons|4|||
155183170|NCT02414139|560108462|FG000|Treatment Period|Adverse Event|11|||
155183171|NCT02414139|560108463|FG001|Treatment Period|Adverse Event|6|||
155183172|NCT02414139|560108464|FG002|Treatment Period|Adverse Event|8|||
155183173|NCT02414139|560108465|FG003|Treatment Period|Adverse Event|5|||
155183174|NCT02414139|560108466|FG004|Treatment Period|Adverse Event|14|||
155183175|NCT02414139|560108467|FG005|Treatment Period|Adverse Event|3|||
155183176|NCT02414139|560108468|FG006|Treatment Period|Adverse Event|6|||
155183177|NCT02414139|560108469|FG007|Treatment Period|Adverse Event|1|||
155183178|NCT02414139|560108470|FG008|Treatment Period|Adverse Event|6|||
155183179|NCT02414139|560108471|FG009|Treatment Period|Adverse Event|8|||
155183180|NCT02414139|560108462|FG000|Treatment Period|Death|0|||
155183181|NCT02414139|560108463|FG001|Treatment Period|Death|0|||
155183182|NCT02414139|560108464|FG002|Treatment Period|Death|1|||
155183183|NCT02414139|560108465|FG003|Treatment Period|Death|1|||
155183184|NCT02414139|560108466|FG004|Treatment Period|Death|0|||
155183185|NCT02414139|560108467|FG005|Treatment Period|Death|0|||
155183186|NCT02414139|560108468|FG006|Treatment Period|Death|0|||
155183187|NCT02414139|560108469|FG007|Treatment Period|Death|0|||
155183188|NCT02414139|560108470|FG008|Treatment Period|Death|0|||
155183189|NCT02414139|560108471|FG009|Treatment Period|Death|1|||
155183190|NCT02414139|560108462|FG000|Treatment Period|Physician Decision|5|||
155183191|NCT02414139|560108463|FG001|Treatment Period|Physician Decision|4|||
155183192|NCT02414139|560108464|FG002|Treatment Period|Physician Decision|6|||
155183193|NCT02414139|560108465|FG003|Treatment Period|Physician Decision|1|||
155183194|NCT02414139|560108466|FG004|Treatment Period|Physician Decision|4|||
155183195|NCT02414139|560108467|FG005|Treatment Period|Physician Decision|0|||
155183196|NCT02414139|560108468|FG006|Treatment Period|Physician Decision|2|||
155183197|NCT02414139|560108469|FG007|Treatment Period|Physician Decision|0|||
155183198|NCT02414139|560108470|FG008|Treatment Period|Physician Decision|1|||
155183199|NCT02414139|560108471|FG009|Treatment Period|Physician Decision|4|||
155183200|NCT02414139|560108462|FG000|Treatment Period|Progressive disease|48|||
155183201|NCT02414139|560108463|FG001|Treatment Period|Progressive disease|31|||
155183202|NCT02414139|560108464|FG002|Treatment Period|Progressive disease|37|||
155183203|NCT02414139|560108465|FG003|Treatment Period|Progressive disease|21|||
155183204|NCT02414139|560108466|FG004|Treatment Period|Progressive disease|43|||
155183205|NCT02414139|560108467|FG005|Treatment Period|Progressive disease|12|||
155183206|NCT02414139|560108468|FG006|Treatment Period|Progressive disease|16|||
155183207|NCT02414139|560108469|FG007|Treatment Period|Progressive disease|2|||
155183208|NCT02414139|560108470|FG008|Treatment Period|Progressive disease|20|||
155183209|NCT02414139|560108471|FG009|Treatment Period|Progressive disease|14|||
155183210|NCT02414139|560108462|FG000|Treatment Period|Protocol deviation|0|||
155183211|NCT02414139|560108463|FG001|Treatment Period|Protocol deviation|0|||
155183212|NCT02414139|560108464|FG002|Treatment Period|Protocol deviation|1|||
155183213|NCT02414139|560108465|FG003|Treatment Period|Protocol deviation|0|||
155183214|NCT02414139|560108466|FG004|Treatment Period|Protocol deviation|0|||
155183215|NCT02414139|560108467|FG005|Treatment Period|Protocol deviation|0|||
155183216|NCT02414139|560108468|FG006|Treatment Period|Protocol deviation|0|||
155183217|NCT02414139|560108469|FG007|Treatment Period|Protocol deviation|0|||
155183218|NCT02414139|560108470|FG008|Treatment Period|Protocol deviation|0|||
155183219|NCT02414139|560108471|FG009|Treatment Period|Protocol deviation|0|||
155183220|NCT02414139|560108462|FG000|Treatment Period|Subject/Guardian decision|5|||
155183221|NCT02414139|560108463|FG001|Treatment Period|Subject/Guardian decision|1|||
155183222|NCT02414139|560108464|FG002|Treatment Period|Subject/Guardian decision|1|||
155183223|NCT02414139|560108465|FG003|Treatment Period|Subject/Guardian decision|2|||
155183224|NCT02414139|560108466|FG004|Treatment Period|Subject/Guardian decision|5|||
155183225|NCT02414139|560108467|FG005|Treatment Period|Subject/Guardian decision|0|||
155183226|NCT02414139|560108468|FG006|Treatment Period|Subject/Guardian decision|2|||
155031312|NCT02612610|559540854|FG002|Overall Study|Cough Improvement|1|||
155031313|NCT02612610|559540855|FG003|Overall Study|Cough Improvement|0|||
155031314|NCT01880086|559540861|FG000|Overall Study|Lost to Follow-up|1|||
155031315|NCT01880086|559540862|FG001|Overall Study|Lost to Follow-up|1|||
155183227|NCT02414139|560108469|FG007|Treatment Period|Subject/Guardian decision|0|||
155183228|NCT02414139|560108470|FG008|Treatment Period|Subject/Guardian decision|1|||
155183229|NCT02414139|560108471|FG009|Treatment Period|Subject/Guardian decision|1|||
155183230|NCT02414139|560108462|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155031316|NCT05174949|559540864|FG000|Overall Study|Physician Decision|1|||
155031317|NCT05174949|559540865|FG001|Overall Study|Physician Decision|2|||
155183231|NCT02414139|560108463|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155183232|NCT02414139|560108464|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155183233|NCT02414139|560108465|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155183234|NCT02414139|560108466|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
155183235|NCT02414139|560108467|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155183236|NCT02414139|560108468|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
155183237|NCT02414139|560108469|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
155183238|NCT02414139|560108470|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
155183239|NCT02414139|560108471|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
155183240|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
155183241|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183242|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183243|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183244|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
155183245|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183246|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183247|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183248|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183249|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
155183250|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Death|0|||
155183251|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Death|1|||
155183252|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Death|0|||
155183253|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Death|0|||
155183254|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Death|1|||
155183255|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Death|0|||
155183256|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Death|0|||
155183257|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Death|0|||
155183258|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Death|0|||
155183259|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Death|1|||
155183260|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
155183261|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183262|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183263|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183264|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183265|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155141262|NCT02178995|559948416|FG004|Open Label|Adverse Event|0|||
155141263|NCT02178995|559948417|FG005|Open Label|Adverse Event|0|||
155141264|NCT02178995|559948418|FG006|Open Label|Adverse Event|0|||
155141265|NCT02178995|559948419|FG007|Open Label|Adverse Event|0|||
155141266|NCT02178995|559948420|FG008|Open Label|Adverse Event|0|||
155141267|NCT01797263|559948421|FG000|Overall Study|Withdrawal by Subject|21|||
155141268|NCT01797263|559948422|FG001|Overall Study|Withdrawal by Subject|25|||
155141269|NCT01797263|559948421|FG000|Overall Study|Death|1|||
155141270|NCT01797263|559948422|FG001|Overall Study|Death|0|||
155141271|NCT01797263|559948421|FG000|Overall Study|Lost to Follow-up|15|||
155141272|NCT01797263|559948422|FG001|Overall Study|Lost to Follow-up|15|||
155141273|NCT02342223|559948423|FG000|Overall Study|Lost to Follow-up|1|||
155141274|NCT01200368|559948424|FG000|Infant Series|Adverse Event|2|||
155141275|NCT01200368|559948425|FG001|Infant Series|Adverse Event|2|||
155141276|NCT01200368|559948426|FG002|Infant Series|Adverse Event|3|||
155141277|NCT01200368|559948424|FG000|Infant Series|Withdrawal by Subject|0|||
155141278|NCT01200368|559948425|FG001|Infant Series|Withdrawal by Subject|2|||
155141279|NCT01200368|559948426|FG002|Infant Series|Withdrawal by Subject|2|||
155141280|NCT01200368|559948424|FG000|Infant Series|Did not meet entrance criteria|0|||
155141281|NCT01200368|559948425|FG001|Infant Series|Did not meet entrance criteria|1|||
155141282|NCT01200368|559948426|FG002|Infant Series|Did not meet entrance criteria|0|||
155141283|NCT01200368|559948424|FG000|Infant Series|Randomized, not vaccinated|0|||
155141284|NCT01200368|559948425|FG001|Infant Series|Randomized, not vaccinated|1|||
155141285|NCT01200368|559948426|FG002|Infant Series|Randomized, not vaccinated|1|||
155141286|NCT01200368|559948424|FG000|Infant Series|Other|1|||
155141287|NCT01200368|559948425|FG001|Infant Series|Other|0|||
155141288|NCT01200368|559948426|FG002|Infant Series|Other|0|||
155141289|NCT01200368|559948424|FG000|After Infant Series|Adverse Event|6|||
155141290|NCT01200368|559948425|FG001|After Infant Series|Adverse Event|6|||
155141291|NCT01200368|559948426|FG002|After Infant Series|Adverse Event|3|||
155141292|NCT01200368|559948424|FG000|After Infant Series|Withdrawal by Subject|10|||
155141293|NCT01200368|559948425|FG001|After Infant Series|Withdrawal by Subject|8|||
155141294|NCT01200368|559948426|FG002|After Infant Series|Withdrawal by Subject|4|||
155141295|NCT01200368|559948424|FG000|After Infant Series|Lost to Follow-up|1|||
155183266|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183267|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183268|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155183269|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
155141296|NCT01200368|559948425|FG001|After Infant Series|Lost to Follow-up|0|||
155141297|NCT01200368|559948426|FG002|After Infant Series|Lost to Follow-up|0|||
155141298|NCT01200368|559948424|FG000|After Infant Series|Other|1|||
155141299|NCT01200368|559948425|FG001|After Infant Series|Other|2|||
155141300|NCT01200368|559948426|FG002|After Infant Series|Other|2|||
155141301|NCT01200368|559948424|FG000|Toddler Dose|Adverse Event|0|||
155141302|NCT01200368|559948425|FG001|Toddler Dose|Adverse Event|3|||
155141303|NCT01200368|559948426|FG002|Toddler Dose|Adverse Event|1|||
155141304|NCT00181766|559948436|FG000|Overall Study|Lost to Follow-up|6|||
155141305|NCT00181766|559948436|FG000|Overall Study|Adverse Event|4|||
155141306|NCT00181766|559948436|FG000|Overall Study|non-compliance|2|||
155141307|NCT00687804|559948444|FG000|Core Study|Adverse Event|5|||
155141308|NCT00687804|559948445|FG001|Core Study|Adverse Event|3|||
155141309|NCT00687804|559948446|FG002|Core Study|Adverse Event|3|||
155141310|NCT00687804|559948444|FG000|Core Study|Abnormal laboratory value(s)|1|||
155141311|NCT00687804|559948445|FG001|Core Study|Abnormal laboratory value(s)|0|||
155141312|NCT00687804|559948446|FG002|Core Study|Abnormal laboratory value(s)|0|||
155141313|NCT00687804|559948444|FG000|Core Study|Lack of Efficacy|1|||
155141314|NCT00687804|559948445|FG001|Core Study|Lack of Efficacy|1|||
155141315|NCT00687804|559948446|FG002|Core Study|Lack of Efficacy|1|||
155141316|NCT00687804|559948444|FG000|Core Study|Withdrawal by Subject|4|||
155141317|NCT00687804|559948445|FG001|Core Study|Withdrawal by Subject|7|||
155141318|NCT00687804|559948446|FG002|Core Study|Withdrawal by Subject|7|||
155141319|NCT00687804|559948444|FG000|Core Study|Lost to Follow-up|0|||
155141320|NCT00687804|559948445|FG001|Core Study|Lost to Follow-up|1|||
155141321|NCT00687804|559948446|FG002|Core Study|Lost to Follow-up|0|||
155141322|NCT00687804|559948444|FG000|Core Study|Death|2|||
155141323|NCT00687804|559948445|FG001|Core Study|Death|2|||
155141324|NCT00687804|559948446|FG002|Core Study|Death|2|||
155141325|NCT00687804|559948444|FG000|Core Study|Protocol Violation|1|||
155141326|NCT00687804|559948445|FG001|Core Study|Protocol Violation|1|||
155141327|NCT00687804|559948446|FG002|Core Study|Protocol Violation|0|||
155141328|NCT00687804|559948444|FG000|Open-Label Extension Study|Adverse Event|2|||
155141329|NCT00687804|559948445|FG001|Open-Label Extension Study|Adverse Event|2|||
155141330|NCT00687804|559948446|FG002|Open-Label Extension Study|Adverse Event|2|||
155141331|NCT00687804|559948444|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
155141332|NCT00687804|559948445|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
155141333|NCT00687804|559948446|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
155141334|NCT00687804|559948444|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
155141335|NCT00687804|559948445|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
155141336|NCT00687804|559948446|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
155141337|NCT00687804|559948444|FG000|Open-Label Extension Study|Administrative problems|1|||
155141338|NCT00687804|559948445|FG001|Open-Label Extension Study|Administrative problems|1|||
155141339|NCT00687804|559948446|FG002|Open-Label Extension Study|Administrative problems|0|||
155141340|NCT00687804|559948444|FG000|Open-Label Extension Study|Death|2|||
155141341|NCT00687804|559948445|FG001|Open-Label Extension Study|Death|3|||
155141342|NCT00687804|559948446|FG002|Open-Label Extension Study|Death|3|||
155141343|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
155141344|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
155141345|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
155141346|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
155141347|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
155141348|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
155141349|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
155141350|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
155141351|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
155141352|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
155141353|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
155141354|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
155141355|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
155141356|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
155141357|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
155141358|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
155141359|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
155141360|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
155141361|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
155141362|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
155141363|NCT03573323|559948447|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
155141364|NCT03573323|559948448|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
155141365|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
155141366|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
155141367|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
155141368|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
155141369|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
155183270|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
155141370|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
155141371|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
155183271|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155183272|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
155141372|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
155141373|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
155141374|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
155141375|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
155141376|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
155141377|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
155141378|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
155141379|NCT03573323|559948447|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
155141380|NCT03573323|559948448|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
155141381|NCT03188432|559948449|FG000|Overall Study|Death|3|||
155141382|NCT03188432|559948449|FG000|Overall Study|Withdrawal by Subject|15|||
155141383|NCT03188432|559948449|FG000|Overall Study|Did not complete protocol treatment|9|||
155141384|NCT00413218|559948455|FG000|Overall Study|Randomized but didn't receive study drug|2|||
155141385|NCT00413218|559948456|FG001|Overall Study|Randomized but didn't receive study drug|8|||
155141386|NCT00413218|559948455|FG000|Overall Study|Death|57|||
155141387|NCT00413218|559948456|FG001|Overall Study|Death|56|||
155141388|NCT00413218|559948455|FG000|Overall Study|Lost to Follow-up|14|||
155141389|NCT00413218|559948456|FG001|Overall Study|Lost to Follow-up|17|||
155141390|NCT00413218|559948455|FG000|Overall Study|Admin|20|||
155141391|NCT00413218|559948456|FG001|Overall Study|Admin|14|||
155141392|NCT00413218|559948455|FG000|Overall Study|Missing|1|||
155141393|NCT00413218|559948456|FG001|Overall Study|Missing|0|||
155141394|NCT00413218|559948455|FG000|Overall Study|Withdrawal by Subject|9|||
155141395|NCT00413218|559948456|FG001|Overall Study|Withdrawal by Subject|1|||
155141396|NCT03672292|559948461|FG000|Overall Study|Adverse Event|3|||
155141397|NCT03672292|559948462|FG001|Overall Study|Adverse Event|1|||
155141398|NCT03672292|559948461|FG000|Overall Study|Physician Decision|0|||
155141399|NCT03672292|559948462|FG001|Overall Study|Physician Decision|1|||
155141400|NCT03672292|559948461|FG000|Overall Study|Withdrawal by Subject|1|||
155141401|NCT03672292|559948462|FG001|Overall Study|Withdrawal by Subject|2|||
155141402|NCT00799903|559948463|FG000|Overall Study|Investigator Site Closed|25|||
155141403|NCT00799903|559948464|FG001|Overall Study|Investigator Site Closed|23|||
155141404|NCT00799903|559948463|FG000|Overall Study|Withdrawal by Subject|179|||
155141405|NCT00799903|559948464|FG001|Overall Study|Withdrawal by Subject|175|||
155141406|NCT00799903|559948463|FG000|Overall Study|Lost to Follow-up|69|||
155141407|NCT00799903|559948464|FG001|Overall Study|Lost to Follow-up|80|||
155141408|NCT03088917|559948465|FG000|Overall Study|In care/cured elsewhere|15|||
155141409|NCT03088917|559948465|FG000|Overall Study|Refuse re-evaluation|13|||
155141410|NCT03088917|559948465|FG000|Overall Study|Contact not established|13|||
155141411|NCT03088917|559948465|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
155141412|NCT03088917|559948465|FG000|Overall Study|Moved outside study region|50|||
155141413|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Progressive disease|50|||
155141414|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Progressive disease|110|||
155141415|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Progressive disease|0|||
155141416|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Progressive disease|0|||
155141417|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
155141418|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
155141419|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155141420|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155141421|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Adverse Event|7|||
155141422|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Adverse Event|7|||
155141423|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Adverse Event|0|||
155141424|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Adverse Event|0|||
155141425|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Other|1|||
155141426|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Other|3|||
155141427|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Other|0|||
155141428|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Other|0|||
155141429|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Physician Decision|6|||
155141430|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Physician Decision|3|||
155141431|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Physician Decision|0|||
155141432|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Physician Decision|0|||
155141433|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Death|1|||
155141434|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Death|1|||
155183273|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
155141435|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Death|0|||
155141436|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Death|0|||
155141437|NCT01695135|559948466|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
155141438|NCT01695135|559948467|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
155141439|NCT01695135|559948468|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
155183274|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
155183275|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155183276|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155183277|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155183278|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
155183279|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155183280|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
155183281|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
155183282|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
155183283|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
155183284|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
155183285|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
155183286|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
155183287|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
155183288|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155183289|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
155183290|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183291|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
155183292|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183293|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183294|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183295|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183296|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183297|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183298|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
155183299|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
155183300|NCT02414139|560108462|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
155183301|NCT02414139|560108463|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155183302|NCT02414139|560108464|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
155183303|NCT02414139|560108465|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155183304|NCT02414139|560108466|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155183305|NCT02414139|560108467|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155031318|NCT05174949|559540866|FG002|Overall Study|Physician Decision|0|||
155141440|NCT01695135|559948469|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
155141441|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
155141442|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
155141443|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
155141444|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
155141445|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
155141446|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
155141447|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
155141448|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
155141449|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
155141450|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
155141451|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
155141452|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
155141453|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Other|0|||
155141454|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Other|0|||
155141455|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Other|4|||
155141456|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Other|7|||
155141457|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
155141458|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
155141459|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
155141460|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
155141461|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Death|0|||
155141462|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Death|0|||
155141463|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Death|2|||
155141464|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Death|7|||
155141465|NCT01695135|559948466|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
155031319|NCT05174949|559540867|FG003|Overall Study|Physician Decision|1|||
155031320|NCT05174949|559540868|FG004|Overall Study|Physician Decision|0|||
155031321|NCT05174949|559540869|FG005|Overall Study|Physician Decision|0|||
155031322|NCT05174949|559540864|FG000|Overall Study|Withdrawal by Subject|0|||
155031323|NCT05174949|559540865|FG001|Overall Study|Withdrawal by Subject|1|||
155031324|NCT05174949|559540866|FG002|Overall Study|Withdrawal by Subject|0|||
155031325|NCT05174949|559540867|FG003|Overall Study|Withdrawal by Subject|0|||
155141466|NCT01695135|559948467|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
155031326|NCT05174949|559540868|FG004|Overall Study|Withdrawal by Subject|0|||
155031327|NCT05174949|559540869|FG005|Overall Study|Withdrawal by Subject|0|||
155031328|NCT05174949|559540864|FG000|Overall Study|Lost to Follow-up|0|||
155031329|NCT05174949|559540865|FG001|Overall Study|Lost to Follow-up|0|||
155031330|NCT05174949|559540866|FG002|Overall Study|Lost to Follow-up|0|||
155141467|NCT01695135|559948468|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
155141468|NCT01695135|559948469|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
155141469|NCT02753946|559948470|FG000|Overall Study|Adverse Event|7|||
155141470|NCT02753946|559948471|FG001|Overall Study|Adverse Event|6|||
155141471|NCT02753946|559948470|FG000|Overall Study|Withdrawal by Subject|6|||
155141472|NCT02753946|559948471|FG001|Overall Study|Withdrawal by Subject|1|||
155141473|NCT02753946|559948470|FG000|Overall Study|Lack of Efficacy|1|||
155141474|NCT02753946|559948471|FG001|Overall Study|Lack of Efficacy|0|||
155141475|NCT02753946|559948470|FG000|Overall Study|Physician Decision|0|||
155141476|NCT02753946|559948471|FG001|Overall Study|Physician Decision|2|||
155141477|NCT01843023|559948474|FG000|Overall Study|Death|1|||
155141478|NCT01843023|559948475|FG001|Overall Study|Death|0|||
155141479|NCT01843023|559948474|FG000|Overall Study|Lost to Follow-up|24|||
155141480|NCT01843023|559948475|FG001|Overall Study|Lost to Follow-up|29|||
155141481|NCT01843023|559948474|FG000|Overall Study|Withdrawal by Subject|8|||
155141482|NCT01843023|559948475|FG001|Overall Study|Withdrawal by Subject|6|||
155031331|NCT05174949|559540867|FG003|Overall Study|Lost to Follow-up|1|||
155031332|NCT05174949|559540868|FG004|Overall Study|Lost to Follow-up|0|||
155031333|NCT05174949|559540869|FG005|Overall Study|Lost to Follow-up|0|||
155031334|NCT04351373|559540870|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
155031335|NCT05083923|559540877|FG000|Overall Study|Adverse Event|2|||
155031336|NCT05083923|559540878|FG001|Overall Study|Adverse Event|0|||
155031337|NCT05083923|559540877|FG000|Overall Study|Lack of Efficacy|1|||
155031338|NCT05083923|559540878|FG001|Overall Study|Lack of Efficacy|3|||
155031339|NCT05083923|559540877|FG000|Overall Study|Withdrawal by Subject|2|||
155031340|NCT05083923|559540878|FG001|Overall Study|Withdrawal by Subject|6|||
155031341|NCT05083923|559540877|FG000|Overall Study|Reason Not Specified|0|||
155031342|NCT05083923|559540878|FG001|Overall Study|Reason Not Specified|1|||
155031343|NCT01537068|559540881|FG000|Overall Study|Lost to Follow-up|2|||
155031344|NCT01537068|559540882|FG001|Overall Study|Lost to Follow-up|1|||
155031345|NCT01537068|559540881|FG000|Overall Study|Adverse Event|0|||
155031346|NCT01537068|559540882|FG001|Overall Study|Adverse Event|1|||
155031347|NCT01537068|559540881|FG000|Overall Study|Withdrawal by Subject|1|||
155031348|NCT01537068|559540882|FG001|Overall Study|Withdrawal by Subject|1|||
155031349|NCT01537068|559540881|FG000|Overall Study|Lack of Efficacy|1|||
155031350|NCT01537068|559540882|FG001|Overall Study|Lack of Efficacy|0|||
155031351|NCT02291601|559540885|FG000|Abdomen|Did not qualify|333|||
155031352|NCT02291601|559540886|FG001|Abdomen|Did not qualify|54|||
155031353|NCT02291601|559540887|FG002|Abdomen|Did not qualify|339|||
155031354|NCT02291601|559540885|FG000|Groin|Did not qualify|183|||
155031355|NCT02291601|559540886|FG001|Groin|Did not qualify|30|||
155031356|NCT02291601|559540887|FG002|Groin|Did not qualify|177|||
155031357|NCT01190267|559540889|FG000|Overall Study|Adverse Event|10|||
155031358|NCT01190267|559540890|FG001|Overall Study|Adverse Event|0|||
155141483|NCT01633541|559948476|FG000|Overall Study|Death|1|||
155141484|NCT01633541|559948477|FG001|Overall Study|Death|0|||
155141485|NCT04669301|559948478|FG000|Overall Study|Lost to Follow-up|0|||
155141486|NCT04669301|559948479|FG001|Overall Study|Lost to Follow-up|1|||
155141487|NCT04669301|559948480|FG002|Overall Study|Lost to Follow-up|0|||
155141488|NCT04669301|559948478|FG000|Overall Study|Withdrawal by Subject|3|||
155141489|NCT04669301|559948479|FG001|Overall Study|Withdrawal by Subject|2|||
155141490|NCT04669301|559948480|FG002|Overall Study|Withdrawal by Subject|0|||
155141491|NCT00362648|559948485|FG000|Overall Study|Adverse Event|12|||
155141492|NCT00362648|559948486|FG001|Overall Study|Adverse Event|21|||
155141493|NCT00362648|559948487|FG002|Overall Study|Adverse Event|1|||
155141494|NCT00362648|559948488|FG003|Overall Study|Adverse Event|0|||
155141495|NCT00362648|559948485|FG000|Overall Study|Lost to Follow-up|62|||
155141496|NCT00362648|559948486|FG001|Overall Study|Lost to Follow-up|69|||
155141497|NCT00362648|559948487|FG002|Overall Study|Lost to Follow-up|4|||
155141498|NCT00362648|559948488|FG003|Overall Study|Lost to Follow-up|3|||
155141499|NCT00362648|559948485|FG000|Overall Study|Protocol Violation|4|||
155141500|NCT00362648|559948486|FG001|Overall Study|Protocol Violation|2|||
155141501|NCT00362648|559948487|FG002|Overall Study|Protocol Violation|2|||
155141502|NCT00362648|559948488|FG003|Overall Study|Protocol Violation|2|||
155141503|NCT00362648|559948485|FG000|Overall Study|Withdrawal by Subject|48|||
155141504|NCT00362648|559948486|FG001|Overall Study|Withdrawal by Subject|42|||
155031359|NCT01190267|559540889|FG000|Overall Study|Treatment Failure|8|||
155031360|NCT01190267|559540890|FG001|Overall Study|Treatment Failure|2|||
155031361|NCT01190267|559540889|FG000|Overall Study|Lost to Follow-up|2|||
155031362|NCT01190267|559540890|FG001|Overall Study|Lost to Follow-up|0|||
155141505|NCT00362648|559948487|FG002|Overall Study|Withdrawal by Subject|2|||
155141506|NCT00362648|559948488|FG003|Overall Study|Withdrawal by Subject|6|||
155141507|NCT00286429|559948494|FG000|Overall Study|Adverse Event|4|||
155141508|NCT00286429|559948495|FG001|Overall Study|Adverse Event|1|||
155141509|NCT00286429|559948496|FG002|Overall Study|Adverse Event|6|||
155183306|NCT02414139|560108468|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155183307|NCT02414139|560108469|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155183308|NCT02414139|560108470|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
155183309|NCT02414139|560108471|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155183310|NCT03523000|560108475|FG000|Overall Study|Withdrawal by Subject|3|||
155183311|NCT03523000|560108476|FG001|Overall Study|Withdrawal by Subject|0|||
155183312|NCT03523000|560108475|FG000|Overall Study|Unsuccessful trial|2|||
155183313|NCT03523000|560108476|FG001|Overall Study|Unsuccessful trial|0|||
155183314|NCT00772070|560108477|FG000|Overall Study|Lost to Follow-up|0|||
155183315|NCT00772070|560108478|FG001|Overall Study|Lost to Follow-up|8|||
155183316|NCT00772070|560108477|FG000|Overall Study|Withdrawal by Subject|0|||
155183317|NCT00772070|560108478|FG001|Overall Study|Withdrawal by Subject|2|||
155183318|NCT00772070|560108477|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
155183319|NCT00772070|560108478|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
155183320|NCT01309308|560108479|FG000|Overall Study|Lost to Follow-up|6|||
155183321|NCT01309308|560108480|FG001|Overall Study|Lost to Follow-up|4|||
155183322|NCT01307020|560108483|FG000|Overall Study|Lost to Follow-up|0|||
155183323|NCT01307020|560108484|FG001|Overall Study|Lost to Follow-up|0|||
155183324|NCT01307020|560108485|FG002|Overall Study|Lost to Follow-up|1|||
155183325|NCT01307020|560108486|FG003|Overall Study|Lost to Follow-up|1|||
155183326|NCT01307020|560108487|FG004|Overall Study|Lost to Follow-up|0|||
155183327|NCT01307020|560108488|FG005|Overall Study|Lost to Follow-up|0|||
155183328|NCT01307020|560108489|FG006|Overall Study|Lost to Follow-up|1|||
155183329|NCT01307020|560108490|FG007|Overall Study|Lost to Follow-up|0|||
155183330|NCT01307020|560108491|FG008|Overall Study|Lost to Follow-up|0|||
155183331|NCT01307020|560108492|FG009|Overall Study|Lost to Follow-up|0|||
155183332|NCT01307020|560108483|FG000|Overall Study|Electronic data capture failure|0|||
155183333|NCT01307020|560108484|FG001|Overall Study|Electronic data capture failure|1|||
155183334|NCT01307020|560108485|FG002|Overall Study|Electronic data capture failure|0|||
155183335|NCT01307020|560108486|FG003|Overall Study|Electronic data capture failure|0|||
155183336|NCT01307020|560108487|FG004|Overall Study|Electronic data capture failure|0|||
155183337|NCT01307020|560108488|FG005|Overall Study|Electronic data capture failure|0|||
155183338|NCT01307020|560108489|FG006|Overall Study|Electronic data capture failure|0|||
155183339|NCT01307020|560108490|FG007|Overall Study|Electronic data capture failure|0|||
155183340|NCT01307020|560108491|FG008|Overall Study|Electronic data capture failure|0|||
155183341|NCT01307020|560108492|FG009|Overall Study|Electronic data capture failure|0|||
155183342|NCT00266864|560108493|FG000|Overall Study|Lost to Follow-up|4|||
155183343|NCT00266864|560108494|FG001|Overall Study|Lost to Follow-up|1|||
155183344|NCT00266864|560108493|FG000|Overall Study|Withdrawal by Subject|1|||
155183345|NCT00266864|560108494|FG001|Overall Study|Withdrawal by Subject|1|||
155183346|NCT00727532|560108495|FG000|Overall Study|Adverse Event|1|||
155183347|NCT00727532|560108495|FG000|Overall Study|Withdrawal by Subject|1|||
155183348|NCT00829933|560108496|FG000|Overall Study|Adverse Event|2|||
155183349|NCT00829933|560108497|FG001|Overall Study|Adverse Event|3|||
155183350|NCT00829933|560108498|FG002|Overall Study|Adverse Event|2|||
155183351|NCT00829933|560108499|FG003|Overall Study|Adverse Event|1|||
155183352|NCT00829933|560108496|FG000|Overall Study|Death|0|||
155183353|NCT00829933|560108497|FG001|Overall Study|Death|0|||
155183354|NCT00829933|560108498|FG002|Overall Study|Death|1|||
155183355|NCT00829933|560108499|FG003|Overall Study|Death|1|||
155183356|NCT00829933|560108496|FG000|Overall Study|Lack of Efficacy|0|||
155183357|NCT00829933|560108497|FG001|Overall Study|Lack of Efficacy|1|||
155183358|NCT00829933|560108498|FG002|Overall Study|Lack of Efficacy|0|||
155183359|NCT00829933|560108499|FG003|Overall Study|Lack of Efficacy|0|||
155183360|NCT00829933|560108496|FG000|Overall Study|Physician Decision|5|||
155183361|NCT00829933|560108497|FG001|Overall Study|Physician Decision|7|||
155183362|NCT00829933|560108498|FG002|Overall Study|Physician Decision|8|||
155183363|NCT00829933|560108499|FG003|Overall Study|Physician Decision|1|||
155183364|NCT00829933|560108496|FG000|Overall Study|Pregnancy|0|||
155183365|NCT00829933|560108497|FG001|Overall Study|Pregnancy|0|||
155183366|NCT00829933|560108498|FG002|Overall Study|Pregnancy|0|||
155183367|NCT00829933|560108499|FG003|Overall Study|Pregnancy|2|||
155183368|NCT00829933|560108496|FG000|Overall Study|Protocol Violation|2|||
155183369|NCT00829933|560108497|FG001|Overall Study|Protocol Violation|1|||
155183370|NCT00829933|560108498|FG002|Overall Study|Protocol Violation|0|||
155183371|NCT00829933|560108499|FG003|Overall Study|Protocol Violation|0|||
155183372|NCT00829933|560108496|FG000|Overall Study|withdrew before treatment started|5|||
155183373|NCT00829933|560108497|FG001|Overall Study|withdrew before treatment started|1|||
155183374|NCT00829933|560108498|FG002|Overall Study|withdrew before treatment started|2|||
155183375|NCT00829933|560108499|FG003|Overall Study|withdrew before treatment started|9|||
155183376|NCT03687970|560108503|FG000|Overall Study|visit scheduling conflicts|2|||
155183377|NCT03687970|560108504|FG001|Overall Study|visit scheduling conflicts|0|||
155183378|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183379|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183380|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183381|NCT05985980|560108505|FG000|Overall Study|Withdrawal by Subject|1|||
155183382|NCT01683019|560110346|FG000|Overall Study|Withdrawal by Subject|2|||
155141510|NCT00286429|559948494|FG000|Overall Study|Lack of Efficacy|52|||
155141511|NCT00286429|559948495|FG001|Overall Study|Lack of Efficacy|27|||
155141512|NCT00286429|559948496|FG002|Overall Study|Lack of Efficacy|25|||
155141513|NCT00286429|559948494|FG000|Overall Study|Lost to Follow-up|2|||
155141514|NCT00286429|559948495|FG001|Overall Study|Lost to Follow-up|4|||
155141515|NCT00286429|559948496|FG002|Overall Study|Lost to Follow-up|3|||
155141516|NCT00286429|559948494|FG000|Overall Study|Physician Decision|10|||
155141517|NCT00286429|559948495|FG001|Overall Study|Physician Decision|7|||
155141518|NCT00286429|559948496|FG002|Overall Study|Physician Decision|7|||
155141519|NCT00286429|559948494|FG000|Overall Study|Protocol Violation|3|||
155141520|NCT00286429|559948495|FG001|Overall Study|Protocol Violation|5|||
155141521|NCT00286429|559948496|FG002|Overall Study|Protocol Violation|4|||
155141522|NCT00286429|559948494|FG000|Overall Study|Withdrawal by Subject|3|||
155141523|NCT00286429|559948495|FG001|Overall Study|Withdrawal by Subject|2|||
155141524|NCT00286429|559948496|FG002|Overall Study|Withdrawal by Subject|6|||
155141525|NCT00286429|559948494|FG000|Overall Study|Administrative Error|1|||
155141526|NCT00286429|559948495|FG001|Overall Study|Administrative Error|1|||
155141527|NCT00286429|559948496|FG002|Overall Study|Administrative Error|1|||
155141528|NCT00286429|559948494|FG000|Overall Study|Administrative Decision|0|||
155141529|NCT00286429|559948495|FG001|Overall Study|Administrative Decision|1|||
155141530|NCT00286429|559948496|FG002|Overall Study|Administrative Decision|0|||
155141531|NCT01746225|559948497|FG000|Overall Study|Death|1|||
155141532|NCT01746225|559948498|FG001|Overall Study|Death|0|||
155141533|NCT01746225|559948499|FG002|Overall Study|Death|1|||
155141534|NCT01746225|559948497|FG000|Overall Study|Withdrawal by Subject|5|||
155141535|NCT01746225|559948498|FG001|Overall Study|Withdrawal by Subject|15|||
155141536|NCT01746225|559948499|FG002|Overall Study|Withdrawal by Subject|19|||
155141537|NCT01746225|559948497|FG000|Overall Study|Physician Decision|14|||
155141538|NCT01746225|559948498|FG001|Overall Study|Physician Decision|11|||
155141539|NCT01746225|559948499|FG002|Overall Study|Physician Decision|3|||
155141540|NCT01746225|559948497|FG000|Overall Study|Adverse Event|15|||
155141541|NCT01746225|559948498|FG001|Overall Study|Adverse Event|12|||
155141542|NCT01746225|559948499|FG002|Overall Study|Adverse Event|17|||
155141543|NCT01746225|559948497|FG000|Overall Study|Continuing Treatment|5|||
155141544|NCT01746225|559948498|FG001|Overall Study|Continuing Treatment|8|||
155141545|NCT01746225|559948499|FG002|Overall Study|Continuing Treatment|3|||
155141546|NCT00595478|559948500|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
155141547|NCT00595478|559948501|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
155141548|NCT00595478|559948500|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
155141549|NCT00595478|559948501|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
155141550|NCT03245775|559948502|FG000|Overall Study|Lost to Follow-up|25|||
155141551|NCT03245775|559948503|FG001|Overall Study|Lost to Follow-up|26|||
155141552|NCT03245775|559948504|FG002|Overall Study|Lost to Follow-up|16|||
155141553|NCT03245775|559948505|FG003|Overall Study|Lost to Follow-up|16|||
155141554|NCT02713828|559948508|FG000|Overall Study|Death|2|||
155141555|NCT02713828|559948509|FG001|Overall Study|Death|0|||
155141556|NCT02713828|559948508|FG000|Overall Study|Withdrawal by Subject|1|||
155141557|NCT02713828|559948509|FG001|Overall Study|Withdrawal by Subject|0|||
155141558|NCT02713828|559948508|FG000|Overall Study|study terminated but patient allowed to|2|||
155141559|NCT02713828|559948509|FG001|Overall Study|study terminated but patient allowed to|0|||
155141560|NCT03302247|559948513|FG000|Overall Study|the study has closed prematurely|2|||
155141561|NCT03302247|559948513|FG000|Overall Study|Death|1|||
155141562|NCT03197376|559948514|FG000|Primary and Booster Phase|Adverse Event|0|||
155141563|NCT03197376|559948515|FG001|Primary and Booster Phase|Adverse Event|0|||
155141564|NCT03197376|559948516|FG002|Primary and Booster Phase|Adverse Event|0|||
155141565|NCT03197376|559948517|FG003|Primary and Booster Phase|Adverse Event|1|||
155141566|NCT03197376|559948514|FG000|Primary and Booster Phase|Death|1|||
155141567|NCT03197376|559948515|FG001|Primary and Booster Phase|Death|0|||
155141568|NCT03197376|559948516|FG002|Primary and Booster Phase|Death|0|||
155141569|NCT03197376|559948517|FG003|Primary and Booster Phase|Death|2|||
155141570|NCT03197376|559948514|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
155141571|NCT03197376|559948515|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
155141572|NCT03197376|559948516|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
155141573|NCT03197376|559948517|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
155141574|NCT03197376|559948514|FG000|Primary and Booster Phase|Physician Decision|1|||
155141575|NCT03197376|559948515|FG001|Primary and Booster Phase|Physician Decision|0|||
155141576|NCT03197376|559948516|FG002|Primary and Booster Phase|Physician Decision|1|||
155141577|NCT03197376|559948517|FG003|Primary and Booster Phase|Physician Decision|3|||
155141578|NCT03197376|559948514|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
155141579|NCT03197376|559948515|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
155141580|NCT03197376|559948516|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
155141581|NCT03197376|559948517|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
155141582|NCT03197376|559948514|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
155141583|NCT03197376|559948515|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
155141584|NCT03197376|559948516|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
155141585|NCT03197376|559948517|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
155183383|NCT01683019|560110347|FG001|Overall Study|Withdrawal by Subject|1|||
155183384|NCT01683019|560110348|FG002|Overall Study|Withdrawal by Subject|4|||
155183385|NCT03437512|560110349|FG000|Randomized|Withdrawal by Subject|0|||
155183386|NCT03437512|560110350|FG001|Randomized|Withdrawal by Subject|2|||
155183387|NCT03437512|560110349|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
155183388|NCT03437512|560110350|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
155183389|NCT00543855|560110351|FG000|Overall Study|Adverse Event|3|||
155183390|NCT00543855|560110352|FG001|Overall Study|Adverse Event|1|||
155183391|NCT00543855|560110353|FG002|Overall Study|Adverse Event|3|||
155183392|NCT00543855|560110354|FG003|Overall Study|Adverse Event|4|||
155183393|NCT00543855|560110351|FG000|Overall Study|Lost to Follow-up|0|||
155183394|NCT00543855|560110352|FG001|Overall Study|Lost to Follow-up|0|||
155183395|NCT00543855|560110353|FG002|Overall Study|Lost to Follow-up|1|||
155183396|NCT00543855|560110354|FG003|Overall Study|Lost to Follow-up|0|||
155183397|NCT00543855|560110351|FG000|Overall Study|Withdrawal by Subject|0|||
155183398|NCT00543855|560110352|FG001|Overall Study|Withdrawal by Subject|1|||
155183399|NCT00543855|560110353|FG002|Overall Study|Withdrawal by Subject|2|||
155183400|NCT00543855|560110354|FG003|Overall Study|Withdrawal by Subject|0|||
155183401|NCT00543855|560110351|FG000|Overall Study|Protocol Violation|1|||
155183402|NCT00543855|560110352|FG001|Overall Study|Protocol Violation|0|||
155183403|NCT00543855|560110353|FG002|Overall Study|Protocol Violation|0|||
155183404|NCT00543855|560110354|FG003|Overall Study|Protocol Violation|0|||
155183405|NCT00301821|560110358|FG000|Overall Study|Ineligible|25|||
155183406|NCT00301821|560110358|FG000|Overall Study|Cancel|1|||
155183407|NCT02294773|560110359|FG000|Overall Study|Withdrawal by Subject|0|||
155183408|NCT02294773|560110360|FG001|Overall Study|Withdrawal by Subject|2|||
155183409|NCT01865084|560110361|FG000|Double Blind Period (DB)|Adverse Event|2|||
155183410|NCT01865084|560110362|FG001|Double Blind Period (DB)|Adverse Event|2|||
155183411|NCT01865084|560110363|FG002|Double Blind Period (DB)|Adverse Event|1|||
155183412|NCT01865084|560110361|FG000|Double Blind Period (DB)|Protocol Violation|0|||
155183413|NCT01865084|560110362|FG001|Double Blind Period (DB)|Protocol Violation|0|||
155183414|NCT01865084|560110363|FG002|Double Blind Period (DB)|Protocol Violation|1|||
155183415|NCT01865084|560110361|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
155183416|NCT01865084|560110362|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
155183417|NCT01865084|560110363|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
155183418|NCT01865084|560110361|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
155183419|NCT01865084|560110362|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
155183420|NCT01865084|560110363|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
155183421|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
155183422|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
155183423|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
155183424|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
155183425|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
155183426|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
155183427|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
155183428|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
155183429|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
155183430|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
155183431|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
155183432|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
155183433|NCT01865084|560110361|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
155183434|NCT01865084|560110362|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
155183435|NCT01865084|560110363|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
155183436|NCT05828095|560110364|FG000|Overall Study|Lost to Follow-up|1|||
155183437|NCT05828095|560110365|FG001|Overall Study|Lost to Follow-up|0|||
155183438|NCT05828095|560110364|FG000|Overall Study|Reactogenicity symptom|0|||
155183439|NCT05828095|560110365|FG001|Overall Study|Reactogenicity symptom|1|||
155183440|NCT01994590|560110368|FG000|Overall Study|Adverse Event|1|||
155183441|NCT01994590|560110368|FG000|Overall Study|Trial Terminated|1|||
155183442|NCT03206073|560110369|FG000|Overall Study|Participant Noncompliance|0|||
155183443|NCT03206073|560110370|FG001|Overall Study|Participant Noncompliance|1|||
155183444|NCT03206073|560110371|FG002|Overall Study|Participant Noncompliance|0|||
155183445|NCT03206073|560110372|FG003|Overall Study|Participant Noncompliance|0|||
155183446|NCT03206073|560110369|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
155183447|NCT03206073|560110370|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
155183448|NCT03206073|560110371|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
155183449|NCT03206073|560110372|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
155183450|NCT03206073|560110369|FG000|Overall Study|Death|0|||
155183451|NCT03206073|560110370|FG001|Overall Study|Death|0|||
155183452|NCT03206073|560110371|FG002|Overall Study|Death|1|||
155183453|NCT03206073|560110372|FG003|Overall Study|Death|0|||
155183454|NCT03206073|560110369|FG000|Overall Study|Taken off active treatment|0|||
155183455|NCT03206073|560110370|FG001|Overall Study|Taken off active treatment|0|||
155183456|NCT03206073|560110371|FG002|Overall Study|Taken off active treatment|3|||
155183457|NCT03206073|560110372|FG003|Overall Study|Taken off active treatment|0|||
155183458|NCT03332771|560110374|FG000|Overall Study|Adverse Event|6|||
155183459|NCT03332771|560110375|FG001|Overall Study|Adverse Event|4|||
155183460|NCT03332771|560110376|FG002|Overall Study|Adverse Event|1|||
155183461|NCT03332771|560110377|FG003|Overall Study|Adverse Event|3|||
155183462|NCT03332771|560110374|FG000|Overall Study|Poor Compliance to Protocol|0|||
155183463|NCT03332771|560110375|FG001|Overall Study|Poor Compliance to Protocol|1|||
155183464|NCT03332771|560110376|FG002|Overall Study|Poor Compliance to Protocol|0|||
155183465|NCT03332771|560110377|FG003|Overall Study|Poor Compliance to Protocol|1|||
155183466|NCT03332771|560110374|FG000|Overall Study|Lost to Follow-up|2|||
155183467|NCT03332771|560110375|FG001|Overall Study|Lost to Follow-up|2|||
155183468|NCT03332771|560110376|FG002|Overall Study|Lost to Follow-up|1|||
155183469|NCT03332771|560110377|FG003|Overall Study|Lost to Follow-up|2|||
155183470|NCT03332771|560110374|FG000|Overall Study|At the Participant's own request|20|||
155183471|NCT03332771|560110375|FG001|Overall Study|At the Participant's own request|26|||
155183472|NCT03332771|560110376|FG002|Overall Study|At the Participant's own request|14|||
155183473|NCT03332771|560110377|FG003|Overall Study|At the Participant's own request|23|||
155183474|NCT03332771|560110374|FG000|Overall Study|Reason Not Specified|6|||
155183475|NCT03332771|560110375|FG001|Overall Study|Reason Not Specified|18|||
155183476|NCT03332771|560110376|FG002|Overall Study|Reason Not Specified|16|||
155183477|NCT03332771|560110377|FG003|Overall Study|Reason Not Specified|19|||
155183478|NCT03442764|560110378|FG000|Overall Study|Adverse Event|1|||
155183479|NCT03442764|560110379|FG001|Overall Study|Adverse Event|0|||
155183480|NCT03442764|560110380|FG002|Overall Study|Adverse Event|0|||
155183481|NCT01801072|560110381|FG000|Overall Study|Lost to Follow-up|17|||
155183482|NCT01801072|560110382|FG001|Overall Study|Lost to Follow-up|14|||
155183483|NCT01801072|560110381|FG000|Overall Study|Physician Decision|2|||
155031363|NCT01190267|559540889|FG000|Overall Study|Withdrawal by Subject|13|||
155183484|NCT01801072|560110382|FG001|Overall Study|Physician Decision|3|||
155183485|NCT01801072|560110381|FG000|Overall Study|Withdrawal by Subject|1|||
155183486|NCT01801072|560110382|FG001|Overall Study|Withdrawal by Subject|0|||
155183487|NCT01801072|560110381|FG000|Overall Study|Protocol Violation|2|||
155183488|NCT01801072|560110382|FG001|Overall Study|Protocol Violation|0|||
155183489|NCT01801072|560110381|FG000|Overall Study|Death|7|||
155183490|NCT01801072|560110382|FG001|Overall Study|Death|8|||
155183491|NCT00719264|560110383|FG000|Overall Study|Adverse Event|41|||
155031364|NCT01190267|559540890|FG001|Overall Study|Withdrawal by Subject|1|||
155031365|NCT01190267|559540889|FG000|Overall Study|Protocol Violation|8|||
155031366|NCT01190267|559540890|FG001|Overall Study|Protocol Violation|1|||
155031367|NCT04017832|559540891|FG000|Overall Study|Withdrawal by Subject|13|||
155031368|NCT04017832|559540892|FG001|Overall Study|Withdrawal by Subject|12|||
155031369|NCT04017832|559540893|FG002|Overall Study|Withdrawal by Subject|21|||
155031370|NCT04017832|559540894|FG003|Overall Study|Withdrawal by Subject|7|||
155031371|NCT04017832|559540891|FG000|Overall Study|Lost to Follow-up|0|||
155031372|NCT04017832|559540892|FG001|Overall Study|Lost to Follow-up|3|||
155031373|NCT04017832|559540893|FG002|Overall Study|Lost to Follow-up|3|||
155031374|NCT04017832|559540894|FG003|Overall Study|Lost to Follow-up|1|||
155031375|NCT04017832|559540891|FG000|Overall Study|Physician Decision|1|||
155031376|NCT04017832|559540892|FG001|Overall Study|Physician Decision|1|||
155031377|NCT04017832|559540893|FG002|Overall Study|Physician Decision|1|||
155031378|NCT04017832|559540894|FG003|Overall Study|Physician Decision|1|||
155031379|NCT04017832|559540891|FG000|Overall Study|Death|2|||
155031380|NCT04017832|559540892|FG001|Overall Study|Death|2|||
155031381|NCT04017832|559540893|FG002|Overall Study|Death|1|||
155031382|NCT04017832|559540894|FG003|Overall Study|Death|0|||
155031383|NCT02375555|559540904|FG000|Induction Period|Adverse Event|7|||
155031384|NCT02375555|559540904|FG000|Induction Period|Withdrawal by Subject|2|||
155031385|NCT02375555|559540904|FG000|Induction Period|Other|1|||
155031386|NCT02375555|559540904|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
155031387|NCT02375555|559540904|FG000|Maintenance Period|Adverse Event|2|||
155031388|NCT02375555|559540904|FG000|Maintenance Period|Withdrawal by Subject|4|||
155031389|NCT02375555|559540904|FG000|Maintenance Period|Death|1|||
155031390|NCT02375555|559540904|FG000|Maintenance Period|Disease Progression|5|||
155031391|NCT02375555|559540904|FG000|Maintenance Period|Patient Non-compliance|1|||
155031392|NCT02375555|559540904|FG000|Maintenance Period|Still on maintenance|16|||
155031393|NCT02091986|559540905|FG000|Overall Study|7 rand in error 1 patient decision|2|||
155031394|NCT02091986|559540906|FG001|Overall Study|7 rand in error 1 patient decision|3|||
155031395|NCT02091986|559540907|FG002|Overall Study|7 rand in error 1 patient decision|3|||
155031396|NCT02091986|559540905|FG000|Overall Study|Lost to Follow-up|1|||
155031397|NCT02091986|559540906|FG001|Overall Study|Lost to Follow-up|0|||
155031398|NCT02091986|559540907|FG002|Overall Study|Lost to Follow-up|0|||
155031399|NCT02091986|559540905|FG000|Overall Study|Withdrawal by Subject|4|||
155031400|NCT02091986|559540906|FG001|Overall Study|Withdrawal by Subject|8|||
155031401|NCT02091986|559540907|FG002|Overall Study|Withdrawal by Subject|3|||
155031402|NCT02091986|559540905|FG000|Overall Study|Adverse Event|0|||
155031403|NCT02091986|559540906|FG001|Overall Study|Adverse Event|0|||
155183492|NCT00719264|560110384|FG001|Overall Study|Adverse Event|49|||
155183493|NCT00719264|560110383|FG000|Overall Study|Death|13|||
155183494|NCT00719264|560110384|FG001|Overall Study|Death|10|||
155183495|NCT00719264|560110383|FG000|Overall Study|Administrative Problems|6|||
155183496|NCT00719264|560110384|FG001|Overall Study|Administrative Problems|4|||
155183497|NCT00719264|560110383|FG000|Overall Study|Lost to Follow-up|1|||
155183498|NCT00719264|560110384|FG001|Overall Study|Lost to Follow-up|1|||
155183499|NCT00719264|560110383|FG000|Overall Study|Withdrawal by Subject|12|||
155183500|NCT00719264|560110384|FG001|Overall Study|Withdrawal by Subject|7|||
155183501|NCT00719264|560110383|FG000|Overall Study|Protocol Deviation|1|||
155183502|NCT00719264|560110384|FG001|Overall Study|Protocol Deviation|3|||
155183503|NCT00719264|560110383|FG000|Overall Study|New Cancer Therapy|4|||
155183504|NCT00719264|560110384|FG001|Overall Study|New Cancer Therapy|2|||
155183505|NCT00719264|560110383|FG000|Overall Study|Disease Progression|104|||
155183506|NCT00719264|560110384|FG001|Overall Study|Disease Progression|107|||
155183507|NCT01277042|560110385|FG000|Overall Study|Adverse Event|4|||
155183508|NCT01277042|560110386|FG001|Overall Study|Adverse Event|3|||
155183509|NCT01277042|560110385|FG000|Overall Study|Lost to Follow-up|2|||
155183510|NCT01277042|560110386|FG001|Overall Study|Lost to Follow-up|2|||
155183511|NCT01277042|560110385|FG000|Overall Study|Withdrawal by Subject|2|||
155183512|NCT01277042|560110386|FG001|Overall Study|Withdrawal by Subject|0|||
155183513|NCT03034200|560110387|FG000|Overall Study|Disease progression|8|||
155183514|NCT03034200|560110388|FG001|Overall Study|Disease progression|10|||
155183515|NCT03034200|560110389|FG002|Overall Study|Disease progression|4|||
155183516|NCT03034200|560110387|FG000|Overall Study|Physician Decision|2|||
155183517|NCT03034200|560110388|FG001|Overall Study|Physician Decision|0|||
155183518|NCT03034200|560110389|FG002|Overall Study|Physician Decision|3|||
155183519|NCT03034200|560110387|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
155183520|NCT03034200|560110388|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
155183521|NCT03034200|560110389|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
155183522|NCT03034200|560110387|FG000|Overall Study|Adjuvant Therapy|0|||
155183523|NCT03034200|560110388|FG001|Overall Study|Adjuvant Therapy|0|||
155183524|NCT03034200|560110389|FG002|Overall Study|Adjuvant Therapy|1|||
155183525|NCT02469038|560110396|FG000|Overall Study|Physician Decision|4|||
155183526|NCT02469038|560110397|FG001|Overall Study|Physician Decision|5|||
155183527|NCT03435640|560110398|FG000|Overall Study|Withdrawal by Subject|0|||
155183528|NCT03435640|560110399|FG001|Overall Study|Withdrawal by Subject|1|||
155183529|NCT03435640|560110400|FG002|Overall Study|Withdrawal by Subject|0|||
155141586|NCT03197376|559948514|FG000|Primary and Booster Phase|Not vaccine related|1|||
155141587|NCT03197376|559948515|FG001|Primary and Booster Phase|Not vaccine related|2|||
155141588|NCT03197376|559948516|FG002|Primary and Booster Phase|Not vaccine related|0|||
155141589|NCT03197376|559948517|FG003|Primary and Booster Phase|Not vaccine related|6|||
155141590|NCT03197376|559948514|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
155141591|NCT03197376|559948515|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
155141592|NCT03197376|559948516|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
155141593|NCT03197376|559948517|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
155141594|NCT03197376|559948514|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
155141595|NCT03197376|559948515|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
155141596|NCT03197376|559948516|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
155141597|NCT03197376|559948517|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
155141598|NCT03197376|559948514|FG000|Immune Persistence Phase|Not vaccine related|1|||
155141599|NCT03197376|559948515|FG001|Immune Persistence Phase|Not vaccine related|0|||
155141600|NCT03197376|559948516|FG002|Immune Persistence Phase|Not vaccine related|1|||
155141601|NCT03197376|559948517|FG003|Immune Persistence Phase|Not vaccine related|1|||
155141602|NCT03857542|559948521|FG000|Overall Study|Adverse Event|1|||
155141603|NCT03857542|559948522|FG001|Overall Study|Adverse Event|3|||
155141604|NCT03857542|559948521|FG000|Overall Study|Withdrawal by Subject|2|||
155141605|NCT03857542|559948522|FG001|Overall Study|Withdrawal by Subject|1|||
155141606|NCT03857542|559948521|FG000|Overall Study|Lost to Follow-up|2|||
155141607|NCT03857542|559948522|FG001|Overall Study|Lost to Follow-up|1|||
155183530|NCT03435640|560110401|FG003|Overall Study|Withdrawal by Subject|2|||
155183531|NCT03435640|560110402|FG004|Overall Study|Withdrawal by Subject|0|||
155183532|NCT03435640|560110403|FG005|Overall Study|Withdrawal by Subject|0|||
155141608|NCT03857542|559948521|FG000|Overall Study|Reason not Specified|1|||
155141609|NCT03857542|559948522|FG001|Overall Study|Reason not Specified|0|||
155141610|NCT02709330|559948523|FG000|Overall Study|Death|5|||
155141611|NCT02709330|559948524|FG001|Overall Study|Death|0|||
155141612|NCT02709330|559948523|FG000|Overall Study|Lost to Follow-up|2|||
155183533|NCT03435640|560110404|FG006|Overall Study|Withdrawal by Subject|3|||
155183534|NCT03435640|560110405|FG007|Overall Study|Withdrawal by Subject|0|||
155183535|NCT03435640|560110406|FG008|Overall Study|Withdrawal by Subject|0|||
155183536|NCT03435640|560110407|FG009|Overall Study|Withdrawal by Subject|2|||
155183537|NCT03435640|560110408|FG010|Overall Study|Withdrawal by Subject|3|||
155183538|NCT03435640|560110398|FG000|Overall Study|Lost to Follow-up|0|||
155183539|NCT03435640|560110399|FG001|Overall Study|Lost to Follow-up|0|||
155183540|NCT03435640|560110400|FG002|Overall Study|Lost to Follow-up|1|||
155183541|NCT03435640|560110401|FG003|Overall Study|Lost to Follow-up|0|||
155183542|NCT03435640|560110402|FG004|Overall Study|Lost to Follow-up|0|||
155183543|NCT03435640|560110403|FG005|Overall Study|Lost to Follow-up|0|||
155183544|NCT03435640|560110404|FG006|Overall Study|Lost to Follow-up|0|||
155183545|NCT03435640|560110405|FG007|Overall Study|Lost to Follow-up|0|||
155183546|NCT03435640|560110406|FG008|Overall Study|Lost to Follow-up|0|||
155183547|NCT03435640|560110407|FG009|Overall Study|Lost to Follow-up|0|||
155183548|NCT03435640|560110408|FG010|Overall Study|Lost to Follow-up|0|||
155183549|NCT00510874|560110409|FG000|Overall Study|Withdrawal by Subject|1|||
155183550|NCT00510874|560110410|FG001|Overall Study|Withdrawal by Subject|1|||
155183551|NCT00510874|560110411|FG002|Overall Study|Withdrawal by Subject|0|||
155183552|NCT00510874|560110412|FG003|Overall Study|Withdrawal by Subject|0|||
155183553|NCT00510874|560110413|FG004|Overall Study|Withdrawal by Subject|3|||
155183554|NCT00510874|560110414|FG005|Overall Study|Withdrawal by Subject|0|||
155183555|NCT00510874|560110415|FG006|Overall Study|Withdrawal by Subject|0|||
155183556|NCT00510874|560110409|FG000|Overall Study|Lost to Follow-up|2|||
155183557|NCT00510874|560110410|FG001|Overall Study|Lost to Follow-up|3|||
155183558|NCT00510874|560110411|FG002|Overall Study|Lost to Follow-up|1|||
155183559|NCT00510874|560110412|FG003|Overall Study|Lost to Follow-up|3|||
155183560|NCT00510874|560110413|FG004|Overall Study|Lost to Follow-up|4|||
155183561|NCT00510874|560110414|FG005|Overall Study|Lost to Follow-up|0|||
155183562|NCT00510874|560110415|FG006|Overall Study|Lost to Follow-up|1|||
155183563|NCT00636987|560110416|FG000|Overall Study|Death|44|||
155183564|NCT00636987|560110416|FG000|Overall Study|Explanted|13|||
155183565|NCT00636987|560110416|FG000|Overall Study|Lost to Follow-up|63|||
155183566|NCT00636987|560110416|FG000|Overall Study|5 year visit window not complete|69|||
155183567|NCT01251146|560110417|FG000|Overall Study|Lost to Follow-up|3|||
155183568|NCT01251146|560110418|FG001|Overall Study|Lost to Follow-up|10|||
155183569|NCT01347307|560110419|FG000|Overall Study|Death|0|||
155183570|NCT01347307|560110420|FG001|Overall Study|Death|4|||
155183571|NCT01347307|560110419|FG000|Overall Study|Physician Decision|0|||
155183572|NCT01347307|560110420|FG001|Overall Study|Physician Decision|1|||
155183573|NCT02239224|560110422|FG000|Overall Study|Administrative|0|||
155183574|NCT02239224|560110423|FG001|Overall Study|Administrative|0|||
155183575|NCT02239224|560110424|FG002|Overall Study|Administrative|3|||
155183576|NCT02239224|560110425|FG003|Overall Study|Administrative|1|||
155183577|NCT03183778|560110426|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
155183578|NCT00737464|560110428|FG000|Overall Study|Adverse Event|1|||
155183579|NCT00737464|560110428|FG000|Overall Study|Death|6|||
155183580|NCT00737464|560110428|FG000|Overall Study|Other - Failure to Return|1|||
155183581|NCT00737464|560110428|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
155183582|NCT00737464|560110428|FG000|Overall Study|Other reasons|4|||
155183583|NCT03228420|560110440|FG000|Overall Study|Lost to Follow-up|5|||
155183584|NCT03228420|560110441|FG001|Overall Study|Lost to Follow-up|3|||
155183585|NCT03228420|560110440|FG000|Overall Study|Withdrawal by Subject|10|||
155183586|NCT03228420|560110441|FG001|Overall Study|Withdrawal by Subject|0|||
155183587|NCT03228420|560110440|FG000|Overall Study|Adverse Event|5|||
155183588|NCT03228420|560110441|FG001|Overall Study|Adverse Event|2|||
155183589|NCT03954041|560110443|FG000|Overall Study|Lost to Follow-up|3|||
155183590|NCT03954041|560110444|FG001|Overall Study|Lost to Follow-up|3|||
155183591|NCT03954041|560110445|FG002|Overall Study|Lost to Follow-up|6|||
155183592|NCT03954041|560110443|FG000|Overall Study|Death|4|||
155183593|NCT03954041|560110444|FG001|Overall Study|Death|0|||
155183594|NCT03954041|560110445|FG002|Overall Study|Death|1|||
155183595|NCT03954041|560110443|FG000|Overall Study|Death by neurologic criteria|0|||
155183596|NCT03954041|560110444|FG001|Overall Study|Death by neurologic criteria|0|||
155183597|NCT03954041|560110445|FG002|Overall Study|Death by neurologic criteria|1|||
155183598|NCT03954041|560110443|FG000|Overall Study|Reason not specified|7|||
155183599|NCT03954041|560110444|FG001|Overall Study|Reason not specified|4|||
155183600|NCT03954041|560110445|FG002|Overall Study|Reason not specified|2|||
155183601|NCT03954041|560110443|FG000|Overall Study|Withdrew prior to dosing|4|||
155031404|NCT02091986|559540907|FG002|Overall Study|Adverse Event|2|||
155031405|NCT00915876|559540910|FG000|Overall Study|Adverse Event|0|||
155031406|NCT00915876|559540911|FG001|Overall Study|Adverse Event|1|||
155031407|NCT03626363|559540914|FG000|Overall Study|Protocol Violation|4|||
155031408|NCT03626363|559540915|FG001|Overall Study|Protocol Violation|0|||
155183602|NCT03954041|560110444|FG001|Overall Study|Withdrew prior to dosing|2|||
155183603|NCT03954041|560110445|FG002|Overall Study|Withdrew prior to dosing|0|||
155183604|NCT03868124|560110448|FG000|Overall Study|Withdrawal by Subject|4|||
155183605|NCT03868124|560110449|FG001|Overall Study|Withdrawal by Subject|0|||
155183606|NCT03868124|560110450|FG002|Overall Study|Withdrawal by Subject|1|||
155183607|NCT03868124|560110448|FG000|Overall Study|Physician Decision|1|||
155183608|NCT03868124|560110449|FG001|Overall Study|Physician Decision|0|||
155183609|NCT03868124|560110450|FG002|Overall Study|Physician Decision|1|||
155183610|NCT03868124|560110448|FG000|Overall Study|Lost to Follow-up|1|||
155183611|NCT03868124|560110449|FG001|Overall Study|Lost to Follow-up|1|||
155183612|NCT03868124|560110450|FG002|Overall Study|Lost to Follow-up|2|||
155183613|NCT03868124|560110448|FG000|Overall Study|Death|1|||
155031409|NCT03626363|559540914|FG000|Overall Study|Lost to Follow-up|5|||
155183614|NCT03868124|560110449|FG001|Overall Study|Death|1|||
155183615|NCT03868124|560110450|FG002|Overall Study|Death|2|||
155183616|NCT03868124|560110448|FG000|Overall Study|Adverse Event|0|||
155183617|NCT03868124|560110449|FG001|Overall Study|Adverse Event|0|||
155183618|NCT03868124|560110450|FG002|Overall Study|Adverse Event|3|||
155183619|NCT03868124|560110448|FG000|Overall Study|Explanted|2|||
155183620|NCT03868124|560110449|FG001|Overall Study|Explanted|1|||
155183621|NCT03868124|560110450|FG002|Overall Study|Explanted|0|||
155183622|NCT03868124|560110448|FG000|Overall Study|Ongoing in study|176|||
155183623|NCT03868124|560110449|FG001|Overall Study|Ongoing in study|180|||
155183624|NCT03868124|560110450|FG002|Overall Study|Ongoing in study|183|||
155183625|NCT04177355|560110451|FG000|Overall Study|Lost to Follow-up|0|||
155183626|NCT04177355|560110452|FG001|Overall Study|Lost to Follow-up|2|||
155183627|NCT04177355|560110453|FG002|Overall Study|Lost to Follow-up|0|||
155183628|NCT04177355|560110454|FG003|Overall Study|Lost to Follow-up|1|||
155183629|NCT04177355|560110455|FG004|Overall Study|Lost to Follow-up|2|||
155183630|NCT04177355|560110456|FG005|Overall Study|Lost to Follow-up|0|||
155183631|NCT04177355|560110457|FG006|Overall Study|Lost to Follow-up|1|||
155183632|NCT04177355|560110458|FG007|Overall Study|Lost to Follow-up|0|||
155183633|NCT04177355|560110459|FG008|Overall Study|Lost to Follow-up|0|||
155183634|NCT04177355|560110460|FG009|Overall Study|Lost to Follow-up|0|||
155183635|NCT04177355|560110461|FG010|Overall Study|Lost to Follow-up|0|||
155183636|NCT04177355|560110451|FG000|Overall Study|Withdrawal by Subject|0|||
155183637|NCT04177355|560110452|FG001|Overall Study|Withdrawal by Subject|0|||
155183638|NCT04177355|560110453|FG002|Overall Study|Withdrawal by Subject|0|||
155183639|NCT04177355|560110454|FG003|Overall Study|Withdrawal by Subject|1|||
155183640|NCT04177355|560110455|FG004|Overall Study|Withdrawal by Subject|1|||
155183641|NCT04177355|560110456|FG005|Overall Study|Withdrawal by Subject|0|||
155183642|NCT04177355|560110457|FG006|Overall Study|Withdrawal by Subject|0|||
155183643|NCT04177355|560110458|FG007|Overall Study|Withdrawal by Subject|0|||
155183644|NCT04177355|560110459|FG008|Overall Study|Withdrawal by Subject|1|||
155183645|NCT04177355|560110460|FG009|Overall Study|Withdrawal by Subject|0|||
155183646|NCT04177355|560110461|FG010|Overall Study|Withdrawal by Subject|0|||
155183647|NCT03823378|560110466|FG000|Overall Study|Adverse Event|2|||
155183648|NCT03823378|560110467|FG001|Overall Study|Adverse Event|2|||
155183649|NCT03823378|560110468|FG002|Overall Study|Adverse Event|0|||
155183650|NCT03823378|560110469|FG003|Overall Study|Adverse Event|0|||
155183651|NCT03823378|560110470|FG004|Overall Study|Adverse Event|0|||
155183652|NCT03823378|560110471|FG005|Overall Study|Adverse Event|0|||
155183653|NCT03823378|560110466|FG000|Overall Study|Lost to Follow-up|0|||
155183654|NCT03823378|560110467|FG001|Overall Study|Lost to Follow-up|1|||
155183655|NCT03823378|560110468|FG002|Overall Study|Lost to Follow-up|0|||
155183656|NCT03823378|560110469|FG003|Overall Study|Lost to Follow-up|0|||
155183657|NCT03823378|560110470|FG004|Overall Study|Lost to Follow-up|1|||
155183658|NCT03823378|560110471|FG005|Overall Study|Lost to Follow-up|0|||
155183659|NCT03823378|560110466|FG000|Overall Study|Withdrawal by Subject|0|||
155183660|NCT03823378|560110467|FG001|Overall Study|Withdrawal by Subject|1|||
155183661|NCT03823378|560110468|FG002|Overall Study|Withdrawal by Subject|4|||
155183662|NCT03823378|560110469|FG003|Overall Study|Withdrawal by Subject|2|||
155183663|NCT03823378|560110470|FG004|Overall Study|Withdrawal by Subject|0|||
155183664|NCT03823378|560110471|FG005|Overall Study|Withdrawal by Subject|1|||
155183665|NCT03823378|560110466|FG000|Overall Study|Other, not specified|19|||
155183666|NCT03823378|560110467|FG001|Overall Study|Other, not specified|12|||
155183667|NCT03823378|560110468|FG002|Overall Study|Other, not specified|6|||
155183668|NCT03823378|560110469|FG003|Overall Study|Other, not specified|8|||
155183669|NCT03823378|560110470|FG004|Overall Study|Other, not specified|17|||
155183670|NCT03823378|560110471|FG005|Overall Study|Other, not specified|7|||
155183671|NCT01606254|560110472|FG000|Overall Study|Withdrawal by Subject|1|||
155183672|NCT01606254|560110473|FG001|Overall Study|Withdrawal by Subject|3|||
155183673|NCT01606254|560110474|FG002|Overall Study|Withdrawal by Subject|0|||
155183674|NCT01606254|560110475|FG003|Overall Study|Withdrawal by Subject|2|||
155183675|NCT01606254|560110472|FG000|Overall Study|Adverse Event|1|||
155183676|NCT01606254|560110473|FG001|Overall Study|Adverse Event|1|||
155183677|NCT01606254|560110474|FG002|Overall Study|Adverse Event|0|||
155183678|NCT01606254|560110475|FG003|Overall Study|Adverse Event|1|||
155183679|NCT02131532|560110476|FG000|Overall Study|Withdrawal by Subject|1|||
155183680|NCT02131532|560110476|FG000|Overall Study|Physician Decision|1|||
155183681|NCT02131532|560110476|FG000|Overall Study|Other health conditions|2|||
155183682|NCT02093026|560110477|FG000|Overall Study|Adverse Event|26|||
155183683|NCT02093026|560110477|FG000|Overall Study|Death|10|||
155183684|NCT02093026|560110477|FG000|Overall Study|Other|157|||
155183685|NCT00174291|560110482|FG000|Overall Study|Lost to Follow-up|1|||
155183686|NCT00174291|560110483|FG001|Overall Study|Lost to Follow-up|1|||
155183687|NCT00174291|560110482|FG000|Overall Study|Protocol Violation|0|||
155183688|NCT00174291|560110483|FG001|Overall Study|Protocol Violation|2|||
155183689|NCT00174291|560110482|FG000|Overall Study|Study terminated by sponsor|1|||
155183690|NCT00174291|560110483|FG001|Overall Study|Study terminated by sponsor|0|||
155183691|NCT00174291|560110482|FG000|Overall Study|Withdrawal by Subject|3|||
155183692|NCT00174291|560110483|FG001|Overall Study|Withdrawal by Subject|3|||
155183693|NCT01582854|560110486|FG000|Overall Study|Death|8|||
155183694|NCT01582854|560110487|FG001|Overall Study|Death|5|||
155183695|NCT01582854|560110486|FG000|Overall Study|Adverse Event|2|||
155183696|NCT01582854|560110487|FG001|Overall Study|Adverse Event|3|||
155183697|NCT01582854|560110486|FG000|Overall Study|Withdrawal by Participant|8|||
155183698|NCT01582854|560110487|FG001|Overall Study|Withdrawal by Participant|11|||
155183699|NCT01582854|560110486|FG000|Overall Study|Lost to Follow-up|1|||
155183700|NCT01582854|560110487|FG001|Overall Study|Lost to Follow-up|2|||
155141613|NCT02709330|559948524|FG001|Overall Study|Lost to Follow-up|0|||
155141614|NCT02709330|559948523|FG000|Overall Study|Physician Decision|2|||
155141615|NCT02709330|559948524|FG001|Overall Study|Physician Decision|0|||
155141616|NCT02709330|559948523|FG000|Overall Study|Withdrawal by Subject|4|||
155141617|NCT02709330|559948524|FG001|Overall Study|Withdrawal by Subject|0|||
155141618|NCT01525615|559950354|FG000|Overall Study|Adverse Event|11|||
155141619|NCT01525615|559950355|FG001|Overall Study|Adverse Event|7|||
155141620|NCT01525615|559950356|FG002|Overall Study|Adverse Event|5|||
155141621|NCT01525615|559950354|FG000|Overall Study|Lost to Follow-up|1|||
155141622|NCT01525615|559950355|FG001|Overall Study|Lost to Follow-up|0|||
155141623|NCT01525615|559950356|FG002|Overall Study|Lost to Follow-up|0|||
155141624|NCT01525615|559950354|FG000|Overall Study|Withdrawal by Subject|1|||
155141625|NCT01525615|559950355|FG001|Overall Study|Withdrawal by Subject|0|||
155141626|NCT01525615|559950356|FG002|Overall Study|Withdrawal by Subject|0|||
155141627|NCT01525615|559950354|FG000|Overall Study|Other reason not described above|1|||
155141628|NCT01525615|559950355|FG001|Overall Study|Other reason not described above|0|||
155141629|NCT01525615|559950356|FG002|Overall Study|Other reason not described above|1|||
155141630|NCT04050618|559950357|FG000|First Intervention|Withdrawal by Subject|2|||
155141631|NCT04050618|559950358|FG001|First Intervention|Withdrawal by Subject|0|||
155141632|NCT04050618|559950357|FG000|Second Intervention|Withdrawal by Subject|1|||
155141633|NCT04050618|559950358|FG001|Second Intervention|Withdrawal by Subject|0|||
155141634|NCT01101035|559950361|FG000|Overall Study|Adverse Event|191|||
155141635|NCT01101035|559950362|FG001|Overall Study|Adverse Event|172|||
155141636|NCT01101035|559950361|FG000|Overall Study|Major Protocol Deviation|52|||
155141637|NCT01101035|559950362|FG001|Overall Study|Major Protocol Deviation|46|||
155141638|NCT01101035|559950361|FG000|Overall Study|Lost to Follow-up|226|||
155141639|NCT01101035|559950362|FG001|Overall Study|Lost to Follow-up|223|||
155141640|NCT01101035|559950361|FG000|Overall Study|Voluntary Withdrawal|595|||
155141641|NCT01101035|559950362|FG001|Overall Study|Voluntary Withdrawal|587|||
155141642|NCT01101035|559950361|FG000|Overall Study|Reason not Specified|333|||
155183701|NCT01582854|560110486|FG000|Overall Study|Physician Decision|0|||
155183702|NCT01582854|560110487|FG001|Overall Study|Physician Decision|1|||
155183703|NCT01582854|560110486|FG000|Overall Study|Recurrent Stroke|13|||
155183704|NCT01582854|560110487|FG001|Overall Study|Recurrent Stroke|8|||
155183705|NCT01582854|560110486|FG000|Overall Study|Disallowed Concomitant Medication|3|||
155183706|NCT01582854|560110487|FG001|Overall Study|Disallowed Concomitant Medication|2|||
155183707|NCT01582854|560110486|FG000|Overall Study|Carotid or Neurosurgery|0|||
155183708|NCT01582854|560110487|FG001|Overall Study|Carotid or Neurosurgery|1|||
155183709|NCT01582854|560110486|FG000|Overall Study|General Anaesthesia|0|||
155183710|NCT01582854|560110487|FG001|Overall Study|General Anaesthesia|1|||
155183711|NCT01582854|560110486|FG000|Overall Study|Other Miscellaneous Reason|1|||
155183712|NCT01582854|560110487|FG001|Overall Study|Other Miscellaneous Reason|0|||
155183713|NCT03101267|560110488|FG000|Primary Study Period|Withdrawal by Subject|1|||
155183714|NCT03101267|560110489|FG001|Primary Study Period|Withdrawal by Subject|2|||
155183715|NCT03101267|560110490|FG002|Primary Study Period|Withdrawal by Subject|3|||
155183716|NCT03101267|560110488|FG000|Primary Study Period|Miscellaneous|2|||
155183717|NCT03101267|560110489|FG001|Primary Study Period|Miscellaneous|0|||
155183718|NCT03101267|560110490|FG002|Primary Study Period|Miscellaneous|0|||
155183719|NCT04068896|560110491|FG000|Overall Study|Adverse Event|2|||
155183720|NCT04068896|560110492|FG001|Overall Study|Adverse Event|0|||
155183721|NCT04068896|560110493|FG002|Overall Study|Adverse Event|1|||
155183722|NCT04068896|560110494|FG003|Overall Study|Adverse Event|0|||
155183723|NCT04068896|560110495|FG004|Overall Study|Adverse Event|0|||
155183724|NCT04068896|560110496|FG005|Overall Study|Adverse Event|0|||
155183725|NCT04068896|560110491|FG000|Overall Study|Death|3|||
155183726|NCT04068896|560110492|FG001|Overall Study|Death|1|||
155183727|NCT04068896|560110493|FG002|Overall Study|Death|3|||
155183728|NCT04068896|560110494|FG003|Overall Study|Death|19|||
155183729|NCT04068896|560110495|FG004|Overall Study|Death|17|||
155183730|NCT04068896|560110496|FG005|Overall Study|Death|0|||
155183731|NCT04068896|560110491|FG000|Overall Study|Physician Decision|0|||
155183732|NCT04068896|560110492|FG001|Overall Study|Physician Decision|0|||
155183733|NCT04068896|560110493|FG002|Overall Study|Physician Decision|0|||
155183734|NCT04068896|560110494|FG003|Overall Study|Physician Decision|1|||
155183735|NCT04068896|560110495|FG004|Overall Study|Physician Decision|0|||
155183736|NCT04068896|560110496|FG005|Overall Study|Physician Decision|0|||
155141643|NCT01101035|559950362|FG001|Overall Study|Reason not Specified|363|||
155141644|NCT02420379|559950363|FG000|Overall Study|Withdrawal by Subject|0|||
155183737|NCT04068896|560110491|FG000|Overall Study|progressive disease|3|||
155141645|NCT02420379|559950364|FG001|Overall Study|Withdrawal by Subject|3|||
155141646|NCT02420379|559950363|FG000|Overall Study|Unable to complete due to schooling|0|||
155141647|NCT02420379|559950364|FG001|Overall Study|Unable to complete due to schooling|1|||
155141648|NCT02420379|559950363|FG000|Overall Study|Transitioned to commercial drug|1|||
155141649|NCT02420379|559950364|FG001|Overall Study|Transitioned to commercial drug|0|||
155141650|NCT03951077|559950373|FG000|Overall Study|Adverse Event|1|||
155141651|NCT03951077|559950374|FG001|Overall Study|Adverse Event|0|||
155141652|NCT03951077|559950375|FG002|Overall Study|Adverse Event|0|||
155141653|NCT03951077|559950376|FG003|Overall Study|Adverse Event|0|||
155141654|NCT03951077|559950377|FG004|Overall Study|Adverse Event|0|||
155141655|NCT03951077|559950378|FG005|Overall Study|Adverse Event|0|||
155141656|NCT03951077|559950373|FG000|Overall Study|Withdrawal by Subject|3|||
155141657|NCT03951077|559950374|FG001|Overall Study|Withdrawal by Subject|3|||
155141658|NCT03951077|559950375|FG002|Overall Study|Withdrawal by Subject|0|||
155141659|NCT03951077|559950376|FG003|Overall Study|Withdrawal by Subject|3|||
155141660|NCT03951077|559950377|FG004|Overall Study|Withdrawal by Subject|3|||
155141661|NCT03951077|559950378|FG005|Overall Study|Withdrawal by Subject|2|||
155141662|NCT03951077|559950373|FG000|Overall Study|Lost to Follow-up|1|||
155141663|NCT03951077|559950374|FG001|Overall Study|Lost to Follow-up|1|||
155141664|NCT03951077|559950375|FG002|Overall Study|Lost to Follow-up|2|||
155141665|NCT03951077|559950376|FG003|Overall Study|Lost to Follow-up|3|||
155141666|NCT03951077|559950377|FG004|Overall Study|Lost to Follow-up|2|||
155141667|NCT03951077|559950378|FG005|Overall Study|Lost to Follow-up|3|||
155141668|NCT03951077|559950373|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
155141669|NCT03951077|559950374|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
155141670|NCT03951077|559950375|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
155141671|NCT03951077|559950376|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
155141672|NCT03951077|559950377|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
155141673|NCT03951077|559950378|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
155141674|NCT03951077|559950373|FG000|Overall Study|Other, Not Specified|12|||
155141675|NCT03951077|559950374|FG001|Overall Study|Other, Not Specified|10|||
155141676|NCT03951077|559950375|FG002|Overall Study|Other, Not Specified|10|||
155141677|NCT03951077|559950376|FG003|Overall Study|Other, Not Specified|5|||
155141678|NCT03951077|559950377|FG004|Overall Study|Other, Not Specified|9|||
155141679|NCT03951077|559950378|FG005|Overall Study|Other, Not Specified|6|||
155141680|NCT03951077|559950373|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
155141681|NCT03951077|559950374|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
155141682|NCT03951077|559950375|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
155141683|NCT03951077|559950376|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
155141684|NCT03951077|559950377|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
155141685|NCT03951077|559950378|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
155141686|NCT00086047|559950380|FG000|Overall Study|Lost to Follow-up|7|||
155141687|NCT00086047|559950381|FG001|Overall Study|Lost to Follow-up|6|||
155141688|NCT00086047|559950380|FG000|Overall Study|Physician Decision|0|||
155141689|NCT00086047|559950381|FG001|Overall Study|Physician Decision|1|||
155141690|NCT01395901|559950382|FG000|Overall Study|Lost to Follow-up|4|||
155141691|NCT01395901|559950383|FG001|Overall Study|Lost to Follow-up|0|||
155141692|NCT01395901|559950382|FG000|Overall Study|Randomized but not received study drug|5|||
155141693|NCT01395901|559950383|FG001|Overall Study|Randomized but not received study drug|4|||
155141694|NCT01395901|559950382|FG000|Overall Study|Adverse Event|0|||
155141695|NCT01395901|559950383|FG001|Overall Study|Adverse Event|1|||
155141696|NCT01395901|559950382|FG000|Overall Study|Withdrawal of consent|1|||
155141697|NCT01395901|559950383|FG001|Overall Study|Withdrawal of consent|0|||
155141698|NCT03579940|559950389|FG000|Period 2|Withdrawal by Subject|0|||
155141699|NCT03579940|559950390|FG001|Period 2|Withdrawal by Subject|0|||
155141700|NCT03579940|559950391|FG002|Period 2|Withdrawal by Subject|1|||
155141701|NCT03579940|559950392|FG003|Period 2|Withdrawal by Subject|0|||
155141702|NCT03579940|559950393|FG004|Period 2|Withdrawal by Subject|0|||
155141703|NCT03579940|559950394|FG005|Period 2|Withdrawal by Subject|0|||
155141704|NCT03579940|559950395|FG006|Period 2|Withdrawal by Subject|0|||
155141705|NCT03579940|559950396|FG007|Period 2|Withdrawal by Subject|0|||
155141706|NCT03579940|559950397|FG008|Period 2|Withdrawal by Subject|0|||
155141707|NCT03579940|559950398|FG009|Period 2|Withdrawal by Subject|0|||
155141708|NCT03579940|559950399|FG010|Period 2|Withdrawal by Subject|0|||
155141709|NCT01641601|559950400|FG000|Overall Study|Study discontinued.|3|||
155141710|NCT01641601|559950401|FG001|Overall Study|Study discontinued.|5|||
155141711|NCT01388907|559950404|FG000|Overall Study|Adverse Event|2|||
155141712|NCT01388907|559950405|FG001|Overall Study|Adverse Event|0|||
155141713|NCT03361293|559950406|FG000|Overall Study|Lost to Follow-up|0|||
155141714|NCT03361293|559950407|FG001|Overall Study|Lost to Follow-up|2|||
155141715|NCT03361293|559950406|FG000|Overall Study|Withdrawal by Subject|1|||
155141716|NCT03361293|559950407|FG001|Overall Study|Withdrawal by Subject|3|||
155141717|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
155141718|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
155141719|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
155141720|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
155183738|NCT04068896|560110492|FG001|Overall Study|progressive disease|5|||
155183739|NCT04068896|560110493|FG002|Overall Study|progressive disease|3|||
155183740|NCT04068896|560110494|FG003|Overall Study|progressive disease|2|||
155183741|NCT04068896|560110495|FG004|Overall Study|progressive disease|1|||
155183742|NCT04068896|560110496|FG005|Overall Study|progressive disease|2|||
155183743|NCT04068896|560110491|FG000|Overall Study|Study terminated by sponsor|0|||
155183744|NCT04068896|560110492|FG001|Overall Study|Study terminated by sponsor|0|||
155183745|NCT04068896|560110493|FG002|Overall Study|Study terminated by sponsor|1|||
155183746|NCT04068896|560110494|FG003|Overall Study|Study terminated by sponsor|2|||
155183747|NCT04068896|560110495|FG004|Overall Study|Study terminated by sponsor|1|||
155183748|NCT04068896|560110496|FG005|Overall Study|Study terminated by sponsor|4|||
155183749|NCT04068896|560110491|FG000|Overall Study|Protocol Violation|0|||
155183750|NCT04068896|560110492|FG001|Overall Study|Protocol Violation|0|||
155183751|NCT04068896|560110493|FG002|Overall Study|Protocol Violation|0|||
155183752|NCT04068896|560110494|FG003|Overall Study|Protocol Violation|1|||
155183753|NCT04068896|560110495|FG004|Overall Study|Protocol Violation|0|||
155183754|NCT04068896|560110496|FG005|Overall Study|Protocol Violation|0|||
155183755|NCT04068896|560110491|FG000|Overall Study|Withdrawal by Subject|0|||
155183756|NCT04068896|560110492|FG001|Overall Study|Withdrawal by Subject|3|||
155183757|NCT04068896|560110493|FG002|Overall Study|Withdrawal by Subject|0|||
155183758|NCT04068896|560110494|FG003|Overall Study|Withdrawal by Subject|2|||
155183759|NCT04068896|560110495|FG004|Overall Study|Withdrawal by Subject|1|||
155183760|NCT04068896|560110496|FG005|Overall Study|Withdrawal by Subject|0|||
155183761|NCT04068896|560110491|FG000|Overall Study|Symptomatic deterioration|2|||
155183762|NCT04068896|560110492|FG001|Overall Study|Symptomatic deterioration|0|||
155183763|NCT04068896|560110493|FG002|Overall Study|Symptomatic deterioration|0|||
155183764|NCT04068896|560110494|FG003|Overall Study|Symptomatic deterioration|0|||
155183765|NCT04068896|560110495|FG004|Overall Study|Symptomatic deterioration|0|||
155183766|NCT04068896|560110496|FG005|Overall Study|Symptomatic deterioration|0|||
155183767|NCT02953509|560110497|FG000|Overall Study|Death|1|||
155183768|NCT02953509|560110498|FG001|Overall Study|Death|3|||
155183769|NCT02953509|560110499|FG002|Overall Study|Death|3|||
155183770|NCT02953509|560110500|FG003|Overall Study|Death|4|||
155183771|NCT02953509|560110501|FG004|Overall Study|Death|12|||
155183772|NCT02953509|560110502|FG005|Overall Study|Death|3|||
155183773|NCT02953509|560110503|FG006|Overall Study|Death|25|||
155183774|NCT02953509|560110504|FG007|Overall Study|Death|10|||
155183775|NCT02953509|560110505|FG008|Overall Study|Death|21|||
155183776|NCT02953509|560110506|FG009|Overall Study|Death|20|||
155183777|NCT02953509|560110497|FG000|Overall Study|Reason Not Specified|0|||
155183778|NCT02953509|560110498|FG001|Overall Study|Reason Not Specified|2|||
155183779|NCT02953509|560110499|FG002|Overall Study|Reason Not Specified|8|||
155183780|NCT02953509|560110500|FG003|Overall Study|Reason Not Specified|2|||
155183781|NCT02953509|560110501|FG004|Overall Study|Reason Not Specified|11|||
155183782|NCT02953509|560110502|FG005|Overall Study|Reason Not Specified|4|||
155183783|NCT02953509|560110503|FG006|Overall Study|Reason Not Specified|12|||
155183784|NCT02953509|560110504|FG007|Overall Study|Reason Not Specified|2|||
155183785|NCT02953509|560110505|FG008|Overall Study|Reason Not Specified|7|||
155183786|NCT02953509|560110506|FG009|Overall Study|Reason Not Specified|2|||
155183787|NCT02953509|560110497|FG000|Overall Study|Consent Withdrawn|1|||
155183788|NCT02953509|560110498|FG001|Overall Study|Consent Withdrawn|1|||
155183789|NCT02953509|560110499|FG002|Overall Study|Consent Withdrawn|2|||
155183790|NCT02953509|560110500|FG003|Overall Study|Consent Withdrawn|1|||
155183791|NCT02953509|560110501|FG004|Overall Study|Consent Withdrawn|3|||
155183792|NCT02953509|560110502|FG005|Overall Study|Consent Withdrawn|0|||
155183793|NCT02953509|560110503|FG006|Overall Study|Consent Withdrawn|4|||
155183794|NCT02953509|560110504|FG007|Overall Study|Consent Withdrawn|1|||
155183795|NCT02953509|560110505|FG008|Overall Study|Consent Withdrawn|1|||
155183796|NCT02953509|560110506|FG009|Overall Study|Consent Withdrawn|4|||
155183797|NCT02953509|560110497|FG000|Overall Study|Lost to Follow-up|0|||
155183798|NCT02953509|560110498|FG001|Overall Study|Lost to Follow-up|0|||
155183799|NCT02953509|560110499|FG002|Overall Study|Lost to Follow-up|0|||
155183800|NCT02953509|560110500|FG003|Overall Study|Lost to Follow-up|0|||
155183801|NCT02953509|560110501|FG004|Overall Study|Lost to Follow-up|0|||
155183802|NCT02953509|560110502|FG005|Overall Study|Lost to Follow-up|0|||
155183803|NCT02953509|560110503|FG006|Overall Study|Lost to Follow-up|1|||
155183804|NCT02953509|560110504|FG007|Overall Study|Lost to Follow-up|1|||
155183805|NCT02953509|560110505|FG008|Overall Study|Lost to Follow-up|1|||
155183806|NCT02953509|560110506|FG009|Overall Study|Lost to Follow-up|1|||
155183807|NCT02953509|560110497|FG000|Overall Study|Study terminated by sponsor|1|||
155183808|NCT02953509|560110498|FG001|Overall Study|Study terminated by sponsor|0|||
155183809|NCT02953509|560110499|FG002|Overall Study|Study terminated by sponsor|0|||
155183810|NCT02953509|560110500|FG003|Overall Study|Study terminated by sponsor|0|||
155183811|NCT02953509|560110501|FG004|Overall Study|Study terminated by sponsor|0|||
155183812|NCT02953509|560110502|FG005|Overall Study|Study terminated by sponsor|0|||
155183813|NCT02953509|560110503|FG006|Overall Study|Study terminated by sponsor|1|||
155183814|NCT02953509|560110504|FG007|Overall Study|Study terminated by sponsor|0|||
155183815|NCT02953509|560110505|FG008|Overall Study|Study terminated by sponsor|1|||
155183816|NCT02953509|560110506|FG009|Overall Study|Study terminated by sponsor|1|||
155183817|NCT00913692|560110508|FG000|Screening (4 Months)|Physician Decision|3|||
155141721|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
155141722|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
155141723|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
155141724|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
155141725|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
155141726|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
155141727|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
155141728|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
155141729|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
155141730|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
155141731|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
155141732|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
155141733|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
155141734|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
155141735|NCT01910402|559950408|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
155141736|NCT01910402|559950409|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
155141737|NCT01910402|559950410|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
155141738|NCT01910402|559950408|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
155141739|NCT01910402|559950409|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
155141740|NCT01910402|559950410|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
155141741|NCT01910402|559950408|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
155141742|NCT01910402|559950409|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
155141743|NCT01910402|559950410|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
155141744|NCT01910402|559950408|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
155141745|NCT01910402|559950409|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
155141746|NCT01910402|559950410|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
155141747|NCT01910402|559950408|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
155141748|NCT01910402|559950409|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
155141749|NCT01910402|559950410|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
155141750|NCT01910402|559950408|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
155141751|NCT01910402|559950409|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
155141752|NCT01910402|559950410|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
155141753|NCT01910402|559950408|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
155141754|NCT01910402|559950409|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
155141755|NCT01910402|559950410|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
155141756|NCT01550757|559950412|FG000|Overall Study|Lost to Follow-up|21|||
155141757|NCT01550757|559950413|FG001|Overall Study|Lost to Follow-up|14|||
155141758|NCT01550757|559950414|FG002|Overall Study|Lost to Follow-up|42|||
155141759|NCT01550757|559950415|FG003|Overall Study|Lost to Follow-up|53|||
155141760|NCT01550757|559950412|FG000|Overall Study|Withdrawal by Subject|2|||
155141761|NCT01550757|559950413|FG001|Overall Study|Withdrawal by Subject|0|||
155141762|NCT01550757|559950414|FG002|Overall Study|Withdrawal by Subject|3|||
155141763|NCT01550757|559950415|FG003|Overall Study|Withdrawal by Subject|1|||
155141764|NCT01426958|559950416|FG000|Overall Study|Adverse Event|2|||
155141765|NCT00991939|559950423|FG000|Overall Study|Lost to Follow-up|0|||
155141766|NCT00991939|559950424|FG001|Overall Study|Lost to Follow-up|1|||
155141767|NCT00991939|559950423|FG000|Overall Study|Withdrawal by Subject|1|||
155141768|NCT00991939|559950424|FG001|Overall Study|Withdrawal by Subject|0|||
155141769|NCT00991939|559950423|FG000|Overall Study|Entire study terminated|4|||
155141770|NCT00991939|559950424|FG001|Overall Study|Entire study terminated|1|||
155141771|NCT00740584|559950425|FG000|Overall Study|Withdrawal by Subject|1|||
155141772|NCT01461707|559950426|FG000|Overall Study|Withdrawal by Subject|1|||
155141773|NCT01461707|559950427|FG001|Overall Study|Withdrawal by Subject|0|||
155141774|NCT00855816|559950430|FG000|Overall Study|Withdrawal by Subject|22|||
155141775|NCT00855816|559950431|FG001|Overall Study|Withdrawal by Subject|15|||
155141776|NCT00855816|559950430|FG000|Overall Study|Lost to Follow-up|3|||
155141777|NCT00855816|559950431|FG001|Overall Study|Lost to Follow-up|5|||
155141778|NCT00855816|559950430|FG000|Overall Study|Death|1|||
155141779|NCT00855816|559950431|FG001|Overall Study|Death|0|||
155141780|NCT00855816|559950430|FG000|Overall Study|Became ineligible|0|||
155141781|NCT00855816|559950431|FG001|Overall Study|Became ineligible|1|||
155141782|NCT00837213|559950433|FG000|Overall Study|Lost to Follow-up|3|||
155141783|NCT00837213|559950434|FG001|Overall Study|Lost to Follow-up|2|||
155141784|NCT00837213|559950433|FG000|Overall Study|Withdrawal by Subject|2|||
155141785|NCT00837213|559950434|FG001|Overall Study|Withdrawal by Subject|2|||
155141786|NCT00837213|559950433|FG000|Overall Study|not stated|1|||
155141787|NCT00837213|559950434|FG001|Overall Study|not stated|1|||
155141788|NCT02524171|559950438|FG000|6-month Follow-up|Lost to Follow-up|53|||
155141789|NCT02524171|559950439|FG001|6-month Follow-up|Lost to Follow-up|45|||
155141790|NCT02524171|559950438|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
155031410|NCT03626363|559540915|FG001|Overall Study|Lost to Follow-up|7|||
155031411|NCT01970475|559540916|FG000|Overall Study|Withdrawal by Subject|11|||
155031412|NCT01970475|559540917|FG001|Overall Study|Withdrawal by Subject|6|||
155031413|NCT01970475|559540916|FG000|Overall Study|Adverse Event|7|||
155183818|NCT00913692|560110508|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
155183819|NCT00913692|560110508|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
155183820|NCT00256282|560110509|FG000|Overall Study|Disease progression, relapse during acti|12|||
155183821|NCT00256282|560110509|FG000|Overall Study|Adverse Event|3|||
155183822|NCT00256282|560110509|FG000|Overall Study|Physician Decision|1|||
155183823|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
155183824|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
155183825|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
155183826|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
155183827|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
155183828|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
155183829|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
155183830|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
155183831|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
155183832|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
155183833|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
155183834|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
155183835|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
155183836|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
155183837|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
155183838|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
155183839|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
155183840|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
155183841|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
155183842|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
155183843|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
155183844|NCT02431247|560110510|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
155183845|NCT02431247|560110511|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
155183846|NCT02431247|560110512|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
155183847|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155183848|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
155183849|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
155183850|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155183851|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
155183852|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
155183853|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155183854|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
155183855|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
155183856|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155183857|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
155183858|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
155183859|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155183860|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
155183861|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
155183862|NCT02431247|560110510|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155183863|NCT02431247|560110511|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
155183864|NCT02431247|560110512|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
155183865|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
155183866|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
155141791|NCT02524171|559950439|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
155141792|NCT02868554|559950446|FG000|Overall Study|Lost to Follow-up|3|||
155141793|NCT02868554|559950447|FG001|Overall Study|Lost to Follow-up|0|||
155031414|NCT01970475|559540917|FG001|Overall Study|Adverse Event|3|||
155141794|NCT02868554|559950448|FG002|Overall Study|Lost to Follow-up|1|||
155141795|NCT00216671|559950449|FG000|Overall Study|Adverse Event|4|||
155141796|NCT00216671|559950450|FG001|Overall Study|Adverse Event|9|||
155141797|NCT00216671|559950449|FG000|Overall Study|Pregnancy|0|||
155141798|NCT00216671|559950450|FG001|Overall Study|Pregnancy|1|||
155141799|NCT00216671|559950449|FG000|Overall Study|Withdrawal by Subject|4|||
155183867|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Other|2|||
155183868|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Other|2|||
155183869|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Personal reasons|2|||
155031415|NCT01970475|559540916|FG000|Overall Study|Lost to Follow-up|2|||
155031416|NCT01970475|559540917|FG001|Overall Study|Lost to Follow-up|2|||
155031417|NCT01970475|559540916|FG000|Overall Study|Protocol Violation|1|||
155141800|NCT00216671|559950450|FG001|Overall Study|Withdrawal by Subject|2|||
155183870|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Personal reasons|2|||
155183871|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
155183872|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
155183873|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
155183874|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
155183875|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
155183876|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
155031418|NCT01970475|559540917|FG001|Overall Study|Protocol Violation|0|||
155031419|NCT00960986|559540918|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
155141801|NCT00216671|559950449|FG000|Overall Study|Refused Injections|3|||
155141802|NCT00216671|559950450|FG001|Overall Study|Refused Injections|13|||
155141803|NCT00216671|559950449|FG000|Overall Study|No Need to Continue Medication|1|||
155141804|NCT00216671|559950450|FG001|Overall Study|No Need to Continue Medication|1|||
155141805|NCT00216671|559950449|FG000|Overall Study|Insufficient Response|9|||
155141806|NCT00216671|559950450|FG001|Overall Study|Insufficient Response|4|||
155141807|NCT00216671|559950449|FG000|Overall Study|Lost to Follow-up|3|||
155141808|NCT00216671|559950450|FG001|Overall Study|Lost to Follow-up|5|||
155141809|NCT00216671|559950449|FG000|Overall Study|Non compliant|2|||
155141810|NCT00216671|559950450|FG001|Overall Study|Non compliant|2|||
155141811|NCT00216671|559950449|FG000|Overall Study|Ineligible|0|||
155141812|NCT00216671|559950450|FG001|Overall Study|Ineligible|2|||
155141813|NCT00216671|559950449|FG000|Overall Study|Physician Decision|1|||
155141814|NCT00216671|559950450|FG001|Overall Study|Physician Decision|1|||
155141815|NCT00216671|559950449|FG000|Overall Study|Protocol Violation|3|||
155141816|NCT00216671|559950450|FG001|Overall Study|Protocol Violation|5|||
155141817|NCT00216671|559950449|FG000|Overall Study|Relapse|1|||
155141818|NCT00216671|559950450|FG001|Overall Study|Relapse|0|||
155141819|NCT00216671|559950449|FG000|Overall Study|Investigator Illness|0|||
155141820|NCT00216671|559950450|FG001|Overall Study|Investigator Illness|1|||
155141821|NCT00216671|559950449|FG000|Overall Study|Patient Moved|0|||
155141822|NCT00216671|559950450|FG001|Overall Study|Patient Moved|1|||
155141823|NCT00216671|559950449|FG000|Overall Study|Ineligible, no efficacy data|2|||
155141824|NCT00216671|559950450|FG001|Overall Study|Ineligible, no efficacy data|2|||
155141825|NCT00216671|559950449|FG000|Overall Study|Insufficient Response Adverse Event|2|||
155141826|NCT00216671|559950450|FG001|Overall Study|Insufficient Response Adverse Event|1|||
155141827|NCT02714569|559950451|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
155141828|NCT02714569|559950452|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
155141829|NCT02714569|559950453|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
155141830|NCT02714569|559950454|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
155141831|NCT02714569|559950455|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
155141832|NCT02714569|559950456|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
155141833|NCT02714569|559950457|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
155141834|NCT02714569|559950458|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
155141835|NCT02714569|559950459|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
155141836|NCT02714569|559950460|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
155141837|NCT02714569|559950461|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
155141838|NCT02714569|559950451|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141839|NCT02714569|559950452|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141840|NCT02714569|559950453|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141841|NCT02714569|559950454|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
155141842|NCT02714569|559950455|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141843|NCT02714569|559950456|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141844|NCT02714569|559950457|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141845|NCT02714569|559950458|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141846|NCT02714569|559950459|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141847|NCT02714569|559950460|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141848|NCT02714569|559950461|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
155141849|NCT02714569|559950451|FG000|Part A Third Intervention|Adverse Event|0|||
155141850|NCT02714569|559950452|FG001|Part A Third Intervention|Adverse Event|0|||
155141851|NCT02714569|559950453|FG002|Part A Third Intervention|Adverse Event|1|||
155141852|NCT02714569|559950454|FG003|Part A Third Intervention|Adverse Event|0|||
155141853|NCT02714569|559950455|FG004|Part A Third Intervention|Adverse Event|0|||
155141854|NCT02714569|559950456|FG005|Part A Third Intervention|Adverse Event|0|||
155141855|NCT02714569|559950457|FG006|Part A Third Intervention|Adverse Event|0|||
155141856|NCT02714569|559950458|FG007|Part A Third Intervention|Adverse Event|0|||
155141857|NCT02714569|559950459|FG008|Part A Third Intervention|Adverse Event|0|||
155141858|NCT02714569|559950460|FG009|Part A Third Intervention|Adverse Event|0|||
155141859|NCT02714569|559950461|FG010|Part A Third Intervention|Adverse Event|0|||
155141860|NCT02714569|559950451|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
155183877|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
155183878|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
155183879|NCT00667446|560110513|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
155183880|NCT00667446|560110514|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
155183881|NCT00667446|560110513|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
155183882|NCT00667446|560110514|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
155183883|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
155183884|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
155183885|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
155183886|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
155183887|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
155183888|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
155183889|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
155183890|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
155183891|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
155183892|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
155183893|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
155183894|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
155183895|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
155183896|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
155183897|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
155183898|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
155183899|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
155183900|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
155183901|NCT00591578|560110515|FG000|Double-Blind Treatment Phase|Other|4|||
155183902|NCT00591578|560110516|FG001|Double-Blind Treatment Phase|Other|9|||
155183903|NCT00591578|560110517|FG002|Double-Blind Treatment Phase|Other|4|||
155183904|NCT00591578|560110515|FG000|Open-Label Extension Phase|Adverse Event|3|||
155183905|NCT00591578|560110516|FG001|Open-Label Extension Phase|Adverse Event|5|||
155183906|NCT00591578|560110517|FG002|Open-Label Extension Phase|Adverse Event|0|||
155183907|NCT00591578|560110515|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
155183908|NCT00591578|560110516|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
155183909|NCT00591578|560110517|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155183910|NCT00591578|560110515|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
155183911|NCT00591578|560110516|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
155183912|NCT00591578|560110517|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
155183913|NCT00591578|560110515|FG000|Open-Label Extension Phase|Other|1|||
155183914|NCT00591578|560110516|FG001|Open-Label Extension Phase|Other|0|||
155183915|NCT00591578|560110517|FG002|Open-Label Extension Phase|Other|0|||
155183916|NCT02380690|560110518|FG000|Overall Study|Lost to Follow-up|14|||
155183917|NCT02380690|560110519|FG001|Overall Study|Lost to Follow-up|4|||
155183918|NCT02380690|560110518|FG000|Overall Study|Withdrawal by Subject|20|||
155183919|NCT02380690|560110519|FG001|Overall Study|Withdrawal by Subject|8|||
155183920|NCT00523367|560110526|FG000|Overall Study|19 screen failures|19|||
155183921|NCT00523367|560110526|FG000|Overall Study|4 Withdrawn by PI|4|||
155183922|NCT00356122|560110530|FG000|TREATMENT|Lack of Efficacy|26|||
155183923|NCT00356122|560110530|FG000|TREATMENT|Adverse Event|10|||
155183924|NCT00356122|560110530|FG000|TREATMENT|Subject's request|4|||
155183925|NCT00356122|560110530|FG000|TREATMENT|Other|4|||
155183926|NCT00356122|560110530|FG000|TREATMENT|Did not receive study medication|1|||
155183927|NCT00356122|560110530|FG000|FOLLOW-UP|Death|37|||
155183928|NCT00356122|560110530|FG000|FOLLOW-UP|Lost to Follow-up|2|||
155183929|NCT00356122|560110530|FG000|FOLLOW-UP|Other|2|||
155183930|NCT00782795|560110531|FG000|Overall Study|Withdrawal by Subject|1|||
155183931|NCT00782795|560110532|FG001|Overall Study|Withdrawal by Subject|2|||
155183932|NCT04480424|560110533|FG000|Overall Study|Withdrawal by Subject|0|||
155183933|NCT04480424|560110534|FG001|Overall Study|Withdrawal by Subject|2|||
155183934|NCT04480424|560110533|FG000|Overall Study|Lost to Follow-up|3|||
155183935|NCT04480424|560110534|FG001|Overall Study|Lost to Follow-up|3|||
155183936|NCT04480424|560110533|FG000|Overall Study|Death|14|||
155183937|NCT04480424|560110534|FG001|Overall Study|Death|16|||
155183938|NCT04480424|560110533|FG000|Overall Study|Reason not Specified|5|||
155183939|NCT04480424|560110534|FG001|Overall Study|Reason not Specified|5|||
155183940|NCT03693170|560112410|FG000|Overall Study|Disease Progression|48|||
155183941|NCT03693170|560112410|FG000|Overall Study|Adverse Event|16|||
155183942|NCT03693170|560112410|FG000|Overall Study|Physician Decision|6|||
155183943|NCT03693170|560112410|FG000|Overall Study|Protocol Violation|2|||
155183944|NCT03693170|560112410|FG000|Overall Study|Death|1|||
155183945|NCT03693170|560112410|FG000|Overall Study|Non compliance with study drug|1|||
155183946|NCT03693170|560112410|FG000|Overall Study|Withdrawal by Subject|1|||
155183947|NCT04444895|560112411|FG000|Overall Study|Adverse Event|2|||
155183948|NCT04444895|560112411|FG000|Overall Study|Lost to Follow-up|2|||
155183949|NCT04444895|560112411|FG000|Overall Study|Withdrawal by Subject|5|||
155183950|NCT03581786|560112412|FG000|Overall Study|Death|67|||
155183951|NCT03581786|560112413|FG001|Overall Study|Death|47|||
155183952|NCT03581786|560112412|FG000|Overall Study|Withdrawal by Subject|2|||
155183953|NCT03581786|560112413|FG001|Overall Study|Withdrawal by Subject|5|||
155183954|NCT03581786|560112412|FG000|Overall Study|Lost to Follow-up|7|||
155183955|NCT03581786|560112413|FG001|Overall Study|Lost to Follow-up|4|||
155183956|NCT03581786|560112412|FG000|Overall Study|reason other than specified above|0|||
155183957|NCT03581786|560112413|FG001|Overall Study|reason other than specified above|1|||
155183958|NCT05523323|560112414|FG000|Overall Study|Death|26|||
155183959|NCT05523323|560112415|FG001|Overall Study|Death|21|||
155183960|NCT05523323|560112414|FG000|Overall Study|Ongoing participants|35|||
155183961|NCT05523323|560112415|FG001|Overall Study|Ongoing participants|30|||
155183962|NCT00920829|560112416|FG000|Allocation|No post randomization data|3|||
155183963|NCT00920829|560112417|FG001|Allocation|No post randomization data|1|||
155183964|NCT00920829|560112418|FG002|Allocation|No post randomization data|0|||
155183965|NCT00920829|560112419|FG003|Allocation|No post randomization data|2|||
155183966|NCT00920829|560112416|FG000|Available for Analysis|Withdrawal by Subject|6|||
155183967|NCT00920829|560112417|FG001|Available for Analysis|Withdrawal by Subject|6|||
155183968|NCT00920829|560112418|FG002|Available for Analysis|Withdrawal by Subject|6|||
155183969|NCT00920829|560112419|FG003|Available for Analysis|Withdrawal by Subject|10|||
155183970|NCT00920829|560112416|FG000|Available for Analysis|Required Medical Treatment|0|||
155183971|NCT00920829|560112417|FG001|Available for Analysis|Required Medical Treatment|1|||
155183972|NCT00920829|560112418|FG002|Available for Analysis|Required Medical Treatment|2|||
155183973|NCT00920829|560112419|FG003|Available for Analysis|Required Medical Treatment|0|||
155183974|NCT00920829|560112416|FG000|Available for Analysis|Adverse Event|1|||
155183975|NCT00920829|560112417|FG001|Available for Analysis|Adverse Event|2|||
155183976|NCT00920829|560112418|FG002|Available for Analysis|Adverse Event|1|||
155183977|NCT00920829|560112419|FG003|Available for Analysis|Adverse Event|0|||
155183978|NCT00920829|560112416|FG000|Available for Analysis|Death|1|||
155183979|NCT00920829|560112417|FG001|Available for Analysis|Death|0|||
155183980|NCT00920829|560112418|FG002|Available for Analysis|Death|0|||
155183981|NCT00920829|560112419|FG003|Available for Analysis|Death|0|||
155183982|NCT00920829|560112416|FG000|Available for Analysis|Protocol Violation|0|||
155183983|NCT00920829|560112417|FG001|Available for Analysis|Protocol Violation|0|||
155183984|NCT00920829|560112418|FG002|Available for Analysis|Protocol Violation|1|||
155183985|NCT00920829|560112419|FG003|Available for Analysis|Protocol Violation|0|||
155183986|NCT00920829|560112416|FG000|Available for Analysis|Required more treatment|0|||
155183987|NCT00920829|560112417|FG001|Available for Analysis|Required more treatment|2|||
155183988|NCT00920829|560112418|FG002|Available for Analysis|Required more treatment|0|||
155183989|NCT00920829|560112419|FG003|Available for Analysis|Required more treatment|1|||
155183990|NCT00053365|560112424|FG000|Overall Study|Incorrect cell type|1|||
155183991|NCT00053365|560112424|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
155183992|NCT00053365|560112424|FG000|Overall Study|Never treated|4|||
155183993|NCT01483690|560112426|FG000|Overall Study|Adverse Event|1|||
155183994|NCT01483690|560112427|FG001|Overall Study|Adverse Event|2|||
155183995|NCT01483690|560112426|FG000|Overall Study|clinical deterioration|1|||
155183996|NCT01483690|560112427|FG001|Overall Study|clinical deterioration|0|||
155183997|NCT01483690|560112426|FG000|Overall Study|Physician Decision|0|||
155183998|NCT01483690|560112427|FG001|Overall Study|Physician Decision|2|||
155183999|NCT01483690|560112426|FG000|Overall Study|exclusionary procedure|0|||
155184000|NCT01483690|560112427|FG001|Overall Study|exclusionary procedure|1|||
155184001|NCT03981822|560112428|FG000|Overall Study|Lost to Follow-up|0|||
155184002|NCT03981822|560112429|FG001|Overall Study|Lost to Follow-up|1|||
155184003|NCT03981822|560112430|FG002|Overall Study|Lost to Follow-up|1|||
155184004|NCT03981822|560112431|FG003|Overall Study|Lost to Follow-up|0|||
155184005|NCT03981822|560112432|FG004|Overall Study|Lost to Follow-up|6|||
155184006|NCT03981822|560112433|FG005|Overall Study|Lost to Follow-up|4|||
155184007|NCT03981822|560112434|FG006|Overall Study|Lost to Follow-up|4|||
155184008|NCT03981822|560112435|FG007|Overall Study|Lost to Follow-up|2|||
155184009|NCT03981822|560112428|FG000|Overall Study|Withdrawal by Subject|0|||
155184010|NCT03981822|560112429|FG001|Overall Study|Withdrawal by Subject|1|||
155184011|NCT03981822|560112430|FG002|Overall Study|Withdrawal by Subject|0|||
155184012|NCT03981822|560112431|FG003|Overall Study|Withdrawal by Subject|0|||
155184013|NCT03981822|560112432|FG004|Overall Study|Withdrawal by Subject|0|||
155184014|NCT03981822|560112433|FG005|Overall Study|Withdrawal by Subject|1|||
155184015|NCT03981822|560112434|FG006|Overall Study|Withdrawal by Subject|0|||
155184016|NCT03981822|560112435|FG007|Overall Study|Withdrawal by Subject|2|||
155184017|NCT03981822|560112428|FG000|Overall Study|COVID-19 Related|0|||
155184018|NCT03981822|560112429|FG001|Overall Study|COVID-19 Related|0|||
155184019|NCT03981822|560112430|FG002|Overall Study|COVID-19 Related|0|||
155184020|NCT03981822|560112431|FG003|Overall Study|COVID-19 Related|0|||
155184021|NCT03981822|560112432|FG004|Overall Study|COVID-19 Related|2|||
155184022|NCT03981822|560112433|FG005|Overall Study|COVID-19 Related|1|||
155184023|NCT03981822|560112434|FG006|Overall Study|COVID-19 Related|2|||
155184024|NCT03981822|560112435|FG007|Overall Study|COVID-19 Related|1|||
155184025|NCT02742246|560112436|FG000|Overall Study|Never initiated treatment|5|||
155184026|NCT02742246|560112437|FG001|Overall Study|Never initiated treatment|3|||
155184027|NCT02742246|560112438|FG002|Overall Study|Never initiated treatment|1|||
155141861|NCT02714569|559950452|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141862|NCT02714569|559950453|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141863|NCT02714569|559950454|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141864|NCT02714569|559950455|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141865|NCT02714569|559950456|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
155141866|NCT02714569|559950457|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141867|NCT02714569|559950458|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141868|NCT02714569|559950459|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141869|NCT02714569|559950460|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141870|NCT02714569|559950461|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
155141871|NCT02714569|559950451|FG000|Part B (Overall)|Lost to Follow-up|0|||
155141872|NCT02714569|559950452|FG001|Part B (Overall)|Lost to Follow-up|0|||
155141873|NCT02714569|559950453|FG002|Part B (Overall)|Lost to Follow-up|0|||
155141874|NCT02714569|559950454|FG003|Part B (Overall)|Lost to Follow-up|0|||
155141875|NCT02714569|559950455|FG004|Part B (Overall)|Lost to Follow-up|0|||
155141876|NCT02714569|559950456|FG005|Part B (Overall)|Lost to Follow-up|0|||
155141877|NCT02714569|559950457|FG006|Part B (Overall)|Lost to Follow-up|1|||
155141878|NCT02714569|559950458|FG007|Part B (Overall)|Lost to Follow-up|0|||
155141879|NCT02714569|559950459|FG008|Part B (Overall)|Lost to Follow-up|0|||
155141880|NCT02714569|559950460|FG009|Part B (Overall)|Lost to Follow-up|0|||
155141881|NCT02714569|559950461|FG010|Part B (Overall)|Lost to Follow-up|0|||
155141882|NCT02714569|559950451|FG000|Part B (Overall)|Withdrawal by Subject|0|||
155141883|NCT02714569|559950452|FG001|Part B (Overall)|Withdrawal by Subject|0|||
155141884|NCT02714569|559950453|FG002|Part B (Overall)|Withdrawal by Subject|0|||
155141885|NCT02714569|559950454|FG003|Part B (Overall)|Withdrawal by Subject|0|||
155141886|NCT02714569|559950455|FG004|Part B (Overall)|Withdrawal by Subject|0|||
155141887|NCT02714569|559950456|FG005|Part B (Overall)|Withdrawal by Subject|0|||
155141888|NCT02714569|559950457|FG006|Part B (Overall)|Withdrawal by Subject|0|||
155141889|NCT02714569|559950458|FG007|Part B (Overall)|Withdrawal by Subject|1|||
155141890|NCT02714569|559950459|FG008|Part B (Overall)|Withdrawal by Subject|0|||
155141891|NCT02714569|559950460|FG009|Part B (Overall)|Withdrawal by Subject|1|||
155141892|NCT02714569|559950461|FG010|Part B (Overall)|Withdrawal by Subject|0|||
155141893|NCT02714569|559950451|FG000|Part B (Overall)|Adverse Event|0|||
155141894|NCT02714569|559950452|FG001|Part B (Overall)|Adverse Event|0|||
155141895|NCT02714569|559950453|FG002|Part B (Overall)|Adverse Event|0|||
155141896|NCT02714569|559950454|FG003|Part B (Overall)|Adverse Event|0|||
155141897|NCT02714569|559950455|FG004|Part B (Overall)|Adverse Event|0|||
155141898|NCT02714569|559950456|FG005|Part B (Overall)|Adverse Event|0|||
155141899|NCT02714569|559950457|FG006|Part B (Overall)|Adverse Event|0|||
155141900|NCT02714569|559950458|FG007|Part B (Overall)|Adverse Event|0|||
155141901|NCT02714569|559950459|FG008|Part B (Overall)|Adverse Event|0|||
155141902|NCT02714569|559950460|FG009|Part B (Overall)|Adverse Event|1|||
155141903|NCT02714569|559950461|FG010|Part B (Overall)|Adverse Event|0|||
155141904|NCT01684202|559950462|FG000|Dose-escalation Period|Adverse Event|0|||
155141905|NCT01684202|559950463|FG001|Dose-escalation Period|Adverse Event|1|||
155141906|NCT01684202|559950464|FG002|Dose-escalation Period|Adverse Event|0|||
155141907|NCT01684202|559950465|FG003|Dose-escalation Period|Adverse Event|0|||
155141908|NCT01684202|559950462|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
155141909|NCT01684202|559950463|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
155141910|NCT01684202|559950464|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
155141911|NCT01684202|559950465|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
155141912|NCT01684202|559950462|FG000|Maintenance Period|Adverse Event|1|||
155141913|NCT01684202|559950463|FG001|Maintenance Period|Adverse Event|1|||
155141914|NCT01684202|559950464|FG002|Maintenance Period|Adverse Event|1|||
155141915|NCT01684202|559950465|FG003|Maintenance Period|Adverse Event|1|||
155141916|NCT01684202|559950462|FG000|Maintenance Period|Physician Decision|0|||
155141917|NCT01684202|559950463|FG001|Maintenance Period|Physician Decision|1|||
155141918|NCT01684202|559950464|FG002|Maintenance Period|Physician Decision|0|||
155141919|NCT01684202|559950465|FG003|Maintenance Period|Physician Decision|0|||
155141920|NCT01684202|559950462|FG000|Maintenance Period|Withdrawal by Subject|0|||
155141921|NCT01684202|559950463|FG001|Maintenance Period|Withdrawal by Subject|1|||
155141922|NCT01684202|559950464|FG002|Maintenance Period|Withdrawal by Subject|0|||
155141923|NCT01684202|559950465|FG003|Maintenance Period|Withdrawal by Subject|0|||
155141924|NCT00191308|559950466|FG000|Overall Study|Adverse Event|1|||
155141925|NCT00466921|559950467|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
155141926|NCT00466921|559950467|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
155141927|NCT00466921|559950467|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
155141928|NCT00466921|559950467|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
155141929|NCT00466921|559950467|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
155141930|NCT00466921|559950467|FG000|Follow up for a Minimum of 1 Year|Death|6|||
155141931|NCT00779025|559950468|FG000|Overall Study|Withdrawal by Subject|1|||
155141932|NCT03710642|559950472|FG000|Overall Study|Adverse Event|5|||
155141933|NCT03710642|559950473|FG001|Overall Study|Adverse Event|1|||
155184028|NCT02742246|560112436|FG000|Overall Study|dropped out during treatment|7|||
155184029|NCT02742246|560112437|FG001|Overall Study|dropped out during treatment|13|||
155184030|NCT02742246|560112438|FG002|Overall Study|dropped out during treatment|10|||
155184031|NCT02742246|560112436|FG000|Overall Study|Death|1|||
155184032|NCT02742246|560112437|FG001|Overall Study|Death|0|||
155184033|NCT02742246|560112438|FG002|Overall Study|Death|0|||
155184034|NCT03489551|560112439|FG000|Overall Study|Withdrawal by Subject|2|||
155184035|NCT00054717|560112440|FG000|Overall Study|Randomized but not treated|2|||
155184036|NCT00054717|560112441|FG001|Overall Study|Randomized but not treated|8|||
155184037|NCT00054717|560112440|FG000|Overall Study|Adverse Event|70|||
155184038|NCT00054717|560112441|FG001|Overall Study|Adverse Event|22|||
155184039|NCT00054717|560112440|FG000|Overall Study|Protocol Violation|18|||
155184040|NCT00054717|560112441|FG001|Overall Study|Protocol Violation|19|||
155184041|NCT00054717|560112440|FG000|Overall Study|Lost to Follow-up|23|||
155184042|NCT00054717|560112441|FG001|Overall Study|Lost to Follow-up|13|||
155184043|NCT00054717|560112440|FG000|Overall Study|Withdrawal by Subject|32|||
155184044|NCT00054717|560112441|FG001|Overall Study|Withdrawal by Subject|20|||
155184045|NCT00054717|560112440|FG000|Overall Study|Other reason not defined above|117|||
155184046|NCT00054717|560112441|FG001|Overall Study|Other reason not defined above|217|||
155184047|NCT01117051|560112445|FG000|Overall Study|Withdrawal by Subject|5|||
155184048|NCT01117051|560112446|FG001|Overall Study|Withdrawal by Subject|3|||
155184049|NCT01117051|560112445|FG000|Overall Study|Adverse Event|4|||
155184050|NCT01117051|560112446|FG001|Overall Study|Adverse Event|3|||
155184051|NCT01117051|560112445|FG000|Overall Study|Lost to Follow-up|0|||
155184052|NCT01117051|560112446|FG001|Overall Study|Lost to Follow-up|1|||
155184053|NCT01117051|560112445|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
155184054|NCT01117051|560112446|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
155184055|NCT01117051|560112445|FG000|Overall Study|Sponsor's decision|3|||
155184056|NCT01117051|560112446|FG001|Overall Study|Sponsor's decision|1|||
155184057|NCT01117051|560112445|FG000|Overall Study|Surgical procedure|0|||
155184058|NCT01117051|560112446|FG001|Overall Study|Surgical procedure|1|||
155184059|NCT01117051|560112445|FG000|Overall Study|Randomized by mistake|0|||
155184060|NCT01117051|560112446|FG001|Overall Study|Randomized by mistake|1|||
155184061|NCT01117051|560112445|FG000|Overall Study|Convenience issue|1|||
155184062|NCT01117051|560112446|FG001|Overall Study|Convenience issue|0|||
155184063|NCT00206076|560112447|FG000|Overall Study|Physician Decision|2|||
155184064|NCT00206076|560112448|FG001|Overall Study|Physician Decision|0|||
155184065|NCT00206076|560112447|FG000|Overall Study|Withdrawal by Subject|1|||
155184066|NCT00206076|560112448|FG001|Overall Study|Withdrawal by Subject|1|||
155184067|NCT00427960|560112449|FG000|Overall Study|Adverse Event|2|||
155184068|NCT00427960|560112450|FG001|Overall Study|Adverse Event|0|||
155184069|NCT00427960|560112449|FG000|Overall Study|Withdrawal by Subject|0|||
155184070|NCT00427960|560112450|FG001|Overall Study|Withdrawal by Subject|3|||
155184071|NCT00427960|560112449|FG000|Overall Study|Other|0|||
155184072|NCT00427960|560112450|FG001|Overall Study|Other|1|||
155184073|NCT01142128|560112451|FG000|Overall Study|Physician Decision|1|||
155184074|NCT01142128|560112451|FG000|Overall Study|Lost to Follow-up|1|||
155184075|NCT01142128|560112451|FG000|Overall Study|Withdrawal by Subject|2|||
155184076|NCT03355664|560112452|FG000|Overall Study|Adverse Event|1|||
155184077|NCT03355664|560112453|FG001|Overall Study|Adverse Event|2|||
155184078|NCT03355664|560112452|FG000|Overall Study|Lost to Follow-up|11|||
155184079|NCT03355664|560112453|FG001|Overall Study|Lost to Follow-up|7|||
155184080|NCT03355664|560112452|FG000|Overall Study|Protocol Violation|1|||
155141934|NCT03710642|559950472|FG000|Overall Study|non-site physician recommendation|1|||
155141935|NCT03710642|559950473|FG001|Overall Study|non-site physician recommendation|0|||
155141936|NCT03710642|559950472|FG000|Overall Study|Participant unwilling or unable to participate|1|||
155141937|NCT03710642|559950473|FG001|Overall Study|Participant unwilling or unable to participate|1|||
155141938|NCT03710642|559950472|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
155141939|NCT03710642|559950473|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
155141940|NCT03710642|559950472|FG000|Overall Study|NA-no code provided|1|||
155141941|NCT03710642|559950473|FG001|Overall Study|NA-no code provided|0|||
155141942|NCT03710642|559950472|FG000|Overall Study|Withdrawal by Subject|1|||
155141943|NCT03710642|559950473|FG001|Overall Study|Withdrawal by Subject|0|||
155141944|NCT00226811|559950474|FG000|Overall Study|Death|8|||
155141945|NCT00226811|559950474|FG000|Overall Study|Adverse Event|11|||
155141946|NCT00226811|559950474|FG000|Overall Study|Lack of Efficacy|55|||
155141947|NCT00226811|559950474|FG000|Overall Study|Withdrawal by Subject|2|||
155141948|NCT02741635|559950477|FG000|Overall Study|Withdrawal by Subject|1|||
155141949|NCT01427933|559950481|FG000|Overall Study|Withdrawal by Subject|5|||
155141950|NCT01427933|559950482|FG001|Overall Study|Withdrawal by Subject|8|||
155184081|NCT03355664|560112453|FG001|Overall Study|Protocol Violation|2|||
155184082|NCT03355664|560112452|FG000|Overall Study|Withdrawal by Subject|2|||
155184083|NCT03355664|560112453|FG001|Overall Study|Withdrawal by Subject|1|||
155184084|NCT03190369|560112455|FG000|Overall Study|Poor compliance to protocol|0|||
155184085|NCT03190369|560112456|FG001|Overall Study|Poor compliance to protocol|1|||
155141951|NCT01427933|559950481|FG000|Overall Study|Lost to Follow-up|1|||
155184086|NCT03190369|560112455|FG000|Overall Study|Withdraw before treatment|1|||
155031420|NCT00960986|559540919|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
155031421|NCT00960986|559540920|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
155031422|NCT00960986|559540921|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
155031423|NCT00960986|559540918|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
155031424|NCT00960986|559540919|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
155031425|NCT00960986|559540920|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
155031426|NCT00960986|559540921|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
155031427|NCT00960986|559540918|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
155031428|NCT00960986|559540919|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
155031429|NCT00960986|559540920|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
155141952|NCT01427933|559950482|FG001|Overall Study|Lost to Follow-up|5|||
155141953|NCT01427933|559950481|FG000|Overall Study|Other|1|||
155141954|NCT01427933|559950482|FG001|Overall Study|Other|0|||
155141955|NCT01427933|559950481|FG000|Overall Study|Investigator's Decision|1|||
155141956|NCT01427933|559950482|FG001|Overall Study|Investigator's Decision|0|||
155141957|NCT01010971|559950485|FG000|Overall Study|Adverse Event|2|||
155141958|NCT01010971|559950486|FG001|Overall Study|Adverse Event|4|||
155141959|NCT01010971|559950487|FG002|Overall Study|Adverse Event|3|||
155141960|NCT01010971|559950485|FG000|Overall Study|Withdrawal by Subject|0|||
155141961|NCT01010971|559950486|FG001|Overall Study|Withdrawal by Subject|2|||
155141962|NCT01010971|559950487|FG002|Overall Study|Withdrawal by Subject|5|||
155141963|NCT01010971|559950485|FG000|Overall Study|Lost to Follow-up|0|||
155141964|NCT01010971|559950486|FG001|Overall Study|Lost to Follow-up|2|||
155141965|NCT01010971|559950487|FG002|Overall Study|Lost to Follow-up|3|||
155141966|NCT01010971|559950485|FG000|Overall Study|Other|1|||
155141967|NCT01010971|559950486|FG001|Overall Study|Other|0|||
155141968|NCT01010971|559950487|FG002|Overall Study|Other|2|||
155141969|NCT05447663|559950488|FG000|Overall Study|Study terminated by Sponsor|5|||
155141970|NCT05447663|559950488|FG000|Overall Study|Death|2|||
155141971|NCT05447663|559950488|FG000|Overall Study|Withdrawal by Subject|1|||
155141972|NCT01100320|559950490|FG000|Period 1|Withdrawal by Subject|2|||
155141973|NCT01100320|559950491|FG001|Period 1|Withdrawal by Subject|4|||
155141974|NCT01100320|559950490|FG000|Period 1|Positive Drug Screen|1|||
155141975|NCT01100320|559950491|FG001|Period 1|Positive Drug Screen|1|||
155141976|NCT01100320|559950490|FG000|Period 1|Adverse Event|2|||
155141977|NCT01100320|559950491|FG001|Period 1|Adverse Event|2|||
155141978|NCT01100320|559950490|FG000|Period 2|Withdrawal by Subject|1|||
155141979|NCT01100320|559950491|FG001|Period 2|Withdrawal by Subject|1|||
155141980|NCT05729568|559950492|FG000|Overall Study|Still on Study|52|||
155141981|NCT05729568|559950493|FG001|Overall Study|Still on Study|26|||
155141982|NCT05729568|559950492|FG000|Overall Study|Randomized but Never Treated|3|||
155141983|NCT05729568|559950493|FG001|Overall Study|Randomized but Never Treated|0|||
155141984|NCT05729568|559950492|FG000|Overall Study|Adverse Event|0|||
155141985|NCT05729568|559950493|FG001|Overall Study|Adverse Event|1|||
155141986|NCT05729568|559950492|FG000|Overall Study|Investigator's Discretion|1|||
155141987|NCT05729568|559950493|FG001|Overall Study|Investigator's Discretion|0|||
155141988|NCT04181762|559950494|FG000|Overall Study|Adverse Event|1|||
155141989|NCT04181762|559950495|FG001|Overall Study|Adverse Event|3|||
155141990|NCT04181762|559950494|FG000|Overall Study|Lost to Follow-up|1|||
155141991|NCT04181762|559950495|FG001|Overall Study|Lost to Follow-up|1|||
155141992|NCT04181762|559950494|FG000|Overall Study|Physician Decision|1|||
155141993|NCT04181762|559950495|FG001|Overall Study|Physician Decision|3|||
155141994|NCT04181762|559950494|FG000|Overall Study|Pregnancy|0|||
155141995|NCT04181762|559950495|FG001|Overall Study|Pregnancy|1|||
155141996|NCT04181762|559950494|FG000|Overall Study|Lack of Efficacy|2|||
155141997|NCT04181762|559950495|FG001|Overall Study|Lack of Efficacy|2|||
155141998|NCT04181762|559950494|FG000|Overall Study|Study terminated by sponsor|95|||
155141999|NCT04181762|559950495|FG001|Overall Study|Study terminated by sponsor|97|||
155142000|NCT04181762|559950494|FG000|Overall Study|Subject decision|11|||
155142001|NCT04181762|559950495|FG001|Overall Study|Subject decision|4|||
155142002|NCT04181762|559950494|FG000|Overall Study|Death|1|||
155142003|NCT04181762|559950495|FG001|Overall Study|Death|1|||
155142004|NCT04181762|559950494|FG000|Overall Study|Protocol deviation|1|||
155142005|NCT04181762|559950495|FG001|Overall Study|Protocol deviation|0|||
155142006|NCT04181762|559950494|FG000|Overall Study|Withdrawal of informed consent|1|||
155142007|NCT04181762|559950495|FG001|Overall Study|Withdrawal of informed consent|3|||
155142008|NCT02534909|559950498|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
155142009|NCT04752332|559950500|FG000|Overall Study|Adverse Event|3|||
155142010|NCT04752332|559950501|FG001|Overall Study|Adverse Event|1|||
155142011|NCT04752332|559950500|FG000|Overall Study|Disease Relapse|1|||
155142012|NCT04752332|559950501|FG001|Overall Study|Disease Relapse|0|||
155142013|NCT04752332|559950500|FG000|Overall Study|Non-compliance With Study Drug|2|||
155142014|NCT04752332|559950501|FG001|Overall Study|Non-compliance With Study Drug|0|||
155142015|NCT04752332|559950500|FG000|Overall Study|Physician Decision|2|||
155142016|NCT04752332|559950501|FG001|Overall Study|Physician Decision|1|||
155142017|NCT04752332|559950500|FG000|Overall Study|Protocol Violation|1|||
155142018|NCT04752332|559950501|FG001|Overall Study|Protocol Violation|1|||
155184087|NCT03190369|560112456|FG001|Overall Study|Withdraw before treatment|5|||
155184088|NCT03190369|560112455|FG000|Overall Study|Randomized but not treated|0|||
155184089|NCT03190369|560112456|FG001|Overall Study|Randomized but not treated|2|||
155184090|NCT04163718|560112457|FG000|Overall Study|Study terminated|12|||
155184091|NCT01289782|560112458|FG000|Overall Study|Lost to Follow-up|14|||
155184092|NCT01289782|560112459|FG001|Overall Study|Lost to Follow-up|7|||
155184093|NCT01289782|560112458|FG000|Overall Study|Protocol Violation|1|||
155184094|NCT01289782|560112459|FG001|Overall Study|Protocol Violation|1|||
155184095|NCT01289782|560112458|FG000|Overall Study|Withdrawal by Subject|8|||
155184096|NCT01289782|560112459|FG001|Overall Study|Withdrawal by Subject|2|||
155031430|NCT00960986|559540921|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
155031431|NCT00960986|559540918|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
155031432|NCT00960986|559540919|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
155031433|NCT00960986|559540920|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
155031434|NCT00960986|559540921|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
155031435|NCT00960986|559540918|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
155031436|NCT00960986|559540919|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
155031437|NCT00960986|559540920|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
155031438|NCT00960986|559540921|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
155031439|NCT00960986|559540918|FG000|Period 3 (7-week Therapy Period)|Death|0|||
155031440|NCT00960986|559540919|FG001|Period 3 (7-week Therapy Period)|Death|0|||
155031441|NCT00960986|559540920|FG002|Period 3 (7-week Therapy Period)|Death|1|||
155031442|NCT00960986|559540921|FG003|Period 3 (7-week Therapy Period)|Death|0|||
155031443|NCT00960986|559540918|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
155031444|NCT00960986|559540919|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
155031445|NCT00960986|559540920|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
155031446|NCT00960986|559540921|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
155031447|NCT00960986|559540918|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
155031448|NCT00960986|559540919|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
155031449|NCT00960986|559540920|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
155031450|NCT00960986|559540921|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
155031451|NCT00960986|559540918|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
155031452|NCT00960986|559540919|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
155031453|NCT00960986|559540920|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
155031454|NCT00960986|559540921|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
155031455|NCT00960986|559540918|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
155031456|NCT00960986|559540919|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
155031457|NCT00960986|559540920|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
155031458|NCT00960986|559540921|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
155031459|NCT01984892|559540922|FG000|Overall Study|Progressive disease|7|||
155031460|NCT04464720|559540923|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
155031461|NCT03495154|559540930|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
155031462|NCT03495154|559540930|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
155031463|NCT03495154|559540930|FG000|Overall Study|Screen Failures During Surgery|6|||
155031464|NCT03495154|559540930|FG000|Overall Study|Death|2|||
155031465|NCT03495154|559540930|FG000|Overall Study|Lost to Follow-up|16|||
155031466|NCT03495154|559540930|FG000|Overall Study|Withdrawal by Subject|2|||
155031467|NCT03495154|559540930|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
155031468|NCT01294696|559540939|FG000|Overall Study|Screening failures|7|||
155031469|NCT01294696|559540939|FG000|Overall Study|Protocol Violation|8|||
155031470|NCT01294696|559540939|FG000|Overall Study|Missing BPI Response|7|||
155031471|NCT01294696|559540939|FG000|Overall Study|Site closure|52|||
155031472|NCT05376241|559542473|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
155031473|NCT05376241|559542473|FG000|Overall Study|103 did not complete the survey|103|||
155031474|NCT05376241|559542473|FG000|Overall Study|17 failed 2 attention check questions|17|||
155031475|NCT03036098|559542474|FG000|Pre-Treatment|Other Reasons|1|||
155031476|NCT03036098|559542475|FG001|Pre-Treatment|Other Reasons|2|||
155184097|NCT01289782|560112458|FG000|Overall Study|Sponsor's Decision|1|||
155184098|NCT01289782|560112459|FG001|Overall Study|Sponsor's Decision|0|||
155184099|NCT01289782|560112458|FG000|Overall Study|Reason not specified|1|||
155184100|NCT01289782|560112459|FG001|Overall Study|Reason not specified|2|||
155184101|NCT00450112|560112476|FG000|Overall Study|Other Treatment Required|5|||
155031477|NCT03036098|559542476|FG002|Pre-Treatment|Other Reasons|0|||
155031478|NCT03036098|559542477|FG003|Pre-Treatment|Other Reasons|5|||
155031479|NCT03036098|559542474|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
155184102|NCT00450112|560112477|FG001|Overall Study|Other Treatment Required|1|||
155031480|NCT03036098|559542475|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
155184103|NCT00450112|560112476|FG000|Overall Study|Withdrawal by Subject|4|||
155184104|NCT00450112|560112477|FG001|Overall Study|Withdrawal by Subject|1|||
155184105|NCT00450112|560112476|FG000|Overall Study|Lost to Follow-up|2|||
155184106|NCT00450112|560112477|FG001|Overall Study|Lost to Follow-up|1|||
155184107|NCT00450112|560112476|FG000|Overall Study|Others|2|||
155184108|NCT00450112|560112477|FG001|Overall Study|Others|3|||
155184109|NCT01056380|560112478|FG000|Overall Study|Lost to Follow-up|2|||
155184110|NCT01056380|560112479|FG001|Overall Study|Lost to Follow-up|3|||
155184111|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
155184112|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
155184113|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
155184114|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
155184115|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
155184116|NCT00586326|560112480|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
155184117|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
155184118|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
155184119|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
155184120|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
155184121|NCT00586326|560112480|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
155184122|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
155184123|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
155184124|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
155184125|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
155184126|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
155184127|NCT00586326|560112480|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
155184128|NCT03595774|560112481|FG000|Overall Study|Adverse Event|1|||
155184129|NCT03595774|560112482|FG001|Overall Study|Adverse Event|0|||
155184130|NCT03595774|560112483|FG002|Overall Study|Adverse Event|1|||
155184131|NCT03595774|560112484|FG003|Overall Study|Adverse Event|0|||
155184132|NCT03595774|560112481|FG000|Overall Study|screen failure|0|||
155184133|NCT03595774|560112482|FG001|Overall Study|screen failure|1|||
155184134|NCT03595774|560112483|FG002|Overall Study|screen failure|0|||
155184135|NCT03595774|560112484|FG003|Overall Study|screen failure|1|||
155184136|NCT00484185|560112490|FG000|Overall Study|Lost to Follow-up|44|||
155184137|NCT00484185|560112490|FG000|Overall Study|Other|20|||
155184138|NCT00484185|560112490|FG000|Overall Study|Randomized but not treated|5|||
155184139|NCT00484185|560112490|FG000|Overall Study|Death|2|||
155184140|NCT02325791|560112493|FG000|Overall Study|Adverse Event|0|||
155184141|NCT02325791|560112494|FG001|Overall Study|Adverse Event|1|||
155184142|NCT02325791|560112495|FG002|Overall Study|Adverse Event|1|||
155184143|NCT02325791|560112496|FG003|Overall Study|Adverse Event|0|||
155184144|NCT02325791|560112493|FG000|Overall Study|Death|0|||
155184145|NCT02325791|560112494|FG001|Overall Study|Death|3|||
155184146|NCT02325791|560112495|FG002|Overall Study|Death|0|||
155184147|NCT02325791|560112496|FG003|Overall Study|Death|1|||
155184148|NCT02325791|560112493|FG000|Overall Study|Lost to Follow-up|0|||
155184149|NCT02325791|560112494|FG001|Overall Study|Lost to Follow-up|15|||
155184150|NCT02325791|560112495|FG002|Overall Study|Lost to Follow-up|14|||
155184151|NCT02325791|560112496|FG003|Overall Study|Lost to Follow-up|9|||
155184152|NCT02325791|560112493|FG000|Overall Study|Physician Decision|0|||
155184153|NCT02325791|560112494|FG001|Overall Study|Physician Decision|1|||
155184154|NCT02325791|560112495|FG002|Overall Study|Physician Decision|1|||
155184155|NCT02325791|560112496|FG003|Overall Study|Physician Decision|0|||
155184156|NCT02325791|560112493|FG000|Overall Study|Protocol Violation|0|||
155184157|NCT02325791|560112494|FG001|Overall Study|Protocol Violation|0|||
155184158|NCT02325791|560112495|FG002|Overall Study|Protocol Violation|1|||
155031481|NCT03036098|559542476|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
155031482|NCT03036098|559542477|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
155031483|NCT03036098|559542474|FG000|Pre-Treatment|Withdrawal by Subject|1|||
155031484|NCT03036098|559542475|FG001|Pre-Treatment|Withdrawal by Subject|14|||
155031485|NCT03036098|559542476|FG002|Pre-Treatment|Withdrawal by Subject|0|||
155031486|NCT03036098|559542477|FG003|Pre-Treatment|Withdrawal by Subject|5|||
155031487|NCT03036098|559542474|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
155031488|NCT03036098|559542475|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
155031489|NCT03036098|559542476|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
155031490|NCT03036098|559542477|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
155184159|NCT02325791|560112496|FG003|Overall Study|Protocol Violation|0|||
155184160|NCT02325791|560112493|FG000|Overall Study|Withdrawal by Subject|0|||
155184161|NCT02325791|560112494|FG001|Overall Study|Withdrawal by Subject|5|||
155031491|NCT03036098|559542474|FG000|Treatment|Disease Progression|130|||
155031492|NCT03036098|559542475|FG001|Treatment|Disease Progression|77|||
155184162|NCT02325791|560112495|FG002|Overall Study|Withdrawal by Subject|8|||
155184163|NCT02325791|560112496|FG003|Overall Study|Withdrawal by Subject|16|||
155184164|NCT00555425|560112498|FG000|Overall Study|Missed Medication > 1 wk|34|||
155184165|NCT00555425|560112499|FG001|Overall Study|Missed Medication > 1 wk|15|||
155184166|NCT00555425|560112498|FG000|Overall Study|Missed 3 physician management visits|1|||
155184167|NCT00555425|560112499|FG001|Overall Study|Missed 3 physician management visits|0|||
155184168|NCT00555425|560112498|FG000|Overall Study|Met criteria for protective transfer|16|||
155184169|NCT00555425|560112499|FG001|Overall Study|Met criteria for protective transfer|3|||
155031493|NCT03036098|559542476|FG002|Treatment|Disease Progression|168|||
155031494|NCT03036098|559542477|FG003|Treatment|Disease Progression|50|||
155031495|NCT03036098|559542474|FG000|Treatment|Study Drug Toxicity|95|||
155142019|NCT04752332|559950500|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
155142020|NCT04752332|559950501|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
155142021|NCT04752332|559950500|FG000|Overall Study|Study Terminated by Sponsor|10|||
155142022|NCT04752332|559950501|FG001|Overall Study|Study Terminated by Sponsor|48|||
155142023|NCT04752332|559950500|FG000|Overall Study|Withdrawal by Subject|11|||
155142024|NCT04752332|559950501|FG001|Overall Study|Withdrawal by Subject|3|||
155142025|NCT02915978|559950504|FG000|Overall Study|Adverse Event|2|||
155142026|NCT02915978|559950505|FG001|Overall Study|Adverse Event|1|||
155184170|NCT00555425|560112498|FG000|Overall Study|Became pregnant and transferred care|0|||
155184171|NCT00555425|560112499|FG001|Overall Study|Became pregnant and transferred care|1|||
155184172|NCT03189381|560112500|FG000|Overall Study|Death|1|||
155031496|NCT03036098|559542475|FG001|Treatment|Study Drug Toxicity|45|||
155031497|NCT03036098|559542476|FG002|Treatment|Study Drug Toxicity|26|||
155031498|NCT03036098|559542477|FG003|Treatment|Study Drug Toxicity|22|||
155031499|NCT03036098|559542474|FG000|Treatment|Death|9|||
155031500|NCT03036098|559542475|FG001|Treatment|Death|3|||
155031501|NCT03036098|559542476|FG002|Treatment|Death|1|||
155031502|NCT03036098|559542477|FG003|Treatment|Death|2|||
155031503|NCT03036098|559542474|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
155031504|NCT03036098|559542475|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
155031505|NCT03036098|559542476|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
155031506|NCT03036098|559542477|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
155031507|NCT03036098|559542474|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
155031508|NCT03036098|559542475|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
155031509|NCT03036098|559542476|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
155031510|NCT03036098|559542477|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
155031511|NCT03036098|559542474|FG000|Treatment|Withdrawal by Subject|2|||
155031512|NCT03036098|559542475|FG001|Treatment|Withdrawal by Subject|9|||
155031513|NCT03036098|559542476|FG002|Treatment|Withdrawal by Subject|2|||
155031514|NCT03036098|559542477|FG003|Treatment|Withdrawal by Subject|4|||
155031515|NCT03036098|559542474|FG000|Treatment|Maximum Clinical Benefit|6|||
155031516|NCT03036098|559542475|FG001|Treatment|Maximum Clinical Benefit|1|||
155031517|NCT03036098|559542476|FG002|Treatment|Maximum Clinical Benefit|6|||
155031518|NCT03036098|559542477|FG003|Treatment|Maximum Clinical Benefit|10|||
155031519|NCT03036098|559542474|FG000|Treatment|Poor/Non Compliance|1|||
155031520|NCT03036098|559542475|FG001|Treatment|Poor/Non Compliance|2|||
155031521|NCT03036098|559542476|FG002|Treatment|Poor/Non Compliance|0|||
155031522|NCT03036098|559542477|FG003|Treatment|Poor/Non Compliance|1|||
155031523|NCT03036098|559542474|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
155031524|NCT03036098|559542475|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
155031525|NCT03036098|559542476|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
155031526|NCT03036098|559542477|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
155031527|NCT03036098|559542474|FG000|Treatment|Administrative Reason by Sponsor|1|||
155031528|NCT03036098|559542475|FG001|Treatment|Administrative Reason by Sponsor|0|||
155031529|NCT03036098|559542476|FG002|Treatment|Administrative Reason by Sponsor|2|||
155031530|NCT03036098|559542477|FG003|Treatment|Administrative Reason by Sponsor|1|||
155031531|NCT03036098|559542474|FG000|Treatment|Other Reasons|31|||
155031532|NCT03036098|559542475|FG001|Treatment|Other Reasons|5|||
155031533|NCT03036098|559542476|FG002|Treatment|Other Reasons|21|||
155031534|NCT03036098|559542477|FG003|Treatment|Other Reasons|8|||
155031535|NCT03036098|559542474|FG000|Treatment|Ongoing Treatment|0|||
155031536|NCT03036098|559542475|FG001|Treatment|Ongoing Treatment|0|||
155031537|NCT03036098|559542476|FG002|Treatment|Ongoing Treatment|23|||
155031538|NCT03036098|559542477|FG003|Treatment|Ongoing Treatment|0|||
155031539|NCT02276053|559542480|FG000|Overall Study|Death|2|||
155031540|NCT02276053|559542480|FG000|Overall Study|Adverse Event|5|||
155031541|NCT02276053|559542480|FG000|Overall Study|Lack of Efficacy|2|||
155031542|NCT02276053|559542480|FG000|Overall Study|Withdrawal by Subject|1|||
155031543|NCT02276053|559542480|FG000|Overall Study|Patient does not meet selection criteria|3|||
155031544|NCT02276053|559542480|FG000|Overall Study|Patient needs to increase baseline AED|1|||
155031545|NCT01004406|559542483|FG000|Overall Study|Withdrawal by Subject|2|||
155031546|NCT01004406|559542484|FG001|Overall Study|Withdrawal by Subject|0|||
155031547|NCT01004406|559542483|FG000|Overall Study|Lost to Follow-up|1|||
155031548|NCT01004406|559542484|FG001|Overall Study|Lost to Follow-up|0|||
155031549|NCT02907593|559542487|FG000|Overall Study|Withdrawal by Subject|0|||
155031550|NCT02907593|559542488|FG001|Overall Study|Withdrawal by Subject|0|||
155031551|NCT02907593|559542489|FG002|Overall Study|Withdrawal by Subject|1|||
155031552|NCT02907593|559542490|FG003|Overall Study|Withdrawal by Subject|0|||
155031553|NCT04488497|559542496|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
155031554|NCT04488497|559542497|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
155031555|NCT04488497|559542496|FG000|Intervention|Physician Decision|2|||
155031556|NCT04488497|559542497|FG001|Intervention|Physician Decision|1|||
155031557|NCT04488497|559542496|FG000|Intervention|Withdrawal by Subject|5|||
155031558|NCT04488497|559542497|FG001|Intervention|Withdrawal by Subject|6|||
155031559|NCT04488497|559542496|FG000|Intervention|Lost to Follow-up|2|||
155031560|NCT04488497|559542497|FG001|Intervention|Lost to Follow-up|0|||
155031561|NCT04488497|559542496|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
155031562|NCT04488497|559542497|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
155142027|NCT02915978|559950506|FG002|Overall Study|Adverse Event|0|||
155142028|NCT00924443|559950507|FG000|Overall Study|Physician Decision|2|||
155142029|NCT00924443|559950507|FG000|Overall Study|Protocol Violation|1|||
155142030|NCT02451124|559950511|FG000|Overall Study|Withdrawal by Subject|1|||
155142031|NCT01248949|559950512|FG000|Overall Study|Lost to Follow-up|2|||
155142032|NCT01248949|559950513|FG001|Overall Study|Lost to Follow-up|2|||
155142033|NCT01248949|559950514|FG002|Overall Study|Lost to Follow-up|2|||
155142034|NCT01248949|559950515|FG003|Overall Study|Lost to Follow-up|1|||
155142035|NCT01248949|559950516|FG004|Overall Study|Lost to Follow-up|0|||
155142036|NCT01248949|559950512|FG000|Overall Study|Withdrawal by Subject|5|||
155142037|NCT01248949|559950513|FG001|Overall Study|Withdrawal by Subject|3|||
155142038|NCT01248949|559950514|FG002|Overall Study|Withdrawal by Subject|11|||
155142039|NCT01248949|559950515|FG003|Overall Study|Withdrawal by Subject|3|||
155142040|NCT01248949|559950516|FG004|Overall Study|Withdrawal by Subject|1|||
155142041|NCT01248949|559950512|FG000|Overall Study|Death|22|||
155142042|NCT01248949|559950513|FG001|Overall Study|Death|7|||
155142043|NCT01248949|559950514|FG002|Overall Study|Death|21|||
155142044|NCT01248949|559950515|FG003|Overall Study|Death|6|||
155142045|NCT01248949|559950516|FG004|Overall Study|Death|2|||
155142046|NCT01248949|559950512|FG000|Overall Study|Alternative Therapy|1|||
155142047|NCT01248949|559950513|FG001|Overall Study|Alternative Therapy|0|||
155142048|NCT01248949|559950514|FG002|Overall Study|Alternative Therapy|0|||
155142049|NCT01248949|559950515|FG003|Overall Study|Alternative Therapy|0|||
155142050|NCT01248949|559950516|FG004|Overall Study|Alternative Therapy|0|||
155142051|NCT01248949|559950512|FG000|Overall Study|Alternative Therapy.|1|||
155142052|NCT01248949|559950513|FG001|Overall Study|Alternative Therapy.|0|||
155142053|NCT01248949|559950514|FG002|Overall Study|Alternative Therapy.|0|||
155142054|NCT01248949|559950515|FG003|Overall Study|Alternative Therapy.|0|||
155142055|NCT01248949|559950516|FG004|Overall Study|Alternative Therapy.|0|||
155142056|NCT01248949|559950512|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
155142057|NCT01248949|559950513|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
155142058|NCT01248949|559950514|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
155142059|NCT01248949|559950515|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
155142060|NCT01248949|559950516|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
155142061|NCT01248949|559950512|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
155142062|NCT01248949|559950513|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
155142063|NCT01248949|559950514|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
155142064|NCT01248949|559950515|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
155142065|NCT01248949|559950516|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
155142066|NCT01248949|559950512|FG000|Overall Study|Participant Went To Hospice|0|||
155142067|NCT01248949|559950513|FG001|Overall Study|Participant Went To Hospice|0|||
155142068|NCT01248949|559950514|FG002|Overall Study|Participant Went To Hospice|1|||
155142069|NCT01248949|559950515|FG003|Overall Study|Participant Went To Hospice|0|||
155142070|NCT01248949|559950516|FG004|Overall Study|Participant Went To Hospice|0|||
155142071|NCT01248949|559950512|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
155142072|NCT01248949|559950513|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155142073|NCT01248949|559950514|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155142074|NCT01248949|559950515|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155142075|NCT01248949|559950516|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
155142076|NCT01248949|559950512|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
155142077|NCT01248949|559950513|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
155142078|NCT01248949|559950514|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
155142079|NCT01248949|559950515|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
155142080|NCT01248949|559950516|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
155184173|NCT03189381|560112501|FG001|Overall Study|Death|0|||
155184174|NCT01975831|560112502|FG000|Overall Study|Adverse Event|1|||
155184175|NCT01975831|560112503|FG001|Overall Study|Adverse Event|2|||
155184176|NCT01975831|560112504|FG002|Overall Study|Adverse Event|2|||
155031563|NCT04488497|559542496|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
155142081|NCT01248949|559950512|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155142082|NCT01248949|559950513|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
155142083|NCT01248949|559950514|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155142084|NCT01248949|559950515|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155142085|NCT01248949|559950516|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
155142086|NCT01248949|559950512|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155184177|NCT01975831|560112505|FG003|Overall Study|Adverse Event|0|||
155184178|NCT01975831|560112506|FG004|Overall Study|Adverse Event|1|||
155184179|NCT01975831|560112507|FG005|Overall Study|Adverse Event|1|||
155184180|NCT01975831|560112508|FG006|Overall Study|Adverse Event|3|||
155184181|NCT01975831|560112509|FG007|Overall Study|Adverse Event|4|||
155184182|NCT01975831|560112510|FG008|Overall Study|Adverse Event|1|||
155184183|NCT01975831|560112502|FG000|Overall Study|Death|1|||
155184184|NCT01975831|560112503|FG001|Overall Study|Death|1|||
155184185|NCT01975831|560112504|FG002|Overall Study|Death|0|||
155184186|NCT01975831|560112505|FG003|Overall Study|Death|0|||
155184187|NCT01975831|560112506|FG004|Overall Study|Death|1|||
155184188|NCT01975831|560112507|FG005|Overall Study|Death|0|||
155184189|NCT01975831|560112508|FG006|Overall Study|Death|1|||
155184190|NCT01975831|560112509|FG007|Overall Study|Death|0|||
155184191|NCT01975831|560112510|FG008|Overall Study|Death|0|||
155184192|NCT01975831|560112502|FG000|Overall Study|Progressive Disease|1|||
155184193|NCT01975831|560112503|FG001|Overall Study|Progressive Disease|3|||
155184194|NCT01975831|560112504|FG002|Overall Study|Progressive Disease|2|||
155184195|NCT01975831|560112505|FG003|Overall Study|Progressive Disease|4|||
155184196|NCT01975831|560112506|FG004|Overall Study|Progressive Disease|13|||
155184197|NCT01975831|560112507|FG005|Overall Study|Progressive Disease|9|||
155184198|NCT01975831|560112508|FG006|Overall Study|Progressive Disease|10|||
155184199|NCT01975831|560112509|FG007|Overall Study|Progressive Disease|8|||
155184200|NCT01975831|560112510|FG008|Overall Study|Progressive Disease|10|||
155184201|NCT01975831|560112502|FG000|Overall Study|Withdrawal by Subject|0|||
155184202|NCT01975831|560112503|FG001|Overall Study|Withdrawal by Subject|3|||
155184203|NCT01975831|560112504|FG002|Overall Study|Withdrawal by Subject|0|||
155184204|NCT01975831|560112505|FG003|Overall Study|Withdrawal by Subject|0|||
155184205|NCT01975831|560112506|FG004|Overall Study|Withdrawal by Subject|3|||
155184206|NCT01975831|560112507|FG005|Overall Study|Withdrawal by Subject|1|||
155184207|NCT01975831|560112508|FG006|Overall Study|Withdrawal by Subject|1|||
155184208|NCT01975831|560112509|FG007|Overall Study|Withdrawal by Subject|0|||
155184209|NCT01975831|560112510|FG008|Overall Study|Withdrawal by Subject|0|||
155184210|NCT01975831|560112502|FG000|Overall Study|Physician Decision|0|||
155184211|NCT01975831|560112503|FG001|Overall Study|Physician Decision|0|||
155184212|NCT01975831|560112504|FG002|Overall Study|Physician Decision|0|||
155184213|NCT01975831|560112505|FG003|Overall Study|Physician Decision|0|||
155184214|NCT01975831|560112506|FG004|Overall Study|Physician Decision|0|||
155184215|NCT01975831|560112507|FG005|Overall Study|Physician Decision|1|||
155184216|NCT01975831|560112508|FG006|Overall Study|Physician Decision|0|||
155184217|NCT01975831|560112509|FG007|Overall Study|Physician Decision|1|||
155184218|NCT01975831|560112510|FG008|Overall Study|Physician Decision|0|||
155184219|NCT01975831|560112502|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
155184220|NCT01975831|560112503|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
155184221|NCT01975831|560112504|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
155184222|NCT01975831|560112505|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
155184223|NCT01975831|560112506|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
155184224|NCT01975831|560112507|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
155184225|NCT01975831|560112508|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
155184226|NCT01975831|560112509|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
155184227|NCT01975831|560112510|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
155184228|NCT01975831|560112502|FG000|Overall Study|Entered Hospice|0|||
155184229|NCT01975831|560112503|FG001|Overall Study|Entered Hospice|0|||
155184230|NCT01975831|560112504|FG002|Overall Study|Entered Hospice|0|||
155184231|NCT01975831|560112505|FG003|Overall Study|Entered Hospice|0|||
155184232|NCT01975831|560112506|FG004|Overall Study|Entered Hospice|0|||
155184233|NCT01975831|560112507|FG005|Overall Study|Entered Hospice|1|||
155184234|NCT01975831|560112508|FG006|Overall Study|Entered Hospice|0|||
155184235|NCT01975831|560112509|FG007|Overall Study|Entered Hospice|0|||
155184236|NCT01975831|560112510|FG008|Overall Study|Entered Hospice|0|||
155184237|NCT01975831|560112502|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184238|NCT01975831|560112503|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184239|NCT01975831|560112504|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184240|NCT01975831|560112505|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184241|NCT01975831|560112506|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184242|NCT01975831|560112507|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184243|NCT01975831|560112508|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
155184244|NCT01975831|560112509|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
155184245|NCT01975831|560112510|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
155184246|NCT00251004|560112511|FG000|Overall Study|Withdrawal by Subject|23|||
155184247|NCT00251004|560112512|FG001|Overall Study|Withdrawal by Subject|16|||
155184248|NCT00251004|560112513|FG002|Overall Study|Withdrawal by Subject|14|||
155184249|NCT00251004|560112511|FG000|Overall Study|Death|9|||
155184250|NCT00251004|560112512|FG001|Overall Study|Death|10|||
155184251|NCT00251004|560112513|FG002|Overall Study|Death|8|||
155184252|NCT00251004|560112511|FG000|Overall Study|Lost to Follow-up|1|||
155184253|NCT00251004|560112512|FG001|Overall Study|Lost to Follow-up|2|||
155184254|NCT00251004|560112513|FG002|Overall Study|Lost to Follow-up|1|||
155184255|NCT00251004|560112511|FG000|Overall Study|Graft Loss|12|||
155184256|NCT00251004|560112512|FG001|Overall Study|Graft Loss|13|||
155031564|NCT04488497|559542497|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
155031565|NCT04322539|559542498|FG000|Overall Study|Adverse Event|2|||
155031566|NCT04322539|559542499|FG001|Overall Study|Adverse Event|0|||
155031567|NCT04322539|559542498|FG000|Overall Study|Death|411|||
155031568|NCT04322539|559542499|FG001|Overall Study|Death|203|||
155031569|NCT04322539|559542498|FG000|Overall Study|Lost to Follow-up|3|||
155142087|NCT01248949|559950513|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155142088|NCT01248949|559950514|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
155142089|NCT01248949|559950515|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155142090|NCT01248949|559950516|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
155142091|NCT02587819|559950523|FG000|Overall Study|Adverse Event|1|||
155142092|NCT02587819|559950523|FG000|Overall Study|Lost to Follow-up|1|||
155142093|NCT00859547|559952003|FG000|Overall Study|Lost to Follow-up|1|||
155142094|NCT00859547|559952003|FG000|Overall Study|Parent withdrew consent|1|||
155142095|NCT01473732|559952004|FG000|Overall Study|Adverse Event|1|||
155142096|NCT01473732|559952005|FG001|Overall Study|Adverse Event|0|||
155142097|NCT01473732|559952004|FG000|Overall Study|Death|1|||
155142098|NCT01473732|559952005|FG001|Overall Study|Death|0|||
155142099|NCT00997035|559952009|FG000|3-week Followup Visit|Lost to Follow-up|9|||
155142100|NCT00997035|559952010|FG001|3-week Followup Visit|Lost to Follow-up|6|||
155142101|NCT00997035|559952009|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
155142102|NCT00997035|559952010|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
155142103|NCT00269919|559952011|FG000|Overall Study|Other|26|||
155142104|NCT00269919|559952011|FG000|Overall Study|Started but not treated|1|||
155142105|NCT02471014|559952012|FG000|Overall Study|Lost to Follow-up|2|||
155142106|NCT02471014|559952013|FG001|Overall Study|Lost to Follow-up|2|||
155142107|NCT04685798|559952014|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
155142108|NCT00824473|559952020|FG000|Overall Study|Adverse Event|4|||
155142109|NCT00824473|559952021|FG001|Overall Study|Adverse Event|5|||
155142110|NCT00824473|559952020|FG000|Overall Study|Lack of Efficacy|2|||
155142111|NCT00824473|559952021|FG001|Overall Study|Lack of Efficacy|2|||
155142112|NCT00824473|559952020|FG000|Overall Study|Protocol Violation|2|||
155142113|NCT00824473|559952021|FG001|Overall Study|Protocol Violation|0|||
155142114|NCT00824473|559952020|FG000|Overall Study|Non-Compliance|4|||
155142115|NCT00824473|559952021|FG001|Overall Study|Non-Compliance|2|||
155142116|NCT00824473|559952020|FG000|Overall Study|Withdrawal by Subject|2|||
155142117|NCT00824473|559952021|FG001|Overall Study|Withdrawal by Subject|3|||
155142118|NCT00824473|559952020|FG000|Overall Study|Other|1|||
155142119|NCT00824473|559952021|FG001|Overall Study|Other|1|||
155142120|NCT01965704|559952022|FG000|Overall Study|Withdrawal by Subject|2|||
155142121|NCT01965704|559952023|FG001|Overall Study|Withdrawal by Subject|2|||
155142122|NCT01965704|559952024|FG002|Overall Study|Withdrawal by Subject|1|||
155142123|NCT01965704|559952025|FG003|Overall Study|Withdrawal by Subject|1|||
155142124|NCT01965704|559952022|FG000|Overall Study|Delivered at home|1|||
155142125|NCT01965704|559952023|FG001|Overall Study|Delivered at home|1|||
155142126|NCT01965704|559952024|FG002|Overall Study|Delivered at home|0|||
155142127|NCT01965704|559952025|FG003|Overall Study|Delivered at home|0|||
155142128|NCT01965704|559952022|FG000|Overall Study|Experienced complications|0|||
155142129|NCT01965704|559952023|FG001|Overall Study|Experienced complications|0|||
155142130|NCT01965704|559952024|FG002|Overall Study|Experienced complications|2|||
155142131|NCT01965704|559952025|FG003|Overall Study|Experienced complications|2|||
155142132|NCT01965704|559952022|FG000|Overall Study|Adverse Event|0|||
155142133|NCT01965704|559952023|FG001|Overall Study|Adverse Event|0|||
155142134|NCT01965704|559952024|FG002|Overall Study|Adverse Event|1|||
155142135|NCT01965704|559952025|FG003|Overall Study|Adverse Event|1|||
155142136|NCT01965704|559952022|FG000|Overall Study|Did not meet inclusion criteria|0|||
155142137|NCT01965704|559952023|FG001|Overall Study|Did not meet inclusion criteria|0|||
155142138|NCT01965704|559952024|FG002|Overall Study|Did not meet inclusion criteria|1|||
155142139|NCT01965704|559952025|FG003|Overall Study|Did not meet inclusion criteria|1|||
155142140|NCT00337207|559952026|FG000|Overall Study|Withdrawal by Subject|3|||
155142141|NCT01479868|559952027|FG000|Overall Study|Adverse Event|1|||
155142142|NCT01479868|559952027|FG000|Overall Study|Lost to Follow-up|4|||
155031570|NCT04322539|559542499|FG001|Overall Study|Lost to Follow-up|1|||
155031571|NCT04322539|559542498|FG000|Overall Study|Withdrawal of consent|14|||
155031572|NCT04322539|559542499|FG001|Overall Study|Withdrawal of consent|8|||
155031573|NCT04322539|559542498|FG000|Overall Study|Radiological Disease Progression|6|||
155142143|NCT01479868|559952027|FG000|Overall Study|Protocol Violation|1|||
155142144|NCT01479868|559952027|FG000|Overall Study|Withdrawal by Subject|1|||
155142145|NCT01479868|559952027|FG000|Overall Study|Sponsor's Decision|1|||
155142146|NCT01479868|559952027|FG000|Overall Study|Initiation of new HCV Therapy|1|||
155142147|NCT01177007|559952028|FG000|Overall Study|Lost to Follow-up|2|||
155142148|NCT01177007|559952028|FG000|Overall Study|Death|4|||
155142149|NCT01177007|559952028|FG000|Overall Study|Entered hospice care|5|||
155142150|NCT01177007|559952028|FG000|Overall Study|Required additional Y90 treatment|6|||
155142151|NCT01177007|559952028|FG000|Overall Study|Change in treatment modality|21|||
155142152|NCT02336230|559952034|FG000|Overall Study|Adverse Event|1|||
155142153|NCT02336230|559952034|FG000|Overall Study|Withdrawal of consent|1|||
155142154|NCT02336230|559952034|FG000|Overall Study|Death|9|||
155142155|NCT02336230|559952034|FG000|Overall Study|Dose not received due to shipping delay|1|||
155142156|NCT02336230|559952034|FG000|Overall Study|Discontinuation of MSC infusion|1|||
155142157|NCT03305770|559952042|FG000|Overall Study|Physician Decision - prior to dispense|0|||
155142158|NCT03305770|559952043|FG001|Overall Study|Physician Decision - prior to dispense|1|||
155142159|NCT03305770|559952042|FG000|Overall Study|Subject moved|1|||
155142160|NCT03305770|559952043|FG001|Overall Study|Subject moved|0|||
155142161|NCT03539601|559952044|FG000|Overall Study|Withdraw by parent/guardian|1|||
155142162|NCT03539601|559952045|FG001|Overall Study|Withdraw by parent/guardian|0|||
155142163|NCT03539601|559952046|FG002|Overall Study|Withdraw by parent/guardian|1|||
155142164|NCT03539601|559952047|FG003|Overall Study|Withdraw by parent/guardian|0|||
155142165|NCT03539601|559952044|FG000|Overall Study|Adverse Event|0|||
155142166|NCT03539601|559952045|FG001|Overall Study|Adverse Event|2|||
155142167|NCT03539601|559952046|FG002|Overall Study|Adverse Event|0|||
155142168|NCT03539601|559952047|FG003|Overall Study|Adverse Event|0|||
155142169|NCT03539601|559952044|FG000|Overall Study|Lost to Follow-up|2|||
155142170|NCT03539601|559952045|FG001|Overall Study|Lost to Follow-up|4|||
155142171|NCT03539601|559952046|FG002|Overall Study|Lost to Follow-up|5|||
155142172|NCT03539601|559952047|FG003|Overall Study|Lost to Follow-up|0|||
155142173|NCT03539601|559952044|FG000|Overall Study|Withdrawal by Subject|2|||
155142174|NCT03539601|559952045|FG001|Overall Study|Withdrawal by Subject|0|||
155142175|NCT03539601|559952046|FG002|Overall Study|Withdrawal by Subject|0|||
155142176|NCT03539601|559952047|FG003|Overall Study|Withdrawal by Subject|1|||
155142177|NCT03539601|559952044|FG000|Overall Study|Randomized but not treated|1|||
155142178|NCT03539601|559952045|FG001|Overall Study|Randomized but not treated|1|||
155142179|NCT03539601|559952046|FG002|Overall Study|Randomized but not treated|0|||
155142180|NCT03539601|559952047|FG003|Overall Study|Randomized but not treated|0|||
155142181|NCT01970306|559952048|FG000|Overall Study|Not eligible|3|||
155142182|NCT01970306|559952048|FG000|Overall Study|Not able to be treated|9|||
155142183|NCT03472326|559952049|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
155142184|NCT03472326|559952050|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
155142185|NCT03472326|559952051|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
155142186|NCT03472326|559952052|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
155142187|NCT03472326|559952049|FG000|Part 2: Combination Therapy|Pregnancy|0|||
155142188|NCT03472326|559952050|FG001|Part 2: Combination Therapy|Pregnancy|0|||
155142189|NCT03472326|559952051|FG002|Part 2: Combination Therapy|Pregnancy|0|||
155142190|NCT03472326|559952052|FG003|Part 2: Combination Therapy|Pregnancy|1|||
155142191|NCT03386721|559952053|FG000|Overall Study|Death|12|||
155142192|NCT03386721|559952054|FG001|Overall Study|Death|21|||
155142193|NCT03386721|559952055|FG002|Overall Study|Death|2|||
155142194|NCT03386721|559952056|FG003|Overall Study|Death|5|||
155142195|NCT03386721|559952057|FG004|Overall Study|Death|1|||
155142196|NCT03386721|559952058|FG005|Overall Study|Death|12|||
155142197|NCT03386721|559952059|FG006|Overall Study|Death|1|||
155142198|NCT03386721|559952060|FG007|Overall Study|Death|1|||
155142199|NCT03386721|559952061|FG008|Overall Study|Death|12|||
155142200|NCT03386721|559952062|FG009|Overall Study|Death|20|||
155142201|NCT03386721|559952063|FG010|Overall Study|Death|21|||
155142202|NCT03386721|559952064|FG011|Overall Study|Death|21|||
155142203|NCT03386721|559952065|FG012|Overall Study|Death|14|||
155142204|NCT03386721|559952066|FG013|Overall Study|Death|2|||
155142205|NCT03386721|559952067|FG014|Overall Study|Death|1|||
155142206|NCT03386721|559952053|FG000|Overall Study|Lost to Follow-up|1|||
155142207|NCT03386721|559952054|FG001|Overall Study|Lost to Follow-up|3|||
155142208|NCT03386721|559952055|FG002|Overall Study|Lost to Follow-up|0|||
155142209|NCT03386721|559952056|FG003|Overall Study|Lost to Follow-up|0|||
155142210|NCT03386721|559952057|FG004|Overall Study|Lost to Follow-up|0|||
155142211|NCT03386721|559952058|FG005|Overall Study|Lost to Follow-up|2|||
155142212|NCT03386721|559952059|FG006|Overall Study|Lost to Follow-up|1|||
155142213|NCT03386721|559952060|FG007|Overall Study|Lost to Follow-up|0|||
155142214|NCT03386721|559952061|FG008|Overall Study|Lost to Follow-up|1|||
155142215|NCT03386721|559952062|FG009|Overall Study|Lost to Follow-up|2|||
155142216|NCT03386721|559952063|FG010|Overall Study|Lost to Follow-up|1|||
155142217|NCT03386721|559952064|FG011|Overall Study|Lost to Follow-up|0|||
155142218|NCT03386721|559952065|FG012|Overall Study|Lost to Follow-up|0|||
155142219|NCT03386721|559952066|FG013|Overall Study|Lost to Follow-up|0|||
155142220|NCT03386721|559952067|FG014|Overall Study|Lost to Follow-up|0|||
155142221|NCT03386721|559952053|FG000|Overall Study|Reason not specified|3|||
155142222|NCT03386721|559952054|FG001|Overall Study|Reason not specified|0|||
155142223|NCT03386721|559952055|FG002|Overall Study|Reason not specified|0|||
155142224|NCT03386721|559952056|FG003|Overall Study|Reason not specified|0|||
155142225|NCT03386721|559952057|FG004|Overall Study|Reason not specified|0|||
155142226|NCT03386721|559952058|FG005|Overall Study|Reason not specified|3|||
155142227|NCT03386721|559952059|FG006|Overall Study|Reason not specified|1|||
155142228|NCT03386721|559952060|FG007|Overall Study|Reason not specified|0|||
155142229|NCT03386721|559952061|FG008|Overall Study|Reason not specified|0|||
155142230|NCT03386721|559952062|FG009|Overall Study|Reason not specified|1|||
155142231|NCT03386721|559952063|FG010|Overall Study|Reason not specified|2|||
155142232|NCT03386721|559952064|FG011|Overall Study|Reason not specified|6|||
155031574|NCT04322539|559542499|FG001|Overall Study|Radiological Disease Progression|0|||
155031575|NCT04322539|559542498|FG000|Overall Study|Sponsor Decision|19|||
155031576|NCT04322539|559542499|FG001|Overall Study|Sponsor Decision|14|||
155031577|NCT04322539|559542498|FG000|Overall Study|Other|6|||
155031578|NCT04322539|559542499|FG001|Overall Study|Other|4|||
155031579|NCT04063657|559542504|FG000|Overall Study|Lost to Follow-up|1|||
155031580|NCT04063657|559542505|FG001|Overall Study|Lost to Follow-up|0|||
155031581|NCT03409107|559542506|FG000|Overall Study|Withdrawal by Subject|4|||
155031582|NCT03409107|559542507|FG001|Overall Study|Withdrawal by Subject|2|||
155031583|NCT03409107|559542506|FG000|Overall Study|Physician Decision|1|||
155031584|NCT03409107|559542507|FG001|Overall Study|Physician Decision|0|||
155031585|NCT03409107|559542506|FG000|Overall Study|Lost to Follow-up|7|||
155031586|NCT03409107|559542507|FG001|Overall Study|Lost to Follow-up|2|||
155031587|NCT03409107|559542506|FG000|Overall Study|Adverse Event|5|||
155031588|NCT03409107|559542507|FG001|Overall Study|Adverse Event|3|||
155031589|NCT01185509|559542508|FG000|Overall Study|Progression/Relapse|9|||
155031590|NCT01185509|559542509|FG001|Overall Study|Progression/Relapse|15|||
155031591|NCT01185509|559542508|FG000|Overall Study|Physician Decision|2|||
155031592|NCT01185509|559542509|FG001|Overall Study|Physician Decision|2|||
155031593|NCT01185509|559542508|FG000|Overall Study|Withdrawal by Subject|0|||
155031594|NCT01185509|559542509|FG001|Overall Study|Withdrawal by Subject|1|||
155031595|NCT01185509|559542508|FG000|Overall Study|Death|0|||
155031596|NCT01185509|559542509|FG001|Overall Study|Death|1|||
155031597|NCT01185509|559542508|FG000|Overall Study|Intercurrent Illness|0|||
155031598|NCT01185509|559542509|FG001|Overall Study|Intercurrent Illness|1|||
155031599|NCT00916344|559542510|FG000|Overall Study|Death|2|||
155031600|NCT00916344|559542510|FG000|Overall Study|ICD upgrade|1|||
155031601|NCT00916344|559542510|FG000|Overall Study|Drop-out|5|||
155031602|NCT01088243|559542518|FG000|Overall Study|Adverse Event|1|||
155031603|NCT01088243|559542519|FG001|Overall Study|Adverse Event|0|||
155031604|NCT02122770|559542520|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
155031605|NCT02122770|559542521|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
155031606|NCT02122770|559542522|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
155031607|NCT02122770|559542523|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
155031608|NCT02122770|559542524|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
155031609|NCT02122770|559542525|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
155031610|NCT02122770|559542520|FG000|Part A: Drug-drug Interaction 2|Other|0|||
155031611|NCT02122770|559542521|FG001|Part A: Drug-drug Interaction 2|Other|0|||
155031612|NCT02122770|559542522|FG002|Part A: Drug-drug Interaction 2|Other|1|||
155031613|NCT02122770|559542523|FG003|Part A: Drug-drug Interaction 2|Other|0|||
155031614|NCT02122770|559542524|FG004|Part A: Drug-drug Interaction 2|Other|0|||
155031615|NCT02122770|559542525|FG005|Part A: Drug-drug Interaction 2|Other|0|||
155031616|NCT02122770|559542520|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155031617|NCT02122770|559542521|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
155031618|NCT02122770|559542522|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155031619|NCT02122770|559542523|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155031620|NCT02122770|559542524|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155031621|NCT02122770|559542525|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
155031622|NCT02122770|559542520|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
155031623|NCT02122770|559542521|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
155031624|NCT02122770|559542522|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
155031625|NCT02122770|559542523|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
155031626|NCT02122770|559542524|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
155031627|NCT02122770|559542525|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
155031628|NCT02122770|559542520|FG000|Part B: Standard of Care|Adverse Event|0|||
155031629|NCT02122770|559542521|FG001|Part B: Standard of Care|Adverse Event|0|||
155031630|NCT02122770|559542522|FG002|Part B: Standard of Care|Adverse Event|0|||
155031631|NCT02122770|559542523|FG003|Part B: Standard of Care|Adverse Event|0|||
155031632|NCT02122770|559542524|FG004|Part B: Standard of Care|Adverse Event|4|||
155031633|NCT02122770|559542525|FG005|Part B: Standard of Care|Adverse Event|1|||
155031634|NCT02122770|559542520|FG000|Part B: Standard of Care|Other|0|||
155031635|NCT02122770|559542521|FG001|Part B: Standard of Care|Other|0|||
155031636|NCT02122770|559542522|FG002|Part B: Standard of Care|Other|0|||
155031637|NCT02122770|559542523|FG003|Part B: Standard of Care|Other|0|||
155031638|NCT02122770|559542524|FG004|Part B: Standard of Care|Other|0|||
155031639|NCT02122770|559542525|FG005|Part B: Standard of Care|Other|2|||
155031640|NCT02122770|559542520|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
155031641|NCT02122770|559542521|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
155031642|NCT02122770|559542522|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
155031643|NCT02122770|559542523|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
155031644|NCT02122770|559542524|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
155031645|NCT02122770|559542525|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
155031646|NCT02122770|559542520|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
155031647|NCT02122770|559542521|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
155031648|NCT02122770|559542522|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
155031649|NCT02122770|559542523|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
155031650|NCT02122770|559542524|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
155031651|NCT02122770|559542525|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
155031652|NCT02122770|559542520|FG000|Part B: Standard of Care|Progressive Disease|0|||
155031653|NCT02122770|559542521|FG001|Part B: Standard of Care|Progressive Disease|0|||
155031654|NCT02122770|559542522|FG002|Part B: Standard of Care|Progressive Disease|0|||
155031655|NCT02122770|559542523|FG003|Part B: Standard of Care|Progressive Disease|0|||
155031656|NCT02122770|559542524|FG004|Part B: Standard of Care|Progressive Disease|10|||
155031657|NCT02122770|559542525|FG005|Part B: Standard of Care|Progressive Disease|8|||
155031658|NCT01041976|559542526|FG000|Overall Study|Withdrawal by Subject|3|||
155031659|NCT01041976|559542527|FG001|Overall Study|Withdrawal by Subject|0|||
155031660|NCT01041976|559542526|FG000|Overall Study|Incarceration|2|||
155031661|NCT01041976|559542527|FG001|Overall Study|Incarceration|0|||
155031662|NCT01041976|559542526|FG000|Overall Study|Death|0|||
155031663|NCT01041976|559542527|FG001|Overall Study|Death|4|||
155031664|NCT02658734|559542528|FG000|Overall Study|Adverse Event|2|||
155031665|NCT02658734|559542528|FG000|Overall Study|Death|4|||
155031666|NCT02658734|559542528|FG000|Overall Study|Lost to Follow-up|7|||
155031667|NCT02658734|559542528|FG000|Overall Study|Withdrawal of Consent|16|||
155031668|NCT02658734|559542528|FG000|Overall Study|Disease Progression|28|||
155031669|NCT02370667|559542544|FG000|Overall Study|Lost to Follow-up|0|||
155031670|NCT02370667|559542545|FG001|Overall Study|Lost to Follow-up|1|||
155031671|NCT02370667|559542546|FG002|Overall Study|Lost to Follow-up|0|||
155031672|NCT03536949|559542547|FG000|Overall Study|Adverse Event|4|||
155031673|NCT03536949|559542548|FG001|Overall Study|Adverse Event|0|||
155031674|NCT03536949|559542547|FG000|Overall Study|Lost to Follow-up|2|||
155031675|NCT03536949|559542548|FG001|Overall Study|Lost to Follow-up|1|||
155031676|NCT03536949|559542547|FG000|Overall Study|Withdrawal by Subject|6|||
155031677|NCT03536949|559542548|FG001|Overall Study|Withdrawal by Subject|0|||
155142233|NCT03386721|559952065|FG012|Overall Study|Reason not specified|1|||
155142234|NCT03386721|559952066|FG013|Overall Study|Reason not specified|0|||
155142235|NCT03386721|559952067|FG014|Overall Study|Reason not specified|0|||
155142236|NCT03386721|559952053|FG000|Overall Study|Progressive Disease|0|||
155142237|NCT03386721|559952054|FG001|Overall Study|Progressive Disease|0|||
155142238|NCT03386721|559952055|FG002|Overall Study|Progressive Disease|1|||
155142239|NCT03386721|559952056|FG003|Overall Study|Progressive Disease|0|||
155142240|NCT03386721|559952057|FG004|Overall Study|Progressive Disease|0|||
155142241|NCT03386721|559952058|FG005|Overall Study|Progressive Disease|1|||
155142242|NCT03386721|559952059|FG006|Overall Study|Progressive Disease|0|||
155142243|NCT03386721|559952060|FG007|Overall Study|Progressive Disease|0|||
155142244|NCT03386721|559952061|FG008|Overall Study|Progressive Disease|2|||
155142245|NCT03386721|559952062|FG009|Overall Study|Progressive Disease|1|||
155142246|NCT03386721|559952063|FG010|Overall Study|Progressive Disease|1|||
155142247|NCT03386721|559952064|FG011|Overall Study|Progressive Disease|0|||
155142248|NCT03386721|559952065|FG012|Overall Study|Progressive Disease|1|||
155142249|NCT03386721|559952066|FG013|Overall Study|Progressive Disease|0|||
155142250|NCT03386721|559952067|FG014|Overall Study|Progressive Disease|0|||
155142251|NCT03386721|559952053|FG000|Overall Study|Site Terminated by Sponsor|5|||
155142252|NCT03386721|559952054|FG001|Overall Study|Site Terminated by Sponsor|5|||
155142253|NCT03386721|559952055|FG002|Overall Study|Site Terminated by Sponsor|0|||
155142254|NCT03386721|559952056|FG003|Overall Study|Site Terminated by Sponsor|0|||
155142255|NCT03386721|559952057|FG004|Overall Study|Site Terminated by Sponsor|1|||
155142256|NCT03386721|559952058|FG005|Overall Study|Site Terminated by Sponsor|3|||
155142257|NCT03386721|559952059|FG006|Overall Study|Site Terminated by Sponsor|0|||
155142258|NCT03386721|559952060|FG007|Overall Study|Site Terminated by Sponsor|1|||
155142259|NCT03386721|559952061|FG008|Overall Study|Site Terminated by Sponsor|4|||
155142260|NCT03386721|559952062|FG009|Overall Study|Site Terminated by Sponsor|5|||
155142261|NCT03386721|559952063|FG010|Overall Study|Site Terminated by Sponsor|3|||
155142262|NCT03386721|559952064|FG011|Overall Study|Site Terminated by Sponsor|11|||
155142263|NCT03386721|559952065|FG012|Overall Study|Site Terminated by Sponsor|6|||
155142264|NCT03386721|559952066|FG013|Overall Study|Site Terminated by Sponsor|0|||
155184257|NCT00251004|560112513|FG002|Overall Study|Graft Loss|8|||
155031678|NCT03536949|559542547|FG000|Overall Study|Non-compliance|2|||
155031679|NCT03536949|559542548|FG001|Overall Study|Non-compliance|1|||
155031680|NCT02954653|559542550|FG000|Overall Study|Death|3|||
155031681|NCT02954653|559542551|FG001|Overall Study|Death|1|||
155031682|NCT02954653|559542552|FG002|Overall Study|Death|0|||
155031683|NCT02954653|559542553|FG003|Overall Study|Death|0|||
155142265|NCT03386721|559952067|FG014|Overall Study|Site Terminated by Sponsor|0|||
155142266|NCT03386721|559952053|FG000|Overall Study|Symptomatic Deterioration|0|||
155184258|NCT02045303|560112516|FG000|Overall Study|Protocol Violation|2|||
155142267|NCT03386721|559952054|FG001|Overall Study|Symptomatic Deterioration|0|||
155142268|NCT03386721|559952055|FG002|Overall Study|Symptomatic Deterioration|0|||
155142269|NCT03386721|559952056|FG003|Overall Study|Symptomatic Deterioration|0|||
155184259|NCT02045303|560112517|FG001|Overall Study|Protocol Violation|1|||
155184260|NCT02045303|560112518|FG002|Overall Study|Protocol Violation|0|||
155184261|NCT02045303|560112516|FG000|Overall Study|Withdrawal by Subject|0|||
155184262|NCT02045303|560112517|FG001|Overall Study|Withdrawal by Subject|2|||
155184263|NCT02045303|560112518|FG002|Overall Study|Withdrawal by Subject|0|||
155184264|NCT01856023|560112519|FG000|Overall Study|Death|1|||
155184265|NCT01856023|560112520|FG001|Overall Study|Death|2|||
155184266|NCT01856023|560112519|FG000|Overall Study|Adverse Event|2|||
155184267|NCT01856023|560112520|FG001|Overall Study|Adverse Event|1|||
155184268|NCT01856023|560112519|FG000|Overall Study|Lack of Efficacy|5|||
155184269|NCT01856023|560112520|FG001|Overall Study|Lack of Efficacy|5|||
155184270|NCT01856023|560112519|FG000|Overall Study|non compliance, study closure|1|||
155184271|NCT01856023|560112520|FG001|Overall Study|non compliance, study closure|3|||
155184272|NCT01856023|560112519|FG000|Overall Study|Withdrawal by Subject|1|||
155184273|NCT01856023|560112520|FG001|Overall Study|Withdrawal by Subject|1|||
155184274|NCT00829283|560112521|FG000|Overall Study|Lost to Follow-up|7|||
155184275|NCT00829283|560112522|FG001|Overall Study|Lost to Follow-up|25|||
155184276|NCT03631355|560112523|FG000|Overall Study|Lost to Follow-up|1|||
155184277|NCT03631355|560112524|FG001|Overall Study|Lost to Follow-up|2|||
155184278|NCT02810340|560112525|FG000|Overall Study|Withdrawal by Subject|1|||
155184279|NCT02810340|560112526|FG001|Overall Study|Withdrawal by Subject|0|||
155184280|NCT02810340|560112527|FG002|Overall Study|Withdrawal by Subject|0|||
155184281|NCT02810340|560112525|FG000|Overall Study|Incarceration|0|||
155184282|NCT02810340|560112526|FG001|Overall Study|Incarceration|1|||
155184283|NCT02810340|560112527|FG002|Overall Study|Incarceration|0|||
155184284|NCT02810340|560112525|FG000|Overall Study|Lost to Follow-up|0|||
155184285|NCT02810340|560112526|FG001|Overall Study|Lost to Follow-up|0|||
155184286|NCT02810340|560112527|FG002|Overall Study|Lost to Follow-up|1|||
155184287|NCT00870233|560112533|FG000|Overall Study|Withdrawal by Subject|18|||
155184288|NCT00870233|560112533|FG000|Overall Study|Did not undergo laparotomy|3|||
155184289|NCT00870233|560112533|FG000|Overall Study|Incompatible internet browser|2|||
155184290|NCT00870233|560112533|FG000|Overall Study|Death|1|||
155184291|NCT00769483|560112534|FG000|Overall Study|Withdrawal by Subject|0|||
155184292|NCT00769483|560112535|FG001|Overall Study|Withdrawal by Subject|1|||
155184293|NCT00769483|560112536|FG002|Overall Study|Withdrawal by Subject|0|||
155184294|NCT00769483|560112537|FG003|Overall Study|Withdrawal by Subject|0|||
155184295|NCT00769483|560112538|FG004|Overall Study|Withdrawal by Subject|1|||
155184296|NCT00769483|560112539|FG005|Overall Study|Withdrawal by Subject|0|||
155184297|NCT00495131|560112552|FG000|Overall Study|Adverse Event|6|||
155184298|NCT00495131|560112553|FG001|Overall Study|Adverse Event|2|||
155184299|NCT00495131|560112552|FG000|Overall Study|Lack of Efficacy|0|||
155184300|NCT00495131|560112553|FG001|Overall Study|Lack of Efficacy|2|||
155184301|NCT00495131|560112552|FG000|Overall Study|Lost to Follow-up|0|||
155184302|NCT00495131|560112553|FG001|Overall Study|Lost to Follow-up|2|||
155184303|NCT00495131|560112552|FG000|Overall Study|Withdrawal by Subject|1|||
155184304|NCT00495131|560112553|FG001|Overall Study|Withdrawal by Subject|0|||
155184305|NCT00976573|560112560|FG000|Overall Study|Ineligible|0|||
155184306|NCT00976573|560112561|FG001|Overall Study|Ineligible|1|||
155184307|NCT00976573|560112560|FG000|Overall Study|Cancel prior to receiving treatment|4|||
155184308|NCT00976573|560112561|FG001|Overall Study|Cancel prior to receiving treatment|2|||
155184309|NCT02117427|560112562|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
155184310|NCT02117427|560112563|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
155184311|NCT02117427|560112564|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
155184312|NCT02117427|560112562|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
155184313|NCT02117427|560112563|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
155184314|NCT02117427|560112564|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
155184315|NCT02117427|560112562|FG000|Overall Study|Physician Decision|0|||
155184316|NCT02117427|560112563|FG001|Overall Study|Physician Decision|2|||
155184317|NCT02117427|560112564|FG002|Overall Study|Physician Decision|0|||
155184318|NCT02117427|560112562|FG000|Overall Study|No longer meets inclusion criteria|0|||
155184319|NCT02117427|560112563|FG001|Overall Study|No longer meets inclusion criteria|1|||
155184320|NCT02117427|560112564|FG002|Overall Study|No longer meets inclusion criteria|0|||
155184321|NCT02117427|560112562|FG000|Overall Study|Death|0|||
155184322|NCT02117427|560112563|FG001|Overall Study|Death|1|||
155184323|NCT02117427|560112564|FG002|Overall Study|Death|0|||
155184324|NCT02730208|560112565|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155184325|NCT02730208|560112566|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
155184326|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
155184327|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
155184328|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
155184329|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
155184330|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
155184331|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
155184332|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
155031684|NCT02954653|559542554|FG004|Overall Study|Death|0|||
155184333|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
155031685|NCT02954653|559542555|FG005|Overall Study|Death|0|||
155031686|NCT02954653|559542556|FG006|Overall Study|Death|0|||
155031687|NCT02954653|559542557|FG007|Overall Study|Death|0|||
155031688|NCT02954653|559542558|FG008|Overall Study|Death|0|||
155031689|NCT02954653|559542550|FG000|Overall Study|Randomized but did not receive treatment|1|||
155031690|NCT02954653|559542551|FG001|Overall Study|Randomized but did not receive treatment|0|||
155031691|NCT02954653|559542552|FG002|Overall Study|Randomized but did not receive treatment|0|||
155031692|NCT02954653|559542553|FG003|Overall Study|Randomized but did not receive treatment|0|||
155031693|NCT02954653|559542554|FG004|Overall Study|Randomized but did not receive treatment|0|||
155031694|NCT02954653|559542555|FG005|Overall Study|Randomized but did not receive treatment|0|||
155031695|NCT02954653|559542556|FG006|Overall Study|Randomized but did not receive treatment|0|||
155142270|NCT03386721|559952057|FG004|Overall Study|Symptomatic Deterioration|0|||
155142271|NCT03386721|559952058|FG005|Overall Study|Symptomatic Deterioration|0|||
155142272|NCT03386721|559952059|FG006|Overall Study|Symptomatic Deterioration|0|||
155142273|NCT03386721|559952060|FG007|Overall Study|Symptomatic Deterioration|0|||
155142274|NCT03386721|559952061|FG008|Overall Study|Symptomatic Deterioration|1|||
155142275|NCT03386721|559952062|FG009|Overall Study|Symptomatic Deterioration|0|||
155142276|NCT03386721|559952063|FG010|Overall Study|Symptomatic Deterioration|0|||
155142277|NCT03386721|559952064|FG011|Overall Study|Symptomatic Deterioration|1|||
155142278|NCT03386721|559952065|FG012|Overall Study|Symptomatic Deterioration|0|||
155142279|NCT03386721|559952066|FG013|Overall Study|Symptomatic Deterioration|0|||
155142280|NCT03386721|559952067|FG014|Overall Study|Symptomatic Deterioration|0|||
155142281|NCT03386721|559952053|FG000|Overall Study|Withdrawal by Subject|1|||
155142282|NCT03386721|559952054|FG001|Overall Study|Withdrawal by Subject|2|||
155142283|NCT03386721|559952055|FG002|Overall Study|Withdrawal by Subject|0|||
155142284|NCT03386721|559952056|FG003|Overall Study|Withdrawal by Subject|0|||
155142285|NCT03386721|559952057|FG004|Overall Study|Withdrawal by Subject|0|||
155142286|NCT03386721|559952058|FG005|Overall Study|Withdrawal by Subject|0|||
155142287|NCT03386721|559952059|FG006|Overall Study|Withdrawal by Subject|0|||
155142288|NCT03386721|559952060|FG007|Overall Study|Withdrawal by Subject|0|||
155142289|NCT03386721|559952061|FG008|Overall Study|Withdrawal by Subject|2|||
155142290|NCT03386721|559952062|FG009|Overall Study|Withdrawal by Subject|1|||
155142291|NCT03386721|559952063|FG010|Overall Study|Withdrawal by Subject|3|||
155142292|NCT03386721|559952064|FG011|Overall Study|Withdrawal by Subject|2|||
155142293|NCT03386721|559952065|FG012|Overall Study|Withdrawal by Subject|3|||
155142294|NCT03386721|559952066|FG013|Overall Study|Withdrawal by Subject|0|||
155142295|NCT03386721|559952067|FG014|Overall Study|Withdrawal by Subject|0|||
155142296|NCT01369784|559952071|FG000|Overall Study|Protocol Violation|12|||
155142297|NCT00596752|559952074|FG000|Overall Study|Other Reason|44|||
155142298|NCT00596752|559952075|FG001|Overall Study|Other Reason|49|||
155142299|NCT00596752|559952074|FG000|Overall Study|Adverse Event|34|||
155142300|NCT00596752|559952075|FG001|Overall Study|Adverse Event|34|||
155142301|NCT00596752|559952074|FG000|Overall Study|Lost to Follow-up|22|||
155142302|NCT00596752|559952075|FG001|Overall Study|Lost to Follow-up|38|||
155142303|NCT00596752|559952074|FG000|Overall Study|Withdrawal by Subject|12|||
155142304|NCT00596752|559952075|FG001|Overall Study|Withdrawal by Subject|9|||
155142305|NCT00596752|559952074|FG000|Overall Study|Unsatisfactory Compliance|9|||
155142306|NCT00596752|559952075|FG001|Overall Study|Unsatisfactory Compliance|6|||
155142307|NCT00596752|559952074|FG000|Overall Study|Lack of Efficacy|4|||
155142308|NCT00596752|559952075|FG001|Overall Study|Lack of Efficacy|7|||
155142309|NCT00596752|559952074|FG000|Overall Study|Protocol Violation|1|||
155142310|NCT00596752|559952075|FG001|Overall Study|Protocol Violation|0|||
155142311|NCT04797780|559952078|FG000|Overall Study|Lost to Follow-up|1|||
155142312|NCT04797780|559952079|FG001|Overall Study|Lost to Follow-up|1|||
155142313|NCT04797780|559952078|FG000|Overall Study|Withdrawal by Subject|14|||
155142314|NCT04797780|559952079|FG001|Overall Study|Withdrawal by Subject|9|||
155142315|NCT04797780|559952078|FG000|Overall Study|Death|49|||
155142316|NCT04797780|559952079|FG001|Overall Study|Death|20|||
155142317|NCT02586727|559952080|FG000|Overall Study|Lost to Follow-up|1|||
155142318|NCT02586727|559952081|FG001|Overall Study|Lost to Follow-up|0|||
155142319|NCT05167825|559952082|FG000|Overall Study|Ongoing|3|||
155142320|NCT02326597|559952094|FG000|Overall Study|Lost to Follow-up|42|||
155142321|NCT02326597|559952095|FG001|Overall Study|Lost to Follow-up|32|||
155031696|NCT02954653|559542557|FG007|Overall Study|Randomized but did not receive treatment|0|||
155142322|NCT02119663|559952096|FG000|Overall Study|Disease progression|26|||
155142323|NCT02119663|559952097|FG001|Overall Study|Disease progression|27|||
155142324|NCT02119663|559952096|FG000|Overall Study|Adverse Event|5|||
155142325|NCT02119663|559952097|FG001|Overall Study|Adverse Event|5|||
155142326|NCT02119663|559952096|FG000|Overall Study|Death|3|||
155142327|NCT02119663|559952097|FG001|Overall Study|Death|2|||
155142328|NCT02119663|559952096|FG000|Overall Study|Physician Decision|1|||
155142329|NCT02119663|559952097|FG001|Overall Study|Physician Decision|2|||
155142330|NCT02119663|559952096|FG000|Overall Study|Other unspecified|2|||
155142331|NCT02119663|559952097|FG001|Overall Study|Other unspecified|0|||
155142332|NCT02119663|559952096|FG000|Overall Study|Subject decision|0|||
155142333|NCT02119663|559952097|FG001|Overall Study|Subject decision|1|||
155142334|NCT02119663|559952096|FG000|Overall Study|Study Terminated by the Sponsor|3|||
155142335|NCT02119663|559952097|FG001|Overall Study|Study Terminated by the Sponsor|4|||
155142336|NCT01870726|559952098|FG000|Overall Study|Withdrawal of informed consent|0|||
155142337|NCT01870726|559952099|FG001|Overall Study|Withdrawal of informed consent|0|||
155142338|NCT01870726|559952100|FG002|Overall Study|Withdrawal of informed consent|0|||
155142339|NCT01870726|559952101|FG003|Overall Study|Withdrawal of informed consent|1|||
155142340|NCT01870726|559952102|FG004|Overall Study|Withdrawal of informed consent|0|||
155142341|NCT01870726|559952103|FG005|Overall Study|Withdrawal of informed consent|0|||
155142342|NCT01870726|559952104|FG006|Overall Study|Withdrawal of informed consent|0|||
155142343|NCT01870726|559952098|FG000|Overall Study|Withdrawal by Subject|0|||
155142344|NCT01870726|559952099|FG001|Overall Study|Withdrawal by Subject|1|||
155142345|NCT01870726|559952100|FG002|Overall Study|Withdrawal by Subject|0|||
155142346|NCT01870726|559952101|FG003|Overall Study|Withdrawal by Subject|0|||
155142347|NCT01870726|559952102|FG004|Overall Study|Withdrawal by Subject|0|||
155142348|NCT01870726|559952103|FG005|Overall Study|Withdrawal by Subject|0|||
155142349|NCT01870726|559952104|FG006|Overall Study|Withdrawal by Subject|0|||
155142350|NCT01870726|559952098|FG000|Overall Study|Adverse Event|0|||
155142351|NCT01870726|559952099|FG001|Overall Study|Adverse Event|0|||
155142352|NCT01870726|559952100|FG002|Overall Study|Adverse Event|0|||
155142353|NCT01870726|559952101|FG003|Overall Study|Adverse Event|0|||
155142354|NCT01870726|559952102|FG004|Overall Study|Adverse Event|1|||
155142355|NCT01870726|559952103|FG005|Overall Study|Adverse Event|1|||
155142356|NCT01870726|559952104|FG006|Overall Study|Adverse Event|0|||
155142357|NCT01870726|559952098|FG000|Overall Study|Progressive disease|5|||
155142358|NCT01870726|559952099|FG001|Overall Study|Progressive disease|5|||
155142359|NCT01870726|559952100|FG002|Overall Study|Progressive disease|4|||
155142360|NCT01870726|559952101|FG003|Overall Study|Progressive disease|5|||
155142361|NCT01870726|559952102|FG004|Overall Study|Progressive disease|6|||
155142362|NCT01870726|559952103|FG005|Overall Study|Progressive disease|4|||
155142363|NCT01870726|559952104|FG006|Overall Study|Progressive disease|10|||
155142364|NCT02978833|559952107|FG000|Overall Study|Study terminated|1|||
155142365|NCT02978833|559952108|FG001|Overall Study|Study terminated|1|||
155142366|NCT01123395|559952109|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
155142367|NCT01123395|559952110|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
155142368|NCT00186901|559952111|FG000|Overall Study|Pregnancy|6|||
155142369|NCT00186901|559952112|FG001|Overall Study|Pregnancy|3|||
155142370|NCT00186901|559952113|FG002|Overall Study|Pregnancy|0|||
155142371|NCT00186901|559952111|FG000|Overall Study|Lost to Follow-up|6|||
155142372|NCT00186901|559952112|FG001|Overall Study|Lost to Follow-up|3|||
155142373|NCT00186901|559952113|FG002|Overall Study|Lost to Follow-up|0|||
155142374|NCT00186901|559952111|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
155142375|NCT00186901|559952112|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
155142376|NCT00186901|559952113|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
155142377|NCT00186901|559952111|FG000|Overall Study|ALL relapse or second malignancy|1|||
155142378|NCT00186901|559952112|FG001|Overall Study|ALL relapse or second malignancy|2|||
155142379|NCT00186901|559952113|FG002|Overall Study|ALL relapse or second malignancy|0|||
155142380|NCT00186901|559952111|FG000|Overall Study|Withdrawal by Subject|4|||
155142381|NCT00186901|559952112|FG001|Overall Study|Withdrawal by Subject|5|||
155142382|NCT00186901|559952113|FG002|Overall Study|Withdrawal by Subject|0|||
155142383|NCT00186901|559952111|FG000|Overall Study|Open label|3|||
155142384|NCT00186901|559952112|FG001|Overall Study|Open label|2|||
155142385|NCT00186901|559952113|FG002|Overall Study|Open label|0|||
155142386|NCT00186901|559952111|FG000|Overall Study|Limited adherence to study requirements|20|||
155142387|NCT00186901|559952112|FG001|Overall Study|Limited adherence to study requirements|23|||
155142388|NCT00186901|559952113|FG002|Overall Study|Limited adherence to study requirements|0|||
155142389|NCT00186901|559952111|FG000|Overall Study|Bone Mineral Density > 0|0|||
155142390|NCT00186901|559952112|FG001|Overall Study|Bone Mineral Density > 0|0|||
155142391|NCT00186901|559952113|FG002|Overall Study|Bone Mineral Density > 0|149|||
155142392|NCT01546688|559952114|FG000|Overall Study|Adverse Event|0|||
155142393|NCT01546688|559952115|FG001|Overall Study|Adverse Event|4|||
155142394|NCT01546688|559952114|FG000|Overall Study|Withdrawal by Subject|2|||
155142395|NCT01546688|559952115|FG001|Overall Study|Withdrawal by Subject|1|||
155184334|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
155142396|NCT01546688|559952114|FG000|Overall Study|Lack of Efficacy|1|||
155142397|NCT01546688|559952115|FG001|Overall Study|Lack of Efficacy|0|||
155142398|NCT00782483|559952119|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
155142399|NCT03543137|559952120|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
155142400|NCT03543137|559952121|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
155142401|NCT03543137|559952120|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
155142402|NCT03543137|559952121|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
155142403|NCT03543137|559952120|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
155142404|NCT03543137|559952121|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
155142405|NCT01052077|559952122|FG000|Phase A|Lost to Follow-up|22|||
155142406|NCT01052077|559952123|FG001|Phase A|Lost to Follow-up|0|||
155142407|NCT01052077|559952124|FG002|Phase A|Lost to Follow-up|0|||
155142408|NCT01052077|559952125|FG003|Phase A|Lost to Follow-up|0|||
155142409|NCT01052077|559952122|FG000|Phase A|Adverse Event|32|||
155031697|NCT02954653|559542558|FG008|Overall Study|Randomized but did not receive treatment|0|||
155031698|NCT02954653|559542550|FG000|Overall Study|Started another anti-cancer therapy|0|||
155031699|NCT02954653|559542551|FG001|Overall Study|Started another anti-cancer therapy|1|||
155031700|NCT02954653|559542552|FG002|Overall Study|Started another anti-cancer therapy|0|||
155031701|NCT02954653|559542553|FG003|Overall Study|Started another anti-cancer therapy|0|||
155031702|NCT02954653|559542554|FG004|Overall Study|Started another anti-cancer therapy|0|||
155031703|NCT02954653|559542555|FG005|Overall Study|Started another anti-cancer therapy|0|||
155031704|NCT02954653|559542556|FG006|Overall Study|Started another anti-cancer therapy|0|||
155031705|NCT02954653|559542557|FG007|Overall Study|Started another anti-cancer therapy|0|||
155031706|NCT02954653|559542558|FG008|Overall Study|Started another anti-cancer therapy|0|||
155031707|NCT02954653|559542550|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
155031708|NCT02954653|559542551|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
155031709|NCT02954653|559542552|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
155031710|NCT02954653|559542553|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
155031711|NCT02954653|559542554|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
155031712|NCT02954653|559542555|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
155031713|NCT02954653|559542556|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
155031714|NCT02954653|559542557|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
155031715|NCT02954653|559542558|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
155031716|NCT03054064|559542559|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
155031717|NCT03054064|559542559|FG000|Overall Study|Investigator Decision|2|||
155031718|NCT03054064|559542559|FG000|Overall Study|Bladder Issue|1|||
155031719|NCT03054064|559542559|FG000|Overall Study|High Blood Pressure|1|||
155031720|NCT03054064|559542559|FG000|Overall Study|Change in Status|1|||
155031721|NCT04329091|559542560|FG000|Overall Study|Physician Decision|5|||
155031722|NCT03787303|559542563|FG000|Overall Study|Death|1|||
155031723|NCT03787303|559542563|FG000|Overall Study|Premature Termination of Study|1|||
155031724|NCT01500213|559542568|FG000|Overall Study|Adverse Event|35|||
155031725|NCT01500213|559542569|FG001|Overall Study|Adverse Event|35|||
155031726|NCT01500213|559542568|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
155142410|NCT01052077|559952123|FG001|Phase A|Adverse Event|0|||
155142411|NCT01052077|559952124|FG002|Phase A|Adverse Event|0|||
155142412|NCT01052077|559952125|FG003|Phase A|Adverse Event|0|||
155142413|NCT01052077|559952122|FG000|Phase A|Met Withdrawal Criteria|26|||
155184335|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
155142414|NCT01052077|559952123|FG001|Phase A|Met Withdrawal Criteria|0|||
155142415|NCT01052077|559952124|FG002|Phase A|Met Withdrawal Criteria|0|||
155142416|NCT01052077|559952125|FG003|Phase A|Met Withdrawal Criteria|0|||
155142417|NCT01052077|559952122|FG000|Phase A|Physician Decision|10|||
155142418|NCT01052077|559952123|FG001|Phase A|Physician Decision|0|||
155142419|NCT01052077|559952124|FG002|Phase A|Physician Decision|0|||
155142420|NCT01052077|559952125|FG003|Phase A|Physician Decision|0|||
155142421|NCT01052077|559952122|FG000|Phase A|Withdrawal by Subject|29|||
155142422|NCT01052077|559952123|FG001|Phase A|Withdrawal by Subject|0|||
155142423|NCT01052077|559952124|FG002|Phase A|Withdrawal by Subject|0|||
155142424|NCT01052077|559952125|FG003|Phase A|Withdrawal by Subject|0|||
155142425|NCT01052077|559952122|FG000|Phase A|Protocol Deviation|27|||
155142426|NCT01052077|559952123|FG001|Phase A|Protocol Deviation|0|||
155142427|NCT01052077|559952124|FG002|Phase A|Protocol Deviation|0|||
155142428|NCT01052077|559952125|FG003|Phase A|Protocol Deviation|0|||
155142429|NCT01052077|559952122|FG000|Phase B|Lost to Follow-up|0|||
155142430|NCT01052077|559952123|FG001|Phase B|Lost to Follow-up|2|||
155142431|NCT01052077|559952124|FG002|Phase B|Lost to Follow-up|3|||
155142432|NCT01052077|559952125|FG003|Phase B|Lost to Follow-up|0|||
155142433|NCT01052077|559952122|FG000|Phase B|Adverse Event|0|||
155142434|NCT01052077|559952123|FG001|Phase B|Adverse Event|9|||
155142435|NCT01052077|559952124|FG002|Phase B|Adverse Event|2|||
155142436|NCT01052077|559952125|FG003|Phase B|Adverse Event|0|||
155184336|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
155184337|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
155184338|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
155184339|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
155184340|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
155184341|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
155031727|NCT01500213|559542569|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
155142437|NCT01052077|559952122|FG000|Phase B|Met Withdrawal Criteria|0|||
155142438|NCT01052077|559952123|FG001|Phase B|Met Withdrawal Criteria|2|||
155142439|NCT01052077|559952124|FG002|Phase B|Met Withdrawal Criteria|1|||
155031728|NCT01500213|559542568|FG000|Overall Study|Withdrawal by Subject|28|||
155031729|NCT01500213|559542569|FG001|Overall Study|Withdrawal by Subject|37|||
155142440|NCT01052077|559952125|FG003|Phase B|Met Withdrawal Criteria|0|||
155142441|NCT01052077|559952122|FG000|Phase B|Physician Decision|0|||
155142442|NCT01052077|559952123|FG001|Phase B|Physician Decision|1|||
155142443|NCT01052077|559952124|FG002|Phase B|Physician Decision|1|||
155142444|NCT01052077|559952125|FG003|Phase B|Physician Decision|0|||
155184342|NCT00491556|560112584|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
155184343|NCT00491556|560112585|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
155184344|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
155184345|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
155184346|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
155184347|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
155184348|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
155184349|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
155184350|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
155184351|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
155184352|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
155184353|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
155184354|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
155184355|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
155184356|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
155184357|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
155184358|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
155184359|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
155184360|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
155184361|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
155184362|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
155184363|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
155184364|NCT00491556|560112584|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
155184365|NCT00491556|560112585|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
155184366|NCT02418156|560112586|FG000|Overall Study|Lost to Follow-up|12|||
155184367|NCT02418156|560112586|FG000|Overall Study|Death|2|||
155184368|NCT02418156|560112586|FG000|Overall Study|Physician Decision|1|||
155184369|NCT02418156|560112586|FG000|Overall Study|Withdrawal by Subject|1|||
155184370|NCT02418156|560112586|FG000|Overall Study|Subject refused to return|1|||
155184371|NCT01909453|560112587|FG000|Overall Study|Ongoing|118|||
155184372|NCT01909453|560112588|FG001|Overall Study|Ongoing|103|||
155184373|NCT01909453|560112589|FG002|Overall Study|Ongoing|83|||
155184374|NCT01909453|560112590|FG003|Overall Study|Ongoing|164|||
155184375|NCT01909453|560112591|FG004|Overall Study|Ongoing|50|||
155184376|NCT01909453|560112587|FG000|Overall Study|Death|69|||
155184377|NCT01909453|560112588|FG001|Overall Study|Death|74|||
155184378|NCT01909453|560112589|FG002|Overall Study|Death|88|||
155184379|NCT01909453|560112590|FG003|Overall Study|Death|86|||
155184380|NCT01909453|560112591|FG004|Overall Study|Death|29|||
155184381|NCT01909453|560112587|FG000|Overall Study|Lost to Follow-up|3|||
155184382|NCT01909453|560112588|FG001|Overall Study|Lost to Follow-up|4|||
155184383|NCT01909453|560112589|FG002|Overall Study|Lost to Follow-up|4|||
155184384|NCT01909453|560112590|FG003|Overall Study|Lost to Follow-up|3|||
155184385|NCT01909453|560112591|FG004|Overall Study|Lost to Follow-up|3|||
155184386|NCT01909453|560112587|FG000|Overall Study|Withdrawal by Subject|2|||
155184387|NCT01909453|560112588|FG001|Overall Study|Withdrawal by Subject|13|||
155184388|NCT01909453|560112589|FG002|Overall Study|Withdrawal by Subject|16|||
155184389|NCT01909453|560112590|FG003|Overall Study|Withdrawal by Subject|5|||
155184390|NCT01909453|560112591|FG004|Overall Study|Withdrawal by Subject|4|||
155184391|NCT02423109|560114554|FG000|Lens 1|Adverse Event|1|||
155184392|NCT02423109|560114555|FG001|Lens 1|Adverse Event|0|||
155184393|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
155184394|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
155184395|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
155184396|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
155184397|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
155184398|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
155184399|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
155184400|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
155184401|NCT03347188|560114556|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
155184402|NCT03347188|560114557|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
155184403|NCT03347188|560114556|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
155184404|NCT03347188|560114557|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
155184405|NCT03347188|560114556|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
155184406|NCT03347188|560114557|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
155184407|NCT03347188|560114556|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
155184408|NCT03347188|560114557|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
155184409|NCT00397943|560114558|FG000|Overall Study|Unspecified reasons|12|||
155184410|NCT00397943|560114559|FG001|Overall Study|Unspecified reasons|9|||
155184411|NCT00397943|560114560|FG002|Overall Study|Unspecified reasons|0|||
155184412|NCT00397943|560114561|FG003|Overall Study|Unspecified reasons|0|||
155184413|NCT00397943|560114562|FG004|Overall Study|Unspecified reasons|0|||
155184414|NCT03139604|560114563|FG000|Overall Study|Other|7|||
155184415|NCT03139604|560114564|FG001|Overall Study|Other|3|||
155184416|NCT03139604|560114563|FG000|Overall Study|Withdrawal by Subject|16|||
155184417|NCT03139604|560114564|FG001|Overall Study|Withdrawal by Subject|17|||
155184418|NCT03139604|560114563|FG000|Overall Study|Physician Decision|1|||
155031730|NCT01500213|559542568|FG000|Overall Study|Death|7|||
155031731|NCT01500213|559542569|FG001|Overall Study|Death|3|||
155031732|NCT01500213|559542568|FG000|Overall Study|Disease Progression|13|||
155031733|NCT01500213|559542569|FG001|Overall Study|Disease Progression|21|||
155031734|NCT01500213|559542568|FG000|Overall Study|Protocol Violation|19|||
155031735|NCT01500213|559542569|FG001|Overall Study|Protocol Violation|19|||
155031736|NCT01500213|559542568|FG000|Overall Study|Physician Decision|12|||
155031737|NCT01500213|559542569|FG001|Overall Study|Physician Decision|10|||
155031738|NCT01500213|559542568|FG000|Overall Study|Lack of Efficacy|9|||
155031739|NCT01500213|559542569|FG001|Overall Study|Lack of Efficacy|7|||
155031740|NCT01500213|559542568|FG000|Overall Study|Lost to Follow-up|3|||
155031741|NCT01500213|559542569|FG001|Overall Study|Lost to Follow-up|6|||
155031742|NCT01500213|559542568|FG000|Overall Study|Other Reasons|7|||
155031743|NCT01500213|559542569|FG001|Overall Study|Other Reasons|5|||
155031744|NCT00785213|559542570|FG000|Quinine Sulfate Alone|Adverse Event|4|||
155031745|NCT00785213|559542570|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
155031746|NCT02386345|559542571|FG000|Overall Study|Not treated|14|||
155031747|NCT02386345|559542571|FG000|Overall Study|Lost to Follow-up|1|||
155031748|NCT02386345|559542571|FG000|Overall Study|Adverse Event|5|||
155031749|NCT02386345|559542571|FG000|Overall Study|Repeat Procedure|10|||
155031750|NCT02386345|559542571|FG000|Overall Study|Did not complete 12-month follow-up|72|||
155031751|NCT01043705|559542574|FG000|Overall Study|Death|28|||
155031752|NCT01043705|559542575|FG001|Overall Study|Death|60|||
155031753|NCT01043705|559542576|FG002|Overall Study|Death|26|||
155031754|NCT01043705|559542574|FG000|Overall Study|Lost to Follow-up|27|||
155031755|NCT01043705|559542575|FG001|Overall Study|Lost to Follow-up|12|||
155031756|NCT01043705|559542576|FG002|Overall Study|Lost to Follow-up|0|||
155031757|NCT01043705|559542574|FG000|Overall Study|Multiple Reasons|4|||
155031758|NCT01043705|559542575|FG001|Overall Study|Multiple Reasons|7|||
155031759|NCT01043705|559542576|FG002|Overall Study|Multiple Reasons|0|||
155031760|NCT01043705|559542574|FG000|Overall Study|Protocol Violation|2|||
155031761|NCT01043705|559542575|FG001|Overall Study|Protocol Violation|1|||
155031762|NCT01043705|559542576|FG002|Overall Study|Protocol Violation|0|||
155031763|NCT01043705|559542574|FG000|Overall Study|Withdrawal by Subject|8|||
155031764|NCT01043705|559542575|FG001|Overall Study|Withdrawal by Subject|6|||
155031765|NCT01043705|559542576|FG002|Overall Study|Withdrawal by Subject|0|||
155031766|NCT01043705|559542574|FG000|Overall Study|Site Closure|8|||
155031767|NCT01043705|559542575|FG001|Overall Study|Site Closure|0|||
155031768|NCT01043705|559542576|FG002|Overall Study|Site Closure|0|||
155031769|NCT01043705|559542574|FG000|Overall Study|Subsequent Procedure|9|||
155031770|NCT01043705|559542575|FG001|Overall Study|Subsequent Procedure|24|||
155031771|NCT01043705|559542576|FG002|Overall Study|Subsequent Procedure|29|||
155031772|NCT01043705|559542574|FG000|Overall Study|Adverse Event|0|||
155031773|NCT01043705|559542575|FG001|Overall Study|Adverse Event|2|||
155031774|NCT01043705|559542576|FG002|Overall Study|Adverse Event|0|||
155031775|NCT01043705|559542574|FG000|Overall Study|Screen Fail|21|||
155031776|NCT01043705|559542575|FG001|Overall Study|Screen Fail|0|||
155031777|NCT01043705|559542576|FG002|Overall Study|Screen Fail|0|||
155031778|NCT01043705|559542574|FG000|Overall Study|Other|0|||
155031779|NCT01043705|559542575|FG001|Overall Study|Other|19|||
155031780|NCT01043705|559542576|FG002|Overall Study|Other|25|||
155031781|NCT02003963|559542578|FG000|Overall Study|Lost to Follow-up|2|||
155031782|NCT02003963|559542579|FG001|Overall Study|Lost to Follow-up|1|||
155031783|NCT00581542|559542580|FG000|Overall Study|they met an exclusion criteria|2|||
155031784|NCT00581542|559542581|FG001|Overall Study|they met an exclusion criteria|2|||
155031785|NCT00581542|559542580|FG000|Overall Study|Lost to Follow-up|9|||
155031786|NCT00581542|559542581|FG001|Overall Study|Lost to Follow-up|21|||
155031787|NCT00176644|559542582|FG000|Overall Study|Withdrawal by Subject|1|||
155031788|NCT01801280|559542583|FG000|Period 1|Withdrawal by Subject|0|||
155031789|NCT01801280|559542584|FG001|Period 1|Withdrawal by Subject|1|||
155031790|NCT01801280|559542585|FG002|Period 1|Withdrawal by Subject|0|||
155031791|NCT01801280|559542586|FG003|Period 1|Withdrawal by Subject|0|||
155031792|NCT01801280|559542583|FG000|Period 2|Withdrawal by Subject|1|||
155031793|NCT01801280|559542584|FG001|Period 2|Withdrawal by Subject|0|||
155031794|NCT01801280|559542585|FG002|Period 2|Withdrawal by Subject|0|||
155031795|NCT01801280|559542586|FG003|Period 2|Withdrawal by Subject|0|||
155031796|NCT01801280|559542583|FG000|Period 4|Protocol Violation|0|||
155031797|NCT01801280|559542584|FG001|Period 4|Protocol Violation|0|||
155031798|NCT01801280|559542585|FG002|Period 4|Protocol Violation|1|||
155184419|NCT03139604|560114564|FG001|Overall Study|Physician Decision|2|||
155184420|NCT03139604|560114563|FG000|Overall Study|Lost to Follow-up|3|||
155031799|NCT01801280|559542586|FG003|Period 4|Protocol Violation|0|||
155031800|NCT05020366|559542587|FG000|Overall Study|Lost to Follow-up|2|||
155031801|NCT05020366|559542588|FG001|Overall Study|Lost to Follow-up|0|||
155031802|NCT05020366|559542587|FG000|Overall Study|Withdrawal by Subject|2|||
155031803|NCT05020366|559542588|FG001|Overall Study|Withdrawal by Subject|0|||
155031804|NCT00478699|559542596|FG000|Overall Study|Inclusion Error|1|||
155031805|NCT00478699|559542597|FG001|Overall Study|Inclusion Error|7|||
155031806|NCT00478699|559542596|FG000|Overall Study|Not receive study treatment|6|||
155031807|NCT00478699|559542597|FG001|Overall Study|Not receive study treatment|30|||
155031808|NCT01252563|559542599|FG000|Overall Study|Contract Deviation|41|||
155031809|NCT01252563|559542599|FG000|Overall Study|Centralized Registration Deviation|30|||
155031810|NCT01252563|559542599|FG000|Overall Study|Lost to Follow-up|161|||
155031811|NCT01252563|559542599|FG000|Overall Study|No visit after first day of treatment|194|||
155031812|NCT01252563|559542599|FG000|Overall Study|No drug administration|6|||
155031813|NCT01866657|559542600|FG000|Overall Study|Surgery canceled|2|||
155031814|NCT01866657|559542601|FG001|Overall Study|Surgery canceled|0|||
155031815|NCT02951533|559542602|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
155031816|NCT02951533|559542603|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
155031817|NCT02951533|559542604|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
155031818|NCT02951533|559542602|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
155031819|NCT02951533|559542603|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
155031820|NCT02951533|559542604|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
155031821|NCT02951533|559542602|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
155142445|NCT01052077|559952122|FG000|Phase B|Withdrawal by Subject|0|||
155142446|NCT01052077|559952123|FG001|Phase B|Withdrawal by Subject|0|||
155142447|NCT01052077|559952124|FG002|Phase B|Withdrawal by Subject|5|||
155142448|NCT01052077|559952125|FG003|Phase B|Withdrawal by Subject|0|||
155142449|NCT01052077|559952122|FG000|Phase B|Protocol Deviation|0|||
155142450|NCT01052077|559952123|FG001|Phase B|Protocol Deviation|3|||
155142451|NCT01052077|559952124|FG002|Phase B|Protocol Deviation|4|||
155142452|NCT01052077|559952125|FG003|Phase B|Protocol Deviation|0|||
155142453|NCT01052077|559952122|FG000|Phase B|Lack of Efficacy|0|||
155142454|NCT01052077|559952123|FG001|Phase B|Lack of Efficacy|1|||
155142455|NCT01052077|559952124|FG002|Phase B|Lack of Efficacy|0|||
155142456|NCT01052077|559952125|FG003|Phase B|Lack of Efficacy|0|||
155142457|NCT01052077|559952122|FG000|Phase A+|Lost to Follow-up|0|||
155142458|NCT01052077|559952123|FG001|Phase A+|Lost to Follow-up|0|||
155142459|NCT01052077|559952124|FG002|Phase A+|Lost to Follow-up|0|||
155142460|NCT01052077|559952125|FG003|Phase A+|Lost to Follow-up|8|||
155142461|NCT01052077|559952122|FG000|Phase A+|Adverse Event|0|||
155142462|NCT01052077|559952123|FG001|Phase A+|Adverse Event|0|||
155142463|NCT01052077|559952124|FG002|Phase A+|Adverse Event|0|||
155142464|NCT01052077|559952125|FG003|Phase A+|Adverse Event|4|||
155142465|NCT01052077|559952122|FG000|Phase A+|Met Withdrawal Criteria|0|||
155142466|NCT01052077|559952123|FG001|Phase A+|Met Withdrawal Criteria|0|||
155142467|NCT01052077|559952124|FG002|Phase A+|Met Withdrawal Criteria|0|||
155142468|NCT01052077|559952125|FG003|Phase A+|Met Withdrawal Criteria|2|||
155142469|NCT01052077|559952122|FG000|Phase A+|Withdrawal by Subject|0|||
155142470|NCT01052077|559952123|FG001|Phase A+|Withdrawal by Subject|0|||
155142471|NCT01052077|559952124|FG002|Phase A+|Withdrawal by Subject|0|||
155142472|NCT01052077|559952125|FG003|Phase A+|Withdrawal by Subject|7|||
155142473|NCT01099397|559952129|FG000|Overall Study|Lost to Follow-up|4|||
155142474|NCT01099397|559952129|FG000|Overall Study|Protocol Violation|4|||
155142475|NCT01099397|559952129|FG000|Overall Study|Withdrawal by Subject|5|||
155142476|NCT02363959|559952130|FG000|Overall Study|Medical instability|1|||
155142477|NCT02363959|559952131|FG001|Overall Study|Medical instability|0|||
155142478|NCT00003199|559952133|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
155142479|NCT00003199|559952133|FG000|Overall Study|Lack of insurance clearance|2|||
155142480|NCT00003199|559952133|FG000|Overall Study|Screen fail|15|||
155142481|NCT00940498|559952134|FG000|Overall Study|Death|2|||
155142482|NCT00940498|559952135|FG001|Overall Study|Death|0|||
155142483|NCT00940498|559952136|FG002|Overall Study|Death|0|||
155142484|NCT00940498|559952137|FG003|Overall Study|Death|1|||
155142485|NCT00940498|559952138|FG004|Overall Study|Death|5|||
155142486|NCT00940498|559952139|FG005|Overall Study|Death|0|||
155142487|NCT00940498|559952140|FG006|Overall Study|Death|1|||
155142488|NCT00940498|559952141|FG007|Overall Study|Death|0|||
155142489|NCT00940498|559952134|FG000|Overall Study|Lost to Follow-up|1|||
155142490|NCT00940498|559952135|FG001|Overall Study|Lost to Follow-up|1|||
155031822|NCT02951533|559542603|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
155031823|NCT02951533|559542604|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
155142491|NCT00940498|559952136|FG002|Overall Study|Lost to Follow-up|2|||
155142492|NCT00940498|559952137|FG003|Overall Study|Lost to Follow-up|0|||
155142493|NCT00940498|559952138|FG004|Overall Study|Lost to Follow-up|1|||
155142494|NCT00940498|559952139|FG005|Overall Study|Lost to Follow-up|0|||
155142495|NCT00940498|559952140|FG006|Overall Study|Lost to Follow-up|0|||
155142496|NCT00940498|559952141|FG007|Overall Study|Lost to Follow-up|1|||
155142497|NCT00940498|559952134|FG000|Overall Study|Disease Progression|0|||
155142498|NCT00940498|559952135|FG001|Overall Study|Disease Progression|0|||
155142499|NCT00940498|559952136|FG002|Overall Study|Disease Progression|1|||
155142500|NCT00940498|559952137|FG003|Overall Study|Disease Progression|1|||
155142501|NCT00940498|559952138|FG004|Overall Study|Disease Progression|0|||
155142502|NCT00940498|559952139|FG005|Overall Study|Disease Progression|1|||
155142503|NCT00940498|559952140|FG006|Overall Study|Disease Progression|0|||
155142504|NCT00940498|559952141|FG007|Overall Study|Disease Progression|0|||
155184421|NCT03139604|560114564|FG001|Overall Study|Lost to Follow-up|1|||
155184422|NCT03139604|560114563|FG000|Overall Study|Death|65|||
155184423|NCT03139604|560114564|FG001|Overall Study|Death|67|||
155184424|NCT03139604|560114563|FG000|Overall Study|Study Terminated by Sponsor|122|||
155184425|NCT03139604|560114564|FG001|Overall Study|Study Terminated by Sponsor|127|||
155184426|NCT03139604|560114563|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
155184427|NCT03139604|560114564|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
155184428|NCT04209426|560114567|FG000|Overall Study|Lost to Follow-up|3|||
155184429|NCT04209426|560114568|FG001|Overall Study|Lost to Follow-up|2|||
155184430|NCT01751802|560114580|FG000|Overall Study|Adverse Event|4|||
155184431|NCT01751802|560114581|FG001|Overall Study|Adverse Event|2|||
155184432|NCT00521001|560114585|FG000|Overall Study|Ineligible|1|||
155184433|NCT02821910|560114586|FG000|Overall Study|Withdrawal by Subject|0|||
155184434|NCT02821910|560114587|FG001|Overall Study|Withdrawal by Subject|0|||
155184435|NCT02821910|560114588|FG002|Overall Study|Withdrawal by Subject|1|||
155184436|NCT02821910|560114589|FG003|Overall Study|Withdrawal by Subject|0|||
155184437|NCT02821910|560114590|FG004|Overall Study|Withdrawal by Subject|0|||
155184438|NCT02821910|560114591|FG005|Overall Study|Withdrawal by Subject|1|||
155184439|NCT02821910|560114586|FG000|Overall Study|Other than specified|1|||
155184440|NCT02821910|560114587|FG001|Overall Study|Other than specified|0|||
155184441|NCT02821910|560114588|FG002|Overall Study|Other than specified|1|||
155184442|NCT02821910|560114589|FG003|Overall Study|Other than specified|0|||
155184443|NCT02821910|560114590|FG004|Overall Study|Other than specified|0|||
155184444|NCT02821910|560114591|FG005|Overall Study|Other than specified|0|||
155184445|NCT00423670|560114594|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
155184446|NCT00423670|560114595|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184447|NCT00423670|560114596|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184448|NCT00423670|560114597|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184449|NCT00423670|560114598|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184450|NCT00423670|560114599|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184451|NCT00423670|560114600|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184452|NCT00423670|560114601|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
155184453|NCT00423670|560114594|FG000|Treatment Period|Adverse Event|8|||
155184454|NCT00423670|560114595|FG001|Treatment Period|Adverse Event|12|||
155184455|NCT00423670|560114596|FG002|Treatment Period|Adverse Event|15|||
155184456|NCT00423670|560114597|FG003|Treatment Period|Adverse Event|20|||
155184457|NCT00423670|560114598|FG004|Treatment Period|Adverse Event|9|||
155184458|NCT00423670|560114599|FG005|Treatment Period|Adverse Event|4|||
155184459|NCT00423670|560114600|FG006|Treatment Period|Adverse Event|7|||
155184460|NCT00423670|560114601|FG007|Treatment Period|Adverse Event|2|||
155184461|NCT00423670|560114594|FG000|Treatment Period|Protocol-defined clinical event|0|||
155184462|NCT00423670|560114595|FG001|Treatment Period|Protocol-defined clinical event|7|||
155184463|NCT00423670|560114596|FG002|Treatment Period|Protocol-defined clinical event|4|||
155184464|NCT00423670|560114597|FG003|Treatment Period|Protocol-defined clinical event|12|||
155184465|NCT00423670|560114598|FG004|Treatment Period|Protocol-defined clinical event|5|||
155184466|NCT00423670|560114599|FG005|Treatment Period|Protocol-defined clinical event|4|||
155184467|NCT00423670|560114600|FG006|Treatment Period|Protocol-defined clinical event|16|||
155184468|NCT00423670|560114601|FG007|Treatment Period|Protocol-defined clinical event|15|||
155184469|NCT00423670|560114594|FG000|Treatment Period|Lost to Follow-up|2|||
155184470|NCT00423670|560114595|FG001|Treatment Period|Lost to Follow-up|1|||
155184471|NCT00423670|560114596|FG002|Treatment Period|Lost to Follow-up|3|||
155184472|NCT00423670|560114597|FG003|Treatment Period|Lost to Follow-up|1|||
155184473|NCT00423670|560114598|FG004|Treatment Period|Lost to Follow-up|6|||
155184474|NCT00423670|560114599|FG005|Treatment Period|Lost to Follow-up|0|||
155184475|NCT00423670|560114600|FG006|Treatment Period|Lost to Follow-up|3|||
155031824|NCT02951533|559542602|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
155031825|NCT02951533|559542603|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
155031826|NCT02951533|559542604|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
155184476|NCT00423670|560114601|FG007|Treatment Period|Lost to Follow-up|1|||
155184477|NCT00423670|560114594|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
155184478|NCT00423670|560114595|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
155184479|NCT00423670|560114596|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
155184480|NCT00423670|560114597|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
155031827|NCT02951533|559542602|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
155031828|NCT02951533|559542603|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
155184481|NCT00423670|560114598|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
155184482|NCT00423670|560114599|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
155184483|NCT00423670|560114600|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
155184484|NCT00423670|560114601|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
155184485|NCT00423670|560114594|FG000|Treatment Period|Investigator decision|0|||
155184486|NCT00423670|560114595|FG001|Treatment Period|Investigator decision|0|||
155184487|NCT00423670|560114596|FG002|Treatment Period|Investigator decision|0|||
155184488|NCT00423670|560114597|FG003|Treatment Period|Investigator decision|0|||
155184489|NCT00423670|560114598|FG004|Treatment Period|Investigator decision|0|||
155184490|NCT00423670|560114599|FG005|Treatment Period|Investigator decision|0|||
155184491|NCT00423670|560114600|FG006|Treatment Period|Investigator decision|0|||
155184492|NCT00423670|560114601|FG007|Treatment Period|Investigator decision|1|||
155184493|NCT00423670|560114594|FG000|Treatment Period|Non-compliance with protocol|3|||
155184494|NCT00423670|560114595|FG001|Treatment Period|Non-compliance with protocol|1|||
155184495|NCT00423670|560114596|FG002|Treatment Period|Non-compliance with protocol|1|||
155184496|NCT00423670|560114597|FG003|Treatment Period|Non-compliance with protocol|3|||
155184497|NCT00423670|560114598|FG004|Treatment Period|Non-compliance with protocol|2|||
155184498|NCT00423670|560114599|FG005|Treatment Period|Non-compliance with protocol|0|||
155184499|NCT00423670|560114600|FG006|Treatment Period|Non-compliance with protocol|2|||
155184500|NCT00423670|560114601|FG007|Treatment Period|Non-compliance with protocol|2|||
155184501|NCT00423670|560114594|FG000|Follow-up Period|Lost to Follow-up|0|||
155184502|NCT00423670|560114595|FG001|Follow-up Period|Lost to Follow-up|12|||
155184503|NCT00423670|560114596|FG002|Follow-up Period|Lost to Follow-up|8|||
155184504|NCT00423670|560114597|FG003|Follow-up Period|Lost to Follow-up|3|||
155184505|NCT00423670|560114598|FG004|Follow-up Period|Lost to Follow-up|1|||
155184506|NCT00423670|560114599|FG005|Follow-up Period|Lost to Follow-up|0|||
155184507|NCT00423670|560114600|FG006|Follow-up Period|Lost to Follow-up|5|||
155184508|NCT00423670|560114601|FG007|Follow-up Period|Lost to Follow-up|0|||
155184509|NCT00423670|560114594|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184510|NCT00423670|560114595|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
155184511|NCT00423670|560114596|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
155184512|NCT00423670|560114597|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184513|NCT00423670|560114598|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184514|NCT00423670|560114599|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
155184515|NCT00423670|560114600|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184516|NCT00423670|560114601|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
155184517|NCT00423670|560114594|FG000|Follow-up Period|Non-compliance with protocol|2|||
155184518|NCT00423670|560114595|FG001|Follow-up Period|Non-compliance with protocol|0|||
155184519|NCT00423670|560114596|FG002|Follow-up Period|Non-compliance with protocol|1|||
155184520|NCT00423670|560114597|FG003|Follow-up Period|Non-compliance with protocol|1|||
155184521|NCT00423670|560114598|FG004|Follow-up Period|Non-compliance with protocol|0|||
155184522|NCT00423670|560114599|FG005|Follow-up Period|Non-compliance with protocol|0|||
155184523|NCT00423670|560114600|FG006|Follow-up Period|Non-compliance with protocol|3|||
155184524|NCT00423670|560114601|FG007|Follow-up Period|Non-compliance with protocol|2|||
155184525|NCT00900601|560114602|FG000|Overall Study|Physician Decision|1|||
155184526|NCT01082640|560114604|FG000|Overall Study|Adverse Event|9|||
155184527|NCT01082640|560114605|FG001|Overall Study|Adverse Event|5|||
155184528|NCT01082640|560114606|FG002|Overall Study|Adverse Event|3|||
155184529|NCT01082640|560114604|FG000|Overall Study|Withdrawal by Subject|3|||
155184530|NCT01082640|560114605|FG001|Overall Study|Withdrawal by Subject|3|||
155184531|NCT01082640|560114606|FG002|Overall Study|Withdrawal by Subject|2|||
155184532|NCT01082640|560114604|FG000|Overall Study|Major protocol deviation|3|||
155184533|NCT01082640|560114605|FG001|Overall Study|Major protocol deviation|3|||
155184534|NCT01082640|560114606|FG002|Overall Study|Major protocol deviation|0|||
155184535|NCT01082640|560114604|FG000|Overall Study|Lost to Follow-up|0|||
155184536|NCT01082640|560114605|FG001|Overall Study|Lost to Follow-up|3|||
155184537|NCT01082640|560114606|FG002|Overall Study|Lost to Follow-up|0|||
155184538|NCT01082640|560114604|FG000|Overall Study|Other|2|||
155184539|NCT01082640|560114605|FG001|Overall Study|Other|1|||
155184540|NCT01082640|560114606|FG002|Overall Study|Other|3|||
155184541|NCT04543409|560114618|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155031829|NCT02951533|559542604|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
155031830|NCT02951533|559542602|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
155031831|NCT02951533|559542603|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
155184542|NCT04543409|560114619|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
155184543|NCT04543409|560114618|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
155184544|NCT04543409|560114619|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
155184545|NCT04543409|560114618|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
155184546|NCT04543409|560114619|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
155184547|NCT04543409|560114618|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
155184548|NCT04543409|560114619|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
155184549|NCT04543409|560114618|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
155184550|NCT04543409|560114619|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
155184551|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
155184552|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
155184553|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
155184554|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
155184555|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
155184556|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
155184557|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
155184558|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
155184559|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
155184560|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
155184561|NCT04543409|560114618|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
155184562|NCT04543409|560114619|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
155184563|NCT01052844|560114620|FG000|Overall Study|Adverse Event|0|||
155184564|NCT01052844|560114621|FG001|Overall Study|Adverse Event|1|||
155184565|NCT03519386|560114624|FG000|Overall Study|Withdrawal by Subject|4|||
155184566|NCT03519386|560114625|FG001|Overall Study|Withdrawal by Subject|1|||
155184567|NCT03519386|560114626|FG002|Overall Study|Withdrawal by Subject|2|||
155184568|NCT03519386|560114624|FG000|Overall Study|Physician Decision|1|||
155184569|NCT03519386|560114625|FG001|Overall Study|Physician Decision|1|||
155184570|NCT03519386|560114626|FG002|Overall Study|Physician Decision|1|||
155184571|NCT03519386|560114624|FG000|Overall Study|Lost to Follow-up|0|||
155184572|NCT03519386|560114625|FG001|Overall Study|Lost to Follow-up|1|||
155184573|NCT03519386|560114626|FG002|Overall Study|Lost to Follow-up|1|||
155184574|NCT03519386|560114624|FG000|Overall Study|Death|1|||
155184575|NCT03519386|560114625|FG001|Overall Study|Death|0|||
155184576|NCT03519386|560114626|FG002|Overall Study|Death|4|||
155184577|NCT03519386|560114624|FG000|Overall Study|Adverse Event|2|||
155184578|NCT03519386|560114625|FG001|Overall Study|Adverse Event|1|||
155184579|NCT03519386|560114626|FG002|Overall Study|Adverse Event|2|||
155184580|NCT03519386|560114624|FG000|Overall Study|Explanted|2|||
155184581|NCT03519386|560114625|FG001|Overall Study|Explanted|1|||
155184582|NCT03519386|560114626|FG002|Overall Study|Explanted|0|||
155184583|NCT03519386|560114624|FG000|Overall Study|Ongoing in study|190|||
155184584|NCT03519386|560114625|FG001|Overall Study|Ongoing in study|192|||
155184585|NCT03519386|560114626|FG002|Overall Study|Ongoing in study|183|||
155184586|NCT01298193|560114628|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
155184587|NCT01298193|560114628|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
155184588|NCT01298193|560114628|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
155184589|NCT01298193|560114628|FG000|Efficacy Phase (Second Cycle)|Death|1|||
155184590|NCT00107952|560114629|FG000|Overall Study|Death|75|||
155184591|NCT00107952|560114630|FG001|Overall Study|Death|61|||
155184592|NCT00107952|560114629|FG000|Overall Study|Lost to Follow-up|0|||
155184593|NCT00107952|560114630|FG001|Overall Study|Lost to Follow-up|3|||
155184594|NCT00107952|560114629|FG000|Overall Study|Withdrawal by Subject|9|||
155184595|NCT00107952|560114630|FG001|Overall Study|Withdrawal by Subject|6|||
155184596|NCT00107952|560114629|FG000|Overall Study|Other|2|||
155184597|NCT00107952|560114630|FG001|Overall Study|Other|5|||
155184598|NCT00107952|560114629|FG000|Overall Study|Never received study treatment|9|||
155184599|NCT00107952|560114630|FG001|Overall Study|Never received study treatment|6|||
155184600|NCT03475875|560114631|FG000|Period 1|Lost to Follow-up|1|||
155184601|NCT03475875|560114632|FG001|Period 1|Lost to Follow-up|0|||
155184602|NCT03475875|560114631|FG000|Period 1|Adverse Event|2|||
155184603|NCT03475875|560114632|FG001|Period 1|Adverse Event|1|||
155184604|NCT03475875|560114631|FG000|Period 2|Adverse Event|3|||
155184605|NCT03475875|560114632|FG001|Period 2|Adverse Event|0|||
155184606|NCT03475875|560114631|FG000|Period 2|Protocol Violation|0|||
155184607|NCT03475875|560114632|FG001|Period 2|Protocol Violation|1|||
155184608|NCT01642407|560114633|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
155184609|NCT01642407|560114633|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
155031832|NCT02951533|559542604|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
155031833|NCT02951533|559542602|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
155031834|NCT02951533|559542603|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
155031835|NCT02951533|559542604|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
155184610|NCT01642407|560114633|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
155184611|NCT00424255|560114634|FG000|Overall Study|Death|115|||
155184612|NCT00424255|560114635|FG001|Overall Study|Death|111|||
155184613|NCT00424255|560114634|FG000|Overall Study|Lost to Follow-up|26|||
155184614|NCT00424255|560114635|FG001|Overall Study|Lost to Follow-up|20|||
155184615|NCT00424255|560114634|FG000|Overall Study|Protocol Violation|0|||
155184616|NCT00424255|560114635|FG001|Overall Study|Protocol Violation|1|||
155031836|NCT02951533|559542602|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
155031837|NCT02951533|559542603|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
155184617|NCT00424255|560114634|FG000|Overall Study|Withdrawal by Subject|34|||
155184618|NCT00424255|560114635|FG001|Overall Study|Withdrawal by Subject|38|||
155184619|NCT00424255|560114634|FG000|Overall Study|Physician Decision|3|||
155184620|NCT00424255|560114635|FG001|Overall Study|Physician Decision|7|||
155184621|NCT00424255|560114634|FG000|Overall Study|Cognitive Disturbance|1|||
155184622|NCT00424255|560114635|FG001|Overall Study|Cognitive Disturbance|0|||
155184623|NCT00424255|560114634|FG000|Overall Study|Non-compliance by Participants|1|||
155184624|NCT00424255|560114635|FG001|Overall Study|Non-compliance by Participants|0|||
155184625|NCT00424255|560114634|FG000|Overall Study|Fatigue|1|||
155184626|NCT00424255|560114635|FG001|Overall Study|Fatigue|0|||
155184627|NCT00424255|560114634|FG000|Overall Study|Disease Progression|0|||
155184628|NCT00424255|560114635|FG001|Overall Study|Disease Progression|2|||
155184629|NCT00424255|560114634|FG000|Overall Study|Sponsor Terminated Study|161|||
155184630|NCT00424255|560114635|FG001|Overall Study|Sponsor Terminated Study|167|||
155184631|NCT02632838|560114637|FG000|Overall Study|Withdrawal by Subject|3|||
155184632|NCT02632838|560114638|FG001|Overall Study|Withdrawal by Subject|0|||
155031838|NCT02951533|559542604|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
155031839|NCT02951533|559542602|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
155031840|NCT02951533|559542603|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
155031841|NCT02951533|559542604|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
155184633|NCT02632838|560114637|FG000|Overall Study|Lost to Follow-up|0|||
155184634|NCT02632838|560114638|FG001|Overall Study|Lost to Follow-up|2|||
155184635|NCT03945175|560114639|FG000|Overall Study|Did not meet inclusion criteria|31|||
155031842|NCT02951533|559542602|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
155031843|NCT02951533|559542603|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
155031844|NCT02951533|559542604|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
155031845|NCT02951533|559542602|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
155031846|NCT02951533|559542603|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
155031847|NCT02951533|559542604|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
155031848|NCT01123941|559542605|FG000|Overall Study|Lost to Follow-up|2|||
155031849|NCT01123941|559542606|FG001|Overall Study|Lost to Follow-up|1|||
155031850|NCT06011161|559542609|FG000|Overall Study|Withdrawal by Subject|2|||
155031851|NCT06011161|559542609|FG000|Overall Study|Lost to Follow-up|5|||
155031852|NCT01597375|559542610|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
155031853|NCT01597375|559542611|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
155031854|NCT01597375|559542610|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
155031855|NCT01597375|559542611|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
155031856|NCT01597375|559542610|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
155031857|NCT01597375|559542611|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
155031858|NCT01597375|559542610|FG000|Washout (2 Weeks)|Adverse Event|1|||
155031859|NCT01597375|559542611|FG001|Washout (2 Weeks)|Adverse Event|0|||
155031860|NCT01597375|559542610|FG000|Second Intervention|Failed to react at both Aspirin|1|||
155031861|NCT01597375|559542611|FG001|Second Intervention|Failed to react at both Aspirin|1|||
155031862|NCT01390428|559544452|FG000|Overall Study|Elective Surgery|0|||
155031863|NCT01390428|559544453|FG001|Overall Study|Elective Surgery|0|||
155031864|NCT01390428|559544454|FG002|Overall Study|Elective Surgery|0|||
155031865|NCT01390428|559544455|FG003|Overall Study|Elective Surgery|0|||
155031866|NCT01390428|559544456|FG004|Overall Study|Elective Surgery|1|||
155031867|NCT01390428|559544457|FG005|Overall Study|Elective Surgery|0|||
155031868|NCT01390428|559544452|FG000|Overall Study|Withdrawal by Subject|0|||
155031869|NCT01390428|559544453|FG001|Overall Study|Withdrawal by Subject|0|||
155031870|NCT01390428|559544454|FG002|Overall Study|Withdrawal by Subject|1|||
155031871|NCT01390428|559544455|FG003|Overall Study|Withdrawal by Subject|0|||
155031872|NCT01390428|559544456|FG004|Overall Study|Withdrawal by Subject|0|||
155031873|NCT01390428|559544457|FG005|Overall Study|Withdrawal by Subject|0|||
155031874|NCT05091346|559544460|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
155031875|NCT05091346|559544461|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
155031876|NCT05091346|559544462|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
155031877|NCT05091346|559544463|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
155031878|NCT05091346|559544464|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
155031879|NCT05091346|559544460|FG000|Overall Study|Death|6|||
155031880|NCT05091346|559544461|FG001|Overall Study|Death|5|||
155031881|NCT05091346|559544462|FG002|Overall Study|Death|8|||
155031882|NCT05091346|559544463|FG003|Overall Study|Death|16|||
155031883|NCT05091346|559544464|FG004|Overall Study|Death|26|||
155031884|NCT05091346|559544460|FG000|Overall Study|Lost to Follow-up|0|||
155031885|NCT05091346|559544461|FG001|Overall Study|Lost to Follow-up|0|||
155031886|NCT05091346|559544462|FG002|Overall Study|Lost to Follow-up|0|||
155031887|NCT05091346|559544463|FG003|Overall Study|Lost to Follow-up|1|||
155031888|NCT05091346|559544464|FG004|Overall Study|Lost to Follow-up|0|||
155031889|NCT05091346|559544460|FG000|Overall Study|Withdrawal by Subject|0|||
155031890|NCT05091346|559544461|FG001|Overall Study|Withdrawal by Subject|1|||
155031891|NCT05091346|559544462|FG002|Overall Study|Withdrawal by Subject|2|||
155031892|NCT05091346|559544463|FG003|Overall Study|Withdrawal by Subject|2|||
155031893|NCT05091346|559544464|FG004|Overall Study|Withdrawal by Subject|1|||
155031894|NCT05897827|559544465|FG000|Overall Study|Lost to Follow-up|33|||
155031895|NCT05897827|559544466|FG001|Overall Study|Lost to Follow-up|14|||
155031896|NCT05897827|559544465|FG000|Overall Study|Withdrawal by Subject|1|||
155031897|NCT05897827|559544466|FG001|Overall Study|Withdrawal by Subject|1|||
155031898|NCT02059434|559544480|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
155184636|NCT03945175|560114639|FG000|Overall Study|Withdrew consent|2|||
155184637|NCT03945175|560114639|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
155184638|NCT03945175|560114639|FG000|Overall Study|Early termination during Mydayis treatment|1|||
155184639|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
155184640|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
155184641|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
155184642|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
155184643|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
155184644|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
155184645|NCT01369485|560114640|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
155184646|NCT01369485|560114641|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
155184647|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
155184648|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
155184649|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
155184650|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
155184651|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
155184652|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
155184653|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
155184654|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
155184655|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
155184656|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
155184657|NCT01369485|560114640|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
155184658|NCT01369485|560114641|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
155184659|NCT01306877|560114644|FG000|Overall Study|Lost to Follow-up|3|||
155184660|NCT01306877|560114645|FG001|Overall Study|Lost to Follow-up|3|||
155184661|NCT01306877|560114644|FG000|Overall Study|Physician Decision|0|||
155184662|NCT01306877|560114645|FG001|Overall Study|Physician Decision|1|||
155184663|NCT00006389|560114646|FG000|Overall Study|Adverse Event|1|||
155184664|NCT00999921|560114652|FG000|Overall Study|Lost to Follow-up|10|||
155184665|NCT00999921|560114653|FG001|Overall Study|Lost to Follow-up|19|||
155184666|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Adverse Event|1|||
155184667|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Adverse Event|0|||
155184668|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Adverse Event|0|||
155184669|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Adverse Event|0|||
155184670|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Adverse Event|0|||
155184671|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184672|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
155184673|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184674|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184675|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
155184676|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
155184677|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
155184678|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
155184679|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
155184680|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
155184681|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184682|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
155184683|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184684|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184685|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
155184686|NCT00473746|560114667|FG000|Period 1 (Phase 1)|Reason not specified|0|||
155184687|NCT00473746|560114668|FG001|Period 1 (Phase 1)|Reason not specified|1|||
155184688|NCT00473746|560114669|FG002|Period 1 (Phase 1)|Reason not specified|0|||
155184689|NCT00473746|560114670|FG003|Period 1 (Phase 1)|Reason not specified|0|||
155184690|NCT00473746|560114671|FG004|Period 1 (Phase 1)|Reason not specified|0|||
155184691|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Adverse Event|0|||
155184692|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Adverse Event|0|||
155184693|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Adverse Event|0|||
155184694|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Adverse Event|0|||
155031899|NCT02059434|559544481|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
155031900|NCT02059434|559544482|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
155031901|NCT02059434|559544483|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
155031902|NCT02059434|559544484|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
155031903|NCT02059434|559544485|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
155031904|NCT02059434|559544486|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
155184695|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Adverse Event|3|||
155184696|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Death|0|||
155184697|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Death|0|||
155184698|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Death|0|||
155184699|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Death|0|||
155184700|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Death|1|||
155184701|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
155184702|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
155184703|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
155184704|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
155184705|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
155184706|NCT00473746|560114667|FG000|Period 2 (Phase 2)|Reason not specified|0|||
155184707|NCT00473746|560114668|FG001|Period 2 (Phase 2)|Reason not specified|0|||
155184708|NCT00473746|560114669|FG002|Period 2 (Phase 2)|Reason not specified|0|||
155184709|NCT00473746|560114670|FG003|Period 2 (Phase 2)|Reason not specified|0|||
155184710|NCT00473746|560114671|FG004|Period 2 (Phase 2)|Reason not specified|3|||
155184711|NCT01017575|560114672|FG000|Overall Study|Lack of Efficacy|0|||
155184712|NCT01017575|560114673|FG001|Overall Study|Lack of Efficacy|1|||
155184713|NCT01017575|560114674|FG002|Overall Study|Lack of Efficacy|0|||
155184714|NCT01017575|560114675|FG003|Overall Study|Lack of Efficacy|1|||
155184715|NCT01017575|560114676|FG004|Overall Study|Lack of Efficacy|1|||
155184716|NCT01017575|560114672|FG000|Overall Study|Adverse Event|0|||
155184717|NCT01017575|560114673|FG001|Overall Study|Adverse Event|1|||
155184718|NCT01017575|560114674|FG002|Overall Study|Adverse Event|0|||
155184719|NCT01017575|560114675|FG003|Overall Study|Adverse Event|0|||
155184720|NCT01017575|560114676|FG004|Overall Study|Adverse Event|2|||
155184721|NCT01017575|560114672|FG000|Overall Study|Withdrawal by Subject|1|||
155184722|NCT01017575|560114673|FG001|Overall Study|Withdrawal by Subject|0|||
155184723|NCT01017575|560114674|FG002|Overall Study|Withdrawal by Subject|0|||
155184724|NCT01017575|560114675|FG003|Overall Study|Withdrawal by Subject|0|||
155184725|NCT01017575|560114676|FG004|Overall Study|Withdrawal by Subject|0|||
155184726|NCT01962922|560114679|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
155142505|NCT00940498|559952134|FG000|Overall Study|Physician Decision|0|||
155142506|NCT00940498|559952135|FG001|Overall Study|Physician Decision|0|||
155142507|NCT00940498|559952136|FG002|Overall Study|Physician Decision|0|||
155142508|NCT00940498|559952137|FG003|Overall Study|Physician Decision|0|||
155142509|NCT00940498|559952138|FG004|Overall Study|Physician Decision|2|||
155142510|NCT00940498|559952139|FG005|Overall Study|Physician Decision|0|||
155142511|NCT00940498|559952140|FG006|Overall Study|Physician Decision|0|||
155142512|NCT00940498|559952141|FG007|Overall Study|Physician Decision|0|||
155142513|NCT00940498|559952134|FG000|Overall Study|Not treated due to disease related pain|0|||
155142514|NCT00940498|559952135|FG001|Overall Study|Not treated due to disease related pain|0|||
155142515|NCT00940498|559952136|FG002|Overall Study|Not treated due to disease related pain|0|||
155142516|NCT00940498|559952137|FG003|Overall Study|Not treated due to disease related pain|0|||
155142517|NCT00940498|559952138|FG004|Overall Study|Not treated due to disease related pain|1|||
155142518|NCT00940498|559952139|FG005|Overall Study|Not treated due to disease related pain|0|||
155142519|NCT00940498|559952140|FG006|Overall Study|Not treated due to disease related pain|0|||
155142520|NCT00940498|559952141|FG007|Overall Study|Not treated due to disease related pain|0|||
155142521|NCT00983385|559952142|FG000|Observation Period|Not eligible to be dosed|20|||
155142522|NCT00983385|559952142|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
155142523|NCT04618744|559952143|FG000|Overall Study|Adverse Event|0|||
155142524|NCT04618744|559952144|FG001|Overall Study|Adverse Event|1|||
155142525|NCT04618744|559952143|FG000|Overall Study|Withdrawal by Subject|0|||
155142526|NCT04618744|559952144|FG001|Overall Study|Withdrawal by Subject|1|||
155142527|NCT00930930|559952145|FG000|Overall Study|Death|1|||
155142528|NCT00930930|559952146|FG001|Overall Study|Death|0|||
155142529|NCT00930930|559952145|FG000|Overall Study|Physician Decision|1|||
155142530|NCT00930930|559952146|FG001|Overall Study|Physician Decision|0|||
155142531|NCT00930930|559952145|FG000|Overall Study|Adverse Event|13|||
155142532|NCT00930930|559952146|FG001|Overall Study|Adverse Event|3|||
155142533|NCT00930930|559952145|FG000|Overall Study|Withdrawal by Subject|3|||
155142534|NCT00930930|559952146|FG001|Overall Study|Withdrawal by Subject|1|||
155142535|NCT00930930|559952145|FG000|Overall Study|Disease progression|2|||
155142536|NCT00930930|559952146|FG001|Overall Study|Disease progression|3|||
155142537|NCT00930930|559952145|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
155142538|NCT00930930|559952146|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
155142539|NCT00930930|559952145|FG000|Overall Study|patients not compliant|1|||
155142540|NCT00930930|559952146|FG001|Overall Study|patients not compliant|1|||
155142541|NCT00900029|559952147|FG000|Overall Study|Lost to Follow-up|0|||
155142542|NCT00900029|559952148|FG001|Overall Study|Lost to Follow-up|2|||
155142543|NCT00900029|559952149|FG002|Overall Study|Lost to Follow-up|1|||
155142544|NCT00900029|559952150|FG003|Overall Study|Lost to Follow-up|4|||
155142545|NCT00900029|559952151|FG004|Overall Study|Lost to Follow-up|4|||
155142546|NCT00900029|559952147|FG000|Overall Study|Withdrawal by Subject|2|||
155142547|NCT00900029|559952148|FG001|Overall Study|Withdrawal by Subject|2|||
155142548|NCT00900029|559952149|FG002|Overall Study|Withdrawal by Subject|1|||
155142549|NCT00900029|559952150|FG003|Overall Study|Withdrawal by Subject|1|||
155142550|NCT00900029|559952151|FG004|Overall Study|Withdrawal by Subject|1|||
155142551|NCT00900029|559952147|FG000|Overall Study|Adverse Event|0|||
155142552|NCT00900029|559952148|FG001|Overall Study|Adverse Event|0|||
155184727|NCT01962922|560114680|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
155184728|NCT01962922|560114679|FG000|PK Portion Day 7|non-compliance|1|||
155184729|NCT01962922|560114680|FG001|PK Portion Day 7|non-compliance|0|||
155031905|NCT02059434|559544487|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
155031906|NCT02059434|559544488|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
155031907|NCT02059434|559544480|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
155031908|NCT02059434|559544481|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
155031909|NCT02059434|559544482|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
155031910|NCT02059434|559544483|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
155031911|NCT02059434|559544484|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
155031912|NCT02059434|559544485|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
155031913|NCT02059434|559544486|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
155031914|NCT02059434|559544487|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
155031915|NCT02059434|559544488|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
155031916|NCT02059434|559544480|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
155031917|NCT02059434|559544481|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
155031918|NCT02059434|559544482|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
155031919|NCT02059434|559544483|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
155031920|NCT02059434|559544484|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
155031921|NCT02059434|559544485|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
155031922|NCT02059434|559544486|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
155031923|NCT02059434|559544487|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
155031924|NCT02059434|559544488|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
155031925|NCT02059434|559544480|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
155031926|NCT02059434|559544481|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
155031927|NCT02059434|559544482|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
155031928|NCT02059434|559544483|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
155031929|NCT02059434|559544484|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
155031930|NCT02059434|559544485|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
155031931|NCT02059434|559544486|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
155031932|NCT02059434|559544487|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
155031933|NCT02059434|559544488|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
155031934|NCT02059434|559544480|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155031935|NCT02059434|559544481|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155031936|NCT02059434|559544482|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155142553|NCT00900029|559952149|FG002|Overall Study|Adverse Event|1|||
155142554|NCT00900029|559952150|FG003|Overall Study|Adverse Event|1|||
155142555|NCT00900029|559952151|FG004|Overall Study|Adverse Event|1|||
155142556|NCT00900029|559952147|FG000|Overall Study|Death|1|||
155142557|NCT00900029|559952148|FG001|Overall Study|Death|0|||
155142558|NCT00900029|559952149|FG002|Overall Study|Death|0|||
155142559|NCT00900029|559952150|FG003|Overall Study|Death|1|||
155142560|NCT00900029|559952151|FG004|Overall Study|Death|0|||
155142561|NCT00511238|559952152|FG000|Overall Study|Adverse Event|13|||
155142562|NCT00511238|559952153|FG001|Overall Study|Adverse Event|33|||
155142563|NCT00511238|559952152|FG000|Overall Study|Withdrawal by Subject|2|||
155142564|NCT00511238|559952153|FG001|Overall Study|Withdrawal by Subject|22|||
155142565|NCT00511238|559952152|FG000|Overall Study|Progressive Disease|23|||
155142566|NCT00511238|559952153|FG001|Overall Study|Progressive Disease|157|||
155142567|NCT00511238|559952152|FG000|Overall Study|various reasons|4|||
155142568|NCT00511238|559952153|FG001|Overall Study|various reasons|14|||
155142569|NCT01929226|559953881|FG000|Overall Study|Lost to Follow-up|4|||
155142570|NCT01929226|559953882|FG001|Overall Study|Lost to Follow-up|0|||
155142571|NCT01929226|559953881|FG000|Overall Study|Withdrawal by Subject|1|||
155142572|NCT01929226|559953882|FG001|Overall Study|Withdrawal by Subject|1|||
155142573|NCT00330759|559953888|FG000|Overall Study|Death|316|||
155142574|NCT00330759|559953889|FG001|Overall Study|Death|310|||
155142575|NCT00330759|559953888|FG000|Overall Study|Disease progression|104|||
155142576|NCT00330759|559953889|FG001|Overall Study|Disease progression|126|||
155142577|NCT00330759|559953888|FG000|Overall Study|Withdrawal by Subject|143|||
155142578|NCT00330759|559953889|FG001|Overall Study|Withdrawal by Subject|124|||
155142579|NCT00330759|559953888|FG000|Overall Study|Adverse Event|48|||
155142580|NCT00330759|559953889|FG001|Overall Study|Adverse Event|36|||
155142581|NCT00330759|559953888|FG000|Overall Study|Participant request|31|||
155142582|NCT00330759|559953889|FG001|Overall Study|Participant request|22|||
155142583|NCT00330759|559953888|FG000|Overall Study|Lost to Follow-up|16|||
155142584|NCT00330759|559953889|FG001|Overall Study|Lost to Follow-up|22|||
155031937|NCT02059434|559544483|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155031938|NCT02059434|559544484|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155031939|NCT02059434|559544485|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155031940|NCT02059434|559544486|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155142585|NCT00330759|559953888|FG000|Overall Study|Noncompliance|15|||
155142586|NCT00330759|559953889|FG001|Overall Study|Noncompliance|17|||
155142587|NCT00330759|559953888|FG000|Overall Study|Physician Decision|1|||
155142588|NCT00330759|559953889|FG001|Overall Study|Physician Decision|2|||
155142589|NCT00330759|559953888|FG000|Overall Study|Protocol deviation|0|||
155142590|NCT00330759|559953889|FG001|Overall Study|Protocol deviation|2|||
155031941|NCT02059434|559544487|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
155031942|NCT02059434|559544488|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
155031943|NCT02928770|559544489|FG000|Overall Study|Withdrawal by Subject|2|||
155031944|NCT03201874|559544490|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
155031945|NCT03201874|559544491|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
155031946|NCT03201874|559544490|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
155031947|NCT03201874|559544491|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
155031948|NCT05128773|559544502|FG000|Overall Study|Sponsor decision to terminate study|3|||
155031949|NCT04250714|559544503|FG000|Overall Study|Treatment - withdrawal by subject|14|||
155031950|NCT04250714|559544503|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
155031951|NCT04250714|559544503|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
155031952|NCT04250714|559544503|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
155031953|NCT04250714|559544503|FG000|Overall Study|Treatment - Death|1|||
155031954|NCT04250714|559544503|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
155031955|NCT04250714|559544503|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
155031956|NCT04250714|559544503|FG000|Overall Study|Attempt|2|||
155184730|NCT01962922|560114679|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
155184731|NCT01962922|560114680|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
155184732|NCT01962922|560114679|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
155184733|NCT01962922|560114680|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
155184734|NCT00744471|560114681|FG000|Overall Study|Randomized but not treated|1|||
155184735|NCT00744471|560114682|FG001|Overall Study|Randomized but not treated|1|||
155184736|NCT00744471|560114683|FG002|Overall Study|Randomized but not treated|4|||
155184737|NCT00744471|560114684|FG003|Overall Study|Randomized but not treated|0|||
155184738|NCT00744471|560114681|FG000|Overall Study|Death|0|||
155184739|NCT00744471|560114682|FG001|Overall Study|Death|0|||
155031957|NCT04250714|559544503|FG000|Overall Study|Intent|7|||
155031958|NCT04697056|559544504|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
155031959|NCT04697056|559544505|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
155031960|NCT03617861|559544506|FG000|Second Intervention (1 Day)|Adverse Event|0|||
155031961|NCT03617861|559544507|FG001|Second Intervention (1 Day)|Adverse Event|0|||
155031962|NCT03617861|559544508|FG002|Second Intervention (1 Day)|Adverse Event|1|||
155142591|NCT00330759|559953888|FG000|Overall Study|Ineligibility determined|2|||
155142592|NCT00330759|559953889|FG001|Overall Study|Ineligibility determined|1|||
155142593|NCT00330759|559953888|FG000|Overall Study|Other|36|||
155142594|NCT00330759|559953889|FG001|Overall Study|Other|44|||
155142595|NCT00592904|559953908|FG000|Overall Study|Adverse Event|15|||
155142596|NCT00592904|559953909|FG001|Overall Study|Adverse Event|25|||
155142597|NCT00592904|559953910|FG002|Overall Study|Adverse Event|13|||
155142598|NCT00592904|559953911|FG003|Overall Study|Adverse Event|5|||
155142599|NCT00592904|559953908|FG000|Overall Study|Protocol Violation|1|||
155142600|NCT00592904|559953909|FG001|Overall Study|Protocol Violation|1|||
155142601|NCT00592904|559953910|FG002|Overall Study|Protocol Violation|0|||
155142602|NCT00592904|559953911|FG003|Overall Study|Protocol Violation|1|||
155142603|NCT00592904|559953908|FG000|Overall Study|Withdrawal by Subject|4|||
155142604|NCT00592904|559953909|FG001|Overall Study|Withdrawal by Subject|16|||
155142605|NCT00592904|559953910|FG002|Overall Study|Withdrawal by Subject|1|||
155142606|NCT00592904|559953911|FG003|Overall Study|Withdrawal by Subject|2|||
155142607|NCT00592904|559953908|FG000|Overall Study|Lack of Efficacy|2|||
155142608|NCT00592904|559953909|FG001|Overall Study|Lack of Efficacy|7|||
155142609|NCT00592904|559953910|FG002|Overall Study|Lack of Efficacy|2|||
155142610|NCT00592904|559953911|FG003|Overall Study|Lack of Efficacy|3|||
155142611|NCT00592904|559953908|FG000|Overall Study|Physician Decision|0|||
155142612|NCT00592904|559953909|FG001|Overall Study|Physician Decision|3|||
155142613|NCT00592904|559953910|FG002|Overall Study|Physician Decision|1|||
155142614|NCT00592904|559953911|FG003|Overall Study|Physician Decision|0|||
155142615|NCT00592904|559953908|FG000|Overall Study|Other|3|||
155142616|NCT00592904|559953909|FG001|Overall Study|Other|3|||
155142617|NCT00592904|559953910|FG002|Overall Study|Other|0|||
155142618|NCT00592904|559953911|FG003|Overall Study|Other|0|||
155142619|NCT03456076|559953912|FG000|Overall Study|Withdrawal by Subject|5|||
155142620|NCT03456076|559953913|FG001|Overall Study|Withdrawal by Subject|9|||
155142621|NCT03456076|559953912|FG000|Overall Study|Protocol deviation|0|||
155142622|NCT03456076|559953913|FG001|Overall Study|Protocol deviation|1|||
155142623|NCT03456076|559953912|FG000|Overall Study|Lost to Follow-up|0|||
155142624|NCT03456076|559953913|FG001|Overall Study|Lost to Follow-up|1|||
155142625|NCT03456076|559953912|FG000|Overall Study|Death|2|||
155142626|NCT03456076|559953913|FG001|Overall Study|Death|5|||
155184740|NCT00744471|560114683|FG002|Overall Study|Death|0|||
155031963|NCT03617861|559544509|FG003|Second Intervention (1 Day)|Adverse Event|0|||
155142627|NCT03456076|559953912|FG000|Overall Study|Study ongoing|123|||
155142628|NCT03456076|559953913|FG001|Overall Study|Study ongoing|111|||
155142629|NCT01359904|559953914|FG000|Overall Study|Withdrawal by Subject|1|||
155142630|NCT01359904|559953915|FG001|Overall Study|Withdrawal by Subject|0|||
155031964|NCT00345878|559544510|FG000|Overall Study|Adverse Event|1|||
155031965|NCT00345878|559544511|FG001|Overall Study|Adverse Event|0|||
155031966|NCT00345878|559544510|FG000|Overall Study|Lost to Follow-up|2|||
155031967|NCT00345878|559544511|FG001|Overall Study|Lost to Follow-up|1|||
155031968|NCT00345878|559544510|FG000|Overall Study|Other|1|||
155031969|NCT00345878|559544511|FG001|Overall Study|Other|0|||
155031970|NCT00308750|559544512|FG000|Overall Study|Adverse Event|9|||
155031971|NCT00308750|559544513|FG001|Overall Study|Adverse Event|9|||
155031972|NCT00308750|559544514|FG002|Overall Study|Adverse Event|13|||
155031973|NCT00308750|559544512|FG000|Overall Study|Withdrawal by Subject|6|||
155031974|NCT00308750|559544513|FG001|Overall Study|Withdrawal by Subject|2|||
155031975|NCT00308750|559544514|FG002|Overall Study|Withdrawal by Subject|3|||
155031976|NCT00308750|559544512|FG000|Overall Study|Physician Decision|3|||
155031977|NCT00308750|559544513|FG001|Overall Study|Physician Decision|4|||
155031978|NCT00308750|559544514|FG002|Overall Study|Physician Decision|3|||
155031979|NCT00308750|559544512|FG000|Overall Study|Sponsor Decision|1|||
155031980|NCT00308750|559544513|FG001|Overall Study|Sponsor Decision|0|||
155031981|NCT00308750|559544514|FG002|Overall Study|Sponsor Decision|0|||
155031982|NCT00308750|559544512|FG000|Overall Study|Disease Progression|47|||
155031983|NCT00308750|559544513|FG001|Overall Study|Disease Progression|24|||
155031984|NCT00308750|559544514|FG002|Overall Study|Disease Progression|28|||
155031985|NCT00308750|559544512|FG000|Overall Study|Unrelated Complication|3|||
155031986|NCT00308750|559544513|FG001|Overall Study|Unrelated Complication|0|||
155031987|NCT00308750|559544514|FG002|Overall Study|Unrelated Complication|1|||
155031988|NCT00308750|559544512|FG000|Overall Study|Death|1|||
155031989|NCT00308750|559544513|FG001|Overall Study|Death|0|||
155031990|NCT00308750|559544514|FG002|Overall Study|Death|1|||
155031991|NCT00308750|559544512|FG000|Overall Study|Protocol Violation|1|||
155031992|NCT00308750|559544513|FG001|Overall Study|Protocol Violation|0|||
155031993|NCT00308750|559544514|FG002|Overall Study|Protocol Violation|0|||
155031994|NCT00308750|559544512|FG000|Overall Study|New Primary Disease Identified|1|||
155031995|NCT00308750|559544513|FG001|Overall Study|New Primary Disease Identified|1|||
155031996|NCT00308750|559544514|FG002|Overall Study|New Primary Disease Identified|0|||
155031997|NCT01358578|559544515|FG000|Induction Period|Adverse Event|2|||
155031998|NCT01358578|559544516|FG001|Induction Period|Adverse Event|4|||
155031999|NCT01358578|559544517|FG002|Induction Period|Adverse Event|2|||
155032000|NCT01358578|559544518|FG003|Induction Period|Adverse Event|6|||
155032001|NCT01358578|559544519|FG004|Induction Period|Adverse Event|0|||
155032002|NCT01358578|559544520|FG005|Induction Period|Adverse Event|0|||
155032003|NCT01358578|559544515|FG000|Induction Period|Lack of Efficacy|0|||
155032004|NCT01358578|559544516|FG001|Induction Period|Lack of Efficacy|0|||
155032005|NCT01358578|559544517|FG002|Induction Period|Lack of Efficacy|9|||
155032006|NCT01358578|559544518|FG003|Induction Period|Lack of Efficacy|1|||
155032007|NCT01358578|559544519|FG004|Induction Period|Lack of Efficacy|0|||
155032008|NCT01358578|559544520|FG005|Induction Period|Lack of Efficacy|0|||
155032009|NCT01358578|559544515|FG000|Induction Period|Lost to Follow-up|0|||
155032010|NCT01358578|559544516|FG001|Induction Period|Lost to Follow-up|0|||
155032011|NCT01358578|559544517|FG002|Induction Period|Lost to Follow-up|1|||
155032012|NCT01358578|559544518|FG003|Induction Period|Lost to Follow-up|4|||
155032013|NCT01358578|559544519|FG004|Induction Period|Lost to Follow-up|0|||
155032014|NCT01358578|559544520|FG005|Induction Period|Lost to Follow-up|0|||
155184741|NCT00744471|560114684|FG003|Overall Study|Death|1|||
155184742|NCT00744471|560114681|FG000|Overall Study|Adverse Event|6|||
155184743|NCT00744471|560114682|FG001|Overall Study|Adverse Event|7|||
155184744|NCT00744471|560114683|FG002|Overall Study|Adverse Event|5|||
155184745|NCT00744471|560114684|FG003|Overall Study|Adverse Event|9|||
155184746|NCT00744471|560114681|FG000|Overall Study|Withdrawal by Subject|9|||
155184747|NCT00744471|560114682|FG001|Overall Study|Withdrawal by Subject|9|||
155184748|NCT00744471|560114683|FG002|Overall Study|Withdrawal by Subject|15|||
155184749|NCT00744471|560114684|FG003|Overall Study|Withdrawal by Subject|12|||
155184750|NCT00744471|560114681|FG000|Overall Study|Protocol Violation|1|||
155184751|NCT00744471|560114682|FG001|Overall Study|Protocol Violation|4|||
155184752|NCT00744471|560114683|FG002|Overall Study|Protocol Violation|1|||
155184753|NCT00744471|560114684|FG003|Overall Study|Protocol Violation|2|||
155184754|NCT00744471|560114681|FG000|Overall Study|Entered extension study|41|||
155032015|NCT01358578|559544515|FG000|Induction Period|Physician Decision|2|||
155032016|NCT01358578|559544516|FG001|Induction Period|Physician Decision|1|||
155032017|NCT01358578|559544517|FG002|Induction Period|Physician Decision|2|||
155032018|NCT01358578|559544518|FG003|Induction Period|Physician Decision|0|||
155032019|NCT01358578|559544519|FG004|Induction Period|Physician Decision|0|||
155032020|NCT01358578|559544520|FG005|Induction Period|Physician Decision|0|||
155032021|NCT01358578|559544515|FG000|Induction Period|Protocol Deviation|3|||
155032022|NCT01358578|559544516|FG001|Induction Period|Protocol Deviation|5|||
155184755|NCT00744471|560114682|FG001|Overall Study|Entered extension study|84|||
155184756|NCT00744471|560114683|FG002|Overall Study|Entered extension study|100|||
155032023|NCT01358578|559544517|FG002|Induction Period|Protocol Deviation|0|||
155032024|NCT01358578|559544518|FG003|Induction Period|Protocol Deviation|3|||
155032025|NCT01358578|559544519|FG004|Induction Period|Protocol Deviation|0|||
155032026|NCT01358578|559544520|FG005|Induction Period|Protocol Deviation|0|||
155032027|NCT01358578|559544515|FG000|Induction Period|technical problems|0|||
155032028|NCT01358578|559544516|FG001|Induction Period|technical problems|0|||
155032029|NCT01358578|559544517|FG002|Induction Period|technical problems|1|||
155032030|NCT01358578|559544518|FG003|Induction Period|technical problems|1|||
155032031|NCT01358578|559544519|FG004|Induction Period|technical problems|0|||
155032032|NCT01358578|559544520|FG005|Induction Period|technical problems|0|||
155032033|NCT01358578|559544515|FG000|Induction Period|Withdrawal by Subject|5|||
155032034|NCT01358578|559544516|FG001|Induction Period|Withdrawal by Subject|5|||
155032035|NCT01358578|559544517|FG002|Induction Period|Withdrawal by Subject|10|||
155032036|NCT01358578|559544518|FG003|Induction Period|Withdrawal by Subject|6|||
155032037|NCT01358578|559544519|FG004|Induction Period|Withdrawal by Subject|0|||
155032038|NCT01358578|559544520|FG005|Induction Period|Withdrawal by Subject|0|||
155032039|NCT01358578|559544515|FG000|Maintenance Period|Adverse Event|2|||
155142631|NCT03594773|559953916|FG000|Overall Study|Withdrawal by Subject|3|||
155142632|NCT03594773|559953917|FG001|Overall Study|Withdrawal by Subject|2|||
155142633|NCT03594773|559953916|FG000|Overall Study|Lost to Follow-up|3|||
155142634|NCT03594773|559953917|FG001|Overall Study|Lost to Follow-up|4|||
155142635|NCT03191630|559953920|FG000|Overall Study|Lost to Follow-up|7|||
155142636|NCT03191630|559953921|FG001|Overall Study|Lost to Follow-up|7|||
155142637|NCT02640547|559953922|FG000|Overall Study|Failure to Return|1|||
155142638|NCT02640547|559953922|FG000|Overall Study|Withdrawal by Subject|1|||
155142639|NCT02640547|559953922|FG000|Overall Study|Death|6|||
155142640|NCT02640547|559953922|FG000|Overall Study|Miscellaneous|3|||
155142641|NCT00193206|559953923|FG000|Preoperative Therapy|Lack of Efficacy|2|||
155142642|NCT00193206|559953923|FG000|Preoperative Therapy|Adverse Event|2|||
155142643|NCT00193206|559953923|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
155142644|NCT00193206|559953923|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
155142645|NCT00193206|559953923|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
155142646|NCT00193206|559953923|FG000|Postoperative Therapy|Physician Decision|3|||
155142647|NCT00193206|559953923|FG000|Postoperative Therapy|Intercurrent Illness|2|||
155142648|NCT00193206|559953923|FG000|Postoperative Therapy|Lack of Efficacy|1|||
155142649|NCT00193206|559953923|FG000|Postoperative Therapy|Protocol Violation|1|||
155142650|NCT03018691|559953924|FG000|Overall Study|Adverse Event|1|||
155142651|NCT03018691|559953925|FG001|Overall Study|Adverse Event|1|||
155142652|NCT03018691|559953926|FG002|Overall Study|Adverse Event|4|||
155142653|NCT03018691|559953924|FG000|Overall Study|Lack of Efficacy|0|||
155142654|NCT03018691|559953925|FG001|Overall Study|Lack of Efficacy|0|||
155142655|NCT03018691|559953926|FG002|Overall Study|Lack of Efficacy|1|||
155142656|NCT03018691|559953924|FG000|Overall Study|Withdrawal by Subject|0|||
155142657|NCT03018691|559953925|FG001|Overall Study|Withdrawal by Subject|0|||
155142658|NCT03018691|559953926|FG002|Overall Study|Withdrawal by Subject|1|||
155142659|NCT03018691|559953924|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155142660|NCT03018691|559953925|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155142661|NCT03018691|559953926|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155142662|NCT01450761|559953929|FG000|Randomization|Subject no longer meets study criteria|1|||
155142663|NCT01450761|559953930|FG001|Randomization|Subject no longer meets study criteria|2|||
155142664|NCT01450761|559953929|FG000|Randomization|Withdrawal by Subject|2|||
155142665|NCT01450761|559953930|FG001|Randomization|Withdrawal by Subject|0|||
155142666|NCT01450761|559953929|FG000|Randomization|Disease progression|0|||
155142667|NCT01450761|559953930|FG001|Randomization|Disease progression|2|||
155142668|NCT01450761|559953929|FG000|Randomization|Adverse Event unrelated to study drug|1|||
155142669|NCT01450761|559953930|FG001|Randomization|Adverse Event unrelated to study drug|0|||
155142670|NCT01450761|559953929|FG000|Randomization|Other|0|||
155142671|NCT01450761|559953930|FG001|Randomization|Other|1|||
155142672|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Disease progression|33|||
155142673|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Disease progression|32|||
155142674|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
155142675|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
155142676|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
155142677|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
155142678|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
155142679|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
155142680|NCT01450761|559953929|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
155142681|NCT01450761|559953930|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
155142682|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Death|3|||
155142683|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Death|3|||
155032040|NCT01358578|559544516|FG001|Maintenance Period|Adverse Event|7|||
155032041|NCT01358578|559544517|FG002|Maintenance Period|Adverse Event|0|||
155032042|NCT01358578|559544518|FG003|Maintenance Period|Adverse Event|6|||
155032043|NCT01358578|559544519|FG004|Maintenance Period|Adverse Event|4|||
155032044|NCT01358578|559544520|FG005|Maintenance Period|Adverse Event|3|||
155142684|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Other|2|||
155142685|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Other|2|||
155142686|NCT01450761|559953929|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
155142687|NCT01450761|559953930|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
155142688|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
155142689|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
155142690|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
155142691|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
155142692|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
155142693|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
155142694|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
155142695|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
155142696|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
155142697|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
155142698|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Death|5|||
155142699|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Death|6|||
155142700|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
155142701|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
155142702|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
155142703|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
155142704|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
155142705|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
155142706|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
155142707|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
155142708|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
155142709|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
155142710|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
155142711|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
155142712|NCT01450761|559953929|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
155142713|NCT01450761|559953930|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
155142714|NCT03801174|559953935|FG000|Overall Study|Withdrawal by Subject|14|||
155142715|NCT03801174|559953936|FG001|Overall Study|Withdrawal by Subject|15|||
155142716|NCT03801174|559953935|FG000|Overall Study|Death|1|||
155142717|NCT03801174|559953936|FG001|Overall Study|Death|0|||
155142718|NCT03801174|559953935|FG000|Overall Study|Pregnancy|2|||
155142719|NCT03801174|559953936|FG001|Overall Study|Pregnancy|2|||
155142720|NCT03801174|559953935|FG000|Overall Study|Lost to Follow-up|19|||
155142721|NCT03801174|559953936|FG001|Overall Study|Lost to Follow-up|10|||
155142722|NCT03801174|559953935|FG000|Overall Study|Other|4|||
155142723|NCT03801174|559953936|FG001|Overall Study|Other|3|||
155142724|NCT03801174|559953935|FG000|Overall Study|Lack of Efficacy|4|||
155142725|NCT03801174|559953936|FG001|Overall Study|Lack of Efficacy|0|||
155142726|NCT03801174|559953935|FG000|Overall Study|Unwilling to complete activities|5|||
155142727|NCT03801174|559953936|FG001|Overall Study|Unwilling to complete activities|6|||
155142728|NCT03801174|559953935|FG000|Overall Study|Moved out of area|3|||
155142729|NCT03801174|559953936|FG001|Overall Study|Moved out of area|0|||
155142730|NCT04435366|559953940|FG000|Year 1 (12 Months)|Adverse Event|3|||
155142731|NCT04435366|559953941|FG001|Year 1 (12 Months)|Adverse Event|0|||
155142732|NCT04435366|559953942|FG002|Year 1 (12 Months)|Adverse Event|2|||
155142733|NCT04435366|559953940|FG000|Year 1 (12 Months)|Death|2|||
155142734|NCT04435366|559953941|FG001|Year 1 (12 Months)|Death|0|||
155142735|NCT04435366|559953942|FG002|Year 1 (12 Months)|Death|1|||
155142736|NCT04435366|559953940|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
155142737|NCT04435366|559953941|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
155142738|NCT04435366|559953942|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
155142739|NCT04435366|559953940|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
155142740|NCT04435366|559953941|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
155142741|NCT04435366|559953942|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
155142742|NCT04435366|559953940|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
155142743|NCT04435366|559953941|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
155142744|NCT04435366|559953942|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
155142745|NCT04435366|559953940|FG000|Year 1 (12 Months)|Not treated|0|||
155142746|NCT04435366|559953941|FG001|Year 1 (12 Months)|Not treated|0|||
155142747|NCT04435366|559953942|FG002|Year 1 (12 Months)|Not treated|1|||
155142748|NCT04435366|559953940|FG000|Year 2 (12 Months)|Death|1|||
155142749|NCT04435366|559953941|FG001|Year 2 (12 Months)|Death|4|||
155142750|NCT04435366|559953942|FG002|Year 2 (12 Months)|Death|6|||
155142751|NCT04435366|559953940|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
155142752|NCT04435366|559953941|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
155142753|NCT04435366|559953942|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
155142754|NCT04435366|559953940|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
155142755|NCT04435366|559953941|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
155142756|NCT04435366|559953942|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
155142757|NCT04435366|559953940|FG000|Year 2 (12 Months)|Adverse Event|2|||
155142758|NCT04435366|559953941|FG001|Year 2 (12 Months)|Adverse Event|1|||
155142759|NCT04435366|559953942|FG002|Year 2 (12 Months)|Adverse Event|6|||
155184757|NCT00744471|560114684|FG003|Overall Study|Entered extension study|91|||
155184758|NCT00744471|560114681|FG000|Overall Study|Other|2|||
155184759|NCT00744471|560114682|FG001|Overall Study|Other|3|||
155184760|NCT00744471|560114683|FG002|Overall Study|Other|6|||
155184761|NCT00744471|560114684|FG003|Overall Study|Other|2|||
155184762|NCT00744471|560114681|FG000|Overall Study|Lack of Efficacy|83|||
155184763|NCT00744471|560114682|FG001|Overall Study|Lack of Efficacy|37|||
155184764|NCT00744471|560114683|FG002|Overall Study|Lack of Efficacy|19|||
155184765|NCT00744471|560114684|FG003|Overall Study|Lack of Efficacy|31|||
155184766|NCT00744471|560114681|FG000|Overall Study|Lost to Follow-up|0|||
155184767|NCT00744471|560114682|FG001|Overall Study|Lost to Follow-up|0|||
155184768|NCT00744471|560114683|FG002|Overall Study|Lost to Follow-up|2|||
155184769|NCT00744471|560114684|FG003|Overall Study|Lost to Follow-up|0|||
155184770|NCT03224546|560114685|FG000|Overall Study|Lost to Follow-up|9|||
155184771|NCT03224546|560114686|FG001|Overall Study|Lost to Follow-up|8|||
155184772|NCT03224546|560114687|FG002|Overall Study|Lost to Follow-up|3|||
155184773|NCT03224546|560114685|FG000|Overall Study|Withdrawal by Subject|7|||
155184774|NCT03224546|560114686|FG001|Overall Study|Withdrawal by Subject|14|||
155184775|NCT03224546|560114687|FG002|Overall Study|Withdrawal by Subject|12|||
155184776|NCT04706416|560114688|FG000|Overall Study|Lost to Follow-up|2|||
155184777|NCT04706416|560114689|FG001|Overall Study|Lost to Follow-up|0|||
155184778|NCT01280955|560114691|FG000|Overall Study|Death|2|||
155184779|NCT01280955|560114691|FG000|Overall Study|Withdrawal by Subject|1|||
155184780|NCT00596362|560114692|FG000|Overall Study|Progressive Disease|1|||
155184781|NCT00817479|560114693|FG000|Overall Study|Physician Decision|1|||
155184782|NCT00817479|560114694|FG001|Overall Study|Physician Decision|1|||
155184783|NCT02793128|560114695|FG000|Overall Study|Death|4|||
155184784|NCT02793128|560114695|FG000|Overall Study|Withdrawal by Subject|2|||
155184785|NCT02793128|560114695|FG000|Overall Study|Physician Decision|1|||
155184786|NCT02793128|560114695|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
155184787|NCT02793128|560114695|FG000|Overall Study|Patient elected nephroureterectomy|1|||
155184788|NCT02359851|560114696|FG000|Overall Study|Death|1|||
155184789|NCT02359851|560114696|FG000|Overall Study|Disease progression|1|||
155184790|NCT00055471|560114697|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
155184791|NCT00055471|560114698|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
155184792|NCT00055471|560114699|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
155184793|NCT00055471|560114697|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
155184794|NCT00055471|560114698|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
155184795|NCT00055471|560114699|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
155184796|NCT00055471|560114697|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
155184797|NCT00055471|560114698|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
155184798|NCT00055471|560114699|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
155184799|NCT01854944|560114700|FG000|Overall Study|Withdrawal by Subject|0|||
155184800|NCT01854944|560114701|FG001|Overall Study|Withdrawal by Subject|0|||
155184801|NCT01854944|560114702|FG002|Overall Study|Withdrawal by Subject|1|||
155184802|NCT00282347|560114705|FG000|Treatment Period|Death|2|||
155184803|NCT00282347|560114706|FG001|Treatment Period|Death|0|||
155184804|NCT00282347|560114705|FG000|Treatment Period|Lost to Follow-up|2|||
155184805|NCT00282347|560114706|FG001|Treatment Period|Lost to Follow-up|5|||
155184806|NCT00282347|560114705|FG000|Treatment Period|Withdrawal by Subject|1|||
155184807|NCT00282347|560114706|FG001|Treatment Period|Withdrawal by Subject|3|||
155184808|NCT00282347|560114705|FG000|Treatment Period|Physician Decision|0|||
155184809|NCT00282347|560114706|FG001|Treatment Period|Physician Decision|1|||
155184810|NCT00282347|560114705|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
155184811|NCT00282347|560114706|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
155184812|NCT00282347|560114705|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
155184813|NCT00282347|560114706|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
155184814|NCT00282347|560114705|FG000|Safety Follow-up Period|Physician Decision|1|||
155184815|NCT00282347|560114706|FG001|Safety Follow-up Period|Physician Decision|1|||
155184816|NCT00282347|560114705|FG000|Safety Follow-up Period|Protocol Deviation|0|||
155184817|NCT00282347|560114706|FG001|Safety Follow-up Period|Protocol Deviation|2|||
155184818|NCT00282347|560114705|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
155184819|NCT00282347|560114706|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
155184820|NCT00282347|560114705|FG000|B Cell Follow-up Period|Physician Decision|1|||
155184821|NCT00282347|560114706|FG001|B Cell Follow-up Period|Physician Decision|0|||
155184822|NCT00282347|560114705|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
155184823|NCT00282347|560114706|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
155184824|NCT02782923|560114707|FG000|Overall Study|Lost to Follow-up|15|||
155184825|NCT01659658|560116211|FG000|Overall Study|Withdrawal by Patient|18|||
155184826|NCT01659658|560116212|FG001|Overall Study|Withdrawal by Patient|4|||
155184827|NCT01659658|560116213|FG002|Overall Study|Withdrawal by Patient|2|||
155184828|NCT01659658|560116214|FG003|Overall Study|Withdrawal by Patient|0|||
155184829|NCT01659658|560116215|FG004|Overall Study|Withdrawal by Patient|11|||
155184830|NCT01659658|560116211|FG000|Overall Study|Study Terminated by Sponsor|9|||
155184831|NCT01659658|560116212|FG001|Overall Study|Study Terminated by Sponsor|7|||
155032045|NCT01358578|559544515|FG000|Maintenance Period|Lack of Efficacy|10|||
155032046|NCT01358578|559544516|FG001|Maintenance Period|Lack of Efficacy|2|||
155032047|NCT01358578|559544517|FG002|Maintenance Period|Lack of Efficacy|0|||
155032048|NCT01358578|559544518|FG003|Maintenance Period|Lack of Efficacy|11|||
155032049|NCT01358578|559544519|FG004|Maintenance Period|Lack of Efficacy|3|||
155032050|NCT01358578|559544520|FG005|Maintenance Period|Lack of Efficacy|0|||
155032051|NCT01358578|559544515|FG000|Maintenance Period|Lost to Follow-up|4|||
155032052|NCT01358578|559544516|FG001|Maintenance Period|Lost to Follow-up|0|||
155032053|NCT01358578|559544517|FG002|Maintenance Period|Lost to Follow-up|0|||
155032054|NCT01358578|559544518|FG003|Maintenance Period|Lost to Follow-up|5|||
155032055|NCT01358578|559544519|FG004|Maintenance Period|Lost to Follow-up|1|||
155032056|NCT01358578|559544520|FG005|Maintenance Period|Lost to Follow-up|1|||
155032057|NCT01358578|559544515|FG000|Maintenance Period|Non-compliance with study treatment|3|||
155032058|NCT01358578|559544516|FG001|Maintenance Period|Non-compliance with study treatment|1|||
155032059|NCT01358578|559544517|FG002|Maintenance Period|Non-compliance with study treatment|0|||
155032060|NCT01358578|559544518|FG003|Maintenance Period|Non-compliance with study treatment|2|||
155032061|NCT01358578|559544519|FG004|Maintenance Period|Non-compliance with study treatment|1|||
155032062|NCT01358578|559544520|FG005|Maintenance Period|Non-compliance with study treatment|2|||
155032063|NCT01358578|559544515|FG000|Maintenance Period|Physician Decision|0|||
155032064|NCT01358578|559544516|FG001|Maintenance Period|Physician Decision|1|||
155032065|NCT01358578|559544517|FG002|Maintenance Period|Physician Decision|0|||
155032066|NCT01358578|559544518|FG003|Maintenance Period|Physician Decision|1|||
155032067|NCT01358578|559544519|FG004|Maintenance Period|Physician Decision|0|||
155032068|NCT01358578|559544520|FG005|Maintenance Period|Physician Decision|0|||
155032069|NCT01358578|559544515|FG000|Maintenance Period|Pregnancy|1|||
155032070|NCT01358578|559544516|FG001|Maintenance Period|Pregnancy|0|||
155032071|NCT01358578|559544517|FG002|Maintenance Period|Pregnancy|0|||
155032072|NCT01358578|559544518|FG003|Maintenance Period|Pregnancy|0|||
155032073|NCT01358578|559544519|FG004|Maintenance Period|Pregnancy|0|||
155032074|NCT01358578|559544520|FG005|Maintenance Period|Pregnancy|0|||
155032075|NCT01358578|559544515|FG000|Maintenance Period|Protocol deviation|7|||
155032076|NCT01358578|559544516|FG001|Maintenance Period|Protocol deviation|4|||
155032077|NCT01358578|559544517|FG002|Maintenance Period|Protocol deviation|0|||
155032078|NCT01358578|559544518|FG003|Maintenance Period|Protocol deviation|2|||
155032079|NCT01358578|559544519|FG004|Maintenance Period|Protocol deviation|2|||
155032080|NCT01358578|559544520|FG005|Maintenance Period|Protocol deviation|2|||
155032081|NCT01358578|559544515|FG000|Maintenance Period|Withdrawal by Subject|12|||
155032082|NCT01358578|559544516|FG001|Maintenance Period|Withdrawal by Subject|7|||
155032083|NCT01358578|559544517|FG002|Maintenance Period|Withdrawal by Subject|2|||
155032084|NCT01358578|559544518|FG003|Maintenance Period|Withdrawal by Subject|15|||
155032085|NCT01358578|559544519|FG004|Maintenance Period|Withdrawal by Subject|6|||
155032086|NCT01358578|559544520|FG005|Maintenance Period|Withdrawal by Subject|3|||
155032087|NCT01358578|559544515|FG000|Follow-up Period|Adverse Event|1|||
155032088|NCT01358578|559544516|FG001|Follow-up Period|Adverse Event|1|||
155032089|NCT01358578|559544517|FG002|Follow-up Period|Adverse Event|0|||
155032090|NCT01358578|559544518|FG003|Follow-up Period|Adverse Event|0|||
155032091|NCT01358578|559544519|FG004|Follow-up Period|Adverse Event|0|||
155032092|NCT01358578|559544520|FG005|Follow-up Period|Adverse Event|0|||
155032093|NCT01358578|559544515|FG000|Follow-up Period|Lack of Efficacy|3|||
155032094|NCT01358578|559544516|FG001|Follow-up Period|Lack of Efficacy|0|||
155032095|NCT01358578|559544517|FG002|Follow-up Period|Lack of Efficacy|4|||
155032096|NCT01358578|559544518|FG003|Follow-up Period|Lack of Efficacy|1|||
155032097|NCT01358578|559544519|FG004|Follow-up Period|Lack of Efficacy|0|||
155032098|NCT01358578|559544520|FG005|Follow-up Period|Lack of Efficacy|0|||
155032099|NCT01358578|559544515|FG000|Follow-up Period|Lost to Follow-up|0|||
155032100|NCT01358578|559544516|FG001|Follow-up Period|Lost to Follow-up|1|||
155032101|NCT01358578|559544517|FG002|Follow-up Period|Lost to Follow-up|0|||
155032102|NCT01358578|559544518|FG003|Follow-up Period|Lost to Follow-up|4|||
155032103|NCT01358578|559544519|FG004|Follow-up Period|Lost to Follow-up|0|||
155032104|NCT01358578|559544520|FG005|Follow-up Period|Lost to Follow-up|0|||
155032105|NCT01358578|559544515|FG000|Follow-up Period|non- compliance with study treatment|1|||
155032106|NCT01358578|559544516|FG001|Follow-up Period|non- compliance with study treatment|0|||
155032107|NCT01358578|559544517|FG002|Follow-up Period|non- compliance with study treatment|0|||
155142760|NCT04112810|559953943|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
155032108|NCT01358578|559544518|FG003|Follow-up Period|non- compliance with study treatment|0|||
155032109|NCT01358578|559544519|FG004|Follow-up Period|non- compliance with study treatment|0|||
155032110|NCT01358578|559544520|FG005|Follow-up Period|non- compliance with study treatment|0|||
155032111|NCT01358578|559544515|FG000|Follow-up Period|Pregnancy|1|||
155032112|NCT01358578|559544516|FG001|Follow-up Period|Pregnancy|0|||
155032113|NCT01358578|559544517|FG002|Follow-up Period|Pregnancy|0|||
155032114|NCT01358578|559544518|FG003|Follow-up Period|Pregnancy|0|||
155032115|NCT01358578|559544519|FG004|Follow-up Period|Pregnancy|0|||
155032116|NCT01358578|559544520|FG005|Follow-up Period|Pregnancy|0|||
155032117|NCT01358578|559544515|FG000|Follow-up Period|Withdrawal by Subject|3|||
155032118|NCT01358578|559544516|FG001|Follow-up Period|Withdrawal by Subject|3|||
155142761|NCT01687296|559953944|FG000|Overall Study|Lack of Efficacy|1|||
155142762|NCT01687296|559953945|FG001|Overall Study|Lack of Efficacy|1|||
155142763|NCT01687296|559953944|FG000|Overall Study|Protocol Violation|0|||
155142764|NCT01687296|559953945|FG001|Overall Study|Protocol Violation|1|||
155142765|NCT01687296|559953944|FG000|Overall Study|Withdrawal by Subject|6|||
155142766|NCT01687296|559953945|FG001|Overall Study|Withdrawal by Subject|3|||
155142767|NCT01618669|559953946|FG000|Overall Study|Lost to Follow-up|1|||
155142768|NCT01618669|559953947|FG001|Overall Study|Lost to Follow-up|1|||
155142769|NCT01618669|559953946|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
155142770|NCT01618669|559953947|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
155142771|NCT01618669|559953946|FG000|Overall Study|Adverse Event|16|||
155142772|NCT01618669|559953947|FG001|Overall Study|Adverse Event|7|||
155142773|NCT01618669|559953946|FG000|Overall Study|Protocol Violation|5|||
155142774|NCT01618669|559953947|FG001|Overall Study|Protocol Violation|3|||
155142775|NCT01618669|559953946|FG000|Overall Study|Withdrawal by Subject|9|||
155142776|NCT01618669|559953947|FG001|Overall Study|Withdrawal by Subject|9|||
155142777|NCT01618669|559953946|FG000|Overall Study|Miscellaneous Reason|0|||
155142778|NCT01618669|559953947|FG001|Overall Study|Miscellaneous Reason|1|||
155142779|NCT03259087|559953950|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155142780|NCT03259087|559953951|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155142781|NCT03259087|559953952|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155142782|NCT03259087|559953953|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
155142783|NCT03259087|559953954|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
155142784|NCT03259087|559953950|FG000|Period 2 of Part 2|Adverse Event|0|||
155142785|NCT03259087|559953951|FG001|Period 2 of Part 2|Adverse Event|0|||
155142786|NCT03259087|559953952|FG002|Period 2 of Part 2|Adverse Event|0|||
155142787|NCT03259087|559953953|FG003|Period 2 of Part 2|Adverse Event|0|||
155142788|NCT03259087|559953954|FG004|Period 2 of Part 2|Adverse Event|1|||
155142789|NCT02396212|559953955|FG000|Overall Study|Adverse Event|1|||
155142790|NCT02396212|559953955|FG000|Overall Study|Lack of Efficacy|2|||
155142791|NCT04950465|559953956|FG000|Overall Study|Lost to Follow-up|1|||
155142792|NCT04950465|559953957|FG001|Overall Study|Lost to Follow-up|0|||
155142793|NCT04950465|559953958|FG002|Overall Study|Lost to Follow-up|0|||
155142794|NCT00580723|559953970|FG000|Overall Study|Did not want to participate in extension|3|||
155142795|NCT00580723|559953970|FG000|Overall Study|Lost to Follow-up|5|||
155142796|NCT00684996|559953971|FG000|Overall Study|Adverse Event|1|||
155142797|NCT00684996|559953971|FG000|Overall Study|Refusal unrelated to adverse event|1|||
155142798|NCT00684996|559953971|FG000|Overall Study|Progression/relapse|2|||
155142799|NCT00684996|559953971|FG000|Overall Study|Other reasons not protocol specified|1|||
155142800|NCT00700713|559953973|FG000|Overall Study|Protocol Violation|1|||
155142801|NCT00700713|559953974|FG001|Overall Study|Protocol Violation|0|||
155142802|NCT00700713|559953975|FG002|Overall Study|Protocol Violation|1|||
155142803|NCT00700713|559953973|FG000|Overall Study|Withdrawal by Subject|0|||
155142804|NCT00700713|559953974|FG001|Overall Study|Withdrawal by Subject|0|||
155142805|NCT00700713|559953975|FG002|Overall Study|Withdrawal by Subject|1|||
155142806|NCT00550953|559953976|FG000|Overall Study|Adverse Event|4|||
155142807|NCT00550953|559953977|FG001|Overall Study|Adverse Event|3|||
155142808|NCT00550953|559953976|FG000|Overall Study|Not able to visit the site|2|||
155142809|NCT00550953|559953977|FG001|Overall Study|Not able to visit the site|3|||
155142810|NCT03797586|559953978|FG000|Overall Study|Lost to Follow-up|3|||
155142811|NCT03797586|559953979|FG001|Overall Study|Lost to Follow-up|6|||
155142812|NCT03797586|559953978|FG000|Overall Study|Death|1|||
155142813|NCT03797586|559953979|FG001|Overall Study|Death|1|||
155142814|NCT03797586|559953978|FG000|Overall Study|Adverse Event|0|||
155142815|NCT03797586|559953979|FG001|Overall Study|Adverse Event|2|||
155142816|NCT01219985|559953980|FG000|Overall Study|Physician Decision|20|||
155142817|NCT02680665|559953981|FG000|Overall Study|No visit after the first prescription|5|||
155142818|NCT02292719|559953982|FG000|Overall Study|Withdrawal by Subject|0|||
155142819|NCT02292719|559953983|FG001|Overall Study|Withdrawal by Subject|0|||
155142820|NCT02292719|559953984|FG002|Overall Study|Withdrawal by Subject|0|||
155142821|NCT02292719|559953985|FG003|Overall Study|Withdrawal by Subject|1|||
155142822|NCT02292719|559953986|FG004|Overall Study|Withdrawal by Subject|1|||
155142823|NCT02292719|559953987|FG005|Overall Study|Withdrawal by Subject|0|||
155142824|NCT02292719|559953982|FG000|Overall Study|Subject enrolled in new study.|0|||
155142825|NCT02292719|559953983|FG001|Overall Study|Subject enrolled in new study.|0|||
155142826|NCT02292719|559953984|FG002|Overall Study|Subject enrolled in new study.|1|||
155142827|NCT02292719|559953985|FG003|Overall Study|Subject enrolled in new study.|0|||
155142828|NCT02292719|559953986|FG004|Overall Study|Subject enrolled in new study.|0|||
155142829|NCT02292719|559953987|FG005|Overall Study|Subject enrolled in new study.|0|||
155142830|NCT02940496|559953988|FG000|Overall Study|Adverse Event|1|||
155142831|NCT02940496|559953989|FG001|Overall Study|Adverse Event|0|||
155142832|NCT02940496|559953988|FG000|Overall Study|Death|2|||
155142833|NCT02940496|559953989|FG001|Overall Study|Death|0|||
155142834|NCT02940496|559953988|FG000|Overall Study|Hospice Care|1|||
155142835|NCT02940496|559953989|FG001|Overall Study|Hospice Care|0|||
155142836|NCT02940496|559953988|FG000|Overall Study|No MRE Done|1|||
155142837|NCT02940496|559953989|FG001|Overall Study|No MRE Done|0|||
155032119|NCT01358578|559544517|FG002|Follow-up Period|Withdrawal by Subject|1|||
155032120|NCT01358578|559544518|FG003|Follow-up Period|Withdrawal by Subject|12|||
155032121|NCT01358578|559544519|FG004|Follow-up Period|Withdrawal by Subject|0|||
155032122|NCT01358578|559544520|FG005|Follow-up Period|Withdrawal by Subject|0|||
155032123|NCT01358578|559544515|FG000|Follow-up Period|Physician Decision|1|||
155032124|NCT01358578|559544516|FG001|Follow-up Period|Physician Decision|1|||
155032125|NCT01358578|559544517|FG002|Follow-up Period|Physician Decision|0|||
155032126|NCT01358578|559544518|FG003|Follow-up Period|Physician Decision|2|||
155032127|NCT01358578|559544519|FG004|Follow-up Period|Physician Decision|0|||
155032128|NCT01358578|559544520|FG005|Follow-up Period|Physician Decision|0|||
155032129|NCT01643798|559544521|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
155032130|NCT01643798|559544522|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
155032131|NCT05014815|559544523|FG000|Overall Study|Death|63|||
155032132|NCT05014815|559544524|FG001|Overall Study|Death|70|||
155032133|NCT05014815|559544523|FG000|Overall Study|Withdrawal by Subject|10|||
155032134|NCT05014815|559544524|FG001|Overall Study|Withdrawal by Subject|10|||
155032135|NCT05014815|559544523|FG000|Overall Study|Lost to Follow-up|4|||
155032136|NCT05014815|559544524|FG001|Overall Study|Lost to Follow-up|2|||
155032137|NCT05014815|559544523|FG000|Overall Study|Physician Decision|2|||
155032138|NCT05014815|559544524|FG001|Overall Study|Physician Decision|4|||
155032139|NCT00348790|559544531|FG000|Completed Treatment|Withdrawal by Subject|4|||
155032140|NCT00348790|559544531|FG000|Completed Treatment|Disease progression|14|||
155032141|NCT00348790|559544531|FG000|Completed Treatment|Adverse Event|4|||
155184832|NCT01659658|560116213|FG002|Overall Study|Study Terminated by Sponsor|0|||
155184833|NCT01659658|560116214|FG003|Overall Study|Study Terminated by Sponsor|1|||
155184834|NCT01659658|560116215|FG004|Overall Study|Study Terminated by Sponsor|4|||
155184835|NCT01659658|560116211|FG000|Overall Study|Reason not Specified|61|||
155184836|NCT01659658|560116212|FG001|Overall Study|Reason not Specified|15|||
155184837|NCT01659658|560116213|FG002|Overall Study|Reason not Specified|8|||
155184838|NCT01659658|560116214|FG003|Overall Study|Reason not Specified|1|||
155184839|NCT01659658|560116215|FG004|Overall Study|Reason not Specified|34|||
155184840|NCT01659658|560116211|FG000|Overall Study|Lost to Follow-up|2|||
155184841|NCT01659658|560116212|FG001|Overall Study|Lost to Follow-up|0|||
155184842|NCT01659658|560116213|FG002|Overall Study|Lost to Follow-up|0|||
155184843|NCT01659658|560116214|FG003|Overall Study|Lost to Follow-up|0|||
155184844|NCT01659658|560116215|FG004|Overall Study|Lost to Follow-up|0|||
155184845|NCT01897714|560116216|FG000|Phase I (Dose Escalation)|Disease progression|3|||
155184846|NCT01897714|560116217|FG001|Phase I (Dose Escalation)|Disease progression|5|||
155184847|NCT01897714|560116218|FG002|Phase I (Dose Escalation)|Disease progression|1|||
155184848|NCT01897714|560116219|FG003|Phase I (Dose Escalation)|Disease progression|3|||
155184849|NCT01897714|560116220|FG004|Phase I (Dose Escalation)|Disease progression|0|||
155184850|NCT01897714|560116221|FG005|Phase I (Dose Escalation)|Disease progression|0|||
155184851|NCT01897714|560116216|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
155184852|NCT01897714|560116217|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
155184853|NCT01897714|560116218|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
155184854|NCT01897714|560116219|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
155184855|NCT01897714|560116220|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
155184856|NCT01897714|560116221|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
155184857|NCT01897714|560116216|FG000|Phase I (Dose Escalation)|Other|0|||
155184858|NCT01897714|560116217|FG001|Phase I (Dose Escalation)|Other|1|||
155184859|NCT01897714|560116218|FG002|Phase I (Dose Escalation)|Other|0|||
155184860|NCT01897714|560116219|FG003|Phase I (Dose Escalation)|Other|0|||
155184861|NCT01897714|560116220|FG004|Phase I (Dose Escalation)|Other|0|||
155184862|NCT01897714|560116221|FG005|Phase I (Dose Escalation)|Other|0|||
155184863|NCT01897714|560116216|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
155184864|NCT01897714|560116217|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
155184865|NCT01897714|560116218|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
155184866|NCT01897714|560116219|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
155184867|NCT01897714|560116220|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
155184868|NCT01897714|560116221|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
155184869|NCT01897714|560116216|FG000|Phase II (MTD)|Lost to Follow-up|0|||
155184870|NCT01897714|560116217|FG001|Phase II (MTD)|Lost to Follow-up|0|||
155184871|NCT01897714|560116218|FG002|Phase II (MTD)|Lost to Follow-up|0|||
155184872|NCT01897714|560116219|FG003|Phase II (MTD)|Lost to Follow-up|0|||
155184873|NCT01897714|560116220|FG004|Phase II (MTD)|Lost to Follow-up|1|||
155032142|NCT00348790|559544531|FG000|Completed Treatment|Required surgery|2|||
155184874|NCT01897714|560116221|FG005|Phase II (MTD)|Lost to Follow-up|0|||
155184875|NCT01897714|560116216|FG000|Phase II (MTD)|Death|0|||
155032143|NCT00348790|559544531|FG000|Completed Treatment|Unable to travel to study site|1|||
155032144|NCT03602391|559544534|FG000|Overall Study|COVID-19|7|||
155184876|NCT01897714|560116217|FG001|Phase II (MTD)|Death|0|||
155032145|NCT03602391|559544535|FG001|Overall Study|COVID-19|6|||
155032146|NCT00108485|559544537|FG000|Overall Study|Withdrawal by Subject|3|||
155032147|NCT00108485|559544538|FG001|Overall Study|Withdrawal by Subject|0|||
155184877|NCT01897714|560116218|FG002|Phase II (MTD)|Death|0|||
155184878|NCT01897714|560116219|FG003|Phase II (MTD)|Death|0|||
155184879|NCT01897714|560116220|FG004|Phase II (MTD)|Death|25|||
155032148|NCT00108485|559544537|FG000|Overall Study|Lost to Follow-up|0|||
155032149|NCT00108485|559544538|FG001|Overall Study|Lost to Follow-up|2|||
155032150|NCT00878969|559544540|FG000|Overall Study|Physician Decision|5|||
155032151|NCT00878969|559544541|FG001|Overall Study|Physician Decision|3|||
155032152|NCT00878969|559544542|FG002|Overall Study|Physician Decision|2|||
155032153|NCT00878969|559544540|FG000|Overall Study|Withdrawal by Subject|1|||
155032154|NCT00878969|559544541|FG001|Overall Study|Withdrawal by Subject|6|||
155032155|NCT00878969|559544542|FG002|Overall Study|Withdrawal by Subject|3|||
155142838|NCT02940496|559953988|FG000|Overall Study|MRE Failure|1|||
155142839|NCT02940496|559953989|FG001|Overall Study|MRE Failure|0|||
155142840|NCT04089761|559953996|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
155142841|NCT04089761|559953996|FG000|"Run In Phase"|Lost to Follow-up|1|||
155142842|NCT04089761|559953996|FG000|"Treatment Phase"|No evaluable data|5|||
155142843|NCT04089761|559953996|FG000|"Treatment Phase"|Lost to Follow-up|1|||
155142844|NCT00770601|559953997|FG000|Overall Study|Withdrawal by Subject|1|||
155142845|NCT04739436|559953998|FG000|Overall Study|Lost to Follow-up|21|||
155142846|NCT04739436|559953999|FG001|Overall Study|Lost to Follow-up|23|||
155142847|NCT04739436|559953998|FG000|Overall Study|Withdrawal by Subject|4|||
155142848|NCT04739436|559953999|FG001|Overall Study|Withdrawal by Subject|6|||
155142849|NCT04739436|559953998|FG000|Overall Study|not randomized properly|1|||
155142850|NCT04739436|559953999|FG001|Overall Study|not randomized properly|0|||
155142851|NCT00428948|559954001|FG000|Overall Study|Lost to Follow-up|15|||
155142852|NCT00428948|559954002|FG001|Overall Study|Lost to Follow-up|8|||
155142853|NCT00428948|559954001|FG000|Overall Study|Adverse Event|148|||
155142854|NCT00428948|559954002|FG001|Overall Study|Adverse Event|24|||
155142855|NCT00428948|559954001|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
155142856|NCT00428948|559954002|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
155142857|NCT00428948|559954001|FG000|Overall Study|Investigator Withdrew Subject|3|||
155142858|NCT00428948|559954002|FG001|Overall Study|Investigator Withdrew Subject|4|||
155142859|NCT00428948|559954001|FG000|Overall Study|Subject Withdrew Consent|50|||
155142860|NCT00428948|559954002|FG001|Overall Study|Subject Withdrew Consent|30|||
155142861|NCT00428948|559954001|FG000|Overall Study|Protocol Deviation|1|||
155142862|NCT00428948|559954002|FG001|Overall Study|Protocol Deviation|1|||
155142863|NCT03622814|559954004|FG000|Overall Study|Lost to Follow-up|8|||
155142864|NCT03622814|559954005|FG001|Overall Study|Lost to Follow-up|14|||
155142865|NCT04417361|559954006|FG000|Overall Study|Withdrawal by Subject|1|||
155142866|NCT04417361|559954007|FG001|Overall Study|Withdrawal by Subject|0|||
155142867|NCT04417361|559954006|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
155142868|NCT04417361|559954007|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
155142869|NCT00892775|559954008|FG000|Overall Study|Protocol Violation|1|||
155142870|NCT00892775|559954009|FG001|Overall Study|Protocol Violation|0|||
155142871|NCT00892775|559954008|FG000|Overall Study|Subject difficulties with blood drawing|1|||
155142872|NCT00892775|559954009|FG001|Overall Study|Subject difficulties with blood drawing|0|||
155142873|NCT00892775|559954008|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
155142874|NCT00892775|559954009|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
155142875|NCT00892775|559954008|FG000|Overall Study|Migrated/ moved from study area|1|||
155142876|NCT00892775|559954009|FG001|Overall Study|Migrated/ moved from study area|0|||
155142877|NCT00892775|559954008|FG000|Overall Study|Withdrawal by Subject|0|||
155142878|NCT00892775|559954009|FG001|Overall Study|Withdrawal by Subject|1|||
155142879|NCT00892775|559954008|FG000|Overall Study|Lost to Follow-up|1|||
155142880|NCT00892775|559954009|FG001|Overall Study|Lost to Follow-up|0|||
155142881|NCT00699660|559954010|FG000|Overall Study|Lost to Follow-up|4|||
155142882|NCT00699660|559954011|FG001|Overall Study|Lost to Follow-up|2|||
155142883|NCT00699660|559954010|FG000|Overall Study|missing reports and recording failures|10|||
155142884|NCT00699660|559954011|FG001|Overall Study|missing reports and recording failures|6|||
155142885|NCT03691571|559954014|FG000|Overall Study|Withdrawal by Subject|9|||
155142886|NCT03691571|559954015|FG001|Overall Study|Withdrawal by Subject|2|||
155142887|NCT04186871|559954016|FG000|Overall Study|Lack of Efficacy|0|||
155142888|NCT04186871|559954017|FG001|Overall Study|Lack of Efficacy|1|||
155142889|NCT04186871|559954018|FG002|Overall Study|Lack of Efficacy|0|||
155142890|NCT04186871|559954019|FG003|Overall Study|Lack of Efficacy|0|||
155142891|NCT04186871|559954020|FG004|Overall Study|Lack of Efficacy|1|||
155142892|NCT04186871|559954021|FG005|Overall Study|Lack of Efficacy|1|||
155142893|NCT04186871|559954016|FG000|Overall Study|Adverse Event|1|||
155142894|NCT04186871|559954017|FG001|Overall Study|Adverse Event|1|||
155142895|NCT04186871|559954018|FG002|Overall Study|Adverse Event|0|||
155142896|NCT04186871|559954019|FG003|Overall Study|Adverse Event|0|||
155142897|NCT04186871|559954020|FG004|Overall Study|Adverse Event|0|||
155142898|NCT04186871|559954021|FG005|Overall Study|Adverse Event|2|||
155142899|NCT04186871|559954016|FG000|Overall Study|Study terminated by sponsor|1|||
155142900|NCT04186871|559954017|FG001|Overall Study|Study terminated by sponsor|2|||
155142901|NCT04186871|559954018|FG002|Overall Study|Study terminated by sponsor|0|||
155142902|NCT04186871|559954019|FG003|Overall Study|Study terminated by sponsor|1|||
155142903|NCT04186871|559954020|FG004|Overall Study|Study terminated by sponsor|0|||
155142904|NCT04186871|559954021|FG005|Overall Study|Study terminated by sponsor|0|||
155142905|NCT04186871|559954016|FG000|Overall Study|Other reasons|0|||
155184880|NCT01897714|560116221|FG005|Phase II (MTD)|Death|10|||
155184881|NCT01897714|560116216|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
155184882|NCT01897714|560116217|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
155184883|NCT01897714|560116218|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
155184884|NCT01897714|560116219|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
155184885|NCT01897714|560116220|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
155184886|NCT01897714|560116221|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
155184887|NCT01897714|560116216|FG000|Phase II (MTD)|Other|0|||
155184888|NCT01897714|560116217|FG001|Phase II (MTD)|Other|0|||
155184889|NCT01897714|560116218|FG002|Phase II (MTD)|Other|0|||
155184890|NCT01897714|560116219|FG003|Phase II (MTD)|Other|0|||
155032156|NCT00878969|559544540|FG000|Overall Study|kidney transplant|2|||
155032157|NCT00878969|559544541|FG001|Overall Study|kidney transplant|3|||
155032158|NCT00878969|559544542|FG002|Overall Study|kidney transplant|2|||
155032159|NCT00878969|559544540|FG000|Overall Study|Adverse Event|3|||
155032160|NCT00878969|559544541|FG001|Overall Study|Adverse Event|1|||
155032161|NCT00878969|559544542|FG002|Overall Study|Adverse Event|2|||
155032162|NCT00878969|559544540|FG000|Overall Study|Lost to Follow-up|2|||
155032163|NCT00878969|559544541|FG001|Overall Study|Lost to Follow-up|1|||
155032164|NCT00878969|559544542|FG002|Overall Study|Lost to Follow-up|0|||
155032165|NCT00878969|559544540|FG000|Overall Study|Protocol Violation|2|||
155032166|NCT00878969|559544541|FG001|Overall Study|Protocol Violation|0|||
155032167|NCT00878969|559544542|FG002|Overall Study|Protocol Violation|0|||
155032168|NCT00878969|559544540|FG000|Overall Study|Death|0|||
155032169|NCT00878969|559544541|FG001|Overall Study|Death|0|||
155032170|NCT00878969|559544542|FG002|Overall Study|Death|2|||
155032171|NCT00878969|559544540|FG000|Overall Study|Pregnancy|0|||
155032172|NCT00878969|559544541|FG001|Overall Study|Pregnancy|1|||
155032173|NCT00878969|559544542|FG002|Overall Study|Pregnancy|0|||
155032174|NCT00655733|559544543|FG000|Overall Study|Lost to Follow-up|2|||
155032175|NCT00655733|559544544|FG001|Overall Study|Lost to Follow-up|2|||
155032176|NCT00655733|559544543|FG000|Overall Study|Adverse Event|2|||
155032177|NCT00655733|559544544|FG001|Overall Study|Adverse Event|2|||
155184891|NCT01897714|560116220|FG004|Phase II (MTD)|Other|3|||
155184892|NCT01897714|560116221|FG005|Phase II (MTD)|Other|0|||
155184893|NCT03875118|560116226|FG000|Overall Study|Withdrawal by Subject|4|||
155184894|NCT03875118|560116227|FG001|Overall Study|Withdrawal by Subject|4|||
155184895|NCT02237911|560116228|FG000|Overall Study|Withdrawal by Subject|4|||
155184896|NCT02237911|560116229|FG001|Overall Study|Withdrawal by Subject|7|||
155184897|NCT02237911|560116230|FG002|Overall Study|Withdrawal by Subject|2|||
155184898|NCT02237911|560116228|FG000|Overall Study|Lost to Follow-up|3|||
155184899|NCT02237911|560116229|FG001|Overall Study|Lost to Follow-up|1|||
155184900|NCT02237911|560116230|FG002|Overall Study|Lost to Follow-up|1|||
155184901|NCT00721123|560116231|FG000|Overall Study|Adverse Event|96|||
155184902|NCT00721123|560116231|FG000|Overall Study|Death|10|||
155184903|NCT00721123|560116231|FG000|Overall Study|Insufficient Therapeutic Response|21|||
155184904|NCT00721123|560116231|FG000|Overall Study|Protocol Violation|1|||
155184905|NCT00721123|560116231|FG000|Overall Study|Refused Treatment|41|||
155184906|NCT00721123|560116231|FG000|Overall Study|Failure to Return|9|||
155184907|NCT00721123|560116231|FG000|Overall Study|Withdrawal by Subject|5|||
155032178|NCT00655733|559544543|FG000|Overall Study|Withdrawal by Subject|3|||
155032179|NCT00655733|559544544|FG001|Overall Study|Withdrawal by Subject|3|||
155032180|NCT00655733|559544543|FG000|Overall Study|Physician Decision|0|||
155032181|NCT00655733|559544544|FG001|Overall Study|Physician Decision|1|||
155032182|NCT04495816|559544552|FG000|Overall Study|Lost to Follow-up|10|||
155032183|NCT04495816|559544553|FG001|Overall Study|Lost to Follow-up|4|||
155032184|NCT04495816|559544552|FG000|Overall Study|Withdrawal by Subject|3|||
155184908|NCT02428608|560116234|FG000|Overall Study|Pregnancy|2|||
155184909|NCT02428608|560116234|FG000|Overall Study|Lost to Follow-up|37|||
155184910|NCT02428608|560116234|FG000|Overall Study|Withdrawal by Subject|2|||
155184911|NCT02428608|560116234|FG000|Overall Study|scheduling conflicts|15|||
155184912|NCT02428608|560116234|FG000|Overall Study|moved away|10|||
155184913|NCT02428608|560116234|FG000|Overall Study|Death|1|||
155184914|NCT02428608|560116234|FG000|Overall Study|various|16|||
155184915|NCT01143207|560116237|FG000|Overall Study|Lost to Follow-up|2|||
155184916|NCT01466595|560116238|FG000|Overall Study|Withdrawal by Subject|0|||
155184917|NCT01466595|560116239|FG001|Overall Study|Withdrawal by Subject|1|||
155184918|NCT02376829|560116240|FG000|Overall Study|Withdrawal by Subject|27|||
155184919|NCT02376829|560116241|FG001|Overall Study|Withdrawal by Subject|44|||
155032185|NCT04495816|559544553|FG001|Overall Study|Withdrawal by Subject|5|||
155032186|NCT01826370|559544558|FG000|Overall Study|Protocol Violation|6|||
155032187|NCT01826370|559544558|FG000|Overall Study|Lost to Follow-up|12|||
155032188|NCT01826370|559544558|FG000|Overall Study|Other reason not defined above|2|||
155032189|NCT04489381|559544559|FG000|Overall Study|Lost to Follow-up|2|||
155032190|NCT04489381|559544560|FG001|Overall Study|Lost to Follow-up|3|||
155184920|NCT00057954|560116242|FG000|Overall Study|Death|1|||
155032191|NCT04489381|559544559|FG000|Overall Study|Withdrawal by Subject|1|||
155032192|NCT04489381|559544560|FG001|Overall Study|Withdrawal by Subject|0|||
155032193|NCT03199612|559544563|FG000|Overall Study|Adverse Event|1|||
155032194|NCT03199612|559544564|FG001|Overall Study|Adverse Event|0|||
155032195|NCT03973918|559544569|FG000|Overall Study|Adverse Event|0|||
155032196|NCT03973918|559544570|FG001|Overall Study|Adverse Event|0|||
155032197|NCT03973918|559544571|FG002|Overall Study|Adverse Event|0|||
155032198|NCT03973918|559544572|FG003|Overall Study|Adverse Event|1|||
155032199|NCT03973918|559544569|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
155032200|NCT03973918|559544570|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
155032201|NCT03973918|559544571|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
155032202|NCT03973918|559544572|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
155032203|NCT04050124|559544575|FG000|Overall Study|Death|1|||
155032204|NCT04050124|559544576|FG001|Overall Study|Death|0|||
155032205|NCT03045276|559544586|FG000|Intervention Phase|Withdrawal by Subject|7|||
155032206|NCT03045276|559544587|FG001|Intervention Phase|Withdrawal by Subject|2|||
155032207|NCT03045276|559544588|FG002|Intervention Phase|Withdrawal by Subject|3|||
155032208|NCT03045276|559544589|FG003|Intervention Phase|Withdrawal by Subject|7|||
155032209|NCT03045276|559544586|FG000|Intervention Phase|Developed exclusionary criteria|3|||
155032210|NCT03045276|559544587|FG001|Intervention Phase|Developed exclusionary criteria|3|||
155032211|NCT03045276|559544588|FG002|Intervention Phase|Developed exclusionary criteria|0|||
155032212|NCT03045276|559544589|FG003|Intervention Phase|Developed exclusionary criteria|0|||
155032213|NCT03045276|559544586|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
155032214|NCT03045276|559544587|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
155032215|NCT03045276|559544588|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
155032216|NCT03045276|559544589|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
155032217|NCT03045276|559544586|FG000|Follow-Up Phase|Lost to Follow-up|0|||
155032218|NCT03045276|559544587|FG001|Follow-Up Phase|Lost to Follow-up|1|||
155032219|NCT03045276|559544588|FG002|Follow-Up Phase|Lost to Follow-up|0|||
155032220|NCT03045276|559544589|FG003|Follow-Up Phase|Lost to Follow-up|1|||
155032221|NCT03045276|559544586|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
155032222|NCT03045276|559544587|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
155032223|NCT03045276|559544588|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
155032224|NCT03045276|559544589|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
155032225|NCT01419080|559544590|FG000|Overall Study|Withdrawal by Subject|75|||
155032226|NCT01419080|559544590|FG000|Overall Study|Death|30|||
155032227|NCT01419080|559544590|FG000|Overall Study|Lost to Follow-up|23|||
155032228|NCT01419080|559544590|FG000|Overall Study|Too Ill|3|||
155032229|NCT03003494|559544599|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
155032230|NCT00794040|559544600|FG000|Overall Study|Withdrawal by Subject|3|||
155032231|NCT00794040|559544601|FG001|Overall Study|Withdrawal by Subject|4|||
155032232|NCT00794040|559544600|FG000|Overall Study|Physician Decision|0|||
155032233|NCT00794040|559544601|FG001|Overall Study|Physician Decision|1|||
155032234|NCT04696354|559544602|FG000|Overall Study|Study termination|6|||
155032235|NCT04696354|559544603|FG001|Overall Study|Study termination|6|||
155032236|NCT03005327|559544604|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
155032237|NCT03005327|559544605|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
155032238|NCT03005327|559544606|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
155032239|NCT03005327|559544607|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
155032240|NCT03005327|559544604|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155032241|NCT03005327|559544605|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
155032242|NCT03005327|559544606|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155032243|NCT03005327|559544607|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
155032244|NCT01263782|559544609|FG000|Overall Study|Death|0|||
155032245|NCT01263782|559544610|FG001|Overall Study|Death|0|||
155032246|NCT01263782|559544611|FG002|Overall Study|Death|1|||
155142906|NCT04186871|559954017|FG001|Overall Study|Other reasons|0|||
155142907|NCT04186871|559954018|FG002|Overall Study|Other reasons|0|||
155142908|NCT04186871|559954019|FG003|Overall Study|Other reasons|0|||
155142909|NCT04186871|559954020|FG004|Overall Study|Other reasons|0|||
155142910|NCT04186871|559954021|FG005|Overall Study|Other reasons|1|||
155142911|NCT04186871|559954016|FG000|Overall Study|Withdrawal by Subject|0|||
155142912|NCT04186871|559954017|FG001|Overall Study|Withdrawal by Subject|0|||
155142913|NCT04186871|559954018|FG002|Overall Study|Withdrawal by Subject|0|||
155142914|NCT04186871|559954019|FG003|Overall Study|Withdrawal by Subject|0|||
155032247|NCT01263782|559544612|FG003|Overall Study|Death|0|||
155032248|NCT01263782|559544609|FG000|Overall Study|Progressive disease|0|||
155032249|NCT01263782|559544610|FG001|Overall Study|Progressive disease|0|||
155032250|NCT01263782|559544611|FG002|Overall Study|Progressive disease|0|||
155142915|NCT04186871|559954020|FG004|Overall Study|Withdrawal by Subject|0|||
155142916|NCT04186871|559954021|FG005|Overall Study|Withdrawal by Subject|1|||
155142917|NCT04186871|559954016|FG000|Overall Study|Lost to Follow-up|0|||
155032251|NCT01263782|559544612|FG003|Overall Study|Progressive disease|1|||
155032252|NCT01263782|559544609|FG000|Overall Study|Too early|0|||
155032253|NCT01263782|559544610|FG001|Overall Study|Too early|0|||
155032254|NCT01263782|559544611|FG002|Overall Study|Too early|1|||
155032255|NCT01263782|559544612|FG003|Overall Study|Too early|0|||
155032256|NCT01263782|559544609|FG000|Overall Study|Inevaluable|0|||
155032257|NCT01263782|559544610|FG001|Overall Study|Inevaluable|0|||
155032258|NCT01263782|559544611|FG002|Overall Study|Inevaluable|1|||
155032259|NCT01263782|559544612|FG003|Overall Study|Inevaluable|0|||
155032260|NCT04545567|559544616|FG000|Overall Study|tested positive for SARS-co-V2|1|||
155032261|NCT04545567|559544617|FG001|Overall Study|tested positive for SARS-co-V2|1|||
155032262|NCT04545567|559544616|FG000|Overall Study|Withdrawal by Subject|0|||
155032263|NCT04545567|559544617|FG001|Overall Study|Withdrawal by Subject|1|||
155032264|NCT02419612|559544621|FG000|Short-term Treatment Period|Adverse Event|1|||
155032265|NCT02419612|559544622|FG001|Short-term Treatment Period|Adverse Event|1|||
155032266|NCT02419612|559544621|FG000|Short-term Treatment Period|Death|0|||
155032267|NCT02419612|559544622|FG001|Short-term Treatment Period|Death|2|||
155032268|NCT02419612|559544621|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
155032269|NCT02419612|559544622|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
155032270|NCT02419612|559544621|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
155032271|NCT02419612|559544622|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
155032272|NCT02419612|559544621|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
155032273|NCT02419612|559544622|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
155032274|NCT02419612|559544621|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
155032275|NCT02419612|559544622|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
155032276|NCT02419612|559544621|FG000|Short-term Treatment Period|Worsening of liver function|0|||
155032277|NCT02419612|559544622|FG001|Short-term Treatment Period|Worsening of liver function|1|||
155032278|NCT02419612|559544621|FG000|Short-term Treatment Period|Subject moved out of state|0|||
155032279|NCT02419612|559544622|FG001|Short-term Treatment Period|Subject moved out of state|1|||
155032280|NCT02419612|559544621|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
155032281|NCT02419612|559544622|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
155032282|NCT02419612|559544621|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
155032283|NCT02419612|559544622|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
155032284|NCT02419612|559544621|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
155032285|NCT02419612|559544622|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
155032286|NCT02419612|559544621|FG000|Long-term Treatment Period|Death|0|||
155032287|NCT02419612|559544622|FG001|Long-term Treatment Period|Death|1|||
155032288|NCT02419612|559544621|FG000|Long-term Treatment Period|Adverse Event|0|||
155032289|NCT02419612|559544622|FG001|Long-term Treatment Period|Adverse Event|5|||
155032290|NCT02419612|559544621|FG000|Long-term Treatment Period|Other|4|||
155032291|NCT02419612|559544622|FG001|Long-term Treatment Period|Other|4|||
155032292|NCT02419612|559544621|FG000|Long-term Treatment Period|Subject Decision|2|||
155032293|NCT02419612|559544622|FG001|Long-term Treatment Period|Subject Decision|4|||
155142918|NCT04186871|559954017|FG001|Overall Study|Lost to Follow-up|0|||
155142919|NCT04186871|559954018|FG002|Overall Study|Lost to Follow-up|0|||
155142920|NCT04186871|559954019|FG003|Overall Study|Lost to Follow-up|0|||
155142921|NCT04186871|559954020|FG004|Overall Study|Lost to Follow-up|0|||
155142922|NCT04186871|559954021|FG005|Overall Study|Lost to Follow-up|1|||
155142923|NCT00250276|559954023|FG000|Overall Study|Serious Adverse Event|0|||
155142924|NCT00250276|559954024|FG001|Overall Study|Serious Adverse Event|0|||
155142925|NCT00250276|559954025|FG002|Overall Study|Serious Adverse Event|1|||
155142926|NCT00250276|559954026|FG003|Overall Study|Serious Adverse Event|0|||
155142927|NCT00250276|559954023|FG000|Overall Study|Non-serious Adverse Event|2|||
155142928|NCT00250276|559954024|FG001|Overall Study|Non-serious Adverse Event|0|||
155142929|NCT00250276|559954025|FG002|Overall Study|Non-serious Adverse Event|0|||
155142930|NCT00250276|559954026|FG003|Overall Study|Non-serious Adverse Event|2|||
155142931|NCT00250276|559954023|FG000|Overall Study|Protocol Violation|0|||
155142932|NCT00250276|559954024|FG001|Overall Study|Protocol Violation|1|||
155142933|NCT00250276|559954025|FG002|Overall Study|Protocol Violation|0|||
155142934|NCT00250276|559954026|FG003|Overall Study|Protocol Violation|0|||
155142935|NCT00250276|559954023|FG000|Overall Study|Withdrawal by Subject|1|||
155142936|NCT00250276|559954024|FG001|Overall Study|Withdrawal by Subject|2|||
155142937|NCT00250276|559954025|FG002|Overall Study|Withdrawal by Subject|3|||
155142938|NCT00250276|559954026|FG003|Overall Study|Withdrawal by Subject|2|||
155142939|NCT00250276|559954023|FG000|Overall Study|Migrated/moved from study area|3|||
155142940|NCT00250276|559954024|FG001|Overall Study|Migrated/moved from study area|0|||
155142941|NCT00250276|559954025|FG002|Overall Study|Migrated/moved from study area|2|||
155032294|NCT02419612|559544621|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
155032295|NCT02419612|559544622|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
155032296|NCT00533702|559544623|FG000|Overall Study|Withdrawal by Subject|3|||
155032297|NCT00533702|559544624|FG001|Overall Study|Withdrawal by Subject|1|||
155032298|NCT00533702|559544623|FG000|Overall Study|Found ineligible after randomization|2|||
155142942|NCT00250276|559954026|FG003|Overall Study|Migrated/moved from study area|7|||
155184921|NCT00057954|560116242|FG000|Overall Study|Disease progression|1|||
155184922|NCT00559754|560116243|FG000|Overall Study|Disease progression|1|||
155184923|NCT00559754|560116243|FG000|Overall Study|Adverse Event|5|||
155032299|NCT00533702|559544624|FG001|Overall Study|Found ineligible after randomization|1|||
155032300|NCT01095978|559544625|FG000|Overall Study|Did not take Klacid SR|2|||
155032301|NCT01095978|559544625|FG000|Overall Study|Adverse Event|1|||
155184924|NCT00559754|560116243|FG000|Overall Study|Protocol Violation|1|||
155032302|NCT00965341|559544633|FG000|Overall Study|Withdrew consent|1|||
155032303|NCT00965341|559544634|FG001|Overall Study|Withdrew consent|5|||
155032304|NCT00965341|559544633|FG000|Overall Study|Lost to Follow-up|1|||
155184925|NCT00559754|560116243|FG000|Overall Study|Investigator criteria|2|||
155184926|NCT00559754|560116243|FG000|Overall Study|Withdrawal by Subject|2|||
155184927|NCT01264016|560116244|FG000|Overall Study|Withdrawal by Subject|1|||
155184928|NCT01264016|560116244|FG000|Overall Study|Felt faint at sight of blood|1|||
155184929|NCT01629706|560116245|FG000|Phase 1 PureVision|Screen Failure|4|||
155184930|NCT01629706|560116245|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
155184931|NCT01629706|560116245|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
155184932|NCT01629706|560116245|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
155184933|NCT01629706|560116245|FG000|Phase 2 Habitual|Screen Failure|6|||
155184934|NCT01629706|560116245|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
155184935|NCT01629706|560116245|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
155184936|NCT01629706|560116245|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
155184937|NCT01629706|560116245|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
155184938|NCT02117414|560116246|FG000|Overall Study|Death|5|||
155184939|NCT02117414|560116247|FG001|Overall Study|Death|2|||
155184940|NCT02117414|560116246|FG000|Overall Study|Withdrawal by Subject|10|||
155184941|NCT02117414|560116247|FG001|Overall Study|Withdrawal by Subject|4|||
155184942|NCT01439347|560116248|FG000|Overall Study|Death|10|||
155184943|NCT01439347|560116249|FG001|Overall Study|Death|9|||
155184944|NCT01439347|560116248|FG000|Overall Study|Withdrawal by Subject|0|||
155184945|NCT01439347|560116249|FG001|Overall Study|Withdrawal by Subject|1|||
155184946|NCT01439347|560116248|FG000|Overall Study|Physician Decision|1|||
155184947|NCT01439347|560116249|FG001|Overall Study|Physician Decision|0|||
155184948|NCT01439347|560116248|FG000|Overall Study|Sponsor Terminated Study|2|||
155184949|NCT01439347|560116249|FG001|Overall Study|Sponsor Terminated Study|3|||
155184950|NCT02537574|560116250|FG000|Overall Study|Adverse Event|1|||
155184951|NCT02537574|560116251|FG001|Overall Study|Adverse Event|3|||
155184952|NCT02537574|560116252|FG002|Overall Study|Adverse Event|2|||
155184953|NCT02537574|560116250|FG000|Overall Study|Lost to Follow-up|40|||
155184954|NCT02537574|560116251|FG001|Overall Study|Lost to Follow-up|51|||
155184955|NCT02537574|560116252|FG002|Overall Study|Lost to Follow-up|55|||
155184956|NCT02537574|560116250|FG000|Overall Study|Noncompliance with study drug|0|||
155184957|NCT02537574|560116251|FG001|Overall Study|Noncompliance with study drug|1|||
155184958|NCT02537574|560116252|FG002|Overall Study|Noncompliance with study drug|1|||
155184959|NCT02537574|560116250|FG000|Overall Study|Physician Decision|2|||
155184960|NCT02537574|560116251|FG001|Overall Study|Physician Decision|0|||
155032305|NCT00965341|559544634|FG001|Overall Study|Lost to Follow-up|0|||
155032306|NCT00965341|559544633|FG000|Overall Study|Transportation issues|4|||
155032307|NCT00965341|559544634|FG001|Overall Study|Transportation issues|3|||
155032308|NCT01077739|559544635|FG000|Overall Study|Premature withdrawal|1|||
155032309|NCT01077739|559544636|FG001|Overall Study|Premature withdrawal|3|||
155032310|NCT01077739|559544635|FG000|Overall Study|Withdrawal by Subject|1|||
155032311|NCT01077739|559544636|FG001|Overall Study|Withdrawal by Subject|0|||
155142943|NCT00250276|559954023|FG000|Overall Study|Lost to Follow-up|11|||
155142944|NCT00250276|559954024|FG001|Overall Study|Lost to Follow-up|18|||
155142945|NCT00250276|559954025|FG002|Overall Study|Lost to Follow-up|13|||
155142946|NCT00250276|559954026|FG003|Overall Study|Lost to Follow-up|8|||
155142947|NCT00555217|559954027|FG000|Overall Study|Withdrawal by Subject|35|||
155142948|NCT00555217|559954028|FG001|Overall Study|Withdrawal by Subject|31|||
155142949|NCT00555217|559954027|FG000|Overall Study|Lost to Follow-up|19|||
155142950|NCT00555217|559954028|FG001|Overall Study|Lost to Follow-up|20|||
155142951|NCT00555217|559954027|FG000|Overall Study|close out sites|21|||
155142952|NCT00555217|559954028|FG001|Overall Study|close out sites|17|||
155142953|NCT00950248|559954032|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
155142954|NCT00950248|559954033|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
155142955|NCT00950248|559954034|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
155142956|NCT00950248|559954032|FG000|Year 1: Baseline|worsening of symptoms|2|||
155142957|NCT00950248|559954033|FG001|Year 1: Baseline|worsening of symptoms|0|||
155142958|NCT00950248|559954034|FG002|Year 1: Baseline|worsening of symptoms|0|||
155142959|NCT00950248|559954032|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
155142960|NCT00950248|559954033|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
155142961|NCT00950248|559954034|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
155142962|NCT00950248|559954032|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
155184961|NCT02537574|560116252|FG002|Overall Study|Physician Decision|0|||
155184962|NCT02537574|560116250|FG000|Overall Study|Protocol Violation|4|||
155184963|NCT02537574|560116251|FG001|Overall Study|Protocol Violation|2|||
155142963|NCT00950248|559954033|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
155142964|NCT00950248|559954034|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
155184964|NCT02537574|560116252|FG002|Overall Study|Protocol Violation|3|||
155184965|NCT02537574|560116250|FG000|Overall Study|Withdrawal by Subject|37|||
155184966|NCT02537574|560116251|FG001|Overall Study|Withdrawal by Subject|27|||
155184967|NCT02537574|560116252|FG002|Overall Study|Withdrawal by Subject|29|||
155184968|NCT02537574|560116250|FG000|Overall Study|Lack of Efficacy|14|||
155032312|NCT01077739|559544635|FG000|Overall Study|Death|0|||
155032313|NCT01077739|559544636|FG001|Overall Study|Death|3|||
155032314|NCT01077739|559544635|FG000|Overall Study|Unacceptable toxicity|1|||
155032315|NCT01077739|559544636|FG001|Overall Study|Unacceptable toxicity|2|||
155032316|NCT01077739|559544635|FG000|Overall Study|Other|2|||
155032317|NCT01077739|559544636|FG001|Overall Study|Other|2|||
155032318|NCT00877071|559544637|FG000|Overall Study|disease progression|2|||
155032319|NCT04413552|559544638|FG000|Overall Study|Adverse Event|0|||
155032320|NCT04413552|559544639|FG001|Overall Study|Adverse Event|0|||
155032321|NCT04413552|559544640|FG002|Overall Study|Adverse Event|0|||
155032322|NCT04413552|559544641|FG003|Overall Study|Adverse Event|0|||
155032323|NCT04413552|559544642|FG004|Overall Study|Adverse Event|0|||
155032324|NCT04413552|559544643|FG005|Overall Study|Adverse Event|0|||
155032325|NCT04413552|559544644|FG006|Overall Study|Adverse Event|1|||
155032326|NCT04413552|559544645|FG007|Overall Study|Adverse Event|0|||
155184969|NCT02537574|560116251|FG001|Overall Study|Lack of Efficacy|16|||
155184970|NCT02537574|560116252|FG002|Overall Study|Lack of Efficacy|15|||
155184971|NCT02537574|560116250|FG000|Overall Study|Duplicate Patient|1|||
155184972|NCT02537574|560116251|FG001|Overall Study|Duplicate Patient|0|||
155184973|NCT02537574|560116252|FG002|Overall Study|Duplicate Patient|0|||
155032327|NCT04413552|559544646|FG008|Overall Study|Adverse Event|0|||
155032328|NCT04413552|559544647|FG009|Overall Study|Adverse Event|0|||
155032329|NCT05723328|559544648|FG000|Overall Study|Investigator's Decision|5|||
155032330|NCT05723328|559544649|FG001|Overall Study|Investigator's Decision|2|||
155032331|NCT01794793|559544651|FG000|Treatment Period|Withdrawal by Subject|24|||
155032332|NCT01794793|559544651|FG000|Treatment Period|Lack of Efficacy|22|||
155032333|NCT01794793|559544651|FG000|Treatment Period|Adverse Event|17|||
155032334|NCT01794793|559544651|FG000|Treatment Period|Physician Decision|14|||
155032335|NCT01794793|559544651|FG000|Treatment Period|Lost to Follow-up|7|||
155032336|NCT01794793|559544651|FG000|Treatment Period|Death|6|||
155032337|NCT01794793|559544651|FG000|Treatment Period|Protocol Violation|5|||
155184974|NCT02537574|560116250|FG000|Overall Study|Patient not Stable|0|||
155184975|NCT02537574|560116251|FG001|Overall Study|Patient not Stable|1|||
155184976|NCT02537574|560116252|FG002|Overall Study|Patient not Stable|0|||
155184977|NCT02537574|560116250|FG000|Overall Study|Incarceration|0|||
155032338|NCT01794793|559544651|FG000|Treatment Period|administrative problem|3|||
155032339|NCT01794793|559544651|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
155032340|NCT01794793|559544651|FG000|Post-treatment Follow-up|Adverse Event|8|||
155032341|NCT01794793|559544651|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
155032342|NCT01794793|559544651|FG000|Post-treatment Follow-up|administrative problem|5|||
155032343|NCT01794793|559544651|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
155032344|NCT01794793|559544651|FG000|Post-treatment Follow-up|Protocol Violation|3|||
155032345|NCT04852679|559544652|FG000|Main Intervention Period|Withdrawal by Subject|3|||
155142965|NCT00950248|559954032|FG000|Year 2&3 Treatment Randomization|Death|0|||
155142966|NCT00950248|559954033|FG001|Year 2&3 Treatment Randomization|Death|0|||
155142967|NCT00950248|559954034|FG002|Year 2&3 Treatment Randomization|Death|1|||
155142968|NCT00950248|559954032|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
155142969|NCT00950248|559954033|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
155142970|NCT00950248|559954034|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
155142971|NCT01657292|559954038|FG000|Overall Study|Adverse Event|6|||
155142972|NCT01657292|559954038|FG000|Overall Study|Withdrawal by Subject|2|||
155142973|NCT01657292|559954038|FG000|Overall Study|Violation of eligibility criteria|1|||
155142974|NCT01657292|559954038|FG000|Overall Study|Change of therapy|1|||
155142975|NCT00650845|559954040|FG000|Overall Study|Withdrawal by Subject|5|||
155142976|NCT00650845|559954041|FG001|Overall Study|Withdrawal by Subject|0|||
155142977|NCT00650845|559954040|FG000|Overall Study|Protocol Violation|0|||
155142978|NCT00650845|559954041|FG001|Overall Study|Protocol Violation|13|||
155142979|NCT01900652|559954042|FG000|Overall Study|Progressive Disease|1|||
155142980|NCT01900652|559954043|FG001|Overall Study|Progressive Disease|0|||
155142981|NCT01900652|559954042|FG000|Overall Study|Consent withdrawn by subject|1|||
155142982|NCT01900652|559954043|FG001|Overall Study|Consent withdrawn by subject|1|||
155142983|NCT01900652|559954042|FG000|Overall Study|Death|3|||
155142984|NCT01900652|559954043|FG001|Overall Study|Death|0|||
155142985|NCT01900652|559954042|FG000|Overall Study|Adverse Event|2|||
155142986|NCT01900652|559954043|FG001|Overall Study|Adverse Event|1|||
155142987|NCT01900652|559954042|FG000|Overall Study|Physician Decision|1|||
155142988|NCT01900652|559954043|FG001|Overall Study|Physician Decision|1|||
155142989|NCT03761810|559954044|FG000|Overall Study|Adverse Event|12|||
155142990|NCT03761810|559954045|FG001|Overall Study|Adverse Event|0|||
155142991|NCT03761810|559954044|FG000|Overall Study|Lost to Follow-up|15|||
155142992|NCT03761810|559954045|FG001|Overall Study|Lost to Follow-up|7|||
155142993|NCT03761810|559954044|FG000|Overall Study|Pregnancy|1|||
155142994|NCT03761810|559954045|FG001|Overall Study|Pregnancy|0|||
155142995|NCT03761810|559954044|FG000|Overall Study|Withdrawal by Subject|14|||
155142996|NCT03761810|559954045|FG001|Overall Study|Withdrawal by Subject|5|||
155142997|NCT03761810|559954044|FG000|Overall Study|Physician Decision|1|||
155142998|NCT03761810|559954045|FG001|Overall Study|Physician Decision|0|||
155184978|NCT02537574|560116251|FG001|Overall Study|Incarceration|1|||
155032346|NCT04852679|559544652|FG000|Main Intervention Period|Adverse Event|1|||
155032347|NCT04852679|559544652|FG000|Main Intervention Period|Progressive Disease|16|||
155032348|NCT04852679|559544652|FG000|Main Intervention Period|Refused study visit|1|||
155032349|NCT04852679|559544652|FG000|Independent Injection Period|Missed study visit|1|||
155032350|NCT02000882|559546527|FG000|Overall Study|Adverse Event|3|||
155032351|NCT02000882|559546527|FG000|Overall Study|Physician Decision|2|||
155032352|NCT02000882|559546527|FG000|Overall Study|Withdrawal by Subject|1|||
155032353|NCT02417961|559546531|FG000|Overall Study|Adverse Event|1|||
155032354|NCT02417961|559546531|FG000|Overall Study|Lost to Follow-up|1|||
155032355|NCT02417961|559546531|FG000|Overall Study|Withdrawal by Subject|2|||
155032356|NCT05079750|559546532|FG000|Overall Study|Lost to Follow-up|0|||
155032357|NCT05079750|559546533|FG001|Overall Study|Lost to Follow-up|0|||
155032358|NCT05079750|559546534|FG002|Overall Study|Lost to Follow-up|1|||
155032359|NCT03569293|559546535|FG000|Overall Study|Adverse Event|4|||
155032360|NCT03569293|559546536|FG001|Overall Study|Adverse Event|1|||
155032361|NCT03569293|559546537|FG002|Overall Study|Adverse Event|5|||
155032362|NCT03569293|559546538|FG003|Overall Study|Adverse Event|1|||
155032363|NCT03569293|559546539|FG004|Overall Study|Adverse Event|0|||
155032364|NCT03569293|559546540|FG005|Overall Study|Adverse Event|0|||
155032365|NCT03569293|559546535|FG000|Overall Study|Withdrawal by Subject|16|||
155032366|NCT03569293|559546536|FG001|Overall Study|Withdrawal by Subject|2|||
155032367|NCT03569293|559546537|FG002|Overall Study|Withdrawal by Subject|4|||
155032368|NCT03569293|559546538|FG003|Overall Study|Withdrawal by Subject|1|||
155032369|NCT03569293|559546539|FG004|Overall Study|Withdrawal by Subject|0|||
155032370|NCT03569293|559546540|FG005|Overall Study|Withdrawal by Subject|0|||
155032371|NCT03569293|559546535|FG000|Overall Study|Lost to Follow-up|1|||
155032372|NCT03569293|559546536|FG001|Overall Study|Lost to Follow-up|3|||
155032373|NCT03569293|559546537|FG002|Overall Study|Lost to Follow-up|1|||
155032374|NCT03569293|559546538|FG003|Overall Study|Lost to Follow-up|1|||
155032375|NCT03569293|559546539|FG004|Overall Study|Lost to Follow-up|0|||
155032376|NCT03569293|559546540|FG005|Overall Study|Lost to Follow-up|0|||
155032377|NCT03569293|559546535|FG000|Overall Study|Other|8|||
155032378|NCT03569293|559546536|FG001|Overall Study|Other|2|||
155032379|NCT03569293|559546537|FG002|Overall Study|Other|1|||
155032380|NCT03569293|559546538|FG003|Overall Study|Other|1|||
155032381|NCT03569293|559546539|FG004|Overall Study|Other|0|||
155032382|NCT03569293|559546540|FG005|Overall Study|Other|0|||
155032383|NCT03569293|559546535|FG000|Overall Study|Ongoing at Time of Analysis|8|||
155032384|NCT03569293|559546536|FG001|Overall Study|Ongoing at Time of Analysis|1|||
155032385|NCT03569293|559546537|FG002|Overall Study|Ongoing at Time of Analysis|3|||
155032386|NCT03569293|559546538|FG003|Overall Study|Ongoing at Time of Analysis|0|||
155032387|NCT03569293|559546539|FG004|Overall Study|Ongoing at Time of Analysis|0|||
155032388|NCT03569293|559546540|FG005|Overall Study|Ongoing at Time of Analysis|0|||
155032389|NCT01752634|559546541|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
155032390|NCT01752634|559546542|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
155032391|NCT01752634|559546543|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
155032392|NCT01752634|559546544|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
155032393|NCT01752634|559546545|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
155142999|NCT03761810|559954044|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
155143000|NCT03761810|559954045|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155143001|NCT03761810|559954044|FG000|Overall Study|Other Than Specified|1|||
155143002|NCT03761810|559954045|FG001|Overall Study|Other Than Specified|0|||
155143003|NCT04178720|559954046|FG000|Overall Study|Withdrawal by Subject|2|||
155143004|NCT04178720|559954047|FG001|Overall Study|Withdrawal by Subject|0|||
155143005|NCT04178720|559954046|FG000|Overall Study|Relocation|0|||
155143006|NCT04178720|559954047|FG001|Overall Study|Relocation|1|||
155143007|NCT00869518|559954048|FG000|Overall Study|Lost to Follow-up|1|||
155143008|NCT00869518|559954049|FG001|Overall Study|Lost to Follow-up|1|||
155143009|NCT03922620|559954050|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
155143010|NCT03922620|559954051|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
155143011|NCT03566082|559954052|FG000|Overall Study|Death|7|||
155143012|NCT03566082|559954052|FG000|Overall Study|Failures (revision required)|2|||
155143013|NCT03566082|559954052|FG000|Overall Study|Lost to Follow-up|8|||
155032394|NCT01752634|559546546|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
155032395|NCT01752634|559546541|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155032396|NCT01752634|559546542|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
155143014|NCT02663622|559954053|FG000|Overall Study|Death|3|||
155032397|NCT01752634|559546543|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155032398|NCT01752634|559546544|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155032399|NCT01752634|559546545|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155032400|NCT01752634|559546546|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
155032401|NCT01752634|559546541|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
155032402|NCT01752634|559546542|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
155032403|NCT01752634|559546543|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
155143015|NCT02663622|559954054|FG001|Overall Study|Death|1|||
155032404|NCT01752634|559546544|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
155032405|NCT01752634|559546545|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
155032406|NCT01752634|559546546|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
155032407|NCT01752634|559546541|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
155032408|NCT01752634|559546542|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
155032409|NCT01752634|559546543|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
155032410|NCT01752634|559546544|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
155032411|NCT01752634|559546545|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
155032412|NCT01752634|559546546|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
155032413|NCT01752634|559546541|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
155032414|NCT01752634|559546542|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
155032415|NCT01752634|559546543|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
155032416|NCT01752634|559546544|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
155032417|NCT01752634|559546545|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
155032418|NCT01752634|559546546|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
155032419|NCT01752634|559546541|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
155032420|NCT01752634|559546542|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
155032421|NCT01752634|559546543|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
155032422|NCT01752634|559546544|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
155032423|NCT01752634|559546545|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
155032424|NCT01752634|559546546|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
155032425|NCT01752634|559546541|FG000|Week 24 to Week 260|Physician Decision|1|||
155032426|NCT01752634|559546542|FG001|Week 24 to Week 260|Physician Decision|2|||
155032427|NCT01752634|559546543|FG002|Week 24 to Week 260|Physician Decision|4|||
155032428|NCT01752634|559546544|FG003|Week 24 to Week 260|Physician Decision|2|||
155032429|NCT01752634|559546545|FG004|Week 24 to Week 260|Physician Decision|1|||
155032430|NCT01752634|559546546|FG005|Week 24 to Week 260|Physician Decision|0|||
155032431|NCT01752634|559546541|FG000|Week 24 to Week 260|Death|0|||
155032432|NCT01752634|559546542|FG001|Week 24 to Week 260|Death|1|||
155032433|NCT01752634|559546543|FG002|Week 24 to Week 260|Death|0|||
155032434|NCT01752634|559546544|FG003|Week 24 to Week 260|Death|0|||
155032435|NCT01752634|559546545|FG004|Week 24 to Week 260|Death|0|||
155032436|NCT01752634|559546546|FG005|Week 24 to Week 260|Death|0|||
155032437|NCT01752634|559546541|FG000|Week 24 to Week 260|Pregnancy|0|||
155032438|NCT01752634|559546542|FG001|Week 24 to Week 260|Pregnancy|0|||
155032439|NCT01752634|559546543|FG002|Week 24 to Week 260|Pregnancy|1|||
155032440|NCT01752634|559546544|FG003|Week 24 to Week 260|Pregnancy|0|||
155032441|NCT01752634|559546545|FG004|Week 24 to Week 260|Pregnancy|0|||
155032442|NCT01752634|559546546|FG005|Week 24 to Week 260|Pregnancy|0|||
155032443|NCT01752634|559546541|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
155032444|NCT01752634|559546542|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
155032445|NCT01752634|559546543|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
155032446|NCT01752634|559546544|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
155032447|NCT01752634|559546545|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
155032448|NCT01752634|559546546|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
155032449|NCT01752634|559546541|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
155032450|NCT01752634|559546542|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
155032451|NCT01752634|559546543|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
155032452|NCT01752634|559546544|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
155032453|NCT01752634|559546545|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
155032454|NCT01752634|559546546|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
155032455|NCT01752634|559546541|FG000|Week 24 to Week 260|Adverse Event|4|||
155032456|NCT01752634|559546542|FG001|Week 24 to Week 260|Adverse Event|8|||
155032457|NCT01752634|559546543|FG002|Week 24 to Week 260|Adverse Event|8|||
155032458|NCT01752634|559546544|FG003|Week 24 to Week 260|Adverse Event|4|||
155032459|NCT01752634|559546545|FG004|Week 24 to Week 260|Adverse Event|2|||
155032460|NCT01752634|559546546|FG005|Week 24 to Week 260|Adverse Event|0|||
155032461|NCT05562934|559546547|FG000|Overall Study|Adverse Event|0|||
155032462|NCT05562934|559546548|FG001|Overall Study|Adverse Event|2|||
155032463|NCT05562934|559546549|FG002|Overall Study|Adverse Event|0|||
155032464|NCT05562934|559546550|FG003|Overall Study|Adverse Event|0|||
155032465|NCT05562934|559546551|FG004|Overall Study|Adverse Event|2|||
155032466|NCT05562934|559546547|FG000|Overall Study|Lost to Follow-up|0|||
155032467|NCT05562934|559546548|FG001|Overall Study|Lost to Follow-up|0|||
155184979|NCT02537574|560116252|FG002|Overall Study|Incarceration|0|||
155032468|NCT05562934|559546549|FG002|Overall Study|Lost to Follow-up|0|||
155032469|NCT05562934|559546550|FG003|Overall Study|Lost to Follow-up|0|||
155032470|NCT05562934|559546551|FG004|Overall Study|Lost to Follow-up|1|||
155032471|NCT05562934|559546547|FG000|Overall Study|Protocol Violation|0|||
155032472|NCT05562934|559546548|FG001|Overall Study|Protocol Violation|0|||
155032473|NCT05562934|559546549|FG002|Overall Study|Protocol Violation|0|||
155032474|NCT05562934|559546550|FG003|Overall Study|Protocol Violation|1|||
155032475|NCT05562934|559546551|FG004|Overall Study|Protocol Violation|1|||
155032476|NCT05562934|559546547|FG000|Overall Study|Withdrawal by Subject|0|||
155032477|NCT05562934|559546548|FG001|Overall Study|Withdrawal by Subject|0|||
155032478|NCT05562934|559546549|FG002|Overall Study|Withdrawal by Subject|1|||
155032479|NCT05562934|559546550|FG003|Overall Study|Withdrawal by Subject|1|||
155032480|NCT05562934|559546551|FG004|Overall Study|Withdrawal by Subject|0|||
155032481|NCT01702532|559546554|FG000|Overall Study|Adverse Event|0|||
155032482|NCT01702532|559546555|FG001|Overall Study|Adverse Event|1|||
155032483|NCT00623597|559546556|FG000|Overall Study|Failed to return|1|||
155032484|NCT00623597|559546557|FG001|Overall Study|Failed to return|0|||
155032485|NCT01451164|559546558|FG000|Overall Study|Adverse Event|19|||
155032486|NCT01451164|559546559|FG001|Overall Study|Adverse Event|12|||
155032487|NCT01451164|559546560|FG002|Overall Study|Adverse Event|18|||
155032488|NCT01451164|559546561|FG003|Overall Study|Adverse Event|21|||
155032489|NCT01451164|559546558|FG000|Overall Study|Withdrawal Criteria|1|||
155032490|NCT01451164|559546559|FG001|Overall Study|Withdrawal Criteria|1|||
155032491|NCT01451164|559546560|FG002|Overall Study|Withdrawal Criteria|1|||
155032492|NCT01451164|559546561|FG003|Overall Study|Withdrawal Criteria|1|||
155032493|NCT01451164|559546558|FG000|Overall Study|Physician Decision|2|||
155032494|NCT01451164|559546559|FG001|Overall Study|Physician Decision|0|||
155032495|NCT01451164|559546560|FG002|Overall Study|Physician Decision|1|||
155032496|NCT01451164|559546561|FG003|Overall Study|Physician Decision|0|||
155032497|NCT01451164|559546558|FG000|Overall Study|Withdrawal by Subject|14|||
155032498|NCT01451164|559546559|FG001|Overall Study|Withdrawal by Subject|11|||
155032499|NCT01451164|559546560|FG002|Overall Study|Withdrawal by Subject|16|||
155032500|NCT01451164|559546561|FG003|Overall Study|Withdrawal by Subject|17|||
155032501|NCT01451164|559546558|FG000|Overall Study|Protocol Violation|0|||
155032502|NCT01451164|559546559|FG001|Overall Study|Protocol Violation|1|||
155032503|NCT01451164|559546560|FG002|Overall Study|Protocol Violation|0|||
155032504|NCT01451164|559546561|FG003|Overall Study|Protocol Violation|0|||
155032505|NCT01451164|559546558|FG000|Overall Study|Lack of Efficacy|7|||
155032506|NCT01451164|559546559|FG001|Overall Study|Lack of Efficacy|9|||
155032507|NCT01451164|559546560|FG002|Overall Study|Lack of Efficacy|9|||
155032508|NCT01451164|559546561|FG003|Overall Study|Lack of Efficacy|7|||
155032509|NCT01846221|559546562|FG000|Overall Study|Catheter Failure|2|||
155032510|NCT01846221|559546563|FG001|Overall Study|Catheter Failure|0|||
155032511|NCT01846221|559546562|FG000|Overall Study|Age Exclusion|1|||
155032512|NCT01846221|559546563|FG001|Overall Study|Age Exclusion|0|||
155032513|NCT04599933|559546564|FG000|Overall Study|Adverse Event|4|||
155032514|NCT04599933|559546565|FG001|Overall Study|Adverse Event|1|||
155032515|NCT04599933|559546564|FG000|Overall Study|Withdrawal by Subject|4|||
155032516|NCT04599933|559546565|FG001|Overall Study|Withdrawal by Subject|2|||
155032517|NCT04599933|559546564|FG000|Overall Study|Lost to Follow-up|0|||
155032518|NCT04599933|559546565|FG001|Overall Study|Lost to Follow-up|1|||
155032519|NCT04599933|559546564|FG000|Overall Study|Physician Decision|0|||
155032520|NCT04599933|559546565|FG001|Overall Study|Physician Decision|1|||
155032521|NCT04599933|559546564|FG000|Overall Study|Screen Failure|1|||
155032522|NCT04599933|559546565|FG001|Overall Study|Screen Failure|2|||
155032523|NCT02963558|559546573|FG000|Overall Study|Withdrawn by investigator|1|||
155032524|NCT02963558|559546574|FG001|Overall Study|Withdrawn by investigator|0|||
155032525|NCT02963558|559546573|FG000|Overall Study|Withdrawal by Subject|0|||
155032526|NCT02963558|559546574|FG001|Overall Study|Withdrawal by Subject|1|||
155032527|NCT03226678|559546579|FG000|Part A (Core Study Phase)|Adverse Event|0|||
155032528|NCT03226678|559546580|FG001|Part A (Core Study Phase)|Adverse Event|1|||
155032529|NCT03226678|559546581|FG002|Part A (Core Study Phase)|Adverse Event|0|||
155032530|NCT03226678|559546582|FG003|Part A (Core Study Phase)|Adverse Event|0|||
155032531|NCT03226678|559546583|FG004|Part A (Core Study Phase)|Adverse Event|0|||
155032532|NCT03226678|559546584|FG005|Part A (Core Study Phase)|Adverse Event|0|||
155032533|NCT03226678|559546579|FG000|Part A (Core Study Phase)|Death|0|||
155032534|NCT03226678|559546580|FG001|Part A (Core Study Phase)|Death|0|||
155032535|NCT03226678|559546581|FG002|Part A (Core Study Phase)|Death|1|||
155032536|NCT03226678|559546582|FG003|Part A (Core Study Phase)|Death|0|||
155032537|NCT03226678|559546583|FG004|Part A (Core Study Phase)|Death|0|||
155032538|NCT03226678|559546584|FG005|Part A (Core Study Phase)|Death|0|||
155143016|NCT02663622|559954055|FG002|Overall Study|Death|1|||
155143017|NCT02663622|559954056|FG003|Overall Study|Death|8|||
155143018|NCT02663622|559954053|FG000|Overall Study|Protocol Violation|0|||
155032539|NCT03226678|559546579|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
155032540|NCT03226678|559546580|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
155032541|NCT03226678|559546581|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
155032542|NCT03226678|559546582|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
155032543|NCT03226678|559546583|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
155032544|NCT03226678|559546584|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
155032545|NCT03226678|559546579|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155032546|NCT03226678|559546580|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155032547|NCT03226678|559546581|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
155032548|NCT03226678|559546582|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155032549|NCT03226678|559546583|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155032550|NCT03226678|559546584|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
155032551|NCT03226678|559546579|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155143019|NCT02663622|559954054|FG001|Overall Study|Protocol Violation|0|||
155032552|NCT03226678|559546580|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155032553|NCT03226678|559546581|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155032554|NCT03226678|559546582|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
155032555|NCT03226678|559546583|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155032556|NCT03226678|559546584|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
155032557|NCT03226678|559546579|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
155032558|NCT03226678|559546580|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
155032559|NCT03226678|559546581|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155032560|NCT03226678|559546582|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155032561|NCT03226678|559546583|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155032562|NCT03226678|559546584|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
155032563|NCT03226678|559546579|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155032564|NCT03226678|559546580|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155032565|NCT03226678|559546581|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155032566|NCT03226678|559546582|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
155032567|NCT03226678|559546583|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
155032568|NCT03226678|559546584|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
155032569|NCT03226678|559546579|FG000|Part B (Long-Term Extension Phase)|Death|0|||
155032570|NCT03226678|559546580|FG001|Part B (Long-Term Extension Phase)|Death|0|||
155032571|NCT03226678|559546581|FG002|Part B (Long-Term Extension Phase)|Death|0|||
155032572|NCT03226678|559546582|FG003|Part B (Long-Term Extension Phase)|Death|0|||
155032573|NCT03226678|559546583|FG004|Part B (Long-Term Extension Phase)|Death|0|||
155032574|NCT03226678|559546584|FG005|Part B (Long-Term Extension Phase)|Death|1|||
155032575|NCT03226678|559546579|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155032576|NCT03226678|559546580|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155032577|NCT03226678|559546581|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155032578|NCT03226678|559546582|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155032579|NCT03226678|559546583|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
155032580|NCT03226678|559546584|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
155032581|NCT03226678|559546579|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155032582|NCT03226678|559546580|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155032583|NCT03226678|559546581|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155032584|NCT03226678|559546582|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
155032585|NCT03226678|559546583|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
155032586|NCT03226678|559546584|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
155032587|NCT03226678|559546579|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155032588|NCT03226678|559546580|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155032589|NCT03226678|559546581|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155032590|NCT03226678|559546582|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155032591|NCT03226678|559546583|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
155032592|NCT03226678|559546584|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
155032593|NCT01371877|559546585|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
155032594|NCT01371877|559546586|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
155032595|NCT03427268|559546587|FG000|Overall Study|Progressive disease|25|||
155032596|NCT03427268|559546587|FG000|Overall Study|Never treated|2|||
155032597|NCT03427268|559546587|FG000|Overall Study|Compassionate use|1|||
155032598|NCT03427268|559546587|FG000|Overall Study|Withdrawal by Subject|1|||
155032599|NCT03427268|559546587|FG000|Overall Study|Adverse Event|3|||
155032600|NCT03605849|559546593|FG000|Overall Study|Adverse Event|20|||
155032601|NCT03605849|559546594|FG001|Overall Study|Adverse Event|21|||
155032602|NCT03605849|559546595|FG002|Overall Study|Adverse Event|29|||
155032603|NCT03605849|559546596|FG003|Overall Study|Adverse Event|11|||
155032604|NCT03605849|559546593|FG000|Overall Study|Lack of Efficacy|4|||
155032605|NCT03605849|559546594|FG001|Overall Study|Lack of Efficacy|7|||
155032606|NCT03605849|559546595|FG002|Overall Study|Lack of Efficacy|9|||
155032607|NCT03605849|559546596|FG003|Overall Study|Lack of Efficacy|2|||
155032608|NCT03605849|559546593|FG000|Overall Study|Lost to Follow-up|8|||
155032609|NCT03605849|559546594|FG001|Overall Study|Lost to Follow-up|8|||
155032610|NCT03605849|559546595|FG002|Overall Study|Lost to Follow-up|14|||
155032611|NCT03605849|559546596|FG003|Overall Study|Lost to Follow-up|11|||
155032612|NCT03605849|559546593|FG000|Overall Study|Non-compliance With IMP|6|||
155032613|NCT03605849|559546594|FG001|Overall Study|Non-compliance With IMP|5|||
155032614|NCT03605849|559546595|FG002|Overall Study|Non-compliance With IMP|2|||
155032615|NCT03605849|559546596|FG003|Overall Study|Non-compliance With IMP|1|||
155032616|NCT03605849|559546593|FG000|Overall Study|Protocol Deviation|1|||
155032617|NCT03605849|559546594|FG001|Overall Study|Protocol Deviation|2|||
155032618|NCT03605849|559546595|FG002|Overall Study|Protocol Deviation|1|||
155032619|NCT03605849|559546596|FG003|Overall Study|Protocol Deviation|3|||
155032620|NCT03605849|559546593|FG000|Overall Study|Withdrawal by Subject|33|||
155032621|NCT03605849|559546594|FG001|Overall Study|Withdrawal by Subject|28|||
155032622|NCT03605849|559546595|FG002|Overall Study|Withdrawal by Subject|30|||
155032623|NCT03605849|559546596|FG003|Overall Study|Withdrawal by Subject|28|||
155032624|NCT03605849|559546593|FG000|Overall Study|Site Terminated by Sponsor|0|||
155032625|NCT03605849|559546594|FG001|Overall Study|Site Terminated by Sponsor|0|||
155032626|NCT03605849|559546595|FG002|Overall Study|Site Terminated by Sponsor|0|||
155032627|NCT03605849|559546596|FG003|Overall Study|Site Terminated by Sponsor|1|||
155032628|NCT03605849|559546593|FG000|Overall Study|Physician Decision|2|||
155032629|NCT03605849|559546594|FG001|Overall Study|Physician Decision|1|||
155032630|NCT03605849|559546595|FG002|Overall Study|Physician Decision|2|||
155032631|NCT03605849|559546596|FG003|Overall Study|Physician Decision|1|||
155032632|NCT03605849|559546593|FG000|Overall Study|Enrolled, but not Treated|2|||
155032633|NCT03605849|559546594|FG001|Overall Study|Enrolled, but not Treated|2|||
155032634|NCT03605849|559546595|FG002|Overall Study|Enrolled, but not Treated|3|||
155032635|NCT03605849|559546596|FG003|Overall Study|Enrolled, but not Treated|2|||
155032636|NCT03605849|559546593|FG000|Overall Study|Other (COVID-19 Related)|0|||
155032637|NCT03605849|559546594|FG001|Overall Study|Other (COVID-19 Related)|1|||
155032638|NCT03605849|559546595|FG002|Overall Study|Other (COVID-19 Related)|1|||
155032639|NCT03605849|559546596|FG003|Overall Study|Other (COVID-19 Related)|0|||
155032640|NCT03605849|559546593|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
155032641|NCT03605849|559546594|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
155032642|NCT03605849|559546595|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
155032643|NCT03605849|559546596|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
155032644|NCT02045732|559546601|FG000|Overall Study|At the discretion of the investigator|1|||
155032645|NCT02045732|559546602|FG001|Overall Study|At the discretion of the investigator|1|||
155032646|NCT06303167|559546607|FG000|Overall Study|Ineligible|1|||
155032647|NCT06303167|559546607|FG000|Overall Study|Never start protocol therapy|2|||
155032648|NCT06303167|559546607|FG000|Overall Study|Disease progression|16|||
155032649|NCT01877551|559546608|FG000|Overall Study|Physician Decision|0|||
155032650|NCT01877551|559546609|FG001|Overall Study|Physician Decision|1|||
155032651|NCT02659514|559546610|FG000|Overall Study|Adverse Event|3|||
155032652|NCT02659514|559546611|FG001|Overall Study|Adverse Event|12|||
155032653|NCT02659514|559546610|FG000|Overall Study|Disease Progression|23|||
155032654|NCT02659514|559546611|FG001|Overall Study|Disease Progression|13|||
155032655|NCT02659514|559546610|FG000|Overall Study|Withdrawal by Subject|0|||
155032656|NCT02659514|559546611|FG001|Overall Study|Withdrawal by Subject|4|||
155032657|NCT02659514|559546610|FG000|Overall Study|Lost to Follow-up|0|||
155032658|NCT02659514|559546611|FG001|Overall Study|Lost to Follow-up|1|||
155032659|NCT02659514|559546610|FG000|Overall Study|Death|6|||
155032660|NCT02659514|559546611|FG001|Overall Study|Death|1|||
155032661|NCT02659514|559546610|FG000|Overall Study|Reason Unspecified|0|||
155032662|NCT02659514|559546611|FG001|Overall Study|Reason Unspecified|3|||
155032663|NCT04186806|559546614|FG000|Period 1: 7 Days|Adverse Event|1|||
155032664|NCT04186806|559546615|FG001|Period 1: 7 Days|Adverse Event|0|||
155032665|NCT03687372|559546619|FG000|Overall Study|Lost to Follow-up|12|||
155032666|NCT03687372|559546620|FG001|Overall Study|Lost to Follow-up|21|||
155032667|NCT03687372|559546619|FG000|Overall Study|Withdrawal by Subject|4|||
155032668|NCT03687372|559546620|FG001|Overall Study|Withdrawal by Subject|17|||
155032669|NCT03687372|559546619|FG000|Overall Study|Investigator Decision|1|||
155032670|NCT03687372|559546620|FG001|Overall Study|Investigator Decision|1|||
155032671|NCT01701193|559546621|FG000|Overall Study|Withdrawal by Subject|2|||
155032672|NCT01701193|559546622|FG001|Overall Study|Withdrawal by Subject|2|||
155032673|NCT01701193|559546623|FG002|Overall Study|Withdrawal by Subject|1|||
155032674|NCT01701193|559546624|FG003|Overall Study|Withdrawal by Subject|2|||
155032675|NCT01701193|559546621|FG000|Overall Study|Adverse Event|1|||
155032676|NCT01701193|559546622|FG001|Overall Study|Adverse Event|0|||
155032677|NCT01701193|559546623|FG002|Overall Study|Adverse Event|0|||
155032678|NCT01701193|559546624|FG003|Overall Study|Adverse Event|0|||
155032679|NCT02720744|559546625|FG000|Overall Study|Protocol Violation|0|||
155032680|NCT02720744|559546626|FG001|Overall Study|Protocol Violation|2|||
155032681|NCT02720744|559546625|FG000|Overall Study|Pregnancy|2|||
155032682|NCT02720744|559546626|FG001|Overall Study|Pregnancy|0|||
155032683|NCT02720744|559546625|FG000|Overall Study|Lack of Efficacy|2|||
155032684|NCT02720744|559546626|FG001|Overall Study|Lack of Efficacy|8|||
155032685|NCT02720744|559546625|FG000|Overall Study|Adverse Event|21|||
155032686|NCT02720744|559546626|FG001|Overall Study|Adverse Event|3|||
155032687|NCT02720744|559546625|FG000|Overall Study|Withdrawal by Subject|11|||
155032688|NCT02720744|559546626|FG001|Overall Study|Withdrawal by Subject|11|||
155032689|NCT02720744|559546625|FG000|Overall Study|Lost to follow up|2|||
155032690|NCT02720744|559546626|FG001|Overall Study|Lost to follow up|0|||
155032691|NCT02720744|559546625|FG000|Overall Study|Non Compliance with Investigational Product|0|||
155032692|NCT02720744|559546626|FG001|Overall Study|Non Compliance with Investigational Product|1|||
155032693|NCT02720744|559546625|FG000|Overall Study|Excluded Concomitant Medication|0|||
155032694|NCT02720744|559546626|FG001|Overall Study|Excluded Concomitant Medication|1|||
155032695|NCT01482962|559546627|FG000|Overall Study|Progressive Disease|65|||
155032696|NCT01482962|559546628|FG001|Overall Study|Progressive Disease|53|||
155143020|NCT02663622|559954055|FG002|Overall Study|Protocol Violation|0|||
155143021|NCT02663622|559954056|FG003|Overall Study|Protocol Violation|1|||
155032697|NCT01482962|559546627|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
155032698|NCT01482962|559546628|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
155032699|NCT01482962|559546627|FG000|Overall Study|Adverse Event|18|||
155032700|NCT01482962|559546628|FG001|Overall Study|Adverse Event|22|||
155032701|NCT01482962|559546627|FG000|Overall Study|Withdrawal by Participant|8|||
155032702|NCT01482962|559546628|FG001|Overall Study|Withdrawal by Participant|13|||
155032703|NCT01482962|559546627|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
155032704|NCT01482962|559546628|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
155032705|NCT01482962|559546627|FG000|Overall Study|Other Reason|1|||
155032706|NCT01482962|559546628|FG001|Overall Study|Other Reason|5|||
155032707|NCT01482962|559546627|FG000|Overall Study|Study Terminated by Sponsor|5|||
155032708|NCT01482962|559546628|FG001|Overall Study|Study Terminated by Sponsor|2|||
155032709|NCT01482962|559546627|FG000|Overall Study|Did not Receive Study Drug|1|||
155032710|NCT01482962|559546628|FG001|Overall Study|Did not Receive Study Drug|6|||
155032711|NCT02407457|559546629|FG000|1 Month|Death|3|||
155032712|NCT02407457|559546630|FG001|1 Month|Death|0|||
155032713|NCT02407457|559546629|FG000|1 Month|Lost to Follow-up|1|||
155032714|NCT02407457|559546630|FG001|1 Month|Lost to Follow-up|1|||
155032715|NCT02407457|559546629|FG000|1 Month|missed visit|2|||
155032716|NCT02407457|559546630|FG001|1 Month|missed visit|5|||
155032717|NCT02407457|559546629|FG000|6-Month|Death|2|||
155032718|NCT02407457|559546630|FG001|6-Month|Death|8|||
155032719|NCT02407457|559546629|FG000|6-Month|Lost to Follow-up|2|||
155032720|NCT02407457|559546630|FG001|6-Month|Lost to Follow-up|2|||
155032721|NCT02407457|559546629|FG000|6-Month|missed visit|16|||
155032722|NCT02407457|559546630|FG001|6-Month|missed visit|14|||
155032723|NCT02407457|559546629|FG000|6-Month|Open Repair|0|||
155032724|NCT02407457|559546630|FG001|6-Month|Open Repair|1|||
155032725|NCT02407457|559546629|FG000|1 Year|Death|6|||
155032726|NCT02407457|559546630|FG001|1 Year|Death|11|||
155032727|NCT02407457|559546629|FG000|1 Year|Lost to Follow-up|3|||
155032728|NCT02407457|559546630|FG001|1 Year|Lost to Follow-up|2|||
155032729|NCT02407457|559546629|FG000|1 Year|Missed Visit|24|||
155032730|NCT02407457|559546630|FG001|1 Year|Missed Visit|14|||
155032731|NCT02407457|559546629|FG000|1 Year|Open Repair|0|||
155032732|NCT02407457|559546630|FG001|1 Year|Open Repair|1|||
155032733|NCT02407457|559546629|FG000|2-year|Death|14|||
155032734|NCT02407457|559546630|FG001|2-year|Death|8|||
155032735|NCT02407457|559546629|FG000|2-year|Lost to Follow-up|7|||
155032736|NCT02407457|559546630|FG001|2-year|Lost to Follow-up|10|||
155032737|NCT02407457|559546629|FG000|2-year|Missed Visit|13|||
155032738|NCT02407457|559546630|FG001|2-year|Missed Visit|15|||
155032739|NCT02407457|559546629|FG000|2-year|Open Repair|0|||
155032740|NCT02407457|559546630|FG001|2-year|Open Repair|2|||
155032741|NCT02407457|559546629|FG000|3-year|Death|11|||
155032742|NCT02407457|559546630|FG001|3-year|Death|10|||
155032743|NCT02407457|559546629|FG000|3-year|Lost to Follow-up|9|||
155032744|NCT02407457|559546630|FG001|3-year|Lost to Follow-up|10|||
155032745|NCT02407457|559546629|FG000|3-year|Missed Visit|19|||
155032746|NCT02407457|559546630|FG001|3-year|Missed Visit|16|||
155032747|NCT02407457|559546629|FG000|4-year|Death|18|||
155032748|NCT02407457|559546630|FG001|4-year|Death|10|||
155032749|NCT02407457|559546629|FG000|4-year|Lost to Follow-up|10|||
155032750|NCT02407457|559546630|FG001|4-year|Lost to Follow-up|12|||
155032751|NCT02407457|559546629|FG000|4-year|Missed Visit|18|||
155032752|NCT02407457|559546630|FG001|4-year|Missed Visit|16|||
155032753|NCT02407457|559546629|FG000|5-year|Death|10|||
155032754|NCT02407457|559546630|FG001|5-year|Death|3|||
155032755|NCT02407457|559546629|FG000|5-year|Lost to Follow-up|22|||
155032756|NCT02407457|559546630|FG001|5-year|Lost to Follow-up|13|||
155032757|NCT02407457|559546629|FG000|5-year|Missed Visit|9|||
155032758|NCT02407457|559546630|FG001|5-year|Missed Visit|1|||
155032759|NCT06137703|559546631|FG000|Overall Study|Other|0|||
155032760|NCT06137703|559546632|FG001|Overall Study|Other|1|||
155032761|NCT06137703|559546633|FG002|Overall Study|Other|0|||
155032762|NCT06137703|559546634|FG003|Overall Study|Other|0|||
155032763|NCT06137703|559546631|FG000|Overall Study|Adverse Event|0|||
155032764|NCT06137703|559546632|FG001|Overall Study|Adverse Event|0|||
155032765|NCT06137703|559546633|FG002|Overall Study|Adverse Event|1|||
155032766|NCT06137703|559546634|FG003|Overall Study|Adverse Event|0|||
155032767|NCT01801358|559546637|FG000|Overall Study|Adverse Event|0|||
155032768|NCT01801358|559546638|FG001|Overall Study|Adverse Event|2|||
155032769|NCT01801358|559546639|FG002|Overall Study|Adverse Event|1|||
155143022|NCT00163020|559954059|FG000|Overall Study|Lost to Follow-up|0|||
155143023|NCT00163020|559954060|FG001|Overall Study|Lost to Follow-up|2|||
155143024|NCT01633788|559956855|FG000|Overall Study|Adverse Event|1|||
155032770|NCT01801358|559546640|FG003|Overall Study|Adverse Event|0|||
155032771|NCT01801358|559546641|FG004|Overall Study|Adverse Event|0|||
155032772|NCT01801358|559546642|FG005|Overall Study|Adverse Event|1|||
155032773|NCT01801358|559546637|FG000|Overall Study|Physician Decision|0|||
155032774|NCT01801358|559546638|FG001|Overall Study|Physician Decision|0|||
155032775|NCT01801358|559546639|FG002|Overall Study|Physician Decision|1|||
155032776|NCT01801358|559546640|FG003|Overall Study|Physician Decision|0|||
155032777|NCT01801358|559546641|FG004|Overall Study|Physician Decision|0|||
155032778|NCT01801358|559546642|FG005|Overall Study|Physician Decision|0|||
155032779|NCT01801358|559546637|FG000|Overall Study|Progressive Disease|6|||
155143025|NCT01633788|559956856|FG001|Overall Study|Adverse Event|3|||
155032780|NCT01801358|559546638|FG001|Overall Study|Progressive Disease|4|||
155032781|NCT01801358|559546639|FG002|Overall Study|Progressive Disease|4|||
155032782|NCT01801358|559546640|FG003|Overall Study|Progressive Disease|5|||
155032783|NCT01801358|559546641|FG004|Overall Study|Progressive Disease|6|||
155032784|NCT01801358|559546642|FG005|Overall Study|Progressive Disease|5|||
155032785|NCT01801358|559546637|FG000|Overall Study|Withdrawal by Subject|0|||
155032786|NCT01801358|559546638|FG001|Overall Study|Withdrawal by Subject|0|||
155032787|NCT01801358|559546639|FG002|Overall Study|Withdrawal by Subject|0|||
155032788|NCT01801358|559546640|FG003|Overall Study|Withdrawal by Subject|1|||
155032789|NCT01801358|559546641|FG004|Overall Study|Withdrawal by Subject|0|||
155032790|NCT01801358|559546642|FG005|Overall Study|Withdrawal by Subject|2|||
155032791|NCT01210495|559546645|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
155032792|NCT01210495|559546646|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
155032793|NCT01210495|559546647|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
155032794|NCT01210495|559546648|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
155032795|NCT01210495|559546645|FG000|Overall Study|Death|14|||
155032796|NCT01210495|559546646|FG001|Overall Study|Death|7|||
155032797|NCT01210495|559546647|FG002|Overall Study|Death|112|||
155032798|NCT01210495|559546648|FG003|Overall Study|Death|54|||
155032799|NCT01210495|559546645|FG000|Overall Study|Study Terminated by Sponsor|0|||
155032800|NCT01210495|559546646|FG001|Overall Study|Study Terminated by Sponsor|0|||
155032801|NCT01210495|559546647|FG002|Overall Study|Study Terminated by Sponsor|4|||
155032802|NCT01210495|559546648|FG003|Overall Study|Study Terminated by Sponsor|11|||
155032803|NCT01210495|559546645|FG000|Overall Study|Lost to Follow-up|0|||
155032804|NCT01210495|559546646|FG001|Overall Study|Lost to Follow-up|0|||
155032805|NCT01210495|559546647|FG002|Overall Study|Lost to Follow-up|1|||
155032806|NCT01210495|559546648|FG003|Overall Study|Lost to Follow-up|1|||
155032807|NCT01210495|559546645|FG000|Overall Study|Other unspecified|0|||
155032808|NCT01210495|559546646|FG001|Overall Study|Other unspecified|0|||
155032809|NCT01210495|559546647|FG002|Overall Study|Other unspecified|6|||
155032810|NCT01210495|559546648|FG003|Overall Study|Other unspecified|0|||
155032811|NCT01384019|559546651|FG000|Overall Study|Withdrawal by Subject|3|||
155032812|NCT01384019|559546652|FG001|Overall Study|Withdrawal by Subject|0|||
155032813|NCT01384019|559546651|FG000|Overall Study|Death|1|||
155032814|NCT01384019|559546652|FG001|Overall Study|Death|0|||
155032815|NCT01384019|559546651|FG000|Overall Study|MRI refusal|6|||
155032816|NCT01384019|559546652|FG001|Overall Study|MRI refusal|6|||
155032817|NCT04416737|559546653|FG000|Week 1 (First Injection)|Physician Decision|0|||
155032818|NCT04416737|559546654|FG001|Week 1 (First Injection)|Physician Decision|1|||
155032819|NCT03332628|559546655|FG000|Overall Study|Physician Decision|2|||
155032820|NCT01472757|559546661|FG000|Overall Study|Withdrawal by Subject|1|||
155032821|NCT01472757|559546662|FG001|Overall Study|Withdrawal by Subject|2|||
155032822|NCT01472757|559546663|FG002|Overall Study|Withdrawal by Subject|2|||
155032823|NCT01472757|559546664|FG003|Overall Study|Withdrawal by Subject|0|||
155032824|NCT01472757|559546661|FG000|Overall Study|Asthma exacerbation|4|||
155032825|NCT01472757|559546662|FG001|Overall Study|Asthma exacerbation|1|||
155032826|NCT01472757|559546663|FG002|Overall Study|Asthma exacerbation|2|||
155032827|NCT01472757|559546664|FG003|Overall Study|Asthma exacerbation|1|||
155032828|NCT01472757|559546661|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
155032829|NCT01472757|559546662|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
155143026|NCT01633788|559956857|FG002|Overall Study|Adverse Event|3|||
155143027|NCT01633788|559956858|FG003|Overall Study|Adverse Event|3|||
155143028|NCT01633788|559956855|FG000|Overall Study|Lost to Follow-up|2|||
155143029|NCT01633788|559956856|FG001|Overall Study|Lost to Follow-up|2|||
155143030|NCT01633788|559956857|FG002|Overall Study|Lost to Follow-up|2|||
155143031|NCT01633788|559956858|FG003|Overall Study|Lost to Follow-up|0|||
155143032|NCT01633788|559956855|FG000|Overall Study|Personal Reasons|3|||
155143033|NCT01633788|559956856|FG001|Overall Study|Personal Reasons|1|||
155143034|NCT01633788|559956857|FG002|Overall Study|Personal Reasons|1|||
155032830|NCT01472757|559546663|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
155032831|NCT01472757|559546664|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
155032832|NCT01472757|559546661|FG000|Overall Study|Protocol Violation|3|||
155032833|NCT01472757|559546662|FG001|Overall Study|Protocol Violation|2|||
155032834|NCT01472757|559546663|FG002|Overall Study|Protocol Violation|4|||
155032835|NCT01472757|559546664|FG003|Overall Study|Protocol Violation|4|||
155032836|NCT01472757|559546661|FG000|Overall Study|Other reasons|1|||
155032837|NCT01472757|559546662|FG001|Overall Study|Other reasons|0|||
155032838|NCT01472757|559546663|FG002|Overall Study|Other reasons|2|||
155032839|NCT01472757|559546664|FG003|Overall Study|Other reasons|2|||
155032840|NCT01549041|559546669|FG000|Overall Study|Lack of Efficacy|2|||
155032841|NCT01549041|559546670|FG001|Overall Study|Lack of Efficacy|4|||
155032842|NCT01549041|559546669|FG000|Overall Study|Adverse Event|0|||
155032843|NCT01549041|559546670|FG001|Overall Study|Adverse Event|4|||
155032844|NCT02543892|559546671|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
155032845|NCT02543892|559546672|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
155032846|NCT02543892|559546673|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
155143035|NCT01633788|559956858|FG003|Overall Study|Personal Reasons|3|||
155143036|NCT01633788|559956855|FG000|Overall Study|Protocol Violation|1|||
155032847|NCT02543892|559546674|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
155032848|NCT02543892|559546675|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
155032849|NCT02543892|559546676|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
155032850|NCT02543892|559546677|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
155032851|NCT02543892|559546678|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
155032852|NCT02543892|559546671|FG000|Received Vaccination 2|Physician Decision|0|||
155032853|NCT02543892|559546672|FG001|Received Vaccination 2|Physician Decision|0|||
155032854|NCT02543892|559546673|FG002|Received Vaccination 2|Physician Decision|0|||
155032855|NCT02543892|559546674|FG003|Received Vaccination 2|Physician Decision|0|||
155032856|NCT02543892|559546675|FG004|Received Vaccination 2|Physician Decision|0|||
155032857|NCT02543892|559546676|FG005|Received Vaccination 2|Physician Decision|1|||
155032858|NCT02543892|559546677|FG006|Received Vaccination 2|Physician Decision|0|||
155032859|NCT02543892|559546678|FG007|Received Vaccination 2|Physician Decision|0|||
155032860|NCT02543892|559546671|FG000|Received Vaccination 2|Adverse Event|0|||
155032861|NCT02543892|559546672|FG001|Received Vaccination 2|Adverse Event|1|||
155032862|NCT02543892|559546673|FG002|Received Vaccination 2|Adverse Event|0|||
155032863|NCT02543892|559546674|FG003|Received Vaccination 2|Adverse Event|0|||
155032864|NCT02543892|559546675|FG004|Received Vaccination 2|Adverse Event|0|||
155032865|NCT02543892|559546676|FG005|Received Vaccination 2|Adverse Event|0|||
155032866|NCT02543892|559546677|FG006|Received Vaccination 2|Adverse Event|0|||
155032867|NCT02543892|559546678|FG007|Received Vaccination 2|Adverse Event|0|||
155032868|NCT02543892|559546671|FG000|Had Immunology Data|Withdrawal by Subject|0|||
155032869|NCT02543892|559546672|FG001|Had Immunology Data|Withdrawal by Subject|0|||
155032870|NCT02543892|559546673|FG002|Had Immunology Data|Withdrawal by Subject|0|||
155032871|NCT02543892|559546674|FG003|Had Immunology Data|Withdrawal by Subject|0|||
155032872|NCT02543892|559546675|FG004|Had Immunology Data|Withdrawal by Subject|0|||
155032873|NCT02543892|559546676|FG005|Had Immunology Data|Withdrawal by Subject|0|||
155032874|NCT02543892|559546677|FG006|Had Immunology Data|Withdrawal by Subject|1|||
155032875|NCT02543892|559546678|FG007|Had Immunology Data|Withdrawal by Subject|0|||
155032876|NCT00526331|559546679|FG000|Overall Study|Sponsor Termination|55|||
155032877|NCT01259375|559546681|FG000|Overall Study|Adverse Event|1|||
155032878|NCT00628095|559546682|FG000|Overall Study|Adverse Event|5|||
155032879|NCT00628095|559546683|FG001|Overall Study|Adverse Event|3|||
155032880|NCT00628095|559546682|FG000|Overall Study|Lack of Efficacy|0|||
155032881|NCT00628095|559546683|FG001|Overall Study|Lack of Efficacy|3|||
155032882|NCT00628095|559546682|FG000|Overall Study|Withdrawal by Subject|2|||
155032883|NCT00628095|559546683|FG001|Overall Study|Withdrawal by Subject|0|||
155032884|NCT00628095|559546682|FG000|Overall Study|Other|0|||
155032885|NCT00628095|559546683|FG001|Overall Study|Other|1|||
155032886|NCT03932331|559546690|FG000|Overall Study|Death|0|||
155032887|NCT03932331|559546691|FG001|Overall Study|Death|7|||
155032888|NCT03932331|559546692|FG002|Overall Study|Death|2|||
155032889|NCT03932331|559546690|FG000|Overall Study|Withdrawal by Subject|0|||
155032890|NCT03932331|559546691|FG001|Overall Study|Withdrawal by Subject|3|||
155032891|NCT03932331|559546692|FG002|Overall Study|Withdrawal by Subject|0|||
155032892|NCT03932331|559546690|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
155032893|NCT03932331|559546691|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
155032894|NCT03932331|559546692|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
155032895|NCT03932331|559546690|FG000|Overall Study|Progressive disease|3|||
155032896|NCT03932331|559546691|FG001|Overall Study|Progressive disease|0|||
155032897|NCT03932331|559546692|FG002|Overall Study|Progressive disease|0|||
155032898|NCT03932331|559546690|FG000|Overall Study|Lung infection|1|||
155032899|NCT03932331|559546691|FG001|Overall Study|Lung infection|0|||
155032900|NCT03932331|559546692|FG002|Overall Study|Lung infection|0|||
155032901|NCT03932331|559546690|FG000|Overall Study|Other|0|||
155032902|NCT03932331|559546691|FG001|Overall Study|Other|0|||
155032903|NCT03932331|559546692|FG002|Overall Study|Other|58|||
155032904|NCT00347919|559546693|FG000|Overall Study|Lost to Follow-up|11|||
155032905|NCT00347919|559546694|FG001|Overall Study|Lost to Follow-up|13|||
155032906|NCT00347919|559546695|FG002|Overall Study|Lost to Follow-up|0|||
155032907|NCT00347919|559546693|FG000|Overall Study|Withdrawal by Subject|6|||
155143037|NCT01633788|559956856|FG001|Overall Study|Protocol Violation|0|||
155143038|NCT01633788|559956857|FG002|Overall Study|Protocol Violation|1|||
155143039|NCT01633788|559956858|FG003|Overall Study|Protocol Violation|0|||
155143040|NCT01633788|559956855|FG000|Overall Study|Other Reasons|0|||
155032908|NCT00347919|559546694|FG001|Overall Study|Withdrawal by Subject|8|||
155032909|NCT00347919|559546695|FG002|Overall Study|Withdrawal by Subject|0|||
155032910|NCT00347919|559546693|FG000|Overall Study|Physician Decision|1|||
155032911|NCT00347919|559546694|FG001|Overall Study|Physician Decision|1|||
155032912|NCT00347919|559546695|FG002|Overall Study|Physician Decision|0|||
155032913|NCT00347919|559546693|FG000|Overall Study|Sponsor terminated study|15|||
155032914|NCT00347919|559546694|FG001|Overall Study|Sponsor terminated study|10|||
155032915|NCT00347919|559546695|FG002|Overall Study|Sponsor terminated study|16|||
155032916|NCT00347919|559546693|FG000|Overall Study|Death|35|||
155032917|NCT00347919|559546694|FG001|Overall Study|Death|42|||
155032918|NCT00347919|559546695|FG002|Overall Study|Death|19|||
155032919|NCT00347919|559546693|FG000|Overall Study|Par. Started Other Treatment|1|||
155032920|NCT00347919|559546694|FG001|Overall Study|Par. Started Other Treatment|1|||
155032921|NCT00347919|559546695|FG002|Overall Study|Par. Started Other Treatment|1|||
155032922|NCT00347919|559546693|FG000|Overall Study|Missing|2|||
155032923|NCT00347919|559546694|FG001|Overall Study|Missing|1|||
155032924|NCT00347919|559546695|FG002|Overall Study|Missing|2|||
155032925|NCT03379753|559546696|FG000|Overall Study|Withdrawal by Subject|2|||
155032926|NCT03379753|559546697|FG001|Overall Study|Withdrawal by Subject|1|||
155032927|NCT03379753|559546696|FG000|Overall Study|not having correct procedure|1|||
155032928|NCT03379753|559546697|FG001|Overall Study|not having correct procedure|2|||
155032929|NCT03379753|559546696|FG000|Overall Study|No primary outcome|12|||
155032930|NCT03379753|559546697|FG001|Overall Study|No primary outcome|22|||
155032931|NCT02225366|559546704|FG000|Overall Study|Lack of Efficacy|1|||
155032932|NCT02225366|559546705|FG001|Overall Study|Lack of Efficacy|0|||
155032933|NCT00742508|559546706|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
155032934|NCT00742508|559546707|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
155032935|NCT00742508|559546706|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
155032936|NCT00742508|559546707|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
155032937|NCT00742508|559546706|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
155032938|NCT00742508|559546707|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
155032939|NCT00742508|559546706|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
155032940|NCT00742508|559546707|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
155032941|NCT00742508|559546706|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
155032942|NCT00742508|559546707|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
155032943|NCT03619902|559546710|FG000|Overall Study|Termination of Study by Investigator|1|||
155032944|NCT03619902|559546710|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
155032945|NCT04450407|559546711|FG000|Overall Study|Withdrawal by Subject|10|||
155032946|NCT04450407|559546712|FG001|Overall Study|Withdrawal by Subject|1|||
155032947|NCT04450407|559546713|FG002|Overall Study|Withdrawal by Subject|4|||
155032948|NCT04450407|559546711|FG000|Overall Study|Adverse Event|0|||
155032949|NCT04450407|559546712|FG001|Overall Study|Adverse Event|0|||
155032950|NCT04450407|559546713|FG002|Overall Study|Adverse Event|1|||
155032951|NCT04450407|559546711|FG000|Overall Study|Lost to Follow-up|1|||
155032952|NCT04450407|559546712|FG001|Overall Study|Lost to Follow-up|0|||
155032953|NCT04450407|559546713|FG002|Overall Study|Lost to Follow-up|0|||
155032954|NCT04450407|559546711|FG000|Overall Study|Physician Decision|0|||
155032955|NCT04450407|559546712|FG001|Overall Study|Physician Decision|0|||
155032956|NCT04450407|559546713|FG002|Overall Study|Physician Decision|1|||
155032957|NCT04450407|559546711|FG000|Overall Study|Pregnancy|1|||
155032958|NCT04450407|559546712|FG001|Overall Study|Pregnancy|0|||
155032959|NCT04450407|559546713|FG002|Overall Study|Pregnancy|0|||
155032960|NCT04450407|559546711|FG000|Overall Study|Protocol Violation|2|||
155032961|NCT04450407|559546712|FG001|Overall Study|Protocol Violation|0|||
155032962|NCT04450407|559546713|FG002|Overall Study|Protocol Violation|0|||
155032963|NCT04450407|559546711|FG000|Overall Study|Investigational site terminated by sponsor|3|||
155032964|NCT04450407|559546712|FG001|Overall Study|Investigational site terminated by sponsor|0|||
155032965|NCT04450407|559546713|FG002|Overall Study|Investigational site terminated by sponsor|2|||
155032966|NCT02537431|559546715|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
155032967|NCT04676412|559548467|FG000|Overall Study|Death|28|||
155032968|NCT04676412|559548468|FG001|Overall Study|Death|31|||
155032969|NCT04676412|559548467|FG000|Overall Study|Lost to Follow-up|1|||
155032970|NCT04676412|559548468|FG001|Overall Study|Lost to Follow-up|2|||
155032971|NCT04676412|559548467|FG000|Overall Study|Sponsor Decision|20|||
155032972|NCT04676412|559548468|FG001|Overall Study|Sponsor Decision|23|||
155143041|NCT01633788|559956856|FG001|Overall Study|Other Reasons|2|||
155143042|NCT01633788|559956857|FG002|Overall Study|Other Reasons|3|||
155143043|NCT01633788|559956858|FG003|Overall Study|Other Reasons|7|||
155143044|NCT01389882|559956863|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
155143045|NCT01389882|559956864|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
155143046|NCT01389882|559956863|FG000|Overall Study|Withdrawal by Subject|0|||
155143047|NCT01389882|559956864|FG001|Overall Study|Withdrawal by Subject|1|||
155143048|NCT03790111|559956865|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
155143049|NCT03811340|559956868|FG000|Overall Study|subjects did not complete the survey.|90|||
155143050|NCT00280917|559956869|FG000|Overall Study|Adverse Event|1|||
155143051|NCT00280917|559956870|FG001|Overall Study|Adverse Event|1|||
155032973|NCT04676412|559548467|FG000|Overall Study|Withdrawal by Subject|0|||
155032974|NCT04676412|559548468|FG001|Overall Study|Withdrawal by Subject|2|||
155032975|NCT05741346|559548469|FG000|Overall Study|Withdrawn due to termination of study|28|||
155032976|NCT05906836|559548473|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
155032977|NCT05906836|559548473|FG000|Overall Study|Lost to Follow-up|1|||
155032978|NCT01458951|559548482|FG000|Overall Study|Other|1|||
155032979|NCT01458951|559548483|FG001|Overall Study|Other|0|||
155032980|NCT01458951|559548484|FG002|Overall Study|Other|0|||
155143052|NCT00280917|559956871|FG002|Overall Study|Adverse Event|4|||
155143053|NCT00280917|559956872|FG003|Overall Study|Adverse Event|1|||
155143054|NCT00280917|559956869|FG000|Overall Study|Change Therapy|1|||
155032981|NCT01458951|559548482|FG000|Overall Study|Protocol Violation|5|||
155032982|NCT01458951|559548483|FG001|Overall Study|Protocol Violation|1|||
155032983|NCT01458951|559548484|FG002|Overall Study|Protocol Violation|0|||
155032984|NCT01458951|559548482|FG000|Overall Study|Withdrawal by Subject|2|||
155032985|NCT01458951|559548483|FG001|Overall Study|Withdrawal by Subject|0|||
155032986|NCT01458951|559548484|FG002|Overall Study|Withdrawal by Subject|2|||
155032987|NCT01458951|559548482|FG000|Overall Study|Adverse Event|7|||
155032988|NCT01458951|559548483|FG001|Overall Study|Adverse Event|0|||
155032989|NCT01458951|559548484|FG002|Overall Study|Adverse Event|2|||
155032990|NCT01458951|559548482|FG000|Overall Study|Insufficient Clinical Response|17|||
155032991|NCT01458951|559548483|FG001|Overall Study|Insufficient Clinical Response|0|||
155032992|NCT01458951|559548484|FG002|Overall Study|Insufficient Clinical Response|11|||
155032993|NCT01668966|559548489|FG000|Overall Study|Withdrawal by Subject|1|||
155032994|NCT01668966|559548489|FG000|Overall Study|Death|1|||
155032995|NCT01668966|559548489|FG000|Overall Study|Not treated|2|||
155032996|NCT04392167|559548491|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
155032997|NCT01573767|559548492|FG000|Overall Study|Adverse Event|0|||
155032998|NCT01573767|559548493|FG001|Overall Study|Adverse Event|1|||
155032999|NCT01573767|559548494|FG002|Overall Study|Adverse Event|0|||
155033000|NCT01573767|559548495|FG003|Overall Study|Adverse Event|1|||
155033001|NCT01573767|559548492|FG000|Overall Study|Lack of Efficacy|18|||
155033002|NCT01573767|559548493|FG001|Overall Study|Lack of Efficacy|15|||
155033003|NCT01573767|559548494|FG002|Overall Study|Lack of Efficacy|12|||
155033004|NCT01573767|559548495|FG003|Overall Study|Lack of Efficacy|17|||
155033005|NCT01573767|559548492|FG000|Overall Study|Protocol Violation|3|||
155033006|NCT01573767|559548493|FG001|Overall Study|Protocol Violation|1|||
155033007|NCT01573767|559548494|FG002|Overall Study|Protocol Violation|1|||
155033008|NCT01573767|559548495|FG003|Overall Study|Protocol Violation|3|||
155033009|NCT01573767|559548492|FG000|Overall Study|Lost to Follow-up|0|||
155033010|NCT01573767|559548493|FG001|Overall Study|Lost to Follow-up|1|||
155033011|NCT01573767|559548494|FG002|Overall Study|Lost to Follow-up|1|||
155033012|NCT01573767|559548495|FG003|Overall Study|Lost to Follow-up|1|||
155033013|NCT01573767|559548492|FG000|Overall Study|Physician Decision|1|||
155033014|NCT01573767|559548493|FG001|Overall Study|Physician Decision|2|||
155033015|NCT01573767|559548494|FG002|Overall Study|Physician Decision|0|||
155033016|NCT01573767|559548495|FG003|Overall Study|Physician Decision|2|||
155033017|NCT01573767|559548492|FG000|Overall Study|Withdrawal by Subject|0|||
155033018|NCT01573767|559548493|FG001|Overall Study|Withdrawal by Subject|1|||
155033019|NCT01573767|559548494|FG002|Overall Study|Withdrawal by Subject|0|||
155033020|NCT01573767|559548495|FG003|Overall Study|Withdrawal by Subject|0|||
155033021|NCT02339155|559548496|FG000|Overall Study|Adverse Event|0|||
155033022|NCT02339155|559548497|FG001|Overall Study|Adverse Event|6|||
155033023|NCT02339155|559548496|FG000|Overall Study|Death|1|||
155033024|NCT02339155|559548497|FG001|Overall Study|Death|1|||
155033025|NCT02339155|559548496|FG000|Overall Study|Lost to Follow-up|8|||
155033026|NCT02339155|559548497|FG001|Overall Study|Lost to Follow-up|9|||
155033027|NCT02339155|559548496|FG000|Overall Study|Physician Decision|2|||
155033028|NCT02339155|559548497|FG001|Overall Study|Physician Decision|1|||
155033029|NCT02339155|559548496|FG000|Overall Study|Withdrawal by Subject|4|||
155033030|NCT02339155|559548497|FG001|Overall Study|Withdrawal by Subject|4|||
155033031|NCT04247880|559548498|FG000|Overall Study|Lost to Follow-up|24|||
155033032|NCT04247880|559548499|FG001|Overall Study|Lost to Follow-up|17|||
155033033|NCT04247880|559548498|FG000|Overall Study|Withdrawal by Subject|3|||
155033034|NCT04247880|559548499|FG001|Overall Study|Withdrawal by Subject|0|||
155033035|NCT04076059|559548502|FG000|Double Blind Phase|Progressive disease|22|||
155033036|NCT04076059|559548503|FG001|Double Blind Phase|Progressive disease|26|||
155033037|NCT04076059|559548504|FG002|Double Blind Phase|Progressive disease|0|||
155033038|NCT04076059|559548502|FG000|Double Blind Phase|Withdrawal by Subject|4|||
155033039|NCT04076059|559548503|FG001|Double Blind Phase|Withdrawal by Subject|11|||
155033040|NCT04076059|559548504|FG002|Double Blind Phase|Withdrawal by Subject|0|||
155033041|NCT04076059|559548502|FG000|Double Blind Phase|Death|1|||
155033042|NCT04076059|559548503|FG001|Double Blind Phase|Death|1|||
155033043|NCT04076059|559548504|FG002|Double Blind Phase|Death|0|||
155033044|NCT04076059|559548502|FG000|Double Blind Phase|Lost to Follow-up|1|||
155033045|NCT04076059|559548503|FG001|Double Blind Phase|Lost to Follow-up|0|||
155033046|NCT04076059|559548504|FG002|Double Blind Phase|Lost to Follow-up|0|||
155033047|NCT04076059|559548502|FG000|Double Blind Phase|Adverse Event|5|||
155033048|NCT04076059|559548503|FG001|Double Blind Phase|Adverse Event|1|||
155033049|NCT04076059|559548504|FG002|Double Blind Phase|Adverse Event|0|||
155033050|NCT04076059|559548502|FG000|Double Blind Phase|Ongoing Participants|82|||
155033051|NCT04076059|559548503|FG001|Double Blind Phase|Ongoing Participants|18|||
155033052|NCT04076059|559548504|FG002|Double Blind Phase|Ongoing Participants|0|||
155033053|NCT04076059|559548502|FG000|Double Blind Phase|Miscellaneous|3|||
155033054|NCT04076059|559548503|FG001|Double Blind Phase|Miscellaneous|1|||
155033055|NCT04076059|559548504|FG002|Double Blind Phase|Miscellaneous|0|||
155033056|NCT04076059|559548502|FG000|Double Blind Phase|Protocol Deviation|1|||
155033057|NCT04076059|559548503|FG001|Double Blind Phase|Protocol Deviation|1|||
155033058|NCT04076059|559548504|FG002|Double Blind Phase|Protocol Deviation|0|||
155033059|NCT04076059|559548502|FG000|Double Blind Phase|Did not take study drug|1|||
155033060|NCT04076059|559548503|FG001|Double Blind Phase|Did not take study drug|1|||
155033061|NCT04076059|559548504|FG002|Double Blind Phase|Did not take study drug|0|||
155033062|NCT04076059|559548502|FG000|Open Label Phase|Progressive disease|0|||
155033063|NCT04076059|559548503|FG001|Open Label Phase|Progressive disease|0|||
155033064|NCT04076059|559548504|FG002|Open Label Phase|Progressive disease|7|||
155033065|NCT04076059|559548502|FG000|Open Label Phase|Withdrawal by Subject|0|||
155033066|NCT04076059|559548503|FG001|Open Label Phase|Withdrawal by Subject|0|||
155033067|NCT04076059|559548504|FG002|Open Label Phase|Withdrawal by Subject|3|||
155033068|NCT04076059|559548502|FG000|Open Label Phase|Death|0|||
155033069|NCT04076059|559548503|FG001|Open Label Phase|Death|0|||
155033070|NCT04076059|559548504|FG002|Open Label Phase|Death|2|||
155033071|NCT04076059|559548502|FG000|Open Label Phase|Ongoing Participants|0|||
155033072|NCT04076059|559548503|FG001|Open Label Phase|Ongoing Participants|0|||
155033073|NCT04076059|559548504|FG002|Open Label Phase|Ongoing Participants|11|||
155033074|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Death|117|||
155033075|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Death|197|||
155033076|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
155033077|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
155033078|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
155033079|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
155033080|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
155033081|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
155033082|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
155033083|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
155033084|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
155033085|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
155033086|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
155033087|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
155033088|NCT02677896|559548505|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
155033089|NCT02677896|559548506|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
155033090|NCT02677896|559548505|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
155033091|NCT02677896|559548506|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
155033092|NCT02677896|559548505|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
155033093|NCT02677896|559548506|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
155033094|NCT02677896|559548505|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
155033095|NCT02677896|559548506|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
155033096|NCT02677896|559548505|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
155033097|NCT02677896|559548506|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
155033098|NCT02677896|559548505|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
155033099|NCT02677896|559548506|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
155033100|NCT02677896|559548505|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
155033101|NCT02677896|559548506|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
155033102|NCT00741091|559548513|FG000|Overall Study|Death|13|||
155033103|NCT00741091|559548513|FG000|Overall Study|Lost to Follow-up|16|||
155033104|NCT00741091|559548513|FG000|Overall Study|Withdrawal by Subject|6|||
155033105|NCT00741091|559548513|FG000|Overall Study|Missed Visit|22|||
155033106|NCT01527487|559548514|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
155033107|NCT01527487|559548515|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
155033108|NCT01527487|559548514|FG000|Overall Study|Disease Progression|4|||
155033109|NCT01527487|559548515|FG001|Overall Study|Disease Progression|1|||
155033110|NCT01527487|559548514|FG000|Overall Study|Adverse Event|1|||
155033111|NCT01527487|559548515|FG001|Overall Study|Adverse Event|1|||
155033112|NCT01527487|559548514|FG000|Overall Study|Death|0|||
155033113|NCT01527487|559548515|FG001|Overall Study|Death|1|||
155033114|NCT00767039|559548516|FG000|Overall Study|Death|5|||
155033115|NCT00767039|559548517|FG001|Overall Study|Death|2|||
155033116|NCT02505334|559548521|FG000|Main Treatment Period|Adverse Event|3|||
155033117|NCT02505334|559548522|FG001|Main Treatment Period|Adverse Event|3|||
155143055|NCT00280917|559956870|FG001|Overall Study|Change Therapy|2|||
155143056|NCT00280917|559956871|FG002|Overall Study|Change Therapy|0|||
155143057|NCT00280917|559956872|FG003|Overall Study|Change Therapy|0|||
155143058|NCT00280917|559956869|FG000|Overall Study|Withdrawal by Subject|0|||
155143059|NCT00280917|559956870|FG001|Overall Study|Withdrawal by Subject|2|||
155143060|NCT00280917|559956871|FG002|Overall Study|Withdrawal by Subject|0|||
155143061|NCT00280917|559956872|FG003|Overall Study|Withdrawal by Subject|1|||
155143062|NCT00280917|559956869|FG000|Overall Study|Noncompliance|0|||
155033118|NCT02505334|559548521|FG000|Main Treatment Period|Lack of Efficacy|7|||
155033119|NCT02505334|559548522|FG001|Main Treatment Period|Lack of Efficacy|17|||
155033120|NCT02505334|559548521|FG000|Main Treatment Period|Protocol Violation|0|||
155033121|NCT02505334|559548522|FG001|Main Treatment Period|Protocol Violation|1|||
155033122|NCT02505334|559548521|FG000|Main Treatment Period|Withdrawal by Subject|1|||
155143063|NCT00280917|559956870|FG001|Overall Study|Noncompliance|1|||
155033123|NCT02505334|559548522|FG001|Main Treatment Period|Withdrawal by Subject|8|||
155033124|NCT02505334|559548521|FG000|Main Treatment Period|Unclassified|4|||
155033125|NCT02505334|559548522|FG001|Main Treatment Period|Unclassified|10|||
155033126|NCT02505334|559548521|FG000|Extension Treatment Period|Adverse Event|5|||
155033127|NCT02505334|559548522|FG001|Extension Treatment Period|Adverse Event|0|||
155033128|NCT02505334|559548521|FG000|Extension Treatment Period|Lack of Efficacy|4|||
155033129|NCT02505334|559548522|FG001|Extension Treatment Period|Lack of Efficacy|0|||
155033130|NCT02505334|559548521|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
155184980|NCT02537574|560116250|FG000|Overall Study|Failed Naloxone Challenge|0|||
155184981|NCT02537574|560116251|FG001|Overall Study|Failed Naloxone Challenge|1|||
155184982|NCT02537574|560116252|FG002|Overall Study|Failed Naloxone Challenge|0|||
155184983|NCT02537574|560116250|FG000|Overall Study|Transportation Issues|0|||
155184984|NCT02537574|560116251|FG001|Overall Study|Transportation Issues|0|||
155184985|NCT02537574|560116252|FG002|Overall Study|Transportation Issues|1|||
155184986|NCT02537574|560116250|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
155184987|NCT02537574|560116251|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
155184988|NCT02537574|560116252|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
155184989|NCT02537574|560116250|FG000|Overall Study|Noncompliance with Protocol|0|||
155184990|NCT02537574|560116251|FG001|Overall Study|Noncompliance with Protocol|0|||
155184991|NCT02537574|560116252|FG002|Overall Study|Noncompliance with Protocol|1|||
155184992|NCT02663687|560116253|FG000|Overall Study|Adverse Event|1|||
155033131|NCT02505334|559548522|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
155033132|NCT02505334|559548521|FG000|Extension Treatment Period|Unclassified|3|||
155033133|NCT02505334|559548522|FG001|Extension Treatment Period|Unclassified|0|||
155033134|NCT00597506|559548523|FG000|Overall Study|Subject is being followed for survival|1|||
155033135|NCT00081731|559548526|FG000|Overall Study|scientific integrity issue|8|||
155033136|NCT00081731|559548527|FG001|Overall Study|scientific integrity issue|8|||
155033137|NCT01199822|559548528|FG000|Overall Study|Investigator discontinued therapy|0|||
155033138|NCT01199822|559548529|FG001|Overall Study|Investigator discontinued therapy|1|||
155033139|NCT01199822|559548530|FG002|Overall Study|Investigator discontinued therapy|0|||
155033140|NCT04027075|559548531|FG000|Overall Study|Lost to Follow-up|41|||
155033141|NCT04027075|559548532|FG001|Overall Study|Lost to Follow-up|22|||
155033142|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
155033143|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
155033144|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
155033145|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
155033146|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|Death|1|||
155033147|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|Death|1|||
155033148|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
155033149|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
155033150|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
155033151|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
155033152|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
155033153|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
155033154|NCT00033657|559548533|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
155033155|NCT00033657|559548534|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
155143064|NCT00280917|559956871|FG002|Overall Study|Noncompliance|2|||
155143065|NCT00280917|559956872|FG003|Overall Study|Noncompliance|0|||
155143066|NCT03529110|559956873|FG000|Overall Study|Progressive Disease|66|||
155143067|NCT03529110|559956874|FG001|Overall Study|Progressive Disease|158|||
155143068|NCT03529110|559956873|FG000|Overall Study|Clinical Progression|4|||
155143069|NCT03529110|559956874|FG001|Overall Study|Clinical Progression|12|||
155143070|NCT03529110|559956873|FG000|Overall Study|Adverse Event|35|||
155143071|NCT03529110|559956874|FG001|Overall Study|Adverse Event|17|||
155143072|NCT03529110|559956873|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
155143073|NCT03529110|559956874|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
155143074|NCT03529110|559956873|FG000|Overall Study|Lack of Efficacy|3|||
155143075|NCT03529110|559956874|FG001|Overall Study|Lack of Efficacy|3|||
155143076|NCT03529110|559956873|FG000|Overall Study|Physician Decision|2|||
155143077|NCT03529110|559956874|FG001|Overall Study|Physician Decision|8|||
155143078|NCT03529110|559956873|FG000|Overall Study|Miscellaneous|2|||
155143079|NCT03529110|559956874|FG001|Overall Study|Miscellaneous|5|||
155143080|NCT05104450|559956875|FG000|Overall Study|Death|1|||
155143081|NCT05104450|559956876|FG001|Overall Study|Death|2|||
155143082|NCT05104450|559956875|FG000|Overall Study|Withdrawal by Subject|3|||
155184993|NCT02663687|560116254|FG001|Overall Study|Adverse Event|0|||
155184994|NCT02663687|560116255|FG002|Overall Study|Adverse Event|0|||
155033156|NCT00033657|559548533|FG000|Surgical Resection|not complete resection|0|||
155033157|NCT00033657|559548534|FG001|Surgical Resection|not complete resection|3|||
155033158|NCT00033657|559548533|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
155033159|NCT00033657|559548534|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
155143083|NCT05104450|559956876|FG001|Overall Study|Withdrawal by Subject|1|||
155143084|NCT03906071|559956887|FG000|Overall Study|Death|180|||
155143085|NCT03906071|559956888|FG001|Overall Study|Death|185|||
155143086|NCT03906071|559956887|FG000|Overall Study|Lost to Follow-up|3|||
155033160|NCT00033657|559548533|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
155033161|NCT00033657|559548534|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
155033162|NCT00033657|559548533|FG000|Adjuvant Chemotherapy|Death|2|||
155033163|NCT00033657|559548534|FG001|Adjuvant Chemotherapy|Death|1|||
155033164|NCT00033657|559548533|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
155033165|NCT00033657|559548534|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
155033166|NCT00033657|559548533|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
155033167|NCT00033657|559548534|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
155033168|NCT00033657|559548533|FG000|Adjuvant Chemotherapy|Other|0|||
155033169|NCT00033657|559548534|FG001|Adjuvant Chemotherapy|Other|2|||
155033170|NCT00656851|559548537|FG000|Overall Study|Withdrawal by Subject|0|||
155033171|NCT00656851|559548538|FG001|Overall Study|Withdrawal by Subject|4|||
155033172|NCT03782298|559548543|FG000|Overall Study|Protocol Deviation|4|||
155033173|NCT02431806|559548544|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
155033174|NCT02431806|559548545|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
155033175|NCT02431806|559548546|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
155033176|NCT02431806|559548547|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
155033177|NCT02431806|559548544|FG000|Double-blind Treatment Period|Adverse Event|4|||
155033178|NCT02431806|559548545|FG001|Double-blind Treatment Period|Adverse Event|7|||
155033179|NCT02431806|559548546|FG002|Double-blind Treatment Period|Adverse Event|11|||
155033180|NCT02431806|559548547|FG003|Double-blind Treatment Period|Adverse Event|7|||
155033181|NCT02431806|559548544|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
155033182|NCT02431806|559548545|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155033183|NCT02431806|559548546|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
155033184|NCT02431806|559548547|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
155033185|NCT02431806|559548544|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
155033186|NCT02431806|559548545|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
155033187|NCT02431806|559548546|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
155033188|NCT02431806|559548547|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
155033189|NCT02431806|559548544|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
155033190|NCT02431806|559548545|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
155033191|NCT02431806|559548546|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
155033192|NCT02431806|559548547|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
155033193|NCT02431806|559548544|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
155033194|NCT02431806|559548545|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
155033195|NCT02431806|559548546|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
155033196|NCT02431806|559548547|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
155033197|NCT02431806|559548544|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
155033198|NCT02431806|559548545|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
155033199|NCT02431806|559548546|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
155033200|NCT02431806|559548547|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
155033201|NCT02484651|559548548|FG000|Overall Study|Patients' data files were corrupted.|1|||
155033202|NCT02484651|559548549|FG001|Overall Study|Patients' data files were corrupted.|1|||
155033203|NCT02484651|559548548|FG000|Overall Study|BIS monitoring failed.|1|||
155033204|NCT02484651|559548549|FG001|Overall Study|BIS monitoring failed.|1|||
155033205|NCT02484651|559548548|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
155033206|NCT02484651|559548549|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
155033207|NCT05238025|559548550|FG000|Overall Study|Adverse Event|2|||
155033208|NCT05238025|559548551|FG001|Overall Study|Adverse Event|2|||
155033209|NCT05238025|559548550|FG000|Overall Study|Lost to Follow-up|334|||
155033210|NCT05238025|559548551|FG001|Overall Study|Lost to Follow-up|339|||
155033211|NCT05238025|559548550|FG000|Overall Study|Withdrawal by Subject|203|||
155033212|NCT05238025|559548551|FG001|Overall Study|Withdrawal by Subject|222|||
155033213|NCT05238025|559548550|FG000|Overall Study|Physician Decision|20|||
155033214|NCT05238025|559548551|FG001|Overall Study|Physician Decision|8|||
155033215|NCT05238025|559548550|FG000|Overall Study|Protocol Violation|6|||
155033216|NCT05238025|559548551|FG001|Overall Study|Protocol Violation|2|||
155033217|NCT05238025|559548550|FG000|Overall Study|Death|38|||
155033218|NCT05238025|559548551|FG001|Overall Study|Death|32|||
155033219|NCT05238025|559548550|FG000|Overall Study|Study terminated by Sponsor|6358|||
155033220|NCT05238025|559548551|FG001|Overall Study|Study terminated by Sponsor|6358|||
155033221|NCT05238025|559548550|FG000|Overall Study|Other Reason|669|||
155143087|NCT03906071|559956888|FG001|Overall Study|Lost to Follow-up|3|||
155143088|NCT03906071|559956887|FG000|Overall Study|Withdrawal by Subject|15|||
155143089|NCT03906071|559956888|FG001|Overall Study|Withdrawal by Subject|27|||
155143090|NCT03906071|559956887|FG000|Overall Study|Other|2|||
155143091|NCT03906071|559956888|FG001|Overall Study|Other|1|||
155143092|NCT03369418|559956892|FG000|Overall Study|Withdrawal by Subject|3|||
155033222|NCT05238025|559548551|FG001|Overall Study|Other Reason|690|||
155033223|NCT02278120|559548558|FG000|Treatment Period|Progressive disease|234|||
155143093|NCT03369418|559956893|FG001|Overall Study|Withdrawal by Subject|3|||
155143094|NCT01485094|559956894|FG000|Overall Study|Adverse Event|1|||
155033224|NCT02278120|559548559|FG001|Treatment Period|Progressive disease|260|||
155033225|NCT02278120|559548558|FG000|Treatment Period|Subject/guardian decision|23|||
155033226|NCT02278120|559548559|FG001|Treatment Period|Subject/guardian decision|20|||
155033227|NCT02278120|559548558|FG000|Treatment Period|Adverse Event|16|||
155033228|NCT02278120|559548559|FG001|Treatment Period|Adverse Event|14|||
155033229|NCT02278120|559548558|FG000|Treatment Period|Physician Decision|14|||
155033230|NCT02278120|559548559|FG001|Treatment Period|Physician Decision|27|||
155033231|NCT02278120|559548558|FG000|Treatment Period|Death|3|||
155033232|NCT02278120|559548559|FG001|Treatment Period|Death|3|||
155033233|NCT02278120|559548558|FG000|Treatment Period|Lost to Follow-up|2|||
155033234|NCT02278120|559548559|FG001|Treatment Period|Lost to Follow-up|0|||
155033235|NCT02278120|559548558|FG000|Treatment Period|Protocol deviation|0|||
155033236|NCT02278120|559548559|FG001|Treatment Period|Protocol deviation|2|||
155033237|NCT02278120|559548558|FG000|Treatment Period|Study terminated as per protocol|43|||
155033238|NCT02278120|559548559|FG001|Treatment Period|Study terminated as per protocol|11|||
155033239|NCT02278120|559548558|FG000|Post-treatment Efficacy Follow-up|Death|0|||
155033240|NCT02278120|559548559|FG001|Post-treatment Efficacy Follow-up|Death|1|||
155033241|NCT02278120|559548558|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
155033242|NCT02278120|559548559|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
155033243|NCT02278120|559548558|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
155033244|NCT02278120|559548559|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
155033245|NCT02278120|559548558|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
155033246|NCT02278120|559548559|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
155033247|NCT02278120|559548558|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155033248|NCT02278120|559548559|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
155033249|NCT03197324|559548563|FG000|Overall Study|Adverse Event|0|||
155033250|NCT03197324|559548564|FG001|Overall Study|Adverse Event|1|||
155033251|NCT00102531|559548565|FG000|Overall Study|Adverse Event|0|||
155033252|NCT00102531|559548566|FG001|Overall Study|Adverse Event|1|||
155033253|NCT00102531|559548565|FG000|Overall Study|Disease Progression|5|||
155033254|NCT00102531|559548566|FG001|Overall Study|Disease Progression|9|||
155033255|NCT00102531|559548565|FG000|Overall Study|Physician Decision|0|||
155033256|NCT00102531|559548566|FG001|Overall Study|Physician Decision|1|||
155033257|NCT00710684|559548570|FG000|Overall Study|Adverse Event|11|||
155033258|NCT00710684|559548571|FG001|Overall Study|Adverse Event|19|||
155033259|NCT00710684|559548572|FG002|Overall Study|Adverse Event|16|||
155033260|NCT00710684|559548570|FG000|Overall Study|Lack of Efficacy|4|||
155033261|NCT00710684|559548571|FG001|Overall Study|Lack of Efficacy|3|||
155033262|NCT00710684|559548572|FG002|Overall Study|Lack of Efficacy|5|||
155033263|NCT00710684|559548570|FG000|Overall Study|Protocol Violation|5|||
155033264|NCT00710684|559548571|FG001|Overall Study|Protocol Violation|5|||
155033265|NCT00710684|559548572|FG002|Overall Study|Protocol Violation|5|||
155033266|NCT00710684|559548570|FG000|Overall Study|Lost to Follow-up|4|||
155033267|NCT00710684|559548571|FG001|Overall Study|Lost to Follow-up|6|||
155033268|NCT00710684|559548572|FG002|Overall Study|Lost to Follow-up|7|||
155033269|NCT00710684|559548570|FG000|Overall Study|Physician Decision|0|||
155033270|NCT00710684|559548571|FG001|Overall Study|Physician Decision|2|||
155033271|NCT00710684|559548572|FG002|Overall Study|Physician Decision|4|||
155033272|NCT00710684|559548570|FG000|Overall Study|Withdrawal by Subject|24|||
155033273|NCT00710684|559548571|FG001|Overall Study|Withdrawal by Subject|18|||
155033274|NCT00710684|559548572|FG002|Overall Study|Withdrawal by Subject|11|||
155033275|NCT00710684|559548570|FG000|Overall Study|Missing|1|||
155033276|NCT00710684|559548571|FG001|Overall Study|Missing|0|||
155033277|NCT00710684|559548572|FG002|Overall Study|Missing|0|||
155033278|NCT00710684|559548570|FG000|Overall Study|Did not continue after week 24|25|||
155033279|NCT00710684|559548571|FG001|Overall Study|Did not continue after week 24|21|||
155033280|NCT00710684|559548572|FG002|Overall Study|Did not continue after week 24|16|||
155033281|NCT04778059|559548573|FG000|Overall Study|Death|2|||
155033282|NCT04778059|559548574|FG001|Overall Study|Death|2|||
155033283|NCT04778059|559548575|FG002|Overall Study|Death|1|||
155033284|NCT04778059|559548576|FG003|Overall Study|Death|1|||
155033285|NCT04778059|559548577|FG004|Overall Study|Death|1|||
155033286|NCT04778059|559548573|FG000|Overall Study|Lost to Follow-up|0|||
155033287|NCT04778059|559548574|FG001|Overall Study|Lost to Follow-up|0|||
155033288|NCT04778059|559548575|FG002|Overall Study|Lost to Follow-up|0|||
155033289|NCT04778059|559548576|FG003|Overall Study|Lost to Follow-up|0|||
155033290|NCT04778059|559548577|FG004|Overall Study|Lost to Follow-up|1|||
155033291|NCT04778059|559548573|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
155033292|NCT04778059|559548574|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
155033293|NCT04778059|559548575|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
155033294|NCT04778059|559548576|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
155033295|NCT04778059|559548577|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
155033296|NCT02832375|559548578|FG000|Overall Study|Lost to Follow-up|1|||
155033297|NCT02832375|559548579|FG001|Overall Study|Lost to Follow-up|0|||
155033298|NCT02832375|559548578|FG000|Overall Study|Withdrawal of Consent|1|||
155033299|NCT02832375|559548579|FG001|Overall Study|Withdrawal of Consent|0|||
155033300|NCT00514904|559548580|FG000|Overall Study|Withdrawal by Subject|3|||
155033301|NCT00514904|559548581|FG001|Overall Study|Withdrawal by Subject|2|||
155033302|NCT00514904|559548580|FG000|Overall Study|Lost to Follow-up|21|||
155033303|NCT00514904|559548581|FG001|Overall Study|Lost to Follow-up|3|||
155033304|NCT00084318|559548582|FG000|Overall Study|Withdrawal by Subject|5|||
155033305|NCT00084318|559548583|FG001|Overall Study|Withdrawal by Subject|2|||
155033306|NCT00084318|559548582|FG000|Overall Study|Protocol Violation|15|||
155033307|NCT00084318|559548583|FG001|Overall Study|Protocol Violation|11|||
155033308|NCT00084318|559548582|FG000|Overall Study|No protocol treatment|2|||
155033309|NCT00084318|559548583|FG001|Overall Study|No protocol treatment|0|||
155033310|NCT01317797|559548584|FG000|Overall Study|Other|0|||
155033311|NCT01317797|559548585|FG001|Overall Study|Other|1|||
155033312|NCT01317797|559548586|FG002|Overall Study|Other|0|||
155033313|NCT01317797|559548584|FG000|Overall Study|Withdrawal of Patient|0|||
155033314|NCT01317797|559548585|FG001|Overall Study|Withdrawal of Patient|0|||
155033315|NCT01317797|559548586|FG002|Overall Study|Withdrawal of Patient|1|||
155033316|NCT03026530|559548590|FG000|Overall Study|Lost to Follow-up|19|||
155033317|NCT03026530|559548591|FG001|Overall Study|Lost to Follow-up|24|||
155033318|NCT03026530|559548590|FG000|Overall Study|Protocol Violation|2|||
155033319|NCT03026530|559548591|FG001|Overall Study|Protocol Violation|5|||
155033320|NCT00954512|559548593|FG000|Overall Study|Withdrawal by Subject|0|||
155033321|NCT00954512|559548594|FG001|Overall Study|Withdrawal by Subject|0|||
155033322|NCT00954512|559548595|FG002|Overall Study|Withdrawal by Subject|0|||
155033323|NCT00954512|559548596|FG003|Overall Study|Withdrawal by Subject|0|||
155033324|NCT00954512|559548597|FG004|Overall Study|Withdrawal by Subject|0|||
155033325|NCT00954512|559548598|FG005|Overall Study|Withdrawal by Subject|1|||
155033326|NCT00954512|559548593|FG000|Overall Study|Adverse Event|0|||
155033327|NCT00954512|559548594|FG001|Overall Study|Adverse Event|0|||
155033328|NCT00954512|559548595|FG002|Overall Study|Adverse Event|0|||
155033329|NCT00954512|559548596|FG003|Overall Study|Adverse Event|0|||
155033330|NCT00954512|559548597|FG004|Overall Study|Adverse Event|1|||
155033331|NCT00954512|559548598|FG005|Overall Study|Adverse Event|2|||
155033332|NCT00954512|559548593|FG000|Overall Study|Physician Decision|0|||
155033333|NCT00954512|559548594|FG001|Overall Study|Physician Decision|1|||
155033334|NCT00954512|559548595|FG002|Overall Study|Physician Decision|0|||
155033335|NCT00954512|559548596|FG003|Overall Study|Physician Decision|1|||
155033336|NCT00954512|559548597|FG004|Overall Study|Physician Decision|0|||
155033337|NCT00954512|559548598|FG005|Overall Study|Physician Decision|0|||
155033338|NCT00954512|559548593|FG000|Overall Study|Symptomatic Deterioration|0|||
155033339|NCT00954512|559548594|FG001|Overall Study|Symptomatic Deterioration|1|||
155033340|NCT00954512|559548595|FG002|Overall Study|Symptomatic Deterioration|0|||
155033341|NCT00954512|559548596|FG003|Overall Study|Symptomatic Deterioration|0|||
155033342|NCT00954512|559548597|FG004|Overall Study|Symptomatic Deterioration|2|||
155033343|NCT00954512|559548598|FG005|Overall Study|Symptomatic Deterioration|0|||
155033344|NCT00954512|559548593|FG000|Overall Study|Progression of Disease|2|||
155033345|NCT00954512|559548594|FG001|Overall Study|Progression of Disease|1|||
155033346|NCT00954512|559548595|FG002|Overall Study|Progression of Disease|0|||
155033347|NCT00954512|559548596|FG003|Overall Study|Progression of Disease|1|||
155033348|NCT00954512|559548597|FG004|Overall Study|Progression of Disease|1|||
155033349|NCT00954512|559548598|FG005|Overall Study|Progression of Disease|1|||
155033350|NCT04814368|559548599|FG000|Overall Study|Study Terminated by Sponsor|0|||
155033351|NCT04814368|559548600|FG001|Overall Study|Study Terminated by Sponsor|3|||
155033352|NCT04814368|559548601|FG002|Overall Study|Study Terminated by Sponsor|0|||
155033353|NCT04814368|559548602|FG003|Overall Study|Study Terminated by Sponsor|2|||
155033354|NCT04814368|559548599|FG000|Overall Study|Subject Decision|1|||
155033355|NCT04814368|559548600|FG001|Overall Study|Subject Decision|2|||
155033356|NCT04814368|559548601|FG002|Overall Study|Subject Decision|0|||
155033357|NCT04814368|559548602|FG003|Overall Study|Subject Decision|0|||
155033358|NCT04216589|559548604|FG000|Overall Study|Withdrawal by Subject|2|||
155033359|NCT04216589|559548604|FG000|Overall Study|Protocol Violation|1|||
155033360|NCT04216589|559548604|FG000|Overall Study|Incarceration|1|||
155033361|NCT03721835|559548605|FG000|Overall Study|Participant not able to return|1|||
155033362|NCT03721835|559548605|FG000|Overall Study|Lost to Follow-up|1|||
155033363|NCT03721835|559548605|FG000|Overall Study|Revision of the components of the study device|2|||
155033364|NCT03721835|559548605|FG000|Overall Study|Sponsor terminated study|6|||
155033365|NCT03721835|559548605|FG000|Overall Study|Death|1|||
155033366|NCT03721835|559548605|FG000|Overall Study|Sponsor decision|1|||
155033367|NCT02100670|559548609|FG000|Overall Study|Adverse Event|10|||
155033368|NCT02100670|559548610|FG001|Overall Study|Adverse Event|3|||
155033369|NCT02100670|559548611|FG002|Overall Study|Adverse Event|3|||
155033370|NCT02100670|559548612|FG003|Overall Study|Adverse Event|0|||
155033371|NCT02100670|559548609|FG000|Overall Study|Lost to Follow-up|1|||
155033372|NCT02100670|559548610|FG001|Overall Study|Lost to Follow-up|0|||
155033373|NCT02100670|559548611|FG002|Overall Study|Lost to Follow-up|0|||
155033374|NCT02100670|559548612|FG003|Overall Study|Lost to Follow-up|0|||
155033375|NCT02100670|559548609|FG000|Overall Study|Protocol Violation|0|||
155033376|NCT02100670|559548610|FG001|Overall Study|Protocol Violation|1|||
155033377|NCT02100670|559548611|FG002|Overall Study|Protocol Violation|0|||
155033378|NCT02100670|559548612|FG003|Overall Study|Protocol Violation|1|||
155033379|NCT02100670|559548609|FG000|Overall Study|Withdrawal of Consent|0|||
155033380|NCT02100670|559548610|FG001|Overall Study|Withdrawal of Consent|1|||
155033381|NCT02100670|559548611|FG002|Overall Study|Withdrawal of Consent|1|||
155033382|NCT02100670|559548612|FG003|Overall Study|Withdrawal of Consent|0|||
155033383|NCT02100670|559548609|FG000|Overall Study|No swelling no pain|1|||
155033384|NCT02100670|559548610|FG001|Overall Study|No swelling no pain|0|||
155033385|NCT02100670|559548611|FG002|Overall Study|No swelling no pain|0|||
155033386|NCT02100670|559548612|FG003|Overall Study|No swelling no pain|0|||
155033387|NCT02100670|559548609|FG000|Overall Study|Poor Efficacy|0|||
155033388|NCT02100670|559548610|FG001|Overall Study|Poor Efficacy|1|||
155033389|NCT02100670|559548611|FG002|Overall Study|Poor Efficacy|0|||
155033390|NCT02100670|559548612|FG003|Overall Study|Poor Efficacy|0|||
155033391|NCT02100670|559548609|FG000|Overall Study|Physician Decision|0|||
155033392|NCT02100670|559548610|FG001|Overall Study|Physician Decision|1|||
155033393|NCT02100670|559548611|FG002|Overall Study|Physician Decision|0|||
155033394|NCT02100670|559548612|FG003|Overall Study|Physician Decision|0|||
155033395|NCT02100670|559548609|FG000|Overall Study|Withdrawal by Subject|1|||
155033396|NCT02100670|559548610|FG001|Overall Study|Withdrawal by Subject|0|||
155033397|NCT02100670|559548611|FG002|Overall Study|Withdrawal by Subject|0|||
155033398|NCT02100670|559548612|FG003|Overall Study|Withdrawal by Subject|0|||
155033399|NCT04439357|559550041|FG000|Overall Study|Disease Progression|4|||
155033400|NCT05932225|559550052|FG000|Overall Study|Lost to Follow-up|0|||
155033401|NCT05932225|559550053|FG001|Overall Study|Lost to Follow-up|1|||
155033402|NCT05932225|559550054|FG002|Overall Study|Lost to Follow-up|0|||
155033403|NCT05932225|559550052|FG000|Overall Study|Withdrawal by Subject|1|||
155033404|NCT05932225|559550053|FG001|Overall Study|Withdrawal by Subject|0|||
155033405|NCT05932225|559550054|FG002|Overall Study|Withdrawal by Subject|0|||
155033406|NCT05932225|559550052|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
155033407|NCT05932225|559550053|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
155033408|NCT05932225|559550054|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
155033409|NCT01911780|559550055|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
155033410|NCT01911780|559550056|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
155033411|NCT01911780|559550055|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
155033412|NCT01911780|559550056|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
155033413|NCT01911780|559550055|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
155033414|NCT01911780|559550056|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
155033415|NCT01911780|559550055|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
155033416|NCT01911780|559550056|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
155033417|NCT01911780|559550055|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
155033418|NCT01911780|559550056|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
155033419|NCT01911780|559550055|FG000|Extension Period (52 Weeks)|Personal reason|1|||
155033420|NCT01911780|559550056|FG001|Extension Period (52 Weeks)|Personal reason|1|||
155033421|NCT01892085|559550059|FG000|Overall Study|Death|4|||
155033422|NCT01892085|559550060|FG001|Overall Study|Death|1|||
155033423|NCT01892085|559550061|FG002|Overall Study|Death|3|||
155033424|NCT01892085|559550059|FG000|Overall Study|Withdrawal by Subject|2|||
155033425|NCT01892085|559550060|FG001|Overall Study|Withdrawal by Subject|0|||
155033426|NCT01892085|559550061|FG002|Overall Study|Withdrawal by Subject|2|||
155033427|NCT01629823|559550064|FG000|Trial Period|Missed visit|11|||
155033428|NCT01629823|559550065|FG001|Trial Period|Missed visit|9|||
155033429|NCT01629823|559550066|FG002|Trial Period|Missed visit|8|||
155033430|NCT01629823|559550064|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
155033431|NCT01629823|559550065|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
155033432|NCT01629823|559550066|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
155033433|NCT01629823|559550064|FG000|Trial Period|Pregnancy|1|||
155033434|NCT01629823|559550065|FG001|Trial Period|Pregnancy|0|||
155033435|NCT01629823|559550066|FG002|Trial Period|Pregnancy|0|||
155033436|NCT01629823|559550064|FG000|Trial Period|Adverse Event|0|||
155033437|NCT01629823|559550065|FG001|Trial Period|Adverse Event|1|||
155033438|NCT01629823|559550066|FG002|Trial Period|Adverse Event|0|||
155033439|NCT01629823|559550064|FG000|Trial Period|Out-of-window visit|0|||
155033440|NCT01629823|559550065|FG001|Trial Period|Out-of-window visit|2|||
155033441|NCT01629823|559550066|FG002|Trial Period|Out-of-window visit|0|||
155033442|NCT01629823|559550064|FG000|Trial Period|Failed to hold medication|0|||
155033443|NCT01629823|559550065|FG001|Trial Period|Failed to hold medication|0|||
155033444|NCT01629823|559550066|FG002|Trial Period|Failed to hold medication|1|||
155033445|NCT01629823|559550064|FG000|Washout Period|Safety|2|||
155033446|NCT01629823|559550065|FG001|Washout Period|Safety|5|||
155033447|NCT01629823|559550066|FG002|Washout Period|Safety|0|||
155033448|NCT01629823|559550064|FG000|Washout Period|Pregnancy|1|||
155033449|NCT01629823|559550065|FG001|Washout Period|Pregnancy|0|||
155033450|NCT01629823|559550066|FG002|Washout Period|Pregnancy|0|||
155033451|NCT01629823|559550064|FG000|Washout Period|Protocol Violation|0|||
155033452|NCT01629823|559550065|FG001|Washout Period|Protocol Violation|1|||
155033453|NCT01629823|559550066|FG002|Washout Period|Protocol Violation|0|||
155033454|NCT00525902|559550068|FG000|Overall Study|Lack of Efficacy|1|||
155033455|NCT00455520|559550070|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
155033456|NCT00455520|559550071|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
155033457|NCT00455520|559550070|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
155033458|NCT00455520|559550071|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
155033459|NCT00455520|559550070|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
155033460|NCT00455520|559550071|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
155033461|NCT00455520|559550070|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
155033462|NCT00455520|559550071|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
155033463|NCT00455520|559550070|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
155033464|NCT00455520|559550071|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
155033465|NCT00455520|559550070|FG000|Open Label Tapentadol Extended Release|All other|33|||
155033466|NCT00455520|559550071|FG001|Open Label Tapentadol Extended Release|All other|0|||
155033467|NCT00455520|559550070|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
155033468|NCT00455520|559550071|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
155033469|NCT00455520|559550070|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
155033470|NCT00455520|559550071|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
155033471|NCT00455520|559550070|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
155033472|NCT00455520|559550071|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
155033473|NCT00455520|559550070|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
155033474|NCT00455520|559550071|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
155033475|NCT00455520|559550070|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
155033476|NCT00455520|559550071|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
155033477|NCT00455520|559550070|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
155033478|NCT00455520|559550071|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
155033479|NCT03448939|559550073|FG000|Overall Study|Adverse Event|5|||
155033480|NCT03448939|559550074|FG001|Overall Study|Adverse Event|1|||
155033481|NCT03448939|559550073|FG000|Overall Study|Lost to Follow-up|6|||
155033482|NCT03448939|559550074|FG001|Overall Study|Lost to Follow-up|6|||
155033483|NCT03448939|559550073|FG000|Overall Study|Pregnancy|1|||
155033484|NCT03448939|559550074|FG001|Overall Study|Pregnancy|1|||
155033485|NCT03448939|559550073|FG000|Overall Study|Withdrawal by Subject|9|||
155033486|NCT03448939|559550074|FG001|Overall Study|Withdrawal by Subject|3|||
155033487|NCT00986986|559550075|FG000|Overall Study|Lost to Follow-up|0|||
155033488|NCT00986986|559550076|FG001|Overall Study|Lost to Follow-up|1|||
155033489|NCT03235115|559550077|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155033490|NCT03235115|559550078|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155033491|NCT03235115|559550079|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155033492|NCT03235115|559550080|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155033493|NCT03235115|559550081|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
155033494|NCT03235115|559550082|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
155033495|NCT05020899|559550084|FG000|8 Week Follow-up|Lost to Follow-up|3|||
155033496|NCT05020899|559550085|FG001|8 Week Follow-up|Lost to Follow-up|6|||
155033497|NCT05020899|559550084|FG000|12 Week Follow-up|Lost to Follow-up|1|||
155033498|NCT05020899|559550085|FG001|12 Week Follow-up|Lost to Follow-up|0|||
155033499|NCT05020899|559550084|FG000|12 Week Follow-up|Death|0|||
155033500|NCT05020899|559550085|FG001|12 Week Follow-up|Death|1|||
155033501|NCT01068626|559550086|FG000|Overall Study|Adverse Event|3|||
155033502|NCT01068626|559550087|FG001|Overall Study|Adverse Event|0|||
155033503|NCT01068626|559550086|FG000|Overall Study|Withdrawal by Subject|0|||
155033504|NCT01068626|559550087|FG001|Overall Study|Withdrawal by Subject|2|||
155033505|NCT01785849|559550088|FG000|Overall Study|Death|7|||
155033506|NCT01785849|559550089|FG001|Overall Study|Death|9|||
155033507|NCT01785849|559550088|FG000|Overall Study|Protocol Specified Criteria|29|||
155033508|NCT01785849|559550089|FG001|Overall Study|Protocol Specified Criteria|1|||
155033509|NCT01785849|559550088|FG000|Overall Study|Withdrawal by Subject|15|||
155033510|NCT01785849|559550089|FG001|Overall Study|Withdrawal by Subject|12|||
155033511|NCT01785849|559550088|FG000|Overall Study|Sponsor Decision|0|||
155033512|NCT01785849|559550089|FG001|Overall Study|Sponsor Decision|1|||
155033513|NCT01785849|559550088|FG000|Overall Study|Lost to Follow-up|10|||
155033514|NCT01785849|559550089|FG001|Overall Study|Lost to Follow-up|11|||
155033515|NCT01032239|559550090|FG000|Overall Study|Lost to Follow-up|3|||
155033516|NCT01032239|559550091|FG001|Overall Study|Lost to Follow-up|2|||
155033517|NCT01032239|559550090|FG000|Overall Study|Withdrawal by Subject|2|||
155033518|NCT01032239|559550091|FG001|Overall Study|Withdrawal by Subject|3|||
155033519|NCT01032239|559550090|FG000|Overall Study|Death|1|||
155033520|NCT01032239|559550091|FG001|Overall Study|Death|0|||
155033521|NCT01032239|559550090|FG000|Overall Study|Protocol Violation|1|||
155033522|NCT01032239|559550091|FG001|Overall Study|Protocol Violation|0|||
155033523|NCT01940900|559550092|FG000|Overall Study|Physician Decision|4|||
155033524|NCT01940900|559550093|FG001|Overall Study|Physician Decision|0|||
155033525|NCT01940900|559550092|FG000|Overall Study|Adverse Event|10|||
155033526|NCT01940900|559550093|FG001|Overall Study|Adverse Event|15|||
155033527|NCT01940900|559550092|FG000|Overall Study|Withdrawal by Subject|11|||
155184995|NCT02663687|560116256|FG003|Overall Study|Adverse Event|0|||
155033528|NCT01940900|559550093|FG001|Overall Study|Withdrawal by Subject|15|||
155033529|NCT01940900|559550092|FG000|Overall Study|Lost to Follow-up|1|||
155033530|NCT01940900|559550093|FG001|Overall Study|Lost to Follow-up|0|||
155033531|NCT01940900|559550092|FG000|Overall Study|Sponsor Decision|1|||
155033532|NCT01940900|559550093|FG001|Overall Study|Sponsor Decision|0|||
155033533|NCT01940900|559550092|FG000|Overall Study|subject non-compliance|1|||
155033534|NCT01940900|559550093|FG001|Overall Study|subject non-compliance|1|||
155033535|NCT01940900|559550092|FG000|Overall Study|other|1|||
155033536|NCT01940900|559550093|FG001|Overall Study|other|0|||
155033537|NCT04713592|559550096|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
155033538|NCT04713592|559550097|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
155033539|NCT04713592|559550098|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
155033540|NCT04713592|559550099|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
155033541|NCT04713592|559550096|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
155033542|NCT04713592|559550097|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
155033543|NCT04713592|559550098|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
155033544|NCT04713592|559550099|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
155033545|NCT04713592|559550096|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
155033546|NCT04713592|559550097|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
155033547|NCT04713592|559550098|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
155033548|NCT04713592|559550099|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
155033549|NCT04713592|559550096|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155033550|NCT04713592|559550097|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
155033551|NCT04713592|559550098|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
155033552|NCT04713592|559550099|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
155033553|NCT04713592|559550096|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
155033554|NCT04713592|559550097|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
155033555|NCT04713592|559550098|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
155033556|NCT04713592|559550099|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
155033557|NCT04713592|559550096|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155033558|NCT04713592|559550097|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
155033559|NCT04713592|559550098|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155033560|NCT04713592|559550099|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
155033561|NCT04713592|559550096|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
155033562|NCT04713592|559550097|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
155033563|NCT04713592|559550098|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
155033564|NCT04713592|559550099|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
155033565|NCT01382225|559550102|FG000|Overall Study|Adverse Event|3|||
155033566|NCT01382225|559550103|FG001|Overall Study|Adverse Event|2|||
155033567|NCT01382225|559550102|FG000|Overall Study|Protocol Violation|2|||
155033568|NCT01382225|559550103|FG001|Overall Study|Protocol Violation|1|||
155033569|NCT01382225|559550102|FG000|Overall Study|Subject Withdrew Consent|5|||
155033570|NCT01382225|559550103|FG001|Overall Study|Subject Withdrew Consent|2|||
155033571|NCT01382225|559550102|FG000|Overall Study|Other|4|||
155033572|NCT01382225|559550103|FG001|Overall Study|Other|2|||
155033573|NCT01797081|559550104|FG000|Overall Study|Adverse Event|1|||
155033574|NCT01797081|559550105|FG001|Overall Study|Adverse Event|0|||
155033575|NCT01797081|559550106|FG002|Overall Study|Adverse Event|1|||
155033576|NCT01797081|559550107|FG003|Overall Study|Adverse Event|0|||
155184996|NCT02663687|560116257|FG004|Overall Study|Adverse Event|0|||
155184997|NCT02663687|560116253|FG000|Overall Study|Other|1|||
155184998|NCT02663687|560116254|FG001|Overall Study|Other|0|||
155184999|NCT02663687|560116255|FG002|Overall Study|Other|1|||
155185000|NCT02663687|560116256|FG003|Overall Study|Other|0|||
155185001|NCT02663687|560116257|FG004|Overall Study|Other|0|||
155185002|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
155185003|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
155185004|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
155185005|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
155185006|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
155033577|NCT01797081|559550104|FG000|Overall Study|Pregnancy|1|||
155033578|NCT01797081|559550105|FG001|Overall Study|Pregnancy|0|||
155185007|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
155185008|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
155185009|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
155185010|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
155185011|NCT00417482|560116258|FG000|Phase B 1st 16 Weeks|Death|1|||
155185012|NCT00417482|560116259|FG001|Phase B 1st 16 Weeks|Death|0|||
155185013|NCT00417482|560116260|FG002|Phase B 1st 16 Weeks|Death|0|||
155033579|NCT01797081|559550106|FG002|Overall Study|Pregnancy|0|||
155033580|NCT01797081|559550107|FG003|Overall Study|Pregnancy|0|||
155185014|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
155033581|NCT01797081|559550104|FG000|Overall Study|Personal Reasons|12|||
155033582|NCT01797081|559550105|FG001|Overall Study|Personal Reasons|4|||
155033583|NCT01797081|559550106|FG002|Overall Study|Personal Reasons|4|||
155033584|NCT01797081|559550107|FG003|Overall Study|Personal Reasons|8|||
155033585|NCT01797081|559550104|FG000|Overall Study|Protocol Violation|0|||
155033586|NCT01797081|559550105|FG001|Overall Study|Protocol Violation|0|||
155033587|NCT01797081|559550106|FG002|Overall Study|Protocol Violation|0|||
155033588|NCT01797081|559550107|FG003|Overall Study|Protocol Violation|1|||
155033589|NCT05513703|559550116|FG000|Overall Study|Death|4|||
155033590|NCT05513703|559550116|FG000|Overall Study|Study terminated by sponsor|5|||
155033591|NCT01793688|559550118|FG000|Overall Study|Protocol Violation|2|||
155033592|NCT00150800|559550121|FG000|Overall Study|Adverse Event|89|||
155033593|NCT00150800|559550121|FG000|Overall Study|Death|18|||
155033594|NCT00150800|559550121|FG000|Overall Study|Lack of Efficacy|166|||
155033595|NCT00150800|559550121|FG000|Overall Study|Lost to Follow-up|58|||
155033596|NCT00150800|559550121|FG000|Overall Study|Subject's choice|90|||
155033597|NCT00150800|559550121|FG000|Overall Study|No compliance|18|||
155033598|NCT00150800|559550121|FG000|Overall Study|IP misshandling|1|||
155033599|NCT00150800|559550121|FG000|Overall Study|Site closure|24|||
155033600|NCT00150800|559550121|FG000|Overall Study|Protocol non-adherence|2|||
155033601|NCT00150800|559550121|FG000|Overall Study|Nobody to accompany patient|1|||
155033602|NCT00150800|559550121|FG000|Overall Study|Distance too long for patient|1|||
155033603|NCT00150800|559550121|FG000|Overall Study|Neurosurgery|2|||
155033604|NCT00150800|559550121|FG000|Overall Study|BRV monotherapy|1|||
155033605|NCT00150800|559550121|FG000|Overall Study|Visit refusal|3|||
155033606|NCT00150800|559550121|FG000|Overall Study|Sponsor's request|2|||
155033607|NCT00150800|559550121|FG000|Overall Study|Generalized Epilepsy|1|||
155033608|NCT00150800|559550121|FG000|Overall Study|Moved from area/country|8|||
155033609|NCT00150800|559550121|FG000|Overall Study|PI retiring|2|||
155033610|NCT00150800|559550121|FG000|Overall Study|PI leaving site|2|||
155033611|NCT00150800|559550121|FG000|Overall Study|Patient insurance|1|||
155033612|NCT00150800|559550121|FG000|Overall Study|Surgical intervention|4|||
155033613|NCT00150800|559550121|FG000|Overall Study|Pregnancy planned|1|||
155033614|NCT00150800|559550121|FG000|Overall Study|PI discontinuation request|1|||
155033615|NCT04972968|559550122|FG000|Overall Study|Adverse Event|3|||
155033616|NCT04972968|559550123|FG001|Overall Study|Adverse Event|1|||
155033617|NCT04972968|559550124|FG002|Overall Study|Adverse Event|1|||
155033618|NCT04972968|559550125|FG003|Overall Study|Adverse Event|7|||
155033619|NCT04972968|559550122|FG000|Overall Study|Lack of Efficacy|2|||
155033620|NCT04972968|559550123|FG001|Overall Study|Lack of Efficacy|1|||
155033621|NCT04972968|559550124|FG002|Overall Study|Lack of Efficacy|0|||
155033622|NCT04972968|559550125|FG003|Overall Study|Lack of Efficacy|0|||
155033623|NCT04972968|559550122|FG000|Overall Study|Withdrawal by Subject|7|||
155033624|NCT04972968|559550123|FG001|Overall Study|Withdrawal by Subject|4|||
155033625|NCT04972968|559550124|FG002|Overall Study|Withdrawal by Subject|3|||
155143095|NCT01485094|559956895|FG001|Overall Study|Adverse Event|1|||
155143096|NCT01485094|559956896|FG002|Overall Study|Adverse Event|1|||
155143097|NCT01485094|559956894|FG000|Overall Study|Lost to Follow-up|1|||
155143098|NCT01485094|559956895|FG001|Overall Study|Lost to Follow-up|0|||
155143099|NCT01485094|559956896|FG002|Overall Study|Lost to Follow-up|0|||
155143100|NCT01485094|559956894|FG000|Overall Study|Withdrawal by Subject|1|||
155143101|NCT01485094|559956895|FG001|Overall Study|Withdrawal by Subject|1|||
155143102|NCT01485094|559956896|FG002|Overall Study|Withdrawal by Subject|0|||
155143103|NCT01172535|559956900|FG000|Overall Study|Death|3|||
155143104|NCT01172535|559956900|FG000|Overall Study|Withdrawal by Subject|2|||
155143105|NCT01172535|559956900|FG000|Overall Study|Lost to Follow-up|1|||
155143106|NCT01172535|559956900|FG000|Overall Study|Ineligible at study entry|1|||
155143107|NCT01172535|559956900|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
155143108|NCT00714415|559956908|FG000|Overall Study|Lack of Efficacy|1|||
155143109|NCT00714415|559956909|FG001|Overall Study|Lack of Efficacy|0|||
155143110|NCT00714415|559956908|FG000|Overall Study|Death|1|||
155143111|NCT00714415|559956909|FG001|Overall Study|Death|0|||
155143112|NCT01818596|559956912|FG000|Overall Study|Enrolled but Not Treated|4|||
155143113|NCT01818596|559956913|FG001|Overall Study|Enrolled but Not Treated|0|||
155143114|NCT01818596|559956912|FG000|Overall Study|Adverse Event|7|||
155143115|NCT01818596|559956913|FG001|Overall Study|Adverse Event|0|||
155143116|NCT01818596|559956912|FG000|Overall Study|Death|3|||
155143117|NCT01818596|559956913|FG001|Overall Study|Death|0|||
155143118|NCT01818596|559956912|FG000|Overall Study|Investigator's Discretion|4|||
155143119|NCT01818596|559956913|FG001|Overall Study|Investigator's Discretion|0|||
155143120|NCT01818596|559956912|FG000|Overall Study|Protocol Violation|1|||
155033626|NCT04972968|559550125|FG003|Overall Study|Withdrawal by Subject|2|||
155033627|NCT04972968|559550122|FG000|Overall Study|Study Terminated by Sponsor|25|||
155143121|NCT01818596|559956913|FG001|Overall Study|Protocol Violation|0|||
155143122|NCT01818596|559956912|FG000|Overall Study|Withdrew Consent|5|||
155033628|NCT04972968|559550123|FG001|Overall Study|Study Terminated by Sponsor|28|||
155033629|NCT04972968|559550124|FG002|Overall Study|Study Terminated by Sponsor|32|||
155143123|NCT01818596|559956913|FG001|Overall Study|Withdrew Consent|0|||
155143124|NCT01818596|559956912|FG000|Overall Study|Lost to Follow-up|7|||
155143125|NCT01818596|559956913|FG001|Overall Study|Lost to Follow-up|0|||
155185015|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
155185016|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
155185017|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
155185018|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
155185019|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
155185020|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
155185021|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
155185022|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
155185023|NCT00417482|560116258|FG000|Phase B 2nd 16 Weeks|Death|1|||
155185024|NCT00417482|560116259|FG001|Phase B 2nd 16 Weeks|Death|1|||
155033630|NCT04972968|559550125|FG003|Overall Study|Study Terminated by Sponsor|27|||
155033631|NCT04972968|559550122|FG000|Overall Study|Other|1|||
155033632|NCT04972968|559550123|FG001|Overall Study|Other|0|||
155033633|NCT04972968|559550124|FG002|Overall Study|Other|1|||
155033634|NCT04972968|559550125|FG003|Overall Study|Other|1|||
155033635|NCT01698879|559550126|FG000|Overall Study|Withdrawal by Subject|1|||
155033636|NCT01698879|559550127|FG001|Overall Study|Withdrawal by Subject|0|||
155033637|NCT01698879|559550128|FG002|Overall Study|Withdrawal by Subject|0|||
155033638|NCT03649178|559550129|FG000|Overall Study|Adverse Event|1|||
155033639|NCT03649178|559550130|FG001|Overall Study|Adverse Event|2|||
155033640|NCT03649178|559550129|FG000|Overall Study|Withdrawal by Subject|0|||
155033641|NCT03649178|559550130|FG001|Overall Study|Withdrawal by Subject|2|||
155033642|NCT03649178|559550129|FG000|Overall Study|COVID regulation required halt in protocol|1|||
155033643|NCT03649178|559550130|FG001|Overall Study|COVID regulation required halt in protocol|0|||
155033644|NCT03814720|559550142|FG000|Overall Study|Lost to Follow-up|0|||
155033645|NCT03814720|559550143|FG001|Overall Study|Lost to Follow-up|1|||
155033646|NCT03814720|559550144|FG002|Overall Study|Lost to Follow-up|0|||
155033647|NCT03814720|559550145|FG003|Overall Study|Lost to Follow-up|0|||
155033648|NCT03814720|559550146|FG004|Overall Study|Lost to Follow-up|0|||
155033649|NCT00474045|559550147|FG000|Overall Study|Adverse Event|18|||
155033650|NCT00474045|559550148|FG001|Overall Study|Adverse Event|8|||
155033651|NCT00474045|559550147|FG000|Overall Study|Unclassified|1|||
155033652|NCT00474045|559550148|FG001|Overall Study|Unclassified|3|||
155033653|NCT00474045|559550147|FG000|Overall Study|Lack of Efficacy|0|||
155033654|NCT00474045|559550148|FG001|Overall Study|Lack of Efficacy|9|||
155033655|NCT00474045|559550147|FG000|Overall Study|Lost to Follow-up|1|||
155033656|NCT00474045|559550148|FG001|Overall Study|Lost to Follow-up|1|||
155033657|NCT00474045|559550147|FG000|Overall Study|Protocol Violation|10|||
155033658|NCT00474045|559550148|FG001|Overall Study|Protocol Violation|12|||
155033659|NCT00474045|559550147|FG000|Overall Study|Withdrawal by Subject|16|||
155033660|NCT00474045|559550148|FG001|Overall Study|Withdrawal by Subject|18|||
155033661|NCT00474045|559550147|FG000|Overall Study|Withdrawal criteria|60|||
155033662|NCT00474045|559550148|FG001|Overall Study|Withdrawal criteria|50|||
155033663|NCT02135107|559550155|FG000|Treatment Period|Withdrawal by Subject|11|||
155033664|NCT02135107|559550156|FG001|Treatment Period|Withdrawal by Subject|0|||
155033665|NCT02135107|559550157|FG002|Treatment Period|Withdrawal by Subject|0|||
155033666|NCT02135107|559550158|FG003|Treatment Period|Withdrawal by Subject|0|||
155033667|NCT02135107|559550155|FG000|Treatment Period|Adverse Event|5|||
155033668|NCT02135107|559550156|FG001|Treatment Period|Adverse Event|2|||
155185025|NCT00417482|560116260|FG002|Phase B 2nd 16 Weeks|Death|0|||
155185026|NCT03343067|560116263|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
155185027|NCT03343067|560116264|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
155185028|NCT03343067|560116265|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
155033669|NCT02135107|559550157|FG002|Treatment Period|Adverse Event|0|||
155033670|NCT02135107|559550158|FG003|Treatment Period|Adverse Event|0|||
155033671|NCT02135107|559550155|FG000|Treatment Period|Pregnancy|1|||
155033672|NCT02135107|559550156|FG001|Treatment Period|Pregnancy|0|||
155033673|NCT02135107|559550157|FG002|Treatment Period|Pregnancy|0|||
155033674|NCT02135107|559550158|FG003|Treatment Period|Pregnancy|0|||
155033675|NCT02135107|559550155|FG000|Treatment Period|Other|115|||
155033676|NCT02135107|559550156|FG001|Treatment Period|Other|24|||
155033677|NCT02135107|559550157|FG002|Treatment Period|Other|0|||
155033678|NCT02135107|559550158|FG003|Treatment Period|Other|0|||
155033679|NCT02135107|559550155|FG000|Maintenance Therapy Period|Adverse Event|0|||
155033680|NCT02135107|559550156|FG001|Maintenance Therapy Period|Adverse Event|0|||
155185029|NCT00116168|560116266|FG000|Overall Study|Lost to Follow-up|6|||
155185030|NCT00116168|560116267|FG001|Overall Study|Lost to Follow-up|5|||
155185031|NCT00116168|560116268|FG002|Overall Study|Lost to Follow-up|0|||
155185032|NCT00116168|560116269|FG003|Overall Study|Lost to Follow-up|0|||
155185033|NCT00048061|560116270|FG000|Overall Study|Adverse Event|41|||
155033681|NCT02135107|559550157|FG002|Maintenance Therapy Period|Adverse Event|3|||
155033682|NCT02135107|559550158|FG003|Maintenance Therapy Period|Adverse Event|7|||
155033683|NCT02135107|559550155|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
155033684|NCT02135107|559550156|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
155033685|NCT02135107|559550157|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
155033686|NCT02135107|559550158|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
155033687|NCT02135107|559550155|FG000|Maintenance Therapy Period|Pregnancy|0|||
155033688|NCT02135107|559550156|FG001|Maintenance Therapy Period|Pregnancy|0|||
155033689|NCT02135107|559550157|FG002|Maintenance Therapy Period|Pregnancy|0|||
155033690|NCT02135107|559550158|FG003|Maintenance Therapy Period|Pregnancy|1|||
155033691|NCT02135107|559550155|FG000|Maintenance Therapy Period|Other|0|||
155033692|NCT02135107|559550156|FG001|Maintenance Therapy Period|Other|0|||
155185034|NCT00048061|560116271|FG001|Overall Study|Adverse Event|32|||
155185035|NCT00048061|560116272|FG002|Overall Study|Adverse Event|44|||
155185036|NCT00048061|560116273|FG003|Overall Study|Adverse Event|37|||
155185037|NCT00048061|560116270|FG000|Overall Study|Lost to Follow-up|3|||
155185038|NCT00048061|560116271|FG001|Overall Study|Lost to Follow-up|2|||
155185039|NCT00048061|560116272|FG002|Overall Study|Lost to Follow-up|4|||
155185040|NCT00048061|560116273|FG003|Overall Study|Lost to Follow-up|5|||
155185041|NCT00048061|560116270|FG000|Overall Study|Withdrawal by Subject|20|||
155185042|NCT00048061|560116271|FG001|Overall Study|Withdrawal by Subject|29|||
155185043|NCT00048061|560116272|FG002|Overall Study|Withdrawal by Subject|29|||
155185044|NCT00048061|560116273|FG003|Overall Study|Withdrawal by Subject|32|||
155185045|NCT00048061|560116270|FG000|Overall Study|Did not follow-up|5|||
155185046|NCT00048061|560116271|FG001|Overall Study|Did not follow-up|5|||
155185047|NCT00048061|560116272|FG002|Overall Study|Did not follow-up|4|||
155185048|NCT00048061|560116273|FG003|Overall Study|Did not follow-up|5|||
155185049|NCT00048061|560116270|FG000|Overall Study|Early improvement|6|||
155185050|NCT00048061|560116271|FG001|Overall Study|Early improvement|5|||
155033693|NCT02135107|559550157|FG002|Maintenance Therapy Period|Other|7|||
155033694|NCT02135107|559550158|FG003|Maintenance Therapy Period|Other|8|||
155143126|NCT03461146|559956922|FG000|Overall Study|Adverse Event|2|||
155143127|NCT03461146|559956922|FG000|Overall Study|Physician Decision|1|||
155143128|NCT02073682|559956923|FG000|Overall Study|Low Creatinine Clearance|1|||
155143129|NCT02073682|559956924|FG001|Overall Study|Low Creatinine Clearance|2|||
155143130|NCT02073682|559956923|FG000|Overall Study|Death|86|||
155143131|NCT02073682|559956924|FG001|Overall Study|Death|100|||
155143132|NCT02073682|559956923|FG000|Overall Study|Cancer Cured|10|||
155143133|NCT02073682|559956924|FG001|Overall Study|Cancer Cured|15|||
155143134|NCT02073682|559956923|FG000|Overall Study|ID: Patient Noncompliance|1|||
155143135|NCT02073682|559956924|FG001|Overall Study|ID: Patient Noncompliance|2|||
155143136|NCT02073682|559956923|FG000|Overall Study|ID: Palliative Treatment Only|10|||
155143137|NCT02073682|559956924|FG001|Overall Study|ID: Palliative Treatment Only|7|||
155143138|NCT02073682|559956923|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
155143139|NCT02073682|559956924|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
155143140|NCT02073682|559956923|FG000|Overall Study|Platelet Count <50,000/mL|1|||
155143141|NCT02073682|559956924|FG001|Overall Study|Platelet Count <50,000/mL|2|||
155143142|NCT02073682|559956923|FG000|Overall Study|Surgery/Medical Procedure|3|||
155143143|NCT02073682|559956924|FG001|Overall Study|Surgery/Medical Procedure|1|||
155143144|NCT02073682|559956923|FG000|Overall Study|Withdrawal by Subject|6|||
155143145|NCT02073682|559956924|FG001|Overall Study|Withdrawal by Subject|8|||
155143146|NCT02073682|559956923|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
155143147|NCT02073682|559956924|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
155143148|NCT02073682|559956923|FG000|Overall Study|Cancer Progression|53|||
155143149|NCT02073682|559956924|FG001|Overall Study|Cancer Progression|33|||
155143150|NCT02073682|559956923|FG000|Overall Study|Protocol Violation|1|||
155143151|NCT02073682|559956924|FG001|Overall Study|Protocol Violation|0|||
155143152|NCT02073682|559956923|FG000|Overall Study|Adverse Event|79|||
155143153|NCT02073682|559956924|FG001|Overall Study|Adverse Event|62|||
155143154|NCT02073682|559956923|FG000|Overall Study|No reason provided|11|||
155143155|NCT02073682|559956924|FG001|Overall Study|No reason provided|9|||
155143156|NCT02073682|559956923|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
155143157|NCT02073682|559956924|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
155143158|NCT02073682|559956923|FG000|Overall Study|Lost to Follow-up|1|||
155143159|NCT02073682|559956924|FG001|Overall Study|Lost to Follow-up|1|||
155143160|NCT02073682|559956923|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
155143161|NCT02073682|559956924|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
155143162|NCT04524858|559956937|FG000|Overall Study|Adverse Event|1|||
155143163|NCT01623115|559956938|FG000|Overall Study|Randomized but not treated|0|||
155143164|NCT01623115|559956939|FG001|Overall Study|Randomized but not treated|1|||
155185051|NCT00048061|560116272|FG002|Overall Study|Early improvement|3|||
155185052|NCT00048061|560116273|FG003|Overall Study|Early improvement|0|||
155185053|NCT03583073|560116274|FG000|Overall Study|Lost to Follow-up|8|||
155185054|NCT03583073|560116275|FG001|Overall Study|Lost to Follow-up|12|||
155185055|NCT01569464|560116278|FG000|Overall Study|Adverse Event|4|||
155033695|NCT02009397|559550159|FG000|Overall Study|Protocol Violation|6|||
155033696|NCT02009397|559550159|FG000|Overall Study|Death|8|||
155143165|NCT01623115|559956938|FG000|Overall Study|Physician Decision|1|||
155143166|NCT01623115|559956939|FG001|Overall Study|Physician Decision|0|||
155143167|NCT01623115|559956938|FG000|Overall Study|Participants moved|1|||
155143168|NCT01623115|559956939|FG001|Overall Study|Participants moved|5|||
155143169|NCT01623115|559956938|FG000|Overall Study|Adverse Event|10|||
155143170|NCT01623115|559956939|FG001|Overall Study|Adverse Event|13|||
155143171|NCT01623115|559956938|FG000|Overall Study|Poor compliance to protocol|4|||
155143172|NCT01623115|559956939|FG001|Overall Study|Poor compliance to protocol|10|||
155185056|NCT01569464|560116279|FG001|Overall Study|Adverse Event|0|||
155185057|NCT01569464|560116278|FG000|Overall Study|Lack of Efficacy|1|||
155033697|NCT02009397|559550159|FG000|Overall Study|Lost to Follow-up|6|||
155033698|NCT00191282|559550163|FG000|Overall Study|Adverse Event|5|||
155033699|NCT00191282|559550164|FG001|Overall Study|Adverse Event|6|||
155033700|NCT00191282|559550163|FG000|Overall Study|Death|51|||
155033701|NCT00191282|559550164|FG001|Overall Study|Death|51|||
155033702|NCT00191282|559550163|FG000|Overall Study|Lack of Efficacy|11|||
155033703|NCT00191282|559550164|FG001|Overall Study|Lack of Efficacy|6|||
155185058|NCT01569464|560116279|FG001|Overall Study|Lack of Efficacy|0|||
155185059|NCT01569464|560116278|FG000|Overall Study|Protocol Violation|1|||
155185060|NCT01569464|560116279|FG001|Overall Study|Protocol Violation|0|||
155185061|NCT01569464|560116278|FG000|Overall Study|Lost to Follow-up|2|||
155185062|NCT01569464|560116279|FG001|Overall Study|Lost to Follow-up|3|||
155185063|NCT01569464|560116278|FG000|Overall Study|Withdrawal by Subject|1|||
155185064|NCT01569464|560116279|FG001|Overall Study|Withdrawal by Subject|1|||
155185065|NCT01569464|560116278|FG000|Overall Study|Other|1|||
155185066|NCT01569464|560116279|FG001|Overall Study|Other|1|||
155185067|NCT03063203|560116285|FG000|Overall Study|Chose alternative therapy|3|||
155185068|NCT03063203|560116285|FG000|Overall Study|Death|2|||
155185069|NCT03063203|560116285|FG000|Overall Study|Disease progression|4|||
155185070|NCT03063203|560116285|FG000|Overall Study|Physician Decision|5|||
155033704|NCT00191282|559550163|FG000|Overall Study|Noncompliance|14|||
155033705|NCT00191282|559550164|FG001|Overall Study|Noncompliance|17|||
155033706|NCT00191282|559550163|FG000|Overall Study|Patient moved|11|||
155033707|NCT00191282|559550164|FG001|Overall Study|Patient moved|14|||
155033708|NCT00191282|559550163|FG000|Overall Study|Withdrawal by Subject|59|||
155033709|NCT00191282|559550164|FG001|Overall Study|Withdrawal by Subject|44|||
155033710|NCT00191282|559550163|FG000|Overall Study|Physician Decision|18|||
155185071|NCT04025710|560116286|FG000|Overall Study|Death|3|||
155185072|NCT04025710|560116286|FG000|Overall Study|Lost to Follow-up|5|||
155185073|NCT04025710|560116286|FG000|Overall Study|Withdrawal by Subject|1|||
155185074|NCT04025710|560116286|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
155185075|NCT04025710|560116286|FG000|Overall Study|Drop-out according to protocol|34|||
155185076|NCT00245583|560116289|FG000|Overall Study|Lost to Follow-up|1|||
155185077|NCT00245583|560116290|FG001|Overall Study|Lost to Follow-up|5|||
155185078|NCT00245583|560116289|FG000|Overall Study|Adverse Event|2|||
155185079|NCT00245583|560116290|FG001|Overall Study|Adverse Event|1|||
155185080|NCT00245583|560116289|FG000|Overall Study|Lack of Efficacy|1|||
155185081|NCT00245583|560116290|FG001|Overall Study|Lack of Efficacy|0|||
155185082|NCT00245583|560116289|FG000|Overall Study|Withdrawal by Subject|2|||
155185083|NCT00245583|560116290|FG001|Overall Study|Withdrawal by Subject|3|||
155185084|NCT04718103|560116291|FG000|Overall Study|Adverse Event|1|||
155185085|NCT04718103|560116292|FG001|Overall Study|Adverse Event|1|||
155185086|NCT04718103|560116291|FG000|Overall Study|Lack of Efficacy|4|||
155185087|NCT04718103|560116292|FG001|Overall Study|Lack of Efficacy|1|||
155185088|NCT04718103|560116291|FG000|Overall Study|Lost to Follow-up|2|||
155185089|NCT04718103|560116292|FG001|Overall Study|Lost to Follow-up|2|||
155185090|NCT04718103|560116291|FG000|Overall Study|Physician Decision|2|||
155185091|NCT04718103|560116292|FG001|Overall Study|Physician Decision|0|||
155185092|NCT04718103|560116291|FG000|Overall Study|Pregnancy|0|||
155185093|NCT04718103|560116292|FG001|Overall Study|Pregnancy|1|||
155185094|NCT04718103|560116291|FG000|Overall Study|Withdrawal by Subject|10|||
155185095|NCT04718103|560116292|FG001|Overall Study|Withdrawal by Subject|6|||
155185096|NCT04718103|560116291|FG000|Overall Study|Randomized, not treated|4|||
155185097|NCT04718103|560116292|FG001|Overall Study|Randomized, not treated|1|||
155185098|NCT04718103|560116291|FG000|Overall Study|GCP violations|7|||
155185099|NCT04718103|560116292|FG001|Overall Study|GCP violations|5|||
155185100|NCT01309893|560116293|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
155185101|NCT01309893|560116294|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
155185102|NCT01309893|560116293|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
155185103|NCT01309893|560116294|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
155185104|NCT01343901|560116295|FG000|Overall Study|Death|85|||
155185105|NCT01343901|560116295|FG000|Overall Study|Physician Decision|4|||
155185106|NCT01343901|560116295|FG000|Overall Study|Lost to Follow-up|12|||
155185107|NCT01343901|560116295|FG000|Overall Study|Management by another medical team|11|||
155185108|NCT01343901|560116295|FG000|Overall Study|Participant decision|1|||
155185109|NCT01484938|560116296|FG000|Overall Study|Adverse Event|2|||
155185110|NCT01484938|560116296|FG000|Overall Study|Lost to Follow-up|1|||
155033711|NCT00191282|559550164|FG001|Overall Study|Physician Decision|15|||
155033712|NCT00191282|559550163|FG000|Overall Study|Protocol entry criteria not met|14|||
155033713|NCT00191282|559550164|FG001|Overall Study|Protocol entry criteria not met|9|||
155033714|NCT00191282|559550163|FG000|Overall Study|Protocol Violation|9|||
155033715|NCT00191282|559550164|FG001|Overall Study|Protocol Violation|12|||
155033716|NCT00191282|559550163|FG000|Overall Study|Severity of outcome|2|||
155033717|NCT00191282|559550164|FG001|Overall Study|Severity of outcome|5|||
155185111|NCT01484938|560116296|FG000|Overall Study|Noncompliance|1|||
155185112|NCT02942576|560116297|FG000|Overall Study|Adverse Event|28|||
155185113|NCT02942576|560116298|FG001|Overall Study|Adverse Event|6|||
155033718|NCT00191282|559550163|FG000|Overall Study|Sponsor's decision|2|||
155033719|NCT00191282|559550164|FG001|Overall Study|Sponsor's decision|2|||
155033720|NCT00191282|559550163|FG000|Overall Study|Lost to Follow-up|24|||
155033721|NCT00191282|559550164|FG001|Overall Study|Lost to Follow-up|31|||
155033722|NCT04756154|559550165|FG000|Overall Study|Did not meet treatment day baseline|30|||
155033723|NCT04756154|559550166|FG001|Overall Study|Did not meet treatment day baseline|28|||
155033724|NCT04756154|559550167|FG002|Overall Study|Did not meet treatment day baseline|7|||
155033725|NCT04756154|559550165|FG000|Overall Study|Did not return for final sample collection|1|||
155033726|NCT04756154|559550166|FG001|Overall Study|Did not return for final sample collection|1|||
155033727|NCT04756154|559550167|FG002|Overall Study|Did not return for final sample collection|0|||
155033728|NCT03430895|559550173|FG000|Overall Study|Not Treated|2|||
155033729|NCT00138073|559550175|FG000|Overall Study|lack of resources|55|||
155033730|NCT03301740|559550176|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
155033731|NCT03301740|559550177|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
155033732|NCT03301740|559550176|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
155033733|NCT03301740|559550177|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
155033734|NCT01173055|559550181|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
155033735|NCT01173055|559550182|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
155033736|NCT01173055|559550181|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
155033737|NCT01173055|559550182|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
155033738|NCT04253782|559550184|FG000|Overall Study|Death|2|||
155033739|NCT04253782|559550185|FG001|Overall Study|Death|0|||
155033740|NCT01306045|559550190|FG000|Met General Eligibility Criteria|Screen failures|193|||
155033741|NCT01306045|559550191|FG001|Met General Eligibility Criteria|Screen failures|11|||
155033742|NCT01306045|559550192|FG002|Met General Eligibility Criteria|Screen failures|8|||
155033743|NCT05685732|559550193|FG000|Overall Study|Withdrawal by Subject|2|||
155033744|NCT05685732|559550194|FG001|Overall Study|Withdrawal by Subject|0|||
155033745|NCT05685732|559550195|FG002|Overall Study|Withdrawal by Subject|2|||
155033746|NCT05685732|559550196|FG003|Overall Study|Withdrawal by Subject|3|||
155033747|NCT05685732|559550193|FG000|Overall Study|Protocol Violation|1|||
155033748|NCT05685732|559550194|FG001|Overall Study|Protocol Violation|2|||
155033749|NCT05685732|559550195|FG002|Overall Study|Protocol Violation|4|||
155033750|NCT05685732|559550196|FG003|Overall Study|Protocol Violation|1|||
155033751|NCT05685732|559550193|FG000|Overall Study|Lost to Follow-up|5|||
155033752|NCT05685732|559550194|FG001|Overall Study|Lost to Follow-up|1|||
155033753|NCT05685732|559550195|FG002|Overall Study|Lost to Follow-up|3|||
155033754|NCT05685732|559550196|FG003|Overall Study|Lost to Follow-up|1|||
155033755|NCT05685732|559550193|FG000|Overall Study|Adverse Event|2|||
155033756|NCT05685732|559550194|FG001|Overall Study|Adverse Event|1|||
155033757|NCT05685732|559550195|FG002|Overall Study|Adverse Event|0|||
155033758|NCT05685732|559550196|FG003|Overall Study|Adverse Event|0|||
155033759|NCT05685732|559550193|FG000|Overall Study|Physician Decision|1|||
155033760|NCT05685732|559550194|FG001|Overall Study|Physician Decision|0|||
155033761|NCT05685732|559550195|FG002|Overall Study|Physician Decision|0|||
155033762|NCT05685732|559550196|FG003|Overall Study|Physician Decision|0|||
155033763|NCT02640404|559550197|FG000|Overall Study|Protocol Violation|1|||
155033764|NCT02640404|559550198|FG001|Overall Study|Protocol Violation|0|||
155033765|NCT02640404|559550197|FG000|Overall Study|Withdrawal by Subject|1|||
155033766|NCT02640404|559550198|FG001|Overall Study|Withdrawal by Subject|0|||
155033767|NCT04908202|559550199|FG000|Pre-Treatment Period|OTHER REASONS|3|||
155143173|NCT01623115|559956938|FG000|Overall Study|Consent withdrawn by participant|2|||
155143174|NCT01623115|559956939|FG001|Overall Study|Consent withdrawn by participant|6|||
155143175|NCT01623115|559956938|FG000|Overall Study|Related to study drug administration|0|||
155143176|NCT01623115|559956939|FG001|Overall Study|Related to study drug administration|2|||
155143177|NCT01623115|559956938|FG000|Overall Study|Last visit outside protocol visit window|14|||
155143178|NCT01623115|559956939|FG001|Overall Study|Last visit outside protocol visit window|26|||
155143179|NCT01623115|559956938|FG000|Overall Study|Site closure|1|||
155143180|NCT01623115|559956939|FG001|Overall Study|Site closure|7|||
155143181|NCT01623115|559956938|FG000|Overall Study|Death|0|||
155143182|NCT01623115|559956939|FG001|Overall Study|Death|4|||
155143183|NCT01623115|559956938|FG000|Overall Study|Other than specified above|0|||
155143184|NCT01623115|559956939|FG001|Overall Study|Other than specified above|3|||
155143185|NCT05202418|559956940|FG000|Overall Study|Withdrawal by Subject|2|||
155143186|NCT05202418|559956941|FG001|Overall Study|Withdrawal by Subject|1|||
155033768|NCT04908202|559550200|FG001|Pre-Treatment Period|OTHER REASONS|1|||
155143187|NCT05202418|559956940|FG000|Overall Study|Lost to Follow-up|1|||
155143188|NCT05202418|559956941|FG001|Overall Study|Lost to Follow-up|1|||
155033769|NCT04908202|559550201|FG002|Pre-Treatment Period|OTHER REASONS|0|||
155033770|NCT04908202|559550202|FG003|Pre-Treatment Period|OTHER REASONS|0|||
155033771|NCT04908202|559550199|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
155143189|NCT02562716|559956942|FG000|Overall Study|Adverse Event|7|||
155143190|NCT02562716|559956943|FG001|Overall Study|Adverse Event|14|||
155143191|NCT02562716|559956942|FG000|Overall Study|Withdrawal unrelated to AE|7|||
155143192|NCT02562716|559956943|FG001|Overall Study|Withdrawal unrelated to AE|1|||
155033772|NCT04908202|559550200|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155143193|NCT02562716|559956942|FG000|Overall Study|Progression|8|||
155033773|NCT04908202|559550201|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155033774|NCT04908202|559550202|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155033775|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
155033776|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
155033777|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155033778|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
155033779|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
155033780|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
155033781|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
155033782|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
155033783|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
155033784|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
155033785|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155033786|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155033787|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
155033788|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
155033789|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155033790|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155033791|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
155033792|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
155033793|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
155033794|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
155033795|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155033796|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
155033797|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155033798|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155033799|NCT04908202|559550199|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
155033800|NCT04908202|559550200|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
155033801|NCT04908202|559550201|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
155033802|NCT04908202|559550202|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
155033803|NCT04908202|559550199|FG000|Active Treatment Period|OTHER REASONS|0|||
155033804|NCT04908202|559550200|FG001|Active Treatment Period|OTHER REASONS|0|||
155033805|NCT04908202|559550201|FG002|Active Treatment Period|OTHER REASONS|1|||
155033806|NCT04908202|559550202|FG003|Active Treatment Period|OTHER REASONS|3|||
155033807|NCT04908202|559550199|FG000|Active Treatment Period|Lack of Efficacy|0|||
155033808|NCT04908202|559550200|FG001|Active Treatment Period|Lack of Efficacy|0|||
155033809|NCT04908202|559550201|FG002|Active Treatment Period|Lack of Efficacy|4|||
155033810|NCT04908202|559550202|FG003|Active Treatment Period|Lack of Efficacy|5|||
155033811|NCT04908202|559550199|FG000|Active Treatment Period|Adverse Event|0|||
155033812|NCT04908202|559550200|FG001|Active Treatment Period|Adverse Event|0|||
155033813|NCT04908202|559550201|FG002|Active Treatment Period|Adverse Event|5|||
155033814|NCT04908202|559550202|FG003|Active Treatment Period|Adverse Event|8|||
155033815|NCT04908202|559550199|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155033816|NCT04908202|559550200|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
155033817|NCT04908202|559550201|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
155033818|NCT04908202|559550202|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
155033819|NCT04908202|559550199|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155033820|NCT04908202|559550200|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
155033821|NCT04908202|559550201|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
155033822|NCT04908202|559550202|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
155033823|NCT04908202|559550199|FG000|Active Treatment Period|Lost to Follow-up|0|||
155033824|NCT04908202|559550200|FG001|Active Treatment Period|Lost to Follow-up|0|||
155033825|NCT04908202|559550201|FG002|Active Treatment Period|Lost to Follow-up|2|||
155033826|NCT04908202|559550202|FG003|Active Treatment Period|Lost to Follow-up|2|||
155033827|NCT04908202|559550199|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
155033828|NCT04908202|559550200|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
155033829|NCT04908202|559550201|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
155033830|NCT04908202|559550202|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
155033831|NCT04908202|559550199|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155033832|NCT04908202|559550200|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
155033833|NCT04908202|559550201|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
155033834|NCT04908202|559550202|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
155033835|NCT04908202|559550199|FG000|Active Treatment Period|ONGOING Treatment|0|||
155033836|NCT04908202|559550200|FG001|Active Treatment Period|ONGOING Treatment|0|||
155033837|NCT04908202|559550201|FG002|Active Treatment Period|ONGOING Treatment|117|||
155033838|NCT04908202|559550202|FG003|Active Treatment Period|ONGOING Treatment|114|||
155033839|NCT05397171|559550203|FG000|Overall Study|Death|2|||
155033840|NCT05397171|559550204|FG001|Overall Study|Death|3|||
155033841|NCT05397171|559550205|FG002|Overall Study|Death|3|||
155033842|NCT05397171|559550203|FG000|Overall Study|Study Terminated By Sponsor|1|||
155033843|NCT05397171|559550204|FG001|Overall Study|Study Terminated By Sponsor|2|||
155033844|NCT05397171|559550205|FG002|Overall Study|Study Terminated By Sponsor|3|||
155033845|NCT05397171|559550203|FG000|Overall Study|Withdrawal by Subject|0|||
155033846|NCT05397171|559550204|FG001|Overall Study|Withdrawal by Subject|1|||
155033847|NCT05397171|559550205|FG002|Overall Study|Withdrawal by Subject|1|||
155033848|NCT03117881|559551838|FG000|Baseline|Withdrawal by Subject|21|||
155033849|NCT03117881|559551839|FG001|Baseline|Withdrawal by Subject|10|||
155033850|NCT03117881|559551840|FG002|Baseline|Withdrawal by Subject|0|||
155033851|NCT03117881|559551838|FG000|Baseline|Lost to Follow-up|22|||
155033852|NCT03117881|559551839|FG001|Baseline|Lost to Follow-up|25|||
155033853|NCT03117881|559551840|FG002|Baseline|Lost to Follow-up|0|||
155033854|NCT03117881|559551838|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
155033855|NCT03117881|559551839|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
155033856|NCT03117881|559551840|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
155033857|NCT03117881|559551838|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
155033858|NCT03117881|559551839|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
155033859|NCT03117881|559551840|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
155033860|NCT03117881|559551838|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
155033861|NCT03117881|559551839|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
155033862|NCT03117881|559551840|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
155033863|NCT03117881|559551838|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
155033864|NCT03117881|559551839|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
155033865|NCT03117881|559551840|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
155033866|NCT03117881|559551838|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
155033867|NCT03117881|559551839|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
155033868|NCT03117881|559551840|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
155033869|NCT03117881|559551838|FG000|6-Month Follow-Up|Did not complete test|53|||
155033870|NCT03117881|559551839|FG001|6-Month Follow-Up|Did not complete test|25|||
155033871|NCT03117881|559551840|FG002|6-Month Follow-Up|Did not complete test|7|||
155033872|NCT03117881|559551838|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
155033873|NCT03117881|559551839|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
155033874|NCT03117881|559551840|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
155033875|NCT03117881|559551838|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
155033876|NCT03117881|559551839|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
155033877|NCT03117881|559551840|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
155033878|NCT03117881|559551838|FG000|12-Month Follow-Up|Did not complete test|40|||
155033879|NCT03117881|559551839|FG001|12-Month Follow-Up|Did not complete test|0|||
155033880|NCT03117881|559551840|FG002|12-Month Follow-Up|Did not complete test|0|||
155033881|NCT01027897|559551841|FG000|Overall Study|Protocol Violation|1|||
155033882|NCT01027897|559551841|FG000|Overall Study|Withdrawal by Subject|1|||
155033883|NCT01661933|559551842|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
155033884|NCT01661933|559551842|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
155033885|NCT03385304|559551843|FG000|Overall Study|Death|19|||
155033886|NCT03385304|559551844|FG001|Overall Study|Death|7|||
155033887|NCT03385304|559551843|FG000|Overall Study|Lost to Follow-up|17|||
155033888|NCT03385304|559551844|FG001|Overall Study|Lost to Follow-up|14|||
155033889|NCT03385304|559551843|FG000|Overall Study|Withdrawal by Subject|3|||
155033890|NCT03385304|559551844|FG001|Overall Study|Withdrawal by Subject|2|||
155033891|NCT03385304|559551843|FG000|Overall Study|Incarceration|2|||
155143194|NCT02562716|559956943|FG001|Overall Study|Progression|10|||
155143195|NCT02562716|559956942|FG000|Overall Study|Death|2|||
155143196|NCT02562716|559956943|FG001|Overall Study|Death|1|||
155143197|NCT02562716|559956942|FG000|Overall Study|Not protocol specified|4|||
155143198|NCT02562716|559956943|FG001|Overall Study|Not protocol specified|2|||
155033892|NCT03385304|559551844|FG001|Overall Study|Incarceration|3|||
155033893|NCT01097421|559551845|FG000|Overall Study|Adverse Event|8|||
155143199|NCT00556998|559956944|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
155143200|NCT00556998|559956944|FG000|Voriconazole Intravenous (IV)|Other|4|||
155143201|NCT00556998|559956944|FG000|Voriconazole Oral|Adverse Event|1|||
155033894|NCT01097421|559551845|FG000|Overall Study|Protocol Violation|2|||
155033895|NCT01097421|559551845|FG000|Overall Study|Lost to Follow-up|1|||
155033896|NCT01097421|559551845|FG000|Overall Study|Withdrawal by Subject|3|||
155033897|NCT01120249|559551846|FG000|Overall Study|No protocol treatment received|21|||
155033898|NCT01120249|559551847|FG001|Overall Study|No protocol treatment received|15|||
155033899|NCT01120249|559551846|FG000|Overall Study|Disease recurrence|107|||
155033900|NCT01120249|559551847|FG001|Overall Study|Disease recurrence|57|||
155033901|NCT01120249|559551846|FG000|Overall Study|Death|1|||
155143202|NCT00556998|559956944|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
155143203|NCT02519439|559956945|FG000|Overall Study|Study Termination|19|||
155033902|NCT01120249|559551847|FG001|Overall Study|Death|0|||
155033903|NCT01120249|559551846|FG000|Overall Study|Adverse Event|40|||
155033904|NCT01120249|559551847|FG001|Overall Study|Adverse Event|276|||
155033905|NCT01120249|559551846|FG000|Overall Study|Participant refusal|34|||
155033906|NCT01120249|559551847|FG001|Overall Study|Participant refusal|42|||
155033907|NCT01120249|559551846|FG000|Overall Study|Other reasons, not protocol specified|29|||
155033908|NCT01120249|559551847|FG001|Overall Study|Other reasons, not protocol specified|22|||
155033909|NCT02052596|559551848|FG000|Active Phase|Adverse Event|3|||
155033910|NCT02052596|559551849|FG001|Active Phase|Adverse Event|2|||
155033911|NCT02052596|559551848|FG000|Active Phase|Lost to Follow-up|8|||
155033912|NCT02052596|559551849|FG001|Active Phase|Lost to Follow-up|11|||
155033913|NCT02052596|559551848|FG000|Active Phase|Protocol Violation|1|||
155033914|NCT02052596|559551849|FG001|Active Phase|Protocol Violation|2|||
155033915|NCT02052596|559551848|FG000|Active Phase|Withdrawal by Subject|3|||
155033916|NCT02052596|559551849|FG001|Active Phase|Withdrawal by Subject|4|||
155033917|NCT02052596|559551848|FG000|Active Phase|Enrolled in error|1|||
155033918|NCT02052596|559551849|FG001|Active Phase|Enrolled in error|0|||
155033919|NCT02052596|559551848|FG000|Active Phase|Lost due to Crohn's disease|0|||
155033920|NCT02052596|559551849|FG001|Active Phase|Lost due to Crohn's disease|1|||
155033921|NCT02052596|559551848|FG000|Safety Phase|Adverse Event|6|||
155033922|NCT02052596|559551849|FG001|Safety Phase|Adverse Event|3|||
155033923|NCT02052596|559551848|FG000|Safety Phase|Lost to Follow-up|11|||
155033924|NCT02052596|559551849|FG001|Safety Phase|Lost to Follow-up|18|||
155033925|NCT02052596|559551848|FG000|Safety Phase|Protocol Violation|1|||
155033926|NCT02052596|559551849|FG001|Safety Phase|Protocol Violation|2|||
155033927|NCT02052596|559551848|FG000|Safety Phase|Withdrawal by Subject|8|||
155033928|NCT02052596|559551849|FG001|Safety Phase|Withdrawal by Subject|11|||
155033929|NCT02052596|559551848|FG000|Safety Phase|Enrolled in error|1|||
155033930|NCT02052596|559551849|FG001|Safety Phase|Enrolled in error|0|||
155033931|NCT02052596|559551848|FG000|Safety Phase|Lost due to Crohn's disease|0|||
155033932|NCT02052596|559551849|FG001|Safety Phase|Lost due to Crohn's disease|1|||
155033933|NCT00558896|559551850|FG000|Overall Study|Adverse Event|1|||
155033934|NCT00558896|559551851|FG001|Overall Study|Adverse Event|1|||
155033935|NCT00558896|559551852|FG002|Overall Study|Adverse Event|1|||
155033936|NCT00558896|559551853|FG003|Overall Study|Adverse Event|3|||
155033937|NCT00558896|559551854|FG004|Overall Study|Adverse Event|4|||
155033938|NCT00558896|559551855|FG005|Overall Study|Adverse Event|10|||
155033939|NCT00558896|559551856|FG006|Overall Study|Adverse Event|3|||
155033940|NCT00558896|559551850|FG000|Overall Study|Death|3|||
155033941|NCT00558896|559551851|FG001|Overall Study|Death|0|||
155033942|NCT00558896|559551852|FG002|Overall Study|Death|2|||
155033943|NCT00558896|559551853|FG003|Overall Study|Death|3|||
155033944|NCT00558896|559551854|FG004|Overall Study|Death|2|||
155033945|NCT00558896|559551855|FG005|Overall Study|Death|2|||
155033946|NCT00558896|559551856|FG006|Overall Study|Death|6|||
155033947|NCT00558896|559551850|FG000|Overall Study|Withdrawal by Subject|2|||
155033948|NCT00558896|559551851|FG001|Overall Study|Withdrawal by Subject|1|||
155033949|NCT00558896|559551852|FG002|Overall Study|Withdrawal by Subject|1|||
155033950|NCT00558896|559551853|FG003|Overall Study|Withdrawal by Subject|1|||
155033951|NCT00558896|559551854|FG004|Overall Study|Withdrawal by Subject|1|||
155033952|NCT00558896|559551855|FG005|Overall Study|Withdrawal by Subject|5|||
155033953|NCT00558896|559551856|FG006|Overall Study|Withdrawal by Subject|5|||
155033954|NCT00558896|559551850|FG000|Overall Study|Alternative Treatment|2|||
155033955|NCT00558896|559551851|FG001|Overall Study|Alternative Treatment|2|||
155033956|NCT00558896|559551852|FG002|Overall Study|Alternative Treatment|0|||
155033957|NCT00558896|559551853|FG003|Overall Study|Alternative Treatment|2|||
155033958|NCT00558896|559551854|FG004|Overall Study|Alternative Treatment|6|||
155033959|NCT00558896|559551855|FG005|Overall Study|Alternative Treatment|7|||
155033960|NCT00558896|559551856|FG006|Overall Study|Alternative Treatment|1|||
155033961|NCT00558896|559551850|FG000|Overall Study|Physician discretion|3|||
155033962|NCT00558896|559551851|FG001|Overall Study|Physician discretion|2|||
155033963|NCT00558896|559551852|FG002|Overall Study|Physician discretion|1|||
155033964|NCT00558896|559551853|FG003|Overall Study|Physician discretion|2|||
155033965|NCT00558896|559551854|FG004|Overall Study|Physician discretion|1|||
155185114|NCT02942576|560116297|FG000|Overall Study|Withdrawal by Subject|7|||
155033966|NCT00558896|559551855|FG005|Overall Study|Physician discretion|3|||
155033967|NCT00558896|559551856|FG006|Overall Study|Physician discretion|3|||
155033968|NCT00558896|559551850|FG000|Overall Study|Continues on treatment|10|||
155033969|NCT00558896|559551851|FG001|Overall Study|Continues on treatment|1|||
155033970|NCT00558896|559551852|FG002|Overall Study|Continues on treatment|0|||
155033971|NCT00558896|559551853|FG003|Overall Study|Continues on treatment|1|||
155033972|NCT00558896|559551854|FG004|Overall Study|Continues on treatment|9|||
155033973|NCT00558896|559551855|FG005|Overall Study|Continues on treatment|25|||
155033974|NCT00558896|559551856|FG006|Overall Study|Continues on treatment|6|||
155033975|NCT00250458|559551860|FG000|Overall Study|Lost to Follow-up|4|||
155033976|NCT00250458|559551861|FG001|Overall Study|Lost to Follow-up|2|||
155033977|NCT00250458|559551860|FG000|Overall Study|Protocol Violation|0|||
155033978|NCT00250458|559551861|FG001|Overall Study|Protocol Violation|1|||
155033979|NCT00250458|559551860|FG000|Overall Study|Withdrawal by Subject|4|||
155033980|NCT00250458|559551861|FG001|Overall Study|Withdrawal by Subject|2|||
155033981|NCT00250458|559551860|FG000|Overall Study|Lack of Migraine Attack|20|||
155033982|NCT00250458|559551861|FG001|Overall Study|Lack of Migraine Attack|9|||
155033983|NCT00250458|559551860|FG000|Overall Study|Qualifying migraine but did not treat|3|||
155033984|NCT00250458|559551861|FG001|Overall Study|Qualifying migraine but did not treat|3|||
155033985|NCT00250458|559551860|FG000|Overall Study|Other|1|||
155033986|NCT00250458|559551861|FG001|Overall Study|Other|0|||
155033987|NCT00723190|559551864|FG000|Overall Study|Withdrawal by Subject|45|||
155033988|NCT00723190|559551864|FG000|Overall Study|Lost to Follow-up|37|||
155033989|NCT00723190|559551864|FG000|Overall Study|Adverse Event|18|||
155033990|NCT00723190|559551864|FG000|Overall Study|Lack of Efficacy|16|||
155033991|NCT00723190|559551864|FG000|Overall Study|Protocol Violation|15|||
155033992|NCT00723190|559551864|FG000|Overall Study|Other-Premature Discontinuation|9|||
155033993|NCT00723190|559551864|FG000|Overall Study|Other-Not included in safety population|2|||
155033994|NCT00480493|559551871|FG000|Overall Study|moved|2|||
155033995|NCT00480493|559551872|FG001|Overall Study|moved|7|||
155033996|NCT03747302|559551873|FG000|Overall Study|Withdrawal by Subject|1|||
155033997|NCT03747302|559551874|FG001|Overall Study|Withdrawal by Subject|2|||
155033998|NCT03769675|559551877|FG000|Overall Study|Lost to Follow-up|1|||
155033999|NCT02844907|559551878|FG000|With Dexamethasone|No IV access|1|||
155034000|NCT00738062|559551879|FG000|Open Label Treatment|Lack of Efficacy|5|||
155034001|NCT00738062|559551880|FG001|Open Label Treatment|Lack of Efficacy|0|||
155034002|NCT00738062|559551881|FG002|Open Label Treatment|Lack of Efficacy|0|||
155034003|NCT00738062|559551879|FG000|Open Label Treatment|Adverse Event|11|||
155034004|NCT00738062|559551880|FG001|Open Label Treatment|Adverse Event|0|||
155034005|NCT00738062|559551881|FG002|Open Label Treatment|Adverse Event|0|||
155034006|NCT00738062|559551879|FG000|Open Label Treatment|Protocol Violation|2|||
155034007|NCT00738062|559551880|FG001|Open Label Treatment|Protocol Violation|0|||
155034008|NCT00738062|559551881|FG002|Open Label Treatment|Protocol Violation|0|||
155034009|NCT00738062|559551879|FG000|Open Label Treatment|Withdrawal by Subject|9|||
155034010|NCT00738062|559551880|FG001|Open Label Treatment|Withdrawal by Subject|0|||
155034011|NCT00738062|559551881|FG002|Open Label Treatment|Withdrawal by Subject|0|||
155034012|NCT00738062|559551879|FG000|Open Label Treatment|Investigator Decision|1|||
155034013|NCT00738062|559551880|FG001|Open Label Treatment|Investigator Decision|0|||
155034014|NCT00738062|559551881|FG002|Open Label Treatment|Investigator Decision|0|||
155034015|NCT00738062|559551879|FG000|Open-Label Extension|Adverse Event|5|||
155034016|NCT00738062|559551880|FG001|Open-Label Extension|Adverse Event|0|||
155034017|NCT00738062|559551881|FG002|Open-Label Extension|Adverse Event|0|||
155034018|NCT00738062|559551879|FG000|Open-Label Extension|Physician Decision|1|||
155034019|NCT00738062|559551880|FG001|Open-Label Extension|Physician Decision|0|||
155034020|NCT00738062|559551881|FG002|Open-Label Extension|Physician Decision|0|||
155034021|NCT00738062|559551879|FG000|Open-Label Extension|Lack of Efficacy|2|||
155034022|NCT00738062|559551880|FG001|Open-Label Extension|Lack of Efficacy|0|||
155034023|NCT00738062|559551881|FG002|Open-Label Extension|Lack of Efficacy|0|||
155034024|NCT00738062|559551879|FG000|Open-Label Extension|Withdrawal by Subject|6|||
155034025|NCT00738062|559551880|FG001|Open-Label Extension|Withdrawal by Subject|0|||
155034026|NCT00738062|559551881|FG002|Open-Label Extension|Withdrawal by Subject|0|||
155034027|NCT00738062|559551879|FG000|Open-Label Extension|Protocol Violation|1|||
155034028|NCT00738062|559551880|FG001|Open-Label Extension|Protocol Violation|0|||
155034029|NCT00738062|559551881|FG002|Open-Label Extension|Protocol Violation|0|||
155034030|NCT00738062|559551879|FG000|Open-Label Extension|Study Terminated|2|||
155034031|NCT00738062|559551880|FG001|Open-Label Extension|Study Terminated|0|||
155034032|NCT00738062|559551881|FG002|Open-Label Extension|Study Terminated|0|||
155034033|NCT02772276|559551882|FG000|Overall Study|Lost to Follow-up|0|||
155034034|NCT02772276|559551883|FG001|Overall Study|Lost to Follow-up|0|||
155034035|NCT02772276|559551884|FG002|Overall Study|Lost to Follow-up|0|||
155034036|NCT02772276|559551885|FG003|Overall Study|Lost to Follow-up|0|||
155034037|NCT02772276|559551886|FG004|Overall Study|Lost to Follow-up|0|||
155034038|NCT02772276|559551887|FG005|Overall Study|Lost to Follow-up|0|||
155034039|NCT02772276|559551888|FG006|Overall Study|Lost to Follow-up|1|||
155034040|NCT02772276|559551889|FG007|Overall Study|Lost to Follow-up|0|||
155034041|NCT02772276|559551890|FG008|Overall Study|Lost to Follow-up|0|||
155034042|NCT02772276|559551891|FG009|Overall Study|Lost to Follow-up|0|||
155034043|NCT02772276|559551892|FG010|Overall Study|Lost to Follow-up|0|||
155034044|NCT02772276|559551893|FG011|Overall Study|Lost to Follow-up|0|||
155034045|NCT02772276|559551894|FG012|Overall Study|Lost to Follow-up|0|||
155034046|NCT02772276|559551882|FG000|Overall Study|Withdrew consent|0|||
155034047|NCT02772276|559551883|FG001|Overall Study|Withdrew consent|0|||
155034048|NCT02772276|559551884|FG002|Overall Study|Withdrew consent|0|||
155034049|NCT02772276|559551885|FG003|Overall Study|Withdrew consent|0|||
155034050|NCT02772276|559551886|FG004|Overall Study|Withdrew consent|0|||
155034051|NCT02772276|559551887|FG005|Overall Study|Withdrew consent|0|||
155185115|NCT02942576|560116298|FG001|Overall Study|Withdrawal by Subject|5|||
155034052|NCT02772276|559551888|FG006|Overall Study|Withdrew consent|0|||
155185116|NCT02942576|560116297|FG000|Overall Study|Physician Decision|1|||
155034053|NCT02772276|559551889|FG007|Overall Study|Withdrew consent|1|||
155034054|NCT02772276|559551890|FG008|Overall Study|Withdrew consent|0|||
155034055|NCT02772276|559551891|FG009|Overall Study|Withdrew consent|0|||
155034056|NCT02772276|559551892|FG010|Overall Study|Withdrew consent|0|||
155034057|NCT02772276|559551893|FG011|Overall Study|Withdrew consent|0|||
155034058|NCT02772276|559551894|FG012|Overall Study|Withdrew consent|0|||
155034059|NCT00550862|559551895|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
155034060|NCT00550862|559551896|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
155034061|NCT00550862|559551897|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
155034062|NCT00550862|559551898|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
155034063|NCT00550862|559551899|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
155034064|NCT00550862|559551895|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
155034065|NCT00550862|559551896|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
155034066|NCT00550862|559551897|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
155034067|NCT00550862|559551898|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
155034068|NCT00550862|559551899|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
155034069|NCT00550862|559551895|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155034070|NCT00550862|559551896|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155034071|NCT00550862|559551897|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
155034072|NCT00550862|559551898|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155034073|NCT00550862|559551899|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
155034074|NCT00550862|559551895|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155034075|NCT00550862|559551896|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155034076|NCT00550862|559551897|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
155034077|NCT00550862|559551898|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155034078|NCT00550862|559551899|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
155034079|NCT00550862|559551895|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155034080|NCT00550862|559551896|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
155034081|NCT00550862|559551897|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155034082|NCT00550862|559551898|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155034083|NCT00550862|559551899|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
155034084|NCT00550862|559551895|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155034085|NCT00550862|559551896|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155034086|NCT00550862|559551897|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155034087|NCT00550862|559551898|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
155034088|NCT00550862|559551899|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
155034089|NCT00550862|559551895|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155034090|NCT00550862|559551896|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155034091|NCT00550862|559551897|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155034092|NCT00550862|559551898|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
155034093|NCT00550862|559551899|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
155034094|NCT00550862|559551895|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155034095|NCT00550862|559551896|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155034096|NCT00550862|559551897|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155034097|NCT00550862|559551898|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
155034098|NCT00550862|559551899|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
155034099|NCT00550862|559551895|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
155034100|NCT00550862|559551896|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
155034101|NCT00550862|559551897|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
155034102|NCT00550862|559551898|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
155034103|NCT00550862|559551899|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
155034104|NCT00550862|559551895|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155034105|NCT00550862|559551896|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155034106|NCT00550862|559551897|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155034107|NCT00550862|559551898|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
155034108|NCT00550862|559551899|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
155034109|NCT02248974|559551903|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
155034110|NCT02248974|559551904|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
155034111|NCT02248974|559551903|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
155034112|NCT02248974|559551904|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
155034113|NCT02248974|559551903|FG000|1-Day Follow-Up|Enrolled in another study|1|||
155034114|NCT02248974|559551904|FG001|1-Day Follow-Up|Enrolled in another study|0|||
155034115|NCT02248974|559551903|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
155034116|NCT02248974|559551904|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
155034117|NCT02248974|559551903|FG000|1-Week Follow-Up|Enrolled in another study|1|||
155034118|NCT02248974|559551904|FG001|1-Week Follow-Up|Enrolled in another study|1|||
155034119|NCT02248974|559551903|FG000|1-Week Follow-Up|Transferred to another facility|1|||
155034120|NCT02248974|559551904|FG001|1-Week Follow-Up|Transferred to another facility|0|||
155034121|NCT02248974|559551903|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
155034122|NCT02248974|559551904|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
155034123|NCT02248974|559551903|FG000|1-Week Follow-Up|Death|1|||
155034124|NCT02248974|559551904|FG001|1-Week Follow-Up|Death|1|||
155034125|NCT02248974|559551903|FG000|1-Week Follow-Up|Excluded because of age|0|||
155034126|NCT02248974|559551904|FG001|1-Week Follow-Up|Excluded because of age|1|||
155034127|NCT02248974|559551903|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
155034128|NCT02248974|559551904|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
155034129|NCT02248974|559551903|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
155034130|NCT02248974|559551904|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
155034131|NCT02248974|559551903|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
155034132|NCT02248974|559551904|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
155034133|NCT02248974|559551903|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
155034134|NCT02248974|559551904|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
155034135|NCT02248974|559551903|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
155034136|NCT02248974|559551904|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
155034137|NCT03488225|559551905|FG000|Overall Study|Off Protocol Therapy|2|||
155034138|NCT03488225|559551905|FG000|Overall Study|Stem Cell Transplant|2|||
155034139|NCT04093492|559551906|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
155034140|NCT04093492|559551907|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
155034141|NCT04093492|559551908|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
155034142|NCT04093492|559551909|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
155034143|NCT04093492|559551906|FG000|25 Weeks Gestational Age (GA)|No response|5|||
155034144|NCT04093492|559551907|FG001|25 Weeks Gestational Age (GA)|No response|5|||
155034145|NCT04093492|559551908|FG002|25 Weeks Gestational Age (GA)|No response|5|||
155034146|NCT04093492|559551909|FG003|25 Weeks Gestational Age (GA)|No response|2|||
155034147|NCT04093492|559551906|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
155034148|NCT04093492|559551907|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
155034149|NCT04093492|559551908|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
155034150|NCT04093492|559551909|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
155034151|NCT04093492|559551906|FG000|30 Weeks GA|Delivered before assessment|1|||
155034152|NCT04093492|559551907|FG001|30 Weeks GA|Delivered before assessment|2|||
155034153|NCT04093492|559551908|FG002|30 Weeks GA|Delivered before assessment|0|||
155034154|NCT04093492|559551909|FG003|30 Weeks GA|Delivered before assessment|0|||
155034155|NCT04093492|559551906|FG000|30 Weeks GA|No response|7|||
155034156|NCT04093492|559551907|FG001|30 Weeks GA|No response|5|||
155034157|NCT04093492|559551908|FG002|30 Weeks GA|No response|5|||
155034158|NCT04093492|559551909|FG003|30 Weeks GA|No response|2|||
155034159|NCT04093492|559551906|FG000|30 Weeks GA|Lost to Follow-up|0|||
155034160|NCT04093492|559551907|FG001|30 Weeks GA|Lost to Follow-up|1|||
155034161|NCT04093492|559551908|FG002|30 Weeks GA|Lost to Follow-up|0|||
155034162|NCT04093492|559551909|FG003|30 Weeks GA|Lost to Follow-up|0|||
155034163|NCT04093492|559551906|FG000|34 Weeks GA|Delivered before assessment|6|||
155034164|NCT04093492|559551907|FG001|34 Weeks GA|Delivered before assessment|3|||
155034165|NCT04093492|559551908|FG002|34 Weeks GA|Delivered before assessment|0|||
155034166|NCT04093492|559551909|FG003|34 Weeks GA|Delivered before assessment|0|||
155034167|NCT04093492|559551906|FG000|34 Weeks GA|No response|0|||
155034168|NCT04093492|559551907|FG001|34 Weeks GA|No response|7|||
155034169|NCT04093492|559551908|FG002|34 Weeks GA|No response|5|||
155034170|NCT04093492|559551909|FG003|34 Weeks GA|No response|3|||
155034171|NCT04093492|559551906|FG000|34 Weeks GA|Lost to Follow-up|0|||
155034172|NCT04093492|559551907|FG001|34 Weeks GA|Lost to Follow-up|1|||
155034173|NCT04093492|559551908|FG002|34 Weeks GA|Lost to Follow-up|0|||
155034174|NCT04093492|559551909|FG003|34 Weeks GA|Lost to Follow-up|0|||
155034175|NCT02945254|559551916|FG000|Overall Study|Lost to Follow-up|1|||
155034176|NCT02945254|559551917|FG001|Overall Study|Lost to Follow-up|0|||
155034177|NCT02945254|559551916|FG000|Overall Study|Withdrawal by Subject|1|||
155034178|NCT02945254|559551917|FG001|Overall Study|Withdrawal by Subject|0|||
155034179|NCT00783224|559551918|FG000|Overall Study|Adverse Event|0|||
155034180|NCT00783224|559551919|FG001|Overall Study|Adverse Event|0|||
155034181|NCT00783224|559551920|FG002|Overall Study|Adverse Event|1|||
155034182|NCT00783224|559551921|FG003|Overall Study|Adverse Event|0|||
155034183|NCT00783224|559551918|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
155185117|NCT02942576|560116298|FG001|Overall Study|Physician Decision|4|||
155034184|NCT00783224|559551919|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
155034185|NCT00783224|559551920|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
155034186|NCT00783224|559551921|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
155034187|NCT00783224|559551918|FG000|Overall Study|Inappropriate as a study subject|0|||
155034188|NCT00783224|559551919|FG001|Overall Study|Inappropriate as a study subject|0|||
155034189|NCT00783224|559551920|FG002|Overall Study|Inappropriate as a study subject|0|||
155034190|NCT00783224|559551921|FG003|Overall Study|Inappropriate as a study subject|1|||
155034191|NCT01711619|559551922|FG000|Overall Study|Early study termination|10|||
155034192|NCT01711619|559551923|FG001|Overall Study|Early study termination|14|||
155034193|NCT01711619|559551922|FG000|Overall Study|Withdrawal by Subject|3|||
155034194|NCT01711619|559551923|FG001|Overall Study|Withdrawal by Subject|7|||
155034195|NCT01711619|559551922|FG000|Overall Study|Protocol Violation|2|||
155034196|NCT01711619|559551923|FG001|Overall Study|Protocol Violation|3|||
155034197|NCT01711619|559551922|FG000|Overall Study|Adverse Event|2|||
155034198|NCT01711619|559551923|FG001|Overall Study|Adverse Event|0|||
155034199|NCT01711619|559551922|FG000|Overall Study|Lost to Follow-up|1|||
155034200|NCT01711619|559551923|FG001|Overall Study|Lost to Follow-up|0|||
155034201|NCT04631107|559551924|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
155034202|NCT04631107|559551924|FG000|Second Intervention (1 Night)|Adverse Event|1|||
155034203|NCT04631107|559551924|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
155034204|NCT04631107|559551924|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
155034205|NCT00503997|559551929|FG000|Overall Study|disease progression|1|||
155034206|NCT00503997|559551929|FG000|Overall Study|Adverse Event|5|||
155034207|NCT00503997|559551929|FG000|Overall Study|Death|1|||
155034208|NCT00503997|559551929|FG000|Overall Study|Withdrawal by Subject|1|||
155034209|NCT01195844|559551930|FG000|Overall Study|Fecal sample not collected|40|||
155034210|NCT00087126|559551931|FG000|Overall Study|Ineligible - second primary|1|||
155034211|NCT00087126|559551931|FG000|Overall Study|Never treated|1|||
155034212|NCT01432275|559551932|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
155034213|NCT01432275|559551933|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
155034214|NCT01432275|559551932|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
155034215|NCT01432275|559551933|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
155143204|NCT02519439|559956945|FG000|Overall Study|Withdrawal by Subject|1|||
155143205|NCT02519439|559956945|FG000|Overall Study|Adverse Event|1|||
155143206|NCT04961541|559956948|FG000|Overall Study|Adverse Event|0|||
155143207|NCT04961541|559956949|FG001|Overall Study|Adverse Event|0|||
155143208|NCT04961541|559956950|FG002|Overall Study|Adverse Event|0|||
155143209|NCT04961541|559956951|FG003|Overall Study|Adverse Event|0|||
155143210|NCT04961541|559956952|FG004|Overall Study|Adverse Event|0|||
155143211|NCT04961541|559956953|FG005|Overall Study|Adverse Event|1|||
155143212|NCT04961541|559956954|FG006|Overall Study|Adverse Event|0|||
155143213|NCT04961541|559956955|FG007|Overall Study|Adverse Event|0|||
155143214|NCT04961541|559956956|FG008|Overall Study|Adverse Event|0|||
155143215|NCT04961541|559956957|FG009|Overall Study|Adverse Event|0|||
155143216|NCT04961541|559956958|FG010|Overall Study|Adverse Event|0|||
155143217|NCT04961541|559956959|FG011|Overall Study|Adverse Event|0|||
155143218|NCT04961541|559956960|FG012|Overall Study|Adverse Event|0|||
155143219|NCT04961541|559956961|FG013|Overall Study|Adverse Event|0|||
155143220|NCT04961541|559956948|FG000|Overall Study|Lost to Follow-up|0|||
155143221|NCT04961541|559956949|FG001|Overall Study|Lost to Follow-up|0|||
155143222|NCT04961541|559956950|FG002|Overall Study|Lost to Follow-up|3|||
155143223|NCT04961541|559956951|FG003|Overall Study|Lost to Follow-up|0|||
155143224|NCT04961541|559956952|FG004|Overall Study|Lost to Follow-up|0|||
155143225|NCT04961541|559956953|FG005|Overall Study|Lost to Follow-up|0|||
155143226|NCT04961541|559956954|FG006|Overall Study|Lost to Follow-up|1|||
155143227|NCT04961541|559956955|FG007|Overall Study|Lost to Follow-up|1|||
155143228|NCT04961541|559956956|FG008|Overall Study|Lost to Follow-up|0|||
155143229|NCT04961541|559956957|FG009|Overall Study|Lost to Follow-up|1|||
155143230|NCT04961541|559956958|FG010|Overall Study|Lost to Follow-up|0|||
155143231|NCT04961541|559956959|FG011|Overall Study|Lost to Follow-up|0|||
155143232|NCT04961541|559956960|FG012|Overall Study|Lost to Follow-up|1|||
155143233|NCT04961541|559956961|FG013|Overall Study|Lost to Follow-up|0|||
155143234|NCT04961541|559956948|FG000|Overall Study|Withdrawal by Subject|0|||
155143235|NCT04961541|559956949|FG001|Overall Study|Withdrawal by Subject|0|||
155143236|NCT04961541|559956950|FG002|Overall Study|Withdrawal by Subject|1|||
155143237|NCT04961541|559956951|FG003|Overall Study|Withdrawal by Subject|1|||
155143238|NCT04961541|559956952|FG004|Overall Study|Withdrawal by Subject|0|||
155143239|NCT04961541|559956953|FG005|Overall Study|Withdrawal by Subject|0|||
155143240|NCT04961541|559956954|FG006|Overall Study|Withdrawal by Subject|0|||
155143241|NCT04961541|559956955|FG007|Overall Study|Withdrawal by Subject|0|||
155143242|NCT04961541|559956956|FG008|Overall Study|Withdrawal by Subject|0|||
155143243|NCT04961541|559956957|FG009|Overall Study|Withdrawal by Subject|1|||
155143244|NCT04961541|559956958|FG010|Overall Study|Withdrawal by Subject|0|||
155143245|NCT04961541|559956959|FG011|Overall Study|Withdrawal by Subject|0|||
155143246|NCT04961541|559956960|FG012|Overall Study|Withdrawal by Subject|0|||
155143247|NCT04961541|559956961|FG013|Overall Study|Withdrawal by Subject|0|||
155143248|NCT02330055|559956963|FG000|Overall Study|technical issues|2|||
155143249|NCT02330055|559956964|FG001|Overall Study|technical issues|0|||
155143250|NCT02330055|559956963|FG000|Overall Study|participant forgot to wear device|5|||
155143251|NCT02330055|559956964|FG001|Overall Study|participant forgot to wear device|5|||
155143252|NCT02330055|559956963|FG000|Overall Study|data for less than 60 minutes|3|||
155143253|NCT02330055|559956964|FG001|Overall Study|data for less than 60 minutes|3|||
155143254|NCT02330055|559956963|FG000|Overall Study|participant did not sleep|0|||
155143255|NCT02330055|559956964|FG001|Overall Study|participant did not sleep|1|||
155143256|NCT02959437|559956965|FG000|Overall Study|Death|33|||
155034216|NCT01432275|559551932|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
155034217|NCT01432275|559551933|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
155034218|NCT01432275|559551932|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
155185118|NCT02942576|560116297|FG000|Overall Study|Other|10|||
155185119|NCT02942576|560116298|FG001|Overall Study|Other|8|||
155185120|NCT01484054|560116309|FG000|Period 1|Withdrawal by Subject|0|||
155185121|NCT01484054|560116310|FG001|Period 1|Withdrawal by Subject|1|||
155185122|NCT05281601|560116311|FG000|Overall Study|Physician Decision|2|||
155185123|NCT05281601|560116312|FG001|Overall Study|Physician Decision|0|||
155185124|NCT05281601|560116311|FG000|Overall Study|Lost to Follow-up|2|||
155185125|NCT05281601|560116312|FG001|Overall Study|Lost to Follow-up|0|||
155185126|NCT05281601|560116311|FG000|Overall Study|Death|1|||
155185127|NCT05281601|560116312|FG001|Overall Study|Death|0|||
155185128|NCT05281601|560116311|FG000|Overall Study|Withdrawal by parent/guardian|2|||
155185129|NCT05281601|560116312|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155185130|NCT00995865|560116319|FG000|Overall Study|Protocol Violation|2|||
155185131|NCT00995865|560116320|FG001|Overall Study|Protocol Violation|0|||
155185132|NCT00995865|560116321|FG002|Overall Study|Protocol Violation|0|||
155185133|NCT00995865|560116319|FG000|Overall Study|Lost to Follow-up|0|||
155185134|NCT00995865|560116320|FG001|Overall Study|Lost to Follow-up|0|||
155185135|NCT00995865|560116321|FG002|Overall Study|Lost to Follow-up|1|||
155185136|NCT02101112|560116323|FG000|Overall Study|Adverse Event|0|||
155185137|NCT02101112|560116324|FG001|Overall Study|Adverse Event|0|||
155185138|NCT02101112|560116325|FG002|Overall Study|Adverse Event|1|||
155185139|NCT02101112|560116326|FG003|Overall Study|Adverse Event|0|||
155185140|NCT02101112|560116327|FG004|Overall Study|Adverse Event|0|||
155185141|NCT02101112|560116328|FG005|Overall Study|Adverse Event|0|||
155185142|NCT02101112|560116323|FG000|Overall Study|Withdrawal by Subject|0|||
155185143|NCT02101112|560116324|FG001|Overall Study|Withdrawal by Subject|0|||
155185144|NCT02101112|560116325|FG002|Overall Study|Withdrawal by Subject|0|||
155185145|NCT02101112|560116326|FG003|Overall Study|Withdrawal by Subject|0|||
155185146|NCT02101112|560116327|FG004|Overall Study|Withdrawal by Subject|1|||
155185147|NCT02101112|560116328|FG005|Overall Study|Withdrawal by Subject|0|||
155185148|NCT04340063|560116329|FG000|Overall Study|Withdrawal by Subject|1|||
155185149|NCT04340063|560116330|FG001|Overall Study|Withdrawal by Subject|2|||
155185150|NCT04340063|560116329|FG000|Overall Study|Lost to Follow-up|3|||
155185151|NCT04340063|560116330|FG001|Overall Study|Lost to Follow-up|1|||
155185152|NCT04340063|560116329|FG000|Overall Study|Protocol Violation|0|||
155185153|NCT04340063|560116330|FG001|Overall Study|Protocol Violation|1|||
155185154|NCT00993044|560116335|FG000|Irinotecan 50 mg|Physician Decision|1|||
155185155|NCT00734747|560116337|FG000|SRS Procedure|No staples placed|3|||
155185156|NCT00734747|560116337|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
155185157|NCT05063318|560116341|FG000|Overall Study|Progressive disease|2|||
155185158|NCT05063318|560116342|FG001|Overall Study|Progressive disease|0|||
155185159|NCT05063318|560116343|FG002|Overall Study|Progressive disease|3|||
155185160|NCT05063318|560116341|FG000|Overall Study|Compassionate use|1|||
155185161|NCT05063318|560116342|FG001|Overall Study|Compassionate use|3|||
155185162|NCT05063318|560116343|FG002|Overall Study|Compassionate use|3|||
155185163|NCT05063318|560116341|FG000|Overall Study|Adverse Event|0|||
155185164|NCT05063318|560116342|FG001|Overall Study|Adverse Event|1|||
155185165|NCT05063318|560116343|FG002|Overall Study|Adverse Event|0|||
155185166|NCT05063318|560116341|FG000|Overall Study|Withdrawal by Subject|0|||
155185167|NCT05063318|560116342|FG001|Overall Study|Withdrawal by Subject|1|||
155185168|NCT05063318|560116343|FG002|Overall Study|Withdrawal by Subject|0|||
155185169|NCT03287635|560116344|FG000|Overall Study|Lost to Follow-up|5|||
155185170|NCT03287635|560116344|FG000|Overall Study|Withdrawal by Subject|1|||
155185171|NCT03287635|560116344|FG000|Overall Study|Physician Decision|1|||
155185172|NCT00323869|560116347|FG000|Overall Study|Death|1|||
155185173|NCT03172910|560117895|FG000|Overall Study|Adverse Event|0|||
155185174|NCT03172910|560117896|FG001|Overall Study|Adverse Event|0|||
155185175|NCT03172910|560117897|FG002|Overall Study|Adverse Event|0|||
155185176|NCT03172910|560117898|FG003|Overall Study|Adverse Event|0|||
155185177|NCT03172910|560117899|FG004|Overall Study|Adverse Event|1|||
155185178|NCT03468985|560117911|FG000|Overall Study|Adverse Event|0|||
155185179|NCT03468985|560117912|FG001|Overall Study|Adverse Event|2|||
155185180|NCT03468985|560117913|FG002|Overall Study|Adverse Event|0|||
155185181|NCT03468985|560117914|FG003|Overall Study|Adverse Event|0|||
155185182|NCT03468985|560117911|FG000|Overall Study|Withdrawal by Subject|0|||
155185183|NCT03468985|560117912|FG001|Overall Study|Withdrawal by Subject|0|||
155185184|NCT03468985|560117913|FG002|Overall Study|Withdrawal by Subject|0|||
155185185|NCT03468985|560117914|FG003|Overall Study|Withdrawal by Subject|1|||
155185186|NCT02806973|560117915|FG000|Period 1|Withdrawal by Subject|0|||
155185187|NCT02806973|560117916|FG001|Period 1|Withdrawal by Subject|2|||
155185188|NCT02806973|560117917|FG002|Period 1|Withdrawal by Subject|1|||
155185189|NCT02806973|560117918|FG003|Period 1|Withdrawal by Subject|1|||
155185190|NCT02806973|560117915|FG000|Period 1|Adverse Event|0|||
155185191|NCT02806973|560117916|FG001|Period 1|Adverse Event|0|||
155185192|NCT02806973|560117917|FG002|Period 1|Adverse Event|0|||
155185193|NCT02806973|560117918|FG003|Period 1|Adverse Event|1|||
155185194|NCT02806973|560117915|FG000|Period 3|Withdrawal by Subject|0|||
155185195|NCT02806973|560117916|FG001|Period 3|Withdrawal by Subject|0|||
155185196|NCT02806973|560117917|FG002|Period 3|Withdrawal by Subject|0|||
155185197|NCT02806973|560117918|FG003|Period 3|Withdrawal by Subject|3|||
155185198|NCT02806973|560117915|FG000|Period 3|Adverse Event|0|||
155185199|NCT02806973|560117916|FG001|Period 3|Adverse Event|0|||
155185200|NCT02806973|560117917|FG002|Period 3|Adverse Event|1|||
155185201|NCT02806973|560117918|FG003|Period 3|Adverse Event|0|||
155185202|NCT04060862|560117919|FG000|Overall Study|Symptomatic Deterioration|1|||
155185203|NCT04060862|560117919|FG000|Overall Study|Un-specified|6|||
155185204|NCT04060862|560117919|FG000|Overall Study|Progressive disease|12|||
155185205|NCT04060862|560117919|FG000|Overall Study|Physician Decision|1|||
155185206|NCT01229397|560117920|FG000|Overall Study|Withdrawal by Subject|3|||
155185207|NCT01229397|560117921|FG001|Overall Study|Withdrawal by Subject|3|||
155185208|NCT01229397|560117920|FG000|Overall Study|Lost to Follow-up|7|||
155185209|NCT01229397|560117921|FG001|Overall Study|Lost to Follow-up|6|||
155185210|NCT01229397|560117920|FG000|Overall Study|Migrated/moved from study area|1|||
155185211|NCT01229397|560117921|FG001|Overall Study|Migrated/moved from study area|0|||
155185212|NCT01869725|560117923|FG000|Overall Study|ineligible after registration|1|||
155185213|NCT01869725|560117923|FG000|Overall Study|Death|1|||
155185214|NCT01869725|560117923|FG000|Overall Study|Lost to Follow-up|2|||
155185215|NCT03416374|560117924|FG000|Between Treatment Period I and II|Other|0|||
155185216|NCT03416374|560117925|FG001|Between Treatment Period I and II|Other|9|||
155185217|NCT03416374|560117924|FG000|Treatment Period II|Lack of Efficacy|3|||
155185218|NCT03416374|560117925|FG001|Treatment Period II|Lack of Efficacy|11|||
155185219|NCT03416374|560117924|FG000|Treatment Period II|Adverse Event|1|||
155185220|NCT03416374|560117925|FG001|Treatment Period II|Adverse Event|4|||
155185221|NCT03416374|560117924|FG000|Treatment Period II|Death|0|||
155185222|NCT03416374|560117925|FG001|Treatment Period II|Death|1|||
155185223|NCT03416374|560117924|FG000|Treatment Period II|Other|0|||
155185224|NCT03416374|560117925|FG001|Treatment Period II|Other|2|||
155185225|NCT03463031|560117928|FG000|Overall Study|Withdrawal by Subject|4|||
155185226|NCT03463031|560117929|FG001|Overall Study|Withdrawal by Subject|2|||
155185227|NCT03463031|560117928|FG000|Overall Study|Investigator/Sponsor Decision|0|||
155185228|NCT03463031|560117929|FG001|Overall Study|Investigator/Sponsor Decision|1|||
155185229|NCT03463031|560117928|FG000|Overall Study|Lost to Follow-up|1|||
155185230|NCT03463031|560117929|FG001|Overall Study|Lost to Follow-up|1|||
155185231|NCT03463031|560117928|FG000|Overall Study|Adverse Event|4|||
155185232|NCT03463031|560117929|FG001|Overall Study|Adverse Event|1|||
155185233|NCT03463031|560117928|FG000|Overall Study|Use of prohibited medication by subject|1|||
155185234|NCT03463031|560117929|FG001|Overall Study|Use of prohibited medication by subject|0|||
155185235|NCT01241240|560117930|FG000|Overall Study|Adverse Event|5|||
155185236|NCT01241240|560117931|FG001|Overall Study|Adverse Event|4|||
155185237|NCT01241240|560117930|FG000|Overall Study|Lost to Follow-up|2|||
155185238|NCT01241240|560117931|FG001|Overall Study|Lost to Follow-up|4|||
155185239|NCT01241240|560117930|FG000|Overall Study|Personal Reasons|1|||
155185240|NCT01241240|560117931|FG001|Overall Study|Personal Reasons|1|||
155185241|NCT01025154|560117932|FG000|Overall Study|Lost to Follow-up|1|||
155185242|NCT01025154|560117932|FG000|Overall Study|Withdrawal by Subject|1|||
155185243|NCT01810432|560117933|FG000|Washout|Protocol Violation|0|||
155185244|NCT01810432|560117934|FG001|Washout|Protocol Violation|1|||
155185245|NCT01810432|560117933|FG000|Washout|Adverse Event|1|||
155185246|NCT01810432|560117934|FG001|Washout|Adverse Event|0|||
155185247|NCT01810432|560117933|FG000|Period 2|Withdrawal by Subject|2|||
155185248|NCT01810432|560117934|FG001|Period 2|Withdrawal by Subject|1|||
155185249|NCT01810432|560117933|FG000|Period 2|Physician Decision|1|||
155185250|NCT01810432|560117934|FG001|Period 2|Physician Decision|0|||
155185251|NCT01810432|560117933|FG000|Period 2|Lost to Follow-up|1|||
155185252|NCT01810432|560117934|FG001|Period 2|Lost to Follow-up|1|||
155185253|NCT01251744|560117935|FG000|Overall Study|Lost to Follow-up|1|||
155185254|NCT01251744|560117936|FG001|Overall Study|Lost to Follow-up|0|||
155185255|NCT02147184|560117937|FG000|Overall Study|Lost to Follow-up|28|||
155185256|NCT02147184|560117938|FG001|Overall Study|Lost to Follow-up|15|||
155185257|NCT02147184|560117937|FG000|Overall Study|Study Burden|11|||
155185258|NCT02147184|560117938|FG001|Overall Study|Study Burden|7|||
155185259|NCT02147184|560117937|FG000|Overall Study|Pregnancy|6|||
155185260|NCT02147184|560117938|FG001|Overall Study|Pregnancy|0|||
155185261|NCT02147184|560117937|FG000|Overall Study|Moved out of state|3|||
155185262|NCT02147184|560117938|FG001|Overall Study|Moved out of state|3|||
155185263|NCT02147184|560117937|FG000|Overall Study|Physician Decision|0|||
155185264|NCT02147184|560117938|FG001|Overall Study|Physician Decision|2|||
155185265|NCT02147184|560117937|FG000|Overall Study|Other|1|||
155185266|NCT02147184|560117938|FG001|Overall Study|Other|0|||
155185267|NCT01151098|560117940|FG000|Overall Study|Adverse Event|82|||
155185268|NCT01151098|560117940|FG000|Overall Study|Lost to Follow-up|6|||
155185269|NCT01151098|560117940|FG000|Overall Study|Lack of Efficacy|15|||
155185270|NCT01151098|560117940|FG000|Overall Study|Protocol Violation|1|||
155185271|NCT01151098|560117940|FG000|Overall Study|Miscellaneous|13|||
155185272|NCT00542451|560117941|FG000|Overall Study|Adverse Event|31|||
155185273|NCT00542451|560117941|FG000|Overall Study|Withdrawal by Subject|30|||
155185274|NCT00542451|560117941|FG000|Overall Study|Physician Decision|4|||
155185275|NCT00542451|560117941|FG000|Overall Study|Recurrent disease|1|||
155185276|NCT00542451|560117941|FG000|Overall Study|unknown reason|1|||
155185277|NCT00542451|560117941|FG000|Overall Study|Death|2|||
155034219|NCT01432275|559551933|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
155034220|NCT01432275|559551932|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
155034221|NCT01432275|559551933|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
155034222|NCT01432275|559551932|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
155034223|NCT01432275|559551933|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
155034224|NCT01432275|559551932|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
155034225|NCT01432275|559551933|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
155034226|NCT01432275|559551932|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
155034227|NCT01432275|559551933|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
155034228|NCT01432275|559551932|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
155034229|NCT01432275|559551933|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
155034230|NCT00096993|559551936|FG000|Overall Study|Death|1|||
155034231|NCT00096993|559551937|FG001|Overall Study|Death|0|||
155034232|NCT00096993|559551936|FG000|Overall Study|Disease progression|56|||
155034233|NCT00096993|559551937|FG001|Overall Study|Disease progression|53|||
155034234|NCT00096993|559551936|FG000|Overall Study|Adverse Event|2|||
155034235|NCT00096993|559551937|FG001|Overall Study|Adverse Event|8|||
155034236|NCT00096993|559551936|FG000|Overall Study|Subject's decision|3|||
155034237|NCT00096993|559551937|FG001|Overall Study|Subject's decision|1|||
155034238|NCT00096993|559551936|FG000|Overall Study|Physician Decision|2|||
155034239|NCT00096993|559551937|FG001|Overall Study|Physician Decision|1|||
155034240|NCT00096993|559551936|FG000|Overall Study|Non-compliance|0|||
155034241|NCT00096993|559551937|FG001|Overall Study|Non-compliance|1|||
155034242|NCT00096993|559551936|FG000|Overall Study|Other unspecified|1|||
155034243|NCT00096993|559551937|FG001|Overall Study|Other unspecified|1|||
155034244|NCT01440569|559551943|FG000|Main Study|Enrolled but not treated|1|||
155034245|NCT01440569|559551944|FG001|Main Study|Enrolled but not treated|0|||
155034246|NCT01440569|559551943|FG000|Main Study|Adverse Event|9|||
155034247|NCT01440569|559551944|FG001|Main Study|Adverse Event|0|||
155034248|NCT01440569|559551943|FG000|Main Study|Pregnancy|1|||
155034249|NCT01440569|559551944|FG001|Main Study|Pregnancy|0|||
155034250|NCT01440569|559551943|FG000|Main Study|Investigator's Discretion|1|||
155034251|NCT01440569|559551944|FG001|Main Study|Investigator's Discretion|1|||
155034252|NCT01440569|559551943|FG000|Main Study|Withdrew Consent|7|||
155034253|NCT01440569|559551944|FG001|Main Study|Withdrew Consent|1|||
155034254|NCT01440569|559551943|FG000|Main Study|Lost to Follow-up|13|||
155034255|NCT01440569|559551944|FG001|Main Study|Lost to Follow-up|2|||
155034256|NCT01440569|559551943|FG000|Main Study|Subject Non-Compliance|3|||
155034257|NCT01440569|559551944|FG001|Main Study|Subject Non-Compliance|0|||
155034258|NCT01440569|559551943|FG000|Main Study|Protocol Violation|1|||
155034259|NCT01440569|559551944|FG001|Main Study|Protocol Violation|0|||
155034260|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Adverse Event|3|||
155034261|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Adverse Event|0|||
155034262|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Pregnancy|1|||
155034263|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Pregnancy|0|||
155034264|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
155034265|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
155034266|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
155034267|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
155034268|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
155034269|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
155034270|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
155034271|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
155034272|NCT01440569|559551943|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
155034273|NCT01440569|559551944|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
155034274|NCT02584959|559551945|FG000|Period 1|Withdrawn from study|3|||
155034275|NCT02584959|559551946|FG001|Period 1|Withdrawn from study|4|||
155034276|NCT02584959|559551947|FG002|Period 1|Withdrawn from study|0|||
155034277|NCT02584959|559551945|FG000|Period 2|Withdrawn from study|6|||
155034278|NCT02584959|559551946|FG001|Period 2|Withdrawn from study|1|||
155034279|NCT02584959|559551947|FG002|Period 2|Withdrawn from study|2|||
155034280|NCT00513357|559551948|FG000|Overall Study|did not receive allocated placebo|2|||
155034281|NCT00513357|559551949|FG001|Overall Study|did not receive allocated placebo|3|||
155034282|NCT00513357|559551948|FG000|Overall Study|Adverse Event|4|||
155034283|NCT00513357|559551949|FG001|Overall Study|Adverse Event|2|||
155034284|NCT00513357|559551948|FG000|Overall Study|Death|2|||
155034285|NCT00513357|559551949|FG001|Overall Study|Death|0|||
155034286|NCT00513357|559551948|FG000|Overall Study|Withdrawal by Subject|5|||
155034287|NCT00513357|559551949|FG001|Overall Study|Withdrawal by Subject|4|||
155034288|NCT00513357|559551948|FG000|Overall Study|Disease Progression|2|||
155034289|NCT00513357|559551949|FG001|Overall Study|Disease Progression|1|||
155034290|NCT01162122|559551950|FG000|Overall Study|Withdrawal by Subject|52|||
155034291|NCT01162122|559551951|FG001|Overall Study|Withdrawal by Subject|43|||
155034292|NCT01162122|559551950|FG000|Overall Study|Lost to Follow-up|73|||
155034293|NCT01162122|559551951|FG001|Overall Study|Lost to Follow-up|91|||
155034294|NCT01162122|559551950|FG000|Overall Study|Adverse Event|3|||
155034295|NCT01162122|559551951|FG001|Overall Study|Adverse Event|2|||
155034296|NCT01162122|559551950|FG000|Overall Study|Death|51|||
155034297|NCT01162122|559551951|FG001|Overall Study|Death|46|||
155143257|NCT02959437|559956966|FG001|Overall Study|Death|3|||
155034298|NCT01162122|559551950|FG000|Overall Study|Protocol Violation|2|||
155034299|NCT01162122|559551951|FG001|Overall Study|Protocol Violation|2|||
155034300|NCT01162122|559551950|FG000|Overall Study|Inappropriate enrollment|5|||
155034301|NCT01162122|559551951|FG001|Overall Study|Inappropriate enrollment|4|||
155034302|NCT01162122|559551950|FG000|Overall Study|Administrative reason|1|||
155034303|NCT01162122|559551951|FG001|Overall Study|Administrative reason|1|||
155034304|NCT01162122|559551950|FG000|Overall Study|Unable to classify|3|||
155034305|NCT01162122|559551951|FG001|Overall Study|Unable to classify|7|||
155034306|NCT01162122|559551950|FG000|Overall Study|Missing primary reason|1|||
155034307|NCT01162122|559551951|FG001|Overall Study|Missing primary reason|0|||
155034308|NCT00435487|559551958|FG000|Overall Study|Death|3|||
155034309|NCT00435487|559551959|FG001|Overall Study|Death|4|||
155034310|NCT00435487|559551958|FG000|Overall Study|Adverse Event|0|||
155034311|NCT00435487|559551959|FG001|Overall Study|Adverse Event|3|||
155034312|NCT00435487|559551958|FG000|Overall Study|Lost to Follow-up|2|||
155034313|NCT00435487|559551959|FG001|Overall Study|Lost to Follow-up|2|||
155034314|NCT00435487|559551958|FG000|Overall Study|Other|5|||
155034315|NCT00435487|559551959|FG001|Overall Study|Other|2|||
155034316|NCT00435487|559551958|FG000|Overall Study|Withdrawal by Subject|2|||
155034317|NCT00435487|559551959|FG001|Overall Study|Withdrawal by Subject|1|||
155034318|NCT00435487|559551958|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
155034319|NCT00435487|559551959|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
155034320|NCT00435487|559551958|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
155034321|NCT00435487|559551959|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
155034322|NCT00835679|559551961|FG000|Overall Study|Withdrawal by Subject|1|||
155034323|NCT00835679|559551962|FG001|Overall Study|Withdrawal by Subject|0|||
155034324|NCT00835679|559551963|FG002|Overall Study|Withdrawal by Subject|0|||
155034325|NCT00835679|559551964|FG003|Overall Study|Withdrawal by Subject|0|||
155034326|NCT00955968|559551968|FG000|Overall Study|Death|2|||
155034327|NCT00955968|559551969|FG001|Overall Study|Death|4|||
155034328|NCT00955968|559551968|FG000|Overall Study|Withdrawal by Subject|35|||
155034329|NCT00955968|559551969|FG001|Overall Study|Withdrawal by Subject|31|||
155034330|NCT00955968|559551968|FG000|Overall Study|Lost to Follow-up|45|||
155034331|NCT00955968|559551969|FG001|Overall Study|Lost to Follow-up|39|||
155034332|NCT00955968|559551968|FG000|Overall Study|Site closed|55|||
155034333|NCT00955968|559551969|FG001|Overall Study|Site closed|52|||
155034334|NCT00204477|559551972|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
155034335|NCT00204477|559551973|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
155034336|NCT00204477|559551972|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
155034337|NCT00204477|559551973|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
155034338|NCT01966068|559551974|FG000|Overall Study|Withdrawal by Subject|57|||
155034339|NCT01966068|559551974|FG000|Overall Study|Lost to Follow-up|81|||
155034340|NCT00808639|559551975|FG000|Overall Study|Disease progression before surgery.|1|||
155034341|NCT03589976|559551980|FG000|Overall Study|Death|5|||
155034342|NCT03589976|559551981|FG001|Overall Study|Death|1|||
155034343|NCT03589976|559551980|FG000|Overall Study|Adverse Event|5|||
155034344|NCT03589976|559551981|FG001|Overall Study|Adverse Event|1|||
155034345|NCT03589976|559551980|FG000|Overall Study|Withdrawal by Subject|4|||
155034346|NCT03589976|559551981|FG001|Overall Study|Withdrawal by Subject|1|||
155034347|NCT03589976|559551980|FG000|Overall Study|Lost to Follow-up|1|||
155034348|NCT03589976|559551981|FG001|Overall Study|Lost to Follow-up|0|||
155034349|NCT03589976|559551980|FG000|Overall Study|Other|4|||
155034350|NCT03589976|559551981|FG001|Overall Study|Other|3|||
155034351|NCT02089334|559551982|FG000|Overall Study|Withdrawal by Subject|0|||
155034352|NCT02089334|559551983|FG001|Overall Study|Withdrawal by Subject|0|||
155034353|NCT02089334|559551984|FG002|Overall Study|Withdrawal by Subject|0|||
155034354|NCT02089334|559551985|FG003|Overall Study|Withdrawal by Subject|2|||
155034355|NCT02089334|559551982|FG000|Overall Study|Adverse Event|0|||
155034356|NCT02089334|559551983|FG001|Overall Study|Adverse Event|0|||
155034357|NCT02089334|559551984|FG002|Overall Study|Adverse Event|0|||
155034358|NCT02089334|559551985|FG003|Overall Study|Adverse Event|2|||
155034359|NCT02089334|559551982|FG000|Overall Study|Progressive disease|0|||
155034360|NCT02089334|559551983|FG001|Overall Study|Progressive disease|0|||
155034361|NCT02089334|559551984|FG002|Overall Study|Progressive disease|0|||
155034362|NCT02089334|559551985|FG003|Overall Study|Progressive disease|2|||
155034363|NCT02089334|559551982|FG000|Overall Study|Physician Decision|0|||
155034364|NCT02089334|559551983|FG001|Overall Study|Physician Decision|0|||
155034365|NCT02089334|559551984|FG002|Overall Study|Physician Decision|1|||
155034366|NCT02089334|559551985|FG003|Overall Study|Physician Decision|1|||
155034367|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
155034368|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
155034369|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
155034370|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
155034371|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
155143258|NCT02959437|559956967|FG002|Overall Study|Death|0|||
155185278|NCT00542451|560117941|FG000|Overall Study|Lost to Follow-up|10|||
155034372|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
155034373|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
155034374|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
155185279|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
155185280|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
155185281|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
155185282|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
155185283|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155185284|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
155185285|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155185286|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
155185287|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
155185288|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
155185289|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
155185290|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
155185291|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
155185292|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
155185293|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
155185294|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
155185295|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Program Termination|3|||
155185296|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Program Termination|0|||
155185297|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Program Termination|1|||
155185298|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Program Termination|1|||
155185299|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
155185300|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
155185301|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
155185302|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
155185303|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
155185304|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
155185305|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
155185306|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
155185307|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
155185308|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
155185309|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
155185310|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
155185311|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
155185312|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
155185313|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
155185314|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
155185315|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
155185316|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
155185317|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
155185318|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
155185319|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
155185320|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
155185321|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
155185322|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
155185323|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
155185324|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
155185325|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
155185326|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
155185327|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
155034375|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
155034376|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
155034377|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
155034378|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
155034379|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
155034380|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
155034381|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
155034382|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
155034383|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
155185328|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
155185329|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
155185330|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
155185331|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
155185332|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
155185333|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
155185334|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
155185335|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
155185336|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
155185337|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
155185338|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
155185339|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
155185340|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
155185341|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
155185342|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
155185343|NCT03739840|560117942|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
155185344|NCT03739840|560117943|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
155185345|NCT03739840|560117944|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
155185346|NCT03739840|560117945|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
155185347|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
155185348|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
155185349|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
155185350|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
155185351|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
155185352|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
155185353|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
155185354|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
155185355|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
155185356|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
155185357|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
155185358|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
155185359|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
155185360|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
155185361|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
155185362|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
155185363|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
155185364|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
155185365|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
155185366|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
155185367|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
155185368|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
155185369|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
155034384|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
155185370|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
155185371|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
155185372|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
155185373|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
155185374|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
155185375|NCT03739840|560117942|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
155185376|NCT03739840|560117943|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
155185377|NCT03739840|560117944|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
155185378|NCT03739840|560117945|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
155185379|NCT01058265|560117948|FG000|Overall Study|Lost to Follow-up|11|||
155185380|NCT01058265|560117949|FG001|Overall Study|Lost to Follow-up|12|||
155185381|NCT01243671|560117950|FG000|Overall Study|Adverse Event|3|||
155034385|NCT02294461|559551991|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
155034386|NCT02294461|559551992|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
155034387|NCT02294461|559551993|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
155034388|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
155034389|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
155034390|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
155034391|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
155034392|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
155034393|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
155034394|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
155034395|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
155034396|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
155034397|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
155034398|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
155185382|NCT01243671|560117950|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
155185383|NCT01243671|560117950|FG000|Overall Study|Other|1|||
155185384|NCT02869438|560117951|FG000|Overall Study|Lost to Follow-up|1|||
155185385|NCT02869438|560117952|FG001|Overall Study|Lost to Follow-up|0|||
155185386|NCT02869438|560117951|FG000|Overall Study|Adverse Event|1|||
155185387|NCT02869438|560117952|FG001|Overall Study|Adverse Event|0|||
155185388|NCT02869438|560117951|FG000|Overall Study|Withdrawal by Subject|1|||
155185389|NCT02869438|560117952|FG001|Overall Study|Withdrawal by Subject|2|||
155185390|NCT02962765|560117953|FG000|Overall Study|Protocol Violation|9|||
155185391|NCT02962765|560117953|FG000|Overall Study|Withdrawal by Subject|3|||
155185392|NCT02962765|560117953|FG000|Overall Study|Lost to Follow-up|1|||
155185393|NCT02962765|560117953|FG000|Overall Study|Death|1|||
155185394|NCT02962765|560117953|FG000|Overall Study|Limited access to study medication|3|||
155185395|NCT02169284|560117956|FG000|Overall Study|Physician Decision|0|||
155185396|NCT02169284|560117957|FG001|Overall Study|Physician Decision|1|||
155185397|NCT02764190|560117959|FG000|Overall Study|Lost to Follow-up|17|||
155185398|NCT02764190|560117960|FG001|Overall Study|Lost to Follow-up|13|||
155185399|NCT02140775|560117966|FG000|Overall Study|Withdrawal by Subject|30|||
155185400|NCT02140775|560117967|FG001|Overall Study|Withdrawal by Subject|7|||
155034399|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
155034400|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
155034401|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
155034402|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
155034403|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
155034404|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
155034405|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
155034406|NCT02294461|559551991|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
155034407|NCT02294461|559551992|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
155034408|NCT02294461|559551993|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
155034409|NCT00549601|559553538|FG000|Randomized|Protocol Violation|0|||
155034410|NCT00549601|559553539|FG001|Randomized|Protocol Violation|0|||
155185401|NCT00938964|560117971|FG000|Overall Study|Death|3|||
155185402|NCT00938964|560117972|FG001|Overall Study|Death|3|||
155185403|NCT00938964|560117971|FG000|Overall Study|Lost to Follow-up|2|||
155034411|NCT00549601|559553540|FG002|Randomized|Protocol Violation|1|||
155034412|NCT00549601|559553538|FG000|Randomized|Withdrawal by Subject|0|||
155034413|NCT00549601|559553539|FG001|Randomized|Withdrawal by Subject|1|||
155034414|NCT00549601|559553540|FG002|Randomized|Withdrawal by Subject|1|||
155034415|NCT00549601|559553538|FG000|Received Study Drug|Adverse Event|2|||
155034416|NCT00549601|559553539|FG001|Received Study Drug|Adverse Event|5|||
155034417|NCT00549601|559553540|FG002|Received Study Drug|Adverse Event|1|||
155034418|NCT00549601|559553538|FG000|Received Study Drug|Death|0|||
155034419|NCT00549601|559553539|FG001|Received Study Drug|Death|1|||
155034420|NCT00549601|559553540|FG002|Received Study Drug|Death|0|||
155034421|NCT00549601|559553538|FG000|Received Study Drug|Lost to Follow-up|0|||
155034422|NCT00549601|559553539|FG001|Received Study Drug|Lost to Follow-up|1|||
155034423|NCT00549601|559553540|FG002|Received Study Drug|Lost to Follow-up|1|||
155034424|NCT00549601|559553538|FG000|Received Study Drug|Protocol Violation|3|||
155034425|NCT00549601|559553539|FG001|Received Study Drug|Protocol Violation|4|||
155034426|NCT00549601|559553540|FG002|Received Study Drug|Protocol Violation|1|||
155034427|NCT00549601|559553538|FG000|Received Study Drug|Withdrawal by Subject|2|||
155034428|NCT00549601|559553539|FG001|Received Study Drug|Withdrawal by Subject|0|||
155034429|NCT00549601|559553540|FG002|Received Study Drug|Withdrawal by Subject|1|||
155034430|NCT00908596|559553544|FG000|Overall Study|Other reasons|46|||
155034431|NCT00908596|559553545|FG001|Overall Study|Other reasons|6|||
155034432|NCT00908596|559553546|FG002|Overall Study|Other reasons|2|||
155034433|NCT00908596|559553547|FG003|Overall Study|Other reasons|0|||
155034434|NCT00908596|559553544|FG000|Overall Study|Lost to Follow-up|0|||
155034435|NCT00908596|559553545|FG001|Overall Study|Lost to Follow-up|1|||
155034436|NCT00908596|559553546|FG002|Overall Study|Lost to Follow-up|12|||
155034437|NCT00908596|559553547|FG003|Overall Study|Lost to Follow-up|4|||
155034438|NCT00908596|559553544|FG000|Overall Study|Death|0|||
155034439|NCT00908596|559553545|FG001|Overall Study|Death|5|||
155034440|NCT00908596|559553546|FG002|Overall Study|Death|57|||
155034441|NCT00908596|559553547|FG003|Overall Study|Death|32|||
155034442|NCT00908596|559553544|FG000|Overall Study|Protocol Violation|1|||
155034443|NCT00908596|559553545|FG001|Overall Study|Protocol Violation|0|||
155034444|NCT00908596|559553546|FG002|Overall Study|Protocol Violation|0|||
155034445|NCT00908596|559553547|FG003|Overall Study|Protocol Violation|0|||
155034446|NCT00908596|559553544|FG000|Overall Study|Withdrawal by Subject|0|||
155034447|NCT00908596|559553545|FG001|Overall Study|Withdrawal by Subject|1|||
155034448|NCT00908596|559553546|FG002|Overall Study|Withdrawal by Subject|3|||
155034449|NCT00908596|559553547|FG003|Overall Study|Withdrawal by Subject|1|||
155034450|NCT00224406|559553548|FG000|Overall Study|Re-transplant|0|||
155034451|NCT00224406|559553549|FG001|Overall Study|Re-transplant|2|||
155034452|NCT00224406|559553548|FG000|Overall Study|Death|0|||
155034453|NCT00224406|559553549|FG001|Overall Study|Death|1|||
155034454|NCT00224406|559553548|FG000|Overall Study|Transplant cancelled|0|||
155034455|NCT00224406|559553549|FG001|Overall Study|Transplant cancelled|4|||
155034456|NCT00224406|559553548|FG000|Overall Study|Drug not delivered|2|||
155034457|NCT00224406|559553549|FG001|Overall Study|Drug not delivered|0|||
155034458|NCT00224406|559553548|FG000|Overall Study|Other|4|||
155034459|NCT00224406|559553549|FG001|Overall Study|Other|0|||
155034460|NCT00224406|559553548|FG000|Overall Study|Transplant cancelled|3|||
155034461|NCT00224406|559553549|FG001|Overall Study|Transplant cancelled|0|||
155143259|NCT02959437|559956968|FG003|Overall Study|Death|0|||
155143260|NCT02959437|559956965|FG000|Overall Study|Lost to Follow-up|3|||
155143261|NCT02959437|559956966|FG001|Overall Study|Lost to Follow-up|1|||
155143262|NCT02959437|559956967|FG002|Overall Study|Lost to Follow-up|0|||
155143263|NCT02959437|559956968|FG003|Overall Study|Lost to Follow-up|0|||
155143264|NCT02959437|559956965|FG000|Overall Study|Withdrawal by Subject|11|||
155143265|NCT02959437|559956966|FG001|Overall Study|Withdrawal by Subject|3|||
155143266|NCT02959437|559956967|FG002|Overall Study|Withdrawal by Subject|0|||
155143267|NCT02959437|559956968|FG003|Overall Study|Withdrawal by Subject|0|||
155143268|NCT02959437|559956965|FG000|Overall Study|Progressive Disease|9|||
155143269|NCT02959437|559956966|FG001|Overall Study|Progressive Disease|1|||
155143270|NCT02959437|559956967|FG002|Overall Study|Progressive Disease|0|||
155143271|NCT02959437|559956968|FG003|Overall Study|Progressive Disease|0|||
155143272|NCT02959437|559956965|FG000|Overall Study|Study Terminated by Sponsor|4|||
155143273|NCT02959437|559956966|FG001|Overall Study|Study Terminated by Sponsor|0|||
155143274|NCT02959437|559956967|FG002|Overall Study|Study Terminated by Sponsor|0|||
155143275|NCT02959437|559956968|FG003|Overall Study|Study Terminated by Sponsor|0|||
155143276|NCT02959437|559956965|FG000|Overall Study|Other Unspecified|2|||
155143277|NCT02959437|559956966|FG001|Overall Study|Other Unspecified|0|||
155143278|NCT02959437|559956967|FG002|Overall Study|Other Unspecified|0|||
155143279|NCT02959437|559956968|FG003|Overall Study|Other Unspecified|0|||
155143280|NCT02905266|559956969|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
155143281|NCT02905266|559956970|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
155143282|NCT02905266|559956969|FG000|Treatment Phase Part 1|Disease Progression|6|||
155143283|NCT02905266|559956970|FG001|Treatment Phase Part 1|Disease Progression|7|||
155143284|NCT02905266|559956969|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
155143285|NCT02905266|559956970|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
155143286|NCT02905266|559956969|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
155143287|NCT02905266|559956970|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
155143288|NCT02905266|559956969|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
155143289|NCT02905266|559956970|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
155143290|NCT02905266|559956969|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
155143291|NCT02905266|559956970|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
155143292|NCT02905266|559956969|FG000|Transition From Part 1 to Part 2|Death|0|||
155143293|NCT02905266|559956970|FG001|Transition From Part 1 to Part 2|Death|1|||
155143294|NCT02905266|559956969|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
155143295|NCT02905266|559956970|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
155143296|NCT02905266|559956969|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
155143297|NCT02905266|559956970|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
155143298|NCT02905266|559956969|FG000|Maintenance Phase Part 2|Disease Progression|9|||
155143299|NCT02905266|559956970|FG001|Maintenance Phase Part 2|Disease Progression|2|||
155143300|NCT02905266|559956969|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
155143301|NCT02905266|559956970|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
155143302|NCT02905266|559956969|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
155143303|NCT02905266|559956970|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
155143304|NCT05973006|559956971|FG000|Overall Study|Early termination|3|||
155143305|NCT05973006|559956972|FG001|Overall Study|Early termination|9|||
155143306|NCT03201419|559956980|FG000|Overall Study|Adverse Event|3|||
155143307|NCT03201419|559956981|FG001|Overall Study|Adverse Event|1|||
155143308|NCT03201419|559956982|FG002|Overall Study|Adverse Event|0|||
155143309|NCT03201419|559956983|FG003|Overall Study|Adverse Event|0|||
155143310|NCT03201419|559956984|FG004|Overall Study|Adverse Event|1|||
155143311|NCT03201419|559956985|FG005|Overall Study|Adverse Event|1|||
155143312|NCT03201419|559956986|FG006|Overall Study|Adverse Event|5|||
155185404|NCT00938964|560117972|FG001|Overall Study|Lost to Follow-up|3|||
155143313|NCT03201419|559956987|FG007|Overall Study|Adverse Event|0|||
155143314|NCT03201419|559956988|FG008|Overall Study|Adverse Event|0|||
155143315|NCT03201419|559956980|FG000|Overall Study|Lost to Follow-up|1|||
155143316|NCT03201419|559956981|FG001|Overall Study|Lost to Follow-up|0|||
155143317|NCT03201419|559956982|FG002|Overall Study|Lost to Follow-up|0|||
155185405|NCT00938964|560117971|FG000|Overall Study|Withdrawal by Subject|22|||
155143318|NCT03201419|559956983|FG003|Overall Study|Lost to Follow-up|0|||
155143319|NCT03201419|559956984|FG004|Overall Study|Lost to Follow-up|0|||
155143320|NCT03201419|559956985|FG005|Overall Study|Lost to Follow-up|0|||
155143321|NCT03201419|559956986|FG006|Overall Study|Lost to Follow-up|0|||
155034462|NCT01556997|559553552|FG000|Overall Study|Adverse Event|10|||
155143322|NCT03201419|559956987|FG007|Overall Study|Lost to Follow-up|0|||
155185406|NCT00938964|560117972|FG001|Overall Study|Withdrawal by Subject|18|||
155185407|NCT00938964|560117971|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
155185408|NCT00938964|560117972|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
155034463|NCT01556997|559553553|FG001|Overall Study|Adverse Event|12|||
155034464|NCT01556997|559553554|FG002|Overall Study|Adverse Event|12|||
155034465|NCT01556997|559553552|FG000|Overall Study|Lost to Follow-up|6|||
155034466|NCT01556997|559553553|FG001|Overall Study|Lost to Follow-up|6|||
155034467|NCT01556997|559553554|FG002|Overall Study|Lost to Follow-up|4|||
155034468|NCT01556997|559553552|FG000|Overall Study|Physician Decision|1|||
155034469|NCT01556997|559553553|FG001|Overall Study|Physician Decision|1|||
155034470|NCT01556997|559553554|FG002|Overall Study|Physician Decision|1|||
155034471|NCT01556997|559553552|FG000|Overall Study|Withdrawal by Subject|7|||
155034472|NCT01556997|559553553|FG001|Overall Study|Withdrawal by Subject|6|||
155185409|NCT01858636|560117973|FG000|Overall Study|No Device Deployment Attempted|24|||
155185410|NCT01858636|560117973|FG000|Overall Study|Physician Decision|1|||
155185411|NCT01858636|560117973|FG000|Overall Study|Death|1|||
155185412|NCT01858636|560117973|FG000|Overall Study|Lost to Follow-up|1|||
155185413|NCT01858636|560117973|FG000|Overall Study|Withdrawal by Subject|1|||
155185414|NCT01227564|560117977|FG000|Overall Study|No Longer Willing to Participate|4|||
155185415|NCT01227564|560117978|FG001|Overall Study|No Longer Willing to Participate|2|||
155185416|NCT01227564|560117979|FG002|Overall Study|No Longer Willing to Participate|5|||
155185417|NCT01227564|560117977|FG000|Overall Study|Participant moved to another town|0|||
155185418|NCT01227564|560117978|FG001|Overall Study|Participant moved to another town|0|||
155185419|NCT01227564|560117979|FG002|Overall Study|Participant moved to another town|1|||
155185420|NCT04650854|560117982|FG000|Overall Study|Adverse Event|1|||
155185421|NCT04650854|560117983|FG001|Overall Study|Adverse Event|12|||
155185422|NCT04650854|560117984|FG002|Overall Study|Adverse Event|14|||
155185423|NCT04650854|560117982|FG000|Overall Study|Lack of Efficacy|1|||
155185424|NCT04650854|560117983|FG001|Overall Study|Lack of Efficacy|3|||
155185425|NCT04650854|560117984|FG002|Overall Study|Lack of Efficacy|6|||
155185426|NCT04650854|560117982|FG000|Overall Study|Lost to Follow-up|1|||
155185427|NCT04650854|560117983|FG001|Overall Study|Lost to Follow-up|1|||
155185428|NCT04650854|560117984|FG002|Overall Study|Lost to Follow-up|0|||
155185429|NCT04650854|560117982|FG000|Overall Study|Withdrawal by Subject|2|||
155185430|NCT04650854|560117983|FG001|Overall Study|Withdrawal by Subject|17|||
155185431|NCT04650854|560117984|FG002|Overall Study|Withdrawal by Subject|9|||
155185432|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
155185433|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
155185434|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
155185435|NCT04650854|560117982|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
155185436|NCT04650854|560117983|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
155185437|NCT04650854|560117984|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
155185438|NCT04650854|560117982|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
155185439|NCT04650854|560117983|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
155185440|NCT04650854|560117984|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
155185441|NCT04650854|560117982|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
155185442|NCT04650854|560117983|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
155185443|NCT04650854|560117984|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
155185444|NCT04650854|560117982|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
155185445|NCT04650854|560117983|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
155185446|NCT04650854|560117984|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
155185447|NCT04650854|560117982|FG000|Overall Study|Use of Rescue Medication|0|||
155185448|NCT04650854|560117983|FG001|Overall Study|Use of Rescue Medication|0|||
155185449|NCT04650854|560117984|FG002|Overall Study|Use of Rescue Medication|1|||
155185450|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Sponsor|0|||
155185451|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Sponsor|0|||
155185452|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Sponsor|2|||
155185453|NCT04650854|560117982|FG000|Overall Study|Rescue Medication|0|||
155185454|NCT04650854|560117983|FG001|Overall Study|Rescue Medication|0|||
155185455|NCT04650854|560117984|FG002|Overall Study|Rescue Medication|1|||
155185456|NCT04650854|560117982|FG000|Overall Study|Participant Want to Start a Family|0|||
155185457|NCT04650854|560117983|FG001|Overall Study|Participant Want to Start a Family|0|||
155185458|NCT04650854|560117984|FG002|Overall Study|Participant Want to Start a Family|1|||
155034473|NCT01556997|559553554|FG002|Overall Study|Withdrawal by Subject|8|||
155185459|NCT04650854|560117982|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
155185460|NCT04650854|560117983|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
155185461|NCT04650854|560117984|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
155185462|NCT04650854|560117982|FG000|Overall Study|Participant Screened For MG0020|0|||
155185463|NCT04650854|560117983|FG001|Overall Study|Participant Screened For MG0020|2|||
155034474|NCT01556997|559553552|FG000|Overall Study|Other|2|||
155185464|NCT04650854|560117984|FG002|Overall Study|Participant Screened For MG0020|3|||
155185465|NCT04650854|560117982|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
155034475|NCT01556997|559553553|FG001|Overall Study|Other|3|||
155034476|NCT01556997|559553554|FG002|Overall Study|Other|7|||
155034477|NCT01250171|559553559|FG000|Overall Study|Administrative reasons|1|||
155034478|NCT01250171|559553560|FG001|Overall Study|Administrative reasons|0|||
155034479|NCT01250171|559553561|FG002|Overall Study|Administrative reasons|0|||
155034480|NCT04550832|559553562|FG000|Overall Study|Adverse Event|0|||
155034481|NCT04550832|559553563|FG001|Overall Study|Adverse Event|0|||
155034482|NCT04550832|559553564|FG002|Overall Study|Adverse Event|2|||
155034483|NCT04550832|559553565|FG003|Overall Study|Adverse Event|0|||
155034484|NCT04550832|559553566|FG004|Overall Study|Adverse Event|1|||
155034485|NCT04823130|559553567|FG000|Overall Study|Withdrawal by Subject|2|||
155034486|NCT04823130|559553568|FG001|Overall Study|Withdrawal by Subject|3|||
155034487|NCT04823130|559553567|FG000|Overall Study|Failure to meet inclusion criteria|6|||
155034488|NCT04823130|559553568|FG001|Overall Study|Failure to meet inclusion criteria|4|||
155034489|NCT04823130|559553567|FG000|Overall Study|Other-unspecified|1|||
155034490|NCT04823130|559553568|FG001|Overall Study|Other-unspecified|0|||
155034491|NCT03315455|559553570|FG000|Overall Study|Ongoing in the Study|13|||
155034492|NCT03315455|559553571|FG001|Overall Study|Ongoing in the Study|24|||
155034493|NCT03315455|559553572|FG002|Overall Study|Ongoing in the Study|17|||
155034494|NCT03315455|559553573|FG003|Overall Study|Ongoing in the Study|15|||
155034495|NCT03315455|559553570|FG000|Overall Study|Withdrawal by Subject|0|||
155034496|NCT03315455|559553571|FG001|Overall Study|Withdrawal by Subject|1|||
155034497|NCT03315455|559553572|FG002|Overall Study|Withdrawal by Subject|0|||
155034498|NCT03315455|559553573|FG003|Overall Study|Withdrawal by Subject|0|||
155034499|NCT02304380|559553576|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155034500|NCT02304380|559553577|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155143323|NCT03201419|559956988|FG008|Overall Study|Lost to Follow-up|0|||
155143324|NCT03201419|559956980|FG000|Overall Study|Protocol Deviation|0|||
155143325|NCT03201419|559956981|FG001|Overall Study|Protocol Deviation|0|||
155143326|NCT03201419|559956982|FG002|Overall Study|Protocol Deviation|0|||
155143327|NCT03201419|559956983|FG003|Overall Study|Protocol Deviation|0|||
155143328|NCT03201419|559956984|FG004|Overall Study|Protocol Deviation|0|||
155143329|NCT03201419|559956985|FG005|Overall Study|Protocol Deviation|0|||
155143330|NCT03201419|559956986|FG006|Overall Study|Protocol Deviation|1|||
155143331|NCT03201419|559956987|FG007|Overall Study|Protocol Deviation|0|||
155143332|NCT03201419|559956988|FG008|Overall Study|Protocol Deviation|0|||
155143333|NCT03201419|559956980|FG000|Overall Study|Withdrawal by Subject|4|||
155143334|NCT03201419|559956981|FG001|Overall Study|Withdrawal by Subject|2|||
155143335|NCT03201419|559956982|FG002|Overall Study|Withdrawal by Subject|1|||
155143336|NCT03201419|559956983|FG003|Overall Study|Withdrawal by Subject|0|||
155143337|NCT03201419|559956984|FG004|Overall Study|Withdrawal by Subject|0|||
155143338|NCT03201419|559956985|FG005|Overall Study|Withdrawal by Subject|0|||
155143339|NCT03201419|559956986|FG006|Overall Study|Withdrawal by Subject|0|||
155143340|NCT03201419|559956987|FG007|Overall Study|Withdrawal by Subject|1|||
155143341|NCT03201419|559956988|FG008|Overall Study|Withdrawal by Subject|2|||
155143342|NCT03201419|559956980|FG000|Overall Study|Other|0|||
155143343|NCT03201419|559956981|FG001|Overall Study|Other|0|||
155143344|NCT03201419|559956982|FG002|Overall Study|Other|1|||
155143345|NCT03201419|559956983|FG003|Overall Study|Other|0|||
155143346|NCT03201419|559956984|FG004|Overall Study|Other|0|||
155143347|NCT03201419|559956985|FG005|Overall Study|Other|0|||
155143348|NCT03201419|559956986|FG006|Overall Study|Other|0|||
155143349|NCT03201419|559956987|FG007|Overall Study|Other|0|||
155143350|NCT03201419|559956988|FG008|Overall Study|Other|0|||
155143351|NCT02777827|559956989|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
155143352|NCT02777827|559956990|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
155143353|NCT02777827|559956991|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
155143354|NCT02777827|559956992|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
155143355|NCT02777827|559956993|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
155143356|NCT02777827|559956994|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
155143357|NCT00398320|559956995|FG000|Overall Study|Death|1|||
155143358|NCT00398320|559956995|FG000|Overall Study|Adverse Event|4|||
155143359|NCT00398320|559956995|FG000|Overall Study|Physician Decision|1|||
155143360|NCT00064792|559956996|FG000|Overall Study|Withdrawal by Subject|2|||
155143361|NCT00064792|559956997|FG001|Overall Study|Withdrawal by Subject|0|||
155143362|NCT00064792|559956996|FG000|Overall Study|Adverse Event|3|||
155143363|NCT00064792|559956997|FG001|Overall Study|Adverse Event|0|||
155143364|NCT00936702|559959365|FG000|Overall Study|Disease progression|34|||
155143365|NCT00936702|559959365|FG000|Overall Study|Adverse Event|8|||
155143366|NCT00936702|559959365|FG000|Overall Study|Withdrawal by Subject|2|||
155143367|NCT00936702|559959365|FG000|Overall Study|Alternative Treatment|1|||
155143368|NCT00936702|559959365|FG000|Overall Study|Other|1|||
155143369|NCT02045095|559959366|FG000|Overall Study|Other|0|||
155143370|NCT02045095|559959367|FG001|Overall Study|Other|0|||
155143371|NCT02045095|559959368|FG002|Overall Study|Other|1|||
155143372|NCT02045095|559959369|FG003|Overall Study|Other|0|||
155143373|NCT02045095|559959370|FG004|Overall Study|Other|0|||
155143374|NCT02045095|559959371|FG005|Overall Study|Other|2|||
155034501|NCT02304380|559553578|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155034502|NCT02304380|559553579|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
155034503|NCT02304380|559553580|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155034504|NCT02304380|559553581|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
155034505|NCT00328094|559553582|FG000|Overall Study|Physician Decision|3|||
155143375|NCT02045095|559959372|FG006|Overall Study|Other|0|||
155143376|NCT02045095|559959366|FG000|Overall Study|Progressive Disease|3|||
155034506|NCT00328094|559553583|FG001|Overall Study|Physician Decision|3|||
155034507|NCT00473824|559553584|FG000|Overall Study|Virologic Breakthrough|1|||
155034508|NCT00473824|559553585|FG001|Overall Study|Virologic Breakthrough|0|||
155034509|NCT00473824|559553584|FG000|Overall Study|Adverse Event|1|||
155034510|NCT00473824|559553585|FG001|Overall Study|Adverse Event|0|||
155034511|NCT00473824|559553584|FG000|Overall Study|Death|1|||
155034512|NCT00473824|559553585|FG001|Overall Study|Death|0|||
155034513|NCT00473824|559553584|FG000|Overall Study|Lost to Follow-up|1|||
155034514|NCT00473824|559553585|FG001|Overall Study|Lost to Follow-up|0|||
155034515|NCT00473824|559553584|FG000|Overall Study|Withdrawal by physician|1|||
155034516|NCT00473824|559553585|FG001|Overall Study|Withdrawal by physician|0|||
155034517|NCT01349322|559553586|FG000|Overall Study|Protocol Violation|45|||
155034518|NCT01349322|559553587|FG001|Overall Study|Protocol Violation|47|||
155034519|NCT00985426|559553591|FG000|Overall Study|Adverse Event|0|||
155034520|NCT00985426|559553592|FG001|Overall Study|Adverse Event|1|||
155034521|NCT00985426|559553591|FG000|Overall Study|Subject Non-Compliance|3|||
155034522|NCT00985426|559553592|FG001|Overall Study|Subject Non-Compliance|3|||
155034523|NCT00985426|559553591|FG000|Overall Study|Withdrawal by Subject|12|||
155034524|NCT00985426|559553592|FG001|Overall Study|Withdrawal by Subject|16|||
155034525|NCT00985426|559553591|FG000|Overall Study|Lost to Follow-up|8|||
155034526|NCT00985426|559553592|FG001|Overall Study|Lost to Follow-up|10|||
155034527|NCT00985426|559553591|FG000|Overall Study|Death|7|||
155034528|NCT00985426|559553592|FG001|Overall Study|Death|3|||
155034529|NCT00985426|559553591|FG000|Overall Study|Protocol Violation|2|||
155034530|NCT00985426|559553592|FG001|Overall Study|Protocol Violation|0|||
155034531|NCT00985426|559553591|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
155034532|NCT00985426|559553592|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
155034533|NCT04829331|559553593|FG000|Overall Study|Lost to Follow-up|1|||
155034534|NCT04829331|559553594|FG001|Overall Study|Lost to Follow-up|0|||
155034535|NCT03181503|559553596|FG000|Overall Study|Adverse Event|2|||
155034536|NCT03181503|559553597|FG001|Overall Study|Adverse Event|2|||
155034537|NCT03181503|559553596|FG000|Overall Study|Protocol Violation|1|||
155034538|NCT03181503|559553597|FG001|Overall Study|Protocol Violation|0|||
155034539|NCT03181503|559553596|FG000|Overall Study|Withdrawal by Subject|3|||
155034540|NCT03181503|559553597|FG001|Overall Study|Withdrawal by Subject|0|||
155034541|NCT03181503|559553596|FG000|Overall Study|Lost to Follow-up|1|||
155034542|NCT03181503|559553597|FG001|Overall Study|Lost to Follow-up|1|||
155034543|NCT01404208|559553602|FG000|Overall Study|Discontinued|3|||
155034544|NCT01404208|559553603|FG001|Overall Study|Discontinued|0|||
155034545|NCT02258542|559553606|FG000|Overall Study|eg. not made to the visit|7|||
155034546|NCT02258542|559553607|FG001|Overall Study|eg. not made to the visit|4|||
155034547|NCT02258542|559553608|FG002|Overall Study|eg. not made to the visit|0|||
155034548|NCT02258542|559553609|FG003|Overall Study|eg. not made to the visit|1|||
155034549|NCT02258542|559553606|FG000|Overall Study|study specific discount. criteria|1|||
155034550|NCT02258542|559553607|FG001|Overall Study|study specific discount. criteria|1|||
155034551|NCT02258542|559553608|FG002|Overall Study|study specific discount. criteria|0|||
155034552|NCT02258542|559553609|FG003|Overall Study|study specific discount. criteria|0|||
155034553|NCT02258542|559553606|FG000|Overall Study|Withdrawal by Subject|20|||
155034554|NCT02258542|559553607|FG001|Overall Study|Withdrawal by Subject|20|||
155034555|NCT02258542|559553608|FG002|Overall Study|Withdrawal by Subject|7|||
155034556|NCT02258542|559553609|FG003|Overall Study|Withdrawal by Subject|1|||
155034557|NCT02258542|559553606|FG000|Overall Study|Lost to Follow-up|5|||
155034558|NCT02258542|559553607|FG001|Overall Study|Lost to Follow-up|12|||
155034559|NCT02258542|559553608|FG002|Overall Study|Lost to Follow-up|1|||
155034560|NCT02258542|559553609|FG003|Overall Study|Lost to Follow-up|2|||
155034561|NCT02258542|559553606|FG000|Overall Study|Death|5|||
155034562|NCT02258542|559553607|FG001|Overall Study|Death|4|||
155034563|NCT02258542|559553608|FG002|Overall Study|Death|0|||
155034564|NCT02258542|559553609|FG003|Overall Study|Death|1|||
155034565|NCT02258542|559553606|FG000|Overall Study|Adverse Event|3|||
155034566|NCT02258542|559553607|FG001|Overall Study|Adverse Event|4|||
155034567|NCT02258542|559553608|FG002|Overall Study|Adverse Event|0|||
155034568|NCT02258542|559553609|FG003|Overall Study|Adverse Event|0|||
155034569|NCT02258542|559553606|FG000|Overall Study|Protocol Violation|1|||
155034570|NCT02258542|559553607|FG001|Overall Study|Protocol Violation|2|||
155034571|NCT02258542|559553608|FG002|Overall Study|Protocol Violation|0|||
155034572|NCT02258542|559553609|FG003|Overall Study|Protocol Violation|0|||
155034573|NCT02258542|559553606|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155034574|NCT02258542|559553607|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
155034575|NCT02258542|559553608|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155185466|NCT04650854|560117983|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
155185467|NCT04650854|560117984|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
155185468|NCT04650854|560117982|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
155185469|NCT04650854|560117983|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
155185470|NCT04650854|560117984|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
155185471|NCT04650854|560117982|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
155185472|NCT04650854|560117983|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
155185473|NCT04650854|560117984|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
155185474|NCT04650854|560117982|FG000|Overall Study|End Of Study|0|||
155185475|NCT04650854|560117983|FG001|Overall Study|End Of Study|2|||
155185476|NCT04650854|560117984|FG002|Overall Study|End Of Study|1|||
155185477|NCT04650854|560117982|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
155185478|NCT04650854|560117983|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
155185479|NCT04650854|560117984|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
155185480|NCT04650854|560117982|FG000|Overall Study|Participant Received Rescue Medication|0|||
155185481|NCT04650854|560117983|FG001|Overall Study|Participant Received Rescue Medication|1|||
155185482|NCT04650854|560117984|FG002|Overall Study|Participant Received Rescue Medication|0|||
155185483|NCT04650854|560117982|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
155185484|NCT04650854|560117983|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
155185485|NCT04650854|560117984|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
155185486|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
155185487|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
155185488|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
155185489|NCT04650854|560117982|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
155185490|NCT04650854|560117983|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
155185491|NCT04650854|560117984|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
155185492|NCT04650854|560117982|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
155185493|NCT04650854|560117983|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
155185494|NCT04650854|560117984|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
155185495|NCT04650854|560117982|FG000|Overall Study|Enrollment Cup|0|||
155185496|NCT04650854|560117983|FG001|Overall Study|Enrollment Cup|0|||
155185497|NCT04650854|560117984|FG002|Overall Study|Enrollment Cup|1|||
155185498|NCT00194675|560117990|FG000|Overall Study|Lost to Follow-up|1|||
155185499|NCT00194675|560117991|FG001|Overall Study|Lost to Follow-up|1|||
155185500|NCT00194675|560117990|FG000|Overall Study|lack of interest|1|||
155185501|NCT00194675|560117991|FG001|Overall Study|lack of interest|1|||
155185502|NCT00194675|560117990|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
155185503|NCT00194675|560117991|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
155185504|NCT00194675|560117990|FG000|Overall Study|Protocol Violation|1|||
155185505|NCT00194675|560117991|FG001|Overall Study|Protocol Violation|0|||
155185506|NCT00194675|560117990|FG000|Overall Study|Death|1|||
155185507|NCT00194675|560117991|FG001|Overall Study|Death|0|||
155185508|NCT00704808|560117992|FG000|Overall Study|Discontinued prior to starting treatment|14|||
155034576|NCT02258542|559553609|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
155034577|NCT02332239|559553610|FG000|Overall Study|Lost to Follow-up|4|||
155034578|NCT02332239|559553611|FG001|Overall Study|Lost to Follow-up|6|||
155034579|NCT01472965|559553614|FG000|Overall Study|Withdrawal by Subject|1|||
155034580|NCT01472965|559553615|FG001|Overall Study|Withdrawal by Subject|0|||
155034581|NCT00334802|559553618|FG000|Overall Study|Progressive Disease|2|||
155034582|NCT00334802|559553619|FG001|Overall Study|Progressive Disease|24|||
155034583|NCT00334802|559553618|FG000|Overall Study|Toxicity|1|||
155034584|NCT00334802|559553619|FG001|Overall Study|Toxicity|5|||
155034585|NCT00334802|559553618|FG000|Overall Study|Lack of Efficacy|1|||
155034586|NCT00334802|559553619|FG001|Overall Study|Lack of Efficacy|3|||
155034587|NCT00334802|559553618|FG000|Overall Study|Patient Condition Aggrevated|1|||
155034588|NCT00334802|559553619|FG001|Overall Study|Patient Condition Aggrevated|0|||
155034589|NCT00334802|559553618|FG000|Overall Study|Physician Decision|1|||
155034590|NCT00334802|559553619|FG001|Overall Study|Physician Decision|0|||
155034591|NCT00334802|559553618|FG000|Overall Study|Withdrawal by Subject|0|||
155034592|NCT00334802|559553619|FG001|Overall Study|Withdrawal by Subject|4|||
155034593|NCT00334802|559553618|FG000|Overall Study|Adverse Event|0|||
155034594|NCT00334802|559553619|FG001|Overall Study|Adverse Event|3|||
155185509|NCT00704808|560117992|FG000|Overall Study|Death|7|||
155034595|NCT00334802|559553618|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
155185510|NCT00704808|560117992|FG000|Overall Study|Tumor progression|80|||
155185511|NCT00704808|560117992|FG000|Overall Study|Patient's decision|11|||
155185512|NCT00704808|560117992|FG000|Overall Study|Early therapy discontinuation|16|||
155185513|NCT00704808|560117992|FG000|Overall Study|Adverse Event|1|||
155185514|NCT00704808|560117992|FG000|Overall Study|Lost to Follow-up|1|||
155034596|NCT00334802|559553619|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
155034597|NCT03422159|559553620|FG000|Overall Study|Exclusion due to terminal disease|2|||
155034598|NCT03422159|559553621|FG001|Overall Study|Exclusion due to terminal disease|1|||
155034599|NCT03436199|559553622|FG000|Overall Study|Adverse Event|15|||
155034600|NCT03436199|559553623|FG001|Overall Study|Adverse Event|40|||
155143377|NCT02045095|559959367|FG001|Overall Study|Progressive Disease|3|||
155143378|NCT02045095|559959368|FG002|Overall Study|Progressive Disease|2|||
155143379|NCT02045095|559959369|FG003|Overall Study|Progressive Disease|4|||
155143380|NCT02045095|559959370|FG004|Overall Study|Progressive Disease|2|||
155143381|NCT02045095|559959371|FG005|Overall Study|Progressive Disease|4|||
155143382|NCT02045095|559959372|FG006|Overall Study|Progressive Disease|1|||
155143383|NCT02045095|559959366|FG000|Overall Study|Withdrawal by Subject|0|||
155143384|NCT02045095|559959367|FG001|Overall Study|Withdrawal by Subject|0|||
155143385|NCT02045095|559959368|FG002|Overall Study|Withdrawal by Subject|0|||
155143386|NCT02045095|559959369|FG003|Overall Study|Withdrawal by Subject|0|||
155143387|NCT02045095|559959370|FG004|Overall Study|Withdrawal by Subject|3|||
155143388|NCT02045095|559959371|FG005|Overall Study|Withdrawal by Subject|0|||
155143389|NCT02045095|559959372|FG006|Overall Study|Withdrawal by Subject|0|||
155143390|NCT02045095|559959366|FG000|Overall Study|Adverse Event|0|||
155143391|NCT02045095|559959367|FG001|Overall Study|Adverse Event|1|||
155143392|NCT02045095|559959368|FG002|Overall Study|Adverse Event|1|||
155143393|NCT02045095|559959369|FG003|Overall Study|Adverse Event|0|||
155143394|NCT02045095|559959370|FG004|Overall Study|Adverse Event|0|||
155143395|NCT02045095|559959371|FG005|Overall Study|Adverse Event|2|||
155143396|NCT02045095|559959372|FG006|Overall Study|Adverse Event|0|||
155143397|NCT04497116|559959374|FG000|Overall Study|Lost to Follow-up|1|||
155143398|NCT04497116|559959375|FG001|Overall Study|Lost to Follow-up|0|||
155143399|NCT04497116|559959376|FG002|Overall Study|Lost to Follow-up|0|||
155143400|NCT04497116|559959377|FG003|Overall Study|Lost to Follow-up|0|||
155143401|NCT04497116|559959378|FG004|Overall Study|Lost to Follow-up|0|||
155143402|NCT04497116|559959379|FG005|Overall Study|Lost to Follow-up|0|||
155143403|NCT04497116|559959380|FG006|Overall Study|Lost to Follow-up|0|||
155143404|NCT04497116|559959381|FG007|Overall Study|Lost to Follow-up|3|||
155143405|NCT04497116|559959382|FG008|Overall Study|Lost to Follow-up|3|||
155143406|NCT04497116|559959383|FG009|Overall Study|Lost to Follow-up|0|||
155034601|NCT03436199|559553624|FG002|Overall Study|Adverse Event|7|||
155034602|NCT03436199|559553622|FG000|Overall Study|Withdrawal by Subject|4|||
155034603|NCT03436199|559553623|FG001|Overall Study|Withdrawal by Subject|10|||
155034604|NCT03436199|559553624|FG002|Overall Study|Withdrawal by Subject|3|||
155034605|NCT03436199|559553622|FG000|Overall Study|Lost to Follow-up|1|||
155034606|NCT03436199|559553623|FG001|Overall Study|Lost to Follow-up|0|||
155034607|NCT03436199|559553624|FG002|Overall Study|Lost to Follow-up|2|||
155034608|NCT03436199|559553622|FG000|Overall Study|Protocol Violation|1|||
155034609|NCT03436199|559553623|FG001|Overall Study|Protocol Violation|1|||
155034610|NCT03436199|559553624|FG002|Overall Study|Protocol Violation|0|||
155034611|NCT03436199|559553622|FG000|Overall Study|Physician Decision|0|||
155034612|NCT03436199|559553623|FG001|Overall Study|Physician Decision|1|||
155034613|NCT03436199|559553624|FG002|Overall Study|Physician Decision|0|||
155034614|NCT03436199|559553622|FG000|Overall Study|Could not return to clinic|1|||
155034615|NCT03436199|559553623|FG001|Overall Study|Could not return to clinic|0|||
155034616|NCT03436199|559553624|FG002|Overall Study|Could not return to clinic|0|||
155034617|NCT03436199|559553622|FG000|Overall Study|Withdrawn per physician|0|||
155034618|NCT03436199|559553623|FG001|Overall Study|Withdrawn per physician|1|||
155034619|NCT03436199|559553624|FG002|Overall Study|Withdrawn per physician|0|||
155034620|NCT01886781|559553629|FG000|Overall Study|Protocol Violation|5|||
155034621|NCT01886781|559553630|FG001|Overall Study|Protocol Violation|0|||
155034622|NCT01886781|559553629|FG000|Overall Study|Adverse Event|1|||
155034623|NCT01886781|559553630|FG001|Overall Study|Adverse Event|0|||
155034624|NCT01886781|559553629|FG000|Overall Study|Lost to Follow-up|5|||
155034625|NCT01886781|559553630|FG001|Overall Study|Lost to Follow-up|0|||
155034626|NCT01886781|559553629|FG000|Overall Study|Withdrawal by Subject|2|||
155034627|NCT01886781|559553630|FG001|Overall Study|Withdrawal by Subject|1|||
155034628|NCT01886781|559553629|FG000|Overall Study|Worsening of symptoms|1|||
155034629|NCT01886781|559553630|FG001|Overall Study|Worsening of symptoms|1|||
155034630|NCT01935700|559553631|FG000|Overall Study|Withdrawal by Subject|1|||
155034631|NCT01935700|559553632|FG001|Overall Study|Withdrawal by Subject|0|||
155034632|NCT01935700|559553631|FG000|Overall Study|Physician Decision|4|||
155034633|NCT01935700|559553632|FG001|Overall Study|Physician Decision|0|||
155034634|NCT01935128|559553633|FG000|Overall Study|Death|1|||
155034635|NCT01935128|559553633|FG000|Overall Study|Adverse Event|6|||
155034636|NCT01438814|559553638|FG000|Overall Study|Adverse Event|3|||
155034637|NCT01438814|559553639|FG001|Overall Study|Adverse Event|3|||
155034638|NCT01438814|559553638|FG000|Overall Study|Protocol Violation|1|||
155034639|NCT01438814|559553639|FG001|Overall Study|Protocol Violation|2|||
155034640|NCT01438814|559553638|FG000|Overall Study|Lost to Follow-up|4|||
155034641|NCT01438814|559553639|FG001|Overall Study|Lost to Follow-up|3|||
155034642|NCT01438814|559553638|FG000|Overall Study|Withdrawal by Subject|4|||
155034643|NCT01438814|559553639|FG001|Overall Study|Withdrawal by Subject|2|||
155034644|NCT01438814|559553638|FG000|Overall Study|Other|2|||
155034645|NCT01438814|559553639|FG001|Overall Study|Other|4|||
155034646|NCT03887117|559553647|FG000|Overall Study|Discontinued prematurely|0|||
155034647|NCT03887117|559553648|FG001|Overall Study|Discontinued prematurely|1|||
155034648|NCT03887117|559553649|FG002|Overall Study|Discontinued prematurely|1|||
155034649|NCT03887117|559553650|FG003|Overall Study|Discontinued prematurely|2|||
155034650|NCT00195494|559553653|FG000|Year 1|Adverse Event|0|||
155034651|NCT00195494|559553654|FG001|Year 1|Adverse Event|0|||
155034652|NCT00195494|559553655|FG002|Year 1|Adverse Event|0|||
155034653|NCT00195494|559553656|FG003|Year 1|Adverse Event|0|||
155034654|NCT00195494|559553657|FG004|Year 1|Adverse Event|34|||
155034655|NCT00195494|559553658|FG005|Year 1|Adverse Event|27|||
155034656|NCT00195494|559553653|FG000|Year 1|System Toxicity|0|||
155034657|NCT00195494|559553654|FG001|Year 1|System Toxicity|0|||
155034658|NCT00195494|559553655|FG002|Year 1|System Toxicity|0|||
155034659|NCT00195494|559553656|FG003|Year 1|System Toxicity|0|||
155034660|NCT00195494|559553657|FG004|Year 1|System Toxicity|0|||
155034661|NCT00195494|559553658|FG005|Year 1|System Toxicity|1|||
155034662|NCT00195494|559553653|FG000|Year 1|Lack of Efficacy|0|||
155034663|NCT00195494|559553654|FG001|Year 1|Lack of Efficacy|0|||
155034664|NCT00195494|559553655|FG002|Year 1|Lack of Efficacy|0|||
155034665|NCT00195494|559553656|FG003|Year 1|Lack of Efficacy|0|||
155034666|NCT00195494|559553657|FG004|Year 1|Lack of Efficacy|24|||
155034667|NCT00195494|559553658|FG005|Year 1|Lack of Efficacy|9|||
155034668|NCT00195494|559553653|FG000|Year 1|Compliance|0|||
155034669|NCT00195494|559553654|FG001|Year 1|Compliance|0|||
155143407|NCT04497116|559959384|FG010|Overall Study|Lost to Follow-up|0|||
155143408|NCT04497116|559959385|FG011|Overall Study|Lost to Follow-up|0|||
155143409|NCT04497116|559959386|FG012|Overall Study|Lost to Follow-up|0|||
155143410|NCT04497116|559959387|FG013|Overall Study|Lost to Follow-up|0|||
155143411|NCT04497116|559959388|FG014|Overall Study|Lost to Follow-up|0|||
155143412|NCT04497116|559959389|FG015|Overall Study|Lost to Follow-up|0|||
155143413|NCT04497116|559959390|FG016|Overall Study|Lost to Follow-up|0|||
155143414|NCT04497116|559959391|FG017|Overall Study|Lost to Follow-up|0|||
155143415|NCT04497116|559959392|FG018|Overall Study|Lost to Follow-up|0|||
155143416|NCT04497116|559959393|FG019|Overall Study|Lost to Follow-up|0|||
155143417|NCT04497116|559959394|FG020|Overall Study|Lost to Follow-up|0|||
155143418|NCT04497116|559959395|FG021|Overall Study|Lost to Follow-up|0|||
155143419|NCT04497116|559959396|FG022|Overall Study|Lost to Follow-up|1|||
155143420|NCT04497116|559959397|FG023|Overall Study|Lost to Follow-up|0|||
155143421|NCT04497116|559959398|FG024|Overall Study|Lost to Follow-up|0|||
155143422|NCT04497116|559959374|FG000|Overall Study|Sponsor decision to terminate study|0|||
155143423|NCT04497116|559959375|FG001|Overall Study|Sponsor decision to terminate study|0|||
155143424|NCT04497116|559959376|FG002|Overall Study|Sponsor decision to terminate study|0|||
155143425|NCT04497116|559959377|FG003|Overall Study|Sponsor decision to terminate study|0|||
155143426|NCT04497116|559959378|FG004|Overall Study|Sponsor decision to terminate study|0|||
155143427|NCT04497116|559959379|FG005|Overall Study|Sponsor decision to terminate study|0|||
155143428|NCT04497116|559959380|FG006|Overall Study|Sponsor decision to terminate study|1|||
155143429|NCT04497116|559959381|FG007|Overall Study|Sponsor decision to terminate study|0|||
155143430|NCT04497116|559959382|FG008|Overall Study|Sponsor decision to terminate study|0|||
155143431|NCT04497116|559959383|FG009|Overall Study|Sponsor decision to terminate study|1|||
155143432|NCT04497116|559959384|FG010|Overall Study|Sponsor decision to terminate study|0|||
155143433|NCT04497116|559959385|FG011|Overall Study|Sponsor decision to terminate study|0|||
155143434|NCT04497116|559959386|FG012|Overall Study|Sponsor decision to terminate study|0|||
155143435|NCT04497116|559959387|FG013|Overall Study|Sponsor decision to terminate study|0|||
155143436|NCT04497116|559959388|FG014|Overall Study|Sponsor decision to terminate study|0|||
155143437|NCT04497116|559959389|FG015|Overall Study|Sponsor decision to terminate study|0|||
155143438|NCT04497116|559959390|FG016|Overall Study|Sponsor decision to terminate study|0|||
155143439|NCT04497116|559959391|FG017|Overall Study|Sponsor decision to terminate study|0|||
155143440|NCT04497116|559959392|FG018|Overall Study|Sponsor decision to terminate study|0|||
155143441|NCT04497116|559959393|FG019|Overall Study|Sponsor decision to terminate study|1|||
155143442|NCT04497116|559959394|FG020|Overall Study|Sponsor decision to terminate study|0|||
155143443|NCT04497116|559959395|FG021|Overall Study|Sponsor decision to terminate study|0|||
155143444|NCT04497116|559959396|FG022|Overall Study|Sponsor decision to terminate study|0|||
155143445|NCT04497116|559959397|FG023|Overall Study|Sponsor decision to terminate study|0|||
155143446|NCT04497116|559959398|FG024|Overall Study|Sponsor decision to terminate study|0|||
155143447|NCT04497116|559959374|FG000|Overall Study|Death|4|||
155143448|NCT04497116|559959375|FG001|Overall Study|Death|5|||
155034670|NCT00195494|559553655|FG002|Year 1|Compliance|0|||
155034671|NCT00195494|559553656|FG003|Year 1|Compliance|0|||
155143449|NCT04497116|559959376|FG002|Overall Study|Death|2|||
155143450|NCT04497116|559959377|FG003|Overall Study|Death|2|||
155143451|NCT04497116|559959378|FG004|Overall Study|Death|1|||
155143452|NCT04497116|559959379|FG005|Overall Study|Death|1|||
155034672|NCT00195494|559553657|FG004|Year 1|Compliance|5|||
155034673|NCT00195494|559553658|FG005|Year 1|Compliance|1|||
155034674|NCT00195494|559553653|FG000|Year 1|Lost to Follow-up|0|||
155034675|NCT00195494|559553654|FG001|Year 1|Lost to Follow-up|0|||
155034676|NCT00195494|559553655|FG002|Year 1|Lost to Follow-up|0|||
155034677|NCT00195494|559553656|FG003|Year 1|Lost to Follow-up|0|||
155034678|NCT00195494|559553657|FG004|Year 1|Lost to Follow-up|1|||
155143453|NCT04497116|559959380|FG006|Overall Study|Death|3|||
155143454|NCT04497116|559959381|FG007|Overall Study|Death|10|||
155143455|NCT04497116|559959382|FG008|Overall Study|Death|37|||
155143456|NCT04497116|559959383|FG009|Overall Study|Death|17|||
155034679|NCT00195494|559553658|FG005|Year 1|Lost to Follow-up|0|||
155034680|NCT00195494|559553653|FG000|Year 1|Missed >4 consecutive doses|0|||
155034681|NCT00195494|559553654|FG001|Year 1|Missed >4 consecutive doses|0|||
155034682|NCT00195494|559553655|FG002|Year 1|Missed >4 consecutive doses|0|||
155034683|NCT00195494|559553656|FG003|Year 1|Missed >4 consecutive doses|0|||
155034684|NCT00195494|559553657|FG004|Year 1|Missed >4 consecutive doses|3|||
155034685|NCT00195494|559553658|FG005|Year 1|Missed >4 consecutive doses|2|||
155034686|NCT00195494|559553653|FG000|Year 1|Protocol deviation|0|||
155034687|NCT00195494|559553654|FG001|Year 1|Protocol deviation|0|||
155034688|NCT00195494|559553655|FG002|Year 1|Protocol deviation|0|||
155034689|NCT00195494|559553656|FG003|Year 1|Protocol deviation|0|||
155034690|NCT00195494|559553657|FG004|Year 1|Protocol deviation|2|||
155034691|NCT00195494|559553658|FG005|Year 1|Protocol deviation|3|||
155034692|NCT00195494|559553653|FG000|Year 1|Physician Decision|0|||
155034693|NCT00195494|559553654|FG001|Year 1|Physician Decision|0|||
155034694|NCT00195494|559553655|FG002|Year 1|Physician Decision|0|||
155034695|NCT00195494|559553656|FG003|Year 1|Physician Decision|0|||
155034696|NCT00195494|559553657|FG004|Year 1|Physician Decision|1|||
155034697|NCT00195494|559553658|FG005|Year 1|Physician Decision|0|||
155034698|NCT00195494|559553653|FG000|Year 1|Withdrawal by Subject|0|||
155034699|NCT00195494|559553654|FG001|Year 1|Withdrawal by Subject|0|||
155034700|NCT00195494|559553655|FG002|Year 1|Withdrawal by Subject|0|||
155034701|NCT00195494|559553656|FG003|Year 1|Withdrawal by Subject|0|||
155034702|NCT00195494|559553657|FG004|Year 1|Withdrawal by Subject|8|||
155034703|NCT00195494|559553658|FG005|Year 1|Withdrawal by Subject|9|||
155034704|NCT00195494|559553653|FG000|Year 1|Protocol Violation|0|||
155034705|NCT00195494|559553654|FG001|Year 1|Protocol Violation|0|||
155034706|NCT00195494|559553655|FG002|Year 1|Protocol Violation|0|||
155034707|NCT00195494|559553656|FG003|Year 1|Protocol Violation|0|||
155034708|NCT00195494|559553657|FG004|Year 1|Protocol Violation|1|||
155185515|NCT00704808|560117992|FG000|Overall Study|Treatment change|1|||
155185516|NCT00667420|560117993|FG000|Overall Study|Adverse Event|2|||
155185517|NCT00667420|560117993|FG000|Overall Study|Lack of Efficacy|5|||
155185518|NCT00667420|560117993|FG000|Overall Study|Physician Decision|1|||
155185519|NCT00667420|560117993|FG000|Overall Study|Withdrawal by Subject|2|||
155185520|NCT03500679|560117994|FG000|Overall Study|Lost to Follow-up|6|||
155185521|NCT03500679|560117995|FG001|Overall Study|Lost to Follow-up|3|||
155185522|NCT03500679|560117994|FG000|Overall Study|Withdrawal by Subject|3|||
155185523|NCT03500679|560117995|FG001|Overall Study|Withdrawal by Subject|0|||
155185524|NCT04223232|560117997|FG000|Overall Study|Withdrawal by Subject|1|||
155185525|NCT00586846|560117998|FG000|Overall Study|Physician Decision|1|||
155185526|NCT00586846|560117998|FG000|Overall Study|Death|1|||
155185527|NCT00586846|560117998|FG000|Overall Study|Evaluable for Toxicity Only|4|||
155185528|NCT00410202|560117999|FG000|On-Treatment|Continuing treatment|69|||
155185529|NCT00410202|560118000|FG001|On-Treatment|Continuing treatment|71|||
155185530|NCT00410202|560118001|FG002|On-Treatment|Continuing treatment|66|||
155185531|NCT00410202|560117999|FG000|On-Treatment|Adverse Event|1|||
155185532|NCT00410202|560118000|FG001|On-Treatment|Adverse Event|3|||
155185533|NCT00410202|560118001|FG002|On-Treatment|Adverse Event|2|||
155185534|NCT00410202|560117999|FG000|On-Treatment|Death|1|||
155185535|NCT00410202|560118000|FG001|On-Treatment|Death|0|||
155185536|NCT00410202|560118001|FG002|On-Treatment|Death|0|||
155185537|NCT00410202|560117999|FG000|On-Treatment|Lost to Follow-up|1|||
155185538|NCT00410202|560118000|FG001|On-Treatment|Lost to Follow-up|0|||
155185539|NCT00410202|560118001|FG002|On-Treatment|Lost to Follow-up|1|||
155185540|NCT00410202|560117999|FG000|On-Treatment|Lack of Efficacy|1|||
155185541|NCT00410202|560118000|FG001|On-Treatment|Lack of Efficacy|4|||
155185542|NCT00410202|560118001|FG002|On-Treatment|Lack of Efficacy|0|||
155185543|NCT00410202|560117999|FG000|On-Treatment|Withdrawal by Subject|2|||
155185544|NCT00410202|560118000|FG001|On-Treatment|Withdrawal by Subject|1|||
155185545|NCT00410202|560118001|FG002|On-Treatment|Withdrawal by Subject|1|||
155185546|NCT00410202|560117999|FG000|On-Treatment|Other Reason|0|||
155185547|NCT00410202|560118000|FG001|On-Treatment|Other Reason|0|||
155185548|NCT00410202|560118001|FG002|On-Treatment|Other Reason|1|||
155185549|NCT00410202|560117999|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
155034709|NCT00195494|559553658|FG005|Year 1|Protocol Violation|1|||
155034710|NCT00195494|559553653|FG000|Year 2|Adverse Event|3|||
155034711|NCT00195494|559553654|FG001|Year 2|Adverse Event|7|||
155034712|NCT00195494|559553655|FG002|Year 2|Adverse Event|5|||
155034713|NCT00195494|559553656|FG003|Year 2|Adverse Event|9|||
155034714|NCT00195494|559553657|FG004|Year 2|Adverse Event|0|||
155034715|NCT00195494|559553658|FG005|Year 2|Adverse Event|0|||
155034716|NCT00195494|559553653|FG000|Year 2|Lack of Efficacy|0|||
155185550|NCT00410202|560118000|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
155185551|NCT00410202|560118001|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
155185552|NCT00410202|560117999|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
155034717|NCT00195494|559553654|FG001|Year 2|Lack of Efficacy|1|||
155034718|NCT00195494|559553655|FG002|Year 2|Lack of Efficacy|7|||
155034719|NCT00195494|559553656|FG003|Year 2|Lack of Efficacy|7|||
155034720|NCT00195494|559553657|FG004|Year 2|Lack of Efficacy|0|||
155034721|NCT00195494|559553658|FG005|Year 2|Lack of Efficacy|0|||
155185553|NCT00410202|560118000|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
155185554|NCT00410202|560118001|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
155185555|NCT00410202|560117999|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
155185556|NCT00410202|560118000|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
155185557|NCT00410202|560118001|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
155185558|NCT00144027|560118002|FG000|Overall Study|Lost to Follow-up|1|||
155185559|NCT00144027|560118003|FG001|Overall Study|Lost to Follow-up|3|||
155185560|NCT00144027|560118002|FG000|Overall Study|Withdrawal by Subject|2|||
155185561|NCT00144027|560118003|FG001|Overall Study|Withdrawal by Subject|2|||
155185562|NCT00144027|560118002|FG000|Overall Study|did not complete baseline assessment|0|||
155185563|NCT00144027|560118003|FG001|Overall Study|did not complete baseline assessment|6|||
155185564|NCT00937391|560118004|FG000|Stage 2|Withdrawal by Subject|1|||
155185565|NCT02021656|560118013|FG000|Overall Study|Adverse Event|1|||
155185566|NCT02021656|560118013|FG000|Overall Study|Lack of Efficacy|2|||
155185567|NCT02021656|560118013|FG000|Overall Study|Lost to Follow-up|1|||
155185568|NCT02021656|560118013|FG000|Overall Study|Withdrew Consent|2|||
155185569|NCT00510952|560118014|FG000|Overall Study|Adverse Event|1|||
155185570|NCT00510952|560118015|FG001|Overall Study|Adverse Event|0|||
155185571|NCT00510952|560118014|FG000|Overall Study|Entry Criteria Not Met|3|||
155185572|NCT00510952|560118015|FG001|Overall Study|Entry Criteria Not Met|1|||
155185573|NCT00510952|560118014|FG000|Overall Study|Lost to Follow-up|5|||
155185574|NCT00510952|560118015|FG001|Overall Study|Lost to Follow-up|3|||
155185575|NCT00510952|560118014|FG000|Overall Study|Physician Decision|1|||
155185576|NCT00510952|560118015|FG001|Overall Study|Physician Decision|1|||
155185577|NCT00510952|560118014|FG000|Overall Study|Protocol Violation|7|||
155185578|NCT00510952|560118015|FG001|Overall Study|Protocol Violation|4|||
155185579|NCT00510952|560118014|FG000|Overall Study|Sponsor Decision|1|||
155185580|NCT00510952|560118015|FG001|Overall Study|Sponsor Decision|0|||
155185581|NCT00510952|560118014|FG000|Overall Study|Withdrawal by Subject|6|||
155185582|NCT00510952|560118015|FG001|Overall Study|Withdrawal by Subject|7|||
155185583|NCT00510952|560118014|FG000|Overall Study|Did Not Receive Study Drug|2|||
155185584|NCT00510952|560118015|FG001|Overall Study|Did Not Receive Study Drug|0|||
155185585|NCT03119701|560118016|FG000|6-day Dosing|Death|4|||
155185586|NCT03119701|560118017|FG001|6-day Dosing|Death|1|||
155185587|NCT03119701|560118016|FG000|6-day Dosing|Adverse Event|3|||
155185588|NCT03119701|560118017|FG001|6-day Dosing|Adverse Event|0|||
155185589|NCT03119701|560118016|FG000|6-day Dosing|Physician Decision|0|||
155185590|NCT03119701|560118017|FG001|6-day Dosing|Physician Decision|1|||
155185591|NCT03119701|560118016|FG000|6-day Dosing|Withdrawal by Subject|0|||
155185592|NCT03119701|560118017|FG001|6-day Dosing|Withdrawal by Subject|1|||
155185593|NCT03119701|560118016|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
155185594|NCT03119701|560118017|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
155185595|NCT02125604|560118021|FG000|Overall Study|Other|4|||
155185596|NCT02125604|560118021|FG000|Overall Study|Investigator Decision|1|||
155185597|NCT02125604|560118021|FG000|Overall Study|Lost to Follow-up|2|||
155185598|NCT02125604|560118021|FG000|Overall Study|Consent Withdrawn|4|||
155185599|NCT02125604|560118021|FG000|Overall Study|Adverse Event|20|||
155185600|NCT00122278|560119596|FG000|Overall Study|Lost to Follow-up|2|||
155185601|NCT00122278|560119597|FG001|Overall Study|Lost to Follow-up|0|||
155185602|NCT01002482|560119598|FG000|Overall Study|Withdrawal by Subject|14|||
155185603|NCT01002482|560119599|FG001|Overall Study|Withdrawal by Subject|21|||
155185604|NCT01002482|560119598|FG000|Overall Study|Included twice|1|||
155185605|NCT01002482|560119599|FG001|Overall Study|Included twice|0|||
155185606|NCT02247531|560119600|FG000|Overall Study|Adverse Event|3|||
155185607|NCT02247531|560119601|FG001|Overall Study|Adverse Event|4|||
155185608|NCT02247531|560119602|FG002|Overall Study|Adverse Event|9|||
155185609|NCT02247531|560119600|FG000|Overall Study|Death|8|||
155185610|NCT02247531|560119601|FG001|Overall Study|Death|9|||
155185611|NCT02247531|560119602|FG002|Overall Study|Death|5|||
155185612|NCT02247531|560119600|FG000|Overall Study|Lost to Follow-up|1|||
155185613|NCT02247531|560119601|FG001|Overall Study|Lost to Follow-up|8|||
155185614|NCT02247531|560119602|FG002|Overall Study|Lost to Follow-up|3|||
155185615|NCT02247531|560119600|FG000|Overall Study|Non-compliance|2|||
155185616|NCT02247531|560119601|FG001|Overall Study|Non-compliance|2|||
155185617|NCT02247531|560119602|FG002|Overall Study|Non-compliance|0|||
155185618|NCT02247531|560119600|FG000|Overall Study|Withdrawal by Subject|26|||
155185619|NCT02247531|560119601|FG001|Overall Study|Withdrawal by Subject|31|||
155185620|NCT02247531|560119602|FG002|Overall Study|Withdrawal by Subject|25|||
155185621|NCT02247531|560119600|FG000|Overall Study|Study Terminated by Sponsor|64|||
155185622|NCT02247531|560119601|FG001|Overall Study|Study Terminated by Sponsor|66|||
155185623|NCT02247531|560119602|FG002|Overall Study|Study Terminated by Sponsor|62|||
155185624|NCT02247531|560119600|FG000|Overall Study|Physician Decision|0|||
155185625|NCT02247531|560119601|FG001|Overall Study|Physician Decision|2|||
155185626|NCT02247531|560119602|FG002|Overall Study|Physician Decision|2|||
155185627|NCT02247531|560119600|FG000|Overall Study|Unspecified Reason|2|||
155185628|NCT02247531|560119601|FG001|Overall Study|Unspecified Reason|3|||
155185629|NCT02247531|560119602|FG002|Overall Study|Unspecified Reason|4|||
155185630|NCT04879225|560119603|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
155185631|NCT04879225|560119603|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
155185632|NCT01298531|560119606|FG000|Overall Study|Lack of Efficacy|0|||
155185633|NCT01298531|560119607|FG001|Overall Study|Lack of Efficacy|1|||
155185634|NCT01298531|560119606|FG000|Overall Study|Lost to Follow-up|2|||
155185635|NCT01298531|560119607|FG001|Overall Study|Lost to Follow-up|0|||
155185636|NCT01298531|560119606|FG000|Overall Study|Protocol Violation|1|||
155185637|NCT01298531|560119607|FG001|Overall Study|Protocol Violation|1|||
155185638|NCT01298531|560119606|FG000|Overall Study|Adverse Event|4|||
155185639|NCT01298531|560119607|FG001|Overall Study|Adverse Event|3|||
155185640|NCT01298531|560119606|FG000|Overall Study|Does not meet entrance criteria|0|||
155185641|NCT01298531|560119607|FG001|Overall Study|Does not meet entrance criteria|1|||
155185642|NCT01298531|560119606|FG000|Overall Study|Other|2|||
155185643|NCT01298531|560119607|FG001|Overall Study|Other|1|||
155185644|NCT00736957|560119608|FG000|Overall Study|Adverse Event|43|||
155185645|NCT00736957|560119608|FG000|Overall Study|Withdrawal by Subject|49|||
155185646|NCT00736957|560119608|FG000|Overall Study|violation of eligibility criteria|2|||
155185647|NCT00736957|560119608|FG000|Overall Study|did not attend hospital appointments|1|||
155185648|NCT00736957|560119608|FG000|Overall Study|not eligible for Treatment Period I|22|||
155185649|NCT00736957|560119608|FG000|Overall Study|Physician Decision|5|||
155185650|NCT04521777|560119609|FG000|Overall Study|Death|2|||
155185651|NCT04521777|560119609|FG000|Overall Study|Withdrawal by Subject|2|||
155185652|NCT00608543|560119610|FG000|Overall Study|Adverse Event|4|||
155185653|NCT01068652|560119620|FG000|Overall Study|Adverse Event|4|||
155185654|NCT01068652|560119621|FG001|Overall Study|Adverse Event|0|||
155185655|NCT01068652|560119620|FG000|Overall Study|Lack of Efficacy|0|||
155185656|NCT01068652|560119621|FG001|Overall Study|Lack of Efficacy|2|||
155185657|NCT01068652|560119620|FG000|Overall Study|Lost to Follow-up|2|||
155034722|NCT00195494|559553653|FG000|Year 2|Compliance|1|||
155034723|NCT00195494|559553654|FG001|Year 2|Compliance|0|||
155034724|NCT00195494|559553655|FG002|Year 2|Compliance|0|||
155034725|NCT00195494|559553656|FG003|Year 2|Compliance|2|||
155034726|NCT00195494|559553657|FG004|Year 2|Compliance|0|||
155034727|NCT00195494|559553658|FG005|Year 2|Compliance|0|||
155034728|NCT00195494|559553653|FG000|Year 2|Lost to Follow-up|0|||
155034729|NCT00195494|559553654|FG001|Year 2|Lost to Follow-up|0|||
155034730|NCT00195494|559553655|FG002|Year 2|Lost to Follow-up|1|||
155034731|NCT00195494|559553656|FG003|Year 2|Lost to Follow-up|1|||
155185658|NCT01068652|560119621|FG001|Overall Study|Lost to Follow-up|1|||
155185659|NCT01068652|560119620|FG000|Overall Study|Protocol Violation|3|||
155185660|NCT01068652|560119621|FG001|Overall Study|Protocol Violation|6|||
155185661|NCT01068652|560119620|FG000|Overall Study|Withdrawal criteria|1|||
155185662|NCT01068652|560119621|FG001|Overall Study|Withdrawal criteria|2|||
155185663|NCT01068652|560119620|FG000|Overall Study|Patient was not eligible|1|||
155185664|NCT01068652|560119621|FG001|Overall Study|Patient was not eligible|0|||
155185665|NCT01068652|560119620|FG000|Overall Study|Unclassified|7|||
155185666|NCT01068652|560119621|FG001|Overall Study|Unclassified|4|||
155185667|NCT05153473|560119622|FG000|Overall Study|Death|46|||
155034732|NCT00195494|559553657|FG004|Year 2|Lost to Follow-up|0|||
155034733|NCT00195494|559553658|FG005|Year 2|Lost to Follow-up|0|||
155034734|NCT00195494|559553653|FG000|Year 2|Missed >4 consecutive doses|1|||
155034735|NCT00195494|559553654|FG001|Year 2|Missed >4 consecutive doses|1|||
155034736|NCT00195494|559553655|FG002|Year 2|Missed >4 consecutive doses|1|||
155034737|NCT00195494|559553656|FG003|Year 2|Missed >4 consecutive doses|0|||
155034738|NCT00195494|559553657|FG004|Year 2|Missed >4 consecutive doses|0|||
155034739|NCT00195494|559553658|FG005|Year 2|Missed >4 consecutive doses|0|||
155034740|NCT00195494|559553653|FG000|Year 2|Protocol deviation|0|||
155034741|NCT00195494|559553654|FG001|Year 2|Protocol deviation|1|||
155034742|NCT00195494|559553655|FG002|Year 2|Protocol deviation|0|||
155034743|NCT00195494|559553656|FG003|Year 2|Protocol deviation|0|||
155034744|NCT00195494|559553657|FG004|Year 2|Protocol deviation|0|||
155034745|NCT00195494|559553658|FG005|Year 2|Protocol deviation|0|||
155034746|NCT00195494|559553653|FG000|Year 2|Physician Decision|1|||
155034747|NCT00195494|559553654|FG001|Year 2|Physician Decision|1|||
155185668|NCT05153473|560119622|FG000|Overall Study|Lost to Follow-up|3|||
155185669|NCT02788474|560119623|FG000|Double Blind Treatment Period|Not treated|1|||
155185670|NCT02788474|560119624|FG001|Double Blind Treatment Period|Not treated|0|||
155034748|NCT00195494|559553655|FG002|Year 2|Physician Decision|0|||
155034749|NCT00195494|559553656|FG003|Year 2|Physician Decision|0|||
155034750|NCT00195494|559553657|FG004|Year 2|Physician Decision|0|||
155034751|NCT00195494|559553658|FG005|Year 2|Physician Decision|0|||
155185671|NCT02788474|560119623|FG000|Double Blind Treatment Period|Patient's refusal|3|||
155185672|NCT02788474|560119624|FG001|Double Blind Treatment Period|Patient's refusal|0|||
155185673|NCT02788474|560119623|FG000|Double Blind Treatment Period|Adverse Event|6|||
155185674|NCT02788474|560119624|FG001|Double Blind Treatment Period|Adverse Event|4|||
155185675|NCT02788474|560119623|FG000|Open Label Treatment Period|Adverse Event|29|||
155034752|NCT00195494|559553653|FG000|Year 2|Withdrawal by Subject|1|||
155034753|NCT00195494|559553654|FG001|Year 2|Withdrawal by Subject|5|||
155034754|NCT00195494|559553655|FG002|Year 2|Withdrawal by Subject|4|||
155034755|NCT00195494|559553656|FG003|Year 2|Withdrawal by Subject|3|||
155034756|NCT00195494|559553657|FG004|Year 2|Withdrawal by Subject|0|||
155034757|NCT00195494|559553658|FG005|Year 2|Withdrawal by Subject|0|||
155034758|NCT00195494|559553653|FG000|Year 2|System toxicity|0|||
155034759|NCT00195494|559553654|FG001|Year 2|System toxicity|0|||
155034760|NCT00195494|559553655|FG002|Year 2|System toxicity|0|||
155034761|NCT00195494|559553656|FG003|Year 2|System toxicity|1|||
155034762|NCT00195494|559553657|FG004|Year 2|System toxicity|0|||
155034763|NCT00195494|559553658|FG005|Year 2|System toxicity|0|||
155034764|NCT02020512|559553659|FG000|Overall Study|Adverse Event|1|||
155034765|NCT02020512|559553659|FG000|Overall Study|Lost to Follow-up|3|||
155034766|NCT02020512|559553659|FG000|Overall Study|Protocol Violation|4|||
155034767|NCT01790828|559553664|FG000|Overall Study|Other|34|||
155034768|NCT01645891|559553666|FG000|Overall Study|Adverse Event|6|||
155034769|NCT01645891|559553667|FG001|Overall Study|Adverse Event|10|||
155034770|NCT01645891|559553666|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
155034771|NCT01645891|559553667|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
155034772|NCT01645891|559553666|FG000|Overall Study|Withdrawal by Subject|3|||
155034773|NCT01645891|559553667|FG001|Overall Study|Withdrawal by Subject|3|||
155034774|NCT01645891|559553666|FG000|Overall Study|Protocol Violation|4|||
155034775|NCT01645891|559553667|FG001|Overall Study|Protocol Violation|0|||
155034776|NCT01645891|559553666|FG000|Overall Study|Lost to Follow-up|4|||
155034777|NCT01645891|559553667|FG001|Overall Study|Lost to Follow-up|1|||
155034778|NCT01645891|559553666|FG000|Overall Study|Death|0|||
155034779|NCT01645891|559553667|FG001|Overall Study|Death|2|||
155034780|NCT01037127|559553669|FG000|Overall Study|Lost to Follow-up|2|||
155034781|NCT01037127|559553670|FG001|Overall Study|Lost to Follow-up|4|||
155034782|NCT01037127|559553669|FG000|Overall Study|Physician Decision|1|||
155034783|NCT01037127|559553670|FG001|Overall Study|Physician Decision|0|||
155034784|NCT01037127|559553669|FG000|Overall Study|Study Closed Terminated|2|||
155034785|NCT01037127|559553670|FG001|Overall Study|Study Closed Terminated|17|||
155185676|NCT02788474|560119624|FG001|Open Label Treatment Period|Adverse Event|9|||
155185677|NCT02788474|560119623|FG000|Open Label Treatment Period|Other than reason specified|1|||
155185678|NCT02788474|560119624|FG001|Open Label Treatment Period|Other than reason specified|0|||
155185679|NCT02788474|560119623|FG000|Open Label Treatment Period|Patient's refusal|1|||
155185680|NCT02788474|560119624|FG001|Open Label Treatment Period|Patient's refusal|3|||
155185681|NCT02788474|560119623|FG000|Open Label Treatment Period|Non-compliance|1|||
155034786|NCT00078949|559555846|FG000|Overall Study|No treated|4|||
155034787|NCT00078949|559555847|FG001|Overall Study|No treated|5|||
155034788|NCT00078949|559555848|FG002|Overall Study|No treated|3|||
155034789|NCT00078949|559555849|FG003|Overall Study|No treated|3|||
155034790|NCT02667626|559555850|FG000|Overall Study|Withdrawal by Subject|0|||
155034791|NCT02667626|559555851|FG001|Overall Study|Withdrawal by Subject|1|||
155034792|NCT02560623|559555852|FG000|Overall Study|Unable to swallow sponge|0|||
155034793|NCT02560623|559555853|FG001|Overall Study|Unable to swallow sponge|1|||
155034794|NCT02560623|559555854|FG002|Overall Study|Unable to swallow sponge|0|||
155034795|NCT02560623|559555855|FG003|Overall Study|Unable to swallow sponge|0|||
155034796|NCT02560623|559555852|FG000|Overall Study|Intervention prior to sponge administration|0|||
155034797|NCT02560623|559555853|FG001|Overall Study|Intervention prior to sponge administration|1|||
155034798|NCT02560623|559555854|FG002|Overall Study|Intervention prior to sponge administration|0|||
155034799|NCT02560623|559555855|FG003|Overall Study|Intervention prior to sponge administration|0|||
155034800|NCT01125813|559555856|FG000|Overall Study|Death|1|||
155034801|NCT01125813|559555856|FG000|Overall Study|Withdrawal by Subject|1|||
155034802|NCT01125813|559555856|FG000|Overall Study|Screen Failures|4|||
155034803|NCT02453282|559555859|FG000|Overall Study|Death|275|||
155034804|NCT02453282|559555860|FG001|Overall Study|Death|277|||
155034805|NCT02453282|559555861|FG002|Overall Study|Death|296|||
155034806|NCT02453282|559555859|FG000|Overall Study|Lost to Follow-up|1|||
155034807|NCT02453282|559555860|FG001|Overall Study|Lost to Follow-up|0|||
155034808|NCT02453282|559555861|FG002|Overall Study|Lost to Follow-up|2|||
155034809|NCT02453282|559555859|FG000|Overall Study|Withdrawal by Subject|12|||
155034810|NCT02453282|559555860|FG001|Overall Study|Withdrawal by Subject|10|||
155034811|NCT02453282|559555861|FG002|Overall Study|Withdrawal by Subject|11|||
155034812|NCT02453282|559555859|FG000|Overall Study|Participants ongoing at data cut-off|85|||
155034813|NCT02453282|559555860|FG001|Overall Study|Participants ongoing at data cut-off|84|||
155034814|NCT02453282|559555861|FG002|Overall Study|Participants ongoing at data cut-off|62|||
155034815|NCT02453282|559555859|FG000|Overall Study|Other|1|||
155185682|NCT02788474|560119624|FG001|Open Label Treatment Period|Non-compliance|0|||
155034816|NCT02453282|559555860|FG001|Overall Study|Other|1|||
155034817|NCT02453282|559555861|FG002|Overall Study|Other|1|||
155034818|NCT01143064|559555862|FG000|Overall Study|Death|109|||
155034819|NCT01143064|559555863|FG001|Overall Study|Death|91|||
155034820|NCT01143064|559555862|FG000|Overall Study|Adverse Event|0|||
155034821|NCT01143064|559555863|FG001|Overall Study|Adverse Event|1|||
155185683|NCT03555435|560119625|FG000|Overall Study|Lost to Follow-up|17|||
155034822|NCT01143064|559555862|FG000|Overall Study|Withdrawal by Subject|7|||
155034823|NCT01143064|559555863|FG001|Overall Study|Withdrawal by Subject|5|||
155034824|NCT01143064|559555862|FG000|Overall Study|Lost to Follow-up|17|||
155034825|NCT01143064|559555863|FG001|Overall Study|Lost to Follow-up|14|||
155034826|NCT01143064|559555862|FG000|Overall Study|Physician Decision|0|||
155034827|NCT01143064|559555863|FG001|Overall Study|Physician Decision|4|||
155034828|NCT02327013|559555866|FG000|Overall Study|Adverse Event|4|||
155034829|NCT02327013|559555867|FG001|Overall Study|Adverse Event|4|||
155034830|NCT02327013|559555868|FG002|Overall Study|Adverse Event|3|||
155034831|NCT02327013|559555869|FG003|Overall Study|Adverse Event|0|||
155034832|NCT02327013|559555870|FG004|Overall Study|Adverse Event|1|||
155034833|NCT02327013|559555866|FG000|Overall Study|Lack of Efficacy|2|||
155034834|NCT02327013|559555867|FG001|Overall Study|Lack of Efficacy|0|||
155034835|NCT02327013|559555868|FG002|Overall Study|Lack of Efficacy|5|||
155034836|NCT02327013|559555869|FG003|Overall Study|Lack of Efficacy|0|||
155034837|NCT02327013|559555870|FG004|Overall Study|Lack of Efficacy|1|||
155034838|NCT02327013|559555866|FG000|Overall Study|Non-compliance with IMP|1|||
155034839|NCT02327013|559555867|FG001|Overall Study|Non-compliance with IMP|2|||
155034840|NCT02327013|559555868|FG002|Overall Study|Non-compliance with IMP|7|||
155034841|NCT02327013|559555869|FG003|Overall Study|Non-compliance with IMP|0|||
155034842|NCT02327013|559555870|FG004|Overall Study|Non-compliance with IMP|0|||
155034843|NCT02327013|559555866|FG000|Overall Study|Withdrawal of Consent|1|||
155034844|NCT02327013|559555867|FG001|Overall Study|Withdrawal of Consent|0|||
155034845|NCT02327013|559555868|FG002|Overall Study|Withdrawal of Consent|3|||
155034846|NCT02327013|559555869|FG003|Overall Study|Withdrawal of Consent|0|||
155034847|NCT02327013|559555870|FG004|Overall Study|Withdrawal of Consent|0|||
155143457|NCT04497116|559959384|FG010|Overall Study|Death|2|||
155143458|NCT04497116|559959385|FG011|Overall Study|Death|1|||
155143459|NCT04497116|559959386|FG012|Overall Study|Death|1|||
155143460|NCT04497116|559959387|FG013|Overall Study|Death|3|||
155143461|NCT04497116|559959388|FG014|Overall Study|Death|18|||
155143462|NCT04497116|559959389|FG015|Overall Study|Death|3|||
155143463|NCT04497116|559959390|FG016|Overall Study|Death|2|||
155143464|NCT04497116|559959391|FG017|Overall Study|Death|1|||
155143465|NCT04497116|559959392|FG018|Overall Study|Death|4|||
155143466|NCT04497116|559959393|FG019|Overall Study|Death|17|||
155143467|NCT04497116|559959394|FG020|Overall Study|Death|1|||
155143468|NCT04497116|559959395|FG021|Overall Study|Death|0|||
155143469|NCT04497116|559959396|FG022|Overall Study|Death|3|||
155143470|NCT04497116|559959397|FG023|Overall Study|Death|5|||
155143471|NCT04497116|559959398|FG024|Overall Study|Death|4|||
155143472|NCT04497116|559959374|FG000|Overall Study|Withdrawal by Subject|1|||
155143473|NCT04497116|559959375|FG001|Overall Study|Withdrawal by Subject|0|||
155143474|NCT04497116|559959376|FG002|Overall Study|Withdrawal by Subject|1|||
155143475|NCT04497116|559959377|FG003|Overall Study|Withdrawal by Subject|0|||
155143476|NCT04497116|559959378|FG004|Overall Study|Withdrawal by Subject|0|||
155143477|NCT04497116|559959379|FG005|Overall Study|Withdrawal by Subject|0|||
155143478|NCT04497116|559959380|FG006|Overall Study|Withdrawal by Subject|0|||
155143479|NCT04497116|559959381|FG007|Overall Study|Withdrawal by Subject|7|||
155143480|NCT04497116|559959382|FG008|Overall Study|Withdrawal by Subject|14|||
155143481|NCT04497116|559959383|FG009|Overall Study|Withdrawal by Subject|3|||
155143482|NCT04497116|559959384|FG010|Overall Study|Withdrawal by Subject|3|||
155143483|NCT04497116|559959385|FG011|Overall Study|Withdrawal by Subject|0|||
155143484|NCT04497116|559959386|FG012|Overall Study|Withdrawal by Subject|1|||
155143485|NCT04497116|559959387|FG013|Overall Study|Withdrawal by Subject|0|||
155143486|NCT04497116|559959388|FG014|Overall Study|Withdrawal by Subject|7|||
155143487|NCT04497116|559959389|FG015|Overall Study|Withdrawal by Subject|1|||
155143488|NCT04497116|559959390|FG016|Overall Study|Withdrawal by Subject|3|||
155143489|NCT04497116|559959391|FG017|Overall Study|Withdrawal by Subject|1|||
155143490|NCT04497116|559959392|FG018|Overall Study|Withdrawal by Subject|1|||
155143491|NCT04497116|559959393|FG019|Overall Study|Withdrawal by Subject|5|||
155143492|NCT04497116|559959394|FG020|Overall Study|Withdrawal by Subject|2|||
155143493|NCT04497116|559959395|FG021|Overall Study|Withdrawal by Subject|2|||
155143494|NCT04497116|559959396|FG022|Overall Study|Withdrawal by Subject|2|||
155143495|NCT04497116|559959397|FG023|Overall Study|Withdrawal by Subject|4|||
155143496|NCT04497116|559959398|FG024|Overall Study|Withdrawal by Subject|3|||
155143497|NCT04497116|559959374|FG000|Overall Study|Physician Decision|0|||
155143498|NCT04497116|559959375|FG001|Overall Study|Physician Decision|0|||
155143499|NCT04497116|559959376|FG002|Overall Study|Physician Decision|0|||
155143500|NCT04497116|559959377|FG003|Overall Study|Physician Decision|0|||
155143501|NCT04497116|559959378|FG004|Overall Study|Physician Decision|0|||
155143502|NCT04497116|559959379|FG005|Overall Study|Physician Decision|0|||
155143503|NCT04497116|559959380|FG006|Overall Study|Physician Decision|0|||
155143504|NCT04497116|559959381|FG007|Overall Study|Physician Decision|0|||
155143505|NCT04497116|559959382|FG008|Overall Study|Physician Decision|0|||
155143506|NCT04497116|559959383|FG009|Overall Study|Physician Decision|0|||
155143507|NCT04497116|559959384|FG010|Overall Study|Physician Decision|0|||
155034848|NCT02327013|559555866|FG000|Overall Study|Lost to Follow-up|2|||
155143508|NCT04497116|559959385|FG011|Overall Study|Physician Decision|0|||
155143509|NCT04497116|559959386|FG012|Overall Study|Physician Decision|0|||
155143510|NCT04497116|559959387|FG013|Overall Study|Physician Decision|0|||
155143511|NCT04497116|559959388|FG014|Overall Study|Physician Decision|0|||
155143512|NCT04497116|559959389|FG015|Overall Study|Physician Decision|0|||
155034849|NCT02327013|559555867|FG001|Overall Study|Lost to Follow-up|4|||
155034850|NCT02327013|559555868|FG002|Overall Study|Lost to Follow-up|5|||
155143513|NCT04497116|559959390|FG016|Overall Study|Physician Decision|0|||
155185684|NCT03555435|560119626|FG001|Overall Study|Lost to Follow-up|19|||
155185685|NCT03555435|560119627|FG002|Overall Study|Lost to Follow-up|8|||
155185686|NCT01323946|560119630|FG000|Overall Study|Lost to Follow-up|0|||
155185687|NCT01323946|560119631|FG001|Overall Study|Lost to Follow-up|1|||
155034851|NCT02327013|559555869|FG003|Overall Study|Lost to Follow-up|0|||
155034852|NCT02327013|559555870|FG004|Overall Study|Lost to Follow-up|0|||
155034853|NCT02327013|559555866|FG000|Overall Study|Administrative or other reason(s)|1|||
155034854|NCT02327013|559555867|FG001|Overall Study|Administrative or other reason(s)|5|||
155034855|NCT02327013|559555868|FG002|Overall Study|Administrative or other reason(s)|11|||
155034856|NCT02327013|559555869|FG003|Overall Study|Administrative or other reason(s)|1|||
155034857|NCT02327013|559555870|FG004|Overall Study|Administrative or other reason(s)|1|||
155034858|NCT02327013|559555866|FG000|Overall Study|Protocol Violation|0|||
155034859|NCT02327013|559555867|FG001|Overall Study|Protocol Violation|0|||
155034860|NCT02327013|559555868|FG002|Overall Study|Protocol Violation|3|||
155185688|NCT01323946|560119632|FG002|Overall Study|Lost to Follow-up|0|||
155185689|NCT01323946|560119630|FG000|Overall Study|Parents refused the last blood draw|1|||
155185690|NCT01323946|560119631|FG001|Overall Study|Parents refused the last blood draw|0|||
155185691|NCT01323946|560119632|FG002|Overall Study|Parents refused the last blood draw|0|||
155185692|NCT01323946|560119630|FG000|Overall Study|Withdrawal by Subject|2|||
155185693|NCT01323946|560119631|FG001|Overall Study|Withdrawal by Subject|2|||
155185694|NCT01323946|560119632|FG002|Overall Study|Withdrawal by Subject|0|||
155185695|NCT02964507|560119633|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185696|NCT02964507|560119634|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
155185697|NCT02964507|560119635|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185698|NCT02964507|560119636|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185699|NCT02964507|560119637|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
155185700|NCT02964507|560119638|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185701|NCT02964507|560119639|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185702|NCT02964507|560119640|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
155185703|NCT02964507|560119633|FG000|Overall Study|Study terminated by Sponsor|9|||
155185704|NCT02964507|560119634|FG001|Overall Study|Study terminated by Sponsor|1|||
155185705|NCT02964507|560119635|FG002|Overall Study|Study terminated by Sponsor|9|||
155185706|NCT02964507|560119636|FG003|Overall Study|Study terminated by Sponsor|3|||
155185707|NCT02964507|560119637|FG004|Overall Study|Study terminated by Sponsor|3|||
155185708|NCT02964507|560119638|FG005|Overall Study|Study terminated by Sponsor|2|||
155185709|NCT02964507|560119639|FG006|Overall Study|Study terminated by Sponsor|0|||
155185710|NCT02964507|560119640|FG007|Overall Study|Study terminated by Sponsor|0|||
155185711|NCT02964507|560119633|FG000|Overall Study|Other|3|||
155185712|NCT02964507|560119634|FG001|Overall Study|Other|0|||
155185713|NCT02964507|560119635|FG002|Overall Study|Other|0|||
155185714|NCT02964507|560119636|FG003|Overall Study|Other|0|||
155185715|NCT02964507|560119637|FG004|Overall Study|Other|1|||
155185716|NCT02964507|560119638|FG005|Overall Study|Other|0|||
155185717|NCT02964507|560119639|FG006|Overall Study|Other|0|||
155185718|NCT02964507|560119640|FG007|Overall Study|Other|0|||
155185719|NCT02964507|560119633|FG000|Overall Study|Death|11|||
155185720|NCT02964507|560119634|FG001|Overall Study|Death|9|||
155185721|NCT02964507|560119635|FG002|Overall Study|Death|12|||
155185722|NCT02964507|560119636|FG003|Overall Study|Death|2|||
155185723|NCT02964507|560119637|FG004|Overall Study|Death|10|||
155185724|NCT02964507|560119638|FG005|Overall Study|Death|5|||
155185725|NCT02964507|560119639|FG006|Overall Study|Death|0|||
155185726|NCT02964507|560119640|FG007|Overall Study|Death|0|||
155185727|NCT02964507|560119633|FG000|Overall Study|Withdrawal by Subject|1|||
155185728|NCT02964507|560119634|FG001|Overall Study|Withdrawal by Subject|0|||
155185729|NCT02964507|560119635|FG002|Overall Study|Withdrawal by Subject|1|||
155185730|NCT02964507|560119636|FG003|Overall Study|Withdrawal by Subject|1|||
155185731|NCT02964507|560119637|FG004|Overall Study|Withdrawal by Subject|0|||
155185732|NCT02964507|560119638|FG005|Overall Study|Withdrawal by Subject|1|||
155185733|NCT02964507|560119639|FG006|Overall Study|Withdrawal by Subject|0|||
155185734|NCT02964507|560119640|FG007|Overall Study|Withdrawal by Subject|0|||
155185735|NCT02964507|560119633|FG000|Overall Study|Physician Decision|2|||
155034861|NCT02327013|559555869|FG003|Overall Study|Protocol Violation|0|||
155034862|NCT02327013|559555870|FG004|Overall Study|Protocol Violation|1|||
155034863|NCT02327013|559555866|FG000|Overall Study|Withdrawal before treatment|2|||
155185736|NCT02964507|560119634|FG001|Overall Study|Physician Decision|0|||
155034864|NCT02327013|559555867|FG001|Overall Study|Withdrawal before treatment|1|||
155185737|NCT02964507|560119635|FG002|Overall Study|Physician Decision|3|||
155185738|NCT02964507|560119636|FG003|Overall Study|Physician Decision|0|||
155185739|NCT02964507|560119637|FG004|Overall Study|Physician Decision|1|||
155185740|NCT02964507|560119638|FG005|Overall Study|Physician Decision|0|||
155185741|NCT02964507|560119639|FG006|Overall Study|Physician Decision|0|||
155185742|NCT02964507|560119640|FG007|Overall Study|Physician Decision|0|||
155034865|NCT02327013|559555868|FG002|Overall Study|Withdrawal before treatment|5|||
155034866|NCT02327013|559555869|FG003|Overall Study|Withdrawal before treatment|0|||
155034867|NCT02327013|559555870|FG004|Overall Study|Withdrawal before treatment|0|||
155185743|NCT04341662|560119641|FG000|Overall Study|Did not have source-verified blood loss data|423|||
155185744|NCT04341662|560119642|FG001|Overall Study|Did not have source-verified blood loss data|514|||
155185745|NCT03953183|560119643|FG000|Overall Study|Physician Decision|0|||
155185746|NCT03953183|560119644|FG001|Overall Study|Physician Decision|1|||
155185747|NCT03953183|560119643|FG000|Overall Study|Withdrawal by Subject|0|||
155185748|NCT03953183|560119644|FG001|Overall Study|Withdrawal by Subject|1|||
155185749|NCT02273739|560119648|FG000|Overall Study|Progression of Disease|3|||
155185750|NCT02273739|560119649|FG001|Overall Study|Progression of Disease|4|||
155185751|NCT02273739|560119650|FG002|Overall Study|Progression of Disease|5|||
155185752|NCT02273739|560119651|FG003|Overall Study|Progression of Disease|2|||
155185753|NCT02273739|560119648|FG000|Overall Study|Death|0|||
155185754|NCT02273739|560119649|FG001|Overall Study|Death|0|||
155185755|NCT02273739|560119650|FG002|Overall Study|Death|0|||
155185756|NCT02273739|560119651|FG003|Overall Study|Death|2|||
155185757|NCT02273739|560119648|FG000|Overall Study|Adverse Event|0|||
155185758|NCT02273739|560119649|FG001|Overall Study|Adverse Event|0|||
155185759|NCT02273739|560119650|FG002|Overall Study|Adverse Event|0|||
155185760|NCT02273739|560119651|FG003|Overall Study|Adverse Event|1|||
155185761|NCT02273739|560119648|FG000|Overall Study|Withdrawal by Subject|0|||
155185762|NCT02273739|560119649|FG001|Overall Study|Withdrawal by Subject|0|||
155185763|NCT02273739|560119650|FG002|Overall Study|Withdrawal by Subject|2|||
155185764|NCT02273739|560119651|FG003|Overall Study|Withdrawal by Subject|1|||
155185765|NCT02273739|560119648|FG000|Overall Study|Physician Decision|0|||
155185766|NCT02273739|560119649|FG001|Overall Study|Physician Decision|0|||
155185767|NCT02273739|560119650|FG002|Overall Study|Physician Decision|0|||
155185768|NCT02273739|560119651|FG003|Overall Study|Physician Decision|1|||
155185769|NCT01562873|560119652|FG000|Overall Study|Disease Progression per RECIST|10|||
155185770|NCT01562873|560119653|FG001|Overall Study|Disease Progression per RECIST|0|||
155185771|NCT01562873|560119652|FG000|Overall Study|Adverse Event|1|||
155185772|NCT01562873|560119653|FG001|Overall Study|Adverse Event|0|||
155185773|NCT01562873|560119652|FG000|Overall Study|Clinical Disease Progression|9|||
155185774|NCT01562873|560119653|FG001|Overall Study|Clinical Disease Progression|0|||
155185775|NCT01562873|560119652|FG000|Overall Study|Clinical PD and adverse event|1|||
155185776|NCT01562873|560119653|FG001|Overall Study|Clinical PD and adverse event|0|||
155185777|NCT03370289|560119656|FG000|Overall Study|Screen Failure|1|||
155185778|NCT03370289|560119656|FG000|Overall Study|Sample Size Sufficient|4|||
155185779|NCT00873860|560119658|FG000|Overall Study|Lost to Follow-up|1|||
155185780|NCT00873860|560119659|FG001|Overall Study|Lost to Follow-up|0|||
155185781|NCT00873860|560119660|FG002|Overall Study|Lost to Follow-up|0|||
155185782|NCT00873860|560119661|FG003|Overall Study|Lost to Follow-up|1|||
155185783|NCT00873860|560119658|FG000|Overall Study|Withdrawal by Subject|1|||
155185784|NCT00873860|560119659|FG001|Overall Study|Withdrawal by Subject|0|||
155185785|NCT00873860|560119660|FG002|Overall Study|Withdrawal by Subject|2|||
155185786|NCT00873860|560119661|FG003|Overall Study|Withdrawal by Subject|0|||
155185787|NCT00873860|560119658|FG000|Overall Study|Death|1|||
155185788|NCT00873860|560119659|FG001|Overall Study|Death|0|||
155185789|NCT00873860|560119660|FG002|Overall Study|Death|0|||
155185790|NCT00873860|560119661|FG003|Overall Study|Death|0|||
155185791|NCT00873860|560119658|FG000|Overall Study|Other|1|||
155185792|NCT00873860|560119659|FG001|Overall Study|Other|0|||
155185793|NCT00873860|560119660|FG002|Overall Study|Other|1|||
155185794|NCT00873860|560119661|FG003|Overall Study|Other|0|||
155185795|NCT01172275|560119664|FG000|Overall Study|Lost to Follow-up|1|||
155185796|NCT01172275|560119665|FG001|Overall Study|Lost to Follow-up|0|||
155185797|NCT01172275|560119664|FG000|Overall Study|Protocol Violation|1|||
155185798|NCT01172275|560119665|FG001|Overall Study|Protocol Violation|0|||
155185799|NCT05308290|560119673|FG000|Overall Study|Death|1|||
155185800|NCT05308290|560119674|FG001|Overall Study|Death|0|||
155185801|NCT05308290|560119673|FG000|Overall Study|Lost to Follow-up|2|||
155185802|NCT05308290|560119674|FG001|Overall Study|Lost to Follow-up|1|||
155185803|NCT05308290|560119673|FG000|Overall Study|still in study followup|0|||
155185804|NCT05308290|560119674|FG001|Overall Study|still in study followup|1|||
155185805|NCT01285960|560119675|FG000|Overall Study|Withdrawal by Subject|2|||
155185806|NCT01285960|560119675|FG000|Overall Study|Lost to Follow-up|2|||
155185807|NCT01285960|560119675|FG000|Overall Study|2 subjects received less 10 sonications|2|||
155185808|NCT04437368|560119682|FG000|Overall Study|Death|3|||
155185809|NCT04437368|560119683|FG001|Overall Study|Death|0|||
155185810|NCT04437368|560119684|FG002|Overall Study|Death|2|||
155185811|NCT04437368|560119682|FG000|Overall Study|Study terminated by sponsor|16|||
155185812|NCT04437368|560119683|FG001|Overall Study|Study terminated by sponsor|1|||
155185813|NCT04437368|560119684|FG002|Overall Study|Study terminated by sponsor|25|||
155185814|NCT04437368|560119682|FG000|Overall Study|Withdrawal by Subject|4|||
155185815|NCT04437368|560119683|FG001|Overall Study|Withdrawal by Subject|0|||
155185816|NCT04437368|560119684|FG002|Overall Study|Withdrawal by Subject|3|||
155185817|NCT04437368|560119682|FG000|Overall Study|Sponsor instructions|23|||
155185818|NCT04437368|560119683|FG001|Overall Study|Sponsor instructions|0|||
155185819|NCT04437368|560119684|FG002|Overall Study|Sponsor instructions|0|||
155185820|NCT00095628|560119685|FG000|Overall Study|Disease progression prior to treatment|1|||
155185821|NCT04271280|560119686|FG000|Overall Study|Lost to Follow-up|300|||
155185822|NCT04271280|560119686|FG000|Overall Study|Death|153|||
155185823|NCT04271280|560119686|FG000|Overall Study|Withdrawal of consent by patient|59|||
155185824|NCT04271280|560119686|FG000|Overall Study|Other|51|||
155185825|NCT04271280|560119686|FG000|Overall Study|No end of study information|42|||
155185826|NCT00364130|560119687|FG000|Intervention Period|Lost to Follow-up|4|||
155185827|NCT00364130|560119688|FG001|Intervention Period|Lost to Follow-up|3|||
155185828|NCT00364130|560119687|FG000|Intervention Period|Pregnancy|1|||
155185829|NCT00364130|560119688|FG001|Intervention Period|Pregnancy|0|||
155185830|NCT00364130|560119687|FG000|Intervention Period|Withdrawal by Subject|4|||
155185831|NCT00364130|560119688|FG001|Intervention Period|Withdrawal by Subject|5|||
155185832|NCT00364130|560119687|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
155185833|NCT00364130|560119688|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
155185834|NCT01178073|560119693|FG000|Overall Study|Adverse Event|34|||
155185835|NCT01178073|560119694|FG001|Overall Study|Adverse Event|27|||
155185836|NCT01178073|560119695|FG002|Overall Study|Adverse Event|24|||
155185837|NCT01178073|560119693|FG000|Overall Study|Protocol Violation|1|||
155185838|NCT01178073|560119694|FG001|Overall Study|Protocol Violation|1|||
155185839|NCT01178073|560119695|FG002|Overall Study|Protocol Violation|1|||
155185840|NCT01178073|560119693|FG000|Overall Study|Lost to Follow-up|2|||
155185841|NCT01178073|560119694|FG001|Overall Study|Lost to Follow-up|0|||
155185842|NCT01178073|560119695|FG002|Overall Study|Lost to Follow-up|3|||
155185843|NCT01178073|560119693|FG000|Overall Study|Physician Decision|14|||
155185844|NCT01178073|560119694|FG001|Overall Study|Physician Decision|10|||
155185845|NCT01178073|560119695|FG002|Overall Study|Physician Decision|10|||
155185846|NCT01178073|560119693|FG000|Overall Study|Withdrawal by Subject|10|||
155185847|NCT01178073|560119694|FG001|Overall Study|Withdrawal by Subject|6|||
155185848|NCT01178073|560119695|FG002|Overall Study|Withdrawal by Subject|8|||
155185849|NCT01178073|560119693|FG000|Overall Study|Missing Completion Status|1|||
155185850|NCT01178073|560119694|FG001|Overall Study|Missing Completion Status|0|||
155185851|NCT01178073|560119695|FG002|Overall Study|Missing Completion Status|0|||
155185852|NCT01674634|560119696|FG000|Overall Study|Withdrawal by Subject|3|||
155185853|NCT01674634|560119696|FG000|Overall Study|Lost to Follow-up|3|||
155185854|NCT05080660|560119697|FG000|Overall Study|Adverse Event|4|||
155185855|NCT05080660|560119698|FG001|Overall Study|Adverse Event|0|||
155185856|NCT05080660|560119697|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
155185857|NCT05080660|560119698|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
155185858|NCT05080660|560119697|FG000|Overall Study|Physician Decision|1|||
155185859|NCT05080660|560119698|FG001|Overall Study|Physician Decision|0|||
155185860|NCT05080660|560119697|FG000|Overall Study|Protocol Deviation|2|||
155185861|NCT05080660|560119698|FG001|Overall Study|Protocol Deviation|0|||
155185862|NCT05080660|560119697|FG000|Overall Study|Withdrawal by Subject|5|||
155185863|NCT05080660|560119698|FG001|Overall Study|Withdrawal by Subject|2|||
155185864|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
155185865|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
155185866|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
155185867|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
155185868|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
155185869|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
155185870|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
155185871|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
155185872|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
155185873|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
155185874|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
155185875|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
155185876|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
155185877|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
155185878|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
155185879|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
155185880|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
155185881|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
155185882|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
155185883|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
155185884|NCT01226043|560119711|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
155185885|NCT01226043|560119712|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
155034868|NCT02380859|559555871|FG000|Overall Study|Withdrawal by Subject|2|||
155185886|NCT01226043|560119713|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
155185887|NCT01226043|560119714|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
155034869|NCT02380859|559555872|FG001|Overall Study|Withdrawal by Subject|0|||
155185888|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Adverse Event|0|||
155185889|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Adverse Event|0|||
155185890|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Adverse Event|1|||
155185891|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Adverse Event|1|||
155034870|NCT01565668|559555873|FG000|Overall Study|Death|2|||
155034871|NCT01565668|559555874|FG001|Overall Study|Death|1|||
155034872|NCT01565668|559555873|FG000|Overall Study|Lack of Efficacy|4|||
155034873|NCT01565668|559555874|FG001|Overall Study|Lack of Efficacy|2|||
155034874|NCT01565668|559555873|FG000|Overall Study|Participant went on Hospice Care|1|||
155034875|NCT01565668|559555874|FG001|Overall Study|Participant went on Hospice Care|0|||
155034876|NCT01565668|559555873|FG000|Overall Study|Adverse Event|6|||
155034877|NCT01565668|559555874|FG001|Overall Study|Adverse Event|1|||
155034878|NCT01565668|559555873|FG000|Overall Study|Randomized, but never received drug|0|||
155034879|NCT01565668|559555874|FG001|Overall Study|Randomized, but never received drug|2|||
155034880|NCT01565668|559555873|FG000|Overall Study|Progressive disease|13|||
155034881|NCT01565668|559555874|FG001|Overall Study|Progressive disease|14|||
155034882|NCT01565668|559555873|FG000|Overall Study|Withdrawal by Subject|1|||
155034883|NCT01565668|559555874|FG001|Overall Study|Withdrawal by Subject|3|||
155034884|NCT01565668|559555873|FG000|Overall Study|HSCT Transplant|11|||
155034885|NCT01565668|559555874|FG001|Overall Study|HSCT Transplant|15|||
155034886|NCT04258254|559555875|FG000|Overall Study|Withdrawal by Subject|0|||
155034887|NCT04258254|559555876|FG001|Overall Study|Withdrawal by Subject|1|||
155034888|NCT04258254|559555877|FG002|Overall Study|Withdrawal by Subject|0|||
155034889|NCT01447446|559555878|FG000|Overall Study|Death|6|||
155034890|NCT01447446|559555879|FG001|Overall Study|Death|3|||
155034891|NCT01447446|559555880|FG002|Overall Study|Death|2|||
155034892|NCT01447446|559555881|FG003|Overall Study|Death|1|||
155034893|NCT01447446|559555882|FG004|Overall Study|Death|7|||
155034894|NCT01447446|559555883|FG005|Overall Study|Death|0|||
155034895|NCT01447446|559555878|FG000|Overall Study|Adverse Event|3|||
155034896|NCT01447446|559555879|FG001|Overall Study|Adverse Event|0|||
155034897|NCT01447446|559555880|FG002|Overall Study|Adverse Event|1|||
155034898|NCT01447446|559555881|FG003|Overall Study|Adverse Event|0|||
155034899|NCT01447446|559555882|FG004|Overall Study|Adverse Event|2|||
155034900|NCT01447446|559555883|FG005|Overall Study|Adverse Event|0|||
155034901|NCT01447446|559555878|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
155034902|NCT01447446|559555879|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
155034903|NCT01447446|559555880|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
155034904|NCT01447446|559555881|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
155034905|NCT01447446|559555882|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
155034906|NCT01447446|559555883|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
155034907|NCT01447446|559555878|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
155034908|NCT01447446|559555879|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
155034909|NCT01447446|559555880|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
155034910|NCT01447446|559555881|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
155034911|NCT01447446|559555882|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
155034912|NCT01447446|559555883|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
155034913|NCT01447446|559555878|FG000|Overall Study|Administrative/Other|34|||
155034914|NCT01447446|559555879|FG001|Overall Study|Administrative/Other|9|||
155034915|NCT01447446|559555880|FG002|Overall Study|Administrative/Other|10|||
155034916|NCT01447446|559555881|FG003|Overall Study|Administrative/Other|2|||
155034917|NCT01447446|559555882|FG004|Overall Study|Administrative/Other|33|||
155034918|NCT01447446|559555883|FG005|Overall Study|Administrative/Other|4|||
155034919|NCT01447446|559555878|FG000|Overall Study|SVR12 Assessment|13|||
155034920|NCT01447446|559555879|FG001|Overall Study|SVR12 Assessment|1|||
155034921|NCT01447446|559555880|FG002|Overall Study|SVR12 Assessment|2|||
155034922|NCT01447446|559555881|FG003|Overall Study|SVR12 Assessment|1|||
155034923|NCT01447446|559555882|FG004|Overall Study|SVR12 Assessment|5|||
155034924|NCT01447446|559555883|FG005|Overall Study|SVR12 Assessment|5|||
155034925|NCT01447446|559555878|FG000|Overall Study|New Treatment Started|8|||
155034926|NCT01447446|559555879|FG001|Overall Study|New Treatment Started|2|||
155034927|NCT01447446|559555880|FG002|Overall Study|New Treatment Started|1|||
155034928|NCT01447446|559555881|FG003|Overall Study|New Treatment Started|0|||
155034929|NCT01447446|559555882|FG004|Overall Study|New Treatment Started|2|||
155143514|NCT04497116|559959391|FG017|Overall Study|Physician Decision|0|||
155143515|NCT04497116|559959392|FG018|Overall Study|Physician Decision|0|||
155143516|NCT04497116|559959393|FG019|Overall Study|Physician Decision|0|||
155143517|NCT04497116|559959394|FG020|Overall Study|Physician Decision|0|||
155143518|NCT04497116|559959395|FG021|Overall Study|Physician Decision|0|||
155143519|NCT04497116|559959396|FG022|Overall Study|Physician Decision|0|||
155143520|NCT04497116|559959397|FG023|Overall Study|Physician Decision|1|||
155143521|NCT04497116|559959398|FG024|Overall Study|Physician Decision|0|||
155143522|NCT04497116|559959374|FG000|Overall Study|Clinical Progression Related|0|||
155143523|NCT04497116|559959375|FG001|Overall Study|Clinical Progression Related|0|||
155143524|NCT04497116|559959376|FG002|Overall Study|Clinical Progression Related|0|||
155143525|NCT04497116|559959377|FG003|Overall Study|Clinical Progression Related|0|||
155143526|NCT04497116|559959378|FG004|Overall Study|Clinical Progression Related|0|||
155034930|NCT01447446|559555883|FG005|Overall Study|New Treatment Started|0|||
155034931|NCT01447446|559555878|FG000|Overall Study|Reason not Specified|1|||
155034932|NCT01447446|559555879|FG001|Overall Study|Reason not Specified|1|||
155034933|NCT01447446|559555880|FG002|Overall Study|Reason not Specified|1|||
155034934|NCT01447446|559555881|FG003|Overall Study|Reason not Specified|1|||
155034935|NCT01447446|559555882|FG004|Overall Study|Reason not Specified|1|||
155034936|NCT01447446|559555883|FG005|Overall Study|Reason not Specified|0|||
155034937|NCT05323994|559555886|FG000|Overall Study|Protocol Violation|1|||
155034938|NCT00454818|559555889|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
155034939|NCT00454818|559555890|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155034940|NCT00454818|559555891|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155034941|NCT00454818|559555892|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155034942|NCT00454818|559555893|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
155034943|NCT00454818|559555889|FG000|Phase I: Open-label Dose-escalation|Death|0|||
155034944|NCT00454818|559555890|FG001|Phase I: Open-label Dose-escalation|Death|1|||
155034945|NCT00454818|559555891|FG002|Phase I: Open-label Dose-escalation|Death|0|||
155034946|NCT00454818|559555892|FG003|Phase I: Open-label Dose-escalation|Death|0|||
155034947|NCT00454818|559555893|FG004|Phase I: Open-label Dose-escalation|Death|0|||
155034948|NCT00454818|559555889|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
155034949|NCT00454818|559555890|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
155034950|NCT00454818|559555891|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
155034951|NCT00454818|559555892|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
155034952|NCT00454818|559555893|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
155034953|NCT00454818|559555889|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
155034954|NCT00454818|559555890|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
155034955|NCT00454818|559555891|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
155034956|NCT00454818|559555892|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
155034957|NCT00454818|559555893|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
155034958|NCT00454818|559555889|FG000|Phase 2: Randomized Double-blind|Death|0|||
155034959|NCT00454818|559555890|FG001|Phase 2: Randomized Double-blind|Death|1|||
155034960|NCT00454818|559555891|FG002|Phase 2: Randomized Double-blind|Death|0|||
155034961|NCT00454818|559555892|FG003|Phase 2: Randomized Double-blind|Death|0|||
155034962|NCT00454818|559555893|FG004|Phase 2: Randomized Double-blind|Death|1|||
155034963|NCT00454818|559555889|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
155034964|NCT00454818|559555890|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
155034965|NCT00454818|559555891|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
155034966|NCT00454818|559555892|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
155034967|NCT00454818|559555893|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
155034968|NCT00454818|559555889|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
155034969|NCT00454818|559555890|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
155034970|NCT00454818|559555891|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
155034971|NCT00454818|559555892|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
155034972|NCT00454818|559555893|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
155034973|NCT01032070|559555901|FG000|Overall Study|Disease progression|13|||
155034974|NCT01032070|559555902|FG001|Overall Study|Disease progression|8|||
155034975|NCT01032070|559555901|FG000|Overall Study|Medical or ethical reasons|0|||
155034976|NCT01032070|559555902|FG001|Overall Study|Medical or ethical reasons|2|||
155034977|NCT01032070|559555901|FG000|Overall Study|Withdrawal by Subject|0|||
155034978|NCT01032070|559555902|FG001|Overall Study|Withdrawal by Subject|2|||
155034979|NCT02554318|559555903|FG000|Overall Study|Withdrawal by Subject|10|||
155034980|NCT02554318|559555904|FG001|Overall Study|Withdrawal by Subject|8|||
155034981|NCT00894790|559555905|FG000|Overall Study|Protocol Violation|0|||
155034982|NCT00894790|559555906|FG001|Overall Study|Protocol Violation|1|||
155034983|NCT00894790|559555905|FG000|Overall Study|Lost to Follow-up|0|||
155034984|NCT00894790|559555906|FG001|Overall Study|Lost to Follow-up|1|||
155143527|NCT04497116|559959379|FG005|Overall Study|Clinical Progression Related|0|||
155143528|NCT04497116|559959380|FG006|Overall Study|Clinical Progression Related|0|||
155143529|NCT04497116|559959381|FG007|Overall Study|Clinical Progression Related|0|||
155143530|NCT04497116|559959382|FG008|Overall Study|Clinical Progression Related|0|||
155143531|NCT04497116|559959383|FG009|Overall Study|Clinical Progression Related|1|||
155143532|NCT04497116|559959384|FG010|Overall Study|Clinical Progression Related|0|||
155143533|NCT04497116|559959385|FG011|Overall Study|Clinical Progression Related|0|||
155143534|NCT04497116|559959386|FG012|Overall Study|Clinical Progression Related|0|||
155143535|NCT04497116|559959387|FG013|Overall Study|Clinical Progression Related|0|||
155143536|NCT04497116|559959388|FG014|Overall Study|Clinical Progression Related|0|||
155143537|NCT04497116|559959389|FG015|Overall Study|Clinical Progression Related|0|||
155143538|NCT04497116|559959390|FG016|Overall Study|Clinical Progression Related|0|||
155143539|NCT04497116|559959391|FG017|Overall Study|Clinical Progression Related|0|||
155143540|NCT04497116|559959392|FG018|Overall Study|Clinical Progression Related|0|||
155143541|NCT04497116|559959393|FG019|Overall Study|Clinical Progression Related|0|||
155143542|NCT04497116|559959394|FG020|Overall Study|Clinical Progression Related|0|||
155143543|NCT04497116|559959395|FG021|Overall Study|Clinical Progression Related|0|||
155034985|NCT00894790|559555905|FG000|Overall Study|Did not meet entrance criteria|1|||
155034986|NCT00894790|559555906|FG001|Overall Study|Did not meet entrance criteria|0|||
155034987|NCT00085098|559555907|FG000|Overall Study|Withdrawal by Subject|0|||
155034988|NCT00085098|559555908|FG001|Overall Study|Withdrawal by Subject|1|||
155034989|NCT00085098|559555907|FG000|Overall Study|Ineligible|1|||
155034990|NCT00085098|559555908|FG001|Overall Study|Ineligible|1|||
155034991|NCT00772005|559555914|FG000|Overall Study|Adverse Event|9|||
155034992|NCT00772005|559555915|FG001|Overall Study|Adverse Event|14|||
155034993|NCT00772005|559555916|FG002|Overall Study|Adverse Event|10|||
155034994|NCT00772005|559555917|FG003|Overall Study|Adverse Event|13|||
155034995|NCT00772005|559555914|FG000|Overall Study|Lack of Efficacy|0|||
155034996|NCT00772005|559555915|FG001|Overall Study|Lack of Efficacy|1|||
155034997|NCT00772005|559555916|FG002|Overall Study|Lack of Efficacy|0|||
155034998|NCT00772005|559555917|FG003|Overall Study|Lack of Efficacy|0|||
155034999|NCT00772005|559555914|FG000|Overall Study|Withdrawal by Subject|3|||
155035000|NCT00772005|559555915|FG001|Overall Study|Withdrawal by Subject|7|||
155035001|NCT00772005|559555916|FG002|Overall Study|Withdrawal by Subject|10|||
155035002|NCT00772005|559555917|FG003|Overall Study|Withdrawal by Subject|2|||
155035003|NCT00772005|559555914|FG000|Overall Study|Protocol Violation|2|||
155035004|NCT00772005|559555915|FG001|Overall Study|Protocol Violation|4|||
155035005|NCT00772005|559555916|FG002|Overall Study|Protocol Violation|1|||
155035006|NCT00772005|559555917|FG003|Overall Study|Protocol Violation|6|||
155035007|NCT00772005|559555914|FG000|Overall Study|Lost to Follow-up|7|||
155035008|NCT00772005|559555915|FG001|Overall Study|Lost to Follow-up|3|||
155035009|NCT00772005|559555916|FG002|Overall Study|Lost to Follow-up|6|||
155035010|NCT00772005|559555917|FG003|Overall Study|Lost to Follow-up|3|||
155035011|NCT00772005|559555914|FG000|Overall Study|Non-compliance with study procedures|1|||
155035012|NCT00772005|559555915|FG001|Overall Study|Non-compliance with study procedures|1|||
155035013|NCT00772005|559555916|FG002|Overall Study|Non-compliance with study procedures|0|||
155035014|NCT00772005|559555917|FG003|Overall Study|Non-compliance with study procedures|1|||
155035015|NCT00772005|559555914|FG000|Overall Study|Non-compliance with drug administration|3|||
155035016|NCT00772005|559555915|FG001|Overall Study|Non-compliance with drug administration|0|||
155035017|NCT00772005|559555916|FG002|Overall Study|Non-compliance with drug administration|1|||
155035018|NCT00772005|559555917|FG003|Overall Study|Non-compliance with drug administration|1|||
155143544|NCT04497116|559959396|FG022|Overall Study|Clinical Progression Related|0|||
155143545|NCT04497116|559959397|FG023|Overall Study|Clinical Progression Related|0|||
155143546|NCT04497116|559959398|FG024|Overall Study|Clinical Progression Related|0|||
155143547|NCT05963022|559959399|FG000|Overall Study|Adverse Event|0|||
155143548|NCT05963022|559959400|FG001|Overall Study|Adverse Event|1|||
155143549|NCT05963022|559959401|FG002|Overall Study|Adverse Event|1|||
155143550|NCT05963022|559959402|FG003|Overall Study|Adverse Event|0|||
155143551|NCT05963022|559959399|FG000|Overall Study|Protocol Violation|0|||
155143552|NCT05963022|559959400|FG001|Overall Study|Protocol Violation|3|||
155143553|NCT05963022|559959401|FG002|Overall Study|Protocol Violation|0|||
155143554|NCT05963022|559959402|FG003|Overall Study|Protocol Violation|0|||
155143555|NCT05963022|559959399|FG000|Overall Study|Pregnancy|0|||
155143556|NCT05963022|559959400|FG001|Overall Study|Pregnancy|1|||
155143557|NCT05963022|559959401|FG002|Overall Study|Pregnancy|1|||
155143558|NCT05963022|559959402|FG003|Overall Study|Pregnancy|1|||
155143559|NCT05963022|559959399|FG000|Overall Study|Withdrawal by Subject|0|||
155143560|NCT05963022|559959400|FG001|Overall Study|Withdrawal by Subject|0|||
155143561|NCT05963022|559959401|FG002|Overall Study|Withdrawal by Subject|2|||
155143562|NCT05963022|559959402|FG003|Overall Study|Withdrawal by Subject|1|||
155143563|NCT05963022|559959399|FG000|Overall Study|Lost to Follow-up|0|||
155143564|NCT05963022|559959400|FG001|Overall Study|Lost to Follow-up|0|||
155143565|NCT05963022|559959401|FG002|Overall Study|Lost to Follow-up|0|||
155143566|NCT05963022|559959402|FG003|Overall Study|Lost to Follow-up|1|||
155143567|NCT05963022|559959399|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
155143568|NCT05963022|559959400|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
155143569|NCT05963022|559959401|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
155035019|NCT03301844|559555918|FG000|Overall Study|suspected colon cancer|1|||
155035020|NCT03301844|559555919|FG001|Overall Study|suspected colon cancer|1|||
155035021|NCT05087966|559555920|FG000|Overall Study|Lost to Follow-up|1|||
155143570|NCT05963022|559959402|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
155143571|NCT02698826|559959403|FG000|Overall Study|Death|13|||
155143572|NCT02698826|559959403|FG000|Overall Study|Adverse Event|1|||
155143573|NCT02915263|559959406|FG000|Overall Study|Covid|3|||
155035022|NCT05087966|559555920|FG000|Overall Study|Withdrawal by Subject|5|||
155035023|NCT00483704|559555922|FG000|Randomization|Withdrawal by Subject|19|||
155035024|NCT00483704|559555923|FG001|Randomization|Withdrawal by Subject|28|||
155035025|NCT00483704|559555924|FG002|Randomization|Withdrawal by Subject|18|||
155035026|NCT00483704|559555922|FG000|Randomization|Protocol Violation|14|||
155035027|NCT00483704|559555923|FG001|Randomization|Protocol Violation|25|||
155035028|NCT00483704|559555924|FG002|Randomization|Protocol Violation|22|||
155035029|NCT00483704|559555922|FG000|Randomization|Lost to Follow-up|14|||
155035030|NCT00483704|559555923|FG001|Randomization|Lost to Follow-up|14|||
155035031|NCT00483704|559555924|FG002|Randomization|Lost to Follow-up|19|||
155035032|NCT00483704|559555922|FG000|Randomization|Pregnancy|1|||
155035033|NCT00483704|559555923|FG001|Randomization|Pregnancy|0|||
155035034|NCT00483704|559555924|FG002|Randomization|Pregnancy|0|||
155035035|NCT00483704|559555922|FG000|Randomization|Physician Decision|2|||
155035036|NCT00483704|559555923|FG001|Randomization|Physician Decision|4|||
155035037|NCT00483704|559555924|FG002|Randomization|Physician Decision|0|||
155035038|NCT00483704|559555922|FG000|Randomization|Progressive disease|0|||
155035039|NCT00483704|559555923|FG001|Randomization|Progressive disease|0|||
155035040|NCT00483704|559555924|FG002|Randomization|Progressive disease|1|||
155035041|NCT00483704|559555922|FG000|Randomization|Lack of qualifying migraines|21|||
155035042|NCT00483704|559555923|FG001|Randomization|Lack of qualifying migraines|25|||
155035043|NCT00483704|559555924|FG002|Randomization|Lack of qualifying migraines|31|||
155035044|NCT00483704|559555922|FG000|Treatment|Lack of qualifying migraines|101|||
155035045|NCT00483704|559555923|FG001|Treatment|Lack of qualifying migraines|99|||
155035046|NCT00483704|559555924|FG002|Treatment|Lack of qualifying migraines|116|||
155035047|NCT00483704|559555922|FG000|Treatment|Adverse Event|3|||
155035048|NCT00483704|559555923|FG001|Treatment|Adverse Event|5|||
155035049|NCT00483704|559555924|FG002|Treatment|Adverse Event|4|||
155035050|NCT00483704|559555922|FG000|Treatment|Withdrawal by Subject|16|||
155035051|NCT00483704|559555923|FG001|Treatment|Withdrawal by Subject|12|||
155035052|NCT00483704|559555924|FG002|Treatment|Withdrawal by Subject|21|||
155035053|NCT00483704|559555922|FG000|Treatment|Protocol Violation|6|||
155035054|NCT00483704|559555923|FG001|Treatment|Protocol Violation|3|||
155035055|NCT00483704|559555924|FG002|Treatment|Protocol Violation|5|||
155035056|NCT00483704|559555922|FG000|Treatment|Lost to Follow-up|2|||
155035057|NCT00483704|559555923|FG001|Treatment|Lost to Follow-up|7|||
155035058|NCT00483704|559555924|FG002|Treatment|Lost to Follow-up|5|||
155035059|NCT00483704|559555922|FG000|Treatment|Lack of Efficacy|1|||
155035060|NCT00483704|559555923|FG001|Treatment|Lack of Efficacy|1|||
155035061|NCT00483704|559555924|FG002|Treatment|Lack of Efficacy|1|||
155035062|NCT00483704|559555922|FG000|Treatment|Pregnancy|0|||
155035063|NCT00483704|559555923|FG001|Treatment|Pregnancy|1|||
155035064|NCT00483704|559555924|FG002|Treatment|Pregnancy|0|||
155035065|NCT00483704|559555922|FG000|Treatment|Physician Decision|0|||
155035066|NCT00483704|559555923|FG001|Treatment|Physician Decision|1|||
155035067|NCT00483704|559555924|FG002|Treatment|Physician Decision|4|||
155035068|NCT02847182|559555926|FG000|Overall Study|Withdrawal by Subject|0|||
155035069|NCT02847182|559555927|FG001|Overall Study|Withdrawal by Subject|1|||
155035070|NCT02345889|559555928|FG000|Overall Study|Inadequate Bowel Prep|17|||
155035071|NCT02345889|559555929|FG001|Overall Study|Inadequate Bowel Prep|16|||
155035072|NCT02345889|559555930|FG002|Overall Study|Inadequate Bowel Prep|18|||
155035073|NCT02345889|559555931|FG003|Overall Study|Inadequate Bowel Prep|14|||
155035074|NCT02345889|559555928|FG000|Overall Study|Polyposis identified during procedure|1|||
155035075|NCT02345889|559555929|FG001|Overall Study|Polyposis identified during procedure|1|||
155035076|NCT02345889|559555930|FG002|Overall Study|Polyposis identified during procedure|0|||
155035077|NCT02345889|559555931|FG003|Overall Study|Polyposis identified during procedure|1|||
155035078|NCT02345889|559555928|FG000|Overall Study|Recognized ineligible post-randomization|1|||
155035079|NCT02345889|559555929|FG001|Overall Study|Recognized ineligible post-randomization|0|||
155035080|NCT02345889|559555930|FG002|Overall Study|Recognized ineligible post-randomization|2|||
155035081|NCT02345889|559555931|FG003|Overall Study|Recognized ineligible post-randomization|1|||
155035082|NCT02345889|559555928|FG000|Overall Study|Ulcerative Colitis identified|1|||
155035083|NCT02345889|559555929|FG001|Overall Study|Ulcerative Colitis identified|0|||
155035084|NCT02345889|559555930|FG002|Overall Study|Ulcerative Colitis identified|0|||
155035085|NCT02345889|559555931|FG003|Overall Study|Ulcerative Colitis identified|0|||
155035086|NCT02345889|559555928|FG000|Overall Study|Cecum not intubated|1|||
155035087|NCT02345889|559555929|FG001|Overall Study|Cecum not intubated|0|||
155035088|NCT02345889|559555930|FG002|Overall Study|Cecum not intubated|0|||
155035089|NCT02345889|559555931|FG003|Overall Study|Cecum not intubated|0|||
155035090|NCT02044874|559555937|FG000|Overall Study|Adverse Event|5|||
155035091|NCT02044874|559555938|FG001|Overall Study|Adverse Event|6|||
155035092|NCT02044874|559555939|FG002|Overall Study|Adverse Event|6|||
155035093|NCT02044874|559555937|FG000|Overall Study|Withdrawal by Subject|8|||
155035094|NCT02044874|559555938|FG001|Overall Study|Withdrawal by Subject|16|||
155035095|NCT02044874|559555939|FG002|Overall Study|Withdrawal by Subject|23|||
155035096|NCT02044874|559555937|FG000|Overall Study|Physician Decision|0|||
155035097|NCT02044874|559555938|FG001|Overall Study|Physician Decision|2|||
155035098|NCT02044874|559555939|FG002|Overall Study|Physician Decision|1|||
155035099|NCT02044874|559555937|FG000|Overall Study|Lost to Follow-up|10|||
155035100|NCT02044874|559555938|FG001|Overall Study|Lost to Follow-up|27|||
155035101|NCT02044874|559555939|FG002|Overall Study|Lost to Follow-up|21|||
155035102|NCT02044874|559555937|FG000|Overall Study|Sponsor Decision|0|||
155035103|NCT02044874|559555938|FG001|Overall Study|Sponsor Decision|1|||
155035104|NCT02044874|559555939|FG002|Overall Study|Sponsor Decision|1|||
155143574|NCT02915263|559959407|FG001|Overall Study|Covid|2|||
155035105|NCT02044874|559555937|FG000|Overall Study|Other|7|||
155035106|NCT02044874|559555938|FG001|Overall Study|Other|3|||
155035107|NCT02044874|559555939|FG002|Overall Study|Other|8|||
155035108|NCT02889835|559555940|FG000|Overall Study|Lost to Follow-up|13|||
155035109|NCT02889835|559555941|FG001|Overall Study|Lost to Follow-up|13|||
155035110|NCT02889835|559555942|FG002|Overall Study|Lost to Follow-up|13|||
155035111|NCT02889835|559555940|FG000|Overall Study|Withdrawal by Subject|2|||
155035112|NCT02889835|559555941|FG001|Overall Study|Withdrawal by Subject|2|||
155035113|NCT02889835|559555942|FG002|Overall Study|Withdrawal by Subject|2|||
155035114|NCT02889835|559555940|FG000|Overall Study|Protocol Violation|1|||
155035115|NCT02889835|559555941|FG001|Overall Study|Protocol Violation|1|||
155035116|NCT02889835|559555942|FG002|Overall Study|Protocol Violation|1|||
155035117|NCT02889835|559555940|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
155035118|NCT02889835|559555941|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
155035119|NCT02889835|559555942|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
155035120|NCT02889835|559555940|FG000|Overall Study|Death|1|||
155035121|NCT02889835|559555941|FG001|Overall Study|Death|1|||
155035122|NCT02889835|559555942|FG002|Overall Study|Death|1|||
155035123|NCT05072964|559555943|FG000|Overall Study|Withdrawal by Subject|4|||
155035124|NCT05072964|559555943|FG000|Overall Study|Death|1|||
155035125|NCT02342548|559555944|FG000|Overall Study|Adverse Event|12|||
155035126|NCT02342548|559555945|FG001|Overall Study|Adverse Event|17|||
155035127|NCT02342548|559555946|FG002|Overall Study|Adverse Event|13|||
155035128|NCT02342548|559555944|FG000|Overall Study|Lost to Follow-up|0|||
155035129|NCT02342548|559555945|FG001|Overall Study|Lost to Follow-up|1|||
155035130|NCT02342548|559555946|FG002|Overall Study|Lost to Follow-up|0|||
155035131|NCT02342548|559555944|FG000|Overall Study|Study terminated by sponsor|20|||
155035132|NCT02342548|559555945|FG001|Overall Study|Study terminated by sponsor|39|||
155035133|NCT02342548|559555946|FG002|Overall Study|Study terminated by sponsor|25|||
155035134|NCT02342548|559555944|FG000|Overall Study|Protocol Violation|0|||
155035135|NCT02342548|559555945|FG001|Overall Study|Protocol Violation|1|||
155035136|NCT02342548|559555946|FG002|Overall Study|Protocol Violation|0|||
155035137|NCT02342548|559555944|FG000|Overall Study|Withdrawal by Subject|1|||
155035138|NCT02342548|559555945|FG001|Overall Study|Withdrawal by Subject|3|||
155035139|NCT02342548|559555946|FG002|Overall Study|Withdrawal by Subject|4|||
155035140|NCT02342548|559555944|FG000|Overall Study|Other|1|||
155035141|NCT02342548|559555945|FG001|Overall Study|Other|1|||
155035142|NCT02342548|559555946|FG002|Overall Study|Other|1|||
155035143|NCT02987972|559555947|FG000|Overall Study|Adverse Event|1|||
155035144|NCT02987972|559555948|FG001|Overall Study|Adverse Event|1|||
155035145|NCT02987972|559555949|FG002|Overall Study|Adverse Event|0|||
155035146|NCT02987972|559555947|FG000|Overall Study|Death|1|||
155035147|NCT02987972|559555948|FG001|Overall Study|Death|0|||
155035148|NCT02987972|559555949|FG002|Overall Study|Death|0|||
155035149|NCT02987972|559555947|FG000|Overall Study|Lack of Efficacy|9|||
155035150|NCT02987972|559555948|FG001|Overall Study|Lack of Efficacy|12|||
155035151|NCT02987972|559555949|FG002|Overall Study|Lack of Efficacy|12|||
155035152|NCT02987972|559555947|FG000|Overall Study|Lost to Follow-up|7|||
155035153|NCT02987972|559555948|FG001|Overall Study|Lost to Follow-up|8|||
155035154|NCT02987972|559555949|FG002|Overall Study|Lost to Follow-up|4|||
155035155|NCT02987972|559555947|FG000|Overall Study|Physician Decision|1|||
155035156|NCT02987972|559555948|FG001|Overall Study|Physician Decision|6|||
155035157|NCT02987972|559555949|FG002|Overall Study|Physician Decision|0|||
155035158|NCT02987972|559555947|FG000|Overall Study|Protocol Violation|2|||
155035159|NCT02987972|559555948|FG001|Overall Study|Protocol Violation|1|||
155035160|NCT02987972|559555949|FG002|Overall Study|Protocol Violation|5|||
155035161|NCT02987972|559555947|FG000|Overall Study|Withdrawal by Subject|22|||
155035162|NCT02987972|559555948|FG001|Overall Study|Withdrawal by Subject|17|||
155035163|NCT02987972|559555949|FG002|Overall Study|Withdrawal by Subject|21|||
155035164|NCT01047332|559555952|FG000|Overall Study|SEMS Obstruction|11|||
155035165|NCT01047332|559555953|FG001|Overall Study|SEMS Obstruction|20|||
155035166|NCT01047332|559555952|FG000|Overall Study|Died Unobstructed|38|||
155035167|NCT01047332|559555953|FG001|Overall Study|Died Unobstructed|41|||
155035168|NCT01047332|559555952|FG000|Overall Study|Lost to Follow-up|8|||
155143575|NCT02478463|559959408|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
155143576|NCT02478463|559959408|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
155143577|NCT02478463|559959408|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
155143578|NCT01879683|559959409|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
155143579|NCT01508169|559959413|FG000|Overall Study|Adverse Event|1|||
155143580|NCT01508169|559959414|FG001|Overall Study|Adverse Event|0|||
155143581|NCT01508169|559959413|FG000|Overall Study|Withdrawal by Subject|1|||
155143582|NCT01508169|559959414|FG001|Overall Study|Withdrawal by Subject|0|||
155143583|NCT01508169|559959413|FG000|Overall Study|Lost to Follow-up|1|||
155035169|NCT01047332|559555953|FG001|Overall Study|Lost to Follow-up|3|||
155035170|NCT00787917|559555959|FG000|Blinded Treatment|Adverse Event|1|||
155035171|NCT00787917|559555960|FG001|Blinded Treatment|Adverse Event|0|||
155035172|NCT00787917|559555959|FG000|Blinded Treatment|Lack of Efficacy|1|||
155035173|NCT00787917|559555960|FG001|Blinded Treatment|Lack of Efficacy|0|||
155035174|NCT00787917|559555959|FG000|Blinded Treatment|Administrative problems|3|||
155035175|NCT00787917|559555960|FG001|Blinded Treatment|Administrative problems|2|||
155035176|NCT00787917|559555959|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
155185892|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
155185893|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
155185894|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
155185895|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
155185896|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
155185897|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
155185898|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
155185899|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
155185900|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
155185901|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
155185902|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
155185903|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
155185904|NCT01226043|560119711|FG000|6-week Re-randomization Phase|Physician Decision|0|||
155185905|NCT01226043|560119712|FG001|6-week Re-randomization Phase|Physician Decision|0|||
155185906|NCT01226043|560119713|FG002|6-week Re-randomization Phase|Physician Decision|3|||
155185907|NCT01226043|560119714|FG003|6-week Re-randomization Phase|Physician Decision|2|||
155185908|NCT01226043|560119711|FG000|6-week Re-randomization Phase|completed in error|0|||
155185909|NCT01226043|560119712|FG001|6-week Re-randomization Phase|completed in error|0|||
155185910|NCT01226043|560119713|FG002|6-week Re-randomization Phase|completed in error|0|||
155185911|NCT01226043|560119714|FG003|6-week Re-randomization Phase|completed in error|1|||
155185912|NCT01226043|560119711|FG000|30-week Observational Phase|Adverse Event|0|||
155185913|NCT01226043|560119712|FG001|30-week Observational Phase|Adverse Event|0|||
155185914|NCT01226043|560119713|FG002|30-week Observational Phase|Adverse Event|1|||
155185915|NCT01226043|560119714|FG003|30-week Observational Phase|Adverse Event|1|||
155185916|NCT01226043|560119711|FG000|30-week Observational Phase|Protocol Violation|0|||
155185917|NCT01226043|560119712|FG001|30-week Observational Phase|Protocol Violation|0|||
155185918|NCT01226043|560119713|FG002|30-week Observational Phase|Protocol Violation|0|||
155185919|NCT01226043|560119714|FG003|30-week Observational Phase|Protocol Violation|1|||
155185920|NCT01226043|560119711|FG000|30-week Observational Phase|Lost to Follow-up|0|||
155185921|NCT01226043|560119712|FG001|30-week Observational Phase|Lost to Follow-up|0|||
155185922|NCT01226043|560119713|FG002|30-week Observational Phase|Lost to Follow-up|2|||
155185923|NCT01226043|560119714|FG003|30-week Observational Phase|Lost to Follow-up|2|||
155185924|NCT01226043|560119711|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
155185925|NCT01226043|560119712|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
155185926|NCT01226043|560119713|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
155185927|NCT01226043|560119714|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
155185928|NCT01226043|560119711|FG000|30-week Observational Phase|Physician Decision|0|||
155185929|NCT01226043|560119712|FG001|30-week Observational Phase|Physician Decision|0|||
155185930|NCT01226043|560119713|FG002|30-week Observational Phase|Physician Decision|2|||
155185931|NCT01226043|560119714|FG003|30-week Observational Phase|Physician Decision|2|||
155185932|NCT01977937|560119719|FG000|Overall Study|Withdrawal by Subject|2|||
155185933|NCT01977937|560119720|FG001|Overall Study|Withdrawal by Subject|1|||
155185934|NCT01977937|560119719|FG000|Overall Study|Adverse Event|1|||
155185935|NCT01977937|560119720|FG001|Overall Study|Adverse Event|0|||
155185936|NCT01977937|560119719|FG000|Overall Study|Physician Decision|0|||
155185937|NCT01977937|560119720|FG001|Overall Study|Physician Decision|1|||
155185938|NCT03004443|560119724|FG000|Overall Study|Pregnancy|0|||
155185939|NCT03004443|560119725|FG001|Overall Study|Pregnancy|1|||
155185940|NCT00406718|560119727|FG000|Overall Study|Withdrawal by Subject|2|||
155185941|NCT00406718|560119728|FG001|Overall Study|Withdrawal by Subject|9|||
155185942|NCT00406718|560119729|FG002|Overall Study|Withdrawal by Subject|4|||
155185943|NCT00406718|560119727|FG000|Overall Study|Lost to Follow-up|2|||
155185944|NCT00406718|560119728|FG001|Overall Study|Lost to Follow-up|5|||
155185945|NCT00406718|560119729|FG002|Overall Study|Lost to Follow-up|4|||
155185946|NCT01888003|560119732|FG000|Overall Study|Study Terminated|5|||
155185947|NCT01888003|560119733|FG001|Overall Study|Study Terminated|6|||
155185948|NCT01888003|560119734|FG002|Overall Study|Study Terminated|40|||
155185949|NCT03187756|560119735|FG000|Overall Study|Termination of study|4|||
155185950|NCT01927341|560121256|FG000|Phase 1b|Lost to Follow-up|1|||
155185951|NCT01927341|560121257|FG001|Phase 1b|Lost to Follow-up|0|||
155185952|NCT01927341|560121258|FG002|Phase 1b|Lost to Follow-up|0|||
155035177|NCT00787917|559555960|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
155035178|NCT00787917|559555959|FG000|Open Label|Administrative problems|3|||
155185953|NCT01927341|560121259|FG003|Phase 1b|Lost to Follow-up|0|||
155185954|NCT01927341|560121260|FG004|Phase 1b|Lost to Follow-up|0|||
155185955|NCT01927341|560121256|FG000|Phase 1b|Death|2|||
155185956|NCT01927341|560121257|FG001|Phase 1b|Death|0|||
155185957|NCT01927341|560121258|FG002|Phase 1b|Death|0|||
155185958|NCT01927341|560121259|FG003|Phase 1b|Death|0|||
155185959|NCT01927341|560121260|FG004|Phase 1b|Death|0|||
155185960|NCT01927341|560121256|FG000|Phase 1b|Follow-up completed|7|||
155035179|NCT00787917|559555960|FG001|Open Label|Administrative problems|0|||
155185961|NCT01927341|560121257|FG001|Phase 1b|Follow-up completed|0|||
155185962|NCT01927341|560121258|FG002|Phase 1b|Follow-up completed|0|||
155185963|NCT01927341|560121259|FG003|Phase 1b|Follow-up completed|0|||
155185964|NCT01927341|560121260|FG004|Phase 1b|Follow-up completed|0|||
155185965|NCT01927341|560121256|FG000|Phase 2|Lost to Follow-up|0|||
155185966|NCT01927341|560121257|FG001|Phase 2|Lost to Follow-up|1|||
155185967|NCT01927341|560121258|FG002|Phase 2|Lost to Follow-up|0|||
155185968|NCT01927341|560121259|FG003|Phase 2|Lost to Follow-up|0|||
155185969|NCT01927341|560121260|FG004|Phase 2|Lost to Follow-up|0|||
155185970|NCT01927341|560121256|FG000|Phase 2|Participant withdrew consent|0|||
155185971|NCT01927341|560121257|FG001|Phase 2|Participant withdrew consent|2|||
155185972|NCT01927341|560121258|FG002|Phase 2|Participant withdrew consent|1|||
155185973|NCT01927341|560121259|FG003|Phase 2|Participant withdrew consent|2|||
155185974|NCT01927341|560121260|FG004|Phase 2|Participant withdrew consent|3|||
155185975|NCT01927341|560121256|FG000|Phase 2|Death|0|||
155185976|NCT01927341|560121257|FG001|Phase 2|Death|4|||
155185977|NCT01927341|560121258|FG002|Phase 2|Death|0|||
155185978|NCT01927341|560121259|FG003|Phase 2|Death|3|||
155185979|NCT01927341|560121260|FG004|Phase 2|Death|2|||
155185980|NCT01927341|560121256|FG000|Phase 2|New cancer therapy|0|||
155185981|NCT01927341|560121257|FG001|Phase 2|New cancer therapy|1|||
155185982|NCT01927341|560121258|FG002|Phase 2|New cancer therapy|0|||
155185983|NCT01927341|560121259|FG003|Phase 2|New cancer therapy|4|||
155185984|NCT01927341|560121260|FG004|Phase 2|New cancer therapy|1|||
155185985|NCT01927341|560121256|FG000|Phase 2|Disease progression|0|||
155185986|NCT01927341|560121257|FG001|Phase 2|Disease progression|1|||
155185987|NCT01927341|560121258|FG002|Phase 2|Disease progression|1|||
155185988|NCT01927341|560121259|FG003|Phase 2|Disease progression|1|||
155185989|NCT01927341|560121260|FG004|Phase 2|Disease progression|0|||
155185990|NCT01927341|560121256|FG000|Phase 2|Follow-up completed|0|||
155185991|NCT01927341|560121257|FG001|Phase 2|Follow-up completed|6|||
155185992|NCT01927341|560121258|FG002|Phase 2|Follow-up completed|3|||
155185993|NCT01927341|560121259|FG003|Phase 2|Follow-up completed|5|||
155185994|NCT01927341|560121260|FG004|Phase 2|Follow-up completed|2|||
155185995|NCT00451451|560121261|FG000|Overall Study|Adverse Event|11|||
155185996|NCT00451451|560121262|FG001|Overall Study|Adverse Event|21|||
155185997|NCT00451451|560121263|FG002|Overall Study|Adverse Event|26|||
155185998|NCT00451451|560121264|FG003|Overall Study|Adverse Event|10|||
155185999|NCT00451451|560121261|FG000|Overall Study|Lost to Follow-up|11|||
155186000|NCT00451451|560121262|FG001|Overall Study|Lost to Follow-up|9|||
155186001|NCT00451451|560121263|FG002|Overall Study|Lost to Follow-up|8|||
155186002|NCT00451451|560121264|FG003|Overall Study|Lost to Follow-up|11|||
155186003|NCT00451451|560121261|FG000|Overall Study|Consent Withdrawn|14|||
155186004|NCT00451451|560121262|FG001|Overall Study|Consent Withdrawn|9|||
155186005|NCT00451451|560121263|FG002|Overall Study|Consent Withdrawn|17|||
155186006|NCT00451451|560121264|FG003|Overall Study|Consent Withdrawn|17|||
155186007|NCT00451451|560121261|FG000|Overall Study|Investigator Decision|6|||
155186008|NCT00451451|560121262|FG001|Overall Study|Investigator Decision|2|||
155186009|NCT00451451|560121263|FG002|Overall Study|Investigator Decision|1|||
155186010|NCT00451451|560121264|FG003|Overall Study|Investigator Decision|2|||
155186011|NCT00451451|560121261|FG000|Overall Study|Subject Non-Compliance|8|||
155186012|NCT00451451|560121262|FG001|Overall Study|Subject Non-Compliance|4|||
155186013|NCT00451451|560121263|FG002|Overall Study|Subject Non-Compliance|3|||
155186014|NCT00451451|560121264|FG003|Overall Study|Subject Non-Compliance|3|||
155186015|NCT00451451|560121261|FG000|Overall Study|Death|1|||
155186016|NCT00451451|560121262|FG001|Overall Study|Death|0|||
155186017|NCT00451451|560121263|FG002|Overall Study|Death|0|||
155186018|NCT00451451|560121264|FG003|Overall Study|Death|1|||
155186019|NCT00451451|560121261|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
155186020|NCT00451451|560121262|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
155186021|NCT00451451|560121263|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
155186022|NCT00451451|560121264|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
155186023|NCT01442038|560121272|FG000|Overall Study|Death|35|||
155186024|NCT01442038|560121273|FG001|Overall Study|Death|29|||
155186025|NCT01442038|560121272|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
155186026|NCT01442038|560121273|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
155186027|NCT01442038|560121272|FG000|Overall Study|Participant Withdrew Consent|137|||
155186028|NCT01442038|560121273|FG001|Overall Study|Participant Withdrew Consent|102|||
155186029|NCT01442038|560121272|FG000|Overall Study|Lost to Follow-up|37|||
155186030|NCT01442038|560121273|FG001|Overall Study|Lost to Follow-up|51|||
155186031|NCT01442038|560121272|FG000|Overall Study|Adverse Event|26|||
155186032|NCT01442038|560121273|FG001|Overall Study|Adverse Event|15|||
155186033|NCT01442038|560121272|FG000|Overall Study|Protocol Deviation|9|||
155186034|NCT01442038|560121273|FG001|Overall Study|Protocol Deviation|20|||
155186035|NCT01442038|560121272|FG000|Overall Study|Investigator's Discretion|13|||
155186036|NCT01442038|560121273|FG001|Overall Study|Investigator's Discretion|16|||
155186037|NCT01442038|560121272|FG000|Overall Study|Study Terminated By Sponsor|2|||
155186038|NCT01442038|560121273|FG001|Overall Study|Study Terminated By Sponsor|3|||
155186039|NCT00089284|560121274|FG000|Overall Study|Adverse event before starting treatment|0|||
155186040|NCT00089284|560121275|FG001|Overall Study|Adverse event before starting treatment|0|||
155186041|NCT00089284|560121276|FG002|Overall Study|Adverse event before starting treatment|0|||
155186042|NCT00089284|560121277|FG003|Overall Study|Adverse event before starting treatment|0|||
155035180|NCT03521817|559555961|FG000|Overall Study|Protocol Violation|0|||
155035181|NCT03521817|559555962|FG001|Overall Study|Protocol Violation|1|||
155035182|NCT02172040|559555965|FG000|Overall Study|Adverse Event|0|||
155035183|NCT02172040|559555966|FG001|Overall Study|Adverse Event|2|||
155035184|NCT02172040|559555967|FG002|Overall Study|Adverse Event|0|||
155035185|NCT02172040|559555968|FG003|Overall Study|Adverse Event|0|||
155035186|NCT02172040|559555965|FG000|Overall Study|Protocol Violation|0|||
155035187|NCT02172040|559555966|FG001|Overall Study|Protocol Violation|1|||
155035188|NCT02172040|559555967|FG002|Overall Study|Protocol Violation|0|||
155035189|NCT02172040|559555968|FG003|Overall Study|Protocol Violation|0|||
155035190|NCT02172040|559555965|FG000|Overall Study|Withdrawal by Subject|0|||
155035191|NCT02172040|559555966|FG001|Overall Study|Withdrawal by Subject|0|||
155035192|NCT02172040|559555967|FG002|Overall Study|Withdrawal by Subject|1|||
155035193|NCT02172040|559555968|FG003|Overall Study|Withdrawal by Subject|0|||
155035194|NCT02172040|559555965|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
155035195|NCT02172040|559555966|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
155035196|NCT02172040|559555967|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
155035197|NCT02172040|559555968|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
155035198|NCT02172040|559555965|FG000|Overall Study|Family emergency abroad|0|||
155035199|NCT02172040|559555966|FG001|Overall Study|Family emergency abroad|0|||
155035200|NCT02172040|559555967|FG002|Overall Study|Family emergency abroad|0|||
155035201|NCT02172040|559555968|FG003|Overall Study|Family emergency abroad|1|||
155035202|NCT00778102|559555973|FG000|Overall Study|Adverse Event|8|||
155035203|NCT00778102|559555974|FG001|Overall Study|Adverse Event|5|||
155035204|NCT00778102|559555973|FG000|Overall Study|Death|1|||
155035205|NCT00778102|559555974|FG001|Overall Study|Death|1|||
155035206|NCT00778102|559555973|FG000|Overall Study|Lost to Follow-up|1|||
155035207|NCT00778102|559555974|FG001|Overall Study|Lost to Follow-up|0|||
155035208|NCT00778102|559555973|FG000|Overall Study|Violation of Selection Criteria|1|||
155143584|NCT01508169|559959414|FG001|Overall Study|Lost to Follow-up|2|||
155143585|NCT03600740|559959420|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
155143586|NCT01702558|559959421|FG000|Overall Study|Withdrawal by Subject|0|||
155143587|NCT01702558|559959422|FG001|Overall Study|Withdrawal by Subject|0|||
155143588|NCT01702558|559959423|FG002|Overall Study|Withdrawal by Subject|0|||
155143589|NCT01702558|559959424|FG003|Overall Study|Withdrawal by Subject|12|||
155143590|NCT01702558|559959425|FG004|Overall Study|Withdrawal by Subject|4|||
155143591|NCT01702558|559959421|FG000|Overall Study|Lost to Follow-up|0|||
155143592|NCT01702558|559959422|FG001|Overall Study|Lost to Follow-up|0|||
155143593|NCT01702558|559959423|FG002|Overall Study|Lost to Follow-up|0|||
155143594|NCT01702558|559959424|FG003|Overall Study|Lost to Follow-up|3|||
155143595|NCT01702558|559959425|FG004|Overall Study|Lost to Follow-up|0|||
155143596|NCT01702558|559959421|FG000|Overall Study|Death|4|||
155143597|NCT01702558|559959422|FG001|Overall Study|Death|3|||
155143598|NCT01702558|559959423|FG002|Overall Study|Death|3|||
155143599|NCT01702558|559959424|FG003|Overall Study|Death|16|||
155143600|NCT01702558|559959425|FG004|Overall Study|Death|20|||
155143601|NCT01702558|559959421|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
155143602|NCT01702558|559959422|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
155143603|NCT01702558|559959423|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
155143604|NCT01702558|559959424|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
155143605|NCT01702558|559959425|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
155143606|NCT01702558|559959421|FG000|Overall Study|Study Terminated by Sponsor|0|||
155143607|NCT01702558|559959422|FG001|Overall Study|Study Terminated by Sponsor|1|||
155143608|NCT01702558|559959423|FG002|Overall Study|Study Terminated by Sponsor|0|||
155143609|NCT01702558|559959424|FG003|Overall Study|Study Terminated by Sponsor|0|||
155143610|NCT01702558|559959425|FG004|Overall Study|Study Terminated by Sponsor|1|||
155143611|NCT01702558|559959421|FG000|Overall Study|Other|0|||
155143612|NCT01702558|559959422|FG001|Overall Study|Other|0|||
155143613|NCT01702558|559959423|FG002|Overall Study|Other|0|||
155143614|NCT01702558|559959424|FG003|Overall Study|Other|16|||
155143615|NCT01702558|559959425|FG004|Overall Study|Other|17|||
155143616|NCT01788566|559959431|FG000|Overall Study|Death|4|||
155143617|NCT01788566|559959431|FG000|Overall Study|Adverse Event|1|||
155143618|NCT01788566|559959431|FG000|Overall Study|Clinical Progressive Disease|3|||
155143619|NCT01338818|559959432|FG000|Overall Study|Adverse Event|8|||
155143620|NCT01338818|559959432|FG000|Overall Study|Lack of Efficacy|5|||
155143621|NCT01338818|559959432|FG000|Overall Study|no longer require study drug|1|||
155143622|NCT01338818|559959432|FG000|Overall Study|Withdrawal by Subject|11|||
155143623|NCT01338818|559959432|FG000|Overall Study|Lost to Follow-up|4|||
155143624|NCT01338818|559959432|FG000|Overall Study|Administrative problems|3|||
155143625|NCT01338818|559959432|FG000|Overall Study|Protocol Deviation|4|||
155143626|NCT01620086|559959433|FG000|Overall Study|Withdrawal by Subject|3|||
155143627|NCT01620086|559959434|FG001|Overall Study|Withdrawal by Subject|3|||
155143628|NCT01620086|559959435|FG002|Overall Study|Withdrawal by Subject|0|||
155143629|NCT01620086|559959433|FG000|Overall Study|failed study criteria|1|||
155143630|NCT01620086|559959434|FG001|Overall Study|failed study criteria|4|||
155143631|NCT01620086|559959435|FG002|Overall Study|failed study criteria|0|||
155143632|NCT01620086|559959433|FG000|Overall Study|Physician Decision|1|||
155143633|NCT01620086|559959434|FG001|Overall Study|Physician Decision|0|||
155143634|NCT01620086|559959435|FG002|Overall Study|Physician Decision|0|||
155143635|NCT03030417|559959438|FG000|Dose Expansion|Disease progression before treatment|0|||
155143636|NCT03030417|559959439|FG001|Dose Expansion|Disease progression before treatment|0|||
155143637|NCT03030417|559959440|FG002|Dose Expansion|Disease progression before treatment|0|||
155143638|NCT03030417|559959441|FG003|Dose Expansion|Disease progression before treatment|0|||
155143639|NCT03030417|559959442|FG004|Dose Expansion|Disease progression before treatment|0|||
155143640|NCT03030417|559959443|FG005|Dose Expansion|Disease progression before treatment|0|||
155143641|NCT03030417|559959444|FG006|Dose Expansion|Disease progression before treatment|0|||
155143642|NCT03030417|559959445|FG007|Dose Expansion|Disease progression before treatment|0|||
155143643|NCT03030417|559959446|FG008|Dose Expansion|Disease progression before treatment|0|||
155143644|NCT03030417|559959447|FG009|Dose Expansion|Disease progression before treatment|0|||
155143645|NCT03030417|559959448|FG010|Dose Expansion|Disease progression before treatment|0|||
155143646|NCT03030417|559959449|FG011|Dose Expansion|Disease progression before treatment|0|||
155143647|NCT03030417|559959450|FG012|Dose Expansion|Disease progression before treatment|1|||
155143648|NCT01539759|559959451|FG000|Overall Study|Lost to Follow-up|6|||
155143649|NCT01539759|559959452|FG001|Overall Study|Lost to Follow-up|8|||
155143650|NCT01078441|559959453|FG000|Overall Study|Withdrawal by Subject|1|||
155143651|NCT01425801|559959454|FG000|Period 1|Withdrawal by Subject|0|||
155143652|NCT01425801|559959455|FG001|Period 1|Withdrawal by Subject|0|||
155143653|NCT01425801|559959456|FG002|Period 1|Withdrawal by Subject|0|||
155143654|NCT01425801|559959457|FG003|Period 1|Withdrawal by Subject|0|||
155143655|NCT01425801|559959458|FG004|Period 1|Withdrawal by Subject|1|||
155143656|NCT01425801|559959459|FG005|Period 1|Withdrawal by Subject|0|||
155143657|NCT01425801|559959454|FG000|Period 2|Withdrawal by Subject|0|||
155143658|NCT01425801|559959455|FG001|Period 2|Withdrawal by Subject|0|||
155143659|NCT01425801|559959456|FG002|Period 2|Withdrawal by Subject|0|||
155143660|NCT01425801|559959457|FG003|Period 2|Withdrawal by Subject|0|||
155143661|NCT01425801|559959458|FG004|Period 2|Withdrawal by Subject|1|||
155143662|NCT01425801|559959459|FG005|Period 2|Withdrawal by Subject|0|||
155143663|NCT01425801|559959454|FG000|Period 3|Stability criteria not fullfilled|0|||
155143664|NCT01425801|559959455|FG001|Period 3|Stability criteria not fullfilled|0|||
155143665|NCT01425801|559959456|FG002|Period 3|Stability criteria not fullfilled|1|||
155143666|NCT01425801|559959457|FG003|Period 3|Stability criteria not fullfilled|0|||
155143667|NCT01425801|559959458|FG004|Period 3|Stability criteria not fullfilled|0|||
155143668|NCT01425801|559959459|FG005|Period 3|Stability criteria not fullfilled|0|||
155143669|NCT01425801|559959454|FG000|Period 4|Not able to maintain visit schedule|0|||
155143670|NCT01425801|559959455|FG001|Period 4|Not able to maintain visit schedule|0|||
155143671|NCT01425801|559959456|FG002|Period 4|Not able to maintain visit schedule|1|||
155143672|NCT01425801|559959457|FG003|Period 4|Not able to maintain visit schedule|0|||
155143673|NCT01425801|559959458|FG004|Period 4|Not able to maintain visit schedule|0|||
155143674|NCT01425801|559959459|FG005|Period 4|Not able to maintain visit schedule|0|||
155143675|NCT02175017|559959460|FG000|Overall Study|Did not receive the investigational product|1|||
155143676|NCT02175017|559959461|FG001|Overall Study|Did not receive the investigational product|2|||
155143677|NCT02175017|559959460|FG000|Overall Study|Withdrawal by Subject|6|||
155143678|NCT02175017|559959461|FG001|Overall Study|Withdrawal by Subject|3|||
155143679|NCT02175017|559959460|FG000|Overall Study|Met an exclusion criteria|0|||
155143680|NCT02175017|559959461|FG001|Overall Study|Met an exclusion criteria|1|||
155143681|NCT02175017|559959460|FG000|Overall Study|Adverse Event|3|||
155143682|NCT02175017|559959461|FG001|Overall Study|Adverse Event|10|||
155143683|NCT02175017|559959460|FG000|Overall Study|Disease progression|20|||
155143684|NCT02175017|559959461|FG001|Overall Study|Disease progression|27|||
155143685|NCT02175017|559959460|FG000|Overall Study|Other than above reasons|3|||
155143686|NCT02175017|559959461|FG001|Overall Study|Other than above reasons|0|||
155143687|NCT04915729|559959462|FG000|Overall Study|Lost to Follow-up|20|||
155143688|NCT04915729|559959463|FG001|Overall Study|Lost to Follow-up|10|||
155143689|NCT04915729|559959462|FG000|Overall Study|Withdrawal by Subject|12|||
155143690|NCT04915729|559959463|FG001|Overall Study|Withdrawal by Subject|5|||
155143691|NCT04915729|559959462|FG000|Overall Study|Death|34|||
155143692|NCT04915729|559959463|FG001|Overall Study|Death|44|||
155143693|NCT04915729|559959462|FG000|Overall Study|not treated|3|||
155143694|NCT04915729|559959463|FG001|Overall Study|not treated|6|||
155143695|NCT04915729|559959462|FG000|Overall Study|Investigator removed subject|1|||
155143696|NCT04915729|559959463|FG001|Overall Study|Investigator removed subject|2|||
155143697|NCT04915729|559959462|FG000|Overall Study|questionnaire result not evaluated|1|||
155143698|NCT04915729|559959463|FG001|Overall Study|questionnaire result not evaluated|0|||
155143699|NCT04915729|559959462|FG000|Overall Study|refuse of hospital visit|1|||
155143700|NCT04915729|559959463|FG001|Overall Study|refuse of hospital visit|3|||
155143701|NCT04915729|559959462|FG000|Overall Study|Subject withdrew|1|||
155143702|NCT04915729|559959463|FG001|Overall Study|Subject withdrew|0|||
155143703|NCT03575403|559959464|FG000|Overall Study|Adverse Event|1|||
155143704|NCT03575403|559959465|FG001|Overall Study|Adverse Event|0|||
155143705|NCT03575403|559959466|FG002|Overall Study|Adverse Event|0|||
155143706|NCT03575403|559959464|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
155143707|NCT03575403|559959465|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
155143708|NCT03575403|559959466|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
155143709|NCT03066596|559959467|FG000|Overall Study|Withdrawal by Subject|4|||
155143710|NCT03066596|559959468|FG001|Overall Study|Withdrawal by Subject|2|||
155143711|NCT03066596|559959467|FG000|Overall Study|Lost to Follow-up|14|||
155143712|NCT03066596|559959468|FG001|Overall Study|Lost to Follow-up|10|||
155143713|NCT00773513|559959469|FG000|Overall Study|Renal Transplant|254|||
155143714|NCT00773513|559959470|FG001|Overall Study|Renal Transplant|263|||
155143715|NCT00773513|559959469|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
155143716|NCT00773513|559959470|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
155143717|NCT00773513|559959469|FG000|Overall Study|Withdrew Consent|68|||
155143718|NCT00773513|559959470|FG001|Overall Study|Withdrew Consent|69|||
155143719|NCT00773513|559959469|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
155143720|NCT00773513|559959470|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
155143721|NCT00773513|559959469|FG000|Overall Study|Failure to Return|22|||
155143722|NCT00773513|559959470|FG001|Overall Study|Failure to Return|8|||
155143723|NCT00773513|559959469|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155143724|NCT00773513|559959470|FG001|Overall Study|Insufficient Therapeutic Response|18|||
155143725|NCT00773513|559959469|FG000|Overall Study|Reason Not Specified|159|||
155143726|NCT00773513|559959470|FG001|Overall Study|Reason Not Specified|126|||
155143727|NCT00773513|559959469|FG000|Overall Study|Death|531|||
155186043|NCT00089284|560121278|FG004|Overall Study|Adverse event before starting treatment|0|||
155186044|NCT00089284|560121279|FG005|Overall Study|Adverse event before starting treatment|0|||
155186045|NCT00089284|560121280|FG006|Overall Study|Adverse event before starting treatment|1|||
155186046|NCT03646643|560121281|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
155186047|NCT03646643|560121282|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
155186048|NCT03646643|560121281|FG000|Overall Study|Lost to Follow-up|0|||
155186049|NCT03646643|560121282|FG001|Overall Study|Lost to Follow-up|1|||
155186050|NCT05314478|560121283|FG000|Overall Study|Physician Decision|1|||
155186051|NCT03583164|560121284|FG000|Overall Study|Death in Main Phase|35|||
155186052|NCT03583164|560121284|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
155186053|NCT03583164|560121284|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
155186054|NCT03583164|560121284|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
155186055|NCT03583164|560121284|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
155186056|NCT03583164|560121284|FG000|Overall Study|Physician decision in Main Phase|1|||
155186057|NCT03583164|560121284|FG000|Overall Study|Physician decision in Extended Phase|2|||
155143728|NCT00773513|559959470|FG001|Overall Study|Death|545|||
155143729|NCT02864901|559959471|FG000|Overall Study|Withdrawal by Subject|1|||
155143730|NCT02864901|559959472|FG001|Overall Study|Withdrawal by Subject|0|||
155143731|NCT00782717|559959478|FG000|Overall Study|Adverse Event|2|||
155143732|NCT00782717|559959479|FG001|Overall Study|Adverse Event|5|||
155143733|NCT00782717|559959478|FG000|Overall Study|Patient decision unrelated to AE|6|||
155143734|NCT00782717|559959479|FG001|Overall Study|Patient decision unrelated to AE|3|||
155143735|NCT00782717|559959478|FG000|Overall Study|Noncompliance|2|||
155143736|NCT00782717|559959479|FG001|Overall Study|Noncompliance|1|||
155143737|NCT00782717|559959478|FG000|Overall Study|Treatment failure|3|||
155143738|NCT00782717|559959479|FG001|Overall Study|Treatment failure|14|||
155143739|NCT00782717|559959478|FG000|Overall Study|Enrollment close prior to surgery|1|||
155143740|NCT00782717|559959479|FG001|Overall Study|Enrollment close prior to surgery|0|||
155143741|NCT00782717|559959478|FG000|Overall Study|Did not meet entrance criteria|1|||
155143742|NCT00782717|559959479|FG001|Overall Study|Did not meet entrance criteria|3|||
155143743|NCT00782717|559959478|FG000|Overall Study|Exited in error|0|||
155143744|NCT00782717|559959479|FG001|Overall Study|Exited in error|2|||
155143745|NCT02446717|559959480|FG000|Overall Study|Adverse Event|0|||
155143746|NCT02446717|559959481|FG001|Overall Study|Adverse Event|0|||
155143747|NCT02446717|559959482|FG002|Overall Study|Adverse Event|1|||
155143748|NCT02446717|559959483|FG003|Overall Study|Adverse Event|0|||
155143749|NCT02446717|559959484|FG004|Overall Study|Adverse Event|0|||
155143750|NCT02446717|559959480|FG000|Overall Study|Lost to Follow-up|0|||
155143751|NCT02446717|559959481|FG001|Overall Study|Lost to Follow-up|1|||
155143752|NCT02446717|559959482|FG002|Overall Study|Lost to Follow-up|1|||
155143753|NCT02446717|559959483|FG003|Overall Study|Lost to Follow-up|0|||
155143754|NCT02446717|559959484|FG004|Overall Study|Lost to Follow-up|1|||
155143755|NCT02446717|559959480|FG000|Overall Study|Withdrew consent|0|||
155143756|NCT02446717|559959481|FG001|Overall Study|Withdrew consent|0|||
155143757|NCT02446717|559959482|FG002|Overall Study|Withdrew consent|0|||
155143758|NCT02446717|559959483|FG003|Overall Study|Withdrew consent|1|||
155143759|NCT02446717|559959484|FG004|Overall Study|Withdrew consent|0|||
155143760|NCT03359174|559959485|FG000|Overall Study|Adverse Event|1|||
155143761|NCT01332994|559959492|FG000|Overall Study|Adverse Event|34|||
155143762|NCT01332994|559959492|FG000|Overall Study|Death|1|||
155186058|NCT03583164|560121284|FG000|Overall Study|Death in Extended Phase|13|||
155186059|NCT03583164|560121284|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
155186060|NCT03583164|560121284|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
155035209|NCT00778102|559555974|FG001|Overall Study|Violation of Selection Criteria|1|||
155035210|NCT00778102|559555973|FG000|Overall Study|Protocol Violation|0|||
155035211|NCT00778102|559555974|FG001|Overall Study|Protocol Violation|1|||
155035212|NCT00778102|559555973|FG000|Overall Study|Refused Treatment|2|||
155035213|NCT00778102|559555974|FG001|Overall Study|Refused Treatment|3|||
155035214|NCT00778102|559555973|FG000|Overall Study|Withdrawal by Subject|1|||
155035215|NCT00778102|559555974|FG001|Overall Study|Withdrawal by Subject|1|||
155035216|NCT00778102|559555973|FG000|Overall Study|Administrative Reason|7|||
155035217|NCT00778102|559555974|FG001|Overall Study|Administrative Reason|10|||
155035218|NCT01328548|559555975|FG000|Overall Study|Death|3|||
155035219|NCT01328548|559555976|FG001|Overall Study|Death|0|||
155035220|NCT01328548|559555975|FG000|Overall Study|Protocol Violation|1|||
155035221|NCT01328548|559555976|FG001|Overall Study|Protocol Violation|0|||
155035222|NCT02824562|559557514|FG000|Overall Study|Lost to Follow-up|3|||
155035223|NCT02824562|559557515|FG001|Overall Study|Lost to Follow-up|4|||
155035224|NCT02824562|559557514|FG000|Overall Study|Death|0|||
155035225|NCT02824562|559557515|FG001|Overall Study|Death|1|||
155035226|NCT03334422|559557516|FG000|Overall Study|Adverse Event|1|||
155035227|NCT03334422|559557517|FG001|Overall Study|Adverse Event|3|||
155035228|NCT03334422|559557518|FG002|Overall Study|Adverse Event|2|||
155035229|NCT03334422|559557519|FG003|Overall Study|Adverse Event|2|||
155035230|NCT03334422|559557516|FG000|Overall Study|Lack of Efficacy|10|||
155035231|NCT03334422|559557517|FG001|Overall Study|Lack of Efficacy|2|||
155035232|NCT03334422|559557518|FG002|Overall Study|Lack of Efficacy|7|||
155035233|NCT03334422|559557519|FG003|Overall Study|Lack of Efficacy|3|||
155035234|NCT03334422|559557516|FG000|Overall Study|Withdrawal by Subject|8|||
155035235|NCT03334422|559557517|FG001|Overall Study|Withdrawal by Subject|3|||
155035236|NCT03334422|559557518|FG002|Overall Study|Withdrawal by Subject|1|||
155035237|NCT03334422|559557519|FG003|Overall Study|Withdrawal by Subject|0|||
155035238|NCT03334422|559557516|FG000|Overall Study|Lost to Follow-up|0|||
155035239|NCT03334422|559557517|FG001|Overall Study|Lost to Follow-up|0|||
155035240|NCT03334422|559557518|FG002|Overall Study|Lost to Follow-up|0|||
155035241|NCT03334422|559557519|FG003|Overall Study|Lost to Follow-up|1|||
155035242|NCT03334422|559557516|FG000|Overall Study|Inability to obtain laboratory samples|0|||
155035243|NCT03334422|559557517|FG001|Overall Study|Inability to obtain laboratory samples|1|||
155035244|NCT03334422|559557518|FG002|Overall Study|Inability to obtain laboratory samples|0|||
155035245|NCT03334422|559557519|FG003|Overall Study|Inability to obtain laboratory samples|0|||
155035246|NCT03334422|559557516|FG000|Overall Study|Pregnancy|0|||
155035247|NCT03334422|559557517|FG001|Overall Study|Pregnancy|1|||
155035248|NCT03334422|559557518|FG002|Overall Study|Pregnancy|0|||
155035249|NCT03334422|559557519|FG003|Overall Study|Pregnancy|0|||
155035250|NCT01313221|559557520|FG000|Overall Study|Protocol Violation|0|||
155035251|NCT01313221|559557521|FG001|Overall Study|Protocol Violation|1|||
155035252|NCT01313221|559557522|FG002|Overall Study|Protocol Violation|1|||
155035253|NCT01313221|559557520|FG000|Overall Study|Non-compliance|3|||
155035254|NCT01313221|559557521|FG001|Overall Study|Non-compliance|0|||
155035255|NCT01313221|559557522|FG002|Overall Study|Non-compliance|2|||
155035256|NCT01313221|559557520|FG000|Overall Study|Withdrawal by Subject|2|||
155035257|NCT01313221|559557521|FG001|Overall Study|Withdrawal by Subject|3|||
155035258|NCT01313221|559557522|FG002|Overall Study|Withdrawal by Subject|5|||
155035259|NCT01313221|559557520|FG000|Overall Study|Requirement for alternative therapy|0|||
155035260|NCT01313221|559557521|FG001|Overall Study|Requirement for alternative therapy|1|||
155035261|NCT01313221|559557522|FG002|Overall Study|Requirement for alternative therapy|1|||
155035262|NCT01313221|559557520|FG000|Overall Study|Lost to Follow-up|6|||
155035263|NCT01313221|559557521|FG001|Overall Study|Lost to Follow-up|3|||
155035264|NCT01313221|559557522|FG002|Overall Study|Lost to Follow-up|1|||
155035265|NCT01313221|559557520|FG000|Overall Study|Other|1|||
155035266|NCT01313221|559557521|FG001|Overall Study|Other|0|||
155035267|NCT01313221|559557522|FG002|Overall Study|Other|0|||
155035268|NCT01313221|559557520|FG000|Overall Study|Adverse Event|0|||
155035269|NCT01313221|559557521|FG001|Overall Study|Adverse Event|0|||
155035270|NCT01313221|559557522|FG002|Overall Study|Adverse Event|7|||
155035271|NCT01313221|559557520|FG000|Overall Study|Disease progression|0|||
155035272|NCT01313221|559557521|FG001|Overall Study|Disease progression|0|||
155035273|NCT01313221|559557522|FG002|Overall Study|Disease progression|2|||
155035274|NCT01313221|559557520|FG000|Overall Study|Physician Decision|0|||
155035275|NCT01313221|559557521|FG001|Overall Study|Physician Decision|0|||
155035276|NCT01313221|559557522|FG002|Overall Study|Physician Decision|2|||
155035277|NCT01313221|559557520|FG000|Overall Study|Pregnancy|0|||
155035278|NCT01313221|559557521|FG001|Overall Study|Pregnancy|0|||
155035279|NCT01313221|559557522|FG002|Overall Study|Pregnancy|2|||
155035280|NCT05459558|559557527|FG000|Overall Study|Adverse Event|1|||
155035281|NCT05459558|559557528|FG001|Overall Study|Adverse Event|0|||
155035282|NCT05459558|559557529|FG002|Overall Study|Adverse Event|0|||
155035283|NCT05459558|559557527|FG000|Overall Study|Scheduling issue|0|||
155035284|NCT05459558|559557528|FG001|Overall Study|Scheduling issue|1|||
155035285|NCT05459558|559557529|FG002|Overall Study|Scheduling issue|3|||
155035286|NCT05459558|559557527|FG000|Overall Study|Withdrawal by Subject|0|||
155035287|NCT05459558|559557528|FG001|Overall Study|Withdrawal by Subject|0|||
155035288|NCT05459558|559557529|FG002|Overall Study|Withdrawal by Subject|2|||
155143763|NCT01332994|559959492|FG000|Overall Study|Lack of Efficacy|1|||
155143764|NCT01332994|559959492|FG000|Overall Study|Lost to Follow-up|4|||
155143765|NCT01332994|559959492|FG000|Overall Study|Protocol Violation|6|||
155143766|NCT01332994|559959492|FG000|Overall Study|Withdrawal by Subject|15|||
155143767|NCT01332994|559959492|FG000|Overall Study|Administrative Problem|2|||
155143768|NCT01332994|559959492|FG000|Overall Study|Other|8|||
155143769|NCT01807598|559959493|FG000|Overall Study|Withdrawal by Subject|4|||
155143770|NCT01807598|559959493|FG000|Overall Study|Adverse Event|1|||
155143771|NCT01807598|559959493|FG000|Overall Study|Other Physician Decision|1|||
155143772|NCT04170543|559959494|FG000|Overall Study|Death|1|||
155143773|NCT04170543|559959495|FG001|Overall Study|Death|1|||
155143774|NCT04170543|559959496|FG002|Overall Study|Death|1|||
155143775|NCT04170543|559959497|FG003|Overall Study|Death|1|||
155143776|NCT04170543|559959498|FG004|Overall Study|Death|1|||
155143777|NCT04170543|559959494|FG000|Overall Study|Lost to Follow-up|3|||
155143778|NCT04170543|559959495|FG001|Overall Study|Lost to Follow-up|3|||
155143779|NCT04170543|559959496|FG002|Overall Study|Lost to Follow-up|0|||
155143780|NCT04170543|559959497|FG003|Overall Study|Lost to Follow-up|3|||
155143781|NCT04170543|559959498|FG004|Overall Study|Lost to Follow-up|1|||
155143782|NCT04170543|559959494|FG000|Overall Study|Withdrawal by Subject|13|||
155143783|NCT04170543|559959495|FG001|Overall Study|Withdrawal by Subject|6|||
155143784|NCT04170543|559959496|FG002|Overall Study|Withdrawal by Subject|5|||
155143785|NCT04170543|559959497|FG003|Overall Study|Withdrawal by Subject|4|||
155186061|NCT03583164|560121284|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
155186062|NCT03583164|560121284|FG000|Overall Study|Treatment failure in Main Phase|2|||
155186063|NCT03583164|560121284|FG000|Overall Study|Treatment failure in Extended Phase|4|||
155186064|NCT03583164|560121284|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
155186065|NCT03583164|560121284|FG000|Overall Study|Other not specified reason in Main Phase|2|||
155186066|NCT00214500|560121285|FG000|Treatment Period|Adverse Event|1|||
155186067|NCT00214500|560121285|FG000|Extension Period|Withdrawal by Subject|2|||
155186068|NCT02675231|560121294|FG000|Overall Study|Withdrawal by Subject|2|||
155186069|NCT02675231|560121295|FG001|Overall Study|Withdrawal by Subject|4|||
155186070|NCT02675231|560121296|FG002|Overall Study|Withdrawal by Subject|2|||
155186071|NCT02675231|560121294|FG000|Overall Study|Lost to Follow-up|3|||
155186072|NCT02675231|560121295|FG001|Overall Study|Lost to Follow-up|4|||
155186073|NCT02675231|560121296|FG002|Overall Study|Lost to Follow-up|3|||
155186074|NCT05323656|560121297|FG000|Overall Study|Still On-Treatment|6|||
155186075|NCT05323656|560121298|FG001|Overall Study|Still On-Treatment|6|||
155186076|NCT05323656|560121297|FG000|Overall Study|Progressive Disease|15|||
155186077|NCT05323656|560121298|FG001|Overall Study|Progressive Disease|14|||
155186078|NCT05323656|560121297|FG000|Overall Study|Adverse Event|2|||
155186079|NCT05323656|560121298|FG001|Overall Study|Adverse Event|3|||
155186080|NCT05323656|560121297|FG000|Overall Study|Death|1|||
155186081|NCT05323656|560121298|FG001|Overall Study|Death|2|||
155186082|NCT05323656|560121297|FG000|Overall Study|Withdrawal by Subject|1|||
155186083|NCT05323656|560121298|FG001|Overall Study|Withdrawal by Subject|0|||
155186084|NCT05323656|560121297|FG000|Overall Study|Clinical disease progression|0|||
155186085|NCT05323656|560121298|FG001|Overall Study|Clinical disease progression|1|||
155186086|NCT05323656|560121297|FG000|Overall Study|Patient and Investigator decision|1|||
155186087|NCT05323656|560121298|FG001|Overall Study|Patient and Investigator decision|0|||
155186088|NCT05323656|560121297|FG000|Overall Study|Physician Decision|0|||
155186089|NCT05323656|560121298|FG001|Overall Study|Physician Decision|1|||
155186090|NCT02495233|560121299|FG000|Overall Study|Miscellaneous|0|||
155186091|NCT02495233|560121300|FG001|Overall Study|Miscellaneous|1|||
155186092|NCT03880461|560121301|FG000|Overall Study|Determined ineligible after enrollment|45|||
155186093|NCT03880461|560121302|FG001|Overall Study|Determined ineligible after enrollment|44|||
155186094|NCT03880461|560121301|FG000|Overall Study|No weight measurement after enrollment|24|||
155186095|NCT03880461|560121302|FG001|Overall Study|No weight measurement after enrollment|17|||
155186096|NCT02652767|560121305|FG000|Overall Study|Death|2|||
155186097|NCT02652767|560121305|FG000|Overall Study|Lost to Follow-up|1|||
155143786|NCT04170543|559959498|FG004|Overall Study|Withdrawal by Subject|9|||
155143787|NCT04170543|559959494|FG000|Overall Study|Not able to transition to phase 2b|8|||
155143788|NCT04170543|559959495|FG001|Overall Study|Not able to transition to phase 2b|0|||
155143789|NCT04170543|559959496|FG002|Overall Study|Not able to transition to phase 2b|10|||
155143790|NCT04170543|559959497|FG003|Overall Study|Not able to transition to phase 2b|0|||
155186098|NCT02652767|560121305|FG000|Overall Study|Withdrawal by Subject|1|||
155186099|NCT00887744|560121316|FG000|Overall Study|Adverse Event|3|||
155143791|NCT04170543|559959498|FG004|Overall Study|Not able to transition to phase 2b|6|||
155186100|NCT00887744|560121316|FG000|Overall Study|Death|1|||
155186101|NCT00887744|560121316|FG000|Overall Study|Lost to Follow-up|3|||
155143792|NCT04170543|559959494|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
155143793|NCT04170543|559959495|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
155143794|NCT04170543|559959496|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
155143795|NCT04170543|559959497|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
155186102|NCT00887744|560121316|FG000|Overall Study|Withdrawal by Subject|18|||
155186103|NCT00887744|560121316|FG000|Overall Study|Various reasons|9|||
155186104|NCT01115803|560121317|FG000|Overall Study|Withdrawal by Subject|0|||
155186105|NCT01115803|560121318|FG001|Overall Study|Withdrawal by Subject|0|||
155186106|NCT01115803|560121319|FG002|Overall Study|Withdrawal by Subject|0|||
155186107|NCT01115803|560121320|FG003|Overall Study|Withdrawal by Subject|0|||
155186108|NCT01115803|560121321|FG004|Overall Study|Withdrawal by Subject|0|||
155186109|NCT01115803|560121322|FG005|Overall Study|Withdrawal by Subject|0|||
155186110|NCT01115803|560121323|FG006|Overall Study|Withdrawal by Subject|1|||
155186111|NCT01115803|560121317|FG000|Overall Study|Lost to Follow-up|0|||
155186112|NCT01115803|560121318|FG001|Overall Study|Lost to Follow-up|0|||
155186113|NCT01115803|560121319|FG002|Overall Study|Lost to Follow-up|1|||
155186114|NCT01115803|560121320|FG003|Overall Study|Lost to Follow-up|0|||
155186115|NCT01115803|560121321|FG004|Overall Study|Lost to Follow-up|0|||
155186116|NCT01115803|560121322|FG005|Overall Study|Lost to Follow-up|0|||
155186117|NCT01115803|560121323|FG006|Overall Study|Lost to Follow-up|0|||
155186118|NCT01115803|560121317|FG000|Overall Study|Progressive Disease during Cycle1|0|||
155186119|NCT01115803|560121318|FG001|Overall Study|Progressive Disease during Cycle1|0|||
155186120|NCT01115803|560121319|FG002|Overall Study|Progressive Disease during Cycle1|0|||
155186121|NCT01115803|560121320|FG003|Overall Study|Progressive Disease during Cycle1|0|||
155186122|NCT01115803|560121321|FG004|Overall Study|Progressive Disease during Cycle1|0|||
155186123|NCT01115803|560121322|FG005|Overall Study|Progressive Disease during Cycle1|0|||
155186124|NCT01115803|560121323|FG006|Overall Study|Progressive Disease during Cycle1|1|||
155186125|NCT03533686|560121324|FG000|Overall Study|Withdrawal by Subject|1|||
155186126|NCT03533686|560121325|FG001|Overall Study|Withdrawal by Subject|0|||
155186127|NCT03533686|560121326|FG002|Overall Study|Withdrawal by Subject|0|||
155186128|NCT03533686|560121327|FG003|Overall Study|Withdrawal by Subject|3|||
155186129|NCT03533686|560121328|FG004|Overall Study|Withdrawal by Subject|5|||
155186130|NCT03533686|560121329|FG005|Overall Study|Withdrawal by Subject|1|||
155186131|NCT03533686|560121324|FG000|Overall Study|Lost to Follow-up|0|||
155186132|NCT03533686|560121325|FG001|Overall Study|Lost to Follow-up|1|||
155186133|NCT03533686|560121326|FG002|Overall Study|Lost to Follow-up|0|||
155186134|NCT03533686|560121327|FG003|Overall Study|Lost to Follow-up|0|||
155186135|NCT03533686|560121328|FG004|Overall Study|Lost to Follow-up|2|||
155186136|NCT03533686|560121329|FG005|Overall Study|Lost to Follow-up|0|||
155186137|NCT03533686|560121324|FG000|Overall Study|Screen Failure|0|||
155186138|NCT03533686|560121325|FG001|Overall Study|Screen Failure|0|||
155186139|NCT03533686|560121326|FG002|Overall Study|Screen Failure|0|||
155186140|NCT03533686|560121327|FG003|Overall Study|Screen Failure|2|||
155186141|NCT03533686|560121328|FG004|Overall Study|Screen Failure|0|||
155186142|NCT03533686|560121329|FG005|Overall Study|Screen Failure|0|||
155186143|NCT02862600|560121331|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
155186144|NCT02862600|560121331|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
155186145|NCT02862600|560121331|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
155186146|NCT02862600|560121331|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
155186147|NCT02961218|560121340|FG000|Overall Study|Lost to Follow-up|0|||
155186148|NCT02961218|560121341|FG001|Overall Study|Lost to Follow-up|2|||
155186149|NCT02961218|560121340|FG000|Overall Study|Physician Decision|0|||
155186150|NCT02961218|560121341|FG001|Overall Study|Physician Decision|2|||
155186151|NCT02961218|560121340|FG000|Overall Study|Subject/Guardian Decision|3|||
155186152|NCT02961218|560121341|FG001|Overall Study|Subject/Guardian Decision|1|||
155186153|NCT01462227|560121347|FG000|Second Assignment|Lost to Follow-up|1|||
155186154|NCT01462227|560121348|FG001|Second Assignment|Lost to Follow-up|0|||
155186155|NCT01462227|560121349|FG002|Second Assignment|Lost to Follow-up|0|||
155186156|NCT01462227|560121350|FG003|Second Assignment|Lost to Follow-up|0|||
155186157|NCT01462227|560121347|FG000|Second Assignment|Protocol Violation|0|||
155186158|NCT01462227|560121348|FG001|Second Assignment|Protocol Violation|1|||
155186159|NCT01462227|560121349|FG002|Second Assignment|Protocol Violation|1|||
155186160|NCT01462227|560121350|FG003|Second Assignment|Protocol Violation|0|||
155186161|NCT00901927|560121355|FG000|Overall Study|Lack of Efficacy|1|||
155186162|NCT00901927|560121355|FG000|Overall Study|Protocol Violation|3|||
155186163|NCT00901927|560121355|FG000|Overall Study|Withdrawal by Subject|2|||
155186164|NCT01702571|560121359|FG000|Overall Study|Death|1067|||
155186165|NCT01702571|560121360|FG001|Overall Study|Death|76|||
155186166|NCT01702571|560121359|FG000|Overall Study|Lost to Follow-up|144|||
155186167|NCT01702571|560121360|FG001|Overall Study|Lost to Follow-up|10|||
155186168|NCT01702571|560121359|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
155186169|NCT01702571|560121360|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
155186170|NCT01702571|560121359|FG000|Overall Study|Investigator Decision|5|||
155186171|NCT01702571|560121360|FG001|Overall Study|Investigator Decision|0|||
155186172|NCT01702571|560121359|FG000|Overall Study|Not Classifiable|1|||
155186173|NCT01702571|560121360|FG001|Overall Study|Not Classifiable|0|||
155186174|NCT01702571|560121359|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
155186175|NCT01702571|560121360|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
155186176|NCT01702571|560121359|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
155186177|NCT01702571|560121360|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
155186178|NCT01702571|560121359|FG000|Overall Study|Progressive Disease|3|||
155186179|NCT01702571|560121360|FG001|Overall Study|Progressive Disease|0|||
155186180|NCT01702571|560121359|FG000|Overall Study|Protocol Violation|2|||
155186181|NCT01702571|560121360|FG001|Overall Study|Protocol Violation|0|||
155186182|NCT01702571|560121359|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
155186183|NCT01702571|560121360|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
155186184|NCT01702571|560121359|FG000|Overall Study|Termination By Sponsor|4|||
155186185|NCT01702571|560121360|FG001|Overall Study|Termination By Sponsor|0|||
155035289|NCT01887288|559557530|FG000|Overall Study|The study was terminated and the PI has|16|||
155035290|NCT01092637|559557531|FG000|Overall Study|Death|47|||
155035291|NCT01092637|559557532|FG001|Overall Study|Death|49|||
155035292|NCT03309696|559557537|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
155035293|NCT03309696|559557538|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
155035294|NCT03309696|559557539|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
155035295|NCT03309696|559557540|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
155035296|NCT04643964|559557541|FG000|Overall Study|Lost to Follow-up|55|||
155186186|NCT01702571|560121359|FG000|Overall Study|Withdrawal by Subject|177|||
155186187|NCT01702571|560121360|FG001|Overall Study|Withdrawal by Subject|29|||
155186188|NCT00828854|560121361|FG000|Overall Study|Disease Progression|17|||
155186189|NCT00828854|560121361|FG000|Overall Study|Adverse Event|9|||
155186190|NCT00828854|560121361|FG000|Overall Study|Reason not Specified|1|||
155186191|NCT04221230|560121362|FG000|Overall Study|Lost to Follow-up|12|||
155186192|NCT04221230|560121363|FG001|Overall Study|Lost to Follow-up|12|||
155186193|NCT04221230|560121362|FG000|Overall Study|Protocol Violation|2|||
155186194|NCT04221230|560121363|FG001|Overall Study|Protocol Violation|2|||
155186195|NCT04221230|560121362|FG000|Overall Study|Adverse Event|0|||
155186196|NCT04221230|560121363|FG001|Overall Study|Adverse Event|8|||
155186197|NCT04221230|560121362|FG000|Overall Study|Physician Decision|1|||
155186198|NCT04221230|560121363|FG001|Overall Study|Physician Decision|0|||
155186199|NCT04221230|560121362|FG000|Overall Study|Withdrawal by Subject|13|||
155186200|NCT04221230|560121363|FG001|Overall Study|Withdrawal by Subject|11|||
155186201|NCT04221230|560121362|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155186202|NCT04221230|560121363|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155186203|NCT04221230|560121362|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155186204|NCT04221230|560121363|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
155186205|NCT04221230|560121362|FG000|Overall Study|Pregnancy|0|||
155186206|NCT04221230|560121363|FG001|Overall Study|Pregnancy|1|||
155186207|NCT04221230|560121362|FG000|Overall Study|Other|1|||
155186208|NCT04221230|560121363|FG001|Overall Study|Other|2|||
155186209|NCT00915356|560121364|FG000|Overall Study|Withdrawal by Subject|1|||
155186210|NCT00915356|560121365|FG001|Overall Study|Withdrawal by Subject|0|||
155186211|NCT00915356|560121366|FG002|Overall Study|Withdrawal by Subject|0|||
155186212|NCT00915356|560121367|FG003|Overall Study|Withdrawal by Subject|0|||
155186213|NCT00915356|560121368|FG004|Overall Study|Withdrawal by Subject|0|||
155186214|NCT00191646|560121370|FG000|Overall Study|Toxicity|26|||
155186215|NCT00191646|560121371|FG001|Overall Study|Toxicity|37|||
155186216|NCT00191646|560121370|FG000|Overall Study|Disease Progression|5|||
155186217|NCT00191646|560121371|FG001|Overall Study|Disease Progression|6|||
155186218|NCT00191646|560121370|FG000|Overall Study|Physician Decision|20|||
155186219|NCT00191646|560121371|FG001|Overall Study|Physician Decision|11|||
155186220|NCT00191646|560121370|FG000|Overall Study|Withdrawal by Subject|58|||
155186221|NCT00191646|560121371|FG001|Overall Study|Withdrawal by Subject|39|||
155186222|NCT00191646|560121370|FG000|Overall Study|Protocol Violation|5|||
155186223|NCT00191646|560121371|FG001|Overall Study|Protocol Violation|7|||
155186224|NCT00191646|560121370|FG000|Overall Study|Death|6|||
155186225|NCT00191646|560121371|FG001|Overall Study|Death|8|||
155186226|NCT00191646|560121370|FG000|Overall Study|Other|33|||
155186227|NCT00191646|560121371|FG001|Overall Study|Other|34|||
155186228|NCT00191646|560121370|FG000|Overall Study|Missing Data|18|||
155186229|NCT00191646|560121371|FG001|Overall Study|Missing Data|11|||
155186230|NCT05211284|560121380|FG000|Overall Study|Study Terminated|3|||
155186231|NCT05211284|560121381|FG001|Overall Study|Study Terminated|1|||
155186232|NCT03194490|560121383|FG000|Overall Study|Lost to Follow-up|1|||
155186233|NCT03194490|560121384|FG001|Overall Study|Lost to Follow-up|3|||
155186234|NCT03194490|560121383|FG000|Overall Study|participant developed specific neck pain|1|||
155186235|NCT03194490|560121384|FG001|Overall Study|participant developed specific neck pain|0|||
155186236|NCT01505647|560121385|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
155186237|NCT01505647|560121386|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
155186238|NCT01505647|560121385|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
155186239|NCT01505647|560121386|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
155186240|NCT01505647|560121385|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
155186241|NCT01505647|560121386|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
155186242|NCT01505647|560121385|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
155035297|NCT04643964|559557542|FG001|Overall Study|Lost to Follow-up|59|||
155035298|NCT04643964|559557543|FG002|Overall Study|Lost to Follow-up|54|||
155035299|NCT04643964|559557544|FG003|Overall Study|Lost to Follow-up|129|||
155186243|NCT01505647|560121386|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
155186244|NCT01505647|560121385|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
155035300|NCT04643964|559557545|FG004|Overall Study|Lost to Follow-up|48|||
155035301|NCT04643964|559557541|FG000|Overall Study|Failed attention check|1|||
155035302|NCT04643964|559557542|FG001|Overall Study|Failed attention check|8|||
155035303|NCT04643964|559557543|FG002|Overall Study|Failed attention check|2|||
155035304|NCT04643964|559557544|FG003|Overall Study|Failed attention check|14|||
155035305|NCT04643964|559557545|FG004|Overall Study|Failed attention check|11|||
155035306|NCT02949908|559557546|FG000|Overall Study|Study termination|2|||
155035307|NCT00577005|559557549|FG000|Overall Study|Lost to Follow-up|3|||
155035308|NCT00577005|559557550|FG001|Overall Study|Lost to Follow-up|2|||
155035309|NCT00577005|559557549|FG000|Overall Study|Withdrawal by Subject|2|||
155035310|NCT00577005|559557550|FG001|Overall Study|Withdrawal by Subject|1|||
155035311|NCT01004432|559557551|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
155035312|NCT01004432|559557552|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155035313|NCT01004432|559557553|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155035314|NCT01004432|559557554|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155035315|NCT01004432|559557555|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
155035316|NCT01004432|559557551|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
155035317|NCT01004432|559557552|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155035318|NCT01004432|559557553|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155035319|NCT01004432|559557554|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155035320|NCT01004432|559557555|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
155035321|NCT01004432|559557551|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
155035322|NCT01004432|559557552|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155035323|NCT01004432|559557553|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155035324|NCT01004432|559557554|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155035325|NCT01004432|559557555|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
155035326|NCT01004432|559557551|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
155035327|NCT01004432|559557552|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155035328|NCT01004432|559557553|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155035329|NCT01004432|559557554|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155035330|NCT01004432|559557555|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
155035331|NCT01004432|559557551|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
155035332|NCT01004432|559557552|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155035333|NCT01004432|559557553|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155035334|NCT01004432|559557554|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155035335|NCT01004432|559557555|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
155035336|NCT01004432|559557551|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
155035337|NCT01004432|559557552|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
155035338|NCT01004432|559557553|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
155035339|NCT01004432|559557554|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
155035340|NCT01004432|559557555|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
155035341|NCT01004432|559557551|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
155035342|NCT01004432|559557552|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
155143796|NCT04170543|559959498|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
155143797|NCT04170543|559959494|FG000|Overall Study|Not Treated|0|||
155143798|NCT04170543|559959495|FG001|Overall Study|Not Treated|0|||
155143799|NCT04170543|559959496|FG002|Overall Study|Not Treated|0|||
155143800|NCT04170543|559959497|FG003|Overall Study|Not Treated|0|||
155143801|NCT04170543|559959498|FG004|Overall Study|Not Treated|2|||
155143802|NCT04170543|559959494|FG000|Overall Study|(CRF)|16|||
155143803|NCT04170543|559959495|FG001|Overall Study|(CRF)|15|||
155143804|NCT04170543|559959496|FG002|Overall Study|(CRF)|12|||
155143805|NCT04170543|559959497|FG003|Overall Study|(CRF)|17|||
155143806|NCT04170543|559959498|FG004|Overall Study|(CRF)|17|||
155143807|NCT04170543|559959494|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
155143808|NCT04170543|559959495|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
155143809|NCT04170543|559959496|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
155143810|NCT04170543|559959497|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
155143811|NCT04170543|559959498|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
155143812|NCT04378270|559959499|FG000|Overall Study|Lack of Efficacy|1|||
155143813|NCT04378270|559959499|FG000|Overall Study|Withdrawal by Subject|1|||
155143814|NCT04378270|559959499|FG000|Overall Study|Screen Failure|1|||
155143815|NCT04378270|559959499|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
155143816|NCT01156714|559959500|FG000|Overall Study|Withdrawal by Subject|9|||
155143817|NCT01156714|559959501|FG001|Overall Study|Withdrawal by Subject|4|||
155143818|NCT01156714|559959502|FG002|Overall Study|Withdrawal by Subject|3|||
155143819|NCT01236521|559959503|FG000|Overall Study|Withdrawal by Subject|12|||
155143820|NCT01236521|559959504|FG001|Overall Study|Withdrawal by Subject|17|||
155143821|NCT01236521|559959503|FG000|Overall Study|Death|2|||
155143822|NCT01236521|559959504|FG001|Overall Study|Death|1|||
155143823|NCT01236521|559959503|FG000|Overall Study|Lost to Follow-up|9|||
155143824|NCT01236521|559959504|FG001|Overall Study|Lost to Follow-up|7|||
155035343|NCT01004432|559557553|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
155035344|NCT01004432|559557554|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
155035345|NCT01004432|559557555|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
155035346|NCT01004432|559557551|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
155035347|NCT01004432|559557552|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
155035348|NCT01004432|559557553|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
155035349|NCT01004432|559557554|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
155035350|NCT01004432|559557555|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
155035351|NCT01004432|559557551|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155035352|NCT01004432|559557552|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155035353|NCT01004432|559557553|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155035354|NCT01004432|559557554|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
155035355|NCT01004432|559557555|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
155035356|NCT01004432|559557551|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
155035357|NCT01004432|559557552|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
155035358|NCT01004432|559557553|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
155035359|NCT01004432|559557554|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
155035360|NCT01004432|559557555|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
155035361|NCT01004432|559557551|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
155035362|NCT01004432|559557552|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
155035363|NCT01004432|559557553|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
155035364|NCT01004432|559557554|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
155035365|NCT01004432|559557555|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
155035366|NCT01004432|559557551|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155035367|NCT01004432|559557552|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155035368|NCT01004432|559557553|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155035369|NCT01004432|559557554|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
155035370|NCT01004432|559557555|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
155035371|NCT01004432|559557551|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155035372|NCT01004432|559557552|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155186245|NCT01505647|560121386|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
155186246|NCT01574079|560121387|FG000|Overall Study|Physician Decision|0|||
155186247|NCT01574079|560121388|FG001|Overall Study|Physician Decision|2|||
155186248|NCT01574079|560121387|FG000|Overall Study|Lost to Follow-up|1|||
155186249|NCT01574079|560121388|FG001|Overall Study|Lost to Follow-up|0|||
155186250|NCT03640559|560121392|FG000|Overall Study|Physician Decision|1|||
155186251|NCT03640559|560121393|FG001|Overall Study|Physician Decision|1|||
155186252|NCT03640559|560121392|FG000|Overall Study|Withdrawal by Subject|1|||
155186253|NCT03640559|560121393|FG001|Overall Study|Withdrawal by Subject|0|||
155186254|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
155186255|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
155186256|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
155186257|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
155186258|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
155186259|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
155186260|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
155186261|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
155186262|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
155186263|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
155186264|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
155186265|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
155186266|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
155186267|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155186268|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
155186269|NCT01436162|560121394|FG000|Single-blind Lead-in Phase|Other|107|||
155186270|NCT01436162|560121395|FG001|Single-blind Lead-in Phase|Other|0|||
155186271|NCT01436162|560121396|FG002|Single-blind Lead-in Phase|Other|0|||
155186272|NCT01436162|560121394|FG000|Randomized Phase|Adverse Event|1|||
155186273|NCT01436162|560121395|FG001|Randomized Phase|Adverse Event|5|||
155186274|NCT01436162|560121396|FG002|Randomized Phase|Adverse Event|6|||
155186275|NCT01436162|560121394|FG000|Randomized Phase|Protocol Violation|4|||
155186276|NCT01436162|560121395|FG001|Randomized Phase|Protocol Violation|4|||
155186277|NCT01436162|560121396|FG002|Randomized Phase|Protocol Violation|2|||
155186278|NCT01436162|560121394|FG000|Randomized Phase|Withdrawal by Subject|16|||
155186279|NCT01436162|560121395|FG001|Randomized Phase|Withdrawal by Subject|9|||
155186280|NCT01436162|560121396|FG002|Randomized Phase|Withdrawal by Subject|8|||
155186281|NCT01436162|560121394|FG000|Randomized Phase|Lost to Follow-up|17|||
155186282|NCT01436162|560121395|FG001|Randomized Phase|Lost to Follow-up|5|||
155186283|NCT01436162|560121396|FG002|Randomized Phase|Lost to Follow-up|4|||
155186284|NCT01436162|560121394|FG000|Randomized Phase|Lack of Efficacy|0|||
155035373|NCT01004432|559557553|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155035374|NCT01004432|559557554|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
155035375|NCT01004432|559557555|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
155035376|NCT01004432|559557551|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155035377|NCT01004432|559557552|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155035378|NCT01004432|559557553|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155035379|NCT01004432|559557554|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
155035380|NCT01004432|559557555|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
155035381|NCT01004432|559557551|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155035382|NCT01004432|559557552|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155035383|NCT01004432|559557553|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155035384|NCT01004432|559557554|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
155035385|NCT01004432|559557555|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
155035386|NCT00590538|559557556|FG000|Overall Study|Study terminated before completed|2|||
155035387|NCT02309723|559557557|FG000|Overall Study|Withdrawal by Subject|24|||
155035388|NCT02309723|559557558|FG001|Overall Study|Withdrawal by Subject|23|||
155035389|NCT02309723|559557559|FG002|Overall Study|Withdrawal by Subject|24|||
155035390|NCT02255552|559557560|FG000|Overall Study|Participants enrolled into another study|0|||
155035391|NCT02255552|559557561|FG001|Overall Study|Participants enrolled into another study|11|||
155035392|NCT02255552|559557560|FG000|Overall Study|Withdrawal by Subject|1|||
155035393|NCT02255552|559557561|FG001|Overall Study|Withdrawal by Subject|4|||
155035394|NCT03435224|559557562|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
155035395|NCT04472026|559557565|FG000|Overall Study|Lost to Follow-up|5|||
155035396|NCT00908076|559557566|FG000|Overall Study|Lack of Efficacy|1|||
155035397|NCT00908076|559557567|FG001|Overall Study|Lack of Efficacy|1|||
155035398|NCT02609724|559557568|FG000|Overall Study|Death|2|||
155035399|NCT02609724|559557569|FG001|Overall Study|Death|0|||
155035400|NCT02609724|559557570|FG002|Overall Study|Death|1|||
155035401|NCT02609724|559557568|FG000|Overall Study|Withdrawal by Subject|1|||
155035402|NCT02609724|559557569|FG001|Overall Study|Withdrawal by Subject|2|||
155035403|NCT02609724|559557570|FG002|Overall Study|Withdrawal by Subject|3|||
155035404|NCT02609724|559557568|FG000|Overall Study|Illness|2|||
155035405|NCT02609724|559557569|FG001|Overall Study|Illness|1|||
155035406|NCT02609724|559557570|FG002|Overall Study|Illness|0|||
155035407|NCT02382796|559557571|FG000|Overall Study|Global deterioration of health status|1|||
155035408|NCT02382796|559557571|FG000|Overall Study|Objective progression or relapse|3|||
155035409|NCT02382796|559557571|FG000|Overall Study|Commercial dacomitinib became available|3|||
155035410|NCT03077659|559557572|FG000|Overall Study|Withdrawal by Subject|0|||
155035411|NCT03077659|559557573|FG001|Overall Study|Withdrawal by Subject|0|||
155035412|NCT03077659|559557574|FG002|Overall Study|Withdrawal by Subject|1|||
155035413|NCT04007107|559557575|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
155035414|NCT04007107|559557576|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
155035415|NCT04007107|559557577|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
155035416|NCT04007107|559557578|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
155035417|NCT04526574|559557579|FG000|Overall Study|Protocol Violation|3|||
155035418|NCT04526574|559557580|FG001|Overall Study|Protocol Violation|1|||
155035419|NCT04526574|559557579|FG000|Overall Study|Withdrawal by Subject|12|||
155035420|NCT04526574|559557580|FG001|Overall Study|Withdrawal by Subject|9|||
155035421|NCT04526574|559557579|FG000|Overall Study|Other|1|||
155035422|NCT04526574|559557580|FG001|Overall Study|Other|2|||
155035423|NCT04526574|559557579|FG000|Overall Study|Adverse Event|1|||
155035424|NCT04526574|559557580|FG001|Overall Study|Adverse Event|1|||
155035425|NCT04526574|559557579|FG000|Overall Study|Death|2|||
155035426|NCT04526574|559557580|FG001|Overall Study|Death|3|||
155035427|NCT04526574|559557579|FG000|Overall Study|Lost to Follow-up|9|||
155035428|NCT04526574|559557580|FG001|Overall Study|Lost to Follow-up|9|||
155035429|NCT04526574|559557579|FG000|Overall Study|No longer meets eligibility criteria|8|||
155035430|NCT04526574|559557580|FG001|Overall Study|No longer meets eligibility criteria|8|||
155035431|NCT04068688|559557581|FG000|Overall Study|Lost to Follow-up|1|||
155035432|NCT04068688|559557582|FG001|Overall Study|Lost to Follow-up|1|||
155035433|NCT04068688|559557583|FG002|Overall Study|Lost to Follow-up|0|||
155035434|NCT04068688|559557584|FG003|Overall Study|Lost to Follow-up|0|||
155035435|NCT04068688|559557585|FG004|Overall Study|Lost to Follow-up|5|||
155035436|NCT04068688|559557586|FG005|Overall Study|Lost to Follow-up|5|||
155035437|NCT04068688|559557587|FG006|Overall Study|Lost to Follow-up|0|||
155035438|NCT04068688|559557588|FG007|Overall Study|Lost to Follow-up|0|||
155035439|NCT04068688|559557589|FG008|Overall Study|Lost to Follow-up|1|||
155035440|NCT04068688|559557590|FG009|Overall Study|Lost to Follow-up|0|||
155035441|NCT04068688|559557581|FG000|Overall Study|Withdrawal by Subject|1|||
155035442|NCT04068688|559557582|FG001|Overall Study|Withdrawal by Subject|1|||
155035443|NCT04068688|559557583|FG002|Overall Study|Withdrawal by Subject|0|||
155035444|NCT04068688|559557584|FG003|Overall Study|Withdrawal by Subject|0|||
155035445|NCT04068688|559557585|FG004|Overall Study|Withdrawal by Subject|0|||
155035446|NCT04068688|559557586|FG005|Overall Study|Withdrawal by Subject|0|||
155035447|NCT04068688|559557587|FG006|Overall Study|Withdrawal by Subject|0|||
155035448|NCT04068688|559557588|FG007|Overall Study|Withdrawal by Subject|0|||
155035449|NCT04068688|559557589|FG008|Overall Study|Withdrawal by Subject|0|||
155035450|NCT04068688|559557590|FG009|Overall Study|Withdrawal by Subject|0|||
155035451|NCT04068688|559557581|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
155035452|NCT04068688|559557582|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
155035453|NCT04068688|559557583|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035454|NCT04068688|559557584|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035455|NCT04068688|559557585|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035456|NCT04068688|559557586|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035457|NCT04068688|559557587|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035458|NCT04068688|559557588|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035459|NCT04068688|559557589|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035460|NCT04068688|559557590|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
155035461|NCT04679051|559557591|FG000|Overall Study|felt tired after restricted time in bed|3|||
155035462|NCT04679051|559557592|FG001|Overall Study|felt tired after restricted time in bed|0|||
155035463|NCT04679051|559557591|FG000|Overall Study|discomfort with blood pressure cuff|2|||
155035464|NCT04679051|559557592|FG001|Overall Study|discomfort with blood pressure cuff|0|||
155035465|NCT04679051|559557591|FG000|Overall Study|scheduling conflict|1|||
155035466|NCT04679051|559557592|FG001|Overall Study|scheduling conflict|1|||
155035467|NCT04679051|559557591|FG000|Overall Study|Protocol Violation|0|||
155035468|NCT04679051|559557592|FG001|Overall Study|Protocol Violation|4|||
155035469|NCT00006305|559557593|FG000|Overall Study|Withdrawal by Subject|17|||
155035470|NCT00006305|559557594|FG001|Overall Study|Withdrawal by Subject|10|||
155035471|NCT00006305|559557595|FG002|Overall Study|Withdrawal by Subject|15|||
155035472|NCT00006305|559557596|FG003|Overall Study|Withdrawal by Subject|14|||
155035473|NCT00662558|559557597|FG000|Overall Study|Adverse Event|21|||
155035474|NCT00662558|559557598|FG001|Overall Study|Adverse Event|59|||
155035475|NCT00662558|559557597|FG000|Overall Study|Lack of Efficacy|4|||
155035476|NCT00662558|559557598|FG001|Overall Study|Lack of Efficacy|7|||
155035477|NCT00662558|559557597|FG000|Overall Study|Lost to Follow-up|13|||
155035478|NCT00662558|559557598|FG001|Overall Study|Lost to Follow-up|10|||
155035479|NCT00662558|559557597|FG000|Overall Study|Other|9|||
155035480|NCT00662558|559557598|FG001|Overall Study|Other|14|||
155035481|NCT00662558|559557597|FG000|Overall Study|Withdrawal by Subject|7|||
155035482|NCT00662558|559557598|FG001|Overall Study|Withdrawal by Subject|12|||
155035483|NCT00662558|559557597|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
155035484|NCT00662558|559557598|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
155035485|NCT00396877|559557602|FG000|Overall Study|Lost to Follow-up|2|||
155035486|NCT00396877|559557603|FG001|Overall Study|Lost to Follow-up|1|||
155186285|NCT01436162|560121395|FG001|Randomized Phase|Lack of Efficacy|1|||
155186286|NCT01436162|560121396|FG002|Randomized Phase|Lack of Efficacy|1|||
155186287|NCT01436162|560121394|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
155186288|NCT01436162|560121395|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
155186289|NCT01436162|560121396|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
155186290|NCT01436162|560121394|FG000|Randomized Phase|Other|2|||
155186291|NCT01436162|560121395|FG001|Randomized Phase|Other|5|||
155186292|NCT01436162|560121396|FG002|Randomized Phase|Other|4|||
155186293|NCT02750943|560121399|FG000|Overall Study|Lost to Follow-up|1|||
155186294|NCT02750943|560121400|FG001|Overall Study|Lost to Follow-up|2|||
155186295|NCT02750943|560121399|FG000|Overall Study|Withdrawal by Subject|5|||
155186296|NCT02750943|560121400|FG001|Overall Study|Withdrawal by Subject|7|||
155186297|NCT04597918|560121401|FG000|Overall Study|Withdrawal by Subject|6|||
155186298|NCT04597918|560121401|FG000|Overall Study|Lost to Follow-up|3|||
155186299|NCT04597918|560121401|FG000|Overall Study|Death|1|||
155186300|NCT05140382|560121402|FG000|Overall Study|Death|3|||
155186301|NCT05140382|560121403|FG001|Overall Study|Death|0|||
155186302|NCT05140382|560121404|FG002|Overall Study|Death|0|||
155186303|NCT05140382|560121402|FG000|Overall Study|Investigator decision|1|||
155186304|NCT05140382|560121403|FG001|Overall Study|Investigator decision|0|||
155186305|NCT05140382|560121404|FG002|Overall Study|Investigator decision|0|||
155186306|NCT05140382|560121402|FG000|Overall Study|Other|4|||
155186307|NCT05140382|560121403|FG001|Overall Study|Other|0|||
155186308|NCT05140382|560121404|FG002|Overall Study|Other|1|||
155186309|NCT05140382|560121402|FG000|Overall Study|Progressive disease|20|||
155186310|NCT05140382|560121403|FG001|Overall Study|Progressive disease|1|||
155186311|NCT05140382|560121404|FG002|Overall Study|Progressive disease|12|||
155186312|NCT05140382|560121402|FG000|Overall Study|Subjective disease progression|2|||
155186313|NCT05140382|560121403|FG001|Overall Study|Subjective disease progression|1|||
155186314|NCT05140382|560121404|FG002|Overall Study|Subjective disease progression|0|||
155186315|NCT05140382|560121402|FG000|Overall Study|Unknown at data cut-off|0|||
155186316|NCT05140382|560121403|FG001|Overall Study|Unknown at data cut-off|0|||
155186317|NCT05140382|560121404|FG002|Overall Study|Unknown at data cut-off|1|||
155186318|NCT05140382|560121402|FG000|Overall Study|Withdrawal by Subject|1|||
155035487|NCT00396877|559557602|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
155035488|NCT00396877|559557603|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
155035489|NCT00980018|559557607|FG000|Overall Study|Adverse Event|8|||
155035490|NCT00980018|559557607|FG000|Overall Study|Patient withdrew consent|3|||
155035491|NCT00980018|559557607|FG000|Overall Study|Lost to Follow-up|1|||
155035492|NCT00551161|559557611|FG000|Overall Study|Withdrawal by Subject|1|||
155035493|NCT00934856|559557612|FG000|Feasibility Part|Progressive disease|4|||
155035494|NCT00934856|559557613|FG001|Feasibility Part|Progressive disease|4|||
155035495|NCT00934856|559557614|FG002|Feasibility Part|Progressive disease|2|||
155035496|NCT00934856|559557615|FG003|Feasibility Part|Progressive disease|3|||
155035497|NCT00934856|559557616|FG004|Feasibility Part|Progressive disease|0|||
155035498|NCT00934856|559557617|FG005|Feasibility Part|Progressive disease|0|||
155035499|NCT00934856|559557612|FG000|Feasibility Part|Physician Decision|0|||
155035500|NCT00934856|559557613|FG001|Feasibility Part|Physician Decision|0|||
155035501|NCT00934856|559557614|FG002|Feasibility Part|Physician Decision|1|||
155035502|NCT00934856|559557615|FG003|Feasibility Part|Physician Decision|0|||
155035503|NCT00934856|559557616|FG004|Feasibility Part|Physician Decision|0|||
155035504|NCT00934856|559557617|FG005|Feasibility Part|Physician Decision|0|||
155035505|NCT00934856|559557612|FG000|Feasibility Part|Adverse Event|1|||
155035506|NCT00934856|559557613|FG001|Feasibility Part|Adverse Event|1|||
155035507|NCT00934856|559557614|FG002|Feasibility Part|Adverse Event|0|||
155035508|NCT00934856|559557615|FG003|Feasibility Part|Adverse Event|1|||
155035509|NCT00934856|559557616|FG004|Feasibility Part|Adverse Event|0|||
155035510|NCT00934856|559557617|FG005|Feasibility Part|Adverse Event|2|||
155035511|NCT00934856|559557612|FG000|Feasibility Part|Withdrawal by Subject|0|||
155035512|NCT00934856|559557613|FG001|Feasibility Part|Withdrawal by Subject|0|||
155035513|NCT00934856|559557614|FG002|Feasibility Part|Withdrawal by Subject|0|||
155035514|NCT00934856|559557615|FG003|Feasibility Part|Withdrawal by Subject|1|||
155035515|NCT00934856|559557616|FG004|Feasibility Part|Withdrawal by Subject|0|||
155035516|NCT00934856|559557617|FG005|Feasibility Part|Withdrawal by Subject|1|||
155035517|NCT00934856|559557612|FG000|Extension Part|Adverse Event|0|||
155035518|NCT00934856|559557613|FG001|Extension Part|Adverse Event|0|||
155035519|NCT00934856|559557614|FG002|Extension Part|Adverse Event|0|||
155035520|NCT00934856|559557615|FG003|Extension Part|Adverse Event|1|||
155035521|NCT00934856|559557616|FG004|Extension Part|Adverse Event|4|||
155035522|NCT00934856|559557617|FG005|Extension Part|Adverse Event|4|||
155035523|NCT00934856|559557612|FG000|Extension Part|Progressive disease|0|||
155035524|NCT00934856|559557613|FG001|Extension Part|Progressive disease|0|||
155035525|NCT00934856|559557614|FG002|Extension Part|Progressive disease|0|||
155035526|NCT00934856|559557615|FG003|Extension Part|Progressive disease|1|||
155035527|NCT00934856|559557616|FG004|Extension Part|Progressive disease|0|||
155035528|NCT00934856|559557617|FG005|Extension Part|Progressive disease|0|||
155035529|NCT00934856|559557612|FG000|Extension Part|Non-compliance with drug|0|||
155186319|NCT05140382|560121403|FG001|Overall Study|Withdrawal by Subject|0|||
155186320|NCT05140382|560121404|FG002|Overall Study|Withdrawal by Subject|4|||
155186321|NCT05140382|560121402|FG000|Overall Study|Withdrawal of consent|0|||
155186322|NCT05140382|560121403|FG001|Overall Study|Withdrawal of consent|0|||
155186323|NCT05140382|560121404|FG002|Overall Study|Withdrawal of consent|1|||
155186324|NCT05419908|560121406|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
155186325|NCT05419908|560121407|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
155186326|NCT05419908|560121406|FG000|Overall Study|Serious Adverse Event|0|||
155186327|NCT05419908|560121407|FG001|Overall Study|Serious Adverse Event|2|||
155186328|NCT05419908|560121406|FG000|Overall Study|Withdrawal by Subject|2|||
155186329|NCT05419908|560121407|FG001|Overall Study|Withdrawal by Subject|0|||
155186330|NCT05419908|560121406|FG000|Overall Study|Miscellaneous|1|||
155186331|NCT05419908|560121407|FG001|Overall Study|Miscellaneous|1|||
155186332|NCT03670836|560121408|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
155186333|NCT03670836|560121409|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
155186334|NCT03670836|560121408|FG000|Per Protocol Population (PP)|Physician Decision|9|||
155186335|NCT03670836|560121409|FG001|Per Protocol Population (PP)|Physician Decision|10|||
155186336|NCT03670836|560121408|FG000|Per Protocol Population (PP)|Physician Decision|4|||
155186337|NCT03670836|560121409|FG001|Per Protocol Population (PP)|Physician Decision|6|||
155186338|NCT03670836|560121408|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
155035530|NCT00934856|559557613|FG001|Extension Part|Non-compliance with drug|0|||
155035531|NCT00934856|559557614|FG002|Extension Part|Non-compliance with drug|0|||
155035532|NCT00934856|559557615|FG003|Extension Part|Non-compliance with drug|0|||
155035533|NCT00934856|559557616|FG004|Extension Part|Non-compliance with drug|0|||
155035534|NCT00934856|559557617|FG005|Extension Part|Non-compliance with drug|1|||
155035535|NCT01273155|559557618|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
155035536|NCT01273155|559557619|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
155186339|NCT03670836|560121409|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
155035537|NCT01273155|559557620|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
155035538|NCT01273155|559557621|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
155035539|NCT01273155|559557622|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
155035540|NCT01273155|559557623|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
155035541|NCT01273155|559557624|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
155035542|NCT01273155|559557618|FG000|Overall Study|Change in liver function/no longer eval.|0|||
155035543|NCT01273155|559557619|FG001|Overall Study|Change in liver function/no longer eval.|1|||
155035544|NCT01273155|559557620|FG002|Overall Study|Change in liver function/no longer eval.|0|||
155035545|NCT01273155|559557621|FG003|Overall Study|Change in liver function/no longer eval.|0|||
155035546|NCT01273155|559557622|FG004|Overall Study|Change in liver function/no longer eval.|1|||
155035547|NCT01273155|559557623|FG005|Overall Study|Change in liver function/no longer eval.|0|||
155035548|NCT01273155|559557624|FG006|Overall Study|Change in liver function/no longer eval.|0|||
155035549|NCT01273155|559557618|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
155035550|NCT01273155|559557619|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
155035551|NCT01273155|559557620|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
155035552|NCT01273155|559557621|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
155035553|NCT01273155|559557622|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
155035554|NCT01273155|559557623|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
155035555|NCT01273155|559557624|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
155035556|NCT01273155|559557618|FG000|Overall Study|Died during Cycle 1|0|||
155035557|NCT01273155|559557619|FG001|Overall Study|Died during Cycle 1|0|||
155035558|NCT01273155|559557620|FG002|Overall Study|Died during Cycle 1|1|||
155035559|NCT01273155|559557621|FG003|Overall Study|Died during Cycle 1|1|||
155035560|NCT01273155|559557622|FG004|Overall Study|Died during Cycle 1|0|||
155035561|NCT01273155|559557623|FG005|Overall Study|Died during Cycle 1|2|||
155035562|NCT01273155|559557624|FG006|Overall Study|Died during Cycle 1|2|||
155035563|NCT01273155|559557618|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
155035564|NCT01273155|559557619|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
155035565|NCT01273155|559557620|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
155035566|NCT01273155|559557621|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
155035567|NCT01273155|559557622|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
155035568|NCT01273155|559557623|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
155035569|NCT01273155|559557624|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
155035570|NCT01256385|559557625|FG000|Overall Study|Physician Decision|1|||
155035571|NCT01256385|559557626|FG001|Overall Study|Physician Decision|1|||
155035572|NCT01256385|559557625|FG000|Overall Study|Withdrawal by Subject|2|||
155035573|NCT01256385|559557626|FG001|Overall Study|Withdrawal by Subject|2|||
155035574|NCT04908475|559557634|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
155035575|NCT04908475|559557635|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155035576|NCT04908475|559557636|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155035577|NCT04908475|559557637|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155035578|NCT04908475|559557638|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155035579|NCT04908475|559557639|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
155035580|NCT04908475|559557634|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
155035581|NCT04908475|559557635|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155035582|NCT04908475|559557636|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155035583|NCT04908475|559557637|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155035584|NCT04908475|559557638|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155035585|NCT04908475|559557639|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
155035586|NCT04908475|559557634|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
155035587|NCT04908475|559557635|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155035588|NCT04908475|559557636|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155035589|NCT04908475|559557637|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155035590|NCT04908475|559557638|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155035591|NCT04908475|559557639|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
155035592|NCT04908475|559557634|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155035593|NCT04908475|559557635|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
155035594|NCT04908475|559557636|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
155035595|NCT04908475|559557637|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
155035596|NCT04908475|559557638|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155035597|NCT04908475|559557639|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
155143825|NCT04661150|559959511|FG000|Overall Study|Ongoing in study|19|||
155143826|NCT04661150|559959512|FG001|Overall Study|Ongoing in study|20|||
155143827|NCT04661150|559959511|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
155143828|NCT04661150|559959512|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
155143829|NCT04661150|559959511|FG000|Overall Study|Death|2|||
155143830|NCT04661150|559959512|FG001|Overall Study|Death|0|||
155035598|NCT04908475|559557634|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
155035599|NCT04908475|559557635|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
155035600|NCT04908475|559557636|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
155035601|NCT04908475|559557637|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
155035602|NCT04908475|559557638|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
155035603|NCT04908475|559557639|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
155035604|NCT04908475|559557634|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
155035605|NCT04908475|559557635|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
155035606|NCT04908475|559557636|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
155035607|NCT04908475|559557637|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
155035608|NCT04908475|559557638|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
155035609|NCT04908475|559557639|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
155035610|NCT01739764|559557640|FG000|Overall Study|Adverse Event|0|||
155035611|NCT01739764|559557641|FG001|Overall Study|Adverse Event|3|||
155035612|NCT01739764|559557642|FG002|Overall Study|Adverse Event|4|||
155035613|NCT01739764|559557640|FG000|Overall Study|Death|4|||
155035614|NCT01739764|559557641|FG001|Overall Study|Death|6|||
155035615|NCT01739764|559557642|FG002|Overall Study|Death|38|||
155035616|NCT01739764|559557640|FG000|Overall Study|Lost to Follow-up|0|||
155035617|NCT01739764|559557641|FG001|Overall Study|Lost to Follow-up|0|||
155035618|NCT01739764|559557642|FG002|Overall Study|Lost to Follow-up|5|||
155035619|NCT01739764|559557640|FG000|Overall Study|Non-Compliance|0|||
155035620|NCT01739764|559557641|FG001|Overall Study|Non-Compliance|0|||
155035621|NCT01739764|559557642|FG002|Overall Study|Non-Compliance|1|||
155035622|NCT01739764|559557640|FG000|Overall Study|Multiple Reasons|3|||
155035623|NCT01739764|559557641|FG001|Overall Study|Multiple Reasons|2|||
155035624|NCT01739764|559557642|FG002|Overall Study|Multiple Reasons|3|||
155035625|NCT01739764|559557640|FG000|Overall Study|Physician Decision|2|||
155035626|NCT01739764|559557641|FG001|Overall Study|Physician Decision|2|||
155035627|NCT01739764|559557642|FG002|Overall Study|Physician Decision|4|||
155035628|NCT01739764|559557640|FG000|Overall Study|Progressive Disease|3|||
155035629|NCT01739764|559557641|FG001|Overall Study|Progressive Disease|5|||
155035630|NCT01739764|559557642|FG002|Overall Study|Progressive Disease|16|||
155035631|NCT01739764|559557640|FG000|Overall Study|Protocol Violation|0|||
155035632|NCT01739764|559557641|FG001|Overall Study|Protocol Violation|0|||
155035633|NCT01739764|559557642|FG002|Overall Study|Protocol Violation|2|||
155035634|NCT01739764|559557640|FG000|Overall Study|Study Terminated by Sponsor|8|||
155035635|NCT01739764|559557641|FG001|Overall Study|Study Terminated by Sponsor|13|||
155035636|NCT01739764|559557642|FG002|Overall Study|Study Terminated by Sponsor|26|||
155035637|NCT01739764|559557640|FG000|Overall Study|Withdrawal by Subject|6|||
155035638|NCT01739764|559557641|FG001|Overall Study|Withdrawal by Subject|5|||
155035639|NCT01739764|559557642|FG002|Overall Study|Withdrawal by Subject|27|||
155035640|NCT00404924|559557643|FG000|Overall Study|Adverse Event|75|||
155035641|NCT00404924|559557644|FG001|Overall Study|Adverse Event|16|||
155035642|NCT00404924|559557643|FG000|Overall Study|Condition under investigation worsened|475|||
155035643|NCT00404924|559557644|FG001|Overall Study|Condition under investigation worsened|264|||
155035644|NCT00404924|559557643|FG000|Overall Study|Lost to Follow-up|1|||
155035645|NCT00404924|559557644|FG001|Overall Study|Lost to Follow-up|1|||
155035646|NCT00404924|559557643|FG000|Overall Study|Withdrawal by Subject|26|||
155035647|NCT00404924|559557644|FG001|Overall Study|Withdrawal by Subject|13|||
155035648|NCT00404924|559557643|FG000|Overall Study|Other|25|||
155035649|NCT00404924|559557644|FG001|Overall Study|Other|11|||
155035650|NCT00404924|559557643|FG000|Overall Study|Randomised but not received treatment|1|||
155035651|NCT00404924|559557644|FG001|Overall Study|Randomised but not received treatment|1|||
155035652|NCT00926536|559557649|FG000|Overall Study|Physician Decision|1|||
155035653|NCT00926536|559557650|FG001|Overall Study|Physician Decision|2|||
155035654|NCT01267201|559557651|FG000|First Intervention Period|Withdrawal by Subject|1|||
155035655|NCT01267201|559557652|FG001|First Intervention Period|Withdrawal by Subject|0|||
155035656|NCT01267201|559557653|FG002|First Intervention Period|Withdrawal by Subject|0|||
155035657|NCT01267201|559557654|FG003|First Intervention Period|Withdrawal by Subject|0|||
155035658|NCT01267201|559557655|FG004|First Intervention Period|Withdrawal by Subject|0|||
155035659|NCT01267201|559557656|FG005|First Intervention Period|Withdrawal by Subject|0|||
155035660|NCT01267201|559557651|FG000|Second Intervention Period|Withdrawal by Subject|0|||
155035661|NCT01267201|559557652|FG001|Second Intervention Period|Withdrawal by Subject|1|||
155035662|NCT01267201|559557653|FG002|Second Intervention Period|Withdrawal by Subject|0|||
155035663|NCT01267201|559557654|FG003|Second Intervention Period|Withdrawal by Subject|0|||
155035664|NCT01267201|559557655|FG004|Second Intervention Period|Withdrawal by Subject|0|||
155035665|NCT01267201|559557656|FG005|Second Intervention Period|Withdrawal by Subject|0|||
155035666|NCT00819780|559557657|FG000|Overall Study|Did not receive study drug|3|||
155035667|NCT00819780|559557658|FG001|Overall Study|Did not receive study drug|4|||
155035668|NCT00819780|559557657|FG000|Overall Study|Still in treatment|25|||
155035669|NCT00819780|559557658|FG001|Overall Study|Still in treatment|17|||
155035670|NCT03912428|559557659|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
155035671|NCT03912428|559557660|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
155035672|NCT03912428|559557661|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
155035673|NCT03912428|559557662|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
155035674|NCT03912428|559557659|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
155035675|NCT03912428|559557660|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
155186340|NCT01397201|560122751|FG000|Overall Study|Not treated|0|||
155035676|NCT03912428|559557661|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
155035677|NCT03912428|559557662|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
155035678|NCT03912428|559557659|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
155035679|NCT03912428|559557660|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
155035680|NCT03912428|559557661|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
155035681|NCT03912428|559557662|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
155035682|NCT02637713|559557663|FG000|Overall Study|Screen Failure|2|||
155035683|NCT04325698|559557664|FG000|Overall Study|Study Terminated By Sponsor|1|||
155035684|NCT04325698|559557665|FG001|Overall Study|Study Terminated By Sponsor|1|||
155035685|NCT04325698|559557664|FG000|Overall Study|Withdrawal by Subject|0|||
155035686|NCT04325698|559557665|FG001|Overall Study|Withdrawal by Subject|2|||
155035687|NCT00962091|559557666|FG000|Overall Study|Withdrawal by Subject|1|||
155035688|NCT00962091|559557667|FG001|Overall Study|Withdrawal by Subject|2|||
155035689|NCT00962091|559557668|FG002|Overall Study|Withdrawal by Subject|1|||
155035690|NCT00962091|559557669|FG003|Overall Study|Withdrawal by Subject|1|||
155035691|NCT00962091|559557670|FG004|Overall Study|Withdrawal by Subject|0|||
155035692|NCT00962091|559557671|FG005|Overall Study|Withdrawal by Subject|1|||
155035693|NCT00962091|559557672|FG006|Overall Study|Withdrawal by Subject|0|||
155035694|NCT00962091|559557666|FG000|Overall Study|Adverse Event|0|||
155035695|NCT00962091|559557667|FG001|Overall Study|Adverse Event|0|||
155035696|NCT00962091|559557668|FG002|Overall Study|Adverse Event|0|||
155035697|NCT00962091|559557669|FG003|Overall Study|Adverse Event|0|||
155035698|NCT00962091|559557670|FG004|Overall Study|Adverse Event|0|||
155035699|NCT00962091|559557671|FG005|Overall Study|Adverse Event|0|||
155035700|NCT00962091|559557672|FG006|Overall Study|Adverse Event|1|||
155035701|NCT02326298|559557673|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035702|NCT02326298|559557674|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035703|NCT02326298|559557675|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
155035704|NCT02326298|559557676|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035705|NCT02326298|559557677|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035706|NCT02326298|559557678|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035707|NCT02326298|559557679|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035708|NCT02326298|559557680|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035709|NCT02326298|559557681|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035710|NCT02326298|559557682|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035711|NCT02326298|559557683|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035712|NCT02326298|559557684|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035713|NCT02326298|559557685|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035714|NCT02326298|559557686|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
155035715|NCT02326298|559557673|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
155035716|NCT02326298|559557674|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035717|NCT02326298|559557675|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035718|NCT02326298|559557676|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035719|NCT02326298|559557677|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035720|NCT02326298|559557678|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035721|NCT02326298|559557679|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035722|NCT02326298|559557680|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035723|NCT02326298|559557681|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035724|NCT02326298|559557682|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155143831|NCT04965688|559959513|FG000|Overall Study|Withdrawal by Subject|2|||
155186341|NCT01397201|560122752|FG001|Overall Study|Not treated|0|||
155143832|NCT05907395|559959514|FG000|Period 1|No longer met eligibility criteria|0|||
155143833|NCT05907395|559959515|FG001|Period 1|No longer met eligibility criteria|1|||
155143834|NCT05907395|559959516|FG002|Period 1|No longer met eligibility criteria|0|||
155143835|NCT05907395|559959517|FG003|Period 1|No longer met eligibility criteria|0|||
155143836|NCT05907395|559959518|FG004|Period 1|No longer met eligibility criteria|0|||
155143837|NCT05907395|559959519|FG005|Period 1|No longer met eligibility criteria|1|||
155143838|NCT05907395|559959520|FG006|Period 1|No longer met eligibility criteria|1|||
155143839|NCT05907395|559959521|FG007|Period 1|No longer met eligibility criteria|0|||
155143840|NCT05907395|559959522|FG008|Period 1|No longer met eligibility criteria|0|||
155143841|NCT05907395|559959523|FG009|Period 1|No longer met eligibility criteria|0|||
155143842|NCT05907395|559959524|FG010|Period 1|No longer met eligibility criteria|0|||
155143843|NCT05907395|559959525|FG011|Period 1|No longer met eligibility criteria|0|||
155143844|NCT05907395|559959514|FG000|Period 2|Adverse Event|0|||
155035725|NCT02326298|559557683|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035726|NCT02326298|559557684|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035727|NCT02326298|559557685|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035728|NCT02326298|559557686|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
155035729|NCT02326298|559557673|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
155035730|NCT02326298|559557674|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
155143845|NCT05907395|559959515|FG001|Period 2|Adverse Event|0|||
155186342|NCT01397201|560122753|FG002|Overall Study|Not treated|1|||
155186343|NCT01397201|560122754|FG003|Overall Study|Not treated|0|||
155186344|NCT01397201|560122755|FG004|Overall Study|Not treated|0|||
155186345|NCT01397201|560122751|FG000|Overall Study|Not yet defined|3|||
155186346|NCT01397201|560122752|FG001|Overall Study|Not yet defined|6|||
155186347|NCT01397201|560122753|FG002|Overall Study|Not yet defined|5|||
155186348|NCT01397201|560122754|FG003|Overall Study|Not yet defined|5|||
155186349|NCT01397201|560122755|FG004|Overall Study|Not yet defined|4|||
155186350|NCT01397201|560122751|FG000|Overall Study|Adverse Event|2|||
155186351|NCT01397201|560122752|FG001|Overall Study|Adverse Event|0|||
155186352|NCT01397201|560122753|FG002|Overall Study|Adverse Event|0|||
155186353|NCT01397201|560122754|FG003|Overall Study|Adverse Event|0|||
155186354|NCT01397201|560122755|FG004|Overall Study|Adverse Event|0|||
155186355|NCT00851630|560122757|FG000|Overall Study|Death|2|||
155186356|NCT00851630|560122758|FG001|Overall Study|Death|1|||
155186357|NCT00851630|560122757|FG000|Overall Study|Clinical failure|0|||
155186358|NCT00851630|560122758|FG001|Overall Study|Clinical failure|1|||
155186359|NCT00401531|560122759|FG000|Overall Study|Adverse Event|2|||
155186360|NCT00401531|560122760|FG001|Overall Study|Adverse Event|0|||
155186361|NCT00401531|560122759|FG000|Overall Study|Protocol Violation|3|||
155186362|NCT00401531|560122760|FG001|Overall Study|Protocol Violation|7|||
155186363|NCT00401531|560122759|FG000|Overall Study|Lost to Follow-up|1|||
155186364|NCT00401531|560122760|FG001|Overall Study|Lost to Follow-up|1|||
155186365|NCT00401531|560122759|FG000|Overall Study|Withdrawal by Subject|3|||
155186366|NCT00401531|560122760|FG001|Overall Study|Withdrawal by Subject|2|||
155186367|NCT01614600|560122763|FG000|Overall Study|Unacceptable fit|1|||
155186368|NCT01614600|560122763|FG000|Overall Study|Discomfort|1|||
155186369|NCT01614600|560122763|FG000|Overall Study|Unable to remove lens at the end of day|1|||
155186370|NCT01614600|560122763|FG000|Overall Study|Protocol deviation|1|||
155186371|NCT02437513|560122764|FG000|Overall Study|Withdrawal by Subject|2|||
155186372|NCT03956056|560122767|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
155186373|NCT03956056|560122767|FG000|Overall Study|Lack of Efficacy|1|||
155186374|NCT03403374|560122768|FG000|Overall Study|Lost to Follow-up|1|||
155186375|NCT01092507|560122772|FG000|Overall Study|Withdrawal by Subject|2|||
155186376|NCT01092507|560122773|FG001|Overall Study|Withdrawal by Subject|0|||
155186377|NCT04629508|560122776|FG000|Overall Study|Adverse Event|1|||
155186378|NCT04629508|560122776|FG000|Overall Study|Death|2|||
155035731|NCT02326298|559557675|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035732|NCT02326298|559557676|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035733|NCT02326298|559557677|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035734|NCT02326298|559557678|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035735|NCT02326298|559557679|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035736|NCT02326298|559557680|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035737|NCT02326298|559557681|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035738|NCT02326298|559557682|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035739|NCT02326298|559557683|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035740|NCT02326298|559557684|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035741|NCT02326298|559557685|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035742|NCT02326298|559557686|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
155035743|NCT02326298|559557673|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
155035744|NCT02326298|559557674|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
155035745|NCT02326298|559557675|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035746|NCT02326298|559557676|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155186379|NCT04629508|560122776|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
155186380|NCT04073368|560122777|FG000|Overall Study|Adverse Event|2|||
155186381|NCT04073368|560122778|FG001|Overall Study|Adverse Event|0|||
155035747|NCT02326298|559557677|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155186382|NCT04073368|560122779|FG002|Overall Study|Adverse Event|1|||
155186383|NCT04073368|560122780|FG003|Overall Study|Adverse Event|1|||
155186384|NCT04073368|560122777|FG000|Overall Study|Withdrawal by Subject|2|||
155186385|NCT04073368|560122778|FG001|Overall Study|Withdrawal by Subject|2|||
155035748|NCT02326298|559557678|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155186386|NCT04073368|560122779|FG002|Overall Study|Withdrawal by Subject|1|||
155186387|NCT04073368|560122780|FG003|Overall Study|Withdrawal by Subject|1|||
155186388|NCT04073368|560122777|FG000|Overall Study|Lost to Follow-up|1|||
155186389|NCT04073368|560122778|FG001|Overall Study|Lost to Follow-up|1|||
155186390|NCT04073368|560122779|FG002|Overall Study|Lost to Follow-up|1|||
155186391|NCT04073368|560122780|FG003|Overall Study|Lost to Follow-up|0|||
155186392|NCT04073368|560122777|FG000|Overall Study|Protocol Violation|0|||
155186393|NCT04073368|560122778|FG001|Overall Study|Protocol Violation|1|||
155186394|NCT04073368|560122779|FG002|Overall Study|Protocol Violation|0|||
155186395|NCT04073368|560122780|FG003|Overall Study|Protocol Violation|0|||
155035749|NCT02326298|559557679|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155186396|NCT04073368|560122777|FG000|Overall Study|Subject noncompliance|7|||
155186397|NCT04073368|560122778|FG001|Overall Study|Subject noncompliance|4|||
155143846|NCT05907395|559959516|FG002|Period 2|Adverse Event|0|||
155143847|NCT05907395|559959517|FG003|Period 2|Adverse Event|1|||
155143848|NCT05907395|559959518|FG004|Period 2|Adverse Event|0|||
155143849|NCT05907395|559959519|FG005|Period 2|Adverse Event|0|||
155143850|NCT05907395|559959520|FG006|Period 2|Adverse Event|0|||
155143851|NCT05907395|559959521|FG007|Period 2|Adverse Event|1|||
155143852|NCT05907395|559959522|FG008|Period 2|Adverse Event|0|||
155143853|NCT05907395|559959523|FG009|Period 2|Adverse Event|0|||
155143854|NCT05907395|559959524|FG010|Period 2|Adverse Event|0|||
155143855|NCT05907395|559959525|FG011|Period 2|Adverse Event|0|||
155143856|NCT05907395|559959514|FG000|Period 2|Personal reason|0|||
155143857|NCT05907395|559959515|FG001|Period 2|Personal reason|0|||
155143858|NCT05907395|559959516|FG002|Period 2|Personal reason|0|||
155143859|NCT05907395|559959517|FG003|Period 2|Personal reason|0|||
155143860|NCT05907395|559959518|FG004|Period 2|Personal reason|0|||
155143861|NCT05907395|559959519|FG005|Period 2|Personal reason|0|||
155143862|NCT05907395|559959520|FG006|Period 2|Personal reason|0|||
155143863|NCT05907395|559959521|FG007|Period 2|Personal reason|0|||
155143864|NCT05907395|559959522|FG008|Period 2|Personal reason|0|||
155143865|NCT05907395|559959523|FG009|Period 2|Personal reason|1|||
155143866|NCT05907395|559959524|FG010|Period 2|Personal reason|0|||
155143867|NCT05907395|559959525|FG011|Period 2|Personal reason|0|||
155143868|NCT05907395|559959514|FG000|Period 3|Adverse Event|0|||
155143869|NCT05907395|559959515|FG001|Period 3|Adverse Event|0|||
155143870|NCT05907395|559959516|FG002|Period 3|Adverse Event|0|||
155143871|NCT05907395|559959517|FG003|Period 3|Adverse Event|0|||
155143872|NCT05907395|559959518|FG004|Period 3|Adverse Event|1|||
155143873|NCT05907395|559959519|FG005|Period 3|Adverse Event|0|||
155143874|NCT05907395|559959520|FG006|Period 3|Adverse Event|0|||
155143875|NCT05907395|559959521|FG007|Period 3|Adverse Event|0|||
155143876|NCT05907395|559959522|FG008|Period 3|Adverse Event|0|||
155143877|NCT05907395|559959523|FG009|Period 3|Adverse Event|0|||
155143878|NCT05907395|559959524|FG010|Period 3|Adverse Event|0|||
155143879|NCT05907395|559959525|FG011|Period 3|Adverse Event|0|||
155143880|NCT02701283|559959526|FG000|Overall Study|Death|25|||
155143881|NCT02701283|559959527|FG001|Overall Study|Death|29|||
155143882|NCT02701283|559959528|FG002|Overall Study|Death|19|||
155143883|NCT02701283|559959526|FG000|Overall Study|Lost to Follow-up|3|||
155143884|NCT02701283|559959527|FG001|Overall Study|Lost to Follow-up|8|||
155143885|NCT02701283|559959528|FG002|Overall Study|Lost to Follow-up|1|||
155143886|NCT02701283|559959526|FG000|Overall Study|Withdrawal by Subject|12|||
155143887|NCT02701283|559959527|FG001|Overall Study|Withdrawal by Subject|41|||
155143888|NCT02701283|559959528|FG002|Overall Study|Withdrawal by Subject|1|||
155143889|NCT02701283|559959526|FG000|Overall Study|Missed 2-year visit|22|||
155143890|NCT02701283|559959527|FG001|Overall Study|Missed 2-year visit|27|||
155143891|NCT02701283|559959528|FG002|Overall Study|Missed 2-year visit|0|||
155143892|NCT02701283|559959526|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
155143893|NCT02701283|559959527|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
155143894|NCT02701283|559959528|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
155143895|NCT04544956|559959529|FG000|Overall Study|Withdrawal by Subject|1|||
155143896|NCT04266795|559959530|FG000|Overall Study|Adverse Event|10|||
155143897|NCT04266795|559959531|FG001|Overall Study|Adverse Event|19|||
155143898|NCT04266795|559959530|FG000|Overall Study|Death|7|||
155143899|NCT04266795|559959531|FG001|Overall Study|Death|8|||
155143900|NCT04266795|559959530|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
155143901|NCT04266795|559959531|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
155143902|NCT04266795|559959530|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
155143903|NCT04266795|559959531|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
155143904|NCT04266795|559959530|FG000|Overall Study|Progressive Disease|12|||
155143905|NCT04266795|559959531|FG001|Overall Study|Progressive Disease|9|||
155143906|NCT04266795|559959530|FG000|Overall Study|Withdrawal by Patient|5|||
155143907|NCT04266795|559959531|FG001|Overall Study|Withdrawal by Patient|6|||
155143908|NCT04266795|559959530|FG000|Overall Study|Disease Relapse|3|||
155143909|NCT04266795|559959531|FG001|Overall Study|Disease Relapse|6|||
155143910|NCT04266795|559959530|FG000|Overall Study|Reason not Specified|12|||
155143911|NCT04266795|559959531|FG001|Overall Study|Reason not Specified|10|||
155143912|NCT04266795|559959530|FG000|Overall Study|Participants Ongoing on Treatment|25|||
155143913|NCT04266795|559959531|FG001|Overall Study|Participants Ongoing on Treatment|23|||
155143914|NCT03043872|559959532|FG000|Overall Study|Withdrawal by Subject|6|||
155143915|NCT03043872|559959533|FG001|Overall Study|Withdrawal by Subject|6|||
155143916|NCT03043872|559959534|FG002|Overall Study|Withdrawal by Subject|15|||
155143917|NCT03043872|559959532|FG000|Overall Study|Lost to Follow-up|2|||
155143918|NCT03043872|559959533|FG001|Overall Study|Lost to Follow-up|1|||
155143919|NCT03043872|559959534|FG002|Overall Study|Lost to Follow-up|1|||
155143920|NCT03043872|559959532|FG000|Overall Study|Death|270|||
155143921|NCT03043872|559959533|FG001|Overall Study|Death|269|||
155143922|NCT03043872|559959534|FG002|Overall Study|Death|296|||
155143923|NCT03868943|559959535|FG000|Overall Study|Adverse Event|1|||
155186398|NCT04073368|560122779|FG002|Overall Study|Subject noncompliance|0|||
155186399|NCT04073368|560122780|FG003|Overall Study|Subject noncompliance|0|||
155186400|NCT00736879|560122783|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
155186401|NCT00736879|560122784|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
155186402|NCT00736879|560122785|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
155186403|NCT00736879|560122786|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
155186404|NCT00736879|560122783|FG000|Double Blind Treatment Period|Adverse Event|0|||
155186405|NCT00736879|560122784|FG001|Double Blind Treatment Period|Adverse Event|1|||
155186406|NCT00736879|560122785|FG002|Double Blind Treatment Period|Adverse Event|1|||
155186407|NCT00736879|560122786|FG003|Double Blind Treatment Period|Adverse Event|0|||
155186408|NCT00736879|560122783|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
155186409|NCT00736879|560122784|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
155186410|NCT00736879|560122785|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
155186411|NCT00736879|560122786|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
155186412|NCT00736879|560122783|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
155186413|NCT00736879|560122784|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
155186414|NCT00736879|560122785|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
155186415|NCT00736879|560122786|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
155186416|NCT00736879|560122783|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
155186417|NCT00736879|560122784|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
155186418|NCT00736879|560122785|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
155186419|NCT00736879|560122786|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
155186420|NCT00736879|560122783|FG000|Double Blind Treatment Period|No longer met criteria|0|||
155186421|NCT00736879|560122784|FG001|Double Blind Treatment Period|No longer met criteria|1|||
155186422|NCT00736879|560122785|FG002|Double Blind Treatment Period|No longer met criteria|0|||
155186423|NCT00736879|560122786|FG003|Double Blind Treatment Period|No longer met criteria|0|||
155186424|NCT00736879|560122783|FG000|Double Blind Treatment Period|non-specified|0|||
155186425|NCT00736879|560122784|FG001|Double Blind Treatment Period|non-specified|1|||
155186426|NCT00736879|560122785|FG002|Double Blind Treatment Period|non-specified|0|||
155035750|NCT02326298|559557680|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035751|NCT02326298|559557681|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155186427|NCT00736879|560122786|FG003|Double Blind Treatment Period|non-specified|0|||
155186428|NCT00736879|560122783|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
155186429|NCT00736879|560122784|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
155186430|NCT00736879|560122785|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
155186431|NCT00736879|560122786|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
155186432|NCT00736879|560122783|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
155186433|NCT00736879|560122784|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
155186434|NCT00736879|560122785|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
155186435|NCT00736879|560122786|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
155186436|NCT00735254|560122787|FG000|Overall Study|Protocol Violation|1|||
155035752|NCT02326298|559557682|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035753|NCT02326298|559557683|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035754|NCT02326298|559557684|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035755|NCT02326298|559557685|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035756|NCT02326298|559557686|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
155035757|NCT02326298|559557673|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035758|NCT02326298|559557674|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035759|NCT02326298|559557675|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
155035760|NCT02326298|559557676|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035761|NCT02326298|559557677|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035762|NCT02326298|559557678|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035763|NCT02326298|559557679|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035764|NCT02326298|559557680|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035765|NCT02326298|559557681|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035766|NCT02326298|559557682|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035767|NCT02326298|559557683|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035768|NCT02326298|559557684|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035769|NCT02326298|559557685|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155035770|NCT02326298|559557686|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
155186437|NCT00735254|560122788|FG001|Overall Study|Protocol Violation|1|||
155186438|NCT00735254|560122789|FG002|Overall Study|Protocol Violation|1|||
155186439|NCT00735254|560122790|FG003|Overall Study|Protocol Violation|0|||
155186440|NCT01031381|560122791|FG000|Overall Study|Physician Decision|3|||
155186441|NCT01031381|560122791|FG000|Overall Study|Withdrawal by Subject|6|||
155186442|NCT00147251|560122792|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
155035771|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035772|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035773|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035774|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035775|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035776|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155035777|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
155035778|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155035779|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155035780|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155035781|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035782|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035783|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035784|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155035785|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035786|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035787|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035788|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035789|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035790|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
155035791|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
155035792|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035793|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
155035794|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035795|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035796|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035797|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035798|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
155035799|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035800|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035801|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035802|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035803|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035804|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
155035805|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035806|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035807|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035808|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035809|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035810|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035811|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035812|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
155035813|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035814|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035815|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035816|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035817|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035818|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035819|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
155035820|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035821|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035822|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035823|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035824|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035825|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035826|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
155035827|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035828|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035829|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155143924|NCT04551066|559959536|FG000|Overall Study|Death|5|||
155143925|NCT04551066|559959537|FG001|Overall Study|Death|3|||
155035830|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035831|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035832|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035833|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035834|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
155035835|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035836|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035837|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035838|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035839|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035840|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
155035841|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035842|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035843|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035844|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035845|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035846|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035847|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
155035848|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
155035849|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035850|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035851|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035852|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035853|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035854|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155035855|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035856|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035857|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035858|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035859|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035860|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035861|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035862|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155143926|NCT04551066|559959536|FG000|Overall Study|Lost to Follow-up|1|||
155143927|NCT04551066|559959537|FG001|Overall Study|Lost to Follow-up|0|||
155143928|NCT04551066|559959536|FG000|Overall Study|Sponsor Decision|104|||
155143929|NCT04551066|559959537|FG001|Overall Study|Sponsor Decision|117|||
155143930|NCT04551066|559959536|FG000|Overall Study|Withdrawal by Subject|8|||
155143931|NCT04551066|559959537|FG001|Overall Study|Withdrawal by Subject|2|||
155143932|NCT04551066|559959536|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
155143933|NCT04551066|559959537|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
155143934|NCT04551066|559959536|FG000|Overall Study|Adverse Event|2|||
155143935|NCT04551066|559959537|FG001|Overall Study|Adverse Event|0|||
155143936|NCT04551066|559959536|FG000|Overall Study|Physician Decision|2|||
155143937|NCT04551066|559959537|FG001|Overall Study|Physician Decision|0|||
155143938|NCT04551066|559959536|FG000|Overall Study|Protocol Violation|1|||
155143939|NCT04551066|559959537|FG001|Overall Study|Protocol Violation|0|||
155143940|NCT04551066|559959536|FG000|Overall Study|Lack of Efficacy|0|||
155143941|NCT04551066|559959537|FG001|Overall Study|Lack of Efficacy|1|||
155143942|NCT04551066|559959536|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
155143943|NCT04551066|559959537|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
155143944|NCT00369577|559959538|FG000|Overall Study|Withdrawal by Subject|0|||
155143945|NCT00369577|559959539|FG001|Overall Study|Withdrawal by Subject|0|||
155143946|NCT00369577|559959540|FG002|Overall Study|Withdrawal by Subject|1|||
155143947|NCT03915470|559959543|FG000|Overall Study|Death|3|||
155143948|NCT03915470|559959544|FG001|Overall Study|Death|1|||
155143949|NCT03915470|559959543|FG000|Overall Study|Adverse Event|1|||
155143950|NCT03915470|559959544|FG001|Overall Study|Adverse Event|0|||
155143951|NCT03915470|559959543|FG000|Overall Study|Physician Decision|1|||
155143952|NCT03915470|559959544|FG001|Overall Study|Physician Decision|0|||
155143953|NCT03915470|559959543|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
155143954|NCT03915470|559959544|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
155143955|NCT03160898|559959545|FG000|Overall Study|Adverse Event|4|||
155143956|NCT03160898|559959546|FG001|Overall Study|Adverse Event|8|||
155143957|NCT03160898|559959547|FG002|Overall Study|Adverse Event|7|||
155143958|NCT03160898|559959548|FG003|Overall Study|Adverse Event|10|||
155143959|NCT03160898|559959545|FG000|Overall Study|Death|1|||
155143960|NCT03160898|559959546|FG001|Overall Study|Death|0|||
155143961|NCT03160898|559959547|FG002|Overall Study|Death|0|||
155035863|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035864|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035865|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035866|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035867|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035868|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155035869|NCT02326298|559557673|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035870|NCT02326298|559557674|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035871|NCT02326298|559557675|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035872|NCT02326298|559557676|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035873|NCT02326298|559557677|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035874|NCT02326298|559557678|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
155035875|NCT02326298|559557679|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035876|NCT02326298|559557680|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035877|NCT02326298|559557681|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035878|NCT02326298|559557682|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035879|NCT02326298|559557683|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035880|NCT02326298|559557684|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035881|NCT02326298|559557685|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035882|NCT02326298|559557686|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
155035883|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
155035884|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
155035885|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
155035886|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
155035887|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
155035888|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
155035889|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
155035890|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
155035891|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
155035892|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
155035893|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
155035894|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
155035895|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
155035896|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
155035897|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035898|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035899|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035900|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035901|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035902|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035903|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035904|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035905|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035906|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035907|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035908|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
155035909|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
155035910|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
155035911|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035912|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035913|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035914|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035915|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035916|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035917|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035918|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035919|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035920|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035921|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155035922|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155035923|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155035924|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155143962|NCT03160898|559959548|FG003|Overall Study|Death|1|||
155143963|NCT03160898|559959545|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
155035925|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035926|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035927|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035928|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035929|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035930|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035931|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035932|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035933|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035934|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035935|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035936|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035937|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
155035938|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
155035939|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035940|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035941|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035942|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035943|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155186443|NCT00147251|560122793|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
155186444|NCT06400979|560122794|FG000|Overall Study|Lost to Follow-up|29|||
155186445|NCT06400979|560122794|FG000|Overall Study|Withdrawal by Subject|1|||
155035944|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035945|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035946|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035947|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035948|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035949|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155035950|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
155035951|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
155035952|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155035953|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035954|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035955|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035956|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035957|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035958|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035959|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035960|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035961|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035962|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035963|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
155035964|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
155035965|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
155035966|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
155035967|NCT02326298|559557673|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035968|NCT02326298|559557674|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035969|NCT02326298|559557675|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035970|NCT02326298|559557676|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035971|NCT02326298|559557677|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035972|NCT02326298|559557678|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035973|NCT02326298|559557679|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035974|NCT02326298|559557680|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035975|NCT02326298|559557681|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035976|NCT02326298|559557682|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035977|NCT02326298|559557683|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155035978|NCT02326298|559557684|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
155035979|NCT02326298|559557685|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
155035980|NCT02326298|559557686|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
155035981|NCT00073983|559557689|FG000|Overall Study|not evaluable|1|||
155035982|NCT03976323|559557692|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
155035983|NCT03976323|559557693|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155035984|NCT03976323|559557694|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
155035985|NCT03976323|559557692|FG000|Induction Phase|Death|80|||
155035986|NCT03976323|559557693|FG001|Induction Phase|Death|0|||
155035987|NCT03976323|559557694|FG002|Induction Phase|Death|0|||
155035988|NCT03976323|559557692|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
155035989|NCT03976323|559557693|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
155035990|NCT03976323|559557694|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
155035991|NCT03976323|559557692|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155035992|NCT03976323|559557693|FG001|Maintenance Phase|Withdrawal by Subject|9|||
155035993|NCT03976323|559557694|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155035994|NCT03976323|559557692|FG000|Maintenance Phase|Physician Decision|0|||
155035995|NCT03976323|559557693|FG001|Maintenance Phase|Physician Decision|0|||
155035996|NCT03976323|559557694|FG002|Maintenance Phase|Physician Decision|1|||
155035997|NCT03976323|559557692|FG000|Maintenance Phase|Death|0|||
155035998|NCT03976323|559557693|FG001|Maintenance Phase|Death|228|||
155035999|NCT03976323|559557694|FG002|Maintenance Phase|Death|234|||
155036000|NCT03800836|559557695|FG000|Overall Study|Other|2|||
155036001|NCT03800836|559557696|FG001|Overall Study|Other|1|||
155036002|NCT03800836|559557697|FG002|Overall Study|Other|0|||
155036003|NCT03800836|559557698|FG003|Overall Study|Other|2|||
155036004|NCT03800836|559557699|FG004|Overall Study|Other|0|||
155036005|NCT03800836|559557700|FG005|Overall Study|Other|1|||
155036006|NCT03800836|559557695|FG000|Overall Study|Lost to Follow-up|2|||
155036007|NCT03800836|559557696|FG001|Overall Study|Lost to Follow-up|0|||
155036008|NCT03800836|559557697|FG002|Overall Study|Lost to Follow-up|1|||
155036009|NCT03800836|559557698|FG003|Overall Study|Lost to Follow-up|1|||
155036010|NCT03800836|559557699|FG004|Overall Study|Lost to Follow-up|3|||
155036011|NCT03800836|559557700|FG005|Overall Study|Lost to Follow-up|0|||
155036012|NCT03800836|559557695|FG000|Overall Study|Withdrawal by Subject|1|||
155036013|NCT03800836|559557696|FG001|Overall Study|Withdrawal by Subject|0|||
155036014|NCT03800836|559557697|FG002|Overall Study|Withdrawal by Subject|0|||
155036015|NCT03800836|559557698|FG003|Overall Study|Withdrawal by Subject|0|||
155036016|NCT03800836|559557699|FG004|Overall Study|Withdrawal by Subject|0|||
155036017|NCT03800836|559557700|FG005|Overall Study|Withdrawal by Subject|0|||
155036018|NCT03800836|559557695|FG000|Overall Study|Physician Decision|31|||
155036019|NCT03800836|559557696|FG001|Overall Study|Physician Decision|3|||
155036020|NCT03800836|559557697|FG002|Overall Study|Physician Decision|6|||
155036021|NCT03800836|559557698|FG003|Overall Study|Physician Decision|4|||
155036022|NCT03800836|559557699|FG004|Overall Study|Physician Decision|4|||
155036023|NCT03800836|559557700|FG005|Overall Study|Physician Decision|5|||
155036024|NCT03800836|559557695|FG000|Overall Study|Death|34|||
155036025|NCT03800836|559557696|FG001|Overall Study|Death|16|||
155036026|NCT03800836|559557697|FG002|Overall Study|Death|5|||
155036027|NCT03800836|559557698|FG003|Overall Study|Death|5|||
155036028|NCT03800836|559557699|FG004|Overall Study|Death|10|||
155036029|NCT03800836|559557700|FG005|Overall Study|Death|0|||
155036030|NCT03800836|559557695|FG000|Overall Study|Symptomatic Deterioration|1|||
155036031|NCT03800836|559557696|FG001|Overall Study|Symptomatic Deterioration|0|||
155036032|NCT03800836|559557697|FG002|Overall Study|Symptomatic Deterioration|1|||
155036033|NCT03800836|559557698|FG003|Overall Study|Symptomatic Deterioration|0|||
155036034|NCT03800836|559557699|FG004|Overall Study|Symptomatic Deterioration|0|||
155036035|NCT03800836|559557700|FG005|Overall Study|Symptomatic Deterioration|0|||
155036036|NCT00994214|559559063|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
155036037|NCT00994214|559559064|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
155036038|NCT00994214|559559065|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
155036039|NCT00994214|559559066|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
155036040|NCT00994214|559559063|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
155036041|NCT00994214|559559064|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
155036042|NCT00994214|559559065|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
155036043|NCT00994214|559559066|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
155036044|NCT00994214|559559063|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
155036045|NCT00994214|559559064|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
155036046|NCT00994214|559559065|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
155036047|NCT00994214|559559066|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
155036048|NCT00994214|559559063|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
155036049|NCT00994214|559559064|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
155036050|NCT00994214|559559065|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
155036051|NCT00994214|559559066|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
155036052|NCT00994214|559559063|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
155036053|NCT00994214|559559064|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
155036054|NCT00994214|559559065|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
155036055|NCT00994214|559559066|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
155186446|NCT02694523|560122795|FG000|Part A|Adverse Event|7|||
155036056|NCT00994214|559559063|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
155036057|NCT00994214|559559064|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
155036058|NCT00994214|559559065|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
155036059|NCT00994214|559559066|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
155036060|NCT03246061|559559067|FG000|Overall Study|Still in follow-up|15|||
155036061|NCT03246061|559559068|FG001|Overall Study|Still in follow-up|21|||
155036062|NCT02864316|559559069|FG000|Overall Study|Progressive Disease|2|||
155036063|NCT02864316|559559070|FG001|Overall Study|Progressive Disease|1|||
155036064|NCT02864316|559559069|FG000|Overall Study|Adverse Event|0|||
155036065|NCT02864316|559559070|FG001|Overall Study|Adverse Event|1|||
155036066|NCT04710368|559559071|FG000|Overall Study|Withdrawal by Subject|9|||
155036067|NCT04710368|559559071|FG000|Overall Study|Lost to Follow-up|4|||
155036068|NCT04710368|559559071|FG000|Overall Study|Death|2|||
155036069|NCT04710368|559559071|FG000|Overall Study|Patient preference|11|||
155036070|NCT04710368|559559071|FG000|Overall Study|Treatment discontinuation|1|||
155036071|NCT01777139|559559077|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
155036072|NCT01777139|559559078|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
155036073|NCT01777139|559559077|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
155036074|NCT01777139|559559078|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
155036075|NCT01777139|559559077|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
155036076|NCT01777139|559559078|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
155036077|NCT01777139|559559077|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
155036078|NCT01777139|559559078|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
155036079|NCT01777139|559559077|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
155036080|NCT01777139|559559078|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
155036081|NCT01777139|559559077|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
155036082|NCT01777139|559559078|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
155036083|NCT01777139|559559077|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
155036084|NCT01777139|559559078|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
155036085|NCT01777139|559559077|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
155036086|NCT01777139|559559078|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
155036087|NCT02921750|559559079|FG000|Overall Study|Adverse Event|1|||
155036088|NCT02921750|559559080|FG001|Overall Study|Adverse Event|2|||
155036089|NCT02921750|559559079|FG000|Overall Study|Withdrawal by Subject|1|||
155036090|NCT02921750|559559080|FG001|Overall Study|Withdrawal by Subject|1|||
155036091|NCT02921750|559559079|FG000|Overall Study|Lost to Follow-up|3|||
155036092|NCT02921750|559559080|FG001|Overall Study|Lost to Follow-up|3|||
155036093|NCT02921750|559559079|FG000|Overall Study|Wound healed|3|||
155036094|NCT02921750|559559080|FG001|Overall Study|Wound healed|3|||
155036095|NCT02921750|559559079|FG000|Overall Study|Serious Adverse Event|1|||
155036096|NCT02921750|559559080|FG001|Overall Study|Serious Adverse Event|2|||
155036097|NCT02638129|559559081|FG000|Overall Study|Study terminated|28|||
155036098|NCT02638129|559559082|FG001|Overall Study|Study terminated|30|||
155036099|NCT02607280|559559084|FG000|Overall Study|Adverse Event|4|||
155036100|NCT02607280|559559085|FG001|Overall Study|Adverse Event|0|||
155036101|NCT02607280|559559084|FG000|Overall Study|Decrease in CrCl <15|0|||
155036102|NCT02607280|559559085|FG001|Overall Study|Decrease in CrCl <15|1|||
155036103|NCT02368210|559559086|FG000|Overall Study|Withdrawal by Subject|1|||
155036104|NCT02368210|559559087|FG001|Overall Study|Withdrawal by Subject|0|||
155036105|NCT02368210|559559086|FG000|Overall Study|Adverse Event|0|||
155036106|NCT02368210|559559087|FG001|Overall Study|Adverse Event|1|||
155036107|NCT02539134|559559088|FG000|Overall Study|Lost to Follow-up|1|||
155036108|NCT02539134|559559089|FG001|Overall Study|Lost to Follow-up|0|||
155036109|NCT02539134|559559090|FG002|Overall Study|Lost to Follow-up|0|||
155036110|NCT02539134|559559091|FG003|Overall Study|Lost to Follow-up|0|||
155036111|NCT02539134|559559092|FG004|Overall Study|Lost to Follow-up|0|||
155036112|NCT02539134|559559093|FG005|Overall Study|Lost to Follow-up|0|||
155036113|NCT00616603|559559095|FG000|Overall Study|Physician Decision|2|||
155036114|NCT00616603|559559096|FG001|Overall Study|Physician Decision|0|||
155036115|NCT00616603|559559097|FG002|Overall Study|Physician Decision|2|||
155036116|NCT00367484|559559102|FG000|Overall Study|Adverse Event|7|||
155036117|NCT00367484|559559102|FG000|Overall Study|Withdrew informed consent|5|||
155036118|NCT00367484|559559102|FG000|Overall Study|Travel to USA|1|||
155186447|NCT02694523|560122796|FG001|Part A|Adverse Event|3|||
155186448|NCT02694523|560122797|FG002|Part A|Adverse Event|0|||
155186449|NCT02694523|560122798|FG003|Part A|Adverse Event|0|||
155186450|NCT02694523|560122799|FG004|Part A|Adverse Event|0|||
155186451|NCT02694523|560122800|FG005|Part A|Adverse Event|0|||
155186452|NCT02694523|560122801|FG006|Part A|Adverse Event|0|||
155186453|NCT02694523|560122795|FG000|Part A|Protocol Violation|1|||
155186454|NCT02694523|560122796|FG001|Part A|Protocol Violation|0|||
155186455|NCT02694523|560122797|FG002|Part A|Protocol Violation|0|||
155186456|NCT02694523|560122798|FG003|Part A|Protocol Violation|0|||
155186457|NCT02694523|560122799|FG004|Part A|Protocol Violation|0|||
155186458|NCT02694523|560122800|FG005|Part A|Protocol Violation|0|||
155186459|NCT02694523|560122801|FG006|Part A|Protocol Violation|0|||
155186460|NCT02694523|560122795|FG000|Part A|Lost to Follow-up|1|||
155186461|NCT02694523|560122796|FG001|Part A|Lost to Follow-up|2|||
155036119|NCT00367484|559559102|FG000|Overall Study|Lost to Follow-up|1|||
155036120|NCT00367484|559559102|FG000|Overall Study|Protocol Violation|1|||
155036121|NCT00367484|559559102|FG000|Overall Study|The choice of the patient|1|||
155036122|NCT00367484|559559102|FG000|Overall Study|Lack of Efficacy|1|||
155036123|NCT02604550|559559103|FG000|Overall Study|Lost to Follow-up|7|||
155036124|NCT02604550|559559104|FG001|Overall Study|Lost to Follow-up|6|||
155036125|NCT02604550|559559103|FG000|Overall Study|Withdrawal by Subject|0|||
155036126|NCT02604550|559559104|FG001|Overall Study|Withdrawal by Subject|1|||
155036127|NCT02604550|559559103|FG000|Overall Study|Incomplete data using paper journal|18|||
155036128|NCT02604550|559559104|FG001|Overall Study|Incomplete data using paper journal|19|||
155036129|NCT00329641|559559105|FG000|Overall Study|Did not start treatment|1|||
155036130|NCT00329641|559559105|FG000|Overall Study|Not eligible|1|||
155036131|NCT00329641|559559105|FG000|Overall Study|Adverse Event|3|||
155036132|NCT00329641|559559105|FG000|Overall Study|Other reason, not protocol specified|1|||
155036133|NCT02470403|559559106|FG000|Overall Study|Adverse Event|1|||
155036134|NCT02470403|559559107|FG001|Overall Study|Adverse Event|0|||
155036135|NCT02470403|559559108|FG002|Overall Study|Adverse Event|0|||
155036136|NCT02470403|559559109|FG003|Overall Study|Adverse Event|0|||
155036137|NCT02470403|559559110|FG004|Overall Study|Adverse Event|0|||
155036138|NCT02470403|559559106|FG000|Overall Study|Lost to Follow-up|0|||
155036139|NCT02470403|559559107|FG001|Overall Study|Lost to Follow-up|1|||
155036140|NCT02470403|559559108|FG002|Overall Study|Lost to Follow-up|0|||
155036141|NCT02470403|559559109|FG003|Overall Study|Lost to Follow-up|0|||
155036142|NCT02470403|559559110|FG004|Overall Study|Lost to Follow-up|0|||
155036143|NCT02470403|559559106|FG000|Overall Study|Subject/guardian decision|1|||
155036144|NCT02470403|559559107|FG001|Overall Study|Subject/guardian decision|0|||
155036145|NCT02470403|559559108|FG002|Overall Study|Subject/guardian decision|0|||
155036146|NCT02470403|559559109|FG003|Overall Study|Subject/guardian decision|4|||
155036147|NCT02470403|559559110|FG004|Overall Study|Subject/guardian decision|0|||
155036148|NCT02631070|559559115|FG000|Overall Study|Withdrawal by Subject|35|||
155036149|NCT02631070|559559116|FG001|Overall Study|Withdrawal by Subject|13|||
155036150|NCT02631070|559559115|FG000|Overall Study|Death|45|||
155036151|NCT02631070|559559116|FG001|Overall Study|Death|24|||
155036152|NCT02631070|559559115|FG000|Overall Study|Lost to Follow-up|5|||
155036153|NCT02631070|559559116|FG001|Overall Study|Lost to Follow-up|1|||
155036154|NCT02631070|559559115|FG000|Overall Study|Transition to rollover protocol|52|||
155036155|NCT02631070|559559116|FG001|Overall Study|Transition to rollover protocol|21|||
155036156|NCT02631070|559559115|FG000|Overall Study|Other reasons|12|||
155036157|NCT02631070|559559116|FG001|Overall Study|Other reasons|5|||
155036158|NCT00987402|559559122|FG000|Overall Study|Insufficient data entry|86|||
155036159|NCT00987402|559559123|FG001|Overall Study|Insufficient data entry|98|||
155036160|NCT01362517|559559124|FG000|Overall Study|Protocol Violation|1|||
155036161|NCT01362517|559559124|FG000|Overall Study|Lost to Follow-up|1|||
155036162|NCT02273908|559559127|FG000|Overall Study|Adverse Event|16|||
155186462|NCT02694523|560122797|FG002|Part A|Lost to Follow-up|0|||
155186463|NCT02694523|560122798|FG003|Part A|Lost to Follow-up|0|||
155186464|NCT02694523|560122799|FG004|Part A|Lost to Follow-up|0|||
155186465|NCT02694523|560122800|FG005|Part A|Lost to Follow-up|0|||
155186466|NCT02694523|560122801|FG006|Part A|Lost to Follow-up|0|||
155186467|NCT02694523|560122795|FG000|Part A|Withdrawal by Subject|3|||
155036163|NCT02273908|559559128|FG001|Overall Study|Adverse Event|0|||
155036164|NCT02273908|559559127|FG000|Overall Study|Lost to Follow-up|10|||
155036165|NCT02273908|559559128|FG001|Overall Study|Lost to Follow-up|1|||
155036166|NCT02273908|559559127|FG000|Overall Study|Did not meet entrance criteria|3|||
155036167|NCT02273908|559559128|FG001|Overall Study|Did not meet entrance criteria|2|||
155036168|NCT02273908|559559127|FG000|Overall Study|Withdrawal by Subject|4|||
155036169|NCT02273908|559559128|FG001|Overall Study|Withdrawal by Subject|2|||
155036170|NCT00369161|559559129|FG000|Overall Study|Adverse Event|15|||
155036171|NCT00369161|559559130|FG001|Overall Study|Adverse Event|13|||
155036172|NCT00369161|559559129|FG000|Overall Study|Abnormal laboratory value|0|||
155036173|NCT00369161|559559130|FG001|Overall Study|Abnormal laboratory value|1|||
155186468|NCT02694523|560122796|FG001|Part A|Withdrawal by Subject|1|||
155186469|NCT02694523|560122797|FG002|Part A|Withdrawal by Subject|0|||
155186470|NCT02694523|560122798|FG003|Part A|Withdrawal by Subject|0|||
155036174|NCT00369161|559559129|FG000|Overall Study|Lack of Efficacy|3|||
155036175|NCT00369161|559559130|FG001|Overall Study|Lack of Efficacy|1|||
155036176|NCT00369161|559559129|FG000|Overall Study|Protocol Violation|0|||
155036177|NCT00369161|559559130|FG001|Overall Study|Protocol Violation|2|||
155036178|NCT00369161|559559129|FG000|Overall Study|Withdrawal by Subject|2|||
155036179|NCT00369161|559559130|FG001|Overall Study|Withdrawal by Subject|3|||
155036180|NCT00369161|559559129|FG000|Overall Study|Death|1|||
155036181|NCT00369161|559559130|FG001|Overall Study|Death|2|||
155036182|NCT00369161|559559129|FG000|Overall Study|Graft loss|4|||
155186471|NCT02694523|560122799|FG004|Part A|Withdrawal by Subject|0|||
155186472|NCT02694523|560122800|FG005|Part A|Withdrawal by Subject|0|||
155036183|NCT00369161|559559130|FG001|Overall Study|Graft loss|0|||
155036184|NCT00369161|559559129|FG000|Overall Study|Administrative Problem|2|||
155036185|NCT00369161|559559130|FG001|Overall Study|Administrative Problem|2|||
155186473|NCT02694523|560122801|FG006|Part A|Withdrawal by Subject|0|||
155036186|NCT03008278|559559135|FG000|Overall Study|Progressive Disease|0|||
155036187|NCT03008278|559559136|FG001|Overall Study|Progressive Disease|0|||
155036188|NCT03008278|559559137|FG002|Overall Study|Progressive Disease|32|||
155036189|NCT03008278|559559135|FG000|Overall Study|Adverse Event|0|||
155036190|NCT03008278|559559136|FG001|Overall Study|Adverse Event|0|||
155036191|NCT03008278|559559137|FG002|Overall Study|Adverse Event|4|||
155036192|NCT03008278|559559135|FG000|Overall Study|Withdrawal by Subject|0|||
155036193|NCT03008278|559559136|FG001|Overall Study|Withdrawal by Subject|0|||
155036194|NCT03008278|559559137|FG002|Overall Study|Withdrawal by Subject|3|||
155036195|NCT03008278|559559135|FG000|Overall Study|Physician Decision|0|||
155036196|NCT03008278|559559136|FG001|Overall Study|Physician Decision|2|||
155036197|NCT03008278|559559137|FG002|Overall Study|Physician Decision|0|||
155036198|NCT00422422|559559138|FG000|Overall Study|Lack of Efficacy|1|||
155036199|NCT00422422|559559138|FG000|Overall Study|Protocol Violation|1|||
155036200|NCT00422422|559559138|FG000|Overall Study|Withdrawal by Subject|2|||
155036201|NCT00422422|559559138|FG000|Overall Study|SAE, non-fatal|1|||
155036202|NCT00422422|559559138|FG000|Overall Study|AE, non-serious non-fatal|5|||
155036203|NCT01389258|559559139|FG000|Overall Study|Lost to Follow-up|5|||
155036204|NCT03313310|559559140|FG000|Phase 2|Lost to Follow-up|4|||
155036205|NCT03313310|559559141|FG001|Phase 2|Lost to Follow-up|0|||
155036206|NCT03313310|559559140|FG000|Phase 3|Lost to Follow-up|0|||
155036207|NCT03313310|559559141|FG001|Phase 3|Lost to Follow-up|1|||
155036208|NCT01593254|559559145|FG000|Overall Study|Disease progression|2|||
155036209|NCT01593254|559559146|FG001|Overall Study|Disease progression|7|||
155036210|NCT01593254|559559145|FG000|Overall Study|Study drug toxicity|6|||
155036211|NCT01593254|559559146|FG001|Overall Study|Study drug toxicity|20|||
155036212|NCT01593254|559559145|FG000|Overall Study|Death|3|||
155036213|NCT01593254|559559146|FG001|Overall Study|Death|3|||
155036214|NCT01593254|559559145|FG000|Overall Study|AE unrelated to study drug|0|||
155036215|NCT01593254|559559146|FG001|Overall Study|AE unrelated to study drug|1|||
155036216|NCT01593254|559559145|FG000|Overall Study|participant request to discontinue study treatment|1|||
155036217|NCT01593254|559559146|FG001|Overall Study|participant request to discontinue study treatment|3|||
155036218|NCT01593254|559559145|FG000|Overall Study|participant withdrew consent|0|||
155036219|NCT01593254|559559146|FG001|Overall Study|participant withdrew consent|9|||
155036220|NCT01593254|559559145|FG000|Overall Study|lost to follow up|1|||
155036221|NCT01593254|559559146|FG001|Overall Study|lost to follow up|6|||
155036222|NCT01593254|559559145|FG000|Overall Study|maximum clinical benefit|1|||
155036223|NCT01593254|559559146|FG001|Overall Study|maximum clinical benefit|2|||
155036224|NCT01593254|559559145|FG000|Overall Study|Poor/non compliance|1|||
155036225|NCT01593254|559559146|FG001|Overall Study|Poor/non compliance|1|||
155036226|NCT01593254|559559145|FG000|Overall Study|Pregnancy|0|||
155036227|NCT01593254|559559146|FG001|Overall Study|Pregnancy|3|||
155036228|NCT01593254|559559145|FG000|Overall Study|participant no longer meets study criteria|1|||
155036229|NCT01593254|559559146|FG001|Overall Study|participant no longer meets study criteria|1|||
155036230|NCT01593254|559559145|FG000|Overall Study|Admin reason by sponsor|7|||
155036231|NCT01593254|559559146|FG001|Overall Study|Admin reason by sponsor|3|||
155036232|NCT01593254|559559145|FG000|Overall Study|Imatinib treatment failure|2|||
155036233|NCT01593254|559559146|FG001|Overall Study|Imatinib treatment failure|0|||
155036234|NCT01593254|559559145|FG000|Overall Study|Other Reasons|61|||
155036235|NCT01593254|559559146|FG001|Overall Study|Other Reasons|115|||
155036236|NCT00501059|559559149|FG000|Overall Study|Protocol Violation|80|||
155036237|NCT00501059|559559150|FG001|Overall Study|Protocol Violation|69|||
155036238|NCT00501059|559559149|FG000|Overall Study|Death|140|||
155036239|NCT00501059|559559150|FG001|Overall Study|Death|137|||
155036240|NCT00501059|559559149|FG000|Overall Study|Other|236|||
155036241|NCT00501059|559559150|FG001|Overall Study|Other|239|||
155036242|NCT00501059|559559149|FG000|Overall Study|Missing end-of-study page|91|||
155036243|NCT00501059|559559150|FG001|Overall Study|Missing end-of-study page|92|||
155036244|NCT00501059|559559149|FG000|Overall Study|Clinical endpoint reached|110|||
155036245|NCT00501059|559559150|FG001|Overall Study|Clinical endpoint reached|123|||
155036246|NCT00501059|559559149|FG000|Overall Study|Insufficient therapeutic effect|4|||
155036247|NCT00501059|559559150|FG001|Overall Study|Insufficient therapeutic effect|5|||
155036248|NCT00501059|559559149|FG000|Overall Study|Consent withdrawn by subject|817|||
155036249|NCT00501059|559559150|FG001|Overall Study|Consent withdrawn by subject|873|||
155036250|NCT00501059|559559149|FG000|Overall Study|Non-compliant with study treatment|23|||
155186474|NCT02694523|560122795|FG000|Part A|Other|1|||
155186475|NCT02694523|560122796|FG001|Part A|Other|1|||
155036251|NCT00501059|559559150|FG001|Overall Study|Non-compliant with study treatment|16|||
155036252|NCT00501059|559559149|FG000|Overall Study|Reason not given|3|||
155036253|NCT00501059|559559150|FG001|Overall Study|Reason not given|1|||
155036254|NCT00501059|559559149|FG000|Overall Study|Adverse Event|129|||
155036255|NCT00501059|559559150|FG001|Overall Study|Adverse Event|122|||
155036256|NCT00501059|559559149|FG000|Overall Study|Lost to Follow-up|210|||
155036257|NCT00501059|559559150|FG001|Overall Study|Lost to Follow-up|198|||
155036258|NCT00501059|559559149|FG000|Overall Study|Not treated|25|||
155036259|NCT00501059|559559150|FG001|Overall Study|Not treated|17|||
155036260|NCT02124759|559559153|FG000|Overall Study|Withdrawal by Subject|3|||
155036261|NCT02124759|559559154|FG001|Overall Study|Withdrawal by Subject|1|||
155186476|NCT02694523|560122797|FG002|Part A|Other|0|||
155036262|NCT02124759|559559155|FG002|Overall Study|Withdrawal by Subject|1|||
155036263|NCT02124759|559559153|FG000|Overall Study|Screen Fail|2|||
155036264|NCT02124759|559559154|FG001|Overall Study|Screen Fail|2|||
155036265|NCT02124759|559559155|FG002|Overall Study|Screen Fail|3|||
155036266|NCT04249622|559559158|FG000|Overall Study|Withdrawal by Subject|1|||
155036267|NCT04249622|559559159|FG001|Overall Study|Withdrawal by Subject|1|||
155036268|NCT04249622|559559158|FG000|Overall Study|Alternative therapy|1|||
155036269|NCT04249622|559559159|FG001|Overall Study|Alternative therapy|0|||
155036270|NCT04249622|559559158|FG000|Overall Study|Discontinuation of pertuzumab|1|||
155036271|NCT04249622|559559159|FG001|Overall Study|Discontinuation of pertuzumab|0|||
155036272|NCT03689543|559559162|FG000|Overall Study|Adverse Event|0|||
155036273|NCT03689543|559559163|FG001|Overall Study|Adverse Event|0|||
155036274|NCT03689543|559559164|FG002|Overall Study|Adverse Event|1|||
155036275|NCT00932451|559559165|FG000|Overall Study|Withdrawal by Subject|69|||
155036276|NCT00932451|559559165|FG000|Overall Study|Lost to Follow-up|22|||
155036277|NCT00932451|559559165|FG000|Overall Study|Death|726|||
155036278|NCT00932451|559559165|FG000|Overall Study|Other reasons|5|||
155186477|NCT02694523|560122798|FG003|Part A|Other|0|||
155186478|NCT02694523|560122799|FG004|Part A|Other|0|||
155186479|NCT02694523|560122800|FG005|Part A|Other|0|||
155186480|NCT02694523|560122801|FG006|Part A|Other|0|||
155186481|NCT02694523|560122795|FG000|Part B|Adverse Event|0|||
155186482|NCT02694523|560122796|FG001|Part B|Adverse Event|0|||
155036279|NCT03191864|559559167|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
155036280|NCT03191864|559559168|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
155036281|NCT03191864|559559169|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
155036282|NCT03191864|559559170|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
155036283|NCT03191864|559559171|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
155036284|NCT03191864|559559172|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
155036285|NCT03191864|559559167|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155036286|NCT03191864|559559168|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155036287|NCT03191864|559559169|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155036288|NCT03191864|559559170|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155036289|NCT03191864|559559171|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
155036290|NCT03191864|559559172|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
155036291|NCT03191864|559559167|FG000|Baseline Symptom Assessment|Adverse Event|0|||
155036292|NCT03191864|559559168|FG001|Baseline Symptom Assessment|Adverse Event|0|||
155036293|NCT03191864|559559169|FG002|Baseline Symptom Assessment|Adverse Event|0|||
155036294|NCT03191864|559559170|FG003|Baseline Symptom Assessment|Adverse Event|0|||
155036295|NCT03191864|559559171|FG004|Baseline Symptom Assessment|Adverse Event|0|||
155036296|NCT03191864|559559172|FG005|Baseline Symptom Assessment|Adverse Event|2|||
155036297|NCT03191864|559559167|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155186483|NCT02694523|560122797|FG002|Part B|Adverse Event|7|||
155186484|NCT02694523|560122798|FG003|Part B|Adverse Event|1|||
155186485|NCT02694523|560122799|FG004|Part B|Adverse Event|1|||
155186486|NCT02694523|560122800|FG005|Part B|Adverse Event|2|||
155186487|NCT02694523|560122801|FG006|Part B|Adverse Event|0|||
155186488|NCT02694523|560122795|FG000|Part B|Protocol Violation|0|||
155186489|NCT02694523|560122796|FG001|Part B|Protocol Violation|0|||
155186490|NCT02694523|560122797|FG002|Part B|Protocol Violation|1|||
155186491|NCT02694523|560122798|FG003|Part B|Protocol Violation|0|||
155186492|NCT02694523|560122799|FG004|Part B|Protocol Violation|0|||
155186493|NCT02694523|560122800|FG005|Part B|Protocol Violation|0|||
155186494|NCT02694523|560122801|FG006|Part B|Protocol Violation|0|||
155186495|NCT02694523|560122795|FG000|Part B|Lost to Follow-up|0|||
155186496|NCT02694523|560122796|FG001|Part B|Lost to Follow-up|0|||
155036298|NCT03191864|559559168|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155036299|NCT03191864|559559169|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155036300|NCT03191864|559559170|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155036301|NCT03191864|559559171|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
155036302|NCT03191864|559559172|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
155036303|NCT03191864|559559167|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155186497|NCT02694523|560122797|FG002|Part B|Lost to Follow-up|2|||
155186498|NCT02694523|560122798|FG003|Part B|Lost to Follow-up|3|||
155186499|NCT02694523|560122799|FG004|Part B|Lost to Follow-up|2|||
155036304|NCT03191864|559559168|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155036305|NCT03191864|559559169|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155036306|NCT03191864|559559170|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155036307|NCT03191864|559559171|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
155186500|NCT02694523|560122800|FG005|Part B|Lost to Follow-up|0|||
155186501|NCT02694523|560122801|FG006|Part B|Lost to Follow-up|1|||
155186502|NCT02694523|560122795|FG000|Part B|Withdrawal by Subject|0|||
155186503|NCT02694523|560122796|FG001|Part B|Withdrawal by Subject|0|||
155186504|NCT02694523|560122797|FG002|Part B|Withdrawal by Subject|9|||
155186505|NCT02694523|560122798|FG003|Part B|Withdrawal by Subject|0|||
155186506|NCT02694523|560122799|FG004|Part B|Withdrawal by Subject|1|||
155186507|NCT02694523|560122800|FG005|Part B|Withdrawal by Subject|3|||
155036308|NCT03191864|559559172|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
155036309|NCT03191864|559559167|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155036310|NCT03191864|559559168|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155036311|NCT03191864|559559169|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
155036312|NCT03191864|559559170|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155036313|NCT03191864|559559171|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
155036314|NCT03191864|559559172|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
155036315|NCT03191864|559559167|FG000|Part 1 - Induction|Adverse Event|0|||
155036316|NCT03191864|559559168|FG001|Part 1 - Induction|Adverse Event|2|||
155036317|NCT03191864|559559169|FG002|Part 1 - Induction|Adverse Event|0|||
155036318|NCT03191864|559559170|FG003|Part 1 - Induction|Adverse Event|1|||
155036319|NCT03191864|559559171|FG004|Part 1 - Induction|Adverse Event|0|||
155036320|NCT03191864|559559172|FG005|Part 1 - Induction|Adverse Event|2|||
155036321|NCT03191864|559559167|FG000|Part 1 - Induction|Randomized but never dosed|0|||
155036322|NCT03191864|559559168|FG001|Part 1 - Induction|Randomized but never dosed|0|||
155036323|NCT03191864|559559169|FG002|Part 1 - Induction|Randomized but never dosed|1|||
155036324|NCT03191864|559559170|FG003|Part 1 - Induction|Randomized but never dosed|0|||
155036325|NCT03191864|559559171|FG004|Part 1 - Induction|Randomized but never dosed|0|||
155036326|NCT03191864|559559172|FG005|Part 1 - Induction|Randomized but never dosed|0|||
155036327|NCT03191864|559559167|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
155036328|NCT03191864|559559168|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
155036329|NCT03191864|559559169|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
155036330|NCT03191864|559559170|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
155036331|NCT03191864|559559171|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
155036332|NCT03191864|559559172|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
155036333|NCT03191864|559559167|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155036334|NCT03191864|559559168|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155036335|NCT03191864|559559169|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
155036336|NCT03191864|559559170|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155036337|NCT03191864|559559171|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155036338|NCT03191864|559559172|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
155036339|NCT03191864|559559167|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
155036340|NCT03191864|559559168|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155036341|NCT03191864|559559169|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155036342|NCT03191864|559559170|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155036343|NCT03191864|559559171|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155036344|NCT03191864|559559172|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
155036345|NCT03191864|559559167|FG000|Part 2 - Maintenance|Physician Decision|1|||
155036346|NCT03191864|559559168|FG001|Part 2 - Maintenance|Physician Decision|0|||
155036347|NCT03191864|559559169|FG002|Part 2 - Maintenance|Physician Decision|0|||
155036348|NCT03191864|559559170|FG003|Part 2 - Maintenance|Physician Decision|0|||
155036349|NCT03191864|559559171|FG004|Part 2 - Maintenance|Physician Decision|0|||
155036350|NCT03191864|559559172|FG005|Part 2 - Maintenance|Physician Decision|0|||
155036351|NCT03191864|559559167|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
155036352|NCT03191864|559559168|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
155036353|NCT03191864|559559169|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
155036354|NCT03191864|559559170|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
155036355|NCT03191864|559559171|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
155036356|NCT03191864|559559172|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
155036357|NCT03191864|559559167|FG000|Part 2 - Maintenance|Adverse Event|0|||
155036358|NCT03191864|559559168|FG001|Part 2 - Maintenance|Adverse Event|0|||
155036359|NCT03191864|559559169|FG002|Part 2 - Maintenance|Adverse Event|0|||
155036360|NCT03191864|559559170|FG003|Part 2 - Maintenance|Adverse Event|0|||
155036361|NCT03191864|559559171|FG004|Part 2 - Maintenance|Adverse Event|1|||
155036362|NCT03191864|559559172|FG005|Part 2 - Maintenance|Adverse Event|0|||
155143964|NCT03160898|559959546|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
155143965|NCT03160898|559959547|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
155143966|NCT03160898|559959548|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
155143967|NCT03160898|559959545|FG000|Overall Study|Lost to Follow-up|1|||
155143968|NCT03160898|559959546|FG001|Overall Study|Lost to Follow-up|1|||
155143969|NCT03160898|559959547|FG002|Overall Study|Lost to Follow-up|1|||
155143970|NCT03160898|559959548|FG003|Overall Study|Lost to Follow-up|2|||
155143971|NCT03160898|559959545|FG000|Overall Study|Physician Decision|1|||
155143972|NCT03160898|559959546|FG001|Overall Study|Physician Decision|0|||
155143973|NCT03160898|559959547|FG002|Overall Study|Physician Decision|0|||
155036363|NCT03191864|559559167|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
155143974|NCT03160898|559959548|FG003|Overall Study|Physician Decision|1|||
155143975|NCT03160898|559959545|FG000|Overall Study|Progressive Disease|4|||
155036364|NCT03191864|559559168|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
155036365|NCT03191864|559559169|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
155036366|NCT03191864|559559170|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
155036367|NCT03191864|559559171|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
155036368|NCT03191864|559559172|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
155036369|NCT03191864|559559167|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155036370|NCT03191864|559559168|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155036371|NCT03191864|559559169|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155036372|NCT03191864|559559170|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155036373|NCT03191864|559559171|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
155036374|NCT03191864|559559172|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
155036375|NCT01447927|559559173|FG000|Overall Study|Adverse Event|4|||
155036376|NCT01447927|559559174|FG001|Overall Study|Adverse Event|3|||
155036377|NCT01447927|559559173|FG000|Overall Study|Withdrawal by Subject|1|||
155036378|NCT01447927|559559174|FG001|Overall Study|Withdrawal by Subject|0|||
155036379|NCT04506905|559559177|FG000|Overall Study|Lost to Follow-up|1|||
155036380|NCT04506905|559559178|FG001|Overall Study|Lost to Follow-up|0|||
155036381|NCT04506905|559559179|FG002|Overall Study|Lost to Follow-up|0|||
155036382|NCT04506905|559559180|FG003|Overall Study|Lost to Follow-up|1|||
155036383|NCT04506905|559559181|FG004|Overall Study|Lost to Follow-up|0|||
155036384|NCT04506905|559559182|FG005|Overall Study|Lost to Follow-up|0|||
155036385|NCT04506905|559559183|FG006|Overall Study|Lost to Follow-up|0|||
155036386|NCT04506905|559559184|FG007|Overall Study|Lost to Follow-up|0|||
155036387|NCT04506905|559559185|FG008|Overall Study|Lost to Follow-up|0|||
155036388|NCT04506905|559559177|FG000|Overall Study|Withdrawal by Subject|0|||
155036389|NCT04506905|559559178|FG001|Overall Study|Withdrawal by Subject|0|||
155036390|NCT04506905|559559179|FG002|Overall Study|Withdrawal by Subject|0|||
155036391|NCT04506905|559559180|FG003|Overall Study|Withdrawal by Subject|2|||
155036392|NCT04506905|559559181|FG004|Overall Study|Withdrawal by Subject|0|||
155036393|NCT04506905|559559182|FG005|Overall Study|Withdrawal by Subject|0|||
155036394|NCT04506905|559559183|FG006|Overall Study|Withdrawal by Subject|0|||
155036395|NCT04506905|559559184|FG007|Overall Study|Withdrawal by Subject|0|||
155036396|NCT04506905|559559185|FG008|Overall Study|Withdrawal by Subject|0|||
155036397|NCT02093390|559559186|FG000|Overall Study|Withdrawal by Subject|0|||
155036398|NCT02093390|559559187|FG001|Overall Study|Withdrawal by Subject|1|||
155036399|NCT02168777|559561698|FG000|Overall Study|Withdrawal by Subject|1|||
155036400|NCT02168777|559561699|FG001|Overall Study|Withdrawal by Subject|0|||
155036401|NCT02168777|559561700|FG002|Overall Study|Withdrawal by Subject|2|||
155036402|NCT02168777|559561698|FG000|Overall Study|Adverse Event|1|||
155036403|NCT02168777|559561699|FG001|Overall Study|Adverse Event|0|||
155036404|NCT02168777|559561700|FG002|Overall Study|Adverse Event|1|||
155036405|NCT02168777|559561698|FG000|Overall Study|Disease recurrence|0|||
155036406|NCT02168777|559561699|FG001|Overall Study|Disease recurrence|0|||
155036407|NCT02168777|559561700|FG002|Overall Study|Disease recurrence|1|||
155036408|NCT02168777|559561698|FG000|Overall Study|Radiological disease progression|0|||
155036409|NCT02168777|559561699|FG001|Overall Study|Radiological disease progression|5|||
155036410|NCT02168777|559561700|FG002|Overall Study|Radiological disease progression|5|||
155036411|NCT02168777|559561698|FG000|Overall Study|Clinical disease progression|0|||
155036412|NCT02168777|559561699|FG001|Overall Study|Clinical disease progression|1|||
155036413|NCT02168777|559561700|FG002|Overall Study|Clinical disease progression|2|||
155036414|NCT02168777|559561698|FG000|Overall Study|Other reason|0|||
155036415|NCT02168777|559561699|FG001|Overall Study|Other reason|1|||
155036416|NCT02168777|559561700|FG002|Overall Study|Other reason|0|||
155036417|NCT00441363|559561701|FG000|Overall Study|Adverse Event|4|||
155036418|NCT00441363|559561702|FG001|Overall Study|Adverse Event|2|||
155036419|NCT00441363|559561701|FG000|Overall Study|Withdrawal by Subject|3|||
155036420|NCT00441363|559561702|FG001|Overall Study|Withdrawal by Subject|4|||
155036421|NCT00441363|559561701|FG000|Overall Study|Physician Decision|6|||
155036422|NCT00441363|559561702|FG001|Overall Study|Physician Decision|7|||
155036423|NCT00441363|559561701|FG000|Overall Study|Lost to Follow-up|2|||
155036424|NCT00441363|559561702|FG001|Overall Study|Lost to Follow-up|2|||
155036425|NCT00441363|559561701|FG000|Overall Study|Other|2|||
155036426|NCT00441363|559561702|FG001|Overall Study|Other|0|||
155036427|NCT01709864|559561703|FG000|Overall Study|Physician Decision|0|||
155036428|NCT01709864|559561704|FG001|Overall Study|Physician Decision|1|||
155036429|NCT01709864|559561703|FG000|Overall Study|subject/guardian decision|5|||
155036430|NCT01709864|559561704|FG001|Overall Study|subject/guardian decision|6|||
155143976|NCT03160898|559959546|FG001|Overall Study|Progressive Disease|1|||
155036431|NCT01709864|559561703|FG000|Overall Study|Lost to Follow-up|1|||
155036432|NCT01709864|559561704|FG001|Overall Study|Lost to Follow-up|0|||
155036433|NCT01709864|559561703|FG000|Overall Study|non-compliance with study treatment|1|||
155036434|NCT01709864|559561704|FG001|Overall Study|non-compliance with study treatment|1|||
155036435|NCT01709864|559561703|FG000|Overall Study|Adverse Event|0|||
155036436|NCT01709864|559561704|FG001|Overall Study|Adverse Event|2|||
155036437|NCT01709864|559561703|FG000|Overall Study|Death|0|||
155036438|NCT01709864|559561704|FG001|Overall Study|Death|1|||
155036439|NCT01066793|559561705|FG000|Overall Study|Death|4|||
155036440|NCT01066793|559561706|FG001|Overall Study|Death|1|||
155036441|NCT01066793|559561707|FG002|Overall Study|Death|1|||
155036442|NCT01066793|559561708|FG003|Overall Study|Death|0|||
155036443|NCT01066793|559561709|FG004|Overall Study|Death|0|||
155036444|NCT01066793|559561710|FG005|Overall Study|Death|0|||
155036445|NCT01066793|559561705|FG000|Overall Study|Lack of Efficacy|2|||
155036446|NCT01066793|559561706|FG001|Overall Study|Lack of Efficacy|1|||
155036447|NCT01066793|559561707|FG002|Overall Study|Lack of Efficacy|0|||
155036448|NCT01066793|559561708|FG003|Overall Study|Lack of Efficacy|0|||
155036449|NCT01066793|559561709|FG004|Overall Study|Lack of Efficacy|0|||
155036450|NCT01066793|559561710|FG005|Overall Study|Lack of Efficacy|0|||
155036451|NCT01066793|559561705|FG000|Overall Study|Lost to Follow-up|180|||
155036452|NCT01066793|559561706|FG001|Overall Study|Lost to Follow-up|39|||
155036453|NCT01066793|559561707|FG002|Overall Study|Lost to Follow-up|82|||
155036454|NCT01066793|559561708|FG003|Overall Study|Lost to Follow-up|16|||
155036455|NCT01066793|559561709|FG004|Overall Study|Lost to Follow-up|0|||
155036456|NCT01066793|559561710|FG005|Overall Study|Lost to Follow-up|1|||
155036457|NCT01066793|559561705|FG000|Overall Study|Physician Decision|3|||
155036458|NCT01066793|559561706|FG001|Overall Study|Physician Decision|0|||
155036459|NCT01066793|559561707|FG002|Overall Study|Physician Decision|0|||
155036460|NCT01066793|559561708|FG003|Overall Study|Physician Decision|0|||
155036461|NCT01066793|559561709|FG004|Overall Study|Physician Decision|0|||
155036462|NCT01066793|559561710|FG005|Overall Study|Physician Decision|0|||
155036463|NCT01066793|559561705|FG000|Overall Study|Protocol Violation|3|||
155036464|NCT01066793|559561706|FG001|Overall Study|Protocol Violation|2|||
155036465|NCT01066793|559561707|FG002|Overall Study|Protocol Violation|2|||
155036466|NCT01066793|559561708|FG003|Overall Study|Protocol Violation|0|||
155036467|NCT01066793|559561709|FG004|Overall Study|Protocol Violation|0|||
155036468|NCT01066793|559561710|FG005|Overall Study|Protocol Violation|0|||
155036469|NCT01066793|559561705|FG000|Overall Study|Withdrawal by Subject|7|||
155036470|NCT01066793|559561706|FG001|Overall Study|Withdrawal by Subject|4|||
155036471|NCT01066793|559561707|FG002|Overall Study|Withdrawal by Subject|1|||
155036472|NCT01066793|559561708|FG003|Overall Study|Withdrawal by Subject|0|||
155036473|NCT01066793|559561709|FG004|Overall Study|Withdrawal by Subject|0|||
155036474|NCT01066793|559561710|FG005|Overall Study|Withdrawal by Subject|0|||
155036475|NCT01066793|559561705|FG000|Overall Study|Early Termination|3|||
155036476|NCT01066793|559561706|FG001|Overall Study|Early Termination|0|||
155036477|NCT01066793|559561707|FG002|Overall Study|Early Termination|0|||
155036478|NCT01066793|559561708|FG003|Overall Study|Early Termination|0|||
155036479|NCT01066793|559561709|FG004|Overall Study|Early Termination|0|||
155036480|NCT01066793|559561710|FG005|Overall Study|Early Termination|0|||
155036481|NCT01066793|559561705|FG000|Overall Study|Lab test not done|7|||
155036482|NCT01066793|559561706|FG001|Overall Study|Lab test not done|0|||
155036483|NCT01066793|559561707|FG002|Overall Study|Lab test not done|0|||
155036484|NCT01066793|559561708|FG003|Overall Study|Lab test not done|1|||
155036485|NCT01066793|559561709|FG004|Overall Study|Lab test not done|0|||
155036486|NCT01066793|559561710|FG005|Overall Study|Lab test not done|0|||
155036487|NCT01066793|559561705|FG000|Overall Study|Miscellaneous|4|||
155036488|NCT01066793|559561706|FG001|Overall Study|Miscellaneous|5|||
155036489|NCT01066793|559561707|FG002|Overall Study|Miscellaneous|6|||
155036490|NCT01066793|559561708|FG003|Overall Study|Miscellaneous|0|||
155036491|NCT01066793|559561709|FG004|Overall Study|Miscellaneous|0|||
155036492|NCT01066793|559561710|FG005|Overall Study|Miscellaneous|0|||
155186508|NCT02694523|560122801|FG006|Part B|Withdrawal by Subject|0|||
155186509|NCT02694523|560122795|FG000|Part B|Other|0|||
155186510|NCT02694523|560122796|FG001|Part B|Other|0|||
155186511|NCT02694523|560122797|FG002|Part B|Other|1|||
155186512|NCT02694523|560122798|FG003|Part B|Other|0|||
155186513|NCT02694523|560122799|FG004|Part B|Other|0|||
155186514|NCT02694523|560122800|FG005|Part B|Other|0|||
155186515|NCT02694523|560122801|FG006|Part B|Other|1|||
155186516|NCT01367119|560122806|FG000|Overall Study|Adverse Event|1|||
155186517|NCT01367119|560122807|FG001|Overall Study|Adverse Event|0|||
155186518|NCT01367119|560122806|FG000|Overall Study|Withdrawal by Subject|1|||
155186519|NCT01367119|560122807|FG001|Overall Study|Withdrawal by Subject|1|||
155186520|NCT01028378|560122812|FG000|Overall Study|Lost to Follow-up|12|||
155186521|NCT01028378|560122812|FG000|Overall Study|Withdrawal by Subject|1|||
155186522|NCT01028378|560122812|FG000|Overall Study|Adminstrative Reasons|4|||
155036493|NCT01066793|559561705|FG000|Overall Study|Non-responders|104|||
155036494|NCT01066793|559561706|FG001|Overall Study|Non-responders|5|||
155036495|NCT01066793|559561707|FG002|Overall Study|Non-responders|11|||
155036496|NCT01066793|559561708|FG003|Overall Study|Non-responders|25|||
155036497|NCT01066793|559561709|FG004|Overall Study|Non-responders|0|||
155036498|NCT01066793|559561710|FG005|Overall Study|Non-responders|0|||
155036499|NCT01066793|559561705|FG000|Overall Study|Other|15|||
155036500|NCT01066793|559561706|FG001|Overall Study|Other|5|||
155036501|NCT01066793|559561707|FG002|Overall Study|Other|6|||
155186523|NCT00064298|560122813|FG000|Overall Study|Withdrawal by Subject|2|||
155186524|NCT00064298|560122814|FG001|Overall Study|Withdrawal by Subject|1|||
155036502|NCT01066793|559561708|FG003|Overall Study|Other|2|||
155036503|NCT01066793|559561709|FG004|Overall Study|Other|0|||
155036504|NCT01066793|559561710|FG005|Overall Study|Other|0|||
155186525|NCT00064298|560122813|FG000|Overall Study|Lost to Follow-up|2|||
155186526|NCT00064298|560122814|FG001|Overall Study|Lost to Follow-up|2|||
155036505|NCT01066793|559561705|FG000|Overall Study|Relapse|20|||
155036506|NCT01066793|559561706|FG001|Overall Study|Relapse|8|||
155036507|NCT01066793|559561707|FG002|Overall Study|Relapse|2|||
155036508|NCT01066793|559561708|FG003|Overall Study|Relapse|3|||
155036509|NCT01066793|559561709|FG004|Overall Study|Relapse|0|||
155036510|NCT01066793|559561710|FG005|Overall Study|Relapse|0|||
155036511|NCT01066793|559561705|FG000|Overall Study|Result Not Available|1|||
155036512|NCT01066793|559561706|FG001|Overall Study|Result Not Available|0|||
155036513|NCT01066793|559561707|FG002|Overall Study|Result Not Available|0|||
155036514|NCT01066793|559561708|FG003|Overall Study|Result Not Available|0|||
155036515|NCT01066793|559561709|FG004|Overall Study|Result Not Available|0|||
155036516|NCT01066793|559561710|FG005|Overall Study|Result Not Available|0|||
155036517|NCT01066793|559561705|FG000|Overall Study|Treatment Interrupted|1|||
155036518|NCT01066793|559561706|FG001|Overall Study|Treatment Interrupted|1|||
155036519|NCT01066793|559561707|FG002|Overall Study|Treatment Interrupted|0|||
155036520|NCT01066793|559561708|FG003|Overall Study|Treatment Interrupted|0|||
155036521|NCT01066793|559561709|FG004|Overall Study|Treatment Interrupted|0|||
155036522|NCT01066793|559561710|FG005|Overall Study|Treatment Interrupted|0|||
155036523|NCT01066793|559561705|FG000|Overall Study|Treatment Never Started|18|||
155036524|NCT01066793|559561706|FG001|Overall Study|Treatment Never Started|5|||
155036525|NCT01066793|559561707|FG002|Overall Study|Treatment Never Started|4|||
155036526|NCT01066793|559561708|FG003|Overall Study|Treatment Never Started|1|||
155036527|NCT01066793|559561709|FG004|Overall Study|Treatment Never Started|0|||
155036528|NCT01066793|559561710|FG005|Overall Study|Treatment Never Started|0|||
155036529|NCT01066793|559561705|FG000|Overall Study|Treatment Stopped|2|||
155036530|NCT01066793|559561706|FG001|Overall Study|Treatment Stopped|1|||
155036531|NCT01066793|559561707|FG002|Overall Study|Treatment Stopped|0|||
155036532|NCT01066793|559561708|FG003|Overall Study|Treatment Stopped|1|||
155036533|NCT01066793|559561709|FG004|Overall Study|Treatment Stopped|0|||
155036534|NCT01066793|559561710|FG005|Overall Study|Treatment Stopped|0|||
155036535|NCT01911793|559561712|FG000|Overall Study|Physician Decision|1|||
155036536|NCT01911793|559561713|FG001|Overall Study|Physician Decision|5|||
155036537|NCT02697916|559561714|FG000|Overall Study|Death|357|||
155036538|NCT02697916|559561715|FG001|Overall Study|Death|315|||
155036539|NCT02697916|559561714|FG000|Overall Study|Withdrawal by Subject|221|||
155036540|NCT02697916|559561715|FG001|Overall Study|Withdrawal by Subject|393|||
155036541|NCT00290693|559561717|FG000|Overall Study|Withdrawal by Subject|2|||
155036542|NCT05625477|559561718|FG000|Overall Study|Lost to Follow-up|2|||
155036543|NCT05625477|559561719|FG001|Overall Study|Lost to Follow-up|2|||
155036544|NCT05625477|559561720|FG002|Overall Study|Lost to Follow-up|1|||
155036545|NCT05625477|559561721|FG003|Overall Study|Lost to Follow-up|1|||
155036546|NCT05625477|559561722|FG004|Overall Study|Lost to Follow-up|0|||
155036547|NCT05625477|559561718|FG000|Overall Study|Covid quarantine|1|||
155186527|NCT00064298|560122813|FG000|Overall Study|Death|0|||
155186528|NCT00064298|560122814|FG001|Overall Study|Death|1|||
155186529|NCT00064298|560122813|FG000|Overall Study|Disease Progression|2|||
155186530|NCT00064298|560122814|FG001|Overall Study|Disease Progression|1|||
155186531|NCT02017171|560122815|FG000|Overall Study|Death|10|||
155186532|NCT02017171|560122816|FG001|Overall Study|Death|4|||
155186533|NCT02017171|560122815|FG000|Overall Study|Withdrawal by Subject|23|||
155186534|NCT02017171|560122816|FG001|Overall Study|Withdrawal by Subject|17|||
155186535|NCT02017171|560122815|FG000|Overall Study|Lost to Follow-up|21|||
155186536|NCT02017171|560122816|FG001|Overall Study|Lost to Follow-up|20|||
155186537|NCT02017171|560122815|FG000|Overall Study|ESKD|6|||
155186538|NCT02017171|560122816|FG001|Overall Study|ESKD|2|||
155186539|NCT02017171|560122815|FG000|Overall Study|Miscellaneous|2|||
155186540|NCT02017171|560122816|FG001|Overall Study|Miscellaneous|3|||
155186541|NCT02220998|560122817|FG000|Overall Study|Randomized but Never Treated|1|||
155186542|NCT02220998|560122818|FG001|Overall Study|Randomized but Never Treated|2|||
155186543|NCT02220998|560122817|FG000|Overall Study|Death|2|||
155186544|NCT02220998|560122818|FG001|Overall Study|Death|0|||
155186545|NCT02220998|560122817|FG000|Overall Study|Lack of Efficacy|0|||
155186546|NCT02220998|560122818|FG001|Overall Study|Lack of Efficacy|5|||
155186547|NCT02220998|560122817|FG000|Overall Study|Lost to Follow-up|4|||
155186548|NCT02220998|560122818|FG001|Overall Study|Lost to Follow-up|4|||
155186549|NCT03309046|560122819|FG000|Overall Study|Withdrawal by Subject|4|||
155036548|NCT05625477|559561719|FG001|Overall Study|Covid quarantine|0|||
155036549|NCT05625477|559561720|FG002|Overall Study|Covid quarantine|0|||
155036550|NCT05625477|559561721|FG003|Overall Study|Covid quarantine|0|||
155036551|NCT05625477|559561722|FG004|Overall Study|Covid quarantine|0|||
155036552|NCT04849416|559561725|FG000|Overall Study|Ongoing Treatment|12|||
155036553|NCT04849416|559561726|FG001|Overall Study|Ongoing Treatment|5|||
155036554|NCT04849416|559561727|FG002|Overall Study|Ongoing Treatment|3|||
155036555|NCT04849416|559561725|FG000|Overall Study|On Post-Treatment Follow-up|8|||
155186550|NCT03309046|560122820|FG001|Overall Study|Withdrawal by Subject|17|||
155186551|NCT02280473|560122822|FG000|Overall Study|Adverse Event|1|||
155186552|NCT02280473|560122823|FG001|Overall Study|Adverse Event|1|||
155186553|NCT02280473|560122822|FG000|Overall Study|Lack of Efficacy|0|||
155186554|NCT02280473|560122823|FG001|Overall Study|Lack of Efficacy|1|||
155036556|NCT04849416|559561726|FG001|Overall Study|On Post-Treatment Follow-up|9|||
155036557|NCT04849416|559561727|FG002|Overall Study|On Post-Treatment Follow-up|10|||
155036558|NCT04849416|559561725|FG000|Overall Study|Withdrawal by Subject|0|||
155036559|NCT04849416|559561726|FG001|Overall Study|Withdrawal by Subject|0|||
155036560|NCT04849416|559561727|FG002|Overall Study|Withdrawal by Subject|1|||
155036561|NCT04849416|559561725|FG000|Overall Study|Lost to Follow-up|1|||
155036562|NCT04849416|559561726|FG001|Overall Study|Lost to Follow-up|0|||
155036563|NCT04849416|559561727|FG002|Overall Study|Lost to Follow-up|0|||
155036564|NCT03292458|559561728|FG000|Period 1|Adverse Event|2|||
155036565|NCT03292458|559561729|FG001|Period 1|Adverse Event|0|||
155036566|NCT00981058|559561740|FG000|Overall Study|Progressive Disease|38|||
155036567|NCT00981058|559561741|FG001|Overall Study|Progressive Disease|31|||
155036568|NCT00981058|559561740|FG000|Overall Study|Lost to Follow-up|3|||
155036569|NCT00981058|559561741|FG001|Overall Study|Lost to Follow-up|2|||
155036570|NCT00981058|559561740|FG000|Overall Study|Physician Decision|4|||
155036571|NCT00981058|559561741|FG001|Overall Study|Physician Decision|5|||
155036572|NCT00981058|559561740|FG000|Overall Study|Randomization Error|0|||
155036573|NCT00981058|559561741|FG001|Overall Study|Randomization Error|1|||
155036574|NCT00981058|559561740|FG000|Overall Study|Withdrawal by Subject|24|||
155036575|NCT00981058|559561741|FG001|Overall Study|Withdrawal by Subject|22|||
155036576|NCT05916131|559561742|FG000|Overall Study|Lost to Follow-up|0|||
155036577|NCT05916131|559561743|FG001|Overall Study|Lost to Follow-up|0|||
155036578|NCT05916131|559561744|FG002|Overall Study|Lost to Follow-up|1|||
155036579|NCT05916131|559561745|FG003|Overall Study|Lost to Follow-up|0|||
155036580|NCT02667587|559561746|FG000|Pre-Treatment|Not reported|1|||
155036581|NCT02667587|559561747|FG001|Pre-Treatment|Not reported|0|||
155036582|NCT02667587|559561746|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155036583|NCT02667587|559561747|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
155036584|NCT02667587|559561746|FG000|Pre-Treatment|Participant withdrew consent|0|||
155036585|NCT02667587|559561747|FG001|Pre-Treatment|Participant withdrew consent|1|||
155036586|NCT02667587|559561746|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
155036587|NCT02667587|559561747|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
155036588|NCT02667587|559561746|FG000|End of Treatment|Disease Progression|193|||
155036589|NCT02667587|559561747|FG001|End of Treatment|Disease Progression|226|||
155036590|NCT02667587|559561746|FG000|End of Treatment|Study Drug Toxicity|75|||
155036591|NCT02667587|559561747|FG001|End of Treatment|Study Drug Toxicity|19|||
155036592|NCT02667587|559561746|FG000|End of Treatment|Death|2|||
155036593|NCT02667587|559561747|FG001|End of Treatment|Death|1|||
155036594|NCT02667587|559561746|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
155036595|NCT02667587|559561747|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
155036596|NCT02667587|559561746|FG000|End of Treatment|participant request to discontinue treatment|33|||
155036597|NCT02667587|559561747|FG001|End of Treatment|participant request to discontinue treatment|35|||
155036598|NCT02667587|559561746|FG000|End of Treatment|participant withdrew consent|5|||
155036599|NCT02667587|559561747|FG001|End of Treatment|participant withdrew consent|6|||
155036600|NCT02667587|559561746|FG000|End of Treatment|Lost to Follow-up|1|||
155036601|NCT02667587|559561747|FG001|End of Treatment|Lost to Follow-up|2|||
155036602|NCT02667587|559561746|FG000|End of Treatment|maximum clinical benefit|4|||
155036603|NCT02667587|559561747|FG001|End of Treatment|maximum clinical benefit|4|||
155036604|NCT02667587|559561746|FG000|End of Treatment|poor or non compliant|0|||
155036605|NCT02667587|559561747|FG001|End of Treatment|poor or non compliant|1|||
155036606|NCT02667587|559561746|FG000|End of Treatment|participant no longer meets study criteria|1|||
155036607|NCT02667587|559561747|FG001|End of Treatment|participant no longer meets study criteria|1|||
155036608|NCT02667587|559561746|FG000|End of Treatment|administrative reason by sponsor|1|||
155036609|NCT02667587|559561747|FG001|End of Treatment|administrative reason by sponsor|29|||
155036610|NCT02667587|559561746|FG000|End of Treatment|other reasonse|21|||
155036611|NCT02667587|559561747|FG001|End of Treatment|other reasonse|10|||
155036612|NCT02542293|559561748|FG000|Overall Study|Death|367|||
155036613|NCT02542293|559561749|FG001|Overall Study|Death|377|||
155036614|NCT02542293|559561748|FG000|Overall Study|Withdrawal by Subject|8|||
155036615|NCT02542293|559561749|FG001|Overall Study|Withdrawal by Subject|19|||
155186555|NCT02280473|560122822|FG000|Overall Study|Lost to Follow-up|0|||
155186556|NCT02280473|560122823|FG001|Overall Study|Lost to Follow-up|1|||
155186557|NCT01539317|560122824|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
155186558|NCT01539317|560122825|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
155186559|NCT02393690|560122826|FG000|Overall Study|Ineligible|0|||
155036616|NCT03030118|559561750|FG000|Overall Study|Achieved SLE Diagnosis|11|||
155036617|NCT03030118|559561751|FG001|Overall Study|Achieved SLE Diagnosis|10|||
155036618|NCT03030118|559561750|FG000|Overall Study|Adverse Event|1|||
155036619|NCT03030118|559561751|FG001|Overall Study|Adverse Event|1|||
155036620|NCT03030118|559561750|FG000|Overall Study|Pregnancy|2|||
155036621|NCT03030118|559561751|FG001|Overall Study|Pregnancy|2|||
155186560|NCT02393690|560122827|FG001|Overall Study|Ineligible|1|||
155036622|NCT03030118|559561750|FG000|Overall Study|Lost to Follow-up|5|||
155186561|NCT00591266|560122828|FG000|Overall Study|Adverse Event|2|||
155036623|NCT03030118|559561751|FG001|Overall Study|Lost to Follow-up|6|||
155036624|NCT03030118|559561750|FG000|Overall Study|Concomitant Medications|1|||
155186562|NCT00591266|560122829|FG001|Overall Study|Adverse Event|2|||
155036625|NCT03030118|559561751|FG001|Overall Study|Concomitant Medications|1|||
155036626|NCT03030118|559561750|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
155036627|NCT03030118|559561751|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
155036628|NCT03030118|559561750|FG000|Overall Study|Other|2|||
155036629|NCT03030118|559561751|FG001|Overall Study|Other|0|||
155036630|NCT03030118|559561750|FG000|Overall Study|Withdrawal by Subject|26|||
155036631|NCT03030118|559561751|FG001|Overall Study|Withdrawal by Subject|21|||
155036632|NCT03030118|559561750|FG000|Overall Study|Protocol Violation|1|||
155036633|NCT03030118|559561751|FG001|Overall Study|Protocol Violation|6|||
155036634|NCT04529850|559561752|FG000|Overall Study|Death|2|||
155036635|NCT04529850|559561752|FG000|Overall Study|Physician Decision|1|||
155036636|NCT04529850|559561752|FG000|Overall Study|Withdrawal by Subject|2|||
155036637|NCT02278367|559561755|FG000|Overall Study|Physician Decision|5|||
155036638|NCT02278367|559561756|FG001|Overall Study|Physician Decision|0|||
155036639|NCT02278367|559561755|FG000|Overall Study|Withdrawal by Subject|5|||
155036640|NCT02278367|559561756|FG001|Overall Study|Withdrawal by Subject|0|||
155036641|NCT01472939|559561760|FG000|Overall Study|Adverse Event|3|||
155036642|NCT01472939|559561761|FG001|Overall Study|Adverse Event|7|||
155036643|NCT01472939|559561762|FG002|Overall Study|Adverse Event|7|||
155036644|NCT01472939|559561763|FG003|Overall Study|Adverse Event|14|||
155036645|NCT01472939|559561760|FG000|Overall Study|Lack of Efficacy|1|||
155036646|NCT01472939|559561761|FG001|Overall Study|Lack of Efficacy|0|||
155036647|NCT01472939|559561762|FG002|Overall Study|Lack of Efficacy|0|||
155036648|NCT01472939|559561763|FG003|Overall Study|Lack of Efficacy|1|||
155036649|NCT01472939|559561760|FG000|Overall Study|Lost to Follow-up|3|||
155036650|NCT01472939|559561761|FG001|Overall Study|Lost to Follow-up|0|||
155036651|NCT01472939|559561762|FG002|Overall Study|Lost to Follow-up|2|||
155036652|NCT01472939|559561763|FG003|Overall Study|Lost to Follow-up|0|||
155036653|NCT01472939|559561760|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
155036654|NCT01472939|559561761|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
155036655|NCT01472939|559561762|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
155036656|NCT01472939|559561763|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
155036657|NCT01472939|559561760|FG000|Overall Study|Prohibited Medication|0|||
155036658|NCT01472939|559561761|FG001|Overall Study|Prohibited Medication|1|||
155036659|NCT01472939|559561762|FG002|Overall Study|Prohibited Medication|0|||
155036660|NCT01472939|559561763|FG003|Overall Study|Prohibited Medication|0|||
155036661|NCT01472939|559561760|FG000|Overall Study|Withdrawal By PI|1|||
155036662|NCT01472939|559561761|FG001|Overall Study|Withdrawal By PI|0|||
155036663|NCT01472939|559561762|FG002|Overall Study|Withdrawal By PI|0|||
155036664|NCT01472939|559561763|FG003|Overall Study|Withdrawal By PI|0|||
155036665|NCT01472939|559561760|FG000|Overall Study|Protocol Violation|3|||
155036666|NCT01472939|559561761|FG001|Overall Study|Protocol Violation|3|||
155036667|NCT01472939|559561762|FG002|Overall Study|Protocol Violation|0|||
155036668|NCT01472939|559561763|FG003|Overall Study|Protocol Violation|1|||
155036669|NCT01472939|559561760|FG000|Overall Study|Withdrawal by Subject|9|||
155036670|NCT01472939|559561761|FG001|Overall Study|Withdrawal by Subject|3|||
155036671|NCT01472939|559561762|FG002|Overall Study|Withdrawal by Subject|1|||
155036672|NCT01472939|559561763|FG003|Overall Study|Withdrawal by Subject|4|||
155036673|NCT00114738|559561764|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
155186563|NCT00591266|560122830|FG002|Overall Study|Adverse Event|3|||
155186564|NCT00591266|560122828|FG000|Overall Study|Lost to Follow-up|0|||
155186565|NCT00591266|560122829|FG001|Overall Study|Lost to Follow-up|1|||
155186566|NCT00591266|560122830|FG002|Overall Study|Lost to Follow-up|0|||
155186567|NCT00591266|560122828|FG000|Overall Study|Protocol Violation|0|||
155186568|NCT00591266|560122829|FG001|Overall Study|Protocol Violation|0|||
155186569|NCT00591266|560122830|FG002|Overall Study|Protocol Violation|1|||
155186570|NCT00591266|560122828|FG000|Overall Study|Withdrawal by Subject|6|||
155036674|NCT00114738|559561765|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
155036675|NCT00114738|559561766|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
155036676|NCT00114738|559561764|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
155036677|NCT00114738|559561765|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
155036678|NCT00114738|559561766|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
155036679|NCT00114738|559561764|FG000|Screening for Randomization|Neuropathy|17|||
155036680|NCT00114738|559561765|FG001|Screening for Randomization|Neuropathy|0|||
155036681|NCT00114738|559561766|FG002|Screening for Randomization|Neuropathy|0|||
155036682|NCT00114738|559561764|FG000|Screening for Randomization|Progressive disease|2|||
155036683|NCT00114738|559561765|FG001|Screening for Randomization|Progressive disease|0|||
155036684|NCT00114738|559561766|FG002|Screening for Randomization|Progressive disease|0|||
155036685|NCT00114738|559561764|FG000|Screening for Randomization|CNS Hemorrhage|1|||
155036686|NCT00114738|559561765|FG001|Screening for Randomization|CNS Hemorrhage|0|||
155036687|NCT00114738|559561766|FG002|Screening for Randomization|CNS Hemorrhage|0|||
155036688|NCT00114738|559561764|FG000|Screening for Randomization|Other|1|||
155036689|NCT00114738|559561765|FG001|Screening for Randomization|Other|0|||
155036690|NCT00114738|559561766|FG002|Screening for Randomization|Other|0|||
155186571|NCT00591266|560122829|FG001|Overall Study|Withdrawal by Subject|2|||
155186572|NCT00591266|560122830|FG002|Overall Study|Withdrawal by Subject|5|||
155036691|NCT00316914|559561767|FG000|Overall Study|Withdrawal by Subject|5|||
155036692|NCT00316914|559561768|FG001|Overall Study|Withdrawal by Subject|3|||
155036693|NCT00316914|559561767|FG000|Overall Study|Adverse Event|8|||
155036694|NCT00316914|559561768|FG001|Overall Study|Adverse Event|7|||
155036695|NCT00316914|559561767|FG000|Overall Study|Other Problems|6|||
155036696|NCT00316914|559561768|FG001|Overall Study|Other Problems|11|||
155036697|NCT00316914|559561767|FG000|Overall Study|Missing end of treatment documentation|14|||
155036698|NCT00316914|559561768|FG001|Overall Study|Missing end of treatment documentation|15|||
155036699|NCT01675154|559561769|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
155036700|NCT01675154|559561770|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
155036701|NCT01675154|559561771|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
155036702|NCT01675154|559561772|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
155036703|NCT02971800|559561773|FG000|Overall Study|Protocol Violation|1|||
155036704|NCT02971800|559561773|FG000|Overall Study|Withdrawal by Subject|1|||
155036705|NCT02971800|559561773|FG000|Overall Study|Exclusion criteria prior intervention|1|||
155036706|NCT02971800|559561773|FG000|Overall Study|Number evaluable participant already reached|4|||
155036707|NCT00766467|559561774|FG000|Overall Study|Withdrawal by Subject|7|||
155036708|NCT00766467|559561775|FG001|Overall Study|Withdrawal by Subject|2|||
155036709|NCT00766467|559561774|FG000|Overall Study|Adverse Event|1|||
155036710|NCT00766467|559561775|FG001|Overall Study|Adverse Event|1|||
155036711|NCT00766467|559561774|FG000|Overall Study|Protocol Violation|2|||
155036712|NCT00766467|559561775|FG001|Overall Study|Protocol Violation|4|||
155036713|NCT00766467|559561774|FG000|Overall Study|Tumor Progression on Study|0|||
155036714|NCT00766467|559561775|FG001|Overall Study|Tumor Progression on Study|1|||
155036715|NCT00766467|559561774|FG000|Overall Study|Physician Decision|1|||
155036716|NCT00766467|559561775|FG001|Overall Study|Physician Decision|0|||
155036717|NCT01917344|559561776|FG000|Overall Study|Withdrawal by Subject|1|||
155036718|NCT03329248|559561777|FG000|Overall Study|Progressive Disease|6|||
155036719|NCT01522235|559561778|FG000|Overall Study|Physician Decision|1|||
155036720|NCT01522235|559561779|FG001|Overall Study|Physician Decision|1|||
155036721|NCT03769194|559561780|FG000|Overall Study|Withdrawal by Subject|0|||
155036722|NCT03769194|559561781|FG001|Overall Study|Withdrawal by Subject|7|||
155036723|NCT03769194|559561782|FG002|Overall Study|Withdrawal by Subject|4|||
155036724|NCT03769194|559561783|FG003|Overall Study|Withdrawal by Subject|1|||
155036725|NCT03769194|559561780|FG000|Overall Study|moved from study area|0|||
155036726|NCT03769194|559561781|FG001|Overall Study|moved from study area|2|||
155036727|NCT03769194|559561782|FG002|Overall Study|moved from study area|1|||
155036728|NCT03769194|559561783|FG003|Overall Study|moved from study area|1|||
155036729|NCT03769194|559561780|FG000|Overall Study|Lost to Follow-up|3|||
155036730|NCT03769194|559561781|FG001|Overall Study|Lost to Follow-up|6|||
155036731|NCT03769194|559561782|FG002|Overall Study|Lost to Follow-up|3|||
155036732|NCT03769194|559561783|FG003|Overall Study|Lost to Follow-up|6|||
155036733|NCT03769194|559561780|FG000|Overall Study|other|1|||
155036734|NCT03769194|559561781|FG001|Overall Study|other|3|||
155036735|NCT03769194|559561782|FG002|Overall Study|other|0|||
155036736|NCT03769194|559561783|FG003|Overall Study|other|1|||
155036737|NCT03000530|559561784|FG000|Overall Study|Adverse Event|0|||
155036738|NCT03000530|559561785|FG001|Overall Study|Adverse Event|0|||
155036739|NCT03000530|559561786|FG002|Overall Study|Adverse Event|2|||
155036740|NCT03000530|559561784|FG000|Overall Study|Lost to Follow-up|0|||
155036741|NCT03000530|559561785|FG001|Overall Study|Lost to Follow-up|3|||
155036742|NCT03000530|559561786|FG002|Overall Study|Lost to Follow-up|1|||
155036743|NCT03000530|559561784|FG000|Overall Study|Withdrawal by Subject|0|||
155036744|NCT03000530|559561785|FG001|Overall Study|Withdrawal by Subject|2|||
155036745|NCT03000530|559561786|FG002|Overall Study|Withdrawal by Subject|1|||
155186573|NCT00591266|560122828|FG000|Overall Study|Lack of Efficacy|0|||
155186574|NCT00591266|560122829|FG001|Overall Study|Lack of Efficacy|2|||
155186575|NCT00591266|560122830|FG002|Overall Study|Lack of Efficacy|0|||
155186576|NCT00591266|560122828|FG000|Overall Study|Other|1|||
155186577|NCT00591266|560122829|FG001|Overall Study|Other|4|||
155186578|NCT00591266|560122830|FG002|Overall Study|Other|5|||
155186579|NCT05298306|560122831|FG000|Overall Study|Physician Decision|0|||
155186580|NCT05298306|560122832|FG001|Overall Study|Physician Decision|0|||
155036746|NCT01430624|559561792|FG000|Overall Study|Lost to Follow-up|23|||
155036747|NCT01430624|559561793|FG001|Overall Study|Lost to Follow-up|29|||
155036748|NCT01430624|559561794|FG002|Overall Study|Lost to Follow-up|27|||
155036749|NCT01430624|559561792|FG000|Overall Study|technical or eligibility|5|||
155186581|NCT05298306|560122833|FG002|Overall Study|Physician Decision|0|||
155186582|NCT05298306|560122834|FG003|Overall Study|Physician Decision|1|||
155186583|NCT05298306|560122835|FG004|Overall Study|Physician Decision|0|||
155036750|NCT01430624|559561793|FG001|Overall Study|technical or eligibility|5|||
155036751|NCT01430624|559561794|FG002|Overall Study|technical or eligibility|2|||
155036752|NCT01133288|559561795|FG000|Eligibility Assessment|met exclusion criteria|5|||
155036753|NCT01133288|559561795|FG000|Intervention Allocation|study terminated|2|||
155036754|NCT02565706|559561800|FG000|Overall Study|Withdrawal by Subject|5|||
155036755|NCT02565706|559561801|FG001|Overall Study|Withdrawal by Subject|7|||
155036756|NCT02565706|559561802|FG002|Overall Study|Withdrawal by Subject|7|||
155186584|NCT05298306|560122836|FG005|Overall Study|Physician Decision|0|||
155036757|NCT02565706|559561803|FG003|Overall Study|Withdrawal by Subject|11|||
155036758|NCT02565706|559561800|FG000|Overall Study|Lost to Follow-up|72|||
155036759|NCT02565706|559561801|FG001|Overall Study|Lost to Follow-up|75|||
155036760|NCT02565706|559561802|FG002|Overall Study|Lost to Follow-up|82|||
155036761|NCT02565706|559561803|FG003|Overall Study|Lost to Follow-up|74|||
155036762|NCT01672294|559561805|FG000|Overall Study|Withdrawal by Subject|4|||
155036763|NCT01672294|559561806|FG001|Overall Study|Withdrawal by Subject|4|||
155036764|NCT01672294|559561807|FG002|Overall Study|Withdrawal by Subject|4|||
155036765|NCT01672294|559561808|FG003|Overall Study|Withdrawal by Subject|4|||
155036766|NCT01672294|559561805|FG000|Overall Study|Excluded by study|1|||
155036767|NCT01672294|559561806|FG001|Overall Study|Excluded by study|1|||
155036768|NCT01672294|559561807|FG002|Overall Study|Excluded by study|0|||
155036769|NCT01672294|559561808|FG003|Overall Study|Excluded by study|0|||
155036770|NCT01672294|559561805|FG000|Overall Study|Lost to Follow-up|1|||
155036771|NCT01672294|559561806|FG001|Overall Study|Lost to Follow-up|16|||
155036772|NCT01672294|559561807|FG002|Overall Study|Lost to Follow-up|7|||
155036773|NCT01672294|559561808|FG003|Overall Study|Lost to Follow-up|9|||
155036774|NCT03379792|559561809|FG000|Overall Study|Physician Decision|0|||
155036775|NCT03379792|559561810|FG001|Overall Study|Physician Decision|0|||
155036776|NCT03379792|559561811|FG002|Overall Study|Physician Decision|0|||
155036777|NCT03379792|559561812|FG003|Overall Study|Physician Decision|1|||
155036778|NCT03379792|559561813|FG004|Overall Study|Physician Decision|0|||
155036779|NCT03379792|559561814|FG005|Overall Study|Physician Decision|0|||
155036780|NCT03379792|559561809|FG000|Overall Study|Withdrawal by Subject|0|||
155036781|NCT03379792|559561810|FG001|Overall Study|Withdrawal by Subject|0|||
155036782|NCT03379792|559561811|FG002|Overall Study|Withdrawal by Subject|0|||
155036783|NCT03379792|559561812|FG003|Overall Study|Withdrawal by Subject|0|||
155036784|NCT03379792|559561813|FG004|Overall Study|Withdrawal by Subject|1|||
155036785|NCT03379792|559561814|FG005|Overall Study|Withdrawal by Subject|1|||
155036786|NCT01285492|559561815|FG000|Overall Study|Adverse Event|11|||
155036787|NCT01285492|559561816|FG001|Overall Study|Adverse Event|0|||
155036788|NCT01285492|559561815|FG000|Overall Study|Protocol Violation|3|||
155036789|NCT01285492|559561816|FG001|Overall Study|Protocol Violation|0|||
155036790|NCT01285492|559561815|FG000|Overall Study|Withdrawal by Subject|2|||
155036791|NCT01285492|559561816|FG001|Overall Study|Withdrawal by Subject|1|||
155036792|NCT01285492|559561815|FG000|Overall Study|Death|1|||
155036793|NCT01285492|559561816|FG001|Overall Study|Death|0|||
155036794|NCT01121536|559561817|FG000|Overall Study|Adverse Event|63|||
155036795|NCT01121536|559561817|FG000|Overall Study|Lack of Efficacy|35|||
155036796|NCT01121536|559561817|FG000|Overall Study|Withdrawal by Subject|65|||
155036797|NCT01121536|559561817|FG000|Overall Study|Protocol Violation|20|||
155036798|NCT01121536|559561817|FG000|Overall Study|Noncompliance with study medication|12|||
155036799|NCT01121536|559561817|FG000|Overall Study|Noncompliance with study procedures|9|||
155036800|NCT01121536|559561817|FG000|Overall Study|Lost to Follow-up|39|||
155036801|NCT01121536|559561817|FG000|Overall Study|Other|118|||
155036802|NCT00401960|559561819|FG000|Overall Study|Lost to Follow-up|3|||
155036803|NCT00401960|559561820|FG001|Overall Study|Lost to Follow-up|0|||
155036804|NCT00401960|559561819|FG000|Overall Study|Death|2|||
155036805|NCT00401960|559561820|FG001|Overall Study|Death|0|||
155036806|NCT02649426|559561821|FG000|Overall Study|Follow-up on going|1|||
155036807|NCT02649426|559561822|FG001|Overall Study|Follow-up on going|26|||
155036808|NCT02649426|559561823|FG002|Overall Study|Follow-up on going|28|||
155036809|NCT02649426|559561824|FG003|Overall Study|Follow-up on going|31|||
155036810|NCT01606202|559561825|FG000|Overall Study|Adverse Event|5|||
155036811|NCT01606202|559561826|FG001|Overall Study|Adverse Event|0|||
155036812|NCT01606202|559561825|FG000|Overall Study|Withdrawal by Subject|2|||
155036813|NCT01606202|559561826|FG001|Overall Study|Withdrawal by Subject|1|||
155036814|NCT01606202|559561825|FG000|Overall Study|Personal problems|0|||
155036815|NCT01606202|559561826|FG001|Overall Study|Personal problems|1|||
155036816|NCT01606202|559561825|FG000|Overall Study|Problems with administration|0|||
155036817|NCT01606202|559561826|FG001|Overall Study|Problems with administration|1|||
155036818|NCT00306787|559561827|FG000|Overall Study|Discontinued without taking study drug|208|||
155036819|NCT00306787|559561828|FG001|Overall Study|Discontinued without taking study drug|215|||
155036820|NCT00306787|559561827|FG000|Overall Study|Adverse Event|1|||
155036821|NCT00306787|559561828|FG001|Overall Study|Adverse Event|1|||
155036822|NCT00306787|559561827|FG000|Overall Study|Lack of Efficacy|1|||
155036823|NCT00306787|559561828|FG001|Overall Study|Lack of Efficacy|0|||
155036824|NCT00306787|559561827|FG000|Overall Study|Protocol Violation|8|||
155036825|NCT00306787|559561828|FG001|Overall Study|Protocol Violation|10|||
155036826|NCT00306787|559561827|FG000|Overall Study|Withdrawal by Subject|2|||
155036827|NCT00306787|559561828|FG001|Overall Study|Withdrawal by Subject|9|||
155036828|NCT00306787|559561827|FG000|Overall Study|Lost to Follow-up|9|||
155036829|NCT00306787|559561828|FG001|Overall Study|Lost to Follow-up|6|||
155036830|NCT00306787|559561827|FG000|Overall Study|Administrative problems|4|||
155036831|NCT00306787|559561828|FG001|Overall Study|Administrative problems|0|||
155036832|NCT00306787|559561827|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155036833|NCT00306787|559561828|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155036834|NCT01870297|559561829|FG000|Overall Study|Adverse Event|0|||
155036835|NCT01870297|559561830|FG001|Overall Study|Adverse Event|0|||
155036836|NCT01870297|559561831|FG002|Overall Study|Adverse Event|0|||
155036837|NCT01870297|559561832|FG003|Overall Study|Adverse Event|0|||
155036838|NCT01870297|559561833|FG004|Overall Study|Adverse Event|2|||
155036839|NCT01870297|559561834|FG005|Overall Study|Adverse Event|0|||
155036840|NCT01870297|559561835|FG006|Overall Study|Adverse Event|0|||
155036841|NCT01870297|559561829|FG000|Overall Study|Lost to Follow-up|0|||
155036842|NCT01870297|559561830|FG001|Overall Study|Lost to Follow-up|1|||
155036843|NCT01870297|559561831|FG002|Overall Study|Lost to Follow-up|1|||
155036844|NCT01870297|559561832|FG003|Overall Study|Lost to Follow-up|0|||
155036845|NCT01870297|559561833|FG004|Overall Study|Lost to Follow-up|0|||
155036846|NCT01870297|559561834|FG005|Overall Study|Lost to Follow-up|0|||
155036847|NCT01870297|559561835|FG006|Overall Study|Lost to Follow-up|0|||
155036848|NCT01870297|559561829|FG000|Overall Study|Withdrawal by Subject|0|||
155036849|NCT01870297|559561830|FG001|Overall Study|Withdrawal by Subject|0|||
155036850|NCT01870297|559561831|FG002|Overall Study|Withdrawal by Subject|0|||
155036851|NCT01870297|559561832|FG003|Overall Study|Withdrawal by Subject|0|||
155036852|NCT01870297|559561833|FG004|Overall Study|Withdrawal by Subject|1|||
155036853|NCT01870297|559561834|FG005|Overall Study|Withdrawal by Subject|1|||
155036854|NCT01870297|559561835|FG006|Overall Study|Withdrawal by Subject|1|||
155036855|NCT01870297|559561829|FG000|Overall Study|Sponsor Decision|0|||
155036856|NCT01870297|559561830|FG001|Overall Study|Sponsor Decision|6|||
155036857|NCT01870297|559561831|FG002|Overall Study|Sponsor Decision|0|||
155036858|NCT01870297|559561832|FG003|Overall Study|Sponsor Decision|0|||
155036859|NCT01870297|559561833|FG004|Overall Study|Sponsor Decision|0|||
155036860|NCT01870297|559561834|FG005|Overall Study|Sponsor Decision|0|||
155036861|NCT01870297|559561835|FG006|Overall Study|Sponsor Decision|1|||
155036862|NCT00337779|559561836|FG000|Overall Study|Withdrawal by Subject|10|||
155036863|NCT00337779|559561837|FG001|Overall Study|Withdrawal by Subject|12|||
155036864|NCT00337779|559561836|FG000|Overall Study|Sponsor decision|1|||
155036865|NCT00337779|559561837|FG001|Overall Study|Sponsor decision|1|||
155036866|NCT00337779|559561836|FG000|Overall Study|Physician Decision|3|||
155036867|NCT00337779|559561837|FG001|Overall Study|Physician Decision|6|||
155036868|NCT00337779|559561836|FG000|Overall Study|Protocol Violation|1|||
155036869|NCT00337779|559561837|FG001|Overall Study|Protocol Violation|1|||
155036870|NCT00337779|559561836|FG000|Overall Study|Lost to Follow-up|6|||
155036871|NCT00337779|559561837|FG001|Overall Study|Lost to Follow-up|5|||
155036872|NCT00337779|559561836|FG000|Overall Study|Adverse Event|28|||
155036873|NCT00337779|559561837|FG001|Overall Study|Adverse Event|51|||
155036874|NCT00337779|559561836|FG000|Overall Study|Pregnancy|3|||
155036875|NCT00337779|559561837|FG001|Overall Study|Pregnancy|2|||
155036876|NCT00337779|559561836|FG000|Overall Study|Death|0|||
155036877|NCT00337779|559561837|FG001|Overall Study|Death|1|||
155036878|NCT01074255|559561838|FG000|Overall Study|Did not receive EMEND|2|||
155036879|NCT03627416|559561856|FG000|Overall Study|Adverse Event|0|||
155036880|NCT03627416|559561857|FG001|Overall Study|Adverse Event|1|||
155036881|NCT01294371|559561858|FG000|Overall Study|Adverse Event|1|||
155036882|NCT01294371|559561858|FG000|Overall Study|Withdrawal by Subject|12|||
155036883|NCT01294371|559561858|FG000|Overall Study|Lost to Follow-up|6|||
155036884|NCT01294371|559561858|FG000|Overall Study|Administrative Reason|1|||
155036885|NCT01294371|559561858|FG000|Overall Study|Other|14|||
155036886|NCT02968433|559561859|FG000|Overall Study|Withdrawal by Subject|1|||
155036887|NCT05619536|559561860|FG000|Overall Study|Withdrawal by Subject|0|||
155036888|NCT05619536|559561861|FG001|Overall Study|Withdrawal by Subject|1|||
155036889|NCT05619536|559561862|FG002|Overall Study|Withdrawal by Subject|0|||
155036890|NCT05619536|559561863|FG003|Overall Study|Withdrawal by Subject|1|||
155036891|NCT05619536|559561860|FG000|Overall Study|Lost to Follow-up|0|||
155036892|NCT05619536|559561861|FG001|Overall Study|Lost to Follow-up|1|||
155036893|NCT05619536|559561862|FG002|Overall Study|Lost to Follow-up|1|||
155036894|NCT05619536|559561863|FG003|Overall Study|Lost to Follow-up|0|||
155036895|NCT00875433|559561864|FG000|Overall Study|Progressive disease|41|||
155036896|NCT00875433|559561864|FG000|Overall Study|Other Adverse Event|14|||
155036897|NCT00875433|559561864|FG000|Overall Study|Withdrawal by Subject|2|||
155036898|NCT00875433|559561864|FG000|Overall Study|Other|3|||
155036899|NCT04272606|559561865|FG000|Overall Study|Protocol Violation|1|||
155036900|NCT04272606|559561866|FG001|Overall Study|Protocol Violation|1|||
155036901|NCT04272606|559561865|FG000|Overall Study|Physician Decision|0|||
155036902|NCT04272606|559561866|FG001|Overall Study|Physician Decision|1|||
155036903|NCT00637806|559561867|FG000|Double-blind Phase|Study Discontinued|2|||
155036904|NCT00637806|559561868|FG001|Double-blind Phase|Study Discontinued|0|||
155036905|NCT00637806|559561869|FG002|Double-blind Phase|Study Discontinued|1|||
155036906|NCT00637806|559561870|FG003|Double-blind Phase|Study Discontinued|0|||
155036907|NCT00637806|559561867|FG000|Extension Phase|Study Discontinued|0|||
155036908|NCT00637806|559561868|FG001|Extension Phase|Study Discontinued|0|||
155036909|NCT00637806|559561869|FG002|Extension Phase|Study Discontinued|0|||
155036910|NCT00637806|559561870|FG003|Extension Phase|Study Discontinued|1|||
155036911|NCT00725101|559561871|FG000|Overall Study|Death|3|||
155036912|NCT00725101|559561871|FG000|Overall Study|Lost to Follow-up|353|||
155036913|NCT00725101|559561871|FG000|Overall Study|Protocol Violation|1|||
155036914|NCT00725101|559561871|FG000|Overall Study|Withdrawal by Subject|127|||
155143977|NCT03160898|559959547|FG002|Overall Study|Progressive Disease|2|||
155036915|NCT00725101|559561871|FG000|Overall Study|not specified/no reason given|11|||
155036916|NCT04148287|559561877|FG000|Overall Study|Death|2|||
155036917|NCT02923245|559561879|FG000|Overall Study|ultrasound order was cancelled|2|||
155036918|NCT02923245|559561880|FG001|Overall Study|ultrasound order was cancelled|1|||
155036919|NCT00824382|559561881|FG000|Overall Study|Adverse Event|4|||
155036920|NCT00824382|559561882|FG001|Overall Study|Adverse Event|1|||
155036921|NCT00824382|559561883|FG002|Overall Study|Adverse Event|1|||
155036922|NCT00824382|559561884|FG003|Overall Study|Adverse Event|4|||
155036923|NCT00824382|559561881|FG000|Overall Study|Protocol Violation|1|||
155036924|NCT00824382|559561882|FG001|Overall Study|Protocol Violation|0|||
155036925|NCT00824382|559561883|FG002|Overall Study|Protocol Violation|0|||
155036926|NCT00824382|559561884|FG003|Overall Study|Protocol Violation|1|||
155036927|NCT00824382|559561881|FG000|Overall Study|Investigator's decision|0|||
155036928|NCT00824382|559561882|FG001|Overall Study|Investigator's decision|1|||
155036929|NCT00824382|559561883|FG002|Overall Study|Investigator's decision|2|||
155036930|NCT00824382|559561884|FG003|Overall Study|Investigator's decision|0|||
155036931|NCT02680834|559561885|FG000|Overall Study|Physician Decision|5|||
155036932|NCT02680834|559561886|FG001|Overall Study|Physician Decision|2|||
155036933|NCT02680834|559561885|FG000|Overall Study|Withdrawal by Subject|6|||
155036934|NCT02680834|559561886|FG001|Overall Study|Withdrawal by Subject|0|||
155036935|NCT02680834|559561885|FG000|Overall Study|Lost to Follow-up|0|||
155036936|NCT02680834|559561886|FG001|Overall Study|Lost to Follow-up|1|||
155036937|NCT02520427|559561887|FG000|Overall Study|Decision by sponsor|0|||
155036938|NCT02520427|559561888|FG001|Overall Study|Decision by sponsor|0|||
155036939|NCT02520427|559561889|FG002|Overall Study|Decision by sponsor|0|||
155036940|NCT02520427|559561890|FG003|Overall Study|Decision by sponsor|0|||
155036941|NCT02520427|559561891|FG004|Overall Study|Decision by sponsor|0|||
155036942|NCT02520427|559561892|FG005|Overall Study|Decision by sponsor|0|||
155036943|NCT02520427|559561893|FG006|Overall Study|Decision by sponsor|0|||
155036944|NCT02520427|559561894|FG007|Overall Study|Decision by sponsor|0|||
155036945|NCT02520427|559561895|FG008|Overall Study|Decision by sponsor|1|||
155036946|NCT02520427|559561896|FG009|Overall Study|Decision by sponsor|1|||
155036947|NCT02520427|559561897|FG010|Overall Study|Decision by sponsor|0|||
155036948|NCT02520427|559561898|FG011|Overall Study|Decision by sponsor|0|||
155036949|NCT02520427|559561899|FG012|Overall Study|Decision by sponsor|0|||
155036950|NCT02520427|559561900|FG013|Overall Study|Decision by sponsor|0|||
155036951|NCT02520427|559561901|FG014|Overall Study|Decision by sponsor|0|||
155036952|NCT02520427|559561902|FG015|Overall Study|Decision by sponsor|0|||
155036953|NCT02520427|559561903|FG016|Overall Study|Decision by sponsor|0|||
155036954|NCT02520427|559561904|FG017|Overall Study|Decision by sponsor|0|||
155036955|NCT02520427|559561905|FG018|Overall Study|Decision by sponsor|0|||
155036956|NCT02520427|559561906|FG019|Overall Study|Decision by sponsor|0|||
155036957|NCT02520427|559561907|FG020|Overall Study|Decision by sponsor|0|||
155036958|NCT02520427|559561908|FG021|Overall Study|Decision by sponsor|0|||
155036959|NCT02520427|559561909|FG022|Overall Study|Decision by sponsor|0|||
155036960|NCT02520427|559561910|FG023|Overall Study|Decision by sponsor|0|||
155036961|NCT02520427|559561911|FG024|Overall Study|Decision by sponsor|0|||
155036962|NCT02520427|559561912|FG025|Overall Study|Decision by sponsor|0|||
155143978|NCT03160898|559959548|FG003|Overall Study|Progressive Disease|1|||
155143979|NCT03160898|559959545|FG000|Overall Study|Protocol Violation|1|||
155143980|NCT03160898|559959546|FG001|Overall Study|Protocol Violation|0|||
155143981|NCT03160898|559959547|FG002|Overall Study|Protocol Violation|2|||
155143982|NCT03160898|559959548|FG003|Overall Study|Protocol Violation|0|||
155143983|NCT03160898|559959545|FG000|Overall Study|Sponsor Discretion|2|||
155143984|NCT03160898|559959546|FG001|Overall Study|Sponsor Discretion|0|||
155143985|NCT03160898|559959547|FG002|Overall Study|Sponsor Discretion|0|||
155143986|NCT03160898|559959548|FG003|Overall Study|Sponsor Discretion|0|||
155143987|NCT03160898|559959545|FG000|Overall Study|Withdrawal by Subject|1|||
155143988|NCT03160898|559959546|FG001|Overall Study|Withdrawal by Subject|3|||
155143989|NCT03160898|559959547|FG002|Overall Study|Withdrawal by Subject|2|||
155143990|NCT03160898|559959548|FG003|Overall Study|Withdrawal by Subject|1|||
155143991|NCT03160898|559959545|FG000|Overall Study|Other|2|||
155143992|NCT03160898|559959546|FG001|Overall Study|Other|0|||
155143993|NCT03160898|559959547|FG002|Overall Study|Other|2|||
155143994|NCT03160898|559959548|FG003|Overall Study|Other|2|||
155143995|NCT00434109|559959551|FG000|Overall Study|Physician Decision|9|||
155143996|NCT00434109|559959551|FG000|Overall Study|Adverse Event|5|||
155143997|NCT00434109|559959551|FG000|Overall Study|Protocol Violation|1|||
155036963|NCT02520427|559561887|FG000|Overall Study|Withdrawal by Subject|0|||
155036964|NCT02520427|559561888|FG001|Overall Study|Withdrawal by Subject|0|||
155036965|NCT02520427|559561889|FG002|Overall Study|Withdrawal by Subject|1|||
155036966|NCT02520427|559561890|FG003|Overall Study|Withdrawal by Subject|0|||
155036967|NCT02520427|559561891|FG004|Overall Study|Withdrawal by Subject|0|||
155143998|NCT00434109|559959551|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
155143999|NCT00103740|559959552|FG000|Period 1 - Core|Adverse Event|1|||
155144000|NCT00103740|559959553|FG001|Period 1 - Core|Adverse Event|0|||
155036968|NCT02520427|559561892|FG005|Overall Study|Withdrawal by Subject|0|||
155144001|NCT00103740|559959552|FG000|Period 1 - Core|Protocol Violation|3|||
155144002|NCT00103740|559959553|FG001|Period 1 - Core|Protocol Violation|2|||
155186585|NCT03497676|560122837|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
155186586|NCT03497676|560122838|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
155186587|NCT03497676|560122839|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
155186588|NCT03497676|560122840|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
155186589|NCT03497676|560122837|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
155186590|NCT03497676|560122838|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
155186591|NCT03497676|560122839|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
155186592|NCT03497676|560122840|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
155186593|NCT03497676|560122837|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
155186594|NCT03497676|560122838|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
155186595|NCT03497676|560122839|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
155186596|NCT03497676|560122840|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
155186597|NCT03497676|560122837|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
155186598|NCT03497676|560122838|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
155186599|NCT03497676|560122839|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
155186600|NCT03497676|560122840|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
155186601|NCT03497676|560122837|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
155186602|NCT03497676|560122838|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
155186603|NCT03497676|560122839|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
155186604|NCT03497676|560122840|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
155186605|NCT03497676|560122837|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
155186606|NCT03497676|560122838|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
155186607|NCT03497676|560122839|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
155186608|NCT03497676|560122840|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
155186609|NCT03497676|560122837|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
155186610|NCT03497676|560122838|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
155186611|NCT03497676|560122839|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
155186612|NCT03497676|560122840|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
155186613|NCT03497676|560122837|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
155186614|NCT03497676|560122838|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
155036969|NCT02520427|559561893|FG006|Overall Study|Withdrawal by Subject|0|||
155036970|NCT02520427|559561894|FG007|Overall Study|Withdrawal by Subject|0|||
155036971|NCT02520427|559561895|FG008|Overall Study|Withdrawal by Subject|0|||
155186615|NCT03497676|560122839|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
155036972|NCT02520427|559561896|FG009|Overall Study|Withdrawal by Subject|0|||
155036973|NCT02520427|559561897|FG010|Overall Study|Withdrawal by Subject|0|||
155036974|NCT02520427|559561898|FG011|Overall Study|Withdrawal by Subject|0|||
155036975|NCT02520427|559561899|FG012|Overall Study|Withdrawal by Subject|1|||
155036976|NCT02520427|559561900|FG013|Overall Study|Withdrawal by Subject|1|||
155036977|NCT02520427|559561901|FG014|Overall Study|Withdrawal by Subject|1|||
155036978|NCT02520427|559561902|FG015|Overall Study|Withdrawal by Subject|0|||
155036979|NCT02520427|559561903|FG016|Overall Study|Withdrawal by Subject|1|||
155036980|NCT02520427|559561904|FG017|Overall Study|Withdrawal by Subject|0|||
155036981|NCT02520427|559561905|FG018|Overall Study|Withdrawal by Subject|0|||
155036982|NCT02520427|559561906|FG019|Overall Study|Withdrawal by Subject|3|||
155036983|NCT02520427|559561907|FG020|Overall Study|Withdrawal by Subject|2|||
155036984|NCT02520427|559561908|FG021|Overall Study|Withdrawal by Subject|0|||
155036985|NCT02520427|559561909|FG022|Overall Study|Withdrawal by Subject|0|||
155036986|NCT02520427|559561910|FG023|Overall Study|Withdrawal by Subject|0|||
155036987|NCT02520427|559561911|FG024|Overall Study|Withdrawal by Subject|0|||
155036988|NCT02520427|559561912|FG025|Overall Study|Withdrawal by Subject|0|||
155036989|NCT02520427|559561887|FG000|Overall Study|Death|1|||
155036990|NCT02520427|559561888|FG001|Overall Study|Death|0|||
155036991|NCT02520427|559561889|FG002|Overall Study|Death|0|||
155036992|NCT02520427|559561890|FG003|Overall Study|Death|0|||
155036993|NCT02520427|559561891|FG004|Overall Study|Death|0|||
155036994|NCT02520427|559561892|FG005|Overall Study|Death|0|||
155036995|NCT02520427|559561893|FG006|Overall Study|Death|0|||
155036996|NCT02520427|559561894|FG007|Overall Study|Death|0|||
155036997|NCT02520427|559561895|FG008|Overall Study|Death|0|||
155036998|NCT02520427|559561896|FG009|Overall Study|Death|0|||
155036999|NCT02520427|559561897|FG010|Overall Study|Death|0|||
155037000|NCT02520427|559561898|FG011|Overall Study|Death|0|||
155037001|NCT02520427|559561899|FG012|Overall Study|Death|0|||
155037002|NCT02520427|559561900|FG013|Overall Study|Death|0|||
155037003|NCT02520427|559561901|FG014|Overall Study|Death|0|||
155037004|NCT02520427|559561902|FG015|Overall Study|Death|0|||
155037005|NCT02520427|559561903|FG016|Overall Study|Death|2|||
155037006|NCT02520427|559561904|FG017|Overall Study|Death|1|||
155037007|NCT02520427|559561905|FG018|Overall Study|Death|3|||
155037008|NCT02520427|559561906|FG019|Overall Study|Death|2|||
155037009|NCT02520427|559561907|FG020|Overall Study|Death|0|||
155037010|NCT02520427|559561908|FG021|Overall Study|Death|0|||
155037011|NCT02520427|559561909|FG022|Overall Study|Death|1|||
155037012|NCT02520427|559561910|FG023|Overall Study|Death|0|||
155037013|NCT02520427|559561911|FG024|Overall Study|Death|1|||
155037014|NCT02520427|559561912|FG025|Overall Study|Death|0|||
155037015|NCT00793624|559561913|FG000|Overall Study|Adverse Event|18|||
155037016|NCT00793624|559561914|FG001|Overall Study|Adverse Event|16|||
155037017|NCT00793624|559561915|FG002|Overall Study|Adverse Event|15|||
155037018|NCT00793624|559561916|FG003|Overall Study|Adverse Event|20|||
155037019|NCT00793624|559561913|FG000|Overall Study|Lost to Follow-up|2|||
155037020|NCT00793624|559561914|FG001|Overall Study|Lost to Follow-up|2|||
155037021|NCT00793624|559561915|FG002|Overall Study|Lost to Follow-up|4|||
155037022|NCT00793624|559561916|FG003|Overall Study|Lost to Follow-up|0|||
155037023|NCT00793624|559561913|FG000|Overall Study|Withdrawal by Subject|20|||
155037024|NCT00793624|559561914|FG001|Overall Study|Withdrawal by Subject|9|||
155037025|NCT00793624|559561915|FG002|Overall Study|Withdrawal by Subject|11|||
155037026|NCT00793624|559561916|FG003|Overall Study|Withdrawal by Subject|14|||
155037027|NCT00793624|559561913|FG000|Overall Study|Lack of Efficacy|9|||
155037028|NCT00793624|559561914|FG001|Overall Study|Lack of Efficacy|2|||
155037029|NCT00793624|559561915|FG002|Overall Study|Lack of Efficacy|1|||
155037030|NCT00793624|559561916|FG003|Overall Study|Lack of Efficacy|3|||
155037031|NCT00793624|559561913|FG000|Overall Study|Non compliance with protocol|2|||
155037032|NCT00793624|559561914|FG001|Overall Study|Non compliance with protocol|3|||
155037033|NCT00793624|559561915|FG002|Overall Study|Non compliance with protocol|2|||
155037034|NCT00793624|559561916|FG003|Overall Study|Non compliance with protocol|3|||
155037035|NCT00793624|559561913|FG000|Overall Study|Other reason not described above|6|||
155037036|NCT00793624|559561914|FG001|Overall Study|Other reason not described above|4|||
155037037|NCT00793624|559561915|FG002|Overall Study|Other reason not described above|6|||
155144003|NCT00103740|559959552|FG000|Period 1 - Core|Patient withdrew consent|3|||
155144004|NCT00103740|559959553|FG001|Period 1 - Core|Patient withdrew consent|2|||
155186616|NCT03497676|560122840|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
155186617|NCT00237185|560122841|FG000|Core|Adverse Event|3|||
155186618|NCT00237185|560122842|FG001|Core|Adverse Event|4|||
155186619|NCT00237185|560122841|FG000|Core|Abnormal laboratory value|0|||
155186620|NCT00237185|560122842|FG001|Core|Abnormal laboratory value|4|||
155186621|NCT00237185|560122841|FG000|Core|Abnormal test procedure results|1|||
155186622|NCT00237185|560122842|FG001|Core|Abnormal test procedure results|0|||
155186623|NCT00237185|560122841|FG000|Core|Lack of Efficacy|30|||
155186624|NCT00237185|560122842|FG001|Core|Lack of Efficacy|23|||
155186625|NCT00237185|560122841|FG000|Core|Protocol Violation|1|||
155186626|NCT00237185|560122842|FG001|Core|Protocol Violation|1|||
155186627|NCT00237185|560122841|FG000|Core|Withdrawal by Subject|4|||
155186628|NCT00237185|560122842|FG001|Core|Withdrawal by Subject|4|||
155186629|NCT00237185|560122841|FG000|Core|Administrative problems|0|||
155186630|NCT00237185|560122842|FG001|Core|Administrative problems|1|||
155186631|NCT00237185|560122841|FG000|Core|Death|4|||
155186632|NCT00237185|560122842|FG001|Core|Death|0|||
155186633|NCT00237185|560122841|FG000|Core|Determined ineligible post randomization|1|||
155186634|NCT00237185|560122842|FG001|Core|Determined ineligible post randomization|0|||
155186635|NCT00237185|560122841|FG000|Extension|Adverse Event|1|||
155144005|NCT00103740|559959552|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
155144006|NCT00103740|559959553|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
155144007|NCT00103740|559959552|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
155144008|NCT00103740|559959553|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
155144009|NCT00103740|559959552|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
155144010|NCT00103740|559959553|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
155144011|NCT00103740|559959552|FG000|Period 2 - Extended Observation Period|Death|6|||
155144012|NCT00103740|559959553|FG001|Period 2 - Extended Observation Period|Death|2|||
155144013|NCT00103740|559959552|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
155144014|NCT00103740|559959553|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
155144015|NCT01463306|559959554|FG000|Overall Study|Adverse Event|6|||
155186636|NCT00237185|560122842|FG001|Extension|Adverse Event|0|||
155186637|NCT00237185|560122841|FG000|Extension|Abnormal laboratory value|0|||
155186638|NCT00237185|560122842|FG001|Extension|Abnormal laboratory value|1|||
155186639|NCT00237185|560122841|FG000|Extension|Lack of Efficacy|9|||
155037038|NCT00793624|559561916|FG003|Overall Study|Other reason not described above|3|||
155037039|NCT00157248|559561917|FG000|Overall Study|Adverse Event|36|||
155037040|NCT00157248|559561918|FG001|Overall Study|Adverse Event|25|||
155037041|NCT00157248|559561919|FG002|Overall Study|Adverse Event|13|||
155037042|NCT00157248|559561920|FG003|Overall Study|Adverse Event|33|||
155037043|NCT00157248|559561917|FG000|Overall Study|Protocol Violation|4|||
155037044|NCT00157248|559561918|FG001|Overall Study|Protocol Violation|0|||
155037045|NCT00157248|559561919|FG002|Overall Study|Protocol Violation|2|||
155037046|NCT00157248|559561920|FG003|Overall Study|Protocol Violation|2|||
155186640|NCT00237185|560122842|FG001|Extension|Lack of Efficacy|14|||
155186641|NCT00237185|560122841|FG000|Extension|Condition no longer required study drug|0|||
155037047|NCT00157248|559561917|FG000|Overall Study|Lost to Follow-up|0|||
155037048|NCT00157248|559561918|FG001|Overall Study|Lost to Follow-up|1|||
155037049|NCT00157248|559561919|FG002|Overall Study|Lost to Follow-up|0|||
155037050|NCT00157248|559561920|FG003|Overall Study|Lost to Follow-up|0|||
155037051|NCT00157248|559561917|FG000|Overall Study|Withdrawal by Subject|1|||
155037052|NCT00157248|559561918|FG001|Overall Study|Withdrawal by Subject|4|||
155037053|NCT00157248|559561919|FG002|Overall Study|Withdrawal by Subject|3|||
155037054|NCT00157248|559561920|FG003|Overall Study|Withdrawal by Subject|3|||
155037055|NCT00157248|559561917|FG000|Overall Study|site closures, subject moving|7|||
155037056|NCT00157248|559561918|FG001|Overall Study|site closures, subject moving|7|||
155037057|NCT00157248|559561919|FG002|Overall Study|site closures, subject moving|3|||
155037058|NCT00157248|559561920|FG003|Overall Study|site closures, subject moving|9|||
155037059|NCT00415597|559561921|FG000|Enrollment|Withdrawal by Subject|1|||
155037060|NCT00415597|559561921|FG000|Enrollment|Protocol Violation|1|||
155037061|NCT00415597|559561921|FG000|Treatment|Adverse Event|110|||
155037062|NCT00415597|559561921|FG000|Treatment|Lack of Efficacy|39|||
155037063|NCT00415597|559561921|FG000|Treatment|Protocol Violation|67|||
155037064|NCT00415597|559561921|FG000|Treatment|Physician Decision|3|||
155037065|NCT00415597|559561921|FG000|Treatment|Withdrawal by Subject|51|||
155037066|NCT00415597|559561921|FG000|Treatment|Lost to Follow-up|28|||
155037067|NCT00415597|559561921|FG000|Treatment|Drug Screen|2|||
155037068|NCT00415597|559561921|FG000|Treatment|Administrative|3|||
155037069|NCT00415597|559561921|FG000|Treatment|Sponsor Decision|1|||
155037070|NCT00415597|559561921|FG000|Treatment|Multiple Reasons|1|||
155037071|NCT04102865|559561922|FG000|Overall Study|Adverse Event|4|||
155037072|NCT04102865|559561923|FG001|Overall Study|Adverse Event|0|||
155037073|NCT04102865|559561922|FG000|Overall Study|Lost to Follow-up|1|||
155037074|NCT04102865|559561923|FG001|Overall Study|Lost to Follow-up|0|||
155037075|NCT04102865|559561922|FG000|Overall Study|Withdrawal by Subject|2|||
155037076|NCT04102865|559561923|FG001|Overall Study|Withdrawal by Subject|0|||
155037077|NCT02227368|559563788|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
155037078|NCT02227368|559563789|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
155037079|NCT02227368|559563788|FG000|Overall Study|Lost to Follow-up|1|||
155037080|NCT02227368|559563789|FG001|Overall Study|Lost to Follow-up|0|||
155037081|NCT02227368|559563788|FG000|Overall Study|Adverse Event|1|||
155037082|NCT02227368|559563789|FG001|Overall Study|Adverse Event|0|||
155037083|NCT02437188|559563792|FG000|Overall Study|Randomized but did not receive surgery|4|||
155037084|NCT02437188|559563793|FG001|Overall Study|Randomized but did not receive surgery|8|||
155037085|NCT02437188|559563792|FG000|Overall Study|Adverse Event|0|||
155037086|NCT02437188|559563793|FG001|Overall Study|Adverse Event|1|||
155037087|NCT01663857|559563794|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
155037088|NCT01663857|559563795|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
155037089|NCT01663857|559563796|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
155037090|NCT01663857|559563797|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
155037091|NCT01663857|559563794|FG000|Overall Study|Lost to Follow-up|0|||
155037092|NCT01663857|559563795|FG001|Overall Study|Lost to Follow-up|0|||
155037093|NCT01663857|559563796|FG002|Overall Study|Lost to Follow-up|3|||
155037094|NCT01663857|559563797|FG003|Overall Study|Lost to Follow-up|1|||
155037095|NCT01172808|559563800|FG000|Overall Study|Adverse Event|8|||
155037096|NCT01172808|559563801|FG001|Overall Study|Adverse Event|4|||
155037097|NCT01172808|559563802|FG002|Overall Study|Adverse Event|8|||
155037098|NCT01172808|559563803|FG003|Overall Study|Adverse Event|3|||
155037099|NCT01172808|559563800|FG000|Overall Study|Lack of Efficacy|1|||
155037100|NCT01172808|559563801|FG001|Overall Study|Lack of Efficacy|0|||
155037101|NCT01172808|559563802|FG002|Overall Study|Lack of Efficacy|0|||
155037102|NCT01172808|559563803|FG003|Overall Study|Lack of Efficacy|0|||
155037103|NCT01172808|559563800|FG000|Overall Study|Protocol Violation|2|||
155037104|NCT01172808|559563801|FG001|Overall Study|Protocol Violation|2|||
155037105|NCT01172808|559563802|FG002|Overall Study|Protocol Violation|2|||
155037106|NCT01172808|559563803|FG003|Overall Study|Protocol Violation|0|||
155037107|NCT01172808|559563800|FG000|Overall Study|Lost to Follow-up|0|||
155037108|NCT01172808|559563801|FG001|Overall Study|Lost to Follow-up|1|||
155037109|NCT01172808|559563802|FG002|Overall Study|Lost to Follow-up|1|||
155037110|NCT01172808|559563803|FG003|Overall Study|Lost to Follow-up|3|||
155037111|NCT01172808|559563800|FG000|Overall Study|Withdrawal by Subject|4|||
155037112|NCT01172808|559563801|FG001|Overall Study|Withdrawal by Subject|1|||
155186642|NCT00237185|560122842|FG001|Extension|Condition no longer required study drug|1|||
155037113|NCT01172808|559563802|FG002|Overall Study|Withdrawal by Subject|3|||
155037114|NCT01172808|559563803|FG003|Overall Study|Withdrawal by Subject|2|||
155037115|NCT01172808|559563800|FG000|Overall Study|Other|6|||
155037116|NCT01172808|559563801|FG001|Overall Study|Other|5|||
155037117|NCT01172808|559563802|FG002|Overall Study|Other|9|||
155037118|NCT01172808|559563803|FG003|Overall Study|Other|7|||
155186643|NCT00237185|560122841|FG000|Extension|Withdrawal by Subject|3|||
155037119|NCT03774394|559563810|FG000|Overall Study|Withdrawal by Subject|2|||
155037120|NCT03774394|559563811|FG001|Overall Study|Withdrawal by Subject|0|||
155037121|NCT03959488|559563812|FG000|Season 1|Other|6|||
155037122|NCT03959488|559563813|FG001|Season 1|Other|7|||
155037123|NCT03959488|559563814|FG002|Season 1|Other|0|||
155037124|NCT03959488|559563815|FG003|Season 1|Other|0|||
155037125|NCT03959488|559563816|FG004|Season 1|Other|0|||
155037126|NCT03959488|559563812|FG000|Season 1|Withdrawal by parent/guardian|43|||
155037127|NCT03959488|559563813|FG001|Season 1|Withdrawal by parent/guardian|28|||
155037128|NCT03959488|559563814|FG002|Season 1|Withdrawal by parent/guardian|0|||
155037129|NCT03959488|559563815|FG003|Season 1|Withdrawal by parent/guardian|0|||
155037130|NCT03959488|559563816|FG004|Season 1|Withdrawal by parent/guardian|0|||
155037131|NCT03959488|559563812|FG000|Season 1|Due to COVID-19 pandemic|2|||
155037132|NCT03959488|559563813|FG001|Season 1|Due to COVID-19 pandemic|3|||
155037133|NCT03959488|559563814|FG002|Season 1|Due to COVID-19 pandemic|0|||
155037134|NCT03959488|559563815|FG003|Season 1|Due to COVID-19 pandemic|0|||
155037135|NCT03959488|559563816|FG004|Season 1|Due to COVID-19 pandemic|0|||
155037136|NCT03959488|559563812|FG000|Season 1|Lost to Follow-up|17|||
155037137|NCT03959488|559563813|FG001|Season 1|Lost to Follow-up|7|||
155037138|NCT03959488|559563814|FG002|Season 1|Lost to Follow-up|0|||
155037139|NCT03959488|559563815|FG003|Season 1|Lost to Follow-up|0|||
155037140|NCT03959488|559563816|FG004|Season 1|Lost to Follow-up|0|||
155037141|NCT03959488|559563812|FG000|Season 1|Death|5|||
155037142|NCT03959488|559563813|FG001|Season 1|Death|1|||
155037143|NCT03959488|559563814|FG002|Season 1|Death|0|||
155037144|NCT03959488|559563815|FG003|Season 1|Death|0|||
155037145|NCT03959488|559563816|FG004|Season 1|Death|0|||
155037146|NCT03959488|559563812|FG000|Season 2|Other|0|||
155037147|NCT03959488|559563813|FG001|Season 2|Other|0|||
155037148|NCT03959488|559563814|FG002|Season 2|Other|2|||
155037149|NCT03959488|559563815|FG003|Season 2|Other|0|||
155186644|NCT00237185|560122842|FG001|Extension|Withdrawal by Subject|2|||
155186645|NCT00237185|560122841|FG000|Extension|Lost to Follow-up|1|||
155186646|NCT00237185|560122842|FG001|Extension|Lost to Follow-up|0|||
155186647|NCT00237185|560122841|FG000|Extension|Administrative problems|1|||
155186648|NCT00237185|560122842|FG001|Extension|Administrative problems|0|||
155186649|NCT00237185|560122841|FG000|Extension|Death|1|||
155186650|NCT00237185|560122842|FG001|Extension|Death|1|||
155186651|NCT00910988|560122849|FG000|Overall Study|Lost to Follow-up|2|||
155186652|NCT00910988|560122850|FG001|Overall Study|Lost to Follow-up|4|||
155186653|NCT00910988|560122851|FG002|Overall Study|Lost to Follow-up|3|||
155186654|NCT00910988|560122852|FG003|Overall Study|Lost to Follow-up|0|||
155186655|NCT03911843|560122857|FG000|Overall Study|Adverse Event|2|||
155186656|NCT03911843|560122858|FG001|Overall Study|Adverse Event|0|||
155186657|NCT03911843|560122857|FG000|Overall Study|Protocol Violation|2|||
155186658|NCT03911843|560122858|FG001|Overall Study|Protocol Violation|0|||
155186659|NCT03911843|560122857|FG000|Overall Study|Lost to Follow-up|0|||
155186660|NCT03911843|560122858|FG001|Overall Study|Lost to Follow-up|1|||
155186661|NCT02819518|560122859|FG000|Overall Study|Death|9|||
155186662|NCT02819518|560122860|FG001|Overall Study|Death|12|||
155186663|NCT02819518|560122861|FG002|Overall Study|Death|9|||
155186664|NCT02819518|560122862|FG003|Overall Study|Death|475|||
155186665|NCT02819518|560122863|FG004|Overall Study|Death|244|||
155186666|NCT02819518|560122859|FG000|Overall Study|Withdrawal by Subject|0|||
155186667|NCT02819518|560122860|FG001|Overall Study|Withdrawal by Subject|0|||
155186668|NCT02819518|560122861|FG002|Overall Study|Withdrawal by Subject|0|||
155186669|NCT02819518|560122862|FG003|Overall Study|Withdrawal by Subject|25|||
155186670|NCT02819518|560122863|FG004|Overall Study|Withdrawal by Subject|8|||
155186671|NCT02819518|560122859|FG000|Overall Study|Lost to Follow-up|0|||
155186672|NCT02819518|560122860|FG001|Overall Study|Lost to Follow-up|0|||
155186673|NCT02819518|560122861|FG002|Overall Study|Lost to Follow-up|0|||
155186674|NCT02819518|560122862|FG003|Overall Study|Lost to Follow-up|0|||
155186675|NCT02819518|560122863|FG004|Overall Study|Lost to Follow-up|1|||
155186676|NCT02819518|560122859|FG000|Overall Study|Sponsor Decision|1|||
155186677|NCT02819518|560122860|FG001|Overall Study|Sponsor Decision|1|||
155186678|NCT02819518|560122861|FG002|Overall Study|Sponsor Decision|0|||
155186679|NCT02819518|560122862|FG003|Overall Study|Sponsor Decision|34|||
155186680|NCT02819518|560122863|FG004|Overall Study|Sponsor Decision|17|||
155186681|NCT02819518|560122859|FG000|Overall Study|Transferred to extension study|1|||
155037150|NCT03959488|559563816|FG004|Season 2|Other|0|||
155037151|NCT03959488|559563812|FG000|Season 2|Withdrawal by parent/guardian|0|||
155186682|NCT02819518|560122860|FG001|Overall Study|Transferred to extension study|1|||
155186683|NCT02819518|560122861|FG002|Overall Study|Transferred to extension study|1|||
155186684|NCT02819518|560122862|FG003|Overall Study|Transferred to extension study|32|||
155186685|NCT02819518|560122863|FG004|Overall Study|Transferred to extension study|11|||
155186686|NCT00880165|560122864|FG000|Overall Study|Withdrawal by Subject|27|||
155037152|NCT03959488|559563813|FG001|Season 2|Withdrawal by parent/guardian|0|||
155037153|NCT03959488|559563814|FG002|Season 2|Withdrawal by parent/guardian|3|||
155037154|NCT03959488|559563815|FG003|Season 2|Withdrawal by parent/guardian|1|||
155037155|NCT03959488|559563816|FG004|Season 2|Withdrawal by parent/guardian|1|||
155037156|NCT03959488|559563812|FG000|Season 2|Lost to Follow-up|0|||
155037157|NCT03959488|559563813|FG001|Season 2|Lost to Follow-up|0|||
155186687|NCT00880165|560122865|FG001|Overall Study|Withdrawal by Subject|23|||
155186688|NCT00880165|560122864|FG000|Overall Study|Not diagnosed with OSA|14|||
155186689|NCT00880165|560122865|FG001|Overall Study|Not diagnosed with OSA|8|||
155186690|NCT00880165|560122864|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
155186691|NCT00880165|560122865|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
155186692|NCT00880165|560122864|FG000|Overall Study|Lost to follow|9|||
155186693|NCT00880165|560122865|FG001|Overall Study|Lost to follow|15|||
155186694|NCT01758289|560122866|FG000|Overall Study|Premature Study Termination|44|||
155186695|NCT01758289|560122866|FG000|Overall Study|Adverse Event|9|||
155186696|NCT00395538|560122871|FG000|Overall Study|Did not re-consent to revised protocol|1|||
155186697|NCT00395538|560122872|FG001|Overall Study|Did not re-consent to revised protocol|10|||
155186698|NCT00395538|560122873|FG002|Overall Study|Did not re-consent to revised protocol|0|||
155186699|NCT00395538|560122871|FG000|Overall Study|FDA partial hold on PTH|0|||
155186700|NCT00395538|560122872|FG001|Overall Study|FDA partial hold on PTH|0|||
155186701|NCT00395538|560122873|FG002|Overall Study|FDA partial hold on PTH|11|||
155186702|NCT00395538|560122871|FG000|Overall Study|Failed screening|0|||
155186703|NCT00395538|560122872|FG001|Overall Study|Failed screening|0|||
155186704|NCT00395538|560122873|FG002|Overall Study|Failed screening|4|||
155186705|NCT00395538|560122871|FG000|Overall Study|Switch to Natpara|0|||
155186706|NCT00395538|560122872|FG001|Overall Study|Switch to Natpara|0|||
155186707|NCT00395538|560122873|FG002|Overall Study|Switch to Natpara|3|||
155186708|NCT00395538|560122871|FG000|Overall Study|Adverse Event|1|||
155186709|NCT00395538|560122872|FG001|Overall Study|Adverse Event|0|||
155186710|NCT00395538|560122873|FG002|Overall Study|Adverse Event|2|||
155186711|NCT00395538|560122871|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
155186712|NCT00395538|560122872|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
155186713|NCT00395538|560122873|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
155186714|NCT00395538|560122871|FG000|Overall Study|Non-compliance with study protocol|0|||
155186715|NCT00395538|560122872|FG001|Overall Study|Non-compliance with study protocol|1|||
155186716|NCT00395538|560122873|FG002|Overall Study|Non-compliance with study protocol|0|||
155186717|NCT00395538|560122871|FG000|Overall Study|PTH resistance|0|||
155186718|NCT00395538|560122872|FG001|Overall Study|PTH resistance|0|||
155186719|NCT00395538|560122873|FG002|Overall Study|PTH resistance|1|||
155186720|NCT00395538|560122871|FG000|Overall Study|Pregnancy|1|||
155186721|NCT00395538|560122872|FG001|Overall Study|Pregnancy|0|||
155186722|NCT00395538|560122873|FG002|Overall Study|Pregnancy|0|||
155186723|NCT00395538|560122871|FG000|Overall Study|Partial recovery of parathyroid function|0|||
155186724|NCT00395538|560122872|FG001|Overall Study|Partial recovery of parathyroid function|0|||
155186725|NCT00395538|560122873|FG002|Overall Study|Partial recovery of parathyroid function|1|||
155186726|NCT00395538|560122871|FG000|Overall Study|Participant elected to discontinue|0|||
155186727|NCT00395538|560122872|FG001|Overall Study|Participant elected to discontinue|0|||
155186728|NCT00395538|560122873|FG002|Overall Study|Participant elected to discontinue|1|||
155186729|NCT04669535|560122880|FG000|Overall Study|Death|1|||
155186730|NCT04669535|560122881|FG001|Overall Study|Death|1|||
155186731|NCT04669535|560122882|FG002|Overall Study|Death|0|||
155186732|NCT04669535|560122883|FG003|Overall Study|Death|0|||
155186733|NCT05169567|560122885|FG000|Overall Study|On study treatment|116|||
155186734|NCT05169567|560122886|FG001|Overall Study|On study treatment|128|||
155186735|NCT05169567|560122885|FG000|Overall Study|Lost to Follow-up|1|||
155186736|NCT05169567|560122886|FG001|Overall Study|Lost to Follow-up|0|||
155186737|NCT05169567|560122885|FG000|Overall Study|Withdrawal by Subject|25|||
155186738|NCT05169567|560122886|FG001|Overall Study|Withdrawal by Subject|21|||
155186739|NCT02211638|560122887|FG000|Overall Study|Case Report Forms Uncollected|291|||
155186740|NCT02211638|560122887|FG000|Overall Study|Protocol Violation|692|||
155186741|NCT04041700|560122890|FG000|Overall Study|Pregnancy|1|||
155186742|NCT04041700|560122890|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
155037158|NCT03959488|559563814|FG002|Season 2|Lost to Follow-up|1|||
155037159|NCT03959488|559563815|FG003|Season 2|Lost to Follow-up|0|||
155037160|NCT03959488|559563816|FG004|Season 2|Lost to Follow-up|1|||
155037161|NCT01716520|559563817|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
155037162|NCT01716520|559563818|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
155037163|NCT01716520|559563819|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
155037164|NCT01716520|559563820|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
155186743|NCT02775903|560122891|FG000|Overall Study|Death|7|||
155186744|NCT02775903|560122892|FG001|Overall Study|Death|11|||
155186745|NCT02775903|560122893|FG002|Overall Study|Death|12|||
155186746|NCT02775903|560122894|FG003|Overall Study|Death|11|||
155186747|NCT02775903|560122891|FG000|Overall Study|Adverse Event|0|||
155186748|NCT02775903|560122892|FG001|Overall Study|Adverse Event|1|||
155186749|NCT02775903|560122893|FG002|Overall Study|Adverse Event|12|||
155186750|NCT02775903|560122894|FG003|Overall Study|Adverse Event|3|||
155186751|NCT02775903|560122891|FG000|Overall Study|Progressive disease|15|||
155186752|NCT02775903|560122892|FG001|Overall Study|Progressive disease|14|||
155186753|NCT02775903|560122893|FG002|Overall Study|Progressive disease|30|||
155186754|NCT02775903|560122894|FG003|Overall Study|Progressive disease|20|||
155186755|NCT02775903|560122891|FG000|Overall Study|Lack of Efficacy|2|||
155186756|NCT02775903|560122892|FG001|Overall Study|Lack of Efficacy|2|||
155037165|NCT01716520|559563821|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
155186757|NCT02775903|560122893|FG002|Overall Study|Lack of Efficacy|2|||
155186758|NCT02775903|560122894|FG003|Overall Study|Lack of Efficacy|6|||
155186759|NCT02775903|560122891|FG000|Overall Study|Withdrawal by Subject|7|||
155186760|NCT02775903|560122892|FG001|Overall Study|Withdrawal by Subject|5|||
155186761|NCT02775903|560122893|FG002|Overall Study|Withdrawal by Subject|5|||
155186762|NCT02775903|560122894|FG003|Overall Study|Withdrawal by Subject|8|||
155186763|NCT02775903|560122891|FG000|Overall Study|Other reasons|7|||
155186764|NCT02775903|560122892|FG001|Overall Study|Other reasons|8|||
155186765|NCT02775903|560122893|FG002|Overall Study|Other reasons|2|||
155186766|NCT02775903|560122894|FG003|Overall Study|Other reasons|12|||
155186767|NCT00458536|560122897|FG000|Overall Study|Disease progression prior to treatment|7|||
155186768|NCT00458536|560122897|FG000|Overall Study|Unable to make vaccine|3|||
155186769|NCT00458536|560122897|FG000|Overall Study|No measurable disease after surgery|2|||
155186770|NCT00458536|560122897|FG000|Overall Study|Did not have renal cell carcinoma|2|||
155186771|NCT00458536|560122897|FG000|Overall Study|Patient did not have surgery|1|||
155186772|NCT00458536|560122897|FG000|Overall Study|Ineligible due to toxicity|1|||
155186773|NCT00458536|560122897|FG000|Overall Study|Withdrawal by Subject|1|||
155186774|NCT00458536|560122897|FG000|Overall Study|Progressive disease during treatment|2|||
155186775|NCT03120624|560122900|FG000|Overall Study|Withdrawal by Subject|0|||
155186776|NCT03120624|560122901|FG001|Overall Study|Withdrawal by Subject|1|||
155186777|NCT03120624|560122902|FG002|Overall Study|Withdrawal by Subject|0|||
155186778|NCT03120624|560122903|FG003|Overall Study|Withdrawal by Subject|0|||
155186779|NCT03120624|560122904|FG004|Overall Study|Withdrawal by Subject|0|||
155186780|NCT03120624|560122905|FG005|Overall Study|Withdrawal by Subject|0|||
155186781|NCT03120624|560122906|FG006|Overall Study|Withdrawal by Subject|0|||
155186782|NCT03120624|560122907|FG007|Overall Study|Withdrawal by Subject|0|||
155186783|NCT00215683|560124563|FG000|Overall Study|Adverse Event|15|||
155186784|NCT00215683|560124564|FG001|Overall Study|Adverse Event|16|||
155186785|NCT00215683|560124565|FG002|Overall Study|Adverse Event|15|||
155186786|NCT00215683|560124563|FG000|Overall Study|Lack of Efficacy|5|||
155186787|NCT00215683|560124564|FG001|Overall Study|Lack of Efficacy|1|||
155186788|NCT00215683|560124565|FG002|Overall Study|Lack of Efficacy|2|||
155186789|NCT00215683|560124563|FG000|Overall Study|Lost to Follow-up|0|||
155186790|NCT00215683|560124564|FG001|Overall Study|Lost to Follow-up|2|||
155186791|NCT00215683|560124565|FG002|Overall Study|Lost to Follow-up|1|||
155186792|NCT00215683|560124563|FG000|Overall Study|Withdrawal by Subject|9|||
155186793|NCT00215683|560124564|FG001|Overall Study|Withdrawal by Subject|4|||
155186794|NCT00215683|560124565|FG002|Overall Study|Withdrawal by Subject|13|||
155186795|NCT00215683|560124563|FG000|Overall Study|Physician Decision|0|||
155186796|NCT00215683|560124564|FG001|Overall Study|Physician Decision|0|||
155186797|NCT00215683|560124565|FG002|Overall Study|Physician Decision|1|||
155186798|NCT00215683|560124563|FG000|Overall Study|Difficult to attend visits|0|||
155186799|NCT00215683|560124564|FG001|Overall Study|Difficult to attend visits|1|||
155186800|NCT00215683|560124565|FG002|Overall Study|Difficult to attend visits|0|||
155186801|NCT00215683|560124563|FG000|Overall Study|No study drug available|0|||
155186802|NCT00215683|560124564|FG001|Overall Study|No study drug available|1|||
155186803|NCT00215683|560124565|FG002|Overall Study|No study drug available|0|||
155186804|NCT00215683|560124563|FG000|Overall Study|Intermittent therapy required|0|||
155186805|NCT00215683|560124564|FG001|Overall Study|Intermittent therapy required|1|||
155186806|NCT00215683|560124565|FG002|Overall Study|Intermittent therapy required|0|||
155186807|NCT02171065|560124566|FG000|Overall Study|Withdrawal by Subject|1|||
155186808|NCT02171065|560124567|FG001|Overall Study|Withdrawal by Subject|0|||
155186809|NCT02171065|560124568|FG002|Overall Study|Withdrawal by Subject|0|||
155186810|NCT02171065|560124566|FG000|Overall Study|Lost to Follow-up|0|||
155186811|NCT02171065|560124567|FG001|Overall Study|Lost to Follow-up|0|||
155186812|NCT02171065|560124568|FG002|Overall Study|Lost to Follow-up|1|||
155186813|NCT00674973|560124569|FG000|Overall Study|Insufficient Therapeutic Response|77|||
155186814|NCT00674973|560124570|FG001|Overall Study|Insufficient Therapeutic Response|72|||
155186815|NCT00674973|560124569|FG000|Overall Study|Refused Treatment|1|||
155186816|NCT00674973|560124570|FG001|Overall Study|Refused Treatment|5|||
155186817|NCT00674973|560124569|FG000|Overall Study|Failure to Return|1|||
155186818|NCT00674973|560124570|FG001|Overall Study|Failure to Return|0|||
155186819|NCT00674973|560124569|FG000|Overall Study|Adverse Event|2|||
155186820|NCT00674973|560124570|FG001|Overall Study|Adverse Event|9|||
155186821|NCT00674973|560124569|FG000|Overall Study|Death|19|||
155186822|NCT00674973|560124570|FG001|Overall Study|Death|15|||
155186823|NCT00674973|560124569|FG000|Overall Study|Protocol Violation|0|||
155186824|NCT00674973|560124570|FG001|Overall Study|Protocol Violation|1|||
155186825|NCT00084838|560124573|FG000|Overall Study|Death|1|||
155186826|NCT00084838|560124573|FG000|Overall Study|Adverse Event|2|||
155186827|NCT00084838|560124573|FG000|Overall Study|Withdrawal by Subject|1|||
155186828|NCT00084838|560124573|FG000|Overall Study|Progressive Disease|4|||
155186829|NCT00084838|560124573|FG000|Overall Study|Pt Non-Compliance|1|||
155186830|NCT00084838|560124573|FG000|Overall Study|Ineligible|4|||
155186831|NCT00518687|560124574|FG000|Overall Study|Adverse Event|201|||
155186832|NCT00518687|560124575|FG001|Overall Study|Adverse Event|177|||
155186833|NCT00518687|560124574|FG000|Overall Study|Lost to Follow-up|144|||
155186834|NCT00518687|560124575|FG001|Overall Study|Lost to Follow-up|155|||
155186835|NCT00518687|560124574|FG000|Overall Study|Physician Decision|42|||
155186836|NCT00518687|560124575|FG001|Overall Study|Physician Decision|48|||
155186837|NCT00518687|560124574|FG000|Overall Study|Progressive disease|2|||
155186838|NCT00518687|560124575|FG001|Overall Study|Progressive disease|2|||
155186839|NCT00518687|560124574|FG000|Overall Study|Protocol Violation|8|||
155186840|NCT00518687|560124575|FG001|Overall Study|Protocol Violation|10|||
155186841|NCT00518687|560124574|FG000|Overall Study|Study terminated by sponsor|930|||
155186842|NCT00518687|560124575|FG001|Overall Study|Study terminated by sponsor|918|||
155186843|NCT00518687|560124574|FG000|Overall Study|Withdrawal by Subject|110|||
155186844|NCT00518687|560124575|FG001|Overall Study|Withdrawal by Subject|110|||
155186845|NCT02231918|560124578|FG000|Overall Study|Withdrawal by Subject|0|||
155186846|NCT02231918|560124579|FG001|Overall Study|Withdrawal by Subject|1|||
155186847|NCT02231918|560124580|FG002|Overall Study|Withdrawal by Subject|0|||
155186848|NCT02231918|560124578|FG000|Overall Study|Adverse Event|0|||
155186849|NCT02231918|560124579|FG001|Overall Study|Adverse Event|0|||
155186850|NCT02231918|560124580|FG002|Overall Study|Adverse Event|1|||
155186851|NCT02395666|560124581|FG000|Overall Study|Physician Decision|3|||
155186852|NCT02395666|560124582|FG001|Overall Study|Physician Decision|0|||
155186853|NCT02395666|560124581|FG000|Overall Study|Lost to Follow-up|1|||
155186854|NCT02395666|560124582|FG001|Overall Study|Lost to Follow-up|0|||
155186855|NCT02395666|560124581|FG000|Overall Study|Withdrawal by Subject|2|||
155186856|NCT02395666|560124582|FG001|Overall Study|Withdrawal by Subject|1|||
155186857|NCT00145600|560124587|FG000|Overall Study|Death|1|||
155186858|NCT00145600|560124588|FG001|Overall Study|Death|2|||
155186859|NCT00145600|560124589|FG002|Overall Study|Death|2|||
155186860|NCT00145600|560124590|FG003|Overall Study|Death|6|||
155186861|NCT00145600|560124587|FG000|Overall Study|Ineligible|3|||
155186862|NCT00145600|560124588|FG001|Overall Study|Ineligible|0|||
155186863|NCT00145600|560124589|FG002|Overall Study|Ineligible|1|||
155186864|NCT00145600|560124590|FG003|Overall Study|Ineligible|5|||
155186865|NCT00145600|560124587|FG000|Overall Study|Lost to Follow-up|2|||
155186866|NCT00145600|560124588|FG001|Overall Study|Lost to Follow-up|6|||
155186867|NCT00145600|560124589|FG002|Overall Study|Lost to Follow-up|2|||
155186868|NCT00145600|560124590|FG003|Overall Study|Lost to Follow-up|4|||
155186869|NCT00145600|560124587|FG000|Overall Study|Noncompliance|1|||
155186870|NCT00145600|560124588|FG001|Overall Study|Noncompliance|0|||
155186871|NCT00145600|560124589|FG002|Overall Study|Noncompliance|0|||
155186872|NCT00145600|560124590|FG003|Overall Study|Noncompliance|0|||
155186873|NCT00145600|560124587|FG000|Overall Study|Withdrawal by Subject|1|||
155186874|NCT00145600|560124588|FG001|Overall Study|Withdrawal by Subject|2|||
155186875|NCT00145600|560124589|FG002|Overall Study|Withdrawal by Subject|0|||
155186876|NCT00145600|560124590|FG003|Overall Study|Withdrawal by Subject|1|||
155186877|NCT04087213|560124591|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
155186878|NCT04087213|560124591|FG000|In-Facility Introduction|Adverse Event|1|||
155186879|NCT04087213|560124591|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
155186880|NCT04087213|560124591|FG000|Assisted Evaluable Period|Personal reasons|3|||
155186881|NCT04087213|560124591|FG000|Transition Period B|Renal Transplantation|1|||
155186882|NCT01272661|560124604|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
155186883|NCT01272661|560124605|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
155186884|NCT01272661|560124606|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
155186885|NCT00750880|560124607|FG000|Overall Study|Adverse Event|76|||
155186886|NCT00750880|560124607|FG000|Overall Study|Death|4|||
155186887|NCT00750880|560124607|FG000|Overall Study|Lack of Efficacy|46|||
155186888|NCT00750880|560124607|FG000|Overall Study|Lost to Follow-up|10|||
155186889|NCT00750880|560124607|FG000|Overall Study|Protocol Violation|15|||
155186890|NCT00750880|560124607|FG000|Overall Study|Withdrawal by Subject|33|||
155186891|NCT00750880|560124607|FG000|Overall Study|Physician Decision|20|||
155186892|NCT00750880|560124607|FG000|Overall Study|Administrative|11|||
155186893|NCT00573248|560124608|FG000|Overall Study|scheduling conflicts|15|||
155186894|NCT00573248|560124609|FG001|Overall Study|scheduling conflicts|11|||
155186895|NCT04505540|560124610|FG000|Baseline|Protocol Violation|10|||
155037166|NCT01716520|559563822|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
155037167|NCT01716520|559563817|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
155037168|NCT01716520|559563818|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037169|NCT01716520|559563819|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
155037170|NCT01716520|559563820|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
155186896|NCT04505540|560124610|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
155186897|NCT04505540|560124610|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
155186898|NCT04505540|560124610|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
155186899|NCT04505540|560124610|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
155186900|NCT04505540|560124610|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
155186901|NCT04505540|560124610|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
155186902|NCT04505540|560124610|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
155186903|NCT04505540|560124610|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
155186904|NCT04505540|560124610|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
155186905|NCT04505540|560124610|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
155186906|NCT04505540|560124610|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
155186907|NCT04505540|560124610|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
155186908|NCT02057393|560124613|FG000|Overall Study|Withdrawal by Subject|1|||
155186909|NCT02057393|560124613|FG000|Overall Study|Patient did not meet criteria|1|||
155186910|NCT03180684|560124614|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
155186911|NCT03180684|560124615|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
155186912|NCT03180684|560124614|FG000|Overall Study|Physician Decision|1|||
155186913|NCT03180684|560124615|FG001|Overall Study|Physician Decision|0|||
155186914|NCT03180684|560124614|FG000|Overall Study|Lost to Follow-up|1|||
155186915|NCT03180684|560124615|FG001|Overall Study|Lost to Follow-up|0|||
155186916|NCT03180684|560124614|FG000|Overall Study|Progressive Disease|1|||
155186917|NCT03180684|560124615|FG001|Overall Study|Progressive Disease|0|||
155186918|NCT01130103|560124618|FG000|Randomized Treatment|Adverse Event|1|||
155186919|NCT01130103|560124619|FG001|Randomized Treatment|Adverse Event|1|||
155186920|NCT01130103|560124618|FG000|Randomized Treatment|Lost to Follow-up|1|||
155186921|NCT01130103|560124619|FG001|Randomized Treatment|Lost to Follow-up|0|||
155186922|NCT01130103|560124618|FG000|Randomized Treatment|Protocol Violation|3|||
155186923|NCT01130103|560124619|FG001|Randomized Treatment|Protocol Violation|2|||
155186924|NCT01130103|560124618|FG000|Randomized Treatment|Withdrawal by Subject|1|||
155186925|NCT01130103|560124619|FG001|Randomized Treatment|Withdrawal by Subject|2|||
155186926|NCT01130103|560124618|FG000|Maintenance Treatment|Lack of Efficacy|0|||
155186927|NCT01130103|560124619|FG001|Maintenance Treatment|Lack of Efficacy|1|||
155186928|NCT01130103|560124618|FG000|Maintenance Treatment|Lost to Follow-up|1|||
155186929|NCT01130103|560124619|FG001|Maintenance Treatment|Lost to Follow-up|1|||
155186930|NCT01130103|560124618|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
155186931|NCT01130103|560124619|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
155186932|NCT03614975|560124620|FG000|Overall Study|Physician Decision|7|||
155186933|NCT03614975|560124621|FG001|Overall Study|Physician Decision|5|||
155186934|NCT03614975|560124620|FG000|Overall Study|Withdrawal by Subject|2|||
155186935|NCT03614975|560124621|FG001|Overall Study|Withdrawal by Subject|2|||
155186936|NCT03614975|560124620|FG000|Overall Study|Specimens not in lab batch shipment|1|||
155186937|NCT03614975|560124621|FG001|Overall Study|Specimens not in lab batch shipment|1|||
155186938|NCT01390220|560124624|FG000|Test Dose Phase|Adverse Event|17|||
155186939|NCT01390220|560124625|FG001|Test Dose Phase|Adverse Event|0|||
155186940|NCT01390220|560124626|FG002|Test Dose Phase|Adverse Event|0|||
155186941|NCT01390220|560124624|FG000|Test Dose Phase|Withdrawal by Subject|8|||
155186942|NCT01390220|560124625|FG001|Test Dose Phase|Withdrawal by Subject|0|||
155186943|NCT01390220|560124626|FG002|Test Dose Phase|Withdrawal by Subject|0|||
155186944|NCT01390220|560124624|FG000|Test Dose Phase|Lost to Follow-up|2|||
155186945|NCT01390220|560124625|FG001|Test Dose Phase|Lost to Follow-up|0|||
155186946|NCT01390220|560124626|FG002|Test Dose Phase|Lost to Follow-up|0|||
155186947|NCT01390220|560124624|FG000|Test Dose Phase|Protocol Violation|8|||
155186948|NCT01390220|560124625|FG001|Test Dose Phase|Protocol Violation|0|||
155186949|NCT01390220|560124626|FG002|Test Dose Phase|Protocol Violation|0|||
155186950|NCT01390220|560124624|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
155186951|NCT01390220|560124625|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
155186952|NCT01390220|560124626|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
155186953|NCT01390220|560124624|FG000|Test Dose Phase|Study/Site closure|6|||
155186954|NCT01390220|560124625|FG001|Test Dose Phase|Study/Site closure|0|||
155186955|NCT01390220|560124626|FG002|Test Dose Phase|Study/Site closure|0|||
155186956|NCT01390220|560124624|FG000|Test Dose Phase|Caregiver no longer available|5|||
155186957|NCT01390220|560124625|FG001|Test Dose Phase|Caregiver no longer available|0|||
155186958|NCT01390220|560124626|FG002|Test Dose Phase|Caregiver no longer available|0|||
155186959|NCT01390220|560124624|FG000|Test Dose Phase|Noncompliance|2|||
155186960|NCT01390220|560124625|FG001|Test Dose Phase|Noncompliance|0|||
155186961|NCT01390220|560124626|FG002|Test Dose Phase|Noncompliance|0|||
155186962|NCT01390220|560124624|FG000|Test Dose Phase|Logistical|6|||
155186963|NCT01390220|560124625|FG001|Test Dose Phase|Logistical|0|||
155186964|NCT01390220|560124626|FG002|Test Dose Phase|Logistical|0|||
155037171|NCT01716520|559563821|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037172|NCT01716520|559563822|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
155037173|NCT01716520|559563817|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155037174|NCT01716520|559563818|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155037175|NCT01716520|559563819|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155037176|NCT01716520|559563820|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155037177|NCT01716520|559563821|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155186965|NCT01390220|560124624|FG000|Comparative Phase|Withdrawal by Subject|0|||
155186966|NCT01390220|560124625|FG001|Comparative Phase|Withdrawal by Subject|1|||
155186967|NCT01390220|560124626|FG002|Comparative Phase|Withdrawal by Subject|0|||
155186968|NCT00249288|560124627|FG000|Overall Study|Lost to Follow-up|3|||
155186969|NCT00249288|560124628|FG001|Overall Study|Lost to Follow-up|3|||
155186970|NCT00249288|560124627|FG000|Overall Study|Withdrawal by Subject|2|||
155186971|NCT00249288|560124628|FG001|Overall Study|Withdrawal by Subject|2|||
155186972|NCT03059446|560124629|FG000|Overall Study|Adverse Event|11|||
155186973|NCT03059446|560124629|FG000|Overall Study|Withdrawal of Consent|16|||
155186974|NCT03059446|560124629|FG000|Overall Study|Lost to Follow-up|3|||
155186975|NCT03059446|560124629|FG000|Overall Study|Protocol Violation|1|||
155186976|NCT03059446|560124629|FG000|Overall Study|Study Terminated by Sponsor|131|||
155186977|NCT03059446|560124629|FG000|Overall Study|Reason not Specified|5|||
155186978|NCT00136604|560124630|FG000|Overall Study|Lost to Follow-up|1|||
155186979|NCT00136604|560124631|FG001|Overall Study|Lost to Follow-up|0|||
155186980|NCT00136604|560124632|FG002|Overall Study|Lost to Follow-up|0|||
155186981|NCT00136604|560124633|FG003|Overall Study|Lost to Follow-up|0|||
155186982|NCT00136604|560124634|FG004|Overall Study|Lost to Follow-up|1|||
155186983|NCT00136604|560124630|FG000|Overall Study|Migrated/moved from study area|0|||
155186984|NCT00136604|560124631|FG001|Overall Study|Migrated/moved from study area|1|||
155186985|NCT00136604|560124632|FG002|Overall Study|Migrated/moved from study area|0|||
155186986|NCT00136604|560124633|FG003|Overall Study|Migrated/moved from study area|0|||
155186987|NCT00136604|560124634|FG004|Overall Study|Migrated/moved from study area|0|||
155186988|NCT03091777|560124635|FG000|Overall Study|Pregnancy|2|||
155186989|NCT03091777|560124636|FG001|Overall Study|Pregnancy|1|||
155186990|NCT03091777|560124637|FG002|Overall Study|Pregnancy|0|||
155186991|NCT03091777|560124635|FG000|Overall Study|Adverse Event|2|||
155186992|NCT03091777|560124636|FG001|Overall Study|Adverse Event|1|||
155186993|NCT03091777|560124637|FG002|Overall Study|Adverse Event|4|||
155186994|NCT03091777|560124635|FG000|Overall Study|Withdrawal by Subject|4|||
155186995|NCT03091777|560124636|FG001|Overall Study|Withdrawal by Subject|2|||
155186996|NCT03091777|560124637|FG002|Overall Study|Withdrawal by Subject|6|||
155186997|NCT03091777|560124635|FG000|Overall Study|Protocol Violation|2|||
155186998|NCT03091777|560124636|FG001|Overall Study|Protocol Violation|1|||
155186999|NCT03091777|560124637|FG002|Overall Study|Protocol Violation|1|||
155187000|NCT03091777|560124635|FG000|Overall Study|Lost to Follow-up|12|||
155187001|NCT03091777|560124636|FG001|Overall Study|Lost to Follow-up|14|||
155187002|NCT03091777|560124637|FG002|Overall Study|Lost to Follow-up|7|||
155187003|NCT03091777|560124635|FG000|Overall Study|Lack of Efficacy|0|||
155187004|NCT03091777|560124636|FG001|Overall Study|Lack of Efficacy|0|||
155187005|NCT03091777|560124637|FG002|Overall Study|Lack of Efficacy|5|||
155187006|NCT03091777|560124635|FG000|Overall Study|Noncompliance with study drug|2|||
155187007|NCT03091777|560124636|FG001|Overall Study|Noncompliance with study drug|3|||
155187008|NCT03091777|560124637|FG002|Overall Study|Noncompliance with study drug|1|||
155187009|NCT03091777|560124635|FG000|Overall Study|Physician Decision|1|||
155187010|NCT03091777|560124636|FG001|Overall Study|Physician Decision|0|||
155187011|NCT03091777|560124637|FG002|Overall Study|Physician Decision|1|||
155187012|NCT03091777|560124635|FG000|Overall Study|Abnormal Laboratory Value|7|||
155187013|NCT03091777|560124636|FG001|Overall Study|Abnormal Laboratory Value|11|||
155187014|NCT03091777|560124637|FG002|Overall Study|Abnormal Laboratory Value|12|||
155187015|NCT02536833|560124638|FG000|Overall Study|Discontinued Before Treatment|0|||
155187016|NCT02536833|560124639|FG001|Overall Study|Discontinued Before Treatment|0|||
155187017|NCT02536833|560124640|FG002|Overall Study|Discontinued Before Treatment|1|||
155187018|NCT02536833|560124641|FG003|Overall Study|Discontinued Before Treatment|2|||
155187019|NCT02536833|560124638|FG000|Overall Study|Adverse Event|1|||
155187020|NCT02536833|560124639|FG001|Overall Study|Adverse Event|3|||
155187021|NCT02536833|560124640|FG002|Overall Study|Adverse Event|4|||
155187022|NCT02536833|560124641|FG003|Overall Study|Adverse Event|1|||
155187023|NCT02536833|560124638|FG000|Overall Study|Lost to Follow-up|2|||
155187024|NCT02536833|560124639|FG001|Overall Study|Lost to Follow-up|1|||
155187025|NCT02536833|560124640|FG002|Overall Study|Lost to Follow-up|2|||
155187026|NCT02536833|560124641|FG003|Overall Study|Lost to Follow-up|2|||
155187027|NCT02536833|560124638|FG000|Overall Study|Physician Decision|0|||
155187028|NCT02536833|560124639|FG001|Overall Study|Physician Decision|0|||
155187029|NCT02536833|560124640|FG002|Overall Study|Physician Decision|0|||
155187030|NCT02536833|560124641|FG003|Overall Study|Physician Decision|1|||
155187031|NCT02536833|560124638|FG000|Overall Study|Site Terminated by Sponsor|2|||
155187032|NCT02536833|560124639|FG001|Overall Study|Site Terminated by Sponsor|2|||
155187033|NCT02536833|560124640|FG002|Overall Study|Site Terminated by Sponsor|2|||
155187034|NCT02536833|560124641|FG003|Overall Study|Site Terminated by Sponsor|2|||
155187035|NCT02536833|560124638|FG000|Overall Study|Subject Non-Compliance|0|||
155187036|NCT02536833|560124639|FG001|Overall Study|Subject Non-Compliance|1|||
155187037|NCT02536833|560124640|FG002|Overall Study|Subject Non-Compliance|1|||
155187038|NCT02536833|560124641|FG003|Overall Study|Subject Non-Compliance|0|||
155187039|NCT02536833|560124638|FG000|Overall Study|Withdrawal by Subject|4|||
155187040|NCT02536833|560124639|FG001|Overall Study|Withdrawal by Subject|3|||
155187041|NCT02536833|560124640|FG002|Overall Study|Withdrawal by Subject|5|||
155187042|NCT02536833|560124641|FG003|Overall Study|Withdrawal by Subject|11|||
155187043|NCT00089674|560124643|FG000|Overall Study|Physician Decision|4|||
155187044|NCT00089674|560124644|FG001|Overall Study|Physician Decision|2|||
155187045|NCT00089674|560124643|FG000|Overall Study|Adverse Event|23|||
155187046|NCT00089674|560124644|FG001|Overall Study|Adverse Event|29|||
155187047|NCT00089674|560124643|FG000|Overall Study|Withdrawal by Subject|143|||
155187048|NCT00089674|560124644|FG001|Overall Study|Withdrawal by Subject|127|||
155187049|NCT00089674|560124643|FG000|Overall Study|Death|43|||
155187050|NCT00089674|560124644|FG001|Overall Study|Death|43|||
155187051|NCT00089674|560124643|FG000|Overall Study|Disease progression|21|||
155187052|NCT00089674|560124644|FG001|Overall Study|Disease progression|23|||
155187053|NCT00089674|560124643|FG000|Overall Study|Ineligibility determined|8|||
155187054|NCT00089674|560124644|FG001|Overall Study|Ineligibility determined|10|||
155187055|NCT00089674|560124643|FG000|Overall Study|Lost to Follow-up|21|||
155187056|NCT00089674|560124644|FG001|Overall Study|Lost to Follow-up|17|||
155187057|NCT00089674|560124643|FG000|Overall Study|Noncompliance|7|||
155187058|NCT00089674|560124644|FG001|Overall Study|Noncompliance|3|||
155187059|NCT00089674|560124643|FG000|Overall Study|Other|5|||
155187060|NCT00089674|560124644|FG001|Overall Study|Other|9|||
155187061|NCT00089674|560124643|FG000|Overall Study|Requirement for alternative therapy|14|||
155187062|NCT00089674|560124644|FG001|Overall Study|Requirement for alternative therapy|4|||
155187063|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
155187064|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
155187065|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
155187066|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
155187067|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
155187068|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
155187069|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187070|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187071|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
155187072|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
155187073|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187074|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
155187075|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
155187076|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
155187077|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
155187078|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
155187079|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
155187080|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
155187081|NCT03963401|560124645|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187082|NCT03963401|560124646|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
155187083|NCT03963401|560124647|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187084|NCT03963401|560124648|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187085|NCT03963401|560124649|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187086|NCT03963401|560124650|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
155187087|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
155187088|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
155187089|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
155187090|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
155187091|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
155187092|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
155187093|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
155187094|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187095|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
155187096|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187097|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187098|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
155187099|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187100|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155037178|NCT01716520|559563822|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155037179|NCT01716520|559563817|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155037180|NCT01716520|559563818|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
155037181|NCT01716520|559563819|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155037182|NCT01716520|559563820|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155037183|NCT01716520|559563821|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155037184|NCT01716520|559563822|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
155187101|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
155187102|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187103|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187104|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
155187105|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
155187106|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155187107|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155037185|NCT01716520|559563817|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155187108|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155187109|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155187110|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
155037186|NCT01716520|559563818|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155037187|NCT01716520|559563819|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155037188|NCT01716520|559563820|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155037189|NCT01716520|559563821|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
155037190|NCT01716520|559563822|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
155037191|NCT01716520|559563817|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155037192|NCT01716520|559563818|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155037193|NCT01716520|559563819|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
155037194|NCT01716520|559563820|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155037195|NCT01716520|559563821|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
155037196|NCT01716520|559563822|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
155037197|NCT01716520|559563817|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
155037198|NCT01716520|559563818|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
155037199|NCT01716520|559563819|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
155037200|NCT01716520|559563820|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
155037201|NCT01716520|559563821|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
155037202|NCT01716520|559563822|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
155037203|NCT01716520|559563817|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155037204|NCT01716520|559563818|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155037205|NCT01716520|559563819|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155037206|NCT01716520|559563820|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155037207|NCT01716520|559563821|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
155037208|NCT01716520|559563822|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
155037209|NCT01716520|559563817|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037210|NCT01716520|559563818|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037211|NCT01716520|559563819|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037212|NCT01716520|559563820|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
155037213|NCT01716520|559563821|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037214|NCT01716520|559563822|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
155037215|NCT01716520|559563817|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
155037216|NCT01716520|559563818|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
155037217|NCT01716520|559563819|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
155037218|NCT01716520|559563820|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
155037219|NCT01716520|559563821|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
155037220|NCT01716520|559563822|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
155037221|NCT01716520|559563817|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
155037222|NCT01716520|559563818|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155037223|NCT01716520|559563819|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155037224|NCT01716520|559563820|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155037225|NCT01716520|559563821|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155037226|NCT01716520|559563822|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
155037227|NCT01716520|559563817|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155037228|NCT01716520|559563818|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155037229|NCT01716520|559563819|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155037230|NCT01716520|559563820|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155037231|NCT01716520|559563821|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
155037232|NCT01716520|559563822|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
155037233|NCT01716520|559563817|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155037234|NCT01716520|559563818|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
155037235|NCT01716520|559563819|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155037236|NCT01716520|559563820|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155037237|NCT01716520|559563821|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155037238|NCT01716520|559563822|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
155037239|NCT01716520|559563817|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155037240|NCT01716520|559563818|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155037241|NCT01716520|559563819|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155037242|NCT01716520|559563820|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155037243|NCT01716520|559563821|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155037244|NCT01716520|559563822|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
155037245|NCT01716520|559563817|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155037246|NCT01716520|559563818|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155037247|NCT01716520|559563819|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
155037248|NCT01716520|559563820|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155037249|NCT01716520|559563821|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155144016|NCT01463306|559959555|FG001|Overall Study|Adverse Event|9|||
155144017|NCT01463306|559959556|FG002|Overall Study|Adverse Event|3|||
155144018|NCT01463306|559959554|FG000|Overall Study|Death|3|||
155187111|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
155187112|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
155187113|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
155187114|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
155187115|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
155187116|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
155187117|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
155187118|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187119|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187120|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187121|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187122|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
155187123|NCT03963401|560124645|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
155187124|NCT03963401|560124646|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
155187125|NCT03963401|560124647|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
155187126|NCT03963401|560124648|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
155187127|NCT03963401|560124649|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
155187128|NCT03963401|560124650|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
155187129|NCT01982331|560124651|FG000|Received Vaccination 2|Adverse Event|1|||
155187130|NCT01982331|560124652|FG001|Received Vaccination 2|Adverse Event|2|||
155187131|NCT01982331|560124651|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
155187132|NCT01982331|560124652|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
155187133|NCT01982331|560124651|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
155187134|NCT01982331|560124652|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
155187135|NCT03488927|560124653|FG000|Overall Study|Withdrawal by Subject|44|||
155187136|NCT03488927|560124654|FG001|Overall Study|Withdrawal by Subject|118|||
155187137|NCT03488927|560124655|FG002|Overall Study|Withdrawal by Subject|217|||
155187138|NCT02204007|560124657|FG000|Overall Study|Surgery Canceled|1|||
155187139|NCT02204007|560124658|FG001|Overall Study|Surgery Canceled|1|||
155187140|NCT02766465|560124659|FG000|Overall Study|Withdrawal by Subject|0|||
155187141|NCT02766465|560124660|FG001|Overall Study|Withdrawal by Subject|10|||
155187142|NCT01907100|560124661|FG000|Overall Study|PD based on modified RECIST criteria|31|||
155187143|NCT01907100|560124662|FG001|Overall Study|PD based on modified RECIST criteria|32|||
155187144|NCT01907100|560124663|FG002|Overall Study|PD based on modified RECIST criteria|95|||
155187145|NCT01907100|560124664|FG003|Overall Study|PD based on modified RECIST criteria|92|||
155187146|NCT01907100|560124661|FG000|Overall Study|Withdrawal by Subject|2|||
155187147|NCT01907100|560124662|FG001|Overall Study|Withdrawal by Subject|5|||
155187148|NCT01907100|560124663|FG002|Overall Study|Withdrawal by Subject|10|||
155187149|NCT01907100|560124664|FG003|Overall Study|Withdrawal by Subject|13|||
155187150|NCT01907100|560124661|FG000|Overall Study|Protocol Violation|0|||
155187151|NCT01907100|560124662|FG001|Overall Study|Protocol Violation|0|||
155187152|NCT01907100|560124663|FG002|Overall Study|Protocol Violation|1|||
155187153|NCT01907100|560124664|FG003|Overall Study|Protocol Violation|1|||
155187154|NCT01907100|560124661|FG000|Overall Study|Lost to Follow-up|0|||
155187155|NCT01907100|560124662|FG001|Overall Study|Lost to Follow-up|0|||
155187156|NCT01907100|560124663|FG002|Overall Study|Lost to Follow-up|0|||
155187157|NCT01907100|560124664|FG003|Overall Study|Lost to Follow-up|1|||
155187158|NCT01907100|560124661|FG000|Overall Study|Not treated|2|||
155187159|NCT01907100|560124662|FG001|Overall Study|Not treated|0|||
155187160|NCT01907100|560124663|FG002|Overall Study|Not treated|1|||
155187161|NCT01907100|560124664|FG003|Overall Study|Not treated|2|||
155037250|NCT01716520|559563822|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
155187162|NCT01907100|560124661|FG000|Overall Study|Other than reasons specified|1|||
155187163|NCT01907100|560124662|FG001|Overall Study|Other than reasons specified|0|||
155187164|NCT01907100|560124663|FG002|Overall Study|Other than reasons specified|10|||
155187165|NCT01907100|560124664|FG003|Overall Study|Other than reasons specified|6|||
155037251|NCT00593606|559563825|FG000|Overall Study|Adverse Event|13|||
155037252|NCT00593606|559563825|FG000|Overall Study|Withdrawal by Subject|1|||
155037253|NCT00593606|559563825|FG000|Overall Study|Protocol Violation|3|||
155037254|NCT00593606|559563825|FG000|Overall Study|Lost to Follow-up|2|||
155037255|NCT00593606|559563825|FG000|Overall Study|Run-In Failure|5|||
155187166|NCT01907100|560124661|FG000|Overall Study|Adverse event (AE)|6|||
155187167|NCT01907100|560124662|FG001|Overall Study|Adverse event (AE)|3|||
155187168|NCT01907100|560124663|FG002|Overall Study|Adverse event (AE)|22|||
155187169|NCT01907100|560124664|FG003|Overall Study|Adverse event (AE)|23|||
155187170|NCT01907100|560124661|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
155187171|NCT01907100|560124662|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
155187172|NCT01907100|560124663|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
155187173|NCT01907100|560124664|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
155037256|NCT00593606|559563825|FG000|Overall Study|Screen Failure|3|||
155037257|NCT00869557|559563826|FG000|Randomized Phase|Lost to Follow-up|2|||
155187174|NCT00667602|560124665|FG000|Overall Study|Withdrawal by Subject|4|||
155187175|NCT00667602|560124666|FG001|Overall Study|Withdrawal by Subject|9|||
155187176|NCT00667602|560124667|FG002|Overall Study|Withdrawal by Subject|10|||
155187177|NCT00667602|560124665|FG000|Overall Study|Lost to Follow-up|4|||
155187178|NCT00667602|560124666|FG001|Overall Study|Lost to Follow-up|5|||
155187179|NCT00667602|560124667|FG002|Overall Study|Lost to Follow-up|6|||
155187180|NCT00667602|560124665|FG000|Overall Study|Administrative reason|0|||
155187181|NCT00667602|560124666|FG001|Overall Study|Administrative reason|0|||
155187182|NCT00667602|560124667|FG002|Overall Study|Administrative reason|2|||
155187183|NCT00667602|560124665|FG000|Overall Study|Protocol Violation|0|||
155187184|NCT00667602|560124666|FG001|Overall Study|Protocol Violation|1|||
155187185|NCT00667602|560124667|FG002|Overall Study|Protocol Violation|0|||
155187186|NCT02301988|560124669|FG000|Overall Study|Withdrawal by Subject|2|||
155187187|NCT02301988|560124670|FG001|Overall Study|Withdrawal by Subject|1|||
155187188|NCT02301988|560124669|FG000|Overall Study|Physician Decision|2|||
155187189|NCT02301988|560124670|FG001|Overall Study|Physician Decision|2|||
155187190|NCT02301988|560124669|FG000|Overall Study|Unknown Reason|1|||
155187191|NCT02301988|560124670|FG001|Overall Study|Unknown Reason|3|||
155187192|NCT02301988|560124669|FG000|Overall Study|Lack of Efficacy|3|||
155187193|NCT02301988|560124670|FG001|Overall Study|Lack of Efficacy|2|||
155187194|NCT02301988|560124669|FG000|Overall Study|Death|1|||
155187195|NCT02301988|560124670|FG001|Overall Study|Death|0|||
155187196|NCT02301988|560124669|FG000|Overall Study|Adverse Event|1|||
155187197|NCT02301988|560124670|FG001|Overall Study|Adverse Event|1|||
155187198|NCT02891161|560124673|FG000|Study Treatment|Disease Progression|2|||
155187199|NCT02891161|560124674|FG001|Study Treatment|Disease Progression|4|||
155187200|NCT02891161|560124673|FG000|Study Treatment|AE/Side Effects/Complications|1|||
155187201|NCT02891161|560124674|FG001|Study Treatment|AE/Side Effects/Complications|5|||
155187202|NCT02891161|560124673|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
155187203|NCT02891161|560124674|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
155187204|NCT02891161|560124673|FG000|Follow up|Death|4|||
155187205|NCT02891161|560124674|FG001|Follow up|Death|8|||
155187206|NCT02891161|560124673|FG000|Follow up|Refused to Follow up|0|||
155187207|NCT02891161|560124674|FG001|Follow up|Refused to Follow up|2|||
155037258|NCT00869557|559563827|FG001|Randomized Phase|Lost to Follow-up|1|||
155037259|NCT00869557|559563826|FG000|Randomized Phase|Investigator's Discretion|1|||
155037260|NCT00869557|559563827|FG001|Randomized Phase|Investigator's Discretion|0|||
155037261|NCT00869557|559563826|FG000|Randomized Phase|Withdrew Consent|0|||
155037262|NCT00869557|559563827|FG001|Randomized Phase|Withdrew Consent|1|||
155037263|NCT00869557|559563826|FG000|Extension Phase|Adverse Event|2|||
155037264|NCT00869557|559563827|FG001|Extension Phase|Adverse Event|2|||
155037265|NCT00869557|559563826|FG000|Extension Phase|Lack of Efficacy|1|||
155037266|NCT00869557|559563827|FG001|Extension Phase|Lack of Efficacy|0|||
155187208|NCT02891161|560124673|FG000|Follow up|Symptomatic deterioration|0|||
155187209|NCT02891161|560124674|FG001|Follow up|Symptomatic deterioration|1|||
155187210|NCT02891161|560124673|FG000|Follow up|Study terminated|0|||
155187211|NCT02891161|560124674|FG001|Follow up|Study terminated|6|||
155187212|NCT01931202|560124676|FG000|Overall Study|Withdrawal by Subject|0|||
155187213|NCT01931202|560124677|FG001|Overall Study|Withdrawal by Subject|0|||
155187214|NCT01931202|560124678|FG002|Overall Study|Withdrawal by Subject|2|||
155187215|NCT01931202|560124676|FG000|Overall Study|Lost to Follow-up|0|||
155187216|NCT01931202|560124677|FG001|Overall Study|Lost to Follow-up|5|||
155187217|NCT01931202|560124678|FG002|Overall Study|Lost to Follow-up|2|||
155187218|NCT01074047|560124679|FG000|Treatment Phase|Adverse Event|89|||
155187219|NCT01074047|560124680|FG001|Treatment Phase|Adverse Event|66|||
155037267|NCT00869557|559563826|FG000|Extension Phase|Lost to Follow-up|3|||
155037268|NCT00869557|559563827|FG001|Extension Phase|Lost to Follow-up|1|||
155037269|NCT00869557|559563826|FG000|Extension Phase|Investigator's Discretion|2|||
155187220|NCT01074047|560124679|FG000|Treatment Phase|Disease Progression|16|||
155037270|NCT00869557|559563827|FG001|Extension Phase|Investigator's Discretion|0|||
155037271|NCT00869557|559563826|FG000|Extension Phase|Withdrew Consent|2|||
155037272|NCT00869557|559563827|FG001|Extension Phase|Withdrew Consent|0|||
155187221|NCT01074047|560124680|FG001|Treatment Phase|Disease Progression|21|||
155187222|NCT01074047|560124679|FG000|Treatment Phase|Withdrawal by Subject|27|||
155187223|NCT01074047|560124680|FG001|Treatment Phase|Withdrawal by Subject|48|||
155187224|NCT01074047|560124679|FG000|Treatment Phase|Death|53|||
155187225|NCT01074047|560124680|FG001|Treatment Phase|Death|58|||
155187226|NCT01074047|560124679|FG000|Treatment Phase|Lost to Follow-up|0|||
155187227|NCT01074047|560124680|FG001|Treatment Phase|Lost to Follow-up|1|||
155187228|NCT01074047|560124679|FG000|Treatment Phase|Protocol Violation|0|||
155037273|NCT02305446|559563828|FG000|Overall Study|Adverse Event|1|||
155037274|NCT05940077|559563829|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
155037275|NCT00388297|559563830|FG000|Overall Study|Lost to Follow-up|16|||
155037276|NCT00388297|559563831|FG001|Overall Study|Lost to Follow-up|12|||
155037277|NCT00388297|559563832|FG002|Overall Study|Lost to Follow-up|11|||
155187229|NCT01074047|560124680|FG001|Treatment Phase|Protocol Violation|1|||
155187230|NCT01074047|560124679|FG000|Treatment Phase|Miscellaneous|32|||
155187231|NCT01074047|560124680|FG001|Treatment Phase|Miscellaneous|39|||
155037278|NCT00388297|559563833|FG003|Overall Study|Lost to Follow-up|8|||
155037279|NCT01492101|559563834|FG000|Overall Study|Death|323|||
155037280|NCT01492101|559563835|FG001|Overall Study|Death|322|||
155037281|NCT01492101|559563834|FG000|Overall Study|Withdrawal by Subject|14|||
155037282|NCT01492101|559563835|FG001|Overall Study|Withdrawal by Subject|18|||
155037283|NCT01492101|559563834|FG000|Overall Study|Lost to Follow-up|0|||
155037284|NCT01492101|559563835|FG001|Overall Study|Lost to Follow-up|2|||
155187232|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
155187233|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
155187234|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
155187235|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
155187236|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Death|116|||
155187237|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Death|124|||
155187238|NCT01074047|560124679|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
155187239|NCT01074047|560124680|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
155187240|NCT01074047|560124679|FG000|Extension Phase|Physician Decision|1|||
155187241|NCT01074047|560124680|FG001|Extension Phase|Physician Decision|0|||
155187242|NCT01074047|560124679|FG000|Extension Phase|Adverse Event|5|||
155187243|NCT01074047|560124680|FG001|Extension Phase|Adverse Event|0|||
155187244|NCT01074047|560124679|FG000|Extension Phase|Disease Progression|9|||
155187245|NCT01074047|560124680|FG001|Extension Phase|Disease Progression|0|||
155187246|NCT01074047|560124679|FG000|Extension Phase|Withdrawal by Subject|2|||
155187247|NCT01074047|560124680|FG001|Extension Phase|Withdrawal by Subject|0|||
155187248|NCT01074047|560124679|FG000|Extension Phase|Death|5|||
155187249|NCT01074047|560124680|FG001|Extension Phase|Death|0|||
155187250|NCT01876810|560124681|FG000|Overall Study|Physician Decision|0|||
155187251|NCT01876810|560124682|FG001|Overall Study|Physician Decision|1|||
155187252|NCT01857583|560124685|FG000|Overall Study|Adverse Event|0|||
155187253|NCT01857583|560124686|FG001|Overall Study|Adverse Event|0|||
155187254|NCT01857583|560124687|FG002|Overall Study|Adverse Event|1|||
155187255|NCT01857583|560124688|FG003|Overall Study|Adverse Event|1|||
155187256|NCT01857583|560124685|FG000|Overall Study|Death|0|||
155187257|NCT01857583|560124686|FG001|Overall Study|Death|1|||
155187258|NCT01857583|560124687|FG002|Overall Study|Death|1|||
155187259|NCT01857583|560124688|FG003|Overall Study|Death|0|||
155187260|NCT01857583|560124685|FG000|Overall Study|Physician Decision|0|||
155187261|NCT01857583|560124686|FG001|Overall Study|Physician Decision|0|||
155187262|NCT01857583|560124687|FG002|Overall Study|Physician Decision|0|||
155187263|NCT01857583|560124688|FG003|Overall Study|Physician Decision|1|||
155187264|NCT01857583|560124685|FG000|Overall Study|Withdrawal by Subject|1|||
155187265|NCT01857583|560124686|FG001|Overall Study|Withdrawal by Subject|0|||
155187266|NCT01857583|560124687|FG002|Overall Study|Withdrawal by Subject|1|||
155187267|NCT01857583|560124688|FG003|Overall Study|Withdrawal by Subject|2|||
155187268|NCT04382755|560124689|FG000|Overall Study|Withdrawal by Subject|1|||
155187269|NCT04382755|560124690|FG001|Overall Study|Withdrawal by Subject|0|||
155187270|NCT04382755|560124689|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
155187271|NCT04382755|560124690|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
155187272|NCT04382755|560124689|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
155187273|NCT04382755|560124690|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
155187274|NCT04571515|560124691|FG000|Overall Study|Physician Decision|0|||
155187275|NCT04571515|560124692|FG001|Overall Study|Physician Decision|0|||
155187276|NCT04571515|560124693|FG002|Overall Study|Physician Decision|0|||
155187277|NCT04571515|560124694|FG003|Overall Study|Physician Decision|0|||
155037285|NCT04105010|559563840|FG000|Overall Study|Death|3|||
155037286|NCT04105010|559563841|FG001|Overall Study|Death|1|||
155037287|NCT04105010|559563842|FG002|Overall Study|Death|1|||
155037288|NCT04105010|559563843|FG003|Overall Study|Death|54|||
155037289|NCT04105010|559563840|FG000|Overall Study|Lost to Follow-up|0|||
155187278|NCT04571515|560124695|FG004|Overall Study|Physician Decision|1|||
155187279|NCT04571515|560124691|FG000|Overall Study|Withdrawal by Subject|0|||
155187280|NCT04571515|560124692|FG001|Overall Study|Withdrawal by Subject|0|||
155187281|NCT04571515|560124693|FG002|Overall Study|Withdrawal by Subject|0|||
155187282|NCT04571515|560124694|FG003|Overall Study|Withdrawal by Subject|0|||
155187283|NCT04571515|560124695|FG004|Overall Study|Withdrawal by Subject|1|||
155187284|NCT04571515|560124691|FG000|Overall Study|insufficient pain|1|||
155187285|NCT04571515|560124692|FG001|Overall Study|insufficient pain|0|||
155187286|NCT04571515|560124693|FG002|Overall Study|insufficient pain|0|||
155187287|NCT04571515|560124694|FG003|Overall Study|insufficient pain|0|||
155187288|NCT04571515|560124695|FG004|Overall Study|insufficient pain|1|||
155187289|NCT01104701|560126223|FG000|Overall Study|Withdrawal by Subject|0|||
155187290|NCT01104701|560126224|FG001|Overall Study|Withdrawal by Subject|1|||
155187291|NCT01104701|560126225|FG002|Overall Study|Withdrawal by Subject|2|||
155187292|NCT01104701|560126226|FG003|Overall Study|Withdrawal by Subject|1|||
155187293|NCT01104701|560126223|FG000|Overall Study|Adverse Event|0|||
155187294|NCT01104701|560126224|FG001|Overall Study|Adverse Event|0|||
155037290|NCT04105010|559563841|FG001|Overall Study|Lost to Follow-up|0|||
155037291|NCT04105010|559563842|FG002|Overall Study|Lost to Follow-up|0|||
155037292|NCT04105010|559563843|FG003|Overall Study|Lost to Follow-up|4|||
155187295|NCT01104701|560126225|FG002|Overall Study|Adverse Event|0|||
155187296|NCT01104701|560126226|FG003|Overall Study|Adverse Event|1|||
155187297|NCT01104701|560126223|FG000|Overall Study|Physician Decision|0|||
155187298|NCT01104701|560126224|FG001|Overall Study|Physician Decision|2|||
155187299|NCT01104701|560126225|FG002|Overall Study|Physician Decision|0|||
155187300|NCT01104701|560126226|FG003|Overall Study|Physician Decision|0|||
155187301|NCT00423722|560126227|FG000|Overall Study|Death|4|||
155187302|NCT00423722|560126228|FG001|Overall Study|Death|4|||
155187303|NCT00423722|560126227|FG000|Overall Study|Declined to participate|2|||
155187304|NCT00423722|560126228|FG001|Overall Study|Declined to participate|3|||
155187305|NCT00423722|560126227|FG000|Overall Study|Unable to complete questionnaires|4|||
155187306|NCT00423722|560126228|FG001|Overall Study|Unable to complete questionnaires|4|||
155187307|NCT00423722|560126227|FG000|Overall Study|Withdrawal by Subject|4|||
155187308|NCT00423722|560126228|FG001|Overall Study|Withdrawal by Subject|2|||
155187309|NCT02598960|560126229|FG000|Treatment Period|Disease Progression|4|||
155187310|NCT02598960|560126230|FG001|Treatment Period|Disease Progression|4|||
155187311|NCT02598960|560126231|FG002|Treatment Period|Disease Progression|4|||
155187312|NCT02598960|560126232|FG003|Treatment Period|Disease Progression|6|||
155037293|NCT04105010|559563840|FG000|Overall Study|Withdrawal by Subject|8|||
155037294|NCT04105010|559563841|FG001|Overall Study|Withdrawal by Subject|1|||
155037295|NCT04105010|559563842|FG002|Overall Study|Withdrawal by Subject|1|||
155037296|NCT04105010|559563843|FG003|Overall Study|Withdrawal by Subject|4|||
155037297|NCT04105010|559563840|FG000|Overall Study|Other reason|4|||
155037298|NCT04105010|559563841|FG001|Overall Study|Other reason|7|||
155037299|NCT04105010|559563842|FG002|Overall Study|Other reason|0|||
155037300|NCT04105010|559563843|FG003|Overall Study|Other reason|19|||
155037301|NCT01211483|559563844|FG000|Phase 1b|Death|6|||
155037302|NCT01211483|559563845|FG001|Phase 1b|Death|0|||
155037303|NCT01211483|559563846|FG002|Phase 1b|Death|0|||
155037304|NCT01211483|559563847|FG003|Phase 1b|Death|0|||
155037305|NCT01211483|559563844|FG000|Phase 1b|Withdrawal by Subject|1|||
155037306|NCT01211483|559563845|FG001|Phase 1b|Withdrawal by Subject|0|||
155037307|NCT01211483|559563846|FG002|Phase 1b|Withdrawal by Subject|0|||
155037308|NCT01211483|559563847|FG003|Phase 1b|Withdrawal by Subject|0|||
155037309|NCT01211483|559563844|FG000|Phase 2|Lost to Follow-up|0|||
155037310|NCT01211483|559563845|FG001|Phase 2|Lost to Follow-up|1|||
155037311|NCT01211483|559563846|FG002|Phase 2|Lost to Follow-up|1|||
155037312|NCT01211483|559563847|FG003|Phase 2|Lost to Follow-up|2|||
155037313|NCT01211483|559563844|FG000|Phase 2|Death|0|||
155037314|NCT01211483|559563845|FG001|Phase 2|Death|64|||
155037315|NCT01211483|559563846|FG002|Phase 2|Death|53|||
155037316|NCT01211483|559563847|FG003|Phase 2|Death|53|||
155037317|NCT01211483|559563844|FG000|Phase 2|Withdrawal by Subject|0|||
155037318|NCT01211483|559563845|FG001|Phase 2|Withdrawal by Subject|1|||
155037319|NCT01211483|559563846|FG002|Phase 2|Withdrawal by Subject|10|||
155037320|NCT01211483|559563847|FG003|Phase 2|Withdrawal by Subject|5|||
155037321|NCT01211483|559563844|FG000|Phase 2|Study terminated by Sponsor|0|||
155037322|NCT01211483|559563845|FG001|Phase 2|Study terminated by Sponsor|6|||
155037323|NCT01211483|559563846|FG002|Phase 2|Study terminated by Sponsor|8|||
155037324|NCT01211483|559563847|FG003|Phase 2|Study terminated by Sponsor|11|||
155037325|NCT01149421|559563850|FG000|Overall Study|Adverse Event|22|||
155037326|NCT01149421|559563851|FG001|Overall Study|Adverse Event|6|||
155037327|NCT01149421|559563852|FG002|Overall Study|Adverse Event|11|||
155037328|NCT01149421|559563850|FG000|Overall Study|Withdrawal by Subject|20|||
155037329|NCT01149421|559563851|FG001|Overall Study|Withdrawal by Subject|12|||
155037330|NCT01149421|559563852|FG002|Overall Study|Withdrawal by Subject|13|||
155037331|NCT01149421|559563850|FG000|Overall Study|Sponsor Decision|0|||
155037332|NCT01149421|559563851|FG001|Overall Study|Sponsor Decision|1|||
155037333|NCT01149421|559563852|FG002|Overall Study|Sponsor Decision|1|||
155037334|NCT01149421|559563850|FG000|Overall Study|Lost to Follow-up|2|||
155037335|NCT01149421|559563851|FG001|Overall Study|Lost to Follow-up|4|||
155037336|NCT01149421|559563852|FG002|Overall Study|Lost to Follow-up|5|||
155037337|NCT01149421|559563850|FG000|Overall Study|Physician Decision|5|||
155037338|NCT01149421|559563851|FG001|Overall Study|Physician Decision|3|||
155037339|NCT01149421|559563852|FG002|Overall Study|Physician Decision|6|||
155037340|NCT01149421|559563850|FG000|Overall Study|Entry Criteria Not Met|1|||
155037341|NCT01149421|559563851|FG001|Overall Study|Entry Criteria Not Met|1|||
155037342|NCT01149421|559563852|FG002|Overall Study|Entry Criteria Not Met|2|||
155037343|NCT01149421|559563850|FG000|Overall Study|Protocol Violation|2|||
155037344|NCT01149421|559563851|FG001|Overall Study|Protocol Violation|2|||
155037345|NCT01149421|559563852|FG002|Overall Study|Protocol Violation|6|||
155037346|NCT03570554|559563853|FG000|Overall Study|Non-compliance with study drug|0|||
155037347|NCT03570554|559563854|FG001|Overall Study|Non-compliance with study drug|0|||
155037348|NCT03570554|559563855|FG002|Overall Study|Non-compliance with study drug|1|||
155037349|NCT03570554|559563856|FG003|Overall Study|Non-compliance with study drug|0|||
155037350|NCT03570554|559563853|FG000|Overall Study|Adverse Event|0|||
155037351|NCT03570554|559563854|FG001|Overall Study|Adverse Event|0|||
155037352|NCT03570554|559563855|FG002|Overall Study|Adverse Event|0|||
155187313|NCT02598960|560126233|FG004|Treatment Period|Disease Progression|8|||
155187314|NCT02598960|560126234|FG005|Treatment Period|Disease Progression|2|||
155187315|NCT02598960|560126235|FG006|Treatment Period|Disease Progression|2|||
155187316|NCT02598960|560126236|FG007|Treatment Period|Disease Progression|3|||
155187317|NCT02598960|560126237|FG008|Treatment Period|Disease Progression|7|||
155187318|NCT02598960|560126238|FG009|Treatment Period|Disease Progression|9|||
155187319|NCT02598960|560126239|FG010|Treatment Period|Disease Progression|7|||
155187320|NCT02598960|560126240|FG011|Treatment Period|Disease Progression|143|||
155187321|NCT02598960|560126241|FG012|Treatment Period|Disease Progression|23|||
155187322|NCT02598960|560126229|FG000|Treatment Period|Study drug toxicity|0|||
155187323|NCT02598960|560126230|FG001|Treatment Period|Study drug toxicity|0|||
155187324|NCT02598960|560126231|FG002|Treatment Period|Study drug toxicity|0|||
155187325|NCT02598960|560126232|FG003|Treatment Period|Study drug toxicity|0|||
155187326|NCT02598960|560126233|FG004|Treatment Period|Study drug toxicity|0|||
155187327|NCT02598960|560126234|FG005|Treatment Period|Study drug toxicity|0|||
155187328|NCT02598960|560126235|FG006|Treatment Period|Study drug toxicity|0|||
155187329|NCT02598960|560126236|FG007|Treatment Period|Study drug toxicity|0|||
155187330|NCT02598960|560126237|FG008|Treatment Period|Study drug toxicity|0|||
155187331|NCT02598960|560126238|FG009|Treatment Period|Study drug toxicity|1|||
155187332|NCT02598960|560126239|FG010|Treatment Period|Study drug toxicity|0|||
155187333|NCT02598960|560126240|FG011|Treatment Period|Study drug toxicity|3|||
155187334|NCT02598960|560126241|FG012|Treatment Period|Study drug toxicity|0|||
155187335|NCT02598960|560126229|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
155187336|NCT02598960|560126230|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
155187337|NCT02598960|560126231|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
155187338|NCT02598960|560126232|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
155187339|NCT02598960|560126233|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
155187340|NCT02598960|560126234|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
155187341|NCT02598960|560126235|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
155187342|NCT02598960|560126236|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
155187343|NCT02598960|560126237|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
155187344|NCT02598960|560126238|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
155187345|NCT02598960|560126239|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
155187346|NCT02598960|560126240|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
155187347|NCT02598960|560126241|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
155187348|NCT02598960|560126229|FG000|Treatment Period|participant request to discontinue|0|||
155187349|NCT02598960|560126230|FG001|Treatment Period|participant request to discontinue|1|||
155187350|NCT02598960|560126231|FG002|Treatment Period|participant request to discontinue|0|||
155187351|NCT02598960|560126232|FG003|Treatment Period|participant request to discontinue|0|||
155187352|NCT02598960|560126233|FG004|Treatment Period|participant request to discontinue|1|||
155187353|NCT02598960|560126234|FG005|Treatment Period|participant request to discontinue|0|||
155187354|NCT02598960|560126235|FG006|Treatment Period|participant request to discontinue|0|||
155187355|NCT02598960|560126236|FG007|Treatment Period|participant request to discontinue|0|||
155187356|NCT02598960|560126237|FG008|Treatment Period|participant request to discontinue|0|||
155187357|NCT02598960|560126238|FG009|Treatment Period|participant request to discontinue|0|||
155187358|NCT02598960|560126239|FG010|Treatment Period|participant request to discontinue|1|||
155187359|NCT02598960|560126240|FG011|Treatment Period|participant request to discontinue|4|||
155187360|NCT02598960|560126241|FG012|Treatment Period|participant request to discontinue|0|||
155187361|NCT02598960|560126229|FG000|Treatment Period|participant withdrew consent|0|||
155187362|NCT02598960|560126230|FG001|Treatment Period|participant withdrew consent|0|||
155187363|NCT02598960|560126231|FG002|Treatment Period|participant withdrew consent|0|||
155187364|NCT02598960|560126232|FG003|Treatment Period|participant withdrew consent|0|||
155187365|NCT02598960|560126233|FG004|Treatment Period|participant withdrew consent|0|||
155187366|NCT02598960|560126234|FG005|Treatment Period|participant withdrew consent|0|||
155187367|NCT02598960|560126235|FG006|Treatment Period|participant withdrew consent|0|||
155187368|NCT02598960|560126236|FG007|Treatment Period|participant withdrew consent|0|||
155187369|NCT02598960|560126237|FG008|Treatment Period|participant withdrew consent|0|||
155187370|NCT02598960|560126238|FG009|Treatment Period|participant withdrew consent|0|||
155187371|NCT02598960|560126239|FG010|Treatment Period|participant withdrew consent|0|||
155187372|NCT02598960|560126240|FG011|Treatment Period|participant withdrew consent|3|||
155187373|NCT02598960|560126241|FG012|Treatment Period|participant withdrew consent|0|||
155187374|NCT02598960|560126229|FG000|Treatment Period|No longer meets study criteria|0|||
155187375|NCT02598960|560126230|FG001|Treatment Period|No longer meets study criteria|0|||
155187376|NCT02598960|560126231|FG002|Treatment Period|No longer meets study criteria|0|||
155187377|NCT02598960|560126232|FG003|Treatment Period|No longer meets study criteria|0|||
155187378|NCT02598960|560126233|FG004|Treatment Period|No longer meets study criteria|0|||
155187379|NCT02598960|560126234|FG005|Treatment Period|No longer meets study criteria|0|||
155187380|NCT02598960|560126235|FG006|Treatment Period|No longer meets study criteria|0|||
155187381|NCT02598960|560126236|FG007|Treatment Period|No longer meets study criteria|0|||
155187382|NCT02598960|560126237|FG008|Treatment Period|No longer meets study criteria|0|||
155187383|NCT02598960|560126238|FG009|Treatment Period|No longer meets study criteria|0|||
155187384|NCT02598960|560126239|FG010|Treatment Period|No longer meets study criteria|0|||
155187385|NCT02598960|560126240|FG011|Treatment Period|No longer meets study criteria|1|||
155187386|NCT02598960|560126241|FG012|Treatment Period|No longer meets study criteria|0|||
155187387|NCT02598960|560126229|FG000|Treatment Period|Other Reasons|0|||
155187388|NCT02598960|560126230|FG001|Treatment Period|Other Reasons|0|||
155187389|NCT02598960|560126231|FG002|Treatment Period|Other Reasons|0|||
155187390|NCT02598960|560126232|FG003|Treatment Period|Other Reasons|0|||
155187391|NCT02598960|560126233|FG004|Treatment Period|Other Reasons|0|||
155187392|NCT02598960|560126234|FG005|Treatment Period|Other Reasons|0|||
155187393|NCT02598960|560126235|FG006|Treatment Period|Other Reasons|0|||
155187394|NCT02598960|560126236|FG007|Treatment Period|Other Reasons|0|||
155187395|NCT02598960|560126237|FG008|Treatment Period|Other Reasons|0|||
155187396|NCT02598960|560126238|FG009|Treatment Period|Other Reasons|0|||
155187397|NCT02598960|560126239|FG010|Treatment Period|Other Reasons|0|||
155187398|NCT02598960|560126240|FG011|Treatment Period|Other Reasons|0|||
155187399|NCT02598960|560126241|FG012|Treatment Period|Other Reasons|1|||
155187400|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|Death|1|||
155187401|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|Death|0|||
155187402|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|Death|0|||
155187403|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|Death|0|||
155187404|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|Death|0|||
155187405|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|Death|0|||
155037353|NCT03570554|559563856|FG003|Overall Study|Adverse Event|1|||
155037354|NCT03738800|559563859|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
155037355|NCT03738800|559563860|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
155037356|NCT03738800|559563861|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
155037357|NCT03738800|559563859|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
155037358|NCT03738800|559563860|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
155037359|NCT03738800|559563861|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
155037360|NCT03738800|559563859|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
155037361|NCT03738800|559563860|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
155037362|NCT03738800|559563861|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
155037363|NCT02719353|559563862|FG000|First Intervention|Physician Decision|0|||
155037364|NCT02719353|559563863|FG001|First Intervention|Physician Decision|1|||
155037365|NCT02223819|559563866|FG000|Overall Study|Lost to Follow-up|2|||
155037366|NCT00943670|559563869|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
155037367|NCT00943670|559563869|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
155037368|NCT00943670|559563869|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
155037369|NCT00943670|559563869|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
155037370|NCT00943670|559563869|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
155187406|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|Death|0|||
155187407|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|Death|0|||
155187408|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|Death|0|||
155187409|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|Death|1|||
155187410|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|Death|0|||
155187411|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|Death|11|||
155187412|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|Death|2|||
155187413|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187414|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187415|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187416|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187417|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187418|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187419|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187420|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187421|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187422|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187423|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187424|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
155187425|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
155187426|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
155187427|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
155187428|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
155187429|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
155187430|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
155187431|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
155187432|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
155187433|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
155187434|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
155187435|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
155187436|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
155187437|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
155187438|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
155187439|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187440|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187441|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187442|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187443|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187444|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187445|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187446|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187447|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187448|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187449|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187450|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
155187451|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
155187452|NCT02598960|560126229|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
155187453|NCT02598960|560126230|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
155187454|NCT02598960|560126231|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
155187455|NCT02598960|560126232|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
155187456|NCT02598960|560126233|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
155187457|NCT02598960|560126234|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
155187458|NCT02598960|560126235|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
155187459|NCT02598960|560126236|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
155187460|NCT02598960|560126237|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
155187461|NCT02598960|560126238|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
155187462|NCT02598960|560126239|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
155187463|NCT02598960|560126240|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
155187464|NCT02598960|560126241|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
155187465|NCT00595465|560126244|FG000|Overall Study|Adverse Event|4|||
155187466|NCT00595465|560126245|FG001|Overall Study|Adverse Event|3|||
155187467|NCT00595465|560126246|FG002|Overall Study|Adverse Event|3|||
155187468|NCT00595465|560126244|FG000|Overall Study|Pregnancy|0|||
155187469|NCT00595465|560126245|FG001|Overall Study|Pregnancy|0|||
155187470|NCT00595465|560126246|FG002|Overall Study|Pregnancy|1|||
155187471|NCT00595465|560126244|FG000|Overall Study|Protocol Violation|2|||
155187472|NCT00595465|560126245|FG001|Overall Study|Protocol Violation|1|||
155187473|NCT00595465|560126246|FG002|Overall Study|Protocol Violation|0|||
155187474|NCT00595465|560126244|FG000|Overall Study|Lost to Follow-up|0|||
155187475|NCT00595465|560126245|FG001|Overall Study|Lost to Follow-up|0|||
155187476|NCT00595465|560126246|FG002|Overall Study|Lost to Follow-up|2|||
155187477|NCT00595465|560126244|FG000|Overall Study|administrative reason|0|||
155187478|NCT00595465|560126245|FG001|Overall Study|administrative reason|0|||
155187479|NCT00595465|560126246|FG002|Overall Study|administrative reason|1|||
155187480|NCT00107783|560126247|FG000|Overall Study|Adverse Event|0|||
155187481|NCT00107783|560126248|FG001|Overall Study|Adverse Event|2|||
155187482|NCT00107783|560126247|FG000|Overall Study|Death|0|||
155187483|NCT00107783|560126248|FG001|Overall Study|Death|1|||
155187484|NCT00107783|560126247|FG000|Overall Study|Withdrawal by Subject|2|||
155187485|NCT00107783|560126248|FG001|Overall Study|Withdrawal by Subject|0|||
155187486|NCT00107783|560126247|FG000|Overall Study|Second hip replacement|1|||
155187487|NCT00107783|560126248|FG001|Overall Study|Second hip replacement|1|||
155187488|NCT00422097|560126249|FG000|Dose Level 2|Still on treatment|0|||
155187489|NCT00422097|560126250|FG001|Dose Level 2|Still on treatment|1|||
155187490|NCT00422097|560126251|FG002|Dose Level 2|Still on treatment|0|||
155037371|NCT00943670|559563869|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
155037372|NCT00943670|559563869|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
155037373|NCT00943670|559563869|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
155037374|NCT00943670|559563869|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
155037375|NCT00943670|559563869|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
155187491|NCT00422097|560126252|FG003|Dose Level 2|Still on treatment|0|||
155187492|NCT00422097|560126253|FG004|Dose Level 2|Still on treatment|0|||
155187493|NCT00422097|560126254|FG005|Dose Level 2|Still on treatment|0|||
155187494|NCT00422097|560126255|FG006|Dose Level 2|Still on treatment|0|||
155187495|NCT00422097|560126256|FG007|Dose Level 2|Still on treatment|0|||
155187496|NCT02360995|560126257|FG000|Overall Study|Lost to Follow-up|2|||
155187497|NCT02360995|560126258|FG001|Overall Study|Lost to Follow-up|0|||
155187498|NCT02360995|560126259|FG002|Overall Study|Lost to Follow-up|2|||
155187499|NCT02360995|560126257|FG000|Overall Study|Withdrawal by Subject|0|||
155187500|NCT02360995|560126258|FG001|Overall Study|Withdrawal by Subject|1|||
155187501|NCT02360995|560126259|FG002|Overall Study|Withdrawal by Subject|0|||
155187502|NCT00331864|560126267|FG000|Overall Study|Adverse Event|30|||
155187503|NCT00331864|560126268|FG001|Overall Study|Adverse Event|1|||
155187504|NCT00331864|560126267|FG000|Overall Study|Lack of Efficacy|4|||
155187505|NCT00331864|560126268|FG001|Overall Study|Lack of Efficacy|0|||
155187506|NCT00331864|560126267|FG000|Overall Study|Protocol Violation|3|||
155187507|NCT00331864|560126268|FG001|Overall Study|Protocol Violation|0|||
155187508|NCT00331864|560126267|FG000|Overall Study|Withdrawal by Subject|10|||
155187509|NCT00331864|560126268|FG001|Overall Study|Withdrawal by Subject|0|||
155187510|NCT00331864|560126267|FG000|Overall Study|Lost to Follow-up|4|||
155187511|NCT00331864|560126268|FG001|Overall Study|Lost to Follow-up|3|||
155187512|NCT00331864|560126267|FG000|Overall Study|Administrative Problems|1|||
155187513|NCT00331864|560126268|FG001|Overall Study|Administrative Problems|0|||
155187514|NCT00331864|560126267|FG000|Overall Study|Death|6|||
155187515|NCT00331864|560126268|FG001|Overall Study|Death|0|||
155187516|NCT00137631|560126269|FG000|Overall Study|Lost to Follow-up|37|||
155187517|NCT00137631|560126270|FG001|Overall Study|Lost to Follow-up|41|||
155187518|NCT00085709|560126273|FG000|Overall Study|Adverse Event|8|||
155187519|NCT00085709|560126274|FG001|Overall Study|Adverse Event|0|||
155187520|NCT00085709|560126273|FG000|Overall Study|Death|8|||
155187521|NCT00085709|560126274|FG001|Overall Study|Death|2|||
155187522|NCT00085709|560126273|FG000|Overall Study|Refusal unrelated to adverse events|1|||
155187523|NCT00085709|560126274|FG001|Overall Study|Refusal unrelated to adverse events|2|||
155187524|NCT00085709|560126273|FG000|Overall Study|Progression|3|||
155187525|NCT00085709|560126274|FG001|Overall Study|Progression|4|||
155187526|NCT00085709|560126273|FG000|Overall Study|Not protocol specified|12|||
155187527|NCT00085709|560126274|FG001|Overall Study|Not protocol specified|22|||
155187528|NCT00085709|560126273|FG000|Overall Study|Not eligible|19|||
155187529|NCT00085709|560126274|FG001|Overall Study|Not eligible|19|||
155187530|NCT00085709|560126273|FG000|Overall Study|Withdrawal by Subject|2|||
155187531|NCT00085709|560126274|FG001|Overall Study|Withdrawal by Subject|1|||
155187532|NCT01409434|560126275|FG000|Overall Study|Protocol Violation|4|||
155187533|NCT00293215|560126276|FG000|Overall Study|Progressive disease|3|||
155187534|NCT00293215|560126277|FG001|Overall Study|Progressive disease|1|||
155187535|NCT00293215|560126276|FG000|Overall Study|Adverse Event|2|||
155187536|NCT00293215|560126277|FG001|Overall Study|Adverse Event|2|||
155187537|NCT01229371|560126278|FG000|Overall Study|Withdrawal by Subject|0|||
155187538|NCT01229371|560126279|FG001|Overall Study|Withdrawal by Subject|1|||
155187539|NCT01229371|560126280|FG002|Overall Study|Withdrawal by Subject|0|||
155187540|NCT01229371|560126281|FG003|Overall Study|Withdrawal by Subject|0|||
155187541|NCT02213042|560126282|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
155187542|NCT02213042|560126283|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
155187543|NCT02213042|560126284|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
155187544|NCT02213042|560126282|FG000|Overall Study|Adverse Event|2|||
155187545|NCT02213042|560126283|FG001|Overall Study|Adverse Event|1|||
155187546|NCT02213042|560126284|FG002|Overall Study|Adverse Event|0|||
155187547|NCT02213042|560126282|FG000|Overall Study|Withdrawal by Subject|0|||
155187548|NCT02213042|560126283|FG001|Overall Study|Withdrawal by Subject|1|||
155187549|NCT02213042|560126284|FG002|Overall Study|Withdrawal by Subject|1|||
155187550|NCT02213042|560126282|FG000|Overall Study|Protocol Violation|1|||
155187551|NCT02213042|560126283|FG001|Overall Study|Protocol Violation|0|||
155187552|NCT02213042|560126284|FG002|Overall Study|Protocol Violation|0|||
155037376|NCT01777295|559563870|FG000|Overall Study|Withdrawal by Subject|2|||
155037377|NCT01777295|559563871|FG001|Overall Study|Withdrawal by Subject|2|||
155187553|NCT02213042|560126282|FG000|Overall Study|Investigator discretion|0|||
155187554|NCT02213042|560126283|FG001|Overall Study|Investigator discretion|0|||
155187555|NCT02213042|560126284|FG002|Overall Study|Investigator discretion|1|||
155187556|NCT04622735|560126285|FG000|Overall Study|Lost to Follow-up|1|||
155187557|NCT04622735|560126286|FG001|Overall Study|Lost to Follow-up|2|||
155187558|NCT04622735|560126287|FG002|Overall Study|Lost to Follow-up|1|||
155187559|NCT04622735|560126285|FG000|Overall Study|Adverse Event|0|||
155187560|NCT04622735|560126286|FG001|Overall Study|Adverse Event|0|||
155187561|NCT04622735|560126287|FG002|Overall Study|Adverse Event|1|||
155187562|NCT04622735|560126285|FG000|Overall Study|Protocol Violation|1|||
155187563|NCT04622735|560126286|FG001|Overall Study|Protocol Violation|0|||
155187564|NCT04622735|560126287|FG002|Overall Study|Protocol Violation|0|||
155187565|NCT02007512|560126289|FG000|Double Blind Treatment Period|Adverse Event|4|||
155187566|NCT02007512|560126290|FG001|Double Blind Treatment Period|Adverse Event|6|||
155187567|NCT02007512|560126291|FG002|Double Blind Treatment Period|Adverse Event|2|||
155187568|NCT02007512|560126292|FG003|Double Blind Treatment Period|Adverse Event|2|||
155187569|NCT02007512|560126289|FG000|Double Blind Treatment Period|Death|1|||
155187570|NCT02007512|560126290|FG001|Double Blind Treatment Period|Death|0|||
155037378|NCT01777295|559563870|FG000|Overall Study|Pregnancy|0|||
155187571|NCT02007512|560126291|FG002|Double Blind Treatment Period|Death|0|||
155187572|NCT02007512|560126292|FG003|Double Blind Treatment Period|Death|0|||
155187573|NCT02007512|560126289|FG000|Double Blind Treatment Period|Disease progression|51|||
155187574|NCT02007512|560126290|FG001|Double Blind Treatment Period|Disease progression|50|||
155187575|NCT02007512|560126291|FG002|Double Blind Treatment Period|Disease progression|57|||
155187576|NCT02007512|560126292|FG003|Double Blind Treatment Period|Disease progression|52|||
155187577|NCT02007512|560126289|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187578|NCT02007512|560126290|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187579|NCT02007512|560126291|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187580|NCT02007512|560126292|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
155187581|NCT02007512|560126289|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155187582|NCT02007512|560126290|FG001|Double Blind Treatment Period|Protocol Violation|0|||
155187583|NCT02007512|560126291|FG002|Double Blind Treatment Period|Protocol Violation|0|||
155187584|NCT02007512|560126292|FG003|Double Blind Treatment Period|Protocol Violation|1|||
155187585|NCT02007512|560126289|FG000|Double Blind Treatment Period|Other|2|||
155187586|NCT02007512|560126290|FG001|Double Blind Treatment Period|Other|1|||
155187587|NCT02007512|560126291|FG002|Double Blind Treatment Period|Other|1|||
155187588|NCT02007512|560126292|FG003|Double Blind Treatment Period|Other|2|||
155187589|NCT02007512|560126289|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
155187590|NCT02007512|560126290|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
155187591|NCT02007512|560126291|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
155187592|NCT02007512|560126292|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
155187593|NCT02007512|560126289|FG000|Open Label Treatment Period|Adverse Event|1|||
155187594|NCT02007512|560126290|FG001|Open Label Treatment Period|Adverse Event|0|||
155187595|NCT02007512|560126291|FG002|Open Label Treatment Period|Adverse Event|0|||
155187596|NCT02007512|560126292|FG003|Open Label Treatment Period|Adverse Event|0|||
155187597|NCT02007512|560126289|FG000|Open Label Treatment Period|Other|1|||
155187598|NCT02007512|560126290|FG001|Open Label Treatment Period|Other|1|||
155187599|NCT02007512|560126291|FG002|Open Label Treatment Period|Other|0|||
155187600|NCT02007512|560126292|FG003|Open Label Treatment Period|Other|0|||
155187601|NCT02007512|560126289|FG000|Open Label Treatment Period|Disease progression|23|||
155187602|NCT02007512|560126290|FG001|Open Label Treatment Period|Disease progression|11|||
155187603|NCT02007512|560126291|FG002|Open Label Treatment Period|Disease progression|0|||
155187604|NCT02007512|560126292|FG003|Open Label Treatment Period|Disease progression|0|||
155187605|NCT03960554|560126299|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
155187606|NCT03960554|560126300|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
155187607|NCT02545075|560126303|FG000|Randomization|Lost to Follow-up|0|||
155187608|NCT02545075|560126304|FG001|Randomization|Lost to Follow-up|1|||
155187609|NCT02545075|560126303|FG000|Randomization|Withdrawal by Subject|0|||
155187610|NCT02545075|560126304|FG001|Randomization|Withdrawal by Subject|6|||
155187611|NCT02545075|560126303|FG000|Treatment|Disease progression|71|||
155187612|NCT02545075|560126304|FG001|Treatment|Disease progression|32|||
155187613|NCT02545075|560126303|FG000|Treatment|Participant dicontinued study treatment|7|||
155187614|NCT02545075|560126304|FG001|Treatment|Participant dicontinued study treatment|9|||
155187615|NCT02545075|560126303|FG000|Treatment|Withdrawal by Subject|1|||
155187616|NCT02545075|560126304|FG001|Treatment|Withdrawal by Subject|0|||
155187617|NCT02545075|560126303|FG000|Treatment|Adverse event not related to study drug|1|||
155187618|NCT02545075|560126304|FG001|Treatment|Adverse event not related to study drug|0|||
155187619|NCT02545075|560126303|FG000|Treatment|Death|1|||
155187620|NCT02545075|560126304|FG001|Treatment|Death|0|||
155187621|NCT02545075|560126303|FG000|Treatment|Participant drug toxicity|1|||
155187622|NCT02545075|560126304|FG001|Treatment|Participant drug toxicity|0|||
155187623|NCT02545075|560126303|FG000|Treatment|Completed treatment|40|||
155187624|NCT02545075|560126304|FG001|Treatment|Completed treatment|12|||
155187625|NCT02180165|560126308|FG000|Overall Study|Not Treated|0|||
155187626|NCT02180165|560126309|FG001|Overall Study|Not Treated|0|||
155187627|NCT02180165|560126310|FG002|Overall Study|Not Treated|1|||
155187628|NCT02180165|560126311|FG003|Overall Study|Not Treated|0|||
155187629|NCT02180165|560126308|FG000|Overall Study|Adverse Event|7|||
155187630|NCT02180165|560126309|FG001|Overall Study|Adverse Event|0|||
155187631|NCT02180165|560126310|FG002|Overall Study|Adverse Event|18|||
155187632|NCT02180165|560126311|FG003|Overall Study|Adverse Event|3|||
155187633|NCT02180165|560126308|FG000|Overall Study|Lack of Efficacy|0|||
155187634|NCT02180165|560126309|FG001|Overall Study|Lack of Efficacy|1|||
155187635|NCT02180165|560126310|FG002|Overall Study|Lack of Efficacy|3|||
155187636|NCT02180165|560126311|FG003|Overall Study|Lack of Efficacy|2|||
155187637|NCT02180165|560126308|FG000|Overall Study|Physician Decision|1|||
155187638|NCT02180165|560126309|FG001|Overall Study|Physician Decision|0|||
155037379|NCT01777295|559563871|FG001|Overall Study|Pregnancy|1|||
155187639|NCT02180165|560126310|FG002|Overall Study|Physician Decision|5|||
155187640|NCT02180165|560126311|FG003|Overall Study|Physician Decision|0|||
155187641|NCT02180165|560126308|FG000|Overall Study|Withdrawal by Subject|3|||
155187642|NCT02180165|560126309|FG001|Overall Study|Withdrawal by Subject|0|||
155037380|NCT01777295|559563870|FG000|Overall Study|Personal problem|1|||
155187643|NCT02180165|560126310|FG002|Overall Study|Withdrawal by Subject|2|||
155187644|NCT02180165|560126311|FG003|Overall Study|Withdrawal by Subject|1|||
155187645|NCT00267189|560126312|FG000|Overall Study|Patient withdrew consent|1|||
155187646|NCT00267189|560126313|FG001|Overall Study|Patient withdrew consent|1|||
155187647|NCT00267189|560126312|FG000|Overall Study|Death|1|||
155187648|NCT00267189|560126313|FG001|Overall Study|Death|0|||
155187649|NCT00267189|560126312|FG000|Overall Study|Missing|3|||
155187650|NCT00267189|560126313|FG001|Overall Study|Missing|0|||
155187651|NCT00751621|560126314|FG000|Overall Study|Adverse Event|1|||
155187652|NCT00751621|560126314|FG000|Overall Study|Withdrawal by Subject|1|||
155187653|NCT00751621|560126314|FG000|Overall Study|Subject moved to another country|1|||
155187654|NCT00751621|560126314|FG000|Overall Study|Poor adherence to asthma treatment|1|||
155187655|NCT01086423|560126316|FG000|Overall Study|Protocol Violation|0|||
155187656|NCT01086423|560126317|FG001|Overall Study|Protocol Violation|0|||
155187657|NCT01086423|560126318|FG002|Overall Study|Protocol Violation|1|||
155187658|NCT01086423|560126316|FG000|Overall Study|Migrated/moved from study area|2|||
155187659|NCT01086423|560126317|FG001|Overall Study|Migrated/moved from study area|0|||
155187660|NCT01086423|560126318|FG002|Overall Study|Migrated/moved from study area|4|||
155187661|NCT01086423|560126316|FG000|Overall Study|Adverse event, fatal|1|||
155187662|NCT01086423|560126317|FG001|Overall Study|Adverse event, fatal|1|||
155187663|NCT01086423|560126318|FG002|Overall Study|Adverse event, fatal|0|||
155187664|NCT01086423|560126316|FG000|Overall Study|Adverse event, non-fatal|2|||
155187665|NCT01086423|560126317|FG001|Overall Study|Adverse event, non-fatal|1|||
155187666|NCT01086423|560126318|FG002|Overall Study|Adverse event, non-fatal|0|||
155187667|NCT01086423|560126316|FG000|Overall Study|Withdrawal by Subject|5|||
155187668|NCT01086423|560126317|FG001|Overall Study|Withdrawal by Subject|1|||
155187669|NCT01086423|560126318|FG002|Overall Study|Withdrawal by Subject|3|||
155187670|NCT01086423|560126316|FG000|Overall Study|Lost to Follow-up|0|||
155187671|NCT01086423|560126317|FG001|Overall Study|Lost to Follow-up|0|||
155187672|NCT01086423|560126318|FG002|Overall Study|Lost to Follow-up|1|||
155187673|NCT00925990|560126320|FG000|Overall Study|Adverse Event|1|||
155187674|NCT00925990|560126321|FG001|Overall Study|Adverse Event|3|||
155187675|NCT00925990|560126320|FG000|Overall Study|Withdrawal by Subject|2|||
155187676|NCT00925990|560126321|FG001|Overall Study|Withdrawal by Subject|2|||
155187677|NCT00925990|560126320|FG000|Overall Study|Lost to Follow-up|1|||
155187678|NCT00925990|560126321|FG001|Overall Study|Lost to Follow-up|3|||
155187679|NCT00925990|560126320|FG000|Overall Study|Physician Decision|1|||
155187680|NCT00925990|560126321|FG001|Overall Study|Physician Decision|1|||
155187681|NCT00925990|560126320|FG000|Overall Study|moved out of state, missed medication|0|||
155187682|NCT00925990|560126321|FG001|Overall Study|moved out of state, missed medication|2|||
155187683|NCT05342532|560126324|FG000|Overall Study|Adverse Event|5|||
155187684|NCT05342532|560126325|FG001|Overall Study|Adverse Event|20|||
155187685|NCT05342532|560126324|FG000|Overall Study|Lost to Follow-up|10|||
155187686|NCT05342532|560126325|FG001|Overall Study|Lost to Follow-up|15|||
155187687|NCT04508140|560126327|FG000|Overall Study|Adverse Event|2|||
155187688|NCT04508140|560126328|FG001|Overall Study|Adverse Event|2|||
155187689|NCT04508140|560126327|FG000|Overall Study|Withdrawal by Subject|0|||
155187690|NCT04508140|560126328|FG001|Overall Study|Withdrawal by Subject|2|||
155187691|NCT04508140|560126327|FG000|Overall Study|progressive disease|9|||
155187692|NCT04508140|560126328|FG001|Overall Study|progressive disease|3|||
155187693|NCT00450385|560126329|FG000|Overall Study|Death|3|||
155187694|NCT00450385|560126329|FG000|Overall Study|Protocol Violation|1|||
155187695|NCT00450385|560126329|FG000|Overall Study|Withdrawal by Subject|2|||
155187696|NCT00450385|560126329|FG000|Overall Study|Lack of Efficacy|2|||
155187697|NCT00450385|560126329|FG000|Overall Study|Adverse Event|1|||
155187698|NCT00450385|560126329|FG000|Overall Study|Physician Decision|1|||
155187699|NCT00450385|560126329|FG000|Overall Study|Other|3|||
155187700|NCT02314143|560126330|FG000|Overall Study|Adverse Event|0|||
155187701|NCT02314143|560126331|FG001|Overall Study|Adverse Event|6|||
155187702|NCT02314143|560126332|FG002|Overall Study|Adverse Event|4|||
155187703|NCT02314143|560126330|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
155187704|NCT02314143|560126331|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
155187705|NCT02314143|560126332|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
155187706|NCT02314143|560126330|FG000|Overall Study|Physician Decision|2|||
155187707|NCT02314143|560126331|FG001|Overall Study|Physician Decision|1|||
155187708|NCT02314143|560126332|FG002|Overall Study|Physician Decision|0|||
155187709|NCT02314143|560126330|FG000|Overall Study|Withdrawal by Subject|1|||
155187710|NCT02314143|560126331|FG001|Overall Study|Withdrawal by Subject|0|||
155187711|NCT02314143|560126332|FG002|Overall Study|Withdrawal by Subject|1|||
155187712|NCT01528215|560126333|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
155187713|NCT01528215|560126334|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
155187714|NCT01528215|560126333|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
155187715|NCT01528215|560126334|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
155187716|NCT01528215|560126333|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
155187717|NCT01528215|560126334|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
155187718|NCT01528215|560126333|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
155187719|NCT01528215|560126334|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
155187720|NCT01476644|560126335|FG000|Overall Study|Death|5|||
155187721|NCT01476644|560126335|FG000|Overall Study|moved to another state|2|||
155187722|NCT01476644|560126335|FG000|Overall Study|Lost to Follow-up|19|||
155187723|NCT01476644|560126335|FG000|Overall Study|Withdrawal by Subject|13|||
155187724|NCT00586066|560126336|FG000|Overall Study|Lost to Follow-up|6|||
155187725|NCT00586066|560126337|FG001|Overall Study|Lost to Follow-up|3|||
155187726|NCT00586066|560126336|FG000|Overall Study|Lack of Efficacy|5|||
155187727|NCT00586066|560126337|FG001|Overall Study|Lack of Efficacy|3|||
155187728|NCT00586066|560126336|FG000|Overall Study|Adverse Event|2|||
155187729|NCT00586066|560126337|FG001|Overall Study|Adverse Event|2|||
155187730|NCT00586066|560126336|FG000|Overall Study|Physician Decision|1|||
155187731|NCT00586066|560126337|FG001|Overall Study|Physician Decision|0|||
155187732|NCT00586066|560126336|FG000|Overall Study|Withdrawal of consent|4|||
155187733|NCT00586066|560126337|FG001|Overall Study|Withdrawal of consent|2|||
155187734|NCT02676466|560126339|FG000|Overall Study|Death|0|||
155187735|NCT02676466|560126340|FG001|Overall Study|Death|2|||
155187736|NCT02676466|560126341|FG002|Overall Study|Death|1|||
155187737|NCT02676466|560126342|FG003|Overall Study|Death|0|||
155187738|NCT02676466|560126343|FG004|Overall Study|Death|0|||
155187739|NCT02676466|560126344|FG005|Overall Study|Death|0|||
155187740|NCT02676466|560126345|FG006|Overall Study|Death|0|||
155187741|NCT02676466|560126346|FG007|Overall Study|Death|0|||
155187742|NCT02676466|560126339|FG000|Overall Study|Withdrawal by Subject|4|||
155187743|NCT02676466|560126340|FG001|Overall Study|Withdrawal by Subject|3|||
155187744|NCT02676466|560126341|FG002|Overall Study|Withdrawal by Subject|1|||
155187745|NCT02676466|560126342|FG003|Overall Study|Withdrawal by Subject|0|||
155187746|NCT02676466|560126343|FG004|Overall Study|Withdrawal by Subject|3|||
155187747|NCT02676466|560126344|FG005|Overall Study|Withdrawal by Subject|1|||
155187748|NCT02676466|560126345|FG006|Overall Study|Withdrawal by Subject|1|||
155187749|NCT02676466|560126346|FG007|Overall Study|Withdrawal by Subject|1|||
155187750|NCT01090973|560126353|FG000|Overall Study|Disease progression|1|||
155187751|NCT00445978|560126354|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
155187752|NCT00445978|560126354|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
155187753|NCT00445978|560126354|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
155187754|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
155187755|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
155187756|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
155187757|NCT00445978|560126354|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
155187758|NCT00445978|560126354|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
155187759|NCT00445978|560126354|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
155187760|NCT00843726|560126355|FG000|Overall Study|Death|1|||
155187761|NCT00843726|560126356|FG001|Overall Study|Death|0|||
155187762|NCT00843726|560126355|FG000|Overall Study|Withdrawal by Subject|0|||
155187763|NCT00843726|560126356|FG001|Overall Study|Withdrawal by Subject|1|||
155187764|NCT00760084|560126365|FG000|Overall Study|Physician Decision|5|||
155187765|NCT00760084|560126365|FG000|Overall Study|Withdrawal by Subject|2|||
155187766|NCT00760084|560126365|FG000|Overall Study|Progressive Disease|3|||
155187767|NCT02567552|560126366|FG000|Overall Study|Adverse Event|0|||
155187768|NCT02567552|560126367|FG001|Overall Study|Adverse Event|1|||
155187769|NCT00171054|560126369|FG000|Overall Study|Protocol Violation|1|||
155187770|NCT00171054|560126370|FG001|Overall Study|Protocol Violation|2|||
155187771|NCT00171054|560126369|FG000|Overall Study|Patient withdrew consent|1|||
155187772|NCT00171054|560126370|FG001|Overall Study|Patient withdrew consent|0|||
155187773|NCT00171054|560126369|FG000|Overall Study|Lost to Follow-up|0|||
155187774|NCT00171054|560126370|FG001|Overall Study|Lost to Follow-up|1|||
155187775|NCT00171054|560126369|FG000|Overall Study|Adverse Event|8|||
155187776|NCT00171054|560126370|FG001|Overall Study|Adverse Event|8|||
155187777|NCT00171054|560126369|FG000|Overall Study|Condition no longer required study drug|0|||
155187778|NCT00171054|560126370|FG001|Overall Study|Condition no longer required study drug|1|||
155187779|NCT00285207|560126381|FG000|Overall Study|Lost to Follow-up|3|||
155187780|NCT00285207|560126382|FG001|Overall Study|Lost to Follow-up|2|||
155187781|NCT00285207|560126381|FG000|Overall Study|Withdrawal by Subject|5|||
155187782|NCT00285207|560126382|FG001|Overall Study|Withdrawal by Subject|2|||
155187783|NCT00285207|560126381|FG000|Overall Study|Pregnancy|1|||
155037381|NCT01777295|559563871|FG001|Overall Study|Personal problem|0|||
155037382|NCT01777295|559563870|FG000|Overall Study|Investigator call for AEs check|1|||
155037383|NCT01777295|559563871|FG001|Overall Study|Investigator call for AEs check|0|||
155187784|NCT00285207|560126382|FG001|Overall Study|Pregnancy|1|||
155037384|NCT00426660|559563876|FG000|Overall Study|Death|14|||
155187785|NCT00285207|560126381|FG000|Overall Study|non-compliance|0|||
155187786|NCT00285207|560126382|FG001|Overall Study|non-compliance|1|||
155187787|NCT03552965|560126383|FG000|Overall Study|Death|1|||
155187788|NCT03552965|560126384|FG001|Overall Study|Death|1|||
155187789|NCT03552965|560126383|FG000|Overall Study|Lost to Follow-up|1|||
155187790|NCT03552965|560126384|FG001|Overall Study|Lost to Follow-up|1|||
155187791|NCT03552965|560126383|FG000|Overall Study|Physician Decision|1|||
155187792|NCT03552965|560126384|FG001|Overall Study|Physician Decision|1|||
155187793|NCT03552965|560126383|FG000|Overall Study|Withdrawal by Subject|0|||
155187794|NCT03552965|560126384|FG001|Overall Study|Withdrawal by Subject|2|||
155187795|NCT03552965|560126383|FG000|Overall Study|Continuation not in patient best interest|1|||
155187796|NCT03552965|560126384|FG001|Overall Study|Continuation not in patient best interest|0|||
155187797|NCT03552965|560126383|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
155187798|NCT03552965|560126384|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
155187799|NCT02160782|560127932|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
155187800|NCT02160782|560127933|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
155187801|NCT02160782|560127934|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
155187802|NCT02160782|560127935|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
155187803|NCT02160782|560127936|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
155187804|NCT02160782|560127932|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187805|NCT02160782|560127933|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187806|NCT02160782|560127934|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187807|NCT02160782|560127935|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
155187808|NCT02160782|560127936|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
155187809|NCT02160782|560127932|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187810|NCT02160782|560127933|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187811|NCT02160782|560127934|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187812|NCT02160782|560127935|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
155187813|NCT02160782|560127936|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
155187814|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187815|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187816|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187817|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
155187818|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
155187819|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187820|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187821|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187822|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
155187823|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
155187824|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187825|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187826|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187827|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
155187828|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
155187829|NCT02160782|560127932|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187830|NCT02160782|560127933|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187831|NCT02160782|560127934|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187832|NCT02160782|560127935|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
155187833|NCT02160782|560127936|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
155187834|NCT01846104|560127940|FG000|Overall Study|Withdrawal by Subject|1|||
155187835|NCT00398411|560127941|FG000|Overall Study|Death|0|||
155187836|NCT00398411|560127942|FG001|Overall Study|Death|1|||
155187837|NCT03061097|560127945|FG000|Overall Study|Withdrawal by Subject|0|||
155187838|NCT03061097|560127946|FG001|Overall Study|Withdrawal by Subject|3|||
155187839|NCT02611960|560127953|FG000|Overall Study|Adverse Event|7|||
155187840|NCT02611960|560127954|FG001|Overall Study|Adverse Event|8|||
155187841|NCT02611960|560127953|FG000|Overall Study|Death|98|||
155187842|NCT02611960|560127954|FG001|Overall Study|Death|92|||
155187843|NCT02611960|560127953|FG000|Overall Study|Withdrawal by Subject|1|||
155187844|NCT02611960|560127954|FG001|Overall Study|Withdrawal by Subject|5|||
155187845|NCT02611960|560127953|FG000|Overall Study|Sponsor Decision|11|||
155187846|NCT02611960|560127954|FG001|Overall Study|Sponsor Decision|11|||
155187847|NCT04131556|560127965|FG000|Overall Study|Adverse Event|1|||
155187848|NCT04131556|560127965|FG000|Overall Study|Withdrawal by Subject|1|||
155187849|NCT03026088|560127968|FG000|Overall Study|Study termination|20|||
155187850|NCT00761579|560127969|FG000|Overall Study|Adverse Event|10|||
155187851|NCT00761579|560127969|FG000|Overall Study|Death|2|||
155187852|NCT00761579|560127969|FG000|Overall Study|Lack of Efficacy|21|||
155187853|NCT00761579|560127969|FG000|Overall Study|Lost to Follow-up|16|||
155187854|NCT00761579|560127969|FG000|Overall Study|Pregnancy|1|||
155187855|NCT00761579|560127969|FG000|Overall Study|Withdrawal by Subject|34|||
155187856|NCT00761579|560127969|FG000|Overall Study|Lack of compliance|2|||
155187857|NCT00761579|560127969|FG000|Overall Study|Protocol deviation|1|||
155037385|NCT00426660|559563876|FG000|Overall Study|Adverse Event|23|||
155037386|NCT00426660|559563876|FG000|Overall Study|Insufficient Clinical Response|22|||
155037387|NCT00426660|559563876|FG000|Overall Study|Lost to Follow-up|15|||
155037388|NCT00426660|559563876|FG000|Overall Study|Other|23|||
155187858|NCT00761579|560127969|FG000|Overall Study|Drug overdose|1|||
155187859|NCT00761579|560127969|FG000|Overall Study|Aggravation of depression|1|||
155187860|NCT00761579|560127969|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
155187861|NCT00761579|560127969|FG000|Overall Study|Lost survey form|1|||
155187862|NCT00761579|560127969|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
155187863|NCT03611010|560127970|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
155187864|NCT03611010|560127971|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
155187865|NCT03611010|560127972|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
155187866|NCT03611010|560127973|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
155187867|NCT00950911|560127975|FG000|Overall Study|Adverse Event|0|||
155187868|NCT00950911|560127976|FG001|Overall Study|Adverse Event|2|||
155187869|NCT00950911|560127975|FG000|Overall Study|Death|4|||
155187870|NCT00950911|560127976|FG001|Overall Study|Death|6|||
155187871|NCT00950911|560127975|FG000|Overall Study|Disease progression|2|||
155187872|NCT00950911|560127976|FG001|Overall Study|Disease progression|2|||
155187873|NCT00950911|560127975|FG000|Overall Study|Consent withdrawn|1|||
155187874|NCT00950911|560127976|FG001|Overall Study|Consent withdrawn|3|||
155187875|NCT00950911|560127975|FG000|Overall Study|Administrative decision|3|||
155187876|NCT00950911|560127976|FG001|Overall Study|Administrative decision|1|||
155187877|NCT00950911|560127975|FG000|Overall Study|Ineligibility determined|1|||
155187878|NCT00950911|560127976|FG001|Overall Study|Ineligibility determined|0|||
155187879|NCT00950911|560127975|FG000|Overall Study|Noncompliance|1|||
155187880|NCT00950911|560127976|FG001|Overall Study|Noncompliance|0|||
155187881|NCT00950911|560127975|FG000|Overall Study|Poor performance status|0|||
155187882|NCT00950911|560127976|FG001|Overall Study|Poor performance status|1|||
155187883|NCT02600351|560127977|FG000|Overall Study|Lack of Efficacy|3|||
155187884|NCT02600351|560127978|FG001|Overall Study|Lack of Efficacy|0|||
155187885|NCT02600351|560127979|FG002|Overall Study|Lack of Efficacy|5|||
155187886|NCT02600351|560127980|FG003|Overall Study|Lack of Efficacy|2|||
155187887|NCT02600351|560127977|FG000|Overall Study|Lost to Follow-up|1|||
155187888|NCT02600351|560127978|FG001|Overall Study|Lost to Follow-up|0|||
155187889|NCT02600351|560127979|FG002|Overall Study|Lost to Follow-up|0|||
155187890|NCT02600351|560127980|FG003|Overall Study|Lost to Follow-up|0|||
155187891|NCT02600351|560127977|FG000|Overall Study|Randomized but Not Treated|1|||
155187892|NCT02600351|560127978|FG001|Overall Study|Randomized but Not Treated|0|||
155187893|NCT02600351|560127979|FG002|Overall Study|Randomized but Not Treated|1|||
155187894|NCT02600351|560127980|FG003|Overall Study|Randomized but Not Treated|3|||
155187895|NCT02063880|560127981|FG000|Overall Study|Death|21|||
155187896|NCT02063880|560127982|FG001|Overall Study|Death|18|||
155187897|NCT02063880|560127981|FG000|Overall Study|Lost to Follow-up|7|||
155187898|NCT02063880|560127982|FG001|Overall Study|Lost to Follow-up|7|||
155187899|NCT02063880|560127981|FG000|Overall Study|Ineligible|0|||
155187900|NCT02063880|560127982|FG001|Overall Study|Ineligible|2|||
155187901|NCT02106910|560127983|FG000|Overall Study|Lost to Follow-up|1|||
155187902|NCT02106910|560127984|FG001|Overall Study|Lost to Follow-up|1|||
155187903|NCT00567593|560127987|FG000|Overall Study|Adverse Event|1|||
155187904|NCT00567593|560127987|FG000|Overall Study|Physician Decision|1|||
155187905|NCT02476422|560127988|FG000|Overall Study|Subject/guardian decision|0|||
155187906|NCT02476422|560127989|FG001|Overall Study|Subject/guardian decision|1|||
155187907|NCT01859143|560127990|FG000|Overall Study|Lost to Follow-up|2|||
155187908|NCT01859143|560127991|FG001|Overall Study|Lost to Follow-up|0|||
155187909|NCT02413372|560127995|FG000|Treatment|Lost to Follow-up|0|||
155187910|NCT02413372|560127996|FG001|Treatment|Lost to Follow-up|2|||
155187911|NCT02413372|560127997|FG002|Treatment|Lost to Follow-up|1|||
155187912|NCT02413372|560127995|FG000|Treatment|Withdrawal by Subject|1|||
155187913|NCT02413372|560127996|FG001|Treatment|Withdrawal by Subject|0|||
155187914|NCT02413372|560127997|FG002|Treatment|Withdrawal by Subject|0|||
155187915|NCT02413372|560127995|FG000|Follow-up|Lost to Follow-up|1|||
155187916|NCT02413372|560127996|FG001|Follow-up|Lost to Follow-up|1|||
155187917|NCT02413372|560127997|FG002|Follow-up|Lost to Follow-up|0|||
155187918|NCT02413372|560127995|FG000|Follow-up|Subject Withdrew Consent|1|||
155187919|NCT02413372|560127996|FG001|Follow-up|Subject Withdrew Consent|0|||
155187920|NCT02413372|560127997|FG002|Follow-up|Subject Withdrew Consent|1|||
155187921|NCT02413372|560127995|FG000|Follow-up|Subject unable to return for visit|0|||
155187922|NCT02413372|560127996|FG001|Follow-up|Subject unable to return for visit|0|||
155187923|NCT02413372|560127997|FG002|Follow-up|Subject unable to return for visit|1|||
155187924|NCT00760214|560128005|FG000|Overall Study|Adverse Event|8|||
155187925|NCT00760214|560128006|FG001|Overall Study|Adverse Event|9|||
155187926|NCT00760214|560128007|FG002|Overall Study|Adverse Event|12|||
155187927|NCT00760214|560128005|FG000|Overall Study|Protocol Violation|3|||
155187928|NCT00760214|560128006|FG001|Overall Study|Protocol Violation|0|||
155187929|NCT00760214|560128007|FG002|Overall Study|Protocol Violation|3|||
155187930|NCT00760214|560128005|FG000|Overall Study|Lost to Follow-up|0|||
155187931|NCT00760214|560128006|FG001|Overall Study|Lost to Follow-up|0|||
155187932|NCT00760214|560128007|FG002|Overall Study|Lost to Follow-up|1|||
155187933|NCT00760214|560128005|FG000|Overall Study|Withdrawal by Subject|12|||
155187934|NCT00760214|560128006|FG001|Overall Study|Withdrawal by Subject|14|||
155187935|NCT00760214|560128007|FG002|Overall Study|Withdrawal by Subject|13|||
155187936|NCT00760214|560128005|FG000|Overall Study|Lack of Efficacy|3|||
155037389|NCT00426660|559563876|FG000|Overall Study|Withdrawal by Subject|18|||
155037390|NCT00426660|559563876|FG000|Overall Study|Protocol Violation|1|||
155037391|NCT00426660|559563876|FG000|Overall Study|Enrolled Not Treated|15|||
155037392|NCT00980174|559563877|FG000|Overall Study|Withdrawal by Subject|1|||
155187937|NCT00760214|560128006|FG001|Overall Study|Lack of Efficacy|2|||
155187938|NCT00760214|560128007|FG002|Overall Study|Lack of Efficacy|4|||
155187939|NCT00760214|560128005|FG000|Overall Study|Pregnancy|0|||
155187940|NCT00760214|560128006|FG001|Overall Study|Pregnancy|0|||
155187941|NCT00760214|560128007|FG002|Overall Study|Pregnancy|1|||
155187942|NCT00760214|560128005|FG000|Overall Study|Physician Decision|1|||
155187943|NCT00760214|560128006|FG001|Overall Study|Physician Decision|1|||
155187944|NCT00760214|560128007|FG002|Overall Study|Physician Decision|1|||
155187945|NCT00760214|560128005|FG000|Overall Study|Other|3|||
155187946|NCT00760214|560128006|FG001|Overall Study|Other|4|||
155187947|NCT00760214|560128007|FG002|Overall Study|Other|6|||
155187948|NCT00700570|560128008|FG000|Overall Study|Adverse Event|2|||
155187949|NCT00700570|560128009|FG001|Overall Study|Adverse Event|6|||
155187950|NCT00700570|560128008|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
155187951|NCT00700570|560128009|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
155187952|NCT00700570|560128008|FG000|Overall Study|Disease Progression|8|||
155187953|NCT00700570|560128009|FG001|Overall Study|Disease Progression|11|||
155187954|NCT00700570|560128008|FG000|Overall Study|Withdrawal by Subject|1|||
155187955|NCT00700570|560128009|FG001|Overall Study|Withdrawal by Subject|6|||
155187956|NCT01134315|560128010|FG000|Overall Study|Adverse Event|1|||
155187957|NCT01134315|560128011|FG001|Overall Study|Adverse Event|2|||
155187958|NCT01134315|560128010|FG000|Overall Study|Other Reason|8|||
155187959|NCT01134315|560128011|FG001|Overall Study|Other Reason|17|||
155187960|NCT04587271|560128012|FG000|Overall Study|Lost to Follow-up|2|||
155187961|NCT04587271|560128013|FG001|Overall Study|Lost to Follow-up|2|||
155187962|NCT04587271|560128014|FG002|Overall Study|Lost to Follow-up|0|||
155187963|NCT04587271|560128015|FG003|Overall Study|Lost to Follow-up|2|||
155187964|NCT04587271|560128016|FG004|Overall Study|Lost to Follow-up|2|||
155187965|NCT04587271|560128017|FG005|Overall Study|Lost to Follow-up|0|||
155187966|NCT04587271|560128012|FG000|Overall Study|Caregiver brought child to visits|0|||
155187967|NCT04587271|560128013|FG001|Overall Study|Caregiver brought child to visits|0|||
155187968|NCT04587271|560128014|FG002|Overall Study|Caregiver brought child to visits|0|||
155187969|NCT04587271|560128015|FG003|Overall Study|Caregiver brought child to visits|1|||
155187970|NCT04587271|560128016|FG004|Overall Study|Caregiver brought child to visits|0|||
155187971|NCT04587271|560128017|FG005|Overall Study|Caregiver brought child to visits|0|||
155187972|NCT02360111|560128018|FG000|Overall Study|Death|2|||
155187973|NCT01933217|560128019|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
155187974|NCT01933217|560128020|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
155187975|NCT01933217|560128019|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
155187976|NCT01933217|560128020|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
155187977|NCT03923738|560128024|FG000|Period 1|Adverse Event|1|||
155187978|NCT03923738|560128024|FG000|Period 1|Withdrawal by Subject|1|||
155187979|NCT05246397|560128025|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
155187980|NCT03875768|560128026|FG000|Overall Study|Lost to Follow-up|16|||
155187981|NCT03875768|560128027|FG001|Overall Study|Lost to Follow-up|13|||
155187982|NCT03875768|560128026|FG000|Overall Study|Withdrawal by Subject|10|||
155187983|NCT03875768|560128027|FG001|Overall Study|Withdrawal by Subject|21|||
155187984|NCT03875768|560128026|FG000|Overall Study|Did not complete assessment|21|||
155187985|NCT03875768|560128027|FG001|Overall Study|Did not complete assessment|12|||
155187986|NCT03875768|560128026|FG000|Overall Study|Became ineligible|1|||
155187987|NCT03875768|560128027|FG001|Overall Study|Became ineligible|0|||
155187988|NCT01925274|560128028|FG000|Overall Study|Death|1|||
155187989|NCT01925274|560128029|FG001|Overall Study|Death|0|||
155187990|NCT01925274|560128030|FG002|Overall Study|Death|0|||
155187991|NCT01925274|560128028|FG000|Overall Study|Lost to Follow-up|0|||
155187992|NCT01925274|560128029|FG001|Overall Study|Lost to Follow-up|1|||
155187993|NCT01925274|560128030|FG002|Overall Study|Lost to Follow-up|0|||
155187994|NCT01925274|560128028|FG000|Overall Study|Withdrawal by Subject|1|||
155187995|NCT01925274|560128029|FG001|Overall Study|Withdrawal by Subject|2|||
155187996|NCT01925274|560128030|FG002|Overall Study|Withdrawal by Subject|0|||
155187997|NCT01925274|560128028|FG000|Overall Study|Study terminated by sponsor|4|||
155187998|NCT01925274|560128029|FG001|Overall Study|Study terminated by sponsor|0|||
155187999|NCT01925274|560128030|FG002|Overall Study|Study terminated by sponsor|0|||
155188000|NCT01925274|560128028|FG000|Overall Study|Protocol amendment|1|||
155188001|NCT01925274|560128029|FG001|Overall Study|Protocol amendment|3|||
155188002|NCT01925274|560128030|FG002|Overall Study|Protocol amendment|6|||
155188003|NCT04327674|560128032|FG000|Overall Study|Protocol Violation|19|||
155188004|NCT00723398|560128037|FG000|Overall Study|Withdrawal by Subject|2|||
155188005|NCT00723398|560128038|FG001|Overall Study|Withdrawal by Subject|6|||
155188006|NCT00723398|560128039|FG002|Overall Study|Withdrawal by Subject|4|||
155188007|NCT00723398|560128040|FG003|Overall Study|Withdrawal by Subject|4|||
155188008|NCT00723398|560128041|FG004|Overall Study|Withdrawal by Subject|4|||
155188009|NCT00723398|560128037|FG000|Overall Study|Protocol Violation|2|||
155188010|NCT00723398|560128038|FG001|Overall Study|Protocol Violation|1|||
155188011|NCT00723398|560128039|FG002|Overall Study|Protocol Violation|5|||
155188012|NCT00723398|560128040|FG003|Overall Study|Protocol Violation|0|||
155188013|NCT00723398|560128041|FG004|Overall Study|Protocol Violation|0|||
155188014|NCT00723398|560128037|FG000|Overall Study|Physician Decision|2|||
155188015|NCT00723398|560128038|FG001|Overall Study|Physician Decision|2|||
155188016|NCT00723398|560128039|FG002|Overall Study|Physician Decision|5|||
155188017|NCT00723398|560128040|FG003|Overall Study|Physician Decision|0|||
155188018|NCT00723398|560128041|FG004|Overall Study|Physician Decision|1|||
155188019|NCT00723398|560128037|FG000|Overall Study|Adverse Event|0|||
155188020|NCT00723398|560128038|FG001|Overall Study|Adverse Event|5|||
155188021|NCT00723398|560128039|FG002|Overall Study|Adverse Event|3|||
155188022|NCT00723398|560128040|FG003|Overall Study|Adverse Event|1|||
155188023|NCT00723398|560128041|FG004|Overall Study|Adverse Event|4|||
155188024|NCT00723398|560128037|FG000|Overall Study|Lost to Follow-up|0|||
155188025|NCT00723398|560128038|FG001|Overall Study|Lost to Follow-up|1|||
155188026|NCT00723398|560128039|FG002|Overall Study|Lost to Follow-up|0|||
155188027|NCT00723398|560128040|FG003|Overall Study|Lost to Follow-up|0|||
155188028|NCT00723398|560128041|FG004|Overall Study|Lost to Follow-up|0|||
155188029|NCT01225887|560128048|FG000|Overall Study|Ineligible:required test not done|2|||
155188030|NCT01225887|560128048|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
155188031|NCT01225887|560128048|FG000|Overall Study|Ineligible:inadequate pathology|2|||
155188032|NCT01400815|560128051|FG000|Overall Study|Adverse Event|3|||
155188033|NCT01400815|560128052|FG001|Overall Study|Adverse Event|0|||
155188034|NCT01400815|560128051|FG000|Overall Study|Death|0|||
155188035|NCT01400815|560128052|FG001|Overall Study|Death|1|||
155188036|NCT01400815|560128051|FG000|Overall Study|Lost to Follow-up|18|||
155188037|NCT01400815|560128052|FG001|Overall Study|Lost to Follow-up|11|||
155188038|NCT01400815|560128051|FG000|Overall Study|Protocol Violation|0|||
155188039|NCT01400815|560128052|FG001|Overall Study|Protocol Violation|1|||
155188040|NCT01400815|560128051|FG000|Overall Study|Physician Decision|1|||
155188041|NCT01400815|560128052|FG001|Overall Study|Physician Decision|0|||
155188042|NCT01400815|560128051|FG000|Overall Study|Withdrawal by Subject|15|||
155188043|NCT01400815|560128052|FG001|Overall Study|Withdrawal by Subject|8|||
155188044|NCT01400815|560128051|FG000|Overall Study|Subject in jail|1|||
155188045|NCT01400815|560128052|FG001|Overall Study|Subject in jail|0|||
155188046|NCT01123850|560128053|FG000|Overall Study|Slow enrollment|45|||
155188047|NCT01822678|560128061|FG000|Overall Study|Withdrawal by Subject|5|||
155188048|NCT01822678|560128062|FG001|Overall Study|Withdrawal by Subject|4|||
155188049|NCT01822678|560128063|FG002|Overall Study|Withdrawal by Subject|4|||
155188050|NCT01822678|560128061|FG000|Overall Study|Adverse Event|4|||
155188051|NCT01822678|560128062|FG001|Overall Study|Adverse Event|3|||
155188052|NCT01822678|560128063|FG002|Overall Study|Adverse Event|1|||
155188053|NCT01822678|560128061|FG000|Overall Study|Lack of Efficacy|3|||
155188054|NCT01822678|560128062|FG001|Overall Study|Lack of Efficacy|6|||
155188055|NCT01822678|560128063|FG002|Overall Study|Lack of Efficacy|5|||
155188056|NCT01822678|560128061|FG000|Overall Study|Lost to Follow-up|0|||
155188057|NCT01822678|560128062|FG001|Overall Study|Lost to Follow-up|2|||
155188058|NCT01822678|560128063|FG002|Overall Study|Lost to Follow-up|1|||
155188059|NCT01437878|560128069|FG000|Overall Study|Withdrawal by Subject|1|||
155188060|NCT01437878|560128070|FG001|Overall Study|Withdrawal by Subject|0|||
155188061|NCT01369615|560128072|FG000|Overall Study|Withdrawal by Subject|0|||
155188062|NCT01369615|560128073|FG001|Overall Study|Withdrawal by Subject|1|||
155188063|NCT01369615|560128072|FG000|Overall Study|Lost to Follow-up|0|||
155188064|NCT01369615|560128073|FG001|Overall Study|Lost to Follow-up|1|||
155188065|NCT04263454|560128074|FG000|Overall Study|Adverse Event|0|||
155188066|NCT04263454|560128075|FG001|Overall Study|Adverse Event|2|||
155188067|NCT04263454|560128074|FG000|Overall Study|Physician Decision|3|||
155188068|NCT04263454|560128075|FG001|Overall Study|Physician Decision|5|||
155188069|NCT04263454|560128074|FG000|Overall Study|Poor Data Quality|0|||
155188070|NCT04263454|560128075|FG001|Overall Study|Poor Data Quality|1|||
155188071|NCT00986479|560128076|FG000|Period 1|Improved mood|1|||
155188072|NCT00986479|560128077|FG001|Period 1|Improved mood|0|||
155188073|NCT00986479|560128076|FG000|Period 1|Administrative reasons|1|||
155188074|NCT00986479|560128077|FG001|Period 1|Administrative reasons|0|||
155188075|NCT01721070|560128078|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
155188076|NCT02035475|560128079|FG000|Overall Study|Withdrawal by Subject|4|||
155188077|NCT02035475|560128079|FG000|Overall Study|Physician Decision|1|||
155188078|NCT02035475|560128079|FG000|Overall Study|Equipment Error|1|||
155188079|NCT01460368|560128080|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188080|NCT01460368|560128081|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188081|NCT01460368|560128082|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188082|NCT01460368|560128083|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188083|NCT01460368|560128084|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
155188084|NCT01460368|560128085|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188085|NCT01460368|560128086|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
155188086|NCT01460368|560128080|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188087|NCT01460368|560128081|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
155188088|NCT01460368|560128082|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188089|NCT01460368|560128083|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188090|NCT01460368|560128084|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188091|NCT01460368|560128085|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
155188092|NCT01460368|560128086|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
155188093|NCT01460368|560128080|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188094|NCT01460368|560128081|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
155188095|NCT01460368|560128082|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188096|NCT01460368|560128083|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188097|NCT01460368|560128084|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188098|NCT01460368|560128085|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188099|NCT01460368|560128086|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
155188100|NCT01460368|560128080|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188101|NCT01460368|560128081|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188102|NCT01460368|560128082|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
155188103|NCT01460368|560128083|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188104|NCT01460368|560128084|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188105|NCT01460368|560128085|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188106|NCT01460368|560128086|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
155188107|NCT01460368|560128080|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188108|NCT01460368|560128081|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188109|NCT01460368|560128082|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
155188110|NCT01460368|560128083|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
155188111|NCT01460368|560128084|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188112|NCT01460368|560128085|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
155188113|NCT01460368|560128086|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
155188114|NCT02322021|560128087|FG000|Core Phase|Adverse Event|1|||
155188115|NCT02322021|560128088|FG001|Core Phase|Adverse Event|3|||
155188116|NCT02322021|560128089|FG002|Core Phase|Adverse Event|4|||
155188117|NCT02322021|560128090|FG003|Core Phase|Adverse Event|2|||
155188118|NCT02322021|560128091|FG004|Core Phase|Adverse Event|0|||
155188119|NCT02322021|560128087|FG000|Core Phase|Participant Choice|4|||
155188120|NCT02322021|560128088|FG001|Core Phase|Participant Choice|5|||
155188121|NCT02322021|560128089|FG002|Core Phase|Participant Choice|4|||
155188122|NCT02322021|560128090|FG003|Core Phase|Participant Choice|2|||
155188123|NCT02322021|560128091|FG004|Core Phase|Participant Choice|0|||
155188124|NCT02322021|560128087|FG000|Core Phase|Lost to Follow-up|0|||
155188125|NCT02322021|560128088|FG001|Core Phase|Lost to Follow-up|0|||
155188126|NCT02322021|560128089|FG002|Core Phase|Lost to Follow-up|0|||
155188127|NCT02322021|560128090|FG003|Core Phase|Lost to Follow-up|1|||
155188128|NCT02322021|560128091|FG004|Core Phase|Lost to Follow-up|0|||
155188129|NCT02322021|560128087|FG000|Core Phase|Other|0|||
155188130|NCT02322021|560128088|FG001|Core Phase|Other|0|||
155188131|NCT02322021|560128089|FG002|Core Phase|Other|1|||
155188132|NCT02322021|560128090|FG003|Core Phase|Other|0|||
155188133|NCT02322021|560128091|FG004|Core Phase|Other|0|||
155188134|NCT02322021|560128087|FG000|Extension Phase|Adverse Event|0|||
155188135|NCT02322021|560128088|FG001|Extension Phase|Adverse Event|0|||
155188136|NCT02322021|560128089|FG002|Extension Phase|Adverse Event|0|||
155188137|NCT02322021|560128090|FG003|Extension Phase|Adverse Event|0|||
155188138|NCT02322021|560128091|FG004|Extension Phase|Adverse Event|3|||
155188139|NCT02322021|560128087|FG000|Extension Phase|Participant Choice|0|||
155188140|NCT02322021|560128088|FG001|Extension Phase|Participant Choice|0|||
155188141|NCT02322021|560128089|FG002|Extension Phase|Participant Choice|0|||
155188142|NCT02322021|560128090|FG003|Extension Phase|Participant Choice|0|||
155188143|NCT02322021|560128091|FG004|Extension Phase|Participant Choice|6|||
155188144|NCT02322021|560128087|FG000|Extension Phase|Other|0|||
155188145|NCT02322021|560128088|FG001|Extension Phase|Other|0|||
155188146|NCT02322021|560128089|FG002|Extension Phase|Other|0|||
155188147|NCT02322021|560128090|FG003|Extension Phase|Other|0|||
155188148|NCT02322021|560128091|FG004|Extension Phase|Other|3|||
155188149|NCT02322021|560128087|FG000|Extension Phase|Lost to Follow-up|0|||
155188150|NCT02322021|560128088|FG001|Extension Phase|Lost to Follow-up|0|||
155188151|NCT02322021|560128089|FG002|Extension Phase|Lost to Follow-up|0|||
155188152|NCT02322021|560128090|FG003|Extension Phase|Lost to Follow-up|0|||
155188153|NCT02322021|560128091|FG004|Extension Phase|Lost to Follow-up|1|||
155188154|NCT02322021|560128087|FG000|Extension Phase|Study terminated by sponsor|0|||
155188155|NCT02322021|560128088|FG001|Extension Phase|Study terminated by sponsor|0|||
155188156|NCT02322021|560128089|FG002|Extension Phase|Study terminated by sponsor|0|||
155188157|NCT02322021|560128090|FG003|Extension Phase|Study terminated by sponsor|0|||
155188158|NCT02322021|560128091|FG004|Extension Phase|Study terminated by sponsor|28|||
155188159|NCT02047227|560128092|FG000|Overall Study|Adverse Event|2|||
155188160|NCT02047227|560128093|FG001|Overall Study|Adverse Event|4|||
155188161|NCT02047227|560128092|FG000|Overall Study|Lost to Follow-up|0|||
155188162|NCT02047227|560128093|FG001|Overall Study|Lost to Follow-up|3|||
155188163|NCT02047227|560128092|FG000|Overall Study|Protocol Violation|1|||
155188164|NCT02047227|560128093|FG001|Overall Study|Protocol Violation|0|||
155188165|NCT02047227|560128092|FG000|Overall Study|Spontaneous pregnancy|1|||
155188166|NCT02047227|560128093|FG001|Overall Study|Spontaneous pregnancy|0|||
155188167|NCT02047227|560128092|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
155188168|NCT02047227|560128093|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
155188169|NCT02047227|560128092|FG000|Overall Study|No oocytes retrieved|21|||
155188170|NCT02047227|560128093|FG001|Overall Study|No oocytes retrieved|20|||
155188171|NCT02047227|560128092|FG000|Overall Study|No fertilization|61|||
155188172|NCT02047227|560128093|FG001|Overall Study|No fertilization|51|||
155188173|NCT02047227|560128092|FG000|Overall Study|Intention to freeze all embryos|1|||
155188174|NCT02047227|560128093|FG001|Overall Study|Intention to freeze all embryos|0|||
155188175|NCT02047227|560128092|FG000|Overall Study|All embryos discarded|12|||
155188176|NCT02047227|560128093|FG001|Overall Study|All embryos discarded|11|||
155188177|NCT02047227|560128092|FG000|Overall Study|Other|10|||
155188178|NCT02047227|560128093|FG001|Overall Study|Other|9|||
155188179|NCT02001181|560128100|FG000|Overall Study|Adverse Event|0|||
155188180|NCT02001181|560128101|FG001|Overall Study|Adverse Event|2|||
155188181|NCT02001181|560128100|FG000|Overall Study|Lost to Follow-up|1|||
155188182|NCT02001181|560128101|FG001|Overall Study|Lost to Follow-up|0|||
155188183|NCT02001181|560128100|FG000|Overall Study|Withdrawal by Subject|0|||
155188184|NCT02001181|560128101|FG001|Overall Study|Withdrawal by Subject|1|||
155188185|NCT02435069|560128106|FG000|Dose Response - First Intervention|Adverse Event|0|||
155188186|NCT02435069|560128107|FG001|Dose Response - First Intervention|Adverse Event|1|||
155188187|NCT02435069|560128108|FG002|Dose Response - First Intervention|Adverse Event|1|||
155188188|NCT02435069|560128109|FG003|Dose Response - First Intervention|Adverse Event|0|||
155188189|NCT02435069|560128110|FG004|Dose Response - First Intervention|Adverse Event|0|||
155188190|NCT02435069|560128106|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188191|NCT02435069|560128107|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188192|NCT02435069|560128108|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188193|NCT02435069|560128109|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
155188194|NCT02435069|560128110|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
155188195|NCT03112590|560128111|FG000|Overall Study|Adverse Event|0|||
155188196|NCT03112590|560128112|FG001|Overall Study|Adverse Event|1|||
155188197|NCT03112590|560128113|FG002|Overall Study|Adverse Event|0|||
155188198|NCT02059005|560128116|FG000|Overall Study|Death|1|||
155188199|NCT02059005|560128117|FG001|Overall Study|Death|3|||
155188200|NCT02059005|560128116|FG000|Overall Study|Lost to Follow-up|19|||
155188201|NCT02059005|560128117|FG001|Overall Study|Lost to Follow-up|19|||
155188202|NCT02059005|560128116|FG000|Overall Study|Incarceration|0|||
155188203|NCT02059005|560128117|FG001|Overall Study|Incarceration|1|||
155188204|NCT02059005|560128116|FG000|Overall Study|Inpatient|0|||
155188205|NCT02059005|560128117|FG001|Overall Study|Inpatient|1|||
155188206|NCT00739596|560128122|FG000|Overall Study|Adverse Event|12|||
155188207|NCT00739596|560128123|FG001|Overall Study|Adverse Event|6|||
155188208|NCT00739596|560128122|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
155188209|NCT00739596|560128123|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
155188210|NCT00739596|560128122|FG000|Overall Study|Patient Withdrew Consent|8|||
155188211|NCT00739596|560128123|FG001|Overall Study|Patient Withdrew Consent|8|||
155188212|NCT00739596|560128122|FG000|Overall Study|Lost to Follow-up|0|||
155188213|NCT00739596|560128123|FG001|Overall Study|Lost to Follow-up|2|||
155188214|NCT00739596|560128122|FG000|Overall Study|Protocol Deviation|1|||
155188215|NCT00739596|560128123|FG001|Overall Study|Protocol Deviation|1|||
155188216|NCT00908011|560128124|FG000|Overall Study|Withdrawal by Subject|2|||
155188217|NCT00908011|560128125|FG001|Overall Study|Withdrawal by Subject|2|||
155188218|NCT02520661|560128126|FG000|Overall Study|Lost to Follow-up|7|||
155188219|NCT02520661|560128127|FG001|Overall Study|Lost to Follow-up|3|||
155188220|NCT02520661|560128126|FG000|Overall Study|Admitted from ED|49|||
155188221|NCT02520661|560128127|FG001|Overall Study|Admitted from ED|48|||
155188222|NCT02520661|560128126|FG000|Overall Study|ED greater than 24 hours|29|||
155188223|NCT02520661|560128127|FG001|Overall Study|ED greater than 24 hours|38|||
155188224|NCT02520661|560128126|FG000|Overall Study|other ineligibility|14|||
155188225|NCT02520661|560128127|FG001|Overall Study|other ineligibility|22|||
155037393|NCT00980174|559563878|FG001|Overall Study|Withdrawal by Subject|4|||
155037394|NCT00980174|559563877|FG000|Overall Study|Adverse Event|0|||
155188226|NCT02520661|560128126|FG000|Overall Study|Withdrawal by Subject|7|||
155188227|NCT02520661|560128127|FG001|Overall Study|Withdrawal by Subject|16|||
155188228|NCT00891462|560129240|FG000|Overall Study|Withdrawal by Subject|9|||
155188229|NCT00891462|560129241|FG001|Overall Study|Withdrawal by Subject|6|||
155188230|NCT00891462|560129242|FG002|Overall Study|Withdrawal by Subject|7|||
155188231|NCT00891462|560129240|FG000|Overall Study|Adverse Event|7|||
155188232|NCT00891462|560129241|FG001|Overall Study|Adverse Event|8|||
155188233|NCT00891462|560129242|FG002|Overall Study|Adverse Event|7|||
155037395|NCT00980174|559563878|FG001|Overall Study|Adverse Event|3|||
155188234|NCT00891462|560129240|FG000|Overall Study|Lack of Efficacy|10|||
155188235|NCT00891462|560129241|FG001|Overall Study|Lack of Efficacy|5|||
155188236|NCT00891462|560129242|FG002|Overall Study|Lack of Efficacy|1|||
155188237|NCT00891462|560129240|FG000|Overall Study|COPD exacerbation|7|||
155188238|NCT00891462|560129241|FG001|Overall Study|COPD exacerbation|4|||
155188239|NCT00891462|560129242|FG002|Overall Study|COPD exacerbation|1|||
155188240|NCT00891462|560129240|FG000|Overall Study|Other Reason|2|||
155188241|NCT00891462|560129241|FG001|Overall Study|Other Reason|5|||
155188242|NCT00891462|560129242|FG002|Overall Study|Other Reason|3|||
155188243|NCT00891462|560129240|FG000|Overall Study|Protocol Violation|2|||
155188244|NCT00891462|560129241|FG001|Overall Study|Protocol Violation|1|||
155188245|NCT00891462|560129242|FG002|Overall Study|Protocol Violation|3|||
155188246|NCT00891462|560129240|FG000|Overall Study|Inclusion/exclusion criteria|0|||
155188247|NCT00891462|560129241|FG001|Overall Study|Inclusion/exclusion criteria|2|||
155188248|NCT00891462|560129242|FG002|Overall Study|Inclusion/exclusion criteria|2|||
155188249|NCT00891462|560129240|FG000|Overall Study|Lost to Follow-up|0|||
155188250|NCT00891462|560129241|FG001|Overall Study|Lost to Follow-up|2|||
155188251|NCT00891462|560129242|FG002|Overall Study|Lost to Follow-up|0|||
155188252|NCT01083485|560129243|FG000|Overall Study|Adverse Event|0|||
155188253|NCT01083485|560129244|FG001|Overall Study|Adverse Event|1|||
155188254|NCT01083485|560129243|FG000|Overall Study|Protocol Violation|1|||
155188255|NCT01083485|560129244|FG001|Overall Study|Protocol Violation|0|||
155188256|NCT01083485|560129243|FG000|Overall Study|Withdrawal by Subject|5|||
155188257|NCT01083485|560129244|FG001|Overall Study|Withdrawal by Subject|2|||
155188258|NCT01083485|560129243|FG000|Overall Study|Other|1|||
155188259|NCT01083485|560129244|FG001|Overall Study|Other|0|||
155188260|NCT05108922|560129245|FG000|Overall Study|Adverse Event|2|||
155188261|NCT05108922|560129246|FG001|Overall Study|Adverse Event|3|||
155188262|NCT05108922|560129245|FG000|Overall Study|Lost to Follow-up|2|||
155188263|NCT05108922|560129246|FG001|Overall Study|Lost to Follow-up|1|||
155188264|NCT05108922|560129245|FG000|Overall Study|Inadvertent enrollment|0|||
155188265|NCT05108922|560129246|FG001|Overall Study|Inadvertent enrollment|1|||
155188266|NCT05108922|560129245|FG000|Overall Study|Physician Decision|2|||
155188267|NCT05108922|560129246|FG001|Overall Study|Physician Decision|3|||
155188268|NCT05108922|560129245|FG000|Overall Study|Protocol deviation|1|||
155188269|NCT05108922|560129246|FG001|Overall Study|Protocol deviation|0|||
155188270|NCT05108922|560129245|FG000|Overall Study|Screen failure|1|||
155188271|NCT05108922|560129246|FG001|Overall Study|Screen failure|0|||
155188272|NCT05108922|560129245|FG000|Overall Study|Withdrawal by Subject|11|||
155188273|NCT05108922|560129246|FG001|Overall Study|Withdrawal by Subject|8|||
155188274|NCT05036369|560129247|FG000|Overall Study|Run In non compliance|1|||
155188275|NCT05036369|560129248|FG001|Overall Study|Run In non compliance|2|||
155188276|NCT05036369|560129247|FG000|Overall Study|Change in eligibility criteria|0|||
155188277|NCT05036369|560129248|FG001|Overall Study|Change in eligibility criteria|1|||
155188278|NCT02095223|560129250|FG000|Overall Study|Withdrawal by Subject|1|||
155188279|NCT02095223|560129251|FG001|Overall Study|Withdrawal by Subject|0|||
155188280|NCT01397162|560129252|FG000|Overall Study|Adverse Event|4|||
155188281|NCT01397162|560129253|FG001|Overall Study|Adverse Event|0|||
155188282|NCT01397162|560129254|FG002|Overall Study|Adverse Event|0|||
155188283|NCT01397162|560129255|FG003|Overall Study|Adverse Event|0|||
155188284|NCT01397162|560129256|FG004|Overall Study|Adverse Event|0|||
155188285|NCT01397162|560129252|FG000|Overall Study|Not yet defined|3|||
155188286|NCT01397162|560129253|FG001|Overall Study|Not yet defined|4|||
155188287|NCT01397162|560129254|FG002|Overall Study|Not yet defined|3|||
155188288|NCT01397162|560129255|FG003|Overall Study|Not yet defined|5|||
155188289|NCT01397162|560129256|FG004|Overall Study|Not yet defined|3|||
155188290|NCT01507298|560129261|FG000|Overall Study|Protocol Violation|0|||
155188291|NCT01507298|560129262|FG001|Overall Study|Protocol Violation|6|||
155188292|NCT03906461|560129263|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
155188293|NCT03906461|560129263|FG000|Completed 12-month Follow-up|Missed Visit|6|||
155188294|NCT01920555|560129264|FG000|Overall Study|Physician Decision|1|||
155188295|NCT01920555|560129265|FG001|Overall Study|Physician Decision|2|||
155188296|NCT01920555|560129266|FG002|Overall Study|Physician Decision|1|||
155188297|NCT01920555|560129267|FG003|Overall Study|Physician Decision|2|||
155188298|NCT01920555|560129268|FG004|Overall Study|Physician Decision|0|||
155188299|NCT01920555|560129264|FG000|Overall Study|Lack of Efficacy|2|||
155037396|NCT00980174|559563877|FG000|Overall Study|Ineligibility determined|2|||
155037397|NCT00980174|559563878|FG001|Overall Study|Ineligibility determined|1|||
155037398|NCT00980174|559563877|FG000|Overall Study|Death|1|||
155037399|NCT00980174|559563878|FG001|Overall Study|Death|1|||
155188300|NCT01920555|560129265|FG001|Overall Study|Lack of Efficacy|0|||
155188301|NCT01920555|560129266|FG002|Overall Study|Lack of Efficacy|0|||
155188302|NCT01920555|560129267|FG003|Overall Study|Lack of Efficacy|0|||
155188303|NCT01920555|560129268|FG004|Overall Study|Lack of Efficacy|0|||
155188304|NCT01920555|560129264|FG000|Overall Study|Travel Difficulties|1|||
155188305|NCT01920555|560129265|FG001|Overall Study|Travel Difficulties|1|||
155188306|NCT01920555|560129266|FG002|Overall Study|Travel Difficulties|0|||
155188307|NCT01920555|560129267|FG003|Overall Study|Travel Difficulties|0|||
155188308|NCT01920555|560129268|FG004|Overall Study|Travel Difficulties|1|||
155188309|NCT01920555|560129264|FG000|Overall Study|Lost to Follow-up|0|||
155188310|NCT01920555|560129265|FG001|Overall Study|Lost to Follow-up|1|||
155188311|NCT01920555|560129266|FG002|Overall Study|Lost to Follow-up|0|||
155188312|NCT01920555|560129267|FG003|Overall Study|Lost to Follow-up|1|||
155188313|NCT01920555|560129268|FG004|Overall Study|Lost to Follow-up|0|||
155188314|NCT01795638|560129271|FG000|Overall Study|Death|0|||
155188315|NCT01795638|560129272|FG001|Overall Study|Death|3|||
155188316|NCT01795638|560129271|FG000|Overall Study|transferred to quaternary hospital|2|||
155188317|NCT01795638|560129272|FG001|Overall Study|transferred to quaternary hospital|3|||
155188318|NCT01795638|560129271|FG000|Overall Study|Protocol Violation|3|||
155188319|NCT01795638|560129272|FG001|Overall Study|Protocol Violation|0|||
155188320|NCT01795638|560129271|FG000|Overall Study|discharged from hospital|7|||
155188321|NCT01795638|560129272|FG001|Overall Study|discharged from hospital|5|||
155188322|NCT01795638|560129271|FG000|Overall Study|Withdrawal by Subject|1|||
155188323|NCT01795638|560129272|FG001|Overall Study|Withdrawal by Subject|0|||
155188324|NCT00611533|560129273|FG000|First Intervention (6 Weeks)|Never started study|0|||
155188325|NCT00611533|560129274|FG001|First Intervention (6 Weeks)|Never started study|1|||
155188326|NCT00611533|560129273|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
155188327|NCT00611533|560129274|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
155188328|NCT00611533|560129273|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
155188329|NCT00611533|560129274|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
155188330|NCT01954342|560129278|FG000|Overall Study|Missing data from 13-16week study visit|0|||
155188331|NCT01954342|560129279|FG001|Overall Study|Missing data from 13-16week study visit|0|||
155188332|NCT01954342|560129280|FG002|Overall Study|Missing data from 13-16week study visit|0|||
155188333|NCT01954342|560129281|FG003|Overall Study|Missing data from 13-16week study visit|1|||
155188334|NCT01954342|560129278|FG000|Overall Study|Miscarriage|0|||
155188335|NCT01954342|560129279|FG001|Overall Study|Miscarriage|0|||
155188336|NCT01954342|560129280|FG002|Overall Study|Miscarriage|0|||
155188337|NCT01954342|560129281|FG003|Overall Study|Miscarriage|3|||
155188338|NCT01954342|560129278|FG000|Overall Study|Lost to Follow-up|0|||
155188339|NCT01954342|560129279|FG001|Overall Study|Lost to Follow-up|0|||
155188340|NCT01954342|560129280|FG002|Overall Study|Lost to Follow-up|0|||
155188341|NCT01954342|560129281|FG003|Overall Study|Lost to Follow-up|5|||
155188342|NCT01954342|560129278|FG000|Overall Study|Preterm delivery|0|||
155188343|NCT01954342|560129279|FG001|Overall Study|Preterm delivery|0|||
155188344|NCT01954342|560129280|FG002|Overall Study|Preterm delivery|0|||
155188345|NCT01954342|560129281|FG003|Overall Study|Preterm delivery|3|||
155188346|NCT01954342|560129278|FG000|Overall Study|Pre-eclampsia|0|||
155188347|NCT01954342|560129279|FG001|Overall Study|Pre-eclampsia|0|||
155188348|NCT01954342|560129280|FG002|Overall Study|Pre-eclampsia|0|||
155188349|NCT01954342|560129281|FG003|Overall Study|Pre-eclampsia|4|||
155188350|NCT01954342|560129278|FG000|Overall Study|Unreliable Data|0|||
155188351|NCT01954342|560129279|FG001|Overall Study|Unreliable Data|0|||
155188352|NCT01954342|560129280|FG002|Overall Study|Unreliable Data|0|||
155188353|NCT01954342|560129281|FG003|Overall Study|Unreliable Data|2|||
155188354|NCT00984568|560129284|FG000|Overall Study|Withdrawal by Subject|1|||
155188355|NCT00984568|560129285|FG001|Overall Study|Withdrawal by Subject|2|||
155188356|NCT00984568|560129284|FG000|Overall Study|Lack of Efficacy|2|||
155188357|NCT00984568|560129285|FG001|Overall Study|Lack of Efficacy|0|||
155188358|NCT00984568|560129284|FG000|Overall Study|Adverse Event|2|||
155188359|NCT00984568|560129285|FG001|Overall Study|Adverse Event|0|||
155188360|NCT00984568|560129284|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
155188361|NCT00984568|560129285|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
155188362|NCT00984568|560129284|FG000|Overall Study|Lost to Follow-up|0|||
155188363|NCT00984568|560129285|FG001|Overall Study|Lost to Follow-up|1|||
155188364|NCT00984568|560129284|FG000|Overall Study|Opportunistic Infection|1|||
155188365|NCT00984568|560129285|FG001|Overall Study|Opportunistic Infection|0|||
155188366|NCT00984568|560129284|FG000|Overall Study|Unknown Reason|1|||
155188367|NCT00984568|560129285|FG001|Overall Study|Unknown Reason|3|||
155188368|NCT02310321|560129292|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
155188369|NCT02310321|560129293|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155188370|NCT02310321|560129294|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155188371|NCT02310321|560129292|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
155037400|NCT00980174|559563877|FG000|Overall Study|Other|0|||
155037401|NCT00980174|559563878|FG001|Overall Study|Other|1|||
155188372|NCT02310321|560129293|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188373|NCT02310321|560129294|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188374|NCT02310321|560129292|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
155188375|NCT02310321|560129293|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188376|NCT02310321|560129294|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
155188377|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
155188378|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
155188379|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
155188380|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155037402|NCT01546038|559563879|FG000|Overall Study|Death|15|||
155188381|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
155037403|NCT01546038|559563880|FG001|Overall Study|Death|6|||
155188382|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
155188383|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
155188384|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
155188385|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
155188386|NCT02310321|560129292|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
155188387|NCT02310321|560129293|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
155188388|NCT02310321|560129294|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
155188389|NCT02310321|560129292|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
155188390|NCT02310321|560129293|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
155188391|NCT02310321|560129294|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
155188392|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
155188393|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
155188394|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
155188395|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
155188396|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
155188397|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
155188398|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
155188399|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
155188400|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
155188401|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
155188402|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
155188403|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
155188404|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
155188405|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
155188406|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
155188407|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
155188408|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
155188409|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
155188410|NCT02310321|560129292|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
155188411|NCT02310321|560129293|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
155188412|NCT02310321|560129294|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
155188413|NCT02310321|560129292|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
155188414|NCT02310321|560129293|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
155188415|NCT02310321|560129294|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
155188416|NCT02310321|560129292|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
155188417|NCT02310321|560129293|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
155188418|NCT02310321|560129294|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
155188419|NCT02310321|560129292|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
155188420|NCT02310321|560129293|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
155188421|NCT02310321|560129294|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
155188422|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
155188423|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
155188424|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
155188425|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
155188426|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
155188427|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
155188428|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
155188429|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
155188430|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
155188431|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
155188432|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
155188433|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
155188434|NCT02310321|560129292|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
155188435|NCT02310321|560129293|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
155188436|NCT02310321|560129294|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
155188437|NCT04950166|560129295|FG000|Overall Study|Withdrawal by Subject|1|||
155188438|NCT05896748|560129296|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
155188439|NCT05896748|560129296|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
155188440|NCT05896748|560129296|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
155037404|NCT01546038|559563881|FG002|Overall Study|Death|4|||
155188441|NCT05896748|560129296|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
155188442|NCT05896748|560129296|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
155188443|NCT00857415|560129299|FG000|Overall Study|Image acquisition failure|2|||
155188444|NCT00857415|560129300|FG001|Overall Study|Image acquisition failure|0|||
155188445|NCT00857415|560129299|FG000|Overall Study|Invalid image or not imaged|3|||
155188446|NCT00857415|560129300|FG001|Overall Study|Invalid image or not imaged|0|||
155188447|NCT00857415|560129299|FG000|Overall Study|Subject still living at end of study|110|||
155188448|NCT00857415|560129300|FG001|Overall Study|Subject still living at end of study|0|||
155188449|NCT00857415|560129299|FG000|Overall Study|Deceased with no autopsy|2|||
155188450|NCT00857415|560129300|FG001|Overall Study|Deceased with no autopsy|0|||
155188451|NCT00764504|560129301|FG000|Overall Study|Death|12|||
155188452|NCT00764504|560129302|FG001|Overall Study|Death|6|||
155188453|NCT00764504|560129303|FG002|Overall Study|Death|13|||
155188454|NCT00764504|560129301|FG000|Overall Study|Revision of Device|12|||
155188455|NCT00764504|560129302|FG001|Overall Study|Revision of Device|23|||
155188456|NCT00764504|560129303|FG002|Overall Study|Revision of Device|14|||
155188457|NCT00764504|560129301|FG000|Overall Study|Physician Decision|1|||
155188458|NCT00764504|560129302|FG001|Overall Study|Physician Decision|0|||
155188459|NCT00764504|560129303|FG002|Overall Study|Physician Decision|0|||
155188460|NCT00764504|560129301|FG000|Overall Study|Withdrawal by Subject|1|||
155188461|NCT00764504|560129302|FG001|Overall Study|Withdrawal by Subject|7|||
155188462|NCT00764504|560129303|FG002|Overall Study|Withdrawal by Subject|4|||
155188463|NCT00764504|560129301|FG000|Overall Study|Lost to Follow-up|40|||
155188464|NCT00764504|560129302|FG001|Overall Study|Lost to Follow-up|34|||
155188465|NCT00764504|560129303|FG002|Overall Study|Lost to Follow-up|72|||
155188466|NCT02456103|560129304|FG000|Overall Study|Study Closure|207|||
155188467|NCT02456103|560129304|FG000|Overall Study|Physician Decision|1|||
155188468|NCT02456103|560129304|FG000|Overall Study|Required prohibited medications|5|||
155188469|NCT02456103|560129304|FG000|Overall Study|Protocol Violation|1|||
155188470|NCT02456103|560129304|FG000|Overall Study|Adverse Event|5|||
155188471|NCT02456103|560129304|FG000|Overall Study|Abnormal Laboratory Value|2|||
155188472|NCT02456103|560129304|FG000|Overall Study|Lost to Follow-up|1|||
155188473|NCT02456103|560129304|FG000|Overall Study|Withdrawal by Subject|24|||
155188474|NCT04795622|560129305|FG000|Overall Study|Adverse Event|1|||
155188475|NCT04795622|560129306|FG001|Overall Study|Adverse Event|0|||
155188476|NCT04795622|560129305|FG000|Overall Study|Withdrawal by Subject|3|||
155188477|NCT04795622|560129306|FG001|Overall Study|Withdrawal by Subject|3|||
155188478|NCT04795622|560129305|FG000|Overall Study|Protocol Violation|0|||
155188479|NCT04795622|560129306|FG001|Overall Study|Protocol Violation|2|||
155188480|NCT04795622|560129305|FG000|Overall Study|Lost to Follow-up|2|||
155188481|NCT04795622|560129306|FG001|Overall Study|Lost to Follow-up|3|||
155188482|NCT04795622|560129305|FG000|Overall Study|Other|7|||
155188483|NCT04795622|560129306|FG001|Overall Study|Other|8|||
155188484|NCT01070043|560129307|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
155188485|NCT01070043|560129308|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
155188486|NCT01070043|560129309|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
155188487|NCT01070043|560129307|FG000|Double-Blind Treatment|Adverse Event|0|||
155188488|NCT01070043|560129308|FG001|Double-Blind Treatment|Adverse Event|0|||
155188489|NCT01070043|560129309|FG002|Double-Blind Treatment|Adverse Event|2|||
155188490|NCT01610271|560129310|FG000|Overall Study|Surgery not complete|0|||
155188491|NCT01610271|560129311|FG001|Overall Study|Surgery not complete|1|||
155188492|NCT01610271|560129310|FG000|Overall Study|Prosthesis not implanted|2|||
155188493|NCT01610271|560129311|FG001|Overall Study|Prosthesis not implanted|3|||
155188494|NCT01638819|560129312|FG000|Overall Study|Lost to Follow-up|1|||
155188495|NCT01638819|560129313|FG001|Overall Study|Lost to Follow-up|0|||
155188496|NCT00471146|560129316|FG000|Overall Study|Adverse Event|32|||
155188497|NCT00471146|560129317|FG001|Overall Study|Adverse Event|33|||
155188498|NCT00471146|560129316|FG000|Overall Study|Withdrawal by Subject|14|||
155188499|NCT00471146|560129317|FG001|Overall Study|Withdrawal by Subject|11|||
155037405|NCT01546038|559563882|FG003|Overall Study|Death|2|||
155037406|NCT01546038|559563883|FG004|Overall Study|Death|9|||
155037407|NCT01546038|559563884|FG005|Overall Study|Death|3|||
155037408|NCT01546038|559563885|FG006|Overall Study|Death|46|||
155037409|NCT01546038|559563886|FG007|Overall Study|Death|76|||
155037410|NCT01546038|559563887|FG008|Overall Study|Death|39|||
155037411|NCT01546038|559563879|FG000|Overall Study|Lost to Follow-up|0|||
155037412|NCT01546038|559563880|FG001|Overall Study|Lost to Follow-up|0|||
155037413|NCT01546038|559563881|FG002|Overall Study|Lost to Follow-up|0|||
155037414|NCT01546038|559563882|FG003|Overall Study|Lost to Follow-up|0|||
155037415|NCT01546038|559563883|FG004|Overall Study|Lost to Follow-up|1|||
155037416|NCT01546038|559563884|FG005|Overall Study|Lost to Follow-up|0|||
155037417|NCT01546038|559563885|FG006|Overall Study|Lost to Follow-up|2|||
155037418|NCT01546038|559563886|FG007|Overall Study|Lost to Follow-up|1|||
155037419|NCT01546038|559563887|FG008|Overall Study|Lost to Follow-up|0|||
155037420|NCT01546038|559563879|FG000|Overall Study|Withdrawal by Subject|1|||
155037421|NCT01546038|559563880|FG001|Overall Study|Withdrawal by Subject|0|||
155037422|NCT01546038|559563881|FG002|Overall Study|Withdrawal by Subject|0|||
155037423|NCT01546038|559563882|FG003|Overall Study|Withdrawal by Subject|1|||
155188500|NCT00471146|560129316|FG000|Overall Study|Death|11|||
155037424|NCT01546038|559563883|FG004|Overall Study|Withdrawal by Subject|0|||
155037425|NCT01546038|559563884|FG005|Overall Study|Withdrawal by Subject|1|||
155188501|NCT00471146|560129317|FG001|Overall Study|Death|12|||
155188502|NCT00471146|560129316|FG000|Overall Study|Lost to Follow-up|4|||
155188503|NCT00471146|560129317|FG001|Overall Study|Lost to Follow-up|2|||
155188504|NCT00471146|560129316|FG000|Overall Study|Protocol Violation|2|||
155188505|NCT00471146|560129317|FG001|Overall Study|Protocol Violation|2|||
155188506|NCT00471146|560129316|FG000|Overall Study|Objective progression or relapse|84|||
155188507|NCT00471146|560129317|FG001|Overall Study|Objective progression or relapse|87|||
155188508|NCT00471146|560129316|FG000|Overall Study|Global deterioration of health status|12|||
155188509|NCT00471146|560129317|FG001|Overall Study|Global deterioration of health status|14|||
155188510|NCT00471146|560129316|FG000|Overall Study|Randomized but not treated|9|||
155188511|NCT00471146|560129317|FG001|Overall Study|Randomized but not treated|8|||
155188512|NCT00471146|560129316|FG000|Overall Study|Other|4|||
155188513|NCT00471146|560129317|FG001|Overall Study|Other|5|||
155188514|NCT00467610|560129320|FG000|Overall Study|Withdrawal by Subject|1|||
155188515|NCT01385371|560129321|FG000|Overall Study|Adverse Event|54|||
155188516|NCT01385371|560129322|FG001|Overall Study|Adverse Event|19|||
155188517|NCT01385371|560129321|FG000|Overall Study|Lost to Follow-up|16|||
155188518|NCT01385371|560129322|FG001|Overall Study|Lost to Follow-up|16|||
155188519|NCT01385371|560129321|FG000|Overall Study|Withdrawal by Subject|52|||
155188520|NCT01385371|560129322|FG001|Overall Study|Withdrawal by Subject|39|||
155188521|NCT01385371|560129321|FG000|Overall Study|Protocol Violation|25|||
155188522|NCT01385371|560129322|FG001|Overall Study|Protocol Violation|21|||
155188523|NCT01385371|560129321|FG000|Overall Study|Administrative|2|||
155188524|NCT01385371|560129322|FG001|Overall Study|Administrative|2|||
155188525|NCT02436681|560129325|FG000|Overall Study|Lost to Follow-up|10|||
155188526|NCT02436681|560129325|FG000|Overall Study|Withdrawal by Subject|2|||
155188527|NCT02436681|560129325|FG000|Overall Study|Death|2|||
155188528|NCT02030938|560129328|FG000|Overall Study|Lost to Follow-up|4|||
155188529|NCT02030938|560129328|FG000|Overall Study|Withdrawal by Subject|1|||
155188530|NCT05430022|560129330|FG000|Overall Study|Withdrawal by Subject|4|||
155188531|NCT05430022|560129331|FG001|Overall Study|Withdrawal by Subject|4|||
155188532|NCT05521906|560129332|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
155188533|NCT05521906|560129333|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
155188534|NCT01828320|560129347|FG000|Overall Study|Lost to Follow-up|1|||
155188535|NCT01828320|560129348|FG001|Overall Study|Lost to Follow-up|3|||
155188536|NCT01828320|560129347|FG000|Overall Study|Withdrawal by Subject|7|||
155188537|NCT01828320|560129348|FG001|Overall Study|Withdrawal by Subject|2|||
155188538|NCT04493333|560131446|FG000|Overall Study|Withdrawal by Subject|1|||
155188539|NCT04493333|560131447|FG001|Overall Study|Withdrawal by Subject|1|||
155188540|NCT04493333|560131446|FG000|Overall Study|Ineligible|0|||
155188541|NCT04493333|560131447|FG001|Overall Study|Ineligible|1|||
155188542|NCT04493333|560131446|FG000|Overall Study|Noncompliance|2|||
155188543|NCT04493333|560131447|FG001|Overall Study|Noncompliance|1|||
155188544|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
155188545|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
155188546|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
155188547|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
155188548|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
155188549|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
155188550|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
155188551|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
155188552|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
155188553|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
155188554|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
155188555|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
155188556|NCT02349061|560131451|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
155188557|NCT02349061|560131452|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
155188558|NCT02349061|560131453|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
155188559|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
155188560|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
155188561|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
155188562|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
155037426|NCT01546038|559563885|FG006|Overall Study|Withdrawal by Subject|3|||
155037427|NCT01546038|559563886|FG007|Overall Study|Withdrawal by Subject|3|||
155037428|NCT01546038|559563887|FG008|Overall Study|Withdrawal by Subject|1|||
155037429|NCT01546038|559563879|FG000|Overall Study|: Randomized, not treated|0|||
155037430|NCT01546038|559563880|FG001|Overall Study|: Randomized, not treated|0|||
155037431|NCT01546038|559563881|FG002|Overall Study|: Randomized, not treated|0|||
155037432|NCT01546038|559563882|FG003|Overall Study|: Randomized, not treated|0|||
155037433|NCT01546038|559563883|FG004|Overall Study|: Randomized, not treated|0|||
155037434|NCT01546038|559563884|FG005|Overall Study|: Randomized, not treated|0|||
155037435|NCT01546038|559563885|FG006|Overall Study|: Randomized, not treated|2|||
155188563|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
155037436|NCT01546038|559563886|FG007|Overall Study|: Randomized, not treated|4|||
155188564|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
155188565|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
155188566|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
155037437|NCT01546038|559563887|FG008|Overall Study|: Randomized, not treated|3|||
155037438|NCT01398410|559563888|FG000|Overall Study|Adverse Event|12|||
155037439|NCT01398410|559563889|FG001|Overall Study|Adverse Event|16|||
155037440|NCT01398410|559563888|FG000|Overall Study|Participants Choice|8|||
155037441|NCT01398410|559563889|FG001|Overall Study|Participants Choice|11|||
155037442|NCT01398410|559563888|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
155037443|NCT01398410|559563889|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
155037444|NCT01398410|559563888|FG000|Overall Study|Other|36|||
155037445|NCT01398410|559563889|FG001|Overall Study|Other|29|||
155037446|NCT04245202|559563890|FG000|Overall Study|Lack of Efficacy|10|||
155037447|NCT04245202|559563891|FG001|Overall Study|Lack of Efficacy|1|||
155037448|NCT00717275|559563892|FG000|Overall Study|Premature study termination.|3|||
155037449|NCT03515629|559563896|FG000|Overall Study|Death|0|||
155037450|NCT03515629|559563897|FG001|Overall Study|Death|1|||
155037451|NCT03515629|559563898|FG002|Overall Study|Death|1|||
155037452|NCT03515629|559563896|FG000|Overall Study|Progressive disease|0|||
155037453|NCT03515629|559563897|FG001|Overall Study|Progressive disease|1|||
155037454|NCT03515629|559563898|FG002|Overall Study|Progressive disease|0|||
155037455|NCT00424021|559563899|FG000|NCT00046319 Study Period|Adverse Event|1|||
155037456|NCT00424021|559563900|FG001|NCT00046319 Study Period|Adverse Event|0|||
155037457|NCT00424021|559563901|FG002|NCT00046319 Study Period|Adverse Event|1|||
155037458|NCT00424021|559563902|FG003|NCT00046319 Study Period|Adverse Event|1|||
155037459|NCT00424021|559563899|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
155037460|NCT00424021|559563900|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
155037461|NCT00424021|559563901|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
155037462|NCT00424021|559563902|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
155037463|NCT00424021|559563899|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
155037464|NCT00424021|559563900|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
155037465|NCT00424021|559563901|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
155037466|NCT00424021|559563902|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
155037467|NCT00424021|559563899|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
155037468|NCT00424021|559563900|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
155037469|NCT00424021|559563901|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
155037470|NCT00424021|559563902|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
155037471|NCT00424021|559563899|FG000|AMB-220-E Study Period|Adverse Event|1|||
155037472|NCT00424021|559563900|FG001|AMB-220-E Study Period|Adverse Event|1|||
155037473|NCT00424021|559563901|FG002|AMB-220-E Study Period|Adverse Event|3|||
155037474|NCT00424021|559563902|FG003|AMB-220-E Study Period|Adverse Event|7|||
155037475|NCT00424021|559563899|FG000|AMB-220-E Study Period|Death|0|||
155037476|NCT00424021|559563900|FG001|AMB-220-E Study Period|Death|0|||
155037477|NCT00424021|559563901|FG002|AMB-220-E Study Period|Death|1|||
155037478|NCT00424021|559563902|FG003|AMB-220-E Study Period|Death|1|||
155037479|NCT00424021|559563899|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
155037480|NCT00424021|559563900|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
155037481|NCT00424021|559563901|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
155037482|NCT00424021|559563902|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
155037483|NCT00424021|559563899|FG000|AMB-220-E Study Period|Physician Decision|0|||
155037484|NCT00424021|559563900|FG001|AMB-220-E Study Period|Physician Decision|0|||
155037485|NCT00424021|559563901|FG002|AMB-220-E Study Period|Physician Decision|0|||
155037486|NCT00424021|559563902|FG003|AMB-220-E Study Period|Physician Decision|1|||
155037487|NCT01254721|559563903|FG000|Overall Study|Lost to Follow-up|0|||
155037488|NCT01254721|559563904|FG001|Overall Study|Lost to Follow-up|4|||
155037489|NCT01254721|559563903|FG000|Overall Study|Lack of Efficacy|4|||
155037490|NCT01254721|559563904|FG001|Overall Study|Lack of Efficacy|2|||
155037491|NCT01254721|559563903|FG000|Overall Study|Death|0|||
155037492|NCT01254721|559563904|FG001|Overall Study|Death|1|||
155037493|NCT01254721|559563903|FG000|Overall Study|technical problum|1|||
155037494|NCT01254721|559563904|FG001|Overall Study|technical problum|0|||
155037495|NCT01254721|559563903|FG000|Overall Study|Adverse Event|2|||
155037496|NCT01254721|559563904|FG001|Overall Study|Adverse Event|3|||
155037497|NCT01254721|559563903|FG000|Overall Study|Withdrawal by Subject|8|||
155037498|NCT01254721|559563904|FG001|Overall Study|Withdrawal by Subject|11|||
155037499|NCT01254721|559563903|FG000|Overall Study|Wrongly randomization|0|||
155037500|NCT01254721|559563904|FG001|Overall Study|Wrongly randomization|1|||
155188567|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
155188568|NCT02349061|560131451|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
155188569|NCT02349061|560131452|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
155037501|NCT03170609|559563906|FG000|Overall Study|Death|0|||
155037502|NCT03170609|559563907|FG001|Overall Study|Death|0|||
155188570|NCT02349061|560131453|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
155188571|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
155188572|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
155188573|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
155037503|NCT03170609|559563908|FG002|Overall Study|Death|1|||
155037504|NCT03170609|559563909|FG003|Overall Study|Death|0|||
155037505|NCT03170609|559563910|FG004|Overall Study|Death|0|||
155037506|NCT03170609|559563911|FG005|Overall Study|Death|0|||
155188574|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
155188575|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
155188576|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
155188577|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
155188578|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
155188579|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
155188580|NCT02349061|560131451|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
155188581|NCT02349061|560131452|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
155188582|NCT02349061|560131453|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
155188583|NCT01854658|560131456|FG000|Overall Study|Protocol Violation|6|||
155188584|NCT01854658|560131457|FG001|Overall Study|Protocol Violation|2|||
155188585|NCT01854658|560131458|FG002|Overall Study|Protocol Violation|2|||
155188586|NCT01854658|560131459|FG003|Overall Study|Protocol Violation|1|||
155188587|NCT01854658|560131456|FG000|Overall Study|Physician Decision|7|||
155188588|NCT01854658|560131457|FG001|Overall Study|Physician Decision|5|||
155188589|NCT01854658|560131458|FG002|Overall Study|Physician Decision|2|||
155188590|NCT01854658|560131459|FG003|Overall Study|Physician Decision|4|||
155188591|NCT01854658|560131456|FG000|Overall Study|Lost to Follow-up|8|||
155188592|NCT01854658|560131457|FG001|Overall Study|Lost to Follow-up|9|||
155188593|NCT01854658|560131458|FG002|Overall Study|Lost to Follow-up|8|||
155188594|NCT01854658|560131459|FG003|Overall Study|Lost to Follow-up|4|||
155188595|NCT01854658|560131456|FG000|Overall Study|Withdrawal by Subject|28|||
155188596|NCT01854658|560131457|FG001|Overall Study|Withdrawal by Subject|21|||
155188597|NCT01854658|560131458|FG002|Overall Study|Withdrawal by Subject|29|||
155188598|NCT01854658|560131459|FG003|Overall Study|Withdrawal by Subject|15|||
155188599|NCT01854658|560131456|FG000|Overall Study|Protocol-specified criteria|15|||
155188600|NCT01854658|560131457|FG001|Overall Study|Protocol-specified criteria|15|||
155188601|NCT01854658|560131458|FG002|Overall Study|Protocol-specified criteria|10|||
155188602|NCT01854658|560131459|FG003|Overall Study|Protocol-specified criteria|7|||
155188603|NCT01854658|560131456|FG000|Overall Study|Lack of Efficacy|3|||
155188604|NCT01854658|560131457|FG001|Overall Study|Lack of Efficacy|8|||
155188605|NCT01854658|560131458|FG002|Overall Study|Lack of Efficacy|4|||
155188606|NCT01854658|560131459|FG003|Overall Study|Lack of Efficacy|7|||
155188607|NCT01854658|560131456|FG000|Overall Study|Adverse Event|21|||
155188608|NCT01854658|560131457|FG001|Overall Study|Adverse Event|14|||
155188609|NCT01854658|560131458|FG002|Overall Study|Adverse Event|23|||
155188610|NCT01854658|560131459|FG003|Overall Study|Adverse Event|19|||
155188611|NCT01854658|560131456|FG000|Overall Study|Administrative reasons|5|||
155188612|NCT01854658|560131457|FG001|Overall Study|Administrative reasons|1|||
155188613|NCT01854658|560131458|FG002|Overall Study|Administrative reasons|2|||
155188614|NCT01854658|560131459|FG003|Overall Study|Administrative reasons|2|||
155188615|NCT00426231|560131460|FG000|Overall Study|Withdrawal by Subject|9|||
155188616|NCT00426231|560131461|FG001|Overall Study|Withdrawal by Subject|12|||
155188617|NCT02367131|560131462|FG000|Overall Study|Adverse Event|64|||
155188618|NCT02367131|560131462|FG000|Overall Study|No visit since the first visit|3|||
155188619|NCT02367131|560131462|FG000|Overall Study|Request by patient|53|||
155188620|NCT02367131|560131462|FG000|Overall Study|Improvement/remission|2|||
155188621|NCT02367131|560131462|FG000|Overall Study|No change/progressive disease|78|||
155188622|NCT02367131|560131462|FG000|Overall Study|Other than stated above|20|||
155188623|NCT02367131|560131462|FG000|Overall Study|Not treated|2|||
155188624|NCT02572388|560131463|FG000|Overall Study|Withdrawal by Subject|1|||
155188625|NCT02572388|560131464|FG001|Overall Study|Withdrawal by Subject|1|||
155188626|NCT02572388|560131465|FG002|Overall Study|Withdrawal by Subject|2|||
155188627|NCT02572388|560131466|FG003|Overall Study|Withdrawal by Subject|2|||
155188628|NCT01051466|560131467|FG000|Overall Study|Adverse Event|1|||
155188629|NCT01051466|560131468|FG001|Overall Study|Adverse Event|0|||
155188630|NCT01051466|560131467|FG000|Overall Study|Lost to Follow-up|1|||
155188631|NCT01051466|560131468|FG001|Overall Study|Lost to Follow-up|1|||
155188632|NCT01051466|560131467|FG000|Overall Study|Withdrawal by Subject|5|||
155188633|NCT01051466|560131468|FG001|Overall Study|Withdrawal by Subject|1|||
155188634|NCT01051466|560131467|FG000|Overall Study|Entry Criteria Not Met|0|||
155188635|NCT01051466|560131468|FG001|Overall Study|Entry Criteria Not Met|3|||
155188636|NCT01051466|560131467|FG000|Overall Study|Physician Decision|1|||
155188637|NCT01051466|560131468|FG001|Overall Study|Physician Decision|0|||
155037507|NCT03170609|559563912|FG006|Overall Study|Death|0|||
155188638|NCT02570074|560131469|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
155188639|NCT02570074|560131470|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
155188640|NCT05061966|560131473|FG000|Overall Study|Lost to Follow-up|13|||
155188641|NCT05061966|560131474|FG001|Overall Study|Lost to Follow-up|13|||
155188642|NCT02923427|560131475|FG000|Overall Study|convert to laparatomy|2|||
155188643|NCT02923427|560131476|FG001|Overall Study|convert to laparatomy|2|||
155188644|NCT02923427|560131475|FG000|Overall Study|destaturation|1|||
155188645|NCT02923427|560131476|FG001|Overall Study|destaturation|0|||
155188646|NCT02923427|560131475|FG000|Overall Study|can not replace LMA|1|||
155188647|NCT02923427|560131476|FG001|Overall Study|can not replace LMA|0|||
155188648|NCT01325623|560131477|FG000|Overall Study|Withdrawal by Subject|3|||
155144019|NCT01463306|559959555|FG001|Overall Study|Death|3|||
155144020|NCT01463306|559959556|FG002|Overall Study|Death|0|||
155144021|NCT01463306|559959554|FG000|Overall Study|Lack of Efficacy|22|||
155144022|NCT01463306|559959555|FG001|Overall Study|Lack of Efficacy|16|||
155144023|NCT01463306|559959556|FG002|Overall Study|Lack of Efficacy|1|||
155144024|NCT01463306|559959554|FG000|Overall Study|Lost to Follow-up|5|||
155144025|NCT01463306|559959555|FG001|Overall Study|Lost to Follow-up|2|||
155144026|NCT01463306|559959556|FG002|Overall Study|Lost to Follow-up|0|||
155144027|NCT01463306|559959554|FG000|Overall Study|Protocol Violation|4|||
155144028|NCT01463306|559959555|FG001|Overall Study|Protocol Violation|0|||
155144029|NCT01463306|559959556|FG002|Overall Study|Protocol Violation|0|||
155144030|NCT01463306|559959554|FG000|Overall Study|Withdrawal by Subject|19|||
155144031|NCT01463306|559959555|FG001|Overall Study|Withdrawal by Subject|9|||
155144032|NCT01463306|559959556|FG002|Overall Study|Withdrawal by Subject|1|||
155144033|NCT01463306|559959554|FG000|Overall Study|Other|26|||
155144034|NCT01463306|559959555|FG001|Overall Study|Other|13|||
155144035|NCT01463306|559959556|FG002|Overall Study|Other|0|||
155144036|NCT01463306|559959554|FG000|Overall Study|Approval expiry at site|1|||
155144037|NCT01463306|559959555|FG001|Overall Study|Approval expiry at site|0|||
155144038|NCT01463306|559959556|FG002|Overall Study|Approval expiry at site|0|||
155144039|NCT00291486|559959563|FG000|Overall Study|Adverse Event|0|||
155144040|NCT00291486|559959564|FG001|Overall Study|Adverse Event|3|||
155144041|NCT00291486|559959565|FG002|Overall Study|Adverse Event|0|||
155144042|NCT00291486|559959566|FG003|Overall Study|Adverse Event|1|||
155144043|NCT00291486|559959567|FG004|Overall Study|Adverse Event|0|||
155144044|NCT00291486|559959563|FG000|Overall Study|Withdrawal by Subject|0|||
155144045|NCT00291486|559959564|FG001|Overall Study|Withdrawal by Subject|0|||
155144046|NCT00291486|559959565|FG002|Overall Study|Withdrawal by Subject|0|||
155144047|NCT00291486|559959566|FG003|Overall Study|Withdrawal by Subject|0|||
155144048|NCT00291486|559959567|FG004|Overall Study|Withdrawal by Subject|1|||
155144049|NCT00291486|559959563|FG000|Overall Study|Disease progression|1|||
155144050|NCT00291486|559959564|FG001|Overall Study|Disease progression|0|||
155144051|NCT00291486|559959565|FG002|Overall Study|Disease progression|1|||
155144052|NCT00291486|559959566|FG003|Overall Study|Disease progression|0|||
155144053|NCT00291486|559959567|FG004|Overall Study|Disease progression|0|||
155144054|NCT01045694|559959568|FG000|Overall Study|Withdrawal by Subject|2|||
155144055|NCT00543387|559959569|FG000|Panel 1 + Panel 2|Adverse Event|0|||
155144056|NCT00543387|559959570|FG001|Panel 1 + Panel 2|Adverse Event|1|||
155144057|NCT00543387|559959571|FG002|Panel 1 + Panel 2|Adverse Event|0|||
155144058|NCT00543387|559959572|FG003|Panel 1 + Panel 2|Adverse Event|0|||
155144059|NCT00543387|559959573|FG004|Panel 1 + Panel 2|Adverse Event|0|||
155144060|NCT00543387|559959574|FG005|Panel 1 + Panel 2|Adverse Event|0|||
155144061|NCT00543387|559959575|FG006|Panel 1 + Panel 2|Adverse Event|0|||
155144062|NCT00543387|559959576|FG007|Panel 1 + Panel 2|Adverse Event|1|||
155144063|NCT00543387|559959577|FG008|Panel 1 + Panel 2|Adverse Event|1|||
155144064|NCT00543387|559959578|FG009|Panel 1 + Panel 2|Adverse Event|0|||
155144065|NCT00543387|559959579|FG010|Panel 1 + Panel 2|Adverse Event|0|||
155144066|NCT00543387|559959569|FG000|Panel 1 + Panel 2|Physician Decision|0|||
155144067|NCT00543387|559959570|FG001|Panel 1 + Panel 2|Physician Decision|0|||
155144068|NCT00543387|559959571|FG002|Panel 1 + Panel 2|Physician Decision|1|||
155144069|NCT00543387|559959572|FG003|Panel 1 + Panel 2|Physician Decision|0|||
155144070|NCT00543387|559959573|FG004|Panel 1 + Panel 2|Physician Decision|0|||
155144071|NCT00543387|559959574|FG005|Panel 1 + Panel 2|Physician Decision|0|||
155144072|NCT00543387|559959575|FG006|Panel 1 + Panel 2|Physician Decision|0|||
155144073|NCT00543387|559959576|FG007|Panel 1 + Panel 2|Physician Decision|1|||
155144074|NCT00543387|559959577|FG008|Panel 1 + Panel 2|Physician Decision|0|||
155144075|NCT00543387|559959578|FG009|Panel 1 + Panel 2|Physician Decision|0|||
155144076|NCT00543387|559959579|FG010|Panel 1 + Panel 2|Physician Decision|0|||
155144077|NCT00543387|559959569|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155144078|NCT00543387|559959570|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
155144079|NCT00543387|559959571|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
155144080|NCT00543387|559959572|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155144081|NCT00543387|559959573|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155144082|NCT00543387|559959574|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
155144083|NCT00543387|559959575|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
155144084|NCT00543387|559959576|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
155144085|NCT00543387|559959577|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
155144086|NCT00543387|559959578|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
155144087|NCT00543387|559959579|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
155144088|NCT00543387|559959569|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144089|NCT00543387|559959570|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144090|NCT00543387|559959571|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144091|NCT00543387|559959572|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144092|NCT00543387|559959573|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144093|NCT00543387|559959574|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155188649|NCT01539642|560131483|FG000|Overall Study|Lack of Efficacy|20|||
155188650|NCT01539642|560131484|FG001|Overall Study|Lack of Efficacy|18|||
155188651|NCT01539642|560131483|FG000|Overall Study|Patient ready for early discharge|8|||
155188652|NCT01539642|560131484|FG001|Overall Study|Patient ready for early discharge|7|||
155188653|NCT01539642|560131483|FG000|Overall Study|Adverse Event|6|||
155188654|NCT01539642|560131484|FG001|Overall Study|Adverse Event|4|||
155188655|NCT01539642|560131483|FG000|Overall Study|Withdrawal by Subject|2|||
155188656|NCT01539642|560131484|FG001|Overall Study|Withdrawal by Subject|2|||
155188657|NCT00598702|560131485|FG000|Overall Study|Other|0|||
155188658|NCT00598702|560131486|FG001|Overall Study|Other|2|||
155188659|NCT00598702|560131487|FG002|Overall Study|Other|0|||
155188660|NCT00598702|560131488|FG003|Overall Study|Other|0|||
155188661|NCT00598702|560131489|FG004|Overall Study|Other|0|||
155188662|NCT00598702|560131490|FG005|Overall Study|Other|1|||
155188663|NCT00598702|560131491|FG006|Overall Study|Other|0|||
155188664|NCT00598702|560131492|FG007|Overall Study|Other|0|||
155188665|NCT00598702|560131485|FG000|Overall Study|Early discharge from hospital|0|||
155188666|NCT00598702|560131486|FG001|Overall Study|Early discharge from hospital|0|||
155188667|NCT00598702|560131487|FG002|Overall Study|Early discharge from hospital|2|||
155188668|NCT00598702|560131488|FG003|Overall Study|Early discharge from hospital|5|||
155188669|NCT00598702|560131489|FG004|Overall Study|Early discharge from hospital|0|||
155188670|NCT00598702|560131490|FG005|Overall Study|Early discharge from hospital|10|||
155188671|NCT00598702|560131491|FG006|Overall Study|Early discharge from hospital|1|||
155188672|NCT00598702|560131492|FG007|Overall Study|Early discharge from hospital|0|||
155188673|NCT00598702|560131485|FG000|Overall Study|Adverse Event|0|||
155188674|NCT00598702|560131486|FG001|Overall Study|Adverse Event|0|||
155188675|NCT00598702|560131487|FG002|Overall Study|Adverse Event|0|||
155188676|NCT00598702|560131488|FG003|Overall Study|Adverse Event|1|||
155188677|NCT00598702|560131489|FG004|Overall Study|Adverse Event|0|||
155188678|NCT00598702|560131490|FG005|Overall Study|Adverse Event|0|||
155188679|NCT00598702|560131491|FG006|Overall Study|Adverse Event|0|||
155188680|NCT00598702|560131492|FG007|Overall Study|Adverse Event|0|||
155188681|NCT00598702|560131485|FG000|Overall Study|Withdrawal by Subject|0|||
155188682|NCT00598702|560131486|FG001|Overall Study|Withdrawal by Subject|0|||
155188683|NCT00598702|560131487|FG002|Overall Study|Withdrawal by Subject|0|||
155188684|NCT00598702|560131488|FG003|Overall Study|Withdrawal by Subject|1|||
155188685|NCT00598702|560131489|FG004|Overall Study|Withdrawal by Subject|1|||
155188686|NCT00598702|560131490|FG005|Overall Study|Withdrawal by Subject|0|||
155188687|NCT00598702|560131491|FG006|Overall Study|Withdrawal by Subject|0|||
155188688|NCT00598702|560131492|FG007|Overall Study|Withdrawal by Subject|0|||
155188689|NCT00598702|560131485|FG000|Overall Study|Physician Decision|0|||
155188690|NCT00598702|560131486|FG001|Overall Study|Physician Decision|0|||
155188691|NCT00598702|560131487|FG002|Overall Study|Physician Decision|0|||
155188692|NCT00598702|560131488|FG003|Overall Study|Physician Decision|0|||
155188693|NCT00598702|560131489|FG004|Overall Study|Physician Decision|1|||
155188694|NCT00598702|560131490|FG005|Overall Study|Physician Decision|0|||
155188695|NCT00598702|560131491|FG006|Overall Study|Physician Decision|0|||
155188696|NCT00598702|560131492|FG007|Overall Study|Physician Decision|0|||
155188697|NCT00598702|560131485|FG000|Overall Study|Dose limiting toxicity|0|||
155188698|NCT00598702|560131486|FG001|Overall Study|Dose limiting toxicity|0|||
155188699|NCT00598702|560131487|FG002|Overall Study|Dose limiting toxicity|0|||
155188700|NCT00598702|560131488|FG003|Overall Study|Dose limiting toxicity|1|||
155188701|NCT00598702|560131489|FG004|Overall Study|Dose limiting toxicity|1|||
155188702|NCT00598702|560131490|FG005|Overall Study|Dose limiting toxicity|1|||
155188703|NCT00598702|560131491|FG006|Overall Study|Dose limiting toxicity|0|||
155188704|NCT00598702|560131492|FG007|Overall Study|Dose limiting toxicity|0|||
155188705|NCT02556203|560131493|FG000|Overall Study|Withdrawal by Subject|21|||
155188706|NCT02556203|560131494|FG001|Overall Study|Withdrawal by Subject|21|||
155188707|NCT02556203|560131493|FG000|Overall Study|Lost to Follow-up|5|||
155188708|NCT02556203|560131494|FG001|Overall Study|Lost to Follow-up|5|||
155188709|NCT02556203|560131493|FG000|Overall Study|Adverse Event|1|||
155188710|NCT02556203|560131494|FG001|Overall Study|Adverse Event|0|||
155188711|NCT02943460|560131501|FG000|Blinded Study Phase|Adverse Event|3|||
155188712|NCT02943460|560131502|FG001|Blinded Study Phase|Adverse Event|0|||
155188713|NCT02943460|560131503|FG002|Blinded Study Phase|Adverse Event|0|||
155188714|NCT02943460|560131501|FG000|Blinded Study Phase|Withdrew Consent|0|||
155188715|NCT02943460|560131502|FG001|Blinded Study Phase|Withdrew Consent|1|||
155188716|NCT02943460|560131503|FG002|Blinded Study Phase|Withdrew Consent|0|||
155188717|NCT02943460|560131501|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
155188718|NCT02943460|560131502|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
155188719|NCT02943460|560131503|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
155188720|NCT02943460|560131501|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
155037508|NCT03170609|559563906|FG000|Overall Study|Withdrawal by Subject|1|||
155188721|NCT02943460|560131502|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
155188722|NCT02943460|560131503|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
155188723|NCT02943460|560131501|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
155188724|NCT02943460|560131502|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
155188725|NCT02943460|560131503|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
155188726|NCT04171765|560131504|FG000|Overall Study|Adverse Event|2|||
155188727|NCT04171765|560131505|FG001|Overall Study|Adverse Event|0|||
155188728|NCT04171765|560131506|FG002|Overall Study|Adverse Event|1|||
155188729|NCT04171765|560131507|FG003|Overall Study|Adverse Event|0|||
155188730|NCT04171765|560131504|FG000|Overall Study|Lost to Follow-up|0|||
155188731|NCT04171765|560131505|FG001|Overall Study|Lost to Follow-up|2|||
155188732|NCT04171765|560131506|FG002|Overall Study|Lost to Follow-up|2|||
155188733|NCT04171765|560131507|FG003|Overall Study|Lost to Follow-up|2|||
155188734|NCT04171765|560131504|FG000|Overall Study|Week 58 visit missed|0|||
155188735|NCT04171765|560131505|FG001|Overall Study|Week 58 visit missed|0|||
155188736|NCT04171765|560131506|FG002|Overall Study|Week 58 visit missed|1|||
155188737|NCT04171765|560131507|FG003|Overall Study|Week 58 visit missed|0|||
155188738|NCT04171765|560131504|FG000|Overall Study|Study terminated by sponsor|2|||
155188739|NCT04171765|560131505|FG001|Overall Study|Study terminated by sponsor|0|||
155188740|NCT04171765|560131506|FG002|Overall Study|Study terminated by sponsor|0|||
155188741|NCT04171765|560131507|FG003|Overall Study|Study terminated by sponsor|0|||
155188742|NCT04171765|560131504|FG000|Overall Study|Withdrawal by Subject|1|||
155188743|NCT04171765|560131505|FG001|Overall Study|Withdrawal by Subject|0|||
155188744|NCT04171765|560131506|FG002|Overall Study|Withdrawal by Subject|0|||
155188745|NCT04171765|560131507|FG003|Overall Study|Withdrawal by Subject|3|||
155188746|NCT00809354|560131511|FG000|Overall Study|Adverse Event|32|||
155188747|NCT00809354|560131512|FG001|Overall Study|Adverse Event|45|||
155188748|NCT00809354|560131513|FG002|Overall Study|Adverse Event|37|||
155037509|NCT03170609|559563907|FG001|Overall Study|Withdrawal by Subject|2|||
155037510|NCT03170609|559563908|FG002|Overall Study|Withdrawal by Subject|0|||
155037511|NCT03170609|559563909|FG003|Overall Study|Withdrawal by Subject|0|||
155037512|NCT03170609|559563910|FG004|Overall Study|Withdrawal by Subject|0|||
155037513|NCT03170609|559563911|FG005|Overall Study|Withdrawal by Subject|0|||
155037514|NCT03170609|559563912|FG006|Overall Study|Withdrawal by Subject|1|||
155037515|NCT03170609|559563906|FG000|Overall Study|Lost to Follow-up|1|||
155188749|NCT00809354|560131514|FG003|Overall Study|Adverse Event|53|||
155188750|NCT00809354|560131515|FG004|Overall Study|Adverse Event|26|||
155188751|NCT00809354|560131516|FG005|Overall Study|Adverse Event|33|||
155188752|NCT00809354|560131517|FG006|Overall Study|Adverse Event|44|||
155188753|NCT00809354|560131518|FG007|Overall Study|Adverse Event|40|||
155188754|NCT00809354|560131519|FG008|Overall Study|Adverse Event|46|||
155188755|NCT00809354|560131520|FG009|Overall Study|Adverse Event|26|||
155188756|NCT00809354|560131511|FG000|Overall Study|Lack of Efficacy|23|||
155188757|NCT00809354|560131512|FG001|Overall Study|Lack of Efficacy|23|||
155188758|NCT00809354|560131513|FG002|Overall Study|Lack of Efficacy|22|||
155188759|NCT00809354|560131514|FG003|Overall Study|Lack of Efficacy|15|||
155188760|NCT00809354|560131515|FG004|Overall Study|Lack of Efficacy|40|||
155188761|NCT00809354|560131516|FG005|Overall Study|Lack of Efficacy|19|||
155188762|NCT00809354|560131517|FG006|Overall Study|Lack of Efficacy|21|||
155188763|NCT00809354|560131518|FG007|Overall Study|Lack of Efficacy|15|||
155188764|NCT00809354|560131519|FG008|Overall Study|Lack of Efficacy|18|||
155188765|NCT00809354|560131520|FG009|Overall Study|Lack of Efficacy|38|||
155188766|NCT00809354|560131511|FG000|Overall Study|Lost to Follow-up|10|||
155188767|NCT00809354|560131512|FG001|Overall Study|Lost to Follow-up|11|||
155188768|NCT00809354|560131513|FG002|Overall Study|Lost to Follow-up|8|||
155188769|NCT00809354|560131514|FG003|Overall Study|Lost to Follow-up|13|||
155188770|NCT00809354|560131515|FG004|Overall Study|Lost to Follow-up|6|||
155188771|NCT00809354|560131516|FG005|Overall Study|Lost to Follow-up|2|||
155188772|NCT00809354|560131517|FG006|Overall Study|Lost to Follow-up|0|||
155188773|NCT00809354|560131518|FG007|Overall Study|Lost to Follow-up|5|||
155188774|NCT00809354|560131519|FG008|Overall Study|Lost to Follow-up|4|||
155188775|NCT00809354|560131520|FG009|Overall Study|Lost to Follow-up|0|||
155188776|NCT00809354|560131511|FG000|Overall Study|Protocol Violation|7|||
155188777|NCT00809354|560131512|FG001|Overall Study|Protocol Violation|14|||
155188778|NCT00809354|560131513|FG002|Overall Study|Protocol Violation|14|||
155188779|NCT00809354|560131514|FG003|Overall Study|Protocol Violation|12|||
155188780|NCT00809354|560131515|FG004|Overall Study|Protocol Violation|14|||
155188781|NCT00809354|560131516|FG005|Overall Study|Protocol Violation|6|||
155188782|NCT00809354|560131517|FG006|Overall Study|Protocol Violation|4|||
155188783|NCT00809354|560131518|FG007|Overall Study|Protocol Violation|6|||
155188784|NCT00809354|560131519|FG008|Overall Study|Protocol Violation|9|||
155188785|NCT00809354|560131520|FG009|Overall Study|Protocol Violation|3|||
155188786|NCT00809354|560131511|FG000|Overall Study|Withdrawal by Subject|32|||
155188787|NCT00809354|560131512|FG001|Overall Study|Withdrawal by Subject|27|||
155188788|NCT00809354|560131513|FG002|Overall Study|Withdrawal by Subject|31|||
155188789|NCT00809354|560131514|FG003|Overall Study|Withdrawal by Subject|33|||
155037516|NCT03170609|559563907|FG001|Overall Study|Lost to Follow-up|0|||
155188790|NCT00809354|560131515|FG004|Overall Study|Withdrawal by Subject|34|||
155188791|NCT00809354|560131516|FG005|Overall Study|Withdrawal by Subject|29|||
155188792|NCT00809354|560131517|FG006|Overall Study|Withdrawal by Subject|27|||
155188793|NCT00809354|560131518|FG007|Overall Study|Withdrawal by Subject|19|||
155188794|NCT00809354|560131519|FG008|Overall Study|Withdrawal by Subject|18|||
155188795|NCT00809354|560131520|FG009|Overall Study|Withdrawal by Subject|20|||
155188796|NCT00809354|560131511|FG000|Overall Study|Other|10|||
155188797|NCT00809354|560131512|FG001|Overall Study|Other|2|||
155188798|NCT00809354|560131513|FG002|Overall Study|Other|7|||
155188799|NCT00809354|560131514|FG003|Overall Study|Other|10|||
155188800|NCT00809354|560131515|FG004|Overall Study|Other|5|||
155188801|NCT00809354|560131516|FG005|Overall Study|Other|3|||
155188802|NCT00809354|560131517|FG006|Overall Study|Other|2|||
155188803|NCT00809354|560131518|FG007|Overall Study|Other|3|||
155188804|NCT00809354|560131519|FG008|Overall Study|Other|4|||
155188805|NCT00809354|560131520|FG009|Overall Study|Other|3|||
155188806|NCT00809354|560131511|FG000|Overall Study|Study terminated by sponsor|138|||
155188807|NCT00809354|560131512|FG001|Overall Study|Study terminated by sponsor|134|||
155188808|NCT00809354|560131513|FG002|Overall Study|Study terminated by sponsor|129|||
155188809|NCT00809354|560131514|FG003|Overall Study|Study terminated by sponsor|120|||
155188810|NCT00809354|560131515|FG004|Overall Study|Study terminated by sponsor|126|||
155188811|NCT00809354|560131516|FG005|Overall Study|Study terminated by sponsor|133|||
155188812|NCT00809354|560131517|FG006|Overall Study|Study terminated by sponsor|124|||
155188813|NCT00809354|560131518|FG007|Overall Study|Study terminated by sponsor|148|||
155188814|NCT00809354|560131519|FG008|Overall Study|Study terminated by sponsor|127|||
155188815|NCT00809354|560131520|FG009|Overall Study|Study terminated by sponsor|135|||
155188816|NCT00809354|560131511|FG000|Overall Study|Withdrawn due to pregnancy|0|||
155188817|NCT00809354|560131512|FG001|Overall Study|Withdrawn due to pregnancy|1|||
155188818|NCT00809354|560131513|FG002|Overall Study|Withdrawn due to pregnancy|0|||
155188819|NCT00809354|560131514|FG003|Overall Study|Withdrawn due to pregnancy|0|||
155188820|NCT00809354|560131515|FG004|Overall Study|Withdrawn due to pregnancy|0|||
155188821|NCT00809354|560131516|FG005|Overall Study|Withdrawn due to pregnancy|0|||
155188822|NCT00809354|560131517|FG006|Overall Study|Withdrawn due to pregnancy|0|||
155188823|NCT00809354|560131518|FG007|Overall Study|Withdrawn due to pregnancy|0|||
155188824|NCT00809354|560131519|FG008|Overall Study|Withdrawn due to pregnancy|0|||
155188825|NCT00809354|560131520|FG009|Overall Study|Withdrawn due to pregnancy|0|||
155188826|NCT00809354|560131511|FG000|Overall Study|Randomized but not Treated|3|||
155188827|NCT00809354|560131512|FG001|Overall Study|Randomized but not Treated|1|||
155188828|NCT00809354|560131513|FG002|Overall Study|Randomized but not Treated|6|||
155188829|NCT00809354|560131514|FG003|Overall Study|Randomized but not Treated|0|||
155188830|NCT00809354|560131515|FG004|Overall Study|Randomized but not Treated|5|||
155188831|NCT00809354|560131516|FG005|Overall Study|Randomized but not Treated|0|||
155188832|NCT00809354|560131517|FG006|Overall Study|Randomized but not Treated|1|||
155188833|NCT00809354|560131518|FG007|Overall Study|Randomized but not Treated|1|||
155188834|NCT00809354|560131519|FG008|Overall Study|Randomized but not Treated|2|||
155188835|NCT00809354|560131520|FG009|Overall Study|Randomized but not Treated|1|||
155188836|NCT00809354|560131511|FG000|Overall Study|Death|0|||
155188837|NCT00809354|560131512|FG001|Overall Study|Death|0|||
155188838|NCT00809354|560131513|FG002|Overall Study|Death|0|||
155188839|NCT00809354|560131514|FG003|Overall Study|Death|0|||
155188840|NCT00809354|560131515|FG004|Overall Study|Death|0|||
155188841|NCT00809354|560131516|FG005|Overall Study|Death|0|||
155188842|NCT00809354|560131517|FG006|Overall Study|Death|0|||
155188843|NCT00809354|560131518|FG007|Overall Study|Death|1|||
155188844|NCT00809354|560131519|FG008|Overall Study|Death|0|||
155188845|NCT00809354|560131520|FG009|Overall Study|Death|0|||
155188846|NCT04137224|560131527|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
155188847|NCT04137224|560131528|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
155188848|NCT04137224|560131527|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
155188849|NCT04137224|560131528|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
155188850|NCT04137224|560131527|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
155188851|NCT04137224|560131528|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
155188852|NCT00566501|560131529|FG000|Overall Study|Adverse Event|68|||
155188853|NCT00566501|560131530|FG001|Overall Study|Adverse Event|59|||
155188854|NCT00566501|560131529|FG000|Overall Study|Medication Non-compliance|5|||
155188855|NCT00566501|560131530|FG001|Overall Study|Medication Non-compliance|0|||
155188856|NCT00566501|560131529|FG000|Overall Study|Protocol Violation|2|||
155188857|NCT00566501|560131530|FG001|Overall Study|Protocol Violation|2|||
155188858|NCT00566501|560131529|FG000|Overall Study|Request of Investigator or Sponsor|6|||
155037517|NCT03170609|559563908|FG002|Overall Study|Lost to Follow-up|5|||
155037518|NCT03170609|559563909|FG003|Overall Study|Lost to Follow-up|2|||
155188859|NCT00566501|560131530|FG001|Overall Study|Request of Investigator or Sponsor|7|||
155188860|NCT00566501|560131529|FG000|Overall Study|Withdrawal by Subject|33|||
155188861|NCT00566501|560131530|FG001|Overall Study|Withdrawal by Subject|30|||
155188862|NCT00566501|560131529|FG000|Overall Study|Lack of Efficacy|8|||
155188863|NCT00566501|560131530|FG001|Overall Study|Lack of Efficacy|3|||
155188864|NCT00566501|560131529|FG000|Overall Study|Other|25|||
155188865|NCT00566501|560131530|FG001|Overall Study|Other|21|||
155188866|NCT01368432|560131533|FG000|Overall Study|Lost to Follow-up|0|||
155188867|NCT01368432|560131534|FG001|Overall Study|Lost to Follow-up|1|||
155188868|NCT00437320|560131537|FG000|Overall Study|Participant request|2|||
155188869|NCT00437320|560131538|FG001|Overall Study|Participant request|1|||
155188870|NCT00437320|560131539|FG002|Overall Study|Participant request|4|||
155188871|NCT02791594|560131540|FG000|Overall Study|Physician Decision|2|||
155188872|NCT01698905|560131542|FG000|Overall Study|Adverse Event|4|||
155188873|NCT01698905|560131542|FG000|Overall Study|Physician Decision|2|||
155188874|NCT01698905|560131542|FG000|Overall Study|Pregnancy|1|||
155188875|NCT01698905|560131542|FG000|Overall Study|Protocol Violation|1|||
155188876|NCT01698905|560131542|FG000|Overall Study|Subject/guardian decision|2|||
155188877|NCT01698905|560131542|FG000|Overall Study|Death|1|||
155188878|NCT02448810|560131543|FG000|Overall Study|Adverse Event|0|||
155188879|NCT02448810|560131544|FG001|Overall Study|Adverse Event|0|||
155188880|NCT02448810|560131545|FG002|Overall Study|Adverse Event|1|||
155188881|NCT02448810|560131546|FG003|Overall Study|Adverse Event|0|||
155188882|NCT02448810|560131547|FG004|Overall Study|Adverse Event|0|||
155188883|NCT02448810|560131548|FG005|Overall Study|Adverse Event|0|||
155188884|NCT02448810|560131549|FG006|Overall Study|Adverse Event|0|||
155188885|NCT02448810|560131550|FG007|Overall Study|Adverse Event|0|||
155188886|NCT02448810|560131543|FG000|Overall Study|Withdrawal by Subject|0|||
155188887|NCT02448810|560131544|FG001|Overall Study|Withdrawal by Subject|0|||
155188888|NCT02448810|560131545|FG002|Overall Study|Withdrawal by Subject|1|||
155188889|NCT02448810|560131546|FG003|Overall Study|Withdrawal by Subject|0|||
155188890|NCT02448810|560131547|FG004|Overall Study|Withdrawal by Subject|3|||
155188891|NCT02448810|560131548|FG005|Overall Study|Withdrawal by Subject|5|||
155188892|NCT02448810|560131549|FG006|Overall Study|Withdrawal by Subject|0|||
155188893|NCT02448810|560131550|FG007|Overall Study|Withdrawal by Subject|2|||
155188894|NCT02448810|560131543|FG000|Overall Study|Other (study terminated by sponsor)|0|||
155188895|NCT02448810|560131544|FG001|Overall Study|Other (study terminated by sponsor)|0|||
155188896|NCT02448810|560131545|FG002|Overall Study|Other (study terminated by sponsor)|0|||
155188897|NCT02448810|560131546|FG003|Overall Study|Other (study terminated by sponsor)|0|||
155188898|NCT02448810|560131547|FG004|Overall Study|Other (study terminated by sponsor)|4|||
155188899|NCT02448810|560131548|FG005|Overall Study|Other (study terminated by sponsor)|2|||
155188900|NCT02448810|560131549|FG006|Overall Study|Other (study terminated by sponsor)|2|||
155188901|NCT02448810|560131550|FG007|Overall Study|Other (study terminated by sponsor)|1|||
155188902|NCT02448810|560131543|FG000|Overall Study|Death|1|||
155188903|NCT02448810|560131544|FG001|Overall Study|Death|0|||
155188904|NCT02448810|560131545|FG002|Overall Study|Death|1|||
155188905|NCT02448810|560131546|FG003|Overall Study|Death|0|||
155188906|NCT02448810|560131547|FG004|Overall Study|Death|1|||
155188907|NCT02448810|560131548|FG005|Overall Study|Death|0|||
155037519|NCT03170609|559563910|FG004|Overall Study|Lost to Follow-up|1|||
155037520|NCT03170609|559563911|FG005|Overall Study|Lost to Follow-up|1|||
155188908|NCT02448810|560131549|FG006|Overall Study|Death|0|||
155188909|NCT02448810|560131550|FG007|Overall Study|Death|0|||
155188910|NCT02448810|560131543|FG000|Overall Study|Other (Progressive disease)|2|||
155188911|NCT02448810|560131544|FG001|Overall Study|Other (Progressive disease)|2|||
155188912|NCT02448810|560131545|FG002|Overall Study|Other (Progressive disease)|0|||
155188913|NCT02448810|560131546|FG003|Overall Study|Other (Progressive disease)|3|||
155188914|NCT02448810|560131547|FG004|Overall Study|Other (Progressive disease)|23|||
155188915|NCT02448810|560131548|FG005|Overall Study|Other (Progressive disease)|9|||
155188916|NCT02448810|560131549|FG006|Overall Study|Other (Progressive disease)|14|||
155188917|NCT02448810|560131550|FG007|Overall Study|Other (Progressive disease)|5|||
155188918|NCT02448810|560131543|FG000|Overall Study|Lost to Follow-up|0|||
155188919|NCT02448810|560131544|FG001|Overall Study|Lost to Follow-up|1|||
155188920|NCT02448810|560131545|FG002|Overall Study|Lost to Follow-up|0|||
155188921|NCT02448810|560131546|FG003|Overall Study|Lost to Follow-up|0|||
155188922|NCT02448810|560131547|FG004|Overall Study|Lost to Follow-up|0|||
155188923|NCT02448810|560131548|FG005|Overall Study|Lost to Follow-up|0|||
155188924|NCT02448810|560131549|FG006|Overall Study|Lost to Follow-up|0|||
155188925|NCT02448810|560131550|FG007|Overall Study|Lost to Follow-up|0|||
155188926|NCT02448810|560131543|FG000|Overall Study|Other (unspecified)|0|||
155188927|NCT02448810|560131544|FG001|Overall Study|Other (unspecified)|0|||
155188928|NCT02448810|560131545|FG002|Overall Study|Other (unspecified)|0|||
155188929|NCT02448810|560131546|FG003|Overall Study|Other (unspecified)|0|||
155188930|NCT02448810|560131547|FG004|Overall Study|Other (unspecified)|0|||
155188931|NCT02448810|560131548|FG005|Overall Study|Other (unspecified)|0|||
155188932|NCT02448810|560131549|FG006|Overall Study|Other (unspecified)|2|||
155188933|NCT02448810|560131550|FG007|Overall Study|Other (unspecified)|0|||
155037521|NCT03170609|559563912|FG006|Overall Study|Lost to Follow-up|0|||
155188934|NCT00470847|560131553|FG000|Overall Study|Pt still receiving treatment|1|||
155188935|NCT00568685|560131559|FG000|Overall Study|Adverse Event|2|||
155188936|NCT00568685|560131560|FG001|Overall Study|Adverse Event|3|||
155188937|NCT00568685|560131561|FG002|Overall Study|Adverse Event|3|||
155188938|NCT00568685|560131559|FG000|Overall Study|Withdrawal by Subject|7|||
155188939|NCT00568685|560131560|FG001|Overall Study|Withdrawal by Subject|2|||
155188940|NCT00568685|560131561|FG002|Overall Study|Withdrawal by Subject|2|||
155188941|NCT00568685|560131559|FG000|Overall Study|Protocol Violation|1|||
155188942|NCT00568685|560131560|FG001|Overall Study|Protocol Violation|0|||
155188943|NCT00568685|560131561|FG002|Overall Study|Protocol Violation|0|||
155188944|NCT00923936|560131564|FG000|Overall Study|progressive disease on study|2|||
155188945|NCT00923936|560131565|FG001|Overall Study|progressive disease on study|1|||
155188946|NCT00923936|560131564|FG000|Overall Study|Adverse Event|2|||
155188947|NCT00923936|560131565|FG001|Overall Study|Adverse Event|1|||
155188948|NCT00923936|560131564|FG000|Overall Study|Lost to follow up|2|||
155188949|NCT00923936|560131565|FG001|Overall Study|Lost to follow up|0|||
155188950|NCT00923936|560131564|FG000|Overall Study|Continuing in follow up period|2|||
155188951|NCT00923936|560131565|FG001|Overall Study|Continuing in follow up period|1|||
155188952|NCT03538431|560131566|FG000|Overall Study|Physician Decision|0|||
155188953|NCT03538431|560131567|FG001|Overall Study|Physician Decision|1|||
155188954|NCT03538431|560131566|FG000|Overall Study|Withdrawal by Subject|1|||
155188955|NCT03538431|560131567|FG001|Overall Study|Withdrawal by Subject|0|||
155188956|NCT05394350|560131568|FG000|Overall Study|Death|2|||
155188957|NCT05394350|560131569|FG001|Overall Study|Death|2|||
155188958|NCT05394350|560131570|FG002|Overall Study|Death|4|||
155188959|NCT05394350|560131571|FG003|Overall Study|Death|0|||
155188960|NCT05394350|560131572|FG004|Overall Study|Death|1|||
155188961|NCT05394350|560131573|FG005|Overall Study|Death|0|||
155188962|NCT05394350|560131568|FG000|Overall Study|Study terminated by sponsor|1|||
155188963|NCT05394350|560131569|FG001|Overall Study|Study terminated by sponsor|1|||
155188964|NCT05394350|560131570|FG002|Overall Study|Study terminated by sponsor|7|||
155188965|NCT05394350|560131571|FG003|Overall Study|Study terminated by sponsor|3|||
155188966|NCT05394350|560131572|FG004|Overall Study|Study terminated by sponsor|2|||
155188967|NCT05394350|560131573|FG005|Overall Study|Study terminated by sponsor|4|||
155188968|NCT01231347|560131576|FG000|Overall Study|Full Consent withdrawn|19|||
155188969|NCT01231347|560131577|FG001|Overall Study|Full Consent withdrawn|19|||
155188970|NCT01231347|560131578|FG002|Overall Study|Full Consent withdrawn|11|||
155188971|NCT01231347|560131576|FG000|Overall Study|Lost to Follow-up|4|||
155188972|NCT01231347|560131577|FG001|Overall Study|Lost to Follow-up|2|||
155188973|NCT01231347|560131578|FG002|Overall Study|Lost to Follow-up|2|||
155188974|NCT01231347|560131576|FG000|Overall Study|Death|202|||
155188975|NCT01231347|560131577|FG001|Overall Study|Death|210|||
155188976|NCT01231347|560131578|FG002|Overall Study|Death|101|||
155188977|NCT01231347|560131576|FG000|Overall Study|other event|7|||
155188978|NCT01231347|560131577|FG001|Overall Study|other event|9|||
155037522|NCT03170609|559563906|FG000|Overall Study|Other|1|||
155037523|NCT03170609|559563907|FG001|Overall Study|Other|0|||
155037524|NCT03170609|559563908|FG002|Overall Study|Other|0|||
155188979|NCT01231347|560131578|FG002|Overall Study|other event|3|||
155188980|NCT01626495|560131591|FG000|Overall Study|Adverse Event|3|||
155188981|NCT01626495|560131591|FG000|Overall Study|Disease progression|27|||
155188982|NCT01626495|560131591|FG000|Overall Study|Withdrawal by Subject|1|||
155188983|NCT01626495|560131591|FG000|Overall Study|Administrative problem|1|||
155188984|NCT01626495|560131591|FG000|Overall Study|Death|2|||
155188985|NCT01626495|560131591|FG000|Overall Study|Physician Decision|1|||
155188986|NCT01626495|560131591|FG000|Overall Study|New cancer therapy|16|||
155188987|NCT01626495|560131591|FG000|Overall Study|Manufacturing failure|1|||
155188988|NCT02979197|560131596|FG000|Overall Study|Adverse Event|4|||
155188989|NCT02979197|560131597|FG001|Overall Study|Adverse Event|2|||
155188990|NCT02979197|560131598|FG002|Overall Study|Adverse Event|0|||
155188991|NCT02979197|560131596|FG000|Overall Study|Protocol Violation|0|||
155188992|NCT02979197|560131597|FG001|Overall Study|Protocol Violation|1|||
155188993|NCT02979197|560131598|FG002|Overall Study|Protocol Violation|0|||
155188994|NCT02979197|560131596|FG000|Overall Study|Subject unable to commit to study dates|0|||
155188995|NCT02979197|560131597|FG001|Overall Study|Subject unable to commit to study dates|1|||
155188996|NCT02979197|560131598|FG002|Overall Study|Subject unable to commit to study dates|0|||
155188997|NCT03643159|560131599|FG000|Overall Study|Adverse Event|1|||
155188998|NCT03643159|560131599|FG000|Overall Study|Withdrawal by Subject|1|||
155188999|NCT03438383|560131600|FG000|Overall Study|Protocol Violation|9|||
155037525|NCT03170609|559563909|FG003|Overall Study|Other|0|||
155037526|NCT03170609|559563910|FG004|Overall Study|Other|0|||
155037527|NCT03170609|559563911|FG005|Overall Study|Other|1|||
155189000|NCT03438383|560131601|FG001|Overall Study|Protocol Violation|3|||
155189001|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
155189002|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
155189003|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
155189004|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
155189005|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|Death|2|||
155037528|NCT03170609|559563912|FG006|Overall Study|Other|0|||
155189006|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|Death|2|||
155189007|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
155189008|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
155189009|NCT01528033|560131602|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
155189010|NCT01528033|560131603|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
155189011|NCT01528033|560131602|FG000|Follow Up|No data available|46|||
155189012|NCT01528033|560131603|FG001|Follow Up|No data available|44|||
155189013|NCT03954132|560131604|FG000|Overall Study|Adverse Event|2|||
155189014|NCT03954132|560131605|FG001|Overall Study|Adverse Event|0|||
155189015|NCT03954132|560131604|FG000|Overall Study|Patient's wish|5|||
155189016|NCT03954132|560131605|FG001|Overall Study|Patient's wish|0|||
155189017|NCT03954132|560131604|FG000|Overall Study|Lost to Follow-up|10|||
155037529|NCT00314132|559563913|FG000|Overall Study|Lost to Follow-up|3|||
155189018|NCT03954132|560131605|FG001|Overall Study|Lost to Follow-up|0|||
155189019|NCT03954132|560131604|FG000|Overall Study|Screening failure|0|||
155189020|NCT03954132|560131605|FG001|Overall Study|Screening failure|1|||
155189021|NCT03954132|560131604|FG000|Overall Study|No registration after Visit 1|5|||
155189022|NCT03954132|560131605|FG001|Overall Study|No registration after Visit 1|2|||
155189023|NCT03954132|560131604|FG000|Overall Study|Other reason than listed|2|||
155189024|NCT03954132|560131605|FG001|Overall Study|Other reason than listed|2|||
155189025|NCT03954132|560131604|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
155189026|NCT03954132|560131605|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
155189027|NCT03954132|560131604|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
155189028|NCT03954132|560131605|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
155189029|NCT01414608|560131608|FG000|Overall Study|Ineligible|5|||
155189030|NCT01414608|560131609|FG001|Overall Study|Ineligible|2|||
155189031|NCT05156073|560131610|FG000|Overall Study|Patient canceled appointment with PCP|1|||
155189032|NCT00973349|560131611|FG000|Overall Study|Adverse Event|0|||
155189033|NCT00973349|560131612|FG001|Overall Study|Adverse Event|0|||
155189034|NCT00973349|560131613|FG002|Overall Study|Adverse Event|0|||
155189035|NCT00973349|560131614|FG003|Overall Study|Adverse Event|0|||
155189036|NCT00973349|560131615|FG004|Overall Study|Adverse Event|1|||
155189037|NCT00973349|560131616|FG005|Overall Study|Adverse Event|0|||
155189038|NCT00973349|560131617|FG006|Overall Study|Adverse Event|0|||
155189039|NCT00973349|560131618|FG007|Overall Study|Adverse Event|0|||
155189040|NCT00973349|560131619|FG008|Overall Study|Adverse Event|1|||
155189041|NCT00973349|560131620|FG009|Overall Study|Adverse Event|0|||
155189042|NCT00973349|560131621|FG010|Overall Study|Adverse Event|0|||
155189043|NCT00973349|560131622|FG011|Overall Study|Adverse Event|0|||
155189044|NCT00973349|560131623|FG012|Overall Study|Adverse Event|0|||
155189045|NCT00973349|560131624|FG013|Overall Study|Adverse Event|0|||
155189046|NCT00973349|560131625|FG014|Overall Study|Adverse Event|1|||
155189047|NCT00973349|560131626|FG015|Overall Study|Adverse Event|0|||
155189048|NCT00973349|560131611|FG000|Overall Study|Withdrawal by Subject|1|||
155189049|NCT00973349|560131612|FG001|Overall Study|Withdrawal by Subject|2|||
155189050|NCT00973349|560131613|FG002|Overall Study|Withdrawal by Subject|2|||
155189051|NCT00973349|560131614|FG003|Overall Study|Withdrawal by Subject|3|||
155189052|NCT00973349|560131615|FG004|Overall Study|Withdrawal by Subject|2|||
155189053|NCT00973349|560131616|FG005|Overall Study|Withdrawal by Subject|0|||
155189054|NCT00973349|560131617|FG006|Overall Study|Withdrawal by Subject|2|||
155189055|NCT00973349|560131618|FG007|Overall Study|Withdrawal by Subject|2|||
155189056|NCT00973349|560131619|FG008|Overall Study|Withdrawal by Subject|0|||
155189057|NCT00973349|560131620|FG009|Overall Study|Withdrawal by Subject|2|||
155189058|NCT00973349|560131621|FG010|Overall Study|Withdrawal by Subject|0|||
155189059|NCT00973349|560131622|FG011|Overall Study|Withdrawal by Subject|1|||
155189060|NCT00973349|560131623|FG012|Overall Study|Withdrawal by Subject|0|||
155189061|NCT00973349|560131624|FG013|Overall Study|Withdrawal by Subject|0|||
155189062|NCT00973349|560131625|FG014|Overall Study|Withdrawal by Subject|0|||
155189063|NCT00973349|560131626|FG015|Overall Study|Withdrawal by Subject|0|||
155189064|NCT00973349|560131611|FG000|Overall Study|Lost to Follow-up|3|||
155189065|NCT00973349|560131612|FG001|Overall Study|Lost to Follow-up|1|||
155189066|NCT00973349|560131613|FG002|Overall Study|Lost to Follow-up|2|||
155189067|NCT00973349|560131614|FG003|Overall Study|Lost to Follow-up|2|||
155189068|NCT00973349|560131615|FG004|Overall Study|Lost to Follow-up|1|||
155189069|NCT00973349|560131616|FG005|Overall Study|Lost to Follow-up|3|||
155189070|NCT00973349|560131617|FG006|Overall Study|Lost to Follow-up|0|||
155189071|NCT00973349|560131618|FG007|Overall Study|Lost to Follow-up|1|||
155189072|NCT00973349|560131619|FG008|Overall Study|Lost to Follow-up|2|||
155189073|NCT00973349|560131620|FG009|Overall Study|Lost to Follow-up|1|||
155189074|NCT00973349|560131621|FG010|Overall Study|Lost to Follow-up|0|||
155189075|NCT00973349|560131622|FG011|Overall Study|Lost to Follow-up|1|||
155189076|NCT00973349|560131623|FG012|Overall Study|Lost to Follow-up|0|||
155189077|NCT00973349|560131624|FG013|Overall Study|Lost to Follow-up|0|||
155189078|NCT00973349|560131625|FG014|Overall Study|Lost to Follow-up|0|||
155037530|NCT00314132|559563914|FG001|Overall Study|Lost to Follow-up|13|||
155037531|NCT00314132|559563913|FG000|Overall Study|Withdrawal by Subject|3|||
155037532|NCT00314132|559563914|FG001|Overall Study|Withdrawal by Subject|5|||
155037533|NCT00314132|559563913|FG000|Overall Study|Adverse Event|1|||
155037534|NCT00314132|559563914|FG001|Overall Study|Adverse Event|0|||
155037535|NCT00314132|559563913|FG000|Overall Study|Physician Decision|1|||
155037536|NCT00314132|559563914|FG001|Overall Study|Physician Decision|0|||
155037537|NCT01592292|559563916|FG000|Overall Study|Follow-up loss|3|||
155037538|NCT01592292|559563917|FG001|Overall Study|Follow-up loss|3|||
155037539|NCT01592292|559563918|FG002|Overall Study|Follow-up loss|1|||
155189079|NCT00973349|560131626|FG015|Overall Study|Lost to Follow-up|1|||
155189080|NCT00973349|560131611|FG000|Overall Study|Inappropriate enrolment|0|||
155189081|NCT00973349|560131612|FG001|Overall Study|Inappropriate enrolment|0|||
155189082|NCT00973349|560131613|FG002|Overall Study|Inappropriate enrolment|1|||
155189083|NCT00973349|560131614|FG003|Overall Study|Inappropriate enrolment|0|||
155189084|NCT00973349|560131615|FG004|Overall Study|Inappropriate enrolment|0|||
155189085|NCT00973349|560131616|FG005|Overall Study|Inappropriate enrolment|0|||
155189086|NCT00973349|560131617|FG006|Overall Study|Inappropriate enrolment|0|||
155189087|NCT00973349|560131618|FG007|Overall Study|Inappropriate enrolment|0|||
155189088|NCT00973349|560131619|FG008|Overall Study|Inappropriate enrolment|0|||
155189089|NCT00973349|560131620|FG009|Overall Study|Inappropriate enrolment|2|||
155189090|NCT00973349|560131621|FG010|Overall Study|Inappropriate enrolment|0|||
155189091|NCT00973349|560131622|FG011|Overall Study|Inappropriate enrolment|0|||
155189092|NCT00973349|560131623|FG012|Overall Study|Inappropriate enrolment|1|||
155189093|NCT00973349|560131624|FG013|Overall Study|Inappropriate enrolment|0|||
155189094|NCT00973349|560131625|FG014|Overall Study|Inappropriate enrolment|1|||
155189095|NCT00973349|560131626|FG015|Overall Study|Inappropriate enrolment|1|||
155189096|NCT00973349|560131611|FG000|Overall Study|Protocol Violation|0|||
155189097|NCT00973349|560131612|FG001|Overall Study|Protocol Violation|0|||
155189098|NCT00973349|560131613|FG002|Overall Study|Protocol Violation|0|||
155189099|NCT00973349|560131614|FG003|Overall Study|Protocol Violation|0|||
155189100|NCT00973349|560131615|FG004|Overall Study|Protocol Violation|0|||
155189101|NCT00973349|560131616|FG005|Overall Study|Protocol Violation|0|||
155189102|NCT00973349|560131617|FG006|Overall Study|Protocol Violation|0|||
155189103|NCT00973349|560131618|FG007|Overall Study|Protocol Violation|0|||
155189104|NCT00973349|560131619|FG008|Overall Study|Protocol Violation|1|||
155189105|NCT00973349|560131620|FG009|Overall Study|Protocol Violation|0|||
155189106|NCT00973349|560131621|FG010|Overall Study|Protocol Violation|0|||
155189107|NCT00973349|560131622|FG011|Overall Study|Protocol Violation|0|||
155189108|NCT00973349|560131623|FG012|Overall Study|Protocol Violation|0|||
155189109|NCT00973349|560131624|FG013|Overall Study|Protocol Violation|0|||
155189110|NCT00973349|560131625|FG014|Overall Study|Protocol Violation|0|||
155189111|NCT00973349|560131626|FG015|Overall Study|Protocol Violation|0|||
155189112|NCT00973349|560131611|FG000|Overall Study|Unable to classify|0|||
155189113|NCT00973349|560131612|FG001|Overall Study|Unable to classify|0|||
155189114|NCT00973349|560131613|FG002|Overall Study|Unable to classify|0|||
155189115|NCT00973349|560131614|FG003|Overall Study|Unable to classify|0|||
155189116|NCT00973349|560131615|FG004|Overall Study|Unable to classify|1|||
155189117|NCT00973349|560131616|FG005|Overall Study|Unable to classify|1|||
155189118|NCT00973349|560131617|FG006|Overall Study|Unable to classify|0|||
155189119|NCT00973349|560131618|FG007|Overall Study|Unable to classify|0|||
155189120|NCT00973349|560131619|FG008|Overall Study|Unable to classify|0|||
155189121|NCT00973349|560131620|FG009|Overall Study|Unable to classify|1|||
155189122|NCT00973349|560131621|FG010|Overall Study|Unable to classify|0|||
155189123|NCT00973349|560131622|FG011|Overall Study|Unable to classify|0|||
155189124|NCT00973349|560131623|FG012|Overall Study|Unable to classify|0|||
155189125|NCT00973349|560131624|FG013|Overall Study|Unable to classify|0|||
155037540|NCT01592292|559563919|FG003|Overall Study|Follow-up loss|0|||
155037541|NCT01592292|559563916|FG000|Overall Study|Withdrew consent|2|||
155037542|NCT01592292|559563917|FG001|Overall Study|Withdrew consent|1|||
155037543|NCT01592292|559563918|FG002|Overall Study|Withdrew consent|0|||
155037544|NCT01592292|559563919|FG003|Overall Study|Withdrew consent|0|||
155037545|NCT01592292|559563916|FG000|Overall Study|Other|1|||
155037546|NCT01592292|559563917|FG001|Overall Study|Other|1|||
155037547|NCT01592292|559563918|FG002|Overall Study|Other|2|||
155037548|NCT01592292|559563919|FG003|Overall Study|Other|1|||
155037549|NCT00622336|559563920|FG000|Treatment Phase|Progression of Disease|181|||
155037550|NCT00622336|559563920|FG000|Treatment Phase|Adverse Event|46|||
155037551|NCT00622336|559563920|FG000|Treatment Phase|Other|40|||
155037552|NCT00622336|559563920|FG000|Treatment Phase|Death|14|||
155037553|NCT00622336|559563920|FG000|Treatment Phase|Lack of therapeutic effect|13|||
155189126|NCT00973349|560131625|FG014|Overall Study|Unable to classify|0|||
155189127|NCT00973349|560131626|FG015|Overall Study|Unable to classify|0|||
155189128|NCT03635788|560131627|FG000|Step 1|Death|1|||
155189129|NCT03635788|560131628|FG001|Step 1|Death|0|||
155189130|NCT03635788|560131629|FG002|Step 1|Death|0|||
155189131|NCT03635788|560131627|FG000|Step 1|Lost to Follow-up|31|||
155189132|NCT03635788|560131628|FG001|Step 1|Lost to Follow-up|0|||
155189133|NCT03635788|560131629|FG002|Step 1|Lost to Follow-up|0|||
155037554|NCT00622336|559563920|FG000|Treatment Phase|Withdrawal by Subject|13|||
155189134|NCT03635788|560131627|FG000|Step 1|Pregnancy|1|||
155189135|NCT03635788|560131628|FG001|Step 1|Pregnancy|0|||
155189136|NCT03635788|560131629|FG002|Step 1|Pregnancy|0|||
155189137|NCT03635788|560131627|FG000|Step 1|Protocol Violation|8|||
155189138|NCT03635788|560131628|FG001|Step 1|Protocol Violation|0|||
155189139|NCT03635788|560131629|FG002|Step 1|Protocol Violation|0|||
155189140|NCT03635788|560131627|FG000|Step 1|Withdrawal by Subject|13|||
155189141|NCT03635788|560131628|FG001|Step 1|Withdrawal by Subject|0|||
155037555|NCT00622336|559563920|FG000|Treatment Phase|Lost to Follow-up|2|||
155189142|NCT03635788|560131629|FG002|Step 1|Withdrawal by Subject|0|||
155037556|NCT00622336|559563920|FG000|Extension Phase|Adverse Event|2|||
155189143|NCT03635788|560131627|FG000|Step 1|Other reasons|12|||
155189144|NCT03635788|560131628|FG001|Step 1|Other reasons|0|||
155189145|NCT03635788|560131629|FG002|Step 1|Other reasons|0|||
155189146|NCT03635788|560131627|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
155189147|NCT03635788|560131628|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
155189148|NCT03635788|560131629|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
155189149|NCT03635788|560131627|FG000|Step 2|Lost to Follow-up|0|||
155189150|NCT03635788|560131628|FG001|Step 2|Lost to Follow-up|8|||
155189151|NCT03635788|560131629|FG002|Step 2|Lost to Follow-up|15|||
155189152|NCT03635788|560131627|FG000|Step 2|Withdrawal by Subject|0|||
155189153|NCT03635788|560131628|FG001|Step 2|Withdrawal by Subject|6|||
155189154|NCT03635788|560131629|FG002|Step 2|Withdrawal by Subject|6|||
155189155|NCT03635788|560131627|FG000|Step 2|Death|0|||
155189156|NCT03635788|560131628|FG001|Step 2|Death|2|||
155189157|NCT03635788|560131629|FG002|Step 2|Death|0|||
155189158|NCT03635788|560131627|FG000|Step 2|Incarceration|0|||
155189159|NCT03635788|560131628|FG001|Step 2|Incarceration|2|||
155189160|NCT03635788|560131629|FG002|Step 2|Incarceration|0|||
155189161|NCT03635788|560131627|FG000|Step 2|Non-Compliance With Study Requirements|0|||
155189162|NCT03635788|560131628|FG001|Step 2|Non-Compliance With Study Requirements|1|||
155189163|NCT03635788|560131629|FG002|Step 2|Non-Compliance With Study Requirements|1|||
155189164|NCT03635788|560131627|FG000|Step 2|Confounding Medical Condition|0|||
155189165|NCT03635788|560131628|FG001|Step 2|Confounding Medical Condition|0|||
155189166|NCT03635788|560131629|FG002|Step 2|Confounding Medical Condition|1|||
155189167|NCT03635788|560131627|FG000|Step 2|Out Of State With No Plan To Return|0|||
155189168|NCT03635788|560131628|FG001|Step 2|Out Of State With No Plan To Return|1|||
155189169|NCT03635788|560131629|FG002|Step 2|Out Of State With No Plan To Return|0|||
155189170|NCT03635788|560131627|FG000|Step 2|Switched To Injectables|0|||
155189171|NCT03635788|560131628|FG001|Step 2|Switched To Injectables|0|||
155189172|NCT03635788|560131629|FG002|Step 2|Switched To Injectables|1|||
155189173|NCT03635788|560131627|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
155189174|NCT03635788|560131628|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
155189175|NCT03635788|560131629|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
155189176|NCT02452697|560131632|FG000|Overall Study|Physician Decision|4|||
155189177|NCT02452697|560131633|FG001|Overall Study|Physician Decision|4|||
155189178|NCT02452697|560131634|FG002|Overall Study|Physician Decision|3|||
155189179|NCT02452697|560131635|FG003|Overall Study|Physician Decision|2|||
155189180|NCT02452697|560131632|FG000|Overall Study|Withdrawal by Subject|1|||
155189181|NCT02452697|560131633|FG001|Overall Study|Withdrawal by Subject|0|||
155189182|NCT02452697|560131634|FG002|Overall Study|Withdrawal by Subject|0|||
155189183|NCT02452697|560131635|FG003|Overall Study|Withdrawal by Subject|0|||
155189184|NCT02452697|560131632|FG000|Overall Study|still in follow-up|2|||
155189185|NCT02452697|560131633|FG001|Overall Study|still in follow-up|2|||
155189186|NCT02452697|560131634|FG002|Overall Study|still in follow-up|1|||
155189187|NCT02452697|560131635|FG003|Overall Study|still in follow-up|3|||
155189188|NCT05098938|560131636|FG000|Overall Study|Adverse Event|4|||
155189189|NCT05098938|560131637|FG001|Overall Study|Adverse Event|3|||
155189190|NCT05098938|560131636|FG000|Overall Study|inclusion/exclusion criteria change|11|||
155189191|NCT05098938|560131637|FG001|Overall Study|inclusion/exclusion criteria change|5|||
155189192|NCT05098938|560131636|FG000|Overall Study|lack of compliance|26|||
155189193|NCT05098938|560131637|FG001|Overall Study|lack of compliance|19|||
155189194|NCT05098938|560131636|FG000|Overall Study|Lost to Follow-up|37|||
155189195|NCT05098938|560131637|FG001|Overall Study|Lost to Follow-up|40|||
155189196|NCT05098938|560131636|FG000|Overall Study|Lost in treatment period|17|||
155189197|NCT05098938|560131637|FG001|Overall Study|Lost in treatment period|13|||
155189198|NCT05098938|560131636|FG000|Overall Study|Met an exclusion criterion|0|||
155189199|NCT05098938|560131637|FG001|Overall Study|Met an exclusion criterion|3|||
155189200|NCT05098938|560131636|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
155189201|NCT05098938|560131637|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
155189202|NCT05098938|560131636|FG000|Overall Study|Physician Decision|25|||
155189203|NCT05098938|560131637|FG001|Overall Study|Physician Decision|32|||
155189204|NCT05098938|560131636|FG000|Overall Study|Run in failure in treatment phase|1|||
155189205|NCT05098938|560131637|FG001|Overall Study|Run in failure in treatment phase|1|||
155189206|NCT05098938|560131636|FG000|Overall Study|Withdrawal by Subject|0|||
155189207|NCT05098938|560131637|FG001|Overall Study|Withdrawal by Subject|3|||
155189208|NCT05098938|560131636|FG000|Overall Study|Run-in Failure in early study|505|||
155189209|NCT05098938|560131637|FG001|Overall Study|Run-in Failure in early study|514|||
155189210|NCT05098938|560131636|FG000|Overall Study|IMP delivery missed|1|||
155189211|NCT05098938|560131637|FG001|Overall Study|IMP delivery missed|5|||
155189212|NCT05098938|560131636|FG000|Overall Study|6 months visit was missed|2|||
155189213|NCT05098938|560131637|FG001|Overall Study|6 months visit was missed|0|||
155189214|NCT05098938|560131636|FG000|Overall Study|fit for use was not completed within window|3|||
155189215|NCT05098938|560131637|FG001|Overall Study|fit for use was not completed within window|0|||
155189216|NCT05098938|560131636|FG000|Overall Study|V2 visit was not completed within window|0|||
155189217|NCT05098938|560131637|FG001|Overall Study|V2 visit was not completed within window|1|||
155189218|NCT05098938|560131636|FG000|Overall Study|exclusionary medication use|1|||
155189219|NCT05098938|560131637|FG001|Overall Study|exclusionary medication use|2|||
155189220|NCT05098938|560131636|FG000|Overall Study|change in medication|1|||
155189221|NCT05098938|560131637|FG001|Overall Study|change in medication|0|||
155189222|NCT05098938|560131636|FG000|Overall Study|treatment failure|2|||
155189223|NCT05098938|560131637|FG001|Overall Study|treatment failure|1|||
155189224|NCT03803683|560131638|FG000|Overall Study|Lost to Follow-up|41|||
155189225|NCT03803683|560131639|FG001|Overall Study|Lost to Follow-up|18|||
155189226|NCT03803683|560131640|FG002|Overall Study|Lost to Follow-up|12|||
155189227|NCT03803683|560131638|FG000|Overall Study|Withdrawal by Subject|9|||
155189228|NCT03803683|560131639|FG001|Overall Study|Withdrawal by Subject|1|||
155189229|NCT03803683|560131640|FG002|Overall Study|Withdrawal by Subject|4|||
155189230|NCT00492050|560131641|FG000|Overall Study|Adverse Event|1|||
155189231|NCT00492050|560131641|FG000|Overall Study|Lack of Efficacy|1|||
155189232|NCT00492050|560131641|FG000|Overall Study|Withdrawal by Subject|3|||
155189233|NCT00492050|560131641|FG000|Overall Study|Unable to collect SCT|2|||
155189234|NCT00492050|560131641|FG000|Overall Study|Progressive Disease|2|||
155189235|NCT02206048|560133414|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
155189236|NCT02925923|560133415|FG000|Overall Study|blood samples hemolyzed|0|||
155189237|NCT02925923|560133416|FG001|Overall Study|blood samples hemolyzed|2|||
155189238|NCT00866788|560133420|FG000|Overall Study|Adverse Event|0|||
155189239|NCT00866788|560133421|FG001|Overall Study|Adverse Event|2|||
155189240|NCT00866788|560133422|FG002|Overall Study|Adverse Event|0|||
155189241|NCT00866788|560133423|FG003|Overall Study|Adverse Event|1|||
155189242|NCT00866788|560133420|FG000|Overall Study|Lost to Follow-up|1|||
155189243|NCT00866788|560133421|FG001|Overall Study|Lost to Follow-up|1|||
155189244|NCT00866788|560133422|FG002|Overall Study|Lost to Follow-up|0|||
155189245|NCT00866788|560133423|FG003|Overall Study|Lost to Follow-up|2|||
155189246|NCT00866788|560133420|FG000|Overall Study|Withdrawal by Subject|2|||
155189247|NCT00866788|560133421|FG001|Overall Study|Withdrawal by Subject|1|||
155189248|NCT00866788|560133422|FG002|Overall Study|Withdrawal by Subject|0|||
155189249|NCT00866788|560133423|FG003|Overall Study|Withdrawal by Subject|1|||
155189250|NCT00866788|560133420|FG000|Overall Study|Pregnancy|0|||
155189251|NCT00866788|560133421|FG001|Overall Study|Pregnancy|1|||
155189252|NCT00866788|560133422|FG002|Overall Study|Pregnancy|0|||
155189253|NCT00866788|560133423|FG003|Overall Study|Pregnancy|0|||
155189254|NCT00866788|560133420|FG000|Overall Study|Disease progression|3|||
155189255|NCT00866788|560133421|FG001|Overall Study|Disease progression|1|||
155189256|NCT00866788|560133422|FG002|Overall Study|Disease progression|1|||
155189257|NCT00866788|560133423|FG003|Overall Study|Disease progression|0|||
155189258|NCT00866788|560133420|FG000|Overall Study|Physician Decision|0|||
155189259|NCT00866788|560133421|FG001|Overall Study|Physician Decision|0|||
155189260|NCT00866788|560133422|FG002|Overall Study|Physician Decision|1|||
155189261|NCT00866788|560133423|FG003|Overall Study|Physician Decision|1|||
155189262|NCT02339285|560133424|FG000|Overall Study|Withdrawal by Subject|0|||
155189263|NCT02339285|560133425|FG001|Overall Study|Withdrawal by Subject|1|||
155189264|NCT02339285|560133426|FG002|Overall Study|Withdrawal by Subject|1|||
155189265|NCT02339285|560133424|FG000|Overall Study|Lost to Follow-up|1|||
155189266|NCT02339285|560133425|FG001|Overall Study|Lost to Follow-up|1|||
155189267|NCT02339285|560133426|FG002|Overall Study|Lost to Follow-up|1|||
155189268|NCT02339285|560133424|FG000|Overall Study|Protocol Deviation|0|||
155189269|NCT02339285|560133425|FG001|Overall Study|Protocol Deviation|1|||
155189270|NCT02339285|560133426|FG002|Overall Study|Protocol Deviation|0|||
155189271|NCT00282412|560133427|FG000|Overall Study|Death|2|||
155189272|NCT03911713|560133428|FG000|Overall Study|Lost to Follow-up|0|||
155189273|NCT03911713|560133429|FG001|Overall Study|Lost to Follow-up|2|||
155189274|NCT03911713|560133430|FG002|Overall Study|Lost to Follow-up|0|||
155189275|NCT03911713|560133431|FG003|Overall Study|Lost to Follow-up|0|||
155189276|NCT03911713|560133432|FG004|Overall Study|Lost to Follow-up|0|||
155189277|NCT03911713|560133428|FG000|Overall Study|Other|0|||
155189278|NCT03911713|560133429|FG001|Overall Study|Other|0|||
155189279|NCT03911713|560133430|FG002|Overall Study|Other|0|||
155189280|NCT03911713|560133431|FG003|Overall Study|Other|1|||
155189281|NCT03911713|560133432|FG004|Overall Study|Other|0|||
155189282|NCT03911713|560133428|FG000|Overall Study|Randomized, Never Dosed|1|||
155189283|NCT03911713|560133429|FG001|Overall Study|Randomized, Never Dosed|0|||
155189284|NCT03911713|560133430|FG002|Overall Study|Randomized, Never Dosed|0|||
155189285|NCT03911713|560133431|FG003|Overall Study|Randomized, Never Dosed|1|||
155189286|NCT03911713|560133432|FG004|Overall Study|Randomized, Never Dosed|0|||
155189287|NCT00108433|560133434|FG000|Overall Study|Lack of Efficacy|1|||
155189288|NCT00108433|560133435|FG001|Overall Study|Lack of Efficacy|2|||
155189289|NCT00108433|560133434|FG000|Overall Study|Death|3|||
155189290|NCT00108433|560133435|FG001|Overall Study|Death|0|||
155189291|NCT00108433|560133434|FG000|Overall Study|Adverse Event|3|||
155189292|NCT00108433|560133435|FG001|Overall Study|Adverse Event|1|||
155189293|NCT00108433|560133434|FG000|Overall Study|Other|14|||
155189294|NCT00108433|560133435|FG001|Overall Study|Other|14|||
155189295|NCT02203071|560133436|FG000|Overall Study|Lost to Follow-up|3|||
155189296|NCT02203071|560133437|FG001|Overall Study|Lost to Follow-up|1|||
155189297|NCT01193660|560133438|FG000|Overall Study|Withdrawal by Subject|2|||
155189298|NCT01193660|560133439|FG001|Overall Study|Withdrawal by Subject|3|||
155189299|NCT01193660|560133440|FG002|Overall Study|Withdrawal by Subject|1|||
155189300|NCT01193660|560133438|FG000|Overall Study|Death|1|||
155189301|NCT01193660|560133439|FG001|Overall Study|Death|0|||
155189302|NCT01193660|560133440|FG002|Overall Study|Death|0|||
155189303|NCT01193660|560133438|FG000|Overall Study|Physician Decision|1|||
155189304|NCT01193660|560133439|FG001|Overall Study|Physician Decision|0|||
155189305|NCT01193660|560133440|FG002|Overall Study|Physician Decision|1|||
155037557|NCT00622336|559563920|FG000|Extension Phase|Progressive Disease|6|||
155189306|NCT00195273|560133441|FG000|Overall Study|Adverse Event|9|||
155189307|NCT00195273|560133442|FG001|Overall Study|Adverse Event|9|||
155189308|NCT00195273|560133441|FG000|Overall Study|Protocol deviation|0|||
155189309|NCT00195273|560133442|FG001|Overall Study|Protocol deviation|1|||
155189310|NCT00195273|560133441|FG000|Overall Study|Lack of Efficacy|3|||
155189311|NCT00195273|560133442|FG001|Overall Study|Lack of Efficacy|1|||
155189312|NCT00195273|560133441|FG000|Overall Study|Procedural complications|9|||
155189313|NCT00195273|560133442|FG001|Overall Study|Procedural complications|3|||
155189314|NCT02595970|560133443|FG000|Overall Study|Withdrawal by Subject|2|||
155189315|NCT02595970|560133443|FG000|Overall Study|Physician Decision|2|||
155189316|NCT02595970|560133443|FG000|Overall Study|Protocol Violation|4|||
155189317|NCT02595970|560133443|FG000|Overall Study|Adverse Event|5|||
155189318|NCT02595970|560133443|FG000|Overall Study|Lack of Efficacy|7|||
155189319|NCT01886716|560133444|FG000|Week 1|Lost to Follow-up|0|||
155189320|NCT01886716|560133445|FG001|Week 1|Lost to Follow-up|0|||
155189321|NCT01886716|560133446|FG002|Week 1|Lost to Follow-up|2|||
155189322|NCT01886716|560133447|FG003|Week 1|Lost to Follow-up|2|||
155189323|NCT01886716|560133444|FG000|Week 2|Lost to Follow-up|3|||
155189324|NCT01886716|560133445|FG001|Week 2|Lost to Follow-up|2|||
155189325|NCT01886716|560133446|FG002|Week 2|Lost to Follow-up|1|||
155189326|NCT01886716|560133447|FG003|Week 2|Lost to Follow-up|3|||
155189327|NCT01886716|560133444|FG000|Week 3|Lost to Follow-up|1|||
155189328|NCT01886716|560133445|FG001|Week 3|Lost to Follow-up|1|||
155189329|NCT01886716|560133446|FG002|Week 3|Lost to Follow-up|0|||
155189330|NCT01886716|560133447|FG003|Week 3|Lost to Follow-up|1|||
155189331|NCT00810108|560133454|FG000|Overall Study|Withdrawal by Subject|1|||
155189332|NCT00810108|560133455|FG001|Overall Study|Withdrawal by Subject|0|||
155189333|NCT03793556|560133463|FG000|Overall Study|Withdrawal by Subject|12|||
155189334|NCT03793556|560133464|FG001|Overall Study|Withdrawal by Subject|1|||
155189335|NCT03793556|560133463|FG000|Overall Study|Lost to Follow-up|1|||
155189336|NCT03793556|560133464|FG001|Overall Study|Lost to Follow-up|1|||
155189337|NCT04416633|560133465|FG000|Overall Study|Death|1|||
155189338|NCT04416633|560133465|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
155189339|NCT04416633|560133465|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
155189340|NCT04416633|560133465|FG000|Overall Study|Adverse Event|6|||
155189341|NCT04416633|560133465|FG000|Overall Study|Withdrawal by Subject|6|||
155189342|NCT00785928|560133466|FG000|Treatment Phase|Adverse Event|1|||
155189343|NCT00785928|560133467|FG001|Treatment Phase|Adverse Event|1|||
155189344|NCT00785928|560133468|FG002|Treatment Phase|Adverse Event|2|||
155189345|NCT00785928|560133469|FG003|Treatment Phase|Adverse Event|0|||
155189346|NCT00785928|560133470|FG004|Treatment Phase|Adverse Event|0|||
155189347|NCT00785928|560133471|FG005|Treatment Phase|Adverse Event|0|||
155189348|NCT00785928|560133472|FG006|Treatment Phase|Adverse Event|2|||
155189349|NCT00785928|560133466|FG000|Treatment Phase|Inadequate Response|0|||
155189350|NCT00785928|560133467|FG001|Treatment Phase|Inadequate Response|1|||
155189351|NCT00785928|560133468|FG002|Treatment Phase|Inadequate Response|0|||
155189352|NCT00785928|560133469|FG003|Treatment Phase|Inadequate Response|0|||
155189353|NCT00785928|560133470|FG004|Treatment Phase|Inadequate Response|0|||
155189354|NCT00785928|560133471|FG005|Treatment Phase|Inadequate Response|0|||
155189355|NCT00785928|560133472|FG006|Treatment Phase|Inadequate Response|0|||
155189356|NCT00785928|560133466|FG000|Treatment Phase|Lack of Efficacy|0|||
155189357|NCT00785928|560133467|FG001|Treatment Phase|Lack of Efficacy|1|||
155189358|NCT00785928|560133468|FG002|Treatment Phase|Lack of Efficacy|1|||
155189359|NCT00785928|560133469|FG003|Treatment Phase|Lack of Efficacy|0|||
155189360|NCT00785928|560133470|FG004|Treatment Phase|Lack of Efficacy|0|||
155189361|NCT00785928|560133471|FG005|Treatment Phase|Lack of Efficacy|0|||
155189362|NCT00785928|560133472|FG006|Treatment Phase|Lack of Efficacy|0|||
155189363|NCT00785928|560133466|FG000|Treatment Phase|Physician Decision|0|||
155189364|NCT00785928|560133467|FG001|Treatment Phase|Physician Decision|0|||
155037558|NCT00622336|559563920|FG000|Extension Phase|Lack of therapeutic effect|2|||
155037559|NCT00622336|559563920|FG000|Extension Phase|Withdrawal by Subject|1|||
155037560|NCT00622336|559563920|FG000|Extension Phase|Lost to Follow-up|1|||
155037561|NCT00622336|559563920|FG000|Extension Phase|Other|9|||
155037562|NCT02240069|559563925|FG000|Overall Study|Withdrawal by Subject|5|||
155189365|NCT00785928|560133468|FG002|Treatment Phase|Physician Decision|0|||
155189366|NCT00785928|560133469|FG003|Treatment Phase|Physician Decision|0|||
155189367|NCT00785928|560133470|FG004|Treatment Phase|Physician Decision|1|||
155189368|NCT00785928|560133471|FG005|Treatment Phase|Physician Decision|0|||
155189369|NCT00785928|560133472|FG006|Treatment Phase|Physician Decision|0|||
155189370|NCT00785928|560133466|FG000|Treatment Phase|Sponsor Decision|1|||
155189371|NCT00785928|560133467|FG001|Treatment Phase|Sponsor Decision|0|||
155037563|NCT02240069|559563926|FG001|Overall Study|Withdrawal by Subject|5|||
155037564|NCT02240069|559563927|FG002|Overall Study|Withdrawal by Subject|2|||
155037565|NCT00948506|559563928|FG000|Overall Study|Withdrawal by Subject|3|||
155189372|NCT00785928|560133468|FG002|Treatment Phase|Sponsor Decision|0|||
155189373|NCT00785928|560133469|FG003|Treatment Phase|Sponsor Decision|0|||
155189374|NCT00785928|560133470|FG004|Treatment Phase|Sponsor Decision|0|||
155189375|NCT00785928|560133471|FG005|Treatment Phase|Sponsor Decision|0|||
155189376|NCT00785928|560133472|FG006|Treatment Phase|Sponsor Decision|1|||
155189377|NCT00785928|560133466|FG000|Treatment Phase|Withdrawal by Subject|1|||
155189378|NCT00785928|560133467|FG001|Treatment Phase|Withdrawal by Subject|2|||
155189379|NCT00785928|560133468|FG002|Treatment Phase|Withdrawal by Subject|0|||
155189380|NCT00785928|560133469|FG003|Treatment Phase|Withdrawal by Subject|0|||
155189381|NCT00785928|560133470|FG004|Treatment Phase|Withdrawal by Subject|1|||
155189382|NCT00785928|560133471|FG005|Treatment Phase|Withdrawal by Subject|0|||
155189383|NCT00785928|560133472|FG006|Treatment Phase|Withdrawal by Subject|0|||
155189384|NCT05021081|560133474|FG000|Phase 2|Subject enrolled in error|1|||
155189385|NCT05021081|560133475|FG001|Phase 2|Subject enrolled in error|1|||
155189386|NCT05021081|560133476|FG002|Phase 2|Subject enrolled in error|0|||
155189387|NCT01461980|560133477|FG000|Overall Study|Other|9|||
155189388|NCT01461980|560133478|FG001|Overall Study|Other|8|||
155189389|NCT01461980|560133479|FG002|Overall Study|Other|6|||
155189390|NCT01461980|560133477|FG000|Overall Study|Medication error|7|||
155189391|NCT01461980|560133478|FG001|Overall Study|Medication error|5|||
155189392|NCT01461980|560133479|FG002|Overall Study|Medication error|6|||
155189393|NCT01461980|560133477|FG000|Overall Study|Adverse Event|12|||
155189394|NCT01461980|560133478|FG001|Overall Study|Adverse Event|5|||
155189395|NCT01461980|560133479|FG002|Overall Study|Adverse Event|6|||
155189396|NCT01461980|560133477|FG000|Overall Study|Protocol Violation|12|||
155189397|NCT01461980|560133478|FG001|Overall Study|Protocol Violation|19|||
155189398|NCT01461980|560133479|FG002|Overall Study|Protocol Violation|16|||
155189399|NCT01461980|560133477|FG000|Overall Study|No longer meets eligibility criteria|18|||
155189400|NCT01461980|560133478|FG001|Overall Study|No longer meets eligibility criteria|9|||
155189401|NCT01461980|560133479|FG002|Overall Study|No longer meets eligibility criteria|19|||
155189402|NCT01461980|560133477|FG000|Overall Study|Lost to Follow-up|52|||
155189403|NCT01461980|560133478|FG001|Overall Study|Lost to Follow-up|53|||
155189404|NCT01461980|560133479|FG002|Overall Study|Lost to Follow-up|51|||
155189405|NCT01461980|560133477|FG000|Overall Study|No longer willing to participate|52|||
155189406|NCT01461980|560133478|FG001|Overall Study|No longer willing to participate|38|||
155189407|NCT01461980|560133479|FG002|Overall Study|No longer willing to participate|54|||
155189408|NCT01461980|560133477|FG000|Overall Study|Randomized but not vaccinated|4|||
155189409|NCT01461980|560133478|FG001|Overall Study|Randomized but not vaccinated|8|||
155189410|NCT01461980|560133479|FG002|Overall Study|Randomized but not vaccinated|7|||
155189411|NCT00122109|560133480|FG000|Overall Study|Did not meet criteria|6|||
155189412|NCT00122109|560133481|FG001|Overall Study|Did not meet criteria|7|||
155189413|NCT00100178|560133482|FG000|Overall Study|Lost to Follow-up|0|||
155189414|NCT00100178|560133483|FG001|Overall Study|Lost to Follow-up|6|||
155189415|NCT00100178|560133484|FG002|Overall Study|Lost to Follow-up|5|||
155189416|NCT00100178|560133482|FG000|Overall Study|Adverse Event|2|||
155189417|NCT00100178|560133483|FG001|Overall Study|Adverse Event|2|||
155189418|NCT00100178|560133484|FG002|Overall Study|Adverse Event|1|||
155189419|NCT00100178|560133482|FG000|Overall Study|Withdrawal by Subject|1|||
155189420|NCT00100178|560133483|FG001|Overall Study|Withdrawal by Subject|1|||
155189421|NCT00100178|560133484|FG002|Overall Study|Withdrawal by Subject|1|||
155189422|NCT00100178|560133482|FG000|Overall Study|Physician Decision|6|||
155189423|NCT00100178|560133483|FG001|Overall Study|Physician Decision|1|||
155189424|NCT00100178|560133484|FG002|Overall Study|Physician Decision|3|||
155189425|NCT01439568|560133487|FG000|Overall Study|Lost to Follow-up|1|||
155189426|NCT01439568|560133488|FG001|Overall Study|Lost to Follow-up|0|||
155189427|NCT01439568|560133487|FG000|Overall Study|Withdrawal by Subject|2|||
155189428|NCT01439568|560133488|FG001|Overall Study|Withdrawal by Subject|2|||
155189429|NCT03161093|560133491|FG000|Overall Study|Protocol Violation|11|||
155189430|NCT03161093|560133492|FG001|Overall Study|Protocol Violation|14|||
155189431|NCT03161093|560133493|FG002|Overall Study|Protocol Violation|6|||
155189432|NCT03161093|560133494|FG003|Overall Study|Protocol Violation|13|||
155189433|NCT03161093|560133495|FG004|Overall Study|Protocol Violation|1|||
155189434|NCT03161093|560133496|FG005|Overall Study|Protocol Violation|0|||
155189435|NCT03161093|560133491|FG000|Overall Study|Adverse Event|5|||
155189436|NCT03161093|560133492|FG001|Overall Study|Adverse Event|21|||
155189437|NCT03161093|560133493|FG002|Overall Study|Adverse Event|16|||
155189438|NCT03161093|560133494|FG003|Overall Study|Adverse Event|35|||
155189439|NCT03161093|560133495|FG004|Overall Study|Adverse Event|2|||
155189440|NCT03161093|560133496|FG005|Overall Study|Adverse Event|1|||
155189441|NCT03161093|560133491|FG000|Overall Study|Lack of Efficacy|9|||
155189442|NCT03161093|560133492|FG001|Overall Study|Lack of Efficacy|13|||
155189443|NCT03161093|560133493|FG002|Overall Study|Lack of Efficacy|9|||
155189444|NCT03161093|560133494|FG003|Overall Study|Lack of Efficacy|24|||
155189445|NCT03161093|560133495|FG004|Overall Study|Lack of Efficacy|4|||
155189446|NCT03161093|560133496|FG005|Overall Study|Lack of Efficacy|1|||
155189447|NCT03161093|560133491|FG000|Overall Study|Physician Decision|0|||
155189448|NCT03161093|560133492|FG001|Overall Study|Physician Decision|1|||
155189449|NCT03161093|560133493|FG002|Overall Study|Physician Decision|0|||
155189450|NCT03161093|560133494|FG003|Overall Study|Physician Decision|2|||
155189451|NCT03161093|560133495|FG004|Overall Study|Physician Decision|17|||
155189452|NCT03161093|560133496|FG005|Overall Study|Physician Decision|15|||
155189453|NCT03161093|560133491|FG000|Overall Study|Withdrawal by Subject|24|||
155189454|NCT03161093|560133492|FG001|Overall Study|Withdrawal by Subject|73|||
155189455|NCT03161093|560133493|FG002|Overall Study|Withdrawal by Subject|44|||
155189456|NCT03161093|560133494|FG003|Overall Study|Withdrawal by Subject|97|||
155189457|NCT03161093|560133495|FG004|Overall Study|Withdrawal by Subject|11|||
155189458|NCT03161093|560133496|FG005|Overall Study|Withdrawal by Subject|10|||
155189459|NCT03161093|560133491|FG000|Overall Study|Lost to Follow-up|3|||
155189460|NCT03161093|560133492|FG001|Overall Study|Lost to Follow-up|12|||
155189461|NCT03161093|560133493|FG002|Overall Study|Lost to Follow-up|4|||
155189462|NCT03161093|560133494|FG003|Overall Study|Lost to Follow-up|7|||
155189463|NCT03161093|560133495|FG004|Overall Study|Lost to Follow-up|8|||
155189464|NCT03161093|560133496|FG005|Overall Study|Lost to Follow-up|13|||
155189465|NCT03161093|560133491|FG000|Overall Study|Death|3|||
155189466|NCT03161093|560133492|FG001|Overall Study|Death|9|||
155189467|NCT03161093|560133493|FG002|Overall Study|Death|7|||
155189468|NCT03161093|560133494|FG003|Overall Study|Death|9|||
155189469|NCT03161093|560133495|FG004|Overall Study|Death|0|||
155189470|NCT03161093|560133496|FG005|Overall Study|Death|0|||
155189471|NCT03161093|560133491|FG000|Overall Study|Unknown - Not reported|0|||
155189472|NCT03161093|560133492|FG001|Overall Study|Unknown - Not reported|1|||
155189473|NCT03161093|560133493|FG002|Overall Study|Unknown - Not reported|0|||
155189474|NCT03161093|560133494|FG003|Overall Study|Unknown - Not reported|0|||
155189475|NCT03161093|560133495|FG004|Overall Study|Unknown - Not reported|0|||
155189476|NCT03161093|560133496|FG005|Overall Study|Unknown - Not reported|1|||
155189477|NCT01649804|560133504|FG000|Overall Study|Administrative/Other|8|||
155189478|NCT03719586|560133505|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
155189479|NCT03719586|560133506|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
155189480|NCT03719586|560133507|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
155189481|NCT03719586|560133508|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
155189482|NCT01199731|560133509|FG000|Overall Study|Adverse Event|0|||
155189483|NCT01199731|560133510|FG001|Overall Study|Adverse Event|1|||
155189484|NCT01199731|560133511|FG002|Overall Study|Adverse Event|0|||
155189485|NCT01199731|560133509|FG000|Overall Study|Study closed/terminated|7|||
155189486|NCT01199731|560133510|FG001|Overall Study|Study closed/terminated|9|||
155189487|NCT01199731|560133511|FG002|Overall Study|Study closed/terminated|7|||
155189488|NCT01199731|560133509|FG000|Overall Study|Lost to Follow-up|0|||
155189489|NCT01199731|560133510|FG001|Overall Study|Lost to Follow-up|0|||
155189490|NCT01199731|560133511|FG002|Overall Study|Lost to Follow-up|2|||
155189491|NCT01199731|560133509|FG000|Overall Study|Physician Decision|0|||
155189492|NCT01199731|560133510|FG001|Overall Study|Physician Decision|1|||
155189493|NCT01199731|560133511|FG002|Overall Study|Physician Decision|1|||
155189494|NCT01199731|560133509|FG000|Overall Study|Withdrawal by Subject|2|||
155189495|NCT01199731|560133510|FG001|Overall Study|Withdrawal by Subject|0|||
155189496|NCT01199731|560133511|FG002|Overall Study|Withdrawal by Subject|0|||
155189497|NCT01465191|560133512|FG000|Overall Study|Protocol Violation|6|||
155189498|NCT01465191|560133513|FG001|Overall Study|Protocol Violation|3|||
155189499|NCT01465191|560133514|FG002|Overall Study|Protocol Violation|3|||
155189500|NCT01465191|560133512|FG000|Overall Study|Lost to Follow-up|3|||
155189501|NCT01465191|560133513|FG001|Overall Study|Lost to Follow-up|6|||
155189502|NCT01465191|560133514|FG002|Overall Study|Lost to Follow-up|4|||
155189503|NCT00943124|560133515|FG000|Period 1|Withdrawal by Subject|1|||
155189504|NCT00943124|560133516|FG001|Period 1|Withdrawal by Subject|1|||
155189505|NCT00943124|560133515|FG000|Period 1|Did Not Follow Study Procedures|1|||
155189506|NCT00943124|560133516|FG001|Period 1|Did Not Follow Study Procedures|0|||
155189507|NCT00943124|560133515|FG000|Period 1|Personal Reasons|0|||
155189508|NCT00943124|560133516|FG001|Period 1|Personal Reasons|1|||
155189509|NCT02992132|560133517|FG000|Overall Study|Adverse Event|4|||
155189510|NCT02992132|560133518|FG001|Overall Study|Adverse Event|1|||
155037566|NCT00948506|559563929|FG001|Overall Study|Withdrawal by Subject|1|||
155037567|NCT03233204|559563930|FG000|Overall Study|Adverse Event|1|||
155037568|NCT03233204|559563930|FG000|Overall Study|Death|1|||
155037569|NCT03233204|559563930|FG000|Overall Study|Withdrawal by Subject|1|||
155037570|NCT03233204|559563930|FG000|Overall Study|Progressive Disease|3|||
155037571|NCT01764997|559563931|FG000|Run-in Period|Adverse Event|15|||
155037572|NCT01764997|559563932|FG001|Run-in Period|Adverse Event|0|||
155189511|NCT02992132|560133519|FG002|Overall Study|Adverse Event|3|||
155189512|NCT02992132|560133517|FG000|Overall Study|Lack of Efficacy|2|||
155189513|NCT02992132|560133518|FG001|Overall Study|Lack of Efficacy|0|||
155189514|NCT02992132|560133519|FG002|Overall Study|Lack of Efficacy|0|||
155189515|NCT02992132|560133517|FG000|Overall Study|Non-compliance with study drug|2|||
155189516|NCT02992132|560133518|FG001|Overall Study|Non-compliance with study drug|0|||
155189517|NCT02992132|560133519|FG002|Overall Study|Non-compliance with study drug|0|||
155189518|NCT02992132|560133517|FG000|Overall Study|Progressive disease|1|||
155189519|NCT02992132|560133518|FG001|Overall Study|Progressive disease|0|||
155189520|NCT02992132|560133519|FG002|Overall Study|Progressive disease|0|||
155189521|NCT02992132|560133517|FG000|Overall Study|Protocol Violation|2|||
155189522|NCT02992132|560133518|FG001|Overall Study|Protocol Violation|2|||
155189523|NCT02992132|560133519|FG002|Overall Study|Protocol Violation|0|||
155189524|NCT02992132|560133517|FG000|Overall Study|Caregiver withdrew consent|2|||
155189525|NCT02992132|560133518|FG001|Overall Study|Caregiver withdrew consent|3|||
155189526|NCT02992132|560133519|FG002|Overall Study|Caregiver withdrew consent|2|||
155189527|NCT02992132|560133517|FG000|Overall Study|Withdrawal by Subject|0|||
155189528|NCT02992132|560133518|FG001|Overall Study|Withdrawal by Subject|2|||
155189529|NCT02992132|560133519|FG002|Overall Study|Withdrawal by Subject|1|||
155189530|NCT02992132|560133517|FG000|Overall Study|Physician Decision|0|||
155189531|NCT02992132|560133518|FG001|Overall Study|Physician Decision|0|||
155189532|NCT02992132|560133519|FG002|Overall Study|Physician Decision|1|||
155189533|NCT00381381|560133532|FG000|Overall Study|Adverse Event|3|||
155189534|NCT00381381|560133532|FG000|Overall Study|Lost to Follow-up|52|||
155189535|NCT00381381|560133532|FG000|Overall Study|Withdrawal by Subject|9|||
155189536|NCT01916967|560133533|FG000|Overall Study|Adverse Event|0|||
155189537|NCT01916967|560133534|FG001|Overall Study|Adverse Event|0|||
155189538|NCT01916967|560133535|FG002|Overall Study|Adverse Event|2|||
155189539|NCT01916967|560133533|FG000|Overall Study|Lack of Efficacy|0|||
155189540|NCT01916967|560133534|FG001|Overall Study|Lack of Efficacy|0|||
155189541|NCT01916967|560133535|FG002|Overall Study|Lack of Efficacy|6|||
155189542|NCT01916967|560133533|FG000|Overall Study|Physician Decision|0|||
155189543|NCT01916967|560133534|FG001|Overall Study|Physician Decision|0|||
155189544|NCT01916967|560133535|FG002|Overall Study|Physician Decision|1|||
155189545|NCT01916967|560133533|FG000|Overall Study|Protocol Violation|0|||
155189546|NCT01916967|560133534|FG001|Overall Study|Protocol Violation|1|||
155189547|NCT01916967|560133535|FG002|Overall Study|Protocol Violation|0|||
155189548|NCT03799211|560133538|FG000|Overall Study|Lost to Follow-up|2|||
155189549|NCT03799211|560133539|FG001|Overall Study|Lost to Follow-up|13|||
155189550|NCT03799211|560133538|FG000|Overall Study|Withdrawal by Subject|2|||
155189551|NCT03799211|560133539|FG001|Overall Study|Withdrawal by Subject|0|||
155189552|NCT00764491|560133540|FG000|Overall Study|Lost to Follow-up|35|||
155189553|NCT00764491|560133541|FG001|Overall Study|Lost to Follow-up|17|||
155189554|NCT00620464|560133542|FG000|Overall Study|Adverse Event|15|||
155189555|NCT00620464|560133543|FG001|Overall Study|Adverse Event|17|||
155189556|NCT00620464|560133542|FG000|Overall Study|Lost to Follow-up|1|||
155189557|NCT00620464|560133543|FG001|Overall Study|Lost to Follow-up|1|||
155189558|NCT00620464|560133542|FG000|Overall Study|Planning Pregnancy|1|||
155189559|NCT00620464|560133543|FG001|Overall Study|Planning Pregnancy|4|||
155189560|NCT00620464|560133542|FG000|Overall Study|Personal|2|||
155189561|NCT00620464|560133543|FG001|Overall Study|Personal|2|||
155189562|NCT00620464|560133542|FG000|Overall Study|Used prohibited medication|1|||
155189563|NCT00620464|560133543|FG001|Overall Study|Used prohibited medication|0|||
155189564|NCT02027376|560133544|FG000|Overall Study|Death|1|||
155189565|NCT02027376|560133545|FG001|Overall Study|Death|0|||
155189566|NCT02027376|560133546|FG002|Overall Study|Death|0|||
155189567|NCT00932737|560133549|FG000|Overall Study|Not treated in second episode|1|||
155189568|NCT00932737|560133550|FG001|Overall Study|Not treated in second episode|0|||
155189569|NCT00932737|560133549|FG000|Overall Study|Adverse Event|0|||
155189570|NCT00932737|560133550|FG001|Overall Study|Adverse Event|1|||
155189571|NCT02949700|560133551|FG000|Phase I|Withdrawal by Subject|1|||
155189572|NCT02949700|560133552|FG001|Phase I|Withdrawal by Subject|1|||
155189573|NCT02949700|560133553|FG002|Phase I|Withdrawal by Subject|0|||
155189574|NCT02949700|560133554|FG003|Phase I|Withdrawal by Subject|0|||
155189575|NCT02949700|560133551|FG000|Phase I|Protocol Violation|1|||
155189576|NCT02949700|560133552|FG001|Phase I|Protocol Violation|0|||
155189577|NCT02949700|560133553|FG002|Phase I|Protocol Violation|0|||
155189578|NCT02949700|560133554|FG003|Phase I|Protocol Violation|0|||
155189579|NCT02949700|560133551|FG000|Phase II|Withdrawal by Subject|0|||
155189580|NCT02949700|560133552|FG001|Phase II|Withdrawal by Subject|0|||
155189581|NCT02949700|560133553|FG002|Phase II|Withdrawal by Subject|0|||
155189582|NCT02949700|560133554|FG003|Phase II|Withdrawal by Subject|2|||
155037573|NCT01764997|559563933|FG002|Run-in Period|Adverse Event|0|||
155037574|NCT01764997|559563934|FG003|Run-in Period|Adverse Event|0|||
155189583|NCT02949700|560133551|FG000|Phase II|Protocol Violation|0|||
155189584|NCT02949700|560133552|FG001|Phase II|Protocol Violation|0|||
155189585|NCT02949700|560133553|FG002|Phase II|Protocol Violation|1|||
155189586|NCT02949700|560133554|FG003|Phase II|Protocol Violation|3|||
155189587|NCT02898116|560133559|FG000|Overall Study|Adverse Event|1|||
155189588|NCT02898116|560133559|FG000|Overall Study|Progressive disease|1|||
155189589|NCT05597020|560133563|FG000|Washout|Forbidden medication|2|||
155189590|NCT05597020|560133564|FG001|Washout|Forbidden medication|0|||
155189591|NCT05597020|560133563|FG000|Treatment Period II|Advice from primary care physician|1|||
155189592|NCT05597020|560133564|FG001|Treatment Period II|Advice from primary care physician|0|||
155189593|NCT05597020|560133563|FG000|Treatment Period II|Subject lost investigational product|1|||
155189594|NCT05597020|560133564|FG001|Treatment Period II|Subject lost investigational product|0|||
155189595|NCT05597020|560133563|FG000|Treatment Period II|Private reasons|0|||
155189596|NCT05597020|560133564|FG001|Treatment Period II|Private reasons|1|||
155189597|NCT01015131|560133565|FG000|Overall Study|Physician Decision|1|||
155189598|NCT01015131|560133565|FG000|Overall Study|Protocol Violation|1|||
155189599|NCT01015131|560133565|FG000|Overall Study|Withdrawal by Subject|2|||
155189600|NCT01015131|560133565|FG000|Overall Study|Other Protocol Specified Criteria|4|||
155189601|NCT00560885|560133566|FG000|Overall Study|Death|7|||
155189602|NCT00560885|560133566|FG000|Overall Study|Withdrawal by Subject|1|||
155189603|NCT02887859|560133567|FG000|Overall Study|Ongoing|6|||
155189604|NCT02887859|560133567|FG000|Overall Study|Adverse Event|7|||
155189605|NCT02887859|560133567|FG000|Overall Study|Death|1|||
155189606|NCT02887859|560133567|FG000|Overall Study|Physician Decision|1|||
155189607|NCT01554397|560133568|FG000|Overall Study|Withdrawal by Subject|1|||
155189608|NCT01554397|560133569|FG001|Overall Study|Withdrawal by Subject|0|||
155189609|NCT01554397|560133568|FG000|Overall Study|Ineligible|7|||
155189610|NCT01554397|560133569|FG001|Overall Study|Ineligible|0|||
155189611|NCT03148275|560133570|FG000|Overall Study|Death|6|||
155189612|NCT03148275|560133570|FG000|Overall Study|Adverse Event|3|||
155189613|NCT03148275|560133570|FG000|Overall Study|Liver transplant|2|||
155189614|NCT03148275|560133570|FG000|Overall Study|Patient decision|5|||
155189615|NCT03148275|560133570|FG000|Overall Study|transition to commercial drug|1|||
155189616|NCT03148275|560133570|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
155189617|NCT00257608|560135522|FG000|Chemotherapy Phase|Adverse Event|138|||
155189618|NCT00257608|560135523|FG001|Chemotherapy Phase|Adverse Event|0|||
155189619|NCT00257608|560135524|FG002|Chemotherapy Phase|Adverse Event|0|||
155189620|NCT00257608|560135522|FG000|Chemotherapy Phase|Disease progression|139|||
155189621|NCT00257608|560135523|FG001|Chemotherapy Phase|Disease progression|0|||
155189622|NCT00257608|560135524|FG002|Chemotherapy Phase|Disease progression|0|||
155189623|NCT00257608|560135522|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
155189624|NCT00257608|560135523|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
155189625|NCT00257608|560135524|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
155189626|NCT00257608|560135522|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
155189627|NCT00257608|560135523|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
155189628|NCT00257608|560135524|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
155189629|NCT00257608|560135522|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
155189630|NCT00257608|560135523|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
155189631|NCT00257608|560135524|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
155189632|NCT00257608|560135522|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
155189633|NCT00257608|560135523|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189634|NCT00257608|560135524|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189635|NCT00257608|560135522|FG000|Chemotherapy Phase|Physician Decision|28|||
155189636|NCT00257608|560135523|FG001|Chemotherapy Phase|Physician Decision|0|||
155189637|NCT00257608|560135524|FG002|Chemotherapy Phase|Physician Decision|0|||
155189638|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Adverse Event|0|||
155189639|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Adverse Event|34|||
155189640|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Adverse Event|38|||
155189641|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Disease progression|0|||
155189642|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Disease progression|204|||
155189643|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Disease progression|168|||
155189644|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
155189645|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
155189646|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
155189647|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
155189648|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
155189649|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
155189650|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
155189651|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
155189652|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
155189653|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189654|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
155189655|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
155189656|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
155189657|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
155189658|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
155189659|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Physician Decision|0|||
155189660|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Physician Decision|8|||
155189661|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Physician Decision|11|||
155189662|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
155189663|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
155189664|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
155189665|NCT00257608|560135522|FG000|Post Chemotherapy Phase|Not treated|0|||
155189666|NCT00257608|560135523|FG001|Post Chemotherapy Phase|Not treated|4|||
155189667|NCT00257608|560135524|FG002|Post Chemotherapy Phase|Not treated|7|||
155189668|NCT03673046|560135525|FG000|Overall Study|Adverse Event|1|||
155189669|NCT03673046|560135526|FG001|Overall Study|Adverse Event|1|||
155189670|NCT03673046|560135525|FG000|Overall Study|Withdrawal by Subject|8|||
155189671|NCT03673046|560135526|FG001|Overall Study|Withdrawal by Subject|2|||
155189672|NCT03817879|560135527|FG000|Overall Study|Drop out|5|||
155189673|NCT03817879|560135528|FG001|Overall Study|Drop out|12|||
155189674|NCT03817879|560135527|FG000|Overall Study|Withdrawal by Subject|0|||
155189675|NCT03817879|560135528|FG001|Overall Study|Withdrawal by Subject|1|||
155189676|NCT03693300|560135529|FG000|Overall Study|Withdrawal by Subject|6|||
155189677|NCT03693300|560135530|FG001|Overall Study|Withdrawal by Subject|0|||
155189678|NCT03693300|560135529|FG000|Overall Study|Death|50|||
155189679|NCT03693300|560135530|FG001|Overall Study|Death|2|||
155189680|NCT03693300|560135529|FG000|Overall Study|Lost to Follow-up|2|||
155189681|NCT03693300|560135530|FG001|Overall Study|Lost to Follow-up|0|||
155189682|NCT00537238|560135531|FG000|Overall Study|Death|1|||
155189683|NCT00537238|560135532|FG001|Overall Study|Death|2|||
155189684|NCT00537238|560135531|FG000|Overall Study|Adverse Event|31|||
155189685|NCT00537238|560135532|FG001|Overall Study|Adverse Event|22|||
155189686|NCT00537238|560135531|FG000|Overall Study|Lack of Efficacy|20|||
155189687|NCT00537238|560135532|FG001|Overall Study|Lack of Efficacy|21|||
155189688|NCT00537238|560135531|FG000|Overall Study|Lost to Follow-up|12|||
155189689|NCT00537238|560135532|FG001|Overall Study|Lost to Follow-up|8|||
155189690|NCT00537238|560135531|FG000|Overall Study|Withdrawal by Subject|51|||
155189691|NCT00537238|560135532|FG001|Overall Study|Withdrawal by Subject|47|||
155189692|NCT00537238|560135531|FG000|Overall Study|Protocol Violation|15|||
155189693|NCT00537238|560135532|FG001|Overall Study|Protocol Violation|19|||
155189694|NCT00537238|560135531|FG000|Overall Study|Does not meet entrance criteria|0|||
155189695|NCT00537238|560135532|FG001|Overall Study|Does not meet entrance criteria|2|||
155189696|NCT00537238|560135531|FG000|Overall Study|Other|44|||
155189697|NCT00537238|560135532|FG001|Overall Study|Other|52|||
155189698|NCT00697073|560135533|FG000|Overall Study|Withdrawal by Subject|2|||
155189699|NCT00697073|560135533|FG000|Overall Study|Pregnancy|1|||
155189700|NCT00697073|560135533|FG000|Overall Study|non compliance and other|6|||
155189701|NCT03265665|560135538|FG000|24-week Data Collection|Withdrawal by Subject|2|||
155189702|NCT03265665|560135539|FG001|24-week Data Collection|Withdrawal by Subject|2|||
155189703|NCT03265665|560135538|FG000|24-week Data Collection|Lost to Follow-up|4|||
155189704|NCT03265665|560135539|FG001|24-week Data Collection|Lost to Follow-up|5|||
155189705|NCT03265665|560135538|FG000|36-week Data Collection|Lost to Follow-up|6|||
155189706|NCT03265665|560135539|FG001|36-week Data Collection|Lost to Follow-up|8|||
155189707|NCT01845818|560135542|FG000|Overall Study|Withdrawal by Subject|0|||
155189708|NCT01845818|560135543|FG001|Overall Study|Withdrawal by Subject|1|||
155189709|NCT01845818|560135542|FG000|Overall Study|Lost to Follow-up|7|||
155189710|NCT01845818|560135543|FG001|Overall Study|Lost to Follow-up|5|||
155189711|NCT01845818|560135542|FG000|Overall Study|Administrative Reasons|3|||
155189712|NCT01845818|560135543|FG001|Overall Study|Administrative Reasons|1|||
155189713|NCT01845818|560135542|FG000|Overall Study|Serious Adverse Event|1|||
155189714|NCT01845818|560135543|FG001|Overall Study|Serious Adverse Event|1|||
155189715|NCT01845818|560135542|FG000|Overall Study|Other|25|||
155189716|NCT01845818|560135543|FG001|Overall Study|Other|8|||
155189717|NCT01845818|560135542|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
155189718|NCT01845818|560135543|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
155189719|NCT01845818|560135542|FG000|Overall Study|No Follow-Up Data Available|4|||
155189720|NCT01845818|560135543|FG001|Overall Study|No Follow-Up Data Available|1|||
155189721|NCT01680965|560135544|FG000|Overall Study|Death|0|||
155189722|NCT01680965|560135545|FG001|Overall Study|Death|0|||
155189723|NCT01680965|560135546|FG002|Overall Study|Death|0|||
155189724|NCT01680965|560135547|FG003|Overall Study|Death|6|||
155189725|NCT04806503|560135552|FG000|Overall Study|Lost to Follow-up|0|||
155189726|NCT04806503|560135553|FG001|Overall Study|Lost to Follow-up|0|||
155189727|NCT04806503|560135554|FG002|Overall Study|Lost to Follow-up|1|||
155189728|NCT04806503|560135555|FG003|Overall Study|Lost to Follow-up|0|||
155189729|NCT04806503|560135556|FG004|Overall Study|Lost to Follow-up|0|||
155189730|NCT04806503|560135552|FG000|Overall Study|Withdrawal by Subject|1|||
155189731|NCT04806503|560135553|FG001|Overall Study|Withdrawal by Subject|0|||
155189732|NCT04806503|560135554|FG002|Overall Study|Withdrawal by Subject|1|||
155189733|NCT04806503|560135555|FG003|Overall Study|Withdrawal by Subject|1|||
155189734|NCT04806503|560135556|FG004|Overall Study|Withdrawal by Subject|1|||
155189735|NCT04806503|560135552|FG000|Overall Study|Adverse Event|1|||
155189736|NCT04806503|560135553|FG001|Overall Study|Adverse Event|1|||
155189737|NCT04806503|560135554|FG002|Overall Study|Adverse Event|0|||
155189738|NCT04806503|560135555|FG003|Overall Study|Adverse Event|1|||
155189739|NCT04806503|560135556|FG004|Overall Study|Adverse Event|0|||
155189740|NCT03589469|560135557|FG000|Overall Study|Withdrawal by Subject|8|||
155037575|NCT01764997|559563935|FG004|Run-in Period|Adverse Event|0|||
155189741|NCT03589469|560135557|FG000|Overall Study|Physician Decision|20|||
155189742|NCT03589469|560135557|FG000|Overall Study|Death|97|||
155189743|NCT03589469|560135557|FG000|Overall Study|Lost to Follow-up|8|||
155189744|NCT03589469|560135557|FG000|Overall Study|Miscellaneous|1|||
155189745|NCT00231842|560135565|FG000|Overall Study|Withdrawal by Subject|3|||
155189746|NCT00231842|560135565|FG000|Overall Study|Did not complete the last 3 cycle|8|||
155189747|NCT02422303|560135566|FG000|Overall Study|Lost to Follow-up|1|||
155189748|NCT02422303|560135567|FG001|Overall Study|Lost to Follow-up|1|||
155189749|NCT00850343|560135568|FG000|Overall Study|Withdrawal by Subject|11|||
155189750|NCT00850343|560135569|FG001|Overall Study|Withdrawal by Subject|0|||
155189751|NCT00850343|560135570|FG002|Overall Study|Withdrawal by Subject|3|||
155189752|NCT00850343|560135571|FG003|Overall Study|Withdrawal by Subject|2|||
155189753|NCT00850343|560135568|FG000|Overall Study|Adverse Event|15|||
155189754|NCT00850343|560135569|FG001|Overall Study|Adverse Event|2|||
155189755|NCT00850343|560135570|FG002|Overall Study|Adverse Event|6|||
155189756|NCT00850343|560135571|FG003|Overall Study|Adverse Event|6|||
155189757|NCT00850343|560135568|FG000|Overall Study|Pregnancy|0|||
155189758|NCT00850343|560135569|FG001|Overall Study|Pregnancy|0|||
155189759|NCT00850343|560135570|FG002|Overall Study|Pregnancy|0|||
155189760|NCT00850343|560135571|FG003|Overall Study|Pregnancy|1|||
155189761|NCT00850343|560135568|FG000|Overall Study|Lack of Efficacy|17|||
155189762|NCT00850343|560135569|FG001|Overall Study|Lack of Efficacy|0|||
155189763|NCT00850343|560135570|FG002|Overall Study|Lack of Efficacy|3|||
155189764|NCT00850343|560135571|FG003|Overall Study|Lack of Efficacy|2|||
155189765|NCT00850343|560135568|FG000|Overall Study|Non-compliance with Study Procedures|1|||
155189766|NCT00850343|560135569|FG001|Overall Study|Non-compliance with Study Procedures|0|||
155189767|NCT00850343|560135570|FG002|Overall Study|Non-compliance with Study Procedures|1|||
155189768|NCT00850343|560135571|FG003|Overall Study|Non-compliance with Study Procedures|1|||
155189769|NCT00850343|560135568|FG000|Overall Study|Physician Decision|2|||
155189770|NCT00850343|560135569|FG001|Overall Study|Physician Decision|1|||
155189771|NCT00850343|560135570|FG002|Overall Study|Physician Decision|1|||
155189772|NCT00850343|560135571|FG003|Overall Study|Physician Decision|1|||
155189773|NCT00639678|560135572|FG000|Overall Study|Withdrawal by Subject|3|||
155189774|NCT00639678|560135573|FG001|Overall Study|Withdrawal by Subject|0|||
155189775|NCT00639678|560135574|FG002|Overall Study|Withdrawal by Subject|4|||
155189776|NCT00639678|560135575|FG003|Overall Study|Withdrawal by Subject|0|||
155189777|NCT00639678|560135572|FG000|Overall Study|Lost to Follow-up|1|||
155189778|NCT00639678|560135573|FG001|Overall Study|Lost to Follow-up|0|||
155189779|NCT00639678|560135574|FG002|Overall Study|Lost to Follow-up|6|||
155189780|NCT00639678|560135575|FG003|Overall Study|Lost to Follow-up|0|||
155189781|NCT00639678|560135572|FG000|Overall Study|Adverse Event|0|||
155189782|NCT00639678|560135573|FG001|Overall Study|Adverse Event|1|||
155189783|NCT00639678|560135574|FG002|Overall Study|Adverse Event|0|||
155189784|NCT00639678|560135575|FG003|Overall Study|Adverse Event|0|||
155189785|NCT00639678|560135572|FG000|Overall Study|Lack of Compliance|0|||
155189786|NCT00639678|560135573|FG001|Overall Study|Lack of Compliance|0|||
155189787|NCT00639678|560135574|FG002|Overall Study|Lack of Compliance|1|||
155189788|NCT00639678|560135575|FG003|Overall Study|Lack of Compliance|0|||
155189789|NCT01973569|560135576|FG000|Overall Study|Adverse Event|9|||
155189790|NCT01973569|560135577|FG001|Overall Study|Adverse Event|2|||
155189791|NCT01973569|560135578|FG002|Overall Study|Adverse Event|4|||
155189792|NCT01973569|560135576|FG000|Overall Study|Protocol Violation|2|||
155189793|NCT01973569|560135577|FG001|Overall Study|Protocol Violation|1|||
155189794|NCT01973569|560135578|FG002|Overall Study|Protocol Violation|3|||
155189795|NCT01973569|560135576|FG000|Overall Study|Withdrawal by Subject|7|||
155189796|NCT01973569|560135577|FG001|Overall Study|Withdrawal by Subject|5|||
155189797|NCT01973569|560135578|FG002|Overall Study|Withdrawal by Subject|2|||
155189798|NCT01973569|560135576|FG000|Overall Study|Invasive dental treatment|3|||
155189799|NCT01973569|560135577|FG001|Overall Study|Invasive dental treatment|5|||
155189800|NCT01973569|560135578|FG002|Overall Study|Invasive dental treatment|6|||
155189801|NCT01973569|560135576|FG000|Overall Study|Prohibited concomitant d|1|||
155189802|NCT01973569|560135577|FG001|Overall Study|Prohibited concomitant d|5|||
155189803|NCT01973569|560135578|FG002|Overall Study|Prohibited concomitant d|0|||
155189804|NCT01973569|560135576|FG000|Overall Study|Disease progression|0|||
155189805|NCT01973569|560135577|FG001|Overall Study|Disease progression|3|||
155189806|NCT01973569|560135578|FG002|Overall Study|Disease progression|0|||
155037576|NCT01764997|559563931|FG000|Run-in Period|Lack of Efficacy|5|||
155037577|NCT01764997|559563932|FG001|Run-in Period|Lack of Efficacy|0|||
155037578|NCT01764997|559563933|FG002|Run-in Period|Lack of Efficacy|0|||
155037579|NCT01764997|559563934|FG003|Run-in Period|Lack of Efficacy|0|||
155037580|NCT01764997|559563935|FG004|Run-in Period|Lack of Efficacy|0|||
155037581|NCT01764997|559563931|FG000|Run-in Period|Poor compliance to protocol|1|||
155037582|NCT01764997|559563932|FG001|Run-in Period|Poor compliance to protocol|0|||
155037583|NCT01764997|559563933|FG002|Run-in Period|Poor compliance to protocol|0|||
155037584|NCT01764997|559563934|FG003|Run-in Period|Poor compliance to protocol|0|||
155189807|NCT01973569|560135576|FG000|Overall Study|Other|1|||
155189808|NCT01973569|560135577|FG001|Overall Study|Other|1|||
155189809|NCT01973569|560135578|FG002|Overall Study|Other|0|||
155189810|NCT01973569|560135576|FG000|Overall Study|Did not receive study drug|6|||
155189811|NCT01973569|560135577|FG001|Overall Study|Did not receive study drug|3|||
155189812|NCT01973569|560135578|FG002|Overall Study|Did not receive study drug|3|||
155189813|NCT00371826|560135579|FG000|Core Phase (12 Months)|Adverse Event|15|||
155189814|NCT00371826|560135580|FG001|Core Phase (12 Months)|Adverse Event|4|||
155189815|NCT00371826|560135581|FG002|Core Phase (12 Months)|Adverse Event|9|||
155189816|NCT00371826|560135579|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
155037585|NCT01764997|559563935|FG004|Run-in Period|Poor compliance to protocol|0|||
155189817|NCT00371826|560135580|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
155189818|NCT00371826|560135581|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
155189819|NCT00371826|560135579|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
155189820|NCT00371826|560135580|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
155189821|NCT00371826|560135581|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
155189822|NCT00371826|560135579|FG000|Core Phase (12 Months)|Protocol Violation|1|||
155189823|NCT00371826|560135580|FG001|Core Phase (12 Months)|Protocol Violation|0|||
155189824|NCT00371826|560135581|FG002|Core Phase (12 Months)|Protocol Violation|1|||
155189825|NCT00371826|560135579|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
155189826|NCT00371826|560135580|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
155189827|NCT00371826|560135581|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
155189828|NCT00371826|560135579|FG000|Core Phase (12 Months)|Administrative problems|1|||
155189829|NCT00371826|560135580|FG001|Core Phase (12 Months)|Administrative problems|0|||
155189830|NCT00371826|560135581|FG002|Core Phase (12 Months)|Administrative problems|8|||
155189831|NCT00371826|560135579|FG000|Core Phase (12 Months)|Graft Loss|0|||
155189832|NCT00371826|560135580|FG001|Core Phase (12 Months)|Graft Loss|1|||
155189833|NCT00371826|560135581|FG002|Core Phase (12 Months)|Graft Loss|0|||
155189834|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Adverse Event|4|||
155189835|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Adverse Event|5|||
155189836|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Adverse Event|0|||
155189837|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
155189838|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
155189839|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
155189840|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
155189841|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
155189842|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
155189843|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
155189844|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
155189845|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
155189846|NCT00371826|560135579|FG000|Extension Phase (24 Months)|Administrative problems|0|||
155189847|NCT00371826|560135580|FG001|Extension Phase (24 Months)|Administrative problems|0|||
155189848|NCT00371826|560135581|FG002|Extension Phase (24 Months)|Administrative problems|2|||
155189849|NCT02436304|560135582|FG000|Overall Study|Lost to Follow-up|0|||
155189850|NCT02436304|560135583|FG001|Overall Study|Lost to Follow-up|1|||
155189851|NCT02436304|560135584|FG002|Overall Study|Lost to Follow-up|0|||
155189852|NCT02436304|560135582|FG000|Overall Study|Withdrawal by Subject|0|||
155189853|NCT02436304|560135583|FG001|Overall Study|Withdrawal by Subject|1|||
155189854|NCT02436304|560135584|FG002|Overall Study|Withdrawal by Subject|0|||
155189855|NCT02436304|560135582|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
155189856|NCT02436304|560135583|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
155189857|NCT02436304|560135584|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
155189858|NCT01675427|560135593|FG000|Overall Study|Withdrawal by Subject|7|||
155189859|NCT01675427|560135593|FG000|Overall Study|Participant Refused Sample Collection|18|||
155189860|NCT01675427|560135593|FG000|Overall Study|Sample not Collected by Mistake|2|||
155189861|NCT01675427|560135593|FG000|Overall Study|Lost to Follow-up|5|||
155189862|NCT01675427|560135593|FG000|Overall Study|Other|2|||
155189863|NCT00369122|560135597|FG000|Overall Study|Ineligible|10|||
155189864|NCT00369122|560135597|FG000|Overall Study|No protocol treatment|1|||
155189865|NCT00408629|560135600|FG000|Overall Study|Adverse Event|13|||
155189866|NCT00408629|560135601|FG001|Overall Study|Adverse Event|27|||
155189867|NCT00408629|560135600|FG000|Overall Study|Withdrawal by Subject|8|||
155189868|NCT00408629|560135601|FG001|Overall Study|Withdrawal by Subject|4|||
155189869|NCT00408629|560135600|FG000|Overall Study|Lost to Follow-up|1|||
155189870|NCT00408629|560135601|FG001|Overall Study|Lost to Follow-up|1|||
155189871|NCT00408629|560135600|FG000|Overall Study|Lack of Efficacy|63|||
155189872|NCT00408629|560135601|FG001|Overall Study|Lack of Efficacy|73|||
155189873|NCT00408629|560135600|FG000|Overall Study|Protocol Violation|1|||
155189874|NCT00408629|560135601|FG001|Overall Study|Protocol Violation|5|||
155189875|NCT00408629|560135600|FG000|Overall Study|Miscellaneous|11|||
155189876|NCT00408629|560135601|FG001|Overall Study|Miscellaneous|15|||
155189877|NCT03633617|560135602|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
155189878|NCT03633617|560135603|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
155189879|NCT03633617|560135604|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189880|NCT03633617|560135605|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189881|NCT03633617|560135606|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189882|NCT03633617|560135607|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189883|NCT03633617|560135608|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189884|NCT03633617|560135609|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189885|NCT03633617|560135610|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189886|NCT03633617|560135611|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189887|NCT03633617|560135612|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
155189888|NCT03633617|560135602|FG000|Part A|Unconfirmed early termination visit|1|||
155189889|NCT03633617|560135603|FG001|Part A|Unconfirmed early termination visit|0|||
155189890|NCT03633617|560135604|FG002|Part A|Unconfirmed early termination visit|0|||
155189891|NCT03633617|560135605|FG003|Part A|Unconfirmed early termination visit|0|||
155189892|NCT03633617|560135606|FG004|Part A|Unconfirmed early termination visit|0|||
155189893|NCT03633617|560135607|FG005|Part A|Unconfirmed early termination visit|0|||
155189894|NCT03633617|560135608|FG006|Part A|Unconfirmed early termination visit|0|||
155037586|NCT01764997|559563931|FG000|Run-in Period|Other than specified above|17|||
155037587|NCT01764997|559563932|FG001|Run-in Period|Other than specified above|0|||
155037588|NCT01764997|559563933|FG002|Run-in Period|Other than specified above|0|||
155189895|NCT03633617|560135609|FG007|Part A|Unconfirmed early termination visit|0|||
155189896|NCT03633617|560135610|FG008|Part A|Unconfirmed early termination visit|0|||
155189897|NCT03633617|560135611|FG009|Part A|Unconfirmed early termination visit|0|||
155189898|NCT03633617|560135612|FG010|Part A|Unconfirmed early termination visit|0|||
155189899|NCT03633617|560135602|FG000|Part A|Adverse Event|0|||
155189900|NCT03633617|560135603|FG001|Part A|Adverse Event|1|||
155189901|NCT03633617|560135604|FG002|Part A|Adverse Event|0|||
155189902|NCT03633617|560135605|FG003|Part A|Adverse Event|0|||
155189903|NCT03633617|560135606|FG004|Part A|Adverse Event|0|||
155189904|NCT03633617|560135607|FG005|Part A|Adverse Event|0|||
155189905|NCT03633617|560135608|FG006|Part A|Adverse Event|0|||
155189906|NCT03633617|560135609|FG007|Part A|Adverse Event|0|||
155189907|NCT03633617|560135610|FG008|Part A|Adverse Event|0|||
155189908|NCT03633617|560135611|FG009|Part A|Adverse Event|0|||
155189909|NCT03633617|560135612|FG010|Part A|Adverse Event|0|||
155189910|NCT03633617|560135602|FG000|Part A|Pregnancy|1|||
155189911|NCT03633617|560135603|FG001|Part A|Pregnancy|0|||
155189912|NCT03633617|560135604|FG002|Part A|Pregnancy|0|||
155189913|NCT03633617|560135605|FG003|Part A|Pregnancy|0|||
155189914|NCT03633617|560135606|FG004|Part A|Pregnancy|0|||
155189915|NCT03633617|560135607|FG005|Part A|Pregnancy|0|||
155189916|NCT03633617|560135608|FG006|Part A|Pregnancy|0|||
155189917|NCT03633617|560135609|FG007|Part A|Pregnancy|0|||
155189918|NCT03633617|560135610|FG008|Part A|Pregnancy|0|||
155189919|NCT03633617|560135611|FG009|Part A|Pregnancy|0|||
155189920|NCT03633617|560135612|FG010|Part A|Pregnancy|0|||
155189921|NCT03633617|560135602|FG000|Part A|Withdrawal by Subject|0|||
155189922|NCT03633617|560135603|FG001|Part A|Withdrawal by Subject|1|||
155189923|NCT03633617|560135604|FG002|Part A|Withdrawal by Subject|0|||
155189924|NCT03633617|560135605|FG003|Part A|Withdrawal by Subject|0|||
155189925|NCT03633617|560135606|FG004|Part A|Withdrawal by Subject|0|||
155189926|NCT03633617|560135607|FG005|Part A|Withdrawal by Subject|0|||
155189927|NCT03633617|560135608|FG006|Part A|Withdrawal by Subject|0|||
155189928|NCT03633617|560135609|FG007|Part A|Withdrawal by Subject|0|||
155189929|NCT03633617|560135610|FG008|Part A|Withdrawal by Subject|0|||
155189930|NCT03633617|560135611|FG009|Part A|Withdrawal by Subject|0|||
155189931|NCT03633617|560135612|FG010|Part A|Withdrawal by Subject|0|||
155189932|NCT03633617|560135602|FG000|Part B|Adverse Event|0|||
155189933|NCT03633617|560135603|FG001|Part B|Adverse Event|0|||
155189934|NCT03633617|560135604|FG002|Part B|Adverse Event|2|||
155189935|NCT03633617|560135605|FG003|Part B|Adverse Event|2|||
155189936|NCT03633617|560135606|FG004|Part B|Adverse Event|1|||
155189937|NCT03633617|560135607|FG005|Part B|Adverse Event|0|||
155189938|NCT03633617|560135608|FG006|Part B|Adverse Event|0|||
155189939|NCT03633617|560135609|FG007|Part B|Adverse Event|0|||
155189940|NCT03633617|560135610|FG008|Part B|Adverse Event|0|||
155189941|NCT03633617|560135611|FG009|Part B|Adverse Event|0|||
155189942|NCT03633617|560135612|FG010|Part B|Adverse Event|0|||
155189943|NCT03633617|560135602|FG000|Part B|Withdrawal by Subject|0|||
155189944|NCT03633617|560135603|FG001|Part B|Withdrawal by Subject|0|||
155189945|NCT03633617|560135604|FG002|Part B|Withdrawal by Subject|1|||
155189946|NCT03633617|560135605|FG003|Part B|Withdrawal by Subject|0|||
155189947|NCT03633617|560135606|FG004|Part B|Withdrawal by Subject|2|||
155189948|NCT03633617|560135607|FG005|Part B|Withdrawal by Subject|0|||
155189949|NCT03633617|560135608|FG006|Part B|Withdrawal by Subject|0|||
155037589|NCT01764997|559563934|FG003|Run-in Period|Other than specified above|0|||
155189950|NCT03633617|560135609|FG007|Part B|Withdrawal by Subject|0|||
155189951|NCT03633617|560135610|FG008|Part B|Withdrawal by Subject|0|||
155189952|NCT03633617|560135611|FG009|Part B|Withdrawal by Subject|0|||
155189953|NCT03633617|560135612|FG010|Part B|Withdrawal by Subject|0|||
155189954|NCT03633617|560135602|FG000|Part B|Lost to Follow-up|0|||
155189955|NCT03633617|560135603|FG001|Part B|Lost to Follow-up|0|||
155189956|NCT03633617|560135604|FG002|Part B|Lost to Follow-up|0|||
155189957|NCT03633617|560135605|FG003|Part B|Lost to Follow-up|0|||
155189958|NCT03633617|560135606|FG004|Part B|Lost to Follow-up|1|||
155189959|NCT03633617|560135607|FG005|Part B|Lost to Follow-up|0|||
155189960|NCT03633617|560135608|FG006|Part B|Lost to Follow-up|0|||
155189961|NCT03633617|560135609|FG007|Part B|Lost to Follow-up|0|||
155189962|NCT03633617|560135610|FG008|Part B|Lost to Follow-up|0|||
155189963|NCT03633617|560135611|FG009|Part B|Lost to Follow-up|0|||
155189964|NCT03633617|560135612|FG010|Part B|Lost to Follow-up|0|||
155189965|NCT03633617|560135602|FG000|Part B|Physician Decision|0|||
155189966|NCT03633617|560135603|FG001|Part B|Physician Decision|0|||
155189967|NCT03633617|560135604|FG002|Part B|Physician Decision|0|||
155189968|NCT03633617|560135605|FG003|Part B|Physician Decision|0|||
155189969|NCT03633617|560135606|FG004|Part B|Physician Decision|1|||
155189970|NCT03633617|560135607|FG005|Part B|Physician Decision|0|||
155189971|NCT03633617|560135608|FG006|Part B|Physician Decision|0|||
155189972|NCT03633617|560135609|FG007|Part B|Physician Decision|0|||
155189973|NCT03633617|560135610|FG008|Part B|Physician Decision|0|||
155189974|NCT03633617|560135611|FG009|Part B|Physician Decision|0|||
155189975|NCT03633617|560135612|FG010|Part B|Physician Decision|0|||
155189976|NCT03633617|560135602|FG000|Part B|COVID-19 Restrictions|0|||
155189977|NCT03633617|560135603|FG001|Part B|COVID-19 Restrictions|0|||
155189978|NCT03633617|560135604|FG002|Part B|COVID-19 Restrictions|1|||
155189979|NCT03633617|560135605|FG003|Part B|COVID-19 Restrictions|0|||
155189980|NCT03633617|560135606|FG004|Part B|COVID-19 Restrictions|0|||
155189981|NCT03633617|560135607|FG005|Part B|COVID-19 Restrictions|0|||
155189982|NCT03633617|560135608|FG006|Part B|COVID-19 Restrictions|0|||
155189983|NCT03633617|560135609|FG007|Part B|COVID-19 Restrictions|0|||
155189984|NCT03633617|560135610|FG008|Part B|COVID-19 Restrictions|0|||
155189985|NCT03633617|560135611|FG009|Part B|COVID-19 Restrictions|0|||
155189986|NCT03633617|560135612|FG010|Part B|COVID-19 Restrictions|0|||
155189987|NCT03633617|560135602|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189988|NCT03633617|560135603|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189989|NCT03633617|560135604|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
155189990|NCT03633617|560135605|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189991|NCT03633617|560135606|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189992|NCT03633617|560135607|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189993|NCT03633617|560135608|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189994|NCT03633617|560135609|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189995|NCT03633617|560135610|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189996|NCT03633617|560135611|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189997|NCT03633617|560135612|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
155189998|NCT03633617|560135602|FG000|Part C (& Follow-up)|Adverse Event|0|||
155189999|NCT03633617|560135603|FG001|Part C (& Follow-up)|Adverse Event|0|||
155190000|NCT03633617|560135604|FG002|Part C (& Follow-up)|Adverse Event|0|||
155190001|NCT03633617|560135605|FG003|Part C (& Follow-up)|Adverse Event|0|||
155190002|NCT03633617|560135606|FG004|Part C (& Follow-up)|Adverse Event|0|||
155190003|NCT03633617|560135607|FG005|Part C (& Follow-up)|Adverse Event|1|||
155190004|NCT03633617|560135608|FG006|Part C (& Follow-up)|Adverse Event|0|||
155190005|NCT03633617|560135609|FG007|Part C (& Follow-up)|Adverse Event|1|||
155190006|NCT03633617|560135610|FG008|Part C (& Follow-up)|Adverse Event|0|||
155190007|NCT03633617|560135611|FG009|Part C (& Follow-up)|Adverse Event|0|||
155190008|NCT03633617|560135612|FG010|Part C (& Follow-up)|Adverse Event|0|||
155190009|NCT03633617|560135602|FG000|Part C (& Follow-up)|Pregnancy|0|||
155190010|NCT03633617|560135603|FG001|Part C (& Follow-up)|Pregnancy|0|||
155190011|NCT03633617|560135604|FG002|Part C (& Follow-up)|Pregnancy|0|||
155190012|NCT03633617|560135605|FG003|Part C (& Follow-up)|Pregnancy|0|||
155190013|NCT03633617|560135606|FG004|Part C (& Follow-up)|Pregnancy|0|||
155190014|NCT03633617|560135607|FG005|Part C (& Follow-up)|Pregnancy|0|||
155190015|NCT03633617|560135608|FG006|Part C (& Follow-up)|Pregnancy|0|||
155190016|NCT03633617|560135609|FG007|Part C (& Follow-up)|Pregnancy|0|||
155190017|NCT03633617|560135610|FG008|Part C (& Follow-up)|Pregnancy|0|||
155190018|NCT03633617|560135611|FG009|Part C (& Follow-up)|Pregnancy|1|||
155190019|NCT03633617|560135612|FG010|Part C (& Follow-up)|Pregnancy|0|||
155190020|NCT03633617|560135602|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190021|NCT03633617|560135603|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190022|NCT03633617|560135604|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
155037590|NCT01764997|559563935|FG004|Run-in Period|Other than specified above|0|||
155037591|NCT01764997|559563931|FG000|Study Drug Treatment Period|Adverse Event|0|||
155037592|NCT01764997|559563932|FG001|Study Drug Treatment Period|Adverse Event|1|||
155190023|NCT03633617|560135605|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190024|NCT03633617|560135606|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190025|NCT03633617|560135607|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
155190026|NCT03633617|560135608|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
155190027|NCT03633617|560135609|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
155190028|NCT03633617|560135610|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
155190029|NCT03633617|560135611|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
155190030|NCT03633617|560135612|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
155190031|NCT03633617|560135602|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
155190032|NCT03633617|560135603|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
155037593|NCT01764997|559563933|FG002|Study Drug Treatment Period|Adverse Event|0|||
155190033|NCT03633617|560135604|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
155190034|NCT03633617|560135605|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
155190035|NCT03633617|560135606|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
155190036|NCT03633617|560135607|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
155190037|NCT03633617|560135608|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
155190038|NCT03633617|560135609|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
155190039|NCT03633617|560135610|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
155190040|NCT03633617|560135611|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
155190041|NCT03633617|560135612|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
155190042|NCT03633617|560135602|FG000|Part C (& Follow-up)|Physician Decision|0|||
155190043|NCT03633617|560135603|FG001|Part C (& Follow-up)|Physician Decision|0|||
155190044|NCT03633617|560135604|FG002|Part C (& Follow-up)|Physician Decision|0|||
155190045|NCT03633617|560135605|FG003|Part C (& Follow-up)|Physician Decision|0|||
155190046|NCT03633617|560135606|FG004|Part C (& Follow-up)|Physician Decision|0|||
155190047|NCT03633617|560135607|FG005|Part C (& Follow-up)|Physician Decision|0|||
155190048|NCT03633617|560135608|FG006|Part C (& Follow-up)|Physician Decision|0|||
155190049|NCT03633617|560135609|FG007|Part C (& Follow-up)|Physician Decision|1|||
155190050|NCT03633617|560135610|FG008|Part C (& Follow-up)|Physician Decision|0|||
155190051|NCT03633617|560135611|FG009|Part C (& Follow-up)|Physician Decision|0|||
155037594|NCT01764997|559563934|FG003|Study Drug Treatment Period|Adverse Event|0|||
155037595|NCT01764997|559563935|FG004|Study Drug Treatment Period|Adverse Event|24|||
155037596|NCT01764997|559563931|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
155037597|NCT01764997|559563932|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
155037598|NCT01764997|559563933|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
155037599|NCT01764997|559563934|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
155037600|NCT01764997|559563935|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
155037601|NCT01764997|559563931|FG000|Study Drug Treatment Period|Other than specified above|0|||
155037602|NCT01764997|559563932|FG001|Study Drug Treatment Period|Other than specified above|0|||
155037603|NCT01764997|559563933|FG002|Study Drug Treatment Period|Other than specified above|0|||
155037604|NCT01764997|559563934|FG003|Study Drug Treatment Period|Other than specified above|0|||
155037605|NCT01764997|559563935|FG004|Study Drug Treatment Period|Other than specified above|10|||
155037606|NCT03046056|559565689|FG000|Overall Study|Non-responder at Week 10|6|||
155037607|NCT03046056|559565690|FG001|Overall Study|Non-responder at Week 10|6|||
155037608|NCT03046056|559565691|FG002|Overall Study|Non-responder at Week 10|4|||
155037609|NCT03046056|559565689|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
155037610|NCT03046056|559565690|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
155037611|NCT03046056|559565691|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
155037612|NCT03046056|559565689|FG000|Overall Study|Adverse Event|1|||
155037613|NCT03046056|559565690|FG001|Overall Study|Adverse Event|5|||
155037614|NCT03046056|559565691|FG002|Overall Study|Adverse Event|0|||
155037615|NCT03046056|559565689|FG000|Overall Study|Non-compliance With Study Drug|0|||
155037616|NCT03046056|559565690|FG001|Overall Study|Non-compliance With Study Drug|0|||
155037617|NCT03046056|559565691|FG002|Overall Study|Non-compliance With Study Drug|2|||
155037618|NCT03046056|559565689|FG000|Overall Study|Protocol Violation|1|||
155037619|NCT03046056|559565690|FG001|Overall Study|Protocol Violation|1|||
155037620|NCT03046056|559565691|FG002|Overall Study|Protocol Violation|0|||
155037621|NCT03046056|559565689|FG000|Overall Study|Investigator's Discretion|0|||
155037622|NCT03046056|559565690|FG001|Overall Study|Investigator's Discretion|1|||
155037623|NCT03046056|559565691|FG002|Overall Study|Investigator's Discretion|0|||
155037624|NCT03046056|559565689|FG000|Overall Study|Withdrew Consent|1|||
155037625|NCT03046056|559565690|FG001|Overall Study|Withdrew Consent|0|||
155037626|NCT03046056|559565691|FG002|Overall Study|Withdrew Consent|0|||
155037627|NCT02290925|559565694|FG000|First Period of Three Months|Lost to Follow-up|2|||
155037628|NCT02290925|559565695|FG001|First Period of Three Months|Lost to Follow-up|1|||
155037629|NCT02290925|559565694|FG000|First Period of Three Months|Death|1|||
155037630|NCT02290925|559565695|FG001|First Period of Three Months|Death|0|||
155190052|NCT03633617|560135612|FG010|Part C (& Follow-up)|Physician Decision|1|||
155190053|NCT03633617|560135602|FG000|Part C (& Follow-up)|COVID-19 related|0|||
155190054|NCT03633617|560135603|FG001|Part C (& Follow-up)|COVID-19 related|0|||
155037631|NCT02290925|559565694|FG000|First Period of Three Months|Insulin Started|1|||
155190055|NCT03633617|560135604|FG002|Part C (& Follow-up)|COVID-19 related|0|||
155190056|NCT03633617|560135605|FG003|Part C (& Follow-up)|COVID-19 related|0|||
155190057|NCT03633617|560135606|FG004|Part C (& Follow-up)|COVID-19 related|0|||
155190058|NCT03633617|560135607|FG005|Part C (& Follow-up)|COVID-19 related|1|||
155190059|NCT03633617|560135608|FG006|Part C (& Follow-up)|COVID-19 related|0|||
155037632|NCT02290925|559565695|FG001|First Period of Three Months|Insulin Started|1|||
155037633|NCT02290925|559565694|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
155037634|NCT02290925|559565695|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
155037635|NCT02290925|559565694|FG000|Second Period of 3 Months|insulin started|0|||
155190060|NCT03633617|560135609|FG007|Part C (& Follow-up)|COVID-19 related|0|||
155190061|NCT03633617|560135610|FG008|Part C (& Follow-up)|COVID-19 related|0|||
155037636|NCT02290925|559565695|FG001|Second Period of 3 Months|insulin started|1|||
155190062|NCT03633617|560135611|FG009|Part C (& Follow-up)|COVID-19 related|0|||
155190063|NCT03633617|560135612|FG010|Part C (& Follow-up)|COVID-19 related|0|||
155190064|NCT03633617|560135602|FG000|Part C (& Follow-up)|Protocol Violation|0|||
155190065|NCT03633617|560135603|FG001|Part C (& Follow-up)|Protocol Violation|0|||
155037637|NCT02956057|559565702|FG000|Overall Study|Discontinued intervention|14|||
155037638|NCT02956057|559565703|FG001|Overall Study|Discontinued intervention|10|||
155190066|NCT03633617|560135604|FG002|Part C (& Follow-up)|Protocol Violation|0|||
155190067|NCT03633617|560135605|FG003|Part C (& Follow-up)|Protocol Violation|0|||
155190068|NCT03633617|560135606|FG004|Part C (& Follow-up)|Protocol Violation|0|||
155190069|NCT03633617|560135607|FG005|Part C (& Follow-up)|Protocol Violation|0|||
155190070|NCT03633617|560135608|FG006|Part C (& Follow-up)|Protocol Violation|0|||
155190071|NCT03633617|560135609|FG007|Part C (& Follow-up)|Protocol Violation|0|||
155190072|NCT03633617|560135610|FG008|Part C (& Follow-up)|Protocol Violation|0|||
155190073|NCT03633617|560135611|FG009|Part C (& Follow-up)|Protocol Violation|3|||
155190074|NCT03633617|560135612|FG010|Part C (& Follow-up)|Protocol Violation|1|||
155190075|NCT03633617|560135602|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
155190076|NCT03633617|560135603|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
155190077|NCT03633617|560135604|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
155190078|NCT03633617|560135605|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
155190079|NCT03633617|560135606|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
155190080|NCT03633617|560135607|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
155190081|NCT03633617|560135608|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
155190082|NCT03633617|560135609|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
155190083|NCT03633617|560135610|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
155190084|NCT03633617|560135611|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
155190085|NCT03633617|560135612|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
155190086|NCT02477839|560135613|FG000|Overall Study|Adverse Event|0|||
155190087|NCT02477839|560135614|FG001|Overall Study|Adverse Event|1|||
155190088|NCT02477839|560135613|FG000|Overall Study|Protocol Violation|0|||
155190089|NCT02477839|560135614|FG001|Overall Study|Protocol Violation|2|||
155190090|NCT02477839|560135613|FG000|Overall Study|Withdrawal by Subject|3|||
155190091|NCT02477839|560135614|FG001|Overall Study|Withdrawal by Subject|3|||
155190092|NCT02477839|560135613|FG000|Overall Study|Participant had PGS during V6|0|||
155190093|NCT02477839|560135614|FG001|Overall Study|Participant had PGS during V6|1|||
155190094|NCT02477839|560135613|FG000|Overall Study|Parents decided to stop medication|0|||
155190095|NCT02477839|560135614|FG001|Overall Study|Parents decided to stop medication|1|||
155190096|NCT02477839|560135613|FG000|Overall Study|Lack of tolerability|0|||
155190097|NCT02477839|560135614|FG001|Overall Study|Lack of tolerability|1|||
155190098|NCT02477839|560135613|FG000|Overall Study|Exclusion criterion|0|||
155190099|NCT02477839|560135614|FG001|Overall Study|Exclusion criterion|1|||
155190100|NCT01578330|560135615|FG000|Overall Study|Adverse Event|2|||
155190101|NCT01578330|560135615|FG000|Overall Study|Protocol Violation|5|||
155190102|NCT01050543|560135616|FG000|Overall Study|Withdrawal by Subject|0|||
155190103|NCT01050543|560135617|FG001|Overall Study|Withdrawal by Subject|2|||
155190104|NCT01050543|560135616|FG000|Overall Study|Protocol Violation|0|||
155190105|NCT01050543|560135617|FG001|Overall Study|Protocol Violation|1|||
155190106|NCT01050543|560135616|FG000|Overall Study|Administrative|4|||
155190107|NCT01050543|560135617|FG001|Overall Study|Administrative|1|||
155190108|NCT03053271|560135618|FG000|Overall Study|Did not meet randomization criteria|3|||
155190109|NCT03053271|560135618|FG000|Overall Study|Withdrawal by Subject|1|||
155190110|NCT00580970|560135619|FG000|Pre-treatment|Non-compliance|1|||
155190111|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Non-compliance|6|||
155190112|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
155190113|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Physician Decision|4|||
155190114|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
155190115|NCT00580970|560135619|FG000|Treatment (Lovastatin)|Death|1|||
155190116|NCT00570765|560135622|FG000|DB Phase|Withdrawal by Subject|1|||
155190117|NCT00570765|560135623|FG001|DB Phase|Withdrawal by Subject|0|||
155190118|NCT00570765|560135624|FG002|DB Phase|Withdrawal by Subject|0|||
155190119|NCT00570765|560135625|FG003|DB Phase|Withdrawal by Subject|0|||
155190120|NCT00570765|560135622|FG000|DB Phase|Protocol Violation|0|||
155190121|NCT00570765|560135623|FG001|DB Phase|Protocol Violation|1|||
155190122|NCT00570765|560135624|FG002|DB Phase|Protocol Violation|0|||
155190123|NCT00570765|560135625|FG003|DB Phase|Protocol Violation|0|||
155190124|NCT00570765|560135622|FG000|DB Phase|Adverse Event|3|||
155190125|NCT00570765|560135623|FG001|DB Phase|Adverse Event|6|||
155190126|NCT00570765|560135624|FG002|DB Phase|Adverse Event|0|||
155190127|NCT00570765|560135625|FG003|DB Phase|Adverse Event|0|||
155190128|NCT00570765|560135622|FG000|DB Phase|Did Not Receive Study Drug|0|||
155190129|NCT00570765|560135623|FG001|DB Phase|Did Not Receive Study Drug|0|||
155190130|NCT00570765|560135624|FG002|DB Phase|Did Not Receive Study Drug|1|||
155190131|NCT00570765|560135625|FG003|DB Phase|Did Not Receive Study Drug|0|||
155190132|NCT00570765|560135622|FG000|LTSE Phase|Withdrawal by Subject|0|||
155190133|NCT00570765|560135623|FG001|LTSE Phase|Withdrawal by Subject|0|||
155190134|NCT00570765|560135624|FG002|LTSE Phase|Withdrawal by Subject|0|||
155190135|NCT00570765|560135625|FG003|LTSE Phase|Withdrawal by Subject|1|||
155190136|NCT00570765|560135622|FG000|LTSE Phase|Adverse Event|0|||
155190137|NCT00570765|560135623|FG001|LTSE Phase|Adverse Event|0|||
155190138|NCT00570765|560135624|FG002|LTSE Phase|Adverse Event|0|||
155190139|NCT00570765|560135625|FG003|LTSE Phase|Adverse Event|7|||
155190140|NCT00570765|560135622|FG000|LTSE Phase|Physician Decision|0|||
155190141|NCT00570765|560135623|FG001|LTSE Phase|Physician Decision|0|||
155190142|NCT00570765|560135624|FG002|LTSE Phase|Physician Decision|0|||
155190143|NCT00570765|560135625|FG003|LTSE Phase|Physician Decision|4|||
155190144|NCT01669928|560135626|FG000|First Intervention|Withdrawal by Subject|3|||
155190145|NCT01669928|560135627|FG001|First Intervention|Withdrawal by Subject|5|||
155190146|NCT00057876|560135630|FG000|Overall Study|Adverse Event|8|||
155190147|NCT00057876|560135631|FG001|Overall Study|Adverse Event|8|||
155190148|NCT00057876|560135630|FG000|Overall Study|Death|2|||
155190149|NCT00057876|560135631|FG001|Overall Study|Death|1|||
155190150|NCT00057876|560135630|FG000|Overall Study|Withdrawal by Subject|5|||
155190151|NCT00057876|560135631|FG001|Overall Study|Withdrawal by Subject|6|||
155190152|NCT00057876|560135630|FG000|Overall Study|Lack of Efficacy|10|||
155190153|NCT00057876|560135631|FG001|Overall Study|Lack of Efficacy|8|||
155190154|NCT00057876|560135630|FG000|Overall Study|Ineligible|1|||
155190155|NCT00057876|560135631|FG001|Overall Study|Ineligible|2|||
155190156|NCT00057876|560135630|FG000|Overall Study|other reason|2|||
155190157|NCT00057876|560135631|FG001|Overall Study|other reason|2|||
155190158|NCT00057876|560135630|FG000|Overall Study|other complicating disease|1|||
155190159|NCT00057876|560135631|FG001|Overall Study|other complicating disease|0|||
155190160|NCT02758171|560135632|FG000|Wash-out|Withdrawal by Subject|1|||
155190161|NCT02758171|560135633|FG001|Wash-out|Withdrawal by Subject|0|||
155190162|NCT02758171|560135632|FG000|Wash-out|Other reason|1|||
155190163|NCT02758171|560135633|FG001|Wash-out|Other reason|0|||
155190164|NCT05085730|560135639|FG000|Overall Study|Withdrawal by Subject|4|||
155190165|NCT05085730|560135639|FG000|Overall Study|Physician Decision|1|||
155190166|NCT05447897|560135640|FG000|Overall Study|Did not participate in survey|2|||
155190167|NCT04010539|560135641|FG000|Overall Study|Withdrawal by Subject|4|||
155190168|NCT04010539|560135642|FG001|Overall Study|Withdrawal by Subject|1|||
155190169|NCT04010539|560135641|FG000|Overall Study|Physician Decision|0|||
155190170|NCT04010539|560135642|FG001|Overall Study|Physician Decision|2|||
155190171|NCT04010539|560135641|FG000|Overall Study|Lost to Follow-up|10|||
155190172|NCT04010539|560135642|FG001|Overall Study|Lost to Follow-up|14|||
155190173|NCT04010539|560135641|FG000|Overall Study|Adverse Event|3|||
155190174|NCT04010539|560135642|FG001|Overall Study|Adverse Event|0|||
155190175|NCT04010539|560135641|FG000|Overall Study|Participant Did Not Receive IP|0|||
155190176|NCT04010539|560135642|FG001|Overall Study|Participant Did Not Receive IP|1|||
155190177|NCT04010539|560135641|FG000|Overall Study|Protocol Deviation|0|||
155190178|NCT04010539|560135642|FG001|Overall Study|Protocol Deviation|1|||
155190179|NCT04010539|560135641|FG000|Overall Study|Randomized in Error/ Mistake|2|||
155190180|NCT04010539|560135642|FG001|Overall Study|Randomized in Error/ Mistake|0|||
155190181|NCT04010539|560135641|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
155190182|NCT04010539|560135642|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
155190183|NCT02038452|560135643|FG000|Overall Study|Withdrawal by Subject|7|||
155190184|NCT02038452|560135644|FG001|Overall Study|Withdrawal by Subject|9|||
155190185|NCT02038452|560135643|FG000|Overall Study|Lost to Follow-up|31|||
155037639|NCT02956057|559565704|FG002|Overall Study|Discontinued intervention|7|||
155037640|NCT02956057|559565705|FG003|Overall Study|Discontinued intervention|14|||
155037641|NCT02956057|559565706|FG004|Overall Study|Discontinued intervention|4|||
155037642|NCT02956057|559565707|FG005|Overall Study|Discontinued intervention|17|||
155037643|NCT02956057|559565702|FG000|Overall Study|Lost to Follow-up|0|||
155037644|NCT02956057|559565703|FG001|Overall Study|Lost to Follow-up|2|||
155037645|NCT02956057|559565704|FG002|Overall Study|Lost to Follow-up|1|||
155037646|NCT02956057|559565705|FG003|Overall Study|Lost to Follow-up|1|||
155037647|NCT02956057|559565706|FG004|Overall Study|Lost to Follow-up|1|||
155037648|NCT02956057|559565707|FG005|Overall Study|Lost to Follow-up|0|||
155037649|NCT01420679|559565710|FG000|Overall Study|Disease Progression|3|||
155037650|NCT01420679|559565711|FG001|Overall Study|Disease Progression|2|||
155037651|NCT01420679|559565710|FG000|Overall Study|Adverse Event|4|||
155190186|NCT02038452|560135644|FG001|Overall Study|Lost to Follow-up|28|||
155190187|NCT03139279|560135645|FG000|Overall Study|Physician Decision|2|||
155190188|NCT03139279|560135646|FG001|Overall Study|Physician Decision|0|||
155190189|NCT03139279|560135645|FG000|Overall Study|Protocol Violation|5|||
155190190|NCT03139279|560135646|FG001|Overall Study|Protocol Violation|4|||
155190191|NCT03139279|560135645|FG000|Overall Study|Withdrawal by Subject|0|||
155190192|NCT03139279|560135646|FG001|Overall Study|Withdrawal by Subject|2|||
155190193|NCT01565642|560135649|FG000|Overall Study|Withdrawal by Subject|2|||
155037652|NCT01420679|559565711|FG001|Overall Study|Adverse Event|0|||
155037653|NCT01420679|559565710|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
155190194|NCT01565642|560135650|FG001|Overall Study|Withdrawal by Subject|1|||
155190195|NCT01934972|560135651|FG000|Overall Study|Withdrawal by Subject|9|||
155190196|NCT01934972|560135652|FG001|Overall Study|Withdrawal by Subject|6|||
155190197|NCT01278160|560135653|FG000|Overall Study|Adverse Event|1|||
155190198|NCT01278160|560135654|FG001|Overall Study|Adverse Event|1|||
155190199|NCT01278160|560135653|FG000|Overall Study|Lost to Follow-up|0|||
155190200|NCT01278160|560135654|FG001|Overall Study|Lost to Follow-up|1|||
155190201|NCT01278160|560135653|FG000|Overall Study|Withdrawal by Subject|3|||
155190202|NCT01278160|560135654|FG001|Overall Study|Withdrawal by Subject|2|||
155190203|NCT01278160|560135653|FG000|Overall Study|Unclassified|1|||
155190204|NCT01278160|560135654|FG001|Overall Study|Unclassified|2|||
155190205|NCT00304239|560135656|FG000|Overall Study|Protocol Deviations/Violations|15|||
155190206|NCT00304239|560135657|FG001|Overall Study|Protocol Deviations/Violations|0|||
155190207|NCT00304239|560135656|FG000|Overall Study|Adverse Event|2|||
155190208|NCT00304239|560135657|FG001|Overall Study|Adverse Event|0|||
155190209|NCT01631812|560135658|FG000|Overall Study|Adverse Event|25|||
155190210|NCT01631812|560135658|FG000|Overall Study|Lack of Efficacy|5|||
155190211|NCT01631812|560135658|FG000|Overall Study|Withdrawal by Subject|4|||
155190212|NCT01631812|560135658|FG000|Overall Study|Physician Decision|3|||
155190213|NCT02718300|560135661|FG000|Overall Study|Death|4|||
155190214|NCT02718300|560135662|FG001|Overall Study|Death|5|||
155190215|NCT02718300|560135663|FG002|Overall Study|Death|17|||
155190216|NCT02718300|560135661|FG000|Overall Study|Lost to Follow-up|1|||
155190217|NCT02718300|560135662|FG001|Overall Study|Lost to Follow-up|0|||
155190218|NCT02718300|560135663|FG002|Overall Study|Lost to Follow-up|2|||
155190219|NCT02718300|560135661|FG000|Overall Study|Physician Decision|1|||
155190220|NCT02718300|560135662|FG001|Overall Study|Physician Decision|0|||
155190221|NCT02718300|560135663|FG002|Overall Study|Physician Decision|2|||
155190222|NCT02718300|560135661|FG000|Overall Study|Study Terminated by Sponsor|6|||
155190223|NCT02718300|560135662|FG001|Overall Study|Study Terminated by Sponsor|3|||
155190224|NCT02718300|560135663|FG002|Overall Study|Study Terminated by Sponsor|4|||
155190225|NCT02718300|560135661|FG000|Overall Study|Withdrawal by Subject|0|||
155190226|NCT02718300|560135662|FG001|Overall Study|Withdrawal by Subject|4|||
155190227|NCT02718300|560135663|FG002|Overall Study|Withdrawal by Subject|3|||
155037654|NCT01420679|559565711|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
155037655|NCT01420679|559565710|FG000|Overall Study|Patient Decision|1|||
155037656|NCT01420679|559565711|FG001|Overall Study|Patient Decision|0|||
155037657|NCT01420679|559565710|FG000|Overall Study|Investigator Decision|1|||
155037658|NCT01420679|559565711|FG001|Overall Study|Investigator Decision|2|||
155037659|NCT01420679|559565710|FG000|Overall Study|Sponsor Decision|3|||
155037660|NCT01420679|559565711|FG001|Overall Study|Sponsor Decision|3|||
155190228|NCT02718300|560135661|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
155190229|NCT02718300|560135662|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
155190230|NCT02718300|560135663|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
155190231|NCT01858376|560137195|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
155190232|NCT03894046|560137199|FG000|Overall Study|Protocol Violation|1|||
155190233|NCT03894046|560137200|FG001|Overall Study|Protocol Violation|0|||
155190234|NCT03894046|560137201|FG002|Overall Study|Protocol Violation|0|||
155190235|NCT03894046|560137199|FG000|Overall Study|Adverse Event|0|||
155190236|NCT03894046|560137200|FG001|Overall Study|Adverse Event|1|||
155190237|NCT03894046|560137201|FG002|Overall Study|Adverse Event|0|||
155190238|NCT03894046|560137199|FG000|Overall Study|Withdrawal by Subject|2|||
155190239|NCT03894046|560137200|FG001|Overall Study|Withdrawal by Subject|3|||
155190240|NCT03894046|560137201|FG002|Overall Study|Withdrawal by Subject|1|||
155190241|NCT03894046|560137199|FG000|Overall Study|Death|15|||
155190242|NCT03894046|560137200|FG001|Overall Study|Death|21|||
155190243|NCT03894046|560137201|FG002|Overall Study|Death|4|||
155190244|NCT03894046|560137199|FG000|Overall Study|No growth of ABC|2|||
155190245|NCT03894046|560137200|FG001|Overall Study|No growth of ABC|1|||
155190246|NCT03894046|560137201|FG002|Overall Study|No growth of ABC|0|||
155190247|NCT03894046|560137199|FG000|Overall Study|Physician Decision|1|||
155190248|NCT03894046|560137200|FG001|Overall Study|Physician Decision|1|||
155190249|NCT03894046|560137201|FG002|Overall Study|Physician Decision|1|||
155190250|NCT03894046|560137199|FG000|Overall Study|Prohibited concomitant medication|1|||
155190251|NCT03894046|560137200|FG001|Overall Study|Prohibited concomitant medication|0|||
155190252|NCT03894046|560137201|FG002|Overall Study|Prohibited concomitant medication|0|||
155190253|NCT03894046|560137199|FG000|Overall Study|Transferred to other arm/group|1|||
155190254|NCT03894046|560137200|FG001|Overall Study|Transferred to other arm/group|1|||
155190255|NCT03894046|560137201|FG002|Overall Study|Transferred to other arm/group|0|||
155190256|NCT02202837|560137207|FG000|Overall Study|Enbrel treatment discontinued|36|||
155190257|NCT02202837|560137208|FG001|Overall Study|Enbrel treatment discontinued|4|||
155190258|NCT02202837|560137207|FG000|Overall Study|Other|10|||
155190259|NCT02202837|560137208|FG001|Overall Study|Other|0|||
155190260|NCT02202837|560137207|FG000|Overall Study|Lost to Follow-up|7|||
155190261|NCT02202837|560137208|FG001|Overall Study|Lost to Follow-up|1|||
155037661|NCT01420679|559565710|FG000|Overall Study|Other|1|||
155037662|NCT01420679|559565711|FG001|Overall Study|Other|0|||
155190262|NCT01890746|560137213|FG000|Overall Study|Death|39|||
155190263|NCT01890746|560137214|FG001|Overall Study|Death|30|||
155190264|NCT01890746|560137213|FG000|Overall Study|Adverse Event|1|||
155190265|NCT01890746|560137214|FG001|Overall Study|Adverse Event|0|||
155190266|NCT01890746|560137213|FG000|Overall Study|Lost to Follow-up|4|||
155190267|NCT01890746|560137214|FG001|Overall Study|Lost to Follow-up|1|||
155190268|NCT01890746|560137213|FG000|Overall Study|Physician Decision|3|||
155190269|NCT01890746|560137214|FG001|Overall Study|Physician Decision|2|||
155190270|NCT01890746|560137213|FG000|Overall Study|Withdrawal by Subject|5|||
155190271|NCT01890746|560137214|FG001|Overall Study|Withdrawal by Subject|8|||
155190272|NCT03257371|560137217|FG000|Overall Study|Lost to Follow-up|1|||
155190273|NCT01031706|560137219|FG000|Overall Study|Adverse Event|1|||
155190274|NCT01031706|560137220|FG001|Overall Study|Adverse Event|0|||
155190275|NCT01031706|560137219|FG000|Overall Study|Withdrawal by Subject|1|||
155190276|NCT01031706|560137220|FG001|Overall Study|Withdrawal by Subject|1|||
155190277|NCT02124161|560137221|FG000|Overall Study|Other unspecified|0|||
155190278|NCT02124161|560137222|FG001|Overall Study|Other unspecified|1|||
155190279|NCT02124161|560137221|FG000|Overall Study|Death|1|||
155190280|NCT02124161|560137222|FG001|Overall Study|Death|0|||
155190281|NCT02124161|560137221|FG000|Overall Study|Protocol Violation|2|||
155190282|NCT02124161|560137222|FG001|Overall Study|Protocol Violation|1|||
155190283|NCT02124161|560137221|FG000|Overall Study|Withdrawal by Subject|1|||
155190284|NCT02124161|560137222|FG001|Overall Study|Withdrawal by Subject|2|||
155190285|NCT02124161|560137221|FG000|Overall Study|Adverse Event|2|||
155190286|NCT02124161|560137222|FG001|Overall Study|Adverse Event|0|||
155190287|NCT02124161|560137221|FG000|Overall Study|Does not meet entrance criteria|2|||
155190288|NCT02124161|560137222|FG001|Overall Study|Does not meet entrance criteria|3|||
155190289|NCT02124161|560137221|FG000|Overall Study|No longer meets eligibility criteria|5|||
155190290|NCT02124161|560137222|FG001|Overall Study|No longer meets eligibility criteria|4|||
155190291|NCT02124161|560137221|FG000|Overall Study|Lost to Follow-up|3|||
155190292|NCT02124161|560137222|FG001|Overall Study|Lost to Follow-up|4|||
155190293|NCT02517866|560137223|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155190294|NCT02517866|560137224|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155190295|NCT02517866|560137225|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155190296|NCT02517866|560137223|FG000|Overall Study|Significant Protocol Deviation|4|||
155190297|NCT02517866|560137224|FG001|Overall Study|Significant Protocol Deviation|1|||
155190298|NCT02517866|560137225|FG002|Overall Study|Significant Protocol Deviation|0|||
155190299|NCT02517866|560137223|FG000|Overall Study|Lost to Follow-up|1|||
155190300|NCT02517866|560137224|FG001|Overall Study|Lost to Follow-up|0|||
155190301|NCT02517866|560137225|FG002|Overall Study|Lost to Follow-up|0|||
155190302|NCT02517866|560137223|FG000|Overall Study|Voluntary Withdrawal|2|||
155190303|NCT02517866|560137224|FG001|Overall Study|Voluntary Withdrawal|2|||
155190304|NCT02517866|560137225|FG002|Overall Study|Voluntary Withdrawal|0|||
155190305|NCT02517866|560137223|FG000|Overall Study|Investigator Decision|2|||
155190306|NCT02517866|560137224|FG001|Overall Study|Investigator Decision|1|||
155190307|NCT02517866|560137225|FG002|Overall Study|Investigator Decision|0|||
155190308|NCT02517866|560137223|FG000|Overall Study|Reason not specified|2|||
155190309|NCT02517866|560137224|FG001|Overall Study|Reason not specified|0|||
155190310|NCT02517866|560137225|FG002|Overall Study|Reason not specified|0|||
155190311|NCT03114488|560137226|FG000|Time Period 2|Withdrawal by Subject|1|||
155190312|NCT03114488|560137227|FG001|Time Period 2|Withdrawal by Subject|3|||
155190313|NCT03711266|560137229|FG000|Overall Study|Lost to Follow-up|10|||
155190314|NCT03387683|560137230|FG000|Overall Study|In receipt of disallowed medication|1|||
155190315|NCT03387683|560137231|FG001|Overall Study|In receipt of disallowed medication|0|||
155190316|NCT03387683|560137230|FG000|Overall Study|Did not receive treatment|1|||
155190317|NCT03387683|560137231|FG001|Overall Study|Did not receive treatment|0|||
155190318|NCT01646073|560137232|FG000|Period A (12 Weeks)|Adverse Event|0|||
155190319|NCT01646073|560137233|FG001|Period A (12 Weeks)|Adverse Event|2|||
155190320|NCT01646073|560137232|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
155190321|NCT01646073|560137233|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
155190322|NCT01646073|560137232|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
155190323|NCT01646073|560137233|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
155190324|NCT01646073|560137232|FG000|Period A (12 Weeks)|Protocol Violation|0|||
155190325|NCT01646073|560137233|FG001|Period A (12 Weeks)|Protocol Violation|1|||
155190326|NCT01646073|560137232|FG000|Period A (12 Weeks)|Other|0|||
155190327|NCT01646073|560137233|FG001|Period A (12 Weeks)|Other|1|||
155190328|NCT01646073|560137232|FG000|Period B (12 Weeks)|Adverse Event|0|||
155190329|NCT01646073|560137233|FG001|Period B (12 Weeks)|Adverse Event|7|||
155190330|NCT01646073|560137232|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
155190331|NCT01646073|560137233|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
155190332|NCT01646073|560137232|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
155190333|NCT01646073|560137233|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
155190334|NCT01393301|560137236|FG000|Overall Study|Lost to Follow-up|5|||
155190335|NCT01393301|560137237|FG001|Overall Study|Lost to Follow-up|3|||
155190336|NCT01393301|560137236|FG000|Overall Study|Withdrawal by Subject|2|||
155190337|NCT01393301|560137237|FG001|Overall Study|Withdrawal by Subject|0|||
155190338|NCT01393301|560137236|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
155190339|NCT01393301|560137237|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
155190340|NCT00853073|560137238|FG000|Overall Study|Withdrawal by Subject|3|||
155190341|NCT00853073|560137239|FG001|Overall Study|Withdrawal by Subject|2|||
155190342|NCT01999114|560137240|FG000|Overall Study|Adverse Event|8|||
155190343|NCT01999114|560137241|FG001|Overall Study|Adverse Event|7|||
155190344|NCT01999114|560137242|FG002|Overall Study|Adverse Event|2|||
155190345|NCT01999114|560137243|FG003|Overall Study|Adverse Event|2|||
155190346|NCT01999114|560137244|FG004|Overall Study|Adverse Event|1|||
155190347|NCT01999114|560137240|FG000|Overall Study|Withdrawal by Subject|0|||
155190348|NCT01999114|560137241|FG001|Overall Study|Withdrawal by Subject|0|||
155190349|NCT01999114|560137242|FG002|Overall Study|Withdrawal by Subject|1|||
155190350|NCT01999114|560137243|FG003|Overall Study|Withdrawal by Subject|0|||
155190351|NCT01999114|560137244|FG004|Overall Study|Withdrawal by Subject|1|||
155190352|NCT01999114|560137240|FG000|Overall Study|Lost to Follow-up|0|||
155190353|NCT01999114|560137241|FG001|Overall Study|Lost to Follow-up|0|||
155190354|NCT01999114|560137242|FG002|Overall Study|Lost to Follow-up|1|||
155190355|NCT01999114|560137243|FG003|Overall Study|Lost to Follow-up|0|||
155190356|NCT01999114|560137244|FG004|Overall Study|Lost to Follow-up|0|||
155190357|NCT01999114|560137240|FG000|Overall Study|Administrative|0|||
155190358|NCT01999114|560137241|FG001|Overall Study|Administrative|0|||
155190359|NCT01999114|560137242|FG002|Overall Study|Administrative|1|||
155190360|NCT01999114|560137243|FG003|Overall Study|Administrative|1|||
155190361|NCT01999114|560137244|FG004|Overall Study|Administrative|2|||
155190362|NCT03342963|560137245|FG000|Overall Study|Adverse Event|1|||
155190363|NCT03342963|560137246|FG001|Overall Study|Adverse Event|2|||
155190364|NCT03342963|560137247|FG002|Overall Study|Adverse Event|0|||
155190365|NCT03342963|560137248|FG003|Overall Study|Adverse Event|0|||
155190366|NCT03342963|560137245|FG000|Overall Study|Withdrawal by Subject|1|||
155190367|NCT03342963|560137246|FG001|Overall Study|Withdrawal by Subject|0|||
155190368|NCT03342963|560137247|FG002|Overall Study|Withdrawal by Subject|0|||
155190369|NCT03342963|560137248|FG003|Overall Study|Withdrawal by Subject|0|||
155190370|NCT01008150|560137249|FG000|Overall Study|did not receive study drug|1|||
155190371|NCT01008150|560137250|FG001|Overall Study|did not receive study drug|1|||
155190372|NCT01008150|560137251|FG002|Overall Study|did not receive study drug|1|||
155190373|NCT01008150|560137252|FG003|Overall Study|did not receive study drug|0|||
155190374|NCT01309165|560137253|FG000|Overall Study|Lost to Follow-up|4|||
155190375|NCT01309165|560137254|FG001|Overall Study|Lost to Follow-up|3|||
155190376|NCT01309165|560137253|FG000|Overall Study|Return to work|1|||
155190377|NCT01309165|560137254|FG001|Overall Study|Return to work|2|||
155190378|NCT01309165|560137253|FG000|Overall Study|Left country|0|||
155190379|NCT01309165|560137254|FG001|Overall Study|Left country|1|||
155190380|NCT01309165|560137253|FG000|Overall Study|No transportation|0|||
155190381|NCT01309165|560137254|FG001|Overall Study|No transportation|1|||
155190382|NCT01309165|560137253|FG000|Overall Study|Admitted to hospital for second stroke|1|||
155190383|NCT01309165|560137254|FG001|Overall Study|Admitted to hospital for second stroke|0|||
155190384|NCT01497275|560137255|FG000|Overall Study|Death|1|||
155190385|NCT01497275|560137255|FG000|Overall Study|Adverse Event|1|||
155190386|NCT01950169|560137256|FG000|Overall Study|Withdrawal by Subject|2|||
155190387|NCT01950169|560137257|FG001|Overall Study|Withdrawal by Subject|8|||
155190388|NCT01950169|560137258|FG002|Overall Study|Withdrawal by Subject|1|||
155190389|NCT01950169|560137256|FG000|Overall Study|Death|1|||
155190390|NCT01950169|560137257|FG001|Overall Study|Death|0|||
155190391|NCT01950169|560137258|FG002|Overall Study|Death|0|||
155190392|NCT01938573|560137259|FG000|Overall Study|Lack of Efficacy|1|||
155190393|NCT01938573|560137260|FG001|Overall Study|Lack of Efficacy|0|||
155190394|NCT01938573|560137259|FG000|Overall Study|Operation at other hospital|1|||
155190395|NCT01938573|560137260|FG001|Overall Study|Operation at other hospital|0|||
155190396|NCT01739309|560137265|FG000|Overall Study|Adverse Event|1|||
155190397|NCT01739309|560137265|FG000|Overall Study|Withdrawal by Subject|1|||
155190398|NCT04553679|560137266|FG000|Overall Study|Withdrawal by Subject|2|||
155190399|NCT04553679|560137267|FG001|Overall Study|Withdrawal by Subject|0|||
155190400|NCT04553679|560137266|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
155190401|NCT04553679|560137267|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
155190402|NCT00178633|560137268|FG000|Overall Study|Lost to Follow-up|6|||
155190403|NCT03845543|560137269|FG000|Overall Study|Death|25|||
155190404|NCT03845543|560137269|FG000|Overall Study|Withdrawal by Subject|2|||
155190405|NCT03845543|560137269|FG000|Overall Study|Lost to Follow-up|12|||
155190406|NCT03845543|560137269|FG000|Overall Study|Adverse Event|17|||
155190407|NCT02028871|560137272|FG000|Overall Study|Positive urine drug screen|1|||
155190408|NCT02028871|560137273|FG001|Overall Study|Positive urine drug screen|1|||
155190409|NCT02028871|560137272|FG000|Overall Study|Withdrawal by Subject|1|||
155190410|NCT02028871|560137273|FG001|Overall Study|Withdrawal by Subject|2|||
155190411|NCT02028871|560137272|FG000|Overall Study|IV placement difficulty|1|||
155190412|NCT02028871|560137273|FG001|Overall Study|IV placement difficulty|0|||
155190413|NCT02028871|560137272|FG000|Overall Study|Current Illness|1|||
155037663|NCT00412217|559565712|FG000|Overall Study|Insufficient Data Available|8|||
155037664|NCT00412217|559565713|FG001|Overall Study|Insufficient Data Available|3|||
155037665|NCT00412217|559565712|FG000|Overall Study|Death|5|||
155190414|NCT02028871|560137273|FG001|Overall Study|Current Illness|0|||
155190415|NCT02633501|560137276|FG000|Overall Study|Adverse Event|0|||
155190416|NCT02633501|560137277|FG001|Overall Study|Adverse Event|0|||
155190417|NCT02633501|560137278|FG002|Overall Study|Adverse Event|1|||
155190418|NCT02633501|560137279|FG003|Overall Study|Adverse Event|0|||
155190419|NCT02633501|560137280|FG004|Overall Study|Adverse Event|1|||
155190420|NCT02633501|560137281|FG005|Overall Study|Adverse Event|1|||
155190421|NCT02633501|560137276|FG000|Overall Study|Withdrawal by Subject|2|||
155190422|NCT02633501|560137277|FG001|Overall Study|Withdrawal by Subject|1|||
155190423|NCT02633501|560137278|FG002|Overall Study|Withdrawal by Subject|2|||
155190424|NCT02633501|560137279|FG003|Overall Study|Withdrawal by Subject|2|||
155190425|NCT02633501|560137280|FG004|Overall Study|Withdrawal by Subject|1|||
155190426|NCT02633501|560137281|FG005|Overall Study|Withdrawal by Subject|3|||
155190427|NCT02633501|560137276|FG000|Overall Study|Various other reasons|0|||
155190428|NCT02633501|560137277|FG001|Overall Study|Various other reasons|2|||
155190429|NCT02633501|560137278|FG002|Overall Study|Various other reasons|4|||
155190430|NCT02633501|560137279|FG003|Overall Study|Various other reasons|1|||
155190431|NCT02633501|560137280|FG004|Overall Study|Various other reasons|7|||
155190432|NCT02633501|560137281|FG005|Overall Study|Various other reasons|11|||
155190433|NCT02633501|560137276|FG000|Overall Study|Lost to Follow-up|0|||
155190434|NCT02633501|560137277|FG001|Overall Study|Lost to Follow-up|0|||
155190435|NCT02633501|560137278|FG002|Overall Study|Lost to Follow-up|0|||
155190436|NCT02633501|560137279|FG003|Overall Study|Lost to Follow-up|1|||
155190437|NCT02633501|560137280|FG004|Overall Study|Lost to Follow-up|2|||
155190438|NCT02633501|560137281|FG005|Overall Study|Lost to Follow-up|0|||
155190439|NCT01104155|560137286|FG000|Overall Study|Adverse Event|15|||
155190440|NCT01104155|560137287|FG001|Overall Study|Adverse Event|8|||
155190441|NCT01104155|560137286|FG000|Overall Study|Participant choice|6|||
155190442|NCT01104155|560137287|FG001|Overall Study|Participant choice|5|||
155190443|NCT01104155|560137286|FG000|Overall Study|Withdrawal of consent|1|||
155190444|NCT01104155|560137287|FG001|Overall Study|Withdrawal of consent|1|||
155190445|NCT01104155|560137286|FG000|Overall Study|Other|3|||
155190446|NCT01104155|560137287|FG001|Overall Study|Other|4|||
155190447|NCT01484132|560137293|FG000|Overall Study|Lost to Follow-up|8|||
155190448|NCT01484132|560137293|FG000|Overall Study|Difficulty with time commitment|2|||
155190449|NCT01484132|560137293|FG000|Overall Study|Ineligible|1|||
155190450|NCT01484132|560137293|FG000|Overall Study|No pre-treatment urine sample collected|1|||
155190451|NCT01484132|560137293|FG000|Overall Study|No post-treatment urine sample collected|10|||
155190452|NCT01912963|560137294|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
155190453|NCT01912963|560137295|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
155190454|NCT01912963|560137296|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
155190455|NCT01912963|560137294|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
155190456|NCT01912963|560137295|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
155190457|NCT01912963|560137296|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
155190458|NCT01912963|560137294|FG000|Overall Study|Adverse Event|0|||
155190459|NCT01912963|560137295|FG001|Overall Study|Adverse Event|1|||
155190460|NCT01912963|560137296|FG002|Overall Study|Adverse Event|1|||
155190461|NCT01912963|560137294|FG000|Overall Study|Withdrawal by Subject|0|||
155190462|NCT01912963|560137295|FG001|Overall Study|Withdrawal by Subject|1|||
155190463|NCT01912963|560137296|FG002|Overall Study|Withdrawal by Subject|0|||
155190464|NCT01912963|560137294|FG000|Overall Study|Sought treatment locally|0|||
155190465|NCT01912963|560137295|FG001|Overall Study|Sought treatment locally|1|||
155190466|NCT01912963|560137296|FG002|Overall Study|Sought treatment locally|0|||
155190467|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Adverse Event|10|||
155190468|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Adverse Event|0|||
155190469|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
155190470|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
155190471|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
155190472|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
155190473|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
155190474|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
155190475|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
155190476|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
155190477|NCT02787551|560137298|FG000|Core Period: 26 Weeks|Other than specified|3|||
155190478|NCT02787551|560137299|FG001|Core Period: 26 Weeks|Other than specified|1|||
155190479|NCT02787551|560137298|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
155190480|NCT02787551|560137299|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
155190481|NCT02787551|560137298|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
155190482|NCT02787551|560137299|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
155190483|NCT02787551|560137298|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
155190484|NCT02787551|560137299|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
155190485|NCT01336569|560137300|FG000|Overall Study|Lost to Follow-up|4|||
155037666|NCT00412217|559565713|FG001|Overall Study|Death|4|||
155037667|NCT00412217|559565712|FG000|Overall Study|Disease Progression|2|||
155190486|NCT02963935|560137301|FG000|Overall Study|Adverse Event|12|||
155190487|NCT02963935|560137302|FG001|Overall Study|Adverse Event|6|||
155190488|NCT02963935|560137301|FG000|Overall Study|Protocol Violation|2|||
155190489|NCT02963935|560137302|FG001|Overall Study|Protocol Violation|1|||
155190490|NCT02963935|560137301|FG000|Overall Study|Lack of Efficacy|0|||
155190491|NCT02963935|560137302|FG001|Overall Study|Lack of Efficacy|2|||
155037668|NCT00412217|559565713|FG001|Overall Study|Disease Progression|3|||
155190492|NCT02963935|560137301|FG000|Overall Study|Lost to Follow-up|1|||
155037669|NCT00412217|559565712|FG000|Overall Study|Investigator Decision|1|||
155037670|NCT00412217|559565713|FG001|Overall Study|Investigator Decision|0|||
155190493|NCT02963935|560137302|FG001|Overall Study|Lost to Follow-up|6|||
155190494|NCT02963935|560137301|FG000|Overall Study|Unclassified|13|||
155190495|NCT02963935|560137302|FG001|Overall Study|Unclassified|22|||
155190496|NCT02337738|560137303|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
155190497|NCT02337738|560137304|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
155190498|NCT02337738|560137305|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
155190499|NCT02337738|560137303|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155190500|NCT02337738|560137304|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
155190501|NCT02337738|560137305|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
155190502|NCT02337738|560137303|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
155190503|NCT02337738|560137304|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
155190504|NCT02337738|560137305|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
155190505|NCT02337738|560137303|FG000|Overall Study|Voluntary Withdrawal|10|||
155037671|NCT00412217|559565712|FG000|Overall Study|Withdrawal by Subject|2|||
155037672|NCT00412217|559565713|FG001|Overall Study|Withdrawal by Subject|0|||
155037673|NCT00412217|559565712|FG000|Overall Study|Lost to Follow-up|1|||
155037674|NCT00412217|559565713|FG001|Overall Study|Lost to Follow-up|4|||
155037675|NCT00412217|559565712|FG000|Overall Study|Study Terminated by Sponsor|26|||
155037676|NCT00412217|559565713|FG001|Overall Study|Study Terminated by Sponsor|33|||
155037677|NCT00412217|559565712|FG000|Overall Study|Other|1|||
155037678|NCT00412217|559565713|FG001|Overall Study|Other|1|||
155037679|NCT01069419|559565714|FG000|Overall Study|Adverse Event|233|||
155037680|NCT01069419|559565714|FG000|Overall Study|Lack of Efficacy|332|||
155037681|NCT01069419|559565714|FG000|Overall Study|Lost to Follow-up|49|||
155037682|NCT01069419|559565714|FG000|Overall Study|Remission of disease|11|||
155037683|NCT01069419|559565714|FG000|Overall Study|Withdrawal by Subject|34|||
155037684|NCT01069419|559565714|FG000|Overall Study|Other Reason|43|||
155037685|NCT01069419|559565714|FG000|Overall Study|Missing termination information|13|||
155037686|NCT03114657|559565717|FG000|Overall Study|Adverse Event|9|||
155037687|NCT03114657|559565718|FG001|Overall Study|Adverse Event|6|||
155037688|NCT03114657|559565717|FG000|Overall Study|Death|4|||
155037689|NCT03114657|559565718|FG001|Overall Study|Death|0|||
155037690|NCT03114657|559565717|FG000|Overall Study|Multiple Reasons|1|||
155037691|NCT03114657|559565718|FG001|Overall Study|Multiple Reasons|2|||
155037692|NCT03114657|559565717|FG000|Overall Study|Physician Decision|2|||
155037693|NCT03114657|559565718|FG001|Overall Study|Physician Decision|2|||
155037694|NCT03114657|559565717|FG000|Overall Study|Study Terminated By Sponsor|355|||
155037695|NCT03114657|559565718|FG001|Overall Study|Study Terminated By Sponsor|374|||
155037696|NCT03114657|559565717|FG000|Overall Study|Symptomatic Deterioration|0|||
155037697|NCT03114657|559565718|FG001|Overall Study|Symptomatic Deterioration|1|||
155037698|NCT03114657|559565717|FG000|Overall Study|Withdrawal by Subject|28|||
155037699|NCT03114657|559565718|FG001|Overall Study|Withdrawal by Subject|22|||
155037700|NCT00115037|559565719|FG000|Phase1|Lost to Follow-up|16|||
155037701|NCT00115037|559565720|FG001|Phase1|Lost to Follow-up|23|||
155037702|NCT00115037|559565721|FG002|Phase1|Lost to Follow-up|0|||
155037703|NCT00115037|559565722|FG003|Phase1|Lost to Follow-up|0|||
155037704|NCT00115037|559565723|FG004|Phase1|Lost to Follow-up|0|||
155037705|NCT00115037|559565724|FG005|Phase1|Lost to Follow-up|0|||
155037706|NCT00115037|559565719|FG000|Phase1|Withdrawal by Subject|9|||
155037707|NCT00115037|559565720|FG001|Phase1|Withdrawal by Subject|4|||
155037708|NCT00115037|559565721|FG002|Phase1|Withdrawal by Subject|0|||
155190506|NCT02337738|560137304|FG001|Overall Study|Voluntary Withdrawal|5|||
155190507|NCT02337738|560137305|FG002|Overall Study|Voluntary Withdrawal|2|||
155190508|NCT02337738|560137303|FG000|Overall Study|Lack of Efficacy|2|||
155190509|NCT02337738|560137304|FG001|Overall Study|Lack of Efficacy|4|||
155037709|NCT00115037|559565722|FG003|Phase1|Withdrawal by Subject|0|||
155037710|NCT00115037|559565723|FG004|Phase1|Withdrawal by Subject|0|||
155037711|NCT00115037|559565724|FG005|Phase1|Withdrawal by Subject|0|||
155037712|NCT00115037|559565719|FG000|Phase2|Death|0|||
155037713|NCT00115037|559565720|FG001|Phase2|Death|0|||
155037714|NCT00115037|559565721|FG002|Phase2|Death|1|||
155037715|NCT00115037|559565722|FG003|Phase2|Death|0|||
155037716|NCT00115037|559565723|FG004|Phase2|Death|0|||
155037717|NCT00115037|559565724|FG005|Phase2|Death|1|||
155037718|NCT00115037|559565719|FG000|Phase2|Withdrawal by Subject|0|||
155037719|NCT00115037|559565720|FG001|Phase2|Withdrawal by Subject|0|||
155037720|NCT00115037|559565721|FG002|Phase2|Withdrawal by Subject|2|||
155190510|NCT02337738|560137305|FG002|Overall Study|Lack of Efficacy|0|||
155190511|NCT02337738|560137303|FG000|Overall Study|Investigator's Judgment|1|||
155037721|NCT00115037|559565722|FG003|Phase2|Withdrawal by Subject|1|||
155037722|NCT00115037|559565723|FG004|Phase2|Withdrawal by Subject|2|||
155037723|NCT00115037|559565724|FG005|Phase2|Withdrawal by Subject|1|||
155037724|NCT00115037|559565719|FG000|Phase2|Lost to Follow-up|0|||
155037725|NCT00115037|559565720|FG001|Phase2|Lost to Follow-up|0|||
155037726|NCT00115037|559565721|FG002|Phase2|Lost to Follow-up|12|||
155037727|NCT00115037|559565722|FG003|Phase2|Lost to Follow-up|14|||
155037728|NCT00115037|559565723|FG004|Phase2|Lost to Follow-up|4|||
155037729|NCT00115037|559565724|FG005|Phase2|Lost to Follow-up|10|||
155037730|NCT01179737|559565725|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
155037731|NCT01179737|559565726|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
155037732|NCT01179737|559565727|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
155190512|NCT02337738|560137304|FG001|Overall Study|Investigator's Judgment|1|||
155190513|NCT02337738|560137305|FG002|Overall Study|Investigator's Judgment|3|||
155190514|NCT03911154|560137306|FG000|Overall Study|Withdrawal by Subject|1|||
155190515|NCT00406354|560137307|FG000|All Randomized Patients|Protocol Violation|0|||
155190516|NCT00406354|560137308|FG001|All Randomized Patients|Protocol Violation|0|||
155190517|NCT00406354|560137309|FG002|All Randomized Patients|Protocol Violation|1|||
155190518|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
155190519|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
155190520|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
155190521|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Adverse Event|6|||
155190522|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Adverse Event|2|||
155190523|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Adverse Event|1|||
155190524|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
155190525|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
155190526|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
155190527|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
155190528|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
155190529|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
155190530|NCT00406354|560137307|FG000|All Randomized and Treated Patients|Physician Decision|0|||
155190531|NCT00406354|560137308|FG001|All Randomized and Treated Patients|Physician Decision|0|||
155190532|NCT00406354|560137309|FG002|All Randomized and Treated Patients|Physician Decision|1|||
155190533|NCT00292318|560137314|FG000|Overall Study|Study terminated by officials|2|||
155190534|NCT00292318|560137315|FG001|Overall Study|Study terminated by officials|1|||
155190535|NCT01822496|560137316|FG000|Overall Study|Protocol Violation|2|||
155190536|NCT01822496|560137317|FG001|Overall Study|Protocol Violation|2|||
155190537|NCT01822496|560137318|FG002|Overall Study|Protocol Violation|0|||
155190538|NCT01822496|560137319|FG003|Overall Study|Protocol Violation|1|||
155190539|NCT01822496|560137316|FG000|Overall Study|Withdrawal by Subject|0|||
155190540|NCT01822496|560137317|FG001|Overall Study|Withdrawal by Subject|0|||
155190541|NCT01822496|560137318|FG002|Overall Study|Withdrawal by Subject|0|||
155190542|NCT01822496|560137319|FG003|Overall Study|Withdrawal by Subject|3|||
155190543|NCT02906332|560137324|FG000|Overall Study|Withdrawal by Subject|1|||
155190544|NCT03945266|560137328|FG000|Overall Study|Withdrawal by Subject|1|||
155190545|NCT03945266|560137329|FG001|Overall Study|Withdrawal by Subject|0|||
155190546|NCT03945266|560137328|FG000|Overall Study|Miscarriage|0|||
155190547|NCT03945266|560137329|FG001|Overall Study|Miscarriage|2|||
155190548|NCT03945266|560137328|FG000|Overall Study|Lost to Follow-up|1|||
155190549|NCT03945266|560137329|FG001|Overall Study|Lost to Follow-up|0|||
155190550|NCT02130024|560137342|FG000|Overall Study|Adverse Event|10|||
155190551|NCT02130024|560137343|FG001|Overall Study|Adverse Event|11|||
155190552|NCT02130024|560137342|FG000|Overall Study|Death|2|||
155190553|NCT02130024|560137343|FG001|Overall Study|Death|2|||
155190554|NCT02130024|560137342|FG000|Overall Study|Lost to Follow-up|1|||
155190555|NCT02130024|560137343|FG001|Overall Study|Lost to Follow-up|1|||
155190556|NCT02130024|560137342|FG000|Overall Study|Physician Decision|1|||
155037733|NCT01179737|559565728|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
155037734|NCT01179737|559565725|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
155037735|NCT01179737|559565726|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
155037736|NCT01179737|559565727|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
155037737|NCT01179737|559565728|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
155037738|NCT01179737|559565725|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
155037739|NCT01179737|559565726|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
155037740|NCT01179737|559565727|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
155037741|NCT01179737|559565728|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
155037742|NCT01179737|559565725|FG000|Cohort 1 & Cohort 2|Death|0|||
155037743|NCT01179737|559565726|FG001|Cohort 1 & Cohort 2|Death|0|||
155037744|NCT01179737|559565727|FG002|Cohort 1 & Cohort 2|Death|1|||
155037745|NCT01179737|559565728|FG003|Cohort 1 & Cohort 2|Death|0|||
155037746|NCT01179737|559565725|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
155037747|NCT01179737|559565726|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
155037748|NCT01179737|559565727|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
155037749|NCT01179737|559565728|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
155037750|NCT01179737|559565725|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
155037751|NCT01179737|559565726|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
155037752|NCT01179737|559565727|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
155037753|NCT01179737|559565728|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
155037754|NCT01179737|559565725|FG000|Extension|The study was terminated|3|||
155190557|NCT02130024|560137343|FG001|Overall Study|Physician Decision|3|||
155190558|NCT02130024|560137342|FG000|Overall Study|Protocol Deviation|4|||
155190559|NCT02130024|560137343|FG001|Overall Study|Protocol Deviation|0|||
155190560|NCT02130024|560137342|FG000|Overall Study|Site Administration Problems|1|||
155190561|NCT02130024|560137343|FG001|Overall Study|Site Administration Problems|0|||
155190562|NCT02130024|560137342|FG000|Overall Study|Subject Withdrew Consent|6|||
155190563|NCT02130024|560137343|FG001|Overall Study|Subject Withdrew Consent|14|||
155190564|NCT02024555|560137344|FG000|Overall Study|Lost to Follow-up|1|||
155190565|NCT02024555|560137345|FG001|Overall Study|Lost to Follow-up|1|||
155190566|NCT02024555|560137344|FG000|Overall Study|Withdrawal by Subject|5|||
155190567|NCT02024555|560137345|FG001|Overall Study|Withdrawal by Subject|1|||
155190568|NCT05736224|560137346|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
155190569|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
155190570|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190571|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190572|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190573|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190574|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190575|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
155190576|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
155190577|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190578|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190579|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190580|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190581|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190582|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
155190583|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
155190584|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190585|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190586|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190587|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190588|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190589|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
155190590|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
155190591|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190592|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190593|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190594|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190595|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190596|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
155190597|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
155190598|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190599|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190600|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190601|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190602|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190603|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
155190604|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
155190605|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190606|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190607|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190608|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190609|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190610|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
155190611|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
155190612|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190613|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190614|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190615|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190616|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190617|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
155190618|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
155190619|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190620|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190621|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190622|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190623|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190624|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
155190625|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
155190626|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190627|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190628|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190629|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190630|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190631|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
155190632|NCT04526509|560137347|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
155190633|NCT04526509|560137348|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190634|NCT04526509|560137349|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190635|NCT04526509|560137350|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190636|NCT04526509|560137351|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190637|NCT04526509|560137352|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190638|NCT04526509|560137353|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
155190639|NCT04526509|560137347|FG000|Enrolled|Study Terminated by Sponsor|0|||
155190640|NCT04526509|560137348|FG001|Enrolled|Study Terminated by Sponsor|0|||
155190641|NCT04526509|560137349|FG002|Enrolled|Study Terminated by Sponsor|0|||
155190642|NCT04526509|560137350|FG003|Enrolled|Study Terminated by Sponsor|0|||
155190643|NCT04526509|560137351|FG004|Enrolled|Study Terminated by Sponsor|0|||
155190644|NCT04526509|560137352|FG005|Enrolled|Study Terminated by Sponsor|0|||
155190645|NCT04526509|560137353|FG006|Enrolled|Study Terminated by Sponsor|1|||
155190646|NCT04526509|560137347|FG000|Enrolled|Death prior to lymphodepletion|0|||
155190647|NCT04526509|560137348|FG001|Enrolled|Death prior to lymphodepletion|0|||
155190648|NCT04526509|560137349|FG002|Enrolled|Death prior to lymphodepletion|0|||
155190649|NCT04526509|560137350|FG003|Enrolled|Death prior to lymphodepletion|1|||
155190650|NCT04526509|560137351|FG004|Enrolled|Death prior to lymphodepletion|0|||
155190651|NCT04526509|560137352|FG005|Enrolled|Death prior to lymphodepletion|0|||
155190652|NCT04526509|560137353|FG006|Enrolled|Death prior to lymphodepletion|0|||
155190653|NCT04526509|560137347|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190654|NCT04526509|560137348|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190655|NCT04526509|560137349|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190656|NCT04526509|560137350|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
155190657|NCT04526509|560137351|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190658|NCT04526509|560137352|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190659|NCT04526509|560137353|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
155190660|NCT04526509|560137347|FG000|Enrolled|Physician Decision|0|||
155190661|NCT04526509|560137348|FG001|Enrolled|Physician Decision|1|||
155190662|NCT04526509|560137349|FG002|Enrolled|Physician Decision|0|||
155190663|NCT04526509|560137350|FG003|Enrolled|Physician Decision|0|||
155190664|NCT04526509|560137351|FG004|Enrolled|Physician Decision|0|||
155190665|NCT04526509|560137352|FG005|Enrolled|Physician Decision|0|||
155190666|NCT04526509|560137353|FG006|Enrolled|Physician Decision|0|||
155190667|NCT01896050|560138895|FG000|Overall Study|Adverse Event|37|||
155190668|NCT01896050|560138896|FG001|Overall Study|Adverse Event|2|||
155190669|NCT01896050|560138895|FG000|Overall Study|Death|1|||
155190670|NCT01896050|560138896|FG001|Overall Study|Death|0|||
155190671|NCT00392015|560138898|FG000|Overall Study|Lost to Follow-up|2|||
155190672|NCT00392015|560138899|FG001|Overall Study|Lost to Follow-up|0|||
155190673|NCT00392015|560138900|FG002|Overall Study|Lost to Follow-up|2|||
155190674|NCT00392015|560138901|FG003|Overall Study|Lost to Follow-up|1|||
155190675|NCT00392015|560138902|FG004|Overall Study|Lost to Follow-up|1|||
155190676|NCT00392015|560138903|FG005|Overall Study|Lost to Follow-up|0|||
155190677|NCT00392015|560138898|FG000|Overall Study|Withdrawal by Subject|0|||
155190678|NCT00392015|560138899|FG001|Overall Study|Withdrawal by Subject|0|||
155190679|NCT00392015|560138900|FG002|Overall Study|Withdrawal by Subject|2|||
155190680|NCT00392015|560138901|FG003|Overall Study|Withdrawal by Subject|0|||
155190681|NCT00392015|560138902|FG004|Overall Study|Withdrawal by Subject|0|||
155190682|NCT00392015|560138903|FG005|Overall Study|Withdrawal by Subject|0|||
155190683|NCT00392015|560138898|FG000|Overall Study|Adverse Event|0|||
155190684|NCT00392015|560138899|FG001|Overall Study|Adverse Event|0|||
155190685|NCT00392015|560138900|FG002|Overall Study|Adverse Event|0|||
155190686|NCT00392015|560138901|FG003|Overall Study|Adverse Event|0|||
155190687|NCT00392015|560138902|FG004|Overall Study|Adverse Event|1|||
155190688|NCT00392015|560138903|FG005|Overall Study|Adverse Event|0|||
155190689|NCT00392015|560138898|FG000|Overall Study|Previous trial recipient|0|||
155190690|NCT00392015|560138899|FG001|Overall Study|Previous trial recipient|0|||
155190691|NCT00392015|560138900|FG002|Overall Study|Previous trial recipient|0|||
155190692|NCT00392015|560138901|FG003|Overall Study|Previous trial recipient|0|||
155190693|NCT00392015|560138902|FG004|Overall Study|Previous trial recipient|1|||
155190694|NCT00392015|560138903|FG005|Overall Study|Previous trial recipient|0|||
155190695|NCT02742441|560138904|FG000|Overall Study|Lost to Follow-up|4|||
155190696|NCT02742441|560138905|FG001|Overall Study|Lost to Follow-up|4|||
155190697|NCT02742441|560138904|FG000|Overall Study|Withdrawal by Subject|2|||
155190698|NCT02742441|560138905|FG001|Overall Study|Withdrawal by Subject|2|||
155190699|NCT02742441|560138904|FG000|Overall Study|Adverse Event|0|||
155190700|NCT02742441|560138905|FG001|Overall Study|Adverse Event|2|||
155190701|NCT01824342|560138907|FG000|Overall Study|Withdrawal by Subject|0|||
155190702|NCT01824342|560138908|FG001|Overall Study|Withdrawal by Subject|3|||
155190703|NCT01824342|560138907|FG000|Overall Study|Adverse Event|1|||
155190704|NCT01824342|560138908|FG001|Overall Study|Adverse Event|1|||
155190705|NCT01824342|560138907|FG000|Overall Study|Disease Progression|1|||
155190706|NCT01824342|560138908|FG001|Overall Study|Disease Progression|1|||
155190707|NCT01824342|560138907|FG000|Overall Study|Physician Decision|5|||
155190708|NCT01824342|560138908|FG001|Overall Study|Physician Decision|0|||
155190709|NCT01824342|560138907|FG000|Overall Study|Death|2|||
155190710|NCT01824342|560138908|FG001|Overall Study|Death|0|||
155190711|NCT04195906|560138911|FG000|Part 1|Adverse Event|3|||
155190712|NCT04195906|560138912|FG001|Part 1|Adverse Event|7|||
155190713|NCT04195906|560138911|FG000|Part 1|Withdrawal by Subject|0|||
155190714|NCT04195906|560138912|FG001|Part 1|Withdrawal by Subject|1|||
155190715|NCT04195906|560138911|FG000|Part 2|Adverse Event|1|||
155190716|NCT04195906|560138912|FG001|Part 2|Adverse Event|1|||
155190717|NCT04195906|560138911|FG000|Part 2|Withdrawal by Subject|0|||
155190718|NCT04195906|560138912|FG001|Part 2|Withdrawal by Subject|3|||
155190719|NCT04195906|560138911|FG000|Part 2|Other|1|||
155190720|NCT04195906|560138912|FG001|Part 2|Other|3|||
155190721|NCT02486302|560138913|FG000|Overall Study|Discontinued prematurely|410|||
155190722|NCT02486302|560138913|FG000|Overall Study|Documentation not completed|255|||
155190723|NCT02486302|560138913|FG000|Overall Study|Excluded due to legal reasons|8|||
155190724|NCT02486302|560138913|FG000|Overall Study|Not treated|3|||
155190725|NCT01871142|560138914|FG000|Overall Study|Adverse Event|1|||
155190726|NCT00734474|560138917|FG000|Overall Study|Entry Criteria Not Met|0|||
155190727|NCT00734474|560138918|FG001|Overall Study|Entry Criteria Not Met|0|||
155190728|NCT00734474|560138919|FG002|Overall Study|Entry Criteria Not Met|5|||
155190729|NCT00734474|560138920|FG003|Overall Study|Entry Criteria Not Met|0|||
155037755|NCT01179737|559565726|FG001|Extension|The study was terminated|0|||
155037756|NCT01179737|559565727|FG002|Extension|The study was terminated|0|||
155190730|NCT00734474|560138921|FG004|Overall Study|Entry Criteria Not Met|3|||
155190731|NCT00734474|560138922|FG005|Overall Study|Entry Criteria Not Met|1|||
155190732|NCT00734474|560138923|FG006|Overall Study|Entry Criteria Not Met|0|||
155190733|NCT00734474|560138924|FG007|Overall Study|Entry Criteria Not Met|1|||
155190734|NCT00734474|560138925|FG008|Overall Study|Entry Criteria Not Met|1|||
155190735|NCT00734474|560138917|FG000|Overall Study|Lost to Follow-up|1|||
155190736|NCT00734474|560138918|FG001|Overall Study|Lost to Follow-up|0|||
155190737|NCT00734474|560138919|FG002|Overall Study|Lost to Follow-up|13|||
155190738|NCT00734474|560138920|FG003|Overall Study|Lost to Follow-up|0|||
155190739|NCT00734474|560138921|FG004|Overall Study|Lost to Follow-up|11|||
155190740|NCT00734474|560138922|FG005|Overall Study|Lost to Follow-up|1|||
155190741|NCT00734474|560138923|FG006|Overall Study|Lost to Follow-up|0|||
155190742|NCT00734474|560138924|FG007|Overall Study|Lost to Follow-up|9|||
155190743|NCT00734474|560138925|FG008|Overall Study|Lost to Follow-up|4|||
155190744|NCT00734474|560138917|FG000|Overall Study|Withdrawal by Subject|2|||
155190745|NCT00734474|560138918|FG001|Overall Study|Withdrawal by Subject|1|||
155190746|NCT00734474|560138919|FG002|Overall Study|Withdrawal by Subject|18|||
155190747|NCT00734474|560138920|FG003|Overall Study|Withdrawal by Subject|0|||
155190748|NCT00734474|560138921|FG004|Overall Study|Withdrawal by Subject|24|||
155190749|NCT00734474|560138922|FG005|Overall Study|Withdrawal by Subject|2|||
155190750|NCT00734474|560138923|FG006|Overall Study|Withdrawal by Subject|0|||
155190751|NCT00734474|560138924|FG007|Overall Study|Withdrawal by Subject|36|||
155190752|NCT00734474|560138925|FG008|Overall Study|Withdrawal by Subject|21|||
155190753|NCT00734474|560138917|FG000|Overall Study|Physician Decision|0|||
155190754|NCT00734474|560138918|FG001|Overall Study|Physician Decision|0|||
155190755|NCT00734474|560138919|FG002|Overall Study|Physician Decision|4|||
155190756|NCT00734474|560138920|FG003|Overall Study|Physician Decision|1|||
155190757|NCT00734474|560138921|FG004|Overall Study|Physician Decision|11|||
155190758|NCT00734474|560138922|FG005|Overall Study|Physician Decision|0|||
155190759|NCT00734474|560138923|FG006|Overall Study|Physician Decision|0|||
155190760|NCT00734474|560138924|FG007|Overall Study|Physician Decision|9|||
155190761|NCT00734474|560138925|FG008|Overall Study|Physician Decision|9|||
155190762|NCT00734474|560138917|FG000|Overall Study|Adverse Event|4|||
155190763|NCT00734474|560138918|FG001|Overall Study|Adverse Event|4|||
155190764|NCT00734474|560138919|FG002|Overall Study|Adverse Event|63|||
155190765|NCT00734474|560138920|FG003|Overall Study|Adverse Event|1|||
155190766|NCT00734474|560138921|FG004|Overall Study|Adverse Event|64|||
155190767|NCT00734474|560138922|FG005|Overall Study|Adverse Event|0|||
155190768|NCT00734474|560138923|FG006|Overall Study|Adverse Event|1|||
155190769|NCT00734474|560138924|FG007|Overall Study|Adverse Event|65|||
155190770|NCT00734474|560138925|FG008|Overall Study|Adverse Event|39|||
155190771|NCT00734474|560138917|FG000|Overall Study|Protocol Violation|0|||
155190772|NCT00734474|560138918|FG001|Overall Study|Protocol Violation|0|||
155190773|NCT00734474|560138919|FG002|Overall Study|Protocol Violation|4|||
155190774|NCT00734474|560138920|FG003|Overall Study|Protocol Violation|0|||
155190775|NCT00734474|560138921|FG004|Overall Study|Protocol Violation|3|||
155190776|NCT00734474|560138922|FG005|Overall Study|Protocol Violation|0|||
155190777|NCT00734474|560138923|FG006|Overall Study|Protocol Violation|0|||
155190778|NCT00734474|560138924|FG007|Overall Study|Protocol Violation|3|||
155190779|NCT00734474|560138925|FG008|Overall Study|Protocol Violation|1|||
155190780|NCT00734474|560138917|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
155190781|NCT00734474|560138918|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
155190782|NCT00734474|560138919|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190783|NCT00734474|560138920|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
155190784|NCT00734474|560138921|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190785|NCT00734474|560138922|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
155190786|NCT00734474|560138923|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
155190787|NCT00734474|560138924|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190788|NCT00734474|560138925|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
155190789|NCT00734474|560138917|FG000|Overall Study|Sponsor Decision|0|||
155190790|NCT00734474|560138918|FG001|Overall Study|Sponsor Decision|0|||
155190791|NCT00734474|560138919|FG002|Overall Study|Sponsor Decision|0|||
155190792|NCT00734474|560138920|FG003|Overall Study|Sponsor Decision|0|||
155190793|NCT00734474|560138921|FG004|Overall Study|Sponsor Decision|2|||
155190794|NCT00734474|560138922|FG005|Overall Study|Sponsor Decision|0|||
155190795|NCT00734474|560138923|FG006|Overall Study|Sponsor Decision|0|||
155190796|NCT00734474|560138924|FG007|Overall Study|Sponsor Decision|0|||
155190797|NCT00734474|560138925|FG008|Overall Study|Sponsor Decision|0|||
155190798|NCT00734474|560138917|FG000|Overall Study|Death|0|||
155190799|NCT00734474|560138918|FG001|Overall Study|Death|0|||
155190800|NCT00734474|560138919|FG002|Overall Study|Death|1|||
155190801|NCT00734474|560138920|FG003|Overall Study|Death|0|||
155190802|NCT00734474|560138921|FG004|Overall Study|Death|0|||
155190803|NCT00734474|560138922|FG005|Overall Study|Death|0|||
155190804|NCT00734474|560138923|FG006|Overall Study|Death|0|||
155190805|NCT00734474|560138924|FG007|Overall Study|Death|2|||
155190806|NCT00734474|560138925|FG008|Overall Study|Death|1|||
155190807|NCT00734474|560138917|FG000|Overall Study|Lack of Efficacy|0|||
155190808|NCT00734474|560138918|FG001|Overall Study|Lack of Efficacy|0|||
155190809|NCT00734474|560138919|FG002|Overall Study|Lack of Efficacy|4|||
155037757|NCT01179737|559565728|FG003|Extension|The study was terminated|0|||
155037758|NCT00312572|559565730|FG000|Overall Study|Adverse Event|10|||
155190810|NCT00734474|560138920|FG003|Overall Study|Lack of Efficacy|0|||
155190811|NCT00734474|560138921|FG004|Overall Study|Lack of Efficacy|0|||
155190812|NCT00734474|560138922|FG005|Overall Study|Lack of Efficacy|0|||
155190813|NCT00734474|560138923|FG006|Overall Study|Lack of Efficacy|0|||
155190814|NCT00734474|560138924|FG007|Overall Study|Lack of Efficacy|4|||
155190815|NCT00734474|560138925|FG008|Overall Study|Lack of Efficacy|6|||
155190816|NCT02104752|560138926|FG000|Overall Study|Withdrawal by Subject|1|||
155190817|NCT02104752|560138927|FG001|Overall Study|Withdrawal by Subject|0|||
155190818|NCT02104752|560138926|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
155190819|NCT02104752|560138927|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
155190820|NCT02899299|560138928|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
155190821|NCT02899299|560138929|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
155190822|NCT02899299|560138928|FG000|Pre-treatment|Participant withdrew consent|1|||
155190823|NCT02899299|560138929|FG001|Pre-treatment|Participant withdrew consent|11|||
155190824|NCT02899299|560138928|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
155190825|NCT02899299|560138929|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
155190826|NCT02899299|560138928|FG000|Pre-treatment|Not reported|0|||
155190827|NCT02899299|560138929|FG001|Pre-treatment|Not reported|1|||
155190828|NCT02899299|560138928|FG000|Treatment|Disease Progression|182|||
155190829|NCT02899299|560138929|FG001|Treatment|Disease Progression|43|||
155190830|NCT02899299|560138928|FG000|Treatment|Study Drug Toxicity|60|||
155190831|NCT02899299|560138929|FG001|Treatment|Study Drug Toxicity|24|||
155190832|NCT02899299|560138928|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
155190833|NCT02899299|560138929|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
155190834|NCT02899299|560138928|FG000|Treatment|Participant request to discontinue Study treatment|4|||
155190835|NCT02899299|560138929|FG001|Treatment|Participant request to discontinue Study treatment|10|||
155190836|NCT02899299|560138928|FG000|Treatment|Participant withdrew consent|6|||
155190837|NCT02899299|560138929|FG001|Treatment|Participant withdrew consent|3|||
155190838|NCT02899299|560138928|FG000|Treatment|Lost to Follow-up|0|||
155190839|NCT02899299|560138929|FG001|Treatment|Lost to Follow-up|2|||
155190840|NCT02899299|560138928|FG000|Treatment|Maximum Clinical Benefit|11|||
155190841|NCT02899299|560138929|FG001|Treatment|Maximum Clinical Benefit|2|||
155190842|NCT02899299|560138928|FG000|Treatment|Poor/Non-compliance|1|||
155190843|NCT02899299|560138929|FG001|Treatment|Poor/Non-compliance|0|||
155190844|NCT02899299|560138928|FG000|Treatment|Participant no longer meets Study criteria|4|||
155190845|NCT02899299|560138929|FG001|Treatment|Participant no longer meets Study criteria|0|||
155190846|NCT02899299|560138928|FG000|Treatment|Administrative reason by Sponsor|2|||
155190847|NCT02899299|560138929|FG001|Treatment|Administrative reason by Sponsor|0|||
155190848|NCT02899299|560138928|FG000|Treatment|Other reasons|12|||
155190849|NCT02899299|560138929|FG001|Treatment|Other reasons|2|||
155190850|NCT02899299|560138928|FG000|Treatment|Not reported|7|||
155190851|NCT02899299|560138929|FG001|Treatment|Not reported|0|||
155190852|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
155190853|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
155190854|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
155190855|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
155190856|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
155190857|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
155190858|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
155190859|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
155190860|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
155190861|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
155190862|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
155190863|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
155190864|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
155190865|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
155190866|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
155190867|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
155190868|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
155190869|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
155190870|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
155190871|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
155190872|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
155190873|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
155190874|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
155190875|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
155190876|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
155190877|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
155190878|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
155190879|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
155190880|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
155190881|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
155190882|NCT00313300|560138931|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
155190883|NCT00313300|560138932|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190884|NCT00313300|560138933|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190885|NCT00313300|560138934|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190886|NCT00313300|560138935|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
155190887|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
155190888|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
155190889|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
155190890|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
155037759|NCT00312572|559565731|FG001|Overall Study|Adverse Event|16|||
155190891|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
155190892|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
155190893|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
155190894|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
155190895|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
155190896|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
155190897|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
155190898|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
155190899|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
155190900|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
155190901|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
155190902|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
155190903|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
155190904|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
155190905|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
155190906|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
155190907|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
155190908|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
155190909|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
155190910|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
155190911|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
155190912|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
155190913|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
155190914|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
155190915|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
155190916|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
155190917|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
155190918|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
155190919|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
155190920|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
155190921|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
155190922|NCT00313300|560138931|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
155190923|NCT00313300|560138932|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190924|NCT00313300|560138933|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190925|NCT00313300|560138934|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190926|NCT00313300|560138935|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
155190927|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
155190928|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
155190929|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
155190930|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
155190931|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
155190932|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190933|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
155190934|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190935|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190936|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
155190937|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
155190938|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
155190939|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
155190940|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
155190941|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
155190942|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
155190943|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190944|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190945|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190946|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
155190947|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
155190948|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
155190949|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
155190950|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
155190951|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
155190952|NCT00313300|560138931|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
155190953|NCT00313300|560138932|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
155190954|NCT00313300|560138933|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
155190955|NCT00313300|560138934|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
155190956|NCT00313300|560138935|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
155190957|NCT00428792|560138936|FG000|Overall Study|Lack of Efficacy|1|||
155190958|NCT00428792|560138937|FG001|Overall Study|Lack of Efficacy|3|||
155190959|NCT00428792|560138936|FG000|Overall Study|Lost to Follow-up|0|||
155190960|NCT00428792|560138937|FG001|Overall Study|Lost to Follow-up|1|||
155190961|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Death|1|||
155190962|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Death|1|||
155190963|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Death|0|||
155190964|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Death|0|||
155190965|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
155190966|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
155190967|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
155190968|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
155190969|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
155190970|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
155190971|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
155190972|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
155190973|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
155190974|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
155190975|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
155190976|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
155190977|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
155190978|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
155190979|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
155190980|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
155190981|NCT04612790|560138938|FG000|DB Period (Up to 36 Weeks)|Other|1|||
155190982|NCT04612790|560138939|FG001|DB Period (Up to 36 Weeks)|Other|0|||
155190983|NCT04612790|560138940|FG002|DB Period (Up to 36 Weeks)|Other|0|||
155190984|NCT04612790|560138941|FG003|DB Period (Up to 36 Weeks)|Other|0|||
155190985|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
155190986|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
155190987|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
155190988|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
155190989|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
155190990|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
155190991|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
155190992|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
155190993|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
155190994|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
155190995|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
155190996|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
155190997|NCT04612790|560138938|FG000|OLE Period (Up to 1 Year)|Other|0|||
155190998|NCT04612790|560138939|FG001|OLE Period (Up to 1 Year)|Other|0|||
155190999|NCT04612790|560138940|FG002|OLE Period (Up to 1 Year)|Other|0|||
155191000|NCT04612790|560138941|FG003|OLE Period (Up to 1 Year)|Other|1|||
155191001|NCT03615326|560138945|FG000|Overall Study|Death|266|||
155191002|NCT03615326|560138946|FG001|Overall Study|Death|286|||
155191003|NCT03615326|560138947|FG002|Overall Study|Death|14|||
155191004|NCT03615326|560138948|FG003|Overall Study|Death|17|||
155191005|NCT03615326|560138945|FG000|Overall Study|Lost to Follow-up|0|||
155191006|NCT03615326|560138946|FG001|Overall Study|Lost to Follow-up|1|||
155191007|NCT03615326|560138947|FG002|Overall Study|Lost to Follow-up|0|||
155191008|NCT03615326|560138948|FG003|Overall Study|Lost to Follow-up|0|||
155191009|NCT03615326|560138945|FG000|Overall Study|Withdrawal by Subject|1|||
155191010|NCT03615326|560138946|FG001|Overall Study|Withdrawal by Subject|3|||
155191011|NCT03615326|560138947|FG002|Overall Study|Withdrawal by Subject|0|||
155191012|NCT03615326|560138948|FG003|Overall Study|Withdrawal by Subject|0|||
155191013|NCT03615326|560138945|FG000|Overall Study|Participants Ongoing|83|||
155191014|NCT03615326|560138946|FG001|Overall Study|Participants Ongoing|58|||
155191015|NCT03615326|560138947|FG002|Overall Study|Participants Ongoing|6|||
155191016|NCT03615326|560138948|FG003|Overall Study|Participants Ongoing|3|||
155191017|NCT02651467|560138960|FG000|Overall Study|Withdrawal by Subject|0|||
155191018|NCT02651467|560138961|FG001|Overall Study|Withdrawal by Subject|0|||
155191019|NCT02651467|560138962|FG002|Overall Study|Withdrawal by Subject|2|||
155191020|NCT02651467|560138960|FG000|Overall Study|Other (Not specified)|1|||
155191021|NCT02651467|560138961|FG001|Overall Study|Other (Not specified)|0|||
155191022|NCT02651467|560138962|FG002|Overall Study|Other (Not specified)|2|||
155191023|NCT00004635|560138963|FG000|Period One|refused|2|||
155191024|NCT00004635|560138964|FG001|Period One|refused|1|||
155191025|NCT00004635|560138963|FG000|Period One|Withdrawal by Subject|1|||
155191026|NCT00004635|560138964|FG001|Period One|Withdrawal by Subject|1|||
155191027|NCT00004635|560138963|FG000|Period One|Protocol Violation|1|||
155037760|NCT00312572|559565730|FG000|Overall Study|Lost to Follow-up|1|||
155037761|NCT00312572|559565731|FG001|Overall Study|Lost to Follow-up|1|||
155191028|NCT00004635|560138964|FG001|Period One|Protocol Violation|0|||
155191029|NCT00004635|560138963|FG000|Period One|PSA did not go <5 ng/mL|1|||
155191030|NCT00004635|560138964|FG001|Period One|PSA did not go <5 ng/mL|0|||
155191031|NCT00004635|560138963|FG000|Period One|second malignancy|1|||
155191032|NCT00004635|560138964|FG001|Period One|second malignancy|0|||
155191033|NCT00004635|560138963|FG000|Period One|progressed|0|||
155191034|NCT00004635|560138964|FG001|Period One|progressed|2|||
155191035|NCT00004635|560138963|FG000|Period One|health problem|0|||
155191036|NCT00004635|560138964|FG001|Period One|health problem|1|||
155191037|NCT00004635|560138963|FG000|Period One|discrepancy in data entry|0|||
155191038|NCT00004635|560138964|FG001|Period One|discrepancy in data entry|1|||
155191039|NCT00004635|560138963|FG000|Period Two|progression|2|||
155191040|NCT00004635|560138964|FG001|Period Two|progression|3|||
155191041|NCT00004635|560138963|FG000|Period Two|Adverse Event|1|||
155191042|NCT00004635|560138964|FG001|Period Two|Adverse Event|0|||
155191043|NCT00004635|560138963|FG000|Period Two|refused|0|||
155191044|NCT00004635|560138964|FG001|Period Two|refused|2|||
155191045|NCT00004635|560138963|FG000|Period Two|health problem|1|||
155191046|NCT00004635|560138964|FG001|Period Two|health problem|1|||
155191047|NCT00004635|560138963|FG000|Period Two|travel issues|0|||
155191048|NCT00004635|560138964|FG001|Period Two|travel issues|1|||
155191049|NCT00004635|560138963|FG000|Period Two|secondary malignancy|1|||
155191050|NCT00004635|560138964|FG001|Period Two|secondary malignancy|1|||
155191051|NCT00004635|560138963|FG000|Period Two|Lost to Follow-up|1|||
155191052|NCT00004635|560138964|FG001|Period Two|Lost to Follow-up|0|||
155191053|NCT00004635|560138963|FG000|Period Two|discrepancy in data entry|0|||
155191054|NCT00004635|560138964|FG001|Period Two|discrepancy in data entry|1|||
155191055|NCT00191906|560138965|FG000|Study Period II|Adverse Event|0|||
155191056|NCT00191906|560138966|FG001|Study Period II|Adverse Event|1|||
155191057|NCT00191906|560138967|FG002|Study Period II|Adverse Event|0|||
155191058|NCT00191906|560138968|FG003|Study Period II|Adverse Event|0|||
155191059|NCT00191906|560138965|FG000|Study Period II|Withdrawal by Subject|0|||
155191060|NCT00191906|560138966|FG001|Study Period II|Withdrawal by Subject|3|||
155191061|NCT00191906|560138967|FG002|Study Period II|Withdrawal by Subject|0|||
155191062|NCT00191906|560138968|FG003|Study Period II|Withdrawal by Subject|0|||
155191063|NCT00191906|560138965|FG000|Study Period II|Parent/Caregiver Decision|0|||
155191064|NCT00191906|560138966|FG001|Study Period II|Parent/Caregiver Decision|1|||
155191065|NCT00191906|560138967|FG002|Study Period II|Parent/Caregiver Decision|0|||
155191066|NCT00191906|560138968|FG003|Study Period II|Parent/Caregiver Decision|0|||
155191067|NCT00191906|560138965|FG000|Study Period II|Entry Criteria Exclusion|0|||
155191068|NCT00191906|560138966|FG001|Study Period II|Entry Criteria Exclusion|0|||
155191069|NCT00191906|560138967|FG002|Study Period II|Entry Criteria Exclusion|1|||
155191070|NCT00191906|560138968|FG003|Study Period II|Entry Criteria Exclusion|0|||
155191071|NCT00191906|560138965|FG000|Study Period III|Adverse Event|1|||
155191072|NCT00191906|560138966|FG001|Study Period III|Adverse Event|0|||
155191073|NCT00191906|560138967|FG002|Study Period III|Adverse Event|0|||
155191074|NCT00191906|560138968|FG003|Study Period III|Adverse Event|0|||
155191075|NCT00191906|560138965|FG000|Study Period III|Lost to Follow-up|0|||
155191076|NCT00191906|560138966|FG001|Study Period III|Lost to Follow-up|1|||
155191077|NCT00191906|560138967|FG002|Study Period III|Lost to Follow-up|0|||
155191078|NCT00191906|560138968|FG003|Study Period III|Lost to Follow-up|0|||
155191079|NCT00191906|560138965|FG000|Study Period III|Parent/Caregiver Decision|1|||
155191080|NCT00191906|560138966|FG001|Study Period III|Parent/Caregiver Decision|0|||
155191081|NCT00191906|560138967|FG002|Study Period III|Parent/Caregiver Decision|0|||
155191082|NCT00191906|560138968|FG003|Study Period III|Parent/Caregiver Decision|0|||
155191083|NCT00191906|560138965|FG000|Study Period III|Lack of Efficacy|3|||
155191084|NCT00191906|560138966|FG001|Study Period III|Lack of Efficacy|3|||
155191085|NCT00191906|560138967|FG002|Study Period III|Lack of Efficacy|0|||
155191086|NCT00191906|560138968|FG003|Study Period III|Lack of Efficacy|0|||
155191087|NCT00573937|560138969|FG000|Overall Study|Study Terminated|0|||
155191088|NCT00573937|560138970|FG001|Overall Study|Study Terminated|1|||
155191089|NCT00333801|560138971|FG000|Overall Study|Moved to another state|5|||
155191090|NCT00333801|560138972|FG001|Overall Study|Moved to another state|3|||
155191091|NCT00333801|560138971|FG000|Overall Study|Lost to Follow-up|2|||
155191092|NCT00333801|560138972|FG001|Overall Study|Lost to Follow-up|0|||
155191093|NCT00333801|560138971|FG000|Overall Study|Incarcerated|1|||
155191094|NCT00333801|560138972|FG001|Overall Study|Incarcerated|2|||
155191095|NCT00333801|560138971|FG000|Overall Study|Withdrawal by Subject|0|||
155191096|NCT00333801|560138972|FG001|Overall Study|Withdrawal by Subject|1|||
155037762|NCT00312572|559565730|FG000|Overall Study|Administrative|4|||
155191097|NCT00777205|560138973|FG000|Overall Study|Lost to Follow-up|25|||
155191098|NCT00777205|560138974|FG001|Overall Study|Lost to Follow-up|9|||
155191099|NCT00777205|560138973|FG000|Overall Study|Withdrawal by Subject|6|||
155191100|NCT00777205|560138974|FG001|Overall Study|Withdrawal by Subject|4|||
155191101|NCT00777205|560138973|FG000|Overall Study|Death|0|||
155191102|NCT00777205|560138974|FG001|Overall Study|Death|2|||
155191103|NCT00777205|560138973|FG000|Overall Study|Protocol Violation|0|||
155191104|NCT00777205|560138974|FG001|Overall Study|Protocol Violation|56|||
155191105|NCT00631696|560138977|FG000|Overall Study|Entered, not randomized to treatment|1|||
155191106|NCT00631696|560138978|FG001|Overall Study|Entered, not randomized to treatment|1|||
155191107|NCT00631696|560138977|FG000|Overall Study|Discontinued after database release date|1|||
155037763|NCT00312572|559565731|FG001|Overall Study|Administrative|2|||
155191108|NCT00631696|560138978|FG001|Overall Study|Discontinued after database release date|0|||
155191109|NCT00631696|560138977|FG000|Overall Study|Follow up after database release date|1|||
155191110|NCT00631696|560138978|FG001|Overall Study|Follow up after database release date|0|||
155191111|NCT00631696|560138977|FG000|Overall Study|Lost to Follow-up|7|||
155191112|NCT00631696|560138978|FG001|Overall Study|Lost to Follow-up|10|||
155191113|NCT00631696|560138977|FG000|Overall Study|Withdrawal by Subject|2|||
155191114|NCT00631696|560138978|FG001|Overall Study|Withdrawal by Subject|9|||
155191115|NCT00631696|560138977|FG000|Overall Study|Other|8|||
155191116|NCT00631696|560138978|FG001|Overall Study|Other|8|||
155037764|NCT00312572|559565730|FG000|Overall Study|Lack of Efficacy|1|||
155037765|NCT00312572|559565731|FG001|Overall Study|Lack of Efficacy|2|||
155037766|NCT03597022|559565732|FG000|Overall Study|Premature termination of the study|7|||
155037767|NCT03597022|559565733|FG001|Overall Study|Premature termination of the study|7|||
155037768|NCT03597022|559565734|FG002|Overall Study|Premature termination of the study|8|||
155037769|NCT03597022|559565732|FG000|Overall Study|Serious adverse event|1|||
155037770|NCT03597022|559565733|FG001|Overall Study|Serious adverse event|1|||
155037771|NCT03597022|559565734|FG002|Overall Study|Serious adverse event|0|||
155037772|NCT05385224|559565735|FG000|Overall Study|Unable to swallow capsule|2|||
155037773|NCT05385224|559565735|FG000|Overall Study|Withdrawal by Subject|2|||
155037774|NCT05385224|559565735|FG000|Overall Study|Did not meet study criteria|1|||
155037775|NCT04521114|559565738|FG000|Overall Study|Lost to Follow-up|1|||
155037776|NCT04521114|559565739|FG001|Overall Study|Lost to Follow-up|2|||
155037777|NCT04521114|559565740|FG002|Overall Study|Lost to Follow-up|0|||
155037778|NCT04521114|559565738|FG000|Overall Study|Withdrawal by Subject|1|||
155191117|NCT00631696|560138977|FG000|Overall Study|Protocol Violation|9|||
155191118|NCT00631696|560138978|FG001|Overall Study|Protocol Violation|9|||
155191119|NCT00631696|560138977|FG000|Overall Study|Study terminated by sponsor|3|||
155191120|NCT00631696|560138978|FG001|Overall Study|Study terminated by sponsor|3|||
155191121|NCT00631696|560138977|FG000|Overall Study|Adverse Event|5|||
155191122|NCT00631696|560138978|FG001|Overall Study|Adverse Event|0|||
155191123|NCT01134731|560138979|FG000|Overall Study|Adverse Event|3|||
155191124|NCT01134731|560138980|FG001|Overall Study|Adverse Event|2|||
155191125|NCT01134731|560138981|FG002|Overall Study|Adverse Event|1|||
155191126|NCT01134731|560138979|FG000|Overall Study|Physician Decision|2|||
155191127|NCT01134731|560138980|FG001|Overall Study|Physician Decision|2|||
155191128|NCT01134731|560138981|FG002|Overall Study|Physician Decision|2|||
155191129|NCT01134731|560138979|FG000|Overall Study|Lack of Efficacy|0|||
155191130|NCT01134731|560138980|FG001|Overall Study|Lack of Efficacy|0|||
155191131|NCT01134731|560138981|FG002|Overall Study|Lack of Efficacy|1|||
155191132|NCT01134731|560138979|FG000|Overall Study|Withdrawal by Subject|3|||
155191133|NCT01134731|560138980|FG001|Overall Study|Withdrawal by Subject|3|||
155191134|NCT01134731|560138981|FG002|Overall Study|Withdrawal by Subject|1|||
155191135|NCT01134731|560138979|FG000|Overall Study|Lost to Follow-up|5|||
155191136|NCT01134731|560138980|FG001|Overall Study|Lost to Follow-up|4|||
155191137|NCT01134731|560138981|FG002|Overall Study|Lost to Follow-up|3|||
155191138|NCT05095454|560138982|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
155191139|NCT05095454|560138983|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
155191140|NCT00679055|560138984|FG000|Overall Study|Adverse Event|0|||
155191141|NCT00679055|560138985|FG001|Overall Study|Adverse Event|1|||
155191142|NCT00679055|560138984|FG000|Overall Study|Other|0|||
155191143|NCT00679055|560138985|FG001|Overall Study|Other|3|||
155191144|NCT00679055|560138984|FG000|Overall Study|Study Terminated|2|||
155191145|NCT00679055|560138985|FG001|Overall Study|Study Terminated|1|||
155191146|NCT00629772|560138986|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
155191147|NCT00629772|560138987|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
155191148|NCT00629772|560138986|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
155191149|NCT00629772|560138987|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
155191150|NCT03840174|560138988|FG000|Overall Study|Withdrawal by Subject|1|||
155191151|NCT03840174|560138989|FG001|Overall Study|Withdrawal by Subject|0|||
155191152|NCT03840174|560138990|FG002|Overall Study|Withdrawal by Subject|0|||
155037779|NCT04521114|559565739|FG001|Overall Study|Withdrawal by Subject|2|||
155191153|NCT03840174|560138991|FG003|Overall Study|Withdrawal by Subject|0|||
155191154|NCT02410551|560138992|FG000|Overall Study|Adverse Event|1|||
155191155|NCT02410551|560138992|FG000|Overall Study|Withdrawal by Subject|1|||
155191156|NCT02410551|560138992|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
155191157|NCT01069627|560139000|FG000|Overall Study|Disease progression|7|||
155191158|NCT01069627|560139000|FG000|Overall Study|Adverse Event|12|||
155191159|NCT01069627|560139000|FG000|Overall Study|Protocol Violation|1|||
155191160|NCT04209348|560139001|FG000|Overall Study|Lost to Follow-up|1|||
155191161|NCT04209348|560139002|FG001|Overall Study|Lost to Follow-up|0|||
155191162|NCT02149875|560139008|FG000|Overall Study|Lost to Follow-up|3|||
155191163|NCT02149875|560139009|FG001|Overall Study|Lost to Follow-up|4|||
155191164|NCT02149875|560139010|FG002|Overall Study|Lost to Follow-up|5|||
155037780|NCT04521114|559565740|FG002|Overall Study|Withdrawal by Subject|2|||
155037781|NCT04521114|559565738|FG000|Overall Study|Adverse Event|1|||
155037782|NCT04521114|559565739|FG001|Overall Study|Adverse Event|0|||
155191165|NCT02149875|560139008|FG000|Overall Study|Withdrawal by Subject|3|||
155191166|NCT02149875|560139009|FG001|Overall Study|Withdrawal by Subject|2|||
155191167|NCT02149875|560139010|FG002|Overall Study|Withdrawal by Subject|2|||
155191168|NCT02149875|560139008|FG000|Overall Study|Physician Decision|1|||
155191169|NCT02149875|560139009|FG001|Overall Study|Physician Decision|2|||
155191170|NCT02149875|560139010|FG002|Overall Study|Physician Decision|2|||
155191171|NCT02955797|560139014|FG000|Overall Study|Protocol Violation|1|||
155191172|NCT02955797|560139015|FG001|Overall Study|Protocol Violation|0|||
155191173|NCT02955797|560139016|FG002|Overall Study|Protocol Violation|0|||
155191174|NCT02955797|560139017|FG003|Overall Study|Protocol Violation|1|||
155191175|NCT02955797|560139014|FG000|Overall Study|Withdrawal by Subject|2|||
155191176|NCT02955797|560139015|FG001|Overall Study|Withdrawal by Subject|2|||
155191177|NCT02955797|560139016|FG002|Overall Study|Withdrawal by Subject|0|||
155191178|NCT02955797|560139017|FG003|Overall Study|Withdrawal by Subject|1|||
155191179|NCT02955797|560139014|FG000|Overall Study|Lost to Follow-up|0|||
155191180|NCT02955797|560139015|FG001|Overall Study|Lost to Follow-up|1|||
155191181|NCT02955797|560139016|FG002|Overall Study|Lost to Follow-up|0|||
155191182|NCT02955797|560139017|FG003|Overall Study|Lost to Follow-up|0|||
155191183|NCT03131453|560139018|FG000|Overall Study|Study terminated by Sponsor|424|||
155191184|NCT03131453|560139019|FG001|Overall Study|Study terminated by Sponsor|222|||
155191185|NCT03131453|560139020|FG002|Overall Study|Study terminated by Sponsor|438|||
155191186|NCT03131453|560139018|FG000|Overall Study|Withdrawal by Subject|18|||
155191187|NCT03131453|560139019|FG001|Overall Study|Withdrawal by Subject|7|||
155191188|NCT03131453|560139020|FG002|Overall Study|Withdrawal by Subject|13|||
155191189|NCT03131453|560139018|FG000|Overall Study|Adverse Event|10|||
155191190|NCT03131453|560139019|FG001|Overall Study|Adverse Event|3|||
155191191|NCT03131453|560139020|FG002|Overall Study|Adverse Event|3|||
155191192|NCT03131453|560139018|FG000|Overall Study|Lost to Follow-up|1|||
155191193|NCT03131453|560139019|FG001|Overall Study|Lost to Follow-up|0|||
155191194|NCT03131453|560139020|FG002|Overall Study|Lost to Follow-up|1|||
155191195|NCT03131453|560139018|FG000|Overall Study|Physician Decision|1|||
155191196|NCT03131453|560139019|FG001|Overall Study|Physician Decision|0|||
155191197|NCT03131453|560139020|FG002|Overall Study|Physician Decision|1|||
155191198|NCT03131453|560139018|FG000|Overall Study|Non-compliance with study treatment|1|||
155191199|NCT03131453|560139019|FG001|Overall Study|Non-compliance with study treatment|0|||
155191200|NCT03131453|560139020|FG002|Overall Study|Non-compliance with study treatment|0|||
155191201|NCT03131453|560139018|FG000|Overall Study|Technical problems|1|||
155191202|NCT03131453|560139019|FG001|Overall Study|Technical problems|0|||
155191203|NCT03131453|560139020|FG002|Overall Study|Technical problems|0|||
155191204|NCT03131453|560139018|FG000|Overall Study|Protocol deviation|0|||
155191205|NCT03131453|560139019|FG001|Overall Study|Protocol deviation|1|||
155191206|NCT03131453|560139020|FG002|Overall Study|Protocol deviation|0|||
155191207|NCT02081183|560139021|FG000|Overall Study|Lost to Follow-up|0|||
155191208|NCT02081183|560139022|FG001|Overall Study|Lost to Follow-up|1|||
155191209|NCT02081183|560139021|FG000|Overall Study|Protocol Violation|1|||
155037783|NCT04521114|559565740|FG002|Overall Study|Adverse Event|0|||
155037784|NCT04521114|559565738|FG000|Overall Study|Sponsor Wish|1|||
155037785|NCT04521114|559565739|FG001|Overall Study|Sponsor Wish|0|||
155037786|NCT04521114|559565740|FG002|Overall Study|Sponsor Wish|0|||
155037787|NCT04521114|559565738|FG000|Overall Study|Withdrawal of Consent|2|||
155037788|NCT04521114|559565739|FG001|Overall Study|Withdrawal of Consent|2|||
155037789|NCT04521114|559565740|FG002|Overall Study|Withdrawal of Consent|0|||
155037790|NCT00553358|559565741|FG000|Overall Study|Randomized but did not receive treatment|3|||
155037791|NCT00553358|559565742|FG001|Overall Study|Randomized but did not receive treatment|3|||
155037792|NCT00553358|559565743|FG002|Overall Study|Randomized but did not receive treatment|1|||
155037793|NCT00553358|559565741|FG000|Overall Study|Lost to Follow-up|22|||
155037794|NCT00553358|559565742|FG001|Overall Study|Lost to Follow-up|26|||
155037795|NCT00553358|559565743|FG002|Overall Study|Lost to Follow-up|18|||
155037796|NCT00553358|559565741|FG000|Overall Study|Withdrew completely|23|||
155037797|NCT00553358|559565742|FG001|Overall Study|Withdrew completely|33|||
155037798|NCT00553358|559565743|FG002|Overall Study|Withdrew completely|34|||
155037799|NCT00553358|559565741|FG000|Overall Study|Died during clinical follow-up|25|||
155037800|NCT00553358|559565742|FG001|Overall Study|Died during clinical follow-up|29|||
155037801|NCT00553358|559565743|FG002|Overall Study|Died during clinical follow-up|32|||
155037802|NCT00553358|559565741|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
155191210|NCT02081183|560139022|FG001|Overall Study|Protocol Violation|0|||
155191211|NCT02081183|560139021|FG000|Overall Study|Other|3|||
155191212|NCT02081183|560139022|FG001|Overall Study|Other|3|||
155037803|NCT00553358|559565742|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
155037804|NCT00553358|559565743|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
155191213|NCT00543543|560139023|FG000|Base Study|Adverse Event|1|||
155191214|NCT00543543|560139024|FG001|Base Study|Adverse Event|11|||
155037805|NCT00553358|559565741|FG000|Overall Study|Died after clinical follow-up ended|1|||
155191215|NCT00543543|560139025|FG002|Base Study|Adverse Event|0|||
155191216|NCT00543543|560139026|FG003|Base Study|Adverse Event|5|||
155191217|NCT00543543|560139023|FG000|Base Study|Lost to Follow-up|12|||
155191218|NCT00543543|560139024|FG001|Base Study|Lost to Follow-up|749|||
155191219|NCT00543543|560139025|FG002|Base Study|Lost to Follow-up|9|||
155191220|NCT00543543|560139026|FG003|Base Study|Lost to Follow-up|701|||
155191221|NCT00543543|560139023|FG000|Base Study|Physician Decision|0|||
155191222|NCT00543543|560139024|FG001|Base Study|Physician Decision|4|||
155191223|NCT00543543|560139025|FG002|Base Study|Physician Decision|0|||
155191224|NCT00543543|560139026|FG003|Base Study|Physician Decision|7|||
155191225|NCT00543543|560139023|FG000|Base Study|Protocol Violation|0|||
155191226|NCT00543543|560139024|FG001|Base Study|Protocol Violation|6|||
155191227|NCT00543543|560139025|FG002|Base Study|Protocol Violation|0|||
155191228|NCT00543543|560139026|FG003|Base Study|Protocol Violation|6|||
155191229|NCT00543543|560139023|FG000|Base Study|Withdrawal by Subject|7|||
155191230|NCT00543543|560139024|FG001|Base Study|Withdrawal by Subject|482|||
155191231|NCT00543543|560139025|FG002|Base Study|Withdrawal by Subject|5|||
155191232|NCT00543543|560139026|FG003|Base Study|Withdrawal by Subject|503|||
155191233|NCT00543543|560139023|FG000|Extension Study|Adverse Event|0|||
155191234|NCT00543543|560139024|FG001|Extension Study|Adverse Event|0|||
155191235|NCT00543543|560139025|FG002|Extension Study|Adverse Event|0|||
155191236|NCT00543543|560139026|FG003|Extension Study|Adverse Event|5|||
155191237|NCT00543543|560139023|FG000|Extension Study|Lost to Follow-up|0|||
155191238|NCT00543543|560139024|FG001|Extension Study|Lost to Follow-up|0|||
155191239|NCT00543543|560139025|FG002|Extension Study|Lost to Follow-up|0|||
155191240|NCT00543543|560139026|FG003|Extension Study|Lost to Follow-up|77|||
155191241|NCT00543543|560139023|FG000|Extension Study|Physician Decision|0|||
155191242|NCT00543543|560139024|FG001|Extension Study|Physician Decision|0|||
155191243|NCT00543543|560139025|FG002|Extension Study|Physician Decision|0|||
155191244|NCT00543543|560139026|FG003|Extension Study|Physician Decision|7|||
155191245|NCT00543543|560139023|FG000|Extension Study|Pregnancy|0|||
155191246|NCT00543543|560139024|FG001|Extension Study|Pregnancy|0|||
155191247|NCT00543543|560139025|FG002|Extension Study|Pregnancy|0|||
155191248|NCT00543543|560139026|FG003|Extension Study|Pregnancy|6|||
155191249|NCT00543543|560139023|FG000|Extension Study|Protocol Violation|0|||
155191250|NCT00543543|560139024|FG001|Extension Study|Protocol Violation|0|||
155191251|NCT00543543|560139025|FG002|Extension Study|Protocol Violation|0|||
155191252|NCT00543543|560139026|FG003|Extension Study|Protocol Violation|11|||
155191253|NCT00543543|560139023|FG000|Extension Study|Withdrawal by Subject|0|||
155191254|NCT00543543|560139024|FG001|Extension Study|Withdrawal by Subject|0|||
155191255|NCT00543543|560139025|FG002|Extension Study|Withdrawal by Subject|0|||
155191256|NCT00543543|560139026|FG003|Extension Study|Withdrawal by Subject|120|||
155191257|NCT04308304|560139027|FG000|Overall Study|Withdrawal by Subject|4|||
155191258|NCT04308304|560139028|FG001|Overall Study|Withdrawal by Subject|0|||
155191259|NCT04308304|560139027|FG000|Overall Study|Protocol Violation|1|||
155191260|NCT04308304|560139028|FG001|Overall Study|Protocol Violation|0|||
155191261|NCT00945555|560139029|FG000|Overall Study|Referred to another hospital|5|||
155191262|NCT00945555|560139029|FG000|Overall Study|Worsening condition, intensive care unit|1|||
155191263|NCT00945555|560139029|FG000|Overall Study|Withdrawal by Subject|2|||
155191264|NCT00945555|560139029|FG000|Overall Study|Participant continued treatment at home|1|||
155191265|NCT00945555|560139029|FG000|Overall Study|Death|18|||
155191266|NCT00945555|560139029|FG000|Overall Study|Other|1|||
155191267|NCT04502979|560139031|FG000|Overall Study|Lost to Follow-up|1|||
155191268|NCT04502979|560139032|FG001|Overall Study|Lost to Follow-up|3|||
155191269|NCT04502979|560139031|FG000|Overall Study|Withdrawal by Subject|2|||
155191270|NCT04502979|560139032|FG001|Overall Study|Withdrawal by Subject|1|||
155037806|NCT00553358|559565742|FG001|Overall Study|Died after clinical follow-up ended|2|||
155037807|NCT00553358|559565743|FG002|Overall Study|Died after clinical follow-up ended|0|||
155037808|NCT00553358|559565741|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
155037809|NCT00553358|559565742|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
155037810|NCT00553358|559565743|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
155037811|NCT02614131|559565744|FG000|Overall Study|Withdrawal by Subject|1|||
155037812|NCT02614131|559565745|FG001|Overall Study|Withdrawal by Subject|0|||
155037813|NCT02614131|559565746|FG002|Overall Study|Withdrawal by Subject|0|||
155037814|NCT02614131|559565747|FG003|Overall Study|Withdrawal by Subject|0|||
155037815|NCT02614131|559565748|FG004|Overall Study|Withdrawal by Subject|0|||
155037816|NCT02614131|559565749|FG005|Overall Study|Withdrawal by Subject|0|||
155037817|NCT02614131|559565750|FG006|Overall Study|Withdrawal by Subject|0|||
155191271|NCT00165984|560139036|FG000|Overall Study|Death|15|||
155191272|NCT01686828|560139037|FG000|Overall Study|Physician Decision|1|||
155191273|NCT01686828|560139038|FG001|Overall Study|Physician Decision|0|||
155191274|NCT01686828|560139039|FG002|Overall Study|Physician Decision|0|||
155191275|NCT01686828|560139040|FG003|Overall Study|Physician Decision|0|||
155191276|NCT01686828|560139037|FG000|Overall Study|New Job|0|||
155191277|NCT01686828|560139038|FG001|Overall Study|New Job|1|||
155037818|NCT02614131|559565744|FG000|Overall Study|Adverse Event|0|||
155191278|NCT01686828|560139039|FG002|Overall Study|New Job|0|||
155191279|NCT01686828|560139040|FG003|Overall Study|New Job|0|||
155191280|NCT01686828|560139037|FG000|Overall Study|Weight Loss|0|||
155191281|NCT01686828|560139038|FG001|Overall Study|Weight Loss|0|||
155191282|NCT01686828|560139039|FG002|Overall Study|Weight Loss|1|||
155191283|NCT01686828|560139040|FG003|Overall Study|Weight Loss|0|||
155037819|NCT02614131|559565745|FG001|Overall Study|Adverse Event|0|||
155037820|NCT02614131|559565746|FG002|Overall Study|Adverse Event|0|||
155037821|NCT02614131|559565747|FG003|Overall Study|Adverse Event|0|||
155037822|NCT02614131|559565748|FG004|Overall Study|Adverse Event|0|||
155037823|NCT02614131|559565749|FG005|Overall Study|Adverse Event|0|||
155037824|NCT02614131|559565750|FG006|Overall Study|Adverse Event|1|||
155037825|NCT01832818|559565751|FG000|Overall Study|Lost to Follow-up|6|||
155037826|NCT02854605|559565752|FG000|Overall Study|Adverse Event|1|||
155037827|NCT02854605|559565753|FG001|Overall Study|Adverse Event|5|||
155037828|NCT02854605|559565754|FG002|Overall Study|Adverse Event|2|||
155191284|NCT01736124|560139041|FG000|Post-intervention Assessment|Death|2|||
155191285|NCT01736124|560139042|FG001|Post-intervention Assessment|Death|2|||
155191286|NCT01736124|560139041|FG000|Post-intervention Assessment|lost computer access|1|||
155191287|NCT01736124|560139042|FG001|Post-intervention Assessment|lost computer access|1|||
155191288|NCT01736124|560139041|FG000|Post-intervention Assessment|Moved away|3|||
155191289|NCT01736124|560139042|FG001|Post-intervention Assessment|Moved away|1|||
155191290|NCT01736124|560139041|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
155191291|NCT01736124|560139042|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
155191292|NCT01736124|560139041|FG000|Post-intervention Assessment|Illness|3|||
155191293|NCT01736124|560139042|FG001|Post-intervention Assessment|Illness|2|||
155191294|NCT01736124|560139041|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
155191295|NCT01736124|560139042|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
155191296|NCT01736124|560139041|FG000|Post-intervention Assessment|Temporarily away|3|||
155191297|NCT01736124|560139042|FG001|Post-intervention Assessment|Temporarily away|1|||
155191298|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
155191299|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
155191300|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
155191301|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
155191302|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
155191303|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
155191304|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
155191305|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
155191306|NCT01736124|560139041|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
155191307|NCT01736124|560139042|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
155191308|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
155191309|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
155191310|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
155191311|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
155191312|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
155191313|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
155191314|NCT01736124|560139041|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
155191315|NCT01736124|560139042|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
155191316|NCT02734433|560139043|FG000|Overall Study|Disease progression|1|||
155191317|NCT02734433|560139044|FG001|Overall Study|Disease progression|5|||
155191318|NCT02734433|560139043|FG000|Overall Study|Clinical progression|0|||
155191319|NCT02734433|560139044|FG001|Overall Study|Clinical progression|1|||
155191320|NCT02734433|560139043|FG000|Overall Study|Withdrawal by Subject|1|||
155191321|NCT02734433|560139044|FG001|Overall Study|Withdrawal by Subject|2|||
155191322|NCT03698331|560139045|FG000|Overall Study|Adverse Event|2|||
155191323|NCT03698331|560139046|FG001|Overall Study|Adverse Event|3|||
155191324|NCT03698331|560139045|FG000|Overall Study|Withdrawal by Subject|1|||
155191325|NCT03698331|560139046|FG001|Overall Study|Withdrawal by Subject|1|||
155191326|NCT03698331|560139045|FG000|Overall Study|Lost to Follow-up|0|||
155191327|NCT03698331|560139046|FG001|Overall Study|Lost to Follow-up|2|||
155191328|NCT03698331|560139045|FG000|Overall Study|Non-compliance with study drug|1|||
155191329|NCT03698331|560139046|FG001|Overall Study|Non-compliance with study drug|0|||
155191330|NCT02719327|560139062|FG000|Overall Study|Withdrawal by Subject|11|||
155191331|NCT02719327|560139063|FG001|Overall Study|Withdrawal by Subject|8|||
155191332|NCT04063384|560140713|FG000|Overall Study|placebo manipulation issue|1|||
155191333|NCT04063384|560140714|FG001|Overall Study|placebo manipulation issue|2|||
155191334|NCT04063384|560140715|FG002|Overall Study|placebo manipulation issue|1|||
155191335|NCT04063384|560140716|FG003|Overall Study|placebo manipulation issue|1|||
155191336|NCT01926015|560140720|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155191337|NCT01926015|560140721|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155191338|NCT01926015|560140720|FG000|Overall Study|Randomized not treated|2|||
155191339|NCT01926015|560140721|FG001|Overall Study|Randomized not treated|0|||
155191340|NCT01364649|560140722|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
155191341|NCT01364649|560140723|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
155037829|NCT02854605|559565752|FG000|Overall Study|Lost to Follow-up|0|||
155191342|NCT01364649|560140722|FG000|Overall Study|Lack of Efficacy|6|||
155191343|NCT01364649|560140723|FG001|Overall Study|Lack of Efficacy|0|||
155191344|NCT01364649|560140722|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
155191345|NCT01364649|560140723|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
155191346|NCT01364649|560140722|FG000|Overall Study|Protocol Deviations|4|||
155191347|NCT01364649|560140723|FG001|Overall Study|Protocol Deviations|8|||
155037830|NCT02854605|559565753|FG001|Overall Study|Lost to Follow-up|2|||
155037831|NCT02854605|559565754|FG002|Overall Study|Lost to Follow-up|0|||
155037832|NCT02854605|559565752|FG000|Overall Study|Withdrew Consent|1|||
155191348|NCT01364649|560140722|FG000|Overall Study|Withdrawal of Consent|9|||
155191349|NCT01364649|560140723|FG001|Overall Study|Withdrawal of Consent|7|||
155191350|NCT01364649|560140722|FG000|Overall Study|Lost to Follow-up|12|||
155191351|NCT01364649|560140723|FG001|Overall Study|Lost to Follow-up|13|||
155191352|NCT01364649|560140722|FG000|Overall Study|Other|4|||
155191353|NCT01364649|560140723|FG001|Overall Study|Other|1|||
155191354|NCT02468232|560140726|FG000|Core Part of Study|Adverse Event|0|||
155191355|NCT02468232|560140727|FG001|Core Part of Study|Adverse Event|1|||
155191356|NCT02468232|560140728|FG002|Core Part of Study|Adverse Event|0|||
155191357|NCT02468232|560140729|FG003|Core Part of Study|Adverse Event|0|||
155191358|NCT02468232|560140726|FG000|Core Part of Study|Death|20|||
155191359|NCT02468232|560140727|FG001|Core Part of Study|Death|17|||
155191360|NCT02468232|560140728|FG002|Core Part of Study|Death|0|||
155191361|NCT02468232|560140729|FG003|Core Part of Study|Death|0|||
155191362|NCT02468232|560140726|FG000|Core Part of Study|Technical Problems|1|||
155191363|NCT02468232|560140727|FG001|Core Part of Study|Technical Problems|1|||
155191364|NCT02468232|560140728|FG002|Core Part of Study|Technical Problems|0|||
155191365|NCT02468232|560140729|FG003|Core Part of Study|Technical Problems|0|||
155191366|NCT02468232|560140726|FG000|OLE Part of Study|Adverse Event|0|||
155191367|NCT02468232|560140727|FG001|OLE Part of Study|Adverse Event|0|||
155191368|NCT02468232|560140728|FG002|OLE Part of Study|Adverse Event|4|||
155191369|NCT02468232|560140729|FG003|OLE Part of Study|Adverse Event|5|||
155191370|NCT02468232|560140726|FG000|OLE Part of Study|Death|0|||
155191371|NCT02468232|560140727|FG001|OLE Part of Study|Death|0|||
155191372|NCT02468232|560140728|FG002|OLE Part of Study|Death|4|||
155191373|NCT02468232|560140729|FG003|OLE Part of Study|Death|2|||
155191374|NCT02468232|560140726|FG000|OLE Part of Study|Physician Decision|0|||
155191375|NCT02468232|560140727|FG001|OLE Part of Study|Physician Decision|0|||
155191376|NCT02468232|560140728|FG002|OLE Part of Study|Physician Decision|4|||
155191377|NCT02468232|560140729|FG003|OLE Part of Study|Physician Decision|0|||
155191378|NCT02468232|560140726|FG000|OLE Part of Study|Subject/Guardian decision|0|||
155191379|NCT02468232|560140727|FG001|OLE Part of Study|Subject/Guardian decision|0|||
155191380|NCT02468232|560140728|FG002|OLE Part of Study|Subject/Guardian decision|2|||
155191381|NCT02468232|560140729|FG003|OLE Part of Study|Subject/Guardian decision|5|||
155191382|NCT01826604|560140730|FG000|Overall Study|Lost to Follow-up|8|||
155191383|NCT01826604|560140731|FG001|Overall Study|Lost to Follow-up|9|||
155191384|NCT04540497|560140734|FG000|Overall Study|Adverse Event|0|||
155191385|NCT04540497|560140735|FG001|Overall Study|Adverse Event|2|||
155191386|NCT04540497|560140734|FG000|Overall Study|Lost to Follow-up|1|||
155191387|NCT04540497|560140735|FG001|Overall Study|Lost to Follow-up|0|||
155191388|NCT04540497|560140734|FG000|Overall Study|Withdrawal by Subject|1|||
155191389|NCT04540497|560140735|FG001|Overall Study|Withdrawal by Subject|1|||
155037833|NCT02854605|559565753|FG001|Overall Study|Withdrew Consent|0|||
155191390|NCT04540497|560140734|FG000|Overall Study|Miscellaneous|2|||
155191391|NCT04540497|560140735|FG001|Overall Study|Miscellaneous|1|||
155191392|NCT05274815|560140736|FG000|Overall Study|Adverse Event|1|||
155191393|NCT05274815|560140736|FG000|Overall Study|Death|2|||
155191394|NCT05274815|560140736|FG000|Overall Study|Lost to Follow-up|4|||
155191395|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to investigator's decision|1|||
155191396|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to participant's decision to withdraw|1|||
155191397|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to severe non-compliance with the protocol|1|||
155191398|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to subject decision|1|||
155191399|NCT05274815|560140736|FG000|Overall Study|Withdrawn due to participant's decision not to continue for personal and family reasons|1|||
155191400|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to the participant stopped visit; agreed to a telephone contact at Week 52|1|||
155191401|NCT05274815|560140736|FG000|Overall Study|Withdrawn from study due to randomization into closed cohort by mistake|1|||
155191402|NCT05274815|560140736|FG000|Overall Study|Withdrawal by Subject|11|||
155191403|NCT06132659|560140737|FG000|Overall Study|Lost to Follow-up|0|||
155191404|NCT06132659|560140738|FG001|Overall Study|Lost to Follow-up|1|||
155191405|NCT06132659|560140739|FG002|Overall Study|Lost to Follow-up|0|||
155191406|NCT03914326|560140740|FG000|Overall Study|Withdrawal by Subject|27|||
155191407|NCT03914326|560140741|FG001|Overall Study|Withdrawal by Subject|34|||
155191408|NCT03914326|560140740|FG000|Overall Study|Lost to Follow-up|43|||
155191409|NCT03914326|560140741|FG001|Overall Study|Lost to Follow-up|51|||
155191410|NCT03914326|560140740|FG000|Overall Study|Randomised more than once|0|||
155191411|NCT03914326|560140741|FG001|Overall Study|Randomised more than once|1|||
155191412|NCT04798781|560140742|FG000|Overall Study|Withdrawal by Subject|1|||
155191413|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
155191414|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
155191415|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
155191416|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
155191417|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
155191418|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
155191419|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
155191420|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
155191421|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
155191422|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
155191423|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
155191424|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
155191425|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
155191426|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
155191427|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
155191428|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
155191429|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
155191430|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
155191431|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
155191432|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
155191433|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
155191434|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
155191435|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
155191436|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
155191437|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Death|2|||
155191438|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Death|1|||
155191439|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Death|0|||
155191440|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Death|0|||
155191441|NCT02607930|560140744|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
155191442|NCT02607930|560140745|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
155191443|NCT02607930|560140746|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
155191444|NCT02607930|560140747|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
155191445|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
155191446|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
155191447|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
155191448|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
155191449|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
155191450|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
155191451|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
155191452|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
155191453|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
155191454|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
155191455|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
155191456|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
155191457|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
155191458|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
155191459|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
155191460|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
155191461|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
155191462|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
155191463|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
155191464|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
155191465|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
155191466|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
155191467|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
155191468|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
155191469|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
155191470|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
155191471|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
155191472|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
155191473|NCT02607930|560140744|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
155191474|NCT02607930|560140745|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
155191475|NCT02607930|560140746|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
155191476|NCT02607930|560140747|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
155191477|NCT03198078|560140750|FG000|Overall Study|Adverse Event|0|||
155191478|NCT03198078|560140751|FG001|Overall Study|Adverse Event|1|||
155191479|NCT03198078|560140752|FG002|Overall Study|Adverse Event|2|||
155191480|NCT03198078|560140750|FG000|Overall Study|Lack of Efficacy|0|||
155191481|NCT03198078|560140751|FG001|Overall Study|Lack of Efficacy|0|||
155191482|NCT03198078|560140752|FG002|Overall Study|Lack of Efficacy|3|||
155191483|NCT03198078|560140750|FG000|Overall Study|Lost to Follow-up|1|||
155191484|NCT03198078|560140751|FG001|Overall Study|Lost to Follow-up|0|||
155191485|NCT03198078|560140752|FG002|Overall Study|Lost to Follow-up|0|||
155191486|NCT03198078|560140750|FG000|Overall Study|Pregnancy|0|||
155191487|NCT03198078|560140751|FG001|Overall Study|Pregnancy|1|||
155191488|NCT03198078|560140752|FG002|Overall Study|Pregnancy|0|||
155191489|NCT03198078|560140750|FG000|Overall Study|Withdrawal by Subject|1|||
155191490|NCT03198078|560140751|FG001|Overall Study|Withdrawal by Subject|0|||
155191491|NCT03198078|560140752|FG002|Overall Study|Withdrawal by Subject|2|||
155191492|NCT03198078|560140750|FG000|Overall Study|Withdrawal by Caregiver|1|||
155191493|NCT03198078|560140751|FG001|Overall Study|Withdrawal by Caregiver|3|||
155191494|NCT03198078|560140752|FG002|Overall Study|Withdrawal by Caregiver|5|||
155191495|NCT01676727|560140753|FG000|Overall Study|Death|18|||
155037834|NCT02854605|559565754|FG002|Overall Study|Withdrew Consent|1|||
155037835|NCT02854605|559565752|FG000|Overall Study|Investigator's Discretion|1|||
155037836|NCT02854605|559565753|FG001|Overall Study|Investigator's Discretion|0|||
155037837|NCT02854605|559565754|FG002|Overall Study|Investigator's Discretion|0|||
155037838|NCT02854605|559565752|FG000|Overall Study|Protocol Violation|0|||
155037839|NCT02854605|559565753|FG001|Overall Study|Protocol Violation|0|||
155037840|NCT02854605|559565754|FG002|Overall Study|Protocol Violation|1|||
155191496|NCT01676727|560140753|FG000|Overall Study|Withdrawal by Subject|6|||
155191497|NCT01676727|560140753|FG000|Overall Study|Screening failure|5|||
155191498|NCT01676727|560140753|FG000|Overall Study|Not willing to attend 1-year visit|2|||
155191499|NCT01676727|560140753|FG000|Overall Study|Valve explanted|1|||
155191500|NCT00722423|560140755|FG000|Overall Study|Protocol Violation|0|||
155191501|NCT00722423|560140756|FG001|Overall Study|Protocol Violation|1|||
155191502|NCT00737438|560140759|FG000|Overall Study|Withdrawal by Subject|2|||
155191503|NCT00737438|560140759|FG000|Overall Study|Patient ineligible|1|||
155191504|NCT05469113|560140760|FG000|Period 2|Adverse Event|0|||
155191505|NCT05469113|560140761|FG001|Period 2|Adverse Event|3|||
155191506|NCT03755791|560140763|FG000|Overall Study|Did not receive any study treatment|3|||
155191507|NCT03755791|560140764|FG001|Overall Study|Did not receive any study treatment|0|||
155191508|NCT03755791|560140765|FG002|Overall Study|Did not receive any study treatment|10|||
155191509|NCT03755791|560140763|FG000|Overall Study|Radiographic progression|204|||
155191510|NCT03755791|560140764|FG001|Overall Study|Radiographic progression|92|||
155191511|NCT03755791|560140765|FG002|Overall Study|Radiographic progression|115|||
155191512|NCT03755791|560140763|FG000|Overall Study|Adverse Event|140|||
155037841|NCT01897571|559565755|FG000|Overall Study|Lost to Follow-up|3|||
155191513|NCT03755791|560140764|FG001|Overall Study|Adverse Event|60|||
155191514|NCT03755791|560140765|FG002|Overall Study|Adverse Event|51|||
155191515|NCT03755791|560140763|FG000|Overall Study|Lack of Efficacy|12|||
155191516|NCT03755791|560140764|FG001|Overall Study|Lack of Efficacy|6|||
155191517|NCT03755791|560140765|FG002|Overall Study|Lack of Efficacy|6|||
155191518|NCT03755791|560140763|FG000|Overall Study|Withdrawal by Subject|26|||
155191519|NCT03755791|560140764|FG001|Overall Study|Withdrawal by Subject|23|||
155191520|NCT03755791|560140765|FG002|Overall Study|Withdrawal by Subject|24|||
155191521|NCT03755791|560140763|FG000|Overall Study|Sponsor decision,|41|||
155191522|NCT03755791|560140764|FG001|Overall Study|Sponsor decision,|5|||
155191523|NCT03755791|560140765|FG002|Overall Study|Sponsor decision,|7|||
155191524|NCT03755791|560140763|FG000|Overall Study|Lost to Follow-up|1|||
155191525|NCT03755791|560140764|FG001|Overall Study|Lost to Follow-up|0|||
155191526|NCT03755791|560140765|FG002|Overall Study|Lost to Follow-up|2|||
155191527|NCT03755791|560140763|FG000|Overall Study|Protocol Violation|0|||
155191528|NCT03755791|560140764|FG001|Overall Study|Protocol Violation|0|||
155191529|NCT03755791|560140765|FG002|Overall Study|Protocol Violation|2|||
155191530|NCT03755791|560140763|FG000|Overall Study|Other than specified|5|||
155191531|NCT03755791|560140764|FG001|Overall Study|Other than specified|2|||
155191532|NCT03755791|560140765|FG002|Overall Study|Other than specified|0|||
155191533|NCT01986140|560140766|FG000|Overall Study|Withdrawal by Subject|31|||
155191534|NCT01986140|560140767|FG001|Overall Study|Withdrawal by Subject|25|||
155191535|NCT01986140|560140766|FG000|Overall Study|alternative treatment|1|||
155191536|NCT01986140|560140767|FG001|Overall Study|alternative treatment|1|||
155191537|NCT01986140|560140766|FG000|Overall Study|found not eligible|3|||
155191538|NCT01986140|560140767|FG001|Overall Study|found not eligible|0|||
155191539|NCT01986140|560140766|FG000|Overall Study|Adverse Event|0|||
155191540|NCT01986140|560140767|FG001|Overall Study|Adverse Event|1|||
155191541|NCT01986140|560140766|FG000|Overall Study|progression disease|0|||
155191542|NCT01986140|560140767|FG001|Overall Study|progression disease|1|||
155191543|NCT00464269|560140774|FG000|Overall Study|Lack of Efficacy|1|||
155191544|NCT00464269|560140775|FG001|Overall Study|Lack of Efficacy|0|||
155191545|NCT00464269|560140776|FG002|Overall Study|Lack of Efficacy|0|||
155191546|NCT00464269|560140777|FG003|Overall Study|Lack of Efficacy|0|||
155191547|NCT00464269|560140774|FG000|Overall Study|Lost to Follow-up|0|||
155037842|NCT01897571|559565756|FG001|Overall Study|Lost to Follow-up|0|||
155191548|NCT00464269|560140775|FG001|Overall Study|Lost to Follow-up|4|||
155191549|NCT00464269|560140776|FG002|Overall Study|Lost to Follow-up|0|||
155191550|NCT00464269|560140777|FG003|Overall Study|Lost to Follow-up|1|||
155191551|NCT00464269|560140774|FG000|Overall Study|Withdrawal by Subject|0|||
155191552|NCT00464269|560140775|FG001|Overall Study|Withdrawal by Subject|2|||
155037843|NCT01897571|559565757|FG002|Overall Study|Lost to Follow-up|0|||
155191553|NCT00464269|560140776|FG002|Overall Study|Withdrawal by Subject|1|||
155191554|NCT00464269|560140777|FG003|Overall Study|Withdrawal by Subject|1|||
155191555|NCT00464269|560140774|FG000|Overall Study|Other reason|3|||
155191556|NCT00464269|560140775|FG001|Overall Study|Other reason|3|||
155191557|NCT00464269|560140776|FG002|Overall Study|Other reason|1|||
155191558|NCT00464269|560140777|FG003|Overall Study|Other reason|1|||
155191559|NCT00464269|560140774|FG000|Overall Study|AE, serious fatal|0|||
155191560|NCT00464269|560140775|FG001|Overall Study|AE, serious fatal|0|||
155191561|NCT00464269|560140776|FG002|Overall Study|AE, serious fatal|1|||
155191562|NCT00464269|560140777|FG003|Overall Study|AE, serious fatal|1|||
155191563|NCT00464269|560140774|FG000|Overall Study|SAE, non-fatal|0|||
155191564|NCT00464269|560140775|FG001|Overall Study|SAE, non-fatal|0|||
155191565|NCT00464269|560140776|FG002|Overall Study|SAE, non-fatal|0|||
155191566|NCT00464269|560140777|FG003|Overall Study|SAE, non-fatal|1|||
155191567|NCT00464269|560140774|FG000|Overall Study|AE, non-serious non-fatal|2|||
155191568|NCT00464269|560140775|FG001|Overall Study|AE, non-serious non-fatal|8|||
155191569|NCT00464269|560140776|FG002|Overall Study|AE, non-serious non-fatal|3|||
155191570|NCT00464269|560140777|FG003|Overall Study|AE, non-serious non-fatal|4|||
155191571|NCT00464269|560140774|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155191572|NCT00464269|560140775|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155191573|NCT00464269|560140776|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
155191574|NCT00464269|560140777|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
155191575|NCT05055128|560140778|FG000|Overall Study|Adverse Event|0|||
155191576|NCT05055128|560140779|FG001|Overall Study|Adverse Event|0|||
155191577|NCT05055128|560140780|FG002|Overall Study|Adverse Event|0|||
155191578|NCT05055128|560140781|FG003|Overall Study|Adverse Event|1|||
155191579|NCT05055128|560140782|FG004|Overall Study|Adverse Event|1|||
155191580|NCT05055128|560140778|FG000|Overall Study|Protocol Violation|0|||
155191581|NCT05055128|560140779|FG001|Overall Study|Protocol Violation|0|||
155191582|NCT05055128|560140780|FG002|Overall Study|Protocol Violation|0|||
155191583|NCT05055128|560140781|FG003|Overall Study|Protocol Violation|1|||
155191584|NCT05055128|560140782|FG004|Overall Study|Protocol Violation|0|||
155191585|NCT05055128|560140778|FG000|Overall Study|Withdrawal by Subject|5|||
155191586|NCT05055128|560140779|FG001|Overall Study|Withdrawal by Subject|2|||
155191587|NCT05055128|560140780|FG002|Overall Study|Withdrawal by Subject|2|||
155191588|NCT05055128|560140781|FG003|Overall Study|Withdrawal by Subject|4|||
155191589|NCT05055128|560140782|FG004|Overall Study|Withdrawal by Subject|2|||
155191590|NCT05055128|560140778|FG000|Overall Study|Randomized By Mistake|0|||
155191591|NCT05055128|560140779|FG001|Overall Study|Randomized By Mistake|1|||
155191592|NCT05055128|560140780|FG002|Overall Study|Randomized By Mistake|0|||
155191593|NCT05055128|560140781|FG003|Overall Study|Randomized By Mistake|0|||
155191594|NCT05055128|560140782|FG004|Overall Study|Randomized By Mistake|0|||
155191595|NCT05055128|560140778|FG000|Overall Study|Other|1|||
155191596|NCT05055128|560140779|FG001|Overall Study|Other|0|||
155191597|NCT05055128|560140780|FG002|Overall Study|Other|0|||
155191598|NCT05055128|560140781|FG003|Overall Study|Other|0|||
155191599|NCT05055128|560140782|FG004|Overall Study|Other|0|||
155191600|NCT00747461|560140789|FG000|Overall Study|study terminated by sponsor|5|||
155191601|NCT04176705|560140791|FG000|Overall Study|Withdrawal by Subject|4|||
155191602|NCT04176705|560140792|FG001|Overall Study|Withdrawal by Subject|4|||
155191603|NCT04176705|560140791|FG000|Overall Study|Death|1|||
155191604|NCT04176705|560140792|FG001|Overall Study|Death|1|||
155191605|NCT04176705|560140791|FG000|Overall Study|Lost to Follow-up|3|||
155191606|NCT04176705|560140792|FG001|Overall Study|Lost to Follow-up|3|||
155191607|NCT04916769|560140795|FG000|Period 1|Physician Decision|0|||
155191608|NCT04916769|560140796|FG001|Period 1|Physician Decision|0|||
155191609|NCT04916769|560140797|FG002|Period 1|Physician Decision|0|||
155191610|NCT04916769|560140798|FG003|Period 1|Physician Decision|0|||
155191611|NCT04916769|560140799|FG004|Period 1|Physician Decision|0|||
155191612|NCT04916769|560140800|FG005|Period 1|Physician Decision|1|||
155191613|NCT04916769|560140795|FG000|Period 2|Physician Decision|0|||
155191614|NCT04916769|560140796|FG001|Period 2|Physician Decision|1|||
155191615|NCT04916769|560140797|FG002|Period 2|Physician Decision|0|||
155191616|NCT04916769|560140798|FG003|Period 2|Physician Decision|0|||
155191617|NCT04916769|560140799|FG004|Period 2|Physician Decision|0|||
155191618|NCT04916769|560140800|FG005|Period 2|Physician Decision|0|||
155191619|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
155191620|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
155191621|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
155191622|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
155191623|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
155191624|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
155191625|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
155191626|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
155191627|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
155191628|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
155191629|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
155191630|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
155191631|NCT03659916|560140801|FG000|Treatment Period (72 Weeks)|Other|1|||
155191632|NCT03659916|560140802|FG001|Treatment Period (72 Weeks)|Other|3|||
155191633|NCT03659916|560140803|FG002|Treatment Period (72 Weeks)|Other|9|||
155191634|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
155191635|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
155191636|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
155191637|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
155191638|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
155191639|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
155191640|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
155191641|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
155191642|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
155191643|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
155191644|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
155191645|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
155191646|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
155191647|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
155191648|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
155191649|NCT03659916|560140801|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
155191650|NCT03659916|560140802|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
155191651|NCT03659916|560140803|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
155191652|NCT03805646|560140804|FG000|Overall Study|Death|40|||
155191653|NCT03805646|560140805|FG001|Overall Study|Death|49|||
155191654|NCT03805646|560140804|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
155191655|NCT03805646|560140805|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
155191656|NCT04686786|560140807|FG000|Overall Study|Adverse Event|9|||
155191657|NCT04686786|560140807|FG000|Overall Study|Death|1|||
155191658|NCT04686786|560140807|FG000|Overall Study|Lack of Efficacy|25|||
155191659|NCT04686786|560140807|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
155191660|NCT04686786|560140807|FG000|Overall Study|Study Terminated by Sponsor|14|||
155191661|NCT04686786|560140807|FG000|Overall Study|Withdrawal by Subject|15|||
155191662|NCT04686786|560140807|FG000|Overall Study|Other than specified|1|||
155191663|NCT05628103|560140808|FG000|Overall Study|Adverse Event|7|||
155191664|NCT05628103|560140808|FG000|Overall Study|Withdrawal by Subject|3|||
155191665|NCT05628103|560140808|FG000|Overall Study|Lost to Follow-up|3|||
155191666|NCT05628103|560140808|FG000|Overall Study|Lack of Efficacy|1|||
155191667|NCT05628103|560140808|FG000|Overall Study|Non-Compliance With Study Drug|4|||
155191668|NCT04840888|560140809|FG000|Period 1|Withdrawal by Subject|0|||
155191669|NCT04840888|560140810|FG001|Period 1|Withdrawal by Subject|0|||
155191670|NCT04840888|560140811|FG002|Period 1|Withdrawal by Subject|0|||
155191671|NCT04840888|560140812|FG003|Period 1|Withdrawal by Subject|0|||
155191672|NCT04840888|560140813|FG004|Period 1|Withdrawal by Subject|1|||
155191673|NCT04840888|560140814|FG005|Period 1|Withdrawal by Subject|0|||
155191674|NCT04840888|560140809|FG000|Period 1|Adverse Event|0|||
155191675|NCT04840888|560140810|FG001|Period 1|Adverse Event|0|||
155191676|NCT04840888|560140811|FG002|Period 1|Adverse Event|1|||
155191677|NCT04840888|560140812|FG003|Period 1|Adverse Event|1|||
155191678|NCT04840888|560140813|FG004|Period 1|Adverse Event|10|||
155191679|NCT04840888|560140814|FG005|Period 1|Adverse Event|1|||
155191680|NCT04340193|560140816|FG000|Overall Study|Other reason|0|||
155191681|NCT04340193|560140817|FG001|Overall Study|Other reason|0|||
155191682|NCT04340193|560140818|FG002|Overall Study|Other reason|1|||
155191683|NCT04340193|560140816|FG000|Overall Study|Disease recurrence|0|||
155191684|NCT04340193|560140817|FG001|Overall Study|Disease recurrence|1|||
155191685|NCT04340193|560140818|FG002|Overall Study|Disease recurrence|0|||
155191686|NCT04340193|560140816|FG000|Overall Study|Study drug toxicity|1|||
155191687|NCT04340193|560140817|FG001|Overall Study|Study drug toxicity|0|||
155191688|NCT04340193|560140818|FG002|Overall Study|Study drug toxicity|0|||
155191689|NCT04340193|560140816|FG000|Overall Study|Disease progression|1|||
155037844|NCT01897571|559565758|FG003|Overall Study|Lost to Follow-up|0|||
155037845|NCT01897571|559565759|FG004|Overall Study|Lost to Follow-up|2|||
155037846|NCT01897571|559565760|FG005|Overall Study|Lost to Follow-up|0|||
155037847|NCT01897571|559565761|FG006|Overall Study|Lost to Follow-up|0|||
155037848|NCT01897571|559565762|FG007|Overall Study|Lost to Follow-up|0|||
155037849|NCT01897571|559565763|FG008|Overall Study|Lost to Follow-up|1|||
155191690|NCT04340193|560140817|FG001|Overall Study|Disease progression|2|||
155191691|NCT04340193|560140818|FG002|Overall Study|Disease progression|3|||
155191692|NCT04340193|560140816|FG000|Overall Study|Administrative reasons by sponsor|0|||
155191693|NCT04340193|560140817|FG001|Overall Study|Administrative reasons by sponsor|1|||
155191694|NCT04340193|560140818|FG002|Overall Study|Administrative reasons by sponsor|0|||
155191695|NCT04340193|560140816|FG000|Overall Study|Adverse Event|1|||
155191696|NCT04340193|560140817|FG001|Overall Study|Adverse Event|1|||
155191697|NCT04340193|560140818|FG002|Overall Study|Adverse Event|0|||
155191698|NCT03924869|560140819|FG000|Overall Study|Death|73|||
155191699|NCT03924869|560140820|FG001|Overall Study|Death|62|||
155037850|NCT01897571|559565764|FG009|Overall Study|Lost to Follow-up|2|||
155191700|NCT03924869|560140819|FG000|Overall Study|Lost to Follow-up|3|||
155191701|NCT03924869|560140820|FG001|Overall Study|Lost to Follow-up|0|||
155191702|NCT03924869|560140819|FG000|Overall Study|Physician Decision|0|||
155191703|NCT03924869|560140820|FG001|Overall Study|Physician Decision|3|||
155191704|NCT03924869|560140819|FG000|Overall Study|Withdrawal by Subject|7|||
155191705|NCT03924869|560140820|FG001|Overall Study|Withdrawal by Subject|3|||
155191706|NCT03924869|560140819|FG000|Overall Study|Study Terminated By Sponsor|144|||
155191707|NCT03924869|560140820|FG001|Overall Study|Study Terminated By Sponsor|153|||
155037851|NCT01897571|559565765|FG010|Overall Study|Lost to Follow-up|4|||
155037852|NCT01897571|559565755|FG000|Overall Study|Withdrawal by Subject|0|||
155037853|NCT01897571|559565756|FG001|Overall Study|Withdrawal by Subject|0|||
155191708|NCT04026711|560140825|FG000|Overall Study|Withdrawal by Subject|1|||
155191709|NCT04026711|560140826|FG001|Overall Study|Withdrawal by Subject|0|||
155191710|NCT04026711|560140825|FG000|Overall Study|mental health crisis|1|||
155191711|NCT04026711|560140826|FG001|Overall Study|mental health crisis|0|||
155191712|NCT04823650|560140827|FG000|Overall Study|Withdrawal by Subject|0|||
155191713|NCT04823650|560140828|FG001|Overall Study|Withdrawal by Subject|0|||
155191714|NCT04823650|560140829|FG002|Overall Study|Withdrawal by Subject|0|||
155191715|NCT04823650|560140830|FG003|Overall Study|Withdrawal by Subject|0|||
155191716|NCT04823650|560140831|FG004|Overall Study|Withdrawal by Subject|1|||
155191717|NCT04823650|560140832|FG005|Overall Study|Withdrawal by Subject|0|||
155191718|NCT04246372|560142245|FG000|Overall Study|Adverse Event|1|||
155191719|NCT04246372|560142245|FG000|Overall Study|Withdrawal by Subject|1|||
155191720|NCT04246372|560142245|FG000|Overall Study|Protocol Violation|2|||
155191721|NCT04246372|560142245|FG000|Overall Study|Physician Decision|1|||
155191722|NCT01314703|560142247|FG000|Overall Study|screen failure and closed enrollment|8|||
155191723|NCT02281773|560142253|FG000|Overall Study|Adverse Event|6|||
155191724|NCT02281773|560142254|FG001|Overall Study|Adverse Event|1|||
155191725|NCT02281773|560142255|FG002|Overall Study|Adverse Event|4|||
155191726|NCT02281773|560142256|FG003|Overall Study|Adverse Event|8|||
155191727|NCT02281773|560142257|FG004|Overall Study|Adverse Event|9|||
155191728|NCT02281773|560142253|FG000|Overall Study|Protocol Violation|1|||
155191729|NCT02281773|560142254|FG001|Overall Study|Protocol Violation|0|||
155191730|NCT02281773|560142255|FG002|Overall Study|Protocol Violation|0|||
155191731|NCT02281773|560142256|FG003|Overall Study|Protocol Violation|2|||
155191732|NCT02281773|560142257|FG004|Overall Study|Protocol Violation|2|||
155191733|NCT02281773|560142253|FG000|Overall Study|Lost to Follow-up|2|||
155191734|NCT02281773|560142254|FG001|Overall Study|Lost to Follow-up|2|||
155191735|NCT02281773|560142255|FG002|Overall Study|Lost to Follow-up|6|||
155191736|NCT02281773|560142256|FG003|Overall Study|Lost to Follow-up|2|||
155191737|NCT02281773|560142257|FG004|Overall Study|Lost to Follow-up|10|||
155191738|NCT02281773|560142253|FG000|Overall Study|Withdrawal by Subject|2|||
155191739|NCT02281773|560142254|FG001|Overall Study|Withdrawal by Subject|8|||
155191740|NCT02281773|560142255|FG002|Overall Study|Withdrawal by Subject|6|||
155191741|NCT02281773|560142256|FG003|Overall Study|Withdrawal by Subject|6|||
155191742|NCT02281773|560142257|FG004|Overall Study|Withdrawal by Subject|8|||
155191743|NCT02281773|560142253|FG000|Overall Study|Other Reason|0|||
155191744|NCT02281773|560142254|FG001|Overall Study|Other Reason|4|||
155191745|NCT02281773|560142255|FG002|Overall Study|Other Reason|2|||
155191746|NCT02281773|560142256|FG003|Overall Study|Other Reason|3|||
155191747|NCT02281773|560142257|FG004|Overall Study|Other Reason|1|||
155191748|NCT00385762|560142259|FG000|Overall Study|Adverse Event|1|||
155191749|NCT00385762|560142259|FG000|Overall Study|Lost to Follow-up|1|||
155191750|NCT03323502|560142263|FG000|Overall Study|Resident could not be linked to CMS data|594|||
155191751|NCT03323502|560142264|FG001|Overall Study|Resident could not be linked to CMS data|435|||
155191752|NCT03323502|560142263|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
155191753|NCT03323502|560142264|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
155191754|NCT03323502|560142263|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
155191755|NCT03323502|560142264|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
155191756|NCT03323502|560142263|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
155191757|NCT03323502|560142264|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
155191758|NCT03323502|560142263|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
155191759|NCT03323502|560142264|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
155191760|NCT03794583|560142265|FG000|Overall Study|Death|8|||
155191761|NCT03794583|560142265|FG000|Overall Study|Study Terminated by Sponsor|24|||
155191762|NCT03794583|560142265|FG000|Overall Study|Withdrawal by Subject|9|||
155191763|NCT02497612|560142267|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
155191764|NCT02497612|560142268|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
155191765|NCT02497612|560142269|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
155191766|NCT02497612|560142270|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
155191767|NCT02497612|560142267|FG000|Overall Study|Participant's request|2|||
155191768|NCT02497612|560142268|FG001|Overall Study|Participant's request|3|||
155191769|NCT02497612|560142269|FG002|Overall Study|Participant's request|4|||
155191770|NCT02497612|560142270|FG003|Overall Study|Participant's request|1|||
155191771|NCT02497612|560142267|FG000|Overall Study|Investigator's judgement|1|||
155191772|NCT02497612|560142268|FG001|Overall Study|Investigator's judgement|0|||
155191773|NCT02497612|560142269|FG002|Overall Study|Investigator's judgement|0|||
155191774|NCT02497612|560142270|FG003|Overall Study|Investigator's judgement|2|||
155191775|NCT02497612|560142267|FG000|Overall Study|Adverse Event|3|||
155191776|NCT02497612|560142268|FG001|Overall Study|Adverse Event|1|||
155191777|NCT02497612|560142269|FG002|Overall Study|Adverse Event|4|||
155191778|NCT02497612|560142270|FG003|Overall Study|Adverse Event|1|||
155191779|NCT02497612|560142267|FG000|Overall Study|Lost to Follow-up|1|||
155191780|NCT02497612|560142268|FG001|Overall Study|Lost to Follow-up|1|||
155191781|NCT02497612|560142269|FG002|Overall Study|Lost to Follow-up|0|||
155191782|NCT02497612|560142270|FG003|Overall Study|Lost to Follow-up|1|||
155191783|NCT02497612|560142267|FG000|Overall Study|Other unspecified|1|||
155191784|NCT02497612|560142268|FG001|Overall Study|Other unspecified|1|||
155191785|NCT02497612|560142269|FG002|Overall Study|Other unspecified|2|||
155191786|NCT02497612|560142270|FG003|Overall Study|Other unspecified|0|||
155191787|NCT02497612|560142267|FG000|Overall Study|Not eligible|1|||
155191788|NCT02497612|560142268|FG001|Overall Study|Not eligible|0|||
155191789|NCT02497612|560142269|FG002|Overall Study|Not eligible|0|||
155191790|NCT02497612|560142270|FG003|Overall Study|Not eligible|1|||
155191791|NCT02699697|560142271|FG000|Overall Study|Death|18|||
155191792|NCT02699697|560142272|FG001|Overall Study|Death|15|||
155191793|NCT02699697|560142271|FG000|Overall Study|Physician Decision|0|||
155191794|NCT02699697|560142272|FG001|Overall Study|Physician Decision|1|||
155191795|NCT02699697|560142271|FG000|Overall Study|Lost to Follow-up|2|||
155191796|NCT02699697|560142272|FG001|Overall Study|Lost to Follow-up|3|||
155191797|NCT02699697|560142271|FG000|Overall Study|Refused to follow up|1|||
155191798|NCT02699697|560142272|FG001|Overall Study|Refused to follow up|1|||
155191799|NCT02699697|560142271|FG000|Overall Study|Entered hospice care|5|||
155191800|NCT02699697|560142272|FG001|Overall Study|Entered hospice care|2|||
155191801|NCT02699697|560142271|FG000|Overall Study|Missing reason for discontinuation|6|||
155191802|NCT02699697|560142272|FG001|Overall Study|Missing reason for discontinuation|5|||
155191803|NCT00902668|560142273|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
155191804|NCT00615108|560142274|FG000|Overall Study|Adverse Event|122|||
155191805|NCT00615108|560142274|FG000|Overall Study|Other|370|||
155191806|NCT00615108|560142274|FG000|Overall Study|Lost to Follow-up|15|||
155191807|NCT01914757|560142275|FG000|Overall Study|Severe non-compliance to protocol|3|||
155191808|NCT01914757|560142276|FG001|Overall Study|Severe non-compliance to protocol|1|||
155191809|NCT01914757|560142277|FG002|Overall Study|Severe non-compliance to protocol|2|||
155191810|NCT01914757|560142275|FG000|Overall Study|Lost to Follow-up|5|||
155191811|NCT01914757|560142276|FG001|Overall Study|Lost to Follow-up|8|||
155191812|NCT01914757|560142277|FG002|Overall Study|Lost to Follow-up|6|||
155191813|NCT01914757|560142275|FG000|Overall Study|Withdrawal by Subject|15|||
155191814|NCT01914757|560142276|FG001|Overall Study|Withdrawal by Subject|27|||
155191815|NCT01914757|560142277|FG002|Overall Study|Withdrawal by Subject|19|||
155191816|NCT01914757|560142275|FG000|Overall Study|Death|2|||
155191817|NCT01914757|560142276|FG001|Overall Study|Death|2|||
155191818|NCT01914757|560142277|FG002|Overall Study|Death|1|||
155191819|NCT01914757|560142275|FG000|Overall Study|Adverse Event|4|||
155191820|NCT01914757|560142276|FG001|Overall Study|Adverse Event|3|||
155191821|NCT01914757|560142277|FG002|Overall Study|Adverse Event|4|||
155191822|NCT01914757|560142275|FG000|Overall Study|Study specific withdrawal criteria|0|||
155191823|NCT01914757|560142276|FG001|Overall Study|Study specific withdrawal criteria|1|||
155191824|NCT01914757|560142277|FG002|Overall Study|Study specific withdrawal criteria|0|||
155191825|NCT01914757|560142275|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155191826|NCT01914757|560142276|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155191827|NCT01914757|560142277|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
155191828|NCT01914757|560142275|FG000|Overall Study|Other reasons|5|||
155191829|NCT01914757|560142276|FG001|Overall Study|Other reasons|9|||
155191830|NCT01914757|560142277|FG002|Overall Study|Other reasons|4|||
155191831|NCT02476201|560142278|FG000|Overall Study|Unable to program MPP|9|||
155191832|NCT02476201|560142278|FG000|Overall Study|Study echo not performed|5|||
155191833|NCT02476201|560142278|FG000|Overall Study|Adverse Event|4|||
155191834|NCT02476201|560142278|FG000|Overall Study|Death|2|||
155191835|NCT02476201|560142278|FG000|Overall Study|Lost to Follow-up|2|||
155191836|NCT02476201|560142278|FG000|Overall Study|MPP programmed to OFF|2|||
155191837|NCT02476201|560142278|FG000|Overall Study|Withdrawal by Subject|1|||
155191838|NCT02476201|560142278|FG000|Overall Study|Unsuccessful implant|1|||
155191839|NCT00694707|560142287|FG000|Overall Study|Did Not Receive Treatment|0|||
155191840|NCT00694707|560142288|FG001|Overall Study|Did Not Receive Treatment|0|||
155191841|NCT00694707|560142289|FG002|Overall Study|Did Not Receive Treatment|1|||
155191842|NCT00694707|560142290|FG003|Overall Study|Did Not Receive Treatment|1|||
155191843|NCT00694707|560142291|FG004|Overall Study|Did Not Receive Treatment|1|||
155191844|NCT00694707|560142287|FG000|Overall Study|Adverse Event|22|||
155191845|NCT00694707|560142288|FG001|Overall Study|Adverse Event|14|||
155191846|NCT00694707|560142289|FG002|Overall Study|Adverse Event|8|||
155191847|NCT00694707|560142290|FG003|Overall Study|Adverse Event|12|||
155191848|NCT00694707|560142291|FG004|Overall Study|Adverse Event|13|||
155191849|NCT00694707|560142287|FG000|Overall Study|Insufficient Therapeutic Response|33|||
155191850|NCT00694707|560142288|FG001|Overall Study|Insufficient Therapeutic Response|18|||
155191851|NCT00694707|560142289|FG002|Overall Study|Insufficient Therapeutic Response|17|||
155191852|NCT00694707|560142290|FG003|Overall Study|Insufficient Therapeutic Response|15|||
155191853|NCT00694707|560142291|FG004|Overall Study|Insufficient Therapeutic Response|10|||
155191854|NCT00694707|560142287|FG000|Overall Study|Protocol Violation|1|||
155191855|NCT00694707|560142288|FG001|Overall Study|Protocol Violation|2|||
155191856|NCT00694707|560142289|FG002|Overall Study|Protocol Violation|1|||
155191857|NCT00694707|560142290|FG003|Overall Study|Protocol Violation|3|||
155191858|NCT00694707|560142291|FG004|Overall Study|Protocol Violation|1|||
155191859|NCT00694707|560142287|FG000|Overall Study|Withdrawal of Consent|14|||
155191860|NCT00694707|560142288|FG001|Overall Study|Withdrawal of Consent|18|||
155191861|NCT00694707|560142289|FG002|Overall Study|Withdrawal of Consent|22|||
155191862|NCT00694707|560142290|FG003|Overall Study|Withdrawal of Consent|16|||
155191863|NCT00694707|560142291|FG004|Overall Study|Withdrawal of Consent|15|||
155191864|NCT00694707|560142287|FG000|Overall Study|Lost to Follow-up|0|||
155191865|NCT00694707|560142288|FG001|Overall Study|Lost to Follow-up|1|||
155191866|NCT00694707|560142289|FG002|Overall Study|Lost to Follow-up|2|||
155191867|NCT00694707|560142290|FG003|Overall Study|Lost to Follow-up|0|||
155191868|NCT00694707|560142291|FG004|Overall Study|Lost to Follow-up|0|||
155191869|NCT00694707|560142287|FG000|Overall Study|Jeopardizing Parole Status|1|||
155191870|NCT00694707|560142288|FG001|Overall Study|Jeopardizing Parole Status|0|||
155191871|NCT00694707|560142289|FG002|Overall Study|Jeopardizing Parole Status|0|||
155191872|NCT00694707|560142290|FG003|Overall Study|Jeopardizing Parole Status|0|||
155191873|NCT00694707|560142291|FG004|Overall Study|Jeopardizing Parole Status|0|||
155037854|NCT01897571|559565757|FG002|Overall Study|Withdrawal by Subject|0|||
155037855|NCT01897571|559565758|FG003|Overall Study|Withdrawal by Subject|0|||
155037856|NCT01897571|559565759|FG004|Overall Study|Withdrawal by Subject|0|||
155037857|NCT01897571|559565760|FG005|Overall Study|Withdrawal by Subject|0|||
155037858|NCT01897571|559565761|FG006|Overall Study|Withdrawal by Subject|0|||
155037859|NCT01897571|559565762|FG007|Overall Study|Withdrawal by Subject|1|||
155037860|NCT01897571|559565763|FG008|Overall Study|Withdrawal by Subject|4|||
155037861|NCT01897571|559565764|FG009|Overall Study|Withdrawal by Subject|3|||
155037862|NCT01897571|559565765|FG010|Overall Study|Withdrawal by Subject|1|||
155037863|NCT01897571|559565755|FG000|Overall Study|Other|1|||
155037864|NCT01897571|559565756|FG001|Overall Study|Other|0|||
155037865|NCT01897571|559565757|FG002|Overall Study|Other|0|||
155037866|NCT01897571|559565758|FG003|Overall Study|Other|3|||
155037867|NCT01897571|559565759|FG004|Overall Study|Other|3|||
155037868|NCT01897571|559565760|FG005|Overall Study|Other|4|||
155191874|NCT00694707|560142287|FG000|Overall Study|Death in the Family|1|||
155191875|NCT00694707|560142288|FG001|Overall Study|Death in the Family|0|||
155191876|NCT00694707|560142289|FG002|Overall Study|Death in the Family|0|||
155191877|NCT00694707|560142290|FG003|Overall Study|Death in the Family|0|||
155191878|NCT00694707|560142291|FG004|Overall Study|Death in the Family|0|||
155191879|NCT00694707|560142287|FG000|Overall Study|Arrest by Police|0|||
155191880|NCT00694707|560142288|FG001|Overall Study|Arrest by Police|1|||
155191881|NCT00694707|560142289|FG002|Overall Study|Arrest by Police|0|||
155191882|NCT00694707|560142290|FG003|Overall Study|Arrest by Police|0|||
155191883|NCT00694707|560142291|FG004|Overall Study|Arrest by Police|0|||
155191884|NCT00694707|560142287|FG000|Overall Study|Administrative Reasons|0|||
155191885|NCT00694707|560142288|FG001|Overall Study|Administrative Reasons|1|||
155191886|NCT00694707|560142289|FG002|Overall Study|Administrative Reasons|0|||
155191887|NCT00694707|560142290|FG003|Overall Study|Administrative Reasons|2|||
155191888|NCT00694707|560142291|FG004|Overall Study|Administrative Reasons|0|||
155191889|NCT00694707|560142287|FG000|Overall Study|Notification of Past Head Injury|0|||
155191890|NCT00694707|560142288|FG001|Overall Study|Notification of Past Head Injury|0|||
155191891|NCT00694707|560142289|FG002|Overall Study|Notification of Past Head Injury|0|||
155191892|NCT00694707|560142290|FG003|Overall Study|Notification of Past Head Injury|1|||
155191893|NCT00694707|560142291|FG004|Overall Study|Notification of Past Head Injury|0|||
155191894|NCT04810481|560142295|FG000|Overall Study|Disqualified data sets|10|||
155191895|NCT04810481|560142296|FG001|Overall Study|Disqualified data sets|28|||
155191896|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
155037869|NCT01897571|559565761|FG006|Overall Study|Other|7|||
155037870|NCT01897571|559565762|FG007|Overall Study|Other|0|||
155037871|NCT01897571|559565763|FG008|Overall Study|Other|0|||
155037872|NCT01897571|559565764|FG009|Overall Study|Other|0|||
155191897|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
155191898|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
155191899|NCT00369707|560142299|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
155191900|NCT00369707|560142299|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
155037873|NCT01897571|559565765|FG010|Overall Study|Other|0|||
155037874|NCT01897571|559565755|FG000|Overall Study|Enrolled in rollover study|0|||
155191901|NCT00369707|560142299|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
155191902|NCT00369707|560142299|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
155191903|NCT00369707|560142299|FG000|Follow up for 2 Years After Treatment|Death|1|||
155191904|NCT00369707|560142299|FG000|Follow up for 2 Years After Treatment|Other|2|||
155191905|NCT04102098|560142301|FG000|Main Study Period|Ongoing in study|302|||
155191906|NCT04102098|560142302|FG001|Main Study Period|Ongoing in study|291|||
155191907|NCT04102098|560142301|FG000|Main Study Period|Death|20|||
155191908|NCT04102098|560142302|FG001|Main Study Period|Death|27|||
155191909|NCT04102098|560142301|FG000|Main Study Period|Lost to Follow-up|1|||
155191910|NCT04102098|560142302|FG001|Main Study Period|Lost to Follow-up|1|||
155191911|NCT04102098|560142301|FG000|Main Study Period|Physician Decision|0|||
155191912|NCT04102098|560142302|FG001|Main Study Period|Physician Decision|1|||
155191913|NCT04102098|560142301|FG000|Main Study Period|Withdrawal by Subject|11|||
155191914|NCT04102098|560142302|FG001|Main Study Period|Withdrawal by Subject|14|||
155191915|NCT04102098|560142301|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
155191916|NCT04102098|560142302|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
155191917|NCT04102098|560142301|FG000|Crossover: AS Who Crossed Over|Death|11|||
155191918|NCT04102098|560142302|FG001|Crossover: AS Who Crossed Over|Death|0|||
155191919|NCT04102098|560142301|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
155191920|NCT04102098|560142302|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
155191921|NCT01254292|560142310|FG000|Comparative Phase|Adverse Event|25|||
155191922|NCT01254292|560142311|FG001|Comparative Phase|Adverse Event|25|||
155191923|NCT01254292|560142310|FG000|Comparative Phase|Lost to Follow-up|3|||
155191924|NCT01254292|560142311|FG001|Comparative Phase|Lost to Follow-up|21|||
155191925|NCT01254292|560142310|FG000|Comparative Phase|Pregnancy|2|||
155191926|NCT01254292|560142311|FG001|Comparative Phase|Pregnancy|6|||
155191927|NCT01254292|560142310|FG000|Comparative Phase|Withdrawal by Subject|20|||
155191928|NCT01254292|560142311|FG001|Comparative Phase|Withdrawal by Subject|21|||
155191929|NCT01254292|560142310|FG000|Comparative Phase|Protocol Violation|1|||
155191930|NCT01254292|560142311|FG001|Comparative Phase|Protocol Violation|2|||
155191931|NCT01254292|560142310|FG000|Comparative Phase|Wish for pregnancy|4|||
155191932|NCT01254292|560142311|FG001|Comparative Phase|Wish for pregnancy|6|||
155191933|NCT01254292|560142310|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
155191934|NCT01254292|560142311|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
155191935|NCT01254292|560142310|FG000|LCS12 Extension Phase|Adverse Event|9|||
155191936|NCT01254292|560142311|FG001|LCS12 Extension Phase|Adverse Event|0|||
155191937|NCT01254292|560142310|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
155191938|NCT01254292|560142311|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
155191939|NCT01254292|560142310|FG000|LCS12 Extension Phase|Other unknown|4|||
155191940|NCT01254292|560142311|FG001|LCS12 Extension Phase|Other unknown|0|||
155191941|NCT01254292|560142310|FG000|LCS12 Extension Phase|Pregnancy|2|||
155191942|NCT01254292|560142311|FG001|LCS12 Extension Phase|Pregnancy|0|||
155191943|NCT01254292|560142310|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
155191944|NCT01254292|560142311|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
155191945|NCT02083081|560142312|FG000|Overall Study|Lost to Follow-up|31|||
155191946|NCT02083081|560142313|FG001|Overall Study|Lost to Follow-up|9|||
155191947|NCT01230710|560142316|FG000|Overall Study|Disease Progression|41|||
155191948|NCT01230710|560142316|FG000|Overall Study|Lost to Follow-up|3|||
155191949|NCT01230710|560142316|FG000|Overall Study|Death|4|||
155191950|NCT01230710|560142316|FG000|Overall Study|Withdrawal of Consent|1|||
155191951|NCT02905149|560142317|FG000|Overall Study|Lost to Follow-up|2|||
155191952|NCT02905149|560142318|FG001|Overall Study|Lost to Follow-up|0|||
155191953|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
155191954|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
155191955|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Physician Decision|1|||
155191956|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Physician Decision|0|||
155191957|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
155191958|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
155191959|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
155191960|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
155191961|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Adverse Event|15|||
155191962|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Adverse Event|0|||
155191963|NCT03277690|560142319|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
155191964|NCT03277690|560142320|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
155191965|NCT03277690|560142319|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
155191966|NCT03277690|560142320|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
155191967|NCT00747812|560142321|FG000|Overall Study|Research Site Staff Relocation|5|||
155037875|NCT01897571|559565756|FG001|Overall Study|Enrolled in rollover study|0|||
155191968|NCT00747812|560142322|FG001|Overall Study|Research Site Staff Relocation|3|||
155191969|NCT03109847|560142323|FG000|Overall Study|Withdrawal by Subject|1|||
155191970|NCT03109847|560142324|FG001|Overall Study|Withdrawal by Subject|0|||
155191971|NCT00299182|560142325|FG000|Overall Study|Withdrawal by Subject|0|||
155191972|NCT00299182|560142326|FG001|Overall Study|Withdrawal by Subject|0|||
155191973|NCT00299182|560142327|FG002|Overall Study|Withdrawal by Subject|1|||
155191974|NCT00299182|560142328|FG003|Overall Study|Withdrawal by Subject|0|||
155191975|NCT00299182|560142329|FG004|Overall Study|Withdrawal by Subject|1|||
155191976|NCT00299182|560142330|FG005|Overall Study|Withdrawal by Subject|2|||
155191977|NCT00299182|560142331|FG006|Overall Study|Withdrawal by Subject|0|||
155191978|NCT00299182|560142325|FG000|Overall Study|Chemotherapy Changed|0|||
155191979|NCT00299182|560142326|FG001|Overall Study|Chemotherapy Changed|0|||
155191980|NCT00299182|560142327|FG002|Overall Study|Chemotherapy Changed|1|||
155191981|NCT00299182|560142328|FG003|Overall Study|Chemotherapy Changed|0|||
155191982|NCT00299182|560142329|FG004|Overall Study|Chemotherapy Changed|1|||
155191983|NCT00299182|560142330|FG005|Overall Study|Chemotherapy Changed|0|||
155191984|NCT00299182|560142331|FG006|Overall Study|Chemotherapy Changed|1|||
155191985|NCT00299182|560142325|FG000|Overall Study|Adverse Event|0|||
155191986|NCT00299182|560142326|FG001|Overall Study|Adverse Event|0|||
155191987|NCT00299182|560142327|FG002|Overall Study|Adverse Event|0|||
155191988|NCT00299182|560142328|FG003|Overall Study|Adverse Event|0|||
155191989|NCT00299182|560142329|FG004|Overall Study|Adverse Event|0|||
155191990|NCT00299182|560142330|FG005|Overall Study|Adverse Event|1|||
155191991|NCT00299182|560142331|FG006|Overall Study|Adverse Event|0|||
155191992|NCT00299182|560142325|FG000|Overall Study|Not Eligible|0|||
155191993|NCT00299182|560142326|FG001|Overall Study|Not Eligible|0|||
155191994|NCT00299182|560142327|FG002|Overall Study|Not Eligible|0|||
155191995|NCT00299182|560142328|FG003|Overall Study|Not Eligible|0|||
155191996|NCT00299182|560142329|FG004|Overall Study|Not Eligible|1|||
155191997|NCT00299182|560142330|FG005|Overall Study|Not Eligible|0|||
155191998|NCT00299182|560142331|FG006|Overall Study|Not Eligible|0|||
155191999|NCT00771316|560142332|FG000|Overall Study|Adverse Event|0|||
155192000|NCT00771316|560142333|FG001|Overall Study|Adverse Event|1|||
155192001|NCT00771316|560142332|FG000|Overall Study|Patient withdrew consent|1|||
155192002|NCT00771316|560142333|FG001|Overall Study|Patient withdrew consent|0|||
155192003|NCT00771316|560142332|FG000|Overall Study|Discontinued due to early termination|1|||
155192004|NCT00771316|560142333|FG001|Overall Study|Discontinued due to early termination|0|||
155192005|NCT04068610|560142337|FG000|Overall Study|Death|4|||
155192006|NCT04068610|560142338|FG001|Overall Study|Death|8|||
155192007|NCT04068610|560142339|FG002|Overall Study|Death|13|||
155192008|NCT04068610|560142337|FG000|Overall Study|Lost to Follow-up|0|||
155192009|NCT04068610|560142338|FG001|Overall Study|Lost to Follow-up|2|||
155192010|NCT04068610|560142339|FG002|Overall Study|Lost to Follow-up|0|||
155192011|NCT04068610|560142337|FG000|Overall Study|Withdrawal by Subject|0|||
155192012|NCT04068610|560142338|FG001|Overall Study|Withdrawal by Subject|4|||
155192013|NCT04068610|560142339|FG002|Overall Study|Withdrawal by Subject|2|||
155192014|NCT04068610|560142337|FG000|Overall Study|Other|3|||
155192015|NCT04068610|560142338|FG001|Overall Study|Other|12|||
155192016|NCT04068610|560142339|FG002|Overall Study|Other|11|||
155192017|NCT05535972|560142340|FG000|Overall Study|Withdrawal by Subject|31|||
155192018|NCT05535972|560142340|FG000|Overall Study|Lost to Follow-up|5|||
155192019|NCT05535972|560142340|FG000|Overall Study|Adverse Event|6|||
155192020|NCT05535972|560142340|FG000|Overall Study|Protocol Deviation|2|||
155192021|NCT02649894|560142342|FG000|Overall Study|Adverse Event|1|||
155192022|NCT02649894|560142343|FG001|Overall Study|Adverse Event|0|||
155192023|NCT02649894|560142342|FG000|Overall Study|Physician Decision|0|||
155192024|NCT02649894|560142343|FG001|Overall Study|Physician Decision|1|||
155192025|NCT02649894|560142342|FG000|Overall Study|Withdrawal by Subject|5|||
155192026|NCT02649894|560142343|FG001|Overall Study|Withdrawal by Subject|2|||
155192027|NCT02649894|560142342|FG000|Overall Study|Lost to Follow-up|2|||
155192028|NCT02649894|560142343|FG001|Overall Study|Lost to Follow-up|1|||
155192029|NCT02649894|560142342|FG000|Overall Study|Death|30|||
155192030|NCT02649894|560142343|FG001|Overall Study|Death|7|||
155192031|NCT02649894|560142342|FG000|Overall Study|Other, not specified|6|||
155192032|NCT02649894|560142343|FG001|Overall Study|Other, not specified|0|||
155192033|NCT04590963|560142344|FG000|Overall Study|Death|118|||
155192034|NCT04590963|560142345|FG001|Overall Study|Death|59|||
155192035|NCT04590963|560142344|FG000|Overall Study|Lost to Follow-up|1|||
155192036|NCT04590963|560142345|FG001|Overall Study|Lost to Follow-up|1|||
155192037|NCT04590963|560142344|FG000|Overall Study|Progressive disease|0|||
155192038|NCT04590963|560142345|FG001|Overall Study|Progressive disease|1|||
155192039|NCT04590963|560142344|FG000|Overall Study|Study terminated by sponsor|103|||
155192040|NCT04590963|560142345|FG001|Overall Study|Study terminated by sponsor|50|||
155192041|NCT04590963|560142344|FG000|Overall Study|Withdrawal by Subject|15|||
155192042|NCT04590963|560142345|FG001|Overall Study|Withdrawal by Subject|8|||
155192043|NCT04590963|560142344|FG000|Overall Study|Ongoing at data cut-off|9|||
155192044|NCT04590963|560142345|FG001|Overall Study|Ongoing at data cut-off|4|||
155192045|NCT04590963|560142344|FG000|Overall Study|Screen failure|1|||
155192046|NCT04590963|560142345|FG001|Overall Study|Screen failure|0|||
155192047|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Death|1|||
155192048|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Death|4|||
155192049|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Death|4|||
155192050|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Death|1|||
155192051|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Death|6|||
155192052|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Death|0|||
155192053|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
155192054|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
155192055|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
155192056|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
155192057|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
155192058|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
155192059|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192060|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
155192061|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192062|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
155192063|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192064|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
155192065|NCT04430738|560142348|FG000|Phase 1: Dose Escalation|Other|1|||
155192066|NCT04430738|560142349|FG001|Phase 1: Dose Escalation|Other|0|||
155192067|NCT04430738|560142350|FG002|Phase 1: Dose Escalation|Other|0|||
155192068|NCT04430738|560142351|FG003|Phase 1: Dose Escalation|Other|0|||
155192069|NCT04430738|560142352|FG004|Phase 1: Dose Escalation|Other|0|||
155192070|NCT04430738|560142353|FG005|Phase 1: Dose Escalation|Other|0|||
155192071|NCT04430738|560142348|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192072|NCT04430738|560142349|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192073|NCT04430738|560142350|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192074|NCT04430738|560142351|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192075|NCT04430738|560142352|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
155192076|NCT04430738|560142353|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
155192077|NCT04430738|560142348|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192078|NCT04430738|560142349|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192079|NCT04430738|560142350|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192080|NCT04430738|560142351|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192081|NCT04430738|560142352|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
155192082|NCT04430738|560142353|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
155192083|NCT02628769|560142355|FG000|First Intervention|Adverse Event|1|||
155192084|NCT02628769|560142356|FG001|First Intervention|Adverse Event|0|||
155192085|NCT02628769|560142355|FG000|First Intervention|Withdrawal by Subject|0|||
155192086|NCT02628769|560142356|FG001|First Intervention|Withdrawal by Subject|1|||
155192087|NCT02628769|560142355|FG000|Second Intervention|Adverse Event|2|||
155192088|NCT02628769|560142356|FG001|Second Intervention|Adverse Event|0|||
155192089|NCT02628769|560142355|FG000|Second Intervention|Physician Decision|0|||
155192090|NCT02628769|560142356|FG001|Second Intervention|Physician Decision|1|||
155192091|NCT01467583|560142357|FG000|Overall Study|Death|1|||
155192092|NCT01467583|560142358|FG001|Overall Study|Death|1|||
155192093|NCT01467583|560142359|FG002|Overall Study|Death|0|||
155192094|NCT01467583|560142357|FG000|Overall Study|Withdrawal by Subject|1|||
155192095|NCT01467583|560142358|FG001|Overall Study|Withdrawal by Subject|0|||
155192096|NCT01467583|560142359|FG002|Overall Study|Withdrawal by Subject|0|||
155192097|NCT01467583|560142357|FG000|Overall Study|Protocol Violation|0|||
155192098|NCT01467583|560142358|FG001|Overall Study|Protocol Violation|0|||
155192099|NCT01467583|560142359|FG002|Overall Study|Protocol Violation|2|||
155192100|NCT00309985|560142361|FG000|Overall Study|Disease progression|12|||
155192101|NCT00309985|560142362|FG001|Overall Study|Disease progression|0|||
155192102|NCT00309985|560142361|FG000|Overall Study|Adverse Event|30|||
155192103|NCT00309985|560142362|FG001|Overall Study|Adverse Event|0|||
155192104|NCT00309985|560142361|FG000|Overall Study|Death|2|||
155192105|NCT00309985|560142362|FG001|Overall Study|Death|0|||
155192106|NCT00309985|560142361|FG000|Overall Study|Withdrawal by Subject|5|||
155192107|NCT00309985|560142362|FG001|Overall Study|Withdrawal by Subject|1|||
155192108|NCT00309985|560142361|FG000|Overall Study|Physician Decision|3|||
155192109|NCT00309985|560142362|FG001|Overall Study|Physician Decision|0|||
155192110|NCT00309985|560142361|FG000|Overall Study|Never started treatment|7|||
155192111|NCT00309985|560142362|FG001|Overall Study|Never started treatment|0|||
155192112|NCT00309985|560142361|FG000|Overall Study|Complicating disease|1|||
155192113|NCT00309985|560142362|FG001|Overall Study|Complicating disease|0|||
155192114|NCT00309985|560142361|FG000|Overall Study|Non-compliance|1|||
155192115|NCT00309985|560142362|FG001|Overall Study|Non-compliance|0|||
155192116|NCT00309985|560142361|FG000|Overall Study|Chemotherapy discontinued only|1|||
155192117|NCT00309985|560142362|FG001|Overall Study|Chemotherapy discontinued only|0|||
155192118|NCT04941456|560142363|FG000|Overall Study|Withdrawal by Subject|1|||
155192119|NCT04941456|560142364|FG001|Overall Study|Withdrawal by Subject|0|||
155192120|NCT04941456|560142363|FG000|Overall Study|Protocol Violation|1|||
155192121|NCT04941456|560142364|FG001|Overall Study|Protocol Violation|0|||
155192122|NCT02296684|560142365|FG000|Overall Study|Withdrawal by Subject|0|||
155192123|NCT02296684|560142366|FG001|Overall Study|Withdrawal by Subject|1|||
155192124|NCT02296684|560142367|FG002|Overall Study|Withdrawal by Subject|1|||
155192125|NCT02296684|560142365|FG000|Overall Study|Death|2|||
155192126|NCT02296684|560142366|FG001|Overall Study|Death|0|||
155192127|NCT02296684|560142367|FG002|Overall Study|Death|0|||
155192128|NCT05171777|560142368|FG000|Treatment Crossover Period|Adverse Event|9|||
155192129|NCT05171777|560142369|FG001|Treatment Crossover Period|Adverse Event|6|||
155192130|NCT05171777|560142370|FG002|Treatment Crossover Period|Adverse Event|0|||
155192131|NCT05171777|560142371|FG003|Treatment Crossover Period|Adverse Event|0|||
155192132|NCT05171777|560142368|FG000|Treatment Crossover Period|Death|5|||
155192133|NCT05171777|560142369|FG001|Treatment Crossover Period|Death|5|||
155192134|NCT05171777|560142370|FG002|Treatment Crossover Period|Death|0|||
155192135|NCT05171777|560142371|FG003|Treatment Crossover Period|Death|0|||
155192136|NCT05171777|560142368|FG000|Treatment Crossover Period|Disease Relapse|1|||
155192137|NCT05171777|560142369|FG001|Treatment Crossover Period|Disease Relapse|0|||
155192138|NCT05171777|560142370|FG002|Treatment Crossover Period|Disease Relapse|0|||
155192139|NCT05171777|560142371|FG003|Treatment Crossover Period|Disease Relapse|0|||
155192140|NCT05171777|560142368|FG000|Treatment Crossover Period|Reason not Specified|1|||
155192141|NCT05171777|560142369|FG001|Treatment Crossover Period|Reason not Specified|1|||
155192142|NCT05171777|560142370|FG002|Treatment Crossover Period|Reason not Specified|0|||
155192143|NCT05171777|560142371|FG003|Treatment Crossover Period|Reason not Specified|0|||
155192144|NCT05171777|560142368|FG000|Treatment Crossover Period|Physician Decision|0|||
155192145|NCT05171777|560142369|FG001|Treatment Crossover Period|Physician Decision|1|||
155192146|NCT05171777|560142370|FG002|Treatment Crossover Period|Physician Decision|0|||
155192147|NCT05171777|560142371|FG003|Treatment Crossover Period|Physician Decision|0|||
155192148|NCT05171777|560142368|FG000|Treatment Crossover Period|Progressive Disease|14|||
155192149|NCT05171777|560142369|FG001|Treatment Crossover Period|Progressive Disease|10|||
155192150|NCT05171777|560142370|FG002|Treatment Crossover Period|Progressive Disease|0|||
155192151|NCT05171777|560142371|FG003|Treatment Crossover Period|Progressive Disease|0|||
155192152|NCT05171777|560142368|FG000|Treatment Crossover Period|Protocol Violation|0|||
155192153|NCT05171777|560142369|FG001|Treatment Crossover Period|Protocol Violation|2|||
155192154|NCT05171777|560142370|FG002|Treatment Crossover Period|Protocol Violation|0|||
155192155|NCT05171777|560142371|FG003|Treatment Crossover Period|Protocol Violation|0|||
155192156|NCT05171777|560142368|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
155192157|NCT05171777|560142369|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
155192158|NCT05171777|560142370|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
155192159|NCT05171777|560142371|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
155192160|NCT05171777|560142368|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
155192161|NCT05171777|560142369|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
155192162|NCT05171777|560142370|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
155192163|NCT05171777|560142371|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
155192164|NCT05171777|560142368|FG000|Treatment Continuation Period|Adverse Event|0|||
155192165|NCT05171777|560142369|FG001|Treatment Continuation Period|Adverse Event|0|||
155192166|NCT05171777|560142370|FG002|Treatment Continuation Period|Adverse Event|3|||
155192167|NCT05171777|560142371|FG003|Treatment Continuation Period|Adverse Event|6|||
155192168|NCT05171777|560142368|FG000|Treatment Continuation Period|Death|0|||
155192169|NCT05171777|560142369|FG001|Treatment Continuation Period|Death|0|||
155192170|NCT05171777|560142370|FG002|Treatment Continuation Period|Death|1|||
155192171|NCT05171777|560142371|FG003|Treatment Continuation Period|Death|3|||
155192172|NCT05171777|560142368|FG000|Treatment Continuation Period|Disease Relapse|0|||
155192173|NCT05171777|560142369|FG001|Treatment Continuation Period|Disease Relapse|0|||
155192174|NCT05171777|560142370|FG002|Treatment Continuation Period|Disease Relapse|1|||
155192175|NCT05171777|560142371|FG003|Treatment Continuation Period|Disease Relapse|0|||
155192176|NCT05171777|560142368|FG000|Treatment Continuation Period|Lack of Efficacy|0|||
155192177|NCT05171777|560142369|FG001|Treatment Continuation Period|Lack of Efficacy|0|||
155192178|NCT05171777|560142370|FG002|Treatment Continuation Period|Lack of Efficacy|0|||
155192179|NCT05171777|560142371|FG003|Treatment Continuation Period|Lack of Efficacy|1|||
155192180|NCT05171777|560142368|FG000|Treatment Continuation Period|Physician Decision|0|||
155192181|NCT05171777|560142369|FG001|Treatment Continuation Period|Physician Decision|0|||
155192182|NCT05171777|560142370|FG002|Treatment Continuation Period|Physician Decision|0|||
155192183|NCT05171777|560142371|FG003|Treatment Continuation Period|Physician Decision|4|||
155192184|NCT05171777|560142368|FG000|Treatment Continuation Period|Progressive Disease|0|||
155192185|NCT05171777|560142369|FG001|Treatment Continuation Period|Progressive Disease|0|||
155192186|NCT05171777|560142370|FG002|Treatment Continuation Period|Progressive Disease|6|||
155192187|NCT05171777|560142371|FG003|Treatment Continuation Period|Progressive Disease|20|||
155192188|NCT05171777|560142368|FG000|Treatment Continuation Period|Study Ended by Sponsor|0|||
155192189|NCT05171777|560142369|FG001|Treatment Continuation Period|Study Ended by Sponsor|0|||
155192190|NCT05171777|560142370|FG002|Treatment Continuation Period|Study Ended by Sponsor|4|||
155192191|NCT05171777|560142371|FG003|Treatment Continuation Period|Study Ended by Sponsor|15|||
155192192|NCT05171777|560142368|FG000|Treatment Continuation Period|Symptomatic Deterioration|0|||
155192193|NCT05171777|560142369|FG001|Treatment Continuation Period|Symptomatic Deterioration|0|||
155192194|NCT05171777|560142370|FG002|Treatment Continuation Period|Symptomatic Deterioration|0|||
155192195|NCT05171777|560142371|FG003|Treatment Continuation Period|Symptomatic Deterioration|2|||
155192196|NCT05171777|560142368|FG000|Treatment Continuation Period|Withdrawal by Subject|0|||
155192197|NCT05171777|560142369|FG001|Treatment Continuation Period|Withdrawal by Subject|0|||
155192198|NCT05171777|560142370|FG002|Treatment Continuation Period|Withdrawal by Subject|0|||
155192199|NCT05171777|560142371|FG003|Treatment Continuation Period|Withdrawal by Subject|6|||
155192200|NCT02364713|560142372|FG000|Overall Study|Ineligible|2|||
155192201|NCT02364713|560142373|FG001|Overall Study|Ineligible|2|||
155192202|NCT05741528|560142376|FG000|Overall Study|Withdrawal by Subject|11|||
155192203|NCT05741528|560142376|FG000|Overall Study|Lost to Follow-up|3|||
155192204|NCT05741528|560142376|FG000|Overall Study|Adverse Event|2|||
155192205|NCT05741528|560142376|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155192206|NCT05741528|560142376|FG000|Overall Study|Reason Not Specified|1|||
155192207|NCT05938920|560142379|FG000|Overall Study|Adverse Event|1|||
155192208|NCT05938920|560142380|FG001|Overall Study|Adverse Event|3|||
155192209|NCT05938920|560142381|FG002|Overall Study|Adverse Event|2|||
155192210|NCT05938920|560142382|FG003|Overall Study|Adverse Event|1|||
155192211|NCT05938920|560142379|FG000|Overall Study|Death|0|||
155192212|NCT05938920|560142380|FG001|Overall Study|Death|1|||
155192213|NCT05938920|560142381|FG002|Overall Study|Death|0|||
155192214|NCT05938920|560142382|FG003|Overall Study|Death|0|||
155192215|NCT05938920|560142379|FG000|Overall Study|Lost to Follow-up|0|||
155192216|NCT05938920|560142380|FG001|Overall Study|Lost to Follow-up|0|||
155192217|NCT05938920|560142381|FG002|Overall Study|Lost to Follow-up|1|||
155192218|NCT05938920|560142382|FG003|Overall Study|Lost to Follow-up|0|||
155192219|NCT05938920|560142379|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
155192220|NCT05938920|560142380|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
155192221|NCT05938920|560142381|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
155192222|NCT05938920|560142382|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
155192223|NCT05938920|560142379|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
155192224|NCT05938920|560142380|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
155192225|NCT05938920|560142381|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
155192226|NCT05938920|560142382|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
155192227|NCT05938920|560142379|FG000|Overall Study|Participant Refused to Come In|0|||
155192228|NCT05938920|560142380|FG001|Overall Study|Participant Refused to Come In|0|||
155192229|NCT05938920|560142381|FG002|Overall Study|Participant Refused to Come In|1|||
155192230|NCT05938920|560142382|FG003|Overall Study|Participant Refused to Come In|0|||
155192231|NCT01251861|560142383|FG000|Overall Study|Disease progression|6|||
155192232|NCT01251861|560142384|FG001|Overall Study|Disease progression|6|||
155192233|NCT01251861|560142383|FG000|Overall Study|Adverse Event|2|||
155192234|NCT01251861|560142384|FG001|Overall Study|Adverse Event|17|||
155192235|NCT01251861|560142383|FG000|Overall Study|Withdrawal by Subject|2|||
155192236|NCT01251861|560142384|FG001|Overall Study|Withdrawal by Subject|2|||
155192237|NCT01251861|560142383|FG000|Overall Study|Alternative therapy|1|||
155192238|NCT01251861|560142384|FG001|Overall Study|Alternative therapy|0|||
155192239|NCT01251861|560142383|FG000|Overall Study|Other complicating disease|0|||
155192240|NCT01251861|560142384|FG001|Overall Study|Other complicating disease|1|||
155192241|NCT01251861|560142383|FG000|Overall Study|Physician Decision|1|||
155192242|NCT01251861|560142384|FG001|Overall Study|Physician Decision|0|||
155192243|NCT01251861|560142383|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
155192244|NCT01251861|560142384|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
155192245|NCT01251861|560142383|FG000|Overall Study|Other|1|||
155192246|NCT01251861|560142384|FG001|Overall Study|Other|0|||
155192247|NCT01251861|560142383|FG000|Overall Study|Never started therapy|4|||
155192248|NCT01251861|560142384|FG001|Overall Study|Never started therapy|1|||
155192249|NCT01251861|560142383|FG000|Overall Study|Potential interaction of drugs|0|||
155192250|NCT01251861|560142384|FG001|Overall Study|Potential interaction of drugs|1|||
155192251|NCT05439941|560143755|FG000|Overall Study|Lack of Efficacy|8|||
155192252|NCT05439941|560143756|FG001|Overall Study|Lack of Efficacy|5|||
155192253|NCT05439941|560143757|FG002|Overall Study|Lack of Efficacy|3|||
155192254|NCT05439941|560143755|FG000|Overall Study|Treatment Failure|0|||
155192255|NCT05439941|560143756|FG001|Overall Study|Treatment Failure|1|||
155192256|NCT05439941|560143757|FG002|Overall Study|Treatment Failure|0|||
155192257|NCT05439941|560143755|FG000|Overall Study|Adverse Event|1|||
155192258|NCT05439941|560143756|FG001|Overall Study|Adverse Event|3|||
155192259|NCT05439941|560143757|FG002|Overall Study|Adverse Event|0|||
155192260|NCT05439941|560143755|FG000|Overall Study|Adverse Event - Parent Study|1|||
155192261|NCT05439941|560143756|FG001|Overall Study|Adverse Event - Parent Study|0|||
155192262|NCT05439941|560143757|FG002|Overall Study|Adverse Event - Parent Study|0|||
155192263|NCT05439941|560143755|FG000|Overall Study|Pregnancy|1|||
155192264|NCT05439941|560143756|FG001|Overall Study|Pregnancy|0|||
155192265|NCT05439941|560143757|FG002|Overall Study|Pregnancy|0|||
155192266|NCT05439941|560143755|FG000|Overall Study|Withdrawal by Subject|9|||
155192267|NCT05439941|560143756|FG001|Overall Study|Withdrawal by Subject|6|||
155192268|NCT05439941|560143757|FG002|Overall Study|Withdrawal by Subject|10|||
155192269|NCT05439941|560143755|FG000|Overall Study|Non-Compliance|1|||
155192270|NCT05439941|560143756|FG001|Overall Study|Non-Compliance|1|||
155192271|NCT05439941|560143757|FG002|Overall Study|Non-Compliance|1|||
155192272|NCT05439941|560143755|FG000|Overall Study|Lost to Follow-up|2|||
155192273|NCT05439941|560143756|FG001|Overall Study|Lost to Follow-up|2|||
155192274|NCT05439941|560143757|FG002|Overall Study|Lost to Follow-up|0|||
155192275|NCT05439941|560143755|FG000|Overall Study|Physician Decision|1|||
155192276|NCT05439941|560143756|FG001|Overall Study|Physician Decision|0|||
155192277|NCT05439941|560143757|FG002|Overall Study|Physician Decision|0|||
155192278|NCT05439941|560143755|FG000|Overall Study|Trial Termination by Sponsor|78|||
155192279|NCT05439941|560143756|FG001|Overall Study|Trial Termination by Sponsor|83|||
155192280|NCT05439941|560143757|FG002|Overall Study|Trial Termination by Sponsor|65|||
155192281|NCT05439941|560143755|FG000|Overall Study|Other than Reasons Listed|2|||
155192282|NCT05439941|560143756|FG001|Overall Study|Other than Reasons Listed|1|||
155192283|NCT05439941|560143757|FG002|Overall Study|Other than Reasons Listed|0|||
155192284|NCT00573183|560143758|FG000|Overall Study|Lost to Follow-up|52|||
155192285|NCT00573183|560143759|FG001|Overall Study|Lost to Follow-up|50|||
155192286|NCT00573183|560143758|FG000|Overall Study|Withdrawal by Subject|8|||
155192287|NCT00573183|560143759|FG001|Overall Study|Withdrawal by Subject|2|||
155192288|NCT00573183|560143758|FG000|Overall Study|Death|0|||
155192289|NCT00573183|560143759|FG001|Overall Study|Death|1|||
155192290|NCT00573183|560143758|FG000|Overall Study|Adverse Event|2|||
155192291|NCT00573183|560143759|FG001|Overall Study|Adverse Event|0|||
155192292|NCT00573183|560143758|FG000|Overall Study|Incarceration|5|||
155192293|NCT00573183|560143759|FG001|Overall Study|Incarceration|8|||
155192294|NCT00573183|560143758|FG000|Overall Study|Other|5|||
155192295|NCT00573183|560143759|FG001|Overall Study|Other|2|||
155192296|NCT02362035|560143760|FG000|Overall Study|Death|67|||
155192297|NCT02362035|560143760|FG000|Overall Study|Lost to Follow-up|3|||
155192298|NCT02362035|560143760|FG000|Overall Study|Adverse Event|1|||
155192299|NCT02362035|560143760|FG000|Overall Study|Physician Decision|1|||
155192300|NCT02362035|560143760|FG000|Overall Study|Subject started another cancer therapy|10|||
155192301|NCT02362035|560143760|FG000|Overall Study|Study terminated by sponsor|45|||
155192302|NCT02362035|560143760|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
155192303|NCT02362035|560143760|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
155192304|NCT02362035|560143760|FG000|Overall Study|Disease progression|11|||
155192305|NCT02362035|560143760|FG000|Overall Study|Withdrawal by Subject|20|||
155192306|NCT01797731|560143763|FG000|Overall Study|Didn't have proper radiographs required|3|||
155192307|NCT01797731|560143764|FG001|Overall Study|Didn't have proper radiographs required|3|||
155192308|NCT01189604|560143770|FG000|Overall Study|Impossible to visit|0|||
155192309|NCT01189604|560143771|FG001|Overall Study|Impossible to visit|0|||
155192310|NCT01189604|560143772|FG002|Overall Study|Impossible to visit|0|||
155192311|NCT01189604|560143773|FG003|Overall Study|Impossible to visit|0|||
155192312|NCT01189604|560143774|FG004|Overall Study|Impossible to visit|0|||
155192313|NCT01189604|560143775|FG005|Overall Study|Impossible to visit|1|||
155192314|NCT01189604|560143776|FG006|Overall Study|Impossible to visit|0|||
155192315|NCT01189604|560143770|FG000|Overall Study|Adverse Event|0|||
155192316|NCT01189604|560143771|FG001|Overall Study|Adverse Event|1|||
155192317|NCT01189604|560143772|FG002|Overall Study|Adverse Event|0|||
155192318|NCT01189604|560143773|FG003|Overall Study|Adverse Event|0|||
155192319|NCT01189604|560143774|FG004|Overall Study|Adverse Event|2|||
155192320|NCT01189604|560143775|FG005|Overall Study|Adverse Event|0|||
155192321|NCT01189604|560143776|FG006|Overall Study|Adverse Event|1|||
155192322|NCT01189604|560143770|FG000|Overall Study|Withdrawal by Subject|1|||
155192323|NCT01189604|560143771|FG001|Overall Study|Withdrawal by Subject|0|||
155192324|NCT01189604|560143772|FG002|Overall Study|Withdrawal by Subject|0|||
155192325|NCT01189604|560143773|FG003|Overall Study|Withdrawal by Subject|0|||
155192326|NCT01189604|560143774|FG004|Overall Study|Withdrawal by Subject|0|||
155192327|NCT01189604|560143775|FG005|Overall Study|Withdrawal by Subject|0|||
155192328|NCT01189604|560143776|FG006|Overall Study|Withdrawal by Subject|0|||
155192329|NCT00986830|560143777|FG000|Overall Study|Death|1|||
155192330|NCT00986830|560143777|FG000|Overall Study|Lost to Follow-up|1|||
155192331|NCT00986830|560143777|FG000|Overall Study|Lack of Efficacy|1|||
155192332|NCT00986830|560143777|FG000|Overall Study|Unable to access sinus with device|5|||
155192333|NCT01495975|560143778|FG000|Overall Study|Lost to Follow-up|1|||
155192334|NCT01495975|560143779|FG001|Overall Study|Lost to Follow-up|0|||
155192335|NCT00808483|560143780|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
155192336|NCT00808483|560143781|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
155192337|NCT00808483|560143780|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
155192338|NCT00808483|560143781|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
155192339|NCT00808483|560143780|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
155192340|NCT00808483|560143781|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
155192341|NCT02038881|560143782|FG000|Overall Study|Withdrawal by Subject|0|||
155192342|NCT02038881|560143783|FG001|Overall Study|Withdrawal by Subject|0|||
155192343|NCT02038881|560143784|FG002|Overall Study|Withdrawal by Subject|1|||
155192344|NCT02038881|560143782|FG000|Overall Study|Lost to Follow-up|2|||
155192345|NCT02038881|560143783|FG001|Overall Study|Lost to Follow-up|0|||
155192346|NCT02038881|560143784|FG002|Overall Study|Lost to Follow-up|0|||
155192347|NCT02038881|560143782|FG000|Overall Study|incarcerated|1|||
155192348|NCT02038881|560143783|FG001|Overall Study|incarcerated|0|||
155192349|NCT02038881|560143784|FG002|Overall Study|incarcerated|0|||
155192350|NCT00333840|560143785|FG000|First-line Treatment Period|Adverse Event|38|||
155192351|NCT00333840|560143786|FG001|First-line Treatment Period|Adverse Event|37|||
155192352|NCT00333840|560143787|FG002|First-line Treatment Period|Adverse Event|0|||
155192353|NCT00333840|560143788|FG003|First-line Treatment Period|Adverse Event|0|||
155192354|NCT00333840|560143785|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
155192355|NCT00333840|560143786|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
155192356|NCT00333840|560143787|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
155192357|NCT00333840|560143788|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
155192358|NCT00333840|560143785|FG000|First-line Treatment Period|Abnormal procedure|2|||
155192359|NCT00333840|560143786|FG001|First-line Treatment Period|Abnormal procedure|0|||
155192360|NCT00333840|560143787|FG002|First-line Treatment Period|Abnormal procedure|0|||
155192361|NCT00333840|560143788|FG003|First-line Treatment Period|Abnormal procedure|0|||
155192362|NCT00333840|560143785|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
155192363|NCT00333840|560143786|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
155192364|NCT00333840|560143787|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192365|NCT00333840|560143788|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192366|NCT00333840|560143785|FG000|First-line Treatment Period|No longer required study drug|21|||
155192367|NCT00333840|560143786|FG001|First-line Treatment Period|No longer required study drug|8|||
155192368|NCT00333840|560143787|FG002|First-line Treatment Period|No longer required study drug|0|||
155192369|NCT00333840|560143788|FG003|First-line Treatment Period|No longer required study drug|0|||
155192370|NCT00333840|560143785|FG000|First-line Treatment Period|Protocol Violation|17|||
155192371|NCT00333840|560143786|FG001|First-line Treatment Period|Protocol Violation|17|||
155192372|NCT00333840|560143787|FG002|First-line Treatment Period|Protocol Violation|0|||
155192373|NCT00333840|560143788|FG003|First-line Treatment Period|Protocol Violation|0|||
155192374|NCT00333840|560143785|FG000|First-line Treatment Period|Subject withdrew consent|57|||
155192375|NCT00333840|560143786|FG001|First-line Treatment Period|Subject withdrew consent|77|||
155192376|NCT00333840|560143787|FG002|First-line Treatment Period|Subject withdrew consent|0|||
155192377|NCT00333840|560143788|FG003|First-line Treatment Period|Subject withdrew consent|0|||
155192378|NCT00333840|560143785|FG000|First-line Treatment Period|Lost to Follow-up|15|||
155192379|NCT00333840|560143786|FG001|First-line Treatment Period|Lost to Follow-up|6|||
155192380|NCT00333840|560143787|FG002|First-line Treatment Period|Lost to Follow-up|0|||
155192381|NCT00333840|560143788|FG003|First-line Treatment Period|Lost to Follow-up|0|||
155192382|NCT00333840|560143785|FG000|First-line Treatment Period|Administrative problems|12|||
155192383|NCT00333840|560143786|FG001|First-line Treatment Period|Administrative problems|6|||
155192384|NCT00333840|560143787|FG002|First-line Treatment Period|Administrative problems|0|||
155192385|NCT00333840|560143788|FG003|First-line Treatment Period|Administrative problems|0|||
155192386|NCT00333840|560143785|FG000|First-line Treatment Period|Death|19|||
155192387|NCT00333840|560143786|FG001|First-line Treatment Period|Death|2|||
155192388|NCT00333840|560143787|FG002|First-line Treatment Period|Death|0|||
155192389|NCT00333840|560143788|FG003|First-line Treatment Period|Death|0|||
155192390|NCT00333840|560143785|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
155192391|NCT00333840|560143786|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
155192392|NCT00333840|560143787|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
155192393|NCT00333840|560143788|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
155192394|NCT00333840|560143785|FG000|Second-line Treatment Period|Adverse Event|0|||
155192395|NCT00333840|560143786|FG001|Second-line Treatment Period|Adverse Event|0|||
155192396|NCT00333840|560143787|FG002|Second-line Treatment Period|Adverse Event|3|||
155192397|NCT00333840|560143788|FG003|Second-line Treatment Period|Adverse Event|34|||
155192398|NCT00333840|560143785|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
155192399|NCT00333840|560143786|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
155192400|NCT00333840|560143787|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
155192401|NCT00333840|560143788|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
155192402|NCT00333840|560143785|FG000|Second-line Treatment Period|Abnormal procedure|0|||
155192403|NCT00333840|560143786|FG001|Second-line Treatment Period|Abnormal procedure|0|||
155192404|NCT00333840|560143787|FG002|Second-line Treatment Period|Abnormal procedure|0|||
155192405|NCT00333840|560143788|FG003|Second-line Treatment Period|Abnormal procedure|1|||
155192406|NCT00333840|560143785|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192407|NCT00333840|560143786|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
155192408|NCT00333840|560143787|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
155192409|NCT00333840|560143788|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
155192410|NCT00333840|560143785|FG000|Second-line Treatment Period|No longer required study drug|0|||
155192411|NCT00333840|560143786|FG001|Second-line Treatment Period|No longer required study drug|0|||
155192412|NCT00333840|560143787|FG002|Second-line Treatment Period|No longer required study drug|1|||
155037876|NCT01897571|559565757|FG002|Overall Study|Enrolled in rollover study|0|||
155192413|NCT00333840|560143788|FG003|Second-line Treatment Period|No longer required study drug|14|||
155192414|NCT00333840|560143785|FG000|Second-line Treatment Period|Protocol Violation|0|||
155192415|NCT00333840|560143786|FG001|Second-line Treatment Period|Protocol Violation|0|||
155192416|NCT00333840|560143787|FG002|Second-line Treatment Period|Protocol Violation|1|||
155037877|NCT01897571|559565758|FG003|Overall Study|Enrolled in rollover study|0|||
155192417|NCT00333840|560143788|FG003|Second-line Treatment Period|Protocol Violation|10|||
155192418|NCT00333840|560143785|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
155192419|NCT00333840|560143786|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
155192420|NCT00333840|560143787|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
155192421|NCT00333840|560143788|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
155192422|NCT00333840|560143785|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
155192423|NCT00333840|560143786|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
155192424|NCT00333840|560143787|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
155192425|NCT00333840|560143788|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
155192426|NCT00333840|560143785|FG000|Second-line Treatment Period|Administrative problems|0|||
155192427|NCT00333840|560143786|FG001|Second-line Treatment Period|Administrative problems|0|||
155192428|NCT00333840|560143787|FG002|Second-line Treatment Period|Administrative problems|0|||
155192429|NCT00333840|560143788|FG003|Second-line Treatment Period|Administrative problems|7|||
155192430|NCT00333840|560143785|FG000|Second-line Treatment Period|Death|0|||
155192431|NCT00333840|560143786|FG001|Second-line Treatment Period|Death|0|||
155192432|NCT00333840|560143787|FG002|Second-line Treatment Period|Death|0|||
155192433|NCT00333840|560143788|FG003|Second-line Treatment Period|Death|9|||
155192434|NCT02357979|560143789|FG000|Overall Study|Lost to Follow-up|5|||
155192435|NCT02357979|560143790|FG001|Overall Study|Lost to Follow-up|5|||
155192436|NCT03945214|560143791|FG000|Overall Study|Lost to Follow-up|3|||
155192437|NCT03945214|560143792|FG001|Overall Study|Lost to Follow-up|4|||
155192438|NCT03945214|560143793|FG002|Overall Study|Lost to Follow-up|7|||
155192439|NCT03945214|560143794|FG003|Overall Study|Lost to Follow-up|4|||
155192440|NCT03449901|560143806|FG000|Overall Study|Progression|57|||
155192441|NCT03449901|560143807|FG001|Overall Study|Progression|12|||
155192442|NCT03449901|560143806|FG000|Overall Study|Adverse Event|3|||
155192443|NCT03449901|560143807|FG001|Overall Study|Adverse Event|0|||
155192444|NCT03449901|560143806|FG000|Overall Study|Death|6|||
155192445|NCT03449901|560143807|FG001|Overall Study|Death|2|||
155192446|NCT03449901|560143806|FG000|Overall Study|Withdrawal by Subject|12|||
155192447|NCT03449901|560143807|FG001|Overall Study|Withdrawal by Subject|1|||
155192448|NCT03449901|560143806|FG000|Overall Study|Physician Decision|1|||
155192449|NCT03449901|560143807|FG001|Overall Study|Physician Decision|0|||
155192450|NCT03449901|560143806|FG000|Overall Study|Patient elected for surgical intervention|1|||
155192451|NCT03449901|560143807|FG001|Overall Study|Patient elected for surgical intervention|0|||
155192452|NCT03449901|560143806|FG000|Overall Study|Patient off for other complicating disease|1|||
155192453|NCT03449901|560143807|FG001|Overall Study|Patient off for other complicating disease|0|||
155192454|NCT03150173|560143808|FG000|Overall Study|Lost to Follow-up|13|||
155192455|NCT03150173|560143809|FG001|Overall Study|Lost to Follow-up|5|||
155192456|NCT04041375|560143815|FG000|Intervention Phase|Withdrawal by Subject|2|||
155192457|NCT04041375|560143816|FG001|Intervention Phase|Withdrawal by Subject|2|||
155192458|NCT04041375|560143815|FG000|Follow-up Phase|Death|2|||
155192459|NCT04041375|560143816|FG001|Follow-up Phase|Death|0|||
155192460|NCT04041375|560143815|FG000|Follow-up Phase|Lost to Follow-up|2|||
155192461|NCT04041375|560143816|FG001|Follow-up Phase|Lost to Follow-up|1|||
155192462|NCT04041375|560143815|FG000|Follow-up Phase|Too ill|3|||
155192463|NCT04041375|560143816|FG001|Follow-up Phase|Too ill|0|||
155192464|NCT02404220|560143822|FG000|Overall Study|Adverse Event|0|||
155192465|NCT02404220|560143823|FG001|Overall Study|Adverse Event|0|||
155192466|NCT02404220|560143824|FG002|Overall Study|Adverse Event|1|||
155192467|NCT02404220|560143825|FG003|Overall Study|Adverse Event|0|||
155192468|NCT02404220|560143822|FG000|Overall Study|Death|5|||
155192469|NCT02404220|560143823|FG001|Overall Study|Death|5|||
155192470|NCT02404220|560143824|FG002|Overall Study|Death|3|||
155192471|NCT02404220|560143825|FG003|Overall Study|Death|8|||
155192472|NCT02404220|560143822|FG000|Overall Study|Progressive Disease|0|||
155192473|NCT02404220|560143823|FG001|Overall Study|Progressive Disease|0|||
155192474|NCT02404220|560143824|FG002|Overall Study|Progressive Disease|1|||
155192475|NCT02404220|560143825|FG003|Overall Study|Progressive Disease|1|||
155192476|NCT02404220|560143822|FG000|Overall Study|Study Terminated by Sponsor|0|||
155192477|NCT02404220|560143823|FG001|Overall Study|Study Terminated by Sponsor|0|||
155037878|NCT01897571|559565759|FG004|Overall Study|Enrolled in rollover study|0|||
155037879|NCT01897571|559565760|FG005|Overall Study|Enrolled in rollover study|0|||
155037880|NCT01897571|559565761|FG006|Overall Study|Enrolled in rollover study|0|||
155037881|NCT01897571|559565762|FG007|Overall Study|Enrolled in rollover study|9|||
155192478|NCT02404220|560143824|FG002|Overall Study|Study Terminated by Sponsor|2|||
155037882|NCT01897571|559565763|FG008|Overall Study|Enrolled in rollover study|7|||
155192479|NCT02404220|560143825|FG003|Overall Study|Study Terminated by Sponsor|1|||
155192480|NCT02404220|560143822|FG000|Overall Study|Withdrawal by Subject|0|||
155192481|NCT02404220|560143823|FG001|Overall Study|Withdrawal by Subject|1|||
155192482|NCT02404220|560143824|FG002|Overall Study|Withdrawal by Subject|0|||
155192483|NCT02404220|560143825|FG003|Overall Study|Withdrawal by Subject|0|||
155192484|NCT02404220|560143822|FG000|Overall Study|Enrolled but Never Treated|0|||
155192485|NCT02404220|560143823|FG001|Overall Study|Enrolled but Never Treated|2|||
155192486|NCT02404220|560143824|FG002|Overall Study|Enrolled but Never Treated|0|||
155192487|NCT02404220|560143825|FG003|Overall Study|Enrolled but Never Treated|0|||
155192488|NCT01708161|560143828|FG000|Overall Study|Adverse Event|1|||
155192489|NCT01708161|560143829|FG001|Overall Study|Adverse Event|3|||
155192490|NCT01708161|560143830|FG002|Overall Study|Adverse Event|4|||
155192491|NCT01708161|560143831|FG003|Overall Study|Adverse Event|2|||
155192492|NCT01708161|560143832|FG004|Overall Study|Adverse Event|3|||
155192493|NCT01708161|560143833|FG005|Overall Study|Adverse Event|0|||
155192494|NCT01708161|560143828|FG000|Overall Study|Death|0|||
155192495|NCT01708161|560143829|FG001|Overall Study|Death|0|||
155192496|NCT01708161|560143830|FG002|Overall Study|Death|0|||
155192497|NCT01708161|560143831|FG003|Overall Study|Death|1|||
155192498|NCT01708161|560143832|FG004|Overall Study|Death|0|||
155192499|NCT01708161|560143833|FG005|Overall Study|Death|1|||
155192500|NCT01708161|560143828|FG000|Overall Study|Withdrawal by Subject|0|||
155192501|NCT01708161|560143829|FG001|Overall Study|Withdrawal by Subject|1|||
155037883|NCT01897571|559565764|FG009|Overall Study|Enrolled in rollover study|9|||
155037884|NCT01897571|559565765|FG010|Overall Study|Enrolled in rollover study|1|||
155037885|NCT01897571|559565755|FG000|Overall Study|Death|2|||
155037886|NCT01897571|559565756|FG001|Overall Study|Death|2|||
155037887|NCT01897571|559565757|FG002|Overall Study|Death|3|||
155037888|NCT01897571|559565758|FG003|Overall Study|Death|6|||
155037889|NCT01897571|559565759|FG004|Overall Study|Death|7|||
155037890|NCT01897571|559565760|FG005|Overall Study|Death|9|||
155037891|NCT01897571|559565761|FG006|Overall Study|Death|5|||
155037892|NCT01897571|559565762|FG007|Overall Study|Death|22|||
155037893|NCT01897571|559565763|FG008|Overall Study|Death|23|||
155037894|NCT01897571|559565764|FG009|Overall Study|Death|129|||
155192502|NCT01708161|560143830|FG002|Overall Study|Withdrawal by Subject|1|||
155192503|NCT01708161|560143831|FG003|Overall Study|Withdrawal by Subject|0|||
155192504|NCT01708161|560143832|FG004|Overall Study|Withdrawal by Subject|0|||
155192505|NCT01708161|560143833|FG005|Overall Study|Withdrawal by Subject|0|||
155192506|NCT01708161|560143828|FG000|Overall Study|Administrative problems|0|||
155192507|NCT01708161|560143829|FG001|Overall Study|Administrative problems|1|||
155192508|NCT01708161|560143830|FG002|Overall Study|Administrative problems|0|||
155192509|NCT01708161|560143831|FG003|Overall Study|Administrative problems|0|||
155192510|NCT01708161|560143832|FG004|Overall Study|Administrative problems|0|||
155192511|NCT01708161|560143833|FG005|Overall Study|Administrative problems|0|||
155192512|NCT01708161|560143828|FG000|Overall Study|Disease progression|3|||
155192513|NCT01708161|560143829|FG001|Overall Study|Disease progression|5|||
155192514|NCT01708161|560143830|FG002|Overall Study|Disease progression|5|||
155192515|NCT01708161|560143831|FG003|Overall Study|Disease progression|13|||
155192516|NCT01708161|560143832|FG004|Overall Study|Disease progression|3|||
155192517|NCT01708161|560143833|FG005|Overall Study|Disease progression|0|||
155192518|NCT01672736|560143837|FG000|Overall Study|Available drug expired on 31 May 16|3|||
155192519|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
155192520|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
155192521|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
155192522|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
155192523|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
155192524|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
155192525|NCT01697358|560143838|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
155192526|NCT01697358|560143839|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
155192527|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
155192528|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
155192529|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
155192530|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
155037895|NCT01897571|559565765|FG010|Overall Study|Death|59|||
155037896|NCT02943785|559565766|FG000|Overall Study|Adverse Event|112|||
155037897|NCT02943785|559565767|FG001|Overall Study|Adverse Event|97|||
155192531|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
155037898|NCT02943785|559565766|FG000|Overall Study|Withdrawal by Subject|63|||
155037899|NCT02943785|559565767|FG001|Overall Study|Withdrawal by Subject|126|||
155037900|NCT02943785|559565766|FG000|Overall Study|Physician Decision|23|||
155037901|NCT02943785|559565767|FG001|Overall Study|Physician Decision|47|||
155037902|NCT02943785|559565766|FG000|Overall Study|Death|46|||
155192532|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
155192533|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
155192534|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
155192535|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
155192536|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
155192537|NCT01697358|560143838|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
155192538|NCT01697358|560143839|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
155192539|NCT02853344|560143840|FG000|Overall Study|Lost to Follow-up|1|||
155192540|NCT02853344|560143841|FG001|Overall Study|Lost to Follow-up|1|||
155037903|NCT02943785|559565767|FG001|Overall Study|Death|46|||
155037904|NCT02943785|559565766|FG000|Overall Study|Lost to Follow-up|1|||
155192541|NCT02853344|560143840|FG000|Overall Study|Withdrawal by Subject|2|||
155192542|NCT02853344|560143841|FG001|Overall Study|Withdrawal by Subject|4|||
155192543|NCT02853344|560143840|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
155192544|NCT02853344|560143841|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
155192545|NCT02853344|560143840|FG000|Overall Study|Death|70|||
155192546|NCT02853344|560143841|FG001|Overall Study|Death|112|||
155192547|NCT04251273|560143842|FG000|Overall Study|Lost to Follow-up|331|||
155192548|NCT04251273|560143843|FG001|Overall Study|Lost to Follow-up|290|||
155192549|NCT00810693|560143844|FG000|Treatment Period|Adverse Event|8|||
155192550|NCT00810693|560143845|FG001|Treatment Period|Adverse Event|1|||
155192551|NCT00810693|560143846|FG002|Treatment Period|Adverse Event|7|||
155192552|NCT00810693|560143844|FG000|Treatment Period|Death|0|||
155192553|NCT00810693|560143845|FG001|Treatment Period|Death|1|||
155192554|NCT00810693|560143846|FG002|Treatment Period|Death|2|||
155192555|NCT00810693|560143844|FG000|Treatment Period|Lack of Efficacy|0|||
155192556|NCT00810693|560143845|FG001|Treatment Period|Lack of Efficacy|0|||
155192557|NCT00810693|560143846|FG002|Treatment Period|Lack of Efficacy|1|||
155192558|NCT00810693|560143844|FG000|Treatment Period|Lost to Follow-up|1|||
155192559|NCT00810693|560143845|FG001|Treatment Period|Lost to Follow-up|0|||
155192560|NCT00810693|560143846|FG002|Treatment Period|Lost to Follow-up|0|||
155192561|NCT00810693|560143844|FG000|Treatment Period|Non-compliance|1|||
155192562|NCT00810693|560143845|FG001|Treatment Period|Non-compliance|0|||
155192563|NCT00810693|560143846|FG002|Treatment Period|Non-compliance|0|||
155192564|NCT00810693|560143844|FG000|Treatment Period|Protocol Violation|1|||
155192565|NCT00810693|560143845|FG001|Treatment Period|Protocol Violation|2|||
155192566|NCT00810693|560143846|FG002|Treatment Period|Protocol Violation|2|||
155192567|NCT00810693|560143844|FG000|Treatment Period|Withdrawal by Subject|6|||
155192568|NCT00810693|560143845|FG001|Treatment Period|Withdrawal by Subject|2|||
155192569|NCT00810693|560143846|FG002|Treatment Period|Withdrawal by Subject|3|||
155192570|NCT00810693|560143844|FG000|Treatment Period|Not treated|0|||
155192571|NCT00810693|560143845|FG001|Treatment Period|Not treated|1|||
155192572|NCT00810693|560143846|FG002|Treatment Period|Not treated|1|||
155192573|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Adverse Event|3|||
155192574|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Adverse Event|1|||
155192575|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Adverse Event|1|||
155192576|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Death|2|||
155192577|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Death|0|||
155192578|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Death|1|||
155192579|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
155192580|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
155192581|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
155192582|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
155192583|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
155192584|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
155192585|NCT00810693|560143844|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
155192586|NCT00810693|560143845|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
155192587|NCT00810693|560143846|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
155192588|NCT00936611|560143851|FG000|Overall Study|Progressive Disease|3|||
155192589|NCT00936611|560143851|FG000|Overall Study|New Systemic Therapy|22|||
155192590|NCT00936611|560143851|FG000|Overall Study|Lost to Follow-up|1|||
155192591|NCT00936611|560143851|FG000|Overall Study|Withdrawal by Subject|2|||
155192592|NCT00936611|560143851|FG000|Overall Study|Still on Follow-up|1|||
155192593|NCT00936611|560143851|FG000|Overall Study|Still on Active Therapy|7|||
155192594|NCT00936611|560143851|FG000|Overall Study|Ineligible for Study Drug|3|||
155192595|NCT02282358|560143854|FG000|Overall Study|Nonevaluable|1|||
155192596|NCT01898208|560143855|FG000|Overall Study|Positive blood culture|17|||
155192597|NCT01898208|560143856|FG001|Overall Study|Positive blood culture|23|||
155192598|NCT01898208|560143857|FG002|Overall Study|Positive blood culture|15|||
155192599|NCT01898208|560143855|FG000|Overall Study|Death/comfort care within 24 hours|10|||
155192600|NCT01898208|560143856|FG001|Overall Study|Death/comfort care within 24 hours|9|||
155192601|NCT01898208|560143857|FG002|Overall Study|Death/comfort care within 24 hours|8|||
155192602|NCT01898208|560143855|FG000|Overall Study|Negative Gram Stain|6|||
155192603|NCT01898208|560143856|FG001|Overall Study|Negative Gram Stain|9|||
155037905|NCT02943785|559565767|FG001|Overall Study|Lost to Follow-up|0|||
155037906|NCT02943785|559565766|FG000|Overall Study|Other|16|||
155037907|NCT02943785|559565767|FG001|Overall Study|Other|19|||
155192604|NCT01898208|560143857|FG002|Overall Study|Negative Gram Stain|6|||
155192605|NCT01898208|560143855|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
155192606|NCT01898208|560143856|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
155192607|NCT01898208|560143857|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
155192608|NCT01898208|560143855|FG000|Overall Study|System/Technical Error|1|||
155192609|NCT01898208|560143856|FG001|Overall Study|System/Technical Error|2|||
155192610|NCT01898208|560143857|FG002|Overall Study|System/Technical Error|3|||
155192611|NCT01898208|560143855|FG000|Overall Study|Lost to Follow-up|3|||
155192612|NCT01898208|560143856|FG001|Overall Study|Lost to Follow-up|1|||
155192613|NCT01898208|560143857|FG002|Overall Study|Lost to Follow-up|1|||
155192614|NCT02155881|560143858|FG000|Overall Study|Withdrawal by Subject|0|||
155192615|NCT02155881|560143859|FG001|Overall Study|Withdrawal by Subject|2|||
155192616|NCT02155881|560143858|FG000|Overall Study|Inappropriately randomized|2|||
155192617|NCT02155881|560143859|FG001|Overall Study|Inappropriately randomized|2|||
155192618|NCT00961649|560143860|FG000|Overall Study|Adverse Event|4|||
155192619|NCT00961649|560143861|FG001|Overall Study|Adverse Event|0|||
155192620|NCT00961649|560143862|FG002|Overall Study|Adverse Event|0|||
155192621|NCT00961649|560143863|FG003|Overall Study|Adverse Event|2|||
155192622|NCT00961649|560143860|FG000|Overall Study|Inadequate control of IOP|0|||
155192623|NCT00961649|560143861|FG001|Overall Study|Inadequate control of IOP|0|||
155192624|NCT00961649|560143862|FG002|Overall Study|Inadequate control of IOP|0|||
155192625|NCT00961649|560143863|FG003|Overall Study|Inadequate control of IOP|1|||
155192626|NCT00961649|560143860|FG000|Overall Study|Patient has travel plans during holidays|0|||
155192627|NCT00961649|560143861|FG001|Overall Study|Patient has travel plans during holidays|0|||
155192628|NCT00961649|560143862|FG002|Overall Study|Patient has travel plans during holidays|1|||
155192629|NCT00961649|560143863|FG003|Overall Study|Patient has travel plans during holidays|0|||
155192630|NCT00961649|560143860|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
155192631|NCT00961649|560143861|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
155192632|NCT00961649|560143862|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
155192633|NCT00961649|560143863|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
155192634|NCT00961649|560143860|FG000|Overall Study|Study terminated by sponsor|4|||
155192635|NCT00961649|560143861|FG001|Overall Study|Study terminated by sponsor|4|||
155037908|NCT02943785|559565766|FG000|Overall Study|Did not receive any study medication|21|||
155037909|NCT02943785|559565767|FG001|Overall Study|Did not receive any study medication|28|||
155037910|NCT01281956|559565768|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
155037911|NCT01281956|559565769|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
155192636|NCT00961649|560143862|FG002|Overall Study|Study terminated by sponsor|4|||
155192637|NCT00961649|560143863|FG003|Overall Study|Study terminated by sponsor|1|||
155192638|NCT04043728|560143864|FG000|Overall Study|Lost to Follow-up|1|||
155192639|NCT04043728|560143865|FG001|Overall Study|Lost to Follow-up|2|||
155192640|NCT04043728|560143866|FG002|Overall Study|Lost to Follow-up|0|||
155192641|NCT03841448|560143867|FG000|Double-blind Treatment (DBT) Period|Death|1|||
155192642|NCT03841448|560143868|FG001|Double-blind Treatment (DBT) Period|Death|1|||
155192643|NCT03841448|560143869|FG002|Double-blind Treatment (DBT) Period|Death|0|||
155192644|NCT03841448|560143870|FG003|Double-blind Treatment (DBT) Period|Death|0|||
155192645|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
155192646|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
155192647|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
155192648|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
155192649|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Death|0|||
155192650|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Death|0|||
155192651|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Death|0|||
155192652|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Death|1|||
155192653|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
155192654|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
155192655|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
155192656|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
155192657|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
155192658|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
155192659|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
155192660|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
155192661|NCT03841448|560143867|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
155192662|NCT03841448|560143868|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
155192663|NCT03841448|560143869|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
155192664|NCT03841448|560143870|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
155192665|NCT00586625|560143871|FG000|Overall Study|Adverse Event|6|||
155192666|NCT00586625|560143872|FG001|Overall Study|Adverse Event|6|||
155192667|NCT00586625|560143871|FG000|Overall Study|Protocol Violation|3|||
155192668|NCT00586625|560143872|FG001|Overall Study|Protocol Violation|0|||
155192669|NCT00586625|560143871|FG000|Overall Study|Withdrawal by Subject|32|||
155192670|NCT00586625|560143872|FG001|Overall Study|Withdrawal by Subject|10|||
155037912|NCT01904903|559565780|FG000|Overall Study|Withdrawal by Subject|1|||
155037913|NCT03578146|559565781|FG000|Overall Study|Did Not Receive Treatment|1|||
155192671|NCT00586625|560143871|FG000|Overall Study|Subject non-compliance|0|||
155192672|NCT00586625|560143872|FG001|Overall Study|Subject non-compliance|1|||
155192673|NCT00586625|560143871|FG000|Overall Study|Subject unable to return for visit|2|||
155192674|NCT00586625|560143872|FG001|Overall Study|Subject unable to return for visit|0|||
155192675|NCT03594994|560143873|FG000|Overall Study|Adverse Event|1|||
155192676|NCT03594994|560143874|FG001|Overall Study|Adverse Event|0|||
155037914|NCT03578146|559565782|FG001|Overall Study|Did Not Receive Treatment|0|||
155192677|NCT03594994|560143873|FG000|Overall Study|Withdrawal by Subject|0|||
155192678|NCT03594994|560143874|FG001|Overall Study|Withdrawal by Subject|1|||
155192679|NCT04452344|560143877|FG000|Overall Study|Withdrawal by Subject|3|||
155037915|NCT03578146|559565783|FG002|Overall Study|Did Not Receive Treatment|0|||
155037916|NCT03578146|559565784|FG003|Overall Study|Did Not Receive Treatment|0|||
155037917|NCT03578146|559565785|FG004|Overall Study|Did Not Receive Treatment|0|||
155037918|NCT03578146|559565786|FG005|Overall Study|Did Not Receive Treatment|2|||
155037919|NCT03578146|559565781|FG000|Overall Study|Lost to Follow-up|0|||
155037920|NCT03578146|559565782|FG001|Overall Study|Lost to Follow-up|1|||
155037921|NCT03578146|559565783|FG002|Overall Study|Lost to Follow-up|1|||
155037922|NCT03578146|559565784|FG003|Overall Study|Lost to Follow-up|0|||
155037923|NCT03578146|559565785|FG004|Overall Study|Lost to Follow-up|0|||
155037924|NCT03578146|559565786|FG005|Overall Study|Lost to Follow-up|1|||
155037925|NCT02079636|559565787|FG000|Overall Study|Death|2|||
155037926|NCT02079636|559565788|FG001|Overall Study|Death|1|||
155144094|NCT00543387|559959575|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
155144095|NCT00543387|559959576|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144096|NCT00543387|559959577|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144097|NCT00543387|559959578|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144098|NCT00543387|559959579|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
155144099|NCT00543387|559959569|FG000|Crossover Participants|Progressive Disease|0|||
155144100|NCT00543387|559959570|FG001|Crossover Participants|Progressive Disease|0|||
155144101|NCT00543387|559959571|FG002|Crossover Participants|Progressive Disease|0|||
155144102|NCT00543387|559959572|FG003|Crossover Participants|Progressive Disease|0|||
155144103|NCT00543387|559959573|FG004|Crossover Participants|Progressive Disease|0|||
155144104|NCT00543387|559959574|FG005|Crossover Participants|Progressive Disease|0|||
155144105|NCT00543387|559959575|FG006|Crossover Participants|Progressive Disease|0|||
155144106|NCT00543387|559959576|FG007|Crossover Participants|Progressive Disease|0|||
155144107|NCT00543387|559959577|FG008|Crossover Participants|Progressive Disease|0|||
155144108|NCT00543387|559959578|FG009|Crossover Participants|Progressive Disease|1|||
155144109|NCT00543387|559959579|FG010|Crossover Participants|Progressive Disease|2|||
155144110|NCT00543387|559959569|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
155144111|NCT00543387|559959570|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
155144112|NCT00543387|559959571|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
155144113|NCT00543387|559959572|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
155144114|NCT00543387|559959573|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
155144115|NCT00543387|559959574|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
155144116|NCT00543387|559959575|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
155144117|NCT00543387|559959576|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
155144118|NCT00543387|559959577|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
155144119|NCT00543387|559959578|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
155144120|NCT00543387|559959579|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
155144121|NCT03932760|559959582|FG000|Overall Study|Became Ineligible|2|||
155144122|NCT03932760|559959583|FG001|Overall Study|Became Ineligible|5|||
155144123|NCT03932760|559959582|FG000|Overall Study|Withdrawal by Subject|6|||
155144124|NCT03932760|559959583|FG001|Overall Study|Withdrawal by Subject|6|||
155144125|NCT01223183|559959587|FG000|Imaging Day 1|Physician Decision|0|||
155144126|NCT01223183|559959588|FG001|Imaging Day 1|Physician Decision|1|||
155144127|NCT01223183|559959587|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
155144128|NCT01223183|559959588|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
155144129|NCT01223183|559959587|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
155144130|NCT01223183|559959588|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
155144131|NCT04725500|559959589|FG000|Screening|Screen Failure|26|||
155144132|NCT04725500|559959589|FG000|Screening|Withdrawal by Subject|1|||
155144133|NCT04725500|559959589|FG000|2 Week Take Home|Screen Fail|5|||
155144134|NCT03772665|559959591|FG000|Overall Study|Protocol Violation|1|||
155144135|NCT03772665|559959592|FG001|Overall Study|Protocol Violation|0|||
155037927|NCT02079636|559565789|FG002|Overall Study|Death|0|||
155037928|NCT02079636|559565790|FG003|Overall Study|Death|5|||
155144136|NCT03553758|559961046|FG000|Overall Study|Lost to Follow-up|1|||
155144137|NCT01467505|559961049|FG000|Overall Study|Adverse Event|1|||
155144138|NCT01467505|559961050|FG001|Overall Study|Adverse Event|0|||
155144139|NCT01467505|559961049|FG000|Overall Study|Withdrawal by Subject|4|||
155037929|NCT02079636|559565791|FG004|Overall Study|Death|1|||
155144140|NCT01467505|559961050|FG001|Overall Study|Withdrawal by Subject|0|||
155144141|NCT01467505|559961049|FG000|Overall Study|Study Terminated by Sponsor|28|||
155144142|NCT01467505|559961050|FG001|Overall Study|Study Terminated by Sponsor|3|||
155144143|NCT02719171|559961051|FG000|Overall Study|Adverse Event|1|||
155144144|NCT02719171|559961052|FG001|Overall Study|Adverse Event|2|||
155144145|NCT02719171|559961053|FG002|Overall Study|Adverse Event|0|||
155144146|NCT02719171|559961054|FG003|Overall Study|Adverse Event|0|||
155144147|NCT02719171|559961055|FG004|Overall Study|Adverse Event|2|||
155144148|NCT02719171|559961051|FG000|Overall Study|Lost to Follow-up|0|||
155144149|NCT02719171|559961052|FG001|Overall Study|Lost to Follow-up|0|||
155144150|NCT02719171|559961053|FG002|Overall Study|Lost to Follow-up|1|||
155144151|NCT02719171|559961054|FG003|Overall Study|Lost to Follow-up|0|||
155144152|NCT02719171|559961055|FG004|Overall Study|Lost to Follow-up|0|||
155144153|NCT02719171|559961051|FG000|Overall Study|Subject Withdrawal|0|||
155192680|NCT04452344|560143878|FG001|Overall Study|Withdrawal by Subject|6|||
155192681|NCT04452344|560143877|FG000|Overall Study|Adverse Event|1|||
155192682|NCT04452344|560143878|FG001|Overall Study|Adverse Event|2|||
155192683|NCT04452344|560143877|FG000|Overall Study|Lost to Follow-up|2|||
155192684|NCT04452344|560143878|FG001|Overall Study|Lost to Follow-up|2|||
155192685|NCT04452344|560143877|FG000|Overall Study|No Post-Op Visit|6|||
155192686|NCT04452344|560143878|FG001|Overall Study|No Post-Op Visit|7|||
155192687|NCT03350620|560143880|FG000|Stage 2|Adverse Event|0|||
155192688|NCT03350620|560143881|FG001|Stage 2|Adverse Event|1|||
155192689|NCT03350620|560143882|FG002|Stage 2|Adverse Event|1|||
155192690|NCT03350620|560143880|FG000|Stage 2|Lack of Efficacy|0|||
155192691|NCT03350620|560143881|FG001|Stage 2|Lack of Efficacy|2|||
155192692|NCT03350620|560143882|FG002|Stage 2|Lack of Efficacy|0|||
155192693|NCT03350620|560143880|FG000|Stage 2|Lost to Follow-up|1|||
155192694|NCT03350620|560143881|FG001|Stage 2|Lost to Follow-up|2|||
155192695|NCT03350620|560143882|FG002|Stage 2|Lost to Follow-up|2|||
155192696|NCT03350620|560143880|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
155192697|NCT03350620|560143881|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
155192698|NCT03350620|560143882|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
155192699|NCT03001882|560143885|FG000|Overall Study|Death|1|||
155192700|NCT03001882|560143886|FG001|Overall Study|Death|0|||
155192701|NCT03001882|560143887|FG002|Overall Study|Death|0|||
155192702|NCT03001882|560143888|FG003|Overall Study|Death|3|||
155192703|NCT03001882|560143885|FG000|Overall Study|Participant withdrew consent|0|||
155192704|NCT03001882|560143886|FG001|Overall Study|Participant withdrew consent|1|||
155192705|NCT03001882|560143887|FG002|Overall Study|Participant withdrew consent|0|||
155192706|NCT03001882|560143888|FG003|Overall Study|Participant withdrew consent|5|||
155192707|NCT03001882|560143885|FG000|Overall Study|Other reasons|1|||
155192708|NCT03001882|560143886|FG001|Overall Study|Other reasons|2|||
155192709|NCT03001882|560143887|FG002|Overall Study|Other reasons|0|||
155192710|NCT03001882|560143888|FG003|Overall Study|Other reasons|5|||
155192711|NCT03001882|560143885|FG000|Overall Study|Administrative reason by sponsor|0|||
155192712|NCT03001882|560143886|FG001|Overall Study|Administrative reason by sponsor|0|||
155192713|NCT03001882|560143887|FG002|Overall Study|Administrative reason by sponsor|0|||
155192714|NCT03001882|560143888|FG003|Overall Study|Administrative reason by sponsor|1|||
155192715|NCT03001882|560143885|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
155192716|NCT03001882|560143886|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
155192717|NCT03001882|560143887|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
155192718|NCT03001882|560143888|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
155192719|NCT03001882|560143885|FG000|Overall Study|Not reported|0|||
155192720|NCT03001882|560143886|FG001|Overall Study|Not reported|0|||
155192721|NCT03001882|560143887|FG002|Overall Study|Not reported|0|||
155192722|NCT03001882|560143888|FG003|Overall Study|Not reported|6|||
155192723|NCT03001882|560143885|FG000|Overall Study|Maximum clinical benefit|2|||
155192724|NCT03001882|560143886|FG001|Overall Study|Maximum clinical benefit|3|||
155192725|NCT03001882|560143887|FG002|Overall Study|Maximum clinical benefit|0|||
155192726|NCT03001882|560143888|FG003|Overall Study|Maximum clinical benefit|10|||
155192727|NCT03001882|560143885|FG000|Overall Study|AE unrelated to study drug|3|||
155192728|NCT03001882|560143886|FG001|Overall Study|AE unrelated to study drug|3|||
155192729|NCT03001882|560143887|FG002|Overall Study|AE unrelated to study drug|0|||
155192730|NCT03001882|560143888|FG003|Overall Study|AE unrelated to study drug|11|||
155192731|NCT03001882|560143885|FG000|Overall Study|Study Drug Toxicity|8|||
155192732|NCT03001882|560143886|FG001|Overall Study|Study Drug Toxicity|5|||
155192733|NCT03001882|560143887|FG002|Overall Study|Study Drug Toxicity|0|||
155192734|NCT03001882|560143888|FG003|Overall Study|Study Drug Toxicity|37|||
155192735|NCT03001882|560143885|FG000|Overall Study|Disease progression|16|||
155192736|NCT03001882|560143886|FG001|Overall Study|Disease progression|14|||
155192737|NCT03001882|560143887|FG002|Overall Study|Disease progression|1|||
155192738|NCT03001882|560143888|FG003|Overall Study|Disease progression|90|||
155192739|NCT03507400|560143889|FG000|Overall Study|discontinued|5|||
155192740|NCT03507400|560143890|FG001|Overall Study|discontinued|1|||
155192741|NCT03507400|560143889|FG000|Overall Study|Lost to Follow-up|8|||
155192742|NCT03507400|560143890|FG001|Overall Study|Lost to Follow-up|6|||
155192743|NCT03507400|560143889|FG000|Overall Study|Protocol Violation|0|||
155192744|NCT03507400|560143890|FG001|Overall Study|Protocol Violation|1|||
155192745|NCT01555983|560143891|FG000|Overall Study|Withdrawal by Subject|1|||
155192746|NCT01555983|560143892|FG001|Overall Study|Withdrawal by Subject|0|||
155192747|NCT01555983|560143893|FG002|Overall Study|Withdrawal by Subject|0|||
155192748|NCT01555983|560143894|FG003|Overall Study|Withdrawal by Subject|0|||
155192749|NCT01555983|560143895|FG004|Overall Study|Withdrawal by Subject|1|||
155192750|NCT01555983|560143896|FG005|Overall Study|Withdrawal by Subject|1|||
155192751|NCT04102189|560143900|FG000|Overall Study|Withdrawal by Subject|1|||
155192752|NCT04102189|560143901|FG001|Overall Study|Withdrawal by Subject|2|||
155192753|NCT04102189|560143900|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155192754|NCT04102189|560143901|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155192755|NCT04102189|560143900|FG000|Overall Study|Lost to Follow-up|1|||
155192756|NCT04102189|560143901|FG001|Overall Study|Lost to Follow-up|0|||
155192757|NCT01950390|560143902|FG000|Overall Study|Never started treatment|3|||
155192758|NCT01950390|560143903|FG001|Overall Study|Never started treatment|2|||
155192759|NCT01950390|560143902|FG000|Overall Study|Disease progression|45|||
155192760|NCT01950390|560143903|FG001|Overall Study|Disease progression|52|||
155192761|NCT01950390|560143902|FG000|Overall Study|Adverse Event|22|||
155192762|NCT01950390|560143903|FG001|Overall Study|Adverse Event|16|||
155192763|NCT01950390|560143902|FG000|Overall Study|Death|5|||
155192764|NCT01950390|560143903|FG001|Overall Study|Death|3|||
155192765|NCT01950390|560143902|FG000|Overall Study|Withdrawal by Subject|5|||
155192766|NCT01950390|560143903|FG001|Overall Study|Withdrawal by Subject|1|||
155192767|NCT01950390|560143902|FG000|Overall Study|Alternative therapy|0|||
155192768|NCT01950390|560143903|FG001|Overall Study|Alternative therapy|3|||
155192769|NCT01950390|560143902|FG000|Overall Study|Complicating disease|1|||
155192770|NCT01950390|560143903|FG001|Overall Study|Complicating disease|0|||
155192771|NCT01950390|560143902|FG000|Overall Study|On treatment|1|||
155192772|NCT01950390|560143903|FG001|Overall Study|On treatment|0|||
155192773|NCT01950390|560143902|FG000|Overall Study|Symptomatic deterioration|2|||
155192774|NCT01950390|560143903|FG001|Overall Study|Symptomatic deterioration|1|||
155192775|NCT01950390|560143902|FG000|Overall Study|Physician Decision|0|||
155192776|NCT01950390|560143903|FG001|Overall Study|Physician Decision|4|||
155192777|NCT01950390|560143902|FG000|Overall Study|Lack of clinical benefit|0|||
155192778|NCT01950390|560143903|FG001|Overall Study|Lack of clinical benefit|1|||
155192779|NCT01950390|560143902|FG000|Overall Study|Maintained PR and moved to observation only|0|||
155192780|NCT01950390|560143903|FG001|Overall Study|Maintained PR and moved to observation only|1|||
155192781|NCT00717093|560145418|FG000|Overall Study|Adverse Event|19|||
155192782|NCT00717093|560145419|FG001|Overall Study|Adverse Event|9|||
155192783|NCT00717093|560145418|FG000|Overall Study|Lack of Efficacy|3|||
155192784|NCT00717093|560145419|FG001|Overall Study|Lack of Efficacy|13|||
155192785|NCT00717093|560145418|FG000|Overall Study|Lost to Follow-up|9|||
155192786|NCT00717093|560145419|FG001|Overall Study|Lost to Follow-up|6|||
155192787|NCT00717093|560145418|FG000|Overall Study|Withdrawal by Subject|12|||
155192788|NCT00717093|560145419|FG001|Overall Study|Withdrawal by Subject|19|||
155192789|NCT00717093|560145418|FG000|Overall Study|Other|0|||
155192790|NCT00717093|560145419|FG001|Overall Study|Other|1|||
155192791|NCT00717093|560145418|FG000|Overall Study|Randomized but not treated|1|||
155192792|NCT00717093|560145419|FG001|Overall Study|Randomized but not treated|0|||
155192793|NCT01543698|560145424|FG000|Phase 1b|Disease progression|2|||
155192794|NCT01543698|560145425|FG001|Phase 1b|Disease progression|4|||
155192795|NCT01543698|560145426|FG002|Phase 1b|Disease progression|3|||
155192796|NCT01543698|560145427|FG003|Phase 1b|Disease progression|2|||
155192797|NCT01543698|560145428|FG004|Phase 1b|Disease progression|10|||
155192798|NCT01543698|560145429|FG005|Phase 1b|Disease progression|6|||
155192799|NCT01543698|560145430|FG006|Phase 1b|Disease progression|5|||
155192800|NCT01543698|560145431|FG007|Phase 1b|Disease progression|3|||
155192801|NCT01543698|560145432|FG008|Phase 1b|Disease progression|4|||
155192802|NCT01543698|560145433|FG009|Phase 1b|Disease progression|5|||
155192803|NCT01543698|560145434|FG010|Phase 1b|Disease progression|1|||
155192804|NCT01543698|560145435|FG011|Phase 1b|Disease progression|0|||
155192805|NCT01543698|560145436|FG012|Phase 1b|Disease progression|0|||
155192806|NCT01543698|560145437|FG013|Phase 1b|Disease progression|0|||
155192807|NCT01543698|560145438|FG014|Phase 1b|Disease progression|0|||
155192808|NCT01543698|560145424|FG000|Phase 1b|Death|0|||
155192809|NCT01543698|560145425|FG001|Phase 1b|Death|0|||
155192810|NCT01543698|560145426|FG002|Phase 1b|Death|1|||
155192811|NCT01543698|560145427|FG003|Phase 1b|Death|1|||
155192812|NCT01543698|560145428|FG004|Phase 1b|Death|0|||
155192813|NCT01543698|560145429|FG005|Phase 1b|Death|0|||
155192814|NCT01543698|560145430|FG006|Phase 1b|Death|0|||
155192815|NCT01543698|560145431|FG007|Phase 1b|Death|0|||
155192816|NCT01543698|560145432|FG008|Phase 1b|Death|0|||
155192817|NCT01543698|560145433|FG009|Phase 1b|Death|0|||
155192818|NCT01543698|560145434|FG010|Phase 1b|Death|1|||
155192819|NCT01543698|560145435|FG011|Phase 1b|Death|0|||
155192820|NCT01543698|560145436|FG012|Phase 1b|Death|0|||
155037930|NCT02079636|559565792|FG005|Overall Study|Death|2|||
155192821|NCT01543698|560145437|FG013|Phase 1b|Death|0|||
155037931|NCT02079636|559565793|FG006|Overall Study|Death|1|||
155192822|NCT01543698|560145438|FG014|Phase 1b|Death|0|||
155192823|NCT01543698|560145424|FG000|Phase 1b|Withdrawal by Subject|0|||
155192824|NCT01543698|560145425|FG001|Phase 1b|Withdrawal by Subject|1|||
155192825|NCT01543698|560145426|FG002|Phase 1b|Withdrawal by Subject|0|||
155192826|NCT01543698|560145427|FG003|Phase 1b|Withdrawal by Subject|1|||
155192827|NCT01543698|560145428|FG004|Phase 1b|Withdrawal by Subject|0|||
155192828|NCT01543698|560145429|FG005|Phase 1b|Withdrawal by Subject|0|||
155192829|NCT01543698|560145430|FG006|Phase 1b|Withdrawal by Subject|1|||
155192830|NCT01543698|560145431|FG007|Phase 1b|Withdrawal by Subject|0|||
155192831|NCT01543698|560145432|FG008|Phase 1b|Withdrawal by Subject|0|||
155192832|NCT01543698|560145433|FG009|Phase 1b|Withdrawal by Subject|0|||
155192833|NCT01543698|560145434|FG010|Phase 1b|Withdrawal by Subject|0|||
155192834|NCT01543698|560145435|FG011|Phase 1b|Withdrawal by Subject|0|||
155192835|NCT01543698|560145436|FG012|Phase 1b|Withdrawal by Subject|0|||
155192836|NCT01543698|560145437|FG013|Phase 1b|Withdrawal by Subject|0|||
155192837|NCT01543698|560145438|FG014|Phase 1b|Withdrawal by Subject|0|||
155192838|NCT01543698|560145424|FG000|Phase 1b|Adverse Event|1|||
155192839|NCT01543698|560145425|FG001|Phase 1b|Adverse Event|0|||
155192840|NCT01543698|560145426|FG002|Phase 1b|Adverse Event|0|||
155192841|NCT01543698|560145427|FG003|Phase 1b|Adverse Event|1|||
155192842|NCT01543698|560145428|FG004|Phase 1b|Adverse Event|2|||
155192843|NCT01543698|560145429|FG005|Phase 1b|Adverse Event|2|||
155192844|NCT01543698|560145430|FG006|Phase 1b|Adverse Event|0|||
155192845|NCT01543698|560145431|FG007|Phase 1b|Adverse Event|0|||
155192846|NCT01543698|560145432|FG008|Phase 1b|Adverse Event|1|||
155192847|NCT01543698|560145433|FG009|Phase 1b|Adverse Event|1|||
155192848|NCT01543698|560145434|FG010|Phase 1b|Adverse Event|2|||
155192849|NCT01543698|560145435|FG011|Phase 1b|Adverse Event|0|||
155192850|NCT01543698|560145436|FG012|Phase 1b|Adverse Event|0|||
155192851|NCT01543698|560145437|FG013|Phase 1b|Adverse Event|0|||
155192852|NCT01543698|560145438|FG014|Phase 1b|Adverse Event|0|||
155192853|NCT01543698|560145424|FG000|Phase 1b|Administrative problems|1|||
155192854|NCT01543698|560145425|FG001|Phase 1b|Administrative problems|0|||
155192855|NCT01543698|560145426|FG002|Phase 1b|Administrative problems|0|||
155192856|NCT01543698|560145427|FG003|Phase 1b|Administrative problems|0|||
155192857|NCT01543698|560145428|FG004|Phase 1b|Administrative problems|1|||
155192858|NCT01543698|560145429|FG005|Phase 1b|Administrative problems|0|||
155192859|NCT01543698|560145430|FG006|Phase 1b|Administrative problems|0|||
155192860|NCT01543698|560145431|FG007|Phase 1b|Administrative problems|1|||
155192861|NCT01543698|560145432|FG008|Phase 1b|Administrative problems|0|||
155192862|NCT01543698|560145433|FG009|Phase 1b|Administrative problems|0|||
155192863|NCT01543698|560145434|FG010|Phase 1b|Administrative problems|2|||
155192864|NCT01543698|560145435|FG011|Phase 1b|Administrative problems|0|||
155192865|NCT01543698|560145436|FG012|Phase 1b|Administrative problems|0|||
155192866|NCT01543698|560145437|FG013|Phase 1b|Administrative problems|0|||
155192867|NCT01543698|560145438|FG014|Phase 1b|Administrative problems|0|||
155192868|NCT01543698|560145424|FG000|Phase 1b|Protocol Violation|2|||
155192869|NCT01543698|560145425|FG001|Phase 1b|Protocol Violation|0|||
155192870|NCT01543698|560145426|FG002|Phase 1b|Protocol Violation|0|||
155192871|NCT01543698|560145427|FG003|Phase 1b|Protocol Violation|0|||
155192872|NCT01543698|560145428|FG004|Phase 1b|Protocol Violation|0|||
155192873|NCT01543698|560145429|FG005|Phase 1b|Protocol Violation|0|||
155192874|NCT01543698|560145430|FG006|Phase 1b|Protocol Violation|0|||
155192875|NCT01543698|560145431|FG007|Phase 1b|Protocol Violation|0|||
155192876|NCT01543698|560145432|FG008|Phase 1b|Protocol Violation|0|||
155192877|NCT01543698|560145433|FG009|Phase 1b|Protocol Violation|0|||
155192878|NCT01543698|560145434|FG010|Phase 1b|Protocol Violation|0|||
155192879|NCT01543698|560145435|FG011|Phase 1b|Protocol Violation|0|||
155192880|NCT01543698|560145436|FG012|Phase 1b|Protocol Violation|0|||
155192881|NCT01543698|560145437|FG013|Phase 1b|Protocol Violation|0|||
155192882|NCT01543698|560145438|FG014|Phase 1b|Protocol Violation|0|||
155192883|NCT01543698|560145424|FG000|Phase 2|Protocol Violation|0|||
155192884|NCT01543698|560145425|FG001|Phase 2|Protocol Violation|0|||
155192885|NCT01543698|560145426|FG002|Phase 2|Protocol Violation|0|||
155037932|NCT02079636|559565794|FG007|Overall Study|Death|0|||
155037933|NCT02079636|559565795|FG008|Overall Study|Death|0|||
155037934|NCT02079636|559565796|FG009|Overall Study|Death|0|||
155037935|NCT02079636|559565797|FG010|Overall Study|Death|0|||
155037936|NCT02079636|559565798|FG011|Overall Study|Death|1|||
155037937|NCT02079636|559565799|FG012|Overall Study|Death|1|||
155037938|NCT02079636|559565800|FG013|Overall Study|Death|0|||
155037939|NCT02079636|559565801|FG014|Overall Study|Death|2|||
155037940|NCT02079636|559565787|FG000|Overall Study|Adverse Event|1|||
155037941|NCT02079636|559565788|FG001|Overall Study|Adverse Event|1|||
155037942|NCT02079636|559565789|FG002|Overall Study|Adverse Event|0|||
155037943|NCT02079636|559565790|FG003|Overall Study|Adverse Event|1|||
155037944|NCT02079636|559565791|FG004|Overall Study|Adverse Event|1|||
155192886|NCT01543698|560145427|FG003|Phase 2|Protocol Violation|0|||
155192887|NCT01543698|560145428|FG004|Phase 2|Protocol Violation|0|||
155192888|NCT01543698|560145429|FG005|Phase 2|Protocol Violation|0|||
155192889|NCT01543698|560145430|FG006|Phase 2|Protocol Violation|0|||
155192890|NCT01543698|560145431|FG007|Phase 2|Protocol Violation|0|||
155192891|NCT01543698|560145432|FG008|Phase 2|Protocol Violation|0|||
155192892|NCT01543698|560145433|FG009|Phase 2|Protocol Violation|0|||
155192893|NCT01543698|560145434|FG010|Phase 2|Protocol Violation|0|||
155192894|NCT01543698|560145435|FG011|Phase 2|Protocol Violation|0|||
155192895|NCT01543698|560145436|FG012|Phase 2|Protocol Violation|1|||
155192896|NCT01543698|560145437|FG013|Phase 2|Protocol Violation|0|||
155192897|NCT01543698|560145438|FG014|Phase 2|Protocol Violation|0|||
155192898|NCT01543698|560145424|FG000|Phase 2|Disease progression|0|||
155037945|NCT02079636|559565792|FG005|Overall Study|Adverse Event|2|||
155192899|NCT01543698|560145425|FG001|Phase 2|Disease progression|0|||
155192900|NCT01543698|560145426|FG002|Phase 2|Disease progression|0|||
155192901|NCT01543698|560145427|FG003|Phase 2|Disease progression|0|||
155192902|NCT01543698|560145428|FG004|Phase 2|Disease progression|0|||
155192903|NCT01543698|560145429|FG005|Phase 2|Disease progression|0|||
155192904|NCT01543698|560145430|FG006|Phase 2|Disease progression|0|||
155192905|NCT01543698|560145431|FG007|Phase 2|Disease progression|0|||
155192906|NCT01543698|560145432|FG008|Phase 2|Disease progression|0|||
155192907|NCT01543698|560145433|FG009|Phase 2|Disease progression|0|||
155192908|NCT01543698|560145434|FG010|Phase 2|Disease progression|0|||
155192909|NCT01543698|560145435|FG011|Phase 2|Disease progression|10|||
155192910|NCT01543698|560145436|FG012|Phase 2|Disease progression|21|||
155192911|NCT01543698|560145437|FG013|Phase 2|Disease progression|30|||
155192912|NCT01543698|560145438|FG014|Phase 2|Disease progression|25|||
155192913|NCT01543698|560145424|FG000|Phase 2|Death|0|||
155192914|NCT01543698|560145425|FG001|Phase 2|Death|0|||
155192915|NCT01543698|560145426|FG002|Phase 2|Death|0|||
155192916|NCT01543698|560145427|FG003|Phase 2|Death|0|||
155192917|NCT01543698|560145428|FG004|Phase 2|Death|0|||
155192918|NCT01543698|560145429|FG005|Phase 2|Death|0|||
155192919|NCT01543698|560145430|FG006|Phase 2|Death|0|||
155192920|NCT01543698|560145431|FG007|Phase 2|Death|0|||
155192921|NCT01543698|560145432|FG008|Phase 2|Death|0|||
155192922|NCT01543698|560145433|FG009|Phase 2|Death|0|||
155192923|NCT01543698|560145434|FG010|Phase 2|Death|0|||
155192924|NCT01543698|560145435|FG011|Phase 2|Death|0|||
155192925|NCT01543698|560145436|FG012|Phase 2|Death|1|||
155192926|NCT01543698|560145437|FG013|Phase 2|Death|1|||
155192927|NCT01543698|560145438|FG014|Phase 2|Death|1|||
155192928|NCT01543698|560145424|FG000|Phase 2|Administrative problems|0|||
155192929|NCT01543698|560145425|FG001|Phase 2|Administrative problems|0|||
155192930|NCT01543698|560145426|FG002|Phase 2|Administrative problems|0|||
155192931|NCT01543698|560145427|FG003|Phase 2|Administrative problems|0|||
155192932|NCT01543698|560145428|FG004|Phase 2|Administrative problems|0|||
155192933|NCT01543698|560145429|FG005|Phase 2|Administrative problems|0|||
155192934|NCT01543698|560145430|FG006|Phase 2|Administrative problems|0|||
155192935|NCT01543698|560145431|FG007|Phase 2|Administrative problems|0|||
155192936|NCT01543698|560145432|FG008|Phase 2|Administrative problems|0|||
155192937|NCT01543698|560145433|FG009|Phase 2|Administrative problems|0|||
155192938|NCT01543698|560145434|FG010|Phase 2|Administrative problems|0|||
155192939|NCT01543698|560145435|FG011|Phase 2|Administrative problems|0|||
155192940|NCT01543698|560145436|FG012|Phase 2|Administrative problems|0|||
155192941|NCT01543698|560145437|FG013|Phase 2|Administrative problems|3|||
155192942|NCT01543698|560145438|FG014|Phase 2|Administrative problems|1|||
155192943|NCT01543698|560145424|FG000|Phase 2|Withdrawal by Subject|0|||
155192944|NCT01543698|560145425|FG001|Phase 2|Withdrawal by Subject|0|||
155192945|NCT01543698|560145426|FG002|Phase 2|Withdrawal by Subject|0|||
155192946|NCT01543698|560145427|FG003|Phase 2|Withdrawal by Subject|0|||
155192947|NCT01543698|560145428|FG004|Phase 2|Withdrawal by Subject|0|||
155192948|NCT01543698|560145429|FG005|Phase 2|Withdrawal by Subject|0|||
155192949|NCT01543698|560145430|FG006|Phase 2|Withdrawal by Subject|0|||
155192950|NCT01543698|560145431|FG007|Phase 2|Withdrawal by Subject|0|||
155192951|NCT01543698|560145432|FG008|Phase 2|Withdrawal by Subject|0|||
155192952|NCT01543698|560145433|FG009|Phase 2|Withdrawal by Subject|0|||
155192953|NCT01543698|560145434|FG010|Phase 2|Withdrawal by Subject|0|||
155192954|NCT01543698|560145435|FG011|Phase 2|Withdrawal by Subject|0|||
155192955|NCT01543698|560145436|FG012|Phase 2|Withdrawal by Subject|0|||
155192956|NCT01543698|560145437|FG013|Phase 2|Withdrawal by Subject|3|||
155192957|NCT01543698|560145438|FG014|Phase 2|Withdrawal by Subject|1|||
155192958|NCT01543698|560145424|FG000|Phase 2|Adverse Event|0|||
155192959|NCT01543698|560145425|FG001|Phase 2|Adverse Event|0|||
155192960|NCT01543698|560145426|FG002|Phase 2|Adverse Event|0|||
155192961|NCT01543698|560145427|FG003|Phase 2|Adverse Event|0|||
155192962|NCT01543698|560145428|FG004|Phase 2|Adverse Event|0|||
155192963|NCT01543698|560145429|FG005|Phase 2|Adverse Event|0|||
155192964|NCT01543698|560145430|FG006|Phase 2|Adverse Event|0|||
155192965|NCT01543698|560145431|FG007|Phase 2|Adverse Event|0|||
155192966|NCT01543698|560145432|FG008|Phase 2|Adverse Event|0|||
155192967|NCT01543698|560145433|FG009|Phase 2|Adverse Event|0|||
155192968|NCT01543698|560145434|FG010|Phase 2|Adverse Event|0|||
155192969|NCT01543698|560145435|FG011|Phase 2|Adverse Event|1|||
155192970|NCT01543698|560145436|FG012|Phase 2|Adverse Event|3|||
155192971|NCT01543698|560145437|FG013|Phase 2|Adverse Event|5|||
155192972|NCT01543698|560145438|FG014|Phase 2|Adverse Event|14|||
155192973|NCT00217620|560145439|FG000|Overall Study|Adverse Event|2|||
155192974|NCT00217620|560145439|FG000|Overall Study|Progression|31|||
155192975|NCT00217620|560145439|FG000|Overall Study|Not Protocol Specified|4|||
155192976|NCT00217620|560145439|FG000|Overall Study|Ineligible|13|||
155192977|NCT00217620|560145439|FG000|Overall Study|Never received treatment|1|||
155192978|NCT01863953|560145454|FG000|Overall Study|Adverse Event|0|||
155192979|NCT01863953|560145455|FG001|Overall Study|Adverse Event|0|||
155192980|NCT01863953|560145456|FG002|Overall Study|Adverse Event|1|||
155192981|NCT02008318|560145459|FG000|Overall Study|Adverse Event|4|||
155192982|NCT02008318|560145460|FG001|Overall Study|Adverse Event|0|||
155192983|NCT02008318|560145459|FG000|Overall Study|Physician Decision|2|||
155192984|NCT02008318|560145460|FG001|Overall Study|Physician Decision|0|||
155192985|NCT02008318|560145459|FG000|Overall Study|Progressive Disease|2|||
155192986|NCT02008318|560145460|FG001|Overall Study|Progressive Disease|0|||
155192987|NCT02008318|560145459|FG000|Overall Study|Protocol Violation|1|||
155192988|NCT02008318|560145460|FG001|Overall Study|Protocol Violation|1|||
155037946|NCT02079636|559565793|FG006|Overall Study|Adverse Event|0|||
155037947|NCT02079636|559565794|FG007|Overall Study|Adverse Event|0|||
155037948|NCT02079636|559565795|FG008|Overall Study|Adverse Event|0|||
155037949|NCT02079636|559565796|FG009|Overall Study|Adverse Event|0|||
155037950|NCT02079636|559565797|FG010|Overall Study|Adverse Event|0|||
155037951|NCT02079636|559565798|FG011|Overall Study|Adverse Event|0|||
155037952|NCT02079636|559565799|FG012|Overall Study|Adverse Event|0|||
155037953|NCT02079636|559565800|FG013|Overall Study|Adverse Event|0|||
155037954|NCT02079636|559565801|FG014|Overall Study|Adverse Event|0|||
155037955|NCT02079636|559565787|FG000|Overall Study|Progressive disease|0|||
155037956|NCT02079636|559565788|FG001|Overall Study|Progressive disease|0|||
155037957|NCT02079636|559565789|FG002|Overall Study|Progressive disease|0|||
155037958|NCT02079636|559565790|FG003|Overall Study|Progressive disease|2|||
155037959|NCT02079636|559565791|FG004|Overall Study|Progressive disease|0|||
155037960|NCT02079636|559565792|FG005|Overall Study|Progressive disease|0|||
155037961|NCT02079636|559565793|FG006|Overall Study|Progressive disease|0|||
155037962|NCT02079636|559565794|FG007|Overall Study|Progressive disease|0|||
155037963|NCT02079636|559565795|FG008|Overall Study|Progressive disease|0|||
155037964|NCT02079636|559565796|FG009|Overall Study|Progressive disease|0|||
155037965|NCT02079636|559565797|FG010|Overall Study|Progressive disease|0|||
155037966|NCT02079636|559565798|FG011|Overall Study|Progressive disease|0|||
155037967|NCT02079636|559565799|FG012|Overall Study|Progressive disease|1|||
155037968|NCT02079636|559565800|FG013|Overall Study|Progressive disease|0|||
155037969|NCT02079636|559565801|FG014|Overall Study|Progressive disease|0|||
155037970|NCT02079636|559565787|FG000|Overall Study|Withdrawal by Subject|0|||
155037971|NCT02079636|559565788|FG001|Overall Study|Withdrawal by Subject|0|||
155037972|NCT02079636|559565789|FG002|Overall Study|Withdrawal by Subject|0|||
155037973|NCT02079636|559565790|FG003|Overall Study|Withdrawal by Subject|4|||
155037974|NCT02079636|559565791|FG004|Overall Study|Withdrawal by Subject|0|||
155037975|NCT02079636|559565792|FG005|Overall Study|Withdrawal by Subject|1|||
155037976|NCT02079636|559565793|FG006|Overall Study|Withdrawal by Subject|0|||
155037977|NCT02079636|559565794|FG007|Overall Study|Withdrawal by Subject|0|||
155037978|NCT02079636|559565795|FG008|Overall Study|Withdrawal by Subject|0|||
155037979|NCT02079636|559565796|FG009|Overall Study|Withdrawal by Subject|2|||
155037980|NCT02079636|559565797|FG010|Overall Study|Withdrawal by Subject|1|||
155037981|NCT02079636|559565798|FG011|Overall Study|Withdrawal by Subject|1|||
155037982|NCT02079636|559565799|FG012|Overall Study|Withdrawal by Subject|1|||
155037983|NCT02079636|559565800|FG013|Overall Study|Withdrawal by Subject|0|||
155037984|NCT02079636|559565801|FG014|Overall Study|Withdrawal by Subject|2|||
155037985|NCT02079636|559565787|FG000|Overall Study|Physician Decision|0|||
155037986|NCT02079636|559565788|FG001|Overall Study|Physician Decision|0|||
155037987|NCT02079636|559565789|FG002|Overall Study|Physician Decision|0|||
155037988|NCT02079636|559565790|FG003|Overall Study|Physician Decision|0|||
155144154|NCT02719171|559961052|FG001|Overall Study|Subject Withdrawal|2|||
155144155|NCT02719171|559961053|FG002|Overall Study|Subject Withdrawal|2|||
155144156|NCT02719171|559961054|FG003|Overall Study|Subject Withdrawal|1|||
155144157|NCT02719171|559961055|FG004|Overall Study|Subject Withdrawal|0|||
155144158|NCT02719171|559961051|FG000|Overall Study|Other|0|||
155144159|NCT02719171|559961052|FG001|Overall Study|Other|0|||
155144160|NCT02719171|559961053|FG002|Overall Study|Other|0|||
155144161|NCT02719171|559961054|FG003|Overall Study|Other|1|||
155144162|NCT02719171|559961055|FG004|Overall Study|Other|0|||
155144163|NCT02807623|559961056|FG000|Overall Study|Lost to Follow-up|23|||
155144164|NCT02807623|559961057|FG001|Overall Study|Lost to Follow-up|18|||
155144165|NCT02807623|559961058|FG002|Overall Study|Lost to Follow-up|22|||
155144166|NCT02807623|559961056|FG000|Overall Study|Drug intolerance|0|||
155144167|NCT02807623|559961057|FG001|Overall Study|Drug intolerance|1|||
155144168|NCT02807623|559961058|FG002|Overall Study|Drug intolerance|0|||
155144169|NCT02807623|559961056|FG000|Overall Study|incomplete blood draw|0|||
155144170|NCT02807623|559961057|FG001|Overall Study|incomplete blood draw|2|||
155144171|NCT02807623|559961058|FG002|Overall Study|incomplete blood draw|1|||
155144172|NCT02614729|559961059|FG000|Overall Study|Withdrawal by Subject|1|||
155144173|NCT02614729|559961060|FG001|Overall Study|Withdrawal by Subject|0|||
155144174|NCT01045967|559961070|FG000|Second Intervention|Protocol Violation|0|||
155144175|NCT01045967|559961071|FG001|Second Intervention|Protocol Violation|1|||
155144176|NCT03493945|559961072|FG000|Phase I Dose Escalation|Ineligible|0|||
155037989|NCT02079636|559565791|FG004|Overall Study|Physician Decision|0|||
155037990|NCT02079636|559565792|FG005|Overall Study|Physician Decision|1|||
155037991|NCT02079636|559565793|FG006|Overall Study|Physician Decision|0|||
155037992|NCT02079636|559565794|FG007|Overall Study|Physician Decision|0|||
155037993|NCT02079636|559565795|FG008|Overall Study|Physician Decision|0|||
155037994|NCT02079636|559565796|FG009|Overall Study|Physician Decision|1|||
155037995|NCT02079636|559565797|FG010|Overall Study|Physician Decision|1|||
155037996|NCT02079636|559565798|FG011|Overall Study|Physician Decision|0|||
155037997|NCT02079636|559565799|FG012|Overall Study|Physician Decision|0|||
155037998|NCT02079636|559565800|FG013|Overall Study|Physician Decision|0|||
155144177|NCT03493945|559961073|FG001|Phase I Dose Escalation|Ineligible|0|||
155144178|NCT03493945|559961074|FG002|Phase I Dose Escalation|Ineligible|1|||
155144179|NCT03493945|559961075|FG003|Phase I Dose Escalation|Ineligible|0|||
155037999|NCT02079636|559565801|FG014|Overall Study|Physician Decision|1|||
155038000|NCT02079636|559565787|FG000|Overall Study|Lost to Follow-up|0|||
155038001|NCT02079636|559565788|FG001|Overall Study|Lost to Follow-up|0|||
155038002|NCT02079636|559565789|FG002|Overall Study|Lost to Follow-up|0|||
155038003|NCT02079636|559565790|FG003|Overall Study|Lost to Follow-up|0|||
155038004|NCT02079636|559565791|FG004|Overall Study|Lost to Follow-up|0|||
155038005|NCT02079636|559565792|FG005|Overall Study|Lost to Follow-up|0|||
155038006|NCT02079636|559565793|FG006|Overall Study|Lost to Follow-up|0|||
155038007|NCT02079636|559565794|FG007|Overall Study|Lost to Follow-up|1|||
155038008|NCT02079636|559565795|FG008|Overall Study|Lost to Follow-up|0|||
155038009|NCT02079636|559565796|FG009|Overall Study|Lost to Follow-up|0|||
155038010|NCT02079636|559565797|FG010|Overall Study|Lost to Follow-up|0|||
155038011|NCT02079636|559565798|FG011|Overall Study|Lost to Follow-up|0|||
155038012|NCT02079636|559565799|FG012|Overall Study|Lost to Follow-up|0|||
155038013|NCT02079636|559565800|FG013|Overall Study|Lost to Follow-up|0|||
155038014|NCT02079636|559565801|FG014|Overall Study|Lost to Follow-up|0|||
155038015|NCT02918552|559565802|FG000|Overall Study|Failed Pharmacokinetics|1|||
155038016|NCT02918552|559565803|FG001|Overall Study|Failed Pharmacokinetics|0|||
155038017|NCT02918552|559565802|FG000|Overall Study|Withdrawal by Subject|0|||
155038018|NCT02918552|559565803|FG001|Overall Study|Withdrawal by Subject|1|||
155038019|NCT02918552|559565802|FG000|Overall Study|Lost to Follow-up|0|||
155038020|NCT02918552|559565803|FG001|Overall Study|Lost to Follow-up|1|||
155038021|NCT04395274|559565804|FG000|Overall Study|Lost to Follow-up|20|||
155038022|NCT04395274|559565805|FG001|Overall Study|Lost to Follow-up|11|||
155038023|NCT04395274|559565804|FG000|Overall Study|Withdrawal by Subject|13|||
155038024|NCT04395274|559565805|FG001|Overall Study|Withdrawal by Subject|10|||
155038025|NCT04395274|559565804|FG000|Overall Study|Moved Abroad|0|||
155038026|NCT04395274|559565805|FG001|Overall Study|Moved Abroad|1|||
155038027|NCT03325894|559565806|FG000|Overall Study|Adverse Event|2|||
155038028|NCT03325894|559565807|FG001|Overall Study|Adverse Event|3|||
155038029|NCT03325894|559565806|FG000|Overall Study|Protocol Violation|1|||
155038030|NCT03325894|559565807|FG001|Overall Study|Protocol Violation|2|||
155038031|NCT03325894|559565806|FG000|Overall Study|Withdrawal by Subject|10|||
155038032|NCT03325894|559565807|FG001|Overall Study|Withdrawal by Subject|6|||
155038033|NCT03325894|559565806|FG000|Overall Study|Lost to Follow-up|4|||
155038034|NCT03325894|559565807|FG001|Overall Study|Lost to Follow-up|9|||
155038035|NCT03325894|559565806|FG000|Overall Study|Lack of Efficacy|8|||
155038036|NCT03325894|559565807|FG001|Overall Study|Lack of Efficacy|14|||
155038037|NCT03325894|559565806|FG000|Overall Study|Study Terminated by Sponsor|38|||
155038038|NCT03325894|559565807|FG001|Overall Study|Study Terminated by Sponsor|43|||
155038039|NCT03325894|559565806|FG000|Overall Study|Other (Not received Treatment)|1|||
155038040|NCT03325894|559565807|FG001|Overall Study|Other (Not received Treatment)|0|||
155038041|NCT00335959|559565810|FG000|Overall Study|Adverse Event|2|||
155038042|NCT00335959|559565810|FG000|Overall Study|Ineligible|1|||
155038043|NCT02028169|559565811|FG000|Overall Study|Lost to Follow-up|21|||
155038044|NCT02028169|559565811|FG000|Overall Study|Lack of Efficacy|2|||
155038045|NCT02028169|559565811|FG000|Overall Study|Withdrawal by Subject|2|||
155038046|NCT02028169|559565811|FG000|Overall Study|Adverse Event|1|||
155038047|NCT02028169|559565811|FG000|Overall Study|Cessation of Drug|1|||
155038048|NCT02028169|559565811|FG000|Overall Study|Concomitant Medication Usage|1|||
155038049|NCT03482167|559565812|FG000|Allocated to Intervention|Physician Decision|1|||
155038050|NCT03482167|559565813|FG001|Allocated to Intervention|Physician Decision|2|||
155038051|NCT03482167|559565812|FG000|Received Intervention|Adverse Event|3|||
155038052|NCT03482167|559565813|FG001|Received Intervention|Adverse Event|1|||
155038053|NCT03482167|559565812|FG000|Received Intervention|Physician Decision|1|||
155038054|NCT03482167|559565813|FG001|Received Intervention|Physician Decision|1|||
155038055|NCT03482167|559565812|FG000|Received Intervention|Withdrawal by Subject|1|||
155038056|NCT03482167|559565813|FG001|Received Intervention|Withdrawal by Subject|0|||
155038057|NCT01001598|559565814|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
155038058|NCT01001598|559565814|FG000|Overall Study|Adverse Event|1|||
155038059|NCT00106639|559565821|FG000|Overall Study|Adverse Event|3|||
155038060|NCT00106639|559565822|FG001|Overall Study|Adverse Event|4|||
155038061|NCT00106639|559565823|FG002|Overall Study|Adverse Event|1|||
155038062|NCT00106639|559565821|FG000|Overall Study|Protocol Violation|0|||
155038063|NCT00106639|559565822|FG001|Overall Study|Protocol Violation|1|||
155144180|NCT03493945|559961076|FG004|Phase I Dose Escalation|Ineligible|0|||
155144181|NCT03493945|559961077|FG005|Phase I Dose Escalation|Ineligible|0|||
155144182|NCT03493945|559961078|FG006|Phase I Dose Escalation|Ineligible|0|||
155038064|NCT00106639|559565823|FG002|Overall Study|Protocol Violation|0|||
155038065|NCT00106639|559565821|FG000|Overall Study|Withdrawal by Subject|0|||
155038066|NCT00106639|559565822|FG001|Overall Study|Withdrawal by Subject|1|||
155038067|NCT00106639|559565823|FG002|Overall Study|Withdrawal by Subject|0|||
155038068|NCT00106639|559565821|FG000|Overall Study|Participant defaulted|0|||
155038069|NCT00106639|559565822|FG001|Overall Study|Participant defaulted|1|||
155038070|NCT00106639|559565823|FG002|Overall Study|Participant defaulted|1|||
155038071|NCT01876979|559565824|FG000|Overall Study|Physician Decision|2|||
155038072|NCT01876979|559565825|FG001|Overall Study|Physician Decision|3|||
155144183|NCT03493945|559961072|FG000|Phase I Dose Escalation|New therapy|0|||
155192989|NCT02008318|560145459|FG000|Overall Study|Withdrawal by Subject|3|||
155192990|NCT02008318|560145460|FG001|Overall Study|Withdrawal by Subject|0|||
155192991|NCT02336373|560145463|FG000|Overall Study|Protocol closed early|4|||
155192992|NCT02336373|560145463|FG000|Overall Study|Physician Decision|14|||
155192993|NCT03270644|560145466|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
155192994|NCT03270644|560145466|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
155192995|NCT00354614|560145471|FG000|Overall Study|Lack of Efficacy|28|||
155192996|NCT03650556|560145472|FG000|Overall Study|Death|2|||
155192997|NCT03650556|560145472|FG000|Overall Study|Withdrawal by Subject|20|||
155192998|NCT03650556|560145472|FG000|Overall Study|Physician Decision|2|||
155192999|NCT03650556|560145472|FG000|Overall Study|Lost to Follow-up|8|||
155193000|NCT03650556|560145472|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
155193001|NCT03650556|560145472|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
155193002|NCT00463580|560145473|FG000|Overall Study|Lost to Follow-up|1|||
155193003|NCT00463580|560145474|FG001|Overall Study|Lost to Follow-up|0|||
155193004|NCT00463580|560145473|FG000|Overall Study|Schedule conflict|2|||
155193005|NCT00463580|560145474|FG001|Overall Study|Schedule conflict|0|||
155193006|NCT00463580|560145473|FG000|Overall Study|Medical/psychiatric complications|0|||
155193007|NCT00463580|560145474|FG001|Overall Study|Medical/psychiatric complications|2|||
155193008|NCT01788046|560145475|FG000|Overall Study|Withdrawal by Subject|12|||
155193009|NCT01788046|560145476|FG001|Overall Study|Withdrawal by Subject|12|||
155193010|NCT01788046|560145475|FG000|Overall Study|Lost to Follow-up|12|||
155193011|NCT01788046|560145476|FG001|Overall Study|Lost to Follow-up|19|||
155193012|NCT01788046|560145475|FG000|Overall Study|Death|7|||
155193013|NCT01788046|560145476|FG001|Overall Study|Death|5|||
155193014|NCT01788046|560145475|FG000|Overall Study|Protocol Specified Criteria|25|||
155193015|NCT01788046|560145476|FG001|Overall Study|Protocol Specified Criteria|1|||
155193016|NCT01147640|560145480|FG000|Overall Study|Adverse Event|2|||
155193017|NCT01147640|560145481|FG001|Overall Study|Adverse Event|0|||
155193018|NCT01147640|560145480|FG000|Overall Study|Physician Decision|1|||
155193019|NCT01147640|560145481|FG001|Overall Study|Physician Decision|0|||
155193020|NCT01147640|560145480|FG000|Overall Study|Withdrawal by Subject|1|||
155193021|NCT01147640|560145481|FG001|Overall Study|Withdrawal by Subject|0|||
155193022|NCT01147640|560145480|FG000|Overall Study|Lost to Follow-up|0|||
155193023|NCT01147640|560145481|FG001|Overall Study|Lost to Follow-up|1|||
155193024|NCT01147640|560145480|FG000|Overall Study|Didn't meet eligibility criteria|1|||
155193025|NCT01147640|560145481|FG001|Overall Study|Didn't meet eligibility criteria|0|||
155193026|NCT01604408|560145482|FG000|Treatment Period 1|Protocol Violation|0|||
155193027|NCT01604408|560145483|FG001|Treatment Period 1|Protocol Violation|1|||
155193028|NCT01604408|560145482|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155193029|NCT01604408|560145483|FG001|Treatment Period 2|Withdrawal by Subject|1|||
155193030|NCT01604408|560145482|FG000|Treatment Period 2|Protocol Violation|1|||
155193031|NCT01604408|560145483|FG001|Treatment Period 2|Protocol Violation|0|||
155193032|NCT01604408|560145482|FG000|Treatment Period 2|Adverse Event|0|||
155193033|NCT01604408|560145483|FG001|Treatment Period 2|Adverse Event|1|||
155193034|NCT01604408|560145482|FG000|Treatment Period 3|Protocol Violation|1|||
155193035|NCT01604408|560145483|FG001|Treatment Period 3|Protocol Violation|1|||
155193036|NCT01604408|560145482|FG000|Treatment Period 3|Adverse Event|0|||
155193037|NCT01604408|560145483|FG001|Treatment Period 3|Adverse Event|3|||
155038073|NCT01096589|559565826|FG000|Overall Study|Adverse Event|2|||
155193038|NCT01604408|560145482|FG000|Treatment Period 3|Withdrawal by Subject|3|||
155193039|NCT01604408|560145483|FG001|Treatment Period 3|Withdrawal by Subject|1|||
155193040|NCT01604408|560145482|FG000|Treatment Period 3|Sponsor Decision|1|||
155193041|NCT01604408|560145483|FG001|Treatment Period 3|Sponsor Decision|0|||
155193042|NCT01604408|560145482|FG000|Treatment Period 4|Death|1|||
155193043|NCT01604408|560145483|FG001|Treatment Period 4|Death|0|||
155193044|NCT01604408|560145482|FG000|Treatment Period 4|Withdrawal by Subject|2|||
155193045|NCT01604408|560145483|FG001|Treatment Period 4|Withdrawal by Subject|1|||
155193046|NCT01604408|560145482|FG000|Treatment Period 4|Adverse Event|0|||
155193047|NCT01604408|560145483|FG001|Treatment Period 4|Adverse Event|1|||
155193048|NCT01604408|560145482|FG000|Treatment Period 5|Adverse Event|4|||
155193049|NCT01604408|560145483|FG001|Treatment Period 5|Adverse Event|0|||
155193050|NCT01604408|560145482|FG000|Treatment Period 6|Lost to Follow-up|0|||
155193051|NCT01604408|560145483|FG001|Treatment Period 6|Lost to Follow-up|1|||
155193052|NCT01604408|560145482|FG000|Treatment Period 6|Adverse Event|2|||
155193053|NCT01604408|560145483|FG001|Treatment Period 6|Adverse Event|0|||
155038074|NCT01096589|559565827|FG001|Overall Study|Adverse Event|1|||
155038075|NCT01096589|559565828|FG002|Overall Study|Adverse Event|2|||
155038076|NCT01096589|559565829|FG003|Overall Study|Adverse Event|1|||
155193054|NCT01604408|560145482|FG000|Treatment Period 6|Sponsor decision|0|||
155193055|NCT01604408|560145483|FG001|Treatment Period 6|Sponsor decision|1|||
155193056|NCT01604408|560145482|FG000|Observation Period|Adverse Event|1|||
155193057|NCT01604408|560145483|FG001|Observation Period|Adverse Event|1|||
155193058|NCT01604408|560145482|FG000|Observation Period|Withdrawal by Subject|0|||
155038077|NCT01096589|559565826|FG000|Overall Study|Withdrawal by Subject|2|||
155193059|NCT01604408|560145483|FG001|Observation Period|Withdrawal by Subject|2|||
155193060|NCT00917501|560145484|FG000|Overall Study|Lost to Follow-up|4|||
155038078|NCT01096589|559565827|FG001|Overall Study|Withdrawal by Subject|1|||
155038079|NCT01096589|559565828|FG002|Overall Study|Withdrawal by Subject|1|||
155038080|NCT01096589|559565829|FG003|Overall Study|Withdrawal by Subject|1|||
155038081|NCT01096589|559565826|FG000|Overall Study|Compliance with protocol|0|||
155038082|NCT01096589|559565827|FG001|Overall Study|Compliance with protocol|0|||
155038083|NCT01096589|559565828|FG002|Overall Study|Compliance with protocol|1|||
155038084|NCT01096589|559565829|FG003|Overall Study|Compliance with protocol|0|||
155038085|NCT01096589|559565826|FG000|Overall Study|found treatment exhausting|0|||
155038086|NCT01096589|559565827|FG001|Overall Study|found treatment exhausting|0|||
155038087|NCT01096589|559565828|FG002|Overall Study|found treatment exhausting|0|||
155038088|NCT01096589|559565829|FG003|Overall Study|found treatment exhausting|1|||
155144184|NCT03493945|559961073|FG001|Phase I Dose Escalation|New therapy|1|||
155144185|NCT03493945|559961074|FG002|Phase I Dose Escalation|New therapy|0|||
155144186|NCT03493945|559961075|FG003|Phase I Dose Escalation|New therapy|0|||
155144187|NCT03493945|559961076|FG004|Phase I Dose Escalation|New therapy|0|||
155144188|NCT03493945|559961077|FG005|Phase I Dose Escalation|New therapy|0|||
155144189|NCT03493945|559961078|FG006|Phase I Dose Escalation|New therapy|0|||
155144190|NCT03493945|559961072|FG000|Phase II Dose Expansion|Refused further treatment|0|||
155144191|NCT03493945|559961073|FG001|Phase II Dose Expansion|Refused further treatment|0|||
155144192|NCT03493945|559961074|FG002|Phase II Dose Expansion|Refused further treatment|0|||
155144193|NCT03493945|559961075|FG003|Phase II Dose Expansion|Refused further treatment|0|||
155144194|NCT03493945|559961076|FG004|Phase II Dose Expansion|Refused further treatment|1|||
155144195|NCT03493945|559961077|FG005|Phase II Dose Expansion|Refused further treatment|1|||
155144196|NCT03493945|559961078|FG006|Phase II Dose Expansion|Refused further treatment|0|||
155144197|NCT03493945|559961072|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
155144198|NCT03493945|559961073|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
155144199|NCT03493945|559961074|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
155144200|NCT03493945|559961075|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
155144201|NCT03493945|559961076|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
155144202|NCT03493945|559961077|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
155144203|NCT03493945|559961078|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
155144204|NCT03310723|559961083|FG000|Overall Study|Withdrawal by Subject|0|||
155144205|NCT03310723|559961084|FG001|Overall Study|Withdrawal by Subject|1|||
155144206|NCT03310723|559961083|FG000|Overall Study|Protocol Violation|0|||
155144207|NCT03310723|559961084|FG001|Overall Study|Protocol Violation|2|||
155144208|NCT02098746|559961085|FG000|Overall Study|Changes of Investigator|2|||
155144209|NCT02098746|559961085|FG000|Overall Study|Other Miscellaneous Reasons|1|||
155144210|NCT02098746|559961085|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
155144211|NCT02098746|559961085|FG000|Overall Study|Data Not Available After Treatment|1|||
155144212|NCT01121146|559961089|FG000|Overall Study|Death|17|||
155144213|NCT01121146|559961090|FG001|Overall Study|Death|15|||
155144214|NCT01121146|559961089|FG000|Overall Study|Adverse Event|2|||
155144215|NCT01121146|559961090|FG001|Overall Study|Adverse Event|11|||
155144216|NCT01121146|559961089|FG000|Overall Study|Lost to Follow-up|7|||
155144217|NCT01121146|559961090|FG001|Overall Study|Lost to Follow-up|16|||
155144218|NCT01132807|559961097|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
155144219|NCT01132807|559961098|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
155144220|NCT01132807|559961099|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
155144221|NCT01132807|559961097|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
155144222|NCT01132807|559961098|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
155144223|NCT01132807|559961099|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
155144224|NCT00742183|559961100|FG000|Overall Study|Adverse Event|2|||
155144225|NCT00742183|559961101|FG001|Overall Study|Adverse Event|2|||
155144226|NCT00742183|559961100|FG000|Overall Study|Death|1|||
155144227|NCT00742183|559961101|FG001|Overall Study|Death|0|||
155144228|NCT00742183|559961100|FG000|Overall Study|Physician Decision|0|||
155144229|NCT00742183|559961101|FG001|Overall Study|Physician Decision|2|||
155144230|NCT00742183|559961100|FG000|Overall Study|Lost to Follow-up|4|||
155144231|NCT00742183|559961101|FG001|Overall Study|Lost to Follow-up|4|||
155144232|NCT00742183|559961100|FG000|Overall Study|Required skin-graft|1|||
155144233|NCT00742183|559961101|FG001|Overall Study|Required skin-graft|1|||
155144234|NCT00742183|559961100|FG000|Overall Study|Withdrawal by Subject|1|||
155144235|NCT00742183|559961101|FG001|Overall Study|Withdrawal by Subject|0|||
155144236|NCT00742183|559961100|FG000|Overall Study|Lack of Efficacy|0|||
155144237|NCT00742183|559961101|FG001|Overall Study|Lack of Efficacy|3|||
155144238|NCT01080807|559961107|FG000|Overall Study|Adverse Event|9|||
155144239|NCT01080807|559961108|FG001|Overall Study|Adverse Event|1|||
155144240|NCT01080807|559961107|FG000|Overall Study|Lack of Efficacy|0|||
155144241|NCT01080807|559961108|FG001|Overall Study|Lack of Efficacy|1|||
155144242|NCT01080807|559961107|FG000|Overall Study|Withdrawal by Subject|7|||
155144243|NCT01080807|559961108|FG001|Overall Study|Withdrawal by Subject|2|||
155144244|NCT01080807|559961107|FG000|Overall Study|Protocol Violation|7|||
155038089|NCT01362244|559565832|FG000|Overall Study|Adverse Event|3|||
155144245|NCT01080807|559961108|FG001|Overall Study|Protocol Violation|6|||
155144246|NCT01080807|559961107|FG000|Overall Study|Lost to Follow-up|6|||
155038090|NCT01362244|559565833|FG001|Overall Study|Adverse Event|5|||
155038091|NCT01362244|559565832|FG000|Overall Study|Lack of Efficacy|5|||
155038092|NCT01362244|559565833|FG001|Overall Study|Lack of Efficacy|11|||
155038093|NCT01362244|559565832|FG000|Overall Study|Lost to Follow-up|0|||
155038094|NCT01362244|559565833|FG001|Overall Study|Lost to Follow-up|2|||
155038095|NCT01362244|559565832|FG000|Overall Study|Protocol Violation|5|||
155038096|NCT01362244|559565833|FG001|Overall Study|Protocol Violation|1|||
155038097|NCT01362244|559565832|FG000|Overall Study|Withdrawal by Subject|2|||
155038098|NCT01362244|559565833|FG001|Overall Study|Withdrawal by Subject|1|||
155038099|NCT01362244|559565832|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
155038100|NCT01362244|559565833|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
155038101|NCT01362244|559565832|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
155038102|NCT01362244|559565833|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
155038103|NCT01712334|559565834|FG000|Treatment Period 1|Randomized in Error|0|||
155038104|NCT01712334|559565835|FG001|Treatment Period 1|Randomized in Error|2|||
155038105|NCT02919267|559565838|FG000|Overall Study|Protocol Violation|0|||
155038106|NCT02919267|559565839|FG001|Overall Study|Protocol Violation|3|||
155038107|NCT02919267|559565840|FG002|Overall Study|Protocol Violation|3|||
155038108|NCT02919267|559565841|FG003|Overall Study|Protocol Violation|4|||
155038109|NCT03467763|559565842|FG000|Overall Study|Lost to Follow-up|1|||
155038110|NCT03467763|559565842|FG000|Overall Study|Protocol Violation|2|||
155038111|NCT02407054|559565843|FG000|Overall Study|Adverse Event|1|||
155038112|NCT02407054|559565844|FG001|Overall Study|Adverse Event|4|||
155038113|NCT02407054|559565845|FG002|Overall Study|Adverse Event|1|||
155038114|NCT02407054|559565843|FG000|Overall Study|Non-compliance with Study|0|||
155038115|NCT02407054|559565844|FG001|Overall Study|Non-compliance with Study|2|||
155038116|NCT02407054|559565845|FG002|Overall Study|Non-compliance with Study|1|||
155038117|NCT02407054|559565843|FG000|Overall Study|Physician Decision|1|||
155038118|NCT02407054|559565844|FG001|Overall Study|Physician Decision|3|||
155038119|NCT02407054|559565845|FG002|Overall Study|Physician Decision|3|||
155038120|NCT02407054|559565843|FG000|Overall Study|Withdrawal by Subject|5|||
155038121|NCT02407054|559565844|FG001|Overall Study|Withdrawal by Subject|9|||
155038122|NCT02407054|559565845|FG002|Overall Study|Withdrawal by Subject|2|||
155038123|NCT00932698|559565848|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
155038124|NCT00932698|559565849|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
155038125|NCT00932698|559565850|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
155038126|NCT00932698|559565851|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
155038127|NCT00932698|559565852|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
155038128|NCT00932698|559565853|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
155038129|NCT00932698|559565854|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
155038130|NCT00932698|559565855|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
155038131|NCT00932698|559565856|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
155038132|NCT00932698|559565857|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
155038133|NCT00932698|559565858|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
155038134|NCT00932698|559565848|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038135|NCT00932698|559565849|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155038136|NCT00932698|559565850|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038137|NCT00932698|559565851|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155038138|NCT00932698|559565852|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038139|NCT00932698|559565853|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155038140|NCT00932698|559565854|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
155038141|NCT00932698|559565855|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038142|NCT00932698|559565856|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038143|NCT00932698|559565857|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038144|NCT00932698|559565858|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
155038145|NCT00932698|559565848|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
155038146|NCT00932698|559565849|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
155038147|NCT00932698|559565850|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
155038148|NCT00932698|559565851|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
155038149|NCT00932698|559565852|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
155038150|NCT00932698|559565853|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
155038151|NCT00932698|559565854|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
155038152|NCT00932698|559565855|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
155144247|NCT01080807|559961108|FG001|Overall Study|Lost to Follow-up|4|||
155144248|NCT01080807|559961107|FG000|Overall Study|Noncompliance with drug administration|1|||
155144249|NCT01080807|559961108|FG001|Overall Study|Noncompliance with drug administration|1|||
155144250|NCT01080807|559961107|FG000|Overall Study|Noncompliance to study procedures|1|||
155144251|NCT01080807|559961108|FG001|Overall Study|Noncompliance to study procedures|1|||
155144252|NCT01080807|559961107|FG000|Overall Study|Began working day shift|0|||
155144253|NCT01080807|559961108|FG001|Overall Study|Began working day shift|2|||
155144254|NCT01080807|559961107|FG000|Overall Study|Laid off or terminated from job|1|||
155144255|NCT01080807|559961108|FG001|Overall Study|Laid off or terminated from job|2|||
155144256|NCT01080807|559961107|FG000|Overall Study|Stopped working consistent night shifts|0|||
155193061|NCT00917501|560145485|FG001|Overall Study|Lost to Follow-up|1|||
155193062|NCT00917501|560145484|FG000|Overall Study|Withdrawal by Subject|3|||
155193063|NCT00917501|560145485|FG001|Overall Study|Withdrawal by Subject|1|||
155193064|NCT00917501|560145484|FG000|Overall Study|Lack of Efficacy|1|||
155193065|NCT00917501|560145485|FG001|Overall Study|Lack of Efficacy|2|||
155193066|NCT00917501|560145484|FG000|Overall Study|trouble swollowing capsules|0|||
155193067|NCT00917501|560145485|FG001|Overall Study|trouble swollowing capsules|1|||
155193068|NCT01453725|560145488|FG000|Overall Study|Adverse Event|3|||
155193069|NCT01453725|560145489|FG001|Overall Study|Adverse Event|3|||
155193070|NCT01453725|560145488|FG000|Overall Study|Lost to Follow-up|4|||
155193071|NCT01453725|560145489|FG001|Overall Study|Lost to Follow-up|0|||
155193072|NCT01453725|560145488|FG000|Overall Study|Non-compliance With Protocol|1|||
155193073|NCT01453725|560145489|FG001|Overall Study|Non-compliance With Protocol|2|||
155193074|NCT01453725|560145488|FG000|Overall Study|Protocol Violation|1|||
155193075|NCT01453725|560145489|FG001|Overall Study|Protocol Violation|0|||
155193076|NCT01453725|560145488|FG000|Overall Study|Withdrawal by Subject|2|||
155193077|NCT01453725|560145489|FG001|Overall Study|Withdrawal by Subject|3|||
155193078|NCT01453725|560145488|FG000|Overall Study|Pregnancy Wish|0|||
155193079|NCT01453725|560145489|FG001|Overall Study|Pregnancy Wish|2|||
155193080|NCT01453725|560145488|FG000|Overall Study|Pregnancy|1|||
155193081|NCT01453725|560145489|FG001|Overall Study|Pregnancy|0|||
155193082|NCT01453725|560145488|FG000|Overall Study|Physician Decision|1|||
155193083|NCT01453725|560145489|FG001|Overall Study|Physician Decision|1|||
155193084|NCT01436396|560145490|FG000|Overall Study|Protocol Violation|7|||
155193085|NCT01436396|560145491|FG001|Overall Study|Protocol Violation|5|||
155193086|NCT01436396|560145490|FG000|Overall Study|Adverse Event|1|||
155193087|NCT01436396|560145491|FG001|Overall Study|Adverse Event|2|||
155193088|NCT01436396|560145490|FG000|Overall Study|Withdrawal by Subject|19|||
155193089|NCT01436396|560145491|FG001|Overall Study|Withdrawal by Subject|29|||
155193090|NCT01436396|560145490|FG000|Overall Study|Serious adverse event|2|||
155193091|NCT01436396|560145491|FG001|Overall Study|Serious adverse event|3|||
155193092|NCT01436396|560145490|FG000|Overall Study|Lost to Follow-up|3|||
155193093|NCT01436396|560145491|FG001|Overall Study|Lost to Follow-up|3|||
155193094|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
155193095|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
155193096|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
155193097|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
155193098|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
155193099|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
155193100|NCT00875979|560145494|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
155193101|NCT00875979|560145495|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
155193102|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
155193103|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
155193104|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
155193105|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
155193106|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
155193107|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
155193108|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
155193109|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
155193110|NCT00875979|560145494|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
155193111|NCT00875979|560145495|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
155193112|NCT00216476|560145497|FG000|Overall Study|Withdrawal by Subject|59|||
155193113|NCT00216476|560145498|FG001|Overall Study|Withdrawal by Subject|72|||
155193114|NCT00216476|560145499|FG002|Overall Study|Withdrawal by Subject|9|||
155193115|NCT00216476|560145497|FG000|Overall Study|Lost to Follow-up|10|||
155193116|NCT00216476|560145498|FG001|Overall Study|Lost to Follow-up|9|||
155193117|NCT00216476|560145499|FG002|Overall Study|Lost to Follow-up|1|||
155193118|NCT00216476|560145497|FG000|Overall Study|Adverse Event|6|||
155193119|NCT00216476|560145498|FG001|Overall Study|Adverse Event|10|||
155193120|NCT00216476|560145499|FG002|Overall Study|Adverse Event|1|||
155193121|NCT00216476|560145497|FG000|Overall Study|Lack of Efficacy|4|||
155193122|NCT00216476|560145498|FG001|Overall Study|Lack of Efficacy|3|||
155193123|NCT00216476|560145499|FG002|Overall Study|Lack of Efficacy|0|||
155193124|NCT00216476|560145497|FG000|Overall Study|Death|2|||
155193125|NCT00216476|560145498|FG001|Overall Study|Death|0|||
155038153|NCT00932698|559565856|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
155193126|NCT00216476|560145499|FG002|Overall Study|Death|0|||
155193127|NCT00216476|560145497|FG000|Overall Study|Pregnancy|0|||
155193128|NCT00216476|560145498|FG001|Overall Study|Pregnancy|1|||
155193129|NCT00216476|560145499|FG002|Overall Study|Pregnancy|1|||
155193130|NCT00216476|560145497|FG000|Overall Study|Other|0|||
155193131|NCT00216476|560145498|FG001|Overall Study|Other|0|||
155193132|NCT00216476|560145499|FG002|Overall Study|Other|1|||
155193133|NCT00216476|560145497|FG000|Overall Study|Refuses Injection|11|||
155193134|NCT00216476|560145498|FG001|Overall Study|Refuses Injection|0|||
155193135|NCT00216476|560145499|FG002|Overall Study|Refuses Injection|0|||
155193136|NCT00216476|560145497|FG000|Overall Study|No Further Need for Treatment|3|||
155193137|NCT00216476|560145498|FG001|Overall Study|No Further Need for Treatment|4|||
155193138|NCT00216476|560145499|FG002|Overall Study|No Further Need for Treatment|1|||
155193139|NCT00216476|560145497|FG000|Overall Study|Non-compliance|0|||
155193140|NCT00216476|560145498|FG001|Overall Study|Non-compliance|4|||
155193141|NCT00216476|560145499|FG002|Overall Study|Non-compliance|1|||
155193142|NCT00216476|560145497|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
155193143|NCT00216476|560145498|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
155193144|NCT00216476|560145499|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
155193145|NCT00216476|560145497|FG000|Overall Study|Administrative Reasons|1|||
155193146|NCT00216476|560145498|FG001|Overall Study|Administrative Reasons|1|||
155193147|NCT00216476|560145499|FG002|Overall Study|Administrative Reasons|0|||
155193148|NCT00216476|560145497|FG000|Overall Study|Protocol Deviation|5|||
155193149|NCT00216476|560145498|FG001|Overall Study|Protocol Deviation|1|||
155193150|NCT00216476|560145499|FG002|Overall Study|Protocol Deviation|0|||
155193151|NCT00216476|560145497|FG000|Overall Study|Patient Moved|2|||
155193152|NCT00216476|560145498|FG001|Overall Study|Patient Moved|2|||
155193153|NCT00216476|560145499|FG002|Overall Study|Patient Moved|0|||
155193154|NCT02191137|560145502|FG000|Treatment|Death|4|||
155193155|NCT02191137|560145502|FG000|Treatment|Withdrawal by Subject|3|||
155193156|NCT02191137|560145502|FG000|Treatment|Adverse Event|2|||
155193157|NCT02191137|560145502|FG000|Treatment|Other|1|||
155193158|NCT02191137|560145502|FG000|Follow-up|Lost to Follow-up|2|||
155193159|NCT02191137|560145502|FG000|Follow-up|Ongoing/unknown|2|||
155193160|NCT02191137|560145502|FG000|Follow-up|Adverse Event|1|||
155193161|NCT00538291|560145503|FG000|Overall Study|Adverse Event|2|||
155193162|NCT00538291|560145503|FG000|Overall Study|Withdrawal by Subject|1|||
155193163|NCT01904058|560145506|FG000|Overall Study|Adverse Event|2|||
155193164|NCT01904058|560145507|FG001|Overall Study|Adverse Event|0|||
155193165|NCT01904058|560145508|FG002|Overall Study|Adverse Event|0|||
155193166|NCT01904058|560145509|FG003|Overall Study|Adverse Event|0|||
155193167|NCT01904058|560145506|FG000|Overall Study|Withdrawal by Subject|1|||
155193168|NCT01904058|560145507|FG001|Overall Study|Withdrawal by Subject|0|||
155193169|NCT01904058|560145508|FG002|Overall Study|Withdrawal by Subject|1|||
155193170|NCT01904058|560145509|FG003|Overall Study|Withdrawal by Subject|0|||
155193171|NCT01904058|560145506|FG000|Overall Study|Pregnancy|0|||
155193172|NCT01904058|560145507|FG001|Overall Study|Pregnancy|0|||
155193173|NCT01904058|560145508|FG002|Overall Study|Pregnancy|0|||
155193174|NCT01904058|560145509|FG003|Overall Study|Pregnancy|1|||
155193175|NCT03096483|560145510|FG000|Overall Study|Withdrawal by site|1|||
155193176|NCT02046733|560145513|FG000|Overall Study|never initiated 'treatment visits'|6|||
155193177|NCT02046733|560145514|FG001|Overall Study|never initiated 'treatment visits'|0|||
155193178|NCT03605212|560145515|FG000|Treatment Period|Adverse Event|1|||
155193179|NCT03605212|560145516|FG001|Treatment Period|Adverse Event|0|||
155193180|NCT03605212|560145517|FG002|Treatment Period|Adverse Event|0|||
155193181|NCT03605212|560145518|FG003|Treatment Period|Adverse Event|0|||
155193182|NCT03605212|560145519|FG004|Treatment Period|Adverse Event|0|||
155193183|NCT03605212|560145515|FG000|Treatment Period|Physician Decision|0|||
155193184|NCT03605212|560145516|FG001|Treatment Period|Physician Decision|0|||
155193185|NCT03605212|560145517|FG002|Treatment Period|Physician Decision|0|||
155193186|NCT03605212|560145518|FG003|Treatment Period|Physician Decision|0|||
155193187|NCT03605212|560145519|FG004|Treatment Period|Physician Decision|1|||
155193188|NCT01756053|560145520|FG000|Period 1 (10 Days)|Protocol Violation|1|||
155193189|NCT01756053|560145521|FG001|Period 1 (10 Days)|Protocol Violation|1|||
155193190|NCT01756053|560145520|FG000|Period 2 (10 Days)|Protocol Violation|0|||
155193191|NCT01756053|560145521|FG001|Period 2 (10 Days)|Protocol Violation|2|||
155193192|NCT00285818|560145522|FG000|Overall Study|Withdrawal by Subject|3|||
155193193|NCT00285818|560145523|FG001|Overall Study|Withdrawal by Subject|2|||
155193194|NCT00285818|560145522|FG000|Overall Study|Lost to Follow-up|1|||
155193195|NCT00285818|560145523|FG001|Overall Study|Lost to Follow-up|0|||
155193196|NCT04674644|560145524|FG000|Overall Study|with missing data|37|||
155193197|NCT01024231|560145526|FG000|Overall Study|Other Reasons|1|||
155193198|NCT01024231|560145527|FG001|Overall Study|Other Reasons|2|||
155193199|NCT01024231|560145528|FG002|Overall Study|Other Reasons|0|||
155193200|NCT01024231|560145529|FG003|Overall Study|Other Reasons|0|||
155193201|NCT01024231|560145530|FG004|Overall Study|Other Reasons|2|||
155193202|NCT01024231|560145531|FG005|Overall Study|Other Reasons|0|||
155193203|NCT01024231|560145532|FG006|Overall Study|Other Reasons|1|||
155193204|NCT01024231|560145526|FG000|Overall Study|Maximum Clinical Benefit|1|||
155193205|NCT01024231|560145527|FG001|Overall Study|Maximum Clinical Benefit|2|||
155193206|NCT01024231|560145528|FG002|Overall Study|Maximum Clinical Benefit|0|||
155193207|NCT01024231|560145529|FG003|Overall Study|Maximum Clinical Benefit|1|||
155193208|NCT01024231|560145530|FG004|Overall Study|Maximum Clinical Benefit|1|||
155193209|NCT01024231|560145531|FG005|Overall Study|Maximum Clinical Benefit|0|||
155193210|NCT01024231|560145532|FG006|Overall Study|Maximum Clinical Benefit|0|||
155193211|NCT01024231|560145526|FG000|Overall Study|Disease Progression|3|||
155193212|NCT01024231|560145527|FG001|Overall Study|Disease Progression|1|||
155193213|NCT01024231|560145528|FG002|Overall Study|Disease Progression|3|||
155193214|NCT01024231|560145529|FG003|Overall Study|Disease Progression|0|||
155193215|NCT01024231|560145530|FG004|Overall Study|Disease Progression|4|||
155193216|NCT01024231|560145531|FG005|Overall Study|Disease Progression|11|||
155193217|NCT01024231|560145532|FG006|Overall Study|Disease Progression|6|||
155193218|NCT01024231|560145526|FG000|Overall Study|AE unrelated to Study Drug|0|||
155193219|NCT01024231|560145527|FG001|Overall Study|AE unrelated to Study Drug|1|||
155193220|NCT01024231|560145528|FG002|Overall Study|AE unrelated to Study Drug|0|||
155193221|NCT01024231|560145529|FG003|Overall Study|AE unrelated to Study Drug|0|||
155193222|NCT01024231|560145530|FG004|Overall Study|AE unrelated to Study Drug|0|||
155193223|NCT01024231|560145531|FG005|Overall Study|AE unrelated to Study Drug|0|||
155193224|NCT01024231|560145532|FG006|Overall Study|AE unrelated to Study Drug|0|||
155193225|NCT01024231|560145526|FG000|Overall Study|No longer meets criteria|0|||
155193226|NCT01024231|560145527|FG001|Overall Study|No longer meets criteria|0|||
155193227|NCT01024231|560145528|FG002|Overall Study|No longer meets criteria|0|||
155193228|NCT01024231|560145529|FG003|Overall Study|No longer meets criteria|0|||
155193229|NCT01024231|560145530|FG004|Overall Study|No longer meets criteria|1|||
155193230|NCT01024231|560145531|FG005|Overall Study|No longer meets criteria|0|||
155193231|NCT01024231|560145532|FG006|Overall Study|No longer meets criteria|1|||
155193232|NCT01024231|560145526|FG000|Overall Study|Study Drug Toxicity|1|||
155193233|NCT01024231|560145527|FG001|Overall Study|Study Drug Toxicity|6|||
155193234|NCT01024231|560145528|FG002|Overall Study|Study Drug Toxicity|6|||
155193235|NCT01024231|560145529|FG003|Overall Study|Study Drug Toxicity|4|||
155193236|NCT01024231|560145530|FG004|Overall Study|Study Drug Toxicity|2|||
155193237|NCT01024231|560145531|FG005|Overall Study|Study Drug Toxicity|0|||
155193238|NCT01024231|560145532|FG006|Overall Study|Study Drug Toxicity|7|||
155193239|NCT01024231|560145526|FG000|Overall Study|Death|6|||
155193240|NCT01024231|560145527|FG001|Overall Study|Death|2|||
155193241|NCT01024231|560145528|FG002|Overall Study|Death|1|||
155193242|NCT01024231|560145529|FG003|Overall Study|Death|0|||
155193243|NCT01024231|560145530|FG004|Overall Study|Death|4|||
155193244|NCT01024231|560145531|FG005|Overall Study|Death|3|||
155193245|NCT01024231|560145532|FG006|Overall Study|Death|5|||
155193246|NCT01024231|560145526|FG000|Overall Study|Lost to Follow-up|0|||
155193247|NCT01024231|560145527|FG001|Overall Study|Lost to Follow-up|0|||
155193248|NCT01024231|560145528|FG002|Overall Study|Lost to Follow-up|0|||
155193249|NCT01024231|560145529|FG003|Overall Study|Lost to Follow-up|0|||
155193250|NCT01024231|560145530|FG004|Overall Study|Lost to Follow-up|0|||
155193251|NCT01024231|560145531|FG005|Overall Study|Lost to Follow-up|0|||
155193252|NCT01024231|560145532|FG006|Overall Study|Lost to Follow-up|1|||
155193253|NCT01024231|560145526|FG000|Overall Study|Withdrew Consent|0|||
155193254|NCT01024231|560145527|FG001|Overall Study|Withdrew Consent|1|||
155193255|NCT01024231|560145528|FG002|Overall Study|Withdrew Consent|0|||
155193256|NCT01024231|560145529|FG003|Overall Study|Withdrew Consent|0|||
155193257|NCT01024231|560145530|FG004|Overall Study|Withdrew Consent|0|||
155193258|NCT01024231|560145531|FG005|Overall Study|Withdrew Consent|0|||
155193259|NCT01024231|560145532|FG006|Overall Study|Withdrew Consent|0|||
155193260|NCT01024231|560145526|FG000|Overall Study|Continuing on Treatment|0|||
155193261|NCT01024231|560145527|FG001|Overall Study|Continuing on Treatment|0|||
155193262|NCT01024231|560145528|FG002|Overall Study|Continuing on Treatment|0|||
155193263|NCT01024231|560145529|FG003|Overall Study|Continuing on Treatment|0|||
155193264|NCT01024231|560145530|FG004|Overall Study|Continuing on Treatment|3|||
155193265|NCT01024231|560145531|FG005|Overall Study|Continuing on Treatment|2|||
155193266|NCT01024231|560145532|FG006|Overall Study|Continuing on Treatment|0|||
155193267|NCT01268150|560145533|FG000|Treatment Phase|Progression of disease|18|||
155193268|NCT01268150|560145533|FG000|Treatment Phase|Adverse Event|3|||
155193269|NCT01268150|560145533|FG000|Treatment Phase|Withdrawal by Subject|3|||
155193270|NCT01268150|560145533|FG000|Treatment Phase|Other|4|||
155193271|NCT01268150|560145533|FG000|Extension Phase|Adverse Event|3|||
155193272|NCT01268150|560145533|FG000|Extension Phase|Disease progression|18|||
155193273|NCT01268150|560145533|FG000|Extension Phase|Other|6|||
155193274|NCT00395733|560145534|FG000|Period 2|Withdrawal by Subject|1|||
155193275|NCT00395733|560145535|FG001|Period 2|Withdrawal by Subject|2|||
155193276|NCT00395733|560145534|FG000|Period 2|Protocol Violation|0|||
155193277|NCT00395733|560145535|FG001|Period 2|Protocol Violation|1|||
155193278|NCT00395733|560145534|FG000|Period 2|Adverse Event|0|||
155193279|NCT00395733|560145535|FG001|Period 2|Adverse Event|2|||
155193280|NCT00395733|560145534|FG000|Period 2|Technical problems|1|||
155193281|NCT00395733|560145535|FG001|Period 2|Technical problems|0|||
155193282|NCT01147172|560145537|FG000|Overall Study|Withdrawal by Subject|2|||
155193283|NCT01147172|560145537|FG000|Overall Study|Lost to Follow-up|2|||
155193284|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
155193285|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
155193286|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Death|1|||
155193287|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Death|0|||
155193288|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
155193289|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
155193290|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
155193291|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
155193292|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
155193293|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
155193294|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
155193295|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
155193296|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
155193297|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
155193298|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
155193299|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
155193300|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
155193301|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
155193302|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
155193303|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
155193304|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
155193305|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
155193306|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
155193307|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
155193308|NCT02927262|560145538|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
155193309|NCT02927262|560145539|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
155193310|NCT02927262|560145538|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
155193311|NCT02927262|560145539|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
155193312|NCT02927262|560145538|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
155193313|NCT02927262|560145539|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
155193314|NCT02927262|560145538|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
155193315|NCT02927262|560145539|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
155193316|NCT04357782|560145545|FG000|Overall Study|Discharged from hospital|1|||
155193317|NCT04357782|560145546|FG001|Overall Study|Discharged from hospital|0|||
155193318|NCT04357782|560145545|FG000|Overall Study|Death|0|||
155193319|NCT04357782|560145546|FG001|Overall Study|Death|2|||
155193320|NCT01786148|560145547|FG000|Overall Study|Lost to Follow-up|21|||
155193321|NCT01786148|560145548|FG001|Overall Study|Lost to Follow-up|13|||
155193322|NCT01786148|560145547|FG000|Overall Study|Death|0|||
155193323|NCT01786148|560145548|FG001|Overall Study|Death|1|||
155193324|NCT01786148|560145547|FG000|Overall Study|Withdrawal by Subject|0|||
155193325|NCT01786148|560145548|FG001|Overall Study|Withdrawal by Subject|7|||
155193326|NCT01786148|560145547|FG000|Overall Study|Incarceration|1|||
155193327|NCT01786148|560145548|FG001|Overall Study|Incarceration|1|||
155193328|NCT00072176|560145550|FG000|Overall Study|Withdrawal by Subject|1|||
155193329|NCT00072176|560145551|FG001|Overall Study|Withdrawal by Subject|0|||
155193330|NCT00072176|560145550|FG000|Overall Study|Protocol Violation|0|||
155193331|NCT00072176|560145551|FG001|Overall Study|Protocol Violation|1|||
155193332|NCT04128371|560145554|FG000|Overall Study|Lack of Efficacy|1|||
155193333|NCT02840721|560145556|FG000|Treatment Period|Adverse Event|1|||
155193334|NCT02840721|560145556|FG000|Follow-Up|Lack of Efficacy|1|||
155193335|NCT02840721|560145556|FG000|Follow-Up|Withdrawal by Subject|4|||
155193336|NCT02840721|560145556|FG000|Follow-Up|Withdrawal of Consent|2|||
155038154|NCT00932698|559565857|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
155038155|NCT00932698|559565858|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
155038156|NCT00932698|559565848|FG000|Part 1 (Dose Escalation)|Other|0|||
155038157|NCT00932698|559565849|FG001|Part 1 (Dose Escalation)|Other|0|||
155038158|NCT00932698|559565850|FG002|Part 1 (Dose Escalation)|Other|1|||
155038159|NCT00932698|559565851|FG003|Part 1 (Dose Escalation)|Other|0|||
155038160|NCT00932698|559565852|FG004|Part 1 (Dose Escalation)|Other|0|||
155038161|NCT00932698|559565853|FG005|Part 1 (Dose Escalation)|Other|0|||
155038162|NCT00932698|559565854|FG006|Part 1 (Dose Escalation)|Other|1|||
155038163|NCT00932698|559565855|FG007|Part 1 (Dose Escalation)|Other|0|||
155038164|NCT00932698|559565856|FG008|Part 1 (Dose Escalation)|Other|0|||
155038165|NCT00932698|559565857|FG009|Part 1 (Dose Escalation)|Other|0|||
155038166|NCT00932698|559565858|FG010|Part 1 (Dose Escalation)|Other|0|||
155038167|NCT00932698|559565848|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
155193337|NCT05274165|560145559|FG000|Overall Study|Withdrawal by Subject|3|||
155193338|NCT05274165|560145560|FG001|Overall Study|Withdrawal by Subject|3|||
155193339|NCT03672643|560145562|FG000|Overall Study|Adverse Event|3|||
155193340|NCT03672643|560145562|FG000|Overall Study|Death|2|||
155193341|NCT03672643|560145562|FG000|Overall Study|Withdrawal by Subject|1|||
155193342|NCT03672643|560145562|FG000|Overall Study|Progressive disease|11|||
155038168|NCT00932698|559565849|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
155038169|NCT00932698|559565850|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
155038170|NCT00932698|559565851|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
155038171|NCT00932698|559565852|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
155038172|NCT00932698|559565853|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
155038173|NCT00932698|559565854|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
155038174|NCT00932698|559565855|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
155038175|NCT00932698|559565856|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
155038176|NCT00932698|559565857|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
155038177|NCT00932698|559565858|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
155038178|NCT00932698|559565848|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038179|NCT00932698|559565849|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038180|NCT00932698|559565850|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038181|NCT00932698|559565851|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038182|NCT00932698|559565852|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038183|NCT00932698|559565853|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038184|NCT00932698|559565854|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038185|NCT00932698|559565855|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
155193343|NCT03672643|560145562|FG000|Overall Study|Global deterioration of health status|1|||
155193344|NCT03672643|560145562|FG000|Overall Study|Refused further treatment|7|||
155193345|NCT03672643|560145562|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
155193346|NCT05985395|560145563|FG000|Overall Study|Physician Decision|2|||
155193347|NCT05985395|560145564|FG001|Overall Study|Physician Decision|1|||
155193348|NCT05985395|560145563|FG000|Overall Study|Withdrawal by Subject|1|||
155193349|NCT05985395|560145564|FG001|Overall Study|Withdrawal by Subject|0|||
155193350|NCT03774082|560145565|FG000|Overall Study|Death|6|||
155193351|NCT03774082|560145566|FG001|Overall Study|Death|3|||
155193352|NCT03774082|560145567|FG002|Overall Study|Death|2|||
155193353|NCT03774082|560145565|FG000|Overall Study|Subject decision|0|||
155193354|NCT03774082|560145566|FG001|Overall Study|Subject decision|3|||
155193355|NCT03774082|560145567|FG002|Overall Study|Subject decision|0|||
155193356|NCT03774082|560145565|FG000|Overall Study|Lost to Follow-up|2|||
155193357|NCT03774082|560145566|FG001|Overall Study|Lost to Follow-up|0|||
155193358|NCT03774082|560145567|FG002|Overall Study|Lost to Follow-up|0|||
155193359|NCT03774082|560145565|FG000|Overall Study|Guardian decision|0|||
155193360|NCT03774082|560145566|FG001|Overall Study|Guardian decision|0|||
155193361|NCT03774082|560145567|FG002|Overall Study|Guardian decision|1|||
155193362|NCT03774082|560145565|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
155193363|NCT03774082|560145566|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
155193364|NCT03774082|560145567|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
155193365|NCT00150709|560147388|FG000|Overall Study|Protocol Violation|7|||
155193366|NCT00150709|560147389|FG001|Overall Study|Protocol Violation|8|||
155193367|NCT00150709|560147390|FG002|Overall Study|Protocol Violation|3|||
155193368|NCT00150709|560147391|FG003|Overall Study|Protocol Violation|1|||
155193369|NCT00150709|560147388|FG000|Overall Study|Adverse Event|8|||
155193370|NCT00150709|560147389|FG001|Overall Study|Adverse Event|2|||
155193371|NCT00150709|560147390|FG002|Overall Study|Adverse Event|2|||
155193372|NCT00150709|560147391|FG003|Overall Study|Adverse Event|3|||
155193373|NCT00150709|560147388|FG000|Overall Study|Lack of Efficacy|6|||
155193374|NCT00150709|560147389|FG001|Overall Study|Lack of Efficacy|11|||
155193375|NCT00150709|560147390|FG002|Overall Study|Lack of Efficacy|9|||
155193376|NCT00150709|560147391|FG003|Overall Study|Lack of Efficacy|0|||
155193377|NCT00150709|560147388|FG000|Overall Study|Withdrawal by Subject|7|||
155193378|NCT00150709|560147389|FG001|Overall Study|Withdrawal by Subject|10|||
155193379|NCT00150709|560147390|FG002|Overall Study|Withdrawal by Subject|5|||
155193380|NCT00150709|560147391|FG003|Overall Study|Withdrawal by Subject|0|||
155193381|NCT00150709|560147388|FG000|Overall Study|Lost to Follow-up|3|||
155193382|NCT00150709|560147389|FG001|Overall Study|Lost to Follow-up|2|||
155193383|NCT00150709|560147390|FG002|Overall Study|Lost to Follow-up|0|||
155193384|NCT00150709|560147391|FG003|Overall Study|Lost to Follow-up|0|||
155193385|NCT00150709|560147388|FG000|Overall Study|Sponsor decision|0|||
155193386|NCT00150709|560147389|FG001|Overall Study|Sponsor decision|0|||
155193387|NCT00150709|560147390|FG002|Overall Study|Sponsor decision|0|||
155193388|NCT00150709|560147391|FG003|Overall Study|Sponsor decision|1|||
155193389|NCT00150709|560147388|FG000|Overall Study|Site/Investigator discontinued the study|5|||
155193390|NCT00150709|560147389|FG001|Overall Study|Site/Investigator discontinued the study|5|||
155038186|NCT00932698|559565856|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
155193391|NCT00150709|560147390|FG002|Overall Study|Site/Investigator discontinued the study|2|||
155193392|NCT00150709|560147391|FG003|Overall Study|Site/Investigator discontinued the study|0|||
155193393|NCT00150709|560147388|FG000|Overall Study|Decision of parent(s)|1|||
155193394|NCT00150709|560147389|FG001|Overall Study|Decision of parent(s)|2|||
155038187|NCT00932698|559565857|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
155038188|NCT00932698|559565858|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
155038189|NCT00932698|559565848|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
155038190|NCT00932698|559565849|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
155193395|NCT00150709|560147390|FG002|Overall Study|Decision of parent(s)|0|||
155193396|NCT00150709|560147391|FG003|Overall Study|Decision of parent(s)|0|||
155193397|NCT00150709|560147388|FG000|Overall Study|Decision of parent(s) and investigator|3|||
155038191|NCT00932698|559565850|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
155193398|NCT00150709|560147389|FG001|Overall Study|Decision of parent(s) and investigator|0|||
155193399|NCT00150709|560147390|FG002|Overall Study|Decision of parent(s) and investigator|0|||
155193400|NCT00150709|560147391|FG003|Overall Study|Decision of parent(s) and investigator|0|||
155193401|NCT00150709|560147388|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
155193402|NCT00150709|560147389|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
155193403|NCT00150709|560147390|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
155193404|NCT00150709|560147391|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
155193405|NCT00150709|560147388|FG000|Overall Study|Investigator decision|1|||
155193406|NCT00150709|560147389|FG001|Overall Study|Investigator decision|0|||
155193407|NCT00150709|560147390|FG002|Overall Study|Investigator decision|0|||
155193408|NCT00150709|560147391|FG003|Overall Study|Investigator decision|1|||
155193409|NCT00150709|560147388|FG000|Overall Study|Subject relocated|2|||
155193410|NCT00150709|560147389|FG001|Overall Study|Subject relocated|2|||
155193411|NCT00150709|560147390|FG002|Overall Study|Subject relocated|1|||
155193412|NCT00150709|560147391|FG003|Overall Study|Subject relocated|0|||
155193413|NCT00150709|560147388|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
155193414|NCT00150709|560147389|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
155193415|NCT00150709|560147390|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
155193416|NCT00150709|560147391|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
155193417|NCT00150709|560147388|FG000|Overall Study|Convenience|0|||
155193418|NCT00150709|560147389|FG001|Overall Study|Convenience|1|||
155193419|NCT00150709|560147390|FG002|Overall Study|Convenience|0|||
155193420|NCT00150709|560147391|FG003|Overall Study|Convenience|0|||
155193421|NCT00150709|560147388|FG000|Overall Study|Subject entered new drug study|0|||
155193422|NCT00150709|560147389|FG001|Overall Study|Subject entered new drug study|1|||
155193423|NCT00150709|560147390|FG002|Overall Study|Subject entered new drug study|0|||
155193424|NCT00150709|560147391|FG003|Overall Study|Subject entered new drug study|0|||
155193425|NCT00150709|560147388|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
155193426|NCT00150709|560147389|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
155193427|NCT00150709|560147390|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
155193428|NCT00150709|560147391|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
155193429|NCT00150709|560147388|FG000|Overall Study|Lack of ease of swallowing|0|||
155193430|NCT00150709|560147389|FG001|Overall Study|Lack of ease of swallowing|1|||
155193431|NCT00150709|560147390|FG002|Overall Study|Lack of ease of swallowing|0|||
155193432|NCT00150709|560147391|FG003|Overall Study|Lack of ease of swallowing|0|||
155193433|NCT00316719|560147392|FG000|Overall Study|Adverse Event|0|||
155193434|NCT00316719|560147393|FG001|Overall Study|Adverse Event|6|||
155193435|NCT00316719|560147392|FG000|Overall Study|Consent withdrawn|2|||
155193436|NCT00316719|560147393|FG001|Overall Study|Consent withdrawn|0|||
155193437|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Adverse Event|16|||
155193438|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Adverse Event|17|||
155193439|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Adverse Event|13|||
155193440|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Adverse Event|18|||
155193441|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Adverse Event|0|||
155193442|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Adverse Event|0|||
155193443|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Adverse Event|0|||
155193444|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Adverse Event|0|||
155193445|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
155193446|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
155193447|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
155193448|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
155193449|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193450|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193451|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193452|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
155193453|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
155193454|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
155193455|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
155193456|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
155193457|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
155193458|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
155193459|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
155193460|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
155193461|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
155193462|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
155193463|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
155193464|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
155193465|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193466|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193467|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193468|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
155193469|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
155193470|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193471|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
155193472|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
155193473|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155038192|NCT00932698|559565851|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
155038193|NCT00932698|559565852|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
155038194|NCT00932698|559565853|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
155038195|NCT00932698|559565854|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
155038196|NCT00932698|559565855|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
155038197|NCT00932698|559565856|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
155193474|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193475|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193476|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
155193477|NCT02975336|560147394|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
155193478|NCT02975336|560147395|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
155193479|NCT02975336|560147396|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
155193480|NCT02975336|560147397|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
155193481|NCT02975336|560147398|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
155193482|NCT02975336|560147399|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
155193483|NCT02975336|560147400|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
155193484|NCT02975336|560147401|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
155193485|NCT02975336|560147394|FG000|LTE (104 Weeks)|Adverse Event|0|||
155193486|NCT02975336|560147395|FG001|LTE (104 Weeks)|Adverse Event|0|||
155193487|NCT02975336|560147396|FG002|LTE (104 Weeks)|Adverse Event|0|||
155193488|NCT02975336|560147397|FG003|LTE (104 Weeks)|Adverse Event|0|||
155193489|NCT02975336|560147398|FG004|LTE (104 Weeks)|Adverse Event|7|||
155193490|NCT02975336|560147399|FG005|LTE (104 Weeks)|Adverse Event|4|||
155193491|NCT02975336|560147400|FG006|LTE (104 Weeks)|Adverse Event|2|||
155193492|NCT02975336|560147401|FG007|LTE (104 Weeks)|Adverse Event|0|||
155193493|NCT02975336|560147394|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
155193494|NCT02975336|560147395|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
155193495|NCT02975336|560147396|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
155193496|NCT02975336|560147397|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
155193497|NCT02975336|560147398|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
155193498|NCT02975336|560147399|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
155193499|NCT02975336|560147400|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
155193500|NCT02975336|560147401|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
155193501|NCT02975336|560147394|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
155193502|NCT02975336|560147395|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
155193503|NCT02975336|560147396|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
155193504|NCT02975336|560147397|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
155193505|NCT02975336|560147398|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
155193506|NCT02975336|560147399|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
155193507|NCT02975336|560147400|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
155193508|NCT02975336|560147401|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
155193509|NCT02975336|560147394|FG000|LTE (104 Weeks)|Other|0|||
155193510|NCT02975336|560147395|FG001|LTE (104 Weeks)|Other|0|||
155193511|NCT02975336|560147396|FG002|LTE (104 Weeks)|Other|0|||
155193512|NCT02975336|560147397|FG003|LTE (104 Weeks)|Other|0|||
155193513|NCT02975336|560147398|FG004|LTE (104 Weeks)|Other|55|||
155193514|NCT02975336|560147399|FG005|LTE (104 Weeks)|Other|63|||
155193515|NCT02975336|560147400|FG006|LTE (104 Weeks)|Other|76|||
155193516|NCT02975336|560147401|FG007|LTE (104 Weeks)|Other|72|||
155193517|NCT02024529|560147407|FG000|Overall Study|Withdrawal by Subject|11|||
155193518|NCT02024529|560147408|FG001|Overall Study|Withdrawal by Subject|21|||
155193519|NCT02024529|560147407|FG000|Overall Study|Lost to Follow-up|2|||
155193520|NCT02024529|560147408|FG001|Overall Study|Lost to Follow-up|4|||
155193521|NCT02642029|560147409|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
155193522|NCT02642029|560147410|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193523|NCT02642029|560147411|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193524|NCT02642029|560147412|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193525|NCT02642029|560147413|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193526|NCT02642029|560147414|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
155193527|NCT02642029|560147409|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193528|NCT02642029|560147410|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
155193529|NCT02642029|560147411|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155038198|NCT00932698|559565857|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
155038199|NCT00932698|559565858|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
155038200|NCT02908074|559565860|FG000|Overall Study|sponsor/ICON decision|0|||
155193530|NCT02642029|560147412|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193531|NCT02642029|560147413|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193532|NCT02642029|560147414|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
155193533|NCT02642029|560147409|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193534|NCT02642029|560147410|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193535|NCT02642029|560147411|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193536|NCT02642029|560147412|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193537|NCT02642029|560147413|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
155038201|NCT02908074|559565861|FG001|Overall Study|sponsor/ICON decision|0|||
155193538|NCT02642029|560147414|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
155193539|NCT02642029|560147409|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
155193540|NCT02642029|560147410|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
155193541|NCT02642029|560147411|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
155193542|NCT02642029|560147412|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
155193543|NCT02642029|560147413|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
155193544|NCT02642029|560147414|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
155193545|NCT02642029|560147409|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
155193546|NCT02642029|560147410|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193547|NCT02642029|560147411|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193548|NCT02642029|560147412|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193549|NCT02642029|560147413|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193550|NCT02642029|560147414|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
155193551|NCT02642029|560147409|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
155193552|NCT02642029|560147410|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193553|NCT02642029|560147411|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193554|NCT02642029|560147412|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193555|NCT02642029|560147413|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193556|NCT02642029|560147414|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
155193557|NCT00691301|560147417|FG000|Overall Study|Adverse Event|10|||
155193558|NCT00691301|560147417|FG000|Overall Study|Death|2|||
155193559|NCT00691301|560147417|FG000|Overall Study|Lack of Efficacy|32|||
155193560|NCT00691301|560147417|FG000|Overall Study|Withdrawal by Subject|4|||
155193561|NCT00691301|560147417|FG000|Overall Study|Concurrent illness|2|||
155193562|NCT00691301|560147417|FG000|Overall Study|other reason|3|||
155193563|NCT00691301|560147417|FG000|Overall Study|Did not initiate study treatment|1|||
155193564|NCT01823146|560147418|FG000|Overall Study|Withdrawal by Subject|0|||
155193565|NCT01823146|560147419|FG001|Overall Study|Withdrawal by Subject|1|||
155193566|NCT01823146|560147418|FG000|Overall Study|Lost to Follow-up|2|||
155193567|NCT01823146|560147419|FG001|Overall Study|Lost to Follow-up|1|||
155193568|NCT00736944|560147420|FG000|Induction|Death|1|||
155193569|NCT00736944|560147420|FG000|Definitive Treatment|Physician Decision|1|||
155193570|NCT01426438|560147421|FG000|Overall Study|Lost to Follow-up|1|||
155193571|NCT01426438|560147422|FG001|Overall Study|Lost to Follow-up|3|||
155193572|NCT01426438|560147421|FG000|Overall Study|Off study Treatment|9|||
155193573|NCT01426438|560147422|FG001|Overall Study|Off study Treatment|3|||
155193574|NCT01426438|560147421|FG000|Overall Study|Poor scan quality|3|||
155193575|NCT01426438|560147422|FG001|Overall Study|Poor scan quality|2|||
155193576|NCT01426438|560147421|FG000|Overall Study|Missed Scan|2|||
155193577|NCT01426438|560147422|FG001|Overall Study|Missed Scan|2|||
155193578|NCT00091442|560147423|FG000|Overall Study|Progressive Disease|220|||
155193579|NCT00091442|560147424|FG001|Overall Study|Progressive Disease|189|||
155193580|NCT00091442|560147423|FG000|Overall Study|Physician Decision|61|||
155193581|NCT00091442|560147424|FG001|Overall Study|Physician Decision|58|||
155193582|NCT00091442|560147423|FG000|Overall Study|Withdrawal by Subject|38|||
155193583|NCT00091442|560147424|FG001|Overall Study|Withdrawal by Subject|46|||
155193584|NCT00091442|560147423|FG000|Overall Study|Adverse Event|29|||
155193585|NCT00091442|560147424|FG001|Overall Study|Adverse Event|48|||
155193586|NCT00091442|560147423|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
155193587|NCT00091442|560147424|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
155193588|NCT00091442|560147423|FG000|Overall Study|Death|9|||
155193589|NCT00091442|560147424|FG001|Overall Study|Death|7|||
155193590|NCT00091442|560147423|FG000|Overall Study|Lost to Follow-up|1|||
155193591|NCT00091442|560147424|FG001|Overall Study|Lost to Follow-up|3|||
155193592|NCT00091442|560147423|FG000|Overall Study|Other|2|||
155193593|NCT00091442|560147424|FG001|Overall Study|Other|6|||
155193594|NCT00845858|560147425|FG000|Overall Study|Withdrawal by Subject|5|||
155193595|NCT00845858|560147426|FG001|Overall Study|Withdrawal by Subject|1|||
155038202|NCT02908074|559565862|FG002|Overall Study|sponsor/ICON decision|1|||
155038203|NCT02908074|559565863|FG003|Overall Study|sponsor/ICON decision|0|||
155038204|NCT02908074|559565864|FG004|Overall Study|sponsor/ICON decision|0|||
155193596|NCT00845858|560147427|FG002|Overall Study|Withdrawal by Subject|1|||
155193597|NCT00845858|560147425|FG000|Overall Study|Adverse Event|3|||
155193598|NCT00845858|560147426|FG001|Overall Study|Adverse Event|8|||
155193599|NCT00845858|560147427|FG002|Overall Study|Adverse Event|4|||
155193600|NCT00845858|560147425|FG000|Overall Study|Protocol Violation|0|||
155193601|NCT00845858|560147426|FG001|Overall Study|Protocol Violation|0|||
155193602|NCT00845858|560147427|FG002|Overall Study|Protocol Violation|1|||
155193603|NCT00845858|560147425|FG000|Overall Study|not eligible|0|||
155193604|NCT00845858|560147426|FG001|Overall Study|not eligible|3|||
155193605|NCT00845858|560147427|FG002|Overall Study|not eligible|2|||
155193606|NCT03725852|560147433|FG000|Overall Study|Death|1|||
155193607|NCT03725852|560147434|FG001|Overall Study|Death|0|||
155193608|NCT03725852|560147433|FG000|Overall Study|Withdrawal by Subject|1|||
155193609|NCT03725852|560147434|FG001|Overall Study|Withdrawal by Subject|0|||
155193610|NCT03725852|560147433|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
155038205|NCT02908074|559565865|FG005|Overall Study|sponsor/ICON decision|0|||
155038206|NCT02908074|559565860|FG000|Overall Study|Protocol Violation|0|||
155038207|NCT02908074|559565861|FG001|Overall Study|Protocol Violation|1|||
155038208|NCT02908074|559565862|FG002|Overall Study|Protocol Violation|0|||
155038209|NCT02908074|559565863|FG003|Overall Study|Protocol Violation|0|||
155193611|NCT03725852|560147434|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
155193612|NCT02808650|560147439|FG000|Overall Study|Death|0|||
155193613|NCT02808650|560147440|FG001|Overall Study|Death|0|||
155193614|NCT02808650|560147441|FG002|Overall Study|Death|0|||
155193615|NCT02808650|560147442|FG003|Overall Study|Death|0|||
155193616|NCT02808650|560147443|FG004|Overall Study|Death|1|||
155038210|NCT02908074|559565864|FG004|Overall Study|Protocol Violation|0|||
155038211|NCT02908074|559565865|FG005|Overall Study|Protocol Violation|0|||
155038212|NCT02908074|559565860|FG000|Overall Study|Adverse Event|5|||
155038213|NCT02908074|559565861|FG001|Overall Study|Adverse Event|2|||
155038214|NCT02908074|559565862|FG002|Overall Study|Adverse Event|0|||
155038215|NCT02908074|559565863|FG003|Overall Study|Adverse Event|0|||
155038216|NCT02908074|559565864|FG004|Overall Study|Adverse Event|1|||
155038217|NCT02908074|559565865|FG005|Overall Study|Adverse Event|0|||
155038218|NCT02908074|559565860|FG000|Overall Study|AESI|1|||
155038219|NCT02908074|559565861|FG001|Overall Study|AESI|0|||
155038220|NCT02908074|559565862|FG002|Overall Study|AESI|1|||
155038221|NCT02908074|559565863|FG003|Overall Study|AESI|0|||
155144257|NCT01080807|559961108|FG001|Overall Study|Stopped working consistent night shifts|1|||
155144258|NCT01080807|559961107|FG000|Overall Study|Work schedule changing|1|||
155144259|NCT01080807|559961108|FG001|Overall Study|Work schedule changing|1|||
155144260|NCT01080807|559961107|FG000|Overall Study|Work schedule and travel|0|||
155144261|NCT01080807|559961108|FG001|Overall Study|Work schedule and travel|1|||
155144262|NCT01080807|559961107|FG000|Overall Study|Switched to first shift|1|||
155144263|NCT01080807|559961108|FG001|Overall Study|Switched to first shift|0|||
155144264|NCT01080807|559961107|FG000|Overall Study|Moved away without notifying center|1|||
155144265|NCT01080807|559961108|FG001|Overall Study|Moved away without notifying center|0|||
155144266|NCT03922581|559961116|FG000|Overall Study|Lost to Follow-up|20|||
155144267|NCT03922581|559961117|FG001|Overall Study|Lost to Follow-up|9|||
155144268|NCT03922581|559961116|FG000|Overall Study|Physician Decision|1|||
155144269|NCT03922581|559961117|FG001|Overall Study|Physician Decision|1|||
155144270|NCT03922581|559961116|FG000|Overall Study|Withdrawal by Subject|1|||
155144271|NCT03922581|559961117|FG001|Overall Study|Withdrawal by Subject|0|||
155144272|NCT00764699|559961120|FG000|Overall Study|PI left and study terminated|3|||
155144273|NCT01508312|559961126|FG000|Overall Study|Lost to Follow-up|1|||
155144274|NCT01508312|559961127|FG001|Overall Study|Lost to Follow-up|0|||
155144275|NCT01508312|559961128|FG002|Overall Study|Lost to Follow-up|0|||
155144276|NCT01508312|559961129|FG003|Overall Study|Lost to Follow-up|0|||
155144277|NCT01508312|559961126|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
155144278|NCT01508312|559961127|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
155144279|NCT01508312|559961128|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
155144280|NCT01508312|559961129|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
155144281|NCT01508312|559961126|FG000|Overall Study|Adverse Event|0|||
155144282|NCT01508312|559961127|FG001|Overall Study|Adverse Event|0|||
155144283|NCT01508312|559961128|FG002|Overall Study|Adverse Event|2|||
155144284|NCT01508312|559961129|FG003|Overall Study|Adverse Event|0|||
155144285|NCT01508312|559961126|FG000|Overall Study|Lack of Efficacy|0|||
155144286|NCT01508312|559961127|FG001|Overall Study|Lack of Efficacy|0|||
155144287|NCT01508312|559961128|FG002|Overall Study|Lack of Efficacy|1|||
155144288|NCT01508312|559961129|FG003|Overall Study|Lack of Efficacy|0|||
155144289|NCT01508312|559961126|FG000|Overall Study|Withdrawal by Subject|0|||
155144290|NCT01508312|559961127|FG001|Overall Study|Withdrawal by Subject|0|||
155144291|NCT01508312|559961128|FG002|Overall Study|Withdrawal by Subject|1|||
155144292|NCT01508312|559961129|FG003|Overall Study|Withdrawal by Subject|0|||
155144293|NCT02223715|559961130|FG000|Overall Study|Death|31|||
155144294|NCT02223715|559961130|FG000|Overall Study|Lost to Follow-up|73|||
155144295|NCT02222558|559961131|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
155144296|NCT02222558|559961132|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
155144297|NCT02222558|559961133|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
155144298|NCT02222558|559961134|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
155144299|NCT02222558|559961135|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
155144300|NCT02222558|559961136|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
155193617|NCT02808650|560147439|FG000|Overall Study|Lack of Efficacy|5|||
155193618|NCT02808650|560147440|FG001|Overall Study|Lack of Efficacy|5|||
155193619|NCT02808650|560147441|FG002|Overall Study|Lack of Efficacy|6|||
155193620|NCT02808650|560147442|FG003|Overall Study|Lack of Efficacy|5|||
155038222|NCT02908074|559565864|FG004|Overall Study|AESI|1|||
155038223|NCT02908074|559565865|FG005|Overall Study|AESI|0|||
155038224|NCT02908074|559565860|FG000|Overall Study|Discontinuation criteria per protocol|0|||
155038225|NCT02908074|559565861|FG001|Overall Study|Discontinuation criteria per protocol|0|||
155038226|NCT02908074|559565862|FG002|Overall Study|Discontinuation criteria per protocol|1|||
155193621|NCT02808650|560147443|FG004|Overall Study|Lack of Efficacy|4|||
155193622|NCT02808650|560147439|FG000|Overall Study|Physician Decision|1|||
155193623|NCT02808650|560147440|FG001|Overall Study|Physician Decision|1|||
155193624|NCT02808650|560147441|FG002|Overall Study|Physician Decision|0|||
155193625|NCT02808650|560147442|FG003|Overall Study|Physician Decision|0|||
155193626|NCT02808650|560147443|FG004|Overall Study|Physician Decision|0|||
155193627|NCT02808650|560147439|FG000|Overall Study|Withdrawal by Subject|0|||
155193628|NCT02808650|560147440|FG001|Overall Study|Withdrawal by Subject|0|||
155193629|NCT02808650|560147441|FG002|Overall Study|Withdrawal by Subject|0|||
155193630|NCT02808650|560147442|FG003|Overall Study|Withdrawal by Subject|1|||
155193631|NCT02808650|560147443|FG004|Overall Study|Withdrawal by Subject|1|||
155193632|NCT00669396|560147450|FG000|Overall Study|Lost to Follow-up|10|||
155193633|NCT00669396|560147451|FG001|Overall Study|Lost to Follow-up|12|||
155193634|NCT01262573|560147452|FG000|Overall Study|Withdrawal by Subject|0|||
155193635|NCT01262573|560147453|FG001|Overall Study|Withdrawal by Subject|1|||
155193636|NCT04402060|560147454|FG000|Overall Study|Death|1|||
155193637|NCT04402060|560147455|FG001|Overall Study|Death|12|||
155193638|NCT04402060|560147456|FG002|Overall Study|Death|7|||
155193639|NCT04402060|560147454|FG000|Overall Study|Adverse Event|0|||
155193640|NCT04402060|560147455|FG001|Overall Study|Adverse Event|0|||
155193641|NCT04402060|560147456|FG002|Overall Study|Adverse Event|1|||
155193642|NCT04402060|560147454|FG000|Overall Study|Withdrawal by Subject|0|||
155193643|NCT04402060|560147455|FG001|Overall Study|Withdrawal by Subject|1|||
155193644|NCT04402060|560147456|FG002|Overall Study|Withdrawal by Subject|2|||
155193645|NCT04402060|560147454|FG000|Overall Study|Sponsor Request|0|||
155193646|NCT04402060|560147455|FG001|Overall Study|Sponsor Request|2|||
155193647|NCT04402060|560147456|FG002|Overall Study|Sponsor Request|0|||
155193648|NCT04402060|560147454|FG000|Overall Study|Physician Decision|0|||
155193649|NCT04402060|560147455|FG001|Overall Study|Physician Decision|0|||
155193650|NCT04402060|560147456|FG002|Overall Study|Physician Decision|1|||
155193651|NCT04402060|560147454|FG000|Overall Study|Other|0|||
155193652|NCT04402060|560147455|FG001|Overall Study|Other|1|||
155193653|NCT04402060|560147456|FG002|Overall Study|Other|0|||
155193654|NCT00331422|560147457|FG000|Overall Study|Did not receive entire study regimen|5|||
155193655|NCT02345226|560147458|FG000|Double-Blind Phase|Adverse Event|5|||
155193656|NCT02345226|560147459|FG001|Double-Blind Phase|Adverse Event|6|||
155193657|NCT02345226|560147458|FG000|Double-Blind Phase|Death|3|||
155193658|NCT02345226|560147459|FG001|Double-Blind Phase|Death|0|||
155193659|NCT02345226|560147458|FG000|Double-Blind Phase|Pregnancy|0|||
155193660|NCT02345226|560147459|FG001|Double-Blind Phase|Pregnancy|1|||
155193661|NCT02345226|560147458|FG000|Double-Blind Phase|Lack of Efficacy|1|||
155193662|NCT02345226|560147459|FG001|Double-Blind Phase|Lack of Efficacy|0|||
155193663|NCT02345226|560147458|FG000|Double-Blind Phase|Investigator's Discretion|4|||
155193664|NCT02345226|560147459|FG001|Double-Blind Phase|Investigator's Discretion|3|||
155193665|NCT02345226|560147458|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
155193666|NCT02345226|560147459|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
155193667|NCT02345226|560147458|FG000|Double-Blind Phase|Withdrew Consent|41|||
155193668|NCT02345226|560147459|FG001|Double-Blind Phase|Withdrew Consent|39|||
155193669|NCT02345226|560147458|FG000|Double-Blind Phase|Lost to Follow-up|12|||
155193670|NCT02345226|560147459|FG001|Double-Blind Phase|Lost to Follow-up|16|||
155193671|NCT02345226|560147458|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
155193672|NCT02345226|560147459|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
155193673|NCT02345226|560147458|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155193674|NCT02345226|560147459|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
155193675|NCT01033851|560147462|FG000|Overall Study|Withdrawal by Subject|3|||
155193676|NCT01033851|560147463|FG001|Overall Study|Withdrawal by Subject|7|||
155193677|NCT00066729|560147464|FG000|Overall Study|Lost to Follow-up|1|||
155193678|NCT00066729|560147464|FG000|Overall Study|Disease progression|1|||
155193679|NCT02349542|560147467|FG000|Overall Study|Withdrawal by Subject|5|||
155193680|NCT02215096|560147468|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
155193681|NCT02215096|560147469|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193682|NCT02215096|560147470|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193683|NCT02215096|560147471|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193684|NCT02215096|560147472|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
155193685|NCT02215096|560147468|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193686|NCT02215096|560147469|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193687|NCT02215096|560147470|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193688|NCT02215096|560147471|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
155193689|NCT02215096|560147472|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
155193690|NCT02215096|560147468|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193691|NCT02215096|560147469|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193692|NCT02215096|560147470|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193693|NCT02215096|560147471|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
155193694|NCT02215096|560147472|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
155193695|NCT02215096|560147468|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
155038227|NCT02908074|559565863|FG003|Overall Study|Discontinuation criteria per protocol|0|||
155038228|NCT02908074|559565864|FG004|Overall Study|Discontinuation criteria per protocol|0|||
155038229|NCT02908074|559565865|FG005|Overall Study|Discontinuation criteria per protocol|1|||
155038230|NCT02908074|559565860|FG000|Overall Study|Withdrawal by Subject|3|||
155038231|NCT02908074|559565861|FG001|Overall Study|Withdrawal by Subject|2|||
155038232|NCT02908074|559565862|FG002|Overall Study|Withdrawal by Subject|2|||
155038233|NCT02908074|559565863|FG003|Overall Study|Withdrawal by Subject|2|||
155038234|NCT02908074|559565864|FG004|Overall Study|Withdrawal by Subject|2|||
155038235|NCT02908074|559565865|FG005|Overall Study|Withdrawal by Subject|2|||
155038236|NCT02908074|559565860|FG000|Overall Study|Lost to Follow-up|0|||
155038237|NCT02908074|559565861|FG001|Overall Study|Lost to Follow-up|1|||
155038238|NCT02908074|559565862|FG002|Overall Study|Lost to Follow-up|1|||
155038239|NCT02908074|559565863|FG003|Overall Study|Lost to Follow-up|1|||
155038240|NCT02908074|559565864|FG004|Overall Study|Lost to Follow-up|0|||
155038241|NCT02908074|559565865|FG005|Overall Study|Lost to Follow-up|1|||
155038242|NCT02073565|559565866|FG000|Cohort A|Withdrawal by Subject|1|||
155038243|NCT02073565|559565867|FG001|Cohort A|Withdrawal by Subject|0|||
155144301|NCT02222558|559961131|FG000|Period 3|Withdrawal by Subject|0|||
155144302|NCT02222558|559961132|FG001|Period 3|Withdrawal by Subject|0|||
155144303|NCT02222558|559961133|FG002|Period 3|Withdrawal by Subject|0|||
155144304|NCT02222558|559961134|FG003|Period 3|Withdrawal by Subject|0|||
155144305|NCT02222558|559961135|FG004|Period 3|Withdrawal by Subject|0|||
155144306|NCT02222558|559961136|FG005|Period 3|Withdrawal by Subject|1|||
155144307|NCT01745367|559961137|FG000|Overall Study|Death|1|||
155144308|NCT01745367|559961138|FG001|Overall Study|Death|0|||
155144309|NCT01745367|559961137|FG000|Overall Study|Withdrawal by Subject|1|||
155144310|NCT01745367|559961138|FG001|Overall Study|Withdrawal by Subject|2|||
155144311|NCT01745367|559961137|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
155144312|NCT01745367|559961138|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
155144313|NCT01745367|559961137|FG000|Overall Study|Other Reasons Unspecified|0|||
155144314|NCT01745367|559961138|FG001|Overall Study|Other Reasons Unspecified|2|||
155144315|NCT02322281|559961141|FG000|Overall Study|Progressive Disease|42|||
155144316|NCT02322281|559961142|FG001|Overall Study|Progressive Disease|14|||
155144317|NCT02322281|559961143|FG002|Overall Study|Progressive Disease|49|||
155144318|NCT02322281|559961141|FG000|Overall Study|Adverse Event|3|||
155144319|NCT02322281|559961142|FG001|Overall Study|Adverse Event|4|||
155144320|NCT02322281|559961143|FG002|Overall Study|Adverse Event|6|||
155144321|NCT02322281|559961141|FG000|Overall Study|Death|3|||
155144322|NCT02322281|559961142|FG001|Overall Study|Death|3|||
155144323|NCT02322281|559961143|FG002|Overall Study|Death|3|||
155144324|NCT02322281|559961141|FG000|Overall Study|Withdrawal by Subject|1|||
155144325|NCT02322281|559961142|FG001|Overall Study|Withdrawal by Subject|1|||
155144326|NCT02322281|559961143|FG002|Overall Study|Withdrawal by Subject|6|||
155144327|NCT02322281|559961141|FG000|Overall Study|Physician Decision|2|||
155144328|NCT02322281|559961142|FG001|Overall Study|Physician Decision|0|||
155144329|NCT02322281|559961143|FG002|Overall Study|Physician Decision|5|||
155144330|NCT02322281|559961141|FG000|Overall Study|Study Terminated by Sponsor|2|||
155144331|NCT02322281|559961142|FG001|Overall Study|Study Terminated by Sponsor|0|||
155144332|NCT02322281|559961143|FG002|Overall Study|Study Terminated by Sponsor|0|||
155144333|NCT02322281|559961141|FG000|Overall Study|Missing|0|||
155144334|NCT02322281|559961142|FG001|Overall Study|Missing|0|||
155144335|NCT02322281|559961143|FG002|Overall Study|Missing|1|||
155144336|NCT02322281|559961141|FG000|Overall Study|Miscellaneous|0|||
155144337|NCT02322281|559961142|FG001|Overall Study|Miscellaneous|0|||
155144338|NCT02322281|559961143|FG002|Overall Study|Miscellaneous|4|||
155144339|NCT02532465|559961147|FG000|Overall Study|Protocol Violation|1|||
155144340|NCT02532465|559961148|FG001|Overall Study|Protocol Violation|0|||
155144341|NCT02532465|559961147|FG000|Overall Study|Lack of Efficacy|0|||
155144342|NCT02532465|559961148|FG001|Overall Study|Lack of Efficacy|1|||
155144343|NCT00354679|559961153|FG000|Overall Study|Patient Not Treated|1|||
155144344|NCT00466440|559961154|FG000|Overall Study|Adverse Event|0|||
155144345|NCT00466440|559961155|FG001|Overall Study|Adverse Event|3|||
155144346|NCT00466440|559961156|FG002|Overall Study|Adverse Event|1|||
155144347|NCT00466440|559961154|FG000|Overall Study|Death|1|||
155038244|NCT02073565|559565866|FG000|Cohort B|Withdrawal by Subject|1|||
155144348|NCT00466440|559961155|FG001|Overall Study|Death|1|||
155144349|NCT00466440|559961156|FG002|Overall Study|Death|0|||
155144350|NCT00466440|559961154|FG000|Overall Study|Progressive disease|13|||
155144351|NCT00466440|559961155|FG001|Overall Study|Progressive disease|5|||
155144352|NCT00466440|559961156|FG002|Overall Study|Progressive disease|4|||
155038245|NCT02073565|559565867|FG001|Cohort B|Withdrawal by Subject|2|||
155038246|NCT02073565|559565866|FG000|Cohort C|Withdrawal by Subject|0|||
155144353|NCT00466440|559961154|FG000|Overall Study|Lost to Follow-up|0|||
155144354|NCT00466440|559961155|FG001|Overall Study|Lost to Follow-up|1|||
155144355|NCT00466440|559961156|FG002|Overall Study|Lost to Follow-up|0|||
155144356|NCT00466440|559961154|FG000|Overall Study|Physician Decision|0|||
155144357|NCT00466440|559961155|FG001|Overall Study|Physician Decision|1|||
155144358|NCT00466440|559961156|FG002|Overall Study|Physician Decision|2|||
155144359|NCT00466440|559961154|FG000|Overall Study|Protocol entry criteria not met|0|||
155038247|NCT02073565|559565867|FG001|Cohort C|Withdrawal by Subject|2|||
155038248|NCT02073565|559565866|FG000|Cohort C|Lost to Follow-up|0|||
155038249|NCT02073565|559565867|FG001|Cohort C|Lost to Follow-up|2|||
155038250|NCT04438499|559565873|FG000|Overall Study|Lack of Efficacy|3|||
155144360|NCT00466440|559961155|FG001|Overall Study|Protocol entry criteria not met|0|||
155144361|NCT00466440|559961156|FG002|Overall Study|Protocol entry criteria not met|4|||
155144362|NCT00466440|559961154|FG000|Overall Study|Withdrawal by Subject|0|||
155144363|NCT00466440|559961155|FG001|Overall Study|Withdrawal by Subject|1|||
155144364|NCT00466440|559961156|FG002|Overall Study|Withdrawal by Subject|0|||
155144365|NCT00466440|559961154|FG000|Overall Study|Sponsor decision|0|||
155144366|NCT00466440|559961155|FG001|Overall Study|Sponsor decision|0|||
155144367|NCT00466440|559961156|FG002|Overall Study|Sponsor decision|1|||
155144368|NCT03187132|559961162|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
155144369|NCT03187132|559961163|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
155144370|NCT03187132|559961162|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
155144371|NCT03187132|559961163|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
155144372|NCT03187132|559961162|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
155144373|NCT03187132|559961163|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
155144374|NCT03187132|559961162|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
155144375|NCT03187132|559961163|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
155144376|NCT03187132|559961162|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
155144377|NCT03187132|559961163|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
155144378|NCT03187132|559961162|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
155144379|NCT03187132|559961163|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
155144380|NCT03187132|559961162|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
155144381|NCT03187132|559961163|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
155144382|NCT03187132|559961162|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
155144383|NCT03187132|559961163|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
155144384|NCT03187132|559961162|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
155144385|NCT03187132|559961163|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
155144386|NCT03187132|559961162|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
155144387|NCT03187132|559961163|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
155144388|NCT03187132|559961162|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
155144389|NCT03187132|559961163|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
155144390|NCT02525588|559961164|FG000|Overall Study|Death|3|||
155144391|NCT02525588|559961165|FG001|Overall Study|Death|1|||
155144392|NCT02525588|559961164|FG000|Overall Study|Lost to Follow-up|2|||
155144393|NCT02525588|559961165|FG001|Overall Study|Lost to Follow-up|0|||
155144394|NCT02525588|559961164|FG000|Overall Study|Withdrawal by Subject|1|||
155144395|NCT02525588|559961165|FG001|Overall Study|Withdrawal by Subject|1|||
155144396|NCT02525588|559961164|FG000|Overall Study|Adverse Event|0|||
155144397|NCT02525588|559961165|FG001|Overall Study|Adverse Event|1|||
155144398|NCT01020786|559961168|FG000|Induction Period|Entry Criteria Not Met|2|||
155144399|NCT01020786|559961168|FG000|Induction Period|Adverse Event|10|||
155144400|NCT01020786|559961168|FG000|Induction Period|Progressive Disease|31|||
155144401|NCT01020786|559961168|FG000|Induction Period|Investigator Decision|3|||
155144402|NCT01020786|559961168|FG000|Induction Period|Withdrawal by Subject|3|||
155144403|NCT01020786|559961168|FG000|Maintenance Period|Adverse Event|8|||
155144404|NCT01020786|559961168|FG000|Maintenance Period|Progressive Disease|43|||
155144405|NCT01020786|559961168|FG000|Maintenance Period|Withdrawal by Subject|8|||
155144406|NCT01020786|559961168|FG000|Maintenance Period|Sponsor Decision|1|||
155144407|NCT02491983|559961169|FG000|Overall Study|Physician Decision|1|||
155144408|NCT02491983|559961170|FG001|Overall Study|Physician Decision|0|||
155144409|NCT02491983|559961169|FG000|Overall Study|Not meet selection criteria|1|||
155144410|NCT02491983|559961170|FG001|Overall Study|Not meet selection criteria|0|||
155144411|NCT02491983|559961169|FG000|Overall Study|Withdrawal by Subject|0|||
155144412|NCT02491983|559961170|FG001|Overall Study|Withdrawal by Subject|1|||
155144413|NCT04628780|559961171|FG000|Overall Study|Death|0|||
155144414|NCT04628780|559961172|FG001|Overall Study|Death|1|||
155144415|NCT04628780|559961173|FG002|Overall Study|Death|0|||
155144416|NCT04628780|559961174|FG003|Overall Study|Death|0|||
155144417|NCT04628780|559961175|FG004|Overall Study|Death|1|||
155144418|NCT04628780|559961176|FG005|Overall Study|Death|0|||
155144419|NCT04628780|559961171|FG000|Overall Study|Physician Decision|2|||
155144420|NCT04628780|559961172|FG001|Overall Study|Physician Decision|0|||
155144421|NCT04628780|559961173|FG002|Overall Study|Physician Decision|0|||
155144422|NCT04628780|559961174|FG003|Overall Study|Physician Decision|0|||
155144423|NCT04628780|559961175|FG004|Overall Study|Physician Decision|2|||
155144424|NCT04628780|559961176|FG005|Overall Study|Physician Decision|0|||
155144425|NCT04628780|559961171|FG000|Overall Study|Progressive disease|2|||
155144426|NCT04628780|559961172|FG001|Overall Study|Progressive disease|2|||
155144427|NCT04628780|559961173|FG002|Overall Study|Progressive disease|2|||
155144428|NCT04628780|559961174|FG003|Overall Study|Progressive disease|3|||
155144429|NCT04628780|559961175|FG004|Overall Study|Progressive disease|9|||
155144430|NCT04628780|559961176|FG005|Overall Study|Progressive disease|4|||
155144431|NCT04628780|559961171|FG000|Overall Study|Withdrawal by Subject|0|||
155144432|NCT04628780|559961172|FG001|Overall Study|Withdrawal by Subject|1|||
155144433|NCT04628780|559961173|FG002|Overall Study|Withdrawal by Subject|2|||
155144434|NCT04628780|559961174|FG003|Overall Study|Withdrawal by Subject|0|||
155144435|NCT04628780|559961175|FG004|Overall Study|Withdrawal by Subject|3|||
155144436|NCT04628780|559961176|FG005|Overall Study|Withdrawal by Subject|1|||
155144437|NCT04628780|559961171|FG000|Overall Study|Global deterioration of health status|0|||
155144438|NCT04628780|559961172|FG001|Overall Study|Global deterioration of health status|0|||
155144439|NCT04628780|559961173|FG002|Overall Study|Global deterioration of health status|0|||
155144440|NCT04628780|559961174|FG003|Overall Study|Global deterioration of health status|0|||
155144441|NCT04628780|559961175|FG004|Overall Study|Global deterioration of health status|1|||
155144442|NCT04628780|559961176|FG005|Overall Study|Global deterioration of health status|1|||
155144443|NCT03269994|559961178|FG000|Overall Study|Withdrawal by Subject|4|||
155144444|NCT03269994|559961179|FG001|Overall Study|Withdrawal by Subject|5|||
155144445|NCT03269994|559961178|FG000|Overall Study|Unresectable at surgery|39|||
155144446|NCT03269994|559961179|FG001|Overall Study|Unresectable at surgery|58|||
155144447|NCT03269994|559961178|FG000|Overall Study|Patient canceled surgery|5|||
155144448|NCT03269994|559961179|FG001|Overall Study|Patient canceled surgery|14|||
155144449|NCT03269994|559961178|FG000|Overall Study|Preoperative progression|14|||
155144450|NCT03269994|559961179|FG001|Overall Study|Preoperative progression|9|||
155144451|NCT03269994|559961178|FG000|Overall Study|Preoperative infection|10|||
155144452|NCT03269994|559961179|FG001|Overall Study|Preoperative infection|4|||
155144453|NCT03269994|559961178|FG000|Overall Study|Kidney insufficiency|1|||
155144454|NCT03269994|559961179|FG001|Overall Study|Kidney insufficiency|0|||
155144455|NCT03269994|559961178|FG000|Overall Study|Drug allergy|0|||
155144456|NCT03269994|559961179|FG001|Overall Study|Drug allergy|2|||
155144457|NCT03269994|559961178|FG000|Overall Study|Operation changed to different resection|9|||
155144458|NCT03269994|559961179|FG001|Overall Study|Operation changed to different resection|0|||
155144459|NCT03269994|559961178|FG000|Overall Study|Preoperative steroid|0|||
155144460|NCT03269994|559961179|FG001|Overall Study|Preoperative steroid|3|||
155144461|NCT03269994|559961178|FG000|Overall Study|Accrual Closed|2|||
155144462|NCT03269994|559961179|FG001|Overall Study|Accrual Closed|0|||
155144463|NCT03269994|559961178|FG000|Overall Study|Operation changed to different resection|0|||
155144464|NCT03269994|559961179|FG001|Overall Study|Operation changed to different resection|10|||
155144465|NCT04303559|559961180|FG000|Overall Study|Study closed due to poor enrollment.|1|||
155144466|NCT01987102|559961181|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
155144467|NCT01987102|559961182|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
155144468|NCT01987102|559961181|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
155144469|NCT01987102|559961182|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
155144470|NCT01987102|559961181|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
155144471|NCT01987102|559961182|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
155144472|NCT01987102|559961181|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
155144473|NCT01987102|559961182|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
155144474|NCT01987102|559961181|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
155144475|NCT01987102|559961182|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
155144476|NCT01987102|559961181|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
155144477|NCT01987102|559961182|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
155144478|NCT01327599|559961185|FG000|Overall Study|Adverse Event|1|||
155144479|NCT01327599|559961185|FG000|Overall Study|Could Not Attend Visit|1|||
155144480|NCT01327599|559961185|FG000|Overall Study|Withdrawal of Consent|1|||
155144481|NCT01132313|559961186|FG000|Overall Study|Lack of Efficacy|1|||
155144482|NCT01132313|559961187|FG001|Overall Study|Lack of Efficacy|0|||
155144483|NCT01132313|559961188|FG002|Overall Study|Lack of Efficacy|0|||
155144484|NCT01132313|559961189|FG003|Overall Study|Lack of Efficacy|0|||
155144485|NCT01132313|559961190|FG004|Overall Study|Lack of Efficacy|0|||
155144486|NCT01132313|559961191|FG005|Overall Study|Lack of Efficacy|0|||
155144487|NCT01132313|559961192|FG006|Overall Study|Lack of Efficacy|0|||
155144488|NCT01132313|559961193|FG007|Overall Study|Lack of Efficacy|3|||
155144489|NCT01132313|559961194|FG008|Overall Study|Lack of Efficacy|14|||
155144490|NCT01132313|559961195|FG009|Overall Study|Lack of Efficacy|16|||
155144491|NCT01132313|559961196|FG010|Overall Study|Lack of Efficacy|0|||
155144492|NCT01132313|559961197|FG011|Overall Study|Lack of Efficacy|0|||
155144493|NCT01132313|559961186|FG000|Overall Study|Not treated|2|||
155144494|NCT01132313|559961187|FG001|Overall Study|Not treated|0|||
155144495|NCT01132313|559961188|FG002|Overall Study|Not treated|0|||
155144496|NCT01132313|559961189|FG003|Overall Study|Not treated|0|||
155144497|NCT01132313|559961190|FG004|Overall Study|Not treated|2|||
155144498|NCT01132313|559961191|FG005|Overall Study|Not treated|1|||
155144499|NCT01132313|559961192|FG006|Overall Study|Not treated|3|||
155144500|NCT01132313|559961193|FG007|Overall Study|Not treated|0|||
155144501|NCT01132313|559961194|FG008|Overall Study|Not treated|0|||
155144502|NCT01132313|559961195|FG009|Overall Study|Not treated|0|||
155144503|NCT01132313|559961196|FG010|Overall Study|Not treated|0|||
155144504|NCT01132313|559961197|FG011|Overall Study|Not treated|0|||
155144505|NCT01132313|559961186|FG000|Overall Study|Adverse Event|0|||
155144506|NCT01132313|559961187|FG001|Overall Study|Adverse Event|0|||
155144507|NCT01132313|559961188|FG002|Overall Study|Adverse Event|4|||
155144508|NCT01132313|559961189|FG003|Overall Study|Adverse Event|10|||
155144509|NCT01132313|559961190|FG004|Overall Study|Adverse Event|19|||
155144510|NCT01132313|559961191|FG005|Overall Study|Adverse Event|6|||
155144511|NCT01132313|559961192|FG006|Overall Study|Adverse Event|5|||
155144512|NCT01132313|559961193|FG007|Overall Study|Adverse Event|3|||
155144513|NCT01132313|559961194|FG008|Overall Study|Adverse Event|7|||
155144514|NCT01132313|559961195|FG009|Overall Study|Adverse Event|2|||
155144515|NCT01132313|559961196|FG010|Overall Study|Adverse Event|0|||
155144516|NCT01132313|559961197|FG011|Overall Study|Adverse Event|0|||
155144517|NCT01132313|559961186|FG000|Overall Study|Protocol Violation|0|||
155144518|NCT01132313|559961187|FG001|Overall Study|Protocol Violation|0|||
155144519|NCT01132313|559961188|FG002|Overall Study|Protocol Violation|0|||
155144520|NCT01132313|559961189|FG003|Overall Study|Protocol Violation|1|||
155144521|NCT01132313|559961190|FG004|Overall Study|Protocol Violation|0|||
155144522|NCT01132313|559961191|FG005|Overall Study|Protocol Violation|0|||
155144523|NCT01132313|559961192|FG006|Overall Study|Protocol Violation|0|||
155144524|NCT01132313|559961193|FG007|Overall Study|Protocol Violation|0|||
155144525|NCT01132313|559961194|FG008|Overall Study|Protocol Violation|0|||
155144526|NCT01132313|559961195|FG009|Overall Study|Protocol Violation|0|||
155144527|NCT01132313|559961196|FG010|Overall Study|Protocol Violation|0|||
155144528|NCT01132313|559961197|FG011|Overall Study|Protocol Violation|0|||
155144529|NCT01132313|559961186|FG000|Overall Study|Lost to Follow-up|0|||
155144530|NCT01132313|559961187|FG001|Overall Study|Lost to Follow-up|0|||
155144531|NCT01132313|559961188|FG002|Overall Study|Lost to Follow-up|1|||
155144532|NCT01132313|559961189|FG003|Overall Study|Lost to Follow-up|0|||
155144533|NCT01132313|559961190|FG004|Overall Study|Lost to Follow-up|0|||
155144534|NCT01132313|559961191|FG005|Overall Study|Lost to Follow-up|0|||
155144535|NCT01132313|559961192|FG006|Overall Study|Lost to Follow-up|0|||
155144536|NCT01132313|559961193|FG007|Overall Study|Lost to Follow-up|1|||
155144537|NCT01132313|559961194|FG008|Overall Study|Lost to Follow-up|0|||
155144538|NCT01132313|559961195|FG009|Overall Study|Lost to Follow-up|0|||
155144539|NCT01132313|559961196|FG010|Overall Study|Lost to Follow-up|0|||
155144540|NCT01132313|559961197|FG011|Overall Study|Lost to Follow-up|0|||
155144541|NCT01132313|559961186|FG000|Overall Study|Withdrawal by Subject|0|||
155144542|NCT01132313|559961187|FG001|Overall Study|Withdrawal by Subject|0|||
155144543|NCT01132313|559961188|FG002|Overall Study|Withdrawal by Subject|3|||
155144544|NCT01132313|559961189|FG003|Overall Study|Withdrawal by Subject|3|||
155144545|NCT01132313|559961190|FG004|Overall Study|Withdrawal by Subject|6|||
155144546|NCT01132313|559961191|FG005|Overall Study|Withdrawal by Subject|0|||
155144547|NCT01132313|559961192|FG006|Overall Study|Withdrawal by Subject|1|||
155144548|NCT01132313|559961193|FG007|Overall Study|Withdrawal by Subject|0|||
155144549|NCT01132313|559961194|FG008|Overall Study|Withdrawal by Subject|0|||
155144550|NCT01132313|559961195|FG009|Overall Study|Withdrawal by Subject|2|||
155144551|NCT01132313|559961196|FG010|Overall Study|Withdrawal by Subject|0|||
155144552|NCT01132313|559961197|FG011|Overall Study|Withdrawal by Subject|0|||
155144553|NCT01132313|559961186|FG000|Overall Study|Lack of antiviral response|0|||
155144554|NCT01132313|559961187|FG001|Overall Study|Lack of antiviral response|0|||
155144555|NCT01132313|559961188|FG002|Overall Study|Lack of antiviral response|12|||
155144556|NCT01132313|559961189|FG003|Overall Study|Lack of antiviral response|18|||
155144557|NCT01132313|559961190|FG004|Overall Study|Lack of antiviral response|18|||
155144558|NCT01132313|559961191|FG005|Overall Study|Lack of antiviral response|18|||
155144559|NCT01132313|559961192|FG006|Overall Study|Lack of antiviral response|21|||
155144560|NCT01132313|559961193|FG007|Overall Study|Lack of antiviral response|0|||
155144561|NCT01132313|559961194|FG008|Overall Study|Lack of antiviral response|0|||
155144562|NCT01132313|559961195|FG009|Overall Study|Lack of antiviral response|0|||
155144563|NCT01132313|559961196|FG010|Overall Study|Lack of antiviral response|1|||
155144564|NCT01132313|559961197|FG011|Overall Study|Lack of antiviral response|0|||
155144565|NCT01132313|559961186|FG000|Overall Study|Other reason not defined above|0|||
155144566|NCT01132313|559961187|FG001|Overall Study|Other reason not defined above|0|||
155144567|NCT01132313|559961188|FG002|Overall Study|Other reason not defined above|0|||
155144568|NCT01132313|559961189|FG003|Overall Study|Other reason not defined above|0|||
155144569|NCT01132313|559961190|FG004|Overall Study|Other reason not defined above|0|||
155144570|NCT01132313|559961191|FG005|Overall Study|Other reason not defined above|0|||
155144571|NCT01132313|559961192|FG006|Overall Study|Other reason not defined above|0|||
155144572|NCT01132313|559961193|FG007|Overall Study|Other reason not defined above|1|||
155144573|NCT01132313|559961194|FG008|Overall Study|Other reason not defined above|0|||
155144574|NCT01132313|559961195|FG009|Overall Study|Other reason not defined above|0|||
155144575|NCT01132313|559961196|FG010|Overall Study|Other reason not defined above|0|||
155144576|NCT01132313|559961197|FG011|Overall Study|Other reason not defined above|0|||
155144577|NCT05864586|559961202|FG000|Overall Study|Ineligible|4|||
155144578|NCT05864586|559961203|FG001|Overall Study|Ineligible|12|||
155144579|NCT05864586|559961202|FG000|Overall Study|Pregnancy|0|||
155144580|NCT05864586|559961203|FG001|Overall Study|Pregnancy|1|||
155144581|NCT05864586|559961202|FG000|Overall Study|Withdrawal by Subject|0|||
155144582|NCT05864586|559961203|FG001|Overall Study|Withdrawal by Subject|1|||
155144583|NCT03405818|559961204|FG000|Overall Study|Withdrawal by Subject|4|||
155144584|NCT03405818|559961204|FG000|Overall Study|Lost to Follow-up|4|||
155144585|NCT00549445|559961213|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
155144586|NCT00549445|559961214|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
155144587|NCT02539797|559963078|FG000|Overall Study|Lost to Follow-up|0|||
155144588|NCT02539797|559963079|FG001|Overall Study|Lost to Follow-up|1|||
155144589|NCT02539797|559963080|FG002|Overall Study|Lost to Follow-up|0|||
155144590|NCT02796677|559963086|FG000|Overall Study|Adverse Event|11|||
155144591|NCT02796677|559963087|FG001|Overall Study|Adverse Event|22|||
155144592|NCT02796677|559963088|FG002|Overall Study|Adverse Event|14|||
155144593|NCT02796677|559963089|FG003|Overall Study|Adverse Event|14|||
155144594|NCT02796677|559963086|FG000|Overall Study|Protocol Violation|7|||
155144595|NCT02796677|559963087|FG001|Overall Study|Protocol Violation|5|||
155144596|NCT02796677|559963088|FG002|Overall Study|Protocol Violation|4|||
155144597|NCT02796677|559963089|FG003|Overall Study|Protocol Violation|8|||
155144598|NCT02796677|559963086|FG000|Overall Study|Lost to Follow-up|1|||
155144599|NCT02796677|559963087|FG001|Overall Study|Lost to Follow-up|5|||
155144600|NCT02796677|559963088|FG002|Overall Study|Lost to Follow-up|2|||
155144601|NCT02796677|559963089|FG003|Overall Study|Lost to Follow-up|2|||
155144602|NCT02796677|559963086|FG000|Overall Study|Lack of Efficacy|7|||
155144603|NCT02796677|559963087|FG001|Overall Study|Lack of Efficacy|9|||
155144604|NCT02796677|559963088|FG002|Overall Study|Lack of Efficacy|14|||
155144605|NCT02796677|559963089|FG003|Overall Study|Lack of Efficacy|20|||
155144606|NCT02796677|559963086|FG000|Overall Study|Withdrawal by Subject|4|||
155144607|NCT02796677|559963087|FG001|Overall Study|Withdrawal by Subject|14|||
155144608|NCT02796677|559963088|FG002|Overall Study|Withdrawal by Subject|6|||
155144609|NCT02796677|559963089|FG003|Overall Study|Withdrawal by Subject|7|||
155144610|NCT02796677|559963086|FG000|Overall Study|Progressive disease|6|||
155144611|NCT02796677|559963087|FG001|Overall Study|Progressive disease|15|||
155144612|NCT02796677|559963088|FG002|Overall Study|Progressive disease|13|||
155144613|NCT02796677|559963089|FG003|Overall Study|Progressive disease|18|||
155144614|NCT02796677|559963086|FG000|Overall Study|Reason not mentioned|2|||
155144615|NCT02796677|559963087|FG001|Overall Study|Reason not mentioned|3|||
155144616|NCT02796677|559963088|FG002|Overall Study|Reason not mentioned|0|||
155144617|NCT02796677|559963089|FG003|Overall Study|Reason not mentioned|5|||
155144618|NCT04002960|559963091|FG000|Overall Study|Withdrawn prior to Completion|2|||
155144619|NCT00961181|559963092|FG000|Overall Study|Death|2|||
155144620|NCT00961181|559963092|FG000|Overall Study|Withdrawal by Subject|2|||
155144621|NCT00961181|559963092|FG000|Overall Study|Lost to Follow-up|1|||
155144622|NCT01777308|559963095|FG000|Overall Study|Withdrawal by Subject|5|||
155144623|NCT01777308|559963096|FG001|Overall Study|Withdrawal by Subject|1|||
155144624|NCT01777308|559963095|FG000|Overall Study|Migrated/moved from study area|1|||
155144625|NCT01777308|559963096|FG001|Overall Study|Migrated/moved from study area|0|||
155144626|NCT01777308|559963095|FG000|Overall Study|Lost to Follow-up|7|||
155144627|NCT01777308|559963096|FG001|Overall Study|Lost to Follow-up|2|||
155144628|NCT01777308|559963095|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
155144629|NCT01777308|559963096|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
155144630|NCT03212326|559963097|FG000|Overall Study|Physician Decision|4|||
155144631|NCT00383786|559963098|FG000|Overall Study|Protocol Violation|2|||
155144632|NCT00383786|559963099|FG001|Overall Study|Protocol Violation|6|||
155144633|NCT00383786|559963098|FG000|Overall Study|Withdrawal by Subject|2|||
155144634|NCT00383786|559963099|FG001|Overall Study|Withdrawal by Subject|5|||
155144635|NCT00383786|559963098|FG000|Overall Study|Physician Decision|0|||
155144636|NCT00383786|559963099|FG001|Overall Study|Physician Decision|1|||
155144637|NCT00985673|559963100|FG000|Overall Study|Lost to Follow-up|6|||
155144638|NCT00985673|559963101|FG001|Overall Study|Lost to Follow-up|7|||
155144639|NCT00985673|559963102|FG002|Overall Study|Lost to Follow-up|6|||
155144640|NCT00985673|559963103|FG003|Overall Study|Lost to Follow-up|10|||
155144641|NCT00985673|559963104|FG004|Overall Study|Lost to Follow-up|5|||
155144642|NCT00985673|559963105|FG005|Overall Study|Lost to Follow-up|3|||
155144643|NCT00985673|559963100|FG000|Overall Study|Withdrawal by Subject|0|||
155144644|NCT00985673|559963101|FG001|Overall Study|Withdrawal by Subject|4|||
155144645|NCT00985673|559963102|FG002|Overall Study|Withdrawal by Subject|5|||
155144646|NCT00985673|559963103|FG003|Overall Study|Withdrawal by Subject|2|||
155144647|NCT00985673|559963104|FG004|Overall Study|Withdrawal by Subject|2|||
155144648|NCT00985673|559963105|FG005|Overall Study|Withdrawal by Subject|3|||
155144649|NCT00985673|559963100|FG000|Overall Study|Other|1|||
155144650|NCT00985673|559963101|FG001|Overall Study|Other|0|||
155144651|NCT00985673|559963102|FG002|Overall Study|Other|1|||
155144652|NCT00985673|559963103|FG003|Overall Study|Other|0|||
155144653|NCT00985673|559963104|FG004|Overall Study|Other|1|||
155144654|NCT00985673|559963105|FG005|Overall Study|Other|0|||
155144655|NCT02252146|559963106|FG000|Overall Study|Lack of Efficacy|4|||
155144656|NCT02252146|559963106|FG000|Overall Study|Entered hospice care|1|||
155144657|NCT02252146|559963106|FG000|Overall Study|Inability to travel to study site|1|||
155144658|NCT00531284|559963107|FG000|Overall Study|Progressive Disease|1|||
155144659|NCT00531284|559963108|FG001|Overall Study|Progressive Disease|3|||
155144660|NCT00531284|559963109|FG002|Overall Study|Progressive Disease|5|||
155144661|NCT00531284|559963110|FG003|Overall Study|Progressive Disease|42|||
155144662|NCT00531284|559963111|FG004|Overall Study|Progressive Disease|4|||
155144663|NCT00531284|559963112|FG005|Overall Study|Progressive Disease|4|||
155144664|NCT00531284|559963113|FG006|Overall Study|Progressive Disease|3|||
155144665|NCT00531284|559963114|FG007|Overall Study|Progressive Disease|8|||
155144666|NCT00531284|559963115|FG008|Overall Study|Progressive Disease|6|||
155144667|NCT00531284|559963116|FG009|Overall Study|Progressive Disease|3|||
155144668|NCT00531284|559963117|FG010|Overall Study|Progressive Disease|3|||
155144669|NCT00531284|559963118|FG011|Overall Study|Progressive Disease|14|||
155144670|NCT00531284|559963119|FG012|Overall Study|Progressive Disease|2|||
155144671|NCT00531284|559963120|FG013|Overall Study|Progressive Disease|1|||
155144672|NCT00531284|559963121|FG014|Overall Study|Progressive Disease|2|||
155144673|NCT00531284|559963122|FG015|Overall Study|Progressive Disease|11|||
155144674|NCT00531284|559963123|FG016|Overall Study|Progressive Disease|5|||
155144675|NCT00531284|559963107|FG000|Overall Study|Adverse Event|0|||
155144676|NCT00531284|559963108|FG001|Overall Study|Adverse Event|1|||
155144677|NCT00531284|559963109|FG002|Overall Study|Adverse Event|1|||
155144678|NCT00531284|559963110|FG003|Overall Study|Adverse Event|7|||
155144679|NCT00531284|559963111|FG004|Overall Study|Adverse Event|0|||
155144680|NCT00531284|559963112|FG005|Overall Study|Adverse Event|2|||
155144681|NCT00531284|559963113|FG006|Overall Study|Adverse Event|3|||
155144682|NCT00531284|559963114|FG007|Overall Study|Adverse Event|2|||
155144683|NCT00531284|559963115|FG008|Overall Study|Adverse Event|3|||
155144684|NCT00531284|559963116|FG009|Overall Study|Adverse Event|0|||
155144685|NCT00531284|559963117|FG010|Overall Study|Adverse Event|0|||
155144686|NCT00531284|559963118|FG011|Overall Study|Adverse Event|5|||
155144687|NCT00531284|559963119|FG012|Overall Study|Adverse Event|0|||
155144688|NCT00531284|559963120|FG013|Overall Study|Adverse Event|1|||
155144689|NCT00531284|559963121|FG014|Overall Study|Adverse Event|1|||
155144690|NCT00531284|559963122|FG015|Overall Study|Adverse Event|0|||
155144691|NCT00531284|559963123|FG016|Overall Study|Adverse Event|2|||
155144692|NCT00531284|559963107|FG000|Overall Study|Withdrawal by Subject|1|||
155144693|NCT00531284|559963108|FG001|Overall Study|Withdrawal by Subject|0|||
155144694|NCT00531284|559963109|FG002|Overall Study|Withdrawal by Subject|0|||
155144695|NCT00531284|559963110|FG003|Overall Study|Withdrawal by Subject|4|||
155144696|NCT00531284|559963111|FG004|Overall Study|Withdrawal by Subject|0|||
155144697|NCT00531284|559963112|FG005|Overall Study|Withdrawal by Subject|0|||
155144698|NCT00531284|559963113|FG006|Overall Study|Withdrawal by Subject|0|||
155144699|NCT00531284|559963114|FG007|Overall Study|Withdrawal by Subject|0|||
155144700|NCT00531284|559963115|FG008|Overall Study|Withdrawal by Subject|0|||
155144701|NCT00531284|559963116|FG009|Overall Study|Withdrawal by Subject|0|||
155144702|NCT00531284|559963117|FG010|Overall Study|Withdrawal by Subject|0|||
155144703|NCT00531284|559963118|FG011|Overall Study|Withdrawal by Subject|3|||
155144704|NCT00531284|559963119|FG012|Overall Study|Withdrawal by Subject|0|||
155144705|NCT00531284|559963120|FG013|Overall Study|Withdrawal by Subject|1|||
155144706|NCT00531284|559963121|FG014|Overall Study|Withdrawal by Subject|0|||
155144707|NCT00531284|559963122|FG015|Overall Study|Withdrawal by Subject|1|||
155144708|NCT00531284|559963123|FG016|Overall Study|Withdrawal by Subject|1|||
155144709|NCT00531284|559963107|FG000|Overall Study|Other|1|||
155144710|NCT00531284|559963108|FG001|Overall Study|Other|0|||
155144711|NCT00531284|559963109|FG002|Overall Study|Other|0|||
155144712|NCT00531284|559963110|FG003|Overall Study|Other|10|||
155144713|NCT00531284|559963111|FG004|Overall Study|Other|2|||
155144714|NCT00531284|559963112|FG005|Overall Study|Other|1|||
155144715|NCT00531284|559963113|FG006|Overall Study|Other|0|||
155144716|NCT00531284|559963114|FG007|Overall Study|Other|0|||
155144717|NCT00531284|559963115|FG008|Overall Study|Other|2|||
155144718|NCT00531284|559963116|FG009|Overall Study|Other|1|||
155144719|NCT00531284|559963117|FG010|Overall Study|Other|0|||
155144720|NCT00531284|559963118|FG011|Overall Study|Other|2|||
155144721|NCT00531284|559963119|FG012|Overall Study|Other|0|||
155144722|NCT00531284|559963120|FG013|Overall Study|Other|0|||
155144723|NCT00531284|559963121|FG014|Overall Study|Other|1|||
155144724|NCT00531284|559963122|FG015|Overall Study|Other|0|||
155144725|NCT00531284|559963123|FG016|Overall Study|Other|0|||
155144726|NCT02219464|559963125|FG000|Overall Study|Withdrawal by Subject|1|||
155144727|NCT02219464|559963126|FG001|Overall Study|Withdrawal by Subject|0|||
155144728|NCT02219464|559963125|FG000|Overall Study|case cancelled|1|||
155144729|NCT02219464|559963126|FG001|Overall Study|case cancelled|0|||
155144730|NCT02219464|559963125|FG000|Overall Study|catheter malfunction|1|||
155144731|NCT02219464|559963126|FG001|Overall Study|catheter malfunction|0|||
155144732|NCT03057496|559963127|FG000|Overall Study|Withdrawal by Subject|8|||
155144733|NCT03057496|559963127|FG000|Overall Study|Lost to Follow-up|5|||
155144734|NCT03057496|559963127|FG000|Overall Study|Did not use device during home trial|3|||
155144735|NCT03057496|559963127|FG000|Overall Study|Device failure|2|||
155144736|NCT02544321|559963133|FG000|Overall Study|Withdrawal by Subject|1|||
155144737|NCT02544321|559963134|FG001|Overall Study|Withdrawal by Subject|2|||
155144738|NCT02544321|559963133|FG000|Overall Study|Adverse Event|1|||
155144739|NCT02544321|559963134|FG001|Overall Study|Adverse Event|1|||
155144740|NCT02544321|559963133|FG000|Overall Study|Protocol Violation|0|||
155144741|NCT02544321|559963134|FG001|Overall Study|Protocol Violation|1|||
155144742|NCT01517750|559963135|FG000|Overall Study|Lost to Follow-up|1|||
155144743|NCT01517750|559963136|FG001|Overall Study|Lost to Follow-up|2|||
155193696|NCT02215096|560147469|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
155193697|NCT02215096|560147470|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
155193698|NCT02215096|560147471|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
155193699|NCT02215096|560147472|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
155193700|NCT01011738|560147473|FG000|Overall Study|Death|12|||
155193701|NCT01011738|560147474|FG001|Overall Study|Death|3|||
155193702|NCT01011738|560147475|FG002|Overall Study|Death|0|||
155193703|NCT01011738|560147473|FG000|Overall Study|Unknown reasons|312|||
155193704|NCT01011738|560147474|FG001|Overall Study|Unknown reasons|291|||
155193705|NCT01011738|560147475|FG002|Overall Study|Unknown reasons|17|||
155193706|NCT03896165|560147478|FG000|Overall Study|Withdrawal by Subject|2|||
155193707|NCT03181893|560147479|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193708|NCT03181893|560147480|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
155193709|NCT03181893|560147481|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193710|NCT03181893|560147482|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193711|NCT03181893|560147483|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193712|NCT03181893|560147484|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193713|NCT03181893|560147485|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193714|NCT03181893|560147486|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193715|NCT03181893|560147487|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193716|NCT03181893|560147488|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193717|NCT03181893|560147489|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
155193718|NCT03181893|560147479|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
155193719|NCT03181893|560147480|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
155193720|NCT03181893|560147481|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193721|NCT03181893|560147482|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193722|NCT03181893|560147483|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193723|NCT03181893|560147484|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193724|NCT03181893|560147485|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193725|NCT03181893|560147486|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193726|NCT03181893|560147487|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193727|NCT03181893|560147488|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193728|NCT03181893|560147489|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
155193729|NCT03181893|560147479|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193730|NCT03181893|560147480|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193731|NCT03181893|560147481|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193732|NCT03181893|560147482|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193733|NCT03181893|560147483|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193734|NCT03181893|560147484|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193735|NCT03181893|560147485|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193736|NCT03181893|560147486|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
155193737|NCT03181893|560147487|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
155193738|NCT03181893|560147488|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193739|NCT03181893|560147489|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
155193740|NCT03181893|560147479|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193741|NCT03181893|560147480|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193742|NCT03181893|560147481|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193743|NCT03181893|560147482|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193744|NCT03181893|560147483|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193745|NCT03181893|560147484|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193746|NCT03181893|560147485|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193747|NCT03181893|560147486|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193748|NCT03181893|560147487|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193749|NCT03181893|560147488|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
155193750|NCT03181893|560147489|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
155193751|NCT03181893|560147479|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193752|NCT03181893|560147480|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193753|NCT03181893|560147481|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193754|NCT03181893|560147482|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193755|NCT03181893|560147483|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193756|NCT03181893|560147484|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155144744|NCT01517750|559963137|FG002|Overall Study|Lost to Follow-up|4|||
155144745|NCT01517750|559963138|FG003|Overall Study|Lost to Follow-up|1|||
155144746|NCT01584232|559963139|FG000|Overall Study|Adverse Event|3|||
155144747|NCT01584232|559963140|FG001|Overall Study|Adverse Event|1|||
155144748|NCT01584232|559963139|FG000|Overall Study|Withdrawal by Subject|2|||
155144749|NCT01584232|559963140|FG001|Overall Study|Withdrawal by Subject|1|||
155144750|NCT01584232|559963139|FG000|Overall Study|Physician Decision|2|||
155144751|NCT01584232|559963140|FG001|Overall Study|Physician Decision|1|||
155144752|NCT01584232|559963139|FG000|Overall Study|Lost to Follow-up|1|||
155144753|NCT01584232|559963140|FG001|Overall Study|Lost to Follow-up|0|||
155144754|NCT01307319|559963141|FG000|Overall Study|Adverse Event|2|||
155144755|NCT01307319|559963142|FG001|Overall Study|Adverse Event|2|||
155144756|NCT01307319|559963143|FG002|Overall Study|Adverse Event|1|||
155144757|NCT01307319|559963141|FG000|Overall Study|Lost to Follow-up|1|||
155144758|NCT01307319|559963142|FG001|Overall Study|Lost to Follow-up|0|||
155144759|NCT01307319|559963143|FG002|Overall Study|Lost to Follow-up|1|||
155144760|NCT01307319|559963141|FG000|Overall Study|Protocol Violation|1|||
155144761|NCT01307319|559963142|FG001|Overall Study|Protocol Violation|1|||
155144762|NCT01307319|559963143|FG002|Overall Study|Protocol Violation|0|||
155144763|NCT01307319|559963141|FG000|Overall Study|Withdrawal by Subject|0|||
155144764|NCT01307319|559963142|FG001|Overall Study|Withdrawal by Subject|1|||
155144765|NCT01307319|559963143|FG002|Overall Study|Withdrawal by Subject|2|||
155144766|NCT01307319|559963141|FG000|Overall Study|Other|0|||
155144767|NCT01307319|559963142|FG001|Overall Study|Other|4|||
155193757|NCT03181893|560147485|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193758|NCT03181893|560147486|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155144768|NCT01307319|559963143|FG002|Overall Study|Other|3|||
155144769|NCT02735239|559963144|FG000|Overall Study|Adverse Event|0|||
155144770|NCT02735239|559963145|FG001|Overall Study|Adverse Event|0|||
155144771|NCT02735239|559963146|FG002|Overall Study|Adverse Event|4|||
155144772|NCT02735239|559963147|FG003|Overall Study|Adverse Event|0|||
155144773|NCT02735239|559963148|FG004|Overall Study|Adverse Event|0|||
155144774|NCT02735239|559963149|FG005|Overall Study|Adverse Event|0|||
155144775|NCT02735239|559963144|FG000|Overall Study|Death|1|||
155144776|NCT02735239|559963145|FG001|Overall Study|Death|1|||
155144777|NCT02735239|559963146|FG002|Overall Study|Death|0|||
155144778|NCT02735239|559963147|FG003|Overall Study|Death|0|||
155144779|NCT02735239|559963148|FG004|Overall Study|Death|0|||
155144780|NCT02735239|559963149|FG005|Overall Study|Death|0|||
155144781|NCT02735239|559963144|FG000|Overall Study|Physician Decision|0|||
155144782|NCT02735239|559963145|FG001|Overall Study|Physician Decision|0|||
155144783|NCT02735239|559963146|FG002|Overall Study|Physician Decision|1|||
155144784|NCT02735239|559963147|FG003|Overall Study|Physician Decision|0|||
155144785|NCT02735239|559963148|FG004|Overall Study|Physician Decision|0|||
155144786|NCT02735239|559963149|FG005|Overall Study|Physician Decision|0|||
155144787|NCT02735239|559963144|FG000|Overall Study|Progressive disease|3|||
155144788|NCT02735239|559963145|FG001|Overall Study|Progressive disease|1|||
155144789|NCT02735239|559963146|FG002|Overall Study|Progressive disease|3|||
155144790|NCT02735239|559963147|FG003|Overall Study|Progressive disease|0|||
155144791|NCT02735239|559963148|FG004|Overall Study|Progressive disease|0|||
155144792|NCT02735239|559963149|FG005|Overall Study|Progressive disease|2|||
155144793|NCT02735239|559963144|FG000|Overall Study|Withdrawal by Subject|0|||
155144794|NCT02735239|559963145|FG001|Overall Study|Withdrawal by Subject|1|||
155144795|NCT02735239|559963146|FG002|Overall Study|Withdrawal by Subject|0|||
155144796|NCT02735239|559963147|FG003|Overall Study|Withdrawal by Subject|0|||
155144797|NCT02735239|559963148|FG004|Overall Study|Withdrawal by Subject|0|||
155144798|NCT02735239|559963149|FG005|Overall Study|Withdrawal by Subject|0|||
155144799|NCT02152631|559963150|FG000|Overall Study|Adverse Event|32|||
155144800|NCT02152631|559963151|FG001|Overall Study|Adverse Event|4|||
155144801|NCT02152631|559963150|FG000|Overall Study|Withdrawal by Subject|13|||
155144802|NCT02152631|559963151|FG001|Overall Study|Withdrawal by Subject|16|||
155144803|NCT02152631|559963150|FG000|Overall Study|Noncompliance with study drug|1|||
155144804|NCT02152631|559963151|FG001|Overall Study|Noncompliance with study drug|0|||
155144805|NCT02152631|559963150|FG000|Overall Study|Physician Decision|1|||
155144806|NCT02152631|559963151|FG001|Overall Study|Physician Decision|2|||
155144807|NCT02152631|559963150|FG000|Overall Study|Lost to Follow-up|0|||
155144808|NCT02152631|559963151|FG001|Overall Study|Lost to Follow-up|1|||
155144809|NCT02152631|559963150|FG000|Overall Study|On Treatment|19|||
155144810|NCT02152631|559963151|FG001|Overall Study|On Treatment|3|||
155144811|NCT01380769|559963164|FG000|Overall Study|Withdrawal by Subject|7|||
155144812|NCT01380769|559963165|FG001|Overall Study|Withdrawal by Subject|11|||
155144813|NCT01380769|559963164|FG000|Overall Study|Physician Decision|1|||
155144814|NCT01380769|559963165|FG001|Overall Study|Physician Decision|1|||
155144815|NCT01380769|559963164|FG000|Overall Study|Adverse Event|1|||
155144816|NCT01380769|559963165|FG001|Overall Study|Adverse Event|1|||
155144817|NCT01380769|559963164|FG000|Overall Study|Protocol Violation|0|||
155144818|NCT01380769|559963165|FG001|Overall Study|Protocol Violation|1|||
155144819|NCT05030350|559963166|FG000|Overall Study|Adverse Event|13|||
155144820|NCT05030350|559963166|FG000|Overall Study|Lack of Efficacy|8|||
155144821|NCT05030350|559963166|FG000|Overall Study|Lost to Follow-up|35|||
155144822|NCT05030350|559963166|FG000|Overall Study|Pregnancy|2|||
155144823|NCT05030350|559963166|FG000|Overall Study|Protocol Violation|2|||
155193759|NCT03181893|560147487|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193760|NCT03181893|560147488|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
155193761|NCT03181893|560147489|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
155193762|NCT02158975|560147490|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
155193763|NCT04815031|560147495|FG000|Overall Study|No adverse event information (missing information)|33|||
155193764|NCT03021304|560147496|FG000|Overall Study|Lack of Efficacy|1|||
155193765|NCT00423514|560147504|FG000|Overall Study|Ineligible|1|||
155193766|NCT00423514|560147505|FG001|Overall Study|Ineligible|0|||
155193767|NCT01361568|560147506|FG000|Overall Study|Adverse Event|0|||
155193768|NCT01361568|560147507|FG001|Overall Study|Adverse Event|0|||
155193769|NCT01361568|560147508|FG002|Overall Study|Adverse Event|0|||
155193770|NCT01361568|560147509|FG003|Overall Study|Adverse Event|0|||
155193771|NCT01361568|560147510|FG004|Overall Study|Adverse Event|1|||
155193772|NCT01361568|560147511|FG005|Overall Study|Adverse Event|0|||
155193773|NCT01361568|560147506|FG000|Overall Study|Physician Decision|0|||
155193774|NCT01361568|560147507|FG001|Overall Study|Physician Decision|0|||
155193775|NCT01361568|560147508|FG002|Overall Study|Physician Decision|0|||
155193776|NCT01361568|560147509|FG003|Overall Study|Physician Decision|0|||
155193777|NCT01361568|560147510|FG004|Overall Study|Physician Decision|0|||
155193778|NCT01361568|560147511|FG005|Overall Study|Physician Decision|1|||
155193779|NCT01361568|560147506|FG000|Overall Study|Withdrawal by Subject|2|||
155193780|NCT01361568|560147507|FG001|Overall Study|Withdrawal by Subject|1|||
155193781|NCT01361568|560147508|FG002|Overall Study|Withdrawal by Subject|0|||
155193782|NCT01361568|560147509|FG003|Overall Study|Withdrawal by Subject|0|||
155193783|NCT01361568|560147510|FG004|Overall Study|Withdrawal by Subject|0|||
155193784|NCT01361568|560147511|FG005|Overall Study|Withdrawal by Subject|1|||
155193785|NCT02728596|560147512|FG000|Overall Study|Refusal unrelated to adverse event|3|||
155193786|NCT02728596|560147513|FG001|Overall Study|Refusal unrelated to adverse event|6|||
155193787|NCT02728596|560147514|FG002|Overall Study|Refusal unrelated to adverse event|7|||
155193788|NCT02728596|560147515|FG003|Overall Study|Refusal unrelated to adverse event|7|||
155193789|NCT02728596|560147512|FG000|Overall Study|Death|44|||
155193790|NCT02728596|560147513|FG001|Overall Study|Death|42|||
155193791|NCT02728596|560147514|FG002|Overall Study|Death|123|||
155193792|NCT02728596|560147515|FG003|Overall Study|Death|68|||
155193793|NCT03439657|560147516|FG000|Overall Study|Adverse Event|2|||
155193794|NCT03439657|560147517|FG001|Overall Study|Adverse Event|3|||
155193795|NCT03439657|560147516|FG000|Overall Study|Lost to Follow-up|1|||
155193796|NCT03439657|560147517|FG001|Overall Study|Lost to Follow-up|0|||
155193797|NCT03439657|560147516|FG000|Overall Study|Protocol Violation|1|||
155193798|NCT03439657|560147517|FG001|Overall Study|Protocol Violation|1|||
155193799|NCT03439657|560147516|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
155193800|NCT03439657|560147517|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
155193801|NCT00667875|560147520|FG000|Overall Study|Adverse Event|0|||
155193802|NCT00667875|560147521|FG001|Overall Study|Adverse Event|2|||
155193803|NCT00667875|560147522|FG002|Overall Study|Adverse Event|6|||
155193804|NCT00667875|560147520|FG000|Overall Study|Withdrawal by Subject|10|||
155193805|NCT00667875|560147521|FG001|Overall Study|Withdrawal by Subject|9|||
155193806|NCT00667875|560147522|FG002|Overall Study|Withdrawal by Subject|7|||
155193807|NCT03553927|560147523|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
155193808|NCT03553927|560147524|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
155193809|NCT03553927|560147523|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
155193810|NCT03553927|560147524|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
155193811|NCT01441180|560147525|FG000|Overall Study|Lost to Follow-up|1|||
155193812|NCT01441180|560147526|FG001|Overall Study|Lost to Follow-up|1|||
155193813|NCT01441180|560147527|FG002|Overall Study|Lost to Follow-up|1|||
155193814|NCT01441180|560147525|FG000|Overall Study|Discontinued|0|||
155193815|NCT01441180|560147526|FG001|Overall Study|Discontinued|0|||
155193816|NCT01441180|560147527|FG002|Overall Study|Discontinued|2|||
155193817|NCT01558739|560147528|FG000|Overall Study|Adverse Event|7|||
155193818|NCT01558739|560147528|FG000|Overall Study|Withdrawal by Subject|2|||
155193819|NCT01558739|560147528|FG000|Overall Study|Death|3|||
155193820|NCT01558739|560147528|FG000|Overall Study|Disease Progression|4|||
155193821|NCT01558739|560147528|FG000|Overall Study|Protocol Violation|1|||
155193822|NCT00142298|560147531|FG000|Overall Study|Adverse Event|10|||
155193823|NCT00142298|560147532|FG001|Overall Study|Adverse Event|10|||
155193824|NCT00142298|560147533|FG002|Overall Study|Adverse Event|1|||
155193825|NCT00142298|560147534|FG003|Overall Study|Adverse Event|5|||
155193826|NCT00142298|560147535|FG004|Overall Study|Adverse Event|2|||
155193827|NCT00142298|560147536|FG005|Overall Study|Adverse Event|2|||
155193828|NCT00142298|560147537|FG006|Overall Study|Adverse Event|0|||
155193829|NCT00142298|560147538|FG007|Overall Study|Adverse Event|0|||
155193830|NCT00142298|560147539|FG008|Overall Study|Adverse Event|0|||
155193831|NCT00142298|560147540|FG009|Overall Study|Adverse Event|0|||
155193832|NCT00142298|560147531|FG000|Overall Study|Clinical disease progression|1|||
155193833|NCT00142298|560147532|FG001|Overall Study|Clinical disease progression|0|||
155193834|NCT00142298|560147533|FG002|Overall Study|Clinical disease progression|0|||
155144824|NCT05030350|559963166|FG000|Overall Study|Withdrawal by Subject|60|||
155144825|NCT05030350|559963166|FG000|Overall Study|Study terminated by sponsor|349|||
155144826|NCT05030350|559963166|FG000|Overall Study|Positive Drug Screen|4|||
155144827|NCT05030350|559963166|FG000|Overall Study|Other|8|||
155144828|NCT03654690|559963168|FG000|Overall Study|Withdrawal by Subject|1|||
155144829|NCT03654690|559963169|FG001|Overall Study|Withdrawal by Subject|0|||
155144830|NCT03654690|559963170|FG002|Overall Study|Withdrawal by Subject|0|||
155144831|NCT02711137|559963171|FG000|Overall Study|Death|1|||
155144832|NCT02711137|559963172|FG001|Overall Study|Death|4|||
155144833|NCT02711137|559963173|FG002|Overall Study|Death|5|||
155144834|NCT02711137|559963174|FG003|Overall Study|Death|5|||
155144835|NCT02711137|559963175|FG004|Overall Study|Death|3|||
155144836|NCT02711137|559963176|FG005|Overall Study|Death|1|||
155144837|NCT02711137|559963177|FG006|Overall Study|Death|61|||
155144838|NCT02711137|559963178|FG007|Overall Study|Death|3|||
155144839|NCT02711137|559963179|FG008|Overall Study|Death|0|||
155144840|NCT02711137|559963180|FG009|Overall Study|Death|1|||
155144841|NCT02711137|559963181|FG010|Overall Study|Death|1|||
155144842|NCT02711137|559963182|FG011|Overall Study|Death|1|||
155144843|NCT02711137|559963183|FG012|Overall Study|Death|0|||
155144844|NCT02711137|559963184|FG013|Overall Study|Death|0|||
155144845|NCT02711137|559963185|FG014|Overall Study|Death|0|||
155144846|NCT02711137|559963171|FG000|Overall Study|Study Terminated by Sponsor|0|||
155144847|NCT02711137|559963172|FG001|Overall Study|Study Terminated by Sponsor|0|||
155144848|NCT02711137|559963173|FG002|Overall Study|Study Terminated by Sponsor|1|||
155144849|NCT02711137|559963174|FG003|Overall Study|Study Terminated by Sponsor|0|||
155144850|NCT02711137|559963175|FG004|Overall Study|Study Terminated by Sponsor|0|||
155144851|NCT02711137|559963176|FG005|Overall Study|Study Terminated by Sponsor|0|||
155144852|NCT02711137|559963177|FG006|Overall Study|Study Terminated by Sponsor|1|||
155144853|NCT02711137|559963178|FG007|Overall Study|Study Terminated by Sponsor|0|||
155144854|NCT02711137|559963179|FG008|Overall Study|Study Terminated by Sponsor|0|||
155144855|NCT02711137|559963180|FG009|Overall Study|Study Terminated by Sponsor|0|||
155144856|NCT02711137|559963181|FG010|Overall Study|Study Terminated by Sponsor|0|||
155144857|NCT02711137|559963182|FG011|Overall Study|Study Terminated by Sponsor|0|||
155144858|NCT02711137|559963183|FG012|Overall Study|Study Terminated by Sponsor|0|||
155144859|NCT02711137|559963184|FG013|Overall Study|Study Terminated by Sponsor|0|||
155144860|NCT02711137|559963185|FG014|Overall Study|Study Terminated by Sponsor|0|||
155144861|NCT02711137|559963171|FG000|Overall Study|Physician Decision|1|||
155144862|NCT02711137|559963172|FG001|Overall Study|Physician Decision|0|||
155144863|NCT02711137|559963173|FG002|Overall Study|Physician Decision|2|||
155144864|NCT02711137|559963174|FG003|Overall Study|Physician Decision|1|||
155144865|NCT02711137|559963175|FG004|Overall Study|Physician Decision|1|||
155144866|NCT02711137|559963176|FG005|Overall Study|Physician Decision|0|||
155144867|NCT02711137|559963177|FG006|Overall Study|Physician Decision|12|||
155144868|NCT02711137|559963178|FG007|Overall Study|Physician Decision|2|||
155144869|NCT02711137|559963179|FG008|Overall Study|Physician Decision|1|||
155144870|NCT02711137|559963180|FG009|Overall Study|Physician Decision|1|||
155144871|NCT02711137|559963181|FG010|Overall Study|Physician Decision|3|||
155144872|NCT02711137|559963182|FG011|Overall Study|Physician Decision|2|||
155144873|NCT02711137|559963183|FG012|Overall Study|Physician Decision|1|||
155144874|NCT02711137|559963184|FG013|Overall Study|Physician Decision|1|||
155144875|NCT02711137|559963185|FG014|Overall Study|Physician Decision|2|||
155144876|NCT02711137|559963171|FG000|Overall Study|Other|0|||
155144877|NCT02711137|559963172|FG001|Overall Study|Other|1|||
155144878|NCT02711137|559963173|FG002|Overall Study|Other|0|||
155144879|NCT02711137|559963174|FG003|Overall Study|Other|0|||
155144880|NCT02711137|559963175|FG004|Overall Study|Other|0|||
155144881|NCT02711137|559963176|FG005|Overall Study|Other|0|||
155144882|NCT02711137|559963177|FG006|Overall Study|Other|3|||
155144883|NCT02711137|559963178|FG007|Overall Study|Other|0|||
155144884|NCT02711137|559963179|FG008|Overall Study|Other|0|||
155144885|NCT02711137|559963180|FG009|Overall Study|Other|0|||
155144886|NCT02711137|559963181|FG010|Overall Study|Other|0|||
155144887|NCT02711137|559963182|FG011|Overall Study|Other|0|||
155144888|NCT02711137|559963183|FG012|Overall Study|Other|0|||
155144889|NCT02711137|559963184|FG013|Overall Study|Other|0|||
155144890|NCT02711137|559963185|FG014|Overall Study|Other|1|||
155144891|NCT02711137|559963171|FG000|Overall Study|Withdrawal by Subject|1|||
155144892|NCT02711137|559963172|FG001|Overall Study|Withdrawal by Subject|0|||
155144893|NCT02711137|559963173|FG002|Overall Study|Withdrawal by Subject|0|||
155144894|NCT02711137|559963174|FG003|Overall Study|Withdrawal by Subject|1|||
155193835|NCT00142298|560147534|FG003|Overall Study|Clinical disease progression|0|||
155144895|NCT02711137|559963175|FG004|Overall Study|Withdrawal by Subject|1|||
155144896|NCT02711137|559963176|FG005|Overall Study|Withdrawal by Subject|0|||
155144897|NCT02711137|559963177|FG006|Overall Study|Withdrawal by Subject|7|||
155193836|NCT00142298|560147535|FG004|Overall Study|Clinical disease progression|0|||
155144898|NCT02711137|559963178|FG007|Overall Study|Withdrawal by Subject|0|||
155144899|NCT02711137|559963179|FG008|Overall Study|Withdrawal by Subject|0|||
155144900|NCT02711137|559963180|FG009|Overall Study|Withdrawal by Subject|0|||
155144901|NCT02711137|559963181|FG010|Overall Study|Withdrawal by Subject|0|||
155144902|NCT02711137|559963182|FG011|Overall Study|Withdrawal by Subject|0|||
155193837|NCT00142298|560147536|FG005|Overall Study|Clinical disease progression|0|||
155193838|NCT00142298|560147537|FG006|Overall Study|Clinical disease progression|0|||
155193839|NCT00142298|560147538|FG007|Overall Study|Clinical disease progression|0|||
155193840|NCT00142298|560147539|FG008|Overall Study|Clinical disease progression|0|||
155193841|NCT00142298|560147540|FG009|Overall Study|Clinical disease progression|0|||
155193842|NCT00142298|560147531|FG000|Overall Study|Death|1|||
155193843|NCT00142298|560147532|FG001|Overall Study|Death|1|||
155193844|NCT00142298|560147533|FG002|Overall Study|Death|1|||
155193845|NCT00142298|560147534|FG003|Overall Study|Death|0|||
155193846|NCT00142298|560147535|FG004|Overall Study|Death|0|||
155193847|NCT00142298|560147536|FG005|Overall Study|Death|6|||
155193848|NCT00142298|560147537|FG006|Overall Study|Death|0|||
155193849|NCT00142298|560147538|FG007|Overall Study|Death|0|||
155193850|NCT00142298|560147539|FG008|Overall Study|Death|0|||
155193851|NCT00142298|560147540|FG009|Overall Study|Death|0|||
155193852|NCT00142298|560147531|FG000|Overall Study|Lack of Efficacy|44|||
155193853|NCT00142298|560147532|FG001|Overall Study|Lack of Efficacy|62|||
155193854|NCT00142298|560147533|FG002|Overall Study|Lack of Efficacy|9|||
155193855|NCT00142298|560147534|FG003|Overall Study|Lack of Efficacy|12|||
155193856|NCT00142298|560147535|FG004|Overall Study|Lack of Efficacy|1|||
155193857|NCT00142298|560147536|FG005|Overall Study|Lack of Efficacy|0|||
155193858|NCT00142298|560147537|FG006|Overall Study|Lack of Efficacy|0|||
155193859|NCT00142298|560147538|FG007|Overall Study|Lack of Efficacy|1|||
155193860|NCT00142298|560147539|FG008|Overall Study|Lack of Efficacy|0|||
155193861|NCT00142298|560147540|FG009|Overall Study|Lack of Efficacy|0|||
155193862|NCT00142298|560147531|FG000|Overall Study|Non-compliance|15|||
155193863|NCT00142298|560147532|FG001|Overall Study|Non-compliance|13|||
155193864|NCT00142298|560147533|FG002|Overall Study|Non-compliance|0|||
155193865|NCT00142298|560147534|FG003|Overall Study|Non-compliance|6|||
155193866|NCT00142298|560147535|FG004|Overall Study|Non-compliance|1|||
155193867|NCT00142298|560147536|FG005|Overall Study|Non-compliance|0|||
155193868|NCT00142298|560147537|FG006|Overall Study|Non-compliance|0|||
155193869|NCT00142298|560147538|FG007|Overall Study|Non-compliance|3|||
155193870|NCT00142298|560147539|FG008|Overall Study|Non-compliance|3|||
155193871|NCT00142298|560147540|FG009|Overall Study|Non-compliance|0|||
155193872|NCT00142298|560147531|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
155193873|NCT00142298|560147532|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
155193874|NCT00142298|560147533|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
155193875|NCT00142298|560147534|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
155193876|NCT00142298|560147535|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
155193877|NCT00142298|560147536|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
155193878|NCT00142298|560147537|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
155193879|NCT00142298|560147538|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
155193880|NCT00142298|560147539|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
155193881|NCT00142298|560147540|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
155193882|NCT00142298|560147531|FG000|Overall Study|Pregnancy|4|||
155193883|NCT00142298|560147532|FG001|Overall Study|Pregnancy|4|||
155193884|NCT00142298|560147533|FG002|Overall Study|Pregnancy|2|||
155193885|NCT00142298|560147534|FG003|Overall Study|Pregnancy|3|||
155193886|NCT00142298|560147535|FG004|Overall Study|Pregnancy|0|||
155193887|NCT00142298|560147536|FG005|Overall Study|Pregnancy|0|||
155193888|NCT00142298|560147537|FG006|Overall Study|Pregnancy|0|||
155193889|NCT00142298|560147538|FG007|Overall Study|Pregnancy|0|||
155193890|NCT00142298|560147539|FG008|Overall Study|Pregnancy|1|||
155193891|NCT00142298|560147540|FG009|Overall Study|Pregnancy|0|||
155193892|NCT00142298|560147531|FG000|Overall Study|Virologic breakthrough|19|||
155193893|NCT00142298|560147532|FG001|Overall Study|Virologic breakthrough|23|||
155193894|NCT00142298|560147533|FG002|Overall Study|Virologic breakthrough|9|||
155144903|NCT02711137|559963183|FG012|Overall Study|Withdrawal by Subject|0|||
155144904|NCT02711137|559963184|FG013|Overall Study|Withdrawal by Subject|1|||
155144905|NCT02711137|559963185|FG014|Overall Study|Withdrawal by Subject|0|||
155144906|NCT02711137|559963171|FG000|Overall Study|Lost to Follow-up|1|||
155144907|NCT02711137|559963172|FG001|Overall Study|Lost to Follow-up|0|||
155144908|NCT02711137|559963173|FG002|Overall Study|Lost to Follow-up|0|||
155144909|NCT02711137|559963174|FG003|Overall Study|Lost to Follow-up|0|||
155193895|NCT00142298|560147534|FG003|Overall Study|Virologic breakthrough|7|||
155193896|NCT00142298|560147535|FG004|Overall Study|Virologic breakthrough|2|||
155193897|NCT00142298|560147536|FG005|Overall Study|Virologic breakthrough|3|||
155144910|NCT02711137|559963175|FG004|Overall Study|Lost to Follow-up|0|||
155193898|NCT00142298|560147537|FG006|Overall Study|Virologic breakthrough|3|||
155193899|NCT00142298|560147538|FG007|Overall Study|Virologic breakthrough|0|||
155193900|NCT00142298|560147539|FG008|Overall Study|Virologic breakthrough|0|||
155144911|NCT02711137|559963176|FG005|Overall Study|Lost to Follow-up|0|||
155144912|NCT02711137|559963177|FG006|Overall Study|Lost to Follow-up|2|||
155193901|NCT00142298|560147540|FG009|Overall Study|Virologic breakthrough|0|||
155193902|NCT00142298|560147531|FG000|Overall Study|Other- not specified|0|||
155193903|NCT00142298|560147532|FG001|Overall Study|Other- not specified|3|||
155193904|NCT00142298|560147533|FG002|Overall Study|Other- not specified|0|||
155193905|NCT00142298|560147534|FG003|Overall Study|Other- not specified|1|||
155193906|NCT00142298|560147535|FG004|Overall Study|Other- not specified|0|||
155193907|NCT00142298|560147536|FG005|Overall Study|Other- not specified|0|||
155193908|NCT00142298|560147537|FG006|Overall Study|Other- not specified|0|||
155144913|NCT02711137|559963178|FG007|Overall Study|Lost to Follow-up|0|||
155144914|NCT02711137|559963179|FG008|Overall Study|Lost to Follow-up|0|||
155144915|NCT02711137|559963180|FG009|Overall Study|Lost to Follow-up|0|||
155144916|NCT02711137|559963181|FG010|Overall Study|Lost to Follow-up|0|||
155144917|NCT02711137|559963182|FG011|Overall Study|Lost to Follow-up|0|||
155144918|NCT02711137|559963183|FG012|Overall Study|Lost to Follow-up|0|||
155144919|NCT02711137|559963184|FG013|Overall Study|Lost to Follow-up|0|||
155144920|NCT02711137|559963185|FG014|Overall Study|Lost to Follow-up|0|||
155144921|NCT01544920|559963188|FG000|Overall Study|Adverse Event|0|||
155144922|NCT01544920|559963189|FG001|Overall Study|Adverse Event|3|||
155144923|NCT01544920|559963188|FG000|Overall Study|Death|0|||
155144924|NCT01544920|559963189|FG001|Overall Study|Death|1|||
155144925|NCT01544920|559963188|FG000|Overall Study|Lost to Follow-up|11|||
155144926|NCT01544920|559963189|FG001|Overall Study|Lost to Follow-up|12|||
155144927|NCT01544920|559963188|FG000|Overall Study|Protocol Violation|0|||
155144928|NCT01544920|559963189|FG001|Overall Study|Protocol Violation|2|||
155144929|NCT01544920|559963188|FG000|Overall Study|Physician Decision|4|||
155144930|NCT01544920|559963189|FG001|Overall Study|Physician Decision|1|||
155193909|NCT00142298|560147538|FG007|Overall Study|Other- not specified|0|||
155193910|NCT00142298|560147539|FG008|Overall Study|Other- not specified|0|||
155193911|NCT00142298|560147540|FG009|Overall Study|Other- not specified|0|||
155193912|NCT00142298|560147531|FG000|Overall Study|Lost to Follow-up|0|||
155193913|NCT00142298|560147532|FG001|Overall Study|Lost to Follow-up|0|||
155193914|NCT00142298|560147533|FG002|Overall Study|Lost to Follow-up|0|||
155193915|NCT00142298|560147534|FG003|Overall Study|Lost to Follow-up|0|||
155193916|NCT00142298|560147535|FG004|Overall Study|Lost to Follow-up|0|||
155193917|NCT00142298|560147536|FG005|Overall Study|Lost to Follow-up|0|||
155193918|NCT00142298|560147537|FG006|Overall Study|Lost to Follow-up|2|||
155193919|NCT00142298|560147538|FG007|Overall Study|Lost to Follow-up|0|||
155193920|NCT00142298|560147539|FG008|Overall Study|Lost to Follow-up|0|||
155193921|NCT00142298|560147540|FG009|Overall Study|Lost to Follow-up|0|||
155193922|NCT00142298|560147531|FG000|Overall Study|Treatment Failure|0|||
155193923|NCT00142298|560147532|FG001|Overall Study|Treatment Failure|0|||
155193924|NCT00142298|560147533|FG002|Overall Study|Treatment Failure|0|||
155193925|NCT00142298|560147534|FG003|Overall Study|Treatment Failure|0|||
155193926|NCT00142298|560147535|FG004|Overall Study|Treatment Failure|0|||
155193927|NCT00142298|560147536|FG005|Overall Study|Treatment Failure|2|||
155193928|NCT00142298|560147537|FG006|Overall Study|Treatment Failure|2|||
155193929|NCT00142298|560147538|FG007|Overall Study|Treatment Failure|0|||
155193930|NCT00142298|560147539|FG008|Overall Study|Treatment Failure|0|||
155193931|NCT00142298|560147540|FG009|Overall Study|Treatment Failure|0|||
155193932|NCT02423772|560147542|FG000|Overall Study|Lost to Follow-up|3|||
155193933|NCT02423772|560147543|FG001|Overall Study|Lost to Follow-up|3|||
155193934|NCT02423772|560147542|FG000|Overall Study|Did not begin intervention|2|||
155193935|NCT02423772|560147543|FG001|Overall Study|Did not begin intervention|5|||
155193936|NCT01386008|560147544|FG000|Overall Study|exited w/o incident /study discontinued|17|||
155193937|NCT01386008|560147544|FG000|Overall Study|Adverse Event|3|||
155193938|NCT04449861|560147545|FG000|Overall Study|Withdrawal by Subject|4|||
155193939|NCT04449861|560147545|FG000|Overall Study|Lost to Follow-up|5|||
155193940|NCT04449861|560147545|FG000|Overall Study|Death|112|||
155193941|NCT05268055|560147546|FG000|Overall Study|Lost to Follow-up|68|||
155193942|NCT05268055|560147547|FG001|Overall Study|Lost to Follow-up|68|||
155193943|NCT05268055|560147546|FG000|Overall Study|Withdrawal by Subject|12|||
155193944|NCT05268055|560147547|FG001|Overall Study|Withdrawal by Subject|8|||
155144931|NCT01544920|559963188|FG000|Overall Study|Withdrawal by Subject|4|||
155144932|NCT01544920|559963189|FG001|Overall Study|Withdrawal by Subject|4|||
155144933|NCT00965081|559963190|FG000|Overall Study|Adverse Event|14|||
155144934|NCT00965081|559963191|FG001|Overall Study|Adverse Event|9|||
155144935|NCT00965081|559963190|FG000|Overall Study|Lack of Efficacy|2|||
155144936|NCT00965081|559963191|FG001|Overall Study|Lack of Efficacy|5|||
155144937|NCT00965081|559963190|FG000|Overall Study|Lost to Follow-up|4|||
155144938|NCT00965081|559963191|FG001|Overall Study|Lost to Follow-up|5|||
155193945|NCT00531934|560149457|FG000|Overall Study|Adverse Event|4|||
155193946|NCT00531934|560149458|FG001|Overall Study|Adverse Event|8|||
155193947|NCT00531934|560149457|FG000|Overall Study|Progression|52|||
155193948|NCT00531934|560149458|FG001|Overall Study|Progression|42|||
155193949|NCT00531934|560149457|FG000|Overall Study|Death|7|||
155193950|NCT00531934|560149458|FG001|Overall Study|Death|10|||
155193951|NCT00531934|560149457|FG000|Overall Study|Withdrawal by Subject|1|||
155193952|NCT00531934|560149458|FG001|Overall Study|Withdrawal by Subject|1|||
155193953|NCT00531934|560149457|FG000|Overall Study|Other|2|||
155193954|NCT00531934|560149458|FG001|Overall Study|Other|2|||
155193955|NCT01816074|560149459|FG000|Phase 1|Time commitment issues|0|||
155193956|NCT01816074|560149460|FG001|Phase 1|Time commitment issues|0|||
155193957|NCT01816074|560149461|FG002|Phase 1|Time commitment issues|1|||
155193958|NCT01816074|560149462|FG003|Phase 1|Time commitment issues|0|||
155144939|NCT00965081|559963190|FG000|Overall Study|Physician Decision|2|||
155144940|NCT00965081|559963191|FG001|Overall Study|Physician Decision|0|||
155144941|NCT00965081|559963190|FG000|Overall Study|Protocol Violation|2|||
155144942|NCT00965081|559963191|FG001|Overall Study|Protocol Violation|5|||
155144943|NCT00965081|559963190|FG000|Overall Study|Sponsor Decision|1|||
155144944|NCT00965081|559963191|FG001|Overall Study|Sponsor Decision|0|||
155144945|NCT00965081|559963190|FG000|Overall Study|Withdrawal by Subject|4|||
155144946|NCT00965081|559963191|FG001|Overall Study|Withdrawal by Subject|7|||
155144947|NCT00965081|559963190|FG000|Overall Study|Switched to Rescue Arm|5|||
155144948|NCT00965081|559963191|FG001|Overall Study|Switched to Rescue Arm|12|||
155144949|NCT01367834|559963194|FG000|Overall Study|Withdrawal by Subject|2|||
155144950|NCT01367834|559963195|FG001|Overall Study|Withdrawal by Subject|2|||
155144951|NCT01367834|559963194|FG000|Overall Study|Study was ended.|0|||
155144952|NCT01367834|559963195|FG001|Overall Study|Study was ended.|1|||
155144953|NCT01569841|559963200|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
155144954|NCT01569841|559963201|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
155144955|NCT01859923|559963202|FG000|Overall Study|Adverse Event|0|||
155144956|NCT01859923|559963203|FG001|Overall Study|Adverse Event|0|||
155144957|NCT01859923|559963204|FG002|Overall Study|Adverse Event|1|||
155144958|NCT01859923|559963205|FG003|Overall Study|Adverse Event|1|||
155144959|NCT01358825|559963212|FG000|Overall Study|Blood sample not drawn|0|||
155144960|NCT01358825|559963213|FG001|Overall Study|Blood sample not drawn|1|||
155144961|NCT03571204|559963214|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
155144962|NCT03571204|559963215|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
155144963|NCT03571204|559963216|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
155144964|NCT03571204|559963214|FG000|Overall Study|Physician Decision|0|||
155144965|NCT03571204|559963215|FG001|Overall Study|Physician Decision|1|||
155144966|NCT03571204|559963216|FG002|Overall Study|Physician Decision|0|||
155144967|NCT00113841|559963217|FG000|Overall Study|Disease progression|0|||
155144968|NCT00113841|559963218|FG001|Overall Study|Disease progression|2|||
155144969|NCT00113841|559963217|FG000|Overall Study|Non-compliant|1|||
155144970|NCT00113841|559963218|FG001|Overall Study|Non-compliant|0|||
155144971|NCT02721875|559963220|FG000|Overall Study|Progressive disease/relapse|1|||
155144972|NCT02721875|559963221|FG001|Overall Study|Progressive disease/relapse|0|||
155144973|NCT02888106|559963222|FG000|Overall Study|Withdrawal by Subject|1|||
155144974|NCT02888106|559963223|FG001|Overall Study|Withdrawal by Subject|2|||
155144975|NCT02888106|559963224|FG002|Overall Study|Withdrawal by Subject|0|||
155144976|NCT02888106|559963225|FG003|Overall Study|Withdrawal by Subject|1|||
155144977|NCT02888106|559963226|FG004|Overall Study|Withdrawal by Subject|0|||
155144978|NCT02888106|559963227|FG005|Overall Study|Withdrawal by Subject|0|||
155144979|NCT02888106|559963222|FG000|Overall Study|Lost to Follow-up|1|||
155144980|NCT02888106|559963223|FG001|Overall Study|Lost to Follow-up|0|||
155144981|NCT02888106|559963224|FG002|Overall Study|Lost to Follow-up|0|||
155144982|NCT02888106|559963225|FG003|Overall Study|Lost to Follow-up|1|||
155144983|NCT02888106|559963226|FG004|Overall Study|Lost to Follow-up|0|||
155144984|NCT02888106|559963227|FG005|Overall Study|Lost to Follow-up|1|||
155144985|NCT02888106|559963222|FG000|Overall Study|Adverse Event|2|||
155144986|NCT02888106|559963223|FG001|Overall Study|Adverse Event|0|||
155144987|NCT02888106|559963224|FG002|Overall Study|Adverse Event|0|||
155144988|NCT02888106|559963225|FG003|Overall Study|Adverse Event|0|||
155144989|NCT02888106|559963226|FG004|Overall Study|Adverse Event|0|||
155144990|NCT02888106|559963227|FG005|Overall Study|Adverse Event|0|||
155144991|NCT02888106|559963222|FG000|Overall Study|Withdrawal of consent|0|||
155144992|NCT02888106|559963223|FG001|Overall Study|Withdrawal of consent|0|||
155144993|NCT02888106|559963224|FG002|Overall Study|Withdrawal of consent|0|||
155144994|NCT02888106|559963225|FG003|Overall Study|Withdrawal of consent|0|||
155144995|NCT02888106|559963226|FG004|Overall Study|Withdrawal of consent|1|||
155144996|NCT02888106|559963227|FG005|Overall Study|Withdrawal of consent|0|||
155144997|NCT02888106|559963222|FG000|Overall Study|Pregnancy|1|||
155144998|NCT02888106|559963223|FG001|Overall Study|Pregnancy|0|||
155144999|NCT02888106|559963224|FG002|Overall Study|Pregnancy|0|||
155145000|NCT02888106|559963225|FG003|Overall Study|Pregnancy|0|||
155145001|NCT02888106|559963226|FG004|Overall Study|Pregnancy|0|||
155145002|NCT02888106|559963227|FG005|Overall Study|Pregnancy|0|||
155145003|NCT00857285|559963228|FG000|Overall Study|Adverse Event|4|||
155145004|NCT00857285|559963229|FG001|Overall Study|Adverse Event|2|||
155145005|NCT00857285|559963228|FG000|Overall Study|Lack of Efficacy|0|||
155145006|NCT00857285|559963229|FG001|Overall Study|Lack of Efficacy|2|||
155145007|NCT00857285|559963228|FG000|Overall Study|Protocol Violation|3|||
155145008|NCT00857285|559963229|FG001|Overall Study|Protocol Violation|1|||
155145009|NCT00857285|559963228|FG000|Overall Study|Withdrawal by Subject|4|||
155145010|NCT00857285|559963229|FG001|Overall Study|Withdrawal by Subject|0|||
155145011|NCT00857285|559963228|FG000|Overall Study|Randomization criteria not met|1|||
155145012|NCT00857285|559963229|FG001|Overall Study|Randomization criteria not met|1|||
155145013|NCT01076959|559963239|FG000|Overall Study|Adverse Event|767|||
155145014|NCT01076959|559963239|FG000|Overall Study|Lack of Efficacy|849|||
155145015|NCT01076959|559963239|FG000|Overall Study|Non-compliance|274|||
155145016|NCT01076959|559963239|FG000|Overall Study|Lost to Follow-up|241|||
155145017|NCT01076959|559963239|FG000|Overall Study|Other|119|||
155145018|NCT03901144|559963240|FG000|Overall Study|Lost to Follow-up|1|||
155145019|NCT03901144|559963241|FG001|Overall Study|Lost to Follow-up|1|||
155145020|NCT03901144|559963242|FG002|Overall Study|Lost to Follow-up|1|||
155145021|NCT03901144|559963243|FG003|Overall Study|Lost to Follow-up|1|||
155145022|NCT02021565|559963244|FG000|Baseline Through Intervention|Death|0|||
155145023|NCT02021565|559963245|FG001|Baseline Through Intervention|Death|1|||
155145024|NCT02021565|559963244|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
155145025|NCT02021565|559963245|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
155145026|NCT02021565|559963244|FG000|Baseline Through Intervention|Protocol Violation|0|||
155145027|NCT02021565|559963245|FG001|Baseline Through Intervention|Protocol Violation|7|||
155145028|NCT02021565|559963244|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
155145029|NCT02021565|559963245|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
155145030|NCT02021565|559963244|FG000|3-month Follow-up|Death|3|||
155145031|NCT02021565|559963245|FG001|3-month Follow-up|Death|0|||
155145032|NCT02021565|559963244|FG000|3-month Follow-up|Withdrawal by Subject|4|||
155145033|NCT02021565|559963245|FG001|3-month Follow-up|Withdrawal by Subject|0|||
155145034|NCT02021565|559963244|FG000|3-month Follow-up|Protocol Violation|3|||
155145035|NCT02021565|559963245|FG001|3-month Follow-up|Protocol Violation|2|||
155145036|NCT05114473|559963247|FG000|Overall Study|Lost to Follow-up|2|||
155145037|NCT05114473|559963248|FG001|Overall Study|Lost to Follow-up|2|||
155145038|NCT05114473|559963249|FG002|Overall Study|Lost to Follow-up|0|||
155145039|NCT04445662|559963250|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
155145040|NCT04445662|559963251|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
155145041|NCT04445662|559963250|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
155145042|NCT04445662|559963251|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
155145043|NCT04445662|559963250|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
155145044|NCT04445662|559963251|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
155145045|NCT04445662|559963250|FG000|Post-treatment (12-24 weeks)|Death|1|||
155145046|NCT04445662|559963251|FG001|Post-treatment (12-24 weeks)|Death|0|||
155145047|NCT00279916|559963252|FG000|Overall Study|Withdrawal by Subject|4|||
155145048|NCT00279916|559963253|FG001|Overall Study|Withdrawal by Subject|3|||
155145049|NCT00279916|559963252|FG000|Overall Study|Lost to Follow-up|3|||
155145050|NCT00279916|559963253|FG001|Overall Study|Lost to Follow-up|2|||
155145051|NCT00731679|559963255|FG000|Overall Study|Adverse Event|7|||
155145052|NCT00731679|559963256|FG001|Overall Study|Adverse Event|8|||
155145053|NCT00731679|559963255|FG000|Overall Study|Withdrawal by Subject|8|||
155145054|NCT00731679|559963256|FG001|Overall Study|Withdrawal by Subject|8|||
155145055|NCT00731679|559963255|FG000|Overall Study|Lost to Follow-up|7|||
155145056|NCT00731679|559963256|FG001|Overall Study|Lost to Follow-up|8|||
155145057|NCT00731679|559963255|FG000|Overall Study|Noncompliance|0|||
155145058|NCT00731679|559963256|FG001|Overall Study|Noncompliance|1|||
155145059|NCT00731679|559963255|FG000|Overall Study|Pregnancy|0|||
155145060|NCT00731679|559963256|FG001|Overall Study|Pregnancy|1|||
155145061|NCT02488005|559963259|FG000|Overall Study|Lost to Follow-up|2|||
155145062|NCT03384940|559963260|FG000|Overall Study|Progressive disease|36|||
155145063|NCT03384940|559963261|FG001|Overall Study|Progressive disease|11|||
155145064|NCT03384940|559963262|FG002|Overall Study|Progressive disease|13|||
155145065|NCT03384940|559963260|FG000|Overall Study|Clinical progression|4|||
155145066|NCT03384940|559963261|FG001|Overall Study|Clinical progression|0|||
155145067|NCT03384940|559963262|FG002|Overall Study|Clinical progression|3|||
155145068|NCT03384940|559963260|FG000|Overall Study|Adverse Event|7|||
155145069|NCT03384940|559963261|FG001|Overall Study|Adverse Event|1|||
155145070|NCT03384940|559963262|FG002|Overall Study|Adverse Event|1|||
155145071|NCT03384940|559963260|FG000|Overall Study|Withdrawal by Subject|3|||
155145072|NCT03384940|559963261|FG001|Overall Study|Withdrawal by Subject|1|||
155145073|NCT03384940|559963262|FG002|Overall Study|Withdrawal by Subject|0|||
155145074|NCT03384940|559963260|FG000|Overall Study|Physician Decision|1|||
155145075|NCT03384940|559963261|FG001|Overall Study|Physician Decision|1|||
155145076|NCT03384940|559963262|FG002|Overall Study|Physician Decision|0|||
155193959|NCT01816074|560149459|FG000|Phase 2|Time commitment Issues|0|||
155193960|NCT01816074|560149460|FG001|Phase 2|Time commitment Issues|2|||
155145077|NCT03384940|559963260|FG000|Overall Study|Death|2|||
155145078|NCT03384940|559963261|FG001|Overall Study|Death|1|||
155145079|NCT03384940|559963262|FG002|Overall Study|Death|0|||
155145080|NCT03384940|559963260|FG000|Overall Study|Other|0|||
155145081|NCT03384940|559963261|FG001|Overall Study|Other|0|||
155145082|NCT03384940|559963262|FG002|Overall Study|Other|1|||
155145083|NCT03089580|559963268|FG000|Overall Study|Lost to Follow-up|2|||
155145084|NCT03087513|559963269|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
155145085|NCT01288989|559963270|FG000|Overall Study|Death|0|||
155145086|NCT01288989|559963271|FG001|Overall Study|Death|0|||
155145087|NCT01288989|559963272|FG002|Overall Study|Death|0|||
155145088|NCT01288989|559963273|FG003|Overall Study|Death|1|||
155145089|NCT01288989|559963274|FG004|Overall Study|Death|0|||
155145090|NCT01288989|559963270|FG000|Overall Study|Dose limiting toxicity|1|||
155145091|NCT01288989|559963271|FG001|Overall Study|Dose limiting toxicity|0|||
155193961|NCT01816074|560149461|FG002|Phase 2|Time commitment Issues|0|||
155145092|NCT01288989|559963272|FG002|Overall Study|Dose limiting toxicity|0|||
155145093|NCT01288989|559963273|FG003|Overall Study|Dose limiting toxicity|0|||
155145094|NCT01288989|559963274|FG004|Overall Study|Dose limiting toxicity|0|||
155145095|NCT01288989|559963270|FG000|Overall Study|Adverse Event|0|||
155145096|NCT01288989|559963271|FG001|Overall Study|Adverse Event|0|||
155145097|NCT01288989|559963272|FG002|Overall Study|Adverse Event|0|||
155145098|NCT01288989|559963273|FG003|Overall Study|Adverse Event|0|||
155145099|NCT01288989|559963274|FG004|Overall Study|Adverse Event|2|||
155145100|NCT01288989|559963270|FG000|Overall Study|Physician Decision|0|||
155145101|NCT01288989|559963271|FG001|Overall Study|Physician Decision|0|||
155145102|NCT01288989|559963272|FG002|Overall Study|Physician Decision|0|||
155145103|NCT01288989|559963273|FG003|Overall Study|Physician Decision|0|||
155145104|NCT01288989|559963274|FG004|Overall Study|Physician Decision|1|||
155145105|NCT01288989|559963270|FG000|Overall Study|Withdrawal by Subject|0|||
155145106|NCT01288989|559963271|FG001|Overall Study|Withdrawal by Subject|0|||
155145107|NCT01288989|559963272|FG002|Overall Study|Withdrawal by Subject|0|||
155145108|NCT01288989|559963273|FG003|Overall Study|Withdrawal by Subject|0|||
155145109|NCT01288989|559963274|FG004|Overall Study|Withdrawal by Subject|3|||
155145110|NCT00165672|559963275|FG000|Overall Study|Adverse Event|0|||
155145111|NCT00165672|559963276|FG001|Overall Study|Adverse Event|1|||
155145112|NCT03635424|559963280|FG000|Overall Study|Adverse Event|1|||
155145113|NCT03635424|559963280|FG000|Overall Study|Death|1|||
155145114|NCT03635424|559963280|FG000|Overall Study|Device not implanted|1|||
155145115|NCT04896593|559963283|FG000|Overall Study|Withdrawal by Subject|2|||
155145116|NCT04896593|559963283|FG000|Overall Study|Lost to Follow-up|1|||
155145117|NCT04896593|559963283|FG000|Overall Study|Did not complete onboarding|2|||
155145118|NCT00992459|559963284|FG000|Overall Study|Withdrawal by Subject|0|||
155145119|NCT00992459|559963285|FG001|Overall Study|Withdrawal by Subject|1|||
155145120|NCT00992459|559963284|FG000|Overall Study|Adverse Event|1|||
155145121|NCT00992459|559963285|FG001|Overall Study|Adverse Event|0|||
155145122|NCT00227721|559965300|FG000|Overall Study|On study, but never treated.|1|||
155145123|NCT00984256|559965315|FG000|Overall Study|Withdrawal by Subject|0|||
155145124|NCT00984256|559965316|FG001|Overall Study|Withdrawal by Subject|1|||
155145125|NCT01131507|559965321|FG000|Overall Study|Adverse Event|1|||
155145126|NCT01131507|559965321|FG000|Overall Study|Lost to Follow-up|1|||
155145127|NCT01131507|559965321|FG000|Overall Study|Withdrawal by Subject|1|||
155145128|NCT01790594|559965322|FG000|Overall Study|Death|1|||
155145129|NCT01790594|559965323|FG001|Overall Study|Death|0|||
155145130|NCT01790594|559965324|FG002|Overall Study|Death|0|||
155145131|NCT01790594|559965322|FG000|Overall Study|Physician Decision|2|||
155145132|NCT01790594|559965323|FG001|Overall Study|Physician Decision|1|||
155145133|NCT01790594|559965324|FG002|Overall Study|Physician Decision|0|||
155145134|NCT01790594|559965322|FG000|Overall Study|Withdrawal by Subject|2|||
155145135|NCT01790594|559965323|FG001|Overall Study|Withdrawal by Subject|0|||
155145136|NCT01790594|559965324|FG002|Overall Study|Withdrawal by Subject|0|||
155145137|NCT01790594|559965322|FG000|Overall Study|Transplant was not done|0|||
155145138|NCT01790594|559965323|FG001|Overall Study|Transplant was not done|0|||
155145139|NCT01790594|559965324|FG002|Overall Study|Transplant was not done|3|||
155145140|NCT01790594|559965322|FG000|Overall Study|Terminated prior to week 76|0|||
155145141|NCT01790594|559965323|FG001|Overall Study|Terminated prior to week 76|2|||
155145142|NCT01790594|559965324|FG002|Overall Study|Terminated prior to week 76|0|||
155145143|NCT02038153|559965325|FG000|Overall Study|Withdrawal by Subject|1|||
155145144|NCT02647281|559965326|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145145|NCT02647281|559965327|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145146|NCT02647281|559965328|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145147|NCT02647281|559965329|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145148|NCT02647281|559965330|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145149|NCT02647281|559965331|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145150|NCT02647281|559965332|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145151|NCT02647281|559965333|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
155145152|NCT02647281|559965334|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
155145153|NCT00527735|559965335|FG000|Overall Study|Disease progression|47|||
155145154|NCT00527735|559965336|FG001|Overall Study|Disease progression|61|||
155145155|NCT00527735|559965337|FG002|Overall Study|Disease progression|53|||
155145156|NCT00527735|559965335|FG000|Overall Study|Death|23|||
155145157|NCT00527735|559965336|FG001|Overall Study|Death|13|||
155145158|NCT00527735|559965337|FG002|Overall Study|Death|15|||
155145159|NCT00527735|559965335|FG000|Overall Study|Completed treatment in treatment phase|14|||
155145160|NCT00527735|559965336|FG001|Overall Study|Completed treatment in treatment phase|13|||
155145161|NCT00527735|559965337|FG002|Overall Study|Completed treatment in treatment phase|18|||
155145162|NCT00527735|559965335|FG000|Overall Study|Adverse Event|10|||
155145163|NCT00527735|559965336|FG001|Overall Study|Adverse Event|6|||
155145164|NCT00527735|559965337|FG002|Overall Study|Adverse Event|7|||
155145165|NCT00527735|559965335|FG000|Overall Study|Not identified|5|||
155145166|NCT00527735|559965336|FG001|Overall Study|Not identified|5|||
155145167|NCT00527735|559965337|FG002|Overall Study|Not identified|5|||
155145168|NCT00527735|559965335|FG000|Overall Study|Withdrawal by Subject|5|||
155145169|NCT00527735|559965336|FG001|Overall Study|Withdrawal by Subject|4|||
155145170|NCT00527735|559965337|FG002|Overall Study|Withdrawal by Subject|3|||
155145171|NCT00527735|559965335|FG000|Overall Study|No longer met study criteria|2|||
155145172|NCT00527735|559965336|FG001|Overall Study|No longer met study criteria|2|||
155145173|NCT00527735|559965337|FG002|Overall Study|No longer met study criteria|1|||
155145174|NCT00527735|559965335|FG000|Overall Study|Lost to Follow-up|0|||
155145175|NCT00527735|559965336|FG001|Overall Study|Lost to Follow-up|0|||
155145176|NCT00527735|559965337|FG002|Overall Study|Lost to Follow-up|3|||
155145177|NCT00527735|559965335|FG000|Overall Study|Poor compliance or noncompliance|0|||
155145178|NCT00527735|559965336|FG001|Overall Study|Poor compliance or noncompliance|1|||
155145179|NCT00527735|559965337|FG002|Overall Study|Poor compliance or noncompliance|1|||
155145180|NCT00527735|559965335|FG000|Overall Study|Completed treatment during maintenance|2|||
155145181|NCT00527735|559965336|FG001|Overall Study|Completed treatment during maintenance|2|||
155145182|NCT00527735|559965337|FG002|Overall Study|Completed treatment during maintenance|1|||
155145183|NCT01855412|559965338|FG000|Overall Study|Death|77|||
155145184|NCT01855412|559965339|FG001|Overall Study|Death|123|||
155145185|NCT01855412|559965340|FG002|Overall Study|Death|30|||
155145186|NCT01855412|559965338|FG000|Overall Study|Lost to Follow-up|28|||
155145187|NCT01855412|559965339|FG001|Overall Study|Lost to Follow-up|46|||
155145188|NCT01855412|559965340|FG002|Overall Study|Lost to Follow-up|15|||
155145189|NCT01855412|559965338|FG000|Overall Study|Withdrawal by Subject|77|||
155145190|NCT01855412|559965339|FG001|Overall Study|Withdrawal by Subject|123|||
155145191|NCT01855412|559965340|FG002|Overall Study|Withdrawal by Subject|24|||
155145192|NCT01855412|559965338|FG000|Overall Study|Physician Decision|25|||
155145193|NCT01855412|559965339|FG001|Overall Study|Physician Decision|31|||
155145194|NCT01855412|559965340|FG002|Overall Study|Physician Decision|3|||
155145195|NCT01855412|559965338|FG000|Overall Study|Site Closure|4|||
155145196|NCT01855412|559965339|FG001|Overall Study|Site Closure|18|||
155145197|NCT01855412|559965340|FG002|Overall Study|Site Closure|1|||
155145198|NCT01855412|559965338|FG000|Overall Study|Reason not Specified|1|||
155145199|NCT01855412|559965339|FG001|Overall Study|Reason not Specified|2|||
155145200|NCT01855412|559965340|FG002|Overall Study|Reason not Specified|3|||
155145201|NCT00404651|559965341|FG000|Overall Study|Serious Adverse Event|0|||
155145202|NCT00404651|559965342|FG001|Overall Study|Serious Adverse Event|0|||
155145203|NCT00404651|559965343|FG002|Overall Study|Serious Adverse Event|2|||
155145204|NCT00404651|559965344|FG003|Overall Study|Serious Adverse Event|0|||
155145205|NCT00404651|559965341|FG000|Overall Study|Protocol Violation|10|||
155145206|NCT00404651|559965342|FG001|Overall Study|Protocol Violation|5|||
155145207|NCT00404651|559965343|FG002|Overall Study|Protocol Violation|14|||
155145208|NCT00404651|559965344|FG003|Overall Study|Protocol Violation|5|||
155145209|NCT00404651|559965341|FG000|Overall Study|Lost to Follow-up|15|||
155145210|NCT00404651|559965342|FG001|Overall Study|Lost to Follow-up|11|||
155145211|NCT00404651|559965343|FG002|Overall Study|Lost to Follow-up|13|||
155145212|NCT00404651|559965344|FG003|Overall Study|Lost to Follow-up|10|||
155145213|NCT00404651|559965341|FG000|Overall Study|Withdrawal by Subject|14|||
155145214|NCT00404651|559965342|FG001|Overall Study|Withdrawal by Subject|12|||
155145215|NCT00404651|559965343|FG002|Overall Study|Withdrawal by Subject|16|||
155145216|NCT00404651|559965344|FG003|Overall Study|Withdrawal by Subject|6|||
155145217|NCT03347123|559965348|FG000|Overall Study|Death|1|||
155145218|NCT03347123|559965349|FG001|Overall Study|Death|2|||
155145219|NCT03347123|559965350|FG002|Overall Study|Death|0|||
155145220|NCT03347123|559965351|FG003|Overall Study|Death|0|||
155145221|NCT03347123|559965352|FG004|Overall Study|Death|0|||
155145222|NCT03347123|559965353|FG005|Overall Study|Death|0|||
155145223|NCT03347123|559965354|FG006|Overall Study|Death|0|||
155145224|NCT03347123|559965348|FG000|Overall Study|Withdrawal by Subject|1|||
155145225|NCT03347123|559965349|FG001|Overall Study|Withdrawal by Subject|0|||
155145226|NCT03347123|559965350|FG002|Overall Study|Withdrawal by Subject|0|||
155145227|NCT03347123|559965351|FG003|Overall Study|Withdrawal by Subject|0|||
155145228|NCT03347123|559965352|FG004|Overall Study|Withdrawal by Subject|0|||
155145229|NCT03347123|559965353|FG005|Overall Study|Withdrawal by Subject|0|||
155145230|NCT03347123|559965354|FG006|Overall Study|Withdrawal by Subject|0|||
155145231|NCT03347123|559965348|FG000|Overall Study|Reason not Specified|3|||
155145232|NCT03347123|559965349|FG001|Overall Study|Reason not Specified|4|||
155145233|NCT03347123|559965350|FG002|Overall Study|Reason not Specified|0|||
155145234|NCT03347123|559965351|FG003|Overall Study|Reason not Specified|0|||
155145235|NCT03347123|559965352|FG004|Overall Study|Reason not Specified|0|||
155145236|NCT03347123|559965353|FG005|Overall Study|Reason not Specified|0|||
155145237|NCT03347123|559965354|FG006|Overall Study|Reason not Specified|0|||
155145238|NCT03431441|559965362|FG000|Overall Study|Withdrawal by Subject|2|||
155145239|NCT03431441|559965362|FG000|Overall Study|Adverse Event|2|||
155145240|NCT03431441|559965362|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
155145241|NCT01276639|559965363|FG000|Week 0 to 16|Death|1|||
155145242|NCT01276639|559965364|FG001|Week 0 to 16|Death|0|||
155145243|NCT01276639|559965365|FG002|Week 0 to 16|Death|0|||
155145244|NCT01276639|559965366|FG003|Week 0 to 16|Death|0|||
155145245|NCT01276639|559965367|FG004|Week 0 to 16|Death|0|||
155145246|NCT01276639|559965363|FG000|Week 0 to 16|Adverse Event|11|||
155145247|NCT01276639|559965364|FG001|Week 0 to 16|Adverse Event|8|||
155145248|NCT01276639|559965365|FG002|Week 0 to 16|Adverse Event|11|||
155145249|NCT01276639|559965366|FG003|Week 0 to 16|Adverse Event|0|||
155145250|NCT01276639|559965367|FG004|Week 0 to 16|Adverse Event|0|||
155145251|NCT01276639|559965363|FG000|Week 0 to 16|Lack of Efficacy|20|||
155145252|NCT01276639|559965364|FG001|Week 0 to 16|Lack of Efficacy|15|||
155145253|NCT01276639|559965365|FG002|Week 0 to 16|Lack of Efficacy|25|||
155145254|NCT01276639|559965366|FG003|Week 0 to 16|Lack of Efficacy|0|||
155145255|NCT01276639|559965367|FG004|Week 0 to 16|Lack of Efficacy|0|||
155145256|NCT01276639|559965363|FG000|Week 0 to 16|Lost to Follow-up|3|||
155145257|NCT01276639|559965364|FG001|Week 0 to 16|Lost to Follow-up|5|||
155145258|NCT01276639|559965365|FG002|Week 0 to 16|Lost to Follow-up|3|||
155145259|NCT01276639|559965366|FG003|Week 0 to 16|Lost to Follow-up|0|||
155145260|NCT01276639|559965367|FG004|Week 0 to 16|Lost to Follow-up|0|||
155145261|NCT01276639|559965363|FG000|Week 0 to 16|Withdrawal by Subject|8|||
155145262|NCT01276639|559965364|FG001|Week 0 to 16|Withdrawal by Subject|5|||
155145263|NCT01276639|559965365|FG002|Week 0 to 16|Withdrawal by Subject|4|||
155145264|NCT01276639|559965366|FG003|Week 0 to 16|Withdrawal by Subject|0|||
155145265|NCT01276639|559965367|FG004|Week 0 to 16|Withdrawal by Subject|0|||
155145266|NCT01276639|559965363|FG000|Week 0 to 16|Other|7|||
155145267|NCT01276639|559965364|FG001|Week 0 to 16|Other|7|||
155145268|NCT01276639|559965365|FG002|Week 0 to 16|Other|2|||
155145269|NCT01276639|559965366|FG003|Week 0 to 16|Other|0|||
155145270|NCT01276639|559965367|FG004|Week 0 to 16|Other|0|||
155145271|NCT01276639|559965363|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
155145272|NCT01276639|559965364|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
155145273|NCT01276639|559965365|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
155145274|NCT01276639|559965366|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
155145275|NCT01276639|559965367|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
155145276|NCT01276639|559965363|FG000|Week 16 to 52|Death|1|||
155145277|NCT01276639|559965364|FG001|Week 16 to 52|Death|0|||
155145278|NCT01276639|559965365|FG002|Week 16 to 52|Death|0|||
155145279|NCT01276639|559965366|FG003|Week 16 to 52|Death|0|||
155145280|NCT01276639|559965367|FG004|Week 16 to 52|Death|0|||
155145281|NCT01276639|559965363|FG000|Week 16 to 52|Adverse Event|10|||
155145282|NCT01276639|559965364|FG001|Week 16 to 52|Adverse Event|13|||
155145283|NCT01276639|559965365|FG002|Week 16 to 52|Adverse Event|0|||
155145284|NCT01276639|559965366|FG003|Week 16 to 52|Adverse Event|1|||
155145285|NCT01276639|559965367|FG004|Week 16 to 52|Adverse Event|3|||
155145286|NCT01276639|559965363|FG000|Week 16 to 52|Lack of Efficacy|99|||
155145287|NCT01276639|559965364|FG001|Week 16 to 52|Lack of Efficacy|71|||
155145288|NCT01276639|559965365|FG002|Week 16 to 52|Lack of Efficacy|0|||
155145289|NCT01276639|559965366|FG003|Week 16 to 52|Lack of Efficacy|14|||
155145290|NCT01276639|559965367|FG004|Week 16 to 52|Lack of Efficacy|13|||
155145291|NCT01276639|559965363|FG000|Week 16 to 52|Lost to Follow-up|3|||
155145292|NCT01276639|559965364|FG001|Week 16 to 52|Lost to Follow-up|1|||
155145293|NCT01276639|559965365|FG002|Week 16 to 52|Lost to Follow-up|0|||
155145294|NCT01276639|559965366|FG003|Week 16 to 52|Lost to Follow-up|0|||
155145295|NCT01276639|559965367|FG004|Week 16 to 52|Lost to Follow-up|1|||
155145296|NCT01276639|559965363|FG000|Week 16 to 52|Withdrawal by Subject|4|||
155145297|NCT01276639|559965364|FG001|Week 16 to 52|Withdrawal by Subject|4|||
155145298|NCT01276639|559965365|FG002|Week 16 to 52|Withdrawal by Subject|0|||
155145299|NCT01276639|559965366|FG003|Week 16 to 52|Withdrawal by Subject|0|||
155145300|NCT01276639|559965367|FG004|Week 16 to 52|Withdrawal by Subject|1|||
155145301|NCT01276639|559965363|FG000|Week 16 to 52|Other|10|||
155145302|NCT01276639|559965364|FG001|Week 16 to 52|Other|12|||
155145303|NCT01276639|559965365|FG002|Week 16 to 52|Other|0|||
155145304|NCT01276639|559965366|FG003|Week 16 to 52|Other|1|||
155145305|NCT01276639|559965367|FG004|Week 16 to 52|Other|3|||
155145306|NCT01285401|559965369|FG000|Overall Study|Prematurely withdrawn from the study|17|||
155145307|NCT01285401|559965370|FG001|Overall Study|Prematurely withdrawn from the study|29|||
155145308|NCT02107703|559965374|FG000|Overall Study|Withdrawal by Subject|46|||
155145309|NCT02107703|559965375|FG001|Overall Study|Withdrawal by Subject|21|||
155145310|NCT02107703|559965374|FG000|Overall Study|Lost to Follow-up|20|||
155145311|NCT02107703|559965375|FG001|Overall Study|Lost to Follow-up|9|||
155145312|NCT02107703|559965374|FG000|Overall Study|On study treatment/follow up|48|||
155145313|NCT02107703|559965375|FG001|Overall Study|On study treatment/follow up|5|||
155145314|NCT02366312|559965376|FG000|Overall Study|Lost to Follow-up|0|||
155145315|NCT02366312|559965377|FG001|Overall Study|Lost to Follow-up|1|||
155145316|NCT03719131|559965379|FG000|Overall Study|Death|1|||
155145317|NCT03719131|559965380|FG001|Overall Study|Death|2|||
155145318|NCT02420093|559965381|FG000|Overall Study|Withdrawal by Subject|1|||
155145319|NCT02420093|559965382|FG001|Overall Study|Withdrawal by Subject|1|||
155145320|NCT03244917|559965385|FG000|Overall Study|Lost to Follow-up|2|||
155145321|NCT03244917|559965386|FG001|Overall Study|Lost to Follow-up|2|||
155145322|NCT01272232|559965389|FG000|Weeks 0-56|Adverse Event|39|||
155145323|NCT01272232|559965390|FG001|Weeks 0-56|Adverse Event|18|||
155145324|NCT01272232|559965391|FG002|Weeks 0-56|Adverse Event|7|||
155145325|NCT01272232|559965389|FG000|Weeks 0-56|Lack of Efficacy|0|||
155145326|NCT01272232|559965390|FG001|Weeks 0-56|Lack of Efficacy|0|||
155145327|NCT01272232|559965391|FG002|Weeks 0-56|Lack of Efficacy|3|||
155145328|NCT01272232|559965389|FG000|Weeks 0-56|Protocol Violation|12|||
155145329|NCT01272232|559965390|FG001|Weeks 0-56|Protocol Violation|8|||
155145330|NCT01272232|559965391|FG002|Weeks 0-56|Protocol Violation|13|||
155145331|NCT01272232|559965389|FG000|Weeks 0-56|Withdrawal criteria|32|||
155145332|NCT01272232|559965390|FG001|Weeks 0-56|Withdrawal criteria|14|||
155145333|NCT01272232|559965391|FG002|Weeks 0-56|Withdrawal criteria|37|||
155145334|NCT01272232|559965389|FG000|Weeks 0-56|Unclassified|16|||
155145335|NCT01272232|559965390|FG001|Weeks 0-56|Unclassified|7|||
155145336|NCT01272232|559965391|FG002|Weeks 0-56|Unclassified|12|||
155145337|NCT01272232|559965389|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
155145338|NCT01272232|559965390|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
155145339|NCT01272232|559965391|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
155145340|NCT01272232|559965389|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
155145341|NCT01272232|559965390|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
155145342|NCT01272232|559965391|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
155145343|NCT01272232|559965389|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
155145344|NCT01272232|559965390|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
155145345|NCT01272232|559965391|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
155145346|NCT01272232|559965389|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
155145347|NCT01272232|559965390|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
155145348|NCT01272232|559965391|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
155145349|NCT01272232|559965389|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
155145350|NCT01272232|559965390|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
155145351|NCT01272232|559965391|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
155145352|NCT02159066|559965392|FG000|Part I|Adverse Event|7|||
155145353|NCT02159066|559965393|FG001|Part I|Adverse Event|5|||
155145354|NCT02159066|559965394|FG002|Part I|Adverse Event|0|||
155145355|NCT02159066|559965395|FG003|Part I|Adverse Event|0|||
155145356|NCT02159066|559965396|FG004|Part I|Adverse Event|0|||
155145357|NCT02159066|559965397|FG005|Part I|Adverse Event|0|||
155145358|NCT02159066|559965392|FG000|Part I|Death|11|||
155145359|NCT02159066|559965393|FG001|Part I|Death|9|||
155145360|NCT02159066|559965394|FG002|Part I|Death|0|||
155145361|NCT02159066|559965395|FG003|Part I|Death|0|||
155145362|NCT02159066|559965396|FG004|Part I|Death|0|||
155145363|NCT02159066|559965397|FG005|Part I|Death|0|||
155145364|NCT02159066|559965392|FG000|Part I|Progressive Disease|37|||
155145365|NCT02159066|559965393|FG001|Part I|Progressive Disease|46|||
155145366|NCT02159066|559965394|FG002|Part I|Progressive Disease|0|||
155145367|NCT02159066|559965395|FG003|Part I|Progressive Disease|0|||
155145368|NCT02159066|559965396|FG004|Part I|Progressive Disease|0|||
155145369|NCT02159066|559965397|FG005|Part I|Progressive Disease|0|||
155145370|NCT02159066|559965392|FG000|Part I|New Therapy for Study Indication|5|||
155145371|NCT02159066|559965393|FG001|Part I|New Therapy for Study Indication|4|||
155145372|NCT02159066|559965394|FG002|Part I|New Therapy for Study Indication|0|||
155145373|NCT02159066|559965395|FG003|Part I|New Therapy for Study Indication|0|||
155145374|NCT02159066|559965396|FG004|Part I|New Therapy for Study Indication|0|||
155145375|NCT02159066|559965397|FG005|Part I|New Therapy for Study Indication|0|||
155145376|NCT02159066|559965392|FG000|Part I|Termination of participants from the study|3|||
155145377|NCT02159066|559965393|FG001|Part I|Termination of participants from the study|3|||
155145378|NCT02159066|559965394|FG002|Part I|Termination of participants from the study|0|||
155145379|NCT02159066|559965395|FG003|Part I|Termination of participants from the study|0|||
155145380|NCT02159066|559965396|FG004|Part I|Termination of participants from the study|0|||
155145381|NCT02159066|559965397|FG005|Part I|Termination of participants from the study|0|||
155145382|NCT02159066|559965392|FG000|Part I|Physician Decision|2|||
155145383|NCT02159066|559965393|FG001|Part I|Physician Decision|9|||
155145384|NCT02159066|559965394|FG002|Part I|Physician Decision|0|||
155145385|NCT02159066|559965395|FG003|Part I|Physician Decision|0|||
155145386|NCT02159066|559965396|FG004|Part I|Physician Decision|0|||
155145387|NCT02159066|559965397|FG005|Part I|Physician Decision|0|||
155145388|NCT02159066|559965392|FG000|Part I|Participant/Guardian Decision|9|||
155145389|NCT02159066|559965393|FG001|Part I|Participant/Guardian Decision|3|||
155145390|NCT02159066|559965394|FG002|Part I|Participant/Guardian Decision|0|||
155145391|NCT02159066|559965395|FG003|Part I|Participant/Guardian Decision|0|||
155145392|NCT02159066|559965396|FG004|Part I|Participant/Guardian Decision|0|||
155145393|NCT02159066|559965397|FG005|Part I|Participant/Guardian Decision|0|||
155145394|NCT02159066|559965392|FG000|Part I|Missing Data|1|||
155145395|NCT02159066|559965393|FG001|Part I|Missing Data|0|||
155145396|NCT02159066|559965394|FG002|Part I|Missing Data|0|||
155145397|NCT02159066|559965395|FG003|Part I|Missing Data|0|||
155145398|NCT02159066|559965396|FG004|Part I|Missing Data|0|||
155145399|NCT02159066|559965397|FG005|Part I|Missing Data|0|||
155145400|NCT02159066|559965392|FG000|Part II|Adverse Event|0|||
155145401|NCT02159066|559965393|FG001|Part II|Adverse Event|0|||
155145402|NCT02159066|559965394|FG002|Part II|Adverse Event|1|||
155145403|NCT02159066|559965395|FG003|Part II|Adverse Event|0|||
155145404|NCT02159066|559965396|FG004|Part II|Adverse Event|1|||
155145405|NCT02159066|559965397|FG005|Part II|Adverse Event|1|||
155145406|NCT02159066|559965392|FG000|Part II|Death|0|||
155145407|NCT02159066|559965393|FG001|Part II|Death|0|||
155145408|NCT02159066|559965394|FG002|Part II|Death|1|||
155145409|NCT02159066|559965395|FG003|Part II|Death|0|||
155145410|NCT02159066|559965396|FG004|Part II|Death|2|||
155145411|NCT02159066|559965397|FG005|Part II|Death|1|||
155145412|NCT02159066|559965392|FG000|Part II|Progressive Disease|0|||
155145413|NCT02159066|559965393|FG001|Part II|Progressive Disease|0|||
155145414|NCT02159066|559965394|FG002|Part II|Progressive Disease|35|||
155145415|NCT02159066|559965395|FG003|Part II|Progressive Disease|1|||
155145416|NCT02159066|559965396|FG004|Part II|Progressive Disease|7|||
155145417|NCT02159066|559965397|FG005|Part II|Progressive Disease|4|||
155145418|NCT02159066|559965392|FG000|Part II|New Therapy for Study Indication|0|||
155145419|NCT02159066|559965393|FG001|Part II|New Therapy for Study Indication|0|||
155145420|NCT02159066|559965394|FG002|Part II|New Therapy for Study Indication|0|||
155145421|NCT02159066|559965395|FG003|Part II|New Therapy for Study Indication|0|||
155145422|NCT02159066|559965396|FG004|Part II|New Therapy for Study Indication|1|||
155145423|NCT02159066|559965397|FG005|Part II|New Therapy for Study Indication|0|||
155145424|NCT02159066|559965392|FG000|Part II|Physician Decision|0|||
155145425|NCT02159066|559965393|FG001|Part II|Physician Decision|0|||
155145426|NCT02159066|559965394|FG002|Part II|Physician Decision|1|||
155145427|NCT02159066|559965395|FG003|Part II|Physician Decision|0|||
155145428|NCT02159066|559965396|FG004|Part II|Physician Decision|0|||
155145429|NCT02159066|559965397|FG005|Part II|Physician Decision|0|||
155145430|NCT02159066|559965392|FG000|Part II|Participant/Guardian Decision|0|||
155145431|NCT02159066|559965393|FG001|Part II|Participant/Guardian Decision|0|||
155145432|NCT02159066|559965394|FG002|Part II|Participant/Guardian Decision|0|||
155145433|NCT02159066|559965395|FG003|Part II|Participant/Guardian Decision|0|||
155145434|NCT02159066|559965396|FG004|Part II|Participant/Guardian Decision|2|||
155145435|NCT02159066|559965397|FG005|Part II|Participant/Guardian Decision|0|||
155145436|NCT00255190|559965398|FG000|Overall Study|Adverse Event|17|||
155145437|NCT00255190|559965399|FG001|Overall Study|Adverse Event|36|||
155145438|NCT00255190|559965398|FG000|Overall Study|Protocol Violation|2|||
155145439|NCT00255190|559965399|FG001|Overall Study|Protocol Violation|2|||
155145440|NCT00255190|559965398|FG000|Overall Study|Lost to Follow-up|10|||
155145441|NCT00255190|559965399|FG001|Overall Study|Lost to Follow-up|27|||
155145442|NCT00255190|559965398|FG000|Overall Study|Withdrew Consent|17|||
155145443|NCT00255190|559965399|FG001|Overall Study|Withdrew Consent|48|||
155145444|NCT00255190|559965398|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155145445|NCT00255190|559965399|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
155145446|NCT00255190|559965398|FG000|Overall Study|Erosive esophagitis not healed|0|||
155145447|NCT00255190|559965399|FG001|Overall Study|Erosive esophagitis not healed|20|||
155145448|NCT00255190|559965398|FG000|Overall Study|Various|4|||
155145449|NCT00255190|559965399|FG001|Overall Study|Various|23|||
155145450|NCT04537793|559965404|FG000|Part B (24 Weeks)|Adverse Event|0|||
155145451|NCT04537793|559965405|FG001|Part B (24 Weeks)|Adverse Event|1|||
155145452|NCT00256724|559965410|FG000|Overall Study|Physician Decision|2|||
155145453|NCT00256724|559965411|FG001|Overall Study|Physician Decision|5|||
155145454|NCT00256724|559965410|FG000|Overall Study|Protocol Violation|3|||
155145455|NCT00256724|559965411|FG001|Overall Study|Protocol Violation|3|||
155145456|NCT01217463|559965412|FG000|Overall Study|Adverse Event|8|||
155145457|NCT01217463|559965413|FG001|Overall Study|Adverse Event|5|||
155145458|NCT01217463|559965412|FG000|Overall Study|Physician Decision|0|||
155145459|NCT01217463|559965413|FG001|Overall Study|Physician Decision|1|||
155145460|NCT01217463|559965412|FG000|Overall Study|Withdrawal by Subject|3|||
155145461|NCT01217463|559965413|FG001|Overall Study|Withdrawal by Subject|0|||
155145462|NCT01217463|559965412|FG000|Overall Study|Surgery on the Target Limb|0|||
155145463|NCT01217463|559965413|FG001|Overall Study|Surgery on the Target Limb|1|||
155145464|NCT01217463|559965412|FG000|Overall Study|Patient Non-compliant|1|||
155145465|NCT01217463|559965413|FG001|Overall Study|Patient Non-compliant|0|||
155145466|NCT01217463|559965412|FG000|Overall Study|Other|1|||
155145467|NCT01217463|559965413|FG001|Overall Study|Other|1|||
155145468|NCT00057863|559965422|FG000|Overall Study|Death|1|||
155145469|NCT00057863|559965422|FG000|Overall Study|Withdrawal by Subject|2|||
155145470|NCT01308736|559965426|FG000|Overall Study|Did not attend a single session|6|||
155145471|NCT01308736|559965427|FG001|Overall Study|Did not attend a single session|5|||
155145472|NCT04491136|559965447|FG000|Overall Study|Patient withdraw informed consent|9|||
155145473|NCT04491136|559965447|FG000|Overall Study|Adverse Event|2|||
155145474|NCT04491136|559965447|FG000|Overall Study|Death|3|||
155145475|NCT04491136|559965447|FG000|Overall Study|Lost to Follow-up|3|||
155145476|NCT04491136|559965447|FG000|Overall Study|Physician Decision|45|||
155145477|NCT04491136|559965447|FG000|Overall Study|sponsor terminated the study early|16|||
155145478|NCT04491136|559965447|FG000|Overall Study|Patient/guardian's decision|1|||
155145479|NCT02452424|559965450|FG000|Overall Study|Death|2|||
155145480|NCT02452424|559965451|FG001|Overall Study|Death|2|||
155145481|NCT02452424|559965452|FG002|Overall Study|Death|2|||
155145482|NCT02452424|559965453|FG003|Overall Study|Death|6|||
155145483|NCT02452424|559965454|FG004|Overall Study|Death|2|||
155145484|NCT02452424|559965455|FG005|Overall Study|Death|0|||
155145485|NCT02452424|559965456|FG006|Overall Study|Death|5|||
155145486|NCT02452424|559965457|FG007|Overall Study|Death|1|||
155145487|NCT02452424|559965458|FG008|Overall Study|Death|3|||
155145488|NCT02452424|559965459|FG009|Overall Study|Death|1|||
155145489|NCT02452424|559965460|FG010|Overall Study|Death|0|||
155145490|NCT02452424|559965450|FG000|Overall Study|Lost to Follow-up|0|||
155145491|NCT02452424|559965451|FG001|Overall Study|Lost to Follow-up|1|||
155145492|NCT02452424|559965452|FG002|Overall Study|Lost to Follow-up|1|||
155145493|NCT02452424|559965453|FG003|Overall Study|Lost to Follow-up|0|||
155145494|NCT02452424|559965454|FG004|Overall Study|Lost to Follow-up|0|||
155145495|NCT02452424|559965455|FG005|Overall Study|Lost to Follow-up|0|||
155145496|NCT02452424|559965456|FG006|Overall Study|Lost to Follow-up|0|||
155145497|NCT02452424|559965457|FG007|Overall Study|Lost to Follow-up|0|||
155145498|NCT02452424|559965458|FG008|Overall Study|Lost to Follow-up|0|||
155145499|NCT02452424|559965459|FG009|Overall Study|Lost to Follow-up|0|||
155145500|NCT02452424|559965460|FG010|Overall Study|Lost to Follow-up|0|||
155145501|NCT02452424|559965450|FG000|Overall Study|Withdrawal by Subject|0|||
155145502|NCT02452424|559965451|FG001|Overall Study|Withdrawal by Subject|0|||
155145503|NCT02452424|559965452|FG002|Overall Study|Withdrawal by Subject|3|||
155145504|NCT02452424|559965453|FG003|Overall Study|Withdrawal by Subject|2|||
155145505|NCT02452424|559965454|FG004|Overall Study|Withdrawal by Subject|0|||
155145506|NCT02452424|559965455|FG005|Overall Study|Withdrawal by Subject|0|||
155145507|NCT02452424|559965456|FG006|Overall Study|Withdrawal by Subject|1|||
155145508|NCT02452424|559965457|FG007|Overall Study|Withdrawal by Subject|0|||
155145509|NCT02452424|559965458|FG008|Overall Study|Withdrawal by Subject|1|||
155145510|NCT02452424|559965459|FG009|Overall Study|Withdrawal by Subject|1|||
155145511|NCT02452424|559965460|FG010|Overall Study|Withdrawal by Subject|0|||
155145512|NCT02452424|559965450|FG000|Overall Study|Other|0|||
155145513|NCT02452424|559965451|FG001|Overall Study|Other|0|||
155145514|NCT02452424|559965452|FG002|Overall Study|Other|1|||
155145515|NCT02452424|559965453|FG003|Overall Study|Other|0|||
155145516|NCT02452424|559965454|FG004|Overall Study|Other|0|||
155145517|NCT02452424|559965455|FG005|Overall Study|Other|1|||
155145518|NCT02452424|559965456|FG006|Overall Study|Other|4|||
155145519|NCT02452424|559965457|FG007|Overall Study|Other|3|||
155145520|NCT02452424|559965458|FG008|Overall Study|Other|0|||
155145521|NCT02452424|559965459|FG009|Overall Study|Other|0|||
155145522|NCT02452424|559965460|FG010|Overall Study|Other|1|||
155145523|NCT02452424|559965450|FG000|Overall Study|Progressive disease (per RECIST)|0|||
155145524|NCT02452424|559965451|FG001|Overall Study|Progressive disease (per RECIST)|0|||
155145525|NCT02452424|559965452|FG002|Overall Study|Progressive disease (per RECIST)|0|||
155145526|NCT02452424|559965453|FG003|Overall Study|Progressive disease (per RECIST)|0|||
155145527|NCT02452424|559965454|FG004|Overall Study|Progressive disease (per RECIST)|0|||
155145528|NCT02452424|559965455|FG005|Overall Study|Progressive disease (per RECIST)|0|||
155145529|NCT02452424|559965456|FG006|Overall Study|Progressive disease (per RECIST)|0|||
155145530|NCT02452424|559965457|FG007|Overall Study|Progressive disease (per RECIST)|0|||
155145531|NCT02452424|559965458|FG008|Overall Study|Progressive disease (per RECIST)|2|||
155145532|NCT02452424|559965459|FG009|Overall Study|Progressive disease (per RECIST)|0|||
155145533|NCT02452424|559965460|FG010|Overall Study|Progressive disease (per RECIST)|0|||
155145534|NCT02452424|559965450|FG000|Overall Study|Adverse Event|0|||
155145535|NCT02452424|559965451|FG001|Overall Study|Adverse Event|0|||
155145536|NCT02452424|559965452|FG002|Overall Study|Adverse Event|0|||
155145537|NCT02452424|559965453|FG003|Overall Study|Adverse Event|0|||
155145538|NCT02452424|559965454|FG004|Overall Study|Adverse Event|0|||
155145539|NCT02452424|559965455|FG005|Overall Study|Adverse Event|0|||
155145540|NCT02452424|559965456|FG006|Overall Study|Adverse Event|0|||
155145541|NCT02452424|559965457|FG007|Overall Study|Adverse Event|0|||
155145542|NCT02452424|559965458|FG008|Overall Study|Adverse Event|0|||
155145543|NCT02452424|559965459|FG009|Overall Study|Adverse Event|0|||
155145544|NCT02452424|559965460|FG010|Overall Study|Adverse Event|1|||
155145545|NCT01059318|559965463|FG000|Core Study (26 Week)|Adverse Event|3|||
155145546|NCT01059318|559965463|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
155145547|NCT01059318|559965463|FG000|Extension (36 Week)|Adverse Event|3|||
155145548|NCT03790917|559965464|FG000|Overall Study|Death|1|||
155145549|NCT00176462|559965468|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
155145550|NCT00176462|559965469|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
155145551|NCT00176462|559965468|FG000|Induction (4 Weeks)|Death|1|||
155145552|NCT00176462|559965469|FG001|Induction (4 Weeks)|Death|2|||
155145553|NCT00176462|559965468|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
155145554|NCT00176462|559965469|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
155145555|NCT00176462|559965468|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
155145556|NCT00176462|559965469|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
155145557|NCT00176462|559965468|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
155145558|NCT00176462|559965469|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
155145559|NCT00176462|559965468|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
155145560|NCT00176462|559965469|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
155145561|NCT00176462|559965468|FG000|Consolidation (12 Weeks)|Not documented|0|||
155145562|NCT00176462|559965469|FG001|Consolidation (12 Weeks)|Not documented|1|||
155145563|NCT00176462|559965468|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
155145564|NCT00176462|559965469|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
155145565|NCT00176462|559965468|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
155145566|NCT00176462|559965469|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
155145567|NCT01150097|559965473|FG000|Months 24 to 36 Post-transplantation|Death|2|||
155145568|NCT01150097|559965474|FG001|Months 24 to 36 Post-transplantation|Death|0|||
155145569|NCT01150097|559965475|FG002|Months 24 to 36 Post-transplantation|Death|0|||
155145570|NCT01150097|559965473|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
155145571|NCT01150097|559965474|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
155145572|NCT01150097|559965475|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
155145573|NCT01150097|559965473|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
155145574|NCT01150097|559965474|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
155145575|NCT01150097|559965475|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
155145576|NCT01150097|559965473|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
155145577|NCT01150097|559965474|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
155145578|NCT01150097|559965475|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
155145579|NCT01150097|559965473|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
155193962|NCT01816074|560149462|FG003|Phase 2|Time commitment Issues|0|||
155193963|NCT01816074|560149459|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
155193964|NCT01816074|560149460|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
155193965|NCT01816074|560149461|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
155193966|NCT01816074|560149462|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
155193967|NCT01816074|560149459|FG000|Phase 2|Physician Decision|0|||
155193968|NCT01816074|560149460|FG001|Phase 2|Physician Decision|0|||
155145580|NCT01150097|559965474|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
155145581|NCT01150097|559965475|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
155145582|NCT01150097|559965473|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
155145583|NCT01150097|559965474|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
155145584|NCT01150097|559965475|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
155145585|NCT01150097|559965473|FG000|Months 24 to 48 Post-transplantation|Death|2|||
155145586|NCT01150097|559965474|FG001|Months 24 to 48 Post-transplantation|Death|0|||
155145587|NCT01150097|559965475|FG002|Months 24 to 48 Post-transplantation|Death|0|||
155145588|NCT01408459|559965476|FG000|Overall Study|Withdrawal by Subject|1|||
155145589|NCT01408459|559965477|FG001|Overall Study|Withdrawal by Subject|1|||
155145590|NCT01301833|559965480|FG000|Overall Study|Adverse Event|7|||
155145591|NCT01301833|559965481|FG001|Overall Study|Adverse Event|5|||
155145592|NCT01301833|559965482|FG002|Overall Study|Adverse Event|5|||
155145593|NCT01301833|559965483|FG003|Overall Study|Adverse Event|5|||
155145594|NCT01301833|559965480|FG000|Overall Study|Lack of Efficacy|1|||
155145595|NCT01301833|559965481|FG001|Overall Study|Lack of Efficacy|1|||
155145596|NCT01301833|559965482|FG002|Overall Study|Lack of Efficacy|0|||
155145597|NCT01301833|559965483|FG003|Overall Study|Lack of Efficacy|0|||
155145598|NCT01301833|559965480|FG000|Overall Study|Physician Decision|3|||
155145599|NCT01301833|559965481|FG001|Overall Study|Physician Decision|1|||
155145600|NCT01301833|559965482|FG002|Overall Study|Physician Decision|1|||
155145601|NCT01301833|559965483|FG003|Overall Study|Physician Decision|0|||
155145602|NCT01301833|559965480|FG000|Overall Study|Withdrawal by Subject|3|||
155145603|NCT01301833|559965481|FG001|Overall Study|Withdrawal by Subject|1|||
155145604|NCT01301833|559965482|FG002|Overall Study|Withdrawal by Subject|1|||
155145605|NCT01301833|559965483|FG003|Overall Study|Withdrawal by Subject|2|||
155145606|NCT01301833|559965480|FG000|Overall Study|Personal matter|1|||
155145607|NCT01301833|559965481|FG001|Overall Study|Personal matter|0|||
155145608|NCT01301833|559965482|FG002|Overall Study|Personal matter|0|||
155145609|NCT01301833|559965483|FG003|Overall Study|Personal matter|0|||
155145610|NCT03985761|559967502|FG000|Overall Study|Withdrawal by Subject|2|||
155145611|NCT03985761|559967503|FG001|Overall Study|Withdrawal by Subject|3|||
155145612|NCT03400852|559967504|FG000|Blinded Treatment Period|Physician Decision|0|||
155145613|NCT03400852|559967505|FG001|Blinded Treatment Period|Physician Decision|1|||
155145614|NCT03400852|559967506|FG002|Blinded Treatment Period|Physician Decision|0|||
155145615|NCT03400852|559967504|FG000|Blinded Treatment Period|Adverse Event|1|||
155145616|NCT03400852|559967505|FG001|Blinded Treatment Period|Adverse Event|1|||
155145617|NCT03400852|559967506|FG002|Blinded Treatment Period|Adverse Event|0|||
155145618|NCT03400852|559967504|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
155145619|NCT03400852|559967505|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
155145620|NCT03400852|559967506|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
155145621|NCT03400852|559967504|FG000|Open Label Period|Physician Decision|0|||
155145622|NCT03400852|559967505|FG001|Open Label Period|Physician Decision|0|||
155145623|NCT03400852|559967506|FG002|Open Label Period|Physician Decision|1|||
155193969|NCT01816074|560149461|FG002|Phase 2|Physician Decision|0|||
155193970|NCT01816074|560149462|FG003|Phase 2|Physician Decision|1|||
155193971|NCT01816074|560149459|FG000|Phase 2|Withdrawal by Subject|1|||
155193972|NCT01816074|560149460|FG001|Phase 2|Withdrawal by Subject|0|||
155145624|NCT03400852|559967504|FG000|Open Label Period|Study terminated by sponsor|0|||
155145625|NCT03400852|559967505|FG001|Open Label Period|Study terminated by sponsor|0|||
155145626|NCT03400852|559967506|FG002|Open Label Period|Study terminated by sponsor|21|||
155145627|NCT03001557|559967508|FG000|Core Phase|Randomized but not treated|0|||
155145628|NCT03001557|559967509|FG001|Core Phase|Randomized but not treated|0|||
155145629|NCT03001557|559967510|FG002|Core Phase|Randomized but not treated|1|||
155145630|NCT03001557|559967511|FG003|Core Phase|Randomized but not treated|0|||
155145631|NCT03001557|559967512|FG004|Core Phase|Randomized but not treated|0|||
155145632|NCT03001557|559967513|FG005|Core Phase|Randomized but not treated|0|||
155145633|NCT03001557|559967514|FG006|Core Phase|Randomized but not treated|0|||
155145634|NCT03001557|559967515|FG007|Core Phase|Randomized but not treated|0|||
155145635|NCT03001557|559967508|FG000|Extension Phase|Adverse Event|0|||
155145636|NCT03001557|559967509|FG001|Extension Phase|Adverse Event|0|||
155145637|NCT03001557|559967510|FG002|Extension Phase|Adverse Event|0|||
155145638|NCT03001557|559967511|FG003|Extension Phase|Adverse Event|0|||
155145639|NCT03001557|559967512|FG004|Extension Phase|Adverse Event|0|||
155145640|NCT03001557|559967513|FG005|Extension Phase|Adverse Event|2|||
155145641|NCT03001557|559967514|FG006|Extension Phase|Adverse Event|0|||
155145642|NCT03001557|559967515|FG007|Extension Phase|Adverse Event|0|||
155145643|NCT03001557|559967508|FG000|Extension Phase|Withdrawal by Subject|0|||
155145644|NCT03001557|559967509|FG001|Extension Phase|Withdrawal by Subject|0|||
155145645|NCT03001557|559967510|FG002|Extension Phase|Withdrawal by Subject|0|||
155145646|NCT03001557|559967511|FG003|Extension Phase|Withdrawal by Subject|0|||
155145647|NCT03001557|559967512|FG004|Extension Phase|Withdrawal by Subject|0|||
155145648|NCT03001557|559967513|FG005|Extension Phase|Withdrawal by Subject|1|||
155145649|NCT03001557|559967514|FG006|Extension Phase|Withdrawal by Subject|5|||
155145650|NCT03001557|559967515|FG007|Extension Phase|Withdrawal by Subject|2|||
155145651|NCT03001557|559967508|FG000|Extension Phase|Lost to Follow-up|0|||
155145652|NCT03001557|559967509|FG001|Extension Phase|Lost to Follow-up|0|||
155145653|NCT03001557|559967510|FG002|Extension Phase|Lost to Follow-up|0|||
155145654|NCT03001557|559967511|FG003|Extension Phase|Lost to Follow-up|0|||
155145655|NCT03001557|559967512|FG004|Extension Phase|Lost to Follow-up|0|||
155145656|NCT03001557|559967513|FG005|Extension Phase|Lost to Follow-up|0|||
155145657|NCT03001557|559967514|FG006|Extension Phase|Lost to Follow-up|2|||
155145658|NCT03001557|559967515|FG007|Extension Phase|Lost to Follow-up|1|||
155145659|NCT03001557|559967508|FG000|Extension Phase|Administrative Reason|0|||
155145660|NCT03001557|559967509|FG001|Extension Phase|Administrative Reason|0|||
155145661|NCT03001557|559967510|FG002|Extension Phase|Administrative Reason|0|||
155145662|NCT03001557|559967511|FG003|Extension Phase|Administrative Reason|0|||
155145663|NCT03001557|559967512|FG004|Extension Phase|Administrative Reason|0|||
155145664|NCT03001557|559967513|FG005|Extension Phase|Administrative Reason|1|||
155145665|NCT03001557|559967514|FG006|Extension Phase|Administrative Reason|3|||
155145666|NCT03001557|559967515|FG007|Extension Phase|Administrative Reason|3|||
155145667|NCT03001557|559967508|FG000|Extension Phase|Loss of caregiver|0|||
155145668|NCT03001557|559967509|FG001|Extension Phase|Loss of caregiver|0|||
155145669|NCT03001557|559967510|FG002|Extension Phase|Loss of caregiver|0|||
155145670|NCT03001557|559967511|FG003|Extension Phase|Loss of caregiver|0|||
155145671|NCT03001557|559967512|FG004|Extension Phase|Loss of caregiver|0|||
155145672|NCT03001557|559967513|FG005|Extension Phase|Loss of caregiver|0|||
155145673|NCT03001557|559967514|FG006|Extension Phase|Loss of caregiver|1|||
155193973|NCT01816074|560149461|FG002|Phase 2|Withdrawal by Subject|0|||
155193974|NCT01816074|560149462|FG003|Phase 2|Withdrawal by Subject|0|||
155193975|NCT03355365|560149463|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
155193976|NCT03355365|560149464|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
155193977|NCT03355365|560149463|FG000|Year 1, First Intervention|Protocol Violation|1|||
155193978|NCT03355365|560149464|FG001|Year 1, First Intervention|Protocol Violation|0|||
155193979|NCT03355365|560149463|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
155193980|NCT03355365|560149464|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
155145674|NCT03001557|559967515|FG007|Extension Phase|Loss of caregiver|0|||
155145675|NCT03001557|559967508|FG000|Extension Phase|Others|0|||
155145676|NCT03001557|559967509|FG001|Extension Phase|Others|0|||
155145677|NCT03001557|559967510|FG002|Extension Phase|Others|0|||
155193981|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
155193982|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
155145678|NCT03001557|559967511|FG003|Extension Phase|Others|0|||
155193983|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
155145679|NCT03001557|559967512|FG004|Extension Phase|Others|0|||
155145680|NCT03001557|559967513|FG005|Extension Phase|Others|1|||
155193984|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
155193985|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|severe COVID|0|||
155145681|NCT03001557|559967514|FG006|Extension Phase|Others|3|||
155145682|NCT03001557|559967515|FG007|Extension Phase|Others|0|||
155145683|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
155145684|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
155145685|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Death|1|||
155145686|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Death|2|||
155145687|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
155145688|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
155145689|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
155145690|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
155145691|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
155145692|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
155145693|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
155145694|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
155145695|NCT01794000|559967516|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
155145696|NCT01794000|559967517|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
155145697|NCT01794000|559967516|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
155145698|NCT01794000|559967517|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
155145699|NCT01135134|559967518|FG000|Overall Study|Adverse Event|1|||
155145700|NCT01135134|559967519|FG001|Overall Study|Adverse Event|1|||
155145701|NCT01135134|559967518|FG000|Overall Study|Did not meet protocol eligibility|1|||
155145702|NCT01135134|559967519|FG001|Overall Study|Did not meet protocol eligibility|0|||
155145703|NCT01156480|559967521|FG000|Overall Study|change in diagnosis|0|||
155145704|NCT01156480|559967522|FG001|Overall Study|change in diagnosis|1|||
155145705|NCT01255423|559967523|FG000|Overall Study|Abnormal Laboratory value|3|||
155145706|NCT01255423|559967524|FG001|Overall Study|Abnormal Laboratory value|2|||
155145707|NCT01255423|559967523|FG000|Overall Study|Use of prohibited medications|0|||
155145708|NCT01255423|559967524|FG001|Overall Study|Use of prohibited medications|1|||
155145709|NCT00988598|559967525|FG000|Overall Study|Withdrawal by Subject|2|||
155145710|NCT00988598|559967526|FG001|Overall Study|Withdrawal by Subject|0|||
155145711|NCT01176058|559967527|FG000|Overall Study|Adverse Event|1|||
155145712|NCT01176058|559967528|FG001|Overall Study|Adverse Event|0|||
155145713|NCT01176058|559967527|FG000|Overall Study|Insufficient clinical response|2|||
155145714|NCT01176058|559967528|FG001|Overall Study|Insufficient clinical response|2|||
155145715|NCT01176058|559967527|FG000|Overall Study|Insufficient mycological response|0|||
155145716|NCT01176058|559967528|FG001|Overall Study|Insufficient mycological response|1|||
155145717|NCT01176058|559967527|FG000|Overall Study|Withdrawal by Subject|1|||
155145718|NCT01176058|559967528|FG001|Overall Study|Withdrawal by Subject|0|||
155145719|NCT01858363|559967529|FG000|Overall Study|Death|35|||
155145720|NCT01858363|559967530|FG001|Overall Study|Death|9|||
155145721|NCT01858363|559967529|FG000|Overall Study|Withdrawal by Subject|28|||
155145722|NCT01858363|559967530|FG001|Overall Study|Withdrawal by Subject|14|||
155145723|NCT01858363|559967529|FG000|Overall Study|Lost to Follow-up|13|||
155145724|NCT01858363|559967530|FG001|Overall Study|Lost to Follow-up|3|||
155145725|NCT00764361|559967539|FG000|Overall Study|Withdrawal by Subject|2|||
155145726|NCT00764361|559967540|FG001|Overall Study|Withdrawal by Subject|3|||
155145727|NCT00764361|559967539|FG000|Overall Study|Adverse Event|0|||
155145728|NCT00764361|559967540|FG001|Overall Study|Adverse Event|1|||
155145729|NCT02090426|559967541|FG000|Overall Study|Lost to Follow-up|12|||
155145730|NCT02090426|559967542|FG001|Overall Study|Lost to Follow-up|6|||
155145731|NCT02079038|559967543|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
155145732|NCT02079038|559967544|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
155145733|NCT02079038|559967543|FG000|Modified Intent to Treat Population|Death|1|||
155145734|NCT02079038|559967544|FG001|Modified Intent to Treat Population|Death|0|||
155145735|NCT02079038|559967543|FG000|Completed 6 Months|Lost to Follow-up|2|||
155145736|NCT02079038|559967544|FG001|Completed 6 Months|Lost to Follow-up|1|||
155145737|NCT01141712|559967545|FG000|Overall Study|Disease progression|3|||
155145738|NCT03480152|559967546|FG000|Phase I|Signed consent. Died before treatment.|1|||
155145739|NCT03480152|559967547|FG001|Phase I|Signed consent. Died before treatment.|0|||
155193986|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|severe COVID|1|||
155193987|NCT03355365|560149463|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
155193988|NCT03355365|560149464|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
155193989|NCT01303861|560149470|FG000|Overall Study|Lost to Follow-up|34|||
155193990|NCT01303861|560149471|FG001|Overall Study|Lost to Follow-up|14|||
155193991|NCT01303861|560149472|FG002|Overall Study|Lost to Follow-up|27|||
155193992|NCT01303861|560149473|FG003|Overall Study|Lost to Follow-up|31|||
155193993|NCT01303861|560149470|FG000|Overall Study|Lack of Efficacy|3|||
155193994|NCT01303861|560149471|FG001|Overall Study|Lack of Efficacy|2|||
155193995|NCT01303861|560149472|FG002|Overall Study|Lack of Efficacy|1|||
155145740|NCT03480152|559967548|FG002|Phase I|Signed consent. Died before treatment.|0|||
155193996|NCT01303861|560149473|FG003|Overall Study|Lack of Efficacy|0|||
155193997|NCT01303861|560149470|FG000|Overall Study|Withdrawal by Subject|16|||
155193998|NCT01303861|560149471|FG001|Overall Study|Withdrawal by Subject|8|||
155193999|NCT01303861|560149472|FG002|Overall Study|Withdrawal by Subject|8|||
155194000|NCT01303861|560149473|FG003|Overall Study|Withdrawal by Subject|23|||
155145741|NCT03634085|559967549|FG000|Overall Study|Adverse Event|1|||
155145742|NCT03634085|559967550|FG001|Overall Study|Adverse Event|0|||
155145743|NCT03634085|559967549|FG000|Overall Study|Withdrawal by Subject|0|||
155194001|NCT01303861|560149470|FG000|Overall Study|Adverse Event|4|||
155194002|NCT01303861|560149471|FG001|Overall Study|Adverse Event|1|||
155194003|NCT01303861|560149472|FG002|Overall Study|Adverse Event|0|||
155145744|NCT03634085|559967550|FG001|Overall Study|Withdrawal by Subject|2|||
155145745|NCT04276233|559967551|FG000|Overall Study|Adverse Event|1|||
155145746|NCT04276233|559967551|FG000|Overall Study|Lost to Follow-up|3|||
155145747|NCT04276233|559967551|FG000|Overall Study|Physician Decision|4|||
155145748|NCT04276233|559967551|FG000|Overall Study|Withdrawal by Subject|2|||
155145749|NCT01946139|559967552|FG000|Overall Study|Withdrawal by Subject|8|||
155145750|NCT01946139|559967552|FG000|Overall Study|ineligible|8|||
155145751|NCT01946139|559967552|FG000|Overall Study|Specimens not available|4|||
155145752|NCT01012258|559967553|FG000|Overall Study|Death|14|||
155145753|NCT01012258|559967553|FG000|Overall Study|Lost to Follow-up|1|||
155145754|NCT01012258|559967553|FG000|Overall Study|Adverse Event|1|||
155145755|NCT01012258|559967553|FG000|Overall Study|Progressive Disease (PD)|18|||
155145756|NCT01012258|559967553|FG000|Overall Study|Symptomatic Deterioration|1|||
155145757|NCT01012258|559967553|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
155145758|NCT01012258|559967553|FG000|Overall Study|Another Tumor Discovered|1|||
155145759|NCT01012258|559967553|FG000|Overall Study|Ongoing|29|||
155145760|NCT01814527|559967556|FG000|Overall Study|RTP greater than 30 days|6|||
155145761|NCT01814527|559967557|FG001|Overall Study|RTP greater than 30 days|1|||
155145762|NCT02366195|559967558|FG000|Overall Study|Protocol-specified criteria|3|||
155145763|NCT02366195|559967558|FG000|Overall Study|Withdrawal by Subject|9|||
155145764|NCT02366195|559967558|FG000|Overall Study|Lost to Follow-up|1|||
155145765|NCT02366195|559967558|FG000|Overall Study|Death|41|||
155145766|NCT00430716|559967560|FG000|Double Blind Phase|Death|1|||
155145767|NCT00430716|559967561|FG001|Double Blind Phase|Death|0|||
155145768|NCT00430716|559967562|FG002|Double Blind Phase|Death|0|||
155145769|NCT00430716|559967560|FG000|Double Blind Phase|No longer willing to participate|2|||
155145770|NCT00430716|559967561|FG001|Double Blind Phase|No longer willing to participate|1|||
155145771|NCT00430716|559967562|FG002|Double Blind Phase|No longer willing to participate|1|||
155145772|NCT00430716|559967560|FG000|Double Blind Phase|Other|0|||
155145773|NCT00430716|559967561|FG001|Double Blind Phase|Other|2|||
155145774|NCT00430716|559967562|FG002|Double Blind Phase|Other|0|||
155145775|NCT00430716|559967560|FG000|Double Blind Phase|Study terminated by sponsor|1|||
155145776|NCT00430716|559967561|FG001|Double Blind Phase|Study terminated by sponsor|1|||
155145777|NCT00430716|559967562|FG002|Double Blind Phase|Study terminated by sponsor|2|||
155145778|NCT00430716|559967560|FG000|Double Blind Phase|Adverse Event|1|||
155145779|NCT00430716|559967561|FG001|Double Blind Phase|Adverse Event|1|||
155145780|NCT00430716|559967562|FG002|Double Blind Phase|Adverse Event|3|||
155145781|NCT00430716|559967560|FG000|Double Blind Phase|Not treated|1|||
155145782|NCT00430716|559967561|FG001|Double Blind Phase|Not treated|0|||
155145783|NCT00430716|559967562|FG002|Double Blind Phase|Not treated|0|||
155145784|NCT00430716|559967560|FG000|Open Label Phase|Lost to Follow-up|1|||
155145785|NCT00430716|559967561|FG001|Open Label Phase|Lost to Follow-up|0|||
155145786|NCT00430716|559967562|FG002|Open Label Phase|Lost to Follow-up|1|||
155145787|NCT00430716|559967560|FG000|Open Label Phase|No longer willing to participate|0|||
155145788|NCT00430716|559967561|FG001|Open Label Phase|No longer willing to participate|1|||
155145789|NCT00430716|559967562|FG002|Open Label Phase|No longer willing to participate|1|||
155145790|NCT00430716|559967560|FG000|Open Label Phase|Other|3|||
155145791|NCT00430716|559967561|FG001|Open Label Phase|Other|1|||
155145792|NCT00430716|559967562|FG002|Open Label Phase|Other|1|||
155145793|NCT00430716|559967560|FG000|Open Label Phase|Protocol Violation|1|||
155145794|NCT00430716|559967561|FG001|Open Label Phase|Protocol Violation|0|||
155145795|NCT00430716|559967562|FG002|Open Label Phase|Protocol Violation|0|||
155145796|NCT00430716|559967560|FG000|Open Label Phase|Study terminated by sponsor|4|||
155145797|NCT00430716|559967561|FG001|Open Label Phase|Study terminated by sponsor|5|||
155145798|NCT00430716|559967562|FG002|Open Label Phase|Study terminated by sponsor|4|||
155145799|NCT01329978|559967565|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
155145800|NCT01329978|559967566|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
155145801|NCT01329978|559967567|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
155145802|NCT01329978|559967568|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
155145803|NCT01329978|559967569|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
155145804|NCT01329978|559967565|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
155145805|NCT01329978|559967566|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
155145806|NCT01329978|559967567|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
155145807|NCT01329978|559967568|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
155145808|NCT01329978|559967569|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
155145809|NCT01329978|559967565|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
155145810|NCT01329978|559967566|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
155145811|NCT01329978|559967567|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
155145812|NCT01329978|559967568|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
155145813|NCT01329978|559967569|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
155145814|NCT01329978|559967565|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155145815|NCT01329978|559967566|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
155145816|NCT01329978|559967567|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155145817|NCT01329978|559967568|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155145818|NCT01329978|559967569|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
155145819|NCT01329978|559967565|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155145820|NCT01329978|559967566|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
155145821|NCT01329978|559967567|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155145822|NCT01329978|559967568|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155145823|NCT01329978|559967569|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
155145824|NCT01329978|559967565|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
155145825|NCT01329978|559967566|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
155145826|NCT01329978|559967567|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
155145827|NCT01329978|559967568|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
155145828|NCT01329978|559967569|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
155145829|NCT01329978|559967565|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155145830|NCT01329978|559967566|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155145831|NCT01329978|559967567|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155145832|NCT01329978|559967568|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
155145833|NCT01329978|559967569|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
155145834|NCT03081884|559967572|FG000|Overall Study|deferred prostate cancer treatment|1|||
155145835|NCT03081884|559967572|FG000|Overall Study|metastasis managed with systemic therapy|3|||
155145836|NCT03948334|559967573|FG000|Overall Study|Adverse Event|1|||
155145837|NCT03948334|559967574|FG001|Overall Study|Adverse Event|4|||
155145838|NCT03948334|559967573|FG000|Overall Study|Lack of Efficacy|2|||
155145839|NCT03948334|559967574|FG001|Overall Study|Lack of Efficacy|0|||
155145840|NCT03948334|559967573|FG000|Overall Study|Lost to Follow-up|1|||
155145841|NCT03948334|559967574|FG001|Overall Study|Lost to Follow-up|0|||
155145842|NCT03948334|559967573|FG000|Overall Study|Physician Decision|1|||
155145843|NCT03948334|559967574|FG001|Overall Study|Physician Decision|0|||
155145844|NCT03948334|559967573|FG000|Overall Study|Pregnancy|0|||
155145845|NCT03948334|559967574|FG001|Overall Study|Pregnancy|1|||
155145846|NCT03948334|559967573|FG000|Overall Study|Protocol Deviation|1|||
155145847|NCT03948334|559967574|FG001|Overall Study|Protocol Deviation|0|||
155145848|NCT03948334|559967573|FG000|Overall Study|Study terminated by Sponsor|50|||
155145849|NCT03948334|559967574|FG001|Overall Study|Study terminated by Sponsor|51|||
155145850|NCT03948334|559967573|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
155145851|NCT03948334|559967574|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
155145852|NCT00154297|559967580|FG000|Overall Study|Death|5|||
155145853|NCT00154297|559967581|FG001|Overall Study|Death|2|||
155145854|NCT00154297|559967580|FG000|Overall Study|Withdrawal by Subject|0|||
155145855|NCT00154297|559967581|FG001|Overall Study|Withdrawal by Subject|5|||
155145856|NCT00154297|559967580|FG000|Overall Study|Lost to Follow-up|3|||
155145857|NCT00154297|559967581|FG001|Overall Study|Lost to Follow-up|0|||
155145858|NCT00650767|559967584|FG000|Overall Study|Adverse Event|0|||
155145859|NCT00650767|559967585|FG001|Overall Study|Adverse Event|3|||
155145860|NCT00650767|559967586|FG002|Overall Study|Adverse Event|10|||
155145861|NCT00650767|559967587|FG003|Overall Study|Adverse Event|8|||
155145862|NCT00650767|559967584|FG000|Overall Study|Death|1|||
155145863|NCT00650767|559967585|FG001|Overall Study|Death|0|||
155145864|NCT00650767|559967586|FG002|Overall Study|Death|0|||
155145865|NCT00650767|559967587|FG003|Overall Study|Death|0|||
155145866|NCT00650767|559967584|FG000|Overall Study|Withdrawal by Subject|2|||
155145867|NCT00650767|559967585|FG001|Overall Study|Withdrawal by Subject|4|||
155145868|NCT00650767|559967586|FG002|Overall Study|Withdrawal by Subject|3|||
155145869|NCT00650767|559967587|FG003|Overall Study|Withdrawal by Subject|3|||
155145870|NCT00650767|559967584|FG000|Overall Study|Lost to Follow-up|1|||
155145871|NCT00650767|559967585|FG001|Overall Study|Lost to Follow-up|1|||
155145872|NCT00650767|559967586|FG002|Overall Study|Lost to Follow-up|1|||
155145873|NCT00650767|559967587|FG003|Overall Study|Lost to Follow-up|0|||
155145874|NCT00650767|559967584|FG000|Overall Study|Other|1|||
155145875|NCT00650767|559967585|FG001|Overall Study|Other|1|||
155194004|NCT01303861|560149473|FG003|Overall Study|Adverse Event|5|||
155145876|NCT00650767|559967586|FG002|Overall Study|Other|0|||
155145877|NCT00650767|559967587|FG003|Overall Study|Other|0|||
155145878|NCT01125800|559967588|FG000|Phase I|Protocol Violation|0|||
155145879|NCT01125800|559967589|FG001|Phase I|Protocol Violation|3|||
155145880|NCT01125800|559967590|FG002|Phase I|Protocol Violation|1|||
155145881|NCT01125800|559967591|FG003|Phase I|Protocol Violation|1|||
155145882|NCT01125800|559967592|FG004|Phase I|Protocol Violation|0|||
155145883|NCT01125800|559967588|FG000|Phase I|Adverse Event|2|||
155145884|NCT01125800|559967589|FG001|Phase I|Adverse Event|2|||
155145885|NCT01125800|559967590|FG002|Phase I|Adverse Event|1|||
155145886|NCT01125800|559967591|FG003|Phase I|Adverse Event|7|||
155145887|NCT01125800|559967592|FG004|Phase I|Adverse Event|0|||
155145888|NCT01125800|559967588|FG000|Phase I|Administrative problems|1|||
155145889|NCT01125800|559967589|FG001|Phase I|Administrative problems|0|||
155145890|NCT01125800|559967590|FG002|Phase I|Administrative problems|0|||
155145891|NCT01125800|559967591|FG003|Phase I|Administrative problems|0|||
155145892|NCT01125800|559967592|FG004|Phase I|Administrative problems|0|||
155145893|NCT01125800|559967588|FG000|Phase I|Withdrawal by Subject|0|||
155145894|NCT01125800|559967589|FG001|Phase I|Withdrawal by Subject|0|||
155145895|NCT01125800|559967590|FG002|Phase I|Withdrawal by Subject|1|||
155145896|NCT01125800|559967591|FG003|Phase I|Withdrawal by Subject|0|||
155145897|NCT01125800|559967592|FG004|Phase I|Withdrawal by Subject|0|||
155145898|NCT01125800|559967588|FG000|Phase I|Disease progression|5|||
155145899|NCT01125800|559967589|FG001|Phase I|Disease progression|4|||
155145900|NCT01125800|559967590|FG002|Phase I|Disease progression|1|||
155145901|NCT01125800|559967591|FG003|Phase I|Disease progression|3|||
155145902|NCT01125800|559967592|FG004|Phase I|Disease progression|0|||
155145903|NCT01125800|559967588|FG000|Phase II|Protocol Violation|0|||
155145904|NCT01125800|559967589|FG001|Phase II|Protocol Violation|0|||
155145905|NCT01125800|559967590|FG002|Phase II|Protocol Violation|0|||
155145906|NCT01125800|559967591|FG003|Phase II|Protocol Violation|0|||
155145907|NCT01125800|559967592|FG004|Phase II|Protocol Violation|1|||
155145908|NCT01125800|559967588|FG000|Phase II|Adverse Event|0|||
155145909|NCT01125800|559967589|FG001|Phase II|Adverse Event|0|||
155145910|NCT01125800|559967590|FG002|Phase II|Adverse Event|0|||
155145911|NCT01125800|559967591|FG003|Phase II|Adverse Event|0|||
155145912|NCT01125800|559967592|FG004|Phase II|Adverse Event|2|||
155145913|NCT01125800|559967588|FG000|Phase II|Disease progression|0|||
155145914|NCT01125800|559967589|FG001|Phase II|Disease progression|0|||
155145915|NCT01125800|559967590|FG002|Phase II|Disease progression|0|||
155145916|NCT01125800|559967591|FG003|Phase II|Disease progression|1|||
155145917|NCT01125800|559967592|FG004|Phase II|Disease progression|8|||
155145918|NCT03775486|559967595|FG000|Initial Therapy Phase|Other reason provided|0|||
155145919|NCT03775486|559967596|FG001|Initial Therapy Phase|Other reason provided|15|||
155145920|NCT03775486|559967595|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
155145921|NCT03775486|559967596|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
155145922|NCT03775486|559967595|FG000|Initial Therapy Phase|Protocol Violation|0|||
155145923|NCT03775486|559967596|FG001|Initial Therapy Phase|Protocol Violation|2|||
155145924|NCT03775486|559967595|FG000|Initial Therapy Phase|Adverse Event|0|||
155145925|NCT03775486|559967596|FG001|Initial Therapy Phase|Adverse Event|34|||
155145926|NCT03775486|559967595|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
155145927|NCT03775486|559967596|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
155145928|NCT03775486|559967595|FG000|Maintenance Phase|Withdrawal by Subject|13|||
155145929|NCT03775486|559967596|FG001|Maintenance Phase|Withdrawal by Subject|12|||
155145930|NCT03775486|559967595|FG000|Maintenance Phase|Death|44|||
155145931|NCT03775486|559967596|FG001|Maintenance Phase|Death|45|||
155145932|NCT05477485|559967597|FG000|Overall Study|Lost to Follow-up|0|||
155145933|NCT05477485|559967598|FG001|Overall Study|Lost to Follow-up|4|||
155145934|NCT05081219|559967599|FG000|Overall Study|Withdrawal by Subject|4|||
155145935|NCT05081219|559967600|FG001|Overall Study|Withdrawal by Subject|0|||
155145936|NCT05081219|559967601|FG002|Overall Study|Withdrawal by Subject|0|||
155145937|NCT05081219|559967602|FG003|Overall Study|Withdrawal by Subject|1|||
155145938|NCT00801216|559967603|FG000|Overall Study|Screening Failure|2|||
155145939|NCT05274958|559967604|FG000|Overall Study|Only completed 1 set of PROMs|22|||
155145940|NCT05274958|559967605|FG001|Overall Study|Only completed 1 set of PROMs|35|||
155145941|NCT05481359|559967606|FG000|Overall Study|Lost to Follow-up|3|||
155145942|NCT05481359|559967606|FG000|Overall Study|Withdrawal by Subject|1|||
155145943|NCT06235905|559967608|FG000|Overall Study|Adverse Event|1|||
155145944|NCT06235905|559967608|FG000|Overall Study|Non-compliant with protocol procedures|1|||
155145945|NCT00866814|559967610|FG000|Overall Study|Lost to Follow-up|12|||
155145946|NCT00866814|559967610|FG000|Overall Study|Adverse Event|2|||
155145947|NCT00866814|559967610|FG000|Overall Study|Physician Decision|1|||
155145948|NCT00866814|559967610|FG000|Overall Study|Death|1|||
155145949|NCT00866814|559967610|FG000|Overall Study|No longer wished to participate|1|||
155145950|NCT00866814|559967610|FG000|Overall Study|Unable to meet follow-up requirements|2|||
155145951|NCT00866814|559967610|FG000|Overall Study|Moved to area without study site|1|||
155145952|NCT00348673|559967611|FG000|Stage 1|Randomized but not Treated|0|||
155145953|NCT00348673|559967612|FG001|Stage 1|Randomized but not Treated|0|||
155145954|NCT00348673|559967613|FG002|Stage 1|Randomized but not Treated|1|||
155145955|NCT00348673|559967614|FG003|Stage 1|Randomized but not Treated|0|||
155145956|NCT00348673|559967615|FG004|Stage 1|Randomized but not Treated|0|||
155145957|NCT00348673|559967616|FG005|Stage 1|Randomized but not Treated|0|||
155145958|NCT00348673|559967617|FG006|Stage 1|Randomized but not Treated|0|||
155145959|NCT00348673|559967618|FG007|Stage 1|Randomized but not Treated|0|||
155145960|NCT00348673|559967619|FG008|Stage 1|Randomized but not Treated|0|||
155145961|NCT00319254|559967621|FG000|Overall Study|Withdrawal by Subject|4|||
155145962|NCT00319254|559967621|FG000|Overall Study|Death|46|||
155145963|NCT00319254|559967621|FG000|Overall Study|Lost to Follow-up|2|||
155145964|NCT00319254|559967621|FG000|Overall Study|Enrolled, Not Treated|2|||
155145965|NCT01505374|559967625|FG000|Overall Study|Lost to Follow-up|1|||
155145966|NCT01505374|559967626|FG001|Overall Study|Lost to Follow-up|0|||
155145967|NCT01712204|559967627|FG000|Overall Study|Adverse Event|3|||
155145968|NCT01712204|559967628|FG001|Overall Study|Adverse Event|1|||
155145969|NCT01712204|559967627|FG000|Overall Study|Withdrawal by Subject|3|||
155145970|NCT01712204|559967628|FG001|Overall Study|Withdrawal by Subject|3|||
155145971|NCT01712204|559967627|FG000|Overall Study|Lost to Follow-up|1|||
155145972|NCT01712204|559967628|FG001|Overall Study|Lost to Follow-up|0|||
155145973|NCT01712204|559967627|FG000|Overall Study|Protocol Violation|1|||
155145974|NCT01712204|559967628|FG001|Overall Study|Protocol Violation|1|||
155145975|NCT02679287|559967632|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
155145976|NCT02679287|559967633|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
155145977|NCT02679287|559967632|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
155145978|NCT02679287|559967633|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
155145979|NCT02679287|559967632|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
155145980|NCT02679287|559967633|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
155145981|NCT02679287|559967632|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
155145982|NCT02679287|559967633|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
155145983|NCT02679287|559967632|FG000|Period 2|Work/Scheduling Conflict|1|||
155145984|NCT02679287|559967633|FG001|Period 2|Work/Scheduling Conflict|0|||
155145985|NCT02679287|559967632|FG000|Period 2|Disliked Mobile System|2|||
155145986|NCT02679287|559967633|FG001|Period 2|Disliked Mobile System|0|||
155145987|NCT02679287|559967632|FG000|Period 3|Work/Scheduling Conflict|0|||
155145988|NCT02679287|559967633|FG001|Period 3|Work/Scheduling Conflict|1|||
155145989|NCT00320515|559967634|FG000|Overall Study|Death|33|||
155145990|NCT00320515|559967634|FG000|Overall Study|Lost to Follow-up|6|||
155145991|NCT00320515|559967634|FG000|Overall Study|Physician Decision|2|||
155145992|NCT00320515|559967634|FG000|Overall Study|Withdrawal by Subject|8|||
155145993|NCT01114828|559967635|FG000|Overall Study|Adverse Event|1|||
155145994|NCT01114828|559967636|FG001|Overall Study|Adverse Event|1|||
155145995|NCT01114828|559967635|FG000|Overall Study|Lack of Efficacy|0|||
155145996|NCT01114828|559967636|FG001|Overall Study|Lack of Efficacy|2|||
155145997|NCT01114828|559967635|FG000|Overall Study|Protocol Violation|2|||
155145998|NCT01114828|559967636|FG001|Overall Study|Protocol Violation|0|||
155145999|NCT01114828|559967635|FG000|Overall Study|Withdrawal by Subject|0|||
155146000|NCT01114828|559967636|FG001|Overall Study|Withdrawal by Subject|1|||
155146001|NCT00851786|559967639|FG000|Overall Study|Withdrawal by Subject|0|||
155146002|NCT00851786|559967640|FG001|Overall Study|Withdrawal by Subject|1|||
155146003|NCT00851786|559967639|FG000|Overall Study|Protocol Violation|0|||
155146004|NCT00851786|559967640|FG001|Overall Study|Protocol Violation|1|||
155146005|NCT00851786|559967639|FG000|Overall Study|Lost to Follow-up|1|||
155146006|NCT00851786|559967640|FG001|Overall Study|Lost to Follow-up|0|||
155146007|NCT00851786|559967639|FG000|Overall Study|Incarceration|1|||
155146008|NCT00851786|559967640|FG001|Overall Study|Incarceration|0|||
155146009|NCT00851786|559967639|FG000|Overall Study|Site Closure|1|||
155146010|NCT00851786|559967640|FG001|Overall Study|Site Closure|0|||
155146011|NCT00851786|559967639|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
155146012|NCT00851786|559967640|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
155146013|NCT04177212|559967642|FG000|Overall Study|Withdrawal by Subject|9|||
155146014|NCT04177212|559967643|FG001|Overall Study|Withdrawal by Subject|7|||
155146015|NCT04177212|559967642|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
155146016|NCT04177212|559967643|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
155146017|NCT04177212|559967642|FG000|Overall Study|Physician Decision|1|||
155146018|NCT04177212|559967643|FG001|Overall Study|Physician Decision|0|||
155146019|NCT04177212|559967642|FG000|Overall Study|Lost to Follow-up|0|||
155146020|NCT04177212|559967643|FG001|Overall Study|Lost to Follow-up|3|||
155146021|NCT04177212|559967642|FG000|Overall Study|Adverse Event|0|||
155146022|NCT04177212|559967643|FG001|Overall Study|Adverse Event|1|||
155146023|NCT04177212|559967642|FG000|Overall Study|Other|1|||
155146024|NCT04177212|559967643|FG001|Overall Study|Other|2|||
155146025|NCT01792115|559967644|FG000|Overall Study|Lost to Follow-up|0|||
155146026|NCT01792115|559967645|FG001|Overall Study|Lost to Follow-up|1|||
155146027|NCT01792115|559967646|FG002|Overall Study|Lost to Follow-up|0|||
155146028|NCT01279681|559967647|FG000|Overall Study|Disease Progression|9|||
155146029|NCT01279681|559967648|FG001|Overall Study|Disease Progression|6|||
155146030|NCT01279681|559967647|FG000|Overall Study|Withdrawal by Subject|3|||
155146031|NCT01279681|559967648|FG001|Overall Study|Withdrawal by Subject|4|||
155146032|NCT01279681|559967647|FG000|Overall Study|Adverse Event|2|||
155146033|NCT01279681|559967648|FG001|Overall Study|Adverse Event|3|||
155146034|NCT01279681|559967647|FG000|Overall Study|Death|0|||
155146035|NCT01279681|559967648|FG001|Overall Study|Death|1|||
155146036|NCT01279681|559967647|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
155146037|NCT01279681|559967648|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
155146038|NCT01279681|559967647|FG000|Overall Study|Physician Decision|1|||
155146039|NCT01279681|559967648|FG001|Overall Study|Physician Decision|0|||
155146040|NCT01279681|559967647|FG000|Overall Study|Other Reason|0|||
155146041|NCT01279681|559967648|FG001|Overall Study|Other Reason|2|||
155146042|NCT01943591|559967649|FG000|Overall Study|Lost to Follow-up|3|||
155146043|NCT01943591|559967650|FG001|Overall Study|Lost to Follow-up|4|||
155146044|NCT01943591|559967649|FG000|Overall Study|Death|2|||
155146045|NCT01943591|559967650|FG001|Overall Study|Death|7|||
155146046|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155146047|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
155194005|NCT01303861|560149470|FG000|Overall Study|Pregnancy|1|||
155146048|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155146049|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155146050|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
155146051|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
155146052|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
155146053|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
155146054|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
155146055|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
155146056|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
155146057|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
155146058|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
155146059|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
155146060|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
155146061|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
155146062|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
155146063|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
155146064|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
155146065|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
155146066|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
155146067|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
155146068|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
155146069|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
155146070|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
155146071|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
155146072|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
155146073|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
155146074|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
155146075|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
155146076|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
155146077|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
155146078|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
155194006|NCT01303861|560149471|FG001|Overall Study|Pregnancy|0|||
155194007|NCT01303861|560149472|FG002|Overall Study|Pregnancy|0|||
155194008|NCT01303861|560149473|FG003|Overall Study|Pregnancy|0|||
155194009|NCT00676338|560149476|FG000|Overall Study|Adverse Event|6|||
155194010|NCT00676338|560149477|FG001|Overall Study|Adverse Event|6|||
155194011|NCT00676338|560149478|FG002|Overall Study|Adverse Event|5|||
155194012|NCT00676338|560149479|FG003|Overall Study|Adverse Event|1|||
155194013|NCT00676338|560149476|FG000|Overall Study|Lost to Follow-up|4|||
155194014|NCT00676338|560149477|FG001|Overall Study|Lost to Follow-up|1|||
155194015|NCT00676338|560149478|FG002|Overall Study|Lost to Follow-up|3|||
155146079|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
155146080|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
155146081|NCT02831764|559969808|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155146082|NCT02831764|559969809|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
155146083|NCT02831764|559969810|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155146084|NCT02831764|559969811|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155146085|NCT02831764|559969812|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
155146086|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155146087|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155146088|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
155146089|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
155146090|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
155146091|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155146092|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155146093|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
155146094|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155146095|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
155194016|NCT00676338|560149479|FG003|Overall Study|Lost to Follow-up|4|||
155194017|NCT00676338|560149476|FG000|Overall Study|Physician Decision|3|||
155194018|NCT00676338|560149477|FG001|Overall Study|Physician Decision|3|||
155194019|NCT00676338|560149478|FG002|Overall Study|Physician Decision|2|||
155194020|NCT00676338|560149479|FG003|Overall Study|Physician Decision|3|||
155194021|NCT00676338|560149476|FG000|Overall Study|Protocol Violation|5|||
155194022|NCT00676338|560149477|FG001|Overall Study|Protocol Violation|9|||
155194023|NCT00676338|560149478|FG002|Overall Study|Protocol Violation|2|||
155194024|NCT00676338|560149479|FG003|Overall Study|Protocol Violation|5|||
155194025|NCT00676338|560149476|FG000|Overall Study|Withdrawal by Subject|17|||
155146096|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155146097|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155146098|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
155146099|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
155146100|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
155146101|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155146102|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155146103|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
155146104|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155146105|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
155146106|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155146107|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155146108|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
155146109|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
155146110|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
155146111|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155146112|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155146113|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
155146114|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
155146115|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
155146116|NCT02831764|559969808|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155146117|NCT02831764|559969809|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155146118|NCT02831764|559969810|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
155146119|NCT02831764|559969811|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
155146120|NCT02831764|559969812|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
155146121|NCT02831764|559969808|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155146122|NCT02831764|559969809|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155146123|NCT02831764|559969810|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155146124|NCT02831764|559969811|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
155146125|NCT02831764|559969812|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
155146126|NCT02831764|559969808|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155146127|NCT02831764|559969809|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155146128|NCT02831764|559969810|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155146129|NCT02831764|559969811|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
155146130|NCT02831764|559969812|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
155146131|NCT02831764|559969808|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155146132|NCT02831764|559969809|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155146133|NCT02831764|559969810|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155146134|NCT02831764|559969811|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
155146135|NCT02831764|559969812|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
155146136|NCT02831764|559969808|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155146137|NCT02831764|559969809|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155146138|NCT02831764|559969810|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155146139|NCT02831764|559969811|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
155146140|NCT02831764|559969812|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
155146141|NCT03798717|559969813|FG000|Overall Study|Failed Screening|0|||
155146142|NCT03798717|559969814|FG001|Overall Study|Failed Screening|0|||
155146143|NCT03798717|559969815|FG002|Overall Study|Failed Screening|0|||
155146144|NCT03798717|559969816|FG003|Overall Study|Failed Screening|0|||
155146145|NCT03798717|559969817|FG004|Overall Study|Failed Screening|0|||
155146146|NCT03798717|559969818|FG005|Overall Study|Failed Screening|1|||
155146147|NCT03798717|559969813|FG000|Overall Study|Physician Decision|1|||
155146148|NCT03798717|559969814|FG001|Overall Study|Physician Decision|0|||
155146149|NCT03798717|559969815|FG002|Overall Study|Physician Decision|1|||
155146150|NCT03798717|559969816|FG003|Overall Study|Physician Decision|0|||
155146151|NCT03798717|559969817|FG004|Overall Study|Physician Decision|0|||
155146152|NCT03798717|559969818|FG005|Overall Study|Physician Decision|0|||
155146153|NCT03798717|559969813|FG000|Overall Study|Withdrawal by Subject|0|||
155146154|NCT03798717|559969814|FG001|Overall Study|Withdrawal by Subject|0|||
155194026|NCT00676338|560149477|FG001|Overall Study|Withdrawal by Subject|9|||
155194027|NCT00676338|560149478|FG002|Overall Study|Withdrawal by Subject|12|||
155194028|NCT00676338|560149479|FG003|Overall Study|Withdrawal by Subject|6|||
155194029|NCT00676338|560149476|FG000|Overall Study|Entry Criteria Not Met|0|||
155194030|NCT00676338|560149477|FG001|Overall Study|Entry Criteria Not Met|2|||
155194031|NCT00676338|560149478|FG002|Overall Study|Entry Criteria Not Met|1|||
155194032|NCT00676338|560149479|FG003|Overall Study|Entry Criteria Not Met|1|||
155146155|NCT03798717|559969815|FG002|Overall Study|Withdrawal by Subject|0|||
155146156|NCT03798717|559969816|FG003|Overall Study|Withdrawal by Subject|1|||
155146157|NCT03798717|559969817|FG004|Overall Study|Withdrawal by Subject|0|||
155146158|NCT03798717|559969818|FG005|Overall Study|Withdrawal by Subject|0|||
155146159|NCT03798717|559969813|FG000|Overall Study|Lost to Follow-up|1|||
155146160|NCT03798717|559969814|FG001|Overall Study|Lost to Follow-up|0|||
155146161|NCT03798717|559969815|FG002|Overall Study|Lost to Follow-up|0|||
155146162|NCT03798717|559969816|FG003|Overall Study|Lost to Follow-up|1|||
155146163|NCT03798717|559969817|FG004|Overall Study|Lost to Follow-up|0|||
155146164|NCT03798717|559969818|FG005|Overall Study|Lost to Follow-up|0|||
155146165|NCT03798717|559969813|FG000|Overall Study|Adverse Event|0|||
155146166|NCT03798717|559969814|FG001|Overall Study|Adverse Event|1|||
155146167|NCT03798717|559969815|FG002|Overall Study|Adverse Event|0|||
155146168|NCT03798717|559969816|FG003|Overall Study|Adverse Event|0|||
155146169|NCT03798717|559969817|FG004|Overall Study|Adverse Event|0|||
155146170|NCT03798717|559969818|FG005|Overall Study|Adverse Event|0|||
155146171|NCT03798717|559969813|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155146172|NCT03798717|559969814|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155146173|NCT03798717|559969815|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155146174|NCT03798717|559969816|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155146175|NCT03798717|559969817|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
155146176|NCT03798717|559969818|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
155146177|NCT04388111|559969819|FG000|Overall Study|Lost to Follow-up|5|||
155146178|NCT04388111|559969820|FG001|Overall Study|Lost to Follow-up|3|||
155146179|NCT04388111|559969819|FG000|Overall Study|Adverse Event|1|||
155146180|NCT04388111|559969820|FG001|Overall Study|Adverse Event|1|||
155146181|NCT04388111|559969819|FG000|Overall Study|Protocol Violation|2|||
155146182|NCT04388111|559969820|FG001|Overall Study|Protocol Violation|4|||
155146183|NCT04388111|559969819|FG000|Overall Study|Withdrawal by Subject|1|||
155146184|NCT04388111|559969820|FG001|Overall Study|Withdrawal by Subject|0|||
155146185|NCT00346216|559969823|FG000|Overall Study|Other|181|||
155146186|NCT00346216|559969824|FG001|Overall Study|Other|231|||
155146187|NCT00346216|559969825|FG002|Overall Study|Other|205|||
155146188|NCT00346216|559969823|FG000|Overall Study|No longer willing to participate|600|||
155146189|NCT00346216|559969824|FG001|Overall Study|No longer willing to participate|606|||
155146190|NCT00346216|559969825|FG002|Overall Study|No longer willing to participate|585|||
155146191|NCT00346216|559969823|FG000|Overall Study|Withdrawal by Subject|661|||
155146192|NCT00346216|559969824|FG001|Overall Study|Withdrawal by Subject|692|||
155146193|NCT00346216|559969825|FG002|Overall Study|Withdrawal by Subject|651|||
155146194|NCT00346216|559969823|FG000|Overall Study|Lost to Follow-up|611|||
155146195|NCT00346216|559969824|FG001|Overall Study|Lost to Follow-up|588|||
155146196|NCT00346216|559969825|FG002|Overall Study|Lost to Follow-up|542|||
155194033|NCT00676338|560149476|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
155194034|NCT00676338|560149477|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
155194035|NCT00676338|560149478|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
155194036|NCT00676338|560149479|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
155194037|NCT02122458|560149480|FG000|Overall Study|Withdrawal by Subject|0|||
155194038|NCT02122458|560149481|FG001|Overall Study|Withdrawal by Subject|0|||
155194039|NCT02122458|560149482|FG002|Overall Study|Withdrawal by Subject|0|||
155194040|NCT02122458|560149483|FG003|Overall Study|Withdrawal by Subject|4|||
155194041|NCT02122458|560149484|FG004|Overall Study|Withdrawal by Subject|4|||
155194042|NCT02122458|560149485|FG005|Overall Study|Withdrawal by Subject|4|||
155194043|NCT02122458|560149486|FG006|Overall Study|Withdrawal by Subject|0|||
155194044|NCT02122458|560149480|FG000|Overall Study|Lost to Follow-up|1|||
155194045|NCT02122458|560149481|FG001|Overall Study|Lost to Follow-up|3|||
155194046|NCT02122458|560149482|FG002|Overall Study|Lost to Follow-up|0|||
155194047|NCT02122458|560149483|FG003|Overall Study|Lost to Follow-up|7|||
155146197|NCT00346216|559969823|FG000|Overall Study|Physician Decision|80|||
155146198|NCT00346216|559969824|FG001|Overall Study|Physician Decision|76|||
155194048|NCT02122458|560149484|FG004|Overall Study|Lost to Follow-up|5|||
155194049|NCT02122458|560149485|FG005|Overall Study|Lost to Follow-up|15|||
155146199|NCT00346216|559969825|FG002|Overall Study|Physician Decision|59|||
155146200|NCT00346216|559969823|FG000|Overall Study|Does not meet entrance criteria|13|||
155146201|NCT00346216|559969824|FG001|Overall Study|Does not meet entrance criteria|10|||
155146202|NCT00346216|559969825|FG002|Overall Study|Does not meet entrance criteria|8|||
155194050|NCT02122458|560149486|FG006|Overall Study|Lost to Follow-up|1|||
155146203|NCT00346216|559969823|FG000|Overall Study|Death|189|||
155146204|NCT00346216|559969824|FG001|Overall Study|Death|192|||
155146205|NCT00346216|559969825|FG002|Overall Study|Death|228|||
155194051|NCT02122458|560149480|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
155194052|NCT02122458|560149481|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
155146206|NCT00346216|559969823|FG000|Overall Study|Study terminated by sponsor|11|||
155146207|NCT00346216|559969824|FG001|Overall Study|Study terminated by sponsor|4|||
155146208|NCT00346216|559969825|FG002|Overall Study|Study terminated by sponsor|8|||
155146209|NCT00346216|559969823|FG000|Overall Study|Missing Subject Summary Status|62|||
155194053|NCT02122458|560149482|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194054|NCT02122458|560149483|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194055|NCT02122458|560149484|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194056|NCT02122458|560149485|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194057|NCT02122458|560149486|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
155194058|NCT02122458|560149480|FG000|Overall Study|Adverse Event|1|||
155194059|NCT02122458|560149481|FG001|Overall Study|Adverse Event|0|||
155194060|NCT02122458|560149482|FG002|Overall Study|Adverse Event|0|||
155194061|NCT02122458|560149483|FG003|Overall Study|Adverse Event|0|||
155194062|NCT02122458|560149484|FG004|Overall Study|Adverse Event|0|||
155194063|NCT02122458|560149485|FG005|Overall Study|Adverse Event|0|||
155194064|NCT02122458|560149486|FG006|Overall Study|Adverse Event|0|||
155194065|NCT02122458|560149480|FG000|Overall Study|Experimental Error|0|||
155194066|NCT02122458|560149481|FG001|Overall Study|Experimental Error|0|||
155194067|NCT02122458|560149482|FG002|Overall Study|Experimental Error|0|||
155194068|NCT02122458|560149483|FG003|Overall Study|Experimental Error|0|||
155194069|NCT02122458|560149484|FG004|Overall Study|Experimental Error|3|||
155194070|NCT02122458|560149485|FG005|Overall Study|Experimental Error|0|||
155194071|NCT02122458|560149486|FG006|Overall Study|Experimental Error|0|||
155194072|NCT02122458|560149480|FG000|Overall Study|Deployed or Moved|0|||
155194073|NCT02122458|560149481|FG001|Overall Study|Deployed or Moved|0|||
155194074|NCT02122458|560149482|FG002|Overall Study|Deployed or Moved|0|||
155194075|NCT02122458|560149483|FG003|Overall Study|Deployed or Moved|0|||
155194076|NCT02122458|560149484|FG004|Overall Study|Deployed or Moved|1|||
155194077|NCT02122458|560149485|FG005|Overall Study|Deployed or Moved|0|||
155194078|NCT02122458|560149486|FG006|Overall Study|Deployed or Moved|0|||
155194079|NCT02122458|560149480|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
155194080|NCT02122458|560149481|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
155146210|NCT00346216|559969824|FG001|Overall Study|Missing Subject Summary Status|61|||
155146211|NCT00346216|559969825|FG002|Overall Study|Missing Subject Summary Status|62|||
155146212|NCT03956550|559969831|FG000|Overall Study|Sponsor decision|65|||
155146213|NCT03956550|559969832|FG001|Overall Study|Sponsor decision|66|||
155146214|NCT03956550|559969833|FG002|Overall Study|Sponsor decision|64|||
155146215|NCT03956550|559969831|FG000|Overall Study|Adverse Event|0|||
155146216|NCT03956550|559969832|FG001|Overall Study|Adverse Event|1|||
155146217|NCT03956550|559969833|FG002|Overall Study|Adverse Event|0|||
155146218|NCT03956550|559969831|FG000|Overall Study|Withdrawal by Subject|5|||
155146219|NCT03956550|559969832|FG001|Overall Study|Withdrawal by Subject|5|||
155146220|NCT03956550|559969833|FG002|Overall Study|Withdrawal by Subject|6|||
155146221|NCT04244253|559969837|FG000|Overall Study|Adverse Event|2|||
155146222|NCT04244253|559969838|FG001|Overall Study|Adverse Event|2|||
155146223|NCT04244253|559969839|FG002|Overall Study|Adverse Event|4|||
155146224|NCT04244253|559969837|FG000|Overall Study|Protocol Violation|1|||
155146225|NCT04244253|559969838|FG001|Overall Study|Protocol Violation|2|||
155146226|NCT04244253|559969839|FG002|Overall Study|Protocol Violation|1|||
155146227|NCT04244253|559969837|FG000|Overall Study|Withdrawal by Subject|0|||
155146228|NCT04244253|559969838|FG001|Overall Study|Withdrawal by Subject|1|||
155146229|NCT04244253|559969839|FG002|Overall Study|Withdrawal by Subject|6|||
155146230|NCT04244253|559969837|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155146231|NCT04244253|559969838|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155146232|NCT04244253|559969839|FG002|Overall Study|Non-Compliance With Study Drug|1|||
155146233|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155146234|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155146235|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155146236|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146237|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146238|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146239|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146240|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146241|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146242|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146243|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146244|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146245|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
155194081|NCT02122458|560149482|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
155194082|NCT02122458|560149483|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
155194083|NCT02122458|560149484|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
155194084|NCT02122458|560149485|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
155194085|NCT02122458|560149486|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
155194086|NCT02122458|560149480|FG000|Overall Study|Noncompliance|0|||
155194087|NCT02122458|560149481|FG001|Overall Study|Noncompliance|1|||
155146246|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155194088|NCT02122458|560149482|FG002|Overall Study|Noncompliance|0|||
155194089|NCT02122458|560149483|FG003|Overall Study|Noncompliance|0|||
155146247|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
155146248|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146249|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155146250|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146251|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146252|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
155146253|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155146254|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
155146255|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
155146256|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146257|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155146258|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146259|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146260|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
155146261|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
155146262|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
155146263|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
155146264|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
155146265|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
155146266|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
155146267|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
155146268|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
155146269|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
155146270|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
155146271|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
155146272|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
155146273|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
155146274|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
155146275|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
155146276|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
155146277|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
155146278|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
155146279|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146280|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146281|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
155146282|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146283|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146284|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146285|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146286|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146287|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146288|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
155146289|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146290|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146291|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146292|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
155146293|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146294|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146295|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146296|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146297|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155146298|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155146299|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146300|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155146301|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146302|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155146303|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155194090|NCT02122458|560149484|FG004|Overall Study|Noncompliance|0|||
155146304|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155146305|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146306|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
155146307|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
155146308|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146309|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146310|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146311|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
155146312|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155194091|NCT02122458|560149485|FG005|Overall Study|Noncompliance|0|||
155146313|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146314|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146315|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146316|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146317|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146318|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
155146319|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146320|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146321|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146322|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
155146323|NCT01147666|559969842|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146324|NCT01147666|559969843|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146325|NCT01147666|559969844|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146326|NCT01147666|559969845|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146327|NCT01147666|559969846|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146328|NCT01147666|559969847|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146329|NCT01147666|559969848|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146330|NCT01147666|559969849|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146331|NCT01147666|559969850|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146332|NCT01147666|559969851|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146333|NCT01147666|559969852|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146334|NCT01147666|559969853|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
155146335|NCT01147666|559969854|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
155146336|NCT01147666|559969855|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
155146337|NCT01147666|559969856|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
155146338|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
155146339|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
155146340|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
155146341|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
155146342|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
155146343|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
155146344|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
155146345|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
155146346|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
155146347|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
155146348|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
155146349|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
155146350|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
155146351|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
155146352|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
155146353|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146354|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146355|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146356|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146357|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
155146358|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
155146359|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
155146360|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
155146361|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146362|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
155146363|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146364|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146365|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
155146366|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
155146367|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
155146368|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146369|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146370|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146371|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
155146372|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146373|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146374|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146375|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146376|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146377|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146378|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155194092|NCT02122458|560149486|FG006|Overall Study|Noncompliance|0|||
155146379|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146380|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146381|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146382|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
155146383|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146384|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146385|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146386|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146387|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155146388|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155146389|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146390|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155146391|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146392|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155146393|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146394|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146395|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146396|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
155146397|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
155146398|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146399|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146400|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146401|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
155146402|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146403|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146404|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146405|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146406|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146407|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146408|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
155146409|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146410|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146411|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146412|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
155146413|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146414|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146415|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146416|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146417|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146418|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146419|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146420|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146421|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146422|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146423|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146424|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146425|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
155146426|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146427|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
155146428|NCT01147666|559969842|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146429|NCT01147666|559969843|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146430|NCT01147666|559969844|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146431|NCT01147666|559969845|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146432|NCT01147666|559969846|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146433|NCT01147666|559969847|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146434|NCT01147666|559969848|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146435|NCT01147666|559969849|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146436|NCT01147666|559969850|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146437|NCT01147666|559969851|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146438|NCT01147666|559969852|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146439|NCT01147666|559969853|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155146440|NCT01147666|559969854|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
155146441|NCT01147666|559969855|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
155194093|NCT00412542|560149487|FG000|Overall Study|Withdrawal by Subject|0|||
155194094|NCT00412542|560149488|FG001|Overall Study|Withdrawal by Subject|2|||
155194095|NCT00412542|560149487|FG000|Overall Study|Not Eligible|0|||
155146442|NCT01147666|559969856|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
155146443|NCT00796666|559969857|FG000|Overall Study|Death|2|||
155146444|NCT00796666|559969858|FG001|Overall Study|Death|4|||
155146445|NCT00796666|559969857|FG000|Overall Study|Withdrawal by Subject|2|||
155146446|NCT00796666|559969858|FG001|Overall Study|Withdrawal by Subject|0|||
155146447|NCT00796666|559969857|FG000|Overall Study|Adverse Event|7|||
155146448|NCT00796666|559969858|FG001|Overall Study|Adverse Event|5|||
155146449|NCT00796666|559969857|FG000|Overall Study|Protocol Violation|1|||
155146450|NCT00796666|559969858|FG001|Overall Study|Protocol Violation|0|||
155146451|NCT00796666|559969857|FG000|Overall Study|Other|1|||
155146452|NCT00796666|559969858|FG001|Overall Study|Other|0|||
155146453|NCT00796666|559969857|FG000|Overall Study|Terminated by sponsor|53|||
155146454|NCT00796666|559969858|FG001|Overall Study|Terminated by sponsor|55|||
155146455|NCT00796666|559969857|FG000|Overall Study|Randomized and not treated|1|||
155146456|NCT00796666|559969858|FG001|Overall Study|Randomized and not treated|0|||
155146457|NCT02576639|559969860|FG000|Overall Study|Withdrawal by Subject|1|||
155146458|NCT02576639|559969861|FG001|Overall Study|Withdrawal by Subject|2|||
155146459|NCT02576639|559969862|FG002|Overall Study|Withdrawal by Subject|1|||
155146460|NCT02576639|559969863|FG003|Overall Study|Withdrawal by Subject|0|||
155146461|NCT02576639|559969864|FG004|Overall Study|Withdrawal by Subject|1|||
155146462|NCT02576639|559969860|FG000|Overall Study|Adverse Event|1|||
155146463|NCT02576639|559969861|FG001|Overall Study|Adverse Event|0|||
155146464|NCT02576639|559969862|FG002|Overall Study|Adverse Event|1|||
155146465|NCT02576639|559969863|FG003|Overall Study|Adverse Event|1|||
155146466|NCT02576639|559969864|FG004|Overall Study|Adverse Event|2|||
155146467|NCT02576639|559969860|FG000|Overall Study|Physician Decision|0|||
155146468|NCT02576639|559969861|FG001|Overall Study|Physician Decision|0|||
155146469|NCT02576639|559969862|FG002|Overall Study|Physician Decision|0|||
155146470|NCT02576639|559969863|FG003|Overall Study|Physician Decision|0|||
155146471|NCT02576639|559969864|FG004|Overall Study|Physician Decision|1|||
155146472|NCT00628030|559969865|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
155146473|NCT00628030|559969866|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
155146474|NCT00628030|559969865|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
155146475|NCT00628030|559969866|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
155146476|NCT00628030|559969865|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
155146477|NCT00628030|559969866|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
155146478|NCT05470387|559969867|FG000|Overall Study|Protocol Violation|0|||
155146479|NCT05470387|559969868|FG001|Overall Study|Protocol Violation|3|||
155146480|NCT03367858|559969869|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
155146481|NCT03367858|559969870|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
155146482|NCT03367858|559969869|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
155146483|NCT03367858|559969870|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
155146484|NCT03367858|559969869|FG000|3 Month Follow Up|Lost to Follow-up|8|||
155146485|NCT03367858|559969870|FG001|3 Month Follow Up|Lost to Follow-up|3|||
155146486|NCT03367858|559969869|FG000|3 Month Follow Up|Moved out of study area|2|||
155146487|NCT03367858|559969870|FG001|3 Month Follow Up|Moved out of study area|6|||
155146488|NCT03367858|559969869|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
155146489|NCT03367858|559969870|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
155146490|NCT03367858|559969869|FG000|3 Month Follow Up|MRI contraindication|2|||
155146491|NCT03367858|559969870|FG001|3 Month Follow Up|MRI contraindication|1|||
155146492|NCT03367858|559969869|FG000|3 Month Follow Up|Incarcerated|0|||
155146493|NCT03367858|559969870|FG001|3 Month Follow Up|Incarcerated|1|||
155146494|NCT03367858|559969869|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
155146495|NCT03367858|559969870|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
155146496|NCT03367858|559969869|FG000|6 Month Follow Up|Lost to Follow-up|5|||
155146497|NCT03367858|559969870|FG001|6 Month Follow Up|Lost to Follow-up|2|||
155146498|NCT03367858|559969869|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
155146499|NCT03367858|559969870|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
155146500|NCT03367858|559969869|FG000|12 Month Follow Up|Lost to Follow-up|3|||
155146501|NCT03367858|559969870|FG001|12 Month Follow Up|Lost to Follow-up|3|||
155146502|NCT03367858|559969869|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
155146503|NCT03367858|559969870|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
155146504|NCT00101686|559969882|FG000|Overall Study|Progressive Disease|37|||
155146505|NCT00101686|559969883|FG001|Overall Study|Progressive Disease|28|||
155146506|NCT00101686|559969884|FG002|Overall Study|Progressive Disease|37|||
155146507|NCT00101686|559969885|FG003|Overall Study|Progressive Disease|38|||
155146508|NCT00101686|559969886|FG004|Overall Study|Progressive Disease|28|||
155146509|NCT00101686|559969887|FG005|Overall Study|Progressive Disease|25|||
155146510|NCT00101686|559969888|FG006|Overall Study|Progressive Disease|5|||
155146511|NCT00101686|559969889|FG007|Overall Study|Progressive Disease|7|||
155146512|NCT00101686|559969890|FG008|Overall Study|Progressive Disease|10|||
155146513|NCT00101686|559969891|FG009|Overall Study|Progressive Disease|8|||
155146514|NCT00101686|559969882|FG000|Overall Study|initiation other anti-cancer treatment|4|||
155146515|NCT00101686|559969883|FG001|Overall Study|initiation other anti-cancer treatment|3|||
155146516|NCT00101686|559969884|FG002|Overall Study|initiation other anti-cancer treatment|4|||
155146517|NCT00101686|559969885|FG003|Overall Study|initiation other anti-cancer treatment|3|||
155146518|NCT00101686|559969886|FG004|Overall Study|initiation other anti-cancer treatment|1|||
155146519|NCT00101686|559969887|FG005|Overall Study|initiation other anti-cancer treatment|1|||
155146520|NCT00101686|559969888|FG006|Overall Study|initiation other anti-cancer treatment|2|||
155146521|NCT00101686|559969889|FG007|Overall Study|initiation other anti-cancer treatment|2|||
155146522|NCT00101686|559969890|FG008|Overall Study|initiation other anti-cancer treatment|3|||
155146523|NCT00101686|559969891|FG009|Overall Study|initiation other anti-cancer treatment|3|||
155146524|NCT00101686|559969882|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
155146525|NCT00101686|559969883|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
155146526|NCT00101686|559969884|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
155146527|NCT00101686|559969885|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
155146528|NCT00101686|559969886|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
155146529|NCT00101686|559969887|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
155146530|NCT00101686|559969888|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
155146531|NCT00101686|559969889|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
155146532|NCT00101686|559969890|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
155146533|NCT00101686|559969891|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
155146534|NCT00101686|559969882|FG000|Overall Study|unacceptable toxicity|3|||
155146535|NCT00101686|559969883|FG001|Overall Study|unacceptable toxicity|9|||
155146536|NCT00101686|559969884|FG002|Overall Study|unacceptable toxicity|10|||
155146537|NCT00101686|559969885|FG003|Overall Study|unacceptable toxicity|6|||
155146538|NCT00101686|559969886|FG004|Overall Study|unacceptable toxicity|16|||
155146539|NCT00101686|559969887|FG005|Overall Study|unacceptable toxicity|10|||
155146540|NCT00101686|559969888|FG006|Overall Study|unacceptable toxicity|4|||
155146541|NCT00101686|559969889|FG007|Overall Study|unacceptable toxicity|2|||
155146542|NCT00101686|559969890|FG008|Overall Study|unacceptable toxicity|1|||
155146543|NCT00101686|559969891|FG009|Overall Study|unacceptable toxicity|4|||
155146544|NCT00101686|559969882|FG000|Overall Study|Randomized but did not receive treament|1|||
155146545|NCT00101686|559969883|FG001|Overall Study|Randomized but did not receive treament|6|||
155146546|NCT00101686|559969884|FG002|Overall Study|Randomized but did not receive treament|2|||
155146547|NCT00101686|559969885|FG003|Overall Study|Randomized but did not receive treament|2|||
155146548|NCT00101686|559969886|FG004|Overall Study|Randomized but did not receive treament|2|||
155146549|NCT00101686|559969887|FG005|Overall Study|Randomized but did not receive treament|2|||
155146550|NCT00101686|559969888|FG006|Overall Study|Randomized but did not receive treament|0|||
155146551|NCT00101686|559969889|FG007|Overall Study|Randomized but did not receive treament|1|||
155146552|NCT00101686|559969890|FG008|Overall Study|Randomized but did not receive treament|0|||
155146553|NCT00101686|559969891|FG009|Overall Study|Randomized but did not receive treament|1|||
155146554|NCT00101686|559969882|FG000|Overall Study|intercurrent non-cancer related illness|0|||
155146555|NCT00101686|559969883|FG001|Overall Study|intercurrent non-cancer related illness|0|||
155146556|NCT00101686|559969884|FG002|Overall Study|intercurrent non-cancer related illness|2|||
155146557|NCT00101686|559969885|FG003|Overall Study|intercurrent non-cancer related illness|0|||
155146558|NCT00101686|559969886|FG004|Overall Study|intercurrent non-cancer related illness|1|||
155146559|NCT00101686|559969887|FG005|Overall Study|intercurrent non-cancer related illness|3|||
155146560|NCT00101686|559969888|FG006|Overall Study|intercurrent non-cancer related illness|1|||
155146561|NCT00101686|559969889|FG007|Overall Study|intercurrent non-cancer related illness|0|||
155146562|NCT00101686|559969890|FG008|Overall Study|intercurrent non-cancer related illness|1|||
155146563|NCT00101686|559969891|FG009|Overall Study|intercurrent non-cancer related illness|1|||
155146564|NCT00101686|559969882|FG000|Overall Study|Physician Decision|10|||
155146565|NCT00101686|559969883|FG001|Overall Study|Physician Decision|13|||
155146566|NCT00101686|559969884|FG002|Overall Study|Physician Decision|6|||
155146567|NCT00101686|559969885|FG003|Overall Study|Physician Decision|7|||
155146568|NCT00101686|559969886|FG004|Overall Study|Physician Decision|8|||
155146569|NCT00101686|559969887|FG005|Overall Study|Physician Decision|9|||
155146570|NCT00101686|559969888|FG006|Overall Study|Physician Decision|5|||
155146571|NCT00101686|559969889|FG007|Overall Study|Physician Decision|5|||
155146572|NCT00101686|559969890|FG008|Overall Study|Physician Decision|1|||
155146573|NCT00101686|559969891|FG009|Overall Study|Physician Decision|1|||
155146574|NCT00101686|559969882|FG000|Overall Study|Other|1|||
155146575|NCT00101686|559969883|FG001|Overall Study|Other|4|||
155146576|NCT00101686|559969884|FG002|Overall Study|Other|1|||
155146577|NCT00101686|559969885|FG003|Overall Study|Other|6|||
155146578|NCT00101686|559969886|FG004|Overall Study|Other|2|||
155146579|NCT00101686|559969887|FG005|Overall Study|Other|12|||
155146580|NCT00101686|559969888|FG006|Overall Study|Other|1|||
155146581|NCT00101686|559969889|FG007|Overall Study|Other|5|||
155146582|NCT00101686|559969890|FG008|Overall Study|Other|3|||
155146583|NCT00101686|559969891|FG009|Overall Study|Other|3|||
155146584|NCT00101686|559969882|FG000|Overall Study|Withdrawal by Subject|9|||
155146585|NCT00101686|559969883|FG001|Overall Study|Withdrawal by Subject|8|||
155146586|NCT00101686|559969884|FG002|Overall Study|Withdrawal by Subject|6|||
155146587|NCT00101686|559969885|FG003|Overall Study|Withdrawal by Subject|8|||
155146588|NCT00101686|559969886|FG004|Overall Study|Withdrawal by Subject|8|||
155146589|NCT00101686|559969887|FG005|Overall Study|Withdrawal by Subject|7|||
155146590|NCT00101686|559969888|FG006|Overall Study|Withdrawal by Subject|7|||
155146591|NCT00101686|559969889|FG007|Overall Study|Withdrawal by Subject|7|||
155146592|NCT00101686|559969890|FG008|Overall Study|Withdrawal by Subject|8|||
155146593|NCT00101686|559969891|FG009|Overall Study|Withdrawal by Subject|9|||
155146594|NCT00296816|559969892|FG000|Overall Study|Disease Progression|37|||
155146595|NCT00296816|559969892|FG000|Overall Study|Adverse Event|18|||
155146596|NCT00296816|559969892|FG000|Overall Study|Investigator/Participant request|5|||
155146597|NCT00296816|559969892|FG000|Overall Study|Non-compliance|1|||
155146598|NCT00296816|559969892|FG000|Overall Study|Missing for end of treatment|4|||
155146599|NCT00296816|559969892|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
155146600|NCT00296816|559969892|FG000|Overall Study|Poor performance status|1|||
155146601|NCT00296816|559969892|FG000|Overall Study|Relocation to Florida|1|||
155146602|NCT00296816|559969892|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
155146603|NCT00296816|559969892|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
155146604|NCT00296816|559969892|FG000|Overall Study|Neuropathy/patient preference|1|||
155146605|NCT00296816|559969892|FG000|Overall Study|Proteinuria|1|||
155146606|NCT00296816|559969892|FG000|Overall Study|ineligibility due to radiation treatment|1|||
155146607|NCT00687401|559969893|FG000|Overall Study|Protocol Violation|7|||
155146608|NCT00687401|559969893|FG000|Overall Study|Adverse Event|6|||
155146609|NCT00687401|559969893|FG000|Overall Study|Lack of Efficacy|6|||
155146610|NCT00687401|559969893|FG000|Overall Study|Withdrawal by Subject|4|||
155146611|NCT00687401|559969893|FG000|Overall Study|Did not return for visit|3|||
155146612|NCT00687401|559969893|FG000|Overall Study|For reasons different from those above|4|||
155146613|NCT02520726|559969894|FG000|Overall Study|Lost to Follow-up|3|||
155146614|NCT02520726|559969895|FG001|Overall Study|Lost to Follow-up|2|||
155146615|NCT00721396|559969898|FG000|Overall Study|Adverse Event|4|||
155146616|NCT00721396|559969899|FG001|Overall Study|Adverse Event|7|||
155146617|NCT00721396|559969900|FG002|Overall Study|Adverse Event|2|||
155146618|NCT00721396|559969901|FG003|Overall Study|Adverse Event|0|||
155146619|NCT00721396|559969898|FG000|Overall Study|Withdrawal by Subject|12|||
155146620|NCT00721396|559969899|FG001|Overall Study|Withdrawal by Subject|15|||
155146621|NCT00721396|559969900|FG002|Overall Study|Withdrawal by Subject|3|||
155146622|NCT00721396|559969901|FG003|Overall Study|Withdrawal by Subject|7|||
155146623|NCT00721396|559969898|FG000|Overall Study|Lost to Follow-up|7|||
155146624|NCT00721396|559969899|FG001|Overall Study|Lost to Follow-up|9|||
155146625|NCT00721396|559969900|FG002|Overall Study|Lost to Follow-up|3|||
155146626|NCT00721396|559969901|FG003|Overall Study|Lost to Follow-up|3|||
155146627|NCT00721396|559969898|FG000|Overall Study|Protocol Violation|4|||
155146628|NCT00721396|559969899|FG001|Overall Study|Protocol Violation|3|||
155146629|NCT00721396|559969900|FG002|Overall Study|Protocol Violation|1|||
155146630|NCT00721396|559969901|FG003|Overall Study|Protocol Violation|0|||
155146631|NCT00721396|559969898|FG000|Overall Study|Inappropriate enrollment|0|||
155146632|NCT00721396|559969899|FG001|Overall Study|Inappropriate enrollment|2|||
155146633|NCT00721396|559969900|FG002|Overall Study|Inappropriate enrollment|0|||
155146634|NCT00721396|559969901|FG003|Overall Study|Inappropriate enrollment|0|||
155146635|NCT00721396|559969898|FG000|Overall Study|Administrative reason|3|||
155146636|NCT00721396|559969899|FG001|Overall Study|Administrative reason|0|||
155146637|NCT00721396|559969900|FG002|Overall Study|Administrative reason|1|||
155146638|NCT00721396|559969901|FG003|Overall Study|Administrative reason|0|||
155146639|NCT00148759|559969902|FG000|Overall Study|Withdrawal by Subject|1|||
155146640|NCT00148759|559969903|FG001|Overall Study|Withdrawal by Subject|1|||
155146641|NCT00148759|559969902|FG000|Overall Study|Lost to Follow-up|1|||
155146642|NCT00148759|559969903|FG001|Overall Study|Lost to Follow-up|0|||
155146643|NCT01188772|559969910|FG000|Overall Study|Randomized but Not Treated|0|||
155146644|NCT01188772|559969911|FG001|Overall Study|Randomized but Not Treated|1|||
155146645|NCT01188772|559969912|FG002|Overall Study|Randomized but Not Treated|0|||
155146646|NCT01188772|559969913|FG003|Overall Study|Randomized but Not Treated|0|||
155146647|NCT01188772|559969910|FG000|Overall Study|Adverse Event|0|||
155146648|NCT01188772|559969911|FG001|Overall Study|Adverse Event|1|||
155146649|NCT01188772|559969912|FG002|Overall Study|Adverse Event|2|||
155146650|NCT01188772|559969913|FG003|Overall Study|Adverse Event|0|||
155146651|NCT01188772|559969910|FG000|Overall Study|Lost to Follow-up|4|||
155146652|NCT01188772|559969911|FG001|Overall Study|Lost to Follow-up|1|||
155146653|NCT01188772|559969912|FG002|Overall Study|Lost to Follow-up|1|||
155146654|NCT01188772|559969913|FG003|Overall Study|Lost to Follow-up|1|||
155146655|NCT01188772|559969910|FG000|Overall Study|Non-responder|0|||
155146656|NCT01188772|559969911|FG001|Overall Study|Non-responder|0|||
155146657|NCT01188772|559969912|FG002|Overall Study|Non-responder|3|||
155146658|NCT01188772|559969913|FG003|Overall Study|Non-responder|0|||
155146659|NCT01188772|559969910|FG000|Overall Study|Physician Decision|0|||
155146660|NCT01188772|559969911|FG001|Overall Study|Physician Decision|0|||
155146661|NCT01188772|559969912|FG002|Overall Study|Physician Decision|1|||
155146662|NCT01188772|559969913|FG003|Overall Study|Physician Decision|0|||
155146663|NCT01188772|559969910|FG000|Overall Study|Terminated by Sponsor|0|||
155146664|NCT01188772|559969911|FG001|Overall Study|Terminated by Sponsor|0|||
155146665|NCT01188772|559969912|FG002|Overall Study|Terminated by Sponsor|1|||
155146666|NCT01188772|559969913|FG003|Overall Study|Terminated by Sponsor|0|||
155194096|NCT00412542|560149488|FG001|Overall Study|Not Eligible|1|||
155194097|NCT02833350|560149489|FG000|Overall Study|Adverse Event|0|||
155194098|NCT02833350|560149490|FG001|Overall Study|Adverse Event|3|||
155194099|NCT02833350|560149491|FG002|Overall Study|Adverse Event|4|||
155194100|NCT02833350|560149492|FG003|Overall Study|Adverse Event|4|||
155194101|NCT02833350|560149493|FG004|Overall Study|Adverse Event|1|||
155194102|NCT02833350|560149494|FG005|Overall Study|Adverse Event|0|||
155194103|NCT02833350|560149495|FG006|Overall Study|Adverse Event|1|||
155194104|NCT02833350|560149489|FG000|Overall Study|Death|0|||
155194105|NCT02833350|560149490|FG001|Overall Study|Death|0|||
155194106|NCT02833350|560149491|FG002|Overall Study|Death|1|||
155194107|NCT02833350|560149492|FG003|Overall Study|Death|0|||
155194108|NCT02833350|560149493|FG004|Overall Study|Death|0|||
155194109|NCT02833350|560149494|FG005|Overall Study|Death|0|||
155194110|NCT02833350|560149495|FG006|Overall Study|Death|0|||
155194111|NCT02833350|560149489|FG000|Overall Study|Lack of Efficacy|0|||
155194112|NCT02833350|560149490|FG001|Overall Study|Lack of Efficacy|2|||
155194113|NCT02833350|560149491|FG002|Overall Study|Lack of Efficacy|1|||
155194114|NCT02833350|560149492|FG003|Overall Study|Lack of Efficacy|4|||
155194115|NCT02833350|560149493|FG004|Overall Study|Lack of Efficacy|0|||
155194116|NCT02833350|560149494|FG005|Overall Study|Lack of Efficacy|1|||
155194117|NCT02833350|560149495|FG006|Overall Study|Lack of Efficacy|1|||
155194118|NCT02833350|560149489|FG000|Overall Study|Lost to Follow-up|0|||
155194119|NCT02833350|560149490|FG001|Overall Study|Lost to Follow-up|1|||
155194120|NCT02833350|560149491|FG002|Overall Study|Lost to Follow-up|0|||
155194121|NCT02833350|560149492|FG003|Overall Study|Lost to Follow-up|0|||
155194122|NCT02833350|560149493|FG004|Overall Study|Lost to Follow-up|0|||
155194123|NCT02833350|560149494|FG005|Overall Study|Lost to Follow-up|0|||
155194124|NCT02833350|560149495|FG006|Overall Study|Lost to Follow-up|1|||
155194125|NCT02833350|560149489|FG000|Overall Study|Withdrawal by Subject|3|||
155194126|NCT02833350|560149490|FG001|Overall Study|Withdrawal by Subject|3|||
155194127|NCT02833350|560149491|FG002|Overall Study|Withdrawal by Subject|2|||
155194128|NCT02833350|560149492|FG003|Overall Study|Withdrawal by Subject|0|||
155194129|NCT02833350|560149493|FG004|Overall Study|Withdrawal by Subject|2|||
155194130|NCT02833350|560149494|FG005|Overall Study|Withdrawal by Subject|0|||
155194131|NCT02833350|560149495|FG006|Overall Study|Withdrawal by Subject|2|||
155194132|NCT01500031|560149496|FG000|Overall Study|Death|1|||
155194133|NCT01500031|560149496|FG000|Overall Study|Withdrawal by Subject|4|||
155194134|NCT01856907|560149499|FG000|Overall Study|Pregnancy|0|||
155194135|NCT01856907|560149500|FG001|Overall Study|Pregnancy|1|||
155194136|NCT01856907|560149501|FG002|Overall Study|Pregnancy|0|||
155194137|NCT01856907|560149499|FG000|Overall Study|Pregnancy|0|||
155194138|NCT01856907|560149500|FG001|Overall Study|Pregnancy|1|||
155194139|NCT01856907|560149501|FG002|Overall Study|Pregnancy|0|||
155194140|NCT01856907|560149499|FG000|Overall Study|Withdrawal by Subject|0|||
155194141|NCT01856907|560149500|FG001|Overall Study|Withdrawal by Subject|1|||
155194142|NCT01856907|560149501|FG002|Overall Study|Withdrawal by Subject|0|||
155194143|NCT00075218|560149502|FG000|Double-Blind Treatment|Adverse Event|23|||
155194144|NCT00075218|560149503|FG001|Double-Blind Treatment|Adverse Event|4|||
155194145|NCT00075218|560149504|FG002|Double-Blind Treatment|Adverse Event|0|||
155194146|NCT00075218|560149502|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
155194147|NCT00075218|560149503|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
155194148|NCT00075218|560149504|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
155194149|NCT00075218|560149502|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
155194150|NCT00075218|560149503|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
155194151|NCT00075218|560149504|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
155194152|NCT00075218|560149502|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
155194153|NCT00075218|560149503|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
155194154|NCT00075218|560149504|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
155194155|NCT00075218|560149502|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
155194156|NCT00075218|560149503|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
155194157|NCT00075218|560149504|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
155194158|NCT00075218|560149502|FG000|Double-Blind Treatment|No study medication taken|2|||
155194159|NCT00075218|560149503|FG001|Double-Blind Treatment|No study medication taken|0|||
155194160|NCT00075218|560149504|FG002|Double-Blind Treatment|No study medication taken|0|||
155194161|NCT00075218|560149502|FG000|Open-Label Treatment|Lack of Efficacy|0|||
155194162|NCT00075218|560149503|FG001|Open-Label Treatment|Lack of Efficacy|0|||
155194163|NCT00075218|560149504|FG002|Open-Label Treatment|Lack of Efficacy|174|||
155194164|NCT00075218|560149502|FG000|Open-Label Treatment|Adverse Event|0|||
155194165|NCT00075218|560149503|FG001|Open-Label Treatment|Adverse Event|0|||
155194166|NCT00075218|560149504|FG002|Open-Label Treatment|Adverse Event|51|||
155194167|NCT00075218|560149502|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
155194168|NCT00075218|560149503|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
155194169|NCT00075218|560149504|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
155194170|NCT00075218|560149502|FG000|Open-Label Treatment|Decision of Sponsor|0|||
155194171|NCT00075218|560149503|FG001|Open-Label Treatment|Decision of Sponsor|0|||
155194172|NCT00075218|560149504|FG002|Open-Label Treatment|Decision of Sponsor|8|||
155194173|NCT00075218|560149502|FG000|Open-Label Treatment|Protocol Violation|0|||
155194174|NCT00075218|560149503|FG001|Open-Label Treatment|Protocol Violation|0|||
155194175|NCT00075218|560149504|FG002|Open-Label Treatment|Protocol Violation|1|||
155194176|NCT00075218|560149502|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
155194177|NCT00075218|560149503|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
155194178|NCT00075218|560149504|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
155194179|NCT03643575|560149505|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
155194180|NCT03643575|560149506|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
155194181|NCT03643575|560149507|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
155194182|NCT03643575|560149508|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
155194183|NCT03643575|560149509|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
155194184|NCT03643575|560149510|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
155194185|NCT03643575|560149505|FG000|Washout: 7 Days|Adverse Event|1|||
155194186|NCT03643575|560149506|FG001|Washout: 7 Days|Adverse Event|0|||
155194187|NCT03643575|560149507|FG002|Washout: 7 Days|Adverse Event|0|||
155194188|NCT03643575|560149508|FG003|Washout: 7 Days|Adverse Event|0|||
155194189|NCT03643575|560149509|FG004|Washout: 7 Days|Adverse Event|0|||
155194190|NCT03643575|560149510|FG005|Washout: 7 Days|Adverse Event|0|||
155194191|NCT03643575|560149505|FG000|Washout: 7 Days|Non compliance check in|0|||
155194192|NCT03643575|560149506|FG001|Washout: 7 Days|Non compliance check in|1|||
155194193|NCT03643575|560149507|FG002|Washout: 7 Days|Non compliance check in|0|||
155194194|NCT03643575|560149508|FG003|Washout: 7 Days|Non compliance check in|0|||
155194195|NCT03643575|560149509|FG004|Washout: 7 Days|Non compliance check in|0|||
155194196|NCT03643575|560149510|FG005|Washout: 7 Days|Non compliance check in|0|||
155194197|NCT00850070|560149511|FG000|Overall Study|Lack of Efficacy|1|||
155194198|NCT00850070|560149512|FG001|Overall Study|Lack of Efficacy|1|||
155194199|NCT00850070|560149511|FG000|Overall Study|Adverse Event|2|||
155194200|NCT00850070|560149512|FG001|Overall Study|Adverse Event|0|||
155194201|NCT01522248|560149513|FG000|Overall Study|Lost to Follow-up|1|||
155194202|NCT01522248|560149514|FG001|Overall Study|Lost to Follow-up|0|||
155194203|NCT01332331|560149515|FG000|Overall Study|Lost to Follow-up|0|||
155194204|NCT01332331|560149516|FG001|Overall Study|Lost to Follow-up|1|||
155194205|NCT01332331|560149515|FG000|Overall Study|Adverse Event|1|||
155194206|NCT01332331|560149516|FG001|Overall Study|Adverse Event|1|||
155194207|NCT01332331|560149515|FG000|Overall Study|Physician Decision|1|||
155194208|NCT01332331|560149516|FG001|Overall Study|Physician Decision|0|||
155194209|NCT01696695|560149517|FG000|Overall Study|Disease progression|373|||
155194210|NCT01696695|560149517|FG000|Overall Study|Death|29|||
155194211|NCT01696695|560149517|FG000|Overall Study|Adverse Event|74|||
155194212|NCT01696695|560149517|FG000|Overall Study|Withdrawal by Subject|92|||
155194213|NCT01696695|560149517|FG000|Overall Study|Lost to Follow-up|48|||
155194214|NCT01696695|560149517|FG000|Overall Study|Other|74|||
155194215|NCT01696695|560149517|FG000|Overall Study|Major Protocol Violation|192|||
155194216|NCT04515394|560149526|FG000|Overall Study|Participant did not receive treatment|1|||
155194217|NCT00199875|560149527|FG000|Overall Study|Withdrawal by Subject|0|||
155194218|NCT00199875|560149528|FG001|Overall Study|Withdrawal by Subject|0|||
155194219|NCT00199875|560149529|FG002|Overall Study|Withdrawal by Subject|0|||
155194220|NCT00199875|560149530|FG003|Overall Study|Withdrawal by Subject|0|||
155194221|NCT00199875|560149531|FG004|Overall Study|Withdrawal by Subject|1|||
155194222|NCT03469934|560149533|FG000|Overall Study|Withdrawal by Subject|0|||
155194223|NCT03469934|560149534|FG001|Overall Study|Withdrawal by Subject|1|||
155194224|NCT01013350|560149537|FG000|Overall Study|Lost to Follow-up|15|||
155194225|NCT01013350|560149538|FG001|Overall Study|Lost to Follow-up|95|||
155194226|NCT01013350|560149537|FG000|Overall Study|Adverse Event|0|||
155194227|NCT01013350|560149538|FG001|Overall Study|Adverse Event|1|||
155194228|NCT01013350|560149537|FG000|Overall Study|Physician Decision|4|||
155194229|NCT01013350|560149538|FG001|Overall Study|Physician Decision|20|||
155194230|NCT01013350|560149537|FG000|Overall Study|Withdrawal by Subject|15|||
155194231|NCT01013350|560149538|FG001|Overall Study|Withdrawal by Subject|38|||
155194232|NCT01013350|560149537|FG000|Overall Study|Death|3|||
155194233|NCT01013350|560149538|FG001|Overall Study|Death|5|||
155194234|NCT01013350|560149537|FG000|Overall Study|Participant entered interventional study|0|||
155194235|NCT01013350|560149538|FG001|Overall Study|Participant entered interventional study|8|||
155194236|NCT01013350|560149537|FG000|Overall Study|Other|1|||
155194237|NCT01013350|560149538|FG001|Overall Study|Other|25|||
155194238|NCT02913612|560149545|FG000|Overall Study|Lost to Follow-up|6|||
155194239|NCT02913612|560149546|FG001|Overall Study|Lost to Follow-up|5|||
155194240|NCT02913612|560149547|FG002|Overall Study|Lost to Follow-up|2|||
155194241|NCT02913612|560149548|FG003|Overall Study|Lost to Follow-up|0|||
155194242|NCT02913612|560149545|FG000|Overall Study|Physician Decision|1|||
155194243|NCT02913612|560149546|FG001|Overall Study|Physician Decision|4|||
155194244|NCT02913612|560149547|FG002|Overall Study|Physician Decision|1|||
155194245|NCT02913612|560149548|FG003|Overall Study|Physician Decision|0|||
155194246|NCT02913612|560149545|FG000|Overall Study|Withdrawal by Subject|2|||
155194247|NCT02913612|560149546|FG001|Overall Study|Withdrawal by Subject|4|||
155194248|NCT02913612|560149547|FG002|Overall Study|Withdrawal by Subject|0|||
155194249|NCT02913612|560149548|FG003|Overall Study|Withdrawal by Subject|0|||
155194250|NCT02913612|560149545|FG000|Overall Study|Hemangioma resolved|1|||
155194251|NCT02913612|560149546|FG001|Overall Study|Hemangioma resolved|0|||
155194252|NCT02913612|560149547|FG002|Overall Study|Hemangioma resolved|0|||
155194253|NCT02913612|560149548|FG003|Overall Study|Hemangioma resolved|0|||
155194254|NCT02913612|560149545|FG000|Overall Study|Local IRB decision|1|||
155194255|NCT02913612|560149546|FG001|Overall Study|Local IRB decision|0|||
155194256|NCT02913612|560149547|FG002|Overall Study|Local IRB decision|0|||
155194257|NCT02913612|560149548|FG003|Overall Study|Local IRB decision|0|||
155194258|NCT02913612|560149545|FG000|Overall Study|Study drug non-compliance|1|||
155194259|NCT02913612|560149546|FG001|Overall Study|Study drug non-compliance|1|||
155194260|NCT02913612|560149547|FG002|Overall Study|Study drug non-compliance|0|||
155194261|NCT02913612|560149548|FG003|Overall Study|Study drug non-compliance|0|||
155194262|NCT02913612|560149545|FG000|Overall Study|Insurance issues|0|||
155194263|NCT02913612|560149546|FG001|Overall Study|Insurance issues|1|||
155194264|NCT02913612|560149547|FG002|Overall Study|Insurance issues|0|||
155194265|NCT02913612|560149548|FG003|Overall Study|Insurance issues|0|||
155194266|NCT02913612|560149545|FG000|Overall Study|Needed to treat second hemangioma|0|||
155194267|NCT02913612|560149546|FG001|Overall Study|Needed to treat second hemangioma|1|||
155194268|NCT02913612|560149547|FG002|Overall Study|Needed to treat second hemangioma|0|||
155194269|NCT02913612|560149548|FG003|Overall Study|Needed to treat second hemangioma|0|||
155194270|NCT02913612|560149545|FG000|Overall Study|Study completion criteria not met|0|||
155194271|NCT02913612|560149546|FG001|Overall Study|Study completion criteria not met|1|||
155194272|NCT02913612|560149547|FG002|Overall Study|Study completion criteria not met|0|||
155194273|NCT02913612|560149548|FG003|Overall Study|Study completion criteria not met|0|||
155194274|NCT02913612|560149545|FG000|Overall Study|Ineligible|0|||
155194275|NCT02913612|560149546|FG001|Overall Study|Ineligible|1|||
155194276|NCT02913612|560149547|FG002|Overall Study|Ineligible|0|||
155194277|NCT02913612|560149548|FG003|Overall Study|Ineligible|0|||
155194278|NCT02507973|560149549|FG000|Overall Study|Adverse Event|1|||
155194279|NCT01927627|560149553|FG000|Overall Study|Adverse Event|3|||
155194280|NCT01927627|560149553|FG000|Overall Study|Lack of Efficacy|1|||
155194281|NCT01927627|560149553|FG000|Overall Study|Financial Concerns|1|||
155194282|NCT01710046|560149554|FG000|Overall Study|Lost to Follow-up|1|||
155194283|NCT01710046|560149555|FG001|Overall Study|Lost to Follow-up|0|||
155146667|NCT01188772|559969910|FG000|Overall Study|Treatment Failure|0|||
155146668|NCT01188772|559969911|FG001|Overall Study|Treatment Failure|0|||
155146669|NCT01188772|559969912|FG002|Overall Study|Treatment Failure|1|||
155146670|NCT01188772|559969913|FG003|Overall Study|Treatment Failure|0|||
155146671|NCT01188772|559969910|FG000|Overall Study|Virologic Failure|1|||
155146672|NCT01188772|559969911|FG001|Overall Study|Virologic Failure|0|||
155146673|NCT01188772|559969912|FG002|Overall Study|Virologic Failure|0|||
155146674|NCT01188772|559969913|FG003|Overall Study|Virologic Failure|0|||
155146675|NCT01188772|559969910|FG000|Overall Study|Withdrawal by Subject|0|||
155146676|NCT01188772|559969911|FG001|Overall Study|Withdrawal by Subject|0|||
155146677|NCT01188772|559969912|FG002|Overall Study|Withdrawal by Subject|2|||
155146678|NCT01188772|559969913|FG003|Overall Study|Withdrawal by Subject|0|||
155146679|NCT02294058|559969917|FG000|Overall Study|Adverse Event|16|||
155146680|NCT02294058|559969918|FG001|Overall Study|Adverse Event|7|||
155146681|NCT02294058|559969919|FG002|Overall Study|Adverse Event|13|||
155146682|NCT02294058|559969917|FG000|Overall Study|Lack of Efficacy|3|||
155146683|NCT02294058|559969918|FG001|Overall Study|Lack of Efficacy|3|||
155146684|NCT02294058|559969919|FG002|Overall Study|Lack of Efficacy|0|||
155146685|NCT02294058|559969917|FG000|Overall Study|Lost to Follow-up|1|||
155146686|NCT02294058|559969918|FG001|Overall Study|Lost to Follow-up|0|||
155146687|NCT02294058|559969919|FG002|Overall Study|Lost to Follow-up|2|||
155146688|NCT02294058|559969917|FG000|Overall Study|Withdrawal by Subject|10|||
155146689|NCT02294058|559969918|FG001|Overall Study|Withdrawal by Subject|14|||
155146690|NCT02294058|559969919|FG002|Overall Study|Withdrawal by Subject|13|||
155146691|NCT02294058|559969917|FG000|Overall Study|Physician Decision|2|||
155146692|NCT02294058|559969918|FG001|Overall Study|Physician Decision|1|||
155146693|NCT02294058|559969919|FG002|Overall Study|Physician Decision|0|||
155146694|NCT02294058|559969917|FG000|Overall Study|Miscellaneous|4|||
155146695|NCT02294058|559969918|FG001|Overall Study|Miscellaneous|1|||
155146696|NCT02294058|559969919|FG002|Overall Study|Miscellaneous|1|||
155146697|NCT03957551|559969926|FG000|Overall Study|Adverse Event|2|||
155146698|NCT03957551|559969927|FG001|Overall Study|Adverse Event|2|||
155146699|NCT03957551|559969928|FG002|Overall Study|Adverse Event|6|||
155146700|NCT03957551|559969926|FG000|Overall Study|Physician Decision|1|||
155146701|NCT03957551|559969927|FG001|Overall Study|Physician Decision|0|||
155146702|NCT03957551|559969928|FG002|Overall Study|Physician Decision|2|||
155146703|NCT03957551|559969926|FG000|Overall Study|Withdrawal by Subject|1|||
155146704|NCT03957551|559969927|FG001|Overall Study|Withdrawal by Subject|0|||
155146705|NCT03957551|559969928|FG002|Overall Study|Withdrawal by Subject|2|||
155146706|NCT03957551|559969926|FG000|Overall Study|Disease progression|1|||
155194284|NCT03386474|560149560|FG000|Overall Study|Death|1|||
155194285|NCT03386474|560149561|FG001|Overall Study|Death|0|||
155194286|NCT03386474|560149560|FG000|Overall Study|Adverse Event|0|||
155194287|NCT03386474|560149561|FG001|Overall Study|Adverse Event|1|||
155194288|NCT02711345|560149566|FG000|Overall Study|Adverse Event|0|||
155194289|NCT02711345|560149567|FG001|Overall Study|Adverse Event|0|||
155194290|NCT02711345|560149568|FG002|Overall Study|Adverse Event|0|||
155194291|NCT02711345|560149569|FG003|Overall Study|Adverse Event|1|||
155194292|NCT02711345|560149570|FG004|Overall Study|Adverse Event|1|||
155194293|NCT02711345|560149571|FG005|Overall Study|Adverse Event|2|||
155194294|NCT02711345|560149572|FG006|Overall Study|Adverse Event|1|||
155194295|NCT02711345|560149573|FG007|Overall Study|Adverse Event|0|||
155194296|NCT02711345|560149574|FG008|Overall Study|Adverse Event|0|||
155194297|NCT02711345|560149575|FG009|Overall Study|Adverse Event|2|||
155194298|NCT02711345|560149566|FG000|Overall Study|Physician Decision|0|||
155194299|NCT02711345|560149567|FG001|Overall Study|Physician Decision|0|||
155194300|NCT02711345|560149568|FG002|Overall Study|Physician Decision|1|||
155194301|NCT02711345|560149569|FG003|Overall Study|Physician Decision|0|||
155194302|NCT02711345|560149570|FG004|Overall Study|Physician Decision|0|||
155194303|NCT02711345|560149571|FG005|Overall Study|Physician Decision|0|||
155194304|NCT02711345|560149572|FG006|Overall Study|Physician Decision|0|||
155194305|NCT02711345|560149573|FG007|Overall Study|Physician Decision|0|||
155194306|NCT02711345|560149574|FG008|Overall Study|Physician Decision|1|||
155194307|NCT02711345|560149575|FG009|Overall Study|Physician Decision|0|||
155194308|NCT02711345|560149566|FG000|Overall Study|Progressive disease|1|||
155194309|NCT02711345|560149567|FG001|Overall Study|Progressive disease|3|||
155194310|NCT02711345|560149568|FG002|Overall Study|Progressive disease|5|||
155194311|NCT02711345|560149569|FG003|Overall Study|Progressive disease|3|||
155194312|NCT02711345|560149570|FG004|Overall Study|Progressive disease|7|||
155194313|NCT02711345|560149571|FG005|Overall Study|Progressive disease|2|||
155194314|NCT02711345|560149572|FG006|Overall Study|Progressive disease|8|||
155194315|NCT02711345|560149573|FG007|Overall Study|Progressive disease|4|||
155194316|NCT02711345|560149574|FG008|Overall Study|Progressive disease|5|||
155194317|NCT02711345|560149575|FG009|Overall Study|Progressive disease|6|||
155194318|NCT02711345|560149566|FG000|Overall Study|Subject/guardian decision|0|||
155194319|NCT02711345|560149567|FG001|Overall Study|Subject/guardian decision|0|||
155194320|NCT02711345|560149568|FG002|Overall Study|Subject/guardian decision|0|||
155194321|NCT02711345|560149569|FG003|Overall Study|Subject/guardian decision|0|||
155194322|NCT02711345|560149570|FG004|Overall Study|Subject/guardian decision|0|||
155194323|NCT02711345|560149571|FG005|Overall Study|Subject/guardian decision|2|||
155194324|NCT02711345|560149572|FG006|Overall Study|Subject/guardian decision|3|||
155194325|NCT02711345|560149573|FG007|Overall Study|Subject/guardian decision|1|||
155194326|NCT02711345|560149574|FG008|Overall Study|Subject/guardian decision|0|||
155194327|NCT02711345|560149575|FG009|Overall Study|Subject/guardian decision|4|||
155194328|NCT02711345|560149566|FG000|Overall Study|Death|1|||
155194329|NCT02711345|560149567|FG001|Overall Study|Death|0|||
155194330|NCT02711345|560149568|FG002|Overall Study|Death|0|||
155194331|NCT02711345|560149569|FG003|Overall Study|Death|0|||
155194332|NCT02711345|560149570|FG004|Overall Study|Death|0|||
155194333|NCT02711345|560149571|FG005|Overall Study|Death|0|||
155194334|NCT02711345|560149572|FG006|Overall Study|Death|0|||
155194335|NCT02711345|560149573|FG007|Overall Study|Death|1|||
155194336|NCT02711345|560149574|FG008|Overall Study|Death|0|||
155194337|NCT02711345|560149575|FG009|Overall Study|Death|0|||
155194338|NCT03780543|560149576|FG000|Overall Study|Adverse Event|1|||
155194339|NCT03780543|560149577|FG001|Overall Study|Adverse Event|0|||
155194340|NCT03780543|560149578|FG002|Overall Study|Adverse Event|2|||
155194341|NCT03780543|560149576|FG000|Overall Study|Lost to Follow-up|2|||
155194342|NCT03780543|560149577|FG001|Overall Study|Lost to Follow-up|0|||
155194343|NCT03780543|560149578|FG002|Overall Study|Lost to Follow-up|1|||
155194344|NCT03780543|560149576|FG000|Overall Study|Study terminated by Sponsor|8|||
155194345|NCT03780543|560149577|FG001|Overall Study|Study terminated by Sponsor|7|||
155194346|NCT03780543|560149578|FG002|Overall Study|Study terminated by Sponsor|13|||
155194347|NCT03780543|560149576|FG000|Overall Study|Withdrawal by Subject|1|||
155194348|NCT03780543|560149577|FG001|Overall Study|Withdrawal by Subject|8|||
155194349|NCT03780543|560149578|FG002|Overall Study|Withdrawal by Subject|1|||
155194350|NCT03780543|560149576|FG000|Overall Study|Noncompliance with study drug|1|||
155194351|NCT03780543|560149577|FG001|Overall Study|Noncompliance with study drug|0|||
155194352|NCT03780543|560149578|FG002|Overall Study|Noncompliance with study drug|0|||
155194353|NCT00338104|560149581|FG000|Overall Study|Protocol Violation|2|||
155194354|NCT00338104|560149582|FG001|Overall Study|Protocol Violation|1|||
155194355|NCT00338104|560149583|FG002|Overall Study|Protocol Violation|3|||
155194356|NCT02362269|560149584|FG000|Overall Study|Moved|1|||
155194357|NCT02362269|560149585|FG001|Overall Study|Moved|0|||
155194358|NCT02362269|560149584|FG000|Overall Study|Lost to Follow-up|0|||
155194359|NCT02362269|560149585|FG001|Overall Study|Lost to Follow-up|6|||
155194360|NCT01163266|560149586|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
155194361|NCT01163266|560149587|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
155194362|NCT01163266|560149588|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
155194363|NCT01163266|560149586|FG000|Overall Study|Lack of Efficacy|1|||
155194364|NCT01163266|560149587|FG001|Overall Study|Lack of Efficacy|3|||
155194365|NCT01163266|560149588|FG002|Overall Study|Lack of Efficacy|1|||
155194366|NCT01163266|560149586|FG000|Overall Study|Noncompliance with Study Drug|0|||
155194367|NCT01163266|560149587|FG001|Overall Study|Noncompliance with Study Drug|2|||
155194368|NCT01163266|560149588|FG002|Overall Study|Noncompliance with Study Drug|0|||
155194369|NCT01163266|560149586|FG000|Overall Study|Protocol Deviations|2|||
155194370|NCT01163266|560149587|FG001|Overall Study|Protocol Deviations|2|||
155194371|NCT01163266|560149588|FG002|Overall Study|Protocol Deviations|5|||
155194372|NCT01163266|560149586|FG000|Overall Study|Withdrawal of Consent|5|||
155194373|NCT01163266|560149587|FG001|Overall Study|Withdrawal of Consent|7|||
155194374|NCT01163266|560149588|FG002|Overall Study|Withdrawal of Consent|3|||
155194375|NCT01163266|560149586|FG000|Overall Study|Lost to Follow-up|7|||
155194376|NCT01163266|560149587|FG001|Overall Study|Lost to Follow-up|7|||
155194377|NCT01163266|560149588|FG002|Overall Study|Lost to Follow-up|10|||
155194378|NCT01163266|560149586|FG000|Overall Study|Other|1|||
155194379|NCT01163266|560149587|FG001|Overall Study|Other|1|||
155194380|NCT01163266|560149588|FG002|Overall Study|Other|2|||
155194381|NCT02586064|560149589|FG000|Overall Study|Other Obligations|6|||
155194382|NCT02586064|560149590|FG001|Overall Study|Other Obligations|6|||
155194383|NCT02586064|560149589|FG000|Overall Study|Other|3|||
155194384|NCT02586064|560149590|FG001|Overall Study|Other|7|||
155194385|NCT02586064|560149589|FG000|Overall Study|Never Started|3|||
155194386|NCT02586064|560149590|FG001|Overall Study|Never Started|3|||
155194387|NCT02586064|560149589|FG000|Overall Study|Lost Interest|1|||
155194388|NCT02586064|560149590|FG001|Overall Study|Lost Interest|4|||
155194389|NCT02586064|560149589|FG000|Overall Study|Miscellaneous Life Issues|0|||
155194390|NCT02586064|560149590|FG001|Overall Study|Miscellaneous Life Issues|5|||
155194391|NCT02586064|560149589|FG000|Overall Study|Infrequent Attendance|2|||
155194392|NCT02586064|560149590|FG001|Overall Study|Infrequent Attendance|1|||
155194393|NCT02586064|560149589|FG000|Overall Study|Timed Out|2|||
155194394|NCT02586064|560149590|FG001|Overall Study|Timed Out|0|||
155194395|NCT02586064|560149589|FG000|Overall Study|AUD relapse|0|||
155194396|NCT02586064|560149590|FG001|Overall Study|AUD relapse|2|||
155194397|NCT02586064|560149589|FG000|Overall Study|Legal Issue|1|||
155194398|NCT02586064|560149590|FG001|Overall Study|Legal Issue|0|||
155194399|NCT02919696|560149591|FG000|Overall Study|Adverse Event|1|||
155194400|NCT02919696|560149592|FG001|Overall Study|Adverse Event|2|||
155194401|NCT02919696|560149591|FG000|Overall Study|Withdrawal by Subject|2|||
155194402|NCT02919696|560149592|FG001|Overall Study|Withdrawal by Subject|1|||
155194403|NCT02919696|560149591|FG000|Overall Study|Sponsor Decision|1|||
155194404|NCT02919696|560149592|FG001|Overall Study|Sponsor Decision|1|||
155194405|NCT02919696|560149591|FG000|Overall Study|Never Treated|0|||
155194406|NCT02919696|560149592|FG001|Overall Study|Never Treated|1|||
155194407|NCT00397215|560149593|FG000|Month 0 (Day 0)|Adverse Event|0|||
155194408|NCT00397215|560149594|FG001|Month 0 (Day 0)|Adverse Event|1|||
155194409|NCT00397215|560149595|FG002|Month 0 (Day 0)|Adverse Event|0|||
155194410|NCT00397215|560149596|FG003|Month 0 (Day 0)|Adverse Event|0|||
155194411|NCT00397215|560149593|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
155194412|NCT00397215|560149594|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
155194413|NCT00397215|560149595|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
155194414|NCT00397215|560149596|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
155194415|NCT00397215|560149593|FG000|Month 0 (Day 0)|Other|4|||
155194416|NCT00397215|560149594|FG001|Month 0 (Day 0)|Other|1|||
155194417|NCT00397215|560149595|FG002|Month 0 (Day 0)|Other|3|||
155194418|NCT00397215|560149596|FG003|Month 0 (Day 0)|Other|3|||
155194419|NCT00397215|560149593|FG000|Month 6 (Day 180)|Adverse Event|0|||
155194420|NCT00397215|560149594|FG001|Month 6 (Day 180)|Adverse Event|3|||
155194421|NCT00397215|560149595|FG002|Month 6 (Day 180)|Adverse Event|2|||
155194422|NCT00397215|560149596|FG003|Month 6 (Day 180)|Adverse Event|0|||
155194423|NCT00397215|560149593|FG000|Month 6 (Day 180)|Other|2|||
155194424|NCT00397215|560149594|FG001|Month 6 (Day 180)|Other|0|||
155194425|NCT00397215|560149595|FG002|Month 6 (Day 180)|Other|3|||
155194426|NCT00397215|560149596|FG003|Month 6 (Day 180)|Other|0|||
155194427|NCT00484094|560149597|FG000|Overall Study|Discontinued|39|||
155194428|NCT00484094|560149597|FG000|Overall Study|Other|3|||
155194429|NCT04032652|560149598|FG000|Overall Study|The study was terminated and the PI has|1|||
155194430|NCT04032652|560149599|FG001|Overall Study|The study was terminated and the PI has|1|||
155194431|NCT00761631|560149601|FG000|Overall Study|Parent/legal guardian request|8|||
155194432|NCT00761631|560149602|FG001|Overall Study|Parent/legal guardian request|3|||
155194433|NCT00761631|560149603|FG002|Overall Study|Parent/legal guardian request|8|||
155194434|NCT00761631|560149604|FG003|Overall Study|Parent/legal guardian request|0|||
155194435|NCT00761631|560149605|FG004|Overall Study|Parent/legal guardian request|5|||
155194436|NCT00761631|560149606|FG005|Overall Study|Parent/legal guardian request|0|||
155194437|NCT00761631|560149601|FG000|Overall Study|Lost to Follow-up|2|||
155194438|NCT00761631|560149602|FG001|Overall Study|Lost to Follow-up|4|||
155194439|NCT00761631|560149603|FG002|Overall Study|Lost to Follow-up|7|||
155194440|NCT00761631|560149604|FG003|Overall Study|Lost to Follow-up|1|||
155194441|NCT00761631|560149605|FG004|Overall Study|Lost to Follow-up|6|||
155194442|NCT00761631|560149606|FG005|Overall Study|Lost to Follow-up|1|||
155194443|NCT00761631|560149601|FG000|Overall Study|Protocol Violation|2|||
155194444|NCT00761631|560149602|FG001|Overall Study|Protocol Violation|0|||
155194445|NCT00761631|560149603|FG002|Overall Study|Protocol Violation|0|||
155194446|NCT00761631|560149604|FG003|Overall Study|Protocol Violation|1|||
155194447|NCT00761631|560149605|FG004|Overall Study|Protocol Violation|5|||
155194448|NCT00761631|560149606|FG005|Overall Study|Protocol Violation|1|||
155194449|NCT00761631|560149601|FG000|Overall Study|Randomized, not treated|1|||
155194450|NCT00761631|560149602|FG001|Overall Study|Randomized, not treated|0|||
155194451|NCT00761631|560149603|FG002|Overall Study|Randomized, not treated|0|||
155194452|NCT00761631|560149604|FG003|Overall Study|Randomized, not treated|0|||
155194453|NCT00761631|560149605|FG004|Overall Study|Randomized, not treated|0|||
155194454|NCT00761631|560149606|FG005|Overall Study|Randomized, not treated|0|||
155194455|NCT00761631|560149601|FG000|Overall Study|Failed to return|1|||
155194456|NCT00761631|560149602|FG001|Overall Study|Failed to return|0|||
155194457|NCT00761631|560149603|FG002|Overall Study|Failed to return|1|||
155194458|NCT00761631|560149604|FG003|Overall Study|Failed to return|1|||
155194459|NCT00761631|560149605|FG004|Overall Study|Failed to return|5|||
155194460|NCT00761631|560149606|FG005|Overall Study|Failed to return|2|||
155194461|NCT00761631|560149601|FG000|Overall Study|Physician Decision|1|||
155194462|NCT00761631|560149602|FG001|Overall Study|Physician Decision|0|||
155194463|NCT00761631|560149603|FG002|Overall Study|Physician Decision|0|||
155194464|NCT00761631|560149604|FG003|Overall Study|Physician Decision|0|||
155194465|NCT00761631|560149605|FG004|Overall Study|Physician Decision|0|||
155194466|NCT00761631|560149606|FG005|Overall Study|Physician Decision|0|||
155194467|NCT00761631|560149601|FG000|Overall Study|Other|0|||
155194468|NCT00761631|560149602|FG001|Overall Study|Other|0|||
155194469|NCT00761631|560149603|FG002|Overall Study|Other|0|||
155194470|NCT00761631|560149604|FG003|Overall Study|Other|0|||
155194471|NCT00761631|560149605|FG004|Overall Study|Other|1|||
155194472|NCT00761631|560149606|FG005|Overall Study|Other|1|||
155194473|NCT01999868|560149607|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
155194474|NCT01999868|560149608|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
155194475|NCT01999868|560149609|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
155194476|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
155194477|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
155194478|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
155194479|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
155194480|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
155194481|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
155194482|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
155194483|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
155194484|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
155194485|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
155194486|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
155194487|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
155194488|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
155194489|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
155194490|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
155194491|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
155194492|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
155194493|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
155194494|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
155194495|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
155194496|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
155146707|NCT03957551|559969927|FG001|Overall Study|Disease progression|0|||
155146708|NCT03957551|559969928|FG002|Overall Study|Disease progression|8|||
155146709|NCT02717494|559969932|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
155146710|NCT02717494|559969933|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
155146711|NCT02717494|559969934|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
155146712|NCT02717494|559969932|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
155146713|NCT02717494|559969933|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
155146714|NCT02717494|559969934|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
155146715|NCT02717494|559969932|FG000|First Intervention (Step 1)|Death|0|||
155146716|NCT02717494|559969933|FG001|First Intervention (Step 1)|Death|0|||
155146717|NCT02717494|559969934|FG002|First Intervention (Step 1)|Death|1|||
155146718|NCT02717494|559969932|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
155146719|NCT02717494|559969933|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
155146720|NCT02717494|559969934|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
155146721|NCT01808196|559969941|FG000|Overall Study|Lost to Follow-up|1|||
155146722|NCT03370718|559969942|FG000|Overall Study|Withdrawal by Subject|1|||
155146723|NCT00479713|559969945|FG000|Overall Study|Adverse Event|8|||
155146724|NCT00479713|559969946|FG001|Overall Study|Adverse Event|6|||
155146725|NCT00479713|559969945|FG000|Overall Study|Death|1|||
155146726|NCT00479713|559969946|FG001|Overall Study|Death|0|||
155146727|NCT00479713|559969945|FG000|Overall Study|Lost to Follow-up|0|||
155146728|NCT00479713|559969946|FG001|Overall Study|Lost to Follow-up|1|||
155146729|NCT00479713|559969945|FG000|Overall Study|Protocol Violation|0|||
155146730|NCT00479713|559969946|FG001|Overall Study|Protocol Violation|1|||
155194497|NCT01999868|560149607|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
155194498|NCT01999868|560149608|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
155194499|NCT01999868|560149609|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
155194500|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
155194501|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
155194502|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
155194503|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
155194504|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
155194505|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
155194506|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
155194507|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
155194508|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
155194509|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
155194510|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
155194511|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
155194512|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
155194513|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
155194514|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
155194515|NCT01999868|560149607|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
155194516|NCT01999868|560149608|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
155194517|NCT01999868|560149609|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
155194518|NCT00289016|560149614|FG000|Overall Study|Disease Progression|29|||
155194519|NCT00289016|560149614|FG000|Overall Study|Death|2|||
155194520|NCT00289016|560149614|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
155194521|NCT00289016|560149614|FG000|Overall Study|Withdrawal by Subject|2|||
155194522|NCT00289016|560149614|FG000|Overall Study|Adverse Event|1|||
155194523|NCT00289016|560149614|FG000|Overall Study|Other|1|||
155194524|NCT00319501|560149615|FG000|Double-blind Period|Withdrawal by Subject|0|||
155194525|NCT00319501|560149616|FG001|Double-blind Period|Withdrawal by Subject|3|||
155194526|NCT00319501|560149615|FG000|Double-blind Period|Sponsor Request|1|||
155194527|NCT00319501|560149616|FG001|Double-blind Period|Sponsor Request|0|||
155194528|NCT00319501|560149615|FG000|Double-blind Period|Did not receive treatment|42|||
155194529|NCT00319501|560149616|FG001|Double-blind Period|Did not receive treatment|29|||
155194530|NCT00319501|560149615|FG000|Open-label Period|Adverse Event|5|||
155194531|NCT00319501|560149616|FG001|Open-label Period|Adverse Event|0|||
155194532|NCT00319501|560149615|FG000|Open-label Period|Protocol Violation|6|||
155146731|NCT00479713|559969945|FG000|Overall Study|Withdrawal by Subject|4|||
155146732|NCT00479713|559969946|FG001|Overall Study|Withdrawal by Subject|1|||
155146733|NCT00141102|559969949|FG000|Overall Study|Adverse Event|233|||
155146734|NCT00141102|559969950|FG001|Overall Study|Adverse Event|305|||
155146735|NCT00141102|559969949|FG000|Overall Study|Laboratory Abnormality|9|||
155146736|NCT00141102|559969950|FG001|Overall Study|Laboratory Abnormality|33|||
155146737|NCT00141102|559969949|FG000|Overall Study|Lack of Efficacy|21|||
155146738|NCT00141102|559969950|FG001|Overall Study|Lack of Efficacy|26|||
155146739|NCT00141102|559969949|FG000|Overall Study|Lost to Follow-up|29|||
155146740|NCT00141102|559969950|FG001|Overall Study|Lost to Follow-up|32|||
155146741|NCT00141102|559969949|FG000|Overall Study|Other|87|||
155146742|NCT00141102|559969950|FG001|Overall Study|Other|76|||
155146743|NCT00141102|559969949|FG000|Overall Study|Withdrawal by Subject|112|||
155146744|NCT00141102|559969950|FG001|Overall Study|Withdrawal by Subject|142|||
155146745|NCT00141102|559969949|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
155146746|NCT00141102|559969950|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
155146747|NCT00141102|559969949|FG000|Overall Study|Death|2|||
155146748|NCT00141102|559969950|FG001|Overall Study|Death|2|||
155146749|NCT03061201|559969951|FG000|Overall Study|Participants Terminated at Month 36|0|||
155146750|NCT03061201|559969952|FG001|Overall Study|Participants Terminated at Month 36|1|||
155146751|NCT03061201|559969953|FG002|Overall Study|Participants Terminated at Month 36|0|||
155146752|NCT03061201|559969954|FG003|Overall Study|Participants Terminated at Month 36|1|||
155146753|NCT03061201|559969951|FG000|Overall Study|Lost to Follow-up|1|||
155146754|NCT03061201|559969952|FG001|Overall Study|Lost to Follow-up|0|||
155146755|NCT03061201|559969953|FG002|Overall Study|Lost to Follow-up|0|||
155146756|NCT03061201|559969954|FG003|Overall Study|Lost to Follow-up|0|||
155146757|NCT01572480|559969955|FG000|Participants Enrolled|Withdrawal by Subject|1|||
155146758|NCT01572480|559969955|FG000|Drug Administration|Discontinued drug/Off Study|1|||
155146759|NCT01572480|559969955|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
155146760|NCT01572480|559969955|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
155146761|NCT03116685|559969956|FG000|Overall Study|Physician Decision|0|||
155146762|NCT03116685|559969957|FG001|Overall Study|Physician Decision|1|||
155146763|NCT04194944|559969958|FG000|Overall Study|Lost to Follow-up|3|||
155146764|NCT04194944|559969959|FG001|Overall Study|Lost to Follow-up|0|||
155146765|NCT04194944|559969958|FG000|Overall Study|Withdrawal by Subject|2|||
155146766|NCT04194944|559969959|FG001|Overall Study|Withdrawal by Subject|2|||
155146767|NCT04194944|559969958|FG000|Overall Study|On Treatment|93|||
155146768|NCT04194944|559969959|FG001|Overall Study|On Treatment|30|||
155146769|NCT03100149|559969960|FG000|Overall Study|Adverse Event|0|||
155146770|NCT03100149|559969961|FG001|Overall Study|Adverse Event|1|||
155146771|NCT03100149|559969962|FG002|Overall Study|Adverse Event|0|||
155146772|NCT03100149|559969960|FG000|Overall Study|Participant Moved out of Country|0|||
155146773|NCT03100149|559969961|FG001|Overall Study|Participant Moved out of Country|0|||
155146774|NCT03100149|559969962|FG002|Overall Study|Participant Moved out of Country|1|||
155146775|NCT03100149|559969960|FG000|Overall Study|Withdrawal by Subject|0|||
155146776|NCT03100149|559969961|FG001|Overall Study|Withdrawal by Subject|3|||
155146777|NCT03100149|559969962|FG002|Overall Study|Withdrawal by Subject|1|||
155146778|NCT05214768|559969965|FG000|Induction Period|Withdrawal by Subject|1|||
155146779|NCT05214768|559969966|FG001|Induction Period|Withdrawal by Subject|0|||
155146780|NCT05214768|559969967|FG002|Induction Period|Withdrawal by Subject|0|||
155146781|NCT05214768|559969968|FG003|Induction Period|Withdrawal by Subject|0|||
155146782|NCT05214768|559969969|FG004|Induction Period|Withdrawal by Subject|0|||
155146783|NCT05214768|559969970|FG005|Induction Period|Withdrawal by Subject|0|||
155146784|NCT05214768|559969965|FG000|Induction Period|Physician Decision|1|||
155146785|NCT05214768|559969966|FG001|Induction Period|Physician Decision|0|||
155146786|NCT05214768|559969967|FG002|Induction Period|Physician Decision|0|||
155146787|NCT05214768|559969968|FG003|Induction Period|Physician Decision|0|||
155146788|NCT05214768|559969969|FG004|Induction Period|Physician Decision|0|||
155146789|NCT05214768|559969970|FG005|Induction Period|Physician Decision|0|||
155146790|NCT05214768|559969965|FG000|Maintenance Period|Other Reasons|0|||
155146791|NCT05214768|559969966|FG001|Maintenance Period|Other Reasons|0|||
155146792|NCT05214768|559969967|FG002|Maintenance Period|Other Reasons|1|||
155146793|NCT05214768|559969968|FG003|Maintenance Period|Other Reasons|1|||
155146794|NCT05214768|559969969|FG004|Maintenance Period|Other Reasons|0|||
155146795|NCT05214768|559969970|FG005|Maintenance Period|Other Reasons|0|||
155146796|NCT05214768|559969965|FG000|Maintenance Period|Withdrawal by Subject|0|||
155146797|NCT05214768|559969966|FG001|Maintenance Period|Withdrawal by Subject|0|||
155146798|NCT05214768|559969967|FG002|Maintenance Period|Withdrawal by Subject|0|||
155146799|NCT05214768|559969968|FG003|Maintenance Period|Withdrawal by Subject|1|||
155146800|NCT05214768|559969969|FG004|Maintenance Period|Withdrawal by Subject|0|||
155146801|NCT05214768|559969970|FG005|Maintenance Period|Withdrawal by Subject|0|||
155146802|NCT05214768|559969965|FG000|Maintenance Period|Lack of Efficacy|0|||
155146803|NCT05214768|559969966|FG001|Maintenance Period|Lack of Efficacy|0|||
155146804|NCT05214768|559969967|FG002|Maintenance Period|Lack of Efficacy|1|||
155146805|NCT05214768|559969968|FG003|Maintenance Period|Lack of Efficacy|0|||
155146806|NCT05214768|559969969|FG004|Maintenance Period|Lack of Efficacy|1|||
155146807|NCT05214768|559969970|FG005|Maintenance Period|Lack of Efficacy|0|||
155146808|NCT05214768|559969965|FG000|Open Label Extension Period|Physician Decision|0|||
155146809|NCT05214768|559969966|FG001|Open Label Extension Period|Physician Decision|0|||
155146810|NCT05214768|559969967|FG002|Open Label Extension Period|Physician Decision|0|||
155146811|NCT05214768|559969968|FG003|Open Label Extension Period|Physician Decision|0|||
155146812|NCT05214768|559969969|FG004|Open Label Extension Period|Physician Decision|0|||
155146813|NCT05214768|559969970|FG005|Open Label Extension Period|Physician Decision|1|||
155146814|NCT05214768|559969965|FG000|Open Label Extension Period|Lack of Efficacy|0|||
155146815|NCT05214768|559969966|FG001|Open Label Extension Period|Lack of Efficacy|0|||
155146816|NCT05214768|559969967|FG002|Open Label Extension Period|Lack of Efficacy|0|||
155146817|NCT05214768|559969968|FG003|Open Label Extension Period|Lack of Efficacy|0|||
155146818|NCT05214768|559969969|FG004|Open Label Extension Period|Lack of Efficacy|0|||
155146819|NCT05214768|559969970|FG005|Open Label Extension Period|Lack of Efficacy|1|||
155146820|NCT05214768|559969965|FG000|Open Label Extension Period|Ongoing Study|0|||
155146821|NCT05214768|559969966|FG001|Open Label Extension Period|Ongoing Study|0|||
155146822|NCT05214768|559969967|FG002|Open Label Extension Period|Ongoing Study|0|||
155146823|NCT05214768|559969968|FG003|Open Label Extension Period|Ongoing Study|0|||
155146824|NCT05214768|559969969|FG004|Open Label Extension Period|Ongoing Study|0|||
155146825|NCT05214768|559969970|FG005|Open Label Extension Period|Ongoing Study|42|||
155146826|NCT05579977|559969980|FG000|Treatment Phase|Other|0|||
155146827|NCT05579977|559969981|FG001|Treatment Phase|Other|0|||
155146828|NCT05579977|559969982|FG002|Treatment Phase|Other|0|||
155146829|NCT05579977|559969983|FG003|Treatment Phase|Other|2|||
155146830|NCT05579977|559969984|FG004|Treatment Phase|Other|1|||
155146831|NCT05579977|559969985|FG005|Treatment Phase|Other|2|||
155146832|NCT05579977|559969986|FG006|Treatment Phase|Other|1|||
155146833|NCT05579977|559969987|FG007|Treatment Phase|Other|2|||
155146834|NCT05579977|559969988|FG008|Treatment Phase|Other|2|||
155146835|NCT05579977|559969989|FG009|Treatment Phase|Other|1|||
155146836|NCT05579977|559969990|FG010|Treatment Phase|Other|0|||
155146837|NCT05579977|559969991|FG011|Treatment Phase|Other|0|||
155146838|NCT05579977|559969992|FG012|Treatment Phase|Other|3|||
155146839|NCT05579977|559969980|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
155146840|NCT05579977|559969981|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
155146841|NCT05579977|559969982|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
155146842|NCT05579977|559969983|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
155146843|NCT05579977|559969984|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
155146844|NCT05579977|559969985|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
155146845|NCT05579977|559969986|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
155146846|NCT05579977|559969987|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
155146847|NCT05579977|559969988|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
155146848|NCT05579977|559969989|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
155146849|NCT05579977|559969990|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
155146850|NCT05579977|559969991|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
155146851|NCT05579977|559969992|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
155146852|NCT05579977|559969980|FG000|Treatment Phase|Withdrawal by Subject|2|||
155146853|NCT05579977|559969981|FG001|Treatment Phase|Withdrawal by Subject|0|||
155146854|NCT05579977|559969982|FG002|Treatment Phase|Withdrawal by Subject|0|||
155146855|NCT05579977|559969983|FG003|Treatment Phase|Withdrawal by Subject|1|||
155146856|NCT05579977|559969984|FG004|Treatment Phase|Withdrawal by Subject|2|||
155146857|NCT05579977|559969985|FG005|Treatment Phase|Withdrawal by Subject|0|||
155146858|NCT05579977|559969986|FG006|Treatment Phase|Withdrawal by Subject|1|||
155146859|NCT05579977|559969987|FG007|Treatment Phase|Withdrawal by Subject|8|||
155146860|NCT05579977|559969988|FG008|Treatment Phase|Withdrawal by Subject|3|||
155146861|NCT05579977|559969989|FG009|Treatment Phase|Withdrawal by Subject|3|||
155146862|NCT05579977|559969990|FG010|Treatment Phase|Withdrawal by Subject|5|||
155146863|NCT05579977|559969991|FG011|Treatment Phase|Withdrawal by Subject|1|||
155146864|NCT05579977|559969992|FG012|Treatment Phase|Withdrawal by Subject|3|||
155146865|NCT05579977|559969980|FG000|Treatment Phase|Study terminated by sponsor|70|||
155146866|NCT05579977|559969981|FG001|Treatment Phase|Study terminated by sponsor|70|||
155146867|NCT05579977|559969982|FG002|Treatment Phase|Study terminated by sponsor|61|||
155146868|NCT05579977|559969983|FG003|Treatment Phase|Study terminated by sponsor|59|||
155146869|NCT05579977|559969984|FG004|Treatment Phase|Study terminated by sponsor|63|||
155146870|NCT05579977|559969985|FG005|Treatment Phase|Study terminated by sponsor|53|||
155146871|NCT05579977|559969986|FG006|Treatment Phase|Study terminated by sponsor|66|||
155146872|NCT05579977|559969987|FG007|Treatment Phase|Study terminated by sponsor|48|||
155146873|NCT05579977|559969988|FG008|Treatment Phase|Study terminated by sponsor|47|||
155146874|NCT05579977|559969989|FG009|Treatment Phase|Study terminated by sponsor|37|||
155146875|NCT05579977|559969990|FG010|Treatment Phase|Study terminated by sponsor|44|||
155146876|NCT05579977|559969991|FG011|Treatment Phase|Study terminated by sponsor|36|||
155146877|NCT05579977|559969992|FG012|Treatment Phase|Study terminated by sponsor|32|||
155146878|NCT05579977|559969980|FG000|Treatment Phase|Pregnancy|0|||
155146879|NCT05579977|559969981|FG001|Treatment Phase|Pregnancy|0|||
155146880|NCT05579977|559969982|FG002|Treatment Phase|Pregnancy|0|||
155146881|NCT05579977|559969983|FG003|Treatment Phase|Pregnancy|0|||
155146882|NCT05579977|559969984|FG004|Treatment Phase|Pregnancy|0|||
155146883|NCT05579977|559969985|FG005|Treatment Phase|Pregnancy|0|||
155146884|NCT05579977|559969986|FG006|Treatment Phase|Pregnancy|0|||
155146885|NCT05579977|559969987|FG007|Treatment Phase|Pregnancy|0|||
155146886|NCT05579977|559969988|FG008|Treatment Phase|Pregnancy|0|||
155146887|NCT05579977|559969989|FG009|Treatment Phase|Pregnancy|1|||
155146888|NCT05579977|559969990|FG010|Treatment Phase|Pregnancy|0|||
155146889|NCT05579977|559969991|FG011|Treatment Phase|Pregnancy|0|||
155146890|NCT05579977|559969992|FG012|Treatment Phase|Pregnancy|0|||
155146891|NCT05579977|559969980|FG000|Treatment Phase|Physician Decision|0|||
155146892|NCT05579977|559969981|FG001|Treatment Phase|Physician Decision|0|||
155146893|NCT05579977|559969982|FG002|Treatment Phase|Physician Decision|0|||
155146894|NCT05579977|559969983|FG003|Treatment Phase|Physician Decision|0|||
155146895|NCT05579977|559969984|FG004|Treatment Phase|Physician Decision|0|||
155146896|NCT05579977|559969985|FG005|Treatment Phase|Physician Decision|0|||
155146897|NCT05579977|559969986|FG006|Treatment Phase|Physician Decision|0|||
155146898|NCT05579977|559969987|FG007|Treatment Phase|Physician Decision|0|||
155146899|NCT05579977|559969988|FG008|Treatment Phase|Physician Decision|0|||
155146900|NCT05579977|559969989|FG009|Treatment Phase|Physician Decision|0|||
155146901|NCT05579977|559969990|FG010|Treatment Phase|Physician Decision|0|||
155146902|NCT05579977|559969991|FG011|Treatment Phase|Physician Decision|1|||
155146903|NCT05579977|559969992|FG012|Treatment Phase|Physician Decision|0|||
155146904|NCT05579977|559969980|FG000|Treatment Phase|Lost to Follow-up|0|||
155146905|NCT05579977|559969981|FG001|Treatment Phase|Lost to Follow-up|0|||
155146906|NCT05579977|559969982|FG002|Treatment Phase|Lost to Follow-up|0|||
155146907|NCT05579977|559969983|FG003|Treatment Phase|Lost to Follow-up|1|||
155146908|NCT05579977|559969984|FG004|Treatment Phase|Lost to Follow-up|1|||
155146909|NCT05579977|559969985|FG005|Treatment Phase|Lost to Follow-up|1|||
155146910|NCT05579977|559969986|FG006|Treatment Phase|Lost to Follow-up|0|||
155146911|NCT05579977|559969987|FG007|Treatment Phase|Lost to Follow-up|1|||
155146912|NCT05579977|559969988|FG008|Treatment Phase|Lost to Follow-up|2|||
155146913|NCT05579977|559969989|FG009|Treatment Phase|Lost to Follow-up|2|||
155146914|NCT05579977|559969990|FG010|Treatment Phase|Lost to Follow-up|1|||
155146915|NCT05579977|559969991|FG011|Treatment Phase|Lost to Follow-up|4|||
155194533|NCT00319501|560149616|FG001|Open-label Period|Protocol Violation|0|||
155146916|NCT05579977|559969992|FG012|Treatment Phase|Lost to Follow-up|3|||
155146917|NCT05579977|559969980|FG000|Treatment Phase|Death|1|||
155146918|NCT05579977|559969981|FG001|Treatment Phase|Death|0|||
155146919|NCT05579977|559969982|FG002|Treatment Phase|Death|0|||
155146920|NCT05579977|559969983|FG003|Treatment Phase|Death|0|||
155146921|NCT05579977|559969984|FG004|Treatment Phase|Death|0|||
155146922|NCT05579977|559969985|FG005|Treatment Phase|Death|0|||
155146923|NCT05579977|559969986|FG006|Treatment Phase|Death|0|||
155146924|NCT05579977|559969987|FG007|Treatment Phase|Death|0|||
155146925|NCT05579977|559969988|FG008|Treatment Phase|Death|0|||
155146926|NCT05579977|559969989|FG009|Treatment Phase|Death|0|||
155146927|NCT05579977|559969990|FG010|Treatment Phase|Death|0|||
155146928|NCT05579977|559969991|FG011|Treatment Phase|Death|0|||
155146929|NCT05579977|559969992|FG012|Treatment Phase|Death|0|||
155146930|NCT05579977|559969980|FG000|Treatment Phase|Adverse Event|0|||
155146931|NCT05579977|559969981|FG001|Treatment Phase|Adverse Event|3|||
155146932|NCT05579977|559969982|FG002|Treatment Phase|Adverse Event|11|||
155146933|NCT05579977|559969983|FG003|Treatment Phase|Adverse Event|10|||
155146934|NCT05579977|559969984|FG004|Treatment Phase|Adverse Event|5|||
155146935|NCT05579977|559969985|FG005|Treatment Phase|Adverse Event|17|||
155146936|NCT05579977|559969986|FG006|Treatment Phase|Adverse Event|5|||
155146937|NCT05579977|559969987|FG007|Treatment Phase|Adverse Event|5|||
155146938|NCT05579977|559969988|FG008|Treatment Phase|Adverse Event|12|||
155146939|NCT05579977|559969989|FG009|Treatment Phase|Adverse Event|20|||
155146940|NCT05579977|559969990|FG010|Treatment Phase|Adverse Event|15|||
155146941|NCT05579977|559969991|FG011|Treatment Phase|Adverse Event|24|||
155146942|NCT05579977|559969992|FG012|Treatment Phase|Adverse Event|23|||
155146943|NCT05579977|559969980|FG000|Treatment Phase|Randomized not treated|0|||
155146944|NCT05579977|559969981|FG001|Treatment Phase|Randomized not treated|0|||
155146945|NCT05579977|559969982|FG002|Treatment Phase|Randomized not treated|0|||
155146946|NCT05579977|559969983|FG003|Treatment Phase|Randomized not treated|0|||
155146947|NCT05579977|559969984|FG004|Treatment Phase|Randomized not treated|1|||
155146948|NCT05579977|559969985|FG005|Treatment Phase|Randomized not treated|0|||
155146949|NCT05579977|559969986|FG006|Treatment Phase|Randomized not treated|0|||
155146950|NCT05579977|559969987|FG007|Treatment Phase|Randomized not treated|0|||
155146951|NCT05579977|559969988|FG008|Treatment Phase|Randomized not treated|0|||
155146952|NCT05579977|559969989|FG009|Treatment Phase|Randomized not treated|0|||
155146953|NCT05579977|559969990|FG010|Treatment Phase|Randomized not treated|0|||
155194534|NCT00319501|560149615|FG000|Open-label Period|Withdrawal by Subject|38|||
155194535|NCT00319501|560149616|FG001|Open-label Period|Withdrawal by Subject|0|||
155194536|NCT00319501|560149615|FG000|Open-label Period|Principal Investigator decision|6|||
155194537|NCT00319501|560149616|FG001|Open-label Period|Principal Investigator decision|0|||
155194538|NCT00319501|560149615|FG000|Open-label Period|Sponsor request|12|||
155194539|NCT00319501|560149616|FG001|Open-label Period|Sponsor request|0|||
155194540|NCT00319501|560149615|FG000|Open-label Period|Lost to Follow-up|5|||
155194541|NCT00319501|560149616|FG001|Open-label Period|Lost to Follow-up|0|||
155194542|NCT00319501|560149615|FG000|Open-label Period|Did not receive treatment|33|||
155194543|NCT00319501|560149616|FG001|Open-label Period|Did not receive treatment|0|||
155194544|NCT00319501|560149615|FG000|Open-label Period|Other|11|||
155194545|NCT00319501|560149616|FG001|Open-label Period|Other|0|||
155194546|NCT00319501|560149615|FG000|Open-label Extension Period|Adverse Event|2|||
155194547|NCT00319501|560149616|FG001|Open-label Extension Period|Adverse Event|0|||
155194548|NCT00319501|560149615|FG000|Open-label Extension Period|Did not receive treatment|18|||
155194549|NCT00319501|560149616|FG001|Open-label Extension Period|Did not receive treatment|0|||
155194550|NCT00319501|560149615|FG000|Open-label Extension Period|Other|1|||
155194551|NCT00319501|560149616|FG001|Open-label Extension Period|Other|0|||
155194552|NCT00319501|560149615|FG000|Open-label Extension Period|Principal investigator decision|2|||
155146954|NCT05579977|559969991|FG011|Treatment Phase|Randomized not treated|0|||
155146955|NCT05579977|559969992|FG012|Treatment Phase|Randomized not treated|0|||
155146956|NCT05579977|559969980|FG000|Follow up|Death|1|||
155146957|NCT05579977|559969981|FG001|Follow up|Death|0|||
155146958|NCT05579977|559969982|FG002|Follow up|Death|0|||
155146959|NCT05579977|559969983|FG003|Follow up|Death|0|||
155194553|NCT00319501|560149616|FG001|Open-label Extension Period|Principal investigator decision|0|||
155194554|NCT00319501|560149615|FG000|Open-label Extension Period|Sponsor request|26|||
155146960|NCT05579977|559969984|FG004|Follow up|Death|0|||
155194555|NCT00319501|560149616|FG001|Open-label Extension Period|Sponsor request|0|||
155194556|NCT00319501|560149615|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
155194557|NCT00319501|560149616|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
155194558|NCT02612129|560149617|FG000|Single Dose Treatment Period|Screening Failure|1|||
155146961|NCT05579977|559969985|FG005|Follow up|Death|0|||
155146962|NCT05579977|559969986|FG006|Follow up|Death|0|||
155146963|NCT05579977|559969987|FG007|Follow up|Death|0|||
155146964|NCT05579977|559969988|FG008|Follow up|Death|0|||
155146965|NCT05579977|559969989|FG009|Follow up|Death|0|||
155146966|NCT05579977|559969990|FG010|Follow up|Death|0|||
155146967|NCT05579977|559969991|FG011|Follow up|Death|0|||
155146968|NCT05579977|559969992|FG012|Follow up|Death|0|||
155146969|NCT05579977|559969980|FG000|Follow up|Lost to Follow-up|0|||
155146970|NCT05579977|559969981|FG001|Follow up|Lost to Follow-up|0|||
155146971|NCT05579977|559969982|FG002|Follow up|Lost to Follow-up|0|||
155146972|NCT05579977|559969983|FG003|Follow up|Lost to Follow-up|1|||
155146973|NCT05579977|559969984|FG004|Follow up|Lost to Follow-up|1|||
155146974|NCT05579977|559969985|FG005|Follow up|Lost to Follow-up|2|||
155146975|NCT05579977|559969986|FG006|Follow up|Lost to Follow-up|1|||
155146976|NCT05579977|559969987|FG007|Follow up|Lost to Follow-up|1|||
155146977|NCT05579977|559969988|FG008|Follow up|Lost to Follow-up|3|||
155146978|NCT05579977|559969989|FG009|Follow up|Lost to Follow-up|2|||
155146979|NCT05579977|559969990|FG010|Follow up|Lost to Follow-up|2|||
155146980|NCT05579977|559969991|FG011|Follow up|Lost to Follow-up|4|||
155146981|NCT05579977|559969992|FG012|Follow up|Lost to Follow-up|4|||
155146982|NCT05579977|559969980|FG000|Follow up|Withdrawal by Subject|2|||
155146983|NCT05579977|559969981|FG001|Follow up|Withdrawal by Subject|0|||
155146984|NCT05579977|559969982|FG002|Follow up|Withdrawal by Subject|0|||
155146985|NCT05579977|559969983|FG003|Follow up|Withdrawal by Subject|0|||
155146986|NCT05579977|559969984|FG004|Follow up|Withdrawal by Subject|1|||
155146987|NCT05579977|559969985|FG005|Follow up|Withdrawal by Subject|0|||
155146988|NCT05579977|559969986|FG006|Follow up|Withdrawal by Subject|1|||
155146989|NCT05579977|559969987|FG007|Follow up|Withdrawal by Subject|4|||
155146990|NCT05579977|559969988|FG008|Follow up|Withdrawal by Subject|2|||
155146991|NCT05579977|559969989|FG009|Follow up|Withdrawal by Subject|3|||
155146992|NCT05579977|559969990|FG010|Follow up|Withdrawal by Subject|3|||
155146993|NCT05579977|559969991|FG011|Follow up|Withdrawal by Subject|1|||
155146994|NCT05579977|559969992|FG012|Follow up|Withdrawal by Subject|3|||
155146995|NCT01611194|559969994|FG000|Overall Study|Lost to Follow-up|0|||
155146996|NCT01611194|559969995|FG001|Overall Study|Lost to Follow-up|1|||
155146997|NCT01611194|559969994|FG000|Overall Study|Withdrawal by Subject|0|||
155146998|NCT01611194|559969995|FG001|Overall Study|Withdrawal by Subject|1|||
155146999|NCT01611194|559969994|FG000|Overall Study|drug use|0|||
155147000|NCT01611194|559969995|FG001|Overall Study|drug use|1|||
155147001|NCT00452790|559969996|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
155147002|NCT00452790|559969997|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
155147003|NCT00452790|559969996|FG000|Infant Series|Parent/legal guardian request|8|||
155147004|NCT00452790|559969997|FG001|Infant Series|Parent/legal guardian request|6|||
155147005|NCT00452790|559969996|FG000|Infant Series|Failed to return|4|||
155147006|NCT00452790|559969997|FG001|Infant Series|Failed to return|1|||
155147007|NCT00452790|559969996|FG000|Infant Series|Protocol Violation|1|||
155147008|NCT00452790|559969997|FG001|Infant Series|Protocol Violation|3|||
155147009|NCT00452790|559969996|FG000|Infant Series|Lost to Follow-up|2|||
155147010|NCT00452790|559969997|FG001|Infant Series|Lost to Follow-up|2|||
155147011|NCT00452790|559969996|FG000|Infant Series|Adverse Event|1|||
155147012|NCT00452790|559969997|FG001|Infant Series|Adverse Event|2|||
155147013|NCT00452790|559969996|FG000|Infant Series|Other reasons|1|||
155147014|NCT00452790|559969997|FG001|Infant Series|Other reasons|2|||
155147015|NCT00452790|559969996|FG000|Infant Series|Investigator request|0|||
155147016|NCT00452790|559969997|FG001|Infant Series|Investigator request|1|||
155147017|NCT00452790|559969996|FG000|Infant Series|Death|0|||
155147018|NCT00452790|559969997|FG001|Infant Series|Death|1|||
155147019|NCT00452790|559969996|FG000|After Infant Series|Investigator request|10|||
155147020|NCT00452790|559969997|FG001|After Infant Series|Investigator request|10|||
155147021|NCT00452790|559969996|FG000|After Infant Series|Adverse Event|4|||
155147022|NCT00452790|559969997|FG001|After Infant Series|Adverse Event|1|||
155147023|NCT00452790|559969996|FG000|After Infant Series|Parent/legal guardian request|1|||
155147024|NCT00452790|559969997|FG001|After Infant Series|Parent/legal guardian request|3|||
155147025|NCT00452790|559969996|FG000|After Infant Series|Lost to Follow-up|4|||
155147026|NCT00452790|559969997|FG001|After Infant Series|Lost to Follow-up|0|||
155147027|NCT00452790|559969996|FG000|After Infant Series|Failed to return|1|||
155147028|NCT00452790|559969997|FG001|After Infant Series|Failed to return|0|||
155147029|NCT00452790|559969996|FG000|After Infant Series|Other reasons|1|||
155147030|NCT00452790|559969997|FG001|After Infant Series|Other reasons|0|||
155147031|NCT00452790|559969996|FG000|Toddler Dose|Failed to return|0|||
155147032|NCT00452790|559969997|FG001|Toddler Dose|Failed to return|1|||
155147033|NCT00452790|559969996|FG000|Toddler Dose|Parent/legal guardian request|0|||
155147034|NCT00452790|559969997|FG001|Toddler Dose|Parent/legal guardian request|1|||
155147035|NCT01871519|559970003|FG000|Overall Study|Death|26|||
155147036|NCT01871519|559970003|FG000|Overall Study|Lost to Follow-up|15|||
155147037|NCT01871519|559970003|FG000|Overall Study|Withdrawal by Subject|49|||
155147038|NCT00794950|559970004|FG000|BCG Induction|Withdrawal by Subject|2|||
155147039|NCT00794950|559970004|FG000|BCG Induction|ineligible|3|||
155147040|NCT00794950|559970004|FG000|BCG Induction|noncompliant w. BCG|1|||
155147041|NCT00794950|559970004|FG000|BCG Induction|Adverse Event|1|||
155147042|NCT00794950|559970004|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
155147043|NCT00794950|559970004|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
155147044|NCT00794950|559970004|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
155147045|NCT00794950|559970004|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
155147046|NCT02485704|559970005|FG000|Overall Study|Lost to Follow-up|4|||
155147047|NCT02485704|559970006|FG001|Overall Study|Lost to Follow-up|5|||
155147048|NCT02485704|559970005|FG000|Overall Study|Withdrawal by Subject|0|||
155147049|NCT02485704|559970006|FG001|Overall Study|Withdrawal by Subject|3|||
155147050|NCT02485704|559970005|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
155147051|NCT02485704|559970006|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
155147052|NCT00387881|559971693|FG000|Overall Study|Lost to Follow-up|23|||
155147053|NCT00387881|559971694|FG001|Overall Study|Lost to Follow-up|23|||
155147054|NCT00387881|559971693|FG000|Overall Study|Protocol Violation|2|||
155147055|NCT00387881|559971694|FG001|Overall Study|Protocol Violation|12|||
155147056|NCT00387881|559971693|FG000|Overall Study|Withdrawal by Subject|15|||
155147057|NCT00387881|559971694|FG001|Overall Study|Withdrawal by Subject|18|||
155147058|NCT00387881|559971693|FG000|Overall Study|Sponsor terminated Study|0|||
155147059|NCT00387881|559971694|FG001|Overall Study|Sponsor terminated Study|1|||
155147060|NCT00387881|559971693|FG000|Overall Study|Not eligible|6|||
155147061|NCT00387881|559971694|FG001|Overall Study|Not eligible|7|||
155194559|NCT02612129|560149618|FG001|Single Dose Treatment Period|Screening Failure|0|||
155194560|NCT02612129|560149619|FG002|Single Dose Treatment Period|Screening Failure|0|||
155194561|NCT02612129|560149617|FG000|Continuous Treatment Period|Early Escape|0|||
155194562|NCT02612129|560149618|FG001|Continuous Treatment Period|Early Escape|2|||
155194563|NCT02612129|560149619|FG002|Continuous Treatment Period|Early Escape|0|||
155194564|NCT02612129|560149617|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
155194565|NCT02612129|560149618|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
155194566|NCT02612129|560149619|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
155194567|NCT02612129|560149617|FG000|Continuous Treatment Period|Safety Reasons|0|||
155194568|NCT02612129|560149618|FG001|Continuous Treatment Period|Safety Reasons|3|||
155194569|NCT02612129|560149619|FG002|Continuous Treatment Period|Safety Reasons|0|||
155194570|NCT02612129|560149617|FG000|Continuous Treatment Period|Death|0|||
155194571|NCT02612129|560149618|FG001|Continuous Treatment Period|Death|1|||
155194572|NCT02612129|560149619|FG002|Continuous Treatment Period|Death|0|||
155194573|NCT02612129|560149617|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
155194574|NCT02612129|560149618|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
155194575|NCT02612129|560149619|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
155194576|NCT02557295|560149620|FG000|Overall Study|Withdrawal by Subject|9|||
155194577|NCT02557295|560149621|FG001|Overall Study|Withdrawal by Subject|2|||
155194578|NCT02557295|560149622|FG002|Overall Study|Withdrawal by Subject|4|||
155194579|NCT02557295|560149623|FG003|Overall Study|Withdrawal by Subject|0|||
155194580|NCT02557295|560149624|FG004|Overall Study|Withdrawal by Subject|0|||
155194581|NCT02557295|560149625|FG005|Overall Study|Withdrawal by Subject|0|||
155194582|NCT02557295|560149626|FG006|Overall Study|Withdrawal by Subject|15|||
155194583|NCT02557295|560149627|FG007|Overall Study|Withdrawal by Subject|1|||
155194584|NCT02557295|560149628|FG008|Overall Study|Withdrawal by Subject|3|||
155194585|NCT02557295|560149620|FG000|Overall Study|Disease Progression|0|||
155194586|NCT02557295|560149621|FG001|Overall Study|Disease Progression|0|||
155194587|NCT02557295|560149622|FG002|Overall Study|Disease Progression|0|||
155194588|NCT02557295|560149623|FG003|Overall Study|Disease Progression|0|||
155194589|NCT02557295|560149624|FG004|Overall Study|Disease Progression|0|||
155194590|NCT02557295|560149625|FG005|Overall Study|Disease Progression|0|||
155194591|NCT02557295|560149626|FG006|Overall Study|Disease Progression|1|||
155194592|NCT02557295|560149627|FG007|Overall Study|Disease Progression|0|||
155194593|NCT02557295|560149628|FG008|Overall Study|Disease Progression|0|||
155194594|NCT02557295|560149620|FG000|Overall Study|Lack of Efficacy|24|||
155194595|NCT02557295|560149621|FG001|Overall Study|Lack of Efficacy|1|||
155194596|NCT02557295|560149622|FG002|Overall Study|Lack of Efficacy|3|||
155194597|NCT02557295|560149623|FG003|Overall Study|Lack of Efficacy|0|||
155147062|NCT00387881|559971693|FG000|Overall Study|No opportunity to treat headache|32|||
155147063|NCT00387881|559971694|FG001|Overall Study|No opportunity to treat headache|34|||
155147064|NCT00387881|559971693|FG000|Overall Study|Not otherwise specified|11|||
155147065|NCT00387881|559971694|FG001|Overall Study|Not otherwise specified|7|||
155147066|NCT05473026|559971695|FG000|Overall Study|Lost to Follow-up|5|||
155194598|NCT02557295|560149624|FG004|Overall Study|Lack of Efficacy|0|||
155194599|NCT02557295|560149625|FG005|Overall Study|Lack of Efficacy|0|||
155194600|NCT02557295|560149626|FG006|Overall Study|Lack of Efficacy|12|||
155194601|NCT02557295|560149627|FG007|Overall Study|Lack of Efficacy|1|||
155194602|NCT02557295|560149628|FG008|Overall Study|Lack of Efficacy|0|||
155194603|NCT02557295|560149620|FG000|Overall Study|Adverse Event|16|||
155194604|NCT02557295|560149621|FG001|Overall Study|Adverse Event|2|||
155194605|NCT02557295|560149622|FG002|Overall Study|Adverse Event|3|||
155194606|NCT02557295|560149623|FG003|Overall Study|Adverse Event|0|||
155194607|NCT02557295|560149624|FG004|Overall Study|Adverse Event|0|||
155194608|NCT02557295|560149625|FG005|Overall Study|Adverse Event|0|||
155194609|NCT02557295|560149626|FG006|Overall Study|Adverse Event|2|||
155147067|NCT05473026|559971696|FG001|Overall Study|Lost to Follow-up|2|||
155147068|NCT01050634|559971697|FG000|Overall Study|Enrolled, but Not Treated|56|||
155147069|NCT01050634|559971697|FG000|Overall Study|Death|2|||
155147070|NCT01050634|559971697|FG000|Overall Study|Adverse Event|42|||
155147071|NCT01050634|559971697|FG000|Overall Study|Lost to Follow-up|2|||
155147072|NCT01050634|559971697|FG000|Overall Study|Other|21|||
155147073|NCT01050634|559971697|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
155147074|NCT00496015|559971698|FG000|Overall Study|Other|1|||
155147075|NCT00496015|559971699|FG001|Overall Study|Other|0|||
155147076|NCT00496015|559971700|FG002|Overall Study|Other|0|||
155147077|NCT00496015|559971701|FG003|Overall Study|Other|1|||
155147078|NCT00496015|559971702|FG004|Overall Study|Other|0|||
155147079|NCT02730728|559971706|FG000|Overall Study|Withdrawal by Subject|0|||
155147080|NCT02730728|559971707|FG001|Overall Study|Withdrawal by Subject|1|||
155147081|NCT02730728|559971708|FG002|Overall Study|Withdrawal by Subject|0|||
155147082|NCT02730728|559971706|FG000|Overall Study|Lack of Efficacy|0|||
155147083|NCT02730728|559971707|FG001|Overall Study|Lack of Efficacy|1|||
155147084|NCT02730728|559971708|FG002|Overall Study|Lack of Efficacy|1|||
155147085|NCT00985465|559971715|FG000|Overall Study|Withdrawal by Subject|1|||
155147086|NCT00985465|559971716|FG001|Overall Study|Withdrawal by Subject|2|||
155147087|NCT00985465|559971715|FG000|Overall Study|Considered to be part of the other group|0|||
155147088|NCT00985465|559971716|FG001|Overall Study|Considered to be part of the other group|1|||
155147089|NCT01054456|559971717|FG000|Overall Study|Other|1|||
155147090|NCT04701333|559971718|FG000|Overall Study|Lost to Follow-up|3|||
155147091|NCT04701333|559971719|FG001|Overall Study|Lost to Follow-up|7|||
155147092|NCT04701333|559971718|FG000|Overall Study|Withdrawal by Subject|0|||
155147093|NCT04701333|559971719|FG001|Overall Study|Withdrawal by Subject|1|||
155147094|NCT01292187|559971720|FG000|Overall Study|Adverse Event|10|||
155147095|NCT01292187|559971721|FG001|Overall Study|Adverse Event|5|||
155147096|NCT01292187|559971720|FG000|Overall Study|Withdrawal by Subject|6|||
155147097|NCT01292187|559971721|FG001|Overall Study|Withdrawal by Subject|5|||
155147098|NCT01292187|559971720|FG000|Overall Study|All other reasons|1|||
155147099|NCT01292187|559971721|FG001|Overall Study|All other reasons|3|||
155147100|NCT01363700|559971723|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155147101|NCT01363700|559971724|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
155147102|NCT01363700|559971725|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155147103|NCT01363700|559971726|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155147104|NCT01363700|559971727|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
155147105|NCT03827655|559971728|FG000|Overall Study|Death|0|||
155147106|NCT03827655|559971729|FG001|Overall Study|Death|0|||
155147107|NCT03827655|559971730|FG002|Overall Study|Death|0|||
155147108|NCT03827655|559971731|FG003|Overall Study|Death|0|||
155147109|NCT03827655|559971732|FG004|Overall Study|Death|1|||
155147110|NCT03827655|559971728|FG000|Overall Study|Protocol Deviation|1|||
155147111|NCT03827655|559971729|FG001|Overall Study|Protocol Deviation|0|||
155147112|NCT03827655|559971730|FG002|Overall Study|Protocol Deviation|1|||
155147113|NCT03827655|559971731|FG003|Overall Study|Protocol Deviation|1|||
155147114|NCT03827655|559971732|FG004|Overall Study|Protocol Deviation|0|||
155147115|NCT03827655|559971728|FG000|Overall Study|Withdrawal by Subject|3|||
155147116|NCT03827655|559971729|FG001|Overall Study|Withdrawal by Subject|2|||
155147117|NCT03827655|559971730|FG002|Overall Study|Withdrawal by Subject|2|||
155147118|NCT03827655|559971731|FG003|Overall Study|Withdrawal by Subject|0|||
155147119|NCT03827655|559971732|FG004|Overall Study|Withdrawal by Subject|1|||
155147120|NCT03827655|559971728|FG000|Overall Study|Reason not Specified|3|||
155147121|NCT03827655|559971729|FG001|Overall Study|Reason not Specified|1|||
155147122|NCT03827655|559971730|FG002|Overall Study|Reason not Specified|1|||
155147123|NCT03827655|559971731|FG003|Overall Study|Reason not Specified|1|||
155147124|NCT03827655|559971732|FG004|Overall Study|Reason not Specified|1|||
155147125|NCT03649217|559971733|FG000|Overall Study|subject had severe ataxia not initially found|1|||
155147126|NCT03649217|559971733|FG000|Overall Study|subject had cognitive issues not initially found|1|||
155147127|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147128|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147129|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147130|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
155147131|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147132|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147133|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147134|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147135|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147136|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
155147137|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
155147138|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
155147139|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155147140|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
155147141|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
155147142|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
155147143|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155147144|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155194610|NCT02557295|560149627|FG007|Overall Study|Adverse Event|1|||
155194611|NCT02557295|560149628|FG008|Overall Study|Adverse Event|1|||
155194612|NCT02557295|560149620|FG000|Overall Study|Lost to Follow-up|4|||
155194613|NCT02557295|560149621|FG001|Overall Study|Lost to Follow-up|0|||
155194614|NCT02557295|560149622|FG002|Overall Study|Lost to Follow-up|0|||
155194615|NCT02557295|560149623|FG003|Overall Study|Lost to Follow-up|0|||
155194616|NCT02557295|560149624|FG004|Overall Study|Lost to Follow-up|0|||
155194617|NCT02557295|560149625|FG005|Overall Study|Lost to Follow-up|0|||
155194618|NCT02557295|560149626|FG006|Overall Study|Lost to Follow-up|9|||
155194619|NCT02557295|560149627|FG007|Overall Study|Lost to Follow-up|0|||
155194620|NCT02557295|560149628|FG008|Overall Study|Lost to Follow-up|0|||
155194621|NCT02557295|560149620|FG000|Overall Study|Study Close|54|||
155194622|NCT02557295|560149621|FG001|Overall Study|Study Close|3|||
155194623|NCT02557295|560149622|FG002|Overall Study|Study Close|5|||
155194624|NCT02557295|560149623|FG003|Overall Study|Study Close|3|||
155194625|NCT02557295|560149624|FG004|Overall Study|Study Close|0|||
155194626|NCT02557295|560149625|FG005|Overall Study|Study Close|0|||
155194627|NCT02557295|560149626|FG006|Overall Study|Study Close|37|||
155194628|NCT02557295|560149627|FG007|Overall Study|Study Close|3|||
155194629|NCT02557295|560149628|FG008|Overall Study|Study Close|19|||
155194630|NCT02557295|560149620|FG000|Overall Study|except for study close|4|||
155194631|NCT02557295|560149621|FG001|Overall Study|except for study close|0|||
155194632|NCT02557295|560149622|FG002|Overall Study|except for study close|0|||
155194633|NCT02557295|560149623|FG003|Overall Study|except for study close|0|||
155194634|NCT02557295|560149624|FG004|Overall Study|except for study close|0|||
155194635|NCT02557295|560149625|FG005|Overall Study|except for study close|0|||
155194636|NCT02557295|560149626|FG006|Overall Study|except for study close|5|||
155194637|NCT02557295|560149627|FG007|Overall Study|except for study close|1|||
155194638|NCT02557295|560149628|FG008|Overall Study|except for study close|0|||
155194639|NCT01066000|560149629|FG000|Overall Study|Protocol Violation|4|||
155194640|NCT01066000|560149629|FG000|Overall Study|Death|3|||
155194641|NCT01066000|560149629|FG000|Overall Study|Withdrawal by Subject|1|||
155194642|NCT01066000|560149629|FG000|Overall Study|Adverse Event|1|||
155194643|NCT01067976|560149630|FG000|Overall Study|Study drug never administered|20|||
155194644|NCT01067976|560149630|FG000|Overall Study|Study prematurely discontinued|2|||
155194645|NCT00566111|560149631|FG000|Overall Study|Adverse Event|0|||
155194646|NCT00566111|560149632|FG001|Overall Study|Adverse Event|2|||
155194647|NCT00976677|560149633|FG000|Overall Study|Adverse Event|1|||
155194648|NCT00976677|560149634|FG001|Overall Study|Adverse Event|0|||
155194649|NCT00976677|560149633|FG000|Overall Study|Withdrawal by Subject|0|||
155194650|NCT00976677|560149634|FG001|Overall Study|Withdrawal by Subject|2|||
155194651|NCT00976677|560149633|FG000|Overall Study|Disease progression|1|||
155194652|NCT00976677|560149634|FG001|Overall Study|Disease progression|1|||
155194653|NCT00976677|560149633|FG000|Overall Study|Trial unblinded|2|||
155194654|NCT00976677|560149634|FG001|Overall Study|Trial unblinded|2|||
155194655|NCT00976677|560149633|FG000|Overall Study|Unknown/Missing|1|||
155194656|NCT00976677|560149634|FG001|Overall Study|Unknown/Missing|0|||
155194657|NCT04092582|560151166|FG000|Overall Study|Death|1|||
155194658|NCT04092582|560151167|FG001|Overall Study|Death|1|||
155194659|NCT04092582|560151166|FG000|Overall Study|Withdrawal by Subject|4|||
155194660|NCT04092582|560151167|FG001|Overall Study|Withdrawal by Subject|1|||
155194661|NCT04092582|560151166|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
155194662|NCT04092582|560151167|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
155194663|NCT01313858|560151170|FG000|Overall Study|Premature Treatment Termination|251|||
155194664|NCT01313858|560151171|FG001|Overall Study|Premature Treatment Termination|219|||
155147145|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155147146|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
155147147|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
155147148|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155147149|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155147150|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155147151|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
155147152|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
155194665|NCT01313858|560151172|FG002|Overall Study|Premature Treatment Termination|191|||
155194666|NCT01313858|560151170|FG000|Overall Study|Lost to Follow-up|35|||
155194667|NCT01313858|560151171|FG001|Overall Study|Lost to Follow-up|51|||
155194668|NCT01313858|560151172|FG002|Overall Study|Lost to Follow-up|47|||
155194669|NCT03689530|560151174|FG000|Overall Study|Withdrawal by Subject|53|||
155194670|NCT03689530|560151175|FG001|Overall Study|Withdrawal by Subject|16|||
155194671|NCT01392443|560151176|FG000|Overall Study|Disease progression|30|||
155194672|NCT01392443|560151176|FG000|Overall Study|Adverse Event|24|||
155194673|NCT01392443|560151176|FG000|Overall Study|Death|7|||
155194674|NCT01392443|560151176|FG000|Overall Study|Withdrawal by Subject|5|||
155194675|NCT01392443|560151176|FG000|Overall Study|Lost to Follow-up|1|||
155147153|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155194676|NCT01392443|560151176|FG000|Overall Study|Protocol Violation|1|||
155194677|NCT01977794|560151177|FG000|Overall Study|Adverse Event|2|||
155147154|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155147155|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155147156|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
155147157|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
155194678|NCT01977794|560151178|FG001|Overall Study|Adverse Event|2|||
155194679|NCT01977794|560151177|FG000|Overall Study|Lost to Follow-up|2|||
155194680|NCT01977794|560151178|FG001|Overall Study|Lost to Follow-up|1|||
155194681|NCT01977794|560151177|FG000|Overall Study|Protocol Violation|1|||
155194682|NCT01977794|560151178|FG001|Overall Study|Protocol Violation|0|||
155194683|NCT01977794|560151177|FG000|Overall Study|Death|1|||
155194684|NCT01977794|560151178|FG001|Overall Study|Death|1|||
155194685|NCT01977794|560151177|FG000|Overall Study|Withdrew consent|2|||
155194686|NCT01977794|560151178|FG001|Overall Study|Withdrew consent|1|||
155194687|NCT01977794|560151177|FG000|Overall Study|Other|0|||
155194688|NCT01977794|560151178|FG001|Overall Study|Other|1|||
155194689|NCT00491075|560151181|FG000|Overall Study|Withdrawal by Subject|1|||
155194690|NCT00491075|560151181|FG000|Overall Study|Physician Decision|1|||
155194691|NCT01603355|560151182|FG000|Overall Study|Lack of Efficacy|2|||
155194692|NCT00246753|560151185|FG000|Overall Study|Withdrawal by Subject|2|||
155194693|NCT00246753|560151185|FG000|Overall Study|Physician Decision|2|||
155194694|NCT00246753|560151185|FG000|Overall Study|Adverse Event|2|||
155194695|NCT00246753|560151185|FG000|Overall Study|Unacceptable toxicity|2|||
155194696|NCT01868503|560151197|FG000|Overall Study|Withdrawal by Subject|1|||
155194697|NCT01868503|560151197|FG000|Overall Study|Protocol Violation|1|||
155194698|NCT03917459|560151200|FG000|Overall Study|Adverse Event|1|||
155194699|NCT03917459|560151201|FG001|Overall Study|Adverse Event|0|||
155194700|NCT03917459|560151200|FG000|Overall Study|Withdrawal by Subject|0|||
155194701|NCT03917459|560151201|FG001|Overall Study|Withdrawal by Subject|1|||
155194702|NCT00131508|560151204|FG000|Overall Study|Disease progression|0|||
155147158|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
155147159|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
155147160|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
155147161|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
155147162|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
155147163|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
155147164|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
155147165|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
155147166|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
155147167|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
155147168|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147169|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
155147170|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147171|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
155147172|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147173|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147174|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147175|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147176|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
155147177|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
155147178|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147179|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147180|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147181|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
155147182|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
155147183|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147184|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147185|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147186|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
155147187|NCT02365649|559971740|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147188|NCT02365649|559971741|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147189|NCT02365649|559971742|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
155147190|NCT02365649|559971743|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147191|NCT02365649|559971744|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147192|NCT02365649|559971745|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155194703|NCT00131508|560151205|FG001|Overall Study|Disease progression|2|||
155194704|NCT00131508|560151204|FG000|Overall Study|Non-Compliance|2|||
155194705|NCT00131508|560151205|FG001|Overall Study|Non-Compliance|4|||
155194706|NCT00131508|560151204|FG000|Overall Study|Withdrawal by Subject|1|||
155194707|NCT00131508|560151205|FG001|Overall Study|Withdrawal by Subject|2|||
155194708|NCT01691898|560151216|FG000|Overall Study|Death|34|||
155194709|NCT01691898|560151217|FG001|Overall Study|Death|32|||
155194710|NCT01691898|560151218|FG002|Overall Study|Death|6|||
155194711|NCT01691898|560151219|FG003|Overall Study|Death|3|||
155194712|NCT01691898|560151220|FG004|Overall Study|Death|8|||
155194713|NCT01691898|560151221|FG005|Overall Study|Death|31|||
155194714|NCT01691898|560151216|FG000|Overall Study|Adverse Event|0|||
155194715|NCT01691898|560151217|FG001|Overall Study|Adverse Event|1|||
155194716|NCT01691898|560151218|FG002|Overall Study|Adverse Event|0|||
155194717|NCT01691898|560151219|FG003|Overall Study|Adverse Event|1|||
155194718|NCT01691898|560151220|FG004|Overall Study|Adverse Event|1|||
155194719|NCT01691898|560151221|FG005|Overall Study|Adverse Event|0|||
155194720|NCT01691898|560151216|FG000|Overall Study|Progression of Disease|1|||
155194721|NCT01691898|560151217|FG001|Overall Study|Progression of Disease|2|||
155194722|NCT01691898|560151218|FG002|Overall Study|Progression of Disease|1|||
155194723|NCT01691898|560151219|FG003|Overall Study|Progression of Disease|0|||
155194724|NCT01691898|560151220|FG004|Overall Study|Progression of Disease|0|||
155194725|NCT01691898|560151221|FG005|Overall Study|Progression of Disease|1|||
155194726|NCT01691898|560151216|FG000|Overall Study|Lost to Follow-up|3|||
155194727|NCT01691898|560151217|FG001|Overall Study|Lost to Follow-up|1|||
155194728|NCT01691898|560151218|FG002|Overall Study|Lost to Follow-up|0|||
155194729|NCT01691898|560151219|FG003|Overall Study|Lost to Follow-up|0|||
155194730|NCT01691898|560151220|FG004|Overall Study|Lost to Follow-up|1|||
155194731|NCT01691898|560151221|FG005|Overall Study|Lost to Follow-up|0|||
155194732|NCT01691898|560151216|FG000|Overall Study|Withdrawal by Subject|9|||
155194733|NCT01691898|560151217|FG001|Overall Study|Withdrawal by Subject|8|||
155194734|NCT01691898|560151218|FG002|Overall Study|Withdrawal by Subject|2|||
155194735|NCT01691898|560151219|FG003|Overall Study|Withdrawal by Subject|1|||
155194736|NCT01691898|560151220|FG004|Overall Study|Withdrawal by Subject|3|||
155194737|NCT01691898|560151221|FG005|Overall Study|Withdrawal by Subject|3|||
155194738|NCT01691898|560151216|FG000|Overall Study|Non-Compliance|0|||
155194739|NCT01691898|560151217|FG001|Overall Study|Non-Compliance|0|||
155194740|NCT01691898|560151218|FG002|Overall Study|Non-Compliance|0|||
155194741|NCT01691898|560151219|FG003|Overall Study|Non-Compliance|0|||
155194742|NCT01691898|560151220|FG004|Overall Study|Non-Compliance|1|||
155194743|NCT01691898|560151221|FG005|Overall Study|Non-Compliance|0|||
155194744|NCT02019277|560151222|FG000|Overall Study|Withdrawal by Subject|3|||
155194745|NCT02019277|560151222|FG000|Overall Study|Death|7|||
155194746|NCT02019277|560151222|FG000|Overall Study|Did no Cooperate|1|||
155194747|NCT02019277|560151222|FG000|Overall Study|Adverse Event|1|||
155194748|NCT04738734|560151223|FG000|Overall Study|Withdrawal by Subject|2|||
155194749|NCT04738734|560151224|FG001|Overall Study|Withdrawal by Subject|4|||
155194750|NCT04738734|560151223|FG000|Overall Study|Lost to Follow-up|5|||
155194751|NCT04738734|560151224|FG001|Overall Study|Lost to Follow-up|2|||
155194752|NCT04738734|560151223|FG000|Overall Study|Physician Decision|0|||
155194753|NCT04738734|560151224|FG001|Overall Study|Physician Decision|1|||
155194754|NCT04738734|560151223|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
155194755|NCT04738734|560151224|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
155194756|NCT04093414|560151225|FG000|3 Month Follow up|Physician Decision|0|||
155194757|NCT04093414|560151226|FG001|3 Month Follow up|Physician Decision|1|||
155194758|NCT04093414|560151225|FG000|6month Follow up|Physician Decision|1|||
155194759|NCT04093414|560151226|FG001|6month Follow up|Physician Decision|3|||
155194760|NCT04889222|560151227|FG000|Overall Study|Did not meet eligibility criteria|8|||
155194761|NCT04889222|560151227|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
155194762|NCT04889222|560151227|FG000|Overall Study|Did not proceed due to time constraints|5|||
155194763|NCT02639546|560151228|FG000|Overall Study|Death|2|||
155194764|NCT02639546|560151229|FG001|Overall Study|Death|2|||
155194765|NCT02639546|560151230|FG002|Overall Study|Death|1|||
155194766|NCT02639546|560151231|FG003|Overall Study|Death|2|||
155194767|NCT02639546|560151232|FG004|Overall Study|Death|2|||
155194768|NCT02639546|560151233|FG005|Overall Study|Death|2|||
155194769|NCT02639546|560151234|FG006|Overall Study|Death|0|||
155194770|NCT02639546|560151235|FG007|Overall Study|Death|0|||
155194771|NCT02639546|560151228|FG000|Overall Study|Lost to Follow-up|0|||
155194772|NCT02639546|560151229|FG001|Overall Study|Lost to Follow-up|0|||
155194773|NCT02639546|560151230|FG002|Overall Study|Lost to Follow-up|1|||
155194774|NCT02639546|560151231|FG003|Overall Study|Lost to Follow-up|0|||
155194775|NCT02639546|560151232|FG004|Overall Study|Lost to Follow-up|1|||
155194776|NCT02639546|560151233|FG005|Overall Study|Lost to Follow-up|1|||
155194777|NCT02639546|560151234|FG006|Overall Study|Lost to Follow-up|0|||
155194778|NCT02639546|560151235|FG007|Overall Study|Lost to Follow-up|1|||
155194779|NCT02639546|560151228|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
155194780|NCT02639546|560151229|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
155194781|NCT02639546|560151230|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
155194782|NCT02639546|560151231|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
155194783|NCT02639546|560151232|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
155194784|NCT02639546|560151233|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
155194785|NCT02639546|560151234|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
155194786|NCT02639546|560151235|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
155194787|NCT02639546|560151228|FG000|Overall Study|Study Terminated By Sponsor|0|||
155194788|NCT02639546|560151229|FG001|Overall Study|Study Terminated By Sponsor|2|||
155194789|NCT02639546|560151230|FG002|Overall Study|Study Terminated By Sponsor|3|||
155194790|NCT02639546|560151231|FG003|Overall Study|Study Terminated By Sponsor|4|||
155194791|NCT02639546|560151232|FG004|Overall Study|Study Terminated By Sponsor|4|||
155194792|NCT02639546|560151233|FG005|Overall Study|Study Terminated By Sponsor|3|||
155194793|NCT02639546|560151234|FG006|Overall Study|Study Terminated By Sponsor|3|||
155194794|NCT02639546|560151235|FG007|Overall Study|Study Terminated By Sponsor|9|||
155194795|NCT02639546|560151228|FG000|Overall Study|Withdrawal by Subject|2|||
155194796|NCT02639546|560151229|FG001|Overall Study|Withdrawal by Subject|2|||
155194797|NCT02639546|560151230|FG002|Overall Study|Withdrawal by Subject|1|||
155194798|NCT02639546|560151231|FG003|Overall Study|Withdrawal by Subject|0|||
155194799|NCT02639546|560151232|FG004|Overall Study|Withdrawal by Subject|0|||
155194800|NCT02639546|560151233|FG005|Overall Study|Withdrawal by Subject|1|||
155194801|NCT02639546|560151234|FG006|Overall Study|Withdrawal by Subject|2|||
155194802|NCT02639546|560151235|FG007|Overall Study|Withdrawal by Subject|1|||
155194803|NCT00113087|560151236|FG000|Overall Study|Death or Transplant|14|||
155194804|NCT00113087|560151237|FG001|Overall Study|Death or Transplant|16|||
155194805|NCT00113087|560151236|FG000|Overall Study|Family or MD withdrew subject|10|||
155194806|NCT00113087|560151237|FG001|Overall Study|Family or MD withdrew subject|5|||
155194807|NCT03452228|560151238|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155194808|NCT03452228|560151239|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
155194809|NCT03452228|560151240|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
155194810|NCT03452228|560151238|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155194811|NCT03452228|560151239|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
155194812|NCT03452228|560151240|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
155194813|NCT03452228|560151238|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
155194814|NCT03452228|560151239|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
155194815|NCT03452228|560151240|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
155194816|NCT03452228|560151238|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155194817|NCT03452228|560151239|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
155194818|NCT03452228|560151240|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
155147193|NCT02365649|559971746|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147194|NCT02365649|559971747|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147195|NCT02365649|559971748|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147196|NCT02365649|559971749|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
155147197|NCT02365649|559971740|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147198|NCT02365649|559971741|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147199|NCT02365649|559971742|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147200|NCT02365649|559971743|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147201|NCT02365649|559971744|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147202|NCT02365649|559971745|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147203|NCT02365649|559971746|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
155147204|NCT02365649|559971747|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147205|NCT02365649|559971748|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147206|NCT02365649|559971749|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
155147207|NCT02365649|559971740|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147208|NCT02365649|559971741|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147209|NCT02365649|559971742|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147210|NCT02365649|559971743|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147211|NCT02365649|559971744|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147212|NCT02365649|559971745|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147213|NCT02365649|559971746|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
155147214|NCT02365649|559971747|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
155147215|NCT02365649|559971748|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
155147216|NCT02365649|559971749|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
155147217|NCT02365649|559971740|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155147218|NCT02365649|559971741|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155147219|NCT02365649|559971742|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155147220|NCT02365649|559971743|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155147221|NCT02365649|559971744|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155147222|NCT02365649|559971745|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
155147223|NCT02365649|559971746|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
155147224|NCT02365649|559971747|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
155147225|NCT02365649|559971748|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
155147226|NCT02365649|559971749|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
155147227|NCT02365649|559971740|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155147228|NCT02365649|559971741|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155194819|NCT04295772|560151244|FG000|Overall Study|Protocol Violation|1|||
155194820|NCT04295772|560151245|FG001|Overall Study|Protocol Violation|0|||
155194821|NCT04295772|560151244|FG000|Overall Study|Ongoing for safety monitoring|14|||
155194822|NCT04295772|560151245|FG001|Overall Study|Ongoing for safety monitoring|1|||
155194823|NCT04295772|560151244|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
155194824|NCT04295772|560151245|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
155194825|NCT00968864|560151246|FG000|Overall Study|Protocol exception/ not evaluable|1|||
155194826|NCT01967173|560151247|FG000|Overall Study|Lost to Follow-up|5|||
155194827|NCT01967173|560151248|FG001|Overall Study|Lost to Follow-up|3|||
155194828|NCT01967173|560151249|FG002|Overall Study|Lost to Follow-up|2|||
155194829|NCT01967173|560151250|FG003|Overall Study|Lost to Follow-up|4|||
155194830|NCT01967173|560151251|FG004|Overall Study|Lost to Follow-up|8|||
155194831|NCT01967173|560151252|FG005|Overall Study|Lost to Follow-up|12|||
155194832|NCT01967173|560151253|FG006|Overall Study|Lost to Follow-up|6|||
155194833|NCT01967173|560151254|FG007|Overall Study|Lost to Follow-up|8|||
155194834|NCT01967173|560151247|FG000|Overall Study|Physician Decision|2|||
155194835|NCT01967173|560151248|FG001|Overall Study|Physician Decision|0|||
155194836|NCT01967173|560151249|FG002|Overall Study|Physician Decision|2|||
155194837|NCT01967173|560151250|FG003|Overall Study|Physician Decision|1|||
155194838|NCT01967173|560151251|FG004|Overall Study|Physician Decision|1|||
155194839|NCT01967173|560151252|FG005|Overall Study|Physician Decision|1|||
155194840|NCT01967173|560151253|FG006|Overall Study|Physician Decision|1|||
155194841|NCT01967173|560151254|FG007|Overall Study|Physician Decision|0|||
155194842|NCT01967173|560151247|FG000|Overall Study|Lack of Efficacy|2|||
155194843|NCT01967173|560151248|FG001|Overall Study|Lack of Efficacy|0|||
155147229|NCT02365649|559971742|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155194844|NCT01967173|560151249|FG002|Overall Study|Lack of Efficacy|2|||
155194845|NCT01967173|560151250|FG003|Overall Study|Lack of Efficacy|2|||
155194846|NCT01967173|560151251|FG004|Overall Study|Lack of Efficacy|0|||
155194847|NCT01967173|560151252|FG005|Overall Study|Lack of Efficacy|1|||
155194848|NCT01967173|560151253|FG006|Overall Study|Lack of Efficacy|0|||
155194849|NCT01967173|560151254|FG007|Overall Study|Lack of Efficacy|2|||
155194850|NCT01967173|560151247|FG000|Overall Study|Pregnancy|0|||
155194851|NCT01967173|560151248|FG001|Overall Study|Pregnancy|0|||
155194852|NCT01967173|560151249|FG002|Overall Study|Pregnancy|0|||
155194853|NCT01967173|560151250|FG003|Overall Study|Pregnancy|0|||
155194854|NCT01967173|560151251|FG004|Overall Study|Pregnancy|0|||
155194855|NCT01967173|560151252|FG005|Overall Study|Pregnancy|0|||
155194856|NCT01967173|560151253|FG006|Overall Study|Pregnancy|1|||
155194857|NCT01967173|560151254|FG007|Overall Study|Pregnancy|1|||
155194858|NCT01967173|560151247|FG000|Overall Study|Adverse Event|0|||
155194859|NCT01967173|560151248|FG001|Overall Study|Adverse Event|0|||
155194860|NCT01967173|560151249|FG002|Overall Study|Adverse Event|0|||
155147230|NCT02365649|559971743|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155147231|NCT02365649|559971744|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155147232|NCT02365649|559971745|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155147233|NCT02365649|559971746|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
155147234|NCT02365649|559971747|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
155147235|NCT02365649|559971748|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
155147236|NCT02365649|559971749|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
155147237|NCT02365649|559971740|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147238|NCT02365649|559971741|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147239|NCT02365649|559971742|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147240|NCT02365649|559971743|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147241|NCT02365649|559971744|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147242|NCT02365649|559971745|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147243|NCT02365649|559971746|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
155194861|NCT01967173|560151250|FG003|Overall Study|Adverse Event|0|||
155194862|NCT01967173|560151251|FG004|Overall Study|Adverse Event|0|||
155194863|NCT01967173|560151252|FG005|Overall Study|Adverse Event|0|||
155194864|NCT01967173|560151253|FG006|Overall Study|Adverse Event|0|||
155194865|NCT01967173|560151254|FG007|Overall Study|Adverse Event|1|||
155194866|NCT01967173|560151247|FG000|Overall Study|Withdrawal by Subject|15|||
155194867|NCT01967173|560151248|FG001|Overall Study|Withdrawal by Subject|14|||
155194868|NCT01967173|560151249|FG002|Overall Study|Withdrawal by Subject|10|||
155194869|NCT01967173|560151250|FG003|Overall Study|Withdrawal by Subject|7|||
155194870|NCT01967173|560151251|FG004|Overall Study|Withdrawal by Subject|8|||
155194871|NCT01967173|560151252|FG005|Overall Study|Withdrawal by Subject|9|||
155194872|NCT01967173|560151253|FG006|Overall Study|Withdrawal by Subject|10|||
155194873|NCT01967173|560151254|FG007|Overall Study|Withdrawal by Subject|12|||
155194874|NCT03666624|560151256|FG000|Overall Study|participant grieving over recent death of parent|1|||
155194875|NCT03666624|560151257|FG001|Overall Study|participant grieving over recent death of parent|0|||
155194876|NCT01254630|560151259|FG000|Overall Study|Adverse Event|36|||
155194877|NCT01254630|560151260|FG001|Overall Study|Adverse Event|15|||
155194878|NCT01254630|560151261|FG002|Overall Study|Adverse Event|40|||
155194879|NCT01254630|560151262|FG003|Overall Study|Adverse Event|8|||
155194880|NCT01254630|560151259|FG000|Overall Study|Death|461|||
155194881|NCT01254630|560151260|FG001|Overall Study|Death|151|||
155194882|NCT01254630|560151261|FG002|Overall Study|Death|478|||
155194883|NCT01254630|560151262|FG003|Overall Study|Death|139|||
155194884|NCT01254630|560151259|FG000|Overall Study|Lost to Follow-up|80|||
155194885|NCT01254630|560151260|FG001|Overall Study|Lost to Follow-up|26|||
155194886|NCT01254630|560151261|FG002|Overall Study|Lost to Follow-up|89|||
155194887|NCT01254630|560151262|FG003|Overall Study|Lost to Follow-up|32|||
155194888|NCT01254630|560151259|FG000|Overall Study|Physician Decision|24|||
155194889|NCT01254630|560151260|FG001|Overall Study|Physician Decision|8|||
155194890|NCT01254630|560151261|FG002|Overall Study|Physician Decision|16|||
155194891|NCT01254630|560151262|FG003|Overall Study|Physician Decision|7|||
155194892|NCT01254630|560151259|FG000|Overall Study|Withdrawal by Subject|201|||
155194893|NCT01254630|560151260|FG001|Overall Study|Withdrawal by Subject|94|||
155194894|NCT01254630|560151261|FG002|Overall Study|Withdrawal by Subject|188|||
155194895|NCT01254630|560151262|FG003|Overall Study|Withdrawal by Subject|89|||
155194896|NCT01254630|560151259|FG000|Overall Study|Study terminated by sponsor|0|||
155194897|NCT01254630|560151260|FG001|Overall Study|Study terminated by sponsor|994|||
155194898|NCT01254630|560151261|FG002|Overall Study|Study terminated by sponsor|0|||
155194899|NCT01254630|560151262|FG003|Overall Study|Study terminated by sponsor|1010|||
155194900|NCT01254630|560151259|FG000|Overall Study|Status not recorded|0|||
155194901|NCT01254630|560151260|FG001|Overall Study|Status not recorded|0|||
155194902|NCT01254630|560151261|FG002|Overall Study|Status not recorded|1|||
155194903|NCT01254630|560151262|FG003|Overall Study|Status not recorded|0|||
155194904|NCT02959983|560151263|FG000|Overall Study|Protocol Violation|0|||
155194905|NCT02959983|560151264|FG001|Overall Study|Protocol Violation|1|||
155194906|NCT02959983|560151263|FG000|Overall Study|Lack of Efficacy|0|||
155194907|NCT02959983|560151264|FG001|Overall Study|Lack of Efficacy|1|||
155194908|NCT02959983|560151263|FG000|Overall Study|Lost to Follow-up|12|||
155194909|NCT02959983|560151264|FG001|Overall Study|Lost to Follow-up|9|||
155194910|NCT02959983|560151263|FG000|Overall Study|Other|1|||
155194911|NCT02959983|560151264|FG001|Overall Study|Other|1|||
155194912|NCT02959983|560151263|FG000|Overall Study|Physician Decision|1|||
155194913|NCT02959983|560151264|FG001|Overall Study|Physician Decision|0|||
155194914|NCT02959983|560151263|FG000|Overall Study|Adverse Event|5|||
155194915|NCT02959983|560151264|FG001|Overall Study|Adverse Event|1|||
155194916|NCT02959983|560151263|FG000|Overall Study|Withdrawal by Subject|7|||
155194917|NCT02959983|560151264|FG001|Overall Study|Withdrawal by Subject|12|||
155194918|NCT03308786|560151269|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
155194919|NCT01193842|560151276|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194920|NCT01193842|560151277|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
155194921|NCT01193842|560151278|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194922|NCT01193842|560151279|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194923|NCT01193842|560151280|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
155194924|NCT01193842|560151276|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
155194925|NCT01193842|560151277|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194926|NCT01193842|560151278|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194927|NCT01193842|560151279|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194928|NCT01193842|560151280|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
155194929|NCT01193842|560151276|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155194930|NCT01193842|560151277|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155147244|NCT02365649|559971747|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147245|NCT02365649|559971748|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
155147246|NCT02365649|559971749|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
155147247|NCT01433172|559971755|FG000|Overall Study|Withdrawal by Subject|0|||
155147248|NCT01433172|559971756|FG001|Overall Study|Withdrawal by Subject|1|||
155147249|NCT01433172|559971757|FG002|Overall Study|Withdrawal by Subject|0|||
155147250|NCT01433172|559971755|FG000|Overall Study|Disease Progression|0|||
155147251|NCT01433172|559971756|FG001|Overall Study|Disease Progression|0|||
155194931|NCT01193842|560151278|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
155194932|NCT01193842|560151279|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155194933|NCT01193842|560151280|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
155147252|NCT01433172|559971757|FG002|Overall Study|Disease Progression|1|||
155147253|NCT01433172|559971755|FG000|Overall Study|Death|0|||
155194934|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Death|0|||
155147254|NCT01433172|559971756|FG001|Overall Study|Death|2|||
155147255|NCT01433172|559971757|FG002|Overall Study|Death|0|||
155147256|NCT03084796|559971760|FG000|Overall Study|Adverse Event|4|||
155194935|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Death|0|||
155194936|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Death|0|||
155194937|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Death|1|||
155194938|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Death|1|||
155194939|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Adverse Event|0|||
155194940|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Adverse Event|0|||
155194941|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Adverse Event|0|||
155194942|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Adverse Event|5|||
155194943|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Adverse Event|3|||
155194944|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
155194945|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
155194946|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
155194947|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
155194948|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
155194949|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Ineligible|0|||
155194950|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Ineligible|0|||
155194951|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Ineligible|0|||
155194952|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Ineligible|0|||
155194953|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Ineligible|1|||
155194954|NCT01193842|560151276|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
155194955|NCT01193842|560151277|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
155194956|NCT01193842|560151278|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
155194957|NCT01193842|560151279|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
155194958|NCT01193842|560151280|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
155194959|NCT02484690|560151282|FG000|Overall Study|Adverse Event|1|||
155194960|NCT02484690|560151283|FG001|Overall Study|Adverse Event|3|||
155194961|NCT02484690|560151284|FG002|Overall Study|Adverse Event|0|||
155194962|NCT02484690|560151285|FG003|Overall Study|Adverse Event|0|||
155194963|NCT02484690|560151286|FG004|Overall Study|Adverse Event|5|||
155194964|NCT02484690|560151282|FG000|Overall Study|Death|0|||
155194965|NCT02484690|560151283|FG001|Overall Study|Death|0|||
155194966|NCT02484690|560151284|FG002|Overall Study|Death|0|||
155194967|NCT02484690|560151285|FG003|Overall Study|Death|0|||
155194968|NCT02484690|560151286|FG004|Overall Study|Death|1|||
155194969|NCT02484690|560151282|FG000|Overall Study|Withdrawal by Subject|1|||
155194970|NCT02484690|560151283|FG001|Overall Study|Withdrawal by Subject|3|||
155194971|NCT02484690|560151284|FG002|Overall Study|Withdrawal by Subject|1|||
155194972|NCT02484690|560151285|FG003|Overall Study|Withdrawal by Subject|2|||
155194973|NCT02484690|560151286|FG004|Overall Study|Withdrawal by Subject|0|||
155194974|NCT02484690|560151282|FG000|Overall Study|Physician Decision|2|||
155194975|NCT02484690|560151283|FG001|Overall Study|Physician Decision|0|||
155194976|NCT02484690|560151284|FG002|Overall Study|Physician Decision|1|||
155194977|NCT02484690|560151285|FG003|Overall Study|Physician Decision|0|||
155194978|NCT02484690|560151286|FG004|Overall Study|Physician Decision|0|||
155194979|NCT02484690|560151282|FG000|Overall Study|Lost to Follow-up|0|||
155194980|NCT02484690|560151283|FG001|Overall Study|Lost to Follow-up|0|||
155194981|NCT02484690|560151284|FG002|Overall Study|Lost to Follow-up|1|||
155194982|NCT02484690|560151285|FG003|Overall Study|Lost to Follow-up|0|||
155194983|NCT02484690|560151286|FG004|Overall Study|Lost to Follow-up|0|||
155194984|NCT01757535|560151287|FG000|Overall Study|Disease Relapse|151|||
155194985|NCT01757535|560151288|FG001|Overall Study|Disease Relapse|181|||
155194986|NCT01757535|560151287|FG000|Overall Study|Other Reasons|28|||
155194987|NCT01757535|560151288|FG001|Overall Study|Other Reasons|27|||
155194988|NCT01757535|560151287|FG000|Overall Study|Adverse Event|31|||
155194989|NCT01757535|560151288|FG001|Overall Study|Adverse Event|11|||
155194990|NCT01757535|560151287|FG000|Overall Study|Withdrew Consent|19|||
155194991|NCT01757535|560151288|FG001|Overall Study|Withdrew Consent|13|||
155194992|NCT01757535|560151287|FG000|Overall Study|Physician Decision|7|||
155194993|NCT01757535|560151288|FG001|Overall Study|Physician Decision|0|||
155194994|NCT01757535|560151287|FG000|Overall Study|Death|2|||
155194995|NCT01757535|560151288|FG001|Overall Study|Death|2|||
155194996|NCT00589290|560151289|FG000|Overall Study|Withdrawal by Subject|1|||
155194997|NCT03487549|560151294|FG000|Overall Study|Protocol Violation|0|||
155194998|NCT03487549|560151295|FG001|Overall Study|Protocol Violation|1|||
155194999|NCT03487549|560151294|FG000|Overall Study|Lost to Follow-up|2|||
155195000|NCT03487549|560151295|FG001|Overall Study|Lost to Follow-up|1|||
155195001|NCT03487549|560151294|FG000|Overall Study|Withdrawal by Subject|2|||
155195002|NCT03487549|560151295|FG001|Overall Study|Withdrawal by Subject|0|||
155195003|NCT02323113|560152796|FG000|Overall Study|Adverse Event|3|||
155195004|NCT02323113|560152797|FG001|Overall Study|Adverse Event|3|||
155195005|NCT02323113|560152798|FG002|Overall Study|Adverse Event|2|||
155195006|NCT02323113|560152799|FG003|Overall Study|Adverse Event|5|||
155195007|NCT02323113|560152800|FG004|Overall Study|Adverse Event|8|||
155195008|NCT02323113|560152801|FG005|Overall Study|Adverse Event|3|||
155195009|NCT02323113|560152802|FG006|Overall Study|Adverse Event|6|||
155195010|NCT02323113|560152803|FG007|Overall Study|Adverse Event|0|||
155195011|NCT02323113|560152796|FG000|Overall Study|Progressive Disease|0|||
155195012|NCT02323113|560152797|FG001|Overall Study|Progressive Disease|1|||
155195013|NCT02323113|560152798|FG002|Overall Study|Progressive Disease|1|||
155195014|NCT02323113|560152799|FG003|Overall Study|Progressive Disease|0|||
155195015|NCT02323113|560152800|FG004|Overall Study|Progressive Disease|0|||
155195016|NCT02323113|560152801|FG005|Overall Study|Progressive Disease|3|||
155195017|NCT02323113|560152802|FG006|Overall Study|Progressive Disease|0|||
155195018|NCT02323113|560152803|FG007|Overall Study|Progressive Disease|0|||
155195019|NCT02323113|560152796|FG000|Overall Study|Symptomatic Deterioration|0|||
155195020|NCT02323113|560152797|FG001|Overall Study|Symptomatic Deterioration|0|||
155195021|NCT02323113|560152798|FG002|Overall Study|Symptomatic Deterioration|1|||
155195022|NCT02323113|560152799|FG003|Overall Study|Symptomatic Deterioration|0|||
155195023|NCT02323113|560152800|FG004|Overall Study|Symptomatic Deterioration|1|||
155195024|NCT02323113|560152801|FG005|Overall Study|Symptomatic Deterioration|0|||
155195025|NCT02323113|560152802|FG006|Overall Study|Symptomatic Deterioration|0|||
155195026|NCT02323113|560152803|FG007|Overall Study|Symptomatic Deterioration|0|||
155195027|NCT02323113|560152796|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
155195028|NCT02323113|560152797|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
155195029|NCT02323113|560152798|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195030|NCT02323113|560152799|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195031|NCT02323113|560152800|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195032|NCT02323113|560152801|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
155195033|NCT02323113|560152802|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195034|NCT02323113|560152803|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
155195035|NCT02323113|560152796|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195036|NCT02323113|560152797|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
155195037|NCT02323113|560152798|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195038|NCT02323113|560152799|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195039|NCT02323113|560152800|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195040|NCT02323113|560152801|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195041|NCT02323113|560152802|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195042|NCT02323113|560152803|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
155195043|NCT02280304|560152806|FG000|Overall Study|Lost to Follow-up|7|||
155195044|NCT02280304|560152807|FG001|Overall Study|Lost to Follow-up|8|||
155195045|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
155147257|NCT03084796|559971761|FG001|Overall Study|Adverse Event|5|||
155147258|NCT03084796|559971762|FG002|Overall Study|Adverse Event|6|||
155147259|NCT03084796|559971763|FG003|Overall Study|Adverse Event|2|||
155147260|NCT03084796|559971764|FG004|Overall Study|Adverse Event|3|||
155147261|NCT03084796|559971765|FG005|Overall Study|Adverse Event|5|||
155147262|NCT03084796|559971760|FG000|Overall Study|Withdrawal by Subject|3|||
155195046|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
155195047|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
155195048|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
155195049|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
155195050|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
155195051|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
155195052|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
155195053|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
155195054|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195055|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195056|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195057|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195058|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195059|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195060|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
155195061|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
155195062|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195063|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195064|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195065|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195066|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195067|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195068|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
155195069|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
155195070|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195071|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195072|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195073|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155147263|NCT03084796|559971761|FG001|Overall Study|Withdrawal by Subject|5|||
155147264|NCT03084796|559971762|FG002|Overall Study|Withdrawal by Subject|2|||
155147265|NCT03084796|559971763|FG003|Overall Study|Withdrawal by Subject|1|||
155147266|NCT03084796|559971764|FG004|Overall Study|Withdrawal by Subject|3|||
155147267|NCT03084796|559971765|FG005|Overall Study|Withdrawal by Subject|0|||
155147268|NCT03084796|559971760|FG000|Overall Study|Protocol Violation|0|||
155147269|NCT03084796|559971761|FG001|Overall Study|Protocol Violation|0|||
155147270|NCT03084796|559971762|FG002|Overall Study|Protocol Violation|1|||
155147271|NCT03084796|559971763|FG003|Overall Study|Protocol Violation|0|||
155147272|NCT03084796|559971764|FG004|Overall Study|Protocol Violation|1|||
155147273|NCT03084796|559971765|FG005|Overall Study|Protocol Violation|1|||
155195074|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195075|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195076|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
155195077|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
155195078|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195079|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195080|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195081|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195082|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195083|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195084|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
155195085|NCT00533897|560152813|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
155195086|NCT00533897|560152814|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195087|NCT00533897|560152815|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195088|NCT00533897|560152816|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195089|NCT00533897|560152817|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195090|NCT00533897|560152818|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195091|NCT00533897|560152819|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195092|NCT00533897|560152820|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
155195093|NCT00533897|560152813|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195094|NCT00533897|560152814|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
155195095|NCT00533897|560152815|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
155195096|NCT00533897|560152816|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195097|NCT00533897|560152817|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195098|NCT00533897|560152818|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195099|NCT00533897|560152819|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195100|NCT00533897|560152820|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
155195101|NCT00533897|560152813|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195102|NCT00533897|560152814|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195103|NCT00533897|560152815|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
155195104|NCT00533897|560152816|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195105|NCT00533897|560152817|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195106|NCT00533897|560152818|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195107|NCT00533897|560152819|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195108|NCT00533897|560152820|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
155195109|NCT00533897|560152813|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195110|NCT00533897|560152814|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195111|NCT00533897|560152815|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155147274|NCT03084796|559971760|FG000|Overall Study|Lack of Efficacy|0|||
155147275|NCT03084796|559971761|FG001|Overall Study|Lack of Efficacy|0|||
155147276|NCT03084796|559971762|FG002|Overall Study|Lack of Efficacy|1|||
155147277|NCT03084796|559971763|FG003|Overall Study|Lack of Efficacy|0|||
155147278|NCT03084796|559971764|FG004|Overall Study|Lack of Efficacy|1|||
155147279|NCT03084796|559971765|FG005|Overall Study|Lack of Efficacy|0|||
155147280|NCT03084796|559971760|FG000|Overall Study|Lost to Follow-up|0|||
155147281|NCT03084796|559971761|FG001|Overall Study|Lost to Follow-up|0|||
155147282|NCT03084796|559971762|FG002|Overall Study|Lost to Follow-up|1|||
155147283|NCT03084796|559971763|FG003|Overall Study|Lost to Follow-up|1|||
155147284|NCT03084796|559971764|FG004|Overall Study|Lost to Follow-up|3|||
155147285|NCT03084796|559971765|FG005|Overall Study|Lost to Follow-up|1|||
155147286|NCT03084796|559971760|FG000|Overall Study|Randomization error|0|||
155147287|NCT03084796|559971761|FG001|Overall Study|Randomization error|0|||
155147288|NCT03084796|559971762|FG002|Overall Study|Randomization error|1|||
155147289|NCT03084796|559971763|FG003|Overall Study|Randomization error|0|||
155147290|NCT03084796|559971764|FG004|Overall Study|Randomization error|0|||
155147291|NCT03084796|559971765|FG005|Overall Study|Randomization error|0|||
155147292|NCT02741245|559971767|FG000|Overall Study|Adverse Event|0|||
155147293|NCT02741245|559971768|FG001|Overall Study|Adverse Event|0|||
155147294|NCT02741245|559971769|FG002|Overall Study|Adverse Event|0|||
155147295|NCT02741245|559971770|FG003|Overall Study|Adverse Event|2|||
155147296|NCT02741245|559971771|FG004|Overall Study|Adverse Event|2|||
155147297|NCT02741245|559971767|FG000|Overall Study|Protocol Violation|0|||
155147298|NCT02741245|559971768|FG001|Overall Study|Protocol Violation|1|||
155147299|NCT02741245|559971769|FG002|Overall Study|Protocol Violation|0|||
155147300|NCT02741245|559971770|FG003|Overall Study|Protocol Violation|1|||
155195112|NCT00533897|560152816|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195113|NCT00533897|560152817|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155147301|NCT02741245|559971771|FG004|Overall Study|Protocol Violation|0|||
155195114|NCT00533897|560152818|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
155195115|NCT00533897|560152819|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195116|NCT00533897|560152820|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
155195117|NCT00533897|560152813|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195118|NCT00533897|560152814|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195119|NCT00533897|560152815|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195120|NCT00533897|560152816|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195121|NCT00533897|560152817|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195122|NCT00533897|560152818|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
155195123|NCT00533897|560152819|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195124|NCT00533897|560152820|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
155195125|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195126|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195127|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195128|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195129|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195130|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
155195131|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
155195132|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
155195133|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Death|0|||
155195134|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Death|0|||
155195135|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Death|0|||
155195136|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Death|0|||
155195137|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Death|0|||
155195138|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Death|0|||
155195139|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Death|1|||
155195140|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Death|3|||
155195141|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195142|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195143|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195144|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195145|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195146|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
155195147|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
155195148|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
155195149|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195150|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195151|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195152|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195153|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195154|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195155|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
155195156|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
155195157|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Adverse Event|0|||
155195158|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Adverse Event|0|||
155195159|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Adverse Event|0|||
155195160|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Adverse Event|0|||
155147302|NCT02741245|559971767|FG000|Overall Study|Withdrawal by Subject|0|||
155147303|NCT02741245|559971768|FG001|Overall Study|Withdrawal by Subject|0|||
155147304|NCT02741245|559971769|FG002|Overall Study|Withdrawal by Subject|0|||
155147305|NCT02741245|559971770|FG003|Overall Study|Withdrawal by Subject|1|||
155147306|NCT02741245|559971771|FG004|Overall Study|Withdrawal by Subject|0|||
155147307|NCT01787461|559971772|FG000|Overall Study|Adverse Event|4|||
155147308|NCT01787461|559971773|FG001|Overall Study|Adverse Event|3|||
155147309|NCT01787461|559971772|FG000|Overall Study|Lost to Follow-up|3|||
155147310|NCT01787461|559971773|FG001|Overall Study|Lost to Follow-up|2|||
155147311|NCT01787461|559971772|FG000|Overall Study|No longer met eligibility criteria|1|||
155195161|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Adverse Event|0|||
155195162|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Adverse Event|0|||
155195163|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Adverse Event|2|||
155147312|NCT01787461|559971773|FG001|Overall Study|No longer met eligibility criteria|0|||
155147313|NCT01787461|559971772|FG000|Overall Study|Withdrawal by Subject|3|||
155147314|NCT01787461|559971773|FG001|Overall Study|Withdrawal by Subject|4|||
155147315|NCT01787461|559971772|FG000|Overall Study|Protocol Violation|3|||
155147316|NCT01787461|559971773|FG001|Overall Study|Protocol Violation|0|||
155195164|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Adverse Event|5|||
155195165|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Pregnancy|0|||
155147317|NCT03259555|559971774|FG000|Overall Study|Adverse Event|6|||
155147318|NCT03259555|559971775|FG001|Overall Study|Adverse Event|4|||
155147319|NCT03259555|559971774|FG000|Overall Study|Lack of Efficacy|6|||
155147320|NCT03259555|559971775|FG001|Overall Study|Lack of Efficacy|4|||
155147321|NCT03259555|559971774|FG000|Overall Study|Lost to Follow-up|0|||
155195166|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Pregnancy|0|||
155195167|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Pregnancy|0|||
155195168|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Pregnancy|0|||
155195169|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Pregnancy|0|||
155195170|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Pregnancy|0|||
155195171|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Pregnancy|0|||
155195172|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Pregnancy|2|||
155195173|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195174|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195175|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195176|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195177|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195178|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
155195179|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
155195180|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
155195181|NCT00533897|560152813|FG000|Long Term Extension (LTE)|Other|0|||
155195182|NCT00533897|560152814|FG001|Long Term Extension (LTE)|Other|0|||
155195183|NCT00533897|560152815|FG002|Long Term Extension (LTE)|Other|0|||
155195184|NCT00533897|560152816|FG003|Long Term Extension (LTE)|Other|0|||
155195185|NCT00533897|560152817|FG004|Long Term Extension (LTE)|Other|0|||
155195186|NCT00533897|560152818|FG005|Long Term Extension (LTE)|Other|0|||
155195187|NCT00533897|560152819|FG006|Long Term Extension (LTE)|Other|1|||
155195188|NCT00533897|560152820|FG007|Long Term Extension (LTE)|Other|6|||
155195189|NCT01546207|560152834|FG000|Overall Study|Death|1|||
155195190|NCT01626456|560152835|FG000|Overall Study|Withdrawal by Subject|21|||
155195191|NCT01626456|560152836|FG001|Overall Study|Withdrawal by Subject|46|||
155195192|NCT01626456|560152835|FG000|Overall Study|Adverse Event|2|||
155195193|NCT01626456|560152836|FG001|Overall Study|Adverse Event|27|||
155195194|NCT01626456|560152835|FG000|Overall Study|Lost to Follow-up|2|||
155195195|NCT01626456|560152836|FG001|Overall Study|Lost to Follow-up|27|||
155195196|NCT01626456|560152835|FG000|Overall Study|Lack of Efficacy|6|||
155195197|NCT01626456|560152836|FG001|Overall Study|Lack of Efficacy|7|||
155195198|NCT01626456|560152835|FG000|Overall Study|Physician Decision|1|||
155195199|NCT01626456|560152836|FG001|Overall Study|Physician Decision|4|||
155195200|NCT01626456|560152835|FG000|Overall Study|Protocol Violation|1|||
155195201|NCT01626456|560152836|FG001|Overall Study|Protocol Violation|1|||
155195202|NCT01626456|560152835|FG000|Overall Study|Site Closure|2|||
155195203|NCT01626456|560152836|FG001|Overall Study|Site Closure|3|||
155195204|NCT01626456|560152835|FG000|Overall Study|Incarceration|0|||
155195205|NCT01626456|560152836|FG001|Overall Study|Incarceration|2|||
155195206|NCT00713323|560152837|FG000|Overall Study|Adverse Event|75|||
155195207|NCT00713323|560152837|FG000|Overall Study|Withdrawal by Subject|15|||
155195208|NCT00713323|560152837|FG000|Overall Study|Lost to Follow-up|11|||
155195209|NCT00713323|560152837|FG000|Overall Study|Lack of Efficacy|36|||
155195210|NCT00713323|560152837|FG000|Overall Study|Low creatine clearance at screening|1|||
155195211|NCT00713323|560152837|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
155195212|NCT00713323|560152837|FG000|Overall Study|Surgery cured allodynic pain|1|||
155195213|NCT00713323|560152837|FG000|Overall Study|Pain free|1|||
155195214|NCT00713323|560152837|FG000|Overall Study|Non-compliance|1|||
155195215|NCT00713323|560152837|FG000|Overall Study|Pain resolved|1|||
155195216|NCT00713323|560152837|FG000|Overall Study|Subject travelling to USA|1|||
155195217|NCT00713323|560152837|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
155195218|NCT00713323|560152837|FG000|Overall Study|Treatment that may interact with Sativex|1|||
155195219|NCT00506662|560152838|FG000|Overall Study|Adverse Event|0|||
155195220|NCT00506662|560152839|FG001|Overall Study|Adverse Event|2|||
155195221|NCT00506662|560152838|FG000|Overall Study|Lack of Efficacy|1|||
155195222|NCT00506662|560152839|FG001|Overall Study|Lack of Efficacy|0|||
155195223|NCT00506662|560152838|FG000|Overall Study|Protocol Violation|2|||
155195224|NCT00506662|560152839|FG001|Overall Study|Protocol Violation|4|||
155195225|NCT00506662|560152838|FG000|Overall Study|Trial terminated|10|||
155195226|NCT00506662|560152839|FG001|Overall Study|Trial terminated|16|||
155195227|NCT00506662|560152838|FG000|Overall Study|Not recorded|4|||
155195228|NCT00506662|560152839|FG001|Overall Study|Not recorded|6|||
155195229|NCT03019185|560152844|FG000|Overall Study|Lost to Follow-up|3|||
155195230|NCT03019185|560152845|FG001|Overall Study|Lost to Follow-up|0|||
155195231|NCT03019185|560152846|FG002|Overall Study|Lost to Follow-up|2|||
155195232|NCT03019185|560152844|FG000|Overall Study|Withdrawal by Subject|1|||
155195233|NCT03019185|560152845|FG001|Overall Study|Withdrawal by Subject|1|||
155195234|NCT03019185|560152846|FG002|Overall Study|Withdrawal by Subject|0|||
155195235|NCT03019185|560152844|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
155195236|NCT03019185|560152845|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
155195237|NCT03019185|560152846|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
155195238|NCT03019185|560152844|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
155195239|NCT03019185|560152845|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
155195240|NCT03019185|560152846|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
155195241|NCT02764333|560152847|FG000|Overall Study|Ineligible|1|||
155147322|NCT03259555|559971775|FG001|Overall Study|Lost to Follow-up|2|||
155147323|NCT03259555|559971774|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155147324|NCT03259555|559971775|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155147325|NCT03259555|559971774|FG000|Overall Study|Progressive Disease|0|||
155147326|NCT03259555|559971775|FG001|Overall Study|Progressive Disease|2|||
155147327|NCT03259555|559971774|FG000|Overall Study|Withdrawal by Subject|19|||
155147328|NCT03259555|559971775|FG001|Overall Study|Withdrawal by Subject|16|||
155147329|NCT03259555|559971774|FG000|Overall Study|Physician Decision|1|||
155147330|NCT03259555|559971775|FG001|Overall Study|Physician Decision|2|||
155147331|NCT03259555|559971774|FG000|Overall Study|Other|1|||
155147332|NCT03259555|559971775|FG001|Overall Study|Other|0|||
155147333|NCT02800863|559971776|FG000|Overall Study|Adverse Event|14|||
155147334|NCT02800863|559971776|FG000|Overall Study|Another Device Implanted|1|||
155147335|NCT02800863|559971776|FG000|Overall Study|Device Explanted|1|||
155147336|NCT02800863|559971776|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
155147337|NCT02800863|559971776|FG000|Overall Study|Health Issues|1|||
155147338|NCT02800863|559971776|FG000|Overall Study|Insurance Denial|8|||
155147339|NCT02800863|559971776|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
155147340|NCT02800863|559971776|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
155147341|NCT02800863|559971776|FG000|Overall Study|Screen Failure|1|||
155147342|NCT02800863|559971776|FG000|Overall Study|Sponsor Request|6|||
155147343|NCT02800863|559971776|FG000|Overall Study|Death|3|||
155147344|NCT02800863|559971776|FG000|Overall Study|Subject Implant at Another Facility|1|||
155147345|NCT02800863|559971776|FG000|Overall Study|Lost to Follow-up|26|||
155147346|NCT02800863|559971776|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
155147347|NCT02800863|559971776|FG000|Overall Study|Subject and/or Family Request|64|||
155147348|NCT02800863|559971776|FG000|Overall Study|Trial Failure|81|||
155147349|NCT02800863|559971776|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
155147350|NCT00607087|559971777|FG000|Overall Study|Withdrawal by Subject|9|||
155147351|NCT00607087|559971778|FG001|Overall Study|Withdrawal by Subject|4|||
155147352|NCT00607087|559971779|FG002|Overall Study|Withdrawal by Subject|4|||
155147353|NCT00607087|559971777|FG000|Overall Study|Adverse Event|3|||
155147354|NCT00607087|559971778|FG001|Overall Study|Adverse Event|2|||
155147355|NCT00607087|559971779|FG002|Overall Study|Adverse Event|3|||
155147356|NCT00607087|559971777|FG000|Overall Study|Other reason|1|||
155147357|NCT00607087|559971778|FG001|Overall Study|Other reason|5|||
155147358|NCT00607087|559971779|FG002|Overall Study|Other reason|2|||
155147359|NCT00607087|559971777|FG000|Overall Study|Poor compliance to protocol|1|||
155147360|NCT00607087|559971778|FG001|Overall Study|Poor compliance to protocol|0|||
155147361|NCT00607087|559971779|FG002|Overall Study|Poor compliance to protocol|1|||
155147362|NCT00607087|559971777|FG000|Overall Study|Lost to Follow-up|1|||
155147363|NCT00607087|559971778|FG001|Overall Study|Lost to Follow-up|0|||
155147364|NCT00607087|559971779|FG002|Overall Study|Lost to Follow-up|0|||
155147365|NCT00607087|559971777|FG000|Period 1|Withdrawal by Subject|7|||
155147366|NCT00607087|559971778|FG001|Period 1|Withdrawal by Subject|2|||
155147367|NCT00607087|559971779|FG002|Period 1|Withdrawal by Subject|3|||
155147368|NCT00607087|559971777|FG000|Period 1|Adverse Event|3|||
155147369|NCT00607087|559971778|FG001|Period 1|Adverse Event|0|||
155147370|NCT00607087|559971779|FG002|Period 1|Adverse Event|0|||
155147371|NCT00607087|559971777|FG000|Period 1|Poor compliance to protocol|1|||
155147372|NCT00607087|559971778|FG001|Period 1|Poor compliance to protocol|0|||
155147373|NCT00607087|559971779|FG002|Period 1|Poor compliance to protocol|0|||
155147374|NCT00607087|559971777|FG000|Period 1|Lost to Follow-up|1|||
155147375|NCT00607087|559971778|FG001|Period 1|Lost to Follow-up|0|||
155147376|NCT00607087|559971779|FG002|Period 1|Lost to Follow-up|0|||
155147377|NCT00607087|559971777|FG000|Period 1|Other reason|0|||
155147378|NCT00607087|559971778|FG001|Period 1|Other reason|4|||
155147379|NCT00607087|559971779|FG002|Period 1|Other reason|2|||
155147380|NCT00607087|559971777|FG000|Period 2|Withdrawal by Subject|0|||
155147381|NCT00607087|559971778|FG001|Period 2|Withdrawal by Subject|1|||
155147382|NCT00607087|559971779|FG002|Period 2|Withdrawal by Subject|1|||
155147383|NCT00607087|559971777|FG000|Period 2|Other reason|1|||
155147384|NCT00607087|559971778|FG001|Period 2|Other reason|1|||
155147385|NCT00607087|559971779|FG002|Period 2|Other reason|0|||
155147386|NCT00607087|559971777|FG000|Period 2|Adverse Event|0|||
155147387|NCT00607087|559971778|FG001|Period 2|Adverse Event|1|||
155147388|NCT00607087|559971779|FG002|Period 2|Adverse Event|3|||
155147389|NCT00607087|559971777|FG000|Period 2|Poor compliance to protocol|0|||
155147390|NCT00607087|559971778|FG001|Period 2|Poor compliance to protocol|0|||
155147391|NCT00607087|559971779|FG002|Period 2|Poor compliance to protocol|1|||
155147392|NCT00607087|559971777|FG000|Period 3|Withdrawal by Subject|2|||
155147393|NCT00607087|559971778|FG001|Period 3|Withdrawal by Subject|1|||
155147394|NCT00607087|559971779|FG002|Period 3|Withdrawal by Subject|0|||
155147395|NCT00607087|559971777|FG000|Period 3|Adverse Event|0|||
155147396|NCT00607087|559971778|FG001|Period 3|Adverse Event|1|||
155147397|NCT00607087|559971779|FG002|Period 3|Adverse Event|0|||
155147398|NCT01774799|559971781|FG000|Overall Study|Lost to Follow-up|1|||
155147399|NCT01774799|559971782|FG001|Overall Study|Lost to Follow-up|1|||
155147400|NCT01774799|559971783|FG002|Overall Study|Lost to Follow-up|0|||
155195242|NCT03626168|560152848|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155195243|NCT03626168|560152849|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
155195244|NCT03626168|560152848|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
155195245|NCT03626168|560152849|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
155195246|NCT03626168|560152848|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155195247|NCT03626168|560152849|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
155195248|NCT01772160|560152850|FG000|Overall Study|Death|3|||
155195249|NCT01772160|560152850|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
155195250|NCT01772160|560152850|FG000|Overall Study|Consent withdrawal|3|||
155195251|NCT01772160|560152850|FG000|Overall Study|Migrated / moved from the study area|4|||
155195252|NCT01772160|560152850|FG000|Overall Study|Lost to Follow-up|30|||
155195253|NCT01772160|560152850|FG000|Overall Study|Other|5|||
155195254|NCT00071396|560152851|FG000|Overall Study|Withdrawal by Subject|1|||
155195255|NCT00071396|560152851|FG000|Overall Study|Physician Decision|2|||
155195256|NCT01032174|560152852|FG000|Overall Study|Adverse Event|0|||
155195257|NCT01032174|560152853|FG001|Overall Study|Adverse Event|1|||
155195258|NCT00386607|560152854|FG000|Core|Adverse Event|40|||
155195259|NCT00386607|560152855|FG001|Core|Adverse Event|0|||
155195260|NCT00386607|560152854|FG000|Core|Abnormal laboratory value(s)|3|||
155195261|NCT00386607|560152855|FG001|Core|Abnormal laboratory value(s)|0|||
155195262|NCT00386607|560152854|FG000|Core|Unsatisfactory therapeutic effect|23|||
155195263|NCT00386607|560152855|FG001|Core|Unsatisfactory therapeutic effect|0|||
155195264|NCT00386607|560152854|FG000|Core|Condition no longer requires study drug|4|||
155195265|NCT00386607|560152855|FG001|Core|Condition no longer requires study drug|0|||
155195266|NCT00386607|560152854|FG000|Core|Patient withdrew consent|15|||
155195267|NCT00386607|560152855|FG001|Core|Patient withdrew consent|0|||
155195268|NCT00386607|560152854|FG000|Core|Lost to Follow-up|23|||
155195269|NCT00386607|560152855|FG001|Core|Lost to Follow-up|0|||
155195270|NCT00386607|560152854|FG000|Core|Administrative problems|1|||
155195271|NCT00386607|560152855|FG001|Core|Administrative problems|0|||
155195272|NCT00386607|560152854|FG000|Core|Protocol Deviation|6|||
155195273|NCT00386607|560152855|FG001|Core|Protocol Deviation|0|||
155195274|NCT00386607|560152854|FG000|Extension|Adverse Event|0|||
155195275|NCT00386607|560152855|FG001|Extension|Adverse Event|6|||
155195276|NCT00386607|560152854|FG000|Extension|Abnormal laboratory value(s)|0|||
155195277|NCT00386607|560152855|FG001|Extension|Abnormal laboratory value(s)|1|||
155195278|NCT00386607|560152854|FG000|Extension|Administrative problems|0|||
155195279|NCT00386607|560152855|FG001|Extension|Administrative problems|1|||
155195280|NCT00386607|560152854|FG000|Extension|Lost to Follow-up|0|||
155195281|NCT00386607|560152855|FG001|Extension|Lost to Follow-up|3|||
155195282|NCT00386607|560152854|FG000|Extension|Patient withdrew consent|0|||
155195283|NCT00386607|560152855|FG001|Extension|Patient withdrew consent|5|||
155195284|NCT00386607|560152854|FG000|Extension|Unsatisfactory therapeutic effect|0|||
155195285|NCT00386607|560152855|FG001|Extension|Unsatisfactory therapeutic effect|1|||
155195286|NCT02761733|560152856|FG000|Overall Study|Death|3|||
155195287|NCT02761733|560152857|FG001|Overall Study|Death|5|||
155195288|NCT02761733|560152858|FG002|Overall Study|Death|1|||
155195289|NCT02761733|560152859|FG003|Overall Study|Death|1|||
155195290|NCT02761733|560152856|FG000|Overall Study|Lost to Follow-up|6|||
155195291|NCT02761733|560152857|FG001|Overall Study|Lost to Follow-up|7|||
155195292|NCT02761733|560152858|FG002|Overall Study|Lost to Follow-up|0|||
155195293|NCT02761733|560152859|FG003|Overall Study|Lost to Follow-up|3|||
155195294|NCT02761733|560152856|FG000|Overall Study|Physician Decision|4|||
155195295|NCT02761733|560152857|FG001|Overall Study|Physician Decision|0|||
155195296|NCT02761733|560152858|FG002|Overall Study|Physician Decision|0|||
155195297|NCT02761733|560152859|FG003|Overall Study|Physician Decision|0|||
155147401|NCT01774799|559971784|FG003|Overall Study|Lost to Follow-up|0|||
155147402|NCT03649074|559971785|FG000|Overall Study|Lost to Follow-up|2|||
155147403|NCT03649074|559971786|FG001|Overall Study|Lost to Follow-up|1|||
155147404|NCT03649074|559971785|FG000|Overall Study|Adverse Event|1|||
155147405|NCT03649074|559971786|FG001|Overall Study|Adverse Event|0|||
155147406|NCT03649074|559971785|FG000|Overall Study|Physician Decision|1|||
155147407|NCT03649074|559971786|FG001|Overall Study|Physician Decision|0|||
155147408|NCT03649074|559971785|FG000|Overall Study|Withdrawal by Subject|0|||
155147409|NCT03649074|559971786|FG001|Overall Study|Withdrawal by Subject|2|||
155147410|NCT03649074|559971785|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
155147411|NCT03649074|559971786|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
155147412|NCT03649074|559971785|FG000|Overall Study|Other|1|||
155195298|NCT02761733|560152856|FG000|Overall Study|Withdrawal by Subject|2|||
155195299|NCT02761733|560152857|FG001|Overall Study|Withdrawal by Subject|0|||
155195300|NCT02761733|560152858|FG002|Overall Study|Withdrawal by Subject|0|||
155195301|NCT02761733|560152859|FG003|Overall Study|Withdrawal by Subject|0|||
155195302|NCT02761733|560152856|FG000|Overall Study|Discharged from Study Site|10|||
155195303|NCT02761733|560152857|FG001|Overall Study|Discharged from Study Site|9|||
155195304|NCT02761733|560152858|FG002|Overall Study|Discharged from Study Site|25|||
155195305|NCT02761733|560152859|FG003|Overall Study|Discharged from Study Site|11|||
155195306|NCT02761733|560152856|FG000|Overall Study|Cognitive Impairment|5|||
155147413|NCT03649074|559971786|FG001|Overall Study|Other|0|||
155147414|NCT04332107|559971789|FG000|Day 3|Lost to Follow-up|23|||
155147415|NCT04332107|559971790|FG001|Day 3|Lost to Follow-up|14|||
155147416|NCT04332107|559971789|FG000|Day 3|Missing outcome data|3|||
155147417|NCT04332107|559971790|FG001|Day 3|Missing outcome data|6|||
155147418|NCT04332107|559971789|FG000|Day 14|Lost to Follow-up|13|||
155147419|NCT04332107|559971790|FG001|Day 14|Lost to Follow-up|4|||
155147420|NCT04332107|559971789|FG000|Day 14|Missing outcome data|4|||
155147421|NCT04332107|559971790|FG001|Day 14|Missing outcome data|4|||
155147422|NCT04332107|559971789|FG000|Day 21|Lost to Follow-up|10|||
155147423|NCT04332107|559971790|FG001|Day 21|Lost to Follow-up|2|||
155147424|NCT00717249|559971791|FG000|Overall Study|Lens Discomfort|4|||
155147425|NCT00717249|559971792|FG001|Overall Study|Lens Discomfort|1|||
155147426|NCT00717249|559971791|FG000|Overall Study|Unsatisfactory visual Response|0|||
155147427|NCT00717249|559971792|FG001|Overall Study|Unsatisfactory visual Response|2|||
155147428|NCT00717249|559971791|FG000|Overall Study|Adverse Event|4|||
155147429|NCT00717249|559971792|FG001|Overall Study|Adverse Event|2|||
155147430|NCT00717249|559971791|FG000|Overall Study|Lost to Follow-up|2|||
155147431|NCT00717249|559971792|FG001|Overall Study|Lost to Follow-up|0|||
155147432|NCT00717249|559971791|FG000|Overall Study|Withdrawal by Subject|1|||
155147433|NCT00717249|559971792|FG001|Overall Study|Withdrawal by Subject|2|||
155147434|NCT00717249|559971791|FG000|Overall Study|Pregnancy|6|||
155147435|NCT00717249|559971792|FG001|Overall Study|Pregnancy|3|||
155147436|NCT00717249|559971791|FG000|Overall Study|Protocol Violation|0|||
155147437|NCT00717249|559971792|FG001|Overall Study|Protocol Violation|2|||
155147438|NCT00717249|559971791|FG000|Overall Study|Subject became Ineligible|1|||
155147439|NCT00717249|559971792|FG001|Overall Study|Subject became Ineligible|1|||
155147440|NCT00717249|559971791|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
155147441|NCT00717249|559971792|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
155147442|NCT00717249|559971791|FG000|Overall Study|Gastric Surgery|0|||
155147443|NCT00717249|559971792|FG001|Overall Study|Gastric Surgery|1|||
155147444|NCT00717249|559971791|FG000|Overall Study|Diagnosed with Diabetes|1|||
155147445|NCT00717249|559971792|FG001|Overall Study|Diagnosed with Diabetes|0|||
155147446|NCT00717249|559971791|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
155147447|NCT00717249|559971792|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
155147448|NCT00717249|559971791|FG000|Overall Study|Subject relocated|1|||
155147449|NCT00717249|559971792|FG001|Overall Study|Subject relocated|0|||
155147450|NCT00717249|559971791|FG000|Overall Study|Headaches|1|||
155147451|NCT00717249|559971792|FG001|Overall Study|Headaches|0|||
155147452|NCT01670721|559971793|FG000|Overall Study|Participant's decision|15|||
155147453|NCT01670721|559971793|FG000|Overall Study|Other than specified above|38|||
155147454|NCT06172348|559971794|FG000|Treatment Period 2|Adverse Event|0|||
155147455|NCT06172348|559971795|FG001|Treatment Period 2|Adverse Event|0|||
155147456|NCT06172348|559971796|FG002|Treatment Period 2|Adverse Event|1|||
155147457|NCT06172348|559971797|FG003|Treatment Period 2|Adverse Event|0|||
155147458|NCT06172348|559971798|FG004|Treatment Period 2|Adverse Event|0|||
155147459|NCT06172348|559971799|FG005|Treatment Period 2|Adverse Event|0|||
155147460|NCT03799341|559971800|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
155147461|NCT03799341|559971801|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
155147462|NCT03799341|559971802|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
155147463|NCT03799341|559971800|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
155147464|NCT03799341|559971801|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
155147465|NCT03799341|559971802|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
155147466|NCT03799341|559971800|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
155147467|NCT03799341|559971801|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
155147468|NCT03799341|559971802|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
155147469|NCT03799341|559971800|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
155147470|NCT03799341|559971801|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
155147471|NCT03799341|559971802|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
155147472|NCT03799341|559971800|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
155147473|NCT03799341|559971801|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
155147474|NCT03799341|559971802|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
155147475|NCT03799341|559971800|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
155147476|NCT03799341|559971801|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
155147477|NCT03799341|559971802|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
155147478|NCT04037891|559971803|FG000|Open-label Period|Withdrawal by Subject|1|||
155147479|NCT04037891|559971804|FG001|Open-label Period|Withdrawal by Subject|0|||
155147480|NCT04037891|559971805|FG002|Open-label Period|Withdrawal by Subject|0|||
155147481|NCT04037891|559971803|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
155147482|NCT04037891|559971804|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
155147483|NCT04037891|559971805|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
155147484|NCT03446313|559971806|FG000|Overall Study|Lost to Follow-up|1|||
155147485|NCT03446313|559971807|FG001|Overall Study|Lost to Follow-up|2|||
155147486|NCT03446313|559971806|FG000|Overall Study|Failed primary screening|3|||
155147487|NCT03446313|559971807|FG001|Overall Study|Failed primary screening|0|||
155147488|NCT03446313|559971806|FG000|Overall Study|Diagnosed with terminal cancer|1|||
155147489|NCT03446313|559971807|FG001|Overall Study|Diagnosed with terminal cancer|0|||
155147490|NCT03446313|559971806|FG000|Overall Study|Excluded from analysis|1|||
155147491|NCT03446313|559971807|FG001|Overall Study|Excluded from analysis|1|||
155147492|NCT02360228|559971811|FG000|Overall Study|Withdrawal by Subject|1|||
155147493|NCT02360228|559971812|FG001|Overall Study|Withdrawal by Subject|0|||
155147494|NCT02360228|559971813|FG002|Overall Study|Withdrawal by Subject|0|||
155147495|NCT02360228|559971811|FG000|Overall Study|Self-discontinued medication|0|||
155147496|NCT02360228|559971812|FG001|Overall Study|Self-discontinued medication|1|||
155147497|NCT02360228|559971813|FG002|Overall Study|Self-discontinued medication|0|||
155147498|NCT02360228|559971811|FG000|Overall Study|Unstable symptoms during screening|0|||
155147499|NCT02360228|559971812|FG001|Overall Study|Unstable symptoms during screening|0|||
155147500|NCT02360228|559971813|FG002|Overall Study|Unstable symptoms during screening|1|||
155147501|NCT00350844|559971816|FG000|Overall Study|Lost to Follow-up|1|||
155147502|NCT01474317|559973134|FG000|Overall Study|Adverse Event|1|||
155147503|NCT01474317|559973134|FG000|Overall Study|Subject ineligible for study|1|||
155147504|NCT00453154|559973137|FG000|Double BIind Maintenance|Adverse Event|0|||
155147505|NCT00453154|559973138|FG001|Double BIind Maintenance|Adverse Event|0|||
155147506|NCT00453154|559973139|FG002|Double BIind Maintenance|Adverse Event|3|||
155147507|NCT00453154|559973140|FG003|Double BIind Maintenance|Adverse Event|12|||
155147508|NCT00453154|559973137|FG000|Double BIind Maintenance|Death|0|||
155147509|NCT00453154|559973138|FG001|Double BIind Maintenance|Death|0|||
155147510|NCT00453154|559973139|FG002|Double BIind Maintenance|Death|2|||
155147511|NCT00453154|559973140|FG003|Double BIind Maintenance|Death|1|||
155147512|NCT00453154|559973137|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
155147513|NCT00453154|559973138|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
155147514|NCT00453154|559973139|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
155147515|NCT00453154|559973140|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
155147516|NCT00453154|559973137|FG000|Double BIind Maintenance|Progression|0|||
155147517|NCT00453154|559973138|FG001|Double BIind Maintenance|Progression|0|||
155147518|NCT00453154|559973139|FG002|Double BIind Maintenance|Progression|29|||
155147519|NCT00453154|559973140|FG003|Double BIind Maintenance|Progression|26|||
155147520|NCT00453154|559973137|FG000|Double BIind Maintenance|Medical Issues|0|||
155147521|NCT00453154|559973138|FG001|Double BIind Maintenance|Medical Issues|0|||
155147522|NCT00453154|559973139|FG002|Double BIind Maintenance|Medical Issues|3|||
155147523|NCT00453154|559973140|FG003|Double BIind Maintenance|Medical Issues|1|||
155147524|NCT00453154|559973137|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
155147525|NCT00453154|559973138|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
155147526|NCT00453154|559973139|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
155147527|NCT00453154|559973140|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
155147528|NCT03629886|559973141|FG000|Overall Study|Migrated / moved from the study area|0|||
155147529|NCT03629886|559973142|FG001|Overall Study|Migrated / moved from the study area|55|||
155147530|NCT03629886|559973141|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
155147531|NCT03629886|559973142|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
155147532|NCT03629886|559973141|FG000|Overall Study|Study vaccine not administrated|0|||
155147533|NCT03629886|559973142|FG001|Overall Study|Study vaccine not administrated|3|||
155147534|NCT03629886|559973141|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
155147535|NCT03629886|559973142|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
155147536|NCT03629886|559973141|FG000|Overall Study|Refused vaccination step of the study|0|||
155147537|NCT03629886|559973142|FG001|Overall Study|Refused vaccination step of the study|44|||
155147538|NCT03291067|559973144|FG000|Overall Study|Adverse Event|0|||
155147539|NCT03291067|559973145|FG001|Overall Study|Adverse Event|2|||
155147540|NCT03291067|559973146|FG002|Overall Study|Adverse Event|17|||
155147541|NCT03291067|559973147|FG003|Overall Study|Adverse Event|3|||
155147542|NCT03291067|559973144|FG000|Overall Study|Lost to Follow-up|2|||
155147543|NCT03291067|559973145|FG001|Overall Study|Lost to Follow-up|1|||
155147544|NCT03291067|559973146|FG002|Overall Study|Lost to Follow-up|0|||
155147545|NCT03291067|559973147|FG003|Overall Study|Lost to Follow-up|1|||
155147546|NCT03291067|559973144|FG000|Overall Study|Physician Decision|0|||
155147547|NCT03291067|559973145|FG001|Overall Study|Physician Decision|0|||
155147548|NCT03291067|559973146|FG002|Overall Study|Physician Decision|1|||
155147549|NCT03291067|559973147|FG003|Overall Study|Physician Decision|0|||
155147550|NCT03291067|559973144|FG000|Overall Study|Protocol Violation|5|||
155147551|NCT03291067|559973145|FG001|Overall Study|Protocol Violation|3|||
155147552|NCT03291067|559973146|FG002|Overall Study|Protocol Violation|4|||
155147553|NCT03291067|559973147|FG003|Overall Study|Protocol Violation|2|||
155147554|NCT03291067|559973144|FG000|Overall Study|Withdrawal by Subject|3|||
155147555|NCT03291067|559973145|FG001|Overall Study|Withdrawal by Subject|4|||
155147556|NCT03291067|559973146|FG002|Overall Study|Withdrawal by Subject|7|||
155147557|NCT03291067|559973147|FG003|Overall Study|Withdrawal by Subject|5|||
155147558|NCT03291067|559973144|FG000|Overall Study|Other|0|||
155147559|NCT03291067|559973145|FG001|Overall Study|Other|4|||
155195307|NCT02761733|560152857|FG001|Overall Study|Cognitive Impairment|0|||
155195308|NCT02761733|560152858|FG002|Overall Study|Cognitive Impairment|1|||
155195309|NCT02761733|560152859|FG003|Overall Study|Cognitive Impairment|0|||
155195310|NCT02713204|560152860|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
155195311|NCT02713204|560152861|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195312|NCT02713204|560152862|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
155195313|NCT02713204|560152863|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195314|NCT02713204|560152864|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195315|NCT02713204|560152865|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195316|NCT02713204|560152866|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195317|NCT02713204|560152867|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
155195318|NCT02713204|560152860|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195319|NCT02713204|560152861|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195320|NCT02713204|560152862|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
155195321|NCT02713204|560152863|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195322|NCT02713204|560152864|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195323|NCT02713204|560152865|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195324|NCT02713204|560152866|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195325|NCT02713204|560152867|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
155195326|NCT02713204|560152860|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195327|NCT02713204|560152861|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
155195328|NCT02713204|560152862|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195329|NCT02713204|560152863|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195330|NCT02713204|560152864|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195331|NCT02713204|560152865|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195332|NCT02713204|560152866|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195333|NCT02713204|560152867|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
155195334|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Adverse Event|1|||
155195335|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Adverse Event|0|||
155195336|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Adverse Event|0|||
155195337|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Adverse Event|1|||
155195338|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Adverse Event|1|||
155195339|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Adverse Event|0|||
155195340|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Adverse Event|2|||
155195341|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Adverse Event|1|||
155195342|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Death|0|||
155195343|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Death|0|||
155195344|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Death|0|||
155195345|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Death|1|||
155195346|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Death|0|||
155195347|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Death|1|||
155195348|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Death|0|||
155195349|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Death|3|||
155195350|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195351|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195352|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195353|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
155195354|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195355|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195356|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195357|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
155195358|NCT02713204|560152860|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
155195359|NCT02713204|560152861|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
155195360|NCT02713204|560152862|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
155195361|NCT02713204|560152863|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
155195362|NCT02713204|560152864|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
155195363|NCT02713204|560152865|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
155195364|NCT02713204|560152866|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
155195365|NCT02713204|560152867|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
155195366|NCT01297920|560152872|FG000|Overall Study|Adverse Event|42|||
155195367|NCT01297920|560152873|FG001|Overall Study|Adverse Event|10|||
155195368|NCT01297920|560152874|FG002|Overall Study|Adverse Event|38|||
155195369|NCT01297920|560152872|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
155195370|NCT01297920|560152873|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
155195371|NCT01297920|560152874|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
155195372|NCT01297920|560152872|FG000|Overall Study|Noncompliance|1|||
155195373|NCT01297920|560152873|FG001|Overall Study|Noncompliance|0|||
155195374|NCT01297920|560152874|FG002|Overall Study|Noncompliance|0|||
155195375|NCT01297920|560152872|FG000|Overall Study|Protocol Violation|1|||
155195376|NCT01297920|560152873|FG001|Overall Study|Protocol Violation|3|||
155195377|NCT01297920|560152874|FG002|Overall Study|Protocol Violation|0|||
155195378|NCT01297920|560152872|FG000|Overall Study|Inadequate Control of IOP|7|||
155195379|NCT01297920|560152873|FG001|Overall Study|Inadequate Control of IOP|9|||
155147560|NCT03291067|559973146|FG002|Overall Study|Other|4|||
155147561|NCT03291067|559973147|FG003|Overall Study|Other|6|||
155147562|NCT03683173|559973148|FG000|Completed Follow-up|Unavailable|235|||
155147563|NCT03683173|559973149|FG001|Completed Follow-up|Unavailable|217|||
155147564|NCT03683173|559973148|FG000|Completed Follow-up|Refused|69|||
155147565|NCT03683173|559973149|FG001|Completed Follow-up|Refused|59|||
155147566|NCT03683173|559973148|FG000|Completed Follow-up|Disconnected phone|65|||
155147567|NCT03683173|559973149|FG001|Completed Follow-up|Disconnected phone|95|||
155147568|NCT03683173|559973148|FG000|Completed Follow-up|Health issue/deceased|10|||
155147569|NCT03683173|559973149|FG001|Completed Follow-up|Health issue/deceased|4|||
155147570|NCT03683173|559973148|FG000|Completed Follow-up|Moved away|8|||
155147571|NCT03683173|559973149|FG001|Completed Follow-up|Moved away|1|||
155147572|NCT01535807|559973150|FG000|Overall Study|Withdrawal by Subject|1|||
155147573|NCT01535807|559973151|FG001|Overall Study|Withdrawal by Subject|1|||
155147574|NCT01535807|559973150|FG000|Overall Study|Data collection error|1|||
155147575|NCT01535807|559973151|FG001|Overall Study|Data collection error|1|||
155147576|NCT01329263|559973154|FG000|Overall Study|Lost to Follow-up|4|||
155147577|NCT01329263|559973155|FG001|Overall Study|Lost to Follow-up|21|||
155147578|NCT01329263|559973154|FG000|Overall Study|Withdrawal by Subject|1|||
155147579|NCT01329263|559973155|FG001|Overall Study|Withdrawal by Subject|2|||
155147580|NCT01702844|559973167|FG000|Overall Study|Adverse Event|9|||
155147581|NCT01702844|559973167|FG000|Overall Study|Death|1|||
155147582|NCT01702844|559973167|FG000|Overall Study|Withdrawal by Subject|3|||
155147583|NCT01702844|559973167|FG000|Overall Study|Physician Decision|6|||
155147584|NCT02995980|559973168|FG000|Overall Study|Lost to Follow-up|14|||
155147585|NCT01169103|559973170|FG000|Overall Study|Lost to Follow-up|3|||
155147586|NCT01169103|559973171|FG001|Overall Study|Lost to Follow-up|3|||
155147587|NCT01169103|559973170|FG000|Overall Study|Withdrawal by Subject|3|||
155147588|NCT01169103|559973171|FG001|Overall Study|Withdrawal by Subject|1|||
155147589|NCT00248495|559973174|FG000|Overall Study|Withdrawal by Subject|1|||
155147590|NCT03360682|559973179|FG000|Overall Study|Adverse Event|3|||
155147591|NCT02920892|559973182|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
155147592|NCT02920892|559973183|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
155147593|NCT02920892|559973184|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
155147594|NCT02920892|559973182|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
155147595|NCT02920892|559973183|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
155147596|NCT02920892|559973184|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
155147597|NCT02920892|559973182|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
155147598|NCT02920892|559973183|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
155147599|NCT02920892|559973184|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
155147600|NCT02920892|559973182|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
155147601|NCT02920892|559973183|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
155147602|NCT02920892|559973184|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
155147603|NCT02920892|559973182|FG000|Placebo-Controlled Period|Physician Decision|0|||
155147604|NCT02920892|559973183|FG001|Placebo-Controlled Period|Physician Decision|0|||
155147605|NCT02920892|559973184|FG002|Placebo-Controlled Period|Physician Decision|1|||
155147606|NCT02920892|559973182|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
155147607|NCT02920892|559973183|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
155147608|NCT02920892|559973184|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
155147609|NCT02920892|559973182|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
155147610|NCT02920892|559973183|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
155147611|NCT02920892|559973184|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
155147612|NCT02920892|559973182|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
155147613|NCT02920892|559973183|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
155147614|NCT02920892|559973184|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
155147615|NCT02336607|559973185|FG000|Overall Study|Physician Decision|1|||
155147616|NCT02336607|559973186|FG001|Overall Study|Physician Decision|4|||
155147617|NCT02336607|559973187|FG002|Overall Study|Physician Decision|3|||
155147618|NCT02336607|559973188|FG003|Overall Study|Physician Decision|15|||
155147619|NCT02336607|559973185|FG000|Overall Study|Lack of Efficacy|1|||
155147620|NCT02336607|559973186|FG001|Overall Study|Lack of Efficacy|0|||
155147621|NCT02336607|559973187|FG002|Overall Study|Lack of Efficacy|0|||
155147622|NCT02336607|559973188|FG003|Overall Study|Lack of Efficacy|2|||
155147623|NCT02336607|559973185|FG000|Overall Study|Lost to Follow-up|2|||
155147624|NCT02336607|559973186|FG001|Overall Study|Lost to Follow-up|1|||
155147625|NCT02336607|559973187|FG002|Overall Study|Lost to Follow-up|0|||
155147626|NCT02336607|559973188|FG003|Overall Study|Lost to Follow-up|21|||
155147627|NCT02336607|559973185|FG000|Overall Study|Protocol Violation|0|||
155147628|NCT02336607|559973186|FG001|Overall Study|Protocol Violation|1|||
155147629|NCT02336607|559973187|FG002|Overall Study|Protocol Violation|1|||
155147630|NCT02336607|559973188|FG003|Overall Study|Protocol Violation|3|||
155147631|NCT02336607|559973185|FG000|Overall Study|Adverse Event|0|||
155147632|NCT02336607|559973186|FG001|Overall Study|Adverse Event|2|||
155147633|NCT02336607|559973187|FG002|Overall Study|Adverse Event|2|||
155147634|NCT02336607|559973188|FG003|Overall Study|Adverse Event|26|||
155147635|NCT02336607|559973185|FG000|Overall Study|Withdrawal by Subject|0|||
155147636|NCT02336607|559973186|FG001|Overall Study|Withdrawal by Subject|2|||
155147637|NCT02336607|559973187|FG002|Overall Study|Withdrawal by Subject|0|||
155147638|NCT02336607|559973188|FG003|Overall Study|Withdrawal by Subject|20|||
155147639|NCT02552966|559973189|FG000|Overall Study|Lost to Follow-up|2|||
155147640|NCT02552966|559973189|FG000|Overall Study|Withdrawal by Subject|3|||
155147641|NCT01721161|559973191|FG000|Overall Study|Adverse Event|2|||
155147642|NCT01721161|559973192|FG001|Overall Study|Adverse Event|3|||
155147643|NCT01721161|559973191|FG000|Overall Study|Lost to Follow-up|1|||
155147644|NCT01721161|559973192|FG001|Overall Study|Lost to Follow-up|2|||
155147645|NCT01721161|559973191|FG000|Overall Study|Withdrawal by Subject|1|||
155147646|NCT01721161|559973192|FG001|Overall Study|Withdrawal by Subject|1|||
155147647|NCT01721161|559973191|FG000|Overall Study|Other|0|||
155147648|NCT01721161|559973192|FG001|Overall Study|Other|1|||
155147649|NCT01454596|559973195|FG000|Overall Study|Death|0|||
155147650|NCT01454596|559973196|FG001|Overall Study|Death|0|||
155147651|NCT01454596|559973197|FG002|Overall Study|Death|0|||
155147652|NCT01454596|559973198|FG003|Overall Study|Death|0|||
155147653|NCT01454596|559973199|FG004|Overall Study|Death|0|||
155147654|NCT01454596|559973200|FG005|Overall Study|Death|0|||
155147655|NCT01454596|559973201|FG006|Overall Study|Death|0|||
155147656|NCT01454596|559973202|FG007|Overall Study|Death|0|||
155147657|NCT01454596|559973203|FG008|Overall Study|Death|0|||
155147658|NCT01454596|559973204|FG009|Overall Study|Death|1|||
155147659|NCT01454596|559973205|FG010|Overall Study|Death|1|||
155147660|NCT01454596|559973206|FG011|Overall Study|Death|0|||
155147661|NCT01506271|559973217|FG000|Overall Study|Progressive disease|0|||
155147662|NCT01506271|559973218|FG001|Overall Study|Progressive disease|1|||
155147663|NCT01506271|559973219|FG002|Overall Study|Progressive disease|0|||
155147664|NCT01506271|559973217|FG000|Overall Study|Protocol Violation|3|||
155147665|NCT01506271|559973218|FG001|Overall Study|Protocol Violation|1|||
155147666|NCT01506271|559973219|FG002|Overall Study|Protocol Violation|0|||
155147667|NCT01506271|559973217|FG000|Overall Study|Death|0|||
155147668|NCT01506271|559973218|FG001|Overall Study|Death|1|||
155147669|NCT01506271|559973219|FG002|Overall Study|Death|0|||
155147670|NCT01506271|559973217|FG000|Overall Study|Adverse Event|0|||
155147671|NCT01506271|559973218|FG001|Overall Study|Adverse Event|2|||
155147672|NCT01506271|559973219|FG002|Overall Study|Adverse Event|0|||
155147673|NCT01506271|559973217|FG000|Overall Study|Insufficient supply of study drug|1|||
155147674|NCT01506271|559973218|FG001|Overall Study|Insufficient supply of study drug|0|||
155147675|NCT01506271|559973219|FG002|Overall Study|Insufficient supply of study drug|0|||
155147676|NCT01506271|559973217|FG000|Overall Study|Withdrawal by Subject|0|||
155147677|NCT01506271|559973218|FG001|Overall Study|Withdrawal by Subject|1|||
155147678|NCT01506271|559973219|FG002|Overall Study|Withdrawal by Subject|1|||
155147679|NCT01506271|559973217|FG000|Overall Study|Lost to Follow-up|0|||
155147680|NCT01506271|559973218|FG001|Overall Study|Lost to Follow-up|1|||
155147681|NCT01506271|559973219|FG002|Overall Study|Lost to Follow-up|2|||
155147682|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
155147683|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
155147684|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
155147685|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
155147686|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
155147687|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
155147688|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Death|7|||
155147689|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Death|5|||
155147690|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Death|6|||
155147691|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
155147692|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
155147693|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
155147694|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
155147695|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
155147696|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
155147697|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Other|1|||
155147698|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Other|0|||
155147699|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Other|0|||
155147700|NCT00104650|559973222|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
155147701|NCT00104650|559973223|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
155147702|NCT00104650|559973224|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
155147703|NCT00104650|559973222|FG000|Follow-up Period|Physician Decision|1|||
155147704|NCT00104650|559973223|FG001|Follow-up Period|Physician Decision|1|||
155147705|NCT00104650|559973224|FG002|Follow-up Period|Physician Decision|0|||
155147706|NCT00104650|559973222|FG000|Follow-up Period|Adverse Event|1|||
155147707|NCT00104650|559973223|FG001|Follow-up Period|Adverse Event|0|||
155147708|NCT00104650|559973224|FG002|Follow-up Period|Adverse Event|1|||
155147709|NCT00104650|559973222|FG000|Follow-up Period|Withdrawal by Subject|0|||
155147710|NCT00104650|559973223|FG001|Follow-up Period|Withdrawal by Subject|3|||
155147711|NCT00104650|559973224|FG002|Follow-up Period|Withdrawal by Subject|3|||
155147712|NCT00104650|559973222|FG000|Follow-up Period|Death|6|||
155147713|NCT00104650|559973223|FG001|Follow-up Period|Death|6|||
155147714|NCT00104650|559973224|FG002|Follow-up Period|Death|4|||
155147715|NCT00104650|559973222|FG000|Follow-up Period|Disease progression|3|||
155147716|NCT00104650|559973223|FG001|Follow-up Period|Disease progression|1|||
155147717|NCT00104650|559973224|FG002|Follow-up Period|Disease progression|0|||
155147718|NCT00104650|559973222|FG000|Follow-up Period|Lost to Follow-up|0|||
155147719|NCT00104650|559973223|FG001|Follow-up Period|Lost to Follow-up|1|||
155147720|NCT00104650|559973224|FG002|Follow-up Period|Lost to Follow-up|2|||
155147721|NCT00104650|559973222|FG000|Follow-up Period|Other|0|||
155147722|NCT00104650|559973223|FG001|Follow-up Period|Other|1|||
155147723|NCT00104650|559973224|FG002|Follow-up Period|Other|0|||
155147724|NCT01391663|559973225|FG000|Overall Study|Withdrawal by Subject|0|||
155147725|NCT01391663|559973226|FG001|Overall Study|Withdrawal by Subject|0|||
155147726|NCT01391663|559973227|FG002|Overall Study|Withdrawal by Subject|1|||
155147727|NCT01391663|559973228|FG003|Overall Study|Withdrawal by Subject|0|||
155147728|NCT01894607|559973229|FG000|Overall Study|Ineligible|1|||
155147729|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
155147730|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
155147731|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
155147732|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
155147733|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
155147734|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
155147735|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
155147736|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
155147737|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
155147738|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
155147739|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
155147740|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
155147741|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
155147742|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
155147743|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
155147744|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
155147745|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
155147746|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
155147747|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
155147748|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
155147749|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
155147750|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
155147751|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
155147752|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
155147753|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
155147754|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
155147755|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
155147756|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
155147757|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
155147758|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
155147759|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
155147760|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
155147761|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
155147762|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
155147763|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
155147764|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
155147765|NCT02586623|559973240|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
155147766|NCT02586623|559973241|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
155147767|NCT02586623|559973242|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
155147768|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
155147769|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
155147770|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
155147771|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
155147772|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
155147773|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
155147774|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
155147775|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
155147776|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
155147777|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
155147778|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
155147779|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
155147780|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
155147781|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
155147782|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
155147783|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
155147784|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
155147785|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
155147786|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
155147787|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
155147788|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
155147789|NCT02586623|559973240|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
155147790|NCT02586623|559973241|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
155147791|NCT02586623|559973242|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
155147792|NCT02910466|559973243|FG000|Overall Study|Adverse Event|1|||
155147793|NCT02910466|559973243|FG000|Overall Study|Withdrawal by Subject|3|||
155147794|NCT02910466|559973243|FG000|Overall Study|Lost to Follow-up|5|||
155147795|NCT02910466|559973243|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
155147796|NCT02910466|559973243|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
155147797|NCT05051579|559973248|FG000|Overall Study|Withdrawal by Subject|3|||
155147798|NCT05051579|559973249|FG001|Overall Study|Withdrawal by Subject|5|||
155147799|NCT05051579|559973250|FG002|Overall Study|Withdrawal by Subject|2|||
155147800|NCT05051579|559973251|FG003|Overall Study|Withdrawal by Subject|1|||
155147801|NCT05051579|559973252|FG004|Overall Study|Withdrawal by Subject|4|||
155147802|NCT05051579|559973253|FG005|Overall Study|Withdrawal by Subject|0|||
155147803|NCT05051579|559973254|FG006|Overall Study|Withdrawal by Subject|4|||
155147804|NCT05051579|559973248|FG000|Overall Study|Lost to Follow-up|1|||
155147805|NCT05051579|559973249|FG001|Overall Study|Lost to Follow-up|0|||
155147806|NCT05051579|559973250|FG002|Overall Study|Lost to Follow-up|0|||
155147807|NCT05051579|559973251|FG003|Overall Study|Lost to Follow-up|0|||
155147808|NCT05051579|559973252|FG004|Overall Study|Lost to Follow-up|1|||
155147809|NCT05051579|559973253|FG005|Overall Study|Lost to Follow-up|0|||
155147810|NCT05051579|559973254|FG006|Overall Study|Lost to Follow-up|1|||
155147811|NCT05051579|559973248|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155147812|NCT05051579|559973249|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155147813|NCT05051579|559973250|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155147814|NCT05051579|559973251|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155147815|NCT05051579|559973252|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155147816|NCT05051579|559973253|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
155147817|NCT05051579|559973254|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
155147818|NCT05051579|559973248|FG000|Overall Study|Adverse Event|2|||
155147819|NCT05051579|559973249|FG001|Overall Study|Adverse Event|1|||
155147820|NCT05051579|559973250|FG002|Overall Study|Adverse Event|0|||
155147821|NCT05051579|559973251|FG003|Overall Study|Adverse Event|4|||
155147822|NCT05051579|559973252|FG004|Overall Study|Adverse Event|1|||
155147823|NCT05051579|559973253|FG005|Overall Study|Adverse Event|2|||
155147824|NCT05051579|559973254|FG006|Overall Study|Adverse Event|0|||
155147825|NCT05051579|559973248|FG000|Overall Study|Inadvertent Enrollment|0|||
155147826|NCT05051579|559973249|FG001|Overall Study|Inadvertent Enrollment|0|||
155147827|NCT05051579|559973250|FG002|Overall Study|Inadvertent Enrollment|0|||
155147828|NCT05051579|559973251|FG003|Overall Study|Inadvertent Enrollment|0|||
155147829|NCT05051579|559973252|FG004|Overall Study|Inadvertent Enrollment|0|||
155147830|NCT05051579|559973253|FG005|Overall Study|Inadvertent Enrollment|0|||
155147831|NCT05051579|559973254|FG006|Overall Study|Inadvertent Enrollment|1|||
155147832|NCT05051579|559973248|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155147833|NCT05051579|559973249|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
155147834|NCT05051579|559973250|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155147835|NCT05051579|559973251|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155147836|NCT05051579|559973252|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155147837|NCT05051579|559973253|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155147838|NCT05051579|559973254|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
155147839|NCT05051579|559973248|FG000|Overall Study|Sponsor Decision|0|||
155147840|NCT05051579|559973249|FG001|Overall Study|Sponsor Decision|0|||
155147841|NCT05051579|559973250|FG002|Overall Study|Sponsor Decision|0|||
155147842|NCT05051579|559973251|FG003|Overall Study|Sponsor Decision|0|||
155147843|NCT05051579|559973252|FG004|Overall Study|Sponsor Decision|1|||
155147844|NCT05051579|559973253|FG005|Overall Study|Sponsor Decision|0|||
155147845|NCT05051579|559973254|FG006|Overall Study|Sponsor Decision|0|||
155147846|NCT05051579|559973248|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155147847|NCT05051579|559973249|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155147848|NCT05051579|559973250|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155147849|NCT05051579|559973251|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155147850|NCT05051579|559973252|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
155147851|NCT05051579|559973253|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155147852|NCT05051579|559973254|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
155147853|NCT01116648|559973262|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
155147854|NCT01116648|559973263|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
155147855|NCT01116648|559973264|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
155147856|NCT01116648|559973265|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
155147857|NCT01116648|559973266|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
155147858|NCT01116648|559973267|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
155147859|NCT01116648|559973268|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
155147860|NCT01116648|559973269|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
155147861|NCT01116648|559973270|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
155147862|NCT01116648|559973271|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
155147863|NCT01116648|559973272|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
155147864|NCT01116648|559973273|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
155147865|NCT01116648|559973274|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
155147866|NCT01116648|559973275|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
155147867|NCT01116648|559973276|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
155147868|NCT04539938|559973277|FG000|Overall Study|Death|30|||
155147869|NCT04539938|559973277|FG000|Overall Study|Withdrawal by Subject|4|||
155147870|NCT01420926|559973292|FG000|Overall Study|Adverse Event|6|||
155147871|NCT01420926|559973293|FG001|Overall Study|Adverse Event|4|||
155147872|NCT01420926|559973292|FG000|Overall Study|Death|18|||
155147873|NCT01420926|559973293|FG001|Overall Study|Death|17|||
155147874|NCT01420926|559973292|FG000|Overall Study|Withdrawal by Subject|11|||
155147875|NCT01420926|559973293|FG001|Overall Study|Withdrawal by Subject|17|||
155147876|NCT01420926|559973292|FG000|Overall Study|Non-protocol treatment|17|||
155147877|NCT01420926|559973293|FG001|Overall Study|Non-protocol treatment|20|||
155147878|NCT01420926|559973292|FG000|Overall Study|Physician Decision|8|||
155147879|NCT01420926|559973293|FG001|Overall Study|Physician Decision|5|||
155147880|NCT01232868|559974392|FG000|Overall Study|Lost to Follow-up|2|||
155147881|NCT01232868|559974393|FG001|Overall Study|Lost to Follow-up|4|||
155147882|NCT04481243|559974394|FG000|Overall Study|Withdrawal by Subject|4|||
155147883|NCT04564846|559974395|FG000|Overall Study|Withdrawal by Subject|2|||
155147884|NCT04564846|559974396|FG001|Overall Study|Withdrawal by Subject|1|||
155147885|NCT04564846|559974395|FG000|Overall Study|Physician Decision|0|||
155147886|NCT04564846|559974396|FG001|Overall Study|Physician Decision|1|||
155147887|NCT04564846|559974395|FG000|Overall Study|Lost to Follow-up|0|||
155147888|NCT04564846|559974396|FG001|Overall Study|Lost to Follow-up|1|||
155147889|NCT04564846|559974395|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
155147890|NCT04564846|559974396|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
155147891|NCT04564846|559974395|FG000|Overall Study|Subject non-compliance|1|||
155147892|NCT04564846|559974396|FG001|Overall Study|Subject non-compliance|0|||
155147893|NCT00865345|559974397|FG000|Overall Study|Withdrawal by Subject|2|||
155147894|NCT03737123|559974398|FG000|Study Treatment|Adverse Event|2|||
155147895|NCT03737123|559974399|FG001|Study Treatment|Adverse Event|0|||
155147896|NCT03737123|559974398|FG000|Study Treatment|Disease Progression|2|||
155147897|NCT03737123|559974399|FG001|Study Treatment|Disease Progression|0|||
155147898|NCT03737123|559974398|FG000|Study Treatment|Withdrawal by Subject|2|||
155147899|NCT03737123|559974399|FG001|Study Treatment|Withdrawal by Subject|0|||
155147900|NCT03737123|559974398|FG000|Follow up|Death|1|||
155147901|NCT03737123|559974399|FG001|Follow up|Death|0|||
155147902|NCT03737123|559974398|FG000|Follow up|Withdrawal by Subject|1|||
155147903|NCT03737123|559974399|FG001|Follow up|Withdrawal by Subject|0|||
155147904|NCT03737123|559974398|FG000|Follow up|Termination of study|4|||
155147905|NCT03737123|559974399|FG001|Follow up|Termination of study|0|||
155147906|NCT01519323|559974400|FG000|Overall Study|Death|3|||
155147907|NCT01519323|559974401|FG001|Overall Study|Death|2|||
155147908|NCT01519323|559974400|FG000|Overall Study|Study terminated by sponsor|0|||
155147909|NCT01519323|559974401|FG001|Overall Study|Study terminated by sponsor|1|||
155147910|NCT00445549|559974402|FG000|Overall Study|progressive disease|12|||
155147911|NCT03858049|559974413|FG000|Overall Study|Adverse Event|16|||
155147912|NCT03858049|559974414|FG001|Overall Study|Adverse Event|9|||
155147913|NCT03858049|559974413|FG000|Overall Study|Other|1|||
155147914|NCT03858049|559974414|FG001|Overall Study|Other|1|||
155147915|NCT04617782|559974415|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
155147916|NCT04617782|559974415|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
155147917|NCT04617782|559974415|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
155147918|NCT04617782|559974415|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
155147919|NCT04617782|559974415|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
155147920|NCT04617782|559974415|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
155147921|NCT01405768|559974424|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
155147922|NCT01405768|559974425|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
155147923|NCT03016312|559974428|FG000|Overall Study|discontinued before the treatment started|0|||
155195380|NCT01297920|560152874|FG002|Overall Study|Inadequate Control of IOP|17|||
155195381|NCT01297920|560152872|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
155195382|NCT01297920|560152873|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
155195383|NCT01297920|560152874|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
155195384|NCT03212690|560152875|FG000|Overall Study|Protocol Violation|1|||
155195385|NCT00474760|560152876|FG000|Overall Study|Death|0|||
155195386|NCT00474760|560152877|FG001|Overall Study|Death|0|||
155195387|NCT00474760|560152878|FG002|Overall Study|Death|0|||
155195388|NCT00474760|560152879|FG003|Overall Study|Death|0|||
155195389|NCT00474760|560152880|FG004|Overall Study|Death|2|||
155195390|NCT00474760|560152881|FG005|Overall Study|Death|0|||
155195391|NCT00474760|560152882|FG006|Overall Study|Death|0|||
155195392|NCT00474760|560152876|FG000|Overall Study|Adverse Event|0|||
155195393|NCT00474760|560152877|FG001|Overall Study|Adverse Event|0|||
155195394|NCT00474760|560152878|FG002|Overall Study|Adverse Event|0|||
155195395|NCT00474760|560152879|FG003|Overall Study|Adverse Event|0|||
155195396|NCT00474760|560152880|FG004|Overall Study|Adverse Event|1|||
155195397|NCT00474760|560152881|FG005|Overall Study|Adverse Event|7|||
155195398|NCT00474760|560152882|FG006|Overall Study|Adverse Event|0|||
155195399|NCT00474760|560152876|FG000|Overall Study|Laboratory abnormality|0|||
155195400|NCT00474760|560152877|FG001|Overall Study|Laboratory abnormality|0|||
155195401|NCT00474760|560152878|FG002|Overall Study|Laboratory abnormality|0|||
155195402|NCT00474760|560152879|FG003|Overall Study|Laboratory abnormality|0|||
155195403|NCT00474760|560152880|FG004|Overall Study|Laboratory abnormality|0|||
155195404|NCT00474760|560152881|FG005|Overall Study|Laboratory abnormality|1|||
155195405|NCT00474760|560152882|FG006|Overall Study|Laboratory abnormality|0|||
155195406|NCT00474760|560152876|FG000|Overall Study|Withdrawal by Subject|0|||
155195407|NCT00474760|560152877|FG001|Overall Study|Withdrawal by Subject|0|||
155195408|NCT00474760|560152878|FG002|Overall Study|Withdrawal by Subject|0|||
155195409|NCT00474760|560152879|FG003|Overall Study|Withdrawal by Subject|1|||
155195410|NCT00474760|560152880|FG004|Overall Study|Withdrawal by Subject|0|||
155195411|NCT00474760|560152881|FG005|Overall Study|Withdrawal by Subject|1|||
155195412|NCT00474760|560152882|FG006|Overall Study|Withdrawal by Subject|1|||
155195413|NCT00474760|560152876|FG000|Overall Study|Other|0|||
155195414|NCT00474760|560152877|FG001|Overall Study|Other|1|||
155195415|NCT00474760|560152878|FG002|Overall Study|Other|0|||
155195416|NCT00474760|560152879|FG003|Overall Study|Other|0|||
155195417|NCT00474760|560152880|FG004|Overall Study|Other|1|||
155195418|NCT00474760|560152881|FG005|Overall Study|Other|0|||
155195419|NCT00474760|560152882|FG006|Overall Study|Other|0|||
155195420|NCT00474760|560152876|FG000|Overall Study|Progressive disease|3|||
155195421|NCT00474760|560152877|FG001|Overall Study|Progressive disease|2|||
155195422|NCT00474760|560152878|FG002|Overall Study|Progressive disease|3|||
155195423|NCT00474760|560152879|FG003|Overall Study|Progressive disease|2|||
155195424|NCT00474760|560152880|FG004|Overall Study|Progressive disease|8|||
155195425|NCT00474760|560152881|FG005|Overall Study|Progressive disease|20|||
155195426|NCT00474760|560152882|FG006|Overall Study|Progressive disease|7|||
155195427|NCT00474760|560152876|FG000|Overall Study|Terminated by sponsor|0|||
155195428|NCT00474760|560152877|FG001|Overall Study|Terminated by sponsor|0|||
155195429|NCT00474760|560152878|FG002|Overall Study|Terminated by sponsor|0|||
155195430|NCT00474760|560152879|FG003|Overall Study|Terminated by sponsor|0|||
155195431|NCT00474760|560152880|FG004|Overall Study|Terminated by sponsor|0|||
155147924|NCT03016312|559974429|FG001|Overall Study|discontinued before the treatment started|1|||
155147925|NCT03016312|559974428|FG000|Overall Study|Withdrawal by Subject|37|||
155147926|NCT03016312|559974429|FG001|Overall Study|Withdrawal by Subject|44|||
155147927|NCT03016312|559974428|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
155147928|NCT03016312|559974429|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
155147929|NCT03016312|559974428|FG000|Overall Study|Physician Decision|1|||
155147930|NCT03016312|559974429|FG001|Overall Study|Physician Decision|3|||
155147931|NCT03016312|559974428|FG000|Overall Study|Lost to Follow-up|12|||
155147932|NCT03016312|559974429|FG001|Overall Study|Lost to Follow-up|12|||
155147933|NCT03016312|559974428|FG000|Overall Study|Death|210|||
155195432|NCT00474760|560152881|FG005|Overall Study|Terminated by sponsor|0|||
155195433|NCT00474760|560152882|FG006|Overall Study|Terminated by sponsor|2|||
155195434|NCT03608254|560152883|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
155195435|NCT03608254|560152883|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
155195436|NCT03000569|560152885|FG000|Overall Study|Withdrawal by Subject|1|||
155195437|NCT03000569|560152886|FG001|Overall Study|Withdrawal by Subject|0|||
155195438|NCT01346969|560152887|FG000|Overall Study|Withdrawal by Subject|0|||
155195439|NCT01346969|560152888|FG001|Overall Study|Withdrawal by Subject|0|||
155195440|NCT01346969|560152889|FG002|Overall Study|Withdrawal by Subject|1|||
155195441|NCT01346969|560152890|FG003|Overall Study|Withdrawal by Subject|0|||
155195442|NCT01346969|560152887|FG000|Overall Study|Lost to Follow-up|1|||
155195443|NCT01346969|560152888|FG001|Overall Study|Lost to Follow-up|0|||
155195444|NCT01346969|560152889|FG002|Overall Study|Lost to Follow-up|2|||
155195445|NCT01346969|560152890|FG003|Overall Study|Lost to Follow-up|0|||
155195446|NCT01346969|560152887|FG000|Overall Study|Physician Decision|0|||
155195447|NCT01346969|560152888|FG001|Overall Study|Physician Decision|0|||
155195448|NCT01346969|560152889|FG002|Overall Study|Physician Decision|0|||
155195449|NCT01346969|560152890|FG003|Overall Study|Physician Decision|1|||
155195450|NCT01346969|560152887|FG000|Overall Study|Randomized but not treated|1|||
155195451|NCT01346969|560152888|FG001|Overall Study|Randomized but not treated|0|||
155195452|NCT01346969|560152889|FG002|Overall Study|Randomized but not treated|0|||
155195453|NCT01346969|560152890|FG003|Overall Study|Randomized but not treated|0|||
155195454|NCT03540030|560152893|FG000|Overall Study|Withdrawal by Subject|2|||
155195455|NCT03540030|560152894|FG001|Overall Study|Withdrawal by Subject|1|||
155195456|NCT03540030|560152893|FG000|Overall Study|screen fail|7|||
155195457|NCT03540030|560152894|FG001|Overall Study|screen fail|1|||
155195458|NCT03540030|560152893|FG000|Overall Study|never had surgery after signing consent|9|||
155195459|NCT03540030|560152894|FG001|Overall Study|never had surgery after signing consent|1|||
155195460|NCT04122534|560152895|FG000|Overall Study|Lost to Follow-up|4|||
155195461|NCT02128932|560152903|FG000|Overall Study|Withdrawal by Subject|11|||
155195462|NCT02128932|560152904|FG001|Overall Study|Withdrawal by Subject|7|||
155195463|NCT02128932|560152905|FG002|Overall Study|Withdrawal by Subject|8|||
155195464|NCT02128932|560152903|FG000|Overall Study|Death|2|||
155195465|NCT02128932|560152904|FG001|Overall Study|Death|0|||
155195466|NCT02128932|560152905|FG002|Overall Study|Death|2|||
155195467|NCT02128932|560152903|FG000|Overall Study|Lost to Follow-up|2|||
155195468|NCT02128932|560152904|FG001|Overall Study|Lost to Follow-up|1|||
155195469|NCT02128932|560152905|FG002|Overall Study|Lost to Follow-up|1|||
155195470|NCT02128932|560152903|FG000|Overall Study|No reason for withdrawal|12|||
155195471|NCT02128932|560152904|FG001|Overall Study|No reason for withdrawal|11|||
155195472|NCT02128932|560152905|FG002|Overall Study|No reason for withdrawal|7|||
155195473|NCT03685123|560152910|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
155195474|NCT03685123|560152911|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
155195475|NCT03685123|560152912|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
155195476|NCT03685123|560152910|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
155195477|NCT03685123|560152911|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
155195478|NCT03685123|560152912|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
155195479|NCT03685123|560152910|FG000|Weight Loss Phase|Lost to Follow-up|1|||
155195480|NCT03685123|560152911|FG001|Weight Loss Phase|Lost to Follow-up|0|||
155195481|NCT03685123|560152912|FG002|Weight Loss Phase|Lost to Follow-up|0|||
155195482|NCT03685123|560152910|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
155195483|NCT03685123|560152911|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
155195484|NCT03685123|560152912|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
155195485|NCT03685123|560152910|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
155195486|NCT03685123|560152911|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
155195487|NCT03685123|560152912|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
155195488|NCT03685123|560152910|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
155195489|NCT03685123|560152911|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
155195490|NCT03685123|560152912|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
155195491|NCT02020577|560152913|FG000|Overall Study|Progressive disease|3|||
155195492|NCT02020577|560152914|FG001|Overall Study|Progressive disease|38|||
155195493|NCT02020577|560152913|FG000|Overall Study|Other AE or clinical progression|0|||
155195494|NCT02020577|560152914|FG001|Overall Study|Other AE or clinical progression|15|||
155195495|NCT02020577|560152913|FG000|Overall Study|Withdrawal by Subject|0|||
155195496|NCT02020577|560152914|FG001|Overall Study|Withdrawal by Subject|1|||
155195497|NCT02020577|560152913|FG000|Overall Study|Other than stated above|0|||
155195498|NCT02020577|560152914|FG001|Overall Study|Other than stated above|1|||
155195499|NCT01893203|560152915|FG000|Overall Study|Withdrawal by Subject|1|||
155195500|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
155195501|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
155195502|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
155195503|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
155195504|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195505|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195506|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195507|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195508|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195509|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195510|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195511|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
155195512|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
155195513|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
155195514|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
155195515|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195516|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195517|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195518|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195519|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195520|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195521|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195522|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195523|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
155195524|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
155195525|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
155195526|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195527|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195528|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195529|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195530|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195531|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195532|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195533|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195534|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195535|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
155195536|NCT02925117|560152916|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
155195537|NCT02925117|560152917|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
155195538|NCT02925117|560152918|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
155195539|NCT02925117|560152919|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
155195540|NCT02925117|560152920|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
155195541|NCT02925117|560152921|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
155195542|NCT02925117|560152922|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
155195543|NCT02925117|560152923|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
155195544|NCT02925117|560152924|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
155195545|NCT02925117|560152925|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
155195546|NCT02925117|560152926|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
155195547|NCT02925117|560152927|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
155195548|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195549|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195550|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195551|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195552|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195553|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
155195554|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195555|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195556|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195557|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
155195558|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
155195559|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
155195560|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195561|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195562|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195563|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195564|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
155195565|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
155195566|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
155195567|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
155195568|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195569|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195570|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195571|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
155195572|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195573|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195574|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195575|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195576|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195577|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
155195578|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195579|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195580|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195581|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195582|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
155195583|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
155195584|NCT02925117|560152916|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
155195585|NCT02925117|560152917|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
155195586|NCT02925117|560152918|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
155195587|NCT02925117|560152919|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
155195588|NCT02925117|560152920|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
155195589|NCT02925117|560152921|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
155195590|NCT02925117|560152922|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
155195591|NCT02925117|560152923|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
155195592|NCT02925117|560152924|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
155195593|NCT02925117|560152925|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
155195594|NCT02925117|560152926|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
155195595|NCT02925117|560152927|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
155195596|NCT02663908|560152928|FG000|Overall Study|Withdrawal by Subject|8|||
155147934|NCT03016312|559974429|FG001|Overall Study|Death|184|||
155147935|NCT03016312|559974428|FG000|Overall Study|loss to contact|1|||
155147936|NCT03016312|559974429|FG001|Overall Study|loss to contact|0|||
155147937|NCT03016312|559974428|FG000|Overall Study|started a new cancer therapy|1|||
155147938|NCT03016312|559974429|FG001|Overall Study|started a new cancer therapy|0|||
155147939|NCT01631435|559974431|FG000|Overall Study|Adverse Event|2|||
155147940|NCT01631435|559974431|FG000|Overall Study|Withdrawal by Subject|2|||
155147941|NCT01631435|559974431|FG000|Overall Study|incomplete study procedure|5|||
155147942|NCT01421017|559974432|FG000|Overall Study|Withdrawal by Subject|2|||
155147943|NCT01421017|559974433|FG001|Overall Study|Withdrawal by Subject|0|||
155147944|NCT01421017|559974434|FG002|Overall Study|Withdrawal by Subject|0|||
155147945|NCT01421017|559974432|FG000|Overall Study|POD|0|||
155147946|NCT01421017|559974433|FG001|Overall Study|POD|6|||
155147947|NCT01421017|559974434|FG002|Overall Study|POD|3|||
155147948|NCT02313766|559974435|FG000|Overall Study|surgery cancelled|1|||
155147949|NCT02313766|559974436|FG001|Overall Study|surgery cancelled|0|||
155147950|NCT02313766|559974437|FG002|Overall Study|surgery cancelled|0|||
155147951|NCT02313766|559974435|FG000|Overall Study|Lost to Follow-up|0|||
155147952|NCT02313766|559974436|FG001|Overall Study|Lost to Follow-up|2|||
155147953|NCT02313766|559974437|FG002|Overall Study|Lost to Follow-up|0|||
155147954|NCT02313766|559974435|FG000|Overall Study|Adverse Event|0|||
155147955|NCT02313766|559974436|FG001|Overall Study|Adverse Event|1|||
155147956|NCT02313766|559974437|FG002|Overall Study|Adverse Event|0|||
155147957|NCT00416624|559974440|FG000|Overall Study|Withdrawal by Subject|1|||
155147958|NCT00416624|559974441|FG001|Overall Study|Withdrawal by Subject|6|||
155147959|NCT00416624|559974442|FG002|Overall Study|Withdrawal by Subject|4|||
155147960|NCT00416624|559974443|FG003|Overall Study|Withdrawal by Subject|9|||
155147961|NCT00416624|559974440|FG000|Overall Study|Death|4|||
155147962|NCT00416624|559974441|FG001|Overall Study|Death|7|||
155147963|NCT00416624|559974442|FG002|Overall Study|Death|7|||
155147964|NCT00416624|559974443|FG003|Overall Study|Death|1|||
155147965|NCT00416624|559974440|FG000|Overall Study|Adverse Event|8|||
155147966|NCT00416624|559974441|FG001|Overall Study|Adverse Event|3|||
155147967|NCT00416624|559974442|FG002|Overall Study|Adverse Event|2|||
155147968|NCT00416624|559974443|FG003|Overall Study|Adverse Event|2|||
155147969|NCT00416624|559974440|FG000|Overall Study|Other|8|||
155147970|NCT00416624|559974441|FG001|Overall Study|Other|11|||
155147971|NCT00416624|559974442|FG002|Overall Study|Other|5|||
155147972|NCT00416624|559974443|FG003|Overall Study|Other|5|||
155147973|NCT00416624|559974440|FG000|Overall Study|Cancel|1|||
155147974|NCT00416624|559974441|FG001|Overall Study|Cancel|0|||
155147975|NCT00416624|559974442|FG002|Overall Study|Cancel|0|||
155147976|NCT00416624|559974443|FG003|Overall Study|Cancel|0|||
155147977|NCT01005251|559974444|FG000|Overall Study|Withdrawal by Subject|2|||
155147978|NCT01005251|559974445|FG001|Overall Study|Withdrawal by Subject|5|||
155147979|NCT01005251|559974446|FG002|Overall Study|Withdrawal by Subject|3|||
155147980|NCT01005251|559974447|FG003|Overall Study|Withdrawal by Subject|4|||
155147981|NCT01005251|559974448|FG004|Overall Study|Withdrawal by Subject|9|||
155147982|NCT01005251|559974444|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
155147983|NCT01005251|559974445|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155147984|NCT01005251|559974446|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
155147985|NCT01005251|559974447|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155147986|NCT01005251|559974448|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155147987|NCT01005251|559974444|FG000|Overall Study|Adverse Event|2|||
155147988|NCT01005251|559974445|FG001|Overall Study|Adverse Event|6|||
155147989|NCT01005251|559974446|FG002|Overall Study|Adverse Event|8|||
155147990|NCT01005251|559974447|FG003|Overall Study|Adverse Event|5|||
155147991|NCT01005251|559974448|FG004|Overall Study|Adverse Event|4|||
155147992|NCT01005251|559974444|FG000|Overall Study|Protocol Violation|1|||
155147993|NCT01005251|559974445|FG001|Overall Study|Protocol Violation|0|||
155147994|NCT01005251|559974446|FG002|Overall Study|Protocol Violation|0|||
155147995|NCT01005251|559974447|FG003|Overall Study|Protocol Violation|0|||
155147996|NCT01005251|559974448|FG004|Overall Study|Protocol Violation|2|||
155147997|NCT01005251|559974444|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
155147998|NCT01005251|559974445|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
155147999|NCT01005251|559974446|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
155148000|NCT01005251|559974447|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
155148001|NCT01005251|559974448|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
155148002|NCT01005251|559974444|FG000|Overall Study|Lost to Follow-up|1|||
155148003|NCT01005251|559974445|FG001|Overall Study|Lost to Follow-up|4|||
155148004|NCT01005251|559974446|FG002|Overall Study|Lost to Follow-up|2|||
155148005|NCT01005251|559974447|FG003|Overall Study|Lost to Follow-up|0|||
155148006|NCT01005251|559974448|FG004|Overall Study|Lost to Follow-up|0|||
155148007|NCT01005251|559974444|FG000|Overall Study|Physician Decision|0|||
155148008|NCT01005251|559974445|FG001|Overall Study|Physician Decision|0|||
155148009|NCT01005251|559974446|FG002|Overall Study|Physician Decision|0|||
155148010|NCT01005251|559974447|FG003|Overall Study|Physician Decision|0|||
155148011|NCT01005251|559974448|FG004|Overall Study|Physician Decision|2|||
155148012|NCT01005251|559974444|FG000|Overall Study|Patient moved|1|||
155195597|NCT02663908|560152929|FG001|Overall Study|Withdrawal by Subject|5|||
155195598|NCT02663908|560152928|FG000|Overall Study|Lost to Follow-up|1|||
155195599|NCT02663908|560152929|FG001|Overall Study|Lost to Follow-up|5|||
155195600|NCT02663908|560152928|FG000|Overall Study|Adverse Event|13|||
155195601|NCT02663908|560152929|FG001|Overall Study|Adverse Event|11|||
155195602|NCT02663908|560152928|FG000|Overall Study|Protocol Violation|1|||
155195603|NCT02663908|560152929|FG001|Overall Study|Protocol Violation|2|||
155195604|NCT02663908|560152928|FG000|Overall Study|Lack of therapeutic response|2|||
155195605|NCT02663908|560152929|FG001|Overall Study|Lack of therapeutic response|0|||
155195606|NCT02663908|560152928|FG000|Overall Study|COVID-19|1|||
155195607|NCT02663908|560152929|FG001|Overall Study|COVID-19|0|||
155195608|NCT02663908|560152928|FG000|Overall Study|Site closed|1|||
155195609|NCT02663908|560152929|FG001|Overall Study|Site closed|0|||
155195610|NCT02663908|560152928|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
155195611|NCT02663908|560152929|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
155195612|NCT02663908|560152928|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
155195613|NCT02663908|560152929|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
155195614|NCT02663908|560152928|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
155195615|NCT02663908|560152929|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
155195616|NCT02663908|560152928|FG000|Overall Study|Death|1|||
155195617|NCT02663908|560152929|FG001|Overall Study|Death|0|||
155195618|NCT02663908|560152928|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
155195619|NCT02663908|560152929|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
155195620|NCT02663908|560152928|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
155195621|NCT02663908|560152929|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
155195622|NCT00370071|560152930|FG000|Overall Study|Withdrawal by Subject|2|||
155195623|NCT02004522|560152931|FG000|Overall Study|Adverse Event|55|||
155195624|NCT02004522|560152932|FG001|Overall Study|Adverse Event|6|||
155195625|NCT02004522|560152931|FG000|Overall Study|Withdrawal by Subject|13|||
155195626|NCT02004522|560152932|FG001|Overall Study|Withdrawal by Subject|7|||
155195627|NCT02004522|560152931|FG000|Overall Study|Death|12|||
155195628|NCT02004522|560152932|FG001|Overall Study|Death|3|||
155195629|NCT02004522|560152931|FG000|Overall Study|Physician Decision|3|||
155195630|NCT02004522|560152932|FG001|Overall Study|Physician Decision|4|||
155148013|NCT01005251|559974445|FG001|Overall Study|Patient moved|0|||
155148014|NCT01005251|559974446|FG002|Overall Study|Patient moved|0|||
155148015|NCT01005251|559974447|FG003|Overall Study|Patient moved|0|||
155148016|NCT01005251|559974448|FG004|Overall Study|Patient moved|0|||
155148017|NCT01005251|559974444|FG000|Overall Study|Wrong drug dispensed|0|||
155148018|NCT01005251|559974445|FG001|Overall Study|Wrong drug dispensed|1|||
155148019|NCT01005251|559974446|FG002|Overall Study|Wrong drug dispensed|0|||
155148020|NCT01005251|559974447|FG003|Overall Study|Wrong drug dispensed|0|||
155148021|NCT01005251|559974448|FG004|Overall Study|Wrong drug dispensed|0|||
155148022|NCT01005251|559974444|FG000|Overall Study|Randomized in error|0|||
155148023|NCT01005251|559974445|FG001|Overall Study|Randomized in error|0|||
155148024|NCT01005251|559974446|FG002|Overall Study|Randomized in error|1|||
155148025|NCT01005251|559974447|FG003|Overall Study|Randomized in error|1|||
155148026|NCT01005251|559974448|FG004|Overall Study|Randomized in error|0|||
155148027|NCT01005251|559974444|FG000|Overall Study|Lack of Efficacy|0|||
155148028|NCT01005251|559974445|FG001|Overall Study|Lack of Efficacy|0|||
155148029|NCT01005251|559974446|FG002|Overall Study|Lack of Efficacy|1|||
155148030|NCT01005251|559974447|FG003|Overall Study|Lack of Efficacy|1|||
155148031|NCT01005251|559974448|FG004|Overall Study|Lack of Efficacy|0|||
155148032|NCT02193776|559974449|FG000|Overall Study|Consent withdrawn|1|||
155148033|NCT02193776|559974450|FG001|Overall Study|Consent withdrawn|0|||
155148034|NCT02193776|559974451|FG002|Overall Study|Consent withdrawn|0|||
155148035|NCT02193776|559974452|FG003|Overall Study|Consent withdrawn|0|||
155148036|NCT02193776|559974449|FG000|Overall Study|Failure to comply with protocol|0|||
155148037|NCT02193776|559974450|FG001|Overall Study|Failure to comply with protocol|1|||
155148038|NCT02193776|559974451|FG002|Overall Study|Failure to comply with protocol|0|||
155148039|NCT02193776|559974452|FG003|Overall Study|Failure to comply with protocol|0|||
155148040|NCT02193776|559974449|FG000|Overall Study|Investigator/Sponsor decision|1|||
155148041|NCT02193776|559974450|FG001|Overall Study|Investigator/Sponsor decision|1|||
155148042|NCT02193776|559974451|FG002|Overall Study|Investigator/Sponsor decision|0|||
155148043|NCT02193776|559974452|FG003|Overall Study|Investigator/Sponsor decision|0|||
155148044|NCT02193776|559974449|FG000|Overall Study|Death|1|||
155148045|NCT02193776|559974450|FG001|Overall Study|Death|0|||
155148046|NCT02193776|559974451|FG002|Overall Study|Death|0|||
155148047|NCT02193776|559974452|FG003|Overall Study|Death|0|||
155148048|NCT02193776|559974449|FG000|Overall Study|Adverse event/Specific toxicity|5|||
155148049|NCT02193776|559974450|FG001|Overall Study|Adverse event/Specific toxicity|5|||
155148050|NCT02193776|559974451|FG002|Overall Study|Adverse event/Specific toxicity|2|||
155148051|NCT02193776|559974452|FG003|Overall Study|Adverse event/Specific toxicity|2|||
155148052|NCT01755234|559974454|FG000|Overall Study|Lost to Follow-up|11|||
155195631|NCT02004522|560152931|FG000|Overall Study|Protocol Violation|1|||
155195632|NCT02004522|560152932|FG001|Overall Study|Protocol Violation|0|||
155195633|NCT02004522|560152931|FG000|Overall Study|Other is reason listed by PI|4|||
155195634|NCT02004522|560152932|FG001|Overall Study|Other is reason listed by PI|1|||
155195635|NCT02004522|560152931|FG000|Overall Study|Never Dosed|2|||
155195636|NCT02004522|560152932|FG001|Overall Study|Never Dosed|4|||
155195637|NCT02004522|560152931|FG000|Overall Study|Disease Progression|35|||
155195638|NCT02004522|560152932|FG001|Overall Study|Disease Progression|31|||
155195639|NCT02004522|560152931|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
155195640|NCT02004522|560152932|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
155195641|NCT01787331|560152934|FG000|Overall Study|Physician Decision|1|||
155195642|NCT01787331|560152934|FG000|Overall Study|Withdrawal by Subject|1|||
155195643|NCT00450255|560152935|FG000|Overall Study|Prior RFA ablation of liver|1|||
155195644|NCT01402011|560152938|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
155195645|NCT01402011|560152939|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
155195646|NCT01402011|560152940|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
155195647|NCT01402011|560152938|FG000|Active Treatment Period|Withdrawal by Subject|1|||
155195648|NCT01402011|560152939|FG001|Active Treatment Period|Withdrawal by Subject|3|||
155195649|NCT01402011|560152940|FG002|Active Treatment Period|Withdrawal by Subject|0|||
155195650|NCT01402011|560152938|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
155195651|NCT01402011|560152939|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
155195652|NCT01402011|560152940|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
155195653|NCT01759511|560152942|FG000|Overall Study|Adverse Event|4|||
155195654|NCT01759511|560152942|FG000|Overall Study|Death|2|||
155195655|NCT01759511|560152942|FG000|Overall Study|Lack of Efficacy|2|||
155195656|NCT01759511|560152942|FG000|Overall Study|Physician Decision|1|||
155195657|NCT01759511|560152942|FG000|Overall Study|Progressive Disease|5|||
155195658|NCT01759511|560152942|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
155195659|NCT01759511|560152942|FG000|Overall Study|Study Terminated by Sponsor|13|||
155195660|NCT01759511|560152942|FG000|Overall Study|Withdrawal by Subject|3|||
155195661|NCT02569671|560152943|FG000|Overall Study|Lost to Follow-up|2|||
155195662|NCT02569671|560152944|FG001|Overall Study|Lost to Follow-up|1|||
155195663|NCT02569671|560152943|FG000|Overall Study|Withdrawal by Subject|1|||
155195664|NCT02569671|560152944|FG001|Overall Study|Withdrawal by Subject|3|||
155195665|NCT05154578|560154464|FG000|Overall Study|Withdrawal by Subject|2|||
155195666|NCT05154578|560154465|FG001|Overall Study|Withdrawal by Subject|3|||
155195667|NCT05154578|560154466|FG002|Overall Study|Withdrawal by Subject|2|||
155195668|NCT05154578|560154467|FG003|Overall Study|Withdrawal by Subject|4|||
155195669|NCT05154578|560154468|FG004|Overall Study|Withdrawal by Subject|0|||
155195670|NCT05154578|560154464|FG000|Overall Study|Lost to Follow-up|0|||
155195671|NCT05154578|560154465|FG001|Overall Study|Lost to Follow-up|1|||
155195672|NCT05154578|560154466|FG002|Overall Study|Lost to Follow-up|0|||
155195673|NCT05154578|560154467|FG003|Overall Study|Lost to Follow-up|3|||
155195674|NCT05154578|560154468|FG004|Overall Study|Lost to Follow-up|0|||
155195675|NCT05154578|560154464|FG000|Overall Study|Adverse Event|0|||
155195676|NCT05154578|560154465|FG001|Overall Study|Adverse Event|0|||
155195677|NCT05154578|560154466|FG002|Overall Study|Adverse Event|0|||
155195678|NCT05154578|560154467|FG003|Overall Study|Adverse Event|1|||
155195679|NCT05154578|560154468|FG004|Overall Study|Adverse Event|0|||
155195680|NCT05154578|560154464|FG000|Overall Study|Relocated to another province|0|||
155195681|NCT05154578|560154465|FG001|Overall Study|Relocated to another province|0|||
155195682|NCT05154578|560154466|FG002|Overall Study|Relocated to another province|1|||
155195683|NCT05154578|560154467|FG003|Overall Study|Relocated to another province|0|||
155195684|NCT05154578|560154468|FG004|Overall Study|Relocated to another province|1|||
155195685|NCT05154578|560154464|FG000|Overall Study|Baby loss|0|||
155195686|NCT05154578|560154465|FG001|Overall Study|Baby loss|1|||
155195687|NCT05154578|560154466|FG002|Overall Study|Baby loss|0|||
155195688|NCT05154578|560154467|FG003|Overall Study|Baby loss|0|||
155195689|NCT05154578|560154468|FG004|Overall Study|Baby loss|0|||
155195690|NCT04622306|560154474|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
155195691|NCT04622306|560154475|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
155195692|NCT04622306|560154476|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
155195693|NCT04622306|560154477|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
155195694|NCT04622306|560154478|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
155195695|NCT04622306|560154479|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
155195696|NCT04622306|560154474|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195697|NCT04622306|560154475|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195698|NCT04622306|560154476|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
155195699|NCT04622306|560154477|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
155195700|NCT04622306|560154478|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195701|NCT04622306|560154479|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
155195702|NCT01200524|560154480|FG000|Overall Study|Withdrawal by Subject|1|||
155195703|NCT01200524|560154481|FG001|Overall Study|Withdrawal by Subject|1|||
155195704|NCT01200524|560154482|FG002|Overall Study|Withdrawal by Subject|3|||
155195705|NCT01200524|560154480|FG000|Overall Study|Adverse Event|1|||
155195706|NCT01200524|560154481|FG001|Overall Study|Adverse Event|0|||
155195707|NCT01200524|560154482|FG002|Overall Study|Adverse Event|0|||
155195708|NCT01200524|560154480|FG000|Overall Study|Non availability of study nurse|0|||
155195709|NCT01200524|560154481|FG001|Overall Study|Non availability of study nurse|0|||
155195710|NCT01200524|560154482|FG002|Overall Study|Non availability of study nurse|1|||
155195711|NCT00491764|560154485|FG000|Overall Study|Adverse Event|1|||
155195712|NCT00491764|560154486|FG001|Overall Study|Adverse Event|2|||
155195713|NCT00491764|560154487|FG002|Overall Study|Adverse Event|4|||
155195714|NCT00491764|560154488|FG003|Overall Study|Adverse Event|4|||
155195715|NCT00491764|560154489|FG004|Overall Study|Adverse Event|0|||
155195716|NCT00491764|560154490|FG005|Overall Study|Adverse Event|1|||
155195717|NCT00491764|560154485|FG000|Overall Study|Lost to Follow-up|0|||
155195718|NCT00491764|560154486|FG001|Overall Study|Lost to Follow-up|1|||
155195719|NCT00491764|560154487|FG002|Overall Study|Lost to Follow-up|0|||
155195720|NCT00491764|560154488|FG003|Overall Study|Lost to Follow-up|1|||
155195721|NCT00491764|560154489|FG004|Overall Study|Lost to Follow-up|0|||
155195722|NCT00491764|560154490|FG005|Overall Study|Lost to Follow-up|3|||
155195723|NCT00491764|560154485|FG000|Overall Study|Withdrawal by Subject|2|||
155195724|NCT00491764|560154486|FG001|Overall Study|Withdrawal by Subject|3|||
155195725|NCT00491764|560154487|FG002|Overall Study|Withdrawal by Subject|1|||
155195726|NCT00491764|560154488|FG003|Overall Study|Withdrawal by Subject|2|||
155195727|NCT00491764|560154489|FG004|Overall Study|Withdrawal by Subject|2|||
155195728|NCT00491764|560154490|FG005|Overall Study|Withdrawal by Subject|4|||
155195729|NCT00491764|560154485|FG000|Overall Study|Non Compliance with the Protocol|1|||
155195730|NCT00491764|560154486|FG001|Overall Study|Non Compliance with the Protocol|0|||
155195731|NCT00491764|560154487|FG002|Overall Study|Non Compliance with the Protocol|0|||
155195732|NCT00491764|560154488|FG003|Overall Study|Non Compliance with the Protocol|0|||
155195733|NCT00491764|560154489|FG004|Overall Study|Non Compliance with the Protocol|0|||
155195734|NCT00491764|560154490|FG005|Overall Study|Non Compliance with the Protocol|0|||
155195735|NCT00491764|560154485|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
155195736|NCT00491764|560154486|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
155195737|NCT00491764|560154487|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
155195738|NCT00491764|560154488|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
155195739|NCT00491764|560154489|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
155195740|NCT00491764|560154490|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
155195741|NCT00491764|560154485|FG000|Overall Study|Administrative|1|||
155195742|NCT00491764|560154486|FG001|Overall Study|Administrative|0|||
155195743|NCT00491764|560154487|FG002|Overall Study|Administrative|2|||
155195744|NCT00491764|560154488|FG003|Overall Study|Administrative|1|||
155195745|NCT00491764|560154489|FG004|Overall Study|Administrative|0|||
155195746|NCT00491764|560154490|FG005|Overall Study|Administrative|0|||
155195747|NCT00894166|560154491|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
155195748|NCT00894166|560154492|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
155195749|NCT00894166|560154493|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
155195750|NCT00894166|560154494|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
155195751|NCT00894166|560154495|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
155195752|NCT00894166|560154496|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
155195753|NCT00894166|560154497|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
155195754|NCT00894166|560154498|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
155195755|NCT00894166|560154491|FG000|Overall Study|Death|0|||
155195756|NCT00894166|560154492|FG001|Overall Study|Death|0|||
155195757|NCT00894166|560154493|FG002|Overall Study|Death|0|||
155195758|NCT00894166|560154494|FG003|Overall Study|Death|1|||
155195759|NCT00894166|560154495|FG004|Overall Study|Death|0|||
155195760|NCT00894166|560154496|FG005|Overall Study|Death|0|||
155195761|NCT00894166|560154497|FG006|Overall Study|Death|0|||
155195762|NCT00894166|560154498|FG007|Overall Study|Death|0|||
155195763|NCT05350410|560154499|FG000|Overall Study|Withdrawal by Subject|1|||
155195764|NCT01601132|560154500|FG000|Overall Study|Patient withdrew consent|1|||
155195765|NCT01601132|560154500|FG000|Overall Study|Protocol deviation|1|||
155195766|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Adverse Event|3|||
155195767|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Adverse Event|0|||
155195768|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
155195769|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
155195770|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
155195771|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
155195772|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Physician Decision|0|||
155195773|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Physician Decision|2|||
155195774|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
155195775|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
155195776|NCT02110238|560154502|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
155195777|NCT02110238|560154503|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
155195778|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
155195779|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
155195780|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
155195781|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
155195782|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
155195783|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
155195784|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
155148053|NCT01755234|559974455|FG001|Overall Study|Lost to Follow-up|6|||
155148054|NCT01755234|559974454|FG000|Overall Study|Change in surgical case|2|||
155148055|NCT01755234|559974455|FG001|Overall Study|Change in surgical case|1|||
155148056|NCT01755234|559974454|FG000|Overall Study|case cancelled|1|||
155148057|NCT01755234|559974455|FG001|Overall Study|case cancelled|0|||
155148058|NCT01755234|559974454|FG000|Overall Study|Withdrawal by Subject|0|||
155148059|NCT01755234|559974455|FG001|Overall Study|Withdrawal by Subject|1|||
155148060|NCT01755234|559974454|FG000|Overall Study|unblinded|1|||
155148061|NCT01755234|559974455|FG001|Overall Study|unblinded|0|||
155148062|NCT03812380|559974456|FG000|Overall Study|Protocol Violation|3|||
155148063|NCT03812380|559974457|FG001|Overall Study|Protocol Violation|3|||
155148064|NCT03812380|559974456|FG000|Overall Study|Withdrawal by Subject|5|||
155148065|NCT03812380|559974457|FG001|Overall Study|Withdrawal by Subject|4|||
155148066|NCT03812380|559974456|FG000|Overall Study|Early termination of study|14|||
155148067|NCT03812380|559974457|FG001|Overall Study|Early termination of study|14|||
155148068|NCT00622505|559974458|FG000|Overall Study|Adverse Event|9|||
155148069|NCT00622505|559974459|FG001|Overall Study|Adverse Event|7|||
155148070|NCT00622505|559974458|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
155195785|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
155195786|NCT02110238|560154502|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
155195787|NCT02110238|560154503|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
155195788|NCT00142935|560154511|FG000|Overall Study|Other reason|1|||
155195789|NCT00142935|560154512|FG001|Overall Study|Other reason|1|||
155148071|NCT00622505|559974459|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
155148072|NCT00622505|559974458|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155148073|NCT00622505|559974459|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
155148074|NCT00622505|559974458|FG000|Overall Study|Withdrawal by Subject|12|||
155148075|NCT00622505|559974459|FG001|Overall Study|Withdrawal by Subject|5|||
155148076|NCT00622505|559974458|FG000|Overall Study|Administrative Problems|2|||
155148077|NCT00622505|559974459|FG001|Overall Study|Administrative Problems|4|||
155148078|NCT00622505|559974458|FG000|Overall Study|Death|2|||
155148079|NCT00622505|559974459|FG001|Overall Study|Death|2|||
155148080|NCT00619515|559974460|FG000|Overall Study|Study Termination by IRB|73|||
155148081|NCT01092728|559974465|FG000|Overall Study|Withdrawal by Subject|2|||
155148082|NCT01092728|559974466|FG001|Overall Study|Withdrawal by Subject|0|||
155148083|NCT01092728|559974465|FG000|Overall Study|Adverse Event|0|||
155148084|NCT01092728|559974466|FG001|Overall Study|Adverse Event|1|||
155148085|NCT01092728|559974465|FG000|Overall Study|Disease Progression|1|||
155148086|NCT01092728|559974466|FG001|Overall Study|Disease Progression|13|||
155148087|NCT01092728|559974465|FG000|Overall Study|Prohibited Concomitant Medications|1|||
155148088|NCT01092728|559974466|FG001|Overall Study|Prohibited Concomitant Medications|0|||
155148089|NCT00614380|559974467|FG000|Overall Study|Adverse Event|14|||
155148090|NCT00614380|559974468|FG001|Overall Study|Adverse Event|4|||
155148091|NCT00614380|559974469|FG002|Overall Study|Adverse Event|0|||
155148092|NCT00614380|559974470|FG003|Overall Study|Adverse Event|0|||
155148093|NCT00614380|559974467|FG000|Overall Study|Lost to Follow-up|6|||
155148094|NCT00614380|559974468|FG001|Overall Study|Lost to Follow-up|1|||
155148095|NCT00614380|559974469|FG002|Overall Study|Lost to Follow-up|0|||
155148096|NCT00614380|559974470|FG003|Overall Study|Lost to Follow-up|0|||
155148097|NCT00614380|559974467|FG000|Overall Study|Non compliant with the protocol|12|||
155148098|NCT00614380|559974468|FG001|Overall Study|Non compliant with the protocol|2|||
155148099|NCT00614380|559974469|FG002|Overall Study|Non compliant with the protocol|1|||
155148100|NCT00614380|559974470|FG003|Overall Study|Non compliant with the protocol|2|||
155148101|NCT00614380|559974467|FG000|Overall Study|Consent withdrawn|3|||
155148102|NCT00614380|559974468|FG001|Overall Study|Consent withdrawn|1|||
155148103|NCT00614380|559974469|FG002|Overall Study|Consent withdrawn|0|||
155148104|NCT00614380|559974470|FG003|Overall Study|Consent withdrawn|0|||
155148105|NCT00920855|559974472|FG000|Overall Study|Adverse Event|1|||
155148106|NCT00920855|559974473|FG001|Overall Study|Adverse Event|1|||
155148107|NCT00920855|559974474|FG002|Overall Study|Adverse Event|4|||
155148108|NCT00920855|559974472|FG000|Overall Study|Withdrawal by Subject|2|||
155148109|NCT00920855|559974473|FG001|Overall Study|Withdrawal by Subject|1|||
155148110|NCT00920855|559974474|FG002|Overall Study|Withdrawal by Subject|6|||
155148111|NCT00920855|559974472|FG000|Overall Study|Disease progression|2|||
155148112|NCT00920855|559974473|FG001|Overall Study|Disease progression|1|||
155148113|NCT00920855|559974474|FG002|Overall Study|Disease progression|10|||
155148114|NCT00920855|559974472|FG000|Overall Study|Noncompliance to study medication|0|||
155148115|NCT00920855|559974473|FG001|Overall Study|Noncompliance to study medication|0|||
155148116|NCT00920855|559974474|FG002|Overall Study|Noncompliance to study medication|1|||
155148117|NCT00920855|559974472|FG000|Overall Study|Response plateau; started maintenance|0|||
155195790|NCT00142935|560154513|FG002|Overall Study|Other reason|1|||
155148118|NCT00920855|559974473|FG001|Overall Study|Response plateau; started maintenance|0|||
155195791|NCT00142935|560154511|FG000|Overall Study|Lost to Follow-up|2|||
155148119|NCT00920855|559974474|FG002|Overall Study|Response plateau; started maintenance|1|||
155148120|NCT00510835|559974477|FG000|Overall Study|Withdrawal by Subject|6|||
155148121|NCT00510835|559974478|FG001|Overall Study|Withdrawal by Subject|2|||
155148122|NCT00510835|559974479|FG002|Overall Study|Withdrawal by Subject|2|||
155148123|NCT00152503|559974481|FG000|Overall Study|Adverse Event|4|||
155148124|NCT03253679|559974482|FG000|Overall Study|Screen Failure|1|||
155148125|NCT04816214|559974483|FG000|Overall Study|Progressive Disease|4|||
155148126|NCT04816214|559974484|FG001|Overall Study|Progressive Disease|0|||
155148127|NCT04816214|559974485|FG002|Overall Study|Progressive Disease|0|||
155148128|NCT04816214|559974483|FG000|Overall Study|Death|1|||
155148129|NCT04816214|559974484|FG001|Overall Study|Death|0|||
155148130|NCT04816214|559974485|FG002|Overall Study|Death|0|||
155148131|NCT04816214|559974483|FG000|Overall Study|Study Terminated by Sponsor|1|||
155148132|NCT04816214|559974484|FG001|Overall Study|Study Terminated by Sponsor|0|||
155148133|NCT04816214|559974485|FG002|Overall Study|Study Terminated by Sponsor|0|||
155148134|NCT04393493|559974486|FG000|First 4 Days of Intervention|Early improvement|5|||
155148135|NCT04393493|559974487|FG001|First 4 Days of Intervention|Early improvement|7|||
155148136|NCT02926638|559974490|FG000|Overall Study|Progression|2|||
155148137|NCT02926638|559974491|FG001|Overall Study|Progression|5|||
155148138|NCT02926638|559974490|FG000|Overall Study|Ineligible|1|||
155148139|NCT02926638|559974491|FG001|Overall Study|Ineligible|0|||
155148140|NCT02926638|559974490|FG000|Overall Study|Not protocol specified|1|||
155148141|NCT02926638|559974491|FG001|Overall Study|Not protocol specified|0|||
155148142|NCT02464410|559974492|FG000|Overall Study|Death|3|||
155148143|NCT02464410|559974493|FG001|Overall Study|Death|4|||
155148144|NCT02464410|559974492|FG000|Overall Study|Lost to Follow-up|7|||
155148145|NCT02464410|559974493|FG001|Overall Study|Lost to Follow-up|9|||
155148146|NCT02464410|559974492|FG000|Overall Study|Withdrawal by Subject|12|||
155148147|NCT02464410|559974493|FG001|Overall Study|Withdrawal by Subject|3|||
155148148|NCT02079740|559976215|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
155148149|NCT02079740|559976216|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
155148150|NCT02079740|559976217|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
155148151|NCT02079740|559976218|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
155148152|NCT02079740|559976219|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
155148153|NCT02079740|559976220|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
155148154|NCT02079740|559976221|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
155148155|NCT02079740|559976222|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
155148156|NCT02079740|559976223|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
155148157|NCT02079740|559976224|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
155148158|NCT02079740|559976225|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
155148159|NCT02079740|559976226|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
155148160|NCT02079740|559976227|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
155148161|NCT02079740|559976215|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
155148162|NCT02079740|559976216|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
155148163|NCT02079740|559976217|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
155148164|NCT02079740|559976218|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
155148165|NCT02079740|559976219|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
155148166|NCT02079740|559976220|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
155148167|NCT02079740|559976221|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
155148168|NCT02079740|559976222|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
155148169|NCT02079740|559976223|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
155148170|NCT02079740|559976224|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
155148171|NCT02079740|559976225|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
155148172|NCT02079740|559976226|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
155148173|NCT02079740|559976227|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
155148174|NCT02079740|559976215|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148175|NCT02079740|559976216|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148176|NCT02079740|559976217|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148177|NCT02079740|559976218|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148178|NCT02079740|559976219|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148179|NCT02079740|559976220|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148180|NCT02079740|559976221|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148181|NCT02079740|559976222|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
155148182|NCT02079740|559976223|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148183|NCT02079740|559976224|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148184|NCT02079740|559976225|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148185|NCT02079740|559976226|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148186|NCT02079740|559976227|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
155148187|NCT02079740|559976215|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148188|NCT02079740|559976216|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148189|NCT02079740|559976217|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148190|NCT02079740|559976218|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148191|NCT02079740|559976219|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155195792|NCT00142935|560154512|FG001|Overall Study|Lost to Follow-up|5|||
155195793|NCT00142935|560154513|FG002|Overall Study|Lost to Follow-up|5|||
155195794|NCT00142935|560154511|FG000|Overall Study|Death|0|||
155195795|NCT00142935|560154512|FG001|Overall Study|Death|2|||
155195796|NCT00142935|560154513|FG002|Overall Study|Death|1|||
155195797|NCT01330030|560154514|FG000|Overall Study|Lost to Follow-up|16|||
155195798|NCT01330030|560154515|FG001|Overall Study|Lost to Follow-up|17|||
155195799|NCT05047770|560154516|FG000|Overall Study|Withdrawal by Subject|15|||
155195800|NCT05047770|560154517|FG001|Overall Study|Withdrawal by Subject|10|||
155195801|NCT05047770|560154518|FG002|Overall Study|Withdrawal by Subject|6|||
155195802|NCT05047770|560154519|FG003|Overall Study|Withdrawal by Subject|12|||
155195803|NCT05047770|560154516|FG000|Overall Study|Lost to Follow-up|7|||
155195804|NCT05047770|560154517|FG001|Overall Study|Lost to Follow-up|5|||
155195805|NCT05047770|560154518|FG002|Overall Study|Lost to Follow-up|12|||
155195806|NCT05047770|560154519|FG003|Overall Study|Lost to Follow-up|13|||
155195807|NCT05047770|560154516|FG000|Overall Study|Other|1|||
155195808|NCT05047770|560154517|FG001|Overall Study|Other|0|||
155195809|NCT05047770|560154518|FG002|Overall Study|Other|1|||
155195810|NCT05047770|560154519|FG003|Overall Study|Other|0|||
155195811|NCT01952145|560154520|FG000|Overall Study|Protocol Violation|2|||
155195812|NCT01952145|560154521|FG001|Overall Study|Protocol Violation|1|||
155195813|NCT01952145|560154520|FG000|Overall Study|Death|0|||
155195814|NCT01952145|560154521|FG001|Overall Study|Death|1|||
155195815|NCT01952145|560154520|FG000|Overall Study|Adverse Event|9|||
155195816|NCT01952145|560154521|FG001|Overall Study|Adverse Event|0|||
155195817|NCT01952145|560154520|FG000|Overall Study|Withdrawal Criteria|16|||
155195818|NCT01952145|560154521|FG001|Overall Study|Withdrawal Criteria|11|||
155195819|NCT01952145|560154520|FG000|Overall Study|Unclassified|1|||
155195820|NCT01952145|560154521|FG001|Overall Study|Unclassified|1|||
155195821|NCT04138810|560154522|FG000|Overall Study|Withdrawal by Subject|0|||
155195822|NCT04138810|560154523|FG001|Overall Study|Withdrawal by Subject|1|||
155195823|NCT04138810|560154522|FG000|Overall Study|Subject cancelled surgery|1|||
155195824|NCT04138810|560154523|FG001|Overall Study|Subject cancelled surgery|0|||
155195825|NCT05224141|560154530|FG000|Overall Study|Ongoing|75|||
155195826|NCT05224141|560154531|FG001|Overall Study|Ongoing|88|||
155195827|NCT05224141|560154530|FG000|Overall Study|Withdrawal by Subject|2|||
155195828|NCT05224141|560154531|FG001|Overall Study|Withdrawal by Subject|4|||
155195829|NCT05224141|560154530|FG000|Overall Study|Death|153|||
155195830|NCT05224141|560154531|FG001|Overall Study|Death|138|||
155195831|NCT04545060|560154537|FG000|Overall Study|Adverse Event|0|||
155195832|NCT04545060|560154538|FG001|Overall Study|Adverse Event|1|||
155195833|NCT04545060|560154537|FG000|Overall Study|Death|0|||
155195834|NCT04545060|560154538|FG001|Overall Study|Death|5|||
155195835|NCT04545060|560154537|FG000|Overall Study|Lost to Follow-up|10|||
155195836|NCT04545060|560154538|FG001|Overall Study|Lost to Follow-up|13|||
155195837|NCT04545060|560154537|FG000|Overall Study|Physician Decision|3|||
155195838|NCT04545060|560154538|FG001|Overall Study|Physician Decision|0|||
155195839|NCT04545060|560154537|FG000|Overall Study|Withdrawal by Subject|17|||
155195840|NCT04545060|560154538|FG001|Overall Study|Withdrawal by Subject|22|||
155195841|NCT00619177|560154539|FG000|Overall Study|Adverse Event|18|||
155195842|NCT00619177|560154539|FG000|Overall Study|Lost to Follow-up|2|||
155195843|NCT00619177|560154539|FG000|Overall Study|Lack of Efficacy|1|||
155195844|NCT00619177|560154539|FG000|Overall Study|Missing termination information|481|||
155195845|NCT00619177|560154539|FG000|Overall Study|Not specified reasons|6|||
155195846|NCT02435147|560154541|FG000|Overall Study|non-evaluable DXA scan|11|||
155195847|NCT02939079|560154542|FG000|Overall Study|Adverse Event|2|||
155195848|NCT02939079|560154543|FG001|Overall Study|Adverse Event|1|||
155195849|NCT02939079|560154542|FG000|Overall Study|Lost to Follow-up|0|||
155195850|NCT02939079|560154543|FG001|Overall Study|Lost to Follow-up|2|||
155195851|NCT02939079|560154542|FG000|Overall Study|Protocol Violation|1|||
155195852|NCT02939079|560154543|FG001|Overall Study|Protocol Violation|0|||
155195853|NCT02939079|560154542|FG000|Overall Study|Withdrawal by Subject|0|||
155195854|NCT02939079|560154543|FG001|Overall Study|Withdrawal by Subject|1|||
155195855|NCT02939079|560154542|FG000|Overall Study|relapse during the study|1|||
155195856|NCT02939079|560154543|FG001|Overall Study|relapse during the study|1|||
155195857|NCT01609231|560154544|FG000|Overall Study|Adverse Event|1|||
155195858|NCT01609231|560154545|FG001|Overall Study|Adverse Event|3|||
155195859|NCT01609231|560154544|FG000|Overall Study|Physician Decision|1|||
155195860|NCT01609231|560154545|FG001|Overall Study|Physician Decision|0|||
155195861|NCT01609231|560154544|FG000|Overall Study|Withdrawal by Subject|1|||
155195862|NCT01609231|560154545|FG001|Overall Study|Withdrawal by Subject|0|||
155195863|NCT01180647|560154546|FG000|Overall Study|Lost to Follow-up|5|||
155195864|NCT01180647|560154547|FG001|Overall Study|Lost to Follow-up|6|||
155195865|NCT04545554|560154558|FG000|Overall Study|Withdrawal by Subject|0|||
155195866|NCT04545554|560154559|FG001|Overall Study|Withdrawal by Subject|0|||
155195867|NCT04545554|560154560|FG002|Overall Study|Withdrawal by Subject|0|||
155195868|NCT04545554|560154561|FG003|Overall Study|Withdrawal by Subject|1|||
155195869|NCT04545554|560154562|FG004|Overall Study|Withdrawal by Subject|0|||
155195870|NCT04545554|560154563|FG005|Overall Study|Withdrawal by Subject|0|||
155195871|NCT02478372|560154564|FG000|Overall Study|Protocol Violation|12|||
155148192|NCT02079740|559976220|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148193|NCT02079740|559976221|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148194|NCT02079740|559976222|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
155148195|NCT02079740|559976223|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148196|NCT02079740|559976224|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148197|NCT02079740|559976225|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148198|NCT02079740|559976226|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148199|NCT02079740|559976227|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
155148200|NCT02079740|559976215|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148201|NCT02079740|559976216|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148202|NCT02079740|559976217|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148203|NCT02079740|559976218|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148204|NCT02079740|559976219|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148205|NCT02079740|559976220|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148206|NCT02079740|559976221|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148207|NCT02079740|559976222|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148208|NCT02079740|559976223|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148209|NCT02079740|559976224|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
155148210|NCT02079740|559976225|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
155148211|NCT02079740|559976226|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
155148212|NCT02079740|559976227|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
155148213|NCT00882440|559976228|FG000|Overall Study|Adverse Event|2|||
155148214|NCT00882440|559976229|FG001|Overall Study|Adverse Event|2|||
155148215|NCT00882440|559976230|FG002|Overall Study|Adverse Event|2|||
155148216|NCT00882440|559976231|FG003|Overall Study|Adverse Event|1|||
155148217|NCT00882440|559976232|FG004|Overall Study|Adverse Event|1|||
155148218|NCT00882440|559976233|FG005|Overall Study|Adverse Event|4|||
155148219|NCT00882440|559976234|FG006|Overall Study|Adverse Event|2|||
155148220|NCT00882440|559976228|FG000|Overall Study|Lack of Efficacy|3|||
155148221|NCT00882440|559976229|FG001|Overall Study|Lack of Efficacy|5|||
155148222|NCT00882440|559976230|FG002|Overall Study|Lack of Efficacy|2|||
155148223|NCT00882440|559976231|FG003|Overall Study|Lack of Efficacy|0|||
155148224|NCT00882440|559976232|FG004|Overall Study|Lack of Efficacy|0|||
155148225|NCT00882440|559976233|FG005|Overall Study|Lack of Efficacy|3|||
155148226|NCT00882440|559976234|FG006|Overall Study|Lack of Efficacy|0|||
155148227|NCT00882440|559976228|FG000|Overall Study|Lost to Follow-up|2|||
155148228|NCT00882440|559976229|FG001|Overall Study|Lost to Follow-up|0|||
155148229|NCT00882440|559976230|FG002|Overall Study|Lost to Follow-up|1|||
155148230|NCT00882440|559976231|FG003|Overall Study|Lost to Follow-up|1|||
155148231|NCT00882440|559976232|FG004|Overall Study|Lost to Follow-up|1|||
155148232|NCT00882440|559976233|FG005|Overall Study|Lost to Follow-up|0|||
155148233|NCT00882440|559976234|FG006|Overall Study|Lost to Follow-up|1|||
155148234|NCT00882440|559976228|FG000|Overall Study|Protocol Violation|0|||
155148235|NCT00882440|559976229|FG001|Overall Study|Protocol Violation|0|||
155148236|NCT00882440|559976230|FG002|Overall Study|Protocol Violation|1|||
155148237|NCT00882440|559976231|FG003|Overall Study|Protocol Violation|1|||
155148238|NCT00882440|559976232|FG004|Overall Study|Protocol Violation|1|||
155148239|NCT00882440|559976233|FG005|Overall Study|Protocol Violation|0|||
155148240|NCT00882440|559976234|FG006|Overall Study|Protocol Violation|0|||
155148241|NCT00882440|559976228|FG000|Overall Study|Withdrawal by Subject|2|||
155148242|NCT00882440|559976229|FG001|Overall Study|Withdrawal by Subject|1|||
155148243|NCT00882440|559976230|FG002|Overall Study|Withdrawal by Subject|1|||
155148244|NCT00882440|559976231|FG003|Overall Study|Withdrawal by Subject|0|||
155148245|NCT00882440|559976232|FG004|Overall Study|Withdrawal by Subject|6|||
155148246|NCT00882440|559976233|FG005|Overall Study|Withdrawal by Subject|0|||
155148247|NCT00882440|559976234|FG006|Overall Study|Withdrawal by Subject|1|||
155148248|NCT00882440|559976228|FG000|Overall Study|Patient Uncooperative|2|||
155148249|NCT00882440|559976229|FG001|Overall Study|Patient Uncooperative|0|||
155148250|NCT00882440|559976230|FG002|Overall Study|Patient Uncooperative|0|||
155148251|NCT00882440|559976231|FG003|Overall Study|Patient Uncooperative|0|||
155148252|NCT00882440|559976232|FG004|Overall Study|Patient Uncooperative|1|||
155148253|NCT00882440|559976233|FG005|Overall Study|Patient Uncooperative|0|||
155148254|NCT00882440|559976234|FG006|Overall Study|Patient Uncooperative|0|||
155148255|NCT05482308|559976238|FG000|Overall Study|Withdrawal by Subject|1|||
155148256|NCT05482308|559976239|FG001|Overall Study|Withdrawal by Subject|0|||
155148257|NCT05482308|559976238|FG000|Overall Study|No longer meets eligibility criteria|0|||
155148258|NCT05482308|559976239|FG001|Overall Study|No longer meets eligibility criteria|1|||
155148259|NCT04319198|559976240|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
155148260|NCT04319198|559976241|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
155148261|NCT04319198|559976242|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
155148262|NCT04319198|559976240|FG000|Overall Study|Death|0|||
155148263|NCT04319198|559976241|FG001|Overall Study|Death|3|||
155148264|NCT04319198|559976242|FG002|Overall Study|Death|3|||
155148265|NCT04319198|559976240|FG000|Overall Study|Reason Not Specified|0|||
155148266|NCT04319198|559976241|FG001|Overall Study|Reason Not Specified|2|||
155148267|NCT04319198|559976242|FG002|Overall Study|Reason Not Specified|4|||
155148268|NCT04319198|559976240|FG000|Overall Study|Withdrawal of Consent|0|||
155148269|NCT04319198|559976241|FG001|Overall Study|Withdrawal of Consent|0|||
155148270|NCT04319198|559976242|FG002|Overall Study|Withdrawal of Consent|5|||
155148271|NCT04319198|559976240|FG000|Overall Study|Site Terminated by Sponsor|0|||
155148272|NCT04319198|559976241|FG001|Overall Study|Site Terminated by Sponsor|1|||
155148273|NCT04319198|559976242|FG002|Overall Study|Site Terminated by Sponsor|0|||
155148274|NCT02123134|559976252|FG000|Overall Study|Withdrawal of consent|3|||
155148275|NCT02123134|559976253|FG001|Overall Study|Withdrawal of consent|2|||
155148276|NCT02123134|559976252|FG000|Overall Study|Administrative decision|0|||
155148277|NCT02123134|559976253|FG001|Overall Study|Administrative decision|1|||
155148278|NCT00962208|559976254|FG000|Overall Study|Could not achieve good vision|9|||
155148279|NCT00962208|559976255|FG001|Overall Study|Could not achieve good vision|0|||
155148280|NCT00962208|559976254|FG000|Overall Study|Contraindicated to continue study|5|||
155148281|NCT00962208|559976255|FG001|Overall Study|Contraindicated to continue study|1|||
155148282|NCT00962208|559976254|FG000|Overall Study|Lost to Follow-up|0|||
155148283|NCT00962208|559976255|FG001|Overall Study|Lost to Follow-up|9|||
155148284|NCT00657540|559976262|FG000|Overall Study|Lost to Follow-up|1|||
155148285|NCT00657540|559976263|FG001|Overall Study|Lost to Follow-up|4|||
155148286|NCT01731912|559976264|FG000|Overall Study|noncompliance|2|||
155148287|NCT00141453|559976265|FG000|Overall Study|Protocol Violation|6|||
155148288|NCT00141453|559976266|FG001|Overall Study|Protocol Violation|5|||
155148289|NCT02043938|559976267|FG000|Overall Study|Withdrawal by Subject|7|||
155148290|NCT02043938|559976267|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
155148291|NCT02043938|559976267|FG000|Overall Study|No show by subject|1|||
155148292|NCT02043938|559976267|FG000|Overall Study|Investigator decision|1|||
155148293|NCT03010527|559976268|FG000|Overall Study|Death|0|||
155148294|NCT03010527|559976269|FG001|Overall Study|Death|0|||
155148295|NCT03010527|559976270|FG002|Overall Study|Death|1|||
155148296|NCT03010527|559976268|FG000|Overall Study|Adverse Event|0|||
155148297|NCT03010527|559976269|FG001|Overall Study|Adverse Event|4|||
155148298|NCT03010527|559976270|FG002|Overall Study|Adverse Event|2|||
155148299|NCT03010527|559976268|FG000|Overall Study|Protocol Violation|0|||
155148300|NCT03010527|559976269|FG001|Overall Study|Protocol Violation|1|||
155148301|NCT03010527|559976270|FG002|Overall Study|Protocol Violation|0|||
155148302|NCT03010527|559976268|FG000|Overall Study|Lost to Follow-up|0|||
155148303|NCT03010527|559976269|FG001|Overall Study|Lost to Follow-up|2|||
155148304|NCT03010527|559976270|FG002|Overall Study|Lost to Follow-up|1|||
155148305|NCT03010527|559976268|FG000|Overall Study|Withdrawal by Subject|0|||
155148306|NCT03010527|559976269|FG001|Overall Study|Withdrawal by Subject|3|||
155148307|NCT03010527|559976270|FG002|Overall Study|Withdrawal by Subject|4|||
155148308|NCT03010527|559976268|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
155148309|NCT03010527|559976269|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
155148310|NCT03010527|559976270|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
155148311|NCT03010527|559976268|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
155148312|NCT03010527|559976269|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
155148313|NCT03010527|559976270|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
155148314|NCT03010527|559976268|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
155148315|NCT03010527|559976269|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
155148316|NCT03010527|559976270|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
155148317|NCT01458639|559976271|FG000|Overall Study|Physician Decision|4|||
155148318|NCT01458639|559976271|FG000|Overall Study|Equipment issue|1|||
155148319|NCT01458639|559976271|FG000|Overall Study|Inability to obtain subject blood sample|1|||
155148320|NCT04245111|559976272|FG000|Overall Study|Lost to Follow-up|5|||
155148321|NCT04245111|559976273|FG001|Overall Study|Lost to Follow-up|1|||
155148322|NCT04245111|559976274|FG002|Overall Study|Lost to Follow-up|1|||
155148323|NCT06039579|559976275|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148324|NCT06039579|559976276|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148325|NCT06039579|559976277|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148326|NCT06039579|559976278|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148327|NCT06039579|559976279|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148328|NCT06039579|559976280|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148329|NCT06039579|559976281|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
155148330|NCT06039579|559976282|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
155148331|NCT02349633|559976283|FG000|Overall Study|Death|0|||
155148332|NCT02349633|559976284|FG001|Overall Study|Death|1|||
155148333|NCT02349633|559976285|FG002|Overall Study|Death|0|||
155148334|NCT02349633|559976286|FG003|Overall Study|Death|0|||
155148335|NCT02349633|559976287|FG004|Overall Study|Death|0|||
155148336|NCT02349633|559976288|FG005|Overall Study|Death|1|||
155148337|NCT02349633|559976289|FG006|Overall Study|Death|1|||
155148338|NCT02349633|559976290|FG007|Overall Study|Death|1|||
155148339|NCT02349633|559976291|FG008|Overall Study|Death|0|||
155148340|NCT02349633|559976292|FG009|Overall Study|Death|1|||
155148341|NCT02349633|559976293|FG010|Overall Study|Death|0|||
155148342|NCT02349633|559976294|FG011|Overall Study|Death|0|||
155148343|NCT02349633|559976295|FG012|Overall Study|Death|0|||
155148344|NCT02349633|559976296|FG013|Overall Study|Death|0|||
155148345|NCT02349633|559976283|FG000|Overall Study|Withdrawal by Subject|0|||
155148346|NCT02349633|559976284|FG001|Overall Study|Withdrawal by Subject|0|||
155148347|NCT02349633|559976285|FG002|Overall Study|Withdrawal by Subject|0|||
155148348|NCT02349633|559976286|FG003|Overall Study|Withdrawal by Subject|1|||
155148349|NCT02349633|559976287|FG004|Overall Study|Withdrawal by Subject|0|||
155148350|NCT02349633|559976288|FG005|Overall Study|Withdrawal by Subject|0|||
155148351|NCT02349633|559976289|FG006|Overall Study|Withdrawal by Subject|0|||
155148352|NCT02349633|559976290|FG007|Overall Study|Withdrawal by Subject|2|||
155148353|NCT02349633|559976291|FG008|Overall Study|Withdrawal by Subject|2|||
155148354|NCT02349633|559976292|FG009|Overall Study|Withdrawal by Subject|1|||
155148355|NCT02349633|559976293|FG010|Overall Study|Withdrawal by Subject|0|||
155148356|NCT02349633|559976294|FG011|Overall Study|Withdrawal by Subject|0|||
155148357|NCT02349633|559976295|FG012|Overall Study|Withdrawal by Subject|0|||
155148358|NCT02349633|559976296|FG013|Overall Study|Withdrawal by Subject|0|||
155148359|NCT02349633|559976283|FG000|Overall Study|Withdrawal of informed consent|0|||
155148360|NCT02349633|559976284|FG001|Overall Study|Withdrawal of informed consent|0|||
155148361|NCT02349633|559976285|FG002|Overall Study|Withdrawal of informed consent|0|||
155148362|NCT02349633|559976286|FG003|Overall Study|Withdrawal of informed consent|1|||
155148363|NCT02349633|559976287|FG004|Overall Study|Withdrawal of informed consent|1|||
155148364|NCT02349633|559976288|FG005|Overall Study|Withdrawal of informed consent|0|||
155148365|NCT02349633|559976289|FG006|Overall Study|Withdrawal of informed consent|0|||
155148366|NCT02349633|559976290|FG007|Overall Study|Withdrawal of informed consent|3|||
155148367|NCT02349633|559976291|FG008|Overall Study|Withdrawal of informed consent|0|||
155148368|NCT02349633|559976292|FG009|Overall Study|Withdrawal of informed consent|0|||
155148369|NCT02349633|559976293|FG010|Overall Study|Withdrawal of informed consent|0|||
155148370|NCT02349633|559976294|FG011|Overall Study|Withdrawal of informed consent|0|||
155148371|NCT02349633|559976295|FG012|Overall Study|Withdrawal of informed consent|0|||
155148372|NCT02349633|559976296|FG013|Overall Study|Withdrawal of informed consent|0|||
155148373|NCT02349633|559976283|FG000|Overall Study|Transition to compassionate use|0|||
155148374|NCT02349633|559976284|FG001|Overall Study|Transition to compassionate use|0|||
155148375|NCT02349633|559976285|FG002|Overall Study|Transition to compassionate use|0|||
155148376|NCT02349633|559976286|FG003|Overall Study|Transition to compassionate use|0|||
155148377|NCT02349633|559976287|FG004|Overall Study|Transition to compassionate use|1|||
155148378|NCT02349633|559976288|FG005|Overall Study|Transition to compassionate use|0|||
155148379|NCT02349633|559976289|FG006|Overall Study|Transition to compassionate use|0|||
155148380|NCT02349633|559976290|FG007|Overall Study|Transition to compassionate use|3|||
155148381|NCT02349633|559976291|FG008|Overall Study|Transition to compassionate use|0|||
155148382|NCT02349633|559976292|FG009|Overall Study|Transition to compassionate use|1|||
155148383|NCT02349633|559976293|FG010|Overall Study|Transition to compassionate use|0|||
155148384|NCT02349633|559976294|FG011|Overall Study|Transition to compassionate use|0|||
155148385|NCT02349633|559976295|FG012|Overall Study|Transition to compassionate use|0|||
155148386|NCT02349633|559976296|FG013|Overall Study|Transition to compassionate use|0|||
155148387|NCT02349633|559976283|FG000|Overall Study|Early termination of survival follow-up|0|||
155148388|NCT02349633|559976284|FG001|Overall Study|Early termination of survival follow-up|0|||
155148389|NCT02349633|559976285|FG002|Overall Study|Early termination of survival follow-up|0|||
155148390|NCT02349633|559976286|FG003|Overall Study|Early termination of survival follow-up|0|||
155148391|NCT02349633|559976287|FG004|Overall Study|Early termination of survival follow-up|0|||
155148392|NCT02349633|559976288|FG005|Overall Study|Early termination of survival follow-up|0|||
155148393|NCT02349633|559976289|FG006|Overall Study|Early termination of survival follow-up|0|||
155148394|NCT02349633|559976290|FG007|Overall Study|Early termination of survival follow-up|4|||
155148395|NCT02349633|559976291|FG008|Overall Study|Early termination of survival follow-up|0|||
155148396|NCT02349633|559976292|FG009|Overall Study|Early termination of survival follow-up|0|||
155148397|NCT02349633|559976293|FG010|Overall Study|Early termination of survival follow-up|0|||
155148398|NCT02349633|559976294|FG011|Overall Study|Early termination of survival follow-up|0|||
155148399|NCT02349633|559976295|FG012|Overall Study|Early termination of survival follow-up|0|||
155148400|NCT02349633|559976296|FG013|Overall Study|Early termination of survival follow-up|0|||
155148401|NCT02349633|559976283|FG000|Overall Study|Termination by sponsor|0|||
155148402|NCT02349633|559976284|FG001|Overall Study|Termination by sponsor|0|||
155148403|NCT02349633|559976285|FG002|Overall Study|Termination by sponsor|0|||
155148404|NCT02349633|559976286|FG003|Overall Study|Termination by sponsor|0|||
155195872|NCT02478372|560154565|FG001|Overall Study|Protocol Violation|8|||
155148405|NCT02349633|559976287|FG004|Overall Study|Termination by sponsor|0|||
155148406|NCT02349633|559976288|FG005|Overall Study|Termination by sponsor|0|||
155148407|NCT02349633|559976289|FG006|Overall Study|Termination by sponsor|0|||
155148408|NCT02349633|559976290|FG007|Overall Study|Termination by sponsor|1|||
155148409|NCT02349633|559976291|FG008|Overall Study|Termination by sponsor|0|||
155148410|NCT02349633|559976292|FG009|Overall Study|Termination by sponsor|2|||
155148411|NCT02349633|559976293|FG010|Overall Study|Termination by sponsor|0|||
155148412|NCT02349633|559976294|FG011|Overall Study|Termination by sponsor|0|||
155148413|NCT02349633|559976295|FG012|Overall Study|Termination by sponsor|0|||
155195873|NCT02478372|560154564|FG000|Overall Study|Lost to Follow-up|1|||
155195874|NCT02478372|560154565|FG001|Overall Study|Lost to Follow-up|4|||
155195875|NCT02478372|560154564|FG000|Overall Study|Death|0|||
155195876|NCT02478372|560154565|FG001|Overall Study|Death|2|||
155195877|NCT00116428|560154566|FG000|Overall Study|Withdrawal by Subject|2|||
155195878|NCT00116428|560154567|FG001|Overall Study|Withdrawal by Subject|5|||
155195879|NCT00116428|560154566|FG000|Overall Study|Did not meet inclusion criteria|1|||
155195880|NCT00116428|560154567|FG001|Overall Study|Did not meet inclusion criteria|0|||
155195881|NCT00788073|560154569|FG000|STX209 Then Placebo|Adverse Event|1|||
155195882|NCT00788073|560154570|FG001|STX209 Then Placebo|Adverse Event|0|||
155195883|NCT00788073|560154569|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
155195884|NCT00788073|560154570|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
155195885|NCT00788073|560154569|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
155195886|NCT00788073|560154570|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
155195887|NCT00788073|560154569|FG000|STX209 Then Placebo|unable to return due to travel|0|||
155195888|NCT00788073|560154570|FG001|STX209 Then Placebo|unable to return due to travel|1|||
155195889|NCT00788073|560154569|FG000|Placebo Then STX209|Adverse Event|2|||
155195890|NCT00788073|560154570|FG001|Placebo Then STX209|Adverse Event|0|||
155195891|NCT00788073|560154569|FG000|Placebo Then STX209|Protocol Violation|0|||
155195892|NCT00788073|560154570|FG001|Placebo Then STX209|Protocol Violation|1|||
155195893|NCT00910273|560154571|FG000|Overall Study|Lack of Efficacy|6|||
155195894|NCT00910273|560154572|FG001|Overall Study|Lack of Efficacy|9|||
155195895|NCT00910273|560154571|FG000|Overall Study|Adverse Event|1|||
155195896|NCT00910273|560154572|FG001|Overall Study|Adverse Event|1|||
155195897|NCT00910273|560154571|FG000|Overall Study|Withdrawal by Subject|1|||
155195898|NCT00910273|560154572|FG001|Overall Study|Withdrawal by Subject|0|||
155195899|NCT00910273|560154571|FG000|Overall Study|Discontinuation of study by sponsor|8|||
155195900|NCT00910273|560154572|FG001|Overall Study|Discontinuation of study by sponsor|2|||
155195901|NCT00910273|560154571|FG000|Overall Study|Protocol Violation|1|||
155148414|NCT02349633|559976296|FG013|Overall Study|Termination by sponsor|0|||
155148415|NCT02349633|559976283|FG000|Overall Study|Other|0|||
155195902|NCT00910273|560154572|FG001|Overall Study|Protocol Violation|0|||
155195903|NCT00910273|560154571|FG000|Overall Study|Lost to Follow-up|1|||
155195904|NCT00910273|560154572|FG001|Overall Study|Lost to Follow-up|1|||
155195905|NCT00660673|560154573|FG000|Overall Study|Adverse Event|84|||
155195906|NCT00660673|560154573|FG000|Overall Study|Lack of Efficacy|7|||
155195907|NCT00660673|560154573|FG000|Overall Study|Withdrawal by Subject|22|||
155195908|NCT00660673|560154573|FG000|Overall Study|Administrative|2|||
155195909|NCT00660673|560154573|FG000|Overall Study|Protocol Violation|2|||
155195910|NCT00579098|560154578|FG000|Overall Study|Lost to Follow-up|2|||
155195911|NCT00579098|560154579|FG001|Overall Study|Lost to Follow-up|0|||
155195912|NCT00579098|560154578|FG000|Overall Study|Adverse Event|2|||
155195913|NCT00579098|560154579|FG001|Overall Study|Adverse Event|3|||
155195914|NCT00579098|560154578|FG000|Overall Study|Withdrawal by Subject|2|||
155195915|NCT00579098|560154579|FG001|Overall Study|Withdrawal by Subject|3|||
155195916|NCT00579098|560154578|FG000|Overall Study|AF returned after ablation|3|||
155195917|NCT00579098|560154579|FG001|Overall Study|AF returned after ablation|2|||
155195918|NCT01254331|560154585|FG000|Initial Phase|Adverse Event|3|||
155195919|NCT01254331|560154585|FG000|Initial Phase|Withdrawal by Subject|1|||
155195920|NCT01254331|560154585|FG000|Initial Phase|Pregnancy|1|||
155195921|NCT01254331|560154585|FG000|Extension Phase|Lack of Efficacy|1|||
155195922|NCT01254331|560154585|FG000|Extension Phase|Lost to Follow-up|3|||
155195923|NCT00633750|560154586|FG000|Overall Study|Adverse Event|2|||
155195924|NCT00633750|560154586|FG000|Overall Study|Withdrawal by Subject|3|||
155195925|NCT01903031|560154587|FG000|Overall Study|Not Able to Attend Clinic|1|||
155195926|NCT01903031|560154588|FG001|Overall Study|Not Able to Attend Clinic|1|||
155148416|NCT02349633|559976284|FG001|Overall Study|Other|0|||
155148417|NCT02349633|559976285|FG002|Overall Study|Other|0|||
155148418|NCT02349633|559976286|FG003|Overall Study|Other|0|||
155195927|NCT01903031|560154589|FG002|Overall Study|Not Able to Attend Clinic|0|||
155195928|NCT01903031|560154587|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
155195929|NCT01903031|560154588|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
155148419|NCT02349633|559976287|FG004|Overall Study|Other|0|||
155195930|NCT01903031|560154589|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
155195931|NCT01903031|560154587|FG000|Overall Study|Adverse Event|0|||
155195932|NCT01903031|560154588|FG001|Overall Study|Adverse Event|1|||
155148420|NCT02349633|559976288|FG005|Overall Study|Other|0|||
155148421|NCT02349633|559976289|FG006|Overall Study|Other|0|||
155148422|NCT02349633|559976290|FG007|Overall Study|Other|2|||
155148423|NCT02349633|559976291|FG008|Overall Study|Other|0|||
155148424|NCT02349633|559976292|FG009|Overall Study|Other|0|||
155148425|NCT02349633|559976293|FG010|Overall Study|Other|0|||
155148426|NCT02349633|559976294|FG011|Overall Study|Other|0|||
155148427|NCT02349633|559976295|FG012|Overall Study|Other|0|||
155148428|NCT02349633|559976296|FG013|Overall Study|Other|0|||
155148429|NCT00981149|559976298|FG000|Overall Study|Lost to Follow-up|1|||
155148430|NCT00981149|559976299|FG001|Overall Study|Lost to Follow-up|2|||
155195933|NCT01903031|560154589|FG002|Overall Study|Adverse Event|0|||
155195934|NCT01903031|560154587|FG000|Overall Study|Withdrawal by Subject|0|||
155148431|NCT00981149|559976298|FG000|Overall Study|Withdrawal by Subject|1|||
155148432|NCT00981149|559976299|FG001|Overall Study|Withdrawal by Subject|1|||
155148433|NCT01220167|559976302|FG000|Period 3|Urine positive for substance abuse|0|||
155148434|NCT01220167|559976303|FG001|Period 3|Urine positive for substance abuse|1|||
155148435|NCT01220167|559976304|FG002|Period 3|Urine positive for substance abuse|0|||
155148436|NCT00667628|559976305|FG000|Overall Study|Lost to Follow-up|1|||
155148437|NCT00667628|559976306|FG001|Overall Study|Lost to Follow-up|0|||
155148438|NCT00667628|559976305|FG000|Overall Study|Death|6|||
155148439|NCT00667628|559976306|FG001|Overall Study|Death|6|||
155148440|NCT00667628|559976305|FG000|Overall Study|Investigator Considers in Best Interest|1|||
155148441|NCT00667628|559976306|FG001|Overall Study|Investigator Considers in Best Interest|0|||
155148442|NCT00667628|559976305|FG000|Overall Study|Sponsor Terminated Study|17|||
155148443|NCT00667628|559976306|FG001|Overall Study|Sponsor Terminated Study|21|||
155148444|NCT04663321|559976307|FG000|Overall Study|Study terminated by Sponsor|2|||
155148445|NCT04663321|559976308|FG001|Overall Study|Study terminated by Sponsor|1|||
155148446|NCT04663321|559976309|FG002|Overall Study|Study terminated by Sponsor|2|||
155148447|NCT04663321|559976307|FG000|Overall Study|Withdrawal by Subject|10|||
155148448|NCT04663321|559976308|FG001|Overall Study|Withdrawal by Subject|3|||
155148449|NCT04663321|559976309|FG002|Overall Study|Withdrawal by Subject|2|||
155148450|NCT04663321|559976307|FG000|Overall Study|Not provided|0|||
155148451|NCT04663321|559976308|FG001|Overall Study|Not provided|0|||
155148452|NCT04663321|559976309|FG002|Overall Study|Not provided|1|||
155148453|NCT04862065|559976310|FG000|Screening|Protocol Violation|54|||
155148454|NCT04862065|559976311|FG001|Screening|Protocol Violation|0|||
155148455|NCT04862065|559976312|FG002|Screening|Protocol Violation|0|||
155148456|NCT04862065|559976310|FG000|Screening|Insufficient Sample|1|||
155195935|NCT01903031|560154588|FG001|Overall Study|Withdrawal by Subject|1|||
155195936|NCT01903031|560154589|FG002|Overall Study|Withdrawal by Subject|1|||
155195937|NCT01903031|560154587|FG000|Overall Study|Protocol Violation|0|||
155195938|NCT01903031|560154588|FG001|Overall Study|Protocol Violation|0|||
155195939|NCT01903031|560154589|FG002|Overall Study|Protocol Violation|2|||
155195940|NCT01903031|560154587|FG000|Overall Study|Lost to Follow-up|0|||
155195941|NCT01903031|560154588|FG001|Overall Study|Lost to Follow-up|0|||
155195942|NCT01903031|560154589|FG002|Overall Study|Lost to Follow-up|1|||
155195943|NCT01903031|560154587|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
155195944|NCT01903031|560154588|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
155195945|NCT01903031|560154589|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
155195946|NCT05213481|560154590|FG000|Overall Study|Adverse Event|3|||
155148457|NCT04862065|559976311|FG001|Screening|Insufficient Sample|0|||
155148458|NCT04862065|559976312|FG002|Screening|Insufficient Sample|0|||
155148459|NCT04862065|559976310|FG000|Follow-Up|Lost to Follow-up|3|||
155148460|NCT04862065|559976311|FG001|Follow-Up|Lost to Follow-up|0|||
155148461|NCT04862065|559976312|FG002|Follow-Up|Lost to Follow-up|0|||
155148462|NCT01453140|559976313|FG000|Overall Study|Adverse Event|3|||
155148463|NCT02634333|559976314|FG000|Overall Study|Completed out of Window|3|||
155148464|NCT02634333|559976315|FG001|Overall Study|Completed out of Window|2|||
155148465|NCT02634333|559976314|FG000|Overall Study|Missed Visit|5|||
155148466|NCT02634333|559976315|FG001|Overall Study|Missed Visit|2|||
155148467|NCT02634333|559976314|FG000|Overall Study|Lost to Follow-up|12|||
155148468|NCT02634333|559976315|FG001|Overall Study|Lost to Follow-up|7|||
155148469|NCT02634333|559976314|FG000|Overall Study|Withdrawal by Subject|9|||
155148470|NCT02634333|559976315|FG001|Overall Study|Withdrawal by Subject|13|||
155148471|NCT02634333|559976314|FG000|Overall Study|Death|11|||
155148472|NCT02634333|559976315|FG001|Overall Study|Death|8|||
155148473|NCT02611479|559976316|FG000|Baseline Enrollment|Exited study|13|||
155148474|NCT02611479|559976316|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
155148475|NCT02611479|559976316|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
155148476|NCT02611479|559976316|FG000|Data Cleaning|No baseline function or pain metrics|2|||
155148477|NCT00743249|559976317|FG000|Overall Study|Adverse Event|0|||
155148478|NCT00743249|559976318|FG001|Overall Study|Adverse Event|4|||
155148479|NCT00743249|559976317|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
155148480|NCT00743249|559976318|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
155148481|NCT00743249|559976317|FG000|Overall Study|Unsuccessful insertion of stent|2|||
155148482|NCT00743249|559976318|FG001|Overall Study|Unsuccessful insertion of stent|1|||
155148483|NCT02748863|559976322|FG000|Treatment Period 1|Adverse Event|0|||
155148484|NCT02748863|559976323|FG001|Treatment Period 1|Adverse Event|1|||
155148485|NCT02748863|559976324|FG002|Treatment Period 1|Adverse Event|0|||
155148486|NCT02748863|559976325|FG003|Treatment Period 1|Adverse Event|0|||
155148487|NCT02748863|559976326|FG004|Treatment Period 1|Adverse Event|0|||
155148488|NCT02748863|559976322|FG000|Treatment Period 1|Lack of Efficacy|0|||
155148489|NCT02748863|559976323|FG001|Treatment Period 1|Lack of Efficacy|0|||
155148490|NCT02748863|559976324|FG002|Treatment Period 1|Lack of Efficacy|1|||
155195947|NCT05213481|560154590|FG000|Overall Study|Lost to Follow-up|1|||
155148491|NCT02748863|559976325|FG003|Treatment Period 1|Lack of Efficacy|0|||
155148492|NCT02748863|559976326|FG004|Treatment Period 1|Lack of Efficacy|0|||
155148493|NCT02748863|559976322|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155148494|NCT02748863|559976323|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155148495|NCT02748863|559976324|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155148496|NCT02748863|559976325|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155148497|NCT02748863|559976326|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155148498|NCT02748863|559976322|FG000|Treatment Period 2|Lost to Follow-up|2|||
155148499|NCT02748863|559976323|FG001|Treatment Period 2|Lost to Follow-up|0|||
155148500|NCT02748863|559976324|FG002|Treatment Period 2|Lost to Follow-up|0|||
155148501|NCT02748863|559976325|FG003|Treatment Period 2|Lost to Follow-up|0|||
155148502|NCT02748863|559976326|FG004|Treatment Period 2|Lost to Follow-up|0|||
155148503|NCT02748863|559976322|FG000|Treatment Period 2|Adverse Event|3|||
155148504|NCT02748863|559976323|FG001|Treatment Period 2|Adverse Event|2|||
155148505|NCT02748863|559976324|FG002|Treatment Period 2|Adverse Event|0|||
155148506|NCT02748863|559976325|FG003|Treatment Period 2|Adverse Event|2|||
155148507|NCT02748863|559976326|FG004|Treatment Period 2|Adverse Event|0|||
155148508|NCT02748863|559976322|FG000|Treatment Period 2|Lack of Efficacy|0|||
155148509|NCT02748863|559976323|FG001|Treatment Period 2|Lack of Efficacy|1|||
155148510|NCT02748863|559976324|FG002|Treatment Period 2|Lack of Efficacy|0|||
155148511|NCT02748863|559976325|FG003|Treatment Period 2|Lack of Efficacy|0|||
155148512|NCT02748863|559976326|FG004|Treatment Period 2|Lack of Efficacy|0|||
155148513|NCT02748863|559976322|FG000|Treatment Period 2|Pregnancy|0|||
155148514|NCT02748863|559976323|FG001|Treatment Period 2|Pregnancy|0|||
155148515|NCT02748863|559976324|FG002|Treatment Period 2|Pregnancy|0|||
155148516|NCT02748863|559976325|FG003|Treatment Period 2|Pregnancy|0|||
155148517|NCT02748863|559976326|FG004|Treatment Period 2|Pregnancy|1|||
155148518|NCT00231777|559976327|FG000|Overall Study|Lost to Follow-up|3|||
155148519|NCT00231777|559976328|FG001|Overall Study|Lost to Follow-up|0|||
155148520|NCT00231777|559976327|FG000|Overall Study|Other|3|||
155148521|NCT00231777|559976328|FG001|Overall Study|Other|2|||
155148522|NCT01009060|559976335|FG000|Overall Study|Adverse Event|1|||
155148523|NCT01009060|559976336|FG001|Overall Study|Adverse Event|2|||
155148524|NCT01009060|559976335|FG000|Overall Study|Protocol Violation|0|||
155148525|NCT01009060|559976336|FG001|Overall Study|Protocol Violation|1|||
155148526|NCT01009060|559976335|FG000|Overall Study|Lost to Follow-up|1|||
155148527|NCT01009060|559976336|FG001|Overall Study|Lost to Follow-up|0|||
155148528|NCT01009060|559976335|FG000|Overall Study|Physician Decision|1|||
155148529|NCT01009060|559976336|FG001|Overall Study|Physician Decision|1|||
155148530|NCT01009060|559976335|FG000|Overall Study|Withdrawal by Subject|1|||
155148531|NCT01009060|559976336|FG001|Overall Study|Withdrawal by Subject|1|||
155148532|NCT00657046|559976337|FG000|Overall Study|Adverse Event|1|||
155148533|NCT00657046|559976338|FG001|Overall Study|Adverse Event|1|||
155148534|NCT00657046|559976339|FG002|Overall Study|Adverse Event|0|||
155148535|NCT00657046|559976337|FG000|Overall Study|Protocol Violation|2|||
155148536|NCT00657046|559976338|FG001|Overall Study|Protocol Violation|2|||
155148537|NCT00657046|559976339|FG002|Overall Study|Protocol Violation|0|||
155148538|NCT00657046|559976337|FG000|Overall Study|Withdrawal by Subject|1|||
155148539|NCT00657046|559976338|FG001|Overall Study|Withdrawal by Subject|0|||
155148540|NCT00657046|559976339|FG002|Overall Study|Withdrawal by Subject|0|||
155148541|NCT00657046|559976337|FG000|Overall Study|Death|0|||
155148542|NCT00657046|559976338|FG001|Overall Study|Death|0|||
155148543|NCT00657046|559976339|FG002|Overall Study|Death|1|||
155148544|NCT00657046|559976337|FG000|Overall Study|Surgery|0|||
155148545|NCT00657046|559976338|FG001|Overall Study|Surgery|0|||
155148546|NCT00657046|559976339|FG002|Overall Study|Surgery|1|||
155148547|NCT00739401|559976340|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
155148548|NCT00739401|559976340|FG000|Overall Study|Death|3|||
155148549|NCT00739401|559976340|FG000|Overall Study|Withdrawal by Subject|4|||
155148550|NCT01239381|559976341|FG000|Overall Study|Protocol Violation|1|||
155148551|NCT01239381|559976341|FG000|Overall Study|Withdrawal by Subject|1|||
155148552|NCT04678115|559976342|FG000|Overall Study|Lost to Follow-up|1|||
155148553|NCT04678115|559976343|FG001|Overall Study|Lost to Follow-up|0|||
155148554|NCT00890825|559976344|FG000|Overall Study|Withdrawal by Subject|1|||
155148555|NCT00890825|559976345|FG001|Overall Study|Withdrawal by Subject|0|||
155148556|NCT00890825|559976344|FG000|Overall Study|Alive at data cut off (DCO)|13|||
155148557|NCT00890825|559976345|FG001|Overall Study|Alive at data cut off (DCO)|14|||
155148558|NCT00844376|559976346|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
155148559|NCT00844376|559976347|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
155148560|NCT00988884|559976348|FG000|Overall Study|Adverse Event|0|||
155148561|NCT00988884|559976349|FG001|Overall Study|Adverse Event|1|||
155148562|NCT00988884|559976348|FG000|Overall Study|Lost to Follow-up|20|||
155148563|NCT00988884|559976349|FG001|Overall Study|Lost to Follow-up|16|||
155148564|NCT00988884|559976348|FG000|Overall Study|Protocol Violation|0|||
155148565|NCT00988884|559976349|FG001|Overall Study|Protocol Violation|1|||
155148566|NCT00988884|559976348|FG000|Overall Study|Withdrawal by Subject|15|||
155148567|NCT00988884|559976349|FG001|Overall Study|Withdrawal by Subject|18|||
155148568|NCT02738008|559976350|FG000|Overall Study|Study Terminated by Sponsor|1|||
155148569|NCT02738008|559976351|FG001|Overall Study|Study Terminated by Sponsor|5|||
155148570|NCT02738008|559976352|FG002|Overall Study|Study Terminated by Sponsor|3|||
155148571|NCT02738008|559976350|FG000|Overall Study|Adverse Event|0|||
155148572|NCT02738008|559976351|FG001|Overall Study|Adverse Event|1|||
155148573|NCT02738008|559976352|FG002|Overall Study|Adverse Event|2|||
155148574|NCT04621448|559976353|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
155148575|NCT04621448|559976354|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
155148576|NCT04621448|559976355|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
155148577|NCT04621448|559976356|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
155148578|NCT04621448|559976353|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
155148579|NCT04621448|559976354|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
155148580|NCT04621448|559976355|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
155148581|NCT04621448|559976356|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
155148582|NCT04621448|559976353|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
155148583|NCT04621448|559976354|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
155148584|NCT04621448|559976355|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
155148585|NCT04621448|559976356|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
155148586|NCT04621448|559976353|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
155148587|NCT04621448|559976354|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
155148588|NCT04621448|559976355|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
155148589|NCT04621448|559976356|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
155148590|NCT04590014|559976363|FG000|Overall Study|Withdrawal by Subject|1|||
155148591|NCT04590014|559976364|FG001|Overall Study|Withdrawal by Subject|0|||
155148592|NCT00468299|559976365|FG000|Overall Study|Withdrawal by Subject|0|||
155148593|NCT00468299|559976366|FG001|Overall Study|Withdrawal by Subject|1|||
155148594|NCT01216202|559976367|FG000|Overall Study|Withdrawal by Subject|8|||
155148595|NCT01216202|559976368|FG001|Overall Study|Withdrawal by Subject|0|||
155148596|NCT01216202|559976367|FG000|Overall Study|Death|0|||
155148597|NCT01216202|559976368|FG001|Overall Study|Death|2|||
155148598|NCT01216202|559976367|FG000|Overall Study|Lost to Follow-up|14|||
155148599|NCT01216202|559976368|FG001|Overall Study|Lost to Follow-up|0|||
155148600|NCT00377520|559976369|FG000|Overall Study|Ineligible (Prior radiation)|1|||
155148601|NCT03515824|559976374|FG000|Overall Study|Death|3|||
155148602|NCT03515824|559976375|FG001|Overall Study|Death|2|||
155148603|NCT03515824|559976376|FG002|Overall Study|Death|6|||
155148604|NCT03515824|559976377|FG003|Overall Study|Death|0|||
155148605|NCT03515824|559976374|FG000|Overall Study|Lost to Follow-up|0|||
155148606|NCT03515824|559976375|FG001|Overall Study|Lost to Follow-up|1|||
155148607|NCT03515824|559976376|FG002|Overall Study|Lost to Follow-up|1|||
155148608|NCT03515824|559976377|FG003|Overall Study|Lost to Follow-up|0|||
155148609|NCT03515824|559976374|FG000|Overall Study|Study terminated by sponsor|0|||
155148610|NCT03515824|559976375|FG001|Overall Study|Study terminated by sponsor|1|||
155148611|NCT03515824|559976376|FG002|Overall Study|Study terminated by sponsor|6|||
155148612|NCT03515824|559976377|FG003|Overall Study|Study terminated by sponsor|0|||
155148613|NCT03515824|559976374|FG000|Overall Study|Status not recorded|0|||
155148614|NCT03515824|559976375|FG001|Overall Study|Status not recorded|0|||
155148615|NCT03515824|559976376|FG002|Overall Study|Status not recorded|2|||
155148616|NCT03515824|559976377|FG003|Overall Study|Status not recorded|0|||
155148617|NCT00539994|559976378|FG000|Overall Study|Lost to Follow-up|2|||
155148618|NCT00539994|559976379|FG001|Overall Study|Lost to Follow-up|1|||
155148619|NCT00539994|559976380|FG002|Overall Study|Lost to Follow-up|0|||
155148620|NCT00539994|559976378|FG000|Overall Study|Withdrawal by Subject|1|||
155195948|NCT00569270|560154591|FG000|Period: First Intervention|Protocol Violation|0|||
155195949|NCT00569270|560154592|FG001|Period: First Intervention|Protocol Violation|1|||
155195950|NCT00447005|560154594|FG000|Overall Study|Adverse Event|1|||
155195951|NCT00447005|560154594|FG000|Overall Study|Lack of Efficacy|11|||
155195952|NCT00492531|560154595|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
155195953|NCT00492531|560154596|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
155195954|NCT00400764|560154601|FG000|Phase Ib|Adverse Event|1|||
155195955|NCT00400764|560154602|FG001|Phase Ib|Adverse Event|0|||
155195956|NCT00400764|560154603|FG002|Phase Ib|Adverse Event|0|||
155195957|NCT00400764|560154604|FG003|Phase Ib|Adverse Event|0|||
155195958|NCT00400764|560154605|FG004|Phase Ib|Adverse Event|0|||
155195959|NCT00400764|560154601|FG000|Phase Ib|Death|1|||
155195960|NCT00400764|560154602|FG001|Phase Ib|Death|0|||
155195961|NCT00400764|560154603|FG002|Phase Ib|Death|0|||
155195962|NCT00400764|560154604|FG003|Phase Ib|Death|0|||
155195963|NCT00400764|560154605|FG004|Phase Ib|Death|0|||
155195964|NCT00400764|560154601|FG000|Phase Ib|Disease Progression|4|||
155195965|NCT00400764|560154602|FG001|Phase Ib|Disease Progression|4|||
155148621|NCT00539994|559976379|FG001|Overall Study|Withdrawal by Subject|0|||
155148622|NCT00539994|559976380|FG002|Overall Study|Withdrawal by Subject|1|||
155148623|NCT00539994|559976378|FG000|Overall Study|Physician Decision|0|||
155148624|NCT00539994|559976379|FG001|Overall Study|Physician Decision|0|||
155195966|NCT00400764|560154603|FG002|Phase Ib|Disease Progression|0|||
155195967|NCT00400764|560154604|FG003|Phase Ib|Disease Progression|0|||
155195968|NCT00400764|560154605|FG004|Phase Ib|Disease Progression|0|||
155195969|NCT00400764|560154601|FG000|Phase II|Death|0|||
155195970|NCT00400764|560154602|FG001|Phase II|Death|0|||
155148625|NCT00539994|559976380|FG002|Overall Study|Physician Decision|1|||
155148626|NCT05470985|559976383|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
155148627|NCT05470985|559976384|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
155195971|NCT00400764|560154603|FG002|Phase II|Death|1|||
155195972|NCT00400764|560154604|FG003|Phase II|Death|2|||
155148628|NCT05470985|559976383|FG000|Double Blind Treatment Period|Physician Decision|0|||
155148629|NCT05470985|559976384|FG001|Double Blind Treatment Period|Physician Decision|1|||
155148630|NCT05470985|559976383|FG000|Long Term Extension|Adverse Event|0|||
155148631|NCT05470985|559976384|FG001|Long Term Extension|Adverse Event|1|||
155148632|NCT05470985|559976383|FG000|Long Term Extension|Study terminated by sponsor|2|||
155148633|NCT05470985|559976384|FG001|Long Term Extension|Study terminated by sponsor|0|||
155148634|NCT04879628|559976386|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
155148635|NCT04879628|559976387|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
155148636|NCT04879628|559976388|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
155148637|NCT04879628|559976389|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
155148638|NCT04879628|559976386|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155148639|NCT04879628|559976387|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155148640|NCT04879628|559976388|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
155148641|NCT04879628|559976389|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
155148642|NCT04879628|559976386|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
155148643|NCT04879628|559976387|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
155148644|NCT04879628|559976388|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
155148645|NCT04879628|559976389|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
155148646|NCT04879628|559976386|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
155148647|NCT04879628|559976387|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
155148648|NCT04879628|559976388|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
155148649|NCT04879628|559976389|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
155148650|NCT03863509|559976391|FG000|Overall Study|COVID-19 shutdown period|0|||
155148651|NCT03863509|559976392|FG001|Overall Study|COVID-19 shutdown period|4|||
155148652|NCT03863509|559976393|FG002|Overall Study|COVID-19 shutdown period|0|||
155148653|NCT03863509|559976391|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
155148654|NCT03863509|559976392|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
155148655|NCT03863509|559976393|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
155148656|NCT03863509|559976391|FG000|Overall Study|Lost to Follow-up|8|||
155148657|NCT03863509|559976392|FG001|Overall Study|Lost to Follow-up|0|||
155148658|NCT03863509|559976393|FG002|Overall Study|Lost to Follow-up|2|||
155148659|NCT03863509|559976391|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
155148660|NCT03863509|559976392|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
155148661|NCT03863509|559976393|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
155148662|NCT03863509|559976391|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
155148663|NCT03863509|559976392|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
155148664|NCT03863509|559976393|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
155148665|NCT03861273|559976394|FG000|Screening Phase (3 Weeks)|Other|1|||
155148666|NCT03861273|559976394|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
155148667|NCT03861273|559976394|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
155148668|NCT03861273|559976394|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
155148669|NCT03861273|559976394|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
155148670|NCT00191334|559976397|FG000|Overall Study|Adverse Event|4|||
155148671|NCT00191334|559976397|FG000|Overall Study|Disease Progression or Relapse|8|||
155148672|NCT00191334|559976397|FG000|Overall Study|Physician Decision|1|||
155148673|NCT00191334|559976397|FG000|Overall Study|Withdrawal by Subject|4|||
155148674|NCT00990106|559976398|FG000|Overall Study|"too busy to continue"|1|||
155148675|NCT00990106|559976399|FG001|Overall Study|"too busy to continue"|2|||
155148676|NCT00990106|559976398|FG000|Overall Study|Lost to Follow-up|1|||
155148677|NCT00990106|559976399|FG001|Overall Study|Lost to Follow-up|3|||
155148678|NCT00990106|559976398|FG000|Overall Study|Withdrawal by Subject|2|||
155148679|NCT00990106|559976399|FG001|Overall Study|Withdrawal by Subject|1|||
155148680|NCT00990106|559976398|FG000|Overall Study|opted for open label prazosin|1|||
155148681|NCT00990106|559976399|FG001|Overall Study|opted for open label prazosin|1|||
155148682|NCT00990106|559976398|FG000|Overall Study|relocation/deployment|4|||
155148683|NCT00990106|559976399|FG001|Overall Study|relocation/deployment|1|||
155148684|NCT00990106|559976398|FG000|Overall Study|started exclusionary medication|0|||
155148685|NCT00990106|559976399|FG001|Overall Study|started exclusionary medication|1|||
155148686|NCT00990106|559976398|FG000|Overall Study|planned major surgery|0|||
155148687|NCT00990106|559976399|FG001|Overall Study|planned major surgery|1|||
155148688|NCT00990106|559976398|FG000|Overall Study|scheduling conflicts|0|||
155148689|NCT00990106|559976399|FG001|Overall Study|scheduling conflicts|2|||
155148690|NCT01063153|559976401|FG000|Overall Study|Found Ineligible During Screening|2|||
155148691|NCT01063153|559976402|FG001|Overall Study|Found Ineligible During Screening|0|||
155148692|NCT01063153|559976401|FG000|Overall Study|Lost to Follow-up|0|||
155148693|NCT01063153|559976402|FG001|Overall Study|Lost to Follow-up|7|||
155195973|NCT00400764|560154605|FG004|Phase II|Death|0|||
155148694|NCT01063153|559976401|FG000|Overall Study|Withdrawal by Subject|0|||
155148695|NCT01063153|559976402|FG001|Overall Study|Withdrawal by Subject|1|||
155148696|NCT01063153|559976401|FG000|Overall Study|Physician Decision|0|||
155148697|NCT01063153|559976402|FG001|Overall Study|Physician Decision|4|||
155148698|NCT01777776|559976403|FG000|Overall Study|Adverse Event|2|||
155148699|NCT01777776|559976404|FG001|Overall Study|Adverse Event|4|||
155148700|NCT01777776|559976405|FG002|Overall Study|Adverse Event|0|||
155148701|NCT01777776|559976406|FG003|Overall Study|Adverse Event|0|||
155148702|NCT01777776|559976403|FG000|Overall Study|Disease Progression|4|||
155148703|NCT01777776|559976404|FG001|Overall Study|Disease Progression|8|||
155148704|NCT01777776|559976405|FG002|Overall Study|Disease Progression|6|||
155148705|NCT01777776|559976406|FG003|Overall Study|Disease Progression|3|||
155148706|NCT01777776|559976403|FG000|Overall Study|Withdrawal by Subject|0|||
155148707|NCT01777776|559976404|FG001|Overall Study|Withdrawal by Subject|0|||
155148708|NCT01777776|559976405|FG002|Overall Study|Withdrawal by Subject|0|||
155148709|NCT01777776|559976406|FG003|Overall Study|Withdrawal by Subject|1|||
155148710|NCT02426580|559978230|FG000|Overall Study|Death|2|||
155148711|NCT02426580|559978231|FG001|Overall Study|Death|2|||
155148712|NCT02426580|559978230|FG000|Overall Study|Lost to Follow-up|0|||
155148713|NCT02426580|559978231|FG001|Overall Study|Lost to Follow-up|9|||
155148714|NCT02426580|559978230|FG000|Overall Study|transfer to hemodialysis|5|||
155148715|NCT02426580|559978231|FG001|Overall Study|transfer to hemodialysis|5|||
155148716|NCT02426580|559978230|FG000|Overall Study|Kidney transplant|3|||
155148717|NCT02426580|559978231|FG001|Overall Study|Kidney transplant|0|||
155148718|NCT02426580|559978230|FG000|Overall Study|Allergic to egg white|1|||
155148719|NCT02426580|559978231|FG001|Overall Study|Allergic to egg white|0|||
155148720|NCT00383552|559978232|FG000|Overall Study|Adverse Event|7|||
155148721|NCT00383552|559978233|FG001|Overall Study|Adverse Event|6|||
155148722|NCT00383552|559978234|FG002|Overall Study|Adverse Event|9|||
155148723|NCT00383552|559978235|FG003|Overall Study|Adverse Event|6|||
155148724|NCT00383552|559978232|FG000|Overall Study|Lack of Efficacy|4|||
155148725|NCT00383552|559978233|FG001|Overall Study|Lack of Efficacy|13|||
155148726|NCT00383552|559978234|FG002|Overall Study|Lack of Efficacy|29|||
155148727|NCT00383552|559978235|FG003|Overall Study|Lack of Efficacy|42|||
155148728|NCT00383552|559978232|FG000|Overall Study|Lost to Follow-up|0|||
155148729|NCT00383552|559978233|FG001|Overall Study|Lost to Follow-up|1|||
155148730|NCT00383552|559978234|FG002|Overall Study|Lost to Follow-up|5|||
155148731|NCT00383552|559978235|FG003|Overall Study|Lost to Follow-up|1|||
155148732|NCT00383552|559978232|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
155148733|NCT00383552|559978233|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
155148734|NCT00383552|559978234|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
155148735|NCT00383552|559978235|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
155148736|NCT00383552|559978232|FG000|Overall Study|Did not wish to continue (related)|1|||
155148737|NCT00383552|559978233|FG001|Overall Study|Did not wish to continue (related)|0|||
155148738|NCT00383552|559978234|FG002|Overall Study|Did not wish to continue (related)|2|||
155148739|NCT00383552|559978235|FG003|Overall Study|Did not wish to continue (related)|3|||
155148740|NCT00383552|559978232|FG000|Overall Study|Noncompliance with the protocol|11|||
155148741|NCT00383552|559978233|FG001|Overall Study|Noncompliance with the protocol|6|||
155148742|NCT00383552|559978234|FG002|Overall Study|Noncompliance with the protocol|8|||
155148743|NCT00383552|559978235|FG003|Overall Study|Noncompliance with the protocol|10|||
155148744|NCT00383552|559978232|FG000|Overall Study|Did not meet protocol eligibility|8|||
155148745|NCT00383552|559978233|FG001|Overall Study|Did not meet protocol eligibility|6|||
155148746|NCT00383552|559978234|FG002|Overall Study|Did not meet protocol eligibility|2|||
155148747|NCT00383552|559978235|FG003|Overall Study|Did not meet protocol eligibility|3|||
155148748|NCT00383552|559978232|FG000|Overall Study|Administrative|1|||
155148749|NCT00383552|559978233|FG001|Overall Study|Administrative|0|||
155148750|NCT00383552|559978234|FG002|Overall Study|Administrative|1|||
155148751|NCT00383552|559978235|FG003|Overall Study|Administrative|1|||
155148752|NCT03096834|559978236|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
155148753|NCT03096834|559978237|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
155148754|NCT03096834|559978238|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
155148755|NCT03096834|559978239|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
155148756|NCT03096834|559978236|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
155148757|NCT03096834|559978237|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
155148758|NCT03096834|559978238|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
155148759|NCT03096834|559978239|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
155148760|NCT03096834|559978236|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
155148761|NCT03096834|559978237|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
155148762|NCT03096834|559978238|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
155148763|NCT03096834|559978239|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
155148764|NCT03096834|559978236|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
155148765|NCT03096834|559978237|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
155148766|NCT03096834|559978238|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
155148767|NCT03096834|559978239|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
155148768|NCT03096834|559978236|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
155148769|NCT03096834|559978237|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
155195974|NCT00400764|560154601|FG000|Phase II|Lost to Follow-up|0|||
155195975|NCT00400764|560154602|FG001|Phase II|Lost to Follow-up|0|||
155195976|NCT00400764|560154603|FG002|Phase II|Lost to Follow-up|1|||
155195977|NCT00400764|560154604|FG003|Phase II|Lost to Follow-up|0|||
155195978|NCT00400764|560154605|FG004|Phase II|Lost to Follow-up|0|||
155195979|NCT00400764|560154601|FG000|Phase II|Physician Decision|0|||
155195980|NCT00400764|560154602|FG001|Phase II|Physician Decision|0|||
155195981|NCT00400764|560154603|FG002|Phase II|Physician Decision|1|||
155195982|NCT00400764|560154604|FG003|Phase II|Physician Decision|1|||
155195983|NCT00400764|560154605|FG004|Phase II|Physician Decision|0|||
155195984|NCT00400764|560154601|FG000|Phase II|Sponsor's decision to terminate|0|||
155195985|NCT00400764|560154602|FG001|Phase II|Sponsor's decision to terminate|0|||
155195986|NCT00400764|560154603|FG002|Phase II|Sponsor's decision to terminate|18|||
155195987|NCT00400764|560154604|FG003|Phase II|Sponsor's decision to terminate|22|||
155195988|NCT00400764|560154605|FG004|Phase II|Sponsor's decision to terminate|11|||
155195989|NCT00400764|560154601|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
155195990|NCT00400764|560154602|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
155195991|NCT00400764|560154603|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
155195992|NCT00400764|560154604|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
155195993|NCT00400764|560154605|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
155195994|NCT00400764|560154601|FG000|Phase II|Withdrawal by Subject|0|||
155195995|NCT00400764|560154602|FG001|Phase II|Withdrawal by Subject|0|||
155195996|NCT00400764|560154603|FG002|Phase II|Withdrawal by Subject|1|||
155195997|NCT00400764|560154604|FG003|Phase II|Withdrawal by Subject|1|||
155195998|NCT00400764|560154605|FG004|Phase II|Withdrawal by Subject|0|||
155195999|NCT03113071|560154608|FG000|Overall Study|Withdrawal by Subject|1|||
155196000|NCT03113071|560154609|FG001|Overall Study|Withdrawal by Subject|0|||
155196001|NCT02764697|560154610|FG000|Overall Study|Lack of Efficacy|3|||
155196002|NCT00302107|560154611|FG000|Overall Study|Lost to Follow-up|6|||
155196003|NCT00302107|560154612|FG001|Overall Study|Lost to Follow-up|5|||
155196004|NCT00302107|560154611|FG000|Overall Study|Protocol Violation|1|||
155196005|NCT00302107|560154612|FG001|Overall Study|Protocol Violation|0|||
155196006|NCT00302107|560154611|FG000|Overall Study|Relocation|0|||
155196007|NCT00302107|560154612|FG001|Overall Study|Relocation|1|||
155196008|NCT00302107|560154611|FG000|Overall Study|Withdrawal by Subject|0|||
155196009|NCT00302107|560154612|FG001|Overall Study|Withdrawal by Subject|3|||
155196010|NCT00302107|560154611|FG000|Overall Study|Adverse Event|1|||
155196011|NCT00302107|560154612|FG001|Overall Study|Adverse Event|0|||
155196012|NCT00437983|560154613|FG000|Overall Study|Adverse Event|6|||
155196013|NCT00437983|560154614|FG001|Overall Study|Adverse Event|6|||
155196014|NCT00437983|560154613|FG000|Overall Study|Protocol Violation|2|||
155148770|NCT03096834|559978238|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
155148771|NCT03096834|559978239|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
155148772|NCT03096834|559978236|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
155148773|NCT03096834|559978237|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
155148774|NCT03096834|559978238|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
155148775|NCT03096834|559978239|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
155148776|NCT03096834|559978236|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
155148777|NCT03096834|559978237|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
155148778|NCT03096834|559978238|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
155148779|NCT03096834|559978239|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
155148780|NCT03096834|559978236|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
155148781|NCT03096834|559978237|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
155148782|NCT03096834|559978238|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
155148783|NCT03096834|559978239|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
155148784|NCT03096834|559978236|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
155148785|NCT03096834|559978237|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
155148786|NCT03096834|559978238|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
155148787|NCT03096834|559978239|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
155148788|NCT03096834|559978236|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
155148789|NCT03096834|559978237|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
155148790|NCT03096834|559978238|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
155196015|NCT00437983|560154614|FG001|Overall Study|Protocol Violation|1|||
155196016|NCT00437983|560154613|FG000|Overall Study|Withdrawal by Subject|5|||
155196017|NCT00437983|560154614|FG001|Overall Study|Withdrawal by Subject|6|||
155196018|NCT00621959|560154615|FG000|Overall Study|Adverse Event|4|||
155148791|NCT03096834|559978239|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
155196019|NCT00621959|560154616|FG001|Overall Study|Adverse Event|2|||
155196020|NCT00621959|560154615|FG000|Overall Study|Lack of Efficacy|1|||
155196021|NCT00621959|560154616|FG001|Overall Study|Lack of Efficacy|1|||
155196022|NCT00621959|560154615|FG000|Overall Study|Lost to Follow-up|0|||
155196023|NCT00621959|560154616|FG001|Overall Study|Lost to Follow-up|2|||
155196024|NCT00621959|560154615|FG000|Overall Study|Withdrawal by Subject|1|||
155196025|NCT00621959|560154616|FG001|Overall Study|Withdrawal by Subject|1|||
155148792|NCT03096834|559978236|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
155148793|NCT03096834|559978237|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
155148794|NCT03096834|559978238|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
155148795|NCT03096834|559978239|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
155148796|NCT03096834|559978236|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
155148797|NCT03096834|559978237|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
155196026|NCT00621959|560154615|FG000|Overall Study|Other|1|||
155196027|NCT00621959|560154616|FG001|Overall Study|Other|3|||
155148798|NCT03096834|559978238|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
155148799|NCT03096834|559978239|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
155148800|NCT00966654|559978240|FG000|Overall Study|Study was terminated,PI left institution|12|||
155148801|NCT01600326|559978247|FG000|Overall Study|Lost to Follow-up|1|||
155148802|NCT01600326|559978248|FG001|Overall Study|Lost to Follow-up|1|||
155148803|NCT04456504|559978249|FG000|Overall Study|Lost to Follow-up|2|||
155148804|NCT00762359|559978250|FG000|Overall Study|Adverse Event|20|||
155148805|NCT00762359|559978251|FG001|Overall Study|Adverse Event|23|||
155148806|NCT00762359|559978250|FG000|Overall Study|Protocol Violation|21|||
155148807|NCT00762359|559978251|FG001|Overall Study|Protocol Violation|13|||
155148808|NCT00762359|559978250|FG000|Overall Study|Withdrawal by Subject|13|||
155148809|NCT00762359|559978251|FG001|Overall Study|Withdrawal by Subject|10|||
155148810|NCT00762359|559978250|FG000|Overall Study|Lack of Efficacy|0|||
155148811|NCT00762359|559978251|FG001|Overall Study|Lack of Efficacy|4|||
155148812|NCT00762359|559978250|FG000|Overall Study|Institution closed|2|||
155148813|NCT00762359|559978251|FG001|Overall Study|Institution closed|3|||
155148814|NCT00762359|559978250|FG000|Overall Study|Physician Decision|2|||
155148815|NCT00762359|559978251|FG001|Overall Study|Physician Decision|3|||
155148816|NCT00762359|559978250|FG000|Overall Study|Removal|0|||
155148817|NCT00762359|559978251|FG001|Overall Study|Removal|1|||
155148818|NCT00762359|559978250|FG000|Overall Study|Withdrew consent|1|||
155148819|NCT00762359|559978251|FG001|Overall Study|Withdrew consent|0|||
155148820|NCT01342913|559978252|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
155148821|NCT01342913|559978253|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155148822|NCT01342913|559978254|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
155148823|NCT01342913|559978252|FG000|2-week Run-in Period|Physician Decision|6|||
155148824|NCT01342913|559978253|FG001|2-week Run-in Period|Physician Decision|0|||
155148825|NCT01342913|559978254|FG002|2-week Run-in Period|Physician Decision|0|||
155148826|NCT01342913|559978252|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
155148827|NCT01342913|559978253|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155148828|NCT01342913|559978254|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155148829|NCT01342913|559978252|FG000|2-week Run-in Period|Adverse Event|2|||
155148830|NCT01342913|559978253|FG001|2-week Run-in Period|Adverse Event|0|||
155148831|NCT01342913|559978254|FG002|2-week Run-in Period|Adverse Event|0|||
155148832|NCT01342913|559978252|FG000|2-week Run-in Period|Protocol Violation|5|||
155148833|NCT01342913|559978253|FG001|2-week Run-in Period|Protocol Violation|0|||
155148834|NCT01342913|559978254|FG002|2-week Run-in Period|Protocol Violation|0|||
155148835|NCT01342913|559978252|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
155148836|NCT01342913|559978253|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
155148837|NCT01342913|559978254|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
155148838|NCT01342913|559978252|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155148839|NCT01342913|559978253|FG001|Double-Blind Treatment Period|Adverse Event|3|||
155148840|NCT01342913|559978254|FG002|Double-Blind Treatment Period|Adverse Event|6|||
155148841|NCT01342913|559978252|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155196028|NCT01790932|560154617|FG000|Overall Study|Disease Progression|41|||
155196029|NCT01790932|560154617|FG000|Overall Study|Adverse Event|7|||
155196030|NCT01790932|560154617|FG000|Overall Study|Physician Decision|1|||
155196031|NCT01790932|560154617|FG000|Overall Study|Withdrawal by Subject|1|||
155148842|NCT01342913|559978253|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
155148843|NCT01342913|559978254|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
155148844|NCT01342913|559978252|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155148845|NCT01342913|559978253|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
155148846|NCT01342913|559978254|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
155148847|NCT01342913|559978252|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155148848|NCT01342913|559978253|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
155148849|NCT01342913|559978254|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
155196032|NCT03360747|560154620|FG000|Overall Study|Voluntary Withdrawal|1|||
155196033|NCT06238362|560154623|FG000|Overall Study|Insufficient total sleep time|1|||
155148850|NCT01342913|559978252|FG000|Double-Blind Treatment Period|Physician Decision|0|||
155148851|NCT01342913|559978253|FG001|Double-Blind Treatment Period|Physician Decision|2|||
155148852|NCT01342913|559978254|FG002|Double-Blind Treatment Period|Physician Decision|0|||
155148853|NCT01342913|559978252|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155196034|NCT06238362|560154624|FG001|Overall Study|Insufficient total sleep time|0|||
155196035|NCT06238362|560154623|FG000|Overall Study|Inadequate signal quality|1|||
155196036|NCT06238362|560154624|FG001|Overall Study|Inadequate signal quality|0|||
155196037|NCT03730012|560154625|FG000|Overall Study|Adverse Event|0|||
155196038|NCT03730012|560154626|FG001|Overall Study|Adverse Event|1|||
155196039|NCT03730012|560154625|FG000|Overall Study|Lack of Efficacy|1|||
155196040|NCT03730012|560154626|FG001|Overall Study|Lack of Efficacy|5|||
155196041|NCT03730012|560154625|FG000|Overall Study|Withdrawal by Subject|0|||
155196042|NCT03730012|560154626|FG001|Overall Study|Withdrawal by Subject|1|||
155196043|NCT03730012|560154625|FG000|Overall Study|Miscellaneous|2|||
155196044|NCT03730012|560154626|FG001|Overall Study|Miscellaneous|1|||
155196045|NCT01798004|560156062|FG000|Overall Study|Death|2|||
155196046|NCT01798004|560156062|FG000|Overall Study|Lack of Efficacy|8|||
155196047|NCT01798004|560156062|FG000|Overall Study|Physician Decision|25|||
155196048|NCT01798004|560156062|FG000|Overall Study|Withdrawal by Subject|4|||
155196049|NCT01798004|560156062|FG000|Overall Study|Ineligible|4|||
155196050|NCT01798004|560156062|FG000|Overall Study|Patient/parent refusal|7|||
155196051|NCT01798004|560156062|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
155196052|NCT01798004|560156062|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
155196053|NCT03320057|560156063|FG000|Overall Study|Lost to Follow-up|4|||
155196054|NCT03320057|560156064|FG001|Overall Study|Lost to Follow-up|17|||
155196055|NCT03320057|560156063|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
155196056|NCT03320057|560156064|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
155196057|NCT06956170|560156065|FG000|Overall Study|Death|2|||
155196058|NCT06956170|560156066|FG001|Overall Study|Death|1|||
155196059|NCT06956170|560156065|FG000|Overall Study|Withdrawal by Subject|1|||
155196060|NCT06956170|560156066|FG001|Overall Study|Withdrawal by Subject|0|||
155196061|NCT06956170|560156065|FG000|Overall Study|Ongoing|7|||
155196062|NCT06956170|560156066|FG001|Overall Study|Ongoing|10|||
155196063|NCT01516437|560156067|FG000|Overall Study|Reason not specified|0|||
155196064|NCT01516437|560156068|FG001|Overall Study|Reason not specified|0|||
155196065|NCT01516437|560156069|FG002|Overall Study|Reason not specified|1|||
155196066|NCT01516437|560156070|FG003|Overall Study|Reason not specified|1|||
155196067|NCT00403234|560156071|FG000|Overall Study|Withdrawal by Subject|0|||
155196068|NCT00403234|560156072|FG001|Overall Study|Withdrawal by Subject|1|||
155196069|NCT00403234|560156073|FG002|Overall Study|Withdrawal by Subject|0|||
155196070|NCT00403234|560156074|FG003|Overall Study|Withdrawal by Subject|0|||
155196071|NCT00403234|560156071|FG000|Overall Study|Adverse Event|1|||
155196072|NCT00403234|560156072|FG001|Overall Study|Adverse Event|0|||
155196073|NCT00403234|560156073|FG002|Overall Study|Adverse Event|1|||
155196074|NCT00403234|560156074|FG003|Overall Study|Adverse Event|0|||
155196075|NCT00825682|560156075|FG000|Overall Study|personal reasons/ inconvenience|13|||
155196076|NCT00825682|560156076|FG001|Overall Study|personal reasons/ inconvenience|5|||
155196077|NCT04805541|560156081|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
155196078|NCT04015336|560156083|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
155148854|NCT01342913|559978253|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155148855|NCT01342913|559978254|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
155148856|NCT02656017|559978257|FG000|Overall Study|Study burden|3|||
155148857|NCT02656017|559978258|FG001|Overall Study|Study burden|3|||
155148858|NCT02656017|559978257|FG000|Overall Study|Adverse Event|2|||
155148859|NCT02656017|559978258|FG001|Overall Study|Adverse Event|1|||
155148860|NCT02656017|559978257|FG000|Overall Study|Unable/unwilling to take study medication|2|||
155148861|NCT02656017|559978258|FG001|Overall Study|Unable/unwilling to take study medication|1|||
155148862|NCT02656017|559978257|FG000|Overall Study|Began Tolvaptan|1|||
155148863|NCT02656017|559978258|FG001|Overall Study|Began Tolvaptan|1|||
155148864|NCT02656017|559978257|FG000|Overall Study|Withdrawal by Subject|1|||
155148865|NCT02656017|559978258|FG001|Overall Study|Withdrawal by Subject|0|||
155148866|NCT02792231|559978265|FG000|Overall Study|Patient/guardian decision|32|||
155148867|NCT02792231|559978266|FG001|Overall Study|Patient/guardian decision|42|||
155148868|NCT02792231|559978265|FG000|Overall Study|Adverse Event|15|||
155148869|NCT02792231|559978266|FG001|Overall Study|Adverse Event|11|||
155148870|NCT02792231|559978265|FG000|Overall Study|Physician Decision|14|||
155148871|NCT02792231|559978266|FG001|Overall Study|Physician Decision|12|||
155148872|NCT02792231|559978265|FG000|Overall Study|Lack of Efficacy|7|||
155148873|NCT02792231|559978266|FG001|Overall Study|Lack of Efficacy|9|||
155148874|NCT02792231|559978265|FG000|Overall Study|Lost to Follow-up|9|||
155148875|NCT02792231|559978266|FG001|Overall Study|Lost to Follow-up|5|||
155148876|NCT02792231|559978265|FG000|Overall Study|Pregnancy|1|||
155148877|NCT02792231|559978266|FG001|Overall Study|Pregnancy|3|||
155148878|NCT02792231|559978265|FG000|Overall Study|Non-compliance with study treatment|2|||
155148879|NCT02792231|559978266|FG001|Overall Study|Non-compliance with study treatment|1|||
155148880|NCT02792231|559978265|FG000|Overall Study|Protocol deviation|2|||
155148881|NCT02792231|559978266|FG001|Overall Study|Protocol deviation|0|||
155148882|NCT02792231|559978265|FG000|Overall Study|Technical problems|0|||
155196079|NCT03228433|560156084|FG000|Overall Study|Lost to Follow-up|1|||
155196080|NCT03228433|560156085|FG001|Overall Study|Lost to Follow-up|0|||
155196081|NCT03228433|560156086|FG002|Overall Study|Lost to Follow-up|0|||
155196082|NCT03228433|560156087|FG003|Overall Study|Lost to Follow-up|0|||
155196083|NCT03228433|560156088|FG004|Overall Study|Lost to Follow-up|0|||
155148883|NCT02792231|559978266|FG001|Overall Study|Technical problems|1|||
155196084|NCT03228433|560156089|FG005|Overall Study|Lost to Follow-up|0|||
155196085|NCT03228433|560156084|FG000|Overall Study|Positive alcohol test|0|||
155148884|NCT02469623|559978267|FG000|Overall Study|Not consented for long-term follow-up|4|||
155148885|NCT02469623|559978267|FG000|Overall Study|Lost to Follow-up|4|||
155148886|NCT02469623|559978267|FG000|Overall Study|Withdrawal by Subject|2|||
155148887|NCT02469623|559978267|FG000|Overall Study|Death|3|||
155148888|NCT04073186|559978268|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
155148889|NCT04073186|559978268|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
155148890|NCT04073186|559978268|FG000|First Wearing Cycle|Protocol Violation|1|||
155148891|NCT04073186|559978268|FG000|First Wearing Cycle|Lens Discomfort|2|||
155148892|NCT04073186|559978268|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
155148893|NCT04073186|559978268|FG000|Second Wearing Cycle|Adverse Event|1|||
155148894|NCT01884077|559978269|FG000|Overall Study|screen fail|0|||
155148895|NCT01884077|559978270|FG001|Overall Study|screen fail|2|||
155148896|NCT01884077|559978269|FG000|Overall Study|canceled surgery|2|||
155148897|NCT01884077|559978270|FG001|Overall Study|canceled surgery|0|||
155148898|NCT01884077|559978269|FG000|Overall Study|Lost to Follow-up|0|||
155148899|NCT01884077|559978270|FG001|Overall Study|Lost to Follow-up|4|||
155148900|NCT01884077|559978269|FG000|Overall Study|study closed|6|||
155148901|NCT01884077|559978270|FG001|Overall Study|study closed|4|||
155148902|NCT00473434|559978271|FG000|Overall Study|Physician Decision|3|||
155148903|NCT00473434|559978271|FG000|Overall Study|Withdrawal by Subject|9|||
155148904|NCT00473434|559978271|FG000|Overall Study|Compliance|3|||
155148905|NCT00473434|559978271|FG000|Overall Study|Lack of Efficacy|3|||
155148906|NCT00473434|559978271|FG000|Overall Study|Adverse Event|3|||
155148907|NCT00473434|559978271|FG000|Overall Study|Patient was selling medication to others|1|||
155148908|NCT00473434|559978271|FG000|Overall Study|Safety evaluation|1|||
155148909|NCT00473434|559978271|FG000|Overall Study|Reason not specified|6|||
155148910|NCT00473434|559978271|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
155148911|NCT00473434|559978271|FG000|Overall Study|Switching to trial medication|1|||
155148912|NCT00473434|559978271|FG000|Overall Study|No longer required|1|||
155148913|NCT02836652|559978272|FG000|Overall Study|Death|3|||
155148914|NCT02836652|559978273|FG001|Overall Study|Death|3|||
155148915|NCT02836652|559978272|FG000|Overall Study|Transplant/Explant|3|||
155148916|NCT02836652|559978273|FG001|Overall Study|Transplant/Explant|4|||
155148917|NCT02836652|559978272|FG000|Overall Study|Withdrawn|9|||
155148918|NCT02836652|559978273|FG001|Overall Study|Withdrawn|9|||
155148919|NCT02836652|559978272|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
155148920|NCT02836652|559978273|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
155148921|NCT01008943|559978279|FG000|Overall Study|Withdrawal by Subject|1|||
155148922|NCT00861705|559978280|FG000|Overall Study|Never Began Treatment|7|||
155148923|NCT00861705|559978281|FG001|Overall Study|Never Began Treatment|3|||
155196086|NCT03228433|560156085|FG001|Overall Study|Positive alcohol test|0|||
155196087|NCT03228433|560156086|FG002|Overall Study|Positive alcohol test|0|||
155196088|NCT03228433|560156087|FG003|Overall Study|Positive alcohol test|1|||
155196089|NCT03228433|560156088|FG004|Overall Study|Positive alcohol test|0|||
155196090|NCT03228433|560156089|FG005|Overall Study|Positive alcohol test|0|||
155196091|NCT00129272|560156098|FG000|Overall Study|Lost to Follow-up|12|||
155196092|NCT00129272|560156099|FG001|Overall Study|Lost to Follow-up|11|||
155196093|NCT00129272|560156098|FG000|Overall Study|Withdrawal by Subject|5|||
155196094|NCT00129272|560156099|FG001|Overall Study|Withdrawal by Subject|11|||
155196095|NCT02601027|560156103|FG000|Registration to Surgery|Withdrawal by Subject|20|||
155196096|NCT02601027|560156104|FG001|Registration to Surgery|Withdrawal by Subject|10|||
155196097|NCT01419626|560156107|FG000|Overall Study|Protocol Violation|3|||
155196098|NCT01419626|560156108|FG001|Overall Study|Protocol Violation|2|||
155196099|NCT01419626|560156109|FG002|Overall Study|Protocol Violation|2|||
155196100|NCT01419626|560156107|FG000|Overall Study|Withdrawal by Subject|1|||
155196101|NCT01419626|560156108|FG001|Overall Study|Withdrawal by Subject|0|||
155196102|NCT01419626|560156109|FG002|Overall Study|Withdrawal by Subject|0|||
155196103|NCT01419626|560156107|FG000|Overall Study|Lost to Follow-up|0|||
155196104|NCT01419626|560156108|FG001|Overall Study|Lost to Follow-up|1|||
155196105|NCT01419626|560156109|FG002|Overall Study|Lost to Follow-up|1|||
155196106|NCT01365052|560156110|FG000|Overall Study|Adverse Event|4|||
155196107|NCT01365052|560156111|FG001|Overall Study|Adverse Event|4|||
155196108|NCT01146912|560156112|FG000|Overall Study|Already received influenza vaccination|817|||
155196109|NCT01146912|560156113|FG001|Overall Study|Already received influenza vaccination|822|||
155196110|NCT01146912|560156114|FG002|Overall Study|Already received influenza vaccination|13|||
155196111|NCT01146912|560156115|FG003|Overall Study|Already received influenza vaccination|15|||
155196112|NCT01146912|560156116|FG004|Overall Study|Already received influenza vaccination|41|||
155196113|NCT01146912|560156117|FG005|Overall Study|Already received influenza vaccination|61|||
155148924|NCT00861705|559978282|FG002|Overall Study|Never Began Treatment|0|||
155148925|NCT00861705|559978283|FG003|Overall Study|Never Began Treatment|1|||
155148926|NCT05789745|559978284|FG000|Overall Study|Withdrawal by Subject|0|||
155196114|NCT01146912|560156118|FG006|Overall Study|Already received influenza vaccination|56|||
155196115|NCT01146912|560156119|FG007|Overall Study|Already received influenza vaccination|0|||
155196116|NCT01146912|560156112|FG000|Overall Study|< 14 weeks gestational age|0|||
155148927|NCT05789745|559978285|FG001|Overall Study|Withdrawal by Subject|0|||
155148928|NCT05789745|559978286|FG002|Overall Study|Withdrawal by Subject|0|||
155148929|NCT05789745|559978287|FG003|Overall Study|Withdrawal by Subject|0|||
155148930|NCT05789745|559978288|FG004|Overall Study|Withdrawal by Subject|1|||
155148931|NCT03294590|559978289|FG000|Overall Study|Lost to Follow-up|105|||
155148932|NCT03294590|559978290|FG001|Overall Study|Lost to Follow-up|107|||
155148933|NCT01962441|559978291|FG000|Randomized Period|Randomized but Never Treated|4|||
155148934|NCT01962441|559978292|FG001|Randomized Period|Randomized but Never Treated|2|||
155148935|NCT01962441|559978293|FG002|Randomized Period|Randomized but Never Treated|3|||
155148936|NCT01962441|559978291|FG000|Randomized Period|Lost to Follow-up|2|||
155148937|NCT01962441|559978292|FG001|Randomized Period|Lost to Follow-up|4|||
155148938|NCT01962441|559978293|FG002|Randomized Period|Lost to Follow-up|4|||
155148939|NCT01962441|559978291|FG000|Randomized Period|Withdrew Consent|3|||
155148940|NCT01962441|559978292|FG001|Randomized Period|Withdrew Consent|3|||
155148941|NCT01962441|559978293|FG002|Randomized Period|Withdrew Consent|2|||
155148942|NCT01962441|559978291|FG000|Randomized Period|Adverse Event|1|||
155148943|NCT01962441|559978292|FG001|Randomized Period|Adverse Event|1|||
155148944|NCT01962441|559978293|FG002|Randomized Period|Adverse Event|0|||
155148945|NCT01962441|559978291|FG000|Randomized Period|Death|0|||
155148946|NCT01962441|559978292|FG001|Randomized Period|Death|0|||
155148947|NCT01962441|559978293|FG002|Randomized Period|Death|2|||
155148948|NCT01962441|559978291|FG000|Randomized Period|Protocol Violation|0|||
155148949|NCT01962441|559978292|FG001|Randomized Period|Protocol Violation|1|||
155148950|NCT01962441|559978293|FG002|Randomized Period|Protocol Violation|0|||
155148951|NCT01962441|559978291|FG000|Retreatment Substudy|Lack of Efficacy|1|||
155148952|NCT01962441|559978292|FG001|Retreatment Substudy|Lack of Efficacy|0|||
155148953|NCT01962441|559978293|FG002|Retreatment Substudy|Lack of Efficacy|0|||
155148954|NCT01962441|559978291|FG000|Retreatment Substudy|Lost to Follow-up|1|||
155148955|NCT01962441|559978292|FG001|Retreatment Substudy|Lost to Follow-up|0|||
155148956|NCT01962441|559978293|FG002|Retreatment Substudy|Lost to Follow-up|0|||
155148957|NCT02055898|559978294|FG000|First Intervention (5 Days)|Physician Decision|2|||
155148958|NCT02055898|559978295|FG001|First Intervention (5 Days)|Physician Decision|0|||
155148959|NCT02055898|559978294|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
155148960|NCT02055898|559978295|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
155148961|NCT00718510|559978297|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
155148962|NCT00718510|559978298|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155148963|NCT00718510|559978297|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
155148964|NCT00718510|559978298|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
155148965|NCT02201524|559978299|FG000|Overall Study|Adverse Event|0|||
155148966|NCT02201524|559978300|FG001|Overall Study|Adverse Event|2|||
155148967|NCT02201524|559978301|FG002|Overall Study|Adverse Event|1|||
155148968|NCT02201524|559978302|FG003|Overall Study|Adverse Event|0|||
155148969|NCT02201524|559978299|FG000|Overall Study|Insufficient clinical response|1|||
155148970|NCT02201524|559978300|FG001|Overall Study|Insufficient clinical response|0|||
155148971|NCT02201524|559978301|FG002|Overall Study|Insufficient clinical response|0|||
155148972|NCT02201524|559978302|FG003|Overall Study|Insufficient clinical response|0|||
155148973|NCT02201524|559978299|FG000|Overall Study|Lost to Follow-up|0|||
155148974|NCT02201524|559978300|FG001|Overall Study|Lost to Follow-up|0|||
155148975|NCT02201524|559978301|FG002|Overall Study|Lost to Follow-up|2|||
155148976|NCT02201524|559978302|FG003|Overall Study|Lost to Follow-up|0|||
155148977|NCT02201524|559978299|FG000|Overall Study|No longer meets eligibility criteria|0|||
155148978|NCT02201524|559978300|FG001|Overall Study|No longer meets eligibility criteria|0|||
155148979|NCT02201524|559978301|FG002|Overall Study|No longer meets eligibility criteria|0|||
155148980|NCT02201524|559978302|FG003|Overall Study|No longer meets eligibility criteria|2|||
155148981|NCT02201524|559978299|FG000|Overall Study|Protocol Violation|0|||
155148982|NCT02201524|559978300|FG001|Overall Study|Protocol Violation|0|||
155148983|NCT02201524|559978301|FG002|Overall Study|Protocol Violation|0|||
155148984|NCT02201524|559978302|FG003|Overall Study|Protocol Violation|1|||
155148985|NCT02201524|559978299|FG000|Overall Study|Withdrawal by Subject|0|||
155148986|NCT02201524|559978300|FG001|Overall Study|Withdrawal by Subject|0|||
155196117|NCT01146912|560156113|FG001|Overall Study|< 14 weeks gestational age|0|||
155196118|NCT01146912|560156114|FG002|Overall Study|< 14 weeks gestational age|3|||
155196119|NCT01146912|560156115|FG003|Overall Study|< 14 weeks gestational age|2|||
155196120|NCT01146912|560156116|FG004|Overall Study|< 14 weeks gestational age|0|||
155196121|NCT01146912|560156117|FG005|Overall Study|< 14 weeks gestational age|0|||
155196122|NCT01146912|560156118|FG006|Overall Study|< 14 weeks gestational age|0|||
155196123|NCT01146912|560156119|FG007|Overall Study|< 14 weeks gestational age|0|||
155196124|NCT01146912|560156112|FG000|Overall Study|Duplicate patient|0|||
155196125|NCT01146912|560156113|FG001|Overall Study|Duplicate patient|0|||
155148987|NCT02201524|559978301|FG002|Overall Study|Withdrawal by Subject|1|||
155148988|NCT02201524|559978302|FG003|Overall Study|Withdrawal by Subject|1|||
155148989|NCT02201524|559978299|FG000|Overall Study|Other|1|||
155148990|NCT02201524|559978300|FG001|Overall Study|Other|1|||
155148991|NCT02201524|559978301|FG002|Overall Study|Other|0|||
155196126|NCT01146912|560156114|FG002|Overall Study|Duplicate patient|1|||
155148992|NCT02201524|559978302|FG003|Overall Study|Other|0|||
155148993|NCT00423657|559978303|FG000|Overall Study|Withdrew consent|10|||
155148994|NCT00423657|559978304|FG001|Overall Study|Withdrew consent|8|||
155148995|NCT00423657|559978303|FG000|Overall Study|Non-compliance|0|||
155148996|NCT00423657|559978304|FG001|Overall Study|Non-compliance|1|||
155148997|NCT00423657|559978303|FG000|Overall Study|Other|15|||
155148998|NCT00423657|559978304|FG001|Overall Study|Other|16|||
155148999|NCT00423657|559978303|FG000|Overall Study|Request of sponsor/investigator|1|||
155149000|NCT00423657|559978304|FG001|Overall Study|Request of sponsor/investigator|0|||
155149001|NCT00474955|559978305|FG000|Overall Study|Adverse Event|2|||
155149002|NCT00474955|559978305|FG000|Overall Study|Drug unavailability|1|||
155196127|NCT01146912|560156115|FG003|Overall Study|Duplicate patient|0|||
155196128|NCT01146912|560156116|FG004|Overall Study|Duplicate patient|0|||
155196129|NCT01146912|560156117|FG005|Overall Study|Duplicate patient|0|||
155196130|NCT01146912|560156118|FG006|Overall Study|Duplicate patient|0|||
155196131|NCT01146912|560156119|FG007|Overall Study|Duplicate patient|0|||
155196132|NCT02980783|560156120|FG000|Overall Study|Lost to Follow-up|1|||
155149003|NCT00474955|559978305|FG000|Overall Study|Personal reasons|5|||
155149004|NCT01620060|559978308|FG000|Overall Study|Adverse Event|9|||
155149005|NCT01620060|559978308|FG000|Overall Study|Protocol Violation|1|||
155149006|NCT01620060|559978308|FG000|Overall Study|Withdrawal by Subject|1|||
155149007|NCT01620060|559978308|FG000|Overall Study|Did not comply with Study Produre|1|||
155149008|NCT01620060|559978308|FG000|Overall Study|Family emergency|1|||
155149009|NCT01620060|559978308|FG000|Overall Study|Per Sponsor Decision|2|||
155149010|NCT02269124|559978309|FG000|Overall Study|Lost to Follow-up|1|||
155196133|NCT00880542|560156121|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
155196134|NCT00880542|560156121|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
155196135|NCT00880542|560156121|FG000|REP: Surgical Resection|progressive disease|1|||
155196136|NCT00074984|560156122|FG000|Overall Study|Death|1|||
155196137|NCT00074984|560156123|FG001|Overall Study|Death|2|||
155196138|NCT00074984|560156122|FG000|Overall Study|Withdrawal by Subject|2|||
155149011|NCT02269124|559978310|FG001|Overall Study|Lost to Follow-up|0|||
155149012|NCT02269124|559978309|FG000|Overall Study|Withdrawal by Subject|0|||
155149013|NCT02269124|559978310|FG001|Overall Study|Withdrawal by Subject|2|||
155149014|NCT01960140|559978311|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
155149015|NCT03452540|559978313|FG000|Overall Study|Adverse Event|1|||
155149016|NCT03452540|559978313|FG000|Overall Study|Withdrawal by Subject|1|||
155149017|NCT03452540|559978313|FG000|Overall Study|Other SAE and AE|2|||
155149018|NCT00499681|559978321|FG000|Overall Study|toxicity|0|||
155149019|NCT00499681|559978322|FG001|Overall Study|toxicity|1|||
155149020|NCT00499681|559978321|FG000|Overall Study|disease progression|0|||
155149021|NCT00499681|559978322|FG001|Overall Study|disease progression|1|||
155149022|NCT04575155|559978323|FG000|2 Month|Withdrawal by Subject|1|||
155149023|NCT04575155|559978324|FG001|2 Month|Withdrawal by Subject|1|||
155149024|NCT04575155|559978323|FG000|2 Month|Lost to Follow-up|5|||
155149025|NCT04575155|559978324|FG001|2 Month|Lost to Follow-up|3|||
155149026|NCT04575155|559978323|FG000|2 Month|Ineligible|1|||
155149027|NCT04575155|559978324|FG001|2 Month|Ineligible|0|||
155196139|NCT00074984|560156123|FG001|Overall Study|Withdrawal by Subject|3|||
155196140|NCT00074984|560156122|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
155196141|NCT00074984|560156123|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
155196142|NCT04289623|560156124|FG000|Wave 1 Emails|Email was not delivered|268|||
155196143|NCT04289623|560156125|FG001|Wave 1 Emails|Email was not delivered|257|||
155196144|NCT04289623|560156126|FG002|Wave 1 Emails|Email was not delivered|0|||
155196145|NCT04289623|560156127|FG003|Wave 1 Emails|Email was not delivered|0|||
155196146|NCT04289623|560156128|FG004|Wave 1 Emails|Email was not delivered|0|||
155196147|NCT04289623|560156129|FG005|Wave 1 Emails|Email was not delivered|0|||
155196148|NCT03758443|560156130|FG000|Induction Period|Adverse Event|2|||
155196149|NCT03758443|560156131|FG001|Induction Period|Adverse Event|4|||
155149028|NCT06237049|559978326|FG000|Overall Study|Death|0|||
155149029|NCT06237049|559978327|FG001|Overall Study|Death|0|||
155149030|NCT06237049|559978328|FG002|Overall Study|Death|0|||
155196150|NCT03758443|560156132|FG002|Induction Period|Adverse Event|2|||
155196151|NCT03758443|560156133|FG003|Induction Period|Adverse Event|3|||
155196152|NCT03758443|560156130|FG000|Induction Period|Physician Decision|1|||
155196153|NCT03758443|560156131|FG001|Induction Period|Physician Decision|1|||
155196154|NCT03758443|560156132|FG002|Induction Period|Physician Decision|3|||
155196155|NCT03758443|560156133|FG003|Induction Period|Physician Decision|0|||
155149031|NCT06237049|559978329|FG003|Overall Study|Death|1|||
155149032|NCT06237049|559978326|FG000|Overall Study|Lost to Follow-up|11|||
155149033|NCT06237049|559978327|FG001|Overall Study|Lost to Follow-up|5|||
155149034|NCT06237049|559978328|FG002|Overall Study|Lost to Follow-up|8|||
155149035|NCT06237049|559978329|FG003|Overall Study|Lost to Follow-up|8|||
155149036|NCT06237049|559978326|FG000|Overall Study|Protocol Violation|0|||
155196156|NCT03758443|560156130|FG000|Induction Period|Protocol Violation|0|||
155196157|NCT03758443|560156131|FG001|Induction Period|Protocol Violation|0|||
155149037|NCT06237049|559978327|FG001|Overall Study|Protocol Violation|1|||
155149038|NCT06237049|559978328|FG002|Overall Study|Protocol Violation|0|||
155149039|NCT06237049|559978329|FG003|Overall Study|Protocol Violation|1|||
155196158|NCT03758443|560156132|FG002|Induction Period|Protocol Violation|0|||
155196159|NCT03758443|560156133|FG003|Induction Period|Protocol Violation|1|||
155149040|NCT06237049|559978326|FG000|Overall Study|Withdrawal by Subject|4|||
155149041|NCT06237049|559978327|FG001|Overall Study|Withdrawal by Subject|2|||
155149042|NCT06237049|559978328|FG002|Overall Study|Withdrawal by Subject|1|||
155149043|NCT06237049|559978329|FG003|Overall Study|Withdrawal by Subject|0|||
155149044|NCT03748823|559978330|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
155149045|NCT03748823|559978331|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
155149046|NCT03748823|559978330|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
155149047|NCT03748823|559978331|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
155149048|NCT03748823|559978330|FG000|Extension Period|Withdrawal by Subject|9|||
155149049|NCT03748823|559978331|FG001|Extension Period|Withdrawal by Subject|12|||
155149050|NCT03748823|559978330|FG000|Extension Period|Death|2|||
155149051|NCT03748823|559978331|FG001|Extension Period|Death|2|||
155149052|NCT03748823|559978330|FG000|Extension Period|Other than Specified|0|||
155149053|NCT03748823|559978331|FG001|Extension Period|Other than Specified|1|||
155149054|NCT03748823|559978330|FG000|Extension Period|Protocol Violation|1|||
155149055|NCT03748823|559978331|FG001|Extension Period|Protocol Violation|0|||
155149056|NCT03748823|559978330|FG000|Extension Period|Lost to Follow-up|0|||
155149057|NCT03748823|559978331|FG001|Extension Period|Lost to Follow-up|1|||
155149058|NCT03748823|559978330|FG000|Extension Period|Lack of Efficacy|0|||
155149059|NCT03748823|559978331|FG001|Extension Period|Lack of Efficacy|1|||
155149060|NCT03748823|559978330|FG000|Extension Period|Physician Decision|1|||
155149061|NCT03748823|559978331|FG001|Extension Period|Physician Decision|2|||
155149062|NCT03275740|559978332|FG000|Overall Study|Adverse Event|0|||
155149063|NCT03275740|559978333|FG001|Overall Study|Adverse Event|0|||
155149064|NCT03275740|559978334|FG002|Overall Study|Adverse Event|0|||
155149065|NCT03275740|559978335|FG003|Overall Study|Adverse Event|0|||
155149066|NCT03275740|559978336|FG004|Overall Study|Adverse Event|1|||
155149067|NCT03275740|559978337|FG005|Overall Study|Adverse Event|0|||
155149068|NCT03275740|559978338|FG006|Overall Study|Adverse Event|0|||
155149069|NCT03275740|559978339|FG007|Overall Study|Adverse Event|0|||
155149070|NCT03275740|559978340|FG008|Overall Study|Adverse Event|0|||
155149071|NCT03275740|559978341|FG009|Overall Study|Adverse Event|0|||
155149072|NCT03275740|559978342|FG010|Overall Study|Adverse Event|0|||
155149073|NCT03275740|559978343|FG011|Overall Study|Adverse Event|0|||
155149074|NCT03275740|559978332|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149075|NCT03275740|559978333|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149076|NCT03275740|559978334|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149077|NCT03275740|559978335|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155196160|NCT03758443|560156130|FG000|Induction Period|Withdrawal by Subject|3|||
155196161|NCT03758443|560156131|FG001|Induction Period|Withdrawal by Subject|2|||
155196162|NCT03758443|560156132|FG002|Induction Period|Withdrawal by Subject|2|||
155196163|NCT03758443|560156133|FG003|Induction Period|Withdrawal by Subject|4|||
155196164|NCT03758443|560156130|FG000|Extended Induction Period|Adverse Event|1|||
155196165|NCT03758443|560156131|FG001|Extended Induction Period|Adverse Event|1|||
155196166|NCT03758443|560156132|FG002|Extended Induction Period|Adverse Event|0|||
155196167|NCT03758443|560156133|FG003|Extended Induction Period|Adverse Event|1|||
155196168|NCT03758443|560156130|FG000|Extended Induction Period|Lost to Follow-up|1|||
155196169|NCT03758443|560156131|FG001|Extended Induction Period|Lost to Follow-up|0|||
155196170|NCT03758443|560156132|FG002|Extended Induction Period|Lost to Follow-up|0|||
155196171|NCT03758443|560156133|FG003|Extended Induction Period|Lost to Follow-up|0|||
155196172|NCT03758443|560156130|FG000|Extended Induction Period|Physician Decision|2|||
155196173|NCT03758443|560156131|FG001|Extended Induction Period|Physician Decision|1|||
155196174|NCT03758443|560156132|FG002|Extended Induction Period|Physician Decision|2|||
155196175|NCT03758443|560156133|FG003|Extended Induction Period|Physician Decision|2|||
155196176|NCT03758443|560156130|FG000|Extended Induction Period|Protocol Violation|0|||
155196177|NCT03758443|560156131|FG001|Extended Induction Period|Protocol Violation|0|||
155196178|NCT03758443|560156132|FG002|Extended Induction Period|Protocol Violation|0|||
155196179|NCT03758443|560156133|FG003|Extended Induction Period|Protocol Violation|1|||
155196180|NCT03758443|560156130|FG000|Extended Induction Period|Withdrawal by Subject|8|||
155196181|NCT03758443|560156131|FG001|Extended Induction Period|Withdrawal by Subject|1|||
155149078|NCT03275740|559978336|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149079|NCT03275740|559978337|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
155149080|NCT03275740|559978338|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149081|NCT03275740|559978339|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155196182|NCT03758443|560156132|FG002|Extended Induction Period|Withdrawal by Subject|7|||
155196183|NCT03758443|560156133|FG003|Extended Induction Period|Withdrawal by Subject|3|||
155196184|NCT03758443|560156130|FG000|Extended Induction Period|Miscellaneous|1|||
155149082|NCT03275740|559978340|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149083|NCT03275740|559978341|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149084|NCT03275740|559978342|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149085|NCT03275740|559978343|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
155149086|NCT03275740|559978332|FG000|Overall Study|Withdrawal by Subject|0|||
155149087|NCT03275740|559978333|FG001|Overall Study|Withdrawal by Subject|0|||
155149088|NCT03275740|559978334|FG002|Overall Study|Withdrawal by Subject|0|||
155149089|NCT03275740|559978335|FG003|Overall Study|Withdrawal by Subject|0|||
155149090|NCT03275740|559978336|FG004|Overall Study|Withdrawal by Subject|0|||
155149091|NCT03275740|559978337|FG005|Overall Study|Withdrawal by Subject|0|||
155149092|NCT03275740|559978338|FG006|Overall Study|Withdrawal by Subject|0|||
155149093|NCT03275740|559978339|FG007|Overall Study|Withdrawal by Subject|0|||
155149094|NCT03275740|559978340|FG008|Overall Study|Withdrawal by Subject|1|||
155149095|NCT03275740|559978341|FG009|Overall Study|Withdrawal by Subject|1|||
155149096|NCT03275740|559978342|FG010|Overall Study|Withdrawal by Subject|0|||
155149097|NCT03275740|559978343|FG011|Overall Study|Withdrawal by Subject|0|||
155149098|NCT04486235|559978348|FG000|Overall Study|Pregnancy|1|||
155149099|NCT04486235|559978349|FG001|Overall Study|Pregnancy|0|||
155149100|NCT04486235|559978348|FG000|Overall Study|Lost to Follow-up|1|||
155149101|NCT04486235|559978349|FG001|Overall Study|Lost to Follow-up|0|||
155149102|NCT03935126|559978350|FG000|Overall Study|Study termination by sponsor|3|||
155149103|NCT03546621|559978351|FG000|Overall Study|Withdrawal by Subject|0|||
155149104|NCT03546621|559978352|FG001|Overall Study|Withdrawal by Subject|1|||
155149105|NCT03546621|559978353|FG002|Overall Study|Withdrawal by Subject|2|||
155149106|NCT03546621|559978354|FG003|Overall Study|Withdrawal by Subject|1|||
155149107|NCT03546621|559978351|FG000|Overall Study|Lost to Follow-up|0|||
155149108|NCT03546621|559978352|FG001|Overall Study|Lost to Follow-up|1|||
155149109|NCT03546621|559978353|FG002|Overall Study|Lost to Follow-up|0|||
155149110|NCT03546621|559978354|FG003|Overall Study|Lost to Follow-up|0|||
155149111|NCT03546621|559978351|FG000|Overall Study|Adverse Event|0|||
155149112|NCT03546621|559978352|FG001|Overall Study|Adverse Event|1|||
155149113|NCT03546621|559978353|FG002|Overall Study|Adverse Event|0|||
155149114|NCT03546621|559978354|FG003|Overall Study|Adverse Event|1|||
155149115|NCT03546621|559978351|FG000|Overall Study|Progressive disease|0|||
155149116|NCT03546621|559978352|FG001|Overall Study|Progressive disease|0|||
155149117|NCT03546621|559978353|FG002|Overall Study|Progressive disease|0|||
155149118|NCT03546621|559978354|FG003|Overall Study|Progressive disease|1|||
155149119|NCT00660192|559978360|FG000|Overall Study|Lost to Follow-up|2|||
155149120|NCT00660192|559978361|FG001|Overall Study|Lost to Follow-up|3|||
155149121|NCT00982735|559978362|FG000|Overall Study|Lost to Follow-up|6|||
155149122|NCT00982735|559978362|FG000|Overall Study|Patient ineligible for trial|224|||
155149123|NCT01091675|559978363|FG000|Overall Study|Adverse Event|7|||
155149124|NCT01091675|559978363|FG000|Overall Study|Lack of Efficacy|27|||
155149125|NCT04908397|559978366|FG000|Overall Study|Withdrawal by Subject|2|||
155149126|NCT03318549|559978367|FG000|Overall Study|Withdrawal by Subject|5|||
155149127|NCT03318549|559978368|FG001|Overall Study|Withdrawal by Subject|19|||
155149128|NCT03318549|559978369|FG002|Overall Study|Withdrawal by Subject|2|||
155149129|NCT03318549|559978370|FG003|Overall Study|Withdrawal by Subject|0|||
155149130|NCT03318549|559978371|FG004|Overall Study|Withdrawal by Subject|0|||
155149131|NCT03318549|559978372|FG005|Overall Study|Withdrawal by Subject|0|||
155149132|NCT03318549|559978373|FG006|Overall Study|Withdrawal by Subject|0|||
155149133|NCT03318549|559978367|FG000|Overall Study|Physician Decision|0|||
155149134|NCT03318549|559978368|FG001|Overall Study|Physician Decision|4|||
155149135|NCT03318549|559978369|FG002|Overall Study|Physician Decision|1|||
155149136|NCT03318549|559978370|FG003|Overall Study|Physician Decision|0|||
155149137|NCT03318549|559978371|FG004|Overall Study|Physician Decision|0|||
155149138|NCT03318549|559978372|FG005|Overall Study|Physician Decision|0|||
155149139|NCT03318549|559978373|FG006|Overall Study|Physician Decision|0|||
155149140|NCT03318549|559978367|FG000|Overall Study|Lost to Follow-up|0|||
155149141|NCT03318549|559978368|FG001|Overall Study|Lost to Follow-up|3|||
155149142|NCT03318549|559978369|FG002|Overall Study|Lost to Follow-up|3|||
155149143|NCT03318549|559978370|FG003|Overall Study|Lost to Follow-up|0|||
155149144|NCT03318549|559978371|FG004|Overall Study|Lost to Follow-up|0|||
155149145|NCT03318549|559978372|FG005|Overall Study|Lost to Follow-up|0|||
155149146|NCT03318549|559978373|FG006|Overall Study|Lost to Follow-up|0|||
155149147|NCT00462306|559978374|FG000|Overall Study|insufficient data|0|||
155149148|NCT00462306|559978375|FG001|Overall Study|insufficient data|13|||
155149149|NCT01917747|559978376|FG000|Overall Study|Withdrawal by Subject|1|||
155149150|NCT01917747|559978377|FG001|Overall Study|Withdrawal by Subject|2|||
155149151|NCT01917747|559978376|FG000|Overall Study|Lost to Follow-up|18|||
155149152|NCT01917747|559978377|FG001|Overall Study|Lost to Follow-up|9|||
155149153|NCT00360412|559978382|FG000|Overall Study|Adverse Event|37|||
155149154|NCT00360412|559978383|FG001|Overall Study|Adverse Event|65|||
155149155|NCT00360412|559978382|FG000|Overall Study|Protocol Violation|2|||
155149156|NCT00360412|559978383|FG001|Overall Study|Protocol Violation|5|||
155149157|NCT00360412|559978382|FG000|Overall Study|Patient withdrew consent|27|||
155149158|NCT00360412|559978383|FG001|Overall Study|Patient withdrew consent|52|||
155149159|NCT00360412|559978382|FG000|Overall Study|Lack of therapeutic efficacy|46|||
155149160|NCT00360412|559978383|FG001|Overall Study|Lack of therapeutic efficacy|61|||
155149161|NCT00360412|559978382|FG000|Overall Study|Physician Decision|2|||
155149162|NCT00360412|559978383|FG001|Overall Study|Physician Decision|4|||
155149163|NCT00360412|559978382|FG000|Overall Study|Other|5|||
155149164|NCT00360412|559978383|FG001|Overall Study|Other|6|||
155149165|NCT00360412|559978382|FG000|Overall Study|Study termination by Sponsor|214|||
155149166|NCT00360412|559978383|FG001|Overall Study|Study termination by Sponsor|469|||
155149167|NCT03064490|559978384|FG000|Overall Study|Physician Decision|5|||
155149168|NCT00948064|559980095|FG000|Phase I|No treatment received|1|||
155149169|NCT00948064|559980096|FG001|Phase I|No treatment received|0|||
155149170|NCT00948064|559980097|FG002|Phase I|No treatment received|0|||
155149171|NCT00948064|559980095|FG000|Phase II|Physician Decision|0|||
155149172|NCT00948064|559980096|FG001|Phase II|Physician Decision|0|||
155149173|NCT00948064|559980097|FG002|Phase II|Physician Decision|1|||
155149174|NCT00948064|559980095|FG000|Phase II|Withdrawal by Subject|0|||
155149175|NCT00948064|559980096|FG001|Phase II|Withdrawal by Subject|1|||
155149176|NCT00948064|559980097|FG002|Phase II|Withdrawal by Subject|0|||
155149177|NCT01393158|559980098|FG000|Overall Study|Adverse Event|1|||
155149178|NCT01393158|559980099|FG001|Overall Study|Adverse Event|0|||
155149179|NCT01690052|559980105|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
155149180|NCT01690052|559980106|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
155149181|NCT00928486|559980107|FG000|Overall Study|Adverse Event|2|||
155149182|NCT00928486|559980107|FG000|Overall Study|Disease Progression|7|||
155149183|NCT00928486|559980107|FG000|Overall Study|Withdrawal by Subject|1|||
155149184|NCT00683878|559980112|FG000|Overall Study|Lack of Efficacy|3|||
155149185|NCT00683878|559980113|FG001|Overall Study|Lack of Efficacy|0|||
155149186|NCT00683878|559980114|FG002|Overall Study|Lack of Efficacy|1|||
155149187|NCT00683878|559980112|FG000|Overall Study|Adverse Event|4|||
155149188|NCT00683878|559980113|FG001|Overall Study|Adverse Event|3|||
155149189|NCT00683878|559980114|FG002|Overall Study|Adverse Event|3|||
155149190|NCT00683878|559980112|FG000|Overall Study|Withdrawal by Subject|9|||
155149191|NCT00683878|559980113|FG001|Overall Study|Withdrawal by Subject|8|||
155149192|NCT00683878|559980114|FG002|Overall Study|Withdrawal by Subject|6|||
155149193|NCT00683878|559980112|FG000|Overall Study|Death|0|||
155149194|NCT00683878|559980113|FG001|Overall Study|Death|1|||
155149195|NCT00683878|559980114|FG002|Overall Study|Death|0|||
155149196|NCT00683878|559980112|FG000|Overall Study|Lost to Follow-up|4|||
155149197|NCT00683878|559980113|FG001|Overall Study|Lost to Follow-up|2|||
155149198|NCT00683878|559980114|FG002|Overall Study|Lost to Follow-up|4|||
155149199|NCT00683878|559980112|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
155149200|NCT00683878|559980113|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
155149201|NCT00683878|559980114|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
155149202|NCT02869633|559980118|FG000|Overall Study|Death|2|||
155149203|NCT02869633|559980119|FG001|Overall Study|Death|1|||
155149204|NCT02869633|559980118|FG000|Overall Study|Patient refused follow-up|1|||
155149205|NCT02869633|559980119|FG001|Overall Study|Patient refused follow-up|0|||
155149206|NCT02869633|559980118|FG000|Overall Study|Provider discretion|1|||
155149207|NCT02869633|559980119|FG001|Overall Study|Provider discretion|0|||
155149208|NCT02869633|559980118|FG000|Overall Study|Investigator decision|1|||
155149209|NCT02869633|559980119|FG001|Overall Study|Investigator decision|0|||
155149210|NCT02869633|559980118|FG000|Overall Study|Lost to Follow-up|0|||
155149211|NCT02869633|559980119|FG001|Overall Study|Lost to Follow-up|1|||
155149212|NCT02869633|559980118|FG000|Overall Study|Not eligible|6|||
155149213|NCT02869633|559980119|FG001|Overall Study|Not eligible|1|||
155149214|NCT02869633|559980118|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
155149215|NCT02869633|559980119|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
155149216|NCT02869633|559980118|FG000|Overall Study|Withdrawal by Subject|0|||
155149217|NCT02869633|559980119|FG001|Overall Study|Withdrawal by Subject|1|||
155149218|NCT04024891|559980120|FG000|Overall Study|Pregnancy|0|||
155149219|NCT04024891|559980121|FG001|Overall Study|Pregnancy|1|||
155149220|NCT03287791|559980128|FG000|Overall Study|Insufficient Therapeutic Response|0|||
155149221|NCT03287791|559980129|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155149222|NCT03287791|559980130|FG002|Overall Study|Insufficient Therapeutic Response|1|||
155149223|NCT03287791|559980128|FG000|Overall Study|Adverse Event|0|||
155149224|NCT03287791|559980129|FG001|Overall Study|Adverse Event|4|||
155149225|NCT03287791|559980130|FG002|Overall Study|Adverse Event|3|||
155149226|NCT03287791|559980128|FG000|Overall Study|Withdrawal by Subject|12|||
155149227|NCT03287791|559980129|FG001|Overall Study|Withdrawal by Subject|12|||
155149228|NCT03287791|559980130|FG002|Overall Study|Withdrawal by Subject|17|||
155149229|NCT03287791|559980128|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
155149230|NCT03287791|559980129|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
155149231|NCT03287791|559980130|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
155149232|NCT03287791|559980128|FG000|Overall Study|Lost to Follow-up|8|||
155149233|NCT03287791|559980129|FG001|Overall Study|Lost to Follow-up|14|||
155149234|NCT03287791|559980130|FG002|Overall Study|Lost to Follow-up|11|||
155149235|NCT03287791|559980128|FG000|Overall Study|Protocol Violation|7|||
155149236|NCT03287791|559980129|FG001|Overall Study|Protocol Violation|2|||
155149237|NCT03287791|559980130|FG002|Overall Study|Protocol Violation|1|||
155149238|NCT03287791|559980128|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
155149239|NCT03287791|559980129|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
155149240|NCT03287791|559980130|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
155149241|NCT03287791|559980128|FG000|Overall Study|Too much time between 2 visits|0|||
155149242|NCT03287791|559980129|FG001|Overall Study|Too much time between 2 visits|1|||
155196185|NCT03758443|560156131|FG001|Extended Induction Period|Miscellaneous|0|||
155196186|NCT03758443|560156132|FG002|Extended Induction Period|Miscellaneous|0|||
155196187|NCT03758443|560156133|FG003|Extended Induction Period|Miscellaneous|0|||
155196188|NCT03758443|560156130|FG000|Maintenance Period|Adverse Event|1|||
155149243|NCT03287791|559980130|FG002|Overall Study|Too much time between 2 visits|0|||
155149244|NCT03287791|559980128|FG000|Overall Study|Non-compliance|0|||
155149245|NCT03287791|559980129|FG001|Overall Study|Non-compliance|1|||
155149246|NCT03287791|559980130|FG002|Overall Study|Non-compliance|0|||
155149247|NCT03287791|559980128|FG000|Overall Study|Did not meet inclusion criteria|1|||
155149248|NCT03287791|559980129|FG001|Overall Study|Did not meet inclusion criteria|0|||
155149249|NCT03287791|559980130|FG002|Overall Study|Did not meet inclusion criteria|0|||
155149250|NCT01381016|559980132|FG000|Overall Study|Lost to Follow-up|1|||
155149251|NCT01381016|559980133|FG001|Overall Study|Lost to Follow-up|1|||
155149252|NCT01381016|559980132|FG000|Overall Study|Screen Failure|2|||
155149253|NCT01381016|559980133|FG001|Overall Study|Screen Failure|2|||
155149254|NCT01381016|559980132|FG000|Overall Study|Withdrawal by Subject|0|||
155149255|NCT01381016|559980133|FG001|Overall Study|Withdrawal by Subject|1|||
155149256|NCT01381016|559980132|FG000|Overall Study|Physician Decision|0|||
155149257|NCT01381016|559980133|FG001|Overall Study|Physician Decision|2|||
155149258|NCT05801991|559980137|FG000|Overall Study|Lost to Follow-up|1|||
155149259|NCT05801991|559980138|FG001|Overall Study|Lost to Follow-up|0|||
155149260|NCT01451723|559980139|FG000|Overall Study|study halted|6|||
155149261|NCT01451723|559980140|FG001|Overall Study|study halted|5|||
155149262|NCT00833040|559980141|FG000|Overall Study|Adverse Event|0|||
155149263|NCT00833040|559980142|FG001|Overall Study|Adverse Event|0|||
155149264|NCT00833040|559980143|FG002|Overall Study|Adverse Event|0|||
155149265|NCT00833040|559980144|FG003|Overall Study|Adverse Event|0|||
155149266|NCT00833040|559980145|FG004|Overall Study|Adverse Event|0|||
155149267|NCT00833040|559980146|FG005|Overall Study|Adverse Event|1|||
155149268|NCT03489863|559980147|FG000|Overall Study|Withdrawal by Subject|0|||
155149269|NCT03489863|559980148|FG001|Overall Study|Withdrawal by Subject|1|||
155149270|NCT03309878|559980150|FG000|Overall Study|Adverse Event|1|||
155149271|NCT03309878|559980151|FG001|Overall Study|Adverse Event|0|||
155149272|NCT03309878|559980152|FG002|Overall Study|Adverse Event|0|||
155149273|NCT03309878|559980153|FG003|Overall Study|Adverse Event|0|||
155149274|NCT03309878|559980150|FG000|Overall Study|Did not maintain eligibility|2|||
155149275|NCT03309878|559980151|FG001|Overall Study|Did not maintain eligibility|1|||
155149276|NCT03309878|559980152|FG002|Overall Study|Did not maintain eligibility|0|||
155149277|NCT03309878|559980153|FG003|Overall Study|Did not maintain eligibility|0|||
155149278|NCT03309878|559980150|FG000|Overall Study|Withdrawal by Subject|0|||
155149279|NCT03309878|559980151|FG001|Overall Study|Withdrawal by Subject|1|||
155149280|NCT03309878|559980152|FG002|Overall Study|Withdrawal by Subject|0|||
155149281|NCT03309878|559980153|FG003|Overall Study|Withdrawal by Subject|0|||
155149282|NCT02648204|559980154|FG000|Overall Study|Withdrawal by Subject|12|||
155149283|NCT02648204|559980155|FG001|Overall Study|Withdrawal by Subject|8|||
155149284|NCT02648204|559980156|FG002|Overall Study|Withdrawal by Subject|2|||
155149285|NCT02648204|559980157|FG003|Overall Study|Withdrawal by Subject|6|||
155149286|NCT02648204|559980154|FG000|Overall Study|Lost to Follow-up|5|||
155149287|NCT02648204|559980155|FG001|Overall Study|Lost to Follow-up|8|||
155149288|NCT02648204|559980156|FG002|Overall Study|Lost to Follow-up|4|||
155149289|NCT02648204|559980157|FG003|Overall Study|Lost to Follow-up|6|||
155149290|NCT02648204|559980154|FG000|Overall Study|Missing follow-up information|4|||
155149291|NCT02648204|559980155|FG001|Overall Study|Missing follow-up information|4|||
155149292|NCT02648204|559980156|FG002|Overall Study|Missing follow-up information|4|||
155149293|NCT02648204|559980157|FG003|Overall Study|Missing follow-up information|2|||
155149294|NCT02648204|559980154|FG000|Overall Study|Death|1|||
155149295|NCT02648204|559980155|FG001|Overall Study|Death|1|||
155149296|NCT02648204|559980156|FG002|Overall Study|Death|2|||
155149297|NCT02648204|559980157|FG003|Overall Study|Death|2|||
155149298|NCT02648204|559980154|FG000|Overall Study|Adverse Event|0|||
155149299|NCT02648204|559980155|FG001|Overall Study|Adverse Event|0|||
155149300|NCT02648204|559980156|FG002|Overall Study|Adverse Event|1|||
155149301|NCT02648204|559980157|FG003|Overall Study|Adverse Event|0|||
155196189|NCT03758443|560156131|FG001|Maintenance Period|Adverse Event|2|||
155149302|NCT02314052|559980162|FG000|Cycle One|Adverse Event|0|||
155149303|NCT02314052|559980163|FG001|Cycle One|Adverse Event|0|||
155149304|NCT02314052|559980164|FG002|Cycle One|Adverse Event|0|||
155149305|NCT02314052|559980165|FG003|Cycle One|Adverse Event|1|||
155149306|NCT02314052|559980166|FG004|Cycle One|Adverse Event|0|||
155149307|NCT02314052|559980167|FG005|Cycle One|Adverse Event|0|||
155149308|NCT02653326|559980168|FG000|Overall Study|Lost to Follow-up|10|||
155149309|NCT02653326|559980169|FG001|Overall Study|Lost to Follow-up|7|||
155149310|NCT01045460|559980172|FG000|Overall Study|Physician Decision|3|||
155149311|NCT01045460|559980173|FG001|Overall Study|Physician Decision|2|||
155196190|NCT03758443|560156132|FG002|Maintenance Period|Adverse Event|0|||
155149312|NCT01045460|559980172|FG000|Overall Study|Lost to Follow-up|0|||
155149313|NCT01045460|559980173|FG001|Overall Study|Lost to Follow-up|1|||
155149314|NCT01045460|559980172|FG000|Overall Study|Lack of Efficacy|3|||
155149315|NCT01045460|559980173|FG001|Overall Study|Lack of Efficacy|0|||
155196191|NCT03758443|560156133|FG003|Maintenance Period|Adverse Event|0|||
155196192|NCT03758443|560156130|FG000|Maintenance Period|Lost to Follow-up|0|||
155196193|NCT03758443|560156131|FG001|Maintenance Period|Lost to Follow-up|0|||
155196194|NCT03758443|560156132|FG002|Maintenance Period|Lost to Follow-up|0|||
155196195|NCT03758443|560156133|FG003|Maintenance Period|Lost to Follow-up|1|||
155196196|NCT03758443|560156130|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
155196197|NCT03758443|560156131|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
155196198|NCT03758443|560156132|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
155196199|NCT03758443|560156133|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
155196200|NCT03758443|560156130|FG000|Maintenance Period|Protocol Violation|0|||
155196201|NCT03758443|560156131|FG001|Maintenance Period|Protocol Violation|1|||
155196202|NCT03758443|560156132|FG002|Maintenance Period|Protocol Violation|0|||
155196203|NCT03758443|560156133|FG003|Maintenance Period|Protocol Violation|0|||
155196204|NCT03758443|560156130|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
155196205|NCT03758443|560156131|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
155196206|NCT03758443|560156132|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
155196207|NCT03758443|560156133|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
155196208|NCT03758443|560156130|FG000|Maintenance Period|Withdrawal by Subject|1|||
155196209|NCT03758443|560156131|FG001|Maintenance Period|Withdrawal by Subject|0|||
155196210|NCT03758443|560156132|FG002|Maintenance Period|Withdrawal by Subject|1|||
155196211|NCT03758443|560156133|FG003|Maintenance Period|Withdrawal by Subject|1|||
155196212|NCT03758443|560156130|FG000|Maintenance Period|Miscellaneous|0|||
155196213|NCT03758443|560156131|FG001|Maintenance Period|Miscellaneous|0|||
155196214|NCT03758443|560156132|FG002|Maintenance Period|Miscellaneous|1|||
155196215|NCT03758443|560156133|FG003|Maintenance Period|Miscellaneous|0|||
155196216|NCT03080454|560156134|FG000|Baseline|Adverse Event|2|||
155196217|NCT03080454|560156134|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
155196218|NCT03080454|560156134|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
155196219|NCT02202980|560156135|FG000|Overall Study|Lack of Efficacy|1|||
155196220|NCT02202980|560156136|FG001|Overall Study|Lack of Efficacy|0|||
155196221|NCT02202980|560156137|FG002|Overall Study|Lack of Efficacy|7|||
155196222|NCT02202980|560156138|FG003|Overall Study|Lack of Efficacy|0|||
155196223|NCT02202980|560156139|FG004|Overall Study|Lack of Efficacy|3|||
155196224|NCT02202980|560156140|FG005|Overall Study|Lack of Efficacy|1|||
155196225|NCT02202980|560156141|FG006|Overall Study|Lack of Efficacy|11|||
155196226|NCT02202980|560156142|FG007|Overall Study|Lack of Efficacy|2|||
155196227|NCT02202980|560156143|FG008|Overall Study|Lack of Efficacy|2|||
155196228|NCT02202980|560156144|FG009|Overall Study|Lack of Efficacy|0|||
155196229|NCT02202980|560156145|FG010|Overall Study|Lack of Efficacy|0|||
155196230|NCT02202980|560156146|FG011|Overall Study|Lack of Efficacy|3|||
155196231|NCT02202980|560156147|FG012|Overall Study|Lack of Efficacy|10|||
155196232|NCT02202980|560156148|FG013|Overall Study|Lack of Efficacy|0|||
155196233|NCT02202980|560156135|FG000|Overall Study|Protocol Violation|0|||
155196234|NCT02202980|560156136|FG001|Overall Study|Protocol Violation|0|||
155196235|NCT02202980|560156137|FG002|Overall Study|Protocol Violation|0|||
155196236|NCT02202980|560156138|FG003|Overall Study|Protocol Violation|3|||
155196237|NCT02202980|560156139|FG004|Overall Study|Protocol Violation|3|||
155196238|NCT02202980|560156140|FG005|Overall Study|Protocol Violation|0|||
155196239|NCT02202980|560156141|FG006|Overall Study|Protocol Violation|0|||
155196240|NCT02202980|560156142|FG007|Overall Study|Protocol Violation|0|||
155196241|NCT02202980|560156143|FG008|Overall Study|Protocol Violation|0|||
155196242|NCT02202980|560156144|FG009|Overall Study|Protocol Violation|0|||
155196243|NCT02202980|560156145|FG010|Overall Study|Protocol Violation|0|||
155196244|NCT02202980|560156146|FG011|Overall Study|Protocol Violation|0|||
155196245|NCT02202980|560156147|FG012|Overall Study|Protocol Violation|0|||
155196246|NCT02202980|560156148|FG013|Overall Study|Protocol Violation|0|||
155196247|NCT02202980|560156135|FG000|Overall Study|Lost to Follow-up|0|||
155196248|NCT02202980|560156136|FG001|Overall Study|Lost to Follow-up|1|||
155196249|NCT02202980|560156137|FG002|Overall Study|Lost to Follow-up|1|||
155196250|NCT02202980|560156138|FG003|Overall Study|Lost to Follow-up|1|||
155196251|NCT02202980|560156139|FG004|Overall Study|Lost to Follow-up|0|||
155196252|NCT02202980|560156140|FG005|Overall Study|Lost to Follow-up|0|||
155196253|NCT02202980|560156141|FG006|Overall Study|Lost to Follow-up|0|||
155196254|NCT02202980|560156142|FG007|Overall Study|Lost to Follow-up|1|||
155196255|NCT02202980|560156143|FG008|Overall Study|Lost to Follow-up|1|||
155196256|NCT02202980|560156144|FG009|Overall Study|Lost to Follow-up|0|||
155196257|NCT02202980|560156145|FG010|Overall Study|Lost to Follow-up|0|||
155196258|NCT02202980|560156146|FG011|Overall Study|Lost to Follow-up|0|||
155196259|NCT02202980|560156147|FG012|Overall Study|Lost to Follow-up|1|||
155196260|NCT02202980|560156148|FG013|Overall Study|Lost to Follow-up|0|||
155196261|NCT02202980|560156135|FG000|Overall Study|Withdrew Consent|0|||
155196262|NCT02202980|560156136|FG001|Overall Study|Withdrew Consent|1|||
155196263|NCT02202980|560156137|FG002|Overall Study|Withdrew Consent|2|||
155196264|NCT02202980|560156138|FG003|Overall Study|Withdrew Consent|0|||
155196265|NCT02202980|560156139|FG004|Overall Study|Withdrew Consent|0|||
155196266|NCT02202980|560156140|FG005|Overall Study|Withdrew Consent|0|||
155196267|NCT02202980|560156141|FG006|Overall Study|Withdrew Consent|0|||
155196268|NCT02202980|560156142|FG007|Overall Study|Withdrew Consent|0|||
155196269|NCT02202980|560156143|FG008|Overall Study|Withdrew Consent|1|||
155196270|NCT02202980|560156144|FG009|Overall Study|Withdrew Consent|0|||
155196271|NCT02202980|560156145|FG010|Overall Study|Withdrew Consent|0|||
155196272|NCT02202980|560156146|FG011|Overall Study|Withdrew Consent|0|||
155196273|NCT02202980|560156147|FG012|Overall Study|Withdrew Consent|0|||
155196274|NCT02202980|560156148|FG013|Overall Study|Withdrew Consent|0|||
155196275|NCT00696800|560156152|FG000|Overall Study|Adverse Event|16|||
155196276|NCT00696800|560156153|FG001|Overall Study|Adverse Event|3|||
155196277|NCT00696800|560156152|FG000|Overall Study|Insufficient compliance with medication|2|||
155196278|NCT00696800|560156153|FG001|Overall Study|Insufficient compliance with medication|1|||
155196279|NCT00696800|560156152|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
155196280|NCT00696800|560156153|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
155196281|NCT00696800|560156152|FG000|Overall Study|Insufficient ovarian response|4|||
155149316|NCT00097500|559980174|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
155149317|NCT00097500|559980175|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
155149318|NCT00097500|559980174|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
155149319|NCT00097500|559980175|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
155149320|NCT00097500|559980174|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
155149321|NCT00097500|559980175|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
155149322|NCT00097500|559980174|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
155149323|NCT00097500|559980175|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
155149324|NCT00097500|559980174|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
155149325|NCT00097500|559980175|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
155149326|NCT00097500|559980174|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
155149327|NCT00097500|559980175|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
155149328|NCT00097500|559980174|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
155149329|NCT00097500|559980175|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
155149330|NCT00524485|559980178|FG000|Overall Study|Withdrawal by Subject|5|||
155149331|NCT00642356|559980182|FG000|Overall Study|Adverse Event|1|||
155149332|NCT00642356|559980183|FG001|Overall Study|Adverse Event|0|||
155149333|NCT00642356|559980182|FG000|Overall Study|Protocol Violation|0|||
155149334|NCT00642356|559980183|FG001|Overall Study|Protocol Violation|3|||
155149335|NCT00642356|559980182|FG000|Overall Study|Lack of Efficacy|1|||
155149336|NCT00642356|559980183|FG001|Overall Study|Lack of Efficacy|0|||
155149337|NCT00005906|559980186|FG000|Overall Study|Lack of Efficacy|3|||
155149338|NCT04551989|559980187|FG000|Overall Study|Adverse Event|4|||
155149339|NCT04551989|559980187|FG000|Overall Study|Protocol Violation|3|||
155149340|NCT04551989|559980187|FG000|Overall Study|Lost to Follow-up|1|||
155149341|NCT04551989|559980187|FG000|Overall Study|Physician Decision|3|||
155149342|NCT04201431|559980188|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
155149343|NCT04201431|559980189|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
155149344|NCT04201431|559980190|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
155149345|NCT00686777|559980193|FG000|Overall Study|Adverse Event|2|||
155149346|NCT00686777|559980193|FG000|Overall Study|Pregnancy|1|||
155149347|NCT00686777|559980193|FG000|Overall Study|Withdrawal by Subject|2|||
155149348|NCT00686777|559980193|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
155149349|NCT00686777|559980193|FG000|Overall Study|No Visit|1|||
155149350|NCT00667888|559980194|FG000|Overall Study|Death|1|||
155149351|NCT00667888|559980195|FG001|Overall Study|Death|1|||
155149352|NCT00667888|559980194|FG000|Overall Study|Withdrawal by Subject|6|||
155149353|NCT00667888|559980195|FG001|Overall Study|Withdrawal by Subject|3|||
155149354|NCT00667888|559980194|FG000|Overall Study|Proceed with other treatment|3|||
155149355|NCT00667888|559980195|FG001|Overall Study|Proceed with other treatment|3|||
155149356|NCT00667888|559980194|FG000|Overall Study|Ineligible after SIM|0|||
155149357|NCT00667888|559980195|FG001|Overall Study|Ineligible after SIM|2|||
155149358|NCT01945021|559980196|FG000|Overall Study|Adverse Event|1|||
155149359|NCT01945021|559980196|FG000|Overall Study|Withdrawal of consent|12|||
155149360|NCT01945021|559980196|FG000|Overall Study|Lost to Follow-up|5|||
155149361|NCT01945021|559980196|FG000|Overall Study|Death|65|||
155149362|NCT00883779|559980197|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
155149363|NCT00883779|559980198|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
155149364|NCT00883779|559980197|FG000|Primary Study Treatment Phase|Disease progression|75|||
155149365|NCT00883779|559980198|FG001|Primary Study Treatment Phase|Disease progression|59|||
155149366|NCT00883779|559980197|FG000|Primary Study Treatment Phase|Adverse Event|16|||
155149367|NCT00883779|559980198|FG001|Primary Study Treatment Phase|Adverse Event|16|||
155149368|NCT00883779|559980197|FG000|Primary Study Treatment Phase|Death|2|||
155149369|NCT00883779|559980198|FG001|Primary Study Treatment Phase|Death|3|||
155149370|NCT00883779|559980197|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
155149371|NCT00883779|559980198|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
155149372|NCT00883779|559980197|FG000|Primary Study Treatment Phase|Other|3|||
155149373|NCT00883779|559980198|FG001|Primary Study Treatment Phase|Other|0|||
155196282|NCT00696800|560156153|FG001|Overall Study|Insufficient ovarian response|1|||
155196283|NCT00696800|560156152|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
155196284|NCT00696800|560156153|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
155196285|NCT00696800|560156152|FG000|Overall Study|Too high ovarian response|6|||
155196286|NCT00696800|560156153|FG001|Overall Study|Too high ovarian response|1|||
155196287|NCT00696800|560156152|FG000|Overall Study|No/too few/bad quality oocytes|4|||
155196288|NCT00696800|560156153|FG001|Overall Study|No/too few/bad quality oocytes|3|||
155196289|NCT00696800|560156152|FG000|Overall Study|No/abnormal fertilization|11|||
155196290|NCT00696800|560156153|FG001|Overall Study|No/abnormal fertilization|13|||
155196291|NCT00696800|560156152|FG000|Overall Study|No/too few/bad quality embryos|24|||
155196292|NCT00696800|560156153|FG001|Overall Study|No/too few/bad quality embryos|18|||
155196293|NCT00696800|560156152|FG000|Overall Study|Other Reasons|5|||
155196294|NCT00696800|560156153|FG001|Overall Study|Other Reasons|3|||
155196295|NCT00696800|560156152|FG000|Overall Study|Not treated|1|||
155196296|NCT00696800|560156153|FG001|Overall Study|Not treated|2|||
155196297|NCT01540838|560156154|FG000|Overall Study|Open nasogastric tube|9|||
155196298|NCT01540838|560156155|FG001|Overall Study|Open nasogastric tube|7|||
155196299|NCT01540838|560156154|FG000|Overall Study|Treatment doses missing|8|||
155196300|NCT01540838|560156155|FG001|Overall Study|Treatment doses missing|12|||
155196301|NCT01540838|560156154|FG000|Overall Study|Additional antibiotic treatment|1|||
155196302|NCT01540838|560156155|FG001|Overall Study|Additional antibiotic treatment|2|||
155196303|NCT01540838|560156154|FG000|Overall Study|Died before treatment initiation|1|||
155196304|NCT01540838|560156155|FG001|Overall Study|Died before treatment initiation|1|||
155196305|NCT01540838|560156154|FG000|Overall Study|Not BM. Other treatment|3|||
155196306|NCT01540838|560156155|FG001|Overall Study|Not BM. Other treatment|1|||
155196307|NCT02130570|560156156|FG000|Overall Study|Death|3|||
155196308|NCT02130570|560156157|FG001|Overall Study|Death|5|||
155196309|NCT02130570|560156156|FG000|Overall Study|Withdrawal by Subject|6|||
155196310|NCT02130570|560156157|FG001|Overall Study|Withdrawal by Subject|3|||
155196311|NCT02130570|560156156|FG000|Overall Study|Part of practice that discontinued study|0|||
155196312|NCT02130570|560156157|FG001|Overall Study|Part of practice that discontinued study|5|||
155196313|NCT00413244|560156163|FG000|Overall Study|Withdrawal by Subject|10|||
155196314|NCT00413244|560156164|FG001|Overall Study|Withdrawal by Subject|1|||
155196315|NCT01058655|560156166|FG000|Overall Study|Withdrawal by Subject|1|||
155196316|NCT01058655|560156167|FG001|Overall Study|Withdrawal by Subject|0|||
155196317|NCT01058655|560156168|FG002|Overall Study|Withdrawal by Subject|3|||
155196318|NCT01058655|560156169|FG003|Overall Study|Withdrawal by Subject|4|||
155196319|NCT01058655|560156166|FG000|Overall Study|Prolonged Treatment Delay|0|||
155196320|NCT01058655|560156167|FG001|Overall Study|Prolonged Treatment Delay|0|||
155196321|NCT01058655|560156168|FG002|Overall Study|Prolonged Treatment Delay|0|||
155196322|NCT01058655|560156169|FG003|Overall Study|Prolonged Treatment Delay|2|||
155196323|NCT01058655|560156166|FG000|Overall Study|Symptomatic Deterioration|0|||
155196324|NCT01058655|560156167|FG001|Overall Study|Symptomatic Deterioration|0|||
155196325|NCT01058655|560156168|FG002|Overall Study|Symptomatic Deterioration|0|||
155196326|NCT01058655|560156169|FG003|Overall Study|Symptomatic Deterioration|1|||
155196327|NCT01058655|560156166|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
155196328|NCT01058655|560156167|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
155196329|NCT01058655|560156168|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
155196330|NCT01058655|560156169|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
155196331|NCT01058655|560156166|FG000|Overall Study|Death|0|||
155196332|NCT01058655|560156167|FG001|Overall Study|Death|1|||
155196333|NCT01058655|560156168|FG002|Overall Study|Death|1|||
155196334|NCT01058655|560156169|FG003|Overall Study|Death|0|||
155196335|NCT01058655|560156166|FG000|Overall Study|Disease Progression|1|||
155196336|NCT01058655|560156167|FG001|Overall Study|Disease Progression|2|||
155196337|NCT01058655|560156168|FG002|Overall Study|Disease Progression|4|||
155196338|NCT01058655|560156169|FG003|Overall Study|Disease Progression|24|||
155196339|NCT01058655|560156166|FG000|Overall Study|Other|0|||
155196340|NCT01058655|560156167|FG001|Overall Study|Other|0|||
155196341|NCT01058655|560156168|FG002|Overall Study|Other|0|||
155196342|NCT01058655|560156169|FG003|Overall Study|Other|4|||
155196343|NCT02635776|560156173|FG000|Overall Study|Physician Decision|1|||
155196344|NCT02635776|560156174|FG001|Overall Study|Physician Decision|0|||
155196345|NCT02635776|560156173|FG000|Overall Study|Adverse Event|51|||
155196346|NCT02635776|560156174|FG001|Overall Study|Adverse Event|3|||
155196347|NCT02635776|560156173|FG000|Overall Study|Withdrawal by Subject|41|||
155196348|NCT02635776|560156174|FG001|Overall Study|Withdrawal by Subject|7|||
155196349|NCT02635776|560156173|FG000|Overall Study|Lost to Follow-up|4|||
155196350|NCT02635776|560156174|FG001|Overall Study|Lost to Follow-up|0|||
155196351|NCT02635776|560156173|FG000|Overall Study|Other reasons|5|||
155196352|NCT02635776|560156174|FG001|Overall Study|Other reasons|1|||
155196353|NCT03208127|560156175|FG000|Overall Study|Death|1|||
155196354|NCT01811225|560156176|FG000|Treatment Period 1|Adverse Event|2|||
155196355|NCT01811225|560156177|FG001|Treatment Period 1|Adverse Event|3|||
155196356|NCT01811225|560156176|FG000|Treatment Period 1|Lost to Follow-up|12|||
155196357|NCT01811225|560156177|FG001|Treatment Period 1|Lost to Follow-up|8|||
155196358|NCT01811225|560156176|FG000|Treatment Period 1|transporation|1|||
155196359|NCT01811225|560156177|FG001|Treatment Period 1|transporation|0|||
155196360|NCT01811225|560156176|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
155196361|NCT01811225|560156177|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
155196362|NCT01811225|560156176|FG000|Treatment Period 2|Lost to Follow-up|1|||
155196363|NCT01811225|560156177|FG001|Treatment Period 2|Lost to Follow-up|2|||
155196364|NCT01811225|560156176|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
155196365|NCT01811225|560156177|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
155196366|NCT00287365|560156178|FG000|Overall Study|sample not acquired|13|||
155196367|NCT02298023|560156179|FG000|Overall Study|Withdrawal by Subject|1|||
155196368|NCT02298023|560156180|FG001|Overall Study|Withdrawal by Subject|0|||
155196369|NCT02298023|560156181|FG002|Overall Study|Withdrawal by Subject|0|||
155196370|NCT01612858|560156183|FG000|Overall Study|Withdrawal by Subject|5|||
155196371|NCT01612858|560156184|FG001|Overall Study|Withdrawal by Subject|1|||
155196372|NCT03113916|560156185|FG000|Overall Study|Withdrawal by Subject|9|||
155196373|NCT03113916|560156186|FG001|Overall Study|Withdrawal by Subject|7|||
155196374|NCT03113916|560156185|FG000|Overall Study|Pregnancy|1|||
155196375|NCT03113916|560156186|FG001|Overall Study|Pregnancy|3|||
155196376|NCT03113916|560156185|FG000|Overall Study|Lost to Follow-up|1|||
155196377|NCT03113916|560156186|FG001|Overall Study|Lost to Follow-up|2|||
155196378|NCT01758523|560156188|FG000|Overall Study|Adverse Event|2|||
155149374|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Adverse Event|2|||
155149375|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Adverse Event|3|||
155149376|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Death|1|||
155149377|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Death|3|||
155149378|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
155149379|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
155149380|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
155149381|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
155149382|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Disease progression|103|||
155149383|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Disease progression|122|||
155149384|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Other|3|||
155149385|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Other|0|||
155149386|NCT00883779|559980197|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
155149387|NCT00883779|559980198|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
155149388|NCT00883779|559980197|FG000|Off-study Phase|Death|185|||
155149389|NCT00883779|559980198|FG001|Off-study Phase|Death|174|||
155149390|NCT00883779|559980197|FG000|Off-study Phase|Refused treatment|1|||
155149391|NCT00883779|559980198|FG001|Off-study Phase|Refused treatment|1|||
155149392|NCT00883779|559980197|FG000|Off-study Phase|Failure to return|5|||
155149393|NCT00883779|559980198|FG001|Off-study Phase|Failure to return|6|||
155149394|NCT00883779|559980197|FG000|Off-study Phase|Other|18|||
155149395|NCT00883779|559980198|FG001|Off-study Phase|Other|21|||
155149396|NCT03915717|559980205|FG000|Overall Study|EchoMark Not Implanted|6|||
155149397|NCT03550378|559980206|FG000|Overall Study|Death|0|||
155149398|NCT03550378|559980207|FG001|Overall Study|Death|1|||
155149399|NCT00626275|559980208|FG000|Part A - Treatment Period 1|Adverse Event|1|||
155149400|NCT00626275|559980209|FG001|Part A - Treatment Period 1|Adverse Event|0|||
155149401|NCT00626275|559980210|FG002|Part A - Treatment Period 1|Adverse Event|0|||
155149402|NCT00626275|559980211|FG003|Part A - Treatment Period 1|Adverse Event|0|||
155149403|NCT00626275|559980212|FG004|Part A - Treatment Period 1|Adverse Event|0|||
155149404|NCT00626275|559980213|FG005|Part A - Treatment Period 1|Adverse Event|0|||
155149405|NCT00626275|559980214|FG006|Part A - Treatment Period 1|Adverse Event|0|||
155149406|NCT00626275|559980215|FG007|Part A - Treatment Period 1|Adverse Event|0|||
155149407|NCT00626275|559980208|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149408|NCT00626275|559980209|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149409|NCT00626275|559980210|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
155149410|NCT00626275|559980211|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149411|NCT00626275|559980212|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149412|NCT00626275|559980213|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149413|NCT00626275|559980214|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149414|NCT00626275|559980215|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
155149415|NCT00626275|559980208|FG000|Part B|Lost to Follow-up|0|||
155149416|NCT00626275|559980209|FG001|Part B|Lost to Follow-up|0|||
155149417|NCT00626275|559980210|FG002|Part B|Lost to Follow-up|0|||
155149418|NCT00626275|559980211|FG003|Part B|Lost to Follow-up|0|||
155149419|NCT00626275|559980212|FG004|Part B|Lost to Follow-up|0|||
155149420|NCT00626275|559980213|FG005|Part B|Lost to Follow-up|0|||
155149421|NCT00626275|559980214|FG006|Part B|Lost to Follow-up|1|||
155149422|NCT00626275|559980215|FG007|Part B|Lost to Follow-up|0|||
155149423|NCT00626275|559980208|FG000|Part B|Withdrawal by Subject|0|||
155149424|NCT00626275|559980209|FG001|Part B|Withdrawal by Subject|0|||
155149425|NCT00626275|559980210|FG002|Part B|Withdrawal by Subject|0|||
155196379|NCT01758523|560156189|FG001|Overall Study|Adverse Event|1|||
155149426|NCT00626275|559980211|FG003|Part B|Withdrawal by Subject|0|||
155149427|NCT00626275|559980212|FG004|Part B|Withdrawal by Subject|0|||
155149428|NCT00626275|559980213|FG005|Part B|Withdrawal by Subject|0|||
155149429|NCT00626275|559980214|FG006|Part B|Withdrawal by Subject|0|||
155149430|NCT00626275|559980215|FG007|Part B|Withdrawal by Subject|1|||
155149431|NCT01362348|559980216|FG000|Overall Study|Protocol-defined stopping criteria|9|||
155149432|NCT01362348|559980216|FG000|Overall Study|Study closed/terminated|5|||
155149433|NCT00399516|559980217|FG000|Overall Study|Lost to Follow-up|2|||
155149434|NCT02898454|559980221|FG000|Overall Study|Adverse Event|4|||
155149435|NCT02898454|559980222|FG001|Overall Study|Adverse Event|1|||
155196380|NCT01758523|560156188|FG000|Overall Study|Lack of Efficacy|4|||
155196381|NCT01758523|560156189|FG001|Overall Study|Lack of Efficacy|2|||
155196382|NCT01758523|560156188|FG000|Overall Study|Lost to Follow-up|3|||
155196383|NCT01758523|560156189|FG001|Overall Study|Lost to Follow-up|4|||
155196384|NCT01758523|560156188|FG000|Overall Study|Withdrawal by Subject|12|||
155196385|NCT01758523|560156189|FG001|Overall Study|Withdrawal by Subject|7|||
155196386|NCT00722800|560156190|FG000|Overall Study|Withdrawal by Subject|1|||
155196387|NCT00722800|560156191|FG001|Overall Study|Withdrawal by Subject|0|||
155196388|NCT00722800|560156190|FG000|Overall Study|Physician Decision|1|||
155196389|NCT00722800|560156191|FG001|Overall Study|Physician Decision|0|||
155196390|NCT04729621|560156192|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
155196391|NCT04729621|560156193|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
155196392|NCT04729621|560156194|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
155196393|NCT04729621|560156195|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
155196394|NCT04729621|560156196|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
155196395|NCT04729621|560156192|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
155196396|NCT04729621|560156193|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
155196397|NCT04729621|560156194|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
155196398|NCT04729621|560156195|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
155196399|NCT04729621|560156196|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
155196400|NCT04729621|560156192|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
155196401|NCT04729621|560156193|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
155196402|NCT04729621|560156194|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
155196403|NCT04729621|560156195|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
155196404|NCT04729621|560156196|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
155196405|NCT04729621|560156192|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155196406|NCT04729621|560156193|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
155196407|NCT04729621|560156194|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
155196408|NCT04729621|560156195|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
155196409|NCT04729621|560156196|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
155196410|NCT04729621|560156192|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196411|NCT04729621|560156193|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155149436|NCT02898454|559980223|FG002|Overall Study|Adverse Event|2|||
155149437|NCT02898454|559980221|FG000|Overall Study|Protocol Violation|1|||
155149438|NCT02898454|559980222|FG001|Overall Study|Protocol Violation|0|||
155149439|NCT02898454|559980223|FG002|Overall Study|Protocol Violation|1|||
155149440|NCT02898454|559980221|FG000|Overall Study|Lack of Efficacy|4|||
155149441|NCT02898454|559980222|FG001|Overall Study|Lack of Efficacy|1|||
155149442|NCT02898454|559980223|FG002|Overall Study|Lack of Efficacy|0|||
155149443|NCT02898454|559980221|FG000|Overall Study|Withdrawal by Subject|6|||
155149444|NCT02898454|559980222|FG001|Overall Study|Withdrawal by Subject|3|||
155149445|NCT02898454|559980223|FG002|Overall Study|Withdrawal by Subject|3|||
155149446|NCT02898454|559980221|FG000|Overall Study|Lost to Follow-up|1|||
155149447|NCT02898454|559980222|FG001|Overall Study|Lost to Follow-up|0|||
155149448|NCT02898454|559980223|FG002|Overall Study|Lost to Follow-up|0|||
155149449|NCT02898454|559980221|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
155149450|NCT02898454|559980222|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
155149451|NCT02898454|559980223|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
155149452|NCT00689390|559980224|FG000|Overall Study|Adverse Event|19|||
155149453|NCT00689390|559980225|FG001|Overall Study|Adverse Event|0|||
155149454|NCT00689390|559980224|FG000|Overall Study|Lost to Follow-up|179|||
155149455|NCT00689390|559980225|FG001|Overall Study|Lost to Follow-up|7|||
155149456|NCT00689390|559980224|FG000|Overall Study|Withdrawal by Subject|117|||
155149457|NCT00689390|559980225|FG001|Overall Study|Withdrawal by Subject|3|||
155149458|NCT00689390|559980224|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
155149459|NCT00689390|559980225|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
155149460|NCT00689390|559980224|FG000|Overall Study|Non-Compliance With Protocol|21|||
155149461|NCT00689390|559980225|FG001|Overall Study|Non-Compliance With Protocol|0|||
155149462|NCT00689390|559980224|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
155149463|NCT00689390|559980225|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
155149464|NCT00689390|559980224|FG000|Overall Study|Administrative|37|||
155149465|NCT00689390|559980225|FG001|Overall Study|Administrative|0|||
155149466|NCT02343263|559980226|FG000|Overall Study|Physician Decision|5|||
155149467|NCT02343263|559980227|FG001|Overall Study|Physician Decision|3|||
155149468|NCT02343263|559980228|FG002|Overall Study|Physician Decision|1|||
155149469|NCT03040141|559980231|FG000|Overall Study|Death|1|||
155149470|NCT03040141|559980232|FG001|Overall Study|Death|2|||
155149471|NCT03040141|559980233|FG002|Overall Study|Death|3|||
155196412|NCT04729621|560156194|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196413|NCT04729621|560156195|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
155196414|NCT04729621|560156196|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
155196415|NCT04729621|560156192|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
155196416|NCT04729621|560156193|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
155196417|NCT04729621|560156194|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
155196418|NCT04729621|560156195|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
155196419|NCT04729621|560156196|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
155196420|NCT01449539|560156197|FG000|Overall Study|Withdrawal by Subject|3|||
155196421|NCT01449539|560156197|FG000|Overall Study|Toxicity not study related|1|||
155196422|NCT01387789|560156198|FG000|Overall Study|Adverse Event|5|||
155196423|NCT01387789|560156198|FG000|Overall Study|Lack of Efficacy|2|||
155196424|NCT01387789|560156198|FG000|Overall Study|Lost to Follow-up|1|||
155196425|NCT00913380|560156201|FG000|Clinical Outcomes|Lost to Follow-up|6|||
155196426|NCT00913380|560156202|FG001|Clinical Outcomes|Lost to Follow-up|6|||
155196427|NCT01788228|560156203|FG000|Overall Study|Migrated/moved from study area|1|||
155196428|NCT01788228|560156204|FG001|Overall Study|Migrated/moved from study area|0|||
155196429|NCT02187744|560156205|FG000|Study|Participant refused further follow-up|1|||
155196430|NCT02187744|560156206|FG001|Study|Participant refused further follow-up|0|||
155196431|NCT02187744|560156205|FG000|Study|Other|2|||
155196432|NCT02187744|560156206|FG001|Study|Other|1|||
155196433|NCT02187744|560156205|FG000|Study|Lost to Follow-up|0|||
155196434|NCT02187744|560156206|FG001|Study|Lost to Follow-up|2|||
155196435|NCT02187744|560156205|FG000|Study|Related adverse event, not serious|0|||
155196436|NCT02187744|560156206|FG001|Study|Related adverse event, not serious|2|||
155196437|NCT02187744|560156205|FG000|Study|Death|1|||
155196438|NCT02187744|560156206|FG001|Study|Death|0|||
155196439|NCT02187744|560156205|FG000|Study|Related adverse event, serious non-fatal|0|||
155196440|NCT02187744|560156206|FG001|Study|Related adverse event, serious non-fatal|1|||
155196441|NCT02187744|560156205|FG000|Treatment|Death|1|||
155196442|NCT02187744|560156206|FG001|Treatment|Death|0|||
155196443|NCT02187744|560156205|FG000|Treatment|Related adverse event, serious non-fatal|0|||
155196444|NCT02187744|560156206|FG001|Treatment|Related adverse event, serious non-fatal|1|||
155196445|NCT02187744|560156205|FG000|Treatment|Related adverse event, not serious|0|||
155196446|NCT02187744|560156206|FG001|Treatment|Related adverse event, not serious|2|||
155196447|NCT02187744|560156205|FG000|Treatment|Lost to Follow-up|0|||
155196448|NCT02187744|560156206|FG001|Treatment|Lost to Follow-up|1|||
155196449|NCT02187744|560156205|FG000|Treatment|Other|2|||
155196450|NCT02187744|560156206|FG001|Treatment|Other|0|||
155196451|NCT02187744|560156205|FG000|Treatment|Participant refused continued treatment|1|||
155196452|NCT02187744|560156206|FG001|Treatment|Participant refused continued treatment|1|||
155196453|NCT01602120|560156210|FG000|Overall Study|Adverse Event|3|||
155196454|NCT01602120|560156211|FG001|Overall Study|Adverse Event|6|||
155196455|NCT01602120|560156212|FG002|Overall Study|Adverse Event|0|||
155196456|NCT01602120|560156213|FG003|Overall Study|Adverse Event|2|||
155196457|NCT01602120|560156210|FG000|Overall Study|Death|0|||
155196458|NCT01602120|560156211|FG001|Overall Study|Death|4|||
155196459|NCT01602120|560156212|FG002|Overall Study|Death|0|||
155196460|NCT01602120|560156213|FG003|Overall Study|Death|0|||
155196461|NCT01602120|560156210|FG000|Overall Study|Lost to Follow-up|0|||
155196462|NCT01602120|560156211|FG001|Overall Study|Lost to Follow-up|1|||
155196463|NCT01602120|560156212|FG002|Overall Study|Lost to Follow-up|0|||
155196464|NCT01602120|560156213|FG003|Overall Study|Lost to Follow-up|1|||
155196465|NCT01602120|560156210|FG000|Overall Study|Protocol Violation|1|||
155196466|NCT01602120|560156211|FG001|Overall Study|Protocol Violation|1|||
155196467|NCT01602120|560156212|FG002|Overall Study|Protocol Violation|0|||
155196468|NCT01602120|560156213|FG003|Overall Study|Protocol Violation|0|||
155196469|NCT01602120|560156210|FG000|Overall Study|Non-compliance|0|||
155196470|NCT01602120|560156211|FG001|Overall Study|Non-compliance|3|||
155196471|NCT01602120|560156212|FG002|Overall Study|Non-compliance|0|||
155196472|NCT01602120|560156213|FG003|Overall Study|Non-compliance|1|||
155196473|NCT01602120|560156210|FG000|Overall Study|Withdrawal by Subject|8|||
155196474|NCT01602120|560156211|FG001|Overall Study|Withdrawal by Subject|17|||
155196475|NCT01602120|560156212|FG002|Overall Study|Withdrawal by Subject|0|||
155196476|NCT01602120|560156213|FG003|Overall Study|Withdrawal by Subject|3|||
155196477|NCT01602120|560156210|FG000|Overall Study|Study Terminated by Sponsor|12|||
155196478|NCT01602120|560156211|FG001|Overall Study|Study Terminated by Sponsor|24|||
155196479|NCT01602120|560156212|FG002|Overall Study|Study Terminated by Sponsor|17|||
155196480|NCT01602120|560156213|FG003|Overall Study|Study Terminated by Sponsor|44|||
155196481|NCT01602120|560156210|FG000|Overall Study|Physician Decision|2|||
155196482|NCT01602120|560156211|FG001|Overall Study|Physician Decision|3|||
155196483|NCT01602120|560156212|FG002|Overall Study|Physician Decision|0|||
155196484|NCT01602120|560156213|FG003|Overall Study|Physician Decision|0|||
155196485|NCT01602120|560156210|FG000|Overall Study|Unspecified Reason|3|||
155196486|NCT01602120|560156211|FG001|Overall Study|Unspecified Reason|1|||
155196487|NCT01602120|560156212|FG002|Overall Study|Unspecified Reason|0|||
155196488|NCT01602120|560156213|FG003|Overall Study|Unspecified Reason|2|||
155196489|NCT01187433|560156222|FG000|Overall Study|Protocol Violation|6|||
155196490|NCT01187433|560156223|FG001|Overall Study|Protocol Violation|2|||
155196491|NCT01187433|560156222|FG000|Overall Study|Withdrawal by Subject|5|||
155196492|NCT01187433|560156223|FG001|Overall Study|Withdrawal by Subject|2|||
155196493|NCT04223973|560156226|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
155196494|NCT04223973|560156227|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
155196495|NCT04223973|560156226|FG000|Overall Study|Adverse Event|4|||
155196496|NCT04223973|560156227|FG001|Overall Study|Adverse Event|0|||
155196497|NCT04223973|560156226|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
155196498|NCT04223973|560156227|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
155196499|NCT04223973|560156226|FG000|Overall Study|Physician Decision|1|||
155196500|NCT04223973|560156227|FG001|Overall Study|Physician Decision|1|||
155196501|NCT04223973|560156226|FG000|Overall Study|Withdrawal by Subject|0|||
155196502|NCT04223973|560156227|FG001|Overall Study|Withdrawal by Subject|1|||
155196503|NCT00594659|560156230|FG000|Overall Study|Lost to Follow-up|13|||
155196504|NCT00594659|560156231|FG001|Overall Study|Lost to Follow-up|9|||
155196505|NCT00594659|560156232|FG002|Overall Study|Lost to Follow-up|7|||
155196506|NCT04439201|560156240|FG000|Overall Study|Ineligible|2|||
155196507|NCT04439201|560156240|FG000|Overall Study|Never start protocol therapy|1|||
155196508|NCT04439201|560156240|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
155196509|NCT04439201|560156240|FG000|Overall Study|Mutation status not confirmed|4|||
155196510|NCT04439201|560156240|FG000|Overall Study|Adverse Event|1|||
155196511|NCT04439201|560156240|FG000|Overall Study|Death|7|||
155196512|NCT04439201|560156240|FG000|Overall Study|Withdrawal by Subject|2|||
155196513|NCT04439201|560156240|FG000|Overall Study|Disease progression|20|||
155196514|NCT04439201|560156240|FG000|Overall Study|Alternative therapy|1|||
155196515|NCT04439201|560156240|FG000|Overall Study|Physician Decision|1|||
155196516|NCT05136690|560156241|FG000|Period 1|Withdrawal by Subject|0|||
155196517|NCT05136690|560156242|FG001|Period 1|Withdrawal by Subject|1|||
155196518|NCT05136690|560156241|FG000|Period 2|Lost to Follow-up|0|||
155196519|NCT05136690|560156242|FG001|Period 2|Lost to Follow-up|3|||
155196520|NCT05136690|560156241|FG000|Period 2|Withdrawal by Subject|0|||
155196521|NCT05136690|560156242|FG001|Period 2|Withdrawal by Subject|1|||
155196522|NCT01995825|560158324|FG000|Overall Study|Withdrawal by Subject|1|||
155196523|NCT01995825|560158325|FG001|Overall Study|Withdrawal by Subject|0|||
155196524|NCT01367002|560158326|FG000|Overall Study|Withdrawal by Subject|1|||
155196525|NCT01367002|560158327|FG001|Overall Study|Withdrawal by Subject|0|||
155196526|NCT01367002|560158326|FG000|Overall Study|Physician Decision|0|||
155196527|NCT01367002|560158327|FG001|Overall Study|Physician Decision|2|||
155196528|NCT00560105|560158330|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
155196529|NCT00560105|560158331|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
155196530|NCT02400333|560158332|FG000|Overall Study|Withdrawal by Subject|0|||
155196531|NCT02400333|560158333|FG001|Overall Study|Withdrawal by Subject|1|||
155196532|NCT02400333|560158334|FG002|Overall Study|Withdrawal by Subject|0|||
155196533|NCT02400333|560158335|FG003|Overall Study|Withdrawal by Subject|1|||
155196534|NCT02400333|560158332|FG000|Overall Study|Protocol Violation|1|||
155196535|NCT02400333|560158333|FG001|Overall Study|Protocol Violation|0|||
155196536|NCT02400333|560158334|FG002|Overall Study|Protocol Violation|2|||
155196537|NCT02400333|560158335|FG003|Overall Study|Protocol Violation|1|||
155196538|NCT03281577|560158337|FG000|Overall Study|Adverse Event|0|||
155196539|NCT03281577|560158338|FG001|Overall Study|Adverse Event|0|||
155196540|NCT03281577|560158339|FG002|Overall Study|Adverse Event|0|||
155196541|NCT03281577|560158340|FG003|Overall Study|Adverse Event|1|||
155196542|NCT03281577|560158337|FG000|Overall Study|Withdrawal by Subject|1|||
155196543|NCT03281577|560158338|FG001|Overall Study|Withdrawal by Subject|0|||
155196544|NCT03281577|560158339|FG002|Overall Study|Withdrawal by Subject|0|||
155196545|NCT03281577|560158340|FG003|Overall Study|Withdrawal by Subject|0|||
155196546|NCT01687998|560158345|FG000|Overall Study|Withdrawal by Subject|49|||
155196547|NCT01687998|560158346|FG001|Overall Study|Withdrawal by Subject|51|||
155196548|NCT01687998|560158345|FG000|Overall Study|Known to be Alive at Study End|54|||
155196549|NCT01687998|560158346|FG001|Overall Study|Known to be Alive at Study End|62|||
155196550|NCT01687998|560158345|FG000|Overall Study|Lost to Follow-up|9|||
155196551|NCT01687998|560158346|FG001|Overall Study|Lost to Follow-up|7|||
155196552|NCT00443261|560158347|FG000|Overall Study|Death|1|||
155196553|NCT01550289|560158348|FG000|Overall Study|Protocol Violation|1|||
155196554|NCT01550289|560158349|FG001|Overall Study|Protocol Violation|0|||
155196555|NCT01550289|560158348|FG000|Overall Study|Lost to Follow-up|1|||
155196556|NCT01550289|560158349|FG001|Overall Study|Lost to Follow-up|1|||
155196557|NCT01550289|560158348|FG000|Overall Study|Withdrawal by Subject|11|||
155196558|NCT01550289|560158349|FG001|Overall Study|Withdrawal by Subject|3|||
155196559|NCT00739674|560158350|FG000|Overall Study|Screening failures|19|||
155196560|NCT00739674|560158351|FG001|Overall Study|Screening failures|17|||
155196561|NCT00739674|560158350|FG000|Overall Study|Site 212 removal|19|||
155196562|NCT00739674|560158351|FG001|Overall Study|Site 212 removal|13|||
155196563|NCT00739674|560158350|FG000|Overall Study|No follow-up data|33|||
155196564|NCT00739674|560158351|FG001|Overall Study|No follow-up data|18|||
155196565|NCT00739674|560158350|FG000|Overall Study|Dietician consultation >30 days|1|||
155196566|NCT00739674|560158351|FG001|Overall Study|Dietician consultation >30 days|9|||
155196567|NCT00739674|560158350|FG000|Overall Study|Adverse Event|22|||
155196568|NCT00739674|560158351|FG001|Overall Study|Adverse Event|13|||
155196569|NCT00739674|560158350|FG000|Overall Study|Death|1|||
155196570|NCT00739674|560158351|FG001|Overall Study|Death|0|||
155196571|NCT00739674|560158350|FG000|Overall Study|Lack of Efficacy|1|||
155196572|NCT00739674|560158351|FG001|Overall Study|Lack of Efficacy|0|||
155196573|NCT00739674|560158350|FG000|Overall Study|Lost to Follow-up|52|||
155196574|NCT00739674|560158351|FG001|Overall Study|Lost to Follow-up|30|||
155196575|NCT00739674|560158350|FG000|Overall Study|Protocol Violation|5|||
155196576|NCT00739674|560158351|FG001|Overall Study|Protocol Violation|5|||
155196577|NCT00739674|560158350|FG000|Overall Study|Withdrawal by Subject|9|||
155196578|NCT00739674|560158351|FG001|Overall Study|Withdrawal by Subject|9|||
155196579|NCT00739674|560158350|FG000|Overall Study|Reason missing|2|||
155196580|NCT00739674|560158351|FG001|Overall Study|Reason missing|0|||
155196581|NCT00739674|560158350|FG000|Overall Study|Clinic closed|6|||
155196582|NCT00739674|560158351|FG001|Overall Study|Clinic closed|4|||
155196583|NCT00739674|560158350|FG000|Overall Study|Patient moved|3|||
155196584|NCT00739674|560158351|FG001|Overall Study|Patient moved|2|||
155196585|NCT00739674|560158350|FG000|Overall Study|Non compliant|4|||
155196586|NCT00739674|560158351|FG001|Overall Study|Non compliant|0|||
155196587|NCT00739674|560158350|FG000|Overall Study|Unable to attend visit|3|||
155196588|NCT00739674|560158351|FG001|Overall Study|Unable to attend visit|1|||
155196589|NCT00739674|560158350|FG000|Overall Study|Home monitoring off meds|1|||
155196590|NCT00739674|560158351|FG001|Overall Study|Home monitoring off meds|0|||
155196591|NCT00739674|560158350|FG000|Overall Study|Erectile dysfunction|0|||
155196592|NCT00739674|560158351|FG001|Overall Study|Erectile dysfunction|1|||
155196593|NCT00354744|560158352|FG000|Overall Study|Adverse Event|2|||
155196594|NCT00354744|560158352|FG000|Overall Study|Death|2|||
155196595|NCT00354744|560158352|FG000|Overall Study|Lack of Efficacy|11|||
155196596|NCT00354744|560158352|FG000|Overall Study|Lost to Follow-up|2|||
155196597|NCT00354744|560158352|FG000|Overall Study|Physician Decision|11|||
155196598|NCT00354744|560158352|FG000|Overall Study|Withdrawal by Subject|14|||
155196599|NCT00541931|560158356|FG000|Overall Study|Adverse Event|1|||
155196600|NCT00541931|560158357|FG001|Overall Study|Adverse Event|0|||
155196601|NCT00541931|560158356|FG000|Overall Study|Lost to Follow-up|3|||
155196602|NCT00541931|560158357|FG001|Overall Study|Lost to Follow-up|3|||
155196603|NCT00541931|560158356|FG000|Overall Study|Withdrawal by Subject|1|||
155196604|NCT00541931|560158357|FG001|Overall Study|Withdrawal by Subject|0|||
155196605|NCT00541931|560158356|FG000|Overall Study|Transportation Issue|0|||
155196606|NCT00541931|560158357|FG001|Overall Study|Transportation Issue|1|||
155196607|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
155196608|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
155196609|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Progression|3|||
155196610|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
155196611|NCT00064337|560158358|FG000|PBSCC or Induction/PBSCC|Death|2|||
155196612|NCT00064337|560158358|FG000|Transplant|Adverse Event|9|||
155196613|NCT00064337|560158358|FG000|Transplant|Not protocol-specified|5|||
155196614|NCT00064337|560158358|FG000|Transplant|Death|3|||
155196615|NCT00064337|560158358|FG000|Transplant|Patient Refusal|2|||
155196616|NCT00064337|560158358|FG000|Transplant|Progression|2|||
155196617|NCT00064337|560158358|FG000|Maintenance|Adverse Event|3|||
155196618|NCT00064337|560158358|FG000|Maintenance|Progression|2|||
155196619|NCT00064337|560158358|FG000|Maintenance|On treatment at time of analysis|2|||
155196620|NCT00064337|560158358|FG000|Maintenance|Not protocol-specified|2|||
155196621|NCT00064337|560158358|FG000|Maintenance|Death|1|||
155196622|NCT00617851|560158361|FG000|Overall Study|Death|0|||
155196623|NCT00617851|560158362|FG001|Overall Study|Death|0|||
155196624|NCT00617851|560158363|FG002|Overall Study|Death|0|||
155196625|NCT00617851|560158364|FG003|Overall Study|Death|1|||
155196626|NCT00617851|560158361|FG000|Overall Study|Withdrawal by Subject|14|||
155196627|NCT00617851|560158362|FG001|Overall Study|Withdrawal by Subject|7|||
155196628|NCT00617851|560158363|FG002|Overall Study|Withdrawal by Subject|12|||
155196629|NCT00617851|560158364|FG003|Overall Study|Withdrawal by Subject|4|||
155196630|NCT00617851|560158361|FG000|Overall Study|Lost to Follow-up|27|||
155196631|NCT00617851|560158362|FG001|Overall Study|Lost to Follow-up|29|||
155196632|NCT00617851|560158363|FG002|Overall Study|Lost to Follow-up|31|||
155196633|NCT00617851|560158364|FG003|Overall Study|Lost to Follow-up|19|||
155196634|NCT00617851|560158361|FG000|Overall Study|Inappropriate Enrollment|5|||
155196635|NCT00617851|560158362|FG001|Overall Study|Inappropriate Enrollment|4|||
155196636|NCT00617851|560158363|FG002|Overall Study|Inappropriate Enrollment|1|||
155196637|NCT00617851|560158364|FG003|Overall Study|Inappropriate Enrollment|1|||
155196638|NCT00617851|560158361|FG000|Overall Study|Unable to classify|1|||
155196639|NCT00617851|560158362|FG001|Overall Study|Unable to classify|0|||
155196640|NCT00617851|560158363|FG002|Overall Study|Unable to classify|1|||
155196641|NCT00617851|560158364|FG003|Overall Study|Unable to classify|0|||
155196642|NCT03750955|560158371|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
155196643|NCT03750955|560158372|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
155196644|NCT03750955|560158371|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
155196645|NCT03750955|560158372|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
155196646|NCT00697788|560158375|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196647|NCT00697788|560158376|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
155196648|NCT00697788|560158377|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196649|NCT00697788|560158378|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196650|NCT00697788|560158379|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196651|NCT00697788|560158380|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196652|NCT00697788|560158381|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196653|NCT00697788|560158382|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
155196654|NCT00697788|560158375|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196655|NCT00697788|560158376|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196656|NCT00697788|560158377|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196657|NCT00697788|560158378|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196658|NCT00697788|560158379|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
155196659|NCT00697788|560158380|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196660|NCT00697788|560158381|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196661|NCT00697788|560158382|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
155196662|NCT01180985|560158384|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
155196663|NCT01180985|560158385|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
155196664|NCT00705289|560158386|FG000|Overall Study|Subject or treating physician's choice|131|||
155196665|NCT01030536|560158387|FG000|Overall Study|Withdrawal by Subject|0|||
155196666|NCT01030536|560158388|FG001|Overall Study|Withdrawal by Subject|0|||
155196667|NCT01030536|560158389|FG002|Overall Study|Withdrawal by Subject|1|||
155196668|NCT01030536|560158390|FG003|Overall Study|Withdrawal by Subject|0|||
155196669|NCT01030536|560158391|FG004|Overall Study|Withdrawal by Subject|0|||
155196670|NCT01030536|560158387|FG000|Overall Study|undefined|1|||
155196671|NCT01030536|560158388|FG001|Overall Study|undefined|0|||
155196672|NCT01030536|560158389|FG002|Overall Study|undefined|1|||
155196673|NCT01030536|560158390|FG003|Overall Study|undefined|1|||
155196674|NCT01030536|560158391|FG004|Overall Study|undefined|0|||
155196675|NCT01030536|560158387|FG000|Overall Study|Adverse Event|0|||
155196676|NCT01030536|560158388|FG001|Overall Study|Adverse Event|3|||
155196677|NCT01030536|560158389|FG002|Overall Study|Adverse Event|1|||
155196678|NCT01030536|560158390|FG003|Overall Study|Adverse Event|0|||
155196679|NCT01030536|560158391|FG004|Overall Study|Adverse Event|1|||
155196680|NCT01030536|560158387|FG000|Overall Study|Progressive disease|6|||
155196681|NCT01030536|560158388|FG001|Overall Study|Progressive disease|2|||
155196682|NCT01030536|560158389|FG002|Overall Study|Progressive disease|3|||
155196683|NCT01030536|560158390|FG003|Overall Study|Progressive disease|2|||
155196684|NCT01030536|560158391|FG004|Overall Study|Progressive disease|0|||
155196685|NCT01030536|560158387|FG000|Overall Study|Death|0|||
155196686|NCT01030536|560158388|FG001|Overall Study|Death|1|||
155196687|NCT01030536|560158389|FG002|Overall Study|Death|0|||
155196688|NCT01030536|560158390|FG003|Overall Study|Death|0|||
155196689|NCT01030536|560158391|FG004|Overall Study|Death|0|||
155196690|NCT02763462|560158394|FG000|Overall Study|Protocol Violation|6|||
155196691|NCT00675948|560158395|FG000|Overall Study|Adverse Event|23|||
155196692|NCT00675948|560158396|FG001|Overall Study|Adverse Event|1|||
155196693|NCT00675948|560158395|FG000|Overall Study|Lack of Efficacy|3|||
155196694|NCT00675948|560158396|FG001|Overall Study|Lack of Efficacy|0|||
155196695|NCT00675948|560158395|FG000|Overall Study|Withdrawal by Subject|7|||
155196696|NCT00675948|560158396|FG001|Overall Study|Withdrawal by Subject|0|||
155196697|NCT00675948|560158395|FG000|Overall Study|Lost to Follow-up|2|||
155196698|NCT00675948|560158396|FG001|Overall Study|Lost to Follow-up|0|||
155196699|NCT00675948|560158395|FG000|Overall Study|Protocol Violation|1|||
155196700|NCT00675948|560158396|FG001|Overall Study|Protocol Violation|0|||
155196701|NCT00675948|560158395|FG000|Overall Study|Pain under control|1|||
155196702|NCT00675948|560158396|FG001|Overall Study|Pain under control|0|||
155196703|NCT00675948|560158395|FG000|Overall Study|Sponsor decision|0|||
155196704|NCT00675948|560158396|FG001|Overall Study|Sponsor decision|1|||
155196705|NCT00675948|560158395|FG000|Overall Study|Patient died|1|||
155196706|NCT00675948|560158396|FG001|Overall Study|Patient died|0|||
155196707|NCT00675948|560158395|FG000|Overall Study|Patient unable to comply with diaries|1|||
155196708|NCT00675948|560158396|FG001|Overall Study|Patient unable to comply with diaries|0|||
155196709|NCT00675948|560158395|FG000|Overall Study|Patient feels unable to take medication|0|||
155196710|NCT00675948|560158396|FG001|Overall Study|Patient feels unable to take medication|1|||
155196711|NCT02100514|560158398|FG000|Treatment Period|Adverse Event|0|||
155196712|NCT02100514|560158399|FG001|Treatment Period|Adverse Event|5|||
155196713|NCT02100514|560158400|FG002|Treatment Period|Adverse Event|0|||
155196714|NCT02100514|560158401|FG003|Treatment Period|Adverse Event|0|||
155196715|NCT02100514|560158402|FG004|Treatment Period|Adverse Event|0|||
155196716|NCT02100514|560158398|FG000|Treatment Period|Death|2|||
155196717|NCT02100514|560158399|FG001|Treatment Period|Death|2|||
155196718|NCT02100514|560158400|FG002|Treatment Period|Death|0|||
155149472|NCT03040141|559980231|FG000|Overall Study|Withdrawal by Subject|3|||
155149473|NCT03040141|559980232|FG001|Overall Study|Withdrawal by Subject|1|||
155149474|NCT03040141|559980233|FG002|Overall Study|Withdrawal by Subject|1|||
155149475|NCT03040141|559980231|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
155149476|NCT03040141|559980232|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
155149477|NCT03040141|559980233|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
155149478|NCT03040141|559980231|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
155149479|NCT03040141|559980232|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
155149480|NCT03040141|559980233|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
155149481|NCT01384734|559980236|FG000|Overall Study|Adverse Event|0|||
155149482|NCT01384734|559980237|FG001|Overall Study|Adverse Event|3|||
155149483|NCT01384734|559980238|FG002|Overall Study|Adverse Event|0|||
155149484|NCT01384734|559980239|FG003|Overall Study|Adverse Event|2|||
155149485|NCT01384734|559980240|FG004|Overall Study|Adverse Event|7|||
155149486|NCT01384734|559980236|FG000|Overall Study|Death|1|||
155149487|NCT01384734|559980237|FG001|Overall Study|Death|0|||
155149488|NCT01384734|559980238|FG002|Overall Study|Death|1|||
155149489|NCT01384734|559980239|FG003|Overall Study|Death|0|||
155149490|NCT01384734|559980240|FG004|Overall Study|Death|0|||
155149491|NCT01384734|559980236|FG000|Overall Study|Continuation criteria not met|0|||
155149492|NCT01384734|559980237|FG001|Overall Study|Continuation criteria not met|0|||
155149493|NCT01384734|559980238|FG002|Overall Study|Continuation criteria not met|1|||
155149494|NCT01384734|559980239|FG003|Overall Study|Continuation criteria not met|1|||
155149495|NCT01384734|559980240|FG004|Overall Study|Continuation criteria not met|0|||
155149496|NCT01384734|559980236|FG000|Overall Study|Lack of Efficacy|3|||
155149497|NCT01384734|559980237|FG001|Overall Study|Lack of Efficacy|7|||
155149498|NCT01384734|559980238|FG002|Overall Study|Lack of Efficacy|4|||
155149499|NCT01384734|559980239|FG003|Overall Study|Lack of Efficacy|4|||
155149500|NCT01384734|559980240|FG004|Overall Study|Lack of Efficacy|2|||
155149501|NCT01384734|559980236|FG000|Overall Study|Lost to Follow-up|5|||
155149502|NCT01384734|559980237|FG001|Overall Study|Lost to Follow-up|3|||
155149503|NCT01384734|559980238|FG002|Overall Study|Lost to Follow-up|3|||
155149504|NCT01384734|559980239|FG003|Overall Study|Lost to Follow-up|8|||
155149505|NCT01384734|559980240|FG004|Overall Study|Lost to Follow-up|5|||
155149506|NCT01384734|559980236|FG000|Overall Study|Non-compliance with study drug|1|||
155149507|NCT01384734|559980237|FG001|Overall Study|Non-compliance with study drug|2|||
155149508|NCT01384734|559980238|FG002|Overall Study|Non-compliance with study drug|6|||
155149509|NCT01384734|559980239|FG003|Overall Study|Non-compliance with study drug|0|||
155149510|NCT01384734|559980240|FG004|Overall Study|Non-compliance with study drug|2|||
155149511|NCT01384734|559980236|FG000|Overall Study|Pregnancy|0|||
155149512|NCT01384734|559980237|FG001|Overall Study|Pregnancy|1|||
155149513|NCT01384734|559980238|FG002|Overall Study|Pregnancy|0|||
155149514|NCT01384734|559980239|FG003|Overall Study|Pregnancy|0|||
155149515|NCT01384734|559980240|FG004|Overall Study|Pregnancy|1|||
155149516|NCT01384734|559980236|FG000|Overall Study|Sponsor terminated|0|||
155149517|NCT01384734|559980237|FG001|Overall Study|Sponsor terminated|0|||
155149518|NCT01384734|559980238|FG002|Overall Study|Sponsor terminated|0|||
155149519|NCT01384734|559980239|FG003|Overall Study|Sponsor terminated|0|||
155149520|NCT01384734|559980240|FG004|Overall Study|Sponsor terminated|1|||
155149521|NCT01384734|559980236|FG000|Overall Study|Withdrawal by Subject|5|||
155149522|NCT01384734|559980237|FG001|Overall Study|Withdrawal by Subject|5|||
155149523|NCT01384734|559980238|FG002|Overall Study|Withdrawal by Subject|6|||
155149524|NCT01384734|559980239|FG003|Overall Study|Withdrawal by Subject|7|||
155149525|NCT01384734|559980240|FG004|Overall Study|Withdrawal by Subject|9|||
155149526|NCT01384734|559980236|FG000|Overall Study|Investigator relocating|0|||
155149527|NCT01384734|559980237|FG001|Overall Study|Investigator relocating|2|||
155149528|NCT01384734|559980238|FG002|Overall Study|Investigator relocating|0|||
155149529|NCT01384734|559980239|FG003|Overall Study|Investigator relocating|3|||
155149530|NCT01384734|559980240|FG004|Overall Study|Investigator relocating|1|||
155149531|NCT01384734|559980236|FG000|Overall Study|Unable to come back for visit|1|||
155149532|NCT01384734|559980237|FG001|Overall Study|Unable to come back for visit|0|||
155149533|NCT01384734|559980238|FG002|Overall Study|Unable to come back for visit|1|||
155149534|NCT01384734|559980239|FG003|Overall Study|Unable to come back for visit|1|||
155149535|NCT01384734|559980240|FG004|Overall Study|Unable to come back for visit|0|||
155149536|NCT01384734|559980236|FG000|Overall Study|Prison|0|||
155149537|NCT01384734|559980237|FG001|Overall Study|Prison|0|||
155149538|NCT01384734|559980238|FG002|Overall Study|Prison|1|||
155149539|NCT01384734|559980239|FG003|Overall Study|Prison|0|||
155149540|NCT01384734|559980240|FG004|Overall Study|Prison|0|||
155149541|NCT01384734|559980236|FG000|Overall Study|As per Exclusion criteria|0|||
155149542|NCT01384734|559980237|FG001|Overall Study|As per Exclusion criteria|1|||
155149543|NCT01384734|559980238|FG002|Overall Study|As per Exclusion criteria|0|||
155149544|NCT01384734|559980239|FG003|Overall Study|As per Exclusion criteria|0|||
155149545|NCT01384734|559980240|FG004|Overall Study|As per Exclusion criteria|0|||
155149546|NCT01384734|559980236|FG000|Overall Study|Missed End of treatment visit|0|||
155149547|NCT01384734|559980237|FG001|Overall Study|Missed End of treatment visit|0|||
155149548|NCT01384734|559980238|FG002|Overall Study|Missed End of treatment visit|0|||
155149549|NCT01384734|559980239|FG003|Overall Study|Missed End of treatment visit|1|||
155149550|NCT01384734|559980240|FG004|Overall Study|Missed End of treatment visit|0|||
155149551|NCT01384734|559980236|FG000|Overall Study|Adhesion problem|0|||
155149552|NCT01384734|559980237|FG001|Overall Study|Adhesion problem|0|||
155149553|NCT01384734|559980238|FG002|Overall Study|Adhesion problem|0|||
155149554|NCT01384734|559980239|FG003|Overall Study|Adhesion problem|1|||
155149555|NCT01384734|559980240|FG004|Overall Study|Adhesion problem|0|||
155149556|NCT01384734|559980236|FG000|Overall Study|Early termination|0|||
155149557|NCT01384734|559980237|FG001|Overall Study|Early termination|0|||
155149558|NCT01384734|559980238|FG002|Overall Study|Early termination|0|||
155149559|NCT01384734|559980239|FG003|Overall Study|Early termination|0|||
155149560|NCT01384734|559980240|FG004|Overall Study|Early termination|1|||
155149561|NCT01384734|559980236|FG000|Overall Study|Physician Decision|1|||
155149562|NCT01384734|559980237|FG001|Overall Study|Physician Decision|0|||
155149563|NCT01384734|559980238|FG002|Overall Study|Physician Decision|0|||
155149564|NCT01384734|559980239|FG003|Overall Study|Physician Decision|0|||
155149565|NCT01384734|559980240|FG004|Overall Study|Physician Decision|0|||
155149566|NCT02922725|559980241|FG000|Overall Study|Withdrawal by Subject|1|||
155149567|NCT02922725|559980242|FG001|Overall Study|Withdrawal by Subject|0|||
155149568|NCT02922725|559980243|FG002|Overall Study|Withdrawal by Subject|0|||
155149569|NCT01300234|559980244|FG000|Overall Study|Adverse Event|1|||
155149570|NCT01300234|559980245|FG001|Overall Study|Adverse Event|1|||
155149571|NCT01300234|559980244|FG000|Overall Study|Protocol Violation|2|||
155149572|NCT01300234|559980245|FG001|Overall Study|Protocol Violation|3|||
155149573|NCT01300234|559980244|FG000|Overall Study|Withdrawal by Subject|5|||
155149574|NCT01300234|559980245|FG001|Overall Study|Withdrawal by Subject|9|||
155149575|NCT01300234|559980244|FG000|Overall Study|Lost to Follow-up|14|||
155149576|NCT01300234|559980245|FG001|Overall Study|Lost to Follow-up|12|||
155149577|NCT01300234|559980244|FG000|Overall Study|Pregnancy|2|||
155149578|NCT01300234|559980245|FG001|Overall Study|Pregnancy|1|||
155149579|NCT01300234|559980244|FG000|Overall Study|Participant reached stopping critera|2|||
155149580|NCT01300234|559980245|FG001|Overall Study|Participant reached stopping critera|0|||
155149581|NCT01300234|559980244|FG000|Overall Study|Participant stopped medication|1|||
155149582|NCT01300234|559980245|FG001|Overall Study|Participant stopped medication|1|||
155149583|NCT01300234|559980244|FG000|Overall Study|Participant refused return to hospital|1|||
155149584|NCT01300234|559980245|FG001|Overall Study|Participant refused return to hospital|0|||
155149585|NCT04612725|559980247|FG000|Overall Study|Adverse Event|1|||
155149586|NCT04612725|559980248|FG001|Overall Study|Adverse Event|3|||
155149587|NCT04612725|559980249|FG002|Overall Study|Adverse Event|1|||
155149588|NCT04612725|559980250|FG003|Overall Study|Adverse Event|0|||
155149589|NCT04612725|559980251|FG004|Overall Study|Adverse Event|1|||
155149590|NCT04612725|559980247|FG000|Overall Study|Lost to Follow-up|0|||
155149591|NCT04612725|559980248|FG001|Overall Study|Lost to Follow-up|1|||
155149592|NCT04612725|559980249|FG002|Overall Study|Lost to Follow-up|0|||
155149593|NCT04612725|559980250|FG003|Overall Study|Lost to Follow-up|0|||
155149594|NCT04612725|559980251|FG004|Overall Study|Lost to Follow-up|0|||
155149595|NCT04612725|559980247|FG000|Overall Study|Physician Decision|2|||
155149596|NCT04612725|559980248|FG001|Overall Study|Physician Decision|0|||
155149597|NCT04612725|559980249|FG002|Overall Study|Physician Decision|0|||
155149598|NCT04612725|559980250|FG003|Overall Study|Physician Decision|0|||
155149599|NCT04612725|559980251|FG004|Overall Study|Physician Decision|0|||
155149600|NCT04612725|559980247|FG000|Overall Study|Study terminated by sponsor|3|||
155149601|NCT04612725|559980248|FG001|Overall Study|Study terminated by sponsor|1|||
155149602|NCT04612725|559980249|FG002|Overall Study|Study terminated by sponsor|2|||
155149603|NCT04612725|559980250|FG003|Overall Study|Study terminated by sponsor|4|||
155149604|NCT04612725|559980251|FG004|Overall Study|Study terminated by sponsor|5|||
155149605|NCT04612725|559980247|FG000|Overall Study|Withdrawal by Subject|8|||
155149606|NCT04612725|559980248|FG001|Overall Study|Withdrawal by Subject|3|||
155149607|NCT04612725|559980249|FG002|Overall Study|Withdrawal by Subject|5|||
155149608|NCT04612725|559980250|FG003|Overall Study|Withdrawal by Subject|1|||
155149609|NCT04612725|559980251|FG004|Overall Study|Withdrawal by Subject|9|||
155149610|NCT04612725|559980247|FG000|Overall Study|Other|0|||
155149611|NCT04612725|559980248|FG001|Overall Study|Other|0|||
155149612|NCT04612725|559980249|FG002|Overall Study|Other|0|||
155149613|NCT04612725|559980250|FG003|Overall Study|Other|0|||
155149614|NCT04612725|559980251|FG004|Overall Study|Other|1|||
155149615|NCT01928927|559980252|FG000|Overall Study|Lost to Follow-up|1|||
155149616|NCT01928927|559980253|FG001|Overall Study|Lost to Follow-up|0|||
155149617|NCT01928927|559980252|FG000|Overall Study|Withdrawal by Subject|1|||
155149618|NCT01928927|559980253|FG001|Overall Study|Withdrawal by Subject|1|||
155149619|NCT02775916|559980254|FG000|Overall Study|Adverse Event|1|||
155149620|NCT02775916|559980255|FG001|Overall Study|Adverse Event|0|||
155149621|NCT02775916|559980254|FG000|Overall Study|Subject/Guardian Decision|2|||
155149622|NCT02775916|559980255|FG001|Overall Study|Subject/Guardian Decision|0|||
155149623|NCT03409796|559981705|FG000|Overall Study|Adverse Event|2|||
155149624|NCT03409796|559981706|FG001|Overall Study|Adverse Event|0|||
155196719|NCT02100514|560158401|FG003|Treatment Period|Death|0|||
155196720|NCT02100514|560158402|FG004|Treatment Period|Death|0|||
155196721|NCT02100514|560158398|FG000|Treatment Period|Lost to Follow-up|5|||
155196722|NCT02100514|560158399|FG001|Treatment Period|Lost to Follow-up|17|||
155196723|NCT02100514|560158400|FG002|Treatment Period|Lost to Follow-up|0|||
155196724|NCT02100514|560158401|FG003|Treatment Period|Lost to Follow-up|0|||
155196725|NCT02100514|560158402|FG004|Treatment Period|Lost to Follow-up|0|||
155196726|NCT02100514|560158398|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
155196727|NCT02100514|560158399|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
155196728|NCT02100514|560158400|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
155149625|NCT03409796|559981705|FG000|Overall Study|Other|0|||
155149626|NCT03409796|559981706|FG001|Overall Study|Other|1|||
155149627|NCT00179621|559981707|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
155149628|NCT00179621|559981708|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
155149629|NCT00179621|559981709|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
155149630|NCT00179621|559981710|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
155149631|NCT00179621|559981707|FG000|Double-Blind Period|Adverse Event|2|||
155149632|NCT00179621|559981708|FG001|Double-Blind Period|Adverse Event|7|||
155149633|NCT00179621|559981709|FG002|Double-Blind Period|Adverse Event|4|||
155149634|NCT00179621|559981710|FG003|Double-Blind Period|Adverse Event|0|||
155149635|NCT00179621|559981707|FG000|Double-Blind Period|Withdrawal by Subject|2|||
155149636|NCT00179621|559981708|FG001|Double-Blind Period|Withdrawal by Subject|1|||
155149637|NCT00179621|559981709|FG002|Double-Blind Period|Withdrawal by Subject|3|||
155149638|NCT00179621|559981710|FG003|Double-Blind Period|Withdrawal by Subject|0|||
155149639|NCT00179621|559981707|FG000|Double-Blind Period|Death|0|||
155149640|NCT00179621|559981708|FG001|Double-Blind Period|Death|1|||
155149641|NCT00179621|559981709|FG002|Double-Blind Period|Death|2|||
155149642|NCT00179621|559981710|FG003|Double-Blind Period|Death|0|||
155149643|NCT00179621|559981707|FG000|Double-Blind Period|Protocol Violation|1|||
155149644|NCT00179621|559981708|FG001|Double-Blind Period|Protocol Violation|0|||
155149645|NCT00179621|559981709|FG002|Double-Blind Period|Protocol Violation|0|||
155149646|NCT00179621|559981710|FG003|Double-Blind Period|Protocol Violation|0|||
155149647|NCT00179621|559981707|FG000|Double-Blind Period|Other|0|||
155149648|NCT00179621|559981708|FG001|Double-Blind Period|Other|2|||
155149649|NCT00179621|559981709|FG002|Double-Blind Period|Other|2|||
155149650|NCT00179621|559981710|FG003|Double-Blind Period|Other|0|||
155149651|NCT00179621|559981707|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
155149652|NCT00179621|559981708|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
155149653|NCT00179621|559981709|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
155149654|NCT00179621|559981710|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
155149655|NCT00179621|559981707|FG000|Open-Label Period|Adverse Event|0|||
155149656|NCT00179621|559981708|FG001|Open-Label Period|Adverse Event|6|||
155149657|NCT00179621|559981709|FG002|Open-Label Period|Adverse Event|5|||
155149658|NCT00179621|559981710|FG003|Open-Label Period|Adverse Event|6|||
155149659|NCT00179621|559981707|FG000|Open-Label Period|Withdrawal by Subject|0|||
155149660|NCT00179621|559981708|FG001|Open-Label Period|Withdrawal by Subject|2|||
155149661|NCT00179621|559981709|FG002|Open-Label Period|Withdrawal by Subject|2|||
155149662|NCT00179621|559981710|FG003|Open-Label Period|Withdrawal by Subject|2|||
155149663|NCT00179621|559981707|FG000|Open-Label Period|Death|0|||
155149664|NCT00179621|559981708|FG001|Open-Label Period|Death|0|||
155149665|NCT00179621|559981709|FG002|Open-Label Period|Death|1|||
155149666|NCT00179621|559981710|FG003|Open-Label Period|Death|2|||
155149667|NCT00179621|559981707|FG000|Open-Label Period|Other|0|||
155149668|NCT00179621|559981708|FG001|Open-Label Period|Other|1|||
155149669|NCT00179621|559981709|FG002|Open-Label Period|Other|1|||
155149670|NCT00179621|559981710|FG003|Open-Label Period|Other|2|||
155149671|NCT02973100|559981711|FG000|Overall Study|Adverse Event|1|||
155149672|NCT02973100|559981712|FG001|Overall Study|Adverse Event|2|||
155149673|NCT02973100|559981713|FG002|Overall Study|Adverse Event|1|||
155149674|NCT02973100|559981714|FG003|Overall Study|Adverse Event|2|||
155149675|NCT02973100|559981711|FG000|Overall Study|Lost to Follow-up|3|||
155149676|NCT02973100|559981712|FG001|Overall Study|Lost to Follow-up|1|||
155149677|NCT02973100|559981713|FG002|Overall Study|Lost to Follow-up|1|||
155149678|NCT02973100|559981714|FG003|Overall Study|Lost to Follow-up|0|||
155149679|NCT02973100|559981711|FG000|Overall Study|Withdrawal by Subject|3|||
155149680|NCT02973100|559981712|FG001|Overall Study|Withdrawal by Subject|5|||
155149681|NCT02973100|559981713|FG002|Overall Study|Withdrawal by Subject|1|||
155149682|NCT02973100|559981714|FG003|Overall Study|Withdrawal by Subject|4|||
155149683|NCT02973100|559981711|FG000|Overall Study|Notification of change in address|0|||
155149684|NCT02973100|559981712|FG001|Overall Study|Notification of change in address|0|||
155149685|NCT02973100|559981713|FG002|Overall Study|Notification of change in address|0|||
155196729|NCT02100514|560158401|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
155196730|NCT02100514|560158402|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
155149686|NCT02973100|559981714|FG003|Overall Study|Notification of change in address|1|||
155149687|NCT02973100|559981711|FG000|Overall Study|Failed to attend Safety followup period|0|||
155196731|NCT02100514|560158398|FG000|Treatment Period|Protocol Violation|1|||
155149688|NCT02973100|559981712|FG001|Overall Study|Failed to attend Safety followup period|0|||
155149689|NCT02973100|559981713|FG002|Overall Study|Failed to attend Safety followup period|1|||
155196732|NCT02100514|560158399|FG001|Treatment Period|Protocol Violation|1|||
155196733|NCT02100514|560158400|FG002|Treatment Period|Protocol Violation|0|||
155196734|NCT02100514|560158401|FG003|Treatment Period|Protocol Violation|0|||
155196735|NCT02100514|560158402|FG004|Treatment Period|Protocol Violation|0|||
155196736|NCT02100514|560158398|FG000|Treatment Period|Withdrawal by Subject|12|||
155196737|NCT02100514|560158399|FG001|Treatment Period|Withdrawal by Subject|37|||
155196738|NCT02100514|560158400|FG002|Treatment Period|Withdrawal by Subject|0|||
155196739|NCT02100514|560158401|FG003|Treatment Period|Withdrawal by Subject|0|||
155196740|NCT02100514|560158402|FG004|Treatment Period|Withdrawal by Subject|0|||
155196741|NCT02100514|560158398|FG000|Treatment Period|Other|9|||
155196742|NCT02100514|560158399|FG001|Treatment Period|Other|11|||
155196743|NCT02100514|560158400|FG002|Treatment Period|Other|0|||
155196744|NCT02100514|560158401|FG003|Treatment Period|Other|0|||
155196745|NCT02100514|560158402|FG004|Treatment Period|Other|0|||
155196746|NCT02100514|560158398|FG000|Extension Period|Withdrew consent|0|||
155196747|NCT02100514|560158399|FG001|Extension Period|Withdrew consent|0|||
155196748|NCT02100514|560158400|FG002|Extension Period|Withdrew consent|2|||
155196749|NCT02100514|560158401|FG003|Extension Period|Withdrew consent|0|||
155196750|NCT02100514|560158402|FG004|Extension Period|Withdrew consent|0|||
155196751|NCT02248701|560158405|FG000|Overall Study|Withdrawal by Subject|2|||
155196752|NCT02248701|560158406|FG001|Overall Study|Withdrawal by Subject|1|||
155196753|NCT02248701|560158405|FG000|Overall Study|Physician Decision|0|||
155196754|NCT02248701|560158406|FG001|Overall Study|Physician Decision|1|||
155196755|NCT02248701|560158405|FG000|Overall Study|Adverse Event|1|||
155196756|NCT02248701|560158406|FG001|Overall Study|Adverse Event|0|||
155196757|NCT02248701|560158405|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
155196758|NCT02248701|560158406|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
155149690|NCT02973100|559981714|FG003|Overall Study|Failed to attend Safety followup period|0|||
155149691|NCT04233801|559981716|FG000|Overall Study|Other than listed|0|||
155149692|NCT04233801|559981717|FG001|Overall Study|Other than listed|0|||
155149693|NCT04233801|559981718|FG002|Overall Study|Other than listed|1|||
155149694|NCT04233801|559981716|FG000|Overall Study|Withdrawal by Subject|0|||
155149695|NCT04233801|559981717|FG001|Overall Study|Withdrawal by Subject|2|||
155196759|NCT00319553|560158409|FG000|Overall Study|Protocol Violation|1|||
155196760|NCT00319553|560158410|FG001|Overall Study|Protocol Violation|2|||
155196761|NCT00319553|560158409|FG000|Overall Study|Lost to Follow-up|2|||
155196762|NCT00319553|560158410|FG001|Overall Study|Lost to Follow-up|1|||
155196763|NCT00319553|560158409|FG000|Overall Study|Withdrawal by Subject|1|||
155196764|NCT00319553|560158410|FG001|Overall Study|Withdrawal by Subject|1|||
155196765|NCT01896102|560158411|FG000|Overall Study|Death|1|||
155196766|NCT01896102|560158411|FG000|Overall Study|Participant to receive allogenic transplant|2|||
155196767|NCT00762385|560158414|FG000|First Intervention|Lens Issue|1|||
155196768|NCT00762385|560158415|FG001|First Intervention|Lens Issue|1|||
155196769|NCT00762385|560158414|FG000|First Intervention|Lost to Follow-up|0|||
155196770|NCT00762385|560158415|FG001|First Intervention|Lost to Follow-up|2|||
155196771|NCT00762385|560158414|FG000|First Intervention|Ineligible|1|||
155196772|NCT00762385|560158415|FG001|First Intervention|Ineligible|0|||
155196773|NCT00762385|560158414|FG000|First Intervention|Protocol Violation|0|||
155196774|NCT00762385|560158415|FG001|First Intervention|Protocol Violation|1|||
155196775|NCT00762385|560158414|FG000|Second Intervention|Protocol Violation|3|||
155149696|NCT04233801|559981718|FG002|Overall Study|Withdrawal by Subject|3|||
155149697|NCT02173769|559981719|FG000|Overall Study|Protocol Violation|4|||
155149698|NCT01453049|559981720|FG000|Overall Study|Protocol Violation|2|||
155149699|NCT01453049|559981721|FG001|Overall Study|Protocol Violation|5|||
155149700|NCT01453049|559981720|FG000|Overall Study|Lost to Follow-up|2|||
155149701|NCT01453049|559981721|FG001|Overall Study|Lost to Follow-up|1|||
155149702|NCT01453049|559981720|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
155149703|NCT01453049|559981721|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
155149704|NCT01453049|559981720|FG000|Overall Study|Withdrawal by Subject|1|||
155149705|NCT01453049|559981721|FG001|Overall Study|Withdrawal by Subject|0|||
155149706|NCT01453049|559981720|FG000|Overall Study|Randomized in Error|1|||
155149707|NCT01453049|559981721|FG001|Overall Study|Randomized in Error|0|||
155149708|NCT02421172|559981722|FG000|Period 1|Adverse Event|1|||
155196776|NCT00762385|560158415|FG001|Second Intervention|Protocol Violation|3|||
155149709|NCT02421172|559981723|FG001|Period 1|Adverse Event|0|||
155149710|NCT02421172|559981724|FG002|Period 1|Adverse Event|0|||
155149711|NCT02421172|559981725|FG003|Period 1|Adverse Event|0|||
155149712|NCT02421172|559981726|FG004|Period 1|Adverse Event|0|||
155149713|NCT02421172|559981722|FG000|Period 1|Lost to Follow-up|3|||
155149714|NCT02421172|559981723|FG001|Period 1|Lost to Follow-up|1|||
155196777|NCT00591344|560158417|FG000|Overall Study|Transportation issues|1|||
155196778|NCT00591344|560158418|FG001|Overall Study|Transportation issues|0|||
155196779|NCT00591344|560158417|FG000|Overall Study|Moved out of state|1|||
155196780|NCT00591344|560158418|FG001|Overall Study|Moved out of state|0|||
155196781|NCT00591344|560158417|FG000|Overall Study|Medical complications|1|||
155196782|NCT00591344|560158418|FG001|Overall Study|Medical complications|3|||
155196783|NCT00591344|560158417|FG000|Overall Study|Underwent DBS|2|||
155196784|NCT00591344|560158418|FG001|Overall Study|Underwent DBS|2|||
155196785|NCT00591344|560158417|FG000|Overall Study|Death|0|||
155196786|NCT00591344|560158418|FG001|Overall Study|Death|1|||
155196787|NCT00591344|560158417|FG000|Overall Study|Lost to Follow-up|0|||
155196788|NCT00591344|560158418|FG001|Overall Study|Lost to Follow-up|1|||
155196789|NCT00591344|560158417|FG000|Overall Study|Did not want to come off medication|0|||
155196790|NCT00591344|560158418|FG001|Overall Study|Did not want to come off medication|1|||
155196791|NCT03863197|560158419|FG000|Overall Study|Lost to Follow-up|2|||
155196792|NCT03863197|560158420|FG001|Overall Study|Lost to Follow-up|3|||
155196793|NCT03863197|560158419|FG000|Overall Study|Withdrawal by Subject|4|||
155196794|NCT03863197|560158420|FG001|Overall Study|Withdrawal by Subject|0|||
155196795|NCT03863197|560158419|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
155196796|NCT03863197|560158420|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
155196797|NCT01065597|560158421|FG000|Overall Study|Adverse Event|1|||
155196798|NCT01781975|560158422|FG000|Overall Study|Death|1|||
155196799|NCT01781975|560158423|FG001|Overall Study|Death|0|||
155196800|NCT01781975|560158422|FG000|Overall Study|Withdrawal by Subject|1|||
155196801|NCT01781975|560158423|FG001|Overall Study|Withdrawal by Subject|1|||
155196802|NCT01622231|560158424|FG000|Overall Study|Physician Decision|1|||
155196803|NCT01622231|560158424|FG000|Overall Study|Withdrawal by Subject|1|||
155196804|NCT02329080|560158425|FG000|Overall Study|Adverse Event|1|||
155196805|NCT02329080|560158425|FG000|Overall Study|Death|4|||
155196806|NCT02329080|560158425|FG000|Overall Study|Lack of Efficacy|22|||
155196807|NCT02329080|560158425|FG000|Overall Study|Lost to Follow-up|1|||
155196808|NCT02329080|560158425|FG000|Overall Study|Physician Decision|2|||
155196809|NCT02329080|560158425|FG000|Overall Study|Partial response|4|||
155196810|NCT02329080|560158425|FG000|Overall Study|Complete response|4|||
155196811|NCT00973674|560158428|FG000|Overall Study|Protocol Violation|2|||
155196812|NCT00973674|560158429|FG001|Overall Study|Protocol Violation|0|||
155196813|NCT03082261|560158436|FG000|Overall Study|Death|4|||
155196814|NCT03082261|560158436|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
155196815|NCT03082261|560158436|FG000|Overall Study|Insurance denial|1|||
155196816|NCT03082261|560158436|FG000|Overall Study|Peripheral lead added|1|||
155196817|NCT03082261|560158436|FG000|Overall Study|Withdrawal by Subject|40|||
155196818|NCT03082261|560158436|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
155196819|NCT03082261|560158436|FG000|Overall Study|Subject implanted with device other than study device|1|||
155196820|NCT03082261|560158436|FG000|Overall Study|Lost to Follow-up|14|||
155196821|NCT03082261|560158436|FG000|Overall Study|Subject moved to a different state|1|||
155196822|NCT03082261|560158436|FG000|Overall Study|Subject non-compliance|2|||
155196823|NCT03082261|560158436|FG000|Overall Study|Subject participation terminated by investigator|9|||
155196824|NCT03082261|560158436|FG000|Overall Study|Subject participation terminated by sponsor|4|||
155196825|NCT03082261|560158436|FG000|Overall Study|System explant|19|||
155196826|NCT03082261|560158436|FG000|Overall Study|Unable to place lead(s)|2|||
155196827|NCT03082261|560158436|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
155196828|NCT00839852|560158437|FG000|Overall Study|Adverse Event|10|||
155196829|NCT00839852|560158437|FG000|Overall Study|Insufficient Therapeutic Response|3|||
155196830|NCT00839852|560158437|FG000|Overall Study|Protocol Violation|9|||
155196831|NCT00839852|560158437|FG000|Overall Study|Withdrawal of Consent|16|||
155196832|NCT00839852|560158437|FG000|Overall Study|Lost to Follow-up|7|||
155196833|NCT00839852|560158437|FG000|Overall Study|Lack of Compliance While in Jail|1|||
155196834|NCT00839852|560158437|FG000|Overall Study|Pregnancy|1|||
155196835|NCT00494299|560158442|FG000|Overall Study|Adverse Event|93|||
155196836|NCT00494299|560158443|FG001|Overall Study|Adverse Event|13|||
155196837|NCT00494299|560158442|FG000|Overall Study|Lost to Follow-up|1|||
155196838|NCT00494299|560158443|FG001|Overall Study|Lost to Follow-up|0|||
155196839|NCT00494299|560158442|FG000|Overall Study|Physician Decision|0|||
155196840|NCT00494299|560158443|FG001|Overall Study|Physician Decision|2|||
155196841|NCT00494299|560158442|FG000|Overall Study|Protocol Violation|1|||
155196842|NCT00494299|560158443|FG001|Overall Study|Protocol Violation|2|||
155196843|NCT00494299|560158442|FG000|Overall Study|Withdrawal by Subject|8|||
155196844|NCT00494299|560158443|FG001|Overall Study|Withdrawal by Subject|3|||
155196845|NCT00494299|560158442|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
155196846|NCT00494299|560158443|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
155196847|NCT00494299|560158442|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
155196848|NCT00494299|560158443|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
155196849|NCT00494299|560158442|FG000|Overall Study|Site Closed by Sponsor|6|||
155196850|NCT00494299|560158443|FG001|Overall Study|Site Closed by Sponsor|0|||
155196851|NCT00494299|560158442|FG000|Overall Study|Protocol Driven Decision Point|11|||
155196852|NCT00494299|560158443|FG001|Overall Study|Protocol Driven Decision Point|22|||
155196853|NCT01281137|560158445|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
155196854|NCT01281137|560158446|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
155196855|NCT01281137|560158445|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
155196856|NCT01281137|560158446|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
155196857|NCT01281137|560158445|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
155196858|NCT01281137|560158446|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
155196859|NCT01281137|560158445|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
155196860|NCT01281137|560158446|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
155196861|NCT01281137|560158445|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
155196862|NCT01281137|560158446|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
155196863|NCT02846324|560158449|FG000|Overall Study|Other|1|||
155196864|NCT02846324|560158450|FG001|Overall Study|Other|0|||
155196865|NCT02846324|560158451|FG002|Overall Study|Other|0|||
155196866|NCT02846324|560158452|FG003|Overall Study|Other|0|||
155196867|NCT02846324|560158449|FG000|Overall Study|Withdrawal by Subject|1|||
155196868|NCT02846324|560158450|FG001|Overall Study|Withdrawal by Subject|0|||
155196869|NCT02846324|560158451|FG002|Overall Study|Withdrawal by Subject|4|||
155196870|NCT02846324|560158452|FG003|Overall Study|Withdrawal by Subject|0|||
155196871|NCT03822182|560158457|FG000|Overall Study|Protocol Violation|0|||
155196872|NCT03822182|560158458|FG001|Overall Study|Protocol Violation|1|||
155196873|NCT03822182|560158459|FG002|Overall Study|Protocol Violation|1|||
155196874|NCT00810355|560158460|FG000|Overall Study|Lost to Follow-up|13|||
155196875|NCT00810355|560158461|FG001|Overall Study|Lost to Follow-up|17|||
155196876|NCT00810355|560158462|FG002|Overall Study|Lost to Follow-up|11|||
155196877|NCT00810355|560158460|FG000|Overall Study|Withdrawal by Subject|1|||
155196878|NCT00810355|560158461|FG001|Overall Study|Withdrawal by Subject|0|||
155196879|NCT00810355|560158462|FG002|Overall Study|Withdrawal by Subject|0|||
155196880|NCT02130297|560158469|FG000|Overall Study|Lost to Follow-up|4|||
155196881|NCT00347360|560158480|FG000|Overall Study|Adverse Event|1|||
155196882|NCT00347360|560158481|FG001|Overall Study|Adverse Event|2|||
155196883|NCT00347360|560158482|FG002|Overall Study|Adverse Event|0|||
155196884|NCT00347360|560158483|FG003|Overall Study|Adverse Event|4|||
155196885|NCT00347360|560158484|FG004|Overall Study|Adverse Event|1|||
155196886|NCT00347360|560158485|FG005|Overall Study|Adverse Event|2|||
155196887|NCT00347360|560158486|FG006|Overall Study|Adverse Event|2|||
155196888|NCT00347360|560158487|FG007|Overall Study|Adverse Event|0|||
155196889|NCT00347360|560158488|FG008|Overall Study|Adverse Event|2|||
155196890|NCT00347360|560158489|FG009|Overall Study|Adverse Event|3|||
155196891|NCT00347360|560158490|FG010|Overall Study|Adverse Event|3|||
155196892|NCT00347360|560158491|FG011|Overall Study|Adverse Event|1|||
155196893|NCT00347360|560158492|FG012|Overall Study|Adverse Event|3|||
155196894|NCT00347360|560158493|FG013|Overall Study|Adverse Event|2|||
155196895|NCT00347360|560158494|FG014|Overall Study|Adverse Event|2|||
155196896|NCT00347360|560158480|FG000|Overall Study|Lost to Follow-up|0|||
155196897|NCT00347360|560158481|FG001|Overall Study|Lost to Follow-up|0|||
155196898|NCT00347360|560158482|FG002|Overall Study|Lost to Follow-up|0|||
155196899|NCT00347360|560158483|FG003|Overall Study|Lost to Follow-up|2|||
155196900|NCT00347360|560158484|FG004|Overall Study|Lost to Follow-up|1|||
155196901|NCT00347360|560158485|FG005|Overall Study|Lost to Follow-up|1|||
155196902|NCT00347360|560158486|FG006|Overall Study|Lost to Follow-up|0|||
155196903|NCT00347360|560158487|FG007|Overall Study|Lost to Follow-up|1|||
155196904|NCT00347360|560158488|FG008|Overall Study|Lost to Follow-up|1|||
155196905|NCT00347360|560158489|FG009|Overall Study|Lost to Follow-up|2|||
155196906|NCT00347360|560158490|FG010|Overall Study|Lost to Follow-up|0|||
155196907|NCT00347360|560158491|FG011|Overall Study|Lost to Follow-up|0|||
155196908|NCT00347360|560158492|FG012|Overall Study|Lost to Follow-up|1|||
155196909|NCT00347360|560158493|FG013|Overall Study|Lost to Follow-up|0|||
155196910|NCT00347360|560158494|FG014|Overall Study|Lost to Follow-up|0|||
155196911|NCT00347360|560158480|FG000|Overall Study|Protocol Violation|2|||
155196912|NCT00347360|560158481|FG001|Overall Study|Protocol Violation|3|||
155196913|NCT00347360|560158482|FG002|Overall Study|Protocol Violation|1|||
155196914|NCT00347360|560158483|FG003|Overall Study|Protocol Violation|2|||
155196915|NCT00347360|560158484|FG004|Overall Study|Protocol Violation|1|||
155196916|NCT00347360|560158485|FG005|Overall Study|Protocol Violation|2|||
155196917|NCT00347360|560158486|FG006|Overall Study|Protocol Violation|0|||
155196918|NCT00347360|560158487|FG007|Overall Study|Protocol Violation|0|||
155196919|NCT00347360|560158488|FG008|Overall Study|Protocol Violation|1|||
155196920|NCT00347360|560158489|FG009|Overall Study|Protocol Violation|2|||
155196921|NCT00347360|560158490|FG010|Overall Study|Protocol Violation|0|||
155196922|NCT00347360|560158491|FG011|Overall Study|Protocol Violation|0|||
155196923|NCT00347360|560158492|FG012|Overall Study|Protocol Violation|0|||
155196924|NCT00347360|560158493|FG013|Overall Study|Protocol Violation|1|||
155196925|NCT00347360|560158494|FG014|Overall Study|Protocol Violation|0|||
155196926|NCT00347360|560158480|FG000|Overall Study|Withdrawal by Subject|0|||
155196927|NCT00347360|560158481|FG001|Overall Study|Withdrawal by Subject|1|||
155196928|NCT00347360|560158482|FG002|Overall Study|Withdrawal by Subject|2|||
155196929|NCT00347360|560158483|FG003|Overall Study|Withdrawal by Subject|4|||
155196930|NCT00347360|560158484|FG004|Overall Study|Withdrawal by Subject|1|||
155196931|NCT00347360|560158485|FG005|Overall Study|Withdrawal by Subject|2|||
155149715|NCT02421172|559981724|FG002|Period 1|Lost to Follow-up|0|||
155149716|NCT02421172|559981725|FG003|Period 1|Lost to Follow-up|0|||
155149717|NCT02421172|559981726|FG004|Period 1|Lost to Follow-up|0|||
155149718|NCT02421172|559981722|FG000|Period 1|Patient/guardian decision|0|||
155149719|NCT02421172|559981723|FG001|Period 1|Patient/guardian decision|1|||
155149720|NCT02421172|559981724|FG002|Period 1|Patient/guardian decision|0|||
155149721|NCT02421172|559981725|FG003|Period 1|Patient/guardian decision|0|||
155149722|NCT02421172|559981726|FG004|Period 1|Patient/guardian decision|0|||
155149723|NCT02421172|559981722|FG000|Period 2|Adverse Event|0|||
155149724|NCT02421172|559981723|FG001|Period 2|Adverse Event|0|||
155149725|NCT02421172|559981724|FG002|Period 2|Adverse Event|4|||
155149726|NCT02421172|559981725|FG003|Period 2|Adverse Event|0|||
155149727|NCT02421172|559981726|FG004|Period 2|Adverse Event|0|||
155149728|NCT02421172|559981722|FG000|Period 2|Lost to Follow-up|0|||
155149729|NCT02421172|559981723|FG001|Period 2|Lost to Follow-up|0|||
155149730|NCT02421172|559981724|FG002|Period 2|Lost to Follow-up|0|||
155149731|NCT02421172|559981725|FG003|Period 2|Lost to Follow-up|1|||
155149732|NCT02421172|559981726|FG004|Period 2|Lost to Follow-up|0|||
155149733|NCT02421172|559981722|FG000|Period 2|Patient/guardian decision|0|||
155149734|NCT02421172|559981723|FG001|Period 2|Patient/guardian decision|0|||
155149735|NCT02421172|559981724|FG002|Period 2|Patient/guardian decision|3|||
155149736|NCT02421172|559981725|FG003|Period 2|Patient/guardian decision|2|||
155149737|NCT02421172|559981726|FG004|Period 2|Patient/guardian decision|1|||
155149738|NCT03095651|559981729|FG000|Overall Study|Lost to Follow-up|1|||
155149739|NCT03095651|559981730|FG001|Overall Study|Lost to Follow-up|1|||
155149740|NCT03095651|559981731|FG002|Overall Study|Lost to Follow-up|0|||
155149741|NCT03095651|559981732|FG003|Overall Study|Lost to Follow-up|1|||
155149742|NCT03095651|559981733|FG004|Overall Study|Lost to Follow-up|0|||
155149743|NCT03095651|559981734|FG005|Overall Study|Lost to Follow-up|0|||
155149744|NCT03095651|559981735|FG006|Overall Study|Lost to Follow-up|0|||
155149745|NCT03095651|559981736|FG007|Overall Study|Lost to Follow-up|0|||
155149746|NCT03095651|559981729|FG000|Overall Study|Withdrawal by Subject|0|||
155149747|NCT03095651|559981730|FG001|Overall Study|Withdrawal by Subject|0|||
155149748|NCT03095651|559981731|FG002|Overall Study|Withdrawal by Subject|0|||
155149749|NCT03095651|559981732|FG003|Overall Study|Withdrawal by Subject|0|||
155149750|NCT03095651|559981733|FG004|Overall Study|Withdrawal by Subject|0|||
155149751|NCT03095651|559981734|FG005|Overall Study|Withdrawal by Subject|1|||
155149752|NCT03095651|559981735|FG006|Overall Study|Withdrawal by Subject|0|||
155149753|NCT03095651|559981736|FG007|Overall Study|Withdrawal by Subject|0|||
155149754|NCT02891174|559981740|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
155149755|NCT02891174|559981741|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
155149756|NCT02891174|559981740|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
155149757|NCT02891174|559981741|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
155149758|NCT02891174|559981740|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
155149759|NCT02891174|559981741|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
155149760|NCT02891174|559981740|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
155149761|NCT02891174|559981741|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
155149762|NCT02891174|559981740|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
155149763|NCT02891174|559981741|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
155149764|NCT02891174|559981740|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
155149765|NCT02891174|559981741|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
155149766|NCT02891174|559981740|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
155149767|NCT02891174|559981741|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
155149768|NCT04607668|559981748|FG000|Overall Study|Death|49|||
155149769|NCT04607668|559981749|FG001|Overall Study|Death|26|||
155149770|NCT04607668|559981748|FG000|Overall Study|Lost to Follow-up|3|||
155149771|NCT04607668|559981749|FG001|Overall Study|Lost to Follow-up|4|||
155149772|NCT04607668|559981748|FG000|Overall Study|Study terminated by Sponsor|92|||
155149773|NCT04607668|559981749|FG001|Overall Study|Study terminated by Sponsor|114|||
155149774|NCT04607668|559981748|FG000|Overall Study|Withdrawal by Subject|12|||
155149775|NCT04607668|559981749|FG001|Overall Study|Withdrawal by Subject|11|||
155149776|NCT04607668|559981748|FG000|Overall Study|Other, unspecified|8|||
155149777|NCT04607668|559981749|FG001|Overall Study|Other, unspecified|7|||
155149778|NCT02250326|559981750|FG000|Treatment|Death|1|||
155149779|NCT02250326|559981751|FG001|Treatment|Death|13|||
155149780|NCT02250326|559981752|FG002|Treatment|Death|2|||
155149781|NCT02250326|559981750|FG000|Treatment|Adverse Event|8|||
155149782|NCT02250326|559981751|FG001|Treatment|Adverse Event|8|||
155149783|NCT02250326|559981752|FG002|Treatment|Adverse Event|9|||
155149784|NCT02250326|559981750|FG000|Treatment|Progressive Disease|42|||
155149785|NCT02250326|559981751|FG001|Treatment|Progressive Disease|40|||
155149786|NCT02250326|559981752|FG002|Treatment|Progressive Disease|47|||
155149787|NCT02250326|559981750|FG000|Treatment|Symptomatic Deterioration|9|||
155149788|NCT02250326|559981751|FG001|Treatment|Symptomatic Deterioration|4|||
155149789|NCT02250326|559981752|FG002|Treatment|Symptomatic Deterioration|10|||
155149790|NCT02250326|559981750|FG000|Treatment|Withdrawal by Subject|11|||
155196932|NCT00347360|560158486|FG006|Overall Study|Withdrawal by Subject|1|||
155196933|NCT00347360|560158487|FG007|Overall Study|Withdrawal by Subject|1|||
155196934|NCT00347360|560158488|FG008|Overall Study|Withdrawal by Subject|1|||
155196935|NCT00347360|560158489|FG009|Overall Study|Withdrawal by Subject|1|||
155196936|NCT00347360|560158490|FG010|Overall Study|Withdrawal by Subject|0|||
155196937|NCT00347360|560158491|FG011|Overall Study|Withdrawal by Subject|3|||
155196938|NCT00347360|560158492|FG012|Overall Study|Withdrawal by Subject|4|||
155196939|NCT00347360|560158493|FG013|Overall Study|Withdrawal by Subject|2|||
155196940|NCT00347360|560158494|FG014|Overall Study|Withdrawal by Subject|1|||
155196941|NCT00347360|560158480|FG000|Overall Study|Lack of Efficacy|1|||
155196942|NCT00347360|560158481|FG001|Overall Study|Lack of Efficacy|1|||
155196943|NCT00347360|560158482|FG002|Overall Study|Lack of Efficacy|3|||
155196944|NCT00347360|560158483|FG003|Overall Study|Lack of Efficacy|1|||
155196945|NCT00347360|560158484|FG004|Overall Study|Lack of Efficacy|0|||
155196946|NCT00347360|560158485|FG005|Overall Study|Lack of Efficacy|1|||
155196947|NCT00347360|560158486|FG006|Overall Study|Lack of Efficacy|0|||
155196948|NCT00347360|560158487|FG007|Overall Study|Lack of Efficacy|1|||
155196949|NCT00347360|560158488|FG008|Overall Study|Lack of Efficacy|1|||
155196950|NCT00347360|560158489|FG009|Overall Study|Lack of Efficacy|0|||
155196951|NCT00347360|560158490|FG010|Overall Study|Lack of Efficacy|0|||
155196952|NCT00347360|560158491|FG011|Overall Study|Lack of Efficacy|0|||
155196953|NCT00347360|560158492|FG012|Overall Study|Lack of Efficacy|0|||
155196954|NCT00347360|560158493|FG013|Overall Study|Lack of Efficacy|0|||
155196955|NCT00347360|560158494|FG014|Overall Study|Lack of Efficacy|0|||
155196956|NCT00347360|560158480|FG000|Overall Study|Reason not listed/blank|1|||
155196957|NCT00347360|560158481|FG001|Overall Study|Reason not listed/blank|0|||
155196958|NCT00347360|560158482|FG002|Overall Study|Reason not listed/blank|0|||
155196959|NCT00347360|560158483|FG003|Overall Study|Reason not listed/blank|0|||
155196960|NCT00347360|560158484|FG004|Overall Study|Reason not listed/blank|0|||
155196961|NCT00347360|560158485|FG005|Overall Study|Reason not listed/blank|0|||
155196962|NCT00347360|560158486|FG006|Overall Study|Reason not listed/blank|1|||
155196963|NCT00347360|560158487|FG007|Overall Study|Reason not listed/blank|0|||
155196964|NCT00347360|560158488|FG008|Overall Study|Reason not listed/blank|0|||
155196965|NCT00347360|560158489|FG009|Overall Study|Reason not listed/blank|0|||
155196966|NCT00347360|560158490|FG010|Overall Study|Reason not listed/blank|0|||
155196967|NCT00347360|560158491|FG011|Overall Study|Reason not listed/blank|0|||
155196968|NCT00347360|560158492|FG012|Overall Study|Reason not listed/blank|0|||
155196969|NCT00347360|560158493|FG013|Overall Study|Reason not listed/blank|1|||
155196970|NCT00347360|560158494|FG014|Overall Study|Reason not listed/blank|0|||
155196971|NCT00347360|560158480|FG000|Overall Study|Per sponsors instruction|0|||
155196972|NCT00347360|560158481|FG001|Overall Study|Per sponsors instruction|1|||
155196973|NCT00347360|560158482|FG002|Overall Study|Per sponsors instruction|0|||
155196974|NCT00347360|560158483|FG003|Overall Study|Per sponsors instruction|0|||
155196975|NCT00347360|560158484|FG004|Overall Study|Per sponsors instruction|0|||
155196976|NCT00347360|560158485|FG005|Overall Study|Per sponsors instruction|0|||
155196977|NCT00347360|560158486|FG006|Overall Study|Per sponsors instruction|0|||
155196978|NCT00347360|560158487|FG007|Overall Study|Per sponsors instruction|0|||
155196979|NCT00347360|560158488|FG008|Overall Study|Per sponsors instruction|0|||
155196980|NCT00347360|560158489|FG009|Overall Study|Per sponsors instruction|0|||
155196981|NCT00347360|560158490|FG010|Overall Study|Per sponsors instruction|0|||
155196982|NCT00347360|560158491|FG011|Overall Study|Per sponsors instruction|0|||
155196983|NCT00347360|560158492|FG012|Overall Study|Per sponsors instruction|0|||
155196984|NCT00347360|560158493|FG013|Overall Study|Per sponsors instruction|0|||
155196985|NCT00347360|560158494|FG014|Overall Study|Per sponsors instruction|0|||
155196986|NCT00347360|560158480|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
155196987|NCT00347360|560158481|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
155196988|NCT00347360|560158482|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
155196989|NCT00347360|560158483|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
155196990|NCT00347360|560158484|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
155196991|NCT00347360|560158485|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
155196992|NCT00347360|560158486|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
155196993|NCT00347360|560158487|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
155196994|NCT00347360|560158488|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
155196995|NCT00347360|560158489|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
155196996|NCT00347360|560158490|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
155196997|NCT00347360|560158491|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
155196998|NCT00347360|560158492|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
155196999|NCT00347360|560158493|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
155197000|NCT00347360|560158494|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
155197001|NCT00347360|560158480|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
155197002|NCT00347360|560158481|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
155197003|NCT00347360|560158482|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
155197004|NCT00347360|560158483|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
155149791|NCT02250326|559981751|FG001|Treatment|Withdrawal by Subject|6|||
155149792|NCT02250326|559981752|FG002|Treatment|Withdrawal by Subject|4|||
155149793|NCT02250326|559981750|FG000|Treatment|Other reasons|8|||
155149794|NCT02250326|559981751|FG001|Treatment|Other reasons|7|||
155149795|NCT02250326|559981752|FG002|Treatment|Other reasons|7|||
155149796|NCT02250326|559981750|FG000|Extension Period|Progressive Disease|0|||
155149797|NCT02250326|559981751|FG001|Extension Period|Progressive Disease|2|||
155149798|NCT02250326|559981752|FG002|Extension Period|Progressive Disease|0|||
155149799|NCT02250326|559981750|FG000|Extension Period|Withdrawal by Subject|0|||
155149800|NCT02250326|559981751|FG001|Extension Period|Withdrawal by Subject|1|||
155149801|NCT02250326|559981752|FG002|Extension Period|Withdrawal by Subject|0|||
155149802|NCT02250326|559981750|FG000|Extension Period|Withdrawal by investigator|0|||
155149803|NCT02250326|559981751|FG001|Extension Period|Withdrawal by investigator|1|||
155149804|NCT02250326|559981752|FG002|Extension Period|Withdrawal by investigator|0|||
155149805|NCT01693029|559981753|FG000|Overall Study|Withdrawal by Subject|15|||
155149806|NCT01693029|559981754|FG001|Overall Study|Withdrawal by Subject|22|||
155149807|NCT01693029|559981753|FG000|Overall Study|Kidney transplantation|7|||
155149808|NCT01693029|559981754|FG001|Overall Study|Kidney transplantation|7|||
155149809|NCT01693029|559981753|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
155149810|NCT01693029|559981754|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
155149811|NCT01693029|559981753|FG000|Overall Study|Protocol Violation|6|||
155149812|NCT01693029|559981754|FG001|Overall Study|Protocol Violation|7|||
155149813|NCT01693029|559981753|FG000|Overall Study|Change in dialysis modality|2|||
155149814|NCT01693029|559981754|FG001|Overall Study|Change in dialysis modality|1|||
155149815|NCT01693029|559981753|FG000|Overall Study|Physician Decision|0|||
155149816|NCT01693029|559981754|FG001|Overall Study|Physician Decision|2|||
155149817|NCT01693029|559981753|FG000|Overall Study|Lost to Follow-up|0|||
155149818|NCT01693029|559981754|FG001|Overall Study|Lost to Follow-up|1|||
155149819|NCT01693029|559981753|FG000|Overall Study|Adverse Event|1|||
155149820|NCT01693029|559981754|FG001|Overall Study|Adverse Event|6|||
155149821|NCT01693029|559981753|FG000|Overall Study|Death|5|||
155149822|NCT01693029|559981754|FG001|Overall Study|Death|8|||
155149823|NCT01693029|559981753|FG000|Overall Study|Non-compliance|2|||
155149824|NCT01693029|559981754|FG001|Overall Study|Non-compliance|1|||
155149825|NCT05196828|559981755|FG000|Overall Study|Withdrawal by Subject|2|||
155149826|NCT05196828|559981756|FG001|Overall Study|Withdrawal by Subject|0|||
155149827|NCT05196828|559981755|FG000|Overall Study|Lost to Follow-up|0|||
155149828|NCT05196828|559981756|FG001|Overall Study|Lost to Follow-up|4|||
155149829|NCT05196828|559981755|FG000|Overall Study|Adverse Event|1|||
155149830|NCT05196828|559981756|FG001|Overall Study|Adverse Event|0|||
155149831|NCT01096316|559981757|FG000|Overall Study|Lost to Follow-up|15|||
155149832|NCT01096316|559981758|FG001|Overall Study|Lost to Follow-up|9|||
155149833|NCT02763644|559981759|FG000|Overall Study|Patient/guardian decision|1|||
155149834|NCT02763644|559981760|FG001|Overall Study|Patient/guardian decision|0|||
155149835|NCT02763644|559981759|FG000|Overall Study|Death|1|||
155149836|NCT02763644|559981760|FG001|Overall Study|Death|1|||
155149837|NCT02763644|559981759|FG000|Overall Study|Adverse Event|1|||
155149838|NCT02763644|559981760|FG001|Overall Study|Adverse Event|1|||
155149839|NCT02356159|559981761|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155149840|NCT02356159|559981762|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155149841|NCT02356159|559981763|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155149842|NCT02356159|559981764|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155149843|NCT02356159|559981765|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
155149844|NCT02356159|559981766|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
155149845|NCT06418152|559981767|FG000|Overall Study|Frequent DBS setting changes|1|||
155149846|NCT06418152|559981767|FG000|Overall Study|Withdrawal by Subject|2|||
155149847|NCT02529852|559981768|FG000|Overall Study|Withdrawal by Subject|2|||
155149848|NCT02422498|559981769|FG000|Overall Study|Inevaluable|4|||
155149849|NCT03206216|559981771|FG000|Overall Study|Withdrawal by Subject|0|||
155149850|NCT03206216|559981772|FG001|Overall Study|Withdrawal by Subject|1|||
155149851|NCT01582061|559981773|FG000|Overall Study|Lack of Efficacy|3|||
155149852|NCT01582061|559981774|FG001|Overall Study|Lack of Efficacy|23|||
155149853|NCT01582061|559981773|FG000|Overall Study|Adverse Event|12|||
155149854|NCT01582061|559981774|FG001|Overall Study|Adverse Event|8|||
155149855|NCT01582061|559981773|FG000|Overall Study|Withdrawal by Subject|10|||
155149856|NCT01582061|559981774|FG001|Overall Study|Withdrawal by Subject|4|||
155149857|NCT01582061|559981773|FG000|Overall Study|Abnormal laboratory value(s)|1|||
155149858|NCT01582061|559981774|FG001|Overall Study|Abnormal laboratory value(s)|0|||
155149859|NCT01582061|559981773|FG000|Overall Study|Death|0|||
155149860|NCT01582061|559981774|FG001|Overall Study|Death|1|||
155149861|NCT01582061|559981773|FG000|Overall Study|condition no longer requires study drug|1|||
155149862|NCT01582061|559981774|FG001|Overall Study|condition no longer requires study drug|0|||
155149863|NCT01582061|559981773|FG000|Overall Study|Lost to Follow-up|1|||
155149864|NCT01582061|559981774|FG001|Overall Study|Lost to Follow-up|0|||
155149865|NCT04664153|559981775|FG000|Overall Study|Lack of Efficacy|0|||
155149866|NCT04664153|559981776|FG001|Overall Study|Lack of Efficacy|0|||
155197005|NCT00347360|560158484|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
155197006|NCT00347360|560158485|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
155197007|NCT00347360|560158486|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
155197008|NCT00347360|560158487|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
155197009|NCT00347360|560158488|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
155197010|NCT00347360|560158489|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
155197011|NCT00347360|560158490|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
155197012|NCT00347360|560158491|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
155197013|NCT00347360|560158492|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
155197014|NCT00347360|560158493|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
155197015|NCT00347360|560158494|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
155197016|NCT00347360|560158480|FG000|Overall Study|Abnormal lab values|0|||
155197017|NCT00347360|560158481|FG001|Overall Study|Abnormal lab values|0|||
155197018|NCT00347360|560158482|FG002|Overall Study|Abnormal lab values|0|||
155197019|NCT00347360|560158483|FG003|Overall Study|Abnormal lab values|0|||
155197020|NCT00347360|560158484|FG004|Overall Study|Abnormal lab values|0|||
155197021|NCT00347360|560158485|FG005|Overall Study|Abnormal lab values|0|||
155197022|NCT00347360|560158486|FG006|Overall Study|Abnormal lab values|1|||
155197023|NCT00347360|560158487|FG007|Overall Study|Abnormal lab values|0|||
155197024|NCT00347360|560158488|FG008|Overall Study|Abnormal lab values|0|||
155197025|NCT00347360|560158489|FG009|Overall Study|Abnormal lab values|0|||
155197026|NCT00347360|560158490|FG010|Overall Study|Abnormal lab values|0|||
155197027|NCT00347360|560158491|FG011|Overall Study|Abnormal lab values|0|||
155197028|NCT00347360|560158492|FG012|Overall Study|Abnormal lab values|0|||
155197029|NCT00347360|560158493|FG013|Overall Study|Abnormal lab values|0|||
155197030|NCT00347360|560158494|FG014|Overall Study|Abnormal lab values|0|||
155197031|NCT00347360|560158480|FG000|Overall Study|PI recommended early withdrawal|0|||
155197032|NCT00347360|560158481|FG001|Overall Study|PI recommended early withdrawal|0|||
155197033|NCT00347360|560158482|FG002|Overall Study|PI recommended early withdrawal|0|||
155197034|NCT00347360|560158483|FG003|Overall Study|PI recommended early withdrawal|0|||
155197035|NCT00347360|560158484|FG004|Overall Study|PI recommended early withdrawal|0|||
155197036|NCT00347360|560158485|FG005|Overall Study|PI recommended early withdrawal|0|||
155197037|NCT00347360|560158486|FG006|Overall Study|PI recommended early withdrawal|0|||
155197038|NCT00347360|560158487|FG007|Overall Study|PI recommended early withdrawal|0|||
155197039|NCT00347360|560158488|FG008|Overall Study|PI recommended early withdrawal|0|||
155197040|NCT00347360|560158489|FG009|Overall Study|PI recommended early withdrawal|1|||
155197041|NCT00347360|560158490|FG010|Overall Study|PI recommended early withdrawal|0|||
155197042|NCT00347360|560158491|FG011|Overall Study|PI recommended early withdrawal|0|||
155197043|NCT00347360|560158492|FG012|Overall Study|PI recommended early withdrawal|0|||
155197044|NCT00347360|560158493|FG013|Overall Study|PI recommended early withdrawal|0|||
155197045|NCT00347360|560158494|FG014|Overall Study|PI recommended early withdrawal|0|||
155197046|NCT00347360|560158480|FG000|Overall Study|Did not meet criteria before ABPM|0|||
155197047|NCT00347360|560158481|FG001|Overall Study|Did not meet criteria before ABPM|0|||
155197048|NCT00347360|560158482|FG002|Overall Study|Did not meet criteria before ABPM|0|||
155197049|NCT00347360|560158483|FG003|Overall Study|Did not meet criteria before ABPM|0|||
155197050|NCT00347360|560158484|FG004|Overall Study|Did not meet criteria before ABPM|0|||
155197051|NCT00347360|560158485|FG005|Overall Study|Did not meet criteria before ABPM|0|||
155197052|NCT00347360|560158486|FG006|Overall Study|Did not meet criteria before ABPM|0|||
155197053|NCT00347360|560158487|FG007|Overall Study|Did not meet criteria before ABPM|0|||
155197054|NCT00347360|560158488|FG008|Overall Study|Did not meet criteria before ABPM|0|||
155197055|NCT00347360|560158489|FG009|Overall Study|Did not meet criteria before ABPM|0|||
155197056|NCT00347360|560158490|FG010|Overall Study|Did not meet criteria before ABPM|1|||
155197057|NCT00347360|560158491|FG011|Overall Study|Did not meet criteria before ABPM|0|||
155197058|NCT00347360|560158492|FG012|Overall Study|Did not meet criteria before ABPM|0|||
155197059|NCT00347360|560158493|FG013|Overall Study|Did not meet criteria before ABPM|0|||
155197060|NCT00347360|560158494|FG014|Overall Study|Did not meet criteria before ABPM|0|||
155197061|NCT00347360|560158480|FG000|Overall Study|Randomized in error|0|||
155197062|NCT00347360|560158481|FG001|Overall Study|Randomized in error|0|||
155197063|NCT00347360|560158482|FG002|Overall Study|Randomized in error|0|||
155197064|NCT00347360|560158483|FG003|Overall Study|Randomized in error|0|||
155197065|NCT00347360|560158484|FG004|Overall Study|Randomized in error|0|||
155197066|NCT00347360|560158485|FG005|Overall Study|Randomized in error|0|||
155197067|NCT00347360|560158486|FG006|Overall Study|Randomized in error|0|||
155197068|NCT00347360|560158487|FG007|Overall Study|Randomized in error|0|||
155197069|NCT00347360|560158488|FG008|Overall Study|Randomized in error|0|||
155197070|NCT00347360|560158489|FG009|Overall Study|Randomized in error|0|||
155197071|NCT00347360|560158490|FG010|Overall Study|Randomized in error|0|||
155197072|NCT00347360|560158491|FG011|Overall Study|Randomized in error|1|||
155197073|NCT00347360|560158492|FG012|Overall Study|Randomized in error|0|||
155197074|NCT00347360|560158493|FG013|Overall Study|Randomized in error|0|||
155197075|NCT00347360|560158494|FG014|Overall Study|Randomized in error|0|||
155197076|NCT00347360|560158480|FG000|Overall Study|Failed inclusion criteria #4|0|||
155197077|NCT00347360|560158481|FG001|Overall Study|Failed inclusion criteria #4|0|||
155197078|NCT00347360|560158482|FG002|Overall Study|Failed inclusion criteria #4|0|||
155197079|NCT00347360|560158483|FG003|Overall Study|Failed inclusion criteria #4|0|||
155197080|NCT00347360|560158484|FG004|Overall Study|Failed inclusion criteria #4|0|||
155197081|NCT00347360|560158485|FG005|Overall Study|Failed inclusion criteria #4|0|||
155197082|NCT00347360|560158486|FG006|Overall Study|Failed inclusion criteria #4|0|||
155197083|NCT00347360|560158487|FG007|Overall Study|Failed inclusion criteria #4|0|||
155197084|NCT00347360|560158488|FG008|Overall Study|Failed inclusion criteria #4|0|||
155197085|NCT00347360|560158489|FG009|Overall Study|Failed inclusion criteria #4|0|||
155197086|NCT00347360|560158490|FG010|Overall Study|Failed inclusion criteria #4|0|||
155197087|NCT00347360|560158491|FG011|Overall Study|Failed inclusion criteria #4|1|||
155197088|NCT00347360|560158492|FG012|Overall Study|Failed inclusion criteria #4|0|||
155197089|NCT00347360|560158493|FG013|Overall Study|Failed inclusion criteria #4|0|||
155197090|NCT00347360|560158494|FG014|Overall Study|Failed inclusion criteria #4|0|||
155197091|NCT00347360|560158480|FG000|Overall Study|Prolonged duration between visits|0|||
155197092|NCT00347360|560158481|FG001|Overall Study|Prolonged duration between visits|0|||
155197093|NCT00347360|560158482|FG002|Overall Study|Prolonged duration between visits|0|||
155197094|NCT00347360|560158483|FG003|Overall Study|Prolonged duration between visits|0|||
155197095|NCT00347360|560158484|FG004|Overall Study|Prolonged duration between visits|0|||
155197096|NCT00347360|560158485|FG005|Overall Study|Prolonged duration between visits|0|||
155197097|NCT00347360|560158486|FG006|Overall Study|Prolonged duration between visits|0|||
155197098|NCT00347360|560158487|FG007|Overall Study|Prolonged duration between visits|0|||
155197099|NCT00347360|560158488|FG008|Overall Study|Prolonged duration between visits|0|||
155197100|NCT00347360|560158489|FG009|Overall Study|Prolonged duration between visits|0|||
155197101|NCT00347360|560158490|FG010|Overall Study|Prolonged duration between visits|0|||
155197102|NCT00347360|560158491|FG011|Overall Study|Prolonged duration between visits|0|||
155197103|NCT00347360|560158492|FG012|Overall Study|Prolonged duration between visits|1|||
155197104|NCT00347360|560158493|FG013|Overall Study|Prolonged duration between visits|0|||
155197105|NCT00347360|560158494|FG014|Overall Study|Prolonged duration between visits|0|||
155197106|NCT00347360|560158480|FG000|Overall Study|Subject left town, ran out of study drug|0|||
155197107|NCT00347360|560158481|FG001|Overall Study|Subject left town, ran out of study drug|0|||
155197108|NCT00347360|560158482|FG002|Overall Study|Subject left town, ran out of study drug|0|||
155197109|NCT00347360|560158483|FG003|Overall Study|Subject left town, ran out of study drug|0|||
155197110|NCT00347360|560158484|FG004|Overall Study|Subject left town, ran out of study drug|0|||
155197111|NCT00347360|560158485|FG005|Overall Study|Subject left town, ran out of study drug|0|||
155197112|NCT00347360|560158486|FG006|Overall Study|Subject left town, ran out of study drug|0|||
155197113|NCT00347360|560158487|FG007|Overall Study|Subject left town, ran out of study drug|0|||
155197114|NCT00347360|560158488|FG008|Overall Study|Subject left town, ran out of study drug|0|||
155197115|NCT00347360|560158489|FG009|Overall Study|Subject left town, ran out of study drug|0|||
155197116|NCT00347360|560158490|FG010|Overall Study|Subject left town, ran out of study drug|0|||
155197117|NCT00347360|560158491|FG011|Overall Study|Subject left town, ran out of study drug|0|||
155197118|NCT00347360|560158492|FG012|Overall Study|Subject left town, ran out of study drug|0|||
155197119|NCT00347360|560158493|FG013|Overall Study|Subject left town, ran out of study drug|1|||
155197120|NCT00347360|560158494|FG014|Overall Study|Subject left town, ran out of study drug|0|||
155197121|NCT00347360|560158480|FG000|Overall Study|Subject refuse to sign updated consent|0|||
155197122|NCT00347360|560158481|FG001|Overall Study|Subject refuse to sign updated consent|0|||
155197123|NCT00347360|560158482|FG002|Overall Study|Subject refuse to sign updated consent|0|||
155197124|NCT00347360|560158483|FG003|Overall Study|Subject refuse to sign updated consent|0|||
155197125|NCT00347360|560158484|FG004|Overall Study|Subject refuse to sign updated consent|0|||
155197126|NCT00347360|560158485|FG005|Overall Study|Subject refuse to sign updated consent|0|||
155197127|NCT00347360|560158486|FG006|Overall Study|Subject refuse to sign updated consent|0|||
155197128|NCT00347360|560158487|FG007|Overall Study|Subject refuse to sign updated consent|0|||
155197129|NCT00347360|560158488|FG008|Overall Study|Subject refuse to sign updated consent|0|||
155197130|NCT00347360|560158489|FG009|Overall Study|Subject refuse to sign updated consent|0|||
155197131|NCT00347360|560158490|FG010|Overall Study|Subject refuse to sign updated consent|0|||
155197132|NCT00347360|560158491|FG011|Overall Study|Subject refuse to sign updated consent|0|||
155197133|NCT00347360|560158492|FG012|Overall Study|Subject refuse to sign updated consent|0|||
155197134|NCT00347360|560158493|FG013|Overall Study|Subject refuse to sign updated consent|0|||
155197135|NCT00347360|560158494|FG014|Overall Study|Subject refuse to sign updated consent|1|||
155197136|NCT00347360|560158480|FG000|Overall Study|Visits conflicted with new job|0|||
155197137|NCT00347360|560158481|FG001|Overall Study|Visits conflicted with new job|0|||
155197138|NCT00347360|560158482|FG002|Overall Study|Visits conflicted with new job|0|||
155197139|NCT00347360|560158483|FG003|Overall Study|Visits conflicted with new job|0|||
155197140|NCT00347360|560158484|FG004|Overall Study|Visits conflicted with new job|0|||
155197141|NCT00347360|560158485|FG005|Overall Study|Visits conflicted with new job|0|||
155197142|NCT00347360|560158486|FG006|Overall Study|Visits conflicted with new job|1|||
155197143|NCT00347360|560158487|FG007|Overall Study|Visits conflicted with new job|0|||
155197144|NCT00347360|560158488|FG008|Overall Study|Visits conflicted with new job|0|||
155197145|NCT00347360|560158489|FG009|Overall Study|Visits conflicted with new job|0|||
155197146|NCT00347360|560158490|FG010|Overall Study|Visits conflicted with new job|0|||
155197147|NCT00347360|560158491|FG011|Overall Study|Visits conflicted with new job|0|||
155197148|NCT00347360|560158492|FG012|Overall Study|Visits conflicted with new job|0|||
155197149|NCT00347360|560158493|FG013|Overall Study|Visits conflicted with new job|0|||
155197150|NCT00347360|560158494|FG014|Overall Study|Visits conflicted with new job|0|||
155197151|NCT01972568|560158499|FG000|Overall Study|Other events|3|||
155197152|NCT01972568|560158500|FG001|Overall Study|Other events|0|||
155197153|NCT01972568|560158501|FG002|Overall Study|Other events|0|||
155197154|NCT01972568|560158499|FG000|Overall Study|Lack of Efficacy|0|||
155197155|NCT01972568|560158500|FG001|Overall Study|Lack of Efficacy|1|||
155197156|NCT01972568|560158501|FG002|Overall Study|Lack of Efficacy|2|||
155197157|NCT01972568|560158499|FG000|Overall Study|Protocol Violation|1|||
155197158|NCT01972568|560158500|FG001|Overall Study|Protocol Violation|2|||
155197159|NCT01972568|560158501|FG002|Overall Study|Protocol Violation|2|||
155197160|NCT01972568|560158499|FG000|Overall Study|Withdrawal by Subject|6|||
155197161|NCT01972568|560158500|FG001|Overall Study|Withdrawal by Subject|3|||
155197162|NCT01972568|560158501|FG002|Overall Study|Withdrawal by Subject|7|||
155197163|NCT01972568|560158499|FG000|Overall Study|Lost to Follow-up|1|||
155197164|NCT01972568|560158500|FG001|Overall Study|Lost to Follow-up|0|||
155197165|NCT01972568|560158501|FG002|Overall Study|Lost to Follow-up|0|||
155197166|NCT01972568|560158499|FG000|Overall Study|Adverse Event|5|||
155197167|NCT01972568|560158500|FG001|Overall Study|Adverse Event|6|||
155197168|NCT01972568|560158501|FG002|Overall Study|Adverse Event|5|||
155197169|NCT02059408|560158504|FG000|Overall Study|Did not get tested|0|||
155197170|NCT02059408|560158505|FG001|Overall Study|Did not get tested|330|||
155197171|NCT02059408|560158506|FG002|Overall Study|Did not get tested|358|||
155197172|NCT00508755|560158507|FG000|Overall Study|Withdrawal by Subject|1|||
155197173|NCT00957580|560158508|FG000|Overall Study|Ongoing at data cut-off|0|||
155197174|NCT00957580|560158509|FG001|Overall Study|Ongoing at data cut-off|1|||
155197175|NCT00957580|560158510|FG002|Overall Study|Ongoing at data cut-off|0|||
155197176|NCT00957580|560158508|FG000|Overall Study|Enrolled but not treated|0|||
155197177|NCT00957580|560158509|FG001|Overall Study|Enrolled but not treated|1|||
155197178|NCT00957580|560158510|FG002|Overall Study|Enrolled but not treated|0|||
155197179|NCT00945893|560158511|FG000|Overall Study|Lost to Follow-up|2|||
155197180|NCT00945893|560158512|FG001|Overall Study|Lost to Follow-up|8|||
155197181|NCT00945893|560158511|FG000|Overall Study|Withdrawal of consent|1|||
155197182|NCT00945893|560158512|FG001|Overall Study|Withdrawal of consent|2|||
155197183|NCT04502433|560158513|FG000|Overall Study|Death|2|||
155197184|NCT04502433|560158514|FG001|Overall Study|Death|4|||
155197185|NCT04502433|560158513|FG000|Overall Study|Lost to Follow-up|1|||
155197186|NCT04502433|560158514|FG001|Overall Study|Lost to Follow-up|0|||
155197187|NCT04502433|560158513|FG000|Overall Study|Physician Decision|0|||
155197188|NCT04502433|560158514|FG001|Overall Study|Physician Decision|1|||
155197189|NCT01999179|560158522|FG000|Overall Study|Adverse Event|1|||
155197190|NCT01999179|560158522|FG000|Overall Study|Lost to Follow-up|1|||
155197191|NCT01999179|560158522|FG000|Overall Study|Change in Therapy|3|||
155197192|NCT01999179|560158522|FG000|Overall Study|New catheter|2|||
155197193|NCT00300274|560158526|FG000|Overall Study|Withdrawal by Subject|12|||
155197194|NCT00300274|560158527|FG001|Overall Study|Withdrawal by Subject|3|||
155197195|NCT00300274|560158528|FG002|Overall Study|Withdrawal by Subject|14|||
155197196|NCT00300274|560158526|FG000|Overall Study|Lost to Follow-up|3|||
155197197|NCT00300274|560158527|FG001|Overall Study|Lost to Follow-up|4|||
155197198|NCT00300274|560158528|FG002|Overall Study|Lost to Follow-up|5|||
155197199|NCT00300274|560158526|FG000|Overall Study|Death|31|||
155197200|NCT00300274|560158527|FG001|Overall Study|Death|20|||
155197201|NCT00300274|560158528|FG002|Overall Study|Death|25|||
155197202|NCT00300274|560158526|FG000|Overall Study|Re-transplant|0|||
155197203|NCT00300274|560158527|FG001|Overall Study|Re-transplant|0|||
155197204|NCT00300274|560158528|FG002|Overall Study|Re-transplant|1|||
155197205|NCT00242216|560158529|FG000|Overall Study|Lost to Follow-up|12|||
155197206|NCT00242216|560158530|FG001|Overall Study|Lost to Follow-up|17|||
155197207|NCT00242216|560158529|FG000|Overall Study|Death|4|||
155197208|NCT00242216|560158530|FG001|Overall Study|Death|2|||
155197209|NCT00242216|560158529|FG000|Overall Study|Lack of Efficacy|1|||
155197210|NCT00242216|560158530|FG001|Overall Study|Lack of Efficacy|2|||
155197211|NCT00242216|560158529|FG000|Overall Study|no medicaiton dispensed|1|||
155197212|NCT00242216|560158530|FG001|Overall Study|no medicaiton dispensed|1|||
155197213|NCT01663532|560159686|FG000|Overall Study|Lost to Follow-up|9|||
155197214|NCT01663532|560159687|FG001|Overall Study|Lost to Follow-up|10|||
155197215|NCT01663532|560159686|FG000|Overall Study|Adverse Event|7|||
155197216|NCT01663532|560159687|FG001|Overall Study|Adverse Event|13|||
155197217|NCT01663532|560159686|FG000|Overall Study|Met Withdrawal Criteria|7|||
155197218|NCT01663532|560159687|FG001|Overall Study|Met Withdrawal Criteria|6|||
155197219|NCT01663532|560159686|FG000|Overall Study|Physician Decision|1|||
155197220|NCT01663532|560159687|FG001|Overall Study|Physician Decision|1|||
155197221|NCT01663532|560159686|FG000|Overall Study|Withdrawal by Subject|35|||
155197222|NCT01663532|560159687|FG001|Overall Study|Withdrawal by Subject|17|||
155197223|NCT01663532|560159686|FG000|Overall Study|Lack of Efficacy|15|||
155197224|NCT01663532|560159687|FG001|Overall Study|Lack of Efficacy|60|||
155149867|NCT04664153|559981777|FG002|Overall Study|Lack of Efficacy|1|||
155197225|NCT03539081|560159693|FG000|Overall Study|Withdrawal by Subject|2|||
155197226|NCT03539081|560159694|FG001|Overall Study|Withdrawal by Subject|3|||
155197227|NCT03539081|560159695|FG002|Overall Study|Withdrawal by Subject|0|||
155197228|NCT03539081|560159693|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
155197229|NCT03539081|560159694|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
155197230|NCT03539081|560159695|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
155197231|NCT02025621|560159696|FG000|Overall Study|Withdrawal by Subject|1|||
155197232|NCT02025621|560159697|FG001|Overall Study|Withdrawal by Subject|0|||
155197233|NCT02025621|560159696|FG000|Overall Study|Death|0|||
155197234|NCT02025621|560159697|FG001|Overall Study|Death|1|||
155197235|NCT02025621|560159696|FG000|Overall Study|No longer eligible|10|||
155197236|NCT02025621|560159697|FG001|Overall Study|No longer eligible|15|||
155197237|NCT02025621|560159696|FG000|Overall Study|Surgery initiated before infusion|3|||
155197238|NCT02025621|560159697|FG001|Overall Study|Surgery initiated before infusion|3|||
155197239|NCT01897454|560159701|FG000|Overall Study|Withdrawal by Subject|1|||
155197240|NCT01560403|560159704|FG000|Overall Study|Lost to Follow-up|0|||
155197241|NCT01560403|560159705|FG001|Overall Study|Lost to Follow-up|1|||
155197242|NCT00983437|560159707|FG000|Overall Study|Adverse Event|9|||
155197243|NCT00983437|560159707|FG000|Overall Study|Lack of Efficacy|1|||
155197244|NCT00983437|560159707|FG000|Overall Study|Withdrawal by Subject|8|||
155197245|NCT00983437|560159707|FG000|Overall Study|Noncompliance to Study Procedures|1|||
155197246|NCT00983437|560159707|FG000|Overall Study|Lost to Follow-up|2|||
155197247|NCT00983437|560159707|FG000|Overall Study|Other Reason|26|||
155197248|NCT00094172|560159708|FG000|Overall Study|Adverse Event|0|||
155197249|NCT00094172|560159709|FG001|Overall Study|Adverse Event|1|||
155197250|NCT00094172|560159708|FG000|Overall Study|Lost to Follow-up|2|||
155197251|NCT00094172|560159709|FG001|Overall Study|Lost to Follow-up|0|||
155197252|NCT00094172|560159708|FG000|Overall Study|Protocol Violation|0|||
155197253|NCT00094172|560159709|FG001|Overall Study|Protocol Violation|1|||
155197254|NCT00094172|560159708|FG000|Overall Study|Withdrawal by Subject|10|||
155197255|NCT00094172|560159709|FG001|Overall Study|Withdrawal by Subject|5|||
155197256|NCT00094172|560159708|FG000|Overall Study|Primary endpoint met.|1|||
155197257|NCT00094172|560159709|FG001|Overall Study|Primary endpoint met.|0|||
155197258|NCT00094172|560159708|FG000|Overall Study|Started other MS therapy due to disease|1|||
155197259|NCT00094172|560159709|FG001|Overall Study|Started other MS therapy due to disease|0|||
155197260|NCT01020981|560159710|FG000|Overall Study|Did not return mailed survey|74|||
155197261|NCT01020981|560159711|FG001|Overall Study|Did not return mailed survey|58|||
155197262|NCT01020981|560159710|FG000|Overall Study|Survey returned undeliverable|8|||
155197263|NCT01020981|560159711|FG001|Overall Study|Survey returned undeliverable|32|||
155149868|NCT04664153|559981778|FG003|Overall Study|Lack of Efficacy|0|||
155149869|NCT04664153|559981775|FG000|Overall Study|Physician Decision|0|||
155149870|NCT04664153|559981776|FG001|Overall Study|Physician Decision|0|||
155149871|NCT04664153|559981777|FG002|Overall Study|Physician Decision|1|||
155149872|NCT04664153|559981778|FG003|Overall Study|Physician Decision|0|||
155149873|NCT04664153|559981775|FG000|Overall Study|Withdrawal by Subject|3|||
155149874|NCT04664153|559981776|FG001|Overall Study|Withdrawal by Subject|2|||
155149875|NCT04664153|559981777|FG002|Overall Study|Withdrawal by Subject|1|||
155149876|NCT04664153|559981778|FG003|Overall Study|Withdrawal by Subject|2|||
155149877|NCT04664153|559981775|FG000|Overall Study|Other|0|||
155149878|NCT04664153|559981776|FG001|Overall Study|Other|1|||
155149879|NCT04664153|559981777|FG002|Overall Study|Other|0|||
155149880|NCT04664153|559981778|FG003|Overall Study|Other|0|||
155149881|NCT04664153|559981775|FG000|Overall Study|Adverse Event|4|||
155149882|NCT04664153|559981776|FG001|Overall Study|Adverse Event|0|||
155149883|NCT04664153|559981777|FG002|Overall Study|Adverse Event|1|||
155149884|NCT04664153|559981778|FG003|Overall Study|Adverse Event|0|||
155149885|NCT01600885|559981780|FG000|First Period|Adverse Event|1|||
155149886|NCT01600885|559981781|FG001|First Period|Adverse Event|1|||
155149887|NCT01600885|559981780|FG000|First Period|moved out of area|1|||
155149888|NCT01600885|559981781|FG001|First Period|moved out of area|0|||
155149889|NCT00088530|559981786|FG000|Overall Study|Progressive/Relapsed Disease|28|||
155149890|NCT00088530|559981787|FG001|Overall Study|Progressive/Relapsed Disease|39|||
155149891|NCT00088530|559981786|FG000|Overall Study|Adverse Event|15|||
155149892|NCT00088530|559981787|FG001|Overall Study|Adverse Event|9|||
155149893|NCT00088530|559981786|FG000|Overall Study|Withdrawal by Subject|2|||
155149894|NCT00088530|559981787|FG001|Overall Study|Withdrawal by Subject|5|||
155149895|NCT00088530|559981786|FG000|Overall Study|Lost to Follow-up|2|||
155149896|NCT00088530|559981787|FG001|Overall Study|Lost to Follow-up|0|||
155149897|NCT00088530|559981786|FG000|Overall Study|Physician Decision|2|||
155149898|NCT00088530|559981787|FG001|Overall Study|Physician Decision|0|||
155149899|NCT00088530|559981786|FG000|Overall Study|Sponsor decision|0|||
155197264|NCT01020981|560159710|FG000|Overall Study|Participant declined to complete survey|2|||
155149900|NCT00088530|559981787|FG001|Overall Study|Sponsor decision|1|||
155149901|NCT00088530|559981786|FG000|Overall Study|Patient never treated|1|||
155149902|NCT00088530|559981787|FG001|Overall Study|Patient never treated|0|||
155149903|NCT00300755|559981788|FG000|Overall Study|Adverse Event|1|||
155149904|NCT00300755|559981789|FG001|Overall Study|Adverse Event|2|||
155149905|NCT00300755|559981790|FG002|Overall Study|Adverse Event|1|||
155149906|NCT00300755|559981788|FG000|Overall Study|Withdrawal by Subject|0|||
155149907|NCT00300755|559981789|FG001|Overall Study|Withdrawal by Subject|2|||
155149908|NCT00300755|559981790|FG002|Overall Study|Withdrawal by Subject|0|||
155149909|NCT00300755|559981788|FG000|Overall Study|Protocol Violation|0|||
155149910|NCT00300755|559981789|FG001|Overall Study|Protocol Violation|0|||
155149911|NCT00300755|559981790|FG002|Overall Study|Protocol Violation|1|||
155149912|NCT04571944|559981791|FG000|Overall Study|Death|1|||
155149913|NCT04571944|559981792|FG001|Overall Study|Death|0|||
155149914|NCT04571944|559981791|FG000|Overall Study|Withdrawal by Subject|3|||
155149915|NCT04571944|559981792|FG001|Overall Study|Withdrawal by Subject|0|||
155149916|NCT04571944|559981791|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
155149917|NCT04571944|559981792|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
155149918|NCT02694744|559981793|FG000|Overall Study|Adverse Event|2|||
155149919|NCT02694744|559981794|FG001|Overall Study|Adverse Event|1|||
155149920|NCT02694744|559981793|FG000|Overall Study|Withdrawal by Subject|2|||
155149921|NCT02694744|559981794|FG001|Overall Study|Withdrawal by Subject|1|||
155149922|NCT02694744|559981793|FG000|Overall Study|Physician Decision|1|||
155149923|NCT02694744|559981794|FG001|Overall Study|Physician Decision|2|||
155149924|NCT02694744|559981793|FG000|Overall Study|Lost to Follow-up|1|||
155149925|NCT02694744|559981794|FG001|Overall Study|Lost to Follow-up|0|||
155149926|NCT02694744|559981793|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
155149927|NCT02694744|559981794|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
155149928|NCT02163902|559981797|FG000|Overall Study|Subject's Request|3|||
155149929|NCT02163902|559981798|FG001|Overall Study|Subject's Request|4|||
155149930|NCT02163902|559981797|FG000|Overall Study|Lost to Follow-up|6|||
155149931|NCT02163902|559981798|FG001|Overall Study|Lost to Follow-up|7|||
155149932|NCT02163902|559981797|FG000|Overall Study|Administrative Decision|2|||
155149933|NCT02163902|559981798|FG001|Overall Study|Administrative Decision|2|||
155149934|NCT02525471|559981799|FG000|Overall Study|Screen Failure|6|||
155149935|NCT02525471|559981799|FG000|Overall Study|Withdrawal by Subject|4|||
155149936|NCT02525471|559981799|FG000|Overall Study|Death|1|||
155149937|NCT00867165|559981801|FG000|Overall Study|Adverse Event|3|||
155149938|NCT00867165|559981802|FG001|Overall Study|Adverse Event|0|||
155149939|NCT00867165|559981801|FG000|Overall Study|Withdrawal by Subject|1|||
155149940|NCT00867165|559981802|FG001|Overall Study|Withdrawal by Subject|0|||
155149941|NCT00539981|559981803|FG000|Overall Study|Adverse events (AE)|3|||
155149942|NCT00539981|559981804|FG001|Overall Study|Adverse events (AE)|3|||
155149943|NCT00539981|559981803|FG000|Overall Study|Lost to Follow-up|260|||
155149944|NCT00539981|559981804|FG001|Overall Study|Lost to Follow-up|251|||
155149945|NCT00539981|559981803|FG000|Overall Study|Withdrew consent|22|||
155149946|NCT00539981|559981804|FG001|Overall Study|Withdrew consent|14|||
155149947|NCT00539981|559981803|FG000|Overall Study|Death|1|||
155149948|NCT00539981|559981804|FG001|Overall Study|Death|1|||
155149949|NCT00539981|559981803|FG000|Overall Study|Other reason-unspecified|9|||
155149950|NCT00539981|559981804|FG001|Overall Study|Other reason-unspecified|13|||
155149951|NCT01759420|559981807|FG000|Overall Study|Screen failure|5|||
155149952|NCT01759420|559981807|FG000|Overall Study|Inaccurate EKG machine readings|1|||
155149953|NCT01129622|559981810|FG000|Overall Study|Withdrawal by Subject|2|||
155149954|NCT02051764|559981811|FG000|Overall Study|Study terminated by sponsor|0|||
155149955|NCT02051764|559981812|FG001|Overall Study|Study terminated by sponsor|7|||
155149956|NCT00591006|559981813|FG000|Overall Study|Withdrawal by Subject|0|||
155149957|NCT00591006|559981814|FG001|Overall Study|Withdrawal by Subject|0|||
155149958|NCT00591006|559981815|FG002|Overall Study|Withdrawal by Subject|0|||
155149959|NCT00591006|559981816|FG003|Overall Study|Withdrawal by Subject|0|||
155149960|NCT00591006|559981817|FG004|Overall Study|Withdrawal by Subject|0|||
155149961|NCT00591006|559981818|FG005|Overall Study|Withdrawal by Subject|0|||
155149962|NCT00591006|559981819|FG006|Overall Study|Withdrawal by Subject|0|||
155149963|NCT00591006|559981820|FG007|Overall Study|Withdrawal by Subject|0|||
155149964|NCT00591006|559981821|FG008|Overall Study|Withdrawal by Subject|0|||
155149965|NCT00591006|559981822|FG009|Overall Study|Withdrawal by Subject|0|||
155149966|NCT00591006|559981823|FG010|Overall Study|Withdrawal by Subject|0|||
155149967|NCT00591006|559981824|FG011|Overall Study|Withdrawal by Subject|0|||
155149968|NCT00591006|559981825|FG012|Overall Study|Withdrawal by Subject|0|||
155149969|NCT00591006|559981826|FG013|Overall Study|Withdrawal by Subject|0|||
155149970|NCT00591006|559981827|FG014|Overall Study|Withdrawal by Subject|0|||
155149971|NCT00591006|559981828|FG015|Overall Study|Withdrawal by Subject|1|||
155149972|NCT00591006|559981829|FG016|Overall Study|Withdrawal by Subject|0|||
155149973|NCT00591006|559981830|FG017|Overall Study|Withdrawal by Subject|0|||
155149974|NCT00591006|559981831|FG018|Overall Study|Withdrawal by Subject|0|||
155149975|NCT00591006|559981832|FG019|Overall Study|Withdrawal by Subject|0|||
155149976|NCT00591006|559981833|FG020|Overall Study|Withdrawal by Subject|0|||
155149977|NCT00591006|559981834|FG021|Overall Study|Withdrawal by Subject|0|||
155149978|NCT00591006|559981835|FG022|Overall Study|Withdrawal by Subject|0|||
155197265|NCT01020981|560159711|FG001|Overall Study|Participant declined to complete survey|0|||
155197266|NCT00289133|560159716|FG000|Overall Study|Non-study device implanted|12|||
155197267|NCT00289133|560159717|FG001|Overall Study|Non-study device implanted|0|||
155197268|NCT00289133|560159716|FG000|Overall Study|Protocol Violation|32|||
155197269|NCT00289133|560159717|FG001|Overall Study|Protocol Violation|38|||
155197270|NCT00289133|560159716|FG000|Overall Study|Withdrawal by Subject|9|||
155197271|NCT00289133|560159717|FG001|Overall Study|Withdrawal by Subject|10|||
155197272|NCT00289133|560159716|FG000|Overall Study|Death|5|||
155197273|NCT00289133|560159717|FG001|Overall Study|Death|10|||
155197274|NCT00289133|560159716|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
155197275|NCT00289133|560159717|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
155197276|NCT00289133|560159716|FG000|Overall Study|Physician Decision|41|||
155197277|NCT00289133|560159717|FG001|Overall Study|Physician Decision|45|||
155197278|NCT00289133|560159716|FG000|Overall Study|Revision|8|||
155197279|NCT00289133|560159717|FG001|Overall Study|Revision|6|||
155197280|NCT00289133|560159716|FG000|Overall Study|Lost to Follow-up|92|||
155197281|NCT00289133|560159717|FG001|Overall Study|Lost to Follow-up|115|||
155197282|NCT03372096|560159722|FG000|Overall Study|Study Closed|8|||
155197283|NCT01397890|560159723|FG000|Overall Study|Withdrawal by Subject|7|||
155197284|NCT01397890|560159724|FG001|Overall Study|Withdrawal by Subject|11|||
155197285|NCT01397890|560159723|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
155197286|NCT01397890|560159724|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
155197287|NCT01397890|560159723|FG000|Overall Study|Death|2|||
155197288|NCT01397890|560159724|FG001|Overall Study|Death|3|||
155197289|NCT01397890|560159723|FG000|Overall Study|Lost to Follow-up|1|||
155197290|NCT01397890|560159724|FG001|Overall Study|Lost to Follow-up|4|||
155149979|NCT00591006|559981836|FG023|Overall Study|Withdrawal by Subject|1|||
155149980|NCT00591006|559981813|FG000|Overall Study|Adverse Event|0|||
155149981|NCT00591006|559981814|FG001|Overall Study|Adverse Event|0|||
155149982|NCT00591006|559981815|FG002|Overall Study|Adverse Event|0|||
155149983|NCT00591006|559981816|FG003|Overall Study|Adverse Event|0|||
155149984|NCT00591006|559981817|FG004|Overall Study|Adverse Event|0|||
155149985|NCT00591006|559981818|FG005|Overall Study|Adverse Event|0|||
155149986|NCT00591006|559981819|FG006|Overall Study|Adverse Event|0|||
155149987|NCT00591006|559981820|FG007|Overall Study|Adverse Event|0|||
155149988|NCT00591006|559981821|FG008|Overall Study|Adverse Event|0|||
155149989|NCT00591006|559981822|FG009|Overall Study|Adverse Event|0|||
155149990|NCT00591006|559981823|FG010|Overall Study|Adverse Event|0|||
155149991|NCT00591006|559981824|FG011|Overall Study|Adverse Event|0|||
155149992|NCT00591006|559981825|FG012|Overall Study|Adverse Event|0|||
155149993|NCT00591006|559981826|FG013|Overall Study|Adverse Event|0|||
155149994|NCT00591006|559981827|FG014|Overall Study|Adverse Event|0|||
155149995|NCT00591006|559981828|FG015|Overall Study|Adverse Event|0|||
155149996|NCT00591006|559981829|FG016|Overall Study|Adverse Event|0|||
155149997|NCT00591006|559981830|FG017|Overall Study|Adverse Event|0|||
155149998|NCT00591006|559981831|FG018|Overall Study|Adverse Event|0|||
155149999|NCT00591006|559981832|FG019|Overall Study|Adverse Event|0|||
155150000|NCT00591006|559981833|FG020|Overall Study|Adverse Event|0|||
155150001|NCT00591006|559981834|FG021|Overall Study|Adverse Event|0|||
155150002|NCT00591006|559981835|FG022|Overall Study|Adverse Event|1|||
155150003|NCT00591006|559981836|FG023|Overall Study|Adverse Event|0|||
155150004|NCT00647296|559981839|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
155150005|NCT00647296|559981840|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
155150006|NCT00647296|559981841|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
155150007|NCT00647296|559981842|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
155150008|NCT00647296|559981839|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
155150009|NCT00647296|559981840|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
155150010|NCT00647296|559981841|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
155150011|NCT00647296|559981842|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
155150012|NCT00647296|559981839|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
155150013|NCT00647296|559981840|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
155150014|NCT00647296|559981841|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
155150015|NCT00647296|559981842|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
155150016|NCT00647296|559981839|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
155150017|NCT00647296|559981840|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
155150018|NCT00647296|559981841|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
155150019|NCT00647296|559981842|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
155197291|NCT01397890|560159723|FG000|Overall Study|Condition under Investigation Worsened|1|||
155197292|NCT01397890|560159724|FG001|Overall Study|Condition under Investigation Worsened|3|||
155197293|NCT01397890|560159723|FG000|Overall Study|Adverse Event|1|||
155197294|NCT01397890|560159724|FG001|Overall Study|Adverse Event|2|||
155197295|NCT01397890|560159723|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
155197296|NCT01397890|560159724|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
155197297|NCT01397890|560159723|FG000|Overall Study|Others|2|||
155197298|NCT01397890|560159724|FG001|Overall Study|Others|1|||
155197299|NCT03094169|560159725|FG000|Overall Study|Lack of Efficacy|0|||
155197300|NCT03094169|560159726|FG001|Overall Study|Lack of Efficacy|0|||
155197301|NCT03094169|560159727|FG002|Overall Study|Lack of Efficacy|0|||
155197302|NCT03094169|560159728|FG003|Overall Study|Lack of Efficacy|0|||
155197303|NCT03094169|560159729|FG004|Overall Study|Lack of Efficacy|0|||
155197304|NCT03094169|560159730|FG005|Overall Study|Lack of Efficacy|0|||
155197305|NCT03094169|560159731|FG006|Overall Study|Lack of Efficacy|0|||
155197306|NCT03094169|560159732|FG007|Overall Study|Lack of Efficacy|21|||
155197307|NCT03094169|560159725|FG000|Overall Study|Adverse Event|0|||
155197308|NCT03094169|560159726|FG001|Overall Study|Adverse Event|0|||
155197309|NCT03094169|560159727|FG002|Overall Study|Adverse Event|0|||
155197310|NCT03094169|560159728|FG003|Overall Study|Adverse Event|0|||
155197311|NCT03094169|560159729|FG004|Overall Study|Adverse Event|0|||
155197312|NCT03094169|560159730|FG005|Overall Study|Adverse Event|0|||
155197313|NCT03094169|560159731|FG006|Overall Study|Adverse Event|0|||
155197314|NCT03094169|560159732|FG007|Overall Study|Adverse Event|2|||
155197315|NCT03094169|560159725|FG000|Overall Study|Withdrawal by Subject|0|||
155197316|NCT03094169|560159726|FG001|Overall Study|Withdrawal by Subject|0|||
155197317|NCT03094169|560159727|FG002|Overall Study|Withdrawal by Subject|0|||
155197318|NCT03094169|560159728|FG003|Overall Study|Withdrawal by Subject|0|||
155197319|NCT03094169|560159729|FG004|Overall Study|Withdrawal by Subject|0|||
155197320|NCT03094169|560159730|FG005|Overall Study|Withdrawal by Subject|0|||
155197321|NCT03094169|560159731|FG006|Overall Study|Withdrawal by Subject|1|||
155197322|NCT03094169|560159732|FG007|Overall Study|Withdrawal by Subject|1|||
155197323|NCT03094169|560159725|FG000|Overall Study|Trial Termination|0|||
155197324|NCT03094169|560159726|FG001|Overall Study|Trial Termination|0|||
155197325|NCT03094169|560159727|FG002|Overall Study|Trial Termination|0|||
155197326|NCT03094169|560159728|FG003|Overall Study|Trial Termination|0|||
155197327|NCT03094169|560159729|FG004|Overall Study|Trial Termination|0|||
155197328|NCT03094169|560159730|FG005|Overall Study|Trial Termination|0|||
155197329|NCT03094169|560159731|FG006|Overall Study|Trial Termination|0|||
155197330|NCT03094169|560159732|FG007|Overall Study|Trial Termination|1|||
155197331|NCT04645953|560159733|FG000|Overall Study|Lost to Follow-up|2|||
155197332|NCT04645953|560159734|FG001|Overall Study|Lost to Follow-up|1|||
155197333|NCT04645953|560159735|FG002|Overall Study|Lost to Follow-up|1|||
155197334|NCT04645953|560159733|FG000|Overall Study|Withdrawal by Subject|0|||
155197335|NCT04645953|560159734|FG001|Overall Study|Withdrawal by Subject|1|||
155197336|NCT04645953|560159735|FG002|Overall Study|Withdrawal by Subject|0|||
155197337|NCT04645953|560159733|FG000|Overall Study|Physician Decision|0|||
155197338|NCT04645953|560159734|FG001|Overall Study|Physician Decision|1|||
155197339|NCT04645953|560159735|FG002|Overall Study|Physician Decision|0|||
155197340|NCT04645953|560159733|FG000|Overall Study|Discontinued Prior to Dosing|0|||
155197341|NCT04645953|560159734|FG001|Overall Study|Discontinued Prior to Dosing|0|||
155197342|NCT04645953|560159735|FG002|Overall Study|Discontinued Prior to Dosing|2|||
155197343|NCT04613375|560159736|FG000|Overall Study|Death|198|||
155197344|NCT04613375|560159736|FG000|Overall Study|Withdrawal by Subject|3|||
155197345|NCT00434954|560159737|FG000|Overall Study|Adverse Event|17|||
155197346|NCT00434954|560159738|FG001|Overall Study|Adverse Event|2|||
155197347|NCT00434954|560159737|FG000|Overall Study|Entry criteria not met|14|||
155197348|NCT00434954|560159738|FG001|Overall Study|Entry criteria not met|16|||
155197349|NCT00434954|560159737|FG000|Overall Study|Lost to Follow-up|0|||
155197350|NCT00434954|560159738|FG001|Overall Study|Lost to Follow-up|1|||
155197351|NCT00434954|560159737|FG000|Overall Study|Physician Decision|6|||
155197352|NCT00434954|560159738|FG001|Overall Study|Physician Decision|3|||
155197353|NCT00434954|560159737|FG000|Overall Study|Protocol Violation|36|||
155197354|NCT00434954|560159738|FG001|Overall Study|Protocol Violation|27|||
155197355|NCT00434954|560159737|FG000|Overall Study|Sponsor decision|1|||
155197356|NCT00434954|560159738|FG001|Overall Study|Sponsor decision|0|||
155197357|NCT00434954|560159737|FG000|Overall Study|Subject decision|8|||
155197358|NCT00434954|560159738|FG001|Overall Study|Subject decision|22|||
155197359|NCT01145625|560159739|FG000|Overall Study|Lost to Follow-up|8|||
155197360|NCT01145625|560159740|FG001|Overall Study|Lost to Follow-up|9|||
155197361|NCT01145625|560159739|FG000|Overall Study|Adverse Event|6|||
155197362|NCT01145625|560159740|FG001|Overall Study|Adverse Event|4|||
155197363|NCT01145625|560159739|FG000|Overall Study|Protocol Violation|3|||
155197364|NCT01145625|560159740|FG001|Overall Study|Protocol Violation|1|||
155197365|NCT01145625|560159739|FG000|Overall Study|Withdrawal by Subject|7|||
155197366|NCT01145625|560159740|FG001|Overall Study|Withdrawal by Subject|16|||
155197367|NCT01145625|560159739|FG000|Overall Study|Pregnancy|0|||
155197368|NCT01145625|560159740|FG001|Overall Study|Pregnancy|1|||
155197369|NCT01751178|560159741|FG000|Overall Study|Adverse Event|2|||
155197370|NCT01751178|560159742|FG001|Overall Study|Adverse Event|0|||
155197371|NCT01751178|560159743|FG002|Overall Study|Adverse Event|0|||
155197372|NCT01751178|560159741|FG000|Overall Study|Other Reason (unknown)|1|||
155197373|NCT01751178|560159742|FG001|Overall Study|Other Reason (unknown)|0|||
155197374|NCT01751178|560159743|FG002|Overall Study|Other Reason (unknown)|2|||
155197375|NCT00885846|560159744|FG000|Overall Study|Withdrawal by Subject|2|||
155197376|NCT00885846|560159745|FG001|Overall Study|Withdrawal by Subject|5|||
155197377|NCT00885846|560159746|FG002|Overall Study|Withdrawal by Subject|2|||
155197378|NCT02747875|560159749|FG000|Overall Study|Physician Decision|1|||
155197379|NCT02747875|560159750|FG001|Overall Study|Physician Decision|0|||
155197380|NCT02747875|560159749|FG000|Overall Study|Adverse Event|0|||
155197381|NCT02747875|560159750|FG001|Overall Study|Adverse Event|1|||
155197382|NCT00493025|560159753|FG000|Overall Study|Physician Decision|19|||
155197383|NCT01986907|560159755|FG000|Overall Study|Adverse Event|11|||
155197384|NCT01986907|560159755|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
155197385|NCT01986907|560159755|FG000|Overall Study|Protocol Violation|4|||
155197386|NCT01986907|560159755|FG000|Overall Study|Withdrawal by Subject|76|||
155197387|NCT01986907|560159755|FG000|Overall Study|Lost to Follow-up|38|||
155197388|NCT01986907|560159755|FG000|Overall Study|Death|9|||
155197389|NCT03800173|560159757|FG000|Overall Study|Lost to Follow-up|0|||
155197390|NCT03800173|560159758|FG001|Overall Study|Lost to Follow-up|0|||
155197391|NCT03800173|560159759|FG002|Overall Study|Lost to Follow-up|0|||
155197392|NCT03800173|560159760|FG003|Overall Study|Lost to Follow-up|0|||
155197393|NCT03800173|560159761|FG004|Overall Study|Lost to Follow-up|1|||
155197394|NCT01313312|560159762|FG000|Overall Study|Adverse Event|5|||
155197395|NCT01313312|560159762|FG000|Overall Study|Withdrawal by Subject|18|||
155197396|NCT01313312|560159762|FG000|Overall Study|Lack of Efficacy|3|||
155197397|NCT01313312|560159762|FG000|Overall Study|Investigator Decision|1|||
155197398|NCT01313312|560159762|FG000|Overall Study|Observational Phase|1|||
155197399|NCT01313312|560159762|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
155197400|NCT01313312|560159762|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
155197401|NCT02716805|560159768|FG000|Overall Study|Progressive disease|2|||
155197402|NCT02716805|560159769|FG001|Overall Study|Progressive disease|0|||
155197403|NCT02716805|560159770|FG002|Overall Study|Progressive disease|0|||
155197404|NCT02716805|560159771|FG003|Overall Study|Progressive disease|0|||
155197405|NCT00066365|560159772|FG000|Overall Study|Adverse Event|1|||
155197406|NCT00066365|560159773|FG001|Overall Study|Adverse Event|0|||
155197407|NCT00066365|560159772|FG000|Overall Study|Lack of Efficacy|15|||
155197408|NCT00066365|560159773|FG001|Overall Study|Lack of Efficacy|12|||
155197409|NCT00066365|560159772|FG000|Overall Study|Physician Decision|1|||
155197410|NCT00066365|560159773|FG001|Overall Study|Physician Decision|0|||
155197411|NCT00066365|560159772|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
155197412|NCT00066365|560159773|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
155197413|NCT00066365|560159772|FG000|Overall Study|Ineligible|4|||
155197414|NCT00066365|560159773|FG001|Overall Study|Ineligible|2|||
155197415|NCT00467857|560159776|FG000|Overall Study|Adverse Event|1|||
155197416|NCT00467857|560159777|FG001|Overall Study|Adverse Event|0|||
155197417|NCT00467857|560159776|FG000|Overall Study|Withdrew consent|2|||
155197418|NCT00467857|560159777|FG001|Overall Study|Withdrew consent|0|||
155197419|NCT00467857|560159776|FG000|Overall Study|Death|0|||
155197420|NCT00467857|560159777|FG001|Overall Study|Death|1|||
155197421|NCT00467857|560159776|FG000|Overall Study|Discharged from court service|0|||
155197422|NCT00467857|560159777|FG001|Overall Study|Discharged from court service|1|||
155197423|NCT00467857|560159776|FG000|Overall Study|Emergency care required|0|||
155197424|NCT00467857|560159777|FG001|Overall Study|Emergency care required|1|||
155197425|NCT00467857|560159776|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
155197426|NCT00467857|560159777|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
155197427|NCT00467857|560159776|FG000|Overall Study|Discontinuation reason missing|0|||
155197428|NCT00467857|560159777|FG001|Overall Study|Discontinuation reason missing|3|||
155197429|NCT00516074|560159781|FG000|Overall Study|Adverse Event|0|||
155197430|NCT00516074|560159782|FG001|Overall Study|Adverse Event|1|||
155197431|NCT00516074|560159781|FG000|Overall Study|Subject Decision|4|||
155197432|NCT00516074|560159782|FG001|Overall Study|Subject Decision|2|||
155150020|NCT00647296|559981839|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
155150021|NCT00647296|559981840|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
155150022|NCT00647296|559981841|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
155150023|NCT00647296|559981842|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
155150024|NCT00647296|559981839|FG000|Part 2: 4-week Placebo Washout|Death|3|||
155150025|NCT00647296|559981840|FG001|Part 2: 4-week Placebo Washout|Death|0|||
155150026|NCT00647296|559981841|FG002|Part 2: 4-week Placebo Washout|Death|0|||
155197433|NCT00516074|560159781|FG000|Overall Study|Loss of Glucose Control|2|||
155197434|NCT00516074|560159782|FG001|Overall Study|Loss of Glucose Control|0|||
155197435|NCT00369824|560159784|FG000|Overall Study|Adverse Event|0|||
155197436|NCT00369824|560159785|FG001|Overall Study|Adverse Event|2|||
155197437|NCT00369824|560159786|FG002|Overall Study|Adverse Event|0|||
155197438|NCT00369824|560159787|FG003|Overall Study|Adverse Event|0|||
155197439|NCT00369824|560159788|FG004|Overall Study|Adverse Event|1|||
155197440|NCT00369824|560159789|FG005|Overall Study|Adverse Event|0|||
155197441|NCT00369824|560159784|FG000|Overall Study|Protocol Violation|0|||
155197442|NCT00369824|560159785|FG001|Overall Study|Protocol Violation|1|||
155197443|NCT00369824|560159786|FG002|Overall Study|Protocol Violation|0|||
155197444|NCT00369824|560159787|FG003|Overall Study|Protocol Violation|1|||
155197445|NCT00369824|560159788|FG004|Overall Study|Protocol Violation|1|||
155197446|NCT00369824|560159789|FG005|Overall Study|Protocol Violation|0|||
155197447|NCT00369824|560159784|FG000|Overall Study|Withdrawal by Subject|9|||
155197448|NCT00369824|560159785|FG001|Overall Study|Withdrawal by Subject|5|||
155150027|NCT00647296|559981842|FG003|Part 2: 4-week Placebo Washout|Death|0|||
155150028|NCT00647296|559981839|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
155150029|NCT00647296|559981840|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
155150030|NCT00647296|559981841|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
155150031|NCT00647296|559981842|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
155150032|NCT00647296|559981839|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
155150033|NCT00647296|559981840|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
155150034|NCT00647296|559981841|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
155150035|NCT00647296|559981842|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
155150036|NCT00647296|559981839|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
155150037|NCT00647296|559981840|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
155150038|NCT00647296|559981841|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
155150039|NCT00647296|559981842|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
155150040|NCT00647296|559981839|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
155150041|NCT00647296|559981840|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
155150042|NCT00647296|559981841|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
155150043|NCT00647296|559981842|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
155150044|NCT00647296|559981839|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
155150045|NCT00647296|559981840|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
155150046|NCT00647296|559981841|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
155150047|NCT00647296|559981842|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
155150048|NCT00871871|559981843|FG000|Part I|Adverse Event|0|||
155150049|NCT00871871|559981844|FG001|Part I|Adverse Event|2|||
155150050|NCT00871871|559981845|FG002|Part I|Adverse Event|0|||
155150051|NCT00871871|559981846|FG003|Part I|Adverse Event|0|||
155150052|NCT00871871|559981843|FG000|Part I|Withdrawal by Subject|3|||
155150053|NCT00871871|559981844|FG001|Part I|Withdrawal by Subject|0|||
155150054|NCT00871871|559981845|FG002|Part I|Withdrawal by Subject|0|||
155150055|NCT00871871|559981846|FG003|Part I|Withdrawal by Subject|0|||
155150056|NCT00871871|559981843|FG000|Part I|Laboratory abnormality|0|||
155150057|NCT00871871|559981844|FG001|Part I|Laboratory abnormality|1|||
155150058|NCT00871871|559981845|FG002|Part I|Laboratory abnormality|0|||
155150059|NCT00871871|559981846|FG003|Part I|Laboratory abnormality|0|||
155150060|NCT00871871|559981843|FG000|Part II|Lack of Efficacy|0|||
155150061|NCT00871871|559981844|FG001|Part II|Lack of Efficacy|0|||
155150062|NCT00871871|559981845|FG002|Part II|Lack of Efficacy|1|||
155150063|NCT00871871|559981846|FG003|Part II|Lack of Efficacy|0|||
155150064|NCT00871871|559981843|FG000|Part II|Withdrawal by Subject|0|||
155150065|NCT00871871|559981844|FG001|Part II|Withdrawal by Subject|0|||
155150066|NCT00871871|559981845|FG002|Part II|Withdrawal by Subject|2|||
155150067|NCT00871871|559981846|FG003|Part II|Withdrawal by Subject|1|||
155150068|NCT00871871|559981843|FG000|Part II|Adverse Event|0|||
155150069|NCT00871871|559981844|FG001|Part II|Adverse Event|0|||
155150070|NCT00871871|559981845|FG002|Part II|Adverse Event|1|||
155150071|NCT00871871|559981846|FG003|Part II|Adverse Event|2|||
155150072|NCT00871871|559981843|FG000|Part II|Protocol Violation|0|||
155150073|NCT00871871|559981844|FG001|Part II|Protocol Violation|0|||
155150074|NCT00871871|559981845|FG002|Part II|Protocol Violation|0|||
155150075|NCT00871871|559981846|FG003|Part II|Protocol Violation|1|||
155150076|NCT02354235|559981847|FG000|Overall Study|Adverse Event|2|||
155150077|NCT02354235|559981848|FG001|Overall Study|Adverse Event|2|||
155150078|NCT02354235|559981847|FG000|Overall Study|Physician Decision|0|||
155150079|NCT02354235|559981848|FG001|Overall Study|Physician Decision|1|||
155150080|NCT02354235|559981847|FG000|Overall Study|Withdrawal by Subject|1|||
155150081|NCT02354235|559981848|FG001|Overall Study|Withdrawal by Subject|3|||
155150082|NCT02354235|559981847|FG000|Overall Study|Conflict with the stopping criteria|0|||
155150083|NCT02354235|559981848|FG001|Overall Study|Conflict with the stopping criteria|1|||
155150084|NCT03069352|559981849|FG000|Overall Study|Ongoing|12|||
155150085|NCT03069352|559981850|FG001|Overall Study|Ongoing|40|||
155150086|NCT02621424|559981851|FG000|Overall Study|Withdrawal by Subject|1|||
155150087|NCT02621424|559981852|FG001|Overall Study|Withdrawal by Subject|2|||
155150088|NCT05148234|559981854|FG000|Phase I|Ineligible|0|||
155150089|NCT05148234|559981855|FG001|Phase I|Ineligible|0|||
155150090|NCT05148234|559981856|FG002|Phase I|Ineligible|0|||
155150091|NCT05148234|559981857|FG003|Phase I|Ineligible|0|||
155150092|NCT05148234|559981858|FG004|Phase I|Ineligible|0|||
155150093|NCT05148234|559981859|FG005|Phase I|Ineligible|0|||
155150094|NCT05148234|559981860|FG006|Phase I|Ineligible|0|||
155150095|NCT05148234|559981861|FG007|Phase I|Ineligible|1|||
155150096|NCT05148234|559981854|FG000|Phase I|Company closed the trial.|0|||
155150097|NCT05148234|559981855|FG001|Phase I|Company closed the trial.|1|||
155150098|NCT05148234|559981856|FG002|Phase I|Company closed the trial.|0|||
155150099|NCT05148234|559981857|FG003|Phase I|Company closed the trial.|0|||
155150100|NCT05148234|559981858|FG004|Phase I|Company closed the trial.|0|||
155150101|NCT05148234|559981859|FG005|Phase I|Company closed the trial.|0|||
155150102|NCT05148234|559981860|FG006|Phase I|Company closed the trial.|0|||
155150103|NCT05148234|559981861|FG007|Phase I|Company closed the trial.|0|||
155150104|NCT04750642|559981863|FG000|Overall Study|Adverse Event|1|||
155150105|NCT04750642|559981864|FG001|Overall Study|Adverse Event|0|||
155150106|NCT04750642|559981863|FG000|Overall Study|Withdrawal by Subject|0|||
155150107|NCT04750642|559981864|FG001|Overall Study|Withdrawal by Subject|1|||
155150108|NCT04750642|559981863|FG000|Overall Study|Protocol Violation|0|||
155150109|NCT04750642|559981864|FG001|Overall Study|Protocol Violation|1|||
155150110|NCT01650194|559981866|FG000|Overall Study|Progressive Disease (PD)|35|||
155150111|NCT01650194|559981866|FG000|Overall Study|Withdrawal by Subject|2|||
155150112|NCT01650194|559981866|FG000|Overall Study|Miscellaneous|10|||
155150113|NCT01908426|559983579|FG000|Overall Study|Adverse Event|98|||
155150114|NCT01908426|559983580|FG001|Overall Study|Adverse Event|11|||
155150115|NCT01908426|559983579|FG000|Overall Study|Clinical Deterioration|72|||
155150116|NCT01908426|559983580|FG001|Overall Study|Clinical Deterioration|38|||
155150117|NCT01908426|559983579|FG000|Overall Study|Lack of Efficacy|3|||
155150118|NCT01908426|559983580|FG001|Overall Study|Lack of Efficacy|0|||
155150119|NCT01908426|559983579|FG000|Overall Study|Lost to Follow-up|0|||
155150120|NCT01908426|559983580|FG001|Overall Study|Lost to Follow-up|1|||
155150121|NCT01908426|559983579|FG000|Overall Study|Physician Decision|3|||
155150122|NCT01908426|559983580|FG001|Overall Study|Physician Decision|3|||
155150123|NCT01908426|559983579|FG000|Overall Study|Withdrawal by Subject|11|||
155150124|NCT01908426|559983580|FG001|Overall Study|Withdrawal by Subject|6|||
155150125|NCT01908426|559983579|FG000|Overall Study|Progressive Disease|206|||
155150126|NCT01908426|559983580|FG001|Overall Study|Progressive Disease|152|||
155150127|NCT01908426|559983579|FG000|Overall Study|Protocol Violation|1|||
155150128|NCT01908426|559983580|FG001|Overall Study|Protocol Violation|0|||
155150129|NCT01908426|559983579|FG000|Overall Study|No Study Treatment Given|3|||
155150130|NCT01908426|559983580|FG001|Overall Study|No Study Treatment Given|0|||
155150131|NCT01419236|559983593|FG000|Overall Study|Adverse Event|1|||
155150132|NCT01419236|559983594|FG001|Overall Study|Adverse Event|0|||
155150133|NCT01419236|559983593|FG000|Overall Study|Lack of Efficacy|0|||
155150134|NCT01419236|559983594|FG001|Overall Study|Lack of Efficacy|1|||
155150135|NCT01419236|559983593|FG000|Overall Study|Lost to Follow-up|1|||
155150136|NCT01419236|559983594|FG001|Overall Study|Lost to Follow-up|0|||
155150137|NCT01419236|559983593|FG000|Overall Study|Physician Decision|1|||
155150138|NCT01419236|559983594|FG001|Overall Study|Physician Decision|0|||
155150139|NCT01419236|559983593|FG000|Overall Study|Withdrawal by Subject|1|||
155150140|NCT01419236|559983594|FG001|Overall Study|Withdrawal by Subject|4|||
155150141|NCT01419236|559983593|FG000|Overall Study|Entry Criteria Not Met|1|||
155150142|NCT01419236|559983594|FG001|Overall Study|Entry Criteria Not Met|0|||
155150143|NCT03224130|559983595|FG000|Overall Study|consent issue|0|||
155150144|NCT03224130|559983596|FG001|Overall Study|consent issue|1|||
155150145|NCT04124939|559983605|FG000|Overall Study|Lost to Follow-up|1|||
155150146|NCT04124939|559983606|FG001|Overall Study|Lost to Follow-up|3|||
155150147|NCT01838694|559983607|FG000|Overall Study|Adverse Event|0|||
155150148|NCT01838694|559983608|FG001|Overall Study|Adverse Event|1|||
155150149|NCT02210000|559983610|FG000|Overall Study|Study Terminated|11|||
155150150|NCT02210000|559983611|FG001|Overall Study|Study Terminated|12|||
155150151|NCT02210000|559983610|FG000|Overall Study|Withdrawal by Subject|7|||
155150152|NCT02210000|559983611|FG001|Overall Study|Withdrawal by Subject|1|||
155150153|NCT02210000|559983610|FG000|Overall Study|Adverse Event|1|||
155150154|NCT02210000|559983611|FG001|Overall Study|Adverse Event|5|||
155150155|NCT02210000|559983610|FG000|Overall Study|Lost to Follow-up|0|||
155150156|NCT02210000|559983611|FG001|Overall Study|Lost to Follow-up|2|||
155150157|NCT02210000|559983610|FG000|Overall Study|Physician Decision|0|||
155150158|NCT02210000|559983611|FG001|Overall Study|Physician Decision|1|||
155150159|NCT00308139|559983612|FG000|Overall Study|Adverse Event|20|||
155150160|NCT00308139|559983613|FG001|Overall Study|Adverse Event|14|||
155150161|NCT00308139|559983612|FG000|Overall Study|Lost to Follow-up|13|||
155150162|NCT00308139|559983613|FG001|Overall Study|Lost to Follow-up|8|||
155150163|NCT00308139|559983612|FG000|Overall Study|Protocol Violation|3|||
155150164|NCT00308139|559983613|FG001|Overall Study|Protocol Violation|2|||
155150165|NCT00308139|559983612|FG000|Overall Study|Withdrawal of Consent|40|||
155150166|NCT00308139|559983613|FG001|Overall Study|Withdrawal of Consent|42|||
155150167|NCT00308139|559983612|FG000|Overall Study|Investigator Decision|11|||
155150168|NCT00308139|559983613|FG001|Overall Study|Investigator Decision|10|||
155150169|NCT00308139|559983612|FG000|Overall Study|Loss of Glucose Control|5|||
155150170|NCT00308139|559983613|FG001|Overall Study|Loss of Glucose Control|7|||
155150171|NCT00308139|559983612|FG000|Overall Study|Administrative|1|||
155150172|NCT00308139|559983613|FG001|Overall Study|Administrative|4|||
155150173|NCT00308139|559983612|FG000|Overall Study|Other|1|||
155150174|NCT00308139|559983613|FG001|Overall Study|Other|0|||
155150175|NCT01751061|559983622|FG000|Overall Study|Death|1|||
155150176|NCT01751061|559983623|FG001|Overall Study|Death|0|||
155150177|NCT01751061|559983622|FG000|Overall Study|patient death|5|||
155150178|NCT01751061|559983623|FG001|Overall Study|patient death|0|||
155150179|NCT01751061|559983622|FG000|Overall Study|Lost to Follow-up|40|||
155197449|NCT00369824|560159786|FG002|Overall Study|Withdrawal by Subject|5|||
155197450|NCT00369824|560159787|FG003|Overall Study|Withdrawal by Subject|4|||
155197451|NCT00369824|560159788|FG004|Overall Study|Withdrawal by Subject|6|||
155197452|NCT00369824|560159789|FG005|Overall Study|Withdrawal by Subject|2|||
155197453|NCT00369824|560159784|FG000|Overall Study|Lost to Follow-up|6|||
155197454|NCT00369824|560159785|FG001|Overall Study|Lost to Follow-up|11|||
155197455|NCT00369824|560159786|FG002|Overall Study|Lost to Follow-up|7|||
155197456|NCT00369824|560159787|FG003|Overall Study|Lost to Follow-up|8|||
155197457|NCT00369824|560159788|FG004|Overall Study|Lost to Follow-up|9|||
155197458|NCT00369824|560159789|FG005|Overall Study|Lost to Follow-up|6|||
155197459|NCT00369824|560159784|FG000|Overall Study|Other|0|||
155197460|NCT00369824|560159785|FG001|Overall Study|Other|0|||
155197461|NCT00369824|560159786|FG002|Overall Study|Other|0|||
155197462|NCT00369824|560159787|FG003|Overall Study|Other|2|||
155197463|NCT00369824|560159788|FG004|Overall Study|Other|1|||
155197464|NCT00369824|560159789|FG005|Overall Study|Other|3|||
155197465|NCT01484275|560159793|FG000|Overall Study|Study terminated by sponsor|28|||
155197466|NCT01484275|560159794|FG001|Overall Study|Study terminated by sponsor|32|||
155197467|NCT01484275|560159793|FG000|Overall Study|Other|10|||
155197468|NCT01484275|560159794|FG001|Overall Study|Other|0|||
155197469|NCT01484275|560159793|FG000|Overall Study|Death|3|||
155197470|NCT01484275|560159794|FG001|Overall Study|Death|4|||
155197471|NCT01484275|560159793|FG000|Overall Study|Withdrawal by Subject|1|||
155197472|NCT01484275|560159794|FG001|Overall Study|Withdrawal by Subject|5|||
155197473|NCT01484275|560159793|FG000|Overall Study|Lost to Follow-up|1|||
155197474|NCT01484275|560159794|FG001|Overall Study|Lost to Follow-up|1|||
155197475|NCT00003487|560159795|FG000|Overall Study|Not evaluable|2|||
155197476|NCT04154930|560159798|FG000|Overall Study|Withdrawal by Subject|15|||
155197477|NCT04154930|560159799|FG001|Overall Study|Withdrawal by Subject|6|||
155197478|NCT04154930|560159798|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
155197479|NCT04154930|560159799|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
155150180|NCT01751061|559983623|FG001|Overall Study|Lost to Follow-up|25|||
155150181|NCT01751061|559983622|FG000|Overall Study|patient regained decisional capacity|4|||
155150182|NCT01751061|559983623|FG001|Overall Study|patient regained decisional capacity|8|||
155150183|NCT01751061|559983622|FG000|Overall Study|Withdrawal by Subject|4|||
155150184|NCT01751061|559983623|FG001|Overall Study|Withdrawal by Subject|1|||
155150185|NCT01751061|559983622|FG000|Overall Study|Physician Decision|2|||
155150186|NCT01751061|559983623|FG001|Overall Study|Physician Decision|0|||
155150187|NCT00768989|559983628|FG000|Prior to Week 24|Withdrawal by Subject|1|||
155150188|NCT00768989|559983629|FG001|Prior to Week 24|Withdrawal by Subject|0|||
155150189|NCT00768989|559983628|FG000|Prior to Week 24|Adverse Event|3|||
155150190|NCT00768989|559983629|FG001|Prior to Week 24|Adverse Event|0|||
155150191|NCT00768989|559983628|FG000|Prior to Week 24|Lost to Follow-up|0|||
155150192|NCT00768989|559983629|FG001|Prior to Week 24|Lost to Follow-up|1|||
155150193|NCT00768989|559983628|FG000|Prior to Week 24|Protocol Violation|0|||
155150194|NCT00768989|559983629|FG001|Prior to Week 24|Protocol Violation|2|||
155150195|NCT00768989|559983628|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
155150196|NCT00768989|559983629|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
155150197|NCT00768989|559983628|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
155150198|NCT00768989|559983629|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
155150199|NCT00768989|559983628|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
155150200|NCT00768989|559983629|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
155150201|NCT00768989|559983628|FG000|On or After Week 36|Lack of Efficacy|1|||
155150202|NCT00768989|559983629|FG001|On or After Week 36|Lack of Efficacy|0|||
155150203|NCT00768989|559983628|FG000|On or After Week 36|Adverse Event|0|||
155150204|NCT00768989|559983629|FG001|On or After Week 36|Adverse Event|1|||
155150205|NCT00768989|559983628|FG000|On or After Week 36|Lost to Follow-up|1|||
155150206|NCT00768989|559983629|FG001|On or After Week 36|Lost to Follow-up|0|||
155150207|NCT00768989|559983628|FG000|On or After Week 36|Poor Compliance|1|||
155150208|NCT00768989|559983629|FG001|On or After Week 36|Poor Compliance|0|||
155150209|NCT00768989|559983628|FG000|On or After Week 36|Protocol Violation|1|||
155150210|NCT00768989|559983629|FG001|On or After Week 36|Protocol Violation|0|||
155150211|NCT00768989|559983628|FG000|On or After Week 36|Did not attend termination visit|2|||
155150212|NCT00768989|559983629|FG001|On or After Week 36|Did not attend termination visit|0|||
155150213|NCT00768989|559983628|FG000|On or After Week 36|Sponsor Termination|45|||
155197480|NCT04154930|560159798|FG000|Overall Study|Lost to Follow-up|14|||
155197481|NCT04154930|560159799|FG001|Overall Study|Lost to Follow-up|6|||
155197482|NCT04154930|560159798|FG000|Overall Study|Other|6|||
155197483|NCT04154930|560159799|FG001|Overall Study|Other|0|||
155197484|NCT00657358|560159800|FG000|Overall Study|Lack of Efficacy|6|||
155197485|NCT04203797|560159808|FG000|Overall Study|Adverse Event|1|||
155197486|NCT04203797|560159809|FG001|Overall Study|Adverse Event|0|||
155150214|NCT00768989|559983629|FG001|On or After Week 36|Sponsor Termination|26|||
155150215|NCT02153086|559983630|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
155150216|NCT02153086|559983630|FG000|Overall Study|Other|2|||
155197487|NCT04203797|560159808|FG000|Overall Study|Did not complete End of Study follow-up|1|||
155197488|NCT04203797|560159809|FG001|Overall Study|Did not complete End of Study follow-up|0|||
155197489|NCT00678080|560159810|FG000|Overall Study|Physician Decision|2|||
155197490|NCT00678080|560159811|FG001|Overall Study|Physician Decision|0|||
155197491|NCT00678080|560159810|FG000|Overall Study|Lost to Follow-up|1|||
155197492|NCT00678080|560159811|FG001|Overall Study|Lost to Follow-up|0|||
155197493|NCT00678080|560159810|FG000|Overall Study|Withdrawal by Subject|0|||
155197494|NCT00678080|560159811|FG001|Overall Study|Withdrawal by Subject|1|||
155197495|NCT01453361|560159812|FG000|Overall Study|Disease Progression|6|||
155197496|NCT01453361|560159812|FG000|Overall Study|Screen-Failures|10|||
155197497|NCT01752985|560159813|FG000|Treatment Period|Subject request to discontinue treatment|1|||
155197498|NCT01752985|560159814|FG001|Treatment Period|Subject request to discontinue treatment|0|||
155197499|NCT01752985|560159815|FG002|Treatment Period|Subject request to discontinue treatment|1|||
155197500|NCT01752985|560159813|FG000|Treatment Period|Subject no longer meets study criteria|0|||
155197501|NCT01752985|560159814|FG001|Treatment Period|Subject no longer meets study criteria|1|||
155197502|NCT01752985|560159815|FG002|Treatment Period|Subject no longer meets study criteria|1|||
155197503|NCT01752985|560159813|FG000|Treatment Period|Adverse Event|2|||
155197504|NCT01752985|560159814|FG001|Treatment Period|Adverse Event|1|||
155197505|NCT01752985|560159815|FG002|Treatment Period|Adverse Event|2|||
155197506|NCT01752985|560159813|FG000|Treatment Period|Withdrawal by Subject|1|||
155197507|NCT01752985|560159814|FG001|Treatment Period|Withdrawal by Subject|1|||
155197508|NCT01752985|560159815|FG002|Treatment Period|Withdrawal by Subject|0|||
155197509|NCT01752985|560159813|FG000|Treatment Period|Lost to Follow-up|0|||
155197510|NCT01752985|560159814|FG001|Treatment Period|Lost to Follow-up|0|||
155197511|NCT01752985|560159815|FG002|Treatment Period|Lost to Follow-up|1|||
155197512|NCT01385566|560161652|FG000|Overall Study|Lost to Follow-up|1|||
155197513|NCT01385566|560161653|FG001|Overall Study|Lost to Follow-up|0|||
155197514|NCT01385566|560161654|FG002|Overall Study|Lost to Follow-up|0|||
155197515|NCT01385566|560161655|FG003|Overall Study|Lost to Follow-up|0|||
155197516|NCT01385566|560161656|FG004|Overall Study|Lost to Follow-up|0|||
155197517|NCT01385566|560161657|FG005|Overall Study|Lost to Follow-up|0|||
155197518|NCT01385566|560161652|FG000|Overall Study|Withdrawal by Subject|0|||
155197519|NCT01385566|560161653|FG001|Overall Study|Withdrawal by Subject|0|||
155197520|NCT01385566|560161654|FG002|Overall Study|Withdrawal by Subject|0|||
155197521|NCT01385566|560161655|FG003|Overall Study|Withdrawal by Subject|1|||
155197522|NCT01385566|560161656|FG004|Overall Study|Withdrawal by Subject|0|||
155197523|NCT01385566|560161657|FG005|Overall Study|Withdrawal by Subject|0|||
155197524|NCT00967668|560161658|FG000|Overall Study|Withdrawal by Subject|13|||
155197525|NCT00967668|560161659|FG001|Overall Study|Withdrawal by Subject|8|||
155197526|NCT00967668|560161660|FG002|Overall Study|Withdrawal by Subject|8|||
155197527|NCT00967668|560161658|FG000|Overall Study|Death|0|||
155197528|NCT00967668|560161659|FG001|Overall Study|Death|2|||
155197529|NCT00967668|560161660|FG002|Overall Study|Death|4|||
155197530|NCT00967668|560161658|FG000|Overall Study|Removed due to behavior|1|||
155197531|NCT00967668|560161659|FG001|Overall Study|Removed due to behavior|1|||
155197532|NCT00967668|560161660|FG002|Overall Study|Removed due to behavior|2|||
155197533|NCT00967668|560161658|FG000|Overall Study|Refused Year 2|11|||
155197534|NCT00967668|560161659|FG001|Overall Study|Refused Year 2|6|||
155197535|NCT00967668|560161660|FG002|Overall Study|Refused Year 2|4|||
155197536|NCT00967668|560161658|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
155197537|NCT00967668|560161659|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
155197538|NCT00967668|560161660|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
155197539|NCT00967668|560161658|FG000|Overall Study|Lost to Follow-up|15|||
155197540|NCT00967668|560161659|FG001|Overall Study|Lost to Follow-up|9|||
155197541|NCT00967668|560161660|FG002|Overall Study|Lost to Follow-up|16|||
155197542|NCT00967668|560161658|FG000|Overall Study|Refused 12-mo assessment|3|||
155150217|NCT00791388|559983631|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155150218|NCT00791388|559983632|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
155150219|NCT00791388|559983633|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155150220|NCT00791388|559983634|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155150221|NCT00791388|559983635|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
155150222|NCT00791388|559983631|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
155150223|NCT00791388|559983632|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155150224|NCT00791388|559983633|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155197543|NCT00967668|560161659|FG001|Overall Study|Refused 12-mo assessment|1|||
155197544|NCT00967668|560161660|FG002|Overall Study|Refused 12-mo assessment|9|||
155197545|NCT00967668|560161658|FG000|Overall Study|Pregnancy|1|||
155197546|NCT00967668|560161659|FG001|Overall Study|Pregnancy|0|||
155197547|NCT00967668|560161660|FG002|Overall Study|Pregnancy|0|||
155197548|NCT02468674|560161663|FG000|Overall Study|Adverse Event|0|||
155197549|NCT02468674|560161664|FG001|Overall Study|Adverse Event|0|||
155197550|NCT02468674|560161665|FG002|Overall Study|Adverse Event|0|||
155197551|NCT02468674|560161666|FG003|Overall Study|Adverse Event|1|||
155197552|NCT02468674|560161667|FG004|Overall Study|Adverse Event|0|||
155197553|NCT02468674|560161668|FG005|Overall Study|Adverse Event|1|||
155197554|NCT02468674|560161669|FG006|Overall Study|Adverse Event|0|||
155197555|NCT02468674|560161670|FG007|Overall Study|Adverse Event|0|||
155197556|NCT02468674|560161671|FG008|Overall Study|Adverse Event|0|||
155197557|NCT02468674|560161663|FG000|Overall Study|Lost to Follow-up|1|||
155150225|NCT00791388|559983634|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155150226|NCT00791388|559983635|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
155150227|NCT00791388|559983631|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155150228|NCT00791388|559983632|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155150229|NCT00791388|559983633|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155150230|NCT00791388|559983634|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
155150231|NCT00791388|559983635|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
155150232|NCT01194830|559983636|FG000|Overall Study|Adverse Event|3|||
155150233|NCT01194830|559983637|FG001|Overall Study|Adverse Event|2|||
155150234|NCT01194830|559983636|FG000|Overall Study|Protocol Violation|5|||
155150235|NCT01194830|559983637|FG001|Overall Study|Protocol Violation|4|||
155150236|NCT01194830|559983636|FG000|Overall Study|Lost to Follow-up|9|||
155150237|NCT01194830|559983637|FG001|Overall Study|Lost to Follow-up|7|||
155150238|NCT01194830|559983636|FG000|Overall Study|Withdrawal by Subject|2|||
155150239|NCT01194830|559983637|FG001|Overall Study|Withdrawal by Subject|1|||
155150240|NCT01194830|559983636|FG000|Overall Study|Lack of Efficacy|1|||
155150241|NCT01194830|559983637|FG001|Overall Study|Lack of Efficacy|1|||
155150242|NCT01194830|559983636|FG000|Overall Study|Non-compliance issues|4|||
155150243|NCT01194830|559983637|FG001|Overall Study|Non-compliance issues|4|||
155150244|NCT01194830|559983636|FG000|Overall Study|Other Reason|12|||
155150245|NCT01194830|559983637|FG001|Overall Study|Other Reason|8|||
155150246|NCT03115359|559983638|FG000|Overall Study|Withdrawal by Subject|29|||
155150247|NCT03115359|559983639|FG001|Overall Study|Withdrawal by Subject|39|||
155150248|NCT03115359|559983638|FG000|Overall Study|Scheduling conflict|25|||
155150249|NCT03115359|559983639|FG001|Overall Study|Scheduling conflict|23|||
155150250|NCT03115359|559983638|FG000|Overall Study|Personal reasons including health|12|||
155150251|NCT03115359|559983639|FG001|Overall Study|Personal reasons including health|9|||
155150252|NCT03115359|559983638|FG000|Overall Study|Transportation barriers|3|||
155150253|NCT03115359|559983639|FG001|Overall Study|Transportation barriers|0|||
155150254|NCT03115359|559983638|FG000|Overall Study|No longer interested|5|||
155150255|NCT03115359|559983639|FG001|Overall Study|No longer interested|4|||
155150256|NCT03115359|559983638|FG000|Overall Study|No reason provided|45|||
155150257|NCT03115359|559983639|FG001|Overall Study|No reason provided|47|||
155150258|NCT01317472|559983640|FG000|Overall Study|Withdrawal by Subject|1|||
155150259|NCT01317472|559983641|FG001|Overall Study|Withdrawal by Subject|0|||
155150260|NCT01317472|559983640|FG000|Overall Study|Unrelated hospitalization|1|||
155150261|NCT01317472|559983641|FG001|Overall Study|Unrelated hospitalization|0|||
155150262|NCT01815918|559983642|FG000|Overall Study|Patient samples not analyzable|3|||
155150263|NCT01815918|559983643|FG001|Overall Study|Patient samples not analyzable|4|||
155150264|NCT01815918|559983642|FG000|Overall Study|Lack of Efficacy|15|||
155150265|NCT01815918|559983643|FG001|Overall Study|Lack of Efficacy|15|||
155150266|NCT02412306|559983655|FG000|Overall Study|Lost to Follow-up|0|||
155150267|NCT02412306|559983656|FG001|Overall Study|Lost to Follow-up|1|||
155150268|NCT02412306|559983657|FG002|Overall Study|Lost to Follow-up|0|||
155150269|NCT02412306|559983658|FG003|Overall Study|Lost to Follow-up|0|||
155150270|NCT02412306|559983659|FG004|Overall Study|Lost to Follow-up|0|||
155150271|NCT02412306|559983655|FG000|Overall Study|Withdrawal by Subject|0|||
155150272|NCT02412306|559983656|FG001|Overall Study|Withdrawal by Subject|0|||
155150273|NCT02412306|559983657|FG002|Overall Study|Withdrawal by Subject|1|||
155150274|NCT02412306|559983658|FG003|Overall Study|Withdrawal by Subject|0|||
155150275|NCT02412306|559983659|FG004|Overall Study|Withdrawal by Subject|0|||
155150276|NCT02412306|559983655|FG000|Overall Study|Death|5|||
155150277|NCT02412306|559983656|FG001|Overall Study|Death|7|||
155150278|NCT02412306|559983657|FG002|Overall Study|Death|15|||
155150279|NCT02412306|559983658|FG003|Overall Study|Death|0|||
155150280|NCT02412306|559983659|FG004|Overall Study|Death|2|||
155150281|NCT00443040|559983665|FG000|Overall Study|Withdrawal by Subject|1|||
155150282|NCT00443040|559983666|FG001|Overall Study|Withdrawal by Subject|0|||
155150283|NCT00443040|559983667|FG002|Overall Study|Withdrawal by Subject|0|||
155150284|NCT00443040|559983665|FG000|Overall Study|Converted to an open laparotomy|3|||
155150285|NCT00443040|559983666|FG001|Overall Study|Converted to an open laparotomy|0|||
155150286|NCT00443040|559983667|FG002|Overall Study|Converted to an open laparotomy|1|||
155150287|NCT00866177|559983668|FG000|Overall Study|Withdrawal by Subject|1|||
155150288|NCT00866177|559983668|FG000|Overall Study|Not Treated|151|||
155150289|NCT00435409|559983670|FG000|Overall Study|Protocol Violation|1|||
155150290|NCT00435409|559983671|FG001|Overall Study|Protocol Violation|2|||
155150291|NCT00435409|559983672|FG002|Overall Study|Protocol Violation|0|||
155150292|NCT00435409|559983670|FG000|Overall Study|Lost to Follow-up|1|||
155150293|NCT00435409|559983671|FG001|Overall Study|Lost to Follow-up|2|||
155150294|NCT00435409|559983672|FG002|Overall Study|Lost to Follow-up|0|||
155150295|NCT00435409|559983670|FG000|Overall Study|Death|8|||
155150296|NCT00435409|559983671|FG001|Overall Study|Death|6|||
155150297|NCT00435409|559983672|FG002|Overall Study|Death|6|||
155150298|NCT00435409|559983670|FG000|Overall Study|Objective progression or relapse|158|||
155150299|NCT00435409|559983671|FG001|Overall Study|Objective progression or relapse|93|||
155150300|NCT00435409|559983672|FG002|Overall Study|Objective progression or relapse|58|||
155150301|NCT00435409|559983670|FG000|Overall Study|Global deterioration of health status|0|||
155197558|NCT02468674|560161664|FG001|Overall Study|Lost to Follow-up|0|||
155197559|NCT02468674|560161665|FG002|Overall Study|Lost to Follow-up|0|||
155197560|NCT02468674|560161666|FG003|Overall Study|Lost to Follow-up|0|||
155197561|NCT02468674|560161667|FG004|Overall Study|Lost to Follow-up|0|||
155197562|NCT02468674|560161668|FG005|Overall Study|Lost to Follow-up|0|||
155197563|NCT02468674|560161669|FG006|Overall Study|Lost to Follow-up|0|||
155197564|NCT02468674|560161670|FG007|Overall Study|Lost to Follow-up|1|||
155197565|NCT02468674|560161671|FG008|Overall Study|Lost to Follow-up|1|||
155197566|NCT02468674|560161663|FG000|Overall Study|Physician Decision|0|||
155197567|NCT02468674|560161664|FG001|Overall Study|Physician Decision|0|||
155197568|NCT02468674|560161665|FG002|Overall Study|Physician Decision|0|||
155197569|NCT02468674|560161666|FG003|Overall Study|Physician Decision|0|||
155197570|NCT02468674|560161667|FG004|Overall Study|Physician Decision|0|||
155197571|NCT02468674|560161668|FG005|Overall Study|Physician Decision|0|||
155197572|NCT02468674|560161669|FG006|Overall Study|Physician Decision|1|||
155197573|NCT02468674|560161670|FG007|Overall Study|Physician Decision|0|||
155197574|NCT02468674|560161671|FG008|Overall Study|Physician Decision|0|||
155197575|NCT02468674|560161663|FG000|Overall Study|Patient/Guardian Decision|0|||
155197576|NCT02468674|560161664|FG001|Overall Study|Patient/Guardian Decision|0|||
155197577|NCT02468674|560161665|FG002|Overall Study|Patient/Guardian Decision|0|||
155197578|NCT02468674|560161666|FG003|Overall Study|Patient/Guardian Decision|0|||
155197579|NCT02468674|560161667|FG004|Overall Study|Patient/Guardian Decision|1|||
155197580|NCT02468674|560161668|FG005|Overall Study|Patient/Guardian Decision|0|||
155197581|NCT02468674|560161669|FG006|Overall Study|Patient/Guardian Decision|0|||
155197582|NCT02468674|560161670|FG007|Overall Study|Patient/Guardian Decision|2|||
155197583|NCT02468674|560161671|FG008|Overall Study|Patient/Guardian Decision|1|||
155197584|NCT02468674|560161663|FG000|Overall Study|Protocol Deviation|0|||
155197585|NCT02468674|560161664|FG001|Overall Study|Protocol Deviation|0|||
155197586|NCT02468674|560161665|FG002|Overall Study|Protocol Deviation|0|||
155197587|NCT02468674|560161666|FG003|Overall Study|Protocol Deviation|0|||
155197588|NCT02468674|560161667|FG004|Overall Study|Protocol Deviation|0|||
155197589|NCT02468674|560161668|FG005|Overall Study|Protocol Deviation|0|||
155197590|NCT02468674|560161669|FG006|Overall Study|Protocol Deviation|0|||
155197591|NCT02468674|560161670|FG007|Overall Study|Protocol Deviation|1|||
155197592|NCT02468674|560161671|FG008|Overall Study|Protocol Deviation|1|||
155197593|NCT01644565|560161674|FG000|Overall Study|Undisclosed Medical History|1|||
155197594|NCT01644565|560161675|FG001|Overall Study|Undisclosed Medical History|0|||
155197595|NCT01644565|560161676|FG002|Overall Study|Undisclosed Medical History|0|||
155197596|NCT01644565|560161677|FG003|Overall Study|Undisclosed Medical History|0|||
155197597|NCT01644565|560161678|FG004|Overall Study|Undisclosed Medical History|0|||
155197598|NCT01644565|560161679|FG005|Overall Study|Undisclosed Medical History|0|||
155197599|NCT01644565|560161680|FG006|Overall Study|Undisclosed Medical History|0|||
155197600|NCT01644565|560161681|FG007|Overall Study|Undisclosed Medical History|0|||
155197601|NCT01644565|560161682|FG008|Overall Study|Undisclosed Medical History|0|||
155197602|NCT01644565|560161674|FG000|Overall Study|Lost to Follow-up|0|||
155197603|NCT01644565|560161675|FG001|Overall Study|Lost to Follow-up|0|||
155197604|NCT01644565|560161676|FG002|Overall Study|Lost to Follow-up|0|||
155197605|NCT01644565|560161677|FG003|Overall Study|Lost to Follow-up|1|||
155197606|NCT01644565|560161678|FG004|Overall Study|Lost to Follow-up|0|||
155197607|NCT01644565|560161679|FG005|Overall Study|Lost to Follow-up|0|||
155197608|NCT01644565|560161680|FG006|Overall Study|Lost to Follow-up|0|||
155197609|NCT01644565|560161681|FG007|Overall Study|Lost to Follow-up|2|||
155197610|NCT01644565|560161682|FG008|Overall Study|Lost to Follow-up|0|||
155197611|NCT01644565|560161674|FG000|Overall Study|Family emergency|0|||
155197612|NCT01644565|560161675|FG001|Overall Study|Family emergency|0|||
155197613|NCT01644565|560161676|FG002|Overall Study|Family emergency|0|||
155197614|NCT01644565|560161677|FG003|Overall Study|Family emergency|0|||
155197615|NCT01644565|560161678|FG004|Overall Study|Family emergency|1|||
155197616|NCT01644565|560161679|FG005|Overall Study|Family emergency|0|||
155197617|NCT01644565|560161680|FG006|Overall Study|Family emergency|0|||
155197618|NCT01644565|560161681|FG007|Overall Study|Family emergency|0|||
155197619|NCT01644565|560161682|FG008|Overall Study|Family emergency|0|||
155197620|NCT01644565|560161674|FG000|Overall Study|Relocation|0|||
155197621|NCT01644565|560161675|FG001|Overall Study|Relocation|0|||
155197622|NCT01644565|560161676|FG002|Overall Study|Relocation|0|||
155197623|NCT01644565|560161677|FG003|Overall Study|Relocation|0|||
155197624|NCT01644565|560161678|FG004|Overall Study|Relocation|0|||
155197625|NCT01644565|560161679|FG005|Overall Study|Relocation|0|||
155197626|NCT01644565|560161680|FG006|Overall Study|Relocation|0|||
155197627|NCT01644565|560161681|FG007|Overall Study|Relocation|0|||
155197628|NCT01644565|560161682|FG008|Overall Study|Relocation|1|||
155197629|NCT02195583|560161685|FG000|Overall Study|Lost to Follow-up|1|||
155197630|NCT02195583|560161685|FG000|Overall Study|Withdrawal by Subject|4|||
155197631|NCT02195583|560161685|FG000|Overall Study|Adverse Event|2|||
155197632|NCT02195583|560161685|FG000|Overall Study|Other Reason|2|||
155197633|NCT00040365|560161688|FG000|Overall Study|Death|1|||
155197634|NCT00040365|560161688|FG000|Overall Study|Progressive disease|7|||
155197635|NCT00040365|560161688|FG000|Overall Study|Lost to Follow-up|3|||
155197636|NCT00680017|560161689|FG000|Overall Study|Adverse Event|13|||
155197637|NCT00680017|560161690|FG001|Overall Study|Adverse Event|7|||
155150302|NCT00435409|559983671|FG001|Overall Study|Global deterioration of health status|0|||
155150303|NCT00435409|559983672|FG002|Overall Study|Global deterioration of health status|4|||
155150304|NCT00435409|559983670|FG000|Overall Study|Withdrawal by Subject|8|||
155150305|NCT00435409|559983671|FG001|Overall Study|Withdrawal by Subject|7|||
155150306|NCT00435409|559983672|FG002|Overall Study|Withdrawal by Subject|1|||
155150307|NCT00435409|559983670|FG000|Overall Study|Other|45|||
155150308|NCT00435409|559983671|FG001|Overall Study|Other|30|||
155150309|NCT00435409|559983672|FG002|Overall Study|Other|1|||
155150310|NCT00435409|559983670|FG000|Overall Study|Adverse Event|0|||
155150311|NCT00435409|559983671|FG001|Overall Study|Adverse Event|0|||
155150312|NCT00435409|559983672|FG002|Overall Study|Adverse Event|8|||
155150313|NCT00435409|559983670|FG000|Overall Study|Sponsor decision|0|||
155150314|NCT00435409|559983671|FG001|Overall Study|Sponsor decision|3|||
155150315|NCT00435409|559983672|FG002|Overall Study|Sponsor decision|0|||
155150316|NCT00117637|559983677|FG000|First Intervention (Period 1)|Adverse Event|11|||
155150317|NCT00117637|559983678|FG001|First Intervention (Period 1)|Adverse Event|16|||
155150318|NCT00117637|559983677|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
155150319|NCT00117637|559983678|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
155150320|NCT00117637|559983677|FG000|First Intervention (Period 1)|Protocol Violation|1|||
155150321|NCT00117637|559983678|FG001|First Intervention (Period 1)|Protocol Violation|0|||
155150322|NCT00117637|559983677|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
155150323|NCT00117637|559983678|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
155150324|NCT00117637|559983677|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
155150325|NCT00117637|559983678|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
155150326|NCT00117637|559983677|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
155150327|NCT00117637|559983678|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
155150328|NCT00117637|559983677|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
155150329|NCT00117637|559983678|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
155150330|NCT00117637|559983677|FG000|First Intervention (Period 1)|reason not reported|0|||
155150331|NCT00117637|559983678|FG001|First Intervention (Period 1)|reason not reported|1|||
155150332|NCT00117637|559983677|FG000|Second Intervention (Period 2)|Adverse Event|0|||
155150333|NCT00117637|559983678|FG001|Second Intervention (Period 2)|Adverse Event|9|||
155150334|NCT00117637|559983677|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
155150335|NCT00117637|559983678|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
155150336|NCT00117637|559983677|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
155150337|NCT00117637|559983678|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
155150338|NCT00117637|559983677|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
155150339|NCT00117637|559983678|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
155150340|NCT00117637|559983677|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
155150341|NCT00117637|559983678|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
155150342|NCT00117637|559983677|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
155150343|NCT00117637|559983678|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
155150344|NCT00117637|559983677|FG000|Second Intervention (Period 2)|reason not reported|1|||
155150345|NCT00117637|559983678|FG001|Second Intervention (Period 2)|reason not reported|0|||
155150346|NCT02914639|559983685|FG000|Overall Study|Withdrawal by Subject|0|||
155150347|NCT02914639|559983686|FG001|Overall Study|Withdrawal by Subject|2|||
155150348|NCT01924845|559983688|FG000|Overall Study|Adverse Event|3|||
155150349|NCT01924845|559983688|FG000|Overall Study|Withdrawal by Subject|2|||
155150350|NCT01924845|559983688|FG000|Overall Study|Protocol Violation|1|||
155150351|NCT00062439|559983689|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
155150352|NCT00062439|559983689|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
155150353|NCT00062439|559983689|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
155150354|NCT00062439|559983689|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
155150355|NCT00062439|559983689|FG000|Post Chemoradiation Assessment|Death|1|||
155150356|NCT00062439|559983689|FG000|Post Chemoradiation Assessment|Disease progression|2|||
155150357|NCT00062439|559983689|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
155150358|NCT00062439|559983689|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
155150359|NCT00062439|559983689|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
155150360|NCT00062439|559983689|FG000|Surgery|Physician Decision|4|||
155150361|NCT00062439|559983689|FG000|Surgery|Death|1|||
155150362|NCT00062439|559983689|FG000|Surgery|Adverse Event|2|||
155150363|NCT00062439|559983689|FG000|Consolidation Chemotherapy|Adverse Event|2|||
155150364|NCT00286442|559983690|FG000|Overall Study|Hyperglycemic Rescue|19|||
155150365|NCT00286442|559983691|FG001|Overall Study|Hyperglycemic Rescue|17|||
155150366|NCT00286442|559983692|FG002|Overall Study|Hyperglycemic Rescue|25|||
155150367|NCT00286442|559983690|FG000|Overall Study|Adverse Event|7|||
155150368|NCT00286442|559983691|FG001|Overall Study|Adverse Event|6|||
155150369|NCT00286442|559983692|FG002|Overall Study|Adverse Event|1|||
155150370|NCT00286442|559983690|FG000|Overall Study|Protocol Violation|2|||
155150371|NCT00286442|559983691|FG001|Overall Study|Protocol Violation|4|||
155197638|NCT00680017|560161689|FG000|Overall Study|Withdrawal by Subject|2|||
155150372|NCT00286442|559983692|FG002|Overall Study|Protocol Violation|2|||
155150373|NCT00286442|559983690|FG000|Overall Study|Lost to Follow-up|5|||
155150374|NCT00286442|559983691|FG001|Overall Study|Lost to Follow-up|2|||
155150375|NCT00286442|559983692|FG002|Overall Study|Lost to Follow-up|1|||
155150376|NCT00286442|559983690|FG000|Overall Study|Physician Decision|1|||
155150377|NCT00286442|559983691|FG001|Overall Study|Physician Decision|1|||
155150378|NCT00286442|559983692|FG002|Overall Study|Physician Decision|1|||
155150379|NCT00286442|559983690|FG000|Overall Study|Administrative Error|1|||
155150380|NCT00286442|559983691|FG001|Overall Study|Administrative Error|1|||
155150381|NCT00286442|559983692|FG002|Overall Study|Administrative Error|0|||
155150382|NCT00286442|559983690|FG000|Overall Study|Withdrawal by Subject|2|||
155150383|NCT00286442|559983691|FG001|Overall Study|Withdrawal by Subject|14|||
155150384|NCT00286442|559983692|FG002|Overall Study|Withdrawal by Subject|2|||
155150385|NCT02140047|559983693|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155150386|NCT02140047|559983694|FG001|Overall Study|Withdrawal by parent/guardian|1|||
155150387|NCT02140047|559983695|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155150388|NCT02174731|559983696|FG000|Overall Study|Participant decision|67|||
155150389|NCT02174731|559983697|FG001|Overall Study|Participant decision|64|||
155150390|NCT02174731|559983696|FG000|Overall Study|Incorrect enrolment before randomization|0|||
155150391|NCT02174731|559983697|FG001|Overall Study|Incorrect enrolment before randomization|1|||
155150392|NCT02174731|559983696|FG000|Overall Study|Missing|2|||
155150393|NCT02174731|559983697|FG001|Overall Study|Missing|0|||
155150394|NCT00079040|559983698|FG000|Overall Study|Withdrew before treatment|1|||
155150395|NCT00079040|559983698|FG000|Overall Study|Ineligible|1|||
155150396|NCT03119259|559983699|FG000|Overall Study|Withdrawn as no longer eligible|1|||
155150397|NCT03119259|559983700|FG001|Overall Study|Withdrawn as no longer eligible|0|||
155150398|NCT03119259|559983699|FG000|Overall Study|Withdrawal by Subject|4|||
155150399|NCT03119259|559983700|FG001|Overall Study|Withdrawal by Subject|2|||
155150400|NCT03119259|559983699|FG000|Overall Study|Lost to Follow-up|0|||
155150401|NCT03119259|559983700|FG001|Overall Study|Lost to Follow-up|1|||
155150402|NCT00325897|559983701|FG000|Overall Study|Lost to Follow-up|12|||
155150403|NCT00325897|559983702|FG001|Overall Study|Lost to Follow-up|13|||
155150404|NCT03261336|559983703|FG000|Overall Study|Adverse Event|1|||
155150405|NCT00292942|559983705|FG000|Overall Study|Withdrawal by Subject|0|||
155150406|NCT00292942|559983706|FG001|Overall Study|Withdrawal by Subject|0|||
155150407|NCT00292942|559983707|FG002|Overall Study|Withdrawal by Subject|1|||
155150408|NCT00292942|559983708|FG003|Overall Study|Withdrawal by Subject|0|||
155150409|NCT00292942|559983705|FG000|Overall Study|Adverse Event|0|||
155150410|NCT00292942|559983706|FG001|Overall Study|Adverse Event|0|||
155150411|NCT00292942|559983707|FG002|Overall Study|Adverse Event|0|||
155150412|NCT00292942|559983708|FG003|Overall Study|Adverse Event|1|||
155150413|NCT04264442|559983709|FG000|Overall Study|Lack of Efficacy|6|||
155150414|NCT04264442|559983709|FG000|Overall Study|Lost to Follow-up|2|||
155150415|NCT04264442|559983709|FG000|Overall Study|Sponsor Decision|23|||
155150416|NCT04264442|559983709|FG000|Overall Study|Withdrawal by Subject|11|||
155150417|NCT04264442|559983709|FG000|Overall Study|Study Termination|5|||
155150418|NCT01290523|559983710|FG000|Overall Study|Death|3|||
155150419|NCT03071263|559983711|FG000|Overall Study|Adverse Event|1|||
155150420|NCT03071263|559983712|FG001|Overall Study|Adverse Event|3|||
155150421|NCT03071263|559983711|FG000|Overall Study|Withdrawal by Subject|1|||
155150422|NCT03071263|559983712|FG001|Overall Study|Withdrawal by Subject|3|||
155150423|NCT03071263|559983711|FG000|Overall Study|Physician Decision|1|||
155150424|NCT03071263|559983712|FG001|Overall Study|Physician Decision|0|||
155150425|NCT03071263|559983711|FG000|Overall Study|Participant moved to another city|0|||
155150426|NCT03071263|559983712|FG001|Overall Study|Participant moved to another city|1|||
155150427|NCT03289208|559983715|FG000|Overall Study|Adverse Event|1|||
155150428|NCT03289208|559983716|FG001|Overall Study|Adverse Event|0|||
155150429|NCT03289208|559983717|FG002|Overall Study|Adverse Event|0|||
155150430|NCT04158583|559983718|FG000|Overall Study|Withdrawal by Subject|1|||
155150431|NCT04158583|559983719|FG001|Overall Study|Withdrawal by Subject|1|||
155150432|NCT04158583|559983720|FG002|Overall Study|Withdrawal by Subject|0|||
155150433|NCT04158583|559983721|FG003|Overall Study|Withdrawal by Subject|0|||
155150434|NCT04158583|559983722|FG004|Overall Study|Withdrawal by Subject|1|||
155150435|NCT04158583|559983723|FG005|Overall Study|Withdrawal by Subject|0|||
155150436|NCT04158583|559983724|FG006|Overall Study|Withdrawal by Subject|0|||
155150437|NCT04158583|559983725|FG007|Overall Study|Withdrawal by Subject|0|||
155150438|NCT04158583|559983726|FG008|Overall Study|Withdrawal by Subject|2|||
155150439|NCT04158583|559983727|FG009|Overall Study|Withdrawal by Subject|0|||
155150440|NCT04158583|559983718|FG000|Overall Study|Study Terminated by Sponsor|0|||
155150441|NCT04158583|559983719|FG001|Overall Study|Study Terminated by Sponsor|0|||
155150442|NCT04158583|559983720|FG002|Overall Study|Study Terminated by Sponsor|0|||
155150443|NCT04158583|559983721|FG003|Overall Study|Study Terminated by Sponsor|1|||
155150444|NCT04158583|559983722|FG004|Overall Study|Study Terminated by Sponsor|0|||
155150445|NCT04158583|559983723|FG005|Overall Study|Study Terminated by Sponsor|0|||
155197639|NCT00680017|560161690|FG001|Overall Study|Withdrawal by Subject|5|||
155197640|NCT00680017|560161689|FG000|Overall Study|Lost to Follow-up|2|||
155197641|NCT00680017|560161690|FG001|Overall Study|Lost to Follow-up|0|||
155197642|NCT02555683|560161694|FG000|Overall Study|Physician Decision|1|||
155197643|NCT02555683|560161695|FG001|Overall Study|Physician Decision|0|||
155197644|NCT02555683|560161696|FG002|Overall Study|Physician Decision|2|||
155197645|NCT02555683|560161694|FG000|Overall Study|Lost to Follow-up|2|||
155197646|NCT02555683|560161695|FG001|Overall Study|Lost to Follow-up|1|||
155197647|NCT02555683|560161696|FG002|Overall Study|Lost to Follow-up|2|||
155197648|NCT02555683|560161694|FG000|Overall Study|Technical Problems|1|||
155197649|NCT02555683|560161695|FG001|Overall Study|Technical Problems|1|||
155197650|NCT02555683|560161696|FG002|Overall Study|Technical Problems|0|||
155197651|NCT02555683|560161694|FG000|Overall Study|Protocol deviation|0|||
155197652|NCT02555683|560161695|FG001|Overall Study|Protocol deviation|1|||
155197653|NCT02555683|560161696|FG002|Overall Study|Protocol deviation|0|||
155197654|NCT02555683|560161694|FG000|Overall Study|Lack of Efficacy|2|||
155197655|NCT02555683|560161695|FG001|Overall Study|Lack of Efficacy|0|||
155197656|NCT02555683|560161696|FG002|Overall Study|Lack of Efficacy|0|||
155197657|NCT02555683|560161694|FG000|Overall Study|Death|0|||
155197658|NCT02555683|560161695|FG001|Overall Study|Death|1|||
155197659|NCT02555683|560161696|FG002|Overall Study|Death|2|||
155197660|NCT02555683|560161694|FG000|Overall Study|Adverse Event|1|||
155197661|NCT02555683|560161695|FG001|Overall Study|Adverse Event|0|||
155197662|NCT02555683|560161696|FG002|Overall Study|Adverse Event|1|||
155197663|NCT02555683|560161694|FG000|Overall Study|Subject/guardian decision|12|||
155197664|NCT02555683|560161695|FG001|Overall Study|Subject/guardian decision|12|||
155197665|NCT02555683|560161696|FG002|Overall Study|Subject/guardian decision|22|||
155197666|NCT02555683|560161694|FG000|Overall Study|Death post Treatment/safety period|0|||
155197667|NCT02555683|560161695|FG001|Overall Study|Death post Treatment/safety period|1|||
155197668|NCT02555683|560161696|FG002|Overall Study|Death post Treatment/safety period|0|||
155197669|NCT01947582|560161701|FG000|Overall Study|Withdrawal by Subject|1|||
155197670|NCT02279420|560161702|FG000|Overall Study|Lost to Follow-up|23|||
155197671|NCT00612040|560161703|FG000|Overall Study|Adverse Event|0|||
155197672|NCT00612040|560161704|FG001|Overall Study|Adverse Event|2|||
155197673|NCT00612040|560161705|FG002|Overall Study|Adverse Event|1|||
155197674|NCT00612040|560161703|FG000|Overall Study|Protocol Violation|1|||
155197675|NCT00612040|560161704|FG001|Overall Study|Protocol Violation|2|||
155197676|NCT00612040|560161705|FG002|Overall Study|Protocol Violation|1|||
155197677|NCT00612040|560161703|FG000|Overall Study|Lack of Efficacy|2|||
155197678|NCT00612040|560161704|FG001|Overall Study|Lack of Efficacy|1|||
155197679|NCT00612040|560161705|FG002|Overall Study|Lack of Efficacy|0|||
155197680|NCT00612040|560161703|FG000|Overall Study|Unclassified|2|||
155197681|NCT00612040|560161704|FG001|Overall Study|Unclassified|2|||
155197682|NCT00612040|560161705|FG002|Overall Study|Unclassified|5|||
155197683|NCT02835820|560161706|FG000|Overall Study|Baseline Screen Failure|0|||
155197684|NCT02835820|560161707|FG001|Overall Study|Baseline Screen Failure|3|||
155197685|NCT02924571|560161716|FG000|Overall Study|Lost to Follow-up|1|||
155197686|NCT02924571|560161717|FG001|Overall Study|Lost to Follow-up|1|||
155197687|NCT02924571|560161718|FG002|Overall Study|Lost to Follow-up|0|||
155197688|NCT00002651|560161722|FG000|Induction|Adverse Event|44|||
155197689|NCT00002651|560161723|FG001|Induction|Adverse Event|0|||
155197690|NCT00002651|560161724|FG002|Induction|Adverse Event|0|||
155197691|NCT00002651|560161722|FG000|Induction|Refusal unrelated to adverse event|50|||
155197692|NCT00002651|560161723|FG001|Induction|Refusal unrelated to adverse event|0|||
155197693|NCT00002651|560161724|FG002|Induction|Refusal unrelated to adverse event|0|||
155197694|NCT00002651|560161722|FG000|Induction|Progression/relapse|274|||
155197695|NCT00002651|560161723|FG001|Induction|Progression/relapse|0|||
155197696|NCT00002651|560161724|FG002|Induction|Progression/relapse|0|||
155197697|NCT00002651|560161722|FG000|Induction|Death|62|||
155197698|NCT00002651|560161723|FG001|Induction|Death|0|||
155197699|NCT00002651|560161724|FG002|Induction|Death|0|||
155197700|NCT00002651|560161722|FG000|Induction|Other|823|||
155150446|NCT04158583|559983724|FG006|Overall Study|Study Terminated by Sponsor|0|||
155150447|NCT04158583|559983725|FG007|Overall Study|Study Terminated by Sponsor|0|||
155150448|NCT04158583|559983726|FG008|Overall Study|Study Terminated by Sponsor|0|||
155150449|NCT04158583|559983727|FG009|Overall Study|Study Terminated by Sponsor|0|||
155150450|NCT04158583|559983718|FG000|Overall Study|Progressive Disease|1|||
155150451|NCT04158583|559983719|FG001|Overall Study|Progressive Disease|0|||
155150452|NCT04158583|559983720|FG002|Overall Study|Progressive Disease|3|||
155150453|NCT04158583|559983721|FG003|Overall Study|Progressive Disease|5|||
155150454|NCT04158583|559983722|FG004|Overall Study|Progressive Disease|0|||
155150455|NCT04158583|559983723|FG005|Overall Study|Progressive Disease|1|||
155150456|NCT04158583|559983724|FG006|Overall Study|Progressive Disease|6|||
155150457|NCT04158583|559983725|FG007|Overall Study|Progressive Disease|2|||
155150458|NCT04158583|559983726|FG008|Overall Study|Progressive Disease|1|||
155150459|NCT04158583|559983727|FG009|Overall Study|Progressive Disease|2|||
155150460|NCT04158583|559983718|FG000|Overall Study|Lost to Follow-up|0|||
155197701|NCT00002651|560161723|FG001|Induction|Other|0|||
155197702|NCT00002651|560161724|FG002|Induction|Other|0|||
155197703|NCT00002651|560161722|FG000|Induction|not eligible|90|||
155197704|NCT00002651|560161723|FG001|Induction|not eligible|0|||
155197705|NCT00002651|560161724|FG002|Induction|not eligible|0|||
155197706|NCT00002651|560161722|FG000|Consolidation and Randomization|Adverse Event|0|||
155197707|NCT00002651|560161723|FG001|Consolidation and Randomization|Adverse Event|36|||
155197708|NCT00002651|560161724|FG002|Consolidation and Randomization|Adverse Event|14|||
155197709|NCT00002651|560161722|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
155197710|NCT00002651|560161723|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
155197711|NCT00002651|560161724|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
155197712|NCT00002651|560161722|FG000|Consolidation and Randomization|Progression/relapse|0|||
155197713|NCT00002651|560161723|FG001|Consolidation and Randomization|Progression/relapse|295|||
155197714|NCT00002651|560161724|FG002|Consolidation and Randomization|Progression/relapse|298|||
155197715|NCT00002651|560161722|FG000|Consolidation and Randomization|Death|0|||
155197716|NCT00002651|560161723|FG001|Consolidation and Randomization|Death|38|||
155197717|NCT00002651|560161724|FG002|Consolidation and Randomization|Death|48|||
155197718|NCT00002651|560161722|FG000|Consolidation and Randomization|Other|0|||
155197719|NCT00002651|560161723|FG001|Consolidation and Randomization|Other|314|||
155197720|NCT00002651|560161724|FG002|Consolidation and Randomization|Other|313|||
155197721|NCT00002651|560161722|FG000|Consolidation and Randomization|not eligible|0|||
155197722|NCT00002651|560161723|FG001|Consolidation and Randomization|not eligible|102|||
155197723|NCT00002651|560161724|FG002|Consolidation and Randomization|not eligible|112|||
155197724|NCT01705730|560161725|FG000|Overall Study|Lack of Efficacy|1|||
155197725|NCT01705730|560161725|FG000|Overall Study|Adverse Event|3|||
155197726|NCT01705730|560161725|FG000|Overall Study|Lost to Follow-up|1|||
155197727|NCT01705730|560161725|FG000|Overall Study|Reason not Specified|4|||
155197728|NCT01773733|560161726|FG000|Overall Study|Adverse Event|3286|||
155197729|NCT01773733|560161727|FG001|Overall Study|Adverse Event|540|||
155197730|NCT01773733|560161726|FG000|Overall Study|Pregnancy|28|||
155197731|NCT01773733|560161727|FG001|Overall Study|Pregnancy|0|||
155197732|NCT01773733|560161726|FG000|Overall Study|Other different categories of not compl|55415|||
155197733|NCT01773733|560161727|FG001|Overall Study|Other different categories of not compl|7781|||
155197734|NCT03345914|560161729|FG000|Overall Study|Transition to another study at week 16|80|||
155197735|NCT03345914|560161730|FG001|Overall Study|Transition to another study at week 16|86|||
155197736|NCT03345914|560161731|FG002|Overall Study|Transition to another study at week 16|78|||
155197737|NCT03345914|560161729|FG000|Overall Study|Transition to OLE during follow-up|37|||
155197738|NCT03345914|560161730|FG001|Overall Study|Transition to OLE during follow-up|33|||
155197739|NCT03345914|560161731|FG002|Overall Study|Transition to OLE during follow-up|39|||
155197740|NCT03345914|560161729|FG000|Overall Study|Physician Decision|0|||
155197741|NCT03345914|560161730|FG001|Overall Study|Physician Decision|1|||
155197742|NCT03345914|560161731|FG002|Overall Study|Physician Decision|1|||
155197743|NCT03345914|560161729|FG000|Overall Study|Withdrawal by Subject|5|||
155197744|NCT03345914|560161730|FG001|Overall Study|Withdrawal by Subject|1|||
155197745|NCT03345914|560161731|FG002|Overall Study|Withdrawal by Subject|2|||
155197746|NCT03345914|560161729|FG000|Overall Study|Other|1|||
155197747|NCT03345914|560161730|FG001|Overall Study|Other|1|||
155197748|NCT03345914|560161731|FG002|Overall Study|Other|1|||
155197749|NCT03345914|560161729|FG000|Overall Study|Ongoing|0|||
155197750|NCT03345914|560161730|FG001|Overall Study|Ongoing|0|||
155197751|NCT03345914|560161731|FG002|Overall Study|Ongoing|1|||
155197752|NCT03576495|560161741|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
155197753|NCT03576495|560161742|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
155197754|NCT02628938|560161745|FG000|Overall Study|Did not attend the follow up recall|2|||
155197755|NCT02628938|560161746|FG001|Overall Study|Did not attend the follow up recall|2|||
155197756|NCT02628938|560161747|FG002|Overall Study|Did not attend the follow up recall|1|||
155197757|NCT02628938|560161745|FG000|Overall Study|Failure to comply with the instructions|3|||
155150461|NCT04158583|559983719|FG001|Overall Study|Lost to Follow-up|0|||
155150462|NCT04158583|559983720|FG002|Overall Study|Lost to Follow-up|1|||
155150463|NCT04158583|559983721|FG003|Overall Study|Lost to Follow-up|1|||
155197758|NCT02628938|560161746|FG001|Overall Study|Failure to comply with the instructions|0|||
155150464|NCT04158583|559983722|FG004|Overall Study|Lost to Follow-up|1|||
155150465|NCT04158583|559983723|FG005|Overall Study|Lost to Follow-up|0|||
155150466|NCT04158583|559983724|FG006|Overall Study|Lost to Follow-up|0|||
155150467|NCT04158583|559983725|FG007|Overall Study|Lost to Follow-up|0|||
155150468|NCT04158583|559983726|FG008|Overall Study|Lost to Follow-up|0|||
155150469|NCT04158583|559983727|FG009|Overall Study|Lost to Follow-up|0|||
155150470|NCT04158583|559983718|FG000|Overall Study|Due To Patient Status|0|||
155197759|NCT02628938|560161747|FG002|Overall Study|Failure to comply with the instructions|3|||
155197760|NCT02058693|560161748|FG000|Phase 1|Withdrawal by Subject|3|||
155197761|NCT02058693|560161749|FG001|Phase 1|Withdrawal by Subject|2|||
155197762|NCT02058693|560161748|FG000|Phase 1|Adverse Event|0|||
155197763|NCT02058693|560161749|FG001|Phase 1|Adverse Event|1|||
155197764|NCT02058693|560161748|FG000|Phase 1|Lack of Efficacy|1|||
155197765|NCT02058693|560161749|FG001|Phase 1|Lack of Efficacy|0|||
155150471|NCT04158583|559983719|FG001|Overall Study|Due To Patient Status|0|||
155197766|NCT02058693|560161748|FG000|Phase 1|Physician Decision|1|||
155197767|NCT02058693|560161749|FG001|Phase 1|Physician Decision|1|||
155197768|NCT02058693|560161748|FG000|Phase 2|Withdrawal by Subject|0|||
155150472|NCT04158583|559983720|FG002|Overall Study|Due To Patient Status|0|||
155150473|NCT04158583|559983721|FG003|Overall Study|Due To Patient Status|0|||
155150474|NCT04158583|559983722|FG004|Overall Study|Due To Patient Status|0|||
155150475|NCT04158583|559983723|FG005|Overall Study|Due To Patient Status|0|||
155150476|NCT04158583|559983724|FG006|Overall Study|Due To Patient Status|0|||
155150477|NCT04158583|559983725|FG007|Overall Study|Due To Patient Status|0|||
155150478|NCT04158583|559983726|FG008|Overall Study|Due To Patient Status|1|||
155150479|NCT04158583|559983727|FG009|Overall Study|Due To Patient Status|0|||
155150480|NCT04158583|559983718|FG000|Overall Study|Death|3|||
155150481|NCT04158583|559983719|FG001|Overall Study|Death|4|||
155150482|NCT04158583|559983720|FG002|Overall Study|Death|2|||
155150483|NCT04158583|559983721|FG003|Overall Study|Death|2|||
155150484|NCT04158583|559983722|FG004|Overall Study|Death|4|||
155150485|NCT04158583|559983723|FG005|Overall Study|Death|3|||
155150486|NCT04158583|559983724|FG006|Overall Study|Death|5|||
155150487|NCT04158583|559983725|FG007|Overall Study|Death|2|||
155150488|NCT04158583|559983726|FG008|Overall Study|Death|0|||
155150489|NCT04158583|559983727|FG009|Overall Study|Death|1|||
155150490|NCT04158583|559983718|FG000|Overall Study|Clinical Progression Disease|0|||
155150491|NCT04158583|559983719|FG001|Overall Study|Clinical Progression Disease|0|||
155150492|NCT04158583|559983720|FG002|Overall Study|Clinical Progression Disease|0|||
155150493|NCT04158583|559983721|FG003|Overall Study|Clinical Progression Disease|1|||
155150494|NCT04158583|559983722|FG004|Overall Study|Clinical Progression Disease|0|||
155150495|NCT04158583|559983723|FG005|Overall Study|Clinical Progression Disease|0|||
155150496|NCT04158583|559983724|FG006|Overall Study|Clinical Progression Disease|0|||
155150497|NCT04158583|559983725|FG007|Overall Study|Clinical Progression Disease|0|||
155150498|NCT04158583|559983726|FG008|Overall Study|Clinical Progression Disease|0|||
155150499|NCT04158583|559983727|FG009|Overall Study|Clinical Progression Disease|0|||
155150500|NCT04158583|559983718|FG000|Overall Study|Clinical Progression|0|||
155150501|NCT04158583|559983719|FG001|Overall Study|Clinical Progression|0|||
155150502|NCT04158583|559983720|FG002|Overall Study|Clinical Progression|0|||
155150503|NCT04158583|559983721|FG003|Overall Study|Clinical Progression|0|||
155150504|NCT04158583|559983722|FG004|Overall Study|Clinical Progression|1|||
155150505|NCT04158583|559983723|FG005|Overall Study|Clinical Progression|0|||
155150506|NCT04158583|559983724|FG006|Overall Study|Clinical Progression|2|||
155150507|NCT04158583|559983725|FG007|Overall Study|Clinical Progression|0|||
155150508|NCT04158583|559983726|FG008|Overall Study|Clinical Progression|0|||
155150509|NCT04158583|559983727|FG009|Overall Study|Clinical Progression|0|||
155150510|NCT04158583|559983718|FG000|Overall Study|Clinical Deterioration|0|||
155150511|NCT04158583|559983719|FG001|Overall Study|Clinical Deterioration|0|||
155150512|NCT04158583|559983720|FG002|Overall Study|Clinical Deterioration|0|||
155150513|NCT04158583|559983721|FG003|Overall Study|Clinical Deterioration|1|||
155150514|NCT04158583|559983722|FG004|Overall Study|Clinical Deterioration|0|||
155150515|NCT04158583|559983723|FG005|Overall Study|Clinical Deterioration|0|||
155150516|NCT04158583|559983724|FG006|Overall Study|Clinical Deterioration|0|||
155150517|NCT04158583|559983725|FG007|Overall Study|Clinical Deterioration|0|||
155150518|NCT04158583|559983726|FG008|Overall Study|Clinical Deterioration|0|||
155150519|NCT04158583|559983727|FG009|Overall Study|Clinical Deterioration|1|||
155150520|NCT00644423|559985684|FG000|Overall Study|Lost to Follow-up|1|||
155150521|NCT00644423|559985685|FG001|Overall Study|Lost to Follow-up|1|||
155150522|NCT03525444|559985686|FG000|Overall Study|Adverse Event|0|||
155150523|NCT03525444|559985687|FG001|Overall Study|Adverse Event|1|||
155150524|NCT03525444|559985686|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155150525|NCT03525444|559985687|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
155150526|NCT03525444|559985686|FG000|Overall Study|Other|0|||
155150527|NCT03525444|559985687|FG001|Overall Study|Other|1|||
155150528|NCT00262860|559985690|FG000|Overall Study|Adverse Event|2|||
155150529|NCT00878501|559985691|FG000|Overall Study|Adverse Event|11|||
155150530|NCT00878501|559985692|FG001|Overall Study|Adverse Event|3|||
155150531|NCT00878501|559985693|FG002|Overall Study|Adverse Event|3|||
155150532|NCT00878501|559985691|FG000|Overall Study|Lack of Efficacy|2|||
155150533|NCT00878501|559985692|FG001|Overall Study|Lack of Efficacy|1|||
155150534|NCT00878501|559985693|FG002|Overall Study|Lack of Efficacy|0|||
155150535|NCT00878501|559985691|FG000|Overall Study|Withdrawal by Subject|2|||
155150536|NCT00878501|559985692|FG001|Overall Study|Withdrawal by Subject|1|||
155150537|NCT00878501|559985693|FG002|Overall Study|Withdrawal by Subject|2|||
155150538|NCT00878501|559985691|FG000|Overall Study|Protocol Violation|0|||
155150539|NCT00878501|559985692|FG001|Overall Study|Protocol Violation|0|||
155150540|NCT00878501|559985693|FG002|Overall Study|Protocol Violation|1|||
155150541|NCT00878501|559985691|FG000|Overall Study|Incorrect enrolment|1|||
155150542|NCT00878501|559985692|FG001|Overall Study|Incorrect enrolment|2|||
155150543|NCT00878501|559985693|FG002|Overall Study|Incorrect enrolment|0|||
155150544|NCT00878501|559985691|FG000|Overall Study|Intake of prohibited concom. medication|0|||
155150545|NCT00878501|559985692|FG001|Overall Study|Intake of prohibited concom. medication|0|||
155150546|NCT00878501|559985693|FG002|Overall Study|Intake of prohibited concom. medication|1|||
155150547|NCT00878501|559985691|FG000|Overall Study|Mis-randomisation of patient|1|||
155150548|NCT00878501|559985692|FG001|Overall Study|Mis-randomisation of patient|0|||
155197769|NCT02058693|560161749|FG001|Phase 2|Withdrawal by Subject|2|||
155197770|NCT00843856|560161750|FG000|Overall Study|Lost to Follow-up|1|||
155197771|NCT00843856|560161751|FG001|Overall Study|Lost to Follow-up|2|||
155197772|NCT03855228|560161752|FG000|Overall Study|Adverse Event|2|||
155197773|NCT03855228|560161753|FG001|Overall Study|Adverse Event|4|||
155197774|NCT03855228|560161754|FG002|Overall Study|Adverse Event|4|||
155197775|NCT03855228|560161755|FG003|Overall Study|Adverse Event|8|||
155197776|NCT03855228|560161752|FG000|Overall Study|Treatment Failure|1|||
155197777|NCT03855228|560161753|FG001|Overall Study|Treatment Failure|2|||
155197778|NCT03855228|560161754|FG002|Overall Study|Treatment Failure|1|||
155197779|NCT03855228|560161755|FG003|Overall Study|Treatment Failure|8|||
155197780|NCT03855228|560161752|FG000|Overall Study|Lost to Follow-up|0|||
155197781|NCT03855228|560161753|FG001|Overall Study|Lost to Follow-up|0|||
155197782|NCT03855228|560161754|FG002|Overall Study|Lost to Follow-up|0|||
155197783|NCT03855228|560161755|FG003|Overall Study|Lost to Follow-up|1|||
155197784|NCT03855228|560161752|FG000|Overall Study|Protocol Violation|0|||
155197785|NCT03855228|560161753|FG001|Overall Study|Protocol Violation|1|||
155197786|NCT03855228|560161754|FG002|Overall Study|Protocol Violation|2|||
155197787|NCT03855228|560161755|FG003|Overall Study|Protocol Violation|1|||
155197788|NCT03855228|560161752|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
155197789|NCT03855228|560161753|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
155197790|NCT03855228|560161754|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
155197791|NCT03855228|560161755|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
155197792|NCT02993757|560161756|FG000|Overall Study|Non compliance with the protocol|155|||
155197793|NCT02993757|560161757|FG001|Overall Study|Non compliance with the protocol|170|||
155197794|NCT02993757|560161756|FG000|Overall Study|Lost to Follow-up|1|||
155197795|NCT02993757|560161757|FG001|Overall Study|Lost to Follow-up|0|||
155197796|NCT02993757|560161756|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
155197797|NCT02993757|560161757|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
155197798|NCT00190671|560161761|FG000|Overall Study|Satisfactory Response|4|||
155197799|NCT00190671|560161762|FG001|Overall Study|Satisfactory Response|7|||
155197800|NCT00190671|560161761|FG000|Overall Study|Lack of Efficacy|19|||
155197801|NCT00190671|560161762|FG001|Overall Study|Lack of Efficacy|24|||
155197802|NCT00190671|560161761|FG000|Overall Study|Death from Study Disease|1|||
155197803|NCT00190671|560161762|FG001|Overall Study|Death from Study Disease|1|||
155197804|NCT00190671|560161761|FG000|Overall Study|Adverse Event|3|||
155197805|NCT00190671|560161762|FG001|Overall Study|Adverse Event|2|||
155197806|NCT00190671|560161761|FG000|Overall Study|Clinical Relapse|0|||
155197807|NCT00190671|560161762|FG001|Overall Study|Clinical Relapse|1|||
155197808|NCT00190671|560161761|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
155197809|NCT00190671|560161762|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
155197810|NCT00190671|560161761|FG000|Overall Study|Death from Other Causes|0|||
155197811|NCT00190671|560161762|FG001|Overall Study|Death from Other Causes|2|||
155197812|NCT00190671|560161761|FG000|Overall Study|Protocol Violation|0|||
155197813|NCT00190671|560161762|FG001|Overall Study|Protocol Violation|1|||
155197814|NCT00190671|560161761|FG000|Overall Study|Withdrawal by Subject|0|||
155197815|NCT00190671|560161762|FG001|Overall Study|Withdrawal by Subject|2|||
155197816|NCT02699593|560161763|FG000|Period 1|Unsatisfactory Visual Response|0|||
155197817|NCT02699593|560161764|FG001|Period 1|Unsatisfactory Visual Response|1|||
155197818|NCT02699593|560161763|FG000|Period 1|Torn Contact Len|4|||
155197819|NCT02699593|560161764|FG001|Period 1|Torn Contact Len|3|||
155197820|NCT02699593|560161763|FG000|Period 1|Protocol Violation|0|||
155197821|NCT02699593|560161764|FG001|Period 1|Protocol Violation|1|||
155197822|NCT02699593|560161763|FG000|Period 1|Withdrawal by Subject|0|||
155197823|NCT02699593|560161764|FG001|Period 1|Withdrawal by Subject|1|||
155197824|NCT02699593|560161763|FG000|Period 1|Adverse Event|1|||
155197825|NCT02699593|560161764|FG001|Period 1|Adverse Event|1|||
155197826|NCT02699593|560161763|FG000|Period 2|Adverse Event|1|||
155197827|NCT02699593|560161764|FG001|Period 2|Adverse Event|1|||
155197828|NCT02699593|560161763|FG000|Period 2|Lost Contact Lens|0|||
155197829|NCT02699593|560161764|FG001|Period 2|Lost Contact Lens|1|||
155197830|NCT02699593|560161763|FG000|Period 2|Torn Contact Lens|1|||
155197831|NCT02699593|560161764|FG001|Period 2|Torn Contact Lens|0|||
155197832|NCT01681472|560161765|FG000|Overall Study|Adverse Event|0|||
155197833|NCT01681472|560161766|FG001|Overall Study|Adverse Event|1|||
155197834|NCT01681472|560161767|FG002|Overall Study|Adverse Event|0|||
155197835|NCT01681472|560161768|FG003|Overall Study|Adverse Event|0|||
155197836|NCT02369016|560161769|FG000|Overall Study|AE associated with clinical disease progression|2|||
155197837|NCT02369016|560161770|FG001|Overall Study|AE associated with clinical disease progression|1|||
155197838|NCT02369016|560161769|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
155197839|NCT02369016|560161770|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
155197840|NCT02369016|560161769|FG000|Overall Study|Progressive disease - clinical progression|1|||
155197841|NCT02369016|560161770|FG001|Overall Study|Progressive disease - clinical progression|4|||
155197842|NCT02369016|560161769|FG000|Overall Study|withdrawal by patient|4|||
155197843|NCT02369016|560161770|FG001|Overall Study|withdrawal by patient|0|||
155197844|NCT02369016|560161769|FG000|Overall Study|Progressive disease - radiological progression|6|||
155197845|NCT02369016|560161770|FG001|Overall Study|Progressive disease - radiological progression|2|||
155197846|NCT02229383|560161771|FG000|Overall Study|Adverse Event|7|||
155197847|NCT02229383|560161772|FG001|Overall Study|Adverse Event|4|||
155197848|NCT02229383|560161771|FG000|Overall Study|Death|0|||
155197849|NCT02229383|560161772|FG001|Overall Study|Death|1|||
155197850|NCT02229383|560161771|FG000|Overall Study|Lost to Follow-up|5|||
155197851|NCT02229383|560161772|FG001|Overall Study|Lost to Follow-up|3|||
155197852|NCT02229383|560161771|FG000|Overall Study|Withdrawal by Subject|4|||
155197853|NCT02229383|560161772|FG001|Overall Study|Withdrawal by Subject|6|||
155197854|NCT02229383|560161771|FG000|Overall Study|Did not receive treatment|1|||
155197855|NCT02229383|560161772|FG001|Overall Study|Did not receive treatment|0|||
155197856|NCT02229383|560161771|FG000|Overall Study|Other|3|||
155197857|NCT02229383|560161772|FG001|Overall Study|Other|8|||
155197858|NCT01696071|560161780|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
155197859|NCT01696071|560161781|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
155197860|NCT00672646|560161788|FG000|Overall Study|Lost to Follow-up|0|||
155197861|NCT00672646|560161789|FG001|Overall Study|Lost to Follow-up|1|||
155197862|NCT00672646|560161790|FG002|Overall Study|Lost to Follow-up|2|||
155197863|NCT00672646|560161788|FG000|Overall Study|Withdrawal by Subject|0|||
155197864|NCT00672646|560161789|FG001|Overall Study|Withdrawal by Subject|0|||
155197865|NCT00672646|560161790|FG002|Overall Study|Withdrawal by Subject|1|||
155197866|NCT00289783|560161791|FG000|Primary Phase|Adverse Event|10|||
155197867|NCT00289783|560161792|FG001|Primary Phase|Adverse Event|1|||
155197868|NCT00289783|560161791|FG000|Primary Phase|Protocol Violation|27|||
155197869|NCT00289783|560161792|FG001|Primary Phase|Protocol Violation|6|||
155197870|NCT00289783|560161791|FG000|Primary Phase|Withdrawal by Subject|93|||
155197871|NCT00289783|560161792|FG001|Primary Phase|Withdrawal by Subject|40|||
155197872|NCT00289783|560161791|FG000|Primary Phase|Lost to Follow-up|60|||
155197873|NCT00289783|560161792|FG001|Primary Phase|Lost to Follow-up|14|||
155197874|NCT00289783|560161791|FG000|Primary Phase|Migration from the study area|26|||
155197875|NCT00289783|560161792|FG001|Primary Phase|Migration from the study area|10|||
155197876|NCT00289783|560161791|FG000|Primary Phase|Other|32|||
155197877|NCT00289783|560161792|FG001|Primary Phase|Other|12|||
155197878|NCT00289783|560161791|FG000|Fourth Dose Phase|Adverse Event|1|||
155197879|NCT00289783|560161792|FG001|Fourth Dose Phase|Adverse Event|0|||
155197880|NCT00289783|560161791|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
155197881|NCT00289783|560161792|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
155197882|NCT00289783|560161791|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
155197883|NCT00289783|560161792|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
155197884|NCT00289783|560161791|FG000|Fourth Dose Phase|Migration from the study area|1|||
155197885|NCT00289783|560161792|FG001|Fourth Dose Phase|Migration from the study area|1|||
155197886|NCT00289783|560161791|FG000|Fourth Dose Phase|Other|22|||
155197887|NCT00289783|560161792|FG001|Fourth Dose Phase|Other|10|||
155197888|NCT03298867|560161804|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
155197889|NCT03298867|560161805|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
155197890|NCT03298867|560161804|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
155197891|NCT03298867|560161805|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
155197892|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
155197893|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
155197894|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
155197895|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
155197896|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
155197897|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
155197898|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
155197899|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
155197900|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
155197901|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
155197902|NCT03298867|560161804|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
155197903|NCT03298867|560161805|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
155197904|NCT03298867|560161804|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
155197905|NCT03298867|560161805|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
155197906|NCT01594281|560163757|FG000|Interventional Core Phase|Protocol Deviation|1|||
155197907|NCT01594281|560163758|FG001|Interventional Core Phase|Protocol Deviation|0|||
155197908|NCT01594281|560163759|FG002|Interventional Core Phase|Protocol Deviation|0|||
155197909|NCT01594281|560163757|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
155197910|NCT01594281|560163758|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
155197911|NCT01594281|560163759|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
155197912|NCT01594281|560163757|FG000|Interventional Core Phase|Death|1|||
155197913|NCT01594281|560163758|FG001|Interventional Core Phase|Death|1|||
155197914|NCT01594281|560163759|FG002|Interventional Core Phase|Death|2|||
155197915|NCT01594281|560163757|FG000|Interventional Core Phase|Lost to Follow-up|1|||
155197916|NCT01594281|560163758|FG001|Interventional Core Phase|Lost to Follow-up|4|||
155197917|NCT01594281|560163759|FG002|Interventional Core Phase|Lost to Follow-up|1|||
155150549|NCT00878501|559985693|FG002|Overall Study|Mis-randomisation of patient|0|||
155150550|NCT00878501|559985691|FG000|Overall Study|Administrative|0|||
155150551|NCT00878501|559985692|FG001|Overall Study|Administrative|0|||
155150552|NCT00878501|559985693|FG002|Overall Study|Administrative|1|||
155150553|NCT04416204|559985694|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
155150554|NCT04416204|559985695|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
155150555|NCT04416204|559985696|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
155150556|NCT04416204|559985697|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
155150557|NCT01959503|559985701|FG000|Overall Study|Death|2|||
155150558|NCT01959503|559985702|FG001|Overall Study|Death|1|||
155150559|NCT01959503|559985701|FG000|Overall Study|Randomized but not treated|1|||
155150560|NCT01959503|559985702|FG001|Overall Study|Randomized but not treated|1|||
155150561|NCT03598036|559985706|FG000|Overall Study|Withdrawal by Subject|1|||
155150562|NCT03598036|559985707|FG001|Overall Study|Withdrawal by Subject|0|||
155150563|NCT03585660|559985714|FG000|Overall Study|operator error|1|||
155150564|NCT03585660|559985714|FG000|Overall Study|technical error|2|||
155150565|NCT03585660|559985714|FG000|Overall Study|hip prosthesis|2|||
155150566|NCT03585660|559985714|FG000|Overall Study|did not undergo biopsy|8|||
155150567|NCT03585660|559985714|FG000|Overall Study|scanner problem|2|||
155150568|NCT05635461|559985715|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155150569|NCT05635461|559985716|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155150570|NCT05635461|559985717|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155150571|NCT05635461|559985718|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155150572|NCT05635461|559985719|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
155150573|NCT05635461|559985720|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
155150574|NCT05635461|559985715|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155150575|NCT05635461|559985716|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
155150576|NCT05635461|559985717|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155150577|NCT05635461|559985718|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155150578|NCT05635461|559985719|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155150579|NCT05635461|559985720|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
155150580|NCT05635461|559985715|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155150581|NCT05635461|559985716|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155150582|NCT05635461|559985717|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155150583|NCT05635461|559985718|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
155150584|NCT05635461|559985719|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155150585|NCT05635461|559985720|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
155150586|NCT03661723|559985721|FG000|Overall Study|Disease Progression|4|||
155150587|NCT03661723|559985722|FG001|Overall Study|Disease Progression|24|||
155150588|NCT03661723|559985723|FG002|Overall Study|Disease Progression|4|||
155150589|NCT03661723|559985724|FG003|Overall Study|Disease Progression|19|||
155150590|NCT03661723|559985721|FG000|Overall Study|Withdrawal by Subject|1|||
155150591|NCT03661723|559985722|FG001|Overall Study|Withdrawal by Subject|0|||
155150592|NCT03661723|559985723|FG002|Overall Study|Withdrawal by Subject|2|||
155150593|NCT03661723|559985724|FG003|Overall Study|Withdrawal by Subject|4|||
155150594|NCT03661723|559985721|FG000|Overall Study|Physician Decision|1|||
155150595|NCT03661723|559985722|FG001|Overall Study|Physician Decision|0|||
155150596|NCT03661723|559985723|FG002|Overall Study|Physician Decision|0|||
155150597|NCT03661723|559985724|FG003|Overall Study|Physician Decision|0|||
155150598|NCT03661723|559985721|FG000|Overall Study|Clinical Deterioration|0|||
155150599|NCT03661723|559985722|FG001|Overall Study|Clinical Deterioration|0|||
155150600|NCT03661723|559985723|FG002|Overall Study|Clinical Deterioration|0|||
155150601|NCT03661723|559985724|FG003|Overall Study|Clinical Deterioration|1|||
155150602|NCT04750824|559985730|FG000|Overall Study|Toxicity/intolerability|3|||
155150603|NCT04750824|559985731|FG001|Overall Study|Toxicity/intolerability|1|||
155150604|NCT04750824|559985730|FG000|Overall Study|Death|1|||
155150605|NCT04750824|559985731|FG001|Overall Study|Death|3|||
155150606|NCT04750824|559985730|FG000|Overall Study|Scheduled duration of therapy complete|1|||
155150607|NCT04750824|559985731|FG001|Overall Study|Scheduled duration of therapy complete|9|||
155150608|NCT04750824|559985730|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
155150609|NCT04750824|559985731|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
155150610|NCT00807911|559985732|FG000|Overall Study|Withdrawal by Subject|12|||
155150611|NCT00807911|559985733|FG001|Overall Study|Withdrawal by Subject|10|||
155150612|NCT00807911|559985732|FG000|Overall Study|Ineligible|0|||
155150613|NCT00807911|559985733|FG001|Overall Study|Ineligible|4|||
155150614|NCT03192176|559985738|FG000|Overall Study|Adverse Event|1|||
155150615|NCT03192176|559985739|FG001|Overall Study|Adverse Event|0|||
155150616|NCT03192176|559985740|FG002|Overall Study|Adverse Event|4|||
155150617|NCT03192176|559985741|FG003|Overall Study|Adverse Event|5|||
155150618|NCT03192176|559985742|FG004|Overall Study|Adverse Event|3|||
155150619|NCT03192176|559985743|FG005|Overall Study|Adverse Event|2|||
155150620|NCT03192176|559985744|FG006|Overall Study|Adverse Event|3|||
155150621|NCT03192176|559985745|FG007|Overall Study|Adverse Event|3|||
155150622|NCT03192176|559985738|FG000|Overall Study|Lost to Follow-up|0|||
155150623|NCT03192176|559985739|FG001|Overall Study|Lost to Follow-up|0|||
155150624|NCT03192176|559985740|FG002|Overall Study|Lost to Follow-up|1|||
155197918|NCT01594281|560163757|FG000|Interventional Core Phase|Adverse Event|4|||
155197919|NCT01594281|560163758|FG001|Interventional Core Phase|Adverse Event|4|||
155197920|NCT01594281|560163759|FG002|Interventional Core Phase|Adverse Event|4|||
155197921|NCT01594281|560163757|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
155197922|NCT01594281|560163758|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
155197923|NCT01594281|560163759|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
155197924|NCT01594281|560163757|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
155197925|NCT01594281|560163758|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
155197926|NCT01594281|560163759|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
155197927|NCT01594281|560163757|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
155197928|NCT01594281|560163758|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
155197929|NCT01594281|560163759|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
155197930|NCT01871532|560163760|FG000|Overall Study|Withdrawal by Subject|1|||
155197931|NCT01871532|560163761|FG001|Overall Study|Withdrawal by Subject|2|||
155197932|NCT00283400|560163762|FG000|Overall Study|Withdrawal by Subject|1|||
155197933|NCT00283400|560163763|FG001|Overall Study|Withdrawal by Subject|1|||
155197934|NCT00283400|560163764|FG002|Overall Study|Withdrawal by Subject|0|||
155197935|NCT00283400|560163765|FG003|Overall Study|Withdrawal by Subject|0|||
155197936|NCT00283400|560163762|FG000|Overall Study|Death|1|||
155197937|NCT00283400|560163763|FG001|Overall Study|Death|0|||
155197938|NCT00283400|560163764|FG002|Overall Study|Death|1|||
155197939|NCT00283400|560163765|FG003|Overall Study|Death|0|||
155197940|NCT01673867|560163767|FG000|Randomization|Adverse event unrelated to study drug|1|||
155197941|NCT01673867|560163768|FG001|Randomization|Adverse event unrelated to study drug|0|||
155197942|NCT01673867|560163767|FG000|Randomization|Participant request to discontinue study treatment|0|||
155197943|NCT01673867|560163768|FG001|Randomization|Participant request to discontinue study treatment|4|||
155197944|NCT01673867|560163767|FG000|Randomization|Withdrawal by participant|0|||
155197945|NCT01673867|560163768|FG001|Randomization|Withdrawal by participant|12|||
155197946|NCT01673867|560163767|FG000|Randomization|Lost to Follow-up|0|||
155197947|NCT01673867|560163768|FG001|Randomization|Lost to Follow-up|1|||
155197948|NCT01673867|560163767|FG000|Randomization|Participant no longer meets study criteria|4|||
155197949|NCT01673867|560163768|FG001|Randomization|Participant no longer meets study criteria|5|||
155197950|NCT01673867|560163767|FG000|Treatment|Disease Progression|208|||
155197951|NCT01673867|560163768|FG001|Treatment|Disease Progression|178|||
155197952|NCT01673867|560163767|FG000|Treatment|Study Drug Toxicity|23|||
155197953|NCT01673867|560163768|FG001|Treatment|Study Drug Toxicity|43|||
155197954|NCT01673867|560163767|FG000|Treatment|Death|2|||
155197955|NCT01673867|560163768|FG001|Treatment|Death|3|||
155197956|NCT01673867|560163767|FG000|Treatment|Adverse event unrelated to study drug|23|||
155197957|NCT01673867|560163768|FG001|Treatment|Adverse event unrelated to study drug|10|||
155197958|NCT01673867|560163767|FG000|Treatment|Participant request to discontinue study treatment|7|||
155197959|NCT01673867|560163768|FG001|Treatment|Participant request to discontinue study treatment|17|||
155197960|NCT01673867|560163767|FG000|Treatment|Withdrawal by participant|5|||
155197961|NCT01673867|560163768|FG001|Treatment|Withdrawal by participant|5|||
155197962|NCT01673867|560163767|FG000|Treatment|Maximum clinical benefit|1|||
155197963|NCT01673867|560163768|FG001|Treatment|Maximum clinical benefit|10|||
155197964|NCT01673867|560163767|FG000|Treatment|Participant no longer meets study criteria|2|||
155197965|NCT01673867|560163768|FG001|Treatment|Participant no longer meets study criteria|0|||
155197966|NCT01673867|560163767|FG000|Treatment|Administrative reason by sponsor|3|||
155197967|NCT01673867|560163768|FG001|Treatment|Administrative reason by sponsor|0|||
155150625|NCT03192176|559985741|FG003|Overall Study|Lost to Follow-up|2|||
155150626|NCT03192176|559985742|FG004|Overall Study|Lost to Follow-up|3|||
155150627|NCT03192176|559985743|FG005|Overall Study|Lost to Follow-up|1|||
155150628|NCT03192176|559985744|FG006|Overall Study|Lost to Follow-up|1|||
155150629|NCT03192176|559985745|FG007|Overall Study|Lost to Follow-up|1|||
155150630|NCT03192176|559985738|FG000|Overall Study|Physician Decision|1|||
155150631|NCT03192176|559985739|FG001|Overall Study|Physician Decision|0|||
155150632|NCT03192176|559985740|FG002|Overall Study|Physician Decision|0|||
155150633|NCT03192176|559985741|FG003|Overall Study|Physician Decision|0|||
155150634|NCT03192176|559985742|FG004|Overall Study|Physician Decision|0|||
155197968|NCT01673867|560163767|FG000|Treatment|Other reason|11|||
155197969|NCT01673867|560163768|FG001|Treatment|Other reason|2|||
155197970|NCT02550106|560163771|FG000|Overall Study|Adverse Event|1|||
155197971|NCT02550106|560163771|FG000|Overall Study|Lack of Efficacy|3|||
155197972|NCT02550106|560163771|FG000|Overall Study|Protocol Violation|6|||
155197973|NCT02550106|560163771|FG000|Overall Study|Withdrawal by Subject|2|||
155197974|NCT04019288|560163772|FG000|Overall Study|Death|1|||
155150635|NCT03192176|559985743|FG005|Overall Study|Physician Decision|2|||
155197975|NCT04019288|560163773|FG001|Overall Study|Death|0|||
155197976|NCT04019288|560163774|FG002|Overall Study|Death|0|||
155197977|NCT03166735|560163775|FG000|Overall Study|Not Treated|1|||
155150636|NCT03192176|559985744|FG006|Overall Study|Physician Decision|1|||
155150637|NCT03192176|559985745|FG007|Overall Study|Physician Decision|0|||
155150638|NCT03192176|559985738|FG000|Overall Study|Protocol Deviation|1|||
155150639|NCT03192176|559985739|FG001|Overall Study|Protocol Deviation|1|||
155150640|NCT03192176|559985740|FG002|Overall Study|Protocol Deviation|0|||
155150641|NCT03192176|559985741|FG003|Overall Study|Protocol Deviation|0|||
155150642|NCT03192176|559985742|FG004|Overall Study|Protocol Deviation|2|||
155150643|NCT03192176|559985743|FG005|Overall Study|Protocol Deviation|0|||
155150644|NCT03192176|559985744|FG006|Overall Study|Protocol Deviation|0|||
155150645|NCT03192176|559985745|FG007|Overall Study|Protocol Deviation|0|||
155150646|NCT03192176|559985738|FG000|Overall Study|Withdrawal by Subject|3|||
155150647|NCT03192176|559985739|FG001|Overall Study|Withdrawal by Subject|4|||
155150648|NCT03192176|559985740|FG002|Overall Study|Withdrawal by Subject|0|||
155150649|NCT03192176|559985741|FG003|Overall Study|Withdrawal by Subject|4|||
155150650|NCT03192176|559985742|FG004|Overall Study|Withdrawal by Subject|3|||
155150651|NCT03192176|559985743|FG005|Overall Study|Withdrawal by Subject|4|||
155150652|NCT03192176|559985744|FG006|Overall Study|Withdrawal by Subject|4|||
155150653|NCT03192176|559985745|FG007|Overall Study|Withdrawal by Subject|2|||
155150654|NCT03192176|559985738|FG000|Overall Study|Miscellaneous|1|||
155150655|NCT03192176|559985739|FG001|Overall Study|Miscellaneous|0|||
155150656|NCT03192176|559985740|FG002|Overall Study|Miscellaneous|1|||
155150657|NCT03192176|559985741|FG003|Overall Study|Miscellaneous|1|||
155150658|NCT03192176|559985742|FG004|Overall Study|Miscellaneous|1|||
155150659|NCT03192176|559985743|FG005|Overall Study|Miscellaneous|2|||
155150660|NCT03192176|559985744|FG006|Overall Study|Miscellaneous|0|||
155150661|NCT03192176|559985745|FG007|Overall Study|Miscellaneous|1|||
155150662|NCT03562195|559985748|FG000|Overall Study|Adverse Event|0|||
155150663|NCT03562195|559985749|FG001|Overall Study|Adverse Event|6|||
155150664|NCT03562195|559985748|FG000|Overall Study|Lack of Efficacy|0|||
155150665|NCT03562195|559985749|FG001|Overall Study|Lack of Efficacy|5|||
155150666|NCT03562195|559985748|FG000|Overall Study|Protocol Violation|0|||
155150667|NCT03562195|559985749|FG001|Overall Study|Protocol Violation|1|||
155150668|NCT03562195|559985748|FG000|Overall Study|Lost to Follow-up|0|||
155150669|NCT03562195|559985749|FG001|Overall Study|Lost to Follow-up|1|||
155150670|NCT03562195|559985748|FG000|Overall Study|Physician Decision|1|||
155150671|NCT03562195|559985749|FG001|Overall Study|Physician Decision|0|||
155150672|NCT03562195|559985748|FG000|Overall Study|Withdrawal by Subject|3|||
155150673|NCT03562195|559985749|FG001|Overall Study|Withdrawal by Subject|0|||
155150674|NCT00836589|559985750|FG000|Overall Study|Lost to Follow-up|246|||
155150675|NCT00836589|559985750|FG000|Overall Study|Death|429|||
155150676|NCT00836589|559985750|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
155150677|NCT00614575|559985751|FG000|Overall Study|Adverse Event|106|||
155150678|NCT00614575|559985751|FG000|Overall Study|Lost to Follow-up|55|||
155150679|NCT00614575|559985751|FG000|Overall Study|Lack of Efficacy|14|||
155150680|NCT00614575|559985751|FG000|Overall Study|Withdrawal by Subject|6|||
155150681|NCT00614575|559985751|FG000|Overall Study|Death|3|||
155150682|NCT00614575|559985751|FG000|Overall Study|Physician Decision|2|||
155150683|NCT00614575|559985751|FG000|Overall Study|No data were collected.|18|||
155150684|NCT00614575|559985751|FG000|Overall Study|Irregularly enrolled patients|23|||
155150685|NCT00614575|559985751|FG000|Overall Study|No treatment|1|||
155150686|NCT01018030|559985752|FG000|Overall Study|Adverse Event|10|||
155150687|NCT01018030|559985753|FG001|Overall Study|Adverse Event|5|||
155150688|NCT01018030|559985754|FG002|Overall Study|Adverse Event|5|||
155150689|NCT01018030|559985752|FG000|Overall Study|Withdrawal by Subject|2|||
155150690|NCT01018030|559985753|FG001|Overall Study|Withdrawal by Subject|2|||
155150691|NCT01018030|559985754|FG002|Overall Study|Withdrawal by Subject|4|||
155150692|NCT01018030|559985752|FG000|Overall Study|Lost to Follow-up|2|||
155150693|NCT01018030|559985753|FG001|Overall Study|Lost to Follow-up|0|||
155150694|NCT01018030|559985754|FG002|Overall Study|Lost to Follow-up|3|||
155150695|NCT01018030|559985752|FG000|Overall Study|Protocol Violation|2|||
155150696|NCT01018030|559985753|FG001|Overall Study|Protocol Violation|1|||
155150697|NCT01018030|559985754|FG002|Overall Study|Protocol Violation|0|||
155150698|NCT01018030|559985752|FG000|Overall Study|Physician Decision|1|||
155150699|NCT01018030|559985753|FG001|Overall Study|Physician Decision|0|||
155150700|NCT01018030|559985754|FG002|Overall Study|Physician Decision|1|||
155150701|NCT01018030|559985752|FG000|Overall Study|Lack of Efficacy|1|||
155150702|NCT01018030|559985753|FG001|Overall Study|Lack of Efficacy|0|||
155150703|NCT01018030|559985754|FG002|Overall Study|Lack of Efficacy|0|||
155150704|NCT01018030|559985752|FG000|Overall Study|Did Not Receive Study Drug|1|||
155150705|NCT01018030|559985753|FG001|Overall Study|Did Not Receive Study Drug|3|||
155150706|NCT01018030|559985754|FG002|Overall Study|Did Not Receive Study Drug|0|||
155150707|NCT00436332|559985758|FG000|Overall Study|Adverse Event|9|||
155150708|NCT00436332|559985758|FG000|Overall Study|Withdrawal by Subject|2|||
155150709|NCT00436332|559985758|FG000|Overall Study|Progression|59|||
155150710|NCT00436332|559985758|FG000|Overall Study|Death|2|||
155150711|NCT00436332|559985758|FG000|Overall Study|Not Protocol Specified|6|||
155150712|NCT00436332|559985758|FG000|Overall Study|Ineligible|2|||
155150713|NCT00436332|559985758|FG000|Overall Study|Never Received Treatment|3|||
155150714|NCT00472108|559985759|FG000|Overall Study|Lost to Follow-up|0|||
155150715|NCT00472108|559985760|FG001|Overall Study|Lost to Follow-up|1|||
155150716|NCT00189540|559985761|FG000|Overall Study|Withdrawal by Subject|3|||
155150717|NCT00189540|559985762|FG001|Overall Study|Withdrawal by Subject|0|||
155150718|NCT00189540|559985761|FG000|Overall Study|Death|4|||
155150719|NCT00189540|559985762|FG001|Overall Study|Death|1|||
155197978|NCT03166735|560163776|FG001|Overall Study|Not Treated|0|||
155197979|NCT03166735|560163777|FG002|Overall Study|Not Treated|0|||
155197980|NCT03166735|560163778|FG003|Overall Study|Not Treated|0|||
155197981|NCT03166735|560163779|FG004|Overall Study|Not Treated|0|||
155197982|NCT03166735|560163775|FG000|Overall Study|follow-up not completed as planned|0|||
155197983|NCT03166735|560163776|FG001|Overall Study|follow-up not completed as planned|1|||
155197984|NCT03166735|560163777|FG002|Overall Study|follow-up not completed as planned|1|||
155197985|NCT03166735|560163778|FG003|Overall Study|follow-up not completed as planned|0|||
155197986|NCT03166735|560163779|FG004|Overall Study|follow-up not completed as planned|1|||
155197987|NCT03166735|560163775|FG000|Overall Study|Withdrawal by Subject|0|||
155197988|NCT03166735|560163776|FG001|Overall Study|Withdrawal by Subject|0|||
155197989|NCT03166735|560163777|FG002|Overall Study|Withdrawal by Subject|1|||
155197990|NCT03166735|560163778|FG003|Overall Study|Withdrawal by Subject|1|||
155197991|NCT03166735|560163779|FG004|Overall Study|Withdrawal by Subject|2|||
155197992|NCT03166735|560163775|FG000|Overall Study|Lost to Follow-up|0|||
155197993|NCT03166735|560163776|FG001|Overall Study|Lost to Follow-up|2|||
155197994|NCT03166735|560163777|FG002|Overall Study|Lost to Follow-up|1|||
155197995|NCT03166735|560163778|FG003|Overall Study|Lost to Follow-up|0|||
155197996|NCT03166735|560163779|FG004|Overall Study|Lost to Follow-up|1|||
155197997|NCT01543958|560163780|FG000|Overall Study|Loss to follow-up|3|||
155197998|NCT01543958|560163780|FG000|Overall Study|ART initiation|1|||
155197999|NCT00926328|560163785|FG000|Overall Study|Lost to Follow-up|12|||
155198000|NCT00926328|560163786|FG001|Overall Study|Lost to Follow-up|14|||
155198001|NCT03486223|560163789|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
155198002|NCT03486223|560163790|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
155198003|NCT01819831|560163791|FG000|Overall Study|Withdrawal by Subject|1|||
155198004|NCT03535844|560163794|FG000|Overall Study|Withdrawal by Subject|0|||
155198005|NCT03535844|560163795|FG001|Overall Study|Withdrawal by Subject|1|||
155198006|NCT01153347|560163798|FG000|Overall Study|Withdrawal by Subject|7|||
155198007|NCT01153347|560163799|FG001|Overall Study|Withdrawal by Subject|7|||
155198008|NCT01153347|560163800|FG002|Overall Study|Withdrawal by Subject|7|||
155198009|NCT01153347|560163801|FG003|Overall Study|Withdrawal by Subject|7|||
155198010|NCT01153347|560163798|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155198011|NCT01153347|560163799|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155198012|NCT01153347|560163800|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
155198013|NCT01153347|560163801|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155198014|NCT01153347|560163798|FG000|Overall Study|Adverse Event|3|||
155198015|NCT01153347|560163799|FG001|Overall Study|Adverse Event|9|||
155198016|NCT01153347|560163800|FG002|Overall Study|Adverse Event|21|||
155198017|NCT01153347|560163801|FG003|Overall Study|Adverse Event|7|||
155198018|NCT01153347|560163798|FG000|Overall Study|Severe non-compliance to protocol|6|||
155198019|NCT01153347|560163799|FG001|Overall Study|Severe non-compliance to protocol|7|||
155198020|NCT01153347|560163800|FG002|Overall Study|Severe non-compliance to protocol|4|||
155198021|NCT01153347|560163801|FG003|Overall Study|Severe non-compliance to protocol|3|||
155198022|NCT01153347|560163798|FG000|Overall Study|Condition under investigation worsened|1|||
155198023|NCT01153347|560163799|FG001|Overall Study|Condition under investigation worsened|1|||
155198024|NCT01153347|560163800|FG002|Overall Study|Condition under investigation worsened|0|||
155198025|NCT01153347|560163801|FG003|Overall Study|Condition under investigation worsened|0|||
155198026|NCT01153347|560163798|FG000|Overall Study|Lack of Efficacy|2|||
155198027|NCT01153347|560163799|FG001|Overall Study|Lack of Efficacy|2|||
155198028|NCT01153347|560163800|FG002|Overall Study|Lack of Efficacy|0|||
155198029|NCT01153347|560163801|FG003|Overall Study|Lack of Efficacy|4|||
155198030|NCT01153347|560163798|FG000|Overall Study|Study-specific withdrawal criteria|4|||
155198031|NCT01153347|560163799|FG001|Overall Study|Study-specific withdrawal criteria|3|||
155198032|NCT01153347|560163800|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155198033|NCT01153347|560163801|FG003|Overall Study|Study-specific withdrawal criteria|2|||
155198034|NCT01153347|560163798|FG000|Overall Study|Lost to Follow-up|4|||
155198035|NCT01153347|560163799|FG001|Overall Study|Lost to Follow-up|9|||
155198036|NCT01153347|560163800|FG002|Overall Study|Lost to Follow-up|11|||
155198037|NCT01153347|560163801|FG003|Overall Study|Lost to Follow-up|8|||
155198038|NCT01153347|560163798|FG000|Overall Study|Other|5|||
155198039|NCT01153347|560163799|FG001|Overall Study|Other|5|||
155198040|NCT01153347|560163800|FG002|Overall Study|Other|4|||
155198041|NCT01153347|560163801|FG003|Overall Study|Other|0|||
155198042|NCT01153347|560163798|FG000|Overall Study|Death|1|||
155198043|NCT01153347|560163799|FG001|Overall Study|Death|0|||
155198044|NCT01153347|560163800|FG002|Overall Study|Death|0|||
155198045|NCT01153347|560163801|FG003|Overall Study|Death|0|||
155198046|NCT00297830|560163802|FG000|6 Month Visit|Death|1|||
155198047|NCT00297830|560163803|FG001|6 Month Visit|Death|0|||
155198048|NCT00297830|560163804|FG002|6 Month Visit|Death|2|||
155198049|NCT00297830|560163802|FG000|6 Month Visit|Withdrawal by Subject|2|||
155198050|NCT00297830|560163803|FG001|6 Month Visit|Withdrawal by Subject|1|||
155198051|NCT00297830|560163804|FG002|6 Month Visit|Withdrawal by Subject|1|||
155198052|NCT00297830|560163802|FG000|6 Month Visit|Adverse Event|0|||
155198053|NCT00297830|560163803|FG001|6 Month Visit|Adverse Event|1|||
155198054|NCT00297830|560163804|FG002|6 Month Visit|Adverse Event|0|||
155198055|NCT00297830|560163802|FG000|12 Month Visit|Lost to Follow-up|1|||
155198056|NCT00297830|560163803|FG001|12 Month Visit|Lost to Follow-up|0|||
155198057|NCT00297830|560163804|FG002|12 Month Visit|Lost to Follow-up|0|||
155198058|NCT00297830|560163802|FG000|12 Month Visit|Adverse Event|0|||
155198059|NCT00297830|560163803|FG001|12 Month Visit|Adverse Event|3|||
155198060|NCT00297830|560163804|FG002|12 Month Visit|Adverse Event|0|||
155198061|NCT00297830|560163802|FG000|12 Month Visit|Withdrawal by Subject|0|||
155198062|NCT00297830|560163803|FG001|12 Month Visit|Withdrawal by Subject|3|||
155150720|NCT01903356|559985763|FG000|Overall Study|Lost to Follow-up|7|||
155150721|NCT01903356|559985763|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
155150722|NCT01903356|559985763|FG000|Overall Study|Violated the dosage and administration|3|||
155150723|NCT04079296|559985764|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
155150724|NCT04079296|559985765|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
155150725|NCT04079296|559985766|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
155150726|NCT04079296|559985767|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
155150727|NCT04079296|559985768|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
155150728|NCT04079296|559985764|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
155150729|NCT04079296|559985765|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
155150730|NCT04079296|559985766|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
155150731|NCT04079296|559985767|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
155150732|NCT04079296|559985768|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
155150733|NCT04079296|559985764|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155150734|NCT04079296|559985765|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155150735|NCT04079296|559985766|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155150736|NCT04079296|559985767|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
155150737|NCT04079296|559985768|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
155150738|NCT04079296|559985764|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155150739|NCT04079296|559985765|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155150740|NCT04079296|559985766|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155150741|NCT04079296|559985767|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
155150742|NCT04079296|559985768|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
155150743|NCT04079296|559985764|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155150744|NCT04079296|559985765|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155150745|NCT04079296|559985766|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155150746|NCT04079296|559985767|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
155150747|NCT04079296|559985768|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
155150748|NCT04079296|559985764|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
155150749|NCT04079296|559985765|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
155150750|NCT04079296|559985766|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
155150751|NCT04079296|559985767|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
155150752|NCT04079296|559985768|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
155150753|NCT04079296|559985764|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
155150754|NCT04079296|559985765|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
155150755|NCT04079296|559985766|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
155150756|NCT04079296|559985767|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
155150757|NCT04079296|559985768|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
155150758|NCT04079296|559985764|FG000|Dose Expansion Phase (168 Days)|Death|0|||
155150759|NCT04079296|559985765|FG001|Dose Expansion Phase (168 Days)|Death|0|||
155150760|NCT04079296|559985766|FG002|Dose Expansion Phase (168 Days)|Death|0|||
155150761|NCT04079296|559985767|FG003|Dose Expansion Phase (168 Days)|Death|1|||
155150762|NCT04079296|559985768|FG004|Dose Expansion Phase (168 Days)|Death|0|||
155150763|NCT00467740|559985769|FG000|Overall Study|Adverse Event|0|||
155150764|NCT00467740|559985770|FG001|Overall Study|Adverse Event|0|||
155150765|NCT00467740|559985771|FG002|Overall Study|Adverse Event|1|||
155150766|NCT00467740|559985772|FG003|Overall Study|Adverse Event|0|||
155150767|NCT00467740|559985773|FG004|Overall Study|Adverse Event|0|||
155150768|NCT00467740|559985769|FG000|Overall Study|Protocol Violation|0|||
155150769|NCT00467740|559985770|FG001|Overall Study|Protocol Violation|0|||
155150770|NCT00467740|559985771|FG002|Overall Study|Protocol Violation|1|||
155150771|NCT00467740|559985772|FG003|Overall Study|Protocol Violation|0|||
155150772|NCT00467740|559985773|FG004|Overall Study|Protocol Violation|0|||
155150773|NCT00467740|559985769|FG000|Overall Study|Lost to Follow-up|0|||
155150774|NCT00467740|559985770|FG001|Overall Study|Lost to Follow-up|1|||
155150775|NCT00467740|559985771|FG002|Overall Study|Lost to Follow-up|0|||
155150776|NCT00467740|559985772|FG003|Overall Study|Lost to Follow-up|0|||
155150777|NCT00467740|559985773|FG004|Overall Study|Lost to Follow-up|0|||
155150778|NCT00467740|559985769|FG000|Overall Study|Withdrawal by Subject|1|||
155150779|NCT00467740|559985770|FG001|Overall Study|Withdrawal by Subject|1|||
155150780|NCT00467740|559985771|FG002|Overall Study|Withdrawal by Subject|0|||
155198063|NCT00297830|560163804|FG002|12 Month Visit|Withdrawal by Subject|0|||
155198064|NCT00003473|560163807|FG000|Overall Study|Three patients were not evaluable.|3|||
155198065|NCT04401423|560163808|FG000|Overall Study|Withdrawal by Subject|3|||
155198066|NCT04401423|560163809|FG001|Overall Study|Withdrawal by Subject|1|||
155198067|NCT04401423|560163808|FG000|Overall Study|Physician Decision|2|||
155198068|NCT04401423|560163809|FG001|Overall Study|Physician Decision|1|||
155198069|NCT00827502|560163810|FG000|Overall Study|randomized but not treated|11|||
155198070|NCT00827502|560163810|FG000|Overall Study|Adverse Event|1|||
155198071|NCT00827502|560163810|FG000|Overall Study|Lost to Follow-up|4|||
155198072|NCT00827502|560163810|FG000|Overall Study|Withdrawal by Subject|5|||
155198073|NCT05096221|560163811|FG000|Part 2|Physician Decision|0|||
155198074|NCT05096221|560163812|FG001|Part 2|Physician Decision|1|||
155198075|NCT02478632|560163816|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
155198076|NCT02478632|560163817|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
155198077|NCT02478632|560163816|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
155198078|NCT02478632|560163817|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
155198079|NCT02478632|560163816|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
155198080|NCT02478632|560163817|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
155198081|NCT01086033|560163818|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
155198082|NCT01086033|560163818|FG000|Overall Study|Lost to Follow-up|86|||
155198083|NCT01086033|560163818|FG000|Overall Study|Adverse Event|42|||
155198084|NCT01086033|560163818|FG000|Overall Study|Withdrawal by Subject|41|||
155198085|NCT01086033|560163818|FG000|Overall Study|Other|14|||
155198086|NCT01086033|560163818|FG000|Overall Study|Other|13|||
155198087|NCT01086033|560163818|FG000|Overall Study|AE and Withdrew Consent|5|||
155198088|NCT01086033|560163818|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
155198089|NCT01086033|560163818|FG000|Overall Study|Withdrew consent and Other Reason|4|||
155198090|NCT01086033|560163818|FG000|Overall Study|AE and Lack of Efficacy|4|||
155198091|NCT01086033|560163818|FG000|Overall Study|Death|1|||
155198092|NCT01086033|560163818|FG000|Overall Study|AE and Lost to Follow-up|1|||
155198093|NCT01086033|560163818|FG000|Overall Study|AE and Other Reason|1|||
155198094|NCT01086033|560163818|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
155198095|NCT02193867|560163820|FG000|Overall Study|Death|2|||
155198096|NCT02193867|560163820|FG000|Overall Study|Sponsor Study Termination|2|||
155198097|NCT03741062|560163823|FG000|Overall Study|Protocol Violation|1|||
155198098|NCT03741062|560163824|FG001|Overall Study|Protocol Violation|0|||
155198099|NCT03417219|560163827|FG000|Overall Study|Lost to Follow-up|0|||
155198100|NCT03417219|560163828|FG001|Overall Study|Lost to Follow-up|3|||
155198101|NCT00762229|560163830|FG000|Overall Study|Lost to Follow-up|1|||
155198102|NCT00762229|560163831|FG001|Overall Study|Lost to Follow-up|1|||
155198103|NCT00762229|560163830|FG000|Overall Study|did not recveive intervention|0|||
155198104|NCT00762229|560163831|FG001|Overall Study|did not recveive intervention|1|||
155198105|NCT02609828|560163832|FG000|Overall Study|Adverse Event|8|||
155198106|NCT02609828|560163833|FG001|Overall Study|Adverse Event|1|||
155198107|NCT02609828|560163834|FG002|Overall Study|Adverse Event|0|||
155198108|NCT02609828|560163835|FG003|Overall Study|Adverse Event|6|||
155198109|NCT02609828|560163832|FG000|Overall Study|Death|15|||
155198110|NCT02609828|560163833|FG001|Overall Study|Death|1|||
155198111|NCT02609828|560163834|FG002|Overall Study|Death|1|||
155198112|NCT02609828|560163835|FG003|Overall Study|Death|19|||
155198113|NCT02609828|560163832|FG000|Overall Study|Insufficient clinical response|2|||
155198114|NCT02609828|560163833|FG001|Overall Study|Insufficient clinical response|1|||
155198115|NCT02609828|560163834|FG002|Overall Study|Insufficient clinical response|0|||
155198116|NCT02609828|560163835|FG003|Overall Study|Insufficient clinical response|0|||
155198117|NCT02609828|560163832|FG000|Overall Study|Lost to Follow-up|0|||
155198118|NCT02609828|560163833|FG001|Overall Study|Lost to Follow-up|0|||
155198119|NCT02609828|560163834|FG002|Overall Study|Lost to Follow-up|0|||
155198120|NCT02609828|560163835|FG003|Overall Study|Lost to Follow-up|1|||
155198121|NCT02609828|560163832|FG000|Overall Study|Protocol Violation|2|||
155198122|NCT02609828|560163833|FG001|Overall Study|Protocol Violation|0|||
155198123|NCT02609828|560163834|FG002|Overall Study|Protocol Violation|0|||
155198124|NCT02609828|560163835|FG003|Overall Study|Protocol Violation|1|||
155198125|NCT02609828|560163832|FG000|Overall Study|Withdrawal by Subject|12|||
155198126|NCT02609828|560163833|FG001|Overall Study|Withdrawal by Subject|1|||
155198127|NCT02609828|560163834|FG002|Overall Study|Withdrawal by Subject|0|||
155198128|NCT02609828|560163835|FG003|Overall Study|Withdrawal by Subject|10|||
155198129|NCT02609828|560163832|FG000|Overall Study|Other|3|||
155198130|NCT02609828|560163833|FG001|Overall Study|Other|0|||
155198131|NCT02609828|560163834|FG002|Overall Study|Other|0|||
155198132|NCT02609828|560163835|FG003|Overall Study|Other|6|||
155198133|NCT02609828|560163832|FG000|Overall Study|Randomized but not treated|1|||
155198134|NCT02609828|560163833|FG001|Overall Study|Randomized but not treated|0|||
155198135|NCT02609828|560163834|FG002|Overall Study|Randomized but not treated|0|||
155198136|NCT02609828|560163835|FG003|Overall Study|Randomized but not treated|0|||
155198137|NCT01281865|560163836|FG000|Overall Study|Adverse Event|1|||
155198138|NCT01281865|560163837|FG001|Overall Study|Adverse Event|1|||
155198139|NCT01281865|560163836|FG000|Overall Study|Withdrawal by Subject|1|||
155198140|NCT01281865|560163837|FG001|Overall Study|Withdrawal by Subject|0|||
155198141|NCT01281865|560163836|FG000|Overall Study|Lack of Efficacy|1|||
155198142|NCT01281865|560163837|FG001|Overall Study|Lack of Efficacy|0|||
155198143|NCT03478657|560163838|FG000|Overall Study|Withdrawal by Subject|0|||
155198144|NCT03478657|560163839|FG001|Overall Study|Withdrawal by Subject|1|||
155198145|NCT03733470|560163842|FG000|Overall Study|PI Decision|1|||
155198146|NCT03733470|560163843|FG001|Overall Study|PI Decision|1|||
155198147|NCT01786668|560163845|FG000|Overall Study|Adverse Event|0|||
155198148|NCT01786668|560163846|FG001|Overall Study|Adverse Event|1|||
155198149|NCT01786668|560163847|FG002|Overall Study|Adverse Event|1|||
155198150|NCT01786668|560163848|FG003|Overall Study|Adverse Event|2|||
155198151|NCT01786668|560163845|FG000|Overall Study|Withdrawal by Subject|0|||
155198152|NCT01786668|560163846|FG001|Overall Study|Withdrawal by Subject|0|||
155198153|NCT01786668|560163847|FG002|Overall Study|Withdrawal by Subject|3|||
155198154|NCT01786668|560163848|FG003|Overall Study|Withdrawal by Subject|1|||
155198155|NCT01786668|560163845|FG000|Overall Study|Pregnancy|0|||
155198156|NCT01786668|560163846|FG001|Overall Study|Pregnancy|0|||
155198157|NCT01786668|560163847|FG002|Overall Study|Pregnancy|0|||
155198158|NCT01786668|560163848|FG003|Overall Study|Pregnancy|1|||
155198159|NCT01786668|560163845|FG000|Overall Study|Lost to Follow-up|1|||
155198160|NCT01786668|560163846|FG001|Overall Study|Lost to Follow-up|0|||
155198161|NCT01786668|560163847|FG002|Overall Study|Lost to Follow-up|1|||
155198162|NCT01786668|560163848|FG003|Overall Study|Lost to Follow-up|0|||
155198163|NCT01776840|560163855|FG000|Overall Study|Lost to Follow-up|12|||
155198164|NCT01776840|560163856|FG001|Overall Study|Lost to Follow-up|7|||
155198165|NCT01776840|560163855|FG000|Overall Study|Withdrawal by Subject|32|||
155198166|NCT01776840|560163856|FG001|Overall Study|Withdrawal by Subject|48|||
155198167|NCT01776840|560163855|FG000|Overall Study|Sponsor decision|89|||
155198168|NCT01776840|560163856|FG001|Overall Study|Sponsor decision|87|||
155198169|NCT03641339|560163857|FG000|Overall Study|Physician Decision|1|||
155198170|NCT03641339|560163858|FG001|Overall Study|Physician Decision|0|||
155198171|NCT03641339|560163859|FG002|Overall Study|Physician Decision|0|||
155198172|NCT03641339|560163860|FG003|Overall Study|Physician Decision|0|||
155198173|NCT03641339|560163861|FG004|Overall Study|Physician Decision|0|||
155198174|NCT03641339|560163862|FG005|Overall Study|Physician Decision|0|||
155198175|NCT03641339|560163857|FG000|Overall Study|Withdrawal by Subject|0|||
155198176|NCT03641339|560163858|FG001|Overall Study|Withdrawal by Subject|2|||
155198177|NCT03641339|560163859|FG002|Overall Study|Withdrawal by Subject|0|||
155198178|NCT03641339|560163860|FG003|Overall Study|Withdrawal by Subject|2|||
155198179|NCT03641339|560163861|FG004|Overall Study|Withdrawal by Subject|0|||
155198180|NCT03641339|560163862|FG005|Overall Study|Withdrawal by Subject|1|||
155198181|NCT05338216|560163864|FG000|Overall Study|Withdrawal by Subject|1|||
155198182|NCT05338216|560163865|FG001|Overall Study|Withdrawal by Subject|1|||
155198183|NCT04457336|560163866|FG000|Period 2: Part A|Withdrawal by Subject|0|||
155198184|NCT04457336|560163867|FG001|Period 2: Part A|Withdrawal by Subject|1|||
155198185|NCT04457336|560163868|FG002|Period 2: Part A|Withdrawal by Subject|1|||
155198186|NCT04457336|560163869|FG003|Period 2: Part A|Withdrawal by Subject|1|||
155198187|NCT04457336|560163870|FG004|Period 2: Part A|Withdrawal by Subject|0|||
155198188|NCT04457336|560163871|FG005|Period 2: Part A|Withdrawal by Subject|0|||
155198189|NCT04457336|560163872|FG006|Period 2: Part A|Withdrawal by Subject|0|||
155198190|NCT04457336|560163873|FG007|Period 2: Part A|Withdrawal by Subject|0|||
155198191|NCT04457336|560163866|FG000|Period 2: Part A|Adverse Event|0|||
155198192|NCT04457336|560163867|FG001|Period 2: Part A|Adverse Event|0|||
155198193|NCT04457336|560163868|FG002|Period 2: Part A|Adverse Event|1|||
155198194|NCT04457336|560163869|FG003|Period 2: Part A|Adverse Event|1|||
155198195|NCT04457336|560163870|FG004|Period 2: Part A|Adverse Event|0|||
155198196|NCT04457336|560163871|FG005|Period 2: Part A|Adverse Event|0|||
155198197|NCT04457336|560163872|FG006|Period 2: Part A|Adverse Event|0|||
155198198|NCT04457336|560163873|FG007|Period 2: Part A|Adverse Event|0|||
155198199|NCT04457336|560163866|FG000|Period 2: Part A|Study Terminated|0|||
155198200|NCT04457336|560163867|FG001|Period 2: Part A|Study Terminated|0|||
155198201|NCT04457336|560163868|FG002|Period 2: Part A|Study Terminated|1|||
155198202|NCT04457336|560163869|FG003|Period 2: Part A|Study Terminated|0|||
155198203|NCT04457336|560163870|FG004|Period 2: Part A|Study Terminated|0|||
155198204|NCT04457336|560163871|FG005|Period 2: Part A|Study Terminated|0|||
155198205|NCT04457336|560163872|FG006|Period 2: Part A|Study Terminated|0|||
155198206|NCT04457336|560163873|FG007|Period 2: Part A|Study Terminated|0|||
155198207|NCT04457336|560163866|FG000|Period 2: Part A|Protocol Violation|0|||
155198208|NCT04457336|560163867|FG001|Period 2: Part A|Protocol Violation|1|||
155198209|NCT04457336|560163868|FG002|Period 2: Part A|Protocol Violation|0|||
155198210|NCT04457336|560163869|FG003|Period 2: Part A|Protocol Violation|0|||
155198211|NCT04457336|560163870|FG004|Period 2: Part A|Protocol Violation|0|||
155198212|NCT04457336|560163871|FG005|Period 2: Part A|Protocol Violation|0|||
155198213|NCT04457336|560163872|FG006|Period 2: Part A|Protocol Violation|0|||
155198214|NCT04457336|560163873|FG007|Period 2: Part A|Protocol Violation|0|||
155198215|NCT04457336|560163866|FG000|Period 2: Part A|Lost to Follow-up|0|||
155198216|NCT04457336|560163867|FG001|Period 2: Part A|Lost to Follow-up|1|||
155198217|NCT04457336|560163868|FG002|Period 2: Part A|Lost to Follow-up|0|||
155198218|NCT04457336|560163869|FG003|Period 2: Part A|Lost to Follow-up|0|||
155198219|NCT04457336|560163870|FG004|Period 2: Part A|Lost to Follow-up|0|||
155198220|NCT04457336|560163871|FG005|Period 2: Part A|Lost to Follow-up|0|||
155198221|NCT04457336|560163872|FG006|Period 2: Part A|Lost to Follow-up|0|||
155198222|NCT04457336|560163873|FG007|Period 2: Part A|Lost to Follow-up|0|||
155198223|NCT04457336|560163866|FG000|Period 2: Part A|Other|0|||
155198224|NCT04457336|560163867|FG001|Period 2: Part A|Other|1|||
155198225|NCT04457336|560163868|FG002|Period 2: Part A|Other|0|||
155198226|NCT04457336|560163869|FG003|Period 2: Part A|Other|0|||
155198227|NCT04457336|560163870|FG004|Period 2: Part A|Other|0|||
155198228|NCT04457336|560163871|FG005|Period 2: Part A|Other|0|||
155198229|NCT04457336|560163872|FG006|Period 2: Part A|Other|0|||
155198230|NCT04457336|560163873|FG007|Period 2: Part A|Other|0|||
155198231|NCT04457336|560163866|FG000|Period 2: Part A|Physician Decision|0|||
155198232|NCT04457336|560163867|FG001|Period 2: Part A|Physician Decision|0|||
155198233|NCT04457336|560163868|FG002|Period 2: Part A|Physician Decision|0|||
155198234|NCT04457336|560163869|FG003|Period 2: Part A|Physician Decision|1|||
155198235|NCT04457336|560163870|FG004|Period 2: Part A|Physician Decision|0|||
155198236|NCT04457336|560163871|FG005|Period 2: Part A|Physician Decision|0|||
155198237|NCT04457336|560163872|FG006|Period 2: Part A|Physician Decision|0|||
155198238|NCT04457336|560163873|FG007|Period 2: Part A|Physician Decision|0|||
155198239|NCT04457336|560163866|FG000|Period 3: Part B|Study Terminated|0|||
155198240|NCT04457336|560163867|FG001|Period 3: Part B|Study Terminated|0|||
155198241|NCT04457336|560163868|FG002|Period 3: Part B|Study Terminated|0|||
155198242|NCT04457336|560163869|FG003|Period 3: Part B|Study Terminated|0|||
155198243|NCT04457336|560163870|FG004|Period 3: Part B|Study Terminated|1|||
155198244|NCT04457336|560163871|FG005|Period 3: Part B|Study Terminated|10|||
155198245|NCT04457336|560163872|FG006|Period 3: Part B|Study Terminated|13|||
155198246|NCT04457336|560163873|FG007|Period 3: Part B|Study Terminated|0|||
155198247|NCT04457336|560163866|FG000|Period 3: Part B|Withdrawal by Subject|0|||
155198248|NCT04457336|560163867|FG001|Period 3: Part B|Withdrawal by Subject|0|||
155198249|NCT04457336|560163868|FG002|Period 3: Part B|Withdrawal by Subject|0|||
155198250|NCT04457336|560163869|FG003|Period 3: Part B|Withdrawal by Subject|0|||
155198251|NCT04457336|560163870|FG004|Period 3: Part B|Withdrawal by Subject|0|||
155198252|NCT04457336|560163871|FG005|Period 3: Part B|Withdrawal by Subject|1|||
155198253|NCT04457336|560163872|FG006|Period 3: Part B|Withdrawal by Subject|2|||
155198254|NCT04457336|560163873|FG007|Period 3: Part B|Withdrawal by Subject|0|||
155198255|NCT04457336|560163866|FG000|Period 4: Part C|Study Terminated|0|||
155198256|NCT04457336|560163867|FG001|Period 4: Part C|Study Terminated|0|||
155198257|NCT04457336|560163868|FG002|Period 4: Part C|Study Terminated|0|||
155198258|NCT04457336|560163869|FG003|Period 4: Part C|Study Terminated|0|||
155198259|NCT04457336|560163870|FG004|Period 4: Part C|Study Terminated|0|||
155198260|NCT04457336|560163871|FG005|Period 4: Part C|Study Terminated|0|||
155198261|NCT04457336|560163872|FG006|Period 4: Part C|Study Terminated|0|||
155198262|NCT04457336|560163873|FG007|Period 4: Part C|Study Terminated|30|||
155198263|NCT04457336|560163866|FG000|Period 4: Part C|Adverse Event|0|||
155198264|NCT04457336|560163867|FG001|Period 4: Part C|Adverse Event|0|||
155198265|NCT04457336|560163868|FG002|Period 4: Part C|Adverse Event|0|||
155198266|NCT04457336|560163869|FG003|Period 4: Part C|Adverse Event|0|||
155198267|NCT04457336|560163870|FG004|Period 4: Part C|Adverse Event|0|||
155198268|NCT04457336|560163871|FG005|Period 4: Part C|Adverse Event|0|||
155198269|NCT04457336|560163872|FG006|Period 4: Part C|Adverse Event|0|||
155198270|NCT04457336|560163873|FG007|Period 4: Part C|Adverse Event|2|||
155150781|NCT00467740|559985772|FG003|Overall Study|Withdrawal by Subject|1|||
155150782|NCT00467740|559985773|FG004|Overall Study|Withdrawal by Subject|0|||
155150783|NCT00467740|559985769|FG000|Overall Study|Lack of Efficacy|0|||
155150784|NCT00467740|559985770|FG001|Overall Study|Lack of Efficacy|1|||
155150785|NCT00467740|559985771|FG002|Overall Study|Lack of Efficacy|0|||
155150786|NCT00467740|559985772|FG003|Overall Study|Lack of Efficacy|0|||
155150787|NCT00467740|559985773|FG004|Overall Study|Lack of Efficacy|0|||
155150788|NCT02903160|559985774|FG000|Overall Study|Adverse Event|2|||
155150789|NCT02903160|559985774|FG000|Overall Study|Death|1|||
155150790|NCT02903160|559985774|FG000|Overall Study|Lost to Follow-up|2|||
155150791|NCT02903160|559985774|FG000|Overall Study|Withdrawal by Subject|1|||
155150792|NCT02903160|559985774|FG000|Overall Study|Medical Insurance Barriers|1|||
155150793|NCT01664910|559985777|FG000|Overall Study|Adverse Event|0|||
155150794|NCT01664910|559985778|FG001|Overall Study|Adverse Event|0|||
155150795|NCT01664910|559985779|FG002|Overall Study|Adverse Event|1|||
155150796|NCT02240485|559985780|FG000|3 Months Post-admission|Lost to Follow-up|1|||
155150797|NCT02240485|559985781|FG001|3 Months Post-admission|Lost to Follow-up|5|||
155198271|NCT04457336|560163866|FG000|Period 4: Part C|Site Terminated|0|||
155198272|NCT04457336|560163867|FG001|Period 4: Part C|Site Terminated|0|||
155198273|NCT04457336|560163868|FG002|Period 4: Part C|Site Terminated|0|||
155198274|NCT04457336|560163869|FG003|Period 4: Part C|Site Terminated|0|||
155198275|NCT04457336|560163870|FG004|Period 4: Part C|Site Terminated|0|||
155198276|NCT04457336|560163871|FG005|Period 4: Part C|Site Terminated|0|||
155150798|NCT02240485|559985780|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
155150799|NCT02240485|559985781|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
155198277|NCT04457336|560163872|FG006|Period 4: Part C|Site Terminated|0|||
155198278|NCT04457336|560163873|FG007|Period 4: Part C|Site Terminated|1|||
155198279|NCT04457336|560163866|FG000|Period 4: Part C|Other|0|||
155198280|NCT04457336|560163867|FG001|Period 4: Part C|Other|0|||
155198281|NCT04457336|560163868|FG002|Period 4: Part C|Other|0|||
155198282|NCT04457336|560163869|FG003|Period 4: Part C|Other|0|||
155198283|NCT04457336|560163870|FG004|Period 4: Part C|Other|0|||
155198284|NCT04457336|560163871|FG005|Period 4: Part C|Other|0|||
155198285|NCT04457336|560163872|FG006|Period 4: Part C|Other|0|||
155198286|NCT04457336|560163873|FG007|Period 4: Part C|Other|2|||
155198287|NCT04457336|560163866|FG000|Period 4: Part C|Withdrawal by Subject|0|||
155198288|NCT04457336|560163867|FG001|Period 4: Part C|Withdrawal by Subject|0|||
155198289|NCT04457336|560163868|FG002|Period 4: Part C|Withdrawal by Subject|0|||
155198290|NCT04457336|560163869|FG003|Period 4: Part C|Withdrawal by Subject|0|||
155198291|NCT04457336|560163870|FG004|Period 4: Part C|Withdrawal by Subject|0|||
155198292|NCT04457336|560163871|FG005|Period 4: Part C|Withdrawal by Subject|0|||
155198293|NCT04457336|560163872|FG006|Period 4: Part C|Withdrawal by Subject|0|||
155198294|NCT04457336|560163873|FG007|Period 4: Part C|Withdrawal by Subject|3|||
155198295|NCT05379231|560163874|FG000|Home Visit|Withdrawal by Subject|2|||
155198296|NCT05379231|560163874|FG000|In-lab Visit|Withdrawal by Subject|2|||
155198297|NCT02693119|560163881|FG000|Open-Label Period|Withdrawal by Subject|0|||
155198298|NCT02693119|560163882|FG001|Open-Label Period|Withdrawal by Subject|1|||
155198299|NCT01719783|560163883|FG000|Dose 2|Physician Decision|1|||
155198300|NCT01719783|560163884|FG001|Dose 2|Physician Decision|0|||
155198301|NCT02319837|560163885|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
155198302|NCT02319837|560163886|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
155198303|NCT02319837|560163887|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
155198304|NCT02319837|560163885|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
155198305|NCT02319837|560163886|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
155198306|NCT02319837|560163887|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
155198307|NCT02319837|560163885|FG000|Study Treatment Phase|Adverse Event|73|||
155198308|NCT02319837|560163886|FG001|Study Treatment Phase|Adverse Event|36|||
155198309|NCT02319837|560163887|FG002|Study Treatment Phase|Adverse Event|63|||
155198310|NCT02319837|560163885|FG000|Study Treatment Phase|Development of castration resistance|0|||
155198311|NCT02319837|560163886|FG001|Study Treatment Phase|Development of castration resistance|2|||
155198312|NCT02319837|560163887|FG002|Study Treatment Phase|Development of castration resistance|0|||
155198313|NCT02319837|560163885|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
155198314|NCT02319837|560163886|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
155198315|NCT02319837|560163887|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
155198316|NCT02319837|560163885|FG000|Study Treatment Phase|Protocol Violation|2|||
155198317|NCT02319837|560163886|FG001|Study Treatment Phase|Protocol Violation|2|||
155198318|NCT02319837|560163887|FG002|Study Treatment Phase|Protocol Violation|1|||
155198319|NCT02319837|560163885|FG000|Study Treatment Phase|Lost to Follow-up|0|||
155198320|NCT02319837|560163886|FG001|Study Treatment Phase|Lost to Follow-up|1|||
155198321|NCT02319837|560163887|FG002|Study Treatment Phase|Lost to Follow-up|0|||
155198322|NCT02319837|560163885|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
155198323|NCT02319837|560163886|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
155198324|NCT02319837|560163887|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
155198325|NCT02319837|560163885|FG000|Study Treatment Phase|Other|0|||
155198326|NCT02319837|560163886|FG001|Study Treatment Phase|Other|1|||
155198327|NCT02319837|560163887|FG002|Study Treatment Phase|Other|0|||
155198328|NCT02319837|560163885|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
155198329|NCT02319837|560163886|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
155198330|NCT02319837|560163887|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
155198331|NCT02319837|560163885|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
155198332|NCT02319837|560163886|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
155198333|NCT02319837|560163887|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
155198334|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
155198335|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
155198336|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
155198337|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
155198338|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
155198339|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
155198340|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
155198341|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
155198342|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
155198343|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
155198344|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
155198345|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
155198346|NCT02319837|560163885|FG000|Long-Term Follow-Up Phase|Death|33|||
155198347|NCT02319837|560163886|FG001|Long-Term Follow-Up Phase|Death|54|||
155198348|NCT02319837|560163887|FG002|Long-Term Follow-Up Phase|Death|42|||
155198349|NCT00753766|560163888|FG000|Overall Study|Physician Decision|1|||
155198350|NCT00753766|560163889|FG001|Overall Study|Physician Decision|0|||
155198351|NCT01206166|560163891|FG000|Overall Study|No evaluable data|2|||
155198352|NCT01206166|560163892|FG001|Overall Study|No evaluable data|3|||
155198353|NCT00932126|560163893|FG000|Overall Study|Adverse Event|0|||
155198354|NCT00932126|560163894|FG001|Overall Study|Adverse Event|0|||
155198355|NCT00932126|560163895|FG002|Overall Study|Adverse Event|0|||
155198356|NCT00932126|560163896|FG003|Overall Study|Adverse Event|0|||
155150800|NCT02240485|559985780|FG000|9 Months Post-admission|Lost to Follow-up|3|||
155150801|NCT02240485|559985781|FG001|9 Months Post-admission|Lost to Follow-up|1|||
155150802|NCT02240485|559985780|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
155150803|NCT02240485|559985781|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
155150804|NCT02240485|559985780|FG000|18 Months Post-admission|Lost to Follow-up|1|||
155150805|NCT02240485|559985781|FG001|18 Months Post-admission|Lost to Follow-up|1|||
155150806|NCT02240485|559985780|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
155150807|NCT02240485|559985781|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
155150808|NCT04059549|559985785|FG000|Overall Study|Withdrawal by Subject|2|||
155150809|NCT04059549|559985786|FG001|Overall Study|Withdrawal by Subject|0|||
155150810|NCT01919229|559985787|FG000|Overall Study|Subject/guardian decision|0|||
155150811|NCT01919229|559985788|FG001|Overall Study|Subject/guardian decision|0|||
155150812|NCT01919229|559985789|FG002|Overall Study|Subject/guardian decision|1|||
155150813|NCT01011673|559985790|FG000|Randomized|Secondary headache|2|||
155150814|NCT01011673|559985791|FG001|Randomized|Secondary headache|1|||
155150815|NCT01011673|559985790|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
155150816|NCT01011673|559985791|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
155150817|NCT01632020|559985792|FG000|Overall Study|Withdrawal by Subject|1|||
155150818|NCT01632020|559985793|FG001|Overall Study|Withdrawal by Subject|0|||
155150819|NCT01632020|559985792|FG000|Overall Study|Adverse Event|1|||
155150820|NCT01632020|559985793|FG001|Overall Study|Adverse Event|0|||
155150821|NCT00549640|559985795|FG000|Overall Study|Withdrawal by Subject|6|||
155150822|NCT00549640|559985796|FG001|Overall Study|Withdrawal by Subject|12|||
155150823|NCT00549640|559985795|FG000|Overall Study|Adverse Event|5|||
155150824|NCT00549640|559985796|FG001|Overall Study|Adverse Event|0|||
155150825|NCT00549640|559985795|FG000|Overall Study|Lost to Follow-up|7|||
155150826|NCT00549640|559985796|FG001|Overall Study|Lost to Follow-up|4|||
155150827|NCT04999839|559985801|FG000|Overall Study|Adverse Event|1|||
155150828|NCT04999839|559985802|FG001|Overall Study|Adverse Event|1|||
155150829|NCT04999839|559985803|FG002|Overall Study|Adverse Event|1|||
155150830|NCT04999839|559985804|FG003|Overall Study|Adverse Event|1|||
155150831|NCT04999839|559985805|FG004|Overall Study|Adverse Event|1|||
155150832|NCT04999839|559985801|FG000|Overall Study|Lost to Follow-up|2|||
155150833|NCT04999839|559985802|FG001|Overall Study|Lost to Follow-up|0|||
155150834|NCT04999839|559985803|FG002|Overall Study|Lost to Follow-up|2|||
155150835|NCT04999839|559985804|FG003|Overall Study|Lost to Follow-up|4|||
155150836|NCT04999839|559985805|FG004|Overall Study|Lost to Follow-up|1|||
155150837|NCT04999839|559985801|FG000|Overall Study|Withdrawal by Subject|6|||
155150838|NCT04999839|559985802|FG001|Overall Study|Withdrawal by Subject|5|||
155150839|NCT04999839|559985803|FG002|Overall Study|Withdrawal by Subject|3|||
155150840|NCT04999839|559985804|FG003|Overall Study|Withdrawal by Subject|2|||
155150841|NCT04999839|559985805|FG004|Overall Study|Withdrawal by Subject|2|||
155150842|NCT04999839|559985801|FG000|Overall Study|Lack of Efficacy|0|||
155150843|NCT04999839|559985802|FG001|Overall Study|Lack of Efficacy|1|||
155150844|NCT04999839|559985803|FG002|Overall Study|Lack of Efficacy|0|||
155150845|NCT04999839|559985804|FG003|Overall Study|Lack of Efficacy|0|||
155150846|NCT04999839|559985805|FG004|Overall Study|Lack of Efficacy|0|||
155150847|NCT04999839|559985801|FG000|Overall Study|Physician Decision|0|||
155150848|NCT04999839|559985802|FG001|Overall Study|Physician Decision|0|||
155150849|NCT04999839|559985803|FG002|Overall Study|Physician Decision|0|||
155150850|NCT04999839|559985804|FG003|Overall Study|Physician Decision|0|||
155150851|NCT04999839|559985805|FG004|Overall Study|Physician Decision|1|||
155150852|NCT04999839|559985801|FG000|Overall Study|Sponsor request|0|||
155150853|NCT04999839|559985802|FG001|Overall Study|Sponsor request|1|||
155150854|NCT04999839|559985803|FG002|Overall Study|Sponsor request|0|||
155150855|NCT04999839|559985804|FG003|Overall Study|Sponsor request|0|||
155150856|NCT04999839|559985805|FG004|Overall Study|Sponsor request|0|||
155150857|NCT04999839|559985801|FG000|Overall Study|Other|0|||
155150858|NCT04999839|559985802|FG001|Overall Study|Other|0|||
155150859|NCT04999839|559985803|FG002|Overall Study|Other|1|||
155150860|NCT04999839|559985804|FG003|Overall Study|Other|0|||
155150861|NCT04999839|559985805|FG004|Overall Study|Other|0|||
155150862|NCT02734693|559985806|FG000|Overall Study|Adverse Event|1|||
155150863|NCT02734693|559985807|FG001|Overall Study|Adverse Event|3|||
155198357|NCT00932126|560163897|FG004|Overall Study|Adverse Event|0|||
155198358|NCT00932126|560163898|FG005|Overall Study|Adverse Event|0|||
155198359|NCT00932126|560163899|FG006|Overall Study|Adverse Event|1|||
155198360|NCT00932126|560163900|FG007|Overall Study|Adverse Event|2|||
155198361|NCT00932126|560163893|FG000|Overall Study|Protocol Violation|0|||
155198362|NCT00932126|560163894|FG001|Overall Study|Protocol Violation|0|||
155198363|NCT00932126|560163895|FG002|Overall Study|Protocol Violation|0|||
155198364|NCT00932126|560163896|FG003|Overall Study|Protocol Violation|0|||
155198365|NCT00932126|560163897|FG004|Overall Study|Protocol Violation|1|||
155198366|NCT00932126|560163898|FG005|Overall Study|Protocol Violation|0|||
155198367|NCT00932126|560163899|FG006|Overall Study|Protocol Violation|0|||
155198368|NCT00932126|560163900|FG007|Overall Study|Protocol Violation|0|||
155198369|NCT00932126|560163893|FG000|Overall Study|Withdrawal by Subject|0|||
155198370|NCT00932126|560163894|FG001|Overall Study|Withdrawal by Subject|0|||
155198371|NCT00932126|560163895|FG002|Overall Study|Withdrawal by Subject|1|||
155198372|NCT00932126|560163896|FG003|Overall Study|Withdrawal by Subject|0|||
155198373|NCT00932126|560163897|FG004|Overall Study|Withdrawal by Subject|0|||
155198374|NCT00932126|560163898|FG005|Overall Study|Withdrawal by Subject|0|||
155198375|NCT00932126|560163899|FG006|Overall Study|Withdrawal by Subject|0|||
155198376|NCT00932126|560163900|FG007|Overall Study|Withdrawal by Subject|1|||
155198377|NCT00932126|560163893|FG000|Overall Study|Objective progression or relapse|3|||
155198378|NCT00932126|560163894|FG001|Overall Study|Objective progression or relapse|3|||
155198379|NCT00932126|560163895|FG002|Overall Study|Objective progression or relapse|2|||
155198380|NCT00932126|560163896|FG003|Overall Study|Objective progression or relapse|3|||
155198381|NCT00932126|560163897|FG004|Overall Study|Objective progression or relapse|3|||
155198382|NCT00932126|560163898|FG005|Overall Study|Objective progression or relapse|3|||
155198383|NCT00932126|560163899|FG006|Overall Study|Objective progression or relapse|3|||
155198384|NCT00932126|560163900|FG007|Overall Study|Objective progression or relapse|5|||
155198385|NCT00932126|560163893|FG000|Overall Study|Other|0|||
155198386|NCT00932126|560163894|FG001|Overall Study|Other|0|||
155150864|NCT02734693|559985808|FG002|Overall Study|Adverse Event|3|||
155150865|NCT02734693|559985806|FG000|Overall Study|Lack of Efficacy|1|||
155150866|NCT02734693|559985807|FG001|Overall Study|Lack of Efficacy|0|||
155150867|NCT02734693|559985808|FG002|Overall Study|Lack of Efficacy|0|||
155150868|NCT02734693|559985806|FG000|Overall Study|Lost to Follow-up|2|||
155150869|NCT02734693|559985807|FG001|Overall Study|Lost to Follow-up|0|||
155150870|NCT02734693|559985808|FG002|Overall Study|Lost to Follow-up|0|||
155150871|NCT02734693|559985806|FG000|Overall Study|Protocol Violation|1|||
155150872|NCT02734693|559985807|FG001|Overall Study|Protocol Violation|0|||
155150873|NCT02734693|559985808|FG002|Overall Study|Protocol Violation|0|||
155150874|NCT02734693|559985806|FG000|Overall Study|Withdrawal by Subject|1|||
155150875|NCT02734693|559985807|FG001|Overall Study|Withdrawal by Subject|0|||
155150876|NCT02734693|559985808|FG002|Overall Study|Withdrawal by Subject|0|||
155150877|NCT00644358|559985809|FG000|Overall Study|Adverse Event|124|||
155150878|NCT00644358|559985809|FG000|Overall Study|Lost to Follow-up|105|||
155150879|NCT00644358|559985809|FG000|Overall Study|Consent Withdrawal|64|||
155150880|NCT00644358|559985809|FG000|Overall Study|Lack of Effectiveness|39|||
155150881|NCT00644358|559985809|FG000|Overall Study|Protocol Violation|5|||
155150882|NCT00644358|559985809|FG000|Overall Study|Noncompliance|14|||
155150883|NCT00644358|559985809|FG000|Overall Study|Other Unspecified|11|||
155150884|NCT00960063|559985814|FG000|Overall Study|Adverse Event|1|||
155150885|NCT00960063|559985815|FG001|Overall Study|Adverse Event|0|||
155150886|NCT00960063|559985816|FG002|Overall Study|Adverse Event|0|||
155150887|NCT00960063|559985814|FG000|Overall Study|Progression of Disease|0|||
155150888|NCT00960063|559985815|FG001|Overall Study|Progression of Disease|0|||
155150889|NCT00960063|559985816|FG002|Overall Study|Progression of Disease|3|||
155150890|NCT05083351|559985821|FG000|Overall Study|Adverse Event|3|||
155150891|NCT05083351|559985821|FG000|Overall Study|Did not meet data inclusion criteria|8|||
155150892|NCT05083351|559985821|FG000|Overall Study|Did not meet eligibility criteria|19|||
155150893|NCT05083351|559985821|FG000|Overall Study|Study Staff Decision|19|||
155150894|NCT01611792|559985822|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
155150895|NCT01611792|559985823|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
155150896|NCT01611792|559985822|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
155150897|NCT01611792|559985823|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
155150898|NCT00584415|559985827|FG000|Overall Study|Adverse Event|7|||
155150899|NCT00556894|559985828|FG000|Overall Study|Adverse Event|2|||
155150900|NCT00556894|559985829|FG001|Overall Study|Adverse Event|3|||
155150901|NCT00556894|559985830|FG002|Overall Study|Adverse Event|3|||
155150902|NCT00556894|559985828|FG000|Overall Study|Death|1|||
155198387|NCT00932126|560163895|FG002|Overall Study|Other|0|||
155150903|NCT00556894|559985829|FG001|Overall Study|Death|0|||
155150904|NCT00556894|559985830|FG002|Overall Study|Death|0|||
155150905|NCT00556894|559985828|FG000|Overall Study|regulatory decision in Bulgaria|10|||
155150906|NCT00556894|559985829|FG001|Overall Study|regulatory decision in Bulgaria|14|||
155150907|NCT00556894|559985830|FG002|Overall Study|regulatory decision in Bulgaria|13|||
155198388|NCT00932126|560163896|FG003|Overall Study|Other|0|||
155150908|NCT00556894|559985828|FG000|Overall Study|Change in therapy|2|||
155150909|NCT00556894|559985829|FG001|Overall Study|Change in therapy|1|||
155150910|NCT00556894|559985830|FG002|Overall Study|Change in therapy|2|||
155198389|NCT00932126|560163897|FG004|Overall Study|Other|1|||
155198390|NCT00932126|560163898|FG005|Overall Study|Other|0|||
155198391|NCT00932126|560163899|FG006|Overall Study|Other|1|||
155198392|NCT00932126|560163900|FG007|Overall Study|Other|2|||
155198393|NCT05306977|560163904|FG000|Overall Study|Withdrawal by Subject|1|||
155198394|NCT00415168|560163905|FG000|Overall Study|Death|26|||
155198395|NCT00415168|560163905|FG000|Overall Study|Lost to Follow-up|3|||
155198396|NCT00415168|560163905|FG000|Overall Study|Physician Decision|13|||
155198397|NCT00415168|560163905|FG000|Overall Study|Sponsor Decision|4|||
155198398|NCT00415168|560163905|FG000|Overall Study|Withdrawal by Subject|6|||
155198399|NCT00241358|560163906|FG000|Overall Study|Determined to be not ineligible|0|||
155198400|NCT00241358|560163907|FG001|Overall Study|Determined to be not ineligible|1|||
155198401|NCT00241358|560163908|FG002|Overall Study|Determined to be not ineligible|1|||
155198402|NCT01611155|560163909|FG000|Overall Study|Adverse Event|1|||
155198403|NCT01611155|560163910|FG001|Overall Study|Adverse Event|1|||
155198404|NCT01611155|560163909|FG000|Overall Study|Refused further treatment|6|||
155198405|NCT01611155|560163910|FG001|Overall Study|Refused further treatment|4|||
155198406|NCT01611155|560163909|FG000|Overall Study|Disease progression|1|||
155198407|NCT01611155|560163910|FG001|Overall Study|Disease progression|0|||
155198408|NCT01611155|560163909|FG000|Overall Study|Withdrawal by Subject|1|||
155198409|NCT01611155|560163910|FG001|Overall Study|Withdrawal by Subject|0|||
155198410|NCT01611155|560163909|FG000|Overall Study|Alternative treatment|0|||
155198411|NCT01611155|560163910|FG001|Overall Study|Alternative treatment|1|||
155198412|NCT01611155|560163909|FG000|Overall Study|Ineligible patient|0|||
155198413|NCT01611155|560163910|FG001|Overall Study|Ineligible patient|1|||
155198414|NCT00087607|560163917|FG000|Overall Study|Adverse Event|14|||
155198415|NCT00087607|560163918|FG001|Overall Study|Adverse Event|24|||
155198416|NCT00087607|560163917|FG000|Overall Study|Death|0|||
155198417|NCT00087607|560163918|FG001|Overall Study|Death|1|||
155198418|NCT00087607|560163917|FG000|Overall Study|Insufficient Therapeutic Response|53|||
155198419|NCT00087607|560163918|FG001|Overall Study|Insufficient Therapeutic Response|42|||
155198420|NCT00087607|560163917|FG000|Overall Study|Failure to return|21|||
155198421|NCT00087607|560163918|FG001|Overall Study|Failure to return|17|||
155198422|NCT00087607|560163917|FG000|Overall Study|Withdrew Consent|12|||
155198423|NCT00087607|560163918|FG001|Overall Study|Withdrew Consent|16|||
155198424|NCT00087607|560163917|FG000|Overall Study|Administrative|12|||
155198425|NCT00087607|560163918|FG001|Overall Study|Administrative|12|||
155198426|NCT00087607|560163917|FG000|Overall Study|Refused Treatment|5|||
155198427|NCT00087607|560163918|FG001|Overall Study|Refused Treatment|7|||
155198428|NCT00087607|560163917|FG000|Overall Study|Other Protocol Violation|5|||
155198429|NCT00087607|560163918|FG001|Overall Study|Other Protocol Violation|2|||
155198430|NCT00087607|560163917|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155198431|NCT00087607|560163918|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155198432|NCT02015754|560163919|FG000|Overall Study|Disease progression|5|||
155198433|NCT02015754|560163919|FG000|Overall Study|Change in treatment modality|5|||
155198434|NCT02015754|560163919|FG000|Overall Study|Lost to Follow-up|1|||
155198435|NCT06934993|560163934|FG000|Overall Study|Withdrawal by Subject|29|||
155198436|NCT06934993|560163934|FG000|Overall Study|elevated postoperative creatinine level|11|||
155198437|NCT06934993|560163934|FG000|Overall Study|Death|3|||
155198438|NCT03749447|560164968|FG000|Overall Study|Adverse Event|11|||
155198439|NCT03749447|560164969|FG001|Overall Study|Adverse Event|3|||
155198440|NCT03749447|560164968|FG000|Overall Study|Death|1|||
155198441|NCT03749447|560164969|FG001|Overall Study|Death|1|||
155198442|NCT03749447|560164968|FG000|Overall Study|Lost to Follow-up|2|||
155198443|NCT03749447|560164969|FG001|Overall Study|Lost to Follow-up|2|||
155198444|NCT03749447|560164968|FG000|Overall Study|Reason Not Specified|0|||
155198445|NCT03749447|560164969|FG001|Overall Study|Reason Not Specified|3|||
155198446|NCT03749447|560164968|FG000|Overall Study|Physician Decision|4|||
155198447|NCT03749447|560164969|FG001|Overall Study|Physician Decision|3|||
155198448|NCT03749447|560164968|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
155198449|NCT03749447|560164969|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
155198450|NCT03749447|560164968|FG000|Overall Study|Study Terminated By Sponsor|112|||
155198451|NCT03749447|560164969|FG001|Overall Study|Study Terminated By Sponsor|105|||
155198452|NCT03749447|560164968|FG000|Overall Study|Withdrawal by Subject|12|||
155198453|NCT03749447|560164969|FG001|Overall Study|Withdrawal by Subject|6|||
155198454|NCT03749447|560164968|FG000|Overall Study|Non-compliance With Study Drug|0|||
155198455|NCT03749447|560164969|FG001|Overall Study|Non-compliance With Study Drug|1|||
155198456|NCT00259649|560164971|FG000|Overall Study|Lost to Follow-up|7|||
155198457|NCT00259649|560164971|FG000|Overall Study|irregular menses|3|||
155198458|NCT00745823|560164972|FG000|Overall Study|Adverse Event|5|||
155198459|NCT00745823|560164973|FG001|Overall Study|Adverse Event|3|||
155198460|NCT00745823|560164972|FG000|Overall Study|Lack of Efficacy|20|||
155198461|NCT00745823|560164973|FG001|Overall Study|Lack of Efficacy|6|||
155198462|NCT00745823|560164972|FG000|Overall Study|Lost to Follow-up|10|||
155198463|NCT00745823|560164973|FG001|Overall Study|Lost to Follow-up|11|||
155198464|NCT00745823|560164972|FG000|Overall Study|Physician Decision|10|||
155198465|NCT00745823|560164973|FG001|Overall Study|Physician Decision|5|||
155198466|NCT00745823|560164972|FG000|Overall Study|Pregnancy|0|||
155198467|NCT00745823|560164973|FG001|Overall Study|Pregnancy|4|||
155198468|NCT00745823|560164972|FG000|Overall Study|Withdrawal by Subject|14|||
155198487|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
155198488|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
155198489|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
155198490|NCT00787891|560164974|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
155198491|NCT00787891|560164975|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
155198492|NCT04218695|560164978|FG000|Overall Study|Adverse Event|1|||
155198493|NCT04218695|560164979|FG001|Overall Study|Adverse Event|0|||
155198494|NCT01890473|560164980|FG000|Overall Study|Lost to Follow-up|1|||
155198495|NCT01890473|560164981|FG001|Overall Study|Lost to Follow-up|0|||
155198496|NCT01890473|560164980|FG000|Overall Study|Poor/non-compliance|1|||
155198497|NCT01890473|560164981|FG001|Overall Study|Poor/non-compliance|0|||
155198498|NCT01945281|560164982|FG000|Overall Study|Adverse Event|1|||
155198499|NCT01945281|560164983|FG001|Overall Study|Adverse Event|0|||
155198500|NCT01945281|560164982|FG000|Overall Study|Death|3|||
155198501|NCT01945281|560164983|FG001|Overall Study|Death|3|||
155198502|NCT01945281|560164982|FG000|Overall Study|Physician Decision|1|||
155198503|NCT01945281|560164983|FG001|Overall Study|Physician Decision|1|||
155198504|NCT01945281|560164982|FG000|Overall Study|Technical Problems|1|||
155198505|NCT01945281|560164983|FG001|Overall Study|Technical Problems|0|||
155198506|NCT00934089|560164984|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
155198507|NCT00934089|560164985|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
155198508|NCT00934089|560164984|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
155198509|NCT00934089|560164985|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
155198510|NCT00799383|560164986|FG000|Overall Study|Protocol Violation|1|||
155198511|NCT00799383|560164987|FG001|Overall Study|Protocol Violation|1|||
155198512|NCT00799383|560164986|FG000|Overall Study|Adverse Event|0|||
155198513|NCT00799383|560164987|FG001|Overall Study|Adverse Event|1|||
155198514|NCT00799383|560164986|FG000|Overall Study|Lost to Follow-up|1|||
155198515|NCT00799383|560164987|FG001|Overall Study|Lost to Follow-up|2|||
155198516|NCT00799383|560164986|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
155198517|NCT00799383|560164987|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
155198518|NCT00799383|560164986|FG000|Overall Study|Withdrawal by Subject|0|||
155198519|NCT00799383|560164987|FG001|Overall Study|Withdrawal by Subject|1|||
155198520|NCT00726986|560164988|FG000|Induction Phase|Adverse Event|4|||
155198521|NCT00726986|560164988|FG000|Induction Phase|Withdrawal by Subject|2|||
155198522|NCT00726986|560164988|FG000|Induction Phase|Death|2|||
155198523|NCT00726986|560164988|FG000|Induction Phase|Lack of Efficacy|5|||
155198524|NCT00726986|560164988|FG000|Induction Phase|Secondary Disease|2|||
155198525|NCT00726986|560164988|FG000|Maintenance Phase|Adverse Event|1|||
155198526|NCT00726986|560164988|FG000|Maintenance Phase|Lack of Efficacy|2|||
155198527|NCT01513343|560164992|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
155198528|NCT01513343|560164993|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
155198529|NCT01513343|560164992|FG000|Post Data Collection|Dropped/withdrew from study|7|||
155198530|NCT01513343|560164993|FG001|Post Data Collection|Dropped/withdrew from study|1|||
155198531|NCT01513343|560164992|FG000|Post Data Collection|Lost to Follow-up|10|||
155198532|NCT01513343|560164993|FG001|Post Data Collection|Lost to Follow-up|23|||
155198533|NCT01513343|560164992|FG000|6-month Follow-up|Lost to Follow-up|28|||
155198534|NCT01513343|560164993|FG001|6-month Follow-up|Lost to Follow-up|17|||
155198535|NCT01513343|560164992|FG000|12-month Follow-up|Lost to Follow-up|10|||
155198536|NCT01513343|560164993|FG001|12-month Follow-up|Lost to Follow-up|3|||
155198537|NCT01434667|560164994|FG000|Overall Study|Lost to Follow-up|5|||
155198538|NCT01434667|560164995|FG001|Overall Study|Lost to Follow-up|10|||
155198539|NCT02034110|560165000|FG000|Overall Study|Physician Decision|0|||
155198540|NCT02034110|560165001|FG001|Overall Study|Physician Decision|0|||
155198541|NCT02034110|560165002|FG002|Overall Study|Physician Decision|0|||
155198542|NCT02034110|560165003|FG003|Overall Study|Physician Decision|0|||
155198543|NCT02034110|560165004|FG004|Overall Study|Physician Decision|2|||
155198544|NCT02034110|560165005|FG005|Overall Study|Physician Decision|0|||
155198545|NCT02034110|560165006|FG006|Overall Study|Physician Decision|1|||
155198546|NCT02034110|560165007|FG007|Overall Study|Physician Decision|0|||
155198547|NCT02034110|560165000|FG000|Overall Study|Lost to Follow-up|1|||
155198548|NCT02034110|560165001|FG001|Overall Study|Lost to Follow-up|0|||
155198549|NCT02034110|560165002|FG002|Overall Study|Lost to Follow-up|0|||
155198550|NCT02034110|560165003|FG003|Overall Study|Lost to Follow-up|0|||
155198551|NCT02034110|560165004|FG004|Overall Study|Lost to Follow-up|1|||
155198552|NCT02034110|560165005|FG005|Overall Study|Lost to Follow-up|0|||
155198553|NCT02034110|560165006|FG006|Overall Study|Lost to Follow-up|1|||
155198554|NCT02034110|560165007|FG007|Overall Study|Lost to Follow-up|0|||
155198555|NCT02034110|560165000|FG000|Overall Study|Withdrawal by Subject|5|||
155198556|NCT02034110|560165001|FG001|Overall Study|Withdrawal by Subject|7|||
155198557|NCT02034110|560165002|FG002|Overall Study|Withdrawal by Subject|0|||
155198558|NCT02034110|560165003|FG003|Overall Study|Withdrawal by Subject|3|||
155198559|NCT02034110|560165004|FG004|Overall Study|Withdrawal by Subject|7|||
155198560|NCT02034110|560165005|FG005|Overall Study|Withdrawal by Subject|0|||
155198561|NCT02034110|560165006|FG006|Overall Study|Withdrawal by Subject|3|||
155151109|NCT00446849|559988184|FG000|Maintenance Phase|Protocol Violation|7|||
155151110|NCT00446849|559988184|FG000|Maintenance Phase|Adverse Event|6|||
155151111|NCT00446849|559988184|FG000|Maintenance Phase|Consent withdrawn|5|||
155151112|NCT00446849|559988184|FG000|Maintenance Phase|Lost to Follow-up|3|||
155151113|NCT00446849|559988184|FG000|Maintenance Phase|Pregnancy|1|||
155198562|NCT02034110|560165007|FG007|Overall Study|Withdrawal by Subject|1|||
155151114|NCT00446849|559988184|FG000|Maintenance Phase|noncompliance|2|||
155151115|NCT00446849|559988184|FG000|Maintenance Phase|prohibited medication use|2|||
155151116|NCT00446849|559988184|FG000|Maintenance Phase|antibiotic use|1|||
155151117|NCT00446849|559988184|FG000|Maintenance Phase|study closure|1|||
155151118|NCT00446849|559988184|FG000|Maintenance Phase|hydrocodone use|1|||
155151119|NCT00446849|559988184|FG000|Maintenance Phase|concomitant medication use|1|||
155151120|NCT05546476|559988188|FG000|Period 1: Part A|Adverse Event|2|||
155151121|NCT05546476|559988189|FG001|Period 1: Part A|Adverse Event|0|||
155151122|NCT05546476|559988190|FG002|Period 1: Part A|Adverse Event|0|||
155151123|NCT05546476|559988191|FG003|Period 1: Part A|Adverse Event|1|||
155151124|NCT05546476|559988188|FG000|Period 1: Part A|Death|4|||
155151125|NCT05546476|559988189|FG001|Period 1: Part A|Death|4|||
155151126|NCT05546476|559988190|FG002|Period 1: Part A|Death|5|||
155151127|NCT05546476|559988191|FG003|Period 1: Part A|Death|6|||
155151128|NCT05546476|559988188|FG000|Period 1: Part A|Lack of Efficacy|0|||
155151129|NCT05546476|559988189|FG001|Period 1: Part A|Lack of Efficacy|0|||
155151130|NCT05546476|559988190|FG002|Period 1: Part A|Lack of Efficacy|0|||
155151131|NCT05546476|559988191|FG003|Period 1: Part A|Lack of Efficacy|1|||
155151132|NCT05546476|559988188|FG000|Period 1: Part A|Lost to Follow-up|0|||
155151133|NCT05546476|559988189|FG001|Period 1: Part A|Lost to Follow-up|0|||
155151134|NCT05546476|559988190|FG002|Period 1: Part A|Lost to Follow-up|0|||
155151135|NCT05546476|559988191|FG003|Period 1: Part A|Lost to Follow-up|1|||
155151136|NCT05546476|559988188|FG000|Period 1: Part A|Physician Decision|1|||
155151137|NCT05546476|559988189|FG001|Period 1: Part A|Physician Decision|0|||
155151138|NCT05546476|559988190|FG002|Period 1: Part A|Physician Decision|0|||
155151139|NCT05546476|559988191|FG003|Period 1: Part A|Physician Decision|0|||
155151140|NCT05546476|559988188|FG000|Period 1: Part A|Progressive disease|3|||
155151141|NCT05546476|559988189|FG001|Period 1: Part A|Progressive disease|5|||
155151142|NCT05546476|559988190|FG002|Period 1: Part A|Progressive disease|0|||
155151143|NCT05546476|559988191|FG003|Period 1: Part A|Progressive disease|1|||
155151144|NCT05546476|559988188|FG000|Period 1: Part A|Withdrawal by Subject|1|||
155151145|NCT05546476|559988189|FG001|Period 1: Part A|Withdrawal by Subject|1|||
155151146|NCT05546476|559988190|FG002|Period 1: Part A|Withdrawal by Subject|1|||
155151147|NCT05546476|559988191|FG003|Period 1: Part A|Withdrawal by Subject|2|||
155151148|NCT05546476|559988188|FG000|Period 1: Part A|Global deterioration of health status|2|||
155151149|NCT05546476|559988189|FG001|Period 1: Part A|Global deterioration of health status|2|||
155151150|NCT05546476|559988190|FG002|Period 1: Part A|Global deterioration of health status|1|||
155151151|NCT05546476|559988191|FG003|Period 1: Part A|Global deterioration of health status|4|||
155151152|NCT05546476|559988188|FG000|Period 1: Part A|Other: Unspecified|0|||
155151153|NCT05546476|559988189|FG001|Period 1: Part A|Other: Unspecified|2|||
155151154|NCT05546476|559988190|FG002|Period 1: Part A|Other: Unspecified|0|||
155151155|NCT05546476|559988191|FG003|Period 1: Part A|Other: Unspecified|0|||
155151156|NCT05546476|559988188|FG000|Period 2: Part B|Ongoing|26|||
155151157|NCT05546476|559988189|FG001|Period 2: Part B|Ongoing|27|||
155151158|NCT05546476|559988190|FG002|Period 2: Part B|Ongoing|35|||
155151159|NCT05546476|559988191|FG003|Period 2: Part B|Ongoing|29|||
155151160|NCT04890652|559988201|FG000|Overall Study|Withdrawal by Subject|2|||
155151161|NCT01706458|559988203|FG000|Overall Study|Physician Decision|3|||
155151162|NCT01706458|559988204|FG001|Overall Study|Physician Decision|4|||
155151163|NCT02766023|559988206|FG000|Overall Study|Lost to Follow-up|23|||
155151164|NCT02766023|559988207|FG001|Overall Study|Lost to Follow-up|11|||
155151165|NCT02766023|559988206|FG000|Overall Study|Pregnancy|1|||
155151166|NCT02766023|559988207|FG001|Overall Study|Pregnancy|0|||
155151167|NCT02766023|559988206|FG000|Overall Study|Adverse Event|1|||
155151168|NCT02766023|559988207|FG001|Overall Study|Adverse Event|0|||
155151169|NCT02766023|559988206|FG000|Overall Study|Withdrawal by Subject|4|||
155151170|NCT02766023|559988207|FG001|Overall Study|Withdrawal by Subject|5|||
155151171|NCT02766023|559988206|FG000|Overall Study|Physician Decision|1|||
155151172|NCT02766023|559988207|FG001|Overall Study|Physician Decision|0|||
155151173|NCT02766023|559988206|FG000|Overall Study|Not Eligible at Enrollment|0|||
155151174|NCT02766023|559988207|FG001|Overall Study|Not Eligible at Enrollment|1|||
155151175|NCT02384551|559988211|FG000|Overall Study|Lost to Follow-up|13|||
155151176|NCT02384551|559988212|FG001|Overall Study|Lost to Follow-up|14|||
155151177|NCT02384551|559988213|FG002|Overall Study|Lost to Follow-up|14|||
155151178|NCT02384551|559988214|FG003|Overall Study|Lost to Follow-up|14|||
155151179|NCT04349891|559988215|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
155151180|NCT04349891|559988216|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
155151181|NCT04349891|559988215|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
155151182|NCT04349891|559988216|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
155198563|NCT02034110|560165000|FG000|Overall Study|Study closed by sponsor|6|||
155198564|NCT02034110|560165001|FG001|Overall Study|Study closed by sponsor|2|||
155198565|NCT02034110|560165002|FG002|Overall Study|Study closed by sponsor|0|||
155198566|NCT02034110|560165003|FG003|Overall Study|Study closed by sponsor|6|||
155198567|NCT02034110|560165004|FG004|Overall Study|Study closed by sponsor|7|||
155198568|NCT02034110|560165005|FG005|Overall Study|Study closed by sponsor|0|||
155198569|NCT02034110|560165006|FG006|Overall Study|Study closed by sponsor|42|||
155198570|NCT02034110|560165007|FG007|Overall Study|Study closed by sponsor|0|||
155198571|NCT02587234|560165008|FG000|Overall Study|Withdrawal by Subject|1|||
155198572|NCT02587234|560165009|FG001|Overall Study|Withdrawal by Subject|1|||
155198573|NCT02587234|560165008|FG000|Overall Study|Lost to Follow-up|0|||
155198574|NCT02587234|560165009|FG001|Overall Study|Lost to Follow-up|2|||
155198575|NCT02165215|560165010|FG000|Induction Phase|Adverse Event|1|||
155198576|NCT02165215|560165011|FG001|Induction Phase|Adverse Event|0|||
155198577|NCT02165215|560165012|FG002|Induction Phase|Adverse Event|0|||
155198578|NCT02165215|560165010|FG000|Induction Phase|Withdrawal by Subject|10|||
155198579|NCT02165215|560165011|FG001|Induction Phase|Withdrawal by Subject|0|||
155198580|NCT02165215|560165012|FG002|Induction Phase|Withdrawal by Subject|0|||
155198581|NCT02165215|560165010|FG000|Induction Phase|Protocol Violation|1|||
155198582|NCT02165215|560165011|FG001|Induction Phase|Protocol Violation|0|||
155198583|NCT02165215|560165012|FG002|Induction Phase|Protocol Violation|0|||
155198584|NCT02165215|560165010|FG000|Induction Phase|Physician Decision|1|||
155198585|NCT02165215|560165011|FG001|Induction Phase|Physician Decision|0|||
155198586|NCT02165215|560165012|FG002|Induction Phase|Physician Decision|0|||
155198587|NCT02165215|560165010|FG000|Induction Phase|Lack of Efficacy|2|||
155198588|NCT02165215|560165011|FG001|Induction Phase|Lack of Efficacy|0|||
155198589|NCT02165215|560165012|FG002|Induction Phase|Lack of Efficacy|0|||
155198590|NCT02165215|560165010|FG000|Induction Phase|Non-Compliance|2|||
155198591|NCT02165215|560165011|FG001|Induction Phase|Non-Compliance|0|||
155198592|NCT02165215|560165012|FG002|Induction Phase|Non-Compliance|0|||
155198593|NCT02165215|560165010|FG000|Induction Phase|Lost to Follow-up|6|||
155198594|NCT02165215|560165011|FG001|Induction Phase|Lost to Follow-up|0|||
155198595|NCT02165215|560165012|FG002|Induction Phase|Lost to Follow-up|0|||
155198596|NCT02165215|560165010|FG000|Maintenance Phase|Withdrawal by Subject|0|||
155198597|NCT02165215|560165011|FG001|Maintenance Phase|Withdrawal by Subject|7|||
155198598|NCT02165215|560165012|FG002|Maintenance Phase|Withdrawal by Subject|3|||
155198599|NCT02165215|560165010|FG000|Maintenance Phase|Multiple reasons|0|||
155198600|NCT02165215|560165011|FG001|Maintenance Phase|Multiple reasons|2|||
155198601|NCT02165215|560165012|FG002|Maintenance Phase|Multiple reasons|1|||
155198602|NCT02165215|560165010|FG000|Maintenance Phase|Lost to Follow-up|0|||
155198603|NCT02165215|560165011|FG001|Maintenance Phase|Lost to Follow-up|2|||
155198604|NCT02165215|560165012|FG002|Maintenance Phase|Lost to Follow-up|0|||
155198605|NCT02165215|560165010|FG000|Maintenance Phase|Adverse Event|0|||
155198606|NCT02165215|560165011|FG001|Maintenance Phase|Adverse Event|1|||
155198607|NCT02165215|560165012|FG002|Maintenance Phase|Adverse Event|1|||
155198608|NCT05074667|560165013|FG000|Overall Study|Death|1|||
155198609|NCT05074667|560165013|FG000|Overall Study|Withdrawal by Subject|4|||
155198610|NCT05074667|560165013|FG000|Overall Study|Lost to Follow-up|10|||
155198611|NCT04678661|560165014|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
155198612|NCT04678661|560165015|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
155198613|NCT04678661|560165014|FG000|Overall Study|Protocol Violation|2|||
155198614|NCT04678661|560165015|FG001|Overall Study|Protocol Violation|0|||
155198615|NCT04678661|560165014|FG000|Overall Study|Withdrawal by Subject|1|||
155198616|NCT04678661|560165015|FG001|Overall Study|Withdrawal by Subject|0|||
155198617|NCT04678661|560165014|FG000|Overall Study|Lost to Follow-up|2|||
155198618|NCT04678661|560165015|FG001|Overall Study|Lost to Follow-up|0|||
155198619|NCT04678661|560165014|FG000|Overall Study|Death|2|||
155198620|NCT04678661|560165015|FG001|Overall Study|Death|0|||
155198621|NCT01867424|560165016|FG000|Overall Study|Patient noncompliance|2|||
155198622|NCT01867424|560165017|FG001|Overall Study|Patient noncompliance|1|||
155198623|NCT00864721|560165018|FG000|Overall Study|Patient request|11|||
155198624|NCT00864721|560165018|FG000|Overall Study|Hospitalized|1|||
155198625|NCT00864721|560165018|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
155198626|NCT00864721|560165018|FG000|Overall Study|Adverse Event|21|||
155198627|NCT01921387|560165019|FG000|Overall Study|Adverse Event|1|||
155198628|NCT00261807|560165020|FG000|Overall Study|Lost to Follow-up|2|||
155198629|NCT00261807|560165020|FG000|Overall Study|Adverse Event|2|||
155198630|NCT00261807|560165020|FG000|Overall Study|Death|1|||
155198631|NCT00261807|560165020|FG000|Overall Study|Protocol Violation|2|||
155198632|NCT01706146|560165021|FG000|Overall Study|Withdrawal by Subject|1|||
155198633|NCT01706146|560165021|FG000|Overall Study|Adverse Event|3|||
155198634|NCT01706146|560165021|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
155198635|NCT02582983|560165022|FG000|Overall Study|Death|3|||
155198636|NCT02582983|560165022|FG000|Overall Study|Withdrawal by Subject|2|||
155198637|NCT02582983|560165022|FG000|Overall Study|Adverse Event|1|||
155198638|NCT02527161|560165023|FG000|Overall Study|Failed MRI|52|||
155198639|NCT02527161|560165023|FG000|Overall Study|Withdrawal by Subject|19|||
155198640|NCT02527161|560165023|FG000|Overall Study|Delay in or unfit for surgery|16|||
155198641|NCT02527161|560165023|FG000|Overall Study|MRI contraindication|6|||
155198642|NCT02527161|560165023|FG000|Overall Study|Consent violation|4|||
155198643|NCT02527161|560165023|FG000|Overall Study|Only Recruited to Part A|27|||
155198644|NCT02527161|560165023|FG000|Overall Study|Physician Decision|1|||
155198645|NCT02527161|560165023|FG000|Overall Study|Adverse Event|1|||
155198646|NCT02527161|560165023|FG000|Overall Study|Lost to Follow-up|6|||
155198647|NCT02021331|560165026|FG000|Overall Study|Adverse Event|0|||
155198648|NCT02021331|560165027|FG001|Overall Study|Adverse Event|2|||
155198649|NCT01081678|560165029|FG000|Overall Study|Ineligibility Determined|0|||
155198650|NCT01081678|560165030|FG001|Overall Study|Ineligibility Determined|0|||
155198651|NCT01081678|560165031|FG002|Overall Study|Ineligibility Determined|1|||
155198652|NCT01081678|560165032|FG003|Overall Study|Ineligibility Determined|1|||
155198653|NCT01081678|560165029|FG000|Overall Study|Noncompliance|3|||
155198654|NCT01081678|560165030|FG001|Overall Study|Noncompliance|4|||
155198655|NCT01081678|560165031|FG002|Overall Study|Noncompliance|5|||
155198656|NCT01081678|560165032|FG003|Overall Study|Noncompliance|2|||
155198657|NCT01081678|560165029|FG000|Overall Study|Adverse Event|2|||
155198658|NCT01081678|560165030|FG001|Overall Study|Adverse Event|1|||
155151183|NCT04349891|559988215|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
155151184|NCT04349891|559988216|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
155151185|NCT04349891|559988215|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
155151186|NCT04349891|559988216|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
155151187|NCT03532542|559988221|FG000|Overall Study|Death|1|||
155151188|NCT03532542|559988222|FG001|Overall Study|Death|0|||
155151189|NCT03532542|559988221|FG000|Overall Study|Study Terminated by Sponsor|41|||
155151190|NCT03532542|559988222|FG001|Overall Study|Study Terminated by Sponsor|65|||
155151191|NCT03532542|559988221|FG000|Overall Study|Withdrawal by Subject|6|||
155151192|NCT03532542|559988222|FG001|Overall Study|Withdrawal by Subject|5|||
155151193|NCT00772538|559988236|FG000|Overall Study|Adverse Event|6|||
155151194|NCT00772538|559988237|FG001|Overall Study|Adverse Event|6|||
155151195|NCT00772538|559988236|FG000|Overall Study|Protocol Violation|3|||
155151196|NCT00772538|559988237|FG001|Overall Study|Protocol Violation|3|||
155151197|NCT00772538|559988236|FG000|Overall Study|Lost to Follow-up|1|||
155151198|NCT00772538|559988237|FG001|Overall Study|Lost to Follow-up|1|||
155151199|NCT00772538|559988236|FG000|Overall Study|Withdrawal by Subject|3|||
155151200|NCT00772538|559988237|FG001|Overall Study|Withdrawal by Subject|8|||
155151201|NCT00772538|559988236|FG000|Overall Study|Lack of Efficacy|0|||
155151202|NCT00772538|559988237|FG001|Overall Study|Lack of Efficacy|1|||
155151203|NCT00772538|559988236|FG000|Overall Study|Other|7|||
155151204|NCT00772538|559988237|FG001|Overall Study|Other|7|||
155151205|NCT00001832|559988238|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
155151206|NCT00001832|559988239|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
155151207|NCT00001832|559988240|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
155151208|NCT00001832|559988241|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
155151209|NCT00001832|559988242|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
155151210|NCT00001832|559988243|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
155151211|NCT00001832|559988244|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
155151212|NCT00001832|559988245|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
155151213|NCT00001832|559988246|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
155151214|NCT00001832|559988247|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
155151215|NCT00001832|559988248|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
155151216|NCT00001832|559988249|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
155151217|NCT00001832|559988250|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
155151218|NCT00001832|559988251|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
155151219|NCT00001832|559988252|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
155151220|NCT00001832|559988238|FG000|Treatment Period|Death during treatment|0|||
155151221|NCT00001832|559988239|FG001|Treatment Period|Death during treatment|0|||
155151222|NCT00001832|559988240|FG002|Treatment Period|Death during treatment|0|||
155151223|NCT00001832|559988241|FG003|Treatment Period|Death during treatment|0|||
155151224|NCT00001832|559988242|FG004|Treatment Period|Death during treatment|0|||
155151225|NCT00001832|559988243|FG005|Treatment Period|Death during treatment|1|||
155151226|NCT00001832|559988244|FG006|Treatment Period|Death during treatment|0|||
155151227|NCT00001832|559988245|FG007|Treatment Period|Death during treatment|0|||
155198659|NCT01081678|560165031|FG002|Overall Study|Adverse Event|2|||
155198660|NCT01081678|560165032|FG003|Overall Study|Adverse Event|2|||
155151228|NCT00001832|559988246|FG008|Treatment Period|Death during treatment|0|||
155198661|NCT01081678|560165029|FG000|Overall Study|Withdrawal by Subject|15|||
155198662|NCT01081678|560165030|FG001|Overall Study|Withdrawal by Subject|7|||
155198663|NCT01081678|560165031|FG002|Overall Study|Withdrawal by Subject|17|||
155151229|NCT00001832|559988247|FG009|Treatment Period|Death during treatment|0|||
155151230|NCT00001832|559988248|FG010|Treatment Period|Death during treatment|0|||
155151231|NCT00001832|559988249|FG011|Treatment Period|Death during treatment|0|||
155198664|NCT01081678|560165032|FG003|Overall Study|Withdrawal by Subject|14|||
155198665|NCT01081678|560165029|FG000|Overall Study|Administrative Decision|1|||
155151232|NCT00001832|559988250|FG012|Treatment Period|Death during treatment|0|||
155151233|NCT00001832|559988251|FG013|Treatment Period|Death during treatment|0|||
155151234|NCT00001832|559988252|FG014|Treatment Period|Death during treatment|0|||
155151235|NCT00001832|559988238|FG000|Treatment Period|Not treated|0|||
155151236|NCT00001832|559988239|FG001|Treatment Period|Not treated|0|||
155151237|NCT00001832|559988240|FG002|Treatment Period|Not treated|0|||
155151238|NCT00001832|559988241|FG003|Treatment Period|Not treated|0|||
155151239|NCT00001832|559988242|FG004|Treatment Period|Not treated|0|||
155151240|NCT00001832|559988243|FG005|Treatment Period|Not treated|0|||
155151241|NCT00001832|559988244|FG006|Treatment Period|Not treated|0|||
155151242|NCT00001832|559988245|FG007|Treatment Period|Not treated|1|||
155151243|NCT00001832|559988246|FG008|Treatment Period|Not treated|0|||
155151244|NCT00001832|559988247|FG009|Treatment Period|Not treated|0|||
155151245|NCT00001832|559988248|FG010|Treatment Period|Not treated|0|||
155151246|NCT00001832|559988249|FG011|Treatment Period|Not treated|0|||
155151247|NCT00001832|559988250|FG012|Treatment Period|Not treated|0|||
155151248|NCT00001832|559988251|FG013|Treatment Period|Not treated|0|||
155151249|NCT00001832|559988252|FG014|Treatment Period|Not treated|0|||
155151250|NCT00713609|559988253|FG000|Overall Study|Adverse Event|2|||
155151251|NCT00713609|559988254|FG001|Overall Study|Adverse Event|0|||
155151252|NCT00713609|559988255|FG002|Overall Study|Adverse Event|2|||
155151253|NCT00713609|559988256|FG003|Overall Study|Adverse Event|2|||
155151254|NCT00713609|559988257|FG004|Overall Study|Adverse Event|3|||
155151255|NCT00713609|559988258|FG005|Overall Study|Adverse Event|1|||
155151256|NCT00713609|559988253|FG000|Overall Study|Lost to Follow-up|5|||
155151257|NCT00713609|559988254|FG001|Overall Study|Lost to Follow-up|7|||
155151258|NCT00713609|559988255|FG002|Overall Study|Lost to Follow-up|5|||
155151259|NCT00713609|559988256|FG003|Overall Study|Lost to Follow-up|5|||
155151260|NCT00713609|559988257|FG004|Overall Study|Lost to Follow-up|7|||
155151261|NCT00713609|559988258|FG005|Overall Study|Lost to Follow-up|0|||
155151262|NCT00713609|559988253|FG000|Overall Study|Lack of Efficacy|1|||
155151263|NCT00713609|559988254|FG001|Overall Study|Lack of Efficacy|3|||
155151264|NCT00713609|559988255|FG002|Overall Study|Lack of Efficacy|0|||
155151265|NCT00713609|559988256|FG003|Overall Study|Lack of Efficacy|0|||
155151266|NCT00713609|559988257|FG004|Overall Study|Lack of Efficacy|1|||
155151267|NCT00713609|559988258|FG005|Overall Study|Lack of Efficacy|0|||
155151268|NCT00713609|559988253|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
155151269|NCT00713609|559988254|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
155151270|NCT00713609|559988255|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
155151271|NCT00713609|559988256|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
155151272|NCT00713609|559988257|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
155151273|NCT00713609|559988258|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
155151274|NCT00713609|559988253|FG000|Overall Study|Withdrawal by Subject|6|||
155151275|NCT00713609|559988254|FG001|Overall Study|Withdrawal by Subject|1|||
155151276|NCT00713609|559988255|FG002|Overall Study|Withdrawal by Subject|5|||
155151277|NCT00713609|559988256|FG003|Overall Study|Withdrawal by Subject|1|||
155151278|NCT00713609|559988257|FG004|Overall Study|Withdrawal by Subject|5|||
155151279|NCT00713609|559988258|FG005|Overall Study|Withdrawal by Subject|7|||
155151280|NCT00713609|559988253|FG000|Overall Study|Protocol Violation|6|||
155151281|NCT00713609|559988254|FG001|Overall Study|Protocol Violation|3|||
155151282|NCT00713609|559988255|FG002|Overall Study|Protocol Violation|1|||
155151283|NCT00713609|559988256|FG003|Overall Study|Protocol Violation|1|||
155151284|NCT00713609|559988257|FG004|Overall Study|Protocol Violation|2|||
155151285|NCT00713609|559988258|FG005|Overall Study|Protocol Violation|0|||
155151286|NCT04529083|559988259|FG000|Overall Study|Withdrawal by Subject|3|||
155151287|NCT04196686|559988264|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
155151288|NCT04196686|559988265|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
155151289|NCT03780452|559988266|FG000|Overall Study|Screening failure|2|||
155151290|NCT01292486|559988269|FG000|Overall Study|Protocol Violation|2|||
155151291|NCT01292486|559988269|FG000|Overall Study|Did not meet screening criteria|2|||
155151292|NCT01292486|559988269|FG000|Overall Study|Adverse Event|1|||
155151293|NCT01292486|559988269|FG000|Overall Study|Physician Decision|1|||
155151294|NCT00087152|559988270|FG000|Overall Study|Ineligible|6|||
155151295|NCT00265564|559988280|FG000|Overall Study|Lost to Follow-up|5|||
155151296|NCT00265564|559988281|FG001|Overall Study|Lost to Follow-up|7|||
155151297|NCT00265564|559988280|FG000|Overall Study|met exclusion criteria|5|||
155198666|NCT01081678|560165030|FG001|Overall Study|Administrative Decision|0|||
155151298|NCT00265564|559988281|FG001|Overall Study|met exclusion criteria|2|||
155198667|NCT01081678|560165031|FG002|Overall Study|Administrative Decision|0|||
155151299|NCT01553084|559988284|FG000|Overall Study|Withdrawal by Subject|15|||
155151300|NCT01553084|559988285|FG001|Overall Study|Withdrawal by Subject|13|||
155151301|NCT01553084|559988286|FG002|Overall Study|Withdrawal by Subject|35|||
155151302|NCT04698343|559988287|FG000|Overall Study|Withdrawal by Subject|6|||
155151303|NCT04698343|559988287|FG000|Overall Study|Physician Decision|2|||
155151304|NCT04698343|559988287|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
155151305|NCT04698343|559988287|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
155151306|NCT04698343|559988287|FG000|Overall Study|Personal reasons|3|||
155198668|NCT01081678|560165032|FG003|Overall Study|Administrative Decision|1|||
155198669|NCT01081678|560165029|FG000|Overall Study|Lost to Follow-up|4|||
155198670|NCT01081678|560165030|FG001|Overall Study|Lost to Follow-up|1|||
155198671|NCT01081678|560165031|FG002|Overall Study|Lost to Follow-up|4|||
155198672|NCT01081678|560165032|FG003|Overall Study|Lost to Follow-up|3|||
155198673|NCT01081678|560165029|FG000|Overall Study|Death|2|||
155198674|NCT01081678|560165030|FG001|Overall Study|Death|2|||
155198675|NCT01081678|560165031|FG002|Overall Study|Death|2|||
155198676|NCT01081678|560165032|FG003|Overall Study|Death|6|||
155198677|NCT01081678|560165029|FG000|Overall Study|Other|0|||
155198678|NCT01081678|560165030|FG001|Overall Study|Other|1|||
155198679|NCT01081678|560165031|FG002|Overall Study|Other|0|||
155198680|NCT01081678|560165032|FG003|Overall Study|Other|0|||
155198681|NCT02589405|560165036|FG000|Overall Study|Adverse Event|3|||
155198682|NCT02589405|560165036|FG000|Overall Study|Withdrawal by Subject|1|||
155198683|NCT00446251|560165039|FG000|Overall Study|On-study Transplants|2|||
155198684|NCT00446251|560165039|FG000|Overall Study|Rituximab Infusion Reaction|2|||
155198685|NCT00446251|560165039|FG000|Overall Study|Lost to Follow-up|1|||
155198686|NCT00939640|560165050|FG000|Overall Study|Physician Decision|1|||
155198687|NCT00590135|560165053|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
155198688|NCT00306189|560165056|FG000|Overall Study|Physician Decision|0|||
155198689|NCT00306189|560165057|FG001|Overall Study|Physician Decision|0|||
155198690|NCT00306189|560165058|FG002|Overall Study|Physician Decision|0|||
155198691|NCT00306189|560165059|FG003|Overall Study|Physician Decision|1|||
155198692|NCT00306189|560165056|FG000|Overall Study|Adverse Event|3|||
155198693|NCT00306189|560165057|FG001|Overall Study|Adverse Event|3|||
155198694|NCT00306189|560165058|FG002|Overall Study|Adverse Event|2|||
155198695|NCT00306189|560165059|FG003|Overall Study|Adverse Event|2|||
155198696|NCT00306189|560165056|FG000|Overall Study|Withdrawal by Subject|4|||
155198697|NCT00306189|560165057|FG001|Overall Study|Withdrawal by Subject|2|||
155198698|NCT00306189|560165058|FG002|Overall Study|Withdrawal by Subject|8|||
155198699|NCT00306189|560165059|FG003|Overall Study|Withdrawal by Subject|1|||
155198700|NCT00306189|560165056|FG000|Overall Study|Ineligibility determined|1|||
155198701|NCT00306189|560165057|FG001|Overall Study|Ineligibility determined|1|||
155198702|NCT00306189|560165058|FG002|Overall Study|Ineligibility determined|1|||
155198703|NCT00306189|560165059|FG003|Overall Study|Ineligibility determined|1|||
155198704|NCT00306189|560165056|FG000|Overall Study|Other|1|||
155198705|NCT00306189|560165057|FG001|Overall Study|Other|0|||
155198706|NCT00306189|560165058|FG002|Overall Study|Other|0|||
155198707|NCT00306189|560165059|FG003|Overall Study|Other|0|||
155198708|NCT05248867|560165060|FG000|Double-blind Period|Lost to Follow-up|0|||
155198709|NCT05248867|560165061|FG001|Double-blind Period|Lost to Follow-up|3|||
155198710|NCT05248867|560165062|FG002|Double-blind Period|Lost to Follow-up|0|||
155198711|NCT05248867|560165063|FG003|Double-blind Period|Lost to Follow-up|0|||
155198712|NCT05248867|560165064|FG004|Double-blind Period|Lost to Follow-up|0|||
155198713|NCT05248867|560165065|FG005|Double-blind Period|Lost to Follow-up|0|||
155198714|NCT05248867|560165060|FG000|Double-blind Period|Withdrawal by Subject|5|||
155198715|NCT05248867|560165061|FG001|Double-blind Period|Withdrawal by Subject|14|||
155198716|NCT05248867|560165062|FG002|Double-blind Period|Withdrawal by Subject|0|||
155198717|NCT05248867|560165063|FG003|Double-blind Period|Withdrawal by Subject|0|||
155198718|NCT05248867|560165064|FG004|Double-blind Period|Withdrawal by Subject|0|||
155198719|NCT05248867|560165065|FG005|Double-blind Period|Withdrawal by Subject|0|||
155198720|NCT05248867|560165060|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198721|NCT05248867|560165061|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
155198722|NCT05248867|560165062|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198723|NCT05248867|560165063|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198724|NCT05248867|560165064|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198725|NCT05248867|560165065|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
155198726|NCT05248867|560165060|FG000|Double-blind Period|Other, not specified|3|||
155198727|NCT05248867|560165061|FG001|Double-blind Period|Other, not specified|8|||
155198728|NCT05248867|560165062|FG002|Double-blind Period|Other, not specified|0|||
155198729|NCT05248867|560165063|FG003|Double-blind Period|Other, not specified|0|||
155198730|NCT05248867|560165064|FG004|Double-blind Period|Other, not specified|0|||
155198731|NCT05248867|560165065|FG005|Double-blind Period|Other, not specified|0|||
155198732|NCT05248867|560165060|FG000|Open-label Period|Withdrawal by Subject|0|||
155198733|NCT05248867|560165061|FG001|Open-label Period|Withdrawal by Subject|0|||
155198734|NCT05248867|560165062|FG002|Open-label Period|Withdrawal by Subject|3|||
155198735|NCT05248867|560165063|FG003|Open-label Period|Withdrawal by Subject|1|||
155198736|NCT05248867|560165064|FG004|Open-label Period|Withdrawal by Subject|7|||
155198737|NCT05248867|560165065|FG005|Open-label Period|Withdrawal by Subject|9|||
155198738|NCT05248867|560165060|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198739|NCT05248867|560165061|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198740|NCT05248867|560165062|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198741|NCT05248867|560165063|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
155198742|NCT05248867|560165064|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198743|NCT05248867|560165065|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
155198744|NCT05248867|560165060|FG000|Open-label Period|Lost to Follow-up|0|||
155151307|NCT04698343|559988287|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
155151308|NCT02756338|559988291|FG000|Overall Study|Withdrawn by Investigator|1|||
155151309|NCT02756338|559988291|FG000|Overall Study|Device Replaced with Pacemaker|4|||
155151310|NCT01339689|559988294|FG000|Overall Study|Adverse Event|1|||
155151311|NCT01339689|559988295|FG001|Overall Study|Adverse Event|2|||
155151312|NCT01339689|559988294|FG000|Overall Study|Lost to Follow-up|9|||
155151313|NCT01339689|559988295|FG001|Overall Study|Lost to Follow-up|3|||
155151314|NCT01339689|559988294|FG000|Overall Study|Withdrawal by Subject|3|||
155151315|NCT01339689|559988295|FG001|Overall Study|Withdrawal by Subject|0|||
155151316|NCT01339689|559988294|FG000|Overall Study|Noncompliance|1|||
155151317|NCT01339689|559988295|FG001|Overall Study|Noncompliance|0|||
155151318|NCT01339689|559988294|FG000|Overall Study|Relocated out of area|0|||
155151319|NCT01339689|559988295|FG001|Overall Study|Relocated out of area|1|||
155151320|NCT01339689|559988294|FG000|Overall Study|Other|2|||
155151321|NCT01339689|559988295|FG001|Overall Study|Other|2|||
155151322|NCT01339689|559988294|FG000|Overall Study|multiple reasons|1|||
155198745|NCT05248867|560165061|FG001|Open-label Period|Lost to Follow-up|0|||
155198746|NCT05248867|560165062|FG002|Open-label Period|Lost to Follow-up|0|||
155198747|NCT05248867|560165063|FG003|Open-label Period|Lost to Follow-up|0|||
155198748|NCT05248867|560165064|FG004|Open-label Period|Lost to Follow-up|5|||
155198749|NCT05248867|560165065|FG005|Open-label Period|Lost to Follow-up|2|||
155198750|NCT05248867|560165060|FG000|Open-label Period|COVID-19 Infection|0|||
155198751|NCT05248867|560165061|FG001|Open-label Period|COVID-19 Infection|0|||
155198752|NCT05248867|560165062|FG002|Open-label Period|COVID-19 Infection|0|||
155198753|NCT05248867|560165063|FG003|Open-label Period|COVID-19 Infection|0|||
155198754|NCT05248867|560165064|FG004|Open-label Period|COVID-19 Infection|1|||
155198755|NCT05248867|560165065|FG005|Open-label Period|COVID-19 Infection|0|||
155198756|NCT05248867|560165060|FG000|Open-label Period|Other, not specified|0|||
155198757|NCT05248867|560165061|FG001|Open-label Period|Other, not specified|0|||
155198758|NCT05248867|560165062|FG002|Open-label Period|Other, not specified|0|||
155198759|NCT05248867|560165063|FG003|Open-label Period|Other, not specified|0|||
155198760|NCT05248867|560165064|FG004|Open-label Period|Other, not specified|4|||
155198761|NCT05248867|560165065|FG005|Open-label Period|Other, not specified|0|||
155198762|NCT03128411|560165066|FG000|Treatment Phase|Adverse Event|21|||
155198763|NCT03128411|560165066|FG000|Treatment Phase|Physician Decision|1|||
155198764|NCT03128411|560165066|FG000|Treatment Phase|Other|2|||
155198765|NCT03128411|560165066|FG000|Long Term Follow-up Phase|Death|2|||
155198766|NCT05147428|560165071|FG000|Overall Study|Removed prior to mailing|289|||
155198767|NCT05147428|560165072|FG001|Overall Study|Removed prior to mailing|306|||
155198768|NCT05147428|560165073|FG002|Overall Study|Removed prior to mailing|270|||
155198769|NCT05147428|560165071|FG000|Overall Study|Died or disenrolled during blackout period|239|||
155198770|NCT05147428|560165072|FG001|Overall Study|Died or disenrolled during blackout period|278|||
155198771|NCT05147428|560165073|FG002|Overall Study|Died or disenrolled during blackout period|273|||
155198772|NCT03128047|560165074|FG000|Overall Study|Withdrawal by Subject|1|||
155198773|NCT00688753|560166474|FG000|Overall Study|Disease progression|55|||
155198774|NCT00688753|560166474|FG000|Overall Study|Missing|1|||
155198775|NCT00688753|560166474|FG000|Overall Study|Death|9|||
155198776|NCT00688753|560166474|FG000|Overall Study|Withdrawal by Subject|3|||
155198777|NCT00688753|560166474|FG000|Overall Study|Adverse Event|20|||
155198778|NCT00688753|560166474|FG000|Overall Study|Protocol Violation|1|||
155198779|NCT00688753|560166474|FG000|Overall Study|Lost to Follow-up|3|||
155198780|NCT05996718|560166476|FG000|Overall Study|Lost to Follow-up|3|||
155198781|NCT01218113|560166477|FG000|Overall Study|Withdrawal by Subject|1|||
155198782|NCT01218113|560166478|FG001|Overall Study|Withdrawal by Subject|0|||
155198783|NCT01218113|560166479|FG002|Overall Study|Withdrawal by Subject|1|||
155198784|NCT01218113|560166477|FG000|Overall Study|Lost to Follow-up|4|||
155198785|NCT01218113|560166478|FG001|Overall Study|Lost to Follow-up|1|||
155151323|NCT01339689|559988295|FG001|Overall Study|multiple reasons|1|||
155198786|NCT01218113|560166479|FG002|Overall Study|Lost to Follow-up|4|||
155198787|NCT01218113|560166477|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
155198788|NCT01218113|560166478|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
155198789|NCT01218113|560166479|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
155198790|NCT01713686|560166480|FG000|Overall Study|Lost to Follow-up|9|||
155198791|NCT01713686|560166480|FG000|Overall Study|Withdrawal by Subject|6|||
155198792|NCT03187197|560166481|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
155151324|NCT03582215|559988296|FG000|Overall Study|Adverse Event|1|||
155151325|NCT03582215|559988297|FG001|Overall Study|Adverse Event|0|||
155151326|NCT03582215|559988298|FG002|Overall Study|Adverse Event|0|||
155151327|NCT03582215|559988299|FG003|Overall Study|Adverse Event|0|||
155198793|NCT03187197|560166482|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
155151328|NCT03582215|559988300|FG004|Overall Study|Adverse Event|0|||
155151329|NCT03582215|559988301|FG005|Overall Study|Adverse Event|0|||
155151330|NCT03582215|559988302|FG006|Overall Study|Adverse Event|2|||
155151331|NCT03582215|559988303|FG007|Overall Study|Adverse Event|2|||
155151332|NCT01791244|559988304|FG000|Overall Study|Adverse Event|5|||
155151333|NCT01791244|559988305|FG001|Overall Study|Adverse Event|7|||
155151334|NCT01791244|559988304|FG000|Overall Study|Insufficient clinical response|10|||
155151335|NCT01791244|559988305|FG001|Overall Study|Insufficient clinical response|10|||
155151336|NCT01791244|559988304|FG000|Overall Study|Laboratory Abnormality|0|||
155151337|NCT01791244|559988305|FG001|Overall Study|Laboratory Abnormality|1|||
155151338|NCT00703014|559988308|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
155151339|NCT00703014|559988309|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
155151340|NCT00703014|559988310|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155151341|NCT00703014|559988311|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155151342|NCT00703014|559988308|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155151343|NCT00703014|559988309|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
155151344|NCT00703014|559988310|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
155151345|NCT00703014|559988311|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
155151346|NCT04949191|559988312|FG000|Overall Study|Non-compliance with Study Drug|1|||
155151347|NCT04949191|559988313|FG001|Overall Study|Non-compliance with Study Drug|0|||
155151348|NCT04949191|559988314|FG002|Overall Study|Non-compliance with Study Drug|0|||
155151349|NCT04949191|559988315|FG003|Overall Study|Non-compliance with Study Drug|0|||
155151350|NCT04949191|559988312|FG000|Overall Study|Progressive Disease|0|||
155151351|NCT04949191|559988313|FG001|Overall Study|Progressive Disease|1|||
155151352|NCT04949191|559988314|FG002|Overall Study|Progressive Disease|0|||
155151353|NCT04949191|559988315|FG003|Overall Study|Progressive Disease|0|||
155151354|NCT04949191|559988312|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
155151355|NCT04949191|559988313|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
155151356|NCT04949191|559988314|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
155151357|NCT04949191|559988315|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
155151358|NCT04949191|559988312|FG000|Overall Study|Sponsor Terminated Study|0|||
155151359|NCT04949191|559988313|FG001|Overall Study|Sponsor Terminated Study|0|||
155151360|NCT04949191|559988314|FG002|Overall Study|Sponsor Terminated Study|1|||
155151361|NCT04949191|559988315|FG003|Overall Study|Sponsor Terminated Study|1|||
155151362|NCT05121766|559988316|FG000|Overall Study|Covid reinfection|3|||
155151363|NCT05121766|559988317|FG001|Overall Study|Covid reinfection|0|||
155151364|NCT05121766|559988316|FG000|Overall Study|Withdrawal by Subject|3|||
155151365|NCT05121766|559988317|FG001|Overall Study|Withdrawal by Subject|1|||
155151366|NCT05121766|559988316|FG000|Overall Study|Adverse Event|2|||
155151367|NCT05121766|559988317|FG001|Overall Study|Adverse Event|4|||
155151368|NCT05121766|559988316|FG000|Overall Study|Lost to Follow-up|0|||
155151369|NCT05121766|559988317|FG001|Overall Study|Lost to Follow-up|1|||
155151370|NCT00730158|559988318|FG000|Overall Study|Withdrawal by Subject|1|||
155151371|NCT00730158|559988319|FG001|Overall Study|Withdrawal by Subject|1|||
155151372|NCT03535974|559988320|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
155151373|NCT03535974|559988321|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
155151374|NCT03535974|559988322|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
155151375|NCT03535974|559988320|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
155151376|NCT03535974|559988321|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
155151377|NCT03535974|559988322|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
155151378|NCT02678351|559988324|FG000|Overall Study|Withdrawal by Subject|1|||
155151379|NCT00651924|559988325|FG000|Overall Study|Withdrawal by PI|0|||
155151380|NCT00651924|559988326|FG001|Overall Study|Withdrawal by PI|2|||
155151381|NCT00651924|559988325|FG000|Overall Study|Withdrawal by Subject|0|||
155151382|NCT00651924|559988326|FG001|Overall Study|Withdrawal by Subject|5|||
155151383|NCT00758771|559988327|FG000|Overall Study|Withdrawal by Subject|1|||
155151384|NCT00758771|559988328|FG001|Overall Study|Withdrawal by Subject|1|||
155151385|NCT00758771|559988327|FG000|Overall Study|Did not meet eligibility criteria|2|||
155151386|NCT00758771|559988328|FG001|Overall Study|Did not meet eligibility criteria|4|||
155151387|NCT00528957|559988329|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
155198794|NCT03187197|560166483|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
155198795|NCT03187197|560166481|FG000|Overall Study|Withdrawal by Subject|8|||
155198796|NCT03187197|560166482|FG001|Overall Study|Withdrawal by Subject|63|||
155198797|NCT03187197|560166483|FG002|Overall Study|Withdrawal by Subject|4|||
155198798|NCT03187197|560166481|FG000|Overall Study|Lost to Follow-up|1|||
155151388|NCT00528957|559988330|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
155198799|NCT03187197|560166482|FG001|Overall Study|Lost to Follow-up|60|||
155151389|NCT00528957|559988329|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
155198800|NCT03187197|560166483|FG002|Overall Study|Lost to Follow-up|7|||
155198801|NCT03187197|560166481|FG000|Overall Study|Adverse Event|6|||
155198802|NCT03187197|560166482|FG001|Overall Study|Adverse Event|29|||
155198803|NCT03187197|560166483|FG002|Overall Study|Adverse Event|0|||
155151390|NCT00528957|559988330|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
155151391|NCT00528957|559988329|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
155198804|NCT03187197|560166481|FG000|Overall Study|Death|0|||
155151392|NCT00528957|559988330|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
155151393|NCT00528957|559988329|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
155151394|NCT00528957|559988330|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
155151395|NCT00528957|559988329|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
155151396|NCT00528957|559988330|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
155151397|NCT00528957|559988329|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
155151398|NCT00528957|559988330|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
155151399|NCT00528957|559988329|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
155151400|NCT00528957|559988330|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
155151401|NCT00528957|559988329|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
155151402|NCT00528957|559988330|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
155151403|NCT00528957|559988329|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
155151404|NCT00528957|559988330|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
155151405|NCT00528957|559988329|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
155151406|NCT00528957|559988330|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
155151407|NCT00528957|559988329|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
155151408|NCT00528957|559988330|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
155151409|NCT00528957|559988329|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
155151410|NCT00528957|559988330|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
155151411|NCT00528957|559988329|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
155151412|NCT00528957|559988330|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
155151413|NCT00528957|559988329|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
155151414|NCT00528957|559988330|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
155151415|NCT00528957|559988329|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
155151416|NCT00528957|559988330|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
155151417|NCT00528957|559988329|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
155151418|NCT00528957|559988330|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
155151419|NCT05190120|559988334|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
155151420|NCT05190120|559988335|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
155151421|NCT05190120|559988336|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
155151422|NCT05190120|559988337|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
155151423|NCT05190120|559988334|FG000|Overall Study|Lost to Follow-up|5|||
155151424|NCT05190120|559988335|FG001|Overall Study|Lost to Follow-up|0|||
155151425|NCT05190120|559988336|FG002|Overall Study|Lost to Follow-up|2|||
155151426|NCT05190120|559988337|FG003|Overall Study|Lost to Follow-up|3|||
155151427|NCT03062358|559988338|FG000|Overall Study|Death|269|||
155151428|NCT03062358|559988339|FG001|Overall Study|Death|145|||
155151429|NCT03062358|559988338|FG000|Overall Study|Withdrawal by Subject|2|||
155151430|NCT03062358|559988339|FG001|Overall Study|Withdrawal by Subject|1|||
155151431|NCT03062358|559988338|FG000|Overall Study|Sponsor Decision|29|||
155151432|NCT03062358|559988339|FG001|Overall Study|Sponsor Decision|7|||
155151433|NCT05893862|559988340|FG000|Overall Study|Physician Decision|0|||
155151434|NCT05893862|559988341|FG001|Overall Study|Physician Decision|1|||
155151435|NCT05893862|559988342|FG002|Overall Study|Physician Decision|0|||
155151436|NCT05893862|559988343|FG003|Overall Study|Physician Decision|0|||
155151437|NCT05893862|559988344|FG004|Overall Study|Physician Decision|1|||
155151438|NCT05893862|559988345|FG005|Overall Study|Physician Decision|0|||
155151439|NCT05893862|559988340|FG000|Overall Study|Withdrawal by Subject|1|||
155151440|NCT05893862|559988341|FG001|Overall Study|Withdrawal by Subject|7|||
155151441|NCT05893862|559988342|FG002|Overall Study|Withdrawal by Subject|1|||
155151442|NCT05893862|559988343|FG003|Overall Study|Withdrawal by Subject|3|||
155151443|NCT05893862|559988344|FG004|Overall Study|Withdrawal by Subject|3|||
155151444|NCT05893862|559988345|FG005|Overall Study|Withdrawal by Subject|2|||
155151445|NCT05893862|559988340|FG000|Overall Study|Adverse Event|1|||
155151446|NCT05893862|559988341|FG001|Overall Study|Adverse Event|4|||
155151447|NCT05893862|559988342|FG002|Overall Study|Adverse Event|2|||
155151448|NCT05893862|559988343|FG003|Overall Study|Adverse Event|2|||
155151449|NCT05893862|559988344|FG004|Overall Study|Adverse Event|1|||
155151450|NCT05893862|559988345|FG005|Overall Study|Adverse Event|0|||
155151451|NCT01400698|559988348|FG000|Overall Study|Lost to Follow-up|2|||
155151452|NCT01400698|559988349|FG001|Overall Study|Lost to Follow-up|5|||
155151453|NCT01400698|559988350|FG002|Overall Study|Lost to Follow-up|2|||
155151454|NCT01400698|559988351|FG003|Overall Study|Lost to Follow-up|1|||
155151455|NCT01400698|559988352|FG004|Overall Study|Lost to Follow-up|4|||
155151456|NCT01400698|559988353|FG005|Overall Study|Lost to Follow-up|3|||
155151457|NCT01400698|559988348|FG000|Overall Study|Withdrawal by Subject|8|||
155151458|NCT01400698|559988349|FG001|Overall Study|Withdrawal by Subject|2|||
155151459|NCT01400698|559988350|FG002|Overall Study|Withdrawal by Subject|0|||
155198805|NCT03187197|560166482|FG001|Overall Study|Death|11|||
155198806|NCT03187197|560166483|FG002|Overall Study|Death|0|||
155198807|NCT03187197|560166481|FG000|Overall Study|Administrative problem|1|||
155198808|NCT03187197|560166482|FG001|Overall Study|Administrative problem|1|||
155198809|NCT03187197|560166483|FG002|Overall Study|Administrative problem|0|||
155198810|NCT03187197|560166481|FG000|Overall Study|Reason not listed|2|||
155198811|NCT03187197|560166482|FG001|Overall Study|Reason not listed|54|||
155198812|NCT03187197|560166483|FG002|Overall Study|Reason not listed|1|||
155198813|NCT03187197|560166481|FG000|Overall Study|Missing|1|||
155198814|NCT03187197|560166482|FG001|Overall Study|Missing|32|||
155198815|NCT03187197|560166483|FG002|Overall Study|Missing|3|||
155198816|NCT03187197|560166481|FG000|Overall Study|Status missing|2|||
155198817|NCT03187197|560166482|FG001|Overall Study|Status missing|33|||
155198818|NCT03187197|560166483|FG002|Overall Study|Status missing|3|||
155198819|NCT03187197|560166481|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
155198820|NCT03187197|560166482|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
155198821|NCT03187197|560166483|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
155198822|NCT02385045|560166484|FG000|Overall Study|Endoscopy could not be completed|4|||
155198823|NCT00115739|560166485|FG000|Overall Study|Lost to Follow-up|3|||
155198824|NCT02955602|560166498|FG000|Overall Study|Adverse Event|0|||
155198825|NCT02955602|560166499|FG001|Overall Study|Adverse Event|3|||
155198826|NCT02955602|560166500|FG002|Overall Study|Adverse Event|0|||
155198827|NCT02955602|560166498|FG000|Overall Study|Withdrawal of informed consent|1|||
155198828|NCT02955602|560166499|FG001|Overall Study|Withdrawal of informed consent|3|||
155198829|NCT02955602|560166500|FG002|Overall Study|Withdrawal of informed consent|2|||
155198830|NCT02955602|560166498|FG000|Overall Study|Lost to Follow-up|0|||
155198831|NCT02955602|560166499|FG001|Overall Study|Lost to Follow-up|0|||
155198832|NCT02955602|560166500|FG002|Overall Study|Lost to Follow-up|1|||
155198833|NCT02955602|560166498|FG000|Overall Study|Other|0|||
155198834|NCT02955602|560166499|FG001|Overall Study|Other|1|||
155198835|NCT02955602|560166500|FG002|Overall Study|Other|3|||
155198836|NCT02980601|560166503|FG000|Overall Study|Lost to Follow-up|2|||
155198837|NCT02980601|560166504|FG001|Overall Study|Lost to Follow-up|2|||
155198838|NCT02980601|560166503|FG000|Overall Study|Death|0|||
155198839|NCT02980601|560166504|FG001|Overall Study|Death|1|||
155198840|NCT02980601|560166503|FG000|Overall Study|Graft loss|1|||
155198841|NCT02980601|560166504|FG001|Overall Study|Graft loss|0|||
155198842|NCT02980601|560166503|FG000|Overall Study|Failed to sign consent|2|||
155198843|NCT02980601|560166504|FG001|Overall Study|Failed to sign consent|0|||
155198844|NCT01575769|560166505|FG000|Overall Study|Adverse Event|1|||
155198845|NCT01575769|560166505|FG000|Overall Study|Study terminated by sponsor|40|||
155198846|NCT01709513|560166506|FG000|Overall Study|Randomized but not treated|0|||
155198847|NCT01709513|560166507|FG001|Overall Study|Randomized but not treated|1|||
155198848|NCT01709513|560166508|FG002|Overall Study|Randomized but not treated|0|||
155198849|NCT01709513|560166506|FG000|Overall Study|Adverse Event|16|||
155198850|NCT01709513|560166507|FG001|Overall Study|Adverse Event|31|||
155198851|NCT01709513|560166508|FG002|Overall Study|Adverse Event|23|||
155198852|NCT01709513|560166506|FG000|Overall Study|Poor compliance to protocol|2|||
155198853|NCT01709513|560166507|FG001|Overall Study|Poor compliance to protocol|0|||
155198854|NCT01709513|560166508|FG002|Overall Study|Poor compliance to protocol|0|||
155198855|NCT01709513|560166506|FG000|Overall Study|Other|3|||
155198856|NCT01709513|560166507|FG001|Overall Study|Other|11|||
155198857|NCT01709513|560166508|FG002|Overall Study|Other|7|||
155198858|NCT01034631|560166509|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
155198859|NCT01034631|560166510|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
155198860|NCT01034631|560166511|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
155198861|NCT01034631|560166509|FG000|Phase II|Not Evaluable per protocol|0|||
155198862|NCT01034631|560166510|FG001|Phase II|Not Evaluable per protocol|0|||
155198863|NCT01034631|560166511|FG002|Phase II|Not Evaluable per protocol|2|||
155198864|NCT01034631|560166509|FG000|Phase II|Determined Ineligible per protocol|0|||
155198865|NCT01034631|560166510|FG001|Phase II|Determined Ineligible per protocol|1|||
155198866|NCT01034631|560166511|FG002|Phase II|Determined Ineligible per protocol|0|||
155198867|NCT01193530|560166512|FG000|Overall Study|Withdrawal by Subject|2|||
155198868|NCT01193530|560166513|FG001|Overall Study|Withdrawal by Subject|2|||
155198869|NCT01193530|560166512|FG000|Overall Study|Began Contraindicated Therapy|1|||
155198870|NCT01193530|560166513|FG001|Overall Study|Began Contraindicated Therapy|0|||
155198871|NCT01193530|560166512|FG000|Overall Study|Lost Light Box|0|||
155198872|NCT01193530|560166513|FG001|Overall Study|Lost Light Box|1|||
155198873|NCT01193530|560166512|FG000|Overall Study|Returned home - out of state|0|||
155198874|NCT01193530|560166513|FG001|Overall Study|Returned home - out of state|1|||
155198875|NCT01193530|560166512|FG000|Overall Study|Non-Compliance|0|||
155198876|NCT01193530|560166513|FG001|Overall Study|Non-Compliance|1|||
155198877|NCT01877265|560166521|FG000|Treatment Period 1|Sponsor Decision|0|||
155198878|NCT01877265|560166522|FG001|Treatment Period 1|Sponsor Decision|0|||
155198879|NCT01877265|560166523|FG002|Treatment Period 1|Sponsor Decision|1|||
155198880|NCT01877265|560166524|FG003|Treatment Period 1|Sponsor Decision|0|||
155198881|NCT01877265|560166525|FG004|Treatment Period 1|Sponsor Decision|0|||
155198882|NCT01877265|560166526|FG005|Treatment Period 1|Sponsor Decision|0|||
155198883|NCT01877265|560166521|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198884|NCT01877265|560166522|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198885|NCT01877265|560166523|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198886|NCT01877265|560166524|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198887|NCT01877265|560166525|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
155198888|NCT01877265|560166526|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
155198889|NCT01877265|560166521|FG000|Treatment Period 3|Lost to Follow-up|1|||
155198890|NCT01877265|560166522|FG001|Treatment Period 3|Lost to Follow-up|0|||
155198891|NCT01877265|560166523|FG002|Treatment Period 3|Lost to Follow-up|0|||
155198892|NCT01877265|560166524|FG003|Treatment Period 3|Lost to Follow-up|0|||
155198893|NCT01877265|560166525|FG004|Treatment Period 3|Lost to Follow-up|0|||
155198894|NCT01877265|560166526|FG005|Treatment Period 3|Lost to Follow-up|0|||
155198895|NCT03039283|560166533|FG000|Overall Study|Protocol Violation|2|||
155198896|NCT01619423|560166543|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
155198897|NCT01619423|560166544|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
155198898|NCT01619423|560166545|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
155198899|NCT01619423|560166546|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
155198900|NCT02590003|560166554|FG000|Overall Study|Death|1|||
155198901|NCT02590003|560166555|FG001|Overall Study|Death|2|||
155198902|NCT02264639|560166556|FG000|Overall Study|Death (after completing single-dose phase)|1|||
155198903|NCT02264639|560166557|FG001|Overall Study|Death (after completing single-dose phase)|0|||
155198904|NCT02264639|560166558|FG002|Overall Study|Death (after completing single-dose phase)|0|||
155198905|NCT02264639|560166559|FG003|Overall Study|Death (after completing single-dose phase)|0|||
155198906|NCT02264639|560166560|FG004|Overall Study|Death (after completing single-dose phase)|0|||
155198907|NCT02264639|560166556|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
155198908|NCT02264639|560166557|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198909|NCT02264639|560166558|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198910|NCT02264639|560166559|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198911|NCT02264639|560166560|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
155198912|NCT02264639|560166556|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198913|NCT02264639|560166557|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198914|NCT02264639|560166558|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
155198915|NCT02264639|560166559|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155198916|NCT02264639|560166560|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
155151460|NCT01400698|559988351|FG003|Overall Study|Withdrawal by Subject|4|||
155151461|NCT01400698|559988352|FG004|Overall Study|Withdrawal by Subject|1|||
155151462|NCT01400698|559988353|FG005|Overall Study|Withdrawal by Subject|3|||
155151463|NCT01400698|559988348|FG000|Overall Study|Protocol Violation|0|||
155151464|NCT01400698|559988349|FG001|Overall Study|Protocol Violation|1|||
155151465|NCT01400698|559988350|FG002|Overall Study|Protocol Violation|0|||
155151466|NCT01400698|559988351|FG003|Overall Study|Protocol Violation|0|||
155151467|NCT01400698|559988352|FG004|Overall Study|Protocol Violation|1|||
155151468|NCT01400698|559988353|FG005|Overall Study|Protocol Violation|0|||
155151469|NCT01400698|559988348|FG000|Overall Study|Non-compliance|0|||
155151470|NCT01400698|559988349|FG001|Overall Study|Non-compliance|1|||
155151471|NCT01400698|559988350|FG002|Overall Study|Non-compliance|0|||
155151472|NCT01400698|559988351|FG003|Overall Study|Non-compliance|1|||
155151473|NCT01400698|559988352|FG004|Overall Study|Non-compliance|0|||
155151474|NCT01400698|559988353|FG005|Overall Study|Non-compliance|0|||
155151475|NCT01400698|559988348|FG000|Overall Study|Adverse Event|1|||
155151476|NCT01400698|559988349|FG001|Overall Study|Adverse Event|0|||
155151477|NCT01400698|559988350|FG002|Overall Study|Adverse Event|0|||
155151478|NCT01400698|559988351|FG003|Overall Study|Adverse Event|0|||
155151479|NCT01400698|559988352|FG004|Overall Study|Adverse Event|0|||
155151480|NCT01400698|559988353|FG005|Overall Study|Adverse Event|0|||
155151481|NCT01400698|559988348|FG000|Overall Study|Other|4|||
155151482|NCT01400698|559988349|FG001|Overall Study|Other|2|||
155151483|NCT01400698|559988350|FG002|Overall Study|Other|0|||
155151484|NCT01400698|559988351|FG003|Overall Study|Other|2|||
155151485|NCT01400698|559988352|FG004|Overall Study|Other|1|||
155151486|NCT01400698|559988353|FG005|Overall Study|Other|0|||
155151487|NCT03760029|559990412|FG000|Overall Study|Death|1|||
155151488|NCT03760029|559990413|FG001|Overall Study|Death|0|||
155151489|NCT03760029|559990414|FG002|Overall Study|Death|0|||
155151490|NCT03760029|559990412|FG000|Overall Study|Lost to Follow-up|0|||
155151491|NCT03760029|559990413|FG001|Overall Study|Lost to Follow-up|2|||
155151492|NCT03760029|559990414|FG002|Overall Study|Lost to Follow-up|1|||
155151493|NCT03760029|559990412|FG000|Overall Study|Withdrawal by Subject|1|||
155151494|NCT03760029|559990413|FG001|Overall Study|Withdrawal by Subject|4|||
155151495|NCT03760029|559990414|FG002|Overall Study|Withdrawal by Subject|1|||
155151496|NCT03760029|559990412|FG000|Overall Study|Withdrawal by parent/guardian|4|||
155151497|NCT03760029|559990413|FG001|Overall Study|Withdrawal by parent/guardian|4|||
155151498|NCT03760029|559990414|FG002|Overall Study|Withdrawal by parent/guardian|1|||
155151499|NCT03760029|559990412|FG000|Overall Study|Other|2|||
155151500|NCT03760029|559990413|FG001|Overall Study|Other|1|||
155198917|NCT02264639|560166556|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198918|NCT02264639|560166557|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198919|NCT02264639|560166558|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198920|NCT02264639|560166559|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
155198921|NCT02264639|560166560|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
155198922|NCT01416272|560166562|FG000|Overall Study|Unacceptable distance visual acuity|2|||
155198923|NCT01416272|560166562|FG000|Overall Study|Lost to Follow-up|1|||
155198924|NCT01416272|560166562|FG000|Overall Study|Study related complaints|1|||
155198925|NCT01350492|560166563|FG000|Intervention|Lost to Follow-up|2|||
155198926|NCT01350492|560166564|FG001|Intervention|Lost to Follow-up|5|||
155198927|NCT01350492|560166563|FG000|Intervention|Withdrawal by Subject|3|||
155198928|NCT01350492|560166564|FG001|Intervention|Withdrawal by Subject|1|||
155198929|NCT01350492|560166563|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
155198930|NCT01350492|560166564|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
155198931|NCT01350492|560166563|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
155198932|NCT01350492|560166564|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
155198933|NCT00702689|560166565|FG000|Overall Study|Withdrawal by Subject|4|||
155198934|NCT00702689|560166565|FG000|Overall Study|Recurrent malignancy|1|||
155198935|NCT00702689|560166565|FG000|Overall Study|Adverse Event|1|||
155198936|NCT02805972|560166568|FG000|Washout Period|Lost to Follow-up|3|||
155198937|NCT02805972|560166569|FG001|Washout Period|Lost to Follow-up|0|||
155198938|NCT00239590|560166571|FG000|Randomized|Lost to Follow-up|0|||
155198939|NCT00239590|560166572|FG001|Randomized|Lost to Follow-up|1|||
155198940|NCT00239590|560166571|FG000|Randomized|Withdrawal by Subject|0|||
155198941|NCT00239590|560166572|FG001|Randomized|Withdrawal by Subject|1|||
155198942|NCT00239590|560166571|FG000|Completed Study Protocol|Adverse Event|1|||
155198943|NCT00239590|560166572|FG001|Completed Study Protocol|Adverse Event|1|||
155198944|NCT00239590|560166571|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
155198945|NCT00239590|560166572|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
155198946|NCT02121522|560166573|FG000|Overall Study|Adverse Event|1|||
155198947|NCT00892047|560166579|FG000|Overall Study|Adverse Event|2|||
155198948|NCT00892047|560166580|FG001|Overall Study|Adverse Event|2|||
155198949|NCT00892047|560166579|FG000|Overall Study|subject burden|2|||
155198950|NCT00892047|560166580|FG001|Overall Study|subject burden|3|||
155198951|NCT00892047|560166579|FG000|Overall Study|Lack of Efficacy|0|||
155198952|NCT00892047|560166580|FG001|Overall Study|Lack of Efficacy|2|||
155198953|NCT01443078|560166581|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
155198954|NCT01443078|560166581|FG000|Overall Study|Withdrawal by Subject|1|||
155198955|NCT01443078|560166581|FG000|Overall Study|Patient had brain mets|1|||
155198956|NCT02106975|560166588|FG000|Overall Study|Death|25|||
155198957|NCT02106975|560166589|FG001|Overall Study|Death|39|||
155198958|NCT03546062|560166590|FG000|Overall Study|Adverse Event|6|||
155198959|NCT03546062|560166591|FG001|Overall Study|Adverse Event|5|||
155198960|NCT03546062|560166592|FG002|Overall Study|Adverse Event|8|||
155198961|NCT00806351|560166593|FG000|Overall Study|Death|5|||
155198962|NCT00806351|560166594|FG001|Overall Study|Death|4|||
155198963|NCT00259610|560166595|FG000|Overall Study|Withdrawal by Subject|33|||
155198964|NCT00259610|560166596|FG001|Overall Study|Withdrawal by Subject|25|||
155198965|NCT00259610|560166597|FG002|Overall Study|Withdrawal by Subject|29|||
155198966|NCT00259610|560166598|FG003|Overall Study|Withdrawal by Subject|19|||
155198967|NCT00259610|560166595|FG000|Overall Study|Lost to Follow-up|19|||
155151501|NCT03760029|559990414|FG002|Overall Study|Other|0|||
155198968|NCT00259610|560166596|FG001|Overall Study|Lost to Follow-up|8|||
155198969|NCT00259610|560166597|FG002|Overall Study|Lost to Follow-up|18|||
155198970|NCT00259610|560166598|FG003|Overall Study|Lost to Follow-up|15|||
155198971|NCT00259610|560166595|FG000|Overall Study|Physician Decision|6|||
155151502|NCT03305666|559990417|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
155151503|NCT03305666|559990418|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
155151504|NCT01001221|559990419|FG000|Overall Study|Adverse Event|1|||
155151505|NCT01001221|559990420|FG001|Overall Study|Adverse Event|2|||
155151506|NCT01001221|559990421|FG002|Overall Study|Adverse Event|0|||
155151507|NCT01001221|559990422|FG003|Overall Study|Adverse Event|2|||
155151508|NCT01001221|559990423|FG004|Overall Study|Adverse Event|0|||
155151509|NCT01001221|559990419|FG000|Overall Study|Disease progression|3|||
155151510|NCT01001221|559990420|FG001|Overall Study|Disease progression|2|||
155198972|NCT00259610|560166596|FG001|Overall Study|Physician Decision|4|||
155198973|NCT00259610|560166597|FG002|Overall Study|Physician Decision|7|||
155198974|NCT00259610|560166598|FG003|Overall Study|Physician Decision|2|||
155198975|NCT00259610|560166595|FG000|Overall Study|Death|1|||
155198976|NCT00259610|560166596|FG001|Overall Study|Death|1|||
155198977|NCT00259610|560166597|FG002|Overall Study|Death|2|||
155198978|NCT00259610|560166598|FG003|Overall Study|Death|0|||
155198979|NCT00259610|560166595|FG000|Overall Study|non medical reason|6|||
155198980|NCT00259610|560166596|FG001|Overall Study|non medical reason|2|||
155198981|NCT00259610|560166597|FG002|Overall Study|non medical reason|10|||
155198982|NCT00259610|560166598|FG003|Overall Study|non medical reason|3|||
155198983|NCT00259610|560166595|FG000|Overall Study|Adverse Event|3|||
155151511|NCT01001221|559990421|FG002|Overall Study|Disease progression|2|||
155151512|NCT01001221|559990422|FG003|Overall Study|Disease progression|4|||
155151513|NCT01001221|559990423|FG004|Overall Study|Disease progression|0|||
155151514|NCT01001221|559990419|FG000|Overall Study|Other|1|||
155151515|NCT01001221|559990420|FG001|Overall Study|Other|1|||
155151516|NCT01001221|559990421|FG002|Overall Study|Other|0|||
155151517|NCT01001221|559990422|FG003|Overall Study|Other|0|||
155151518|NCT01001221|559990423|FG004|Overall Study|Other|0|||
155151519|NCT01001221|559990419|FG000|Overall Study|Not treated; protocol exclusion|0|||
155151520|NCT01001221|559990420|FG001|Overall Study|Not treated; protocol exclusion|0|||
155151521|NCT01001221|559990421|FG002|Overall Study|Not treated; protocol exclusion|1|||
155151522|NCT01001221|559990422|FG003|Overall Study|Not treated; protocol exclusion|0|||
155151523|NCT01001221|559990423|FG004|Overall Study|Not treated; protocol exclusion|0|||
155151524|NCT02388269|559990424|FG000|Overall Study|Adverse Event|2|||
155151525|NCT02388269|559990425|FG001|Overall Study|Adverse Event|0|||
155151526|NCT02388269|559990426|FG002|Overall Study|Adverse Event|0|||
155151527|NCT02388269|559990424|FG000|Overall Study|Withdrawal by Subject|1|||
155151528|NCT02388269|559990425|FG001|Overall Study|Withdrawal by Subject|2|||
155151529|NCT02388269|559990426|FG002|Overall Study|Withdrawal by Subject|0|||
155151530|NCT02388269|559990424|FG000|Overall Study|less than 50% stimulations|1|||
155151531|NCT02388269|559990425|FG001|Overall Study|less than 50% stimulations|0|||
155151532|NCT02388269|559990426|FG002|Overall Study|less than 50% stimulations|0|||
155151533|NCT02388269|559990424|FG000|Overall Study|no diary data|3|||
155151534|NCT02388269|559990425|FG001|Overall Study|no diary data|0|||
155151535|NCT02388269|559990426|FG002|Overall Study|no diary data|0|||
155151536|NCT02388269|559990424|FG000|Overall Study|Protocol Violation|2|||
155151537|NCT02388269|559990425|FG001|Overall Study|Protocol Violation|0|||
155151538|NCT02388269|559990426|FG002|Overall Study|Protocol Violation|0|||
155151539|NCT02388269|559990424|FG000|Overall Study|Screen Failure|0|||
155151540|NCT02388269|559990425|FG001|Overall Study|Screen Failure|0|||
155151541|NCT02388269|559990426|FG002|Overall Study|Screen Failure|10|||
155151542|NCT03882021|559990427|FG000|Enrollment|Procedure aborted/cancelled|2|||
155151543|NCT03882021|559990427|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
155151544|NCT03882021|559990427|FG000|Enrollment to 3-Month|Death|1|||
155151545|NCT03882021|559990427|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
155151546|NCT03882021|559990427|FG000|Enrollment to 3-Month|Missed Visit|4|||
155151547|NCT03882021|559990427|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
155151548|NCT03882021|559990427|FG000|6-Month to 12-Month Visit|Death|1|||
155151549|NCT03882021|559990427|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
155151550|NCT02542865|559990429|FG000|Overall Study|Identified as screen failure|1|||
155151551|NCT02542865|559990430|FG001|Overall Study|Identified as screen failure|0|||
155151552|NCT02542865|559990429|FG000|Overall Study|Withdrawal by Subject|16|||
155151553|NCT02542865|559990430|FG001|Overall Study|Withdrawal by Subject|0|||
155151554|NCT01469221|559990431|FG000|Double Blind Phase|Protocol Violation|1|||
155151555|NCT01469221|559990432|FG001|Double Blind Phase|Protocol Violation|0|||
155151556|NCT01469221|559990433|FG002|Double Blind Phase|Protocol Violation|0|||
155151557|NCT01469221|559990431|FG000|Double Blind Phase|Physician Decision|1|||
155151558|NCT01469221|559990432|FG001|Double Blind Phase|Physician Decision|1|||
155151559|NCT01469221|559990433|FG002|Double Blind Phase|Physician Decision|0|||
155151560|NCT01469221|559990431|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
155151561|NCT01469221|559990432|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
155151562|NCT01469221|559990433|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
155151563|NCT00659061|559990434|FG000|Overall Study|Migration due to political unrest|21|||
155151564|NCT00659061|559990435|FG001|Overall Study|Migration due to political unrest|15|||
155151565|NCT01168349|559990444|FG000|Overall Study|Death|157|||
155151566|NCT01168349|559990444|FG000|Overall Study|Lost to Follow-up|34|||
155151567|NCT01168349|559990444|FG000|Overall Study|Withdrawal by Subject|9|||
155151568|NCT01168349|559990444|FG000|Overall Study|Kidney transplantation|3|||
155151569|NCT01168349|559990444|FG000|Overall Study|Other|22|||
155151570|NCT01168349|559990444|FG000|Overall Study|Protocol Violation|76|||
155151571|NCT03259230|559990445|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
155151572|NCT03259230|559990446|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
155151573|NCT01033240|559990447|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
155198984|NCT00259610|560166596|FG001|Overall Study|Adverse Event|4|||
155151574|NCT01033240|559990448|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
155151575|NCT01033240|559990449|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
155198985|NCT00259610|560166597|FG002|Overall Study|Adverse Event|5|||
155151576|NCT01033240|559990447|FG000|Overall Study|Death|2|||
155151577|NCT01033240|559990448|FG001|Overall Study|Death|0|||
155151578|NCT01033240|559990449|FG002|Overall Study|Death|0|||
155151579|NCT01033240|559990447|FG000|Overall Study|Withdrew Consent|2|||
155151580|NCT01033240|559990448|FG001|Overall Study|Withdrew Consent|9|||
155151581|NCT01033240|559990449|FG002|Overall Study|Withdrew Consent|2|||
155151582|NCT01033240|559990447|FG000|Overall Study|Disease Progression|35|||
155151583|NCT01033240|559990448|FG001|Overall Study|Disease Progression|32|||
155198986|NCT00259610|560166598|FG003|Overall Study|Adverse Event|2|||
155198987|NCT00259610|560166595|FG000|Overall Study|Serious Adverse Event|8|||
155198988|NCT00259610|560166596|FG001|Overall Study|Serious Adverse Event|2|||
155198989|NCT00259610|560166597|FG002|Overall Study|Serious Adverse Event|2|||
155198990|NCT00259610|560166598|FG003|Overall Study|Serious Adverse Event|2|||
155198991|NCT01201785|560166602|FG000|Overall Study|Lost to Follow-up|16|||
155151584|NCT01033240|559990449|FG002|Overall Study|Disease Progression|41|||
155151585|NCT01033240|559990447|FG000|Overall Study|Investigator Discretion|0|||
155151586|NCT01033240|559990448|FG001|Overall Study|Investigator Discretion|0|||
155151587|NCT01033240|559990449|FG002|Overall Study|Investigator Discretion|2|||
155151588|NCT01033240|559990447|FG000|Overall Study|Other|0|||
155151589|NCT01033240|559990448|FG001|Overall Study|Other|1|||
155151590|NCT01033240|559990449|FG002|Overall Study|Other|2|||
155151591|NCT02913482|559990450|FG000|Overall Study|Death|0|||
155151592|NCT02913482|559990451|FG001|Overall Study|Death|2|||
155151593|NCT02913482|559990452|FG002|Overall Study|Death|2|||
155151594|NCT02913482|559990450|FG000|Overall Study|Progressive Disease|1|||
155151595|NCT02913482|559990451|FG001|Overall Study|Progressive Disease|1|||
155151596|NCT02913482|559990452|FG002|Overall Study|Progressive Disease|1|||
155151597|NCT02913482|559990450|FG000|Overall Study|Reason not specified|0|||
155151598|NCT02913482|559990451|FG001|Overall Study|Reason not specified|0|||
155151599|NCT02913482|559990452|FG002|Overall Study|Reason not specified|1|||
155151600|NCT02913482|559990450|FG000|Overall Study|Withdrawal by Subject|0|||
155151601|NCT02913482|559990451|FG001|Overall Study|Withdrawal by Subject|1|||
155151602|NCT02913482|559990452|FG002|Overall Study|Withdrawal by Subject|1|||
155198992|NCT02151110|560166603|FG000|Overall Study|Withdrawal by Subject|0|||
155198993|NCT02151110|560166604|FG001|Overall Study|Withdrawal by Subject|0|||
155151603|NCT05468814|559990453|FG000|Overall Study|Lost to Follow-up|5|||
155151604|NCT05468814|559990454|FG001|Overall Study|Lost to Follow-up|6|||
155151605|NCT04716426|559990456|FG000|Overall Study|Vaccination|1|||
155151606|NCT04716426|559990457|FG001|Overall Study|Vaccination|1|||
155151607|NCT04716426|559990456|FG000|Overall Study|Contamination|1|||
155151608|NCT04716426|559990457|FG001|Overall Study|Contamination|0|||
155151609|NCT01046565|559990462|FG000|Overall Study|Adverse Event|2|||
155151610|NCT01046565|559990462|FG000|Overall Study|Withdrawal by Subject|7|||
155151611|NCT03740048|559990463|FG000|Overall Study|Withdrawal by Subject|1|||
155151612|NCT03740048|559990464|FG001|Overall Study|Withdrawal by Subject|1|||
155151613|NCT03740048|559990463|FG000|Overall Study|Death|1|||
155151614|NCT03740048|559990464|FG001|Overall Study|Death|6|||
155151615|NCT03740048|559990463|FG000|Overall Study|Switched to thrice-weekly HD|2|||
155151616|NCT03740048|559990464|FG001|Overall Study|Switched to thrice-weekly HD|0|||
155151617|NCT03740048|559990463|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
155151618|NCT03740048|559990464|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
155151619|NCT03740048|559990463|FG000|Overall Study|Lost to Follow-up|0|||
155151620|NCT03740048|559990464|FG001|Overall Study|Lost to Follow-up|1|||
155151621|NCT03740048|559990463|FG000|Overall Study|Non-compliance with HD|0|||
155151622|NCT03740048|559990464|FG001|Overall Study|Non-compliance with HD|1|||
155151623|NCT01069484|559990465|FG000|Overall Study|Death-in-near-family|1|||
155151624|NCT01069484|559990466|FG001|Overall Study|Death-in-near-family|0|||
155151625|NCT01069484|559990465|FG000|Overall Study|No specific reason|8|||
155151626|NCT01069484|559990466|FG001|Overall Study|No specific reason|2|||
155151627|NCT01069484|559990465|FG000|Overall Study|Illness mother or child|3|||
155151628|NCT01069484|559990466|FG001|Overall Study|Illness mother or child|1|||
155151629|NCT02675907|559990469|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
155151630|NCT02675907|559990470|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
155151631|NCT02675907|559990469|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
155151632|NCT02675907|559990470|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
155151633|NCT02675907|559990469|FG000|Study Overall|Lack of Efficacy|1|||
155151634|NCT02675907|559990470|FG001|Study Overall|Lack of Efficacy|0|||
155151635|NCT02675907|559990469|FG000|Study Overall|Withdrawal by Subject|2|||
155151636|NCT02675907|559990470|FG001|Study Overall|Withdrawal by Subject|2|||
155151637|NCT02675907|559990469|FG000|Study Overall|Lost to Follow-up|0|||
155151638|NCT02675907|559990470|FG001|Study Overall|Lost to Follow-up|2|||
155151639|NCT01323582|559990474|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
155151640|NCT01323582|559990475|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
155151641|NCT01323582|559990474|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
155151642|NCT01323582|559990475|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
155151643|NCT01323582|559990474|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
155151644|NCT01323582|559990475|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
155151645|NCT00960375|559990480|FG000|Overall Study|Lost to Follow-up|20|||
155151646|NCT00960375|559990481|FG001|Overall Study|Lost to Follow-up|22|||
155151647|NCT00083889|559990482|FG000|Overall Study|Adverse Event|76|||
155151648|NCT00083889|559990483|FG001|Overall Study|Adverse Event|86|||
155151649|NCT00083889|559990482|FG000|Overall Study|Protocol Violation|2|||
155151650|NCT00083889|559990483|FG001|Overall Study|Protocol Violation|2|||
155151651|NCT00083889|559990482|FG000|Overall Study|Withdrawal by Subject|22|||
155198994|NCT02151110|560166605|FG002|Overall Study|Withdrawal by Subject|0|||
155151652|NCT00083889|559990483|FG001|Overall Study|Withdrawal by Subject|24|||
155198995|NCT02151110|560166606|FG003|Overall Study|Withdrawal by Subject|0|||
155198996|NCT02151110|560166607|FG004|Overall Study|Withdrawal by Subject|0|||
155198997|NCT02151110|560166608|FG005|Overall Study|Withdrawal by Subject|0|||
155198998|NCT02151110|560166609|FG006|Overall Study|Withdrawal by Subject|0|||
155198999|NCT02151110|560166610|FG007|Overall Study|Withdrawal by Subject|1|||
155199000|NCT02151110|560166603|FG000|Overall Study|Lost to Follow-up|0|||
155199001|NCT02151110|560166604|FG001|Overall Study|Lost to Follow-up|0|||
155199002|NCT02151110|560166605|FG002|Overall Study|Lost to Follow-up|0|||
155199003|NCT02151110|560166606|FG003|Overall Study|Lost to Follow-up|0|||
155199004|NCT02151110|560166607|FG004|Overall Study|Lost to Follow-up|0|||
155199005|NCT02151110|560166608|FG005|Overall Study|Lost to Follow-up|0|||
155199006|NCT02151110|560166609|FG006|Overall Study|Lost to Follow-up|0|||
155199007|NCT02151110|560166610|FG007|Overall Study|Lost to Follow-up|2|||
155199008|NCT01064310|560166611|FG000|Period 1|Adverse Event|7|||
155199009|NCT01064310|560166612|FG001|Period 1|Adverse Event|10|||
155199010|NCT01064310|560166613|FG002|Period 1|Adverse Event|0|||
155199011|NCT01064310|560166611|FG000|Period 1|Physician Decision|1|||
155199012|NCT01064310|560166612|FG001|Period 1|Physician Decision|0|||
155199013|NCT01064310|560166613|FG002|Period 1|Physician Decision|0|||
155199014|NCT01064310|560166611|FG000|Period 1|Withdrawal by Subject|2|||
155199015|NCT01064310|560166612|FG001|Period 1|Withdrawal by Subject|2|||
155199016|NCT01064310|560166613|FG002|Period 1|Withdrawal by Subject|0|||
155199017|NCT01064310|560166611|FG000|Period 1|Lack of Efficacy|3|||
155199018|NCT01064310|560166612|FG001|Period 1|Lack of Efficacy|5|||
155199019|NCT01064310|560166613|FG002|Period 1|Lack of Efficacy|0|||
155199020|NCT01064310|560166611|FG000|Period 1|Entered Open-label Period|1|||
155199021|NCT01064310|560166612|FG001|Period 1|Entered Open-label Period|1|||
155199022|NCT01064310|560166613|FG002|Period 1|Entered Open-label Period|0|||
155199023|NCT01064310|560166611|FG000|Period 2|Adverse Event|2|||
155199024|NCT01064310|560166612|FG001|Period 2|Adverse Event|1|||
155199025|NCT01064310|560166613|FG002|Period 2|Adverse Event|0|||
155199026|NCT01064310|560166611|FG000|Period 2|Physician Decision|0|||
155199027|NCT01064310|560166612|FG001|Period 2|Physician Decision|1|||
155199028|NCT01064310|560166613|FG002|Period 2|Physician Decision|0|||
155199029|NCT01064310|560166611|FG000|Period 2|Entered Open-label Period|1|||
155199030|NCT01064310|560166612|FG001|Period 2|Entered Open-label Period|0|||
155199031|NCT01064310|560166613|FG002|Period 2|Entered Open-label Period|0|||
155199032|NCT01064310|560166611|FG000|Period 2|Lack of Efficacy|1|||
155199033|NCT01064310|560166612|FG001|Period 2|Lack of Efficacy|4|||
155199034|NCT01064310|560166613|FG002|Period 2|Lack of Efficacy|0|||
155199035|NCT01064310|560166611|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
155199036|NCT01064310|560166612|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
155199037|NCT01064310|560166613|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
155199038|NCT01064310|560166611|FG000|Open Label Pazopinib|Adverse Event|0|||
155199039|NCT01064310|560166612|FG001|Open Label Pazopinib|Adverse Event|0|||
155199040|NCT01064310|560166613|FG002|Open Label Pazopinib|Adverse Event|12|||
155199041|NCT01064310|560166611|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
155199042|NCT01064310|560166612|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
155199043|NCT01064310|560166613|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
155199044|NCT01064310|560166611|FG000|Open Label Pazopinib|Physician Decision|0|||
155199045|NCT01064310|560166612|FG001|Open Label Pazopinib|Physician Decision|0|||
155199046|NCT01064310|560166613|FG002|Open Label Pazopinib|Physician Decision|20|||
155199047|NCT00001880|560166614|FG000|Overall Study|Death|14|||
155199048|NCT02639065|560166615|FG000|Study Treatment|Disease Progression|13|||
155199049|NCT02639065|560166615|FG000|Study Treatment|Adverse Event|9|||
155199050|NCT02639065|560166615|FG000|Study Treatment|Withdrawal by Subject|1|||
155199051|NCT02639065|560166615|FG000|Follow up|Subject refused to follow up|1|||
155199052|NCT02639065|560166615|FG000|Follow up|Symptomatic Deterioration|2|||
155199053|NCT02639065|560166615|FG000|Follow up|Death|2|||
155199054|NCT02639065|560166615|FG000|Follow up|Study Terminated|1|||
155199055|NCT02639065|560166615|FG000|Follow up|Disease Progression|3|||
155199056|NCT00873015|560166616|FG000|Overall Study|Withdrawal by Subject|0|||
155199057|NCT00873015|560166617|FG001|Overall Study|Withdrawal by Subject|1|||
155199058|NCT00873015|560166618|FG002|Overall Study|Withdrawal by Subject|0|||
155199059|NCT00873015|560166619|FG003|Overall Study|Withdrawal by Subject|0|||
155199060|NCT00345839|560166620|FG000|Overall Study|Withdrawal by Subject|91|||
155199061|NCT00345839|560166621|FG001|Overall Study|Withdrawal by Subject|98|||
155199062|NCT00345839|560166620|FG000|Overall Study|Lost to Follow-up|58|||
155199063|NCT00345839|560166621|FG001|Overall Study|Lost to Follow-up|61|||
155199064|NCT00660699|560166627|FG000|Overall Study|Withdrawal by Subject|2|||
155199065|NCT00599924|560168416|FG000|Overall Study|Lack of Efficacy|3|||
155199066|NCT00599924|560168417|FG001|Overall Study|Lack of Efficacy|5|||
155199067|NCT00599924|560168418|FG002|Overall Study|Lack of Efficacy|1|||
155199068|NCT00599924|560168419|FG003|Overall Study|Lack of Efficacy|2|||
155199069|NCT00599924|560168420|FG004|Overall Study|Lack of Efficacy|3|||
155199070|NCT00599924|560168421|FG005|Overall Study|Lack of Efficacy|2|||
155199071|NCT00599924|560168422|FG006|Overall Study|Lack of Efficacy|0|||
155199072|NCT00599924|560168416|FG000|Overall Study|Adverse Event|0|||
155199073|NCT00599924|560168417|FG001|Overall Study|Adverse Event|0|||
155151653|NCT00083889|559990482|FG000|Overall Study|Lack of Efficacy|240|||
155151654|NCT00083889|559990483|FG001|Overall Study|Lack of Efficacy|219|||
155151655|NCT00083889|559990482|FG000|Overall Study|Decision of sponsor|32|||
155151656|NCT00083889|559990483|FG001|Overall Study|Decision of sponsor|4|||
155151657|NCT00083889|559990482|FG000|Overall Study|Randomized: did not take study drug|0|||
155151658|NCT00083889|559990483|FG001|Overall Study|Randomized: did not take study drug|15|||
155151659|NCT00083889|559990482|FG000|Overall Study|Completed on marketed sunitinub|3|||
155151660|NCT00083889|559990483|FG001|Overall Study|Completed on marketed sunitinub|0|||
155151661|NCT00083889|559990482|FG000|Overall Study|Crossover to SU011248|0|||
155151662|NCT00083889|559990483|FG001|Overall Study|Crossover to SU011248|25|||
155151663|NCT00004563|559990495|FG000|Overall Study|Withdrawal by Subject|20|||
155151664|NCT00004563|559990496|FG001|Overall Study|Withdrawal by Subject|16|||
155151665|NCT00004563|559990495|FG000|Overall Study|Lack of Efficacy|3|||
155151666|NCT00004563|559990496|FG001|Overall Study|Lack of Efficacy|5|||
155151667|NCT00004563|559990495|FG000|Overall Study|Death|2|||
155151668|NCT00004563|559990496|FG001|Overall Study|Death|3|||
155151669|NCT03473236|559990498|FG000|Overall Study|Withdrawal by Subject|0|||
155151670|NCT03473236|559990499|FG001|Overall Study|Withdrawal by Subject|0|||
155151671|NCT03473236|559990500|FG002|Overall Study|Withdrawal by Subject|0|||
155151672|NCT03473236|559990501|FG003|Overall Study|Withdrawal by Subject|0|||
155151673|NCT03473236|559990502|FG004|Overall Study|Withdrawal by Subject|0|||
155151674|NCT03473236|559990503|FG005|Overall Study|Withdrawal by Subject|1|||
155151675|NCT03473236|559990504|FG006|Overall Study|Withdrawal by Subject|0|||
155151676|NCT03473236|559990505|FG007|Overall Study|Withdrawal by Subject|0|||
155151677|NCT03473236|559990506|FG008|Overall Study|Withdrawal by Subject|1|||
155151678|NCT03473236|559990507|FG009|Overall Study|Withdrawal by Subject|0|||
155151679|NCT04258423|559990517|FG000|Overall Study|Study Closure|2|||
155151680|NCT04258423|559990518|FG001|Overall Study|Study Closure|2|||
155151681|NCT03353675|559990522|FG000|Overall Study|Adverse Event|4|||
155151682|NCT00402168|559990523|FG000|Randomized|Lost to Follow-up|1|||
155151683|NCT00402168|559990524|FG001|Randomized|Lost to Follow-up|0|||
155151684|NCT00402168|559990523|FG000|Randomized|Withdrawal by Subject|0|||
155151685|NCT00402168|559990524|FG001|Randomized|Withdrawal by Subject|1|||
155151686|NCT00402168|559990523|FG000|Treatment (up to 12 Months)|Death|0|||
155151687|NCT00402168|559990524|FG001|Treatment (up to 12 Months)|Death|1|||
155151688|NCT00402168|559990523|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
155151689|NCT00402168|559990524|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
155151690|NCT00402168|559990523|FG000|Treatment (up to 12 Months)|non-specified|0|||
155151691|NCT00402168|559990524|FG001|Treatment (up to 12 Months)|non-specified|1|||
155151692|NCT00402168|559990523|FG000|Long Term (LT)|Adverse Event|1|||
155151693|NCT00402168|559990524|FG001|Long Term (LT)|Adverse Event|5|||
155151694|NCT00402168|559990523|FG000|Long Term (LT)|Withdrawal by Subject|4|||
155151695|NCT00402168|559990524|FG001|Long Term (LT)|Withdrawal by Subject|7|||
155151696|NCT00402168|559990523|FG000|Long Term (LT)|Pregnancy|0|||
155151697|NCT00402168|559990524|FG001|Long Term (LT)|Pregnancy|1|||
155151698|NCT00402168|559990523|FG000|Long Term (LT)|Lost to Follow-up|1|||
155151699|NCT00402168|559990524|FG001|Long Term (LT)|Lost to Follow-up|0|||
155151700|NCT00402168|559990523|FG000|Long Term (LT)|Death|4|||
155151701|NCT00402168|559990524|FG001|Long Term (LT)|Death|0|||
155151702|NCT00402168|559990523|FG000|Long Term (LT)|Lack of Efficacy|0|||
155151703|NCT00402168|559990524|FG001|Long Term (LT)|Lack of Efficacy|2|||
155151704|NCT00402168|559990523|FG000|Long Term (LT)|non-specified|1|||
155151705|NCT00402168|559990524|FG001|Long Term (LT)|non-specified|2|||
155151706|NCT00402168|559990523|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
155151707|NCT00402168|559990524|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
155151708|NCT00402168|559990523|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
155151709|NCT00402168|559990524|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
155151710|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
155151711|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
155151712|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
155151713|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
155151714|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
155151715|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
155151716|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
155151717|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
155151718|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
155151719|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
155151720|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
155151721|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
155151722|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
155151723|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
155151724|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
155151725|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
155151726|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
155151727|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
155151728|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
155151729|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
155151730|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
155151731|NCT00550407|559990525|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
155151732|NCT00550407|559990526|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
155151733|NCT00550407|559990527|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
155151734|NCT00550407|559990525|FG000|26-Week Randomized Phase|Adverse Event|0|||
155151735|NCT00550407|559990526|FG001|26-Week Randomized Phase|Adverse Event|5|||
155151736|NCT00550407|559990527|FG002|26-Week Randomized Phase|Adverse Event|2|||
155151737|NCT00550407|559990525|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
155151738|NCT00550407|559990526|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
155151739|NCT00550407|559990527|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
155151740|NCT00550407|559990525|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
155151741|NCT00550407|559990526|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
155151742|NCT00550407|559990527|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
155151743|NCT00550407|559990525|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
155151744|NCT00550407|559990526|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
155151745|NCT00550407|559990527|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
155151746|NCT02370420|559990528|FG000|Overall Study|Physician Decision|3|||
155151747|NCT02370420|559990529|FG001|Overall Study|Physician Decision|3|||
155151748|NCT02370420|559990528|FG000|Overall Study|Lost to Follow-up|11|||
155151749|NCT02370420|559990529|FG001|Overall Study|Lost to Follow-up|9|||
155151750|NCT02919761|559990532|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
155151751|NCT02919761|559990533|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
155151752|NCT02919761|559990534|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
155151753|NCT02919761|559990532|FG000|Part 1: Open Label|Adverse Event|1|||
155151754|NCT02919761|559990533|FG001|Part 1: Open Label|Adverse Event|0|||
155151755|NCT02919761|559990534|FG002|Part 1: Open Label|Adverse Event|0|||
155151756|NCT02919761|559990532|FG000|Part 1: Open Label|Lost to Follow-up|1|||
155151757|NCT02919761|559990533|FG001|Part 1: Open Label|Lost to Follow-up|0|||
155151758|NCT02919761|559990534|FG002|Part 1: Open Label|Lost to Follow-up|0|||
155151759|NCT02919761|559990532|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
155151760|NCT02919761|559990533|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
155151761|NCT02919761|559990534|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
155151762|NCT02919761|559990532|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
155151763|NCT02919761|559990533|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
155151764|NCT02919761|559990534|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
155151765|NCT02919761|559990532|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
155151766|NCT02919761|559990533|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
155151767|NCT02919761|559990534|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
155151768|NCT02919761|559990532|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
155151769|NCT02919761|559990533|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
155151770|NCT02919761|559990534|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
155151771|NCT02919761|559990532|FG000|Part 1: Open Label|Termination by Sponsor|1|||
155151772|NCT02919761|559990533|FG001|Part 1: Open Label|Termination by Sponsor|0|||
155151773|NCT02919761|559990534|FG002|Part 1: Open Label|Termination by Sponsor|0|||
155151774|NCT02919761|559990532|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
155151775|NCT02919761|559990533|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
155151776|NCT02919761|559990534|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
155151777|NCT02919761|559990532|FG000|Part 2: Double-blind|Adverse Event|0|||
155151778|NCT02919761|559990533|FG001|Part 2: Double-blind|Adverse Event|1|||
155151779|NCT02919761|559990534|FG002|Part 2: Double-blind|Adverse Event|0|||
155151780|NCT02919761|559990532|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
155151781|NCT02919761|559990533|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
155151782|NCT02919761|559990534|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
155151783|NCT02919761|559990532|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
155151784|NCT02919761|559990533|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
155151785|NCT02919761|559990534|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
155151786|NCT02919761|559990532|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
155151787|NCT02919761|559990533|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
155151788|NCT02919761|559990534|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
155151789|NCT02919761|559990532|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
155151790|NCT02919761|559990533|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
155151791|NCT02919761|559990534|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
155151792|NCT02919761|559990532|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
155151793|NCT02919761|559990533|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
155151794|NCT02919761|559990534|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
155151795|NCT02919761|559990532|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
155151796|NCT02919761|559990533|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
155151797|NCT02919761|559990534|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
155151798|NCT00410956|559990535|FG000|Overall Study|Adverse Event|1|||
155151799|NCT00410956|559990535|FG000|Overall Study|Death|2|||
155151800|NCT00410956|559990535|FG000|Overall Study|Lack of Efficacy|10|||
155151801|NCT00410956|559990535|FG000|Overall Study|Physician Decision|6|||
155151802|NCT01766050|559991960|FG000|Overall Study|Adverse Event|1|||
155151803|NCT01766050|559991960|FG000|Overall Study|Lost to Follow-up|1|||
155151804|NCT01766050|559991960|FG000|Overall Study|Withdrawal by Subject|2|||
155151805|NCT00385671|559991961|FG000|Overall Study|Adverse Event|14|||
155151806|NCT00385671|559991962|FG001|Overall Study|Adverse Event|27|||
155151807|NCT00385671|559991963|FG002|Overall Study|Adverse Event|18|||
155151808|NCT00385671|559991961|FG000|Overall Study|Lack of Efficacy|5|||
155151809|NCT00385671|559991962|FG001|Overall Study|Lack of Efficacy|9|||
155151810|NCT00385671|559991963|FG002|Overall Study|Lack of Efficacy|5|||
155151811|NCT00385671|559991961|FG000|Overall Study|Lost to Follow-up|6|||
155151812|NCT00385671|559991962|FG001|Overall Study|Lost to Follow-up|6|||
155151813|NCT00385671|559991963|FG002|Overall Study|Lost to Follow-up|5|||
155151814|NCT00385671|559991961|FG000|Overall Study|Physician Decision|2|||
155151815|NCT00385671|559991962|FG001|Overall Study|Physician Decision|1|||
155151816|NCT00385671|559991963|FG002|Overall Study|Physician Decision|2|||
155151817|NCT00385671|559991961|FG000|Overall Study|Protocol Violation|5|||
155151818|NCT00385671|559991962|FG001|Overall Study|Protocol Violation|2|||
155151819|NCT00385671|559991963|FG002|Overall Study|Protocol Violation|1|||
155151820|NCT00385671|559991961|FG000|Overall Study|Sponsor Decision|2|||
155151821|NCT00385671|559991962|FG001|Overall Study|Sponsor Decision|2|||
155151822|NCT00385671|559991963|FG002|Overall Study|Sponsor Decision|1|||
155151823|NCT00385671|559991961|FG000|Overall Study|Withdrawal by Subject|4|||
155151824|NCT00385671|559991962|FG001|Overall Study|Withdrawal by Subject|4|||
155151825|NCT00385671|559991963|FG002|Overall Study|Withdrawal by Subject|4|||
155151826|NCT01021020|559991971|FG000|Period I|Protocol Violation|1|||
155151827|NCT01021020|559991971|FG000|Period I|Withdrawal by Subject|1|||
155151828|NCT01021020|559991971|FG000|14 Day Washout Period A|Physician Decision|1|||
155151829|NCT00755183|559991972|FG000|Overall Study|Adverse Event|5|||
155151830|NCT00755183|559991973|FG001|Overall Study|Adverse Event|2|||
155151831|NCT00755183|559991972|FG000|Overall Study|Protocol Violation|0|||
155151832|NCT00755183|559991973|FG001|Overall Study|Protocol Violation|1|||
155151833|NCT00755183|559991972|FG000|Overall Study|Withdrawal by Subject|0|||
155151834|NCT00755183|559991973|FG001|Overall Study|Withdrawal by Subject|2|||
155151835|NCT00755183|559991972|FG000|Overall Study|Administrative|2|||
155151836|NCT00755183|559991973|FG001|Overall Study|Administrative|1|||
155151837|NCT03547518|559991978|FG000|Overall Study|Lost to Follow-up|2|||
155151838|NCT03547518|559991979|FG001|Overall Study|Lost to Follow-up|0|||
155151839|NCT04742556|559991983|FG000|Overall Study|Withdrawal by Subject|0|||
155151840|NCT04742556|559991984|FG001|Overall Study|Withdrawal by Subject|1|||
155151841|NCT04742556|559991985|FG002|Overall Study|Withdrawal by Subject|0|||
155151842|NCT04742556|559991983|FG000|Overall Study|Adverse Event|0|||
155151843|NCT04742556|559991984|FG001|Overall Study|Adverse Event|0|||
155151844|NCT04742556|559991985|FG002|Overall Study|Adverse Event|2|||
155151845|NCT04742556|559991983|FG000|Overall Study|Clinical disease progression|0|||
155151846|NCT04742556|559991984|FG001|Overall Study|Clinical disease progression|1|||
155151847|NCT04742556|559991985|FG002|Overall Study|Clinical disease progression|2|||
155151848|NCT04742556|559991983|FG000|Overall Study|Objective disease progression|3|||
155151849|NCT04742556|559991984|FG001|Overall Study|Objective disease progression|2|||
155151850|NCT04742556|559991985|FG002|Overall Study|Objective disease progression|4|||
155151851|NCT04247347|559991986|FG000|Overall Study|Withdrawal by Subject|2|||
155151852|NCT04247347|559991987|FG001|Overall Study|Withdrawal by Subject|3|||
155151853|NCT04247347|559991988|FG002|Overall Study|Withdrawal by Subject|3|||
155151854|NCT04247347|559991986|FG000|Overall Study|Lost to Follow-up|1|||
155151855|NCT04247347|559991987|FG001|Overall Study|Lost to Follow-up|1|||
155151856|NCT04247347|559991988|FG002|Overall Study|Lost to Follow-up|1|||
155151857|NCT03035032|559991989|FG000|Overall Study|Adverse Event|2|||
155151858|NCT03035032|559991989|FG000|Overall Study|Death|9|||
155151859|NCT03035032|559991989|FG000|Overall Study|Lost to Follow-up|1|||
155151860|NCT03035032|559991989|FG000|Overall Study|Progressive Disease|22|||
155151861|NCT03035032|559991989|FG000|Overall Study|Protocol Violation|2|||
155151862|NCT03035032|559991989|FG000|Overall Study|Withdrawal by Subject|2|||
155151863|NCT03035032|559991989|FG000|Overall Study|Physician Decision|5|||
155151864|NCT02923726|559991992|FG000|Overall Study|Death|196|||
155151865|NCT02923726|559991993|FG001|Overall Study|Death|175|||
155151866|NCT02923726|559991992|FG000|Overall Study|Withdrawal by Subject|337|||
155151867|NCT02923726|559991993|FG001|Overall Study|Withdrawal by Subject|307|||
155151868|NCT02399215|559991997|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
155151869|NCT02399215|559991997|FG000|Overall Study|Withdrawal by Subject|1|||
155151870|NCT01089504|559991998|FG000|Overall Study|Lost to Follow-up|1|||
155151871|NCT01089504|559991999|FG001|Overall Study|Lost to Follow-up|1|||
155151872|NCT01089504|559991998|FG000|Overall Study|Withdrawal by Subject|2|||
155151873|NCT01089504|559991999|FG001|Overall Study|Withdrawal by Subject|0|||
155151874|NCT00914849|559992003|FG000|Overall Study|Withdrawal by Subject|1|||
155199074|NCT00599924|560168418|FG002|Overall Study|Adverse Event|0|||
155199075|NCT00599924|560168419|FG003|Overall Study|Adverse Event|2|||
155199076|NCT00599924|560168420|FG004|Overall Study|Adverse Event|0|||
155199077|NCT00599924|560168421|FG005|Overall Study|Adverse Event|0|||
155199078|NCT00599924|560168422|FG006|Overall Study|Adverse Event|2|||
155199079|NCT00599924|560168416|FG000|Overall Study|Death|0|||
155199080|NCT00599924|560168417|FG001|Overall Study|Death|0|||
155199081|NCT00599924|560168418|FG002|Overall Study|Death|0|||
155199082|NCT00599924|560168419|FG003|Overall Study|Death|2|||
155199083|NCT00599924|560168420|FG004|Overall Study|Death|0|||
155199084|NCT00599924|560168421|FG005|Overall Study|Death|2|||
155199085|NCT00599924|560168422|FG006|Overall Study|Death|1|||
155199086|NCT00599924|560168416|FG000|Overall Study|Protocol Violation|0|||
155199087|NCT00599924|560168417|FG001|Overall Study|Protocol Violation|0|||
155199088|NCT00599924|560168418|FG002|Overall Study|Protocol Violation|0|||
155199089|NCT00599924|560168419|FG003|Overall Study|Protocol Violation|1|||
155199090|NCT00599924|560168420|FG004|Overall Study|Protocol Violation|0|||
155199091|NCT00599924|560168421|FG005|Overall Study|Protocol Violation|0|||
155199092|NCT00599924|560168422|FG006|Overall Study|Protocol Violation|0|||
155199093|NCT00599924|560168416|FG000|Overall Study|Withdrawal by Subject|0|||
155199094|NCT00599924|560168417|FG001|Overall Study|Withdrawal by Subject|0|||
155199095|NCT00599924|560168418|FG002|Overall Study|Withdrawal by Subject|1|||
155199096|NCT00599924|560168419|FG003|Overall Study|Withdrawal by Subject|0|||
155151875|NCT00914849|559992004|FG001|Overall Study|Withdrawal by Subject|0|||
155151876|NCT00914849|559992003|FG000|Overall Study|Not eligible|0|||
155151877|NCT00914849|559992004|FG001|Overall Study|Not eligible|1|||
155151878|NCT05106959|559992005|FG000|Overall Study|Lost to Follow-up|1|||
155151879|NCT03448406|559992006|FG000|Overall Study|Noncompliance of scheduled visits|1|||
155151880|NCT03448406|559992007|FG001|Overall Study|Noncompliance of scheduled visits|2|||
155151881|NCT03448406|559992006|FG000|Overall Study|Withdrawal by Subject|1|||
155151882|NCT03448406|559992007|FG001|Overall Study|Withdrawal by Subject|2|||
155151883|NCT03448406|559992006|FG000|Overall Study|Protocol Violation|1|||
155151884|NCT03448406|559992007|FG001|Overall Study|Protocol Violation|0|||
155151885|NCT03448406|559992006|FG000|Overall Study|Adverse Event|8|||
155151886|NCT03448406|559992007|FG001|Overall Study|Adverse Event|9|||
155151887|NCT04602390|559992009|FG000|Overall Study|Withdrawal by Subject|0|||
155151888|NCT04602390|559992010|FG001|Overall Study|Withdrawal by Subject|0|||
155151889|NCT04602390|559992011|FG002|Overall Study|Withdrawal by Subject|0|||
155151890|NCT04602390|559992012|FG003|Overall Study|Withdrawal by Subject|0|||
155151891|NCT04602390|559992013|FG004|Overall Study|Withdrawal by Subject|1|||
155151892|NCT04602390|559992014|FG005|Overall Study|Withdrawal by Subject|0|||
155151893|NCT04602390|559992009|FG000|Overall Study|Adverse Event|0|||
155151894|NCT04602390|559992010|FG001|Overall Study|Adverse Event|0|||
155151895|NCT04602390|559992011|FG002|Overall Study|Adverse Event|0|||
155151896|NCT04602390|559992012|FG003|Overall Study|Adverse Event|0|||
155151897|NCT04602390|559992013|FG004|Overall Study|Adverse Event|0|||
155151898|NCT04602390|559992014|FG005|Overall Study|Adverse Event|1|||
155151899|NCT01546857|559992015|FG000|Overall Study|Withdrawal by Subject|2|||
155199097|NCT00599924|560168420|FG004|Overall Study|Withdrawal by Subject|1|||
155199098|NCT00599924|560168421|FG005|Overall Study|Withdrawal by Subject|0|||
155199099|NCT00599924|560168422|FG006|Overall Study|Withdrawal by Subject|0|||
155199100|NCT00599924|560168416|FG000|Overall Study|Other|0|||
155199101|NCT00599924|560168417|FG001|Overall Study|Other|0|||
155199102|NCT00599924|560168418|FG002|Overall Study|Other|0|||
155199103|NCT00599924|560168419|FG003|Overall Study|Other|1|||
155199104|NCT00599924|560168420|FG004|Overall Study|Other|2|||
155199105|NCT00599924|560168421|FG005|Overall Study|Other|0|||
155199106|NCT00599924|560168422|FG006|Overall Study|Other|2|||
155199107|NCT01806298|560168423|FG000|Overall Study|Adverse Event|3|||
155199108|NCT01806298|560168423|FG000|Overall Study|Protocol Non-compliance|1|||
155199109|NCT01806298|560168423|FG000|Overall Study|Withdrawal by Subject|1|||
155199110|NCT01806298|560168423|FG000|Overall Study|Other|5|||
155199111|NCT00592384|560168424|FG000|Overall Study|Withdrawal by Subject|5|||
155199112|NCT00592384|560168425|FG001|Overall Study|Withdrawal by Subject|6|||
155151900|NCT01546857|559992016|FG001|Overall Study|Withdrawal by Subject|3|||
155151901|NCT01176032|559992017|FG000|Overall Study|Adverse Event|1|||
155151902|NCT01176032|559992018|FG001|Overall Study|Adverse Event|0|||
155151903|NCT01176032|559992017|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155151904|NCT01176032|559992018|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155151905|NCT01176032|559992017|FG000|Overall Study|Protocol Violation|1|||
155199113|NCT00590720|560168430|FG000|Overall Study|Lost to Follow-up|1|||
155199114|NCT00590720|560168431|FG001|Overall Study|Lost to Follow-up|0|||
155199115|NCT00590720|560168430|FG000|Overall Study|Withdrawal by Subject|0|||
155199116|NCT00590720|560168431|FG001|Overall Study|Withdrawal by Subject|1|||
155199117|NCT00867568|560168435|FG000|Overall Study|Lack of Efficacy|10|||
155199118|NCT00867568|560168435|FG000|Overall Study|Adverse Event|4|||
155199119|NCT00867568|560168435|FG000|Overall Study|Withdrawal by Subject|1|||
155199120|NCT01056653|560168436|FG000|Overall Study|Lost to Follow-up|0|||
155199121|NCT01056653|560168437|FG001|Overall Study|Lost to Follow-up|0|||
155199122|NCT01056653|560168438|FG002|Overall Study|Lost to Follow-up|2|||
155199123|NCT03639935|560168439|FG000|Overall Study|Death|3|||
155199124|NCT03639935|560168439|FG000|Overall Study|Adverse Event|1|||
155199125|NCT06333613|560168441|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
155199126|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
155199127|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
155199128|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
155199129|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
155199130|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199131|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199132|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199133|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199134|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199135|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199136|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
155199137|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
155199138|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
155199139|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
155199140|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
155199141|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199142|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199143|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199144|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199145|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199146|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199147|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
155199148|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
155199149|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
155199150|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
155199151|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
155199152|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199153|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199154|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199155|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199156|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199157|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199158|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
155199159|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199160|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199161|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199162|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
155199163|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199164|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199165|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199166|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199167|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199168|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199169|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
155199170|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
155199171|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
155199172|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
155199173|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
155199174|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199175|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199176|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199177|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199178|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199179|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199180|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
155199181|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
155199182|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
155199183|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
155199184|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
155199185|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199186|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199187|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199188|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199189|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199190|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199191|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
155199192|NCT01847274|560168442|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
155199193|NCT01847274|560168443|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
155199194|NCT01847274|560168444|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
155199195|NCT01847274|560168445|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
155199196|NCT01847274|560168446|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199197|NCT01847274|560168447|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199198|NCT01847274|560168448|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199199|NCT01847274|560168449|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199200|NCT01847274|560168450|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199201|NCT01847274|560168451|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199202|NCT01847274|560168452|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
155199203|NCT01847274|560168442|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199204|NCT01847274|560168443|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199205|NCT01847274|560168444|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199206|NCT01847274|560168445|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199207|NCT01847274|560168446|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199208|NCT01847274|560168447|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
155199209|NCT01847274|560168448|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199210|NCT01847274|560168449|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199211|NCT01847274|560168450|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199212|NCT01847274|560168451|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199213|NCT01847274|560168452|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
155199214|NCT01847274|560168442|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199215|NCT01847274|560168443|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199216|NCT01847274|560168444|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199217|NCT01847274|560168445|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199218|NCT01847274|560168446|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
155199219|NCT01847274|560168447|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199220|NCT01847274|560168448|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199221|NCT01847274|560168449|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199222|NCT01847274|560168450|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199223|NCT01847274|560168451|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199224|NCT01847274|560168452|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
155199225|NCT01847274|560168442|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199226|NCT01847274|560168443|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199227|NCT01847274|560168444|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199228|NCT01847274|560168445|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199229|NCT01847274|560168446|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199230|NCT01847274|560168447|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199231|NCT01847274|560168448|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
155199232|NCT01847274|560168449|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199233|NCT01847274|560168450|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199234|NCT01847274|560168451|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199235|NCT01847274|560168452|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
155199236|NCT01847274|560168442|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199237|NCT01847274|560168443|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199238|NCT01847274|560168444|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199239|NCT01847274|560168445|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199240|NCT01847274|560168446|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199241|NCT01847274|560168447|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199242|NCT01847274|560168448|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
155199243|NCT01847274|560168449|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199244|NCT01847274|560168450|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199245|NCT01847274|560168451|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199246|NCT01847274|560168452|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
155199247|NCT01847274|560168442|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199248|NCT01847274|560168443|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199249|NCT01847274|560168444|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199250|NCT01847274|560168445|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199251|NCT01847274|560168446|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199252|NCT01847274|560168447|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199253|NCT01847274|560168448|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
155199254|NCT01847274|560168449|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199255|NCT01847274|560168450|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199256|NCT01847274|560168451|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199257|NCT01847274|560168452|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
155199258|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199259|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199260|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199261|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199262|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199263|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199264|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
155199265|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
155199266|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
155199267|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
155199268|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
155199269|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199270|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199271|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199272|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199273|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199274|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199275|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199276|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
155199277|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199278|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
155199279|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
155199280|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199281|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199282|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199283|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199284|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199285|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199286|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199287|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
155199288|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
155199289|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
155199290|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
155199291|NCT01847274|560168442|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199292|NCT01847274|560168443|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199293|NCT01847274|560168444|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199294|NCT01847274|560168445|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199295|NCT01847274|560168446|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199296|NCT01847274|560168447|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199297|NCT01847274|560168448|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199298|NCT01847274|560168449|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199299|NCT01847274|560168450|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199300|NCT01847274|560168451|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
155199301|NCT01847274|560168452|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
155199302|NCT03727230|560168453|FG000|Overall Study|Lost to Follow-up|12|||
155199303|NCT02059395|560168456|FG000|Overall Study|Lost to Follow-up|2|||
155199304|NCT02059395|560168457|FG001|Overall Study|Lost to Follow-up|4|||
155199305|NCT05209360|560168458|FG000|Overall Study|Withdrawal by Subject|0|||
155199306|NCT05209360|560168459|FG001|Overall Study|Withdrawal by Subject|0|||
155199307|NCT05209360|560168460|FG002|Overall Study|Withdrawal by Subject|1|||
155199308|NCT05209360|560168461|FG003|Overall Study|Withdrawal by Subject|0|||
155199309|NCT05209360|560168462|FG004|Overall Study|Withdrawal by Subject|0|||
155199310|NCT05209360|560168463|FG005|Overall Study|Withdrawal by Subject|0|||
155199311|NCT00134082|560168464|FG000|Overall Study|Adverse Event|2|||
155199312|NCT00134082|560168464|FG000|Overall Study|Death|1|||
155199313|NCT00724932|560168467|FG000|Overall Study|Lost to Follow-up|1|||
155199314|NCT00724932|560168468|FG001|Overall Study|Lost to Follow-up|0|||
155199315|NCT00724932|560168467|FG000|Overall Study|Not treated|4|||
155199316|NCT00724932|560168468|FG001|Overall Study|Not treated|3|||
155199317|NCT02849678|560168469|FG000|Overall Study|Protocol Violation|3|||
155199318|NCT02849678|560168470|FG001|Overall Study|Protocol Violation|6|||
155199319|NCT00289991|560168472|FG000|Overall Study|Death|35|||
155199320|NCT00289991|560168473|FG001|Overall Study|Death|38|||
155199321|NCT00289991|560168472|FG000|Overall Study|Adverse Event|15|||
155199322|NCT00289991|560168473|FG001|Overall Study|Adverse Event|13|||
155199323|NCT00289991|560168472|FG000|Overall Study|Failure of prophylaxis|1|||
155199324|NCT00289991|560168473|FG001|Overall Study|Failure of prophylaxis|1|||
155199325|NCT00289991|560168472|FG000|Overall Study|Fungal breakthrough infection|0|||
155199326|NCT00289991|560168473|FG001|Overall Study|Fungal breakthrough infection|1|||
155199327|NCT00289991|560168472|FG000|Overall Study|Lost to Follow-up|0|||
155199328|NCT00289991|560168473|FG001|Overall Study|Lost to Follow-up|1|||
155199329|NCT00289991|560168472|FG000|Overall Study|Withdrawal by Subject|2|||
155199330|NCT00289991|560168473|FG001|Overall Study|Withdrawal by Subject|12|||
155199331|NCT00289991|560168472|FG000|Overall Study|Other|5|||
155199332|NCT00289991|560168473|FG001|Overall Study|Other|14|||
155199333|NCT02340975|560168476|FG000|Overall Study|Death|6|||
155199334|NCT02340975|560168477|FG001|Overall Study|Death|23|||
155199335|NCT02340975|560168478|FG002|Overall Study|Death|21|||
155199336|NCT02340975|560168479|FG003|Overall Study|Death|7|||
155199337|NCT02340975|560168480|FG004|Overall Study|Death|21|||
155199338|NCT02340975|560168481|FG005|Overall Study|Death|13|||
155199339|NCT02340975|560168476|FG000|Overall Study|Lost to Follow-up|0|||
155199340|NCT02340975|560168477|FG001|Overall Study|Lost to Follow-up|0|||
155199341|NCT02340975|560168478|FG002|Overall Study|Lost to Follow-up|0|||
155199342|NCT02340975|560168479|FG003|Overall Study|Lost to Follow-up|0|||
155199343|NCT02340975|560168480|FG004|Overall Study|Lost to Follow-up|2|||
155199344|NCT02340975|560168481|FG005|Overall Study|Lost to Follow-up|0|||
155199345|NCT02340975|560168476|FG000|Overall Study|Withdrawal by Subject|0|||
155199346|NCT02340975|560168477|FG001|Overall Study|Withdrawal by Subject|0|||
155199347|NCT02340975|560168478|FG002|Overall Study|Withdrawal by Subject|3|||
155199348|NCT02340975|560168479|FG003|Overall Study|Withdrawal by Subject|3|||
155199349|NCT02340975|560168480|FG004|Overall Study|Withdrawal by Subject|2|||
155199350|NCT02340975|560168481|FG005|Overall Study|Withdrawal by Subject|0|||
155199351|NCT02340975|560168476|FG000|Overall Study|Other|0|||
155199352|NCT02340975|560168477|FG001|Overall Study|Other|4|||
155199353|NCT02340975|560168478|FG002|Overall Study|Other|0|||
155199354|NCT02340975|560168479|FG003|Overall Study|Other|2|||
155199355|NCT02340975|560168480|FG004|Overall Study|Other|0|||
155199356|NCT02340975|560168481|FG005|Overall Study|Other|6|||
155199357|NCT01007812|560168482|FG000|Period 1, One Week|Lost to Follow-up|0|||
155199358|NCT01007812|560168483|FG001|Period 1, One Week|Lost to Follow-up|1|||
155199359|NCT01007812|560168482|FG000|Period 1, One Week|Discomfort|1|||
155199360|NCT01007812|560168483|FG001|Period 1, One Week|Discomfort|0|||
155199361|NCT01091974|560168484|FG000|Overall Study|Did not start intervention|3|||
155199362|NCT01091974|560168485|FG001|Overall Study|Did not start intervention|1|||
155199363|NCT01091974|560168486|FG002|Overall Study|Did not start intervention|3|||
155199364|NCT01091974|560168487|FG003|Overall Study|Did not start intervention|1|||
155199365|NCT01091974|560168484|FG000|Overall Study|resumed sleep medication|0|||
155199366|NCT01091974|560168485|FG001|Overall Study|resumed sleep medication|0|||
155199367|NCT01091974|560168486|FG002|Overall Study|resumed sleep medication|1|||
155199368|NCT01091974|560168487|FG003|Overall Study|resumed sleep medication|2|||
155199369|NCT01091974|560168484|FG000|Overall Study|Withdrawal by Subject|1|||
155199370|NCT01091974|560168485|FG001|Overall Study|Withdrawal by Subject|3|||
155199371|NCT01091974|560168486|FG002|Overall Study|Withdrawal by Subject|2|||
155199372|NCT01091974|560168487|FG003|Overall Study|Withdrawal by Subject|2|||
155199373|NCT01091974|560168484|FG000|Overall Study|side-effects|1|||
155199374|NCT01091974|560168485|FG001|Overall Study|side-effects|1|||
155199375|NCT01091974|560168486|FG002|Overall Study|side-effects|0|||
155199376|NCT01091974|560168487|FG003|Overall Study|side-effects|2|||
155199377|NCT04891978|560168488|FG000|Baseline|Protocol Violation|2|||
155199378|NCT04891978|560168489|FG001|Baseline|Protocol Violation|1|||
155199379|NCT04891978|560168490|FG002|Baseline|Protocol Violation|0|||
155199380|NCT04891978|560168488|FG000|Baseline|Missing AIRQ|1|||
155199381|NCT04891978|560168489|FG001|Baseline|Missing AIRQ|0|||
155199382|NCT04891978|560168490|FG002|Baseline|Missing AIRQ|0|||
155199383|NCT04891978|560168488|FG000|Baseline|Did not attend a baseline visit|0|||
155199384|NCT04891978|560168489|FG001|Baseline|Did not attend a baseline visit|0|||
155199385|NCT04891978|560168490|FG002|Baseline|Did not attend a baseline visit|9|||
155199386|NCT03948581|560168491|FG000|Overall Study|Lost to Follow-up|0|||
155199387|NCT03948581|560168492|FG001|Overall Study|Lost to Follow-up|1|||
155199388|NCT03068455|560168493|FG000|Pre-treatment Period|Disease progression|0|||
155199389|NCT03068455|560168494|FG001|Pre-treatment Period|Disease progression|1|||
155199390|NCT03068455|560168493|FG000|Pre-treatment Period|Participant withdrew consent|1|||
155199391|NCT03068455|560168494|FG001|Pre-treatment Period|Participant withdrew consent|1|||
155199392|NCT03068455|560168493|FG000|Pre-treatment Period|Poor/non-compliance|0|||
155199393|NCT03068455|560168494|FG001|Pre-treatment Period|Poor/non-compliance|1|||
155199394|NCT03068455|560168493|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
155199395|NCT03068455|560168494|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
155199396|NCT03068455|560168493|FG000|Pre-treatment Period|Not reported|2|||
155199397|NCT03068455|560168494|FG001|Pre-treatment Period|Not reported|1|||
155199398|NCT03068455|560168493|FG000|Treatment Period|Disease progression|166|||
155199399|NCT03068455|560168494|FG001|Treatment Period|Disease progression|208|||
155199400|NCT03068455|560168493|FG000|Treatment Period|Study drug toxicity|317|||
155199401|NCT03068455|560168494|FG001|Treatment Period|Study drug toxicity|104|||
155199402|NCT03068455|560168493|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
155199403|NCT03068455|560168494|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
155199404|NCT03068455|560168493|FG000|Treatment Period|Participant request to stop therapy|33|||
155199405|NCT03068455|560168494|FG001|Treatment Period|Participant request to stop therapy|20|||
155199406|NCT03068455|560168493|FG000|Treatment Period|Participant withdrew consent|5|||
155199407|NCT03068455|560168494|FG001|Treatment Period|Participant withdrew consent|10|||
155199408|NCT03068455|560168493|FG000|Treatment Period|Poor/non-compliance|3|||
155199409|NCT03068455|560168494|FG001|Treatment Period|Poor/non-compliance|0|||
155199410|NCT03068455|560168493|FG000|Treatment Period|Participant no longer meets study criteria|1|||
155199411|NCT03068455|560168494|FG001|Treatment Period|Participant no longer meets study criteria|3|||
155199412|NCT03068455|560168493|FG000|Treatment Period|Other reasons|12|||
155199413|NCT03068455|560168494|FG001|Treatment Period|Other reasons|4|||
155199414|NCT03330288|560168500|FG000|Overall Study|Other reason|1|||
155199415|NCT03330288|560168501|FG001|Overall Study|Other reason|1|||
155199416|NCT03330288|560168500|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
155199417|NCT03330288|560168501|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
155199418|NCT03330288|560168500|FG000|Overall Study|Adverse Event|1|||
155199419|NCT03330288|560168501|FG001|Overall Study|Adverse Event|0|||
155199420|NCT03330288|560168500|FG000|Overall Study|Withdrawal by Subject|1|||
155199421|NCT03330288|560168501|FG001|Overall Study|Withdrawal by Subject|0|||
155199422|NCT03330288|560168500|FG000|Overall Study|Lost to Follow-up|26|||
155199423|NCT03330288|560168501|FG001|Overall Study|Lost to Follow-up|7|||
155199424|NCT01235689|560168510|FG000|Overall Study|Adverse Event|12|||
155199425|NCT01235689|560168511|FG001|Overall Study|Adverse Event|16|||
155199426|NCT01235689|560168510|FG000|Overall Study|Lack of Efficacy|12|||
155199427|NCT01235689|560168511|FG001|Overall Study|Lack of Efficacy|5|||
155199428|NCT01235689|560168510|FG000|Overall Study|Withdrawal by Subject|3|||
155199429|NCT01235689|560168511|FG001|Overall Study|Withdrawal by Subject|4|||
155199430|NCT01235689|560168510|FG000|Overall Study|Lost to Follow-up|1|||
155199431|NCT01235689|560168511|FG001|Overall Study|Lost to Follow-up|2|||
155199432|NCT01235689|560168510|FG000|Overall Study|Miscellaneous|1|||
155199433|NCT01235689|560168511|FG001|Overall Study|Miscellaneous|5|||
155199434|NCT02217878|560168516|FG000|Overall Study|required morphine due to chest pain|1|||
155199435|NCT02217878|560168517|FG001|Overall Study|required morphine due to chest pain|2|||
155199436|NCT02217878|560168516|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
155199437|NCT02217878|560168517|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
155199438|NCT01390649|560168518|FG000|Overall Study|Physician Decision|1|||
155199439|NCT00389597|560168519|FG000|Overall Study|Lost to Follow-up|8|||
155199440|NCT00389597|560168520|FG001|Overall Study|Lost to Follow-up|6|||
155199441|NCT00389597|560168521|FG002|Overall Study|Lost to Follow-up|4|||
155199442|NCT00389597|560168522|FG003|Overall Study|Lost to Follow-up|6|||
155199443|NCT00005044|560168523|FG000|Overall Study|Protocol Violation|37|||
155199444|NCT00005044|560168524|FG001|Overall Study|Protocol Violation|46|||
155199445|NCT00005044|560168523|FG000|Overall Study|Withdrawal by Subject|1|||
155199446|NCT00005044|560168524|FG001|Overall Study|Withdrawal by Subject|5|||
155199447|NCT00005044|560168523|FG000|Overall Study|No protocol treatment|0|||
155199448|NCT00005044|560168524|FG001|Overall Study|No protocol treatment|1|||
155199449|NCT00181155|560168525|FG000|Overall Study|Physician Decision|1|||
155199450|NCT00181155|560168526|FG001|Overall Study|Physician Decision|0|||
155199451|NCT00181155|560168525|FG000|Overall Study|Withdrawal by Subject|1|||
155199452|NCT00181155|560168526|FG001|Overall Study|Withdrawal by Subject|0|||
155199453|NCT02572401|560168527|FG000|Overall Study|Lost to Follow-up|5|||
155199454|NCT02572401|560168528|FG001|Overall Study|Lost to Follow-up|8|||
155199455|NCT02572401|560168529|FG002|Overall Study|Lost to Follow-up|9|||
155199456|NCT02572401|560168530|FG003|Overall Study|Lost to Follow-up|9|||
155199457|NCT02572401|560168527|FG000|Overall Study|Death|0|||
155199458|NCT02572401|560168528|FG001|Overall Study|Death|0|||
155199459|NCT02572401|560168529|FG002|Overall Study|Death|0|||
155199460|NCT02572401|560168530|FG003|Overall Study|Death|1|||
155199461|NCT01548287|560168531|FG000|Screening|No reason provided|0|||
155199462|NCT01548287|560168532|FG001|Screening|No reason provided|0|||
155199463|NCT01548287|560168533|FG002|Screening|No reason provided|0|||
155199464|NCT01548287|560168534|FG003|Screening|No reason provided|0|||
155199465|NCT01548287|560168535|FG004|Screening|No reason provided|9|||
155199466|NCT01548287|560168531|FG000|Screening|Did not meet eligibility criteria|0|||
155199467|NCT01548287|560168532|FG001|Screening|Did not meet eligibility criteria|0|||
155199468|NCT01548287|560168533|FG002|Screening|Did not meet eligibility criteria|0|||
155199469|NCT01548287|560168534|FG003|Screening|Did not meet eligibility criteria|0|||
155199470|NCT01548287|560168535|FG004|Screening|Did not meet eligibility criteria|74|||
155199471|NCT01548287|560168531|FG000|Randomized Period|Did not meet inclusion criteria|0|||
155199472|NCT01548287|560168532|FG001|Randomized Period|Did not meet inclusion criteria|0|||
155199473|NCT01548287|560168533|FG002|Randomized Period|Did not meet inclusion criteria|2|||
155199474|NCT01548287|560168534|FG003|Randomized Period|Did not meet inclusion criteria|0|||
155199475|NCT01548287|560168535|FG004|Randomized Period|Did not meet inclusion criteria|0|||
155199476|NCT01548287|560168531|FG000|Randomized Period|Adverse Event|0|||
155199477|NCT01548287|560168532|FG001|Randomized Period|Adverse Event|2|||
155199478|NCT01548287|560168533|FG002|Randomized Period|Adverse Event|5|||
155199479|NCT01548287|560168534|FG003|Randomized Period|Adverse Event|0|||
155199480|NCT01548287|560168535|FG004|Randomized Period|Adverse Event|0|||
155199481|NCT01768286|560168540|FG000|Overall Study|Randomized But Not Treated|0|||
155199482|NCT01768286|560168541|FG001|Overall Study|Randomized But Not Treated|0|||
155199483|NCT01768286|560168542|FG002|Overall Study|Randomized But Not Treated|1|||
155199484|NCT01768286|560168543|FG003|Overall Study|Randomized But Not Treated|0|||
155199485|NCT01768286|560168540|FG000|Overall Study|Lack of Efficacy|7|||
155199486|NCT01768286|560168541|FG001|Overall Study|Lack of Efficacy|4|||
155199487|NCT01768286|560168542|FG002|Overall Study|Lack of Efficacy|0|||
155199488|NCT01768286|560168543|FG003|Overall Study|Lack of Efficacy|1|||
155199489|NCT01768286|560168540|FG000|Overall Study|Withdrew Consent|0|||
155199490|NCT01768286|560168541|FG001|Overall Study|Withdrew Consent|0|||
155199491|NCT01768286|560168542|FG002|Overall Study|Withdrew Consent|1|||
155199492|NCT01768286|560168543|FG003|Overall Study|Withdrew Consent|0|||
155199493|NCT02083965|560168544|FG000|Treatment Period|Other|1|||
155199494|NCT02083965|560168545|FG001|Treatment Period|Other|0|||
155199495|NCT00868608|560168547|FG000|Overall Study|Withdrawal by Subject|3|||
155199496|NCT00868608|560168548|FG001|Overall Study|Withdrawal by Subject|1|||
155199497|NCT00868608|560168549|FG002|Overall Study|Withdrawal by Subject|0|||
155199498|NCT00868608|560168547|FG000|Overall Study|Lost to Follow-up|3|||
155199499|NCT00868608|560168548|FG001|Overall Study|Lost to Follow-up|0|||
155199500|NCT00868608|560168549|FG002|Overall Study|Lost to Follow-up|1|||
155199501|NCT00868608|560168547|FG000|Overall Study|Death|16|||
155151906|NCT01176032|559992018|FG001|Overall Study|Protocol Violation|0|||
155151907|NCT01176032|559992017|FG000|Overall Study|Informed consent withdrawn|3|||
155151908|NCT01176032|559992018|FG001|Overall Study|Informed consent withdrawn|0|||
155151909|NCT01176032|559992017|FG000|Overall Study|Other|1|||
155151910|NCT01176032|559992018|FG001|Overall Study|Other|0|||
155151911|NCT01277744|559992026|FG000|Overall Study|Physician Decision|2|||
155151912|NCT02358473|559992027|FG000|Overall Study|Disease Progession|6|||
155151913|NCT02358473|559992027|FG000|Overall Study|Adverse Event|3|||
155151914|NCT02358473|559992027|FG000|Overall Study|Withdrawal by Subject|2|||
155151915|NCT02358473|559992027|FG000|Overall Study|Physician Decision|2|||
155151916|NCT04038359|559992031|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
155151917|NCT04038359|559992032|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
155151918|NCT04038359|559992031|FG000|Overall Study|Death|8|||
155151919|NCT04038359|559992032|FG001|Overall Study|Death|7|||
155151920|NCT04038359|559992031|FG000|Overall Study|Lost to Follow-up|3|||
155151921|NCT04038359|559992032|FG001|Overall Study|Lost to Follow-up|0|||
155151922|NCT04038359|559992031|FG000|Overall Study|Participant Moved|1|||
155151923|NCT04038359|559992032|FG001|Overall Study|Participant Moved|0|||
155151924|NCT04038359|559992031|FG000|Overall Study|Withdrawal by Subject|4|||
155151925|NCT04038359|559992032|FG001|Overall Study|Withdrawal by Subject|3|||
155151926|NCT04038359|559992031|FG000|Overall Study|Physician Decision|3|||
155151927|NCT04038359|559992032|FG001|Overall Study|Physician Decision|2|||
155151928|NCT04038359|559992031|FG000|Overall Study|Adverse Event|0|||
155151929|NCT04038359|559992032|FG001|Overall Study|Adverse Event|2|||
155151930|NCT04038359|559992031|FG000|Overall Study|Progressive Disease|0|||
155151931|NCT04038359|559992032|FG001|Overall Study|Progressive Disease|1|||
155151932|NCT00475670|559992033|FG000|Overall Study|Death|0|||
155151933|NCT00475670|559992034|FG001|Overall Study|Death|1|||
155151934|NCT00475670|559992033|FG000|Overall Study|Lack of Efficacy|3|||
155151935|NCT00475670|559992034|FG001|Overall Study|Lack of Efficacy|34|||
155151936|NCT00475670|559992033|FG000|Overall Study|Refused treatment|0|||
155151937|NCT00475670|559992034|FG001|Overall Study|Refused treatment|2|||
155199502|NCT00868608|560168548|FG001|Overall Study|Death|2|||
155199503|NCT00868608|560168549|FG002|Overall Study|Death|4|||
155151938|NCT00475670|559992033|FG000|Overall Study|Failure to Return|0|||
155199504|NCT00868608|560168547|FG000|Overall Study|Other - Unspecified|1|||
155199505|NCT00868608|560168548|FG001|Overall Study|Other - Unspecified|0|||
155199506|NCT00868608|560168549|FG002|Overall Study|Other - Unspecified|0|||
155199507|NCT00674362|560168551|FG000|Double Blind|Adverse Event|6|||
155199508|NCT00674362|560168552|FG001|Double Blind|Adverse Event|6|||
155151939|NCT00475670|559992034|FG001|Overall Study|Failure to Return|1|||
155151940|NCT00475670|559992033|FG000|Overall Study|Other|0|||
155151941|NCT00475670|559992034|FG001|Overall Study|Other|3|||
155151942|NCT02004236|559992035|FG000|Overall Study|Lack of Efficacy|0|||
155151943|NCT02004236|559992036|FG001|Overall Study|Lack of Efficacy|0|||
155199509|NCT00674362|560168551|FG000|Double Blind|Lack of Efficacy|2|||
155199510|NCT00674362|560168552|FG001|Double Blind|Lack of Efficacy|6|||
155199511|NCT00674362|560168551|FG000|Double Blind|Loss of efficacy|0|||
155199512|NCT00674362|560168552|FG001|Double Blind|Loss of efficacy|1|||
155199513|NCT00674362|560168551|FG000|Double Blind|Withdrawal by Subject|4|||
155199514|NCT00674362|560168552|FG001|Double Blind|Withdrawal by Subject|3|||
155199515|NCT00674362|560168551|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
155199516|NCT00674362|560168552|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
155199517|NCT00674362|560168551|FG000|Double Blind|Other: Surgery|0|||
155199518|NCT00674362|560168552|FG001|Double Blind|Other: Surgery|1|||
155199519|NCT00674362|560168551|FG000|Open Label|Adverse Event|1|||
155199520|NCT00674362|560168552|FG001|Open Label|Adverse Event|0|||
155199521|NCT00674362|560168551|FG000|Open Label|Other: Subject moved to extension study|1|||
155199522|NCT00674362|560168552|FG001|Open Label|Other: Subject moved to extension study|0|||
155199523|NCT00939770|560168555|FG000|Overall Study|Adverse Event|1|||
155199524|NCT00939770|560168556|FG001|Overall Study|Adverse Event|1|||
155199525|NCT00939770|560168557|FG002|Overall Study|Adverse Event|0|||
155199526|NCT00939770|560168558|FG003|Overall Study|Adverse Event|0|||
155199527|NCT00939770|560168559|FG004|Overall Study|Adverse Event|6|||
155199528|NCT00939770|560168560|FG005|Overall Study|Adverse Event|2|||
155199529|NCT00939770|560168561|FG006|Overall Study|Adverse Event|1|||
155199530|NCT00939770|560168562|FG007|Overall Study|Adverse Event|1|||
155199531|NCT00939770|560168555|FG000|Overall Study|Lack of Efficacy|4|||
155199532|NCT00939770|560168556|FG001|Overall Study|Lack of Efficacy|6|||
155199533|NCT00939770|560168557|FG002|Overall Study|Lack of Efficacy|13|||
155199534|NCT00939770|560168558|FG003|Overall Study|Lack of Efficacy|9|||
155199535|NCT00939770|560168559|FG004|Overall Study|Lack of Efficacy|16|||
155199536|NCT00939770|560168560|FG005|Overall Study|Lack of Efficacy|8|||
155199537|NCT00939770|560168561|FG006|Overall Study|Lack of Efficacy|11|||
155199538|NCT00939770|560168562|FG007|Overall Study|Lack of Efficacy|1|||
155199539|NCT00939770|560168555|FG000|Overall Study|Lost to Follow-up|0|||
155199540|NCT00939770|560168556|FG001|Overall Study|Lost to Follow-up|0|||
155199541|NCT00939770|560168557|FG002|Overall Study|Lost to Follow-up|0|||
155199542|NCT00939770|560168558|FG003|Overall Study|Lost to Follow-up|0|||
155199543|NCT00939770|560168559|FG004|Overall Study|Lost to Follow-up|1|||
155199544|NCT00939770|560168560|FG005|Overall Study|Lost to Follow-up|0|||
155199545|NCT00939770|560168561|FG006|Overall Study|Lost to Follow-up|0|||
155199546|NCT00939770|560168562|FG007|Overall Study|Lost to Follow-up|0|||
155199547|NCT00939770|560168555|FG000|Overall Study|Physician Decision|0|||
155199548|NCT00939770|560168556|FG001|Overall Study|Physician Decision|0|||
155199549|NCT00939770|560168557|FG002|Overall Study|Physician Decision|2|||
155199550|NCT00939770|560168558|FG003|Overall Study|Physician Decision|0|||
155199551|NCT00939770|560168559|FG004|Overall Study|Physician Decision|7|||
155199552|NCT00939770|560168560|FG005|Overall Study|Physician Decision|1|||
155199553|NCT00939770|560168561|FG006|Overall Study|Physician Decision|0|||
155199554|NCT00939770|560168562|FG007|Overall Study|Physician Decision|6|||
155199555|NCT00939770|560168555|FG000|Overall Study|Protocol Violation|0|||
155199556|NCT00939770|560168556|FG001|Overall Study|Protocol Violation|0|||
155199557|NCT00939770|560168557|FG002|Overall Study|Protocol Violation|0|||
155199558|NCT00939770|560168558|FG003|Overall Study|Protocol Violation|0|||
155199559|NCT00939770|560168559|FG004|Overall Study|Protocol Violation|1|||
155199560|NCT00939770|560168560|FG005|Overall Study|Protocol Violation|0|||
155199561|NCT00939770|560168561|FG006|Overall Study|Protocol Violation|0|||
155199562|NCT00939770|560168562|FG007|Overall Study|Protocol Violation|0|||
155199563|NCT00939770|560168555|FG000|Overall Study|Withdrawal by Subject|0|||
155199564|NCT00939770|560168556|FG001|Overall Study|Withdrawal by Subject|1|||
155199565|NCT00939770|560168557|FG002|Overall Study|Withdrawal by Subject|5|||
155199566|NCT00939770|560168558|FG003|Overall Study|Withdrawal by Subject|2|||
155199567|NCT00939770|560168559|FG004|Overall Study|Withdrawal by Subject|6|||
155199568|NCT00939770|560168560|FG005|Overall Study|Withdrawal by Subject|0|||
155199569|NCT00939770|560168561|FG006|Overall Study|Withdrawal by Subject|2|||
155199570|NCT00939770|560168562|FG007|Overall Study|Withdrawal by Subject|2|||
155199571|NCT04066023|560168563|FG000|Overall Study|Adverse Event|0|||
155199572|NCT04066023|560168564|FG001|Overall Study|Adverse Event|0|||
155199573|NCT04066023|560168565|FG002|Overall Study|Adverse Event|1|||
155199574|NCT04066023|560168563|FG000|Overall Study|Sponsor decision|3|||
155199575|NCT04066023|560168564|FG001|Overall Study|Sponsor decision|6|||
155199576|NCT04066023|560168565|FG002|Overall Study|Sponsor decision|2|||
155199577|NCT04066023|560168563|FG000|Overall Study|Physician Decision|0|||
155199578|NCT04066023|560168564|FG001|Overall Study|Physician Decision|0|||
155199579|NCT04066023|560168565|FG002|Overall Study|Physician Decision|1|||
155199580|NCT04066023|560168563|FG000|Overall Study|Lost to Follow-up|0|||
155199581|NCT04066023|560168564|FG001|Overall Study|Lost to Follow-up|1|||
155199582|NCT04066023|560168565|FG002|Overall Study|Lost to Follow-up|1|||
155199583|NCT04066023|560168563|FG000|Overall Study|Noncompliance|0|||
155199584|NCT04066023|560168564|FG001|Overall Study|Noncompliance|1|||
155199585|NCT04066023|560168565|FG002|Overall Study|Noncompliance|1|||
155199586|NCT04665856|560168566|FG000|Overall Study|Site Terminated by Sponsor|1|||
155199587|NCT04665856|560168567|FG001|Overall Study|Site Terminated by Sponsor|0|||
155199588|NCT04665856|560168566|FG000|Overall Study|Withdrawal by Subject|2|||
155199589|NCT04665856|560168567|FG001|Overall Study|Withdrawal by Subject|0|||
155151944|NCT02004236|559992037|FG002|Overall Study|Lack of Efficacy|16|||
155151945|NCT01650558|559992039|FG000|Overall Study|Migration out of study area|61|||
155151946|NCT01650558|559992040|FG001|Overall Study|Migration out of study area|71|||
155151947|NCT01650558|559992041|FG002|Overall Study|Migration out of study area|56|||
155151948|NCT01650558|559992039|FG000|Overall Study|Lost to Follow-up|10|||
155151949|NCT01650558|559992040|FG001|Overall Study|Lost to Follow-up|13|||
155151950|NCT01650558|559992041|FG002|Overall Study|Lost to Follow-up|6|||
155151951|NCT01650558|559992039|FG000|Overall Study|Death|10|||
155151952|NCT01650558|559992040|FG001|Overall Study|Death|6|||
155151953|NCT01650558|559992041|FG002|Overall Study|Death|8|||
155151954|NCT01650558|559992039|FG000|Overall Study|Withdrawal by Subject|1|||
155151955|NCT01650558|559992040|FG001|Overall Study|Withdrawal by Subject|1|||
155151956|NCT01650558|559992041|FG002|Overall Study|Withdrawal by Subject|3|||
155151957|NCT01650558|559992039|FG000|Overall Study|Non-compliant participant|1|||
155151958|NCT01650558|559992040|FG001|Overall Study|Non-compliant participant|0|||
155151959|NCT01650558|559992041|FG002|Overall Study|Non-compliant participant|2|||
155151960|NCT01650558|559992039|FG000|Overall Study|Physician Decision|0|||
155151961|NCT01650558|559992040|FG001|Overall Study|Physician Decision|1|||
155151962|NCT01650558|559992041|FG002|Overall Study|Physician Decision|0|||
155151963|NCT02960217|559992042|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
155151964|NCT02960217|559992043|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
155151965|NCT02960217|559992042|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
155151966|NCT02960217|559992043|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
155151967|NCT02960217|559992042|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
155151968|NCT02960217|559992043|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
155151969|NCT02960217|559992042|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
155151970|NCT02960217|559992043|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
155151971|NCT02960217|559992042|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
155151972|NCT02960217|559992043|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
155151973|NCT02960217|559992042|FG000|Open-Label Extension Phase|Adverse Event|1|||
155151974|NCT02960217|559992043|FG001|Open-Label Extension Phase|Adverse Event|0|||
155151975|NCT02960217|559992042|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
155151976|NCT02960217|559992043|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
155151977|NCT02960217|559992042|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
155151978|NCT02960217|559992043|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
155151979|NCT02960217|559992042|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
155151980|NCT02960217|559992043|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
155151981|NCT00918385|559992044|FG000|Monotherapy|Adverse Event|1|||
155151982|NCT00918385|559992045|FG001|Monotherapy|Adverse Event|6|||
155151983|NCT00918385|559992044|FG000|Monotherapy|Complicating illness|1|||
155151984|NCT00918385|559992045|FG001|Monotherapy|Complicating illness|0|||
155151985|NCT00918385|559992044|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
155151986|NCT00918385|559992045|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
155151987|NCT00918385|559992044|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
155151988|NCT00918385|559992045|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
155151989|NCT00918385|559992044|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
155151990|NCT00918385|559992045|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
155151991|NCT00918385|559992044|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
155151992|NCT00918385|559992045|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
155151993|NCT01476722|559992047|FG000|Overall Study|Adverse Event|1|||
155151994|NCT00625131|559992053|FG000|Overall Study|Lost to Follow-up|3|||
155151995|NCT00625131|559992054|FG001|Overall Study|Lost to Follow-up|2|||
155151996|NCT00625131|559992055|FG002|Overall Study|Lost to Follow-up|0|||
155151997|NCT00625131|559992053|FG000|Overall Study|Withdrawal by Subject|1|||
155151998|NCT00625131|559992054|FG001|Overall Study|Withdrawal by Subject|0|||
155151999|NCT00625131|559992055|FG002|Overall Study|Withdrawal by Subject|5|||
155152000|NCT00918281|559992058|FG000|Overall Study|Physician Decision|29|||
155152001|NCT02978417|559992061|FG000|Overall Study|Lost to Follow-up|2|||
155152002|NCT02978417|559992062|FG001|Overall Study|Lost to Follow-up|2|||
155152003|NCT03416868|559992065|FG000|Overall Study|Withdrawal by Subject|2|||
155152004|NCT03416868|559992065|FG000|Overall Study|Lost to Follow-up|1|||
155152005|NCT03624881|559992066|FG000|Overall Study|Screen Failure|14|||
155152006|NCT03624881|559992067|FG001|Overall Study|Screen Failure|0|||
155152007|NCT03624881|559992066|FG000|Overall Study|No Catheter Inserted|6|||
155152008|NCT03624881|559992067|FG001|Overall Study|No Catheter Inserted|1|||
155152009|NCT03624881|559992066|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
155152010|NCT03624881|559992067|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
155152011|NCT03624881|559992066|FG000|Overall Study|Death|2|||
155152012|NCT03624881|559992067|FG001|Overall Study|Death|0|||
155152013|NCT03624881|559992066|FG000|Overall Study|Lost to Follow-up|10|||
155152014|NCT03624881|559992067|FG001|Overall Study|Lost to Follow-up|4|||
155199590|NCT04665856|560168566|FG000|Overall Study|Lost to Follow-up|3|||
155152015|NCT03624881|559992066|FG000|Overall Study|Withdrawal by Subject|12|||
155152016|NCT03624881|559992067|FG001|Overall Study|Withdrawal by Subject|1|||
155152017|NCT00168844|559992068|FG000|Overall Study|Adverse Event|31|||
155152018|NCT00168844|559992069|FG001|Overall Study|Adverse Event|32|||
155152019|NCT00168844|559992070|FG002|Overall Study|Adverse Event|48|||
155152020|NCT00168844|559992068|FG000|Overall Study|Lost to Follow-up|4|||
155152021|NCT00168844|559992069|FG001|Overall Study|Lost to Follow-up|5|||
155152022|NCT00168844|559992070|FG002|Overall Study|Lost to Follow-up|11|||
155152023|NCT00168844|559992068|FG000|Overall Study|Withdrawal by Subject|12|||
155152024|NCT00168844|559992069|FG001|Overall Study|Withdrawal by Subject|9|||
155152025|NCT00168844|559992070|FG002|Overall Study|Withdrawal by Subject|19|||
155152026|NCT00168844|559992068|FG000|Overall Study|Protocol Violation|2|||
155152027|NCT00168844|559992069|FG001|Overall Study|Protocol Violation|2|||
155152028|NCT00168844|559992070|FG002|Overall Study|Protocol Violation|4|||
155152029|NCT00168844|559992068|FG000|Overall Study|Other|6|||
155152030|NCT00168844|559992069|FG001|Overall Study|Other|7|||
155152031|NCT00168844|559992070|FG002|Overall Study|Other|9|||
155152032|NCT03309020|559992071|FG000|Overall Study|Death|1|||
155152033|NCT03309020|559992072|FG001|Overall Study|Death|0|||
155152034|NCT03309020|559992071|FG000|Overall Study|Did not undergo surgery|2|||
155152035|NCT03309020|559992072|FG001|Overall Study|Did not undergo surgery|1|||
155152036|NCT00601835|559992076|FG000|Overall Study|Withdrawal by Subject|9|||
155152037|NCT00601835|559992077|FG001|Overall Study|Withdrawal by Subject|6|||
155152038|NCT00601835|559992076|FG000|Overall Study|Physician Decision|1|||
155152039|NCT00601835|559992077|FG001|Overall Study|Physician Decision|0|||
155152040|NCT00601835|559992076|FG000|Overall Study|Lost to Follow-up|37|||
155152041|NCT00601835|559992077|FG001|Overall Study|Lost to Follow-up|5|||
155152042|NCT00601835|559992076|FG000|Overall Study|Adverse Event|1|||
155152043|NCT00601835|559992077|FG001|Overall Study|Adverse Event|1|||
155152044|NCT00601835|559992076|FG000|Overall Study|Relocate|12|||
155152045|NCT00601835|559992077|FG001|Overall Study|Relocate|2|||
155152046|NCT00880620|559992078|FG000|Overall Study|Adverse Event|4|||
155152047|NCT00880620|559992079|FG001|Overall Study|Adverse Event|5|||
155152048|NCT00880620|559992080|FG002|Overall Study|Adverse Event|15|||
155152049|NCT00880620|559992081|FG003|Overall Study|Adverse Event|15|||
155152050|NCT00880620|559992078|FG000|Overall Study|Death|0|||
155152051|NCT00880620|559992079|FG001|Overall Study|Death|0|||
155152052|NCT00880620|559992080|FG002|Overall Study|Death|1|||
155152053|NCT00880620|559992081|FG003|Overall Study|Death|0|||
155152054|NCT00880620|559992078|FG000|Overall Study|Lack of Efficacy|12|||
155152055|NCT00880620|559992079|FG001|Overall Study|Lack of Efficacy|4|||
155152056|NCT00880620|559992080|FG002|Overall Study|Lack of Efficacy|0|||
155152057|NCT00880620|559992081|FG003|Overall Study|Lack of Efficacy|1|||
155152058|NCT00880620|559992078|FG000|Overall Study|Lost to Follow-up|0|||
155152059|NCT00880620|559992079|FG001|Overall Study|Lost to Follow-up|1|||
155152060|NCT00880620|559992080|FG002|Overall Study|Lost to Follow-up|1|||
155152061|NCT00880620|559992081|FG003|Overall Study|Lost to Follow-up|0|||
155152062|NCT00880620|559992078|FG000|Overall Study|Protocol Violation|0|||
155152063|NCT00880620|559992079|FG001|Overall Study|Protocol Violation|1|||
155152064|NCT00880620|559992080|FG002|Overall Study|Protocol Violation|0|||
155152065|NCT00880620|559992081|FG003|Overall Study|Protocol Violation|2|||
155152066|NCT00880620|559992078|FG000|Overall Study|Withdrawal by Subject|4|||
155152067|NCT00880620|559992079|FG001|Overall Study|Withdrawal by Subject|3|||
155152068|NCT00880620|559992080|FG002|Overall Study|Withdrawal by Subject|1|||
155152069|NCT00880620|559992081|FG003|Overall Study|Withdrawal by Subject|3|||
155152070|NCT00880620|559992078|FG000|Overall Study|Noncompliance|0|||
155152071|NCT00880620|559992079|FG001|Overall Study|Noncompliance|0|||
155152072|NCT00880620|559992080|FG002|Overall Study|Noncompliance|1|||
155152073|NCT00880620|559992081|FG003|Overall Study|Noncompliance|1|||
155152074|NCT00880620|559992078|FG000|Overall Study|Other|1|||
155152075|NCT00880620|559992079|FG001|Overall Study|Other|1|||
155152076|NCT00880620|559992080|FG002|Overall Study|Other|2|||
155152077|NCT00880620|559992081|FG003|Overall Study|Other|2|||
155152078|NCT00880698|559992084|FG000|Overall Study|Death|0|||
155152079|NCT00880698|559992085|FG001|Overall Study|Death|0|||
155152080|NCT00880698|559992086|FG002|Overall Study|Death|1|||
155152081|NCT00880698|559992087|FG003|Overall Study|Death|2|||
155152082|NCT00880698|559992084|FG000|Overall Study|Lost to Follow-up|1|||
155152083|NCT00880698|559992085|FG001|Overall Study|Lost to Follow-up|3|||
155152084|NCT00880698|559992086|FG002|Overall Study|Lost to Follow-up|0|||
155152085|NCT00880698|559992087|FG003|Overall Study|Lost to Follow-up|1|||
155152086|NCT04972162|559992090|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
155152087|NCT04972162|559992091|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
155199591|NCT04665856|560168567|FG001|Overall Study|Lost to Follow-up|2|||
155199592|NCT04665856|560168566|FG000|Overall Study|Death|39|||
155199593|NCT04665856|560168567|FG001|Overall Study|Death|44|||
155199594|NCT04665856|560168566|FG000|Overall Study|Ongoing in study|17|||
155199595|NCT04665856|560168567|FG001|Overall Study|Ongoing in study|15|||
155199596|NCT03386448|560168568|FG000|Overall Study|Adverse Event|0|||
155199597|NCT03386448|560168569|FG001|Overall Study|Adverse Event|2|||
155199598|NCT03338010|560168570|FG000|Overall Study|Withdrawal by Subject|14|||
155199599|NCT03338010|560168571|FG001|Overall Study|Withdrawal by Subject|8|||
155199600|NCT03338010|560168570|FG000|Overall Study|Lost to Follow-up|4|||
155199601|NCT03338010|560168571|FG001|Overall Study|Lost to Follow-up|2|||
155199602|NCT03338010|560168570|FG000|Overall Study|Adverse Event|3|||
155199603|NCT03338010|560168571|FG001|Overall Study|Adverse Event|2|||
155199604|NCT03338010|560168570|FG000|Overall Study|Physician Decision|2|||
155199605|NCT03338010|560168571|FG001|Overall Study|Physician Decision|2|||
155199606|NCT03338010|560168570|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155199607|NCT03338010|560168571|FG001|Overall Study|Non-Compliance with Study Drug|3|||
155199608|NCT03338010|560168570|FG000|Overall Study|Protocol Violation|0|||
155199609|NCT03338010|560168571|FG001|Overall Study|Protocol Violation|1|||
155199610|NCT01146665|560168572|FG000|Overall Study|Withdrawal by Subject|10|||
155199611|NCT01146665|560168573|FG001|Overall Study|Withdrawal by Subject|16|||
155199612|NCT02538029|560168575|FG000|Overall Study|unable to complete cognitive assessments|1|||
155199613|NCT02538029|560168576|FG001|Overall Study|unable to complete cognitive assessments|0|||
155199614|NCT02538029|560168577|FG002|Overall Study|unable to complete cognitive assessments|1|||
155199615|NCT00481078|560168581|FG000|Overall Study|Progression of disease|11|||
155199616|NCT00481078|560168582|FG001|Overall Study|Progression of disease|11|||
155199617|NCT00481078|560168581|FG000|Overall Study|Adverse Event|15|||
155199618|NCT00481078|560168582|FG001|Overall Study|Adverse Event|3|||
155199619|NCT00481078|560168581|FG000|Overall Study|Death|5|||
155199620|NCT00481078|560168582|FG001|Overall Study|Death|3|||
155199621|NCT00481078|560168581|FG000|Overall Study|Intercurrent illness|1|||
155199622|NCT00481078|560168582|FG001|Overall Study|Intercurrent illness|0|||
155199623|NCT00481078|560168581|FG000|Overall Study|Withdrawal by Subject|7|||
155199624|NCT00481078|560168582|FG001|Overall Study|Withdrawal by Subject|1|||
155199625|NCT00481078|560168581|FG000|Overall Study|Information not available|1|||
155199626|NCT00481078|560168582|FG001|Overall Study|Information not available|0|||
155199627|NCT00481078|560168581|FG000|Overall Study|Received other treatment|2|||
155199628|NCT00481078|560168582|FG001|Overall Study|Received other treatment|1|||
155199629|NCT00481078|560168581|FG000|Overall Study|Brain metastasis|0|||
155199630|NCT00481078|560168582|FG001|Overall Study|Brain metastasis|1|||
155199631|NCT03192462|560170432|FG000|Overall Study|Death|13|||
155199632|NCT03192462|560170433|FG001|Overall Study|Death|11|||
155199633|NCT03192462|560170434|FG002|Overall Study|Death|10|||
155199634|NCT03192462|560170432|FG000|Overall Study|Lost to Follow-up|0|||
155199635|NCT03192462|560170433|FG001|Overall Study|Lost to Follow-up|1|||
155199636|NCT03192462|560170434|FG002|Overall Study|Lost to Follow-up|0|||
155199637|NCT02200211|560170438|FG000|Overall Study|Lost to Follow-up|7|||
155199638|NCT02200211|560170439|FG001|Overall Study|Lost to Follow-up|7|||
155199639|NCT02200211|560170440|FG002|Overall Study|Lost to Follow-up|1|||
155199640|NCT02200211|560170441|FG003|Overall Study|Lost to Follow-up|2|||
155199641|NCT02200211|560170438|FG000|Overall Study|Withdrawal by Subject|1|||
155199642|NCT02200211|560170439|FG001|Overall Study|Withdrawal by Subject|0|||
155199643|NCT02200211|560170440|FG002|Overall Study|Withdrawal by Subject|0|||
155199644|NCT02200211|560170441|FG003|Overall Study|Withdrawal by Subject|0|||
155199645|NCT00381485|560170442|FG000|Open-Label Run-In Period|Adverse Event|9|||
155199646|NCT00381485|560170443|FG001|Open-Label Run-In Period|Adverse Event|0|||
155199647|NCT00381485|560170444|FG002|Open-Label Run-In Period|Adverse Event|0|||
155199648|NCT00381485|560170445|FG003|Open-Label Run-In Period|Adverse Event|0|||
155199649|NCT00381485|560170442|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
155199650|NCT00381485|560170443|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
155199651|NCT00381485|560170444|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
155199652|NCT00381485|560170445|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
155199653|NCT00381485|560170442|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
155199654|NCT00381485|560170443|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
155199655|NCT00381485|560170444|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
155199656|NCT00381485|560170445|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
155199657|NCT00381485|560170442|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
155199658|NCT00381485|560170443|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
155199659|NCT00381485|560170444|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
155199660|NCT00381485|560170445|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
155199661|NCT00381485|560170442|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
155199662|NCT00381485|560170443|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
155199663|NCT00381485|560170444|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
155199664|NCT00381485|560170445|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
155199665|NCT00381485|560170442|FG000|Open-Label Run-In Period|Treatment failure|1|||
155199666|NCT00381485|560170443|FG001|Open-Label Run-In Period|Treatment failure|0|||
155199667|NCT00381485|560170444|FG002|Open-Label Run-In Period|Treatment failure|0|||
155199668|NCT00381485|560170445|FG003|Open-Label Run-In Period|Treatment failure|0|||
155199669|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155199670|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Adverse Event|2|||
155199671|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Adverse Event|2|||
155199672|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Adverse Event|5|||
155199673|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
155199674|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
155199675|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
155199676|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
155199677|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155199678|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
155199679|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
155199680|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
155199681|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
155199682|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
155199683|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
155199684|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
155199685|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
155199686|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155199687|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
155199688|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155199689|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
155199690|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
155199691|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
155199692|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
155199693|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
155199694|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
155199695|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
155199696|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
155199697|NCT00381485|560170442|FG000|Double-Blind Treatment Period|Administrative|0|||
155199698|NCT00381485|560170443|FG001|Double-Blind Treatment Period|Administrative|1|||
155199699|NCT00381485|560170444|FG002|Double-Blind Treatment Period|Administrative|0|||
155199700|NCT00381485|560170445|FG003|Double-Blind Treatment Period|Administrative|1|||
155199701|NCT01235351|560170446|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
155199702|NCT01235351|560170447|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
155199703|NCT00126191|560170450|FG000|Overall Study|Physician Decision|0|||
155199704|NCT00126191|560170451|FG001|Overall Study|Physician Decision|1|||
155199705|NCT00126191|560170450|FG000|Overall Study|Death|0|||
155199706|NCT00126191|560170451|FG001|Overall Study|Death|1|||
155199707|NCT00307294|560170452|FG000|Overall Study|Withdrawal by Subject|1|||
155199708|NCT01433991|560170461|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
155199709|NCT01433991|560170462|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
155199710|NCT01433991|560170463|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
155199711|NCT01433991|560170464|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
155199712|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
155199713|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
155199714|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
155199715|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
155199716|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
155199717|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
155199718|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
155199719|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
155199720|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
155199721|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
155199722|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
155199723|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
155199724|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
155199725|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
155199726|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
155199727|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
155199728|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
155199729|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
155199730|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
155199731|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
155199732|NCT01433991|560170461|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
155199733|NCT01433991|560170462|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
155199734|NCT01433991|560170463|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
155199735|NCT01433991|560170464|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
155199736|NCT00290888|560170467|FG000|Overall Study|Physician Decision|3|||
155199737|NCT00290888|560170468|FG001|Overall Study|Physician Decision|1|||
155199738|NCT01473836|560170471|FG000|Overall Study|Adverse Event|4|||
155199739|NCT01473836|560170471|FG000|Overall Study|Lack of Efficacy|1|||
155199740|NCT01473836|560170471|FG000|Overall Study|Does not meet entrance criteria|1|||
155199741|NCT03068130|560170474|FG000|Overall Study|Adverse Event|19|||
155199742|NCT03068130|560170474|FG000|Overall Study|Death|14|||
155199743|NCT03068130|560170474|FG000|Overall Study|Lost to Follow-up|4|||
155199744|NCT03068130|560170474|FG000|Overall Study|Withdrawal by Subject|26|||
155199745|NCT03068130|560170474|FG000|Overall Study|Administrative Reasons|3|||
155199746|NCT03068130|560170474|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
155199747|NCT03068130|560170474|FG000|Overall Study|Study terminated by sponsor|194|||
155199748|NCT01001377|560170475|FG000|Overall Study|Ineligibility determined|2|||
155199749|NCT01001377|560170476|FG001|Overall Study|Ineligibility determined|0|||
155199750|NCT01001377|560170475|FG000|Overall Study|Withdrawal by Subject|19|||
155199751|NCT01001377|560170476|FG001|Overall Study|Withdrawal by Subject|20|||
155199752|NCT01001377|560170475|FG000|Overall Study|Lost to Follow-up|14|||
155199753|NCT01001377|560170476|FG001|Overall Study|Lost to Follow-up|17|||
155199754|NCT01001377|560170475|FG000|Overall Study|Death|391|||
155199755|NCT01001377|560170476|FG001|Overall Study|Death|384|||
155199756|NCT00964860|560170479|FG000|Overall Study|Withdrawal by Subject|0|||
155199757|NCT00964860|560170480|FG001|Overall Study|Withdrawal by Subject|1|||
155199758|NCT03570697|560170483|FG000|Overall Study|Lost to Follow-up|0|||
155199759|NCT03570697|560170484|FG001|Overall Study|Lost to Follow-up|1|||
155199760|NCT03570697|560170483|FG000|Overall Study|Death|2|||
155199761|NCT03570697|560170484|FG001|Overall Study|Death|0|||
155199762|NCT03570697|560170483|FG000|Overall Study|Withdrawal by Subject|4|||
155199763|NCT03570697|560170484|FG001|Overall Study|Withdrawal by Subject|2|||
155199764|NCT01849783|560170485|FG000|Overall Study|Adverse Event|5|||
155199765|NCT01849783|560170485|FG000|Overall Study|Death|2|||
155199766|NCT01849783|560170485|FG000|Overall Study|Physician Decision|1|||
155199767|NCT01849783|560170485|FG000|Overall Study|Withdrawal by Subject|1|||
155199768|NCT01849783|560170485|FG000|Overall Study|Unable to comply|2|||
155199769|NCT01849783|560170485|FG000|Overall Study|Disease progression|11|||
155199770|NCT01876420|560170488|FG000|Overall Study|Missed 30 day visit|1|||
155199771|NCT03173313|560170489|FG000|Overall Study|Lost to Follow-up|2|||
155199772|NCT03173313|560170490|FG001|Overall Study|Lost to Follow-up|3|||
155199773|NCT03173313|560170489|FG000|Overall Study|Withdrawal by Subject|0|||
155199774|NCT03173313|560170490|FG001|Overall Study|Withdrawal by Subject|1|||
155199775|NCT03173313|560170489|FG000|Overall Study|Death|5|||
155199776|NCT03173313|560170490|FG001|Overall Study|Death|0|||
155199777|NCT03173313|560170489|FG000|Overall Study|Physician Decision|1|||
155199778|NCT03173313|560170490|FG001|Overall Study|Physician Decision|0|||
155199779|NCT03173313|560170489|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
155199780|NCT03173313|560170490|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
155199781|NCT03173313|560170489|FG000|Overall Study|Bone Fracture|1|||
155199782|NCT03173313|560170490|FG001|Overall Study|Bone Fracture|0|||
155199783|NCT03095612|560170496|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199784|NCT03095612|560170497|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
155199785|NCT03095612|560170498|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199786|NCT03095612|560170499|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199787|NCT03095612|560170500|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199788|NCT03095612|560170501|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199789|NCT03095612|560170502|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
155199790|NCT04447794|560170503|FG000|Overall Study|Lost to Follow-up|2|||
155199791|NCT04447794|560170504|FG001|Overall Study|Lost to Follow-up|3|||
155199792|NCT04447794|560170505|FG002|Overall Study|Lost to Follow-up|8|||
155199793|NCT04447794|560170503|FG000|Overall Study|Withdrawal by Subject|1|||
155199794|NCT04447794|560170504|FG001|Overall Study|Withdrawal by Subject|1|||
155199795|NCT04447794|560170505|FG002|Overall Study|Withdrawal by Subject|0|||
155199796|NCT01042678|560170506|FG000|Overall Study|Physician Decision|1|||
155199797|NCT01042678|560170507|FG001|Overall Study|Physician Decision|0|||
155199798|NCT01042678|560170508|FG002|Overall Study|Physician Decision|0|||
155199799|NCT01042678|560170509|FG003|Overall Study|Physician Decision|0|||
155199800|NCT01042678|560170510|FG004|Overall Study|Physician Decision|0|||
155199801|NCT01042678|560170511|FG005|Overall Study|Physician Decision|0|||
155199802|NCT00205881|560170516|FG000|Overall Study|Withdrawal by Subject|16|||
155199803|NCT04203498|560170519|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
155199804|NCT04203498|560170520|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
155199805|NCT04203498|560170519|FG000|Overall Study|Withdrawal of patient consent|7|||
155199806|NCT04203498|560170520|FG001|Overall Study|Withdrawal of patient consent|2|||
155199807|NCT04203498|560170519|FG000|Overall Study|Adverse Event|4|||
155199808|NCT04203498|560170520|FG001|Overall Study|Adverse Event|1|||
155199809|NCT04203498|560170519|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
155199810|NCT04203498|560170520|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
155199811|NCT04203498|560170519|FG000|Overall Study|Did not receive IMP|2|||
155199812|NCT04203498|560170520|FG001|Overall Study|Did not receive IMP|0|||
155199813|NCT00781274|560170521|FG000|Overall Study|Withdrawal by Subject|2|||
155199814|NCT02762578|560170524|FG000|Overall Study|Adverse Event|1|||
155199815|NCT02762578|560170525|FG001|Overall Study|Adverse Event|6|||
155199816|NCT02762578|560170524|FG000|Overall Study|Protocol Violation|4|||
155199817|NCT02762578|560170525|FG001|Overall Study|Protocol Violation|2|||
155199818|NCT02762578|560170524|FG000|Overall Study|Withdrawal by Subject|4|||
155199819|NCT02762578|560170525|FG001|Overall Study|Withdrawal by Subject|2|||
155199820|NCT02762578|560170524|FG000|Overall Study|Unclassified|6|||
155199821|NCT02762578|560170525|FG001|Overall Study|Unclassified|0|||
155199822|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199823|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199824|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199825|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
155199826|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
155199827|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
155199828|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
155199829|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
155199830|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199831|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
155199832|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199833|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199834|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199835|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199836|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
155199837|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
155199838|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199839|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199840|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
155199841|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199842|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199843|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199844|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199845|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199846|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Other|0|||
155199847|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Other|0|||
155199848|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Other|1|||
155199849|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Other|1|||
155199850|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Other|2|||
155199851|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Other|0|||
155199852|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Other|0|||
155199853|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Other|0|||
155199854|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199855|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199856|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199857|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199858|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
155199859|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199860|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199861|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
155199862|NCT01090492|560170526|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
155199863|NCT01090492|560170527|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
155199864|NCT01090492|560170528|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
155199865|NCT01090492|560170529|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
155199866|NCT01090492|560170530|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
155199867|NCT01090492|560170531|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
155199868|NCT01090492|560170532|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
155199869|NCT01090492|560170533|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
155199870|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199871|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199872|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199873|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199874|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199875|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
155199876|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199877|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
155199878|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199879|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
155199880|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199881|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199882|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199883|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199884|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199885|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
155199886|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Other|0|||
155199887|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Other|1|||
155199888|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Other|1|||
155199889|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Other|0|||
155199890|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Other|0|||
155199891|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Other|0|||
155199892|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Other|0|||
155199893|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Other|0|||
155199894|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
155199895|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
155199896|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199897|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
155199898|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199899|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199900|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
155199901|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
155199902|NCT01090492|560170526|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199903|NCT01090492|560170527|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199904|NCT01090492|560170528|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199905|NCT01090492|560170529|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199906|NCT01090492|560170530|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199907|NCT01090492|560170531|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199908|NCT01090492|560170532|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
155199909|NCT01090492|560170533|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
155199910|NCT00282984|560170534|FG000|Overall Study|Death|2|||
155199911|NCT00282984|560170535|FG001|Overall Study|Death|5|||
155199912|NCT00282984|560170534|FG000|Overall Study|Adverse Event|8|||
155199913|NCT00282984|560170535|FG001|Overall Study|Adverse Event|5|||
155199914|NCT00282984|560170534|FG000|Overall Study|Lack of Efficacy|0|||
155199915|NCT00282984|560170535|FG001|Overall Study|Lack of Efficacy|2|||
155199916|NCT00282984|560170534|FG000|Overall Study|Lost to Follow-up|14|||
155199917|NCT00282984|560170535|FG001|Overall Study|Lost to Follow-up|10|||
155199918|NCT00282984|560170534|FG000|Overall Study|Withdrawal by Participant|22|||
155199919|NCT00282984|560170535|FG001|Overall Study|Withdrawal by Participant|34|||
155199920|NCT00282984|560170534|FG000|Overall Study|Participant stopped study medication|2|||
155199921|NCT00282984|560170535|FG001|Overall Study|Participant stopped study medication|2|||
155199922|NCT00282984|560170534|FG000|Overall Study|Participant only allowed phone follow-up|0|||
155199923|NCT00282984|560170535|FG001|Overall Study|Participant only allowed phone follow-up|1|||
155199924|NCT00282984|560170534|FG000|Overall Study|Participant used antipsychosis meds|0|||
155199925|NCT00282984|560170535|FG001|Overall Study|Participant used antipsychosis meds|1|||
155199926|NCT00282984|560170534|FG000|Overall Study|lack of motivation|1|||
155199927|NCT00282984|560170535|FG001|Overall Study|lack of motivation|0|||
155199928|NCT00282984|560170534|FG000|Overall Study|in prison|0|||
155199929|NCT00282984|560170535|FG001|Overall Study|in prison|1|||
155199930|NCT00282984|560170534|FG000|Overall Study|Protocol Violation|2|||
155199931|NCT00282984|560170535|FG001|Overall Study|Protocol Violation|0|||
155199932|NCT00911547|560170536|FG000|Overall Study|Adverse Event|8|||
155199933|NCT00911547|560170537|FG001|Overall Study|Adverse Event|27|||
155199934|NCT00911547|560170538|FG002|Overall Study|Adverse Event|11|||
155199935|NCT00911547|560170539|FG003|Overall Study|Adverse Event|6|||
155199936|NCT00911547|560170536|FG000|Overall Study|Lost to Follow-up|0|||
155199937|NCT00911547|560170537|FG001|Overall Study|Lost to Follow-up|0|||
155199938|NCT00911547|560170538|FG002|Overall Study|Lost to Follow-up|2|||
155199939|NCT00911547|560170539|FG003|Overall Study|Lost to Follow-up|1|||
155199940|NCT00911547|560170536|FG000|Overall Study|Protocol Violation|0|||
155199941|NCT00911547|560170537|FG001|Overall Study|Protocol Violation|5|||
155199942|NCT00911547|560170538|FG002|Overall Study|Protocol Violation|5|||
155199943|NCT00911547|560170539|FG003|Overall Study|Protocol Violation|1|||
155199944|NCT00911547|560170536|FG000|Overall Study|Withdrawal by Subject|3|||
155199945|NCT00911547|560170537|FG001|Overall Study|Withdrawal by Subject|10|||
155199946|NCT00911547|560170538|FG002|Overall Study|Withdrawal by Subject|4|||
155199947|NCT00911547|560170539|FG003|Overall Study|Withdrawal by Subject|8|||
155199948|NCT00457301|560170540|FG000|Overall Study|Withdrawal by Subject|3|||
155199949|NCT00457301|560170541|FG001|Overall Study|Withdrawal by Subject|3|||
155199950|NCT00457301|560170540|FG000|Overall Study|Censored out of the study|15|||
155199951|NCT00457301|560170541|FG001|Overall Study|Censored out of the study|14|||
155199952|NCT00457301|560170540|FG000|Overall Study|Death|5|||
155199953|NCT00457301|560170541|FG001|Overall Study|Death|7|||
155199954|NCT00191269|560170542|FG000|Overall Study|Protocol Violation|0|||
155199955|NCT00191269|560170543|FG001|Overall Study|Protocol Violation|2|||
155199956|NCT00191269|560170542|FG000|Overall Study|Adverse Event|1|||
155199957|NCT00191269|560170543|FG001|Overall Study|Adverse Event|4|||
155199958|NCT00191269|560170542|FG000|Overall Study|Progression of Disease|4|||
155199959|NCT00191269|560170543|FG001|Overall Study|Progression of Disease|42|||
155199960|NCT00191269|560170542|FG000|Overall Study|Lack of Efficacy|1|||
155199961|NCT00191269|560170543|FG001|Overall Study|Lack of Efficacy|5|||
155199962|NCT00191269|560170542|FG000|Overall Study|Withdrawal by Subject|0|||
155199963|NCT00191269|560170543|FG001|Overall Study|Withdrawal by Subject|1|||
155199964|NCT00191269|560170542|FG000|Overall Study|Pathologic Aggrevation|0|||
155199965|NCT00191269|560170543|FG001|Overall Study|Pathologic Aggrevation|1|||
155199966|NCT00191269|560170542|FG000|Overall Study|Physician Decision|0|||
155199967|NCT00191269|560170543|FG001|Overall Study|Physician Decision|3|||
155199968|NCT03344796|560170548|FG000|Overall Study|Lost to Follow-up|0|||
155199969|NCT03344796|560170549|FG001|Overall Study|Lost to Follow-up|0|||
155199970|NCT03344796|560170550|FG002|Overall Study|Lost to Follow-up|0|||
155199971|NCT03344796|560170551|FG003|Overall Study|Lost to Follow-up|0|||
155199972|NCT03344796|560170552|FG004|Overall Study|Lost to Follow-up|0|||
155199973|NCT03344796|560170553|FG005|Overall Study|Lost to Follow-up|2|||
155199974|NCT02564796|560170560|FG000|Overall Study|Physician Decision|2|||
155199975|NCT02564796|560170561|FG001|Overall Study|Physician Decision|2|||
155199976|NCT00293033|560170562|FG000|Open-label Titration Period|Adverse Event|10|||
155199977|NCT00293033|560170562|FG000|Open-label Titration Period|Death|3|||
155199978|NCT00293033|560170562|FG000|Open-label Titration Period|Lack of Efficacy|5|||
155199979|NCT00293033|560170562|FG000|Open-label Titration Period|Protocol Violation|2|||
155199980|NCT00293033|560170562|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
155199981|NCT00293033|560170562|FG000|Open-label Titration Period|Noncompliance and other|27|||
155199982|NCT00293033|560170562|FG000|Double-blind Treatment Period|Adverse Event|3|||
155199983|NCT00293033|560170562|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
155199984|NCT00293033|560170562|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
155199985|NCT00293033|560170562|FG000|Double-blind Treatment Period|Noncompliance|4|||
155199986|NCT03583697|560170563|FG000|Overall Study|Withdrawal by Subject|0|||
155199987|NCT03583697|560170564|FG001|Overall Study|Withdrawal by Subject|0|||
155199988|NCT03583697|560170565|FG002|Overall Study|Withdrawal by Subject|1|||
155199989|NCT03583697|560170563|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
155199990|NCT03583697|560170564|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
155199991|NCT03583697|560170565|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
155199992|NCT00453063|560170566|FG000|Overall Study|Adverse Event|1|||
155199993|NCT00453063|560170567|FG001|Overall Study|Adverse Event|2|||
155199994|NCT00453063|560170566|FG000|Overall Study|Withdrawal by Subject|1|||
155199995|NCT00453063|560170567|FG001|Overall Study|Withdrawal by Subject|1|||
155199996|NCT00453063|560170566|FG000|Overall Study|Protocol Violation|1|||
155199997|NCT00453063|560170567|FG001|Overall Study|Protocol Violation|0|||
155199998|NCT00114530|560170569|FG000|Overall Study|Death|3|||
155199999|NCT00114530|560170570|FG001|Overall Study|Death|11|||
155200000|NCT00114530|560170569|FG000|Overall Study|Lost to Follow-up|1|||
155200001|NCT00114530|560170570|FG001|Overall Study|Lost to Follow-up|1|||
155200002|NCT00114530|560170569|FG000|Overall Study|Physician Decision|1|||
155200003|NCT00114530|560170570|FG001|Overall Study|Physician Decision|1|||
155200004|NCT00114530|560170569|FG000|Overall Study|Withdrawal by Subject|2|||
155200005|NCT00114530|560170570|FG001|Overall Study|Withdrawal by Subject|6|||
155200006|NCT00114530|560170569|FG000|Overall Study|Breast Cancer|1|||
155200007|NCT00114530|560170570|FG001|Overall Study|Breast Cancer|0|||
155200008|NCT00114530|560170569|FG000|Overall Study|Subject decision after endpoint failure|0|||
155200009|NCT00114530|560170570|FG001|Overall Study|Subject decision after endpoint failure|1|||
155200010|NCT00114530|560170569|FG000|Overall Study|Ineligible|1|||
155200011|NCT00114530|560170570|FG001|Overall Study|Ineligible|0|||
155200012|NCT00365508|560170573|FG000|Overall Study|Lost to Follow-up|139|||
155200013|NCT00365508|560170574|FG001|Overall Study|Lost to Follow-up|154|||
155200014|NCT03724032|560170575|FG000|Overall Study|Physician Decision|1|||
155200015|NCT03724032|560170576|FG001|Overall Study|Physician Decision|0|||
155200016|NCT03724032|560170577|FG002|Overall Study|Physician Decision|0|||
155200017|NCT03724032|560170575|FG000|Overall Study|Protocol Violation|2|||
155200018|NCT03724032|560170576|FG001|Overall Study|Protocol Violation|2|||
155200019|NCT03724032|560170577|FG002|Overall Study|Protocol Violation|1|||
155200020|NCT00404235|560170579|FG000|Overall Study|Withdrawal by Subject|1|||
155200021|NCT00404235|560170580|FG001|Overall Study|Withdrawal by Subject|2|||
155200022|NCT00743483|560170581|FG000|Baseline Period|Physician Decision|1|||
155200023|NCT00743483|560170581|FG000|Treatment Period|Adverse Event|1|||
155200024|NCT00873912|560170582|FG000|Overall Study|Withdrawal by Subject|1|||
155200025|NCT00873912|560170583|FG001|Overall Study|Withdrawal by Subject|0|||
155200026|NCT00873912|560170582|FG000|Overall Study|Lost to Follow-up|2|||
155200027|NCT00873912|560170583|FG001|Overall Study|Lost to Follow-up|0|||
155200028|NCT01785069|560170586|FG000|Overall Study|Implanted with nonstudy device|1|||
155200029|NCT01785069|560170587|FG001|Overall Study|Implanted with nonstudy device|2|||
155200030|NCT01785069|560170588|FG002|Overall Study|Implanted with nonstudy device|1|||
155200031|NCT01785069|560170589|FG003|Overall Study|Implanted with nonstudy device|0|||
155200032|NCT01785069|560170586|FG000|Overall Study|Death|0|||
155200033|NCT01785069|560170587|FG001|Overall Study|Death|0|||
155200034|NCT01785069|560170588|FG002|Overall Study|Death|2|||
155200035|NCT01785069|560170589|FG003|Overall Study|Death|0|||
155200036|NCT01785069|560170586|FG000|Overall Study|Subject choice|2|||
155200037|NCT01785069|560170587|FG001|Overall Study|Subject choice|2|||
155200038|NCT01785069|560170588|FG002|Overall Study|Subject choice|0|||
155200039|NCT01785069|560170589|FG003|Overall Study|Subject choice|1|||
155200040|NCT01785069|560170586|FG000|Overall Study|Lost to Follow-up|1|||
155200041|NCT01785069|560170587|FG001|Overall Study|Lost to Follow-up|2|||
155200042|NCT01785069|560170588|FG002|Overall Study|Lost to Follow-up|4|||
155200043|NCT01785069|560170589|FG003|Overall Study|Lost to Follow-up|1|||
155200044|NCT01785069|560170586|FG000|Overall Study|Reason not Specified|1|||
155200045|NCT01785069|560170587|FG001|Overall Study|Reason not Specified|2|||
155200046|NCT01785069|560170588|FG002|Overall Study|Reason not Specified|1|||
155200047|NCT01785069|560170589|FG003|Overall Study|Reason not Specified|4|||
155200048|NCT01785069|560170586|FG000|Overall Study|Not evaluable|7|||
155200049|NCT01785069|560170587|FG001|Overall Study|Not evaluable|4|||
155200050|NCT01785069|560170588|FG002|Overall Study|Not evaluable|5|||
155200051|NCT01785069|560170589|FG003|Overall Study|Not evaluable|8|||
155200052|NCT01088997|560170592|FG000|Overall Study|Physician Decision|1|||
155200053|NCT01088997|560170593|FG001|Overall Study|Physician Decision|1|||
155200054|NCT01088997|560170592|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
155200055|NCT01088997|560170593|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
155200056|NCT01088997|560170592|FG000|Overall Study|Excluded prior to receiving drug|1|||
155200057|NCT01088997|560170593|FG001|Overall Study|Excluded prior to receiving drug|1|||
155200058|NCT05570500|560170598|FG000|Overall Study|Lost to Follow-up|7|||
155200059|NCT05570500|560170599|FG001|Overall Study|Lost to Follow-up|5|||
155200060|NCT01095731|560170600|FG000|Overall Study|Protocol Violation|1|||
155200061|NCT01095731|560170601|FG001|Overall Study|Protocol Violation|1|||
155200062|NCT01095731|560170600|FG000|Overall Study|Withdrawal by Subject|0|||
155200063|NCT01095731|560170601|FG001|Overall Study|Withdrawal by Subject|1|||
155200064|NCT02302807|560170604|FG000|Overall Study|Withdrawal by Subject|28|||
155200065|NCT02302807|560170605|FG001|Overall Study|Withdrawal by Subject|11|||
155200066|NCT02302807|560170604|FG000|Overall Study|Lost to Follow-up|4|||
155200067|NCT02302807|560170605|FG001|Overall Study|Lost to Follow-up|6|||
155200068|NCT02302807|560170604|FG000|Overall Study|Death|397|||
155200069|NCT02302807|560170605|FG001|Overall Study|Death|385|||
155200070|NCT02302807|560170604|FG000|Overall Study|Study Terminated By Sponsor|35|||
155200071|NCT02302807|560170605|FG001|Overall Study|Study Terminated By Sponsor|64|||
155200072|NCT02302807|560170604|FG000|Overall Study|Physician Decision|0|||
155200073|NCT02302807|560170605|FG001|Overall Study|Physician Decision|1|||
155200074|NCT04840615|560172359|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
155200075|NCT04840615|560172360|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
155200076|NCT04840615|560172361|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
155200077|NCT01749137|560172366|FG000|Overall Study|Adverse Event|4|||
155200078|NCT01749137|560172367|FG001|Overall Study|Adverse Event|4|||
155200079|NCT01749137|560172366|FG000|Overall Study|Lost to Follow-up|2|||
155200080|NCT01749137|560172367|FG001|Overall Study|Lost to Follow-up|3|||
155200081|NCT01749137|560172366|FG000|Overall Study|Physician Decision|1|||
155200082|NCT01749137|560172367|FG001|Overall Study|Physician Decision|0|||
155200083|NCT01749137|560172366|FG000|Overall Study|Withdrawal by Subject|8|||
155200084|NCT01749137|560172367|FG001|Overall Study|Withdrawal by Subject|4|||
155200085|NCT00621985|560172372|FG000|Dexamethasone Admission|Adverse Event|1|||
155200086|NCT00980057|560172378|FG000|Overall Study|Death|13|||
155200087|NCT00980057|560172379|FG001|Overall Study|Death|3|||
155200088|NCT00980057|560172378|FG000|Overall Study|Adverse Event|0|||
155200089|NCT00980057|560172379|FG001|Overall Study|Adverse Event|1|||
155200090|NCT00980057|560172378|FG000|Overall Study|Physician Decision|4|||
155200091|NCT00980057|560172379|FG001|Overall Study|Physician Decision|0|||
155200092|NCT00980057|560172378|FG000|Overall Study|Lost to Follow-up|1|||
155200093|NCT00980057|560172379|FG001|Overall Study|Lost to Follow-up|0|||
155200094|NCT00980057|560172378|FG000|Overall Study|Withdrawal by Subject|1|||
155200095|NCT00980057|560172379|FG001|Overall Study|Withdrawal by Subject|1|||
155200096|NCT00691015|560172383|FG000|Overall Study|Refused further treatment|1|||
155200097|NCT04160195|560172386|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
155200098|NCT04160195|560172387|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
155200099|NCT03766581|560172390|FG000|Randomization|Other reasons|2|||
155200100|NCT03766581|560172391|FG001|Randomization|Other reasons|1|||
155200101|NCT03766581|560172392|FG002|Randomization|Other reasons|0|||
155200102|NCT03766581|560172393|FG003|Randomization|Other reasons|1|||
155200103|NCT03766581|560172394|FG004|Randomization|Other reasons|0|||
155200104|NCT03766581|560172395|FG005|Randomization|Other reasons|0|||
155200105|NCT03766581|560172396|FG006|Randomization|Other reasons|0|||
155200106|NCT03766581|560172397|FG007|Randomization|Other reasons|0|||
155200107|NCT03766581|560172390|FG000|Randomization|Participant no longer meets study criteria|5|||
155200108|NCT03766581|560172391|FG001|Randomization|Participant no longer meets study criteria|3|||
155200109|NCT03766581|560172392|FG002|Randomization|Participant no longer meets study criteria|4|||
155200110|NCT03766581|560172393|FG003|Randomization|Participant no longer meets study criteria|0|||
155200111|NCT03766581|560172394|FG004|Randomization|Participant no longer meets study criteria|2|||
155200112|NCT03766581|560172395|FG005|Randomization|Participant no longer meets study criteria|3|||
155200113|NCT03766581|560172396|FG006|Randomization|Participant no longer meets study criteria|0|||
155200114|NCT03766581|560172397|FG007|Randomization|Participant no longer meets study criteria|1|||
155200115|NCT03766581|560172390|FG000|Randomization|Participant request to discontinue study treatment|1|||
155200116|NCT03766581|560172391|FG001|Randomization|Participant request to discontinue study treatment|0|||
155200117|NCT03766581|560172392|FG002|Randomization|Participant request to discontinue study treatment|0|||
155200118|NCT03766581|560172393|FG003|Randomization|Participant request to discontinue study treatment|0|||
155200119|NCT03766581|560172394|FG004|Randomization|Participant request to discontinue study treatment|1|||
155200120|NCT03766581|560172395|FG005|Randomization|Participant request to discontinue study treatment|2|||
155200121|NCT03766581|560172396|FG006|Randomization|Participant request to discontinue study treatment|0|||
155200122|NCT03766581|560172397|FG007|Randomization|Participant request to discontinue study treatment|0|||
155200123|NCT03766581|560172390|FG000|Randomization|Participant withdrew consent|1|||
155200124|NCT03766581|560172391|FG001|Randomization|Participant withdrew consent|0|||
155200125|NCT03766581|560172392|FG002|Randomization|Participant withdrew consent|1|||
155200126|NCT03766581|560172393|FG003|Randomization|Participant withdrew consent|2|||
155200127|NCT03766581|560172394|FG004|Randomization|Participant withdrew consent|1|||
155200128|NCT03766581|560172395|FG005|Randomization|Participant withdrew consent|1|||
155200129|NCT03766581|560172396|FG006|Randomization|Participant withdrew consent|0|||
155200130|NCT03766581|560172397|FG007|Randomization|Participant withdrew consent|0|||
155200131|NCT03766581|560172390|FG000|Treatment|Adverse Event|82|||
155200132|NCT03766581|560172391|FG001|Treatment|Adverse Event|44|||
155200133|NCT03766581|560172392|FG002|Treatment|Adverse Event|47|||
155200134|NCT03766581|560172393|FG003|Treatment|Adverse Event|46|||
155200135|NCT03766581|560172394|FG004|Treatment|Adverse Event|50|||
155200136|NCT03766581|560172395|FG005|Treatment|Adverse Event|77|||
155200137|NCT03766581|560172396|FG006|Treatment|Adverse Event|5|||
155200138|NCT03766581|560172397|FG007|Treatment|Adverse Event|2|||
155200139|NCT03766581|560172390|FG000|Treatment|Participant request to discontinue treatment|34|||
155200140|NCT03766581|560172391|FG001|Treatment|Participant request to discontinue treatment|6|||
155200141|NCT03766581|560172392|FG002|Treatment|Participant request to discontinue treatment|10|||
155200142|NCT03766581|560172393|FG003|Treatment|Participant request to discontinue treatment|10|||
155200143|NCT03766581|560172394|FG004|Treatment|Participant request to discontinue treatment|14|||
155200144|NCT03766581|560172395|FG005|Treatment|Participant request to discontinue treatment|15|||
155200145|NCT03766581|560172396|FG006|Treatment|Participant request to discontinue treatment|0|||
155200146|NCT03766581|560172397|FG007|Treatment|Participant request to discontinue treatment|1|||
155200147|NCT03766581|560172390|FG000|Treatment|Participant withdrew consent|11|||
155200148|NCT03766581|560172391|FG001|Treatment|Participant withdrew consent|4|||
155200149|NCT03766581|560172392|FG002|Treatment|Participant withdrew consent|5|||
155200150|NCT03766581|560172393|FG003|Treatment|Participant withdrew consent|5|||
155200151|NCT03766581|560172394|FG004|Treatment|Participant withdrew consent|4|||
155200152|NCT03766581|560172395|FG005|Treatment|Participant withdrew consent|4|||
155200153|NCT03766581|560172396|FG006|Treatment|Participant withdrew consent|0|||
155200154|NCT03766581|560172397|FG007|Treatment|Participant withdrew consent|0|||
155200155|NCT03766581|560172390|FG000|Treatment|Death|1|||
155200156|NCT03766581|560172391|FG001|Treatment|Death|0|||
155200157|NCT03766581|560172392|FG002|Treatment|Death|0|||
155200158|NCT03766581|560172393|FG003|Treatment|Death|0|||
155200159|NCT03766581|560172394|FG004|Treatment|Death|0|||
155200160|NCT03766581|560172395|FG005|Treatment|Death|0|||
155200161|NCT03766581|560172396|FG006|Treatment|Death|0|||
155200162|NCT03766581|560172397|FG007|Treatment|Death|0|||
155200163|NCT03766581|560172390|FG000|Treatment|Lost to Follow-up|1|||
155200164|NCT03766581|560172391|FG001|Treatment|Lost to Follow-up|0|||
155200165|NCT03766581|560172392|FG002|Treatment|Lost to Follow-up|0|||
155200166|NCT03766581|560172393|FG003|Treatment|Lost to Follow-up|1|||
155200167|NCT03766581|560172394|FG004|Treatment|Lost to Follow-up|0|||
155200168|NCT03766581|560172395|FG005|Treatment|Lost to Follow-up|0|||
155200169|NCT03766581|560172396|FG006|Treatment|Lost to Follow-up|0|||
155200170|NCT03766581|560172397|FG007|Treatment|Lost to Follow-up|0|||
155200171|NCT03766581|560172390|FG000|Treatment|Poor/Non compliance|2|||
155200172|NCT03766581|560172391|FG001|Treatment|Poor/Non compliance|2|||
155200173|NCT03766581|560172392|FG002|Treatment|Poor/Non compliance|1|||
155200174|NCT03766581|560172393|FG003|Treatment|Poor/Non compliance|1|||
155200175|NCT03766581|560172394|FG004|Treatment|Poor/Non compliance|1|||
155200176|NCT03766581|560172395|FG005|Treatment|Poor/Non compliance|1|||
155200177|NCT03766581|560172396|FG006|Treatment|Poor/Non compliance|0|||
155200178|NCT03766581|560172397|FG007|Treatment|Poor/Non compliance|0|||
155200179|NCT03766581|560172390|FG000|Treatment|Participant no longer meets study criteria|9|||
155200180|NCT03766581|560172391|FG001|Treatment|Participant no longer meets study criteria|1|||
155200181|NCT03766581|560172392|FG002|Treatment|Participant no longer meets study criteria|5|||
155200182|NCT03766581|560172393|FG003|Treatment|Participant no longer meets study criteria|4|||
155200183|NCT03766581|560172394|FG004|Treatment|Participant no longer meets study criteria|4|||
155200184|NCT03766581|560172395|FG005|Treatment|Participant no longer meets study criteria|4|||
155200185|NCT03766581|560172396|FG006|Treatment|Participant no longer meets study criteria|2|||
155200186|NCT03766581|560172397|FG007|Treatment|Participant no longer meets study criteria|0|||
155200187|NCT03766581|560172390|FG000|Treatment|Other reasons|13|||
155200188|NCT03766581|560172391|FG001|Treatment|Other reasons|8|||
155200189|NCT03766581|560172392|FG002|Treatment|Other reasons|3|||
155200190|NCT03766581|560172393|FG003|Treatment|Other reasons|7|||
155200191|NCT03766581|560172394|FG004|Treatment|Other reasons|3|||
155200192|NCT03766581|560172395|FG005|Treatment|Other reasons|3|||
155200193|NCT03766581|560172396|FG006|Treatment|Other reasons|0|||
155200194|NCT03766581|560172397|FG007|Treatment|Other reasons|0|||
155200195|NCT02732119|560172398|FG000|Phase I|Adverse Event|1|||
155200196|NCT02732119|560172399|FG001|Phase I|Adverse Event|3|||
155200197|NCT02732119|560172400|FG002|Phase I|Adverse Event|1|||
155200198|NCT02732119|560172401|FG003|Phase I|Adverse Event|0|||
155200199|NCT02732119|560172402|FG004|Phase I|Adverse Event|0|||
155200200|NCT02732119|560172398|FG000|Phase I|Progressive disease|7|||
155200201|NCT02732119|560172399|FG001|Phase I|Progressive disease|3|||
155200202|NCT02732119|560172400|FG002|Phase I|Progressive disease|2|||
155200203|NCT02732119|560172401|FG003|Phase I|Progressive disease|0|||
155200204|NCT02732119|560172402|FG004|Phase I|Progressive disease|0|||
155200205|NCT02732119|560172398|FG000|Phase I|Protocol deviation|0|||
155200206|NCT02732119|560172399|FG001|Phase I|Protocol deviation|1|||
155200207|NCT02732119|560172400|FG002|Phase I|Protocol deviation|0|||
155200208|NCT02732119|560172401|FG003|Phase I|Protocol deviation|0|||
155200209|NCT02732119|560172402|FG004|Phase I|Protocol deviation|0|||
155200210|NCT02732119|560172398|FG000|Phase I|Physician Decision|0|||
155200211|NCT02732119|560172399|FG001|Phase I|Physician Decision|3|||
155200212|NCT02732119|560172400|FG002|Phase I|Physician Decision|4|||
155200213|NCT02732119|560172401|FG003|Phase I|Physician Decision|0|||
155200214|NCT02732119|560172402|FG004|Phase I|Physician Decision|0|||
155200215|NCT02732119|560172398|FG000|Phase II|Adverse Event|0|||
155200216|NCT02732119|560172399|FG001|Phase II|Adverse Event|0|||
155200217|NCT02732119|560172400|FG002|Phase II|Adverse Event|0|||
155200218|NCT02732119|560172401|FG003|Phase II|Adverse Event|3|||
155200219|NCT02732119|560172402|FG004|Phase II|Adverse Event|3|||
155200220|NCT02732119|560172398|FG000|Phase II|Death|0|||
155200221|NCT02732119|560172399|FG001|Phase II|Death|0|||
155200222|NCT02732119|560172400|FG002|Phase II|Death|0|||
155200223|NCT02732119|560172401|FG003|Phase II|Death|1|||
155200224|NCT02732119|560172402|FG004|Phase II|Death|0|||
155200225|NCT02732119|560172398|FG000|Phase II|Progressive dissease|0|||
155200226|NCT02732119|560172399|FG001|Phase II|Progressive dissease|0|||
155200227|NCT02732119|560172400|FG002|Phase II|Progressive dissease|0|||
155200228|NCT02732119|560172401|FG003|Phase II|Progressive dissease|30|||
155200229|NCT02732119|560172402|FG004|Phase II|Progressive dissease|23|||
155200230|NCT02732119|560172398|FG000|Phase II|Study terminated by sponsor|0|||
155200231|NCT02732119|560172399|FG001|Phase II|Study terminated by sponsor|0|||
155200232|NCT02732119|560172400|FG002|Phase II|Study terminated by sponsor|0|||
155200233|NCT02732119|560172401|FG003|Phase II|Study terminated by sponsor|2|||
155200234|NCT02732119|560172402|FG004|Phase II|Study terminated by sponsor|2|||
155200235|NCT02732119|560172398|FG000|Phase II|Other|0|||
155200236|NCT02732119|560172399|FG001|Phase II|Other|0|||
155200237|NCT02732119|560172400|FG002|Phase II|Other|0|||
155200238|NCT02732119|560172401|FG003|Phase II|Other|2|||
155200239|NCT02732119|560172402|FG004|Phase II|Other|0|||
155200240|NCT02732119|560172398|FG000|Phase II|Physician Decision|0|||
155200241|NCT02732119|560172399|FG001|Phase II|Physician Decision|0|||
155200242|NCT02732119|560172400|FG002|Phase II|Physician Decision|0|||
155200243|NCT02732119|560172401|FG003|Phase II|Physician Decision|8|||
155200244|NCT02732119|560172402|FG004|Phase II|Physician Decision|5|||
155200245|NCT05275400|560172403|FG000|Treatment Period|Adverse Event|7|||
155200246|NCT05275400|560172404|FG001|Treatment Period|Adverse Event|1|||
155200247|NCT05275400|560172403|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
155200248|NCT05275400|560172404|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
155200249|NCT05275400|560172403|FG000|Treatment Period|Death|5|||
155200250|NCT05275400|560172404|FG001|Treatment Period|Death|2|||
155200251|NCT05275400|560172403|FG000|Treatment Period|Protocol Violation|1|||
155200252|NCT05275400|560172404|FG001|Treatment Period|Protocol Violation|0|||
155200253|NCT05275400|560172403|FG000|Treatment Period|Physician Decision|5|||
155200254|NCT05275400|560172404|FG001|Treatment Period|Physician Decision|4|||
155200255|NCT05275400|560172403|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
155200256|NCT05275400|560172404|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
155200257|NCT05275400|560172403|FG000|Treatment Period|Withdrawal by Subject|30|||
155200258|NCT05275400|560172404|FG001|Treatment Period|Withdrawal by Subject|12|||
155200259|NCT05275400|560172403|FG000|Treatment Period|Lost to Follow-up|1|||
155200260|NCT05275400|560172404|FG001|Treatment Period|Lost to Follow-up|5|||
155200261|NCT05275400|560172403|FG000|Treatment Period|Lack of Efficacy|1|||
155200262|NCT05275400|560172404|FG001|Treatment Period|Lack of Efficacy|0|||
155200263|NCT05275400|560172403|FG000|Treatment Period|Sponsor Decision|1|||
155200264|NCT05275400|560172404|FG001|Treatment Period|Sponsor Decision|0|||
155200265|NCT05275400|560172403|FG000|Follow-Up Period|Death|2|||
155200266|NCT05275400|560172404|FG001|Follow-Up Period|Death|0|||
155200267|NCT05275400|560172403|FG000|Follow-Up Period|Protocol Violation|1|||
155200268|NCT05275400|560172404|FG001|Follow-Up Period|Protocol Violation|0|||
155200269|NCT05275400|560172403|FG000|Follow-Up Period|Withdrawal by Subject|3|||
155200270|NCT05275400|560172404|FG001|Follow-Up Period|Withdrawal by Subject|0|||
155200271|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Physician Decision|0|||
155200272|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Physician Decision|1|||
155200273|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Physician Decision|0|||
155200274|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
155200275|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
155200276|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
155200277|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
155200278|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
155200279|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
155200280|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Other|4|||
155200281|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Other|4|||
155200282|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Other|0|||
155200283|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
155200284|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
155200285|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
155200286|NCT02585960|560172405|FG000|PK/Safety Assessment Period|Screen Failure|0|||
155200287|NCT02585960|560172406|FG001|PK/Safety Assessment Period|Screen Failure|0|||
155200288|NCT02585960|560172407|FG002|PK/Safety Assessment Period|Screen Failure|1|||
155200289|NCT02585960|560172405|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
155200290|NCT02585960|560172406|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
155200291|NCT02585960|560172407|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
155200292|NCT02585960|560172405|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
155200293|NCT02585960|560172406|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
155200294|NCT02585960|560172407|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
155200295|NCT01651039|560172409|FG000|Overall Study|Non-evaluables|5|||
155200296|NCT01651039|560172409|FG000|Overall Study|Physician Decision|2|||
155200297|NCT01651039|560172409|FG000|Overall Study|Withdrawal by Subject|1|||
155200298|NCT01651039|560172409|FG000|Overall Study|Progressive Disease|22|||
155200299|NCT04377620|560172411|FG000|Overall Study|Death|42|||
155200300|NCT04377620|560172412|FG001|Overall Study|Death|48|||
155200301|NCT04377620|560172413|FG002|Overall Study|Death|36|||
155200302|NCT04377620|560172411|FG000|Overall Study|Withdrawal by Subject|0|||
155200303|NCT04377620|560172412|FG001|Overall Study|Withdrawal by Subject|2|||
155200304|NCT04377620|560172413|FG002|Overall Study|Withdrawal by Subject|0|||
155200305|NCT04930965|560172414|FG000|Overall Study|Lost to Follow-up|7|||
155200306|NCT04930965|560172415|FG001|Overall Study|Lost to Follow-up|5|||
155200307|NCT00288054|560172416|FG000|Overall Study|Protocol Violation|2|||
155200308|NCT00288054|560172416|FG000|Overall Study|Lack of Efficacy|16|||
155200309|NCT00288054|560172416|FG000|Overall Study|Adverse Event|3|||
155200310|NCT00288054|560172416|FG000|Overall Study|Withdrawal by Subject|1|||
155200311|NCT00288054|560172416|FG000|Overall Study|Not protocol specified|2|||
155200312|NCT00444912|560172424|FG000|Overall Study|Death|1|||
155200313|NCT00444912|560172425|FG001|Overall Study|Death|2|||
155200314|NCT00444912|560172424|FG000|Overall Study|Lost to Follow-up|1|||
155200315|NCT00444912|560172425|FG001|Overall Study|Lost to Follow-up|0|||
155200316|NCT00444912|560172424|FG000|Overall Study|Participant Failed Mobilization|1|||
155200317|NCT00444912|560172425|FG001|Overall Study|Participant Failed Mobilization|0|||
155200318|NCT01606007|560172426|FG000|Overall Study|Reason 'Other' in the protocol|0|||
155200319|NCT01606007|560172427|FG001|Overall Study|Reason 'Other' in the protocol|1|||
155200320|NCT01606007|560172428|FG002|Overall Study|Reason 'Other' in the protocol|1|||
155200321|NCT01606007|560172426|FG000|Overall Study|Pregnancy|0|||
155200322|NCT01606007|560172427|FG001|Overall Study|Pregnancy|1|||
155200323|NCT01606007|560172428|FG002|Overall Study|Pregnancy|1|||
155200324|NCT01606007|560172426|FG000|Overall Study|Withdrawal by Subject|8|||
155200325|NCT01606007|560172427|FG001|Overall Study|Withdrawal by Subject|6|||
155200326|NCT01606007|560172428|FG002|Overall Study|Withdrawal by Subject|1|||
155200327|NCT01606007|560172426|FG000|Overall Study|Adverse Event|0|||
155200328|NCT01606007|560172427|FG001|Overall Study|Adverse Event|1|||
155200329|NCT01606007|560172428|FG002|Overall Study|Adverse Event|1|||
155200330|NCT01606007|560172426|FG000|Overall Study|discontinue study treatment|0|||
155200331|NCT01606007|560172427|FG001|Overall Study|discontinue study treatment|2|||
155200332|NCT01606007|560172428|FG002|Overall Study|discontinue study treatment|1|||
155200333|NCT01606007|560172426|FG000|Overall Study|Lost to Follow-up|6|||
155200334|NCT01606007|560172427|FG001|Overall Study|Lost to Follow-up|8|||
155200335|NCT01606007|560172428|FG002|Overall Study|Lost to Follow-up|5|||
155200336|NCT01606007|560172426|FG000|Overall Study|Poor/Non-compliance|1|||
155200337|NCT01606007|560172427|FG001|Overall Study|Poor/Non-compliance|0|||
155200338|NCT01606007|560172428|FG002|Overall Study|Poor/Non-compliance|0|||
155200339|NCT03758066|560172429|FG000|Overall Study|Lost to Follow-up|14|||
155200340|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
155200341|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
155200342|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
155200343|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
155200344|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
155200345|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
155200346|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
155200347|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
155200348|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
155200349|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
155200350|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
155200351|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
155200352|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
155200353|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
155200354|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
155200355|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
155200356|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
155200357|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
155200358|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
155200359|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
155200360|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200361|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200362|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
155200363|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200364|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
155200365|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200366|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200367|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
155200368|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200369|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
155200370|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
155200371|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200372|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200373|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200374|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
155200375|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200376|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
155200377|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200378|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200379|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
155200380|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
155200381|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
155200382|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
155200383|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
155200384|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
155200385|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200386|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200387|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
155200388|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200389|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
155200390|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
155200391|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
155200392|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
155200393|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
155200394|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
155200395|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200396|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
155200397|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200398|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200399|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
155200400|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200401|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200402|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200403|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
155200404|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
155200405|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200406|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200407|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
155200408|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200409|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
155200410|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Change of location|0|||
155200411|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Change of location|0|||
155200412|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Change of location|0|||
155200413|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Change of location|1|||
155200414|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Change of location|0|||
155200415|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
155200416|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
155200417|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
155200418|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
155200419|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
155200420|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200421|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200422|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200423|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
155200424|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
155200425|NCT00730405|560172434|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
155200426|NCT00730405|560172435|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200427|NCT00730405|560172436|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200428|NCT00730405|560172437|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200429|NCT00730405|560172438|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
155200430|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
155200431|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
155200432|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
155200433|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
155200434|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
155200435|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
155200436|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
155200437|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
155200438|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
155200439|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
155200440|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
155200441|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
155200442|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
155200443|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
155200444|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
155200445|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Death|0|||
155200446|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Death|1|||
155200447|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Death|0|||
155200448|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Death|1|||
155200449|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Death|0|||
155200450|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Change of location|1|||
155200451|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Change of location|1|||
155200452|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Change of location|0|||
155200453|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Change of location|1|||
155200454|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Change of location|0|||
155200455|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200456|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200457|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
155200458|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200459|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
155200460|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200461|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200462|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
155200463|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200464|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
155200465|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200466|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200467|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
155200468|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200469|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
155200470|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200471|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200472|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200473|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
155200474|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
155200475|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
155200476|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200477|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200478|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200479|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
155200480|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200481|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200482|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200483|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
155200484|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
155200485|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
155200486|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
155200487|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
155200488|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
155200489|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
155200490|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
155200491|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
155200492|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
155200493|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
155200494|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
155200495|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200496|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
155200497|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200498|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200499|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
155200500|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
155200501|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
155200502|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
155200503|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
155200504|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
155200505|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Missing|0|||
155200506|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Missing|0|||
155200507|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Missing|2|||
155200508|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Missing|0|||
155200509|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Missing|0|||
155200510|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200511|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200512|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200513|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
155200514|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
155200515|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200516|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200517|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
155200518|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200519|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
155200520|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
155200521|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
155200522|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
155200523|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
155200524|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
155200525|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200526|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200527|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
155200528|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200529|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
155200530|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200531|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200532|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200533|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
155200534|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
155200535|NCT00730405|560172434|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
155200536|NCT00730405|560172435|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200537|NCT00730405|560172436|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200538|NCT00730405|560172437|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200539|NCT00730405|560172438|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
155200540|NCT01496807|560172439|FG000|Overall Study|Progressive Disease|21|||
155200541|NCT01496807|560172439|FG000|Overall Study|Participant preference/toxicity|8|||
155200542|NCT01496807|560172439|FG000|Overall Study|Change in diagnosis|1|||
155200543|NCT00963937|560172445|FG000|Overall Study|Protocol Violation|1|||
155200544|NCT00963937|560172446|FG001|Overall Study|Protocol Violation|1|||
155200545|NCT00963937|560172447|FG002|Overall Study|Protocol Violation|0|||
155200546|NCT00963937|560172445|FG000|Overall Study|Physician Decision|18|||
155200547|NCT00963937|560172446|FG001|Overall Study|Physician Decision|10|||
155200548|NCT00963937|560172447|FG002|Overall Study|Physician Decision|4|||
155200549|NCT00334958|560172448|FG000|Overall Study|Medication Noncompliance|0|||
155200550|NCT00334958|560172449|FG001|Overall Study|Medication Noncompliance|3|||
155200551|NCT00334958|560172448|FG000|Overall Study|Protocol Violation|2|||
155200552|NCT00334958|560172449|FG001|Overall Study|Protocol Violation|2|||
155200553|NCT00334958|560172448|FG000|Overall Study|Request of the investigator or sponsor|0|||
155200554|NCT00334958|560172449|FG001|Overall Study|Request of the investigator or sponsor|1|||
155200555|NCT00334958|560172448|FG000|Overall Study|Withdrawal by Subject|7|||
155200556|NCT00334958|560172449|FG001|Overall Study|Withdrawal by Subject|4|||
155200557|NCT00334958|560172448|FG000|Overall Study|Adverse Event|27|||
155200558|NCT00334958|560172449|FG001|Overall Study|Adverse Event|12|||
155200559|NCT00334958|560172448|FG000|Overall Study|Other|1|||
155200560|NCT00334958|560172449|FG001|Overall Study|Other|2|||
155200561|NCT03988088|560172450|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
155200562|NCT03988088|560172451|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
155200563|NCT03988088|560172452|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
155200564|NCT03988088|560172453|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
155200565|NCT03988088|560172450|FG000|Open-Label Addendum|Lost to Follow-up|0|||
155200566|NCT03988088|560172451|FG001|Open-Label Addendum|Lost to Follow-up|0|||
155200567|NCT03988088|560172452|FG002|Open-Label Addendum|Lost to Follow-up|1|||
155200568|NCT03988088|560172453|FG003|Open-Label Addendum|Lost to Follow-up|0|||
155200569|NCT02935842|560172456|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
155200570|NCT02935842|560172457|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
155200571|NCT02935842|560172458|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
155200572|NCT02935842|560172459|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
155200573|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
155200574|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
155200575|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
155200576|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
155200577|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
155200578|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
155200579|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
155200580|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
155200581|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
155200582|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
155200583|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
155200584|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
155200585|NCT02935842|560172456|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
155200586|NCT02935842|560172457|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
155200587|NCT02935842|560172458|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
155200588|NCT02935842|560172459|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
155200589|NCT00923156|560172469|FG000|Overall Study|Adverse Event|0|||
155200590|NCT00923156|560172470|FG001|Overall Study|Adverse Event|2|||
155200591|NCT00923156|560172471|FG002|Overall Study|Adverse Event|1|||
155200592|NCT00923156|560172469|FG000|Overall Study|Abnormal laboratory values|0|||
155200593|NCT00923156|560172470|FG001|Overall Study|Abnormal laboratory values|0|||
155200594|NCT00923156|560172471|FG002|Overall Study|Abnormal laboratory values|1|||
155200595|NCT00923156|560172469|FG000|Overall Study|Withdrawal by Subject|0|||
155200596|NCT00923156|560172470|FG001|Overall Study|Withdrawal by Subject|1|||
155200597|NCT00923156|560172471|FG002|Overall Study|Withdrawal by Subject|0|||
155200598|NCT00923156|560172469|FG000|Overall Study|Death|0|||
155200599|NCT00923156|560172470|FG001|Overall Study|Death|1|||
155200600|NCT00923156|560172471|FG002|Overall Study|Death|0|||
155200601|NCT00923156|560172469|FG000|Overall Study|Lack of Efficacy|0|||
155200602|NCT00923156|560172470|FG001|Overall Study|Lack of Efficacy|0|||
155200603|NCT00923156|560172471|FG002|Overall Study|Lack of Efficacy|1|||
155200604|NCT01201850|560172474|FG000|Overall Study|Tumor progression|4|||
155200605|NCT03137537|560172475|FG000|Overall Study|Adverse Event|0|||
155200606|NCT03137537|560172476|FG001|Overall Study|Adverse Event|1|||
155200607|NCT01552694|560172477|FG000|Overall Study|Lost to Follow-up|0|||
155200608|NCT01552694|560172478|FG001|Overall Study|Lost to Follow-up|1|||
155200609|NCT01552694|560172477|FG000|Overall Study|Protocol Violation|0|||
155200610|NCT01552694|560172478|FG001|Overall Study|Protocol Violation|1|||
155200611|NCT00191139|560172480|FG000|Overall Study|Adverse Event|2|||
155200612|NCT00191139|560172481|FG001|Overall Study|Adverse Event|6|||
155200613|NCT00191139|560172480|FG000|Overall Study|Death|2|||
155200614|NCT00191139|560172481|FG001|Overall Study|Death|0|||
155200615|NCT00191139|560172480|FG000|Overall Study|Withdrawal by Subject|0|||
155200616|NCT00191139|560172481|FG001|Overall Study|Withdrawal by Subject|3|||
155200617|NCT00191139|560172480|FG000|Overall Study|Disease Progression|0|||
155200618|NCT00191139|560172481|FG001|Overall Study|Disease Progression|1|||
155200619|NCT00191139|560172480|FG000|Overall Study|Other|1|||
155200620|NCT00191139|560172481|FG001|Overall Study|Other|2|||
155200621|NCT00816595|560172484|FG000|Overall Study|Withdrawal by Subject|2|||
155200622|NCT00816595|560172485|FG001|Overall Study|Withdrawal by Subject|0|||
155200623|NCT00751933|560172486|FG000|Overall Study|Withdrawal by Subject|0|||
155200624|NCT00751933|560172487|FG001|Overall Study|Withdrawal by Subject|1|||
155200625|NCT00751933|560172488|FG002|Overall Study|Withdrawal by Subject|0|||
155200626|NCT00751933|560172489|FG003|Overall Study|Withdrawal by Subject|0|||
155200627|NCT00751933|560172486|FG000|Overall Study|Physician Decision|0|||
155200628|NCT00751933|560172487|FG001|Overall Study|Physician Decision|0|||
155200629|NCT00751933|560172488|FG002|Overall Study|Physician Decision|1|||
155200630|NCT00751933|560172489|FG003|Overall Study|Physician Decision|1|||
155200631|NCT01817530|560172490|FG000|Overall Study|Exclusionary Medication Received|0|||
155200632|NCT01817530|560172491|FG001|Overall Study|Exclusionary Medication Received|0|||
155200633|NCT01817530|560172492|FG002|Overall Study|Exclusionary Medication Received|0|||
155200634|NCT01817530|560172493|FG003|Overall Study|Exclusionary Medication Received|0|||
155200635|NCT01817530|560172494|FG004|Overall Study|Exclusionary Medication Received|1|||
155200636|NCT01817530|560172495|FG005|Overall Study|Exclusionary Medication Received|0|||
155200637|NCT01817530|560172496|FG006|Overall Study|Exclusionary Medication Received|0|||
155200638|NCT01817530|560172497|FG007|Overall Study|Exclusionary Medication Received|0|||
155200639|NCT01817530|560172490|FG000|Overall Study|Adverse Event|6|||
155200640|NCT01817530|560172491|FG001|Overall Study|Adverse Event|3|||
155200641|NCT01817530|560172492|FG002|Overall Study|Adverse Event|2|||
155200642|NCT01817530|560172493|FG003|Overall Study|Adverse Event|5|||
155200643|NCT01817530|560172494|FG004|Overall Study|Adverse Event|0|||
155200644|NCT01817530|560172495|FG005|Overall Study|Adverse Event|10|||
155200645|NCT01817530|560172496|FG006|Overall Study|Adverse Event|5|||
155200646|NCT01817530|560172497|FG007|Overall Study|Adverse Event|8|||
155200647|NCT01817530|560172490|FG000|Overall Study|Subject Noncompliant|3|||
155200648|NCT01817530|560172491|FG001|Overall Study|Subject Noncompliant|1|||
155200649|NCT01817530|560172492|FG002|Overall Study|Subject Noncompliant|0|||
155200650|NCT01817530|560172493|FG003|Overall Study|Subject Noncompliant|4|||
155200651|NCT01817530|560172494|FG004|Overall Study|Subject Noncompliant|0|||
155200652|NCT01817530|560172495|FG005|Overall Study|Subject Noncompliant|1|||
155200653|NCT01817530|560172496|FG006|Overall Study|Subject Noncompliant|1|||
155200654|NCT01817530|560172497|FG007|Overall Study|Subject Noncompliant|1|||
155200655|NCT01817530|560172490|FG000|Overall Study|Lack of Efficacy|1|||
155200656|NCT01817530|560172491|FG001|Overall Study|Lack of Efficacy|0|||
155200657|NCT01817530|560172492|FG002|Overall Study|Lack of Efficacy|0|||
155200658|NCT01817530|560172493|FG003|Overall Study|Lack of Efficacy|0|||
155200659|NCT01817530|560172494|FG004|Overall Study|Lack of Efficacy|0|||
155200660|NCT01817530|560172495|FG005|Overall Study|Lack of Efficacy|1|||
155200661|NCT01817530|560172496|FG006|Overall Study|Lack of Efficacy|0|||
155200662|NCT01817530|560172497|FG007|Overall Study|Lack of Efficacy|1|||
155200663|NCT01817530|560172490|FG000|Overall Study|Pregnancy|0|||
155200664|NCT01817530|560172491|FG001|Overall Study|Pregnancy|0|||
155200665|NCT01817530|560172492|FG002|Overall Study|Pregnancy|0|||
155200666|NCT01817530|560172493|FG003|Overall Study|Pregnancy|0|||
155200667|NCT01817530|560172494|FG004|Overall Study|Pregnancy|0|||
155200668|NCT01817530|560172495|FG005|Overall Study|Pregnancy|1|||
155200669|NCT01817530|560172496|FG006|Overall Study|Pregnancy|0|||
155200670|NCT01817530|560172497|FG007|Overall Study|Pregnancy|0|||
155200671|NCT01817530|560172490|FG000|Overall Study|Other|0|||
155200672|NCT01817530|560172491|FG001|Overall Study|Other|1|||
155200673|NCT01817530|560172492|FG002|Overall Study|Other|0|||
155200674|NCT01817530|560172493|FG003|Overall Study|Other|0|||
155200675|NCT01817530|560172494|FG004|Overall Study|Other|1|||
155200676|NCT01817530|560172495|FG005|Overall Study|Other|0|||
155200677|NCT01817530|560172496|FG006|Overall Study|Other|5|||
155200678|NCT01817530|560172497|FG007|Overall Study|Other|0|||
155200679|NCT01817530|560172490|FG000|Overall Study|Surgery or Invasive Intervention|1|||
155200680|NCT01817530|560172491|FG001|Overall Study|Surgery or Invasive Intervention|0|||
155200681|NCT01817530|560172492|FG002|Overall Study|Surgery or Invasive Intervention|0|||
155200682|NCT01817530|560172493|FG003|Overall Study|Surgery or Invasive Intervention|0|||
155200683|NCT01817530|560172494|FG004|Overall Study|Surgery or Invasive Intervention|1|||
155200684|NCT01817530|560172495|FG005|Overall Study|Surgery or Invasive Intervention|1|||
155200685|NCT01817530|560172496|FG006|Overall Study|Surgery or Invasive Intervention|1|||
155200686|NCT01817530|560172497|FG007|Overall Study|Surgery or Invasive Intervention|0|||
155200687|NCT01817530|560172490|FG000|Overall Study|Consent Withdrawn by Subject|3|||
155200688|NCT01817530|560172491|FG001|Overall Study|Consent Withdrawn by Subject|4|||
155200689|NCT01817530|560172492|FG002|Overall Study|Consent Withdrawn by Subject|7|||
155200690|NCT01817530|560172493|FG003|Overall Study|Consent Withdrawn by Subject|3|||
155200691|NCT01817530|560172494|FG004|Overall Study|Consent Withdrawn by Subject|5|||
155200692|NCT01817530|560172495|FG005|Overall Study|Consent Withdrawn by Subject|3|||
155200693|NCT01817530|560172496|FG006|Overall Study|Consent Withdrawn by Subject|3|||
155200694|NCT01817530|560172497|FG007|Overall Study|Consent Withdrawn by Subject|10|||
155200695|NCT01817530|560172490|FG000|Overall Study|Lost to Follow-up|1|||
155200696|NCT01817530|560172491|FG001|Overall Study|Lost to Follow-up|4|||
155200697|NCT01817530|560172492|FG002|Overall Study|Lost to Follow-up|2|||
155200698|NCT01817530|560172493|FG003|Overall Study|Lost to Follow-up|1|||
155200699|NCT01817530|560172494|FG004|Overall Study|Lost to Follow-up|3|||
155200700|NCT01817530|560172495|FG005|Overall Study|Lost to Follow-up|2|||
155200701|NCT01817530|560172496|FG006|Overall Study|Lost to Follow-up|8|||
155200702|NCT01817530|560172497|FG007|Overall Study|Lost to Follow-up|4|||
155200703|NCT03846804|560172498|FG000|Overall Study|Refused blood draw|1|||
155200704|NCT03846804|560172498|FG000|Overall Study|Protocol Violation|1|||
155200705|NCT00566995|560172499|FG000|Overall Study|Toxicity|4|||
155200706|NCT00566995|560172499|FG000|Overall Study|Withdrew consent|3|||
155200707|NCT00679432|560172500|FG000|Overall Study|Adverse Event|5|||
155200708|NCT00679432|560172501|FG001|Overall Study|Adverse Event|6|||
155200709|NCT00679432|560172502|FG002|Overall Study|Adverse Event|10|||
155200710|NCT00679432|560172503|FG003|Overall Study|Adverse Event|7|||
155200711|NCT00679432|560172500|FG000|Overall Study|Protocol Violation|1|||
155200712|NCT00679432|560172501|FG001|Overall Study|Protocol Violation|1|||
155200713|NCT00679432|560172502|FG002|Overall Study|Protocol Violation|2|||
155200714|NCT00679432|560172503|FG003|Overall Study|Protocol Violation|1|||
155200715|NCT00679432|560172500|FG000|Overall Study|Withdrawal by Subject|8|||
155200716|NCT00679432|560172501|FG001|Overall Study|Withdrawal by Subject|11|||
155200717|NCT00679432|560172502|FG002|Overall Study|Withdrawal by Subject|10|||
155200718|NCT00679432|560172503|FG003|Overall Study|Withdrawal by Subject|9|||
155200719|NCT00679432|560172500|FG000|Overall Study|Lost to Follow-up|1|||
155200720|NCT00679432|560172501|FG001|Overall Study|Lost to Follow-up|5|||
155200721|NCT00679432|560172502|FG002|Overall Study|Lost to Follow-up|4|||
155200722|NCT00679432|560172503|FG003|Overall Study|Lost to Follow-up|2|||
155200723|NCT00679432|560172500|FG000|Overall Study|Physician Decision|3|||
155200724|NCT00679432|560172501|FG001|Overall Study|Physician Decision|2|||
155200725|NCT00679432|560172502|FG002|Overall Study|Physician Decision|2|||
155200726|NCT00679432|560172503|FG003|Overall Study|Physician Decision|2|||
155200727|NCT00679432|560172500|FG000|Overall Study|Sponsor decision|1|||
155200728|NCT00679432|560172501|FG001|Overall Study|Sponsor decision|0|||
155200729|NCT00679432|560172502|FG002|Overall Study|Sponsor decision|0|||
155200730|NCT00679432|560172503|FG003|Overall Study|Sponsor decision|0|||
155200731|NCT00679432|560172500|FG000|Overall Study|Lack of Efficacy|13|||
155200732|NCT00679432|560172501|FG001|Overall Study|Lack of Efficacy|9|||
155200733|NCT00679432|560172502|FG002|Overall Study|Lack of Efficacy|14|||
155200734|NCT00679432|560172503|FG003|Overall Study|Lack of Efficacy|8|||
155200735|NCT00679432|560172500|FG000|Overall Study|Infectious colitis, normal histology|5|||
155200736|NCT00679432|560172501|FG001|Overall Study|Infectious colitis, normal histology|4|||
155200737|NCT00679432|560172502|FG002|Overall Study|Infectious colitis, normal histology|8|||
155200738|NCT00679432|560172503|FG003|Overall Study|Infectious colitis, normal histology|3|||
155200739|NCT00679432|560172500|FG000|Overall Study|Randomization error, return to prior Rx|0|||
155200740|NCT00679432|560172501|FG001|Overall Study|Randomization error, return to prior Rx|0|||
155200741|NCT00679432|560172502|FG002|Overall Study|Randomization error, return to prior Rx|3|||
155200742|NCT00679432|560172503|FG003|Overall Study|Randomization error, return to prior Rx|0|||
155200743|NCT00824720|560172504|FG000|Overall Study|failed plug insertion|3|||
155200744|NCT00824720|560172505|FG001|Overall Study|failed plug insertion|1|||
155200745|NCT00824720|560172506|FG002|Overall Study|failed plug insertion|0|||
155200746|NCT00824720|560172504|FG000|Overall Study|Protocol Violation|0|||
155200747|NCT00824720|560172505|FG001|Overall Study|Protocol Violation|0|||
155200748|NCT00824720|560172506|FG002|Overall Study|Protocol Violation|1|||
155200749|NCT01558271|560172507|FG000|Overall Study|Adverse Event|6|||
155200750|NCT01558271|560172508|FG001|Overall Study|Adverse Event|3|||
155200751|NCT01558271|560172509|FG002|Overall Study|Adverse Event|4|||
155200752|NCT01558271|560172507|FG000|Overall Study|Lost to Follow-up|1|||
155200753|NCT01558271|560172508|FG001|Overall Study|Lost to Follow-up|0|||
155200754|NCT01558271|560172509|FG002|Overall Study|Lost to Follow-up|0|||
155200755|NCT01558271|560172507|FG000|Overall Study|Protocol Violation|1|||
155200756|NCT01558271|560172508|FG001|Overall Study|Protocol Violation|0|||
155200757|NCT01558271|560172509|FG002|Overall Study|Protocol Violation|0|||
155200758|NCT01558271|560172507|FG000|Overall Study|Withdrawal by Subject|10|||
155200759|NCT01558271|560172508|FG001|Overall Study|Withdrawal by Subject|6|||
155200760|NCT01558271|560172509|FG002|Overall Study|Withdrawal by Subject|12|||
155200761|NCT01558271|560172507|FG000|Overall Study|Physician Decision|0|||
155200762|NCT01558271|560172508|FG001|Overall Study|Physician Decision|2|||
155200763|NCT01558271|560172509|FG002|Overall Study|Physician Decision|1|||
155200764|NCT02339584|560172510|FG000|Overall Study|Adverse Event|11|||
155200765|NCT02339584|560172511|FG001|Overall Study|Adverse Event|7|||
155200766|NCT02339584|560172510|FG000|Overall Study|Lack of Efficacy|0|||
155200767|NCT02339584|560172511|FG001|Overall Study|Lack of Efficacy|1|||
155200768|NCT02339584|560172510|FG000|Overall Study|Physician Decision|1|||
155200769|NCT02339584|560172511|FG001|Overall Study|Physician Decision|2|||
155200770|NCT02339584|560172510|FG000|Overall Study|Protocol Violation|1|||
155200771|NCT02339584|560172511|FG001|Overall Study|Protocol Violation|1|||
155200772|NCT02339584|560172510|FG000|Overall Study|Withdrawal by Subject|2|||
155200773|NCT02339584|560172511|FG001|Overall Study|Withdrawal by Subject|4|||
155200774|NCT02610725|560172512|FG000|Overall Study|Lost to Follow-up|197|||
155200775|NCT02610725|560172512|FG000|Overall Study|self-reported contraindication|9|||
155200776|NCT04094883|560172513|FG000|Overall Study|Withdrawal by Subject|1|||
155200777|NCT01084083|560172514|FG000|Overall Study|Adverse Event|5|||
155200778|NCT01084083|560172514|FG000|Overall Study|Death|1|||
155200779|NCT01084083|560172514|FG000|Overall Study|Withdrawal by Subject|2|||
155200780|NCT01084083|560172514|FG000|Overall Study|Complicating disease|1|||
155200781|NCT01084083|560172514|FG000|Overall Study|Other|2|||
155200782|NCT01084083|560172514|FG000|Overall Study|Never started assigned therapy|1|||
155200783|NCT00228384|560172515|FG000|Overall Study|Death|9|||
155200784|NCT00228384|560172516|FG001|Overall Study|Death|3|||
155200785|NCT00228384|560172515|FG000|Overall Study|Lost to Follow-up|6|||
155200786|NCT00228384|560172516|FG001|Overall Study|Lost to Follow-up|10|||
155200787|NCT00228384|560172515|FG000|Overall Study|Surgical Intervention (bypass)|5|||
155200788|NCT00228384|560172516|FG001|Overall Study|Surgical Intervention (bypass)|5|||
155200789|NCT00228384|560172515|FG000|Overall Study|Withdrawal by Subject|9|||
155200790|NCT00228384|560172516|FG001|Overall Study|Withdrawal by Subject|10|||
155200791|NCT00228384|560172515|FG000|Overall Study|Physician Decision|0|||
155200792|NCT00228384|560172516|FG001|Overall Study|Physician Decision|1|||
155200793|NCT01466153|560172520|FG000|Overall Study|Disease Progression|2|||
155200794|NCT01466153|560172521|FG001|Overall Study|Disease Progression|2|||
155200795|NCT01466153|560172522|FG002|Overall Study|Disease Progression|0|||
155200796|NCT01466153|560172520|FG000|Overall Study|Adverse Event|14|||
155200797|NCT01466153|560172521|FG001|Overall Study|Adverse Event|13|||
155200798|NCT01466153|560172522|FG002|Overall Study|Adverse Event|17|||
155200799|NCT01466153|560172520|FG000|Overall Study|Withdrawal of Consent|2|||
155200800|NCT01466153|560172521|FG001|Overall Study|Withdrawal of Consent|0|||
155200801|NCT01466153|560172522|FG002|Overall Study|Withdrawal of Consent|0|||
155200802|NCT01466153|560172520|FG000|Overall Study|Investigator Discretion|3|||
155200803|NCT01466153|560172521|FG001|Overall Study|Investigator Discretion|2|||
155200804|NCT01466153|560172522|FG002|Overall Study|Investigator Discretion|2|||
155200805|NCT01466153|560172520|FG000|Overall Study|Randomized-Not Treated|2|||
155200806|NCT01466153|560172521|FG001|Overall Study|Randomized-Not Treated|3|||
155200807|NCT01466153|560172522|FG002|Overall Study|Randomized-Not Treated|4|||
155200808|NCT01466153|560172520|FG000|Overall Study|Other-Unspecified|6|||
155200809|NCT01466153|560172521|FG001|Overall Study|Other-Unspecified|4|||
155200810|NCT01466153|560172522|FG002|Overall Study|Other-Unspecified|2|||
155200811|NCT05695209|560172523|FG000|3-months|Withdrawal by Subject|2|||
155200812|NCT05695209|560172524|FG001|3-months|Withdrawal by Subject|0|||
155200813|NCT05695209|560172523|FG000|3-months|Unable to contact for 3-month data collection|0|||
155200814|NCT05695209|560172524|FG001|3-months|Unable to contact for 3-month data collection|1|||
155200815|NCT05695209|560172523|FG000|6-months|Lost to Follow-up|1|||
155200816|NCT05695209|560172524|FG001|6-months|Lost to Follow-up|1|||
155200817|NCT04362072|560172527|FG000|Treatment|Adverse Event|1|||
155200818|NCT04362072|560172527|FG000|Treatment|Death|9|||
155200819|NCT04362072|560172527|FG000|Treatment|Physician Decision|2|||
155200820|NCT04362072|560172527|FG000|Treatment|Progressive disease|27|||
155200821|NCT04362072|560172527|FG000|Treatment|Withdrawal by Subject|4|||
155200822|NCT04362072|560172527|FG000|Treatment|Global deterioration of health status|1|||
155200823|NCT04362072|560172527|FG000|Treatment|Switched to commercial Lorlatinib|13|||
155200824|NCT04362072|560172527|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
155200825|NCT04362072|560172527|FG000|Treatment|Other|3|||
155200826|NCT04362072|560172527|FG000|Follow up|Death|2|||
155200827|NCT04362072|560172527|FG000|Follow up|Other|2|||
155200828|NCT01133522|560172528|FG000|Overall Study|Withdrawal by Subject|0|||
155200829|NCT01133522|560172529|FG001|Overall Study|Withdrawal by Subject|1|||
155200830|NCT01133522|560172530|FG002|Overall Study|Withdrawal by Subject|0|||
155200831|NCT01133522|560172531|FG003|Overall Study|Withdrawal by Subject|1|||
155200832|NCT01133522|560172532|FG004|Overall Study|Withdrawal by Subject|0|||
155200833|NCT01133522|560172533|FG005|Overall Study|Withdrawal by Subject|0|||
155200834|NCT01133522|560172534|FG006|Overall Study|Withdrawal by Subject|0|||
155200835|NCT01133522|560172535|FG007|Overall Study|Withdrawal by Subject|0|||
155200836|NCT01133522|560172536|FG008|Overall Study|Withdrawal by Subject|0|||
155200837|NCT01133522|560172537|FG009|Overall Study|Withdrawal by Subject|0|||
155200838|NCT01133522|560172528|FG000|Overall Study|Physician Decision|0|||
155200839|NCT01133522|560172529|FG001|Overall Study|Physician Decision|0|||
155200840|NCT01133522|560172530|FG002|Overall Study|Physician Decision|0|||
155200841|NCT01133522|560172531|FG003|Overall Study|Physician Decision|0|||
155200842|NCT01133522|560172532|FG004|Overall Study|Physician Decision|1|||
155200843|NCT01133522|560172533|FG005|Overall Study|Physician Decision|0|||
155200844|NCT01133522|560172534|FG006|Overall Study|Physician Decision|0|||
155200845|NCT01133522|560172535|FG007|Overall Study|Physician Decision|0|||
155200846|NCT01133522|560172536|FG008|Overall Study|Physician Decision|0|||
155200847|NCT01133522|560172537|FG009|Overall Study|Physician Decision|0|||
155200848|NCT04731363|560172543|FG000|Overall Study|Could not obtain samples|0|||
155200849|NCT04731363|560172544|FG001|Overall Study|Could not obtain samples|1|||
155200850|NCT04731363|560172545|FG002|Overall Study|Could not obtain samples|0|||
155200851|NCT04731363|560172546|FG003|Overall Study|Could not obtain samples|0|||
155200852|NCT04731363|560172543|FG000|Overall Study|Physician Decision|0|||
155200853|NCT04731363|560172544|FG001|Overall Study|Physician Decision|1|||
155200854|NCT04731363|560172545|FG002|Overall Study|Physician Decision|0|||
155200855|NCT04731363|560172546|FG003|Overall Study|Physician Decision|0|||
155200856|NCT01918774|560174553|FG000|Overall Study|Lost prior to first CBTw session|4|||
155200857|NCT01918774|560174553|FG000|Overall Study|Lost to Follow-up|1|||
155200858|NCT01606800|560174554|FG000|Overall Study|Adverse Event|3|||
155200859|NCT01606800|560174555|FG001|Overall Study|Adverse Event|1|||
155200860|NCT01606800|560174554|FG000|Overall Study|Participant withdrew consent|0|||
155200861|NCT01606800|560174555|FG001|Overall Study|Participant withdrew consent|1|||
155200862|NCT01606800|560174554|FG000|Overall Study|Missing completion status|2|||
155200863|NCT01606800|560174555|FG001|Overall Study|Missing completion status|0|||
155200864|NCT00717197|560174561|FG000|Overall Study|Unable to purchase study drug|5|||
155200865|NCT00717197|560174561|FG000|Overall Study|Tumor Progression|1|||
155200866|NCT00717197|560174561|FG000|Overall Study|Physician Decision|1|||
155200867|NCT00982137|560174562|FG000|Overall Study|Lost to Follow-up|0|||
155200868|NCT00982137|560174563|FG001|Overall Study|Lost to Follow-up|0|||
155200869|NCT00982137|560174564|FG002|Overall Study|Lost to Follow-up|0|||
155200870|NCT00982137|560174565|FG003|Overall Study|Lost to Follow-up|1|||
155200871|NCT00982137|560174562|FG000|Overall Study|Withdrawal by Subject|0|||
155200872|NCT00982137|560174563|FG001|Overall Study|Withdrawal by Subject|1|||
155200873|NCT00982137|560174564|FG002|Overall Study|Withdrawal by Subject|0|||
155200874|NCT00982137|560174565|FG003|Overall Study|Withdrawal by Subject|0|||
155200875|NCT01898806|560174568|FG000|Overall Study|Withdrawal by Subject|2|||
155200876|NCT01898806|560174568|FG000|Overall Study|Physician Decision|1|||
155200877|NCT03003390|560174569|FG000|Overall Study|Physician Decision|2|||
155200878|NCT03003390|560174570|FG001|Overall Study|Physician Decision|0|||
155200879|NCT03003390|560174569|FG000|Overall Study|Parent refused intervention|2|||
155200880|NCT03003390|560174570|FG001|Overall Study|Parent refused intervention|0|||
155200881|NCT03000439|560174589|FG000|Open Label Part 1|Adverse Event|6|||
155200882|NCT03000439|560174590|FG001|Open Label Part 1|Adverse Event|0|||
155200883|NCT03000439|560174591|FG002|Open Label Part 1|Adverse Event|0|||
155200884|NCT03000439|560174592|FG003|Open Label Part 1|Adverse Event|0|||
155200885|NCT03000439|560174589|FG000|Open Label Part 1|Other|2|||
155200886|NCT03000439|560174590|FG001|Open Label Part 1|Other|0|||
155200887|NCT03000439|560174591|FG002|Open Label Part 1|Other|0|||
155200888|NCT03000439|560174592|FG003|Open Label Part 1|Other|0|||
155200889|NCT03000439|560174589|FG000|Open Label Part 1|Insufficient clinical response|16|||
155200890|NCT03000439|560174590|FG001|Open Label Part 1|Insufficient clinical response|0|||
155200891|NCT03000439|560174591|FG002|Open Label Part 1|Insufficient clinical response|0|||
155200892|NCT03000439|560174592|FG003|Open Label Part 1|Insufficient clinical response|0|||
155200893|NCT03000439|560174589|FG000|Open Label Part 2|Other|0|||
155200894|NCT03000439|560174590|FG001|Open Label Part 2|Other|5|||
155200895|NCT03000439|560174591|FG002|Open Label Part 2|Other|0|||
155200896|NCT03000439|560174592|FG003|Open Label Part 2|Other|0|||
155200897|NCT03000439|560174589|FG000|Open Label Part 2|Insufficient clinical response|0|||
155200898|NCT03000439|560174590|FG001|Open Label Part 2|Insufficient clinical response|12|||
155200899|NCT03000439|560174591|FG002|Open Label Part 2|Insufficient clinical response|0|||
155200900|NCT03000439|560174592|FG003|Open Label Part 2|Insufficient clinical response|0|||
155200901|NCT03000439|560174589|FG000|Double Blind Phase|Adverse Event|0|||
155200902|NCT03000439|560174590|FG001|Double Blind Phase|Adverse Event|0|||
155200903|NCT03000439|560174591|FG002|Double Blind Phase|Adverse Event|2|||
155200904|NCT03000439|560174592|FG003|Double Blind Phase|Adverse Event|1|||
155200905|NCT03000439|560174589|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
155200906|NCT03000439|560174590|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
155200907|NCT03000439|560174591|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
155200908|NCT03000439|560174592|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
155200909|NCT03000439|560174589|FG000|Double Blind Phase|Other|0|||
155200910|NCT03000439|560174590|FG001|Double Blind Phase|Other|0|||
155200911|NCT03000439|560174591|FG002|Double Blind Phase|Other|10|||
155200912|NCT03000439|560174592|FG003|Double Blind Phase|Other|11|||
155200913|NCT03000439|560174589|FG000|Double Blind Phase|Insufficient clinical response|0|||
155200914|NCT03000439|560174590|FG001|Double Blind Phase|Insufficient clinical response|0|||
155200915|NCT03000439|560174591|FG002|Double Blind Phase|Insufficient clinical response|0|||
155200916|NCT03000439|560174592|FG003|Double Blind Phase|Insufficient clinical response|2|||
155200917|NCT02370160|560174593|FG000|Overall Study|Death|3|||
155200918|NCT02370160|560174594|FG001|Overall Study|Death|4|||
155200919|NCT02370160|560174595|FG002|Overall Study|Death|1|||
155200920|NCT02501473|560174598|FG000|Overall Study|Study Terminated|2|||
155200921|NCT02501473|560174599|FG001|Overall Study|Study Terminated|3|||
155200922|NCT02501473|560174600|FG002|Overall Study|Study Terminated|7|||
155200923|NCT02501473|560174601|FG003|Overall Study|Study Terminated|9|||
155200924|NCT02501473|560174602|FG004|Overall Study|Study Terminated|2|||
155200925|NCT02501473|560174603|FG005|Overall Study|Study Terminated|10|||
155200926|NCT02501473|560174604|FG006|Overall Study|Study Terminated|1|||
155200927|NCT02501473|560174605|FG007|Overall Study|Study Terminated|0|||
155200928|NCT02501473|560174598|FG000|Overall Study|Withdrawal by Subject|0|||
155200929|NCT02501473|560174599|FG001|Overall Study|Withdrawal by Subject|0|||
155200930|NCT02501473|560174600|FG002|Overall Study|Withdrawal by Subject|3|||
155200931|NCT02501473|560174601|FG003|Overall Study|Withdrawal by Subject|3|||
155200932|NCT02501473|560174602|FG004|Overall Study|Withdrawal by Subject|2|||
155200933|NCT02501473|560174603|FG005|Overall Study|Withdrawal by Subject|2|||
155200934|NCT02501473|560174604|FG006|Overall Study|Withdrawal by Subject|0|||
155200935|NCT02501473|560174605|FG007|Overall Study|Withdrawal by Subject|0|||
155200936|NCT02501473|560174598|FG000|Overall Study|Death|0|||
155200937|NCT02501473|560174599|FG001|Overall Study|Death|0|||
155200938|NCT02501473|560174600|FG002|Overall Study|Death|1|||
155200939|NCT02501473|560174601|FG003|Overall Study|Death|1|||
155200940|NCT02501473|560174602|FG004|Overall Study|Death|0|||
155200941|NCT02501473|560174603|FG005|Overall Study|Death|1|||
155200942|NCT02501473|560174604|FG006|Overall Study|Death|0|||
155200943|NCT02501473|560174605|FG007|Overall Study|Death|0|||
155200944|NCT02501473|560174598|FG000|Overall Study|Lost to Follow-up|1|||
155200945|NCT02501473|560174599|FG001|Overall Study|Lost to Follow-up|0|||
155200946|NCT02501473|560174600|FG002|Overall Study|Lost to Follow-up|1|||
155200947|NCT02501473|560174601|FG003|Overall Study|Lost to Follow-up|0|||
155200948|NCT02501473|560174602|FG004|Overall Study|Lost to Follow-up|0|||
155200949|NCT02501473|560174603|FG005|Overall Study|Lost to Follow-up|1|||
155200950|NCT02501473|560174604|FG006|Overall Study|Lost to Follow-up|0|||
155200951|NCT02501473|560174605|FG007|Overall Study|Lost to Follow-up|0|||
155200952|NCT02501473|560174598|FG000|Overall Study|Reason not specified|0|||
155200953|NCT02501473|560174599|FG001|Overall Study|Reason not specified|0|||
155200954|NCT02501473|560174600|FG002|Overall Study|Reason not specified|1|||
155200955|NCT02501473|560174601|FG003|Overall Study|Reason not specified|1|||
155200956|NCT02501473|560174602|FG004|Overall Study|Reason not specified|0|||
155200957|NCT02501473|560174603|FG005|Overall Study|Reason not specified|0|||
155200958|NCT02501473|560174604|FG006|Overall Study|Reason not specified|0|||
155200959|NCT02501473|560174605|FG007|Overall Study|Reason not specified|0|||
155200960|NCT01581931|560174606|FG000|Washout|Adverse Event|0|||
155200961|NCT01581931|560174607|FG001|Washout|Adverse Event|1|||
155200962|NCT02954237|560174612|FG000|Overall Study|Withdrawal by Subject|25|||
155200963|NCT02954237|560174612|FG000|Overall Study|Missed visit|16|||
155200964|NCT02954237|560174612|FG000|Overall Study|Death|2|||
155200965|NCT00674700|560174613|FG000|Year 1|Adverse Event|17|||
155200966|NCT00674700|560174614|FG001|Year 1|Adverse Event|20|||
155200967|NCT00674700|560174615|FG002|Year 1|Adverse Event|5|||
155200968|NCT00674700|560174613|FG000|Year 1|Withdrawal by Subject|7|||
155200969|NCT00674700|560174614|FG001|Year 1|Withdrawal by Subject|7|||
155200970|NCT00674700|560174615|FG002|Year 1|Withdrawal by Subject|6|||
155200971|NCT00674700|560174613|FG000|Year 1|Any other reason not above-mentioned|7|||
155200972|NCT00674700|560174614|FG001|Year 1|Any other reason not above-mentioned|7|||
155200973|NCT00674700|560174615|FG002|Year 1|Any other reason not above-mentioned|6|||
155200974|NCT00674700|560174613|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
155200975|NCT00674700|560174614|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
155200976|NCT00674700|560174615|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
155200977|NCT00674700|560174613|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
155200978|NCT00674700|560174614|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
155200979|NCT00674700|560174615|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
155200980|NCT00674700|560174613|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
155200981|NCT00674700|560174614|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
155200982|NCT00674700|560174615|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
155200983|NCT00395304|560174616|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155200984|NCT00395304|560174617|FG001|Treatment Period 1|Withdrawal by Subject|3|||
155200985|NCT00395304|560174618|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155200986|NCT00395304|560174619|FG003|Treatment Period 1|Withdrawal by Subject|2|||
155200987|NCT00395304|560174620|FG004|Treatment Period 1|Withdrawal by Subject|1|||
155200988|NCT00395304|560174621|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155200989|NCT00395304|560174616|FG000|Treatment Period 1|Lost to Follow-up|1|||
155200990|NCT00395304|560174617|FG001|Treatment Period 1|Lost to Follow-up|0|||
155200991|NCT00395304|560174618|FG002|Treatment Period 1|Lost to Follow-up|0|||
155200992|NCT00395304|560174619|FG003|Treatment Period 1|Lost to Follow-up|1|||
155200993|NCT00395304|560174620|FG004|Treatment Period 1|Lost to Follow-up|0|||
155200994|NCT00395304|560174621|FG005|Treatment Period 1|Lost to Follow-up|1|||
155200995|NCT00395304|560174616|FG000|Treatment Period 1|Physician Decision|0|||
155200996|NCT00395304|560174617|FG001|Treatment Period 1|Physician Decision|1|||
155200997|NCT00395304|560174618|FG002|Treatment Period 1|Physician Decision|0|||
155200998|NCT00395304|560174619|FG003|Treatment Period 1|Physician Decision|0|||
155200999|NCT00395304|560174620|FG004|Treatment Period 1|Physician Decision|0|||
155201000|NCT00395304|560174621|FG005|Treatment Period 1|Physician Decision|0|||
155201001|NCT00395304|560174616|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155201002|NCT00395304|560174617|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155201003|NCT00395304|560174618|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155201004|NCT00395304|560174619|FG003|Treatment Period 2|Withdrawal by Subject|1|||
155201005|NCT00395304|560174620|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155201006|NCT00395304|560174621|FG005|Treatment Period 2|Withdrawal by Subject|2|||
155201007|NCT00395304|560174616|FG000|Treatment Period 2|Lost to Follow-up|0|||
155201008|NCT00395304|560174617|FG001|Treatment Period 2|Lost to Follow-up|3|||
155201009|NCT00395304|560174618|FG002|Treatment Period 2|Lost to Follow-up|0|||
155201010|NCT00395304|560174619|FG003|Treatment Period 2|Lost to Follow-up|0|||
155201011|NCT00395304|560174620|FG004|Treatment Period 2|Lost to Follow-up|0|||
155201012|NCT00395304|560174621|FG005|Treatment Period 2|Lost to Follow-up|0|||
155201013|NCT00395304|560174616|FG000|Treatment Period 2|Physician Decision|0|||
155201014|NCT00395304|560174617|FG001|Treatment Period 2|Physician Decision|0|||
155201015|NCT00395304|560174618|FG002|Treatment Period 2|Physician Decision|1|||
155201016|NCT00395304|560174619|FG003|Treatment Period 2|Physician Decision|0|||
155201017|NCT00395304|560174620|FG004|Treatment Period 2|Physician Decision|0|||
155201018|NCT00395304|560174621|FG005|Treatment Period 2|Physician Decision|0|||
155201019|NCT00395304|560174616|FG000|Treatment Period 2|Other|0|||
155201020|NCT00395304|560174617|FG001|Treatment Period 2|Other|1|||
155201021|NCT00395304|560174618|FG002|Treatment Period 2|Other|0|||
155201022|NCT00395304|560174619|FG003|Treatment Period 2|Other|0|||
155201023|NCT00395304|560174620|FG004|Treatment Period 2|Other|0|||
155201024|NCT00395304|560174621|FG005|Treatment Period 2|Other|0|||
155201025|NCT00395304|560174616|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155201026|NCT00395304|560174617|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155201027|NCT00395304|560174618|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155201028|NCT00395304|560174619|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155201029|NCT00395304|560174620|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155201030|NCT00395304|560174621|FG005|Treatment Period 3|Withdrawal by Subject|1|||
155201031|NCT00395304|560174616|FG000|Treatment Period 3|Lost to Follow-up|1|||
155201032|NCT00395304|560174617|FG001|Treatment Period 3|Lost to Follow-up|1|||
155201033|NCT00395304|560174618|FG002|Treatment Period 3|Lost to Follow-up|0|||
155201034|NCT00395304|560174619|FG003|Treatment Period 3|Lost to Follow-up|0|||
155201035|NCT00395304|560174620|FG004|Treatment Period 3|Lost to Follow-up|0|||
155201036|NCT00395304|560174621|FG005|Treatment Period 3|Lost to Follow-up|0|||
155201037|NCT00395304|560174616|FG000|Treatment Period 3|Physician Decision|0|||
155201038|NCT00395304|560174617|FG001|Treatment Period 3|Physician Decision|1|||
155201039|NCT00395304|560174618|FG002|Treatment Period 3|Physician Decision|0|||
155201040|NCT00395304|560174619|FG003|Treatment Period 3|Physician Decision|0|||
155201041|NCT00395304|560174620|FG004|Treatment Period 3|Physician Decision|0|||
155201042|NCT00395304|560174621|FG005|Treatment Period 3|Physician Decision|0|||
155201043|NCT00395304|560174616|FG000|Treatment Period 3|Other|0|||
155201044|NCT00395304|560174617|FG001|Treatment Period 3|Other|0|||
155201045|NCT00395304|560174618|FG002|Treatment Period 3|Other|0|||
155201046|NCT00395304|560174619|FG003|Treatment Period 3|Other|1|||
155201047|NCT00395304|560174620|FG004|Treatment Period 3|Other|0|||
155201048|NCT00395304|560174621|FG005|Treatment Period 3|Other|0|||
155201049|NCT03130257|560174622|FG000|Overall Study|Withdrawal by Subject|1|||
155201050|NCT03130257|560174623|FG001|Overall Study|Withdrawal by Subject|0|||
155201051|NCT03130257|560174624|FG002|Overall Study|Withdrawal by Subject|2|||
155201052|NCT03600818|560174625|FG000|Overall Study|Adverse Event|4|||
155201053|NCT03600818|560174626|FG001|Overall Study|Adverse Event|7|||
155201054|NCT03600818|560174625|FG000|Overall Study|Lack of Efficacy|9|||
155201055|NCT03600818|560174626|FG001|Overall Study|Lack of Efficacy|4|||
155201056|NCT03600818|560174625|FG000|Overall Study|Withdrawal by Subject|4|||
155201057|NCT03600818|560174626|FG001|Overall Study|Withdrawal by Subject|3|||
155201058|NCT03600818|560174625|FG000|Overall Study|Other-unspecified|5|||
155201059|NCT03600818|560174626|FG001|Overall Study|Other-unspecified|3|||
155201060|NCT03600818|560174625|FG000|Overall Study|Randomized and not treated|0|||
155201061|NCT03600818|560174626|FG001|Overall Study|Randomized and not treated|1|||
155201062|NCT01488370|560174629|FG000|Overall Study|Protocol Violation|0|||
155201063|NCT01488370|560174630|FG001|Overall Study|Protocol Violation|1|||
155201064|NCT01488370|560174631|FG002|Overall Study|Protocol Violation|1|||
155201065|NCT04189081|560174633|FG000|Overall Study|Lost to Follow-up|1|||
155201066|NCT04189081|560174634|FG001|Overall Study|Lost to Follow-up|0|||
155201067|NCT04189081|560174635|FG002|Overall Study|Lost to Follow-up|0|||
155201068|NCT04189081|560174633|FG000|Overall Study|Withdrawal by Subject|0|||
155201069|NCT04189081|560174634|FG001|Overall Study|Withdrawal by Subject|0|||
155201070|NCT04189081|560174635|FG002|Overall Study|Withdrawal by Subject|1|||
155201071|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
155201072|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
155201073|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
155201074|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
155201075|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
155201076|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
155201077|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
155201078|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
155201079|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
155201080|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
155201081|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
155201082|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
155201083|NCT00044083|560174636|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
155201084|NCT00044083|560174637|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
155201085|NCT00044083|560174636|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
155201086|NCT00044083|560174637|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
155201087|NCT00044083|560174636|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
155201088|NCT00044083|560174637|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
155201089|NCT00044083|560174636|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
155201090|NCT00044083|560174637|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
155201091|NCT00851747|560174644|FG000|Overall Study|Physician Decision|6|||
155201092|NCT00851747|560174645|FG001|Overall Study|Physician Decision|6|||
155201093|NCT00851747|560174646|FG002|Overall Study|Physician Decision|6|||
155201094|NCT02499783|560174651|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
155201095|NCT02499783|560174652|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
155201096|NCT02499783|560174653|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
155201097|NCT02499783|560174651|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
155201098|NCT02499783|560174652|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
155201099|NCT02499783|560174653|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
155201100|NCT02499783|560174651|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
155201101|NCT02499783|560174652|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
155201102|NCT02499783|560174653|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
155201103|NCT02499783|560174651|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
155201104|NCT02499783|560174652|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
155201105|NCT02499783|560174653|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
155201106|NCT02499783|560174651|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
155201107|NCT02499783|560174652|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
155201108|NCT02499783|560174653|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
155201109|NCT02499783|560174651|FG000|DB Period: Weeks 0-8|Other|1|||
155201110|NCT02499783|560174652|FG001|DB Period: Weeks 0-8|Other|1|||
155201111|NCT02499783|560174653|FG002|DB Period: Weeks 0-8|Other|0|||
155201112|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
155201113|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
155201114|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
155201115|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
155201116|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
155201117|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
155201118|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
155201119|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
155201120|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
155201121|NCT02499783|560174651|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
155201122|NCT02499783|560174652|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
155201123|NCT02499783|560174653|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
155201124|NCT02228460|560174654|FG000|Overall Study|Adverse Event|1|||
155201125|NCT02228460|560174654|FG000|Overall Study|Lost to Follow-up|1|||
155201126|NCT01243892|560174655|FG000|Overall Study|Did not meet eligibility criteria|2|||
155201127|NCT01243892|560174656|FG001|Overall Study|Did not meet eligibility criteria|0|||
155201128|NCT00119106|560174657|FG000|Overall Study|HIV infected at baseline|179|||
155201129|NCT00119106|560174658|FG001|Overall Study|HIV infected at baseline|178|||
155201130|NCT01866293|560174659|FG000|Overall Study|Adverse Event|2|||
155201131|NCT01010061|560174660|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
155201132|NCT01010061|560174661|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
155201133|NCT01010061|560174660|FG000|Overall Study|Disease Progression|2|||
155201134|NCT01010061|560174661|FG001|Overall Study|Disease Progression|8|||
155201135|NCT01010061|560174660|FG000|Overall Study|Withdrew Consent|5|||
155201136|NCT01010061|560174661|FG001|Overall Study|Withdrew Consent|1|||
155201137|NCT01010061|560174660|FG000|Overall Study|Death|3|||
155201138|NCT01010061|560174661|FG001|Overall Study|Death|6|||
155201139|NCT01010061|560174660|FG000|Overall Study|Administrative/Other|0|||
155201140|NCT01010061|560174661|FG001|Overall Study|Administrative/Other|1|||
155201141|NCT01010061|560174660|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
155201142|NCT01010061|560174661|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
155201143|NCT01010061|560174660|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155201144|NCT01010061|560174661|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155201145|NCT01010061|560174660|FG000|Overall Study|Violation of Selection Criteria|0|||
155201146|NCT01010061|560174661|FG001|Overall Study|Violation of Selection Criteria|1|||
155201147|NCT01010061|560174660|FG000|Overall Study|Did Not Receive Treatment|2|||
155201148|NCT01010061|560174661|FG001|Overall Study|Did Not Receive Treatment|2|||
155201149|NCT03066804|560174662|FG000|Overall Study|Physician Decision|0|||
155201150|NCT03066804|560174663|FG001|Overall Study|Physician Decision|4|||
155201151|NCT03066804|560174662|FG000|Overall Study|Death|23|||
155201152|NCT03066804|560174663|FG001|Overall Study|Death|17|||
155201153|NCT03066804|560174662|FG000|Overall Study|Withdrawal by Subject|19|||
155201154|NCT03066804|560174663|FG001|Overall Study|Withdrawal by Subject|25|||
155201155|NCT03066804|560174662|FG000|Overall Study|Lost to Follow-up|2|||
155201156|NCT03066804|560174663|FG001|Overall Study|Lost to Follow-up|0|||
155201157|NCT03066804|560174662|FG000|Overall Study|Adverse Event|2|||
155201158|NCT03066804|560174663|FG001|Overall Study|Adverse Event|3|||
155201159|NCT03066804|560174662|FG000|Overall Study|Technical problems|5|||
155201160|NCT03066804|560174663|FG001|Overall Study|Technical problems|1|||
155201161|NCT03470441|560174667|FG000|Overall Study|Death|0|||
155201162|NCT03470441|560174668|FG001|Overall Study|Death|1|||
155201163|NCT03470441|560174669|FG002|Overall Study|Death|1|||
155201164|NCT03470441|560174670|FG003|Overall Study|Death|0|||
155201165|NCT03470441|560174667|FG000|Overall Study|Adverse Event|0|||
155201166|NCT03470441|560174668|FG001|Overall Study|Adverse Event|0|||
155201167|NCT03470441|560174669|FG002|Overall Study|Adverse Event|0|||
155201168|NCT03470441|560174670|FG003|Overall Study|Adverse Event|1|||
155201169|NCT03470441|560174667|FG000|Overall Study|Withdrawal by Subject|1|||
155201170|NCT03470441|560174668|FG001|Overall Study|Withdrawal by Subject|4|||
155201171|NCT03470441|560174669|FG002|Overall Study|Withdrawal by Subject|1|||
155201172|NCT03470441|560174670|FG003|Overall Study|Withdrawal by Subject|3|||
155201173|NCT03982368|560174671|FG000|Overall Study|Adverse Event|6|||
155201174|NCT03982368|560174672|FG001|Overall Study|Adverse Event|4|||
155201175|NCT03982368|560174673|FG002|Overall Study|Adverse Event|3|||
155201176|NCT03982368|560174671|FG000|Overall Study|Lost to Follow-up|2|||
155201177|NCT03982368|560174672|FG001|Overall Study|Lost to Follow-up|1|||
155201178|NCT03982368|560174673|FG002|Overall Study|Lost to Follow-up|0|||
155201179|NCT03982368|560174671|FG000|Overall Study|Withdrawal by Subject|1|||
155201180|NCT03982368|560174672|FG001|Overall Study|Withdrawal by Subject|2|||
155201181|NCT03982368|560174673|FG002|Overall Study|Withdrawal by Subject|0|||
155201182|NCT03982368|560174671|FG000|Overall Study|unknow|4|||
155201183|NCT03982368|560174672|FG001|Overall Study|unknow|0|||
155201184|NCT03982368|560174673|FG002|Overall Study|unknow|2|||
155201185|NCT00518284|560174674|FG000|Overall Study|Adverse Event|0|||
155201186|NCT00518284|560174675|FG001|Overall Study|Adverse Event|1|||
155201187|NCT00518284|560174676|FG002|Overall Study|Adverse Event|0|||
155201188|NCT00518284|560174677|FG003|Overall Study|Adverse Event|0|||
155201189|NCT00518284|560174674|FG000|Overall Study|Study Termination|0|||
155201190|NCT00518284|560174675|FG001|Overall Study|Study Termination|2|||
155201191|NCT00518284|560174676|FG002|Overall Study|Study Termination|1|||
155201192|NCT00518284|560174677|FG003|Overall Study|Study Termination|2|||
155201193|NCT03768414|560174678|FG000|Overall Study|Adverse Event or side effects|72|||
155201194|NCT03768414|560174679|FG001|Overall Study|Adverse Event or side effects|28|||
155201195|NCT03768414|560174678|FG000|Overall Study|Refusal unrelated to adverse event|33|||
155201196|NCT03768414|560174679|FG001|Overall Study|Refusal unrelated to adverse event|33|||
155201197|NCT03768414|560174678|FG000|Overall Study|Progression/relapse|132|||
155201198|NCT03768414|560174679|FG001|Overall Study|Progression/relapse|60|||
155201199|NCT03768414|560174678|FG000|Overall Study|Death|9|||
155201200|NCT03768414|560174679|FG001|Overall Study|Death|6|||
155201201|NCT03768414|560174678|FG000|Overall Study|Other - not protocol specified|45|||
155201202|NCT03768414|560174679|FG001|Overall Study|Other - not protocol specified|18|||
155201203|NCT03768414|560174678|FG000|Overall Study|Reason under review|3|||
155201204|NCT03768414|560174679|FG001|Overall Study|Reason under review|2|||
155201205|NCT02571777|560174681|FG000|Overall Study|Subject/guardian decision|34|||
155201206|NCT02571777|560174682|FG001|Overall Study|Subject/guardian decision|26|||
155201207|NCT02571777|560174683|FG002|Overall Study|Subject/guardian decision|26|||
155201208|NCT02571777|560174684|FG003|Overall Study|Subject/guardian decision|25|||
155201209|NCT02571777|560174685|FG004|Overall Study|Subject/guardian decision|27|||
155201210|NCT02571777|560174681|FG000|Overall Study|Protocol Deviation|2|||
155201211|NCT02571777|560174682|FG001|Overall Study|Protocol Deviation|3|||
155201212|NCT02571777|560174683|FG002|Overall Study|Protocol Deviation|4|||
155201213|NCT02571777|560174684|FG003|Overall Study|Protocol Deviation|8|||
155201214|NCT02571777|560174685|FG004|Overall Study|Protocol Deviation|4|||
155201215|NCT02571777|560174681|FG000|Overall Study|Death|1|||
155201216|NCT02571777|560174682|FG001|Overall Study|Death|1|||
155201217|NCT02571777|560174683|FG002|Overall Study|Death|4|||
155201218|NCT02571777|560174684|FG003|Overall Study|Death|0|||
155201219|NCT02571777|560174685|FG004|Overall Study|Death|0|||
155201220|NCT02571777|560174681|FG000|Overall Study|Lost to Follow-up|1|||
155201221|NCT02571777|560174682|FG001|Overall Study|Lost to Follow-up|1|||
155201222|NCT02571777|560174683|FG002|Overall Study|Lost to Follow-up|2|||
155201223|NCT02571777|560174684|FG003|Overall Study|Lost to Follow-up|0|||
155201224|NCT02571777|560174685|FG004|Overall Study|Lost to Follow-up|1|||
155201225|NCT02571777|560174681|FG000|Overall Study|Physician Decision|1|||
155201226|NCT02571777|560174682|FG001|Overall Study|Physician Decision|7|||
155201227|NCT02571777|560174683|FG002|Overall Study|Physician Decision|5|||
155201228|NCT02571777|560174684|FG003|Overall Study|Physician Decision|2|||
155201229|NCT02571777|560174685|FG004|Overall Study|Physician Decision|4|||
155201230|NCT02571777|560174681|FG000|Overall Study|Pregnancy|0|||
155201231|NCT02571777|560174682|FG001|Overall Study|Pregnancy|0|||
155201232|NCT02571777|560174683|FG002|Overall Study|Pregnancy|0|||
155201233|NCT02571777|560174684|FG003|Overall Study|Pregnancy|2|||
155201234|NCT02571777|560174685|FG004|Overall Study|Pregnancy|0|||
155201235|NCT03706079|560174686|FG000|Predecessor Study|Death|0|||
155201236|NCT03706079|560174687|FG001|Predecessor Study|Death|2|||
155201237|NCT03706079|560174688|FG002|Predecessor Study|Death|0|||
155201238|NCT03706079|560174689|FG003|Predecessor Study|Death|1|||
155201239|NCT03706079|560174690|FG004|Predecessor Study|Death|0|||
155201240|NCT03706079|560174691|FG005|Predecessor Study|Death|0|||
155201241|NCT03706079|560174686|FG000|Predecessor Study|Lost to Follow-up|5|||
155201242|NCT03706079|560174687|FG001|Predecessor Study|Lost to Follow-up|2|||
155201243|NCT03706079|560174688|FG002|Predecessor Study|Lost to Follow-up|0|||
155201244|NCT03706079|560174689|FG003|Predecessor Study|Lost to Follow-up|0|||
155201245|NCT03706079|560174690|FG004|Predecessor Study|Lost to Follow-up|1|||
155201246|NCT03706079|560174691|FG005|Predecessor Study|Lost to Follow-up|0|||
155201247|NCT03706079|560174686|FG000|Predecessor Study|Withdrawal by Subject|8|||
155201248|NCT03706079|560174687|FG001|Predecessor Study|Withdrawal by Subject|15|||
155201249|NCT03706079|560174688|FG002|Predecessor Study|Withdrawal by Subject|0|||
155201250|NCT03706079|560174689|FG003|Predecessor Study|Withdrawal by Subject|5|||
155201251|NCT03706079|560174690|FG004|Predecessor Study|Withdrawal by Subject|2|||
155201252|NCT03706079|560174691|FG005|Predecessor Study|Withdrawal by Subject|0|||
155201253|NCT03706079|560174686|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
155201254|NCT03706079|560174687|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
155201255|NCT03706079|560174688|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201256|NCT03706079|560174689|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201257|NCT03706079|560174690|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201258|NCT03706079|560174691|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
155201259|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201260|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201261|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201262|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201263|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
155201264|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
155201265|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
155201266|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201267|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
155201268|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201269|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201270|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
155201271|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
155201272|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201273|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201274|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201275|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201276|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
155201277|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201278|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201279|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201280|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
155201281|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
155201282|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
155201283|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
155201284|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
155201285|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
155201286|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
155201287|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
155201288|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
155201289|NCT03706079|560174686|FG000|Long Term Extension (DESTINATION)|Death|8|||
155201290|NCT03706079|560174687|FG001|Long Term Extension (DESTINATION)|Death|2|||
155201291|NCT03706079|560174688|FG002|Long Term Extension (DESTINATION)|Death|2|||
155201292|NCT03706079|560174689|FG003|Long Term Extension (DESTINATION)|Death|1|||
155201293|NCT03706079|560174690|FG004|Long Term Extension (DESTINATION)|Death|0|||
155201294|NCT03706079|560174691|FG005|Long Term Extension (DESTINATION)|Death|0|||
155201295|NCT00329238|560174692|FG000|Overall Study|Adverse Event|147|||
155201296|NCT00329238|560174693|FG001|Overall Study|Adverse Event|129|||
155201297|NCT00329238|560174692|FG000|Overall Study|Protocol Violation|23|||
155201298|NCT00329238|560174693|FG001|Overall Study|Protocol Violation|34|||
155201299|NCT00329238|560174692|FG000|Overall Study|Lost to Follow-up|2|||
155201300|NCT00329238|560174693|FG001|Overall Study|Lost to Follow-up|6|||
155201301|NCT00329238|560174692|FG000|Overall Study|Withdrawal by Subject|64|||
155201302|NCT00329238|560174693|FG001|Overall Study|Withdrawal by Subject|58|||
155201303|NCT00329238|560174692|FG000|Overall Study|Other reason (not specified)|40|||
155201304|NCT00329238|560174693|FG001|Overall Study|Other reason (not specified)|54|||
155201305|NCT00801632|560174694|FG000|Overall Study|Re-transplant|1|||
155201306|NCT00915278|560174702|FG000|Overall Study|Death|1|||
155201307|NCT00915278|560174703|FG001|Overall Study|Death|0|||
155201308|NCT00915278|560174704|FG002|Overall Study|Death|0|||
155201309|NCT00915278|560174705|FG003|Overall Study|Death|0|||
155201310|NCT00915278|560174706|FG004|Overall Study|Death|0|||
155201311|NCT00915278|560174707|FG005|Overall Study|Death|0|||
155201312|NCT00915278|560174702|FG000|Overall Study|Lost to Follow-up|0|||
155201313|NCT00915278|560174703|FG001|Overall Study|Lost to Follow-up|1|||
155201314|NCT00915278|560174704|FG002|Overall Study|Lost to Follow-up|0|||
155201315|NCT00915278|560174705|FG003|Overall Study|Lost to Follow-up|0|||
155201316|NCT00915278|560174706|FG004|Overall Study|Lost to Follow-up|0|||
155201317|NCT00915278|560174707|FG005|Overall Study|Lost to Follow-up|0|||
155201318|NCT00915278|560174702|FG000|Overall Study|Withdrawal by Subject|0|||
155201319|NCT00915278|560174703|FG001|Overall Study|Withdrawal by Subject|1|||
155201320|NCT00915278|560174704|FG002|Overall Study|Withdrawal by Subject|0|||
155201321|NCT00915278|560174705|FG003|Overall Study|Withdrawal by Subject|0|||
155201322|NCT00915278|560174706|FG004|Overall Study|Withdrawal by Subject|1|||
155201323|NCT00915278|560174707|FG005|Overall Study|Withdrawal by Subject|4|||
155201324|NCT00915278|560174702|FG000|Overall Study|Adverse Event|4|||
155201325|NCT00915278|560174703|FG001|Overall Study|Adverse Event|1|||
155201326|NCT00915278|560174704|FG002|Overall Study|Adverse Event|0|||
155201327|NCT00915278|560174705|FG003|Overall Study|Adverse Event|0|||
155201328|NCT00915278|560174706|FG004|Overall Study|Adverse Event|0|||
155201329|NCT00915278|560174707|FG005|Overall Study|Adverse Event|0|||
155201330|NCT00915278|560174702|FG000|Overall Study|Progressive disease/clinical progression|0|||
155201331|NCT00915278|560174703|FG001|Overall Study|Progressive disease/clinical progression|0|||
155201332|NCT00915278|560174704|FG002|Overall Study|Progressive disease/clinical progression|0|||
155201333|NCT00915278|560174705|FG003|Overall Study|Progressive disease/clinical progression|3|||
155201334|NCT00915278|560174706|FG004|Overall Study|Progressive disease/clinical progression|1|||
155201335|NCT00915278|560174707|FG005|Overall Study|Progressive disease/clinical progression|2|||
155201336|NCT00915278|560174702|FG000|Overall Study|Infusion related AEs|0|||
155201337|NCT00915278|560174703|FG001|Overall Study|Infusion related AEs|0|||
155201338|NCT00915278|560174704|FG002|Overall Study|Infusion related AEs|0|||
155201339|NCT00915278|560174705|FG003|Overall Study|Infusion related AEs|0|||
155201340|NCT00915278|560174706|FG004|Overall Study|Infusion related AEs|0|||
155201341|NCT00915278|560174707|FG005|Overall Study|Infusion related AEs|2|||
155201342|NCT00915278|560174702|FG000|Overall Study|Admission to hospice|0|||
155201343|NCT00915278|560174703|FG001|Overall Study|Admission to hospice|0|||
155201344|NCT00915278|560174704|FG002|Overall Study|Admission to hospice|1|||
155201345|NCT00915278|560174705|FG003|Overall Study|Admission to hospice|0|||
155201346|NCT00915278|560174706|FG004|Overall Study|Admission to hospice|0|||
155201347|NCT00915278|560174707|FG005|Overall Study|Admission to hospice|0|||
155201348|NCT01702961|560174708|FG000|Overall Study|Additional treatment|3|||
155201349|NCT01702961|560174708|FG000|Overall Study|Progressive disease|5|||
155201350|NCT01702961|560174708|FG000|Overall Study|Relapse|20|||
155201351|NCT01702961|560174708|FG000|Overall Study|Death|6|||
155201352|NCT01702961|560174708|FG000|Overall Study|Lost to Follow-up|2|||
155201353|NCT01702961|560174708|FG000|Overall Study|Ongoing|11|||
155201354|NCT02465515|560174709|FG000|Overall Study|Investigator site closed|4|||
155201355|NCT02465515|560174710|FG001|Overall Study|Investigator site closed|5|||
155201356|NCT02465515|560174709|FG000|Overall Study|Withdrawal by Subject|74|||
155201357|NCT02465515|560174710|FG001|Overall Study|Withdrawal by Subject|43|||
155201358|NCT02465515|560174709|FG000|Overall Study|Physician Decision|8|||
155201359|NCT02465515|560174710|FG001|Overall Study|Physician Decision|12|||
155201360|NCT02465515|560174709|FG000|Overall Study|Lost to Follow-up|68|||
155201361|NCT02465515|560174710|FG001|Overall Study|Lost to Follow-up|51|||
155201362|NCT01273597|560174711|FG000|Overall Study|Adverse Event|5|||
155201363|NCT01273597|560174711|FG000|Overall Study|Underwent Kidney Transplantation|2|||
155201364|NCT01273597|560174711|FG000|Overall Study|Reason Not Reported|1|||
155201365|NCT01594762|560174712|FG000|Overall Study|Withdrawal by Subject|1|||
155201366|NCT01594762|560174713|FG001|Overall Study|Withdrawal by Subject|0|||
155201367|NCT01594762|560174712|FG000|Overall Study|Lost to Follow-up|10|||
155201368|NCT01594762|560174713|FG001|Overall Study|Lost to Follow-up|10|||
155201369|NCT03288129|560174717|FG000|Overall Study|Adverse Event|10|||
155201370|NCT03288129|560174717|FG000|Overall Study|Lost to Follow-up|3|||
155201371|NCT03288129|560174717|FG000|Overall Study|Withdrawal by Subject|3|||
155201372|NCT03288129|560174717|FG000|Overall Study|Withdrawal of consent/assent|1|||
155201373|NCT03288129|560174717|FG000|Overall Study|Other|5|||
155201374|NCT02777333|560174718|FG000|Overall Study|Withdrawal by Subject|0|||
155201375|NCT02777333|560174719|FG001|Overall Study|Withdrawal by Subject|1|||
155201376|NCT02777333|560174718|FG000|Overall Study|Lost to Follow-up|0|||
155201377|NCT02777333|560174719|FG001|Overall Study|Lost to Follow-up|1|||
155201378|NCT01980940|560174720|FG000|Overall Study|Protocol Violation|0|||
155201379|NCT01980940|560174721|FG001|Overall Study|Protocol Violation|0|||
155201380|NCT01980940|560174722|FG002|Overall Study|Protocol Violation|0|||
155201381|NCT01980940|560174723|FG003|Overall Study|Protocol Violation|0|||
155201382|NCT01980940|560174724|FG004|Overall Study|Protocol Violation|0|||
155201383|NCT01980940|560174725|FG005|Overall Study|Protocol Violation|2|||
155201384|NCT01980940|560174726|FG006|Overall Study|Protocol Violation|0|||
155201385|NCT01980940|560174727|FG007|Overall Study|Protocol Violation|0|||
155201386|NCT00837811|560174728|FG000|Overall Study|Adverse Event|4|||
155201387|NCT00837811|560174729|FG001|Overall Study|Adverse Event|6|||
155201388|NCT00837811|560174730|FG002|Overall Study|Adverse Event|0|||
155201389|NCT00837811|560174728|FG000|Overall Study|Death|1|||
155201390|NCT00837811|560174729|FG001|Overall Study|Death|1|||
155201391|NCT00837811|560174730|FG002|Overall Study|Death|0|||
155201392|NCT00837811|560174728|FG000|Overall Study|Lack of Efficacy|0|||
155201393|NCT00837811|560174729|FG001|Overall Study|Lack of Efficacy|11|||
155201394|NCT00837811|560174730|FG002|Overall Study|Lack of Efficacy|0|||
155201395|NCT00837811|560174728|FG000|Overall Study|Lost to Follow-up|1|||
155201396|NCT00837811|560174729|FG001|Overall Study|Lost to Follow-up|3|||
155201397|NCT00837811|560174730|FG002|Overall Study|Lost to Follow-up|0|||
155201398|NCT00837811|560174728|FG000|Overall Study|Physician Decision|0|||
155201399|NCT00837811|560174729|FG001|Overall Study|Physician Decision|2|||
155201400|NCT00837811|560174730|FG002|Overall Study|Physician Decision|1|||
155201401|NCT00837811|560174728|FG000|Overall Study|Withdrawal by Subject|1|||
155201402|NCT00837811|560174729|FG001|Overall Study|Withdrawal by Subject|9|||
155201403|NCT00837811|560174730|FG002|Overall Study|Withdrawal by Subject|0|||
155201404|NCT00837811|560174728|FG000|Overall Study|Sponsor Decision|0|||
155201405|NCT00837811|560174729|FG001|Overall Study|Sponsor Decision|2|||
155201406|NCT00837811|560174730|FG002|Overall Study|Sponsor Decision|0|||
155201407|NCT01648101|560176617|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
155201408|NCT01648101|560176618|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
155201409|NCT01648101|560176619|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
155201410|NCT01648101|560176617|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
155201411|NCT01648101|560176618|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
155201412|NCT01648101|560176619|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
155201413|NCT01648101|560176617|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
155201414|NCT01648101|560176618|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
155201415|NCT01648101|560176619|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
155201416|NCT01648101|560176617|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
155201417|NCT01648101|560176618|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
155201418|NCT01648101|560176619|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
155201419|NCT01648101|560176617|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
155201420|NCT01648101|560176618|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
155201421|NCT01648101|560176619|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
155201422|NCT01648101|560176617|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
155201423|NCT01648101|560176618|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
155201424|NCT01648101|560176619|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
155201425|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
155201426|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
155201427|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
155201428|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
155201429|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
155201430|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
155201431|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
155201432|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
155201433|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
155201434|NCT01648101|560176617|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
155201435|NCT01648101|560176618|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
155201436|NCT01648101|560176619|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
155201437|NCT01648101|560176617|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
155201438|NCT01648101|560176618|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
155201439|NCT01648101|560176619|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
155201440|NCT02469298|560176620|FG000|Overall Study|Protocol Violation|0|||
155201441|NCT02469298|560176621|FG001|Overall Study|Protocol Violation|1|||
155201442|NCT02469298|560176622|FG002|Overall Study|Protocol Violation|1|||
155201443|NCT02469298|560176623|FG003|Overall Study|Protocol Violation|0|||
155201444|NCT02469298|560176620|FG000|Overall Study|Lost to Follow-up|1|||
155201445|NCT02469298|560176621|FG001|Overall Study|Lost to Follow-up|0|||
155201446|NCT02469298|560176622|FG002|Overall Study|Lost to Follow-up|1|||
155201447|NCT02469298|560176623|FG003|Overall Study|Lost to Follow-up|0|||
155201448|NCT02469298|560176620|FG000|Overall Study|Physician Decision|0|||
155201449|NCT02469298|560176621|FG001|Overall Study|Physician Decision|0|||
155201450|NCT02469298|560176622|FG002|Overall Study|Physician Decision|0|||
155201451|NCT02469298|560176623|FG003|Overall Study|Physician Decision|1|||
155201452|NCT02469298|560176620|FG000|Overall Study|Withdrawal by Subject|0|||
155201453|NCT02469298|560176621|FG001|Overall Study|Withdrawal by Subject|0|||
155201454|NCT02469298|560176622|FG002|Overall Study|Withdrawal by Subject|0|||
155201455|NCT02469298|560176623|FG003|Overall Study|Withdrawal by Subject|1|||
155201456|NCT03797014|560176628|FG000|Overall Study|Withdrawal by Subject|1|||
155201457|NCT03797014|560176628|FG000|Overall Study|Lost to Follow-up|1|||
155201458|NCT03797014|560176628|FG000|Overall Study|Protocol Violation|1|||
155201459|NCT03305575|560176633|FG000|Overall Study|Physician Decision|1|||
155201460|NCT03305575|560176634|FG001|Overall Study|Physician Decision|0|||
155201461|NCT01389817|560176635|FG000|Overall Study|Physician Decision|1|||
155201462|NCT01389817|560176636|FG001|Overall Study|Physician Decision|0|||
155201463|NCT01389817|560176635|FG000|Overall Study|Lost to Follow-up|1|||
155201464|NCT01389817|560176636|FG001|Overall Study|Lost to Follow-up|0|||
155201465|NCT01389817|560176635|FG000|Overall Study|Withdrawal by Subject|2|||
155201466|NCT01389817|560176636|FG001|Overall Study|Withdrawal by Subject|0|||
155201467|NCT00105469|560176637|FG000|Overall Study|Adverse Event|9|||
155201468|NCT00105469|560176638|FG001|Overall Study|Adverse Event|8|||
155201469|NCT00105469|560176637|FG000|Overall Study|Protocol Violation|4|||
155201470|NCT00105469|560176638|FG001|Overall Study|Protocol Violation|0|||
155201471|NCT00105469|560176637|FG000|Overall Study|Withdrawal by Subject|2|||
155201472|NCT00105469|560176638|FG001|Overall Study|Withdrawal by Subject|3|||
155201473|NCT00105469|560176637|FG000|Overall Study|Lost to Follow-up|1|||
155201474|NCT00105469|560176638|FG001|Overall Study|Lost to Follow-up|0|||
155201475|NCT00105469|560176637|FG000|Overall Study|Lack of Efficacy|2|||
155201476|NCT00105469|560176638|FG001|Overall Study|Lack of Efficacy|0|||
155201477|NCT00105469|560176637|FG000|Overall Study|Other Reason|4|||
155201478|NCT00105469|560176638|FG001|Overall Study|Other Reason|0|||
155201479|NCT04980040|560176639|FG000|Overall Study|Violated the Inclusion Criteria|260|||
155201480|NCT04980040|560176639|FG000|Overall Study|Violated the Administration & Dosage|225|||
155201481|NCT04980040|560176639|FG000|Overall Study|Lost to Safety-Follow-up|4|||
155201482|NCT04980040|560176639|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
155201483|NCT01408485|560176640|FG000|Overall Study|Withdrawal by Subject|21|||
155201484|NCT01508650|560176641|FG000|Overall Study|Lost to Follow-up|0|||
155201485|NCT01508650|560176642|FG001|Overall Study|Lost to Follow-up|3|||
155201486|NCT02064894|560176643|FG000|Overall Study|Withdrawal by Subject|43|||
155201487|NCT02064894|560176644|FG001|Overall Study|Withdrawal by Subject|102|||
155201488|NCT02064894|560176645|FG002|Overall Study|Withdrawal by Subject|115|||
155201489|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
155201490|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
155201491|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201492|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201493|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201494|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201495|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201496|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
155201497|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
155201498|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
155201499|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201500|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201501|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201502|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201503|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201504|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
155201505|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
155201506|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
155201507|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201508|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201509|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201510|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201511|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201512|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
155201513|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201514|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
155201515|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201516|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201517|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201518|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201519|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201520|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
155201521|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
155201522|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
155201523|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201524|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201525|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201526|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201527|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201528|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
155201529|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
155201530|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201531|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201532|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201533|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201534|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201535|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201536|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
155201537|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
155201538|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
155201539|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201540|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201541|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201542|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201543|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201544|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
155201545|NCT03095066|560176646|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
155201546|NCT03095066|560176647|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
155201547|NCT03095066|560176648|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201548|NCT03095066|560176649|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201549|NCT03095066|560176650|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201550|NCT03095066|560176651|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201551|NCT03095066|560176652|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201552|NCT03095066|560176653|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
155201553|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201554|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201555|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
155201556|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201557|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201558|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201559|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
155201560|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
155201561|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201562|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201563|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
155201564|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201565|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201566|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201567|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
155201568|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
155201569|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201570|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201571|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
155201572|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201573|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201574|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201575|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
155201576|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
155201577|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201578|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201579|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
155201580|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201581|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201582|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201583|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
155201584|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
155201585|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201586|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201587|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
155201588|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201589|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201590|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201591|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201592|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
155201593|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201594|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201595|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
155201596|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201597|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201598|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201599|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
155201600|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
155201601|NCT03095066|560176646|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201602|NCT03095066|560176647|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201603|NCT03095066|560176648|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201604|NCT03095066|560176649|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201605|NCT03095066|560176650|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201606|NCT03095066|560176651|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201607|NCT03095066|560176652|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
155201608|NCT03095066|560176653|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
155201609|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201610|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201611|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201612|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201613|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201614|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
155201615|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201616|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
155201617|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201618|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201619|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201620|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201621|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
155201622|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201623|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
155201624|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
155201625|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201626|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201627|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201628|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201629|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
155201630|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201631|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
155201632|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
155201633|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201634|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201635|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201636|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201637|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
155201638|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201639|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
155201640|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
155201641|NCT03095066|560176646|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201642|NCT03095066|560176647|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201643|NCT03095066|560176648|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201644|NCT03095066|560176649|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
155201645|NCT03095066|560176650|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201646|NCT03095066|560176651|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
155201647|NCT03095066|560176652|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201648|NCT03095066|560176653|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
155201649|NCT00160693|560176654|FG000|Overall Study|Adverse Event|97|||
155201650|NCT00160693|560176654|FG000|Overall Study|Lack of Efficacy|30|||
155201651|NCT00160693|560176654|FG000|Overall Study|Protocol Violation|24|||
155201652|NCT00160693|560176654|FG000|Overall Study|Lost to Follow-up|15|||
155201653|NCT00160693|560176654|FG000|Overall Study|Withdrawal by Subject|54|||
155201654|NCT00160693|560176654|FG000|Overall Study|Study terminated by sponsor|15|||
155201655|NCT03716024|560176655|FG000|Overall Study|Randomized, not Treated|7|||
155201656|NCT03716024|560176656|FG001|Overall Study|Randomized, not Treated|8|||
155201657|NCT03716024|560176655|FG000|Overall Study|Adverse Event|1|||
155201658|NCT03716024|560176656|FG001|Overall Study|Adverse Event|2|||
155201659|NCT03716024|560176655|FG000|Overall Study|Treatment Failure|1|||
155201660|NCT03716024|560176656|FG001|Overall Study|Treatment Failure|0|||
155201661|NCT03716024|560176655|FG000|Overall Study|Lost to Follow-up|2|||
155201662|NCT03716024|560176656|FG001|Overall Study|Lost to Follow-up|6|||
155201663|NCT03716024|560176655|FG000|Overall Study|Withdrawal by Subject|0|||
155201664|NCT03716024|560176656|FG001|Overall Study|Withdrawal by Subject|1|||
155201665|NCT03716024|560176655|FG000|Overall Study|Missing Reason|0|||
155201666|NCT03716024|560176656|FG001|Overall Study|Missing Reason|1|||
155201667|NCT04343261|560176657|FG000|Overall Study|Adverse Event|1|||
155201668|NCT04343261|560176657|FG000|Overall Study|received inadequate amount of antibodies|7|||
155201669|NCT05988619|560176658|FG000|Overall Study|Lost to Follow-up|1|||
155201670|NCT05988619|560176659|FG001|Overall Study|Lost to Follow-up|4|||
155201671|NCT05988619|560176658|FG000|Overall Study|Withdrawal by Subject|2|||
155201672|NCT05988619|560176659|FG001|Overall Study|Withdrawal by Subject|9|||
155201673|NCT00587054|560176662|FG000|Overall Study|Patient not treated|9|||
155201674|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Death|0|||
155201675|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Death|0|||
155201676|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Death|0|||
155201677|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Death|0|||
155201678|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Death|1|||
155201679|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Death|0|||
155201680|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Death|0|||
155201681|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Death|0|||
155201682|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
155201683|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
155201684|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
155201685|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
155201686|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
155201687|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
155201688|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
155201689|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
155201690|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
155201691|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201692|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201693|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
155201694|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201695|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
155201696|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201697|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
155201698|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
155201699|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
155201700|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
155201701|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
155201702|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
155201703|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
155201704|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
155201705|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
155201706|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
155201707|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
155201708|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
155201709|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
155201710|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
155201711|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
155201712|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
155201713|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
155201714|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
155201715|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201716|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201717|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
155201718|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
155201719|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
155201720|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201721|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
155201722|NCT00726232|560176664|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
155201723|NCT00726232|560176665|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201724|NCT00726232|560176666|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201725|NCT00726232|560176667|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201726|NCT00726232|560176668|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201727|NCT00726232|560176669|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201728|NCT00726232|560176670|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201729|NCT00726232|560176671|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
155201730|NCT00726232|560176664|FG000|Expansion Phase|Death|0|||
155201731|NCT00726232|560176665|FG001|Expansion Phase|Death|0|||
155201732|NCT00726232|560176666|FG002|Expansion Phase|Death|0|||
155201733|NCT00726232|560176667|FG003|Expansion Phase|Death|0|||
155201734|NCT00726232|560176668|FG004|Expansion Phase|Death|0|||
155201735|NCT00726232|560176669|FG005|Expansion Phase|Death|0|||
155201736|NCT00726232|560176670|FG006|Expansion Phase|Death|0|||
155201737|NCT00726232|560176671|FG007|Expansion Phase|Death|1|||
155201738|NCT00726232|560176664|FG000|Expansion Phase|Adverse Event|0|||
155201739|NCT00726232|560176665|FG001|Expansion Phase|Adverse Event|0|||
155201740|NCT00726232|560176666|FG002|Expansion Phase|Adverse Event|0|||
155201741|NCT00726232|560176667|FG003|Expansion Phase|Adverse Event|0|||
155201742|NCT00726232|560176668|FG004|Expansion Phase|Adverse Event|0|||
155201743|NCT00726232|560176669|FG005|Expansion Phase|Adverse Event|0|||
155201744|NCT00726232|560176670|FG006|Expansion Phase|Adverse Event|6|||
155201745|NCT00726232|560176671|FG007|Expansion Phase|Adverse Event|11|||
155201746|NCT00726232|560176664|FG000|Expansion Phase|Withdrawal by Subject|0|||
155201747|NCT00726232|560176665|FG001|Expansion Phase|Withdrawal by Subject|0|||
155201748|NCT00726232|560176666|FG002|Expansion Phase|Withdrawal by Subject|0|||
155201749|NCT00726232|560176667|FG003|Expansion Phase|Withdrawal by Subject|0|||
155201750|NCT00726232|560176668|FG004|Expansion Phase|Withdrawal by Subject|0|||
155201751|NCT00726232|560176669|FG005|Expansion Phase|Withdrawal by Subject|0|||
155201752|NCT00726232|560176670|FG006|Expansion Phase|Withdrawal by Subject|2|||
155201753|NCT00726232|560176671|FG007|Expansion Phase|Withdrawal by Subject|3|||
155201754|NCT00726232|560176664|FG000|Expansion Phase|Disease progression|0|||
155201755|NCT00726232|560176665|FG001|Expansion Phase|Disease progression|0|||
155201756|NCT00726232|560176666|FG002|Expansion Phase|Disease progression|0|||
155201757|NCT00726232|560176667|FG003|Expansion Phase|Disease progression|0|||
155201758|NCT00726232|560176668|FG004|Expansion Phase|Disease progression|0|||
155201759|NCT00726232|560176669|FG005|Expansion Phase|Disease progression|0|||
155201760|NCT00726232|560176670|FG006|Expansion Phase|Disease progression|4|||
155201761|NCT00726232|560176671|FG007|Expansion Phase|Disease progression|0|||
155201762|NCT00726232|560176664|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
155201763|NCT00726232|560176665|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
155201764|NCT00726232|560176666|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
155201765|NCT00726232|560176667|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
155201766|NCT00726232|560176668|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
155201767|NCT00726232|560176669|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
155201768|NCT00726232|560176670|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
155201769|NCT00726232|560176671|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
155201770|NCT00726232|560176664|FG000|Expansion Phase|Per Investigator: lack of response|0|||
155201771|NCT00726232|560176665|FG001|Expansion Phase|Per Investigator: lack of response|0|||
155201772|NCT00726232|560176666|FG002|Expansion Phase|Per Investigator: lack of response|0|||
155201773|NCT00726232|560176667|FG003|Expansion Phase|Per Investigator: lack of response|0|||
155201774|NCT00726232|560176668|FG004|Expansion Phase|Per Investigator: lack of response|0|||
155201775|NCT00726232|560176669|FG005|Expansion Phase|Per Investigator: lack of response|0|||
155201776|NCT00726232|560176670|FG006|Expansion Phase|Per Investigator: lack of response|1|||
155201777|NCT00726232|560176671|FG007|Expansion Phase|Per Investigator: lack of response|7|||
155201778|NCT00726232|560176664|FG000|Expansion Phase|Unspecified reason|0|||
155201779|NCT00726232|560176665|FG001|Expansion Phase|Unspecified reason|0|||
155201780|NCT00726232|560176666|FG002|Expansion Phase|Unspecified reason|0|||
155201781|NCT00726232|560176667|FG003|Expansion Phase|Unspecified reason|0|||
155201782|NCT00726232|560176668|FG004|Expansion Phase|Unspecified reason|0|||
155201783|NCT00726232|560176669|FG005|Expansion Phase|Unspecified reason|0|||
155201784|NCT00726232|560176670|FG006|Expansion Phase|Unspecified reason|1|||
155201785|NCT00726232|560176671|FG007|Expansion Phase|Unspecified reason|0|||
155201786|NCT00709761|560176672|FG000|Overall Study|Withdrawal by Subject|8|||
155201787|NCT00709761|560176672|FG000|Overall Study|study closed/terminated|17|||
155201788|NCT00709761|560176672|FG000|Overall Study|Lost to Follow-up|2|||
155201789|NCT03478930|560176673|FG000|Overall Study|Adverse Event|0|||
155201790|NCT03478930|560176674|FG001|Overall Study|Adverse Event|1|||
155201791|NCT03478930|560176673|FG000|Overall Study|Lack of Efficacy|3|||
155201792|NCT03478930|560176674|FG001|Overall Study|Lack of Efficacy|3|||
155201793|NCT03478930|560176673|FG000|Overall Study|Withdrawal by Subject|6|||
155201794|NCT03478930|560176674|FG001|Overall Study|Withdrawal by Subject|5|||
155201795|NCT00553644|560176677|FG000|Overall Study|Adverse Event|17|||
155201796|NCT00553644|560176677|FG000|Overall Study|Withdrawal by Subject|4|||
155201797|NCT00553644|560176677|FG000|Overall Study|Physician Decision|1|||
155201798|NCT00553644|560176677|FG000|Overall Study|Alternative therapy|6|||
155201799|NCT00705484|560176678|FG000|Overall Study|Adverse Event|28|||
155201800|NCT00705484|560176679|FG001|Overall Study|Adverse Event|27|||
155201801|NCT00705484|560176678|FG000|Overall Study|Lost to Follow-up|169|||
155201802|NCT00705484|560176679|FG001|Overall Study|Lost to Follow-up|250|||
155201803|NCT00705484|560176678|FG000|Overall Study|Withdrawal by Subject|96|||
155201804|NCT00705484|560176679|FG001|Overall Study|Withdrawal by Subject|72|||
155201805|NCT00705484|560176678|FG000|Overall Study|Administrative|89|||
155201806|NCT00705484|560176679|FG001|Overall Study|Administrative|59|||
155201807|NCT02197247|560176680|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
155201808|NCT02197247|560176680|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
155201809|NCT02197247|560176680|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
155201810|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
155201811|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
155201812|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
155201813|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
155201814|NCT02197247|560176680|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
155201815|NCT03851705|560176686|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
155201816|NCT03851705|560176687|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155201817|NCT03851705|560176688|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155201818|NCT03851705|560176689|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
155201819|NCT03851705|560176686|FG000|Part 1: Double-Blind Period|Other reason|1|||
155201820|NCT03851705|560176687|FG001|Part 1: Double-Blind Period|Other reason|0|||
155201821|NCT03851705|560176688|FG002|Part 1: Double-Blind Period|Other reason|0|||
155201822|NCT03851705|560176689|FG003|Part 1: Double-Blind Period|Other reason|0|||
155201823|NCT03851705|560176686|FG000|Part 2: Open-Label Period|Other reason|0|||
155201824|NCT03851705|560176687|FG001|Part 2: Open-Label Period|Other reason|0|||
155201825|NCT03851705|560176688|FG002|Part 2: Open-Label Period|Other reason|0|||
155201826|NCT03851705|560176689|FG003|Part 2: Open-Label Period|Other reason|1|||
155201827|NCT03851705|560176686|FG000|Part 2: Open-Label Period|Death|0|||
155201828|NCT03851705|560176687|FG001|Part 2: Open-Label Period|Death|0|||
155201829|NCT03851705|560176688|FG002|Part 2: Open-Label Period|Death|3|||
155201830|NCT03851705|560176689|FG003|Part 2: Open-Label Period|Death|0|||
155201831|NCT03851705|560176686|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
155201832|NCT03851705|560176687|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
155201833|NCT03851705|560176688|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
155201834|NCT03851705|560176689|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
155201835|NCT04431453|560176690|FG000|Overall Study|Withdrew Consent|0|||
155201836|NCT04431453|560176691|FG001|Overall Study|Withdrew Consent|1|||
155201837|NCT04431453|560176692|FG002|Overall Study|Withdrew Consent|0|||
155201838|NCT04431453|560176693|FG003|Overall Study|Withdrew Consent|2|||
155201839|NCT04431453|560176694|FG004|Overall Study|Withdrew Consent|0|||
155201840|NCT04431453|560176695|FG005|Overall Study|Withdrew Consent|0|||
155201841|NCT04431453|560176696|FG006|Overall Study|Withdrew Consent|0|||
155201842|NCT04431453|560176697|FG007|Overall Study|Withdrew Consent|0|||
155201843|NCT04431453|560176690|FG000|Overall Study|Death|1|||
155201844|NCT04431453|560176691|FG001|Overall Study|Death|0|||
155201845|NCT04431453|560176692|FG002|Overall Study|Death|0|||
155201846|NCT04431453|560176693|FG003|Overall Study|Death|0|||
155201847|NCT04431453|560176694|FG004|Overall Study|Death|0|||
155201848|NCT04431453|560176695|FG005|Overall Study|Death|0|||
155201849|NCT04431453|560176696|FG006|Overall Study|Death|0|||
155201850|NCT04431453|560176697|FG007|Overall Study|Death|1|||
155201851|NCT04431453|560176690|FG000|Overall Study|Lost to Follow-up|0|||
155201852|NCT04431453|560176691|FG001|Overall Study|Lost to Follow-up|0|||
155201853|NCT04431453|560176692|FG002|Overall Study|Lost to Follow-up|1|||
155201854|NCT04431453|560176693|FG003|Overall Study|Lost to Follow-up|1|||
155201855|NCT04431453|560176694|FG004|Overall Study|Lost to Follow-up|0|||
155201856|NCT04431453|560176695|FG005|Overall Study|Lost to Follow-up|0|||
155201857|NCT04431453|560176696|FG006|Overall Study|Lost to Follow-up|0|||
155201858|NCT04431453|560176697|FG007|Overall Study|Lost to Follow-up|0|||
155201859|NCT04431453|560176690|FG000|Overall Study|Enrolled but Never Treated|0|||
155201860|NCT04431453|560176691|FG001|Overall Study|Enrolled but Never Treated|0|||
155201861|NCT04431453|560176692|FG002|Overall Study|Enrolled but Never Treated|0|||
155201862|NCT04431453|560176693|FG003|Overall Study|Enrolled but Never Treated|0|||
155201863|NCT04431453|560176694|FG004|Overall Study|Enrolled but Never Treated|1|||
155201864|NCT04431453|560176695|FG005|Overall Study|Enrolled but Never Treated|0|||
155201865|NCT04431453|560176696|FG006|Overall Study|Enrolled but Never Treated|0|||
155201866|NCT04431453|560176697|FG007|Overall Study|Enrolled but Never Treated|0|||
155201867|NCT00622401|560176698|FG000|Overall Study|Disease progression prior to treatment|3|||
155201868|NCT00622401|560176699|FG001|Overall Study|Disease progression prior to treatment|2|||
155201869|NCT00622401|560176700|FG002|Overall Study|Disease progression prior to treatment|0|||
155201870|NCT03087643|560176708|FG000|Overall Study|Withdrawal by Subject|2|||
155201871|NCT03087643|560176709|FG001|Overall Study|Withdrawal by Subject|4|||
155201872|NCT03087643|560176708|FG000|Overall Study|Death|2|||
155201873|NCT03087643|560176709|FG001|Overall Study|Death|2|||
155201874|NCT02083783|560176710|FG000|Overall Study|Withdrawal by Subject|1|||
155201875|NCT02083783|560176711|FG001|Overall Study|Withdrawal by Subject|0|||
155201876|NCT02021773|560176717|FG000|Overall Study|Adverse Event|1|||
155201877|NCT02021773|560176718|FG001|Overall Study|Adverse Event|4|||
155201878|NCT02021773|560176719|FG002|Overall Study|Adverse Event|3|||
155201879|NCT02021773|560176717|FG000|Overall Study|Lack of Efficacy|2|||
155201880|NCT02021773|560176718|FG001|Overall Study|Lack of Efficacy|2|||
155201881|NCT02021773|560176719|FG002|Overall Study|Lack of Efficacy|2|||
155201882|NCT02021773|560176717|FG000|Overall Study|Protocol Violation|2|||
155201883|NCT02021773|560176718|FG001|Overall Study|Protocol Violation|3|||
155201884|NCT02021773|560176719|FG002|Overall Study|Protocol Violation|1|||
155201885|NCT02021773|560176717|FG000|Overall Study|Withdrawal by Subject|3|||
155201886|NCT02021773|560176718|FG001|Overall Study|Withdrawal by Subject|4|||
155201887|NCT02021773|560176719|FG002|Overall Study|Withdrawal by Subject|5|||
155201888|NCT02021773|560176717|FG000|Overall Study|Lost to Follow-up|1|||
155201889|NCT02021773|560176718|FG001|Overall Study|Lost to Follow-up|3|||
155201890|NCT02021773|560176719|FG002|Overall Study|Lost to Follow-up|0|||
155201891|NCT02021773|560176717|FG000|Overall Study|Reason not specified|3|||
155201892|NCT02021773|560176718|FG001|Overall Study|Reason not specified|0|||
155201893|NCT02021773|560176719|FG002|Overall Study|Reason not specified|0|||
155201894|NCT00530946|560176720|FG000|Overall Study|Adverse Event|1|||
155201895|NCT00530946|560176721|FG001|Overall Study|Adverse Event|2|||
155201896|NCT00530946|560176722|FG002|Overall Study|Adverse Event|1|||
155201897|NCT00530946|560176723|FG003|Overall Study|Adverse Event|1|||
155201898|NCT00530946|560176720|FG000|Overall Study|Protocol Violation|0|||
155201899|NCT00530946|560176721|FG001|Overall Study|Protocol Violation|0|||
155201900|NCT00530946|560176722|FG002|Overall Study|Protocol Violation|0|||
155201901|NCT00530946|560176723|FG003|Overall Study|Protocol Violation|1|||
155201902|NCT00530946|560176720|FG000|Overall Study|Noncompliance|1|||
155201903|NCT00530946|560176721|FG001|Overall Study|Noncompliance|0|||
155201904|NCT00530946|560176722|FG002|Overall Study|Noncompliance|0|||
155201905|NCT00530946|560176723|FG003|Overall Study|Noncompliance|0|||
155201906|NCT01534962|560176724|FG000|Overall Study|Randomized but did not start treatment|2|||
155201907|NCT01534962|560176725|FG001|Overall Study|Randomized but did not start treatment|0|||
155201908|NCT01534962|560176726|FG002|Overall Study|Randomized but did not start treatment|0|||
155201909|NCT01534962|560176727|FG003|Overall Study|Randomized but did not start treatment|1|||
155201910|NCT01534962|560176724|FG000|Overall Study|Discontinued at AF recurrence|35|||
155201911|NCT01534962|560176725|FG001|Overall Study|Discontinued at AF recurrence|26|||
155201912|NCT01534962|560176726|FG002|Overall Study|Discontinued at AF recurrence|24|||
155201913|NCT01534962|560176727|FG003|Overall Study|Discontinued at AF recurrence|31|||
155201914|NCT02243696|560176728|FG000|Overall Study|Death|282|||
155201915|NCT02243696|560176728|FG000|Overall Study|Withdrawal by Subject|79|||
155201916|NCT02243696|560176728|FG000|Overall Study|Lost to Follow-up|57|||
155201917|NCT02243696|560176728|FG000|Overall Study|Subject No Longer has Study System|42|||
155201918|NCT02243696|560176728|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
155201919|NCT02243696|560176728|FG000|Overall Study|Study Terminated for EP PASSION|961|||
155201920|NCT00622284|560176729|FG000|Overall Study|Lack of Efficacy|45|||
155201921|NCT00622284|560176730|FG001|Overall Study|Lack of Efficacy|15|||
155201922|NCT00622284|560176729|FG000|Overall Study|Adverse Event|61|||
155201923|NCT00622284|560176730|FG001|Overall Study|Adverse Event|90|||
155201924|NCT00622284|560176729|FG000|Overall Study|Protocol Violation|12|||
155201925|NCT00622284|560176730|FG001|Overall Study|Protocol Violation|5|||
155201926|NCT00622284|560176729|FG000|Overall Study|Lost to Follow-up|11|||
155201927|NCT00622284|560176730|FG001|Overall Study|Lost to Follow-up|13|||
155201928|NCT00622284|560176729|FG000|Overall Study|Withdrawal by Subject|27|||
155201929|NCT00622284|560176730|FG001|Overall Study|Withdrawal by Subject|24|||
155201930|NCT00622284|560176729|FG000|Overall Study|Other reason (not specified)|33|||
155201931|NCT00622284|560176730|FG001|Overall Study|Other reason (not specified)|24|||
155201932|NCT04545385|560176731|FG000|Overall Study|Withdrawal by Subject|2|||
155201933|NCT04545385|560176732|FG001|Overall Study|Withdrawal by Subject|0|||
155201934|NCT04545385|560176731|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
155201935|NCT04545385|560176732|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
155201936|NCT04545385|560176731|FG000|Overall Study|Study termination|10|||
155201937|NCT04545385|560176732|FG001|Overall Study|Study termination|10|||
155201938|NCT04545385|560176731|FG000|Overall Study|Sponsor decision|2|||
155201939|NCT04545385|560176732|FG001|Overall Study|Sponsor decision|2|||
155201940|NCT04545385|560176731|FG000|Overall Study|Other than specified|1|||
155201941|NCT04545385|560176732|FG001|Overall Study|Other than specified|0|||
155201942|NCT02412618|560176735|FG000|Overall Study|Withdrawal by Subject|1|||
155201943|NCT02412618|560176736|FG001|Overall Study|Withdrawal by Subject|1|||
155201944|NCT02412618|560176735|FG000|Overall Study|Expulsion|1|||
155201945|NCT02412618|560176736|FG001|Overall Study|Expulsion|1|||
155201946|NCT02094677|560176743|FG000|Overall Study|Screening|3|||
155201947|NCT02094677|560176744|FG001|Overall Study|Screening|1|||
155201948|NCT03408483|560176745|FG000|Overall Study|Physician Decision|3|||
155201949|NCT03408483|560176746|FG001|Overall Study|Physician Decision|3|||
155201950|NCT03408483|560176745|FG000|Overall Study|Lost to Follow-up|3|||
155201951|NCT03408483|560176746|FG001|Overall Study|Lost to Follow-up|0|||
155201952|NCT05399641|560176747|FG000|Overall Study|Adverse Event|0|||
155201953|NCT05399641|560176748|FG001|Overall Study|Adverse Event|1|||
155201954|NCT05399641|560176749|FG002|Overall Study|Adverse Event|1|||
155201955|NCT05399641|560176747|FG000|Overall Study|Lost to Follow-up|1|||
155201956|NCT05399641|560176748|FG001|Overall Study|Lost to Follow-up|2|||
155201957|NCT05399641|560176749|FG002|Overall Study|Lost to Follow-up|2|||
155201958|NCT05399641|560176747|FG000|Overall Study|Physician Decision|1|||
155201959|NCT05399641|560176748|FG001|Overall Study|Physician Decision|3|||
155201960|NCT05399641|560176749|FG002|Overall Study|Physician Decision|3|||
155201961|NCT05399641|560176747|FG000|Overall Study|Withdrawal by Subject|4|||
155201962|NCT05399641|560176748|FG001|Overall Study|Withdrawal by Subject|11|||
155201963|NCT05399641|560176749|FG002|Overall Study|Withdrawal by Subject|7|||
155201964|NCT05399641|560176747|FG000|Overall Study|Reason not defined|3|||
155201965|NCT05399641|560176748|FG001|Overall Study|Reason not defined|5|||
155201966|NCT05399641|560176749|FG002|Overall Study|Reason not defined|6|||
155201967|NCT00478231|560176750|FG000|Overall Study|Death|7|||
155201968|NCT00478231|560176750|FG000|Overall Study|Lack of Efficacy|47|||
155201969|NCT00478231|560176750|FG000|Overall Study|Lost to Follow-up|7|||
155201970|NCT00478231|560176750|FG000|Overall Study|Withdrawal by Subject|6|||
155201971|NCT00478231|560176750|FG000|Overall Study|Other|9|||
155201972|NCT00478231|560176750|FG000|Overall Study|Adverse Event|5|||
155201973|NCT00478231|560176750|FG000|Overall Study|Randomized, not treated|3|||
155201974|NCT00602797|560176753|FG000|Overall Study|Adverse Event|1|||
155201975|NCT00629707|560176756|FG000|Overall Study|Withdrawal by Subject|0|||
155201976|NCT00629707|560176757|FG001|Overall Study|Withdrawal by Subject|1|||
155201977|NCT00629707|560176756|FG000|Overall Study|Physician Decision|0|||
155201978|NCT00629707|560176757|FG001|Overall Study|Physician Decision|1|||
155201979|NCT02657369|560176758|FG000|Overall Study|Death|27|||
155201980|NCT02657369|560176758|FG000|Overall Study|Study terminated by sponsor|7|||
155201981|NCT02605824|560176759|FG000|Overall Study|Physician Decision|1|||
155201982|NCT02605824|560176760|FG001|Overall Study|Physician Decision|0|||
155201983|NCT04875195|560176761|FG000|Overall Study|Death|9|||
155201984|NCT04875195|560176762|FG001|Overall Study|Death|3|||
155201985|NCT04875195|560176761|FG000|Overall Study|Withdrawal by Subject|2|||
155201986|NCT04875195|560176762|FG001|Overall Study|Withdrawal by Subject|1|||
155201987|NCT04875195|560176761|FG000|Overall Study|Ongoing in study|49|||
155201988|NCT04875195|560176762|FG001|Overall Study|Ongoing in study|2|||
155201989|NCT00826943|560176765|FG000|Overall Study|Withdrawal by Subject|0|||
155201990|NCT00826943|560176766|FG001|Overall Study|Withdrawal by Subject|0|||
155201991|NCT00826943|560176767|FG002|Overall Study|Withdrawal by Subject|0|||
155201992|NCT00826943|560176768|FG003|Overall Study|Withdrawal by Subject|0|||
155201993|NCT00826943|560176769|FG004|Overall Study|Withdrawal by Subject|1|||
155201994|NCT00826943|560176770|FG005|Overall Study|Withdrawal by Subject|0|||
155201995|NCT03715530|560176771|FG000|Overall Study|Lost to Follow-up|3|||
155201996|NCT03715530|560176772|FG001|Overall Study|Lost to Follow-up|1|||
155201997|NCT03715530|560176773|FG002|Overall Study|Lost to Follow-up|2|||
155201998|NCT03547583|560176774|FG000|Overall Study|Adverse Event|16|||
155201999|NCT03547583|560176775|FG001|Overall Study|Adverse Event|11|||
155202000|NCT03547583|560176776|FG002|Overall Study|Adverse Event|10|||
155202001|NCT03547583|560176774|FG000|Overall Study|Death|11|||
155202002|NCT03547583|560176775|FG001|Overall Study|Death|7|||
155202003|NCT03547583|560176776|FG002|Overall Study|Death|4|||
155202004|NCT03547583|560176774|FG000|Overall Study|Lost to Follow-up|1|||
155202005|NCT03547583|560176775|FG001|Overall Study|Lost to Follow-up|0|||
155202006|NCT03547583|560176776|FG002|Overall Study|Lost to Follow-up|0|||
155202007|NCT03547583|560176774|FG000|Overall Study|Non-compliance with study drug|0|||
155202008|NCT03547583|560176775|FG001|Overall Study|Non-compliance with study drug|0|||
155202009|NCT03547583|560176776|FG002|Overall Study|Non-compliance with study drug|1|||
155202010|NCT03547583|560176774|FG000|Overall Study|Physician Decision|1|||
155202011|NCT03547583|560176775|FG001|Overall Study|Physician Decision|0|||
155202012|NCT03547583|560176776|FG002|Overall Study|Physician Decision|3|||
155202013|NCT03547583|560176774|FG000|Overall Study|Protocol Violation|2|||
155202014|NCT03547583|560176775|FG001|Overall Study|Protocol Violation|1|||
155202015|NCT03547583|560176776|FG002|Overall Study|Protocol Violation|1|||
155202016|NCT03547583|560176774|FG000|Overall Study|Withdrawal by Subject|12|||
155202017|NCT03547583|560176775|FG001|Overall Study|Withdrawal by Subject|19|||
155202018|NCT03547583|560176776|FG002|Overall Study|Withdrawal by Subject|10|||
155202019|NCT03547583|560176774|FG000|Overall Study|Other|2|||
155202020|NCT03547583|560176775|FG001|Overall Study|Other|2|||
155202021|NCT03547583|560176776|FG002|Overall Study|Other|3|||
155202022|NCT01744197|560176777|FG000|Overall Study|Received 1 patch|2|||
155202023|NCT01744197|560176778|FG001|Overall Study|Received 1 patch|1|||
155202024|NCT01744197|560176777|FG000|Overall Study|No patch received|2|||
155202025|NCT01744197|560176778|FG001|Overall Study|No patch received|2|||
155202026|NCT04706091|560176779|FG000|Treatment 2|Withdrawal by Subject|1|||
155202027|NCT04706091|560176780|FG001|Treatment 2|Withdrawal by Subject|0|||
155202028|NCT03329573|560176781|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
155202029|NCT03329573|560176782|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
155202030|NCT03329573|560176783|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
155202031|NCT03329573|560176784|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
155202032|NCT03329573|560176781|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
155202033|NCT03329573|560176782|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
155202034|NCT03329573|560176783|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155202035|NCT03329573|560176784|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
155202036|NCT03329573|560176781|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
155202037|NCT03329573|560176782|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
155202038|NCT03329573|560176783|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
155202039|NCT03329573|560176784|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
155202040|NCT03329573|560176781|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
155202041|NCT03329573|560176782|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
155202042|NCT03329573|560176783|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
155202043|NCT03329573|560176784|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
155202044|NCT02166905|560176787|FG000|Overall Study|Withdrawal by Subject|1|||
155202045|NCT02166905|560176788|FG001|Overall Study|Withdrawal by Subject|0|||
155202046|NCT02166905|560176789|FG002|Overall Study|Withdrawal by Subject|0|||
155202047|NCT02166905|560176790|FG003|Overall Study|Withdrawal by Subject|0|||
155202048|NCT05243641|560176792|FG000|Overall Study|Adverse Event|3|||
155202049|NCT05243641|560176793|FG001|Overall Study|Adverse Event|0|||
155202050|NCT05243641|560176794|FG002|Overall Study|Adverse Event|0|||
155202051|NCT05243641|560176795|FG003|Overall Study|Adverse Event|1|||
155202052|NCT05243641|560176796|FG004|Overall Study|Adverse Event|0|||
155202053|NCT05243641|560176797|FG005|Overall Study|Adverse Event|0|||
155202054|NCT05243641|560176792|FG000|Overall Study|Disease progression|4|||
155202055|NCT05243641|560176793|FG001|Overall Study|Disease progression|0|||
155202056|NCT05243641|560176794|FG002|Overall Study|Disease progression|0|||
155202057|NCT05243641|560176795|FG003|Overall Study|Disease progression|2|||
155202058|NCT05243641|560176796|FG004|Overall Study|Disease progression|0|||
155202059|NCT05243641|560176797|FG005|Overall Study|Disease progression|0|||
155202060|NCT05372419|560176801|FG000|Overall Study|Protocol Deviation|1|||
155202061|NCT05372419|560176801|FG000|Overall Study|Withdrawal by Subject|5|||
155202062|NCT05372419|560176801|FG000|Overall Study|Lost to Follow-up|7|||
155202063|NCT04997304|560176802|FG000|Overall Study|Lost to Follow-up|11|||
155202064|NCT04997304|560176802|FG000|Overall Study|Death|1|||
155202065|NCT04997304|560176802|FG000|Overall Study|Withdrawal by Subject|14|||
155202066|NCT03311724|560178957|FG000|Overall Study|Physician Decision|0|||
155202067|NCT03311724|560178958|FG001|Overall Study|Physician Decision|0|||
155202068|NCT03311724|560178959|FG002|Overall Study|Physician Decision|0|||
155202069|NCT03311724|560178960|FG003|Overall Study|Physician Decision|1|||
155202070|NCT03311724|560178957|FG000|Overall Study|Protocol Violation|1|||
155202071|NCT03311724|560178958|FG001|Overall Study|Protocol Violation|0|||
155202072|NCT03311724|560178959|FG002|Overall Study|Protocol Violation|1|||
155202073|NCT03311724|560178960|FG003|Overall Study|Protocol Violation|0|||
155202074|NCT03311724|560178957|FG000|Overall Study|Withdrawal by Subject|1|||
155202075|NCT03311724|560178958|FG001|Overall Study|Withdrawal by Subject|1|||
155202076|NCT03311724|560178959|FG002|Overall Study|Withdrawal by Subject|0|||
155202077|NCT03311724|560178960|FG003|Overall Study|Withdrawal by Subject|0|||
155202078|NCT03311724|560178957|FG000|Overall Study|Lost to Follow-up|1|||
155202079|NCT03311724|560178958|FG001|Overall Study|Lost to Follow-up|0|||
155202080|NCT03311724|560178959|FG002|Overall Study|Lost to Follow-up|0|||
155202081|NCT03311724|560178960|FG003|Overall Study|Lost to Follow-up|0|||
155202082|NCT03311724|560178957|FG000|Overall Study|Sponsor Decision|0|||
155202083|NCT03311724|560178958|FG001|Overall Study|Sponsor Decision|0|||
155202084|NCT03311724|560178959|FG002|Overall Study|Sponsor Decision|1|||
155202085|NCT03311724|560178960|FG003|Overall Study|Sponsor Decision|0|||
155202086|NCT01970397|560178963|FG000|Overall Study|Adverse Event|0|||
155202087|NCT01970397|560178964|FG001|Overall Study|Adverse Event|1|||
155202088|NCT01970397|560178963|FG000|Overall Study|Lost to Follow-up|0|||
155202089|NCT01970397|560178964|FG001|Overall Study|Lost to Follow-up|1|||
155202090|NCT01970397|560178963|FG000|Overall Study|Personal Reasons|1|||
155202091|NCT01970397|560178964|FG001|Overall Study|Personal Reasons|2|||
155202092|NCT01970397|560178963|FG000|Overall Study|Protocol Violation|1|||
155202093|NCT01970397|560178964|FG001|Overall Study|Protocol Violation|1|||
155202094|NCT01471171|560178970|FG000|Treatment Period 1|Adverse Event|4|||
155202095|NCT01471171|560178971|FG001|Treatment Period 1|Adverse Event|1|||
155202096|NCT01471171|560178970|FG000|Treatment Period 2|Adverse Event|1|||
155202097|NCT01471171|560178971|FG001|Treatment Period 2|Adverse Event|0|||
155202098|NCT00407797|560178972|FG000|Overall Study|Lost to Follow-up|2|||
155202099|NCT00407797|560178972|FG000|Overall Study|Adverse Event|6|||
155202100|NCT00407797|560178972|FG000|Overall Study|Other|7|||
155202101|NCT00407797|560178972|FG000|Overall Study|Withdrawal by Subject|3|||
155202102|NCT01812174|560178973|FG000|Overall Study|Death|1|||
155202103|NCT01812174|560178974|FG001|Overall Study|Death|0|||
155202104|NCT01812174|560178973|FG000|Overall Study|Protocol Violation|2|||
155202105|NCT01812174|560178974|FG001|Overall Study|Protocol Violation|0|||
155202106|NCT00555971|560178975|FG000|Overall Study|Adverse Event|1|||
155202107|NCT00555971|560178976|FG001|Overall Study|Adverse Event|1|||
155202108|NCT05469178|560178977|FG000|Overall Study|Death|1|||
155202109|NCT05469178|560178978|FG001|Overall Study|Death|1|||
155202110|NCT05469178|560178979|FG002|Overall Study|Death|3|||
155202111|NCT05469178|560178980|FG003|Overall Study|Death|6|||
155202112|NCT05469178|560178977|FG000|Overall Study|Lack of Efficacy|2|||
155202113|NCT05469178|560178978|FG001|Overall Study|Lack of Efficacy|2|||
155202114|NCT05469178|560178979|FG002|Overall Study|Lack of Efficacy|1|||
155202115|NCT05469178|560178980|FG003|Overall Study|Lack of Efficacy|10|||
155202116|NCT05393895|560178981|FG000|Overall Study|Adverse Event|2|||
155202117|NCT05393895|560178982|FG001|Overall Study|Adverse Event|3|||
155202118|NCT05393895|560178981|FG000|Overall Study|Lost to Follow-up|4|||
155202119|NCT05393895|560178982|FG001|Overall Study|Lost to Follow-up|3|||
155202120|NCT05393895|560178981|FG000|Overall Study|Protocol Violation|1|||
155202121|NCT05393895|560178982|FG001|Overall Study|Protocol Violation|0|||
155202122|NCT05393895|560178981|FG000|Overall Study|Withdrawal by Subject|1|||
155202123|NCT05393895|560178982|FG001|Overall Study|Withdrawal by Subject|4|||
155202124|NCT01203098|560178987|FG000|Overall Study|Adverse Event|3|||
155202125|NCT01203098|560178988|FG001|Overall Study|Adverse Event|1|||
155202126|NCT01203098|560178989|FG002|Overall Study|Adverse Event|7|||
155202127|NCT01203098|560178987|FG000|Overall Study|Lost to Follow-up|0|||
155202128|NCT01203098|560178988|FG001|Overall Study|Lost to Follow-up|0|||
155202129|NCT01203098|560178989|FG002|Overall Study|Lost to Follow-up|1|||
155202130|NCT01203098|560178987|FG000|Overall Study|Physician Decision|2|||
155202131|NCT01203098|560178988|FG001|Overall Study|Physician Decision|2|||
155202132|NCT01203098|560178989|FG002|Overall Study|Physician Decision|0|||
155202133|NCT01203098|560178987|FG000|Overall Study|Withdrawal by Subject|1|||
155202134|NCT01203098|560178988|FG001|Overall Study|Withdrawal by Subject|1|||
155202135|NCT01203098|560178989|FG002|Overall Study|Withdrawal by Subject|3|||
155202136|NCT00621582|560178997|FG000|Overall Study|Adverse Event|7|||
155202137|NCT00621582|560178997|FG000|Overall Study|Protocol Violation|57|||
155202138|NCT00621582|560178997|FG000|Overall Study|Lost to Follow-up|24|||
155202139|NCT00621582|560178997|FG000|Overall Study|issues not identified by investigators|18|||
155202140|NCT03617185|560178998|FG000|Baseline|Lost to Follow-up|0|||
155202141|NCT03617185|560178999|FG001|Baseline|Lost to Follow-up|2|||
155202142|NCT03617185|560179000|FG002|Baseline|Lost to Follow-up|1|||
155202143|NCT03617185|560179001|FG003|Baseline|Lost to Follow-up|1|||
155202144|NCT03617185|560178998|FG000|Baseline|Withdrawal by Subject|0|||
155202145|NCT03617185|560178999|FG001|Baseline|Withdrawal by Subject|1|||
155202146|NCT03617185|560179000|FG002|Baseline|Withdrawal by Subject|0|||
155202147|NCT03617185|560179001|FG003|Baseline|Withdrawal by Subject|1|||
155202148|NCT03617185|560178998|FG000|Baseline|Driving Distance/Travel|0|||
155202149|NCT03617185|560178999|FG001|Baseline|Driving Distance/Travel|0|||
155202150|NCT03617185|560179000|FG002|Baseline|Driving Distance/Travel|2|||
155202151|NCT03617185|560179001|FG003|Baseline|Driving Distance/Travel|0|||
155202152|NCT03617185|560178998|FG000|Baseline|Family Obligations|0|||
155202153|NCT03617185|560178999|FG001|Baseline|Family Obligations|0|||
155202154|NCT03617185|560179000|FG002|Baseline|Family Obligations|0|||
155202155|NCT03617185|560179001|FG003|Baseline|Family Obligations|1|||
155202156|NCT03617185|560178998|FG000|3 Months|Lost to Follow-up|4|||
155202157|NCT03617185|560178999|FG001|3 Months|Lost to Follow-up|1|||
155202158|NCT03617185|560179000|FG002|3 Months|Lost to Follow-up|0|||
155202159|NCT03617185|560179001|FG003|3 Months|Lost to Follow-up|2|||
155202160|NCT03617185|560178998|FG000|3 Months|Withdrawal by Subject|1|||
155202161|NCT03617185|560178999|FG001|3 Months|Withdrawal by Subject|3|||
155202162|NCT03617185|560179000|FG002|3 Months|Withdrawal by Subject|0|||
155202163|NCT03617185|560179001|FG003|3 Months|Withdrawal by Subject|0|||
155202164|NCT03617185|560178998|FG000|3 Months|Driving Distance/Travel|1|||
155202165|NCT03617185|560178999|FG001|3 Months|Driving Distance/Travel|0|||
155202166|NCT03617185|560179000|FG002|3 Months|Driving Distance/Travel|0|||
155202167|NCT03617185|560179001|FG003|3 Months|Driving Distance/Travel|0|||
155202168|NCT03617185|560178998|FG000|3 Months|Family Obligations|0|||
155202169|NCT03617185|560178999|FG001|3 Months|Family Obligations|0|||
155202170|NCT03617185|560179000|FG002|3 Months|Family Obligations|0|||
155202171|NCT03617185|560179001|FG003|3 Months|Family Obligations|1|||
155202172|NCT03617185|560178998|FG000|12 Months|Lost to Follow-up|3|||
155202173|NCT03617185|560178999|FG001|12 Months|Lost to Follow-up|1|||
155202174|NCT03617185|560179000|FG002|12 Months|Lost to Follow-up|3|||
155202175|NCT03617185|560179001|FG003|12 Months|Lost to Follow-up|0|||
155202176|NCT03617185|560178998|FG000|12 Months|Withdrawal by Subject|0|||
155202177|NCT03617185|560178999|FG001|12 Months|Withdrawal by Subject|0|||
155202178|NCT03617185|560179000|FG002|12 Months|Withdrawal by Subject|0|||
155202179|NCT03617185|560179001|FG003|12 Months|Withdrawal by Subject|1|||
155202180|NCT03617185|560178998|FG000|12 Months|Driving Distance/Travel|0|||
155202181|NCT03617185|560178999|FG001|12 Months|Driving Distance/Travel|0|||
155202182|NCT03617185|560179000|FG002|12 Months|Driving Distance/Travel|1|||
155202183|NCT03617185|560179001|FG003|12 Months|Driving Distance/Travel|0|||
155202184|NCT01387932|560179003|FG000|Randomized and Treated|Physician Decision|3|||
155202185|NCT01387932|560179004|FG001|Randomized and Treated|Physician Decision|2|||
155202186|NCT01387932|560179003|FG000|Randomized and Treated|Withdrawal by Subject|4|||
155202187|NCT01387932|560179004|FG001|Randomized and Treated|Withdrawal by Subject|2|||
155202188|NCT01387932|560179003|FG000|Survival Follow-up|Liver Transplant|24|||
155202189|NCT01387932|560179004|FG001|Survival Follow-up|Liver Transplant|28|||
155202190|NCT01387932|560179003|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
155202191|NCT01387932|560179004|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
155202192|NCT01387932|560179003|FG000|Survival Follow-up|Withdrawal by Subject|2|||
155202193|NCT01387932|560179004|FG001|Survival Follow-up|Withdrawal by Subject|4|||
155202194|NCT01387932|560179003|FG000|Survival Follow-up|Lost to Follow-up|6|||
155202195|NCT01387932|560179004|FG001|Survival Follow-up|Lost to Follow-up|5|||
155202196|NCT01964430|560179005|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
155202197|NCT01964430|560179006|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
155202198|NCT01964430|560179005|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
155202199|NCT01964430|560179006|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
155202200|NCT01964430|560179005|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
155202201|NCT01964430|560179006|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
155202202|NCT01964430|560179005|FG000|Treatment Period|Adverse Event|71|||
155202203|NCT01964430|560179006|FG001|Treatment Period|Adverse Event|37|||
155202204|NCT01964430|560179005|FG000|Treatment Period|Withdrawal by Subject|36|||
155202205|NCT01964430|560179006|FG001|Treatment Period|Withdrawal by Subject|27|||
155202206|NCT01964430|560179005|FG000|Treatment Period|Death|1|||
155202207|NCT01964430|560179006|FG001|Treatment Period|Death|3|||
155202208|NCT01964430|560179005|FG000|Treatment Period|Protocol Deviation|0|||
155202209|NCT01964430|560179006|FG001|Treatment Period|Protocol Deviation|1|||
155202210|NCT01964430|560179005|FG000|Treatment Period|Physician Decision|5|||
155202211|NCT01964430|560179006|FG001|Treatment Period|Physician Decision|4|||
155202212|NCT01964430|560179005|FG000|Treatment Period|Disease Relapse|28|||
155202213|NCT01964430|560179006|FG001|Treatment Period|Disease Relapse|38|||
155202214|NCT01964430|560179005|FG000|Treatment Period|Other reasons|1|||
155202215|NCT01964430|560179006|FG001|Treatment Period|Other reasons|3|||
155202216|NCT02591290|560179007|FG000|Overall Study|Withdrawal by Subject|2|||
155202217|NCT02571075|560179008|FG000|Overall Study|Lost to Follow-up|20|||
155202218|NCT02571075|560179009|FG001|Overall Study|Lost to Follow-up|24|||
155202219|NCT02197520|560179015|FG000|Period 1|Withdrawal by Subject|1|||
155202220|NCT02197520|560179016|FG001|Period 1|Withdrawal by Subject|0|||
155202221|NCT02197520|560179015|FG000|Period 2|Adverse Event|0|||
155202222|NCT02197520|560179016|FG001|Period 2|Adverse Event|2|||
155202223|NCT02197520|560179015|FG000|Period 2|Withdrawal by Subject|1|||
155202224|NCT02197520|560179016|FG001|Period 2|Withdrawal by Subject|0|||
155202225|NCT00913497|560179017|FG000|Overall Study|Adverse Event|1|||
155202226|NCT00913497|560179017|FG000|Overall Study|Withdrawal by Subject|2|||
155202227|NCT01306942|560179018|FG000|Phase I|Adverse Event|2|||
155202228|NCT01306942|560179019|FG001|Phase I|Adverse Event|2|||
155202229|NCT01306942|560179020|FG002|Phase I|Adverse Event|0|||
155202230|NCT01306942|560179021|FG003|Phase I|Adverse Event|0|||
155202231|NCT01306942|560179018|FG000|Phase I|Physician Decision|3|||
155202232|NCT01306942|560179019|FG001|Phase I|Physician Decision|1|||
155202233|NCT01306942|560179020|FG002|Phase I|Physician Decision|0|||
155202234|NCT01306942|560179021|FG003|Phase I|Physician Decision|0|||
155202235|NCT01306942|560179018|FG000|Phase II|Adverse Event|0|||
155202236|NCT01306942|560179019|FG001|Phase II|Adverse Event|0|||
155202237|NCT01306942|560179020|FG002|Phase II|Adverse Event|0|||
155202238|NCT01306942|560179021|FG003|Phase II|Adverse Event|6|||
155202239|NCT01306942|560179018|FG000|Phase II|Physician Decision|2|||
155202240|NCT01306942|560179019|FG001|Phase II|Physician Decision|0|||
155202241|NCT01306942|560179020|FG002|Phase II|Physician Decision|0|||
155202242|NCT01306942|560179021|FG003|Phase II|Physician Decision|5|||
155202243|NCT01306942|560179018|FG000|Phase II|Withdrawal by Subject|0|||
155202244|NCT01306942|560179019|FG001|Phase II|Withdrawal by Subject|0|||
155202245|NCT01306942|560179020|FG002|Phase II|Withdrawal by Subject|0|||
155202246|NCT01306942|560179021|FG003|Phase II|Withdrawal by Subject|2|||
155202247|NCT01306942|560179018|FG000|Phase II|Death|0|||
155202248|NCT01306942|560179019|FG001|Phase II|Death|0|||
155202249|NCT01306942|560179020|FG002|Phase II|Death|0|||
155202250|NCT01306942|560179021|FG003|Phase II|Death|1|||
155202251|NCT01306942|560179018|FG000|Phase II|Not finished treatment|0|||
155202252|NCT01306942|560179019|FG001|Phase II|Not finished treatment|0|||
155202253|NCT01306942|560179020|FG002|Phase II|Not finished treatment|0|||
155202254|NCT01306942|560179021|FG003|Phase II|Not finished treatment|1|||
155202255|NCT01306942|560179018|FG000|Phase II|Protocol Violation|0|||
155202256|NCT01306942|560179019|FG001|Phase II|Protocol Violation|0|||
155202257|NCT01306942|560179020|FG002|Phase II|Protocol Violation|0|||
155202258|NCT01306942|560179021|FG003|Phase II|Protocol Violation|1|||
155202259|NCT03190915|560179022|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
155202260|NCT03190915|560179022|FG000|Overall Study|Progressive Disease|3|||
155202261|NCT03385564|560179023|FG000|Overall Study|Adverse Event|0|||
155202262|NCT03385564|560179024|FG001|Overall Study|Adverse Event|0|||
155202263|NCT03385564|560179025|FG002|Overall Study|Adverse Event|3|||
155202264|NCT03385564|560179026|FG003|Overall Study|Adverse Event|3|||
155202265|NCT03385564|560179023|FG000|Overall Study|Other than listed|0|||
155202266|NCT03385564|560179024|FG001|Overall Study|Other than listed|0|||
155202267|NCT03385564|560179025|FG002|Overall Study|Other than listed|0|||
155202268|NCT03385564|560179026|FG003|Overall Study|Other than listed|5|||
155202269|NCT03385564|560179023|FG000|Overall Study|Withdrawal by Subject|0|||
155202270|NCT03385564|560179024|FG001|Overall Study|Withdrawal by Subject|1|||
155202271|NCT03385564|560179025|FG002|Overall Study|Withdrawal by Subject|1|||
155202272|NCT03385564|560179026|FG003|Overall Study|Withdrawal by Subject|0|||
155202273|NCT03385564|560179023|FG000|Overall Study|Lack of Efficacy|0|||
155202274|NCT03385564|560179024|FG001|Overall Study|Lack of Efficacy|0|||
155202275|NCT03385564|560179025|FG002|Overall Study|Lack of Efficacy|0|||
155202276|NCT03385564|560179026|FG003|Overall Study|Lack of Efficacy|1|||
155202277|NCT03385564|560179023|FG000|Overall Study|Death|0|||
155202278|NCT03385564|560179024|FG001|Overall Study|Death|0|||
155202279|NCT03385564|560179025|FG002|Overall Study|Death|1|||
155202280|NCT03385564|560179026|FG003|Overall Study|Death|0|||
155202281|NCT01546883|560179033|FG000|Overall Study|Withdrawal by Subject|3|||
155202282|NCT01546883|560179033|FG000|Overall Study|Adverse Event|4|||
155202283|NCT01546883|560179033|FG000|Overall Study|Lost to Follow-up|2|||
155202284|NCT01546883|560179033|FG000|Overall Study|early closure of study|2|||
155202285|NCT01546883|560179033|FG000|Overall Study|other unrelated illness|1|||
155202286|NCT02256631|560179034|FG000|Overall Study|Lost to Follow-up|1|||
155202287|NCT02256631|560179035|FG001|Overall Study|Lost to Follow-up|1|||
155202288|NCT02256631|560179036|FG002|Overall Study|Lost to Follow-up|0|||
155202289|NCT02256631|560179037|FG003|Overall Study|Lost to Follow-up|2|||
155202290|NCT02256631|560179038|FG004|Overall Study|Lost to Follow-up|0|||
155202291|NCT02256631|560179039|FG005|Overall Study|Lost to Follow-up|4|||
155202292|NCT02256631|560179040|FG006|Overall Study|Lost to Follow-up|1|||
155202293|NCT02256631|560179034|FG000|Overall Study|Withdrawal by Subject|0|||
155202294|NCT02256631|560179035|FG001|Overall Study|Withdrawal by Subject|0|||
155202295|NCT02256631|560179036|FG002|Overall Study|Withdrawal by Subject|0|||
155202296|NCT02256631|560179037|FG003|Overall Study|Withdrawal by Subject|1|||
155202297|NCT02256631|560179038|FG004|Overall Study|Withdrawal by Subject|1|||
155202298|NCT02256631|560179039|FG005|Overall Study|Withdrawal by Subject|0|||
155202299|NCT02256631|560179040|FG006|Overall Study|Withdrawal by Subject|1|||
155202300|NCT02256631|560179034|FG000|Overall Study|Unable to get to clinic|0|||
155202301|NCT02256631|560179035|FG001|Overall Study|Unable to get to clinic|2|||
155202302|NCT02256631|560179036|FG002|Overall Study|Unable to get to clinic|0|||
155202303|NCT02256631|560179037|FG003|Overall Study|Unable to get to clinic|1|||
155202304|NCT02256631|560179038|FG004|Overall Study|Unable to get to clinic|0|||
155202305|NCT02256631|560179039|FG005|Overall Study|Unable to get to clinic|1|||
155202306|NCT02256631|560179040|FG006|Overall Study|Unable to get to clinic|2|||
155202307|NCT01427972|560179041|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202308|NCT01427972|560179042|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202309|NCT01427972|560179043|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202310|NCT01427972|560179044|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202311|NCT01427972|560179045|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202312|NCT01427972|560179046|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202313|NCT01427972|560179047|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202314|NCT01427972|560179048|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
155202315|NCT01427972|560179049|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202316|NCT01427972|560179050|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202317|NCT01427972|560179051|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202318|NCT01427972|560179052|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
155202319|NCT01427972|560179041|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202320|NCT01427972|560179042|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202321|NCT01427972|560179043|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202322|NCT01427972|560179044|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202323|NCT01427972|560179045|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202324|NCT01427972|560179046|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
155202325|NCT01427972|560179047|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202326|NCT01427972|560179048|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202327|NCT01427972|560179049|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202328|NCT01427972|560179050|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202329|NCT01427972|560179051|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202330|NCT01427972|560179052|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
155202331|NCT01427972|560179041|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202332|NCT01427972|560179042|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
155202333|NCT01427972|560179043|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202334|NCT01427972|560179044|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202335|NCT01427972|560179045|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202336|NCT01427972|560179046|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202337|NCT01427972|560179047|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202338|NCT01427972|560179048|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202339|NCT01427972|560179049|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202340|NCT01427972|560179050|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202341|NCT01427972|560179051|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202342|NCT01427972|560179052|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
155202343|NCT01128842|560179060|FG000|Overall Study|Adverse Event|1|||
155202344|NCT01128842|560179060|FG000|Overall Study|Disease Progression|6|||
155202345|NCT03322631|560179061|FG000|Overall Study|Withdrawal by Subject|0|||
155202346|NCT03322631|560179062|FG001|Overall Study|Withdrawal by Subject|1|||
155202347|NCT03322631|560179063|FG002|Overall Study|Withdrawal by Subject|0|||
155202348|NCT03322631|560179064|FG003|Overall Study|Withdrawal by Subject|0|||
155202349|NCT03322631|560179061|FG000|Overall Study|Adverse Event|0|||
155202350|NCT03322631|560179062|FG001|Overall Study|Adverse Event|0|||
155202351|NCT03322631|560179063|FG002|Overall Study|Adverse Event|1|||
155202352|NCT03322631|560179064|FG003|Overall Study|Adverse Event|0|||
155202353|NCT02378961|560179066|FG000|Overall Study|Lack of Efficacy|4|||
155202354|NCT02378961|560179067|FG001|Overall Study|Lack of Efficacy|2|||
155202355|NCT02378961|560179068|FG002|Overall Study|Lack of Efficacy|0|||
155202356|NCT02378961|560179069|FG003|Overall Study|Lack of Efficacy|1|||
155202357|NCT02378961|560179066|FG000|Overall Study|Death|0|||
155202358|NCT02378961|560179067|FG001|Overall Study|Death|0|||
155202359|NCT02378961|560179068|FG002|Overall Study|Death|1|||
155202360|NCT02378961|560179069|FG003|Overall Study|Death|0|||
155202361|NCT04528732|560179070|FG000|Overall Study|Death|1|||
155202362|NCT04528732|560179071|FG001|Overall Study|Death|0|||
155202363|NCT04528732|560179072|FG002|Overall Study|Death|1|||
155202364|NCT04528732|560179070|FG000|Overall Study|Lost to Follow-up|0|||
155202365|NCT04528732|560179071|FG001|Overall Study|Lost to Follow-up|1|||
155202366|NCT04528732|560179072|FG002|Overall Study|Lost to Follow-up|2|||
155202367|NCT01253408|560179073|FG000|Overall Study|Adverse Event|0|||
155202368|NCT01253408|560179074|FG001|Overall Study|Adverse Event|1|||
155202369|NCT01253408|560179075|FG002|Overall Study|Adverse Event|0|||
155202370|NCT01300650|560179076|FG000|Overall Study|Adverse Event|1|||
155202371|NCT02784431|560179082|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
155202372|NCT02784431|560179082|FG000|Overall Study|Early Study Termination|19|||
155202373|NCT00361569|560179083|FG000|Overall Study|Protocol Violation|3|||
155202374|NCT00361569|560179084|FG001|Overall Study|Protocol Violation|2|||
155202375|NCT00361569|560179085|FG002|Overall Study|Protocol Violation|4|||
155202376|NCT00361569|560179086|FG003|Overall Study|Protocol Violation|2|||
155202377|NCT00361569|560179083|FG000|Overall Study|Withdrawal by Subject|2|||
155202378|NCT00361569|560179084|FG001|Overall Study|Withdrawal by Subject|1|||
155202379|NCT00361569|560179085|FG002|Overall Study|Withdrawal by Subject|9|||
155202380|NCT00361569|560179086|FG003|Overall Study|Withdrawal by Subject|14|||
155202381|NCT00361569|560179083|FG000|Overall Study|Adverse Event|3|||
155202382|NCT00361569|560179084|FG001|Overall Study|Adverse Event|5|||
155202383|NCT00361569|560179085|FG002|Overall Study|Adverse Event|2|||
155202384|NCT00361569|560179086|FG003|Overall Study|Adverse Event|2|||
155202385|NCT00361569|560179083|FG000|Overall Study|Lost to Follow-up|2|||
155202386|NCT00361569|560179084|FG001|Overall Study|Lost to Follow-up|3|||
155202387|NCT00361569|560179085|FG002|Overall Study|Lost to Follow-up|3|||
155202388|NCT00361569|560179086|FG003|Overall Study|Lost to Follow-up|2|||
155202389|NCT00361569|560179083|FG000|Overall Study|Not specified by investigator|2|||
155202390|NCT00361569|560179084|FG001|Overall Study|Not specified by investigator|0|||
155202391|NCT00361569|560179085|FG002|Overall Study|Not specified by investigator|0|||
155202392|NCT00361569|560179086|FG003|Overall Study|Not specified by investigator|1|||
155202393|NCT00074152|560179087|FG000|Overall Study|Death|21|||
155202394|NCT00074152|560179088|FG001|Overall Study|Death|9|||
155202395|NCT00074152|560179087|FG000|Overall Study|Lack of Efficacy|34|||
155202396|NCT00074152|560179088|FG001|Overall Study|Lack of Efficacy|24|||
155202397|NCT01446289|560179089|FG000|Overall Study|Withdrawal by Subject|1|||
155202398|NCT01446289|560179090|FG001|Overall Study|Withdrawal by Subject|0|||
155202399|NCT01446289|560179091|FG002|Overall Study|Withdrawal by Subject|1|||
155202400|NCT01446289|560179092|FG003|Overall Study|Withdrawal by Subject|0|||
155202401|NCT03307967|560179093|FG000|Overall Study|Lost to Follow-up|4|||
155202402|NCT02915016|560179094|FG000|Overall Study|Lost to Follow-up|4|||
155202403|NCT02915016|560179095|FG001|Overall Study|Lost to Follow-up|2|||
155202404|NCT02915016|560179096|FG002|Overall Study|Lost to Follow-up|5|||
155202405|NCT02915016|560179097|FG003|Overall Study|Lost to Follow-up|3|||
155202406|NCT02915016|560179098|FG004|Overall Study|Lost to Follow-up|5|||
155202407|NCT02915016|560179099|FG005|Overall Study|Lost to Follow-up|2|||
155202408|NCT02915016|560179100|FG006|Overall Study|Lost to Follow-up|8|||
155202409|NCT02915016|560179101|FG007|Overall Study|Lost to Follow-up|2|||
155202410|NCT02915016|560179094|FG000|Overall Study|Physician Decision|0|||
155202411|NCT02915016|560179095|FG001|Overall Study|Physician Decision|0|||
155202412|NCT02915016|560179096|FG002|Overall Study|Physician Decision|1|||
155202413|NCT02915016|560179097|FG003|Overall Study|Physician Decision|0|||
155202414|NCT02915016|560179098|FG004|Overall Study|Physician Decision|0|||
155202415|NCT02915016|560179099|FG005|Overall Study|Physician Decision|1|||
155202416|NCT02915016|560179100|FG006|Overall Study|Physician Decision|2|||
155202417|NCT02915016|560179101|FG007|Overall Study|Physician Decision|0|||
155202418|NCT02915016|560179094|FG000|Overall Study|Withdrawal by Subject|2|||
155202419|NCT02915016|560179095|FG001|Overall Study|Withdrawal by Subject|0|||
155202420|NCT02915016|560179096|FG002|Overall Study|Withdrawal by Subject|1|||
155202421|NCT02915016|560179097|FG003|Overall Study|Withdrawal by Subject|0|||
155202422|NCT02915016|560179098|FG004|Overall Study|Withdrawal by Subject|1|||
155202423|NCT02915016|560179099|FG005|Overall Study|Withdrawal by Subject|3|||
155202424|NCT02915016|560179100|FG006|Overall Study|Withdrawal by Subject|1|||
155202425|NCT02915016|560179101|FG007|Overall Study|Withdrawal by Subject|1|||
155202426|NCT02915016|560179094|FG000|Overall Study|Elected not to continue|0|||
155202427|NCT02915016|560179095|FG001|Overall Study|Elected not to continue|0|||
155202428|NCT02915016|560179096|FG002|Overall Study|Elected not to continue|0|||
155202429|NCT02915016|560179097|FG003|Overall Study|Elected not to continue|1|||
155202430|NCT02915016|560179098|FG004|Overall Study|Elected not to continue|0|||
155202431|NCT02915016|560179099|FG005|Overall Study|Elected not to continue|0|||
155202432|NCT02915016|560179100|FG006|Overall Study|Elected not to continue|1|||
155202433|NCT02915016|560179101|FG007|Overall Study|Elected not to continue|0|||
155202434|NCT02915016|560179094|FG000|Overall Study|HIV infection|1|||
155202435|NCT02915016|560179095|FG001|Overall Study|HIV infection|1|||
155202436|NCT02915016|560179096|FG002|Overall Study|HIV infection|1|||
155202437|NCT02915016|560179097|FG003|Overall Study|HIV infection|0|||
155202438|NCT02915016|560179098|FG004|Overall Study|HIV infection|1|||
155202439|NCT02915016|560179099|FG005|Overall Study|HIV infection|0|||
155202440|NCT02915016|560179100|FG006|Overall Study|HIV infection|0|||
155202441|NCT02915016|560179101|FG007|Overall Study|HIV infection|0|||
155202442|NCT02915016|560179094|FG000|Overall Study|Participant unable to adhere|0|||
155202443|NCT02915016|560179095|FG001|Overall Study|Participant unable to adhere|0|||
155202444|NCT02915016|560179096|FG002|Overall Study|Participant unable to adhere|0|||
155202445|NCT02915016|560179097|FG003|Overall Study|Participant unable to adhere|0|||
155202446|NCT02915016|560179098|FG004|Overall Study|Participant unable to adhere|0|||
155202447|NCT02915016|560179099|FG005|Overall Study|Participant unable to adhere|0|||
155202448|NCT02915016|560179100|FG006|Overall Study|Participant unable to adhere|0|||
155202449|NCT02915016|560179101|FG007|Overall Study|Participant unable to adhere|1|||
155202450|NCT02578316|560179102|FG000|Extension Phase|Progression of disease|6|||
155202451|NCT02617628|560179103|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
155202452|NCT02617628|560179104|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
155202453|NCT03278873|560179108|FG000|Overall Study|Withdrawal by Subject|0|||
155202454|NCT03278873|560179109|FG001|Overall Study|Withdrawal by Subject|1|||
155202455|NCT03278873|560179110|FG002|Overall Study|Withdrawal by Subject|0|||
155202456|NCT03278873|560179111|FG003|Overall Study|Withdrawal by Subject|0|||
155202457|NCT03278873|560179108|FG000|Overall Study|Sponsor's decision|0|||
155202458|NCT03278873|560179109|FG001|Overall Study|Sponsor's decision|1|||
155202459|NCT03278873|560179110|FG002|Overall Study|Sponsor's decision|0|||
155202460|NCT03278873|560179111|FG003|Overall Study|Sponsor's decision|0|||
155202461|NCT03278873|560179108|FG000|Overall Study|Early Termination|2|||
155202462|NCT03278873|560179109|FG001|Overall Study|Early Termination|6|||
155202463|NCT03278873|560179110|FG002|Overall Study|Early Termination|0|||
155202464|NCT03278873|560179111|FG003|Overall Study|Early Termination|4|||
155202465|NCT03278873|560179108|FG000|Overall Study|Lost to Follow-up|0|||
155202466|NCT03278873|560179109|FG001|Overall Study|Lost to Follow-up|0|||
155202467|NCT03278873|560179110|FG002|Overall Study|Lost to Follow-up|2|||
155202468|NCT03278873|560179111|FG003|Overall Study|Lost to Follow-up|0|||
155202469|NCT03278873|560179108|FG000|Overall Study|The patient decided to withdraw via email|1|||
155202470|NCT03278873|560179109|FG001|Overall Study|The patient decided to withdraw via email|0|||
155202471|NCT03278873|560179110|FG002|Overall Study|The patient decided to withdraw via email|0|||
155202472|NCT03278873|560179111|FG003|Overall Study|The patient decided to withdraw via email|0|||
155202473|NCT03278873|560179108|FG000|Overall Study|The patient was unresponsive to contact|0|||
155202474|NCT03278873|560179109|FG001|Overall Study|The patient was unresponsive to contact|0|||
155202475|NCT03278873|560179110|FG002|Overall Study|The patient was unresponsive to contact|0|||
155202476|NCT03278873|560179111|FG003|Overall Study|The patient was unresponsive to contact|4|||
155202477|NCT03278873|560179108|FG000|Overall Study|The patient wished to participate no longer|0|||
155202478|NCT03278873|560179109|FG001|Overall Study|The patient wished to participate no longer|1|||
155202479|NCT03278873|560179110|FG002|Overall Study|The patient wished to participate no longer|0|||
155202480|NCT03278873|560179111|FG003|Overall Study|The patient wished to participate no longer|0|||
155202481|NCT03278873|560179108|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
155202482|NCT03278873|560179109|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
155202483|NCT03278873|560179110|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
155202484|NCT03278873|560179111|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
155202485|NCT04518306|560179127|FG000|Double-Blind Period|Run in failure|0|||
155202486|NCT04518306|560179128|FG001|Double-Blind Period|Run in failure|0|||
155202487|NCT04518306|560179129|FG002|Double-Blind Period|Run in failure|1|||
155202488|NCT04518306|560179127|FG000|Double-Blind Period|Adverse Event|0|||
155202489|NCT04518306|560179128|FG001|Double-Blind Period|Adverse Event|2|||
155202490|NCT04518306|560179129|FG002|Double-Blind Period|Adverse Event|2|||
155202491|NCT04518306|560179127|FG000|Double-Blind Period|Lost to Follow-up|1|||
155202492|NCT04518306|560179128|FG001|Double-Blind Period|Lost to Follow-up|2|||
155202493|NCT04518306|560179129|FG002|Double-Blind Period|Lost to Follow-up|2|||
155202494|NCT04518306|560179127|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
155202495|NCT04518306|560179128|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
155202496|NCT04518306|560179129|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
155202497|NCT04518306|560179127|FG000|Double-Blind Period|Other|0|||
155202498|NCT04518306|560179128|FG001|Double-Blind Period|Other|2|||
155202499|NCT04518306|560179129|FG002|Double-Blind Period|Other|0|||
155202500|NCT04518306|560179127|FG000|Double-Blind Period|Missing|0|||
155202501|NCT04518306|560179128|FG001|Double-Blind Period|Missing|1|||
155202502|NCT04518306|560179129|FG002|Double-Blind Period|Missing|0|||
155202503|NCT03268954|560179130|FG000|Overall Study|Withdrawal by Subject|27|||
155202504|NCT03268954|560179131|FG001|Overall Study|Withdrawal by Subject|17|||
155202505|NCT03268954|560179130|FG000|Overall Study|Lost to Follow-up|2|||
155202506|NCT03268954|560179131|FG001|Overall Study|Lost to Follow-up|3|||
155202507|NCT03268954|560179130|FG000|Overall Study|Reason Not Specified|3|||
155202508|NCT03268954|560179131|FG001|Overall Study|Reason Not Specified|8|||
155202509|NCT05358444|560179134|FG000|Overall Study|Withdrawal by Subject|0|||
155202510|NCT05358444|560179135|FG001|Overall Study|Withdrawal by Subject|1|||
155202511|NCT05358444|560179134|FG000|Overall Study|Lost to Follow-up|0|||
155202512|NCT05358444|560179135|FG001|Overall Study|Lost to Follow-up|3|||
155202513|NCT02801331|560179136|FG000|Overall Study|Transferred to another hospital|8|||
155202514|NCT02801331|560179137|FG001|Overall Study|Transferred to another hospital|7|||
155202515|NCT02801331|560179136|FG000|Overall Study|Withdrawal by Subject|0|||
155202516|NCT02801331|560179137|FG001|Overall Study|Withdrawal by Subject|4|||
155202517|NCT02801331|560179136|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
155202518|NCT02801331|560179137|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
155202519|NCT02443987|560179138|FG000|Overall Study|Bladder injury|1|||
155202520|NCT02443987|560179139|FG001|Overall Study|Bladder injury|1|||
155202521|NCT02443987|560179138|FG000|Overall Study|Other|0|||
155202522|NCT02443987|560179139|FG001|Overall Study|Other|1|||
155202523|NCT04698187|560179145|FG000|Overall Study|Withdrawal by Subject|7|||
155202524|NCT04698187|560179145|FG000|Overall Study|Death|21|||
155202525|NCT04698187|560179145|FG000|Overall Study|Sponsor Decision|15|||
155202526|NCT04698187|560179145|FG000|Overall Study|In-transit Disease|1|||
155202527|NCT03820986|560179146|FG000|Overall Study|Death|201|||
155202528|NCT03820986|560179147|FG001|Overall Study|Death|175|||
155202529|NCT03820986|560179146|FG000|Overall Study|Lost to Follow-up|1|||
155202530|NCT03820986|560179147|FG001|Overall Study|Lost to Follow-up|1|||
155202531|NCT03820986|560179146|FG000|Overall Study|Physician Decision|1|||
155202532|NCT03820986|560179147|FG001|Overall Study|Physician Decision|0|||
155202533|NCT03820986|560179146|FG000|Overall Study|Sponsor Decision|122|||
155202534|NCT03820986|560179147|FG001|Overall Study|Sponsor Decision|160|||
155202535|NCT03820986|560179146|FG000|Overall Study|Withdrawal by Subject|9|||
155202536|NCT03820986|560179147|FG001|Overall Study|Withdrawal by Subject|4|||
155202537|NCT03069378|560179148|FG000|Overall Study|Withdrawal by Subject|1|||
155202538|NCT02993146|560179149|FG000|Overall Study|Withdrawal by Subject|0|||
155202539|NCT02993146|560179150|FG001|Overall Study|Withdrawal by Subject|0|||
155202540|NCT02993146|560179151|FG002|Overall Study|Withdrawal by Subject|1|||
155202541|NCT02993146|560179152|FG003|Overall Study|Withdrawal by Subject|1|||
155202542|NCT01397708|560179153|FG000|Overall Study|Withdrawal by Subject|0|||
155202543|NCT01397708|560179154|FG001|Overall Study|Withdrawal by Subject|0|||
155202544|NCT01397708|560179155|FG002|Overall Study|Withdrawal by Subject|1|||
155202545|NCT01397708|560179156|FG003|Overall Study|Withdrawal by Subject|0|||
155202546|NCT01397708|560179157|FG004|Overall Study|Withdrawal by Subject|0|||
155202547|NCT01397708|560179158|FG005|Overall Study|Withdrawal by Subject|0|||
155202548|NCT01397708|560179159|FG006|Overall Study|Withdrawal by Subject|0|||
155202549|NCT01397708|560179160|FG007|Overall Study|Withdrawal by Subject|1|||
155202550|NCT01397708|560179153|FG000|Overall Study|Death|0|||
155202551|NCT01397708|560179154|FG001|Overall Study|Death|0|||
155202552|NCT01397708|560179155|FG002|Overall Study|Death|1|||
155202553|NCT01397708|560179156|FG003|Overall Study|Death|1|||
155202554|NCT01397708|560179157|FG004|Overall Study|Death|0|||
155202555|NCT01397708|560179158|FG005|Overall Study|Death|0|||
155202556|NCT01397708|560179159|FG006|Overall Study|Death|0|||
155202557|NCT01397708|560179160|FG007|Overall Study|Death|0|||
155202558|NCT01397708|560179153|FG000|Overall Study|Lost to Follow-up|0|||
155202559|NCT01397708|560179154|FG001|Overall Study|Lost to Follow-up|0|||
155202560|NCT01397708|560179155|FG002|Overall Study|Lost to Follow-up|0|||
155202561|NCT01397708|560179156|FG003|Overall Study|Lost to Follow-up|0|||
155202562|NCT01397708|560179157|FG004|Overall Study|Lost to Follow-up|1|||
155202563|NCT01397708|560179158|FG005|Overall Study|Lost to Follow-up|0|||
155202564|NCT01397708|560179159|FG006|Overall Study|Lost to Follow-up|0|||
155202565|NCT01397708|560179160|FG007|Overall Study|Lost to Follow-up|0|||
155202566|NCT01397708|560179153|FG000|Overall Study|Other|0|||
155202567|NCT01397708|560179154|FG001|Overall Study|Other|0|||
155202568|NCT01397708|560179155|FG002|Overall Study|Other|0|||
155202569|NCT01397708|560179156|FG003|Overall Study|Other|0|||
155202570|NCT01397708|560179157|FG004|Overall Study|Other|0|||
155202571|NCT01397708|560179158|FG005|Overall Study|Other|0|||
155202572|NCT01397708|560179159|FG006|Overall Study|Other|1|||
155202573|NCT01397708|560179160|FG007|Overall Study|Other|0|||
155202574|NCT04524689|560179163|FG000|Overall Study|Withdrawal by Subject|1|||
155202575|NCT04524689|560179164|FG001|Overall Study|Withdrawal by Subject|1|||
155202576|NCT04524689|560179165|FG002|Overall Study|Withdrawal by Subject|0|||
155202577|NCT04524689|560179166|FG003|Overall Study|Withdrawal by Subject|0|||
155202578|NCT04524689|560179167|FG004|Overall Study|Withdrawal by Subject|2|||
155202579|NCT04524689|560179168|FG005|Overall Study|Withdrawal by Subject|0|||
155202580|NCT04524689|560179163|FG000|Overall Study|Study terminated by Sponsor|6|||
155202581|NCT04524689|560179164|FG001|Overall Study|Study terminated by Sponsor|0|||
155202582|NCT04524689|560179165|FG002|Overall Study|Study terminated by Sponsor|1|||
155202583|NCT04524689|560179166|FG003|Overall Study|Study terminated by Sponsor|0|||
155202584|NCT04524689|560179167|FG004|Overall Study|Study terminated by Sponsor|4|||
155202585|NCT04524689|560179168|FG005|Overall Study|Study terminated by Sponsor|0|||
155202586|NCT04524689|560179163|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
155202587|NCT04524689|560179164|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
155202588|NCT04524689|560179165|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
155202589|NCT04524689|560179166|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
155202590|NCT04524689|560179167|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
155202591|NCT04524689|560179168|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
155202592|NCT04487730|560180744|FG000|Overall Study|Withdrawal by Subject|3|||
155202593|NCT04487730|560180745|FG001|Overall Study|Withdrawal by Subject|1|||
155202594|NCT04487730|560180744|FG000|Overall Study|Lost to Follow-up|0|||
155202595|NCT04487730|560180745|FG001|Overall Study|Lost to Follow-up|1|||
155202596|NCT04487730|560180744|FG000|Overall Study|Physician Decision|0|||
155202597|NCT04487730|560180745|FG001|Overall Study|Physician Decision|1|||
155202598|NCT00907777|560180746|FG000|Overall Study|Withdrawal by Subject|0|||
155202599|NCT00907777|560180747|FG001|Overall Study|Withdrawal by Subject|1|||
155202600|NCT03364023|560180750|FG000|Overall Study|Lost to Follow-up|3|||
155202601|NCT03364023|560180750|FG000|Overall Study|Death|14|||
155202602|NCT02820753|560180757|FG000|2 Month|Withdrawal by Subject|3|||
155202603|NCT02820753|560180758|FG001|2 Month|Withdrawal by Subject|3|||
155202604|NCT02820753|560180757|FG000|2 Month|Lost to Follow-up|24|||
155202605|NCT02820753|560180758|FG001|2 Month|Lost to Follow-up|26|||
155202606|NCT02820753|560180757|FG000|2 Month|Stopped per NIH Hold|51|||
155202607|NCT02820753|560180758|FG001|2 Month|Stopped per NIH Hold|13|||
155202608|NCT02820753|560180757|FG000|6 Month|Withdrawal by Subject|2|||
155202609|NCT02820753|560180758|FG001|6 Month|Withdrawal by Subject|2|||
155202610|NCT02820753|560180757|FG000|6 Month|Lost to Follow-up|20|||
155202611|NCT02820753|560180758|FG001|6 Month|Lost to Follow-up|27|||
155202612|NCT02820753|560180757|FG000|6 Month|Stopped per NIH Hold|81|||
155202613|NCT02820753|560180758|FG001|6 Month|Stopped per NIH Hold|81|||
155202614|NCT02820753|560180757|FG000|6 Month|Death|0|||
155202615|NCT02820753|560180758|FG001|6 Month|Death|1|||
155202616|NCT01397084|560180759|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
155202617|NCT01397084|560180759|FG000|Overall Study|Protocol Violation|2|||
155202618|NCT01397084|560180759|FG000|Overall Study|Adverse Event|2|||
155202619|NCT01397084|560180759|FG000|Overall Study|Withdrawal by Subject|1|||
155202620|NCT01397084|560180759|FG000|Overall Study|Lost to Follow-up|1|||
155202621|NCT01397084|560180759|FG000|Overall Study|Used other proton pump inhibitor|1|||
155202622|NCT02155608|560180763|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
155202623|NCT02155608|560180764|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
155202624|NCT02155608|560180763|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
155202625|NCT02155608|560180764|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
155202626|NCT00684593|560180765|FG000|Overall Study|Adverse Event|0|||
155202627|NCT00684593|560180766|FG001|Overall Study|Adverse Event|2|||
155202628|NCT01751867|560180767|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
155202629|NCT01751867|560180768|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
155202630|NCT01751867|560180767|FG000|Overall Study|Diease Progression|4|||
155202631|NCT01751867|560180768|FG001|Overall Study|Diease Progression|18|||
155202632|NCT01751867|560180767|FG000|Overall Study|Adverse Event|8|||
155202633|NCT01751867|560180768|FG001|Overall Study|Adverse Event|15|||
155202634|NCT01751867|560180767|FG000|Overall Study|Poor Compliance|0|||
155202635|NCT01751867|560180768|FG001|Overall Study|Poor Compliance|5|||
155202636|NCT01751867|560180767|FG000|Overall Study|Withdrawal by Subject|3|||
155202637|NCT01751867|560180768|FG001|Overall Study|Withdrawal by Subject|1|||
155202638|NCT01751867|560180767|FG000|Overall Study|Physician Decision|4|||
155202639|NCT01751867|560180768|FG001|Overall Study|Physician Decision|7|||
155202640|NCT01751867|560180767|FG000|Overall Study|Protocol Violation|0|||
155202641|NCT01751867|560180768|FG001|Overall Study|Protocol Violation|2|||
155202642|NCT01751867|560180767|FG000|Overall Study|Death|0|||
155202643|NCT01751867|560180768|FG001|Overall Study|Death|5|||
155202644|NCT01751867|560180767|FG000|Overall Study|Other|11|||
155202645|NCT01751867|560180768|FG001|Overall Study|Other|37|||
155202646|NCT01751867|560180767|FG000|Overall Study|Randomized but not treated.|2|||
155202647|NCT01751867|560180768|FG001|Overall Study|Randomized but not treated.|1|||
155202648|NCT04932096|560180769|FG000|Overall Study|Withdrawal by Subject|1|||
155202649|NCT04932096|560180770|FG001|Overall Study|Withdrawal by Subject|1|||
155202650|NCT04932096|560180769|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
155202651|NCT04932096|560180770|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
155202652|NCT01396148|560180771|FG000|Overall Study|Patient Decision|1|||
155202653|NCT00224042|560180778|FG000|Overall Study|Adverse Event|2|||
155202654|NCT00224042|560180779|FG001|Overall Study|Adverse Event|1|||
155202655|NCT00224042|560180778|FG000|Overall Study|Protocol Violation|0|||
155202656|NCT00224042|560180779|FG001|Overall Study|Protocol Violation|1|||
155202657|NCT00224042|560180778|FG000|Overall Study|Physician Decision|0|||
155202658|NCT00224042|560180779|FG001|Overall Study|Physician Decision|1|||
155202659|NCT00224042|560180778|FG000|Overall Study|Did not meet lab incusion criteria|2|||
155202660|NCT00224042|560180779|FG001|Overall Study|Did not meet lab incusion criteria|3|||
155202661|NCT00224042|560180778|FG000|Overall Study|Other|2|||
155202662|NCT00224042|560180779|FG001|Overall Study|Other|0|||
155202663|NCT00840450|560180780|FG000|Overall Study|Adverse Event|1|||
155202664|NCT00840450|560180780|FG000|Overall Study|Lack of Efficacy|2|||
155202665|NCT03052725|560180783|FG000|Overall Study|Adverse Event|2|||
155202666|NCT03052725|560180784|FG001|Overall Study|Adverse Event|0|||
155202667|NCT03052725|560180783|FG000|Overall Study|Withdrawal by Subject|3|||
155202668|NCT03052725|560180784|FG001|Overall Study|Withdrawal by Subject|4|||
155202669|NCT03052725|560180783|FG000|Overall Study|Pregnancy|0|||
155202670|NCT03052725|560180784|FG001|Overall Study|Pregnancy|1|||
155202671|NCT03052725|560180783|FG000|Overall Study|Site closure|0|||
155202672|NCT03052725|560180784|FG001|Overall Study|Site closure|1|||
155202673|NCT03052725|560180783|FG000|Overall Study|Study terminated by sponsor|143|||
155202674|NCT03052725|560180784|FG001|Overall Study|Study terminated by sponsor|144|||
155202675|NCT01976338|560180789|FG000|Overall Study|Physician Decision|0|||
155202676|NCT01976338|560180790|FG001|Overall Study|Physician Decision|1|||
155202677|NCT01976338|560180789|FG000|Overall Study|Lost to Follow-up|3|||
155202678|NCT01976338|560180790|FG001|Overall Study|Lost to Follow-up|0|||
155202679|NCT01976338|560180789|FG000|Overall Study|Withdrawal by Subject|5|||
155202680|NCT01976338|560180790|FG001|Overall Study|Withdrawal by Subject|2|||
155202681|NCT01976338|560180789|FG000|Overall Study|Adverse Event|5|||
155202682|NCT01976338|560180790|FG001|Overall Study|Adverse Event|1|||
155202683|NCT04213079|560180791|FG000|Overall Study|Lost to Follow-up|0|||
155202684|NCT04213079|560180792|FG001|Overall Study|Lost to Follow-up|2|||
155202685|NCT00520936|560180794|FG000|Overall Study|Physician Decision|0|||
155202686|NCT00520936|560180795|FG001|Overall Study|Physician Decision|2|||
155202687|NCT00520936|560180796|FG002|Overall Study|Physician Decision|1|||
155202688|NCT00520936|560180797|FG003|Overall Study|Physician Decision|0|||
155202689|NCT00520936|560180798|FG004|Overall Study|Physician Decision|0|||
155202690|NCT00520936|560180799|FG005|Overall Study|Physician Decision|0|||
155202691|NCT00520936|560180800|FG006|Overall Study|Physician Decision|0|||
155202692|NCT00520936|560180801|FG007|Overall Study|Physician Decision|0|||
155202693|NCT00520936|560180794|FG000|Overall Study|Withdrawal by Subject|0|||
155202694|NCT00520936|560180795|FG001|Overall Study|Withdrawal by Subject|0|||
155202695|NCT00520936|560180796|FG002|Overall Study|Withdrawal by Subject|0|||
155202696|NCT00520936|560180797|FG003|Overall Study|Withdrawal by Subject|0|||
155202697|NCT00520936|560180798|FG004|Overall Study|Withdrawal by Subject|0|||
155202698|NCT00520936|560180799|FG005|Overall Study|Withdrawal by Subject|0|||
155202699|NCT00520936|560180800|FG006|Overall Study|Withdrawal by Subject|0|||
155202700|NCT00520936|560180801|FG007|Overall Study|Withdrawal by Subject|1|||
155202701|NCT00520936|560180794|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
155202702|NCT00520936|560180795|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
155202703|NCT00520936|560180796|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
155202704|NCT00520936|560180797|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
155202705|NCT00520936|560180798|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
155202706|NCT00520936|560180799|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
155202707|NCT00520936|560180800|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
155202708|NCT00520936|560180801|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
155202709|NCT00520936|560180794|FG000|Overall Study|Death|0|||
155202710|NCT00520936|560180795|FG001|Overall Study|Death|0|||
155202711|NCT00520936|560180796|FG002|Overall Study|Death|0|||
155202712|NCT00520936|560180797|FG003|Overall Study|Death|0|||
155202713|NCT00520936|560180798|FG004|Overall Study|Death|0|||
155202714|NCT00520936|560180799|FG005|Overall Study|Death|0|||
155202715|NCT00520936|560180800|FG006|Overall Study|Death|1|||
155202716|NCT00520936|560180801|FG007|Overall Study|Death|0|||
155202717|NCT00520936|560180794|FG000|Overall Study|Protocol Violation|0|||
155202718|NCT00520936|560180795|FG001|Overall Study|Protocol Violation|1|||
155202719|NCT00520936|560180796|FG002|Overall Study|Protocol Violation|1|||
155202720|NCT00520936|560180797|FG003|Overall Study|Protocol Violation|0|||
155202721|NCT00520936|560180798|FG004|Overall Study|Protocol Violation|1|||
155202722|NCT00520936|560180799|FG005|Overall Study|Protocol Violation|0|||
155202723|NCT00520936|560180800|FG006|Overall Study|Protocol Violation|1|||
155202724|NCT00520936|560180801|FG007|Overall Study|Protocol Violation|0|||
155202725|NCT01061177|560180809|FG000|Overall Study|Adverse Event|117|||
155202726|NCT01061177|560180809|FG000|Overall Study|Withdrawal by Subject|27|||
155202727|NCT01061177|560180809|FG000|Overall Study|Disease progression|17|||
155202728|NCT01061177|560180809|FG000|Overall Study|Protocol Violation|11|||
155202729|NCT01061177|560180809|FG000|Overall Study|Lost to Follow-up|9|||
155202730|NCT01061177|560180809|FG000|Overall Study|New cancer therapy|9|||
155202731|NCT01061177|560180809|FG000|Overall Study|Abnormal laboratory values|6|||
155202732|NCT01061177|560180809|FG000|Overall Study|Abnormal test procedure results|4|||
155202733|NCT01061177|560180809|FG000|Overall Study|Administratie problems|4|||
155202734|NCT01061177|560180809|FG000|Overall Study|Death|4|||
155202735|NCT03984994|560180810|FG000|Overall Study|Withdrawal by Subject|2|||
155202736|NCT03984994|560180811|FG001|Overall Study|Withdrawal by Subject|1|||
155202737|NCT03010176|560180812|FG000|Overall Study|Death|21|||
155202738|NCT03010176|560180813|FG001|Overall Study|Death|35|||
155202739|NCT03010176|560180814|FG002|Overall Study|Death|19|||
155202740|NCT03010176|560180815|FG003|Overall Study|Death|19|||
155202741|NCT03010176|560180816|FG004|Overall Study|Death|14|||
155202742|NCT03010176|560180817|FG005|Overall Study|Death|0|||
155202743|NCT03010176|560180812|FG000|Overall Study|Lost to Follow-up|0|||
155202744|NCT03010176|560180813|FG001|Overall Study|Lost to Follow-up|0|||
155202745|NCT03010176|560180814|FG002|Overall Study|Lost to Follow-up|0|||
155202746|NCT03010176|560180815|FG003|Overall Study|Lost to Follow-up|0|||
155202747|NCT03010176|560180816|FG004|Overall Study|Lost to Follow-up|1|||
155202748|NCT03010176|560180817|FG005|Overall Study|Lost to Follow-up|0|||
155202749|NCT03010176|560180812|FG000|Overall Study|Physician Decision|0|||
155202750|NCT03010176|560180813|FG001|Overall Study|Physician Decision|4|||
155202751|NCT03010176|560180814|FG002|Overall Study|Physician Decision|0|||
155202752|NCT03010176|560180815|FG003|Overall Study|Physician Decision|1|||
155202753|NCT03010176|560180816|FG004|Overall Study|Physician Decision|0|||
155202754|NCT03010176|560180817|FG005|Overall Study|Physician Decision|0|||
155202755|NCT03010176|560180812|FG000|Overall Study|Sponsor Decision|0|||
155202756|NCT03010176|560180813|FG001|Overall Study|Sponsor Decision|4|||
155202757|NCT03010176|560180814|FG002|Overall Study|Sponsor Decision|4|||
155202758|NCT03010176|560180815|FG003|Overall Study|Sponsor Decision|1|||
155202759|NCT03010176|560180816|FG004|Overall Study|Sponsor Decision|6|||
155202760|NCT03010176|560180817|FG005|Overall Study|Sponsor Decision|0|||
155202761|NCT03010176|560180812|FG000|Overall Study|Withdrawal by Subject|11|||
155202762|NCT03010176|560180813|FG001|Overall Study|Withdrawal by Subject|9|||
155202763|NCT03010176|560180814|FG002|Overall Study|Withdrawal by Subject|3|||
155202764|NCT03010176|560180815|FG003|Overall Study|Withdrawal by Subject|0|||
155202765|NCT03010176|560180816|FG004|Overall Study|Withdrawal by Subject|4|||
155202766|NCT03010176|560180817|FG005|Overall Study|Withdrawal by Subject|0|||
155202767|NCT04220866|560180818|FG000|Overall Study|Death|4|||
155202768|NCT04220866|560180819|FG001|Overall Study|Death|5|||
155202769|NCT04220866|560180818|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
155202770|NCT04220866|560180819|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
155202771|NCT04220866|560180818|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
155202772|NCT04220866|560180819|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
155202773|NCT04220866|560180818|FG000|Overall Study|Withdrawal by Subject|0|||
155202774|NCT04220866|560180819|FG001|Overall Study|Withdrawal by Subject|1|||
155202775|NCT03897465|560180825|FG000|Overall Study|Lost to Follow-up|2|||
155202776|NCT03897465|560180826|FG001|Overall Study|Lost to Follow-up|1|||
155202777|NCT03897465|560180825|FG000|Overall Study|Adverse Event|2|||
155202778|NCT03897465|560180826|FG001|Overall Study|Adverse Event|0|||
155202779|NCT03897465|560180825|FG000|Overall Study|complete healing by V2|1|||
155202780|NCT03897465|560180826|FG001|Overall Study|complete healing by V2|0|||
155202781|NCT03897465|560180825|FG000|Overall Study|occurence of exclusion criterion|1|||
155202782|NCT03897465|560180826|FG001|Overall Study|occurence of exclusion criterion|1|||
155202783|NCT03897465|560180825|FG000|Overall Study|Other|1|||
155202784|NCT03897465|560180826|FG001|Overall Study|Other|0|||
155202785|NCT00521014|560180827|FG000|Overall Study|Inevaluable, not treated|1|||
155202786|NCT02864498|560180828|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
155202787|NCT02864498|560180829|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
155202788|NCT02864498|560180830|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
155202789|NCT02864498|560180828|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
155202790|NCT02864498|560180829|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
155202791|NCT02864498|560180830|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
155202792|NCT02864498|560180828|FG000|Overall Study|Investigator Discretion|0|||
155202793|NCT02864498|560180829|FG001|Overall Study|Investigator Discretion|2|||
155202794|NCT02864498|560180830|FG002|Overall Study|Investigator Discretion|1|||
155202795|NCT02864498|560180828|FG000|Overall Study|Lost to Follow-up|8|||
155202796|NCT02864498|560180829|FG001|Overall Study|Lost to Follow-up|6|||
155202797|NCT02864498|560180830|FG002|Overall Study|Lost to Follow-up|3|||
155202798|NCT02864498|560180828|FG000|Overall Study|Lack of Efficacy|5|||
155202799|NCT02864498|560180829|FG001|Overall Study|Lack of Efficacy|3|||
155202800|NCT02864498|560180830|FG002|Overall Study|Lack of Efficacy|3|||
155202801|NCT02864498|560180828|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
155202802|NCT02864498|560180829|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
155202803|NCT02864498|560180830|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
155202804|NCT02864498|560180828|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
155202805|NCT02864498|560180829|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
155202806|NCT02864498|560180830|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
155202807|NCT02864498|560180828|FG000|Overall Study|Subject moved out of the country.|0|||
155202808|NCT02864498|560180829|FG001|Overall Study|Subject moved out of the country.|0|||
155202809|NCT02864498|560180830|FG002|Overall Study|Subject moved out of the country.|1|||
155202810|NCT03132220|560180832|FG000|Overall Study|Lost to Follow-up|17|||
155202811|NCT03132220|560180833|FG001|Overall Study|Lost to Follow-up|8|||
155202812|NCT03132220|560180832|FG000|Overall Study|Withdrawal by Subject|1|||
155202813|NCT03132220|560180833|FG001|Overall Study|Withdrawal by Subject|4|||
155202814|NCT00601458|560180834|FG000|Overall Study|Dosing Error|1|||
155202815|NCT00601458|560180835|FG001|Overall Study|Dosing Error|0|||
155202816|NCT00601458|560180836|FG002|Overall Study|Dosing Error|0|||
155202817|NCT00601458|560180834|FG000|Overall Study|Incomplete Data|0|||
155202818|NCT00601458|560180835|FG001|Overall Study|Incomplete Data|2|||
155202819|NCT00601458|560180836|FG002|Overall Study|Incomplete Data|0|||
155202820|NCT00601458|560180834|FG000|Overall Study|Protocol Violation|3|||
155202821|NCT00601458|560180835|FG001|Overall Study|Protocol Violation|2|||
155202822|NCT00601458|560180836|FG002|Overall Study|Protocol Violation|1|||
155202823|NCT00601458|560180834|FG000|Overall Study|Early Termination|0|||
155202824|NCT00601458|560180835|FG001|Overall Study|Early Termination|1|||
155202825|NCT00601458|560180836|FG002|Overall Study|Early Termination|1|||
155202826|NCT00370032|560180837|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
155202827|NCT00370032|560180838|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
155202828|NCT00370032|560180837|FG000|Washout Period|Withdrawal by Subject|0|||
155202829|NCT00370032|560180838|FG001|Washout Period|Withdrawal by Subject|1|||
155202830|NCT00370032|560180837|FG000|Washout Period|Lost to Follow-up|0|||
155202831|NCT00370032|560180838|FG001|Washout Period|Lost to Follow-up|1|||
155202832|NCT00370032|560180837|FG000|Washout Period|Adverse Event|1|||
155202833|NCT00370032|560180838|FG001|Washout Period|Adverse Event|0|||
155202834|NCT00370032|560180837|FG000|Follow-up Period|Withdrawal by Subject|1|||
155202835|NCT00370032|560180838|FG001|Follow-up Period|Withdrawal by Subject|0|||
155202836|NCT00518986|560180839|FG000|Overall Study|Adverse Event|12|||
155202837|NCT00518986|560180840|FG001|Overall Study|Adverse Event|7|||
155202838|NCT00518986|560180839|FG000|Overall Study|Lack of Efficacy|0|||
155202839|NCT00518986|560180840|FG001|Overall Study|Lack of Efficacy|2|||
155202840|NCT00518986|560180839|FG000|Overall Study|Lost to Follow-up|3|||
155202841|NCT00518986|560180840|FG001|Overall Study|Lost to Follow-up|2|||
155202842|NCT00518986|560180839|FG000|Overall Study|Physician Decision|0|||
155202843|NCT00518986|560180840|FG001|Overall Study|Physician Decision|3|||
155202844|NCT00518986|560180839|FG000|Overall Study|Protocol Violation|5|||
155202845|NCT00518986|560180840|FG001|Overall Study|Protocol Violation|7|||
155202846|NCT00518986|560180839|FG000|Overall Study|Withdrawal by Subject|4|||
155202847|NCT00518986|560180840|FG001|Overall Study|Withdrawal by Subject|4|||
155202848|NCT00518986|560180839|FG000|Overall Study|Non-Specific|2|||
155202849|NCT00518986|560180840|FG001|Overall Study|Non-Specific|1|||
155202850|NCT00968513|560180841|FG000|Overall Study|Death|4|||
155202851|NCT00968513|560180842|FG001|Overall Study|Death|10|||
155202852|NCT00968513|560180843|FG002|Overall Study|Death|15|||
155202853|NCT01328431|560180844|FG000|Baseline|Protocol Violation|0|||
155202854|NCT01328431|560180845|FG001|Baseline|Protocol Violation|2|||
155202855|NCT01328431|560180844|FG000|1 Month (1M)|Lost to Follow-up|55|||
155202856|NCT01328431|560180845|FG001|1 Month (1M)|Lost to Follow-up|58|||
155202857|NCT01328431|560180844|FG000|3 Month (3M)|Death|2|||
155202858|NCT01328431|560180845|FG001|3 Month (3M)|Death|2|||
155202859|NCT01328431|560180844|FG000|3 Month (3M)|Lost to Follow-up|75|||
155202860|NCT01328431|560180845|FG001|3 Month (3M)|Lost to Follow-up|70|||
155202861|NCT01328431|560180844|FG000|12 Month (12M)|Death|2|||
155202862|NCT01328431|560180845|FG001|12 Month (12M)|Death|6|||
155202863|NCT01328431|560180844|FG000|12 Month (12M)|Lost to Follow-up|82|||
155202864|NCT01328431|560180845|FG001|12 Month (12M)|Lost to Follow-up|91|||
155202865|NCT05466682|560180849|FG000|Overall Study|Withdrawal by Subject|0|||
155202866|NCT05466682|560180850|FG001|Overall Study|Withdrawal by Subject|2|||
155202867|NCT05466682|560180849|FG000|Overall Study|Lost to Follow-up|2|||
155202868|NCT05466682|560180850|FG001|Overall Study|Lost to Follow-up|1|||
155202869|NCT02801396|560180851|FG000|Period 1|Withdrawal by Subject|0|||
155202870|NCT02801396|560180852|FG001|Period 1|Withdrawal by Subject|0|||
155202871|NCT02801396|560180853|FG002|Period 1|Withdrawal by Subject|0|||
155202872|NCT02801396|560180854|FG003|Period 1|Withdrawal by Subject|0|||
155202873|NCT02801396|560180855|FG004|Period 1|Withdrawal by Subject|1|||
155202874|NCT02801396|560180856|FG005|Period 1|Withdrawal by Subject|0|||
155202875|NCT03208244|560180857|FG000|Overall Study|Death|1|||
155202876|NCT04967443|560180864|FG000|Open Label Treatment|Death|1|||
155202877|NCT04967443|560180865|FG001|Open Label Treatment|Death|0|||
155202878|NCT04967443|560180866|FG002|Open Label Treatment|Death|0|||
155202879|NCT04967443|560180867|FG003|Open Label Treatment|Death|0|||
155202880|NCT04967443|560180868|FG004|Open Label Treatment|Death|0|||
155202881|NCT04967443|560180869|FG005|Open Label Treatment|Death|0|||
155202882|NCT04967443|560180870|FG006|Open Label Treatment|Death|0|||
155202883|NCT04967443|560180871|FG007|Open Label Treatment|Death|0|||
155202884|NCT04967443|560180864|FG000|Open Label Treatment|Lost to Follow-up|0|||
155202885|NCT04967443|560180865|FG001|Open Label Treatment|Lost to Follow-up|0|||
155202886|NCT04967443|560180866|FG002|Open Label Treatment|Lost to Follow-up|1|||
155202887|NCT04967443|560180867|FG003|Open Label Treatment|Lost to Follow-up|0|||
155202888|NCT04967443|560180868|FG004|Open Label Treatment|Lost to Follow-up|0|||
155202889|NCT04967443|560180869|FG005|Open Label Treatment|Lost to Follow-up|0|||
155202890|NCT04967443|560180870|FG006|Open Label Treatment|Lost to Follow-up|0|||
155202891|NCT04967443|560180871|FG007|Open Label Treatment|Lost to Follow-up|0|||
155202892|NCT04967443|560180864|FG000|Open Label Treatment|Withdrawal by Subject|0|||
155202893|NCT04967443|560180865|FG001|Open Label Treatment|Withdrawal by Subject|1|||
155202894|NCT04967443|560180866|FG002|Open Label Treatment|Withdrawal by Subject|0|||
155202895|NCT04967443|560180867|FG003|Open Label Treatment|Withdrawal by Subject|1|||
155202896|NCT04967443|560180868|FG004|Open Label Treatment|Withdrawal by Subject|0|||
155202897|NCT04967443|560180869|FG005|Open Label Treatment|Withdrawal by Subject|1|||
155202898|NCT04967443|560180870|FG006|Open Label Treatment|Withdrawal by Subject|2|||
155202899|NCT04967443|560180871|FG007|Open Label Treatment|Withdrawal by Subject|3|||
155202900|NCT04967443|560180864|FG000|Follow-Up|Death|1|||
155202901|NCT04967443|560180865|FG001|Follow-Up|Death|0|||
155202902|NCT04967443|560180866|FG002|Follow-Up|Death|0|||
155202903|NCT04967443|560180867|FG003|Follow-Up|Death|0|||
155202904|NCT04967443|560180868|FG004|Follow-Up|Death|0|||
155202905|NCT04967443|560180869|FG005|Follow-Up|Death|0|||
155202906|NCT04967443|560180870|FG006|Follow-Up|Death|0|||
155202907|NCT04967443|560180871|FG007|Follow-Up|Death|0|||
155202908|NCT04967443|560180864|FG000|Follow-Up|Lost to Follow-up|0|||
155202909|NCT04967443|560180865|FG001|Follow-Up|Lost to Follow-up|0|||
155202910|NCT04967443|560180866|FG002|Follow-Up|Lost to Follow-up|1|||
155202911|NCT04967443|560180867|FG003|Follow-Up|Lost to Follow-up|1|||
155202912|NCT04967443|560180868|FG004|Follow-Up|Lost to Follow-up|0|||
155202913|NCT04967443|560180869|FG005|Follow-Up|Lost to Follow-up|0|||
155202914|NCT04967443|560180870|FG006|Follow-Up|Lost to Follow-up|0|||
155202915|NCT04967443|560180871|FG007|Follow-Up|Lost to Follow-up|0|||
155202916|NCT04967443|560180864|FG000|Follow-Up|Withdrawal by Subject|0|||
155202917|NCT04967443|560180865|FG001|Follow-Up|Withdrawal by Subject|1|||
155202918|NCT04967443|560180866|FG002|Follow-Up|Withdrawal by Subject|0|||
155202919|NCT04967443|560180867|FG003|Follow-Up|Withdrawal by Subject|1|||
155202920|NCT04967443|560180868|FG004|Follow-Up|Withdrawal by Subject|0|||
155202921|NCT04967443|560180869|FG005|Follow-Up|Withdrawal by Subject|1|||
155202922|NCT04967443|560180870|FG006|Follow-Up|Withdrawal by Subject|2|||
155202923|NCT04967443|560180871|FG007|Follow-Up|Withdrawal by Subject|3|||
155202924|NCT02405780|560180872|FG000|Period I|Adverse Event|8|||
155202925|NCT02405780|560180873|FG001|Period I|Adverse Event|0|||
155202926|NCT02405780|560180874|FG002|Period I|Adverse Event|3|||
155202927|NCT02405780|560180875|FG003|Period I|Adverse Event|7|||
155202928|NCT02405780|560180872|FG000|Period I|Medical reasons|1|||
155202929|NCT02405780|560180873|FG001|Period I|Medical reasons|1|||
155202930|NCT02405780|560180874|FG002|Period I|Medical reasons|0|||
155202931|NCT02405780|560180875|FG003|Period I|Medical reasons|1|||
155202932|NCT02405780|560180872|FG000|Period I|Screening Failure|1|||
155202933|NCT02405780|560180873|FG001|Period I|Screening Failure|0|||
155202934|NCT02405780|560180874|FG002|Period I|Screening Failure|1|||
155202935|NCT02405780|560180875|FG003|Period I|Screening Failure|0|||
155202936|NCT02405780|560180872|FG000|Period I|Withdrawal by Subject|9|||
155202937|NCT02405780|560180873|FG001|Period I|Withdrawal by Subject|1|||
155202938|NCT02405780|560180874|FG002|Period I|Withdrawal by Subject|3|||
155202939|NCT02405780|560180875|FG003|Period I|Withdrawal by Subject|4|||
155202940|NCT02405780|560180872|FG000|Period I|Non-compliance with study procedures|8|||
155202941|NCT02405780|560180873|FG001|Period I|Non-compliance with study procedures|6|||
155202942|NCT02405780|560180874|FG002|Period I|Non-compliance with study procedures|8|||
155202943|NCT02405780|560180875|FG003|Period I|Non-compliance with study procedures|11|||
155202944|NCT02405780|560180872|FG000|Period II|Adverse Event|3|||
155202945|NCT02405780|560180873|FG001|Period II|Adverse Event|5|||
155202946|NCT02405780|560180874|FG002|Period II|Adverse Event|4|||
155202947|NCT02405780|560180875|FG003|Period II|Adverse Event|11|||
155202948|NCT02405780|560180872|FG000|Period II|Medical reason|0|||
155202949|NCT02405780|560180873|FG001|Period II|Medical reason|1|||
155202950|NCT02405780|560180874|FG002|Period II|Medical reason|0|||
155202951|NCT02405780|560180875|FG003|Period II|Medical reason|0|||
155202952|NCT02405780|560180872|FG000|Period II|Pregnancy|0|||
155202953|NCT02405780|560180873|FG001|Period II|Pregnancy|0|||
155202954|NCT02405780|560180874|FG002|Period II|Pregnancy|1|||
155202955|NCT02405780|560180875|FG003|Period II|Pregnancy|0|||
155202956|NCT02405780|560180872|FG000|Period II|Withdrawal by Subject|7|||
155202957|NCT02405780|560180873|FG001|Period II|Withdrawal by Subject|4|||
155202958|NCT02405780|560180874|FG002|Period II|Withdrawal by Subject|0|||
155202959|NCT02405780|560180875|FG003|Period II|Withdrawal by Subject|3|||
155202960|NCT02405780|560180872|FG000|Period II|Non-compliance with study procedures|5|||
155202961|NCT02405780|560180873|FG001|Period II|Non-compliance with study procedures|2|||
155202962|NCT02405780|560180874|FG002|Period II|Non-compliance with study procedures|7|||
155202963|NCT02405780|560180875|FG003|Period II|Non-compliance with study procedures|4|||
155202964|NCT01654536|560180876|FG000|Overall Study|Lost to Follow-up|5|||
155202965|NCT01654536|560180877|FG001|Overall Study|Lost to Follow-up|5|||
155202966|NCT01654536|560180876|FG000|Overall Study|Physician Decision|12|||
155202967|NCT01654536|560180877|FG001|Overall Study|Physician Decision|8|||
155202968|NCT01654536|560180876|FG000|Overall Study|Withdrawal by Subject|27|||
155202969|NCT01654536|560180877|FG001|Overall Study|Withdrawal by Subject|25|||
155202970|NCT00668707|560180878|FG000|Overall Study|Cancer Recurrence|58|||
155202971|NCT00668707|560180879|FG001|Overall Study|Cancer Recurrence|58|||
155202972|NCT00668707|560180878|FG000|Overall Study|Withdrawal by Subject|117|||
155202973|NCT00668707|560180879|FG001|Overall Study|Withdrawal by Subject|100|||
155202974|NCT00668707|560180878|FG000|Overall Study|Lost to Follow-up|3|||
155202975|NCT00668707|560180879|FG001|Overall Study|Lost to Follow-up|6|||
155202976|NCT00668707|560180878|FG000|Overall Study|Protocol Violation|10|||
155202977|NCT00668707|560180879|FG001|Overall Study|Protocol Violation|12|||
155202978|NCT00668707|560180878|FG000|Overall Study|Death|11|||
155202979|NCT00668707|560180879|FG001|Overall Study|Death|4|||
155202980|NCT04502693|560180880|FG000|Overall Study|Adverse Event|7|||
155202981|NCT04502693|560180881|FG001|Overall Study|Adverse Event|6|||
155202982|NCT04502693|560180882|FG002|Overall Study|Adverse Event|11|||
155202983|NCT04502693|560180883|FG003|Overall Study|Adverse Event|1|||
155202984|NCT04502693|560180880|FG000|Overall Study|Lost to Follow-up|32|||
155202985|NCT04502693|560180881|FG001|Overall Study|Lost to Follow-up|36|||
155202986|NCT04502693|560180882|FG002|Overall Study|Lost to Follow-up|69|||
155202987|NCT04502693|560180883|FG003|Overall Study|Lost to Follow-up|4|||
155202988|NCT04502693|560180880|FG000|Overall Study|Protocol Violation|8|||
155202989|NCT04502693|560180881|FG001|Overall Study|Protocol Violation|8|||
155202990|NCT04502693|560180882|FG002|Overall Study|Protocol Violation|16|||
155202991|NCT04502693|560180883|FG003|Overall Study|Protocol Violation|1|||
155202992|NCT04502693|560180880|FG000|Overall Study|Withdrawal by Subject|46|||
155202993|NCT04502693|560180881|FG001|Overall Study|Withdrawal by Subject|38|||
155202994|NCT04502693|560180882|FG002|Overall Study|Withdrawal by Subject|54|||
155202995|NCT04502693|560180883|FG003|Overall Study|Withdrawal by Subject|7|||
155202996|NCT04502693|560180880|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
155202997|NCT04502693|560180881|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
155202998|NCT04502693|560180882|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
155202999|NCT04502693|560180883|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155203000|NCT04502693|560180880|FG000|Overall Study|Other|1|||
155203001|NCT04502693|560180881|FG001|Overall Study|Other|0|||
155203002|NCT04502693|560180882|FG002|Overall Study|Other|1|||
155203003|NCT04502693|560180883|FG003|Overall Study|Other|1|||
155203004|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
155203005|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
155203006|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
155203007|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
155203008|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
155203009|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
155203010|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
155203011|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
155203012|NCT03943147|560180884|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
155203013|NCT03943147|560180885|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
155203014|NCT03943147|560180884|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
155203015|NCT03943147|560180885|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
155203016|NCT00968201|560180888|FG000|Base Study - (Period II)|Adverse Event|8|||
155203017|NCT00968201|560180889|FG001|Base Study - (Period II)|Adverse Event|0|||
155203018|NCT00968201|560180890|FG002|Base Study - (Period II)|Adverse Event|16|||
155203019|NCT00968201|560180888|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
155203020|NCT00968201|560180889|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
155203021|NCT00968201|560180890|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
155203022|NCT00968201|560180888|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
155203023|NCT00968201|560180889|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
155203024|NCT00968201|560180890|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
155203025|NCT00968201|560180888|FG000|Base Study - (Period II)|Protocol Violation|12|||
155203026|NCT00968201|560180889|FG001|Base Study - (Period II)|Protocol Violation|0|||
155203027|NCT00968201|560180890|FG002|Base Study - (Period II)|Protocol Violation|12|||
155203028|NCT00968201|560180888|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
155203029|NCT00968201|560180889|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
155203030|NCT00968201|560180890|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
155203031|NCT00968201|560180888|FG000|Base Study - (Period II)|Site Error|0|||
155203032|NCT00968201|560180889|FG001|Base Study - (Period II)|Site Error|0|||
155203033|NCT00968201|560180890|FG002|Base Study - (Period II)|Site Error|1|||
155203034|NCT00968201|560180888|FG000|Extension Study - (Period III)|Adverse Event|0|||
155203035|NCT00968201|560180889|FG001|Extension Study - (Period III)|Adverse Event|5|||
155203036|NCT00968201|560180890|FG002|Extension Study - (Period III)|Adverse Event|22|||
155203037|NCT00968201|560180888|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
155203038|NCT00968201|560180889|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
155203039|NCT00968201|560180890|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
155203040|NCT00968201|560180888|FG000|Extension Study - (Period III)|Protocol Violation|0|||
155203041|NCT00968201|560180889|FG001|Extension Study - (Period III)|Protocol Violation|17|||
155203042|NCT00968201|560180890|FG002|Extension Study - (Period III)|Protocol Violation|14|||
155203043|NCT00968201|560180888|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
155203044|NCT00968201|560180889|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
155203045|NCT00968201|560180890|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
155203046|NCT00968201|560180888|FG000|Extension Study - (Period III)|Patient Relocated|0|||
155203047|NCT00968201|560180889|FG001|Extension Study - (Period III)|Patient Relocated|1|||
155203048|NCT00968201|560180890|FG002|Extension Study - (Period III)|Patient Relocated|1|||
155203049|NCT00968201|560180888|FG000|Extension Study - (Period III)|Noncompliance|0|||
155203050|NCT00968201|560180889|FG001|Extension Study - (Period III)|Noncompliance|0|||
155203051|NCT00968201|560180890|FG002|Extension Study - (Period III)|Noncompliance|3|||
155203052|NCT00968201|560180888|FG000|Extension Study - (Period III)|Other|0|||
155203053|NCT00968201|560180889|FG001|Extension Study - (Period III)|Other|0|||
155203054|NCT00968201|560180890|FG002|Extension Study - (Period III)|Other|2|||
155203055|NCT00968201|560180888|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
155203056|NCT00968201|560180889|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
155203057|NCT00968201|560180890|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
155203058|NCT01382212|560180892|FG000|Overall Study|Kidney transplant|1|||
155203059|NCT01382212|560180892|FG000|Overall Study|Withdrew consent|1|||
155203060|NCT01949506|560180900|FG000|Overall Study|Physician Decision|1|||
155203061|NCT02513394|560180901|FG000|Overall Study|Withdrawal by Subject|11|||
155203062|NCT02513394|560180902|FG001|Overall Study|Withdrawal by Subject|23|||
155203063|NCT02513394|560180901|FG000|Overall Study|Ineligible|1|||
155203064|NCT02513394|560180902|FG001|Overall Study|Ineligible|0|||
155203065|NCT00612690|560182672|FG000|Overall Study|Lost to Follow-up|72|||
155203066|NCT00612690|560182673|FG001|Overall Study|Lost to Follow-up|98|||
155203067|NCT00612690|560182672|FG000|Overall Study|Withdrawal by Subject|32|||
155203068|NCT00612690|560182673|FG001|Overall Study|Withdrawal by Subject|20|||
155203069|NCT00612690|560182672|FG000|Overall Study|Withdrawal by Site|11|||
155203070|NCT00612690|560182673|FG001|Overall Study|Withdrawal by Site|0|||
155203071|NCT01664533|560182674|FG000|Overall Study|Death|42|||
155203072|NCT01664533|560182674|FG000|Overall Study|Lost to Follow-up|3|||
155203073|NCT01664533|560182674|FG000|Overall Study|Study termination|9|||
155203074|NCT01664533|560182674|FG000|Overall Study|Protocol Violation|3|||
155203075|NCT00844831|560182676|FG000|Overall Study|Withdrawal by Subject|4|||
155203076|NCT00844831|560182676|FG000|Overall Study|Adverse Event|1|||
155203077|NCT00844831|560182676|FG000|Overall Study|Physician Decision|1|||
155203078|NCT05255068|560182677|FG000|Overall Study|Lost to Follow-up|0|||
155203079|NCT05255068|560182678|FG001|Overall Study|Lost to Follow-up|1|||
155203080|NCT03156543|560182680|FG000|Overall Study|Withdrawal by Subject|1|||
155203081|NCT03156543|560182681|FG001|Overall Study|Withdrawal by Subject|0|||
155203082|NCT02674529|560182682|FG000|Overall Study|Lost to Follow-up|1|||
155203083|NCT02674529|560182683|FG001|Overall Study|Lost to Follow-up|2|||
155203084|NCT02674529|560182682|FG000|Overall Study|Withdrawal by Subject|2|||
155203085|NCT02674529|560182683|FG001|Overall Study|Withdrawal by Subject|1|||
155203086|NCT02674529|560182682|FG000|Overall Study|Physician Decision|0|||
155203087|NCT02674529|560182683|FG001|Overall Study|Physician Decision|1|||
155203088|NCT02674529|560182682|FG000|Overall Study|Protocol Violation|0|||
155203089|NCT02674529|560182683|FG001|Overall Study|Protocol Violation|1|||
155203090|NCT02891850|560182684|FG000|Overall Study|Adverse Event|3|||
155203091|NCT02891850|560182685|FG001|Overall Study|Adverse Event|0|||
155203092|NCT02891850|560182684|FG000|Overall Study|Death|0|||
155203093|NCT02891850|560182685|FG001|Overall Study|Death|4|||
155203094|NCT02891850|560182684|FG000|Overall Study|Physician Decision|1|||
155203095|NCT02891850|560182685|FG001|Overall Study|Physician Decision|0|||
155203096|NCT02891850|560182684|FG000|Overall Study|Pregnancy|1|||
155203097|NCT02891850|560182685|FG001|Overall Study|Pregnancy|0|||
155203098|NCT02891850|560182684|FG000|Overall Study|Withdrawal by Subject|2|||
155203099|NCT02891850|560182685|FG001|Overall Study|Withdrawal by Subject|3|||
155203100|NCT02397278|560182693|FG000|Overall Study|Withdrawal by Subject|0|||
155203101|NCT02397278|560182694|FG001|Overall Study|Withdrawal by Subject|2|||
155203102|NCT02397278|560182693|FG000|Overall Study|Deemed ineligible following surgery|1|||
155203103|NCT02397278|560182694|FG001|Overall Study|Deemed ineligible following surgery|1|||
155203104|NCT02871297|560182702|FG000|Overall Study|Adverse Event|34|||
155203105|NCT02871297|560182702|FG000|Overall Study|Lack of Efficacy|10|||
155203106|NCT02871297|560182702|FG000|Overall Study|Non-compliance with study drug|15|||
155203107|NCT02871297|560182702|FG000|Overall Study|Protocol Violation|3|||
155203108|NCT02871297|560182702|FG000|Overall Study|Withdrawal by Subject|20|||
155203109|NCT02871297|560182702|FG000|Overall Study|Lost to Follow-up|13|||
155203110|NCT02871297|560182702|FG000|Overall Study|Rolled over to 13546A|2|||
155203111|NCT02871297|560182702|FG000|Overall Study|Other than specified|39|||
155203112|NCT02966028|560182706|FG000|Overall Study|Adverse Event|7|||
155203113|NCT02966028|560182707|FG001|Overall Study|Adverse Event|13|||
155203114|NCT02966028|560182708|FG002|Overall Study|Adverse Event|10|||
155203115|NCT02966028|560182706|FG000|Overall Study|Physician Decision|1|||
155203116|NCT02966028|560182707|FG001|Overall Study|Physician Decision|0|||
155203117|NCT02966028|560182708|FG002|Overall Study|Physician Decision|2|||
155203118|NCT02966028|560182706|FG000|Overall Study|Withdrawal by Subject|7|||
155203119|NCT02966028|560182707|FG001|Overall Study|Withdrawal by Subject|5|||
155203120|NCT02966028|560182708|FG002|Overall Study|Withdrawal by Subject|5|||
155203121|NCT02966028|560182706|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
155203122|NCT02966028|560182707|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
155203123|NCT02966028|560182708|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
155203124|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
155203125|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
155203126|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
155203127|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203128|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203129|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203130|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
155203131|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
155203132|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
155203133|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
155203134|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203135|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203136|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203137|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
155203138|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
155203139|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203140|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203141|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203142|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203143|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203144|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
155203145|NCT04115839|560182709|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203146|NCT04115839|560182710|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203147|NCT04115839|560182711|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
155203148|NCT04115839|560182712|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203149|NCT04115839|560182713|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203150|NCT04115839|560182714|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203151|NCT04115839|560182715|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
155203152|NCT04115839|560182709|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
155203153|NCT04115839|560182710|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
155203154|NCT04115839|560182711|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
155203155|NCT04115839|560182712|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
155203156|NCT04115839|560182713|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
155203157|NCT04115839|560182714|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
155203158|NCT04115839|560182715|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
155203159|NCT04115839|560182709|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203160|NCT04115839|560182710|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203161|NCT04115839|560182711|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203162|NCT04115839|560182712|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
155203163|NCT04115839|560182713|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
155203164|NCT04115839|560182714|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203165|NCT04115839|560182715|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
155203166|NCT03808545|560182716|FG000|Overall Study|Withdrawal by Subject|1|||
155203167|NCT03808545|560182717|FG001|Overall Study|Withdrawal by Subject|1|||
155203168|NCT02161731|560182718|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
155203169|NCT02161731|560182719|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
155203170|NCT02161731|560182718|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
155203171|NCT02161731|560182719|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
155203172|NCT00790023|560182724|FG000|Overall Study|Adverse Event|2|||
155203173|NCT00790023|560182725|FG001|Overall Study|Adverse Event|1|||
155203174|NCT00790023|560182726|FG002|Overall Study|Adverse Event|4|||
155203175|NCT00790023|560182724|FG000|Overall Study|Protocol Violation|2|||
155203176|NCT00790023|560182725|FG001|Overall Study|Protocol Violation|4|||
155203177|NCT00790023|560182726|FG002|Overall Study|Protocol Violation|2|||
155203178|NCT00790023|560182724|FG000|Overall Study|Withdrawal by Subject|2|||
155203179|NCT00790023|560182725|FG001|Overall Study|Withdrawal by Subject|0|||
155203180|NCT00790023|560182726|FG002|Overall Study|Withdrawal by Subject|6|||
155203181|NCT00790023|560182724|FG000|Overall Study|Lost to Follow-up|0|||
155203182|NCT00790023|560182725|FG001|Overall Study|Lost to Follow-up|0|||
155203183|NCT00790023|560182726|FG002|Overall Study|Lost to Follow-up|1|||
155203184|NCT00790023|560182724|FG000|Overall Study|Other|5|||
155203185|NCT00790023|560182725|FG001|Overall Study|Other|5|||
155203186|NCT00790023|560182726|FG002|Overall Study|Other|8|||
155203187|NCT00573469|560182727|FG000|Overall Study|Adverse Event|1|||
155203188|NCT00573469|560182728|FG001|Overall Study|Adverse Event|1|||
155203189|NCT00573469|560182729|FG002|Overall Study|Adverse Event|1|||
155203190|NCT00573469|560182727|FG000|Overall Study|Withdrawal by Subject|0|||
155203191|NCT00573469|560182728|FG001|Overall Study|Withdrawal by Subject|2|||
155203192|NCT00573469|560182729|FG002|Overall Study|Withdrawal by Subject|0|||
155203193|NCT00573469|560182727|FG000|Overall Study|Other|5|||
155203194|NCT00573469|560182728|FG001|Overall Study|Other|1|||
155203195|NCT00573469|560182729|FG002|Overall Study|Other|3|||
155203196|NCT01338792|560182730|FG000|Overall Study|Adverse Event|2|||
155203197|NCT01338792|560182730|FG000|Overall Study|Death|1|||
155203198|NCT01338792|560182730|FG000|Overall Study|Withdrawal by Subject|1|||
155203199|NCT00004978|560182731|FG000|Overall Study|Death|107|||
155203200|NCT00004978|560182732|FG001|Overall Study|Death|116|||
155203201|NCT00004978|560182731|FG000|Overall Study|Lost to Follow-up|101|||
155203202|NCT00004978|560182732|FG001|Overall Study|Lost to Follow-up|108|||
155203203|NCT00004978|560182731|FG000|Overall Study|Withdrawal by Subject|17|||
155203204|NCT00004978|560182732|FG001|Overall Study|Withdrawal by Subject|26|||
155203205|NCT00004978|560182731|FG000|Overall Study|site closure - not in analysis cohort|19|||
155203206|NCT00004978|560182732|FG001|Overall Study|site closure - not in analysis cohort|20|||
155203207|NCT01652703|560182736|FG000|Overall Study|Withdrawal by Subject|0|||
155203208|NCT01652703|560182737|FG001|Overall Study|Withdrawal by Subject|1|||
155203209|NCT01652703|560182738|FG002|Overall Study|Withdrawal by Subject|3|||
155203210|NCT01652703|560182739|FG003|Overall Study|Withdrawal by Subject|1|||
155203211|NCT01652703|560182740|FG004|Overall Study|Withdrawal by Subject|0|||
155203212|NCT01652703|560182741|FG005|Overall Study|Withdrawal by Subject|1|||
155203213|NCT01652703|560182736|FG000|Overall Study|Other|0|||
155203214|NCT01652703|560182737|FG001|Overall Study|Other|0|||
155203215|NCT01652703|560182738|FG002|Overall Study|Other|0|||
155203216|NCT01652703|560182739|FG003|Overall Study|Other|1|||
155203217|NCT01652703|560182740|FG004|Overall Study|Other|1|||
155203218|NCT01652703|560182741|FG005|Overall Study|Other|1|||
155203219|NCT00062374|560182743|FG000|Overall Study|Not treated|12|||
155203220|NCT02151591|560182744|FG000|Overall Study|Lost to Follow-up|6|||
155203221|NCT02151591|560182745|FG001|Overall Study|Lost to Follow-up|3|||
155203222|NCT03555591|560182748|FG000|Overall Study|Protocol Violation|77|||
155203223|NCT03633695|560182749|FG000|Overall Study|Lost to Follow-up|4|||
155203224|NCT03633695|560182750|FG001|Overall Study|Lost to Follow-up|5|||
155203225|NCT03633695|560182749|FG000|Overall Study|Discontinued|8|||
155203226|NCT03633695|560182750|FG001|Overall Study|Discontinued|4|||
155203227|NCT01532414|560182751|FG000|Overall Study|Lost to Follow-up|3|||
155203228|NCT01532414|560182752|FG001|Overall Study|Lost to Follow-up|0|||
155203229|NCT01532414|560182753|FG002|Overall Study|Lost to Follow-up|1|||
155203230|NCT01532414|560182751|FG000|Overall Study|Withdrawal by Subject|3|||
155203231|NCT01532414|560182752|FG001|Overall Study|Withdrawal by Subject|0|||
155203232|NCT01532414|560182753|FG002|Overall Study|Withdrawal by Subject|0|||
155203233|NCT01532414|560182751|FG000|Overall Study|No V6 semen sample|0|||
155203234|NCT01532414|560182752|FG001|Overall Study|No V6 semen sample|1|||
155203235|NCT01532414|560182753|FG002|Overall Study|No V6 semen sample|0|||
155203236|NCT01532414|560182751|FG000|Overall Study|Adverse Event|0|||
155203237|NCT01532414|560182752|FG001|Overall Study|Adverse Event|1|||
155203238|NCT01532414|560182753|FG002|Overall Study|Adverse Event|1|||
155203239|NCT01532414|560182751|FG000|Overall Study|Unable to complete 24 hour PK|0|||
155203240|NCT01532414|560182752|FG001|Overall Study|Unable to complete 24 hour PK|0|||
155203241|NCT01532414|560182753|FG002|Overall Study|Unable to complete 24 hour PK|1|||
155203242|NCT01532414|560182751|FG000|Overall Study|Withdrawn by sponsor|1|||
155203243|NCT01532414|560182752|FG001|Overall Study|Withdrawn by sponsor|0|||
155203244|NCT01532414|560182753|FG002|Overall Study|Withdrawn by sponsor|0|||
155203245|NCT02380677|560182763|FG000|Overall Study|Adverse Event|0|||
155203246|NCT02380677|560182764|FG001|Overall Study|Adverse Event|0|||
155203247|NCT02380677|560182765|FG002|Overall Study|Adverse Event|0|||
155203248|NCT02380677|560182766|FG003|Overall Study|Adverse Event|1|||
155203249|NCT02380677|560182767|FG004|Overall Study|Adverse Event|1|||
155203250|NCT02380677|560182768|FG005|Overall Study|Adverse Event|4|||
155203251|NCT02380677|560182769|FG006|Overall Study|Adverse Event|2|||
155203252|NCT02380677|560182770|FG007|Overall Study|Adverse Event|2|||
155203253|NCT02380677|560182771|FG008|Overall Study|Adverse Event|2|||
155203254|NCT02380677|560182772|FG009|Overall Study|Adverse Event|1|||
155203255|NCT02380677|560182773|FG010|Overall Study|Adverse Event|2|||
155203256|NCT02380677|560182774|FG011|Overall Study|Adverse Event|1|||
155203257|NCT02380677|560182763|FG000|Overall Study|Physician Decision|1|||
155203258|NCT02380677|560182764|FG001|Overall Study|Physician Decision|0|||
155203259|NCT02380677|560182765|FG002|Overall Study|Physician Decision|1|||
155203260|NCT02380677|560182766|FG003|Overall Study|Physician Decision|1|||
155203261|NCT02380677|560182767|FG004|Overall Study|Physician Decision|0|||
155203262|NCT02380677|560182768|FG005|Overall Study|Physician Decision|0|||
155203263|NCT02380677|560182769|FG006|Overall Study|Physician Decision|0|||
155203264|NCT02380677|560182770|FG007|Overall Study|Physician Decision|0|||
155203265|NCT02380677|560182771|FG008|Overall Study|Physician Decision|0|||
155203266|NCT02380677|560182772|FG009|Overall Study|Physician Decision|0|||
155203267|NCT02380677|560182773|FG010|Overall Study|Physician Decision|0|||
155203268|NCT02380677|560182774|FG011|Overall Study|Physician Decision|0|||
155203269|NCT02380677|560182763|FG000|Overall Study|Lack of Efficacy|0|||
155203270|NCT02380677|560182764|FG001|Overall Study|Lack of Efficacy|1|||
155203271|NCT02380677|560182765|FG002|Overall Study|Lack of Efficacy|2|||
155203272|NCT02380677|560182766|FG003|Overall Study|Lack of Efficacy|0|||
155203273|NCT02380677|560182767|FG004|Overall Study|Lack of Efficacy|4|||
155203274|NCT02380677|560182768|FG005|Overall Study|Lack of Efficacy|1|||
155203275|NCT02380677|560182769|FG006|Overall Study|Lack of Efficacy|1|||
155203276|NCT02380677|560182770|FG007|Overall Study|Lack of Efficacy|2|||
155203277|NCT02380677|560182771|FG008|Overall Study|Lack of Efficacy|2|||
155203278|NCT02380677|560182772|FG009|Overall Study|Lack of Efficacy|0|||
155203279|NCT02380677|560182773|FG010|Overall Study|Lack of Efficacy|2|||
155203280|NCT02380677|560182774|FG011|Overall Study|Lack of Efficacy|1|||
155203281|NCT02380677|560182763|FG000|Overall Study|Withdrawal by Subject|0|||
155203282|NCT02380677|560182764|FG001|Overall Study|Withdrawal by Subject|0|||
155203283|NCT02380677|560182765|FG002|Overall Study|Withdrawal by Subject|0|||
155203284|NCT02380677|560182766|FG003|Overall Study|Withdrawal by Subject|0|||
155203285|NCT02380677|560182767|FG004|Overall Study|Withdrawal by Subject|0|||
155203286|NCT02380677|560182768|FG005|Overall Study|Withdrawal by Subject|0|||
155203287|NCT02380677|560182769|FG006|Overall Study|Withdrawal by Subject|0|||
155203288|NCT02380677|560182770|FG007|Overall Study|Withdrawal by Subject|0|||
155203289|NCT02380677|560182771|FG008|Overall Study|Withdrawal by Subject|0|||
155203290|NCT02380677|560182772|FG009|Overall Study|Withdrawal by Subject|1|||
155203291|NCT02380677|560182773|FG010|Overall Study|Withdrawal by Subject|0|||
155203292|NCT02380677|560182774|FG011|Overall Study|Withdrawal by Subject|3|||
155203293|NCT02380677|560182763|FG000|Overall Study|Other|0|||
155203294|NCT02380677|560182764|FG001|Overall Study|Other|0|||
155203295|NCT02380677|560182765|FG002|Overall Study|Other|0|||
155203296|NCT02380677|560182766|FG003|Overall Study|Other|1|||
155203297|NCT02380677|560182767|FG004|Overall Study|Other|1|||
155203298|NCT02380677|560182768|FG005|Overall Study|Other|1|||
155203299|NCT02380677|560182769|FG006|Overall Study|Other|0|||
155203300|NCT02380677|560182770|FG007|Overall Study|Other|0|||
155203301|NCT02380677|560182771|FG008|Overall Study|Other|0|||
155203302|NCT02380677|560182772|FG009|Overall Study|Other|0|||
155203303|NCT02380677|560182773|FG010|Overall Study|Other|0|||
155203304|NCT02380677|560182774|FG011|Overall Study|Other|0|||
155203305|NCT02599129|560182780|FG000|Overall Study|Lack of Efficacy|2|||
155203306|NCT02599129|560182781|FG001|Overall Study|Lack of Efficacy|2|||
155203307|NCT02599129|560182780|FG000|Overall Study|Lost to Follow-up|1|||
155203308|NCT02599129|560182781|FG001|Overall Study|Lost to Follow-up|0|||
155203309|NCT02599129|560182780|FG000|Overall Study|Withdrawal by Subject|2|||
155203310|NCT02599129|560182781|FG001|Overall Study|Withdrawal by Subject|1|||
155203311|NCT00617773|560182782|FG000|Overall Study|Physician Decision|1|||
155203312|NCT00617773|560182782|FG000|Overall Study|Lack of compliance with the protocol|1|||
155203313|NCT00617773|560182782|FG000|Overall Study|Withdrawal by Subject|1|||
155203314|NCT00617773|560182782|FG000|Overall Study|Death|1|||
155203315|NCT00617773|560182782|FG000|Overall Study|Progressive disease|19|||
155203316|NCT00617773|560182782|FG000|Overall Study|Protocol Violation|1|||
155203317|NCT01029795|560182783|FG000|Overall Study|Entry Criteria Not Met|2|||
155203318|NCT01029795|560182784|FG001|Overall Study|Entry Criteria Not Met|1|||
155203319|NCT01029795|560182783|FG000|Overall Study|Physician Decision|2|||
155203320|NCT01029795|560182784|FG001|Overall Study|Physician Decision|1|||
155203321|NCT01029795|560182783|FG000|Overall Study|Sponsor Decision|11|||
155203322|NCT01029795|560182784|FG001|Overall Study|Sponsor Decision|17|||
155203323|NCT01029795|560182783|FG000|Overall Study|Withdrawal by Subject|1|||
155203324|NCT01029795|560182784|FG001|Overall Study|Withdrawal by Subject|3|||
155203325|NCT01342796|560182785|FG000|Overall Study|Withdrawal by Subject|2|||
155203326|NCT01342796|560182786|FG001|Overall Study|Withdrawal by Subject|0|||
155203327|NCT01342796|560182785|FG000|Overall Study|Lost to Follow-up|0|||
155203328|NCT01342796|560182786|FG001|Overall Study|Lost to Follow-up|3|||
155203329|NCT01342796|560182785|FG000|Overall Study|Inappropriate enrollment|1|||
155203330|NCT01342796|560182786|FG001|Overall Study|Inappropriate enrollment|0|||
155203331|NCT03217175|560182787|FG000|Overall Study|Physician Decision|4|||
155203332|NCT03217175|560182788|FG001|Overall Study|Physician Decision|1|||
155203333|NCT05526716|560182795|FG000|Overall Study|Death|1|||
155203334|NCT05526716|560182796|FG001|Overall Study|Death|2|||
155203335|NCT05526716|560182795|FG000|Overall Study|Lost to Follow-up|17|||
155203336|NCT05526716|560182796|FG001|Overall Study|Lost to Follow-up|15|||
155203337|NCT05526716|560182795|FG000|Overall Study|Physician Decision|0|||
155203338|NCT05526716|560182796|FG001|Overall Study|Physician Decision|1|||
155203339|NCT05526716|560182795|FG000|Overall Study|Randomized by mistake without study treatment|0|||
155203340|NCT05526716|560182796|FG001|Overall Study|Randomized by mistake without study treatment|1|||
155203341|NCT05526716|560182795|FG000|Overall Study|Withdrawal by Subject|12|||
155203342|NCT05526716|560182796|FG001|Overall Study|Withdrawal by Subject|12|||
155203343|NCT05526716|560182795|FG000|Overall Study|Not reported|0|||
155203344|NCT05526716|560182796|FG001|Overall Study|Not reported|2|||
155203345|NCT04182763|560182803|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203346|NCT04182763|560182804|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203347|NCT04182763|560182805|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203348|NCT04182763|560182806|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
155203349|NCT04182763|560182807|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
155203350|NCT04182763|560182803|FG000|Double-Blind Period, initial 6 months|Death|0|||
155203351|NCT04182763|560182804|FG001|Double-Blind Period, initial 6 months|Death|1|||
155203352|NCT04182763|560182805|FG002|Double-Blind Period, initial 6 months|Death|0|||
155203353|NCT04182763|560182806|FG003|Double-Blind Period, initial 6 months|Death|0|||
155203354|NCT04182763|560182807|FG004|Double-Blind Period, initial 6 months|Death|0|||
155203355|NCT04182763|560182803|FG000|Open-Label Period, subsequent 18 months|Death|3|||
155203356|NCT04182763|560182804|FG001|Open-Label Period, subsequent 18 months|Death|2|||
155203357|NCT04182763|560182805|FG002|Open-Label Period, subsequent 18 months|Death|2|||
155203358|NCT04182763|560182806|FG003|Open-Label Period, subsequent 18 months|Death|0|||
155203359|NCT04182763|560182807|FG004|Open-Label Period, subsequent 18 months|Death|1|||
155203360|NCT04182763|560182803|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
155203361|NCT04182763|560182804|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
155203362|NCT04182763|560182805|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
155203363|NCT04182763|560182806|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
155203364|NCT04182763|560182807|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
155203365|NCT04182763|560182803|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
155203366|NCT04182763|560182804|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
155203367|NCT04182763|560182805|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
155203368|NCT04182763|560182806|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
155203369|NCT04182763|560182807|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
155203370|NCT03616600|560182808|FG000|Overall Study|Withdrawal by Subject|1|||
155203371|NCT03616600|560182809|FG001|Overall Study|Withdrawal by Subject|0|||
155203372|NCT03858309|560182812|FG000|Overall Study|Withdrawal by Subject|2|||
155203373|NCT03858309|560182813|FG001|Overall Study|Withdrawal by Subject|3|||
155203374|NCT00730132|560182819|FG000|Overall Study|Protocol Violation|154|||
155203375|NCT00730132|560182819|FG000|Overall Study|Death|1|||
155203376|NCT02002091|560182824|FG000|Screening|Lost to Follow-up|10|||
155203377|NCT02002091|560182825|FG001|Screening|Lost to Follow-up|12|||
155203378|NCT02002091|560182824|FG000|Screening|Death|3|||
155203379|NCT02002091|560182825|FG001|Screening|Death|2|||
155203380|NCT00390468|560182833|FG000|Overall Study|Protocol Violation|2|||
155203381|NCT00390468|560182833|FG000|Overall Study|Lack of Efficacy|1|||
155203382|NCT03736447|560182835|FG000|Overall Study|Adverse Event|5|||
155203383|NCT03736447|560182836|FG001|Overall Study|Adverse Event|1|||
155203384|NCT03736447|560182835|FG000|Overall Study|Withdrawal by Subject|5|||
155203385|NCT03736447|560182836|FG001|Overall Study|Withdrawal by Subject|1|||
155203386|NCT03736447|560182835|FG000|Overall Study|Lost to Follow-up|1|||
155203387|NCT03736447|560182836|FG001|Overall Study|Lost to Follow-up|0|||
155203388|NCT03736447|560182835|FG000|Overall Study|Physician Decision|1|||
155203389|NCT03736447|560182836|FG001|Overall Study|Physician Decision|0|||
155203390|NCT03736447|560182835|FG000|Overall Study|Continued commitment to study treatment|3|||
155203391|NCT03736447|560182836|FG001|Overall Study|Continued commitment to study treatment|0|||
155203392|NCT03736447|560182835|FG000|Overall Study|Taste aversion to study product|0|||
155203393|NCT03736447|560182836|FG001|Overall Study|Taste aversion to study product|1|||
155203394|NCT02619175|560182837|FG000|Overall Study|Withdrawal by Subject|1|||
155203395|NCT02619175|560182838|FG001|Overall Study|Withdrawal by Subject|0|||
155203396|NCT02619175|560182837|FG000|Overall Study|foot pain|1|||
155203397|NCT02619175|560182838|FG001|Overall Study|foot pain|0|||
155203398|NCT02695329|560182840|FG000|Overall Study|Adverse Event|1|||
155203399|NCT02695329|560182841|FG001|Overall Study|Adverse Event|0|||
155203400|NCT02695329|560182840|FG000|Overall Study|Poor X-ray quality for measurement|4|||
155203401|NCT02695329|560182841|FG001|Overall Study|Poor X-ray quality for measurement|5|||
155203402|NCT00393029|560182842|FG000|Overall Study|Not treated|0|||
155203403|NCT00393029|560182843|FG001|Overall Study|Not treated|1|||
155203404|NCT00382252|560182844|FG000|Overall Study|Death|4|||
155203405|NCT00382252|560182844|FG000|Overall Study|Protocol Violation|8|||
155203406|NCT00382252|560182844|FG000|Overall Study|Not treated by RFA|1|||
155203407|NCT03338998|560182846|FG000|Treatment Period|Withdrawal by Subject|1|||
155203408|NCT03338998|560182847|FG001|Treatment Period|Withdrawal by Subject|1|||
155203409|NCT03338998|560182846|FG000|Treatment Period|Adverse Event|0|||
155203410|NCT03338998|560182847|FG001|Treatment Period|Adverse Event|2|||
155203411|NCT03338998|560182846|FG000|Treatment Period|Protocol deviation|1|||
155203412|NCT03338998|560182847|FG001|Treatment Period|Protocol deviation|0|||
155203413|NCT03338998|560182846|FG000|Treatment Period|Physician Decision|2|||
155203414|NCT03338998|560182847|FG001|Treatment Period|Physician Decision|0|||
155203415|NCT03338998|560182846|FG000|Treatment Period|Subject failed swallow test|4|||
155203416|NCT03338998|560182847|FG001|Treatment Period|Subject failed swallow test|0|||
155203417|NCT03338998|560182846|FG000|Safety Follow-Up Period|Adverse Event|0|||
155203418|NCT03338998|560182847|FG001|Safety Follow-Up Period|Adverse Event|1|||
155203419|NCT03338998|560182846|FG000|Safety Follow-Up Period|Protocol deviation|1|||
155203420|NCT03338998|560182847|FG001|Safety Follow-Up Period|Protocol deviation|0|||
155203421|NCT03338998|560182846|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
155203422|NCT03338998|560182847|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
155203423|NCT00039130|560182848|FG000|Overall Study|Adverse Event|11|||
155203424|NCT00039130|560182848|FG000|Overall Study|Death|9|||
155203425|NCT00039130|560182848|FG000|Overall Study|Withdrawal by Subject|3|||
155203426|NCT00039130|560182848|FG000|Overall Study|Progression|2|||
155203427|NCT00039130|560182848|FG000|Overall Study|Subsequent treatment|2|||
155203428|NCT00039130|560182848|FG000|Overall Study|Physician Decision|3|||
155203429|NCT02612727|560182849|FG000|Overall Study|Parent request|4|||
155203430|NCT02612727|560182850|FG001|Overall Study|Parent request|1|||
155203431|NCT02612727|560182849|FG000|Overall Study|Needed treatment incompatible with PT|1|||
155203432|NCT02612727|560182850|FG001|Overall Study|Needed treatment incompatible with PT|1|||
155203433|NCT02612727|560182849|FG000|Overall Study|Direct hyperbilirubinemia|0|||
155203434|NCT02612727|560182850|FG001|Overall Study|Direct hyperbilirubinemia|2|||
155203435|NCT01063868|560182851|FG000|Overall Study|Adverse Event|9|||
155203436|NCT01063868|560182852|FG001|Overall Study|Adverse Event|7|||
155203437|NCT01063868|560182851|FG000|Overall Study|Withdrawal by Subject|3|||
155203438|NCT01063868|560182852|FG001|Overall Study|Withdrawal by Subject|1|||
155203439|NCT01063868|560182851|FG000|Overall Study|Study Terminated By Sponsor|23|||
155203440|NCT01063868|560182852|FG001|Overall Study|Study Terminated By Sponsor|4|||
155203441|NCT03199274|560182853|FG000|Overall Study|Withdrawal by Subject|4|||
155203442|NCT03199274|560182854|FG001|Overall Study|Withdrawal by Subject|0|||
155203443|NCT03199274|560182853|FG000|Overall Study|Lost to Follow-up|0|||
155203444|NCT03199274|560182854|FG001|Overall Study|Lost to Follow-up|1|||
155203445|NCT03199274|560182853|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
155203446|NCT03199274|560182854|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
155203447|NCT05766423|560182855|FG000|Overall Study|Withdrawal by Subject|1|||
155203448|NCT05766423|560182856|FG001|Overall Study|Withdrawal by Subject|0|||
155203449|NCT05766423|560182855|FG000|Overall Study|Consented, not scheduled|3|||
155203450|NCT05766423|560182856|FG001|Overall Study|Consented, not scheduled|5|||
155203451|NCT00540514|560184491|FG000|Overall Study|Still on treatment|3|||
155203452|NCT00540514|560184492|FG001|Overall Study|Still on treatment|0|||
155203453|NCT00540514|560184491|FG000|Overall Study|Unacceptable Toxicity|61|||
155203454|NCT00540514|560184492|FG001|Overall Study|Unacceptable Toxicity|62|||
155203455|NCT00540514|560184491|FG000|Overall Study|Adverse Event|20|||
155203456|NCT00540514|560184492|FG001|Overall Study|Adverse Event|24|||
155203457|NCT00540514|560184491|FG000|Overall Study|Physician Decision|86|||
155203458|NCT00540514|560184492|FG001|Overall Study|Physician Decision|99|||
155203459|NCT00540514|560184491|FG000|Overall Study|Protocol Deviation|3|||
155203460|NCT00540514|560184492|FG001|Overall Study|Protocol Deviation|4|||
155203461|NCT00540514|560184491|FG000|Overall Study|Lost to Follow-up|1|||
155203462|NCT00540514|560184492|FG001|Overall Study|Lost to Follow-up|1|||
155203463|NCT00540514|560184491|FG000|Overall Study|Withdrawal by Subject|65|||
155203464|NCT00540514|560184492|FG001|Overall Study|Withdrawal by Subject|67|||
155203465|NCT00540514|560184491|FG000|Overall Study|Excluded prior to treatment|7|||
155203466|NCT00540514|560184492|FG001|Overall Study|Excluded prior to treatment|7|||
155203467|NCT00540514|560184491|FG000|Overall Study|Paclitaxel not available|0|||
155203468|NCT00540514|560184492|FG001|Overall Study|Paclitaxel not available|2|||
155203469|NCT00638378|560184493|FG000|Overall Study|Death|2|||
155203470|NCT00638378|560184493|FG000|Overall Study|Adverse Event|1|||
155203471|NCT00638378|560184493|FG000|Overall Study|Disease progression|15|||
155203472|NCT00638378|560184493|FG000|Overall Study|Physician Decision|4|||
155203473|NCT03291808|560184494|FG000|Overall Study|Lost to Follow-up|6|||
155203474|NCT03291808|560184494|FG000|Overall Study|Research burden|4|||
155203475|NCT01892293|560184497|FG000|Overall Study|Apheresed but not treated|4|||
155203476|NCT03602482|560184502|FG000|Overall Study|Withdrawal by Subject|6|||
155203477|NCT03602482|560184503|FG001|Overall Study|Withdrawal by Subject|7|||
155203478|NCT03602482|560184504|FG002|Overall Study|Withdrawal by Subject|0|||
155203479|NCT03602482|560184505|FG003|Overall Study|Withdrawal by Subject|0|||
155203480|NCT02601469|560184508|FG000|Overall Study|Enrolled in Error|1|||
155203481|NCT02601469|560184509|FG001|Overall Study|Enrolled in Error|0|||
155203482|NCT00618072|560184510|FG000|Overall Study|Lost to Follow-up|2|||
155203483|NCT00618072|560184511|FG001|Overall Study|Lost to Follow-up|0|||
155203484|NCT00618072|560184512|FG002|Overall Study|Lost to Follow-up|3|||
155203485|NCT00618072|560184510|FG000|Overall Study|Physician Decision|0|||
155203486|NCT00618072|560184511|FG001|Overall Study|Physician Decision|1|||
155203487|NCT00618072|560184512|FG002|Overall Study|Physician Decision|1|||
155203488|NCT05035550|560184515|FG000|Overall Study|Withdrawal by Subject|3|||
155203489|NCT05035550|560184516|FG001|Overall Study|Withdrawal by Subject|0|||
155203490|NCT00429273|560184517|FG000|Overall Study|Lost to Follow-up|1|||
155203491|NCT00429273|560184518|FG001|Overall Study|Lost to Follow-up|2|||
155203492|NCT00429273|560184519|FG002|Overall Study|Lost to Follow-up|2|||
155203493|NCT00429273|560184517|FG000|Overall Study|Physician Decision|6|||
155203494|NCT00429273|560184518|FG001|Overall Study|Physician Decision|5|||
155203495|NCT00429273|560184519|FG002|Overall Study|Physician Decision|5|||
155203496|NCT00429273|560184517|FG000|Overall Study|Adverse Event|1|||
155203497|NCT00429273|560184518|FG001|Overall Study|Adverse Event|1|||
155203498|NCT00429273|560184519|FG002|Overall Study|Adverse Event|2|||
155203499|NCT01438957|560184520|FG000|Overall Study|Physician Decision|1|||
155203500|NCT01438957|560184521|FG001|Overall Study|Physician Decision|1|||
155203501|NCT01438957|560184522|FG002|Overall Study|Physician Decision|0|||
155203502|NCT01438957|560184523|FG003|Overall Study|Physician Decision|1|||
155203503|NCT01438957|560184524|FG004|Overall Study|Physician Decision|0|||
155203504|NCT00617123|560184526|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
155203505|NCT00617123|560184527|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
155203506|NCT00617123|560184526|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
155203507|NCT00617123|560184527|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
155203508|NCT00617123|560184526|FG000|Referral Screening Period|Adverse Event|0|||
155203509|NCT00617123|560184527|FG001|Referral Screening Period|Adverse Event|1|||
155203510|NCT00617123|560184526|FG000|Study Treatment Period|Withdrawal by Subject|8|||
155203511|NCT00617123|560184527|FG001|Study Treatment Period|Withdrawal by Subject|12|||
155203512|NCT00617123|560184526|FG000|Study Treatment Period|Adverse Event|7|||
155203513|NCT00617123|560184527|FG001|Study Treatment Period|Adverse Event|3|||
155203514|NCT00617123|560184526|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
155203515|NCT00617123|560184527|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
155203516|NCT00617123|560184526|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
155203517|NCT00617123|560184527|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
155203518|NCT00777608|560184531|FG000|Overall Study|Lost to Follow-up|1|||
155203519|NCT00777608|560184532|FG001|Overall Study|Lost to Follow-up|1|||
155203520|NCT00777608|560184531|FG000|Overall Study|Withdrawal by Subject|1|||
155203521|NCT00777608|560184532|FG001|Overall Study|Withdrawal by Subject|3|||
155203522|NCT00777608|560184531|FG000|Overall Study|Protocol Violation|1|||
155203523|NCT00777608|560184532|FG001|Overall Study|Protocol Violation|0|||
155203524|NCT00777608|560184531|FG000|Overall Study|Investigator Decision|1|||
155203525|NCT00777608|560184532|FG001|Overall Study|Investigator Decision|2|||
155203526|NCT02853604|560184535|FG000|Overall Study|Withdrawal by Subject|12|||
155203527|NCT02853604|560184536|FG001|Overall Study|Withdrawal by Subject|35|||
155203528|NCT02853604|560184535|FG000|Overall Study|Lost to Follow-up|4|||
155203529|NCT02853604|560184536|FG001|Overall Study|Lost to Follow-up|8|||
155203530|NCT02853604|560184535|FG000|Overall Study|Death|1|||
155203531|NCT02853604|560184536|FG001|Overall Study|Death|5|||
155203532|NCT02853604|560184535|FG000|Overall Study|Miscellaneous|11|||
155203533|NCT02853604|560184536|FG001|Overall Study|Miscellaneous|2|||
155203534|NCT02853604|560184535|FG000|Overall Study|Progressive Disease|0|||
155203535|NCT02853604|560184536|FG001|Overall Study|Progressive Disease|2|||
155203536|NCT00727025|560184537|FG000|Overall Study|Physician Decision|23|||
155203537|NCT01539538|560184539|FG000|Overall Study|Adverse Event|13|||
155203538|NCT01539538|560184540|FG001|Overall Study|Adverse Event|18|||
155203539|NCT01539538|560184539|FG000|Overall Study|Lack of Efficacy|13|||
155203540|NCT01539538|560184540|FG001|Overall Study|Lack of Efficacy|16|||
155203541|NCT01539538|560184539|FG000|Overall Study|Withdrawal by Subject|2|||
155203542|NCT01539538|560184540|FG001|Overall Study|Withdrawal by Subject|3|||
155203543|NCT01539538|560184539|FG000|Overall Study|PCA no longer required or PCA problem|3|||
155203544|NCT01539538|560184540|FG001|Overall Study|PCA no longer required or PCA problem|7|||
155203545|NCT00847379|560184541|FG000|Overall Study|Study terminated by Sponsor|59|||
155203546|NCT00847379|560184542|FG001|Overall Study|Study terminated by Sponsor|57|||
155203547|NCT00847379|560184543|FG002|Overall Study|Study terminated by Sponsor|57|||
155203548|NCT00378378|560184544|FG000|Overall Study|Withdrawal by Subject|0|||
155203549|NCT00378378|560184545|FG001|Overall Study|Withdrawal by Subject|1|||
155203550|NCT00378378|560184546|FG002|Overall Study|Withdrawal by Subject|0|||
155203551|NCT00378378|560184544|FG000|Overall Study|Treatment Failure|0|||
155203552|NCT00378378|560184545|FG001|Overall Study|Treatment Failure|0|||
155203553|NCT00378378|560184546|FG002|Overall Study|Treatment Failure|1|||
155203554|NCT00378378|560184544|FG000|Overall Study|Non-compliance with protocol|0|||
155203555|NCT00378378|560184545|FG001|Overall Study|Non-compliance with protocol|0|||
155203556|NCT00378378|560184546|FG002|Overall Study|Non-compliance with protocol|1|||
155203557|NCT00982878|560184559|FG000|Overall Study|Physician Decision|1|||
155203558|NCT01854710|560184560|FG000|Overall Study|Withdrawal by Subject|2|||
155203559|NCT01854710|560184561|FG001|Overall Study|Withdrawal by Subject|1|||
155203560|NCT01854710|560184562|FG002|Overall Study|Withdrawal by Subject|0|||
155203561|NCT01854710|560184563|FG003|Overall Study|Withdrawal by Subject|0|||
155203562|NCT01854710|560184564|FG004|Overall Study|Withdrawal by Subject|0|||
155203563|NCT01854710|560184565|FG005|Overall Study|Withdrawal by Subject|0|||
155203564|NCT01854710|560184560|FG000|Overall Study|CRI procedural error|2|||
155203565|NCT01854710|560184561|FG001|Overall Study|CRI procedural error|2|||
155203566|NCT01854710|560184562|FG002|Overall Study|CRI procedural error|2|||
155203567|NCT01854710|560184563|FG003|Overall Study|CRI procedural error|2|||
155203568|NCT01854710|560184564|FG004|Overall Study|CRI procedural error|2|||
155203569|NCT01854710|560184565|FG005|Overall Study|CRI procedural error|2|||
155203570|NCT01336764|560184570|FG000|Overall Study|Withdrawal by Subject|5|||
155203571|NCT01336764|560184571|FG001|Overall Study|Withdrawal by Subject|5|||
155203572|NCT01626391|560184572|FG000|Overall Study|Physician Decision|1|||
155203573|NCT01626391|560184573|FG001|Overall Study|Physician Decision|0|||
155203574|NCT01626391|560184572|FG000|Overall Study|Withdrawal by Subject|1|||
155203575|NCT01626391|560184573|FG001|Overall Study|Withdrawal by Subject|0|||
155203576|NCT05683249|560184574|FG000|Overall Study|Adverse Event|3|||
155203577|NCT05683249|560184575|FG001|Overall Study|Adverse Event|1|||
155203578|NCT05683249|560184574|FG000|Overall Study|Lack of Efficacy|0|||
155203579|NCT05683249|560184575|FG001|Overall Study|Lack of Efficacy|2|||
155203580|NCT05683249|560184574|FG000|Overall Study|Lost to Follow-up|6|||
155203581|NCT05683249|560184575|FG001|Overall Study|Lost to Follow-up|5|||
155203582|NCT05683249|560184574|FG000|Overall Study|Non-compliance with Study Drug|2|||
155203583|NCT05683249|560184575|FG001|Overall Study|Non-compliance with Study Drug|0|||
155203584|NCT05683249|560184574|FG000|Overall Study|Protocol Violation|6|||
155203585|NCT05683249|560184575|FG001|Overall Study|Protocol Violation|3|||
155203586|NCT05683249|560184574|FG000|Overall Study|Withdrawal by Subject|9|||
155203587|NCT05683249|560184575|FG001|Overall Study|Withdrawal by Subject|8|||
155203588|NCT05683249|560184574|FG000|Overall Study|Other|0|||
155203589|NCT05683249|560184575|FG001|Overall Study|Other|2|||
155203590|NCT01930123|560184576|FG000|Overall Study|Adverse Event|1|||
155203591|NCT01930123|560184577|FG001|Overall Study|Adverse Event|0|||
155203592|NCT01930123|560184576|FG000|Overall Study|Physician Decision|21|||
155203593|NCT01930123|560184577|FG001|Overall Study|Physician Decision|8|||
155203594|NCT01930123|560184576|FG000|Overall Study|Withdrawal by Subject|1|||
155203595|NCT01930123|560184577|FG001|Overall Study|Withdrawal by Subject|0|||
155203596|NCT03310021|560184581|FG000|Overall Study|Withdrawal by Subject|0|||
155203597|NCT03310021|560184582|FG001|Overall Study|Withdrawal by Subject|0|||
155203598|NCT03310021|560184583|FG002|Overall Study|Withdrawal by Subject|0|||
155203599|NCT03310021|560184584|FG003|Overall Study|Withdrawal by Subject|0|||
155203600|NCT03310021|560184585|FG004|Overall Study|Withdrawal by Subject|0|||
155203601|NCT03310021|560184586|FG005|Overall Study|Withdrawal by Subject|0|||
155203602|NCT03310021|560184587|FG006|Overall Study|Withdrawal by Subject|1|||
155203603|NCT03310021|560184588|FG007|Overall Study|Withdrawal by Subject|0|||
155203604|NCT03310021|560184589|FG008|Overall Study|Withdrawal by Subject|0|||
155203605|NCT03310021|560184590|FG009|Overall Study|Withdrawal by Subject|0|||
155203606|NCT03310021|560184591|FG010|Overall Study|Withdrawal by Subject|0|||
155203607|NCT03310021|560184592|FG011|Overall Study|Withdrawal by Subject|0|||
155203608|NCT03310021|560184593|FG012|Overall Study|Withdrawal by Subject|0|||
155203609|NCT03310021|560184594|FG013|Overall Study|Withdrawal by Subject|0|||
155203610|NCT03310021|560184595|FG014|Overall Study|Withdrawal by Subject|0|||
155203611|NCT03310021|560184596|FG015|Overall Study|Withdrawal by Subject|0|||
155203612|NCT03310021|560184597|FG016|Overall Study|Withdrawal by Subject|0|||
155203613|NCT03310021|560184598|FG017|Overall Study|Withdrawal by Subject|0|||
155203614|NCT03310021|560184599|FG018|Overall Study|Withdrawal by Subject|0|||
155203615|NCT03310021|560184600|FG019|Overall Study|Withdrawal by Subject|0|||
155203616|NCT03310021|560184581|FG000|Overall Study|Lost to Follow-up|0|||
155203617|NCT03310021|560184582|FG001|Overall Study|Lost to Follow-up|0|||
155203618|NCT03310021|560184583|FG002|Overall Study|Lost to Follow-up|0|||
155203619|NCT03310021|560184584|FG003|Overall Study|Lost to Follow-up|0|||
155203620|NCT03310021|560184585|FG004|Overall Study|Lost to Follow-up|0|||
155203621|NCT03310021|560184586|FG005|Overall Study|Lost to Follow-up|0|||
155203622|NCT03310021|560184587|FG006|Overall Study|Lost to Follow-up|0|||
155203623|NCT03310021|560184588|FG007|Overall Study|Lost to Follow-up|0|||
155203624|NCT03310021|560184589|FG008|Overall Study|Lost to Follow-up|0|||
155203625|NCT03310021|560184590|FG009|Overall Study|Lost to Follow-up|0|||
155203626|NCT03310021|560184591|FG010|Overall Study|Lost to Follow-up|1|||
155203627|NCT03310021|560184592|FG011|Overall Study|Lost to Follow-up|0|||
155203628|NCT03310021|560184593|FG012|Overall Study|Lost to Follow-up|0|||
155203629|NCT03310021|560184594|FG013|Overall Study|Lost to Follow-up|0|||
155203630|NCT03310021|560184595|FG014|Overall Study|Lost to Follow-up|0|||
155203631|NCT03310021|560184596|FG015|Overall Study|Lost to Follow-up|0|||
155203632|NCT03310021|560184597|FG016|Overall Study|Lost to Follow-up|0|||
155203633|NCT03310021|560184598|FG017|Overall Study|Lost to Follow-up|0|||
155203634|NCT03310021|560184599|FG018|Overall Study|Lost to Follow-up|0|||
155203635|NCT03310021|560184600|FG019|Overall Study|Lost to Follow-up|0|||
155203636|NCT00702923|560184603|FG000|Overall Study|Adverse Event|1|||
155203637|NCT01233258|560184604|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203638|NCT01233258|560184605|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203639|NCT01233258|560184606|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203640|NCT01233258|560184607|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
155203641|NCT01233258|560184608|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
155203642|NCT01233258|560184609|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
155203643|NCT01233258|560184604|FG000|First Intervention (6 Months)|Protocol Violation|0|||
155203644|NCT01233258|560184605|FG001|First Intervention (6 Months)|Protocol Violation|0|||
155203645|NCT01233258|560184606|FG002|First Intervention (6 Months)|Protocol Violation|1|||
155203646|NCT01233258|560184607|FG003|First Intervention (6 Months)|Protocol Violation|0|||
155203647|NCT01233258|560184608|FG004|First Intervention (6 Months)|Protocol Violation|0|||
155203648|NCT01233258|560184609|FG005|First Intervention (6 Months)|Protocol Violation|0|||
155203649|NCT01233258|560184604|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
155203650|NCT01233258|560184605|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203651|NCT01233258|560184606|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203652|NCT01233258|560184607|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203653|NCT01233258|560184608|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203654|NCT01233258|560184609|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
155203655|NCT02795832|560184613|FG000|Overall Study|Adverse Event|0|||
155203656|NCT02795832|560184614|FG001|Overall Study|Adverse Event|0|||
155203657|NCT02795832|560184615|FG002|Overall Study|Adverse Event|0|||
155203658|NCT02795832|560184616|FG003|Overall Study|Adverse Event|0|||
155203659|NCT02795832|560184617|FG004|Overall Study|Adverse Event|0|||
155203660|NCT02795832|560184618|FG005|Overall Study|Adverse Event|3|||
155203661|NCT00256750|560184620|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
155203662|NCT00256750|560184621|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
155203663|NCT00256750|560184622|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
155203664|NCT00256750|560184620|FG000|Transplanted Pre-Treatment|Other|2|||
155203665|NCT00256750|560184621|FG001|Transplanted Pre-Treatment|Other|0|||
155203666|NCT00256750|560184622|FG002|Transplanted Pre-Treatment|Other|0|||
155203667|NCT00256750|560184620|FG000|Transplanted Pre-Treatment|Death|1|||
155203668|NCT00256750|560184621|FG001|Transplanted Pre-Treatment|Death|0|||
155203669|NCT00256750|560184622|FG002|Transplanted Pre-Treatment|Death|0|||
155203670|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
155203671|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
155203672|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
155203673|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Death|3|||
155203674|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Death|2|||
155203675|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Death|4|||
155203676|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
155203677|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
155203678|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
155203679|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
155203680|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
155203681|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
155203682|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Other|5|||
155203683|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Other|4|||
155203684|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Other|2|||
155203685|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
155203686|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
155203687|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
155203688|NCT00256750|560184620|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
155203689|NCT00256750|560184621|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
155203690|NCT00256750|560184622|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
155203691|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
155203692|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
155203693|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
155203694|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
155203695|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
155203696|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
155203697|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Death|3|||
155203698|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Death|0|||
155203699|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Death|0|||
155203700|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
155203701|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
155203702|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
155203703|NCT00256750|560184620|FG000|Post-Transplant Treated (24 Months)|Other|2|||
155203704|NCT00256750|560184621|FG001|Post-Transplant Treated (24 Months)|Other|0|||
155203705|NCT00256750|560184622|FG002|Post-Transplant Treated (24 Months)|Other|1|||
155203706|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
155203707|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
155203708|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
155203709|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
155203710|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
155203711|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
155203712|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Death|0|||
155203713|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Death|2|||
155203714|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Death|1|||
155203715|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
155203716|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
155203717|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
155203718|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
155203719|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
155203720|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
155203721|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
155203722|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
155203723|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
155203724|NCT00256750|560184620|FG000|Post-Transplant Treated (36 Months)|Other|0|||
155203725|NCT00256750|560184621|FG001|Post-Transplant Treated (36 Months)|Other|1|||
155203726|NCT00256750|560184622|FG002|Post-Transplant Treated (36 Months)|Other|1|||
155203727|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
155203728|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
155203729|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
155203730|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
155203731|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
155203732|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
155203733|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
155203734|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
155203735|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
155203736|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
155203737|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
155203738|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
155203739|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
155203740|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
155203741|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
155203742|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
155203743|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
155203744|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
155203745|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
155203746|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
155203747|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
155203748|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
155203749|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
155203750|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
155203751|NCT00256750|560184620|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
155203752|NCT00256750|560184621|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
155203753|NCT00256750|560184622|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
155203754|NCT01348165|560184623|FG000|Overall Study|Adverse Event|0|||
155203755|NCT01348165|560184624|FG001|Overall Study|Adverse Event|0|||
155203756|NCT01348165|560184625|FG002|Overall Study|Adverse Event|0|||
155203757|NCT01348165|560184626|FG003|Overall Study|Adverse Event|0|||
155203758|NCT01348165|560184627|FG004|Overall Study|Adverse Event|0|||
155203759|NCT01348165|560184628|FG005|Overall Study|Adverse Event|0|||
155203760|NCT01348165|560184629|FG006|Overall Study|Adverse Event|1|||
155203761|NCT04659161|560184630|FG000|Overall Study|Adverse Event|10|||
155203762|NCT04659161|560184631|FG001|Overall Study|Adverse Event|6|||
155203763|NCT04659161|560184630|FG000|Overall Study|Withdrawal by Subject|13|||
155203764|NCT04659161|560184631|FG001|Overall Study|Withdrawal by Subject|12|||
155203765|NCT04659161|560184630|FG000|Overall Study|Other|9|||
155203766|NCT04659161|560184631|FG001|Overall Study|Other|8|||
155203767|NCT01929343|560184633|FG000|Overall Study|Physician Decision|0|||
155203768|NCT01929343|560184634|FG001|Overall Study|Physician Decision|2|||
155203769|NCT01929343|560184635|FG002|Overall Study|Physician Decision|0|||
155203770|NCT01929343|560184633|FG000|Overall Study|Withdrawal by Subject|1|||
155203771|NCT01929343|560184634|FG001|Overall Study|Withdrawal by Subject|0|||
155203772|NCT01929343|560184635|FG002|Overall Study|Withdrawal by Subject|0|||
155203773|NCT02197130|560184638|FG000|Overall Study|Adverse Event|13|||
155203774|NCT02197130|560184639|FG001|Overall Study|Adverse Event|4|||
155203775|NCT02197130|560184640|FG002|Overall Study|Adverse Event|23|||
155203776|NCT02197130|560184638|FG000|Overall Study|Death|0|||
155203777|NCT02197130|560184639|FG001|Overall Study|Death|1|||
155203778|NCT02197130|560184640|FG002|Overall Study|Death|0|||
155203779|NCT02197130|560184638|FG000|Overall Study|Lost to Follow-up|2|||
155203780|NCT02197130|560184639|FG001|Overall Study|Lost to Follow-up|0|||
155203781|NCT02197130|560184640|FG002|Overall Study|Lost to Follow-up|1|||
155203782|NCT02197130|560184638|FG000|Overall Study|Does not meet entrance criteria|0|||
155203783|NCT02197130|560184639|FG001|Overall Study|Does not meet entrance criteria|0|||
155203784|NCT02197130|560184640|FG002|Overall Study|Does not meet entrance criteria|1|||
155203785|NCT02197130|560184638|FG000|Overall Study|Withdrawal by Subject|0|||
155203786|NCT02197130|560184639|FG001|Overall Study|Withdrawal by Subject|3|||
155203787|NCT02197130|560184640|FG002|Overall Study|Withdrawal by Subject|4|||
155203788|NCT02197130|560184638|FG000|Overall Study|Other|1|||
155203789|NCT02197130|560184639|FG001|Overall Study|Other|0|||
155203790|NCT02197130|560184640|FG002|Overall Study|Other|3|||
155203791|NCT03648983|560184643|FG000|Overall Study|Study was terminated due to PI departure|95|||
155203792|NCT01269463|560184646|FG000|First Intervention|Withdrawal by Subject|1|||
155203793|NCT01269463|560184647|FG001|First Intervention|Withdrawal by Subject|0|||
155203794|NCT01269463|560184646|FG000|First Intervention|Adverse Event|1|||
155203795|NCT01269463|560184647|FG001|First Intervention|Adverse Event|0|||
155203796|NCT01269463|560184646|FG000|First Intervention|Lack of Efficacy|0|||
155203797|NCT01269463|560184647|FG001|First Intervention|Lack of Efficacy|1|||
155203798|NCT01269463|560184646|FG000|First Intervention|Physician Decision|0|||
155203799|NCT01269463|560184647|FG001|First Intervention|Physician Decision|1|||
155203800|NCT04404361|560184649|FG000|Overall Study|Death|12|||
155203801|NCT04404361|560184650|FG001|Overall Study|Death|12|||
155203802|NCT04404361|560184649|FG000|Overall Study|Withdrawal by Subject|13|||
155203803|NCT04404361|560184650|FG001|Overall Study|Withdrawal by Subject|5|||
155203804|NCT04404361|560184649|FG000|Overall Study|Lost to Follow-up|6|||
155203805|NCT04404361|560184650|FG001|Overall Study|Lost to Follow-up|3|||
155203806|NCT04404361|560184649|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
155203807|NCT04404361|560184650|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
155203808|NCT00558558|560184651|FG000|Overall Study|Unable to swallow|1|||
155203809|NCT00558558|560184651|FG000|Overall Study|Withdrawal by Subject|1|||
155203810|NCT00558558|560184651|FG000|Overall Study|Lack of Efficacy|4|||
155203811|NCT02549937|560184653|FG000|Overall Study|Death|0|||
155203812|NCT02549937|560184654|FG001|Overall Study|Death|1|||
155203813|NCT02549937|560184655|FG002|Overall Study|Death|0|||
155203814|NCT02549937|560184656|FG003|Overall Study|Death|1|||
155203815|NCT02549937|560184657|FG004|Overall Study|Death|0|||
155203816|NCT02549937|560184658|FG005|Overall Study|Death|8|||
155203817|NCT02549937|560184659|FG006|Overall Study|Death|0|||
155203818|NCT02549937|560184660|FG007|Overall Study|Death|0|||
155203819|NCT02549937|560184661|FG008|Overall Study|Death|19|||
155203820|NCT02549937|560184653|FG000|Overall Study|No follow up required|3|||
155203821|NCT02549937|560184654|FG001|Overall Study|No follow up required|6|||
155203822|NCT02549937|560184655|FG002|Overall Study|No follow up required|3|||
155203823|NCT02549937|560184656|FG003|Overall Study|No follow up required|8|||
155203824|NCT02549937|560184657|FG004|Overall Study|No follow up required|12|||
155203825|NCT02549937|560184658|FG005|Overall Study|No follow up required|21|||
155203826|NCT02549937|560184659|FG006|Overall Study|No follow up required|9|||
155203827|NCT02549937|560184660|FG007|Overall Study|No follow up required|11|||
155203828|NCT02549937|560184661|FG008|Overall Study|No follow up required|0|||
155203829|NCT02549937|560184653|FG000|Overall Study|Other|0|||
155203830|NCT02549937|560184654|FG001|Overall Study|Other|0|||
155203831|NCT02549937|560184655|FG002|Overall Study|Other|0|||
155203832|NCT02549937|560184656|FG003|Overall Study|Other|0|||
155203833|NCT02549937|560184657|FG004|Overall Study|Other|1|||
155203834|NCT02549937|560184658|FG005|Overall Study|Other|0|||
155203835|NCT02549937|560184659|FG006|Overall Study|Other|3|||
155203836|NCT02549937|560184660|FG007|Overall Study|Other|2|||
155203837|NCT02549937|560184661|FG008|Overall Study|Other|3|||
155203838|NCT02549937|560184653|FG000|Overall Study|Lost to Follow-up|0|||
155203839|NCT02549937|560184654|FG001|Overall Study|Lost to Follow-up|0|||
155203840|NCT02549937|560184655|FG002|Overall Study|Lost to Follow-up|0|||
155203841|NCT02549937|560184656|FG003|Overall Study|Lost to Follow-up|0|||
155203842|NCT02549937|560184657|FG004|Overall Study|Lost to Follow-up|0|||
155203843|NCT02549937|560184658|FG005|Overall Study|Lost to Follow-up|0|||
155203844|NCT02549937|560184659|FG006|Overall Study|Lost to Follow-up|0|||
155203845|NCT02549937|560184660|FG007|Overall Study|Lost to Follow-up|0|||
155203846|NCT02549937|560184661|FG008|Overall Study|Lost to Follow-up|3|||
155203847|NCT02549937|560184653|FG000|Overall Study|Withdrawal by Subject|0|||
155203848|NCT02549937|560184654|FG001|Overall Study|Withdrawal by Subject|0|||
155203849|NCT02549937|560184655|FG002|Overall Study|Withdrawal by Subject|0|||
155203850|NCT02549937|560184656|FG003|Overall Study|Withdrawal by Subject|0|||
155203851|NCT02549937|560184657|FG004|Overall Study|Withdrawal by Subject|0|||
155203852|NCT02549937|560184658|FG005|Overall Study|Withdrawal by Subject|1|||
155203853|NCT02549937|560184659|FG006|Overall Study|Withdrawal by Subject|4|||
155203854|NCT02549937|560184660|FG007|Overall Study|Withdrawal by Subject|3|||
155203855|NCT02549937|560184661|FG008|Overall Study|Withdrawal by Subject|2|||
155203856|NCT02549937|560184653|FG000|Overall Study|Sponsor Decision|0|||
155203857|NCT02549937|560184654|FG001|Overall Study|Sponsor Decision|0|||
155203858|NCT02549937|560184655|FG002|Overall Study|Sponsor Decision|0|||
155203859|NCT02549937|560184656|FG003|Overall Study|Sponsor Decision|0|||
155203860|NCT02549937|560184657|FG004|Overall Study|Sponsor Decision|0|||
155203861|NCT02549937|560184658|FG005|Overall Study|Sponsor Decision|0|||
155203862|NCT02549937|560184659|FG006|Overall Study|Sponsor Decision|0|||
155203863|NCT02549937|560184660|FG007|Overall Study|Sponsor Decision|0|||
155203864|NCT02549937|560184661|FG008|Overall Study|Sponsor Decision|6|||
155203865|NCT05330702|560184664|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
155203866|NCT05330702|560184665|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
155203867|NCT05330702|560184666|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
155203868|NCT01411774|560186074|FG000|Overall Study|Withdrawal by Subject|0|||
155203869|NCT01411774|560186075|FG001|Overall Study|Withdrawal by Subject|3|||
155203870|NCT00056316|560186076|FG000|Overall Study|Withdrawal by Subject|2|||
155203871|NCT00056316|560186077|FG001|Overall Study|Withdrawal by Subject|2|||
155203872|NCT00056316|560186076|FG000|Overall Study|Death/NH placement of pt|1|||
155203873|NCT00056316|560186077|FG001|Overall Study|Death/NH placement of pt|1|||
155203874|NCT01315678|560186080|FG000|Overall Study|Withdrawal by Subject|7|||
155203875|NCT01315678|560186081|FG001|Overall Study|Withdrawal by Subject|3|||
155203876|NCT01315678|560186080|FG000|Overall Study|Adverse Event|3|||
155203877|NCT01315678|560186081|FG001|Overall Study|Adverse Event|1|||
155203878|NCT01315678|560186080|FG000|Overall Study|Lost to Follow-up|1|||
155203879|NCT01315678|560186081|FG001|Overall Study|Lost to Follow-up|0|||
155203880|NCT01315678|560186080|FG000|Overall Study|similar reason to those listed above|3|||
155203881|NCT01315678|560186081|FG001|Overall Study|similar reason to those listed above|2|||
155203882|NCT00331682|560186090|FG000|Overall Study|Adverse Event|1|||
155203883|NCT02468414|560186091|FG000|Overall Study|Early Study Termination by Sponsor|1|||
155203884|NCT02468414|560186092|FG001|Overall Study|Early Study Termination by Sponsor|0|||
155203885|NCT02468414|560186091|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
155203886|NCT02468414|560186092|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
155203887|NCT02468414|560186091|FG000|Overall Study|Screen Failure|1|||
155203888|NCT02468414|560186092|FG001|Overall Study|Screen Failure|0|||
155203889|NCT03292588|560186093|FG000|Overall Study|Death|1|||
155203890|NCT03292588|560186094|FG001|Overall Study|Death|0|||
155203891|NCT03292588|560186093|FG000|Overall Study|Lost to Follow-up|12|||
155203892|NCT03292588|560186094|FG001|Overall Study|Lost to Follow-up|16|||
155203893|NCT03292588|560186093|FG000|Overall Study|Physician Decision|0|||
155203894|NCT03292588|560186094|FG001|Overall Study|Physician Decision|1|||
155203895|NCT03292588|560186093|FG000|Overall Study|Withdrawal by Subject|4|||
155203896|NCT03292588|560186094|FG001|Overall Study|Withdrawal by Subject|4|||
155203897|NCT03292588|560186093|FG000|Overall Study|Move out of town|1|||
155203898|NCT03292588|560186094|FG001|Overall Study|Move out of town|0|||
155203899|NCT03292588|560186093|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
155203900|NCT03292588|560186094|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
155203901|NCT00187486|560186095|FG000|Overall Study|Protocol Violation|1|||
155203902|NCT00543140|560186096|FG000|Overall Study|Lost to Follow-up|33|||
155203903|NCT00543140|560186096|FG000|Overall Study|Withdrawal by Subject|13|||
155203904|NCT00543140|560186096|FG000|Overall Study|Protocol Violation|10|||
155203905|NCT00543140|560186096|FG000|Overall Study|Insufficient weight loss|10|||
155203906|NCT00543140|560186096|FG000|Overall Study|SAE leading to explant of SAGB|3|||
155203907|NCT00543140|560186096|FG000|Overall Study|Death|1|||
155203908|NCT00543140|560186096|FG000|Overall Study|Subject moved|1|||
155203909|NCT00543140|560186096|FG000|Overall Study|Conversion to different procedure|1|||
155203910|NCT02483520|560186097|FG000|Overall Study|Lost to Follow-up|3|||
155203911|NCT02483520|560186098|FG001|Overall Study|Lost to Follow-up|4|||
155203912|NCT02483520|560186097|FG000|Overall Study|Withdrawal by Subject|4|||
155203913|NCT02483520|560186098|FG001|Overall Study|Withdrawal by Subject|14|||
155203914|NCT02483520|560186097|FG000|Overall Study|Hospitalized|2|||
155203915|NCT02483520|560186098|FG001|Overall Study|Hospitalized|3|||
155203916|NCT02483520|560186097|FG000|Overall Study|Moved to LTC|2|||
155203917|NCT02483520|560186098|FG001|Overall Study|Moved to LTC|3|||
155203918|NCT01104493|560186105|FG000|Overall Study|Lost to Follow-up|0|||
155203919|NCT01104493|560186106|FG001|Overall Study|Lost to Follow-up|2|||
155203920|NCT02511184|560186107|FG000|Overall Study|Death|1|||
155203921|NCT02511184|560186108|FG001|Overall Study|Death|0|||
155203922|NCT02511184|560186107|FG000|Overall Study|Lost to Follow-up|0|||
155203923|NCT02511184|560186108|FG001|Overall Study|Lost to Follow-up|1|||
155203924|NCT02511184|560186107|FG000|Overall Study|Study terminated by sponsor|1|||
155203925|NCT02511184|560186108|FG001|Overall Study|Study terminated by sponsor|5|||
155203926|NCT02511184|560186107|FG000|Overall Study|Withdrawal by Subject|0|||
155203927|NCT02511184|560186108|FG001|Overall Study|Withdrawal by Subject|1|||
155203928|NCT00133952|560186113|FG000|Overall Study|Adverse Event|1|||
155203929|NCT00133952|560186114|FG001|Overall Study|Adverse Event|2|||
155203930|NCT00133952|560186113|FG000|Overall Study|Death|3|||
155203931|NCT00133952|560186114|FG001|Overall Study|Death|2|||
155203932|NCT00133952|560186113|FG000|Overall Study|Lost to Follow-up|9|||
155203933|NCT00133952|560186114|FG001|Overall Study|Lost to Follow-up|14|||
155203934|NCT00133952|560186113|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
155203935|NCT00133952|560186114|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
155203936|NCT00133952|560186113|FG000|Overall Study|Protocol Violation|1|||
155203937|NCT00133952|560186114|FG001|Overall Study|Protocol Violation|1|||
155203938|NCT00133952|560186113|FG000|Overall Study|Withdrawal by Subject|20|||
155203939|NCT00133952|560186114|FG001|Overall Study|Withdrawal by Subject|4|||
155203940|NCT00133952|560186113|FG000|Overall Study|Physician Decision|4|||
155203941|NCT00133952|560186114|FG001|Overall Study|Physician Decision|3|||
155203942|NCT00133952|560186113|FG000|Overall Study|Sponsor Decision|0|||
155203943|NCT00133952|560186114|FG001|Overall Study|Sponsor Decision|1|||
155203944|NCT02170298|560186117|FG000|Overall Study|Withdrawal by Subject|0|||
155203945|NCT02170298|560186118|FG001|Overall Study|Withdrawal by Subject|1|||
155203946|NCT02170298|560186117|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
155203947|NCT02170298|560186118|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
155203948|NCT00003499|560186131|FG000|Overall Study|Not evaluable|8|||
155203949|NCT01256008|560186136|FG000|Overall Study|Lost to Follow-up|6|||
155203950|NCT01256008|560186137|FG001|Overall Study|Lost to Follow-up|4|||
155203951|NCT01256008|560186138|FG002|Overall Study|Lost to Follow-up|11|||
155203952|NCT01256008|560186136|FG000|Overall Study|Withdrawal by Subject|2|||
155203953|NCT01256008|560186137|FG001|Overall Study|Withdrawal by Subject|3|||
155203954|NCT01256008|560186138|FG002|Overall Study|Withdrawal by Subject|10|||
155203955|NCT01402492|560186141|FG000|Overall Study|Withdrawal by Subject|17|||
155203956|NCT01402492|560186142|FG001|Overall Study|Withdrawal by Subject|11|||
155203957|NCT01402492|560186143|FG002|Overall Study|Withdrawal by Subject|11|||
155203958|NCT01402492|560186141|FG000|Overall Study|Adverse Event|2|||
155203959|NCT01402492|560186142|FG001|Overall Study|Adverse Event|3|||
155203960|NCT01402492|560186143|FG002|Overall Study|Adverse Event|4|||
155203961|NCT01402492|560186141|FG000|Overall Study|Physician Decision|0|||
155203962|NCT01402492|560186142|FG001|Overall Study|Physician Decision|3|||
155203963|NCT01402492|560186143|FG002|Overall Study|Physician Decision|0|||
155203964|NCT01402492|560186141|FG000|Overall Study|Incarcerated (N=3)|2|||
155203965|NCT01402492|560186142|FG001|Overall Study|Incarcerated (N=3)|0|||
155203966|NCT01402492|560186143|FG002|Overall Study|Incarcerated (N=3)|1|||
155203967|NCT02573311|560186146|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
155203968|NCT02573311|560186147|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
155203969|NCT02573311|560186146|FG000|Disposition for Part 2|Physician Decision|25|||
155203970|NCT02573311|560186147|FG001|Disposition for Part 2|Physician Decision|7|||
155203971|NCT02573311|560186146|FG000|Disposition for Part 2|Adverse Event|36|||
155203972|NCT02573311|560186147|FG001|Disposition for Part 2|Adverse Event|5|||
155203973|NCT02573311|560186146|FG000|Disposition for Part 2|Lost to Follow-up|76|||
155203974|NCT02573311|560186147|FG001|Disposition for Part 2|Lost to Follow-up|7|||
155203975|NCT02573311|560186146|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
155203976|NCT02573311|560186147|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
155203977|NCT02573311|560186146|FG000|Disposition for Part 2|Investigator decision|0|||
155203978|NCT02573311|560186147|FG001|Disposition for Part 2|Investigator decision|1|||
155203979|NCT02573311|560186146|FG000|Disposition for Part 2|Other than specified above|13|||
155203980|NCT02573311|560186147|FG001|Disposition for Part 2|Other than specified above|3|||
155203981|NCT04862585|560186149|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
155203982|NCT04862585|560186150|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
155203983|NCT04862585|560186149|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
155203984|NCT04862585|560186150|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
155203985|NCT04862585|560186149|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
155203986|NCT04862585|560186150|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
155203987|NCT04862585|560186149|FG000|Overall Study|one withdrew without providing a reason|0|||
155203988|NCT04862585|560186150|FG001|Overall Study|one withdrew without providing a reason|1|||
155203989|NCT05537883|560186153|FG000|Overall Study|revisional surgery|4|||
155203990|NCT05537883|560186154|FG001|Overall Study|revisional surgery|2|||
155203991|NCT05537883|560186153|FG000|Overall Study|surgeries were cancelled|0|||
155203992|NCT05537883|560186154|FG001|Overall Study|surgeries were cancelled|2|||
155203993|NCT05537883|560186153|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
155203994|NCT05537883|560186154|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
155203995|NCT02296320|560186156|FG000|Overall Study|Withdrawal by Subject|4|||
155203996|NCT02296320|560186157|FG001|Overall Study|Withdrawal by Subject|0|||
155203997|NCT02296320|560186158|FG002|Overall Study|Withdrawal by Subject|2|||
155203998|NCT02296320|560186156|FG000|Overall Study|Death|24|||
155203999|NCT02296320|560186157|FG001|Overall Study|Death|3|||
155204000|NCT02296320|560186158|FG002|Overall Study|Death|27|||
155204001|NCT02296320|560186156|FG000|Overall Study|Lost to Follow-up|5|||
155204002|NCT02296320|560186157|FG001|Overall Study|Lost to Follow-up|2|||
155204003|NCT02296320|560186158|FG002|Overall Study|Lost to Follow-up|7|||
155204004|NCT02296320|560186156|FG000|Overall Study|Not treated|2|||
155204005|NCT02296320|560186157|FG001|Overall Study|Not treated|0|||
155204006|NCT02296320|560186158|FG002|Overall Study|Not treated|0|||
155204007|NCT02296320|560186156|FG000|Overall Study|Not - specified|0|||
155204008|NCT02296320|560186157|FG001|Overall Study|Not - specified|0|||
155204009|NCT02296320|560186158|FG002|Overall Study|Not - specified|1|||
155204010|NCT05229406|560186162|FG000|Overall Study|Withdrawal by Subject|1|||
155204011|NCT05229406|560186163|FG001|Overall Study|Withdrawal by Subject|2|||
155204012|NCT00040664|560186164|FG000|Overall Study|Adverse Event|12|||
155204013|NCT00040664|560186165|FG001|Overall Study|Adverse Event|3|||
155204014|NCT00040664|560186166|FG002|Overall Study|Adverse Event|2|||
155204015|NCT00040664|560186167|FG003|Overall Study|Adverse Event|7|||
155204016|NCT00040664|560186164|FG000|Overall Study|Lack of Efficacy|9|||
155204017|NCT00040664|560186165|FG001|Overall Study|Lack of Efficacy|2|||
155204018|NCT00040664|560186166|FG002|Overall Study|Lack of Efficacy|3|||
155204019|NCT00040664|560186167|FG003|Overall Study|Lack of Efficacy|4|||
155204020|NCT00040664|560186164|FG000|Overall Study|Insufficient CD4 response|1|||
155204021|NCT00040664|560186165|FG001|Overall Study|Insufficient CD4 response|0|||
155204022|NCT00040664|560186166|FG002|Overall Study|Insufficient CD4 response|1|||
155204023|NCT00040664|560186167|FG003|Overall Study|Insufficient CD4 response|0|||
155204024|NCT00040664|560186164|FG000|Overall Study|Lost to Follow-up|4|||
155204025|NCT00040664|560186165|FG001|Overall Study|Lost to Follow-up|2|||
155204026|NCT00040664|560186166|FG002|Overall Study|Lost to Follow-up|0|||
155204027|NCT00040664|560186167|FG003|Overall Study|Lost to Follow-up|2|||
155204028|NCT00040664|560186164|FG000|Overall Study|Protocol Violation|2|||
155204029|NCT00040664|560186165|FG001|Overall Study|Protocol Violation|1|||
155204030|NCT00040664|560186166|FG002|Overall Study|Protocol Violation|0|||
155204031|NCT00040664|560186167|FG003|Overall Study|Protocol Violation|1|||
155204032|NCT00040664|560186164|FG000|Overall Study|Withdrawal by Subject|7|||
155204033|NCT00040664|560186165|FG001|Overall Study|Withdrawal by Subject|0|||
155204034|NCT00040664|560186166|FG002|Overall Study|Withdrawal by Subject|3|||
155204035|NCT00040664|560186167|FG003|Overall Study|Withdrawal by Subject|4|||
155204036|NCT00040664|560186164|FG000|Overall Study|Pregnancy|3|||
155204037|NCT00040664|560186165|FG001|Overall Study|Pregnancy|0|||
155204038|NCT00040664|560186166|FG002|Overall Study|Pregnancy|0|||
155204039|NCT00040664|560186167|FG003|Overall Study|Pregnancy|3|||
155204040|NCT00040664|560186164|FG000|Overall Study|Medication adherence/compliance problems|8|||
155204041|NCT00040664|560186165|FG001|Overall Study|Medication adherence/compliance problems|2|||
155204042|NCT00040664|560186166|FG002|Overall Study|Medication adherence/compliance problems|1|||
155204043|NCT00040664|560186167|FG003|Overall Study|Medication adherence/compliance problems|5|||
155204044|NCT00040664|560186164|FG000|Overall Study|Poor taste|2|||
155204045|NCT00040664|560186165|FG001|Overall Study|Poor taste|0|||
155204046|NCT00040664|560186166|FG002|Overall Study|Poor taste|2|||
155204047|NCT00040664|560186167|FG003|Overall Study|Poor taste|0|||
155204048|NCT00040664|560186164|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
155204049|NCT00040664|560186165|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
155204050|NCT00040664|560186166|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
155204051|NCT00040664|560186167|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
155204052|NCT00040664|560186164|FG000|Overall Study|Change of formulation|2|||
155204053|NCT00040664|560186165|FG001|Overall Study|Change of formulation|2|||
155204054|NCT00040664|560186166|FG002|Overall Study|Change of formulation|0|||
155204055|NCT00040664|560186167|FG003|Overall Study|Change of formulation|0|||
155204056|NCT00040664|560186164|FG000|Overall Study|Non-viability of oral suspension|1|||
155204057|NCT00040664|560186165|FG001|Overall Study|Non-viability of oral suspension|0|||
155204058|NCT00040664|560186166|FG002|Overall Study|Non-viability of oral suspension|1|||
155204059|NCT00040664|560186167|FG003|Overall Study|Non-viability of oral suspension|0|||
155204060|NCT01709162|560186168|FG000|Overall Study|Disease progression|3|||
155204061|NCT01709162|560186169|FG001|Overall Study|Disease progression|3|||
155204062|NCT01709162|560186168|FG000|Overall Study|Study drug toxicity|2|||
155204063|NCT01709162|560186169|FG001|Overall Study|Study drug toxicity|0|||
155204064|NCT01709162|560186168|FG000|Overall Study|Administrative reason by sponsor|0|||
155204065|NCT01709162|560186169|FG001|Overall Study|Administrative reason by sponsor|1|||
155204066|NCT01709162|560186168|FG000|Overall Study|Other|1|||
155204067|NCT01709162|560186169|FG001|Overall Study|Other|0|||
155204068|NCT01709162|560186168|FG000|Overall Study|Withdrawal by Subject|0|||
155204069|NCT01709162|560186169|FG001|Overall Study|Withdrawal by Subject|1|||
155204070|NCT03953820|560186171|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
155204071|NCT03953820|560186172|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
155204072|NCT03953820|560186173|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
155204073|NCT03953820|560186171|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
155204074|NCT03953820|560186172|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
155204075|NCT03953820|560186173|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
155204076|NCT01049308|560186174|FG000|Pill Counts|Withdrawal by Subject|83|||
155204077|NCT03845985|560186175|FG000|Overall Study|Lost to Follow-up|2|||
155204078|NCT03845985|560186176|FG001|Overall Study|Lost to Follow-up|1|||
155204079|NCT03845985|560186175|FG000|Overall Study|Physician Decision|1|||
155204080|NCT03845985|560186176|FG001|Overall Study|Physician Decision|0|||
155204081|NCT03845985|560186175|FG000|Overall Study|Withdrawal by Subject|4|||
155204082|NCT03845985|560186176|FG001|Overall Study|Withdrawal by Subject|1|||
155204083|NCT01318993|560186177|FG000|Overall Study|Adverse Event|53|||
155204084|NCT01318993|560186177|FG000|Overall Study|Lack of Efficacy|121|||
155204085|NCT01318993|560186177|FG000|Overall Study|Protocol Violation|3|||
155204086|NCT01318993|560186177|FG000|Overall Study|Protocol based stopping criteria|6|||
155204087|NCT01318993|560186177|FG000|Overall Study|Study closed or terminated|174|||
155204088|NCT01318993|560186177|FG000|Overall Study|Lost to Follow-up|4|||
155204089|NCT01318993|560186177|FG000|Overall Study|Physician Decision|13|||
155204090|NCT01318993|560186177|FG000|Overall Study|Withdrawal by Subject|24|||
155204091|NCT03334539|560186178|FG000|Overall Study|Adverse Event|3|||
155204092|NCT03334539|560186179|FG001|Overall Study|Adverse Event|5|||
155204093|NCT03334539|560186180|FG002|Overall Study|Adverse Event|0|||
155204094|NCT03334539|560186178|FG000|Overall Study|Withdrawal by Subject|0|||
155204095|NCT03334539|560186179|FG001|Overall Study|Withdrawal by Subject|1|||
155204096|NCT03334539|560186180|FG002|Overall Study|Withdrawal by Subject|1|||
155204097|NCT03334539|560186178|FG000|Overall Study|Administrative Reasons|1|||
155204098|NCT03334539|560186179|FG001|Overall Study|Administrative Reasons|0|||
155204099|NCT03334539|560186180|FG002|Overall Study|Administrative Reasons|0|||
155204100|NCT03334539|560186178|FG000|Overall Study|Hypertension Not Controlled|0|||
155204101|NCT03334539|560186179|FG001|Overall Study|Hypertension Not Controlled|1|||
155204102|NCT03334539|560186180|FG002|Overall Study|Hypertension Not Controlled|0|||
155204103|NCT04974697|560186184|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
155204104|NCT04974697|560186184|FG000|Overall Study|Lens discomfort|1|||
155204105|NCT03706456|560186185|FG000|Overall Study|Adverse Event|1|||
155204106|NCT03706456|560186185|FG000|Overall Study|Lack of Efficacy|2|||
155204107|NCT01845831|560186187|FG000|Inpatient Phase|Withdrawal by Subject|1|||
155204108|NCT01845831|560186188|FG001|Inpatient Phase|Withdrawal by Subject|1|||
155204109|NCT01845831|560186189|FG002|Inpatient Phase|Withdrawal by Subject|0|||
155204110|NCT01845831|560186190|FG003|Inpatient Phase|Withdrawal by Subject|0|||
155204111|NCT01845831|560186191|FG004|Inpatient Phase|Withdrawal by Subject|0|||
155204112|NCT00221403|560186192|FG000|Overall Study|Protocol Violation|1|||
155204113|NCT00221403|560186193|FG001|Overall Study|Protocol Violation|0|||
155204114|NCT00221403|560186194|FG002|Overall Study|Protocol Violation|0|||
155204115|NCT00221403|560186192|FG000|Overall Study|Physician Decision|1|||
155204116|NCT00221403|560186193|FG001|Overall Study|Physician Decision|0|||
155204117|NCT00221403|560186194|FG002|Overall Study|Physician Decision|0|||
155204118|NCT00221403|560186192|FG000|Overall Study|Withdrawal by Subject|0|||
155204119|NCT00221403|560186193|FG001|Overall Study|Withdrawal by Subject|3|||
155204120|NCT00221403|560186194|FG002|Overall Study|Withdrawal by Subject|0|||
155204121|NCT00221403|560186192|FG000|Overall Study|Lack of Efficacy|0|||
155204122|NCT00221403|560186193|FG001|Overall Study|Lack of Efficacy|1|||
155204123|NCT00221403|560186194|FG002|Overall Study|Lack of Efficacy|0|||
155204124|NCT00221403|560186192|FG000|Overall Study|Adverse Event|0|||
155204125|NCT00221403|560186193|FG001|Overall Study|Adverse Event|1|||
155204126|NCT00221403|560186194|FG002|Overall Study|Adverse Event|0|||
155204127|NCT00279305|560186201|FG000|Overall Study|Pregnancy|1|||
155204128|NCT00279305|560186202|FG001|Overall Study|Pregnancy|0|||
155204129|NCT00279305|560186201|FG000|Overall Study|Withdrawal by Subject|2|||
155204130|NCT00279305|560186202|FG001|Overall Study|Withdrawal by Subject|0|||
155204131|NCT00279305|560186201|FG000|Overall Study|Dificulting establishing IV|1|||
155204132|NCT00279305|560186202|FG001|Overall Study|Dificulting establishing IV|0|||
155204133|NCT00279305|560186201|FG000|Overall Study|FDA Safety Alert|4|||
155204134|NCT00279305|560186202|FG001|Overall Study|FDA Safety Alert|1|||
155204135|NCT02521870|560186203|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204136|NCT02521870|560186204|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
155204137|NCT02521870|560186205|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204138|NCT02521870|560186206|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204139|NCT02521870|560186207|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204140|NCT02521870|560186208|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204141|NCT02521870|560186209|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204142|NCT02521870|560186210|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204143|NCT02521870|560186211|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204144|NCT02521870|560186212|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204145|NCT02521870|560186213|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204146|NCT02521870|560186214|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155204147|NCT02521870|560186203|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
155204148|NCT02521870|560186204|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
155204149|NCT02521870|560186205|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
155204150|NCT02521870|560186206|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
155204151|NCT02521870|560186207|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
155204152|NCT02521870|560186208|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
155204153|NCT02521870|560186209|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
155204154|NCT02521870|560186210|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
155204155|NCT02521870|560186211|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
155204156|NCT02521870|560186212|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
155204157|NCT02521870|560186213|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
155204158|NCT02521870|560186214|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
155204159|NCT02521870|560186203|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
155204160|NCT02521870|560186204|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
155204161|NCT02521870|560186205|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
155204162|NCT02521870|560186206|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
155204163|NCT02521870|560186207|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
155204164|NCT02521870|560186208|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
155204165|NCT02521870|560186209|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
155204166|NCT02521870|560186210|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
155204167|NCT02521870|560186211|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
155204168|NCT02521870|560186212|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
155204169|NCT02521870|560186213|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
155204170|NCT02521870|560186214|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
155204171|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204172|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204173|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204174|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204175|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
155204176|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204177|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204178|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204179|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204180|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
155204181|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
155204182|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155204183|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
155204184|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
155204185|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
155204186|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
155204187|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
155204188|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
155204189|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
155204190|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
155204191|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
155204192|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
155204193|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
155204194|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
155204195|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
155204196|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
155204197|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
155204198|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
155204199|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
155204200|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
155204201|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
155204202|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
155204203|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
155204204|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
155204205|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
155204206|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
155204207|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Death|0|||
155204208|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Death|0|||
155204209|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Death|0|||
155204210|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Death|0|||
155204211|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Death|1|||
155204212|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Death|1|||
155204213|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Death|3|||
155204214|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Death|1|||
155204215|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Death|1|||
155204216|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Death|5|||
155204217|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Death|2|||
155204218|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Death|2|||
155204219|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Other|0|||
155204220|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Other|0|||
155204221|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Other|0|||
155204222|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Other|0|||
155204223|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Other|10|||
155204224|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Other|3|||
155204225|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Other|2|||
155204226|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Other|0|||
155204227|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Other|10|||
155204228|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Other|5|||
155204229|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Other|1|||
155204230|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Other|7|||
155204231|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204232|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204233|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204234|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204235|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
155204236|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204237|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204238|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204239|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204240|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204241|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204242|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155204243|NCT02521870|560186203|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204244|NCT02521870|560186204|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204245|NCT02521870|560186205|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204246|NCT02521870|560186206|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204247|NCT02521870|560186207|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
155204248|NCT02521870|560186208|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204249|NCT02521870|560186209|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204250|NCT02521870|560186210|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204251|NCT02521870|560186211|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204252|NCT02521870|560186212|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204253|NCT02521870|560186213|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204254|NCT02521870|560186214|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
155204255|NCT01638546|560186225|FG000|Overall Study|Adverse Event|1|||
155204256|NCT01638546|560186226|FG001|Overall Study|Adverse Event|3|||
155204257|NCT04292743|560186229|FG000|Overall Study|Physician Decision|1|||
155204258|NCT04292743|560186230|FG001|Overall Study|Physician Decision|3|||
155204259|NCT04292743|560186231|FG002|Overall Study|Physician Decision|0|||
155204260|NCT04292743|560186232|FG003|Overall Study|Physician Decision|0|||
155204261|NCT04292743|560186229|FG000|Overall Study|Withdrawal by Subject|0|||
155204262|NCT04292743|560186230|FG001|Overall Study|Withdrawal by Subject|5|||
155204263|NCT04292743|560186231|FG002|Overall Study|Withdrawal by Subject|0|||
155204264|NCT04292743|560186232|FG003|Overall Study|Withdrawal by Subject|0|||
155204265|NCT04292743|560186229|FG000|Overall Study|Death|0|||
155204266|NCT04292743|560186230|FG001|Overall Study|Death|1|||
155204267|NCT04292743|560186231|FG002|Overall Study|Death|0|||
155204268|NCT04292743|560186232|FG003|Overall Study|Death|0|||
155204269|NCT04292743|560186229|FG000|Overall Study|Progression of Disease|2|||
155204270|NCT04292743|560186230|FG001|Overall Study|Progression of Disease|5|||
155204271|NCT04292743|560186231|FG002|Overall Study|Progression of Disease|0|||
155204272|NCT04292743|560186232|FG003|Overall Study|Progression of Disease|0|||
155204273|NCT04292743|560186229|FG000|Overall Study|No Treatment per protocol|0|||
155204274|NCT04292743|560186230|FG001|Overall Study|No Treatment per protocol|2|||
155204275|NCT04292743|560186231|FG002|Overall Study|No Treatment per protocol|0|||
155204276|NCT04292743|560186232|FG003|Overall Study|No Treatment per protocol|0|||
155204277|NCT02881554|560186233|FG000|Overall Study|Withdrawal by Subject|2|||
155204278|NCT02881554|560186234|FG001|Overall Study|Withdrawal by Subject|0|||
155204279|NCT00684307|560188270|FG000|Overall Study|Adverse Event|11|||
155204280|NCT00684307|560188271|FG001|Overall Study|Adverse Event|6|||
155204281|NCT00684307|560188272|FG002|Overall Study|Adverse Event|15|||
155204282|NCT00684307|560188273|FG003|Overall Study|Adverse Event|16|||
155204283|NCT00684307|560188274|FG004|Overall Study|Adverse Event|8|||
155204284|NCT00684307|560188270|FG000|Overall Study|Development of increasing Liver Function|0|||
155204285|NCT00684307|560188271|FG001|Overall Study|Development of increasing Liver Function|2|||
155204286|NCT00684307|560188272|FG002|Overall Study|Development of increasing Liver Function|0|||
155204287|NCT00684307|560188273|FG003|Overall Study|Development of increasing Liver Function|1|||
155204288|NCT00684307|560188274|FG004|Overall Study|Development of increasing Liver Function|0|||
155204289|NCT00684307|560188270|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
155204290|NCT00684307|560188271|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
155204291|NCT00684307|560188272|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
155204292|NCT00684307|560188273|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
155204293|NCT00684307|560188274|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
155204294|NCT00684307|560188270|FG000|Overall Study|Incorrect enrolment or randomization|4|||
155204295|NCT00684307|560188271|FG001|Overall Study|Incorrect enrolment or randomization|0|||
155204296|NCT00684307|560188272|FG002|Overall Study|Incorrect enrolment or randomization|0|||
155204297|NCT00684307|560188273|FG003|Overall Study|Incorrect enrolment or randomization|0|||
155204298|NCT00684307|560188274|FG004|Overall Study|Incorrect enrolment or randomization|0|||
155204299|NCT00684307|560188270|FG000|Overall Study|Interupted IP for more than 7 days|0|||
155204300|NCT00684307|560188271|FG001|Overall Study|Interupted IP for more than 7 days|4|||
155204301|NCT00684307|560188272|FG002|Overall Study|Interupted IP for more than 7 days|1|||
155204302|NCT00684307|560188273|FG003|Overall Study|Interupted IP for more than 7 days|3|||
155204303|NCT00684307|560188274|FG004|Overall Study|Interupted IP for more than 7 days|3|||
155204304|NCT00684307|560188270|FG000|Overall Study|Severe non compliance to protocol|1|||
155204305|NCT00684307|560188271|FG001|Overall Study|Severe non compliance to protocol|0|||
155204306|NCT00684307|560188272|FG002|Overall Study|Severe non compliance to protocol|0|||
155204307|NCT00684307|560188273|FG003|Overall Study|Severe non compliance to protocol|1|||
155204308|NCT00684307|560188274|FG004|Overall Study|Severe non compliance to protocol|2|||
155204309|NCT00684307|560188270|FG000|Overall Study|Participant not willing to continue|7|||
155204310|NCT00684307|560188271|FG001|Overall Study|Participant not willing to continue|10|||
155204311|NCT00684307|560188272|FG002|Overall Study|Participant not willing to continue|11|||
155204312|NCT00684307|560188273|FG003|Overall Study|Participant not willing to continue|5|||
155204313|NCT00684307|560188274|FG004|Overall Study|Participant not willing to continue|8|||
155204314|NCT00684307|560188270|FG000|Overall Study|Criteria from the CSR|0|||
155204315|NCT00684307|560188271|FG001|Overall Study|Criteria from the CSR|0|||
155204316|NCT00684307|560188272|FG002|Overall Study|Criteria from the CSR|1|||
155204317|NCT00684307|560188273|FG003|Overall Study|Criteria from the CSR|3|||
155204318|NCT00684307|560188274|FG004|Overall Study|Criteria from the CSR|3|||
155204319|NCT00759031|560188275|FG000|First Intervention (1 Day)|Physician Decision|1|||
155204320|NCT00759031|560188276|FG001|First Intervention (1 Day)|Physician Decision|0|||
155204321|NCT00759031|560188275|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
155204322|NCT00759031|560188276|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
155204323|NCT00759031|560188275|FG000|First Intervention (1 Day)|Screening failure|1|||
155204324|NCT00759031|560188276|FG001|First Intervention (1 Day)|Screening failure|0|||
155204325|NCT04532164|560188277|FG000|Overall Study|Adverse Event|1|||
155204326|NCT04532164|560188277|FG000|Overall Study|Protocol Violation|5|||
155204327|NCT04532164|560188277|FG000|Overall Study|Lost to Follow-up|1|||
155204328|NCT04532164|560188277|FG000|Overall Study|Found to be Ineligible|3|||
155204329|NCT04532164|560188277|FG000|Overall Study|Withdrawal by Subject|14|||
155204330|NCT04492618|560188278|FG000|Overall Study|Withdrawal by Subject|1|||
155204331|NCT03489720|560188279|FG000|Overall Study|Withdrawal by Subject|2|||
155204332|NCT03489720|560188280|FG001|Overall Study|Withdrawal by Subject|0|||
155204333|NCT01806545|560188281|FG000|Overall Study|Adverse Event|2|||
155204334|NCT01806545|560188282|FG001|Overall Study|Adverse Event|3|||
155204335|NCT01806545|560188281|FG000|Overall Study|Lost to Follow-up|1|||
155204336|NCT01806545|560188282|FG001|Overall Study|Lost to Follow-up|0|||
155204337|NCT01806545|560188281|FG000|Overall Study|Withdrawal by Subject|3|||
155204338|NCT01806545|560188282|FG001|Overall Study|Withdrawal by Subject|2|||
155204339|NCT00884312|560188285|FG000|Overall Study|Non-fatal Progressive Disease|0|||
155204340|NCT00884312|560188286|FG001|Overall Study|Non-fatal Progressive Disease|8|||
155204341|NCT00884312|560188285|FG000|Overall Study|Fatal Progressive Disease|0|||
155204342|NCT00884312|560188286|FG001|Overall Study|Fatal Progressive Disease|1|||
155204343|NCT00884312|560188285|FG000|Overall Study|Non-fatal Adverse Event|1|||
155204344|NCT00884312|560188286|FG001|Overall Study|Non-fatal Adverse Event|0|||
155204345|NCT00884312|560188285|FG000|Overall Study|Fatal Adverse Event|1|||
155204346|NCT00884312|560188286|FG001|Overall Study|Fatal Adverse Event|4|||
155204347|NCT00884312|560188285|FG000|Overall Study|Withdrawal by Subject|0|||
155204348|NCT00884312|560188286|FG001|Overall Study|Withdrawal by Subject|6|||
155204349|NCT00884312|560188285|FG000|Overall Study|Physician Decision|0|||
155204350|NCT00884312|560188286|FG001|Overall Study|Physician Decision|1|||
155204351|NCT00884312|560188285|FG000|Overall Study|Other|0|||
155204352|NCT00884312|560188286|FG001|Overall Study|Other|4|||
155204353|NCT00884312|560188285|FG000|Overall Study|Did Not Receive Study Drug|0|||
155204354|NCT00884312|560188286|FG001|Overall Study|Did Not Receive Study Drug|1|||
155204355|NCT03902574|560188287|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
155204356|NCT03902574|560188288|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
155204357|NCT03902574|560188289|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
155204358|NCT03521934|560188297|FG000|Overall Study|Death|65|||
155204359|NCT03521934|560188298|FG001|Overall Study|Death|73|||
155204360|NCT03521934|560188297|FG000|Overall Study|Withdrawal by Subject|18|||
155204361|NCT03521934|560188298|FG001|Overall Study|Withdrawal by Subject|23|||
155204362|NCT03521934|560188297|FG000|Overall Study|Site Terminated by Sponsor|39|||
155204363|NCT03521934|560188298|FG001|Overall Study|Site Terminated by Sponsor|35|||
155204364|NCT03521934|560188297|FG000|Overall Study|Study Terminated by Sponsor|483|||
155204365|NCT03521934|560188298|FG001|Overall Study|Study Terminated by Sponsor|477|||
155204366|NCT03521934|560188297|FG000|Overall Study|Reason not Specified|3|||
155204367|NCT03521934|560188298|FG001|Overall Study|Reason not Specified|6|||
155204368|NCT05048784|560188299|FG000|Period 1|Adverse Event|3|||
155204369|NCT05048784|560188300|FG001|Period 1|Adverse Event|1|||
155204370|NCT05048784|560188301|FG002|Period 1|Adverse Event|0|||
155204371|NCT05048784|560188302|FG003|Period 1|Adverse Event|0|||
155204372|NCT05048784|560188299|FG000|Period 2|Lost to Follow-up|0|||
155204373|NCT05048784|560188300|FG001|Period 2|Lost to Follow-up|1|||
155204374|NCT05048784|560188301|FG002|Period 2|Lost to Follow-up|0|||
155204375|NCT05048784|560188302|FG003|Period 2|Lost to Follow-up|0|||
155204376|NCT02101060|560188305|FG000|Overall Study|Adverse Event|1|||
155204377|NCT02101060|560188306|FG001|Overall Study|Adverse Event|0|||
155204378|NCT02101060|560188305|FG000|Overall Study|Withdrawal by Subject|1|||
155204379|NCT02101060|560188306|FG001|Overall Study|Withdrawal by Subject|1|||
155204380|NCT02101060|560188305|FG000|Overall Study|Lost to Follow-up|3|||
155204381|NCT02101060|560188306|FG001|Overall Study|Lost to Follow-up|3|||
155204382|NCT02269241|560188307|FG000|Overall Study|Lost to Follow-up|269|||
155204383|NCT02269241|560188307|FG000|Overall Study|Withdrawal by Subject|155|||
155204384|NCT02269241|560188307|FG000|Overall Study|Protocol Violation|1|||
155204385|NCT02269241|560188307|FG000|Overall Study|Physician Decision|7|||
155204386|NCT02269241|560188307|FG000|Overall Study|Pregnancy|15|||
155204387|NCT02269241|560188307|FG000|Overall Study|Wish for pregnancy|5|||
155204388|NCT02269241|560188307|FG000|Overall Study|Development of an exclusion criteria|16|||
155204389|NCT02269241|560188307|FG000|Overall Study|Adverse Event|113|||
155204390|NCT02269241|560188307|FG000|Overall Study|At the specific request of the sponsor|20|||
155204391|NCT02269241|560188307|FG000|Overall Study|Several reasons not classified|53|||
155204392|NCT02269241|560188307|FG000|Overall Study|Screening failures|546|||
155204393|NCT03020160|560188308|FG000|Overall Study|Withdrawal by Subject|1|||
155204394|NCT03020160|560188309|FG001|Overall Study|Withdrawal by Subject|0|||
155204395|NCT02270957|560188310|FG000|Overall Study|Lack of Efficacy|2|||
155204396|NCT02270957|560188311|FG001|Overall Study|Lack of Efficacy|4|||
155204397|NCT02270957|560188310|FG000|Overall Study|Adverse Event|2|||
155204398|NCT02270957|560188311|FG001|Overall Study|Adverse Event|0|||
155204399|NCT00284050|560188315|FG000|Overall Study|Adverse Event|1|||
155204400|NCT00284050|560188316|FG001|Overall Study|Adverse Event|1|||
155204401|NCT00284050|560188317|FG002|Overall Study|Adverse Event|1|||
155204402|NCT00284050|560188315|FG000|Overall Study|Lack of Efficacy|0|||
155204403|NCT00284050|560188316|FG001|Overall Study|Lack of Efficacy|1|||
155204404|NCT00284050|560188317|FG002|Overall Study|Lack of Efficacy|3|||
155204405|NCT00284050|560188315|FG000|Overall Study|Protocol Violation|0|||
155204406|NCT00284050|560188316|FG001|Overall Study|Protocol Violation|1|||
155204407|NCT00284050|560188317|FG002|Overall Study|Protocol Violation|2|||
155204408|NCT00284050|560188315|FG000|Overall Study|Withdrawal by Subject|2|||
155204409|NCT00284050|560188316|FG001|Overall Study|Withdrawal by Subject|2|||
155204410|NCT00284050|560188317|FG002|Overall Study|Withdrawal by Subject|2|||
155204411|NCT00284050|560188315|FG000|Overall Study|Lost to Follow-up|1|||
155204412|NCT00284050|560188316|FG001|Overall Study|Lost to Follow-up|0|||
155204413|NCT00284050|560188317|FG002|Overall Study|Lost to Follow-up|1|||
155204414|NCT00284050|560188315|FG000|Overall Study|Death|1|||
155204415|NCT00284050|560188316|FG001|Overall Study|Death|0|||
155204416|NCT00284050|560188317|FG002|Overall Study|Death|0|||
155204417|NCT00166114|560188321|FG000|Overall Study|Protocol Violation|2|||
155204418|NCT00166114|560188322|FG001|Overall Study|Protocol Violation|1|||
155204419|NCT00166114|560188321|FG000|Overall Study|Withdrawal by Subject|10|||
155204420|NCT00166114|560188322|FG001|Overall Study|Withdrawal by Subject|4|||
155204421|NCT00166114|560188321|FG000|Overall Study|Adverse Event|2|||
155204422|NCT00166114|560188322|FG001|Overall Study|Adverse Event|1|||
155204423|NCT00545168|560188329|FG000|Overall Study|Lost to Follow-up|5|||
155204424|NCT00545168|560188330|FG001|Overall Study|Lost to Follow-up|5|||
155204425|NCT00545168|560188331|FG002|Overall Study|Lost to Follow-up|5|||
155204426|NCT00545168|560188329|FG000|Overall Study|Withdrawal by Subject|9|||
155204427|NCT00545168|560188330|FG001|Overall Study|Withdrawal by Subject|0|||
155204428|NCT00545168|560188331|FG002|Overall Study|Withdrawal by Subject|13|||
155204429|NCT00545168|560188329|FG000|Overall Study|Protocol Violation|1|||
155204430|NCT00545168|560188330|FG001|Overall Study|Protocol Violation|0|||
155204431|NCT00545168|560188331|FG002|Overall Study|Protocol Violation|1|||
155204432|NCT00545168|560188329|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
155204433|NCT00545168|560188330|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
155204434|NCT00545168|560188331|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
155204435|NCT01218204|560188332|FG000|Part B Washout|Adverse Event|0|||
155204436|NCT01218204|560188333|FG001|Part B Washout|Adverse Event|1|||
155204437|NCT01218204|560188334|FG002|Part B Washout|Adverse Event|0|||
155204438|NCT01218204|560188335|FG003|Part B Washout|Adverse Event|0|||
155204439|NCT01218204|560188332|FG000|Part B Washout|Lost to Follow-up|0|||
155204440|NCT01218204|560188333|FG001|Part B Washout|Lost to Follow-up|2|||
155204441|NCT01218204|560188334|FG002|Part B Washout|Lost to Follow-up|0|||
155204442|NCT01218204|560188335|FG003|Part B Washout|Lost to Follow-up|0|||
155204443|NCT01218204|560188332|FG000|Part B Washout|Physician Decision|0|||
155204444|NCT01218204|560188333|FG001|Part B Washout|Physician Decision|14|||
155204445|NCT01218204|560188334|FG002|Part B Washout|Physician Decision|0|||
155204446|NCT01218204|560188335|FG003|Part B Washout|Physician Decision|0|||
155204447|NCT01218204|560188332|FG000|Part B Washout|Withdrawal by Subject|0|||
155204448|NCT01218204|560188333|FG001|Part B Washout|Withdrawal by Subject|14|||
155204449|NCT01218204|560188334|FG002|Part B Washout|Withdrawal by Subject|0|||
155204450|NCT01218204|560188335|FG003|Part B Washout|Withdrawal by Subject|0|||
155204451|NCT01218204|560188332|FG000|Part B Washout|Reached defined stopping criteria|0|||
155204452|NCT01218204|560188333|FG001|Part B Washout|Reached defined stopping criteria|2|||
155204453|NCT01218204|560188334|FG002|Part B Washout|Reached defined stopping criteria|0|||
155204454|NCT01218204|560188335|FG003|Part B Washout|Reached defined stopping criteria|0|||
155204455|NCT01218204|560188332|FG000|Part B Washout|Did not meet continuation criteria|0|||
155204456|NCT01218204|560188333|FG001|Part B Washout|Did not meet continuation criteria|112|||
155204457|NCT01218204|560188334|FG002|Part B Washout|Did not meet continuation criteria|0|||
155204458|NCT01218204|560188335|FG003|Part B Washout|Did not meet continuation criteria|0|||
155204459|NCT01218204|560188332|FG000|Part B Run-in|Adverse Event|0|||
155204460|NCT01218204|560188333|FG001|Part B Run-in|Adverse Event|0|||
155204461|NCT01218204|560188334|FG002|Part B Run-in|Adverse Event|1|||
155204462|NCT01218204|560188335|FG003|Part B Run-in|Adverse Event|0|||
155204463|NCT01218204|560188332|FG000|Part B Run-in|Protocol Violation|0|||
155204464|NCT01218204|560188333|FG001|Part B Run-in|Protocol Violation|0|||
155204465|NCT01218204|560188334|FG002|Part B Run-in|Protocol Violation|2|||
155204466|NCT01218204|560188335|FG003|Part B Run-in|Protocol Violation|0|||
155204467|NCT01218204|560188332|FG000|Part B Run-in|Withdrawal by Subject|0|||
155204468|NCT01218204|560188333|FG001|Part B Run-in|Withdrawal by Subject|0|||
155204469|NCT01218204|560188334|FG002|Part B Run-in|Withdrawal by Subject|3|||
155204470|NCT01218204|560188335|FG003|Part B Run-in|Withdrawal by Subject|0|||
155204471|NCT01218204|560188332|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
155204472|NCT01218204|560188333|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
155204473|NCT01218204|560188334|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
155204474|NCT01218204|560188335|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
155204475|NCT01218204|560188332|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
155204476|NCT01218204|560188333|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
155204477|NCT01218204|560188334|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
155204478|NCT01218204|560188335|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
155204479|NCT04390191|560188338|FG000|Overall Study|Withdrawal by Subject|1|||
155204480|NCT04390191|560188339|FG001|Overall Study|Withdrawal by Subject|0|||
155204481|NCT03978832|560188340|FG000|Overall Study|Adverse Event|1|||
155204482|NCT03978832|560188340|FG000|Overall Study|Lost to Follow-up|1|||
155204483|NCT03978832|560188340|FG000|Overall Study|Withdrawal by Subject|6|||
155204484|NCT03978832|560188340|FG000|Overall Study|Physician Decision|2|||
155204485|NCT03978832|560188340|FG000|Overall Study|did not pass screening criteria|44|||
155204486|NCT02244606|560188341|FG000|Overall Study|Adverse Event|0|||
155204487|NCT02244606|560188342|FG001|Overall Study|Adverse Event|1|||
155204488|NCT02244606|560188343|FG002|Overall Study|Adverse Event|1|||
155204489|NCT02244606|560188344|FG003|Overall Study|Adverse Event|0|||
155204490|NCT02244606|560188341|FG000|Overall Study|Lost to Follow-up|2|||
155204491|NCT02244606|560188342|FG001|Overall Study|Lost to Follow-up|2|||
155204492|NCT02244606|560188343|FG002|Overall Study|Lost to Follow-up|1|||
155204493|NCT02244606|560188344|FG003|Overall Study|Lost to Follow-up|0|||
155204494|NCT02244606|560188341|FG000|Overall Study|Protocol Violation|0|||
155204495|NCT02244606|560188342|FG001|Overall Study|Protocol Violation|0|||
155204496|NCT02244606|560188343|FG002|Overall Study|Protocol Violation|0|||
155204497|NCT02244606|560188344|FG003|Overall Study|Protocol Violation|1|||
155204498|NCT02244606|560188341|FG000|Overall Study|Withdrawal by Subject|1|||
155204499|NCT02244606|560188342|FG001|Overall Study|Withdrawal by Subject|1|||
155204500|NCT02244606|560188343|FG002|Overall Study|Withdrawal by Subject|0|||
155204501|NCT02244606|560188344|FG003|Overall Study|Withdrawal by Subject|0|||
155204502|NCT02244606|560188341|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
155204503|NCT02244606|560188342|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
155204504|NCT02244606|560188343|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
155204505|NCT02244606|560188344|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
155204506|NCT04605484|560188349|FG000|Overall Study|Lost to Follow-up|0|||
155204507|NCT04605484|560188350|FG001|Overall Study|Lost to Follow-up|1|||
155204508|NCT04605484|560188351|FG002|Overall Study|Lost to Follow-up|1|||
155204509|NCT04605484|560188349|FG000|Overall Study|Other|0|||
155204510|NCT04605484|560188350|FG001|Overall Study|Other|1|||
155204511|NCT04605484|560188351|FG002|Overall Study|Other|0|||
155204512|NCT04171531|560188352|FG000|Overall Study|Lost to Follow-up|4|||
155204513|NCT04171531|560188353|FG001|Overall Study|Lost to Follow-up|5|||
155204514|NCT04171531|560188352|FG000|Overall Study|Consent only through 6 months|1|||
155204515|NCT04171531|560188353|FG001|Overall Study|Consent only through 6 months|1|||
155204516|NCT04171531|560188352|FG000|Overall Study|Insurance did not cover procedure|0|||
155204517|NCT04171531|560188353|FG001|Overall Study|Insurance did not cover procedure|1|||
155204518|NCT04171531|560188352|FG000|Overall Study|Physician Decision|0|||
155204519|NCT04171531|560188353|FG001|Overall Study|Physician Decision|3|||
155204520|NCT04171531|560188352|FG000|Overall Study|Withdrawal by Subject|1|||
155204521|NCT04171531|560188353|FG001|Overall Study|Withdrawal by Subject|5|||
155204522|NCT03366337|560188355|FG000|Overall Study|Lost to Follow-up|1|||
155204523|NCT03366337|560188356|FG001|Overall Study|Lost to Follow-up|0|||
155204524|NCT03366337|560188357|FG002|Overall Study|Lost to Follow-up|1|||
155204525|NCT03366337|560188358|FG003|Overall Study|Lost to Follow-up|0|||
155204526|NCT03366337|560188355|FG000|Overall Study|Withdrawal by Subject|2|||
155204527|NCT03366337|560188356|FG001|Overall Study|Withdrawal by Subject|0|||
155204528|NCT03366337|560188357|FG002|Overall Study|Withdrawal by Subject|1|||
155204529|NCT03366337|560188358|FG003|Overall Study|Withdrawal by Subject|1|||
155204530|NCT05288062|560188359|FG000|Overall Study|Ineligible|0|||
155204531|NCT05288062|560188360|FG001|Overall Study|Ineligible|0|||
155204532|NCT05288062|560188361|FG002|Overall Study|Ineligible|1|||
155204533|NCT05288062|560188362|FG003|Overall Study|Ineligible|0|||
155204534|NCT05288062|560188359|FG000|Overall Study|Withdrawal by Subject|0|||
155204535|NCT05288062|560188360|FG001|Overall Study|Withdrawal by Subject|0|||
155204536|NCT05288062|560188361|FG002|Overall Study|Withdrawal by Subject|1|||
155204537|NCT05288062|560188362|FG003|Overall Study|Withdrawal by Subject|0|||
155204538|NCT02099708|560188363|FG000|Overall Study|Data Not Available|30|||
155204539|NCT02099708|560188363|FG000|Overall Study|Lost to Follow-up|141|||
155204540|NCT02099708|560188363|FG000|Overall Study|Other|29|||
155204541|NCT01658072|560188372|FG000|Overall Study|Protocol Violation|4|||
155204542|NCT01658072|560188373|FG001|Overall Study|Protocol Violation|2|||
155204543|NCT00799422|560188378|FG000|First Week of Wear|Lost to Follow-up|0|||
155204544|NCT00799422|560188379|FG001|First Week of Wear|Lost to Follow-up|0|||
155204545|NCT00799422|560188380|FG002|First Week of Wear|Lost to Follow-up|1|||
155204546|NCT00799422|560188381|FG003|First Week of Wear|Lost to Follow-up|0|||
155204547|NCT00799422|560188382|FG004|First Week of Wear|Lost to Follow-up|0|||
155204548|NCT00799422|560188383|FG005|First Week of Wear|Lost to Follow-up|0|||
155204549|NCT00799422|560188378|FG000|First Week of Wear|Adverse Event|0|||
155204550|NCT00799422|560188379|FG001|First Week of Wear|Adverse Event|0|||
155204551|NCT00799422|560188380|FG002|First Week of Wear|Adverse Event|0|||
155204552|NCT00799422|560188381|FG003|First Week of Wear|Adverse Event|1|||
155204553|NCT00799422|560188382|FG004|First Week of Wear|Adverse Event|0|||
155204554|NCT00799422|560188383|FG005|First Week of Wear|Adverse Event|0|||
155204555|NCT00880009|560188384|FG000|Overall Study|Study terminated by sponsor|14|||
155204556|NCT00880009|560188384|FG000|Overall Study|Withdrawal by Subject|1|||
155204557|NCT00880009|560188384|FG000|Overall Study|Protocol Violation|1|||
155204558|NCT04584645|560188386|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
155204559|NCT04584645|560188387|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
155204560|NCT03708328|560188396|FG000|Overall Study|Death|3|||
155204561|NCT03708328|560188397|FG001|Overall Study|Death|3|||
155204562|NCT03708328|560188398|FG002|Overall Study|Death|4|||
155204563|NCT03708328|560188399|FG003|Overall Study|Death|2|||
155204564|NCT03708328|560188400|FG004|Overall Study|Death|2|||
155204565|NCT03708328|560188401|FG005|Overall Study|Death|13|||
155204566|NCT03708328|560188402|FG006|Overall Study|Death|26|||
155204567|NCT03708328|560188403|FG007|Overall Study|Death|18|||
155204568|NCT03708328|560188404|FG008|Overall Study|Death|13|||
155204569|NCT03708328|560188405|FG009|Overall Study|Death|8|||
155204570|NCT03708328|560188396|FG000|Overall Study|Lost to Follow-up|0|||
155204571|NCT03708328|560188397|FG001|Overall Study|Lost to Follow-up|1|||
155204572|NCT03708328|560188398|FG002|Overall Study|Lost to Follow-up|0|||
155204573|NCT03708328|560188399|FG003|Overall Study|Lost to Follow-up|1|||
155204574|NCT03708328|560188400|FG004|Overall Study|Lost to Follow-up|0|||
155204575|NCT03708328|560188401|FG005|Overall Study|Lost to Follow-up|3|||
155204576|NCT03708328|560188402|FG006|Overall Study|Lost to Follow-up|3|||
155204577|NCT03708328|560188403|FG007|Overall Study|Lost to Follow-up|0|||
155204578|NCT03708328|560188404|FG008|Overall Study|Lost to Follow-up|0|||
155204579|NCT03708328|560188405|FG009|Overall Study|Lost to Follow-up|1|||
155204580|NCT03708328|560188396|FG000|Overall Study|Physician Decision|0|||
155204581|NCT03708328|560188397|FG001|Overall Study|Physician Decision|0|||
155204582|NCT03708328|560188398|FG002|Overall Study|Physician Decision|0|||
155204583|NCT03708328|560188399|FG003|Overall Study|Physician Decision|0|||
155204584|NCT03708328|560188400|FG004|Overall Study|Physician Decision|0|||
155204585|NCT03708328|560188401|FG005|Overall Study|Physician Decision|1|||
155204586|NCT03708328|560188402|FG006|Overall Study|Physician Decision|0|||
155204587|NCT03708328|560188403|FG007|Overall Study|Physician Decision|0|||
155204588|NCT03708328|560188404|FG008|Overall Study|Physician Decision|0|||
155204589|NCT03708328|560188405|FG009|Overall Study|Physician Decision|0|||
155204590|NCT03708328|560188396|FG000|Overall Study|Withdrawal by Subject|0|||
155204591|NCT03708328|560188397|FG001|Overall Study|Withdrawal by Subject|0|||
155204592|NCT03708328|560188398|FG002|Overall Study|Withdrawal by Subject|0|||
155204593|NCT03708328|560188399|FG003|Overall Study|Withdrawal by Subject|0|||
155204594|NCT03708328|560188400|FG004|Overall Study|Withdrawal by Subject|1|||
155204595|NCT03708328|560188401|FG005|Overall Study|Withdrawal by Subject|0|||
155204596|NCT03708328|560188402|FG006|Overall Study|Withdrawal by Subject|2|||
155204597|NCT03708328|560188403|FG007|Overall Study|Withdrawal by Subject|4|||
155204598|NCT03708328|560188404|FG008|Overall Study|Withdrawal by Subject|1|||
155204599|NCT03708328|560188405|FG009|Overall Study|Withdrawal by Subject|5|||
155204600|NCT03708328|560188396|FG000|Overall Study|Study Closed Locally|0|||
155204601|NCT03708328|560188397|FG001|Overall Study|Study Closed Locally|0|||
155204602|NCT03708328|560188398|FG002|Overall Study|Study Closed Locally|0|||
155204603|NCT03708328|560188399|FG003|Overall Study|Study Closed Locally|0|||
155204604|NCT03708328|560188400|FG004|Overall Study|Study Closed Locally|0|||
155204605|NCT03708328|560188401|FG005|Overall Study|Study Closed Locally|0|||
155204606|NCT03708328|560188402|FG006|Overall Study|Study Closed Locally|0|||
155204607|NCT03708328|560188403|FG007|Overall Study|Study Closed Locally|1|||
155204608|NCT03708328|560188404|FG008|Overall Study|Study Closed Locally|0|||
155204609|NCT03708328|560188405|FG009|Overall Study|Study Closed Locally|0|||
155204610|NCT03708328|560188396|FG000|Overall Study|Study Ended By Sponsor|0|||
155204611|NCT03708328|560188397|FG001|Overall Study|Study Ended By Sponsor|0|||
155204612|NCT03708328|560188398|FG002|Overall Study|Study Ended By Sponsor|0|||
155204613|NCT03708328|560188399|FG003|Overall Study|Study Ended By Sponsor|0|||
155204614|NCT03708328|560188400|FG004|Overall Study|Study Ended By Sponsor|0|||
155204615|NCT03708328|560188401|FG005|Overall Study|Study Ended By Sponsor|1|||
155204616|NCT03708328|560188402|FG006|Overall Study|Study Ended By Sponsor|0|||
155204617|NCT03708328|560188403|FG007|Overall Study|Study Ended By Sponsor|1|||
155204618|NCT03708328|560188404|FG008|Overall Study|Study Ended By Sponsor|0|||
155204619|NCT03708328|560188405|FG009|Overall Study|Study Ended By Sponsor|0|||
155204620|NCT03708328|560188396|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204621|NCT03708328|560188397|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204622|NCT03708328|560188398|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204623|NCT03708328|560188399|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204624|NCT03708328|560188400|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204625|NCT03708328|560188401|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204626|NCT03708328|560188402|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204627|NCT03708328|560188403|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204628|NCT03708328|560188404|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
155204629|NCT03708328|560188405|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
155204630|NCT04523220|560188406|FG000|Main Treatment Period|Physician Decision|1|||
155204631|NCT04523220|560188407|FG001|Main Treatment Period|Physician Decision|1|||
155204632|NCT04523220|560188408|FG002|Main Treatment Period|Physician Decision|0|||
155204633|NCT04523220|560188406|FG000|Main Treatment Period|Other|5|||
155204634|NCT04523220|560188407|FG001|Main Treatment Period|Other|2|||
155204635|NCT04523220|560188408|FG002|Main Treatment Period|Other|4|||
155204636|NCT04523220|560188406|FG000|Main Treatment Period|Subject Decision|5|||
155204637|NCT04523220|560188407|FG001|Main Treatment Period|Subject Decision|7|||
155204638|NCT04523220|560188408|FG002|Main Treatment Period|Subject Decision|3|||
155204639|NCT04523220|560188406|FG000|Main Treatment Period|Death|5|||
155204640|NCT04523220|560188407|FG001|Main Treatment Period|Death|11|||
155204641|NCT04523220|560188408|FG002|Main Treatment Period|Death|4|||
155204642|NCT04523220|560188406|FG000|Main Treatment Period|Adverse Event|11|||
155204643|NCT04523220|560188407|FG001|Main Treatment Period|Adverse Event|9|||
155204644|NCT04523220|560188408|FG002|Main Treatment Period|Adverse Event|9|||
155204645|NCT04523220|560188406|FG000|Main Treatment Period|Withdrawal by Subject|3|||
155204646|NCT04523220|560188407|FG001|Main Treatment Period|Withdrawal by Subject|3|||
155204647|NCT04523220|560188408|FG002|Main Treatment Period|Withdrawal by Subject|4|||
155204648|NCT04523220|560188406|FG000|Main Treatment Period|Study drug never adminstered|10|||
155204649|NCT04523220|560188407|FG001|Main Treatment Period|Study drug never adminstered|3|||
155204650|NCT04523220|560188408|FG002|Main Treatment Period|Study drug never adminstered|5|||
155204651|NCT04523220|560188406|FG000|Extension Treatment Period|Physician Decision|1|||
155204652|NCT04523220|560188407|FG001|Extension Treatment Period|Physician Decision|0|||
155204653|NCT04523220|560188408|FG002|Extension Treatment Period|Physician Decision|3|||
155204654|NCT04523220|560188406|FG000|Extension Treatment Period|Other|2|||
155204655|NCT04523220|560188407|FG001|Extension Treatment Period|Other|6|||
155204656|NCT04523220|560188408|FG002|Extension Treatment Period|Other|6|||
155204657|NCT04523220|560188406|FG000|Extension Treatment Period|Subject Decision|5|||
155204658|NCT04523220|560188407|FG001|Extension Treatment Period|Subject Decision|2|||
155204659|NCT04523220|560188408|FG002|Extension Treatment Period|Subject Decision|4|||
155204660|NCT04523220|560188406|FG000|Extension Treatment Period|Death|6|||
155204661|NCT04523220|560188407|FG001|Extension Treatment Period|Death|4|||
155204662|NCT04523220|560188408|FG002|Extension Treatment Period|Death|7|||
155204663|NCT04523220|560188406|FG000|Extension Treatment Period|Adverse Event|6|||
155204664|NCT04523220|560188407|FG001|Extension Treatment Period|Adverse Event|7|||
155204665|NCT04523220|560188408|FG002|Extension Treatment Period|Adverse Event|9|||
155204666|NCT04523220|560188406|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
155204667|NCT04523220|560188407|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
155204668|NCT04523220|560188408|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
155204669|NCT04523220|560188406|FG000|Extension Treatment Period|Study drug never administered|0|||
155204670|NCT04523220|560188407|FG001|Extension Treatment Period|Study drug never administered|1|||
155204671|NCT04523220|560188408|FG002|Extension Treatment Period|Study drug never administered|0|||
155204672|NCT02010775|560188409|FG000|Overall Study|Adverse Event|0|||
155204673|NCT02010775|560188410|FG001|Overall Study|Adverse Event|0|||
155204674|NCT02010775|560188411|FG002|Overall Study|Adverse Event|0|||
155204675|NCT02010775|560188412|FG003|Overall Study|Adverse Event|0|||
155204676|NCT02010775|560188413|FG004|Overall Study|Adverse Event|1|||
155204677|NCT02010775|560188409|FG000|Overall Study|Pregnancy|0|||
155204678|NCT02010775|560188410|FG001|Overall Study|Pregnancy|0|||
155204679|NCT02010775|560188411|FG002|Overall Study|Pregnancy|2|||
155204680|NCT02010775|560188412|FG003|Overall Study|Pregnancy|0|||
155204681|NCT02010775|560188413|FG004|Overall Study|Pregnancy|0|||
155204682|NCT02010775|560188409|FG000|Overall Study|Lost to Follow-up|2|||
155204683|NCT02010775|560188410|FG001|Overall Study|Lost to Follow-up|0|||
155204684|NCT02010775|560188411|FG002|Overall Study|Lost to Follow-up|0|||
155204685|NCT02010775|560188412|FG003|Overall Study|Lost to Follow-up|1|||
155204686|NCT02010775|560188413|FG004|Overall Study|Lost to Follow-up|1|||
155204687|NCT02010775|560188409|FG000|Overall Study|Personal Reasons|3|||
155204688|NCT02010775|560188410|FG001|Overall Study|Personal Reasons|3|||
155204689|NCT02010775|560188411|FG002|Overall Study|Personal Reasons|1|||
155204690|NCT02010775|560188412|FG003|Overall Study|Personal Reasons|2|||
155204691|NCT02010775|560188413|FG004|Overall Study|Personal Reasons|4|||
155204692|NCT02006719|560188414|FG000|Overall Study|Withdrawal by Subject|10|||
155204693|NCT02006719|560188415|FG001|Overall Study|Withdrawal by Subject|2|||
155204694|NCT02006719|560188414|FG000|Overall Study|Lost to Follow-up|5|||
155204695|NCT02006719|560188415|FG001|Overall Study|Lost to Follow-up|1|||
155204696|NCT02006719|560188414|FG000|Overall Study|Protocol Violation|2|||
155204697|NCT02006719|560188415|FG001|Overall Study|Protocol Violation|0|||
155204698|NCT02006719|560188414|FG000|Overall Study|Adverse Event|1|||
155204699|NCT02006719|560188415|FG001|Overall Study|Adverse Event|1|||
155204700|NCT02006719|560188414|FG000|Overall Study|Other/Unknown|0|||
155204701|NCT02006719|560188415|FG001|Overall Study|Other/Unknown|1|||
155204702|NCT02439138|560188417|FG000|Overall Study|Adverse Event|1|||
155204703|NCT02439138|560188417|FG000|Overall Study|PI decision to terminate the study|2|||
155204704|NCT02615145|560188422|FG000|Overall Study|Did Not Start Treatment|0|||
155204705|NCT02615145|560188423|FG001|Overall Study|Did Not Start Treatment|0|||
155204706|NCT02615145|560188424|FG002|Overall Study|Did Not Start Treatment|1|||
155204707|NCT02615145|560188425|FG003|Overall Study|Did Not Start Treatment|1|||
155204708|NCT02615145|560188422|FG000|Overall Study|Failure to Return|20|||
155204709|NCT02615145|560188423|FG001|Overall Study|Failure to Return|10|||
155204710|NCT02615145|560188424|FG002|Overall Study|Failure to Return|7|||
155204711|NCT02615145|560188425|FG003|Overall Study|Failure to Return|0|||
155204712|NCT02615145|560188422|FG000|Overall Study|Death|2|||
155204713|NCT02615145|560188423|FG001|Overall Study|Death|3|||
155204714|NCT02615145|560188424|FG002|Overall Study|Death|0|||
155204715|NCT02615145|560188425|FG003|Overall Study|Death|0|||
155204716|NCT02615145|560188422|FG000|Overall Study|Other, Not Specified|5|||
155204717|NCT02615145|560188423|FG001|Overall Study|Other, Not Specified|2|||
155204718|NCT02615145|560188424|FG002|Overall Study|Other, Not Specified|0|||
155204719|NCT02615145|560188425|FG003|Overall Study|Other, Not Specified|0|||
155204720|NCT00006237|560188426|FG000|Overall Study|Adverse Event|39|||
155204721|NCT00006237|560188427|FG001|Overall Study|Adverse Event|29|||
155204722|NCT00006237|560188426|FG000|Overall Study|Death|1|||
155204723|NCT00006237|560188427|FG001|Overall Study|Death|0|||
155204724|NCT00006237|560188426|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
155204725|NCT00006237|560188427|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
155204726|NCT00006237|560188426|FG000|Overall Study|Progression/relapse|54|||
155204727|NCT00006237|560188427|FG001|Overall Study|Progression/relapse|2|||
155204728|NCT00006237|560188426|FG000|Overall Study|Not eligible|9|||
155204729|NCT00006237|560188427|FG001|Overall Study|Not eligible|20|||
155204730|NCT00006237|560188426|FG000|Overall Study|Withdrawal by Subject|0|||
155204731|NCT00006237|560188427|FG001|Overall Study|Withdrawal by Subject|1|||
155204732|NCT00006237|560188426|FG000|Overall Study|Not protocol specified|14|||
155204733|NCT00006237|560188427|FG001|Overall Study|Not protocol specified|5|||
155204734|NCT03727347|560188428|FG000|Overall Study|Withdrawal by Subject|2|||
155204735|NCT03727347|560188428|FG000|Overall Study|Lost to Follow-up|1|||
155204736|NCT01846416|560188433|FG000|Treatment Phase|Death|2|||
155204737|NCT01846416|560188434|FG001|Treatment Phase|Death|9|||
155204738|NCT01846416|560188435|FG002|Treatment Phase|Death|1|||
155204739|NCT01846416|560188433|FG000|Treatment Phase|Withdrawal by Subject|2|||
155204740|NCT01846416|560188434|FG001|Treatment Phase|Withdrawal by Subject|4|||
155204741|NCT01846416|560188435|FG002|Treatment Phase|Withdrawal by Subject|2|||
155204742|NCT01846416|560188433|FG000|Treatment Phase|Other|1|||
155204743|NCT01846416|560188434|FG001|Treatment Phase|Other|5|||
155204744|NCT01846416|560188435|FG002|Treatment Phase|Other|1|||
155204745|NCT01846416|560188433|FG000|Treatment Phase|Physician Decision|1|||
155204746|NCT01846416|560188434|FG001|Treatment Phase|Physician Decision|2|||
155204747|NCT01846416|560188435|FG002|Treatment Phase|Physician Decision|0|||
155204748|NCT01846416|560188433|FG000|Treatment Phase|Adverse Event|3|||
155204749|NCT01846416|560188434|FG001|Treatment Phase|Adverse Event|4|||
155204750|NCT01846416|560188435|FG002|Treatment Phase|Adverse Event|0|||
155204751|NCT01846416|560188433|FG000|Treatment Phase|Non-compliance|0|||
155204752|NCT01846416|560188434|FG001|Treatment Phase|Non-compliance|2|||
155204753|NCT01846416|560188435|FG002|Treatment Phase|Non-compliance|0|||
155204754|NCT01846416|560188433|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
155204755|NCT01846416|560188434|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
155204756|NCT01846416|560188435|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
155204757|NCT01846416|560188433|FG000|Treatment Phase|Progressive Disease|21|||
155204758|NCT01846416|560188434|FG001|Treatment Phase|Progressive Disease|63|||
155204759|NCT01846416|560188435|FG002|Treatment Phase|Progressive Disease|9|||
155204760|NCT01846416|560188433|FG000|Survival Follow-up|Death|21|||
155204761|NCT01846416|560188434|FG001|Survival Follow-up|Death|62|||
155204762|NCT01846416|560188435|FG002|Survival Follow-up|Death|9|||
155204763|NCT01846416|560188433|FG000|Survival Follow-up|Lost to Follow-up|0|||
155204764|NCT01846416|560188434|FG001|Survival Follow-up|Lost to Follow-up|2|||
155204765|NCT01846416|560188435|FG002|Survival Follow-up|Lost to Follow-up|2|||
155204766|NCT01846416|560188433|FG000|Survival Follow-up|Withdrawal by Subject|2|||
155204767|NCT01846416|560188434|FG001|Survival Follow-up|Withdrawal by Subject|7|||
155204768|NCT01846416|560188435|FG002|Survival Follow-up|Withdrawal by Subject|0|||
155204769|NCT01846416|560188433|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
155204770|NCT01846416|560188434|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
155204771|NCT01846416|560188435|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
155204772|NCT01846416|560188433|FG000|Survival Follow-up|Other|3|||
155204773|NCT01846416|560188434|FG001|Survival Follow-up|Other|1|||
155204774|NCT01846416|560188435|FG002|Survival Follow-up|Other|1|||
155204775|NCT02144012|560188438|FG000|Overall Study|Adverse Event|1|||
155204776|NCT02144012|560188439|FG001|Overall Study|Adverse Event|0|||
155204777|NCT02144012|560188438|FG000|Overall Study|Death|1|||
155204778|NCT02144012|560188439|FG001|Overall Study|Death|0|||
155204779|NCT02144012|560188438|FG000|Overall Study|Withdrawal by Subject|11|||
155204780|NCT02144012|560188439|FG001|Overall Study|Withdrawal by Subject|3|||
155204781|NCT02144012|560188438|FG000|Overall Study|Study Terminated by Sponsor|18|||
155204782|NCT02144012|560188439|FG001|Overall Study|Study Terminated by Sponsor|12|||
155204783|NCT02144012|560188438|FG000|Overall Study|Other|3|||
155204784|NCT02144012|560188439|FG001|Overall Study|Other|0|||
155204785|NCT00317356|560188440|FG000|Overall Study|Adverse Event|0|||
155204786|NCT00317356|560188441|FG001|Overall Study|Adverse Event|0|||
155204787|NCT00317356|560188442|FG002|Overall Study|Adverse Event|1|||
155204788|NCT00317356|560188443|FG003|Overall Study|Adverse Event|0|||
155204789|NCT00317356|560188440|FG000|Overall Study|Lack of Efficacy|1|||
155204790|NCT00317356|560188441|FG001|Overall Study|Lack of Efficacy|1|||
155204791|NCT00317356|560188442|FG002|Overall Study|Lack of Efficacy|0|||
155204792|NCT00317356|560188443|FG003|Overall Study|Lack of Efficacy|3|||
155204793|NCT00317356|560188440|FG000|Overall Study|Physician Decision|0|||
155204794|NCT00317356|560188441|FG001|Overall Study|Physician Decision|1|||
155204795|NCT00317356|560188442|FG002|Overall Study|Physician Decision|0|||
155204796|NCT00317356|560188443|FG003|Overall Study|Physician Decision|0|||
155204797|NCT00598832|560188444|FG000|Overall Study|Lack of Efficacy|3|||
155204798|NCT00598832|560188445|FG001|Overall Study|Lack of Efficacy|7|||
155204799|NCT00598832|560188444|FG000|Overall Study|Adverse Event|6|||
155204800|NCT00598832|560188445|FG001|Overall Study|Adverse Event|2|||
155204801|NCT00598832|560188444|FG000|Overall Study|Withdrawal by Subject|25|||
155204802|NCT00598832|560188445|FG001|Overall Study|Withdrawal by Subject|36|||
155204803|NCT00598832|560188444|FG000|Overall Study|Protocol Violation|0|||
155204804|NCT00598832|560188445|FG001|Overall Study|Protocol Violation|2|||
155204805|NCT00598832|560188444|FG000|Overall Study|Lost to Follow-up|24|||
155204806|NCT00598832|560188445|FG001|Overall Study|Lost to Follow-up|29|||
155204807|NCT00598832|560188444|FG000|Overall Study|Pregnancy|2|||
155204808|NCT00598832|560188445|FG001|Overall Study|Pregnancy|2|||
155204809|NCT00598832|560188444|FG000|Overall Study|Physician Decision|1|||
155204810|NCT00598832|560188445|FG001|Overall Study|Physician Decision|4|||
155204811|NCT00598832|560188444|FG000|Overall Study|Non compliance|1|||
155204812|NCT00598832|560188445|FG001|Overall Study|Non compliance|0|||
155204813|NCT02142959|560188446|FG000|Overall Study|Adverse Event|1|||
155204814|NCT02142959|560188447|FG001|Overall Study|Adverse Event|0|||
155204815|NCT02142959|560188448|FG002|Overall Study|Adverse Event|0|||
155204816|NCT02142959|560188446|FG000|Overall Study|Death|0|||
155204817|NCT02142959|560188447|FG001|Overall Study|Death|1|||
155204818|NCT02142959|560188448|FG002|Overall Study|Death|0|||
155204819|NCT02142959|560188446|FG000|Overall Study|Withdrawal by Subject|3|||
155204820|NCT02142959|560188447|FG001|Overall Study|Withdrawal by Subject|1|||
155204821|NCT02142959|560188448|FG002|Overall Study|Withdrawal by Subject|3|||
155204822|NCT02142959|560188446|FG000|Overall Study|Administrative Reasons|1|||
155204823|NCT02142959|560188447|FG001|Overall Study|Administrative Reasons|0|||
155204824|NCT02142959|560188448|FG002|Overall Study|Administrative Reasons|1|||
155204825|NCT02142959|560188446|FG000|Overall Study|Missing|0|||
155204826|NCT02142959|560188447|FG001|Overall Study|Missing|1|||
155204827|NCT02142959|560188448|FG002|Overall Study|Missing|0|||
155204828|NCT02142959|560188446|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
155204829|NCT02142959|560188447|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
155204830|NCT02142959|560188448|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
155204831|NCT02142959|560188446|FG000|Overall Study|Patient didn't complete end of study visit|0|||
155204832|NCT02142959|560188447|FG001|Overall Study|Patient didn't complete end of study visit|0|||
155204833|NCT02142959|560188448|FG002|Overall Study|Patient didn't complete end of study visit|1|||
155204834|NCT01943292|560190234|FG000|Overall Study|Withdrawal by Subject|1|||
155204835|NCT01943292|560190235|FG001|Overall Study|Withdrawal by Subject|0|||
155204836|NCT01943292|560190236|FG002|Overall Study|Withdrawal by Subject|0|||
155204837|NCT00911820|560190237|FG000|Overall Study|RECIST progression|12|||
155204838|NCT00911820|560190238|FG001|Overall Study|RECIST progression|8|||
155204839|NCT00911820|560190237|FG000|Overall Study|Adverse Event|8|||
155204840|NCT00911820|560190238|FG001|Overall Study|Adverse Event|8|||
155204841|NCT00911820|560190237|FG000|Overall Study|Clinical Progression|7|||
155204842|NCT00911820|560190238|FG001|Overall Study|Clinical Progression|5|||
155204843|NCT00911820|560190237|FG000|Overall Study|Physician Decision|5|||
155204844|NCT00911820|560190238|FG001|Overall Study|Physician Decision|9|||
155204845|NCT00911820|560190237|FG000|Overall Study|Decline in Performance Status|4|||
155204846|NCT00911820|560190238|FG001|Overall Study|Decline in Performance Status|2|||
155204847|NCT00911820|560190237|FG000|Overall Study|Withdrawal by Subject|3|||
155204848|NCT00911820|560190238|FG001|Overall Study|Withdrawal by Subject|4|||
155204849|NCT00911820|560190237|FG000|Overall Study|Death|1|||
155204850|NCT00911820|560190238|FG001|Overall Study|Death|2|||
155204851|NCT00911820|560190237|FG000|Overall Study|Pursue surgery|1|||
155204852|NCT00911820|560190238|FG001|Overall Study|Pursue surgery|1|||
155204853|NCT00911820|560190237|FG000|Overall Study|Pursue Radiation|1|||
155204854|NCT00911820|560190238|FG001|Overall Study|Pursue Radiation|0|||
155204855|NCT00911820|560190237|FG000|Overall Study|Still on Therapy|2|||
155204856|NCT00911820|560190238|FG001|Overall Study|Still on Therapy|2|||
155204857|NCT00911820|560190237|FG000|Overall Study|Pathology Not Confirmed|1|||
155204858|NCT00911820|560190238|FG001|Overall Study|Pathology Not Confirmed|0|||
155204859|NCT00911820|560190237|FG000|Overall Study|Withdraw before Receive Treatment|0|||
155204860|NCT00911820|560190238|FG001|Overall Study|Withdraw before Receive Treatment|2|||
155204861|NCT00996216|560190239|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
155204862|NCT00996216|560190239|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
155204863|NCT00996216|560190239|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
155204864|NCT00963547|560190248|FG000|Overall Study|Adverse Event|0|||
155204865|NCT00963547|560190249|FG001|Overall Study|Adverse Event|1|||
155204866|NCT00963547|560190250|FG002|Overall Study|Adverse Event|0|||
155204867|NCT00963547|560190251|FG003|Overall Study|Adverse Event|1|||
155204868|NCT00963547|560190252|FG004|Overall Study|Adverse Event|0|||
155204869|NCT00963547|560190253|FG005|Overall Study|Adverse Event|0|||
155204870|NCT00963547|560190254|FG006|Overall Study|Adverse Event|0|||
155204871|NCT00963547|560190248|FG000|Overall Study|Physician Decision|1|||
155204872|NCT00963547|560190249|FG001|Overall Study|Physician Decision|1|||
155204873|NCT00963547|560190250|FG002|Overall Study|Physician Decision|0|||
155204874|NCT00963547|560190251|FG003|Overall Study|Physician Decision|0|||
155204875|NCT00963547|560190252|FG004|Overall Study|Physician Decision|0|||
155204876|NCT00963547|560190253|FG005|Overall Study|Physician Decision|0|||
155204877|NCT00963547|560190254|FG006|Overall Study|Physician Decision|0|||
155204878|NCT00963547|560190248|FG000|Overall Study|Progressive Disease|3|||
155204879|NCT00963547|560190249|FG001|Overall Study|Progressive Disease|8|||
155204880|NCT00963547|560190250|FG002|Overall Study|Progressive Disease|9|||
155204881|NCT00963547|560190251|FG003|Overall Study|Progressive Disease|5|||
155204882|NCT00963547|560190252|FG004|Overall Study|Progressive Disease|0|||
155204883|NCT00963547|560190253|FG005|Overall Study|Progressive Disease|0|||
155204884|NCT00963547|560190254|FG006|Overall Study|Progressive Disease|0|||
155204885|NCT00963547|560190248|FG000|Overall Study|Withdrawal by Subject|0|||
155204886|NCT00963547|560190249|FG001|Overall Study|Withdrawal by Subject|0|||
155204887|NCT00963547|560190250|FG002|Overall Study|Withdrawal by Subject|3|||
155204888|NCT00963547|560190251|FG003|Overall Study|Withdrawal by Subject|0|||
155204889|NCT00963547|560190252|FG004|Overall Study|Withdrawal by Subject|0|||
155204890|NCT00963547|560190253|FG005|Overall Study|Withdrawal by Subject|0|||
155204891|NCT00963547|560190254|FG006|Overall Study|Withdrawal by Subject|0|||
155204892|NCT00963547|560190248|FG000|Overall Study|Reason Unknown|0|||
155204893|NCT00963547|560190249|FG001|Overall Study|Reason Unknown|1|||
155204894|NCT00963547|560190250|FG002|Overall Study|Reason Unknown|0|||
155204895|NCT00963547|560190251|FG003|Overall Study|Reason Unknown|0|||
155204896|NCT00963547|560190252|FG004|Overall Study|Reason Unknown|0|||
155204897|NCT00963547|560190253|FG005|Overall Study|Reason Unknown|0|||
155204898|NCT00963547|560190254|FG006|Overall Study|Reason Unknown|0|||
155204899|NCT03761277|560190258|FG000|Enrollment to Implant|Screen Failure|17|||
155204900|NCT03761277|560190258|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
155204901|NCT03761277|560190258|FG000|Enrollment to Implant|Physician Decision|2|||
155204902|NCT03761277|560190258|FG000|Enrollment to Implant|Site Closure|3|||
155204903|NCT03761277|560190258|FG000|Enrollment to Implant|Sponsor Request|2|||
155204904|NCT03761277|560190258|FG000|Post-Implant to 6 Months|Adverse Event|2|||
155204905|NCT03761277|560190258|FG000|Post-Implant to 6 Months|Death|1|||
155204906|NCT03761277|560190258|FG000|Post-Implant to 6 Months|Site Closure|2|||
155204907|NCT03761277|560190258|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
155204908|NCT03761277|560190258|FG000|6 Months to 12 Months|Physician Decision|2|||
155204909|NCT03761277|560190258|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
155204910|NCT00903695|560190259|FG000|Overall Study|medical exclusion after 1st testing|1|||
155204911|NCT00903695|560190260|FG001|Overall Study|medical exclusion after 1st testing|0|||
155204912|NCT00903695|560190259|FG000|Overall Study|lung cancer|1|||
155204913|NCT00903695|560190260|FG001|Overall Study|lung cancer|0|||
155204914|NCT02430311|560190262|FG000|Part A|Adverse Event|0|||
155204915|NCT02430311|560190263|FG001|Part A|Adverse Event|1|||
155204916|NCT02430311|560190262|FG000|Part A|Withdrawal by Subject|1|||
155204917|NCT02430311|560190263|FG001|Part A|Withdrawal by Subject|0|||
155204918|NCT02430311|560190262|FG000|Part B|Meet study-specific withdrawal criteria|6|||
155204919|NCT02430311|560190263|FG001|Part B|Meet study-specific withdrawal criteria|6|||
155204920|NCT02430311|560190262|FG000|Part B|Withdrawal by Subject|2|||
155204921|NCT02430311|560190263|FG001|Part B|Withdrawal by Subject|2|||
155204922|NCT02430311|560190262|FG000|Part B|Adverse Event|1|||
155204923|NCT02430311|560190263|FG001|Part B|Adverse Event|0|||
155204924|NCT02430311|560190262|FG000|Part B|Death|1|||
155204925|NCT02430311|560190263|FG001|Part B|Death|0|||
155204926|NCT00578812|560190264|FG000|Overall Study|Not treated|6|||
155204927|NCT00578812|560190265|FG001|Overall Study|Not treated|7|||
155204928|NCT00309387|560190267|FG000|Overall Study|Death|72|||
155204929|NCT00309387|560190268|FG001|Overall Study|Death|73|||
155204930|NCT00309387|560190267|FG000|Overall Study|Lost to Follow-up|70|||
155204931|NCT00309387|560190268|FG001|Overall Study|Lost to Follow-up|86|||
155204932|NCT01599234|560190279|FG000|Overall Study|Adverse Event|9|||
155204933|NCT01599234|560190280|FG001|Overall Study|Adverse Event|5|||
155204934|NCT01599234|560190279|FG000|Overall Study|Withdrawal by Subject|2|||
155204935|NCT01599234|560190280|FG001|Overall Study|Withdrawal by Subject|1|||
155204936|NCT01599234|560190279|FG000|Overall Study|Lost to Follow-up|1|||
155204937|NCT01599234|560190280|FG001|Overall Study|Lost to Follow-up|2|||
155204938|NCT01599234|560190279|FG000|Overall Study|Lack of Efficacy|2|||
155204939|NCT01599234|560190280|FG001|Overall Study|Lack of Efficacy|4|||
155204940|NCT01599234|560190279|FG000|Overall Study|Unable to operate spray|1|||
155204941|NCT01599234|560190280|FG001|Overall Study|Unable to operate spray|0|||
155204942|NCT01599234|560190279|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
155204943|NCT01599234|560190280|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
155204944|NCT01599234|560190279|FG000|Overall Study|Death|1|||
155204945|NCT01599234|560190280|FG001|Overall Study|Death|0|||
155204946|NCT01599234|560190279|FG000|Overall Study|Patient would not stop driving|1|||
155204947|NCT01599234|560190280|FG001|Overall Study|Patient would not stop driving|0|||
155204948|NCT01599234|560190279|FG000|Overall Study|Contra-indication discovered|0|||
155204949|NCT01599234|560190280|FG001|Overall Study|Contra-indication discovered|1|||
155204950|NCT01599234|560190279|FG000|Overall Study|Pregnancy|0|||
155204951|NCT01599234|560190280|FG001|Overall Study|Pregnancy|1|||
155204952|NCT02041286|560190283|FG000|Overall Study|Adverse Event|1|||
155204953|NCT01349790|560190290|FG000|Overall Study|Investigator Judgement|3|||
155204954|NCT01349790|560190290|FG000|Overall Study|Death|2|||
155204955|NCT01349790|560190290|FG000|Overall Study|Withdrawal by Patient|2|||
155204956|NCT01349790|560190290|FG000|Overall Study|Adverse Event|1|||
155204957|NCT01349790|560190290|FG000|Overall Study|Lost to Follow-up|1|||
155204958|NCT02495168|560190291|FG000|Overall Study|Other than Specified|18|||
155204959|NCT02495168|560190292|FG001|Overall Study|Other than Specified|22|||
155204960|NCT02495168|560190293|FG002|Overall Study|Other than Specified|5|||
155204961|NCT02495168|560190291|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
155204962|NCT02495168|560190292|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
155204963|NCT02495168|560190293|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
155204964|NCT02495168|560190291|FG000|Overall Study|Physician Decision|1|||
155204965|NCT02495168|560190292|FG001|Overall Study|Physician Decision|1|||
155204966|NCT02495168|560190293|FG002|Overall Study|Physician Decision|0|||
155204967|NCT02495168|560190291|FG000|Overall Study|Lost to Follow-up|10|||
155204968|NCT02495168|560190292|FG001|Overall Study|Lost to Follow-up|6|||
155204969|NCT02495168|560190293|FG002|Overall Study|Lost to Follow-up|1|||
155204970|NCT02495168|560190291|FG000|Overall Study|Withdrawal by Subject|1|||
155204971|NCT02495168|560190292|FG001|Overall Study|Withdrawal by Subject|4|||
155204972|NCT02495168|560190293|FG002|Overall Study|Withdrawal by Subject|2|||
155204973|NCT02495168|560190291|FG000|Overall Study|Protocol Violation|0|||
155204974|NCT02495168|560190292|FG001|Overall Study|Protocol Violation|10|||
155204975|NCT02495168|560190293|FG002|Overall Study|Protocol Violation|1|||
155204976|NCT02495168|560190291|FG000|Overall Study|Adverse Event|4|||
155204977|NCT02495168|560190292|FG001|Overall Study|Adverse Event|8|||
155204978|NCT02495168|560190293|FG002|Overall Study|Adverse Event|3|||
155204979|NCT02495168|560190291|FG000|Overall Study|Lack of Efficacy|0|||
155204980|NCT02495168|560190292|FG001|Overall Study|Lack of Efficacy|0|||
155204981|NCT02495168|560190293|FG002|Overall Study|Lack of Efficacy|3|||
155204982|NCT04166435|560190296|FG000|Overall Study|2 patients ineligible for response|2|||
155204983|NCT03462082|560190297|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204984|NCT03462082|560190298|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204985|NCT03462082|560190299|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204986|NCT03462082|560190300|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204987|NCT03462082|560190301|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204988|NCT03462082|560190302|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
155204989|NCT03462082|560190303|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
155204990|NCT03462082|560190304|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
155204991|NCT00127660|560190309|FG000|Overall Study|Protocol Violation|3|||
155204992|NCT00127660|560190310|FG001|Overall Study|Protocol Violation|3|||
155204993|NCT00127660|560190311|FG002|Overall Study|Protocol Violation|5|||
155204994|NCT00127660|560190312|FG003|Overall Study|Protocol Violation|0|||
155204995|NCT01833520|560190313|FG000|Overall Study|Lack of Efficacy|3|||
155204996|NCT01833520|560190314|FG001|Overall Study|Lack of Efficacy|3|||
155204997|NCT01833520|560190315|FG002|Overall Study|Lack of Efficacy|8|||
155204998|NCT01833520|560190316|FG003|Overall Study|Lack of Efficacy|3|||
155204999|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
155205000|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
155205001|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
155205002|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
155205003|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
155205004|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
155205005|NCT00489541|560190321|FG000|12-Month Clinical Follow-up|Death|3|||
155205006|NCT00489541|560190322|FG001|12-Month Clinical Follow-up|Death|2|||
155205007|NCT00489541|560190321|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
155205008|NCT00489541|560190322|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
155205009|NCT00489541|560190321|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
155205010|NCT00489541|560190322|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
155205011|NCT05131646|560190323|FG000|Overall Study|Withdrawal by Subject|1|||
155205012|NCT05131646|560190324|FG001|Overall Study|Withdrawal by Subject|0|||
155205013|NCT05131646|560190325|FG002|Overall Study|Withdrawal by Subject|0|||
155205014|NCT00003479|560190332|FG000|Overall Study|Not evaluable|3|||
155205015|NCT02128113|560190334|FG000|Overall Study|Withdrawal by Subject|3|||
155205016|NCT02128113|560190335|FG001|Overall Study|Withdrawal by Subject|1|||
155205017|NCT02128113|560190336|FG002|Overall Study|Withdrawal by Subject|0|||
155205018|NCT02128113|560190334|FG000|Overall Study|Protocol Violation|0|||
155205019|NCT02128113|560190335|FG001|Overall Study|Protocol Violation|1|||
155205020|NCT02128113|560190336|FG002|Overall Study|Protocol Violation|0|||
155205021|NCT02128113|560190334|FG000|Overall Study|Surgery cancelled|0|||
155205022|NCT02128113|560190335|FG001|Overall Study|Surgery cancelled|1|||
155205023|NCT02128113|560190336|FG002|Overall Study|Surgery cancelled|0|||
155205024|NCT02128113|560190334|FG000|Overall Study|Adverse Event|0|||
155205025|NCT02128113|560190335|FG001|Overall Study|Adverse Event|0|||
155205026|NCT02128113|560190336|FG002|Overall Study|Adverse Event|1|||
155205027|NCT00299104|560190337|FG000|Treatment Period|Adverse Event|14|||
155205028|NCT00299104|560190338|FG001|Treatment Period|Adverse Event|9|||
155205029|NCT00299104|560190339|FG002|Treatment Period|Adverse Event|7|||
155205030|NCT00299104|560190337|FG000|Treatment Period|Death|1|||
155205031|NCT00299104|560190338|FG001|Treatment Period|Death|1|||
155205032|NCT00299104|560190339|FG002|Treatment Period|Death|1|||
155205033|NCT00299104|560190337|FG000|Treatment Period|Insufficient therapeutic response|34|||
155205034|NCT00299104|560190338|FG001|Treatment Period|Insufficient therapeutic response|13|||
155205035|NCT00299104|560190339|FG002|Treatment Period|Insufficient therapeutic response|8|||
155205036|NCT00299104|560190337|FG000|Treatment Period|Failure to return|9|||
155205037|NCT00299104|560190338|FG001|Treatment Period|Failure to return|8|||
155205038|NCT00299104|560190339|FG002|Treatment Period|Failure to return|8|||
155205039|NCT00299104|560190337|FG000|Treatment Period|Violation of selection criteria|1|||
155205040|NCT00299104|560190338|FG001|Treatment Period|Violation of selection criteria|2|||
155205041|NCT00299104|560190339|FG002|Treatment Period|Violation of selection criteria|0|||
155205042|NCT00299104|560190337|FG000|Treatment Period|Protocol Violation|1|||
155205043|NCT00299104|560190338|FG001|Treatment Period|Protocol Violation|1|||
155205044|NCT00299104|560190339|FG002|Treatment Period|Protocol Violation|0|||
155205045|NCT00299104|560190337|FG000|Treatment Period|Refused treatment|9|||
155205046|NCT00299104|560190338|FG001|Treatment Period|Refused treatment|2|||
155205047|NCT00299104|560190339|FG002|Treatment Period|Refused treatment|2|||
155205048|NCT00299104|560190337|FG000|Treatment Period|Withdrew consent|14|||
155205049|NCT00299104|560190338|FG001|Treatment Period|Withdrew consent|19|||
155205050|NCT00299104|560190339|FG002|Treatment Period|Withdrew consent|9|||
155205051|NCT00299104|560190337|FG000|Treatment Period|Administrative reasons|106|||
155205052|NCT00299104|560190338|FG001|Treatment Period|Administrative reasons|120|||
155205053|NCT00299104|560190339|FG002|Treatment Period|Administrative reasons|137|||
155205054|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Death|3|||
155205055|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Death|2|||
155205056|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Death|1|||
155205057|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
155205058|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
155205059|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
155205060|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
155205061|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
155205062|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
155205063|NCT00299104|560190337|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
155205064|NCT00299104|560190338|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
155205065|NCT00299104|560190339|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
155205066|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
155205067|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
155205068|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
155205069|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
155205070|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
155205071|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
155205072|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
155205073|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
155205074|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
155205075|NCT00299104|560190337|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
155205076|NCT00299104|560190338|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
155205077|NCT00299104|560190339|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
155205078|NCT02969369|560190341|FG000|Study|Adverse Event|1|||
155205079|NCT02969369|560190342|FG001|Study|Adverse Event|6|||
155205080|NCT02969369|560190341|FG000|Study|Lack of Efficacy|0|||
155205081|NCT02969369|560190342|FG001|Study|Lack of Efficacy|1|||
155205082|NCT02969369|560190341|FG000|Study|Lost to Follow-up|0|||
155205083|NCT02969369|560190342|FG001|Study|Lost to Follow-up|1|||
155205084|NCT02969369|560190341|FG000|Study|Withdrawal by Subject|3|||
155205085|NCT02969369|560190342|FG001|Study|Withdrawal by Subject|5|||
155205086|NCT02969369|560190341|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
155205087|NCT02969369|560190342|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
155205088|NCT02969369|560190341|FG000|Double-blind Period|Adverse Event|1|||
155205089|NCT02969369|560190342|FG001|Double-blind Period|Adverse Event|5|||
155205090|NCT02969369|560190341|FG000|Double-blind Period|Lost to Follow-up|0|||
155205091|NCT02969369|560190342|FG001|Double-blind Period|Lost to Follow-up|1|||
155205092|NCT02969369|560190341|FG000|Double-blind Period|Withdrawal by Subject|2|||
155205093|NCT02969369|560190342|FG001|Double-blind Period|Withdrawal by Subject|3|||
155205094|NCT02969369|560190341|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
155205095|NCT02969369|560190342|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
155205096|NCT02969369|560190341|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
155205097|NCT02969369|560190342|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
155205098|NCT02969369|560190341|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
155205099|NCT02969369|560190342|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
155205100|NCT02969369|560190341|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
155205101|NCT02969369|560190342|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
155205102|NCT01484197|560190350|FG000|Treatment Period 1|Adverse Event|1|||
155205103|NCT01484197|560190351|FG001|Treatment Period 1|Adverse Event|0|||
155205104|NCT01484197|560190352|FG002|Treatment Period 1|Adverse Event|0|||
155205105|NCT01484197|560190353|FG003|Treatment Period 1|Adverse Event|0|||
155205106|NCT01484197|560190350|FG000|Treatment Period 2|Subject withdrew consent|0|||
155205107|NCT01484197|560190351|FG001|Treatment Period 2|Subject withdrew consent|0|||
155205108|NCT01484197|560190352|FG002|Treatment Period 2|Subject withdrew consent|0|||
155205109|NCT01484197|560190353|FG003|Treatment Period 2|Subject withdrew consent|1|||
155205110|NCT01727297|560190354|FG000|Overall Study|Death|13|||
155205111|NCT01727297|560190355|FG001|Overall Study|Death|0|||
155205112|NCT01727297|560190354|FG000|Overall Study|Protocol Violation|1|||
155205113|NCT01727297|560190355|FG001|Overall Study|Protocol Violation|10|||
155205114|NCT01727297|560190354|FG000|Overall Study|Adverse Event|3|||
155205115|NCT01727297|560190355|FG001|Overall Study|Adverse Event|1|||
155205116|NCT01727297|560190354|FG000|Overall Study|Lost to Follow-up|11|||
155205117|NCT01727297|560190355|FG001|Overall Study|Lost to Follow-up|0|||
155205118|NCT01727297|560190354|FG000|Overall Study|Withdrawal by Subject|26|||
155205119|NCT01727297|560190355|FG001|Overall Study|Withdrawal by Subject|27|||
155205120|NCT01727297|560190354|FG000|Overall Study|Physician Decision|19|||
155205121|NCT01727297|560190355|FG001|Overall Study|Physician Decision|5|||
155205122|NCT01727297|560190354|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
155205123|NCT01727297|560190355|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
155205124|NCT02042183|560190356|FG000|Overall Study|Physician Decision|7|||
155205125|NCT02042183|560190357|FG001|Overall Study|Physician Decision|2|||
155205126|NCT02042183|560190356|FG000|Overall Study|Lack of Efficacy|4|||
155205127|NCT02042183|560190357|FG001|Overall Study|Lack of Efficacy|3|||
155205128|NCT02042183|560190356|FG000|Overall Study|Non-compliance with Study Drug|2|||
155205129|NCT02042183|560190357|FG001|Overall Study|Non-compliance with Study Drug|3|||
155205130|NCT02042183|560190356|FG000|Overall Study|Adverse Event|17|||
155205131|NCT02042183|560190357|FG001|Overall Study|Adverse Event|6|||
155205132|NCT02042183|560190356|FG000|Overall Study|Other|3|||
155205133|NCT02042183|560190357|FG001|Overall Study|Other|3|||
155205134|NCT02042183|560190356|FG000|Overall Study|Withdrawal by Subject|21|||
155205135|NCT02042183|560190357|FG001|Overall Study|Withdrawal by Subject|16|||
155205136|NCT02042183|560190356|FG000|Overall Study|Site Terminated by Sponsor|2|||
155205137|NCT02042183|560190357|FG001|Overall Study|Site Terminated by Sponsor|1|||
155205138|NCT02042183|560190356|FG000|Overall Study|Lost to Follow-up|9|||
155205139|NCT02042183|560190357|FG001|Overall Study|Lost to Follow-up|2|||
155205140|NCT01192516|560190358|FG000|Overall Study|Lost to Follow-up|7|||
155205141|NCT01192516|560190359|FG001|Overall Study|Lost to Follow-up|10|||
155205142|NCT01192516|560190360|FG002|Overall Study|Lost to Follow-up|7|||
155205143|NCT01192516|560190358|FG000|Overall Study|Withdrawal by Subject|4|||
155205144|NCT01192516|560190359|FG001|Overall Study|Withdrawal by Subject|4|||
155205145|NCT01192516|560190360|FG002|Overall Study|Withdrawal by Subject|1|||
155205146|NCT01192516|560190358|FG000|Overall Study|started new treatment|5|||
155205147|NCT01192516|560190359|FG001|Overall Study|started new treatment|1|||
155205148|NCT01192516|560190360|FG002|Overall Study|started new treatment|0|||
155205149|NCT01192516|560190358|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
155205150|NCT01192516|560190359|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
155205151|NCT01192516|560190360|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
155205152|NCT02321800|560190368|FG000|Overall Study|Withdrawal by Subject|3|||
155205153|NCT02321800|560190369|FG001|Overall Study|Withdrawal by Subject|3|||
155205154|NCT02321800|560190368|FG000|Overall Study|Death|1|||
155205155|NCT02321800|560190369|FG001|Overall Study|Death|0|||
155205156|NCT02321800|560190368|FG000|Overall Study|Protocol Violation|1|||
155205157|NCT02321800|560190369|FG001|Overall Study|Protocol Violation|0|||
155205158|NCT02321800|560190368|FG000|Overall Study|Lost to Follow-up|10|||
155205159|NCT02321800|560190369|FG001|Overall Study|Lost to Follow-up|4|||
155205160|NCT02321800|560190368|FG000|Overall Study|Adverse Event|2|||
155205161|NCT02321800|560190369|FG001|Overall Study|Adverse Event|3|||
155205162|NCT02321800|560190368|FG000|Overall Study|Other, Miscellaneous|3|||
155205163|NCT02321800|560190369|FG001|Overall Study|Other, Miscellaneous|1|||
155205164|NCT01051323|560190370|FG000|Overall Study|Discontinuation of treatment|103|||
155205165|NCT01051323|560190370|FG000|Overall Study|Transplantation|28|||
155205166|NCT01051323|560190370|FG000|Overall Study|Dialysis dependency|22|||
155205167|NCT01051323|560190370|FG000|Overall Study|Withdrawal by Subject|13|||
155205168|NCT01051323|560190370|FG000|Overall Study|Lost to Follow-up|31|||
155205169|NCT01051323|560190370|FG000|Overall Study|Death|129|||
155205170|NCT01051323|560190370|FG000|Overall Study|Hospitalization|28|||
155205171|NCT01051323|560190370|FG000|Overall Study|Other|148|||
155205172|NCT01051323|560190370|FG000|Overall Study|Missing|37|||
155205173|NCT03926169|560190372|FG000|Period A|Adverse Event|2|||
155205174|NCT03926169|560190373|FG001|Period A|Adverse Event|2|||
155205175|NCT03926169|560190374|FG002|Period A|Adverse Event|1|||
155205176|NCT03926169|560190372|FG000|Period A|Withdrawal by Subject|2|||
155205177|NCT03926169|560190373|FG001|Period A|Withdrawal by Subject|2|||
155205178|NCT03926169|560190374|FG002|Period A|Withdrawal by Subject|2|||
155205179|NCT03926169|560190372|FG000|Period A|Lost to Follow-up|3|||
155205180|NCT03926169|560190373|FG001|Period A|Lost to Follow-up|1|||
155205181|NCT03926169|560190374|FG002|Period A|Lost to Follow-up|0|||
155205182|NCT03926169|560190372|FG000|Period A|Lack of Efficacy|0|||
155205183|NCT03926169|560190373|FG001|Period A|Lack of Efficacy|2|||
155205184|NCT03926169|560190374|FG002|Period A|Lack of Efficacy|2|||
155205185|NCT03926169|560190372|FG000|Period A|COVID-19 Infection|0|||
155205186|NCT03926169|560190373|FG001|Period A|COVID-19 Infection|1|||
155205187|NCT03926169|560190374|FG002|Period A|COVID-19 Infection|0|||
155205188|NCT03926169|560190372|FG000|Period A|COVID-19 Logistical Restrictions|0|||
155205189|NCT03926169|560190373|FG001|Period A|COVID-19 Logistical Restrictions|2|||
155205190|NCT03926169|560190374|FG002|Period A|COVID-19 Logistical Restrictions|1|||
155205191|NCT03926169|560190372|FG000|Period A|Other, Not Specified|1|||
155205192|NCT03926169|560190373|FG001|Period A|Other, Not Specified|0|||
155205193|NCT03926169|560190374|FG002|Period A|Other, Not Specified|0|||
155205194|NCT03926169|560190372|FG000|Period B|Adverse Event|3|||
155205195|NCT03926169|560190373|FG001|Period B|Adverse Event|1|||
155205196|NCT03926169|560190374|FG002|Period B|Adverse Event|1|||
155205197|NCT03926169|560190372|FG000|Period B|Withdrawal by Subject|1|||
155205198|NCT03926169|560190373|FG001|Period B|Withdrawal by Subject|3|||
155205199|NCT03926169|560190374|FG002|Period B|Withdrawal by Subject|0|||
155205200|NCT03926169|560190372|FG000|Period B|Lack of Efficacy|3|||
155205201|NCT03926169|560190373|FG001|Period B|Lack of Efficacy|1|||
155205202|NCT03926169|560190374|FG002|Period B|Lack of Efficacy|1|||
155205203|NCT03926169|560190372|FG000|Period B|Lost to Follow-up|1|||
155205204|NCT03926169|560190373|FG001|Period B|Lost to Follow-up|1|||
155205205|NCT03926169|560190374|FG002|Period B|Lost to Follow-up|4|||
155205206|NCT03926169|560190372|FG000|Period B|Other, Not Specified|62|||
155205207|NCT03926169|560190373|FG001|Period B|Other, Not Specified|57|||
155205208|NCT03926169|560190374|FG002|Period B|Other, Not Specified|65|||
155205209|NCT03302234|560190375|FG000|Overall Study|Death|191|||
155205210|NCT03302234|560190376|FG001|Overall Study|Death|192|||
155205211|NCT03302234|560190375|FG000|Overall Study|Withdrawal by Subject|2|||
155205212|NCT03302234|560190376|FG001|Overall Study|Withdrawal by Subject|2|||
155205213|NCT03302234|560190375|FG000|Overall Study|Sponsor Decision|90|||
155205214|NCT03302234|560190376|FG001|Overall Study|Sponsor Decision|89|||
155205215|NCT03302234|560190375|FG000|Overall Study|Laryngeal carcinoma|0|||
155205216|NCT03302234|560190376|FG001|Overall Study|Laryngeal carcinoma|1|||
155205217|NCT03302234|560190375|FG000|Overall Study|Not Reported|1|||
155205218|NCT03302234|560190376|FG001|Overall Study|Not Reported|0|||
155205219|NCT04112784|560190377|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
155205220|NCT04112784|560190377|FG000|Overall Study|Screen Failures|4|||
155205221|NCT02030041|560190379|FG000|Overall Study|Withdrawal by Subject|2|||
155205222|NCT02030041|560190380|FG001|Overall Study|Withdrawal by Subject|2|||
155205223|NCT02030041|560190381|FG002|Overall Study|Withdrawal by Subject|1|||
155205224|NCT00833794|560190382|FG000|Open-label Phase|Adverse Event|225|||
155205225|NCT00833794|560190383|FG001|Open-label Phase|Adverse Event|0|||
155205226|NCT00833794|560190382|FG000|Open-label Phase|Lack of Efficacy|28|||
155205227|NCT00833794|560190383|FG001|Open-label Phase|Lack of Efficacy|0|||
155205228|NCT00833794|560190382|FG000|Open-label Phase|Withdrawal by Subject|48|||
155205229|NCT00833794|560190383|FG001|Open-label Phase|Withdrawal by Subject|0|||
155205230|NCT00833794|560190382|FG000|Open-label Phase|Physician Decision|20|||
155205231|NCT00833794|560190383|FG001|Open-label Phase|Physician Decision|0|||
155205232|NCT00833794|560190382|FG000|Open-label Phase|Administrative reason|1|||
155205233|NCT00833794|560190383|FG001|Open-label Phase|Administrative reason|0|||
155205234|NCT00833794|560190382|FG000|Open-label Phase|Protocol Violation|47|||
155205235|NCT00833794|560190383|FG001|Open-label Phase|Protocol Violation|0|||
155205236|NCT00833794|560190382|FG000|Open-label Phase|Did not complete wash-out period|12|||
155205237|NCT00833794|560190383|FG001|Open-label Phase|Did not complete wash-out period|0|||
155205238|NCT00833794|560190382|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
155205239|NCT00833794|560190383|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
155205240|NCT00833794|560190382|FG000|Double-blind Phase|Adverse Event|44|||
155205241|NCT00833794|560190383|FG001|Double-blind Phase|Adverse Event|11|||
155205242|NCT00833794|560190382|FG000|Double-blind Phase|Lack of Efficacy|34|||
155205243|NCT00833794|560190383|FG001|Double-blind Phase|Lack of Efficacy|22|||
155205244|NCT00833794|560190382|FG000|Double-blind Phase|Withdrawal by Subject|23|||
155205245|NCT00833794|560190383|FG001|Double-blind Phase|Withdrawal by Subject|6|||
155205246|NCT00833794|560190382|FG000|Double-blind Phase|Physician Decision|4|||
155205247|NCT00833794|560190383|FG001|Double-blind Phase|Physician Decision|7|||
155205248|NCT00833794|560190382|FG000|Double-blind Phase|Administrative reason|1|||
155205249|NCT00833794|560190383|FG001|Double-blind Phase|Administrative reason|3|||
155205250|NCT01866930|560190387|FG000|Treatment Period|Other|1|||
155205251|NCT01866930|560190388|FG001|Treatment Period|Other|0|||
155205252|NCT01866930|560190387|FG000|Treatment Period|Death|0|||
155205253|NCT01866930|560190388|FG001|Treatment Period|Death|2|||
155205254|NCT01866930|560190387|FG000|Treatment Period|Poor/non compliance|0|||
155205255|NCT01866930|560190388|FG001|Treatment Period|Poor/non compliance|2|||
155205256|NCT01866930|560190387|FG000|Treatment Period|No longer meets study criteria|0|||
155205257|NCT01866930|560190388|FG001|Treatment Period|No longer meets study criteria|1|||
155205258|NCT01866930|560190387|FG000|Treatment Period|Withdrawal by Subject|2|||
155205259|NCT01866930|560190388|FG001|Treatment Period|Withdrawal by Subject|8|||
155205260|NCT01866930|560190387|FG000|Treatment Period|Lack of Efficacy|1|||
155205261|NCT01866930|560190388|FG001|Treatment Period|Lack of Efficacy|9|||
155205262|NCT01866930|560190387|FG000|Treatment Period|Adverse Event|4|||
155205263|NCT01866930|560190388|FG001|Treatment Period|Adverse Event|12|||
155205264|NCT01866930|560190387|FG000|Treatment Period|Lost to Follow-up|1|||
155205265|NCT01866930|560190388|FG001|Treatment Period|Lost to Follow-up|1|||
155205266|NCT01866930|560190387|FG000|Follow-up Period|Lost to Follow-up|1|||
155205267|NCT01866930|560190388|FG001|Follow-up Period|Lost to Follow-up|1|||
155205268|NCT01866930|560190387|FG000|Follow-up Period|Other|1|||
155205269|NCT01866930|560190388|FG001|Follow-up Period|Other|5|||
155205270|NCT01866930|560190387|FG000|Follow-up Period|No longer required per protocol|1|||
155205271|NCT01866930|560190388|FG001|Follow-up Period|No longer required per protocol|0|||
155205272|NCT01866930|560190387|FG000|Follow-up Period|Withdrawal by Subject|3|||
155205273|NCT01866930|560190388|FG001|Follow-up Period|Withdrawal by Subject|3|||
155205274|NCT00519831|560190391|FG000|Overall Study|Adverse Event|3|||
155205275|NCT02854631|560190392|FG000|Overall Study|Adverse Event|1|||
155205276|NCT02854631|560190393|FG001|Overall Study|Adverse Event|2|||
155205277|NCT02854631|560190392|FG000|Overall Study|Withdrew Consent|3|||
155205278|NCT02854631|560190393|FG001|Overall Study|Withdrew Consent|2|||
155205279|NCT02854631|560190392|FG000|Overall Study|Investigator's Discretion|2|||
155205280|NCT02854631|560190393|FG001|Overall Study|Investigator's Discretion|0|||
155205281|NCT02854631|560190392|FG000|Overall Study|Death|12|||
155205282|NCT02854631|560190393|FG001|Overall Study|Death|8|||
155205283|NCT02854631|560190392|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
155205284|NCT02854631|560190393|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
155205285|NCT02854631|560190392|FG000|Overall Study|Protocol Violation|0|||
155205286|NCT02854631|560190393|FG001|Overall Study|Protocol Violation|1|||
155205287|NCT02854631|560190392|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
155205288|NCT02854631|560190393|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
155205289|NCT02854631|560190392|FG000|Overall Study|Lost to Follow-up|4|||
155205290|NCT02854631|560190393|FG001|Overall Study|Lost to Follow-up|2|||
155205291|NCT02862171|560190394|FG000|Overall Study|Death|1|||
155205292|NCT02862171|560190394|FG000|Overall Study|Lost to Follow-up|13|||
155205293|NCT02862171|560190394|FG000|Overall Study|Withdrawal by Subject|57|||
155205294|NCT02862171|560190394|FG000|Overall Study|Non-compliance|4|||
155205295|NCT02862171|560190394|FG000|Overall Study|HIV-1 seroconversion|18|||
155205296|NCT03930797|560190395|FG000|Overall Study|Lost to Follow-up|3|||
155205297|NCT03930797|560190396|FG001|Overall Study|Lost to Follow-up|10|||
155205298|NCT00662012|560190397|FG000|Overall Study|Lost to Follow-up|85|||
155205299|NCT00662012|560190397|FG000|Overall Study|Death|1|||
155205300|NCT00662012|560190397|FG000|Overall Study|Withdrawal by Subject|1|||
155205301|NCT00753415|560190398|FG000|Part A|Disease progression|1|||
155205302|NCT00753415|560190399|FG001|Part A|Disease progression|0|||
155205303|NCT00753415|560190400|FG002|Part A|Disease progression|1|||
155205304|NCT00753415|560190401|FG003|Part A|Disease progression|2|||
155205305|NCT00753415|560190402|FG004|Part A|Disease progression|0|||
155205306|NCT00753415|560190403|FG005|Part A|Disease progression|0|||
155205307|NCT00753415|560190404|FG006|Part A|Disease progression|0|||
155205308|NCT00753415|560190405|FG007|Part A|Disease progression|0|||
155205309|NCT00753415|560190406|FG008|Part A|Disease progression|0|||
155205310|NCT00753415|560190407|FG009|Part A|Disease progression|0|||
155205311|NCT00753415|560190398|FG000|Part A|Withdrawal by Subject|0|||
155205312|NCT00753415|560190399|FG001|Part A|Withdrawal by Subject|0|||
155205313|NCT00753415|560190400|FG002|Part A|Withdrawal by Subject|1|||
155205314|NCT00753415|560190401|FG003|Part A|Withdrawal by Subject|0|||
155205315|NCT00753415|560190402|FG004|Part A|Withdrawal by Subject|0|||
155205316|NCT00753415|560190403|FG005|Part A|Withdrawal by Subject|0|||
155205317|NCT00753415|560190404|FG006|Part A|Withdrawal by Subject|0|||
155205318|NCT00753415|560190405|FG007|Part A|Withdrawal by Subject|0|||
155205319|NCT00753415|560190406|FG008|Part A|Withdrawal by Subject|0|||
155205320|NCT00753415|560190407|FG009|Part A|Withdrawal by Subject|0|||
155205321|NCT00753415|560190398|FG000|Part B|Lost to Follow-up|0|||
155205322|NCT00753415|560190399|FG001|Part B|Lost to Follow-up|0|||
155205323|NCT00753415|560190400|FG002|Part B|Lost to Follow-up|0|||
155205324|NCT00753415|560190401|FG003|Part B|Lost to Follow-up|0|||
155205325|NCT00753415|560190402|FG004|Part B|Lost to Follow-up|0|||
155205326|NCT00753415|560190403|FG005|Part B|Lost to Follow-up|0|||
155205327|NCT00753415|560190404|FG006|Part B|Lost to Follow-up|0|||
155205328|NCT00753415|560190405|FG007|Part B|Lost to Follow-up|1|||
155205329|NCT00753415|560190406|FG008|Part B|Lost to Follow-up|1|||
155205330|NCT00753415|560190407|FG009|Part B|Lost to Follow-up|0|||
155205331|NCT00753415|560190398|FG000|Part B|Disease progression|0|||
155205332|NCT00753415|560190399|FG001|Part B|Disease progression|0|||
155205333|NCT00753415|560190400|FG002|Part B|Disease progression|0|||
155205334|NCT00753415|560190401|FG003|Part B|Disease progression|0|||
155205335|NCT00753415|560190402|FG004|Part B|Disease progression|0|||
155205336|NCT00753415|560190403|FG005|Part B|Disease progression|0|||
155205337|NCT00753415|560190404|FG006|Part B|Disease progression|0|||
155205338|NCT00753415|560190405|FG007|Part B|Disease progression|0|||
155205339|NCT00753415|560190406|FG008|Part B|Disease progression|2|||
155205340|NCT00753415|560190407|FG009|Part B|Disease progression|1|||
155205341|NCT02700815|560192094|FG000|Overall Study|Adverse Event|0|||
155205342|NCT02700815|560192095|FG001|Overall Study|Adverse Event|6|||
155205343|NCT02700815|560192096|FG002|Overall Study|Adverse Event|2|||
155205344|NCT02700815|560192097|FG003|Overall Study|Adverse Event|3|||
155205345|NCT02700815|560192094|FG000|Overall Study|Lack of Efficacy|0|||
155205346|NCT02700815|560192095|FG001|Overall Study|Lack of Efficacy|0|||
155205347|NCT02700815|560192096|FG002|Overall Study|Lack of Efficacy|1|||
155205348|NCT02700815|560192097|FG003|Overall Study|Lack of Efficacy|2|||
155205349|NCT02700815|560192094|FG000|Overall Study|Lost to Follow-up|1|||
155205350|NCT02700815|560192095|FG001|Overall Study|Lost to Follow-up|0|||
155205351|NCT02700815|560192096|FG002|Overall Study|Lost to Follow-up|0|||
155205352|NCT02700815|560192097|FG003|Overall Study|Lost to Follow-up|1|||
155205353|NCT02700815|560192094|FG000|Overall Study|Refusal to continue medication|0|||
155205354|NCT02700815|560192095|FG001|Overall Study|Refusal to continue medication|1|||
155205355|NCT02700815|560192096|FG002|Overall Study|Refusal to continue medication|0|||
155205356|NCT02700815|560192097|FG003|Overall Study|Refusal to continue medication|1|||
155205357|NCT02700815|560192094|FG000|Overall Study|Withdrawal by Subject|0|||
155205358|NCT02700815|560192095|FG001|Overall Study|Withdrawal by Subject|0|||
155205359|NCT02700815|560192096|FG002|Overall Study|Withdrawal by Subject|1|||
155205360|NCT02700815|560192097|FG003|Overall Study|Withdrawal by Subject|0|||
155205361|NCT02324569|560192103|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
155205362|NCT02324569|560192104|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
155205363|NCT02324569|560192103|FG000|Overall Study|Voluntary Withdrawal|3|||
155205364|NCT02324569|560192104|FG001|Overall Study|Voluntary Withdrawal|6|||
155205365|NCT02324569|560192103|FG000|Overall Study|Lack of Efficacy|2|||
155205366|NCT02324569|560192104|FG001|Overall Study|Lack of Efficacy|3|||
155205367|NCT02324569|560192103|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
155205368|NCT02324569|560192104|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
155205369|NCT02324569|560192103|FG000|Overall Study|Inconvenient Schedule|2|||
155205370|NCT02324569|560192104|FG001|Overall Study|Inconvenient Schedule|0|||
155205371|NCT00085631|560192109|FG000|Overall Study|Missing Data|4|||
155205372|NCT00085631|560192110|FG001|Overall Study|Missing Data|11|||
155205373|NCT00085631|560192111|FG002|Overall Study|Missing Data|7|||
155205374|NCT01513473|560192112|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
155205375|NCT01513473|560192113|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
155205376|NCT01513473|560192112|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
155205377|NCT01513473|560192113|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
155205378|NCT01513473|560192112|FG000|Main Trial (26 Weeks)|Unclassified|0|||
155205379|NCT01513473|560192113|FG001|Main Trial (26 Weeks)|Unclassified|2|||
155205380|NCT01513473|560192112|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
155205381|NCT01513473|560192113|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
155205382|NCT01513473|560192112|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
155205383|NCT01513473|560192113|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
155205384|NCT00743340|560192118|FG000|Overall Study|Study medication non-compliance|1|||
155205385|NCT00743340|560192118|FG000|Overall Study|Lost to Follow-up|1|||
155205386|NCT00743340|560192118|FG000|Overall Study|Withdrawal from the Study|5|||
155205387|NCT00743340|560192118|FG000|Overall Study|Protocol Violation|1|||
155205388|NCT00743340|560192118|FG000|Overall Study|Virologic failure|8|||
155205389|NCT00743340|560192118|FG000|Overall Study|Pregnancy|1|||
155205390|NCT00743340|560192118|FG000|Overall Study|Rolled over to other Gilead Study|23|||
155205391|NCT00743340|560192118|FG000|Overall Study|Participant Relocated|1|||
155205392|NCT01425281|560192119|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
155205393|NCT01425281|560192120|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
155205394|NCT01425281|560192119|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
155205395|NCT01425281|560192120|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
155205396|NCT01425281|560192119|FG000|At 180-day Clinical Follow-up|Death|0|||
155205397|NCT01425281|560192120|FG001|At 180-day Clinical Follow-up|Death|1|||
155205398|NCT01425281|560192119|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
155205399|NCT01425281|560192120|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
155205400|NCT01425281|560192119|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
155205401|NCT01425281|560192120|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
155205402|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
155205403|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
155205404|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Death|2|||
155205405|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Death|0|||
155205406|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
155205407|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
155205408|NCT01425281|560192119|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
155205409|NCT01425281|560192120|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
155205410|NCT01425281|560192119|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
155205411|NCT01425281|560192120|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
155205412|NCT01425281|560192119|FG000|At 3-year Clinical Follow-up|Death|2|||
155205413|NCT01425281|560192120|FG001|At 3-year Clinical Follow-up|Death|3|||
155205414|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Death|7|||
155205415|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Death|3|||
155205416|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
155205417|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
155205418|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
155205419|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
155205420|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
155205421|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
155205422|NCT01425281|560192119|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
155205423|NCT01425281|560192120|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
155205424|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Death|2|||
155205425|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Death|0|||
155205426|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
155205427|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
155205428|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
155205429|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
155205430|NCT01425281|560192119|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
155205431|NCT01425281|560192120|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
155205432|NCT03266107|560192121|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
155205433|NCT03266107|560192121|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
155205434|NCT03266107|560192121|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
155205435|NCT03266107|560192121|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
155205436|NCT02548650|560192122|FG000|Triple Therapy|Adverse Event|1|||
155205437|NCT02548650|560192123|FG001|Triple Therapy|Adverse Event|0|||
155205438|NCT02548650|560192122|FG000|Triple Therapy|Withdrawal by Subject|0|||
155205439|NCT02548650|560192123|FG001|Triple Therapy|Withdrawal by Subject|4|||
155205440|NCT02548650|560192122|FG000|Double Therapy|Adverse Event|1|||
155205441|NCT02548650|560192123|FG001|Double Therapy|Adverse Event|1|||
155205442|NCT02548650|560192122|FG000|Double Therapy|Withdrawal by Subject|0|||
155205443|NCT02548650|560192123|FG001|Double Therapy|Withdrawal by Subject|1|||
155205444|NCT01191801|560192124|FG000|Overall Study|Death|36|||
155205445|NCT01191801|560192125|FG001|Overall Study|Death|12|||
155205446|NCT01191801|560192124|FG000|Overall Study|Lack of Efficacy|176|||
155205447|NCT01191801|560192125|FG001|Overall Study|Lack of Efficacy|258|||
155205448|NCT01191801|560192124|FG000|Overall Study|Adverse Event|9|||
155205449|NCT01191801|560192125|FG001|Overall Study|Adverse Event|8|||
155205450|NCT01191801|560192124|FG000|Overall Study|Protocol Violation|2|||
155205451|NCT01191801|560192125|FG001|Overall Study|Protocol Violation|4|||
155205452|NCT01191801|560192124|FG000|Overall Study|Physician Decision|47|||
155205453|NCT01191801|560192125|FG001|Overall Study|Physician Decision|24|||
155205454|NCT01191801|560192124|FG000|Overall Study|Withdrawal by Subject|1|||
155205455|NCT01191801|560192125|FG001|Overall Study|Withdrawal by Subject|4|||
155205456|NCT01191801|560192124|FG000|Overall Study|Not Provided|45|||
155205457|NCT01191801|560192125|FG001|Overall Study|Not Provided|27|||
155205458|NCT00814164|560192126|FG000|Overall Study|Progression|7|||
155205459|NCT00814164|560192126|FG000|Overall Study|not stated|7|||
155205460|NCT00814164|560192126|FG000|Overall Study|Death|5|||
155205461|NCT01980992|560192127|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
155205462|NCT01980992|560192128|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
155205463|NCT01980992|560192127|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
155205464|NCT01980992|560192128|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
155205465|NCT01980992|560192127|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
155205466|NCT01980992|560192128|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
155205467|NCT01980992|560192127|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
155205468|NCT01980992|560192128|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
155205469|NCT01980992|560192127|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
155205470|NCT01980992|560192128|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
155205471|NCT01980992|560192127|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
155205472|NCT01980992|560192128|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
155205473|NCT01169493|560192136|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
155205474|NCT01169493|560192137|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
155205475|NCT01169493|560192138|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
155205476|NCT01169493|560192139|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
155205477|NCT01169493|560192140|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
155205478|NCT01169493|560192141|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
155205479|NCT01169493|560192136|FG000|Period 3 (6 Months)|Adverse Event|0|||
155205480|NCT01169493|560192137|FG001|Period 3 (6 Months)|Adverse Event|1|||
155205481|NCT01169493|560192138|FG002|Period 3 (6 Months)|Adverse Event|0|||
155205482|NCT01169493|560192139|FG003|Period 3 (6 Months)|Adverse Event|0|||
155205483|NCT01169493|560192140|FG004|Period 3 (6 Months)|Adverse Event|0|||
155205484|NCT01169493|560192141|FG005|Period 3 (6 Months)|Adverse Event|0|||
155205485|NCT01169493|560192136|FG000|Period 3 (6 Months)|Physician Decision|0|||
155205486|NCT01169493|560192137|FG001|Period 3 (6 Months)|Physician Decision|1|||
155205487|NCT01169493|560192138|FG002|Period 3 (6 Months)|Physician Decision|1|||
155205488|NCT01169493|560192139|FG003|Period 3 (6 Months)|Physician Decision|0|||
155205489|NCT01169493|560192140|FG004|Period 3 (6 Months)|Physician Decision|0|||
155205490|NCT01169493|560192141|FG005|Period 3 (6 Months)|Physician Decision|0|||
155205491|NCT05228132|560192142|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
155205492|NCT05228132|560192142|FG000|Overall Study|Adverse Event|3|||
155205493|NCT05228132|560192142|FG000|Overall Study|Lost to Follow-up|1|||
155205494|NCT05228132|560192142|FG000|Overall Study|Arteriovenous-fistula mature|1|||
155205495|NCT02627144|560192145|FG000|Overall Study|Serious adverse event|32|||
155205496|NCT02627144|560192145|FG000|Overall Study|Cancer progression|171|||
155205497|NCT02627144|560192145|FG000|Overall Study|Death from cancer|20|||
155205498|NCT02627144|560192145|FG000|Overall Study|Death from other cause|8|||
155205499|NCT02627144|560192145|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
155205500|NCT02627144|560192145|FG000|Overall Study|Administrative reasons|65|||
155205501|NCT02627144|560192145|FG000|Overall Study|Lost to Follow-up|8|||
155205502|NCT02627144|560192145|FG000|Overall Study|Enrolled, not treated|6|||
155205503|NCT02627144|560192145|FG000|Overall Study|Other|17|||
155205504|NCT02651922|560192151|FG000|Overall Study|due to exclusion criteria|2|||
155205505|NCT03018704|560192154|FG000|Overall Study|Lost to Follow-up|1|||
155205506|NCT03018704|560192155|FG001|Overall Study|Lost to Follow-up|1|||
155205507|NCT00642460|560192156|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205508|NCT00642460|560192157|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
155205509|NCT00642460|560192158|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
155205510|NCT00642460|560192159|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205511|NCT00642460|560192160|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205512|NCT00642460|560192161|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
155205513|NCT00642460|560192156|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
155205514|NCT00642460|560192157|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205515|NCT00642460|560192158|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205516|NCT00642460|560192159|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205517|NCT00642460|560192160|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205518|NCT00642460|560192161|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
155205519|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
155205520|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
155205521|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205522|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205523|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205524|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
155205525|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Death|0|||
155205526|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Death|1|||
155205527|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Death|0|||
155205528|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Death|2|||
155205529|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Death|0|||
155205530|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Death|0|||
155205531|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
155205532|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
155205533|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205534|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205535|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205536|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
155205537|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
155205538|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
155205539|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205540|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205541|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205542|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
155205543|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205544|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
155205545|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205546|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205547|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205548|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
155205549|NCT00642460|560192156|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205550|NCT00642460|560192157|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205551|NCT00642460|560192158|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205552|NCT00642460|560192159|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
155205553|NCT00642460|560192160|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205554|NCT00642460|560192161|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
155205555|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205556|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205557|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205558|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
155205559|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
155205560|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
155205561|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205562|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205563|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205564|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
155205565|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
155205566|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
155205567|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205568|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205569|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205570|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
155205571|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
155205572|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
155205573|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205574|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205575|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205576|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
155205577|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
155205578|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
155205579|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Other|0|||
155205580|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Other|0|||
155205581|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Other|0|||
155205582|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Other|0|||
155205583|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Other|2|||
155205584|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Other|2|||
155205585|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Death|0|||
155205586|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Death|0|||
155205587|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Death|0|||
155205588|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Death|0|||
155205589|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Death|0|||
155205590|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Death|3|||
155205591|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205592|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205593|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205594|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205595|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
155205596|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
155205597|NCT00642460|560192156|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205598|NCT00642460|560192157|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205599|NCT00642460|560192158|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205600|NCT00642460|560192159|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
155205601|NCT00642460|560192160|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
155205602|NCT00642460|560192161|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
155205603|NCT04448171|560192162|FG000|Overall Study|Procedure Cancelled|1|||
155205604|NCT04448171|560192163|FG001|Overall Study|Procedure Cancelled|0|||
155205605|NCT04448171|560192162|FG000|Overall Study|Protocol Violation|1|||
155205606|NCT04448171|560192163|FG001|Overall Study|Protocol Violation|0|||
155205607|NCT01025752|560192172|FG000|Overall Study|Lost to Follow-up|7|||
155205608|NCT01025752|560192173|FG001|Overall Study|Lost to Follow-up|10|||
155205609|NCT01025752|560192172|FG000|Overall Study|Physician Decision|1|||
155205610|NCT01025752|560192173|FG001|Overall Study|Physician Decision|3|||
155205611|NCT00211809|560192174|FG000|Overall Study|Lack of Efficacy|1|||
155205612|NCT00211809|560192174|FG000|Overall Study|Lost to Follow-up|2|||
155205613|NCT00211809|560192174|FG000|Overall Study|Pregnancy|1|||
155205614|NCT00211809|560192174|FG000|Overall Study|side effects|2|||
155205615|NCT00023764|560192175|FG000|Overall Study|Other|1|||
155205616|NCT00023764|560192175|FG000|Overall Study|Adverse Event|4|||
155205617|NCT00023764|560192175|FG000|Overall Study|Withdrawal by Subject|1|||
155205618|NCT00023764|560192175|FG000|Overall Study|Progression of disease|6|||
155205619|NCT00023764|560192175|FG000|Overall Study|patient received other treatment|1|||
155205620|NCT00023764|560192175|FG000|Overall Study|delay in obtaining staging images|1|||
155205621|NCT01537393|560192176|FG000|Overall Study|Exclude prior to study|32|||
155205622|NCT01537393|560192177|FG001|Overall Study|Exclude prior to study|44|||
155205623|NCT01537393|560192176|FG000|Overall Study|Death|20|||
155205624|NCT01537393|560192177|FG001|Overall Study|Death|32|||
155205625|NCT01537393|560192176|FG000|Overall Study|Withdrawal by Subject|18|||
155205626|NCT01537393|560192177|FG001|Overall Study|Withdrawal by Subject|17|||
155205627|NCT01537393|560192176|FG000|Overall Study|Lost to Follow-up|53|||
155205628|NCT01537393|560192177|FG001|Overall Study|Lost to Follow-up|48|||
155205629|NCT01537393|560192176|FG000|Overall Study|Failure - Regrafted|28|||
155205630|NCT01537393|560192177|FG001|Overall Study|Failure - Regrafted|43|||
155205631|NCT01537393|560192176|FG000|Overall Study|Failure - Not regrafted|2|||
155205632|NCT01537393|560192177|FG001|Overall Study|Failure - Not regrafted|6|||
155205633|NCT01537393|560192176|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
155205634|NCT01537393|560192177|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
155205635|NCT01697566|560192181|FG000|Overall Study|Withdrawal by Subject|0|||
155205636|NCT01697566|560192182|FG001|Overall Study|Withdrawal by Subject|0|||
155205637|NCT01697566|560192183|FG002|Overall Study|Withdrawal by Subject|1|||
155205638|NCT01697566|560192184|FG003|Overall Study|Withdrawal by Subject|1|||
155205639|NCT01697566|560192181|FG000|Overall Study|Final biopsy not obtained|0|||
155205640|NCT01697566|560192182|FG001|Overall Study|Final biopsy not obtained|0|||
155205641|NCT01697566|560192183|FG002|Overall Study|Final biopsy not obtained|1|||
155205642|NCT01697566|560192184|FG003|Overall Study|Final biopsy not obtained|0|||
155205643|NCT00459953|560192186|FG000|Overall Study|not analyzed-household member in study|1|||
155205644|NCT00459953|560192187|FG001|Overall Study|not analyzed-household member in study|1|||
155205645|NCT01447433|560192188|FG000|Overall Study|Lost to Follow-up|0|||
155205646|NCT01447433|560192189|FG001|Overall Study|Lost to Follow-up|2|||
155205647|NCT01447433|560192188|FG000|Overall Study|Withdrawal by Subject|3|||
155205648|NCT01447433|560192189|FG001|Overall Study|Withdrawal by Subject|3|||
155205649|NCT01447433|560192188|FG000|Overall Study|Protocol Violation|1|||
155205650|NCT01447433|560192189|FG001|Overall Study|Protocol Violation|1|||
155205651|NCT00036270|560192190|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
155205652|NCT00036270|560192191|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
155205653|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
155205654|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
155205655|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
155205656|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
155205657|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
155205658|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
155205659|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Other|277|||
155205660|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Other|288|||
155205661|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
155205662|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
155205663|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
155205664|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
155205665|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
155205666|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
155205667|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
155205668|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
155205669|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
155205670|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
155205671|NCT00036270|560192190|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
155205672|NCT00036270|560192191|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
155205673|NCT00496470|560192192|FG000|Overall Study|Adverse Event|8|||
155205674|NCT00496470|560192193|FG001|Overall Study|Adverse Event|10|||
155205675|NCT00496470|560192192|FG000|Overall Study|Withdrawal by Subject|5|||
155205676|NCT00496470|560192193|FG001|Overall Study|Withdrawal by Subject|12|||
155205677|NCT00496470|560192192|FG000|Overall Study|Incorrectly enrolled|13|||
155205678|NCT00496470|560192193|FG001|Overall Study|Incorrectly enrolled|5|||
155205679|NCT00496470|560192192|FG000|Overall Study|Other reason|0|||
155205680|NCT00496470|560192193|FG001|Overall Study|Other reason|2|||
155205681|NCT02516163|560192194|FG000|Overall Study|Withdrawal by Subject|1|||
155205682|NCT02516163|560192194|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
155205683|NCT02516163|560192194|FG000|Overall Study|Unfit/delay in surgery|3|||
155205684|NCT02516163|560192194|FG000|Overall Study|Use of incorrect measurement technique|5|||
155205685|NCT02516163|560192194|FG000|Overall Study|Data not recorded|2|||
155205686|NCT02516163|560192194|FG000|Overall Study|MRI contraindication exclusion|6|||
155205687|NCT01217814|560192195|FG000|Overall Study|Adverse Event|1|||
155205688|NCT01217814|560192196|FG001|Overall Study|Adverse Event|1|||
155205689|NCT01217814|560192197|FG002|Overall Study|Adverse Event|0|||
155205690|NCT01217814|560192195|FG000|Overall Study|Lack of Efficacy|0|||
155205691|NCT01217814|560192196|FG001|Overall Study|Lack of Efficacy|0|||
155205692|NCT01217814|560192197|FG002|Overall Study|Lack of Efficacy|1|||
155205693|NCT01370356|560192198|FG000|Overall Study|Death|1|||
155205694|NCT01370356|560192199|FG001|Overall Study|Death|0|||
155205695|NCT01370356|560192198|FG000|Overall Study|Lack of Efficacy|6|||
155205696|NCT01370356|560192199|FG001|Overall Study|Lack of Efficacy|28|||
155205697|NCT01370356|560192198|FG000|Overall Study|Lost to Follow-up|76|||
155205698|NCT01370356|560192199|FG001|Overall Study|Lost to Follow-up|81|||
155205699|NCT01370356|560192198|FG000|Overall Study|Withdrawal by Subject|54|||
155205700|NCT01370356|560192199|FG001|Overall Study|Withdrawal by Subject|59|||
155205701|NCT01370356|560192198|FG000|Overall Study|Reason not specified|39|||
155205702|NCT01370356|560192199|FG001|Overall Study|Reason not specified|43|||
155205703|NCT01370356|560192198|FG000|Overall Study|Protocol Violation|3|||
155205704|NCT01370356|560192199|FG001|Overall Study|Protocol Violation|3|||
155205705|NCT01370356|560192198|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
155205706|NCT01370356|560192199|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
155205707|NCT01370356|560192198|FG000|Overall Study|AE Not Related to Study Drug|1|||
155205708|NCT01370356|560192199|FG001|Overall Study|AE Not Related to Study Drug|4|||
155205709|NCT00729651|560192202|FG000|Overall Study|Withdrawal by Subject|5|||
155205710|NCT00729651|560192203|FG001|Overall Study|Withdrawal by Subject|6|||
155205711|NCT00729651|560192202|FG000|Overall Study|Lost to Follow-up|5|||
155205712|NCT00729651|560192203|FG001|Overall Study|Lost to Follow-up|4|||
155205713|NCT00729651|560192202|FG000|Overall Study|Protocol Violation|0|||
155205714|NCT00729651|560192203|FG001|Overall Study|Protocol Violation|1|||
155205715|NCT00729651|560192202|FG000|Overall Study|Adverse Event|7|||
155205716|NCT00729651|560192203|FG001|Overall Study|Adverse Event|3|||
155205717|NCT00729651|560192202|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
155205718|NCT00729651|560192203|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
155205719|NCT00729651|560192202|FG000|Overall Study|Subject's private reason|2|||
155205720|NCT00729651|560192203|FG001|Overall Study|Subject's private reason|0|||
155205721|NCT01874054|560192204|FG000|Overall Study|Withdrawal by Subject|3|||
155205722|NCT01874054|560192204|FG000|Overall Study|Study Termination by Sponsor|42|||
155205723|NCT01874054|560192204|FG000|Overall Study|Lost to Follow-up|5|||
155205724|NCT01874054|560192204|FG000|Overall Study|Death|5|||
155205725|NCT01844518|560192208|FG000|Overall Study|Adverse Event|7|||
155205726|NCT01844518|560192209|FG001|Overall Study|Adverse Event|1|||
155205727|NCT01844518|560192208|FG000|Overall Study|Lack of Efficacy|17|||
155205728|NCT01844518|560192209|FG001|Overall Study|Lack of Efficacy|5|||
155205729|NCT01844518|560192208|FG000|Overall Study|Participant's request to discontinue|4|||
155205730|NCT01844518|560192209|FG001|Overall Study|Participant's request to discontinue|1|||
155205731|NCT01844518|560192208|FG000|Overall Study|Poor/Non-compliance|1|||
155205732|NCT01844518|560192209|FG001|Overall Study|Poor/Non-compliance|0|||
155205733|NCT01844518|560192208|FG000|Overall Study|No Longer Met Study Criteria|2|||
155205734|NCT01844518|560192209|FG001|Overall Study|No Longer Met Study Criteria|0|||
155205735|NCT01844518|560192208|FG000|Overall Study|Withdrawal by Subject|9|||
155205736|NCT01844518|560192209|FG001|Overall Study|Withdrawal by Subject|0|||
155205737|NCT01844518|560192208|FG000|Overall Study|Pregnancy|1|||
155205738|NCT01844518|560192209|FG001|Overall Study|Pregnancy|0|||
155205739|NCT01217801|560192210|FG000|Period 1|Protocol Violation|1|||
155205740|NCT01217801|560192211|FG001|Period 1|Protocol Violation|1|||
155205741|NCT01217801|560192210|FG000|Period 1|Withdrawal by Subject|0|||
155205742|NCT01217801|560192211|FG001|Period 1|Withdrawal by Subject|1|||
155205743|NCT00291577|560192212|FG000|Overall Study|Adverse Event|1|||
155205744|NCT00291577|560192212|FG000|Overall Study|Other|4|||
155205745|NCT00291577|560192212|FG000|Overall Study|Withdrawal by Subject|2|||
155205746|NCT00291577|560192212|FG000|Overall Study|Lack of Efficacy|14|||
155205747|NCT01197560|560192215|FG000|Overall Study|Adverse Event|6|||
155205748|NCT01197560|560192216|FG001|Overall Study|Adverse Event|8|||
155205749|NCT01197560|560192215|FG000|Overall Study|Death|3|||
155205750|NCT01197560|560192216|FG001|Overall Study|Death|5|||
155205751|NCT01197560|560192215|FG000|Overall Study|Withdrawal by Subject|1|||
155205752|NCT01197560|560192216|FG001|Overall Study|Withdrawal by Subject|1|||
155205753|NCT01197560|560192215|FG000|Overall Study|Disease progression|40|||
155205754|NCT01197560|560192216|FG001|Overall Study|Disease progression|35|||
155205755|NCT01197560|560192215|FG000|Overall Study|Miscellaneous|4|||
155205756|NCT01197560|560192216|FG001|Overall Study|Miscellaneous|3|||
155205757|NCT01197560|560192215|FG000|Overall Study|Missing|0|||
155205758|NCT01197560|560192216|FG001|Overall Study|Missing|1|||
155205759|NCT00621153|560192221|FG000|Overall Study|Safety Reason|8|||
155205760|NCT00621153|560192222|FG001|Overall Study|Safety Reason|7|||
155205761|NCT00621153|560192221|FG000|Overall Study|Adverse Event|3|||
155205762|NCT00621153|560192222|FG001|Overall Study|Adverse Event|2|||
155205763|NCT00621153|560192221|FG000|Overall Study|Lost to Follow-up|5|||
155205764|NCT00621153|560192222|FG001|Overall Study|Lost to Follow-up|1|||
155205765|NCT00621153|560192221|FG000|Overall Study|Withdrawal by Subject|4|||
155205766|NCT00621153|560192222|FG001|Overall Study|Withdrawal by Subject|5|||
155205767|NCT04212650|560192223|FG000|Overall Study|Withdrawal by Subject|1|||
155205768|NCT04212650|560192224|FG001|Overall Study|Withdrawal by Subject|0|||
155205769|NCT00357968|560192229|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
155205770|NCT00357968|560192230|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
155205771|NCT00357968|560192229|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
155205772|NCT00357968|560192230|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
155205773|NCT00679302|560192232|FG000|Overall Study|Lost to Follow-up|8|||
155205774|NCT00679302|560192233|FG001|Overall Study|Lost to Follow-up|4|||
155205775|NCT03547687|560192234|FG000|Overall Study|Withdrawal by Subject|1|||
155205776|NCT03547687|560192234|FG000|Overall Study|Death|1|||
155205777|NCT04656691|560192237|FG000|Overall Study|Adverse Event|1|||
155205778|NCT02846779|560192240|FG000|Overall Study|Lost Enrollment|83|||
155205779|NCT02846779|560192241|FG001|Overall Study|Lost Enrollment|82|||
155205780|NCT02846779|560192242|FG002|Overall Study|Lost Enrollment|86|||
155205781|NCT02846779|560192240|FG000|Overall Study|Less than 31 days of follow-up|56|||
155205782|NCT02846779|560192241|FG001|Overall Study|Less than 31 days of follow-up|45|||
155205783|NCT02846779|560192242|FG002|Overall Study|Less than 31 days of follow-up|52|||
155205784|NCT01753856|560192245|FG000|Overall Study|Adverse Event|1|||
155205785|NCT01753856|560192246|FG001|Overall Study|Adverse Event|0|||
155205786|NCT01753856|560192245|FG000|Overall Study|Withdrawal by Subject|0|||
155205787|NCT01753856|560192246|FG001|Overall Study|Withdrawal by Subject|2|||
155205788|NCT01753856|560192245|FG000|Overall Study|Sponsor Decision|2|||
155205789|NCT01753856|560192246|FG001|Overall Study|Sponsor Decision|0|||
155205790|NCT00887978|560192247|FG000|Overall Study|Adverse Event|18|||
155205791|NCT00887978|560192248|FG001|Overall Study|Adverse Event|5|||
155205792|NCT00887978|560192247|FG000|Overall Study|Clinical Worsening|4|||
155205793|NCT00887978|560192248|FG001|Overall Study|Clinical Worsening|4|||
155205794|NCT00887978|560192247|FG000|Overall Study|Death|2|||
155205795|NCT00887978|560192248|FG001|Overall Study|Death|3|||
155205796|NCT00887978|560192247|FG000|Overall Study|Withdrawal by Subject|1|||
155205797|NCT00887978|560192248|FG001|Overall Study|Withdrawal by Subject|2|||
155205798|NCT00887978|560192247|FG000|Overall Study|Lost to Follow-up|0|||
155205799|NCT00887978|560192248|FG001|Overall Study|Lost to Follow-up|1|||
155205800|NCT05980182|560192249|FG000|Overall Study|Lost to Follow-up|10|||
155205801|NCT01955733|560194425|FG000|Period 1|Lost to Follow-up|1|||
155205802|NCT01955733|560194426|FG001|Period 1|Lost to Follow-up|0|||
155205803|NCT01955733|560194427|FG002|Period 1|Lost to Follow-up|0|||
155205804|NCT01955733|560194425|FG000|Period 2|Adverse Event|1|||
155205805|NCT01955733|560194426|FG001|Period 2|Adverse Event|0|||
155205806|NCT01955733|560194427|FG002|Period 2|Adverse Event|0|||
155205807|NCT01955733|560194425|FG000|Period 2|Physician Decision|0|||
155205808|NCT01955733|560194426|FG001|Period 2|Physician Decision|0|||
155205809|NCT01955733|560194427|FG002|Period 2|Physician Decision|1|||
155205810|NCT01955733|560194425|FG000|Period 2|Withdrawal by Subject|1|||
155205811|NCT01955733|560194426|FG001|Period 2|Withdrawal by Subject|3|||
155205812|NCT01955733|560194427|FG002|Period 2|Withdrawal by Subject|2|||
155205813|NCT01955733|560194425|FG000|Period 2|Study terminated by sponsor|8|||
155205814|NCT01955733|560194426|FG001|Period 2|Study terminated by sponsor|14|||
155205815|NCT01955733|560194427|FG002|Period 2|Study terminated by sponsor|16|||
155205816|NCT01955733|560194425|FG000|Period 2|Lost to Follow-up|2|||
155205817|NCT01955733|560194426|FG001|Period 2|Lost to Follow-up|0|||
155205818|NCT01955733|560194427|FG002|Period 2|Lost to Follow-up|0|||
155205819|NCT01955733|560194425|FG000|Period 2|Other not defined above|0|||
155205820|NCT01955733|560194426|FG001|Period 2|Other not defined above|2|||
155205821|NCT01955733|560194427|FG002|Period 2|Other not defined above|2|||
155205822|NCT02239978|560194430|FG000|Overall Study|Withdrawal by Subject|2|||
155205823|NCT02239978|560194431|FG001|Overall Study|Withdrawal by Subject|0|||
155205824|NCT01852110|560194439|FG000|Overall Study|Adverse Event|12|||
155205825|NCT01852110|560194440|FG001|Overall Study|Adverse Event|5|||
155205826|NCT01852110|560194441|FG002|Overall Study|Adverse Event|0|||
155205827|NCT01852110|560194442|FG003|Overall Study|Adverse Event|0|||
155205828|NCT01852110|560194443|FG004|Overall Study|Adverse Event|0|||
155205829|NCT01852110|560194444|FG005|Overall Study|Adverse Event|0|||
155205830|NCT01852110|560194439|FG000|Overall Study|Lost to Follow-up|1|||
155205831|NCT01852110|560194440|FG001|Overall Study|Lost to Follow-up|3|||
155205832|NCT01852110|560194441|FG002|Overall Study|Lost to Follow-up|0|||
155205833|NCT01852110|560194442|FG003|Overall Study|Lost to Follow-up|0|||
155205834|NCT01852110|560194443|FG004|Overall Study|Lost to Follow-up|0|||
155205835|NCT01852110|560194444|FG005|Overall Study|Lost to Follow-up|0|||
155205836|NCT01852110|560194439|FG000|Overall Study|Non-compliance with Study Drug|2|||
155205837|NCT01852110|560194440|FG001|Overall Study|Non-compliance with Study Drug|1|||
155205838|NCT01852110|560194441|FG002|Overall Study|Non-compliance with Study Drug|0|||
155205839|NCT01852110|560194442|FG003|Overall Study|Non-compliance with Study Drug|0|||
155205840|NCT01852110|560194443|FG004|Overall Study|Non-compliance with Study Drug|0|||
155205841|NCT01852110|560194444|FG005|Overall Study|Non-compliance with Study Drug|0|||
155205842|NCT01852110|560194439|FG000|Overall Study|Physician Decision|1|||
155205843|NCT01852110|560194440|FG001|Overall Study|Physician Decision|0|||
155205844|NCT01852110|560194441|FG002|Overall Study|Physician Decision|0|||
155205845|NCT01852110|560194442|FG003|Overall Study|Physician Decision|0|||
155205846|NCT01852110|560194443|FG004|Overall Study|Physician Decision|0|||
155205847|NCT01852110|560194444|FG005|Overall Study|Physician Decision|0|||
155205848|NCT01852110|560194439|FG000|Overall Study|Protocol Violation|0|||
155205849|NCT01852110|560194440|FG001|Overall Study|Protocol Violation|1|||
155205850|NCT01852110|560194441|FG002|Overall Study|Protocol Violation|0|||
155205851|NCT01852110|560194442|FG003|Overall Study|Protocol Violation|0|||
155205852|NCT01852110|560194443|FG004|Overall Study|Protocol Violation|0|||
155205853|NCT01852110|560194444|FG005|Overall Study|Protocol Violation|0|||
155205854|NCT01852110|560194439|FG000|Overall Study|Study Terminated by Sponsor|30|||
155205855|NCT01852110|560194440|FG001|Overall Study|Study Terminated by Sponsor|32|||
155205856|NCT01852110|560194441|FG002|Overall Study|Study Terminated by Sponsor|0|||
155205857|NCT01852110|560194442|FG003|Overall Study|Study Terminated by Sponsor|0|||
155205858|NCT01852110|560194443|FG004|Overall Study|Study Terminated by Sponsor|0|||
155205859|NCT01852110|560194444|FG005|Overall Study|Study Terminated by Sponsor|0|||
155205860|NCT01852110|560194439|FG000|Overall Study|Withdrawal by Subject|4|||
155205861|NCT01852110|560194440|FG001|Overall Study|Withdrawal by Subject|4|||
155205862|NCT01852110|560194441|FG002|Overall Study|Withdrawal by Subject|0|||
155205863|NCT01852110|560194442|FG003|Overall Study|Withdrawal by Subject|0|||
155205864|NCT01852110|560194443|FG004|Overall Study|Withdrawal by Subject|0|||
155205865|NCT01852110|560194444|FG005|Overall Study|Withdrawal by Subject|0|||
155205866|NCT01549860|560194450|FG000|Overall Study|Withdrawal by Subject|1|||
155205867|NCT01549860|560194451|FG001|Overall Study|Withdrawal by Subject|0|||
155205868|NCT01549860|560194450|FG000|Overall Study|Physician Decision|1|||
155205869|NCT01549860|560194451|FG001|Overall Study|Physician Decision|1|||
155205870|NCT01366521|560194452|FG000|Overall Study|Adverse Event|1|||
155205871|NCT01366521|560194453|FG001|Overall Study|Adverse Event|0|||
155205872|NCT01366521|560194454|FG002|Overall Study|Adverse Event|0|||
155205873|NCT01366521|560194455|FG003|Overall Study|Adverse Event|0|||
155205874|NCT01366521|560194452|FG000|Overall Study|Protocol Violation|0|||
155205875|NCT01366521|560194453|FG001|Overall Study|Protocol Violation|0|||
155205876|NCT01366521|560194454|FG002|Overall Study|Protocol Violation|1|||
155205877|NCT01366521|560194455|FG003|Overall Study|Protocol Violation|0|||
155205878|NCT01366521|560194452|FG000|Overall Study|Physician Decision|0|||
155205879|NCT01366521|560194453|FG001|Overall Study|Physician Decision|0|||
155205880|NCT01366521|560194454|FG002|Overall Study|Physician Decision|1|||
155205881|NCT01366521|560194455|FG003|Overall Study|Physician Decision|0|||
155205882|NCT01366521|560194452|FG000|Overall Study|Withdrawal by Subject|0|||
155205883|NCT01366521|560194453|FG001|Overall Study|Withdrawal by Subject|1|||
155205884|NCT01366521|560194454|FG002|Overall Study|Withdrawal by Subject|0|||
155205885|NCT01366521|560194455|FG003|Overall Study|Withdrawal by Subject|0|||
155205886|NCT02899988|560194456|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
155205887|NCT02899988|560194457|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
155205888|NCT02899988|560194458|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205889|NCT02899988|560194459|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205890|NCT02899988|560194460|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205891|NCT02899988|560194461|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205892|NCT02899988|560194462|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205893|NCT02899988|560194463|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205894|NCT02899988|560194464|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205895|NCT02899988|560194465|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205896|NCT02899988|560194466|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
155205897|NCT02899988|560194456|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
155205898|NCT02899988|560194457|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
155205899|NCT02899988|560194458|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
155205900|NCT02899988|560194459|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
155205901|NCT02899988|560194460|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
155205902|NCT02899988|560194461|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
155205903|NCT02899988|560194462|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
155205904|NCT02899988|560194463|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
155205905|NCT02899988|560194464|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
155205906|NCT02899988|560194465|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
155205907|NCT02899988|560194466|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
155205908|NCT02899988|560194456|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
155205909|NCT02899988|560194457|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
155205910|NCT02899988|560194458|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
155205911|NCT02899988|560194459|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
155205912|NCT02899988|560194460|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
155205913|NCT02899988|560194461|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
155205914|NCT02899988|560194462|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
155205915|NCT02899988|560194463|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
155205916|NCT02899988|560194464|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
155205917|NCT02899988|560194465|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
155205918|NCT02899988|560194466|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
155205919|NCT02899988|560194456|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205920|NCT02899988|560194457|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205921|NCT02899988|560194458|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205922|NCT02899988|560194459|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
155205923|NCT02899988|560194460|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
155205924|NCT02899988|560194461|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205925|NCT02899988|560194462|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
155205926|NCT02899988|560194463|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205927|NCT02899988|560194464|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205928|NCT02899988|560194465|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
155205929|NCT02899988|560194466|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
155205930|NCT02899988|560194456|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205931|NCT02899988|560194457|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205932|NCT02899988|560194458|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205933|NCT02899988|560194459|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205934|NCT02899988|560194460|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205935|NCT02899988|560194461|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
155205936|NCT02899988|560194462|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205937|NCT02899988|560194463|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
155205938|NCT02899988|560194464|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205939|NCT02899988|560194465|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205940|NCT02899988|560194466|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
155205941|NCT02899988|560194456|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205942|NCT02899988|560194457|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205943|NCT02899988|560194458|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205944|NCT02899988|560194459|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205945|NCT02899988|560194460|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
155205946|NCT02899988|560194461|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205947|NCT02899988|560194462|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
155205948|NCT02899988|560194463|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
155205949|NCT02899988|560194464|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
155205950|NCT02899988|560194465|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
155205951|NCT02899988|560194466|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
155205952|NCT02485301|560194468|FG000|Overall Study|Serious Adverse Events|2|||
155205953|NCT02485301|560194469|FG001|Overall Study|Serious Adverse Events|1|||
155205954|NCT02485301|560194468|FG000|Overall Study|Protocol Violation|0|||
155205955|NCT02485301|560194469|FG001|Overall Study|Protocol Violation|1|||
155205956|NCT02485301|560194468|FG000|Overall Study|Withdrawal by Subject|6|||
155205957|NCT02485301|560194469|FG001|Overall Study|Withdrawal by Subject|7|||
155205958|NCT02485301|560194468|FG000|Overall Study|Migrated/moved from study area|10|||
155205959|NCT02485301|560194469|FG001|Overall Study|Migrated/moved from study area|19|||
155205960|NCT02485301|560194468|FG000|Overall Study|Lost to Follow-up|17|||
155205961|NCT02485301|560194469|FG001|Overall Study|Lost to Follow-up|17|||
155205962|NCT02485301|560194468|FG000|Overall Study|Other|3|||
155205963|NCT02485301|560194469|FG001|Overall Study|Other|4|||
155205964|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205965|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205966|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205967|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205968|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205969|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
155205970|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
155205971|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205972|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205973|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205974|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205975|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205976|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
155205977|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
155205978|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205979|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205980|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205981|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205982|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205983|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
155205984|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
155205985|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205986|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205987|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205988|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205989|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205990|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
155205991|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
155205992|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
155205993|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
155205994|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
155205995|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
155205996|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
155205997|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
155205998|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
155205999|NCT01059825|560194470|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
155206000|NCT01059825|560194471|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
155206001|NCT01059825|560194472|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
155206002|NCT01059825|560194473|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
155206003|NCT01059825|560194474|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
155206004|NCT01059825|560194475|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
155206005|NCT01059825|560194476|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
155206006|NCT01059825|560194470|FG000|Treatment Period|Lost to Follow-up|2|||
155206007|NCT01059825|560194471|FG001|Treatment Period|Lost to Follow-up|1|||
155206008|NCT01059825|560194472|FG002|Treatment Period|Lost to Follow-up|0|||
155206009|NCT01059825|560194473|FG003|Treatment Period|Lost to Follow-up|1|||
155206010|NCT01059825|560194474|FG004|Treatment Period|Lost to Follow-up|2|||
155206011|NCT01059825|560194475|FG005|Treatment Period|Lost to Follow-up|0|||
155206012|NCT01059825|560194476|FG006|Treatment Period|Lost to Follow-up|0|||
155206013|NCT01059825|560194470|FG000|Treatment Period|Withdrawal by Subject|3|||
155206014|NCT01059825|560194471|FG001|Treatment Period|Withdrawal by Subject|0|||
155206015|NCT01059825|560194472|FG002|Treatment Period|Withdrawal by Subject|1|||
155206016|NCT01059825|560194473|FG003|Treatment Period|Withdrawal by Subject|5|||
155206017|NCT01059825|560194474|FG004|Treatment Period|Withdrawal by Subject|4|||
155206018|NCT01059825|560194475|FG005|Treatment Period|Withdrawal by Subject|1|||
155206019|NCT01059825|560194476|FG006|Treatment Period|Withdrawal by Subject|0|||
155206020|NCT01059825|560194470|FG000|Treatment Period|Other reason not specified|1|||
155206021|NCT01059825|560194471|FG001|Treatment Period|Other reason not specified|2|||
155206022|NCT01059825|560194472|FG002|Treatment Period|Other reason not specified|1|||
155206023|NCT01059825|560194473|FG003|Treatment Period|Other reason not specified|2|||
155206024|NCT01059825|560194474|FG004|Treatment Period|Other reason not specified|0|||
155206025|NCT01059825|560194475|FG005|Treatment Period|Other reason not specified|0|||
155206026|NCT01059825|560194476|FG006|Treatment Period|Other reason not specified|0|||
155206027|NCT01059825|560194470|FG000|Treatment Period|Protocol Violation|0|||
155206028|NCT01059825|560194471|FG001|Treatment Period|Protocol Violation|0|||
155206029|NCT01059825|560194472|FG002|Treatment Period|Protocol Violation|1|||
155206030|NCT01059825|560194473|FG003|Treatment Period|Protocol Violation|1|||
155206031|NCT01059825|560194474|FG004|Treatment Period|Protocol Violation|1|||
155206032|NCT01059825|560194475|FG005|Treatment Period|Protocol Violation|1|||
155206033|NCT01059825|560194476|FG006|Treatment Period|Protocol Violation|0|||
155206034|NCT01059825|560194470|FG000|Treatment Period|Adverse event related to study drug|1|||
155206035|NCT01059825|560194471|FG001|Treatment Period|Adverse event related to study drug|0|||
155206036|NCT01059825|560194472|FG002|Treatment Period|Adverse event related to study drug|1|||
155206037|NCT01059825|560194473|FG003|Treatment Period|Adverse event related to study drug|1|||
155206038|NCT01059825|560194474|FG004|Treatment Period|Adverse event related to study drug|0|||
155206039|NCT01059825|560194475|FG005|Treatment Period|Adverse event related to study drug|0|||
155206040|NCT01059825|560194476|FG006|Treatment Period|Adverse event related to study drug|0|||
155206041|NCT01059825|560194470|FG000|Treatment Period|Insufficient clinical response|3|||
155206042|NCT01059825|560194471|FG001|Treatment Period|Insufficient clinical response|0|||
155206043|NCT01059825|560194472|FG002|Treatment Period|Insufficient clinical response|0|||
155206044|NCT01059825|560194473|FG003|Treatment Period|Insufficient clinical response|0|||
155206045|NCT01059825|560194474|FG004|Treatment Period|Insufficient clinical response|0|||
155206046|NCT01059825|560194475|FG005|Treatment Period|Insufficient clinical response|0|||
155206047|NCT01059825|560194476|FG006|Treatment Period|Insufficient clinical response|0|||
155206048|NCT01059825|560194470|FG000|Treatment Period|Adverse event not related to study drug|0|||
155206049|NCT01059825|560194471|FG001|Treatment Period|Adverse event not related to study drug|1|||
155206050|NCT01059825|560194472|FG002|Treatment Period|Adverse event not related to study drug|2|||
155206051|NCT01059825|560194473|FG003|Treatment Period|Adverse event not related to study drug|1|||
155206052|NCT01059825|560194474|FG004|Treatment Period|Adverse event not related to study drug|1|||
155206053|NCT01059825|560194475|FG005|Treatment Period|Adverse event not related to study drug|1|||
155206054|NCT01059825|560194476|FG006|Treatment Period|Adverse event not related to study drug|0|||
155206055|NCT00105482|560194477|FG000|Overall Study|Adverse Event|1|||
155206056|NCT00105482|560194478|FG001|Overall Study|Adverse Event|1|||
155206057|NCT00105482|560194477|FG000|Overall Study|Lost to Follow-up|26|||
155206058|NCT00105482|560194478|FG001|Overall Study|Lost to Follow-up|17|||
155206059|NCT00105482|560194477|FG000|Overall Study|Withdrawal by Subject|0|||
155206060|NCT00105482|560194478|FG001|Overall Study|Withdrawal by Subject|1|||
155206061|NCT00105482|560194477|FG000|Overall Study|Lost Interest|29|||
155206062|NCT00105482|560194478|FG001|Overall Study|Lost Interest|32|||
155206063|NCT00105482|560194477|FG000|Overall Study|Scheduling Conflict|2|||
155206064|NCT00105482|560194478|FG001|Overall Study|Scheduling Conflict|3|||
155206065|NCT00105482|560194477|FG000|Overall Study|Withdrawn by PI|1|||
155206066|NCT00105482|560194478|FG001|Overall Study|Withdrawn by PI|1|||
155206067|NCT02708121|560194479|FG000|Overall Study|Withdrawn by Study Team|1|||
155206068|NCT02708121|560194480|FG001|Overall Study|Withdrawn by Study Team|1|||
155206069|NCT02708121|560194479|FG000|Overall Study|Withdrawal by Subject|0|||
155206070|NCT02708121|560194480|FG001|Overall Study|Withdrawal by Subject|4|||
155206071|NCT01749514|560194483|FG000|Overall Study|Lost to Follow-up|0|||
155206072|NCT01749514|560194484|FG001|Overall Study|Lost to Follow-up|0|||
155206073|NCT01749514|560194485|FG002|Overall Study|Lost to Follow-up|0|||
155206074|NCT01749514|560194486|FG003|Overall Study|Lost to Follow-up|0|||
155206075|NCT01749514|560194487|FG004|Overall Study|Lost to Follow-up|0|||
155206076|NCT01749514|560194488|FG005|Overall Study|Lost to Follow-up|0|||
155206077|NCT01749514|560194489|FG006|Overall Study|Lost to Follow-up|0|||
155206078|NCT01749514|560194490|FG007|Overall Study|Lost to Follow-up|1|||
155206079|NCT01749514|560194483|FG000|Overall Study|Withdrawal by Subject|0|||
155206080|NCT01749514|560194484|FG001|Overall Study|Withdrawal by Subject|0|||
155206081|NCT01749514|560194485|FG002|Overall Study|Withdrawal by Subject|0|||
155206082|NCT01749514|560194486|FG003|Overall Study|Withdrawal by Subject|0|||
155206083|NCT01749514|560194487|FG004|Overall Study|Withdrawal by Subject|0|||
155206084|NCT01749514|560194488|FG005|Overall Study|Withdrawal by Subject|1|||
155206085|NCT01749514|560194489|FG006|Overall Study|Withdrawal by Subject|0|||
155206086|NCT01749514|560194490|FG007|Overall Study|Withdrawal by Subject|1|||
155206087|NCT01749514|560194483|FG000|Overall Study|Not Reported|0|||
155206088|NCT01749514|560194484|FG001|Overall Study|Not Reported|0|||
155206089|NCT01749514|560194485|FG002|Overall Study|Not Reported|0|||
155206090|NCT01749514|560194486|FG003|Overall Study|Not Reported|0|||
155206091|NCT01749514|560194487|FG004|Overall Study|Not Reported|0|||
155206092|NCT01749514|560194488|FG005|Overall Study|Not Reported|0|||
155206093|NCT01749514|560194489|FG006|Overall Study|Not Reported|0|||
155206094|NCT01749514|560194490|FG007|Overall Study|Not Reported|5|||
155206095|NCT02551731|560194491|FG000|Overall Study|Withdrawal by Subject|2|||
155206096|NCT01750242|560194492|FG000|Overall Study|Unreadable Images|3|||
155206097|NCT03765918|560194498|FG000|Overall Study|Death|109|||
155206098|NCT03765918|560194499|FG001|Overall Study|Death|127|||
155206099|NCT03765918|560194498|FG000|Overall Study|Lost to Follow-up|2|||
155206100|NCT03765918|560194499|FG001|Overall Study|Lost to Follow-up|3|||
155206101|NCT03765918|560194498|FG000|Overall Study|Withdrawal by Subject|12|||
155206102|NCT03765918|560194499|FG001|Overall Study|Withdrawal by Subject|16|||
155206103|NCT03765918|560194498|FG000|Overall Study|Participants Ongoing|240|||
155206104|NCT03765918|560194499|FG001|Overall Study|Participants Ongoing|205|||
155206105|NCT04202965|560194500|FG000|Overall Study|Adverse Event|3|||
155206106|NCT04202965|560194500|FG000|Overall Study|Did not meet inclusion criteria|1|||
155206107|NCT00299975|560194503|FG000|Overall Study|Adverse Event|1|||
155206108|NCT00299975|560194504|FG001|Overall Study|Adverse Event|0|||
155206109|NCT00299975|560194505|FG002|Overall Study|Adverse Event|2|||
155206110|NCT00299975|560194503|FG000|Overall Study|Pregnancy|0|||
155206111|NCT00299975|560194504|FG001|Overall Study|Pregnancy|0|||
155206112|NCT00299975|560194505|FG002|Overall Study|Pregnancy|1|||
155206113|NCT00299975|560194503|FG000|Overall Study|Lack of Efficacy|1|||
155206114|NCT00299975|560194504|FG001|Overall Study|Lack of Efficacy|0|||
155206115|NCT00299975|560194505|FG002|Overall Study|Lack of Efficacy|1|||
155206116|NCT00299975|560194503|FG000|Overall Study|Lost to Follow-up|1|||
155206117|NCT00299975|560194504|FG001|Overall Study|Lost to Follow-up|0|||
155206118|NCT00299975|560194505|FG002|Overall Study|Lost to Follow-up|0|||
155206119|NCT00299975|560194503|FG000|Overall Study|Withdrawal by Subject|0|||
155206120|NCT00299975|560194504|FG001|Overall Study|Withdrawal by Subject|1|||
155206121|NCT00299975|560194505|FG002|Overall Study|Withdrawal by Subject|3|||
155206122|NCT00299975|560194503|FG000|Overall Study|Physician Decision|0|||
155206123|NCT00299975|560194504|FG001|Overall Study|Physician Decision|0|||
155206124|NCT00299975|560194505|FG002|Overall Study|Physician Decision|1|||
155206125|NCT03167411|560194507|FG000|Overall Study|Adverse Event|0|||
155206126|NCT03167411|560194508|FG001|Overall Study|Adverse Event|1|||
155206127|NCT01578187|560194509|FG000|Usability Phase|Withdrawal by Subject|1|||
155206128|NCT01218243|560194510|FG000|Overall Study|Lack of Efficacy|1|||
155206129|NCT01218243|560194511|FG001|Overall Study|Lack of Efficacy|1|||
155206130|NCT01218243|560194510|FG000|Overall Study|Lost to Follow-up|3|||
155206131|NCT01218243|560194511|FG001|Overall Study|Lost to Follow-up|3|||
155206132|NCT01218243|560194510|FG000|Overall Study|Protocol Violation|5|||
155206133|NCT01218243|560194511|FG001|Overall Study|Protocol Violation|10|||
155206134|NCT01637272|560194513|FG000|Overall Study|Adverse Event|6|||
155206135|NCT01637272|560194513|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155206136|NCT01637272|560194513|FG000|Overall Study|Withdrawal by Subject|3|||
155206137|NCT01637272|560194513|FG000|Overall Study|Lost to Follow-up|2|||
155206138|NCT01637272|560194513|FG000|Overall Study|completed core, did not enter ext. phase|4|||
155206139|NCT01637272|560194513|FG000|Overall Study|Administrative problems|1|||
155206140|NCT01637272|560194513|FG000|Overall Study|Protocol Violation|2|||
155206141|NCT01496612|560194514|FG000|1st Intervention|Adverse Event|1|||
155206142|NCT01496612|560194515|FG001|1st Intervention|Adverse Event|0|||
155206143|NCT01496612|560194514|FG000|1st Intervention|Withdrawal by Subject|1|||
155206144|NCT01496612|560194515|FG001|1st Intervention|Withdrawal by Subject|0|||
155206145|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
155206146|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
155206147|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
155206148|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
155206149|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
155206150|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
155206151|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
155206152|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
155206153|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
155206154|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
155206155|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
155206156|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
155206157|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
155206158|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
155206159|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
155206160|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
155206161|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
155206162|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
155206163|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
155206164|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
155206165|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
155206166|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
155206167|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
155206168|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
155206169|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
155206170|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
155206171|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
155206172|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206173|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206174|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206175|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206176|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206177|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206178|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206179|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206180|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206181|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206182|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206183|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206184|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206185|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206186|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206187|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206188|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206189|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206190|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206191|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206192|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206193|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206194|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206195|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206196|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
155206197|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
155206198|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
155206199|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206200|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206201|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206202|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206203|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206204|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206205|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206206|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206207|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206208|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206209|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206210|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206211|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206212|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206213|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206214|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206215|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206216|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206217|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206218|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206219|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206220|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206221|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206222|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
155206223|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
155206224|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
155206225|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206226|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206227|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206228|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206229|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206230|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206231|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206232|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206233|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206234|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206235|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206236|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206237|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206238|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206239|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206240|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206241|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206242|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206243|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206244|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206245|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206246|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206247|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206248|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
155206249|NCT03129100|560194520|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206250|NCT03129100|560194521|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
155206251|NCT03129100|560194522|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206252|NCT03129100|560194523|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206253|NCT03129100|560194524|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206254|NCT03129100|560194525|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206255|NCT03129100|560194526|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206256|NCT03129100|560194527|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206257|NCT03129100|560194528|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206258|NCT03129100|560194529|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206259|NCT03129100|560194530|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206260|NCT03129100|560194531|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206261|NCT03129100|560194532|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206262|NCT03129100|560194533|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206263|NCT03129100|560194534|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206264|NCT03129100|560194535|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206265|NCT03129100|560194536|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206266|NCT03129100|560194537|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206267|NCT03129100|560194538|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206268|NCT03129100|560194539|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206269|NCT03129100|560194540|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206270|NCT03129100|560194541|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206271|NCT03129100|560194542|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206272|NCT03129100|560194543|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206273|NCT03129100|560194544|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206274|NCT03129100|560194545|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
155206275|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206276|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206277|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
155206278|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
155206279|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206280|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
155206281|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206282|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206283|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206284|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206285|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206286|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206287|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206288|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206289|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206290|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206291|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206292|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206293|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206294|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206295|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206296|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206297|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206298|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206299|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206300|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
155206301|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Death|0|||
155206302|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Death|0|||
155206303|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Death|1|||
155206304|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Death|0|||
155206305|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Death|0|||
155206306|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Death|0|||
155206307|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Death|0|||
155206308|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Death|0|||
155206309|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Death|0|||
155206310|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Death|0|||
155206311|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Death|0|||
155206312|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Death|0|||
155206313|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Death|0|||
155206314|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Death|0|||
155206315|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Death|0|||
155206316|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Death|0|||
155206317|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Death|0|||
155206318|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Death|0|||
155206319|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Death|0|||
155206320|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Death|0|||
155206321|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Death|0|||
155206322|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Death|0|||
155206323|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Death|0|||
155206324|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Death|0|||
155206325|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Death|0|||
155206326|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Death|0|||
155206327|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206328|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206329|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
155206330|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
155206331|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
155206332|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
155206333|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
155206334|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206335|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206336|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206337|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206338|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206339|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206340|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206341|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206342|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206343|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206344|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206345|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206346|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206347|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206348|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206349|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206350|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206351|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206352|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
155206353|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206354|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206355|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
155206356|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206357|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206358|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206359|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206360|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206361|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206362|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206363|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206364|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206365|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206366|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206367|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206368|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206369|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206370|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206371|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206372|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206373|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206374|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206375|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206376|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206377|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206378|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
155206379|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206380|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206381|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
155206382|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206383|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206384|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206385|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206386|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206387|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206388|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206389|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206390|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206391|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206392|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206393|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206394|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206395|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206396|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206397|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206398|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206399|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206400|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206401|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206402|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206403|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206404|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
155206405|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206406|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206407|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
155206408|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206409|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206410|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206411|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206412|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206413|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206414|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206415|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206416|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206417|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206418|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206419|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206420|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206421|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206422|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206423|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206424|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206425|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206426|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206427|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206428|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206429|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206430|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
155206431|NCT03129100|560194520|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206432|NCT03129100|560194521|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206433|NCT03129100|560194522|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206434|NCT03129100|560194523|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206435|NCT03129100|560194524|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
155206436|NCT03129100|560194525|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
155206437|NCT03129100|560194526|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
155206438|NCT03129100|560194527|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206439|NCT03129100|560194528|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206440|NCT03129100|560194529|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206441|NCT03129100|560194530|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206442|NCT03129100|560194531|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206443|NCT03129100|560194532|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206444|NCT03129100|560194533|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206445|NCT03129100|560194534|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206446|NCT03129100|560194535|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206447|NCT03129100|560194536|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206448|NCT03129100|560194537|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206449|NCT03129100|560194538|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206450|NCT03129100|560194539|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206451|NCT03129100|560194540|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206452|NCT03129100|560194541|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206453|NCT03129100|560194542|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206454|NCT03129100|560194543|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206455|NCT03129100|560194544|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206456|NCT03129100|560194545|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
155206457|NCT03129100|560194520|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206458|NCT03129100|560194521|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206459|NCT03129100|560194522|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206460|NCT03129100|560194523|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206461|NCT03129100|560194524|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206462|NCT03129100|560194525|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206463|NCT03129100|560194526|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206464|NCT03129100|560194527|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206465|NCT03129100|560194528|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206466|NCT03129100|560194529|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
155206467|NCT03129100|560194530|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206468|NCT03129100|560194531|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206469|NCT03129100|560194532|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206470|NCT03129100|560194533|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206471|NCT03129100|560194534|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206472|NCT03129100|560194535|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206473|NCT03129100|560194536|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206474|NCT03129100|560194537|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206475|NCT03129100|560194538|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206476|NCT03129100|560194539|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206477|NCT03129100|560194540|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206478|NCT03129100|560194541|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206479|NCT03129100|560194542|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206480|NCT03129100|560194543|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206481|NCT03129100|560194544|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206482|NCT03129100|560194545|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
155206483|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206484|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206485|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206486|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206487|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206488|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206489|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206490|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206491|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206492|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206493|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206494|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
155206495|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206496|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206497|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206498|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206499|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206500|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206501|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206502|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206503|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206504|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206505|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206506|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206507|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206508|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
155206509|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206510|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206511|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206512|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206513|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206514|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206515|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206516|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206517|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206518|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206519|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206520|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
155206521|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
155206522|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
155206523|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
155206524|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206525|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206526|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206527|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206528|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206529|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206530|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206531|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206532|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206533|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206534|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
155206535|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206536|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206537|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206538|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206539|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206540|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206541|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206542|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206543|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206544|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206545|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206546|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
155206547|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206548|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
155206549|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
155206550|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206551|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206552|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206553|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206554|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206555|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206556|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206557|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206558|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206559|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206560|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
155206561|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206562|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206563|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206564|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206565|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206566|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206567|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206568|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206569|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206570|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206571|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206572|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206573|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206574|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206575|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206576|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
155206577|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206578|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206579|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206580|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206581|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206582|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206583|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206584|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206585|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206586|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
155206587|NCT03129100|560194520|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206588|NCT03129100|560194521|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206589|NCT03129100|560194522|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206590|NCT03129100|560194523|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206591|NCT03129100|560194524|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206592|NCT03129100|560194525|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206593|NCT03129100|560194526|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206594|NCT03129100|560194527|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206595|NCT03129100|560194528|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206596|NCT03129100|560194529|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206597|NCT03129100|560194530|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206598|NCT03129100|560194531|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206599|NCT03129100|560194532|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
155206600|NCT03129100|560194533|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206601|NCT03129100|560194534|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
155206602|NCT03129100|560194535|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
155206603|NCT03129100|560194536|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206604|NCT03129100|560194537|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206605|NCT03129100|560194538|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206606|NCT03129100|560194539|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206607|NCT03129100|560194540|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206608|NCT03129100|560194541|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206609|NCT03129100|560194542|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206610|NCT03129100|560194543|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206611|NCT03129100|560194544|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206612|NCT03129100|560194545|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
155206613|NCT03129100|560194520|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206614|NCT03129100|560194521|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206615|NCT03129100|560194522|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206616|NCT03129100|560194523|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206617|NCT03129100|560194524|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206618|NCT03129100|560194525|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206619|NCT03129100|560194526|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206620|NCT03129100|560194527|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206621|NCT03129100|560194528|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206622|NCT03129100|560194529|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206623|NCT03129100|560194530|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206624|NCT03129100|560194531|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206625|NCT03129100|560194532|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206626|NCT03129100|560194533|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206627|NCT03129100|560194534|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206628|NCT03129100|560194535|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206629|NCT03129100|560194536|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206630|NCT03129100|560194537|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
155206631|NCT03129100|560194538|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206632|NCT03129100|560194539|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
155206633|NCT03129100|560194540|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206634|NCT03129100|560194541|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206635|NCT03129100|560194542|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206636|NCT03129100|560194543|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206637|NCT03129100|560194544|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206638|NCT03129100|560194545|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
155206639|NCT03129100|560194520|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206640|NCT03129100|560194521|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206641|NCT03129100|560194522|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206642|NCT03129100|560194523|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206643|NCT03129100|560194524|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206644|NCT03129100|560194525|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206645|NCT03129100|560194526|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206646|NCT03129100|560194527|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206647|NCT03129100|560194528|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206648|NCT03129100|560194529|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206649|NCT03129100|560194530|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206650|NCT03129100|560194531|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206651|NCT03129100|560194532|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206652|NCT03129100|560194533|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206653|NCT03129100|560194534|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206654|NCT03129100|560194535|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206655|NCT03129100|560194536|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206656|NCT03129100|560194537|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206657|NCT03129100|560194538|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206658|NCT03129100|560194539|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206659|NCT03129100|560194540|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
155206660|NCT03129100|560194541|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206661|NCT03129100|560194542|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206662|NCT03129100|560194543|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206663|NCT03129100|560194544|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206664|NCT03129100|560194545|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
155206665|NCT03129100|560194520|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
155206666|NCT03129100|560194521|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
155206667|NCT03129100|560194522|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
155206668|NCT03129100|560194523|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
155206669|NCT03129100|560194524|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
155206670|NCT03129100|560194525|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
155206671|NCT03129100|560194526|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
155206672|NCT03129100|560194527|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
155206673|NCT03129100|560194528|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
155206674|NCT03129100|560194529|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
155206675|NCT03129100|560194530|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
155206676|NCT03129100|560194531|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
155206677|NCT03129100|560194532|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
155206678|NCT03129100|560194533|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
155206679|NCT03129100|560194534|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
155206680|NCT03129100|560194535|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
155206681|NCT03129100|560194536|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
155206682|NCT03129100|560194537|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
155206683|NCT03129100|560194538|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
155206684|NCT03129100|560194539|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
155206685|NCT03129100|560194540|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
155206686|NCT03129100|560194541|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
155206687|NCT03129100|560194542|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
155206688|NCT03129100|560194543|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
155206689|NCT03129100|560194544|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
155206690|NCT03129100|560194545|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
155206691|NCT03129100|560194520|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206692|NCT03129100|560194521|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206693|NCT03129100|560194522|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206694|NCT03129100|560194523|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206695|NCT03129100|560194524|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206696|NCT03129100|560194525|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206697|NCT03129100|560194526|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206698|NCT03129100|560194527|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206699|NCT03129100|560194528|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206700|NCT03129100|560194529|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206701|NCT03129100|560194530|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206702|NCT03129100|560194531|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206703|NCT03129100|560194532|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206704|NCT03129100|560194533|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206705|NCT03129100|560194534|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206706|NCT03129100|560194535|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206707|NCT03129100|560194536|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206708|NCT03129100|560194537|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206709|NCT03129100|560194538|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206710|NCT03129100|560194539|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206711|NCT03129100|560194540|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
155206712|NCT03129100|560194541|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206713|NCT03129100|560194542|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206714|NCT03129100|560194543|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206715|NCT03129100|560194544|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206716|NCT03129100|560194545|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
155206717|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
155206718|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
155206719|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
155206720|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
155206721|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
155206722|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
155206723|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
155206724|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
155206725|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
155206726|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
155206727|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
155206728|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
155206729|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
155206730|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
155206731|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
155206732|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
155206733|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
155206734|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
155206735|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
155206736|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
155206737|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
155206738|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
155206739|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
155206740|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
155206741|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
155206742|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
155206743|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206744|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206745|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206746|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206747|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206748|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206749|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206750|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206751|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206752|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206753|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206754|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206755|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206756|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206757|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206758|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206759|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206760|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206761|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206762|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206763|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206764|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206765|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206766|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
155206767|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
155206768|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
155206769|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206770|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206771|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206772|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206773|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206774|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206775|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206776|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206777|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206778|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206779|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206780|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206781|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206782|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206783|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206784|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206785|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206786|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206787|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206788|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206789|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206790|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206791|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
155206792|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
155206793|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
155206794|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
155206795|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206796|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206797|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206798|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206799|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206800|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206801|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206802|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206803|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206804|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206805|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206806|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206807|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206808|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206809|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206810|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206811|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206812|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206813|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206814|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206815|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206816|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206817|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206818|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206819|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
155206820|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
155206821|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206822|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206823|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206824|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206825|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206826|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206827|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206828|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206829|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206830|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206831|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206832|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206833|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206834|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206835|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206836|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206837|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206838|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206839|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206840|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206841|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206842|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206843|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206844|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206845|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
155206846|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
155206847|NCT03129100|560194520|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
155206848|NCT03129100|560194521|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
155206849|NCT03129100|560194522|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
155206850|NCT03129100|560194523|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
155206851|NCT03129100|560194524|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
155206852|NCT03129100|560194525|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
155206853|NCT03129100|560194526|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
155206854|NCT03129100|560194527|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
155206855|NCT03129100|560194528|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
155206856|NCT03129100|560194529|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
155206857|NCT03129100|560194530|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
155206858|NCT03129100|560194531|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
155206859|NCT03129100|560194532|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
155206860|NCT03129100|560194533|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
155206861|NCT03129100|560194534|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
155206862|NCT03129100|560194535|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
155206863|NCT03129100|560194536|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
155206864|NCT03129100|560194537|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
155206865|NCT03129100|560194538|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
155206866|NCT03129100|560194539|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
155206867|NCT03129100|560194540|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
155206868|NCT03129100|560194541|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
155206869|NCT03129100|560194542|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
155206870|NCT03129100|560194543|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
155206871|NCT03129100|560194544|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
155206872|NCT03129100|560194545|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
155206873|NCT01587001|560194546|FG000|Overall Study|Lost to Follow-up|2|||
155206874|NCT01587001|560194547|FG001|Overall Study|Lost to Follow-up|0|||
155206875|NCT01587001|560194546|FG000|Overall Study|Insufficient samples to complete testing|4|||
155206876|NCT01587001|560194547|FG001|Overall Study|Insufficient samples to complete testing|1|||
155206877|NCT02756013|560194548|FG000|Overall Study|Adverse Event|1|||
155206878|NCT02756013|560194548|FG000|Overall Study|Hypersensitivity|1|||
155206879|NCT00571948|560194549|FG000|Overall Study|Lost to Follow-up|2|||
155206880|NCT00571948|560194550|FG001|Overall Study|Lost to Follow-up|0|||
155206881|NCT00571948|560194549|FG000|Overall Study|Withdrawal by Subject|1|||
155206882|NCT00571948|560194550|FG001|Overall Study|Withdrawal by Subject|2|||
155206883|NCT00571948|560194549|FG000|Overall Study|Protocol Violation|3|||
155206884|NCT00571948|560194550|FG001|Overall Study|Protocol Violation|3|||
155206885|NCT00571948|560194549|FG000|Overall Study|infant refused study meal|3|||
155206886|NCT00571948|560194550|FG001|Overall Study|infant refused study meal|4|||
155206887|NCT00571948|560194549|FG000|Overall Study|Parent were afraid of blood colection|2|||
155206888|NCT00571948|560194550|FG001|Overall Study|Parent were afraid of blood colection|5|||
155206889|NCT01032837|560194551|FG000|Overall Study|Adverse event/internal illness|0|||
155206890|NCT01032837|560194552|FG001|Overall Study|Adverse event/internal illness|1|||
155206891|NCT01032837|560194553|FG002|Overall Study|Adverse event/internal illness|0|||
155206892|NCT01032837|560194554|FG003|Overall Study|Adverse event/internal illness|1|||
155206893|NCT01032837|560194551|FG000|Overall Study|Withdrew consent|0|||
155206894|NCT01032837|560194552|FG001|Overall Study|Withdrew consent|2|||
155206895|NCT01032837|560194553|FG002|Overall Study|Withdrew consent|0|||
155206896|NCT01032837|560194554|FG003|Overall Study|Withdrew consent|1|||
155206897|NCT01032837|560194551|FG000|Overall Study|Failed to return|0|||
155206898|NCT01032837|560194552|FG001|Overall Study|Failed to return|0|||
155206899|NCT01032837|560194553|FG002|Overall Study|Failed to return|1|||
155206900|NCT01032837|560194554|FG003|Overall Study|Failed to return|0|||
155206901|NCT01032837|560194551|FG000|Overall Study|Refused treatment|0|||
155206902|NCT01032837|560194552|FG001|Overall Study|Refused treatment|0|||
155206903|NCT01032837|560194553|FG002|Overall Study|Refused treatment|0|||
155206904|NCT01032837|560194554|FG003|Overall Study|Refused treatment|1|||
155206905|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
155206906|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
155206907|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206908|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206909|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206910|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
155206911|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
155206912|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
155206913|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206914|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206915|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206916|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
155206917|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
155206918|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
155206919|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206920|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206921|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206922|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
155206923|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
155206924|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
155206925|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206926|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206927|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206928|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
155206929|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
155206930|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
155206931|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206932|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206933|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206934|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
155206935|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206936|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
155206937|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206938|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206939|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206940|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
155206941|NCT00843024|560194555|FG000|Single-blind Placebo Run-In Phase|Other|0|||
155206942|NCT00843024|560194556|FG001|Single-blind Placebo Run-In Phase|Other|1|||
155206943|NCT00843024|560194557|FG002|Single-blind Placebo Run-In Phase|Other|0|||
155206944|NCT00843024|560194558|FG003|Single-blind Placebo Run-In Phase|Other|0|||
155206945|NCT00843024|560194559|FG004|Single-blind Placebo Run-In Phase|Other|0|||
155206946|NCT00843024|560194560|FG005|Single-blind Placebo Run-In Phase|Other|0|||
155206947|NCT00843024|560194555|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
155206948|NCT00843024|560194556|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
155206949|NCT00843024|560194557|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
155206950|NCT00843024|560194558|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
155206951|NCT00843024|560194559|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
155206952|NCT00843024|560194560|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
155206953|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155206954|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
155206955|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
155206956|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
155206957|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
155206958|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
155206959|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206960|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206961|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206962|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
155206963|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155206964|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
155206965|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
155206966|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
155206967|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
155206968|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
155206969|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
155206970|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
155206971|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Physician Decision|0|||
155206972|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Physician Decision|0|||
155206973|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Physician Decision|0|||
155206974|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Physician Decision|3|||
155206975|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Physician Decision|1|||
155206976|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Physician Decision|1|||
155206977|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155206978|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Adverse Event|0|||
155206979|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Adverse Event|0|||
155206980|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Adverse Event|0|||
155206981|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Adverse Event|1|||
155206982|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Adverse Event|1|||
155206983|NCT00843024|560194555|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206984|NCT00843024|560194556|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206985|NCT00843024|560194557|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206986|NCT00843024|560194558|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206987|NCT00843024|560194559|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
155206988|NCT00843024|560194560|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
155206989|NCT05201703|560194561|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
155206990|NCT05201703|560194562|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
155206991|NCT05201703|560194561|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
155206992|NCT05201703|560194562|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
155206993|NCT01487200|560194563|FG000|Overall Study|Withdrawal by Subject|0|||
155206994|NCT01487200|560194564|FG001|Overall Study|Withdrawal by Subject|1|||
155206995|NCT01487200|560194565|FG002|Overall Study|Withdrawal by Subject|0|||
155206996|NCT01487200|560194566|FG003|Overall Study|Withdrawal by Subject|0|||
155206997|NCT00496054|560194571|FG000|Overall Study|Adverse Event|1|||
155206998|NCT00496054|560194571|FG000|Overall Study|Lost to Follow-up|7|||
155206999|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207000|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
155207001|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207002|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
155207003|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
155207004|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207005|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207006|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207007|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207008|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207009|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207010|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207011|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207012|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207013|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
155207014|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
155207015|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
155207016|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
155207017|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207018|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207019|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207020|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207021|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207022|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207023|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207024|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207025|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207026|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207027|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207028|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
155207029|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207030|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207031|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207032|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
155207033|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207034|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207035|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207036|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207037|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207038|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207039|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207040|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207041|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207042|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207043|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
155207044|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207045|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
155207046|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207047|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207048|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207049|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207050|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207051|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207052|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207053|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207054|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207055|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207056|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207057|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207058|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
155207059|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207060|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207061|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207062|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207063|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
155207064|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207065|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207066|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207067|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207068|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207069|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207070|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207071|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207072|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207073|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
155207074|NCT01737697|560194572|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207075|NCT01737697|560194573|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
155207076|NCT01737697|560194574|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
155207077|NCT01737697|560194575|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
155207078|NCT01737697|560194576|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
155207079|NCT01737697|560194577|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207080|NCT01737697|560194578|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207081|NCT01737697|560194579|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207082|NCT01737697|560194580|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207083|NCT01737697|560194581|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207084|NCT01737697|560194582|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207085|NCT01737697|560194583|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207086|NCT01737697|560194584|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207087|NCT01737697|560194585|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207088|NCT01737697|560194586|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
155207089|NCT01737697|560194572|FG000|Subacute Phase|Adverse Event|0|||
155207090|NCT01737697|560194573|FG001|Subacute Phase|Adverse Event|0|||
155207091|NCT01737697|560194574|FG002|Subacute Phase|Adverse Event|0|||
155207092|NCT01737697|560194575|FG003|Subacute Phase|Adverse Event|0|||
155207093|NCT01737697|560194576|FG004|Subacute Phase|Adverse Event|0|||
155207094|NCT01737697|560194577|FG005|Subacute Phase|Adverse Event|1|||
155207095|NCT01737697|560194578|FG006|Subacute Phase|Adverse Event|1|||
155207096|NCT01737697|560194579|FG007|Subacute Phase|Adverse Event|1|||
155207097|NCT01737697|560194580|FG008|Subacute Phase|Adverse Event|1|||
155207098|NCT01737697|560194581|FG009|Subacute Phase|Adverse Event|1|||
155207099|NCT01737697|560194582|FG010|Subacute Phase|Adverse Event|4|||
155207100|NCT01737697|560194583|FG011|Subacute Phase|Adverse Event|1|||
155207101|NCT01737697|560194584|FG012|Subacute Phase|Adverse Event|1|||
155207102|NCT01737697|560194585|FG013|Subacute Phase|Adverse Event|0|||
155207103|NCT01737697|560194586|FG014|Subacute Phase|Adverse Event|0|||
155207104|NCT01737697|560194572|FG000|Subacute Phase|Withdrawal by Subject|0|||
155207105|NCT01737697|560194573|FG001|Subacute Phase|Withdrawal by Subject|0|||
155207106|NCT01737697|560194574|FG002|Subacute Phase|Withdrawal by Subject|0|||
155207107|NCT01737697|560194575|FG003|Subacute Phase|Withdrawal by Subject|0|||
155207108|NCT01737697|560194576|FG004|Subacute Phase|Withdrawal by Subject|0|||
155207109|NCT01737697|560194577|FG005|Subacute Phase|Withdrawal by Subject|1|||
155207110|NCT01737697|560194578|FG006|Subacute Phase|Withdrawal by Subject|0|||
155207111|NCT01737697|560194579|FG007|Subacute Phase|Withdrawal by Subject|2|||
155207112|NCT01737697|560194580|FG008|Subacute Phase|Withdrawal by Subject|0|||
155207113|NCT01737697|560194581|FG009|Subacute Phase|Withdrawal by Subject|1|||
155207114|NCT01737697|560194582|FG010|Subacute Phase|Withdrawal by Subject|0|||
155207115|NCT01737697|560194583|FG011|Subacute Phase|Withdrawal by Subject|1|||
155207116|NCT01737697|560194584|FG012|Subacute Phase|Withdrawal by Subject|1|||
155207117|NCT01737697|560194585|FG013|Subacute Phase|Withdrawal by Subject|1|||
155207118|NCT01737697|560194586|FG014|Subacute Phase|Withdrawal by Subject|0|||
155207119|NCT01737697|560194572|FG000|Subacute Phase|Lost to Follow-up|0|||
155207120|NCT01737697|560194573|FG001|Subacute Phase|Lost to Follow-up|0|||
155207121|NCT01737697|560194574|FG002|Subacute Phase|Lost to Follow-up|0|||
155207122|NCT01737697|560194575|FG003|Subacute Phase|Lost to Follow-up|0|||
155207123|NCT01737697|560194576|FG004|Subacute Phase|Lost to Follow-up|0|||
155207124|NCT01737697|560194577|FG005|Subacute Phase|Lost to Follow-up|0|||
155207125|NCT01737697|560194578|FG006|Subacute Phase|Lost to Follow-up|0|||
155207126|NCT01737697|560194579|FG007|Subacute Phase|Lost to Follow-up|0|||
155207127|NCT01737697|560194580|FG008|Subacute Phase|Lost to Follow-up|0|||
155207128|NCT01737697|560194581|FG009|Subacute Phase|Lost to Follow-up|0|||
155207129|NCT01737697|560194582|FG010|Subacute Phase|Lost to Follow-up|0|||
155207130|NCT01737697|560194583|FG011|Subacute Phase|Lost to Follow-up|0|||
155207131|NCT01737697|560194584|FG012|Subacute Phase|Lost to Follow-up|0|||
155207132|NCT01737697|560194585|FG013|Subacute Phase|Lost to Follow-up|0|||
155207133|NCT01737697|560194586|FG014|Subacute Phase|Lost to Follow-up|1|||
155207134|NCT01737697|560194572|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
155207135|NCT01737697|560194573|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
155207136|NCT01737697|560194574|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
155207137|NCT01737697|560194575|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
155207138|NCT01737697|560194576|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
155207139|NCT01737697|560194577|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
155207140|NCT01737697|560194578|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
155207141|NCT01737697|560194579|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
155207142|NCT01737697|560194580|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
155207143|NCT01737697|560194581|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
155207144|NCT01737697|560194582|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
155207145|NCT01737697|560194583|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
155207146|NCT01737697|560194584|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
155207147|NCT01737697|560194585|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
155207148|NCT01737697|560194586|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
155207149|NCT01737697|560194572|FG000|Subacute Phase|Protocol Violation|0|||
155207150|NCT01737697|560194573|FG001|Subacute Phase|Protocol Violation|0|||
155207151|NCT01737697|560194574|FG002|Subacute Phase|Protocol Violation|0|||
155207152|NCT01737697|560194575|FG003|Subacute Phase|Protocol Violation|0|||
155207153|NCT01737697|560194576|FG004|Subacute Phase|Protocol Violation|0|||
155207154|NCT01737697|560194577|FG005|Subacute Phase|Protocol Violation|1|||
155207155|NCT01737697|560194578|FG006|Subacute Phase|Protocol Violation|0|||
155207156|NCT01737697|560194579|FG007|Subacute Phase|Protocol Violation|0|||
155207157|NCT01737697|560194580|FG008|Subacute Phase|Protocol Violation|0|||
155207158|NCT01737697|560194581|FG009|Subacute Phase|Protocol Violation|0|||
155207159|NCT01737697|560194582|FG010|Subacute Phase|Protocol Violation|1|||
155207160|NCT01737697|560194583|FG011|Subacute Phase|Protocol Violation|0|||
155207161|NCT01737697|560194584|FG012|Subacute Phase|Protocol Violation|0|||
155207162|NCT01737697|560194585|FG013|Subacute Phase|Protocol Violation|0|||
155207163|NCT01737697|560194586|FG014|Subacute Phase|Protocol Violation|0|||
155207164|NCT01737697|560194572|FG000|Subacute Phase|Physician Decision|0|||
155207165|NCT01737697|560194573|FG001|Subacute Phase|Physician Decision|0|||
155207166|NCT01737697|560194574|FG002|Subacute Phase|Physician Decision|0|||
155207167|NCT01737697|560194575|FG003|Subacute Phase|Physician Decision|0|||
155207168|NCT01737697|560194576|FG004|Subacute Phase|Physician Decision|0|||
155207169|NCT01737697|560194577|FG005|Subacute Phase|Physician Decision|0|||
155207170|NCT01737697|560194578|FG006|Subacute Phase|Physician Decision|0|||
155207171|NCT01737697|560194579|FG007|Subacute Phase|Physician Decision|0|||
155207172|NCT01737697|560194580|FG008|Subacute Phase|Physician Decision|1|||
155207173|NCT01737697|560194581|FG009|Subacute Phase|Physician Decision|0|||
155207174|NCT01737697|560194582|FG010|Subacute Phase|Physician Decision|0|||
155207175|NCT01737697|560194583|FG011|Subacute Phase|Physician Decision|0|||
155207176|NCT01737697|560194584|FG012|Subacute Phase|Physician Decision|0|||
155207177|NCT01737697|560194585|FG013|Subacute Phase|Physician Decision|0|||
155207178|NCT01737697|560194586|FG014|Subacute Phase|Physician Decision|0|||
155207179|NCT01737697|560194572|FG000|Subacute Phase|Death|0|||
155207180|NCT01737697|560194573|FG001|Subacute Phase|Death|0|||
155207181|NCT01737697|560194574|FG002|Subacute Phase|Death|0|||
155207182|NCT01737697|560194575|FG003|Subacute Phase|Death|0|||
155207183|NCT01737697|560194576|FG004|Subacute Phase|Death|0|||
155207184|NCT01737697|560194577|FG005|Subacute Phase|Death|0|||
155207185|NCT01737697|560194578|FG006|Subacute Phase|Death|0|||
155207186|NCT01737697|560194579|FG007|Subacute Phase|Death|0|||
155207187|NCT01737697|560194580|FG008|Subacute Phase|Death|0|||
155207188|NCT01737697|560194581|FG009|Subacute Phase|Death|0|||
155207189|NCT01737697|560194582|FG010|Subacute Phase|Death|1|||
155207190|NCT01737697|560194583|FG011|Subacute Phase|Death|0|||
155207191|NCT01737697|560194584|FG012|Subacute Phase|Death|0|||
155207192|NCT01737697|560194585|FG013|Subacute Phase|Death|0|||
155207193|NCT01737697|560194586|FG014|Subacute Phase|Death|0|||
155207194|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
155207195|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
155207196|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
155207197|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207198|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207199|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207200|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207201|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207202|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207203|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207204|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
155207205|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
155207206|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207207|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
155207208|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207209|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207210|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207211|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207212|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207213|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207214|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207215|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
155207216|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
155207217|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
155207218|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
155207219|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207220|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207221|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207222|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207223|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207224|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207225|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207226|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
155207227|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
155207228|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
155207229|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207230|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207231|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207232|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207233|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207234|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207235|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207236|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207237|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
155207238|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
155207239|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
155207240|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
155207241|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207242|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207243|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207244|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207245|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207246|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207247|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207248|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
155207249|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207250|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
155207251|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
155207252|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207253|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207254|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207255|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207256|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207257|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207258|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207259|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
155207260|NCT02207244|560194589|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207261|NCT02207244|560194590|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
155207262|NCT02207244|560194591|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207263|NCT02207244|560194592|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207264|NCT02207244|560194593|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207265|NCT02207244|560194594|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207266|NCT02207244|560194595|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207267|NCT02207244|560194596|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207268|NCT02207244|560194597|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207269|NCT02207244|560194598|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207270|NCT02207244|560194599|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
155207271|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207272|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207273|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207274|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207275|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
155207276|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
155207277|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207278|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207279|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207280|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207281|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
155207282|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207283|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207284|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207285|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207286|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207287|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
155207288|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207289|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207290|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207291|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207292|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
155207293|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207294|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207295|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207296|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
155207297|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
155207298|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
155207299|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207300|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207301|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207302|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207303|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
155207304|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207305|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207306|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207307|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
155207308|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
155207309|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
155207310|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207311|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207312|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207313|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207314|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
155207315|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207316|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207317|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207318|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
155207319|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207320|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
155207321|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207322|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207323|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207324|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207325|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
155207326|NCT02207244|560194589|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207327|NCT02207244|560194590|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207328|NCT02207244|560194591|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207329|NCT02207244|560194592|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
155207330|NCT02207244|560194593|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207331|NCT02207244|560194594|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207332|NCT02207244|560194595|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207333|NCT02207244|560194596|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207334|NCT02207244|560194597|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207335|NCT02207244|560194598|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207336|NCT02207244|560194599|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
155207337|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207338|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207339|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207340|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207341|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207342|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207343|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
155207344|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
155207345|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
155207346|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
155207347|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
155207348|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207349|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207350|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207351|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207352|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207353|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207354|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207355|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
155207356|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207357|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207358|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
155207359|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207360|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207361|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207362|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207363|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207364|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207365|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
155207366|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
155207367|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
155207368|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
155207369|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
155207370|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207371|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207372|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207373|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207374|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207375|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207376|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
155207377|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
155207378|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207379|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
155207380|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
155207381|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207382|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207383|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207384|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207385|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207386|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207387|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
155207388|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
155207389|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
155207390|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
155207391|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
155207392|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207393|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207394|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207395|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207396|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207397|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207398|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207399|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
155207400|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
155207401|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207402|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
155207403|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207404|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207405|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207406|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207407|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207408|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207409|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207410|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207411|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
155207412|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207413|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
155207414|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207415|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207416|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207417|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207418|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207419|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207420|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207421|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
155207422|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207423|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207424|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
155207425|NCT02207244|560194589|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207426|NCT02207244|560194590|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207427|NCT02207244|560194591|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207428|NCT02207244|560194592|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207429|NCT02207244|560194593|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207430|NCT02207244|560194594|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207431|NCT02207244|560194595|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
155207432|NCT02207244|560194596|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207433|NCT02207244|560194597|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207434|NCT02207244|560194598|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207435|NCT02207244|560194599|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
155207436|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207437|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207438|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207439|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207440|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207441|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207442|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207443|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207444|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
155207445|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
155207446|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
155207447|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207448|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207449|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207450|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207451|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207452|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207453|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207454|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207455|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
155207456|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
155207457|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
155207458|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207459|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207460|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207461|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207462|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207463|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207464|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207465|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207466|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
155207467|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
155207468|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
155207469|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207470|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207471|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207472|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207473|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207474|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207475|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207476|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207477|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
155207478|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
155207479|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
155207480|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
155207481|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
155207482|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
155207483|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
155207484|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
155207485|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
155207486|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
155207487|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
155207488|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
155207489|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
155207490|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
155207491|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
155207492|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
155207493|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
155207494|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
155207495|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
155207496|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
155207497|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
155207498|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
155207499|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
155207500|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
155207501|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
155207502|NCT02207244|560194589|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207503|NCT02207244|560194590|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207504|NCT02207244|560194591|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207505|NCT02207244|560194592|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207506|NCT02207244|560194593|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207507|NCT02207244|560194594|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207508|NCT02207244|560194595|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207509|NCT02207244|560194596|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207510|NCT02207244|560194597|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207511|NCT02207244|560194598|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
155207512|NCT02207244|560194599|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
155207513|NCT01950741|560194602|FG000|Overall Study|Lost to Follow-up|1|||
155207514|NCT01950741|560194602|FG000|Overall Study|Death|1|||
155207515|NCT01950741|560194602|FG000|Overall Study|Withdrawal by Subject|1|||
155207516|NCT00471328|560194607|FG000|Core Phase|Adverse Event|18|||
155207517|NCT00471328|560194608|FG001|Core Phase|Adverse Event|6|||
155207518|NCT00471328|560194607|FG000|Core Phase|Death|8|||
155207519|NCT00471328|560194608|FG001|Core Phase|Death|4|||
155207520|NCT00471328|560194607|FG000|Core Phase|Withdrawal by Subject|2|||
155207521|NCT00471328|560194608|FG001|Core Phase|Withdrawal by Subject|2|||
155207522|NCT00471328|560194607|FG000|Core Phase|Abnormal laboratory value|1|||
155207523|NCT00471328|560194608|FG001|Core Phase|Abnormal laboratory value|0|||
155207524|NCT00471328|560194607|FG000|Core Phase|Disease Progression|78|||
155207525|NCT00471328|560194608|FG001|Core Phase|Disease Progression|53|||
155207526|NCT00471328|560194607|FG000|Core Phase|Administrative Problem|0|||
155207527|NCT00471328|560194608|FG001|Core Phase|Administrative Problem|1|||
155207528|NCT00471328|560194607|FG000|Core Phase|Protocol Deviation|0|||
155207529|NCT00471328|560194608|FG001|Core Phase|Protocol Deviation|1|||
155207530|NCT00471328|560194607|FG000|Extension Phase|Adverse Event|3|||
155207531|NCT00471328|560194608|FG001|Extension Phase|Adverse Event|12|||
155207532|NCT00471328|560194607|FG000|Extension Phase|Withdrawal by Subject|0|||
155207533|NCT00471328|560194608|FG001|Extension Phase|Withdrawal by Subject|2|||
155207534|NCT00471328|560194607|FG000|Extension Phase|Death|1|||
155207535|NCT00471328|560194608|FG001|Extension Phase|Death|7|||
155207536|NCT00471328|560194607|FG000|Extension Phase|Protocol Deviation|3|||
155207537|NCT00471328|560194608|FG001|Extension Phase|Protocol Deviation|1|||
155207538|NCT00471328|560194607|FG000|Extension Phase|Treatment duration as per protocol|0|||
155207539|NCT00471328|560194608|FG001|Extension Phase|Treatment duration as per protocol|1|||
155207540|NCT00471328|560194607|FG000|Extension Phase|Disease Progression|32|||
155207541|NCT00471328|560194608|FG001|Extension Phase|Disease Progression|44|||
155207542|NCT00471328|560194607|FG000|Extension Phase|New cancer Therapy|1|||
155207543|NCT00471328|560194608|FG001|Extension Phase|New cancer Therapy|0|||
155207544|NCT00471328|560194607|FG000|Extension Phase|Administrative Problem|1|||
155207545|NCT00471328|560194608|FG001|Extension Phase|Administrative Problem|0|||
155207546|NCT04051008|560194609|FG000|Overall Study|Withdrawal by Subject|2|||
155207547|NCT04051008|560194610|FG001|Overall Study|Withdrawal by Subject|0|||
155207548|NCT04051008|560194611|FG002|Overall Study|Withdrawal by Subject|1|||
155207549|NCT02233647|560194612|FG000|Overall Study|Adverse Event|1|||
155207550|NCT00458211|560194616|FG000|Overall Study|Lack of Efficacy|12|||
155207551|NCT00458211|560194616|FG000|Overall Study|Withdrawal by Subject|2|||
155207552|NCT00458211|560194616|FG000|Overall Study|Protocol Violation|2|||
155207553|NCT04342897|560194617|FG000|Overall Study|Death|7|||
155207554|NCT04342897|560194618|FG001|Overall Study|Death|4|||
155207555|NCT04342897|560194617|FG000|Overall Study|Lost to Follow-up|6|||
155207556|NCT04342897|560194618|FG001|Overall Study|Lost to Follow-up|6|||
155207557|NCT04342897|560194617|FG000|Overall Study|Withdrawal by Subject|1|||
155207558|NCT04342897|560194618|FG001|Overall Study|Withdrawal by Subject|2|||
155207559|NCT04600921|560194628|FG000|Overall Study|Withdrawal by Subject|3|||
155207560|NCT04600921|560194629|FG001|Overall Study|Withdrawal by Subject|5|||
155207561|NCT04600921|560194628|FG000|Overall Study|Death|0|||
155207562|NCT04600921|560194629|FG001|Overall Study|Death|1|||
155207563|NCT05425745|560194633|FG000|Overall Study|Withdrawal of Consent|3|||
155207564|NCT05425745|560194634|FG001|Overall Study|Withdrawal of Consent|3|||
155207565|NCT05425745|560194633|FG000|Overall Study|Death|2|||
155207566|NCT05425745|560194634|FG001|Overall Study|Death|3|||
155207567|NCT05425745|560194633|FG000|Overall Study|Lost to Follow-up|1|||
155207568|NCT05425745|560194634|FG001|Overall Study|Lost to Follow-up|2|||
155207569|NCT05425745|560194633|FG000|Overall Study|Adverse Event|0|||
155207570|NCT05425745|560194634|FG001|Overall Study|Adverse Event|1|||
155207571|NCT05425745|560194633|FG000|Overall Study|Did not return for end of study visit|0|||
155207572|NCT05425745|560194634|FG001|Overall Study|Did not return for end of study visit|1|||
155207573|NCT05425745|560194633|FG000|Overall Study|End of study visit completed by phone|1|||
155207574|NCT05425745|560194634|FG001|Overall Study|End of study visit completed by phone|0|||
155207575|NCT05425745|560194633|FG000|Overall Study|Subject decision|1|||
155207576|NCT05425745|560194634|FG001|Overall Study|Subject decision|0|||
155207577|NCT00524368|560196330|FG000|Overall Study|Adverse Event|10|||
155207578|NCT00524368|560196331|FG001|Overall Study|Adverse Event|12|||
155207579|NCT00524368|560196330|FG000|Overall Study|Lost to Follow-up|9|||
155207580|NCT00524368|560196331|FG001|Overall Study|Lost to Follow-up|13|||
155207581|NCT00524368|560196330|FG000|Overall Study|Withdrawal by Subject|4|||
155207582|NCT00524368|560196331|FG001|Overall Study|Withdrawal by Subject|5|||
155207583|NCT00524368|560196330|FG000|Overall Study|Non-compliant|8|||
155207584|NCT00524368|560196331|FG001|Overall Study|Non-compliant|9|||
155207585|NCT00524368|560196330|FG000|Overall Study|Reached a Virologic Endpoint|3|||
155207586|NCT00524368|560196331|FG001|Overall Study|Reached a Virologic Endpoint|2|||
155207587|NCT00524368|560196330|FG000|Overall Study|Sponsor's Decision|2|||
155207588|NCT00524368|560196331|FG001|Overall Study|Sponsor's Decision|0|||
155207589|NCT00524368|560196330|FG000|Overall Study|Ineligible to Continue the study|2|||
155207590|NCT00524368|560196331|FG001|Overall Study|Ineligible to Continue the study|5|||
155207591|NCT00524368|560196330|FG000|Overall Study|Other|3|||
155207592|NCT00524368|560196331|FG001|Overall Study|Other|2|||
155207593|NCT04023526|560196332|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
155207594|NCT04023526|560196333|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
155207595|NCT04023526|560196332|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
155207596|NCT04023526|560196333|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
155207597|NCT00793403|560196340|FG000|Overall Study|Other|73|||
155207598|NCT00842712|560196343|FG000|Safety Run-in Part|Adverse Event|0|||
155207599|NCT00842712|560196344|FG001|Safety Run-in Part|Adverse Event|1|||
155207600|NCT00842712|560196345|FG002|Safety Run-in Part|Adverse Event|0|||
155207601|NCT00842712|560196346|FG003|Safety Run-in Part|Adverse Event|0|||
155207602|NCT00842712|560196347|FG004|Safety Run-in Part|Adverse Event|0|||
155207603|NCT00842712|560196348|FG005|Safety Run-in Part|Adverse Event|0|||
155207604|NCT00842712|560196349|FG006|Safety Run-in Part|Adverse Event|0|||
155207605|NCT00842712|560196343|FG000|Safety Run-in Part|Progressive disease|3|||
155207606|NCT00842712|560196344|FG001|Safety Run-in Part|Progressive disease|1|||
155207607|NCT00842712|560196345|FG002|Safety Run-in Part|Progressive disease|0|||
155207608|NCT00842712|560196346|FG003|Safety Run-in Part|Progressive disease|1|||
155207609|NCT00842712|560196347|FG004|Safety Run-in Part|Progressive disease|0|||
155207610|NCT00842712|560196348|FG005|Safety Run-in Part|Progressive disease|0|||
155207611|NCT00842712|560196349|FG006|Safety Run-in Part|Progressive disease|0|||
155207612|NCT00842712|560196343|FG000|Randomized Part|Randomized but not treated|0|||
155207613|NCT00842712|560196344|FG001|Randomized Part|Randomized but not treated|0|||
155207614|NCT00842712|560196345|FG002|Randomized Part|Randomized but not treated|0|||
155207615|NCT00842712|560196346|FG003|Randomized Part|Randomized but not treated|0|||
155207616|NCT00842712|560196347|FG004|Randomized Part|Randomized but not treated|0|||
155207617|NCT00842712|560196348|FG005|Randomized Part|Randomized but not treated|1|||
155207618|NCT00842712|560196349|FG006|Randomized Part|Randomized but not treated|4|||
155207619|NCT00842712|560196343|FG000|Randomized Part|Ongoing at cut-off date|0|||
155207620|NCT00842712|560196344|FG001|Randomized Part|Ongoing at cut-off date|0|||
155207621|NCT00842712|560196345|FG002|Randomized Part|Ongoing at cut-off date|0|||
155207622|NCT00842712|560196346|FG003|Randomized Part|Ongoing at cut-off date|0|||
155207623|NCT00842712|560196347|FG004|Randomized Part|Ongoing at cut-off date|0|||
155207624|NCT00842712|560196348|FG005|Randomized Part|Ongoing at cut-off date|0|||
155207625|NCT00842712|560196349|FG006|Randomized Part|Ongoing at cut-off date|2|||
155207626|NCT00410046|560196350|FG000|Overall Study|Adverse Event|3|||
155207627|NCT00410046|560196350|FG000|Overall Study|Withdrawal by Subject|1|||
155207628|NCT00410046|560196350|FG000|Overall Study|Lost to Follow-up|1|||
155207629|NCT02141282|560196358|FG000|Overall Study|Adverse event, not related to progression|8|||
155207630|NCT02141282|560196359|FG001|Overall Study|Adverse event, not related to progression|1|||
155207631|NCT02141282|560196360|FG002|Overall Study|Adverse event, not related to progression|3|||
155207632|NCT02141282|560196361|FG003|Overall Study|Adverse event, not related to progression|1|||
155207633|NCT02141282|560196358|FG000|Overall Study|Adverse event, related to progression|1|||
155207634|NCT02141282|560196359|FG001|Overall Study|Adverse event, related to progression|0|||
155207635|NCT02141282|560196360|FG002|Overall Study|Adverse event, related to progression|2|||
155207636|NCT02141282|560196361|FG003|Overall Study|Adverse event, related to progression|0|||
155207637|NCT02141282|560196358|FG000|Overall Study|COVID-19 infection|1|||
155207638|NCT02141282|560196359|FG001|Overall Study|COVID-19 infection|0|||
155207639|NCT02141282|560196360|FG002|Overall Study|COVID-19 infection|0|||
155207640|NCT02141282|560196361|FG003|Overall Study|COVID-19 infection|0|||
155207641|NCT02141282|560196358|FG000|Overall Study|Lost to Follow-up|0|||
155207642|NCT02141282|560196359|FG001|Overall Study|Lost to Follow-up|0|||
155207643|NCT02141282|560196360|FG002|Overall Study|Lost to Follow-up|4|||
155207644|NCT02141282|560196361|FG003|Overall Study|Lost to Follow-up|2|||
155207645|NCT02141282|560196358|FG000|Overall Study|Other, not specified|14|||
155207646|NCT02141282|560196359|FG001|Overall Study|Other, not specified|11|||
155207647|NCT02141282|560196360|FG002|Overall Study|Other, not specified|23|||
155207648|NCT02141282|560196361|FG003|Overall Study|Other, not specified|9|||
155207649|NCT02141282|560196358|FG000|Overall Study|Progressive disease, Richter's|4|||
155207650|NCT02141282|560196359|FG001|Overall Study|Progressive disease, Richter's|1|||
155207651|NCT02141282|560196360|FG002|Overall Study|Progressive disease, Richter's|1|||
155207652|NCT02141282|560196361|FG003|Overall Study|Progressive disease, Richter's|1|||
155207653|NCT02141282|560196358|FG000|Overall Study|Progressive disease per protocol|12|||
155207654|NCT02141282|560196359|FG001|Overall Study|Progressive disease per protocol|7|||
155207655|NCT02141282|560196360|FG002|Overall Study|Progressive disease per protocol|9|||
155207656|NCT02141282|560196361|FG003|Overall Study|Progressive disease per protocol|2|||
155207657|NCT02141282|560196358|FG000|Overall Study|Stem cell transplant|1|||
155207658|NCT02141282|560196359|FG001|Overall Study|Stem cell transplant|0|||
155207659|NCT02141282|560196360|FG002|Overall Study|Stem cell transplant|1|||
155207660|NCT02141282|560196361|FG003|Overall Study|Stem cell transplant|0|||
155207661|NCT02141282|560196358|FG000|Overall Study|Study terminated by Sponsor|0|||
155207662|NCT02141282|560196359|FG001|Overall Study|Study terminated by Sponsor|1|||
155207663|NCT02141282|560196360|FG002|Overall Study|Study terminated by Sponsor|0|||
155207664|NCT02141282|560196361|FG003|Overall Study|Study terminated by Sponsor|0|||
155207665|NCT02141282|560196358|FG000|Overall Study|Subject non-compliance|0|||
155207666|NCT02141282|560196359|FG001|Overall Study|Subject non-compliance|0|||
155207667|NCT02141282|560196360|FG002|Overall Study|Subject non-compliance|1|||
155207668|NCT02141282|560196361|FG003|Overall Study|Subject non-compliance|0|||
155207669|NCT02141282|560196358|FG000|Overall Study|Withdrew consent|2|||
155207670|NCT02141282|560196359|FG001|Overall Study|Withdrew consent|0|||
155207671|NCT02141282|560196360|FG002|Overall Study|Withdrew consent|4|||
155207672|NCT02141282|560196361|FG003|Overall Study|Withdrew consent|0|||
155207673|NCT03312933|560196362|FG000|Overall Study|Protocol Violation|15|||
155207674|NCT03312933|560196362|FG000|Overall Study|Lost to Follow-up|36|||
155207675|NCT03312933|560196362|FG000|Overall Study|Withdrawal by Subject|3|||
155207676|NCT01752907|560196364|FG000|Overall Study|Withdrawal by Subject|4|||
155207677|NCT01752907|560196365|FG001|Overall Study|Withdrawal by Subject|10|||
155207678|NCT01752907|560196364|FG000|Overall Study|Lost to Follow-up|2|||
155207679|NCT01752907|560196365|FG001|Overall Study|Lost to Follow-up|1|||
155207680|NCT01752907|560196364|FG000|Overall Study|Decision by Sponsor|6|||
155207681|NCT01752907|560196365|FG001|Overall Study|Decision by Sponsor|9|||
155207682|NCT03098550|560196366|FG000|Overall Study|Disease Progression|30|||
155207683|NCT03098550|560196367|FG001|Overall Study|Disease Progression|19|||
155207684|NCT03098550|560196368|FG002|Overall Study|Disease Progression|41|||
155207685|NCT03098550|560196366|FG000|Overall Study|Study Drug Toxicity|2|||
155207686|NCT03098550|560196367|FG001|Overall Study|Study Drug Toxicity|1|||
155207687|NCT03098550|560196368|FG002|Overall Study|Study Drug Toxicity|0|||
155207688|NCT03098550|560196366|FG000|Overall Study|Death|1|||
155207689|NCT03098550|560196367|FG001|Overall Study|Death|0|||
155207690|NCT03098550|560196368|FG002|Overall Study|Death|0|||
155207691|NCT03098550|560196366|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
155207692|NCT03098550|560196367|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
155207693|NCT03098550|560196368|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
155207694|NCT03098550|560196366|FG000|Overall Study|Administrative reason by sponsor|0|||
155207695|NCT03098550|560196367|FG001|Overall Study|Administrative reason by sponsor|0|||
155207696|NCT03098550|560196368|FG002|Overall Study|Administrative reason by sponsor|1|||
155207697|NCT03098550|560196366|FG000|Overall Study|Other reasons|2|||
155207698|NCT03098550|560196367|FG001|Overall Study|Other reasons|0|||
155207699|NCT03098550|560196368|FG002|Overall Study|Other reasons|0|||
155207700|NCT01384760|560196369|FG000|Overall Study|Lost to Follow-up|0|||
155207701|NCT01384760|560196370|FG001|Overall Study|Lost to Follow-up|6|||
155207702|NCT01384760|560196369|FG000|Overall Study|Protocol Violation|16|||
155207703|NCT01384760|560196370|FG001|Overall Study|Protocol Violation|0|||
155207704|NCT00630396|560196371|FG000|Overall Study|Death|4|||
155207705|NCT00630396|560196371|FG000|Overall Study|Lost to Follow-up|3|||
155207706|NCT02990910|560196375|FG000|Overall Study|Lack of Efficacy|6|||
155207707|NCT02990910|560196376|FG001|Overall Study|Lack of Efficacy|10|||
155207708|NCT02989194|560196386|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
155207709|NCT02989194|560196387|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
155207710|NCT02989194|560196388|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
155207711|NCT02989194|560196386|FG000|Overall Study|Lost to Follow-up|0|||
155207712|NCT02989194|560196387|FG001|Overall Study|Lost to Follow-up|1|||
155207713|NCT02989194|560196388|FG002|Overall Study|Lost to Follow-up|0|||
155207714|NCT02989194|560196386|FG000|Overall Study|Withdrawal by Subject|0|||
155207715|NCT02989194|560196387|FG001|Overall Study|Withdrawal by Subject|1|||
155207716|NCT02989194|560196388|FG002|Overall Study|Withdrawal by Subject|0|||
155207717|NCT00482612|560196389|FG000|In-treatment Period|No study medication administered|0|||
155207718|NCT00482612|560196390|FG001|In-treatment Period|No study medication administered|0|||
155207719|NCT00482612|560196391|FG002|In-treatment Period|No study medication administered|1|||
155207720|NCT00482612|560196392|FG003|In-treatment Period|No study medication administered|0|||
155207721|NCT00482612|560196389|FG000|Follow-up Period|Other|4|||
155207722|NCT00482612|560196390|FG001|Follow-up Period|Other|2|||
155207723|NCT00482612|560196391|FG002|Follow-up Period|Other|1|||
155207724|NCT00482612|560196392|FG003|Follow-up Period|Other|2|||
155207725|NCT00482612|560196389|FG000|Follow-up Period|Lack of compliance|0|||
155207726|NCT00482612|560196390|FG001|Follow-up Period|Lack of compliance|0|||
155207727|NCT00482612|560196391|FG002|Follow-up Period|Lack of compliance|1|||
155207728|NCT00482612|560196392|FG003|Follow-up Period|Lack of compliance|0|||
155207729|NCT00482612|560196389|FG000|Follow-up Period|Lost to Follow-up|0|||
155207730|NCT00482612|560196390|FG001|Follow-up Period|Lost to Follow-up|4|||
155207731|NCT00482612|560196391|FG002|Follow-up Period|Lost to Follow-up|2|||
155207732|NCT00482612|560196392|FG003|Follow-up Period|Lost to Follow-up|1|||
155207733|NCT00482612|560196389|FG000|Follow-up Period|Adverse Event|4|||
155207734|NCT00482612|560196390|FG001|Follow-up Period|Adverse Event|7|||
155207735|NCT00482612|560196391|FG002|Follow-up Period|Adverse Event|9|||
155207736|NCT00482612|560196392|FG003|Follow-up Period|Adverse Event|0|||
155207737|NCT00482612|560196389|FG000|Follow-up Period|Lack of Efficacy|2|||
155207738|NCT00482612|560196390|FG001|Follow-up Period|Lack of Efficacy|0|||
155207739|NCT00482612|560196391|FG002|Follow-up Period|Lack of Efficacy|1|||
155207740|NCT00482612|560196392|FG003|Follow-up Period|Lack of Efficacy|0|||
155207741|NCT00482612|560196389|FG000|Follow-up Period|Withdrawal by Subject|3|||
155207742|NCT00482612|560196390|FG001|Follow-up Period|Withdrawal by Subject|5|||
155207743|NCT00482612|560196391|FG002|Follow-up Period|Withdrawal by Subject|7|||
155207744|NCT00482612|560196392|FG003|Follow-up Period|Withdrawal by Subject|2|||
155207745|NCT00482612|560196389|FG000|Follow-up Period|Reasons not related to trial|1|||
155207746|NCT00482612|560196390|FG001|Follow-up Period|Reasons not related to trial|0|||
155207747|NCT00482612|560196391|FG002|Follow-up Period|Reasons not related to trial|1|||
155207748|NCT00482612|560196392|FG003|Follow-up Period|Reasons not related to trial|3|||
155207749|NCT03506815|560196393|FG000|Overall Study|Adverse Event|8|||
155207750|NCT03506815|560196394|FG001|Overall Study|Adverse Event|0|||
155207751|NCT03506815|560196393|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
155207752|NCT03506815|560196394|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
155207753|NCT03506815|560196393|FG000|Overall Study|Protocol Violation|1|||
155207754|NCT03506815|560196394|FG001|Overall Study|Protocol Violation|0|||
155207755|NCT03506815|560196393|FG000|Overall Study|Elective Surgery|1|||
155207756|NCT03506815|560196394|FG001|Overall Study|Elective Surgery|0|||
155207757|NCT04160091|560196395|FG000|Overall Study|Terminated by Sponsor|7|||
155207758|NCT04160091|560196396|FG001|Overall Study|Terminated by Sponsor|3|||
155207759|NCT04160091|560196397|FG002|Overall Study|Terminated by Sponsor|5|||
155207760|NCT04160091|560196398|FG003|Overall Study|Terminated by Sponsor|2|||
155207761|NCT04160091|560196395|FG000|Overall Study|Noncompliance|0|||
155207762|NCT04160091|560196396|FG001|Overall Study|Noncompliance|0|||
155207763|NCT04160091|560196397|FG002|Overall Study|Noncompliance|0|||
155207764|NCT04160091|560196398|FG003|Overall Study|Noncompliance|1|||
155207765|NCT04160091|560196395|FG000|Overall Study|Withdrawal by Subject|0|||
155207766|NCT04160091|560196396|FG001|Overall Study|Withdrawal by Subject|0|||
155207767|NCT04160091|560196397|FG002|Overall Study|Withdrawal by Subject|0|||
155207768|NCT04160091|560196398|FG003|Overall Study|Withdrawal by Subject|1|||
155207769|NCT00381095|560196402|FG000|Overall Study|Death|3|||
155207770|NCT00381095|560196403|FG001|Overall Study|Death|4|||
155207771|NCT00381095|560196402|FG000|Overall Study|Lack of Efficacy|2|||
155207772|NCT00381095|560196403|FG001|Overall Study|Lack of Efficacy|4|||
155207773|NCT00381095|560196402|FG000|Overall Study|Other|2|||
155207774|NCT00381095|560196403|FG001|Overall Study|Other|2|||
155207775|NCT00381095|560196402|FG000|Overall Study|Protocol Violation|1|||
155207776|NCT00381095|560196403|FG001|Overall Study|Protocol Violation|1|||
155207777|NCT00381095|560196402|FG000|Overall Study|Withdrawal by Subject|3|||
155207778|NCT00381095|560196403|FG001|Overall Study|Withdrawal by Subject|3|||
155207779|NCT00381095|560196402|FG000|Overall Study|Adverse Event|2|||
155207780|NCT00381095|560196403|FG001|Overall Study|Adverse Event|7|||
155207781|NCT00856284|560196410|FG000|Overall Study|Hyperglycemic rescue|231|||
155207782|NCT00856284|560196411|FG001|Overall Study|Hyperglycemic rescue|201|||
155207783|NCT00856284|560196412|FG002|Overall Study|Hyperglycemic rescue|235|||
155207784|NCT00856284|560196410|FG000|Overall Study|Adverse Event|60|||
155207785|NCT00856284|560196411|FG001|Overall Study|Adverse Event|74|||
155207786|NCT00856284|560196412|FG002|Overall Study|Adverse Event|82|||
155207787|NCT00856284|560196410|FG000|Overall Study|Major protocol deviation|24|||
155207788|NCT00856284|560196411|FG001|Overall Study|Major protocol deviation|16|||
155207789|NCT00856284|560196412|FG002|Overall Study|Major protocol deviation|15|||
155207790|NCT00856284|560196410|FG000|Overall Study|Lost to Follow-up|20|||
155207791|NCT00856284|560196411|FG001|Overall Study|Lost to Follow-up|22|||
155207792|NCT00856284|560196412|FG002|Overall Study|Lost to Follow-up|28|||
155207793|NCT00856284|560196410|FG000|Overall Study|Voluntary withdrawal|48|||
155207794|NCT00856284|560196411|FG001|Overall Study|Voluntary withdrawal|52|||
155207795|NCT00856284|560196412|FG002|Overall Study|Voluntary withdrawal|62|||
155207796|NCT00856284|560196410|FG000|Overall Study|Pregnancy|1|||
155207797|NCT00856284|560196411|FG001|Overall Study|Pregnancy|2|||
155207798|NCT00856284|560196412|FG002|Overall Study|Pregnancy|0|||
155207799|NCT00856284|560196410|FG000|Overall Study|Investigator discretion|9|||
155207800|NCT00856284|560196411|FG001|Overall Study|Investigator discretion|8|||
155207801|NCT00856284|560196412|FG002|Overall Study|Investigator discretion|10|||
155207802|NCT00856284|560196410|FG000|Overall Study|Other|15|||
155207803|NCT00856284|560196411|FG001|Overall Study|Other|17|||
155207804|NCT00856284|560196412|FG002|Overall Study|Other|14|||
155207805|NCT00856284|560196410|FG000|Overall Study|Randomized in error|0|||
155207806|NCT00856284|560196411|FG001|Overall Study|Randomized in error|0|||
155207807|NCT00856284|560196412|FG002|Overall Study|Randomized in error|1|||
155207808|NCT01327885|560196417|FG000|Overall Study|Disease progression-according to RECIST|173|||
155207809|NCT01327885|560196418|FG001|Overall Study|Disease progression-according to RECIST|165|||
155207810|NCT01327885|560196417|FG000|Overall Study|Clinical progression|24|||
155207811|NCT01327885|560196418|FG001|Overall Study|Clinical progression|27|||
155207812|NCT01327885|560196417|FG000|Overall Study|Adverse Event|14|||
155207813|NCT01327885|560196418|FG001|Overall Study|Adverse Event|10|||
155207814|NCT01327885|560196417|FG000|Overall Study|Subject choice|5|||
155207815|NCT01327885|560196418|FG001|Overall Study|Subject choice|10|||
155207816|NCT01327885|560196417|FG000|Overall Study|Other|8|||
155207817|NCT01327885|560196418|FG001|Overall Study|Other|6|||
155207818|NCT01327885|560196417|FG000|Overall Study|Withdrawal of consent from study|3|||
155207819|NCT01327885|560196418|FG001|Overall Study|Withdrawal of consent from study|4|||
155207820|NCT01327885|560196417|FG000|Overall Study|Not treated|1|||
155207821|NCT01327885|560196418|FG001|Overall Study|Not treated|1|||
155207822|NCT01327885|560196417|FG000|Overall Study|Administrative decision|0|||
155207823|NCT01327885|560196418|FG001|Overall Study|Administrative decision|1|||
155207824|NCT04271605|560196421|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
155207825|NCT03138889|560196423|FG000|Overall Study|Withdrawal by Subject|5|||
155207826|NCT03138889|560196424|FG001|Overall Study|Withdrawal by Subject|5|||
155207827|NCT03138889|560196425|FG002|Overall Study|Withdrawal by Subject|0|||
155207828|NCT03138889|560196426|FG003|Overall Study|Withdrawal by Subject|2|||
155207829|NCT03138889|560196427|FG004|Overall Study|Withdrawal by Subject|1|||
155207830|NCT03138889|560196428|FG005|Overall Study|Withdrawal by Subject|3|||
155207831|NCT03138889|560196429|FG006|Overall Study|Withdrawal by Subject|0|||
155207832|NCT03138889|560196430|FG007|Overall Study|Withdrawal by Subject|1|||
155207833|NCT00411645|560196431|FG000|Overall Study|Consent Withdrawn|13|||
155207834|NCT00411645|560196432|FG001|Overall Study|Consent Withdrawn|22|||
155207835|NCT00411645|560196431|FG000|Overall Study|Death|56|||
155207836|NCT00411645|560196432|FG001|Overall Study|Death|135|||
155207837|NCT00411645|560196431|FG000|Overall Study|Investigator/Sponsor Decision|10|||
155207838|NCT00411645|560196432|FG001|Overall Study|Investigator/Sponsor Decision|7|||
155207839|NCT00411645|560196431|FG000|Overall Study|Lost to Follow-up|2|||
155207840|NCT00411645|560196432|FG001|Overall Study|Lost to Follow-up|0|||
155207841|NCT04016285|560196433|FG000|Overall Study|Did not progress to surgery|2|||
155207842|NCT04016285|560196434|FG001|Overall Study|Did not progress to surgery|5|||
155207843|NCT04016285|560196433|FG000|Overall Study|Failed to collect outcome data|5|||
155207844|NCT04016285|560196434|FG001|Overall Study|Failed to collect outcome data|3|||
155207845|NCT01987505|560196435|FG000|Overall Study|Other|9|||
155207846|NCT01987505|560196435|FG000|Overall Study|Withdrawal by Subject|2|||
155207847|NCT01987505|560196435|FG000|Overall Study|Other Reason|2|||
155207848|NCT01987505|560196435|FG000|Overall Study|Lost to Follow-up|15|||
155207849|NCT01987505|560196435|FG000|Overall Study|Investigator Decision|2|||
155207850|NCT01987505|560196435|FG000|Overall Study|Death|4|||
155207851|NCT03042533|560196437|FG000|Overall Study|MD left program|1|||
155207852|NCT03042533|560196438|FG001|Overall Study|MD left program|4|||
155207853|NCT03042533|560196439|FG002|Overall Study|MD left program|1|||
155207854|NCT02794883|560196442|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
155207855|NCT02794883|560196443|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
155207856|NCT02794883|560196444|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
155207857|NCT02794883|560196442|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
155207858|NCT02794883|560196443|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
155207859|NCT02794883|560196444|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
155207860|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
155207861|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
155207862|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
155207863|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
155207864|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
155207865|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
155207866|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
155207867|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
155207868|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
155207869|NCT02794883|560196442|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
155207870|NCT02794883|560196443|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
155207871|NCT02794883|560196444|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
155207872|NCT02794883|560196442|FG000|Follow-up Period (up to 2 Years)|Death|12|||
155207873|NCT02794883|560196443|FG001|Follow-up Period (up to 2 Years)|Death|10|||
155207874|NCT02794883|560196444|FG002|Follow-up Period (up to 2 Years)|Death|10|||
155207875|NCT01366209|560196447|FG000|Overall Study|Adverse Event|6|||
155207876|NCT01366209|560196448|FG001|Overall Study|Adverse Event|7|||
155207877|NCT01366209|560196447|FG000|Overall Study|Withdrawal by Subject|4|||
155207878|NCT01366209|560196448|FG001|Overall Study|Withdrawal by Subject|4|||
155207879|NCT01366209|560196447|FG000|Overall Study|Death|12|||
155207880|NCT01366209|560196448|FG001|Overall Study|Death|19|||
155207881|NCT01366209|560196447|FG000|Overall Study|Lung transplantation|6|||
155207882|NCT01366209|560196448|FG001|Overall Study|Lung transplantation|1|||
155207883|NCT01366209|560196447|FG000|Overall Study|Lost to Follow-up|2|||
155207884|NCT01366209|560196448|FG001|Overall Study|Lost to Follow-up|1|||
155207885|NCT01366209|560196447|FG000|Overall Study|Physician Decision|1|||
155207886|NCT01366209|560196448|FG001|Overall Study|Physician Decision|0|||
155207887|NCT01366209|560196447|FG000|Overall Study|Sponsors decision|0|||
155207888|NCT01366209|560196448|FG001|Overall Study|Sponsors decision|1|||
155207889|NCT01366209|560196447|FG000|Overall Study|Withdrew consent|4|||
155207890|NCT01366209|560196448|FG001|Overall Study|Withdrew consent|3|||
155207891|NCT01053221|560196449|FG000|Overall Study|The study was closed prematurely|5|||
155207892|NCT01053221|560196450|FG001|Overall Study|The study was closed prematurely|9|||
155207893|NCT02266225|560196451|FG000|Overall Study|Lost to Follow-up|2|||
155207894|NCT02266225|560196451|FG000|Overall Study|Death|1|||
155207895|NCT02266225|560196451|FG000|Overall Study|Withdrawal by Subject|13|||
155207896|NCT00420927|560196452|FG000|Period 1|Adverse Event|19|||
155207897|NCT00420927|560196453|FG001|Period 1|Adverse Event|15|||
155207898|NCT00420927|560196454|FG002|Period 1|Adverse Event|0|||
155207899|NCT00420927|560196455|FG003|Period 1|Adverse Event|0|||
155207900|NCT00420927|560196456|FG004|Period 1|Adverse Event|0|||
155207901|NCT00420927|560196457|FG005|Period 1|Adverse Event|0|||
155207902|NCT00420927|560196458|FG006|Period 1|Adverse Event|0|||
155207903|NCT00420927|560196452|FG000|Period 1|Withdrawal by Subject|7|||
155207904|NCT00420927|560196453|FG001|Period 1|Withdrawal by Subject|12|||
155207905|NCT00420927|560196454|FG002|Period 1|Withdrawal by Subject|0|||
155207906|NCT00420927|560196455|FG003|Period 1|Withdrawal by Subject|0|||
155207907|NCT00420927|560196456|FG004|Period 1|Withdrawal by Subject|0|||
155207908|NCT00420927|560196457|FG005|Period 1|Withdrawal by Subject|0|||
155207909|NCT00420927|560196458|FG006|Period 1|Withdrawal by Subject|0|||
155207910|NCT00420927|560196452|FG000|Period 1|Lost to Follow-up|8|||
155207911|NCT00420927|560196453|FG001|Period 1|Lost to Follow-up|6|||
155207912|NCT00420927|560196454|FG002|Period 1|Lost to Follow-up|0|||
155207913|NCT00420927|560196455|FG003|Period 1|Lost to Follow-up|0|||
155207914|NCT00420927|560196456|FG004|Period 1|Lost to Follow-up|0|||
155207915|NCT00420927|560196457|FG005|Period 1|Lost to Follow-up|0|||
155207916|NCT00420927|560196458|FG006|Period 1|Lost to Follow-up|0|||
155207917|NCT00420927|560196452|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
155207918|NCT00420927|560196453|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
155207919|NCT00420927|560196454|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207920|NCT00420927|560196455|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207921|NCT00420927|560196456|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207922|NCT00420927|560196457|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207923|NCT00420927|560196458|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
155207924|NCT00420927|560196452|FG000|Period 1|Death|2|||
155207925|NCT00420927|560196453|FG001|Period 1|Death|0|||
155207926|NCT00420927|560196454|FG002|Period 1|Death|0|||
155207927|NCT00420927|560196455|FG003|Period 1|Death|0|||
155207928|NCT00420927|560196456|FG004|Period 1|Death|0|||
155207929|NCT00420927|560196457|FG005|Period 1|Death|0|||
155207930|NCT00420927|560196458|FG006|Period 1|Death|0|||
155207931|NCT00420927|560196452|FG000|Period 1|Subject moved/relocated|0|||
155207932|NCT00420927|560196453|FG001|Period 1|Subject moved/relocated|2|||
155207933|NCT00420927|560196454|FG002|Period 1|Subject moved/relocated|0|||
155207934|NCT00420927|560196455|FG003|Period 1|Subject moved/relocated|0|||
155207935|NCT00420927|560196456|FG004|Period 1|Subject moved/relocated|0|||
155207936|NCT00420927|560196457|FG005|Period 1|Subject moved/relocated|0|||
155207937|NCT00420927|560196458|FG006|Period 1|Subject moved/relocated|0|||
155207938|NCT00420927|560196452|FG000|Period 1|Noncompliant with study drug|1|||
155207939|NCT00420927|560196453|FG001|Period 1|Noncompliant with study drug|1|||
155207940|NCT00420927|560196454|FG002|Period 1|Noncompliant with study drug|0|||
155207941|NCT00420927|560196455|FG003|Period 1|Noncompliant with study drug|0|||
155207942|NCT00420927|560196456|FG004|Period 1|Noncompliant with study drug|0|||
155207943|NCT00420927|560196457|FG005|Period 1|Noncompliant with study drug|0|||
155207944|NCT00420927|560196458|FG006|Period 1|Noncompliant with study drug|0|||
155207945|NCT00420927|560196452|FG000|Period 1|Randomization error|1|||
155207946|NCT00420927|560196453|FG001|Period 1|Randomization error|0|||
155207947|NCT00420927|560196454|FG002|Period 1|Randomization error|0|||
155207948|NCT00420927|560196455|FG003|Period 1|Randomization error|0|||
155207949|NCT00420927|560196456|FG004|Period 1|Randomization error|0|||
155207950|NCT00420927|560196457|FG005|Period 1|Randomization error|0|||
155207951|NCT00420927|560196458|FG006|Period 1|Randomization error|0|||
155207952|NCT00420927|560196452|FG000|Period 1|Suspected tuberculosis/positive test|1|||
155207953|NCT00420927|560196453|FG001|Period 1|Suspected tuberculosis/positive test|1|||
155207954|NCT00420927|560196454|FG002|Period 1|Suspected tuberculosis/positive test|0|||
155207955|NCT00420927|560196455|FG003|Period 1|Suspected tuberculosis/positive test|0|||
155207956|NCT00420927|560196456|FG004|Period 1|Suspected tuberculosis/positive test|0|||
155207957|NCT00420927|560196457|FG005|Period 1|Suspected tuberculosis/positive test|0|||
155207958|NCT00420927|560196458|FG006|Period 1|Suspected tuberculosis/positive test|0|||
155207959|NCT00420927|560196452|FG000|Period 1|Study site closure|0|||
155207960|NCT00420927|560196453|FG001|Period 1|Study site closure|1|||
155207961|NCT00420927|560196454|FG002|Period 1|Study site closure|0|||
155207962|NCT00420927|560196455|FG003|Period 1|Study site closure|0|||
155207963|NCT00420927|560196456|FG004|Period 1|Study site closure|0|||
155207964|NCT00420927|560196457|FG005|Period 1|Study site closure|0|||
155207965|NCT00420927|560196458|FG006|Period 1|Study site closure|0|||
155207966|NCT00420927|560196452|FG000|Period 1|Subject received new diagnosis|0|||
155207967|NCT00420927|560196453|FG001|Period 1|Subject received new diagnosis|2|||
155207968|NCT00420927|560196454|FG002|Period 1|Subject received new diagnosis|0|||
155207969|NCT00420927|560196455|FG003|Period 1|Subject received new diagnosis|0|||
155207970|NCT00420927|560196456|FG004|Period 1|Subject received new diagnosis|0|||
155207971|NCT00420927|560196457|FG005|Period 1|Subject received new diagnosis|0|||
155207972|NCT00420927|560196458|FG006|Period 1|Subject received new diagnosis|0|||
155207973|NCT00420927|560196452|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
155207974|NCT00420927|560196453|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
155207975|NCT00420927|560196454|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
155207976|NCT00420927|560196455|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
155207977|NCT00420927|560196456|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
155207978|NCT00420927|560196457|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
155207979|NCT00420927|560196458|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
155207980|NCT00420927|560196452|FG000|Period 1|Failed to meet entry criteria|8|||
155207981|NCT00420927|560196453|FG001|Period 1|Failed to meet entry criteria|7|||
155207982|NCT00420927|560196454|FG002|Period 1|Failed to meet entry criteria|0|||
155207983|NCT00420927|560196455|FG003|Period 1|Failed to meet entry criteria|0|||
155207984|NCT00420927|560196456|FG004|Period 1|Failed to meet entry criteria|0|||
155207985|NCT00420927|560196457|FG005|Period 1|Failed to meet entry criteria|0|||
155207986|NCT00420927|560196458|FG006|Period 1|Failed to meet entry criteria|0|||
155207987|NCT00420927|560196452|FG000|Period 1|Took prohibited medication|1|||
155207988|NCT00420927|560196453|FG001|Period 1|Took prohibited medication|3|||
155207989|NCT00420927|560196454|FG002|Period 1|Took prohibited medication|0|||
155207990|NCT00420927|560196455|FG003|Period 1|Took prohibited medication|0|||
155207991|NCT00420927|560196456|FG004|Period 1|Took prohibited medication|0|||
155207992|NCT00420927|560196457|FG005|Period 1|Took prohibited medication|0|||
155207993|NCT00420927|560196458|FG006|Period 1|Took prohibited medication|0|||
155207994|NCT00420927|560196452|FG000|Period 2|Adverse Event|0|||
155207995|NCT00420927|560196453|FG001|Period 2|Adverse Event|0|||
155207996|NCT00420927|560196454|FG002|Period 2|Adverse Event|7|||
155207997|NCT00420927|560196455|FG003|Period 2|Adverse Event|3|||
155207998|NCT00420927|560196456|FG004|Period 2|Adverse Event|17|||
155207999|NCT00420927|560196457|FG005|Period 2|Adverse Event|6|||
155208000|NCT00420927|560196458|FG006|Period 2|Adverse Event|20|||
155208001|NCT00420927|560196452|FG000|Period 2|Withdrawal by Subject|0|||
155208002|NCT00420927|560196453|FG001|Period 2|Withdrawal by Subject|0|||
155208003|NCT00420927|560196454|FG002|Period 2|Withdrawal by Subject|1|||
155208004|NCT00420927|560196455|FG003|Period 2|Withdrawal by Subject|3|||
155208005|NCT00420927|560196456|FG004|Period 2|Withdrawal by Subject|11|||
155208006|NCT00420927|560196457|FG005|Period 2|Withdrawal by Subject|2|||
155208007|NCT00420927|560196458|FG006|Period 2|Withdrawal by Subject|12|||
155208008|NCT00420927|560196452|FG000|Period 2|Lost to Follow-up|0|||
155208009|NCT00420927|560196453|FG001|Period 2|Lost to Follow-up|0|||
155208010|NCT00420927|560196454|FG002|Period 2|Lost to Follow-up|2|||
155208011|NCT00420927|560196455|FG003|Period 2|Lost to Follow-up|2|||
155208012|NCT00420927|560196456|FG004|Period 2|Lost to Follow-up|6|||
155208013|NCT00420927|560196457|FG005|Period 2|Lost to Follow-up|3|||
155208014|NCT00420927|560196458|FG006|Period 2|Lost to Follow-up|9|||
155208015|NCT00420927|560196452|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
155208016|NCT00420927|560196453|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
155208017|NCT00420927|560196454|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
155208018|NCT00420927|560196455|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
155208019|NCT00420927|560196456|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
155208020|NCT00420927|560196457|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
155208021|NCT00420927|560196458|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
155208022|NCT00420927|560196452|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
155208023|NCT00420927|560196453|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
155208024|NCT00420927|560196454|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
155208025|NCT00420927|560196455|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
155208026|NCT00420927|560196456|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
155208027|NCT00420927|560196457|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
155208028|NCT00420927|560196458|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
155208029|NCT00420927|560196452|FG000|Period 2|Subject unable to find transportation|0|||
155208030|NCT00420927|560196453|FG001|Period 2|Subject unable to find transportation|0|||
155208031|NCT00420927|560196454|FG002|Period 2|Subject unable to find transportation|0|||
155208032|NCT00420927|560196455|FG003|Period 2|Subject unable to find transportation|0|||
155208033|NCT00420927|560196456|FG004|Period 2|Subject unable to find transportation|0|||
155208034|NCT00420927|560196457|FG005|Period 2|Subject unable to find transportation|0|||
155208035|NCT00420927|560196458|FG006|Period 2|Subject unable to find transportation|1|||
155208036|NCT00420927|560196452|FG000|Period 2|Physician Decision|0|||
155208037|NCT00420927|560196453|FG001|Period 2|Physician Decision|0|||
155208038|NCT00420927|560196454|FG002|Period 2|Physician Decision|0|||
155208039|NCT00420927|560196455|FG003|Period 2|Physician Decision|0|||
155208040|NCT00420927|560196456|FG004|Period 2|Physician Decision|1|||
155208041|NCT00420927|560196457|FG005|Period 2|Physician Decision|1|||
155208042|NCT00420927|560196458|FG006|Period 2|Physician Decision|0|||
155208043|NCT00420927|560196452|FG000|Period 2|Sponsor decision|0|||
155208044|NCT00420927|560196453|FG001|Period 2|Sponsor decision|0|||
155208045|NCT00420927|560196454|FG002|Period 2|Sponsor decision|1|||
155208046|NCT00420927|560196455|FG003|Period 2|Sponsor decision|0|||
155208047|NCT00420927|560196456|FG004|Period 2|Sponsor decision|0|||
155208048|NCT00420927|560196457|FG005|Period 2|Sponsor decision|0|||
155208049|NCT00420927|560196458|FG006|Period 2|Sponsor decision|1|||
155208050|NCT00420927|560196452|FG000|Period 2|Randomization error|0|||
155208051|NCT00420927|560196453|FG001|Period 2|Randomization error|0|||
155208052|NCT00420927|560196454|FG002|Period 2|Randomization error|0|||
155208053|NCT00420927|560196455|FG003|Period 2|Randomization error|0|||
155208054|NCT00420927|560196456|FG004|Period 2|Randomization error|1|||
155208055|NCT00420927|560196457|FG005|Period 2|Randomization error|1|||
155208056|NCT00420927|560196458|FG006|Period 2|Randomization error|0|||
155208057|NCT00420927|560196452|FG000|Period 2|Noncompliant with study drug|0|||
155208058|NCT00420927|560196453|FG001|Period 2|Noncompliant with study drug|0|||
155208059|NCT00420927|560196454|FG002|Period 2|Noncompliant with study drug|0|||
155208060|NCT00420927|560196455|FG003|Period 2|Noncompliant with study drug|1|||
155208061|NCT00420927|560196456|FG004|Period 2|Noncompliant with study drug|0|||
155208062|NCT00420927|560196457|FG005|Period 2|Noncompliant with study drug|0|||
155208063|NCT00420927|560196458|FG006|Period 2|Noncompliant with study drug|2|||
155208064|NCT00420927|560196452|FG000|Period 2|Methotrexate intolerance|0|||
155208065|NCT00420927|560196453|FG001|Period 2|Methotrexate intolerance|0|||
155208066|NCT00420927|560196454|FG002|Period 2|Methotrexate intolerance|0|||
155208067|NCT00420927|560196455|FG003|Period 2|Methotrexate intolerance|0|||
155208068|NCT00420927|560196456|FG004|Period 2|Methotrexate intolerance|0|||
155208069|NCT00420927|560196457|FG005|Period 2|Methotrexate intolerance|0|||
155208070|NCT00420927|560196458|FG006|Period 2|Methotrexate intolerance|1|||
155208071|NCT00420927|560196452|FG000|Period 2|Took prohibited medication|0|||
155208072|NCT00420927|560196453|FG001|Period 2|Took prohibited medication|0|||
155208073|NCT00420927|560196454|FG002|Period 2|Took prohibited medication|0|||
155208074|NCT00420927|560196455|FG003|Period 2|Took prohibited medication|0|||
155208075|NCT00420927|560196456|FG004|Period 2|Took prohibited medication|1|||
155208076|NCT00420927|560196457|FG005|Period 2|Took prohibited medication|0|||
155208077|NCT00420927|560196458|FG006|Period 2|Took prohibited medication|0|||
155208078|NCT00320411|560196459|FG000|Overall Study|No investigational product admin.|4|||
155208079|NCT02088047|560196462|FG000|Overall Study|Withdrawal by Subject|1|||
155208080|NCT02088047|560196463|FG001|Overall Study|Withdrawal by Subject|0|||
155208081|NCT01417234|560196464|FG000|Overall Study|Subject non-compliant|3|||
155208082|NCT02268084|560196466|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
155208083|NCT02268084|560196467|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
155208084|NCT02268084|560196466|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
155208085|NCT02268084|560196467|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
155208086|NCT05227027|560196468|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
155208087|NCT05227027|560196469|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
155208088|NCT00855920|560196470|FG000|Overall Study|Protocol Violation|0|||
155208089|NCT00855920|560196471|FG001|Overall Study|Protocol Violation|0|||
155208090|NCT00855920|560196472|FG002|Overall Study|Protocol Violation|2|||
155208091|NCT00855920|560196470|FG000|Overall Study|Adverse Event|2|||
155208092|NCT00855920|560196471|FG001|Overall Study|Adverse Event|1|||
155208093|NCT00855920|560196472|FG002|Overall Study|Adverse Event|1|||
155208094|NCT00855920|560196470|FG000|Overall Study|Lack of Efficacy|2|||
155208095|NCT00855920|560196471|FG001|Overall Study|Lack of Efficacy|2|||
155208096|NCT00855920|560196472|FG002|Overall Study|Lack of Efficacy|2|||
155208097|NCT00855920|560196470|FG000|Overall Study|Withdrawal by Subject|2|||
155208098|NCT00855920|560196471|FG001|Overall Study|Withdrawal by Subject|3|||
155208099|NCT00855920|560196472|FG002|Overall Study|Withdrawal by Subject|2|||
155208100|NCT00855920|560196470|FG000|Overall Study|Lost to Follow-up|1|||
155208101|NCT00855920|560196471|FG001|Overall Study|Lost to Follow-up|0|||
155208102|NCT00855920|560196472|FG002|Overall Study|Lost to Follow-up|2|||
155208103|NCT00855920|560196470|FG000|Overall Study|Death|0|||
155208104|NCT00855920|560196471|FG001|Overall Study|Death|1|||
155208105|NCT00855920|560196472|FG002|Overall Study|Death|0|||
155208106|NCT00855920|560196470|FG000|Overall Study|Decision by the sponsor|0|||
155208107|NCT00855920|560196471|FG001|Overall Study|Decision by the sponsor|1|||
155208108|NCT00855920|560196472|FG002|Overall Study|Decision by the sponsor|1|||
155208109|NCT00855920|560196470|FG000|Overall Study|Other than specified above|1|||
155208110|NCT00855920|560196471|FG001|Overall Study|Other than specified above|1|||
155208111|NCT00855920|560196472|FG002|Overall Study|Other than specified above|1|||
155208112|NCT00211510|560196473|FG000|Overall Study|Physician Decision|3|||
155208113|NCT00211510|560196474|FG001|Overall Study|Physician Decision|1|||
155208114|NCT00211510|560196473|FG000|Overall Study|Withdrawal by Subject|3|||
155208115|NCT00211510|560196474|FG001|Overall Study|Withdrawal by Subject|1|||
155208116|NCT02216591|560196475|FG000|Overall Study|Lost to Follow-up|0|||
155208117|NCT02216591|560196476|FG001|Overall Study|Lost to Follow-up|1|||
155208118|NCT02837783|560196478|FG000|Overall Study|Adverse Event|1|||
155208119|NCT02837783|560196479|FG001|Overall Study|Adverse Event|0|||
155208120|NCT02837783|560196478|FG000|Overall Study|Other, Not Specified|1|||
155208121|NCT02837783|560196479|FG001|Overall Study|Other, Not Specified|2|||
155208122|NCT01962896|560196480|FG000|Overall Study|Lack of Efficacy|4|||
155208123|NCT03200860|560196481|FG000|Overall Study|Withdrawal by Subject|1|||
155208124|NCT03200860|560196482|FG001|Overall Study|Withdrawal by Subject|0|||
155208125|NCT00844896|560196483|FG000|Overall Study|Lost to Follow-up|12|||
155208126|NCT00844896|560196484|FG001|Overall Study|Lost to Follow-up|16|||
155208127|NCT00844896|560196483|FG000|Overall Study|Parents did not have time to complete|0|||
155208128|NCT00844896|560196484|FG001|Overall Study|Parents did not have time to complete|1|||
155208129|NCT02634320|560196485|FG000|Overall Study|Adverse Event|2|||
155208130|NCT02634320|560196485|FG000|Overall Study|Lost to Follow-up|3|||
155208131|NCT02634320|560196485|FG000|Overall Study|Moved out of area|2|||
155208132|NCT02634320|560196485|FG000|Overall Study|Out of window for study visits|1|||
155208133|NCT02634320|560196485|FG000|Overall Study|Protocol Violation|1|||
155208134|NCT02634320|560196485|FG000|Overall Study|Withdrawal by Subject|5|||
155208135|NCT02634320|560196485|FG000|Overall Study|Lack of Efficacy|2|||
155208136|NCT00838578|560196486|FG000|Overall Study|Protocol Violation|2|||
155208137|NCT03919799|560196487|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
155208138|NCT03919799|560196488|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
155208139|NCT03919799|560196489|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
155208140|NCT03919799|560196490|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
155208141|NCT03919799|560196491|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
155208142|NCT03919799|560196487|FG000|DB Period (28 Weeks)|Adverse Event|1|||
155208143|NCT03919799|560196488|FG001|DB Period (28 Weeks)|Adverse Event|1|||
155208144|NCT03919799|560196489|FG002|DB Period (28 Weeks)|Adverse Event|1|||
155208145|NCT03919799|560196490|FG003|DB Period (28 Weeks)|Adverse Event|0|||
155208146|NCT03919799|560196491|FG004|DB Period (28 Weeks)|Adverse Event|0|||
155208147|NCT03919799|560196487|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208148|NCT03919799|560196488|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
155208149|NCT03919799|560196489|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208150|NCT03919799|560196490|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208151|NCT03919799|560196491|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
155208152|NCT03919799|560196487|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208153|NCT03919799|560196488|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
155208154|NCT03919799|560196489|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208155|NCT03919799|560196490|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208156|NCT03919799|560196491|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
155208157|NCT03919799|560196487|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
155208158|NCT03919799|560196488|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
155208159|NCT03919799|560196489|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
155208160|NCT03919799|560196490|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
155208161|NCT03919799|560196491|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
155208162|NCT00646776|560196494|FG000|Overall Study|Adverse Event|1|||
155208163|NCT00646776|560196495|FG001|Overall Study|Adverse Event|9|||
155208164|NCT00646776|560196494|FG000|Overall Study|Investigator discretion|0|||
155208165|NCT00646776|560196495|FG001|Overall Study|Investigator discretion|4|||
155208166|NCT00439244|560196497|FG000|Overall Study|Adverse Event|5|||
155208167|NCT00439244|560196498|FG001|Overall Study|Adverse Event|2|||
155208168|NCT00439244|560196499|FG002|Overall Study|Adverse Event|3|||
155208169|NCT00439244|560196497|FG000|Overall Study|Withdrawal by Subject|3|||
155208170|NCT00439244|560196498|FG001|Overall Study|Withdrawal by Subject|1|||
155208171|NCT00439244|560196499|FG002|Overall Study|Withdrawal by Subject|2|||
155208172|NCT00439244|560196497|FG000|Overall Study|Lost to Follow-up|2|||
155208173|NCT00439244|560196498|FG001|Overall Study|Lost to Follow-up|1|||
155208174|NCT00439244|560196499|FG002|Overall Study|Lost to Follow-up|2|||
155208175|NCT00439244|560196497|FG000|Overall Study|Death|0|||
155208176|NCT00439244|560196498|FG001|Overall Study|Death|1|||
155208177|NCT00439244|560196499|FG002|Overall Study|Death|0|||
155208178|NCT00439244|560196497|FG000|Overall Study|Protocol Violation|0|||
155208179|NCT00439244|560196498|FG001|Overall Study|Protocol Violation|1|||
155208180|NCT00439244|560196499|FG002|Overall Study|Protocol Violation|0|||
155208181|NCT00439244|560196497|FG000|Overall Study|Administrative problems|1|||
155208182|NCT00439244|560196498|FG001|Overall Study|Administrative problems|0|||
155208183|NCT00439244|560196499|FG002|Overall Study|Administrative problems|0|||
155208184|NCT02762266|560198045|FG000|Overall Study|Physician Decision|2|||
155208185|NCT02762266|560198046|FG001|Overall Study|Physician Decision|0|||
155208186|NCT02961751|560198057|FG000|Overall Study|Lost to Follow-up|11|||
155208187|NCT02961751|560198057|FG000|Overall Study|Physician Decision|2|||
155208188|NCT02961751|560198057|FG000|Overall Study|Not Eligible at Enrollment|1|||
155208189|NCT02961751|560198057|FG000|Overall Study|Protocol Violation|1|||
155208190|NCT02373202|560198059|FG000|Overall Study|Adverse Event|2|||
155208191|NCT02373202|560198060|FG001|Overall Study|Adverse Event|5|||
155208192|NCT02373202|560198061|FG002|Overall Study|Adverse Event|2|||
155208193|NCT02373202|560198062|FG003|Overall Study|Adverse Event|1|||
155208194|NCT02373202|560198059|FG000|Overall Study|Lack of Efficacy|0|||
155208195|NCT02373202|560198060|FG001|Overall Study|Lack of Efficacy|0|||
155208196|NCT02373202|560198061|FG002|Overall Study|Lack of Efficacy|1|||
155208197|NCT02373202|560198062|FG003|Overall Study|Lack of Efficacy|0|||
155208198|NCT02373202|560198059|FG000|Overall Study|Other|0|||
155208199|NCT02373202|560198060|FG001|Overall Study|Other|1|||
155208200|NCT02373202|560198061|FG002|Overall Study|Other|0|||
155208201|NCT02373202|560198062|FG003|Overall Study|Other|0|||
155208202|NCT03010254|560198063|FG000|Overall Study|Adverse Event|0|||
155208203|NCT03010254|560198064|FG001|Overall Study|Adverse Event|1|||
155208204|NCT03010254|560198063|FG000|Overall Study|Lost to Follow-up|4|||
155208205|NCT03010254|560198064|FG001|Overall Study|Lost to Follow-up|0|||
155208206|NCT03010254|560198063|FG000|Overall Study|Withdrawal by Subject|1|||
155208207|NCT03010254|560198064|FG001|Overall Study|Withdrawal by Subject|1|||
155208208|NCT03010254|560198063|FG000|Overall Study|Other|2|||
155208209|NCT03010254|560198064|FG001|Overall Study|Other|3|||
155208210|NCT03909295|560198068|FG000|Overall Study|Adverse Event|2|||
155208211|NCT03909295|560198068|FG000|Overall Study|Study terminated by sponsor|50|||
155208212|NCT00848081|560198072|FG000|Overall Study|Adverse Event|6|||
155208213|NCT00848081|560198073|FG001|Overall Study|Adverse Event|7|||
155208214|NCT00848081|560198072|FG000|Overall Study|Protocol Violation|8|||
155208215|NCT00848081|560198073|FG001|Overall Study|Protocol Violation|5|||
155208216|NCT00848081|560198072|FG000|Overall Study|Lost to Follow-up|1|||
155208217|NCT00848081|560198073|FG001|Overall Study|Lost to Follow-up|0|||
155208218|NCT00848081|560198072|FG000|Overall Study|Physician Decision|0|||
155208219|NCT00848081|560198073|FG001|Overall Study|Physician Decision|3|||
155208220|NCT00848081|560198072|FG000|Overall Study|Withdrawal by Subject|5|||
155208221|NCT00848081|560198073|FG001|Overall Study|Withdrawal by Subject|3|||
155208222|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208223|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208224|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208225|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
155208226|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
155208227|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
155208228|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208229|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208230|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208231|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
155208232|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Other|1|||
155208233|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Other|1|||
155208234|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Other|0|||
155208235|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Other|0|||
155208236|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Other|0|||
155208237|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
155208238|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
155208239|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
155208240|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
155208241|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
155208242|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208243|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208244|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208245|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
155208246|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
155208247|NCT02310568|560198074|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208248|NCT02310568|560198075|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208249|NCT02310568|560198076|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208250|NCT02310568|560198077|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
155208251|NCT02310568|560198078|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
155208252|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
155208253|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
155208254|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
155208255|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
155208256|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
155208257|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Other|0|||
155208258|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Other|1|||
155208259|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Other|1|||
155208260|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Other|0|||
155208261|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Other|0|||
155208262|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
155208263|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
155208264|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
155208265|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
155208266|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
155208267|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208268|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208269|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208270|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
155208271|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
155208272|NCT02310568|560198074|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208273|NCT02310568|560198075|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208274|NCT02310568|560198076|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208275|NCT02310568|560198077|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
155208276|NCT02310568|560198078|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
155208277|NCT02064868|560198085|FG000|Overall Study|Lost to Follow-up|14|||
155208278|NCT02064868|560198086|FG001|Overall Study|Lost to Follow-up|8|||
155208279|NCT02064868|560198085|FG000|Overall Study|Physician Decision|1|||
155208280|NCT02064868|560198086|FG001|Overall Study|Physician Decision|0|||
155208281|NCT02064868|560198085|FG000|Overall Study|Withdrawal by Subject|14|||
155208282|NCT02064868|560198086|FG001|Overall Study|Withdrawal by Subject|3|||
155208283|NCT02064868|560198085|FG000|Overall Study|Technical Problems or Missing|5|||
155208284|NCT02064868|560198086|FG001|Overall Study|Technical Problems or Missing|2|||
155208285|NCT03342690|560198097|FG000|Overall Study|Missing Information|9|||
155208286|NCT03342690|560198097|FG000|Overall Study|Protocol Violation|16|||
155208287|NCT02289690|560198098|FG000|Overall Study|Adverse Event Related to Progression|0|||
155208288|NCT02289690|560198099|FG001|Overall Study|Adverse Event Related to Progression|1|||
155208289|NCT02289690|560198100|FG002|Overall Study|Adverse Event Related to Progression|1|||
155208290|NCT02289690|560198101|FG003|Overall Study|Adverse Event Related to Progression|0|||
155208291|NCT02289690|560198102|FG004|Overall Study|Adverse Event Related to Progression|1|||
155208292|NCT02289690|560198103|FG005|Overall Study|Adverse Event Related to Progression|0|||
155208293|NCT02289690|560198104|FG006|Overall Study|Adverse Event Related to Progression|1|||
155208294|NCT02289690|560198105|FG007|Overall Study|Adverse Event Related to Progression|0|||
155208295|NCT02289690|560198106|FG008|Overall Study|Adverse Event Related to Progression|0|||
155208296|NCT02289690|560198107|FG009|Overall Study|Adverse Event Related to Progression|0|||
155208297|NCT02289690|560198098|FG000|Overall Study|Withdrawal by Subject|1|||
155208298|NCT02289690|560198099|FG001|Overall Study|Withdrawal by Subject|0|||
155208299|NCT02289690|560198100|FG002|Overall Study|Withdrawal by Subject|0|||
155208300|NCT02289690|560198101|FG003|Overall Study|Withdrawal by Subject|0|||
155208301|NCT02289690|560198102|FG004|Overall Study|Withdrawal by Subject|1|||
155208302|NCT02289690|560198103|FG005|Overall Study|Withdrawal by Subject|1|||
155208303|NCT02289690|560198104|FG006|Overall Study|Withdrawal by Subject|0|||
155208304|NCT02289690|560198105|FG007|Overall Study|Withdrawal by Subject|0|||
155208305|NCT02289690|560198106|FG008|Overall Study|Withdrawal by Subject|4|||
155208306|NCT02289690|560198107|FG009|Overall Study|Withdrawal by Subject|2|||
155208307|NCT02289690|560198098|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
155208308|NCT02289690|560198099|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
155208309|NCT02289690|560198100|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
155208310|NCT02289690|560198101|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
155208311|NCT02289690|560198102|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
155208312|NCT02289690|560198103|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
155208313|NCT02289690|560198104|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
155208314|NCT02289690|560198105|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
155208315|NCT02289690|560198106|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
155208316|NCT02289690|560198107|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
155208317|NCT02289690|560198098|FG000|Overall Study|Lost to Follow-up|0|||
155208318|NCT02289690|560198099|FG001|Overall Study|Lost to Follow-up|0|||
155208319|NCT02289690|560198100|FG002|Overall Study|Lost to Follow-up|0|||
155208320|NCT02289690|560198101|FG003|Overall Study|Lost to Follow-up|0|||
155208321|NCT02289690|560198102|FG004|Overall Study|Lost to Follow-up|0|||
155208322|NCT02289690|560198103|FG005|Overall Study|Lost to Follow-up|0|||
155208323|NCT02289690|560198104|FG006|Overall Study|Lost to Follow-up|0|||
155208324|NCT02289690|560198105|FG007|Overall Study|Lost to Follow-up|1|||
155208325|NCT02289690|560198106|FG008|Overall Study|Lost to Follow-up|0|||
155208326|NCT02289690|560198107|FG009|Overall Study|Lost to Follow-up|2|||
155208327|NCT02289690|560198098|FG000|Overall Study|Death|0|||
155208328|NCT02289690|560198099|FG001|Overall Study|Death|0|||
155208329|NCT02289690|560198100|FG002|Overall Study|Death|0|||
155208330|NCT02289690|560198101|FG003|Overall Study|Death|0|||
155208331|NCT02289690|560198102|FG004|Overall Study|Death|0|||
155208332|NCT02289690|560198103|FG005|Overall Study|Death|0|||
155208333|NCT02289690|560198104|FG006|Overall Study|Death|0|||
155208334|NCT02289690|560198105|FG007|Overall Study|Death|49|||
155208335|NCT02289690|560198106|FG008|Overall Study|Death|45|||
155208336|NCT02289690|560198107|FG009|Overall Study|Death|41|||
155208337|NCT02289690|560198098|FG000|Overall Study|Sponsor Discontinued Study|0|||
155208338|NCT02289690|560198099|FG001|Overall Study|Sponsor Discontinued Study|0|||
155208339|NCT02289690|560198100|FG002|Overall Study|Sponsor Discontinued Study|0|||
155208340|NCT02289690|560198101|FG003|Overall Study|Sponsor Discontinued Study|0|||
155208341|NCT02289690|560198102|FG004|Overall Study|Sponsor Discontinued Study|0|||
155208342|NCT02289690|560198103|FG005|Overall Study|Sponsor Discontinued Study|0|||
155208343|NCT02289690|560198104|FG006|Overall Study|Sponsor Discontinued Study|0|||
155208344|NCT02289690|560198105|FG007|Overall Study|Sponsor Discontinued Study|9|||
155208345|NCT02289690|560198106|FG008|Overall Study|Sponsor Discontinued Study|7|||
155208346|NCT02289690|560198107|FG009|Overall Study|Sponsor Discontinued Study|15|||
155208347|NCT02289690|560198098|FG000|Overall Study|Other|0|||
155208348|NCT02289690|560198099|FG001|Overall Study|Other|0|||
155208349|NCT02289690|560198100|FG002|Overall Study|Other|0|||
155208350|NCT02289690|560198101|FG003|Overall Study|Other|1|||
155208351|NCT02289690|560198102|FG004|Overall Study|Other|1|||
155208352|NCT02289690|560198103|FG005|Overall Study|Other|0|||
155208353|NCT02289690|560198104|FG006|Overall Study|Other|1|||
155208354|NCT02289690|560198105|FG007|Overall Study|Other|2|||
155208355|NCT02289690|560198106|FG008|Overall Study|Other|3|||
155208356|NCT02289690|560198107|FG009|Overall Study|Other|1|||
155208357|NCT02573350|560198110|FG000|Overall Study|Lost to Follow-up|2|||
155208358|NCT02573350|560198111|FG001|Overall Study|Lost to Follow-up|1|||
155208359|NCT02573350|560198110|FG000|Overall Study|Adverse Event|3|||
155208360|NCT02573350|560198111|FG001|Overall Study|Adverse Event|4|||
155208361|NCT02573350|560198110|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
155208362|NCT02573350|560198111|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
155208363|NCT02573350|560198110|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
155208364|NCT02573350|560198111|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
155208365|NCT02573350|560198110|FG000|Overall Study|Subject withdrew consent to participate|6|||
155208366|NCT02573350|560198111|FG001|Overall Study|Subject withdrew consent to participate|1|||
155208367|NCT02573350|560198110|FG000|Overall Study|Protocol Deviation|1|||
155208368|NCT02573350|560198111|FG001|Overall Study|Protocol Deviation|1|||
155208369|NCT02743520|560198112|FG000|Overall Study|Withdrawal by Subject|1|||
155208370|NCT03247530|560198113|FG000|Overall Study|Withdrawal by caregiver|19|||
155208371|NCT03247530|560198114|FG001|Overall Study|Withdrawal by caregiver|8|||
155208372|NCT03247530|560198115|FG002|Overall Study|Withdrawal by caregiver|10|||
155208373|NCT03247530|560198113|FG000|Overall Study|Lost to Follow-up|3|||
155208374|NCT03247530|560198114|FG001|Overall Study|Lost to Follow-up|9|||
155208375|NCT03247530|560198115|FG002|Overall Study|Lost to Follow-up|6|||
155208376|NCT03247530|560198113|FG000|Overall Study|Adverse Event|2|||
155208377|NCT03247530|560198114|FG001|Overall Study|Adverse Event|5|||
155208378|NCT03247530|560198115|FG002|Overall Study|Adverse Event|2|||
155208379|NCT03247530|560198113|FG000|Overall Study|Failure to follow procedure|1|||
155208380|NCT03247530|560198114|FG001|Overall Study|Failure to follow procedure|1|||
155208381|NCT03247530|560198115|FG002|Overall Study|Failure to follow procedure|1|||
155208382|NCT03247530|560198113|FG000|Overall Study|Withdrawal by Subject|1|||
155208383|NCT03247530|560198114|FG001|Overall Study|Withdrawal by Subject|1|||
155208384|NCT03247530|560198115|FG002|Overall Study|Withdrawal by Subject|0|||
155208385|NCT03247530|560198113|FG000|Overall Study|Study medication misuse|0|||
155208386|NCT03247530|560198114|FG001|Overall Study|Study medication misuse|1|||
155208387|NCT03247530|560198115|FG002|Overall Study|Study medication misuse|0|||
155208388|NCT03247530|560198113|FG000|Overall Study|Other, multiple categories|1|||
155208389|NCT03247530|560198114|FG001|Overall Study|Other, multiple categories|3|||
155208390|NCT03247530|560198115|FG002|Overall Study|Other, multiple categories|1|||
155208391|NCT02509156|560198117|FG000|Randomized Phase|Death|1|||
155208392|NCT02509156|560198118|FG001|Randomized Phase|Death|0|||
155208393|NCT02509156|560198117|FG000|Randomized Phase|Withdrawal by Subject|1|||
155208394|NCT02509156|560198118|FG001|Randomized Phase|Withdrawal by Subject|1|||
155208395|NCT02547649|560198120|FG000|Overall Study|Lost to Follow-up|3|||
155208396|NCT02547649|560198121|FG001|Overall Study|Lost to Follow-up|1|||
155208397|NCT02547649|560198122|FG002|Overall Study|Lost to Follow-up|1|||
155208398|NCT02547649|560198120|FG000|Overall Study|Not vaccinated|0|||
155208399|NCT02547649|560198121|FG001|Overall Study|Not vaccinated|0|||
155208400|NCT02547649|560198122|FG002|Overall Study|Not vaccinated|1|||
155208401|NCT02547649|560198120|FG000|Overall Study|Withdrawal by Subject|0|||
155208402|NCT02547649|560198121|FG001|Overall Study|Withdrawal by Subject|4|||
155208403|NCT02547649|560198122|FG002|Overall Study|Withdrawal by Subject|2|||
155208404|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Left Oranization|1|||
155208405|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Left Oranization|1|||
155208406|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
155208407|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
155208408|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
155208409|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
155208410|NCT03454997|560198123|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
155208411|NCT03454997|560198124|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
155208412|NCT03454997|560198123|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
155208413|NCT03454997|560198124|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
155208414|NCT03454997|560198123|FG000|Overall Study|Client with SMI - Left organization|0|||
155208415|NCT03454997|560198124|FG001|Overall Study|Client with SMI - Left organization|1|||
155208416|NCT03454997|560198123|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
155208417|NCT03454997|560198124|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
155208418|NCT01111149|560198130|FG000|Overall Study|Protocol Violation|1|||
155208419|NCT01111149|560198131|FG001|Overall Study|Protocol Violation|1|||
155208420|NCT01111149|560198132|FG002|Overall Study|Protocol Violation|2|||
155208421|NCT01111149|560198130|FG000|Overall Study|Withdrawal by Subject|1|||
155208422|NCT01111149|560198131|FG001|Overall Study|Withdrawal by Subject|0|||
155208423|NCT01111149|560198132|FG002|Overall Study|Withdrawal by Subject|2|||
155208424|NCT00006903|560198135|FG000|Overall Study|Still receiving treatment|0|||
155208425|NCT00006903|560198136|FG001|Overall Study|Still receiving treatment|0|||
155208426|NCT00006903|560198137|FG002|Overall Study|Still receiving treatment|1|||
155208427|NCT00006903|560198135|FG000|Overall Study|Refused further treatment|0|||
155208428|NCT00006903|560198136|FG001|Overall Study|Refused further treatment|2|||
155208429|NCT00006903|560198137|FG002|Overall Study|Refused further treatment|1|||
155208430|NCT00006903|560198135|FG000|Overall Study|Adverse Event|0|||
155208431|NCT00006903|560198136|FG001|Overall Study|Adverse Event|0|||
155208432|NCT00006903|560198137|FG002|Overall Study|Adverse Event|1|||
155208433|NCT00006903|560198135|FG000|Overall Study|Death|0|||
155208434|NCT00006903|560198136|FG001|Overall Study|Death|1|||
155208435|NCT00006903|560198137|FG002|Overall Study|Death|0|||
155208436|NCT00006903|560198135|FG000|Overall Study|Patient never treated|0|||
155208437|NCT00006903|560198136|FG001|Overall Study|Patient never treated|0|||
155208438|NCT00006903|560198137|FG002|Overall Study|Patient never treated|1|||
155208439|NCT00006903|560198135|FG000|Overall Study|Ineligible|10|||
155208440|NCT00006903|560198136|FG001|Overall Study|Ineligible|1|||
155208441|NCT00006903|560198137|FG002|Overall Study|Ineligible|2|||
155208442|NCT01909674|560198138|FG000|Overall Study|Withdrawal by Subject|5|||
155208443|NCT01909674|560198139|FG001|Overall Study|Withdrawal by Subject|2|||
155208444|NCT01906008|560198144|FG000|Overall Study|Lost to Follow-up|2|||
155208445|NCT01906008|560198145|FG001|Overall Study|Lost to Follow-up|0|||
155208446|NCT01906008|560198144|FG000|Overall Study|Oxaliplatin toxicity|2|||
155208447|NCT01906008|560198145|FG001|Overall Study|Oxaliplatin toxicity|0|||
155208448|NCT01906008|560198144|FG000|Overall Study|Protocol Violation|0|||
155208449|NCT01906008|560198145|FG001|Overall Study|Protocol Violation|1|||
155208450|NCT01906008|560198144|FG000|Overall Study|Withdrawal by Subject|1|||
155208451|NCT01906008|560198145|FG001|Overall Study|Withdrawal by Subject|5|||
155208452|NCT01906008|560198144|FG000|Overall Study|Did not start study med|3|||
155208453|NCT01906008|560198145|FG001|Overall Study|Did not start study med|4|||
155208454|NCT01906008|560198144|FG000|Overall Study|Oxaliplatin stops|10|||
155208455|NCT01906008|560198145|FG001|Overall Study|Oxaliplatin stops|8|||
155208456|NCT01906008|560198144|FG000|Overall Study|Hospice|1|||
155208457|NCT01906008|560198145|FG001|Overall Study|Hospice|0|||
155208458|NCT01906008|560198144|FG000|Overall Study|Physician Decision|3|||
155208459|NCT01906008|560198145|FG001|Overall Study|Physician Decision|3|||
155208460|NCT01906008|560198144|FG000|Overall Study|Lack of compliance of study med|5|||
155208461|NCT01906008|560198145|FG001|Overall Study|Lack of compliance of study med|3|||
155208462|NCT01906008|560198144|FG000|Overall Study|Adverse Event|0|||
155208463|NCT01906008|560198145|FG001|Overall Study|Adverse Event|3|||
155208464|NCT01465997|560198146|FG000|Overall Study|Adverse Event|12|||
155208465|NCT01465997|560198147|FG001|Overall Study|Adverse Event|22|||
155208466|NCT01465997|560198146|FG000|Overall Study|Lack of Efficacy|13|||
155208467|NCT01465997|560198147|FG001|Overall Study|Lack of Efficacy|1|||
155208468|NCT01465997|560198146|FG000|Overall Study|Protocol Violation|1|||
155208469|NCT01465997|560198147|FG001|Overall Study|Protocol Violation|4|||
155208470|NCT01465997|560198146|FG000|Overall Study|Lost to Follow-up|6|||
155208471|NCT01465997|560198147|FG001|Overall Study|Lost to Follow-up|9|||
155208472|NCT01465997|560198146|FG000|Overall Study|Withdrawal by Subject|32|||
155208473|NCT01465997|560198147|FG001|Overall Study|Withdrawal by Subject|35|||
155208474|NCT01465997|560198146|FG000|Overall Study|investigator's decision|1|||
155208475|NCT01465997|560198147|FG001|Overall Study|investigator's decision|1|||
155208476|NCT01465997|560198146|FG000|Overall Study|Death|0|||
155208477|NCT01465997|560198147|FG001|Overall Study|Death|1|||
155208478|NCT01465997|560198146|FG000|Overall Study|sponsor's decision|1|||
155208479|NCT01465997|560198147|FG001|Overall Study|sponsor's decision|1|||
155208480|NCT01465997|560198146|FG000|Overall Study|subject withdrew consent|1|||
155208481|NCT01465997|560198147|FG001|Overall Study|subject withdrew consent|0|||
155208482|NCT01465997|560198146|FG000|Overall Study|local lab unblinded site|1|||
155208483|NCT01465997|560198147|FG001|Overall Study|local lab unblinded site|0|||
155208484|NCT01465997|560198146|FG000|Overall Study|withdrew before follow-up|0|||
155208485|NCT01465997|560198147|FG001|Overall Study|withdrew before follow-up|13|||
155208486|NCT01465997|560198146|FG000|Overall Study|decision by site staff|0|||
155208487|NCT01465997|560198147|FG001|Overall Study|decision by site staff|1|||
155208488|NCT01465997|560198146|FG000|Overall Study|subject left participation SP0993|0|||
155208489|NCT01465997|560198147|FG001|Overall Study|subject left participation SP0993|1|||
155208490|NCT00660309|560198148|FG000|Overall Study|Adverse Event|2|||
155208491|NCT00660309|560198149|FG001|Overall Study|Adverse Event|0|||
155208492|NCT00660309|560198148|FG000|Overall Study|Withdrawal by Subject|0|||
155208493|NCT00660309|560198149|FG001|Overall Study|Withdrawal by Subject|3|||
155208494|NCT01666782|560198154|FG000|Overall Study|Received 2 doses of vaccine|0|||
155208495|NCT01666782|560198155|FG001|Overall Study|Received 2 doses of vaccine|1|||
155208496|NCT01666782|560198154|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
155208497|NCT01666782|560198155|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
155208498|NCT04786990|560198156|FG000|Overall Study|Withdrawal by Subject|1|||
155208499|NCT04786990|560198156|FG000|Overall Study|Adverse Event|1|||
155208500|NCT04786990|560198156|FG000|Overall Study|Lost to Follow-up|1|||
155208501|NCT04786990|560198156|FG000|Overall Study|Noncompliance|1|||
155208502|NCT04786990|560198156|FG000|Overall Study|Unable to complete site visits|1|||
155208503|NCT04786990|560198156|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
155208504|NCT02007109|560198157|FG000|Overall Study|Diary not returned or excluded|102|||
155208505|NCT02007109|560198157|FG000|Overall Study|Excluded - Age<7yo|9|||
155208506|NCT00687323|560198158|FG000|Overall Study|Death|25|||
155208507|NCT00687323|560198158|FG000|Overall Study|Withdrawal by Subject|1|||
155208508|NCT00687323|560198158|FG000|Overall Study|Excluded from efficacy evaluations|6|||
155208509|NCT00687323|560198158|FG000|Overall Study|Screen failure|148|||
155208510|NCT03031678|560198164|FG000|Overall Study|Study closed prior to completion|1|||
155208511|NCT04557371|560198165|FG000|Overall Study|Covid-19-related|0|||
155208512|NCT04557371|560198166|FG001|Overall Study|Covid-19-related|1|||
155208513|NCT04557371|560198167|FG002|Overall Study|Covid-19-related|0|||
155208514|NCT04557371|560198165|FG000|Overall Study|Withdrawal by Subject|0|||
155208515|NCT04557371|560198166|FG001|Overall Study|Withdrawal by Subject|1|||
155208516|NCT04557371|560198167|FG002|Overall Study|Withdrawal by Subject|0|||
155208517|NCT04557371|560198165|FG000|Overall Study|Adverse Event|1|||
155208518|NCT04557371|560198166|FG001|Overall Study|Adverse Event|0|||
155208519|NCT04557371|560198167|FG002|Overall Study|Adverse Event|0|||
155208520|NCT01482884|560198170|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
155208521|NCT01482884|560198171|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
155208522|NCT01482884|560198170|FG000|Overall Study|Protocol Violation|1|||
155208523|NCT01482884|560198171|FG001|Overall Study|Protocol Violation|0|||
155208524|NCT01482884|560198170|FG000|Overall Study|Lost to Follow-up|2|||
155208525|NCT01482884|560198171|FG001|Overall Study|Lost to Follow-up|2|||
155208526|NCT01482884|560198170|FG000|Overall Study|Lack of Efficacy|0|||
155208527|NCT01482884|560198171|FG001|Overall Study|Lack of Efficacy|1|||
155208528|NCT01482884|560198170|FG000|Overall Study|Adverse Event|2|||
155208529|NCT01482884|560198171|FG001|Overall Study|Adverse Event|1|||
155208530|NCT01482884|560198170|FG000|Overall Study|Withdrawal by Subject|8|||
155208531|NCT01482884|560198171|FG001|Overall Study|Withdrawal by Subject|13|||
155208532|NCT05353985|560198178|FG000|Overall Study|Adverse Event|5|||
155208533|NCT05353985|560198179|FG001|Overall Study|Adverse Event|7|||
155208534|NCT05353985|560198178|FG000|Overall Study|Lost to Follow-up|1|||
155208535|NCT05353985|560198179|FG001|Overall Study|Lost to Follow-up|1|||
155208536|NCT05353985|560198178|FG000|Overall Study|Protocol Violation|1|||
155208537|NCT05353985|560198179|FG001|Overall Study|Protocol Violation|0|||
155208538|NCT05353985|560198178|FG000|Overall Study|Withdrawal by Subject|13|||
155208539|NCT05353985|560198179|FG001|Overall Study|Withdrawal by Subject|17|||
155208540|NCT05353985|560198178|FG000|Overall Study|Reason Not Specified|1|||
155208541|NCT05353985|560198179|FG001|Overall Study|Reason Not Specified|0|||
155208542|NCT05353985|560198178|FG000|Overall Study|Randomized in Error & Not Treated|0|||
155208543|NCT05353985|560198179|FG001|Overall Study|Randomized in Error & Not Treated|1|||
155208544|NCT04419714|560198180|FG000|Overall Study|Technical Fault|5|||
155208545|NCT04419714|560198180|FG000|Overall Study|Protocol Deviation|2|||
155208546|NCT04419714|560198180|FG000|Overall Study|Withdrawal by Subject|1|||
155208547|NCT02057406|560199621|FG000|Overall Study|Physician Decision|0|||
155208548|NCT02057406|560199622|FG001|Overall Study|Physician Decision|0|||
155208549|NCT02057406|560199623|FG002|Overall Study|Physician Decision|2|||
155208550|NCT02057406|560199621|FG000|Overall Study|Withdrawal by Subject|0|||
155208551|NCT02057406|560199622|FG001|Overall Study|Withdrawal by Subject|2|||
155208552|NCT02057406|560199623|FG002|Overall Study|Withdrawal by Subject|0|||
155208553|NCT02057406|560199621|FG000|Overall Study|Lost to Follow-up|0|||
155208554|NCT02057406|560199622|FG001|Overall Study|Lost to Follow-up|0|||
155208555|NCT02057406|560199623|FG002|Overall Study|Lost to Follow-up|1|||
155208556|NCT02057406|560199621|FG000|Overall Study|Death|1|||
155208557|NCT02057406|560199622|FG001|Overall Study|Death|0|||
155208558|NCT02057406|560199623|FG002|Overall Study|Death|0|||
155208559|NCT02057406|560199621|FG000|Overall Study|Protocol Violation|0|||
155208560|NCT02057406|560199622|FG001|Overall Study|Protocol Violation|1|||
155208561|NCT02057406|560199623|FG002|Overall Study|Protocol Violation|0|||
155208562|NCT02057406|560199621|FG000|Overall Study|Patient transportation issues|0|||
155208563|NCT02057406|560199622|FG001|Overall Study|Patient transportation issues|0|||
155208564|NCT02057406|560199623|FG002|Overall Study|Patient transportation issues|1|||
155208565|NCT02692716|560199624|FG000|Overall Study|Lost to Follow-up|2|||
155208566|NCT02692716|560199625|FG001|Overall Study|Lost to Follow-up|5|||
155208567|NCT02692716|560199624|FG000|Overall Study|Withdrawal by Subject|3|||
155208568|NCT02692716|560199625|FG001|Overall Study|Withdrawal by Subject|1|||
155208569|NCT03562481|560199630|FG000|First Intervention|Lost to Follow-up|1|||
155208570|NCT03562481|560199631|FG001|First Intervention|Lost to Follow-up|0|||
155208571|NCT03654651|560199633|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
155208572|NCT03654651|560199634|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
155208573|NCT01401283|560199635|FG000|Overall Study|surgery cancelled|5|||
155208574|NCT01401283|560199636|FG001|Overall Study|surgery cancelled|8|||
155208575|NCT01401283|560199635|FG000|Overall Study|preoperative arrhythmia|5|||
155208576|NCT01401283|560199636|FG001|Overall Study|preoperative arrhythmia|0|||
155208577|NCT01401283|560199635|FG000|Overall Study|no central venous access|0|||
155208578|NCT01401283|560199636|FG001|Overall Study|no central venous access|1|||
155208579|NCT01401283|560199635|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
155208580|NCT01401283|560199636|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
155208581|NCT02433483|560199637|FG000|Overall Study|Unacceptable toxicity|1|||
155208582|NCT02433483|560199637|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
155208583|NCT03824912|560199638|FG000|Overall Study|Lost to Follow-up|18|||
155208584|NCT03824912|560199639|FG001|Overall Study|Lost to Follow-up|15|||
155208585|NCT03824912|560199640|FG002|Overall Study|Lost to Follow-up|8|||
155208586|NCT03824912|560199638|FG000|Overall Study|Negative Baseline Culture Result|118|||
155208587|NCT03824912|560199639|FG001|Overall Study|Negative Baseline Culture Result|112|||
155208588|NCT03824912|560199640|FG002|Overall Study|Negative Baseline Culture Result|57|||
155208589|NCT03824912|560199638|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155208590|NCT03824912|560199639|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155208591|NCT03824912|560199640|FG002|Overall Study|Non-Compliance with Study Drug|1|||
155208592|NCT03824912|560199638|FG000|Overall Study|Protocol Violation|1|||
155208593|NCT03824912|560199639|FG001|Overall Study|Protocol Violation|4|||
155208594|NCT03824912|560199640|FG002|Overall Study|Protocol Violation|1|||
155208595|NCT03824912|560199638|FG000|Overall Study|Withdrawal by Subject|3|||
155208596|NCT03824912|560199639|FG001|Overall Study|Withdrawal by Subject|2|||
155208597|NCT03824912|560199640|FG002|Overall Study|Withdrawal by Subject|1|||
155208598|NCT03824912|560199638|FG000|Overall Study|Participation in another study|0|||
155208599|NCT03824912|560199639|FG001|Overall Study|Participation in another study|1|||
155208600|NCT03824912|560199640|FG002|Overall Study|Participation in another study|0|||
155208601|NCT01414114|560199646|FG000|Overall Study|Adverse Event|2|||
155208602|NCT01414114|560199646|FG000|Overall Study|Withdrawal by Subject|1|||
155208603|NCT01414114|560199646|FG000|Overall Study|Other|2|||
155208604|NCT05620563|560199651|FG000|Overall Study|Adverse Event|3|||
155208605|NCT05620563|560199652|FG001|Overall Study|Adverse Event|1|||
155208606|NCT05620563|560199651|FG000|Overall Study|Lost to Follow-up|0|||
155208607|NCT05620563|560199652|FG001|Overall Study|Lost to Follow-up|2|||
155208608|NCT05620563|560199651|FG000|Overall Study|Protocol Deviation|1|||
155208609|NCT05620563|560199652|FG001|Overall Study|Protocol Deviation|2|||
155208610|NCT05620563|560199651|FG000|Overall Study|Withdrawal by Subject|3|||
155208611|NCT05620563|560199652|FG001|Overall Study|Withdrawal by Subject|3|||
155208612|NCT05620563|560199651|FG000|Overall Study|Physician Decision|0|||
155208613|NCT05620563|560199652|FG001|Overall Study|Physician Decision|1|||
155208614|NCT02085785|560199658|FG000|Overall Study|Withdrawal by Subject|2|||
155208615|NCT02085785|560199659|FG001|Overall Study|Withdrawal by Subject|1|||
155208616|NCT02085785|560199658|FG000|Overall Study|Lost to Follow-up|0|||
155208617|NCT02085785|560199659|FG001|Overall Study|Lost to Follow-up|1|||
155208618|NCT00779467|560199660|FG000|Overall Study|Lack of Efficacy|11|||
155208619|NCT00779467|560199661|FG001|Overall Study|Lack of Efficacy|2|||
155208620|NCT00779467|560199662|FG002|Overall Study|Lack of Efficacy|6|||
155208621|NCT00779467|560199663|FG003|Overall Study|Lack of Efficacy|11|||
155208622|NCT00779467|560199660|FG000|Overall Study|failed inclusion criteria|3|||
155208623|NCT00779467|560199661|FG001|Overall Study|failed inclusion criteria|3|||
155208624|NCT00779467|560199662|FG002|Overall Study|failed inclusion criteria|1|||
155208625|NCT00779467|560199663|FG003|Overall Study|failed inclusion criteria|2|||
155208626|NCT00779467|560199660|FG000|Overall Study|missing data|1|||
155208627|NCT00779467|560199661|FG001|Overall Study|missing data|0|||
155208628|NCT00779467|560199662|FG002|Overall Study|missing data|1|||
155208629|NCT00779467|560199663|FG003|Overall Study|missing data|4|||
155208630|NCT00779467|560199660|FG000|Overall Study|technical issue|0|||
155208631|NCT00779467|560199661|FG001|Overall Study|technical issue|0|||
155208632|NCT00779467|560199662|FG002|Overall Study|technical issue|2|||
155208633|NCT00779467|560199663|FG003|Overall Study|technical issue|1|||
155208634|NCT00779467|560199660|FG000|Overall Study|unavailable research staff|0|||
155208635|NCT00779467|560199661|FG001|Overall Study|unavailable research staff|0|||
155208636|NCT00779467|560199662|FG002|Overall Study|unavailable research staff|0|||
155208637|NCT00779467|560199663|FG003|Overall Study|unavailable research staff|1|||
155208638|NCT00644995|560199664|FG000|Overall Study|Lost to Follow-up|1|||
155208639|NCT00644995|560199665|FG001|Overall Study|Lost to Follow-up|4|||
155208640|NCT00644995|560199664|FG000|Overall Study|Refused|1|||
155208641|NCT00644995|560199665|FG001|Overall Study|Refused|0|||
155208642|NCT00865124|560199672|FG000|Overall Study|Physician Decision|2|||
155208643|NCT00865124|560199673|FG001|Overall Study|Physician Decision|1|||
155208644|NCT00865124|560199674|FG002|Overall Study|Physician Decision|0|||
155208645|NCT00865124|560199672|FG000|Overall Study|Withdrawn consent|2|||
155208646|NCT00865124|560199673|FG001|Overall Study|Withdrawn consent|0|||
155208647|NCT00865124|560199674|FG002|Overall Study|Withdrawn consent|0|||
155208648|NCT01678911|560199682|FG000|Second Intervention|Lost to Follow-up|2|||
155208649|NCT01678911|560199683|FG001|Second Intervention|Lost to Follow-up|0|||
155208650|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
155208651|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
155208652|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
155208653|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
155208654|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
155208655|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
155208656|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
155208657|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
155208658|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Patient Request|1|||
155208659|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Patient Request|0|||
155208660|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
155208661|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
155208662|NCT04649060|560199684|FG000|Arm A/Arm B Treatment|Other|1|||
155208663|NCT04649060|560199685|FG001|Arm A/Arm B Treatment|Other|0|||
155208664|NCT04649060|560199684|FG000|Crossover (Arm B)|Adverse Event|0|||
155208665|NCT04649060|560199685|FG001|Crossover (Arm B)|Adverse Event|1|||
155208666|NCT04649060|560199684|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
155208667|NCT04649060|560199685|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
155208668|NCT02117648|560199686|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
155208669|NCT02117648|560199686|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
155208670|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
155208671|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
155208672|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
155208673|NCT02117648|560199686|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
155208674|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
155208675|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
155208676|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
155208677|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
155208678|NCT02117648|560199686|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
155208679|NCT00171730|560199688|FG000|Overall Study|Adverse Event|3|||
155208680|NCT00171730|560199688|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
155208681|NCT00171730|560199688|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
155208682|NCT00171730|560199688|FG000|Overall Study|Withdrawal by Subject|3|||
155208683|NCT05025241|560199689|FG000|Screening|Failed Screening|5|||
155208684|NCT05025241|560199689|FG000|Treatment and Follow Up|Adverse Event|3|||
155208685|NCT02670837|560199690|FG000|Overall Study|Death|2|||
155208686|NCT02670837|560199691|FG001|Overall Study|Death|0|||
155208687|NCT02670837|560199692|FG002|Overall Study|Death|0|||
155208688|NCT01985867|560199693|FG000|Overall Study|Lost to Follow-up|3|||
155208689|NCT01985867|560199694|FG001|Overall Study|Lost to Follow-up|4|||
155208690|NCT01985867|560199693|FG000|Overall Study|Adverse Event|3|||
155208691|NCT01985867|560199694|FG001|Overall Study|Adverse Event|2|||
155208692|NCT01985867|560199693|FG000|Overall Study|Lack of Efficacy|1|||
155208693|NCT01985867|560199694|FG001|Overall Study|Lack of Efficacy|0|||
155208694|NCT02220205|560199695|FG000|Overall Study|Withdrawal by Subject|1|||
155208695|NCT02220205|560199696|FG001|Overall Study|Withdrawal by Subject|0|||
155208696|NCT02557646|560199699|FG000|Overall Study|Adverse Event|40|||
155208697|NCT02557646|560199699|FG000|Overall Study|Death|1|||
155208698|NCT02557646|560199699|FG000|Overall Study|Lack of Efficacy|186|||
155208699|NCT02557646|560199699|FG000|Overall Study|Withdrawal by Subject|18|||
155208700|NCT02557646|560199699|FG000|Overall Study|Lost to Follow-up|17|||
155208701|NCT02557646|560199699|FG000|Overall Study|Other|14|||
155208702|NCT00137046|560199700|FG000|Overall Study|Death|2|||
155208703|NCT00137046|560199701|FG001|Overall Study|Death|1|||
155208704|NCT00137046|560199700|FG000|Overall Study|Adverse Event|16|||
155208705|NCT00137046|560199701|FG001|Overall Study|Adverse Event|5|||
155208706|NCT00137046|560199700|FG000|Overall Study|Laboratory Abnormality|2|||
155208707|NCT00137046|560199701|FG001|Overall Study|Laboratory Abnormality|0|||
155208708|NCT00137046|560199700|FG000|Overall Study|Lack of Efficacy|13|||
155208709|NCT00137046|560199701|FG001|Overall Study|Lack of Efficacy|1|||
155208710|NCT00137046|560199700|FG000|Overall Study|Lost to Follow-up|8|||
155208711|NCT00137046|560199701|FG001|Overall Study|Lost to Follow-up|24|||
155208712|NCT00137046|560199700|FG000|Overall Study|Other|23|||
155208713|NCT00137046|560199701|FG001|Overall Study|Other|19|||
155208714|NCT00137046|560199700|FG000|Overall Study|Withdrawal by Subject|33|||
155208715|NCT00137046|560199701|FG001|Overall Study|Withdrawal by Subject|42|||
155208716|NCT00137046|560199700|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
155208717|NCT00137046|560199701|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
155208718|NCT00137046|560199700|FG000|Overall Study|Withdrew prior to study treatment|1|||
155208719|NCT00137046|560199701|FG001|Overall Study|Withdrew prior to study treatment|1|||
155208720|NCT02532972|560199702|FG000|Overall Study|Withdrawal by Subject|1|||
155208721|NCT03552198|560199705|FG000|Overall Study|Lost to Follow-up|42|||
155208722|NCT03552198|560199706|FG001|Overall Study|Lost to Follow-up|48|||
155208723|NCT03552198|560199707|FG002|Overall Study|Lost to Follow-up|15|||
155208724|NCT03552198|560199708|FG003|Overall Study|Lost to Follow-up|19|||
155208725|NCT03552198|560199705|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
155208726|NCT03552198|560199706|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
155208727|NCT03552198|560199707|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
155208728|NCT03552198|560199708|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
155208729|NCT03552198|560199705|FG000|Overall Study|Did not receive air alerts|1|||
155208730|NCT03552198|560199706|FG001|Overall Study|Did not receive air alerts|0|||
155208731|NCT03552198|560199707|FG002|Overall Study|Did not receive air alerts|0|||
155208732|NCT03552198|560199708|FG003|Overall Study|Did not receive air alerts|1|||
155208733|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
155208734|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
155208735|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
155208736|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
155208737|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
155208738|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155208739|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
155208740|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
155208741|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Other|1|||
155208742|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Other|4|||
155208743|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Other|3|||
155208744|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Other|6|||
155208745|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
155208746|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
155208747|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
155208748|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
155208749|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
155208750|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
155208751|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
155208752|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
155208753|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155208754|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
155208755|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
155208756|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
155208757|NCT02925494|560199709|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
155208758|NCT02925494|560199710|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
155208759|NCT02925494|560199711|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
155208760|NCT02925494|560199712|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
155208761|NCT03334448|560199718|FG000|Washout|Personal Reason|0|||
155208762|NCT03334448|560199719|FG001|Washout|Personal Reason|1|||
155208763|NCT03334448|560199720|FG002|Washout|Personal Reason|0|||
155208764|NCT03334448|560199721|FG003|Washout|Personal Reason|0|||
155208765|NCT03334448|560199718|FG000|Washout|Protocol Violation|0|||
155208766|NCT03334448|560199719|FG001|Washout|Protocol Violation|0|||
155208767|NCT03334448|560199720|FG002|Washout|Protocol Violation|0|||
155208768|NCT03334448|560199721|FG003|Washout|Protocol Violation|1|||
155208769|NCT06149247|560199722|FG000|Overall Study|Adverse Event|0|||
155208770|NCT06149247|560199723|FG001|Overall Study|Adverse Event|1|||
155208771|NCT01365910|560199729|FG000|Overall Study|Withdrawal by Subject|7|||
155208772|NCT01365910|560199729|FG000|Overall Study|disease progression|18|||
155208773|NCT01365910|560199729|FG000|Overall Study|Adverse Event|3|||
155208774|NCT01365910|560199729|FG000|Overall Study|other complicating disease|1|||
155208775|NCT01365910|560199729|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
155208776|NCT00371137|560199730|FG000|Overall Study|Adverse Event|20|||
155208777|NCT00371137|560199731|FG001|Overall Study|Adverse Event|35|||
155208778|NCT00371137|560199732|FG002|Overall Study|Adverse Event|42|||
155208779|NCT00371137|560199730|FG000|Overall Study|Withdrawal by Subject|11|||
155208780|NCT00371137|560199731|FG001|Overall Study|Withdrawal by Subject|10|||
155208781|NCT00371137|560199732|FG002|Overall Study|Withdrawal by Subject|15|||
155208782|NCT00371137|560199730|FG000|Overall Study|Lost to Follow-up|6|||
155208783|NCT00371137|560199731|FG001|Overall Study|Lost to Follow-up|3|||
155208784|NCT00371137|560199732|FG002|Overall Study|Lost to Follow-up|5|||
155208785|NCT00371137|560199730|FG000|Overall Study|Lack of Efficacy|30|||
155208786|NCT00371137|560199731|FG001|Overall Study|Lack of Efficacy|12|||
155208787|NCT00371137|560199732|FG002|Overall Study|Lack of Efficacy|13|||
155208788|NCT00371137|560199730|FG000|Overall Study|Sponsor Decision|2|||
155208789|NCT00371137|560199731|FG001|Overall Study|Sponsor Decision|1|||
155208790|NCT00371137|560199732|FG002|Overall Study|Sponsor Decision|2|||
155208791|NCT00371137|560199730|FG000|Overall Study|Physician Decision|1|||
155208792|NCT00371137|560199731|FG001|Overall Study|Physician Decision|1|||
155208793|NCT00371137|560199732|FG002|Overall Study|Physician Decision|1|||
155208794|NCT00371137|560199730|FG000|Overall Study|Protocol Violation|2|||
155208795|NCT00371137|560199731|FG001|Overall Study|Protocol Violation|1|||
155208796|NCT00371137|560199732|FG002|Overall Study|Protocol Violation|1|||
155208797|NCT02013791|560199733|FG000|Period 1|Lost to Follow-up|0|||
155208798|NCT02013791|560199734|FG001|Period 1|Lost to Follow-up|0|||
155208799|NCT02013791|560199735|FG002|Period 1|Lost to Follow-up|0|||
155208800|NCT02013791|560199736|FG003|Period 1|Lost to Follow-up|1|||
155208801|NCT02013791|560199737|FG004|Period 1|Lost to Follow-up|0|||
155208802|NCT02013791|560199738|FG005|Period 1|Lost to Follow-up|0|||
155208803|NCT02013791|560199739|FG006|Period 1|Lost to Follow-up|1|||
155208804|NCT02013791|560199740|FG007|Period 1|Lost to Follow-up|1|||
155208805|NCT02013791|560199741|FG008|Period 1|Lost to Follow-up|0|||
155208806|NCT02013791|560199733|FG000|Period 1|Other Miscellaneous Reasons|0|||
155208807|NCT02013791|560199734|FG001|Period 1|Other Miscellaneous Reasons|2|||
155208808|NCT02013791|560199735|FG002|Period 1|Other Miscellaneous Reasons|0|||
155208809|NCT02013791|560199736|FG003|Period 1|Other Miscellaneous Reasons|0|||
155208810|NCT02013791|560199737|FG004|Period 1|Other Miscellaneous Reasons|0|||
155208811|NCT02013791|560199738|FG005|Period 1|Other Miscellaneous Reasons|0|||
155208812|NCT02013791|560199739|FG006|Period 1|Other Miscellaneous Reasons|0|||
155208813|NCT02013791|560199740|FG007|Period 1|Other Miscellaneous Reasons|0|||
155208814|NCT02013791|560199741|FG008|Period 1|Other Miscellaneous Reasons|0|||
155208815|NCT01782222|560199755|FG000|Overall Study|Adverse Event|4|||
155208816|NCT01782222|560199756|FG001|Overall Study|Adverse Event|5|||
155208817|NCT01782222|560199757|FG002|Overall Study|Adverse Event|3|||
155208818|NCT01782222|560199755|FG000|Overall Study|Lack of Efficacy|2|||
155208819|NCT01782222|560199756|FG001|Overall Study|Lack of Efficacy|1|||
155208820|NCT01782222|560199757|FG002|Overall Study|Lack of Efficacy|0|||
155208821|NCT01782222|560199755|FG000|Overall Study|Protocol Violation|1|||
155208822|NCT01782222|560199756|FG001|Overall Study|Protocol Violation|0|||
155208823|NCT01782222|560199757|FG002|Overall Study|Protocol Violation|0|||
155208824|NCT01782222|560199755|FG000|Overall Study|Withdrawal by Subject|1|||
155208825|NCT01782222|560199756|FG001|Overall Study|Withdrawal by Subject|4|||
155208826|NCT01782222|560199757|FG002|Overall Study|Withdrawal by Subject|1|||
155208827|NCT01782222|560199755|FG000|Overall Study|Moved to other state|0|||
155208828|NCT01782222|560199756|FG001|Overall Study|Moved to other state|1|||
155208829|NCT01782222|560199757|FG002|Overall Study|Moved to other state|0|||
155208830|NCT01756898|560199761|FG000|Overall Study|Adverse Event|7|||
155208831|NCT01756898|560199762|FG001|Overall Study|Adverse Event|1|||
155208832|NCT01756898|560199763|FG002|Overall Study|Adverse Event|0|||
155208833|NCT01756898|560199764|FG003|Overall Study|Adverse Event|0|||
155208834|NCT01756898|560199761|FG000|Overall Study|Lack of Efficacy|4|||
155208835|NCT01756898|560199762|FG001|Overall Study|Lack of Efficacy|7|||
155208836|NCT01756898|560199763|FG002|Overall Study|Lack of Efficacy|6|||
155208837|NCT01756898|560199764|FG003|Overall Study|Lack of Efficacy|6|||
155208838|NCT01756898|560199761|FG000|Overall Study|Lost to Follow-up|2|||
155208839|NCT01756898|560199762|FG001|Overall Study|Lost to Follow-up|4|||
155208840|NCT01756898|560199763|FG002|Overall Study|Lost to Follow-up|2|||
155208841|NCT01756898|560199764|FG003|Overall Study|Lost to Follow-up|3|||
155208842|NCT01756898|560199761|FG000|Overall Study|Protocol Violation|1|||
155208843|NCT01756898|560199762|FG001|Overall Study|Protocol Violation|2|||
155208844|NCT01756898|560199763|FG002|Overall Study|Protocol Violation|2|||
155208845|NCT01756898|560199764|FG003|Overall Study|Protocol Violation|1|||
155208846|NCT01756898|560199761|FG000|Overall Study|Withdrew Consent|5|||
155208847|NCT01756898|560199762|FG001|Overall Study|Withdrew Consent|3|||
155208848|NCT01756898|560199763|FG002|Overall Study|Withdrew Consent|5|||
155208849|NCT01756898|560199764|FG003|Overall Study|Withdrew Consent|6|||
155208850|NCT01756898|560199761|FG000|Overall Study|Other|0|||
155208851|NCT01756898|560199762|FG001|Overall Study|Other|2|||
155208852|NCT01756898|560199763|FG002|Overall Study|Other|2|||
155208853|NCT01756898|560199764|FG003|Overall Study|Other|0|||
155208854|NCT01500694|560199765|FG000|Overall Study|Adverse Event|4|||
155208855|NCT01500694|560199766|FG001|Overall Study|Adverse Event|3|||
155208856|NCT01500694|560199765|FG000|Overall Study|Protocol Violation|0|||
155208857|NCT01500694|560199766|FG001|Overall Study|Protocol Violation|1|||
155208858|NCT01500694|560199765|FG000|Overall Study|Withdrawal by Subject|23|||
155208859|NCT01500694|560199766|FG001|Overall Study|Withdrawal by Subject|14|||
155208860|NCT01500694|560199765|FG000|Overall Study|Lost to Follow-up|2|||
155208861|NCT01500694|560199766|FG001|Overall Study|Lost to Follow-up|3|||
155208862|NCT01500694|560199765|FG000|Overall Study|Lack of Efficacy|14|||
155208863|NCT01500694|560199766|FG001|Overall Study|Lack of Efficacy|5|||
155208864|NCT01500694|560199765|FG000|Overall Study|Other|9|||
155208865|NCT01500694|560199766|FG001|Overall Study|Other|3|||
155208866|NCT01691781|560199767|FG000|Overall Study|Withdrawal by Subject|4|||
155208867|NCT01691781|560199768|FG001|Overall Study|Withdrawal by Subject|3|||
155208868|NCT01691781|560199767|FG000|Overall Study|Physician Decision|1|||
155208869|NCT01691781|560199768|FG001|Overall Study|Physician Decision|1|||
155208870|NCT01691781|560199767|FG000|Overall Study|Protocol Violation|2|||
155208871|NCT01691781|560199768|FG001|Overall Study|Protocol Violation|2|||
155208872|NCT01691781|560199767|FG000|Overall Study|Adverse Event|0|||
155208873|NCT01691781|560199768|FG001|Overall Study|Adverse Event|1|||
155208874|NCT03978520|560199769|FG000|Overall Study|Adverse Event|2|||
155208875|NCT03978520|560199770|FG001|Overall Study|Adverse Event|5|||
155208876|NCT03978520|560199771|FG002|Overall Study|Adverse Event|3|||
155208877|NCT03978520|560199772|FG003|Overall Study|Adverse Event|5|||
155208878|NCT03978520|560199773|FG004|Overall Study|Adverse Event|6|||
155208879|NCT03978520|560199769|FG000|Overall Study|Withdrawal by Subject|10|||
155208880|NCT03978520|560199770|FG001|Overall Study|Withdrawal by Subject|4|||
155208881|NCT03978520|560199771|FG002|Overall Study|Withdrawal by Subject|5|||
155208882|NCT03978520|560199772|FG003|Overall Study|Withdrawal by Subject|6|||
155208883|NCT03978520|560199773|FG004|Overall Study|Withdrawal by Subject|5|||
155208884|NCT03978520|560199769|FG000|Overall Study|Lost to Follow-up|2|||
155208885|NCT03978520|560199770|FG001|Overall Study|Lost to Follow-up|2|||
155208886|NCT03978520|560199771|FG002|Overall Study|Lost to Follow-up|2|||
155208887|NCT03978520|560199772|FG003|Overall Study|Lost to Follow-up|0|||
155208888|NCT03978520|560199773|FG004|Overall Study|Lost to Follow-up|1|||
155208889|NCT03978520|560199769|FG000|Overall Study|COVID-19 infection|0|||
155208890|NCT03978520|560199770|FG001|Overall Study|COVID-19 infection|1|||
155208891|NCT03978520|560199771|FG002|Overall Study|COVID-19 infection|0|||
155208892|NCT03978520|560199772|FG003|Overall Study|COVID-19 infection|0|||
155208893|NCT03978520|560199773|FG004|Overall Study|COVID-19 infection|0|||
155208894|NCT03978520|560199769|FG000|Overall Study|Other, not specified|9|||
155208895|NCT03978520|560199770|FG001|Overall Study|Other, not specified|4|||
155208896|NCT03978520|560199771|FG002|Overall Study|Other, not specified|1|||
155208897|NCT03978520|560199772|FG003|Overall Study|Other, not specified|1|||
155208898|NCT03978520|560199773|FG004|Overall Study|Other, not specified|2|||
155208899|NCT03978520|560199769|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
155208900|NCT03978520|560199770|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
155208901|NCT03978520|560199771|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
155208902|NCT03978520|560199772|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
155208903|NCT03978520|560199773|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
155208904|NCT01918085|560199776|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
155208905|NCT01918085|560199777|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
155208906|NCT02132130|560199784|FG000|Overall Study|Lost to Follow-up|0|||
155208907|NCT02132130|560199785|FG001|Overall Study|Lost to Follow-up|2|||
155208908|NCT02132130|560199786|FG002|Overall Study|Lost to Follow-up|0|||
155208909|NCT02132130|560199787|FG003|Overall Study|Lost to Follow-up|0|||
155208910|NCT02132130|560199784|FG000|Overall Study|Withdrawal by Subject|0|||
155208911|NCT02132130|560199785|FG001|Overall Study|Withdrawal by Subject|0|||
155208912|NCT02132130|560199786|FG002|Overall Study|Withdrawal by Subject|0|||
155208913|NCT02132130|560199787|FG003|Overall Study|Withdrawal by Subject|1|||
155208914|NCT02760069|560199788|FG000|Overall Study|Withdrawal by Subject|0|||
155208915|NCT02760069|560199789|FG001|Overall Study|Withdrawal by Subject|1|||
155208916|NCT02760069|560199790|FG002|Overall Study|Withdrawal by Subject|1|||
155208917|NCT00600483|560199795|FG000|Overall Study|Lost to Follow-up|26|||
155208918|NCT00600483|560199796|FG001|Overall Study|Lost to Follow-up|47|||
155208919|NCT00600483|560199795|FG000|Overall Study|Randomized but not treated|10|||
155208920|NCT00600483|560199796|FG001|Overall Study|Randomized but not treated|0|||
155208921|NCT02547454|560199805|FG000|Overall Study|Due to hemodialysis|53|||
155208922|NCT02547454|560199805|FG000|Overall Study|Due to transplantation|1|||
155208923|NCT02547454|560199805|FG000|Overall Study|Due to no further need to treat|4|||
155208924|NCT02547454|560199805|FG000|Overall Study|Death|38|||
155208925|NCT02547454|560199805|FG000|Overall Study|Lost to Follow-up|26|||
155208926|NCT02547454|560199805|FG000|Overall Study|Other|39|||
155208927|NCT02547454|560199805|FG000|Overall Study|No data|11|||
155208928|NCT03655691|560199808|FG000|Overall Study|Adverse Event|0|||
155208929|NCT03655691|560199809|FG001|Overall Study|Adverse Event|0|||
155208930|NCT03655691|560199810|FG002|Overall Study|Adverse Event|1|||
155208931|NCT03655691|560199808|FG000|Overall Study|Lost to Follow-up|1|||
155208932|NCT03655691|560199809|FG001|Overall Study|Lost to Follow-up|1|||
155208933|NCT03655691|560199810|FG002|Overall Study|Lost to Follow-up|2|||
155208934|NCT03655691|560199808|FG000|Overall Study|Protocol Violation|0|||
155208935|NCT03655691|560199809|FG001|Overall Study|Protocol Violation|1|||
155208936|NCT03655691|560199810|FG002|Overall Study|Protocol Violation|0|||
155208937|NCT03655691|560199808|FG000|Overall Study|Withdrawal by Subject|1|||
155208938|NCT03655691|560199809|FG001|Overall Study|Withdrawal by Subject|1|||
155208939|NCT03655691|560199810|FG002|Overall Study|Withdrawal by Subject|0|||
155208940|NCT03694821|560199813|FG000|Overall Study|Study terminated|4|||
155208941|NCT03694821|560199814|FG001|Overall Study|Study terminated|8|||
155208942|NCT03694821|560199815|FG002|Overall Study|Study terminated|4|||
155208943|NCT04221009|560201918|FG000|Overall Study|Withdrawal by Subject|4|||
155208944|NCT00793598|560201919|FG000|Overall Study|Patient Request|0|||
155208945|NCT00793598|560201920|FG001|Overall Study|Patient Request|1|||
155208946|NCT00793598|560201921|FG002|Overall Study|Patient Request|0|||
155208947|NCT00793598|560201922|FG003|Overall Study|Patient Request|0|||
155208948|NCT00793598|560201923|FG004|Overall Study|Patient Request|0|||
155208949|NCT00793598|560201924|FG005|Overall Study|Patient Request|0|||
155208950|NCT00793598|560201925|FG006|Overall Study|Patient Request|0|||
155208951|NCT00793598|560201926|FG007|Overall Study|Patient Request|0|||
155208952|NCT00793598|560201919|FG000|Overall Study|Protocol Violation|0|||
155208953|NCT00793598|560201920|FG001|Overall Study|Protocol Violation|0|||
155208954|NCT00793598|560201921|FG002|Overall Study|Protocol Violation|0|||
155208955|NCT00793598|560201922|FG003|Overall Study|Protocol Violation|0|||
155208956|NCT00793598|560201923|FG004|Overall Study|Protocol Violation|0|||
155208957|NCT00793598|560201924|FG005|Overall Study|Protocol Violation|0|||
155208958|NCT00793598|560201925|FG006|Overall Study|Protocol Violation|0|||
155208959|NCT00793598|560201926|FG007|Overall Study|Protocol Violation|1|||
155208960|NCT00793598|560201919|FG000|Overall Study|Subject not dosed|0|||
155208961|NCT00793598|560201920|FG001|Overall Study|Subject not dosed|0|||
155208962|NCT00793598|560201921|FG002|Overall Study|Subject not dosed|0|||
155208963|NCT00793598|560201922|FG003|Overall Study|Subject not dosed|0|||
155208964|NCT00793598|560201923|FG004|Overall Study|Subject not dosed|0|||
155208965|NCT00793598|560201924|FG005|Overall Study|Subject not dosed|1|||
155208966|NCT00793598|560201925|FG006|Overall Study|Subject not dosed|0|||
155208967|NCT00793598|560201926|FG007|Overall Study|Subject not dosed|0|||
155208968|NCT02154490|560201927|FG000|Overall Study|No tissue submitted|23|||
155208969|NCT02154490|560201927|FG000|Overall Study|No biomarker results|167|||
155208970|NCT02154490|560201927|FG000|Overall Study|Not assigned to a sub-study|270|||
155208971|NCT02154490|560201927|FG000|Overall Study|Did not register to a sub-study|749|||
155208972|NCT01404325|560201928|FG000|Overall Study|Lost to Follow-up|1|||
155208973|NCT01404325|560201929|FG001|Overall Study|Lost to Follow-up|0|||
155208974|NCT01404325|560201928|FG000|Overall Study|Death|2|||
155208975|NCT01404325|560201929|FG001|Overall Study|Death|0|||
155208976|NCT01404325|560201928|FG000|Overall Study|Graft loss/Retransplantation|1|||
155208977|NCT01404325|560201929|FG001|Overall Study|Graft loss/Retransplantation|0|||
155208978|NCT01404325|560201928|FG000|Overall Study|non-specified reason|0|||
155208979|NCT01404325|560201929|FG001|Overall Study|non-specified reason|2|||
155208980|NCT00660023|560201932|FG000|Overall Study|Adverse Event|2|||
155208981|NCT00660023|560201932|FG000|Overall Study|Death|8|||
155208982|NCT00660023|560201932|FG000|Overall Study|Blood Transfusion|5|||
155208983|NCT00660023|560201932|FG000|Overall Study|Renal Transplantation|3|||
155208984|NCT00660023|560201932|FG000|Overall Study|Withdrawal by Subject|1|||
155208985|NCT00660023|560201932|FG000|Overall Study|Missed Pregnancy Test|1|||
155208986|NCT00660023|560201932|FG000|Overall Study|Other Screening Failure|9|||
155208987|NCT04180488|560201934|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
155208988|NCT04180488|560201935|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
155208989|NCT04180488|560201936|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
155208990|NCT04180488|560201937|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
155208991|NCT04180488|560201938|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
155208992|NCT04180488|560201939|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
155208993|NCT04180488|560201934|FG000|Overall Study|Withdrawal by Subject|8|||
155208994|NCT04180488|560201935|FG001|Overall Study|Withdrawal by Subject|4|||
155208995|NCT04180488|560201936|FG002|Overall Study|Withdrawal by Subject|5|||
155208996|NCT04180488|560201937|FG003|Overall Study|Withdrawal by Subject|2|||
155208997|NCT04180488|560201938|FG004|Overall Study|Withdrawal by Subject|8|||
155208998|NCT04180488|560201939|FG005|Overall Study|Withdrawal by Subject|6|||
155208999|NCT04180488|560201934|FG000|Overall Study|Adverse Event|3|||
155209000|NCT04180488|560201935|FG001|Overall Study|Adverse Event|2|||
155209001|NCT04180488|560201936|FG002|Overall Study|Adverse Event|0|||
155209002|NCT04180488|560201937|FG003|Overall Study|Adverse Event|0|||
155209003|NCT04180488|560201938|FG004|Overall Study|Adverse Event|0|||
155209004|NCT04180488|560201939|FG005|Overall Study|Adverse Event|0|||
155209005|NCT04180488|560201934|FG000|Overall Study|Poor compliance to protocol|0|||
155209006|NCT04180488|560201935|FG001|Overall Study|Poor compliance to protocol|0|||
155209007|NCT04180488|560201936|FG002|Overall Study|Poor compliance to protocol|1|||
155209008|NCT04180488|560201937|FG003|Overall Study|Poor compliance to protocol|0|||
155209009|NCT04180488|560201938|FG004|Overall Study|Poor compliance to protocol|0|||
155209010|NCT04180488|560201939|FG005|Overall Study|Poor compliance to protocol|0|||
155209011|NCT00464087|560201945|FG000|Overall Study|No PCI per inclusion criteria|0|||
155209012|NCT00464087|560201946|FG001|Overall Study|No PCI per inclusion criteria|0|||
155209013|NCT00464087|560201947|FG002|Overall Study|No PCI per inclusion criteria|29|||
155209014|NCT00418314|560201949|FG000|Overall Study|Withdrawal by Subject|1|||
155209015|NCT00418314|560201950|FG001|Overall Study|Withdrawal by Subject|2|||
155209016|NCT01224431|560201951|FG000|Overall Study|not randomized|0|||
155209017|NCT01224431|560201952|FG001|Overall Study|not randomized|4|||
155209018|NCT01224431|560201951|FG000|Overall Study|no video record|0|||
155209019|NCT01224431|560201952|FG001|Overall Study|no video record|1|||
155209020|NCT00549302|560201955|FG000|Double-Blind|Death|2|||
155209021|NCT00549302|560201956|FG001|Double-Blind|Death|9|||
155209022|NCT00549302|560201957|FG002|Double-Blind|Death|0|||
155209023|NCT00549302|560201955|FG000|Double-Blind|Adverse Event|3|||
155209024|NCT00549302|560201956|FG001|Double-Blind|Adverse Event|16|||
155209025|NCT00549302|560201957|FG002|Double-Blind|Adverse Event|0|||
155209026|NCT00549302|560201955|FG000|Double-Blind|Withdrawal by Subject|3|||
155209027|NCT00549302|560201956|FG001|Double-Blind|Withdrawal by Subject|8|||
155209028|NCT00549302|560201957|FG002|Double-Blind|Withdrawal by Subject|0|||
155209029|NCT00549302|560201955|FG000|Double-Blind|Investigator Decision|1|||
155209030|NCT00549302|560201956|FG001|Double-Blind|Investigator Decision|5|||
155209031|NCT00549302|560201957|FG002|Double-Blind|Investigator Decision|0|||
155209032|NCT00549302|560201955|FG000|Double-Blind|Sponsor Decision|0|||
155209033|NCT00549302|560201956|FG001|Double-Blind|Sponsor Decision|1|||
155209034|NCT00549302|560201957|FG002|Double-Blind|Sponsor Decision|0|||
155209035|NCT00549302|560201955|FG000|Double-Blind|Lost to Follow-up|1|||
155209036|NCT00549302|560201956|FG001|Double-Blind|Lost to Follow-up|2|||
155209037|NCT00549302|560201957|FG002|Double-Blind|Lost to Follow-up|0|||
155209038|NCT00549302|560201955|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
155209039|NCT00549302|560201956|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
155209040|NCT00549302|560201957|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
155209041|NCT00549302|560201955|FG000|Double-Blind|New condition or starts new therapy|0|||
155209042|NCT00549302|560201956|FG001|Double-Blind|New condition or starts new therapy|2|||
155209043|NCT00549302|560201957|FG002|Double-Blind|New condition or starts new therapy|0|||
155209044|NCT00549302|560201955|FG000|Open-Label|Adverse Event|0|||
155209045|NCT00549302|560201956|FG001|Open-Label|Adverse Event|0|||
155209046|NCT00549302|560201957|FG002|Open-Label|Adverse Event|11|||
155209047|NCT00549302|560201955|FG000|Open-Label|Death|0|||
155209048|NCT00549302|560201956|FG001|Open-Label|Death|0|||
155209049|NCT00549302|560201957|FG002|Open-Label|Death|40|||
155209050|NCT00549302|560201955|FG000|Open-Label|Investigator Decision|0|||
155209051|NCT00549302|560201956|FG001|Open-Label|Investigator Decision|0|||
155209052|NCT00549302|560201957|FG002|Open-Label|Investigator Decision|5|||
155209053|NCT00549302|560201955|FG000|Open-Label|Lost to Follow-up|0|||
155209054|NCT00549302|560201956|FG001|Open-Label|Lost to Follow-up|0|||
155209055|NCT00549302|560201957|FG002|Open-Label|Lost to Follow-up|2|||
155209056|NCT00549302|560201955|FG000|Open-Label|Other|0|||
155209057|NCT00549302|560201956|FG001|Open-Label|Other|0|||
155209058|NCT00549302|560201957|FG002|Open-Label|Other|3|||
155209059|NCT00549302|560201955|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
155209060|NCT00549302|560201956|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
155209061|NCT00549302|560201957|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
155209062|NCT00549302|560201955|FG000|Open-Label|Withdrawal by Subject|0|||
155209063|NCT00549302|560201956|FG001|Open-Label|Withdrawal by Subject|0|||
155209064|NCT00549302|560201957|FG002|Open-Label|Withdrawal by Subject|6|||
155209065|NCT03585504|560201958|FG000|Overall Study|Lost to Follow-up|26|||
155209066|NCT03585504|560201959|FG001|Overall Study|Lost to Follow-up|29|||
155209067|NCT03590041|560201960|FG000|Overall Study|Protocol Violation|4|||
155209068|NCT03590041|560201961|FG001|Overall Study|Protocol Violation|3|||
155209069|NCT03590041|560201960|FG000|Overall Study|No session data recorded|14|||
155209070|NCT03590041|560201961|FG001|Overall Study|No session data recorded|2|||
155209071|NCT02692703|560201962|FG000|Overall Study|Lost to Follow-up|1|||
155209072|NCT02692703|560201962|FG000|Overall Study|Other|1|||
155209073|NCT04626297|560201963|FG000|Overall Study|Adverse Event|5|||
155209074|NCT04626297|560201964|FG001|Overall Study|Adverse Event|3|||
155209075|NCT04626297|560201963|FG000|Overall Study|Lost to Follow-up|7|||
155209076|NCT04626297|560201964|FG001|Overall Study|Lost to Follow-up|3|||
155209077|NCT04626297|560201963|FG000|Overall Study|Protocol Violation|5|||
155209078|NCT04626297|560201964|FG001|Overall Study|Protocol Violation|1|||
155209079|NCT04626297|560201963|FG000|Overall Study|Withdrawal by Subject|20|||
155209080|NCT04626297|560201964|FG001|Overall Study|Withdrawal by Subject|6|||
155209081|NCT04626297|560201963|FG000|Overall Study|Sponsor decision|2|||
155209082|NCT04626297|560201964|FG001|Overall Study|Sponsor decision|1|||
155209083|NCT04118166|560201965|FG000|Overall Study|Adverse Event|1|||
155209084|NCT03303079|560201969|FG000|Overall Study|Adverse Event|0|||
155209085|NCT03303079|560201970|FG001|Overall Study|Adverse Event|1|||
155209086|NCT03303079|560201971|FG002|Overall Study|Adverse Event|3|||
155209087|NCT03303079|560201969|FG000|Overall Study|Protocol Violation|5|||
155209088|NCT03303079|560201970|FG001|Overall Study|Protocol Violation|4|||
155209089|NCT03303079|560201971|FG002|Overall Study|Protocol Violation|7|||
155209090|NCT03303079|560201969|FG000|Overall Study|Withdrawal by Subject|2|||
155209091|NCT03303079|560201970|FG001|Overall Study|Withdrawal by Subject|4|||
155209092|NCT03303079|560201971|FG002|Overall Study|Withdrawal by Subject|2|||
155209093|NCT03303079|560201969|FG000|Overall Study|Other than specified|0|||
155209094|NCT03303079|560201970|FG001|Overall Study|Other than specified|2|||
155209095|NCT03303079|560201971|FG002|Overall Study|Other than specified|0|||
155209096|NCT01829191|560201972|FG000|Overall Study|Relocation|0|||
155209097|NCT01829191|560201973|FG001|Overall Study|Relocation|1|||
155209098|NCT01829191|560201972|FG000|Overall Study|Lens discomfort|0|||
155209099|NCT01829191|560201973|FG001|Overall Study|Lens discomfort|3|||
155209100|NCT01829191|560201972|FG000|Overall Study|Lens handling difficulty|1|||
155209101|NCT01829191|560201973|FG001|Overall Study|Lens handling difficulty|4|||
155209102|NCT01829191|560201972|FG000|Overall Study|Protocol Violation|4|||
155209103|NCT01829191|560201973|FG001|Overall Study|Protocol Violation|1|||
155209104|NCT01829191|560201972|FG000|Overall Study|Withdrawal by Subject|2|||
155209105|NCT01829191|560201973|FG001|Overall Study|Withdrawal by Subject|3|||
155209106|NCT01829191|560201972|FG000|Overall Study|Lost to Follow-up|0|||
155209107|NCT01829191|560201973|FG001|Overall Study|Lost to Follow-up|1|||
155209108|NCT01829191|560201972|FG000|Overall Study|Subject was fit for ortho - k|0|||
155209109|NCT01829191|560201973|FG001|Overall Study|Subject was fit for ortho - k|1|||
155209110|NCT01276353|560201974|FG000|Double-blind|Adverse Event|2|||
155209111|NCT01276353|560201975|FG001|Double-blind|Adverse Event|0|||
155209112|NCT01276353|560201974|FG000|Double-blind|Withdrawal by Subject|1|||
155209113|NCT01276353|560201975|FG001|Double-blind|Withdrawal by Subject|0|||
155209114|NCT01276353|560201974|FG000|Extension|Adverse Event|2|||
155209115|NCT01276353|560201975|FG001|Extension|Adverse Event|5|||
155209116|NCT01276353|560201974|FG000|Extension|Withdrawal by Subject|1|||
155209117|NCT01276353|560201975|FG001|Extension|Withdrawal by Subject|2|||
155209118|NCT01276353|560201974|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
155209119|NCT01276353|560201975|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
155209120|NCT01276353|560201974|FG000|Extension|Physician Decision|1|||
155209121|NCT01276353|560201975|FG001|Extension|Physician Decision|0|||
155209122|NCT01276353|560201974|FG000|Extension|Prohibited concomitant medications|0|||
155209123|NCT01276353|560201975|FG001|Extension|Prohibited concomitant medications|1|||
155209124|NCT02205814|560201980|FG000|Overall Study|Lost to Follow-up|0|||
155209125|NCT02205814|560201981|FG001|Overall Study|Lost to Follow-up|0|||
155209126|NCT02205814|560201982|FG002|Overall Study|Lost to Follow-up|0|||
155209127|NCT02205814|560201983|FG003|Overall Study|Lost to Follow-up|1|||
155209128|NCT02205814|560201980|FG000|Overall Study|Lack of Efficacy|1|||
155209129|NCT02205814|560201981|FG001|Overall Study|Lack of Efficacy|0|||
155209130|NCT02205814|560201982|FG002|Overall Study|Lack of Efficacy|1|||
155209131|NCT02205814|560201983|FG003|Overall Study|Lack of Efficacy|1|||
155209132|NCT02205814|560201980|FG000|Overall Study|Physician Decision|0|||
155209133|NCT02205814|560201981|FG001|Overall Study|Physician Decision|0|||
155209134|NCT02205814|560201982|FG002|Overall Study|Physician Decision|1|||
155209135|NCT02205814|560201983|FG003|Overall Study|Physician Decision|0|||
155209136|NCT02205814|560201980|FG000|Overall Study|Protocol Violation|1|||
155209137|NCT02205814|560201981|FG001|Overall Study|Protocol Violation|0|||
155209138|NCT02205814|560201982|FG002|Overall Study|Protocol Violation|0|||
155209139|NCT02205814|560201983|FG003|Overall Study|Protocol Violation|1|||
155209140|NCT02205814|560201980|FG000|Overall Study|Withdrawal by Subject|0|||
155209141|NCT02205814|560201981|FG001|Overall Study|Withdrawal by Subject|1|||
155209142|NCT02205814|560201982|FG002|Overall Study|Withdrawal by Subject|2|||
155209143|NCT02205814|560201983|FG003|Overall Study|Withdrawal by Subject|1|||
155209144|NCT02205814|560201980|FG000|Overall Study|not compliant with study procedures|0|||
155209145|NCT02205814|560201981|FG001|Overall Study|not compliant with study procedures|0|||
155209146|NCT02205814|560201982|FG002|Overall Study|not compliant with study procedures|1|||
155209147|NCT02205814|560201983|FG003|Overall Study|not compliant with study procedures|0|||
155209148|NCT01426373|560201984|FG000|Overall Study|Adverse Event|6|||
155209149|NCT01426373|560201984|FG000|Overall Study|Lost to Follow-up|14|||
155209150|NCT01426373|560201984|FG000|Overall Study|Participant Convenience|10|||
155209151|NCT01426373|560201984|FG000|Overall Study|Miscellaneous Reasons|4|||
155209152|NCT02246660|560201985|FG000|Overall Study|Withdrawal by Subject|0|||
155209153|NCT02246660|560201986|FG001|Overall Study|Withdrawal by Subject|1|||
155209154|NCT02246660|560201987|FG002|Overall Study|Withdrawal by Subject|0|||
155209155|NCT02246660|560201985|FG000|Overall Study|Death|0|||
155209156|NCT02246660|560201986|FG001|Overall Study|Death|0|||
155209157|NCT02246660|560201987|FG002|Overall Study|Death|1|||
155209158|NCT00726661|560201988|FG000|Overall Study|Lost to Follow-up|36|||
155209159|NCT00726661|560201989|FG001|Overall Study|Lost to Follow-up|11|||
155209160|NCT00726661|560201988|FG000|Overall Study|Withdrawal by Subject|17|||
155209161|NCT00726661|560201989|FG001|Overall Study|Withdrawal by Subject|13|||
155209162|NCT00726661|560201988|FG000|Overall Study|Trial terminated by sponsor|214|||
155209163|NCT00726661|560201989|FG001|Overall Study|Trial terminated by sponsor|187|||
155209164|NCT00726661|560201988|FG000|Overall Study|Death|475|||
155209165|NCT00726661|560201989|FG001|Overall Study|Death|159|||
155209166|NCT00726661|560201988|FG000|Overall Study|Physician Decision|25|||
155209167|NCT00726661|560201989|FG001|Overall Study|Physician Decision|13|||
155209168|NCT00726661|560201988|FG000|Overall Study|Other|47|||
155209169|NCT00726661|560201989|FG001|Overall Study|Other|35|||
155209170|NCT00587639|560201992|FG000|Overall Study|Withdrawal by Subject|1|||
155209171|NCT01574326|560201993|FG000|Overall Study|Randomized but not treated|0|||
155209172|NCT01574326|560201994|FG001|Overall Study|Randomized but not treated|1|||
155209173|NCT01574326|560201993|FG000|Overall Study|Withdrawal by Participant|2|||
155209174|NCT01574326|560201994|FG001|Overall Study|Withdrawal by Participant|4|||
155209175|NCT01574326|560201993|FG000|Overall Study|Physician Decision|5|||
155209176|NCT01574326|560201994|FG001|Overall Study|Physician Decision|3|||
155209177|NCT01574326|560201993|FG000|Overall Study|Adverse Event|1|||
155209178|NCT01574326|560201994|FG001|Overall Study|Adverse Event|3|||
155209179|NCT01574326|560201993|FG000|Overall Study|Other: Mainly kidney transplant|8|||
155209180|NCT01574326|560201994|FG001|Overall Study|Other: Mainly kidney transplant|8|||
155209181|NCT00005937|560202004|FG000|Overall Study|Lack of Efficacy|5|||
155209182|NCT01288469|560202005|FG000|Overall Study|Adverse Event|4|||
155209183|NCT01288469|560202006|FG001|Overall Study|Adverse Event|1|||
155209184|NCT01288469|560202007|FG002|Overall Study|Adverse Event|1|||
155209185|NCT01288469|560202005|FG000|Overall Study|Poor compliance to protocol|0|||
155209186|NCT01288469|560202006|FG001|Overall Study|Poor compliance to protocol|1|||
155209187|NCT01288469|560202007|FG002|Overall Study|Poor compliance to protocol|0|||
155209188|NCT01288469|560202005|FG000|Overall Study|Participant Moved|1|||
155209189|NCT01288469|560202006|FG001|Overall Study|Participant Moved|0|||
155209190|NCT01288469|560202007|FG002|Overall Study|Participant Moved|0|||
155209191|NCT01288469|560202005|FG000|Overall Study|Consent withdrawn by subject|1|||
155209192|NCT01288469|560202006|FG001|Overall Study|Consent withdrawn by subject|1|||
155209193|NCT01288469|560202007|FG002|Overall Study|Consent withdrawn by subject|1|||
155209194|NCT01288469|560202005|FG000|Overall Study|Exclusion criteria finally met|1|||
155209195|NCT01288469|560202006|FG001|Overall Study|Exclusion criteria finally met|0|||
155209196|NCT01288469|560202007|FG002|Overall Study|Exclusion criteria finally met|0|||
155209197|NCT00582166|560202011|FG000|Overall Study|Death|1|||
155209198|NCT00582166|560202011|FG000|Overall Study|Ineligible pathology|1|||
155209199|NCT01606436|560202014|FG000|Overall Study|Withdrawal by Subject|0|||
155209200|NCT01606436|560202015|FG001|Overall Study|Withdrawal by Subject|0|||
155209201|NCT01606436|560202016|FG002|Overall Study|Withdrawal by Subject|1|||
155209202|NCT01606436|560202017|FG003|Overall Study|Withdrawal by Subject|1|||
155209203|NCT01606436|560202018|FG004|Overall Study|Withdrawal by Subject|1|||
155209204|NCT01606436|560202019|FG005|Overall Study|Withdrawal by Subject|0|||
155209205|NCT01606436|560202014|FG000|Overall Study|Adverse Event|0|||
155209206|NCT01606436|560202015|FG001|Overall Study|Adverse Event|0|||
155209207|NCT01606436|560202016|FG002|Overall Study|Adverse Event|1|||
155209208|NCT01606436|560202017|FG003|Overall Study|Adverse Event|0|||
155209209|NCT01606436|560202018|FG004|Overall Study|Adverse Event|0|||
154924260|NCT01869959|559146445|FG003|Treatment Period|Withdrawal by Subject|0|||
155209210|NCT01606436|560202019|FG005|Overall Study|Adverse Event|0|||
155209211|NCT01606436|560202014|FG000|Overall Study|Sponsor Decision|0|||
155209212|NCT01606436|560202015|FG001|Overall Study|Sponsor Decision|0|||
155209213|NCT01606436|560202016|FG002|Overall Study|Sponsor Decision|0|||
155209214|NCT01606436|560202017|FG003|Overall Study|Sponsor Decision|1|||
155209215|NCT01606436|560202018|FG004|Overall Study|Sponsor Decision|0|||
155209216|NCT01606436|560202019|FG005|Overall Study|Sponsor Decision|0|||
155209217|NCT02859454|560202020|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
155209218|NCT04294472|560202021|FG000|Overall Study|Adverse Event|0|||
155209219|NCT04294472|560202022|FG001|Overall Study|Adverse Event|1|||
155209220|NCT04294472|560202023|FG002|Overall Study|Adverse Event|1|||
155209221|NCT04294472|560202021|FG000|Overall Study|Randomized but not treated|0|||
155209222|NCT04294472|560202022|FG001|Overall Study|Randomized but not treated|1|||
155209223|NCT04294472|560202023|FG002|Overall Study|Randomized but not treated|1|||
155209224|NCT00110149|560202024|FG000|Overall Study|Physician Decision|3|||
155209225|NCT02452398|560202025|FG000|Overall Study|Adverse Event|1|||
155209226|NCT02452398|560202025|FG000|Overall Study|Lost to Follow-up|28|||
155209227|NCT02452398|560202025|FG000|Overall Study|Physician Decision|2|||
155209228|NCT02452398|560202025|FG000|Overall Study|Withdrawal by Subject|6|||
155209229|NCT02452398|560202025|FG000|Overall Study|Moved away|4|||
155209230|NCT03944954|560202028|FG000|Overall Study|Withdrawal by Subject|22|||
155209231|NCT03944954|560202029|FG001|Overall Study|Withdrawal by Subject|4|||
155209232|NCT03944954|560202028|FG000|Overall Study|Lost to Follow-up|18|||
155209233|NCT03944954|560202029|FG001|Overall Study|Lost to Follow-up|0|||
155209234|NCT03944954|560202028|FG000|Overall Study|Failed Medical Screening|7|||
155209235|NCT03944954|560202029|FG001|Overall Study|Failed Medical Screening|0|||
155209236|NCT00748033|560202030|FG000|Overall Study|Adverse Event|0|||
155209237|NCT00748033|560202031|FG001|Overall Study|Adverse Event|1|||
155209238|NCT01018186|560202032|FG000|2-week Run-in Period|Protocol Violation|1|||
155209239|NCT01018186|560202033|FG001|2-week Run-in Period|Protocol Violation|0|||
155209240|NCT01018186|560202034|FG002|2-week Run-in Period|Protocol Violation|0|||
155209241|NCT01018186|560202035|FG003|2-week Run-in Period|Protocol Violation|0|||
155209242|NCT01018186|560202032|FG000|2-week Run-in Period|Lost to Follow-up|2|||
155209243|NCT01018186|560202033|FG001|2-week Run-in Period|Lost to Follow-up|0|||
155209244|NCT01018186|560202034|FG002|2-week Run-in Period|Lost to Follow-up|0|||
155209245|NCT01018186|560202035|FG003|2-week Run-in Period|Lost to Follow-up|0|||
155209246|NCT01018186|560202032|FG000|2-week Run-in Period|Physician Decision|3|||
155209247|NCT01018186|560202033|FG001|2-week Run-in Period|Physician Decision|0|||
155209248|NCT01018186|560202034|FG002|2-week Run-in Period|Physician Decision|0|||
155209249|NCT01018186|560202035|FG003|2-week Run-in Period|Physician Decision|0|||
155209250|NCT01018186|560202032|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
155209251|NCT01018186|560202033|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
155209252|NCT01018186|560202034|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
155209253|NCT01018186|560202035|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
155209254|NCT01018186|560202032|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
155209255|NCT01018186|560202033|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155209256|NCT01018186|560202034|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155209257|NCT01018186|560202035|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
155209258|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
155209259|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
155209260|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
155209261|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
155209262|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
155209263|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
155209264|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
155209265|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
155209266|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
155209267|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
155209268|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
155209269|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
155209270|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
155209271|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
155209272|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
155209273|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
155209274|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
155209275|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
155209276|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
155209277|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
155209278|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
155209279|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
155209280|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
155209281|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
155209282|NCT01018186|560202032|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
155209283|NCT01018186|560202033|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
155209284|NCT01018186|560202034|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
155209285|NCT01018186|560202035|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
155209286|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209287|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
155209288|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209289|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209290|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209291|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
155209292|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
155209293|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
155209294|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
155209295|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
155209296|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
155209297|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
155209298|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
155209299|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
155209300|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
155209301|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
155209302|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
155209303|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
155209304|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209305|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209306|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209307|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209308|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
155209309|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
155209310|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209311|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
155209312|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209313|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209314|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209315|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
155209316|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
155209317|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
155209318|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
155209319|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
155209320|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
155209321|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
155209322|NCT02603419|560202036|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209323|NCT02603419|560202037|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209324|NCT02603419|560202038|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209325|NCT02603419|560202039|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
155209326|NCT02603419|560202040|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209327|NCT02603419|560202041|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
155209328|NCT02603419|560202036|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209329|NCT02603419|560202037|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209330|NCT02603419|560202038|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209331|NCT02603419|560202039|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209332|NCT02603419|560202040|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
155209333|NCT02603419|560202041|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
155209334|NCT02603419|560202036|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209335|NCT02603419|560202037|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209336|NCT02603419|560202038|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209337|NCT02603419|560202039|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209338|NCT02603419|560202040|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
155209339|NCT02603419|560202041|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
155209340|NCT02603419|560202036|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209341|NCT02603419|560202037|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209342|NCT02603419|560202038|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209343|NCT02603419|560202039|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209344|NCT02603419|560202040|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
155209345|NCT02603419|560202041|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
155209346|NCT04102020|560202046|FG000|Overall Study|Adverse Event|1|||
155209347|NCT04102020|560202047|FG001|Overall Study|Adverse Event|0|||
155209348|NCT04102020|560202048|FG002|Overall Study|Adverse Event|0|||
155209349|NCT04102020|560202049|FG003|Overall Study|Adverse Event|1|||
155209350|NCT04102020|560202050|FG004|Overall Study|Adverse Event|0|||
155209351|NCT04102020|560202046|FG000|Overall Study|Withdrawal by Subject|0|||
155209352|NCT04102020|560202047|FG001|Overall Study|Withdrawal by Subject|1|||
155209353|NCT04102020|560202048|FG002|Overall Study|Withdrawal by Subject|1|||
155209354|NCT04102020|560202049|FG003|Overall Study|Withdrawal by Subject|1|||
155209355|NCT04102020|560202050|FG004|Overall Study|Withdrawal by Subject|1|||
155209356|NCT04102020|560202046|FG000|Overall Study|Death|1|||
155209357|NCT04102020|560202047|FG001|Overall Study|Death|4|||
155209358|NCT04102020|560202048|FG002|Overall Study|Death|1|||
155209359|NCT04102020|560202049|FG003|Overall Study|Death|1|||
155209360|NCT04102020|560202050|FG004|Overall Study|Death|0|||
155209361|NCT04102020|560202046|FG000|Overall Study|Physician Decision|1|||
155209362|NCT04102020|560202047|FG001|Overall Study|Physician Decision|2|||
155209363|NCT04102020|560202048|FG002|Overall Study|Physician Decision|2|||
155209364|NCT04102020|560202049|FG003|Overall Study|Physician Decision|0|||
155209365|NCT04102020|560202050|FG004|Overall Study|Physician Decision|1|||
155209366|NCT04102020|560202046|FG000|Overall Study|COVID-19 Infection|1|||
155209367|NCT04102020|560202047|FG001|Overall Study|COVID-19 Infection|0|||
155209368|NCT04102020|560202048|FG002|Overall Study|COVID-19 Infection|0|||
155209369|NCT04102020|560202049|FG003|Overall Study|COVID-19 Infection|0|||
155209370|NCT04102020|560202050|FG004|Overall Study|COVID-19 Infection|0|||
155209371|NCT04102020|560202046|FG000|Overall Study|Not disclosed|5|||
155209372|NCT04102020|560202047|FG001|Overall Study|Not disclosed|3|||
155209373|NCT04102020|560202048|FG002|Overall Study|Not disclosed|8|||
155209374|NCT04102020|560202049|FG003|Overall Study|Not disclosed|0|||
155209375|NCT04102020|560202050|FG004|Overall Study|Not disclosed|1|||
155209376|NCT04102020|560202046|FG000|Overall Study|MIssing|1|||
155209377|NCT04102020|560202047|FG001|Overall Study|MIssing|0|||
155209378|NCT04102020|560202048|FG002|Overall Study|MIssing|1|||
155209379|NCT04102020|560202049|FG003|Overall Study|MIssing|1|||
155209380|NCT04102020|560202050|FG004|Overall Study|MIssing|1|||
155209381|NCT04102020|560202046|FG000|Overall Study|Continuing in ongoing study|13|||
155209382|NCT04102020|560202047|FG001|Overall Study|Continuing in ongoing study|13|||
155209383|NCT04102020|560202048|FG002|Overall Study|Continuing in ongoing study|7|||
155209384|NCT04102020|560202049|FG003|Overall Study|Continuing in ongoing study|26|||
155209385|NCT04102020|560202050|FG004|Overall Study|Continuing in ongoing study|12|||
155209386|NCT05109442|560202051|FG000|Overall Study|Withdrawal by Subject|0|||
155209387|NCT05109442|560202052|FG001|Overall Study|Withdrawal by Subject|0|||
155209388|NCT05109442|560202053|FG002|Overall Study|Withdrawal by Subject|1|||
155209389|NCT05109442|560202054|FG003|Overall Study|Withdrawal by Subject|0|||
155209390|NCT05109442|560202055|FG004|Overall Study|Withdrawal by Subject|0|||
155209391|NCT05109442|560202056|FG005|Overall Study|Withdrawal by Subject|0|||
155209392|NCT05109442|560202051|FG000|Overall Study|Adverse Event|0|||
155209393|NCT05109442|560202052|FG001|Overall Study|Adverse Event|1|||
155209394|NCT05109442|560202053|FG002|Overall Study|Adverse Event|5|||
155209395|NCT05109442|560202054|FG003|Overall Study|Adverse Event|0|||
155209396|NCT05109442|560202055|FG004|Overall Study|Adverse Event|0|||
155209397|NCT05109442|560202056|FG005|Overall Study|Adverse Event|2|||
155209398|NCT05109442|560202051|FG000|Overall Study|Death|0|||
155209399|NCT05109442|560202052|FG001|Overall Study|Death|0|||
155209400|NCT05109442|560202053|FG002|Overall Study|Death|4|||
155209401|NCT05109442|560202054|FG003|Overall Study|Death|0|||
155209402|NCT05109442|560202055|FG004|Overall Study|Death|0|||
155209403|NCT05109442|560202056|FG005|Overall Study|Death|1|||
155209404|NCT05109442|560202051|FG000|Overall Study|Physician Decision|1|||
155209405|NCT05109442|560202052|FG001|Overall Study|Physician Decision|0|||
155209406|NCT05109442|560202053|FG002|Overall Study|Physician Decision|1|||
155209407|NCT05109442|560202054|FG003|Overall Study|Physician Decision|0|||
155209408|NCT05109442|560202055|FG004|Overall Study|Physician Decision|0|||
155209409|NCT05109442|560202056|FG005|Overall Study|Physician Decision|2|||
155209410|NCT05109442|560202051|FG000|Overall Study|Other than listed|0|||
155209411|NCT05109442|560202052|FG001|Overall Study|Other than listed|0|||
155209412|NCT05109442|560202053|FG002|Overall Study|Other than listed|9|||
155209413|NCT05109442|560202054|FG003|Overall Study|Other than listed|2|||
155209414|NCT05109442|560202055|FG004|Overall Study|Other than listed|0|||
155209415|NCT05109442|560202056|FG005|Overall Study|Other than listed|8|||
155209416|NCT05109442|560202051|FG000|Overall Study|Lack of Efficacy|3|||
155209417|NCT05109442|560202052|FG001|Overall Study|Lack of Efficacy|5|||
155209418|NCT05109442|560202053|FG002|Overall Study|Lack of Efficacy|29|||
155209419|NCT05109442|560202054|FG003|Overall Study|Lack of Efficacy|10|||
155209420|NCT05109442|560202055|FG004|Overall Study|Lack of Efficacy|11|||
155209421|NCT05109442|560202056|FG005|Overall Study|Lack of Efficacy|17|||
155209422|NCT04853225|560202061|FG000|Overall Study|Withdrawal by Subject|81|||
155209423|NCT04853225|560202062|FG001|Overall Study|Withdrawal by Subject|4|||
155209424|NCT04853225|560202063|FG002|Overall Study|Withdrawal by Subject|1|||
155209425|NCT04853225|560202061|FG000|Overall Study|Physician Decision|12|||
155209426|NCT04853225|560202062|FG001|Overall Study|Physician Decision|4|||
155209427|NCT04853225|560202063|FG002|Overall Study|Physician Decision|1|||
155209428|NCT04853225|560202061|FG000|Overall Study|Lost to Follow-up|50|||
155209429|NCT04853225|560202062|FG001|Overall Study|Lost to Follow-up|0|||
155209430|NCT04853225|560202063|FG002|Overall Study|Lost to Follow-up|0|||
155209431|NCT04853225|560202061|FG000|Overall Study|Other|102|||
155209432|NCT04853225|560202062|FG001|Overall Study|Other|11|||
155209433|NCT04853225|560202063|FG002|Overall Study|Other|5|||
155209434|NCT04853225|560202061|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
155209435|NCT04853225|560202062|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
155209436|NCT04853225|560202063|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
155209437|NCT04853225|560202061|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
155209438|NCT04853225|560202062|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
155209439|NCT04853225|560202063|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
155209440|NCT03918447|560202064|FG000|Overall Study|Death|1|||
155209441|NCT03918447|560202065|FG001|Overall Study|Death|0|||
155209442|NCT03918447|560202064|FG000|Overall Study|Lost to Follow-up|13|||
155209443|NCT03918447|560202065|FG001|Overall Study|Lost to Follow-up|6|||
155209444|NCT03918447|560202064|FG000|Overall Study|Withdrawal by Subject|19|||
155209445|NCT03918447|560202065|FG001|Overall Study|Withdrawal by Subject|17|||
155209446|NCT03918447|560202064|FG000|Overall Study|Study Terminated by Sponsor|195|||
155209447|NCT03918447|560202065|FG001|Overall Study|Study Terminated by Sponsor|197|||
155209448|NCT03918447|560202064|FG000|Overall Study|Reason not Specified|0|||
155209449|NCT03918447|560202065|FG001|Overall Study|Reason not Specified|1|||
155209450|NCT03278613|560202066|FG000|Overall Study|Lost to Follow-up|3|||
155209451|NCT03278613|560202067|FG001|Overall Study|Lost to Follow-up|1|||
155209452|NCT01405456|560202068|FG000|Overall Study|Lost to Follow-up|2|||
155209453|NCT01405456|560202069|FG001|Overall Study|Lost to Follow-up|1|||
155209454|NCT01405456|560202068|FG000|Overall Study|Physician Decision|1|||
155209455|NCT01405456|560202069|FG001|Overall Study|Physician Decision|0|||
155209456|NCT05475236|560202070|FG000|Overall Study|Withdrawal by Subject|0|||
155209457|NCT05475236|560202071|FG001|Overall Study|Withdrawal by Subject|1|||
155209458|NCT01774968|560202072|FG000|Overall Study|Adverse Event|4|||
155209459|NCT01774968|560202073|FG001|Overall Study|Adverse Event|4|||
155209460|NCT01774968|560202072|FG000|Overall Study|Death|0|||
155209461|NCT01774968|560202073|FG001|Overall Study|Death|1|||
155209462|NCT01774968|560202072|FG000|Overall Study|Lost to Follow-up|1|||
155209463|NCT01774968|560202073|FG001|Overall Study|Lost to Follow-up|3|||
155209464|NCT01774968|560202072|FG000|Overall Study|Physician Decision|5|||
155209465|NCT01774968|560202073|FG001|Overall Study|Physician Decision|1|||
155209466|NCT01774968|560202072|FG000|Overall Study|Protocol Violation|14|||
155209467|NCT01774968|560202073|FG001|Overall Study|Protocol Violation|13|||
155209468|NCT01774968|560202072|FG000|Overall Study|Sponsor Decision|0|||
155209469|NCT01774968|560202073|FG001|Overall Study|Sponsor Decision|2|||
155209470|NCT01774968|560202072|FG000|Overall Study|Withdrawal by Subject|6|||
155209471|NCT01774968|560202073|FG001|Overall Study|Withdrawal by Subject|11|||
155209472|NCT05355805|560202076|FG000|Overall Study|Lost to Follow-up|6|||
155209473|NCT05355805|560202077|FG001|Overall Study|Lost to Follow-up|11|||
155209474|NCT05355805|560202078|FG002|Overall Study|Lost to Follow-up|10|||
155209475|NCT05355805|560202079|FG003|Overall Study|Lost to Follow-up|6|||
155209476|NCT05355805|560202076|FG000|Overall Study|Decision by Sponsor|0|||
155209477|NCT05355805|560202077|FG001|Overall Study|Decision by Sponsor|0|||
155209478|NCT05355805|560202078|FG002|Overall Study|Decision by Sponsor|1|||
155209479|NCT05355805|560202079|FG003|Overall Study|Decision by Sponsor|0|||
155209480|NCT05355805|560202076|FG000|Overall Study|Withdrawal by Subject|7|||
155209481|NCT05355805|560202077|FG001|Overall Study|Withdrawal by Subject|14|||
155209482|NCT05355805|560202078|FG002|Overall Study|Withdrawal by Subject|15|||
155209483|NCT05355805|560202079|FG003|Overall Study|Withdrawal by Subject|13|||
155209484|NCT04847557|560202081|FG000|Overall Study|Adverse Event|1|||
155209485|NCT04847557|560202082|FG001|Overall Study|Adverse Event|0|||
155209486|NCT04847557|560202081|FG000|Overall Study|Death|19|||
155209487|NCT04847557|560202082|FG001|Overall Study|Death|15|||
155209488|NCT04847557|560202081|FG000|Overall Study|Lost to Follow-up|3|||
155209489|NCT04847557|560202082|FG001|Overall Study|Lost to Follow-up|6|||
155209490|NCT04847557|560202081|FG000|Overall Study|Physician Decision|1|||
155209491|NCT04847557|560202082|FG001|Overall Study|Physician Decision|0|||
155209492|NCT04847557|560202081|FG000|Overall Study|Protocol Violation|0|||
155209493|NCT04847557|560202082|FG001|Overall Study|Protocol Violation|1|||
155209494|NCT04847557|560202081|FG000|Overall Study|Withdrawal by Subject|8|||
155209495|NCT04847557|560202082|FG001|Overall Study|Withdrawal by Subject|14|||
155209496|NCT01325584|560202083|FG000|Overall Study|Death|1|||
155209497|NCT01986855|560203506|FG000|Overall Study|Adverse Event|1|||
155209498|NCT01986855|560203507|FG001|Overall Study|Adverse Event|0|||
155209499|NCT01986855|560203508|FG002|Overall Study|Adverse Event|0|||
155209500|NCT01986855|560203506|FG000|Overall Study|Death|3|||
155209501|NCT01986855|560203507|FG001|Overall Study|Death|4|||
155209502|NCT01986855|560203508|FG002|Overall Study|Death|4|||
155209503|NCT01986855|560203506|FG000|Overall Study|Lost to Follow-up|2|||
155209504|NCT01986855|560203507|FG001|Overall Study|Lost to Follow-up|1|||
155209505|NCT01986855|560203508|FG002|Overall Study|Lost to Follow-up|0|||
155209506|NCT01986855|560203506|FG000|Overall Study|Screen Failure|0|||
155209507|NCT01986855|560203507|FG001|Overall Study|Screen Failure|1|||
155209508|NCT01986855|560203508|FG002|Overall Study|Screen Failure|0|||
155209509|NCT01986855|560203506|FG000|Overall Study|Participant Moved|0|||
155209510|NCT01986855|560203507|FG001|Overall Study|Participant Moved|0|||
155209511|NCT01986855|560203508|FG002|Overall Study|Participant Moved|2|||
155209512|NCT01986855|560203506|FG000|Overall Study|Withdrawal by Subject|7|||
155209513|NCT01986855|560203507|FG001|Overall Study|Withdrawal by Subject|8|||
155209514|NCT01986855|560203508|FG002|Overall Study|Withdrawal by Subject|5|||
155209515|NCT04317066|560203509|FG000|Overall Study|Sponsor decision|5|||
155209516|NCT04317066|560203509|FG000|Overall Study|Death|2|||
155209517|NCT02825992|560203513|FG000|Overall Study|Withdrawal by Subject|4|||
155209518|NCT02825992|560203513|FG000|Overall Study|Lost to Follow-up|2|||
155209519|NCT02825992|560203513|FG000|Overall Study|Procedure terminated|2|||
155209520|NCT02279173|560203517|FG000|Overall Study|Protocol-specified Criteria|67|||
155209521|NCT02279173|560203517|FG000|Overall Study|Withdrawal by Subject|20|||
155209522|NCT02279173|560203517|FG000|Overall Study|Decision by Sponsor|4|||
155209523|NCT02279173|560203517|FG000|Overall Study|Lost to Follow-up|3|||
155209524|NCT01164956|560203519|FG000|Overall Study|Side Effects|1|||
155209525|NCT01164956|560203520|FG001|Overall Study|Side Effects|0|||
155209526|NCT01164956|560203521|FG002|Overall Study|Side Effects|1|||
155209527|NCT00609492|560203522|FG000|Overall Study|Withdrawal by Subject|0|||
155209528|NCT00609492|560203523|FG001|Overall Study|Withdrawal by Subject|2|||
155209529|NCT00609492|560203524|FG002|Overall Study|Withdrawal by Subject|3|||
155209530|NCT00609492|560203522|FG000|Overall Study|Lost to Follow-up|1|||
155209531|NCT00609492|560203523|FG001|Overall Study|Lost to Follow-up|1|||
155209532|NCT00609492|560203524|FG002|Overall Study|Lost to Follow-up|4|||
155209533|NCT00720434|560203525|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
155209534|NCT00720434|560203526|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
155209535|NCT00720434|560203527|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
155209536|NCT00720434|560203528|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
155209537|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
155209538|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
155209539|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
155209540|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
155209541|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
155209542|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
155209543|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
155209544|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
155209545|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
155209546|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
155209547|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
155209548|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
155209549|NCT00720434|560203525|FG000|Open-Label Period (Week 5-72)|Other|4|||
155209550|NCT00720434|560203526|FG001|Open-Label Period (Week 5-72)|Other|3|||
155209551|NCT00720434|560203527|FG002|Open-Label Period (Week 5-72)|Other|3|||
155209552|NCT00720434|560203528|FG003|Open-Label Period (Week 5-72)|Other|2|||
155209553|NCT02425046|560203529|FG000|Overall Study|Lost to Follow-up|52|||
155209554|NCT02425046|560203530|FG001|Overall Study|Lost to Follow-up|50|||
155209555|NCT02425046|560203531|FG002|Overall Study|Lost to Follow-up|56|||
155209556|NCT02425046|560203529|FG000|Overall Study|Withdrawal by Subject|16|||
155209557|NCT02425046|560203530|FG001|Overall Study|Withdrawal by Subject|12|||
155209558|NCT02425046|560203531|FG002|Overall Study|Withdrawal by Subject|0|||
155209559|NCT02782780|560203532|FG000|Overall Study|dropped out after randomization.|7|||
155209560|NCT02782780|560203533|FG001|Overall Study|dropped out after randomization.|5|||
155209561|NCT02782780|560203532|FG000|Overall Study|Protocol Violation|0|||
155209562|NCT02782780|560203533|FG001|Overall Study|Protocol Violation|2|||
155209563|NCT01413191|560203534|FG000|Overall Study|Lost to Follow-up|5|||
155209564|NCT01413191|560203534|FG000|Overall Study|Disease Progression|5|||
155209565|NCT01413191|560203534|FG000|Overall Study|Death|1|||
155209566|NCT02904512|560203535|FG000|Overall Study|Withdrawal by Subject|1|||
155209567|NCT02904512|560203536|FG001|Overall Study|Withdrawal by Subject|0|||
155209568|NCT02904512|560203535|FG000|Overall Study|Transferred to ICU|1|||
155209569|NCT02904512|560203536|FG001|Overall Study|Transferred to ICU|0|||
155209570|NCT02904512|560203535|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
155209571|NCT02904512|560203536|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
155209572|NCT01963403|560203551|FG000|Overall Study|Lost to Follow-up|2|||
155209573|NCT01963403|560203552|FG001|Overall Study|Lost to Follow-up|3|||
155209574|NCT01963403|560203551|FG000|Overall Study|Implant removal|0|||
155209575|NCT01963403|560203552|FG001|Overall Study|Implant removal|1|||
155209576|NCT00589914|560203553|FG000|Overall Study|Adverse Event|19|||
155209577|NCT00589914|560203554|FG001|Overall Study|Adverse Event|10|||
155209578|NCT00589914|560203553|FG000|Overall Study|Death|2|||
155209579|NCT00589914|560203554|FG001|Overall Study|Death|0|||
155209580|NCT00589914|560203553|FG000|Overall Study|Lack of Efficacy|40|||
155209581|NCT00589914|560203554|FG001|Overall Study|Lack of Efficacy|43|||
155209582|NCT00589914|560203553|FG000|Overall Study|Lost to Follow-up|11|||
155209583|NCT00589914|560203554|FG001|Overall Study|Lost to Follow-up|18|||
155209584|NCT00589914|560203553|FG000|Overall Study|Pregnancy|1|||
155209585|NCT00589914|560203554|FG001|Overall Study|Pregnancy|0|||
155209586|NCT00589914|560203553|FG000|Overall Study|Withdrawal by Subject|55|||
155209587|NCT00589914|560203554|FG001|Overall Study|Withdrawal by Subject|49|||
155209588|NCT00589914|560203553|FG000|Overall Study|Other|22|||
155209589|NCT00589914|560203554|FG001|Overall Study|Other|17|||
155209590|NCT03519932|560203555|FG000|First Intervention|Adverse Event|1|||
155209591|NCT03519932|560203556|FG001|First Intervention|Adverse Event|3|||
155209592|NCT01979016|560203557|FG000|Overall Study|Withdrawal by Subject|2|||
155209593|NCT01979016|560203558|FG001|Overall Study|Withdrawal by Subject|0|||
155209594|NCT01979016|560203557|FG000|Overall Study|Adverse Event|0|||
155209595|NCT01979016|560203558|FG001|Overall Study|Adverse Event|1|||
155209596|NCT01442493|560203559|FG000|Overall Study|withdrawn from study|3|||
155209597|NCT01442493|560203560|FG001|Overall Study|withdrawn from study|2|||
155209598|NCT04326231|560203562|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
155209599|NCT00759954|560203563|FG000|Overall Study|Personal reason|1|||
155209600|NCT00759954|560203564|FG001|Overall Study|Personal reason|0|||
155209601|NCT00759954|560203563|FG000|Overall Study|Adverse Event|1|||
155209602|NCT00759954|560203564|FG001|Overall Study|Adverse Event|2|||
155209603|NCT00372112|560203566|FG000|Overall Study|Adverse Event|0|||
155209604|NCT00372112|560203567|FG001|Overall Study|Adverse Event|1|||
155209605|NCT00372112|560203568|FG002|Overall Study|Adverse Event|1|||
155209606|NCT00372112|560203569|FG003|Overall Study|Adverse Event|1|||
155209607|NCT00372112|560203566|FG000|Overall Study|Withdrawal by Subject|0|||
155209608|NCT00372112|560203567|FG001|Overall Study|Withdrawal by Subject|0|||
155209609|NCT00372112|560203568|FG002|Overall Study|Withdrawal by Subject|2|||
155209610|NCT00372112|560203569|FG003|Overall Study|Withdrawal by Subject|1|||
155209611|NCT00372112|560203566|FG000|Overall Study|Exacerbation|0|||
155209612|NCT00372112|560203567|FG001|Overall Study|Exacerbation|0|||
155209613|NCT00372112|560203568|FG002|Overall Study|Exacerbation|0|||
155209614|NCT00372112|560203569|FG003|Overall Study|Exacerbation|1|||
155209615|NCT00372112|560203566|FG000|Overall Study|PR >240 at Visit 3|0|||
155209616|NCT00372112|560203567|FG001|Overall Study|PR >240 at Visit 3|0|||
155209617|NCT00372112|560203568|FG002|Overall Study|PR >240 at Visit 3|0|||
155209618|NCT00372112|560203569|FG003|Overall Study|PR >240 at Visit 3|1|||
155209619|NCT00372112|560203566|FG000|Overall Study|Hepatitis B|1|||
155209620|NCT00372112|560203567|FG001|Overall Study|Hepatitis B|0|||
155209621|NCT00372112|560203568|FG002|Overall Study|Hepatitis B|0|||
155209622|NCT00372112|560203569|FG003|Overall Study|Hepatitis B|0|||
155209623|NCT00372112|560203566|FG000|Overall Study|Other-protocol violation|0|||
155209624|NCT00372112|560203567|FG001|Overall Study|Other-protocol violation|0|||
155209625|NCT00372112|560203568|FG002|Overall Study|Other-protocol violation|1|||
155209626|NCT00372112|560203569|FG003|Overall Study|Other-protocol violation|0|||
155209627|NCT02706691|560203570|FG000|Overall Study|Adverse Event|1|||
155209628|NCT02927431|560203571|FG000|Overall Study|Withdrawal by Subject|0|||
155209629|NCT02927431|560203572|FG001|Overall Study|Withdrawal by Subject|0|||
155209630|NCT02927431|560203573|FG002|Overall Study|Withdrawal by Subject|1|||
155209631|NCT01830972|560203574|FG000|Part II|Withdrawal by Subject|2|||
155209632|NCT01830972|560203575|FG001|Part II|Withdrawal by Subject|2|||
155209633|NCT01830972|560203574|FG000|Part III|Withdrawal by Subject|1|||
155209634|NCT01830972|560203575|FG001|Part III|Withdrawal by Subject|0|||
155209635|NCT01830972|560203574|FG000|Part III|Noncompliance|1|||
155209636|NCT01830972|560203575|FG001|Part III|Noncompliance|0|||
155209637|NCT01830972|560203574|FG000|Part IV|Withdrawal by Subject|2|||
155209638|NCT01830972|560203575|FG001|Part IV|Withdrawal by Subject|1|||
155209639|NCT01830972|560203574|FG000|Part IV|Non-Compliance|1|||
155209640|NCT01830972|560203575|FG001|Part IV|Non-Compliance|0|||
155209641|NCT00553514|560203576|FG000|Overall Study|Protocol deviation|0|||
155209642|NCT00553514|560203577|FG001|Overall Study|Protocol deviation|0|||
155209643|NCT00553514|560203578|FG002|Overall Study|Protocol deviation|0|||
155209644|NCT00553514|560203579|FG003|Overall Study|Protocol deviation|1|||
155209645|NCT00553514|560203580|FG004|Overall Study|Protocol deviation|0|||
155209646|NCT00553514|560203576|FG000|Overall Study|Lack of ovarian response|4|||
155209647|NCT00553514|560203577|FG001|Overall Study|Lack of ovarian response|5|||
155209648|NCT00553514|560203578|FG002|Overall Study|Lack of ovarian response|5|||
155209649|NCT00553514|560203579|FG003|Overall Study|Lack of ovarian response|5|||
155209650|NCT00553514|560203580|FG004|Overall Study|Lack of ovarian response|6|||
155209651|NCT00553514|560203576|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
155209652|NCT00553514|560203577|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155209653|NCT00553514|560203578|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
155209654|NCT00553514|560203579|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155209655|NCT00553514|560203580|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
155209656|NCT00553514|560203576|FG000|Overall Study|Risk of multiple pregnancy|0|||
155209657|NCT00553514|560203577|FG001|Overall Study|Risk of multiple pregnancy|2|||
155209658|NCT00553514|560203578|FG002|Overall Study|Risk of multiple pregnancy|0|||
155209659|NCT00553514|560203579|FG003|Overall Study|Risk of multiple pregnancy|1|||
155209660|NCT00553514|560203580|FG004|Overall Study|Risk of multiple pregnancy|0|||
155209661|NCT00553514|560203576|FG000|Overall Study|Other|1|||
155209662|NCT00553514|560203577|FG001|Overall Study|Other|1|||
155209663|NCT00553514|560203578|FG002|Overall Study|Other|0|||
155209664|NCT00553514|560203579|FG003|Overall Study|Other|0|||
155209665|NCT00553514|560203580|FG004|Overall Study|Other|1|||
155209666|NCT00143403|560203582|FG000|Overall Study|Adverse Event|3|||
155209667|NCT00143403|560203583|FG001|Overall Study|Adverse Event|8|||
155209668|NCT00143403|560203582|FG000|Overall Study|Death|1|||
155209669|NCT00143403|560203583|FG001|Overall Study|Death|0|||
155209670|NCT00143403|560203582|FG000|Overall Study|Withdrawal by Subject|3|||
155209671|NCT00143403|560203583|FG001|Overall Study|Withdrawal by Subject|12|||
155209672|NCT00143403|560203582|FG000|Overall Study|Relapse|15|||
155209673|NCT00143403|560203583|FG001|Overall Study|Relapse|7|||
155209674|NCT00143403|560203582|FG000|Overall Study|Protocol Violation|2|||
155209675|NCT00143403|560203583|FG001|Overall Study|Protocol Violation|2|||
155209676|NCT00143403|560203582|FG000|Overall Study|specified by site|4|||
155209677|NCT00143403|560203583|FG001|Overall Study|specified by site|9|||
155209678|NCT00143403|560203582|FG000|Overall Study|Randomized Not Treated|7|||
155209679|NCT00143403|560203583|FG001|Overall Study|Randomized Not Treated|8|||
155209680|NCT03798483|560203588|FG000|Overall Study|Lost to Follow-up|2|||
155209681|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
155209682|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209683|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
155209684|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209685|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209686|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209687|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209688|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209689|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
155209690|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
155209691|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
155209692|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
155209693|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209694|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209695|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209696|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209697|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209698|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
155209699|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209700|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
155209701|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209702|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209703|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209704|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209705|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209706|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209707|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
155209708|NCT02289417|560203589|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
155209709|NCT02289417|560203590|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209710|NCT02289417|560203591|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209711|NCT02289417|560203592|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209712|NCT02289417|560203593|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209713|NCT02289417|560203594|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209714|NCT02289417|560203595|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209715|NCT02289417|560203596|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209716|NCT02289417|560203597|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
155209717|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209718|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
155209719|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
155209720|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
155209721|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
155209722|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
155209723|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209724|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209725|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
155209726|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209727|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209728|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
155209729|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209730|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209731|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209732|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209733|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209734|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
155209735|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209736|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
155209737|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
155209738|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
155209739|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
155209740|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
155209741|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209742|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209743|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
155209744|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209745|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209746|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
155209747|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209748|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
155209749|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
155209750|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209751|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209752|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
155209753|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209754|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209755|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209756|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209757|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209758|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209759|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
155209760|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209761|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
155209762|NCT02289417|560203589|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209763|NCT02289417|560203590|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209764|NCT02289417|560203591|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209765|NCT02289417|560203592|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
155209766|NCT02289417|560203593|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209767|NCT02289417|560203594|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209768|NCT02289417|560203595|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
155209769|NCT02289417|560203596|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209770|NCT02289417|560203597|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
155209771|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
155209772|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
155209773|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
155209774|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
155209775|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
155209776|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
155209777|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
155209778|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
155209779|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
155209780|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209781|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209782|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209783|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209784|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209785|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209786|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
155209787|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
155209788|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
155209789|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209790|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209791|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209792|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209793|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209794|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209795|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
155209796|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
155209797|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
155209798|NCT02289417|560203589|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209799|NCT02289417|560203590|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209800|NCT02289417|560203591|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209801|NCT02289417|560203592|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209802|NCT02289417|560203593|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209803|NCT02289417|560203594|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209804|NCT02289417|560203595|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209805|NCT02289417|560203596|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
155209806|NCT02289417|560203597|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
155209807|NCT02725710|560203598|FG000|Overall Study|Lost to Follow-up|1|||
155209808|NCT02725710|560203599|FG001|Overall Study|Lost to Follow-up|0|||
155209809|NCT01858389|560203602|FG000|Overall Study|Death|1|||
155209810|NCT01858389|560203603|FG001|Overall Study|Death|3|||
155209811|NCT01858389|560203602|FG000|Overall Study|Study terminated by sponsor|0|||
155209812|NCT01858389|560203603|FG001|Overall Study|Study terminated by sponsor|2|||
155209813|NCT01858389|560203602|FG000|Overall Study|Withdrawal by Subject|0|||
155209814|NCT01858389|560203603|FG001|Overall Study|Withdrawal by Subject|1|||
155209815|NCT01858389|560203602|FG000|Overall Study|Progressive disease|10|||
155209816|NCT01858389|560203603|FG001|Overall Study|Progressive disease|11|||
155209817|NCT01858389|560203602|FG000|Overall Study|Other|2|||
155209818|NCT01858389|560203603|FG001|Overall Study|Other|4|||
155209819|NCT01858389|560203602|FG000|Overall Study|Adverse Event|3|||
155209820|NCT01858389|560203603|FG001|Overall Study|Adverse Event|1|||
155209821|NCT01858389|560203602|FG000|Overall Study|Did not receive treatment|0|||
155209822|NCT01858389|560203603|FG001|Overall Study|Did not receive treatment|3|||
155209823|NCT03572062|560203604|FG000|Overall Study|Adverse Event|0|||
155209824|NCT03572062|560203605|FG001|Overall Study|Adverse Event|0|||
155209825|NCT03572062|560203606|FG002|Overall Study|Adverse Event|0|||
155209826|NCT03572062|560203607|FG003|Overall Study|Adverse Event|0|||
155209827|NCT03572062|560203608|FG004|Overall Study|Adverse Event|0|||
155209828|NCT03572062|560203609|FG005|Overall Study|Adverse Event|0|||
155209829|NCT03572062|560203610|FG006|Overall Study|Adverse Event|0|||
155209830|NCT03572062|560203611|FG007|Overall Study|Adverse Event|0|||
155209831|NCT03572062|560203612|FG008|Overall Study|Adverse Event|1|||
155209832|NCT03572062|560203613|FG009|Overall Study|Adverse Event|3|||
155209833|NCT03572062|560203604|FG000|Overall Study|Death|0|||
155209834|NCT03572062|560203605|FG001|Overall Study|Death|0|||
155209835|NCT03572062|560203606|FG002|Overall Study|Death|0|||
155209836|NCT03572062|560203607|FG003|Overall Study|Death|0|||
155209837|NCT03572062|560203608|FG004|Overall Study|Death|0|||
155209838|NCT03572062|560203609|FG005|Overall Study|Death|1|||
155209839|NCT03572062|560203610|FG006|Overall Study|Death|0|||
155209840|NCT03572062|560203611|FG007|Overall Study|Death|0|||
155209841|NCT03572062|560203612|FG008|Overall Study|Death|0|||
155209842|NCT03572062|560203613|FG009|Overall Study|Death|0|||
155209843|NCT03572062|560203604|FG000|Overall Study|Lost to Follow-up|0|||
155209844|NCT03572062|560203605|FG001|Overall Study|Lost to Follow-up|0|||
155209845|NCT03572062|560203606|FG002|Overall Study|Lost to Follow-up|0|||
155209846|NCT03572062|560203607|FG003|Overall Study|Lost to Follow-up|0|||
155209847|NCT03572062|560203608|FG004|Overall Study|Lost to Follow-up|0|||
155209848|NCT03572062|560203609|FG005|Overall Study|Lost to Follow-up|1|||
155209849|NCT03572062|560203610|FG006|Overall Study|Lost to Follow-up|1|||
155209850|NCT03572062|560203611|FG007|Overall Study|Lost to Follow-up|0|||
155209851|NCT03572062|560203612|FG008|Overall Study|Lost to Follow-up|0|||
155209852|NCT03572062|560203613|FG009|Overall Study|Lost to Follow-up|0|||
155209853|NCT03572062|560203604|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209854|NCT03572062|560203605|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209855|NCT03572062|560203606|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209856|NCT03572062|560203607|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209857|NCT03572062|560203608|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209858|NCT03572062|560203609|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209859|NCT03572062|560203610|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209860|NCT03572062|560203611|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209861|NCT03572062|560203612|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
155209862|NCT03572062|560203613|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
155209863|NCT03572062|560203604|FG000|Overall Study|Study Terminated By Sponsor|0|||
155209864|NCT03572062|560203605|FG001|Overall Study|Study Terminated By Sponsor|0|||
155209865|NCT03572062|560203606|FG002|Overall Study|Study Terminated By Sponsor|0|||
155209866|NCT03572062|560203607|FG003|Overall Study|Study Terminated By Sponsor|0|||
155209867|NCT03572062|560203608|FG004|Overall Study|Study Terminated By Sponsor|0|||
155209868|NCT03572062|560203609|FG005|Overall Study|Study Terminated By Sponsor|0|||
155209869|NCT03572062|560203610|FG006|Overall Study|Study Terminated By Sponsor|0|||
155209870|NCT03572062|560203611|FG007|Overall Study|Study Terminated By Sponsor|0|||
155209871|NCT03572062|560203612|FG008|Overall Study|Study Terminated By Sponsor|29|||
155209872|NCT03572062|560203613|FG009|Overall Study|Study Terminated By Sponsor|27|||
155209873|NCT03572062|560203604|FG000|Overall Study|Physician Decision|0|||
155209874|NCT03572062|560203605|FG001|Overall Study|Physician Decision|0|||
155209875|NCT03572062|560203606|FG002|Overall Study|Physician Decision|0|||
155209876|NCT03572062|560203607|FG003|Overall Study|Physician Decision|0|||
155209877|NCT03572062|560203608|FG004|Overall Study|Physician Decision|0|||
155209878|NCT03572062|560203609|FG005|Overall Study|Physician Decision|0|||
155209879|NCT03572062|560203610|FG006|Overall Study|Physician Decision|0|||
155209880|NCT03572062|560203611|FG007|Overall Study|Physician Decision|0|||
155209881|NCT03572062|560203612|FG008|Overall Study|Physician Decision|1|||
155209882|NCT03572062|560203613|FG009|Overall Study|Physician Decision|0|||
155209883|NCT03572062|560203604|FG000|Overall Study|Withdrawal by Subject|0|||
155209884|NCT03572062|560203605|FG001|Overall Study|Withdrawal by Subject|0|||
155209885|NCT03572062|560203606|FG002|Overall Study|Withdrawal by Subject|0|||
155209886|NCT03572062|560203607|FG003|Overall Study|Withdrawal by Subject|0|||
155209887|NCT03572062|560203608|FG004|Overall Study|Withdrawal by Subject|0|||
155209888|NCT03572062|560203609|FG005|Overall Study|Withdrawal by Subject|0|||
155209889|NCT03572062|560203610|FG006|Overall Study|Withdrawal by Subject|0|||
155209890|NCT03572062|560203611|FG007|Overall Study|Withdrawal by Subject|0|||
155209891|NCT03572062|560203612|FG008|Overall Study|Withdrawal by Subject|0|||
155209892|NCT03572062|560203613|FG009|Overall Study|Withdrawal by Subject|1|||
155209893|NCT03572062|560203604|FG000|Overall Study|Randomized But Not Treated|0|||
155209894|NCT03572062|560203605|FG001|Overall Study|Randomized But Not Treated|0|||
155209895|NCT03572062|560203606|FG002|Overall Study|Randomized But Not Treated|0|||
155209896|NCT03572062|560203607|FG003|Overall Study|Randomized But Not Treated|0|||
155209897|NCT03572062|560203608|FG004|Overall Study|Randomized But Not Treated|1|||
155209898|NCT03572062|560203609|FG005|Overall Study|Randomized But Not Treated|2|||
155209899|NCT03572062|560203610|FG006|Overall Study|Randomized But Not Treated|0|||
155209900|NCT03572062|560203611|FG007|Overall Study|Randomized But Not Treated|1|||
155209901|NCT03572062|560203612|FG008|Overall Study|Randomized But Not Treated|0|||
155209902|NCT03572062|560203613|FG009|Overall Study|Randomized But Not Treated|0|||
155209903|NCT01605877|560203614|FG000|Overall Study|Withdrawal by Subject|1|||
155209904|NCT00580606|560203626|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
155209905|NCT00580606|560203627|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
155209906|NCT00580606|560203626|FG000|Open Label (OL)|Withdrawal by Subject|4|||
155209907|NCT00580606|560203627|FG001|Open Label (OL)|Withdrawal by Subject|6|||
155209908|NCT00580606|560203626|FG000|Open Label (OL)|Dosing Symptoms|0|||
155209909|NCT00580606|560203627|FG001|Open Label (OL)|Dosing Symptoms|1|||
155209910|NCT00580606|560203626|FG000|Open Label (OL)|Lost to Follow-up|0|||
155209911|NCT00580606|560203627|FG001|Open Label (OL)|Lost to Follow-up|1|||
155209912|NCT00580606|560203626|FG000|Open Label (OL)|Pregnancy|0|||
155209913|NCT00580606|560203627|FG001|Open Label (OL)|Pregnancy|1|||
155209914|NCT00580606|560203626|FG000|Open Label (OL)|Non-compliance|2|||
155209915|NCT00580606|560203627|FG001|Open Label (OL)|Non-compliance|0|||
155209916|NCT00580606|560203626|FG000|Open Label (OL)|Physician Decision|1|||
155209917|NCT00580606|560203627|FG001|Open Label (OL)|Physician Decision|1|||
155209918|NCT00580606|560203626|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
155209919|NCT00580606|560203627|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
155209920|NCT03064451|560203629|FG000|Overall Study|Lost to Follow-up|1|||
155209921|NCT03064451|560203629|FG000|Overall Study|Mapping Failure|4|||
155209922|NCT03064451|560203629|FG000|Overall Study|Exited prior to procedure|8|||
155209923|NCT03064451|560203629|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
155209924|NCT00750204|560203632|FG000|Overall Study|study halted prematurely|1|||
155209925|NCT00750204|560203633|FG001|Overall Study|study halted prematurely|1|||
155209926|NCT01428453|560203634|FG000|Overall Study|Adverse Event|2|||
155209927|NCT01428453|560203635|FG001|Overall Study|Adverse Event|7|||
155209928|NCT01428453|560203634|FG000|Overall Study|Protocol Violation|1|||
155209929|NCT01428453|560203635|FG001|Overall Study|Protocol Violation|0|||
155209930|NCT01428453|560203634|FG000|Overall Study|Lost to Follow-up|0|||
155209931|NCT01428453|560203635|FG001|Overall Study|Lost to Follow-up|1|||
155209932|NCT01428453|560203634|FG000|Overall Study|Withdrawal by Subject|3|||
155209933|NCT01428453|560203635|FG001|Overall Study|Withdrawal by Subject|1|||
155209934|NCT01996709|560203636|FG000|Overall Study|Withdrawal by Subject|1|||
155209935|NCT01996709|560203637|FG001|Overall Study|Withdrawal by Subject|0|||
155209936|NCT01996709|560203636|FG000|Overall Study|Lost to Follow-up|3|||
155209937|NCT01996709|560203637|FG001|Overall Study|Lost to Follow-up|0|||
155209938|NCT01996709|560203636|FG000|Overall Study|Subject Non-Compliant|1|||
155209939|NCT01996709|560203637|FG001|Overall Study|Subject Non-Compliant|0|||
155209940|NCT01996709|560203636|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
155209941|NCT01996709|560203637|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
155209942|NCT00477971|560203638|FG000|Overall Study|Disease progression|6|||
155209943|NCT00477971|560203639|FG001|Overall Study|Disease progression|0|||
155209944|NCT00477971|560203638|FG000|Overall Study|Withdrawal by Subject|3|||
155209945|NCT00477971|560203639|FG001|Overall Study|Withdrawal by Subject|1|||
155209946|NCT00477971|560203638|FG000|Overall Study|Adverse Event|3|||
155209947|NCT00477971|560203639|FG001|Overall Study|Adverse Event|0|||
155209948|NCT00477971|560203638|FG000|Overall Study|Death|2|||
155209949|NCT00477971|560203639|FG001|Overall Study|Death|4|||
155209950|NCT00477971|560203638|FG000|Overall Study|Alternative treatment|3|||
155209951|NCT00477971|560203639|FG001|Overall Study|Alternative treatment|1|||
155209952|NCT02167893|560203640|FG000|Overall Study|Investigator transferred|85|||
155209953|NCT02167893|560203640|FG000|Overall Study|Investigator health reasons|10|||
155209954|NCT02167893|560203640|FG000|Overall Study|Case report forms not collected|68|||
155209955|NCT01438424|560205308|FG000|Overall Study|Continuing treatment|29|||
155209956|NCT01438424|560205308|FG000|Overall Study|Minimal virologic response|95|||
155209957|NCT01438424|560205308|FG000|Overall Study|Not identified|55|||
155209958|NCT01438424|560205308|FG000|Overall Study|Withdrawal by Subject|104|||
155209959|NCT01438424|560205308|FG000|Overall Study|Progression of chronic hepatitis B|22|||
155209960|NCT01438424|560205308|FG000|Overall Study|Death|22|||
155209961|NCT01438424|560205308|FG000|Overall Study|Adverse Event|17|||
155209962|NCT01438424|560205308|FG000|Overall Study|Lost to Follow-up|17|||
155209963|NCT01438424|560205308|FG000|Overall Study|Abnormal laboratory test result|14|||
155209964|NCT01438424|560205308|FG000|Overall Study|Need for drug prohibited by protocol|14|||
155209965|NCT01438424|560205308|FG000|Overall Study|Pregnancy|7|||
155209966|NCT01438424|560205308|FG000|Overall Study|No longer met inclusion criteria|1|||
155209967|NCT01438424|560205308|FG000|Overall Study|Participant noncompliance|20|||
155209968|NCT02927080|560205309|FG000|Overall Study|Withdrawal by Subject|0|||
155209969|NCT02927080|560205310|FG001|Overall Study|Withdrawal by Subject|0|||
155209970|NCT02927080|560205311|FG002|Overall Study|Withdrawal by Subject|0|||
155209971|NCT02927080|560205312|FG003|Overall Study|Withdrawal by Subject|0|||
155209972|NCT02927080|560205313|FG004|Overall Study|Withdrawal by Subject|1|||
155209973|NCT02927080|560205314|FG005|Overall Study|Withdrawal by Subject|0|||
155209974|NCT02927080|560205315|FG006|Overall Study|Withdrawal by Subject|1|||
155209975|NCT02927080|560205316|FG007|Overall Study|Withdrawal by Subject|1|||
155209976|NCT02927080|560205317|FG008|Overall Study|Withdrawal by Subject|0|||
155209977|NCT02927080|560205318|FG009|Overall Study|Withdrawal by Subject|2|||
155209978|NCT02927080|560205309|FG000|Overall Study|Willingness to comply with protocol|0|||
155209979|NCT02927080|560205310|FG001|Overall Study|Willingness to comply with protocol|0|||
155209980|NCT02927080|560205311|FG002|Overall Study|Willingness to comply with protocol|0|||
155209981|NCT02927080|560205312|FG003|Overall Study|Willingness to comply with protocol|0|||
155209982|NCT02927080|560205313|FG004|Overall Study|Willingness to comply with protocol|0|||
155209983|NCT02927080|560205314|FG005|Overall Study|Willingness to comply with protocol|0|||
155209984|NCT02927080|560205315|FG006|Overall Study|Willingness to comply with protocol|0|||
155209985|NCT02927080|560205316|FG007|Overall Study|Willingness to comply with protocol|0|||
155209986|NCT02927080|560205317|FG008|Overall Study|Willingness to comply with protocol|0|||
155209987|NCT02927080|560205318|FG009|Overall Study|Willingness to comply with protocol|1|||
155209988|NCT02927080|560205309|FG000|Overall Study|Study terminated by Sponsor|0|||
155209989|NCT02927080|560205310|FG001|Overall Study|Study terminated by Sponsor|0|||
155209990|NCT02927080|560205311|FG002|Overall Study|Study terminated by Sponsor|0|||
155209991|NCT02927080|560205312|FG003|Overall Study|Study terminated by Sponsor|0|||
155209992|NCT02927080|560205313|FG004|Overall Study|Study terminated by Sponsor|0|||
155209993|NCT02927080|560205314|FG005|Overall Study|Study terminated by Sponsor|0|||
155209994|NCT02927080|560205315|FG006|Overall Study|Study terminated by Sponsor|6|||
155209995|NCT02927080|560205316|FG007|Overall Study|Study terminated by Sponsor|7|||
155209996|NCT02927080|560205317|FG008|Overall Study|Study terminated by Sponsor|2|||
155209997|NCT02927080|560205318|FG009|Overall Study|Study terminated by Sponsor|3|||
155209998|NCT02927080|560205309|FG000|Overall Study|Adverse Event|0|||
155209999|NCT02927080|560205310|FG001|Overall Study|Adverse Event|1|||
155210000|NCT02927080|560205311|FG002|Overall Study|Adverse Event|0|||
155210001|NCT02927080|560205312|FG003|Overall Study|Adverse Event|0|||
155210002|NCT02927080|560205313|FG004|Overall Study|Adverse Event|0|||
155210003|NCT02927080|560205314|FG005|Overall Study|Adverse Event|0|||
155210004|NCT02927080|560205315|FG006|Overall Study|Adverse Event|0|||
155210005|NCT02927080|560205316|FG007|Overall Study|Adverse Event|1|||
155210006|NCT02927080|560205317|FG008|Overall Study|Adverse Event|0|||
155210007|NCT02927080|560205318|FG009|Overall Study|Adverse Event|1|||
155210008|NCT02927080|560205309|FG000|Overall Study|Other|0|||
155210009|NCT02927080|560205310|FG001|Overall Study|Other|0|||
155210010|NCT02927080|560205311|FG002|Overall Study|Other|0|||
155210011|NCT02927080|560205312|FG003|Overall Study|Other|0|||
155210012|NCT02927080|560205313|FG004|Overall Study|Other|0|||
155210013|NCT02927080|560205314|FG005|Overall Study|Other|0|||
155210014|NCT02927080|560205315|FG006|Overall Study|Other|1|||
155210015|NCT02927080|560205316|FG007|Overall Study|Other|0|||
155210016|NCT02927080|560205317|FG008|Overall Study|Other|1|||
155210017|NCT02927080|560205318|FG009|Overall Study|Other|0|||
155210018|NCT01411228|560205319|FG000|Overall Study|Lost to Follow-up|0|||
155210019|NCT01411228|560205320|FG001|Overall Study|Lost to Follow-up|0|||
155210020|NCT01411228|560205321|FG002|Overall Study|Lost to Follow-up|1|||
155210021|NCT01411228|560205319|FG000|Overall Study|Withdrawal by Subject|1|||
155210022|NCT01411228|560205320|FG001|Overall Study|Withdrawal by Subject|0|||
155210023|NCT01411228|560205321|FG002|Overall Study|Withdrawal by Subject|0|||
155210024|NCT00664742|560205322|FG000|Overall Study|Withdrawn due to adverse events|3|||
155210025|NCT00664742|560205322|FG000|Overall Study|Withdrawal by Subject|31|||
155210026|NCT00664742|560205322|FG000|Overall Study|Lost to Follow-up|92|||
155210027|NCT02670083|560205323|FG000|Overall Study|Adverse Event|16|||
155210028|NCT02670083|560205324|FG001|Overall Study|Adverse Event|13|||
155210029|NCT02670083|560205323|FG000|Overall Study|Death|4|||
155210030|NCT02670083|560205324|FG001|Overall Study|Death|6|||
155210031|NCT02670083|560205323|FG000|Overall Study|Lost to Follow-up|2|||
155210032|NCT02670083|560205324|FG001|Overall Study|Lost to Follow-up|2|||
155210033|NCT02670083|560205323|FG000|Overall Study|Multiple Reasons|9|||
155210034|NCT02670083|560205324|FG001|Overall Study|Multiple Reasons|9|||
155210035|NCT02670083|560205323|FG000|Overall Study|Physician Decision|0|||
155210036|NCT02670083|560205324|FG001|Overall Study|Physician Decision|2|||
155210037|NCT02670083|560205323|FG000|Overall Study|Study Terminated By Sponsor|257|||
155210038|NCT02670083|560205324|FG001|Overall Study|Study Terminated By Sponsor|254|||
155210039|NCT02670083|560205323|FG000|Overall Study|Symptomatic Deterioration|0|||
155210040|NCT02670083|560205324|FG001|Overall Study|Symptomatic Deterioration|2|||
155210041|NCT02670083|560205323|FG000|Overall Study|Withdrawal by Subject|32|||
155210042|NCT02670083|560205324|FG001|Overall Study|Withdrawal by Subject|31|||
155210043|NCT02670083|560205323|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155210044|NCT02670083|560205324|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155210045|NCT03045328|560205328|FG000|Overall Study|Withdrawal by Subject|2|||
155210046|NCT02564042|560205329|FG000|Overall Study|Adverse Event|4|||
155210047|NCT02564042|560205330|FG001|Overall Study|Adverse Event|4|||
155210048|NCT02564042|560205331|FG002|Overall Study|Adverse Event|3|||
155210049|NCT02564042|560205332|FG003|Overall Study|Adverse Event|0|||
155210050|NCT02564042|560205333|FG004|Overall Study|Adverse Event|0|||
155210051|NCT02564042|560205334|FG005|Overall Study|Adverse Event|1|||
155210052|NCT02564042|560205329|FG000|Overall Study|Lost to Follow-up|1|||
155210053|NCT02564042|560205330|FG001|Overall Study|Lost to Follow-up|1|||
155210054|NCT02564042|560205331|FG002|Overall Study|Lost to Follow-up|1|||
155210055|NCT02564042|560205332|FG003|Overall Study|Lost to Follow-up|0|||
155210056|NCT02564042|560205333|FG004|Overall Study|Lost to Follow-up|1|||
155210057|NCT02564042|560205334|FG005|Overall Study|Lost to Follow-up|1|||
155210058|NCT02564042|560205329|FG000|Overall Study|Physician Decision|1|||
155210059|NCT02564042|560205330|FG001|Overall Study|Physician Decision|0|||
155210060|NCT02564042|560205331|FG002|Overall Study|Physician Decision|0|||
155210061|NCT02564042|560205332|FG003|Overall Study|Physician Decision|1|||
155210062|NCT02564042|560205333|FG004|Overall Study|Physician Decision|0|||
155210063|NCT02564042|560205334|FG005|Overall Study|Physician Decision|0|||
155210064|NCT02564042|560205329|FG000|Overall Study|Withdrawal by Subject|5|||
155210065|NCT02564042|560205330|FG001|Overall Study|Withdrawal by Subject|3|||
155210066|NCT02564042|560205331|FG002|Overall Study|Withdrawal by Subject|2|||
155210067|NCT02564042|560205332|FG003|Overall Study|Withdrawal by Subject|2|||
155210068|NCT02564042|560205333|FG004|Overall Study|Withdrawal by Subject|10|||
155210069|NCT02564042|560205334|FG005|Overall Study|Withdrawal by Subject|12|||
155210070|NCT01356966|560205335|FG000|Overall Study|Withdrawal by Subject|1|||
155210071|NCT01356966|560205336|FG001|Overall Study|Withdrawal by Subject|2|||
155210072|NCT01356966|560205335|FG000|Overall Study|Physician Decision|1|||
155210073|NCT01356966|560205336|FG001|Overall Study|Physician Decision|0|||
155210074|NCT02743806|560205337|FG000|Overall Study|Adverse Event|9|||
155210075|NCT02743806|560205337|FG000|Overall Study|Lost to Follow-up|8|||
155210076|NCT02743806|560205337|FG000|Overall Study|Voluntary Withdrawal|54|||
155210077|NCT02743806|560205337|FG000|Overall Study|Study Termination|65|||
155210078|NCT02743806|560205337|FG000|Overall Study|Pregnancy|6|||
155210079|NCT02743806|560205337|FG000|Overall Study|No Longer Clinically Benefiting|27|||
155210080|NCT02743806|560205337|FG000|Overall Study|Reason Not Specified|12|||
155210081|NCT00849381|560205339|FG000|Overall Study|Adverse Event|1|||
155210082|NCT00849381|560205339|FG000|Overall Study|Lost to Follow-up|129|||
155210083|NCT00849381|560205339|FG000|Overall Study|Protocol Violation|5|||
155210084|NCT00849381|560205339|FG000|Overall Study|Withdrawal by Subject|6|||
155210085|NCT00849381|560205339|FG000|Overall Study|Other|4|||
155210086|NCT04429061|560205343|FG000|Overall Study|Lost to Follow-up|62|||
155210087|NCT04429061|560205344|FG001|Overall Study|Lost to Follow-up|87|||
155210088|NCT04429061|560205343|FG000|Overall Study|Withdrawal by Subject|3|||
155210089|NCT04429061|560205344|FG001|Overall Study|Withdrawal by Subject|4|||
155210090|NCT02618434|560205349|FG000|Overall Study|Withdrawal by Subject|0|||
155210091|NCT02618434|560205350|FG001|Overall Study|Withdrawal by Subject|2|||
155210092|NCT02618434|560205351|FG002|Overall Study|Withdrawal by Subject|3|||
155210093|NCT02618434|560205349|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
155210094|NCT02618434|560205350|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
155210095|NCT02618434|560205351|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
155210096|NCT02618434|560205349|FG000|Overall Study|Lost to Follow-up|3|||
155210097|NCT02618434|560205350|FG001|Overall Study|Lost to Follow-up|1|||
155210098|NCT02618434|560205351|FG002|Overall Study|Lost to Follow-up|3|||
155210099|NCT02618434|560205349|FG000|Overall Study|Adverse Event|1|||
155210100|NCT02618434|560205350|FG001|Overall Study|Adverse Event|0|||
155210101|NCT02618434|560205351|FG002|Overall Study|Adverse Event|12|||
155210102|NCT02618434|560205349|FG000|Overall Study|Physician Decision|0|||
155210103|NCT02618434|560205350|FG001|Overall Study|Physician Decision|1|||
155210104|NCT02618434|560205351|FG002|Overall Study|Physician Decision|0|||
155210105|NCT02618434|560205349|FG000|Overall Study|Protocol Violation|0|||
155210106|NCT02618434|560205350|FG001|Overall Study|Protocol Violation|0|||
155210107|NCT02618434|560205351|FG002|Overall Study|Protocol Violation|1|||
155210108|NCT02618434|560205349|FG000|Overall Study|Other, Multiple categories|1|||
155210109|NCT02618434|560205350|FG001|Overall Study|Other, Multiple categories|1|||
155210110|NCT02618434|560205351|FG002|Overall Study|Other, Multiple categories|1|||
155210111|NCT02289898|560205357|FG000|Overall Study|Death|5|||
155210112|NCT02289898|560205358|FG001|Overall Study|Death|4|||
155210113|NCT02289898|560205359|FG002|Overall Study|Death|3|||
155210114|NCT02289898|560205357|FG000|Overall Study|Physician Decision|2|||
155210115|NCT02289898|560205358|FG001|Overall Study|Physician Decision|5|||
155210116|NCT02289898|560205359|FG002|Overall Study|Physician Decision|2|||
155210117|NCT02289898|560205357|FG000|Overall Study|Withdrawal by Subject|0|||
155210118|NCT02289898|560205358|FG001|Overall Study|Withdrawal by Subject|4|||
155210119|NCT02289898|560205359|FG002|Overall Study|Withdrawal by Subject|1|||
155210120|NCT02289898|560205357|FG000|Overall Study|Adverse Event|3|||
155210121|NCT02289898|560205358|FG001|Overall Study|Adverse Event|5|||
155210122|NCT02289898|560205359|FG002|Overall Study|Adverse Event|5|||
155210123|NCT02289898|560205357|FG000|Overall Study|Disease progression|34|||
155210124|NCT02289898|560205358|FG001|Overall Study|Disease progression|28|||
155210125|NCT02289898|560205359|FG002|Overall Study|Disease progression|34|||
155210126|NCT02289898|560205357|FG000|Overall Study|Use of another anticancer therapy|0|||
155210127|NCT02289898|560205358|FG001|Overall Study|Use of another anticancer therapy|0|||
155210128|NCT02289898|560205359|FG002|Overall Study|Use of another anticancer therapy|1|||
155210129|NCT02289898|560205357|FG000|Overall Study|Other|8|||
155210130|NCT02289898|560205358|FG001|Overall Study|Other|7|||
155210131|NCT02289898|560205359|FG002|Overall Study|Other|10|||
155210132|NCT00885105|560205360|FG000|Overall Study|Withdrawal by Subject|0|||
155210133|NCT00885105|560205361|FG001|Overall Study|Withdrawal by Subject|8|||
155210134|NCT00885105|560205360|FG000|Overall Study|Adverse Event|1|||
155210135|NCT00885105|560205361|FG001|Overall Study|Adverse Event|0|||
155210136|NCT00885105|560205360|FG000|Overall Study|Protocol Violation|0|||
155210137|NCT00885105|560205361|FG001|Overall Study|Protocol Violation|2|||
155210138|NCT02254486|560205362|FG000|Overall Study|Adverse Event|1|||
155210139|NCT02254486|560205363|FG001|Overall Study|Adverse Event|1|||
155210140|NCT02254486|560205362|FG000|Overall Study|Lack of Efficacy|1|||
155210141|NCT02254486|560205363|FG001|Overall Study|Lack of Efficacy|0|||
155210142|NCT02254486|560205362|FG000|Overall Study|Lost to Follow-up|2|||
155210143|NCT02254486|560205363|FG001|Overall Study|Lost to Follow-up|4|||
155210144|NCT02254486|560205362|FG000|Overall Study|Protocol Violation|1|||
155210145|NCT02254486|560205363|FG001|Overall Study|Protocol Violation|2|||
155210146|NCT02254486|560205362|FG000|Overall Study|Withdrawal by Subject|17|||
155210147|NCT02254486|560205363|FG001|Overall Study|Withdrawal by Subject|15|||
155210148|NCT02254486|560205362|FG000|Overall Study|GFR<60mL/min|16|||
155210149|NCT02254486|560205363|FG001|Overall Study|GFR<60mL/min|21|||
155210150|NCT02254486|560205362|FG000|Overall Study|Various|12|||
155210151|NCT02254486|560205363|FG001|Overall Study|Various|12|||
155210152|NCT01350414|560205364|FG000|Overall Study|Lost to Follow-up|13|||
155210153|NCT01350414|560205364|FG000|Overall Study|Withdrawal by Subject|4|||
155210154|NCT01350414|560205364|FG000|Overall Study|Physician Decision|2|||
155210155|NCT00267046|560205370|FG000|Overall Study|Disease progression|4|||
155210156|NCT00267046|560205371|FG001|Overall Study|Disease progression|2|||
155210157|NCT00267046|560205370|FG000|Overall Study|Chemotoxicity|2|||
155210158|NCT00267046|560205371|FG001|Overall Study|Chemotoxicity|0|||
155210159|NCT00267046|560205370|FG000|Overall Study|Open-label palifermin|2|||
155210160|NCT00267046|560205371|FG001|Overall Study|Open-label palifermin|7|||
155210161|NCT00267046|560205370|FG000|Overall Study|Surgery|3|||
155210162|NCT00267046|560205371|FG001|Overall Study|Surgery|1|||
155210163|NCT00267046|560205370|FG000|Overall Study|Withdrawal by Subject|1|||
155210164|NCT00267046|560205371|FG001|Overall Study|Withdrawal by Subject|0|||
155210165|NCT00267046|560205370|FG000|Overall Study|Radiation|0|||
155210166|NCT00267046|560205371|FG001|Overall Study|Radiation|1|||
155210167|NCT00460408|560205372|FG000|Overall Study|Adverse Event|1|||
155210168|NCT00460408|560205373|FG001|Overall Study|Adverse Event|0|||
155210169|NCT00460408|560205374|FG002|Overall Study|Adverse Event|0|||
155210170|NCT00460408|560205375|FG003|Overall Study|Adverse Event|0|||
155210171|NCT00460408|560205372|FG000|Overall Study|Death|7|||
155210172|NCT00460408|560205373|FG001|Overall Study|Death|0|||
155210173|NCT00460408|560205374|FG002|Overall Study|Death|0|||
155210174|NCT00460408|560205375|FG003|Overall Study|Death|0|||
155210175|NCT00460408|560205372|FG000|Overall Study|Lost to Follow-up|11|||
155210176|NCT00460408|560205373|FG001|Overall Study|Lost to Follow-up|0|||
155210177|NCT00460408|560205374|FG002|Overall Study|Lost to Follow-up|1|||
155210178|NCT00460408|560205375|FG003|Overall Study|Lost to Follow-up|0|||
155210179|NCT00460408|560205372|FG000|Overall Study|Withdrawal by Subject|31|||
155210180|NCT00460408|560205373|FG001|Overall Study|Withdrawal by Subject|0|||
155210181|NCT00460408|560205374|FG002|Overall Study|Withdrawal by Subject|0|||
155210182|NCT00460408|560205375|FG003|Overall Study|Withdrawal by Subject|0|||
155210183|NCT00460408|560205372|FG000|Overall Study|Insufficient clinical response|5|||
155210184|NCT00460408|560205373|FG001|Overall Study|Insufficient clinical response|1|||
155210185|NCT00460408|560205374|FG002|Overall Study|Insufficient clinical response|5|||
155210186|NCT00460408|560205375|FG003|Overall Study|Insufficient clinical response|0|||
155210187|NCT00460408|560205372|FG000|Overall Study|Other|12|||
155210188|NCT00460408|560205373|FG001|Overall Study|Other|2|||
155210189|NCT00460408|560205374|FG002|Overall Study|Other|0|||
155210190|NCT00460408|560205375|FG003|Overall Study|Other|0|||
155210191|NCT00103142|560205376|FG000|Overall Study|Adverse Event|1|||
155210192|NCT00103142|560205377|FG001|Overall Study|Adverse Event|0|||
155210193|NCT00103142|560205376|FG000|Overall Study|Progression of disease|2|||
155210194|NCT00103142|560205377|FG001|Overall Study|Progression of disease|1|||
155210195|NCT04983264|560205381|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
155210196|NCT04983264|560205382|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
155210197|NCT04983264|560205383|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
155210198|NCT04983264|560205381|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
155210199|NCT04983264|560205382|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
155210200|NCT04983264|560205383|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
155210201|NCT00938639|560205384|FG000|Overall Study|Moved away from study area|0|||
155210202|NCT00938639|560205385|FG001|Overall Study|Moved away from study area|1|||
155210203|NCT00938639|560205384|FG000|Overall Study|Lost to Follow-up|1|||
155210204|NCT00938639|560205385|FG001|Overall Study|Lost to Follow-up|2|||
155210205|NCT00938639|560205384|FG000|Overall Study|Family issues|1|||
155210206|NCT00938639|560205385|FG001|Overall Study|Family issues|1|||
155210207|NCT00938639|560205384|FG000|Overall Study|Participant noncompliance|1|||
155210208|NCT00938639|560205385|FG001|Overall Study|Participant noncompliance|0|||
155210209|NCT00010374|560205390|FG000|Overall Study|False positive phrenic nerve test|1|||
155210210|NCT01741701|560205396|FG000|Overall Study|Adverse Event|5|||
155210211|NCT01741701|560205397|FG001|Overall Study|Adverse Event|1|||
155210212|NCT01741701|560205396|FG000|Overall Study|Withdrawal by Subject|0|||
155210213|NCT01741701|560205397|FG001|Overall Study|Withdrawal by Subject|1|||
155210214|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
155210215|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
155210216|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
155210217|NCT03033394|560205404|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
155210218|NCT03033394|560205404|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
155210219|NCT00356369|560205405|FG000|Active Phase|Withdrawal by Subject|2|||
155210220|NCT00356369|560205406|FG001|Active Phase|Withdrawal by Subject|1|||
155210221|NCT00673465|560205410|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210222|NCT00673465|560205411|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210223|NCT00673465|560205412|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210224|NCT00673465|560205413|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210225|NCT00673465|560205414|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
155210226|NCT00673465|560205415|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
155210227|NCT00673465|560205416|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210228|NCT00673465|560205417|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210229|NCT00673465|560205418|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210230|NCT00673465|560205419|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210231|NCT00673465|560205420|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210232|NCT00673465|560205421|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
155210233|NCT00673465|560205410|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210234|NCT00673465|560205411|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210235|NCT00673465|560205412|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210236|NCT00673465|560205413|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210237|NCT00673465|560205414|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
155210238|NCT00673465|560205415|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210239|NCT00673465|560205416|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210240|NCT00673465|560205417|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210241|NCT00673465|560205418|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210242|NCT00673465|560205419|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210243|NCT00673465|560205420|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210244|NCT00673465|560205421|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
155210245|NCT04952402|560205422|FG000|Overall Study|Lost to Follow-up|1|||
155210246|NCT04952402|560205423|FG001|Overall Study|Lost to Follow-up|3|||
155210247|NCT04952402|560205422|FG000|Overall Study|Lack Of Venous Access|0|||
155210248|NCT04952402|560205423|FG001|Overall Study|Lack Of Venous Access|1|||
155210249|NCT01919723|560205426|FG000|Overall Study|Blood Samples Hemolyzed|2|||
155210250|NCT01919723|560205427|FG001|Overall Study|Blood Samples Hemolyzed|2|||
155210251|NCT04502589|560205428|FG000|Overall Study|Physician Decision|1|||
155210252|NCT04502589|560205429|FG001|Overall Study|Physician Decision|0|||
155210253|NCT01574612|560205430|FG000|Overall Study|Adverse Event|3|||
155210254|NCT01574612|560205430|FG000|Overall Study|non compliant with drug|2|||
155210255|NCT01574612|560205430|FG000|Overall Study|Withdrawal by Subject|1|||
155210256|NCT01574612|560205430|FG000|Overall Study|Lost to Follow-up|2|||
155210257|NCT01683383|560205431|FG000|Overall Study|Infant was not transported|1|||
155210258|NCT01683383|560205432|FG001|Overall Study|Infant was not transported|0|||
155210259|NCT02496611|560205433|FG000|Overall Study|Lost to Follow-up|2|||
155210260|NCT02496611|560205434|FG001|Overall Study|Lost to Follow-up|1|||
155210261|NCT02496611|560205433|FG000|Overall Study|Withdrawal by Subject|5|||
155210262|NCT02496611|560205434|FG001|Overall Study|Withdrawal by Subject|2|||
155210263|NCT02850965|560205435|FG000|Overall Study|Other than listed|3|||
155210264|NCT02850965|560205436|FG001|Overall Study|Other than listed|4|||
155210265|NCT02850965|560205435|FG000|Overall Study|Protocol Violation|0|||
155210266|NCT02850965|560205436|FG001|Overall Study|Protocol Violation|2|||
155210267|NCT02850965|560205435|FG000|Overall Study|Lost to Follow-up|5|||
155210268|NCT02850965|560205436|FG001|Overall Study|Lost to Follow-up|3|||
155210269|NCT02850965|560205435|FG000|Overall Study|Lack of Efficacy|4|||
155210270|NCT02850965|560205436|FG001|Overall Study|Lack of Efficacy|8|||
155210271|NCT02850965|560205435|FG000|Overall Study|Adverse Event|3|||
155210272|NCT02850965|560205436|FG001|Overall Study|Adverse Event|2|||
155210273|NCT02850965|560205435|FG000|Overall Study|Withdrawal by Subject|3|||
155210274|NCT02850965|560205436|FG001|Overall Study|Withdrawal by Subject|4|||
155210275|NCT02850965|560205435|FG000|Overall Study|Physician Decision|0|||
155210276|NCT02850965|560205436|FG001|Overall Study|Physician Decision|1|||
155210277|NCT02850965|560205435|FG000|Overall Study|Randomized but not treated|0|||
155210278|NCT02850965|560205436|FG001|Overall Study|Randomized but not treated|1|||
155210279|NCT00536198|560205437|FG000|Overall Study|Lost to Follow-up|15|||
155210280|NCT00536198|560205438|FG001|Overall Study|Lost to Follow-up|14|||
155210281|NCT00536198|560205437|FG000|Overall Study|Withdrawal by Subject|16|||
155210282|NCT00536198|560205438|FG001|Overall Study|Withdrawal by Subject|12|||
155210283|NCT00536198|560205437|FG000|Overall Study|Adverse Event|2|||
155210284|NCT00536198|560205438|FG001|Overall Study|Adverse Event|2|||
155210285|NCT00536198|560205437|FG000|Overall Study|Rescue|3|||
155210286|NCT00536198|560205438|FG001|Overall Study|Rescue|9|||
155210287|NCT00536198|560205437|FG000|Overall Study|Pregnancy|1|||
155210288|NCT00536198|560205438|FG001|Overall Study|Pregnancy|1|||
155210289|NCT00536198|560205437|FG000|Overall Study|Protocol Violation|0|||
155210290|NCT00536198|560205438|FG001|Overall Study|Protocol Violation|1|||
155210291|NCT02643082|560205439|FG000|Period 1|Adverse Event|1|||
155210292|NCT02643082|560205440|FG001|Period 1|Adverse Event|0|||
155210293|NCT00276744|560205441|FG000|PART A|Reason unknown|98|||
155210294|NCT02860169|560205442|FG000|Part A|Withdrawal by Subject|1|||
155210295|NCT02860169|560205442|FG000|Part A|Other (Screening failure)|6|||
155210296|NCT02860169|560205442|FG000|Part A|Other (Survey not completed)|3|||
155210297|NCT02860169|560205442|FG000|Part A|Other (did not completed consent)|1|||
155210298|NCT02860169|560205442|FG000|Part B|Other (Screening failure)|10|||
155210299|NCT02860169|560205442|FG000|Part B|Withdrawal by Subject|1|||
155210300|NCT02860169|560205442|FG000|Part C|Other (Screening failure)|1|||
155210301|NCT00165776|560205444|FG000|Overall Study|Lack of Efficacy|0|||
155210302|NCT00165776|560205445|FG001|Overall Study|Lack of Efficacy|0|||
155210303|NCT00165776|560205446|FG002|Overall Study|Lack of Efficacy|0|||
155210304|NCT00165776|560205447|FG003|Overall Study|Lack of Efficacy|1|||
155210305|NCT00165776|560205444|FG000|Overall Study|Withdrawal by Subject|4|||
155210306|NCT00165776|560205445|FG001|Overall Study|Withdrawal by Subject|1|||
155210307|NCT00165776|560205446|FG002|Overall Study|Withdrawal by Subject|2|||
155210308|NCT00165776|560205447|FG003|Overall Study|Withdrawal by Subject|0|||
155210309|NCT00165776|560205444|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
155210310|NCT00165776|560205445|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
155210311|NCT00165776|560205446|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
155210312|NCT00165776|560205447|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
155210313|NCT03310775|560205453|FG000|Overall Study|Lost to Follow-up|2|||
155210314|NCT03310775|560205454|FG001|Overall Study|Lost to Follow-up|3|||
155210315|NCT03310775|560205453|FG000|Overall Study|aggravation of depression|0|||
155210316|NCT03310775|560205454|FG001|Overall Study|aggravation of depression|1|||
155210317|NCT02066233|560207754|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
155210318|NCT02066233|560207755|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
155210319|NCT02772081|560207756|FG000|Overall Study|Physician Decision|1|||
155210320|NCT02772081|560207757|FG001|Overall Study|Physician Decision|1|||
155210321|NCT02772081|560207756|FG000|Overall Study|Death|1|||
155210322|NCT02772081|560207757|FG001|Overall Study|Death|1|||
155210323|NCT02598076|560207761|FG000|Overall Study|Lost to Follow-up|2|||
155210324|NCT02598076|560207762|FG001|Overall Study|Lost to Follow-up|3|||
155210325|NCT01828281|560207763|FG000|Overall Study|Withdrawal by Subject|1|||
155210326|NCT01828281|560207764|FG001|Overall Study|Withdrawal by Subject|0|||
155210327|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
155210328|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
155210329|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
155210330|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
155210331|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
155210332|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
155210333|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
155210334|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
155210335|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
155210336|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
155210337|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
155210338|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
155210339|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
155210340|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
155210341|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
155210342|NCT01124422|560207765|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
155210343|NCT01124422|560207766|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
155210344|NCT01124422|560207767|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
155210345|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
155210346|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
155210347|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
155210348|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
155210349|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
155210350|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
155210351|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
155210352|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
155210353|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
155210354|NCT01124422|560207765|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
155210355|NCT01124422|560207766|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
155210356|NCT01124422|560207767|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
155210357|NCT02709785|560207772|FG000|Overall Study|Withdrawal by Subject|1|||
155210358|NCT02709785|560207773|FG001|Overall Study|Withdrawal by Subject|2|||
155210359|NCT02709785|560207774|FG002|Overall Study|Withdrawal by Subject|1|||
155210360|NCT01961323|560207775|FG000|Overall Study|Withdrawal by Subject|7|||
155210361|NCT01961323|560207775|FG000|Overall Study|Lost to Follow-up|8|||
155210362|NCT01961323|560207775|FG000|Overall Study|screen failure|34|||
155210363|NCT03315208|560207776|FG000|Overall Study|Lost to Follow-up|11|||
155210364|NCT03315208|560207777|FG001|Overall Study|Lost to Follow-up|6|||
155210365|NCT03315208|560207776|FG000|Overall Study|Withdrawal by Subject|2|||
155210366|NCT03315208|560207777|FG001|Overall Study|Withdrawal by Subject|0|||
155210367|NCT02875860|560207780|FG000|Overall Study|Withdrawal by Subject|0|||
155210368|NCT02875860|560207781|FG001|Overall Study|Withdrawal by Subject|1|||
155210369|NCT02320149|560207788|FG000|Overall Study|Adverse Event|3|||
155210370|NCT02320149|560207789|FG001|Overall Study|Adverse Event|7|||
155210371|NCT02320149|560207788|FG000|Overall Study|Withdrawal of Consent|28|||
155210372|NCT02320149|560207789|FG001|Overall Study|Withdrawal of Consent|32|||
155210373|NCT02320149|560207788|FG000|Overall Study|Lost to Follow-up|21|||
155210374|NCT02320149|560207789|FG001|Overall Study|Lost to Follow-up|34|||
155210375|NCT02320149|560207788|FG000|Overall Study|Protocol Violation|2|||
155210376|NCT02320149|560207789|FG001|Overall Study|Protocol Violation|1|||
155210377|NCT02320149|560207788|FG000|Overall Study|Noncompliance with Study Treatment|7|||
155210378|NCT02320149|560207789|FG001|Overall Study|Noncompliance with Study Treatment|2|||
155210379|NCT02320149|560207788|FG000|Overall Study|Lack of Efficacy|0|||
155210380|NCT02320149|560207789|FG001|Overall Study|Lack of Efficacy|1|||
155210381|NCT02320149|560207788|FG000|Overall Study|Other Miscellaneous Reasons|2|||
155210382|NCT02320149|560207789|FG001|Overall Study|Other Miscellaneous Reasons|3|||
155210383|NCT01156311|560207793|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
155210384|NCT01156311|560207794|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
155210385|NCT01156311|560207795|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
155210386|NCT01156311|560207796|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
155210387|NCT01156311|560207793|FG000|2-Month Monotherapy Period|Physician Decision|0|||
155210388|NCT01156311|560207794|FG001|2-Month Monotherapy Period|Physician Decision|1|||
155210389|NCT01156311|560207795|FG002|2-Month Monotherapy Period|Physician Decision|0|||
155210390|NCT01156311|560207796|FG003|2-Month Monotherapy Period|Physician Decision|0|||
155210391|NCT01156311|560207793|FG000|2-Month Monotherapy Period|Other|1|||
155210392|NCT01156311|560207794|FG001|2-Month Monotherapy Period|Other|0|||
155210393|NCT01156311|560207795|FG002|2-Month Monotherapy Period|Other|0|||
155210394|NCT01156311|560207796|FG003|2-Month Monotherapy Period|Other|0|||
155210395|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
155210396|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
155210397|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
155210398|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
155210399|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
155210400|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
155210401|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
155210402|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
155210403|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
155210404|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
155210405|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
155210406|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
155210407|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
155210408|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
155210409|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
155210410|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
155210411|NCT01156311|560207793|FG000|6-month Add-on Therapy Period|Other|0|||
155210412|NCT01156311|560207794|FG001|6-month Add-on Therapy Period|Other|0|||
155210413|NCT01156311|560207795|FG002|6-month Add-on Therapy Period|Other|1|||
155210414|NCT01156311|560207796|FG003|6-month Add-on Therapy Period|Other|2|||
155210415|NCT06133348|560207797|FG000|Overall Study|Death|3|||
155210416|NCT06133348|560207797|FG000|Overall Study|Lost to Follow-up|1|||
155210417|NCT06133348|560207797|FG000|Overall Study|Physician Decision|1|||
155210418|NCT06133348|560207797|FG000|Overall Study|Withdrawal by Subject|5|||
155210419|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
155210420|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
155210421|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
155210422|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
155210423|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
155210424|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
155210425|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
155210426|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
155210427|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
155210428|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
155210429|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
155210430|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
155210431|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
155210432|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
155210433|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
155210434|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
155210435|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
155210436|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
155210437|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
155210438|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
155210439|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
155210440|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
155210441|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
155210442|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
155210443|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
155210444|NCT01285310|560207798|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
155210445|NCT01285310|560207799|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
155210446|NCT01285310|560207800|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
155210447|NCT01285310|560207801|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
155210448|NCT01285310|560207802|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
155210449|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
155210450|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
155210451|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
155210452|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
155210453|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
155210454|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
155210455|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
155210456|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
155210457|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
155210458|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
155210459|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
155210460|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
155210461|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
155210462|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
155210463|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
155210464|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
155210465|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
155210466|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
155210467|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
155210468|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
155210469|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
155210470|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
155210471|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
155210472|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
155210473|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
155210474|NCT01285310|560207798|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
155210475|NCT01285310|560207799|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
155210476|NCT01285310|560207800|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
155210477|NCT01285310|560207801|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
155210478|NCT01285310|560207802|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
155210479|NCT01996982|560207803|FG000|Overall Study|PI/team left institution|7|||
155210480|NCT01195415|560207824|FG000|Overall Study|No repeat biopsy due to progression|2|||
155210481|NCT00533845|560207825|FG000|Overall Study|Physician Decision|1|||
155210482|NCT00533845|560207826|FG001|Overall Study|Physician Decision|0|||
155210483|NCT01442675|560207831|FG000|Overall Study|Protocol Violation|6|||
155210484|NCT01442675|560207831|FG000|Overall Study|Lost to Follow-up|2|||
155210485|NCT01442675|560207831|FG000|Overall Study|Withdrawal by Subject|4|||
155210486|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
155210487|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
155210488|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
155210489|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
155210490|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
155210491|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
155210492|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
155210493|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
155210494|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
155210495|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
155210496|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Death|2|||
155210497|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Death|1|||
155210498|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Death|4|||
155210499|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Death|0|||
155210500|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Death|0|||
155210501|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
155210502|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
155210503|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
155210504|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
155210505|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
155210506|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Other Reason|1|||
155210507|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Other Reason|3|||
155210508|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Other Reason|2|||
155210509|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Other Reason|0|||
155210510|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Other Reason|0|||
155210511|NCT00555321|560207832|FG000|Treatment Phase up to 12-months|Never treated|2|||
155210512|NCT00555321|560207833|FG001|Treatment Phase up to 12-months|Never treated|3|||
155210513|NCT00555321|560207834|FG002|Treatment Phase up to 12-months|Never treated|1|||
155210514|NCT00555321|560207835|FG003|Treatment Phase up to 12-months|Never treated|0|||
155210515|NCT00555321|560207836|FG004|Treatment Phase up to 12-months|Never treated|4|||
155210516|NCT00555321|560207832|FG000|Long-term Extension Phase|Adverse Event|2|||
155210517|NCT00555321|560207833|FG001|Long-term Extension Phase|Adverse Event|5|||
155210518|NCT00555321|560207834|FG002|Long-term Extension Phase|Adverse Event|2|||
155210519|NCT00555321|560207835|FG003|Long-term Extension Phase|Adverse Event|1|||
155210520|NCT00555321|560207836|FG004|Long-term Extension Phase|Adverse Event|0|||
155210521|NCT00555321|560207832|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
155210522|NCT00555321|560207833|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
155210523|NCT00555321|560207834|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
155210524|NCT00555321|560207835|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
155210525|NCT00555321|560207836|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
155210526|NCT00555321|560207832|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
155210527|NCT00555321|560207833|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
155210528|NCT00555321|560207834|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
155210529|NCT00555321|560207835|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
155210530|NCT00555321|560207836|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
155210531|NCT00555321|560207832|FG000|Long-term Extension Phase|Death|2|||
155210532|NCT00555321|560207833|FG001|Long-term Extension Phase|Death|0|||
155210533|NCT00555321|560207834|FG002|Long-term Extension Phase|Death|0|||
155210534|NCT00555321|560207835|FG003|Long-term Extension Phase|Death|3|||
155210535|NCT00555321|560207836|FG004|Long-term Extension Phase|Death|0|||
155210536|NCT00555321|560207832|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210537|NCT00555321|560207833|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210538|NCT00555321|560207834|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210539|NCT00555321|560207835|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
155210540|NCT00555321|560207836|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
155210541|NCT00555321|560207832|FG000|Long-term Extension Phase|Other Reason|1|||
155210542|NCT00555321|560207833|FG001|Long-term Extension Phase|Other Reason|0|||
155210543|NCT00555321|560207834|FG002|Long-term Extension Phase|Other Reason|2|||
155210544|NCT00555321|560207835|FG003|Long-term Extension Phase|Other Reason|0|||
155210545|NCT00555321|560207836|FG004|Long-term Extension Phase|Other Reason|0|||
155210546|NCT00160251|560207837|FG000|Prior to Amendment 2|Adverse Event|2|||
155210547|NCT00160251|560207838|FG001|Prior to Amendment 2|Adverse Event|1|||
155210548|NCT00160251|560207839|FG002|Prior to Amendment 2|Adverse Event|3|||
155210549|NCT00160251|560207840|FG003|Prior to Amendment 2|Adverse Event|1|||
155210550|NCT00160251|560207841|FG004|Prior to Amendment 2|Adverse Event|1|||
155210551|NCT00160251|560207842|FG005|Prior to Amendment 2|Adverse Event|1|||
155210552|NCT00160251|560207843|FG006|Prior to Amendment 2|Adverse Event|1|||
155210553|NCT00160251|560207844|FG007|Prior to Amendment 2|Adverse Event|0|||
155210554|NCT00160251|560207837|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
155210555|NCT00160251|560207838|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
155210556|NCT00160251|560207839|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
155210557|NCT00160251|560207840|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
155210558|NCT00160251|560207841|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
155210559|NCT00160251|560207842|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
155210560|NCT00160251|560207843|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
155210561|NCT00160251|560207844|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
155210562|NCT00160251|560207837|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
155210563|NCT00160251|560207838|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
155210564|NCT00160251|560207839|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
155210565|NCT00160251|560207840|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
155210566|NCT00160251|560207841|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
155210567|NCT00160251|560207842|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
155210568|NCT00160251|560207843|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
155210569|NCT00160251|560207844|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
155210570|NCT00160251|560207837|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
155210571|NCT00160251|560207838|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
155210572|NCT00160251|560207839|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
155210573|NCT00160251|560207840|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
155210574|NCT00160251|560207841|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
155210575|NCT00160251|560207842|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
155210576|NCT00160251|560207843|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
155210577|NCT00160251|560207844|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
155210578|NCT00160251|560207837|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
155210579|NCT00160251|560207838|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
155210580|NCT00160251|560207839|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
155210581|NCT00160251|560207840|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
155210582|NCT00160251|560207841|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
155210583|NCT00160251|560207842|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
155210584|NCT00160251|560207843|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
155210585|NCT00160251|560207844|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
155210586|NCT00160251|560207837|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
155210587|NCT00160251|560207838|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
155210588|NCT00160251|560207839|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
155210589|NCT00160251|560207840|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
155210590|NCT00160251|560207841|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
155210591|NCT00160251|560207842|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
155210592|NCT00160251|560207843|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
155210593|NCT00160251|560207844|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
155210594|NCT00160251|560207837|FG000|Post-amendment 2|Adverse Event|0|||
155210595|NCT00160251|560207838|FG001|Post-amendment 2|Adverse Event|0|||
155210596|NCT00160251|560207839|FG002|Post-amendment 2|Adverse Event|0|||
155210597|NCT00160251|560207840|FG003|Post-amendment 2|Adverse Event|0|||
155210598|NCT00160251|560207841|FG004|Post-amendment 2|Adverse Event|0|||
155210599|NCT00160251|560207842|FG005|Post-amendment 2|Adverse Event|0|||
155210600|NCT00160251|560207843|FG006|Post-amendment 2|Adverse Event|0|||
155210601|NCT00160251|560207844|FG007|Post-amendment 2|Adverse Event|20|||
155210602|NCT00160251|560207837|FG000|Post-amendment 2|Lack of Efficacy|0|||
155210603|NCT00160251|560207838|FG001|Post-amendment 2|Lack of Efficacy|0|||
155210604|NCT00160251|560207839|FG002|Post-amendment 2|Lack of Efficacy|0|||
155210605|NCT00160251|560207840|FG003|Post-amendment 2|Lack of Efficacy|0|||
155210606|NCT00160251|560207841|FG004|Post-amendment 2|Lack of Efficacy|0|||
155210607|NCT00160251|560207842|FG005|Post-amendment 2|Lack of Efficacy|0|||
155210608|NCT00160251|560207843|FG006|Post-amendment 2|Lack of Efficacy|0|||
155210609|NCT00160251|560207844|FG007|Post-amendment 2|Lack of Efficacy|24|||
155210610|NCT00160251|560207837|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210611|NCT00160251|560207838|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210612|NCT00160251|560207839|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210613|NCT00160251|560207840|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210614|NCT00160251|560207841|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210615|NCT00160251|560207842|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210616|NCT00160251|560207843|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
155210617|NCT00160251|560207844|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
155210618|NCT00563381|560207846|FG000|Overall Study|Adverse Event|264|||
155210619|NCT00563381|560207847|FG001|Overall Study|Adverse Event|292|||
155210620|NCT00563381|560207846|FG000|Overall Study|Protocol Violation|66|||
155210621|NCT00563381|560207847|FG001|Overall Study|Protocol Violation|74|||
155210622|NCT00563381|560207846|FG000|Overall Study|Lost to Follow-up|7|||
155210623|NCT00563381|560207847|FG001|Overall Study|Lost to Follow-up|15|||
155210624|NCT00563381|560207846|FG000|Overall Study|Withdrawal by Subject|192|||
155210625|NCT00563381|560207847|FG001|Overall Study|Withdrawal by Subject|209|||
155210626|NCT00563381|560207846|FG000|Overall Study|Lack of Efficacy|32|||
155210627|NCT00563381|560207847|FG001|Overall Study|Lack of Efficacy|24|||
155210628|NCT00563381|560207846|FG000|Overall Study|Individual different reasons|24|||
155210629|NCT00563381|560207847|FG001|Overall Study|Individual different reasons|34|||
155210630|NCT02407704|560207850|FG000|Overall Study|Lost to Follow-up|0|||
155210631|NCT02407704|560207851|FG001|Overall Study|Lost to Follow-up|0|||
155210632|NCT02407704|560207852|FG002|Overall Study|Lost to Follow-up|0|||
155210633|NCT02407704|560207853|FG003|Overall Study|Lost to Follow-up|2|||
155210634|NCT02407704|560207850|FG000|Overall Study|Protocol Violation|0|||
155210635|NCT02407704|560207851|FG001|Overall Study|Protocol Violation|0|||
155210636|NCT02407704|560207852|FG002|Overall Study|Protocol Violation|0|||
155210637|NCT02407704|560207853|FG003|Overall Study|Protocol Violation|1|||
155210638|NCT02407704|560207850|FG000|Overall Study|Withdrawal by Subject|0|||
155210639|NCT02407704|560207851|FG001|Overall Study|Withdrawal by Subject|0|||
155210640|NCT02407704|560207852|FG002|Overall Study|Withdrawal by Subject|1|||
155210641|NCT02407704|560207853|FG003|Overall Study|Withdrawal by Subject|0|||
155210642|NCT01957644|560207854|FG000|Overall Study|Adverse Event|4|||
155210643|NCT01957644|560207855|FG001|Overall Study|Adverse Event|2|||
155210644|NCT01957644|560207856|FG002|Overall Study|Adverse Event|0|||
155210645|NCT01957644|560207857|FG003|Overall Study|Adverse Event|0|||
155210646|NCT01957644|560207858|FG004|Overall Study|Adverse Event|1|||
155210647|NCT01957644|560207854|FG000|Overall Study|Progressive disease / relapse|0|||
155210648|NCT01957644|560207855|FG001|Overall Study|Progressive disease / relapse|1|||
155210649|NCT01957644|560207856|FG002|Overall Study|Progressive disease / relapse|0|||
155210650|NCT01957644|560207857|FG003|Overall Study|Progressive disease / relapse|1|||
155210651|NCT01957644|560207858|FG004|Overall Study|Progressive disease / relapse|0|||
155210652|NCT01957644|560207854|FG000|Overall Study|Other reason|1|||
155210653|NCT01957644|560207855|FG001|Overall Study|Other reason|2|||
155210654|NCT01957644|560207856|FG002|Overall Study|Other reason|1|||
155210655|NCT01957644|560207857|FG003|Overall Study|Other reason|1|||
155210656|NCT01957644|560207858|FG004|Overall Study|Other reason|0|||
155210657|NCT01957644|560207854|FG000|Overall Study|Withdrawal by Subject|1|||
155210658|NCT01957644|560207855|FG001|Overall Study|Withdrawal by Subject|0|||
155210659|NCT01957644|560207856|FG002|Overall Study|Withdrawal by Subject|0|||
155210660|NCT01957644|560207857|FG003|Overall Study|Withdrawal by Subject|0|||
155210661|NCT01957644|560207858|FG004|Overall Study|Withdrawal by Subject|0|||
155210662|NCT01957644|560207854|FG000|Overall Study|Protocol Violation|0|||
155210663|NCT01957644|560207855|FG001|Overall Study|Protocol Violation|1|||
155210664|NCT01957644|560207856|FG002|Overall Study|Protocol Violation|0|||
155210665|NCT01957644|560207857|FG003|Overall Study|Protocol Violation|0|||
155210666|NCT01957644|560207858|FG004|Overall Study|Protocol Violation|0|||
155210667|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
155210668|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
155210669|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
155210670|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
155210671|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
155210672|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
155210673|NCT01957553|560207859|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
155210674|NCT01957553|560207860|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
155210675|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
155210676|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
155210677|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
155210678|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
155210679|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
155210680|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
155210681|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
155210682|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
155210683|NCT01957553|560207859|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
155210684|NCT01957553|560207860|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
155210685|NCT04044716|560207861|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
155210686|NCT04044716|560207862|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
155210687|NCT04044716|560207863|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
155210688|NCT04044716|560207861|FG000|Overall Study|Lost to Follow-up|2|||
155210689|NCT04044716|560207862|FG001|Overall Study|Lost to Follow-up|3|||
155210690|NCT04044716|560207863|FG002|Overall Study|Lost to Follow-up|0|||
155210691|NCT03235154|560207866|FG000|Overall Study|Withdrawal by Subject|1|||
155210692|NCT03235154|560207866|FG000|Overall Study|Adverse Event|1|||
155210693|NCT03235154|560207866|FG000|Overall Study|Lost to Follow-up|2|||
155210694|NCT01922089|560207871|FG000|Overall Study|Adverse Event|18|||
155210695|NCT01922089|560207872|FG001|Overall Study|Adverse Event|13|||
155210696|NCT01922089|560207871|FG000|Overall Study|Protocol Deviation|10|||
155210697|NCT01922089|560207872|FG001|Overall Study|Protocol Deviation|7|||
155210698|NCT01922089|560207871|FG000|Overall Study|Withdrawal by Subject|3|||
155210699|NCT01922089|560207872|FG001|Overall Study|Withdrawal by Subject|4|||
155210700|NCT01922089|560207871|FG000|Overall Study|administrative problems|4|||
155210701|NCT01922089|560207872|FG001|Overall Study|administrative problems|1|||
155210702|NCT01922089|560207871|FG000|Overall Study|Physician Decision|2|||
155210703|NCT01922089|560207872|FG001|Overall Study|Physician Decision|3|||
155210704|NCT01922089|560207871|FG000|Overall Study|Death|2|||
155210705|NCT01922089|560207872|FG001|Overall Study|Death|1|||
155210706|NCT01922089|560207871|FG000|Overall Study|Lost to Follow-up|0|||
155210707|NCT01922089|560207872|FG001|Overall Study|Lost to Follow-up|1|||
155210708|NCT02326025|560207874|FG000|Overall Study|Adverse Event|3|||
155210709|NCT02326025|560207875|FG001|Overall Study|Adverse Event|0|||
155210710|NCT02326025|560207874|FG000|Overall Study|Physician Decision|1|||
155210711|NCT02326025|560207875|FG001|Overall Study|Physician Decision|2|||
155210712|NCT02326025|560207874|FG000|Overall Study|Physician and Participant Decision|1|||
155210713|NCT02326025|560207875|FG001|Overall Study|Physician and Participant Decision|0|||
155210714|NCT02326025|560207874|FG000|Overall Study|Withdrawal by Subject|0|||
155210715|NCT02326025|560207875|FG001|Overall Study|Withdrawal by Subject|2|||
155210716|NCT02326025|560207874|FG000|Overall Study|Protocol Violation|0|||
155210717|NCT02326025|560207875|FG001|Overall Study|Protocol Violation|1|||
155210718|NCT00881712|560207876|FG000|Overall Study|Death|1|||
155210719|NCT00881712|560207877|FG001|Overall Study|Death|0|||
155210720|NCT00881712|560207878|FG002|Overall Study|Death|0|||
155210721|NCT00881712|560207876|FG000|Overall Study|Withdrawal by Subject|1|||
155210722|NCT00881712|560207877|FG001|Overall Study|Withdrawal by Subject|0|||
155210723|NCT00881712|560207878|FG002|Overall Study|Withdrawal by Subject|0|||
155210724|NCT01324999|560207879|FG000|Overall Study|Adverse Event|3|||
155210725|NCT01324999|560207879|FG000|Overall Study|Withdrawal by Subject|2|||
155210726|NCT02505867|560207884|FG000|Overall Study|Lack of Efficacy|6|||
155210727|NCT02505867|560207885|FG001|Overall Study|Lack of Efficacy|6|||
155210728|NCT03681405|560207886|FG000|Overall Study|Found to be ineligible after randomized|1|||
155210729|NCT03681405|560207887|FG001|Overall Study|Found to be ineligible after randomized|0|||
155210730|NCT01714635|560207895|FG000|Overall Study|Discontinued|1|||
155210731|NCT01714635|560207896|FG001|Overall Study|Discontinued|0|||
155210732|NCT01714635|560207897|FG002|Overall Study|Discontinued|2|||
155210733|NCT01714635|560207895|FG000|Overall Study|Missed 6-month exam|1|||
155210734|NCT01714635|560207896|FG001|Overall Study|Missed 6-month exam|0|||
155210735|NCT01714635|560207897|FG002|Overall Study|Missed 6-month exam|0|||
155210736|NCT01129960|560207898|FG000|Overall Study|Withdrawal by Subject|3|||
155210737|NCT01129960|560207899|FG001|Overall Study|Withdrawal by Subject|0|||
155210738|NCT01129960|560207900|FG002|Overall Study|Withdrawal by Subject|3|||
155210739|NCT01129960|560207901|FG003|Overall Study|Withdrawal by Subject|2|||
155210740|NCT01129960|560207898|FG000|Overall Study|Lack of Efficacy|1|||
155210741|NCT01129960|560207899|FG001|Overall Study|Lack of Efficacy|1|||
155210742|NCT01129960|560207900|FG002|Overall Study|Lack of Efficacy|1|||
155210743|NCT01129960|560207901|FG003|Overall Study|Lack of Efficacy|1|||
155210744|NCT01129960|560207898|FG000|Overall Study|Adverse Event|23|||
155210745|NCT01129960|560207899|FG001|Overall Study|Adverse Event|16|||
155210746|NCT01129960|560207900|FG002|Overall Study|Adverse Event|16|||
155210747|NCT01129960|560207901|FG003|Overall Study|Adverse Event|7|||
155210748|NCT01129960|560207898|FG000|Overall Study|Protocol Violation|1|||
155210749|NCT01129960|560207899|FG001|Overall Study|Protocol Violation|2|||
155210750|NCT01129960|560207900|FG002|Overall Study|Protocol Violation|3|||
155210751|NCT01129960|560207901|FG003|Overall Study|Protocol Violation|0|||
155210752|NCT01129960|560207898|FG000|Overall Study|Lost to Follow-up|0|||
155210753|NCT01129960|560207899|FG001|Overall Study|Lost to Follow-up|2|||
155210754|NCT01129960|560207900|FG002|Overall Study|Lost to Follow-up|3|||
155210755|NCT01129960|560207901|FG003|Overall Study|Lost to Follow-up|3|||
155210756|NCT01129960|560207898|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
155210757|NCT01129960|560207899|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
155210758|NCT01129960|560207900|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
155210759|NCT01129960|560207901|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
155210760|NCT01129960|560207898|FG000|Overall Study|Physician Decision|1|||
155210761|NCT01129960|560207899|FG001|Overall Study|Physician Decision|0|||
155210762|NCT01129960|560207900|FG002|Overall Study|Physician Decision|0|||
155210763|NCT01129960|560207901|FG003|Overall Study|Physician Decision|0|||
155210764|NCT01129960|560207898|FG000|Overall Study|Pregnancy|1|||
155210765|NCT01129960|560207899|FG001|Overall Study|Pregnancy|0|||
155210766|NCT01129960|560207900|FG002|Overall Study|Pregnancy|0|||
155210767|NCT01129960|560207901|FG003|Overall Study|Pregnancy|0|||
155210768|NCT00230607|560207902|FG000|Overall Study|Other|3|||
155210769|NCT01835587|560207903|FG000|Overall Study|Disease Recurrence or Relapse|0|||
155210770|NCT01835587|560207904|FG001|Overall Study|Disease Recurrence or Relapse|3|||
155210771|NCT01835587|560207905|FG002|Overall Study|Disease Recurrence or Relapse|0|||
155210772|NCT01835587|560207906|FG003|Overall Study|Disease Recurrence or Relapse|3|||
155210773|NCT01835587|560207903|FG000|Overall Study|Withdrawal by Subject|2|||
155210774|NCT01835587|560207904|FG001|Overall Study|Withdrawal by Subject|0|||
155210775|NCT01835587|560207905|FG002|Overall Study|Withdrawal by Subject|0|||
155210776|NCT01835587|560207906|FG003|Overall Study|Withdrawal by Subject|3|||
155210777|NCT01835587|560207903|FG000|Overall Study|Adverse Event|0|||
155210778|NCT01835587|560207904|FG001|Overall Study|Adverse Event|0|||
155210779|NCT01835587|560207905|FG002|Overall Study|Adverse Event|2|||
155210780|NCT01835587|560207906|FG003|Overall Study|Adverse Event|2|||
155210781|NCT01835587|560207903|FG000|Overall Study|Death|0|||
155210782|NCT01835587|560207904|FG001|Overall Study|Death|0|||
155210783|NCT01835587|560207905|FG002|Overall Study|Death|0|||
155210784|NCT01835587|560207906|FG003|Overall Study|Death|1|||
155210785|NCT01835587|560207903|FG000|Overall Study|Miscellaneous|0|||
155210786|NCT01835587|560207904|FG001|Overall Study|Miscellaneous|1|||
155210787|NCT01835587|560207905|FG002|Overall Study|Miscellaneous|0|||
155210788|NCT01835587|560207906|FG003|Overall Study|Miscellaneous|0|||
155210789|NCT00126568|560207909|FG000|Overall Study|Death|2|||
155210790|NCT03358290|560207910|FG000|Overall Study|Study discontinued by Sponsor|0|||
155210791|NCT03358290|560207911|FG001|Overall Study|Study discontinued by Sponsor|1|||
155210792|NCT03358290|560207912|FG002|Overall Study|Study discontinued by Sponsor|1|||
155210793|NCT03358290|560207913|FG003|Overall Study|Study discontinued by Sponsor|0|||
155210794|NCT03358290|560207914|FG004|Overall Study|Study discontinued by Sponsor|0|||
155210795|NCT03358290|560207910|FG000|Overall Study|Adverse Event|0|||
155210796|NCT03358290|560207911|FG001|Overall Study|Adverse Event|0|||
155210797|NCT03358290|560207912|FG002|Overall Study|Adverse Event|1|||
155210798|NCT03358290|560207913|FG003|Overall Study|Adverse Event|2|||
155210799|NCT03358290|560207914|FG004|Overall Study|Adverse Event|0|||
155210800|NCT03358290|560207910|FG000|Overall Study|Withdrawal by Subject|0|||
155210801|NCT03358290|560207911|FG001|Overall Study|Withdrawal by Subject|0|||
155210802|NCT03358290|560207912|FG002|Overall Study|Withdrawal by Subject|0|||
155210803|NCT03358290|560207913|FG003|Overall Study|Withdrawal by Subject|0|||
155210804|NCT03358290|560207914|FG004|Overall Study|Withdrawal by Subject|1|||
155210805|NCT00203996|560207915|FG000|Overall Study|Lost to Follow-up|0|||
155210806|NCT00203996|560207916|FG001|Overall Study|Lost to Follow-up|0|||
155210807|NCT00203996|560207917|FG002|Overall Study|Lost to Follow-up|0|||
155210808|NCT00203996|560207918|FG003|Overall Study|Lost to Follow-up|1|||
155210809|NCT00203996|560207919|FG004|Overall Study|Lost to Follow-up|0|||
155210810|NCT00203996|560207920|FG005|Overall Study|Lost to Follow-up|0|||
155210811|NCT00203996|560207921|FG006|Overall Study|Lost to Follow-up|0|||
155210812|NCT00203996|560207922|FG007|Overall Study|Lost to Follow-up|0|||
155210813|NCT00203996|560207923|FG008|Overall Study|Lost to Follow-up|0|||
155210814|NCT00203996|560207924|FG009|Overall Study|Lost to Follow-up|0|||
155210815|NCT00203996|560207915|FG000|Overall Study|Protocol Violation|0|||
155210816|NCT00203996|560207916|FG001|Overall Study|Protocol Violation|0|||
155210817|NCT00203996|560207917|FG002|Overall Study|Protocol Violation|0|||
155210818|NCT00203996|560207918|FG003|Overall Study|Protocol Violation|6|||
155210819|NCT00203996|560207919|FG004|Overall Study|Protocol Violation|1|||
155210820|NCT00203996|560207920|FG005|Overall Study|Protocol Violation|0|||
155210821|NCT00203996|560207921|FG006|Overall Study|Protocol Violation|0|||
155210822|NCT00203996|560207922|FG007|Overall Study|Protocol Violation|0|||
155210823|NCT00203996|560207923|FG008|Overall Study|Protocol Violation|0|||
155210824|NCT00203996|560207924|FG009|Overall Study|Protocol Violation|0|||
155210825|NCT00203996|560207915|FG000|Overall Study|Physician Decision|0|||
155210826|NCT00203996|560207916|FG001|Overall Study|Physician Decision|0|||
155210827|NCT00203996|560207917|FG002|Overall Study|Physician Decision|0|||
155210828|NCT00203996|560207918|FG003|Overall Study|Physician Decision|2|||
155210829|NCT00203996|560207919|FG004|Overall Study|Physician Decision|0|||
155210830|NCT00203996|560207920|FG005|Overall Study|Physician Decision|0|||
155210831|NCT00203996|560207921|FG006|Overall Study|Physician Decision|0|||
155210832|NCT00203996|560207922|FG007|Overall Study|Physician Decision|0|||
155210833|NCT00203996|560207923|FG008|Overall Study|Physician Decision|0|||
155210834|NCT00203996|560207924|FG009|Overall Study|Physician Decision|1|||
155210835|NCT00203996|560207915|FG000|Overall Study|CPAP machine malfunction|0|||
155210836|NCT00203996|560207916|FG001|Overall Study|CPAP machine malfunction|0|||
155210837|NCT00203996|560207917|FG002|Overall Study|CPAP machine malfunction|0|||
155210838|NCT00203996|560207918|FG003|Overall Study|CPAP machine malfunction|1|||
155210839|NCT00203996|560207919|FG004|Overall Study|CPAP machine malfunction|0|||
155210840|NCT00203996|560207920|FG005|Overall Study|CPAP machine malfunction|0|||
155210841|NCT00203996|560207921|FG006|Overall Study|CPAP machine malfunction|0|||
155210842|NCT00203996|560207922|FG007|Overall Study|CPAP machine malfunction|0|||
155210843|NCT00203996|560207923|FG008|Overall Study|CPAP machine malfunction|0|||
155210844|NCT00203996|560207924|FG009|Overall Study|CPAP machine malfunction|0|||
155210845|NCT00203996|560207915|FG000|Overall Study|Scheduling issue|0|||
155210846|NCT00203996|560207916|FG001|Overall Study|Scheduling issue|0|||
155210847|NCT00203996|560207917|FG002|Overall Study|Scheduling issue|0|||
155210848|NCT00203996|560207918|FG003|Overall Study|Scheduling issue|0|||
155210849|NCT00203996|560207919|FG004|Overall Study|Scheduling issue|0|||
155210850|NCT00203996|560207920|FG005|Overall Study|Scheduling issue|0|||
155210851|NCT00203996|560207921|FG006|Overall Study|Scheduling issue|0|||
155210852|NCT00203996|560207922|FG007|Overall Study|Scheduling issue|2|||
155210853|NCT00203996|560207923|FG008|Overall Study|Scheduling issue|0|||
155210854|NCT00203996|560207924|FG009|Overall Study|Scheduling issue|0|||
155210855|NCT00897104|560207925|FG000|Overall Study|Lost to Follow-up|12|||
155210856|NCT00897104|560207926|FG001|Overall Study|Lost to Follow-up|17|||
155210857|NCT00897104|560207927|FG002|Overall Study|Lost to Follow-up|2|||
155210858|NCT00897104|560207925|FG000|Overall Study|Pregnancy|0|||
155210859|NCT00897104|560207926|FG001|Overall Study|Pregnancy|1|||
155210860|NCT00897104|560207927|FG002|Overall Study|Pregnancy|0|||
155210861|NCT00897104|560207925|FG000|Overall Study|Protocol Violation|0|||
155210862|NCT00897104|560207926|FG001|Overall Study|Protocol Violation|1|||
155210863|NCT00897104|560207927|FG002|Overall Study|Protocol Violation|0|||
155210864|NCT00897104|560207925|FG000|Overall Study|Withdrawal by Subject|23|||
155210865|NCT00897104|560207926|FG001|Overall Study|Withdrawal by Subject|27|||
155210866|NCT00897104|560207927|FG002|Overall Study|Withdrawal by Subject|3|||
155210867|NCT00897104|560207925|FG000|Overall Study|Abnormal Prestudy Labs|2|||
155210868|NCT00897104|560207926|FG001|Overall Study|Abnormal Prestudy Labs|0|||
155210869|NCT00897104|560207927|FG002|Overall Study|Abnormal Prestudy Labs|0|||
155210870|NCT00897104|560207925|FG000|Overall Study|Abnormal Baseline ECG|2|||
155210871|NCT00897104|560207926|FG001|Overall Study|Abnormal Baseline ECG|2|||
155210872|NCT00897104|560207927|FG002|Overall Study|Abnormal Baseline ECG|0|||
155210873|NCT00897104|560207925|FG000|Overall Study|Need for Concom. Med.|0|||
155210874|NCT00897104|560207926|FG001|Overall Study|Need for Concom. Med.|1|||
155210875|NCT00897104|560207927|FG002|Overall Study|Need for Concom. Med.|1|||
155210876|NCT00897104|560207925|FG000|Overall Study|Lack of Migraine Attack|20|||
155210877|NCT00897104|560207926|FG001|Overall Study|Lack of Migraine Attack|22|||
155210878|NCT00897104|560207927|FG002|Overall Study|Lack of Migraine Attack|1|||
155210879|NCT00897104|560207925|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
155210880|NCT00897104|560207926|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155210881|NCT00897104|560207927|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
155210882|NCT00897104|560207925|FG000|Overall Study|Other|3|||
155210883|NCT00897104|560207926|FG001|Overall Study|Other|0|||
155210884|NCT00897104|560207927|FG002|Overall Study|Other|0|||
155210885|NCT00897104|560207925|FG000|Overall Study|Protocol Violation|1|||
155210886|NCT00897104|560207926|FG001|Overall Study|Protocol Violation|0|||
155210887|NCT00897104|560207927|FG002|Overall Study|Protocol Violation|0|||
155210888|NCT00897104|560207925|FG000|Overall Study|Withdrawal by Subject|0|||
155210889|NCT00897104|560207926|FG001|Overall Study|Withdrawal by Subject|0|||
155210890|NCT00897104|560207927|FG002|Overall Study|Withdrawal by Subject|1|||
155210891|NCT00434330|560207928|FG000|Overall Study|Adverse Event|0|||
155210892|NCT00434330|560207929|FG001|Overall Study|Adverse Event|0|||
155210893|NCT00434330|560207930|FG002|Overall Study|Adverse Event|1|||
155210894|NCT00434330|560207931|FG003|Overall Study|Adverse Event|0|||
155210895|NCT00434330|560207932|FG004|Overall Study|Adverse Event|0|||
155210896|NCT00434330|560207933|FG005|Overall Study|Adverse Event|0|||
155210897|NCT00434330|560207928|FG000|Overall Study|Death|1|||
155210898|NCT00434330|560207929|FG001|Overall Study|Death|0|||
155210899|NCT00434330|560207930|FG002|Overall Study|Death|0|||
155210900|NCT00434330|560207931|FG003|Overall Study|Death|0|||
155210901|NCT00434330|560207932|FG004|Overall Study|Death|1|||
155210902|NCT00434330|560207933|FG005|Overall Study|Death|1|||
155210903|NCT00434330|560207928|FG000|Overall Study|Withdrawal by Subject|0|||
155210904|NCT00434330|560207929|FG001|Overall Study|Withdrawal by Subject|0|||
155210905|NCT00434330|560207930|FG002|Overall Study|Withdrawal by Subject|1|||
155210906|NCT00434330|560207931|FG003|Overall Study|Withdrawal by Subject|1|||
155210907|NCT00434330|560207932|FG004|Overall Study|Withdrawal by Subject|0|||
155210908|NCT00434330|560207933|FG005|Overall Study|Withdrawal by Subject|0|||
155210909|NCT00434330|560207928|FG000|Overall Study|Renal transplant|0|||
155210910|NCT00434330|560207929|FG001|Overall Study|Renal transplant|0|||
155210911|NCT00434330|560207930|FG002|Overall Study|Renal transplant|0|||
155210912|NCT00434330|560207931|FG003|Overall Study|Renal transplant|1|||
155210913|NCT00434330|560207932|FG004|Overall Study|Renal transplant|0|||
155210914|NCT00434330|560207933|FG005|Overall Study|Renal transplant|0|||
155210915|NCT00434330|560207928|FG000|Overall Study|Subject Not Compliant With Study|0|||
155210916|NCT00434330|560207929|FG001|Overall Study|Subject Not Compliant With Study|0|||
155210917|NCT00434330|560207930|FG002|Overall Study|Subject Not Compliant With Study|1|||
155210918|NCT00434330|560207931|FG003|Overall Study|Subject Not Compliant With Study|0|||
155210919|NCT00434330|560207932|FG004|Overall Study|Subject Not Compliant With Study|0|||
155210920|NCT00434330|560207933|FG005|Overall Study|Subject Not Compliant With Study|0|||
155210921|NCT03789318|560207936|FG000|Overall Study|Adverse Event|0|||
155210922|NCT03789318|560207937|FG001|Overall Study|Adverse Event|0|||
155210923|NCT03789318|560207938|FG002|Overall Study|Adverse Event|1|||
155210924|NCT03789318|560207939|FG003|Overall Study|Adverse Event|1|||
155210925|NCT03789318|560207940|FG004|Overall Study|Adverse Event|0|||
155210926|NCT03789318|560207936|FG000|Overall Study|Lost to Follow-up|0|||
155210927|NCT03789318|560207937|FG001|Overall Study|Lost to Follow-up|0|||
155210928|NCT03789318|560207938|FG002|Overall Study|Lost to Follow-up|1|||
155210929|NCT03789318|560207939|FG003|Overall Study|Lost to Follow-up|0|||
155210930|NCT03789318|560207940|FG004|Overall Study|Lost to Follow-up|0|||
155210931|NCT03789318|560207936|FG000|Overall Study|Withdrawal by Subject|0|||
155210932|NCT03789318|560207937|FG001|Overall Study|Withdrawal by Subject|0|||
155210933|NCT03789318|560207938|FG002|Overall Study|Withdrawal by Subject|1|||
155210934|NCT03789318|560207939|FG003|Overall Study|Withdrawal by Subject|0|||
155210935|NCT03789318|560207940|FG004|Overall Study|Withdrawal by Subject|0|||
155210936|NCT00850564|560207941|FG000|Overall Study|Withdrawal by Subject|2|||
155210937|NCT01937559|560207942|FG000|Overall Study|Physician Decision|3|||
155210938|NCT01937559|560207943|FG001|Overall Study|Physician Decision|3|||
155210939|NCT01937559|560207944|FG002|Overall Study|Physician Decision|0|||
155210940|NCT01937559|560207942|FG000|Overall Study|Withdrawal by Subject|6|||
155210941|NCT01937559|560207943|FG001|Overall Study|Withdrawal by Subject|4|||
155210942|NCT01937559|560207944|FG002|Overall Study|Withdrawal by Subject|0|||
155210943|NCT01937559|560207942|FG000|Overall Study|screen fail|2|||
155210944|NCT01937559|560207943|FG001|Overall Study|screen fail|4|||
155210945|NCT01937559|560207944|FG002|Overall Study|screen fail|0|||
155210946|NCT00531232|560210012|FG000|Overall Study|Investigator decision|0|||
155210947|NCT00531232|560210013|FG001|Overall Study|Investigator decision|0|||
155210948|NCT00531232|560210014|FG002|Overall Study|Investigator decision|4|||
155210949|NCT00531232|560210012|FG000|Overall Study|Participants refused further treatment|0|||
155210950|NCT00531232|560210013|FG001|Overall Study|Participants refused further treatment|1|||
155210951|NCT00531232|560210014|FG002|Overall Study|Participants refused further treatment|2|||
155210952|NCT00531232|560210012|FG000|Overall Study|Adverse events (AEs)|1|||
155210953|NCT00531232|560210013|FG001|Overall Study|Adverse events (AEs)|2|||
155210954|NCT00531232|560210014|FG002|Overall Study|Adverse events (AEs)|2|||
155210955|NCT00531232|560210012|FG000|Overall Study|Treatment failure|1|||
155210956|NCT00531232|560210013|FG001|Overall Study|Treatment failure|3|||
155210957|NCT00531232|560210014|FG002|Overall Study|Treatment failure|7|||
155210958|NCT00531232|560210012|FG000|Overall Study|Disease recurrence|0|||
155210959|NCT00531232|560210013|FG001|Overall Study|Disease recurrence|0|||
155210960|NCT00531232|560210014|FG002|Overall Study|Disease recurrence|1|||
155210961|NCT00531232|560210012|FG000|Overall Study|Deceased|2|||
155210962|NCT00531232|560210013|FG001|Overall Study|Deceased|2|||
155210963|NCT00531232|560210014|FG002|Overall Study|Deceased|2|||
155210964|NCT00531232|560210012|FG000|Overall Study|Withdrawal by Subject|0|||
155210965|NCT00531232|560210013|FG001|Overall Study|Withdrawal by Subject|1|||
155210966|NCT00531232|560210014|FG002|Overall Study|Withdrawal by Subject|2|||
155210967|NCT00531232|560210012|FG000|Overall Study|Other|0|||
155210968|NCT00531232|560210013|FG001|Overall Study|Other|0|||
155210969|NCT00531232|560210014|FG002|Overall Study|Other|5|||
155210970|NCT00397982|560210015|FG000|Overall Study|Withdrawal by Subject|1|||
155210971|NCT00397982|560210015|FG000|Overall Study|Adverse Event|1|||
155210972|NCT00397982|560210015|FG000|Overall Study|noncompliance|1|||
155210973|NCT00397982|560210015|FG000|Overall Study|Unrelated health issues|1|||
155210974|NCT04232124|560210016|FG000|Overall Study|Lost to Follow-up|3|||
155210975|NCT02345850|560210019|FG000|Overall Study|Not transplanted|10|||
155210976|NCT02345850|560210020|FG001|Overall Study|Not transplanted|5|||
155210977|NCT02345850|560210021|FG002|Overall Study|Not transplanted|4|||
155210978|NCT02345850|560210019|FG000|Overall Study|Lost to Follow-up|2|||
155210979|NCT02345850|560210020|FG001|Overall Study|Lost to Follow-up|3|||
155210980|NCT02345850|560210021|FG002|Overall Study|Lost to Follow-up|2|||
155210981|NCT02345850|560210019|FG000|Overall Study|Withdrawal by Subject|1|||
155210982|NCT02345850|560210020|FG001|Overall Study|Withdrawal by Subject|0|||
155210983|NCT02345850|560210021|FG002|Overall Study|Withdrawal by Subject|0|||
155210984|NCT02392247|560210022|FG000|Overall Study|Withdrawal by Subject|1|||
155210985|NCT02392247|560210022|FG000|Overall Study|Surgery cancelled; no data|1|||
155210986|NCT01991067|560210023|FG000|Overall Study|Lost to Follow-up|6|||
155210987|NCT01991067|560210024|FG001|Overall Study|Lost to Follow-up|5|||
155210988|NCT00224055|560210026|FG000|Overall Study|Adverse Event|9|||
155210989|NCT00224055|560210027|FG001|Overall Study|Adverse Event|3|||
155210990|NCT00224055|560210026|FG000|Overall Study|Lost to Follow-up|1|||
155210991|NCT00224055|560210027|FG001|Overall Study|Lost to Follow-up|2|||
155210992|NCT00224055|560210026|FG000|Overall Study|Protocol Violation|1|||
155210993|NCT00224055|560210027|FG001|Overall Study|Protocol Violation|1|||
155210994|NCT00224055|560210026|FG000|Overall Study|Inclusion Violation|3|||
155210995|NCT00224055|560210027|FG001|Overall Study|Inclusion Violation|6|||
155210996|NCT00224055|560210026|FG000|Overall Study|Withdrawal by Subject|0|||
155210997|NCT00224055|560210027|FG001|Overall Study|Withdrawal by Subject|2|||
155210998|NCT00224055|560210026|FG000|Overall Study|Other|1|||
155210999|NCT00224055|560210027|FG001|Overall Study|Other|0|||
155211000|NCT00407563|560210030|FG000|Overall Study|Patient continues on treatment|1|||
155211001|NCT02014597|560210031|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
155211002|NCT02014597|560210032|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
155211003|NCT00754624|560210033|FG000|Overall Study|Adverse Event|16|||
155211004|NCT00754624|560210033|FG000|Overall Study|Death|1|||
155211005|NCT00754624|560210033|FG000|Overall Study|Physician Decision|8|||
155211006|NCT00754624|560210033|FG000|Overall Study|Protocol Violation|1|||
155211007|NCT00754624|560210033|FG000|Overall Study|Withdrawal by Subject|28|||
155211008|NCT00754624|560210033|FG000|Overall Study|Various|12|||
155211009|NCT00754624|560210033|FG000|Overall Study|Lost to Follow-up|3|||
155211010|NCT04067544|560210034|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
155211011|NCT00967798|560210035|FG000|Overall Study|Withdrawal by Subject|5|||
155211012|NCT00967798|560210036|FG001|Overall Study|Withdrawal by Subject|2|||
155211013|NCT00967798|560210035|FG000|Overall Study|Lost to Follow-up|4|||
155211014|NCT00967798|560210036|FG001|Overall Study|Lost to Follow-up|1|||
155211015|NCT00592839|560210046|FG000|Overall Study|Withdrawal by Subject|1|||
155211016|NCT00592839|560210047|FG001|Overall Study|Withdrawal by Subject|1|||
155211017|NCT00592839|560210048|FG002|Overall Study|Withdrawal by Subject|3|||
155211018|NCT00592839|560210046|FG000|Overall Study|Protocol Violation|1|||
155211019|NCT00592839|560210047|FG001|Overall Study|Protocol Violation|1|||
155211020|NCT00592839|560210048|FG002|Overall Study|Protocol Violation|2|||
155211021|NCT00592839|560210046|FG000|Overall Study|Adverse Event|0|||
155211022|NCT00592839|560210047|FG001|Overall Study|Adverse Event|1|||
155211023|NCT00592839|560210048|FG002|Overall Study|Adverse Event|0|||
155211024|NCT00592839|560210046|FG000|Overall Study|Lost to Follow-up|0|||
155211025|NCT00592839|560210047|FG001|Overall Study|Lost to Follow-up|1|||
155211026|NCT00592839|560210048|FG002|Overall Study|Lost to Follow-up|1|||
155211027|NCT02282020|560210049|FG000|Overall Study|Objective Disease Progression|128|||
155211028|NCT02282020|560210050|FG001|Overall Study|Objective Disease Progression|30|||
155211029|NCT02282020|560210049|FG000|Overall Study|Adverse Event|18|||
155211030|NCT02282020|560210050|FG001|Overall Study|Adverse Event|15|||
155211031|NCT02282020|560210049|FG000|Overall Study|Withdrawal by Subject|7|||
155211032|NCT02282020|560210050|FG001|Overall Study|Withdrawal by Subject|10|||
155211033|NCT02282020|560210049|FG000|Overall Study|Miscellaneous|5|||
155211034|NCT02282020|560210050|FG001|Overall Study|Miscellaneous|19|||
155211035|NCT02282020|560210049|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
155211036|NCT02282020|560210050|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
155211037|NCT02282020|560210049|FG000|Overall Study|Developed Discontinuation Criteria|0|||
155211038|NCT02282020|560210050|FG001|Overall Study|Developed Discontinuation Criteria|2|||
155211039|NCT02282020|560210049|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
155211040|NCT02282020|560210050|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
155211041|NCT01500629|560210051|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
155211042|NCT01500629|560210052|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
155211043|NCT00249444|560210053|FG000|Overall Study|Lost to Follow-up|2|||
155211044|NCT00249444|560210054|FG001|Overall Study|Lost to Follow-up|2|||
155211045|NCT00249444|560210053|FG000|Overall Study|non-compliant|9|||
155211046|NCT00249444|560210054|FG001|Overall Study|non-compliant|11|||
155211047|NCT00249444|560210053|FG000|Overall Study|Adverse Event|1|||
155211048|NCT00249444|560210054|FG001|Overall Study|Adverse Event|1|||
155211049|NCT00249444|560210053|FG000|Overall Study|life event|0|||
155211050|NCT00249444|560210054|FG001|Overall Study|life event|1|||
155211051|NCT01499667|560210055|FG000|Overall Study|administrative problems|4|||
155211052|NCT01499667|560210056|FG001|Overall Study|administrative problems|5|||
155211053|NCT01499667|560210057|FG002|Overall Study|administrative problems|5|||
155211054|NCT01499667|560210055|FG000|Overall Study|Protocol Violation|1|||
155211055|NCT01499667|560210056|FG001|Overall Study|Protocol Violation|3|||
155211056|NCT01499667|560210057|FG002|Overall Study|Protocol Violation|2|||
155211057|NCT01499667|560210055|FG000|Overall Study|Adverse Event|0|||
155211058|NCT01499667|560210056|FG001|Overall Study|Adverse Event|2|||
155211059|NCT01499667|560210057|FG002|Overall Study|Adverse Event|2|||
155211060|NCT01499667|560210055|FG000|Overall Study|Withdrawal by Subject|2|||
155211061|NCT01499667|560210056|FG001|Overall Study|Withdrawal by Subject|1|||
155211062|NCT01499667|560210057|FG002|Overall Study|Withdrawal by Subject|1|||
155211063|NCT01499667|560210055|FG000|Overall Study|Lack of Efficacy|2|||
155211064|NCT01499667|560210056|FG001|Overall Study|Lack of Efficacy|0|||
155211065|NCT01499667|560210057|FG002|Overall Study|Lack of Efficacy|0|||
155211066|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Death|3|||
155211067|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Death|3|||
155211068|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Death|0|||
155211069|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Death|0|||
155211070|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
155211071|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
155211072|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
155211073|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
155211074|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
155211075|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
155211076|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
155211077|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
155211078|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
155211079|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
155211080|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
155211081|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
155211082|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
155211083|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
155211084|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
155211085|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
155211086|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
155211087|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
155211088|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
155211089|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
155211090|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
155211091|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
155211092|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
155211093|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
155211094|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Other|6|||
155211095|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Other|3|||
155211096|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Other|0|||
155211097|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Other|0|||
155211098|NCT02051608|560210060|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
155211099|NCT02051608|560210061|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
155211100|NCT02051608|560210062|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
155211101|NCT02051608|560210063|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
155211102|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Adverse Event|0|||
155211103|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Adverse Event|0|||
155211104|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Adverse Event|6|||
155211105|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Adverse Event|8|||
155211106|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Death|0|||
155211107|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Death|0|||
155211108|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Death|7|||
155211109|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Death|4|||
155211110|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
155211111|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
155211112|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
155211113|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
155211114|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
155211115|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
155211116|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
155211117|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
155211118|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
155211119|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
155211120|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
155211121|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
155211122|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
155211123|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
155211124|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
155211125|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
155211126|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Physician Decision|0|||
155211127|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Physician Decision|0|||
155211128|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Physician Decision|8|||
155211129|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Physician Decision|5|||
155211130|NCT02051608|560210060|FG000|Part 2: Open-label Extension|Other|0|||
155211131|NCT02051608|560210061|FG001|Part 2: Open-label Extension|Other|0|||
155211132|NCT02051608|560210062|FG002|Part 2: Open-label Extension|Other|9|||
155211133|NCT02051608|560210063|FG003|Part 2: Open-label Extension|Other|9|||
155211134|NCT00142584|560210064|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
155211135|NCT00142584|560210065|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
155211136|NCT00142584|560210064|FG000|Overall Study|Withdrawal by Subject|30|||
155211137|NCT00142584|560210065|FG001|Overall Study|Withdrawal by Subject|16|||
155211138|NCT00142584|560210064|FG000|Overall Study|Lost to Follow-up|22|||
155211139|NCT00142584|560210065|FG001|Overall Study|Lost to Follow-up|12|||
155211140|NCT00142584|560210064|FG000|Overall Study|Adverse Event|14|||
155211141|NCT00142584|560210065|FG001|Overall Study|Adverse Event|5|||
155211142|NCT00142584|560210064|FG000|Overall Study|Protocol Violation|4|||
155211143|NCT00142584|560210065|FG001|Overall Study|Protocol Violation|7|||
155211144|NCT00142584|560210064|FG000|Overall Study|Treatment Failure|2|||
155211145|NCT00142584|560210065|FG001|Overall Study|Treatment Failure|0|||
155211146|NCT03070782|560210066|FG000|Overall Study|Adverse Event|3|||
155211147|NCT03070782|560210067|FG001|Overall Study|Adverse Event|0|||
155211148|NCT03070782|560210068|FG002|Overall Study|Adverse Event|3|||
155211149|NCT03070782|560210069|FG003|Overall Study|Adverse Event|1|||
155211150|NCT03070782|560210070|FG004|Overall Study|Adverse Event|6|||
155211151|NCT03070782|560210071|FG005|Overall Study|Adverse Event|2|||
155211152|NCT03070782|560210066|FG000|Overall Study|Withdrawal by Subject|2|||
155211153|NCT03070782|560210067|FG001|Overall Study|Withdrawal by Subject|1|||
155211154|NCT03070782|560210068|FG002|Overall Study|Withdrawal by Subject|1|||
155211155|NCT03070782|560210069|FG003|Overall Study|Withdrawal by Subject|0|||
155211156|NCT03070782|560210070|FG004|Overall Study|Withdrawal by Subject|4|||
155211157|NCT03070782|560210071|FG005|Overall Study|Withdrawal by Subject|3|||
155211158|NCT03070782|560210066|FG000|Overall Study|Reason Not Specified|2|||
155211159|NCT03070782|560210067|FG001|Overall Study|Reason Not Specified|0|||
155211160|NCT03070782|560210068|FG002|Overall Study|Reason Not Specified|0|||
155211161|NCT03070782|560210069|FG003|Overall Study|Reason Not Specified|1|||
155211162|NCT03070782|560210070|FG004|Overall Study|Reason Not Specified|2|||
155211163|NCT03070782|560210071|FG005|Overall Study|Reason Not Specified|1|||
155211164|NCT03070782|560210066|FG000|Overall Study|Ineligibility|0|||
155211165|NCT03070782|560210067|FG001|Overall Study|Ineligibility|0|||
155211166|NCT03070782|560210068|FG002|Overall Study|Ineligibility|0|||
155211167|NCT03070782|560210069|FG003|Overall Study|Ineligibility|1|||
155211168|NCT03070782|560210070|FG004|Overall Study|Ineligibility|0|||
155211169|NCT03070782|560210071|FG005|Overall Study|Ineligibility|1|||
155211170|NCT03070782|560210066|FG000|Overall Study|Pregnancy|0|||
155211171|NCT03070782|560210067|FG001|Overall Study|Pregnancy|0|||
155211172|NCT03070782|560210068|FG002|Overall Study|Pregnancy|0|||
155211173|NCT03070782|560210069|FG003|Overall Study|Pregnancy|1|||
155211174|NCT03070782|560210070|FG004|Overall Study|Pregnancy|0|||
155211175|NCT03070782|560210071|FG005|Overall Study|Pregnancy|0|||
155211176|NCT03070782|560210066|FG000|Overall Study|Investigator Judgement|0|||
155211177|NCT03070782|560210067|FG001|Overall Study|Investigator Judgement|0|||
155211178|NCT03070782|560210068|FG002|Overall Study|Investigator Judgement|0|||
155211179|NCT03070782|560210069|FG003|Overall Study|Investigator Judgement|1|||
155211180|NCT03070782|560210070|FG004|Overall Study|Investigator Judgement|0|||
155211181|NCT03070782|560210071|FG005|Overall Study|Investigator Judgement|0|||
155211182|NCT02288559|560210072|FG000|Overall Study|Adverse Event|1|||
155211183|NCT02288559|560210073|FG001|Overall Study|Adverse Event|1|||
155211184|NCT02288559|560210074|FG002|Overall Study|Adverse Event|5|||
155211185|NCT02288559|560210075|FG003|Overall Study|Adverse Event|0|||
155211186|NCT02288559|560210072|FG000|Overall Study|Death|0|||
155211187|NCT02288559|560210073|FG001|Overall Study|Death|0|||
155211188|NCT02288559|560210074|FG002|Overall Study|Death|1|||
155211189|NCT02288559|560210075|FG003|Overall Study|Death|0|||
155211190|NCT02288559|560210072|FG000|Overall Study|Lost to Follow-up|0|||
155211191|NCT02288559|560210073|FG001|Overall Study|Lost to Follow-up|0|||
155211192|NCT02288559|560210074|FG002|Overall Study|Lost to Follow-up|0|||
155211193|NCT02288559|560210075|FG003|Overall Study|Lost to Follow-up|1|||
155211194|NCT02288559|560210072|FG000|Overall Study|Withdrawal by Subject|0|||
155211195|NCT02288559|560210073|FG001|Overall Study|Withdrawal by Subject|0|||
155211196|NCT02288559|560210074|FG002|Overall Study|Withdrawal by Subject|2|||
155211197|NCT02288559|560210075|FG003|Overall Study|Withdrawal by Subject|1|||
155211198|NCT02288559|560210072|FG000|Overall Study|Reason Not Specified|0|||
155211199|NCT02288559|560210073|FG001|Overall Study|Reason Not Specified|0|||
155211200|NCT02288559|560210074|FG002|Overall Study|Reason Not Specified|3|||
155211201|NCT02288559|560210075|FG003|Overall Study|Reason Not Specified|0|||
155211202|NCT00558025|560210076|FG000|Overall Study|Adverse Event|1|||
155211203|NCT00558025|560210077|FG001|Overall Study|Adverse Event|1|||
155211204|NCT00558025|560210076|FG000|Overall Study|Withdrawal by Subject|2|||
155211205|NCT00558025|560210077|FG001|Overall Study|Withdrawal by Subject|2|||
155211206|NCT00558025|560210076|FG000|Overall Study|Protocol Violation|1|||
155211207|NCT00558025|560210077|FG001|Overall Study|Protocol Violation|0|||
155211208|NCT00449540|560210078|FG000|Pretreatment Phase|No migraine experienced|66|||
155211209|NCT00449540|560210079|FG001|Pretreatment Phase|No migraine experienced|0|||
155211210|NCT00449540|560210080|FG002|Pretreatment Phase|No migraine experienced|0|||
155211211|NCT00449540|560210078|FG000|Treatment Phase|did not experience or treat migraine|0|||
155211212|NCT00449540|560210079|FG001|Treatment Phase|did not experience or treat migraine|20|||
155211213|NCT00449540|560210080|FG002|Treatment Phase|did not experience or treat migraine|17|||
155211214|NCT01881776|560210081|FG000|Overall Study|Lost to Follow-up|1|||
155211215|NCT01881776|560210082|FG001|Overall Study|Lost to Follow-up|2|||
155211216|NCT01881776|560210083|FG002|Overall Study|Lost to Follow-up|1|||
155211217|NCT01881776|560210081|FG000|Overall Study|Protocol Violation|0|||
155211218|NCT01881776|560210082|FG001|Overall Study|Protocol Violation|2|||
155211219|NCT01881776|560210083|FG002|Overall Study|Protocol Violation|1|||
155211220|NCT00022633|560210084|FG000|Overall Study|Adverse Event|11|||
155211221|NCT00022633|560210085|FG001|Overall Study|Adverse Event|1|||
155211222|NCT00022633|560210084|FG000|Overall Study|Refusal unrelated to adverse event|1|||
155211223|NCT00022633|560210085|FG001|Overall Study|Refusal unrelated to adverse event|0|||
155211224|NCT00022633|560210084|FG000|Overall Study|Progression/relapse|9|||
155211225|NCT00022633|560210085|FG001|Overall Study|Progression/relapse|2|||
155211226|NCT00022633|560210084|FG000|Overall Study|Death|4|||
155211227|NCT00022633|560210085|FG001|Overall Study|Death|0|||
155211228|NCT00022633|560210084|FG000|Overall Study|Other - not protocol specified|3|||
155211229|NCT00022633|560210085|FG001|Overall Study|Other - not protocol specified|2|||
155211230|NCT00022633|560210084|FG000|Overall Study|Ineligible|4|||
155211231|NCT00022633|560210085|FG001|Overall Study|Ineligible|0|||
155211232|NCT02036294|560210100|FG000|Overall Study|Death|7|||
155211233|NCT02036294|560210101|FG001|Overall Study|Death|8|||
155211234|NCT02036294|560210100|FG000|Overall Study|Withdrawal by Subject|2|||
155211235|NCT02036294|560210101|FG001|Overall Study|Withdrawal by Subject|3|||
155211236|NCT02393547|560210102|FG000|Overall Study|Adverse Event|2|||
155211237|NCT02393547|560210102|FG000|Overall Study|Withdrawal by Subject|3|||
155211238|NCT02393547|560210102|FG000|Overall Study|Lost to Follow-up|1|||
155211239|NCT00514540|560210103|FG000|First-Line Chemo|Withdrawal by Subject|1|||
155211240|NCT00514540|560210103|FG000|First-Line Chemo|Protocol Violation|7|||
155211241|NCT00514540|560210103|FG000|Second-Line|Physician/Patient Decision|31|||
155211242|NCT00752232|560210120|FG000|Overall Study|Protocol Violation|0|||
155211243|NCT00752232|560210121|FG001|Overall Study|Protocol Violation|0|||
155211244|NCT00752232|560210122|FG002|Overall Study|Protocol Violation|0|||
155211245|NCT00752232|560210123|FG003|Overall Study|Protocol Violation|0|||
155211246|NCT00752232|560210124|FG004|Overall Study|Protocol Violation|0|||
155211247|NCT00752232|560210125|FG005|Overall Study|Protocol Violation|1|||
155211248|NCT00752232|560210126|FG006|Overall Study|Protocol Violation|0|||
155211249|NCT00752232|560210120|FG000|Overall Study|Caregiver request|2|||
155211250|NCT00752232|560210121|FG001|Overall Study|Caregiver request|0|||
155211251|NCT00752232|560210122|FG002|Overall Study|Caregiver request|0|||
155211252|NCT00752232|560210123|FG003|Overall Study|Caregiver request|0|||
155211253|NCT00752232|560210124|FG004|Overall Study|Caregiver request|1|||
155211254|NCT00752232|560210125|FG005|Overall Study|Caregiver request|0|||
155211255|NCT00752232|560210126|FG006|Overall Study|Caregiver request|0|||
155211256|NCT00752232|560210120|FG000|Overall Study|Investigator request|0|||
155211257|NCT00752232|560210121|FG001|Overall Study|Investigator request|0|||
155211258|NCT00752232|560210122|FG002|Overall Study|Investigator request|0|||
155211259|NCT00752232|560210123|FG003|Overall Study|Investigator request|0|||
155211260|NCT00752232|560210124|FG004|Overall Study|Investigator request|1|||
155211261|NCT00752232|560210125|FG005|Overall Study|Investigator request|0|||
155211262|NCT00752232|560210126|FG006|Overall Study|Investigator request|0|||
155211263|NCT00752232|560210120|FG000|Overall Study|Subject request|0|||
155211264|NCT00752232|560210121|FG001|Overall Study|Subject request|0|||
155211265|NCT00752232|560210122|FG002|Overall Study|Subject request|1|||
155211266|NCT00752232|560210123|FG003|Overall Study|Subject request|0|||
155211267|NCT00752232|560210124|FG004|Overall Study|Subject request|0|||
155211268|NCT00752232|560210125|FG005|Overall Study|Subject request|0|||
155211269|NCT00752232|560210126|FG006|Overall Study|Subject request|0|||
155211270|NCT00752232|560210120|FG000|Overall Study|Group home admission|0|||
155211271|NCT00752232|560210121|FG001|Overall Study|Group home admission|0|||
155211272|NCT00752232|560210122|FG002|Overall Study|Group home admission|0|||
155211273|NCT00752232|560210123|FG003|Overall Study|Group home admission|1|||
155211274|NCT00752232|560210124|FG004|Overall Study|Group home admission|0|||
155211275|NCT00752232|560210125|FG005|Overall Study|Group home admission|0|||
155211276|NCT00752232|560210126|FG006|Overall Study|Group home admission|0|||
155211277|NCT00752232|560210120|FG000|Overall Study|Caregiver could not attend the subject|0|||
155211278|NCT00752232|560210121|FG001|Overall Study|Caregiver could not attend the subject|0|||
155211279|NCT00752232|560210122|FG002|Overall Study|Caregiver could not attend the subject|0|||
155211280|NCT00752232|560210123|FG003|Overall Study|Caregiver could not attend the subject|0|||
155211281|NCT00752232|560210124|FG004|Overall Study|Caregiver could not attend the subject|1|||
155211282|NCT00752232|560210125|FG005|Overall Study|Caregiver could not attend the subject|0|||
155211283|NCT00752232|560210126|FG006|Overall Study|Caregiver could not attend the subject|0|||
155211284|NCT02788357|560210134|FG000|Overall Study|Lost to Follow-up|3|||
155211285|NCT02788357|560210135|FG001|Overall Study|Lost to Follow-up|0|||
155211286|NCT02170051|560210136|FG000|Overall Study|Withdrawal by Subject|10|||
155211287|NCT02170051|560210137|FG001|Overall Study|Withdrawal by Subject|10|||
155211288|NCT02170051|560210136|FG000|Overall Study|Lost to Follow-up|1|||
155211289|NCT02170051|560210137|FG001|Overall Study|Lost to Follow-up|3|||
155211290|NCT03672747|560210140|FG000|Overall Study|Lost to Follow-up|1|||
155211291|NCT03672747|560210141|FG001|Overall Study|Lost to Follow-up|1|||
155211292|NCT03672747|560210142|FG002|Overall Study|Lost to Follow-up|2|||
155211293|NCT03672747|560210143|FG003|Overall Study|Lost to Follow-up|2|||
155211294|NCT03672747|560210144|FG004|Overall Study|Lost to Follow-up|2|||
155211295|NCT03672747|560210145|FG005|Overall Study|Lost to Follow-up|1|||
155211296|NCT00071513|560210152|FG000|Intervention Component|Withdrawal by Subject|2|||
155211297|NCT00071513|560210153|FG001|Intervention Component|Withdrawal by Subject|3|||
155211298|NCT00071513|560210152|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
155211299|NCT00071513|560210153|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
155211300|NCT01648205|560210154|FG000|Placebo|Pregnancy|1|||
155211301|NCT01648205|560210154|FG000|Placebo|Withdrawal by Subject|1|||
155211302|NCT01648205|560210154|FG000|Placebo|Protocol Violation|2|||
155211303|NCT01648205|560210154|FG000|Ranolazine|Death|1|||
155211304|NCT01648205|560210154|FG000|Ranolazine|Withdrawal by Subject|1|||
155211305|NCT01648205|560210154|FG000|Ranolazine|Protocol Violation|3|||
155211306|NCT01958008|560210155|FG000|Overall Study|Worsening of disease under study|0|||
155211307|NCT01958008|560210156|FG001|Overall Study|Worsening of disease under study|0|||
155211308|NCT01958008|560210157|FG002|Overall Study|Worsening of disease under study|1|||
155211309|NCT01958008|560210158|FG003|Overall Study|Worsening of disease under study|0|||
155211310|NCT01958008|560210155|FG000|Overall Study|Other adverse event|1|||
155211311|NCT01958008|560210156|FG001|Overall Study|Other adverse event|0|||
155211312|NCT01958008|560210157|FG002|Overall Study|Other adverse event|0|||
155211313|NCT01958008|560210158|FG003|Overall Study|Other adverse event|0|||
155211314|NCT01634360|560210159|FG000|Overall Study|Adverse Event|10|||
155211315|NCT01634360|560210160|FG001|Overall Study|Adverse Event|34|||
155211316|NCT01634360|560210159|FG000|Overall Study|subject withdrew consent|13|||
155211317|NCT01634360|560210160|FG001|Overall Study|subject withdrew consent|23|||
155211318|NCT01634360|560210159|FG000|Overall Study|Protocol Violation|1|||
155211319|NCT01634360|560210160|FG001|Overall Study|Protocol Violation|1|||
155211320|NCT01634360|560210159|FG000|Overall Study|Lack of Efficacy|4|||
155211321|NCT01634360|560210160|FG001|Overall Study|Lack of Efficacy|14|||
155211322|NCT01634360|560210159|FG000|Overall Study|Other|3|||
155211323|NCT01634360|560210160|FG001|Overall Study|Other|20|||
155211324|NCT01634360|560210159|FG000|Overall Study|Study termination by sponsor|18|||
155211325|NCT01634360|560210160|FG001|Overall Study|Study termination by sponsor|44|||
155211326|NCT03667924|560210161|FG000|Baseline Completed|Lost to Follow-up|0|||
155211327|NCT03667924|560210162|FG001|Baseline Completed|Lost to Follow-up|2|||
155211328|NCT03667924|560210163|FG002|Baseline Completed|Lost to Follow-up|0|||
155211329|NCT03667924|560210161|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
155211330|NCT03667924|560210162|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
155211331|NCT03667924|560210163|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
155211332|NCT03667924|560210161|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
155211333|NCT03667924|560210162|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
155211334|NCT03667924|560210163|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
155211335|NCT03667924|560210161|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
155211336|NCT03667924|560210162|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
155211337|NCT03667924|560210163|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
155211338|NCT03667924|560210161|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
155211339|NCT03667924|560210162|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
155211340|NCT03667924|560210163|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
155211341|NCT03667924|560210161|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
155211342|NCT03667924|560210162|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
155211343|NCT03667924|560210163|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
155211344|NCT03667924|560210161|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
155211345|NCT03667924|560210162|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
155211346|NCT03667924|560210163|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
155211347|NCT02260921|560210170|FG000|Overall Study|Adverse Event|1|||
155211348|NCT02260921|560210171|FG001|Overall Study|Adverse Event|0|||
155211349|NCT02260921|560210170|FG000|Overall Study|Lost to Follow-up|4|||
155211350|NCT02260921|560210171|FG001|Overall Study|Lost to Follow-up|3|||
155211351|NCT02260921|560210170|FG000|Overall Study|Withdraw Consent|4|||
155211352|NCT02260921|560210171|FG001|Overall Study|Withdraw Consent|1|||
155211353|NCT02260921|560210170|FG000|Overall Study|Death|1|||
155211354|NCT02260921|560210171|FG001|Overall Study|Death|0|||
155211355|NCT02260921|560210170|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
155211356|NCT02260921|560210171|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
155211357|NCT01244425|560210172|FG000|Overall Study|Withdrawal by Subject|2|||
155211358|NCT01244425|560210173|FG001|Overall Study|Withdrawal by Subject|2|||
155211359|NCT01244425|560210172|FG000|Overall Study|Adverse Event|1|||
155211360|NCT01244425|560210173|FG001|Overall Study|Adverse Event|1|||
155211361|NCT02743871|560210174|FG000|Overall Study|Lost to Follow-up|0|||
155211362|NCT02743871|560210175|FG001|Overall Study|Lost to Follow-up|0|||
155211363|NCT02743871|560210176|FG002|Overall Study|Lost to Follow-up|0|||
155211364|NCT02743871|560210177|FG003|Overall Study|Lost to Follow-up|1|||
155211365|NCT02743871|560210178|FG004|Overall Study|Lost to Follow-up|0|||
155211366|NCT02743871|560210179|FG005|Overall Study|Lost to Follow-up|0|||
155211367|NCT02743871|560210180|FG006|Overall Study|Lost to Follow-up|1|||
155211368|NCT02743871|560210181|FG007|Overall Study|Lost to Follow-up|0|||
155211369|NCT02743871|560210182|FG008|Overall Study|Lost to Follow-up|0|||
155211370|NCT02743871|560210183|FG009|Overall Study|Lost to Follow-up|0|||
155211371|NCT02743871|560210184|FG010|Overall Study|Lost to Follow-up|0|||
155211372|NCT02743871|560210185|FG011|Overall Study|Lost to Follow-up|2|||
155211373|NCT02743871|560210186|FG012|Overall Study|Lost to Follow-up|0|||
155211374|NCT02743871|560210187|FG013|Overall Study|Lost to Follow-up|0|||
155211375|NCT02743871|560210174|FG000|Overall Study|Withdrawal by Subject|0|||
155211376|NCT02743871|560210175|FG001|Overall Study|Withdrawal by Subject|0|||
155211377|NCT02743871|560210176|FG002|Overall Study|Withdrawal by Subject|0|||
155211378|NCT02743871|560210177|FG003|Overall Study|Withdrawal by Subject|0|||
155211379|NCT02743871|560210178|FG004|Overall Study|Withdrawal by Subject|0|||
155211380|NCT02743871|560210179|FG005|Overall Study|Withdrawal by Subject|0|||
155211381|NCT02743871|560210180|FG006|Overall Study|Withdrawal by Subject|0|||
155211382|NCT02743871|560210181|FG007|Overall Study|Withdrawal by Subject|0|||
155211383|NCT02743871|560210182|FG008|Overall Study|Withdrawal by Subject|0|||
155211384|NCT02743871|560210183|FG009|Overall Study|Withdrawal by Subject|0|||
155211385|NCT02743871|560210184|FG010|Overall Study|Withdrawal by Subject|1|||
155211386|NCT02743871|560210185|FG011|Overall Study|Withdrawal by Subject|0|||
155211387|NCT02743871|560210186|FG012|Overall Study|Withdrawal by Subject|12|||
155211388|NCT02743871|560210187|FG013|Overall Study|Withdrawal by Subject|6|||
155211389|NCT02743871|560210174|FG000|Overall Study|Adverse Event|1|||
155211390|NCT02743871|560210175|FG001|Overall Study|Adverse Event|0|||
155211391|NCT02743871|560210176|FG002|Overall Study|Adverse Event|0|||
155211392|NCT02743871|560210177|FG003|Overall Study|Adverse Event|0|||
155211393|NCT02743871|560210178|FG004|Overall Study|Adverse Event|0|||
155211394|NCT02743871|560210179|FG005|Overall Study|Adverse Event|0|||
155211395|NCT02743871|560210180|FG006|Overall Study|Adverse Event|0|||
155211396|NCT02743871|560210181|FG007|Overall Study|Adverse Event|0|||
155211397|NCT02743871|560210182|FG008|Overall Study|Adverse Event|0|||
155211398|NCT02743871|560210183|FG009|Overall Study|Adverse Event|0|||
155211399|NCT02743871|560210184|FG010|Overall Study|Adverse Event|0|||
155211400|NCT02743871|560210185|FG011|Overall Study|Adverse Event|0|||
155211401|NCT02743871|560210186|FG012|Overall Study|Adverse Event|0|||
155211402|NCT02743871|560210187|FG013|Overall Study|Adverse Event|0|||
155211403|NCT02743871|560210174|FG000|Overall Study|Other|0|||
155211404|NCT02743871|560210175|FG001|Overall Study|Other|0|||
155211405|NCT02743871|560210176|FG002|Overall Study|Other|0|||
155211406|NCT02743871|560210177|FG003|Overall Study|Other|0|||
155211407|NCT02743871|560210178|FG004|Overall Study|Other|0|||
155211408|NCT02743871|560210179|FG005|Overall Study|Other|0|||
155211409|NCT02743871|560210180|FG006|Overall Study|Other|0|||
155211410|NCT02743871|560210181|FG007|Overall Study|Other|0|||
155211411|NCT02743871|560210182|FG008|Overall Study|Other|0|||
155211412|NCT02743871|560210183|FG009|Overall Study|Other|0|||
155211413|NCT02743871|560210184|FG010|Overall Study|Other|0|||
155211414|NCT02743871|560210185|FG011|Overall Study|Other|1|||
155211415|NCT02743871|560210186|FG012|Overall Study|Other|1|||
155211416|NCT02743871|560210187|FG013|Overall Study|Other|1|||
155211417|NCT02743871|560210174|FG000|Overall Study|Protocol Violation|0|||
155211418|NCT02743871|560210175|FG001|Overall Study|Protocol Violation|0|||
155211419|NCT02743871|560210176|FG002|Overall Study|Protocol Violation|0|||
155211420|NCT02743871|560210177|FG003|Overall Study|Protocol Violation|0|||
155211421|NCT02743871|560210178|FG004|Overall Study|Protocol Violation|0|||
155211422|NCT02743871|560210179|FG005|Overall Study|Protocol Violation|0|||
155211423|NCT02743871|560210180|FG006|Overall Study|Protocol Violation|0|||
155211424|NCT02743871|560210181|FG007|Overall Study|Protocol Violation|0|||
155211425|NCT02743871|560210182|FG008|Overall Study|Protocol Violation|0|||
155211426|NCT02743871|560210183|FG009|Overall Study|Protocol Violation|0|||
155211427|NCT02743871|560210184|FG010|Overall Study|Protocol Violation|0|||
155211428|NCT02743871|560210185|FG011|Overall Study|Protocol Violation|0|||
155211429|NCT02743871|560210186|FG012|Overall Study|Protocol Violation|2|||
155211430|NCT02743871|560210187|FG013|Overall Study|Protocol Violation|0|||
155211431|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
155211432|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
155211433|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
155211434|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
155211435|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Death|7|||
155211436|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Death|5|||
155211437|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
155211438|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
155211439|NCT02999854|560210188|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
155211440|NCT02999854|560210189|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
155211441|NCT02999854|560210188|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
155211442|NCT02999854|560210189|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
155211443|NCT02999854|560210188|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
155211444|NCT02999854|560210189|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
155211445|NCT02999854|560210188|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
155211446|NCT02999854|560210189|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
155211447|NCT03032705|560210190|FG000|Overall Study|Lost to Follow-up|16|||
155211448|NCT03032705|560210191|FG001|Overall Study|Lost to Follow-up|17|||
155211449|NCT03032705|560210190|FG000|Overall Study|did not quality|6|||
155211450|NCT03032705|560210191|FG001|Overall Study|did not quality|6|||
155211451|NCT04818840|560210194|FG000|Overall Study|Lost to Follow-up|0|||
155211452|NCT04818840|560210195|FG001|Overall Study|Lost to Follow-up|5|||
155211453|NCT04818840|560210194|FG000|Overall Study|Physician Decision|1|||
155211454|NCT04818840|560210195|FG001|Overall Study|Physician Decision|0|||
155211455|NCT04818840|560210194|FG000|Overall Study|Site Terminated by Sponsor|0|||
155211456|NCT04818840|560210195|FG001|Overall Study|Site Terminated by Sponsor|3|||
155211457|NCT04818840|560210194|FG000|Overall Study|Study Terminated by Sponsor|43|||
155211458|NCT04818840|560210195|FG001|Overall Study|Study Terminated by Sponsor|7|||
155211459|NCT04818840|560210194|FG000|Overall Study|Withdrawal by Subject|0|||
155211460|NCT04818840|560210195|FG001|Overall Study|Withdrawal by Subject|1|||
155211461|NCT00733408|560212256|FG000|Overall Study|Adverse Event|4|||
155211462|NCT01134783|560212258|FG000|Overall Study|Pregnancy|16|||
155211463|NCT01134783|560212259|FG001|Overall Study|Pregnancy|8|||
155211464|NCT01134783|560212258|FG000|Overall Study|Withdrawal by Subject|15|||
155211465|NCT01134783|560212259|FG001|Overall Study|Withdrawal by Subject|9|||
155211466|NCT01134783|560212258|FG000|Overall Study|Lost to Follow-up|5|||
155211467|NCT01134783|560212259|FG001|Overall Study|Lost to Follow-up|20|||
155211468|NCT02329730|560212266|FG000|Overall Study|Protocol Violation|0|||
155211469|NCT02329730|560212267|FG001|Overall Study|Protocol Violation|0|||
155211470|NCT02329730|560212268|FG002|Overall Study|Protocol Violation|0|||
155211471|NCT02329730|560212269|FG003|Overall Study|Protocol Violation|0|||
155211472|NCT02329730|560212270|FG004|Overall Study|Protocol Violation|2|||
155211473|NCT02329730|560212271|FG005|Overall Study|Protocol Violation|2|||
155211474|NCT02329730|560212272|FG006|Overall Study|Protocol Violation|0|||
155211475|NCT02329730|560212273|FG007|Overall Study|Protocol Violation|0|||
155211476|NCT02329730|560212274|FG008|Overall Study|Protocol Violation|0|||
155211477|NCT02329730|560212275|FG009|Overall Study|Protocol Violation|0|||
155211478|NCT02329730|560212276|FG010|Overall Study|Protocol Violation|0|||
155211479|NCT02329730|560212277|FG011|Overall Study|Protocol Violation|0|||
155211480|NCT02329730|560212266|FG000|Overall Study|Withdrawal by Subject|0|||
155211481|NCT02329730|560212267|FG001|Overall Study|Withdrawal by Subject|0|||
155211482|NCT02329730|560212268|FG002|Overall Study|Withdrawal by Subject|0|||
155211483|NCT02329730|560212269|FG003|Overall Study|Withdrawal by Subject|0|||
155211484|NCT02329730|560212270|FG004|Overall Study|Withdrawal by Subject|1|||
155211485|NCT02329730|560212271|FG005|Overall Study|Withdrawal by Subject|0|||
155211486|NCT02329730|560212272|FG006|Overall Study|Withdrawal by Subject|1|||
155211487|NCT02329730|560212273|FG007|Overall Study|Withdrawal by Subject|1|||
155211488|NCT02329730|560212274|FG008|Overall Study|Withdrawal by Subject|1|||
155211489|NCT02329730|560212275|FG009|Overall Study|Withdrawal by Subject|1|||
155211490|NCT02329730|560212276|FG010|Overall Study|Withdrawal by Subject|0|||
155211491|NCT02329730|560212277|FG011|Overall Study|Withdrawal by Subject|0|||
155211492|NCT00463346|560212282|FG000|Overall Study|Withdrawal by Subject|3|||
155211493|NCT00463346|560212283|FG001|Overall Study|Withdrawal by Subject|3|||
155211494|NCT03641651|560212285|FG000|Overall Study|organizational issues at one study site|1|||
155211495|NCT00951665|560212287|FG000|Phase 1b|Adverse Event|2|||
155211496|NCT00951665|560212288|FG001|Phase 1b|Adverse Event|1|||
155211497|NCT00951665|560212289|FG002|Phase 1b|Adverse Event|0|||
155211498|NCT00951665|560212290|FG003|Phase 1b|Adverse Event|1|||
155211499|NCT00951665|560212291|FG004|Phase 1b|Adverse Event|0|||
155211500|NCT00951665|560212292|FG005|Phase 1b|Adverse Event|0|||
155211501|NCT00951665|560212287|FG000|Phase 1b|Death|1|||
155211502|NCT00951665|560212288|FG001|Phase 1b|Death|0|||
155211503|NCT00951665|560212289|FG002|Phase 1b|Death|2|||
155211504|NCT00951665|560212290|FG003|Phase 1b|Death|0|||
155211505|NCT00951665|560212291|FG004|Phase 1b|Death|0|||
155211506|NCT00951665|560212292|FG005|Phase 1b|Death|0|||
155211507|NCT00951665|560212287|FG000|Phase 1b|Physician Decision|4|||
155211508|NCT00951665|560212288|FG001|Phase 1b|Physician Decision|0|||
155211509|NCT00951665|560212289|FG002|Phase 1b|Physician Decision|1|||
155211510|NCT00951665|560212290|FG003|Phase 1b|Physician Decision|0|||
155211511|NCT00951665|560212291|FG004|Phase 1b|Physician Decision|0|||
155211512|NCT00951665|560212292|FG005|Phase 1b|Physician Decision|0|||
155211513|NCT00951665|560212287|FG000|Phase 1b|Withdrawal by Subject|0|||
155211514|NCT00951665|560212288|FG001|Phase 1b|Withdrawal by Subject|1|||
155211515|NCT00951665|560212289|FG002|Phase 1b|Withdrawal by Subject|0|||
155211516|NCT00951665|560212290|FG003|Phase 1b|Withdrawal by Subject|0|||
155211517|NCT00951665|560212291|FG004|Phase 1b|Withdrawal by Subject|0|||
155211518|NCT00951665|560212292|FG005|Phase 1b|Withdrawal by Subject|0|||
155211519|NCT00951665|560212287|FG000|Phase 1b|Disease Progression|13|||
155211520|NCT00951665|560212288|FG001|Phase 1b|Disease Progression|2|||
155211521|NCT00951665|560212289|FG002|Phase 1b|Disease Progression|14|||
155211522|NCT00951665|560212290|FG003|Phase 1b|Disease Progression|0|||
155211523|NCT00951665|560212291|FG004|Phase 1b|Disease Progression|0|||
155211524|NCT00951665|560212292|FG005|Phase 1b|Disease Progression|0|||
155211525|NCT00951665|560212287|FG000|Phase 1b|Protocol Violation|2|||
155211526|NCT00951665|560212288|FG001|Phase 1b|Protocol Violation|0|||
155211527|NCT00951665|560212289|FG002|Phase 1b|Protocol Violation|0|||
155211528|NCT00951665|560212290|FG003|Phase 1b|Protocol Violation|0|||
155211529|NCT00951665|560212291|FG004|Phase 1b|Protocol Violation|0|||
155211530|NCT00951665|560212292|FG005|Phase 1b|Protocol Violation|0|||
155211531|NCT00951665|560212287|FG000|Phase 2a|Adverse Event|0|||
155211532|NCT00951665|560212288|FG001|Phase 2a|Adverse Event|0|||
155211533|NCT00951665|560212289|FG002|Phase 2a|Adverse Event|0|||
155211534|NCT00951665|560212290|FG003|Phase 2a|Adverse Event|0|||
155211535|NCT00951665|560212291|FG004|Phase 2a|Adverse Event|2|||
155211536|NCT00951665|560212292|FG005|Phase 2a|Adverse Event|0|||
155211537|NCT00951665|560212287|FG000|Phase 2a|Death|0|||
155211538|NCT00951665|560212288|FG001|Phase 2a|Death|0|||
155211539|NCT00951665|560212289|FG002|Phase 2a|Death|0|||
155211540|NCT00951665|560212290|FG003|Phase 2a|Death|0|||
155211541|NCT00951665|560212291|FG004|Phase 2a|Death|1|||
155211542|NCT00951665|560212292|FG005|Phase 2a|Death|1|||
155211543|NCT00951665|560212287|FG000|Phase 2a|Lost to Follow-up|0|||
155211544|NCT00951665|560212288|FG001|Phase 2a|Lost to Follow-up|0|||
155211545|NCT00951665|560212289|FG002|Phase 2a|Lost to Follow-up|0|||
155211546|NCT00951665|560212290|FG003|Phase 2a|Lost to Follow-up|0|||
155211547|NCT00951665|560212291|FG004|Phase 2a|Lost to Follow-up|1|||
155211548|NCT00951665|560212292|FG005|Phase 2a|Lost to Follow-up|0|||
155211549|NCT00951665|560212287|FG000|Phase 2a|Physician Decision|0|||
155211550|NCT00951665|560212288|FG001|Phase 2a|Physician Decision|0|||
155211551|NCT00951665|560212289|FG002|Phase 2a|Physician Decision|0|||
155211552|NCT00951665|560212290|FG003|Phase 2a|Physician Decision|0|||
155211553|NCT00951665|560212291|FG004|Phase 2a|Physician Decision|0|||
155211554|NCT00951665|560212292|FG005|Phase 2a|Physician Decision|1|||
155211555|NCT00951665|560212287|FG000|Phase 2a|Withdrawal by Subject|0|||
155211556|NCT00951665|560212288|FG001|Phase 2a|Withdrawal by Subject|0|||
155211557|NCT00951665|560212289|FG002|Phase 2a|Withdrawal by Subject|0|||
155211558|NCT00951665|560212290|FG003|Phase 2a|Withdrawal by Subject|0|||
155211559|NCT00951665|560212291|FG004|Phase 2a|Withdrawal by Subject|2|||
155211560|NCT00951665|560212292|FG005|Phase 2a|Withdrawal by Subject|0|||
155211561|NCT00951665|560212287|FG000|Phase 2a|Disease Progression|0|||
155211562|NCT00951665|560212288|FG001|Phase 2a|Disease Progression|0|||
155211563|NCT00951665|560212289|FG002|Phase 2a|Disease Progression|0|||
155211564|NCT00951665|560212290|FG003|Phase 2a|Disease Progression|0|||
155211565|NCT00951665|560212291|FG004|Phase 2a|Disease Progression|6|||
155211566|NCT00951665|560212292|FG005|Phase 2a|Disease Progression|5|||
155211567|NCT02068443|560212293|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155211568|NCT02068443|560212294|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
155211569|NCT02068443|560212295|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
155211570|NCT02068443|560212293|FG000|Overall Study|Voluntary Withdrawal|4|||
155211571|NCT02068443|560212294|FG001|Overall Study|Voluntary Withdrawal|0|||
155211572|NCT02068443|560212295|FG002|Overall Study|Voluntary Withdrawal|1|||
155211573|NCT02068443|560212293|FG000|Overall Study|Lack of Efficacy|2|||
155211574|NCT02068443|560212294|FG001|Overall Study|Lack of Efficacy|1|||
155211575|NCT02068443|560212295|FG002|Overall Study|Lack of Efficacy|0|||
155211576|NCT02068443|560212293|FG000|Overall Study|Other Reason Not Specified|1|||
155211577|NCT02068443|560212294|FG001|Overall Study|Other Reason Not Specified|0|||
155211578|NCT02068443|560212295|FG002|Overall Study|Other Reason Not Specified|0|||
155211579|NCT00127712|560212296|FG000|Overall Study|Adverse Event|3|||
155211580|NCT00127712|560212297|FG001|Overall Study|Adverse Event|0|||
155211581|NCT00127712|560212296|FG000|Overall Study|Lack of GI access to continue|2|||
155211582|NCT00127712|560212297|FG001|Overall Study|Lack of GI access to continue|0|||
155211583|NCT02450903|560212300|FG000|Overall Study|Adverse Event|3|||
155211584|NCT02450903|560212300|FG000|Overall Study|Progressive disease|15|||
155211585|NCT02450903|560212300|FG000|Overall Study|Switched to commercial drug|1|||
155211586|NCT02450903|560212300|FG000|Overall Study|Subject/guardian decision|1|||
155211587|NCT05126901|560212301|FG000|Overall Study|Withdrawal by Subject|1|||
155211588|NCT05126901|560212302|FG001|Overall Study|Withdrawal by Subject|1|||
155211589|NCT05126901|560212303|FG002|Overall Study|Withdrawal by Subject|4|||
155211590|NCT05126901|560212301|FG000|Overall Study|Adverse Event|0|||
155211591|NCT05126901|560212302|FG001|Overall Study|Adverse Event|0|||
155211592|NCT05126901|560212303|FG002|Overall Study|Adverse Event|1|||
155211593|NCT05126901|560212301|FG000|Overall Study|Lost to Follow-up|0|||
155211594|NCT05126901|560212302|FG001|Overall Study|Lost to Follow-up|2|||
155211595|NCT05126901|560212303|FG002|Overall Study|Lost to Follow-up|0|||
155211596|NCT01320085|560212304|FG000|Overall Study|Disease Progression|26|||
155211597|NCT01320085|560212305|FG001|Overall Study|Disease Progression|93|||
155211598|NCT01320085|560212306|FG002|Overall Study|Disease Progression|17|||
155211599|NCT01320085|560212304|FG000|Overall Study|Adverse Event|12|||
155211600|NCT01320085|560212305|FG001|Overall Study|Adverse Event|20|||
155211601|NCT01320085|560212306|FG002|Overall Study|Adverse Event|5|||
155211602|NCT01320085|560212304|FG000|Overall Study|Withdrawal by Subject|2|||
155211603|NCT01320085|560212305|FG001|Overall Study|Withdrawal by Subject|4|||
155211604|NCT01320085|560212306|FG002|Overall Study|Withdrawal by Subject|1|||
155211605|NCT01320085|560212304|FG000|Overall Study|Protocol Deviation|1|||
155211606|NCT01320085|560212305|FG001|Overall Study|Protocol Deviation|0|||
155211607|NCT01320085|560212306|FG002|Overall Study|Protocol Deviation|1|||
155211608|NCT01320085|560212304|FG000|Overall Study|Administrative problems|0|||
155211609|NCT01320085|560212305|FG001|Overall Study|Administrative problems|0|||
155211610|NCT01320085|560212306|FG002|Overall Study|Administrative problems|1|||
155211611|NCT01409564|560212307|FG000|Overall Study|low medication compliance|4|||
155211612|NCT01409564|560212308|FG001|Overall Study|low medication compliance|3|||
155211613|NCT01409564|560212307|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
155211614|NCT01409564|560212308|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
155211615|NCT05040386|560212309|FG000|Overall Study|Withdrawal by Subject|1|||
155211616|NCT05040386|560212310|FG001|Overall Study|Withdrawal by Subject|0|||
155211617|NCT05040386|560212311|FG002|Overall Study|Withdrawal by Subject|1|||
155211618|NCT05040386|560212312|FG003|Overall Study|Withdrawal by Subject|0|||
155211619|NCT05040386|560212309|FG000|Overall Study|Lost to Follow-up|0|||
155211620|NCT05040386|560212310|FG001|Overall Study|Lost to Follow-up|0|||
155211621|NCT05040386|560212311|FG002|Overall Study|Lost to Follow-up|1|||
155211622|NCT05040386|560212312|FG003|Overall Study|Lost to Follow-up|0|||
155211623|NCT01702454|560212313|FG000|Overall Study|Consent withdrawal|0|||
155211624|NCT01702454|560212314|FG001|Overall Study|Consent withdrawal|1|||
155211625|NCT01702454|560212313|FG000|Overall Study|Migrated/moved from study area|0|||
155211626|NCT01702454|560212314|FG001|Overall Study|Migrated/moved from study area|1|||
155211627|NCT01702454|560212313|FG000|Overall Study|Lost to Follow-up|3|||
155211628|NCT01702454|560212314|FG001|Overall Study|Lost to Follow-up|6|||
155211629|NCT00710710|560212315|FG000|Overall Study|Consent withdrawn|2|||
155211630|NCT00710710|560212316|FG001|Overall Study|Consent withdrawn|2|||
155211631|NCT00710710|560212315|FG000|Overall Study|Protocol Violation|0|||
155211632|NCT00710710|560212316|FG001|Overall Study|Protocol Violation|1|||
155211633|NCT00710710|560212315|FG000|Overall Study|Adverse Event|3|||
155211634|NCT00710710|560212316|FG001|Overall Study|Adverse Event|3|||
155211635|NCT00710710|560212315|FG000|Overall Study|Progressive disease|40|||
155211636|NCT00710710|560212316|FG001|Overall Study|Progressive disease|38|||
155211637|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
155211638|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
155211639|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
155211640|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
155211641|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
155211642|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
155211643|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
155211644|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
155211645|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
155211646|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
155211647|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
155211648|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
155211649|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
155211650|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
155211651|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
155211652|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
155211653|NCT03510884|560212317|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
155211654|NCT03510884|560212318|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
155211655|NCT03510884|560212319|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
155211656|NCT03510884|560212320|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
155211657|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
155211658|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
155211659|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
155211660|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
155211661|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
155211662|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
155211663|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
155211664|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
155211665|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
155211666|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
155211667|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
155211668|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
155211669|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
155211670|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
155211671|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
155211672|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
155211673|NCT03510884|560212317|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
155211674|NCT03510884|560212318|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
155211675|NCT03510884|560212319|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
155211676|NCT03510884|560212320|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
155211677|NCT00715078|560212321|FG000|Overall Study|Death|29|||
155211678|NCT00715078|560212322|FG001|Overall Study|Death|36|||
155211679|NCT00715078|560212323|FG002|Overall Study|Death|36|||
155211680|NCT00715078|560212321|FG000|Overall Study|Withdrawal by Subject|1|||
155211681|NCT00715078|560212322|FG001|Overall Study|Withdrawal by Subject|0|||
155211682|NCT00715078|560212323|FG002|Overall Study|Withdrawal by Subject|1|||
155211683|NCT00715078|560212321|FG000|Overall Study|Unable to start due to disease prog.|0|||
155211684|NCT00715078|560212322|FG001|Overall Study|Unable to start due to disease prog.|0|||
155211685|NCT00715078|560212323|FG002|Overall Study|Unable to start due to disease prog.|1|||
155211686|NCT01313767|560212324|FG000|Overall Study|Adverse Event|1|||
155211687|NCT01313767|560212325|FG001|Overall Study|Adverse Event|0|||
155211688|NCT01313767|560212324|FG000|Overall Study|Lost to Follow-up|1|||
155211689|NCT01313767|560212325|FG001|Overall Study|Lost to Follow-up|0|||
155211690|NCT01313767|560212324|FG000|Overall Study|Withdrawal by Subject|2|||
155211691|NCT01313767|560212325|FG001|Overall Study|Withdrawal by Subject|1|||
155211692|NCT01313767|560212324|FG000|Overall Study|Protocol Violation|3|||
155211693|NCT01313767|560212325|FG001|Overall Study|Protocol Violation|1|||
155211694|NCT00157950|560212326|FG000|Overall Study|Death|1|||
155211695|NCT00157950|560212327|FG001|Overall Study|Death|0|||
155211696|NCT02673489|560212328|FG000|Treatment Period|Lost to Follow-up|3|||
155211697|NCT02673489|560212329|FG001|Treatment Period|Lost to Follow-up|0|||
155211698|NCT02673489|560212328|FG000|Treatment Period|Participant request to discontinue|1|||
155211699|NCT02673489|560212329|FG001|Treatment Period|Participant request to discontinue|1|||
155211700|NCT02673489|560212328|FG000|Treatment Period|Participant moved to another province|1|||
155211701|NCT02673489|560212329|FG001|Treatment Period|Participant moved to another province|0|||
155211702|NCT02673489|560212328|FG000|Treatment Period|Participant was incarcerated|0|||
155211703|NCT02673489|560212329|FG001|Treatment Period|Participant was incarcerated|1|||
155211704|NCT02673489|560212328|FG000|Treatment Period|Adverse Event|0|||
155211705|NCT02673489|560212329|FG001|Treatment Period|Adverse Event|1|||
155211706|NCT02673489|560212328|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
155211707|NCT02673489|560212329|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
155211708|NCT02673489|560212328|FG000|Follow Up Period|Unable to return for follow-up|0|||
155211709|NCT02673489|560212329|FG001|Follow Up Period|Unable to return for follow-up|1|||
155211710|NCT00759863|560212330|FG000|Overall Study|Death, moved, or lost contact|20|||
155211711|NCT00759863|560212331|FG001|Overall Study|Death, moved, or lost contact|18|||
155211712|NCT01988103|560212333|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
155211713|NCT01988103|560212334|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
155211714|NCT01988103|560212335|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
155211715|NCT01988103|560212336|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
155211716|NCT01988103|560212337|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
155211717|NCT01988103|560212333|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
155211718|NCT01988103|560212334|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
155211719|NCT01988103|560212335|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
155211720|NCT01988103|560212336|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
155211721|NCT01988103|560212337|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
155211722|NCT01988103|560212333|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
155211723|NCT01988103|560212334|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
155211724|NCT01988103|560212335|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
155211725|NCT01988103|560212336|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
155211726|NCT01988103|560212337|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
155211727|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
155211728|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
155211729|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
155211730|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
155211731|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
155211732|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
155211733|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
155211734|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
155211735|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
155211736|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
155211737|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
155211738|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
155211739|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
155211740|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
155211741|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
155211742|NCT01988103|560212333|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
155211743|NCT01988103|560212334|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
155211744|NCT01988103|560212335|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
155211745|NCT01988103|560212336|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
155211746|NCT01988103|560212337|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
155211747|NCT02506153|560212338|FG000|Overall Study|Adverse Event|359|||
155211748|NCT02506153|560212339|FG001|Overall Study|Adverse Event|114|||
155211749|NCT02506153|560212338|FG000|Overall Study|Refused unrelated to adverse event|127|||
155211750|NCT02506153|560212339|FG001|Overall Study|Refused unrelated to adverse event|18|||
155211751|NCT02506153|560212338|FG000|Overall Study|Progression/relapse|91|||
155211752|NCT02506153|560212339|FG001|Overall Study|Progression/relapse|136|||
155211753|NCT02506153|560212338|FG000|Overall Study|Death|2|||
155211754|NCT02506153|560212339|FG001|Overall Study|Death|1|||
155211755|NCT02506153|560212338|FG000|Overall Study|Other - not protocol specified|23|||
155211756|NCT02506153|560212339|FG001|Overall Study|Other - not protocol specified|12|||
155211757|NCT00311623|560212342|FG000|Overall Study|Physician Decision|0|||
155211758|NCT00311623|560212343|FG001|Overall Study|Physician Decision|0|||
155211759|NCT00311623|560212344|FG002|Overall Study|Physician Decision|2|||
155211760|NCT03103919|560212345|FG000|Overall Study|Adverse Event|2|||
155211761|NCT03103919|560212346|FG001|Overall Study|Adverse Event|2|||
155211762|NCT03998189|560212347|FG000|Overall Study|Lack of Efficacy|0|||
155211763|NCT03998189|560212348|FG001|Overall Study|Lack of Efficacy|1|||
155211764|NCT01402544|560212349|FG000|Overall Study|Withdrawal by Subject|6|||
155211765|NCT04876274|560212352|FG000|Overall Study|Lost to Follow-up|9|||
155211766|NCT04876274|560212353|FG001|Overall Study|Lost to Follow-up|12|||
155211767|NCT03454893|560212354|FG000|Overall Study|Study Terminated by the Sponsor|5|||
155211768|NCT03454893|560212354|FG000|Overall Study|Did not pass screening|4|||
155211769|NCT01986985|560212355|FG000|Overall Study|Withdrawal by Subject|4|||
155211770|NCT01986985|560212355|FG000|Overall Study|Scan not completed due to malfunction|3|||
155211771|NCT01083576|560212356|FG000|Overall Study|Treatment Failure|6|||
155211772|NCT01083576|560212357|FG001|Overall Study|Treatment Failure|1|||
155211773|NCT03527966|560212358|FG000|Overall Study|Lost to Follow-up|3|||
155211774|NCT03527966|560212359|FG001|Overall Study|Lost to Follow-up|0|||
155211775|NCT01948050|560212360|FG000|Overall Study|Withdrawal by Subject|0|||
155211776|NCT01948050|560212361|FG001|Overall Study|Withdrawal by Subject|1|||
155211777|NCT02005445|560212362|FG000|Overall Study|Dual study enrollment|0|||
155211778|NCT02005445|560212363|FG001|Overall Study|Dual study enrollment|1|||
155211779|NCT00333866|560212366|FG000|Overall Study|Adverse Event|23|||
155211780|NCT00333866|560212367|FG001|Overall Study|Adverse Event|37|||
155211781|NCT00333866|560212368|FG002|Overall Study|Adverse Event|38|||
155211782|NCT00333866|560212369|FG003|Overall Study|Adverse Event|47|||
155211783|NCT00333866|560212366|FG000|Overall Study|Other|3|||
155211784|NCT00333866|560212367|FG001|Overall Study|Other|2|||
155211785|NCT00333866|560212368|FG002|Overall Study|Other|2|||
155211786|NCT00333866|560212369|FG003|Overall Study|Other|2|||
155211787|NCT00333866|560212366|FG000|Overall Study|Lack of Efficacy|8|||
155211788|NCT00333866|560212367|FG001|Overall Study|Lack of Efficacy|6|||
155211789|NCT00333866|560212368|FG002|Overall Study|Lack of Efficacy|3|||
155211790|NCT00333866|560212369|FG003|Overall Study|Lack of Efficacy|5|||
155211791|NCT00333866|560212366|FG000|Overall Study|Lost to Follow-up|1|||
155211792|NCT00333866|560212367|FG001|Overall Study|Lost to Follow-up|2|||
155211793|NCT00333866|560212368|FG002|Overall Study|Lost to Follow-up|2|||
155211794|NCT00333866|560212369|FG003|Overall Study|Lost to Follow-up|2|||
155211795|NCT00333866|560212366|FG000|Overall Study|Withdrawal by Subject|8|||
155211796|NCT00333866|560212367|FG001|Overall Study|Withdrawal by Subject|14|||
155211797|NCT00333866|560212368|FG002|Overall Study|Withdrawal by Subject|4|||
155211798|NCT00333866|560212369|FG003|Overall Study|Withdrawal by Subject|9|||
155211799|NCT00333866|560212366|FG000|Overall Study|Randomized but not Treated|5|||
155211800|NCT00333866|560212367|FG001|Overall Study|Randomized but not Treated|3|||
155211801|NCT00333866|560212368|FG002|Overall Study|Randomized but not Treated|2|||
155211802|NCT00333866|560212369|FG003|Overall Study|Randomized but not Treated|1|||
155211803|NCT06073119|560212370|FG000|Overall Study|Adverse Event|1|||
155211804|NCT06073119|560212371|FG001|Overall Study|Adverse Event|3|||
155211805|NCT06073119|560212372|FG002|Overall Study|Adverse Event|0|||
155211806|NCT06073119|560212373|FG003|Overall Study|Adverse Event|0|||
155211807|NCT06073119|560212374|FG004|Overall Study|Adverse Event|1|||
155211808|NCT06073119|560212375|FG005|Overall Study|Adverse Event|0|||
155211809|NCT06073119|560212370|FG000|Overall Study|Non-compliance with study schedule|1|||
155211810|NCT06073119|560212371|FG001|Overall Study|Non-compliance with study schedule|0|||
155211811|NCT06073119|560212372|FG002|Overall Study|Non-compliance with study schedule|0|||
155211812|NCT06073119|560212373|FG003|Overall Study|Non-compliance with study schedule|0|||
155211813|NCT06073119|560212374|FG004|Overall Study|Non-compliance with study schedule|1|||
155211814|NCT06073119|560212375|FG005|Overall Study|Non-compliance with study schedule|0|||
155211815|NCT06073119|560212370|FG000|Overall Study|Withdrawal by Subject|4|||
155211816|NCT06073119|560212371|FG001|Overall Study|Withdrawal by Subject|4|||
155211817|NCT06073119|560212372|FG002|Overall Study|Withdrawal by Subject|3|||
155211818|NCT06073119|560212373|FG003|Overall Study|Withdrawal by Subject|5|||
155211819|NCT06073119|560212374|FG004|Overall Study|Withdrawal by Subject|3|||
155211820|NCT06073119|560212375|FG005|Overall Study|Withdrawal by Subject|1|||
155211821|NCT06073119|560212370|FG000|Overall Study|Other|2|||
155211822|NCT06073119|560212371|FG001|Overall Study|Other|4|||
155211823|NCT06073119|560212372|FG002|Overall Study|Other|1|||
155211824|NCT06073119|560212373|FG003|Overall Study|Other|0|||
155211825|NCT06073119|560212374|FG004|Overall Study|Other|1|||
155211826|NCT06073119|560212375|FG005|Overall Study|Other|0|||
155211827|NCT05185089|560212376|FG000|First Intervention (4 weeks)|Adverse Event|0|||
155211828|NCT05185089|560212377|FG001|First Intervention (4 weeks)|Adverse Event|0|||
155211829|NCT05185089|560212378|FG002|First Intervention (4 weeks)|Adverse Event|0|||
155211830|NCT05185089|560212379|FG003|First Intervention (4 weeks)|Adverse Event|1|||
155211831|NCT05185089|560212376|FG000|Second Intervention (4 weeks)|Death|0|||
155211832|NCT05185089|560212377|FG001|Second Intervention (4 weeks)|Death|1|||
155211833|NCT05185089|560212378|FG002|Second Intervention (4 weeks)|Death|0|||
155211834|NCT05185089|560212379|FG003|Second Intervention (4 weeks)|Death|0|||
155211835|NCT05185089|560212376|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
155211836|NCT05185089|560212377|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
155211837|NCT05185089|560212378|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
155211838|NCT05185089|560212379|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
155211839|NCT04997161|560212380|FG000|Overall Study|Study terminated by sponsor|3|||
155211840|NCT00667368|560212381|FG000|Overall Study|Lost to Follow-up|176|||
155211841|NCT00667368|560212382|FG001|Overall Study|Lost to Follow-up|155|||
155211842|NCT00667368|560212381|FG000|Overall Study|Discontinued early|24|||
155211843|NCT00667368|560212382|FG001|Overall Study|Discontinued early|17|||
155211844|NCT02730455|560212383|FG000|Overall Study|Death|5|||
155211845|NCT02730455|560212384|FG001|Overall Study|Death|6|||
155211846|NCT02730455|560212385|FG002|Overall Study|Death|4|||
155211847|NCT02730455|560212383|FG000|Overall Study|Consent withdrawn|2|||
155211848|NCT02730455|560212384|FG001|Overall Study|Consent withdrawn|4|||
155211849|NCT02730455|560212385|FG002|Overall Study|Consent withdrawn|1|||
155211850|NCT02730455|560212383|FG000|Overall Study|Lost to Follow-up|3|||
155211851|NCT02730455|560212384|FG001|Overall Study|Lost to Follow-up|1|||
155211852|NCT02730455|560212385|FG002|Overall Study|Lost to Follow-up|4|||
155211853|NCT02730455|560212383|FG000|Overall Study|Other|1|||
155211854|NCT02730455|560212384|FG001|Overall Study|Other|1|||
155211855|NCT02730455|560212385|FG002|Overall Study|Other|2|||
155211856|NCT02730455|560212383|FG000|Overall Study|Other|2|||
155211857|NCT02730455|560212384|FG001|Overall Study|Other|2|||
155211858|NCT02730455|560212385|FG002|Overall Study|Other|0|||
155211859|NCT02733367|560212386|FG000|Overall Study|Withdrawal by Subject|6|||
155211860|NCT01348347|560212387|FG000|Overall Study|Withdrawal by Subject|1|||
155211861|NCT01348347|560212388|FG001|Overall Study|Withdrawal by Subject|1|||
155211862|NCT01348347|560212389|FG002|Overall Study|Withdrawal by Subject|1|||
155211863|NCT01348347|560212387|FG000|Overall Study|Progressive disease|2|||
155211864|NCT01348347|560212388|FG001|Overall Study|Progressive disease|5|||
155211865|NCT01348347|560212389|FG002|Overall Study|Progressive disease|5|||
155211866|NCT03049280|560212396|FG000|Overall Study|Physician Decision|1|||
155211867|NCT00996307|560212397|FG000|Overall Study|Adverse Event|0|||
155211868|NCT00996307|560212398|FG001|Overall Study|Adverse Event|1|||
155211869|NCT00996307|560212399|FG002|Overall Study|Adverse Event|0|||
155211870|NCT00996307|560212400|FG003|Overall Study|Adverse Event|0|||
155211871|NCT00996307|560212397|FG000|Overall Study|Withdrawal by Subject|3|||
155211872|NCT00996307|560212398|FG001|Overall Study|Withdrawal by Subject|2|||
155211873|NCT00996307|560212399|FG002|Overall Study|Withdrawal by Subject|5|||
155211874|NCT00996307|560212400|FG003|Overall Study|Withdrawal by Subject|5|||
155211875|NCT00996307|560212397|FG000|Overall Study|Lost to Follow-up|13|||
155211876|NCT00996307|560212398|FG001|Overall Study|Lost to Follow-up|13|||
155211877|NCT00996307|560212399|FG002|Overall Study|Lost to Follow-up|7|||
155211878|NCT00996307|560212400|FG003|Overall Study|Lost to Follow-up|15|||
155211879|NCT00996307|560212397|FG000|Overall Study|Administrative reason|0|||
155211880|NCT00996307|560212398|FG001|Overall Study|Administrative reason|1|||
155211881|NCT00996307|560212399|FG002|Overall Study|Administrative reason|0|||
155211882|NCT00996307|560212400|FG003|Overall Study|Administrative reason|0|||
155211883|NCT00996307|560212397|FG000|Overall Study|Unable to classify|4|||
155211884|NCT00996307|560212398|FG001|Overall Study|Unable to classify|0|||
155211885|NCT00996307|560212399|FG002|Overall Study|Unable to classify|2|||
155211886|NCT00996307|560212400|FG003|Overall Study|Unable to classify|1|||
155211887|NCT00001723|560212401|FG000|Overall Study|Lack of Efficacy|6|||
155211888|NCT00001723|560212402|FG001|Overall Study|Lack of Efficacy|7|||
155211889|NCT00001723|560212401|FG000|Overall Study|Lack of family interest|4|||
155211890|NCT00001723|560212402|FG001|Overall Study|Lack of family interest|5|||
155211891|NCT00001723|560212401|FG000|Overall Study|Lost to Follow-up|2|||
155211892|NCT00001723|560212402|FG001|Overall Study|Lost to Follow-up|2|||
155211893|NCT00001723|560212401|FG000|Overall Study|medication intolerance|1|||
155211894|NCT00001723|560212402|FG001|Overall Study|medication intolerance|2|||
155211895|NCT01867021|560212403|FG000|Overall Study|Adverse Event|0|||
155211896|NCT01867021|560212404|FG001|Overall Study|Adverse Event|1|||
155211897|NCT01867021|560212403|FG000|Overall Study|Not Eligible|0|||
155211898|NCT01867021|560212404|FG001|Overall Study|Not Eligible|1|||
155211899|NCT01867021|560212403|FG000|Overall Study|Death|1|||
155211900|NCT01867021|560212404|FG001|Overall Study|Death|0|||
155211901|NCT01867021|560212403|FG000|Overall Study|Lost to Follow-up|0|||
155211902|NCT01867021|560212404|FG001|Overall Study|Lost to Follow-up|2|||
155211903|NCT01867021|560212403|FG000|Overall Study|Withdrawal by Subject|1|||
155211904|NCT01867021|560212404|FG001|Overall Study|Withdrawal by Subject|6|||
155211905|NCT00640601|560212405|FG000|Overall Study|Adverse Event|43|||
155211906|NCT00640601|560212405|FG000|Overall Study|Withdrawal by Subject|20|||
155211907|NCT00640601|560212405|FG000|Overall Study|Protocol Violation|6|||
155211908|NCT00640601|560212405|FG000|Overall Study|Lack of Efficacy|16|||
155211909|NCT00640601|560212405|FG000|Overall Study|Lost to Follow-up|9|||
155211910|NCT00640601|560212405|FG000|Overall Study|Physician Decision|8|||
155211911|NCT00640601|560212405|FG000|Overall Study|treatment naive, combination therapy|10|||
155211912|NCT01862874|560212406|FG000|Overall Study|Randomized not treated|1|||
155211913|NCT01862874|560212407|FG001|Overall Study|Randomized not treated|0|||
155211914|NCT01862874|560212406|FG000|Overall Study|Adverse Event|0|||
155211915|NCT01862874|560212407|FG001|Overall Study|Adverse Event|3|||
155211916|NCT01862874|560212406|FG000|Overall Study|Lost to Follow-up|26|||
155211917|NCT01862874|560212407|FG001|Overall Study|Lost to Follow-up|29|||
155211918|NCT01862874|560212406|FG000|Overall Study|Physician Decision|5|||
155211919|NCT01862874|560212407|FG001|Overall Study|Physician Decision|3|||
155211920|NCT01862874|560212406|FG000|Overall Study|Withdrawn by parent/guardian|1|||
155211921|NCT01862874|560212407|FG001|Overall Study|Withdrawn by parent/guardian|1|||
155211922|NCT01862874|560212406|FG000|Overall Study|Withdrawal by Subject|46|||
155211923|NCT01862874|560212407|FG001|Overall Study|Withdrawal by Subject|40|||
155211924|NCT01862874|560212406|FG000|Overall Study|Death|0|||
155211925|NCT01862874|560212407|FG001|Overall Study|Death|1|||
155211926|NCT03198234|560212408|FG000|Overall Study|Relapse of primary disease|0|||
155211927|NCT03198234|560212409|FG001|Overall Study|Relapse of primary disease|1|||
155211928|NCT03198234|560212410|FG002|Overall Study|Relapse of primary disease|0|||
155211929|NCT04285879|560212411|FG000|Overall Study|Lost to Follow-up|1|||
155211930|NCT04285879|560212412|FG001|Overall Study|Lost to Follow-up|8|||
155211931|NCT04285879|560212411|FG000|Overall Study|medical/surgical exclusion|16|||
155211932|NCT04285879|560212412|FG001|Overall Study|medical/surgical exclusion|0|||
155211933|NCT03228537|560212415|FG000|Neoadjuvant|Adverse Event|2|||
155211934|NCT03228537|560212415|FG000|Neoadjuvant|Progression/Relapse|4|||
155211935|NCT03228537|560212415|FG000|Neoadjuvant|Death|1|||
155211936|NCT03228537|560212415|FG000|Surgery|Death|1|||
155211937|NCT03228537|560212415|FG000|Surgery|Other - Not Protocol Specified|2|||
155211938|NCT03228537|560212415|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
155211939|NCT03228537|560212415|FG000|Maintenance|Progression/Relapse|10|||
155211940|NCT01927367|560212416|FG000|Overall Study|Withdrawal by Subject|7|||
155211941|NCT01927367|560212417|FG001|Overall Study|Withdrawal by Subject|4|||
155211942|NCT01927367|560212416|FG000|Overall Study|No baseline data|0|||
155211943|NCT01927367|560212417|FG001|Overall Study|No baseline data|1|||
155211944|NCT02622321|560212418|FG000|Overall Study|Withdrawal by Subject|2|||
155211945|NCT02622321|560212419|FG001|Overall Study|Withdrawal by Subject|0|||
155211946|NCT02622321|560212420|FG002|Overall Study|Withdrawal by Subject|0|||
155211947|NCT02622321|560212421|FG003|Overall Study|Withdrawal by Subject|0|||
155211948|NCT02622321|560212418|FG000|Overall Study|Death|0|||
155211949|NCT02622321|560212419|FG001|Overall Study|Death|0|||
155211950|NCT02622321|560212420|FG002|Overall Study|Death|1|||
155211951|NCT02622321|560212421|FG003|Overall Study|Death|0|||
155211952|NCT02622321|560212418|FG000|Overall Study|Physician Decision|1|||
155211953|NCT02622321|560212419|FG001|Overall Study|Physician Decision|0|||
155211954|NCT02622321|560212420|FG002|Overall Study|Physician Decision|0|||
155211955|NCT02622321|560212421|FG003|Overall Study|Physician Decision|0|||
155211956|NCT00241280|560212424|FG000|Overall Study|Adverse Event|2|||
155211957|NCT00241280|560212425|FG001|Overall Study|Adverse Event|6|||
155211958|NCT00241280|560212424|FG000|Overall Study|Discomfort|11|||
155211959|NCT00241280|560212425|FG001|Overall Study|Discomfort|16|||
155211960|NCT00241280|560212424|FG000|Overall Study|Pregnancy|1|||
155211961|NCT00241280|560212425|FG001|Overall Study|Pregnancy|5|||
155211962|NCT00241280|560212424|FG000|Overall Study|Lost to Follow-up|5|||
155211963|NCT00241280|560212425|FG001|Overall Study|Lost to Follow-up|8|||
155211964|NCT00241280|560212424|FG000|Overall Study|Withdrawal by Subject|7|||
155211965|NCT00241280|560212425|FG001|Overall Study|Withdrawal by Subject|4|||
155211966|NCT00241280|560212424|FG000|Overall Study|Protocol Violation|4|||
155211967|NCT00241280|560212425|FG001|Overall Study|Protocol Violation|10|||
155211968|NCT00241280|560212424|FG000|Overall Study|Relocation|4|||
155211969|NCT00241280|560212425|FG001|Overall Study|Relocation|4|||
155211970|NCT00241280|560212424|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
155211971|NCT00241280|560212425|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
155211972|NCT00241280|560212424|FG000|Overall Study|Unsatisfactory Visual Response|1|||
155211973|NCT00241280|560212425|FG001|Overall Study|Unsatisfactory Visual Response|1|||
155211974|NCT00241280|560212424|FG000|Overall Study|Diabetic|1|||
155211975|NCT00241280|560212425|FG001|Overall Study|Diabetic|0|||
155211976|NCT00241280|560212424|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
155211977|NCT00241280|560212425|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
155211978|NCT00241280|560212424|FG000|Overall Study|Dispensed incorrect test article|1|||
155211979|NCT00241280|560212425|FG001|Overall Study|Dispensed incorrect test article|2|||
155211980|NCT00241280|560212424|FG000|Overall Study|Unacceptable Fit|0|||
155211981|NCT00241280|560212425|FG001|Overall Study|Unacceptable Fit|1|||
155211982|NCT00241280|560212424|FG000|Overall Study|Scheduling Conflict|0|||
155211983|NCT00241280|560212425|FG001|Overall Study|Scheduling Conflict|2|||
155211984|NCT00241280|560212424|FG000|Overall Study|History of Ocular Surgery|0|||
155211985|NCT00241280|560212425|FG001|Overall Study|History of Ocular Surgery|1|||
155211986|NCT00241280|560212424|FG000|Overall Study|Coating on Lens|1|||
155211987|NCT00241280|560212425|FG001|Overall Study|Coating on Lens|0|||
155211988|NCT00241280|560212424|FG000|Overall Study|Excessive Dryness|0|||
155211989|NCT00241280|560212425|FG001|Overall Study|Excessive Dryness|1|||
155211990|NCT00965718|560212426|FG000|Overall Study|Withdrawal by Subject|4|||
155211991|NCT01414855|560212428|FG000|Overall Study|Death|17|||
155211992|NCT01414855|560212428|FG000|Overall Study|Lost to Follow-up|5|||
155211993|NCT01414855|560212428|FG000|Overall Study|Withdrawal by Subject|7|||
155211994|NCT01572909|560214212|FG000|Overall Study|Adverse Event|7|||
155211995|NCT01572909|560214213|FG001|Overall Study|Adverse Event|2|||
155211996|NCT01572909|560214212|FG000|Overall Study|Death|3|||
155211997|NCT01572909|560214213|FG001|Overall Study|Death|1|||
155211998|NCT01572909|560214212|FG000|Overall Study|Lost to Follow-up|8|||
155211999|NCT01572909|560214213|FG001|Overall Study|Lost to Follow-up|7|||
155212000|NCT01572909|560214212|FG000|Overall Study|Physician Decision|1|||
155212001|NCT01572909|560214213|FG001|Overall Study|Physician Decision|1|||
155212002|NCT01572909|560214212|FG000|Overall Study|Technical Issues|1|||
155212003|NCT01572909|560214213|FG001|Overall Study|Technical Issues|0|||
155212004|NCT01572909|560214212|FG000|Overall Study|Withdrawal by Subject|12|||
155212005|NCT01572909|560214213|FG001|Overall Study|Withdrawal by Subject|11|||
155212006|NCT01572909|560214212|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
155212007|NCT01572909|560214213|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
155212008|NCT04779489|560214214|FG000|Overall Study|Physician Decision|1|||
155212009|NCT02723084|560214216|FG000|Overall Study|Withdrawal by Subject|1|||
155212010|NCT02723084|560214217|FG001|Overall Study|Withdrawal by Subject|1|||
155212011|NCT02723084|560214216|FG000|Overall Study|Lost to Follow-up|3|||
155212012|NCT02723084|560214217|FG001|Overall Study|Lost to Follow-up|0|||
155212013|NCT05024058|560214220|FG000|Treatment|Study terminated by sponsor|5|||
155212014|NCT05024058|560214221|FG001|Treatment|Study terminated by sponsor|6|||
155212015|NCT05024058|560214222|FG002|Treatment|Study terminated by sponsor|4|||
155212016|NCT05024058|560214223|FG003|Treatment|Study terminated by sponsor|2|||
155212017|NCT05024058|560214224|FG004|Treatment|Study terminated by sponsor|3|||
155212018|NCT05024058|560214225|FG005|Treatment|Study terminated by sponsor|3|||
155212019|NCT05024058|560214226|FG006|Treatment|Study terminated by sponsor|1|||
155212020|NCT05024058|560214227|FG007|Treatment|Study terminated by sponsor|3|||
155212021|NCT05024058|560214228|FG008|Treatment|Study terminated by sponsor|6|||
155212022|NCT05024058|560214229|FG009|Treatment|Study terminated by sponsor|6|||
155212023|NCT05024058|560214220|FG000|Follow-up|Withdrawal by Subject|1|||
155212024|NCT05024058|560214221|FG001|Follow-up|Withdrawal by Subject|0|||
155212025|NCT05024058|560214222|FG002|Follow-up|Withdrawal by Subject|1|||
155212026|NCT05024058|560214223|FG003|Follow-up|Withdrawal by Subject|0|||
155212027|NCT05024058|560214224|FG004|Follow-up|Withdrawal by Subject|0|||
155212028|NCT05024058|560214225|FG005|Follow-up|Withdrawal by Subject|0|||
155212029|NCT05024058|560214226|FG006|Follow-up|Withdrawal by Subject|0|||
155212030|NCT05024058|560214227|FG007|Follow-up|Withdrawal by Subject|1|||
155212031|NCT05024058|560214228|FG008|Follow-up|Withdrawal by Subject|0|||
155212032|NCT05024058|560214229|FG009|Follow-up|Withdrawal by Subject|1|||
155212033|NCT03055260|560214233|FG000|Overall Study|Withdrawal by Subject|1|||
155212034|NCT03055260|560214234|FG001|Overall Study|Withdrawal by Subject|0|||
155212035|NCT00931762|560214235|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
155212036|NCT00931762|560214235|FG000|Overall Study|Administrative Problems|5|||
155212037|NCT00931762|560214235|FG000|Overall Study|Death|1|||
155212038|NCT00931762|560214235|FG000|Overall Study|Disease Progression|3|||
155212039|NCT00931762|560214235|FG000|Overall Study|Adverse Event (s)|11|||
155212040|NCT00931762|560214235|FG000|Overall Study|Subject withdrew consent|13|||
155212041|NCT00225251|560214238|FG000|Overall Study|Withdrawal by Subject|1|||
155212042|NCT00225251|560214239|FG001|Overall Study|Withdrawal by Subject|1|||
155212043|NCT02664441|560214240|FG000|Randomization|Withdrawal by Subject|0|||
155212044|NCT02664441|560214241|FG001|Randomization|Withdrawal by Subject|1|||
155212045|NCT02664441|560214240|FG000|36-week Randomized Trial|Adverse Event|2|||
155212046|NCT02664441|560214241|FG001|36-week Randomized Trial|Adverse Event|0|||
155212047|NCT02664441|560214240|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
155212048|NCT02664441|560214241|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
155212049|NCT02664441|560214240|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
155212050|NCT02664441|560214241|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
155212051|NCT02664441|560214240|FG000|18-week Open Label Extension|Adverse Event|1|||
155212052|NCT02664441|560214241|FG001|18-week Open Label Extension|Adverse Event|0|||
155212053|NCT02664441|560214240|FG000|18-week Open Label Extension|Physician Decision|1|||
155212054|NCT02664441|560214241|FG001|18-week Open Label Extension|Physician Decision|0|||
155212055|NCT02664441|560214240|FG000|18-week Open Label Extension|Death|1|||
155212056|NCT02664441|560214241|FG001|18-week Open Label Extension|Death|0|||
155212057|NCT02664441|560214240|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
155212058|NCT02664441|560214241|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
155212059|NCT01529346|560214246|FG000|Overall Study|Lost to Follow-up|2|||
155212060|NCT01529346|560214247|FG001|Overall Study|Lost to Follow-up|0|||
155212061|NCT01529346|560214248|FG002|Overall Study|Lost to Follow-up|1|||
155212062|NCT01529346|560214249|FG003|Overall Study|Lost to Follow-up|0|||
155212063|NCT01529346|560214250|FG004|Overall Study|Lost to Follow-up|0|||
155212064|NCT01529346|560214246|FG000|Overall Study|Other|0|||
155212065|NCT01529346|560214247|FG001|Overall Study|Other|1|||
155212066|NCT01529346|560214248|FG002|Overall Study|Other|1|||
155212067|NCT01529346|560214249|FG003|Overall Study|Other|0|||
155212068|NCT01529346|560214250|FG004|Overall Study|Other|0|||
155212069|NCT02892760|560214251|FG000|Overall Study|Withdrawal by Subject|3|||
155212070|NCT00386776|560214258|FG000|Overall Study|Withdrawal by Subject|8|||
155212071|NCT00588848|560214259|FG000|Overall Study|Physician Decision|0|||
155212072|NCT00588848|560214260|FG001|Overall Study|Physician Decision|3|||
155212073|NCT00082355|560214261|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
155212074|NCT00082355|560214261|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
155212075|NCT00082355|560214261|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
155212076|NCT02335489|560214262|FG000|Overall Study|Sponsor terminated study|4|||
155212077|NCT02335489|560214262|FG000|Overall Study|Lost to Follow-up|1|||
155212078|NCT02335489|560214262|FG000|Overall Study|Withdrawal by Subject|2|||
155212079|NCT02335489|560214262|FG000|Overall Study|Physician Decision|2|||
155212080|NCT02335489|560214262|FG000|Overall Study|Lack of Efficacy|1|||
155212081|NCT00412854|560214269|FG000|Overall Study|Withdrawn due to adverse events|1|||
155212082|NCT00412854|560214270|FG001|Overall Study|Withdrawn due to adverse events|5|||
155212083|NCT00412854|560214269|FG000|Overall Study|Withdrawn for other reasons|13|||
155212084|NCT00412854|560214270|FG001|Overall Study|Withdrawn for other reasons|11|||
155212085|NCT00531050|560214272|FG000|Part 1: Period 1|Adverse Event|0|||
155212086|NCT00531050|560214273|FG001|Part 1: Period 1|Adverse Event|1|||
155212087|NCT00531050|560214274|FG002|Part 1: Period 1|Adverse Event|0|||
155212088|NCT00531050|560214275|FG003|Part 1: Period 1|Adverse Event|0|||
155212089|NCT00531050|560214276|FG004|Part 1: Period 1|Adverse Event|0|||
155212090|NCT00531050|560214277|FG005|Part 1: Period 1|Adverse Event|0|||
155212091|NCT00531050|560214272|FG000|Part 1: Period 1|Protocol Deviation|0|||
155212092|NCT00531050|560214273|FG001|Part 1: Period 1|Protocol Deviation|0|||
155212093|NCT00531050|560214274|FG002|Part 1: Period 1|Protocol Deviation|0|||
155212094|NCT00531050|560214275|FG003|Part 1: Period 1|Protocol Deviation|1|||
155212095|NCT00531050|560214276|FG004|Part 1: Period 1|Protocol Deviation|0|||
155212096|NCT00531050|560214277|FG005|Part 1: Period 1|Protocol Deviation|0|||
155212097|NCT00531050|560214272|FG000|Part 1: Period 3|Adverse Event|1|||
155212098|NCT00531050|560214273|FG001|Part 1: Period 3|Adverse Event|0|||
155212099|NCT00531050|560214274|FG002|Part 1: Period 3|Adverse Event|0|||
155212100|NCT00531050|560214275|FG003|Part 1: Period 3|Adverse Event|0|||
155212101|NCT00531050|560214276|FG004|Part 1: Period 3|Adverse Event|0|||
155212102|NCT00531050|560214277|FG005|Part 1: Period 3|Adverse Event|0|||
155212103|NCT00531050|560214272|FG000|Part 2: Period 1|Adverse Event|0|||
155212104|NCT00531050|560214273|FG001|Part 2: Period 1|Adverse Event|0|||
155212105|NCT00531050|560214274|FG002|Part 2: Period 1|Adverse Event|0|||
155212106|NCT00531050|560214275|FG003|Part 2: Period 1|Adverse Event|0|||
155212107|NCT00531050|560214276|FG004|Part 2: Period 1|Adverse Event|0|||
155212108|NCT00531050|560214277|FG005|Part 2: Period 1|Adverse Event|1|||
155212109|NCT00531050|560214272|FG000|Part 2: Period 3|Abnormal test procedure|1|||
155212110|NCT00531050|560214273|FG001|Part 2: Period 3|Abnormal test procedure|0|||
155212111|NCT00531050|560214274|FG002|Part 2: Period 3|Abnormal test procedure|0|||
155212112|NCT00531050|560214275|FG003|Part 2: Period 3|Abnormal test procedure|0|||
155212113|NCT00531050|560214276|FG004|Part 2: Period 3|Abnormal test procedure|0|||
155212114|NCT00531050|560214277|FG005|Part 2: Period 3|Abnormal test procedure|1|||
155212115|NCT02233309|560214279|FG000|Overall Study|Physician Decision|5|||
155212116|NCT00799487|560214284|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
155212117|NCT00799487|560214285|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
155212118|NCT00799487|560214286|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
155212119|NCT00799487|560214284|FG000|Dose Adjustment Period|Adverse Event|2|||
155212120|NCT00799487|560214285|FG001|Dose Adjustment Period|Adverse Event|0|||
155212121|NCT00799487|560214286|FG002|Dose Adjustment Period|Adverse Event|0|||
155212122|NCT00799487|560214284|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
155212123|NCT00799487|560214285|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
155212124|NCT00799487|560214286|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
155212125|NCT00799487|560214284|FG000|Dose Adjustment Period|Investigator Discretion|2|||
155212126|NCT00799487|560214285|FG001|Dose Adjustment Period|Investigator Discretion|0|||
155212127|NCT00799487|560214286|FG002|Dose Adjustment Period|Investigator Discretion|0|||
155212128|NCT00799487|560214284|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
155212129|NCT00799487|560214285|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
155212130|NCT00799487|560214286|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
155212131|NCT00799487|560214284|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
155212132|NCT00799487|560214285|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
155212133|NCT00799487|560214286|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
155212134|NCT00799487|560214284|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
155212135|NCT00799487|560214285|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
155212136|NCT00799487|560214286|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
155212137|NCT00799487|560214284|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
155212138|NCT00799487|560214285|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
155212139|NCT00799487|560214286|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
155212140|NCT00799487|560214284|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
155212141|NCT00799487|560214285|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
155212142|NCT00799487|560214286|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
155212143|NCT00799487|560214284|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
155212144|NCT00799487|560214285|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
155212145|NCT00799487|560214286|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
155212146|NCT00799487|560214284|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
155212147|NCT00799487|560214285|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
155212148|NCT00799487|560214286|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
155212149|NCT00799487|560214284|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
155212150|NCT00799487|560214285|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
155212151|NCT00799487|560214286|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
155212152|NCT00232817|560214287|FG000|Overall Study|Protocol Violation|2|||
155212153|NCT00232817|560214288|FG001|Overall Study|Protocol Violation|1|||
155212154|NCT01484873|560214289|FG000|Overall Study|Withdrawal by Subject|2|||
155212155|NCT01549392|560214290|FG000|Overall Study|Withdrawal by Subject|1|||
155212156|NCT01549392|560214291|FG001|Overall Study|Withdrawal by Subject|0|||
155212157|NCT00227903|560214292|FG000|Overall Study|Withdrawal by Subject|2|||
155212158|NCT00227903|560214293|FG001|Overall Study|Withdrawal by Subject|5|||
155212159|NCT00227903|560214292|FG000|Overall Study|Subject moved out of area|1|||
155212160|NCT00227903|560214293|FG001|Overall Study|Subject moved out of area|2|||
155212161|NCT00227903|560214292|FG000|Overall Study|Lost to Follow-up|1|||
155212162|NCT00227903|560214293|FG001|Overall Study|Lost to Follow-up|3|||
155212163|NCT00227903|560214292|FG000|Overall Study|Miscarriage|1|||
155212164|NCT00227903|560214293|FG001|Overall Study|Miscarriage|0|||
155212165|NCT04273217|560214294|FG000|Overall Study|Lost to Follow-up|0|||
155212166|NCT04273217|560214295|FG001|Overall Study|Lost to Follow-up|0|||
155212167|NCT04273217|560214296|FG002|Overall Study|Lost to Follow-up|0|||
155212168|NCT04273217|560214297|FG003|Overall Study|Lost to Follow-up|0|||
155212169|NCT04273217|560214298|FG004|Overall Study|Lost to Follow-up|0|||
155212170|NCT04273217|560214299|FG005|Overall Study|Lost to Follow-up|1|||
155212171|NCT04273217|560214294|FG000|Overall Study|Participant non-compliance|0|||
155212172|NCT04273217|560214295|FG001|Overall Study|Participant non-compliance|0|||
155212173|NCT04273217|560214296|FG002|Overall Study|Participant non-compliance|0|||
155212174|NCT04273217|560214297|FG003|Overall Study|Participant non-compliance|0|||
155212175|NCT04273217|560214298|FG004|Overall Study|Participant non-compliance|1|||
155212176|NCT04273217|560214299|FG005|Overall Study|Participant non-compliance|0|||
155212177|NCT04273217|560214294|FG000|Overall Study|Positive urine drug screen|1|||
155212178|NCT04273217|560214295|FG001|Overall Study|Positive urine drug screen|0|||
155212179|NCT04273217|560214296|FG002|Overall Study|Positive urine drug screen|1|||
155212180|NCT04273217|560214297|FG003|Overall Study|Positive urine drug screen|0|||
155212181|NCT04273217|560214298|FG004|Overall Study|Positive urine drug screen|0|||
155212182|NCT04273217|560214299|FG005|Overall Study|Positive urine drug screen|1|||
155212183|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
155212184|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
155212185|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
155212186|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
155212187|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
155212188|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
155212189|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212190|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212191|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212192|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
155212193|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
155212194|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
155212195|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
155212196|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
155212197|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
155212198|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
155212199|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
155212200|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
155212201|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212202|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212203|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212204|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
155212205|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
155212206|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
155212207|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
155212208|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
155212209|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
155212210|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
155212211|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
155212212|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
155212213|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
155212214|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
155212215|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
155212216|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
155212217|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
155212218|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
155212219|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212220|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212221|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212222|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
155212223|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
155212224|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
155212225|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
155212226|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
155212227|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
155212228|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
155212229|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
155212230|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
155212231|NCT03720470|560214304|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212232|NCT03720470|560214305|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212233|NCT03720470|560214306|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212234|NCT03720470|560214307|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212235|NCT03720470|560214308|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
155212236|NCT03720470|560214309|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
155212237|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
155212238|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
155212239|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
155212240|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
155212241|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
155212242|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
155212243|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212244|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212245|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
155212246|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212247|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212248|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
155212249|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212250|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212251|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212252|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
155212253|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
155212254|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
155212255|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212256|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212257|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212258|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212259|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
155212260|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
155212261|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212262|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212263|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
155212264|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212265|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212266|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
155212267|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
155212268|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
155212269|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
155212270|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
155212271|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
155212272|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
155212273|NCT03720470|560214304|FG000|Treatment Period: Final 4 Weeks|Other|0|||
155212274|NCT03720470|560214305|FG001|Treatment Period: Final 4 Weeks|Other|1|||
155212275|NCT03720470|560214306|FG002|Treatment Period: Final 4 Weeks|Other|0|||
155212276|NCT03720470|560214307|FG003|Treatment Period: Final 4 Weeks|Other|2|||
155212277|NCT03720470|560214308|FG004|Treatment Period: Final 4 Weeks|Other|1|||
155212278|NCT03720470|560214309|FG005|Treatment Period: Final 4 Weeks|Other|0|||
155212279|NCT00460031|560214310|FG000|Overall Study|Adverse Event|5|||
155212280|NCT00460031|560214310|FG000|Overall Study|Withdrawal by Subject|5|||
155212281|NCT00460031|560214310|FG000|Overall Study|Death|1|||
155212282|NCT04532099|560214311|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
155212283|NCT04532099|560214312|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
155212284|NCT04532099|560214313|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
155212285|NCT05492942|560214318|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
155212286|NCT05492942|560214319|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
155212287|NCT05492942|560214320|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
155212288|NCT05492942|560214321|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
155212289|NCT01907815|560214322|FG000|Overall Study|Withdrawal by Subject|1|||
155212290|NCT01907815|560214323|FG001|Overall Study|Withdrawal by Subject|0|||
155212291|NCT01712490|560214327|FG000|Overall Study|Ongoing|601|||
155212292|NCT01712490|560214328|FG001|Overall Study|Ongoing|586|||
155212293|NCT01712490|560214327|FG000|Overall Study|Other|11|||
155212294|NCT01712490|560214328|FG001|Overall Study|Other|11|||
155212295|NCT01712490|560214327|FG000|Overall Study|Withdrawal by Subject|36|||
155212296|NCT01712490|560214328|FG001|Overall Study|Withdrawal by Subject|44|||
155212297|NCT01712490|560214327|FG000|Overall Study|Lost to Follow-up|16|||
155212298|NCT01712490|560214328|FG001|Overall Study|Lost to Follow-up|29|||
155212299|NCT02056340|560214334|FG000|Overall Study|Lost to Follow-up|5|||
155212300|NCT02056340|560214335|FG001|Overall Study|Lost to Follow-up|5|||
155212301|NCT02056340|560214334|FG000|Overall Study|Withdrawal by Subject|2|||
155212302|NCT02056340|560214335|FG001|Overall Study|Withdrawal by Subject|6|||
155212303|NCT01782495|560214336|FG000|Overall Study|Adverse Event|0|||
155212304|NCT01782495|560214337|FG001|Overall Study|Adverse Event|0|||
155212305|NCT01782495|560214338|FG002|Overall Study|Adverse Event|0|||
155212306|NCT01782495|560214339|FG003|Overall Study|Adverse Event|0|||
155212307|NCT01782495|560214340|FG004|Overall Study|Adverse Event|0|||
155212308|NCT01782495|560214341|FG005|Overall Study|Adverse Event|0|||
155212309|NCT01782495|560214342|FG006|Overall Study|Adverse Event|0|||
155212310|NCT01782495|560214343|FG007|Overall Study|Adverse Event|2|||
155212311|NCT01782495|560214344|FG008|Overall Study|Adverse Event|0|||
155212312|NCT01782495|560214345|FG009|Overall Study|Adverse Event|0|||
155212313|NCT01782495|560214346|FG010|Overall Study|Adverse Event|0|||
155212314|NCT01782495|560214336|FG000|Overall Study|Withdrew Consent|0|||
155212315|NCT01782495|560214337|FG001|Overall Study|Withdrew Consent|1|||
155212316|NCT01782495|560214338|FG002|Overall Study|Withdrew Consent|0|||
155212317|NCT01782495|560214339|FG003|Overall Study|Withdrew Consent|0|||
155212318|NCT01782495|560214340|FG004|Overall Study|Withdrew Consent|0|||
155212319|NCT01782495|560214341|FG005|Overall Study|Withdrew Consent|0|||
155212320|NCT01782495|560214342|FG006|Overall Study|Withdrew Consent|0|||
155212321|NCT01782495|560214343|FG007|Overall Study|Withdrew Consent|1|||
155212322|NCT01782495|560214344|FG008|Overall Study|Withdrew Consent|0|||
155212323|NCT01782495|560214345|FG009|Overall Study|Withdrew Consent|0|||
155212324|NCT01782495|560214346|FG010|Overall Study|Withdrew Consent|0|||
155212325|NCT02848651|560214348|FG000|Overall Study|Death|85|||
155212326|NCT02848651|560214348|FG000|Overall Study|Lost to Follow-up|1|||
155212327|NCT02848651|560214348|FG000|Overall Study|Non-Compliance|1|||
155212328|NCT02848651|560214348|FG000|Overall Study|Symptomatic Deterioration|1|||
155212329|NCT02848651|560214348|FG000|Overall Study|Physician Decision|4|||
155212330|NCT02848651|560214348|FG000|Overall Study|Withdrawal by Subject|14|||
155212331|NCT02480114|560214353|FG000|Overall Study|Not completing surveys|3|||
155212332|NCT02480114|560214354|FG001|Overall Study|Not completing surveys|2|||
155212333|NCT02480114|560214353|FG000|Overall Study|Withdrawal by Subject|2|||
155212334|NCT02480114|560214354|FG001|Overall Study|Withdrawal by Subject|4|||
155212335|NCT02480114|560214353|FG000|Overall Study|Disease progression|3|||
155212336|NCT02480114|560214354|FG001|Overall Study|Disease progression|0|||
155212337|NCT02480114|560214353|FG000|Overall Study|Improper completion of survey|1|||
155212338|NCT02480114|560214354|FG001|Overall Study|Improper completion of survey|1|||
155212339|NCT02480114|560214353|FG000|Overall Study|Not eligible|0|||
155212340|NCT02480114|560214354|FG001|Overall Study|Not eligible|1|||
155212341|NCT01535053|560214355|FG000|Overall Study|Ineligible|1|||
155212342|NCT01535053|560214356|FG001|Overall Study|Ineligible|2|||
155212343|NCT01031069|560214357|FG000|Overall Study|Serious Adverse Event|0|||
155212344|NCT01031069|560214358|FG001|Overall Study|Serious Adverse Event|1|||
155212345|NCT01031069|560214359|FG002|Overall Study|Serious Adverse Event|0|||
155212346|NCT01031069|560214360|FG003|Overall Study|Serious Adverse Event|0|||
155212347|NCT01031069|560214357|FG000|Overall Study|Withdrawal by Subject|2|||
155212348|NCT01031069|560214358|FG001|Overall Study|Withdrawal by Subject|3|||
155212349|NCT01031069|560214359|FG002|Overall Study|Withdrawal by Subject|18|||
155212350|NCT01031069|560214360|FG003|Overall Study|Withdrawal by Subject|18|||
155212351|NCT01031069|560214357|FG000|Overall Study|Migrated/moved from study area|1|||
155212352|NCT01031069|560214358|FG001|Overall Study|Migrated/moved from study area|2|||
155212353|NCT01031069|560214359|FG002|Overall Study|Migrated/moved from study area|1|||
155212354|NCT01031069|560214360|FG003|Overall Study|Migrated/moved from study area|1|||
155212355|NCT01031069|560214357|FG000|Overall Study|Lost to Follow-up|9|||
155212356|NCT01031069|560214358|FG001|Overall Study|Lost to Follow-up|5|||
155212357|NCT01031069|560214359|FG002|Overall Study|Lost to Follow-up|21|||
155212358|NCT01031069|560214360|FG003|Overall Study|Lost to Follow-up|15|||
155212359|NCT01031069|560214357|FG000|Overall Study|Other|0|||
155212360|NCT01031069|560214358|FG001|Overall Study|Other|0|||
155212361|NCT01031069|560214359|FG002|Overall Study|Other|1|||
155212362|NCT01031069|560214360|FG003|Overall Study|Other|0|||
155212363|NCT00512707|560214361|FG000|Overall Study|Lost to Follow-up|5|||
155212364|NCT00512707|560214362|FG001|Overall Study|Lost to Follow-up|11|||
155212365|NCT00512707|560214361|FG000|Overall Study|Developed skin irritation|2|||
155212366|NCT00512707|560214362|FG001|Overall Study|Developed skin irritation|1|||
155212367|NCT00512707|560214361|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
155212368|NCT00512707|560214362|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
155212369|NCT00512707|560214361|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
155212370|NCT00512707|560214362|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
155212371|NCT01317160|560214363|FG000|Overall Study|Incorrect inclusion|1|||
155212372|NCT01317160|560214364|FG001|Overall Study|Incorrect inclusion|1|||
155212373|NCT01317160|560214363|FG000|Overall Study|Lost to Follow-up|3|||
155212374|NCT01317160|560214364|FG001|Overall Study|Lost to Follow-up|3|||
155212375|NCT01317160|560214363|FG000|Overall Study|Withdrawal by Subject|0|||
155212376|NCT01317160|560214364|FG001|Overall Study|Withdrawal by Subject|2|||
155212377|NCT04405037|560214366|FG000|Overall Study|Withdrawal by Subject|1|||
155212378|NCT04405037|560214367|FG001|Overall Study|Withdrawal by Subject|0|||
155212379|NCT04405037|560214366|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
155212380|NCT04405037|560214367|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
155212381|NCT01853826|560216000|FG000|Overall Study|Patients who switched to commercial drug|11|||
155212382|NCT01853826|560216000|FG000|Overall Study|Patient refused to continue medication|21|||
155212383|NCT01853826|560216000|FG000|Overall Study|Lost to Follow-up|2|||
155212384|NCT01853826|560216000|FG000|Overall Study|Non-compliant with protocol|4|||
155212385|NCT01853826|560216000|FG000|Overall Study|Other adverse events (AE)|62|||
155212386|NCT01853826|560216000|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
155212387|NCT01853826|560216000|FG000|Overall Study|Progressive disease|342|||
155212388|NCT01853826|560216000|FG000|Overall Study|Other than listed|13|||
155212389|NCT01853826|560216000|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
155212390|NCT03653637|560216001|FG000|Overall Study|Death|1|||
155212391|NCT03653637|560216002|FG001|Overall Study|Death|3|||
155212392|NCT03653637|560216001|FG000|Overall Study|Lost to Follow-up|29|||
155212393|NCT03653637|560216002|FG001|Overall Study|Lost to Follow-up|30|||
155212394|NCT03653637|560216001|FG000|Overall Study|Physician Decision|1|||
155212395|NCT03653637|560216002|FG001|Overall Study|Physician Decision|1|||
155212396|NCT03653637|560216001|FG000|Overall Study|Withdrawal by Subject|7|||
155212397|NCT03653637|560216002|FG001|Overall Study|Withdrawal by Subject|4|||
155212398|NCT05661942|560216003|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
155212399|NCT05661942|560216004|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
155212400|NCT01287897|560216013|FG000|Overall Study|Adverse Event|5|||
155212401|NCT01287897|560216014|FG001|Overall Study|Adverse Event|3|||
155212402|NCT01287897|560216015|FG002|Overall Study|Adverse Event|6|||
155212403|NCT01287897|560216016|FG003|Overall Study|Adverse Event|4|||
155212404|NCT01287897|560216013|FG000|Overall Study|Lack of Efficacy|2|||
155212405|NCT01287897|560216014|FG001|Overall Study|Lack of Efficacy|0|||
155212406|NCT01287897|560216015|FG002|Overall Study|Lack of Efficacy|0|||
155212407|NCT01287897|560216016|FG003|Overall Study|Lack of Efficacy|0|||
155212408|NCT01287897|560216013|FG000|Overall Study|Protocol Violation|1|||
155212409|NCT01287897|560216014|FG001|Overall Study|Protocol Violation|1|||
155212410|NCT01287897|560216015|FG002|Overall Study|Protocol Violation|0|||
155212411|NCT01287897|560216016|FG003|Overall Study|Protocol Violation|1|||
155212412|NCT01287897|560216013|FG000|Overall Study|Lost to Follow-up|0|||
155212413|NCT01287897|560216014|FG001|Overall Study|Lost to Follow-up|0|||
155212414|NCT01287897|560216015|FG002|Overall Study|Lost to Follow-up|2|||
155212415|NCT01287897|560216016|FG003|Overall Study|Lost to Follow-up|0|||
155212416|NCT01287897|560216013|FG000|Overall Study|Withdrawal by Subject|1|||
155212417|NCT01287897|560216014|FG001|Overall Study|Withdrawal by Subject|5|||
155212418|NCT01287897|560216015|FG002|Overall Study|Withdrawal by Subject|3|||
155212419|NCT01287897|560216016|FG003|Overall Study|Withdrawal by Subject|2|||
155212420|NCT01287897|560216013|FG000|Overall Study|Not consented properly|0|||
155212421|NCT01287897|560216014|FG001|Overall Study|Not consented properly|1|||
155212422|NCT01287897|560216015|FG002|Overall Study|Not consented properly|0|||
155212423|NCT01287897|560216016|FG003|Overall Study|Not consented properly|0|||
155212424|NCT01287897|560216013|FG000|Overall Study|Not meeting entrance criteria|1|||
155212425|NCT01287897|560216014|FG001|Overall Study|Not meeting entrance criteria|1|||
155212426|NCT01287897|560216015|FG002|Overall Study|Not meeting entrance criteria|0|||
155212427|NCT01287897|560216016|FG003|Overall Study|Not meeting entrance criteria|0|||
155212428|NCT01287897|560216013|FG000|Overall Study|Other|1|||
155212429|NCT01287897|560216014|FG001|Overall Study|Other|0|||
155212430|NCT01287897|560216015|FG002|Overall Study|Other|1|||
155212431|NCT01287897|560216016|FG003|Overall Study|Other|0|||
155212432|NCT02902965|560216017|FG000|Overall Study|Withdrawal by Subject|10|||
155212433|NCT03263442|560216018|FG000|Inpatient Phase|Death|1|||
155212434|NCT03263442|560216019|FG001|Inpatient Phase|Death|0|||
155212435|NCT03263442|560216018|FG000|Inpatient Phase|Withdrawal by Subject|1|||
155212436|NCT03263442|560216019|FG001|Inpatient Phase|Withdrawal by Subject|0|||
155212437|NCT03263442|560216018|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
155212438|NCT03263442|560216019|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
155212439|NCT03263442|560216018|FG000|1-month Follow-Up|Lost to Follow-up|1|||
155212440|NCT03263442|560216019|FG001|1-month Follow-Up|Lost to Follow-up|0|||
155212441|NCT03263442|560216018|FG000|3-month Follow-Up|Lost to Follow-up|1|||
155212442|NCT03263442|560216019|FG001|3-month Follow-Up|Lost to Follow-up|3|||
155212443|NCT03263442|560216018|FG000|6-month Follow-Up|Lost to Follow-up|2|||
155212444|NCT03263442|560216019|FG001|6-month Follow-Up|Lost to Follow-up|2|||
155212445|NCT02436889|560216020|FG000|Overall Study|No improvement in symptoms|1|||
155212446|NCT02436889|560216021|FG001|Overall Study|No improvement in symptoms|0|||
155212447|NCT02436889|560216020|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
155212448|NCT02436889|560216021|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
155212449|NCT01084174|560216022|FG000|Overall Study|gastrointestinal symptoms|1|||
155212450|NCT01084174|560216023|FG001|Overall Study|gastrointestinal symptoms|1|||
155212451|NCT01084174|560216022|FG000|Overall Study|Eosinophilic esophagitis|0|||
155212452|NCT01084174|560216023|FG001|Overall Study|Eosinophilic esophagitis|1|||
155212453|NCT01084174|560216022|FG000|Overall Study|Anaphylaxis|0|||
155212454|NCT01084174|560216023|FG001|Overall Study|Anaphylaxis|1|||
155212455|NCT01084174|560216022|FG000|Overall Study|Participant noncompliance|0|||
155212456|NCT01084174|560216023|FG001|Overall Study|Participant noncompliance|1|||
155212457|NCT00708643|560216024|FG000|Overall Study|Adverse Event|0|||
155212458|NCT00708643|560216025|FG001|Overall Study|Adverse Event|1|||
155212459|NCT01946425|560216027|FG000|Overall Study|Protocol Violation|1|||
155212460|NCT01946425|560216028|FG001|Overall Study|Protocol Violation|0|||
155212461|NCT01946425|560216027|FG000|Overall Study|Withdrawal by Subject|1|||
155212462|NCT01946425|560216028|FG001|Overall Study|Withdrawal by Subject|0|||
155212463|NCT05682326|560216034|FG000|Overall Study|Withdrawal by Subject|1|||
155212464|NCT05682326|560216035|FG001|Overall Study|Withdrawal by Subject|0|||
155212465|NCT03414424|560216036|FG000|Overall Study|Screened out after consent|0|||
155212466|NCT03414424|560216037|FG001|Overall Study|Screened out after consent|2|||
155212467|NCT03414424|560216036|FG000|Overall Study|Lost to Follow-up|0|||
155212468|NCT03414424|560216037|FG001|Overall Study|Lost to Follow-up|1|||
155212469|NCT01506479|560216042|FG000|Overall Study|Lost to Follow-up|1|||
155212470|NCT01506479|560216043|FG001|Overall Study|Lost to Follow-up|2|||
155212471|NCT01506479|560216044|FG002|Overall Study|Lost to Follow-up|2|||
155212472|NCT01506479|560216042|FG000|Overall Study|Withdrawal by Subject|1|||
155212473|NCT01506479|560216043|FG001|Overall Study|Withdrawal by Subject|2|||
155212474|NCT01506479|560216044|FG002|Overall Study|Withdrawal by Subject|1|||
155212475|NCT01506479|560216042|FG000|Overall Study|Missing assessment|1|||
155212476|NCT01506479|560216043|FG001|Overall Study|Missing assessment|0|||
155212477|NCT01506479|560216044|FG002|Overall Study|Missing assessment|0|||
155212478|NCT01506479|560216042|FG000|Overall Study|Adverse Event|0|||
155212479|NCT01506479|560216043|FG001|Overall Study|Adverse Event|1|||
155212480|NCT01506479|560216044|FG002|Overall Study|Adverse Event|0|||
155212481|NCT01846507|560216045|FG000|Overall Study|Lost to Follow-up|4|||
155212482|NCT01846507|560216045|FG000|Overall Study|Protocol Violation|1|||
155212483|NCT01846507|560216045|FG000|Overall Study|Missing data|2|||
155212484|NCT01314443|560216046|FG000|Overall Study|Withdrawal by Subject|2|||
155212485|NCT01314443|560216047|FG001|Overall Study|Withdrawal by Subject|1|||
155212486|NCT01314443|560216048|FG002|Overall Study|Withdrawal by Subject|1|||
155212487|NCT01314443|560216049|FG003|Overall Study|Withdrawal by Subject|1|||
155212488|NCT01314443|560216046|FG000|Overall Study|Protocol Violation|2|||
155212489|NCT01314443|560216047|FG001|Overall Study|Protocol Violation|2|||
155212490|NCT01314443|560216048|FG002|Overall Study|Protocol Violation|1|||
155212491|NCT01314443|560216049|FG003|Overall Study|Protocol Violation|1|||
155212492|NCT04545866|560216051|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
155212493|NCT04545866|560216052|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
155212494|NCT04545866|560216051|FG000|Overall Study|Withdrawal by Physician|1|||
155212495|NCT04545866|560216052|FG001|Overall Study|Withdrawal by Physician|0|||
155212496|NCT05247866|560216053|FG000|Overall Study|Adverse Event|2|||
155212497|NCT05247866|560216053|FG000|Overall Study|Lack of Efficacy|1|||
155212498|NCT05247866|560216053|FG000|Overall Study|Protocol Violation|1|||
155212499|NCT05247866|560216053|FG000|Overall Study|Withdrawal by Subject|3|||
155212500|NCT04463719|560216058|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
155212501|NCT04463719|560216059|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
155212502|NCT04463719|560216060|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
155212503|NCT04577118|560216061|FG000|Overall Study|Withdrawal by Subject|4|||
155212504|NCT00810407|560216062|FG000|Overall Study|Protocol Violation|3|||
155212505|NCT00810407|560216062|FG000|Overall Study|No Visit After First Day of Treatment|3|||
155212506|NCT02746874|560216063|FG000|Overall Study|Withdrawal by Subject|0|||
155212507|NCT02746874|560216064|FG001|Overall Study|Withdrawal by Subject|1|||
155212508|NCT02746874|560216063|FG000|Overall Study|Surgery Date Changed|0|||
155212509|NCT02746874|560216064|FG001|Overall Study|Surgery Date Changed|2|||
155212510|NCT00487747|560216065|FG000|Overall Study|Adverse Event|1|||
155212511|NCT00487747|560216065|FG000|Overall Study|Lost to Follow-up|9|||
155212512|NCT00487747|560216065|FG000|Overall Study|Lack of Efficacy|1|||
155212513|NCT00276159|560216066|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
155212514|NCT01359449|560216069|FG000|Overall Study|Lost to Follow-up|1|||
155212515|NCT01359449|560216070|FG001|Overall Study|Lost to Follow-up|0|||
155212516|NCT01359449|560216069|FG000|Overall Study|Protocol Violation|0|||
155212517|NCT01359449|560216070|FG001|Overall Study|Protocol Violation|2|||
155212518|NCT01359449|560216069|FG000|Overall Study|Withdrawal by Subject|3|||
155212519|NCT01359449|560216070|FG001|Overall Study|Withdrawal by Subject|2|||
155212520|NCT02979522|560216077|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
155212521|NCT02979522|560216078|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
155212522|NCT02979522|560216077|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
155212523|NCT02979522|560216078|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
155212524|NCT02485574|560216081|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
155212525|NCT01408914|560216082|FG000|Overall Study|Could not complete tx in protocol period|5|||
155212526|NCT01408914|560216083|FG001|Overall Study|Could not complete tx in protocol period|5|||
155212527|NCT01408914|560216084|FG002|Overall Study|Could not complete tx in protocol period|6|||
155212528|NCT01408914|560216082|FG000|Overall Study|Lost to Follow-up|4|||
155212529|NCT01408914|560216083|FG001|Overall Study|Lost to Follow-up|1|||
155212530|NCT01408914|560216084|FG002|Overall Study|Lost to Follow-up|2|||
155212531|NCT01408914|560216082|FG000|Overall Study|Physician Decision|1|||
155212532|NCT01408914|560216083|FG001|Overall Study|Physician Decision|1|||
155212533|NCT01408914|560216084|FG002|Overall Study|Physician Decision|0|||
155212534|NCT01408914|560216082|FG000|Overall Study|Withdrawal by Subject|1|||
155212535|NCT01408914|560216083|FG001|Overall Study|Withdrawal by Subject|0|||
155212536|NCT01408914|560216084|FG002|Overall Study|Withdrawal by Subject|1|||
155212537|NCT01408914|560216082|FG000|Overall Study|Moved out of study jurisdiction|1|||
155212538|NCT01408914|560216083|FG001|Overall Study|Moved out of study jurisdiction|1|||
155212539|NCT01408914|560216084|FG002|Overall Study|Moved out of study jurisdiction|0|||
155212540|NCT01408914|560216082|FG000|Overall Study|Late exclusion|0|||
155212541|NCT01408914|560216083|FG001|Overall Study|Late exclusion|3|||
155212542|NCT01408914|560216084|FG002|Overall Study|Late exclusion|3|||
155212543|NCT01408914|560216082|FG000|Overall Study|Change in local TB/HIV norms|0|||
155212544|NCT01408914|560216083|FG001|Overall Study|Change in local TB/HIV norms|1|||
155212545|NCT01408914|560216084|FG002|Overall Study|Change in local TB/HIV norms|1|||
155212546|NCT00191789|560216087|FG000|Overall Study|Adverse Event|5|||
155212547|NCT00191789|560216087|FG000|Overall Study|Patient: Satisfactory Response|5|||
155212548|NCT00191789|560216087|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
155212549|NCT00191789|560216087|FG000|Overall Study|Withdrawal by Subject|4|||
155212550|NCT00191789|560216087|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
155212551|NCT00191789|560216087|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
155212552|NCT00191789|560216087|FG000|Overall Study|Death - Not Study-Drug Related|1|||
155212553|NCT05582889|560216088|FG000|Overall Study|Health event|3|||
155212554|NCT05582889|560216089|FG001|Overall Study|Health event|2|||
155212555|NCT05582889|560216088|FG000|Overall Study|Lost to Follow-up|2|||
155212556|NCT05582889|560216089|FG001|Overall Study|Lost to Follow-up|4|||
155212557|NCT06112756|560216090|FG000|Overall Study|Withdrawal by Subject|0|||
155212558|NCT06112756|560216091|FG001|Overall Study|Withdrawal by Subject|2|||
155212559|NCT06112756|560216090|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
155212560|NCT06112756|560216091|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
155212561|NCT06112756|560216090|FG000|Overall Study|Adverse Event|2|||
155212562|NCT06112756|560216091|FG001|Overall Study|Adverse Event|2|||
155212563|NCT04551092|560216092|FG000|Overall Study|Lost to Follow-up|7|||
155212564|NCT04551092|560216092|FG000|Overall Study|Withdrawal by Subject|4|||
155212565|NCT03060629|560216095|FG000|Overall Study|Death|4|||
155212566|NCT03060629|560216096|FG001|Overall Study|Death|5|||
155212567|NCT03060629|560216095|FG000|Overall Study|Withdrawal by Subject|50|||
155212568|NCT03060629|560216096|FG001|Overall Study|Withdrawal by Subject|35|||
155212569|NCT03060629|560216095|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
155212570|NCT03060629|560216096|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
155212571|NCT03060629|560216095|FG000|Overall Study|Participant Relocate|15|||
155212572|NCT03060629|560216096|FG001|Overall Study|Participant Relocate|15|||
155212573|NCT03060629|560216095|FG000|Overall Study|Unable to Contact Participant|34|||
155212574|NCT03060629|560216096|FG001|Overall Study|Unable to Contact Participant|23|||
155212575|NCT03060629|560216095|FG000|Overall Study|Investigator Decision|7|||
155212576|NCT03060629|560216096|FG001|Overall Study|Investigator Decision|7|||
155212577|NCT03060629|560216095|FG000|Overall Study|Study Terminated by Sponsor|1100|||
155212578|NCT03060629|560216096|FG001|Overall Study|Study Terminated by Sponsor|1123|||
155212579|NCT03060629|560216095|FG000|Overall Study|Other|4|||
155212580|NCT03060629|560216096|FG001|Overall Study|Other|4|||
155212581|NCT00867009|560216102|FG000|Induction Period|Nonserious Adverse Event|5|||
155212582|NCT00867009|560216102|FG000|Induction Period|Serious Adverse Event|10|||
155212583|NCT00867009|560216102|FG000|Induction Period|Death due to serious adverse event|6|||
155212584|NCT00867009|560216102|FG000|Induction Period|Death due to Study Disease|4|||
155212585|NCT00867009|560216102|FG000|Induction Period|Protocol Violation|1|||
155212586|NCT00867009|560216102|FG000|Induction Period|Withdrawal by Subject|8|||
155212587|NCT00867009|560216102|FG000|Induction Period|Physician Decision|3|||
155212588|NCT00867009|560216102|FG000|Induction Period|Progressive Disease (PD)|25|||
155212589|NCT00867009|560216102|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
155212590|NCT03266094|560216103|FG000|Overall Study|Lost to Follow-up|1|||
155212591|NCT03266094|560216103|FG000|Overall Study|Withdrawal by Subject|1|||
155212592|NCT04140292|560216112|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
155212593|NCT04140292|560216113|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
155212594|NCT00396591|560216114|FG000|Overall Study|Disease Progression|13|||
155212595|NCT00396591|560216114|FG000|Overall Study|Adverse Event|2|||
155212596|NCT00396591|560216114|FG000|Overall Study|Participant request|1|||
155212597|NCT03036072|560216120|FG000|Overall Study|Death|0|||
155212598|NCT03036072|560216121|FG001|Overall Study|Death|1|||
155212599|NCT03036072|560216120|FG000|Overall Study|Withdrawal by Subject|0|||
155212600|NCT03036072|560216121|FG001|Overall Study|Withdrawal by Subject|1|||
155212601|NCT03036072|560216120|FG000|Overall Study|Physician Decision|0|||
155212602|NCT03036072|560216121|FG001|Overall Study|Physician Decision|1|||
155212603|NCT00680043|560216122|FG000|Overall Study|Withdrawal by Subject|1|||
155212604|NCT00680043|560216123|FG001|Overall Study|Withdrawal by Subject|0|||
155212605|NCT00680043|560216124|FG002|Overall Study|Withdrawal by Subject|0|||
155212606|NCT00680043|560216122|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
155212607|NCT00680043|560216123|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
155212608|NCT00680043|560216124|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
155212609|NCT00680043|560216122|FG000|Overall Study|Renal Transplant|1|||
155212610|NCT00680043|560216123|FG001|Overall Study|Renal Transplant|0|||
155212611|NCT00680043|560216124|FG002|Overall Study|Renal Transplant|4|||
155212612|NCT02484729|560216125|FG000|Overall Study|Failure of IntelliCap Error|0|||
155212613|NCT02484729|560216126|FG001|Overall Study|Failure of IntelliCap Error|0|||
155212614|NCT02484729|560216127|FG002|Overall Study|Failure of IntelliCap Error|0|||
155212615|NCT02484729|560216128|FG003|Overall Study|Failure of IntelliCap Error|0|||
155212616|NCT02484729|560216129|FG004|Overall Study|Failure of IntelliCap Error|0|||
155212617|NCT02484729|560216130|FG005|Overall Study|Failure of IntelliCap Error|0|||
155212618|NCT02484729|560216131|FG006|Overall Study|Failure of IntelliCap Error|0|||
155212619|NCT02484729|560216132|FG007|Overall Study|Failure of IntelliCap Error|0|||
155212620|NCT02484729|560216133|FG008|Overall Study|Failure of IntelliCap Error|0|||
155212621|NCT02484729|560216134|FG009|Overall Study|Failure of IntelliCap Error|1|||
155212622|NCT00662363|560216135|FG000|Overall Study|Withdrawal by Subject|6|||
155212623|NCT00662363|560216136|FG001|Overall Study|Withdrawal by Subject|5|||
155212624|NCT00662363|560216135|FG000|Overall Study|Adverse Event|0|||
155212625|NCT00662363|560216136|FG001|Overall Study|Adverse Event|3|||
155212626|NCT00662363|560216135|FG000|Overall Study|Discharged early from rehab|4|||
155212627|NCT00662363|560216136|FG001|Overall Study|Discharged early from rehab|1|||
155212628|NCT00662363|560216135|FG000|Overall Study|Protocol Violation|1|||
155212629|NCT00662363|560216136|FG001|Overall Study|Protocol Violation|1|||
155212630|NCT05119569|560216137|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
155212631|NCT05119569|560216138|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
155212632|NCT05119569|560216139|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
155212633|NCT05119569|560216140|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
155212634|NCT05119569|560216137|FG000|Double Blind Treatment Phase|Adverse Event|6|||
155212635|NCT05119569|560216138|FG001|Double Blind Treatment Phase|Adverse Event|0|||
155212636|NCT05119569|560216139|FG002|Double Blind Treatment Phase|Adverse Event|0|||
155212637|NCT05119569|560216140|FG003|Double Blind Treatment Phase|Adverse Event|0|||
155212638|NCT05119569|560216137|FG000|Open Label Extension Phase|Ongoing in the study|0|||
155212639|NCT05119569|560216138|FG001|Open Label Extension Phase|Ongoing in the study|0|||
155212640|NCT05119569|560216139|FG002|Open Label Extension Phase|Ongoing in the study|65|||
155212641|NCT05119569|560216140|FG003|Open Label Extension Phase|Ongoing in the study|34|||
155212642|NCT03334903|560216141|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
155212643|NCT03334903|560216142|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
155212644|NCT03334903|560216141|FG000|Overall Study|Protocol Violation|1|||
155212645|NCT03334903|560216142|FG001|Overall Study|Protocol Violation|3|||
155212646|NCT03334903|560216141|FG000|Overall Study|Surgery postponed|1|||
155212647|NCT03334903|560216142|FG001|Overall Study|Surgery postponed|0|||
155212648|NCT03334903|560216141|FG000|Overall Study|Adverse Event|1|||
155212649|NCT03334903|560216142|FG001|Overall Study|Adverse Event|1|||
155212650|NCT03334903|560216141|FG000|Overall Study|Withdrawal by Subject|0|||
155212651|NCT03334903|560216142|FG001|Overall Study|Withdrawal by Subject|1|||
155212652|NCT02081690|560217447|FG000|Overall Study|Death|3|||
155212653|NCT02081690|560217447|FG000|Overall Study|Physician Decision|3|||
155212654|NCT02081690|560217447|FG000|Overall Study|Withdrawal by Subject|1|||
155212655|NCT01463878|560217451|FG000|Overall Study|no longer met criteria for tube feed|2|||
155212656|NCT01463878|560217452|FG001|Overall Study|no longer met criteria for tube feed|2|||
155212657|NCT01034462|560217453|FG000|Overall Study|Adverse Event|7|||
155212658|NCT01034462|560217454|FG001|Overall Study|Adverse Event|17|||
155212659|NCT01034462|560217453|FG000|Overall Study|Lack of Efficacy|4|||
155212660|NCT01034462|560217454|FG001|Overall Study|Lack of Efficacy|4|||
155212661|NCT01034462|560217453|FG000|Overall Study|Protocol Violation|10|||
155212662|NCT01034462|560217454|FG001|Overall Study|Protocol Violation|7|||
155212663|NCT01034462|560217453|FG000|Overall Study|Withdrawal by Subject|9|||
155212664|NCT01034462|560217454|FG001|Overall Study|Withdrawal by Subject|8|||
155212665|NCT01034462|560217453|FG000|Overall Study|Lost to Follow-up|14|||
155212666|NCT01034462|560217454|FG001|Overall Study|Lost to Follow-up|16|||
155212667|NCT01034462|560217453|FG000|Overall Study|Other reasons|1|||
155212668|NCT01034462|560217454|FG001|Overall Study|Other reasons|2|||
155212669|NCT01594125|560217455|FG000|Overall Study|Withdrawal by Subject|1|||
155212670|NCT01594125|560217456|FG001|Overall Study|Withdrawal by Subject|0|||
155212671|NCT01594125|560217457|FG002|Overall Study|Withdrawal by Subject|0|||
155212672|NCT01594125|560217458|FG003|Overall Study|Withdrawal by Subject|1|||
155212673|NCT01594125|560217459|FG004|Overall Study|Withdrawal by Subject|0|||
155212674|NCT01594125|560217455|FG000|Overall Study|Progressive Disease|3|||
155212675|NCT01594125|560217456|FG001|Overall Study|Progressive Disease|12|||
155212676|NCT01594125|560217457|FG002|Overall Study|Progressive Disease|3|||
155212677|NCT01594125|560217458|FG003|Overall Study|Progressive Disease|3|||
155212678|NCT01594125|560217459|FG004|Overall Study|Progressive Disease|7|||
155212679|NCT01475331|560217462|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
155212680|NCT01475331|560217463|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
155212681|NCT01475331|560217462|FG000|Overall Study|excessive main duct communication|1|||
155212682|NCT01475331|560217463|FG001|Overall Study|excessive main duct communication|1|||
155212683|NCT01475331|560217462|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
155212684|NCT01475331|560217463|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
155212685|NCT01475331|560217462|FG000|Overall Study|Sign of malignancy during the procedure|2|||
155212686|NCT01475331|560217463|FG001|Overall Study|Sign of malignancy during the procedure|0|||
155212687|NCT01475331|560217462|FG000|Overall Study|cyst found to be prohibitively small|0|||
155212688|NCT01475331|560217463|FG001|Overall Study|cyst found to be prohibitively small|1|||
155212689|NCT00462761|560217464|FG000|Overall Study|Adverse Event|6|||
155212690|NCT00462761|560217464|FG000|Overall Study|Withdrawal by Subject|9|||
155212691|NCT00462761|560217464|FG000|Overall Study|Physician Decision|5|||
155212692|NCT00462761|560217464|FG000|Overall Study|Disease progression|43|||
155212693|NCT00462761|560217464|FG000|Overall Study|Death|12|||
155212694|NCT00462761|560217464|FG000|Overall Study|Other|1|||
155212695|NCT02877082|560217465|FG000|Overall Study|Trial was closed early|5|||
155212696|NCT01949051|560217466|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
155212697|NCT01949051|560217467|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212698|NCT01949051|560217468|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212699|NCT01949051|560217469|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
155212700|NCT01949051|560217470|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212701|NCT01949051|560217471|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
155212702|NCT01949051|560217466|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
155212703|NCT01949051|560217467|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212704|NCT01949051|560217468|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212705|NCT01949051|560217469|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212706|NCT01949051|560217470|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212707|NCT01949051|560217471|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
155212708|NCT01949051|560217466|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212709|NCT01949051|560217467|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212710|NCT01949051|560217468|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212711|NCT01949051|560217469|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212712|NCT01949051|560217470|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
155212713|NCT01949051|560217471|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
155212714|NCT01949051|560217466|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212715|NCT01949051|560217467|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
155212716|NCT01949051|560217468|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212717|NCT01949051|560217469|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212718|NCT01949051|560217470|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212719|NCT01949051|560217471|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
155212720|NCT01949051|560217466|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212721|NCT01949051|560217467|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212722|NCT01949051|560217468|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
155212723|NCT01949051|560217469|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212724|NCT01949051|560217470|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212725|NCT01949051|560217471|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
155212726|NCT01782859|560217472|FG000|Overall Study|Protocol Violation|6|||
155212727|NCT01782859|560217473|FG001|Overall Study|Protocol Violation|6|||
155212728|NCT01782859|560217472|FG000|Overall Study|Withdrawal by Subject|0|||
155212729|NCT01782859|560217473|FG001|Overall Study|Withdrawal by Subject|1|||
155212730|NCT02436356|560217474|FG000|Overall Study|Excluded by MRI Screening|0|||
155212731|NCT02436356|560217475|FG001|Overall Study|Excluded by MRI Screening|0|||
155212732|NCT02436356|560217476|FG002|Overall Study|Excluded by MRI Screening|2|||
155212733|NCT02436356|560217474|FG000|Overall Study|Lost to Follow-up|0|||
155212734|NCT02436356|560217475|FG001|Overall Study|Lost to Follow-up|1|||
155212735|NCT02436356|560217476|FG002|Overall Study|Lost to Follow-up|0|||
155212736|NCT02436356|560217474|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
155212737|NCT02436356|560217475|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
155212738|NCT02436356|560217476|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
155212739|NCT02436356|560217474|FG000|Overall Study|Excluded due to other medical conditions|3|||
155212740|NCT02436356|560217475|FG001|Overall Study|Excluded due to other medical conditions|0|||
155212741|NCT02436356|560217476|FG002|Overall Study|Excluded due to other medical conditions|0|||
155212742|NCT02436356|560217474|FG000|Overall Study|Withdrawal by Subject|1|||
155212743|NCT02436356|560217475|FG001|Overall Study|Withdrawal by Subject|0|||
155212744|NCT02436356|560217476|FG002|Overall Study|Withdrawal by Subject|0|||
155212745|NCT04483011|560217477|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
155212746|NCT04483011|560217478|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
155212747|NCT00429104|560217481|FG000|Overall Study|Protocol Violation|1|||
155212748|NCT01896531|560217484|FG000|Overall Study|Death|57|||
155212749|NCT01896531|560217485|FG001|Overall Study|Death|59|||
155212750|NCT01896531|560217484|FG000|Overall Study|Lost to Follow-up|3|||
155212751|NCT01896531|560217485|FG001|Overall Study|Lost to Follow-up|0|||
155212752|NCT01896531|560217484|FG000|Overall Study|Non-compliance|0|||
155212753|NCT01896531|560217485|FG001|Overall Study|Non-compliance|1|||
155212754|NCT01896531|560217484|FG000|Overall Study|Study Ended by Sponsor|7|||
155212755|NCT01896531|560217485|FG001|Overall Study|Study Ended by Sponsor|20|||
155212756|NCT01896531|560217484|FG000|Overall Study|Withdrawal by Subject|3|||
155212757|NCT01896531|560217485|FG001|Overall Study|Withdrawal by Subject|2|||
155212758|NCT01896531|560217484|FG000|Overall Study|Death Prior to Treatment|1|||
155212759|NCT01896531|560217485|FG001|Overall Study|Death Prior to Treatment|0|||
155212760|NCT02956486|560217486|FG000|Core Phase|Adverse Event|51|||
155212761|NCT02956486|560217487|FG001|Core Phase|Adverse Event|88|||
155212762|NCT02956486|560217488|FG002|Core Phase|Adverse Event|0|||
155212763|NCT02956486|560217486|FG000|Core Phase|Lost to Follow-up|8|||
155212764|NCT02956486|560217487|FG001|Core Phase|Lost to Follow-up|6|||
155212765|NCT02956486|560217488|FG002|Core Phase|Lost to Follow-up|0|||
155212766|NCT02956486|560217486|FG000|Core Phase|Inadequate therapeutic effect|4|||
155212767|NCT02956486|560217487|FG001|Core Phase|Inadequate therapeutic effect|5|||
155212768|NCT02956486|560217488|FG002|Core Phase|Inadequate therapeutic effect|0|||
155212769|NCT02956486|560217486|FG000|Core Phase|Withdrawal by Subject|101|||
155212770|NCT02956486|560217487|FG001|Core Phase|Withdrawal by Subject|104|||
155212771|NCT02956486|560217488|FG002|Core Phase|Withdrawal by Subject|0|||
155212772|NCT02956486|560217486|FG000|Core Phase|Study terminated by sponsor|888|||
155212773|NCT02956486|560217487|FG001|Core Phase|Study terminated by sponsor|848|||
155212774|NCT02956486|560217488|FG002|Core Phase|Study terminated by sponsor|0|||
155212775|NCT02956486|560217486|FG000|Core Phase|Other|27|||
155212776|NCT02956486|560217487|FG001|Core Phase|Other|18|||
155212777|NCT02956486|560217488|FG002|Core Phase|Other|0|||
155212778|NCT02956486|560217486|FG000|Core Phase|Not treated|0|||
155212779|NCT02956486|560217487|FG001|Core Phase|Not treated|3|||
155212780|NCT02956486|560217488|FG002|Core Phase|Not treated|0|||
155212781|NCT02956486|560217486|FG000|Extension Phase|Adverse Event|0|||
155212782|NCT02956486|560217487|FG001|Extension Phase|Adverse Event|0|||
155212783|NCT02956486|560217488|FG002|Extension Phase|Adverse Event|2|||
155212784|NCT02956486|560217486|FG000|Extension Phase|Study terminated by sponsor|0|||
155212785|NCT02956486|560217487|FG001|Extension Phase|Study terminated by sponsor|0|||
155212786|NCT02956486|560217488|FG002|Extension Phase|Study terminated by sponsor|16|||
155212787|NCT02956486|560217486|FG000|Extension Phase|Not Treated|0|||
155212788|NCT02956486|560217487|FG001|Extension Phase|Not Treated|0|||
155212789|NCT02956486|560217488|FG002|Extension Phase|Not Treated|1|||
155212790|NCT00680745|560217489|FG000|Overall Study|Withdrawal by Subject|8|||
155212791|NCT00680745|560217490|FG001|Overall Study|Withdrawal by Subject|3|||
155212792|NCT00680745|560217491|FG002|Overall Study|Withdrawal by Subject|2|||
155212793|NCT00680745|560217492|FG003|Overall Study|Withdrawal by Subject|8|||
155212794|NCT00680745|560217489|FG000|Overall Study|Lost to Follow-up|0|||
155212795|NCT00680745|560217490|FG001|Overall Study|Lost to Follow-up|1|||
155212796|NCT00680745|560217491|FG002|Overall Study|Lost to Follow-up|1|||
155212797|NCT00680745|560217492|FG003|Overall Study|Lost to Follow-up|0|||
155212798|NCT00680745|560217489|FG000|Overall Study|Death|1|||
155212799|NCT00680745|560217490|FG001|Overall Study|Death|0|||
155212800|NCT00680745|560217491|FG002|Overall Study|Death|1|||
155212801|NCT00680745|560217492|FG003|Overall Study|Death|0|||
155212802|NCT00680745|560217489|FG000|Overall Study|Adverse Event|5|||
155212803|NCT00680745|560217490|FG001|Overall Study|Adverse Event|3|||
155212804|NCT00680745|560217491|FG002|Overall Study|Adverse Event|3|||
155212805|NCT00680745|560217492|FG003|Overall Study|Adverse Event|3|||
155212806|NCT00680745|560217489|FG000|Overall Study|Poor/Non-compliance|0|||
155212807|NCT00680745|560217490|FG001|Overall Study|Poor/Non-compliance|3|||
155212808|NCT00680745|560217491|FG002|Overall Study|Poor/Non-compliance|0|||
155212809|NCT00680745|560217492|FG003|Overall Study|Poor/Non-compliance|0|||
155212810|NCT00680745|560217489|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
155212811|NCT00680745|560217490|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
155212812|NCT00680745|560217491|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
155212813|NCT00680745|560217492|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
155212814|NCT00680745|560217489|FG000|Overall Study|False Treatment|0|||
155212815|NCT00680745|560217490|FG001|Overall Study|False Treatment|1|||
155212816|NCT00680745|560217491|FG002|Overall Study|False Treatment|3|||
155212817|NCT00680745|560217492|FG003|Overall Study|False Treatment|0|||
155212818|NCT04851314|560217497|FG000|Overall Study|Unable to complete research set-up procedures|0|||
155212819|NCT04851314|560217498|FG001|Overall Study|Unable to complete research set-up procedures|2|||
155212820|NCT04851314|560217497|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
155212821|NCT04851314|560217498|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
155212822|NCT03171415|560217499|FG000|Overall Study|Lost to Follow-up|0|||
155212823|NCT03171415|560217500|FG001|Overall Study|Lost to Follow-up|0|||
155212824|NCT03171415|560217501|FG002|Overall Study|Lost to Follow-up|0|||
155212825|NCT03171415|560217502|FG003|Overall Study|Lost to Follow-up|0|||
155212826|NCT03171415|560217503|FG004|Overall Study|Lost to Follow-up|2|||
155212827|NCT01339429|560217504|FG000|Overall Study|Withdrawal by Subject|1|||
155212828|NCT01339429|560217504|FG000|Overall Study|Physician Decision|3|||
155212829|NCT01085591|560217505|FG000|Overall Study|Adverse Event|0|||
155212830|NCT01085591|560217506|FG001|Overall Study|Adverse Event|1|||
155212831|NCT01085591|560217507|FG002|Overall Study|Adverse Event|3|||
155212832|NCT01085591|560217505|FG000|Overall Study|Physician Decision|1|||
155212833|NCT01085591|560217506|FG001|Overall Study|Physician Decision|0|||
155212834|NCT01085591|560217507|FG002|Overall Study|Physician Decision|1|||
155212835|NCT01085591|560217505|FG000|Overall Study|Withdrawal by Subject|0|||
155212836|NCT01085591|560217506|FG001|Overall Study|Withdrawal by Subject|2|||
155212837|NCT01085591|560217507|FG002|Overall Study|Withdrawal by Subject|1|||
155212838|NCT01085591|560217505|FG000|Overall Study|Lost to Follow-up|0|||
155212839|NCT01085591|560217506|FG001|Overall Study|Lost to Follow-up|1|||
155212840|NCT01085591|560217507|FG002|Overall Study|Lost to Follow-up|1|||
155212841|NCT01085591|560217505|FG000|Overall Study|Protocol Violation|1|||
155212842|NCT01085591|560217506|FG001|Overall Study|Protocol Violation|1|||
155212843|NCT01085591|560217507|FG002|Overall Study|Protocol Violation|1|||
155212844|NCT01085591|560217505|FG000|Overall Study|Other|0|||
155212845|NCT01085591|560217506|FG001|Overall Study|Other|1|||
155212846|NCT01085591|560217507|FG002|Overall Study|Other|0|||
155212847|NCT01085591|560217505|FG000|Overall Study|Not Properly Consented|1|||
155212848|NCT01085591|560217506|FG001|Overall Study|Not Properly Consented|0|||
155212849|NCT01085591|560217507|FG002|Overall Study|Not Properly Consented|0|||
155212850|NCT00459667|560217510|FG000|Overall Study|Adverse Event|9|||
155212851|NCT00459667|560217511|FG001|Overall Study|Adverse Event|12|||
155212852|NCT00459667|560217512|FG002|Overall Study|Adverse Event|8|||
155212853|NCT00459667|560217510|FG000|Overall Study|Lost to Follow-up|5|||
155212854|NCT00459667|560217511|FG001|Overall Study|Lost to Follow-up|9|||
155212855|NCT00459667|560217512|FG002|Overall Study|Lost to Follow-up|3|||
155212856|NCT00459667|560217510|FG000|Overall Study|Pregnancy|1|||
155212857|NCT00459667|560217511|FG001|Overall Study|Pregnancy|1|||
155212858|NCT00459667|560217512|FG002|Overall Study|Pregnancy|1|||
155212859|NCT00459667|560217510|FG000|Overall Study|Protocol Violation|1|||
155212860|NCT00459667|560217511|FG001|Overall Study|Protocol Violation|0|||
155212861|NCT00459667|560217512|FG002|Overall Study|Protocol Violation|0|||
155212862|NCT00459667|560217510|FG000|Overall Study|Withdrawal by Subject|3|||
155212863|NCT00459667|560217511|FG001|Overall Study|Withdrawal by Subject|5|||
155212864|NCT00459667|560217512|FG002|Overall Study|Withdrawal by Subject|5|||
155212865|NCT00459667|560217510|FG000|Overall Study|Other disease modifying treatment|1|||
155212866|NCT00459667|560217511|FG001|Overall Study|Other disease modifying treatment|2|||
155212867|NCT00459667|560217512|FG002|Overall Study|Other disease modifying treatment|1|||
155212868|NCT00459667|560217510|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
155212869|NCT00459667|560217511|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
155212870|NCT00459667|560217512|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
155212871|NCT00459667|560217510|FG000|Overall Study|No treatment administered|6|||
155212872|NCT00459667|560217511|FG001|Overall Study|No treatment administered|3|||
155212873|NCT00459667|560217512|FG002|Overall Study|No treatment administered|1|||
155212874|NCT01013701|560217513|FG000|Overall Study|study prematurely terminated|7|||
155212875|NCT03241342|560217514|FG000|Overall Study|Adverse Event|5|||
155212876|NCT03241342|560217515|FG001|Overall Study|Adverse Event|8|||
155212877|NCT03241342|560217516|FG002|Overall Study|Adverse Event|4|||
155212878|NCT03241342|560217514|FG000|Overall Study|Lack of Efficacy|0|||
155212879|NCT03241342|560217515|FG001|Overall Study|Lack of Efficacy|0|||
155212880|NCT03241342|560217516|FG002|Overall Study|Lack of Efficacy|1|||
155212881|NCT03241342|560217514|FG000|Overall Study|noncompliance with study drug|2|||
155212882|NCT03241342|560217515|FG001|Overall Study|noncompliance with study drug|1|||
155212883|NCT03241342|560217516|FG002|Overall Study|noncompliance with study drug|1|||
155212884|NCT03241342|560217514|FG000|Overall Study|sponsor decision|0|||
155212885|NCT03241342|560217515|FG001|Overall Study|sponsor decision|1|||
155212886|NCT03241342|560217516|FG002|Overall Study|sponsor decision|2|||
155212887|NCT03241342|560217514|FG000|Overall Study|not reported|15|||
155212888|NCT03241342|560217515|FG001|Overall Study|not reported|21|||
155212889|NCT03241342|560217516|FG002|Overall Study|not reported|19|||
155212890|NCT00556712|560217518|FG000|Overall Study|Adverse Event|7|||
155212891|NCT00556712|560217519|FG001|Overall Study|Adverse Event|19|||
155212892|NCT00556712|560217518|FG000|Overall Study|Death|5|||
155212893|NCT00556712|560217519|FG001|Overall Study|Death|10|||
155212894|NCT00556712|560217518|FG000|Overall Study|Progressive Disease|383|||
155212895|NCT00556712|560217519|FG001|Overall Study|Progressive Disease|320|||
155212896|NCT00556712|560217518|FG000|Overall Study|Protocol Violation|3|||
155212897|NCT00556712|560217519|FG001|Overall Study|Protocol Violation|2|||
155212898|NCT00556712|560217518|FG000|Overall Study|Refused Treatment|17|||
155212899|NCT00556712|560217519|FG001|Overall Study|Refused Treatment|16|||
155212900|NCT00556712|560217518|FG000|Overall Study|Failure to Return|2|||
155212901|NCT00556712|560217519|FG001|Overall Study|Failure to Return|3|||
155212902|NCT00556712|560217518|FG000|Overall Study|Other|2|||
155212903|NCT00556712|560217519|FG001|Overall Study|Other|2|||
155212904|NCT00556712|560217518|FG000|Overall Study|Ongoing at Data Cutoff|32|||
155212905|NCT00556712|560217519|FG001|Overall Study|Ongoing at Data Cutoff|66|||
155212906|NCT01846611|560217522|FG000|Overall Study|Lost to Follow-up|4|||
155212907|NCT01846611|560217523|FG001|Overall Study|Lost to Follow-up|6|||
155212908|NCT01846611|560217522|FG000|Overall Study|Withdrawal by Subject|15|||
155212909|NCT01846611|560217523|FG001|Overall Study|Withdrawal by Subject|19|||
155212910|NCT01846611|560217522|FG000|Overall Study|Other|19|||
155212911|NCT01846611|560217523|FG001|Overall Study|Other|18|||
155212912|NCT00541034|560217524|FG000|Overall Study|Non-Compliance|3|||
155212913|NCT00847704|560217526|FG000|Overall Study|Withdrawal by Subject|1|||
155212914|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
155212915|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
155212916|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
155212917|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
155212918|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
155212919|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
155212920|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
155212921|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
155212922|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
155212923|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
155212924|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
155212925|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
155212926|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
155212927|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
155212928|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
155212929|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
155212930|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
155212931|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
155212932|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
155212933|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
155212934|NCT01962207|560217527|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
155212935|NCT01962207|560217528|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
155212936|NCT01962207|560217529|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
155212937|NCT01962207|560217530|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
155212938|NCT02289079|560217531|FG000|Overall Study|Physician Decision|2|||
155212939|NCT02289079|560217532|FG001|Overall Study|Physician Decision|0|||
155212940|NCT02289079|560217531|FG000|Overall Study|Lost to Follow-up|0|||
155212941|NCT02289079|560217532|FG001|Overall Study|Lost to Follow-up|1|||
155212942|NCT02671422|560217533|FG000|Overall Study|Lost to Follow-up|1|||
155212943|NCT02671422|560217533|FG000|Overall Study|Adverse Event|68|||
155212944|NCT02671422|560217533|FG000|Overall Study|Lack of Efficacy|1|||
155212945|NCT02671422|560217533|FG000|Overall Study|Lost to Follow-up|4|||
155212946|NCT02671422|560217533|FG000|Overall Study|Withdrawal by Subject|7|||
155212947|NCT02671422|560217533|FG000|Overall Study|Progressive Disease|156|||
155212948|NCT02671422|560217533|FG000|Overall Study|Worsening of Disease|4|||
155212949|NCT02671422|560217533|FG000|Overall Study|Sponsor decision|5|||
155212950|NCT02671422|560217533|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
155212951|NCT02671422|560217533|FG000|Overall Study|Not treated with Vargatef®|3|||
155212952|NCT02671422|560217533|FG000|Overall Study|Other not defined above|3|||
155212953|NCT02111850|560217534|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212954|NCT02111850|560217535|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212955|NCT02111850|560217536|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212956|NCT02111850|560217537|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212957|NCT02111850|560217538|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
155212958|NCT02111850|560217539|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212959|NCT02111850|560217540|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212960|NCT02111850|560217541|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212961|NCT02111850|560217542|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212962|NCT02111850|560217543|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212963|NCT02111850|560217544|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
155212964|NCT03061331|560217545|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
155212965|NCT03061331|560217546|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
155212966|NCT02625259|560217547|FG000|First Intervention (Day 1)|Other|0|||
155212967|NCT02625259|560217548|FG001|First Intervention (Day 1)|Other|0|||
155212968|NCT02625259|560217549|FG002|First Intervention (Day 1)|Other|1|||
155212969|NCT02625259|560217550|FG003|First Intervention (Day 1)|Other|0|||
155212970|NCT02625259|560217551|FG004|First Intervention (Day 1)|Other|0|||
155212971|NCT02625259|560217547|FG000|First Intervention (Day 1)|Adverse Event|2|||
155212972|NCT02625259|560217548|FG001|First Intervention (Day 1)|Adverse Event|1|||
155212973|NCT02625259|560217549|FG002|First Intervention (Day 1)|Adverse Event|0|||
155212974|NCT02625259|560217550|FG003|First Intervention (Day 1)|Adverse Event|0|||
155212975|NCT02625259|560217551|FG004|First Intervention (Day 1)|Adverse Event|0|||
155212976|NCT02625259|560217547|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212977|NCT02625259|560217548|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212978|NCT02625259|560217549|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212979|NCT02625259|560217550|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
155212980|NCT02625259|560217551|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
155212981|NCT01980875|560217552|FG000|Overall Study|Withdrew Consent|1|||
155212982|NCT01980875|560217553|FG001|Overall Study|Withdrew Consent|1|||
155212983|NCT01980875|560217554|FG002|Overall Study|Withdrew Consent|1|||
155212984|NCT01980875|560217552|FG000|Overall Study|Study Terminated by Sponsor|7|||
155212985|NCT01980875|560217553|FG001|Overall Study|Study Terminated by Sponsor|24|||
155212986|NCT01980875|560217554|FG002|Overall Study|Study Terminated by Sponsor|22|||
155212987|NCT01980875|560217552|FG000|Overall Study|Lost to Follow-up|0|||
155212988|NCT01980875|560217553|FG001|Overall Study|Lost to Follow-up|0|||
155212989|NCT01980875|560217554|FG002|Overall Study|Lost to Follow-up|1|||
155212990|NCT00513474|560217555|FG000|Overall Study|Death|6|||
155212991|NCT00513474|560217556|FG001|Overall Study|Death|9|||
155212992|NCT00513474|560217555|FG000|Overall Study|Participant Withdrew Consent|1|||
155212993|NCT00513474|560217556|FG001|Overall Study|Participant Withdrew Consent|0|||
155212994|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Adverse Event|82|||
155212995|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Death|6|||
155212996|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
155212997|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
155212998|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
155212999|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
155213000|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
155213001|NCT00195676|560217557|FG000|Period O - Open-label Treatment|Other reasons|68|||
155213002|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
155213003|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
155213004|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
155213005|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
155213006|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
155213007|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
155213008|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
155213009|NCT00195676|560217557|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
155213010|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
155213011|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
155213012|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
155213013|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
155213014|NCT00195676|560217557|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
155213015|NCT01189812|560217558|FG000|Overall Study|Withdrawal by Subject|2|||
155213016|NCT01189812|560217559|FG001|Overall Study|Withdrawal by Subject|3|||
155213017|NCT01189812|560217558|FG000|Overall Study|Adverse Event|1|||
155213018|NCT01189812|560217559|FG001|Overall Study|Adverse Event|0|||
155213019|NCT01189812|560217558|FG000|Overall Study|Out of Window|4|||
155213020|NCT01189812|560217559|FG001|Overall Study|Out of Window|3|||
155213021|NCT01189812|560217558|FG000|Overall Study|Moved out of State|1|||
155213022|NCT01189812|560217559|FG001|Overall Study|Moved out of State|2|||
155213023|NCT01905657|560217560|FG000|Overall Study|Adverse Event|23|||
155213024|NCT01905657|560217561|FG001|Overall Study|Adverse Event|17|||
155213025|NCT01905657|560217562|FG002|Overall Study|Adverse Event|18|||
155213026|NCT01905657|560217560|FG000|Overall Study|Clinical Progression|103|||
155213027|NCT01905657|560217561|FG001|Overall Study|Clinical Progression|78|||
155213028|NCT01905657|560217562|FG002|Overall Study|Clinical Progression|59|||
155213029|NCT01905657|560217560|FG000|Overall Study|Death|40|||
155213030|NCT01905657|560217561|FG001|Overall Study|Death|43|||
155213031|NCT01905657|560217562|FG002|Overall Study|Death|47|||
155213032|NCT01905657|560217560|FG000|Overall Study|Excluded Medication|13|||
155213033|NCT01905657|560217561|FG001|Overall Study|Excluded Medication|16|||
155213034|NCT01905657|560217562|FG002|Overall Study|Excluded Medication|9|||
155213035|NCT01905657|560217560|FG000|Overall Study|Lost to Follow-up|1|||
155213036|NCT01905657|560217561|FG001|Overall Study|Lost to Follow-up|2|||
155213037|NCT01905657|560217562|FG002|Overall Study|Lost to Follow-up|1|||
155213038|NCT01905657|560217560|FG000|Overall Study|Physician Decision|5|||
155213039|NCT01905657|560217561|FG001|Overall Study|Physician Decision|8|||
155213040|NCT01905657|560217562|FG002|Overall Study|Physician Decision|12|||
155213041|NCT01905657|560217560|FG000|Overall Study|Protocol Violation|2|||
155213042|NCT01905657|560217561|FG001|Overall Study|Protocol Violation|1|||
155213043|NCT01905657|560217562|FG002|Overall Study|Protocol Violation|1|||
155213044|NCT01905657|560217560|FG000|Overall Study|Screen Failure|0|||
155213045|NCT01905657|560217561|FG001|Overall Study|Screen Failure|1|||
155213046|NCT01905657|560217562|FG002|Overall Study|Screen Failure|0|||
155213047|NCT01905657|560217560|FG000|Overall Study|Withdrawal by Subject|15|||
155213048|NCT01905657|560217561|FG001|Overall Study|Withdrawal by Subject|21|||
155213049|NCT01905657|560217562|FG002|Overall Study|Withdrawal by Subject|53|||
155213050|NCT01905657|560217560|FG000|Overall Study|Sponsor Decision|1|||
155213051|NCT01905657|560217561|FG001|Overall Study|Sponsor Decision|0|||
155213052|NCT01905657|560217562|FG002|Overall Study|Sponsor Decision|0|||
155213053|NCT04080297|560217564|FG000|Overall Study|Adverse Event|1|||
155213054|NCT04080297|560217565|FG001|Overall Study|Adverse Event|3|||
155213055|NCT04080297|560217564|FG000|Overall Study|concurrent illness|1|||
155213056|NCT04080297|560217565|FG001|Overall Study|concurrent illness|0|||
155213057|NCT05838742|560217567|FG000|Overall Study|Adverse Event|2|||
155213058|NCT05838742|560217568|FG001|Overall Study|Adverse Event|0|||
155213059|NCT05838742|560217569|FG002|Overall Study|Adverse Event|1|||
155213060|NCT05838742|560217570|FG003|Overall Study|Adverse Event|0|||
155213061|NCT05838742|560217571|FG004|Overall Study|Adverse Event|1|||
155213062|NCT05838742|560217567|FG000|Overall Study|Lost to Follow-up|1|||
155213063|NCT05838742|560217568|FG001|Overall Study|Lost to Follow-up|1|||
155213064|NCT05838742|560217569|FG002|Overall Study|Lost to Follow-up|1|||
155213065|NCT05838742|560217570|FG003|Overall Study|Lost to Follow-up|0|||
155213066|NCT05838742|560217571|FG004|Overall Study|Lost to Follow-up|0|||
155213067|NCT05838742|560217567|FG000|Overall Study|Physician Decision|0|||
155213068|NCT05838742|560217568|FG001|Overall Study|Physician Decision|0|||
155213069|NCT05838742|560217569|FG002|Overall Study|Physician Decision|0|||
155213070|NCT05838742|560217570|FG003|Overall Study|Physician Decision|0|||
155213071|NCT05838742|560217571|FG004|Overall Study|Physician Decision|1|||
155213072|NCT05838742|560217567|FG000|Overall Study|Withdrawal by Subject|8|||
155213073|NCT05838742|560217568|FG001|Overall Study|Withdrawal by Subject|3|||
155213074|NCT05838742|560217569|FG002|Overall Study|Withdrawal by Subject|3|||
155213075|NCT05838742|560217570|FG003|Overall Study|Withdrawal by Subject|1|||
155213076|NCT05838742|560217571|FG004|Overall Study|Withdrawal by Subject|4|||
155213077|NCT05838742|560217567|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
155213078|NCT05838742|560217568|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
155213079|NCT05838742|560217569|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
155213080|NCT05838742|560217570|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
155213081|NCT05838742|560217571|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
155213082|NCT05838742|560217567|FG000|Overall Study|Lack of Efficacy|0|||
155213083|NCT05838742|560217568|FG001|Overall Study|Lack of Efficacy|0|||
155213084|NCT05838742|560217569|FG002|Overall Study|Lack of Efficacy|0|||
155213085|NCT05838742|560217570|FG003|Overall Study|Lack of Efficacy|1|||
155213086|NCT05838742|560217571|FG004|Overall Study|Lack of Efficacy|0|||
155213087|NCT05838742|560217567|FG000|Overall Study|Randomized, not treated|2|||
155213088|NCT05838742|560217568|FG001|Overall Study|Randomized, not treated|1|||
155213089|NCT05838742|560217569|FG002|Overall Study|Randomized, not treated|0|||
155213090|NCT05838742|560217570|FG003|Overall Study|Randomized, not treated|1|||
155213091|NCT05838742|560217571|FG004|Overall Study|Randomized, not treated|0|||
155213092|NCT02623439|560217576|FG000|Overall Study|Withdrawal by Subject|1|||
155213093|NCT02623439|560217576|FG000|Overall Study|Screen Failure|1|||
155213094|NCT02200445|560217580|FG000|Overall Study|Lack of Efficacy|1|||
155213095|NCT02200445|560217581|FG001|Overall Study|Lack of Efficacy|2|||
155213096|NCT02200445|560217582|FG002|Overall Study|Lack of Efficacy|2|||
155213097|NCT02200445|560217580|FG000|Overall Study|Adverse Event|0|||
155213098|NCT02200445|560217581|FG001|Overall Study|Adverse Event|2|||
155213099|NCT02200445|560217582|FG002|Overall Study|Adverse Event|0|||
155213100|NCT04484142|560217583|FG000|Overall Study|Adverse Event|13|||
155213101|NCT04484142|560217583|FG000|Overall Study|Progressive Disease|87|||
155213102|NCT04484142|560217583|FG000|Overall Study|Clinical Progression|10|||
155213103|NCT04484142|560217583|FG000|Overall Study|Withdrawal by Subject|6|||
155213104|NCT04484142|560217583|FG000|Overall Study|Physician Decision|1|||
155213105|NCT03700671|560217584|FG000|Overall Study|Lack of Efficacy|1|||
155213106|NCT03700671|560217585|FG001|Overall Study|Lack of Efficacy|2|||
155213107|NCT05371509|560217586|FG000|Overall Study|Physician Decision|1|||
155213108|NCT05371509|560217587|FG001|Overall Study|Physician Decision|0|||
155213109|NCT03851302|560217594|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
155213110|NCT03851302|560217595|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
155213111|NCT03851302|560217596|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
155213112|NCT03851302|560217597|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
155213113|NCT03851302|560217598|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
155213114|NCT03851302|560217599|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
155213115|NCT03851302|560217594|FG000|Screening (1 Day)|Screened out|0|||
155213116|NCT03851302|560217595|FG001|Screening (1 Day)|Screened out|0|||
155213117|NCT03851302|560217596|FG002|Screening (1 Day)|Screened out|1|||
155213118|NCT03851302|560217597|FG003|Screening (1 Day)|Screened out|1|||
155213119|NCT03851302|560217598|FG004|Screening (1 Day)|Screened out|0|||
155213120|NCT03851302|560217599|FG005|Screening (1 Day)|Screened out|0|||
155213121|NCT03851302|560217594|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
155213122|NCT03851302|560217595|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213123|NCT03851302|560217596|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213124|NCT03851302|560217597|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213125|NCT03851302|560217598|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213126|NCT03851302|560217599|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
155213127|NCT03578367|560217600|FG000|Overall Study|Adverse Event|0|||
155213128|NCT03578367|560217601|FG001|Overall Study|Adverse Event|3|||
155213129|NCT03578367|560217602|FG002|Overall Study|Adverse Event|0|||
155213130|NCT03578367|560217603|FG003|Overall Study|Adverse Event|5|||
155213131|NCT03578367|560217600|FG000|Overall Study|Withdrawal by Subject|2|||
155213132|NCT03578367|560217601|FG001|Overall Study|Withdrawal by Subject|2|||
155213133|NCT03578367|560217602|FG002|Overall Study|Withdrawal by Subject|1|||
155213134|NCT03578367|560217603|FG003|Overall Study|Withdrawal by Subject|3|||
155213135|NCT03578367|560217600|FG000|Overall Study|Physician Decision|0|||
155213136|NCT03578367|560217601|FG001|Overall Study|Physician Decision|0|||
155213137|NCT03578367|560217602|FG002|Overall Study|Physician Decision|14|||
155213138|NCT03578367|560217603|FG003|Overall Study|Physician Decision|0|||
155213139|NCT03578367|560217600|FG000|Overall Study|Death|1|||
155213140|NCT03578367|560217601|FG001|Overall Study|Death|0|||
155213141|NCT03578367|560217602|FG002|Overall Study|Death|0|||
155213142|NCT03578367|560217603|FG003|Overall Study|Death|0|||
155213143|NCT03578367|560217600|FG000|Overall Study|Not treated|0|||
155213144|NCT03578367|560217601|FG001|Overall Study|Not treated|0|||
155213145|NCT03578367|560217602|FG002|Overall Study|Not treated|1|||
155213146|NCT03578367|560217603|FG003|Overall Study|Not treated|0|||
155213147|NCT00587561|560219372|FG000|Overall Study|Lost to Follow-up|6|||
155213148|NCT00587561|560219373|FG001|Overall Study|Lost to Follow-up|4|||
155213149|NCT00982488|560219374|FG000|Overall Study|Administrative reason by sponsor|81|||
155213150|NCT00982488|560219375|FG001|Overall Study|Administrative reason by sponsor|3|||
155213151|NCT00982488|560219376|FG002|Overall Study|Administrative reason by sponsor|11|||
155213152|NCT00982488|560219377|FG003|Overall Study|Administrative reason by sponsor|0|||
155213153|NCT00982488|560219378|FG004|Overall Study|Administrative reason by sponsor|0|||
155213154|NCT00982488|560219374|FG000|Overall Study|Adverse event unrelated to study drug|5|||
155213155|NCT00982488|560219375|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155213156|NCT00982488|560219376|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155213157|NCT00982488|560219377|FG003|Overall Study|Adverse event unrelated to study drug|0|||
155213158|NCT00982488|560219378|FG004|Overall Study|Adverse event unrelated to study drug|0|||
155213159|NCT00982488|560219374|FG000|Overall Study|Death|11|||
155213160|NCT00982488|560219375|FG001|Overall Study|Death|0|||
155213161|NCT00982488|560219376|FG002|Overall Study|Death|2|||
155213162|NCT00982488|560219377|FG003|Overall Study|Death|0|||
155213163|NCT00982488|560219378|FG004|Overall Study|Death|0|||
155213164|NCT00982488|560219374|FG000|Overall Study|Disease progression|30|||
155213165|NCT00982488|560219375|FG001|Overall Study|Disease progression|5|||
155213166|NCT00982488|560219376|FG002|Overall Study|Disease progression|10|||
155213167|NCT00982488|560219377|FG003|Overall Study|Disease progression|1|||
155213168|NCT00982488|560219378|FG004|Overall Study|Disease progression|1|||
155213169|NCT00982488|560219374|FG000|Overall Study|Lost to Follow-up|1|||
155213170|NCT00982488|560219375|FG001|Overall Study|Lost to Follow-up|0|||
155213171|NCT00982488|560219376|FG002|Overall Study|Lost to Follow-up|0|||
155213172|NCT00982488|560219377|FG003|Overall Study|Lost to Follow-up|0|||
155213173|NCT00982488|560219378|FG004|Overall Study|Lost to Follow-up|0|||
155213174|NCT00982488|560219374|FG000|Overall Study|Maximum clinical benefit|1|||
155213175|NCT00982488|560219375|FG001|Overall Study|Maximum clinical benefit|1|||
155213176|NCT00982488|560219376|FG002|Overall Study|Maximum clinical benefit|1|||
155213177|NCT00982488|560219377|FG003|Overall Study|Maximum clinical benefit|0|||
155213178|NCT00982488|560219378|FG004|Overall Study|Maximum clinical benefit|0|||
155213179|NCT00982488|560219374|FG000|Overall Study|Other|15|||
155213180|NCT00982488|560219375|FG001|Overall Study|Other|1|||
155213181|NCT00982488|560219376|FG002|Overall Study|Other|3|||
155213182|NCT00982488|560219377|FG003|Overall Study|Other|1|||
155213183|NCT00982488|560219378|FG004|Overall Study|Other|0|||
155213184|NCT00982488|560219374|FG000|Overall Study|Poor compliance/noncompliance|0|||
155213185|NCT00982488|560219375|FG001|Overall Study|Poor compliance/noncompliance|1|||
155213186|NCT00982488|560219376|FG002|Overall Study|Poor compliance/noncompliance|0|||
155213187|NCT00982488|560219377|FG003|Overall Study|Poor compliance/noncompliance|0|||
155213188|NCT00982488|560219378|FG004|Overall Study|Poor compliance/noncompliance|0|||
155213189|NCT00982488|560219374|FG000|Overall Study|Stem cell transplant|2|||
155213190|NCT00982488|560219375|FG001|Overall Study|Stem cell transplant|0|||
155213191|NCT00982488|560219376|FG002|Overall Study|Stem cell transplant|0|||
155213192|NCT00982488|560219377|FG003|Overall Study|Stem cell transplant|1|||
155213193|NCT00982488|560219378|FG004|Overall Study|Stem cell transplant|0|||
155213194|NCT00982488|560219374|FG000|Overall Study|Study drug toxicity|34|||
155213195|NCT00982488|560219375|FG001|Overall Study|Study drug toxicity|1|||
155213196|NCT00982488|560219376|FG002|Overall Study|Study drug toxicity|6|||
155213197|NCT00982488|560219377|FG003|Overall Study|Study drug toxicity|0|||
155213198|NCT00982488|560219378|FG004|Overall Study|Study drug toxicity|0|||
155213199|NCT00982488|560219374|FG000|Overall Study|Withdrawal by Subject|5|||
155213200|NCT00982488|560219375|FG001|Overall Study|Withdrawal by Subject|1|||
155213201|NCT00982488|560219376|FG002|Overall Study|Withdrawal by Subject|1|||
155213202|NCT00982488|560219377|FG003|Overall Study|Withdrawal by Subject|0|||
155213203|NCT00982488|560219378|FG004|Overall Study|Withdrawal by Subject|0|||
155213204|NCT04244786|560219379|FG000|Overall Study|Adverse Event|0|||
155213205|NCT04244786|560219380|FG001|Overall Study|Adverse Event|0|||
155213206|NCT04244786|560219381|FG002|Overall Study|Adverse Event|2|||
155213207|NCT04244786|560219379|FG000|Overall Study|Withdrawal by Subject|0|||
155213208|NCT04244786|560219380|FG001|Overall Study|Withdrawal by Subject|0|||
155213209|NCT04244786|560219381|FG002|Overall Study|Withdrawal by Subject|5|||
155213210|NCT01199289|560219382|FG000|Overall Study|Ineligibility determined|2|||
155213211|NCT01199289|560219383|FG001|Overall Study|Ineligibility determined|1|||
155213212|NCT01199289|560219384|FG002|Overall Study|Ineligibility determined|0|||
155213213|NCT01199289|560219385|FG003|Overall Study|Ineligibility determined|0|||
155213214|NCT01199289|560219382|FG000|Overall Study|Protocol Violation|1|||
155213215|NCT01199289|560219383|FG001|Overall Study|Protocol Violation|0|||
155213216|NCT01199289|560219384|FG002|Overall Study|Protocol Violation|0|||
155213217|NCT01199289|560219385|FG003|Overall Study|Protocol Violation|1|||
155213218|NCT01199289|560219382|FG000|Overall Study|Noncompliance|1|||
155213219|NCT01199289|560219383|FG001|Overall Study|Noncompliance|0|||
155213220|NCT01199289|560219384|FG002|Overall Study|Noncompliance|2|||
155213221|NCT01199289|560219385|FG003|Overall Study|Noncompliance|0|||
155213222|NCT01199289|560219382|FG000|Overall Study|Adverse Event|0|||
155213223|NCT01199289|560219383|FG001|Overall Study|Adverse Event|3|||
155213224|NCT01199289|560219384|FG002|Overall Study|Adverse Event|1|||
155213225|NCT01199289|560219385|FG003|Overall Study|Adverse Event|4|||
155213226|NCT01199289|560219382|FG000|Overall Study|Full consent withdrawn|2|||
155213227|NCT01199289|560219383|FG001|Overall Study|Full consent withdrawn|2|||
155213228|NCT01199289|560219384|FG002|Overall Study|Full consent withdrawn|2|||
155213229|NCT01199289|560219385|FG003|Overall Study|Full consent withdrawn|3|||
155213230|NCT01199289|560219382|FG000|Overall Study|Administrative decision|0|||
155213231|NCT01199289|560219383|FG001|Overall Study|Administrative decision|0|||
155213232|NCT01199289|560219384|FG002|Overall Study|Administrative decision|0|||
155213233|NCT01199289|560219385|FG003|Overall Study|Administrative decision|1|||
155213234|NCT01199289|560219382|FG000|Overall Study|Lost to Follow-up|0|||
155213235|NCT01199289|560219383|FG001|Overall Study|Lost to Follow-up|0|||
155213236|NCT01199289|560219384|FG002|Overall Study|Lost to Follow-up|0|||
155213237|NCT01199289|560219385|FG003|Overall Study|Lost to Follow-up|1|||
155213238|NCT01199289|560219382|FG000|Overall Study|Protocol-specified criteria|3|||
155213239|NCT01199289|560219383|FG001|Overall Study|Protocol-specified criteria|0|||
155213240|NCT01199289|560219384|FG002|Overall Study|Protocol-specified criteria|0|||
155213241|NCT01199289|560219385|FG003|Overall Study|Protocol-specified criteria|1|||
155213242|NCT01199289|560219382|FG000|Overall Study|Pregnancy|0|||
155213243|NCT01199289|560219383|FG001|Overall Study|Pregnancy|1|||
155213244|NCT01199289|560219384|FG002|Overall Study|Pregnancy|0|||
155213245|NCT01199289|560219385|FG003|Overall Study|Pregnancy|1|||
155213246|NCT00415909|560219387|FG000|Overall Study|Withdrawal by Subject|2|||
155213247|NCT00415909|560219387|FG000|Overall Study|Death|1|||
155213248|NCT02734810|560219388|FG000|Overall Study|Adverse Event|1|||
155213249|NCT02734810|560219389|FG001|Overall Study|Adverse Event|0|||
155213250|NCT02734810|560219388|FG000|Overall Study|Lack of Efficacy|1|||
155213251|NCT02734810|560219389|FG001|Overall Study|Lack of Efficacy|0|||
155213252|NCT02507505|560219391|FG000|Overall Study|Withdrawal by Subject|13|||
155213253|NCT02507505|560219392|FG001|Overall Study|Withdrawal by Subject|11|||
155213254|NCT02507505|560219391|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
155213255|NCT02507505|560219392|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
155213256|NCT02507505|560219391|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
155213257|NCT02507505|560219392|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
155213258|NCT02507505|560219391|FG000|Overall Study|Death before receipt of anesthesia|0|||
155213259|NCT02507505|560219392|FG001|Overall Study|Death before receipt of anesthesia|1|||
155213260|NCT00254540|560219393|FG000|Overall Study|Adverse Event|6|||
155213261|NCT00254540|560219394|FG001|Overall Study|Adverse Event|7|||
155213262|NCT00254540|560219393|FG000|Overall Study|Lack of Efficacy|13|||
155213263|NCT00254540|560219394|FG001|Overall Study|Lack of Efficacy|13|||
155213264|NCT00254540|560219393|FG000|Overall Study|Death|0|||
155213265|NCT00254540|560219394|FG001|Overall Study|Death|1|||
155213266|NCT00254540|560219393|FG000|Overall Study|Laboratory Test Abnormality|0|||
155213267|NCT00254540|560219394|FG001|Overall Study|Laboratory Test Abnormality|1|||
155213268|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
155213269|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
155213270|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
155213271|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
155213272|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
155213273|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
155213274|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
155213275|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
155213276|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
155213277|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
155213278|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
155213279|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
155213280|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
155213281|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
155213282|NCT00293254|560219395|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
155213283|NCT00293254|560219396|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
155213284|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
155213285|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
155213286|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Death|4|||
155213287|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Death|1|||
155213288|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
155213289|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
155213290|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
155213291|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
155213292|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
155213293|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
155213294|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
155213295|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
155213296|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
155213297|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
155213298|NCT00293254|560219395|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
155213299|NCT00293254|560219396|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
155213300|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
155213301|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
155213302|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
155213303|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
155213304|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
155213305|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
155213306|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
155213307|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
155213308|NCT00293254|560219395|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
155213309|NCT00293254|560219396|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
155213310|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
155213311|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
155213312|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
155213313|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
155213314|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
155213315|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
155213316|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
155213317|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
155213318|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
155213319|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
155213320|NCT00293254|560219395|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
155213321|NCT00293254|560219396|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
155213322|NCT00503308|560219397|FG000|Overall Study|Protocol Violation|2|||
155213323|NCT00503308|560219398|FG001|Overall Study|Protocol Violation|1|||
155213324|NCT04481750|560219399|FG000|Period 1 (Fasted)|Adverse Event|0|||
155213325|NCT04481750|560219400|FG001|Period 1 (Fasted)|Adverse Event|0|||
155213326|NCT04481750|560219401|FG002|Period 1 (Fasted)|Adverse Event|1|||
155213327|NCT04481750|560219402|FG003|Period 1 (Fasted)|Adverse Event|0|||
155213328|NCT04481750|560219403|FG004|Period 1 (Fasted)|Adverse Event|0|||
155213329|NCT04481750|560219404|FG005|Period 1 (Fasted)|Adverse Event|0|||
155213330|NCT04481750|560219405|FG006|Period 1 (Fasted)|Adverse Event|0|||
155213331|NCT04481750|560219406|FG007|Period 1 (Fasted)|Adverse Event|0|||
155213332|NCT04481750|560219407|FG008|Period 1 (Fasted)|Adverse Event|0|||
155213333|NCT04481750|560219408|FG009|Period 1 (Fasted)|Adverse Event|0|||
155213334|NCT04481750|560219409|FG010|Period 1 (Fasted)|Adverse Event|0|||
155213335|NCT00475176|560219410|FG000|Overall Study|Adverse Event|2|||
155213336|NCT00475176|560219410|FG000|Overall Study|Withdrawal by Subject|1|||
155213337|NCT00475176|560219410|FG000|Overall Study|Protocol Violation|1|||
155213338|NCT01113801|560219413|FG000|Overall Study|Adverse Event|4|||
155213339|NCT01113801|560219414|FG001|Overall Study|Adverse Event|0|||
155213340|NCT01113801|560219415|FG002|Overall Study|Adverse Event|2|||
155213341|NCT01113801|560219416|FG003|Overall Study|Adverse Event|6|||
155213342|NCT01113801|560219413|FG000|Overall Study|Death|4|||
155213343|NCT01113801|560219414|FG001|Overall Study|Death|5|||
155213344|NCT01113801|560219415|FG002|Overall Study|Death|3|||
155213345|NCT01113801|560219416|FG003|Overall Study|Death|4|||
155213346|NCT01113801|560219413|FG000|Overall Study|Protocol Violation|0|||
155213347|NCT01113801|560219414|FG001|Overall Study|Protocol Violation|1|||
155213348|NCT01113801|560219415|FG002|Overall Study|Protocol Violation|0|||
155213349|NCT01113801|560219416|FG003|Overall Study|Protocol Violation|0|||
155213350|NCT01113801|560219413|FG000|Overall Study|Withdrawal by Subject|9|||
155213351|NCT01113801|560219414|FG001|Overall Study|Withdrawal by Subject|7|||
155213352|NCT01113801|560219415|FG002|Overall Study|Withdrawal by Subject|7|||
155213353|NCT01113801|560219416|FG003|Overall Study|Withdrawal by Subject|8|||
155213354|NCT01113801|560219413|FG000|Overall Study|Physician Decision|2|||
155213355|NCT01113801|560219414|FG001|Overall Study|Physician Decision|2|||
155213356|NCT01113801|560219415|FG002|Overall Study|Physician Decision|3|||
155213357|NCT01113801|560219416|FG003|Overall Study|Physician Decision|3|||
155213358|NCT01113801|560219413|FG000|Overall Study|Sponsor Decision|15|||
155213359|NCT01113801|560219414|FG001|Overall Study|Sponsor Decision|21|||
155213360|NCT01113801|560219415|FG002|Overall Study|Sponsor Decision|20|||
155213361|NCT01113801|560219416|FG003|Overall Study|Sponsor Decision|15|||
155213362|NCT01113801|560219413|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
155213363|NCT01113801|560219414|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
155213364|NCT01113801|560219415|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
155213365|NCT01113801|560219416|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
155213366|NCT03287804|560219417|FG000|Overall Study|Death|1|||
155213367|NCT03287804|560219417|FG000|Overall Study|Physician Decision|2|||
155213368|NCT03287804|560219417|FG000|Overall Study|Progressive disease|8|||
155213369|NCT03178773|560219428|FG000|Overall Study|Death|0|||
155213370|NCT03178773|560219429|FG001|Overall Study|Death|1|||
155213371|NCT03178773|560219428|FG000|Overall Study|Lost to Follow-up|29|||
155213372|NCT03178773|560219429|FG001|Overall Study|Lost to Follow-up|25|||
155213373|NCT03178773|560219428|FG000|Overall Study|Withdrawal by Subject|10|||
155213374|NCT03178773|560219429|FG001|Overall Study|Withdrawal by Subject|14|||
155213375|NCT00770289|560219430|FG000|Overall Study|Other|6|||
155213376|NCT02733991|560219431|FG000|Overall Study|Adverse Event|1|||
155213377|NCT02733991|560219432|FG001|Overall Study|Adverse Event|0|||
155213378|NCT02733991|560219431|FG000|Overall Study|Withdrawal by Subject|0|||
155213379|NCT02733991|560219432|FG001|Overall Study|Withdrawal by Subject|5|||
155213380|NCT02617511|560219438|FG000|Overall Study|Withdrawal by Subject|1|||
155213381|NCT02617511|560219439|FG001|Overall Study|Withdrawal by Subject|0|||
155213382|NCT00255047|560219440|FG000|Overall Study|Serious Adverse Events|2|||
155213383|NCT00255047|560219441|FG001|Overall Study|Serious Adverse Events|1|||
155213384|NCT00255047|560219442|FG002|Overall Study|Serious Adverse Events|2|||
155213385|NCT00255047|560219443|FG003|Overall Study|Serious Adverse Events|1|||
155213386|NCT00255047|560219440|FG000|Overall Study|Adverse Event|0|||
155213387|NCT00255047|560219441|FG001|Overall Study|Adverse Event|3|||
155213388|NCT00255047|560219442|FG002|Overall Study|Adverse Event|2|||
155213389|NCT00255047|560219443|FG003|Overall Study|Adverse Event|1|||
155213390|NCT00255047|560219440|FG000|Overall Study|Protocol Violation|13|||
155213391|NCT00255047|560219441|FG001|Overall Study|Protocol Violation|13|||
155213392|NCT00255047|560219442|FG002|Overall Study|Protocol Violation|16|||
155213393|NCT00255047|560219443|FG003|Overall Study|Protocol Violation|20|||
155213394|NCT00255047|560219440|FG000|Overall Study|Lost to Follow-up|9|||
155213395|NCT00255047|560219441|FG001|Overall Study|Lost to Follow-up|8|||
155213396|NCT00255047|560219442|FG002|Overall Study|Lost to Follow-up|5|||
155213397|NCT00255047|560219443|FG003|Overall Study|Lost to Follow-up|6|||
155213398|NCT00255047|560219440|FG000|Overall Study|Withdrawal by Subject|24|||
155213399|NCT00255047|560219441|FG001|Overall Study|Withdrawal by Subject|23|||
155213400|NCT00255047|560219442|FG002|Overall Study|Withdrawal by Subject|25|||
155213401|NCT00255047|560219443|FG003|Overall Study|Withdrawal by Subject|18|||
155213402|NCT00811473|560219444|FG000|Overall Study|Adverse Event|3|||
155213403|NCT00811473|560219445|FG001|Overall Study|Adverse Event|12|||
155213404|NCT00811473|560219444|FG000|Overall Study|Lost to Follow-up|5|||
155213405|NCT00811473|560219445|FG001|Overall Study|Lost to Follow-up|1|||
155213406|NCT00811473|560219444|FG000|Overall Study|Withdrawal by Subject|2|||
155213407|NCT00811473|560219445|FG001|Overall Study|Withdrawal by Subject|4|||
155213408|NCT00811473|560219444|FG000|Overall Study|Severe non-compliance to protocol|2|||
155213409|NCT00811473|560219445|FG001|Overall Study|Severe non-compliance to protocol|4|||
155213410|NCT00811473|560219444|FG000|Overall Study|Lack of therapeutic response|4|||
155213411|NCT00811473|560219445|FG001|Overall Study|Lack of therapeutic response|1|||
155213412|NCT00811473|560219444|FG000|Overall Study|Condition under investigation worsened|1|||
155213413|NCT00811473|560219445|FG001|Overall Study|Condition under investigation worsened|3|||
155213414|NCT00811473|560219444|FG000|Overall Study|Other 2|4|||
155213415|NCT00811473|560219445|FG001|Overall Study|Other 2|1|||
155213416|NCT00811473|560219444|FG000|Overall Study|Incorrect Enrollment|1|||
155213417|NCT00811473|560219445|FG001|Overall Study|Incorrect Enrollment|0|||
155213418|NCT00811473|560219444|FG000|Overall Study|Safety Reasons|1|||
155213419|NCT00811473|560219445|FG001|Overall Study|Safety Reasons|0|||
155213420|NCT01585194|560219455|FG000|Overall Study|Withdrawal by Subject|1|||
155213421|NCT01585194|560219455|FG000|Overall Study|Physician Decision|2|||
155213422|NCT01585194|560219455|FG000|Overall Study|Lack of insurance|1|||
155213423|NCT01119131|560219456|FG000|Overall Study|Adverse Event|1|||
155213424|NCT01119131|560219457|FG001|Overall Study|Adverse Event|1|||
155213425|NCT01119131|560219458|FG002|Overall Study|Adverse Event|1|||
155213426|NCT01119131|560219456|FG000|Overall Study|Non-Compliance|1|||
155213427|NCT01119131|560219457|FG001|Overall Study|Non-Compliance|0|||
155213428|NCT01119131|560219458|FG002|Overall Study|Non-Compliance|4|||
155213429|NCT01119131|560219456|FG000|Overall Study|Physician Decision|0|||
155213430|NCT01119131|560219457|FG001|Overall Study|Physician Decision|0|||
155213431|NCT01119131|560219458|FG002|Overall Study|Physician Decision|1|||
155213432|NCT00732615|560219459|FG000|Overall Study|Withdrawal by Subject|3|||
155213433|NCT00732615|560219460|FG001|Overall Study|Withdrawal by Subject|1|||
155213434|NCT00732615|560219459|FG000|Overall Study|Lost to Follow-up|0|||
155213435|NCT00732615|560219460|FG001|Overall Study|Lost to Follow-up|1|||
155213436|NCT00732615|560219459|FG000|Overall Study|Adverse Event|0|||
155213437|NCT00732615|560219460|FG001|Overall Study|Adverse Event|2|||
155213438|NCT00732615|560219459|FG000|Overall Study|Physician Decision|3|||
155213439|NCT00732615|560219460|FG001|Overall Study|Physician Decision|0|||
155213440|NCT00732615|560219459|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
155213441|NCT00732615|560219460|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
155213442|NCT00993291|560219461|FG000|Overall Study|Withdrawal by Subject|1|||
155213443|NCT00003492|560219462|FG000|Overall Study|Not evaluable|6|||
155213444|NCT01333059|560219463|FG000|Overall Study|Physician Decision|3|||
155213445|NCT01333059|560219464|FG001|Overall Study|Physician Decision|3|||
155213446|NCT01333059|560219463|FG000|Overall Study|Protocol Violation|3|||
155213447|NCT01333059|560219464|FG001|Overall Study|Protocol Violation|0|||
155213448|NCT03566823|560219465|FG000|Overall Study|Lack of Efficacy|0|||
155213449|NCT03566823|560219466|FG001|Overall Study|Lack of Efficacy|1|||
155213450|NCT03566823|560219467|FG002|Overall Study|Lack of Efficacy|0|||
155213451|NCT03566823|560219465|FG000|Overall Study|Withdrawal by Subject|1|||
155213452|NCT03566823|560219466|FG001|Overall Study|Withdrawal by Subject|2|||
155213453|NCT03566823|560219467|FG002|Overall Study|Withdrawal by Subject|0|||
155213454|NCT03566823|560219465|FG000|Overall Study|Adverse Event|1|||
155213455|NCT03566823|560219466|FG001|Overall Study|Adverse Event|0|||
155213456|NCT03566823|560219467|FG002|Overall Study|Adverse Event|2|||
155213457|NCT04446377|560219468|FG000|Overall Study|Withdrawal by Subject|6|||
155213458|NCT04446377|560219469|FG001|Overall Study|Withdrawal by Subject|1|||
155213459|NCT04446377|560219468|FG000|Overall Study|Physician Decision|1|||
155213460|NCT04446377|560219469|FG001|Overall Study|Physician Decision|1|||
155213461|NCT04446377|560219468|FG000|Overall Study|Lost to Follow-up|0|||
155213462|NCT04446377|560219469|FG001|Overall Study|Lost to Follow-up|2|||
155213463|NCT04446377|560219468|FG000|Overall Study|Not eligible|0|||
155213464|NCT04446377|560219469|FG001|Overall Study|Not eligible|1|||
155213465|NCT01414075|560219477|FG000|Overall Study|Adverse Event|1|||
155213466|NCT01414075|560219478|FG001|Overall Study|Adverse Event|0|||
155213467|NCT01414075|560219479|FG002|Overall Study|Adverse Event|1|||
155213468|NCT01414075|560219480|FG003|Overall Study|Adverse Event|0|||
155213469|NCT01414075|560219477|FG000|Overall Study|Death|1|||
155213470|NCT01414075|560219478|FG001|Overall Study|Death|0|||
155213471|NCT01414075|560219479|FG002|Overall Study|Death|0|||
155213472|NCT01414075|560219480|FG003|Overall Study|Death|1|||
155213473|NCT01414075|560219477|FG000|Overall Study|Withdrawal by Subject|0|||
155213474|NCT01414075|560219478|FG001|Overall Study|Withdrawal by Subject|0|||
155213475|NCT01414075|560219479|FG002|Overall Study|Withdrawal by Subject|0|||
155213476|NCT01414075|560219480|FG003|Overall Study|Withdrawal by Subject|1|||
155213477|NCT01414075|560219477|FG000|Overall Study|Other than specified|1|||
155213478|NCT01414075|560219478|FG001|Overall Study|Other than specified|0|||
155213479|NCT01414075|560219479|FG002|Overall Study|Other than specified|1|||
155213480|NCT01414075|560219480|FG003|Overall Study|Other than specified|0|||
155213481|NCT01187043|560219483|FG000|Overall Study|Adverse Event|0|||
155213482|NCT01187043|560219484|FG001|Overall Study|Adverse Event|0|||
155213483|NCT01187043|560219485|FG002|Overall Study|Adverse Event|0|||
155213484|NCT01187043|560219486|FG003|Overall Study|Adverse Event|0|||
155213485|NCT01187043|560219487|FG004|Overall Study|Adverse Event|1|||
155213486|NCT01187043|560219483|FG000|Overall Study|Unable to make scheduled visits|1|||
155213487|NCT01187043|560219484|FG001|Overall Study|Unable to make scheduled visits|0|||
155213488|NCT01187043|560219485|FG002|Overall Study|Unable to make scheduled visits|4|||
155213489|NCT01187043|560219486|FG003|Overall Study|Unable to make scheduled visits|0|||
155213490|NCT01187043|560219487|FG004|Overall Study|Unable to make scheduled visits|1|||
155213491|NCT04903626|560219488|FG000|Overall Study|Lost to Follow-up|6|||
155213492|NCT04903626|560219488|FG000|Overall Study|Withdrawal by Subject|1|||
155213493|NCT04903626|560219488|FG000|Overall Study|Other, Not Specified|1|||
155213494|NCT00573534|560219489|FG000|Overall Study|oppositional behavior|3|||
155213495|NCT03035409|560219490|FG000|Overall Study|Adverse Event|5|||
155213496|NCT03035409|560219490|FG000|Overall Study|Death|2|||
155213497|NCT03035409|560219490|FG000|Overall Study|Withdrawal by Subject|2|||
155213498|NCT03035409|560219490|FG000|Overall Study|Non compliance|4|||
155213499|NCT03035409|560219490|FG000|Overall Study|Patient was jittery|1|||
155213500|NCT03035409|560219490|FG000|Overall Study|Did not like Questionnaire|1|||
155213501|NCT03035409|560219490|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
155213502|NCT03035409|560219490|FG000|Overall Study|Did not like taking drugs|1|||
155213503|NCT00927784|560219495|FG000|Overall Study|Death|1|||
155213504|NCT00927784|560219496|FG001|Overall Study|Death|0|||
155213505|NCT00927784|560219495|FG000|Overall Study|Withdrawal by Subject|1|||
155213506|NCT00927784|560219496|FG001|Overall Study|Withdrawal by Subject|0|||
155213507|NCT02457910|560219497|FG000|Overall Study|Withdrawal by Subject|0|||
155213508|NCT02457910|560219498|FG001|Overall Study|Withdrawal by Subject|0|||
155213509|NCT02457910|560219499|FG002|Overall Study|Withdrawal by Subject|0|||
155213510|NCT02457910|560219500|FG003|Overall Study|Withdrawal by Subject|0|||
155213511|NCT02457910|560219501|FG004|Overall Study|Withdrawal by Subject|0|||
155213512|NCT02457910|560219502|FG005|Overall Study|Withdrawal by Subject|1|||
155213513|NCT02457910|560219497|FG000|Overall Study|Adverse Event|0|||
155213514|NCT02457910|560219498|FG001|Overall Study|Adverse Event|2|||
155213515|NCT02457910|560219499|FG002|Overall Study|Adverse Event|1|||
155213516|NCT02457910|560219500|FG003|Overall Study|Adverse Event|1|||
155213517|NCT02457910|560219501|FG004|Overall Study|Adverse Event|1|||
155213518|NCT02457910|560219502|FG005|Overall Study|Adverse Event|3|||
155213519|NCT02457910|560219497|FG000|Overall Study|Disease progression|3|||
155213520|NCT02457910|560219498|FG001|Overall Study|Disease progression|3|||
155213521|NCT02457910|560219499|FG002|Overall Study|Disease progression|1|||
155213522|NCT02457910|560219500|FG003|Overall Study|Disease progression|1|||
155213523|NCT02457910|560219501|FG004|Overall Study|Disease progression|4|||
155213524|NCT02457910|560219502|FG005|Overall Study|Disease progression|6|||
155213525|NCT02457910|560219497|FG000|Overall Study|Other complicating illness|0|||
155213526|NCT02457910|560219498|FG001|Overall Study|Other complicating illness|0|||
155213527|NCT02457910|560219499|FG002|Overall Study|Other complicating illness|0|||
155213528|NCT02457910|560219500|FG003|Overall Study|Other complicating illness|0|||
155213529|NCT02457910|560219501|FG004|Overall Study|Other complicating illness|0|||
155213530|NCT02457910|560219502|FG005|Overall Study|Other complicating illness|1|||
155213531|NCT02457910|560219497|FG000|Overall Study|Death|0|||
155213532|NCT02457910|560219498|FG001|Overall Study|Death|0|||
155213533|NCT02457910|560219499|FG002|Overall Study|Death|1|||
155213534|NCT02457910|560219500|FG003|Overall Study|Death|0|||
155213535|NCT02457910|560219501|FG004|Overall Study|Death|0|||
155213536|NCT02457910|560219502|FG005|Overall Study|Death|0|||
155213537|NCT00467259|560219503|FG000|Overall Study|Adverse Event|24|||
155213538|NCT00467259|560219504|FG001|Overall Study|Adverse Event|90|||
155213539|NCT00467259|560219503|FG000|Overall Study|Protocol Violation|1|||
155213540|NCT00467259|560219504|FG001|Overall Study|Protocol Violation|7|||
155213541|NCT00467259|560219503|FG000|Overall Study|Withdrawal by Subject|34|||
155213542|NCT00467259|560219504|FG001|Overall Study|Withdrawal by Subject|108|||
155213543|NCT00467259|560219503|FG000|Overall Study|Physician Decision|0|||
155213544|NCT00467259|560219504|FG001|Overall Study|Physician Decision|2|||
155213545|NCT00467259|560219503|FG000|Overall Study|Lost to Follow-up|14|||
155213546|NCT00467259|560219504|FG001|Overall Study|Lost to Follow-up|34|||
155213547|NCT00467259|560219503|FG000|Overall Study|Site Closed|2|||
155213548|NCT00467259|560219504|FG001|Overall Study|Site Closed|1|||
155213549|NCT06079320|560219508|FG000|Follow up Phase|Lost to Follow-up|1|||
155213550|NCT06079320|560219509|FG001|Follow up Phase|Lost to Follow-up|0|||
155213551|NCT01405742|560219510|FG000|Overall Study|Lost to Follow-up|1|||
155213552|NCT01405742|560219511|FG001|Overall Study|Lost to Follow-up|0|||
155213553|NCT04900220|560219512|FG000|Overall Study|Lost to Follow-up|1|||
155213554|NCT04900220|560219513|FG001|Overall Study|Lost to Follow-up|1|||
155213555|NCT02196558|560219514|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
155213556|NCT02196558|560219515|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
155213557|NCT02196558|560219516|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
155213558|NCT02196558|560219514|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
155213559|NCT02196558|560219515|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
155213560|NCT02196558|560219516|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
155213561|NCT02196558|560219514|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
155213562|NCT02196558|560219515|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
155213563|NCT02196558|560219516|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
155213564|NCT02196558|560219514|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
155213565|NCT02196558|560219515|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
155213566|NCT02196558|560219516|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
155213567|NCT02196558|560219514|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
155213568|NCT02196558|560219515|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
155213569|NCT02196558|560219516|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
155213570|NCT03428360|560219517|FG000|Overall Study|Informed consent withdrawn|5|||
155213571|NCT03428360|560219517|FG000|Overall Study|Withdrawal by Subject|4|||
155213572|NCT03428360|560219517|FG000|Overall Study|Lost to Follow-up|5|||
155213573|NCT03428360|560219517|FG000|Overall Study|Physician Decision|2|||
155213574|NCT03428360|560219517|FG000|Overall Study|Informed consent withdrawn|5|||
155213575|NCT03428360|560219517|FG000|Overall Study|Study terminated by sponsor|10|||
155213576|NCT03428360|560219517|FG000|Overall Study|Non-compliant with study|1|||
155213577|NCT03428360|560219517|FG000|Overall Study|Non-compliant with study drug|3|||
155213578|NCT03428360|560219517|FG000|Overall Study|Death|3|||
155213579|NCT03428360|560219517|FG000|Overall Study|Adverse Event|1|||
155213580|NCT03428360|560219517|FG000|Overall Study|Not on antiepileptic drug|1|||
155213581|NCT02107482|560219521|FG000|Overall Study|inconveinence|2|||
155213582|NCT02107482|560219521|FG000|Overall Study|Lost to Follow-up|1|||
155213583|NCT02107482|560219521|FG000|Overall Study|Lack of Efficacy|1|||
155213584|NCT00576927|560219524|FG000|Clinical Assessment|Lack of Efficacy|24|||
155213585|NCT00576927|560219524|FG000|Clinical Assessment|Death|1|||
155213586|NCT00576927|560219524|FG000|Clinical Assessment|Withdrawal by Subject|10|||
155213587|NCT00576927|560219524|FG000|Clinical Assessment|Physician Decision|1|||
155213588|NCT00576927|560219524|FG000|Baseline|Physician Decision|9|||
155213589|NCT00576927|560219524|FG000|Baseline|Medication Change by PCP of subject|1|||
155213590|NCT00576927|560219524|FG000|Baseline|Withdrawal by Subject|3|||
155213591|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
155213592|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
155213593|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
155213594|NCT00576927|560219524|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
155213595|NCT00576927|560219524|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
155213596|NCT03128892|560219525|FG000|Overall Study|Withdrawal by Subject|2|||
155213597|NCT03128892|560219525|FG000|Overall Study|Physician Decision|1|||
155213598|NCT01850524|560219528|FG000|Overall Study|Lost to Follow-up|5|||
155213599|NCT01850524|560219529|FG001|Overall Study|Lost to Follow-up|10|||
155213600|NCT01850524|560219528|FG000|Overall Study|Withdrawal by Subject|24|||
155213601|NCT01850524|560219529|FG001|Overall Study|Withdrawal by Subject|22|||
155213602|NCT01850524|560219528|FG000|Overall Study|Reason not Specified|142|||
155213603|NCT01850524|560219529|FG001|Overall Study|Reason not Specified|141|||
155213604|NCT00368355|560219530|FG000|Overall Study|Adverse Event|1|||
155213605|NCT00368355|560219531|FG001|Overall Study|Adverse Event|0|||
155213606|NCT00368355|560219530|FG000|Overall Study|Death|2|||
155213607|NCT00368355|560219531|FG001|Overall Study|Death|4|||
155213608|NCT00368355|560219530|FG000|Overall Study|Relapse|6|||
155213609|NCT00368355|560219531|FG001|Overall Study|Relapse|10|||
155213610|NCT00368355|560219530|FG000|Overall Study|Subsequent transplant|0|||
155213611|NCT00368355|560219531|FG001|Overall Study|Subsequent transplant|3|||
155213612|NCT00368355|560219530|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
155213613|NCT00368355|560219531|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
155213614|NCT03473808|560219541|FG000|Overall Study|Withdrawal by Subject|1|||
155213615|NCT04059094|560219544|FG000|Overall Study|Adverse Event|0|||
155213616|NCT04059094|560219545|FG001|Overall Study|Adverse Event|0|||
155213617|NCT04059094|560219546|FG002|Overall Study|Adverse Event|0|||
155213618|NCT04059094|560219547|FG003|Overall Study|Adverse Event|0|||
155213619|NCT04059094|560219548|FG004|Overall Study|Adverse Event|1|||
155213620|NCT04059094|560219544|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213621|NCT04059094|560219545|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
155213622|NCT04059094|560219546|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213623|NCT04059094|560219547|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213624|NCT04059094|560219548|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
155213625|NCT00883116|560219553|FG000|Overall Study|Adverse event unrelated to study drug|5|||
155213626|NCT00883116|560219554|FG001|Overall Study|Adverse event unrelated to study drug|10|||
155213627|NCT00883116|560219553|FG000|Overall Study|Death|6|||
155213628|NCT00883116|560219554|FG001|Overall Study|Death|2|||
155213629|NCT00883116|560219553|FG000|Overall Study|Disease progression|130|||
155213630|NCT00883116|560219554|FG001|Overall Study|Disease progression|128|||
155213631|NCT00883116|560219553|FG000|Overall Study|Lost to Follow-up|0|||
155213632|NCT00883116|560219554|FG001|Overall Study|Lost to Follow-up|1|||
155213633|NCT00883116|560219553|FG000|Overall Study|Maximum clinical benefit|13|||
155213634|NCT00883116|560219554|FG001|Overall Study|Maximum clinical benefit|46|||
155213635|NCT00883116|560219553|FG000|Overall Study|Not identified|3|||
155213636|NCT00883116|560219554|FG001|Overall Study|Not identified|6|||
155213637|NCT00883116|560219553|FG000|Overall Study|Study drug toxicity|36|||
155213638|NCT00883116|560219554|FG001|Overall Study|Study drug toxicity|16|||
155213639|NCT00883116|560219553|FG000|Overall Study|Withdrawal by Subject|14|||
155213640|NCT00883116|560219554|FG001|Overall Study|Withdrawal by Subject|8|||
155213641|NCT00883116|560219553|FG000|Overall Study|No longer meets study criteria|2|||
155213642|NCT00883116|560219554|FG001|Overall Study|No longer meets study criteria|2|||
155213643|NCT01059799|560219557|FG000|Overall Study|Adverse Event|2|||
155213644|NCT01059799|560219558|FG001|Overall Study|Adverse Event|3|||
155213645|NCT01059799|560219557|FG000|Overall Study|Lack of Efficacy|1|||
155213646|NCT01059799|560219558|FG001|Overall Study|Lack of Efficacy|0|||
155213647|NCT01059799|560219557|FG000|Overall Study|Protocol Violation|3|||
155213648|NCT01059799|560219558|FG001|Overall Study|Protocol Violation|2|||
155213649|NCT01059799|560219557|FG000|Overall Study|Withdrawal criteria|13|||
155213650|NCT01059799|560219558|FG001|Overall Study|Withdrawal criteria|2|||
155213651|NCT01059799|560219557|FG000|Overall Study|Other|12|||
155213652|NCT01059799|560219558|FG001|Overall Study|Other|3|||
155213653|NCT04772755|560219562|FG000|Overall Study|Withdrawal by Subject|1|||
155213654|NCT04772755|560219563|FG001|Overall Study|Withdrawal by Subject|0|||
155213655|NCT04772755|560219562|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
155213656|NCT04772755|560219563|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
155213657|NCT03204981|560222007|FG000|Overall Study|Physician Decision|2|||
155213658|NCT03204981|560222007|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
155213659|NCT04203238|560222008|FG000|Overall Study|Withdrawal by Subject|1|||
155213660|NCT04203238|560222009|FG001|Overall Study|Withdrawal by Subject|1|||
155213661|NCT04203238|560222008|FG000|Overall Study|Covid-19|3|||
155213662|NCT04203238|560222009|FG001|Overall Study|Covid-19|0|||
155213663|NCT00001596|560222012|FG000|Overall Study|Death|1|||
155213664|NCT00001596|560222013|FG001|Overall Study|Death|0|||
155213665|NCT00001596|560222012|FG000|Overall Study|Withdrawal by Subject|3|||
155213666|NCT00001596|560222013|FG001|Overall Study|Withdrawal by Subject|1|||
155213667|NCT00001596|560222012|FG000|Overall Study|Study Termination|12|||
155213668|NCT00001596|560222013|FG001|Overall Study|Study Termination|9|||
155213669|NCT00001596|560222012|FG000|Overall Study|Adverse Event|1|||
155213670|NCT00001596|560222013|FG001|Overall Study|Adverse Event|0|||
155213671|NCT03274687|560222014|FG000|Overall Study|Protocol Violation|1|||
155213672|NCT03274687|560222015|FG001|Overall Study|Protocol Violation|1|||
155213673|NCT00180414|560222020|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
155213674|NCT00180414|560222021|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
155213675|NCT00613938|560222026|FG000|Overall Study|Withdrawal by Subject|2|||
155213676|NCT00613938|560222027|FG001|Overall Study|Withdrawal by Subject|4|||
155213677|NCT00613938|560222028|FG002|Overall Study|Withdrawal by Subject|9|||
155213678|NCT00613938|560222029|FG003|Overall Study|Withdrawal by Subject|9|||
155213679|NCT00613938|560222026|FG000|Overall Study|Adverse Event|1|||
155213680|NCT00613938|560222027|FG001|Overall Study|Adverse Event|4|||
155213681|NCT00613938|560222028|FG002|Overall Study|Adverse Event|8|||
155213682|NCT00613938|560222029|FG003|Overall Study|Adverse Event|5|||
155213683|NCT00613938|560222026|FG000|Overall Study|Lack of Efficacy|16|||
155213684|NCT00613938|560222027|FG001|Overall Study|Lack of Efficacy|18|||
155213685|NCT00613938|560222028|FG002|Overall Study|Lack of Efficacy|5|||
155213686|NCT00613938|560222029|FG003|Overall Study|Lack of Efficacy|9|||
155213687|NCT00613938|560222026|FG000|Overall Study|Other|1|||
155213688|NCT00613938|560222027|FG001|Overall Study|Other|2|||
155213689|NCT00613938|560222028|FG002|Overall Study|Other|1|||
155213690|NCT00613938|560222029|FG003|Overall Study|Other|3|||
155213691|NCT00623727|560222030|FG000|Double Blind (DB)|Adverse Event|1|||
155213692|NCT00623727|560222031|FG001|Double Blind (DB)|Adverse Event|3|||
155213693|NCT00623727|560222030|FG000|Double Blind (DB)|Physician Decision|0|||
155213694|NCT00623727|560222031|FG001|Double Blind (DB)|Physician Decision|1|||
155213695|NCT00623727|560222030|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
155213696|NCT00623727|560222031|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
155213697|NCT00623727|560222030|FG000|Double Blind (DB)|Lack of Efficacy|2|||
155213698|NCT00623727|560222031|FG001|Double Blind (DB)|Lack of Efficacy|2|||
155213699|NCT00623727|560222030|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
155213700|NCT00623727|560222031|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
155213701|NCT00623727|560222030|FG000|Double Blind (DB)|Lost to Follow-up|1|||
155213702|NCT00623727|560222031|FG001|Double Blind (DB)|Lost to Follow-up|1|||
155213703|NCT00623727|560222030|FG000|Double Blind (DB)|Protocol Violation|2|||
155213704|NCT00623727|560222031|FG001|Double Blind (DB)|Protocol Violation|2|||
155213705|NCT00623727|560222030|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
155213706|NCT00623727|560222031|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
155213707|NCT00623727|560222030|FG000|Open Label Follow-up|Study termination|0|||
155213708|NCT00623727|560222031|FG001|Open Label Follow-up|Study termination|6|||
155213709|NCT00623727|560222030|FG000|Open Label Follow-up|Participant convenience|0|||
155213710|NCT00623727|560222031|FG001|Open Label Follow-up|Participant convenience|1|||
155213711|NCT02636868|560222032|FG000|Overall Study|Death|0|||
155213712|NCT02636868|560222033|FG001|Overall Study|Death|1|||
155213713|NCT02636868|560222034|FG002|Overall Study|Death|2|||
155213714|NCT03220217|560222035|FG000|Overall Study|Withdrawal by Subject|0|||
155213715|NCT03220217|560222036|FG001|Overall Study|Withdrawal by Subject|1|||
155213716|NCT03220217|560222037|FG002|Overall Study|Withdrawal by Subject|0|||
155213717|NCT03220217|560222035|FG000|Overall Study|Subject Missed Procedure|0|||
155213718|NCT03220217|560222036|FG001|Overall Study|Subject Missed Procedure|0|||
155213719|NCT03220217|560222037|FG002|Overall Study|Subject Missed Procedure|1|||
155213720|NCT03025542|560222038|FG000|Overall Study|Adverse Event|0|||
155213721|NCT03025542|560222039|FG001|Overall Study|Adverse Event|2|||
155213722|NCT03025542|560222038|FG000|Overall Study|Lost to Follow-up|1|||
155213723|NCT03025542|560222039|FG001|Overall Study|Lost to Follow-up|0|||
155213724|NCT03025542|560222038|FG000|Overall Study|Withdrawal by Subject|1|||
155213725|NCT03025542|560222039|FG001|Overall Study|Withdrawal by Subject|0|||
155213726|NCT03745937|560222040|FG000|Overall Study|Withdrawal by Subject|0|||
155213727|NCT03745937|560222041|FG001|Overall Study|Withdrawal by Subject|0|||
155213728|NCT03745937|560222042|FG002|Overall Study|Withdrawal by Subject|0|||
155213729|NCT03745937|560222043|FG003|Overall Study|Withdrawal by Subject|1|||
155213730|NCT03745937|560222040|FG000|Overall Study|Not-specifed|0|||
155213731|NCT03745937|560222041|FG001|Overall Study|Not-specifed|1|||
155213732|NCT03745937|560222042|FG002|Overall Study|Not-specifed|0|||
155213733|NCT03745937|560222043|FG003|Overall Study|Not-specifed|1|||
155213734|NCT00501293|560222044|FG000|Optimization Period|Enrolled in error|1|||
155213735|NCT00501293|560222045|FG001|Optimization Period|Enrolled in error|0|||
155213736|NCT00501293|560222044|FG000|Maintenance Period|Withdrawal by Subject|14|||
155213737|NCT00501293|560222045|FG001|Maintenance Period|Withdrawal by Subject|13|||
155213738|NCT00501293|560222044|FG000|Maintenance Period|Lost to Follow-up|12|||
155213739|NCT00501293|560222045|FG001|Maintenance Period|Lost to Follow-up|7|||
155213740|NCT00501293|560222044|FG000|Maintenance Period|Adverse Event|6|||
155213741|NCT00501293|560222045|FG001|Maintenance Period|Adverse Event|6|||
155213742|NCT00501293|560222044|FG000|Maintenance Period|Protocol Violation|2|||
155213743|NCT00501293|560222045|FG001|Maintenance Period|Protocol Violation|1|||
155213744|NCT00501293|560222044|FG000|Maintenance Period|Lack of Efficacy|4|||
155213745|NCT00501293|560222045|FG001|Maintenance Period|Lack of Efficacy|1|||
155213746|NCT00501293|560222044|FG000|Maintenance Period|Noncompliant with study medication|5|||
155213747|NCT00501293|560222045|FG001|Maintenance Period|Noncompliant with study medication|0|||
155213748|NCT00501293|560222044|FG000|Maintenance Period|Went into rehabilitation|1|||
155213749|NCT00501293|560222045|FG001|Maintenance Period|Went into rehabilitation|0|||
155213750|NCT00501293|560222044|FG000|Maintenance Period|Would not wear patch|1|||
155213751|NCT00501293|560222045|FG001|Maintenance Period|Would not wear patch|0|||
155213752|NCT00501293|560222044|FG000|Maintenance Period|Application site reaction|1|||
155213753|NCT00501293|560222045|FG001|Maintenance Period|Application site reaction|0|||
155213754|NCT00488345|560222046|FG000|Overall Study|Adverse Event|0|||
155213755|NCT00488345|560222047|FG001|Overall Study|Adverse Event|1|||
155213756|NCT00488345|560222048|FG002|Overall Study|Adverse Event|1|||
155213757|NCT00488345|560222046|FG000|Overall Study|Unable to administer antibiotics at home|0|||
155213758|NCT00488345|560222047|FG001|Overall Study|Unable to administer antibiotics at home|1|||
155213759|NCT00488345|560222048|FG002|Overall Study|Unable to administer antibiotics at home|0|||
155213760|NCT00488345|560222046|FG000|Overall Study|Institutional Review Board review|0|||
155213761|NCT00488345|560222047|FG001|Overall Study|Institutional Review Board review|0|||
155213762|NCT00488345|560222048|FG002|Overall Study|Institutional Review Board review|1|||
155213763|NCT00488345|560222046|FG000|Overall Study|Surgical team recommendation|0|||
155213764|NCT00488345|560222047|FG001|Overall Study|Surgical team recommendation|1|||
155213765|NCT00488345|560222048|FG002|Overall Study|Surgical team recommendation|0|||
155213766|NCT00488345|560222046|FG000|Overall Study|Parent/legal guardian request|0|||
155213767|NCT00488345|560222047|FG001|Overall Study|Parent/legal guardian request|1|||
155213768|NCT00488345|560222048|FG002|Overall Study|Parent/legal guardian request|1|||
155213769|NCT00903617|560222051|FG000|Overall Study|Adverse Event|0|||
155213770|NCT00903617|560222052|FG001|Overall Study|Adverse Event|1|||
155213771|NCT00903617|560222053|FG002|Overall Study|Adverse Event|1|||
155213772|NCT00903617|560222054|FG003|Overall Study|Adverse Event|0|||
155213773|NCT00903617|560222051|FG000|Overall Study|Protocol-defined stopping criteria|0|||
155213774|NCT00903617|560222052|FG001|Overall Study|Protocol-defined stopping criteria|2|||
155213775|NCT00903617|560222053|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155213776|NCT00903617|560222054|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155213777|NCT00903617|560222051|FG000|Overall Study|Lost to Follow-up|2|||
155213778|NCT00903617|560222052|FG001|Overall Study|Lost to Follow-up|0|||
155213779|NCT00903617|560222053|FG002|Overall Study|Lost to Follow-up|1|||
155213780|NCT00903617|560222054|FG003|Overall Study|Lost to Follow-up|1|||
155213781|NCT00903617|560222051|FG000|Overall Study|Withdrawal by Subject|1|||
155213782|NCT00903617|560222052|FG001|Overall Study|Withdrawal by Subject|2|||
155213783|NCT00903617|560222053|FG002|Overall Study|Withdrawal by Subject|3|||
155213784|NCT00903617|560222054|FG003|Overall Study|Withdrawal by Subject|0|||
155213785|NCT01104636|560222055|FG000|Overall Study|Lack of Efficacy|43|||
155213786|NCT01104636|560222055|FG000|Overall Study|Lost to Follow-up|24|||
155213787|NCT01104636|560222055|FG000|Overall Study|Withdrawal by Subject|4|||
155213788|NCT01104636|560222055|FG000|Overall Study|Other|43|||
155213789|NCT01104636|560222055|FG000|Overall Study|Study terminated by sponsor|1|||
155213790|NCT01104636|560222055|FG000|Overall Study|Pregnancy|2|||
155213791|NCT01104636|560222055|FG000|Overall Study|Adverse Event|40|||
155213792|NCT01104636|560222055|FG000|Overall Study|Ongoing|21|||
155213793|NCT01706003|560222056|FG000|Overall Study|Withdrawal by Subject|2|||
155213794|NCT01706003|560222057|FG001|Overall Study|Withdrawal by Subject|0|||
155213795|NCT01706003|560222056|FG000|Overall Study|Not scheduled|3|||
155213796|NCT01706003|560222057|FG001|Overall Study|Not scheduled|0|||
155213797|NCT01706003|560222056|FG000|Overall Study|Lost to Follow-up|6|||
155213798|NCT01706003|560222057|FG001|Overall Study|Lost to Follow-up|4|||
155213799|NCT03182829|560222060|FG000|Overall Study|Protocol Violation|12|||
155213800|NCT03182829|560222061|FG001|Overall Study|Protocol Violation|12|||
155213801|NCT03182829|560222060|FG000|Overall Study|Other|4|||
155213802|NCT03182829|560222061|FG001|Overall Study|Other|3|||
155213803|NCT03316131|560222062|FG000|Treatment Period 2|Protocol deviation|1|||
155213804|NCT03316131|560222063|FG001|Treatment Period 2|Protocol deviation|0|||
155213805|NCT05608005|560222064|FG000|Overall Study|Adverse Event|2|||
155213806|NCT05608005|560222065|FG001|Overall Study|Adverse Event|1|||
155213807|NCT05608005|560222066|FG002|Overall Study|Adverse Event|3|||
155213808|NCT05608005|560222064|FG000|Overall Study|Protocol Violation|2|||
155213809|NCT05608005|560222065|FG001|Overall Study|Protocol Violation|3|||
155213810|NCT05608005|560222066|FG002|Overall Study|Protocol Violation|0|||
155213811|NCT05608005|560222064|FG000|Overall Study|Withdrawal by Subject|10|||
155213812|NCT05608005|560222065|FG001|Overall Study|Withdrawal by Subject|12|||
155213813|NCT05608005|560222066|FG002|Overall Study|Withdrawal by Subject|4|||
155213814|NCT05608005|560222064|FG000|Overall Study|Lost to Follow-up|25|||
155213815|NCT05608005|560222065|FG001|Overall Study|Lost to Follow-up|27|||
155213816|NCT05608005|560222066|FG002|Overall Study|Lost to Follow-up|15|||
155213817|NCT05608005|560222064|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
155213818|NCT05608005|560222065|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
155213819|NCT05608005|560222066|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
155213820|NCT02259582|560222073|FG000|Overall Study|Physician Decision|0|||
155213821|NCT02259582|560222074|FG001|Overall Study|Physician Decision|1|||
155213822|NCT02259582|560222075|FG002|Overall Study|Physician Decision|0|||
155213823|NCT02259582|560222073|FG000|Overall Study|Death|0|||
155213824|NCT02259582|560222074|FG001|Overall Study|Death|0|||
155213825|NCT02259582|560222075|FG002|Overall Study|Death|1|||
155213826|NCT02259582|560222073|FG000|Overall Study|Adverse Event|1|||
155213827|NCT02259582|560222074|FG001|Overall Study|Adverse Event|0|||
155213828|NCT02259582|560222075|FG002|Overall Study|Adverse Event|1|||
155213829|NCT02259582|560222073|FG000|Overall Study|Withdrawal by Subject|0|||
155213830|NCT02259582|560222074|FG001|Overall Study|Withdrawal by Subject|0|||
155213831|NCT02259582|560222075|FG002|Overall Study|Withdrawal by Subject|1|||
155213832|NCT02259582|560222073|FG000|Overall Study|Disease progression|14|||
155213833|NCT02259582|560222074|FG001|Overall Study|Disease progression|15|||
155213834|NCT02259582|560222075|FG002|Overall Study|Disease progression|17|||
155213835|NCT02259582|560222073|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
155213836|NCT02259582|560222074|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
155213837|NCT02259582|560222075|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
155213838|NCT03518073|560222076|FG000|Overall Study|Adverse Event|2|||
155213839|NCT03518073|560222077|FG001|Overall Study|Adverse Event|4|||
155213840|NCT03518073|560222078|FG002|Overall Study|Adverse Event|2|||
155213841|NCT03518073|560222076|FG000|Overall Study|Death|2|||
155213842|NCT03518073|560222077|FG001|Overall Study|Death|1|||
155213843|NCT03518073|560222078|FG002|Overall Study|Death|3|||
155213844|NCT03518073|560222076|FG000|Overall Study|Lost to Follow-up|1|||
155213845|NCT03518073|560222077|FG001|Overall Study|Lost to Follow-up|0|||
155213846|NCT03518073|560222078|FG002|Overall Study|Lost to Follow-up|1|||
155213847|NCT03518073|560222076|FG000|Overall Study|Physician Decision|5|||
155213848|NCT03518073|560222077|FG001|Overall Study|Physician Decision|0|||
155213849|NCT03518073|560222078|FG002|Overall Study|Physician Decision|2|||
155213850|NCT03518073|560222076|FG000|Overall Study|Progressive disease|1|||
155213851|NCT03518073|560222077|FG001|Overall Study|Progressive disease|1|||
155213852|NCT03518073|560222078|FG002|Overall Study|Progressive disease|1|||
155213853|NCT03518073|560222076|FG000|Overall Study|Protocol Violation|1|||
155213854|NCT03518073|560222077|FG001|Overall Study|Protocol Violation|0|||
155213855|NCT03518073|560222078|FG002|Overall Study|Protocol Violation|0|||
155213856|NCT03518073|560222076|FG000|Overall Study|Withdrawal by Subject|30|||
155213857|NCT03518073|560222077|FG001|Overall Study|Withdrawal by Subject|34|||
155213858|NCT03518073|560222078|FG002|Overall Study|Withdrawal by Subject|29|||
155213859|NCT03518073|560222076|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
155213860|NCT03518073|560222077|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
155213861|NCT03518073|560222078|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
155213862|NCT03518073|560222076|FG000|Overall Study|Covid-19|1|||
155213863|NCT03518073|560222077|FG001|Overall Study|Covid-19|2|||
155213864|NCT03518073|560222078|FG002|Overall Study|Covid-19|1|||
155213865|NCT03045081|560222079|FG000|Overall Study|Withdrawal by Subject|6|||
155213866|NCT03045081|560222080|FG001|Overall Study|Withdrawal by Subject|11|||
155213867|NCT01853046|560222081|FG000|Overall Study|Withdrawal by Subject|1|||
155213868|NCT01853046|560222082|FG001|Overall Study|Withdrawal by Subject|1|||
155213869|NCT01853046|560222081|FG000|Overall Study|Adverse Event|4|||
155213870|NCT01853046|560222082|FG001|Overall Study|Adverse Event|2|||
155213871|NCT01853046|560222081|FG000|Overall Study|Disease progression|13|||
155213872|NCT01853046|560222082|FG001|Overall Study|Disease progression|3|||
155213873|NCT03804879|560222083|FG000|Overall Study|Adverse Event|3|||
155213874|NCT03804879|560222084|FG001|Overall Study|Adverse Event|0|||
155213875|NCT03804879|560222083|FG000|Overall Study|Study Terminated By Sponsor|10|||
155213876|NCT03804879|560222084|FG001|Overall Study|Study Terminated By Sponsor|12|||
155213877|NCT03804879|560222083|FG000|Overall Study|Withdrawal by Subject|3|||
155213878|NCT03804879|560222084|FG001|Overall Study|Withdrawal by Subject|1|||
155213879|NCT00708162|560222085|FG000|Randomized Phase|Randomized but Not Treated|7|||
155213880|NCT00708162|560222086|FG001|Randomized Phase|Randomized but Not Treated|5|||
155213881|NCT00708162|560222085|FG000|Randomized Phase|Participant Noncompliance|40|||
155213882|NCT00708162|560222086|FG001|Randomized Phase|Participant Noncompliance|32|||
155213883|NCT00708162|560222085|FG000|Randomized Phase|Lost to Follow-up|34|||
155213884|NCT00708162|560222086|FG001|Randomized Phase|Lost to Follow-up|34|||
155213885|NCT00708162|560222085|FG000|Randomized Phase|Withdrew Consent|31|||
155213886|NCT00708162|560222086|FG001|Randomized Phase|Withdrew Consent|22|||
155213887|NCT00708162|560222085|FG000|Randomized Phase|Lack of Efficacy|14|||
155213888|NCT00708162|560222086|FG001|Randomized Phase|Lack of Efficacy|19|||
155213889|NCT00708162|560222085|FG000|Randomized Phase|Protocol Violation|10|||
155213890|NCT00708162|560222086|FG001|Randomized Phase|Protocol Violation|11|||
155213891|NCT00708162|560222085|FG000|Randomized Phase|Adverse Event|8|||
155213892|NCT00708162|560222086|FG001|Randomized Phase|Adverse Event|12|||
155213893|NCT00708162|560222085|FG000|Randomized Phase|Investigator's Discretion|7|||
155213894|NCT00708162|560222086|FG001|Randomized Phase|Investigator's Discretion|10|||
155213895|NCT00708162|560222085|FG000|Randomized Phase|Death|2|||
155213896|NCT00708162|560222086|FG001|Randomized Phase|Death|9|||
155213897|NCT00708162|560222085|FG000|Randomized Phase|Pregnancy|3|||
155213898|NCT00708162|560222086|FG001|Randomized Phase|Pregnancy|0|||
155213899|NCT00708162|560222085|FG000|Open-Label Phase|Lost to Follow-up|10|||
155213900|NCT00708162|560222086|FG001|Open-Label Phase|Lost to Follow-up|8|||
155213901|NCT00708162|560222085|FG000|Open-Label Phase|Withdrew Consent|12|||
155213902|NCT00708162|560222086|FG001|Open-Label Phase|Withdrew Consent|6|||
155213903|NCT00708162|560222085|FG000|Open-Label Phase|Participant Noncompliance|7|||
155213904|NCT00708162|560222086|FG001|Open-Label Phase|Participant Noncompliance|7|||
155213905|NCT00708162|560222085|FG000|Open-Label Phase|Lack of Efficacy|7|||
155213906|NCT00708162|560222086|FG001|Open-Label Phase|Lack of Efficacy|4|||
155213907|NCT00708162|560222085|FG000|Open-Label Phase|Investigator's Discretion|3|||
155213908|NCT00708162|560222086|FG001|Open-Label Phase|Investigator's Discretion|2|||
155213909|NCT00708162|560222085|FG000|Open-Label Phase|Death|3|||
155213910|NCT00708162|560222086|FG001|Open-Label Phase|Death|1|||
155213911|NCT00708162|560222085|FG000|Open-Label Phase|Adverse Event|1|||
155213912|NCT00708162|560222086|FG001|Open-Label Phase|Adverse Event|2|||
155213913|NCT00708162|560222085|FG000|Open-Label Phase|Other|1|||
155213914|NCT00708162|560222086|FG001|Open-Label Phase|Other|0|||
155213915|NCT02699554|560222088|FG000|Overall Study|Lost to Follow-up|9|||
155213916|NCT00788151|560222089|FG000|Overall Study|Other adverse event|0|||
155213917|NCT00788151|560222090|FG001|Overall Study|Other adverse event|2|||
155213918|NCT00788151|560222089|FG000|Overall Study|Protocol Violation|0|||
155213919|NCT00788151|560222090|FG001|Overall Study|Protocol Violation|1|||
155213920|NCT00788151|560222089|FG000|Overall Study|Withdrawal by Subject|13|||
155213921|NCT00788151|560222090|FG001|Overall Study|Withdrawal by Subject|6|||
155213922|NCT00788151|560222089|FG000|Overall Study|Enrolled but not treated|1|||
155213923|NCT00788151|560222090|FG001|Overall Study|Enrolled but not treated|1|||
155213924|NCT00503009|560222091|FG000|Overall Study|Protocol Violation|1|||
155213925|NCT00503009|560222092|FG001|Overall Study|Protocol Violation|0|||
155213926|NCT00503009|560222093|FG002|Overall Study|Protocol Violation|1|||
155213927|NCT00503009|560222091|FG000|Overall Study|Withdrawal by Subject|0|||
155213928|NCT00503009|560222092|FG001|Overall Study|Withdrawal by Subject|1|||
155213929|NCT00503009|560222093|FG002|Overall Study|Withdrawal by Subject|1|||
155213930|NCT00503009|560222091|FG000|Overall Study|Physician Decision|0|||
155213931|NCT00503009|560222092|FG001|Overall Study|Physician Decision|1|||
155213932|NCT00503009|560222093|FG002|Overall Study|Physician Decision|1|||
155213933|NCT02169739|560222096|FG000|Overall Study|Lost to Follow-up|0|||
155213934|NCT02169739|560222097|FG001|Overall Study|Lost to Follow-up|4|||
155213935|NCT03635957|560222098|FG000|Run-In Period|Lost to Follow-up|1|||
155213936|NCT03635957|560222098|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
155213937|NCT01710033|560222099|FG000|Stage 2|Adverse Event|0|||
155213938|NCT01710033|560222100|FG001|Stage 2|Adverse Event|0|||
155213939|NCT01710033|560222101|FG002|Stage 2|Adverse Event|0|||
155213940|NCT01710033|560222102|FG003|Stage 2|Adverse Event|0|||
155213941|NCT01710033|560222103|FG004|Stage 2|Adverse Event|1|||
155213942|NCT00100815|560222104|FG000|Overall Study|Progression|24|||
155213943|NCT00100815|560222104|FG000|Overall Study|Adverse Event|18|||
155213944|NCT00100815|560222104|FG000|Overall Study|Death|4|||
155213945|NCT00100815|560222104|FG000|Overall Study|Other|3|||
155213946|NCT01525550|560222111|FG000|Overall Study|Lost to Follow-up|8|||
155213947|NCT01525550|560222112|FG001|Overall Study|Lost to Follow-up|2|||
155213948|NCT01525550|560222111|FG000|Overall Study|Death|19|||
155213949|NCT01525550|560222112|FG001|Overall Study|Death|28|||
155213950|NCT01525550|560222111|FG000|Overall Study|Other|0|||
155213951|NCT01525550|560222112|FG001|Overall Study|Other|4|||
155213952|NCT01525550|560222111|FG000|Overall Study|Sponsor's Decision|30|||
155213953|NCT01525550|560222112|FG001|Overall Study|Sponsor's Decision|11|||
155213954|NCT01525550|560222111|FG000|Overall Study|Withdrawal by Subject|4|||
155213955|NCT01525550|560222112|FG001|Overall Study|Withdrawal by Subject|0|||
155213956|NCT02522286|560222114|FG000|Overall Study|Withdrawal by Subject|3|||
155213957|NCT02522286|560222115|FG001|Overall Study|Withdrawal by Subject|0|||
155213958|NCT02522286|560222116|FG002|Overall Study|Withdrawal by Subject|0|||
155213959|NCT02522286|560222117|FG003|Overall Study|Withdrawal by Subject|3|||
155213960|NCT01244906|560222118|FG000|Overall Study|Death|2|||
155213961|NCT01244906|560222118|FG000|Overall Study|Progression of disease post treatment|6|||
155213962|NCT03480750|560222121|FG000|Overall Study|Withdrawal by Subject|0|||
155213963|NCT03480750|560222122|FG001|Overall Study|Withdrawal by Subject|1|||
155213964|NCT03480750|560222123|FG002|Overall Study|Withdrawal by Subject|0|||
155213965|NCT03480750|560222124|FG003|Overall Study|Withdrawal by Subject|0|||
155213966|NCT03480750|560222125|FG004|Overall Study|Withdrawal by Subject|0|||
155213967|NCT03480750|560222126|FG005|Overall Study|Withdrawal by Subject|0|||
155213968|NCT03480750|560222121|FG000|Overall Study|The interruption in Trientine shippment|0|||
155213969|NCT03480750|560222122|FG001|Overall Study|The interruption in Trientine shippment|0|||
155213970|NCT03480750|560222123|FG002|Overall Study|The interruption in Trientine shippment|0|||
155213971|NCT03480750|560222124|FG003|Overall Study|The interruption in Trientine shippment|0|||
155213972|NCT03480750|560222125|FG004|Overall Study|The interruption in Trientine shippment|0|||
155213973|NCT03480750|560222126|FG005|Overall Study|The interruption in Trientine shippment|1|||
155213974|NCT00723892|560222127|FG000|Overall Study|Participant not tracked|33|||
155213975|NCT00723892|560222128|FG001|Overall Study|Participant not tracked|35|||
155213976|NCT00723892|560222127|FG000|Overall Study|Virological criterion|24|||
155213977|NCT00723892|560222128|FG001|Overall Study|Virological criterion|9|||
155213978|NCT00723892|560222127|FG000|Overall Study|Withdrawal by Subject|6|||
155213979|NCT00723892|560222128|FG001|Overall Study|Withdrawal by Subject|9|||
155213980|NCT00723892|560222127|FG000|Overall Study|End planned|11|||
155213981|NCT00723892|560222128|FG001|Overall Study|End planned|7|||
155213982|NCT00723892|560222127|FG000|Overall Study|Bad tolerance|5|||
155213983|NCT00723892|560222128|FG001|Overall Study|Bad tolerance|5|||
155213984|NCT00723892|560222127|FG000|Overall Study|Multiple reasons|17|||
155213985|NCT00723892|560222128|FG001|Overall Study|Multiple reasons|12|||
155213986|NCT00723892|560222127|FG000|Overall Study|Other|6|||
155213987|NCT00723892|560222128|FG001|Overall Study|Other|3|||
155213988|NCT00723892|560222127|FG000|Overall Study|Study end|1|||
155213989|NCT00723892|560222128|FG001|Overall Study|Study end|3|||
155213990|NCT00723892|560222127|FG000|Overall Study|Weight loss|1|||
155213991|NCT00723892|560222128|FG001|Overall Study|Weight loss|3|||
155213992|NCT00723892|560222127|FG000|Overall Study|Alcohol abuse|0|||
155213993|NCT00723892|560222128|FG001|Overall Study|Alcohol abuse|1|||
155213994|NCT00723892|560222127|FG000|Overall Study|Intercurrent infection|2|||
155213995|NCT00723892|560222128|FG001|Overall Study|Intercurrent infection|0|||
155213996|NCT00723892|560222127|FG000|Overall Study|Drug addiction|1|||
155213997|NCT00723892|560222128|FG001|Overall Study|Drug addiction|0|||
155213998|NCT02411292|560222129|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
155213999|NCT02411292|560222129|FG000|Overall Study|Death|2|||
155214000|NCT02411292|560222129|FG000|Overall Study|Lost to Follow-up|3|||
155214001|NCT03060447|560222130|FG000|Overall Study|Withdrawal by Subject|2|||
155214002|NCT03060447|560222131|FG001|Overall Study|Withdrawal by Subject|0|||
155214003|NCT02232425|560222132|FG000|Overall Study|Lost to Follow-up|6|||
155214004|NCT02232425|560222133|FG001|Overall Study|Lost to Follow-up|2|||
155214005|NCT02232425|560222132|FG000|Overall Study|Adverse Event|2|||
155214006|NCT02232425|560222133|FG001|Overall Study|Adverse Event|0|||
155214007|NCT02232425|560222132|FG000|Overall Study|Withdrawal by Subject|5|||
155214008|NCT02232425|560222133|FG001|Overall Study|Withdrawal by Subject|6|||
155214009|NCT02232425|560222132|FG000|Overall Study|Lack of Efficacy|1|||
155214010|NCT02232425|560222133|FG001|Overall Study|Lack of Efficacy|0|||
155214011|NCT01601626|560222136|FG000|Overall Study|Death|1|||
155214012|NCT01601626|560222137|FG001|Overall Study|Death|1|||
155214013|NCT01601626|560222138|FG002|Overall Study|Death|1|||
155214014|NCT01601626|560222136|FG000|Overall Study|Lost to Follow-up|1|||
155214015|NCT01601626|560222137|FG001|Overall Study|Lost to Follow-up|2|||
155214016|NCT01601626|560222138|FG002|Overall Study|Lost to Follow-up|0|||
155214017|NCT01601626|560222136|FG000|Overall Study|Unable to Get to Clinic|0|||
155214018|NCT01601626|560222137|FG001|Overall Study|Unable to Get to Clinic|1|||
155214019|NCT01601626|560222138|FG002|Overall Study|Unable to Get to Clinic|0|||
155214020|NCT01601626|560222136|FG000|Overall Study|Withdrawal by Subject|0|||
155214021|NCT01601626|560222137|FG001|Overall Study|Withdrawal by Subject|1|||
155214022|NCT01601626|560222138|FG002|Overall Study|Withdrawal by Subject|1|||
155214023|NCT01601626|560222136|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
155214024|NCT01601626|560222137|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
155214025|NCT01601626|560222138|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
155214026|NCT00498602|560222139|FG000|Overall Study|Death|0|||
155214027|NCT00498602|560222140|FG001|Overall Study|Death|0|||
155214028|NCT00498602|560222141|FG002|Overall Study|Death|0|||
155214029|NCT00498602|560222142|FG003|Overall Study|Death|0|||
155214030|NCT00498602|560222143|FG004|Overall Study|Death|0|||
155214031|NCT00498602|560222144|FG005|Overall Study|Death|1|||
155214032|NCT00498602|560222145|FG006|Overall Study|Death|0|||
155214033|NCT00498602|560222139|FG000|Overall Study|Lack of Efficacy|1|||
155214034|NCT00498602|560222140|FG001|Overall Study|Lack of Efficacy|0|||
155214035|NCT00498602|560222141|FG002|Overall Study|Lack of Efficacy|0|||
155214036|NCT00498602|560222142|FG003|Overall Study|Lack of Efficacy|0|||
155214037|NCT00498602|560222143|FG004|Overall Study|Lack of Efficacy|0|||
155214038|NCT00498602|560222144|FG005|Overall Study|Lack of Efficacy|0|||
155214039|NCT00498602|560222145|FG006|Overall Study|Lack of Efficacy|0|||
155214040|NCT00498602|560222139|FG000|Overall Study|Lost to Follow-up|0|||
155214041|NCT00498602|560222140|FG001|Overall Study|Lost to Follow-up|2|||
155214042|NCT00498602|560222141|FG002|Overall Study|Lost to Follow-up|0|||
155214043|NCT00498602|560222142|FG003|Overall Study|Lost to Follow-up|2|||
155214044|NCT00498602|560222143|FG004|Overall Study|Lost to Follow-up|0|||
155214045|NCT00498602|560222144|FG005|Overall Study|Lost to Follow-up|0|||
155214046|NCT00498602|560222145|FG006|Overall Study|Lost to Follow-up|0|||
155214047|NCT00498602|560222139|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
155214048|NCT00498602|560222140|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155214049|NCT00498602|560222141|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
155214050|NCT00498602|560222142|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
155214051|NCT00498602|560222143|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155214052|NCT00498602|560222144|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
155214053|NCT00498602|560222145|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
155214054|NCT00498602|560222139|FG000|Overall Study|AE not related to Study Drug|1|||
155214055|NCT00498602|560222140|FG001|Overall Study|AE not related to Study Drug|3|||
155214056|NCT00498602|560222141|FG002|Overall Study|AE not related to Study Drug|0|||
155214057|NCT00498602|560222142|FG003|Overall Study|AE not related to Study Drug|0|||
155214058|NCT00498602|560222143|FG004|Overall Study|AE not related to Study Drug|2|||
155214059|NCT00498602|560222144|FG005|Overall Study|AE not related to Study Drug|2|||
155214060|NCT00498602|560222145|FG006|Overall Study|AE not related to Study Drug|1|||
155214061|NCT00498602|560222139|FG000|Overall Study|Caregiver Request|2|||
155214062|NCT00498602|560222140|FG001|Overall Study|Caregiver Request|2|||
155214063|NCT00498602|560222141|FG002|Overall Study|Caregiver Request|2|||
155214064|NCT00498602|560222142|FG003|Overall Study|Caregiver Request|0|||
155214065|NCT00498602|560222143|FG004|Overall Study|Caregiver Request|1|||
155214066|NCT00498602|560222144|FG005|Overall Study|Caregiver Request|2|||
155214067|NCT00498602|560222145|FG006|Overall Study|Caregiver Request|0|||
155214068|NCT00498602|560222139|FG000|Overall Study|Investigator Request|0|||
155214069|NCT00498602|560222140|FG001|Overall Study|Investigator Request|0|||
155214070|NCT00498602|560222141|FG002|Overall Study|Investigator Request|1|||
155214071|NCT00498602|560222142|FG003|Overall Study|Investigator Request|0|||
155214072|NCT00498602|560222143|FG004|Overall Study|Investigator Request|0|||
155214073|NCT00498602|560222144|FG005|Overall Study|Investigator Request|0|||
155214074|NCT00498602|560222145|FG006|Overall Study|Investigator Request|0|||
155214075|NCT00498602|560222139|FG000|Overall Study|Subject Request|3|||
155214076|NCT00498602|560222140|FG001|Overall Study|Subject Request|0|||
155214077|NCT00498602|560222141|FG002|Overall Study|Subject Request|1|||
155214078|NCT00498602|560222142|FG003|Overall Study|Subject Request|1|||
155214079|NCT00498602|560222143|FG004|Overall Study|Subject Request|1|||
155214080|NCT00498602|560222144|FG005|Overall Study|Subject Request|4|||
155214081|NCT00498602|560222145|FG006|Overall Study|Subject Request|1|||
155214082|NCT00498602|560222139|FG000|Overall Study|Other|2|||
155214083|NCT00498602|560222140|FG001|Overall Study|Other|3|||
155214084|NCT00498602|560222141|FG002|Overall Study|Other|1|||
155214085|NCT00498602|560222142|FG003|Overall Study|Other|0|||
155214086|NCT00498602|560222143|FG004|Overall Study|Other|0|||
155214087|NCT00498602|560222144|FG005|Overall Study|Other|3|||
155214088|NCT00498602|560222145|FG006|Overall Study|Other|0|||
155214089|NCT02632552|560222146|FG000|Overall Study|Lost to Follow-up|14|||
155214090|NCT02632552|560222147|FG001|Overall Study|Lost to Follow-up|8|||
155214091|NCT02632552|560222146|FG000|Overall Study|Withdrawal by Subject|2|||
155214092|NCT02632552|560222147|FG001|Overall Study|Withdrawal by Subject|0|||
155214093|NCT02632552|560222146|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
155214094|NCT02632552|560222147|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
155214095|NCT02611778|560222148|FG000|Overall Study|Withdrawal by Subject|2|||
155214096|NCT02611778|560222149|FG001|Overall Study|Withdrawal by Subject|8|||
155214097|NCT02611778|560222148|FG000|Overall Study|Adverse Event|1|||
155214098|NCT02611778|560222149|FG001|Overall Study|Adverse Event|2|||
155214099|NCT02611778|560222148|FG000|Overall Study|Death|2|||
155214100|NCT02611778|560222149|FG001|Overall Study|Death|1|||
155214101|NCT02611778|560222148|FG000|Overall Study|Protocol Violation|1|||
155214102|NCT02611778|560222149|FG001|Overall Study|Protocol Violation|0|||
155214103|NCT02611778|560222148|FG000|Overall Study|Lost to Follow-up|3|||
155214104|NCT02611778|560222149|FG001|Overall Study|Lost to Follow-up|1|||
155214105|NCT02611778|560222148|FG000|Overall Study|Need for alternative treatment|1|||
155214106|NCT02611778|560222149|FG001|Overall Study|Need for alternative treatment|0|||
155214107|NCT02611778|560222148|FG000|Overall Study|Other Reason|2|||
155214108|NCT02611778|560222149|FG001|Overall Study|Other Reason|1|||
155214109|NCT03108027|560222150|FG000|Period 1|Subject/Guardian Decision|0|||
155214110|NCT03108027|560222151|FG001|Period 1|Subject/Guardian Decision|0|||
155214111|NCT03108027|560222152|FG002|Period 1|Subject/Guardian Decision|0|||
155214112|NCT03108027|560222153|FG003|Period 1|Subject/Guardian Decision|2|||
155214113|NCT03108027|560222154|FG004|Period 1|Subject/Guardian Decision|0|||
155214114|NCT03108027|560222155|FG005|Period 1|Subject/Guardian Decision|0|||
155214115|NCT03108027|560222150|FG000|Period 3|Adverse Event|0|||
155214116|NCT03108027|560222151|FG001|Period 3|Adverse Event|1|||
155214117|NCT03108027|560222152|FG002|Period 3|Adverse Event|0|||
155214118|NCT03108027|560222153|FG003|Period 3|Adverse Event|0|||
155214119|NCT03108027|560222154|FG004|Period 3|Adverse Event|0|||
155214120|NCT03108027|560222155|FG005|Period 3|Adverse Event|0|||
155214121|NCT02426892|560222156|FG000|Overall Study|Adverse Event|2|||
155214122|NCT02426892|560222156|FG000|Overall Study|Lack of Efficacy|17|||
155214123|NCT02426892|560222156|FG000|Overall Study|Withdrawal by Subject|1|||
155214124|NCT03402386|560222157|FG000|Overall Study|Adverse Event|3|||
155214125|NCT03402386|560222157|FG000|Overall Study|Physician Decision|1|||
155214126|NCT03402386|560222157|FG000|Overall Study|Difficult to control Hb|2|||
155214127|NCT00268996|560222158|FG000|Overall Study|Adverse Event|11|||
155214128|NCT00268996|560222159|FG001|Overall Study|Adverse Event|7|||
155214129|NCT00268996|560222158|FG000|Overall Study|Lost to Follow-up|3|||
155214130|NCT00268996|560222159|FG001|Overall Study|Lost to Follow-up|1|||
155214131|NCT00268996|560222158|FG000|Overall Study|Withdrawal by Subject|5|||
155214132|NCT00268996|560222159|FG001|Overall Study|Withdrawal by Subject|11|||
155214133|NCT00268996|560222158|FG000|Overall Study|Non-compliance|1|||
155214134|NCT00268996|560222159|FG001|Overall Study|Non-compliance|0|||
155214135|NCT00268996|560222158|FG000|Overall Study|Other|1|||
155214136|NCT00268996|560222159|FG001|Overall Study|Other|1|||
155214137|NCT03325075|560222160|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
155214138|NCT03325075|560222161|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
155214139|NCT03325075|560222162|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
155214140|NCT03325075|560222163|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
155214141|NCT03325075|560222160|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
155214142|NCT03325075|560222161|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
155214143|NCT03325075|560222162|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
155214144|NCT03325075|560222163|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
155214145|NCT03325075|560222160|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
155214146|NCT03325075|560222161|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
155214147|NCT03325075|560222162|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
155214148|NCT03325075|560222163|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
155214149|NCT02744391|560222164|FG000|Overall Study|Lost to Follow-up|9|||
155214150|NCT02744391|560222164|FG000|Overall Study|Physician Decision|2|||
155214151|NCT02744391|560222164|FG000|Overall Study|Withdrawal by Subject|3|||
155214152|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
155214153|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
155214154|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
155214155|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
155214156|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
155214157|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
155214158|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
155214159|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
155214160|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
155214161|NCT04434092|560222167|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
155214162|NCT04434092|560222168|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
155214163|NCT04434092|560222169|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
155214164|NCT04434092|560222167|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
155214165|NCT04434092|560222168|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
155214166|NCT04434092|560222169|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
155214167|NCT04434092|560222167|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
155214168|NCT04434092|560222168|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
155214169|NCT04434092|560222169|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
155214170|NCT04434092|560222167|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
155214171|NCT04434092|560222168|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
155214172|NCT04434092|560222169|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
155214173|NCT02554812|560222170|FG000|Overall Study|Adverse Event|2|||
155214174|NCT02554812|560222171|FG001|Overall Study|Adverse Event|5|||
155214175|NCT02554812|560222172|FG002|Overall Study|Adverse Event|3|||
155214176|NCT02554812|560222173|FG003|Overall Study|Adverse Event|0|||
155214177|NCT02554812|560222174|FG004|Overall Study|Adverse Event|5|||
155214178|NCT02554812|560222175|FG005|Overall Study|Adverse Event|0|||
155214179|NCT02554812|560222176|FG006|Overall Study|Adverse Event|1|||
155214180|NCT02554812|560222177|FG007|Overall Study|Adverse Event|6|||
155214181|NCT02554812|560222178|FG008|Overall Study|Adverse Event|2|||
155214182|NCT02554812|560222179|FG009|Overall Study|Adverse Event|2|||
155214183|NCT02554812|560222180|FG010|Overall Study|Adverse Event|1|||
155214184|NCT02554812|560222181|FG011|Overall Study|Adverse Event|2|||
155214185|NCT02554812|560222182|FG012|Overall Study|Adverse Event|0|||
155214186|NCT02554812|560222183|FG013|Overall Study|Adverse Event|3|||
155214187|NCT02554812|560222184|FG014|Overall Study|Adverse Event|2|||
155214188|NCT02554812|560222185|FG015|Overall Study|Adverse Event|1|||
155214189|NCT02554812|560222186|FG016|Overall Study|Adverse Event|0|||
155214190|NCT02554812|560222187|FG017|Overall Study|Adverse Event|1|||
155214191|NCT02554812|560222188|FG018|Overall Study|Adverse Event|0|||
155214192|NCT02554812|560222189|FG019|Overall Study|Adverse Event|0|||
155214193|NCT02554812|560222190|FG020|Overall Study|Adverse Event|0|||
155214194|NCT02554812|560222191|FG021|Overall Study|Adverse Event|2|||
155214195|NCT02554812|560222192|FG022|Overall Study|Adverse Event|1|||
155214196|NCT02554812|560222193|FG023|Overall Study|Adverse Event|1|||
155214197|NCT02554812|560222194|FG024|Overall Study|Adverse Event|1|||
155214198|NCT02554812|560222195|FG025|Overall Study|Adverse Event|2|||
155214199|NCT02554812|560222196|FG026|Overall Study|Adverse Event|1|||
155214200|NCT02554812|560222170|FG000|Overall Study|Death|1|||
155214201|NCT02554812|560222171|FG001|Overall Study|Death|2|||
155214202|NCT02554812|560222172|FG002|Overall Study|Death|2|||
155214203|NCT02554812|560222173|FG003|Overall Study|Death|2|||
155214204|NCT02554812|560222174|FG004|Overall Study|Death|0|||
155214205|NCT02554812|560222175|FG005|Overall Study|Death|1|||
155214206|NCT02554812|560222176|FG006|Overall Study|Death|1|||
155214207|NCT02554812|560222177|FG007|Overall Study|Death|1|||
155214208|NCT02554812|560222178|FG008|Overall Study|Death|0|||
155214209|NCT02554812|560222179|FG009|Overall Study|Death|0|||
155214210|NCT02554812|560222180|FG010|Overall Study|Death|0|||
155214211|NCT02554812|560222181|FG011|Overall Study|Death|0|||
155214212|NCT02554812|560222182|FG012|Overall Study|Death|0|||
155214213|NCT02554812|560222183|FG013|Overall Study|Death|0|||
155214214|NCT02554812|560222184|FG014|Overall Study|Death|1|||
155214215|NCT02554812|560222185|FG015|Overall Study|Death|1|||
155214216|NCT02554812|560222186|FG016|Overall Study|Death|1|||
155214217|NCT02554812|560222187|FG017|Overall Study|Death|0|||
155214218|NCT02554812|560222188|FG018|Overall Study|Death|1|||
155214219|NCT02554812|560222189|FG019|Overall Study|Death|2|||
155214220|NCT02554812|560222190|FG020|Overall Study|Death|0|||
155214221|NCT02554812|560222191|FG021|Overall Study|Death|1|||
155214222|NCT02554812|560222192|FG022|Overall Study|Death|1|||
155214223|NCT02554812|560222193|FG023|Overall Study|Death|0|||
155214224|NCT02554812|560222194|FG024|Overall Study|Death|0|||
155214225|NCT02554812|560222195|FG025|Overall Study|Death|0|||
155214226|NCT02554812|560222196|FG026|Overall Study|Death|0|||
155214227|NCT02554812|560222170|FG000|Overall Study|Lost to Follow-up|0|||
155214228|NCT02554812|560222171|FG001|Overall Study|Lost to Follow-up|1|||
155214229|NCT02554812|560222172|FG002|Overall Study|Lost to Follow-up|0|||
155214230|NCT02554812|560222173|FG003|Overall Study|Lost to Follow-up|0|||
155214231|NCT02554812|560222174|FG004|Overall Study|Lost to Follow-up|0|||
155214232|NCT02554812|560222175|FG005|Overall Study|Lost to Follow-up|0|||
155214233|NCT02554812|560222176|FG006|Overall Study|Lost to Follow-up|0|||
155214234|NCT02554812|560222177|FG007|Overall Study|Lost to Follow-up|0|||
155214235|NCT02554812|560222178|FG008|Overall Study|Lost to Follow-up|0|||
155214236|NCT02554812|560222179|FG009|Overall Study|Lost to Follow-up|0|||
155214237|NCT02554812|560222180|FG010|Overall Study|Lost to Follow-up|0|||
155214238|NCT02554812|560222181|FG011|Overall Study|Lost to Follow-up|0|||
155214239|NCT02554812|560222182|FG012|Overall Study|Lost to Follow-up|0|||
155214240|NCT02554812|560222183|FG013|Overall Study|Lost to Follow-up|0|||
155214241|NCT02554812|560222184|FG014|Overall Study|Lost to Follow-up|0|||
155214242|NCT02554812|560222185|FG015|Overall Study|Lost to Follow-up|0|||
155214243|NCT02554812|560222186|FG016|Overall Study|Lost to Follow-up|0|||
155214244|NCT02554812|560222187|FG017|Overall Study|Lost to Follow-up|0|||
155214245|NCT02554812|560222188|FG018|Overall Study|Lost to Follow-up|0|||
155214246|NCT02554812|560222189|FG019|Overall Study|Lost to Follow-up|0|||
155214247|NCT02554812|560222190|FG020|Overall Study|Lost to Follow-up|0|||
155214248|NCT02554812|560222191|FG021|Overall Study|Lost to Follow-up|0|||
155214249|NCT02554812|560222192|FG022|Overall Study|Lost to Follow-up|0|||
155214250|NCT02554812|560222193|FG023|Overall Study|Lost to Follow-up|0|||
155214251|NCT02554812|560222194|FG024|Overall Study|Lost to Follow-up|0|||
155214252|NCT02554812|560222195|FG025|Overall Study|Lost to Follow-up|0|||
155214253|NCT02554812|560222196|FG026|Overall Study|Lost to Follow-up|0|||
155214254|NCT02554812|560222170|FG000|Overall Study|Global deterioration of health status|4|||
155214255|NCT02554812|560222171|FG001|Overall Study|Global deterioration of health status|3|||
155214256|NCT02554812|560222172|FG002|Overall Study|Global deterioration of health status|3|||
155214257|NCT02554812|560222173|FG003|Overall Study|Global deterioration of health status|2|||
155214258|NCT02554812|560222174|FG004|Overall Study|Global deterioration of health status|5|||
155214259|NCT02554812|560222175|FG005|Overall Study|Global deterioration of health status|0|||
155214260|NCT02554812|560222176|FG006|Overall Study|Global deterioration of health status|2|||
155214261|NCT02554812|560222177|FG007|Overall Study|Global deterioration of health status|1|||
155214262|NCT02554812|560222178|FG008|Overall Study|Global deterioration of health status|1|||
155214263|NCT02554812|560222179|FG009|Overall Study|Global deterioration of health status|1|||
155214264|NCT02554812|560222180|FG010|Overall Study|Global deterioration of health status|2|||
155214265|NCT02554812|560222181|FG011|Overall Study|Global deterioration of health status|1|||
155214266|NCT02554812|560222182|FG012|Overall Study|Global deterioration of health status|0|||
155214267|NCT02554812|560222183|FG013|Overall Study|Global deterioration of health status|0|||
155214268|NCT02554812|560222184|FG014|Overall Study|Global deterioration of health status|0|||
155214269|NCT02554812|560222185|FG015|Overall Study|Global deterioration of health status|1|||
155214270|NCT02554812|560222186|FG016|Overall Study|Global deterioration of health status|0|||
155214271|NCT02554812|560222187|FG017|Overall Study|Global deterioration of health status|0|||
155214272|NCT02554812|560222188|FG018|Overall Study|Global deterioration of health status|0|||
155214273|NCT02554812|560222189|FG019|Overall Study|Global deterioration of health status|0|||
155214274|NCT02554812|560222190|FG020|Overall Study|Global deterioration of health status|0|||
155214275|NCT02554812|560222191|FG021|Overall Study|Global deterioration of health status|0|||
155214276|NCT02554812|560222192|FG022|Overall Study|Global deterioration of health status|0|||
155214277|NCT02554812|560222193|FG023|Overall Study|Global deterioration of health status|0|||
155214278|NCT02554812|560222194|FG024|Overall Study|Global deterioration of health status|0|||
155214279|NCT02554812|560222195|FG025|Overall Study|Global deterioration of health status|0|||
155214280|NCT02554812|560222196|FG026|Overall Study|Global deterioration of health status|0|||
155214281|NCT02554812|560222170|FG000|Overall Study|Progressive disease|20|||
155214282|NCT02554812|560222171|FG001|Overall Study|Progressive disease|16|||
155214283|NCT02554812|560222172|FG002|Overall Study|Progressive disease|19|||
155214284|NCT02554812|560222173|FG003|Overall Study|Progressive disease|18|||
155214285|NCT02554812|560222174|FG004|Overall Study|Progressive disease|21|||
155214286|NCT02554812|560222175|FG005|Overall Study|Progressive disease|15|||
155214287|NCT02554812|560222176|FG006|Overall Study|Progressive disease|6|||
155214288|NCT02554812|560222177|FG007|Overall Study|Progressive disease|13|||
155214289|NCT02554812|560222178|FG008|Overall Study|Progressive disease|6|||
155214290|NCT02554812|560222179|FG009|Overall Study|Progressive disease|6|||
155214291|NCT02554812|560222180|FG010|Overall Study|Progressive disease|8|||
155214292|NCT02554812|560222181|FG011|Overall Study|Progressive disease|8|||
155214293|NCT02554812|560222182|FG012|Overall Study|Progressive disease|6|||
155214294|NCT02554812|560222183|FG013|Overall Study|Progressive disease|10|||
155214295|NCT02554812|560222184|FG014|Overall Study|Progressive disease|20|||
155214296|NCT02554812|560222185|FG015|Overall Study|Progressive disease|6|||
155214297|NCT02554812|560222186|FG016|Overall Study|Progressive disease|3|||
155214298|NCT02554812|560222187|FG017|Overall Study|Progressive disease|3|||
155214299|NCT02554812|560222188|FG018|Overall Study|Progressive disease|11|||
155214300|NCT02554812|560222189|FG019|Overall Study|Progressive disease|7|||
155214301|NCT02554812|560222190|FG020|Overall Study|Progressive disease|11|||
155214302|NCT02554812|560222191|FG021|Overall Study|Progressive disease|6|||
155214303|NCT02554812|560222192|FG022|Overall Study|Progressive disease|9|||
155214304|NCT02554812|560222193|FG023|Overall Study|Progressive disease|9|||
155214305|NCT02554812|560222194|FG024|Overall Study|Progressive disease|4|||
155214306|NCT02554812|560222195|FG025|Overall Study|Progressive disease|5|||
155214307|NCT02554812|560222196|FG026|Overall Study|Progressive disease|5|||
155214308|NCT02554812|560222170|FG000|Overall Study|Other|0|||
155214309|NCT02554812|560222171|FG001|Overall Study|Other|0|||
155214310|NCT02554812|560222172|FG002|Overall Study|Other|2|||
155214311|NCT02554812|560222173|FG003|Overall Study|Other|3|||
155214312|NCT02554812|560222174|FG004|Overall Study|Other|2|||
155214313|NCT02554812|560222175|FG005|Overall Study|Other|1|||
155214314|NCT02554812|560222176|FG006|Overall Study|Other|0|||
155214315|NCT02554812|560222177|FG007|Overall Study|Other|0|||
155214316|NCT02554812|560222178|FG008|Overall Study|Other|1|||
155214317|NCT02554812|560222179|FG009|Overall Study|Other|1|||
155214318|NCT02554812|560222180|FG010|Overall Study|Other|0|||
155214319|NCT02554812|560222181|FG011|Overall Study|Other|0|||
155214320|NCT02554812|560222182|FG012|Overall Study|Other|1|||
155214321|NCT02554812|560222183|FG013|Overall Study|Other|0|||
155214322|NCT02554812|560222184|FG014|Overall Study|Other|1|||
155214323|NCT02554812|560222185|FG015|Overall Study|Other|0|||
155214324|NCT02554812|560222186|FG016|Overall Study|Other|0|||
155214325|NCT02554812|560222187|FG017|Overall Study|Other|0|||
155214326|NCT02554812|560222188|FG018|Overall Study|Other|0|||
155214327|NCT02554812|560222189|FG019|Overall Study|Other|0|||
155214328|NCT02554812|560222190|FG020|Overall Study|Other|0|||
155214329|NCT02554812|560222191|FG021|Overall Study|Other|2|||
155214330|NCT02554812|560222192|FG022|Overall Study|Other|0|||
155214331|NCT02554812|560222193|FG023|Overall Study|Other|0|||
155214332|NCT02554812|560222194|FG024|Overall Study|Other|0|||
155214333|NCT02554812|560222195|FG025|Overall Study|Other|0|||
155214334|NCT02554812|560222196|FG026|Overall Study|Other|0|||
155214335|NCT02554812|560222170|FG000|Overall Study|Withdrawal by Subject|1|||
155214336|NCT02554812|560222171|FG001|Overall Study|Withdrawal by Subject|0|||
155214337|NCT02554812|560222172|FG002|Overall Study|Withdrawal by Subject|0|||
155214338|NCT02554812|560222173|FG003|Overall Study|Withdrawal by Subject|2|||
155214339|NCT02554812|560222174|FG004|Overall Study|Withdrawal by Subject|2|||
155214340|NCT02554812|560222175|FG005|Overall Study|Withdrawal by Subject|3|||
155214341|NCT02554812|560222176|FG006|Overall Study|Withdrawal by Subject|0|||
155214342|NCT02554812|560222177|FG007|Overall Study|Withdrawal by Subject|0|||
155214343|NCT02554812|560222178|FG008|Overall Study|Withdrawal by Subject|1|||
155214344|NCT02554812|560222179|FG009|Overall Study|Withdrawal by Subject|1|||
155214345|NCT02554812|560222180|FG010|Overall Study|Withdrawal by Subject|0|||
155214346|NCT02554812|560222181|FG011|Overall Study|Withdrawal by Subject|1|||
155214347|NCT02554812|560222182|FG012|Overall Study|Withdrawal by Subject|1|||
155214348|NCT02554812|560222183|FG013|Overall Study|Withdrawal by Subject|1|||
155214349|NCT02554812|560222184|FG014|Overall Study|Withdrawal by Subject|1|||
155214350|NCT02554812|560222185|FG015|Overall Study|Withdrawal by Subject|1|||
155214351|NCT02554812|560222186|FG016|Overall Study|Withdrawal by Subject|3|||
155214352|NCT02554812|560222187|FG017|Overall Study|Withdrawal by Subject|1|||
155214353|NCT02554812|560222188|FG018|Overall Study|Withdrawal by Subject|0|||
155214354|NCT02554812|560222189|FG019|Overall Study|Withdrawal by Subject|2|||
155214355|NCT02554812|560222190|FG020|Overall Study|Withdrawal by Subject|0|||
155214356|NCT02554812|560222191|FG021|Overall Study|Withdrawal by Subject|1|||
155214357|NCT02554812|560222192|FG022|Overall Study|Withdrawal by Subject|0|||
155214358|NCT02554812|560222193|FG023|Overall Study|Withdrawal by Subject|1|||
155214359|NCT02554812|560222194|FG024|Overall Study|Withdrawal by Subject|0|||
155214360|NCT02554812|560222195|FG025|Overall Study|Withdrawal by Subject|0|||
155214361|NCT02554812|560222196|FG026|Overall Study|Withdrawal by Subject|1|||
155214362|NCT02554812|560222170|FG000|Overall Study|Physician Decision|1|||
155214363|NCT02554812|560222171|FG001|Overall Study|Physician Decision|0|||
155214364|NCT02554812|560222172|FG002|Overall Study|Physician Decision|0|||
155214365|NCT02554812|560222173|FG003|Overall Study|Physician Decision|1|||
155214366|NCT02554812|560222174|FG004|Overall Study|Physician Decision|0|||
155214367|NCT02554812|560222175|FG005|Overall Study|Physician Decision|1|||
155214368|NCT02554812|560222176|FG006|Overall Study|Physician Decision|0|||
155214369|NCT02554812|560222177|FG007|Overall Study|Physician Decision|0|||
155214370|NCT02554812|560222178|FG008|Overall Study|Physician Decision|0|||
155214371|NCT02554812|560222179|FG009|Overall Study|Physician Decision|0|||
155214372|NCT02554812|560222180|FG010|Overall Study|Physician Decision|1|||
155214373|NCT02554812|560222181|FG011|Overall Study|Physician Decision|0|||
155214374|NCT02554812|560222182|FG012|Overall Study|Physician Decision|0|||
155214375|NCT02554812|560222183|FG013|Overall Study|Physician Decision|0|||
155214376|NCT02554812|560222184|FG014|Overall Study|Physician Decision|0|||
155214377|NCT02554812|560222185|FG015|Overall Study|Physician Decision|0|||
155214378|NCT02554812|560222186|FG016|Overall Study|Physician Decision|1|||
155214379|NCT02554812|560222187|FG017|Overall Study|Physician Decision|1|||
155214380|NCT02554812|560222188|FG018|Overall Study|Physician Decision|0|||
155214381|NCT02554812|560222189|FG019|Overall Study|Physician Decision|1|||
155214382|NCT02554812|560222190|FG020|Overall Study|Physician Decision|1|||
155214383|NCT02554812|560222191|FG021|Overall Study|Physician Decision|0|||
155214384|NCT02554812|560222192|FG022|Overall Study|Physician Decision|1|||
155214385|NCT02554812|560222193|FG023|Overall Study|Physician Decision|0|||
155214386|NCT02554812|560222194|FG024|Overall Study|Physician Decision|0|||
155214387|NCT02554812|560222195|FG025|Overall Study|Physician Decision|0|||
155214388|NCT02554812|560222196|FG026|Overall Study|Physician Decision|0|||
155214389|NCT02554812|560222170|FG000|Overall Study|Study terminated by sponsor|0|||
155214390|NCT02554812|560222171|FG001|Overall Study|Study terminated by sponsor|0|||
155214391|NCT02554812|560222172|FG002|Overall Study|Study terminated by sponsor|0|||
155214392|NCT02554812|560222173|FG003|Overall Study|Study terminated by sponsor|0|||
155214393|NCT02554812|560222174|FG004|Overall Study|Study terminated by sponsor|0|||
155214394|NCT02554812|560222175|FG005|Overall Study|Study terminated by sponsor|0|||
155214395|NCT02554812|560222176|FG006|Overall Study|Study terminated by sponsor|0|||
155214396|NCT02554812|560222177|FG007|Overall Study|Study terminated by sponsor|0|||
155214397|NCT02554812|560222178|FG008|Overall Study|Study terminated by sponsor|0|||
155214398|NCT02554812|560222179|FG009|Overall Study|Study terminated by sponsor|0|||
155214399|NCT02554812|560222180|FG010|Overall Study|Study terminated by sponsor|0|||
155214400|NCT02554812|560222181|FG011|Overall Study|Study terminated by sponsor|0|||
155214401|NCT02554812|560222182|FG012|Overall Study|Study terminated by sponsor|0|||
155214402|NCT02554812|560222183|FG013|Overall Study|Study terminated by sponsor|0|||
155214403|NCT02554812|560222184|FG014|Overall Study|Study terminated by sponsor|0|||
155214404|NCT02554812|560222185|FG015|Overall Study|Study terminated by sponsor|0|||
155214405|NCT02554812|560222186|FG016|Overall Study|Study terminated by sponsor|0|||
155214406|NCT02554812|560222187|FG017|Overall Study|Study terminated by sponsor|0|||
155214407|NCT02554812|560222188|FG018|Overall Study|Study terminated by sponsor|0|||
155214408|NCT02554812|560222189|FG019|Overall Study|Study terminated by sponsor|0|||
155214409|NCT02554812|560222190|FG020|Overall Study|Study terminated by sponsor|0|||
155214410|NCT02554812|560222191|FG021|Overall Study|Study terminated by sponsor|0|||
155214411|NCT02554812|560222192|FG022|Overall Study|Study terminated by sponsor|0|||
155214412|NCT02554812|560222193|FG023|Overall Study|Study terminated by sponsor|0|||
155214413|NCT02554812|560222194|FG024|Overall Study|Study terminated by sponsor|1|||
155214414|NCT02554812|560222195|FG025|Overall Study|Study terminated by sponsor|0|||
155214415|NCT02554812|560222196|FG026|Overall Study|Study terminated by sponsor|0|||
155214416|NCT02554812|560222170|FG000|Overall Study|No longer meets eligibility criteria|0|||
155214417|NCT02554812|560222171|FG001|Overall Study|No longer meets eligibility criteria|1|||
155214418|NCT02554812|560222172|FG002|Overall Study|No longer meets eligibility criteria|0|||
155214419|NCT02554812|560222173|FG003|Overall Study|No longer meets eligibility criteria|0|||
155214420|NCT02554812|560222174|FG004|Overall Study|No longer meets eligibility criteria|0|||
155214421|NCT02554812|560222175|FG005|Overall Study|No longer meets eligibility criteria|0|||
155214422|NCT02554812|560222176|FG006|Overall Study|No longer meets eligibility criteria|0|||
155214423|NCT02554812|560222177|FG007|Overall Study|No longer meets eligibility criteria|0|||
155214424|NCT02554812|560222178|FG008|Overall Study|No longer meets eligibility criteria|0|||
155214425|NCT02554812|560222179|FG009|Overall Study|No longer meets eligibility criteria|0|||
155214426|NCT02554812|560222180|FG010|Overall Study|No longer meets eligibility criteria|0|||
155214427|NCT02554812|560222181|FG011|Overall Study|No longer meets eligibility criteria|0|||
155214428|NCT02554812|560222182|FG012|Overall Study|No longer meets eligibility criteria|0|||
155214429|NCT02554812|560222183|FG013|Overall Study|No longer meets eligibility criteria|0|||
155214430|NCT02554812|560222184|FG014|Overall Study|No longer meets eligibility criteria|0|||
155214431|NCT02554812|560222185|FG015|Overall Study|No longer meets eligibility criteria|0|||
155214432|NCT02554812|560222186|FG016|Overall Study|No longer meets eligibility criteria|0|||
155214433|NCT02554812|560222187|FG017|Overall Study|No longer meets eligibility criteria|0|||
155214434|NCT02554812|560222188|FG018|Overall Study|No longer meets eligibility criteria|0|||
155214435|NCT02554812|560222189|FG019|Overall Study|No longer meets eligibility criteria|0|||
155214436|NCT02554812|560222190|FG020|Overall Study|No longer meets eligibility criteria|0|||
155214437|NCT02554812|560222191|FG021|Overall Study|No longer meets eligibility criteria|0|||
155214438|NCT02554812|560222192|FG022|Overall Study|No longer meets eligibility criteria|0|||
155214439|NCT02554812|560222193|FG023|Overall Study|No longer meets eligibility criteria|0|||
155214440|NCT02554812|560222194|FG024|Overall Study|No longer meets eligibility criteria|0|||
155214441|NCT02554812|560222195|FG025|Overall Study|No longer meets eligibility criteria|0|||
155214442|NCT02554812|560222196|FG026|Overall Study|No longer meets eligibility criteria|0|||
155214443|NCT02879305|560222197|FG000|Overall Study|Investigator Site Closed|55|||
155214444|NCT02879305|560222198|FG001|Overall Study|Investigator Site Closed|57|||
155214445|NCT02879305|560222197|FG000|Overall Study|Withdrawal by Subject|44|||
155214446|NCT02879305|560222198|FG001|Overall Study|Withdrawal by Subject|42|||
155214447|NCT02879305|560222197|FG000|Overall Study|Lost to Follow-up|17|||
155214448|NCT02879305|560222198|FG001|Overall Study|Lost to Follow-up|12|||
155214449|NCT02879305|560222197|FG000|Overall Study|Other|1|||
155214450|NCT02879305|560222198|FG001|Overall Study|Other|0|||
155214451|NCT00936910|560224055|FG000|Overall Study|Lack of Efficacy|3|||
155214452|NCT03020407|560224057|FG000|Overall Study|Withdrawal by Subject|2|||
155214453|NCT03020407|560224058|FG001|Overall Study|Withdrawal by Subject|1|||
155214454|NCT03020407|560224057|FG000|Overall Study|Lost to Follow-up|2|||
155214455|NCT03020407|560224058|FG001|Overall Study|Lost to Follow-up|3|||
155214456|NCT03020407|560224057|FG000|Overall Study|Protocol Violation|0|||
155214457|NCT03020407|560224058|FG001|Overall Study|Protocol Violation|1|||
155214458|NCT01585428|560224059|FG000|Overall Study|Death during treatment|1|||
155214459|NCT01585428|560224060|FG001|Overall Study|Death during treatment|0|||
155214460|NCT02057198|560224061|FG000|Overall Study|Death|0|||
155214461|NCT02057198|560224062|FG001|Overall Study|Death|0|||
155214462|NCT02057198|560224063|FG002|Overall Study|Death|1|||
155214463|NCT02057198|560224061|FG000|Overall Study|Discharged early; lost to followup|0|||
155214464|NCT02057198|560224062|FG001|Overall Study|Discharged early; lost to followup|1|||
155214465|NCT02057198|560224063|FG002|Overall Study|Discharged early; lost to followup|0|||
155214466|NCT00065507|560224064|FG000|Overall Study|Death|16|||
155214467|NCT00065507|560224065|FG001|Overall Study|Death|17|||
155214468|NCT00065507|560224064|FG000|Overall Study|Adverse Event|4|||
155214469|NCT00065507|560224065|FG001|Overall Study|Adverse Event|3|||
155214470|NCT00065507|560224064|FG000|Overall Study|Lack of Efficacy|0|||
155214471|NCT00065507|560224065|FG001|Overall Study|Lack of Efficacy|6|||
155214472|NCT00065507|560224064|FG000|Overall Study|Poor/Non-compliance|3|||
155214473|NCT00065507|560224065|FG001|Overall Study|Poor/Non-compliance|2|||
155214474|NCT00065507|560224064|FG000|Overall Study|Lost to Follow-up|3|||
155214475|NCT00065507|560224065|FG001|Overall Study|Lost to Follow-up|0|||
155214476|NCT00065507|560224064|FG000|Overall Study|Subject Withdrew Consent|2|||
155214477|NCT00065507|560224065|FG001|Overall Study|Subject Withdrew Consent|1|||
155214478|NCT00065507|560224064|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
155214479|NCT00065507|560224065|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
155214480|NCT00350636|560224066|FG000|Overall Study|Adverse Event|19|||
155214481|NCT00350636|560224067|FG001|Overall Study|Adverse Event|13|||
155214482|NCT00350636|560224066|FG000|Overall Study|Protocol Violation|1|||
155214483|NCT00350636|560224067|FG001|Overall Study|Protocol Violation|3|||
155214484|NCT00350636|560224066|FG000|Overall Study|Withdrawal by Subject|13|||
155214485|NCT00350636|560224067|FG001|Overall Study|Withdrawal by Subject|17|||
155214486|NCT00350636|560224066|FG000|Overall Study|Lost to Follow-up|9|||
155214487|NCT00350636|560224067|FG001|Overall Study|Lost to Follow-up|8|||
155214488|NCT00350636|560224066|FG000|Overall Study|Physician Decision|0|||
155214489|NCT00350636|560224067|FG001|Overall Study|Physician Decision|2|||
155214490|NCT00350636|560224066|FG000|Overall Study|Other|1|||
155214491|NCT00350636|560224067|FG001|Overall Study|Other|2|||
155214492|NCT01647282|560224070|FG000|Overall Study|Physician Decision|7|||
155214493|NCT01647282|560224071|FG001|Overall Study|Physician Decision|5|||
155214494|NCT01042236|560224072|FG000|Treatment Period 1|Adverse Event|0|||
155214495|NCT01042236|560224073|FG001|Treatment Period 1|Adverse Event|1|||
155214496|NCT01042236|560224074|FG002|Treatment Period 1|Adverse Event|0|||
155214497|NCT01042236|560224075|FG003|Treatment Period 1|Adverse Event|0|||
155214498|NCT01042236|560224076|FG004|Treatment Period 1|Adverse Event|1|||
155214499|NCT01042236|560224077|FG005|Treatment Period 1|Adverse Event|0|||
155214500|NCT01042236|560224072|FG000|Treatment Period 3|Adverse Event|0|||
155214501|NCT01042236|560224073|FG001|Treatment Period 3|Adverse Event|0|||
155214502|NCT01042236|560224074|FG002|Treatment Period 3|Adverse Event|0|||
155214503|NCT01042236|560224075|FG003|Treatment Period 3|Adverse Event|1|||
155214504|NCT01042236|560224076|FG004|Treatment Period 3|Adverse Event|0|||
155214505|NCT01042236|560224077|FG005|Treatment Period 3|Adverse Event|0|||
155214506|NCT01042236|560224072|FG000|Treatment Period 3|Protocol Violation|0|||
155214507|NCT01042236|560224073|FG001|Treatment Period 3|Protocol Violation|0|||
155214508|NCT01042236|560224074|FG002|Treatment Period 3|Protocol Violation|0|||
155214509|NCT01042236|560224075|FG003|Treatment Period 3|Protocol Violation|1|||
155214510|NCT01042236|560224076|FG004|Treatment Period 3|Protocol Violation|0|||
155214511|NCT01042236|560224077|FG005|Treatment Period 3|Protocol Violation|0|||
155214512|NCT02345811|560224078|FG000|First Intervention|Withdrawal by Subject|1|||
155214513|NCT02345811|560224079|FG001|First Intervention|Withdrawal by Subject|1|||
155214514|NCT03683758|560224084|FG000|Overall Study|Non-study commitment conflict|1|||
155214515|NCT03683758|560224085|FG001|Overall Study|Non-study commitment conflict|3|||
155214516|NCT03683758|560224084|FG000|Overall Study|Illness preventing participation|1|||
155214517|NCT03683758|560224085|FG001|Overall Study|Illness preventing participation|0|||
155214518|NCT03683758|560224084|FG000|Overall Study|Adverse Event|1|||
155214519|NCT03683758|560224085|FG001|Overall Study|Adverse Event|0|||
155214520|NCT00453921|560224086|FG000|Overall Study|Withdrawal by Subject|1|||
155214521|NCT00453921|560224087|FG001|Overall Study|Withdrawal by Subject|1|||
155214522|NCT00453921|560224088|FG002|Overall Study|Withdrawal by Subject|1|||
155214523|NCT00453921|560224089|FG003|Overall Study|Withdrawal by Subject|1|||
155214524|NCT00453921|560224086|FG000|Overall Study|Lost to Follow-up|0|||
155214525|NCT00453921|560224087|FG001|Overall Study|Lost to Follow-up|0|||
155214526|NCT00453921|560224088|FG002|Overall Study|Lost to Follow-up|1|||
155214527|NCT00453921|560224089|FG003|Overall Study|Lost to Follow-up|0|||
155214528|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
155214529|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
155214530|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
155214531|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
155214532|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
155214533|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
155214534|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
155214535|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
155214536|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Other|4|||
155214537|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Other|1|||
155214538|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
155214539|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
155214540|NCT00303498|560224090|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
155214541|NCT00303498|560224091|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
155214542|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
155214543|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
155214544|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Death|1|||
155214545|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Death|0|||
155214546|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
155214547|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
155214548|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
155214549|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
155214550|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
155214551|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
155214552|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
155214553|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
155214554|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Other|1|||
155214555|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Other|0|||
155214556|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
155214557|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
155214558|NCT00303498|560224090|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
155214559|NCT00303498|560224091|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
155214560|NCT00174915|560224092|FG000|Overall Study|Lost to Follow-up|19|||
155214561|NCT00174915|560224093|FG001|Overall Study|Lost to Follow-up|17|||
155214562|NCT00174915|560224094|FG002|Overall Study|Lost to Follow-up|9|||
155214563|NCT00174915|560224095|FG003|Overall Study|Lost to Follow-up|17|||
155214564|NCT00174915|560224096|FG004|Overall Study|Lost to Follow-up|10|||
155214565|NCT00174915|560224092|FG000|Overall Study|Adverse Event|18|||
155214566|NCT00174915|560224093|FG001|Overall Study|Adverse Event|16|||
155214567|NCT00174915|560224094|FG002|Overall Study|Adverse Event|11|||
155214568|NCT00174915|560224095|FG003|Overall Study|Adverse Event|18|||
155214569|NCT00174915|560224096|FG004|Overall Study|Adverse Event|5|||
155214570|NCT00174915|560224092|FG000|Overall Study|Personal Reason(s)|16|||
155214571|NCT00174915|560224093|FG001|Overall Study|Personal Reason(s)|16|||
155214572|NCT00174915|560224094|FG002|Overall Study|Personal Reason(s)|9|||
155214573|NCT00174915|560224095|FG003|Overall Study|Personal Reason(s)|9|||
155214574|NCT00174915|560224096|FG004|Overall Study|Personal Reason(s)|9|||
155214575|NCT00174915|560224092|FG000|Overall Study|Other|15|||
155214576|NCT00174915|560224093|FG001|Overall Study|Other|8|||
155214577|NCT00174915|560224094|FG002|Overall Study|Other|6|||
155214578|NCT00174915|560224095|FG003|Overall Study|Other|5|||
155214579|NCT00174915|560224096|FG004|Overall Study|Other|3|||
155214580|NCT00174915|560224092|FG000|Overall Study|Gout Flare|13|||
155214581|NCT00174915|560224093|FG001|Overall Study|Gout Flare|6|||
155214582|NCT00174915|560224094|FG002|Overall Study|Gout Flare|8|||
155214583|NCT00174915|560224095|FG003|Overall Study|Gout Flare|1|||
155214584|NCT00174915|560224096|FG004|Overall Study|Gout Flare|0|||
155214585|NCT00174915|560224092|FG000|Overall Study|Protocol Violation|6|||
155214586|NCT00174915|560224093|FG001|Overall Study|Protocol Violation|3|||
155214587|NCT00174915|560224094|FG002|Overall Study|Protocol Violation|3|||
155214588|NCT00174915|560224095|FG003|Overall Study|Protocol Violation|6|||
155214589|NCT00174915|560224096|FG004|Overall Study|Protocol Violation|3|||
155214590|NCT00174915|560224092|FG000|Overall Study|Therapeutic Failure|6|||
155214591|NCT00174915|560224093|FG001|Overall Study|Therapeutic Failure|3|||
155214592|NCT00174915|560224094|FG002|Overall Study|Therapeutic Failure|2|||
155214593|NCT00174915|560224095|FG003|Overall Study|Therapeutic Failure|1|||
155214594|NCT00174915|560224096|FG004|Overall Study|Therapeutic Failure|3|||
155214595|NCT03045887|560224097|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
155214596|NCT03045887|560224098|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214597|NCT03045887|560224099|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214598|NCT03045887|560224100|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214599|NCT03045887|560224101|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214600|NCT03045887|560224102|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214601|NCT03045887|560224103|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214602|NCT03045887|560224104|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214603|NCT03045887|560224105|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214604|NCT03045887|560224106|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
155214605|NCT03045887|560224097|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214606|NCT03045887|560224098|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214607|NCT03045887|560224099|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214608|NCT03045887|560224100|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
155214609|NCT03045887|560224101|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214610|NCT03045887|560224102|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214611|NCT03045887|560224103|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214612|NCT03045887|560224104|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214613|NCT03045887|560224105|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214614|NCT03045887|560224106|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
155214615|NCT03045887|560224097|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
155214616|NCT03045887|560224098|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214617|NCT03045887|560224099|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214618|NCT03045887|560224100|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214619|NCT03045887|560224101|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214620|NCT03045887|560224102|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214621|NCT03045887|560224103|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214622|NCT03045887|560224104|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214623|NCT03045887|560224105|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214624|NCT03045887|560224106|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
155214625|NCT03045887|560224097|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214626|NCT03045887|560224098|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214627|NCT03045887|560224099|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
155214628|NCT03045887|560224100|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
155214629|NCT03045887|560224101|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214630|NCT03045887|560224102|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214631|NCT03045887|560224103|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214632|NCT03045887|560224104|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214633|NCT03045887|560224105|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214634|NCT03045887|560224106|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
155214635|NCT03045887|560224097|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214636|NCT03045887|560224098|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214637|NCT03045887|560224099|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214638|NCT03045887|560224100|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
155214639|NCT03045887|560224101|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214640|NCT03045887|560224102|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214641|NCT03045887|560224103|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214642|NCT03045887|560224104|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214643|NCT03045887|560224105|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214644|NCT03045887|560224106|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
155214645|NCT02132767|560224107|FG000|Overall Study|Death|3|||
155214646|NCT02132767|560224108|FG001|Overall Study|Death|2|||
155214647|NCT02132767|560224107|FG000|Overall Study|Withdrawal by Subject|10|||
155214648|NCT02132767|560224108|FG001|Overall Study|Withdrawal by Subject|9|||
155214649|NCT02132767|560224107|FG000|Overall Study|Lost to Follow-up|4|||
155214650|NCT02132767|560224108|FG001|Overall Study|Lost to Follow-up|4|||
155214651|NCT00546637|560224111|FG000|Overall Study|Adverse Event|46|||
155214652|NCT00546637|560224112|FG001|Overall Study|Adverse Event|20|||
155214653|NCT00546637|560224111|FG000|Overall Study|Lack of Efficacy|5|||
155214654|NCT00546637|560224112|FG001|Overall Study|Lack of Efficacy|5|||
155214655|NCT00546637|560224111|FG000|Overall Study|Lost to Follow-up|2|||
155214656|NCT00546637|560224112|FG001|Overall Study|Lost to Follow-up|2|||
155214657|NCT00546637|560224111|FG000|Overall Study|Other|10|||
155214658|NCT00546637|560224112|FG001|Overall Study|Other|12|||
155214659|NCT00546637|560224111|FG000|Overall Study|Withdrawal by Subject|7|||
155214660|NCT00546637|560224112|FG001|Overall Study|Withdrawal by Subject|9|||
155214661|NCT00546637|560224111|FG000|Overall Study|Randomized, but not treated|3|||
155214662|NCT00546637|560224112|FG001|Overall Study|Randomized, but not treated|1|||
155214663|NCT02968563|560224117|FG000|Overall Study|Adverse Event|0|||
155214664|NCT02968563|560224118|FG001|Overall Study|Adverse Event|6|||
155214665|NCT02968563|560224117|FG000|Overall Study|Death|1|||
155214666|NCT02968563|560224118|FG001|Overall Study|Death|1|||
155214667|NCT02968563|560224117|FG000|Overall Study|Lost to Follow-up|0|||
155214668|NCT02968563|560224118|FG001|Overall Study|Lost to Follow-up|1|||
155214669|NCT04008030|560224121|FG000|Pre-Treatment|Withdrawal by Subject|0|||
155214670|NCT04008030|560224122|FG001|Pre-Treatment|Withdrawal by Subject|0|||
155214671|NCT04008030|560224123|FG002|Pre-Treatment|Withdrawal by Subject|9|||
155214672|NCT04008030|560224121|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
155214673|NCT04008030|560224122|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
155214674|NCT04008030|560224123|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
155214675|NCT04008030|560224121|FG000|Pre-Treatment|Other reasons|0|||
155214676|NCT04008030|560224122|FG001|Pre-Treatment|Other reasons|1|||
155214677|NCT04008030|560224123|FG002|Pre-Treatment|Other reasons|6|||
155214678|NCT04008030|560224121|FG000|Treatment|Withdrawal by Subject|1|||
155214679|NCT04008030|560224122|FG001|Treatment|Withdrawal by Subject|1|||
155214680|NCT04008030|560224123|FG002|Treatment|Withdrawal by Subject|1|||
155214681|NCT04008030|560224121|FG000|Treatment|Death|2|||
155214682|NCT04008030|560224122|FG001|Treatment|Death|4|||
155214683|NCT04008030|560224123|FG002|Treatment|Death|0|||
155214684|NCT04008030|560224121|FG000|Treatment|Pregnancy|0|||
155214685|NCT04008030|560224122|FG001|Treatment|Pregnancy|1|||
155214686|NCT04008030|560224123|FG002|Treatment|Pregnancy|0|||
155214687|NCT04008030|560224121|FG000|Treatment|Participant no longer meets study criteria|0|||
155214688|NCT04008030|560224122|FG001|Treatment|Participant no longer meets study criteria|1|||
155214689|NCT04008030|560224123|FG002|Treatment|Participant no longer meets study criteria|0|||
155214690|NCT04008030|560224121|FG000|Treatment|Other reasons|5|||
155214691|NCT04008030|560224122|FG001|Treatment|Other reasons|13|||
155214692|NCT04008030|560224123|FG002|Treatment|Other reasons|6|||
155214693|NCT04008030|560224121|FG000|Treatment|Disease Progression|137|||
155214694|NCT04008030|560224122|FG001|Treatment|Disease Progression|82|||
155214695|NCT04008030|560224123|FG002|Treatment|Disease Progression|85|||
155214696|NCT04008030|560224121|FG000|Treatment|Study drug toxicity|28|||
155214697|NCT04008030|560224122|FG001|Treatment|Study drug toxicity|48|||
155214698|NCT04008030|560224123|FG002|Treatment|Study drug toxicity|8|||
155214699|NCT04008030|560224121|FG000|Treatment|Adverse Event unrelated to study drug|28|||
155214700|NCT04008030|560224122|FG001|Treatment|Adverse Event unrelated to study drug|22|||
155214701|NCT04008030|560224123|FG002|Treatment|Adverse Event unrelated to study drug|6|||
155214702|NCT04008030|560224121|FG000|Treatment|Maximum Clinical Benefit|0|||
155214703|NCT04008030|560224122|FG001|Treatment|Maximum Clinical Benefit|1|||
155214704|NCT04008030|560224123|FG002|Treatment|Maximum Clinical Benefit|9|||
155214705|NCT04008030|560224121|FG000|Treatment|On-going treatment|13|||
155214706|NCT04008030|560224122|FG001|Treatment|On-going treatment|20|||
155214707|NCT04008030|560224123|FG002|Treatment|On-going treatment|0|||
155214708|NCT02574247|560224126|FG000|Overall Study|Withdrawal by Subject|1|||
155214709|NCT02574247|560224127|FG001|Overall Study|Withdrawal by Subject|0|||
155214710|NCT02574247|560224128|FG002|Overall Study|Withdrawal by Subject|0|||
155214711|NCT02574247|560224126|FG000|Overall Study|Did not meet inclusion criteria|4|||
155214712|NCT02574247|560224127|FG001|Overall Study|Did not meet inclusion criteria|3|||
155214713|NCT02574247|560224128|FG002|Overall Study|Did not meet inclusion criteria|5|||
155214714|NCT01382446|560224129|FG000|Overall Study|Withdrawal by Subject|0|||
155214715|NCT01382446|560224130|FG001|Overall Study|Withdrawal by Subject|1|||
155214716|NCT01382446|560224129|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
155214717|NCT01382446|560224130|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
155214718|NCT00422591|560224135|FG000|Overall Study|Physician Decision|4|||
155214719|NCT00422591|560224135|FG000|Overall Study|Withdrawal by Subject|2|||
155214720|NCT04210310|560224138|FG000|Overall Study|Lost to Follow-up|32|||
155214721|NCT04210310|560224139|FG001|Overall Study|Lost to Follow-up|1|||
155214722|NCT00495170|560224140|FG000|Overall Study|Lost to Follow-up|9|||
155214723|NCT00495170|560224140|FG000|Overall Study|Withdrawal by Subject|3|||
155214724|NCT00495170|560224140|FG000|Overall Study|Inappropriate staging|8|||
155214725|NCT04191499|560224141|FG000|Overall Study|Adverse Event|1|||
155214726|NCT04191499|560224142|FG001|Overall Study|Adverse Event|0|||
155214727|NCT04191499|560224141|FG000|Overall Study|Death|42|||
155214728|NCT04191499|560224142|FG001|Overall Study|Death|55|||
155214729|NCT04191499|560224141|FG000|Overall Study|Lost to Follow-up|4|||
155214730|NCT04191499|560224142|FG001|Overall Study|Lost to Follow-up|1|||
155214731|NCT04191499|560224141|FG000|Overall Study|Physician Decision|1|||
155214732|NCT04191499|560224142|FG001|Overall Study|Physician Decision|0|||
155214733|NCT04191499|560224141|FG000|Overall Study|Progressive Disease|1|||
155214734|NCT04191499|560224142|FG001|Overall Study|Progressive Disease|0|||
155214735|NCT04191499|560224141|FG000|Overall Study|Symptomatic Deterioration|1|||
155214736|NCT04191499|560224142|FG001|Overall Study|Symptomatic Deterioration|0|||
155214737|NCT04191499|560224141|FG000|Overall Study|Withdrawal by Subject|7|||
155214738|NCT04191499|560224142|FG001|Overall Study|Withdrawal by Subject|11|||
155214739|NCT04191499|560224141|FG000|Overall Study|Ongoing in the study|104|||
155214740|NCT04191499|560224142|FG001|Overall Study|Ongoing in the study|97|||
155214741|NCT01928329|560224143|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
155214742|NCT01928329|560224144|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
155214743|NCT01928329|560224143|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
155214744|NCT01928329|560224144|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
155214745|NCT01928329|560224143|FG000|Overall Study|Adverse Event|5|||
155214746|NCT01928329|560224144|FG001|Overall Study|Adverse Event|3|||
155214747|NCT01928329|560224143|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
155214748|NCT01928329|560224144|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
155214749|NCT01928329|560224143|FG000|Overall Study|Withdrawal by Subject|1|||
155214750|NCT01928329|560224144|FG001|Overall Study|Withdrawal by Subject|5|||
155214751|NCT01928329|560224143|FG000|Overall Study|Physician Decision|1|||
155214752|NCT01928329|560224144|FG001|Overall Study|Physician Decision|1|||
155214753|NCT00330616|560224145|FG000|Overall Study|Adverse Event|13|||
155214754|NCT00330616|560224145|FG000|Overall Study|Lack of Efficacy|1|||
155214755|NCT00330616|560224145|FG000|Overall Study|Lost to Follow-up|2|||
155214756|NCT00330616|560224145|FG000|Overall Study|Withdrawal by Subject|4|||
155214757|NCT00330616|560224145|FG000|Overall Study|Other|1|||
155214758|NCT02141997|560224150|FG000|Overall Study|Adverse Event|0|||
155214759|NCT02141997|560224151|FG001|Overall Study|Adverse Event|2|||
155214760|NCT02141997|560224152|FG002|Overall Study|Adverse Event|0|||
155214761|NCT02141997|560224153|FG003|Overall Study|Adverse Event|1|||
155214762|NCT02141997|560224150|FG000|Overall Study|Participant noncompliance|1|||
155214763|NCT02141997|560224151|FG001|Overall Study|Participant noncompliance|0|||
155214764|NCT02141997|560224152|FG002|Overall Study|Participant noncompliance|0|||
155214765|NCT02141997|560224153|FG003|Overall Study|Participant noncompliance|0|||
155214766|NCT02141997|560224150|FG000|Overall Study|Withdrew consent|1|||
155214767|NCT02141997|560224151|FG001|Overall Study|Withdrew consent|0|||
155214768|NCT02141997|560224152|FG002|Overall Study|Withdrew consent|3|||
155214769|NCT02141997|560224153|FG003|Overall Study|Withdrew consent|0|||
155214770|NCT02141997|560224150|FG000|Overall Study|Other|1|||
155214771|NCT02141997|560224151|FG001|Overall Study|Other|4|||
155214772|NCT02141997|560224152|FG002|Overall Study|Other|0|||
155214773|NCT02141997|560224153|FG003|Overall Study|Other|0|||
155214774|NCT03557151|560224163|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
155214775|NCT03557151|560224164|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
155214776|NCT03557151|560224163|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
155214777|NCT03557151|560224164|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
155214778|NCT03557151|560224163|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
155214779|NCT03557151|560224164|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
155214780|NCT00840294|560224165|FG000|Overall Study|Withdrawal by Subject|2|||
155214781|NCT00840294|560224166|FG001|Overall Study|Withdrawal by Subject|1|||
155214782|NCT00840294|560224165|FG000|Overall Study|Protocol Violation|1|||
155214783|NCT00840294|560224166|FG001|Overall Study|Protocol Violation|3|||
155214784|NCT00840294|560224165|FG000|Overall Study|Illness|0|||
155214785|NCT00840294|560224166|FG001|Overall Study|Illness|1|||
155214786|NCT02028065|560224173|FG000|Randomization Through Start Treatment|Not treated|1|||
155214787|NCT02028065|560224174|FG001|Randomization Through Start Treatment|Not treated|3|||
155214788|NCT02028065|560224175|FG002|Randomization Through Start Treatment|Not treated|3|||
155214789|NCT02028065|560224173|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
155214790|NCT02028065|560224174|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
155214791|NCT02028065|560224175|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
155214792|NCT02028065|560224173|FG000|Treatment Through Study Completion|Physician Decision|1|||
155214793|NCT02028065|560224174|FG001|Treatment Through Study Completion|Physician Decision|0|||
155214794|NCT02028065|560224175|FG002|Treatment Through Study Completion|Physician Decision|0|||
155214795|NCT02028065|560224173|FG000|Treatment Through Study Completion|Protocol Violation|1|||
155214796|NCT02028065|560224174|FG001|Treatment Through Study Completion|Protocol Violation|4|||
155214797|NCT02028065|560224175|FG002|Treatment Through Study Completion|Protocol Violation|0|||
155214798|NCT02028065|560224173|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
155214799|NCT02028065|560224174|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
155214800|NCT02028065|560224175|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
155214801|NCT02028065|560224173|FG000|Treatment Through Study Completion|Adverse Event|3|||
155214802|NCT02028065|560224174|FG001|Treatment Through Study Completion|Adverse Event|3|||
155214803|NCT02028065|560224175|FG002|Treatment Through Study Completion|Adverse Event|5|||
155214804|NCT04868890|560224176|FG000|Overall Study|Death|2|||
155214805|NCT04868890|560224177|FG001|Overall Study|Death|1|||
155214806|NCT04868890|560224176|FG000|Overall Study|Withdrawal by Subject|1|||
155214807|NCT04868890|560224177|FG001|Overall Study|Withdrawal by Subject|5|||
155214808|NCT02669433|560224180|FG000|Overall Study|Protocol Violation|0|||
155214809|NCT02669433|560224181|FG001|Overall Study|Protocol Violation|4|||
155214810|NCT02669433|560224182|FG002|Overall Study|Protocol Violation|1|||
155214811|NCT02669433|560224180|FG000|Overall Study|Disease Progression|1|||
155214812|NCT02669433|560224181|FG001|Overall Study|Disease Progression|0|||
155214813|NCT02669433|560224182|FG002|Overall Study|Disease Progression|0|||
155214814|NCT02669433|560224180|FG000|Overall Study|Physician Decision|1|||
155214815|NCT02669433|560224181|FG001|Overall Study|Physician Decision|1|||
155214816|NCT02669433|560224182|FG002|Overall Study|Physician Decision|0|||
155214817|NCT02669433|560224180|FG000|Overall Study|Adverse Event|6|||
155214818|NCT02669433|560224181|FG001|Overall Study|Adverse Event|7|||
155214819|NCT02669433|560224182|FG002|Overall Study|Adverse Event|10|||
155214820|NCT02669433|560224180|FG000|Overall Study|Sponsor Termination|1|||
155214821|NCT02669433|560224181|FG001|Overall Study|Sponsor Termination|0|||
155214822|NCT02669433|560224182|FG002|Overall Study|Sponsor Termination|1|||
155214823|NCT02669433|560224180|FG000|Overall Study|Withdrawal by Subject|5|||
155214824|NCT02669433|560224181|FG001|Overall Study|Withdrawal by Subject|1|||
155214825|NCT02669433|560224182|FG002|Overall Study|Withdrawal by Subject|0|||
155214826|NCT02669433|560224180|FG000|Overall Study|Withdrawal by Caregiver|1|||
155214827|NCT02669433|560224181|FG001|Overall Study|Withdrawal by Caregiver|0|||
155214828|NCT02669433|560224182|FG002|Overall Study|Withdrawal by Caregiver|2|||
155214829|NCT02669433|560224180|FG000|Overall Study|Death|0|||
155214830|NCT02669433|560224181|FG001|Overall Study|Death|1|||
155214831|NCT02669433|560224182|FG002|Overall Study|Death|1|||
155214832|NCT02157298|560224184|FG000|Overall Study|Adverse Event|1|||
155214833|NCT02157298|560224185|FG001|Overall Study|Adverse Event|0|||
155214834|NCT02157298|560224184|FG000|Overall Study|Subject no longer meets study criteria|1|||
155214835|NCT02157298|560224185|FG001|Overall Study|Subject no longer meets study criteria|2|||
155214836|NCT02157298|560224184|FG000|Overall Study|Poor/Non-compliance|1|||
155214837|NCT02157298|560224185|FG001|Overall Study|Poor/Non-compliance|0|||
155214838|NCT02157298|560224184|FG000|Overall Study|Withdrawal by Subject|1|||
155214839|NCT02157298|560224185|FG001|Overall Study|Withdrawal by Subject|0|||
155214840|NCT00818662|560224188|FG000|Overall Study|Adverse Event|5|||
155214841|NCT00818662|560224189|FG001|Overall Study|Adverse Event|14|||
155214842|NCT00818662|560224190|FG002|Overall Study|Adverse Event|4|||
155214843|NCT00818662|560224191|FG003|Overall Study|Adverse Event|3|||
155214844|NCT00818662|560224188|FG000|Overall Study|Withdrawal by Subject|5|||
155214845|NCT00818662|560224189|FG001|Overall Study|Withdrawal by Subject|4|||
155214846|NCT00818662|560224190|FG002|Overall Study|Withdrawal by Subject|2|||
155214847|NCT00818662|560224191|FG003|Overall Study|Withdrawal by Subject|2|||
155214848|NCT00818662|560224188|FG000|Overall Study|Death|1|||
155214849|NCT00818662|560224189|FG001|Overall Study|Death|3|||
155214850|NCT00818662|560224190|FG002|Overall Study|Death|0|||
155214851|NCT00818662|560224191|FG003|Overall Study|Death|0|||
155214852|NCT00818662|560224188|FG000|Overall Study|Physician Decision|1|||
155214853|NCT00818662|560224189|FG001|Overall Study|Physician Decision|0|||
155214854|NCT00818662|560224190|FG002|Overall Study|Physician Decision|0|||
155214855|NCT00818662|560224191|FG003|Overall Study|Physician Decision|0|||
155214856|NCT00818662|560224188|FG000|Overall Study|Lost to Follow-up|0|||
155214857|NCT00818662|560224189|FG001|Overall Study|Lost to Follow-up|0|||
155214858|NCT00818662|560224190|FG002|Overall Study|Lost to Follow-up|0|||
155214859|NCT00818662|560224191|FG003|Overall Study|Lost to Follow-up|1|||
155214860|NCT00818662|560224188|FG000|Overall Study|Unwilling or Unable to Participate|4|||
155214861|NCT00818662|560224189|FG001|Overall Study|Unwilling or Unable to Participate|6|||
155214862|NCT00818662|560224190|FG002|Overall Study|Unwilling or Unable to Participate|2|||
155214863|NCT00818662|560224191|FG003|Overall Study|Unwilling or Unable to Participate|4|||
155214864|NCT00818662|560224188|FG000|Overall Study|Protocol Violation|1|||
155214865|NCT00818662|560224189|FG001|Overall Study|Protocol Violation|1|||
155214866|NCT00818662|560224190|FG002|Overall Study|Protocol Violation|0|||
155214867|NCT00818662|560224191|FG003|Overall Study|Protocol Violation|0|||
155214868|NCT00818662|560224188|FG000|Overall Study|Requires a Prohibited Medication|1|||
155214869|NCT00818662|560224189|FG001|Overall Study|Requires a Prohibited Medication|0|||
155214870|NCT00818662|560224190|FG002|Overall Study|Requires a Prohibited Medication|0|||
155214871|NCT00818662|560224191|FG003|Overall Study|Requires a Prohibited Medication|0|||
155214872|NCT00818662|560224188|FG000|Overall Study|Safety Risk|1|||
155214873|NCT00818662|560224189|FG001|Overall Study|Safety Risk|1|||
155214874|NCT00818662|560224190|FG002|Overall Study|Safety Risk|0|||
155214875|NCT00818662|560224191|FG003|Overall Study|Safety Risk|1|||
155214876|NCT00818662|560224188|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
155214877|NCT00818662|560224189|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
155214878|NCT00818662|560224190|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
155214879|NCT00818662|560224191|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
155214880|NCT00818662|560224188|FG000|Overall Study|Participant's health declined|0|||
155214881|NCT00818662|560224189|FG001|Overall Study|Participant's health declined|0|||
155214882|NCT00818662|560224190|FG002|Overall Study|Participant's health declined|0|||
155214883|NCT00818662|560224191|FG003|Overall Study|Participant's health declined|1|||
155214884|NCT00818662|560224188|FG000|Overall Study|Caregiver to pursue other treatment|0|||
155214885|NCT00818662|560224189|FG001|Overall Study|Caregiver to pursue other treatment|1|||
155214886|NCT00818662|560224190|FG002|Overall Study|Caregiver to pursue other treatment|0|||
155214887|NCT00818662|560224191|FG003|Overall Study|Caregiver to pursue other treatment|0|||
155214888|NCT00818662|560224188|FG000|Overall Study|Moving out of state|0|||
155214889|NCT00818662|560224189|FG001|Overall Study|Moving out of state|0|||
155214890|NCT00818662|560224190|FG002|Overall Study|Moving out of state|0|||
155214891|NCT00818662|560224191|FG003|Overall Study|Moving out of state|1|||
155214892|NCT00818662|560224188|FG000|Overall Study|Declined move to another study site|1|||
155214893|NCT00818662|560224189|FG001|Overall Study|Declined move to another study site|0|||
155214894|NCT00818662|560224190|FG002|Overall Study|Declined move to another study site|0|||
155214895|NCT00818662|560224191|FG003|Overall Study|Declined move to another study site|0|||
155214896|NCT00818662|560224188|FG000|Overall Study|Change in living situation|0|||
155214897|NCT00818662|560224189|FG001|Overall Study|Change in living situation|0|||
155214898|NCT00818662|560224190|FG002|Overall Study|Change in living situation|0|||
155214899|NCT00818662|560224191|FG003|Overall Study|Change in living situation|1|||
155214900|NCT00818662|560224188|FG000|Overall Study|Study partner decision|0|||
155214901|NCT00818662|560224189|FG001|Overall Study|Study partner decision|0|||
155214902|NCT00818662|560224190|FG002|Overall Study|Study partner decision|0|||
155214903|NCT00818662|560224191|FG003|Overall Study|Study partner decision|1|||
155214904|NCT00818662|560224188|FG000|Overall Study|Admitted to long term nursing care|0|||
155214905|NCT00818662|560224189|FG001|Overall Study|Admitted to long term nursing care|1|||
155214906|NCT00818662|560224190|FG002|Overall Study|Admitted to long term nursing care|0|||
155214907|NCT00818662|560224191|FG003|Overall Study|Admitted to long term nursing care|0|||
155214908|NCT01722071|560224192|FG000|Overall Study|Protocol Violation|1|||
155214909|NCT01722071|560224193|FG001|Overall Study|Protocol Violation|0|||
155214910|NCT03021265|560224194|FG000|Overall Study|Adverse Event|29|||
155214911|NCT03021265|560224194|FG000|Overall Study|Lack of Efficacy|3|||
155214912|NCT03021265|560224194|FG000|Overall Study|Improved|17|||
155214913|NCT03021265|560224194|FG000|Overall Study|Lost to Follow-up|67|||
155214914|NCT03021265|560224194|FG000|Overall Study|No reason given|2|||
155214915|NCT03021265|560224194|FG000|Overall Study|No visit since the first visit|4|||
155214916|NCT01338493|560224195|FG000|Enrolled|Withdrawal by Subject|1|||
155214917|NCT01338493|560224195|FG000|Enrolled|Patient not implanted|4|||
155214918|NCT01338493|560224195|FG000|Discharge|Death|1|||
155214919|NCT01338493|560224195|FG000|Discharge|Missed visit|1|||
155214920|NCT01338493|560224195|FG000|6 Months Follow up|Lost to Follow-up|11|||
155214921|NCT01338493|560224195|FG000|6 Months Follow up|Missed visit|8|||
155214922|NCT01338493|560224195|FG000|12 Months Follow up|Lost to Follow-up|9|||
155214923|NCT01698801|560224196|FG000|Treatment Phase|Adverse Event|4|||
155214924|NCT01698801|560224196|FG000|Treatment Phase|Protocol Violation|1|||
155214925|NCT01698801|560224196|FG000|Treatment Phase|Other|4|||
155214926|NCT01698801|560224196|FG000|Treatment Phase|Withdrawal by Subject|1|||
155214927|NCT01698801|560224196|FG000|Treatment Phase|Disease progression|1|||
155214928|NCT01698801|560224196|FG000|Follow Up Phase|Withdrawal by Subject|1|||
155214929|NCT01698801|560224196|FG000|Follow Up Phase|Death|4|||
155214930|NCT01614067|560224197|FG000|Overall Study|Pregnancy|1|||
155214931|NCT01614067|560224198|FG001|Overall Study|Pregnancy|0|||
155214932|NCT01614067|560224197|FG000|Overall Study|Physician Decision|6|||
155214933|NCT01614067|560224198|FG001|Overall Study|Physician Decision|5|||
155214934|NCT01614067|560224197|FG000|Overall Study|Withdrawal by Subject|0|||
155214935|NCT01614067|560224198|FG001|Overall Study|Withdrawal by Subject|1|||
155214936|NCT01614067|560224197|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
155214937|NCT01614067|560224198|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
155214938|NCT02062879|560224199|FG000|Overall Study|Withdrawal by Subject|4|||
155214939|NCT02062879|560224200|FG001|Overall Study|Withdrawal by Subject|1|||
155214940|NCT00665847|560224203|FG000|Overall Study|Adverse Event|8|||
155214941|NCT00665847|560224203|FG000|Overall Study|Withdrawal by Subject|2|||
155214942|NCT00665847|560224203|FG000|Overall Study|Subject non-compliant|8|||
155214943|NCT00665847|560224203|FG000|Overall Study|Subject reached a virologic endpoint|4|||
155214944|NCT00665847|560224203|FG000|Overall Study|Resistance to TMC125|1|||
155214945|NCT00665847|560224203|FG000|Overall Study|Subject ineligible to continue the trial|1|||
155214946|NCT00665847|560224203|FG000|Overall Study|Switch to Commercial Medication|1|||
155214947|NCT00511667|560224209|FG000|Overall Study|Adverse Event|1|||
155214948|NCT00511667|560224210|FG001|Overall Study|Adverse Event|0|||
155214949|NCT00511667|560224209|FG000|Overall Study|Protocol Violation|1|||
155214950|NCT00511667|560224210|FG001|Overall Study|Protocol Violation|1|||
155214951|NCT00511667|560224209|FG000|Overall Study|Withdrawal by Subject|2|||
155214952|NCT00511667|560224210|FG001|Overall Study|Withdrawal by Subject|0|||
155214953|NCT00511667|560224209|FG000|Overall Study|Site terminated|6|||
155214954|NCT00511667|560224210|FG001|Overall Study|Site terminated|1|||
155214955|NCT00511667|560224209|FG000|Overall Study|Other|2|||
155214956|NCT00511667|560224210|FG001|Overall Study|Other|1|||
155214957|NCT00616655|560224211|FG000|Overall Study|Adverse Event|10|||
155214958|NCT00616655|560224212|FG001|Overall Study|Adverse Event|7|||
155214959|NCT00616655|560224213|FG002|Overall Study|Adverse Event|12|||
155214960|NCT00616655|560224211|FG000|Overall Study|Lack of Efficacy|5|||
155214961|NCT00616655|560224212|FG001|Overall Study|Lack of Efficacy|5|||
155214962|NCT00616655|560224213|FG002|Overall Study|Lack of Efficacy|5|||
155214963|NCT00616655|560224211|FG000|Overall Study|Lost to Follow-up|3|||
155214964|NCT00616655|560224212|FG001|Overall Study|Lost to Follow-up|12|||
155214965|NCT00616655|560224213|FG002|Overall Study|Lost to Follow-up|10|||
155214966|NCT00616655|560224211|FG000|Overall Study|Protocol Violation|2|||
155214967|NCT00616655|560224212|FG001|Overall Study|Protocol Violation|4|||
155214968|NCT00616655|560224213|FG002|Overall Study|Protocol Violation|3|||
155214969|NCT00616655|560224211|FG000|Overall Study|Withdrawal by Subject|9|||
155214970|NCT00616655|560224212|FG001|Overall Study|Withdrawal by Subject|7|||
155214971|NCT00616655|560224213|FG002|Overall Study|Withdrawal by Subject|11|||
155214972|NCT00616655|560224211|FG000|Overall Study|Does not meet in/ex criteria|0|||
155214973|NCT00616655|560224212|FG001|Overall Study|Does not meet in/ex criteria|0|||
155214974|NCT00616655|560224213|FG002|Overall Study|Does not meet in/ex criteria|2|||
155214975|NCT00616655|560224211|FG000|Overall Study|Other|6|||
155214976|NCT00616655|560224212|FG001|Overall Study|Other|6|||
155214977|NCT00616655|560224213|FG002|Overall Study|Other|5|||
155214978|NCT03761147|560224214|FG000|Overall Study|Withdrawal by Subject|6|||
155214979|NCT03761147|560224215|FG001|Overall Study|Withdrawal by Subject|1|||
155214980|NCT03761147|560224214|FG000|Overall Study|Adverse Event|1|||
155214981|NCT03761147|560224215|FG001|Overall Study|Adverse Event|3|||
155214982|NCT00309842|560224216|FG000|Overall Study|Lost to Follow-up|1|||
155214983|NCT03564145|560224217|FG000|Overall Study|Adverse Event|4|||
155214984|NCT03564145|560224217|FG000|Overall Study|Lost to Follow-up|21|||
155214985|NCT03564145|560224217|FG000|Overall Study|Protocol Violation|2|||
155214986|NCT03564145|560224217|FG000|Overall Study|Withdrawal by Subject|48|||
155214987|NCT03564145|560224217|FG000|Overall Study|Study Terminated by Sponsor|146|||
155214988|NCT03564145|560224217|FG000|Overall Study|Physician Decision|1|||
155214989|NCT03564145|560224217|FG000|Overall Study|Other Than Specified|1|||
155214990|NCT03564145|560224217|FG000|Overall Study|Pregnancy|1|||
155214991|NCT02045797|560224218|FG000|Overall Study|Adverse Event|3|||
155214992|NCT02045797|560224219|FG001|Overall Study|Adverse Event|1|||
155214993|NCT02045797|560224220|FG002|Overall Study|Adverse Event|0|||
155214994|NCT02045797|560224218|FG000|Overall Study|Lack of Efficacy|1|||
155214995|NCT02045797|560224219|FG001|Overall Study|Lack of Efficacy|0|||
155214996|NCT02045797|560224220|FG002|Overall Study|Lack of Efficacy|0|||
155214997|NCT02045797|560224218|FG000|Overall Study|Lost to Follow-up|2|||
155214998|NCT02045797|560224219|FG001|Overall Study|Lost to Follow-up|3|||
155214999|NCT02045797|560224220|FG002|Overall Study|Lost to Follow-up|1|||
155215000|NCT02045797|560224218|FG000|Overall Study|Physician Decision|0|||
155215001|NCT02045797|560224219|FG001|Overall Study|Physician Decision|1|||
155215002|NCT02045797|560224220|FG002|Overall Study|Physician Decision|0|||
155215003|NCT02045797|560224218|FG000|Overall Study|Withdrawal by Subject|1|||
155215004|NCT02045797|560224219|FG001|Overall Study|Withdrawal by Subject|2|||
155215005|NCT02045797|560224220|FG002|Overall Study|Withdrawal by Subject|0|||
155215006|NCT00670800|560225879|FG000|Overall Study|2 controls were insulin resistant|0|||
155215007|NCT00670800|560225880|FG001|Overall Study|2 controls were insulin resistant|2|||
155215008|NCT02355691|560225882|FG000|Overall Study|Loss of Research Personnel|7|||
155215009|NCT02355691|560225883|FG001|Overall Study|Loss of Research Personnel|9|||
155215010|NCT00778700|560225892|FG000|Overall Study|Adverse Event|6|||
155215011|NCT00778700|560225893|FG001|Overall Study|Adverse Event|1|||
155215012|NCT00778700|560225894|FG002|Overall Study|Adverse Event|3|||
155215013|NCT00778700|560225895|FG003|Overall Study|Adverse Event|5|||
155215014|NCT00778700|560225892|FG000|Overall Study|Protocol Violation|1|||
155215015|NCT00778700|560225893|FG001|Overall Study|Protocol Violation|1|||
155215016|NCT00778700|560225894|FG002|Overall Study|Protocol Violation|0|||
155215017|NCT00778700|560225895|FG003|Overall Study|Protocol Violation|0|||
155215018|NCT00778700|560225892|FG000|Overall Study|Subject Withdrew Consent|6|||
155215019|NCT00778700|560225893|FG001|Overall Study|Subject Withdrew Consent|4|||
155215020|NCT00778700|560225894|FG002|Overall Study|Subject Withdrew Consent|1|||
155215021|NCT00778700|560225895|FG003|Overall Study|Subject Withdrew Consent|4|||
155215022|NCT00778700|560225892|FG000|Overall Study|Lost to Follow-up|3|||
155215023|NCT00778700|560225893|FG001|Overall Study|Lost to Follow-up|1|||
155215024|NCT00778700|560225894|FG002|Overall Study|Lost to Follow-up|0|||
155215025|NCT00778700|560225895|FG003|Overall Study|Lost to Follow-up|1|||
155215026|NCT00778700|560225892|FG000|Overall Study|Reason not Specified|2|||
155215027|NCT00778700|560225893|FG001|Overall Study|Reason not Specified|0|||
155215028|NCT00778700|560225894|FG002|Overall Study|Reason not Specified|1|||
155215029|NCT00778700|560225895|FG003|Overall Study|Reason not Specified|3|||
155215030|NCT00778700|560225892|FG000|Overall Study|Other|0|||
155215031|NCT00778700|560225893|FG001|Overall Study|Other|0|||
155215032|NCT00778700|560225894|FG002|Overall Study|Other|1|||
155215033|NCT00778700|560225895|FG003|Overall Study|Other|0|||
155215034|NCT03227029|560225896|FG000|Overall Study|Child Wheezed (no treatment)|0|||
155215035|NCT03227029|560225897|FG001|Overall Study|Child Wheezed (no treatment)|1|||
155215036|NCT03227029|560225898|FG002|Overall Study|Child Wheezed (no treatment)|0|||
155215037|NCT03227029|560225896|FG000|Overall Study|No post RSV season visit due to COVID|3|||
155215038|NCT03227029|560225897|FG001|Overall Study|No post RSV season visit due to COVID|3|||
155215039|NCT03227029|560225898|FG002|Overall Study|No post RSV season visit due to COVID|2|||
155215040|NCT03227029|560225896|FG000|Overall Study|Not able to get to clinic|0|||
155215041|NCT03227029|560225897|FG001|Overall Study|Not able to get to clinic|0|||
155215042|NCT03227029|560225898|FG002|Overall Study|Not able to get to clinic|1|||
155215043|NCT03227029|560225896|FG000|Overall Study|Withdrawal by Subject|1|||
155215044|NCT03227029|560225897|FG001|Overall Study|Withdrawal by Subject|0|||
155215045|NCT03227029|560225898|FG002|Overall Study|Withdrawal by Subject|0|||
155215046|NCT03227029|560225896|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
155215047|NCT03227029|560225897|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
155215048|NCT03227029|560225898|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
155215049|NCT03274440|560225899|FG000|Overall Study|Time commitment too great|1|||
155215050|NCT03274440|560225900|FG001|Overall Study|Time commitment too great|0|||
155215051|NCT03274440|560225901|FG002|Overall Study|Time commitment too great|0|||
155215052|NCT03274440|560225902|FG003|Overall Study|Time commitment too great|1|||
155215053|NCT03274440|560225903|FG004|Overall Study|Time commitment too great|0|||
155215054|NCT03274440|560225904|FG005|Overall Study|Time commitment too great|0|||
155215055|NCT01291173|560225905|FG000|Overall Study|Adverse Event|0|||
155215056|NCT01291173|560225906|FG001|Overall Study|Adverse Event|3|||
155215057|NCT01291173|560225907|FG002|Overall Study|Adverse Event|1|||
155215058|NCT01291173|560225908|FG003|Overall Study|Adverse Event|3|||
155215059|NCT01291173|560225905|FG000|Overall Study|Protocol Violation|7|||
155215060|NCT01291173|560225906|FG001|Overall Study|Protocol Violation|2|||
155215061|NCT01291173|560225907|FG002|Overall Study|Protocol Violation|2|||
155215062|NCT01291173|560225908|FG003|Overall Study|Protocol Violation|5|||
155215063|NCT01291173|560225905|FG000|Overall Study|Withdrawal by Subject|6|||
155215064|NCT01291173|560225906|FG001|Overall Study|Withdrawal by Subject|4|||
155215065|NCT01291173|560225907|FG002|Overall Study|Withdrawal by Subject|4|||
155215066|NCT01291173|560225908|FG003|Overall Study|Withdrawal by Subject|2|||
155215067|NCT01291173|560225905|FG000|Overall Study|Lost to Follow-up|4|||
155215068|NCT01291173|560225906|FG001|Overall Study|Lost to Follow-up|6|||
155215069|NCT01291173|560225907|FG002|Overall Study|Lost to Follow-up|3|||
155215070|NCT01291173|560225908|FG003|Overall Study|Lost to Follow-up|2|||
155215071|NCT01291173|560225905|FG000|Overall Study|Unable to meet visit schedule|0|||
155215072|NCT01291173|560225906|FG001|Overall Study|Unable to meet visit schedule|0|||
155215073|NCT01291173|560225907|FG002|Overall Study|Unable to meet visit schedule|1|||
155215074|NCT01291173|560225908|FG003|Overall Study|Unable to meet visit schedule|0|||
155215075|NCT01291173|560225905|FG000|Overall Study|Lack of compliance|0|||
155215076|NCT01291173|560225906|FG001|Overall Study|Lack of compliance|0|||
155215077|NCT01291173|560225907|FG002|Overall Study|Lack of compliance|0|||
155215078|NCT01291173|560225908|FG003|Overall Study|Lack of compliance|1|||
155215079|NCT01291173|560225905|FG000|Overall Study|Subject was unblinded|0|||
155215080|NCT01291173|560225906|FG001|Overall Study|Subject was unblinded|0|||
155215081|NCT01291173|560225907|FG002|Overall Study|Subject was unblinded|1|||
155215082|NCT01291173|560225908|FG003|Overall Study|Subject was unblinded|0|||
155215083|NCT01291173|560225905|FG000|Overall Study|Excluded therapy|0|||
155215084|NCT01291173|560225906|FG001|Overall Study|Excluded therapy|0|||
155215085|NCT01291173|560225907|FG002|Overall Study|Excluded therapy|1|||
155215086|NCT01291173|560225908|FG003|Overall Study|Excluded therapy|0|||
155215087|NCT00450450|560225909|FG000|Overall Study|Death|1|||
155215088|NCT00450450|560225910|FG001|Overall Study|Death|3|||
155215089|NCT00450450|560225909|FG000|Overall Study|Relapse|2|||
155215090|NCT00450450|560225910|FG001|Overall Study|Relapse|0|||
155215091|NCT00450450|560225909|FG000|Overall Study|Missing Data|2|||
155215092|NCT00450450|560225910|FG001|Overall Study|Missing Data|0|||
155215093|NCT04984993|560225911|FG000|Overall Study|Withdrawal by Subject|8|||
155215094|NCT04984993|560225912|FG001|Overall Study|Withdrawal by Subject|2|||
155215095|NCT04984993|560225911|FG000|Overall Study|Lost to Follow-up|2|||
155215096|NCT04984993|560225912|FG001|Overall Study|Lost to Follow-up|2|||
155215097|NCT04984993|560225911|FG000|Overall Study|Both patients moved to another country|4|||
155215098|NCT04984993|560225912|FG001|Overall Study|Both patients moved to another country|0|||
155215099|NCT01110707|560225913|FG000|Overall Study|Protocol Violation|0|||
155215100|NCT01110707|560225914|FG001|Overall Study|Protocol Violation|3|||
155215101|NCT03318315|560225915|FG000|Overall Study|Lost to Follow-up|3|||
155215102|NCT03318315|560225916|FG001|Overall Study|Lost to Follow-up|2|||
155215103|NCT03318315|560225917|FG002|Overall Study|Lost to Follow-up|1|||
155215104|NCT03318315|560225915|FG000|Overall Study|Protocol Violation|1|||
155215105|NCT03318315|560225916|FG001|Overall Study|Protocol Violation|1|||
155215106|NCT03318315|560225917|FG002|Overall Study|Protocol Violation|1|||
155215107|NCT03318315|560225915|FG000|Overall Study|Withdrawal by Subject|0|||
155215108|NCT03318315|560225916|FG001|Overall Study|Withdrawal by Subject|0|||
155215109|NCT03318315|560225917|FG002|Overall Study|Withdrawal by Subject|2|||
155215110|NCT00674661|560225927|FG000|Overall Study|Other|5|||
155215111|NCT00674661|560225928|FG001|Overall Study|Other|7|||
155215112|NCT00674661|560225927|FG000|Overall Study|Lost to Follow-up|6|||
155215113|NCT00674661|560225928|FG001|Overall Study|Lost to Follow-up|3|||
155215114|NCT00674661|560225927|FG000|Overall Study|Withdrawal by Subject|0|||
155215115|NCT00674661|560225928|FG001|Overall Study|Withdrawal by Subject|5|||
155215116|NCT00003901|560225930|FG000|Overall Study|Adverse Event|1|||
155215117|NCT00003901|560225930|FG000|Overall Study|Withdrawal by Subject|1|||
155215118|NCT00003901|560225930|FG000|Overall Study|Ineligible|6|||
155215119|NCT00003901|560225930|FG000|Overall Study|CT Scan not within protocol requirement|2|||
155215120|NCT00003901|560225930|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
155215121|NCT00003901|560225930|FG000|Overall Study|Medical problems|6|||
155215122|NCT02659631|560225934|FG000|Overall Study|Lost to Follow-up|0|||
155215123|NCT02659631|560225935|FG001|Overall Study|Lost to Follow-up|0|||
155215124|NCT02659631|560225936|FG002|Overall Study|Lost to Follow-up|2|||
155215125|NCT02659631|560225937|FG003|Overall Study|Lost to Follow-up|0|||
155215126|NCT02659631|560225938|FG004|Overall Study|Lost to Follow-up|0|||
155215127|NCT02659631|560225939|FG005|Overall Study|Lost to Follow-up|1|||
155215128|NCT02659631|560225940|FG006|Overall Study|Lost to Follow-up|0|||
155215129|NCT02659631|560225941|FG007|Overall Study|Lost to Follow-up|0|||
155215130|NCT02659631|560225942|FG008|Overall Study|Lost to Follow-up|0|||
155215131|NCT02659631|560225943|FG009|Overall Study|Lost to Follow-up|0|||
155215132|NCT02659631|560225934|FG000|Overall Study|Withdrawal prior to treatment|0|||
155215133|NCT02659631|560225935|FG001|Overall Study|Withdrawal prior to treatment|0|||
155215134|NCT02659631|560225936|FG002|Overall Study|Withdrawal prior to treatment|0|||
155215135|NCT02659631|560225937|FG003|Overall Study|Withdrawal prior to treatment|0|||
155215136|NCT02659631|560225938|FG004|Overall Study|Withdrawal prior to treatment|1|||
155215137|NCT02659631|560225939|FG005|Overall Study|Withdrawal prior to treatment|0|||
155215138|NCT02659631|560225940|FG006|Overall Study|Withdrawal prior to treatment|0|||
155215139|NCT02659631|560225941|FG007|Overall Study|Withdrawal prior to treatment|0|||
155215140|NCT02659631|560225942|FG008|Overall Study|Withdrawal prior to treatment|0|||
155215141|NCT02659631|560225943|FG009|Overall Study|Withdrawal prior to treatment|0|||
155215142|NCT02659631|560225934|FG000|Overall Study|Participant refused further follow-up|0|||
155215143|NCT02659631|560225935|FG001|Overall Study|Participant refused further follow-up|0|||
155215144|NCT02659631|560225936|FG002|Overall Study|Participant refused further follow-up|0|||
155215145|NCT02659631|560225937|FG003|Overall Study|Participant refused further follow-up|1|||
155215146|NCT02659631|560225938|FG004|Overall Study|Participant refused further follow-up|0|||
155215147|NCT02659631|560225939|FG005|Overall Study|Participant refused further follow-up|0|||
155215148|NCT02659631|560225940|FG006|Overall Study|Participant refused further follow-up|0|||
155215149|NCT02659631|560225941|FG007|Overall Study|Participant refused further follow-up|0|||
155215150|NCT02659631|560225942|FG008|Overall Study|Participant refused further follow-up|1|||
155215151|NCT02659631|560225943|FG009|Overall Study|Participant refused further follow-up|0|||
155215152|NCT02659631|560225934|FG000|Overall Study|Death (follow-up phase)|1|||
155215153|NCT02659631|560225935|FG001|Overall Study|Death (follow-up phase)|2|||
155215154|NCT02659631|560225936|FG002|Overall Study|Death (follow-up phase)|1|||
155215155|NCT02659631|560225937|FG003|Overall Study|Death (follow-up phase)|1|||
155215156|NCT02659631|560225938|FG004|Overall Study|Death (follow-up phase)|3|||
155215157|NCT02659631|560225939|FG005|Overall Study|Death (follow-up phase)|2|||
155215158|NCT02659631|560225940|FG006|Overall Study|Death (follow-up phase)|0|||
155215159|NCT02659631|560225941|FG007|Overall Study|Death (follow-up phase)|3|||
155215160|NCT02659631|560225942|FG008|Overall Study|Death (follow-up phase)|1|||
155215161|NCT02659631|560225943|FG009|Overall Study|Death (follow-up phase)|0|||
155215162|NCT02659631|560225934|FG000|Overall Study|Death (treatment phase)|0|||
155215163|NCT02659631|560225935|FG001|Overall Study|Death (treatment phase)|0|||
155215164|NCT02659631|560225936|FG002|Overall Study|Death (treatment phase)|0|||
155215165|NCT02659631|560225937|FG003|Overall Study|Death (treatment phase)|0|||
155215166|NCT02659631|560225938|FG004|Overall Study|Death (treatment phase)|1|||
155215167|NCT02659631|560225939|FG005|Overall Study|Death (treatment phase)|0|||
155215168|NCT02659631|560225940|FG006|Overall Study|Death (treatment phase)|1|||
155215169|NCT02659631|560225941|FG007|Overall Study|Death (treatment phase)|0|||
155215170|NCT02659631|560225942|FG008|Overall Study|Death (treatment phase)|0|||
155215171|NCT02659631|560225943|FG009|Overall Study|Death (treatment phase)|0|||
155215172|NCT02377466|560225944|FG000|Overall Study|Other: Randomized and not treated|0|||
155215173|NCT02377466|560225945|FG001|Overall Study|Other: Randomized and not treated|2|||
155215174|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
155215175|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
155215176|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215177|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215178|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215179|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
155215180|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
155215181|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
155215182|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215183|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215184|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215185|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
155215186|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215187|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
155215188|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215189|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215190|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215191|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
155215192|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
155215193|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
155215194|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215195|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215196|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215197|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
155215198|NCT01496313|560225948|FG000|Randomized Period (up to 14 Months)|Other|1|||
155215199|NCT01496313|560225949|FG001|Randomized Period (up to 14 Months)|Other|2|||
155215200|NCT01496313|560225950|FG002|Randomized Period (up to 14 Months)|Other|0|||
155215201|NCT01496313|560225951|FG003|Randomized Period (up to 14 Months)|Other|0|||
155215202|NCT01496313|560225952|FG004|Randomized Period (up to 14 Months)|Other|0|||
155215203|NCT01496313|560225953|FG005|Randomized Period (up to 14 Months)|Other|0|||
155215204|NCT01496313|560225948|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215205|NCT01496313|560225949|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215206|NCT01496313|560225950|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215207|NCT01496313|560225951|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215208|NCT01496313|560225952|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
155215209|NCT01496313|560225953|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
155215210|NCT01496313|560225948|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215211|NCT01496313|560225949|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215212|NCT01496313|560225950|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215213|NCT01496313|560225951|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215214|NCT01496313|560225952|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
155215215|NCT01496313|560225953|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
155215216|NCT01496313|560225948|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
155215217|NCT01496313|560225949|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
155215218|NCT01496313|560225950|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
155215219|NCT01496313|560225951|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
155215220|NCT01496313|560225952|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
155215221|NCT01496313|560225953|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
155215222|NCT00451321|560225958|FG000|Overall Study|Lost to Follow-up|3|||
155215223|NCT00451321|560225959|FG001|Overall Study|Lost to Follow-up|3|||
155215224|NCT00451321|560225960|FG002|Overall Study|Lost to Follow-up|1|||
155215225|NCT00451321|560225961|FG003|Overall Study|Lost to Follow-up|3|||
155215226|NCT00451321|560225962|FG004|Overall Study|Lost to Follow-up|0|||
155215227|NCT00451321|560225963|FG005|Overall Study|Lost to Follow-up|1|||
155215228|NCT00451321|560225964|FG006|Overall Study|Lost to Follow-up|0|||
155215229|NCT00451321|560225965|FG007|Overall Study|Lost to Follow-up|0|||
155215230|NCT00451321|560225958|FG000|Overall Study|Withdrawal by Subject|3|||
155215231|NCT00451321|560225959|FG001|Overall Study|Withdrawal by Subject|1|||
155215232|NCT00451321|560225960|FG002|Overall Study|Withdrawal by Subject|0|||
155215233|NCT00451321|560225961|FG003|Overall Study|Withdrawal by Subject|4|||
155215234|NCT00451321|560225962|FG004|Overall Study|Withdrawal by Subject|0|||
155215235|NCT00451321|560225963|FG005|Overall Study|Withdrawal by Subject|0|||
155215236|NCT00451321|560225964|FG006|Overall Study|Withdrawal by Subject|0|||
155215237|NCT00451321|560225965|FG007|Overall Study|Withdrawal by Subject|0|||
155215238|NCT00451321|560225958|FG000|Overall Study|Study closed/terminated|1|||
155215239|NCT00451321|560225959|FG001|Overall Study|Study closed/terminated|1|||
155215240|NCT00451321|560225960|FG002|Overall Study|Study closed/terminated|17|||
155215241|NCT00451321|560225961|FG003|Overall Study|Study closed/terminated|5|||
155215242|NCT00451321|560225962|FG004|Overall Study|Study closed/terminated|7|||
155215243|NCT00451321|560225963|FG005|Overall Study|Study closed/terminated|7|||
155215244|NCT00451321|560225964|FG006|Overall Study|Study closed/terminated|5|||
155215245|NCT00451321|560225965|FG007|Overall Study|Study closed/terminated|3|||
155215246|NCT00451321|560225958|FG000|Overall Study|Sponsor decision to amend protocol|0|||
155215247|NCT00451321|560225959|FG001|Overall Study|Sponsor decision to amend protocol|0|||
155215248|NCT00451321|560225960|FG002|Overall Study|Sponsor decision to amend protocol|0|||
155215249|NCT00451321|560225961|FG003|Overall Study|Sponsor decision to amend protocol|0|||
155215250|NCT00451321|560225962|FG004|Overall Study|Sponsor decision to amend protocol|0|||
155215251|NCT00451321|560225963|FG005|Overall Study|Sponsor decision to amend protocol|1|||
155215252|NCT00451321|560225964|FG006|Overall Study|Sponsor decision to amend protocol|1|||
155215253|NCT00451321|560225965|FG007|Overall Study|Sponsor decision to amend protocol|3|||
155215254|NCT00597766|560225968|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
155215255|NCT00597766|560225969|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
155215256|NCT00597766|560225970|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
155215257|NCT00597766|560225968|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
155215258|NCT00597766|560225969|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
155215259|NCT00597766|560225970|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
155215260|NCT01528254|560225972|FG000|Overall Study|Administrative problems|96|||
155215261|NCT01528254|560225973|FG001|Overall Study|Administrative problems|94|||
155215262|NCT01528254|560225972|FG000|Overall Study|Adverse Event|28|||
155215263|NCT01528254|560225973|FG001|Overall Study|Adverse Event|44|||
155215264|NCT01528254|560225972|FG000|Overall Study|Lost to Follow-up|17|||
155215265|NCT01528254|560225973|FG001|Overall Study|Lost to Follow-up|24|||
155215266|NCT01528254|560225972|FG000|Overall Study|Death|13|||
155215267|NCT01528254|560225973|FG001|Overall Study|Death|9|||
155215268|NCT01528254|560225972|FG000|Overall Study|Protocol deviation|9|||
155215269|NCT01528254|560225973|FG001|Overall Study|Protocol deviation|19|||
155215270|NCT01528254|560225972|FG000|Overall Study|New therapy for study indication|8|||
155215271|NCT01528254|560225973|FG001|Overall Study|New therapy for study indication|6|||
155215272|NCT01528254|560225972|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155215273|NCT01528254|560225973|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
155215274|NCT01528254|560225972|FG000|Overall Study|Withdrawal by Subject|5|||
155215275|NCT01528254|560225973|FG001|Overall Study|Withdrawal by Subject|4|||
155215276|NCT01528254|560225972|FG000|Overall Study|Abnormal laboratory value(s)|3|||
155215277|NCT01528254|560225973|FG001|Overall Study|Abnormal laboratory value(s)|7|||
155215278|NCT01528254|560225972|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155215279|NCT01528254|560225973|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155215280|NCT01528254|560225972|FG000|Overall Study|No longer requires study drug|1|||
155215281|NCT01528254|560225973|FG001|Overall Study|No longer requires study drug|1|||
155215282|NCT01166763|560225974|FG000|Overall Study|Withdrawal by Subject|3|||
155215283|NCT01909479|560225975|FG000|From Baseline to Week 26|Adverse Event|3|||
155215284|NCT01909479|560225976|FG001|From Baseline to Week 26|Adverse Event|2|||
155215285|NCT01909479|560225975|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
155215286|NCT01909479|560225976|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
155215287|NCT01909479|560225975|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
155215288|NCT01909479|560225976|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
155215289|NCT01909479|560225975|FG000|26 - 52 Weeks|Adverse Event|0|||
155215290|NCT01909479|560225976|FG001|26 - 52 Weeks|Adverse Event|1|||
155215291|NCT01909479|560225975|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
155215292|NCT01909479|560225976|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
155215293|NCT01909479|560225975|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
155215294|NCT01909479|560225976|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
155215295|NCT01909479|560225975|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
155215296|NCT01909479|560225976|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
155215297|NCT01909479|560225975|FG000|52 Weeks to End of Study|Adverse Event|2|||
155215298|NCT01909479|560225976|FG001|52 Weeks to End of Study|Adverse Event|1|||
155215299|NCT01909479|560225975|FG000|52 Weeks to End of Study|Death|0|||
155215300|NCT01909479|560225976|FG001|52 Weeks to End of Study|Death|1|||
155215301|NCT01909479|560225975|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
155215302|NCT01909479|560225976|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
155215303|NCT01909479|560225975|FG000|52 Weeks to End of Study|Protocol Violation|1|||
155215304|NCT01909479|560225976|FG001|52 Weeks to End of Study|Protocol Violation|0|||
155215305|NCT01909479|560225975|FG000|52 Weeks to End of Study|Progressive disease|1|||
155215306|NCT01909479|560225976|FG001|52 Weeks to End of Study|Progressive disease|1|||
155215307|NCT01909479|560225975|FG000|52 Weeks to End of Study|Personal reasons|2|||
155215308|NCT01909479|560225976|FG001|52 Weeks to End of Study|Personal reasons|1|||
155215309|NCT01909479|560225975|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
155215310|NCT01909479|560225976|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
155215311|NCT01909479|560225975|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
155215312|NCT01909479|560225976|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
155215313|NCT01909479|560225975|FG000|52 Weeks to End of Study|Lack of contact|1|||
155215314|NCT01909479|560225976|FG001|52 Weeks to End of Study|Lack of contact|0|||
155215315|NCT01909479|560225975|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
155215316|NCT01909479|560225976|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
155215317|NCT01909479|560225975|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
155215318|NCT01909479|560225976|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
155215319|NCT02049957|560225977|FG000|Overall Study|Progressive Disease|5|||
155215320|NCT02049957|560225978|FG001|Overall Study|Progressive Disease|4|||
155215321|NCT02049957|560225979|FG002|Overall Study|Progressive Disease|2|||
155215322|NCT02049957|560225980|FG003|Overall Study|Progressive Disease|2|||
155215323|NCT02049957|560225981|FG004|Overall Study|Progressive Disease|6|||
155215324|NCT02049957|560225982|FG005|Overall Study|Progressive Disease|35|||
155215325|NCT02049957|560225983|FG006|Overall Study|Progressive Disease|7|||
155215326|NCT02049957|560225984|FG007|Overall Study|Progressive Disease|26|||
155215327|NCT02049957|560225985|FG008|Overall Study|Progressive Disease|6|||
155215328|NCT02049957|560225977|FG000|Overall Study|Adverse Event|1|||
155215329|NCT02049957|560225978|FG001|Overall Study|Adverse Event|1|||
155215330|NCT02049957|560225979|FG002|Overall Study|Adverse Event|1|||
155215331|NCT02049957|560225980|FG003|Overall Study|Adverse Event|0|||
155215332|NCT02049957|560225981|FG004|Overall Study|Adverse Event|0|||
155215333|NCT02049957|560225982|FG005|Overall Study|Adverse Event|5|||
155215334|NCT02049957|560225983|FG006|Overall Study|Adverse Event|0|||
155215335|NCT02049957|560225984|FG007|Overall Study|Adverse Event|6|||
155215336|NCT02049957|560225985|FG008|Overall Study|Adverse Event|1|||
155215337|NCT02049957|560225977|FG000|Overall Study|Study Terminated by Sponsor|0|||
155215338|NCT02049957|560225978|FG001|Overall Study|Study Terminated by Sponsor|1|||
155215339|NCT02049957|560225979|FG002|Overall Study|Study Terminated by Sponsor|0|||
155215340|NCT02049957|560225980|FG003|Overall Study|Study Terminated by Sponsor|0|||
155215341|NCT02049957|560225981|FG004|Overall Study|Study Terminated by Sponsor|0|||
155215342|NCT02049957|560225982|FG005|Overall Study|Study Terminated by Sponsor|0|||
155215343|NCT02049957|560225983|FG006|Overall Study|Study Terminated by Sponsor|1|||
155215344|NCT02049957|560225984|FG007|Overall Study|Study Terminated by Sponsor|0|||
155215345|NCT02049957|560225985|FG008|Overall Study|Study Terminated by Sponsor|0|||
155215346|NCT02049957|560225977|FG000|Overall Study|Withdrawal by Subject|0|||
155215347|NCT02049957|560225978|FG001|Overall Study|Withdrawal by Subject|0|||
155215348|NCT02049957|560225979|FG002|Overall Study|Withdrawal by Subject|0|||
155215349|NCT02049957|560225980|FG003|Overall Study|Withdrawal by Subject|1|||
155215350|NCT02049957|560225981|FG004|Overall Study|Withdrawal by Subject|0|||
155215351|NCT02049957|560225982|FG005|Overall Study|Withdrawal by Subject|2|||
155215352|NCT02049957|560225983|FG006|Overall Study|Withdrawal by Subject|0|||
155215353|NCT02049957|560225984|FG007|Overall Study|Withdrawal by Subject|3|||
155215354|NCT02049957|560225985|FG008|Overall Study|Withdrawal by Subject|1|||
155215355|NCT02049957|560225977|FG000|Overall Study|Physician Decision|0|||
155215356|NCT02049957|560225978|FG001|Overall Study|Physician Decision|0|||
155215357|NCT02049957|560225979|FG002|Overall Study|Physician Decision|0|||
155215358|NCT02049957|560225980|FG003|Overall Study|Physician Decision|0|||
155215359|NCT02049957|560225981|FG004|Overall Study|Physician Decision|0|||
155215360|NCT02049957|560225982|FG005|Overall Study|Physician Decision|1|||
155215361|NCT02049957|560225983|FG006|Overall Study|Physician Decision|0|||
155215362|NCT02049957|560225984|FG007|Overall Study|Physician Decision|0|||
155215363|NCT02049957|560225985|FG008|Overall Study|Physician Decision|0|||
155215364|NCT02810392|560225986|FG000|Overall Study|Subject too ill to continue|1|||
155215365|NCT02810392|560225987|FG001|Overall Study|Subject too ill to continue|0|||
155215366|NCT02810392|560225986|FG000|Overall Study|COVID 19 research restrictions|0|||
155215367|NCT02810392|560225987|FG001|Overall Study|COVID 19 research restrictions|1|||
155215368|NCT03715764|560225992|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
155215369|NCT03715764|560225993|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
155215370|NCT03715764|560225992|FG000|3 Month Follow-up|Lost to Follow-up|2|||
155215371|NCT03715764|560225993|FG001|3 Month Follow-up|Lost to Follow-up|2|||
155215372|NCT03715764|560225992|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
155215373|NCT03715764|560225993|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
155215374|NCT03715764|560225992|FG000|6 Month Follow-up|Lost to Follow-up|3|||
155215375|NCT03715764|560225993|FG001|6 Month Follow-up|Lost to Follow-up|0|||
155215376|NCT03715764|560225992|FG000|12 Month Follow-up|Lost to Follow-up|2|||
155215377|NCT03715764|560225993|FG001|12 Month Follow-up|Lost to Follow-up|3|||
155215378|NCT03715764|560225992|FG000|12 Month Follow-up|Pregnancy|0|||
155215379|NCT03715764|560225993|FG001|12 Month Follow-up|Pregnancy|1|||
155215380|NCT03715764|560225992|FG000|12 Month Follow-up|Surgery|2|||
155215381|NCT03715764|560225993|FG001|12 Month Follow-up|Surgery|0|||
155215382|NCT03715764|560225992|FG000|12 Month Follow-up|Wrong address|1|||
155215383|NCT03715764|560225993|FG001|12 Month Follow-up|Wrong address|0|||
155215384|NCT03715764|560225992|FG000|12 Month Follow-up|No symptoms|1|||
155215385|NCT03715764|560225993|FG001|12 Month Follow-up|No symptoms|0|||
155215386|NCT03715764|560225992|FG000|12 Month Follow-up|Changed primary care centre|0|||
155215387|NCT03715764|560225993|FG001|12 Month Follow-up|Changed primary care centre|1|||
155215388|NCT01361464|560225995|FG000|Overall Study|Death|1|||
155215389|NCT01361464|560225995|FG000|Overall Study|Withdrawal by Subject|2|||
155215390|NCT01106898|560225996|FG000|Overall Study|Adverse Event|6|||
155215391|NCT01705652|560225997|FG000|Overall Study|Adverse Event|1|||
155215392|NCT01705652|560225998|FG001|Overall Study|Adverse Event|0|||
155215393|NCT01705652|560225997|FG000|Overall Study|Withdrawal by Subject|1|||
155215394|NCT01705652|560225998|FG001|Overall Study|Withdrawal by Subject|2|||
155215395|NCT01705652|560225997|FG000|Overall Study|non-compliance|1|||
155215396|NCT01705652|560225998|FG001|Overall Study|non-compliance|1|||
155215397|NCT00656474|560225999|FG000|Overall Study|Other Reason|1|||
155215398|NCT02998840|560226003|FG000|Overall Study|Lost to Follow-up|1|||
155215399|NCT02998840|560226004|FG001|Overall Study|Lost to Follow-up|1|||
155215400|NCT02998840|560226005|FG002|Overall Study|Lost to Follow-up|2|||
155215401|NCT02998840|560226006|FG003|Overall Study|Lost to Follow-up|3|||
155215402|NCT02998840|560226003|FG000|Overall Study|Withdrawal by Subject|1|||
155215403|NCT02998840|560226004|FG001|Overall Study|Withdrawal by Subject|1|||
155215404|NCT02998840|560226005|FG002|Overall Study|Withdrawal by Subject|0|||
155215405|NCT02998840|560226006|FG003|Overall Study|Withdrawal by Subject|1|||
155215406|NCT02998840|560226003|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
155215407|NCT02998840|560226004|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
155215408|NCT02998840|560226005|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
155215409|NCT02998840|560226006|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
155215410|NCT01686633|560226007|FG000|Overall Study|Lack of Efficacy|33|||
155215411|NCT01686633|560226008|FG001|Overall Study|Lack of Efficacy|13|||
155215412|NCT01686633|560226009|FG002|Overall Study|Lack of Efficacy|11|||
155215413|NCT01686633|560226007|FG000|Overall Study|Withdrawal by Subject|8|||
155215414|NCT01686633|560226008|FG001|Overall Study|Withdrawal by Subject|8|||
155215415|NCT01686633|560226009|FG002|Overall Study|Withdrawal by Subject|5|||
155215416|NCT01686633|560226007|FG000|Overall Study|Physician Decision|3|||
155215417|NCT01686633|560226008|FG001|Overall Study|Physician Decision|4|||
155215418|NCT01686633|560226009|FG002|Overall Study|Physician Decision|4|||
155215419|NCT01686633|560226007|FG000|Overall Study|Adverse Event|4|||
155215420|NCT01686633|560226008|FG001|Overall Study|Adverse Event|3|||
155215421|NCT01686633|560226009|FG002|Overall Study|Adverse Event|3|||
155215422|NCT01686633|560226007|FG000|Overall Study|Protocol Violation|2|||
155215423|NCT01686633|560226008|FG001|Overall Study|Protocol Violation|3|||
155215424|NCT01686633|560226009|FG002|Overall Study|Protocol Violation|0|||
155215425|NCT01686633|560226007|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
155215426|NCT01686633|560226008|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
155215427|NCT01686633|560226009|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
155215428|NCT01686633|560226007|FG000|Overall Study|Lost to Follow-up|0|||
155215429|NCT01686633|560226008|FG001|Overall Study|Lost to Follow-up|1|||
155215430|NCT01686633|560226009|FG002|Overall Study|Lost to Follow-up|1|||
155215431|NCT00056407|560226010|FG000|Overall Study|Adverse Event|282|||
155215432|NCT00056407|560226011|FG001|Overall Study|Adverse Event|364|||
155215433|NCT00056407|560226010|FG000|Overall Study|Withdrawal by Subject|377|||
155215434|NCT00056407|560226011|FG001|Overall Study|Withdrawal by Subject|361|||
155215435|NCT00056407|560226010|FG000|Overall Study|Lost to Follow-up|123|||
155215436|NCT00056407|560226011|FG001|Overall Study|Lost to Follow-up|113|||
155215437|NCT00056407|560226010|FG000|Overall Study|Protocol Violation|104|||
155215438|NCT00056407|560226011|FG001|Overall Study|Protocol Violation|95|||
155215439|NCT00056407|560226010|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
155215440|NCT00056407|560226011|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
155215441|NCT00056407|560226010|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
155215442|NCT00056407|560226011|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
155215443|NCT00056407|560226010|FG000|Overall Study|Missing|25|||
155215444|NCT00056407|560226011|FG001|Overall Study|Missing|34|||
155215445|NCT03605303|560226012|FG000|Period 1|Study Terminated|2|||
155215446|NCT03605303|560226013|FG001|Period 1|Study Terminated|1|||
155215447|NCT01026792|560226014|FG000|Overall Study|Protocol Violation|1|||
155215448|NCT01472081|560226019|FG000|Overall Study|Continuing treatment at time of analysis|1|||
155215449|NCT01472081|560226020|FG001|Overall Study|Continuing treatment at time of analysis|4|||
155215450|NCT01472081|560226021|FG002|Overall Study|Continuing treatment at time of analysis|1|||
155215451|NCT01472081|560226022|FG003|Overall Study|Continuing treatment at time of analysis|8|||
155215452|NCT01472081|560226023|FG004|Overall Study|Continuing treatment at time of analysis|9|||
155215453|NCT01472081|560226024|FG005|Overall Study|Continuing treatment at time of analysis|0|||
155215454|NCT01472081|560226019|FG000|Overall Study|Disease Progression|4|||
155215455|NCT01472081|560226020|FG001|Overall Study|Disease Progression|10|||
155215456|NCT01472081|560226021|FG002|Overall Study|Disease Progression|12|||
155215457|NCT01472081|560226022|FG003|Overall Study|Disease Progression|31|||
155215458|NCT01472081|560226023|FG004|Overall Study|Disease Progression|22|||
155215459|NCT01472081|560226024|FG005|Overall Study|Disease Progression|3|||
155215460|NCT01472081|560226019|FG000|Overall Study|Study drug toxicity|2|||
155215461|NCT01472081|560226020|FG001|Overall Study|Study drug toxicity|9|||
155215462|NCT01472081|560226021|FG002|Overall Study|Study drug toxicity|4|||
155215463|NCT01472081|560226022|FG003|Overall Study|Study drug toxicity|6|||
155215464|NCT01472081|560226023|FG004|Overall Study|Study drug toxicity|13|||
155215465|NCT01472081|560226024|FG005|Overall Study|Study drug toxicity|2|||
155215466|NCT01472081|560226019|FG000|Overall Study|Death|0|||
155215467|NCT01472081|560226020|FG001|Overall Study|Death|0|||
155215468|NCT01472081|560226021|FG002|Overall Study|Death|0|||
155215469|NCT01472081|560226022|FG003|Overall Study|Death|0|||
155215470|NCT01472081|560226023|FG004|Overall Study|Death|1|||
155215471|NCT01472081|560226024|FG005|Overall Study|Death|0|||
155215472|NCT01472081|560226019|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
155215473|NCT01472081|560226020|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
155215474|NCT01472081|560226021|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
155215475|NCT01472081|560226022|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
155215476|NCT01472081|560226023|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
155215477|NCT01472081|560226024|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
155215478|NCT01472081|560226019|FG000|Overall Study|Withdrawal by Subject|0|||
155215479|NCT01472081|560226020|FG001|Overall Study|Withdrawal by Subject|0|||
155215480|NCT01472081|560226021|FG002|Overall Study|Withdrawal by Subject|0|||
155215481|NCT01472081|560226022|FG003|Overall Study|Withdrawal by Subject|0|||
155215482|NCT01472081|560226023|FG004|Overall Study|Withdrawal by Subject|0|||
155215483|NCT01472081|560226024|FG005|Overall Study|Withdrawal by Subject|1|||
155215484|NCT01472081|560226019|FG000|Overall Study|Poor/non-compliance|0|||
155215485|NCT01472081|560226020|FG001|Overall Study|Poor/non-compliance|0|||
155215486|NCT01472081|560226021|FG002|Overall Study|Poor/non-compliance|1|||
155215487|NCT01472081|560226022|FG003|Overall Study|Poor/non-compliance|0|||
155215488|NCT01472081|560226023|FG004|Overall Study|Poor/non-compliance|1|||
155215489|NCT01472081|560226024|FG005|Overall Study|Poor/non-compliance|0|||
155215490|NCT01472081|560226019|FG000|Overall Study|No longer meets study criteria|0|||
155215491|NCT01472081|560226020|FG001|Overall Study|No longer meets study criteria|0|||
155215492|NCT01472081|560226021|FG002|Overall Study|No longer meets study criteria|1|||
155215493|NCT01472081|560226022|FG003|Overall Study|No longer meets study criteria|0|||
155215494|NCT01472081|560226023|FG004|Overall Study|No longer meets study criteria|0|||
155215495|NCT01472081|560226024|FG005|Overall Study|No longer meets study criteria|0|||
155215496|NCT01472081|560226019|FG000|Overall Study|Subject request to discontinue treatment|0|||
155215497|NCT01472081|560226020|FG001|Overall Study|Subject request to discontinue treatment|3|||
155215498|NCT01472081|560226021|FG002|Overall Study|Subject request to discontinue treatment|1|||
155215499|NCT01472081|560226022|FG003|Overall Study|Subject request to discontinue treatment|1|||
155215500|NCT01472081|560226023|FG004|Overall Study|Subject request to discontinue treatment|0|||
155215501|NCT01472081|560226024|FG005|Overall Study|Subject request to discontinue treatment|0|||
155215502|NCT04702997|560226025|FG000|Overall Study|Withdrawal by Subject|1|||
155215503|NCT04702997|560226026|FG001|Overall Study|Withdrawal by Subject|1|||
155215504|NCT01386554|560226029|FG000|Overall Study|Lost to Follow-up|0|||
155215505|NCT01386554|560226030|FG001|Overall Study|Lost to Follow-up|0|||
155215506|NCT01386554|560226031|FG002|Overall Study|Lost to Follow-up|1|||
155215507|NCT01386554|560226029|FG000|Overall Study|Adverse Event|2|||
155215508|NCT01386554|560226030|FG001|Overall Study|Adverse Event|5|||
155215509|NCT01386554|560226031|FG002|Overall Study|Adverse Event|2|||
155215510|NCT01386554|560226029|FG000|Overall Study|Progressive disease|1|||
155215511|NCT01386554|560226030|FG001|Overall Study|Progressive disease|2|||
155215512|NCT01386554|560226031|FG002|Overall Study|Progressive disease|2|||
155215513|NCT01386554|560226029|FG000|Overall Study|Administration of live vaccines|0|||
155215514|NCT01386554|560226030|FG001|Overall Study|Administration of live vaccines|1|||
155215515|NCT01386554|560226031|FG002|Overall Study|Administration of live vaccines|0|||
155215516|NCT01386554|560226029|FG000|Overall Study|Investigator discretion|0|||
155215517|NCT01386554|560226030|FG001|Overall Study|Investigator discretion|0|||
155215518|NCT01386554|560226031|FG002|Overall Study|Investigator discretion|1|||
155215519|NCT01386554|560226029|FG000|Overall Study|Reason not collected|0|||
155215520|NCT01386554|560226030|FG001|Overall Study|Reason not collected|1|||
155215521|NCT01386554|560226031|FG002|Overall Study|Reason not collected|0|||
155215522|NCT00353262|560226032|FG000|Overall Study|Adverse Event|8|||
155215523|NCT00353262|560226032|FG000|Overall Study|Withdrawal by Subject|2|||
155215524|NCT00353262|560226032|FG000|Overall Study|Insufficient Therapeutic Response|13|||
155215525|NCT00353262|560226032|FG000|Overall Study|Progression|1|||
155215526|NCT00353262|560226032|FG000|Overall Study|Surgery|4|||
155215527|NCT00353262|560226032|FG000|Overall Study|Break from Chemotherapy|1|||
155215528|NCT05286307|560226033|FG000|Overall Study|Incomplete outcome assessments|2|||
155215529|NCT05286307|560226034|FG001|Overall Study|Incomplete outcome assessments|1|||
155215530|NCT05286307|560226033|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
155215531|NCT05286307|560226034|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
155215532|NCT05286307|560226033|FG000|Overall Study|Lost to follow up at 6 months|25|||
155215533|NCT05286307|560226034|FG001|Overall Study|Lost to follow up at 6 months|35|||
155215534|NCT05286307|560226033|FG000|Overall Study|Study medication not available|1|||
155215535|NCT05286307|560226034|FG001|Overall Study|Study medication not available|1|||
155215536|NCT02759471|560226035|FG000|Overall Study|discomfort|2|||
155215537|NCT01103284|560226038|FG000|Overall Study|Death|2|||
155215538|NCT01103284|560226039|FG001|Overall Study|Death|0|||
155215539|NCT01103284|560226038|FG000|Overall Study|Lost to Follow-up|9|||
155215540|NCT01103284|560226039|FG001|Overall Study|Lost to Follow-up|10|||
155215541|NCT01103284|560226038|FG000|Overall Study|Pregnancy|3|||
155215542|NCT01103284|560226039|FG001|Overall Study|Pregnancy|1|||
155215543|NCT01103284|560226038|FG000|Overall Study|Protocol Violation|12|||
155215544|NCT01103284|560226039|FG001|Overall Study|Protocol Violation|5|||
155215545|NCT01103284|560226038|FG000|Overall Study|Adverse Event|0|||
155215546|NCT01103284|560226039|FG001|Overall Study|Adverse Event|5|||
155215547|NCT01103284|560226038|FG000|Overall Study|Withdrawal by Subject|14|||
155215548|NCT01103284|560226039|FG001|Overall Study|Withdrawal by Subject|18|||
155215549|NCT01103284|560226038|FG000|Overall Study|Dermal Hypersensitivity|0|||
155215550|NCT01103284|560226039|FG001|Overall Study|Dermal Hypersensitivity|1|||
155215551|NCT01103284|560226038|FG000|Overall Study|Termination by the Sponsor|0|||
155215552|NCT01103284|560226039|FG001|Overall Study|Termination by the Sponsor|1|||
155215553|NCT01103284|560226038|FG000|Overall Study|Not described|2|||
155215554|NCT01103284|560226039|FG001|Overall Study|Not described|1|||
155215555|NCT01103284|560226038|FG000|Overall Study|Missing CRF entries for study completion|0|||
155215556|NCT01103284|560226039|FG001|Overall Study|Missing CRF entries for study completion|2|||
155215557|NCT01786629|560227204|FG000|Overall Study|Lack of Efficacy|0|||
155215558|NCT01786629|560227205|FG001|Overall Study|Lack of Efficacy|4|||
155215559|NCT01786629|560227204|FG000|Overall Study|Adverse Event|0|||
155215560|NCT01786629|560227205|FG001|Overall Study|Adverse Event|1|||
155215561|NCT00410761|560227206|FG000|Randomized Treatment Period|Adverse Event|34|||
155215562|NCT00410761|560227207|FG001|Randomized Treatment Period|Adverse Event|3|||
155215563|NCT00410761|560227206|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
155215564|NCT00410761|560227207|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
155215565|NCT00410761|560227206|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
155215566|NCT00410761|560227207|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
155215567|NCT00410761|560227206|FG000|Randomized Treatment Period|Other|69|||
155215568|NCT00410761|560227207|FG001|Randomized Treatment Period|Other|21|||
155215569|NCT00410761|560227206|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
155215570|NCT00410761|560227207|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
155215571|NCT00410761|560227206|FG000|Open-Label Treatment Period|Adverse Event|13|||
155215572|NCT00410761|560227207|FG001|Open-Label Treatment Period|Adverse Event|15|||
155215573|NCT00410761|560227206|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
155215574|NCT00410761|560227207|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
155215575|NCT00410761|560227206|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
155215576|NCT00410761|560227207|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
155215577|NCT00410761|560227206|FG000|Open-Label Treatment Period|Other|18|||
155215578|NCT00410761|560227207|FG001|Open-Label Treatment Period|Other|9|||
155215579|NCT00312494|560227210|FG000|Overall Study|Randomized; not treated with study drug|9|||
155215580|NCT00312494|560227211|FG001|Overall Study|Randomized; not treated with study drug|10|||
155215581|NCT00312494|560227212|FG002|Overall Study|Randomized; not treated with study drug|5|||
155215582|NCT00312494|560227210|FG000|Overall Study|Adverse Event|33|||
155215583|NCT00312494|560227211|FG001|Overall Study|Adverse Event|15|||
155215584|NCT00312494|560227212|FG002|Overall Study|Adverse Event|11|||
155215585|NCT00312494|560227210|FG000|Overall Study|Lack of Efficacy|4|||
155215586|NCT00312494|560227211|FG001|Overall Study|Lack of Efficacy|6|||
155215587|NCT00312494|560227212|FG002|Overall Study|Lack of Efficacy|8|||
155215588|NCT00312494|560227210|FG000|Overall Study|Laboratory abnormality|1|||
155215589|NCT00312494|560227211|FG001|Overall Study|Laboratory abnormality|0|||
155215590|NCT00312494|560227212|FG002|Overall Study|Laboratory abnormality|0|||
155215591|NCT00312494|560227210|FG000|Overall Study|Lost to Follow-up|8|||
155215592|NCT00312494|560227211|FG001|Overall Study|Lost to Follow-up|8|||
155215593|NCT00312494|560227212|FG002|Overall Study|Lost to Follow-up|8|||
155215594|NCT00312494|560227210|FG000|Overall Study|Withdrawal by Subject|6|||
155215595|NCT00312494|560227211|FG001|Overall Study|Withdrawal by Subject|9|||
155215596|NCT00312494|560227212|FG002|Overall Study|Withdrawal by Subject|10|||
155215597|NCT00312494|560227210|FG000|Overall Study|Other|10|||
155215598|NCT00312494|560227211|FG001|Overall Study|Other|10|||
155215599|NCT00312494|560227212|FG002|Overall Study|Other|1|||
155215600|NCT02642614|560227213|FG000|Overall Study|Adverse Event|1|||
155215601|NCT02642614|560227214|FG001|Overall Study|Adverse Event|1|||
155215602|NCT02642614|560227215|FG002|Overall Study|Adverse Event|2|||
155215603|NCT02642614|560227216|FG003|Overall Study|Adverse Event|2|||
155215604|NCT02642614|560227213|FG000|Overall Study|Lost to Follow-up|1|||
155215605|NCT02642614|560227214|FG001|Overall Study|Lost to Follow-up|0|||
155215606|NCT02642614|560227215|FG002|Overall Study|Lost to Follow-up|0|||
155215607|NCT02642614|560227216|FG003|Overall Study|Lost to Follow-up|0|||
155215608|NCT02642614|560227213|FG000|Overall Study|Withdrawal by Subject|1|||
155215609|NCT02642614|560227214|FG001|Overall Study|Withdrawal by Subject|1|||
155215610|NCT02642614|560227215|FG002|Overall Study|Withdrawal by Subject|0|||
155215611|NCT02642614|560227216|FG003|Overall Study|Withdrawal by Subject|0|||
155215612|NCT01349803|560227218|FG000|Overall Study|Adverse Event|0|||
155215613|NCT01349803|560227219|FG001|Overall Study|Adverse Event|0|||
155215614|NCT01349803|560227220|FG002|Overall Study|Adverse Event|0|||
155215615|NCT01349803|560227221|FG003|Overall Study|Adverse Event|2|||
155215616|NCT01349803|560227218|FG000|Overall Study|Withdrawal by Subject|1|||
155215617|NCT01349803|560227219|FG001|Overall Study|Withdrawal by Subject|0|||
155215618|NCT01349803|560227220|FG002|Overall Study|Withdrawal by Subject|0|||
155215619|NCT01349803|560227221|FG003|Overall Study|Withdrawal by Subject|0|||
155215620|NCT01349803|560227218|FG000|Overall Study|Protocol-specified criteria|0|||
155215621|NCT01349803|560227219|FG001|Overall Study|Protocol-specified criteria|1|||
155215622|NCT01349803|560227220|FG002|Overall Study|Protocol-specified criteria|3|||
155215623|NCT01349803|560227221|FG003|Overall Study|Protocol-specified criteria|0|||
155215624|NCT03232281|560227222|FG000|Overall Study|Adverse Event|1|||
155215625|NCT03232281|560227223|FG001|Overall Study|Adverse Event|1|||
155215626|NCT03232281|560227222|FG000|Overall Study|Withdrawal by Subject|5|||
155215627|NCT03232281|560227223|FG001|Overall Study|Withdrawal by Subject|4|||
155215628|NCT03232281|560227222|FG000|Overall Study|Protocol Deviation|1|||
155215629|NCT03232281|560227223|FG001|Overall Study|Protocol Deviation|1|||
155215630|NCT00605813|560227226|FG000|Overall Study|Protocol Violation|25|||
155215631|NCT01172847|560227227|FG000|Overall Study|Withdrawal by Subject|3|||
155215632|NCT01163279|560227228|FG000|Overall Study|Withdrawal by Subject|2|||
155215633|NCT01163279|560227229|FG001|Overall Study|Withdrawal by Subject|0|||
155215634|NCT00665353|560227234|FG000|Study Step 1|Adverse Event|1|||
155215635|NCT00665353|560227234|FG000|Study Step 1|Withdrawal by Subject|2|||
155215636|NCT00665353|560227234|FG000|Study Step 2|Lost to Follow-up|2|||
155215637|NCT00665353|560227234|FG000|Study Step 2|Lack of Efficacy|12|||
155215638|NCT00573755|560227235|FG000|Overall Study|Still receiving treatment|1|||
155215639|NCT00573755|560227236|FG001|Overall Study|Still receiving treatment|0|||
155215640|NCT03724812|560227237|FG000|Overall Study|Missed Visit|1|||
155215641|NCT03724812|560227237|FG000|Overall Study|Death|2|||
155215642|NCT03724812|560227237|FG000|Overall Study|Withdrawal by Subject|1|||
155215643|NCT01870583|560227242|FG000|Overall Study|Protocol Violation|0|||
155215644|NCT01870583|560227243|FG001|Overall Study|Protocol Violation|5|||
155215645|NCT01870583|560227244|FG002|Overall Study|Protocol Violation|3|||
155215646|NCT01870583|560227242|FG000|Overall Study|Lost to Follow-up|11|||
155215647|NCT01870583|560227243|FG001|Overall Study|Lost to Follow-up|13|||
155215648|NCT01870583|560227244|FG002|Overall Study|Lost to Follow-up|5|||
155215649|NCT00390858|560227245|FG000|Overall Study|Adverse Event|6|||
155215650|NCT00390858|560227246|FG001|Overall Study|Adverse Event|2|||
155215651|NCT00390858|560227245|FG000|Overall Study|Lack of Efficacy|0|||
155215652|NCT00390858|560227246|FG001|Overall Study|Lack of Efficacy|1|||
155215653|NCT00390858|560227245|FG000|Overall Study|Withdrawal by Subject|3|||
155215654|NCT00390858|560227246|FG001|Overall Study|Withdrawal by Subject|4|||
155215655|NCT02865187|560227253|FG000|Overall Study|Lost to Follow-up|12|||
155215656|NCT02865187|560227254|FG001|Overall Study|Lost to Follow-up|7|||
155215657|NCT02865187|560227253|FG000|Overall Study|Adverse Event|1|||
155215658|NCT02865187|560227254|FG001|Overall Study|Adverse Event|0|||
155215659|NCT04267133|560227255|FG000|Overall Study|Withdrawal by Subject|1|||
155215660|NCT04267133|560227255|FG000|Overall Study|Adverse Event|4|||
155215661|NCT02369341|560227256|FG000|Overall Study|Migrated/moved from study area|1|||
155215662|NCT02369341|560227257|FG001|Overall Study|Migrated/moved from study area|0|||
155215663|NCT00857220|560227265|FG000|Overall Study|Adverse Event|35|||
155215664|NCT00857220|560227265|FG000|Overall Study|Death|1|||
155215665|NCT00857220|560227265|FG000|Overall Study|Lack of Efficacy|11|||
155215666|NCT00857220|560227265|FG000|Overall Study|Lost to Follow-up|30|||
155215667|NCT00857220|560227265|FG000|Overall Study|Physician Decision|4|||
155215668|NCT00857220|560227265|FG000|Overall Study|Protocol Violation|16|||
155215669|NCT00857220|560227265|FG000|Overall Study|Withdrawal by Subject|67|||
155215670|NCT00857220|560227265|FG000|Overall Study|Clinical Hold|6|||
155215671|NCT00857220|560227265|FG000|Overall Study|Site Closed|5|||
155215672|NCT00857220|560227265|FG000|Overall Study|Miscellaneous|8|||
155215673|NCT02612428|560227266|FG000|VTL-308|Death|14|||
155215674|NCT02612428|560227267|FG001|VTL-308|Death|16|||
155215675|NCT02612428|560227266|FG000|VTL-308|Withdrawal by Subject|0|||
155215676|NCT02612428|560227267|FG001|VTL-308|Withdrawal by Subject|1|||
155215677|NCT02612428|560227266|FG000|VTL-308E|Death|9|||
155215678|NCT02612428|560227267|FG001|VTL-308E|Death|7|||
155215679|NCT02612428|560227266|FG000|VTL-308E|Lost to Follow-up|2|||
155215680|NCT02612428|560227267|FG001|VTL-308E|Lost to Follow-up|0|||
155215681|NCT00742001|560227268|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
155215682|NCT00742001|560227269|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
155215683|NCT00742001|560227270|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
155215684|NCT00137423|560227271|FG000|Overall Study|Adverse Event|7|||
155215685|NCT00137423|560227272|FG001|Overall Study|Adverse Event|9|||
155215686|NCT00137423|560227271|FG000|Overall Study|consent withdrawn|1|||
155215687|NCT00137423|560227272|FG001|Overall Study|consent withdrawn|1|||
155215688|NCT00137423|560227271|FG000|Overall Study|Lack of Efficacy|31|||
155215689|NCT00137423|560227272|FG001|Overall Study|Lack of Efficacy|33|||
155215690|NCT00137423|560227271|FG000|Overall Study|Death|0|||
155215691|NCT00137423|560227272|FG001|Overall Study|Death|1|||
155215692|NCT03187262|560227274|FG000|Induction|Lack of Efficacy|2|||
155215693|NCT03187262|560227274|FG000|Induction|Progressive Disease|4|||
155215694|NCT03187262|560227274|FG000|Consolidation|Progressive Disease|5|||
155215695|NCT00909389|560227278|FG000|Overall Study|Adverse Event|6|||
155215696|NCT00909389|560227278|FG000|Overall Study|Death|4|||
155215697|NCT00909389|560227278|FG000|Overall Study|Poor Compliance|16|||
155215698|NCT00909389|560227278|FG000|Overall Study|Lost to Follow-up|4|||
155215699|NCT00909389|560227278|FG000|Overall Study|No Information|103|||
155215700|NCT00737282|560227282|FG000|Overall Study|Study prematurely terminated|175|||
155215701|NCT02763189|560227283|FG000|Overall Study|Device failure|0|||
155215702|NCT02763189|560227284|FG001|Overall Study|Device failure|2|||
155215703|NCT00416078|560227287|FG000|Overall Study|Death|3|||
155215704|NCT00416078|560227288|FG001|Overall Study|Death|4|||
155215705|NCT00416078|560227287|FG000|Overall Study|Withdrawal by Subject|3|||
155215706|NCT00416078|560227288|FG001|Overall Study|Withdrawal by Subject|2|||
155215707|NCT00416078|560227287|FG000|Overall Study|Physician Decision|1|||
155215708|NCT00416078|560227288|FG001|Overall Study|Physician Decision|0|||
155215709|NCT00416078|560227287|FG000|Overall Study|Lost to Follow-up|4|||
155215710|NCT00416078|560227288|FG001|Overall Study|Lost to Follow-up|2|||
155215711|NCT02626520|560227302|FG000|Overall Study|Physician Decision|1|||
155215712|NCT02626520|560227303|FG001|Overall Study|Physician Decision|1|||
155215713|NCT02626520|560227302|FG000|Overall Study|Adverse Event|0|||
155215714|NCT02626520|560227303|FG001|Overall Study|Adverse Event|4|||
155215715|NCT02626520|560227302|FG000|Overall Study|Lack of Efficacy|0|||
155215716|NCT02626520|560227303|FG001|Overall Study|Lack of Efficacy|2|||
155215717|NCT02626520|560227302|FG000|Overall Study|Did not start protocol therapy|0|||
155215718|NCT02626520|560227303|FG001|Overall Study|Did not start protocol therapy|2|||
155215719|NCT02626520|560227302|FG000|Overall Study|Study terminated|0|||
155215720|NCT02626520|560227303|FG001|Overall Study|Study terminated|1|||
155215721|NCT00492115|560227304|FG000|Overall Study|Withdrawal by Subject|3|||
155215722|NCT00492115|560227305|FG001|Overall Study|Withdrawal by Subject|4|||
155215723|NCT03915496|560227308|FG000|Overall Study|Adverse Event|2|||
155215724|NCT03915496|560227309|FG001|Overall Study|Adverse Event|1|||
155215725|NCT03915496|560227310|FG002|Overall Study|Adverse Event|2|||
155215726|NCT02472795|560227311|FG000|Overall Study|Adverse Event|0|||
155215727|NCT02472795|560227312|FG001|Overall Study|Adverse Event|1|||
155215728|NCT02472795|560227313|FG002|Overall Study|Adverse Event|0|||
155215729|NCT02472795|560227314|FG003|Overall Study|Adverse Event|0|||
155215730|NCT02472795|560227315|FG004|Overall Study|Adverse Event|2|||
155215731|NCT02472795|560227311|FG000|Overall Study|Withdrawal by Subject|0|||
155215732|NCT02472795|560227312|FG001|Overall Study|Withdrawal by Subject|0|||
155215733|NCT02472795|560227313|FG002|Overall Study|Withdrawal by Subject|0|||
155215734|NCT02472795|560227314|FG003|Overall Study|Withdrawal by Subject|0|||
155215735|NCT02472795|560227315|FG004|Overall Study|Withdrawal by Subject|1|||
155215736|NCT04166513|560227316|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
155215737|NCT04166513|560227317|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
155215738|NCT04166513|560227318|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
155215739|NCT04166513|560227319|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
155215740|NCT04166513|560227316|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
155215741|NCT04166513|560227317|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
155215742|NCT04166513|560227318|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
155215743|NCT04166513|560227319|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
155215744|NCT04166513|560227316|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
155215745|NCT04166513|560227317|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
155215746|NCT04166513|560227318|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
155215747|NCT04166513|560227319|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
155215748|NCT04166513|560227316|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
155215749|NCT04166513|560227317|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
155215750|NCT04166513|560227318|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
155215751|NCT04166513|560227319|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
155215752|NCT04166513|560227316|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
155215753|NCT04166513|560227317|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
155215754|NCT04166513|560227318|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
155215755|NCT04166513|560227319|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
155215756|NCT04219891|560227321|FG000|Overall Study|Lost to Follow-up|3|||
155215757|NCT04219891|560227321|FG000|Overall Study|Withdrawal by Subject|2|||
155215758|NCT00597012|560227322|FG000|Overall Study|Death|1|||
155215759|NCT00597012|560227323|FG001|Overall Study|Death|1|||
155215760|NCT00597012|560227322|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
155215761|NCT00597012|560227323|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
155215762|NCT00597012|560227322|FG000|Overall Study|Withdrawal by Subject|7|||
155215763|NCT00597012|560227323|FG001|Overall Study|Withdrawal by Subject|4|||
155215764|NCT00597012|560227322|FG000|Overall Study|Ineligible|2|||
155215765|NCT00597012|560227323|FG001|Overall Study|Ineligible|0|||
155215766|NCT00597012|560227322|FG000|Overall Study|Lost to Follow-up|0|||
155215767|NCT00597012|560227323|FG001|Overall Study|Lost to Follow-up|2|||
155215768|NCT00696696|560229430|FG000|Overall Study|Adverse Event|5|||
155215769|NCT00696696|560229430|FG000|Overall Study|Withdrawal by Subject|8|||
155215770|NCT00696696|560229430|FG000|Overall Study|Physician Decision|2|||
155215771|NCT00696696|560229430|FG000|Overall Study|Death|3|||
155215772|NCT01485640|560229431|FG000|Overall Study|Adverse Event|10|||
155215773|NCT01485640|560229431|FG000|Overall Study|Lack of Efficacy|2|||
155215774|NCT01485640|560229431|FG000|Overall Study|Protocol Violation|1|||
155215775|NCT01485640|560229431|FG000|Overall Study|Withdrawal by Subject|14|||
155215776|NCT01485640|560229431|FG000|Overall Study|Terminated by Sponsor|95|||
155215777|NCT01851720|560229435|FG000|Overall Study|Lost to Follow-up|0|||
155215778|NCT01851720|560229436|FG001|Overall Study|Lost to Follow-up|1|||
155215779|NCT01394523|560229437|FG000|Overall Study|Unable to place block|1|||
155215780|NCT01394523|560229438|FG001|Overall Study|Unable to place block|0|||
155215781|NCT01394523|560229439|FG002|Overall Study|Unable to place block|0|||
155215782|NCT02389998|560229440|FG000|Overall Study|car accident|1|||
155215783|NCT02389998|560229441|FG001|Overall Study|car accident|0|||
155215784|NCT03525574|560229442|FG000|Overall Study|Adverse Event|15|||
155215785|NCT03525574|560229443|FG001|Overall Study|Adverse Event|0|||
155215786|NCT03525574|560229442|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
155215787|NCT03525574|560229443|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
155215788|NCT03525574|560229442|FG000|Overall Study|Lost to Follow-up|4|||
155215789|NCT03525574|560229443|FG001|Overall Study|Lost to Follow-up|0|||
155215790|NCT03525574|560229442|FG000|Overall Study|Commercial drug is Available for participant|48|||
155215791|NCT03525574|560229443|FG001|Overall Study|Commercial drug is Available for participant|0|||
155215792|NCT03525574|560229442|FG000|Overall Study|Death|1|||
155215793|NCT03525574|560229443|FG001|Overall Study|Death|0|||
155215794|NCT03525574|560229442|FG000|Overall Study|Other non-compliance|2|||
155215795|NCT03525574|560229443|FG001|Overall Study|Other non-compliance|0|||
155215796|NCT03525574|560229442|FG000|Overall Study|Physician Decision|6|||
155215797|NCT03525574|560229443|FG001|Overall Study|Physician Decision|0|||
155215798|NCT03525574|560229442|FG000|Overall Study|Other|58|||
155215799|NCT03525574|560229443|FG001|Overall Study|Other|0|||
155215800|NCT03525574|560229442|FG000|Overall Study|Enrolled but never dosed|1|||
155215801|NCT03525574|560229443|FG001|Overall Study|Enrolled but never dosed|0|||
155215802|NCT03525574|560229442|FG000|Overall Study|Not enrolled in 105 study|0|||
155215803|NCT03525574|560229443|FG001|Overall Study|Not enrolled in 105 study|3|||
155215804|NCT04741074|560229446|FG000|Overall Study|Withdrawal by Subject|1|||
155215805|NCT04741074|560229447|FG001|Overall Study|Withdrawal by Subject|1|||
155215806|NCT04741074|560229446|FG000|Overall Study|Study terminated prematurely|1|||
155215807|NCT04741074|560229447|FG001|Overall Study|Study terminated prematurely|0|||
155215808|NCT01770379|560229448|FG000|Overall Study|Technical issues|1|||
155215809|NCT01770379|560229449|FG001|Overall Study|Technical issues|0|||
155215810|NCT01770379|560229450|FG002|Overall Study|Technical issues|0|||
155215811|NCT01770379|560229448|FG000|Overall Study|Withdrawal by Subject|7|||
155215812|NCT01770379|560229449|FG001|Overall Study|Withdrawal by Subject|10|||
155215813|NCT01770379|560229450|FG002|Overall Study|Withdrawal by Subject|7|||
155215814|NCT01770379|560229448|FG000|Overall Study|study terminated by sponsor|22|||
155215815|NCT01770379|560229449|FG001|Overall Study|study terminated by sponsor|23|||
155215816|NCT01770379|560229450|FG002|Overall Study|study terminated by sponsor|22|||
155215817|NCT01770379|560229448|FG000|Overall Study|Protocol Violation|0|||
155215818|NCT01770379|560229449|FG001|Overall Study|Protocol Violation|1|||
155215819|NCT01770379|560229450|FG002|Overall Study|Protocol Violation|1|||
155215820|NCT01770379|560229448|FG000|Overall Study|Physician Decision|0|||
155215821|NCT01770379|560229449|FG001|Overall Study|Physician Decision|1|||
155215822|NCT01770379|560229450|FG002|Overall Study|Physician Decision|2|||
155215823|NCT01770379|560229448|FG000|Overall Study|Lost to Follow-up|0|||
155215824|NCT01770379|560229449|FG001|Overall Study|Lost to Follow-up|0|||
155215825|NCT01770379|560229450|FG002|Overall Study|Lost to Follow-up|2|||
155215826|NCT01770379|560229448|FG000|Overall Study|Lack of Efficacy|8|||
155215827|NCT01770379|560229449|FG001|Overall Study|Lack of Efficacy|6|||
155215828|NCT01770379|560229450|FG002|Overall Study|Lack of Efficacy|6|||
155215829|NCT01770379|560229448|FG000|Overall Study|Adverse Event|1|||
155215830|NCT01770379|560229449|FG001|Overall Study|Adverse Event|3|||
155215831|NCT01770379|560229450|FG002|Overall Study|Adverse Event|2|||
155215832|NCT01074450|560229463|FG000|First Intervention|Emesis in Dosing Interval|0|||
155215833|NCT01074450|560229464|FG001|First Intervention|Emesis in Dosing Interval|2|||
155215834|NCT01074450|560229463|FG000|Second Intervention|Protocol Violation|1|||
155215835|NCT01074450|560229464|FG001|Second Intervention|Protocol Violation|0|||
155215836|NCT01074450|560229463|FG000|Second Intervention|Physician Decision|0|||
155215837|NCT01074450|560229464|FG001|Second Intervention|Physician Decision|1|||
155215838|NCT03226392|560229465|FG000|Overall Study|Protocol Deviation|1|||
155215839|NCT03226392|560229466|FG001|Overall Study|Protocol Deviation|0|||
155215840|NCT03226392|560229465|FG000|Overall Study|Physician Decision|1|||
155215841|NCT03226392|560229466|FG001|Overall Study|Physician Decision|0|||
155215842|NCT03226392|560229465|FG000|Overall Study|Lost to Follow-up|1|||
155215843|NCT03226392|560229466|FG001|Overall Study|Lost to Follow-up|0|||
155215844|NCT03226392|560229465|FG000|Overall Study|Adverse Event|1|||
155215845|NCT03226392|560229466|FG001|Overall Study|Adverse Event|0|||
155215846|NCT03226392|560229465|FG000|Overall Study|Technical Problems|0|||
155215847|NCT03226392|560229466|FG001|Overall Study|Technical Problems|2|||
155215848|NCT03226392|560229465|FG000|Overall Study|Subject/Guardian Decision|7|||
155215849|NCT03226392|560229466|FG001|Overall Study|Subject/Guardian Decision|6|||
155215850|NCT02728895|560229467|FG000|Overall Study|Other|1|||
155215851|NCT02728895|560229468|FG001|Overall Study|Other|2|||
155215852|NCT02728895|560229467|FG000|Overall Study|Withdrawal by Subject|0|||
155215853|NCT02728895|560229468|FG001|Overall Study|Withdrawal by Subject|3|||
155215854|NCT02769247|560229469|FG000|Overall Study|Withdrawal by Subject|1|||
155215855|NCT02769247|560229470|FG001|Overall Study|Withdrawal by Subject|0|||
155215856|NCT02769247|560229471|FG002|Overall Study|Withdrawal by Subject|0|||
155215857|NCT02769247|560229472|FG003|Overall Study|Withdrawal by Subject|1|||
155215858|NCT02769247|560229469|FG000|Overall Study|Protocol Violation|0|||
155215859|NCT02769247|560229470|FG001|Overall Study|Protocol Violation|0|||
155215860|NCT02769247|560229471|FG002|Overall Study|Protocol Violation|1|||
155215861|NCT02769247|560229472|FG003|Overall Study|Protocol Violation|0|||
155215862|NCT02769247|560229469|FG000|Overall Study|Physician Decision|1|||
155215863|NCT02769247|560229470|FG001|Overall Study|Physician Decision|0|||
155215864|NCT02769247|560229471|FG002|Overall Study|Physician Decision|0|||
155215865|NCT02769247|560229472|FG003|Overall Study|Physician Decision|0|||
155215866|NCT04788953|560229473|FG000|Overall Study|Adverse Event|1|||
155215867|NCT04788953|560229474|FG001|Overall Study|Adverse Event|1|||
155215868|NCT04788953|560229473|FG000|Overall Study|Withdrawal by Subject|1|||
155215869|NCT04788953|560229474|FG001|Overall Study|Withdrawal by Subject|0|||
155215870|NCT04788953|560229473|FG000|Overall Study|Protocol Violation|0|||
155215871|NCT04788953|560229474|FG001|Overall Study|Protocol Violation|1|||
155215872|NCT00937157|560229475|FG000|Overall Study|Pregnancy|1|||
155215873|NCT00937157|560229475|FG000|Overall Study|Lost to Follow-up|3|||
155215874|NCT00469092|560229476|FG000|Overall Study|Adverse Event|5|||
155215875|NCT00469092|560229477|FG001|Overall Study|Adverse Event|4|||
155215876|NCT00469092|560229476|FG000|Overall Study|Lack of Efficacy|1|||
155215877|NCT00469092|560229477|FG001|Overall Study|Lack of Efficacy|0|||
155215878|NCT00469092|560229476|FG000|Overall Study|Lost to Follow-up|1|||
155215879|NCT00469092|560229477|FG001|Overall Study|Lost to Follow-up|2|||
155215880|NCT00469092|560229476|FG000|Overall Study|Protocol Violation|3|||
155215881|NCT00469092|560229477|FG001|Overall Study|Protocol Violation|3|||
155215882|NCT00469092|560229476|FG000|Overall Study|Withdrawal by Subject|4|||
155215883|NCT00469092|560229477|FG001|Overall Study|Withdrawal by Subject|4|||
155215884|NCT00469092|560229476|FG000|Overall Study|Withdrawal Criteria|3|||
155215885|NCT00469092|560229477|FG001|Overall Study|Withdrawal Criteria|4|||
155215886|NCT00469092|560229476|FG000|Overall Study|Incorrectly Randomised|4|||
155215887|NCT00469092|560229477|FG001|Overall Study|Incorrectly Randomised|3|||
155215888|NCT00469092|560229476|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
155215889|NCT00469092|560229477|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
155215890|NCT00469092|560229476|FG000|Overall Study|Use of lipid lowering drug|1|||
155215891|NCT00469092|560229477|FG001|Overall Study|Use of lipid lowering drug|0|||
155215892|NCT00469092|560229476|FG000|Overall Study|Hypoglycaemic Episodes|1|||
155215893|NCT00469092|560229477|FG001|Overall Study|Hypoglycaemic Episodes|1|||
155215894|NCT00469092|560229476|FG000|Overall Study|Abnormal lab value|1|||
155215895|NCT00469092|560229477|FG001|Overall Study|Abnormal lab value|0|||
155215896|NCT00469092|560229476|FG000|Overall Study|Use of Corticosteroid|1|||
155215897|NCT00469092|560229477|FG001|Overall Study|Use of Corticosteroid|0|||
155215898|NCT01998737|560229485|FG000|Overall Study|Corrupted database|23|||
155215899|NCT01998737|560229486|FG001|Overall Study|Corrupted database|0|||
155215900|NCT02092662|560229487|FG000|Overall Study|Lost to Follow-up|13|||
155215901|NCT02092662|560229488|FG001|Overall Study|Lost to Follow-up|0|||
155215902|NCT02268864|560229489|FG000|Overall Study|Withdrawal by Subject|2|||
155215903|NCT02268864|560229490|FG001|Overall Study|Withdrawal by Subject|0|||
155215904|NCT02268864|560229491|FG002|Overall Study|Withdrawal by Subject|0|||
155215905|NCT02268864|560229489|FG000|Overall Study|Death|0|||
155215906|NCT02268864|560229490|FG001|Overall Study|Death|1|||
155215907|NCT02268864|560229491|FG002|Overall Study|Death|0|||
155215908|NCT05407675|560229492|FG000|Overall Study|Withdrawal by Subject|0|||
155215909|NCT05407675|560229493|FG001|Overall Study|Withdrawal by Subject|2|||
155215910|NCT05407675|560229494|FG002|Overall Study|Withdrawal by Subject|3|||
155215911|NCT05407675|560229495|FG003|Overall Study|Withdrawal by Subject|5|||
155215912|NCT05407675|560229496|FG004|Overall Study|Withdrawal by Subject|0|||
155215913|NCT05407675|560229497|FG005|Overall Study|Withdrawal by Subject|2|||
155215914|NCT05407675|560229498|FG006|Overall Study|Withdrawal by Subject|0|||
155215915|NCT05407675|560229499|FG007|Overall Study|Withdrawal by Subject|0|||
155215916|NCT05407675|560229500|FG008|Overall Study|Withdrawal by Subject|2|||
155215917|NCT05407675|560229501|FG009|Overall Study|Withdrawal by Subject|0|||
155215918|NCT05407675|560229502|FG010|Overall Study|Withdrawal by Subject|1|||
155215919|NCT05407675|560229503|FG011|Overall Study|Withdrawal by Subject|0|||
155215920|NCT05407675|560229504|FG012|Overall Study|Withdrawal by Subject|0|||
155215921|NCT05407675|560229492|FG000|Overall Study|Site terminated by sponsor|0|||
155215922|NCT05407675|560229493|FG001|Overall Study|Site terminated by sponsor|0|||
155215923|NCT05407675|560229494|FG002|Overall Study|Site terminated by sponsor|1|||
155215924|NCT05407675|560229495|FG003|Overall Study|Site terminated by sponsor|0|||
155215925|NCT05407675|560229496|FG004|Overall Study|Site terminated by sponsor|2|||
155215926|NCT05407675|560229497|FG005|Overall Study|Site terminated by sponsor|0|||
155215927|NCT05407675|560229498|FG006|Overall Study|Site terminated by sponsor|1|||
155215928|NCT05407675|560229499|FG007|Overall Study|Site terminated by sponsor|0|||
155215929|NCT05407675|560229500|FG008|Overall Study|Site terminated by sponsor|0|||
155215930|NCT05407675|560229501|FG009|Overall Study|Site terminated by sponsor|2|||
155215931|NCT05407675|560229502|FG010|Overall Study|Site terminated by sponsor|2|||
155215932|NCT05407675|560229503|FG011|Overall Study|Site terminated by sponsor|2|||
155215933|NCT05407675|560229504|FG012|Overall Study|Site terminated by sponsor|1|||
155215934|NCT05407675|560229492|FG000|Overall Study|Disease Progression|0|||
155215935|NCT05407675|560229493|FG001|Overall Study|Disease Progression|0|||
155215936|NCT05407675|560229494|FG002|Overall Study|Disease Progression|0|||
155215937|NCT05407675|560229495|FG003|Overall Study|Disease Progression|0|||
155215938|NCT05407675|560229496|FG004|Overall Study|Disease Progression|0|||
155215939|NCT05407675|560229497|FG005|Overall Study|Disease Progression|0|||
155215940|NCT05407675|560229498|FG006|Overall Study|Disease Progression|0|||
155215941|NCT05407675|560229499|FG007|Overall Study|Disease Progression|0|||
155215942|NCT05407675|560229500|FG008|Overall Study|Disease Progression|0|||
155215943|NCT05407675|560229501|FG009|Overall Study|Disease Progression|0|||
155215944|NCT05407675|560229502|FG010|Overall Study|Disease Progression|1|||
155215945|NCT05407675|560229503|FG011|Overall Study|Disease Progression|0|||
155215946|NCT05407675|560229504|FG012|Overall Study|Disease Progression|0|||
155215947|NCT05407675|560229492|FG000|Overall Study|Physician Decision|0|||
155215948|NCT05407675|560229493|FG001|Overall Study|Physician Decision|0|||
155215949|NCT05407675|560229494|FG002|Overall Study|Physician Decision|0|||
155215950|NCT05407675|560229495|FG003|Overall Study|Physician Decision|0|||
155215951|NCT05407675|560229496|FG004|Overall Study|Physician Decision|0|||
155215952|NCT05407675|560229497|FG005|Overall Study|Physician Decision|0|||
155215953|NCT05407675|560229498|FG006|Overall Study|Physician Decision|0|||
155215954|NCT05407675|560229499|FG007|Overall Study|Physician Decision|0|||
155215955|NCT05407675|560229500|FG008|Overall Study|Physician Decision|0|||
155215956|NCT05407675|560229501|FG009|Overall Study|Physician Decision|0|||
155215957|NCT05407675|560229502|FG010|Overall Study|Physician Decision|1|||
155215958|NCT05407675|560229503|FG011|Overall Study|Physician Decision|0|||
155215959|NCT05407675|560229504|FG012|Overall Study|Physician Decision|0|||
155215960|NCT05407675|560229492|FG000|Overall Study|Other reasons|0|||
155215961|NCT05407675|560229493|FG001|Overall Study|Other reasons|0|||
155215962|NCT05407675|560229494|FG002|Overall Study|Other reasons|0|||
155215963|NCT05407675|560229495|FG003|Overall Study|Other reasons|0|||
155215964|NCT05407675|560229496|FG004|Overall Study|Other reasons|0|||
155215965|NCT05407675|560229497|FG005|Overall Study|Other reasons|0|||
155215966|NCT05407675|560229498|FG006|Overall Study|Other reasons|0|||
155215967|NCT05407675|560229499|FG007|Overall Study|Other reasons|0|||
155215968|NCT05407675|560229500|FG008|Overall Study|Other reasons|1|||
155215969|NCT05407675|560229501|FG009|Overall Study|Other reasons|1|||
155215970|NCT05407675|560229502|FG010|Overall Study|Other reasons|1|||
155215971|NCT05407675|560229503|FG011|Overall Study|Other reasons|1|||
155215972|NCT05407675|560229504|FG012|Overall Study|Other reasons|0|||
155215973|NCT05407675|560229492|FG000|Overall Study|Death|3|||
155215974|NCT05407675|560229493|FG001|Overall Study|Death|4|||
155215975|NCT05407675|560229494|FG002|Overall Study|Death|3|||
155215976|NCT05407675|560229495|FG003|Overall Study|Death|6|||
155215977|NCT05407675|560229496|FG004|Overall Study|Death|0|||
155215978|NCT05407675|560229497|FG005|Overall Study|Death|2|||
155215979|NCT05407675|560229498|FG006|Overall Study|Death|4|||
155215980|NCT05407675|560229499|FG007|Overall Study|Death|2|||
155215981|NCT05407675|560229500|FG008|Overall Study|Death|2|||
155215982|NCT05407675|560229501|FG009|Overall Study|Death|4|||
155215983|NCT05407675|560229502|FG010|Overall Study|Death|2|||
155215984|NCT05407675|560229503|FG011|Overall Study|Death|1|||
155215985|NCT05407675|560229504|FG012|Overall Study|Death|0|||
155215986|NCT05407675|560229492|FG000|Overall Study|Adverse Event|0|||
155215987|NCT05407675|560229493|FG001|Overall Study|Adverse Event|0|||
155215988|NCT05407675|560229494|FG002|Overall Study|Adverse Event|0|||
155215989|NCT05407675|560229495|FG003|Overall Study|Adverse Event|0|||
155215990|NCT05407675|560229496|FG004|Overall Study|Adverse Event|1|||
155215991|NCT05407675|560229497|FG005|Overall Study|Adverse Event|0|||
155215992|NCT05407675|560229498|FG006|Overall Study|Adverse Event|0|||
155215993|NCT05407675|560229499|FG007|Overall Study|Adverse Event|0|||
155215994|NCT05407675|560229500|FG008|Overall Study|Adverse Event|0|||
155215995|NCT05407675|560229501|FG009|Overall Study|Adverse Event|0|||
155215996|NCT05407675|560229502|FG010|Overall Study|Adverse Event|0|||
155215997|NCT05407675|560229503|FG011|Overall Study|Adverse Event|1|||
155215998|NCT05407675|560229504|FG012|Overall Study|Adverse Event|0|||
155215999|NCT05407675|560229492|FG000|Overall Study|Ongoing Treatment|0|||
155216000|NCT05407675|560229493|FG001|Overall Study|Ongoing Treatment|0|||
155216001|NCT05407675|560229494|FG002|Overall Study|Ongoing Treatment|0|||
155216002|NCT05407675|560229495|FG003|Overall Study|Ongoing Treatment|0|||
155216003|NCT05407675|560229496|FG004|Overall Study|Ongoing Treatment|0|||
155216004|NCT05407675|560229497|FG005|Overall Study|Ongoing Treatment|0|||
155216005|NCT05407675|560229498|FG006|Overall Study|Ongoing Treatment|0|||
155216006|NCT05407675|560229499|FG007|Overall Study|Ongoing Treatment|0|||
155216007|NCT05407675|560229500|FG008|Overall Study|Ongoing Treatment|1|||
155216008|NCT05407675|560229501|FG009|Overall Study|Ongoing Treatment|0|||
155216009|NCT05407675|560229502|FG010|Overall Study|Ongoing Treatment|0|||
155216010|NCT05407675|560229503|FG011|Overall Study|Ongoing Treatment|0|||
155216011|NCT05407675|560229504|FG012|Overall Study|Ongoing Treatment|0|||
155216012|NCT01050257|560229505|FG000|Overall Study|Adverse Event|4|||
155216013|NCT01050257|560229506|FG001|Overall Study|Adverse Event|4|||
155216014|NCT01050257|560229507|FG002|Overall Study|Adverse Event|2|||
155216015|NCT01050257|560229505|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
155216016|NCT01050257|560229506|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
155216017|NCT01050257|560229507|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
155216018|NCT01050257|560229505|FG000|Overall Study|Withdrawal by Subject|0|||
155216019|NCT01050257|560229506|FG001|Overall Study|Withdrawal by Subject|3|||
155216020|NCT01050257|560229507|FG002|Overall Study|Withdrawal by Subject|0|||
155216021|NCT01050257|560229505|FG000|Overall Study|No reason specified|0|||
155216022|NCT01050257|560229506|FG001|Overall Study|No reason specified|0|||
155216023|NCT01050257|560229507|FG002|Overall Study|No reason specified|2|||
155216024|NCT01050257|560229505|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
155216025|NCT01050257|560229506|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
155216026|NCT01050257|560229507|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
155216027|NCT01050257|560229505|FG000|Overall Study|Violation criteria|0|||
155216028|NCT01050257|560229506|FG001|Overall Study|Violation criteria|1|||
155216029|NCT01050257|560229507|FG002|Overall Study|Violation criteria|0|||
155216030|NCT01050257|560229505|FG000|Overall Study|Failure to return|0|||
155216031|NCT01050257|560229506|FG001|Overall Study|Failure to return|2|||
155216032|NCT01050257|560229507|FG002|Overall Study|Failure to return|0|||
155216033|NCT01050257|560229505|FG000|Overall Study|Death|0|||
155216034|NCT01050257|560229506|FG001|Overall Study|Death|0|||
155216035|NCT01050257|560229507|FG002|Overall Study|Death|1|||
155216036|NCT00171223|560229508|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
155216037|NCT00171223|560229509|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
155216038|NCT00171223|560229510|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
155216039|NCT00171223|560229508|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
155216040|NCT00171223|560229509|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
155216041|NCT00171223|560229510|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
155216042|NCT00171223|560229508|FG000|Overall Study|Abnormal Procedure|1|||
155216043|NCT00171223|560229509|FG001|Overall Study|Abnormal Procedure|0|||
155216044|NCT00171223|560229510|FG002|Overall Study|Abnormal Procedure|0|||
155216045|NCT00171223|560229508|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
155216046|NCT00171223|560229509|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
155216047|NCT00171223|560229510|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
155216048|NCT00171223|560229508|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
155216049|NCT00171223|560229509|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
155216050|NCT00171223|560229510|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
155216051|NCT00171223|560229508|FG000|Overall Study|Protocol Violation|2|||
155216052|NCT00171223|560229509|FG001|Overall Study|Protocol Violation|2|||
155216053|NCT00171223|560229510|FG002|Overall Study|Protocol Violation|3|||
155216054|NCT00171223|560229508|FG000|Overall Study|Participant Withdrew Consent|12|||
155216055|NCT00171223|560229509|FG001|Overall Study|Participant Withdrew Consent|21|||
155216056|NCT00171223|560229510|FG002|Overall Study|Participant Withdrew Consent|15|||
155216057|NCT00171223|560229508|FG000|Overall Study|Lost to Follow-up|5|||
155216058|NCT00171223|560229509|FG001|Overall Study|Lost to Follow-up|2|||
155216059|NCT00171223|560229510|FG002|Overall Study|Lost to Follow-up|3|||
155216060|NCT00171223|560229508|FG000|Overall Study|Administrative Problems|4|||
155216061|NCT00171223|560229509|FG001|Overall Study|Administrative Problems|7|||
155216062|NCT00171223|560229510|FG002|Overall Study|Administrative Problems|6|||
155216063|NCT00171223|560229508|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
155216064|NCT00171223|560229509|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
155216065|NCT00171223|560229510|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
155216066|NCT00171223|560229508|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
155216067|NCT00171223|560229509|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
155216068|NCT00171223|560229510|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
155216069|NCT00278109|560229512|FG000|Overall Study|Adverse Event|3|||
155216070|NCT00278109|560229512|FG000|Overall Study|social circumstances|1|||
155216071|NCT02064166|560229513|FG000|Overall Study|Adverse Event|1|||
155216072|NCT02064166|560229514|FG001|Overall Study|Adverse Event|0|||
155216073|NCT04339296|560229515|FG000|Overall Study|Refuse to participate after allocation|1|||
155216074|NCT04339296|560229516|FG001|Overall Study|Refuse to participate after allocation|1|||
155216075|NCT04339296|560229515|FG000|Overall Study|Withdrew after completion of baseline|2|||
155216076|NCT04339296|560229516|FG001|Overall Study|Withdrew after completion of baseline|1|||
155216077|NCT04339296|560229515|FG000|Overall Study|Lost to Follow-up|0|||
155216078|NCT04339296|560229516|FG001|Overall Study|Lost to Follow-up|4|||
155216079|NCT04339296|560229515|FG000|Overall Study|Discontinued intervention|5|||
155216080|NCT04339296|560229516|FG001|Overall Study|Discontinued intervention|3|||
155216081|NCT00383149|560229520|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
155216082|NCT00383149|560229520|FG000|Overall Study|Death|2|||
155216083|NCT00383149|560229520|FG000|Overall Study|Disease Progression|38|||
155216084|NCT00383149|560229520|FG000|Overall Study|Lost to Follow-up|1|||
155216085|NCT00383149|560229520|FG000|Overall Study|Other|1|||
155216086|NCT00383149|560229520|FG000|Overall Study|Study Drug Toxicity|4|||
155216087|NCT00383149|560229520|FG000|Overall Study|Request to Discontinue Treatment|4|||
155216088|NCT00383149|560229520|FG000|Overall Study|Participant Withdrew Consent|1|||
155216089|NCT03721276|560229523|FG000|Overall Study|Lost to Follow-up|5|||
155216090|NCT03721276|560229524|FG001|Overall Study|Lost to Follow-up|3|||
155216091|NCT03721276|560229523|FG000|Overall Study|Adverse Event|0|||
155216092|NCT03721276|560229524|FG001|Overall Study|Adverse Event|1|||
155216093|NCT01340898|560229527|FG000|Primary Phase|Serious Adverse Events|0|||
155216094|NCT01340898|560229528|FG001|Primary Phase|Serious Adverse Events|0|||
155216095|NCT01340898|560229529|FG002|Primary Phase|Serious Adverse Events|1|||
155216096|NCT01340898|560229527|FG000|Primary Phase|Withdrawal by Subject|8|||
155216097|NCT01340898|560229528|FG001|Primary Phase|Withdrawal by Subject|7|||
155216098|NCT01340898|560229529|FG002|Primary Phase|Withdrawal by Subject|5|||
155216099|NCT01340898|560229527|FG000|Primary Phase|Migrated/moved from study area|4|||
155216100|NCT01340898|560229528|FG001|Primary Phase|Migrated/moved from study area|1|||
155216101|NCT01340898|560229529|FG002|Primary Phase|Migrated/moved from study area|0|||
155216102|NCT01340898|560229527|FG000|Primary Phase|Lost to Follow-up|4|||
155216103|NCT01340898|560229528|FG001|Primary Phase|Lost to Follow-up|1|||
155216104|NCT01340898|560229529|FG002|Primary Phase|Lost to Follow-up|0|||
155216105|NCT01340898|560229527|FG000|Booster Phase|Withdrawal by Subject|3|||
155216106|NCT01340898|560229528|FG001|Booster Phase|Withdrawal by Subject|0|||
155216107|NCT01340898|560229529|FG002|Booster Phase|Withdrawal by Subject|4|||
155216108|NCT01340898|560229527|FG000|Booster Phase|Migrated/moved from study area|3|||
155216109|NCT01340898|560229528|FG001|Booster Phase|Migrated/moved from study area|0|||
155216110|NCT01340898|560229529|FG002|Booster Phase|Migrated/moved from study area|0|||
155216111|NCT01340898|560229527|FG000|Booster Phase|Lost to Follow-up|4|||
155216112|NCT01340898|560229528|FG001|Booster Phase|Lost to Follow-up|2|||
155216113|NCT01340898|560229529|FG002|Booster Phase|Lost to Follow-up|3|||
155216114|NCT02375113|560229530|FG000|Overall Study|Undisclosed Reason(s).|1|||
155216115|NCT02375113|560229531|FG001|Overall Study|Undisclosed Reason(s).|1|||
155216116|NCT02375113|560229530|FG000|Overall Study|Poor adherence (<70%).|1|||
155216117|NCT02375113|560229531|FG001|Overall Study|Poor adherence (<70%).|0|||
155216118|NCT02375113|560229530|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
155216119|NCT02375113|560229531|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
155216120|NCT00969150|560229534|FG000|Overall Study|Adverse Event|4|||
155216121|NCT00969150|560229535|FG001|Overall Study|Adverse Event|14|||
155216122|NCT00969150|560229534|FG000|Overall Study|Lack of Efficacy|1|||
155216123|NCT00969150|560229535|FG001|Overall Study|Lack of Efficacy|1|||
155216124|NCT00969150|560229534|FG000|Overall Study|Protocol Violation|9|||
155216125|NCT00969150|560229535|FG001|Overall Study|Protocol Violation|12|||
155216126|NCT00969150|560229534|FG000|Overall Study|Withdrawal by Subject|13|||
155216127|NCT00969150|560229535|FG001|Overall Study|Withdrawal by Subject|9|||
155216128|NCT00969150|560229534|FG000|Overall Study|Lost to Follow-up|5|||
155216129|NCT00969150|560229535|FG001|Overall Study|Lost to Follow-up|4|||
155216130|NCT00969150|560229534|FG000|Overall Study|Other reasons|1|||
155216131|NCT00969150|560229535|FG001|Overall Study|Other reasons|0|||
155216132|NCT00461682|560229539|FG000|Overall Study|Protocol Violation|1|||
155216133|NCT04128267|560229545|FG000|Overall Study|Withdrawal by Subject|6|||
155216134|NCT04128267|560229545|FG000|Overall Study|Death|2|||
155216135|NCT04128267|560229545|FG000|Overall Study|Disease progression|1|||
155216136|NCT04128267|560229545|FG000|Overall Study|Participant had other medical issues|4|||
155216137|NCT04128267|560229545|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
155216138|NCT04501666|560229548|FG000|Overall Study|Physician Decision|0|||
155216139|NCT04501666|560229549|FG001|Overall Study|Physician Decision|1|||
155216140|NCT04501666|560229548|FG000|Overall Study|Adverse Event|12|||
155216141|NCT04501666|560229549|FG001|Overall Study|Adverse Event|4|||
155216142|NCT04501666|560229548|FG000|Overall Study|Subject's request|10|||
155216143|NCT04501666|560229549|FG001|Overall Study|Subject's request|6|||
155216144|NCT04501666|560229548|FG000|Overall Study|Protocol Deviation|2|||
155216145|NCT04501666|560229549|FG001|Overall Study|Protocol Deviation|1|||
155216146|NCT04501666|560229548|FG000|Overall Study|Other-- site permanently closing|0|||
155216147|NCT04501666|560229549|FG001|Overall Study|Other-- site permanently closing|1|||
155216148|NCT00642941|560229550|FG000|Overall Study|Physician Decision|3|||
155216149|NCT00642941|560229551|FG001|Overall Study|Physician Decision|1|||
155216150|NCT00642941|560229552|FG002|Overall Study|Physician Decision|0|||
155216151|NCT00642941|560229553|FG003|Overall Study|Physician Decision|0|||
155216152|NCT00642941|560229554|FG004|Overall Study|Physician Decision|0|||
155216153|NCT00642941|560229555|FG005|Overall Study|Physician Decision|0|||
155216154|NCT00642941|560229556|FG006|Overall Study|Physician Decision|1|||
155216155|NCT00642941|560229557|FG007|Overall Study|Physician Decision|0|||
155216156|NCT00642941|560229558|FG008|Overall Study|Physician Decision|0|||
155216157|NCT00642941|560229559|FG009|Overall Study|Physician Decision|1|||
155216158|NCT00642941|560229560|FG010|Overall Study|Physician Decision|0|||
155216159|NCT00642941|560229561|FG011|Overall Study|Physician Decision|1|||
155216160|NCT00642941|560229550|FG000|Overall Study|Death|4|||
155216161|NCT00642941|560229551|FG001|Overall Study|Death|0|||
155216162|NCT00642941|560229552|FG002|Overall Study|Death|1|||
155216163|NCT00642941|560229553|FG003|Overall Study|Death|1|||
155216164|NCT00642941|560229554|FG004|Overall Study|Death|2|||
155216165|NCT00642941|560229555|FG005|Overall Study|Death|1|||
155216166|NCT00642941|560229556|FG006|Overall Study|Death|0|||
155216167|NCT00642941|560229557|FG007|Overall Study|Death|0|||
155216168|NCT00642941|560229558|FG008|Overall Study|Death|0|||
155216169|NCT00642941|560229559|FG009|Overall Study|Death|0|||
155216170|NCT00642941|560229560|FG010|Overall Study|Death|0|||
155216171|NCT00642941|560229561|FG011|Overall Study|Death|1|||
155216172|NCT00642941|560229550|FG000|Overall Study|Study closed by Sponsor|0|||
155216173|NCT00642941|560229551|FG001|Overall Study|Study closed by Sponsor|1|||
155216174|NCT00642941|560229552|FG002|Overall Study|Study closed by Sponsor|0|||
155216175|NCT00642941|560229553|FG003|Overall Study|Study closed by Sponsor|0|||
155216176|NCT00642941|560229554|FG004|Overall Study|Study closed by Sponsor|0|||
155216177|NCT00642941|560229555|FG005|Overall Study|Study closed by Sponsor|0|||
155216178|NCT00642941|560229556|FG006|Overall Study|Study closed by Sponsor|0|||
155216179|NCT00642941|560229557|FG007|Overall Study|Study closed by Sponsor|0|||
155216180|NCT00642941|560229558|FG008|Overall Study|Study closed by Sponsor|0|||
155216181|NCT00642941|560229559|FG009|Overall Study|Study closed by Sponsor|0|||
155216182|NCT00642941|560229560|FG010|Overall Study|Study closed by Sponsor|0|||
155216183|NCT00642941|560229561|FG011|Overall Study|Study closed by Sponsor|0|||
155216184|NCT00642941|560229550|FG000|Overall Study|Withdrawal by Subject|1|||
155216185|NCT00642941|560229551|FG001|Overall Study|Withdrawal by Subject|0|||
155216186|NCT00642941|560229552|FG002|Overall Study|Withdrawal by Subject|0|||
155216187|NCT00642941|560229553|FG003|Overall Study|Withdrawal by Subject|2|||
155216188|NCT00642941|560229554|FG004|Overall Study|Withdrawal by Subject|0|||
155216189|NCT00642941|560229555|FG005|Overall Study|Withdrawal by Subject|0|||
155216190|NCT00642941|560229556|FG006|Overall Study|Withdrawal by Subject|2|||
155216191|NCT00642941|560229557|FG007|Overall Study|Withdrawal by Subject|0|||
155216192|NCT00642941|560229558|FG008|Overall Study|Withdrawal by Subject|1|||
155216193|NCT00642941|560229559|FG009|Overall Study|Withdrawal by Subject|0|||
155216194|NCT00642941|560229560|FG010|Overall Study|Withdrawal by Subject|0|||
155216195|NCT00642941|560229561|FG011|Overall Study|Withdrawal by Subject|1|||
155216196|NCT00642941|560229550|FG000|Overall Study|Protocol Violation|0|||
155216197|NCT00642941|560229551|FG001|Overall Study|Protocol Violation|0|||
155216198|NCT00642941|560229552|FG002|Overall Study|Protocol Violation|0|||
155216199|NCT00642941|560229553|FG003|Overall Study|Protocol Violation|0|||
155216200|NCT00642941|560229554|FG004|Overall Study|Protocol Violation|0|||
155216201|NCT00642941|560229555|FG005|Overall Study|Protocol Violation|0|||
155216202|NCT00642941|560229556|FG006|Overall Study|Protocol Violation|1|||
155216203|NCT00642941|560229557|FG007|Overall Study|Protocol Violation|0|||
155216204|NCT00642941|560229558|FG008|Overall Study|Protocol Violation|0|||
155216205|NCT00642941|560229559|FG009|Overall Study|Protocol Violation|0|||
155216206|NCT00642941|560229560|FG010|Overall Study|Protocol Violation|0|||
155216207|NCT00642941|560229561|FG011|Overall Study|Protocol Violation|0|||
155216208|NCT00642941|560229550|FG000|Overall Study|Adverse Event|1|||
155216209|NCT00642941|560229551|FG001|Overall Study|Adverse Event|1|||
155216210|NCT00642941|560229552|FG002|Overall Study|Adverse Event|0|||
155216211|NCT00642941|560229553|FG003|Overall Study|Adverse Event|0|||
155216212|NCT00642941|560229554|FG004|Overall Study|Adverse Event|0|||
155216213|NCT00642941|560229555|FG005|Overall Study|Adverse Event|0|||
155216214|NCT00642941|560229556|FG006|Overall Study|Adverse Event|1|||
155216215|NCT00642941|560229557|FG007|Overall Study|Adverse Event|1|||
155216216|NCT00642941|560229558|FG008|Overall Study|Adverse Event|0|||
155216217|NCT00642941|560229559|FG009|Overall Study|Adverse Event|1|||
155216218|NCT00642941|560229560|FG010|Overall Study|Adverse Event|0|||
155216219|NCT00642941|560229561|FG011|Overall Study|Adverse Event|0|||
155216220|NCT00642941|560229550|FG000|Overall Study|Other|1|||
155216221|NCT00642941|560229551|FG001|Overall Study|Other|1|||
155216222|NCT00642941|560229552|FG002|Overall Study|Other|1|||
155216223|NCT00642941|560229553|FG003|Overall Study|Other|1|||
155216224|NCT00642941|560229554|FG004|Overall Study|Other|0|||
155216225|NCT00642941|560229555|FG005|Overall Study|Other|1|||
155216226|NCT00642941|560229556|FG006|Overall Study|Other|0|||
155216227|NCT00642941|560229557|FG007|Overall Study|Other|1|||
155216228|NCT00642941|560229558|FG008|Overall Study|Other|0|||
155216229|NCT00642941|560229559|FG009|Overall Study|Other|0|||
155216230|NCT00642941|560229560|FG010|Overall Study|Other|0|||
155216231|NCT00642941|560229561|FG011|Overall Study|Other|1|||
155216232|NCT00642941|560229550|FG000|Overall Study|Disease progression|60|||
155216233|NCT00642941|560229551|FG001|Overall Study|Disease progression|50|||
155216234|NCT00642941|560229552|FG002|Overall Study|Disease progression|5|||
155216235|NCT00642941|560229553|FG003|Overall Study|Disease progression|36|||
155216236|NCT00642941|560229554|FG004|Overall Study|Disease progression|23|||
155216237|NCT00642941|560229555|FG005|Overall Study|Disease progression|39|||
155216238|NCT00642941|560229556|FG006|Overall Study|Disease progression|18|||
155216239|NCT00642941|560229557|FG007|Overall Study|Disease progression|12|||
155216240|NCT00642941|560229558|FG008|Overall Study|Disease progression|10|||
155216241|NCT00642941|560229559|FG009|Overall Study|Disease progression|7|||
155216242|NCT00642941|560229560|FG010|Overall Study|Disease progression|12|||
155216243|NCT00642941|560229561|FG011|Overall Study|Disease progression|7|||
155216244|NCT03051607|560229563|FG000|Overall Study|Adverse Event|66|||
155216245|NCT01505868|560229564|FG000|Overall Study|Withdrawal by Subject|1|||
155216246|NCT01505868|560229565|FG001|Overall Study|Withdrawal by Subject|0|||
155216247|NCT01505868|560229566|FG002|Overall Study|Withdrawal by Subject|0|||
155216248|NCT01505868|560229567|FG003|Overall Study|Withdrawal by Subject|0|||
155216249|NCT01505868|560229568|FG004|Overall Study|Withdrawal by Subject|0|||
155216250|NCT00553150|560229570|FG000|Overall Study|Withdrawal by Subject|0|||
155216251|NCT00553150|560229571|FG001|Overall Study|Withdrawal by Subject|0|||
155216252|NCT00553150|560229572|FG002|Overall Study|Withdrawal by Subject|0|||
155216253|NCT00553150|560229573|FG003|Overall Study|Withdrawal by Subject|2|||
155216254|NCT00553150|560229570|FG000|Overall Study|Protocol Violation|0|||
155216255|NCT00553150|560229571|FG001|Overall Study|Protocol Violation|0|||
155216256|NCT00553150|560229572|FG002|Overall Study|Protocol Violation|0|||
155216257|NCT00553150|560229573|FG003|Overall Study|Protocol Violation|1|||
155216258|NCT00553150|560229570|FG000|Overall Study|Ineligible|0|||
155216259|NCT00553150|560229571|FG001|Overall Study|Ineligible|0|||
155216260|NCT00553150|560229572|FG002|Overall Study|Ineligible|0|||
155216261|NCT00553150|560229573|FG003|Overall Study|Ineligible|1|||
155216262|NCT03251079|560229575|FG000|Overall Study|Withdrawal by Subject|1|||
155216263|NCT03204305|560229581|FG000|Overall Study|Lost to Follow-up|6|||
155216264|NCT03204305|560229582|FG001|Overall Study|Lost to Follow-up|4|||
155216265|NCT03204305|560229583|FG002|Overall Study|Lost to Follow-up|0|||
155216266|NCT03204305|560229584|FG003|Overall Study|Lost to Follow-up|0|||
155216267|NCT03204305|560229581|FG000|Overall Study|Physician Decision|1|||
155216268|NCT03204305|560229582|FG001|Overall Study|Physician Decision|0|||
155216269|NCT03204305|560229583|FG002|Overall Study|Physician Decision|0|||
155216270|NCT03204305|560229584|FG003|Overall Study|Physician Decision|0|||
155216271|NCT03204305|560229581|FG000|Overall Study|failure to place arterial line|2|||
155216272|NCT03204305|560229582|FG001|Overall Study|failure to place arterial line|1|||
155216273|NCT03204305|560229583|FG002|Overall Study|failure to place arterial line|0|||
155216274|NCT03204305|560229584|FG003|Overall Study|failure to place arterial line|0|||
155216275|NCT03204305|560229581|FG000|Overall Study|Withdrawal by Subject|2|||
155216276|NCT03204305|560229582|FG001|Overall Study|Withdrawal by Subject|0|||
155216277|NCT03204305|560229583|FG002|Overall Study|Withdrawal by Subject|0|||
155216278|NCT03204305|560229584|FG003|Overall Study|Withdrawal by Subject|0|||
155216279|NCT01603459|560229587|FG000|Overall Study|Adverse Event|5|||
155216280|NCT01603459|560229587|FG000|Overall Study|Withdrawal by Subject|5|||
155216281|NCT01603459|560229587|FG000|Overall Study|Lost to Follow-up|3|||
155216282|NCT01603459|560229587|FG000|Overall Study|Predefined discontinuation criteria|3|||
155216283|NCT01603459|560229587|FG000|Overall Study|Non-compliance|1|||
155216284|NCT01603459|560229587|FG000|Overall Study|Administrative reason|1|||
155216285|NCT00399360|560229589|FG000|Overall Study|Lost to Follow-up|2|||
155216286|NCT00399360|560229590|FG001|Overall Study|Lost to Follow-up|1|||
155216287|NCT00399360|560229591|FG002|Overall Study|Lost to Follow-up|2|||
155216288|NCT00399360|560229592|FG003|Overall Study|Lost to Follow-up|4|||
155216289|NCT00399360|560229589|FG000|Overall Study|Adverse Event|0|||
155216290|NCT00399360|560229590|FG001|Overall Study|Adverse Event|0|||
155216291|NCT00399360|560229591|FG002|Overall Study|Adverse Event|1|||
155216292|NCT00399360|560229592|FG003|Overall Study|Adverse Event|0|||
155216293|NCT00399360|560229589|FG000|Overall Study|Withdrawal by Subject|0|||
155216294|NCT00399360|560229590|FG001|Overall Study|Withdrawal by Subject|2|||
155216295|NCT00399360|560229591|FG002|Overall Study|Withdrawal by Subject|0|||
155216296|NCT00399360|560229592|FG003|Overall Study|Withdrawal by Subject|2|||
155216297|NCT00535223|560229593|FG000|Overall Study|Withdrawal by Subject|4|||
155216298|NCT00535223|560229594|FG001|Overall Study|Withdrawal by Subject|1|||
155216299|NCT01367158|560229598|FG000|Overall Study|Withdrew consent|0|||
155216300|NCT01367158|560229599|FG001|Overall Study|Withdrew consent|2|||
155216301|NCT01367158|560229600|FG002|Overall Study|Withdrew consent|1|||
155216302|NCT01367158|560229601|FG003|Overall Study|Withdrew consent|0|||
155216303|NCT01367158|560229602|FG004|Overall Study|Withdrew consent|2|||
155216304|NCT01367158|560229603|FG005|Overall Study|Withdrew consent|0|||
155216305|NCT01367158|560229604|FG006|Overall Study|Withdrew consent|0|||
155216306|NCT01367158|560229605|FG007|Overall Study|Withdrew consent|1|||
155216307|NCT01367158|560229606|FG008|Overall Study|Withdrew consent|0|||
155216308|NCT01367158|560229607|FG009|Overall Study|Withdrew consent|0|||
155216309|NCT01367158|560229608|FG010|Overall Study|Withdrew consent|0|||
155216310|NCT01367158|560229598|FG000|Overall Study|Lost to Follow-up|0|||
155216311|NCT01367158|560229599|FG001|Overall Study|Lost to Follow-up|0|||
155216312|NCT01367158|560229600|FG002|Overall Study|Lost to Follow-up|0|||
155216313|NCT01367158|560229601|FG003|Overall Study|Lost to Follow-up|1|||
155216314|NCT01367158|560229602|FG004|Overall Study|Lost to Follow-up|0|||
155216315|NCT01367158|560229603|FG005|Overall Study|Lost to Follow-up|2|||
155216316|NCT01367158|560229604|FG006|Overall Study|Lost to Follow-up|0|||
155216317|NCT01367158|560229605|FG007|Overall Study|Lost to Follow-up|1|||
155216318|NCT01367158|560229606|FG008|Overall Study|Lost to Follow-up|0|||
155216319|NCT01367158|560229607|FG009|Overall Study|Lost to Follow-up|0|||
155216320|NCT01367158|560229608|FG010|Overall Study|Lost to Follow-up|1|||
155216321|NCT01367158|560229598|FG000|Overall Study|Protocol Violation|0|||
155216322|NCT01367158|560229599|FG001|Overall Study|Protocol Violation|1|||
155216323|NCT01367158|560229600|FG002|Overall Study|Protocol Violation|0|||
155216324|NCT01367158|560229601|FG003|Overall Study|Protocol Violation|0|||
155216325|NCT01367158|560229602|FG004|Overall Study|Protocol Violation|0|||
155216326|NCT01367158|560229603|FG005|Overall Study|Protocol Violation|0|||
155216327|NCT01367158|560229604|FG006|Overall Study|Protocol Violation|0|||
155216328|NCT01367158|560229605|FG007|Overall Study|Protocol Violation|0|||
155216329|NCT01367158|560229606|FG008|Overall Study|Protocol Violation|0|||
155216330|NCT01367158|560229607|FG009|Overall Study|Protocol Violation|0|||
155216331|NCT01367158|560229608|FG010|Overall Study|Protocol Violation|0|||
155216332|NCT01765153|560229609|FG000|Training Phase 1|Format of intervention differed|1|||
155216333|NCT01765153|560229610|FG001|Training Phase 1|Format of intervention differed|0|||
155216334|NCT01765153|560229609|FG000|Training Phase 1|Poor participation in intervention|0|||
155216335|NCT01765153|560229610|FG001|Training Phase 1|Poor participation in intervention|1|||
155216336|NCT01765153|560229609|FG000|Rest Phase 1|Withdrawal by Subject|0|||
155216337|NCT01765153|560229610|FG001|Rest Phase 1|Withdrawal by Subject|1|||
155216338|NCT01765153|560229609|FG000|Training Phase 2|Withdrawal by Subject|0|||
155216339|NCT01765153|560229610|FG001|Training Phase 2|Withdrawal by Subject|1|||
155216340|NCT01765153|560229609|FG000|Rest Phase 2|Lost to Follow-up|2|||
155216341|NCT01765153|560229610|FG001|Rest Phase 2|Lost to Follow-up|1|||
155216342|NCT02663674|560229611|FG000|Overall Study|Lost to Follow-up|5|||
155216343|NCT02663674|560229612|FG001|Overall Study|Lost to Follow-up|4|||
155216344|NCT02663674|560229611|FG000|Overall Study|Withdrawal by Subject|1|||
155216345|NCT02663674|560229612|FG001|Overall Study|Withdrawal by Subject|4|||
155216346|NCT02663674|560229611|FG000|Overall Study|Physician Decision|1|||
155216347|NCT02663674|560229612|FG001|Overall Study|Physician Decision|1|||
155216348|NCT02663674|560229611|FG000|Overall Study|Other Event (Health Related)|0|||
155216349|NCT02663674|560229612|FG001|Overall Study|Other Event (Health Related)|1|||
155216350|NCT03712904|560230776|FG000|Overall Study|Death|0|||
155216351|NCT03712904|560230777|FG001|Overall Study|Death|1|||
155216352|NCT03712904|560230776|FG000|Overall Study|Withdrawal by Subject|0|||
155216353|NCT03712904|560230777|FG001|Overall Study|Withdrawal by Subject|1|||
155216354|NCT03712904|560230776|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
155216355|NCT03712904|560230777|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
155216356|NCT01852942|560230778|FG000|Overall Study|Physician Decision|1|||
155216357|NCT01852942|560230779|FG001|Overall Study|Physician Decision|0|||
155216358|NCT01852942|560230778|FG000|Overall Study|Death|1|||
155216359|NCT01852942|560230779|FG001|Overall Study|Death|1|||
155216360|NCT01852942|560230778|FG000|Overall Study|Withdrawal by Subject|2|||
155216361|NCT01852942|560230779|FG001|Overall Study|Withdrawal by Subject|3|||
155216362|NCT01852942|560230778|FG000|Overall Study|Lost to Follow-up|1|||
155216363|NCT01852942|560230779|FG001|Overall Study|Lost to Follow-up|2|||
155216364|NCT04708886|560230786|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
155216365|NCT04708886|560230786|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
155216366|NCT01729754|560230787|FG000|Part 1|Adverse Event|2|||
155216367|NCT01729754|560230788|FG001|Part 1|Adverse Event|0|||
155216368|NCT01729754|560230789|FG002|Part 1|Adverse Event|0|||
155216369|NCT01729754|560230790|FG003|Part 1|Adverse Event|1|||
155216370|NCT01729754|560230791|FG004|Part 1|Adverse Event|0|||
155216371|NCT01729754|560230792|FG005|Part 1|Adverse Event|0|||
155216372|NCT01729754|560230793|FG006|Part 1|Adverse Event|2|||
155216373|NCT01729754|560230794|FG007|Part 1|Adverse Event|0|||
155216374|NCT01729754|560230795|FG008|Part 1|Adverse Event|0|||
155216375|NCT01729754|560230796|FG009|Part 1|Adverse Event|5|||
155216376|NCT01729754|560230787|FG000|Part 1|Lack of Efficacy|1|||
155216377|NCT01729754|560230788|FG001|Part 1|Lack of Efficacy|0|||
155216378|NCT01729754|560230789|FG002|Part 1|Lack of Efficacy|0|||
155216379|NCT01729754|560230790|FG003|Part 1|Lack of Efficacy|0|||
155216380|NCT01729754|560230791|FG004|Part 1|Lack of Efficacy|0|||
155216381|NCT01729754|560230792|FG005|Part 1|Lack of Efficacy|0|||
155216382|NCT01729754|560230793|FG006|Part 1|Lack of Efficacy|2|||
155216383|NCT01729754|560230794|FG007|Part 1|Lack of Efficacy|0|||
155216384|NCT01729754|560230795|FG008|Part 1|Lack of Efficacy|0|||
155216385|NCT01729754|560230796|FG009|Part 1|Lack of Efficacy|0|||
155216386|NCT01729754|560230787|FG000|Part 1|Lost to Follow-up|1|||
155216387|NCT01729754|560230788|FG001|Part 1|Lost to Follow-up|0|||
155216388|NCT01729754|560230789|FG002|Part 1|Lost to Follow-up|0|||
155216389|NCT01729754|560230790|FG003|Part 1|Lost to Follow-up|2|||
155216390|NCT01729754|560230791|FG004|Part 1|Lost to Follow-up|0|||
155216391|NCT01729754|560230792|FG005|Part 1|Lost to Follow-up|0|||
155216392|NCT01729754|560230793|FG006|Part 1|Lost to Follow-up|3|||
155216393|NCT01729754|560230794|FG007|Part 1|Lost to Follow-up|0|||
155216394|NCT01729754|560230795|FG008|Part 1|Lost to Follow-up|0|||
155216395|NCT01729754|560230796|FG009|Part 1|Lost to Follow-up|3|||
155216396|NCT01729754|560230787|FG000|Part 1|Non-compliance with Study Drug|1|||
155216397|NCT01729754|560230788|FG001|Part 1|Non-compliance with Study Drug|0|||
155216398|NCT01729754|560230789|FG002|Part 1|Non-compliance with Study Drug|0|||
155216399|NCT01729754|560230790|FG003|Part 1|Non-compliance with Study Drug|0|||
155216400|NCT01729754|560230791|FG004|Part 1|Non-compliance with Study Drug|0|||
155216401|NCT01729754|560230792|FG005|Part 1|Non-compliance with Study Drug|0|||
155216402|NCT01729754|560230793|FG006|Part 1|Non-compliance with Study Drug|0|||
155216403|NCT01729754|560230794|FG007|Part 1|Non-compliance with Study Drug|0|||
155216404|NCT01729754|560230795|FG008|Part 1|Non-compliance with Study Drug|0|||
155216405|NCT01729754|560230796|FG009|Part 1|Non-compliance with Study Drug|0|||
155216406|NCT01729754|560230787|FG000|Part 1|Physician Decision|0|||
155216407|NCT01729754|560230788|FG001|Part 1|Physician Decision|0|||
155216408|NCT01729754|560230789|FG002|Part 1|Physician Decision|0|||
155216409|NCT01729754|560230790|FG003|Part 1|Physician Decision|0|||
155216410|NCT01729754|560230791|FG004|Part 1|Physician Decision|0|||
155216411|NCT01729754|560230792|FG005|Part 1|Physician Decision|0|||
155216412|NCT01729754|560230793|FG006|Part 1|Physician Decision|0|||
155216413|NCT01729754|560230794|FG007|Part 1|Physician Decision|0|||
155216414|NCT01729754|560230795|FG008|Part 1|Physician Decision|0|||
155216415|NCT01729754|560230796|FG009|Part 1|Physician Decision|4|||
155216416|NCT01729754|560230787|FG000|Part 1|Pregnancy|0|||
155216417|NCT01729754|560230788|FG001|Part 1|Pregnancy|0|||
155216418|NCT01729754|560230789|FG002|Part 1|Pregnancy|0|||
155216419|NCT01729754|560230790|FG003|Part 1|Pregnancy|1|||
155216420|NCT01729754|560230791|FG004|Part 1|Pregnancy|0|||
155216421|NCT01729754|560230792|FG005|Part 1|Pregnancy|0|||
155216422|NCT01729754|560230793|FG006|Part 1|Pregnancy|0|||
155216423|NCT01729754|560230794|FG007|Part 1|Pregnancy|0|||
155216424|NCT01729754|560230795|FG008|Part 1|Pregnancy|0|||
155216425|NCT01729754|560230796|FG009|Part 1|Pregnancy|1|||
155216426|NCT01729754|560230787|FG000|Part 1|Progressive Disease|0|||
155216427|NCT01729754|560230788|FG001|Part 1|Progressive Disease|0|||
155216428|NCT01729754|560230789|FG002|Part 1|Progressive Disease|0|||
155216429|NCT01729754|560230790|FG003|Part 1|Progressive Disease|0|||
155216430|NCT01729754|560230791|FG004|Part 1|Progressive Disease|0|||
155216431|NCT01729754|560230792|FG005|Part 1|Progressive Disease|0|||
155216432|NCT01729754|560230793|FG006|Part 1|Progressive Disease|0|||
155216433|NCT01729754|560230794|FG007|Part 1|Progressive Disease|0|||
155216434|NCT01729754|560230795|FG008|Part 1|Progressive Disease|0|||
155216435|NCT01729754|560230796|FG009|Part 1|Progressive Disease|1|||
155216436|NCT01729754|560230787|FG000|Part 1|Protocol Violation|2|||
155216437|NCT01729754|560230788|FG001|Part 1|Protocol Violation|0|||
155216438|NCT01729754|560230789|FG002|Part 1|Protocol Violation|0|||
155216439|NCT01729754|560230790|FG003|Part 1|Protocol Violation|1|||
155216440|NCT01729754|560230791|FG004|Part 1|Protocol Violation|0|||
155216441|NCT01729754|560230792|FG005|Part 1|Protocol Violation|0|||
155216442|NCT01729754|560230793|FG006|Part 1|Protocol Violation|1|||
155216443|NCT01729754|560230794|FG007|Part 1|Protocol Violation|0|||
155216444|NCT01729754|560230795|FG008|Part 1|Protocol Violation|0|||
155216445|NCT01729754|560230796|FG009|Part 1|Protocol Violation|0|||
155216446|NCT01729754|560230787|FG000|Part 1|Withdrawal by Subject|5|||
155216447|NCT01729754|560230788|FG001|Part 1|Withdrawal by Subject|0|||
155216448|NCT01729754|560230789|FG002|Part 1|Withdrawal by Subject|0|||
155216449|NCT01729754|560230790|FG003|Part 1|Withdrawal by Subject|7|||
155216450|NCT01729754|560230791|FG004|Part 1|Withdrawal by Subject|0|||
155216451|NCT01729754|560230792|FG005|Part 1|Withdrawal by Subject|0|||
155216452|NCT01729754|560230793|FG006|Part 1|Withdrawal by Subject|5|||
155216453|NCT01729754|560230794|FG007|Part 1|Withdrawal by Subject|0|||
155216454|NCT01729754|560230795|FG008|Part 1|Withdrawal by Subject|0|||
155216455|NCT01729754|560230796|FG009|Part 1|Withdrawal by Subject|6|||
155216456|NCT01729754|560230787|FG000|Part 1|Other Protocol Specified Criteria|2|||
155216457|NCT01729754|560230788|FG001|Part 1|Other Protocol Specified Criteria|0|||
155216458|NCT01729754|560230789|FG002|Part 1|Other Protocol Specified Criteria|0|||
155216459|NCT01729754|560230790|FG003|Part 1|Other Protocol Specified Criteria|0|||
155216460|NCT01729754|560230791|FG004|Part 1|Other Protocol Specified Criteria|0|||
155216461|NCT01729754|560230792|FG005|Part 1|Other Protocol Specified Criteria|0|||
155216462|NCT01729754|560230793|FG006|Part 1|Other Protocol Specified Criteria|1|||
155216463|NCT01729754|560230794|FG007|Part 1|Other Protocol Specified Criteria|0|||
155216464|NCT01729754|560230795|FG008|Part 1|Other Protocol Specified Criteria|0|||
155216465|NCT01729754|560230796|FG009|Part 1|Other Protocol Specified Criteria|4|||
155216466|NCT01729754|560230787|FG000|Part 2|Adverse Event|2|||
155216467|NCT01729754|560230788|FG001|Part 2|Adverse Event|0|||
155216468|NCT01729754|560230789|FG002|Part 2|Adverse Event|0|||
155216469|NCT01729754|560230790|FG003|Part 2|Adverse Event|0|||
155216470|NCT01729754|560230791|FG004|Part 2|Adverse Event|0|||
155216471|NCT01729754|560230792|FG005|Part 2|Adverse Event|0|||
155216472|NCT01729754|560230793|FG006|Part 2|Adverse Event|0|||
155216473|NCT01729754|560230794|FG007|Part 2|Adverse Event|0|||
155216474|NCT01729754|560230795|FG008|Part 2|Adverse Event|1|||
155216475|NCT01729754|560230796|FG009|Part 2|Adverse Event|2|||
155216476|NCT01729754|560230787|FG000|Part 2|Lack of Efficacy|0|||
155216477|NCT01729754|560230788|FG001|Part 2|Lack of Efficacy|0|||
155216478|NCT01729754|560230789|FG002|Part 2|Lack of Efficacy|0|||
155216479|NCT01729754|560230790|FG003|Part 2|Lack of Efficacy|0|||
155216480|NCT01729754|560230791|FG004|Part 2|Lack of Efficacy|0|||
155216481|NCT01729754|560230792|FG005|Part 2|Lack of Efficacy|0|||
155216482|NCT01729754|560230793|FG006|Part 2|Lack of Efficacy|0|||
155216483|NCT01729754|560230794|FG007|Part 2|Lack of Efficacy|0|||
155216484|NCT01729754|560230795|FG008|Part 2|Lack of Efficacy|2|||
155216485|NCT01729754|560230796|FG009|Part 2|Lack of Efficacy|2|||
155216486|NCT01729754|560230787|FG000|Part 2|Lost to Follow-up|0|||
155216487|NCT01729754|560230788|FG001|Part 2|Lost to Follow-up|0|||
155216488|NCT01729754|560230789|FG002|Part 2|Lost to Follow-up|0|||
155216489|NCT01729754|560230790|FG003|Part 2|Lost to Follow-up|2|||
155216490|NCT01729754|560230791|FG004|Part 2|Lost to Follow-up|0|||
155216491|NCT01729754|560230792|FG005|Part 2|Lost to Follow-up|0|||
155216492|NCT01729754|560230793|FG006|Part 2|Lost to Follow-up|0|||
155216493|NCT01729754|560230794|FG007|Part 2|Lost to Follow-up|1|||
155216494|NCT01729754|560230795|FG008|Part 2|Lost to Follow-up|0|||
155216495|NCT01729754|560230796|FG009|Part 2|Lost to Follow-up|2|||
155216496|NCT01729754|560230787|FG000|Part 2|Non-Compliance with Study Drug|0|||
155216497|NCT01729754|560230788|FG001|Part 2|Non-Compliance with Study Drug|0|||
155216498|NCT01729754|560230789|FG002|Part 2|Non-Compliance with Study Drug|0|||
155216499|NCT01729754|560230790|FG003|Part 2|Non-Compliance with Study Drug|0|||
155216500|NCT01729754|560230791|FG004|Part 2|Non-Compliance with Study Drug|0|||
155216501|NCT01729754|560230792|FG005|Part 2|Non-Compliance with Study Drug|0|||
155216502|NCT01729754|560230793|FG006|Part 2|Non-Compliance with Study Drug|0|||
155216503|NCT01729754|560230794|FG007|Part 2|Non-Compliance with Study Drug|0|||
155216504|NCT01729754|560230795|FG008|Part 2|Non-Compliance with Study Drug|0|||
155216505|NCT01729754|560230796|FG009|Part 2|Non-Compliance with Study Drug|1|||
155216506|NCT01729754|560230787|FG000|Part 2|Pregnancy|0|||
155216507|NCT01729754|560230788|FG001|Part 2|Pregnancy|0|||
155216508|NCT01729754|560230789|FG002|Part 2|Pregnancy|0|||
155216509|NCT01729754|560230790|FG003|Part 2|Pregnancy|1|||
155216510|NCT01729754|560230791|FG004|Part 2|Pregnancy|0|||
155216511|NCT01729754|560230792|FG005|Part 2|Pregnancy|0|||
155216512|NCT01729754|560230793|FG006|Part 2|Pregnancy|0|||
155216513|NCT01729754|560230794|FG007|Part 2|Pregnancy|0|||
155216514|NCT01729754|560230795|FG008|Part 2|Pregnancy|0|||
155216515|NCT01729754|560230796|FG009|Part 2|Pregnancy|1|||
155216516|NCT01729754|560230787|FG000|Part 2|Withdrawal by Subject|3|||
155216517|NCT01729754|560230788|FG001|Part 2|Withdrawal by Subject|0|||
155216518|NCT01729754|560230789|FG002|Part 2|Withdrawal by Subject|0|||
155216519|NCT01729754|560230790|FG003|Part 2|Withdrawal by Subject|2|||
155216520|NCT01729754|560230791|FG004|Part 2|Withdrawal by Subject|0|||
155216521|NCT01729754|560230792|FG005|Part 2|Withdrawal by Subject|0|||
155216522|NCT01729754|560230793|FG006|Part 2|Withdrawal by Subject|0|||
155216523|NCT01729754|560230794|FG007|Part 2|Withdrawal by Subject|1|||
155216524|NCT01729754|560230795|FG008|Part 2|Withdrawal by Subject|1|||
155216525|NCT01729754|560230796|FG009|Part 2|Withdrawal by Subject|4|||
155216526|NCT01729754|560230787|FG000|Part 2|Other Protocol Specified Criteria|1|||
155216527|NCT01729754|560230788|FG001|Part 2|Other Protocol Specified Criteria|0|||
155216528|NCT01729754|560230789|FG002|Part 2|Other Protocol Specified Criteria|0|||
155216529|NCT01729754|560230790|FG003|Part 2|Other Protocol Specified Criteria|0|||
155216530|NCT01729754|560230791|FG004|Part 2|Other Protocol Specified Criteria|0|||
155216531|NCT01729754|560230792|FG005|Part 2|Other Protocol Specified Criteria|0|||
155216532|NCT01729754|560230793|FG006|Part 2|Other Protocol Specified Criteria|0|||
155216533|NCT01729754|560230794|FG007|Part 2|Other Protocol Specified Criteria|1|||
155216534|NCT01729754|560230795|FG008|Part 2|Other Protocol Specified Criteria|0|||
155216535|NCT01729754|560230796|FG009|Part 2|Other Protocol Specified Criteria|0|||
155216536|NCT01729754|560230787|FG000|Part 3|Adverse Event|0|||
155216537|NCT01729754|560230788|FG001|Part 3|Adverse Event|0|||
155216538|NCT01729754|560230789|FG002|Part 3|Adverse Event|1|||
155216539|NCT01729754|560230790|FG003|Part 3|Adverse Event|0|||
155216540|NCT01729754|560230791|FG004|Part 3|Adverse Event|0|||
155216541|NCT01729754|560230792|FG005|Part 3|Adverse Event|5|||
155216542|NCT01729754|560230793|FG006|Part 3|Adverse Event|0|||
155216543|NCT01729754|560230794|FG007|Part 3|Adverse Event|0|||
155216544|NCT01729754|560230795|FG008|Part 3|Adverse Event|0|||
155216545|NCT01729754|560230796|FG009|Part 3|Adverse Event|3|||
155216546|NCT01729754|560230787|FG000|Part 3|Death|0|||
155216547|NCT01729754|560230788|FG001|Part 3|Death|0|||
155216548|NCT01729754|560230789|FG002|Part 3|Death|0|||
155216549|NCT01729754|560230790|FG003|Part 3|Death|0|||
155216550|NCT01729754|560230791|FG004|Part 3|Death|0|||
155216551|NCT01729754|560230792|FG005|Part 3|Death|2|||
155216552|NCT01729754|560230793|FG006|Part 3|Death|0|||
155216553|NCT01729754|560230794|FG007|Part 3|Death|0|||
155216554|NCT01729754|560230795|FG008|Part 3|Death|0|||
155216555|NCT01729754|560230796|FG009|Part 3|Death|0|||
155216556|NCT01729754|560230787|FG000|Part 3|Lack of Efficacy|0|||
155216557|NCT01729754|560230788|FG001|Part 3|Lack of Efficacy|0|||
155216558|NCT01729754|560230789|FG002|Part 3|Lack of Efficacy|0|||
155216559|NCT01729754|560230790|FG003|Part 3|Lack of Efficacy|0|||
155216560|NCT01729754|560230791|FG004|Part 3|Lack of Efficacy|2|||
155216561|NCT01729754|560230792|FG005|Part 3|Lack of Efficacy|0|||
155216562|NCT01729754|560230793|FG006|Part 3|Lack of Efficacy|0|||
155216563|NCT01729754|560230794|FG007|Part 3|Lack of Efficacy|0|||
155216564|NCT01729754|560230795|FG008|Part 3|Lack of Efficacy|0|||
155216565|NCT01729754|560230796|FG009|Part 3|Lack of Efficacy|4|||
155216566|NCT01729754|560230787|FG000|Part 3|Lost to Follow-up|0|||
155216567|NCT01729754|560230788|FG001|Part 3|Lost to Follow-up|1|||
155216568|NCT01729754|560230789|FG002|Part 3|Lost to Follow-up|2|||
155216569|NCT01729754|560230790|FG003|Part 3|Lost to Follow-up|0|||
155216570|NCT01729754|560230791|FG004|Part 3|Lost to Follow-up|0|||
155216571|NCT01729754|560230792|FG005|Part 3|Lost to Follow-up|3|||
155216572|NCT01729754|560230793|FG006|Part 3|Lost to Follow-up|0|||
155216573|NCT01729754|560230794|FG007|Part 3|Lost to Follow-up|0|||
155216574|NCT01729754|560230795|FG008|Part 3|Lost to Follow-up|1|||
155216575|NCT01729754|560230796|FG009|Part 3|Lost to Follow-up|0|||
155216576|NCT01729754|560230787|FG000|Part 3|Physician Decision|0|||
155216577|NCT01729754|560230788|FG001|Part 3|Physician Decision|0|||
155216578|NCT01729754|560230789|FG002|Part 3|Physician Decision|1|||
155216579|NCT01729754|560230790|FG003|Part 3|Physician Decision|0|||
155216580|NCT01729754|560230791|FG004|Part 3|Physician Decision|0|||
155216581|NCT01729754|560230792|FG005|Part 3|Physician Decision|0|||
155216582|NCT01729754|560230793|FG006|Part 3|Physician Decision|0|||
155216583|NCT01729754|560230794|FG007|Part 3|Physician Decision|0|||
155216584|NCT01729754|560230795|FG008|Part 3|Physician Decision|0|||
155216585|NCT01729754|560230796|FG009|Part 3|Physician Decision|0|||
155216586|NCT01729754|560230787|FG000|Part 3|Withdrawal by Subject|0|||
155216587|NCT01729754|560230788|FG001|Part 3|Withdrawal by Subject|4|||
155216588|NCT01729754|560230789|FG002|Part 3|Withdrawal by Subject|1|||
155216589|NCT01729754|560230790|FG003|Part 3|Withdrawal by Subject|0|||
155216590|NCT01729754|560230791|FG004|Part 3|Withdrawal by Subject|2|||
155216591|NCT01729754|560230792|FG005|Part 3|Withdrawal by Subject|1|||
155216592|NCT01729754|560230793|FG006|Part 3|Withdrawal by Subject|0|||
155216593|NCT01729754|560230794|FG007|Part 3|Withdrawal by Subject|2|||
155216594|NCT01729754|560230795|FG008|Part 3|Withdrawal by Subject|0|||
155216595|NCT01729754|560230796|FG009|Part 3|Withdrawal by Subject|0|||
155216596|NCT01729754|560230787|FG000|Part 3|Other Protocol Specified Criteria|0|||
155216597|NCT01729754|560230788|FG001|Part 3|Other Protocol Specified Criteria|0|||
155216598|NCT01729754|560230789|FG002|Part 3|Other Protocol Specified Criteria|0|||
155216599|NCT01729754|560230790|FG003|Part 3|Other Protocol Specified Criteria|0|||
155216600|NCT01729754|560230791|FG004|Part 3|Other Protocol Specified Criteria|0|||
155216601|NCT01729754|560230792|FG005|Part 3|Other Protocol Specified Criteria|2|||
155216602|NCT01729754|560230793|FG006|Part 3|Other Protocol Specified Criteria|0|||
155216603|NCT01729754|560230794|FG007|Part 3|Other Protocol Specified Criteria|1|||
155216604|NCT01729754|560230795|FG008|Part 3|Other Protocol Specified Criteria|0|||
155216605|NCT01729754|560230796|FG009|Part 3|Other Protocol Specified Criteria|0|||
155216606|NCT02489344|560230804|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
155216607|NCT02489344|560230804|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
155216608|NCT02489344|560230804|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
155216609|NCT02489344|560230804|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
155216610|NCT01132482|560230805|FG000|Overall Study|Adverse Event|1|||
155216611|NCT01132482|560230806|FG001|Overall Study|Adverse Event|0|||
155216612|NCT05333900|560230807|FG000|Overall Study|Protocol Violation|0|||
155216613|NCT05333900|560230808|FG001|Overall Study|Protocol Violation|1|||
155216614|NCT05333900|560230807|FG000|Overall Study|Withdrawal by Subject|0|||
155216615|NCT05333900|560230808|FG001|Overall Study|Withdrawal by Subject|1|||
155216616|NCT05333900|560230807|FG000|Overall Study|COVID-19 Pandemic|1|||
155216617|NCT05333900|560230808|FG001|Overall Study|COVID-19 Pandemic|1|||
155216618|NCT02024867|560230809|FG000|Overall Study|Protocol Violation|3|||
155216619|NCT02024867|560230810|FG001|Overall Study|Protocol Violation|3|||
155216620|NCT02024867|560230809|FG000|Overall Study|Lost to Follow-up|6|||
155216621|NCT02024867|560230810|FG001|Overall Study|Lost to Follow-up|4|||
155216622|NCT02150954|560230811|FG000|Overall Study|Protocol Violation|1|||
155216623|NCT02150954|560230812|FG001|Overall Study|Protocol Violation|0|||
155216624|NCT01086540|560230815|FG000|Overall Study|Death|3|||
155216625|NCT01086540|560230816|FG001|Overall Study|Death|1|||
155216626|NCT01086540|560230815|FG000|Overall Study|Physician Decision|2|||
155216627|NCT01086540|560230816|FG001|Overall Study|Physician Decision|1|||
155216628|NCT01086540|560230815|FG000|Overall Study|Addition of new therapy for PAH|1|||
155216629|NCT01086540|560230816|FG001|Overall Study|Addition of new therapy for PAH|0|||
155216630|NCT00227305|560230818|FG000|Overall Study|Adverse Event|40|||
155216631|NCT00227305|560230818|FG000|Overall Study|Withdrawal by Subject|42|||
155216632|NCT00227305|560230818|FG000|Overall Study|Lost to Follow-up|33|||
155216633|NCT00227305|560230818|FG000|Overall Study|Study specific discontinuation|13|||
155216634|NCT00227305|560230818|FG000|Overall Study|MOVED OUT OF AREA|3|||
155216635|NCT00227305|560230818|FG000|Overall Study|Lack of Efficacy|7|||
155216636|NCT00227305|560230818|FG000|Overall Study|Physician Decision|3|||
155216637|NCT00227305|560230818|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
155216638|NCT00227305|560230818|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
155216639|NCT00227305|560230818|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
155216640|NCT02707991|560230820|FG000|Overall Study|Protocol Violation|1|||
155216641|NCT02707991|560230821|FG001|Overall Study|Protocol Violation|0|||
155216642|NCT02707991|560230820|FG000|Overall Study|Became ineligible|0|||
155216643|NCT02707991|560230821|FG001|Overall Study|Became ineligible|1|||
155216644|NCT02580357|560230827|FG000|Overall Study|Lost to Follow-up|2|||
155216645|NCT02580357|560230828|FG001|Overall Study|Lost to Follow-up|0|||
155216646|NCT02580357|560230829|FG002|Overall Study|Lost to Follow-up|0|||
155216647|NCT02580357|560230827|FG000|Overall Study|Protocol Violation|1|||
155216648|NCT02580357|560230828|FG001|Overall Study|Protocol Violation|0|||
155216649|NCT02580357|560230829|FG002|Overall Study|Protocol Violation|0|||
155216650|NCT00619801|560230835|FG000|Overall Study|Lack of Efficacy|0|||
155216651|NCT00619801|560230836|FG001|Overall Study|Lack of Efficacy|1|||
155216652|NCT00619801|560230835|FG000|Overall Study|Withdrawal by Subject|1|||
155216653|NCT00619801|560230836|FG001|Overall Study|Withdrawal by Subject|1|||
155216654|NCT00619801|560230835|FG000|Overall Study|Loss of efficacy|0|||
155216655|NCT00619801|560230836|FG001|Overall Study|Loss of efficacy|1|||
155216656|NCT00450333|560230837|FG000|Overall Study|Study terminated|47|||
155216657|NCT00450333|560230838|FG001|Overall Study|Study terminated|54|||
155216658|NCT00450333|560230839|FG002|Overall Study|Study terminated|16|||
155216659|NCT00450333|560230840|FG003|Overall Study|Study terminated|21|||
155216660|NCT00450333|560230837|FG000|Overall Study|Adverse Event|1|||
155216661|NCT00450333|560230838|FG001|Overall Study|Adverse Event|7|||
155216662|NCT00450333|560230839|FG002|Overall Study|Adverse Event|2|||
155216663|NCT00450333|560230840|FG003|Overall Study|Adverse Event|2|||
155216664|NCT00450333|560230837|FG000|Overall Study|Protocol Violation|1|||
155216665|NCT00450333|560230838|FG001|Overall Study|Protocol Violation|0|||
155216666|NCT00450333|560230839|FG002|Overall Study|Protocol Violation|1|||
155216667|NCT00450333|560230840|FG003|Overall Study|Protocol Violation|0|||
155216668|NCT00450333|560230837|FG000|Overall Study|Withdrawal by Subject|1|||
155216669|NCT00450333|560230838|FG001|Overall Study|Withdrawal by Subject|0|||
155216670|NCT00450333|560230839|FG002|Overall Study|Withdrawal by Subject|3|||
155216671|NCT00450333|560230840|FG003|Overall Study|Withdrawal by Subject|0|||
155216672|NCT00450333|560230837|FG000|Overall Study|Kidney transplant|1|||
155216673|NCT00450333|560230838|FG001|Overall Study|Kidney transplant|0|||
155216674|NCT00450333|560230839|FG002|Overall Study|Kidney transplant|1|||
155216675|NCT00450333|560230840|FG003|Overall Study|Kidney transplant|3|||
155216676|NCT00450333|560230837|FG000|Overall Study|Death|3|||
155216677|NCT00450333|560230838|FG001|Overall Study|Death|2|||
155216678|NCT00450333|560230839|FG002|Overall Study|Death|2|||
155216679|NCT00450333|560230840|FG003|Overall Study|Death|2|||
155216680|NCT01214629|560230849|FG000|Overall Study|Progressive Disease|1|||
155216681|NCT01214629|560230850|FG001|Overall Study|Progressive Disease|1|||
155216682|NCT01214629|560230851|FG002|Overall Study|Progressive Disease|0|||
155216683|NCT01214629|560230852|FG003|Overall Study|Progressive Disease|1|||
155216684|NCT01214629|560230853|FG004|Overall Study|Progressive Disease|2|||
155216685|NCT01214629|560230854|FG005|Overall Study|Progressive Disease|3|||
155216686|NCT01214629|560230855|FG006|Overall Study|Progressive Disease|1|||
155216687|NCT01214629|560230856|FG007|Overall Study|Progressive Disease|1|||
155216688|NCT01214629|560230857|FG008|Overall Study|Progressive Disease|1|||
155216689|NCT01214629|560230858|FG009|Overall Study|Progressive Disease|5|||
155216690|NCT01214629|560230859|FG010|Overall Study|Progressive Disease|1|||
155216691|NCT01214629|560230849|FG000|Overall Study|Adverse Event|0|||
155216692|NCT01214629|560230850|FG001|Overall Study|Adverse Event|0|||
155216693|NCT01214629|560230851|FG002|Overall Study|Adverse Event|0|||
155216694|NCT01214629|560230852|FG003|Overall Study|Adverse Event|1|||
155216695|NCT01214629|560230853|FG004|Overall Study|Adverse Event|0|||
155216696|NCT01214629|560230854|FG005|Overall Study|Adverse Event|1|||
155216697|NCT01214629|560230855|FG006|Overall Study|Adverse Event|0|||
155216698|NCT01214629|560230856|FG007|Overall Study|Adverse Event|0|||
155216699|NCT01214629|560230857|FG008|Overall Study|Adverse Event|0|||
155216700|NCT01214629|560230858|FG009|Overall Study|Adverse Event|1|||
155216701|NCT01214629|560230859|FG010|Overall Study|Adverse Event|0|||
155216702|NCT01214629|560230849|FG000|Overall Study|Physician Decision|0|||
155216703|NCT01214629|560230850|FG001|Overall Study|Physician Decision|0|||
155216704|NCT01214629|560230851|FG002|Overall Study|Physician Decision|0|||
155216705|NCT01214629|560230852|FG003|Overall Study|Physician Decision|0|||
155216706|NCT01214629|560230853|FG004|Overall Study|Physician Decision|0|||
155216707|NCT01214629|560230854|FG005|Overall Study|Physician Decision|0|||
155216708|NCT01214629|560230855|FG006|Overall Study|Physician Decision|0|||
155216709|NCT01214629|560230856|FG007|Overall Study|Physician Decision|0|||
155216710|NCT01214629|560230857|FG008|Overall Study|Physician Decision|0|||
155216711|NCT01214629|560230858|FG009|Overall Study|Physician Decision|0|||
155216712|NCT01214629|560230859|FG010|Overall Study|Physician Decision|1|||
155216713|NCT01214629|560230849|FG000|Overall Study|Withdrawal by Subject|0|||
155216714|NCT01214629|560230850|FG001|Overall Study|Withdrawal by Subject|0|||
155216715|NCT01214629|560230851|FG002|Overall Study|Withdrawal by Subject|0|||
155216716|NCT01214629|560230852|FG003|Overall Study|Withdrawal by Subject|0|||
155216717|NCT01214629|560230853|FG004|Overall Study|Withdrawal by Subject|0|||
155216718|NCT01214629|560230854|FG005|Overall Study|Withdrawal by Subject|0|||
155216719|NCT01214629|560230855|FG006|Overall Study|Withdrawal by Subject|0|||
155216720|NCT01214629|560230856|FG007|Overall Study|Withdrawal by Subject|0|||
155216721|NCT01214629|560230857|FG008|Overall Study|Withdrawal by Subject|0|||
155216722|NCT01214629|560230858|FG009|Overall Study|Withdrawal by Subject|1|||
155216723|NCT01214629|560230859|FG010|Overall Study|Withdrawal by Subject|0|||
155216724|NCT00877383|560230862|FG000|Overall Study|Adverse Event|13|||
155216725|NCT00877383|560230863|FG001|Overall Study|Adverse Event|14|||
155216726|NCT00877383|560230862|FG000|Overall Study|Lost to Follow-up|5|||
155216727|NCT00877383|560230863|FG001|Overall Study|Lost to Follow-up|3|||
155216728|NCT00877383|560230862|FG000|Overall Study|Subject withdrew consent|3|||
155216729|NCT00877383|560230863|FG001|Overall Study|Subject withdrew consent|12|||
155216730|NCT00877383|560230862|FG000|Overall Study|Subject no longer requires study drug|2|||
155216731|NCT00877383|560230863|FG001|Overall Study|Subject no longer requires study drug|0|||
155216732|NCT00877383|560230862|FG000|Overall Study|Administrative problems|2|||
155216733|NCT00877383|560230863|FG001|Overall Study|Administrative problems|0|||
155216734|NCT00877383|560230862|FG000|Overall Study|Protocol deviation|2|||
155216735|NCT00877383|560230863|FG001|Overall Study|Protocol deviation|6|||
155216736|NCT00877383|560230862|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
155216737|NCT00877383|560230863|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155216738|NCT00877383|560230862|FG000|Overall Study|Death|1|||
155216739|NCT00877383|560230863|FG001|Overall Study|Death|2|||
155216740|NCT00459108|560230864|FG000|Overall Study|Withdrawal by Subject|5|||
155216741|NCT00459108|560230864|FG000|Overall Study|Adverse Event|3|||
155216742|NCT00459108|560230864|FG000|Overall Study|Death|2|||
155216743|NCT00459108|560230864|FG000|Overall Study|Progression|1|||
155216744|NCT01829230|560230870|FG000|Overall Study|Protocol Violation|0|||
155216745|NCT01829230|560230871|FG001|Overall Study|Protocol Violation|2|||
155216746|NCT01829230|560230870|FG000|Overall Study|Withdrawal by Subject|0|||
155216747|NCT01829230|560230871|FG001|Overall Study|Withdrawal by Subject|1|||
155216748|NCT01829230|560230870|FG000|Overall Study|Lost to Follow-up|1|||
155216749|NCT01829230|560230871|FG001|Overall Study|Lost to Follow-up|1|||
155216750|NCT03855280|560230875|FG000|Treatment Phase|Adverse Event|1|||
155216751|NCT03855280|560230875|FG000|Treatment Phase|Withdrawal by Subject|1|||
155216752|NCT03855280|560230875|FG000|Continuation Phase|Protocol Violation|1|||
155216753|NCT03855280|560230875|FG000|Continuation Phase|Adverse Event|1|||
155216754|NCT03855280|560230875|FG000|Continuation Phase|Sponsor Concluded Study|1|||
155216755|NCT04568590|560232877|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
155216756|NCT01190254|560232879|FG000|Overall Study|Adverse Event|3|||
155216757|NCT01190254|560232880|FG001|Overall Study|Adverse Event|6|||
155216758|NCT01190254|560232881|FG002|Overall Study|Adverse Event|8|||
155216759|NCT01190254|560232879|FG000|Overall Study|Lack of Efficacy|7|||
155216760|NCT01190254|560232880|FG001|Overall Study|Lack of Efficacy|4|||
155216761|NCT01190254|560232881|FG002|Overall Study|Lack of Efficacy|5|||
155216762|NCT01190254|560232879|FG000|Overall Study|Lost to Follow-up|4|||
155216763|NCT01190254|560232880|FG001|Overall Study|Lost to Follow-up|2|||
155216764|NCT01190254|560232881|FG002|Overall Study|Lost to Follow-up|0|||
155216765|NCT01190254|560232879|FG000|Overall Study|Withdrawal by Subject|4|||
155216766|NCT01190254|560232880|FG001|Overall Study|Withdrawal by Subject|5|||
155216767|NCT01190254|560232881|FG002|Overall Study|Withdrawal by Subject|7|||
155216768|NCT01190254|560232879|FG000|Overall Study|Protocol Violation|2|||
155216769|NCT01190254|560232880|FG001|Overall Study|Protocol Violation|0|||
155216770|NCT01190254|560232881|FG002|Overall Study|Protocol Violation|2|||
155216771|NCT01190254|560232879|FG000|Overall Study|Did not meet protocol eligibility|1|||
155216772|NCT01190254|560232880|FG001|Overall Study|Did not meet protocol eligibility|0|||
155216773|NCT01190254|560232881|FG002|Overall Study|Did not meet protocol eligibility|0|||
155216774|NCT00773292|560232882|FG000|Treatment 48 Weeks|Adverse Event|1|||
155216775|NCT00773292|560232882|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
155216776|NCT04105998|560232883|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
155216777|NCT04105998|560232884|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
155216778|NCT02604212|560232885|FG000|Overall Study|Study Terminated by Sponsor|2|||
155216779|NCT02604212|560232886|FG001|Overall Study|Study Terminated by Sponsor|1|||
155216780|NCT02604212|560232887|FG002|Overall Study|Study Terminated by Sponsor|3|||
155216781|NCT02604212|560232888|FG003|Overall Study|Study Terminated by Sponsor|3|||
155216782|NCT02604212|560232885|FG000|Overall Study|Withdrawal by Subject|0|||
155216783|NCT02604212|560232886|FG001|Overall Study|Withdrawal by Subject|0|||
155216784|NCT02604212|560232887|FG002|Overall Study|Withdrawal by Subject|1|||
155216785|NCT02604212|560232888|FG003|Overall Study|Withdrawal by Subject|0|||
155216786|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216787|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
155216788|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216789|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216790|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216791|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216792|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
155216793|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
155216794|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
155216795|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
155216796|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
155216797|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
155216798|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
155216799|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
155216800|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
155216801|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
155216802|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
155216803|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
155216804|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
155216805|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
155216806|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
155216807|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216808|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
155216809|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216810|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216811|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216812|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
155216813|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
155216814|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
155216815|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
155216816|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
155216817|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
155216818|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
155216819|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
155216820|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
155216821|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216822|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216823|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216824|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216825|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216826|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
155216827|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
155216828|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
155216829|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
155216830|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
155216831|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
155216832|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
155216833|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
155216834|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
155216835|NCT03742037|560232891|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216836|NCT03742037|560232892|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216837|NCT03742037|560232893|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216838|NCT03742037|560232894|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216839|NCT03742037|560232895|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216840|NCT03742037|560232896|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
155216841|NCT03742037|560232897|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
155216842|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
155216843|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
155216844|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
155216845|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
155216846|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
155216847|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
155216848|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
155216849|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216850|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216851|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
155216852|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
155216853|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216854|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
155216855|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
155216856|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216857|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
155216858|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
155216859|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216860|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216861|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216862|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
155216863|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
155216864|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216865|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216866|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216867|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216868|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
155216869|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
155216870|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
155216871|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
155216872|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
155216873|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
155216874|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
155216875|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
155216876|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
155216877|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
155216878|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216879|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
155216880|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216881|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216882|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
155216883|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
155216884|NCT03742037|560232891|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216885|NCT03742037|560232892|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216886|NCT03742037|560232893|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
155216887|NCT03742037|560232894|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216888|NCT03742037|560232895|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216889|NCT03742037|560232896|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216890|NCT03742037|560232897|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
155216891|NCT04447755|560232898|FG000|Overall Study|Death|9|||
155216892|NCT04447755|560232899|FG001|Overall Study|Death|16|||
155216893|NCT04447755|560232900|FG002|Overall Study|Death|8|||
155216894|NCT04447755|560232901|FG003|Overall Study|Death|9|||
155216895|NCT04447755|560232902|FG004|Overall Study|Death|8|||
155216896|NCT04447755|560232903|FG005|Overall Study|Death|9|||
155216897|NCT04447755|560232904|FG006|Overall Study|Death|55|||
155216898|NCT04447755|560232898|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155216899|NCT04447755|560232899|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155216900|NCT04447755|560232900|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
155216901|NCT04447755|560232901|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
155216902|NCT04447755|560232902|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
155216903|NCT04447755|560232903|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
155216904|NCT04447755|560232904|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
155216905|NCT04447755|560232898|FG000|Overall Study|Sponsor Decision|0|||
155216906|NCT04447755|560232899|FG001|Overall Study|Sponsor Decision|0|||
155216907|NCT04447755|560232900|FG002|Overall Study|Sponsor Decision|0|||
155216908|NCT04447755|560232901|FG003|Overall Study|Sponsor Decision|0|||
155216909|NCT04447755|560232902|FG004|Overall Study|Sponsor Decision|1|||
155216910|NCT04447755|560232903|FG005|Overall Study|Sponsor Decision|0|||
155216911|NCT04447755|560232904|FG006|Overall Study|Sponsor Decision|10|||
155216912|NCT04447755|560232898|FG000|Overall Study|Lost to Follow-up|0|||
155216913|NCT04447755|560232899|FG001|Overall Study|Lost to Follow-up|0|||
155216914|NCT04447755|560232900|FG002|Overall Study|Lost to Follow-up|0|||
155216915|NCT04447755|560232901|FG003|Overall Study|Lost to Follow-up|0|||
155216916|NCT04447755|560232902|FG004|Overall Study|Lost to Follow-up|0|||
155216917|NCT04447755|560232903|FG005|Overall Study|Lost to Follow-up|0|||
155216918|NCT04447755|560232904|FG006|Overall Study|Lost to Follow-up|1|||
155216919|NCT00071760|560232905|FG000|Overall Study|Adverse Event|2|||
155216920|NCT00071760|560232906|FG001|Overall Study|Adverse Event|1|||
155216921|NCT00071760|560232905|FG000|Overall Study|Lost to Follow-up|0|||
155216922|NCT00071760|560232906|FG001|Overall Study|Lost to Follow-up|3|||
155216923|NCT00071760|560232905|FG000|Overall Study|Protocol Violation|1|||
155216924|NCT00071760|560232906|FG001|Overall Study|Protocol Violation|0|||
155216925|NCT00071760|560232905|FG000|Overall Study|Withdrawal by Subject|0|||
155216926|NCT00071760|560232906|FG001|Overall Study|Withdrawal by Subject|1|||
155216927|NCT00071760|560232905|FG000|Overall Study|Insufficient Viral Load Response|1|||
155216928|NCT00071760|560232906|FG001|Overall Study|Insufficient Viral Load Response|1|||
155216929|NCT00071760|560232905|FG000|Overall Study|Lack of availability of RTV|1|||
155216930|NCT00071760|560232906|FG001|Overall Study|Lack of availability of RTV|0|||
155216931|NCT00071760|560232905|FG000|Overall Study|Physician Decision|2|||
155216932|NCT00071760|560232906|FG001|Overall Study|Physician Decision|1|||
155216933|NCT00071760|560232905|FG000|Overall Study|Relocation|0|||
155216934|NCT00071760|560232906|FG001|Overall Study|Relocation|1|||
155216935|NCT02073279|560232907|FG000|Double-blind Period|Adverse Event|1|||
155216936|NCT02073279|560232908|FG001|Double-blind Period|Adverse Event|1|||
155216937|NCT02073279|560232907|FG000|Double-blind Period|Switched to another treatment|1|||
155216938|NCT02073279|560232908|FG001|Double-blind Period|Switched to another treatment|2|||
155216939|NCT02073279|560232907|FG000|Double-blind Period|Protocol Violation|0|||
155216940|NCT02073279|560232908|FG001|Double-blind Period|Protocol Violation|1|||
155216941|NCT02073279|560232907|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
155216942|NCT02073279|560232908|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
155216943|NCT02073279|560232907|FG000|Double-blind Period|Withdrawal by Subject|2|||
155216944|NCT02073279|560232908|FG001|Double-blind Period|Withdrawal by Subject|2|||
155216945|NCT02073279|560232907|FG000|Open-label Extension Period|Adverse Event|1|||
155216946|NCT02073279|560232908|FG001|Open-label Extension Period|Adverse Event|0|||
155216947|NCT02073279|560232907|FG000|Open-label Extension Period|Lack of Efficacy|1|||
155216948|NCT02073279|560232908|FG001|Open-label Extension Period|Lack of Efficacy|0|||
155216949|NCT02073279|560232907|FG000|Open-label Extension Period|Lost to Follow-up|0|||
155216950|NCT02073279|560232908|FG001|Open-label Extension Period|Lost to Follow-up|4|||
155216951|NCT02073279|560232907|FG000|Open-label Extension Period|Switched to another treatment|1|||
155216952|NCT02073279|560232908|FG001|Open-label Extension Period|Switched to another treatment|4|||
155216953|NCT02073279|560232907|FG000|Open-label Extension Period|Protocol Violation|0|||
155216954|NCT02073279|560232908|FG001|Open-label Extension Period|Protocol Violation|1|||
155216955|NCT02073279|560232907|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
155216956|NCT02073279|560232908|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
155216957|NCT02073279|560232907|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
155216958|NCT02073279|560232908|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
155216959|NCT01994629|560232909|FG000|Overall Study|Withdrawal by Subject|1|||
155216960|NCT01994629|560232910|FG001|Overall Study|Withdrawal by Subject|0|||
155216961|NCT01994629|560232909|FG000|Overall Study|Lost to Follow-up|0|||
155216962|NCT01994629|560232910|FG001|Overall Study|Lost to Follow-up|3|||
155216963|NCT03338062|560232913|FG000|Overall Study|Alternative Therapy|1|||
155216964|NCT03338062|560232914|FG001|Overall Study|Alternative Therapy|0|||
155216965|NCT03424265|560232926|FG000|Overall Study|screening failure|1|||
155216966|NCT03424265|560232927|FG001|Overall Study|screening failure|0|||
155216967|NCT03424265|560232926|FG000|Overall Study|Withdrawal by Subject|0|||
155216968|NCT03424265|560232927|FG001|Overall Study|Withdrawal by Subject|2|||
155216969|NCT00453544|560232931|FG000|Overall Study|Withdrawal by Subject|1|||
155216970|NCT00453544|560232932|FG001|Overall Study|Withdrawal by Subject|0|||
155216971|NCT00453544|560232933|FG002|Overall Study|Withdrawal by Subject|0|||
155216972|NCT00453544|560232934|FG003|Overall Study|Withdrawal by Subject|0|||
155216973|NCT00453544|560232931|FG000|Overall Study|Primary outcome measure not completed|1|||
155216974|NCT00453544|560232932|FG001|Overall Study|Primary outcome measure not completed|1|||
155216975|NCT00453544|560232933|FG002|Overall Study|Primary outcome measure not completed|0|||
155216976|NCT00453544|560232934|FG003|Overall Study|Primary outcome measure not completed|1|||
155216977|NCT01558752|560232935|FG000|Overall Study|Physician Decision|2|||
155216978|NCT01558752|560232936|FG001|Overall Study|Physician Decision|0|||
155216979|NCT04340362|560232939|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
155216980|NCT00391274|560232943|FG000|Overall Study|Death Due to Study Disease|55|||
155216981|NCT00391274|560232944|FG001|Overall Study|Death Due to Study Disease|45|||
155216982|NCT00391274|560232943|FG000|Overall Study|Lost to Follow-up|0|||
155216983|NCT00391274|560232944|FG001|Overall Study|Lost to Follow-up|3|||
155216984|NCT00391274|560232943|FG000|Overall Study|Physician Decision|4|||
155216985|NCT00391274|560232944|FG001|Overall Study|Physician Decision|2|||
155216986|NCT00391274|560232943|FG000|Overall Study|Withdrawal by Subject|0|||
155216987|NCT00391274|560232944|FG001|Overall Study|Withdrawal by Subject|3|||
155216988|NCT00391274|560232943|FG000|Overall Study|Death Due to Adverse Event|1|||
155216989|NCT00391274|560232944|FG001|Overall Study|Death Due to Adverse Event|3|||
155216990|NCT00391274|560232943|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
155216991|NCT00391274|560232944|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
155216992|NCT00391274|560232943|FG000|Overall Study|Death Not Study Related|0|||
155216993|NCT00391274|560232944|FG001|Overall Study|Death Not Study Related|1|||
155216994|NCT00894322|560232945|FG000|Overall Study|Withdrawal by Subject|1|||
155216995|NCT00894322|560232946|FG001|Overall Study|Withdrawal by Subject|0|||
155216996|NCT00894322|560232947|FG002|Overall Study|Withdrawal by Subject|0|||
155216997|NCT03338855|560232950|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
155216998|NCT03338855|560232951|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
155216999|NCT00975481|560232960|FG000|Second Intervention Period|Adverse Event|2|||
155217000|NCT00975481|560232961|FG001|Second Intervention Period|Adverse Event|1|||
155217001|NCT00975481|560232962|FG002|Second Intervention Period|Adverse Event|0|||
155217002|NCT00975481|560232963|FG003|Second Intervention Period|Adverse Event|0|||
155217003|NCT00975481|560232964|FG004|Second Intervention Period|Adverse Event|0|||
155217004|NCT00975481|560232965|FG005|Second Intervention Period|Adverse Event|0|||
155217005|NCT00975481|560232960|FG000|Second Intervention Period|Withdrawal by Subject|0|||
155217006|NCT00975481|560232961|FG001|Second Intervention Period|Withdrawal by Subject|0|||
155217007|NCT00975481|560232962|FG002|Second Intervention Period|Withdrawal by Subject|1|||
155217008|NCT00975481|560232963|FG003|Second Intervention Period|Withdrawal by Subject|0|||
155217009|NCT00975481|560232964|FG004|Second Intervention Period|Withdrawal by Subject|0|||
155217010|NCT00975481|560232965|FG005|Second Intervention Period|Withdrawal by Subject|0|||
155217011|NCT00975481|560232960|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
155217012|NCT00975481|560232961|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
155217013|NCT00975481|560232962|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
155217014|NCT00975481|560232963|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
155217015|NCT00975481|560232964|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
155217016|NCT00975481|560232965|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
155217017|NCT00975481|560232960|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
155217018|NCT00975481|560232961|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
155217019|NCT00975481|560232962|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
155217020|NCT00975481|560232963|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
155217021|NCT00975481|560232964|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
155217022|NCT00975481|560232965|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
155217023|NCT03559257|560232968|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
155217024|NCT03559257|560232969|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
155217025|NCT03559257|560232968|FG000|Double Blind Treatment Period|Protocol Violation|1|||
155217026|NCT03559257|560232969|FG001|Double Blind Treatment Period|Protocol Violation|4|||
155217027|NCT03559257|560232968|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
155217028|NCT03559257|560232969|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
155217029|NCT03559257|560232968|FG000|Double Blind Treatment Period|Adverse Event|0|||
155217030|NCT03559257|560232969|FG001|Double Blind Treatment Period|Adverse Event|1|||
155217031|NCT03559257|560232968|FG000|Double Blind Treatment Period|Screen Failure|0|||
155217032|NCT03559257|560232969|FG001|Double Blind Treatment Period|Screen Failure|1|||
155217033|NCT03559257|560232968|FG000|Open-label Treatment Period|Adverse Event|1|||
155217034|NCT03559257|560232969|FG001|Open-label Treatment Period|Adverse Event|4|||
155217035|NCT03559257|560232968|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
155217036|NCT03559257|560232969|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
155217037|NCT03559257|560232968|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
155217038|NCT03559257|560232969|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
155217039|NCT03559257|560232968|FG000|Open-label Treatment Period|Protocol Violation|2|||
155217040|NCT03559257|560232969|FG001|Open-label Treatment Period|Protocol Violation|0|||
155217041|NCT03559257|560232968|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
155217042|NCT03559257|560232969|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
155217043|NCT03559257|560232968|FG000|Open-label Treatment Period|Physician Decision|0|||
155217044|NCT03559257|560232969|FG001|Open-label Treatment Period|Physician Decision|1|||
155217045|NCT02738450|560232970|FG000|Overall Study|Withdrawal by Subject|0|||
155217046|NCT02738450|560232971|FG001|Overall Study|Withdrawal by Subject|2|||
155217047|NCT02738450|560232972|FG002|Overall Study|Withdrawal by Subject|0|||
155217048|NCT03630120|560232973|FG000|Overall Study|Disease progression|0|||
155217049|NCT03630120|560232974|FG001|Overall Study|Disease progression|1|||
155217050|NCT03630120|560232975|FG002|Overall Study|Disease progression|1|||
155217051|NCT03630120|560232976|FG003|Overall Study|Disease progression|1|||
155217052|NCT01519960|560232977|FG000|Overall Study|Withdrawal from the study|26|||
155217053|NCT01519960|560232978|FG001|Overall Study|Withdrawal from the study|22|||
155217054|NCT01519960|560232979|FG002|Overall Study|Withdrawal from the study|5|||
155217055|NCT01387347|560232980|FG000|Overall Study|Lost to Follow-up|2|||
155217056|NCT01387347|560232981|FG001|Overall Study|Lost to Follow-up|1|||
155217057|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
155217058|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
155217059|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
155217060|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
155217061|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
155217062|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
155217063|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
155217064|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
155217065|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
155217066|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
155217067|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
155217068|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
155217069|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
155217070|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
155217071|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
155217072|NCT00561080|560232985|FG000|Vaccination Period (up to Month 4)|Other|0|||
155217073|NCT00561080|560232986|FG001|Vaccination Period (up to Month 4)|Other|2|||
155217074|NCT00561080|560232987|FG002|Vaccination Period (up to Month 4)|Other|1|||
155217075|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
155217076|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
155217077|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
155217078|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
155217079|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
155217080|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
155217081|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
155217082|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
155217083|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
155217084|NCT00561080|560232985|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
155217085|NCT00561080|560232986|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
155217086|NCT00561080|560232987|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
155217087|NCT01165554|560232988|FG000|Overall Study|Withdrawal by Subject|23|||
155217088|NCT02953314|560232991|FG000|Overall Study|Adverse Event|0|||
155217089|NCT02953314|560232992|FG001|Overall Study|Adverse Event|1|||
155217090|NCT02953314|560232991|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
155217091|NCT02953314|560232992|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
155217092|NCT02335099|560232993|FG000|Treatment|Withdrawal by Subject|1|||
155217093|NCT02335099|560232994|FG001|Treatment|Withdrawal by Subject|3|||
155217094|NCT02335099|560232993|FG000|Treatment|Lost to Follow-up|2|||
155217095|NCT02335099|560232994|FG001|Treatment|Lost to Follow-up|0|||
155217096|NCT02335099|560232993|FG000|Treatment|Death|1|||
155217097|NCT02335099|560232994|FG001|Treatment|Death|0|||
155217098|NCT02335099|560232993|FG000|Treatment|Adverse Event|1|||
155217099|NCT02335099|560232994|FG001|Treatment|Adverse Event|2|||
155217100|NCT02335099|560232993|FG000|Follow-up|Death|0|||
155217101|NCT02335099|560232994|FG001|Follow-up|Death|1|||
155217102|NCT01288287|560232995|FG000|Overall Study|Lost to Follow-up|8|||
155217103|NCT01288287|560232995|FG000|Overall Study|Withdrawal by Subject|4|||
155217104|NCT01288287|560232995|FG000|Overall Study|Lack of Efficacy|13|||
155217105|NCT01288287|560232995|FG000|Overall Study|Other Reason|13|||
155217106|NCT01288287|560232995|FG000|Overall Study|Unknown Reason|1|||
155217107|NCT01288287|560232995|FG000|Overall Study|Unknown Status|7|||
155217108|NCT01641692|560233001|FG000|Treatment Period 1|Adverse Event|1|||
155217109|NCT01641692|560233002|FG001|Treatment Period 1|Adverse Event|0|||
155217110|NCT01641692|560233003|FG002|Treatment Period 1|Adverse Event|0|||
155217111|NCT01641692|560233004|FG003|Treatment Period 1|Adverse Event|0|||
155217112|NCT01641692|560233005|FG004|Treatment Period 1|Adverse Event|0|||
155217113|NCT01641692|560233006|FG005|Treatment Period 1|Adverse Event|0|||
155217114|NCT01641692|560233007|FG006|Treatment Period 1|Adverse Event|0|||
155217115|NCT01641692|560233008|FG007|Treatment Period 1|Adverse Event|0|||
155217116|NCT01641692|560233001|FG000|Treatment Period 1|Lack of Efficacy|0|||
155217117|NCT01641692|560233002|FG001|Treatment Period 1|Lack of Efficacy|0|||
155217118|NCT01641692|560233003|FG002|Treatment Period 1|Lack of Efficacy|0|||
155217119|NCT01641692|560233004|FG003|Treatment Period 1|Lack of Efficacy|0|||
155217120|NCT01641692|560233005|FG004|Treatment Period 1|Lack of Efficacy|0|||
155217121|NCT01641692|560233006|FG005|Treatment Period 1|Lack of Efficacy|0|||
155217122|NCT01641692|560233007|FG006|Treatment Period 1|Lack of Efficacy|0|||
155217123|NCT01641692|560233008|FG007|Treatment Period 1|Lack of Efficacy|1|||
155217124|NCT01641692|560233001|FG000|Treatment Period 1|Protocol Violation|1|||
155217125|NCT01641692|560233002|FG001|Treatment Period 1|Protocol Violation|0|||
155217126|NCT01641692|560233003|FG002|Treatment Period 1|Protocol Violation|0|||
155217127|NCT01641692|560233004|FG003|Treatment Period 1|Protocol Violation|0|||
155217128|NCT01641692|560233005|FG004|Treatment Period 1|Protocol Violation|2|||
155217129|NCT01641692|560233006|FG005|Treatment Period 1|Protocol Violation|0|||
155217130|NCT01641692|560233007|FG006|Treatment Period 1|Protocol Violation|0|||
155217131|NCT01641692|560233008|FG007|Treatment Period 1|Protocol Violation|0|||
155217132|NCT01641692|560233001|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217133|NCT01641692|560233002|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217134|NCT01641692|560233003|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217135|NCT01641692|560233004|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217136|NCT01641692|560233005|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
155217137|NCT01641692|560233006|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217138|NCT01641692|560233007|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
155217139|NCT01641692|560233008|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
155217140|NCT01641692|560233001|FG000|Treatment Period 1|Lost to Follow-up|0|||
155217141|NCT01641692|560233002|FG001|Treatment Period 1|Lost to Follow-up|0|||
155217142|NCT01641692|560233003|FG002|Treatment Period 1|Lost to Follow-up|1|||
155217143|NCT01641692|560233004|FG003|Treatment Period 1|Lost to Follow-up|0|||
155217144|NCT01641692|560233005|FG004|Treatment Period 1|Lost to Follow-up|0|||
155217145|NCT01641692|560233006|FG005|Treatment Period 1|Lost to Follow-up|0|||
155217146|NCT01641692|560233007|FG006|Treatment Period 1|Lost to Follow-up|0|||
155217147|NCT01641692|560233008|FG007|Treatment Period 1|Lost to Follow-up|0|||
155217148|NCT01641692|560233001|FG000|Treatment Period 1|Physician Decision|0|||
155217149|NCT01641692|560233002|FG001|Treatment Period 1|Physician Decision|0|||
155217150|NCT01641692|560233003|FG002|Treatment Period 1|Physician Decision|0|||
155217151|NCT01641692|560233004|FG003|Treatment Period 1|Physician Decision|0|||
155217152|NCT01641692|560233005|FG004|Treatment Period 1|Physician Decision|1|||
155217153|NCT01641692|560233006|FG005|Treatment Period 1|Physician Decision|0|||
155217154|NCT01641692|560233007|FG006|Treatment Period 1|Physician Decision|0|||
155217155|NCT01641692|560233008|FG007|Treatment Period 1|Physician Decision|0|||
155217156|NCT01641692|560233001|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155217157|NCT01641692|560233002|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155217158|NCT01641692|560233003|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155217159|NCT01641692|560233004|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155217160|NCT01641692|560233005|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155217161|NCT01641692|560233006|FG005|Treatment Period 1|Withdrawal by Subject|2|||
155217162|NCT01641692|560233007|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155217163|NCT01641692|560233008|FG007|Treatment Period 1|Withdrawal by Subject|1|||
155217164|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
155217165|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217166|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217167|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217168|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217169|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217170|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217171|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
155217172|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217173|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217174|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217175|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217176|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217177|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217178|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
155217179|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155217180|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217181|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217182|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
155217183|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217184|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
155217185|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217186|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217187|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217188|NCT01641692|560233001|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217189|NCT01641692|560233002|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217190|NCT01641692|560233003|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155217191|NCT01641692|560233004|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217192|NCT01641692|560233005|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217193|NCT01641692|560233006|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155217194|NCT01641692|560233007|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155217195|NCT01641692|560233008|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155217196|NCT01641692|560233001|FG000|Treatment Period 2|Lack of Efficacy|1|||
155217197|NCT01641692|560233002|FG001|Treatment Period 2|Lack of Efficacy|0|||
155217198|NCT01641692|560233003|FG002|Treatment Period 2|Lack of Efficacy|0|||
155217199|NCT01641692|560233004|FG003|Treatment Period 2|Lack of Efficacy|0|||
155217200|NCT01641692|560233005|FG004|Treatment Period 2|Lack of Efficacy|0|||
155217201|NCT01641692|560233006|FG005|Treatment Period 2|Lack of Efficacy|0|||
155217202|NCT01641692|560233007|FG006|Treatment Period 2|Lack of Efficacy|0|||
155217203|NCT01641692|560233008|FG007|Treatment Period 2|Lack of Efficacy|0|||
155217204|NCT01641692|560233001|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
155217205|NCT01641692|560233002|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217206|NCT01641692|560233003|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217207|NCT01641692|560233004|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217208|NCT01641692|560233005|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217209|NCT01641692|560233006|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217210|NCT01641692|560233007|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217211|NCT01641692|560233008|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
155217212|NCT01641692|560233001|FG000|Treatment Period 2|Lost to Follow-up|0|||
155217213|NCT01641692|560233002|FG001|Treatment Period 2|Lost to Follow-up|0|||
155217214|NCT01641692|560233003|FG002|Treatment Period 2|Lost to Follow-up|0|||
155217215|NCT01641692|560233004|FG003|Treatment Period 2|Lost to Follow-up|0|||
155217216|NCT01641692|560233005|FG004|Treatment Period 2|Lost to Follow-up|0|||
155217217|NCT01641692|560233006|FG005|Treatment Period 2|Lost to Follow-up|1|||
155217218|NCT01641692|560233007|FG006|Treatment Period 2|Lost to Follow-up|0|||
155217219|NCT01641692|560233008|FG007|Treatment Period 2|Lost to Follow-up|0|||
155217220|NCT01641692|560233001|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155217221|NCT01641692|560233002|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155217222|NCT01641692|560233003|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155217223|NCT01641692|560233004|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155217224|NCT01641692|560233005|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155217225|NCT01641692|560233006|FG005|Treatment Period 2|Withdrawal by Subject|1|||
155217226|NCT01641692|560233007|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155217227|NCT01641692|560233008|FG007|Treatment Period 2|Withdrawal by Subject|1|||
155217228|NCT01641692|560233001|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217229|NCT01641692|560233002|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217230|NCT01641692|560233003|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217231|NCT01641692|560233004|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217232|NCT01641692|560233005|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
155217233|NCT01641692|560233006|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217234|NCT01641692|560233007|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
155217235|NCT01641692|560233008|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
155217236|NCT01641692|560233001|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217237|NCT01641692|560233002|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217238|NCT01641692|560233003|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155217239|NCT01641692|560233004|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217240|NCT01641692|560233005|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217241|NCT01641692|560233006|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155217242|NCT01641692|560233007|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155217243|NCT01641692|560233008|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155217244|NCT01641692|560233001|FG000|Treatment Period 3|Adverse Event|0|||
155217245|NCT01641692|560233002|FG001|Treatment Period 3|Adverse Event|0|||
155217246|NCT01641692|560233003|FG002|Treatment Period 3|Adverse Event|0|||
155217247|NCT01641692|560233004|FG003|Treatment Period 3|Adverse Event|0|||
155217248|NCT01641692|560233005|FG004|Treatment Period 3|Adverse Event|0|||
155217249|NCT01641692|560233006|FG005|Treatment Period 3|Adverse Event|0|||
155217250|NCT01641692|560233007|FG006|Treatment Period 3|Adverse Event|1|||
155217251|NCT01641692|560233008|FG007|Treatment Period 3|Adverse Event|0|||
155217252|NCT01641692|560233001|FG000|Treatment Period 3|Protocol Violation|0|||
155217253|NCT01641692|560233002|FG001|Treatment Period 3|Protocol Violation|0|||
155217254|NCT01641692|560233003|FG002|Treatment Period 3|Protocol Violation|1|||
155217255|NCT01641692|560233004|FG003|Treatment Period 3|Protocol Violation|0|||
155217256|NCT01641692|560233005|FG004|Treatment Period 3|Protocol Violation|0|||
155217257|NCT01641692|560233006|FG005|Treatment Period 3|Protocol Violation|0|||
155217258|NCT01641692|560233007|FG006|Treatment Period 3|Protocol Violation|0|||
155217259|NCT01641692|560233008|FG007|Treatment Period 3|Protocol Violation|0|||
155217260|NCT01641692|560233001|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217261|NCT01641692|560233002|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217262|NCT01641692|560233003|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217263|NCT01641692|560233004|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217264|NCT01641692|560233005|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217265|NCT01641692|560233006|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217266|NCT01641692|560233007|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
155217267|NCT01641692|560233008|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
155217268|NCT01641692|560233001|FG000|Treatment Period 3|Lost to Follow-up|0|||
155217269|NCT01641692|560233002|FG001|Treatment Period 3|Lost to Follow-up|1|||
155217270|NCT01641692|560233003|FG002|Treatment Period 3|Lost to Follow-up|0|||
155217271|NCT01641692|560233004|FG003|Treatment Period 3|Lost to Follow-up|0|||
155217272|NCT01641692|560233005|FG004|Treatment Period 3|Lost to Follow-up|0|||
155217273|NCT01641692|560233006|FG005|Treatment Period 3|Lost to Follow-up|0|||
155217274|NCT01641692|560233007|FG006|Treatment Period 3|Lost to Follow-up|0|||
155217275|NCT01641692|560233008|FG007|Treatment Period 3|Lost to Follow-up|0|||
155217276|NCT01641692|560233001|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217277|NCT01641692|560233002|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217278|NCT01641692|560233003|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217279|NCT01641692|560233004|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217280|NCT01641692|560233005|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217281|NCT01641692|560233006|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
155217282|NCT01641692|560233007|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217283|NCT01641692|560233008|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
155217284|NCT01641692|560233001|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217285|NCT01641692|560233002|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
155217286|NCT01641692|560233003|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217287|NCT01641692|560233004|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217288|NCT01641692|560233005|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
155217289|NCT01641692|560233006|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217290|NCT01641692|560233007|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
155217291|NCT01641692|560233008|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
155217292|NCT04948450|560233014|FG000|Overall Study|Return home|1|||
155217293|NCT04948450|560233015|FG001|Overall Study|Return home|3|||
155217294|NCT00101907|560233019|FG000|Overall Study|Adverse Event|1|||
155217295|NCT00101907|560233020|FG001|Overall Study|Adverse Event|0|||
155217296|NCT00101907|560233021|FG002|Overall Study|Adverse Event|0|||
155217297|NCT00101907|560233022|FG003|Overall Study|Adverse Event|0|||
155217298|NCT00101907|560233023|FG004|Overall Study|Adverse Event|0|||
155217299|NCT00101907|560233024|FG005|Overall Study|Adverse Event|0|||
155217300|NCT00101907|560233019|FG000|Overall Study|Death|0|||
155217301|NCT00101907|560233020|FG001|Overall Study|Death|1|||
155217302|NCT00101907|560233021|FG002|Overall Study|Death|0|||
155217303|NCT00101907|560233022|FG003|Overall Study|Death|0|||
155217304|NCT00101907|560233023|FG004|Overall Study|Death|3|||
155217305|NCT00101907|560233024|FG005|Overall Study|Death|0|||
155217306|NCT00101907|560233019|FG000|Overall Study|Physician Decision|0|||
155217307|NCT00101907|560233020|FG001|Overall Study|Physician Decision|0|||
155217308|NCT00101907|560233021|FG002|Overall Study|Physician Decision|0|||
155217309|NCT00101907|560233022|FG003|Overall Study|Physician Decision|1|||
155217310|NCT00101907|560233023|FG004|Overall Study|Physician Decision|1|||
155217311|NCT00101907|560233024|FG005|Overall Study|Physician Decision|0|||
155217312|NCT00101907|560233019|FG000|Overall Study|Withdrawal by Subject|1|||
155217313|NCT00101907|560233020|FG001|Overall Study|Withdrawal by Subject|0|||
155217314|NCT00101907|560233021|FG002|Overall Study|Withdrawal by Subject|1|||
155217315|NCT00101907|560233022|FG003|Overall Study|Withdrawal by Subject|0|||
155217316|NCT00101907|560233023|FG004|Overall Study|Withdrawal by Subject|1|||
155217317|NCT00101907|560233024|FG005|Overall Study|Withdrawal by Subject|0|||
155217318|NCT00624052|560233025|FG000|Overall Study|Adverse Event|7|||
155217319|NCT00624052|560233026|FG001|Overall Study|Adverse Event|6|||
155217320|NCT00624052|560233027|FG002|Overall Study|Adverse Event|0|||
155217321|NCT00624052|560233028|FG003|Overall Study|Adverse Event|3|||
155217322|NCT00624052|560233025|FG000|Overall Study|Lack of Efficacy|1|||
155217323|NCT00624052|560233026|FG001|Overall Study|Lack of Efficacy|1|||
155217324|NCT00624052|560233027|FG002|Overall Study|Lack of Efficacy|0|||
155217325|NCT00624052|560233028|FG003|Overall Study|Lack of Efficacy|0|||
155217326|NCT00624052|560233025|FG000|Overall Study|Lost to Follow-up|2|||
155217327|NCT00624052|560233026|FG001|Overall Study|Lost to Follow-up|3|||
155217328|NCT00624052|560233027|FG002|Overall Study|Lost to Follow-up|1|||
155217329|NCT00624052|560233028|FG003|Overall Study|Lost to Follow-up|0|||
155217330|NCT00624052|560233025|FG000|Overall Study|Non compliant with the protocol|2|||
155217331|NCT00624052|560233026|FG001|Overall Study|Non compliant with the protocol|1|||
155217332|NCT00624052|560233027|FG002|Overall Study|Non compliant with the protocol|1|||
155217333|NCT00624052|560233028|FG003|Overall Study|Non compliant with the protocol|1|||
155217334|NCT00624052|560233025|FG000|Overall Study|Consent withdrawn|3|||
155217335|NCT00624052|560233026|FG001|Overall Study|Consent withdrawn|1|||
155217336|NCT00624052|560233027|FG002|Overall Study|Consent withdrawn|1|||
155217337|NCT00624052|560233028|FG003|Overall Study|Consent withdrawn|0|||
155217338|NCT00624052|560233025|FG000|Overall Study|Changed job/ran out if meds|0|||
155217339|NCT00624052|560233026|FG001|Overall Study|Changed job/ran out if meds|2|||
155217340|NCT00624052|560233027|FG002|Overall Study|Changed job/ran out if meds|0|||
155217341|NCT00624052|560233028|FG003|Overall Study|Changed job/ran out if meds|0|||
155217342|NCT03658538|560233031|FG000|Overall Study|Death|2|||
155217343|NCT03658538|560233032|FG001|Overall Study|Death|1|||
155217344|NCT03658538|560233031|FG000|Overall Study|Cancer diagnosis|1|||
155217345|NCT03658538|560233032|FG001|Overall Study|Cancer diagnosis|0|||
155217346|NCT03658538|560233031|FG000|Overall Study|Change residence|1|||
155217347|NCT03658538|560233032|FG001|Overall Study|Change residence|2|||
155217348|NCT03658538|560233031|FG000|Overall Study|Lost to Follow-up|3|||
155217349|NCT03658538|560233032|FG001|Overall Study|Lost to Follow-up|3|||
155217350|NCT03658538|560233031|FG000|Overall Study|Unblinded|2|||
155217351|NCT03658538|560233032|FG001|Overall Study|Unblinded|3|||
155217352|NCT03658538|560233031|FG000|Overall Study|Physician Decision|0|||
155217353|NCT03658538|560233032|FG001|Overall Study|Physician Decision|1|||
155217354|NCT03658538|560233031|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
155217355|NCT03658538|560233032|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
155217356|NCT03658538|560233031|FG000|Overall Study|Evicted from home|1|||
155217357|NCT03658538|560233032|FG001|Overall Study|Evicted from home|0|||
155217358|NCT00202644|560234501|FG000|Overall Study|Adverse Event|12|||
155217359|NCT00202644|560234502|FG001|Overall Study|Adverse Event|13|||
155217360|NCT00202644|560234501|FG000|Overall Study|Withdrawal by Subject|8|||
155217361|NCT00202644|560234502|FG001|Overall Study|Withdrawal by Subject|6|||
155217362|NCT00202644|560234501|FG000|Overall Study|Lack of Efficacy|6|||
155217363|NCT00202644|560234502|FG001|Overall Study|Lack of Efficacy|6|||
155217364|NCT00202644|560234501|FG000|Overall Study|Lost to Follow-up|0|||
155217365|NCT00202644|560234502|FG001|Overall Study|Lost to Follow-up|1|||
155217366|NCT00202644|560234501|FG000|Overall Study|Other|9|||
155217367|NCT00202644|560234502|FG001|Overall Study|Other|1|||
155217368|NCT02750592|560234503|FG000|Overall Study|Adverse Event|3|||
155217369|NCT02750592|560234503|FG000|Overall Study|Lack of Efficacy|2|||
155217370|NCT02981342|560234504|FG000|Overall Study|Adverse Event|0|||
155217371|NCT02981342|560234505|FG001|Overall Study|Adverse Event|0|||
155217372|NCT02981342|560234506|FG002|Overall Study|Adverse Event|0|||
155217373|NCT02981342|560234507|FG003|Overall Study|Adverse Event|1|||
155217374|NCT02981342|560234504|FG000|Overall Study|Death|0|||
155217375|NCT02981342|560234505|FG001|Overall Study|Death|9|||
155217376|NCT02981342|560234506|FG002|Overall Study|Death|9|||
155217377|NCT02981342|560234507|FG003|Overall Study|Death|4|||
155217378|NCT02981342|560234504|FG000|Overall Study|Withdrawal by Subject|0|||
155217379|NCT02981342|560234505|FG001|Overall Study|Withdrawal by Subject|0|||
155217380|NCT02981342|560234506|FG002|Overall Study|Withdrawal by Subject|3|||
155217381|NCT02981342|560234507|FG003|Overall Study|Withdrawal by Subject|1|||
155217382|NCT02981342|560234504|FG000|Overall Study|Study closed by sponsor|0|||
155217383|NCT02981342|560234505|FG001|Overall Study|Study closed by sponsor|0|||
155217384|NCT02981342|560234506|FG002|Overall Study|Study closed by sponsor|1|||
155217385|NCT02981342|560234507|FG003|Overall Study|Study closed by sponsor|1|||
155217386|NCT02981342|560234504|FG000|Overall Study|Randomized, Never Treated|0|||
155217387|NCT02981342|560234505|FG001|Overall Study|Randomized, Never Treated|1|||
155217388|NCT02981342|560234506|FG002|Overall Study|Randomized, Never Treated|0|||
155217389|NCT02981342|560234507|FG003|Overall Study|Randomized, Never Treated|7|||
155217390|NCT02981342|560234504|FG000|Overall Study|Lost to Follow-up|0|||
155217391|NCT02981342|560234505|FG001|Overall Study|Lost to Follow-up|1|||
155217392|NCT02981342|560234506|FG002|Overall Study|Lost to Follow-up|0|||
155217393|NCT02981342|560234507|FG003|Overall Study|Lost to Follow-up|0|||
155217394|NCT01372501|560234508|FG000|Overall Study|Adverse Event|4|||
155217395|NCT01372501|560234508|FG000|Overall Study|Device migration|1|||
155217396|NCT01277523|560234509|FG000|Overall Study|Adverse Event|1|||
155217397|NCT01277523|560234510|FG001|Overall Study|Adverse Event|0|||
155217398|NCT01277523|560234511|FG002|Overall Study|Adverse Event|0|||
155217399|NCT01277523|560234509|FG000|Overall Study|Protocol Violation|2|||
155217400|NCT01277523|560234510|FG001|Overall Study|Protocol Violation|0|||
155217401|NCT01277523|560234511|FG002|Overall Study|Protocol Violation|0|||
155217402|NCT01277523|560234509|FG000|Overall Study|Other Reason not Defined|0|||
155217403|NCT01277523|560234510|FG001|Overall Study|Other Reason not Defined|1|||
155217404|NCT01277523|560234511|FG002|Overall Study|Other Reason not Defined|0|||
155217405|NCT01859494|560234514|FG000|Overall Study|Adverse Event|1|||
155217406|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Death|3|||
155217407|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Death|2|||
155217408|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Death|4|||
155217409|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Death|3|||
155217410|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Death|0|||
155217411|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Death|0|||
155217412|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217413|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
155217414|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
155217415|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217416|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217417|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
155217418|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
155217419|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217420|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217421|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217422|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217423|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
155217424|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
155217425|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
155217426|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
155217427|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
155217428|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
155217429|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
155217430|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217431|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217432|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
155217433|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
155217434|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217435|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
155217436|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
155217437|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
155217438|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
155217439|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
155217440|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
155217441|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
155217442|NCT02432846|560234515|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217443|NCT02432846|560234516|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217444|NCT02432846|560234517|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
155217445|NCT02432846|560234518|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217446|NCT02432846|560234519|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217447|NCT02432846|560234520|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
155217448|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
155217449|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
155217450|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
155217451|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
155217452|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
155217453|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
155217454|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217455|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217456|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217457|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
155217458|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
155217459|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
155217460|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217461|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217462|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217463|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217464|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
155217465|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
155217466|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217467|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217468|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217469|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
155217470|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
155217471|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
155217472|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217473|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217474|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217475|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
155217476|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
155217477|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
155217478|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217479|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217480|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217481|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
155217482|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
155217483|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
155217484|NCT02432846|560234515|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217485|NCT02432846|560234516|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217486|NCT02432846|560234517|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217487|NCT02432846|560234518|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217488|NCT02432846|560234519|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
155217489|NCT02432846|560234520|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
155217490|NCT01912287|560234521|FG000|Overall Study|Ineligible|1|||
155217491|NCT01912287|560234522|FG001|Overall Study|Ineligible|0|||
155217492|NCT01912287|560234523|FG002|Overall Study|Ineligible|1|||
155217493|NCT01912287|560234521|FG000|Overall Study|No-show|0|||
155217494|NCT01912287|560234522|FG001|Overall Study|No-show|0|||
155217495|NCT01912287|560234523|FG002|Overall Study|No-show|1|||
155217496|NCT01912287|560234521|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
155217497|NCT01912287|560234522|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
155217498|NCT01912287|560234523|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
155217499|NCT01912287|560234521|FG000|Overall Study|Felt treatment no longer needed|0|||
155217500|NCT01912287|560234522|FG001|Overall Study|Felt treatment no longer needed|1|||
155217501|NCT01912287|560234523|FG002|Overall Study|Felt treatment no longer needed|0|||
155217502|NCT01912287|560234521|FG000|Overall Study|Life circumstances|4|||
155217503|NCT01912287|560234522|FG001|Overall Study|Life circumstances|2|||
155217504|NCT01912287|560234523|FG002|Overall Study|Life circumstances|0|||
155217505|NCT01912287|560234521|FG000|Overall Study|Lost Interest|1|||
155217506|NCT01912287|560234522|FG001|Overall Study|Lost Interest|0|||
155217507|NCT01912287|560234523|FG002|Overall Study|Lost Interest|0|||
155217508|NCT01912287|560234521|FG000|Overall Study|Uknown reason - subject drop out|5|||
155217509|NCT01912287|560234522|FG001|Overall Study|Uknown reason - subject drop out|7|||
155217510|NCT01912287|560234523|FG002|Overall Study|Uknown reason - subject drop out|3|||
155217511|NCT01912287|560234521|FG000|Overall Study|Missed Assesment|1|||
155217512|NCT01912287|560234522|FG001|Overall Study|Missed Assesment|1|||
155217513|NCT01912287|560234523|FG002|Overall Study|Missed Assesment|1|||
155217514|NCT01912287|560234521|FG000|Overall Study|Scheduling/change in availability|17|||
155217515|NCT01912287|560234522|FG001|Overall Study|Scheduling/change in availability|10|||
155217516|NCT01912287|560234523|FG002|Overall Study|Scheduling/change in availability|8|||
155217517|NCT02631850|560234524|FG000|Treatment Period|Lost to Follow-up|0|||
155217518|NCT02631850|560234525|FG001|Treatment Period|Lost to Follow-up|1|||
155217519|NCT02631850|560234526|FG002|Treatment Period|Lost to Follow-up|0|||
155217520|NCT02631850|560234527|FG003|Treatment Period|Lost to Follow-up|0|||
155217521|NCT02631850|560234524|FG000|Treatment Period|Protocol Violation|1|||
155217522|NCT02631850|560234525|FG001|Treatment Period|Protocol Violation|0|||
155217523|NCT02631850|560234526|FG002|Treatment Period|Protocol Violation|0|||
155217524|NCT02631850|560234527|FG003|Treatment Period|Protocol Violation|0|||
155217525|NCT02631850|560234524|FG000|Treatment Period|Withdrawal by Subject|0|||
155217526|NCT02631850|560234525|FG001|Treatment Period|Withdrawal by Subject|5|||
155217527|NCT02631850|560234526|FG002|Treatment Period|Withdrawal by Subject|2|||
155217528|NCT02631850|560234527|FG003|Treatment Period|Withdrawal by Subject|2|||
155217529|NCT02631850|560234524|FG000|Treatment Period|Adverse Event|1|||
155217530|NCT02631850|560234525|FG001|Treatment Period|Adverse Event|0|||
155217531|NCT02631850|560234526|FG002|Treatment Period|Adverse Event|2|||
155217532|NCT02631850|560234527|FG003|Treatment Period|Adverse Event|3|||
155217533|NCT02631850|560234524|FG000|Treatment Period|Family medical issue|1|||
155217534|NCT02631850|560234525|FG001|Treatment Period|Family medical issue|0|||
155217535|NCT02631850|560234526|FG002|Treatment Period|Family medical issue|0|||
155217536|NCT02631850|560234527|FG003|Treatment Period|Family medical issue|0|||
155217537|NCT02631850|560234524|FG000|6 Month Follow up|Lost to Follow-up|5|||
155217538|NCT02631850|560234525|FG001|6 Month Follow up|Lost to Follow-up|8|||
155217539|NCT02631850|560234526|FG002|6 Month Follow up|Lost to Follow-up|3|||
155217540|NCT02631850|560234527|FG003|6 Month Follow up|Lost to Follow-up|5|||
155217541|NCT02631850|560234524|FG000|6 Month Follow up|Withdrawal by Subject|1|||
155217542|NCT02631850|560234525|FG001|6 Month Follow up|Withdrawal by Subject|0|||
155217543|NCT02631850|560234526|FG002|6 Month Follow up|Withdrawal by Subject|0|||
155217544|NCT02631850|560234527|FG003|6 Month Follow up|Withdrawal by Subject|2|||
155217545|NCT02631850|560234524|FG000|6 Month Follow up|Adverse Event|1|||
155217546|NCT02631850|560234525|FG001|6 Month Follow up|Adverse Event|4|||
155217547|NCT02631850|560234526|FG002|6 Month Follow up|Adverse Event|1|||
155217548|NCT02631850|560234527|FG003|6 Month Follow up|Adverse Event|3|||
155217549|NCT02631850|560234524|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
155217550|NCT02631850|560234525|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
155217551|NCT02631850|560234526|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
155217552|NCT02631850|560234527|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
155217553|NCT01462084|560234528|FG000|Overall Study|Withdrawal by Subject|1|||
155217554|NCT01462084|560234529|FG001|Overall Study|Withdrawal by Subject|0|||
155217555|NCT01462084|560234528|FG000|Overall Study|Protocol Violation|1|||
155217556|NCT01462084|560234529|FG001|Overall Study|Protocol Violation|1|||
155217557|NCT02278263|560234530|FG000|Overall Study|Protocol Violation|7|||
155217558|NCT02278263|560234531|FG001|Overall Study|Protocol Violation|0|||
155217559|NCT02278263|560234532|FG002|Overall Study|Protocol Violation|9|||
155217560|NCT00326950|560234536|FG000|Overall Study|Progressive Disease|1|||
155217561|NCT01514760|560234537|FG000|Overall Study|Lost to Follow-up|2|||
155217562|NCT01266460|560234540|FG000|Overall Study|Adverse Event|3|||
155217563|NCT01266460|560234540|FG000|Overall Study|Withdrawal by Subject|5|||
155217564|NCT01266460|560234540|FG000|Overall Study|Disease Progression|18|||
155217565|NCT01266460|560234540|FG000|Overall Study|Not otherwise specified|8|||
155217566|NCT01132547|560234541|FG000|Overall Study|Withdrawal by Subject|3|||
155217567|NCT01132547|560234542|FG001|Overall Study|Withdrawal by Subject|1|||
155217568|NCT01132547|560234541|FG000|Overall Study|Death|1|||
155217569|NCT01132547|560234542|FG001|Overall Study|Death|0|||
155217570|NCT05811234|560234543|FG000|Overall Study|Loss of Effectiveness|2|||
155217571|NCT05811234|560234543|FG000|Overall Study|Adverse Event|4|||
155217572|NCT05811234|560234543|FG000|Overall Study|Pregnancy|1|||
155217573|NCT05811234|560234543|FG000|Overall Study|Disease progression|1|||
155217574|NCT05811234|560234543|FG000|Overall Study|Withdrawal by Subject|4|||
155217575|NCT05811234|560234543|FG000|Overall Study|Lost to Follow-up|13|||
155217576|NCT05811234|560234543|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
155217577|NCT02710045|560234544|FG000|Overall Study|Death|1|||
155217578|NCT02710045|560234545|FG001|Overall Study|Death|2|||
155217579|NCT02710045|560234546|FG002|Overall Study|Death|0|||
155217580|NCT02710045|560234544|FG000|Overall Study|Withdrawal by Subject|6|||
155217581|NCT02710045|560234545|FG001|Overall Study|Withdrawal by Subject|6|||
155217582|NCT02710045|560234546|FG002|Overall Study|Withdrawal by Subject|2|||
155217583|NCT02710045|560234544|FG000|Overall Study|Protocol Violation|1|||
155217584|NCT02710045|560234545|FG001|Overall Study|Protocol Violation|2|||
155217585|NCT02710045|560234546|FG002|Overall Study|Protocol Violation|3|||
155217586|NCT02710045|560234544|FG000|Overall Study|Lost to Follow-up|3|||
155217587|NCT02710045|560234545|FG001|Overall Study|Lost to Follow-up|6|||
155217588|NCT02710045|560234546|FG002|Overall Study|Lost to Follow-up|7|||
155217589|NCT02710045|560234544|FG000|Overall Study|Physician Decision|0|||
155217590|NCT02710045|560234545|FG001|Overall Study|Physician Decision|0|||
155217591|NCT02710045|560234546|FG002|Overall Study|Physician Decision|1|||
155217592|NCT02710045|560234544|FG000|Overall Study|Poor Attendance|0|||
155217593|NCT02710045|560234545|FG001|Overall Study|Poor Attendance|1|||
155217594|NCT02710045|560234546|FG002|Overall Study|Poor Attendance|0|||
155217595|NCT01275833|560234547|FG000|Overall Study|Study terminated|1|||
155217596|NCT01275833|560234548|FG001|Overall Study|Study terminated|1|||
155217597|NCT02118012|560234554|FG000|Overall Study|Adverse Event|0|||
155217598|NCT02118012|560234555|FG001|Overall Study|Adverse Event|1|||
155217599|NCT02118012|560234554|FG000|Overall Study|Physician Decision|0|||
155217600|NCT02118012|560234555|FG001|Overall Study|Physician Decision|1|||
155217601|NCT00483379|560234556|FG000|Treatment Period|Adverse Event|1|||
155217602|NCT00483379|560234557|FG001|Treatment Period|Adverse Event|0|||
155217603|NCT00483379|560234556|FG000|Treatment Period|Withdrawal by Subject|1|||
155217604|NCT00483379|560234557|FG001|Treatment Period|Withdrawal by Subject|0|||
155217605|NCT00536107|560234560|FG000|Overall Study|Death|5|||
155217606|NCT00536107|560234561|FG001|Overall Study|Death|1|||
155217607|NCT00536107|560234560|FG000|Overall Study|Incorrect enrolment|1|||
155217608|NCT00536107|560234561|FG001|Overall Study|Incorrect enrolment|0|||
155217609|NCT00536107|560234560|FG000|Overall Study|Withdrawal by Subject|0|||
155217610|NCT00536107|560234561|FG001|Overall Study|Withdrawal by Subject|1|||
155217611|NCT00536107|560234560|FG000|Overall Study|Study Termination|2|||
155217612|NCT00536107|560234561|FG001|Overall Study|Study Termination|4|||
155217613|NCT04519645|560234566|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
155217614|NCT04519645|560234567|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
155217615|NCT04519645|560234568|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
155217616|NCT04519645|560234566|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
155217617|NCT04519645|560234567|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
155217618|NCT04519645|560234568|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
155217619|NCT04519645|560234566|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
155217620|NCT04519645|560234567|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
155217621|NCT04519645|560234568|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
155217622|NCT04519645|560234566|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
155217623|NCT04519645|560234567|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
155217624|NCT04519645|560234568|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
155217625|NCT04387435|560234575|FG000|Overall Study|Physician Decision|1|||
155217626|NCT03447990|560234583|FG000|Overall Study|Withdrawal by Subject|0|||
155217627|NCT03447990|560234584|FG001|Overall Study|Withdrawal by Subject|0|||
155217628|NCT03447990|560234585|FG002|Overall Study|Withdrawal by Subject|0|||
155217629|NCT03447990|560234586|FG003|Overall Study|Withdrawal by Subject|0|||
155217630|NCT03447990|560234587|FG004|Overall Study|Withdrawal by Subject|0|||
155217631|NCT03447990|560234588|FG005|Overall Study|Withdrawal by Subject|0|||
155217632|NCT03447990|560234589|FG006|Overall Study|Withdrawal by Subject|1|||
155217633|NCT00423150|560234590|FG000|Overall Study|Adverse Event|11|||
155217634|NCT00423150|560234590|FG000|Overall Study|Progression of disease being studied|69|||
155217635|NCT00423150|560234590|FG000|Overall Study|Withdrawal by Subject|1|||
155217636|NCT00423150|560234590|FG000|Overall Study|Non-compliance with protocol|1|||
155217637|NCT00423150|560234590|FG000|Overall Study|Administrative|4|||
155217638|NCT02951156|560234591|FG000|Overall Study|Death|3|||
155217639|NCT02951156|560234592|FG001|Overall Study|Death|8|||
155217640|NCT02951156|560234593|FG002|Overall Study|Death|5|||
155217641|NCT02951156|560234591|FG000|Overall Study|Progressive disease|1|||
155217642|NCT02951156|560234592|FG001|Overall Study|Progressive disease|0|||
155217643|NCT02951156|560234593|FG002|Overall Study|Progressive disease|1|||
155217644|NCT02951156|560234591|FG000|Overall Study|Withdrawal by Subject|0|||
155217645|NCT02951156|560234592|FG001|Overall Study|Withdrawal by Subject|0|||
155217646|NCT02951156|560234593|FG002|Overall Study|Withdrawal by Subject|1|||
155217647|NCT02951156|560234591|FG000|Overall Study|Study terminated by sponsor|0|||
155217648|NCT02951156|560234592|FG001|Overall Study|Study terminated by sponsor|0|||
155217649|NCT02951156|560234593|FG002|Overall Study|Study terminated by sponsor|1|||
155217650|NCT02951156|560234591|FG000|Overall Study|Other|5|||
155217651|NCT02951156|560234592|FG001|Overall Study|Other|1|||
155217652|NCT02951156|560234593|FG002|Overall Study|Other|2|||
155217653|NCT03519347|560234594|FG000|Interventional Crossover Period 1|Death|0|||
155217654|NCT03519347|560234595|FG001|Interventional Crossover Period 1|Death|0|||
155217655|NCT03519347|560234596|FG002|Interventional Crossover Period 1|Death|0|||
155217656|NCT03519347|560234597|FG003|Interventional Crossover Period 1|Death|1|||
155217657|NCT01092182|560234598|FG000|Overall Study|Death|0|||
155217658|NCT01092182|560234599|FG001|Overall Study|Death|5|||
155217659|NCT01092182|560234600|FG002|Overall Study|Death|3|||
155217660|NCT01092182|560234598|FG000|Overall Study|participant safety|1|||
155217661|NCT01092182|560234599|FG001|Overall Study|participant safety|2|||
155217662|NCT01092182|560234600|FG002|Overall Study|participant safety|0|||
155217663|NCT01092182|560234598|FG000|Overall Study|Physician Decision|0|||
155217664|NCT01092182|560234599|FG001|Overall Study|Physician Decision|6|||
155217665|NCT01092182|560234600|FG002|Overall Study|Physician Decision|0|||
155217666|NCT01092182|560234598|FG000|Overall Study|Did not meet criteria|0|||
155217667|NCT01092182|560234599|FG001|Overall Study|Did not meet criteria|0|||
155217668|NCT01092182|560234600|FG002|Overall Study|Did not meet criteria|25|||
155217669|NCT01092182|560234598|FG000|Overall Study|Non-compliance|0|||
155217670|NCT01092182|560234599|FG001|Overall Study|Non-compliance|3|||
155217671|NCT01092182|560234600|FG002|Overall Study|Non-compliance|0|||
155217672|NCT01092182|560234598|FG000|Overall Study|Participant refused follow-up|0|||
155217673|NCT01092182|560234599|FG001|Overall Study|Participant refused follow-up|2|||
155217674|NCT01092182|560234600|FG002|Overall Study|Participant refused follow-up|0|||
155217675|NCT02515045|560234601|FG000|Overall Study|Adverse Event|0|||
155217676|NCT02515045|560234602|FG001|Overall Study|Adverse Event|3|||
155217677|NCT02515045|560234603|FG002|Overall Study|Adverse Event|3|||
155217678|NCT02515045|560234601|FG000|Overall Study|Lost to Follow-up|0|||
155217679|NCT02515045|560234602|FG001|Overall Study|Lost to Follow-up|1|||
155217680|NCT02515045|560234603|FG002|Overall Study|Lost to Follow-up|1|||
155217681|NCT01474876|560234607|FG000|Overall Study|Adverse Event|11|||
155217682|NCT01474876|560234608|FG001|Overall Study|Adverse Event|5|||
155217683|NCT01474876|560234609|FG002|Overall Study|Adverse Event|0|||
155217684|NCT01474876|560234607|FG000|Overall Study|Serious Adverse Event|2|||
155217685|NCT01474876|560234608|FG001|Overall Study|Serious Adverse Event|3|||
155217686|NCT01474876|560234609|FG002|Overall Study|Serious Adverse Event|0|||
155217687|NCT01474876|560234607|FG000|Overall Study|Lost to Follow-up|5|||
155217688|NCT01474876|560234608|FG001|Overall Study|Lost to Follow-up|4|||
155217689|NCT01474876|560234609|FG002|Overall Study|Lost to Follow-up|0|||
155217690|NCT01474876|560234607|FG000|Overall Study|Investigator's decision|28|||
155217691|NCT01474876|560234608|FG001|Overall Study|Investigator's decision|6|||
155217692|NCT01474876|560234609|FG002|Overall Study|Investigator's decision|0|||
155217693|NCT01474876|560234607|FG000|Overall Study|Patient's request|19|||
155217694|NCT01474876|560234608|FG001|Overall Study|Patient's request|5|||
155217695|NCT01474876|560234609|FG002|Overall Study|Patient's request|0|||
155217696|NCT01474876|560234607|FG000|Overall Study|Investigator's decision and pt request|1|||
155217697|NCT01474876|560234608|FG001|Overall Study|Investigator's decision and pt request|0|||
155217698|NCT01474876|560234609|FG002|Overall Study|Investigator's decision and pt request|0|||
155217699|NCT02291055|560234610|FG000|Overall Study|Death|2|||
155217700|NCT02291055|560234611|FG001|Overall Study|Death|2|||
155217701|NCT02291055|560234612|FG002|Overall Study|Death|5|||
155217702|NCT02291055|560234613|FG003|Overall Study|Death|8|||
155217703|NCT02291055|560234614|FG004|Overall Study|Death|12|||
155217704|NCT02291055|560234610|FG000|Overall Study|Lost to Follow-up|0|||
155217705|NCT02291055|560234611|FG001|Overall Study|Lost to Follow-up|0|||
155217706|NCT02291055|560234612|FG002|Overall Study|Lost to Follow-up|0|||
155217707|NCT02291055|560234613|FG003|Overall Study|Lost to Follow-up|1|||
155217708|NCT02291055|560234614|FG004|Overall Study|Lost to Follow-up|2|||
155217709|NCT02291055|560234610|FG000|Overall Study|Withdrawal by Subject|3|||
155217710|NCT02291055|560234611|FG001|Overall Study|Withdrawal by Subject|1|||
155217711|NCT02291055|560234612|FG002|Overall Study|Withdrawal by Subject|1|||
155217712|NCT02291055|560234613|FG003|Overall Study|Withdrawal by Subject|5|||
155217713|NCT02291055|560234614|FG004|Overall Study|Withdrawal by Subject|10|||
155217714|NCT02291055|560234610|FG000|Overall Study|Progressive Disease|0|||
155217715|NCT02291055|560234611|FG001|Overall Study|Progressive Disease|0|||
155217716|NCT02291055|560234612|FG002|Overall Study|Progressive Disease|1|||
155217717|NCT02291055|560234613|FG003|Overall Study|Progressive Disease|4|||
155217718|NCT02291055|560234614|FG004|Overall Study|Progressive Disease|2|||
155217719|NCT02291055|560234610|FG000|Overall Study|Study Terminated by Sponsor|0|||
155217720|NCT02291055|560234611|FG001|Overall Study|Study Terminated by Sponsor|0|||
155217721|NCT02291055|560234612|FG002|Overall Study|Study Terminated by Sponsor|0|||
155217722|NCT02291055|560234613|FG003|Overall Study|Study Terminated by Sponsor|5|||
155217723|NCT02291055|560234614|FG004|Overall Study|Study Terminated by Sponsor|1|||
155217724|NCT02291055|560234610|FG000|Overall Study|Other|0|||
155217725|NCT02291055|560234611|FG001|Overall Study|Other|2|||
155217726|NCT02291055|560234612|FG002|Overall Study|Other|1|||
155217727|NCT02291055|560234613|FG003|Overall Study|Other|4|||
155217728|NCT02291055|560234614|FG004|Overall Study|Other|0|||
155217729|NCT01523886|560234617|FG000|Overall Study|surgery cancelled|0|||
155217730|NCT01523886|560234618|FG001|Overall Study|surgery cancelled|1|||
155217731|NCT03333044|560234622|FG000|Overall Study|Pregnancy|1|||
155217732|NCT03333044|560234623|FG001|Overall Study|Pregnancy|0|||
155217733|NCT03333044|560234624|FG002|Overall Study|Pregnancy|0|||
155217734|NCT03333044|560234622|FG000|Overall Study|Lost to Follow-up|0|||
155217735|NCT03333044|560234623|FG001|Overall Study|Lost to Follow-up|14|||
155217736|NCT03333044|560234624|FG002|Overall Study|Lost to Follow-up|6|||
155217737|NCT02921776|560234625|FG000|Overall Study|patient deterioration, fatigue|2|||
155217738|NCT02921776|560234626|FG001|Overall Study|patient deterioration, fatigue|6|||
155217739|NCT02921776|560234627|FG002|Overall Study|patient deterioration, fatigue|0|||
155217740|NCT02921776|560234628|FG003|Overall Study|patient deterioration, fatigue|0|||
155217741|NCT02921776|560234629|FG004|Overall Study|patient deterioration, fatigue|0|||
155217742|NCT02921776|560234630|FG005|Overall Study|patient deterioration, fatigue|0|||
155217743|NCT02921776|560234631|FG006|Overall Study|patient deterioration, fatigue|0|||
155217744|NCT02921776|560234632|FG007|Overall Study|patient deterioration, fatigue|0|||
155217745|NCT02921776|560234625|FG000|Overall Study|Withdrawal by Subject|0|||
155217746|NCT02921776|560234626|FG001|Overall Study|Withdrawal by Subject|2|||
155217747|NCT02921776|560234627|FG002|Overall Study|Withdrawal by Subject|0|||
155217748|NCT02921776|560234628|FG003|Overall Study|Withdrawal by Subject|1|||
155217749|NCT02921776|560234629|FG004|Overall Study|Withdrawal by Subject|1|||
155217750|NCT02921776|560234630|FG005|Overall Study|Withdrawal by Subject|0|||
155217751|NCT02921776|560234631|FG006|Overall Study|Withdrawal by Subject|8|||
155217752|NCT02921776|560234632|FG007|Overall Study|Withdrawal by Subject|1|||
155217753|NCT02921776|560234625|FG000|Overall Study|Death|0|||
155217754|NCT02921776|560234626|FG001|Overall Study|Death|0|||
155217755|NCT02921776|560234627|FG002|Overall Study|Death|0|||
155217756|NCT02921776|560234628|FG003|Overall Study|Death|2|||
155217757|NCT02921776|560234629|FG004|Overall Study|Death|0|||
155217758|NCT02921776|560234630|FG005|Overall Study|Death|0|||
155217759|NCT02921776|560234631|FG006|Overall Study|Death|0|||
155217760|NCT02921776|560234632|FG007|Overall Study|Death|0|||
155217761|NCT02921776|560234625|FG000|Overall Study|extubation or early discharge|0|||
155217762|NCT02921776|560234626|FG001|Overall Study|extubation or early discharge|0|||
155217763|NCT02921776|560234627|FG002|Overall Study|extubation or early discharge|0|||
155217764|NCT02921776|560234628|FG003|Overall Study|extubation or early discharge|5|||
155217765|NCT02921776|560234629|FG004|Overall Study|extubation or early discharge|5|||
155217766|NCT02921776|560234630|FG005|Overall Study|extubation or early discharge|0|||
155217767|NCT02921776|560234631|FG006|Overall Study|extubation or early discharge|0|||
155217768|NCT02921776|560234632|FG007|Overall Study|extubation or early discharge|0|||
155217769|NCT02921776|560234625|FG000|Overall Study|Lost to Follow-up|0|||
155217770|NCT02921776|560234626|FG001|Overall Study|Lost to Follow-up|0|||
155217771|NCT02921776|560234627|FG002|Overall Study|Lost to Follow-up|0|||
155217772|NCT02921776|560234628|FG003|Overall Study|Lost to Follow-up|0|||
155217773|NCT02921776|560234629|FG004|Overall Study|Lost to Follow-up|0|||
155217774|NCT02921776|560234630|FG005|Overall Study|Lost to Follow-up|2|||
155217775|NCT02921776|560234631|FG006|Overall Study|Lost to Follow-up|3|||
155217776|NCT02921776|560234632|FG007|Overall Study|Lost to Follow-up|6|||
155217777|NCT04537234|560234634|FG000|Overall Study|Withdrawal by Subject|2|||
155217778|NCT04537234|560234635|FG001|Overall Study|Withdrawal by Subject|0|||
155217779|NCT02070744|560234636|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217780|NCT02070744|560234637|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217781|NCT02070744|560234638|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217782|NCT02070744|560234639|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
155217783|NCT02070744|560234640|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
155217784|NCT02070744|560234636|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217785|NCT02070744|560234637|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217786|NCT02070744|560234638|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217787|NCT02070744|560234639|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
155217788|NCT02070744|560234640|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
155217789|NCT02070744|560234636|FG000|OLE Phase (48 Weeks)|Other|0|||
155217790|NCT02070744|560234637|FG001|OLE Phase (48 Weeks)|Other|0|||
155217791|NCT02070744|560234638|FG002|OLE Phase (48 Weeks)|Other|0|||
155217792|NCT02070744|560234639|FG003|OLE Phase (48 Weeks)|Other|0|||
155217793|NCT02070744|560234640|FG004|OLE Phase (48 Weeks)|Other|1|||
155217794|NCT07114198|560234641|FG000|Overall Study|Protocol Violation|1|||
155217795|NCT07114198|560234642|FG001|Overall Study|Protocol Violation|1|||
155217796|NCT04318080|560236778|FG000|Overall Study|Study closed by sponsor|10|||
155217797|NCT04318080|560236779|FG001|Overall Study|Study closed by sponsor|22|||
155217798|NCT04318080|560236778|FG000|Overall Study|Death|3|||
155217799|NCT04318080|560236779|FG001|Overall Study|Death|9|||
155217800|NCT04318080|560236778|FG000|Overall Study|Withdrawal by Subject|1|||
155217801|NCT04318080|560236779|FG001|Overall Study|Withdrawal by Subject|0|||
155217802|NCT04318080|560236778|FG000|Overall Study|Protocol Deviation|1|||
155217803|NCT04318080|560236779|FG001|Overall Study|Protocol Deviation|0|||
155217804|NCT06308822|560236780|FG000|Overall Study|Mutation Status Not Confirmed|17|||
155217805|NCT06308822|560236780|FG000|Overall Study|Adverse Event|1|||
155217806|NCT06308822|560236780|FG000|Overall Study|Death|5|||
155217807|NCT06308822|560236780|FG000|Overall Study|Disease progression|8|||
155217808|NCT06308822|560236780|FG000|Overall Study|Withdrawal by Subject|1|||
155217809|NCT06308822|560236780|FG000|Overall Study|Physician Decision|3|||
155217810|NCT02926924|560236781|FG000|Overall Study|withdrawal - reason unknown|0|||
155217811|NCT02926924|560236782|FG001|Overall Study|withdrawal - reason unknown|1|||
155217812|NCT04734652|560236793|FG000|Overall Study|Withdrawal by Subject|2|||
155217813|NCT04734652|560236794|FG001|Overall Study|Withdrawal by Subject|0|||
155217814|NCT04734652|560236793|FG000|Overall Study|Death|0|||
155217815|NCT04734652|560236794|FG001|Overall Study|Death|1|||
155217816|NCT01921179|560236795|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
155217817|NCT01921179|560236796|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
155217818|NCT01921179|560236795|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
155217819|NCT01921179|560236796|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
155217820|NCT02356783|560236797|FG000|Overall Study|Lost to Follow-up|1|||
155217821|NCT02356783|560236798|FG001|Overall Study|Lost to Follow-up|3|||
155217822|NCT02603809|560236799|FG000|Overall Study|Withdrawal by Subject|4|||
155217823|NCT02603809|560236800|FG001|Overall Study|Withdrawal by Subject|1|||
155217824|NCT02603809|560236801|FG002|Overall Study|Withdrawal by Subject|2|||
155217825|NCT02603809|560236802|FG003|Overall Study|Withdrawal by Subject|3|||
155217826|NCT02603809|560236803|FG004|Overall Study|Withdrawal by Subject|3|||
155217827|NCT02603809|560236804|FG005|Overall Study|Withdrawal by Subject|4|||
155217828|NCT02603809|560236799|FG000|Overall Study|Lost to Follow-up|2|||
155217829|NCT02603809|560236800|FG001|Overall Study|Lost to Follow-up|3|||
155217830|NCT02603809|560236801|FG002|Overall Study|Lost to Follow-up|1|||
155217831|NCT02603809|560236802|FG003|Overall Study|Lost to Follow-up|4|||
155217832|NCT02603809|560236803|FG004|Overall Study|Lost to Follow-up|2|||
155217833|NCT02603809|560236804|FG005|Overall Study|Lost to Follow-up|2|||
155217834|NCT02603809|560236799|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
155217835|NCT02603809|560236800|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
155217836|NCT02603809|560236801|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
155217837|NCT02603809|560236802|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
155217838|NCT02603809|560236803|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
155217839|NCT02603809|560236804|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
155217840|NCT02603809|560236799|FG000|Overall Study|Physician Decision|0|||
155217841|NCT02603809|560236800|FG001|Overall Study|Physician Decision|0|||
155217842|NCT02603809|560236801|FG002|Overall Study|Physician Decision|0|||
155217843|NCT02603809|560236802|FG003|Overall Study|Physician Decision|1|||
155217844|NCT02603809|560236803|FG004|Overall Study|Physician Decision|2|||
155217845|NCT02603809|560236804|FG005|Overall Study|Physician Decision|1|||
155217846|NCT02603809|560236799|FG000|Overall Study|Adverse Event|3|||
155217847|NCT02603809|560236800|FG001|Overall Study|Adverse Event|0|||
155217848|NCT02603809|560236801|FG002|Overall Study|Adverse Event|2|||
155217849|NCT02603809|560236802|FG003|Overall Study|Adverse Event|2|||
155217850|NCT02603809|560236803|FG004|Overall Study|Adverse Event|1|||
155217851|NCT02603809|560236804|FG005|Overall Study|Adverse Event|1|||
155217852|NCT02603809|560236799|FG000|Overall Study|Lack of Efficacy|0|||
155217853|NCT02603809|560236800|FG001|Overall Study|Lack of Efficacy|1|||
155217854|NCT02603809|560236801|FG002|Overall Study|Lack of Efficacy|0|||
155217855|NCT02603809|560236802|FG003|Overall Study|Lack of Efficacy|0|||
155217856|NCT02603809|560236803|FG004|Overall Study|Lack of Efficacy|0|||
155217857|NCT02603809|560236804|FG005|Overall Study|Lack of Efficacy|1|||
155217858|NCT04146545|560236805|FG000|Overall Study|deemed ineligible after randomization|1|||
155217859|NCT04146545|560236806|FG001|Overall Study|deemed ineligible after randomization|0|||
155217860|NCT00112502|560236807|FG000|Overall Study|Withdrawal by Subject|0|||
155217861|NCT00112502|560236808|FG001|Overall Study|Withdrawal by Subject|1|||
155217862|NCT00112502|560236809|FG002|Overall Study|Withdrawal by Subject|1|||
155217863|NCT00112502|560236810|FG003|Overall Study|Withdrawal by Subject|4|||
155217864|NCT00112502|560236811|FG004|Overall Study|Withdrawal by Subject|2|||
155217865|NCT00112502|560236812|FG005|Overall Study|Withdrawal by Subject|5|||
155217866|NCT00112502|560236813|FG006|Overall Study|Withdrawal by Subject|3|||
155217867|NCT00112502|560236814|FG007|Overall Study|Withdrawal by Subject|7|||
155217868|NCT00265343|560236815|FG000|Overall Study|Adverse Event|10|||
155217869|NCT00265343|560236816|FG001|Overall Study|Adverse Event|7|||
155217870|NCT00265343|560236815|FG000|Overall Study|Withdrawal by Subject|3|||
155217871|NCT00265343|560236816|FG001|Overall Study|Withdrawal by Subject|9|||
155217872|NCT00265343|560236815|FG000|Overall Study|Other|8|||
155217873|NCT00265343|560236816|FG001|Overall Study|Other|3|||
155217874|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
155217875|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217876|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217877|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217878|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217879|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217880|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217881|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217882|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
155217883|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217884|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
155217885|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217886|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217887|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217888|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217889|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217890|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217891|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
155217892|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
155217893|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
155217894|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
155217895|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
155217896|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
155217897|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
155217898|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
155217899|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
155217900|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
155217901|NCT03662542|560236820|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
155217902|NCT03662542|560236821|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217903|NCT03662542|560236822|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217904|NCT03662542|560236823|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217905|NCT03662542|560236824|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217906|NCT03662542|560236825|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217907|NCT03662542|560236826|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217908|NCT03662542|560236827|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217909|NCT03662542|560236828|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
155217910|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217911|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217912|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217913|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217914|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217915|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
155217916|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217917|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217918|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
155217919|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217920|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217921|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217922|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
155217923|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
155217924|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217925|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217926|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217927|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
155217928|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217929|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217930|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217931|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
155217932|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
155217933|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
155217934|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217935|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217936|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
155217937|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217938|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217939|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217940|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217941|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
155217942|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
155217943|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217944|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217945|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
155217946|NCT03662542|560236820|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217947|NCT03662542|560236821|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217948|NCT03662542|560236822|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217949|NCT03662542|560236823|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217950|NCT03662542|560236824|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217951|NCT03662542|560236825|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
155217952|NCT03662542|560236826|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217953|NCT03662542|560236827|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217954|NCT03662542|560236828|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
155217955|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217956|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217957|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217958|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217959|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217960|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217961|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217962|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
155217963|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
155217964|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217965|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217966|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217967|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217968|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217969|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217970|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
155217971|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
155217972|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
155217973|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217974|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217975|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217976|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217977|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217978|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217979|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
155217980|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
155217981|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
155217982|NCT03662542|560236820|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217983|NCT03662542|560236821|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217984|NCT03662542|560236822|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217985|NCT03662542|560236823|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217986|NCT03662542|560236824|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217987|NCT03662542|560236825|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
155217988|NCT03662542|560236826|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
155217989|NCT03662542|560236827|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
155217990|NCT03662542|560236828|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
155217991|NCT01217060|560236830|FG000|Overall Study|Withdrawal by Subject|1|||
155217992|NCT01998633|560236848|FG000|Overall Study|Death|1|||
155217993|NCT00413192|560236849|FG000|Overall Study|Disease progression|26|||
155217994|NCT00413192|560236850|FG001|Overall Study|Disease progression|31|||
155217995|NCT00413192|560236851|FG002|Overall Study|Disease progression|16|||
155217996|NCT00413192|560236852|FG003|Overall Study|Disease progression|25|||
155217997|NCT00413192|560236849|FG000|Overall Study|Toxicity|3|||
155217998|NCT00413192|560236850|FG001|Overall Study|Toxicity|2|||
155217999|NCT00413192|560236851|FG002|Overall Study|Toxicity|2|||
155218000|NCT00413192|560236852|FG003|Overall Study|Toxicity|2|||
155218001|NCT00413192|560236849|FG000|Overall Study|Withdrawal by Subject|3|||
155218002|NCT00413192|560236850|FG001|Overall Study|Withdrawal by Subject|5|||
155218003|NCT00413192|560236851|FG002|Overall Study|Withdrawal by Subject|0|||
155218004|NCT00413192|560236852|FG003|Overall Study|Withdrawal by Subject|1|||
155218005|NCT00413192|560236849|FG000|Overall Study|Intercurrent illness|0|||
155218006|NCT00413192|560236850|FG001|Overall Study|Intercurrent illness|0|||
155218007|NCT00413192|560236851|FG002|Overall Study|Intercurrent illness|0|||
155218008|NCT00413192|560236852|FG003|Overall Study|Intercurrent illness|1|||
155218009|NCT00413192|560236849|FG000|Overall Study|Intercurrent death|0|||
155218010|NCT00413192|560236850|FG001|Overall Study|Intercurrent death|1|||
155218011|NCT00413192|560236851|FG002|Overall Study|Intercurrent death|0|||
155218012|NCT00413192|560236852|FG003|Overall Study|Intercurrent death|0|||
155218013|NCT00413192|560236849|FG000|Overall Study|Other|5|||
155218014|NCT00413192|560236850|FG001|Overall Study|Other|1|||
155218015|NCT00413192|560236851|FG002|Overall Study|Other|1|||
155218016|NCT00413192|560236852|FG003|Overall Study|Other|2|||
155218017|NCT00413192|560236849|FG000|Overall Study|Not treated|0|||
155218018|NCT00413192|560236850|FG001|Overall Study|Not treated|0|||
155218019|NCT00413192|560236851|FG002|Overall Study|Not treated|0|||
155218020|NCT00413192|560236852|FG003|Overall Study|Not treated|1|||
155218021|NCT03814746|560236853|FG000|Overall Study|Participant decision|9|||
155218022|NCT03814746|560236854|FG001|Overall Study|Participant decision|6|||
155218023|NCT03814746|560236855|FG002|Overall Study|Participant decision|15|||
155218024|NCT03814746|560236853|FG000|Overall Study|Physician Decision|2|||
155218025|NCT03814746|560236854|FG001|Overall Study|Physician Decision|2|||
155218026|NCT03814746|560236855|FG002|Overall Study|Physician Decision|4|||
155218027|NCT03814746|560236853|FG000|Overall Study|Death|2|||
155218028|NCT03814746|560236854|FG001|Overall Study|Death|2|||
155218029|NCT03814746|560236855|FG002|Overall Study|Death|2|||
155218030|NCT03814746|560236853|FG000|Overall Study|Adverse Event|2|||
155218031|NCT03814746|560236854|FG001|Overall Study|Adverse Event|2|||
155218032|NCT03814746|560236855|FG002|Overall Study|Adverse Event|1|||
155218033|NCT03814746|560236853|FG000|Overall Study|Lost to Follow-up|2|||
155218034|NCT03814746|560236854|FG001|Overall Study|Lost to Follow-up|1|||
155218035|NCT03814746|560236855|FG002|Overall Study|Lost to Follow-up|2|||
155218036|NCT03814746|560236853|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
155218037|NCT03814746|560236854|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
155218038|NCT03814746|560236855|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
155218039|NCT03814746|560236853|FG000|Overall Study|Pregnancy|0|||
155218040|NCT03814746|560236854|FG001|Overall Study|Pregnancy|1|||
155218041|NCT03814746|560236855|FG002|Overall Study|Pregnancy|1|||
155218042|NCT03814746|560236853|FG000|Overall Study|Protocol Violation|1|||
155218043|NCT03814746|560236854|FG001|Overall Study|Protocol Violation|0|||
155218044|NCT03814746|560236855|FG002|Overall Study|Protocol Violation|0|||
155218045|NCT05089682|560236856|FG000|Overall Study|Withdrawal by Subject|2|||
155218046|NCT03992781|560236857|FG000|Overall Study|Lost to Follow-up|5|||
155218047|NCT03992781|560236857|FG000|Overall Study|Adverse Event|1|||
155218048|NCT03992781|560236857|FG000|Overall Study|Lack of Efficacy|5|||
155218049|NCT01996826|560236858|FG000|Overall Study|Lost to Follow-up|6|||
155218050|NCT01996826|560236859|FG001|Overall Study|Lost to Follow-up|2|||
155218051|NCT01996826|560236858|FG000|Overall Study|Physician Decision|1|||
155218052|NCT01996826|560236859|FG001|Overall Study|Physician Decision|1|||
155218053|NCT00695396|560236860|FG000|Overall Study|Study Closed Prematurely|5|||
155218054|NCT00695396|560236861|FG001|Overall Study|Study Closed Prematurely|6|||
155218055|NCT00695396|560236862|FG002|Overall Study|Study Closed Prematurely|8|||
155218056|NCT00695396|560236860|FG000|Overall Study|Withdrawal by Subject|2|||
155218057|NCT00695396|560236861|FG001|Overall Study|Withdrawal by Subject|2|||
155218058|NCT00695396|560236862|FG002|Overall Study|Withdrawal by Subject|0|||
155218059|NCT00518323|560236864|FG000|Overall Study|Lack of Efficacy|14|||
155218060|NCT00518323|560236865|FG001|Overall Study|Lack of Efficacy|2|||
155218061|NCT00518323|560236866|FG002|Overall Study|Lack of Efficacy|4|||
155218062|NCT00518323|560236867|FG003|Overall Study|Lack of Efficacy|20|||
155218063|NCT00518323|560236864|FG000|Overall Study|Withdrawal by Subject|1|||
155218064|NCT00518323|560236865|FG001|Overall Study|Withdrawal by Subject|2|||
155218065|NCT00518323|560236866|FG002|Overall Study|Withdrawal by Subject|4|||
155218066|NCT00518323|560236867|FG003|Overall Study|Withdrawal by Subject|2|||
155218067|NCT00518323|560236864|FG000|Overall Study|Lost to Follow-up|0|||
155218068|NCT00518323|560236865|FG001|Overall Study|Lost to Follow-up|2|||
155218069|NCT00518323|560236866|FG002|Overall Study|Lost to Follow-up|1|||
155218070|NCT00518323|560236867|FG003|Overall Study|Lost to Follow-up|3|||
155218071|NCT00518323|560236864|FG000|Overall Study|Adverse Event|1|||
155218072|NCT00518323|560236865|FG001|Overall Study|Adverse Event|1|||
155218073|NCT00518323|560236866|FG002|Overall Study|Adverse Event|1|||
155218074|NCT00518323|560236867|FG003|Overall Study|Adverse Event|0|||
155218075|NCT00518323|560236864|FG000|Overall Study|Prohibited medication and others|3|||
155218076|NCT00518323|560236865|FG001|Overall Study|Prohibited medication and others|1|||
155218077|NCT00518323|560236866|FG002|Overall Study|Prohibited medication and others|1|||
155218078|NCT00518323|560236867|FG003|Overall Study|Prohibited medication and others|0|||
155218079|NCT03164928|560236869|FG000|Overall Study|Lost to Follow-up|1|||
155218080|NCT03164928|560236870|FG001|Overall Study|Lost to Follow-up|0|||
155218081|NCT00772707|560236871|FG000|Overall Study|Withdrawn|3|||
155218082|NCT04499781|560236872|FG000|Overall Study|Lost to Follow-up|2|||
155218083|NCT04499781|560236873|FG001|Overall Study|Lost to Follow-up|3|||
155218084|NCT04499781|560236872|FG000|Overall Study|Withdrawal by Subject|2|||
155218085|NCT04499781|560236873|FG001|Overall Study|Withdrawal by Subject|0|||
155218086|NCT00371254|560236874|FG000|Overall Study|Disease progression|13|||
155218087|NCT00371254|560236875|FG001|Overall Study|Disease progression|13|||
155218088|NCT00371254|560236874|FG000|Overall Study|Study drug toxicity|3|||
155218089|NCT00371254|560236875|FG001|Overall Study|Study drug toxicity|5|||
155218090|NCT00371254|560236874|FG000|Overall Study|Subject request|5|||
155218091|NCT00371254|560236875|FG001|Overall Study|Subject request|0|||
155218092|NCT00371254|560236874|FG000|Overall Study|Investigator Decision|2|||
155218093|NCT00371254|560236875|FG001|Overall Study|Investigator Decision|0|||
155218094|NCT00371254|560236874|FG000|Overall Study|Adverse event unrelated to study drug|0|||
155218095|NCT00371254|560236875|FG001|Overall Study|Adverse event unrelated to study drug|1|||
155218096|NCT00371254|560236874|FG000|Overall Study|Lost to Follow-up|0|||
155218097|NCT00371254|560236875|FG001|Overall Study|Lost to Follow-up|1|||
155218098|NCT00371254|560236874|FG000|Overall Study|Withdrawal by Subject|0|||
155218099|NCT00371254|560236875|FG001|Overall Study|Withdrawal by Subject|1|||
155218100|NCT03329690|560236876|FG000|Overall Study|Progressive disease per RECIST|85|||
155218101|NCT03329690|560236877|FG001|Overall Study|Progressive disease per RECIST|44|||
155218102|NCT03329690|560236878|FG002|Overall Study|Progressive disease per RECIST|6|||
155218103|NCT03329690|560236879|FG003|Overall Study|Progressive disease per RECIST|16|||
155218104|NCT03329690|560236880|FG004|Overall Study|Progressive disease per RECIST|20|||
155218105|NCT03329690|560236876|FG000|Overall Study|Clinical progression|7|||
155218106|NCT03329690|560236877|FG001|Overall Study|Clinical progression|4|||
155218107|NCT03329690|560236878|FG002|Overall Study|Clinical progression|1|||
155218108|NCT03329690|560236879|FG003|Overall Study|Clinical progression|1|||
155218109|NCT03329690|560236880|FG004|Overall Study|Clinical progression|1|||
155218110|NCT03329690|560236876|FG000|Overall Study|Adverse Event|22|||
155218111|NCT03329690|560236877|FG001|Overall Study|Adverse Event|4|||
155218112|NCT03329690|560236878|FG002|Overall Study|Adverse Event|0|||
155218113|NCT03329690|560236879|FG003|Overall Study|Adverse Event|1|||
155218114|NCT03329690|560236880|FG004|Overall Study|Adverse Event|2|||
155218115|NCT03329690|560236876|FG000|Overall Study|Death|2|||
155218116|NCT03329690|560236877|FG001|Overall Study|Death|0|||
155218117|NCT03329690|560236878|FG002|Overall Study|Death|0|||
155218118|NCT03329690|560236879|FG003|Overall Study|Death|1|||
155218119|NCT03329690|560236880|FG004|Overall Study|Death|0|||
155218120|NCT03329690|560236876|FG000|Overall Study|Withdrawal by Subject|2|||
155218121|NCT03329690|560236877|FG001|Overall Study|Withdrawal by Subject|3|||
155218122|NCT03329690|560236878|FG002|Overall Study|Withdrawal by Subject|0|||
155218123|NCT03329690|560236879|FG003|Overall Study|Withdrawal by Subject|1|||
155218124|NCT03329690|560236880|FG004|Overall Study|Withdrawal by Subject|0|||
155218125|NCT03329690|560236876|FG000|Overall Study|Physician Decision|1|||
155218126|NCT03329690|560236877|FG001|Overall Study|Physician Decision|0|||
155218127|NCT03329690|560236878|FG002|Overall Study|Physician Decision|0|||
155218128|NCT03329690|560236879|FG003|Overall Study|Physician Decision|0|||
155218129|NCT03329690|560236880|FG004|Overall Study|Physician Decision|1|||
155218130|NCT03329690|560236876|FG000|Overall Study|Miscellaneous|6|||
155218131|NCT03329690|560236877|FG001|Overall Study|Miscellaneous|0|||
155218132|NCT03329690|560236878|FG002|Overall Study|Miscellaneous|0|||
155218133|NCT03329690|560236879|FG003|Overall Study|Miscellaneous|0|||
155218134|NCT03329690|560236880|FG004|Overall Study|Miscellaneous|0|||
155218135|NCT03329690|560236876|FG000|Overall Study|Did not receive treatment|1|||
155218136|NCT03329690|560236877|FG001|Overall Study|Did not receive treatment|0|||
155218137|NCT03329690|560236878|FG002|Overall Study|Did not receive treatment|0|||
155218138|NCT03329690|560236879|FG003|Overall Study|Did not receive treatment|1|||
155218139|NCT03329690|560236880|FG004|Overall Study|Did not receive treatment|0|||
155218140|NCT01817725|560236881|FG000|Overall Study|Withdrawal by Subject|1|||
155218141|NCT02337907|560236884|FG000|Overall Study|Other than listed|1|||
155218142|NCT02337907|560236885|FG001|Overall Study|Other than listed|0|||
155218143|NCT02337907|560236886|FG002|Overall Study|Other than listed|0|||
155218144|NCT02337907|560236887|FG003|Overall Study|Other than listed|1|||
155218145|NCT02337907|560236888|FG004|Overall Study|Other than listed|1|||
155218146|NCT02337907|560236889|FG005|Overall Study|Other than listed|0|||
155218147|NCT02337907|560236884|FG000|Overall Study|Withdrawal by Subject|2|||
155218148|NCT02337907|560236885|FG001|Overall Study|Withdrawal by Subject|3|||
155218149|NCT02337907|560236886|FG002|Overall Study|Withdrawal by Subject|0|||
155218150|NCT02337907|560236887|FG003|Overall Study|Withdrawal by Subject|2|||
155218151|NCT02337907|560236888|FG004|Overall Study|Withdrawal by Subject|5|||
155218152|NCT02337907|560236889|FG005|Overall Study|Withdrawal by Subject|0|||
155218153|NCT02337907|560236884|FG000|Overall Study|Lost to Follow-up|0|||
155218154|NCT02337907|560236885|FG001|Overall Study|Lost to Follow-up|0|||
155218155|NCT02337907|560236886|FG002|Overall Study|Lost to Follow-up|0|||
155218156|NCT02337907|560236887|FG003|Overall Study|Lost to Follow-up|0|||
155218157|NCT02337907|560236888|FG004|Overall Study|Lost to Follow-up|0|||
155218158|NCT02337907|560236889|FG005|Overall Study|Lost to Follow-up|1|||
155218159|NCT02337907|560236884|FG000|Overall Study|Adverse Event|1|||
155218160|NCT02337907|560236885|FG001|Overall Study|Adverse Event|1|||
155218161|NCT02337907|560236886|FG002|Overall Study|Adverse Event|1|||
155218162|NCT02337907|560236887|FG003|Overall Study|Adverse Event|1|||
155218163|NCT02337907|560236888|FG004|Overall Study|Adverse Event|4|||
155218164|NCT02337907|560236889|FG005|Overall Study|Adverse Event|0|||
155218165|NCT01679002|560236890|FG000|Overall Study|Adverse Event|1|||
155218166|NCT01679002|560236891|FG001|Overall Study|Adverse Event|1|||
155218167|NCT01679002|560236892|FG002|Overall Study|Adverse Event|0|||
155218168|NCT00613015|560236900|FG000|Overall Study|Lost to Follow-up|0|||
155218169|NCT00613015|560236901|FG001|Overall Study|Lost to Follow-up|1|||
155218170|NCT00613015|560236902|FG002|Overall Study|Lost to Follow-up|3|||
155218171|NCT00613015|560236903|FG003|Overall Study|Lost to Follow-up|3|||
155218172|NCT00613015|560236904|FG004|Overall Study|Lost to Follow-up|2|||
155218173|NCT00613015|560236905|FG005|Overall Study|Lost to Follow-up|3|||
155218174|NCT04327388|560236908|FG000|Overall Study|Adverse Event|17|||
155218175|NCT04327388|560236909|FG001|Overall Study|Adverse Event|18|||
155218176|NCT04327388|560236910|FG002|Overall Study|Adverse Event|9|||
155218177|NCT04327388|560236908|FG000|Overall Study|Other|1|||
155218178|NCT04327388|560236909|FG001|Overall Study|Other|2|||
155218179|NCT04327388|560236910|FG002|Overall Study|Other|0|||
155218180|NCT04327388|560236908|FG000|Overall Study|Randomized and not treated|2|||
155218181|NCT04327388|560236909|FG001|Overall Study|Randomized and not treated|0|||
155218182|NCT04327388|560236910|FG002|Overall Study|Randomized and not treated|2|||
155218183|NCT04829318|560236911|FG000|Overall Study|Adverse Event|6|||
155218184|NCT04829318|560236911|FG000|Overall Study|Death|1|||
155218185|NCT04829318|560236911|FG000|Overall Study|Lost to Follow-up|1|||
155218186|NCT04829318|560236911|FG000|Overall Study|Physician Decision|1|||
155218187|NCT04829318|560236911|FG000|Overall Study|Withdrawal by Subject|19|||
155218188|NCT04829318|560236911|FG000|Overall Study|Site terminated by sponsor|1|||
155218189|NCT04829318|560236911|FG000|Overall Study|Sponsor decision|5|||
155218190|NCT04829318|560236911|FG000|Overall Study|Other|1|||
155218191|NCT00728130|560236912|FG000|Overall Study|Withdrawal by Subject|1|||
155218192|NCT00728130|560236912|FG000|Overall Study|Paperwork not completed in time|1|||
155218193|NCT00728130|560236912|FG000|Overall Study|Physician Decision|1|||
155218194|NCT04053023|560236915|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
155218195|NCT04053023|560236916|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
155218196|NCT00455429|560236920|FG000|Overall Study|Study Terminated by Sponsor|0|||
155218197|NCT00455429|560236921|FG001|Overall Study|Study Terminated by Sponsor|0|||
155218198|NCT00455429|560236922|FG002|Overall Study|Study Terminated by Sponsor|0|||
155218199|NCT00455429|560236923|FG003|Overall Study|Study Terminated by Sponsor|3|||
155218200|NCT00455429|560236920|FG000|Overall Study|Lost to Follow-up|1|||
155218201|NCT00455429|560236921|FG001|Overall Study|Lost to Follow-up|0|||
155218202|NCT00455429|560236922|FG002|Overall Study|Lost to Follow-up|0|||
155218203|NCT00455429|560236923|FG003|Overall Study|Lost to Follow-up|3|||
155218204|NCT00455429|560236920|FG000|Overall Study|Withdrawal by Subject|0|||
155218205|NCT00455429|560236921|FG001|Overall Study|Withdrawal by Subject|1|||
155218206|NCT00455429|560236922|FG002|Overall Study|Withdrawal by Subject|1|||
155218207|NCT00455429|560236923|FG003|Overall Study|Withdrawal by Subject|0|||
155218208|NCT00455429|560236920|FG000|Overall Study|Lack of Efficacy|0|||
155218209|NCT00455429|560236921|FG001|Overall Study|Lack of Efficacy|1|||
155218210|NCT00455429|560236922|FG002|Overall Study|Lack of Efficacy|0|||
155218211|NCT00455429|560236923|FG003|Overall Study|Lack of Efficacy|1|||
155218212|NCT00455429|560236920|FG000|Overall Study|Adverse Event|0|||
155218213|NCT00455429|560236921|FG001|Overall Study|Adverse Event|1|||
155218214|NCT00455429|560236922|FG002|Overall Study|Adverse Event|0|||
155218215|NCT00455429|560236923|FG003|Overall Study|Adverse Event|3|||
155218216|NCT00455429|560236920|FG000|Overall Study|Randomly assigned but not treated|0|||
155218217|NCT00455429|560236921|FG001|Overall Study|Randomly assigned but not treated|0|||
155218218|NCT00455429|560236922|FG002|Overall Study|Randomly assigned but not treated|0|||
155218219|NCT00455429|560236923|FG003|Overall Study|Randomly assigned but not treated|2|||
155218220|NCT00455429|560236920|FG000|Overall Study|Personal Reason|1|||
155218221|NCT00455429|560236921|FG001|Overall Study|Personal Reason|0|||
155218222|NCT00455429|560236922|FG002|Overall Study|Personal Reason|0|||
155218223|NCT00455429|560236923|FG003|Overall Study|Personal Reason|0|||
155218224|NCT00455429|560236920|FG000|Overall Study|Non-compliance|0|||
155218225|NCT00455429|560236921|FG001|Overall Study|Non-compliance|0|||
155218226|NCT00455429|560236922|FG002|Overall Study|Non-compliance|0|||
155218227|NCT00455429|560236923|FG003|Overall Study|Non-compliance|1|||
155218228|NCT00455429|560236920|FG000|Overall Study|Other|0|||
155218229|NCT00455429|560236921|FG001|Overall Study|Other|2|||
155218230|NCT00455429|560236922|FG002|Overall Study|Other|0|||
155218231|NCT00455429|560236923|FG003|Overall Study|Other|1|||
155218232|NCT01412021|560236924|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
155218233|NCT01412021|560236924|FG000|Overall Study|Treatment Prior to Approval|3|||
155218234|NCT01412021|560236924|FG000|Overall Study|Transferred to Other Hospital|9|||
155218235|NCT00238121|560236925|FG000|Overall Study|Withdrawal by Subject|1|||
155218236|NCT00238121|560236926|FG001|Overall Study|Withdrawal by Subject|1|||
155218237|NCT00238121|560236925|FG000|Overall Study|Adverse Event|2|||
155218238|NCT00238121|560236926|FG001|Overall Study|Adverse Event|1|||
155218239|NCT03255382|560236927|FG000|Overall Study|Adverse Event|3|||
155218240|NCT03255382|560236928|FG001|Overall Study|Adverse Event|0|||
155218241|NCT03255382|560236927|FG000|Overall Study|Lost to Follow-up|2|||
155218242|NCT03255382|560236928|FG001|Overall Study|Lost to Follow-up|0|||
155218243|NCT03255382|560236927|FG000|Overall Study|Withdrawal by Subject|2|||
155218244|NCT03255382|560236928|FG001|Overall Study|Withdrawal by Subject|0|||
155218245|NCT03255382|560236927|FG000|Overall Study|Other|6|||
155218246|NCT03255382|560236928|FG001|Overall Study|Other|0|||
155218247|NCT01166178|560236929|FG000|Overall Study|Withdrawal by Subject|1|||
155218248|NCT01166178|560236930|FG001|Overall Study|Withdrawal by Subject|0|||
155218249|NCT01166178|560236929|FG000|Overall Study|Study was terminated|20|||
155218250|NCT01166178|560236930|FG001|Overall Study|Study was terminated|8|||
155218251|NCT00484939|560236931|FG000|Overall Study|Death|9|||
155218252|NCT00484939|560236932|FG001|Overall Study|Death|13|||
155218253|NCT00484939|560236931|FG000|Overall Study|Adverse Event|22|||
155218254|NCT00484939|560236932|FG001|Overall Study|Adverse Event|12|||
155218255|NCT00484939|560236931|FG000|Overall Study|Patient Withdrew Consent|19|||
155218256|NCT00484939|560236932|FG001|Overall Study|Patient Withdrew Consent|10|||
155218257|NCT00484939|560236931|FG000|Overall Study|Protocol Violation|3|||
155218258|NCT00484939|560236932|FG001|Overall Study|Protocol Violation|3|||
155218259|NCT00484939|560236931|FG000|Overall Study|Lost to Follow-up|0|||
155218260|NCT00484939|560236932|FG001|Overall Study|Lost to Follow-up|3|||
155218261|NCT00484939|560236931|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
155218262|NCT00484939|560236932|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
155218263|NCT00484939|560236931|FG000|Overall Study|Disease progression|67|||
155218264|NCT00484939|560236932|FG001|Overall Study|Disease progression|88|||
155218265|NCT00484939|560236931|FG000|Overall Study|Screen Failure|2|||
155218266|NCT00484939|560236932|FG001|Overall Study|Screen Failure|2|||
155218267|NCT00484939|560236931|FG000|Overall Study|Reason Not Specified|11|||
155218268|NCT00484939|560236932|FG001|Overall Study|Reason Not Specified|6|||
155218269|NCT02466555|560236933|FG000|Overall Study|Lost to Follow-up|2|||
155218270|NCT02113956|560236940|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
155218271|NCT02113956|560236941|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
155218272|NCT02113956|560236940|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
155218273|NCT02113956|560236941|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
155218274|NCT02113956|560236940|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
155218275|NCT02113956|560236941|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
155218276|NCT01499563|560236944|FG000|Overall Study|Withdrawal by Subject|10|||
155218277|NCT01499563|560236945|FG001|Overall Study|Withdrawal by Subject|11|||
155218278|NCT01499563|560236946|FG002|Overall Study|Withdrawal by Subject|7|||
155218279|NCT01499563|560236947|FG003|Overall Study|Withdrawal by Subject|8|||
155218280|NCT01499563|560236944|FG000|Overall Study|Physician Decision|2|||
155218281|NCT01499563|560236945|FG001|Overall Study|Physician Decision|1|||
155218282|NCT01499563|560236946|FG002|Overall Study|Physician Decision|3|||
155218283|NCT01499563|560236947|FG003|Overall Study|Physician Decision|0|||
155218284|NCT01499563|560236944|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
155218285|NCT01499563|560236945|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
155218286|NCT01499563|560236946|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
155218287|NCT01499563|560236947|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
155218288|NCT01499563|560236944|FG000|Overall Study|Adverse Event|2|||
155218289|NCT01499563|560236945|FG001|Overall Study|Adverse Event|0|||
155218290|NCT01499563|560236946|FG002|Overall Study|Adverse Event|1|||
155218291|NCT01499563|560236947|FG003|Overall Study|Adverse Event|3|||
155218292|NCT01499563|560236944|FG000|Overall Study|Lack of Efficacy|0|||
155218293|NCT01499563|560236945|FG001|Overall Study|Lack of Efficacy|1|||
155218294|NCT01499563|560236946|FG002|Overall Study|Lack of Efficacy|6|||
155218295|NCT01499563|560236947|FG003|Overall Study|Lack of Efficacy|3|||
155218296|NCT01499563|560236944|FG000|Overall Study|Other|8|||
155218297|NCT01499563|560236945|FG001|Overall Study|Other|6|||
155218298|NCT01499563|560236946|FG002|Overall Study|Other|6|||
155218299|NCT01499563|560236947|FG003|Overall Study|Other|4|||
155218300|NCT01239368|560239468|FG000|Overall Study|Principal investigator discretion|1|||
155218301|NCT01239368|560239469|FG001|Overall Study|Principal investigator discretion|0|||
155218302|NCT01239368|560239470|FG002|Overall Study|Principal investigator discretion|0|||
155218303|NCT01239368|560239471|FG003|Overall Study|Principal investigator discretion|0|||
155218304|NCT01239368|560239472|FG004|Overall Study|Principal investigator discretion|1|||
155218305|NCT01239368|560239473|FG005|Overall Study|Principal investigator discretion|2|||
155218306|NCT01239368|560239474|FG006|Overall Study|Principal investigator discretion|0|||
155218307|NCT01239368|560239475|FG007|Overall Study|Principal investigator discretion|0|||
155218308|NCT01239368|560239476|FG008|Overall Study|Principal investigator discretion|0|||
155218309|NCT01239368|560239477|FG009|Overall Study|Principal investigator discretion|1|||
155218310|NCT01239368|560239468|FG000|Overall Study|Disease progression on study|1|||
155218311|NCT01239368|560239469|FG001|Overall Study|Disease progression on study|1|||
155218312|NCT01239368|560239470|FG002|Overall Study|Disease progression on study|1|||
155218313|NCT01239368|560239471|FG003|Overall Study|Disease progression on study|1|||
155218314|NCT01239368|560239472|FG004|Overall Study|Disease progression on study|4|||
155218315|NCT01239368|560239473|FG005|Overall Study|Disease progression on study|2|||
155218316|NCT01239368|560239474|FG006|Overall Study|Disease progression on study|5|||
155218317|NCT01239368|560239475|FG007|Overall Study|Disease progression on study|0|||
155218318|NCT01239368|560239476|FG008|Overall Study|Disease progression on study|0|||
155218319|NCT01239368|560239477|FG009|Overall Study|Disease progression on study|2|||
155218320|NCT01239368|560239468|FG000|Overall Study|Refused further treatment|0|||
155218321|NCT01239368|560239469|FG001|Overall Study|Refused further treatment|0|||
155218322|NCT01239368|560239470|FG002|Overall Study|Refused further treatment|0|||
155218323|NCT01239368|560239471|FG003|Overall Study|Refused further treatment|0|||
155218324|NCT01239368|560239472|FG004|Overall Study|Refused further treatment|0|||
155218325|NCT01239368|560239473|FG005|Overall Study|Refused further treatment|0|||
155218326|NCT01239368|560239474|FG006|Overall Study|Refused further treatment|0|||
155218327|NCT01239368|560239475|FG007|Overall Study|Refused further treatment|0|||
155218328|NCT01239368|560239476|FG008|Overall Study|Refused further treatment|0|||
155218329|NCT01239368|560239477|FG009|Overall Study|Refused further treatment|1|||
155218330|NCT01239368|560239468|FG000|Overall Study|Death|0|||
155218331|NCT01239368|560239469|FG001|Overall Study|Death|0|||
155218332|NCT01239368|560239470|FG002|Overall Study|Death|0|||
155218333|NCT01239368|560239471|FG003|Overall Study|Death|0|||
155218334|NCT01239368|560239472|FG004|Overall Study|Death|0|||
155218335|NCT01239368|560239473|FG005|Overall Study|Death|0|||
155218336|NCT01239368|560239474|FG006|Overall Study|Death|1|||
155218337|NCT01239368|560239475|FG007|Overall Study|Death|0|||
155218338|NCT01239368|560239476|FG008|Overall Study|Death|0|||
155218339|NCT01239368|560239477|FG009|Overall Study|Death|0|||
155218340|NCT03181399|560239479|FG000|6 Months on Treatment|Protocol non-compliance|7|||
155218341|NCT03181399|560239479|FG000|6 Months on Treatment|Adverse Event|4|||
155218342|NCT03181399|560239479|FG000|6 Months on Treatment|Tried alternative treatment|2|||
155218343|NCT03181399|560239479|FG000|6 Months on Treatment|Lost to Follow-up|2|||
155218344|NCT03181399|560239479|FG000|6 Months on Treatment|Personal reasons|1|||
155218345|NCT03181399|560239479|FG000|3 Months Off-treatment|Parent unable to travel|1|||
155218346|NCT01536379|560239480|FG000|Overall Study|Adverse Event|1|||
155218347|NCT01536379|560239481|FG001|Overall Study|Adverse Event|2|||
155218348|NCT01536379|560239480|FG000|Overall Study|Withdrawal by Subject|1|||
155218349|NCT01536379|560239481|FG001|Overall Study|Withdrawal by Subject|1|||
155218350|NCT00939809|560239484|FG000|Overall Study|Adverse Event|2|||
155218351|NCT00939809|560239484|FG000|Overall Study|Death|1|||
155218352|NCT00380978|560239485|FG000|Overall Study|Refused allocated intervention|0|||
155218353|NCT00380978|560239486|FG001|Overall Study|Refused allocated intervention|6|||
155218354|NCT00380978|560239485|FG000|Overall Study|Wrong study envelope|0|||
155218355|NCT00380978|560239486|FG001|Overall Study|Wrong study envelope|2|||
155218356|NCT00380978|560239485|FG000|Overall Study|Allocation prior to analgesia request|1|||
155218357|NCT00380978|560239486|FG001|Overall Study|Allocation prior to analgesia request|2|||
155218358|NCT00380978|560239485|FG000|Overall Study|Parous patient|1|||
155218359|NCT00380978|560239486|FG001|Overall Study|Parous patient|0|||
155218360|NCT04729127|560239487|FG000|Overall Study|Suspended/Terminated EI Services|4|||
155218361|NCT04729127|560239488|FG001|Overall Study|Suspended/Terminated EI Services|0|||
155218362|NCT04729127|560239489|FG002|Overall Study|Suspended/Terminated EI Services|4|||
155218363|NCT04729127|560239490|FG003|Overall Study|Suspended/Terminated EI Services|6|||
155218364|NCT04729127|560239491|FG004|Overall Study|Suspended/Terminated EI Services|0|||
155218365|NCT04729127|560239492|FG005|Overall Study|Suspended/Terminated EI Services|6|||
155218366|NCT04729127|560239493|FG006|Overall Study|Suspended/Terminated EI Services|2|||
155218367|NCT04729127|560239494|FG007|Overall Study|Suspended/Terminated EI Services|0|||
155218368|NCT04729127|560239495|FG008|Overall Study|Suspended/Terminated EI Services|2|||
155218369|NCT04729127|560239487|FG000|Overall Study|Withdrawal by Subject|1|||
155218370|NCT04729127|560239488|FG001|Overall Study|Withdrawal by Subject|0|||
155218371|NCT04729127|560239489|FG002|Overall Study|Withdrawal by Subject|1|||
155218372|NCT04729127|560239490|FG003|Overall Study|Withdrawal by Subject|0|||
155218373|NCT04729127|560239491|FG004|Overall Study|Withdrawal by Subject|0|||
155218374|NCT04729127|560239492|FG005|Overall Study|Withdrawal by Subject|0|||
155218375|NCT04729127|560239493|FG006|Overall Study|Withdrawal by Subject|0|||
155218376|NCT04729127|560239494|FG007|Overall Study|Withdrawal by Subject|0|||
155218377|NCT04729127|560239495|FG008|Overall Study|Withdrawal by Subject|0|||
155218378|NCT04729127|560239487|FG000|Overall Study|Switched Agency/Setting|1|||
155218379|NCT04729127|560239488|FG001|Overall Study|Switched Agency/Setting|0|||
155218380|NCT04729127|560239489|FG002|Overall Study|Switched Agency/Setting|1|||
155218381|NCT04729127|560239490|FG003|Overall Study|Switched Agency/Setting|1|||
155218382|NCT04729127|560239491|FG004|Overall Study|Switched Agency/Setting|0|||
155218383|NCT04729127|560239492|FG005|Overall Study|Switched Agency/Setting|1|||
155218384|NCT04729127|560239493|FG006|Overall Study|Switched Agency/Setting|1|||
155218385|NCT04729127|560239494|FG007|Overall Study|Switched Agency/Setting|0|||
155218386|NCT04729127|560239495|FG008|Overall Study|Switched Agency/Setting|1|||
155218387|NCT02608268|560239498|FG000|Overall Study|Adverse Event|0|||
155218388|NCT02608268|560239499|FG001|Overall Study|Adverse Event|0|||
155218389|NCT02608268|560239500|FG002|Overall Study|Adverse Event|1|||
155218390|NCT02608268|560239501|FG003|Overall Study|Adverse Event|0|||
155218391|NCT02608268|560239502|FG004|Overall Study|Adverse Event|0|||
155218392|NCT02608268|560239503|FG005|Overall Study|Adverse Event|0|||
155218393|NCT02608268|560239504|FG006|Overall Study|Adverse Event|0|||
155218394|NCT02608268|560239505|FG007|Overall Study|Adverse Event|0|||
155218395|NCT02608268|560239506|FG008|Overall Study|Adverse Event|0|||
155218396|NCT02608268|560239507|FG009|Overall Study|Adverse Event|0|||
155218397|NCT02608268|560239508|FG010|Overall Study|Adverse Event|0|||
155218398|NCT02608268|560239509|FG011|Overall Study|Adverse Event|0|||
155218399|NCT02608268|560239510|FG012|Overall Study|Adverse Event|2|||
155218400|NCT02608268|560239511|FG013|Overall Study|Adverse Event|0|||
155218401|NCT02608268|560239512|FG014|Overall Study|Adverse Event|0|||
155218402|NCT02608268|560239513|FG015|Overall Study|Adverse Event|0|||
155218403|NCT02608268|560239514|FG016|Overall Study|Adverse Event|0|||
155218404|NCT02608268|560239515|FG017|Overall Study|Adverse Event|0|||
155218405|NCT02608268|560239516|FG018|Overall Study|Adverse Event|0|||
155218406|NCT02608268|560239517|FG019|Overall Study|Adverse Event|0|||
155218407|NCT02608268|560239518|FG020|Overall Study|Adverse Event|1|||
155218408|NCT02608268|560239519|FG021|Overall Study|Adverse Event|1|||
155218409|NCT02608268|560239520|FG022|Overall Study|Adverse Event|0|||
155218410|NCT02608268|560239521|FG023|Overall Study|Adverse Event|0|||
155218411|NCT02608268|560239522|FG024|Overall Study|Adverse Event|1|||
155218412|NCT02608268|560239523|FG025|Overall Study|Adverse Event|0|||
155218413|NCT02608268|560239524|FG026|Overall Study|Adverse Event|0|||
155218414|NCT02608268|560239525|FG027|Overall Study|Adverse Event|0|||
155218415|NCT02608268|560239526|FG028|Overall Study|Adverse Event|1|||
155218416|NCT02608268|560239527|FG029|Overall Study|Adverse Event|0|||
155218417|NCT02608268|560239498|FG000|Overall Study|Death|1|||
155218418|NCT02608268|560239499|FG001|Overall Study|Death|0|||
155218419|NCT02608268|560239500|FG002|Overall Study|Death|0|||
155218420|NCT02608268|560239501|FG003|Overall Study|Death|0|||
155218421|NCT02608268|560239502|FG004|Overall Study|Death|0|||
155218422|NCT02608268|560239503|FG005|Overall Study|Death|0|||
155218423|NCT02608268|560239504|FG006|Overall Study|Death|0|||
155218424|NCT02608268|560239505|FG007|Overall Study|Death|0|||
155218425|NCT02608268|560239506|FG008|Overall Study|Death|1|||
155218426|NCT02608268|560239507|FG009|Overall Study|Death|1|||
155218427|NCT02608268|560239508|FG010|Overall Study|Death|0|||
155218428|NCT02608268|560239509|FG011|Overall Study|Death|0|||
155218429|NCT02608268|560239510|FG012|Overall Study|Death|0|||
155218430|NCT02608268|560239511|FG013|Overall Study|Death|0|||
155218431|NCT02608268|560239512|FG014|Overall Study|Death|0|||
155218432|NCT02608268|560239513|FG015|Overall Study|Death|1|||
155218433|NCT02608268|560239514|FG016|Overall Study|Death|0|||
155218434|NCT02608268|560239515|FG017|Overall Study|Death|1|||
155218435|NCT02608268|560239516|FG018|Overall Study|Death|0|||
155218436|NCT02608268|560239517|FG019|Overall Study|Death|1|||
155218437|NCT02608268|560239518|FG020|Overall Study|Death|1|||
155218438|NCT02608268|560239519|FG021|Overall Study|Death|0|||
155218439|NCT02608268|560239520|FG022|Overall Study|Death|0|||
155218440|NCT02608268|560239521|FG023|Overall Study|Death|0|||
155218441|NCT02608268|560239522|FG024|Overall Study|Death|1|||
155218442|NCT02608268|560239523|FG025|Overall Study|Death|2|||
155218443|NCT02608268|560239524|FG026|Overall Study|Death|0|||
155218444|NCT02608268|560239525|FG027|Overall Study|Death|1|||
155218445|NCT02608268|560239526|FG028|Overall Study|Death|4|||
155218446|NCT02608268|560239527|FG029|Overall Study|Death|0|||
155218447|NCT02608268|560239498|FG000|Overall Study|Physician Decision|0|||
155218448|NCT02608268|560239499|FG001|Overall Study|Physician Decision|0|||
155218449|NCT02608268|560239500|FG002|Overall Study|Physician Decision|0|||
155218450|NCT02608268|560239501|FG003|Overall Study|Physician Decision|0|||
155218451|NCT02608268|560239502|FG004|Overall Study|Physician Decision|0|||
155218452|NCT02608268|560239503|FG005|Overall Study|Physician Decision|0|||
155218453|NCT02608268|560239504|FG006|Overall Study|Physician Decision|0|||
155218454|NCT02608268|560239505|FG007|Overall Study|Physician Decision|0|||
155218455|NCT02608268|560239506|FG008|Overall Study|Physician Decision|0|||
155218456|NCT02608268|560239507|FG009|Overall Study|Physician Decision|0|||
155218457|NCT02608268|560239508|FG010|Overall Study|Physician Decision|1|||
155218458|NCT02608268|560239509|FG011|Overall Study|Physician Decision|0|||
155218459|NCT02608268|560239510|FG012|Overall Study|Physician Decision|0|||
155218460|NCT02608268|560239511|FG013|Overall Study|Physician Decision|1|||
155218461|NCT02608268|560239512|FG014|Overall Study|Physician Decision|0|||
155218462|NCT02608268|560239513|FG015|Overall Study|Physician Decision|0|||
155218463|NCT02608268|560239514|FG016|Overall Study|Physician Decision|0|||
155218464|NCT02608268|560239515|FG017|Overall Study|Physician Decision|0|||
155218465|NCT02608268|560239516|FG018|Overall Study|Physician Decision|0|||
155218466|NCT02608268|560239517|FG019|Overall Study|Physician Decision|0|||
155218467|NCT02608268|560239518|FG020|Overall Study|Physician Decision|0|||
155218468|NCT02608268|560239519|FG021|Overall Study|Physician Decision|0|||
155218469|NCT02608268|560239520|FG022|Overall Study|Physician Decision|1|||
155218470|NCT02608268|560239521|FG023|Overall Study|Physician Decision|1|||
155218471|NCT02608268|560239522|FG024|Overall Study|Physician Decision|1|||
155218472|NCT02608268|560239523|FG025|Overall Study|Physician Decision|0|||
155218473|NCT02608268|560239524|FG026|Overall Study|Physician Decision|0|||
155218474|NCT02608268|560239525|FG027|Overall Study|Physician Decision|2|||
155218475|NCT02608268|560239526|FG028|Overall Study|Physician Decision|1|||
155218476|NCT02608268|560239527|FG029|Overall Study|Physician Decision|1|||
155218477|NCT02608268|560239498|FG000|Overall Study|Progressive disease|12|||
155218478|NCT02608268|560239499|FG001|Overall Study|Progressive disease|8|||
155218479|NCT02608268|560239500|FG002|Overall Study|Progressive disease|13|||
155218480|NCT02608268|560239501|FG003|Overall Study|Progressive disease|5|||
155218481|NCT02608268|560239502|FG004|Overall Study|Progressive disease|2|||
155218482|NCT02608268|560239503|FG005|Overall Study|Progressive disease|4|||
155218483|NCT02608268|560239504|FG006|Overall Study|Progressive disease|6|||
155218484|NCT02608268|560239505|FG007|Overall Study|Progressive disease|2|||
155218485|NCT02608268|560239506|FG008|Overall Study|Progressive disease|5|||
155218486|NCT02608268|560239507|FG009|Overall Study|Progressive disease|6|||
155218487|NCT02608268|560239508|FG010|Overall Study|Progressive disease|5|||
155218488|NCT02608268|560239509|FG011|Overall Study|Progressive disease|5|||
155218489|NCT02608268|560239510|FG012|Overall Study|Progressive disease|4|||
155218490|NCT02608268|560239511|FG013|Overall Study|Progressive disease|11|||
155218491|NCT02608268|560239512|FG014|Overall Study|Progressive disease|6|||
155218492|NCT02608268|560239513|FG015|Overall Study|Progressive disease|3|||
155218493|NCT02608268|560239514|FG016|Overall Study|Progressive disease|5|||
155218494|NCT02608268|560239515|FG017|Overall Study|Progressive disease|5|||
155218495|NCT02608268|560239516|FG018|Overall Study|Progressive disease|5|||
155218496|NCT02608268|560239517|FG019|Overall Study|Progressive disease|2|||
155218497|NCT02608268|560239518|FG020|Overall Study|Progressive disease|10|||
155218498|NCT02608268|560239519|FG021|Overall Study|Progressive disease|4|||
155218499|NCT02608268|560239520|FG022|Overall Study|Progressive disease|5|||
155218500|NCT02608268|560239521|FG023|Overall Study|Progressive disease|5|||
155218501|NCT02608268|560239522|FG024|Overall Study|Progressive disease|3|||
155218502|NCT02608268|560239523|FG025|Overall Study|Progressive disease|11|||
155218503|NCT02608268|560239524|FG026|Overall Study|Progressive disease|16|||
155218504|NCT02608268|560239525|FG027|Overall Study|Progressive disease|11|||
155218505|NCT02608268|560239526|FG028|Overall Study|Progressive disease|10|||
155218506|NCT02608268|560239527|FG029|Overall Study|Progressive disease|15|||
155218507|NCT02608268|560239498|FG000|Overall Study|Subject/guardian decision|1|||
155218508|NCT02608268|560239499|FG001|Overall Study|Subject/guardian decision|1|||
155218509|NCT02608268|560239500|FG002|Overall Study|Subject/guardian decision|2|||
155218510|NCT02608268|560239501|FG003|Overall Study|Subject/guardian decision|0|||
155218511|NCT02608268|560239502|FG004|Overall Study|Subject/guardian decision|0|||
155218512|NCT02608268|560239503|FG005|Overall Study|Subject/guardian decision|0|||
155218513|NCT02608268|560239504|FG006|Overall Study|Subject/guardian decision|0|||
155218514|NCT02608268|560239505|FG007|Overall Study|Subject/guardian decision|0|||
155218515|NCT02608268|560239506|FG008|Overall Study|Subject/guardian decision|2|||
155218516|NCT02608268|560239507|FG009|Overall Study|Subject/guardian decision|2|||
155218517|NCT02608268|560239508|FG010|Overall Study|Subject/guardian decision|0|||
155218518|NCT02608268|560239509|FG011|Overall Study|Subject/guardian decision|1|||
155218519|NCT02608268|560239510|FG012|Overall Study|Subject/guardian decision|0|||
155218520|NCT02608268|560239511|FG013|Overall Study|Subject/guardian decision|1|||
155218521|NCT02608268|560239512|FG014|Overall Study|Subject/guardian decision|0|||
155218522|NCT02608268|560239513|FG015|Overall Study|Subject/guardian decision|1|||
155218523|NCT02608268|560239514|FG016|Overall Study|Subject/guardian decision|0|||
155218524|NCT02608268|560239515|FG017|Overall Study|Subject/guardian decision|0|||
155218525|NCT02608268|560239516|FG018|Overall Study|Subject/guardian decision|1|||
155218526|NCT02608268|560239517|FG019|Overall Study|Subject/guardian decision|0|||
155218527|NCT02608268|560239518|FG020|Overall Study|Subject/guardian decision|0|||
155218528|NCT02608268|560239519|FG021|Overall Study|Subject/guardian decision|0|||
155218529|NCT02608268|560239520|FG022|Overall Study|Subject/guardian decision|1|||
155218530|NCT02608268|560239521|FG023|Overall Study|Subject/guardian decision|0|||
155218531|NCT02608268|560239522|FG024|Overall Study|Subject/guardian decision|0|||
155218532|NCT02608268|560239523|FG025|Overall Study|Subject/guardian decision|1|||
155218533|NCT02608268|560239524|FG026|Overall Study|Subject/guardian decision|1|||
155218534|NCT02608268|560239525|FG027|Overall Study|Subject/guardian decision|1|||
155218535|NCT02608268|560239526|FG028|Overall Study|Subject/guardian decision|1|||
155218536|NCT02608268|560239527|FG029|Overall Study|Subject/guardian decision|0|||
155218537|NCT04014075|560239528|FG000|Overall Study|Progressive Disease|53|||
155218538|NCT04014075|560239528|FG000|Overall Study|Adverse Event|15|||
155218539|NCT04014075|560239528|FG000|Overall Study|Clinical Progression|4|||
155218540|NCT04014075|560239528|FG000|Overall Study|Death|2|||
155218541|NCT04014075|560239528|FG000|Overall Study|Withdrawal by Subject|2|||
155218542|NCT04014075|560239528|FG000|Overall Study|Miscellaneous|2|||
155218543|NCT04014075|560239528|FG000|Overall Study|Physician Decision|1|||
155218544|NCT02584504|560239529|FG000|Double-blind Treatment|Participant withdrew consent|0|||
155218545|NCT02584504|560239530|FG001|Double-blind Treatment|Participant withdrew consent|0|||
155218546|NCT02584504|560239531|FG002|Double-blind Treatment|Participant withdrew consent|1|||
155218547|NCT02584504|560239529|FG000|Double-blind Treatment|Adverse Event|0|||
155218548|NCT02584504|560239530|FG001|Double-blind Treatment|Adverse Event|1|||
155218549|NCT02584504|560239531|FG002|Double-blind Treatment|Adverse Event|0|||
155218550|NCT02584504|560239529|FG000|Double-blind Treatment|Family Matter|0|||
155218551|NCT02584504|560239530|FG001|Double-blind Treatment|Family Matter|1|||
155218552|NCT02584504|560239531|FG002|Double-blind Treatment|Family Matter|0|||
155218553|NCT02584504|560239529|FG000|Open-label Treatment|Participant withdrew consent|0|||
155218554|NCT02584504|560239530|FG001|Open-label Treatment|Participant withdrew consent|0|||
155218555|NCT02584504|560239531|FG002|Open-label Treatment|Participant withdrew consent|4|||
155218556|NCT02584504|560239529|FG000|Open-label Treatment|Adverse Event|2|||
155218557|NCT02584504|560239530|FG001|Open-label Treatment|Adverse Event|2|||
155218558|NCT02584504|560239531|FG002|Open-label Treatment|Adverse Event|3|||
155218559|NCT02584504|560239529|FG000|Open-label Treatment|Physician Decision|0|||
155218560|NCT02584504|560239530|FG001|Open-label Treatment|Physician Decision|1|||
155218561|NCT02584504|560239531|FG002|Open-label Treatment|Physician Decision|0|||
155218562|NCT02584504|560239529|FG000|Open-label Treatment|Entered but not treated|0|||
155218563|NCT02584504|560239530|FG001|Open-label Treatment|Entered but not treated|1|||
155218564|NCT02584504|560239531|FG002|Open-label Treatment|Entered but not treated|1|||
155218565|NCT05172544|560239535|FG000|Overall Study|Withdrawal by Subject|1|||
155218566|NCT05172544|560239536|FG001|Overall Study|Withdrawal by Subject|0|||
155218567|NCT05172544|560239537|FG002|Overall Study|Withdrawal by Subject|0|||
155218568|NCT05172544|560239535|FG000|Overall Study|Physician Decision|0|||
155218569|NCT05172544|560239536|FG001|Overall Study|Physician Decision|0|||
155218570|NCT05172544|560239537|FG002|Overall Study|Physician Decision|1|||
155218571|NCT01179477|560239542|FG000|Overall Study|Death|542|||
155218572|NCT01179477|560239542|FG000|Overall Study|Unsuccessful implant|80|||
155218573|NCT01179477|560239542|FG000|Overall Study|Non-death withdrawal|438|||
155218574|NCT01179477|560239542|FG000|Overall Study|Did not complete final visit|27|||
155218575|NCT02221284|560239546|FG000|Overall Study|Case Report Forms Uncollected|56|||
155218576|NCT02221284|560239546|FG000|Overall Study|Protocol Deviation|5|||
155218577|NCT00529542|560239549|FG000|Overall Study|Withdrawal by Subject|1|||
155218578|NCT00529542|560239550|FG001|Overall Study|Withdrawal by Subject|0|||
155218579|NCT00529542|560239549|FG000|Overall Study|Lost to Follow-up|0|||
155218580|NCT00529542|560239550|FG001|Overall Study|Lost to Follow-up|1|||
155218581|NCT03839212|560239557|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
155218582|NCT00679263|560239562|FG000|Visit 2/Dose 1|Adverse Event|1|||
155218583|NCT00679263|560239563|FG001|Visit 2/Dose 1|Adverse Event|0|||
155218584|NCT00679263|560239564|FG002|Visit 2/Dose 1|Adverse Event|0|||
155218585|NCT00679263|560239562|FG000|Visit 2/Dose 1|subject not compliance|1|||
155218586|NCT00679263|560239563|FG001|Visit 2/Dose 1|subject not compliance|1|||
155218587|NCT00679263|560239564|FG002|Visit 2/Dose 1|subject not compliance|0|||
155218588|NCT05104567|560239566|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218589|NCT05104567|560239567|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
155218590|NCT05104567|560239568|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218591|NCT05104567|560239569|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218592|NCT05104567|560239570|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218593|NCT05104567|560239571|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218594|NCT05104567|560239572|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
155218595|NCT05104567|560239566|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
155218596|NCT05104567|560239567|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
155218597|NCT05104567|560239568|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
155218598|NCT05104567|560239569|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
155218599|NCT05104567|560239570|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
155218600|NCT05104567|560239571|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
155218601|NCT05104567|560239572|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
155218602|NCT05104567|560239566|FG000|Overall Study|Progressive disease|3|||
155218603|NCT05104567|560239567|FG001|Overall Study|Progressive disease|13|||
155218604|NCT05104567|560239568|FG002|Overall Study|Progressive disease|13|||
155218605|NCT05104567|560239569|FG003|Overall Study|Progressive disease|17|||
155218606|NCT05104567|560239570|FG004|Overall Study|Progressive disease|17|||
155218607|NCT05104567|560239571|FG005|Overall Study|Progressive disease|28|||
155218608|NCT05104567|560239572|FG006|Overall Study|Progressive disease|24|||
155218609|NCT05104567|560239566|FG000|Overall Study|Withdrawal by Subject|1|||
155218610|NCT05104567|560239567|FG001|Overall Study|Withdrawal by Subject|1|||
155218611|NCT05104567|560239568|FG002|Overall Study|Withdrawal by Subject|2|||
155218612|NCT05104567|560239569|FG003|Overall Study|Withdrawal by Subject|0|||
155218613|NCT05104567|560239570|FG004|Overall Study|Withdrawal by Subject|0|||
155218614|NCT05104567|560239571|FG005|Overall Study|Withdrawal by Subject|0|||
155218615|NCT05104567|560239572|FG006|Overall Study|Withdrawal by Subject|0|||
155218616|NCT05104567|560239566|FG000|Overall Study|Other|1|||
155218617|NCT05104567|560239567|FG001|Overall Study|Other|1|||
155218618|NCT05104567|560239568|FG002|Overall Study|Other|1|||
155218619|NCT05104567|560239569|FG003|Overall Study|Other|0|||
155218620|NCT05104567|560239570|FG004|Overall Study|Other|0|||
155218621|NCT05104567|560239571|FG005|Overall Study|Other|0|||
155218622|NCT05104567|560239572|FG006|Overall Study|Other|0|||
155218623|NCT01464346|560239576|FG000|Overall Study|Withdrawal by Subject|0|||
155218624|NCT01464346|560239577|FG001|Overall Study|Withdrawal by Subject|0|||
155218625|NCT01464346|560239578|FG002|Overall Study|Withdrawal by Subject|1|||
155218626|NCT00733746|560239579|FG000|Overall Study|Ineligible|5|||
155218627|NCT02295995|560239580|FG000|Overall Study|Lost to Follow-up|5|||
155218628|NCT02295995|560239581|FG001|Overall Study|Lost to Follow-up|1|||
155218629|NCT01173718|560239582|FG000|Overall Study|Death|17|||
155218630|NCT01173718|560239582|FG000|Overall Study|Abandonment of study graft|27|||
155218631|NCT01498458|560239584|FG000|Overall Study|Adverse Event|4|||
155218632|NCT01498458|560239584|FG000|Overall Study|Physician Decision|3|||
155218633|NCT02226003|560239585|FG000|Overall Study|Lost to Follow-up|2|||
155218634|NCT02226003|560239586|FG001|Overall Study|Lost to Follow-up|1|||
155218635|NCT02226003|560239587|FG002|Overall Study|Lost to Follow-up|3|||
155218636|NCT02226003|560239585|FG000|Overall Study|Withdrawal by Subject|0|||
155218637|NCT02226003|560239586|FG001|Overall Study|Withdrawal by Subject|0|||
155218638|NCT02226003|560239587|FG002|Overall Study|Withdrawal by Subject|3|||
155218639|NCT03279692|560239594|FG000|Overall Study|Withdrawal by Subject|1|||
155218640|NCT05198843|560239597|FG000|Overall Study|Lack of Efficacy|1|||
155218641|NCT02446990|560239598|FG000|Overall Study|Death|485|||
155218642|NCT02446990|560239599|FG001|Overall Study|Death|458|||
155218643|NCT02446990|560239598|FG000|Overall Study|Lost to Follow-up|3|||
155218644|NCT02446990|560239599|FG001|Overall Study|Lost to Follow-up|1|||
155218645|NCT02446990|560239598|FG000|Overall Study|Physician Decision|1|||
155218646|NCT02446990|560239599|FG001|Overall Study|Physician Decision|0|||
155218647|NCT02446990|560239598|FG000|Overall Study|Withdrawal by Subject|231|||
155218648|NCT02446990|560239599|FG001|Overall Study|Withdrawal by Subject|199|||
155218649|NCT01064401|560239600|FG000|Overall Study|Adverse Event|47|||
155218650|NCT01064401|560239601|FG001|Overall Study|Adverse Event|56|||
155218651|NCT01064401|560239600|FG000|Overall Study|Lack of Efficacy|46|||
155218652|NCT01064401|560239601|FG001|Overall Study|Lack of Efficacy|23|||
155218653|NCT01064401|560239600|FG000|Overall Study|Lost to Follow-up|12|||
155218654|NCT01064401|560239601|FG001|Overall Study|Lost to Follow-up|9|||
155218655|NCT01064401|560239600|FG000|Overall Study|Consent Withdrawn|98|||
155218656|NCT01064401|560239601|FG001|Overall Study|Consent Withdrawn|80|||
155218657|NCT01064401|560239600|FG000|Overall Study|Investigator Decision|4|||
155218658|NCT01064401|560239601|FG001|Overall Study|Investigator Decision|6|||
155218659|NCT01064401|560239600|FG000|Overall Study|Death|4|||
155218660|NCT01064401|560239601|FG001|Overall Study|Death|0|||
155218661|NCT01064401|560239600|FG000|Overall Study|Pregnancy|4|||
155218662|NCT01064401|560239601|FG001|Overall Study|Pregnancy|7|||
155218663|NCT01064401|560239600|FG000|Overall Study|Noncompliance|7|||
155218664|NCT01064401|560239601|FG001|Overall Study|Noncompliance|8|||
155218665|NCT01064401|560239600|FG000|Overall Study|Site Closure|4|||
155218666|NCT01064401|560239601|FG001|Overall Study|Site Closure|5|||
155218667|NCT01064401|560239600|FG000|Overall Study|Other|2|||
155218668|NCT01064401|560239601|FG001|Overall Study|Other|1|||
155218669|NCT03158051|560239602|FG000|Overall Study|Lost to Follow-up|41|||
155218670|NCT03158051|560239603|FG001|Overall Study|Lost to Follow-up|47|||
155218671|NCT03158051|560239602|FG000|Overall Study|Physician Decision|6|||
155218672|NCT03158051|560239603|FG001|Overall Study|Physician Decision|7|||
155218673|NCT03158051|560239602|FG000|Overall Study|Withdrawal by Subject|24|||
155218674|NCT03158051|560239603|FG001|Overall Study|Withdrawal by Subject|15|||
155218675|NCT03158051|560239602|FG000|Overall Study|Death|0|||
155218676|NCT03158051|560239603|FG001|Overall Study|Death|1|||
155218677|NCT02588833|560239604|FG000|Part 1|Withdrawal by Subject|1|||
155218678|NCT02588833|560239605|FG001|Part 1|Withdrawal by Subject|0|||
155218679|NCT02588833|560239604|FG000|Part 2A|Physician Decision|0|||
155218680|NCT02588833|560239605|FG001|Part 2A|Physician Decision|1|||
155218681|NCT02588833|560239604|FG000|Part 2A|Withdrawal by Subject|0|||
155218682|NCT02588833|560239605|FG001|Part 2A|Withdrawal by Subject|1|||
155218683|NCT02588833|560239604|FG000|Part 2B|Adverse Event|0|||
155218684|NCT02588833|560239605|FG001|Part 2B|Adverse Event|1|||
155218685|NCT02588833|560239604|FG000|Part 2C|Adverse Event|0|||
155218686|NCT02588833|560239605|FG001|Part 2C|Adverse Event|1|||
155218687|NCT02588833|560239604|FG000|Part 2C|Withdrawal by Subject|0|||
155218688|NCT02588833|560239605|FG001|Part 2C|Withdrawal by Subject|1|||
155218689|NCT02588833|560239604|FG000|Part 3 (Safety Follow-up)|Other|0|||
155218690|NCT02588833|560239605|FG001|Part 3 (Safety Follow-up)|Other|2|||
155218691|NCT02005250|560239606|FG000|Overall Study|Lost to Follow-up|15|||
155218692|NCT02005250|560239607|FG001|Overall Study|Lost to Follow-up|5|||
155218693|NCT02738151|560239608|FG000|Overall Study|Randomized but not treated|4|||
155218694|NCT02738151|560239609|FG001|Overall Study|Randomized but not treated|1|||
155218695|NCT02738151|560239608|FG000|Overall Study|Adverse Event|4|||
155218696|NCT02738151|560239609|FG001|Overall Study|Adverse Event|5|||
155218697|NCT02738151|560239608|FG000|Overall Study|Hypoglycemia|0|||
155218698|NCT02738151|560239609|FG001|Overall Study|Hypoglycemia|1|||
155218699|NCT02738151|560239608|FG000|Overall Study|Poor Compliance to Protocol|4|||
155218700|NCT02738151|560239609|FG001|Overall Study|Poor Compliance to Protocol|3|||
155218701|NCT02738151|560239608|FG000|Overall Study|Other than specified above|11|||
155218702|NCT02738151|560239609|FG001|Overall Study|Other than specified above|21|||
155218703|NCT03649711|560239615|FG000|Overall Study|Adverse Event|0|||
155218704|NCT03649711|560239616|FG001|Overall Study|Adverse Event|1|||
155218705|NCT03649711|560239617|FG002|Overall Study|Adverse Event|0|||
155218706|NCT03649711|560239615|FG000|Overall Study|Kidney Transplant|1|||
155218707|NCT03649711|560239616|FG001|Overall Study|Kidney Transplant|0|||
155218708|NCT03649711|560239617|FG002|Overall Study|Kidney Transplant|0|||
155218709|NCT04007094|560239622|FG000|Overall Study|Lost to Follow-up|1|||
155218710|NCT04007094|560239623|FG001|Overall Study|Lost to Follow-up|1|||
155218711|NCT04350788|560239639|FG000|Overall Study|Lost to Follow-up|6|||
155218712|NCT04350788|560239640|FG001|Overall Study|Lost to Follow-up|2|||
155218713|NCT04350788|560239639|FG000|Overall Study|Withdrawal by Subject|2|||
155218714|NCT04350788|560239640|FG001|Overall Study|Withdrawal by Subject|4|||
155218715|NCT04350788|560239639|FG000|Overall Study|Protocol Violation|4|||
155218716|NCT04350788|560239640|FG001|Overall Study|Protocol Violation|0|||
155218717|NCT01581307|560239641|FG000|Overall Study|Withdrawal by Subject|1|||
155218718|NCT00378209|560239646|FG000|Overall Study|Progressive disease|11|||
155218719|NCT00378209|560239646|FG000|Overall Study|Adverse Event|3|||
155218720|NCT00378209|560239646|FG000|Overall Study|Initiation of non-protocol therapy|3|||
155218721|NCT00378209|560239646|FG000|Overall Study|Physician Decision|3|||
155218722|NCT00378209|560239646|FG000|Overall Study|Death|1|||
155218723|NCT00378209|560239646|FG000|Overall Study|Treatment delay|1|||
155218724|NCT01894581|560239647|FG000|Overall Study|Withdrawal by Subject|2|||
155218725|NCT01894581|560239648|FG001|Overall Study|Withdrawal by Subject|3|||
155218726|NCT01894581|560239647|FG000|Overall Study|Screen Failure|3|||
155218727|NCT01894581|560239648|FG001|Overall Study|Screen Failure|4|||
155218728|NCT03795298|560239652|FG000|Overall Study|Death|34|||
155218729|NCT03795298|560239653|FG001|Overall Study|Death|29|||
155218730|NCT03795298|560239652|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
155218731|NCT03795298|560239653|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
155218732|NCT03795298|560239652|FG000|Overall Study|Lost to Follow-up|28|||
155218733|NCT03795298|560239653|FG001|Overall Study|Lost to Follow-up|17|||
155218734|NCT03795298|560239652|FG000|Overall Study|Physician Decision|5|||
155218735|NCT03795298|560239653|FG001|Overall Study|Physician Decision|4|||
155218736|NCT03795298|560239652|FG000|Overall Study|Withdrawal by Subject|43|||
155218737|NCT03795298|560239653|FG001|Overall Study|Withdrawal by Subject|28|||
155218738|NCT03795298|560239652|FG000|Overall Study|Reason not reported|7|||
155218739|NCT03795298|560239653|FG001|Overall Study|Reason not reported|9|||
155218740|NCT01252940|560239654|FG000|Main Study Phase|Randomized but not treated|4|||
155218741|NCT01252940|560239655|FG001|Main Study Phase|Randomized but not treated|2|||
155218742|NCT01252940|560239654|FG000|Main Study Phase|Adverse Event|3|||
155218743|NCT01252940|560239655|FG001|Main Study Phase|Adverse Event|1|||
155218744|NCT01252940|560239654|FG000|Main Study Phase|Lack of Efficacy|1|||
155218745|NCT01252940|560239655|FG001|Main Study Phase|Lack of Efficacy|0|||
155218746|NCT01252940|560239654|FG000|Main Study Phase|Lost to Follow-up|6|||
155218747|NCT01252940|560239655|FG001|Main Study Phase|Lost to Follow-up|1|||
155218748|NCT01252940|560239654|FG000|Main Study Phase|Physician Decision|1|||
155218749|NCT01252940|560239655|FG001|Main Study Phase|Physician Decision|0|||
155218750|NCT01252940|560239654|FG000|Main Study Phase|Protocol Violation|4|||
155218751|NCT01252940|560239655|FG001|Main Study Phase|Protocol Violation|2|||
155218752|NCT01252940|560239654|FG000|Main Study Phase|Withdrawal by Subject|6|||
155218753|NCT01252940|560239655|FG001|Main Study Phase|Withdrawal by Subject|5|||
155218754|NCT01252940|560239654|FG000|Main Study Phase|Subject Non-compliance|1|||
155218755|NCT01252940|560239655|FG001|Main Study Phase|Subject Non-compliance|1|||
155218756|NCT01252940|560239654|FG000|Extension Phase|Adverse Event|2|||
155218757|NCT01252940|560239655|FG001|Extension Phase|Adverse Event|1|||
155218758|NCT01252940|560239654|FG000|Extension Phase|Lack of Efficacy|1|||
155218759|NCT01252940|560239655|FG001|Extension Phase|Lack of Efficacy|0|||
155218760|NCT01252940|560239654|FG000|Extension Phase|Lost to Follow-up|5|||
155218761|NCT01252940|560239655|FG001|Extension Phase|Lost to Follow-up|0|||
155218762|NCT01252940|560239654|FG000|Extension Phase|Physician Decision|0|||
155218763|NCT01252940|560239655|FG001|Extension Phase|Physician Decision|1|||
155218764|NCT01252940|560239654|FG000|Extension Phase|Subject Non-compliance|1|||
155218765|NCT01252940|560239655|FG001|Extension Phase|Subject Non-compliance|0|||
155218766|NCT01252940|560239654|FG000|Extension Phase|Withdrawal by Subject|1|||
155218767|NCT01252940|560239655|FG001|Extension Phase|Withdrawal by Subject|1|||
155218768|NCT04199117|560239656|FG000|Overall Study|Withdrawal by Subject|3|||
155218769|NCT04199117|560239657|FG001|Overall Study|Withdrawal by Subject|0|||
155218770|NCT04199117|560239658|FG002|Overall Study|Withdrawal by Subject|0|||
155218771|NCT04199117|560239659|FG003|Overall Study|Withdrawal by Subject|1|||
155218772|NCT04199117|560239660|FG004|Overall Study|Withdrawal by Subject|1|||
155218773|NCT04199117|560239661|FG005|Overall Study|Withdrawal by Subject|0|||
155218774|NCT04199117|560239662|FG006|Overall Study|Withdrawal by Subject|0|||
155218775|NCT04199117|560239663|FG007|Overall Study|Withdrawal by Subject|2|||
155218776|NCT04199117|560239664|FG008|Overall Study|Withdrawal by Subject|0|||
155218777|NCT04199117|560239665|FG009|Overall Study|Withdrawal by Subject|0|||
155218778|NCT04199117|560239666|FG010|Overall Study|Withdrawal by Subject|1|||
155218779|NCT04199117|560239667|FG011|Overall Study|Withdrawal by Subject|1|||
155218780|NCT04199117|560239668|FG012|Overall Study|Withdrawal by Subject|2|||
155218781|NCT04199117|560239669|FG013|Overall Study|Withdrawal by Subject|1|||
155218782|NCT04199117|560239670|FG014|Overall Study|Withdrawal by Subject|1|||
155218783|NCT04199117|560239671|FG015|Overall Study|Withdrawal by Subject|1|||
155218784|NCT04199117|560239656|FG000|Overall Study|Death|1|||
155218785|NCT04199117|560239657|FG001|Overall Study|Death|1|||
155218786|NCT04199117|560239658|FG002|Overall Study|Death|0|||
155218787|NCT04199117|560239659|FG003|Overall Study|Death|0|||
155218788|NCT04199117|560239660|FG004|Overall Study|Death|0|||
155218789|NCT04199117|560239661|FG005|Overall Study|Death|0|||
155218790|NCT04199117|560239662|FG006|Overall Study|Death|0|||
155218791|NCT04199117|560239663|FG007|Overall Study|Death|0|||
155218792|NCT04199117|560239664|FG008|Overall Study|Death|0|||
155218793|NCT04199117|560239665|FG009|Overall Study|Death|0|||
155218794|NCT04199117|560239666|FG010|Overall Study|Death|0|||
155218795|NCT04199117|560239667|FG011|Overall Study|Death|1|||
155218796|NCT04199117|560239668|FG012|Overall Study|Death|0|||
155218797|NCT04199117|560239669|FG013|Overall Study|Death|1|||
155218798|NCT04199117|560239670|FG014|Overall Study|Death|0|||
155218799|NCT04199117|560239671|FG015|Overall Study|Death|0|||
155218800|NCT04199117|560239656|FG000|Overall Study|Withdrawal by PI|0|||
155218801|NCT04199117|560239657|FG001|Overall Study|Withdrawal by PI|0|||
155218802|NCT04199117|560239658|FG002|Overall Study|Withdrawal by PI|0|||
155218803|NCT04199117|560239659|FG003|Overall Study|Withdrawal by PI|0|||
155218804|NCT04199117|560239660|FG004|Overall Study|Withdrawal by PI|0|||
155218805|NCT04199117|560239661|FG005|Overall Study|Withdrawal by PI|0|||
155218806|NCT04199117|560239662|FG006|Overall Study|Withdrawal by PI|0|||
155218807|NCT04199117|560239663|FG007|Overall Study|Withdrawal by PI|0|||
155218808|NCT04199117|560239664|FG008|Overall Study|Withdrawal by PI|0|||
155218809|NCT04199117|560239665|FG009|Overall Study|Withdrawal by PI|0|||
155218810|NCT04199117|560239666|FG010|Overall Study|Withdrawal by PI|0|||
155218811|NCT04199117|560239667|FG011|Overall Study|Withdrawal by PI|0|||
155218812|NCT04199117|560239668|FG012|Overall Study|Withdrawal by PI|1|||
155218813|NCT04199117|560239669|FG013|Overall Study|Withdrawal by PI|0|||
155218814|NCT04199117|560239670|FG014|Overall Study|Withdrawal by PI|0|||
155218815|NCT04199117|560239671|FG015|Overall Study|Withdrawal by PI|0|||
155218816|NCT04383743|560239672|FG000|Overall Study|Withdrawal by Subject|1|||
155218817|NCT04383743|560239672|FG000|Overall Study|Adverse Event|1|||
155218818|NCT03482791|560239679|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
155218819|NCT03482791|560239680|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
155218820|NCT00296374|560239681|FG000|Overall Study|Adverse Event|14|||
155218821|NCT00296374|560239682|FG001|Overall Study|Adverse Event|10|||
155218822|NCT00296374|560239683|FG002|Overall Study|Adverse Event|7|||
155218823|NCT00296374|560239681|FG000|Overall Study|Withdrawal by Subject|3|||
155218824|NCT00296374|560239682|FG001|Overall Study|Withdrawal by Subject|5|||
155218825|NCT00296374|560239683|FG002|Overall Study|Withdrawal by Subject|11|||
155218826|NCT00296374|560239681|FG000|Overall Study|Incorrect enrollment|3|||
155218827|NCT00296374|560239682|FG001|Overall Study|Incorrect enrollment|3|||
155218828|NCT00296374|560239683|FG002|Overall Study|Incorrect enrollment|4|||
155218829|NCT00296374|560239681|FG000|Overall Study|Protocol Violation|1|||
155218830|NCT00296374|560239682|FG001|Overall Study|Protocol Violation|2|||
155218831|NCT00296374|560239683|FG002|Overall Study|Protocol Violation|3|||
155218832|NCT00296374|560239681|FG000|Overall Study|Lost to Follow-up|3|||
155218833|NCT00296374|560239682|FG001|Overall Study|Lost to Follow-up|1|||
155218834|NCT00296374|560239683|FG002|Overall Study|Lost to Follow-up|1|||
155218835|NCT00296374|560239681|FG000|Overall Study|Relocated to another state|1|||
155218836|NCT00296374|560239682|FG001|Overall Study|Relocated to another state|0|||
155218837|NCT00296374|560239683|FG002|Overall Study|Relocated to another state|0|||
155218838|NCT00296374|560239681|FG000|Overall Study|Stopped drug before end of study visit|0|||
155218839|NCT00296374|560239682|FG001|Overall Study|Stopped drug before end of study visit|1|||
155218840|NCT00296374|560239683|FG002|Overall Study|Stopped drug before end of study visit|0|||
155218841|NCT00296374|560239681|FG000|Overall Study|Nephrologist introduced ACE|0|||
155218842|NCT00296374|560239682|FG001|Overall Study|Nephrologist introduced ACE|1|||
155218843|NCT00296374|560239683|FG002|Overall Study|Nephrologist introduced ACE|0|||
155218844|NCT00296374|560239681|FG000|Overall Study|Pregnancy|0|||
155218845|NCT00296374|560239682|FG001|Overall Study|Pregnancy|0|||
155218846|NCT00296374|560239683|FG002|Overall Study|Pregnancy|2|||
155218847|NCT00296374|560239681|FG000|Overall Study|Other|0|||
155218848|NCT00296374|560239682|FG001|Overall Study|Other|0|||
155218849|NCT00296374|560239683|FG002|Overall Study|Other|1|||
155218850|NCT01721330|560239684|FG000|Overall Study|Withdrawal by Subject|0|||
155218851|NCT01721330|560239685|FG001|Overall Study|Withdrawal by Subject|1|||
155218852|NCT04709575|560241134|FG000|Overall Study|Withdrawal by Subject|6|||
155218853|NCT04709575|560241135|FG001|Overall Study|Withdrawal by Subject|2|||
155218854|NCT04709575|560241134|FG000|Overall Study|Lost to Follow-up|2|||
155218855|NCT04709575|560241135|FG001|Overall Study|Lost to Follow-up|2|||
155218856|NCT04709575|560241134|FG000|Overall Study|Adverse Event|1|||
155218857|NCT04709575|560241135|FG001|Overall Study|Adverse Event|0|||
155218858|NCT04709575|560241134|FG000|Overall Study|Protocol Violation|1|||
155218859|NCT04709575|560241135|FG001|Overall Study|Protocol Violation|1|||
155218860|NCT00542919|560241136|FG000|Overall Study|Adverse Event|1|||
155218861|NCT00542919|560241137|FG001|Overall Study|Adverse Event|5|||
155218862|NCT00542919|560241138|FG002|Overall Study|Adverse Event|1|||
155218863|NCT00542919|560241136|FG000|Overall Study|Withdrawal by Subject|1|||
155218864|NCT00542919|560241137|FG001|Overall Study|Withdrawal by Subject|0|||
155218865|NCT00542919|560241138|FG002|Overall Study|Withdrawal by Subject|3|||
155218866|NCT00542919|560241136|FG000|Overall Study|Physician Decision|2|||
155218867|NCT00542919|560241137|FG001|Overall Study|Physician Decision|2|||
155218868|NCT00542919|560241138|FG002|Overall Study|Physician Decision|1|||
155218869|NCT00542919|560241136|FG000|Overall Study|Sponsor Decision|1|||
155218870|NCT00542919|560241137|FG001|Overall Study|Sponsor Decision|0|||
155218871|NCT00542919|560241138|FG002|Overall Study|Sponsor Decision|0|||
155218872|NCT00542919|560241136|FG000|Overall Study|Lost to Follow-up|2|||
155218873|NCT00542919|560241137|FG001|Overall Study|Lost to Follow-up|0|||
155218874|NCT00542919|560241138|FG002|Overall Study|Lost to Follow-up|1|||
155218875|NCT02385266|560241139|FG000|Overall Study|Withdrawal by Subject|1|||
155218876|NCT02385266|560241140|FG001|Overall Study|Withdrawal by Subject|3|||
155218877|NCT02082210|560241147|FG000|Overall Study|Death|0|||
155218878|NCT02082210|560241148|FG001|Overall Study|Death|0|||
155218879|NCT02082210|560241149|FG002|Overall Study|Death|1|||
155218880|NCT02082210|560241150|FG003|Overall Study|Death|1|||
155218881|NCT02082210|560241151|FG004|Overall Study|Death|1|||
155218882|NCT02082210|560241152|FG005|Overall Study|Death|0|||
155218883|NCT02082210|560241147|FG000|Overall Study|Withdrawal by Subject|0|||
155218884|NCT02082210|560241148|FG001|Overall Study|Withdrawal by Subject|0|||
155218885|NCT02082210|560241149|FG002|Overall Study|Withdrawal by Subject|0|||
155218886|NCT02082210|560241150|FG003|Overall Study|Withdrawal by Subject|1|||
155218887|NCT02082210|560241151|FG004|Overall Study|Withdrawal by Subject|2|||
155218888|NCT02082210|560241152|FG005|Overall Study|Withdrawal by Subject|2|||
155218889|NCT02082210|560241147|FG000|Overall Study|Clinical Progression|0|||
155218890|NCT02082210|560241148|FG001|Overall Study|Clinical Progression|0|||
155218891|NCT02082210|560241149|FG002|Overall Study|Clinical Progression|0|||
155218892|NCT02082210|560241150|FG003|Overall Study|Clinical Progression|1|||
155218893|NCT02082210|560241151|FG004|Overall Study|Clinical Progression|0|||
155218894|NCT02082210|560241152|FG005|Overall Study|Clinical Progression|0|||
155218895|NCT02082210|560241147|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218896|NCT02082210|560241148|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218897|NCT02082210|560241149|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
155218898|NCT02082210|560241150|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
155218899|NCT02082210|560241151|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218900|NCT02082210|560241152|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
155218901|NCT02082210|560241147|FG000|Overall Study|Physician Decision|0|||
155218902|NCT02082210|560241148|FG001|Overall Study|Physician Decision|0|||
155218903|NCT02082210|560241149|FG002|Overall Study|Physician Decision|1|||
155218904|NCT02082210|560241150|FG003|Overall Study|Physician Decision|1|||
155218905|NCT02082210|560241151|FG004|Overall Study|Physician Decision|0|||
155218906|NCT02082210|560241152|FG005|Overall Study|Physician Decision|0|||
155218907|NCT04762680|560241153|FG000|Phase 2|Adverse Event|0|||
155218908|NCT04762680|560241154|FG001|Phase 2|Adverse Event|1|||
155218909|NCT04762680|560241155|FG002|Phase 2|Adverse Event|0|||
155218910|NCT04762680|560241156|FG003|Phase 2|Adverse Event|0|||
155218911|NCT04762680|560241157|FG004|Phase 2|Adverse Event|0|||
155218912|NCT04762680|560241158|FG005|Phase 2|Adverse Event|0|||
155218913|NCT04762680|560241159|FG006|Phase 2|Adverse Event|0|||
155218914|NCT04762680|560241160|FG007|Phase 2|Adverse Event|0|||
155218915|NCT04762680|560241161|FG008|Phase 2|Adverse Event|0|||
155218916|NCT04762680|560241162|FG009|Phase 2|Adverse Event|0|||
155218917|NCT04762680|560241163|FG010|Phase 2|Adverse Event|0|||
155218918|NCT04762680|560241164|FG011|Phase 2|Adverse Event|0|||
155218919|NCT04762680|560241165|FG012|Phase 2|Adverse Event|0|||
155218920|NCT04762680|560241166|FG013|Phase 2|Adverse Event|0|||
155218921|NCT04762680|560241167|FG014|Phase 2|Adverse Event|0|||
155218922|NCT04762680|560241168|FG015|Phase 2|Adverse Event|0|||
155218923|NCT04762680|560241169|FG016|Phase 2|Adverse Event|0|||
155218924|NCT04762680|560241170|FG017|Phase 2|Adverse Event|0|||
155218925|NCT04762680|560241171|FG018|Phase 2|Adverse Event|0|||
155218926|NCT04762680|560241172|FG019|Phase 2|Adverse Event|0|||
155218927|NCT04762680|560241173|FG020|Phase 2|Adverse Event|0|||
155218928|NCT04762680|560241174|FG021|Phase 2|Adverse Event|0|||
155218929|NCT04762680|560241153|FG000|Phase 2|Protocol Violation|5|||
155218930|NCT04762680|560241154|FG001|Phase 2|Protocol Violation|5|||
155218931|NCT04762680|560241155|FG002|Phase 2|Protocol Violation|1|||
155218932|NCT04762680|560241156|FG003|Phase 2|Protocol Violation|0|||
155218933|NCT04762680|560241157|FG004|Phase 2|Protocol Violation|0|||
155218934|NCT04762680|560241158|FG005|Phase 2|Protocol Violation|0|||
155218935|NCT04762680|560241159|FG006|Phase 2|Protocol Violation|0|||
155218936|NCT04762680|560241160|FG007|Phase 2|Protocol Violation|0|||
155218937|NCT04762680|560241161|FG008|Phase 2|Protocol Violation|0|||
155218938|NCT04762680|560241162|FG009|Phase 2|Protocol Violation|0|||
155218939|NCT04762680|560241163|FG010|Phase 2|Protocol Violation|0|||
155218940|NCT04762680|560241164|FG011|Phase 2|Protocol Violation|0|||
155218941|NCT04762680|560241165|FG012|Phase 2|Protocol Violation|0|||
155218942|NCT04762680|560241166|FG013|Phase 2|Protocol Violation|0|||
155218943|NCT04762680|560241167|FG014|Phase 2|Protocol Violation|0|||
155218944|NCT04762680|560241168|FG015|Phase 2|Protocol Violation|0|||
155218945|NCT04762680|560241169|FG016|Phase 2|Protocol Violation|0|||
155218946|NCT04762680|560241170|FG017|Phase 2|Protocol Violation|0|||
155218947|NCT04762680|560241171|FG018|Phase 2|Protocol Violation|0|||
155218948|NCT04762680|560241172|FG019|Phase 2|Protocol Violation|0|||
155218949|NCT04762680|560241173|FG020|Phase 2|Protocol Violation|0|||
155218950|NCT04762680|560241174|FG021|Phase 2|Protocol Violation|0|||
155218951|NCT04762680|560241153|FG000|Phase 2|Withdrawal by Subject|23|||
155218952|NCT04762680|560241154|FG001|Phase 2|Withdrawal by Subject|21|||
155218953|NCT04762680|560241155|FG002|Phase 2|Withdrawal by Subject|28|||
155218954|NCT04762680|560241156|FG003|Phase 2|Withdrawal by Subject|0|||
155218955|NCT04762680|560241157|FG004|Phase 2|Withdrawal by Subject|0|||
155218956|NCT04762680|560241158|FG005|Phase 2|Withdrawal by Subject|0|||
155218957|NCT04762680|560241159|FG006|Phase 2|Withdrawal by Subject|0|||
155218958|NCT04762680|560241160|FG007|Phase 2|Withdrawal by Subject|0|||
155218959|NCT04762680|560241161|FG008|Phase 2|Withdrawal by Subject|0|||
155218960|NCT04762680|560241162|FG009|Phase 2|Withdrawal by Subject|0|||
155218961|NCT04762680|560241163|FG010|Phase 2|Withdrawal by Subject|0|||
155218962|NCT04762680|560241164|FG011|Phase 2|Withdrawal by Subject|0|||
155218963|NCT04762680|560241165|FG012|Phase 2|Withdrawal by Subject|0|||
155218964|NCT04762680|560241166|FG013|Phase 2|Withdrawal by Subject|0|||
155218965|NCT04762680|560241167|FG014|Phase 2|Withdrawal by Subject|0|||
155218966|NCT04762680|560241168|FG015|Phase 2|Withdrawal by Subject|0|||
155218967|NCT04762680|560241169|FG016|Phase 2|Withdrawal by Subject|0|||
155218968|NCT04762680|560241170|FG017|Phase 2|Withdrawal by Subject|0|||
155218969|NCT04762680|560241171|FG018|Phase 2|Withdrawal by Subject|0|||
155218970|NCT04762680|560241172|FG019|Phase 2|Withdrawal by Subject|0|||
155218971|NCT04762680|560241173|FG020|Phase 2|Withdrawal by Subject|0|||
155218972|NCT04762680|560241174|FG021|Phase 2|Withdrawal by Subject|0|||
155218973|NCT04762680|560241153|FG000|Phase 2|Lost to Follow-up|14|||
155218974|NCT04762680|560241154|FG001|Phase 2|Lost to Follow-up|8|||
155218975|NCT04762680|560241155|FG002|Phase 2|Lost to Follow-up|9|||
155218976|NCT04762680|560241156|FG003|Phase 2|Lost to Follow-up|0|||
155218977|NCT04762680|560241157|FG004|Phase 2|Lost to Follow-up|0|||
155218978|NCT04762680|560241158|FG005|Phase 2|Lost to Follow-up|0|||
155218979|NCT04762680|560241159|FG006|Phase 2|Lost to Follow-up|0|||
155218980|NCT04762680|560241160|FG007|Phase 2|Lost to Follow-up|0|||
155218981|NCT04762680|560241161|FG008|Phase 2|Lost to Follow-up|0|||
155218982|NCT04762680|560241162|FG009|Phase 2|Lost to Follow-up|0|||
155218983|NCT04762680|560241163|FG010|Phase 2|Lost to Follow-up|0|||
155218984|NCT04762680|560241164|FG011|Phase 2|Lost to Follow-up|0|||
155218985|NCT04762680|560241165|FG012|Phase 2|Lost to Follow-up|0|||
155218986|NCT04762680|560241166|FG013|Phase 2|Lost to Follow-up|0|||
155218987|NCT04762680|560241167|FG014|Phase 2|Lost to Follow-up|0|||
155218988|NCT04762680|560241168|FG015|Phase 2|Lost to Follow-up|0|||
155218989|NCT04762680|560241169|FG016|Phase 2|Lost to Follow-up|0|||
155218990|NCT04762680|560241170|FG017|Phase 2|Lost to Follow-up|0|||
155218991|NCT04762680|560241171|FG018|Phase 2|Lost to Follow-up|0|||
155218992|NCT04762680|560241172|FG019|Phase 2|Lost to Follow-up|0|||
155218993|NCT04762680|560241173|FG020|Phase 2|Lost to Follow-up|0|||
155218994|NCT04762680|560241174|FG021|Phase 2|Lost to Follow-up|0|||
155218995|NCT04762680|560241153|FG000|Phase 3|Adverse Event|0|||
155218996|NCT04762680|560241154|FG001|Phase 3|Adverse Event|0|||
155218997|NCT04762680|560241155|FG002|Phase 3|Adverse Event|0|||
155218998|NCT04762680|560241156|FG003|Phase 3|Adverse Event|1|||
155218999|NCT04762680|560241157|FG004|Phase 3|Adverse Event|0|||
155219000|NCT04762680|560241158|FG005|Phase 3|Adverse Event|0|||
155219001|NCT04762680|560241159|FG006|Phase 3|Adverse Event|0|||
155219002|NCT04762680|560241160|FG007|Phase 3|Adverse Event|0|||
155219003|NCT04762680|560241161|FG008|Phase 3|Adverse Event|0|||
155219004|NCT04762680|560241162|FG009|Phase 3|Adverse Event|0|||
155219005|NCT04762680|560241163|FG010|Phase 3|Adverse Event|0|||
155219006|NCT04762680|560241164|FG011|Phase 3|Adverse Event|0|||
155219007|NCT04762680|560241165|FG012|Phase 3|Adverse Event|0|||
155219008|NCT04762680|560241166|FG013|Phase 3|Adverse Event|0|||
155219009|NCT04762680|560241167|FG014|Phase 3|Adverse Event|0|||
155219010|NCT04762680|560241168|FG015|Phase 3|Adverse Event|0|||
155219011|NCT04762680|560241169|FG016|Phase 3|Adverse Event|0|||
155219012|NCT04762680|560241170|FG017|Phase 3|Adverse Event|3|||
155219013|NCT04762680|560241171|FG018|Phase 3|Adverse Event|0|||
155219014|NCT04762680|560241172|FG019|Phase 3|Adverse Event|0|||
155219015|NCT04762680|560241173|FG020|Phase 3|Adverse Event|0|||
155219016|NCT04762680|560241174|FG021|Phase 3|Adverse Event|0|||
155219017|NCT04762680|560241153|FG000|Phase 3|Protocol Violation|0|||
155219018|NCT04762680|560241154|FG001|Phase 3|Protocol Violation|0|||
155219019|NCT04762680|560241155|FG002|Phase 3|Protocol Violation|0|||
155219020|NCT04762680|560241156|FG003|Phase 3|Protocol Violation|4|||
155219021|NCT04762680|560241157|FG004|Phase 3|Protocol Violation|1|||
155219022|NCT04762680|560241158|FG005|Phase 3|Protocol Violation|5|||
155219023|NCT04762680|560241159|FG006|Phase 3|Protocol Violation|1|||
155219024|NCT04762680|560241160|FG007|Phase 3|Protocol Violation|0|||
155219025|NCT04762680|560241161|FG008|Phase 3|Protocol Violation|0|||
155219026|NCT04762680|560241162|FG009|Phase 3|Protocol Violation|0|||
155219027|NCT04762680|560241163|FG010|Phase 3|Protocol Violation|0|||
155219028|NCT04762680|560241164|FG011|Phase 3|Protocol Violation|2|||
155219029|NCT04762680|560241165|FG012|Phase 3|Protocol Violation|3|||
155219030|NCT04762680|560241166|FG013|Phase 3|Protocol Violation|0|||
155219031|NCT04762680|560241167|FG014|Phase 3|Protocol Violation|0|||
155219032|NCT04762680|560241168|FG015|Phase 3|Protocol Violation|1|||
155219033|NCT04762680|560241169|FG016|Phase 3|Protocol Violation|0|||
155219034|NCT04762680|560241170|FG017|Phase 3|Protocol Violation|10|||
155219035|NCT04762680|560241171|FG018|Phase 3|Protocol Violation|0|||
155219036|NCT04762680|560241172|FG019|Phase 3|Protocol Violation|0|||
155219037|NCT04762680|560241173|FG020|Phase 3|Protocol Violation|0|||
155219038|NCT04762680|560241174|FG021|Phase 3|Protocol Violation|0|||
155219039|NCT04762680|560241153|FG000|Phase 3|Withdrawal by Subject|0|||
155219040|NCT04762680|560241154|FG001|Phase 3|Withdrawal by Subject|0|||
155219041|NCT04762680|560241155|FG002|Phase 3|Withdrawal by Subject|0|||
155219042|NCT04762680|560241156|FG003|Phase 3|Withdrawal by Subject|13|||
155219043|NCT04762680|560241157|FG004|Phase 3|Withdrawal by Subject|17|||
155219044|NCT04762680|560241158|FG005|Phase 3|Withdrawal by Subject|12|||
155219045|NCT04762680|560241159|FG006|Phase 3|Withdrawal by Subject|8|||
155219046|NCT04762680|560241160|FG007|Phase 3|Withdrawal by Subject|3|||
155219047|NCT04762680|560241161|FG008|Phase 3|Withdrawal by Subject|2|||
155219048|NCT04762680|560241162|FG009|Phase 3|Withdrawal by Subject|4|||
155219049|NCT04762680|560241163|FG010|Phase 3|Withdrawal by Subject|3|||
155219050|NCT04762680|560241164|FG011|Phase 3|Withdrawal by Subject|1|||
155219051|NCT04762680|560241165|FG012|Phase 3|Withdrawal by Subject|3|||
155219052|NCT04762680|560241166|FG013|Phase 3|Withdrawal by Subject|2|||
155219053|NCT04762680|560241167|FG014|Phase 3|Withdrawal by Subject|1|||
155219054|NCT04762680|560241168|FG015|Phase 3|Withdrawal by Subject|4|||
155219055|NCT04762680|560241169|FG016|Phase 3|Withdrawal by Subject|6|||
155219056|NCT04762680|560241170|FG017|Phase 3|Withdrawal by Subject|32|||
155219057|NCT04762680|560241171|FG018|Phase 3|Withdrawal by Subject|0|||
155219058|NCT04762680|560241172|FG019|Phase 3|Withdrawal by Subject|0|||
155219059|NCT04762680|560241173|FG020|Phase 3|Withdrawal by Subject|0|||
155219060|NCT04762680|560241174|FG021|Phase 3|Withdrawal by Subject|0|||
155219061|NCT04762680|560241153|FG000|Phase 3|Lost to Follow-up|0|||
155219062|NCT04762680|560241154|FG001|Phase 3|Lost to Follow-up|0|||
155219063|NCT04762680|560241155|FG002|Phase 3|Lost to Follow-up|0|||
155219064|NCT04762680|560241156|FG003|Phase 3|Lost to Follow-up|9|||
155219065|NCT04762680|560241157|FG004|Phase 3|Lost to Follow-up|22|||
155219066|NCT04762680|560241158|FG005|Phase 3|Lost to Follow-up|24|||
155219067|NCT04762680|560241159|FG006|Phase 3|Lost to Follow-up|2|||
155219068|NCT04762680|560241160|FG007|Phase 3|Lost to Follow-up|4|||
155219069|NCT04762680|560241161|FG008|Phase 3|Lost to Follow-up|6|||
155219070|NCT04762680|560241162|FG009|Phase 3|Lost to Follow-up|4|||
155219071|NCT04762680|560241163|FG010|Phase 3|Lost to Follow-up|3|||
155219072|NCT04762680|560241164|FG011|Phase 3|Lost to Follow-up|0|||
155219073|NCT04762680|560241165|FG012|Phase 3|Lost to Follow-up|5|||
155219074|NCT04762680|560241166|FG013|Phase 3|Lost to Follow-up|4|||
155219075|NCT04762680|560241167|FG014|Phase 3|Lost to Follow-up|6|||
155219076|NCT04762680|560241168|FG015|Phase 3|Lost to Follow-up|1|||
155219077|NCT04762680|560241169|FG016|Phase 3|Lost to Follow-up|1|||
155219078|NCT04762680|560241170|FG017|Phase 3|Lost to Follow-up|66|||
155219079|NCT04762680|560241171|FG018|Phase 3|Lost to Follow-up|0|||
155219080|NCT04762680|560241172|FG019|Phase 3|Lost to Follow-up|0|||
155219081|NCT04762680|560241173|FG020|Phase 3|Lost to Follow-up|0|||
155219082|NCT04762680|560241174|FG021|Phase 3|Lost to Follow-up|0|||
155219083|NCT04762680|560241153|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219084|NCT04762680|560241154|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219085|NCT04762680|560241155|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219086|NCT04762680|560241156|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219087|NCT04762680|560241157|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219088|NCT04762680|560241158|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219089|NCT04762680|560241159|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219090|NCT04762680|560241160|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219091|NCT04762680|560241161|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219092|NCT04762680|560241162|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219093|NCT04762680|560241163|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219094|NCT04762680|560241164|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219095|NCT04762680|560241165|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219096|NCT04762680|560241166|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219097|NCT04762680|560241167|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219098|NCT04762680|560241168|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219099|NCT04762680|560241169|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219100|NCT04762680|560241170|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219101|NCT04762680|560241171|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219102|NCT04762680|560241172|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219103|NCT04762680|560241173|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
155219104|NCT04762680|560241174|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
155219105|NCT04762680|560241153|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219106|NCT04762680|560241154|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219107|NCT04762680|560241155|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219108|NCT04762680|560241156|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219109|NCT04762680|560241157|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219110|NCT04762680|560241158|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219111|NCT04762680|560241159|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219112|NCT04762680|560241160|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219113|NCT04762680|560241161|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219114|NCT04762680|560241162|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219115|NCT04762680|560241163|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219116|NCT04762680|560241164|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219117|NCT04762680|560241165|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219118|NCT04762680|560241166|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219119|NCT04762680|560241167|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219120|NCT04762680|560241168|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219121|NCT04762680|560241169|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219122|NCT04762680|560241170|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219123|NCT04762680|560241171|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219124|NCT04762680|560241172|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
155219125|NCT04762680|560241173|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219126|NCT04762680|560241174|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
155219127|NCT03388138|560241175|FG000|Overall Study|Protocol Violation|1|||
155219128|NCT03388138|560241176|FG001|Overall Study|Protocol Violation|0|||
155219129|NCT01528072|560241177|FG000|Overall Study|Withdrawal by Subject|5|||
155219130|NCT01528072|560241177|FG000|Overall Study|Physician Decision|1|||
155219131|NCT01528072|560241177|FG000|Overall Study|Determined not eligible by AEAC|1|||
155219132|NCT01528072|560241177|FG000|Overall Study|Missed Visit|2|||
155219133|NCT01528072|560241177|FG000|Overall Study|Lost to Follow-up|5|||
155219134|NCT01528072|560241177|FG000|Overall Study|Explanted|2|||
155219135|NCT01528072|560241177|FG000|Overall Study|Site Closure|4|||
155219136|NCT01528072|560241177|FG000|Overall Study|Death|2|||
155219137|NCT01528072|560241177|FG000|Overall Study|Early Termination of Study|52|||
155219138|NCT02436759|560241193|FG000|Overall Study|Adverse Event|3|||
155219139|NCT02436759|560241194|FG001|Overall Study|Adverse Event|0|||
155219140|NCT02436759|560241193|FG000|Overall Study|Protocol Violation|1|||
155219141|NCT02436759|560241194|FG001|Overall Study|Protocol Violation|0|||
155219142|NCT02436759|560241193|FG000|Overall Study|Withdrawal by Subject|0|||
155219143|NCT02436759|560241194|FG001|Overall Study|Withdrawal by Subject|1|||
155219144|NCT01290666|560241196|FG000|Overall Study|Lost to Follow-up|11|||
155219145|NCT01290666|560241196|FG000|Overall Study|Withdrawal by Subject|23|||
155219146|NCT01290666|560241196|FG000|Overall Study|Early Termination of Study|4|||
155219147|NCT01652664|560241199|FG000|Overall Study|Treatment Failure|5|||
155219148|NCT01652664|560241200|FG001|Overall Study|Treatment Failure|1|||
155219149|NCT01652664|560241199|FG000|Overall Study|Inadequate IOP control|1|||
155219150|NCT01652664|560241200|FG001|Overall Study|Inadequate IOP control|0|||
155219151|NCT00297037|560241201|FG000|Overall Study|Withdrawal by Subject|2|||
155219152|NCT00297037|560241202|FG001|Overall Study|Withdrawal by Subject|0|||
155219153|NCT00581776|560241203|FG000|Overall Study|Disease progression or no response|3|||
155219154|NCT02357901|560241204|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
155219155|NCT02357901|560241205|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
155219156|NCT02357901|560241206|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
155219157|NCT02357901|560241207|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
155219158|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
155219159|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
155219160|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
155219161|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
155219162|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
155219163|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
155219164|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
155219165|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
155219166|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
155219167|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
155219168|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
155219169|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
155219170|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
155219171|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
155219172|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
155219173|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
155219174|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
155219175|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
155219176|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
155219177|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
155219178|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
155219179|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
155219180|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
155219181|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
155219182|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
155219183|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
155219184|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
155219185|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
155219186|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
155219187|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
155219188|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
155219189|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
155219190|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
155219191|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
155219192|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
155219193|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
155219194|NCT02357901|560241204|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
155219195|NCT02357901|560241205|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
155219196|NCT02357901|560241206|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
155219197|NCT02357901|560241207|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
155219198|NCT00491387|560241214|FG000|Overall Study|study terminated|20|||
155219199|NCT02418468|560241223|FG000|Overall Study|Adverse Event|1|||
155219200|NCT02418468|560241224|FG001|Overall Study|Adverse Event|0|||
155219201|NCT02418468|560241223|FG000|Overall Study|Withdrawal of informed consent|1|||
155219202|NCT02418468|560241224|FG001|Overall Study|Withdrawal of informed consent|1|||
155219203|NCT00909779|560241225|FG000|Overall Study|Adverse Event|53|||
155219204|NCT00909779|560241226|FG001|Overall Study|Adverse Event|55|||
155219205|NCT00909779|560241225|FG000|Overall Study|Lack of Efficacy|7|||
155219206|NCT00909779|560241226|FG001|Overall Study|Lack of Efficacy|4|||
155219207|NCT00909779|560241225|FG000|Overall Study|Lost to Follow-up|19|||
155219208|NCT00909779|560241226|FG001|Overall Study|Lost to Follow-up|15|||
155219209|NCT00909779|560241225|FG000|Overall Study|Physician Decision|8|||
155219210|NCT00909779|560241226|FG001|Overall Study|Physician Decision|2|||
155219211|NCT00909779|560241225|FG000|Overall Study|Protocol Violation|2|||
155219212|NCT00909779|560241226|FG001|Overall Study|Protocol Violation|5|||
155219213|NCT00909779|560241225|FG000|Overall Study|Withdrawal by Subject|116|||
155219214|NCT00909779|560241226|FG001|Overall Study|Withdrawal by Subject|80|||
155219215|NCT00909779|560241225|FG000|Overall Study|Site Ceasing Operation|2|||
155219216|NCT00909779|560241226|FG001|Overall Study|Site Ceasing Operation|2|||
155219217|NCT00909779|560241225|FG000|Overall Study|Medical Monitor Decision|1|||
155219218|NCT00909779|560241226|FG001|Overall Study|Medical Monitor Decision|0|||
155219219|NCT00909779|560241225|FG000|Overall Study|Noncompliance|1|||
155219220|NCT00909779|560241226|FG001|Overall Study|Noncompliance|1|||
155219221|NCT00909779|560241225|FG000|Overall Study|Randomized in error|1|||
155219222|NCT00909779|560241226|FG001|Overall Study|Randomized in error|1|||
155219223|NCT01592344|560241227|FG000|Overall Study|Adverse Event|1|||
155219224|NCT01592344|560241228|FG001|Overall Study|Adverse Event|1|||
155219225|NCT01592344|560241227|FG000|Overall Study|Lack of Efficacy|1|||
155219226|NCT01592344|560241228|FG001|Overall Study|Lack of Efficacy|0|||
155219227|NCT01592344|560241227|FG000|Overall Study|not available at primary outcome visit|2|||
155219228|NCT01592344|560241228|FG001|Overall Study|not available at primary outcome visit|4|||
155219229|NCT00099437|560241229|FG000|Overall Study|Lost to Follow-up|30|||
155219230|NCT00099437|560241230|FG001|Overall Study|Lost to Follow-up|33|||
155219231|NCT00099437|560241229|FG000|Overall Study|Death|293|||
155219232|NCT00099437|560241230|FG001|Overall Study|Death|261|||
155219233|NCT00099437|560241229|FG000|Overall Study|Withdrawal by Subject|6|||
155219234|NCT00099437|560241230|FG001|Overall Study|Withdrawal by Subject|10|||
155219235|NCT00099437|560241229|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
155219236|NCT00099437|560241230|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
155219237|NCT00949325|560241231|FG000|Overall Study|Adverse Event|0|||
155219238|NCT00949325|560241232|FG001|Overall Study|Adverse Event|2|||
155219239|NCT00949325|560241233|FG002|Overall Study|Adverse Event|0|||
155219240|NCT02809677|560241234|FG000|Overall Study|Withdrawal by Subject|8|||
155219241|NCT00730912|560241235|FG000|Overall Study|Discontinued|0|||
155219242|NCT00730912|560241236|FG001|Overall Study|Discontinued|0|||
155219243|NCT00730912|560241237|FG002|Overall Study|Discontinued|1|||
155219244|NCT03311659|560241238|FG000|Overall Study|Protocol Violation|1|||
155219245|NCT02205333|560241239|FG000|Overall Study|Death|5|||
155219246|NCT02205333|560241240|FG001|Overall Study|Death|6|||
155219247|NCT02205333|560241241|FG002|Overall Study|Death|2|||
155219248|NCT02205333|560241242|FG003|Overall Study|Death|6|||
155219249|NCT02205333|560241243|FG004|Overall Study|Death|5|||
155219250|NCT02205333|560241244|FG005|Overall Study|Death|3|||
155219251|NCT02205333|560241245|FG006|Overall Study|Death|3|||
155219252|NCT02205333|560241246|FG007|Overall Study|Death|2|||
155219253|NCT02205333|560241247|FG008|Overall Study|Death|0|||
155219254|NCT02205333|560241239|FG000|Overall Study|Withdrawal by Subject|1|||
155219255|NCT02205333|560241240|FG001|Overall Study|Withdrawal by Subject|0|||
155219256|NCT02205333|560241241|FG002|Overall Study|Withdrawal by Subject|0|||
155219257|NCT02205333|560241242|FG003|Overall Study|Withdrawal by Subject|1|||
155219258|NCT02205333|560241243|FG004|Overall Study|Withdrawal by Subject|0|||
155219259|NCT02205333|560241244|FG005|Overall Study|Withdrawal by Subject|0|||
155219260|NCT02205333|560241245|FG006|Overall Study|Withdrawal by Subject|2|||
155219261|NCT02205333|560241246|FG007|Overall Study|Withdrawal by Subject|0|||
155219262|NCT02205333|560241247|FG008|Overall Study|Withdrawal by Subject|0|||
155219263|NCT01176266|560241248|FG000|Overall Study|Death|6|||
155219264|NCT01176266|560241248|FG000|Overall Study|Withdrawal by Subject|3|||
155219265|NCT04351087|560241251|FG000|Overall Study|Lost to Follow-up|7|||
155219266|NCT04351087|560241252|FG001|Overall Study|Lost to Follow-up|3|||
155219267|NCT04351087|560241251|FG000|Overall Study|Withdrawal by Subject|3|||
155219268|NCT04351087|560241252|FG001|Overall Study|Withdrawal by Subject|4|||
155219269|NCT04351087|560241251|FG000|Overall Study|Lack of Efficacy|3|||
155219270|NCT04351087|560241252|FG001|Overall Study|Lack of Efficacy|2|||
155219271|NCT05517382|560241253|FG000|Overall Study|Lost to Follow-up|0|||
155219272|NCT05517382|560241254|FG001|Overall Study|Lost to Follow-up|1|||
155219273|NCT01374087|560241257|FG000|Overall Study|Adverse Event|1|||
155219274|NCT01374087|560241258|FG001|Overall Study|Adverse Event|0|||
155219275|NCT01374087|560241257|FG000|Overall Study|Disease progression|2|||
155219276|NCT01374087|560241258|FG001|Overall Study|Disease progression|2|||
155219277|NCT01374087|560241257|FG000|Overall Study|Study discontinued|13|||
155219278|NCT01374087|560241258|FG001|Overall Study|Study discontinued|13|||
155219279|NCT00271947|560241261|FG000|Overall Study|Lost to Follow-up|1|||
155219280|NCT01522365|560241264|FG000|Overall Study|Withdrawal by Subject|1|||
155219281|NCT01522365|560241265|FG001|Overall Study|Withdrawal by Subject|1|||
155219282|NCT01522365|560241264|FG000|Overall Study|Lost to Follow-up|1|||
155219283|NCT01522365|560241265|FG001|Overall Study|Lost to Follow-up|1|||
155219284|NCT00651755|560241266|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
155219285|NCT00651755|560241267|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
155219286|NCT00651755|560241266|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
155219287|NCT00651755|560241267|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
155219288|NCT01120756|560241268|FG000|Overall Study|Withdrawal by Subject|1|||
155219289|NCT01120756|560241269|FG001|Overall Study|Withdrawal by Subject|1|||
155219290|NCT00698581|560241270|FG000|Overall Study|Lack of Efficacy|23|||
155219291|NCT00698581|560241271|FG001|Overall Study|Lack of Efficacy|11|||
155219292|NCT00698581|560241270|FG000|Overall Study|Withdrawal by Subject|6|||
155219293|NCT00698581|560241271|FG001|Overall Study|Withdrawal by Subject|0|||
155219294|NCT00698581|560241270|FG000|Overall Study|Other reason|9|||
155219295|NCT00698581|560241271|FG001|Overall Study|Other reason|1|||
155219296|NCT00698581|560241270|FG000|Overall Study|SAE, non-fatal|1|||
155219297|NCT00698581|560241271|FG001|Overall Study|SAE, non-fatal|0|||
155219298|NCT00698581|560241270|FG000|Overall Study|AE, non-serious non-fatal|4|||
155219299|NCT00698581|560241271|FG001|Overall Study|AE, non-serious non-fatal|0|||
155219300|NCT00698581|560241270|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155219301|NCT00698581|560241271|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155219302|NCT00698581|560241270|FG000|Overall Study|AE of unknown type|1|||
155219303|NCT00698581|560241271|FG001|Overall Study|AE of unknown type|0|||
155219304|NCT03760146|560241272|FG000|Overall Study|Adverse Event|11|||
155219305|NCT03760146|560241273|FG001|Overall Study|Adverse Event|8|||
155219306|NCT03760146|560241274|FG002|Overall Study|Adverse Event|0|||
155219307|NCT03760146|560241275|FG003|Overall Study|Adverse Event|0|||
155219308|NCT03760146|560241276|FG004|Overall Study|Adverse Event|0|||
155219309|NCT03760146|560241277|FG005|Overall Study|Adverse Event|0|||
155219310|NCT03760146|560241272|FG000|Overall Study|Death|1|||
155219311|NCT03760146|560241273|FG001|Overall Study|Death|0|||
155219312|NCT03760146|560241274|FG002|Overall Study|Death|0|||
155219313|NCT03760146|560241275|FG003|Overall Study|Death|0|||
155219314|NCT03760146|560241276|FG004|Overall Study|Death|0|||
155219315|NCT03760146|560241277|FG005|Overall Study|Death|0|||
155219316|NCT03760146|560241272|FG000|Overall Study|Lost to Follow-up|41|||
155219317|NCT03760146|560241273|FG001|Overall Study|Lost to Follow-up|28|||
155219318|NCT03760146|560241274|FG002|Overall Study|Lost to Follow-up|9|||
155219319|NCT03760146|560241275|FG003|Overall Study|Lost to Follow-up|2|||
155219320|NCT03760146|560241276|FG004|Overall Study|Lost to Follow-up|14|||
155219321|NCT03760146|560241277|FG005|Overall Study|Lost to Follow-up|8|||
155219322|NCT03760146|560241272|FG000|Overall Study|No longer met eligibility criteria|3|||
155219323|NCT03760146|560241273|FG001|Overall Study|No longer met eligibility criteria|9|||
155219324|NCT03760146|560241274|FG002|Overall Study|No longer met eligibility criteria|0|||
155219325|NCT03760146|560241275|FG003|Overall Study|No longer met eligibility criteria|0|||
155219326|NCT03760146|560241276|FG004|Overall Study|No longer met eligibility criteria|1|||
155219327|NCT03760146|560241277|FG005|Overall Study|No longer met eligibility criteria|0|||
155219328|NCT03760146|560241272|FG000|Overall Study|Protocol Violation|21|||
155219329|NCT03760146|560241273|FG001|Overall Study|Protocol Violation|13|||
155219330|NCT03760146|560241274|FG002|Overall Study|Protocol Violation|1|||
155219331|NCT03760146|560241275|FG003|Overall Study|Protocol Violation|0|||
155219332|NCT03760146|560241276|FG004|Overall Study|Protocol Violation|1|||
155219333|NCT03760146|560241277|FG005|Overall Study|Protocol Violation|0|||
155219334|NCT03760146|560241272|FG000|Overall Study|Withdrawal by Subject|19|||
155219335|NCT03760146|560241273|FG001|Overall Study|Withdrawal by Subject|20|||
155219336|NCT03760146|560241274|FG002|Overall Study|Withdrawal by Subject|1|||
155219337|NCT03760146|560241275|FG003|Overall Study|Withdrawal by Subject|0|||
155219338|NCT03760146|560241276|FG004|Overall Study|Withdrawal by Subject|1|||
155219339|NCT03760146|560241277|FG005|Overall Study|Withdrawal by Subject|0|||
155219340|NCT00449644|560241278|FG000|Overall Study|Adverse Event|0|||
155219341|NCT00449644|560241279|FG001|Overall Study|Adverse Event|0|||
155219342|NCT00449644|560241280|FG002|Overall Study|Adverse Event|3|||
155219343|NCT00449644|560241281|FG003|Overall Study|Adverse Event|5|||
155219344|NCT00449644|560241278|FG000|Overall Study|Death|1|||
155219345|NCT00449644|560241279|FG001|Overall Study|Death|0|||
155219346|NCT00449644|560241280|FG002|Overall Study|Death|6|||
155219347|NCT00449644|560241281|FG003|Overall Study|Death|1|||
155219348|NCT00449644|560241278|FG000|Overall Study|Lost to Follow-up|1|||
155219349|NCT00449644|560241279|FG001|Overall Study|Lost to Follow-up|1|||
155219350|NCT00449644|560241280|FG002|Overall Study|Lost to Follow-up|5|||
155219351|NCT00449644|560241281|FG003|Overall Study|Lost to Follow-up|3|||
155219352|NCT00449644|560241278|FG000|Overall Study|Pregnancy|0|||
155219353|NCT00449644|560241279|FG001|Overall Study|Pregnancy|0|||
155219354|NCT00449644|560241280|FG002|Overall Study|Pregnancy|3|||
155219355|NCT00449644|560241281|FG003|Overall Study|Pregnancy|2|||
155219356|NCT00449644|560241278|FG000|Overall Study|Protocol Violation|4|||
155219357|NCT00449644|560241279|FG001|Overall Study|Protocol Violation|4|||
155219358|NCT00449644|560241280|FG002|Overall Study|Protocol Violation|3|||
155219359|NCT00449644|560241281|FG003|Overall Study|Protocol Violation|7|||
155219360|NCT00449644|560241278|FG000|Overall Study|Withdrawal by Subject|3|||
155219361|NCT00449644|560241279|FG001|Overall Study|Withdrawal by Subject|4|||
155219362|NCT00449644|560241280|FG002|Overall Study|Withdrawal by Subject|6|||
155219363|NCT00449644|560241281|FG003|Overall Study|Withdrawal by Subject|7|||
155219364|NCT00449644|560241278|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
155219365|NCT00449644|560241279|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
155219366|NCT00449644|560241280|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
155219367|NCT00449644|560241281|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
155219368|NCT00449644|560241278|FG000|Overall Study|Other|1|||
155219369|NCT00449644|560241279|FG001|Overall Study|Other|4|||
155219370|NCT00449644|560241280|FG002|Overall Study|Other|1|||
155219371|NCT00449644|560241281|FG003|Overall Study|Other|0|||
155219372|NCT00449644|560241278|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
155219373|NCT00449644|560241279|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
155219374|NCT00449644|560241280|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
155219375|NCT00449644|560241281|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
155219376|NCT01816893|560241283|FG000|Washout Period|Withdrawal by Subject|2|||
155219377|NCT01816893|560241284|FG001|Washout Period|Withdrawal by Subject|0|||
155219378|NCT00858442|560242825|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
155219379|NCT00858442|560242826|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
155219380|NCT02016625|560242829|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
155219381|NCT02016625|560242830|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
155219382|NCT02016625|560242829|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
155219383|NCT02016625|560242830|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
155219384|NCT02016625|560242829|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
155219385|NCT02016625|560242830|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
155219386|NCT02155738|560242831|FG000|Overall Study|Missing critical information|1|||
155219387|NCT02155738|560242832|FG001|Overall Study|Missing critical information|0|||
155219388|NCT02155738|560242833|FG002|Overall Study|Missing critical information|0|||
155219389|NCT02155738|560242834|FG003|Overall Study|Missing critical information|1|||
155219390|NCT01254227|560242839|FG000|Overall Study|Withdrawal by Subject|6|||
155219391|NCT01254227|560242839|FG000|Overall Study|Lost to Follow-up|6|||
155219392|NCT01254227|560242839|FG000|Overall Study|Adverse Event|5|||
155219393|NCT01254227|560242839|FG000|Overall Study|Abnormal test procedure result|5|||
155219394|NCT01254227|560242839|FG000|Overall Study|Administrative problems|2|||
155219395|NCT01254227|560242839|FG000|Overall Study|Death|1|||
155219396|NCT01254227|560242839|FG000|Overall Study|Protocol deviation|1|||
155219397|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
155219398|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
155219399|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
155219400|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
155219401|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
155219402|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
155219403|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
155219404|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
155219405|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
155219406|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
155219407|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
155219408|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
155219409|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
155219410|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
155219411|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
155219412|NCT03970733|560242840|FG000|Main Study Phase (18 Months)|Other|1|||
155219413|NCT03970733|560242841|FG001|Main Study Phase (18 Months)|Other|1|||
155219414|NCT03970733|560242842|FG002|Main Study Phase (18 Months)|Other|0|||
155219415|NCT03970733|560242843|FG003|Main Study Phase (18 Months)|Other|0|||
155219416|NCT03970733|560242844|FG004|Main Study Phase (18 Months)|Other|0|||
155219417|NCT03970733|560242840|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219418|NCT03970733|560242841|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219419|NCT03970733|560242842|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219420|NCT03970733|560242843|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
155219421|NCT03970733|560242844|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
155219422|NCT02189473|560242848|FG000|Overall Study|Death|22|||
155219423|NCT02189473|560242849|FG001|Overall Study|Death|23|||
155219424|NCT02189473|560242848|FG000|Overall Study|Lost to Follow-up|1|||
155219425|NCT02189473|560242849|FG001|Overall Study|Lost to Follow-up|2|||
155219426|NCT02784821|560242850|FG000|Overall Study|Death|0|||
155219427|NCT02784821|560242851|FG001|Overall Study|Death|5|||
155219428|NCT02784821|560242852|FG002|Overall Study|Death|4|||
155219429|NCT02784821|560242853|FG003|Overall Study|Death|5|||
155219430|NCT01139450|560242854|FG000|Overall Study|Withdrawal by Subject|7|||
155219431|NCT01139450|560242855|FG001|Overall Study|Withdrawal by Subject|10|||
155219432|NCT01139450|560242856|FG002|Overall Study|Withdrawal by Subject|13|||
155219433|NCT01139450|560242854|FG000|Overall Study|Lack of Efficacy|3|||
155219434|NCT01139450|560242855|FG001|Overall Study|Lack of Efficacy|1|||
155219435|NCT01139450|560242856|FG002|Overall Study|Lack of Efficacy|8|||
155219436|NCT01139450|560242854|FG000|Overall Study|Protocol Violation|6|||
155219437|NCT01139450|560242855|FG001|Overall Study|Protocol Violation|5|||
155219438|NCT01139450|560242856|FG002|Overall Study|Protocol Violation|2|||
155219439|NCT01139450|560242854|FG000|Overall Study|Lost to Follow-up|9|||
155219440|NCT01139450|560242855|FG001|Overall Study|Lost to Follow-up|7|||
155219441|NCT01139450|560242856|FG002|Overall Study|Lost to Follow-up|11|||
155219442|NCT01139450|560242854|FG000|Overall Study|Administrative|0|||
155219443|NCT01139450|560242855|FG001|Overall Study|Administrative|0|||
155219444|NCT01139450|560242856|FG002|Overall Study|Administrative|1|||
155219445|NCT01139450|560242854|FG000|Overall Study|Adverse Event|2|||
155219446|NCT01139450|560242855|FG001|Overall Study|Adverse Event|2|||
155219447|NCT01139450|560242856|FG002|Overall Study|Adverse Event|3|||
155219448|NCT02794103|560242857|FG000|Overall Study|Loss to follow up due to high sedation|3|||
155219449|NCT04608500|560242858|FG000|Overall Study|Adverse Event|2|||
155219450|NCT04608500|560242859|FG001|Overall Study|Adverse Event|0|||
155219451|NCT04608500|560242858|FG000|Overall Study|Lost to Follow-up|15|||
155219452|NCT04608500|560242859|FG001|Overall Study|Lost to Follow-up|9|||
155219453|NCT04608500|560242858|FG000|Overall Study|Participant request|11|||
155219454|NCT04608500|560242859|FG001|Overall Study|Participant request|7|||
155219455|NCT04608500|560242858|FG000|Overall Study|Protocol Violation|1|||
155219456|NCT04608500|560242859|FG001|Overall Study|Protocol Violation|0|||
155219457|NCT04608500|560242858|FG000|Overall Study|Other|6|||
155219458|NCT04608500|560242859|FG001|Overall Study|Other|2|||
155219459|NCT01881230|560242866|FG000|Overall Study|Death|2|||
155219460|NCT01881230|560242867|FG001|Overall Study|Death|0|||
155219461|NCT01881230|560242868|FG002|Overall Study|Death|1|||
155219462|NCT01881230|560242866|FG000|Overall Study|Adverse Event|9|||
155219463|NCT01881230|560242867|FG001|Overall Study|Adverse Event|13|||
155219464|NCT01881230|560242868|FG002|Overall Study|Adverse Event|12|||
155219465|NCT01881230|560242866|FG000|Overall Study|Progressive Disease|31|||
155219466|NCT01881230|560242867|FG001|Overall Study|Progressive Disease|35|||
155219467|NCT01881230|560242868|FG002|Overall Study|Progressive Disease|36|||
155219468|NCT01881230|560242866|FG000|Overall Study|Symptomatic Deterioration|3|||
155219469|NCT01881230|560242867|FG001|Overall Study|Symptomatic Deterioration|3|||
155219470|NCT01881230|560242868|FG002|Overall Study|Symptomatic Deterioration|1|||
155219471|NCT01881230|560242866|FG000|Overall Study|Withdrawal by Subject|6|||
155219472|NCT01881230|560242867|FG001|Overall Study|Withdrawal by Subject|4|||
155219473|NCT01881230|560242868|FG002|Overall Study|Withdrawal by Subject|6|||
155219474|NCT01881230|560242866|FG000|Overall Study|Physician Decision|4|||
155219475|NCT01881230|560242867|FG001|Overall Study|Physician Decision|3|||
155219476|NCT01881230|560242868|FG002|Overall Study|Physician Decision|6|||
155219477|NCT01881230|560242866|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155219478|NCT01881230|560242867|FG001|Overall Study|Non-Compliance with Study Drug|2|||
155219479|NCT01881230|560242868|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155219480|NCT01881230|560242866|FG000|Overall Study|Given Commercially Available Drug|0|||
155219481|NCT01881230|560242867|FG001|Overall Study|Given Commercially Available Drug|0|||
155219482|NCT01881230|560242868|FG002|Overall Study|Given Commercially Available Drug|2|||
155219483|NCT01881230|560242866|FG000|Overall Study|Protocol Violation|1|||
155219484|NCT01881230|560242867|FG001|Overall Study|Protocol Violation|1|||
155219485|NCT01881230|560242868|FG002|Overall Study|Protocol Violation|0|||
155219486|NCT01881230|560242866|FG000|Overall Study|Miscellaneous|3|||
155219487|NCT01881230|560242867|FG001|Overall Study|Miscellaneous|3|||
155219488|NCT01881230|560242868|FG002|Overall Study|Miscellaneous|0|||
155219489|NCT01881230|560242866|FG000|Overall Study|Untreated: Other|0|||
155219490|NCT01881230|560242867|FG001|Overall Study|Untreated: Other|0|||
155219491|NCT01881230|560242868|FG002|Overall Study|Untreated: Other|1|||
155219492|NCT01881230|560242866|FG000|Overall Study|Untreated: Death|0|||
155219493|NCT01881230|560242867|FG001|Overall Study|Untreated: Death|0|||
155219494|NCT01881230|560242868|FG002|Overall Study|Untreated: Death|1|||
155219495|NCT01881230|560242866|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
155219496|NCT01881230|560242867|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
155219497|NCT01881230|560242868|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
155219498|NCT05123222|560242869|FG000|Overall Study|Lost to Follow-up|2|||
155219499|NCT05123222|560242870|FG001|Overall Study|Lost to Follow-up|0|||
155219500|NCT05123222|560242871|FG002|Overall Study|Lost to Follow-up|0|||
155219501|NCT05123222|560242872|FG003|Overall Study|Lost to Follow-up|0|||
155219502|NCT05123222|560242869|FG000|Overall Study|Protocol Violation|0|||
155219503|NCT05123222|560242870|FG001|Overall Study|Protocol Violation|0|||
155219504|NCT05123222|560242871|FG002|Overall Study|Protocol Violation|1|||
155219505|NCT05123222|560242872|FG003|Overall Study|Protocol Violation|0|||
155219506|NCT00914810|560242875|FG000|Overall Study|Withdrawal by Subject|1|||
155219507|NCT00914810|560242876|FG001|Overall Study|Withdrawal by Subject|0|||
155219508|NCT00914810|560242875|FG000|Overall Study|Relocated out of state|1|||
155219509|NCT00914810|560242876|FG001|Overall Study|Relocated out of state|0|||
155219510|NCT00914810|560242875|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
155219511|NCT00914810|560242876|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
155219512|NCT02747420|560242877|FG000|Overall Study|Lost to Follow-up|4|||
155219513|NCT02747420|560242878|FG001|Overall Study|Lost to Follow-up|2|||
155219514|NCT02747420|560242877|FG000|Overall Study|Withdrawal by Subject|3|||
155219515|NCT02747420|560242878|FG001|Overall Study|Withdrawal by Subject|2|||
155219516|NCT04782856|560242879|FG000|Overall Study|Withdrawal by Subject|0|||
155219517|NCT04782856|560242880|FG001|Overall Study|Withdrawal by Subject|1|||
155219518|NCT02535741|560242881|FG000|Overall Study|Adverse Event|3|||
155219519|NCT02535741|560242881|FG000|Overall Study|Withdrawal by Subject|9|||
155219520|NCT02535741|560242881|FG000|Overall Study|Lost to Follow-up|10|||
155219521|NCT02535741|560242881|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
155219522|NCT02535741|560242881|FG000|Overall Study|Missing data|6|||
155219523|NCT01030523|560242882|FG000|Initial Study (5 Years)|Death|1|||
155219524|NCT01030523|560242883|FG001|Initial Study (5 Years)|Death|0|||
155219525|NCT01030523|560242882|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
155219526|NCT01030523|560242883|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
155219527|NCT01030523|560242882|FG000|Initial Study (5 Years)|Implant failure|1|||
155219528|NCT01030523|560242883|FG001|Initial Study (5 Years)|Implant failure|0|||
155219529|NCT01030523|560242882|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
155219530|NCT01030523|560242883|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
155219531|NCT01030523|560242882|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
155219532|NCT01030523|560242883|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
155219533|NCT01030523|560242882|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
155219534|NCT01030523|560242883|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
155219535|NCT00798369|560242886|FG000|Overall Study|Subject withdrew consent|0|||
155219536|NCT00798369|560242887|FG001|Overall Study|Subject withdrew consent|0|||
155219537|NCT00798369|560242888|FG002|Overall Study|Subject withdrew consent|1|||
155219538|NCT00798369|560242889|FG003|Overall Study|Subject withdrew consent|1|||
155219539|NCT00798369|560242890|FG004|Overall Study|Subject withdrew consent|0|||
155219540|NCT00798369|560242891|FG005|Overall Study|Subject withdrew consent|2|||
155219541|NCT00798369|560242886|FG000|Overall Study|Lost to Follow-up|1|||
155219542|NCT00798369|560242887|FG001|Overall Study|Lost to Follow-up|1|||
155219543|NCT00798369|560242888|FG002|Overall Study|Lost to Follow-up|1|||
155219544|NCT00798369|560242889|FG003|Overall Study|Lost to Follow-up|0|||
155219545|NCT00798369|560242890|FG004|Overall Study|Lost to Follow-up|1|||
155219546|NCT00798369|560242891|FG005|Overall Study|Lost to Follow-up|0|||
155219547|NCT00798369|560242886|FG000|Overall Study|Adminstrative problems|0|||
155219548|NCT00798369|560242887|FG001|Overall Study|Adminstrative problems|0|||
155219549|NCT00798369|560242888|FG002|Overall Study|Adminstrative problems|0|||
155219550|NCT00798369|560242889|FG003|Overall Study|Adminstrative problems|0|||
155219551|NCT00798369|560242890|FG004|Overall Study|Adminstrative problems|0|||
155219552|NCT00798369|560242891|FG005|Overall Study|Adminstrative problems|1|||
155219553|NCT04475588|560242892|FG000|Overall Study|Adverse Event|2|||
155219554|NCT04475588|560242893|FG001|Overall Study|Adverse Event|0|||
155219555|NCT03020823|560242894|FG000|Overall Study|Physician Decision|4|||
155219556|NCT03020823|560242894|FG000|Overall Study|Lack of Efficacy|4|||
155219557|NCT03020823|560242894|FG000|Overall Study|Adverse Event|2|||
155219558|NCT00588822|560242895|FG000|Overall Study|progression of disease|8|||
155219559|NCT01413360|560242899|FG000|Overall Study|Lost to Follow-up|2|||
155219560|NCT01413360|560242899|FG000|Overall Study|Adverse Event|1|||
155219561|NCT02246673|560242902|FG000|Overall Study|Sponsor Decision|1|||
155219562|NCT02246673|560242903|FG001|Overall Study|Sponsor Decision|0|||
155219563|NCT02246673|560242904|FG002|Overall Study|Sponsor Decision|0|||
155219564|NCT02246673|560242905|FG003|Overall Study|Sponsor Decision|0|||
155219565|NCT02246673|560242906|FG004|Overall Study|Sponsor Decision|0|||
155219566|NCT02246673|560242902|FG000|Overall Study|Withdrawal by Subject|0|||
155219567|NCT02246673|560242903|FG001|Overall Study|Withdrawal by Subject|0|||
155219568|NCT02246673|560242904|FG002|Overall Study|Withdrawal by Subject|0|||
155219569|NCT02246673|560242905|FG003|Overall Study|Withdrawal by Subject|0|||
155219570|NCT02246673|560242906|FG004|Overall Study|Withdrawal by Subject|1|||
155219571|NCT02246673|560242902|FG000|Overall Study|Lost to Follow-up|0|||
155219572|NCT02246673|560242903|FG001|Overall Study|Lost to Follow-up|0|||
155219573|NCT02246673|560242904|FG002|Overall Study|Lost to Follow-up|0|||
155219574|NCT02246673|560242905|FG003|Overall Study|Lost to Follow-up|1|||
155219575|NCT02246673|560242906|FG004|Overall Study|Lost to Follow-up|0|||
155219576|NCT02246673|560242902|FG000|Overall Study|Protocol Violation|0|||
155219577|NCT02246673|560242903|FG001|Overall Study|Protocol Violation|0|||
155219578|NCT02246673|560242904|FG002|Overall Study|Protocol Violation|0|||
155219579|NCT02246673|560242905|FG003|Overall Study|Protocol Violation|1|||
155219580|NCT02246673|560242906|FG004|Overall Study|Protocol Violation|0|||
155219581|NCT02914769|560242907|FG000|Overall Study|Protocol Violation|3|||
155219582|NCT02914769|560242908|FG001|Overall Study|Protocol Violation|2|||
155219583|NCT02914769|560242907|FG000|Overall Study|Withdrawal by Subject|0|||
155219584|NCT02914769|560242908|FG001|Overall Study|Withdrawal by Subject|1|||
155219585|NCT02410954|560242909|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
155219586|NCT02410954|560242910|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
155219587|NCT02410954|560242909|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
155219588|NCT02410954|560242910|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
155219589|NCT02738333|560242911|FG000|Overall Study|Death|1|||
155219590|NCT02738333|560242912|FG001|Overall Study|Death|0|||
155219591|NCT02738333|560242913|FG002|Overall Study|Death|0|||
155219592|NCT02738333|560242911|FG000|Overall Study|Lost to Follow-up|1|||
155219593|NCT02738333|560242912|FG001|Overall Study|Lost to Follow-up|0|||
155219594|NCT02738333|560242913|FG002|Overall Study|Lost to Follow-up|0|||
155219595|NCT05413369|560242914|FG000|Overall Study|Adverse Event|1|||
155219596|NCT05413369|560242915|FG001|Overall Study|Adverse Event|1|||
155219597|NCT05413369|560242914|FG000|Overall Study|Withdrawal by Subject|13|||
155219598|NCT05413369|560242915|FG001|Overall Study|Withdrawal by Subject|4|||
155219599|NCT05413369|560242914|FG000|Overall Study|Non-compliance with study schedule|2|||
155219600|NCT05413369|560242915|FG001|Overall Study|Non-compliance with study schedule|1|||
155219601|NCT05413369|560242914|FG000|Overall Study|Other|1|||
155219602|NCT05413369|560242915|FG001|Overall Study|Other|1|||
155219603|NCT03165110|560242916|FG000|Overall Study|Anroid phone software incompatibility|1|||
155219604|NCT00454987|560242923|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
155219605|NCT00454987|560242924|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
155219606|NCT00454987|560242925|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
155219607|NCT00454987|560242923|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
155219608|NCT00454987|560242924|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
155219609|NCT00454987|560242925|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
155219610|NCT00454987|560242923|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
155219611|NCT00454987|560242924|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
155219612|NCT00454987|560242925|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
155219613|NCT02642432|560242927|FG000|Overall Study|Adverse Event|2|||
155219614|NCT02642432|560242927|FG000|Overall Study|Withdrew Consent|1|||
155219615|NCT02642432|560242927|FG000|Overall Study|Lost to Follow-up|2|||
155219616|NCT02642432|560242927|FG000|Overall Study|Other|3|||
155219617|NCT03999892|560242928|FG000|Overall Study|Lost to Follow-up|1|||
155219618|NCT01848756|560242929|FG000|Overall Study|Adverse Event|1|||
155219619|NCT01848756|560242929|FG000|Overall Study|Withdrawal by Subject|1|||
155219620|NCT01848756|560242929|FG000|Overall Study|Enrolled in Error|1|||
155219621|NCT03245008|560242930|FG000|Overall Study|Adverse Event|15|||
155219622|NCT03245008|560242931|FG001|Overall Study|Adverse Event|18|||
155219623|NCT03245008|560242932|FG002|Overall Study|Adverse Event|15|||
155219624|NCT03245008|560242933|FG003|Overall Study|Adverse Event|0|||
155219625|NCT03245008|560242934|FG004|Overall Study|Adverse Event|1|||
155219626|NCT03245008|560242930|FG000|Overall Study|Lack of Efficacy|0|||
155219627|NCT03245008|560242931|FG001|Overall Study|Lack of Efficacy|1|||
155219628|NCT03245008|560242932|FG002|Overall Study|Lack of Efficacy|0|||
155219629|NCT03245008|560242933|FG003|Overall Study|Lack of Efficacy|0|||
155219630|NCT03245008|560242934|FG004|Overall Study|Lack of Efficacy|0|||
155219631|NCT03245008|560242930|FG000|Overall Study|Lost to Follow-up|4|||
155219632|NCT03245008|560242931|FG001|Overall Study|Lost to Follow-up|1|||
155219633|NCT03245008|560242932|FG002|Overall Study|Lost to Follow-up|0|||
155219634|NCT03245008|560242933|FG003|Overall Study|Lost to Follow-up|0|||
155219635|NCT03245008|560242934|FG004|Overall Study|Lost to Follow-up|1|||
155219636|NCT03245008|560242930|FG000|Overall Study|Physician Decision|1|||
155219637|NCT03245008|560242931|FG001|Overall Study|Physician Decision|3|||
155219638|NCT03245008|560242932|FG002|Overall Study|Physician Decision|4|||
155219639|NCT03245008|560242933|FG003|Overall Study|Physician Decision|0|||
155219640|NCT03245008|560242934|FG004|Overall Study|Physician Decision|0|||
155219641|NCT03245008|560242930|FG000|Overall Study|Protocol Violation|0|||
155219642|NCT03245008|560242931|FG001|Overall Study|Protocol Violation|1|||
155219643|NCT03245008|560242932|FG002|Overall Study|Protocol Violation|0|||
155219644|NCT03245008|560242933|FG003|Overall Study|Protocol Violation|0|||
155219645|NCT03245008|560242934|FG004|Overall Study|Protocol Violation|0|||
155219646|NCT03245008|560242930|FG000|Overall Study|Withdrawal by Subject|20|||
155219647|NCT03245008|560242931|FG001|Overall Study|Withdrawal by Subject|19|||
155219648|NCT03245008|560242932|FG002|Overall Study|Withdrawal by Subject|11|||
155219649|NCT03245008|560242933|FG003|Overall Study|Withdrawal by Subject|0|||
155219650|NCT03245008|560242934|FG004|Overall Study|Withdrawal by Subject|0|||
155219651|NCT03245008|560242930|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
155219652|NCT03245008|560242931|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
155219653|NCT03245008|560242932|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
155219654|NCT03245008|560242933|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
155219655|NCT03245008|560242934|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
155219656|NCT03245008|560242930|FG000|Overall Study|Failure to meet randomization criteria|0|||
155219657|NCT03245008|560242931|FG001|Overall Study|Failure to meet randomization criteria|1|||
155219658|NCT03245008|560242932|FG002|Overall Study|Failure to meet randomization criteria|0|||
155219659|NCT03245008|560242933|FG003|Overall Study|Failure to meet randomization criteria|1|||
155219660|NCT03245008|560242934|FG004|Overall Study|Failure to meet randomization criteria|0|||
155219661|NCT02075658|560242935|FG000|Overall Study|Physician Decision|2|||
155219662|NCT02075658|560242936|FG001|Overall Study|Physician Decision|2|||
155219663|NCT01286012|560242937|FG000|Overall Study|Adverse Event|3|||
155219664|NCT01286012|560242938|FG001|Overall Study|Adverse Event|3|||
155219665|NCT01286012|560242937|FG000|Overall Study|Death|2|||
155219666|NCT01286012|560242938|FG001|Overall Study|Death|3|||
155219667|NCT01286012|560242937|FG000|Overall Study|Protocol Violation|1|||
155219668|NCT01286012|560242938|FG001|Overall Study|Protocol Violation|1|||
155219669|NCT01286012|560242937|FG000|Overall Study|Withdrawal by Subject|4|||
155219670|NCT01286012|560242938|FG001|Overall Study|Withdrawal by Subject|4|||
155219671|NCT01286012|560242937|FG000|Overall Study|Physician Decision|2|||
155219672|NCT01286012|560242938|FG001|Overall Study|Physician Decision|0|||
155219673|NCT01286012|560242937|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
155219674|NCT01286012|560242938|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
155219675|NCT04056195|560242941|FG000|Overall Study|Adverse Event|1|||
155219676|NCT04056195|560242942|FG001|Overall Study|Adverse Event|0|||
155219677|NCT04056195|560242943|FG002|Overall Study|Adverse Event|0|||
155219678|NCT04056195|560242941|FG000|Overall Study|Withdrawal by Subject|0|||
155219679|NCT04056195|560242942|FG001|Overall Study|Withdrawal by Subject|1|||
155219680|NCT04056195|560242943|FG002|Overall Study|Withdrawal by Subject|1|||
155219681|NCT04056195|560242941|FG000|Overall Study|Physician Decision|1|||
155219682|NCT04056195|560242942|FG001|Overall Study|Physician Decision|1|||
155219683|NCT04056195|560242943|FG002|Overall Study|Physician Decision|1|||
155219684|NCT02406651|560242944|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
155219685|NCT00718328|560242948|FG000|Overall Study|Lost to Follow-up|1|||
155219686|NCT00718328|560242949|FG001|Overall Study|Lost to Follow-up|0|||
155219687|NCT02865915|560242950|FG000|Overall Study|Pregnancy|1|||
155219688|NCT02865915|560242951|FG001|Overall Study|Pregnancy|0|||
155219689|NCT02865915|560242950|FG000|Overall Study|Withdrawal by Subject|1|||
155219690|NCT02865915|560242951|FG001|Overall Study|Withdrawal by Subject|1|||
155219691|NCT02865915|560242950|FG000|Overall Study|Adverse Event|0|||
155219692|NCT02865915|560242951|FG001|Overall Study|Adverse Event|4|||
155219693|NCT02865915|560242950|FG000|Overall Study|Lost to Follow-up|0|||
155219694|NCT02865915|560242951|FG001|Overall Study|Lost to Follow-up|1|||
155219695|NCT02865915|560242950|FG000|Overall Study|Protocol Violation|0|||
155219696|NCT02865915|560242951|FG001|Overall Study|Protocol Violation|1|||
155219697|NCT02865915|560242950|FG000|Overall Study|Study terminated by sponsor|23|||
155219698|NCT02865915|560242951|FG001|Overall Study|Study terminated by sponsor|18|||
155219699|NCT02865915|560242950|FG000|Overall Study|Dosing group discontinued|0|||
155219700|NCT02865915|560242951|FG001|Overall Study|Dosing group discontinued|5|||
155219701|NCT00663052|560242952|FG000|Overall Study|Adverse Event|6|||
155219702|NCT00663052|560242953|FG001|Overall Study|Adverse Event|3|||
155219703|NCT00663052|560242952|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
155219704|NCT00663052|560242953|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
155219705|NCT00663052|560242952|FG000|Overall Study|Protocol Violation|1|||
155219706|NCT00663052|560242953|FG001|Overall Study|Protocol Violation|0|||
155219707|NCT00663052|560242952|FG000|Overall Study|Withdrawal by Subject|2|||
155219708|NCT00663052|560242953|FG001|Overall Study|Withdrawal by Subject|5|||
155219709|NCT00663052|560242952|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
155219710|NCT00663052|560242953|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
155219711|NCT00663052|560242952|FG000|Overall Study|Other|0|||
155219712|NCT00663052|560242953|FG001|Overall Study|Other|1|||
155219713|NCT01602380|560242956|FG000|Overall Study|Death|147|||
155219714|NCT01602380|560242957|FG001|Overall Study|Death|145|||
155219715|NCT01602380|560242956|FG000|Overall Study|Withdrawal by Subject|39|||
155219716|NCT01602380|560242957|FG001|Overall Study|Withdrawal by Subject|41|||
155219717|NCT01602380|560242956|FG000|Overall Study|Lost to Follow-up|15|||
155219718|NCT01602380|560242957|FG001|Overall Study|Lost to Follow-up|12|||
155219719|NCT01602380|560242956|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155219720|NCT01602380|560242957|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
155219721|NCT01602380|560242956|FG000|Overall Study|Other|2|||
155219722|NCT01602380|560242957|FG001|Overall Study|Other|0|||
155219723|NCT05760300|560242960|FG000|Overall Study|Adverse Event|0|||
155219724|NCT05760300|560242961|FG001|Overall Study|Adverse Event|0|||
155219725|NCT05760300|560242962|FG002|Overall Study|Adverse Event|1|||
155219726|NCT05760300|560242963|FG003|Overall Study|Adverse Event|0|||
155219727|NCT05760300|560242960|FG000|Overall Study|Participant Decision|1|||
155219728|NCT05760300|560242961|FG001|Overall Study|Participant Decision|0|||
155219729|NCT05760300|560242962|FG002|Overall Study|Participant Decision|0|||
155219730|NCT05760300|560242963|FG003|Overall Study|Participant Decision|0|||
155219731|NCT03313804|560242964|FG000|Treatment|Death|5|||
155219732|NCT03313804|560242964|FG000|Treatment|still on treatment|2|||
155219733|NCT03313804|560242964|FG000|Follow Up|still on follow up|3|||
155219734|NCT01502423|560242965|FG000|Overall Study|Withdrawal by Subject|0|||
155219735|NCT01502423|560242966|FG001|Overall Study|Withdrawal by Subject|1|||
155219736|NCT00567892|560242967|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219737|NCT00567892|560242968|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219738|NCT00567892|560242969|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
155219739|NCT00567892|560242970|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
155219740|NCT00567892|560242967|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219741|NCT00567892|560242968|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219742|NCT00567892|560242969|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
155219743|NCT00567892|560242970|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
155219744|NCT04814433|560242971|FG000|Overall Study|Survey not returned|4|||
155219745|NCT04814433|560242972|FG001|Overall Study|Survey not returned|8|||
155219746|NCT04814433|560242973|FG002|Overall Study|Survey not returned|4|||
155219747|NCT04814433|560242974|FG003|Overall Study|Survey not returned|5|||
155219748|NCT01545817|560244891|FG000|Pazopanib|Disease progression|51|||
155219749|NCT01545817|560244892|FG001|Pazopanib|Disease progression|0|||
155219750|NCT01545817|560244891|FG000|Pazopanib|Adverse Event|19|||
155219751|NCT01545817|560244892|FG001|Pazopanib|Adverse Event|0|||
155219752|NCT01545817|560244891|FG000|Pazopanib|Other reason|4|||
155219753|NCT01545817|560244892|FG001|Pazopanib|Other reason|0|||
155219754|NCT01545817|560244891|FG000|Everolimus|Other reason|0|||
155219755|NCT01545817|560244892|FG001|Everolimus|Other reason|7|||
155219756|NCT01545817|560244891|FG000|Everolimus|Disease progression|0|||
155219757|NCT01545817|560244892|FG001|Everolimus|Disease progression|25|||
155219758|NCT01545817|560244891|FG000|Everolimus|Adverse Event|0|||
155219759|NCT01545817|560244892|FG001|Everolimus|Adverse Event|6|||
155219760|NCT04439253|560244893|FG000|Overall Study|Adverse Event|1|||
155219761|NCT04439253|560244893|FG000|Overall Study|Disease progression|2|||
155219762|NCT04439253|560244893|FG000|Overall Study|Complicating disease|1|||
155219763|NCT03971695|560244894|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219764|NCT03971695|560244895|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219765|NCT03971695|560244896|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219766|NCT03971695|560244897|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
155219767|NCT03971695|560244898|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
155219768|NCT03971695|560244899|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219769|NCT03971695|560244900|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219770|NCT03971695|560244901|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219771|NCT03971695|560244902|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
155219772|NCT03971695|560244903|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
155219773|NCT03971695|560244904|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
155219774|NCT03971695|560244905|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
155219775|NCT03971695|560244906|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
155219776|NCT04447417|560244907|FG000|Overall Study|Withdrawal by Subject|1|||
155219777|NCT04447417|560244908|FG001|Overall Study|Withdrawal by Subject|0|||
155219778|NCT04447417|560244907|FG000|Overall Study|Failure to meet inclusion criteria|1|||
155219779|NCT04447417|560244908|FG001|Overall Study|Failure to meet inclusion criteria|0|||
155219780|NCT04447417|560244907|FG000|Overall Study|Lost to Follow-up|1|||
155219781|NCT04447417|560244908|FG001|Overall Study|Lost to Follow-up|0|||
155219782|NCT00702403|560244909|FG000|From Consent to Engraftment|Progressive leukemia|6|||
155219783|NCT00702403|560244909|FG000|From Consent to Engraftment|Critically ill|2|||
155219784|NCT00702403|560244909|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
155219785|NCT00702403|560244909|FG000|From Consent to Engraftment|Myocardial infarction|1|||
155219786|NCT00702403|560244909|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
155219787|NCT00702403|560244909|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
155219788|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
155219789|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
155219790|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Non-compliance|2|||
155219791|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
155219792|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
155219793|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Suicide|1|||
155219794|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
155219795|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
155219796|NCT00702403|560244909|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
155219797|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
155219798|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
155219799|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
155219800|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
155219801|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
155219802|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
155219803|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
155219804|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
155219805|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
155219806|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
155219807|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
155219808|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
155219809|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
155219810|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
155219811|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
155219812|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
155219813|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
155219814|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
155219815|NCT00887354|560244915|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
155219816|NCT00887354|560244916|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
155219817|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
155219818|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
155219819|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
155219820|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
155219821|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
155219822|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
155219823|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
155219824|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
155219825|NCT00887354|560244915|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
155219826|NCT00887354|560244916|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
155219827|NCT01466348|560244919|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
155219828|NCT01466348|560244920|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
155219829|NCT00192504|560244923|FG000|Overall Study|Lost to Follow-up|1|||
155219830|NCT00192504|560244924|FG001|Overall Study|Lost to Follow-up|0|||
155219831|NCT00192504|560244925|FG002|Overall Study|Lost to Follow-up|0|||
155219832|NCT00192504|560244926|FG003|Overall Study|Lost to Follow-up|0|||
155219833|NCT00192504|560244923|FG000|Overall Study|Dosing window missed|0|||
155219834|NCT00192504|560244924|FG001|Overall Study|Dosing window missed|0|||
155219835|NCT00192504|560244925|FG002|Overall Study|Dosing window missed|1|||
155219836|NCT00192504|560244926|FG003|Overall Study|Dosing window missed|0|||
155219837|NCT03989440|560244927|FG000|Overall Study|COVID-19 travel restrictions|0|||
155219838|NCT03989440|560244928|FG001|Overall Study|COVID-19 travel restrictions|0|||
155219839|NCT03989440|560244929|FG002|Overall Study|COVID-19 travel restrictions|1|||
155219840|NCT03989440|560244930|FG003|Overall Study|COVID-19 travel restrictions|0|||
155219841|NCT03989440|560244931|FG004|Overall Study|COVID-19 travel restrictions|0|||
155219842|NCT03989440|560244932|FG005|Overall Study|COVID-19 travel restrictions|0|||
155219843|NCT03989440|560244927|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
155219844|NCT03989440|560244928|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
155219845|NCT03989440|560244929|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
155219846|NCT03989440|560244930|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
155219847|NCT03989440|560244931|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
155219848|NCT03989440|560244932|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
155219849|NCT01955161|560244935|FG000|Overall Study|Withdrawal before treatment|2|||
155219850|NCT01955161|560244936|FG001|Overall Study|Withdrawal before treatment|0|||
155219851|NCT01955161|560244937|FG002|Overall Study|Withdrawal before treatment|1|||
155219852|NCT01955161|560244935|FG000|Overall Study|Adverse Event|10|||
155219853|NCT01955161|560244936|FG001|Overall Study|Adverse Event|14|||
155219854|NCT01955161|560244937|FG002|Overall Study|Adverse Event|15|||
155219855|NCT01955161|560244935|FG000|Overall Study|Death|1|||
155219856|NCT01955161|560244936|FG001|Overall Study|Death|1|||
155219857|NCT01955161|560244937|FG002|Overall Study|Death|3|||
155219858|NCT01955161|560244935|FG000|Overall Study|Withdrawal by Subject|9|||
155219859|NCT01955161|560244936|FG001|Overall Study|Withdrawal by Subject|8|||
155219860|NCT01955161|560244937|FG002|Overall Study|Withdrawal by Subject|12|||
155219861|NCT01955161|560244935|FG000|Overall Study|Protocol Violation|2|||
155219862|NCT01955161|560244936|FG001|Overall Study|Protocol Violation|0|||
155219863|NCT01955161|560244937|FG002|Overall Study|Protocol Violation|0|||
155219864|NCT01955161|560244935|FG000|Overall Study|Other reason: physician decision|0|||
155219865|NCT01955161|560244936|FG001|Overall Study|Other reason: physician decision|1|||
155219866|NCT01955161|560244937|FG002|Overall Study|Other reason: physician decision|1|||
155219867|NCT01955161|560244935|FG000|Overall Study|Other reason: disallowed medication|1|||
155219868|NCT01955161|560244936|FG001|Overall Study|Other reason: disallowed medication|0|||
155219869|NCT01955161|560244937|FG002|Overall Study|Other reason: disallowed medication|1|||
155219870|NCT01955161|560244935|FG000|Overall Study|Other reason: caregiver unavailable|1|||
155219871|NCT01955161|560244936|FG001|Overall Study|Other reason: caregiver unavailable|0|||
155219872|NCT01955161|560244937|FG002|Overall Study|Other reason: caregiver unavailable|0|||
155219873|NCT01955161|560244935|FG000|Overall Study|Other reason: moved to nursing home|0|||
155219874|NCT01955161|560244936|FG001|Overall Study|Other reason: moved to nursing home|1|||
155219875|NCT01955161|560244937|FG002|Overall Study|Other reason: moved to nursing home|0|||
155219876|NCT01955161|560244935|FG000|Overall Study|Other reason: insufficient compliance|0|||
155219877|NCT01955161|560244936|FG001|Overall Study|Other reason: insufficient compliance|0|||
155219878|NCT01955161|560244937|FG002|Overall Study|Other reason: insufficient compliance|1|||
155219879|NCT01955161|560244935|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
155219880|NCT01955161|560244936|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
155219881|NCT01955161|560244937|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
155219882|NCT01955161|560244935|FG000|Overall Study|Other reason: patient's will|0|||
155219883|NCT01955161|560244936|FG001|Overall Study|Other reason: patient's will|0|||
155219884|NCT01955161|560244937|FG002|Overall Study|Other reason: patient's will|1|||
155219885|NCT05129488|560244943|FG000|Overall Study|Protocol Violation|3|||
155219886|NCT00706641|560244948|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
155219887|NCT00706641|560244948|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
155219888|NCT00706641|560244948|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
155219889|NCT01327300|560244949|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
155219890|NCT01327300|560244950|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
155219891|NCT03739112|560244951|FG000|Overall Study|Adverse Event|2|||
155219892|NCT03739112|560244952|FG001|Overall Study|Adverse Event|2|||
155219893|NCT03739112|560244951|FG000|Overall Study|Withdrawal by Subject|38|||
155219894|NCT03739112|560244952|FG001|Overall Study|Withdrawal by Subject|19|||
155219895|NCT03739112|560244951|FG000|Overall Study|Lost to Follow-up|31|||
155219896|NCT03739112|560244952|FG001|Overall Study|Lost to Follow-up|33|||
155219897|NCT03739112|560244951|FG000|Overall Study|Protocol Deviation|12|||
155219898|NCT03739112|560244952|FG001|Overall Study|Protocol Deviation|9|||
155219899|NCT03739112|560244951|FG000|Overall Study|Physician Decision|1|||
155219900|NCT03739112|560244952|FG001|Overall Study|Physician Decision|0|||
155219901|NCT03739112|560244951|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
155219902|NCT03739112|560244952|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
155219903|NCT03739112|560244951|FG000|Overall Study|Site went on hold|65|||
155219904|NCT03739112|560244952|FG001|Overall Study|Site went on hold|67|||
155219905|NCT03739112|560244951|FG000|Overall Study|Other than specified|8|||
155219906|NCT03739112|560244952|FG001|Overall Study|Other than specified|5|||
155219907|NCT03739112|560244951|FG000|Overall Study|Randomized but not vaccinated|31|||
155219908|NCT03739112|560244952|FG001|Overall Study|Randomized but not vaccinated|25|||
155219909|NCT04307446|560244954|FG000|Overall Study|Lost to Follow-up|2|||
155219910|NCT04307446|560244955|FG001|Overall Study|Lost to Follow-up|0|||
155219911|NCT01063764|560244956|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
155219912|NCT01063764|560244956|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
155219913|NCT01063764|560244956|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
155219914|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
155219915|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
155219916|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
155219917|NCT01063764|560244956|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
155219918|NCT01727141|560244959|FG000|Overall Study|Physician Decision|0|||
155219919|NCT01727141|560244960|FG001|Overall Study|Physician Decision|1|||
155219920|NCT01727141|560244961|FG002|Overall Study|Physician Decision|0|||
155219921|NCT01727141|560244962|FG003|Overall Study|Physician Decision|2|||
155219922|NCT01727141|560244959|FG000|Overall Study|Lost to Follow-up|0|||
155219923|NCT01727141|560244960|FG001|Overall Study|Lost to Follow-up|2|||
155219924|NCT01727141|560244961|FG002|Overall Study|Lost to Follow-up|0|||
155219925|NCT01727141|560244962|FG003|Overall Study|Lost to Follow-up|0|||
155219926|NCT01727141|560244959|FG000|Overall Study|Death|0|||
155219927|NCT01727141|560244960|FG001|Overall Study|Death|1|||
155219928|NCT01727141|560244961|FG002|Overall Study|Death|1|||
155219929|NCT01727141|560244962|FG003|Overall Study|Death|1|||
155219930|NCT01727141|560244959|FG000|Overall Study|Protocol deviation|1|||
155219931|NCT01727141|560244960|FG001|Overall Study|Protocol deviation|1|||
155219932|NCT01727141|560244961|FG002|Overall Study|Protocol deviation|0|||
155219933|NCT01727141|560244962|FG003|Overall Study|Protocol deviation|1|||
155219934|NCT01727141|560244959|FG000|Overall Study|Withdrawal by Subject|4|||
155219935|NCT01727141|560244960|FG001|Overall Study|Withdrawal by Subject|4|||
155219936|NCT01727141|560244961|FG002|Overall Study|Withdrawal by Subject|2|||
155219937|NCT01727141|560244962|FG003|Overall Study|Withdrawal by Subject|11|||
155219938|NCT02529137|560244963|FG000|Overall Study|Discontinuation for different reasons|8|||
155219939|NCT01660711|560244966|FG000|Overall Study|Adverse Event|7|||
155219940|NCT01660711|560244966|FG000|Overall Study|Withdrawal by Subject|1|||
155219941|NCT00952341|560244967|FG000|Cycle 1|Adverse Event|4|||
155219942|NCT00952341|560244968|FG001|Cycle 1|Adverse Event|1|||
155219943|NCT00952341|560244967|FG000|Cycle 1|Withdrawal by Subject|3|||
155219944|NCT00952341|560244968|FG001|Cycle 1|Withdrawal by Subject|8|||
155219945|NCT00952341|560244967|FG000|Cycle 1|Protocol Violation|2|||
155219946|NCT00952341|560244968|FG001|Cycle 1|Protocol Violation|1|||
155219947|NCT00952341|560244967|FG000|Cycle 1|Lost to Follow-up|11|||
155219948|NCT00952341|560244968|FG001|Cycle 1|Lost to Follow-up|2|||
155219949|NCT00952341|560244967|FG000|Cycle 1|Physician Decision|0|||
155219950|NCT00952341|560244968|FG001|Cycle 1|Physician Decision|1|||
155219951|NCT00952341|560244967|FG000|Cycle 2|Withdrawal by Subject|1|||
155219952|NCT00952341|560244968|FG001|Cycle 2|Withdrawal by Subject|1|||
155219953|NCT00952341|560244967|FG000|Cycle 2|Protocol Violation|1|||
155219954|NCT00952341|560244968|FG001|Cycle 2|Protocol Violation|0|||
155219955|NCT00952341|560244967|FG000|Cycle 2|Lost to Follow-up|6|||
155219956|NCT00952341|560244968|FG001|Cycle 2|Lost to Follow-up|9|||
155219957|NCT00952341|560244967|FG000|Cycle 2|Physician Decision|1|||
155219958|NCT00952341|560244968|FG001|Cycle 2|Physician Decision|1|||
155219959|NCT00952341|560244967|FG000|Cycle 2|Progressive Disease|0|||
155219960|NCT00952341|560244968|FG001|Cycle 2|Progressive Disease|1|||
155219961|NCT02066467|560244971|FG000|Overall Study|Did not undergo implant procedure|24|||
155219962|NCT02066467|560244971|FG000|Overall Study|Attempted to implant withoput success|43|||
155219963|NCT02066467|560244971|FG000|Overall Study|Consent ineligible|1|||
155219964|NCT02066467|560244971|FG000|Overall Study|Death|54|||
155219965|NCT02066467|560244971|FG000|Overall Study|Lost to Follow-up|51|||
155219966|NCT02066467|560244971|FG000|Overall Study|Adverse Event|20|||
155219967|NCT02066467|560244971|FG000|Overall Study|Withdrawal by Subject|16|||
155219968|NCT02066467|560244971|FG000|Overall Study|Physician Decision|2|||
155219969|NCT02066467|560244971|FG000|Overall Study|Not defined|4|||
155219970|NCT02759120|560244977|FG000|Overall Study|Death|34|||
155219971|NCT02759120|560244978|FG001|Overall Study|Death|36|||
155219972|NCT02759120|560244977|FG000|Overall Study|Lost to Follow-up|4|||
155219973|NCT02759120|560244978|FG001|Overall Study|Lost to Follow-up|7|||
155219974|NCT02759120|560244977|FG000|Overall Study|Physician Decision|3|||
155219975|NCT02759120|560244978|FG001|Overall Study|Physician Decision|0|||
155219976|NCT02759120|560244977|FG000|Overall Study|Withdrawal by Subject|28|||
155219977|NCT02759120|560244978|FG001|Overall Study|Withdrawal by Subject|15|||
155219978|NCT02759120|560244977|FG000|Overall Study|Moved out of area|3|||
155219979|NCT02759120|560244978|FG001|Overall Study|Moved out of area|4|||
155219980|NCT02759120|560244977|FG000|Overall Study|Lung transplant|3|||
155219981|NCT02759120|560244978|FG001|Overall Study|Lung transplant|5|||
155219982|NCT02759120|560244977|FG000|Overall Study|Other reason not completed|10|||
155219983|NCT02759120|560244978|FG001|Overall Study|Other reason not completed|12|||
155219984|NCT04461015|560244979|FG000|Overall Study|IV access lost during the study|0|||
155219985|NCT04461015|560244980|FG001|Overall Study|IV access lost during the study|1|||
155219986|NCT04461015|560244979|FG000|Overall Study|Withdrawal by Subject|0|||
155219987|NCT04461015|560244980|FG001|Overall Study|Withdrawal by Subject|1|||
155219988|NCT03538158|560244982|FG000|Overall Study|Lost to Follow-up|13|||
155219989|NCT03538158|560244983|FG001|Overall Study|Lost to Follow-up|7|||
155219990|NCT03538158|560244982|FG000|Overall Study|Withdrawal by Subject|2|||
155219991|NCT03538158|560244983|FG001|Overall Study|Withdrawal by Subject|1|||
155219992|NCT04356963|560244987|FG000|First Session|Withdrawal by Subject|1|||
155219993|NCT04356963|560244987|FG000|Second Session|Withdrawal by Subject|3|||
155219994|NCT04356963|560244987|FG000|Second Session|Lost to Follow-up|1|||
155219995|NCT04356963|560244987|FG000|Third Session|Lost to Follow-up|6|||
155219996|NCT04356963|560244987|FG000|Third Session|Withdrawal by Subject|1|||
155219997|NCT00791518|560244989|FG000|Overall Study|Protocol Violation|93|||
155219998|NCT04256785|560244996|FG000|Overall Study|Adverse Event|8|||
155219999|NCT04256785|560244997|FG001|Overall Study|Adverse Event|6|||
155220000|NCT04256785|560244996|FG000|Overall Study|Lack of Efficacy|3|||
155220001|NCT04256785|560244997|FG001|Overall Study|Lack of Efficacy|4|||
155220002|NCT04256785|560244996|FG000|Overall Study|Lost to Follow-up|7|||
155220003|NCT04256785|560244997|FG001|Overall Study|Lost to Follow-up|7|||
155220004|NCT04256785|560244996|FG000|Overall Study|Protocol Violation|1|||
155220005|NCT04256785|560244997|FG001|Overall Study|Protocol Violation|0|||
155220006|NCT04256785|560244996|FG000|Overall Study|Withdrawal by Subject|4|||
155220007|NCT04256785|560244997|FG001|Overall Study|Withdrawal by Subject|1|||
155220008|NCT04256785|560244996|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
155220009|NCT04256785|560244997|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
155220010|NCT00271609|560244999|FG000|Overall Study|Adverse Event|11|||
155220011|NCT00271609|560245000|FG001|Overall Study|Adverse Event|3|||
155220012|NCT00271609|560244999|FG000|Overall Study|Withdrawal by Subject|2|||
155220013|NCT00271609|560245000|FG001|Overall Study|Withdrawal by Subject|0|||
155220014|NCT03341533|560245001|FG000|Overall Study|Withdrawal by Subject|1|||
155220015|NCT03341533|560245002|FG001|Overall Study|Withdrawal by Subject|1|||
155220016|NCT03341533|560245001|FG000|Overall Study|Not eligible after randomization|2|||
155220017|NCT03341533|560245002|FG001|Overall Study|Not eligible after randomization|1|||
155220018|NCT00643682|560245003|FG000|Overall Study|did not keep appointment|522|||
155220019|NCT00643682|560245004|FG001|Overall Study|did not keep appointment|509|||
155220020|NCT03755414|560245006|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
155220021|NCT03755414|560245007|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
155220022|NCT03755414|560245008|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
155220023|NCT03755414|560245006|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
155220024|NCT03755414|560245007|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
155220025|NCT03755414|560245008|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
155220026|NCT03755414|560245006|FG000|Overall Study|Non-compliance|0|||
155220027|NCT03755414|560245007|FG001|Overall Study|Non-compliance|1|||
155220028|NCT03755414|560245008|FG002|Overall Study|Non-compliance|0|||
155220029|NCT02153112|560245009|FG000|Overall Study|Adverse Event|0|||
155220030|NCT02153112|560245010|FG001|Overall Study|Adverse Event|0|||
155220031|NCT02153112|560245011|FG002|Overall Study|Adverse Event|1|||
155220032|NCT02153112|560245012|FG003|Overall Study|Adverse Event|0|||
155220033|NCT02153112|560245013|FG004|Overall Study|Adverse Event|0|||
155220034|NCT02153112|560245014|FG005|Overall Study|Adverse Event|0|||
155220035|NCT02153112|560245015|FG006|Overall Study|Adverse Event|0|||
155220036|NCT02153112|560245016|FG007|Overall Study|Adverse Event|0|||
155220037|NCT02153112|560245017|FG008|Overall Study|Adverse Event|0|||
155220038|NCT02153112|560245018|FG009|Overall Study|Adverse Event|0|||
155220039|NCT02153112|560245009|FG000|Overall Study|Lost to Follow-up|1|||
155220040|NCT02153112|560245010|FG001|Overall Study|Lost to Follow-up|1|||
155220041|NCT02153112|560245011|FG002|Overall Study|Lost to Follow-up|0|||
155220042|NCT02153112|560245012|FG003|Overall Study|Lost to Follow-up|0|||
155220043|NCT02153112|560245013|FG004|Overall Study|Lost to Follow-up|2|||
155220044|NCT02153112|560245014|FG005|Overall Study|Lost to Follow-up|1|||
155220045|NCT02153112|560245015|FG006|Overall Study|Lost to Follow-up|1|||
155220046|NCT02153112|560245016|FG007|Overall Study|Lost to Follow-up|0|||
155220047|NCT02153112|560245017|FG008|Overall Study|Lost to Follow-up|1|||
155220048|NCT02153112|560245018|FG009|Overall Study|Lost to Follow-up|1|||
155220049|NCT02153112|560245009|FG000|Overall Study|Withdrawal by Subject|3|||
155220050|NCT02153112|560245010|FG001|Overall Study|Withdrawal by Subject|1|||
155220051|NCT02153112|560245011|FG002|Overall Study|Withdrawal by Subject|2|||
155220052|NCT02153112|560245012|FG003|Overall Study|Withdrawal by Subject|2|||
155220053|NCT02153112|560245013|FG004|Overall Study|Withdrawal by Subject|1|||
155220054|NCT02153112|560245014|FG005|Overall Study|Withdrawal by Subject|1|||
155220055|NCT02153112|560245015|FG006|Overall Study|Withdrawal by Subject|7|||
155220056|NCT02153112|560245016|FG007|Overall Study|Withdrawal by Subject|2|||
155220057|NCT02153112|560245017|FG008|Overall Study|Withdrawal by Subject|13|||
155220058|NCT02153112|560245018|FG009|Overall Study|Withdrawal by Subject|12|||
155220059|NCT02153112|560245009|FG000|Overall Study|Reason not Specified|0|||
155220060|NCT02153112|560245010|FG001|Overall Study|Reason not Specified|0|||
155220061|NCT02153112|560245011|FG002|Overall Study|Reason not Specified|0|||
155220062|NCT02153112|560245012|FG003|Overall Study|Reason not Specified|0|||
155220063|NCT02153112|560245013|FG004|Overall Study|Reason not Specified|0|||
155220064|NCT02153112|560245014|FG005|Overall Study|Reason not Specified|0|||
155220065|NCT02153112|560245015|FG006|Overall Study|Reason not Specified|0|||
155220066|NCT02153112|560245016|FG007|Overall Study|Reason not Specified|0|||
155220067|NCT02153112|560245017|FG008|Overall Study|Reason not Specified|1|||
155220068|NCT02153112|560245018|FG009|Overall Study|Reason not Specified|1|||
155220069|NCT01675128|560245021|FG000|Overall Study|Disease progression on study|1|||
155220070|NCT01675128|560245022|FG001|Overall Study|Disease progression on study|1|||
155220071|NCT01675128|560245023|FG002|Overall Study|Disease progression on study|1|||
155220072|NCT01675128|560245021|FG000|Overall Study|Refused further treatment|1|||
155220073|NCT01675128|560245022|FG001|Overall Study|Refused further treatment|0|||
155220074|NCT01675128|560245023|FG002|Overall Study|Refused further treatment|0|||
155220075|NCT01675128|560245021|FG000|Overall Study|Pulmonary complication; off study|0|||
155220076|NCT01675128|560245022|FG001|Overall Study|Pulmonary complication; off study|1|||
155220077|NCT01675128|560245023|FG002|Overall Study|Pulmonary complication; off study|0|||
155220078|NCT03011307|560245027|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
155220079|NCT03011307|560245028|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
155220080|NCT03011307|560245027|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
155220081|NCT03011307|560245028|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
155220082|NCT03011307|560245027|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
155220083|NCT03011307|560245028|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
155220084|NCT03526458|560245029|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
155220085|NCT03526458|560245030|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
155220086|NCT03526458|560245029|FG000|Overall Study|Stone passed, surgery cancelled|2|||
155220087|NCT03526458|560245030|FG001|Overall Study|Stone passed, surgery cancelled|1|||
155220088|NCT03526458|560245029|FG000|Overall Study|Withdrawal by Subject|1|||
155220089|NCT03526458|560245030|FG001|Overall Study|Withdrawal by Subject|0|||
155220090|NCT03526458|560245029|FG000|Overall Study|Physician Decision|2|||
155220091|NCT03526458|560245030|FG001|Overall Study|Physician Decision|1|||
155220092|NCT03526458|560245029|FG000|Overall Study|Lack of equipment|1|||
155220093|NCT03526458|560245030|FG001|Overall Study|Lack of equipment|1|||
155220094|NCT01782664|560245031|FG000|Overall Study|Adverse Event|2|||
155220095|NCT01782664|560245032|FG001|Overall Study|Adverse Event|2|||
155220096|NCT01782664|560245033|FG002|Overall Study|Adverse Event|2|||
155220097|NCT01782664|560245034|FG003|Overall Study|Adverse Event|2|||
155220098|NCT01782664|560245035|FG004|Overall Study|Adverse Event|0|||
155220099|NCT01782664|560245036|FG005|Overall Study|Adverse Event|0|||
155220100|NCT01782664|560245031|FG000|Overall Study|Lack of Efficacy|2|||
155220101|NCT01782664|560245032|FG001|Overall Study|Lack of Efficacy|0|||
155220102|NCT01782664|560245033|FG002|Overall Study|Lack of Efficacy|2|||
155220103|NCT01782664|560245034|FG003|Overall Study|Lack of Efficacy|2|||
155220104|NCT01782664|560245035|FG004|Overall Study|Lack of Efficacy|0|||
155220105|NCT01782664|560245036|FG005|Overall Study|Lack of Efficacy|0|||
155220106|NCT01782664|560245031|FG000|Overall Study|Protocol Violation|0|||
155220107|NCT01782664|560245032|FG001|Overall Study|Protocol Violation|1|||
155220108|NCT01782664|560245033|FG002|Overall Study|Protocol Violation|0|||
155220109|NCT01782664|560245034|FG003|Overall Study|Protocol Violation|1|||
155220110|NCT01782664|560245035|FG004|Overall Study|Protocol Violation|0|||
155220111|NCT01782664|560245036|FG005|Overall Study|Protocol Violation|0|||
155220112|NCT01782664|560245031|FG000|Overall Study|Withdrawal by Subject|2|||
155220113|NCT01782664|560245032|FG001|Overall Study|Withdrawal by Subject|2|||
155220114|NCT01782664|560245033|FG002|Overall Study|Withdrawal by Subject|0|||
155220115|NCT01782664|560245034|FG003|Overall Study|Withdrawal by Subject|0|||
155220116|NCT01782664|560245035|FG004|Overall Study|Withdrawal by Subject|0|||
155220117|NCT01782664|560245036|FG005|Overall Study|Withdrawal by Subject|0|||
155220118|NCT04170348|560245039|FG000|Overall Study|Lost to Follow-up|2|||
155220119|NCT04170348|560245040|FG001|Overall Study|Lost to Follow-up|2|||
155220120|NCT04170348|560245039|FG000|Overall Study|Withdrawal by Subject|1|||
155220121|NCT04170348|560245040|FG001|Overall Study|Withdrawal by Subject|5|||
155220122|NCT04170348|560245039|FG000|Overall Study|Non-adherence|1|||
155220123|NCT04170348|560245040|FG001|Overall Study|Non-adherence|1|||
155220124|NCT04170348|560245039|FG000|Overall Study|Adverse Event|1|||
155220125|NCT04170348|560245040|FG001|Overall Study|Adverse Event|0|||
155220126|NCT01082965|560245044|FG000|Overall Study|Protocol Violation|0|||
155220127|NCT01082965|560245045|FG001|Overall Study|Protocol Violation|1|||
155220128|NCT01082965|560245044|FG000|Overall Study|Other|1|||
155220129|NCT01082965|560245045|FG001|Overall Study|Other|1|||
155220130|NCT03642717|560245046|FG000|Overall Study|Lost to Follow-up|2|||
155220131|NCT03642717|560245046|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
155220132|NCT03642717|560245046|FG000|Overall Study|Taken study drug prior to contract date|3|||
155220133|NCT02587065|560245047|FG000|Overall Study|Adverse Event|14|||
155220134|NCT02587065|560245047|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
155220135|NCT02587065|560245047|FG000|Overall Study|Non-adherence to the Protocol|3|||
155220136|NCT02587065|560245047|FG000|Overall Study|Discontinuation of Study Medication|2|||
155220137|NCT02587065|560245047|FG000|Overall Study|Reason not Specified|3|||
155220138|NCT01559012|560245048|FG000|Overall Study|Withdrawal by Subject|0|||
155220139|NCT01559012|560245049|FG001|Overall Study|Withdrawal by Subject|1|||
155220140|NCT00302458|560245052|FG000|Overall Study|Lost to Follow-up|1|||
155220141|NCT00302458|560245052|FG000|Overall Study|Ineligible after screening|1|||
155220142|NCT00302458|560245052|FG000|Overall Study|Withdrawal by Subject|1|||
155220143|NCT00946712|560245053|FG000|Overall Study|Adverse Event|118|||
155220144|NCT00946712|560245054|FG001|Overall Study|Adverse Event|124|||
155220145|NCT00946712|560245053|FG000|Overall Study|Disease progression|308|||
155220146|NCT00946712|560245054|FG001|Overall Study|Disease progression|404|||
155220147|NCT00946712|560245053|FG000|Overall Study|Death|21|||
155220148|NCT00946712|560245054|FG001|Overall Study|Death|22|||
155220149|NCT00946712|560245053|FG000|Overall Study|No treatment given|25|||
155220150|NCT00946712|560245054|FG001|Overall Study|No treatment given|29|||
155220151|NCT00946712|560245053|FG000|Overall Study|Other reasons|61|||
155220152|NCT00946712|560245054|FG001|Overall Study|Other reasons|73|||
155220153|NCT00946712|560245053|FG000|Overall Study|On Treatment|0|||
155220154|NCT00946712|560245054|FG001|Overall Study|On Treatment|4|||
155220155|NCT00946712|560245053|FG000|Overall Study|Ineligible|14|||
155220156|NCT00946712|560245054|FG001|Overall Study|Ineligible|6|||
155220157|NCT02967692|560246458|FG000|Overall Study|Progressive disease|3|||
155220158|NCT02967692|560246459|FG001|Overall Study|Progressive disease|15|||
155220159|NCT02967692|560246460|FG002|Overall Study|Progressive disease|114|||
155220160|NCT02967692|560246461|FG003|Overall Study|Progressive disease|151|||
155220161|NCT02967692|560246458|FG000|Overall Study|Subject/guardian decision|1|||
155220162|NCT02967692|560246459|FG001|Overall Study|Subject/guardian decision|1|||
155220163|NCT02967692|560246460|FG002|Overall Study|Subject/guardian decision|14|||
155220164|NCT02967692|560246461|FG003|Overall Study|Subject/guardian decision|22|||
155220165|NCT02967692|560246458|FG000|Overall Study|Death|0|||
155220166|NCT02967692|560246459|FG001|Overall Study|Death|1|||
155220167|NCT02967692|560246460|FG002|Overall Study|Death|13|||
155220168|NCT02967692|560246461|FG003|Overall Study|Death|13|||
155220169|NCT02967692|560246458|FG000|Overall Study|Protocol deviation|1|||
155220170|NCT02967692|560246459|FG001|Overall Study|Protocol deviation|0|||
155220171|NCT02967692|560246460|FG002|Overall Study|Protocol deviation|1|||
155220172|NCT02967692|560246461|FG003|Overall Study|Protocol deviation|1|||
155220173|NCT02967692|560246458|FG000|Overall Study|Lost to Follow-up|0|||
155220174|NCT02967692|560246459|FG001|Overall Study|Lost to Follow-up|0|||
155220175|NCT02967692|560246460|FG002|Overall Study|Lost to Follow-up|1|||
155220176|NCT02967692|560246461|FG003|Overall Study|Lost to Follow-up|0|||
155220177|NCT02967692|560246458|FG000|Overall Study|Physician Decision|0|||
155220178|NCT02967692|560246459|FG001|Overall Study|Physician Decision|0|||
155220179|NCT02967692|560246460|FG002|Overall Study|Physician Decision|22|||
155220180|NCT02967692|560246461|FG003|Overall Study|Physician Decision|13|||
155220181|NCT02967692|560246458|FG000|Overall Study|Adverse Event|2|||
155220182|NCT02967692|560246459|FG001|Overall Study|Adverse Event|9|||
155220183|NCT02967692|560246460|FG002|Overall Study|Adverse Event|60|||
155220184|NCT02967692|560246461|FG003|Overall Study|Adverse Event|28|||
155220185|NCT02967692|560246458|FG000|Overall Study|Study terminated by sponsor|2|||
155220186|NCT02967692|560246459|FG001|Overall Study|Study terminated by sponsor|1|||
155220187|NCT02967692|560246460|FG002|Overall Study|Study terminated by sponsor|42|||
155220188|NCT02967692|560246461|FG003|Overall Study|Study terminated by sponsor|37|||
155220189|NCT02731729|560246468|FG000|Overall Study|Death|2|||
155220190|NCT02731729|560246469|FG001|Overall Study|Death|2|||
155220191|NCT02731729|560246468|FG000|Overall Study|Study terminated by Sponsor|6|||
155220192|NCT02731729|560246469|FG001|Overall Study|Study terminated by Sponsor|6|||
155220193|NCT02731729|560246468|FG000|Overall Study|Withdrawal by Subject|1|||
155220194|NCT02731729|560246469|FG001|Overall Study|Withdrawal by Subject|0|||
155220195|NCT01344447|560246470|FG000|Overall Study|Adverse Event|1|||
155220196|NCT01344447|560246470|FG000|Overall Study|Protocol Violation|1|||
155220197|NCT01344447|560246470|FG000|Overall Study|Withdrawal by Subject|1|||
155220198|NCT01344447|560246470|FG000|Overall Study|The contrast was not seen|1|||
155220199|NCT01344447|560246470|FG000|Overall Study|Physician Decision|1|||
155220200|NCT01344447|560246470|FG000|Overall Study|MRA unsuccessful|1|||
155220201|NCT01344447|560246470|FG000|Overall Study|Bolus tracking failed|1|||
155220202|NCT01344447|560246470|FG000|Overall Study|Error of power injector|1|||
155220203|NCT02063854|560246479|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
155220204|NCT02063854|560246480|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
155220205|NCT02063854|560246481|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
155220206|NCT02063854|560246482|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
155220207|NCT02063854|560246483|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
155220208|NCT02063854|560246484|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
155220209|NCT02063854|560246485|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
155220210|NCT02063854|560246479|FG000|Overall Study|Major Protocol Deviation|0|||
155220211|NCT02063854|560246480|FG001|Overall Study|Major Protocol Deviation|0|||
155220212|NCT02063854|560246481|FG002|Overall Study|Major Protocol Deviation|3|||
155220213|NCT02063854|560246482|FG003|Overall Study|Major Protocol Deviation|0|||
155220214|NCT02063854|560246483|FG004|Overall Study|Major Protocol Deviation|0|||
155220215|NCT02063854|560246484|FG005|Overall Study|Major Protocol Deviation|0|||
155220216|NCT02063854|560246485|FG006|Overall Study|Major Protocol Deviation|0|||
155220217|NCT02063854|560246479|FG000|Overall Study|Voluntary Withdrawal|2|||
155220218|NCT02063854|560246480|FG001|Overall Study|Voluntary Withdrawal|0|||
155220219|NCT02063854|560246481|FG002|Overall Study|Voluntary Withdrawal|8|||
155220220|NCT02063854|560246482|FG003|Overall Study|Voluntary Withdrawal|1|||
155220221|NCT02063854|560246483|FG004|Overall Study|Voluntary Withdrawal|3|||
155220222|NCT02063854|560246484|FG005|Overall Study|Voluntary Withdrawal|6|||
155220223|NCT02063854|560246485|FG006|Overall Study|Voluntary Withdrawal|1|||
155220224|NCT02063854|560246479|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
155220225|NCT02063854|560246480|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
155220226|NCT02063854|560246481|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
155220227|NCT02063854|560246482|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
155220228|NCT02063854|560246483|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
155220229|NCT02063854|560246484|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
155220230|NCT02063854|560246485|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
155220231|NCT02063854|560246479|FG000|Overall Study|Reason Not Specified|1|||
155220232|NCT02063854|560246480|FG001|Overall Study|Reason Not Specified|0|||
155220233|NCT02063854|560246481|FG002|Overall Study|Reason Not Specified|0|||
155220234|NCT02063854|560246482|FG003|Overall Study|Reason Not Specified|0|||
155220235|NCT02063854|560246483|FG004|Overall Study|Reason Not Specified|0|||
155220236|NCT02063854|560246484|FG005|Overall Study|Reason Not Specified|0|||
155220237|NCT02063854|560246485|FG006|Overall Study|Reason Not Specified|0|||
155220238|NCT02063854|560246479|FG000|Overall Study|Did Not Receive Study Drug|0|||
155220239|NCT02063854|560246480|FG001|Overall Study|Did Not Receive Study Drug|0|||
155220240|NCT02063854|560246481|FG002|Overall Study|Did Not Receive Study Drug|0|||
155220241|NCT02063854|560246482|FG003|Overall Study|Did Not Receive Study Drug|0|||
155220242|NCT02063854|560246483|FG004|Overall Study|Did Not Receive Study Drug|0|||
155220243|NCT02063854|560246484|FG005|Overall Study|Did Not Receive Study Drug|1|||
155220244|NCT02063854|560246485|FG006|Overall Study|Did Not Receive Study Drug|0|||
155220245|NCT02419742|560246488|FG000|Overall Study|Adverse Event|2|||
155220246|NCT02419742|560246489|FG001|Overall Study|Adverse Event|0|||
155220247|NCT02419742|560246488|FG000|Overall Study|Disease Progression|0|||
155220248|NCT02419742|560246489|FG001|Overall Study|Disease Progression|1|||
155220249|NCT02419742|560246488|FG000|Overall Study|Withdrew Consent|2|||
155220250|NCT02419742|560246489|FG001|Overall Study|Withdrew Consent|1|||
155220251|NCT02419742|560246488|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
155220252|NCT02419742|560246489|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
155220253|NCT02255981|560246492|FG000|Overall Study|Lost to Follow-up|3|||
155220254|NCT02255981|560246492|FG000|Overall Study|Withdrawal by Subject|1|||
155220255|NCT03425331|560246495|FG000|Overall Study|Withdrawal by Subject|1|||
155220256|NCT03425331|560246495|FG000|Overall Study|Death|1|||
155220257|NCT03425331|560246495|FG000|Overall Study|Adverse Event|1|||
155220258|NCT03425331|560246495|FG000|Overall Study|Disease Progression|2|||
155220259|NCT01454570|560246498|FG000|Overall Study|Withdrawal by Subject|2|||
155220260|NCT01454570|560246498|FG000|Overall Study|Screen Failure|7|||
155220261|NCT01852812|560246499|FG000|Overall Study|Adverse Event|0|||
155220262|NCT01852812|560246500|FG001|Overall Study|Adverse Event|0|||
155220263|NCT01852812|560246501|FG002|Overall Study|Adverse Event|1|||
155220264|NCT01852812|560246499|FG000|Overall Study|Non-compliance With Study Drug|0|||
155220265|NCT01852812|560246500|FG001|Overall Study|Non-compliance With Study Drug|1|||
155220266|NCT01852812|560246501|FG002|Overall Study|Non-compliance With Study Drug|0|||
155220267|NCT02488681|560246508|FG000|Overall Study|Implant unsuccessful|7|||
155220268|NCT00720057|560246509|FG000|Overall Study|Lost to Follow-up|0|||
155220269|NCT00720057|560246510|FG001|Overall Study|Lost to Follow-up|2|||
155220270|NCT00720057|560246509|FG000|Overall Study|Protocol Violation|1|||
155220271|NCT00720057|560246510|FG001|Overall Study|Protocol Violation|0|||
155220272|NCT00720057|560246509|FG000|Overall Study|Withdrawal by Subject|0|||
155220273|NCT00720057|560246510|FG001|Overall Study|Withdrawal by Subject|1|||
155220274|NCT04969224|560246513|FG000|Overall Study|Adverse Event|1|||
155220275|NCT04969224|560246513|FG000|Overall Study|Enrolled but never dosed|1|||
155220276|NCT01498952|560246514|FG000|Overall Study|Death|2|||
155220277|NCT01498952|560246515|FG001|Overall Study|Death|2|||
155220278|NCT01498952|560246516|FG002|Overall Study|Death|0|||
155220279|NCT01498952|560246517|FG003|Overall Study|Death|0|||
155220280|NCT01498952|560246518|FG004|Overall Study|Death|0|||
155220281|NCT05533632|560246519|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
155220282|NCT05533632|560246519|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
155220283|NCT05533632|560246519|FG000|Overall Study|Lost to Follow-up|1|||
155220284|NCT05533632|560246519|FG000|Overall Study|Withdrawal by Subject|4|||
155220285|NCT05533632|560246519|FG000|Overall Study|Adverse Event|4|||
155220286|NCT02726074|560246520|FG000|Overall Study|Withdrawal by Subject|4|||
155220287|NCT02726074|560246520|FG000|Overall Study|Adverse Event|14|||
155220288|NCT02726074|560246520|FG000|Overall Study|Protocol Violation|3|||
155220289|NCT02726074|560246520|FG000|Overall Study|Lost to Follow-up|2|||
155220290|NCT02726074|560246520|FG000|Overall Study|Others|3|||
155220291|NCT00579826|560246521|FG000|Overall Study|Withdrawal by Subject|5|||
155220292|NCT00579826|560246522|FG001|Overall Study|Withdrawal by Subject|3|||
155220293|NCT03054870|560246526|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
155220294|NCT03054870|560246526|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
155220295|NCT02009046|560246527|FG000|Overall Study|Lost to Follow-up|256|||
155220296|NCT02009046|560246528|FG001|Overall Study|Lost to Follow-up|206|||
155220297|NCT00973479|560246533|FG000|Overall Study|Lost to Follow-up|0|||
155220298|NCT00973479|560246534|FG001|Overall Study|Lost to Follow-up|3|||
155220299|NCT00973479|560246533|FG000|Overall Study|Death|2|||
155220300|NCT00973479|560246534|FG001|Overall Study|Death|2|||
155220301|NCT00973479|560246533|FG000|Overall Study|Withdrawal by Subject|15|||
155220302|NCT00973479|560246534|FG001|Overall Study|Withdrawal by Subject|16|||
155220303|NCT00973479|560246533|FG000|Overall Study|Lack of Efficacy|5|||
155220304|NCT00973479|560246534|FG001|Overall Study|Lack of Efficacy|7|||
155220305|NCT00973479|560246533|FG000|Overall Study|Adverse Event|12|||
155220306|NCT00973479|560246534|FG001|Overall Study|Adverse Event|32|||
155220307|NCT00973479|560246533|FG000|Overall Study|Protocol Violation|2|||
155220308|NCT00973479|560246534|FG001|Overall Study|Protocol Violation|2|||
155220309|NCT00973479|560246533|FG000|Overall Study|Other|1|||
155220310|NCT00973479|560246534|FG001|Overall Study|Other|7|||
155220311|NCT05075850|560246535|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
155220312|NCT01154218|560246536|FG000|Third Intervention Period|Adverse Event|0|||
155220313|NCT01154218|560246537|FG001|Third Intervention Period|Adverse Event|1|||
155220314|NCT01154218|560246538|FG002|Third Intervention Period|Adverse Event|0|||
155220315|NCT01154218|560246539|FG003|Third Intervention Period|Adverse Event|0|||
155220316|NCT01154218|560246536|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155220317|NCT01154218|560246537|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155220318|NCT01154218|560246538|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
155220319|NCT01154218|560246539|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
155220320|NCT01154218|560246536|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
155220321|NCT01154218|560246537|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
155220322|NCT01154218|560246538|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
155220323|NCT01154218|560246539|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
155220324|NCT01265849|560246540|FG000|Overall Study|Randomized//Treatment not initiated|1|||
155220325|NCT01265849|560246541|FG001|Overall Study|Randomized//Treatment not initiated|4|||
155220326|NCT01265849|560246542|FG002|Overall Study|Randomized//Treatment not initiated|0|||
155220327|NCT01265849|560246540|FG000|Overall Study|Physician Decision|1|||
155220328|NCT01265849|560246541|FG001|Overall Study|Physician Decision|2|||
155220329|NCT01265849|560246542|FG002|Overall Study|Physician Decision|0|||
155220330|NCT01265849|560246540|FG000|Overall Study|Lost to Follow-up|18|||
155220331|NCT01265849|560246541|FG001|Overall Study|Lost to Follow-up|15|||
155220332|NCT01265849|560246542|FG002|Overall Study|Lost to Follow-up|5|||
155220333|NCT01265849|560246540|FG000|Overall Study|Not otherwise specified|1|||
155220334|NCT01265849|560246541|FG001|Overall Study|Not otherwise specified|6|||
155220335|NCT01265849|560246542|FG002|Overall Study|Not otherwise specified|1|||
155220336|NCT01265849|560246540|FG000|Overall Study|Withdrawal by Subject|25|||
155220337|NCT01265849|560246541|FG001|Overall Study|Withdrawal by Subject|34|||
155220338|NCT01265849|560246542|FG002|Overall Study|Withdrawal by Subject|13|||
155220339|NCT00362115|560246543|FG000|Overall Study|Adverse Event|0|||
155220340|NCT00362115|560246544|FG001|Overall Study|Adverse Event|1|||
155220341|NCT00362115|560246545|FG002|Overall Study|Adverse Event|1|||
155220342|NCT00362115|560246546|FG003|Overall Study|Adverse Event|1|||
155220343|NCT00362115|560246547|FG004|Overall Study|Adverse Event|2|||
155220344|NCT00362115|560246548|FG005|Overall Study|Adverse Event|2|||
155220345|NCT00362115|560246549|FG006|Overall Study|Adverse Event|1|||
155220346|NCT00362115|560246543|FG000|Overall Study|Protocol Violation|0|||
155220347|NCT00362115|560246544|FG001|Overall Study|Protocol Violation|0|||
155220348|NCT00362115|560246545|FG002|Overall Study|Protocol Violation|0|||
155220349|NCT00362115|560246546|FG003|Overall Study|Protocol Violation|0|||
155220350|NCT00362115|560246547|FG004|Overall Study|Protocol Violation|0|||
155220351|NCT00362115|560246548|FG005|Overall Study|Protocol Violation|1|||
155220352|NCT00362115|560246549|FG006|Overall Study|Protocol Violation|0|||
155220353|NCT00362115|560246543|FG000|Overall Study|Lost to Follow-up|0|||
155220354|NCT00362115|560246544|FG001|Overall Study|Lost to Follow-up|1|||
155220355|NCT00362115|560246545|FG002|Overall Study|Lost to Follow-up|0|||
155220356|NCT00362115|560246546|FG003|Overall Study|Lost to Follow-up|0|||
155220357|NCT00362115|560246547|FG004|Overall Study|Lost to Follow-up|2|||
155220358|NCT00362115|560246548|FG005|Overall Study|Lost to Follow-up|0|||
155220359|NCT00362115|560246549|FG006|Overall Study|Lost to Follow-up|1|||
155220360|NCT00362115|560246543|FG000|Overall Study|Withdrawal by Subject|1|||
155220361|NCT00362115|560246544|FG001|Overall Study|Withdrawal by Subject|3|||
155220362|NCT00362115|560246545|FG002|Overall Study|Withdrawal by Subject|1|||
155220363|NCT00362115|560246546|FG003|Overall Study|Withdrawal by Subject|0|||
155220364|NCT00362115|560246547|FG004|Overall Study|Withdrawal by Subject|1|||
155220365|NCT00362115|560246548|FG005|Overall Study|Withdrawal by Subject|3|||
155220366|NCT00362115|560246549|FG006|Overall Study|Withdrawal by Subject|4|||
155220367|NCT00362115|560246543|FG000|Overall Study|Lack of Efficacy|1|||
155220368|NCT00362115|560246544|FG001|Overall Study|Lack of Efficacy|0|||
155220369|NCT00362115|560246545|FG002|Overall Study|Lack of Efficacy|5|||
155220370|NCT00362115|560246546|FG003|Overall Study|Lack of Efficacy|2|||
155220371|NCT00362115|560246547|FG004|Overall Study|Lack of Efficacy|2|||
155220372|NCT00362115|560246548|FG005|Overall Study|Lack of Efficacy|0|||
155220373|NCT00362115|560246549|FG006|Overall Study|Lack of Efficacy|3|||
155220374|NCT00362115|560246543|FG000|Overall Study|Physician Decision|0|||
155220375|NCT00362115|560246544|FG001|Overall Study|Physician Decision|0|||
155220376|NCT00362115|560246545|FG002|Overall Study|Physician Decision|0|||
155220377|NCT00362115|560246546|FG003|Overall Study|Physician Decision|0|||
155220378|NCT00362115|560246547|FG004|Overall Study|Physician Decision|0|||
155220379|NCT00362115|560246548|FG005|Overall Study|Physician Decision|0|||
155220380|NCT00362115|560246549|FG006|Overall Study|Physician Decision|3|||
155220381|NCT00362115|560246543|FG000|Overall Study|Other|0|||
155220382|NCT00362115|560246544|FG001|Overall Study|Other|1|||
155220383|NCT00362115|560246545|FG002|Overall Study|Other|0|||
155220384|NCT00362115|560246546|FG003|Overall Study|Other|1|||
155220385|NCT00362115|560246547|FG004|Overall Study|Other|0|||
155220386|NCT00362115|560246548|FG005|Overall Study|Other|1|||
155220387|NCT00362115|560246549|FG006|Overall Study|Other|0|||
155220388|NCT01170091|560246550|FG000|Overall Study|Missing efficacy evaluation|3|||
155220389|NCT01170091|560246550|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
155220390|NCT03194321|560246551|FG000|Overall Study|Withdrawal by Subject|1|||
155220391|NCT03194321|560246551|FG000|Overall Study|Lost to Follow-up|1|||
155220392|NCT03194321|560246551|FG000|Overall Study|Travel for Follow-up|1|||
155220393|NCT02188589|560246552|FG000|Overall Study|Withdrawal by Subject|5|||
155220394|NCT00003641|560246560|FG000|Overall Study|Withdrawal by Subject|0|||
155220395|NCT00003641|560246561|FG001|Overall Study|Withdrawal by Subject|100|||
155220396|NCT00003641|560246560|FG000|Overall Study|Adverse Event|0|||
155220397|NCT00003641|560246561|FG001|Overall Study|Adverse Event|38|||
155220398|NCT00003641|560246560|FG000|Overall Study|Disease progression|0|||
155220399|NCT00003641|560246561|FG001|Overall Study|Disease progression|2|||
155220400|NCT00003641|560246560|FG000|Overall Study|Unknown/missing|0|||
155220401|NCT00003641|560246561|FG001|Overall Study|Unknown/missing|22|||
155220402|NCT00003641|560246560|FG000|Overall Study|Should not receive interferon therapy|2|||
155220403|NCT00003641|560246561|FG001|Overall Study|Should not receive interferon therapy|0|||
155220404|NCT00003641|560246560|FG000|Overall Study|Never started interferon|567|||
155220405|NCT00003641|560246561|FG001|Overall Study|Never started interferon|12|||
155220406|NCT02154581|560246564|FG000|Overall Study|Lost to Follow-up|7|||
155220407|NCT02154581|560246565|FG001|Overall Study|Lost to Follow-up|8|||
155220408|NCT03886220|560246568|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
155220409|NCT03886220|560246569|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
155220410|NCT03886220|560246568|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
155220411|NCT03886220|560246569|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
155220412|NCT03886220|560246568|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
155220413|NCT03886220|560246569|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
155220414|NCT03082599|560246572|FG000|Overall Study|Lost to Follow-up|1|||
155220415|NCT03082599|560246573|FG001|Overall Study|Lost to Follow-up|0|||
155220416|NCT00832585|560246576|FG000|Overall Study|Withdrawal by Subject|1|||
155220417|NCT00832585|560246576|FG000|Overall Study|Lost to Follow-up|1|||
155220418|NCT04404855|560246577|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
155220419|NCT04404855|560246578|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
155220420|NCT00853723|560246581|FG000|Overall Study|Adverse Event|3|||
155220421|NCT00853723|560246582|FG001|Overall Study|Adverse Event|4|||
155220422|NCT00853723|560246583|FG002|Overall Study|Adverse Event|1|||
155220423|NCT00853723|560246581|FG000|Overall Study|Withdrawal by Subject|2|||
155220424|NCT00853723|560246582|FG001|Overall Study|Withdrawal by Subject|1|||
155220425|NCT00853723|560246583|FG002|Overall Study|Withdrawal by Subject|0|||
155220426|NCT00853723|560246581|FG000|Overall Study|Protocol Violation|1|||
155220427|NCT00853723|560246582|FG001|Overall Study|Protocol Violation|2|||
155220428|NCT00853723|560246583|FG002|Overall Study|Protocol Violation|1|||
155220429|NCT04248933|560246586|FG000|Overall Study|Lost to Follow-up|9|||
155220430|NCT04248933|560246586|FG000|Overall Study|Withdrawal by Subject|2|||
155220431|NCT00445965|560246587|FG000|Overall Study|Adverse Event|2|||
155220432|NCT00445965|560246587|FG000|Overall Study|Physician Decision|1|||
155220433|NCT00445965|560246587|FG000|Overall Study|Enrolled but not treated|1|||
155220434|NCT00445965|560246587|FG000|Overall Study|Removed due to progressive disease|29|||
155220435|NCT02447081|560246588|FG000|Overall Study|Death|161|||
155220436|NCT02447081|560246588|FG000|Overall Study|Lost to Follow-up|36|||
155220437|NCT02447081|560246588|FG000|Overall Study|Visit not completed|17|||
155220438|NCT02447081|560246588|FG000|Overall Study|unsuccessful implant procedure|10|||
155220439|NCT05778786|560246589|FG000|Period 1|COVID-19 Related|3|||
155220440|NCT05778786|560246590|FG001|Period 1|COVID-19 Related|3|||
155220441|NCT05778786|560246589|FG000|Period 1|Withdrew Consent during Study|1|||
155220442|NCT05778786|560246590|FG001|Period 1|Withdrew Consent during Study|0|||
155220443|NCT05778786|560246589|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
155220444|NCT05778786|560246590|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
155220445|NCT05778786|560246589|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
155220446|NCT05778786|560246590|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
155220447|NCT05497284|560246594|FG000|Overall Study|Adverse Event|1|||
155220448|NCT05497284|560246595|FG001|Overall Study|Adverse Event|0|||
155220449|NCT05497284|560246594|FG000|Overall Study|Physician Decision|0|||
155220450|NCT05497284|560246595|FG001|Overall Study|Physician Decision|1|||
155220451|NCT05497284|560246594|FG000|Overall Study|Study terminated by sponsor|7|||
155220452|NCT05497284|560246595|FG001|Overall Study|Study terminated by sponsor|4|||
155220453|NCT05497284|560246594|FG000|Overall Study|Subject Decision|0|||
155220454|NCT05497284|560246595|FG001|Overall Study|Subject Decision|1|||
155220455|NCT00066066|560248632|FG000|Overall Study|Lost to Follow-up|6|||
155220456|NCT00066066|560248633|FG001|Overall Study|Lost to Follow-up|4|||
155220457|NCT00066066|560248634|FG002|Overall Study|Lost to Follow-up|7|||
155220458|NCT00066066|560248635|FG003|Overall Study|Lost to Follow-up|4|||
155220459|NCT00066066|560248636|FG004|Overall Study|Lost to Follow-up|3|||
155220460|NCT00066066|560248637|FG005|Overall Study|Lost to Follow-up|5|||
155220461|NCT02515942|560248640|FG000|Overall Study|Adverse Event|5|||
155220462|NCT02515942|560248641|FG001|Overall Study|Adverse Event|0|||
155220463|NCT02515942|560248642|FG002|Overall Study|Adverse Event|0|||
155220464|NCT02515942|560248640|FG000|Overall Study|Death|0|||
155220465|NCT02515942|560248641|FG001|Overall Study|Death|0|||
155220466|NCT02515942|560248642|FG002|Overall Study|Death|1|||
155220467|NCT02515942|560248640|FG000|Overall Study|Lack of Efficacy|0|||
155220468|NCT02515942|560248641|FG001|Overall Study|Lack of Efficacy|0|||
155220469|NCT02515942|560248642|FG002|Overall Study|Lack of Efficacy|1|||
155220470|NCT02515942|560248640|FG000|Overall Study|Lost to Follow-up|2|||
155220471|NCT02515942|560248641|FG001|Overall Study|Lost to Follow-up|0|||
155220472|NCT02515942|560248642|FG002|Overall Study|Lost to Follow-up|0|||
155220473|NCT02515942|560248640|FG000|Overall Study|Withdrawal by Subject|0|||
155220474|NCT02515942|560248641|FG001|Overall Study|Withdrawal by Subject|3|||
155220475|NCT02515942|560248642|FG002|Overall Study|Withdrawal by Subject|2|||
155220476|NCT00697515|560248643|FG000|Dose Optimization Period|Adverse Event|4|||
155220477|NCT00697515|560248644|FG001|Dose Optimization Period|Adverse Event|0|||
155220478|NCT00697515|560248643|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
155220479|NCT00697515|560248644|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
155220480|NCT00697515|560248643|FG000|Dose Optimization Period|Lost to Follow-up|2|||
155220481|NCT00697515|560248644|FG001|Dose Optimization Period|Lost to Follow-up|0|||
155220482|NCT00697515|560248643|FG000|Dose Optimization Period|sponsor request|2|||
155220483|NCT00697515|560248644|FG001|Dose Optimization Period|sponsor request|0|||
155220484|NCT00697515|560248643|FG000|Dose Optimization Period|called to active duty|1|||
155220485|NCT00697515|560248644|FG001|Dose Optimization Period|called to active duty|0|||
155220486|NCT00697515|560248643|FG000|Dose Optimization Period|elevated QTc|1|||
155220487|NCT00697515|560248644|FG001|Dose Optimization Period|elevated QTc|0|||
155220488|NCT00697515|560248643|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
155220489|NCT00697515|560248644|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
155220490|NCT00697515|560248643|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
155220491|NCT00697515|560248644|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
155220492|NCT00697515|560248643|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
155220493|NCT00697515|560248644|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
155220494|NCT00697515|560248643|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
155220495|NCT00697515|560248644|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
155220496|NCT02603432|560248645|FG000|Overall Study|Adverse Event|1|||
155220497|NCT02603432|560248646|FG001|Overall Study|Adverse Event|0|||
155220498|NCT02603432|560248645|FG000|Overall Study|Death|221|||
155220499|NCT02603432|560248646|FG001|Overall Study|Death|242|||
155220500|NCT02603432|560248645|FG000|Overall Study|Lost to Follow-up|3|||
155220501|NCT02603432|560248646|FG001|Overall Study|Lost to Follow-up|9|||
155220502|NCT02603432|560248645|FG000|Overall Study|Progressive Disease|7|||
155220503|NCT02603432|560248646|FG001|Overall Study|Progressive Disease|5|||
155220504|NCT02603432|560248645|FG000|Overall Study|Withdrawal by Subject|12|||
155220505|NCT02603432|560248646|FG001|Overall Study|Withdrawal by Subject|18|||
155220506|NCT02603432|560248645|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
155220507|NCT02603432|560248646|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
155220508|NCT02603432|560248645|FG000|Overall Study|Study terminated by sponsor|74|||
155220509|NCT02603432|560248646|FG001|Overall Study|Study terminated by sponsor|75|||
155220510|NCT02603432|560248645|FG000|Overall Study|Other|13|||
155220511|NCT02603432|560248646|FG001|Overall Study|Other|0|||
155220512|NCT00666757|560248647|FG000|Overall Study|Lost to Follow-up|39|||
155220513|NCT00666757|560248648|FG001|Overall Study|Lost to Follow-up|35|||
155220514|NCT00666757|560248647|FG000|Overall Study|Protocol Violation|23|||
155220515|NCT00666757|560248648|FG001|Overall Study|Protocol Violation|24|||
155220516|NCT00666757|560248647|FG000|Overall Study|Adverse Event|22|||
155220517|NCT00666757|560248648|FG001|Overall Study|Adverse Event|12|||
155220518|NCT00666757|560248647|FG000|Overall Study|Withdrawal by Subject|13|||
155220519|NCT00666757|560248648|FG001|Overall Study|Withdrawal by Subject|17|||
155220520|NCT00666757|560248647|FG000|Overall Study|Lack of Efficacy|3|||
155220521|NCT00666757|560248648|FG001|Overall Study|Lack of Efficacy|6|||
155220522|NCT00666757|560248647|FG000|Overall Study|Physician Decision|0|||
155220523|NCT00666757|560248648|FG001|Overall Study|Physician Decision|2|||
155220524|NCT00666757|560248647|FG000|Overall Study|Sponsor decision|0|||
155220525|NCT00666757|560248648|FG001|Overall Study|Sponsor decision|1|||
155220526|NCT05954052|560248649|FG000|Overall Study|Adverse Event|1|||
155220527|NCT01957462|560248650|FG000|Test Period 1|Withdrawal by Subject|1|||
155220528|NCT01957462|560248651|FG001|Test Period 1|Withdrawal by Subject|0|||
155220529|NCT01957462|560248650|FG000|Test Period 1|Adverse Event|1|||
155220530|NCT01957462|560248651|FG001|Test Period 1|Adverse Event|0|||
155220531|NCT01723163|560248654|FG000|Treatment Phase|Withdrawal by Subject|14|||
155220532|NCT01723163|560248655|FG001|Treatment Phase|Withdrawal by Subject|6|||
155220533|NCT01723163|560248654|FG000|Treatment Phase|Withdrawal by PI|5|||
155220534|NCT01723163|560248655|FG001|Treatment Phase|Withdrawal by PI|1|||
155220535|NCT01723163|560248654|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
155220536|NCT01723163|560248655|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
155220537|NCT01723163|560248654|FG000|3-Month Follow-up|Unable to Contact|12|||
155220538|NCT01723163|560248655|FG001|3-Month Follow-up|Unable to Contact|19|||
155220539|NCT01723163|560248654|FG000|6-Month Follow-up|Death|1|||
155220540|NCT01723163|560248655|FG001|6-Month Follow-up|Death|0|||
155220541|NCT01723163|560248654|FG000|6-Month Follow-up|Unable to Contact|17|||
155220542|NCT01723163|560248655|FG001|6-Month Follow-up|Unable to Contact|15|||
155220543|NCT01723163|560248654|FG000|12-Month Follow-up|Death|1|||
155220544|NCT01723163|560248655|FG001|12-Month Follow-up|Death|0|||
155220545|NCT01723163|560248654|FG000|12-Month Follow-up|Unable to Contact|23|||
155220546|NCT01723163|560248655|FG001|12-Month Follow-up|Unable to Contact|28|||
155220547|NCT02510794|560248656|FG000|Overall Study|Adverse Event|0|||
155220548|NCT02510794|560248657|FG001|Overall Study|Adverse Event|1|||
155220549|NCT02510794|560248658|FG002|Overall Study|Adverse Event|0|||
155220550|NCT02510794|560248659|FG003|Overall Study|Adverse Event|0|||
155220551|NCT02510794|560248656|FG000|Overall Study|Death|1|||
155220552|NCT02510794|560248657|FG001|Overall Study|Death|2|||
155220553|NCT02510794|560248658|FG002|Overall Study|Death|1|||
155220554|NCT02510794|560248659|FG003|Overall Study|Death|1|||
155220555|NCT02510794|560248656|FG000|Overall Study|Lack of Efficacy|3|||
155220556|NCT02510794|560248657|FG001|Overall Study|Lack of Efficacy|1|||
155220557|NCT02510794|560248658|FG002|Overall Study|Lack of Efficacy|1|||
155220558|NCT02510794|560248659|FG003|Overall Study|Lack of Efficacy|0|||
155220559|NCT02510794|560248656|FG000|Overall Study|Participant moved out of the area|0|||
155220560|NCT02510794|560248657|FG001|Overall Study|Participant moved out of the area|0|||
155220561|NCT02510794|560248658|FG002|Overall Study|Participant moved out of the area|0|||
155220562|NCT02510794|560248659|FG003|Overall Study|Participant moved out of the area|1|||
155220563|NCT02510794|560248656|FG000|Overall Study|Physician Decision|3|||
155220564|NCT02510794|560248657|FG001|Overall Study|Physician Decision|0|||
155220565|NCT02510794|560248658|FG002|Overall Study|Physician Decision|0|||
155220566|NCT02510794|560248659|FG003|Overall Study|Physician Decision|0|||
155220567|NCT02510794|560248656|FG000|Overall Study|Protocol Violation|0|||
155220568|NCT02510794|560248657|FG001|Overall Study|Protocol Violation|0|||
155220569|NCT02510794|560248658|FG002|Overall Study|Protocol Violation|1|||
155220570|NCT02510794|560248659|FG003|Overall Study|Protocol Violation|0|||
155220571|NCT02510794|560248656|FG000|Overall Study|Withdrawal by Subject|1|||
155220572|NCT02510794|560248657|FG001|Overall Study|Withdrawal by Subject|2|||
155220573|NCT02510794|560248658|FG002|Overall Study|Withdrawal by Subject|4|||
155220574|NCT02510794|560248659|FG003|Overall Study|Withdrawal by Subject|3|||
155220575|NCT01649375|560248660|FG000|Up to Week 16|Adverse Event|2|||
155220576|NCT01649375|560248661|FG001|Up to Week 16|Adverse Event|5|||
155220577|NCT01649375|560248662|FG002|Up to Week 16|Adverse Event|4|||
155220578|NCT01649375|560248663|FG003|Up to Week 16|Adverse Event|0|||
155220579|NCT01649375|560248664|FG004|Up to Week 16|Adverse Event|0|||
155220580|NCT01649375|560248660|FG000|Up to Week 16|Lack of Efficacy|0|||
155220581|NCT01649375|560248661|FG001|Up to Week 16|Lack of Efficacy|0|||
155220582|NCT01649375|560248662|FG002|Up to Week 16|Lack of Efficacy|1|||
155220583|NCT01649375|560248663|FG003|Up to Week 16|Lack of Efficacy|0|||
155220584|NCT01649375|560248664|FG004|Up to Week 16|Lack of Efficacy|0|||
155220585|NCT01649375|560248660|FG000|Up to Week 16|Physician Decision|0|||
155220586|NCT01649375|560248661|FG001|Up to Week 16|Physician Decision|0|||
155220587|NCT01649375|560248662|FG002|Up to Week 16|Physician Decision|1|||
155220588|NCT01649375|560248663|FG003|Up to Week 16|Physician Decision|0|||
155220589|NCT01649375|560248664|FG004|Up to Week 16|Physician Decision|0|||
155220590|NCT01649375|560248660|FG000|Up to Week 16|Withdrawal by Subject|2|||
155220591|NCT01649375|560248661|FG001|Up to Week 16|Withdrawal by Subject|1|||
155220592|NCT01649375|560248662|FG002|Up to Week 16|Withdrawal by Subject|2|||
155220593|NCT01649375|560248663|FG003|Up to Week 16|Withdrawal by Subject|0|||
155220594|NCT01649375|560248664|FG004|Up to Week 16|Withdrawal by Subject|0|||
155220595|NCT01649375|560248660|FG000|Up to Week 16|Death|1|||
155220596|NCT01649375|560248661|FG001|Up to Week 16|Death|0|||
155220597|NCT01649375|560248662|FG002|Up to Week 16|Death|0|||
155220598|NCT01649375|560248663|FG003|Up to Week 16|Death|0|||
155220599|NCT01649375|560248664|FG004|Up to Week 16|Death|0|||
155220600|NCT01649375|560248660|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
155220601|NCT01649375|560248661|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
155220602|NCT01649375|560248662|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
155220603|NCT01649375|560248663|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
155220604|NCT01649375|560248664|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
155220605|NCT01649375|560248660|FG000|Week 16 up to Week 260|Non-compliance|0|||
155220606|NCT01649375|560248661|FG001|Week 16 up to Week 260|Non-compliance|1|||
155220607|NCT01649375|560248662|FG002|Week 16 up to Week 260|Non-compliance|0|||
155220608|NCT01649375|560248663|FG003|Week 16 up to Week 260|Non-compliance|1|||
155220609|NCT01649375|560248664|FG004|Week 16 up to Week 260|Non-compliance|0|||
155220610|NCT01649375|560248660|FG000|Week 16 up to Week 260|Physician Decision|0|||
155220611|NCT01649375|560248661|FG001|Week 16 up to Week 260|Physician Decision|2|||
155220612|NCT01649375|560248662|FG002|Week 16 up to Week 260|Physician Decision|0|||
155220613|NCT01649375|560248663|FG003|Week 16 up to Week 260|Physician Decision|0|||
155220614|NCT01649375|560248664|FG004|Week 16 up to Week 260|Physician Decision|0|||
155220615|NCT01649375|560248660|FG000|Week 16 up to Week 260|Technical issues|0|||
155220616|NCT01649375|560248661|FG001|Week 16 up to Week 260|Technical issues|1|||
155220617|NCT01649375|560248662|FG002|Week 16 up to Week 260|Technical issues|0|||
155220618|NCT01649375|560248663|FG003|Week 16 up to Week 260|Technical issues|1|||
155220619|NCT01649375|560248664|FG004|Week 16 up to Week 260|Technical issues|0|||
155220620|NCT01649375|560248660|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
155220621|NCT01649375|560248661|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
155220622|NCT01649375|560248662|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
155220623|NCT01649375|560248663|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
155220624|NCT01649375|560248664|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
155220625|NCT01649375|560248660|FG000|Week 16 up to Week 260|Death|1|||
155220626|NCT01649375|560248661|FG001|Week 16 up to Week 260|Death|1|||
155220627|NCT01649375|560248662|FG002|Week 16 up to Week 260|Death|0|||
155220628|NCT01649375|560248663|FG003|Week 16 up to Week 260|Death|0|||
155220629|NCT01649375|560248664|FG004|Week 16 up to Week 260|Death|0|||
155220630|NCT01649375|560248660|FG000|Week 16 up to Week 260|Adverse Event|5|||
155220631|NCT01649375|560248661|FG001|Week 16 up to Week 260|Adverse Event|2|||
155220632|NCT01649375|560248662|FG002|Week 16 up to Week 260|Adverse Event|0|||
155220633|NCT01649375|560248663|FG003|Week 16 up to Week 260|Adverse Event|3|||
155220634|NCT01649375|560248664|FG004|Week 16 up to Week 260|Adverse Event|2|||
155220635|NCT01856790|560248667|FG000|Closed Loop Control|Withdrawal by Subject|2|||
155220636|NCT01856790|560248667|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
155220637|NCT04091646|560248668|FG000|Overall Study|Adverse Event|2|||
155220638|NCT04091646|560248669|FG001|Overall Study|Adverse Event|1|||
155220639|NCT04091646|560248668|FG000|Overall Study|Lost to Follow-up|6|||
155220640|NCT04091646|560248669|FG001|Overall Study|Lost to Follow-up|2|||
155220641|NCT04091646|560248668|FG000|Overall Study|Protocol Violation|0|||
155220642|NCT04091646|560248669|FG001|Overall Study|Protocol Violation|1|||
155220643|NCT04091646|560248668|FG000|Overall Study|Withdrawal by Subject|4|||
155220644|NCT04091646|560248669|FG001|Overall Study|Withdrawal by Subject|1|||
155220645|NCT04091646|560248668|FG000|Overall Study|Participant Incarcerated|1|||
155220646|NCT04091646|560248669|FG001|Overall Study|Participant Incarcerated|0|||
155220647|NCT01921829|560248670|FG000|Overall Study|Withdrawal by Subject|0|||
155220648|NCT01921829|560248671|FG001|Overall Study|Withdrawal by Subject|1|||
155220649|NCT03102918|560248672|FG000|Overall Study|Protocol Violation|1|||
155220650|NCT03102918|560248673|FG001|Overall Study|Protocol Violation|0|||
155220651|NCT00539838|560248674|FG000|Overall Study|Fail to return|2|||
155220652|NCT00539838|560248675|FG001|Overall Study|Fail to return|0|||
155220653|NCT00539838|560248676|FG002|Overall Study|Fail to return|0|||
155220654|NCT00539838|560248674|FG000|Overall Study|Withdrawal by Subject|0|||
155220655|NCT00539838|560248675|FG001|Overall Study|Withdrawal by Subject|4|||
155220656|NCT00539838|560248676|FG002|Overall Study|Withdrawal by Subject|0|||
155220657|NCT00539838|560248674|FG000|Overall Study|Death|0|||
155220658|NCT00539838|560248675|FG001|Overall Study|Death|2|||
155220659|NCT00539838|560248676|FG002|Overall Study|Death|0|||
155220660|NCT00539838|560248674|FG000|Overall Study|Did not cooperate|1|||
155220661|NCT00539838|560248675|FG001|Overall Study|Did not cooperate|0|||
155220662|NCT00539838|560248676|FG002|Overall Study|Did not cooperate|1|||
155220663|NCT00539838|560248674|FG000|Overall Study|Administrative|4|||
155220664|NCT00539838|560248675|FG001|Overall Study|Administrative|0|||
155220665|NCT00539838|560248676|FG002|Overall Study|Administrative|8|||
155220666|NCT02658890|560248682|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220667|NCT02658890|560248683|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220668|NCT02658890|560248684|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220669|NCT02658890|560248685|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220670|NCT02658890|560248686|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220671|NCT02658890|560248687|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220672|NCT02658890|560248688|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220673|NCT02658890|560248689|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220674|NCT02658890|560248690|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220675|NCT02658890|560248691|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220676|NCT02658890|560248692|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220677|NCT02658890|560248693|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220678|NCT02658890|560248694|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220679|NCT02658890|560248695|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220680|NCT02658890|560248696|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220681|NCT02658890|560248697|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220682|NCT02658890|560248698|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220683|NCT02658890|560248699|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220684|NCT02658890|560248700|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220685|NCT02658890|560248701|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220686|NCT02658890|560248702|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220687|NCT02658890|560248703|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220688|NCT02658890|560248704|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220689|NCT02658890|560248705|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220690|NCT02658890|560248706|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220691|NCT02658890|560248707|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220692|NCT02658890|560248708|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220693|NCT02658890|560248682|FG000|Treatment Phase|Adverse Event|0|||
155220694|NCT02658890|560248683|FG001|Treatment Phase|Adverse Event|1|||
155220695|NCT02658890|560248684|FG002|Treatment Phase|Adverse Event|2|||
155220696|NCT02658890|560248685|FG003|Treatment Phase|Adverse Event|2|||
155220697|NCT02658890|560248686|FG004|Treatment Phase|Adverse Event|1|||
155220698|NCT02658890|560248687|FG005|Treatment Phase|Adverse Event|0|||
155220699|NCT02658890|560248688|FG006|Treatment Phase|Adverse Event|0|||
155220700|NCT02658890|560248689|FG007|Treatment Phase|Adverse Event|2|||
155220701|NCT02658890|560248690|FG008|Treatment Phase|Adverse Event|1|||
155220702|NCT02658890|560248691|FG009|Treatment Phase|Adverse Event|2|||
155220703|NCT02658890|560248692|FG010|Treatment Phase|Adverse Event|3|||
155220704|NCT02658890|560248693|FG011|Treatment Phase|Adverse Event|0|||
155220705|NCT02658890|560248694|FG012|Treatment Phase|Adverse Event|1|||
155220706|NCT02658890|560248695|FG013|Treatment Phase|Adverse Event|4|||
155220707|NCT02658890|560248696|FG014|Treatment Phase|Adverse Event|0|||
155220708|NCT02658890|560248697|FG015|Treatment Phase|Adverse Event|0|||
155220709|NCT02658890|560248698|FG016|Treatment Phase|Adverse Event|0|||
155220710|NCT02658890|560248699|FG017|Treatment Phase|Adverse Event|0|||
155220711|NCT02658890|560248700|FG018|Treatment Phase|Adverse Event|5|||
155220712|NCT02658890|560248701|FG019|Treatment Phase|Adverse Event|1|||
155220713|NCT02658890|560248702|FG020|Treatment Phase|Adverse Event|3|||
155220714|NCT02658890|560248703|FG021|Treatment Phase|Adverse Event|0|||
155220715|NCT02658890|560248704|FG022|Treatment Phase|Adverse Event|5|||
155220716|NCT02658890|560248705|FG023|Treatment Phase|Adverse Event|0|||
155220717|NCT02658890|560248706|FG024|Treatment Phase|Adverse Event|0|||
155220718|NCT02658890|560248707|FG025|Treatment Phase|Adverse Event|2|||
155220719|NCT02658890|560248708|FG026|Treatment Phase|Adverse Event|1|||
155220720|NCT02658890|560248682|FG000|Treatment Phase|Death|0|||
155220721|NCT02658890|560248683|FG001|Treatment Phase|Death|0|||
155220722|NCT02658890|560248684|FG002|Treatment Phase|Death|0|||
155220723|NCT02658890|560248685|FG003|Treatment Phase|Death|0|||
155220724|NCT02658890|560248686|FG004|Treatment Phase|Death|0|||
155220725|NCT02658890|560248687|FG005|Treatment Phase|Death|0|||
155220726|NCT02658890|560248688|FG006|Treatment Phase|Death|0|||
155220727|NCT02658890|560248689|FG007|Treatment Phase|Death|0|||
155220728|NCT02658890|560248690|FG008|Treatment Phase|Death|0|||
155220729|NCT02658890|560248691|FG009|Treatment Phase|Death|0|||
155220730|NCT02658890|560248692|FG010|Treatment Phase|Death|0|||
155220731|NCT02658890|560248693|FG011|Treatment Phase|Death|0|||
155220732|NCT02658890|560248694|FG012|Treatment Phase|Death|0|||
155220733|NCT02658890|560248695|FG013|Treatment Phase|Death|0|||
155220734|NCT02658890|560248696|FG014|Treatment Phase|Death|0|||
155220735|NCT02658890|560248697|FG015|Treatment Phase|Death|0|||
155220736|NCT02658890|560248698|FG016|Treatment Phase|Death|0|||
155220737|NCT02658890|560248699|FG017|Treatment Phase|Death|0|||
155220738|NCT02658890|560248700|FG018|Treatment Phase|Death|1|||
155220739|NCT02658890|560248701|FG019|Treatment Phase|Death|0|||
155220740|NCT02658890|560248702|FG020|Treatment Phase|Death|0|||
155220741|NCT02658890|560248703|FG021|Treatment Phase|Death|0|||
155220742|NCT02658890|560248704|FG022|Treatment Phase|Death|0|||
155220743|NCT02658890|560248705|FG023|Treatment Phase|Death|0|||
155220744|NCT02658890|560248706|FG024|Treatment Phase|Death|0|||
155220745|NCT02658890|560248707|FG025|Treatment Phase|Death|0|||
155220746|NCT02658890|560248708|FG026|Treatment Phase|Death|0|||
155220747|NCT02658890|560248682|FG000|Treatment Phase|Lost to Follow-up|0|||
155220748|NCT02658890|560248683|FG001|Treatment Phase|Lost to Follow-up|0|||
155220749|NCT02658890|560248684|FG002|Treatment Phase|Lost to Follow-up|0|||
155220750|NCT02658890|560248685|FG003|Treatment Phase|Lost to Follow-up|0|||
155220751|NCT02658890|560248686|FG004|Treatment Phase|Lost to Follow-up|0|||
155220752|NCT02658890|560248687|FG005|Treatment Phase|Lost to Follow-up|0|||
155220753|NCT02658890|560248688|FG006|Treatment Phase|Lost to Follow-up|1|||
155220754|NCT02658890|560248689|FG007|Treatment Phase|Lost to Follow-up|0|||
155220755|NCT02658890|560248690|FG008|Treatment Phase|Lost to Follow-up|0|||
155220756|NCT02658890|560248691|FG009|Treatment Phase|Lost to Follow-up|0|||
155220757|NCT02658890|560248692|FG010|Treatment Phase|Lost to Follow-up|0|||
155220758|NCT02658890|560248693|FG011|Treatment Phase|Lost to Follow-up|0|||
155220759|NCT02658890|560248694|FG012|Treatment Phase|Lost to Follow-up|0|||
155220760|NCT02658890|560248695|FG013|Treatment Phase|Lost to Follow-up|0|||
155220761|NCT02658890|560248696|FG014|Treatment Phase|Lost to Follow-up|0|||
155220762|NCT02658890|560248697|FG015|Treatment Phase|Lost to Follow-up|0|||
155220763|NCT02658890|560248698|FG016|Treatment Phase|Lost to Follow-up|0|||
155220764|NCT02658890|560248699|FG017|Treatment Phase|Lost to Follow-up|0|||
155220765|NCT02658890|560248700|FG018|Treatment Phase|Lost to Follow-up|0|||
155220766|NCT02658890|560248701|FG019|Treatment Phase|Lost to Follow-up|0|||
155220767|NCT02658890|560248702|FG020|Treatment Phase|Lost to Follow-up|0|||
155220768|NCT02658890|560248703|FG021|Treatment Phase|Lost to Follow-up|0|||
155220769|NCT02658890|560248704|FG022|Treatment Phase|Lost to Follow-up|0|||
155220770|NCT02658890|560248705|FG023|Treatment Phase|Lost to Follow-up|0|||
155220771|NCT02658890|560248706|FG024|Treatment Phase|Lost to Follow-up|0|||
155220772|NCT02658890|560248707|FG025|Treatment Phase|Lost to Follow-up|0|||
155220773|NCT02658890|560248708|FG026|Treatment Phase|Lost to Follow-up|0|||
155220774|NCT02658890|560248682|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
155220775|NCT02658890|560248683|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
155220776|NCT02658890|560248684|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
155220777|NCT02658890|560248685|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
155220778|NCT02658890|560248686|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
155220779|NCT02658890|560248687|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
155220780|NCT02658890|560248688|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
155220781|NCT02658890|560248689|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
155220782|NCT02658890|560248690|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
155220783|NCT02658890|560248691|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
155220784|NCT02658890|560248692|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
155220785|NCT02658890|560248693|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
155220786|NCT02658890|560248694|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
155220787|NCT02658890|560248695|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
155220788|NCT02658890|560248696|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
155220789|NCT02658890|560248697|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
155220790|NCT02658890|560248698|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
155220791|NCT02658890|560248699|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
155220792|NCT02658890|560248700|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
155220793|NCT02658890|560248701|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
155220794|NCT02658890|560248702|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
155220795|NCT02658890|560248703|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
155220796|NCT02658890|560248704|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
155220797|NCT02658890|560248705|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
155220798|NCT02658890|560248706|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
155220799|NCT02658890|560248707|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
155220800|NCT02658890|560248708|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
155220801|NCT02658890|560248682|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
155220802|NCT02658890|560248683|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
155220803|NCT02658890|560248684|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
155220804|NCT02658890|560248685|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
155220805|NCT02658890|560248686|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
155220806|NCT02658890|560248687|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
155220807|NCT02658890|560248688|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
155220808|NCT02658890|560248689|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
155220809|NCT02658890|560248690|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
155220810|NCT02658890|560248691|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
155220811|NCT02658890|560248692|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
155220812|NCT02658890|560248693|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
155220813|NCT02658890|560248694|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
155220814|NCT02658890|560248695|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
155220815|NCT02658890|560248696|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
155220816|NCT02658890|560248697|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
155220817|NCT02658890|560248698|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
155220818|NCT02658890|560248699|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
155220819|NCT02658890|560248700|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
155220820|NCT02658890|560248701|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
155220821|NCT02658890|560248702|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
155220822|NCT02658890|560248703|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
155220823|NCT02658890|560248704|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
155220824|NCT02658890|560248705|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
155220825|NCT02658890|560248706|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
155220826|NCT02658890|560248707|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
155220827|NCT02658890|560248708|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
155220828|NCT02658890|560248682|FG000|Treatment Phase|Other Reasons|0|||
155220829|NCT02658890|560248683|FG001|Treatment Phase|Other Reasons|0|||
155220830|NCT02658890|560248684|FG002|Treatment Phase|Other Reasons|0|||
155220831|NCT02658890|560248685|FG003|Treatment Phase|Other Reasons|0|||
155220832|NCT02658890|560248686|FG004|Treatment Phase|Other Reasons|0|||
155220833|NCT02658890|560248687|FG005|Treatment Phase|Other Reasons|0|||
155220834|NCT02658890|560248688|FG006|Treatment Phase|Other Reasons|1|||
155220835|NCT02658890|560248689|FG007|Treatment Phase|Other Reasons|0|||
155220836|NCT02658890|560248690|FG008|Treatment Phase|Other Reasons|1|||
155220837|NCT02658890|560248691|FG009|Treatment Phase|Other Reasons|0|||
155220838|NCT02658890|560248692|FG010|Treatment Phase|Other Reasons|0|||
155220839|NCT02658890|560248693|FG011|Treatment Phase|Other Reasons|0|||
155220840|NCT02658890|560248694|FG012|Treatment Phase|Other Reasons|0|||
155220841|NCT02658890|560248695|FG013|Treatment Phase|Other Reasons|2|||
155220842|NCT02658890|560248696|FG014|Treatment Phase|Other Reasons|0|||
155220843|NCT02658890|560248697|FG015|Treatment Phase|Other Reasons|0|||
155220844|NCT02658890|560248698|FG016|Treatment Phase|Other Reasons|0|||
155220845|NCT02658890|560248699|FG017|Treatment Phase|Other Reasons|0|||
155220846|NCT02658890|560248700|FG018|Treatment Phase|Other Reasons|1|||
155220847|NCT02658890|560248701|FG019|Treatment Phase|Other Reasons|0|||
155220848|NCT02658890|560248702|FG020|Treatment Phase|Other Reasons|0|||
155220849|NCT02658890|560248703|FG021|Treatment Phase|Other Reasons|0|||
155220850|NCT02658890|560248704|FG022|Treatment Phase|Other Reasons|0|||
155220851|NCT02658890|560248705|FG023|Treatment Phase|Other Reasons|0|||
155220852|NCT02658890|560248706|FG024|Treatment Phase|Other Reasons|1|||
155220853|NCT02658890|560248707|FG025|Treatment Phase|Other Reasons|0|||
155220854|NCT02658890|560248708|FG026|Treatment Phase|Other Reasons|1|||
155220855|NCT02658890|560248682|FG000|Treatment Phase|Progressive Disease|6|||
155220856|NCT02658890|560248683|FG001|Treatment Phase|Progressive Disease|7|||
155220857|NCT02658890|560248684|FG002|Treatment Phase|Progressive Disease|6|||
155220858|NCT02658890|560248685|FG003|Treatment Phase|Progressive Disease|12|||
155220859|NCT02658890|560248686|FG004|Treatment Phase|Progressive Disease|6|||
155220860|NCT02658890|560248687|FG005|Treatment Phase|Progressive Disease|18|||
155220861|NCT02658890|560248688|FG006|Treatment Phase|Progressive Disease|12|||
155220862|NCT02658890|560248689|FG007|Treatment Phase|Progressive Disease|19|||
155220863|NCT02658890|560248690|FG008|Treatment Phase|Progressive Disease|26|||
155220864|NCT02658890|560248691|FG009|Treatment Phase|Progressive Disease|8|||
155220865|NCT02658890|560248692|FG010|Treatment Phase|Progressive Disease|7|||
155220866|NCT02658890|560248693|FG011|Treatment Phase|Progressive Disease|9|||
155220867|NCT02658890|560248694|FG012|Treatment Phase|Progressive Disease|8|||
155220868|NCT02658890|560248695|FG013|Treatment Phase|Progressive Disease|29|||
155220869|NCT02658890|560248696|FG014|Treatment Phase|Progressive Disease|6|||
155220870|NCT02658890|560248697|FG015|Treatment Phase|Progressive Disease|2|||
155220871|NCT02658890|560248698|FG016|Treatment Phase|Progressive Disease|32|||
155220872|NCT02658890|560248699|FG017|Treatment Phase|Progressive Disease|14|||
155220873|NCT02658890|560248700|FG018|Treatment Phase|Progressive Disease|40|||
155220874|NCT02658890|560248701|FG019|Treatment Phase|Progressive Disease|32|||
155220875|NCT02658890|560248702|FG020|Treatment Phase|Progressive Disease|19|||
155220876|NCT02658890|560248703|FG021|Treatment Phase|Progressive Disease|30|||
155220877|NCT02658890|560248704|FG022|Treatment Phase|Progressive Disease|15|||
155220878|NCT02658890|560248705|FG023|Treatment Phase|Progressive Disease|0|||
155220879|NCT02658890|560248706|FG024|Treatment Phase|Progressive Disease|0|||
155220880|NCT02658890|560248707|FG025|Treatment Phase|Progressive Disease|14|||
155220881|NCT02658890|560248708|FG026|Treatment Phase|Progressive Disease|11|||
155220882|NCT02658890|560248682|FG000|Treatment Phase|Study Drug Toxicity|0|||
155220883|NCT02658890|560248683|FG001|Treatment Phase|Study Drug Toxicity|0|||
155220884|NCT02658890|560248684|FG002|Treatment Phase|Study Drug Toxicity|2|||
155220885|NCT02658890|560248685|FG003|Treatment Phase|Study Drug Toxicity|0|||
155220886|NCT02658890|560248686|FG004|Treatment Phase|Study Drug Toxicity|0|||
155220887|NCT02658890|560248687|FG005|Treatment Phase|Study Drug Toxicity|0|||
155220888|NCT02658890|560248688|FG006|Treatment Phase|Study Drug Toxicity|0|||
155220889|NCT02658890|560248689|FG007|Treatment Phase|Study Drug Toxicity|0|||
155220890|NCT02658890|560248690|FG008|Treatment Phase|Study Drug Toxicity|3|||
155220891|NCT02658890|560248691|FG009|Treatment Phase|Study Drug Toxicity|0|||
155220892|NCT02658890|560248692|FG010|Treatment Phase|Study Drug Toxicity|1|||
155220893|NCT02658890|560248693|FG011|Treatment Phase|Study Drug Toxicity|1|||
155220894|NCT02658890|560248694|FG012|Treatment Phase|Study Drug Toxicity|2|||
155220895|NCT02658890|560248695|FG013|Treatment Phase|Study Drug Toxicity|9|||
155220896|NCT02658890|560248696|FG014|Treatment Phase|Study Drug Toxicity|0|||
155220897|NCT02658890|560248697|FG015|Treatment Phase|Study Drug Toxicity|1|||
155220898|NCT02658890|560248698|FG016|Treatment Phase|Study Drug Toxicity|1|||
155220899|NCT02658890|560248699|FG017|Treatment Phase|Study Drug Toxicity|0|||
155220900|NCT02658890|560248700|FG018|Treatment Phase|Study Drug Toxicity|8|||
155220901|NCT02658890|560248701|FG019|Treatment Phase|Study Drug Toxicity|3|||
155220902|NCT02658890|560248702|FG020|Treatment Phase|Study Drug Toxicity|2|||
155220903|NCT02658890|560248703|FG021|Treatment Phase|Study Drug Toxicity|0|||
155220904|NCT02658890|560248704|FG022|Treatment Phase|Study Drug Toxicity|8|||
155220905|NCT02658890|560248705|FG023|Treatment Phase|Study Drug Toxicity|0|||
155220906|NCT02658890|560248706|FG024|Treatment Phase|Study Drug Toxicity|0|||
155220907|NCT02658890|560248707|FG025|Treatment Phase|Study Drug Toxicity|2|||
155220908|NCT02658890|560248708|FG026|Treatment Phase|Study Drug Toxicity|0|||
155220909|NCT02658890|560248682|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220910|NCT02658890|560248683|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220911|NCT02658890|560248684|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220912|NCT02658890|560248685|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220913|NCT02658890|560248686|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220914|NCT02658890|560248687|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220915|NCT02658890|560248688|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220916|NCT02658890|560248689|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220917|NCT02658890|560248690|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220918|NCT02658890|560248691|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220919|NCT02658890|560248692|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220920|NCT02658890|560248693|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220921|NCT02658890|560248694|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220922|NCT02658890|560248695|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220923|NCT02658890|560248696|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220924|NCT02658890|560248697|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220925|NCT02658890|560248698|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220926|NCT02658890|560248699|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220927|NCT02658890|560248700|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220928|NCT02658890|560248701|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220929|NCT02658890|560248702|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220930|NCT02658890|560248703|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220931|NCT02658890|560248704|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
155220932|NCT02658890|560248705|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220933|NCT02658890|560248706|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220934|NCT02658890|560248707|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220935|NCT02658890|560248708|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
155220936|NCT02658890|560248682|FG000|Treatment Phase|Withdrawal by Subject|0|||
155220937|NCT02658890|560248683|FG001|Treatment Phase|Withdrawal by Subject|1|||
155220938|NCT02658890|560248684|FG002|Treatment Phase|Withdrawal by Subject|0|||
155220939|NCT02658890|560248685|FG003|Treatment Phase|Withdrawal by Subject|0|||
155220940|NCT02658890|560248686|FG004|Treatment Phase|Withdrawal by Subject|0|||
155220941|NCT02658890|560248687|FG005|Treatment Phase|Withdrawal by Subject|0|||
155220942|NCT02658890|560248688|FG006|Treatment Phase|Withdrawal by Subject|1|||
155220943|NCT02658890|560248689|FG007|Treatment Phase|Withdrawal by Subject|0|||
155220944|NCT02658890|560248690|FG008|Treatment Phase|Withdrawal by Subject|0|||
155220945|NCT02658890|560248691|FG009|Treatment Phase|Withdrawal by Subject|1|||
155220946|NCT02658890|560248692|FG010|Treatment Phase|Withdrawal by Subject|0|||
155220947|NCT02658890|560248693|FG011|Treatment Phase|Withdrawal by Subject|0|||
155220948|NCT02658890|560248694|FG012|Treatment Phase|Withdrawal by Subject|1|||
155220949|NCT02658890|560248695|FG013|Treatment Phase|Withdrawal by Subject|3|||
155220950|NCT02658890|560248696|FG014|Treatment Phase|Withdrawal by Subject|0|||
155220951|NCT02658890|560248697|FG015|Treatment Phase|Withdrawal by Subject|0|||
155220952|NCT02658890|560248698|FG016|Treatment Phase|Withdrawal by Subject|1|||
155220953|NCT02658890|560248699|FG017|Treatment Phase|Withdrawal by Subject|0|||
155220954|NCT02658890|560248700|FG018|Treatment Phase|Withdrawal by Subject|4|||
155220955|NCT02658890|560248701|FG019|Treatment Phase|Withdrawal by Subject|3|||
155220956|NCT02658890|560248702|FG020|Treatment Phase|Withdrawal by Subject|0|||
155220957|NCT02658890|560248703|FG021|Treatment Phase|Withdrawal by Subject|4|||
155220958|NCT02658890|560248704|FG022|Treatment Phase|Withdrawal by Subject|1|||
155220959|NCT02658890|560248705|FG023|Treatment Phase|Withdrawal by Subject|1|||
155220960|NCT02658890|560248706|FG024|Treatment Phase|Withdrawal by Subject|0|||
155220961|NCT02658890|560248707|FG025|Treatment Phase|Withdrawal by Subject|0|||
155220962|NCT02658890|560248708|FG026|Treatment Phase|Withdrawal by Subject|0|||
155220963|NCT02474199|560248709|FG000|Overall Study|Lost to Follow-up|1|||
155220964|NCT02474199|560248710|FG001|Overall Study|Lost to Follow-up|0|||
155220965|NCT02474199|560248711|FG002|Overall Study|Lost to Follow-up|0|||
155220966|NCT02474199|560248712|FG003|Overall Study|Lost to Follow-up|0|||
155220967|NCT02474199|560248709|FG000|Overall Study|Withdrawal by Subject|1|||
155220968|NCT02474199|560248710|FG001|Overall Study|Withdrawal by Subject|2|||
155220969|NCT02474199|560248711|FG002|Overall Study|Withdrawal by Subject|0|||
155220970|NCT02474199|560248712|FG003|Overall Study|Withdrawal by Subject|1|||
155220971|NCT02474199|560248709|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
155220972|NCT02474199|560248710|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
155220973|NCT02474199|560248711|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
155220974|NCT02474199|560248712|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
155220975|NCT02474199|560248709|FG000|Overall Study|Did not meet eligibility criteria|0|||
155220976|NCT02474199|560248710|FG001|Overall Study|Did not meet eligibility criteria|0|||
155220977|NCT02474199|560248711|FG002|Overall Study|Did not meet eligibility criteria|2|||
155220978|NCT02474199|560248712|FG003|Overall Study|Did not meet eligibility criteria|2|||
155220979|NCT03090100|560248713|FG000|Overall Study|Adverse Event|9|||
155220980|NCT03090100|560248714|FG001|Overall Study|Adverse Event|11|||
155220981|NCT03090100|560248713|FG000|Overall Study|Pregnancy|1|||
155220982|NCT03090100|560248714|FG001|Overall Study|Pregnancy|1|||
155220983|NCT03090100|560248713|FG000|Overall Study|Lack of Efficacy|2|||
155220984|NCT03090100|560248714|FG001|Overall Study|Lack of Efficacy|7|||
155220985|NCT03090100|560248713|FG000|Overall Study|Lost to Follow-up|2|||
155220986|NCT03090100|560248714|FG001|Overall Study|Lost to Follow-up|2|||
155220987|NCT03090100|560248713|FG000|Overall Study|Withdrawal by Subject|7|||
155220988|NCT03090100|560248714|FG001|Overall Study|Withdrawal by Subject|19|||
155220989|NCT03090100|560248713|FG000|Overall Study|Protocol Violation|2|||
155220990|NCT03090100|560248714|FG001|Overall Study|Protocol Violation|6|||
155220991|NCT03090100|560248713|FG000|Overall Study|Non-compliance|2|||
155220992|NCT03090100|560248714|FG001|Overall Study|Non-compliance|0|||
155220993|NCT03090100|560248713|FG000|Overall Study|Other|2|||
155220994|NCT03090100|560248714|FG001|Overall Study|Other|2|||
155220995|NCT04765358|560248717|FG000|Overall Study|Withdrawal by Subject|1|||
155220996|NCT00159588|560248718|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
155220997|NCT00159588|560248719|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
155220998|NCT00159588|560248720|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
155220999|NCT03446040|560248721|FG000|Overall Study|Disease progression|3|||
155221000|NCT03446040|560248722|FG001|Overall Study|Disease progression|3|||
155221001|NCT03446040|560248723|FG002|Overall Study|Disease progression|3|||
155221002|NCT03446040|560248724|FG003|Overall Study|Disease progression|4|||
155221003|NCT03446040|560248725|FG004|Overall Study|Disease progression|4|||
155221004|NCT03446040|560248726|FG005|Overall Study|Disease progression|6|||
155221005|NCT03446040|560248727|FG006|Overall Study|Disease progression|3|||
155221006|NCT03446040|560248728|FG007|Overall Study|Disease progression|4|||
155221007|NCT03446040|560248729|FG008|Overall Study|Disease progression|2|||
155221008|NCT03446040|560248730|FG009|Overall Study|Disease progression|4|||
155221009|NCT03446040|560248731|FG010|Overall Study|Disease progression|9|||
155221010|NCT03446040|560248732|FG011|Overall Study|Disease progression|3|||
155221011|NCT03446040|560248733|FG012|Overall Study|Disease progression|7|||
155221012|NCT03446040|560248734|FG013|Overall Study|Disease progression|7|||
155221013|NCT03446040|560248721|FG000|Overall Study|Study drug toxicity|0|||
155221014|NCT03446040|560248722|FG001|Overall Study|Study drug toxicity|0|||
155221015|NCT03446040|560248723|FG002|Overall Study|Study drug toxicity|0|||
155221016|NCT03446040|560248724|FG003|Overall Study|Study drug toxicity|0|||
155221017|NCT03446040|560248725|FG004|Overall Study|Study drug toxicity|0|||
155221018|NCT03446040|560248726|FG005|Overall Study|Study drug toxicity|0|||
155221019|NCT03446040|560248727|FG006|Overall Study|Study drug toxicity|0|||
155221020|NCT03446040|560248728|FG007|Overall Study|Study drug toxicity|0|||
155221021|NCT03446040|560248729|FG008|Overall Study|Study drug toxicity|1|||
155221022|NCT03446040|560248730|FG009|Overall Study|Study drug toxicity|0|||
155221023|NCT03446040|560248731|FG010|Overall Study|Study drug toxicity|0|||
155221024|NCT03446040|560248732|FG011|Overall Study|Study drug toxicity|0|||
155221025|NCT03446040|560248733|FG012|Overall Study|Study drug toxicity|0|||
155221026|NCT03446040|560248734|FG013|Overall Study|Study drug toxicity|0|||
155221027|NCT03446040|560248721|FG000|Overall Study|Adverse Event|0|||
155221028|NCT03446040|560248722|FG001|Overall Study|Adverse Event|0|||
155221029|NCT03446040|560248723|FG002|Overall Study|Adverse Event|0|||
155221030|NCT03446040|560248724|FG003|Overall Study|Adverse Event|0|||
155221031|NCT03446040|560248725|FG004|Overall Study|Adverse Event|0|||
155221032|NCT03446040|560248726|FG005|Overall Study|Adverse Event|2|||
155221033|NCT03446040|560248727|FG006|Overall Study|Adverse Event|0|||
155221034|NCT03446040|560248728|FG007|Overall Study|Adverse Event|0|||
155221035|NCT03446040|560248729|FG008|Overall Study|Adverse Event|1|||
155221036|NCT03446040|560248730|FG009|Overall Study|Adverse Event|0|||
155221037|NCT03446040|560248731|FG010|Overall Study|Adverse Event|0|||
155221038|NCT03446040|560248732|FG011|Overall Study|Adverse Event|0|||
155221039|NCT03446040|560248733|FG012|Overall Study|Adverse Event|0|||
155221040|NCT03446040|560248734|FG013|Overall Study|Adverse Event|0|||
155221041|NCT03446040|560248721|FG000|Overall Study|Death|0|||
155221042|NCT03446040|560248722|FG001|Overall Study|Death|0|||
155221043|NCT03446040|560248723|FG002|Overall Study|Death|0|||
155221044|NCT03446040|560248724|FG003|Overall Study|Death|0|||
155221045|NCT03446040|560248725|FG004|Overall Study|Death|0|||
155221046|NCT03446040|560248726|FG005|Overall Study|Death|0|||
155221047|NCT03446040|560248727|FG006|Overall Study|Death|0|||
155221048|NCT03446040|560248728|FG007|Overall Study|Death|0|||
155221049|NCT03446040|560248729|FG008|Overall Study|Death|0|||
155221050|NCT03446040|560248730|FG009|Overall Study|Death|0|||
155221051|NCT03446040|560248731|FG010|Overall Study|Death|1|||
155221052|NCT03446040|560248732|FG011|Overall Study|Death|0|||
155221053|NCT03446040|560248733|FG012|Overall Study|Death|0|||
155221054|NCT03446040|560248734|FG013|Overall Study|Death|2|||
155221055|NCT03446040|560248721|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
155221056|NCT03446040|560248722|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
155221057|NCT03446040|560248723|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
155221058|NCT03446040|560248724|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
155221059|NCT03446040|560248725|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
155221060|NCT03446040|560248726|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
155221061|NCT03446040|560248727|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
155221062|NCT03446040|560248728|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
155221063|NCT03446040|560248729|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
155221064|NCT03446040|560248730|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
155221065|NCT03446040|560248731|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
155221066|NCT03446040|560248732|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
155221067|NCT03446040|560248733|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
155221068|NCT03446040|560248734|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
155221069|NCT03446040|560248721|FG000|Overall Study|Participant withdrew consent|0|||
155221070|NCT03446040|560248722|FG001|Overall Study|Participant withdrew consent|0|||
155221071|NCT03446040|560248723|FG002|Overall Study|Participant withdrew consent|0|||
155221072|NCT03446040|560248724|FG003|Overall Study|Participant withdrew consent|0|||
155221073|NCT03446040|560248725|FG004|Overall Study|Participant withdrew consent|0|||
155221074|NCT03446040|560248726|FG005|Overall Study|Participant withdrew consent|1|||
155221075|NCT03446040|560248727|FG006|Overall Study|Participant withdrew consent|0|||
155221076|NCT03446040|560248728|FG007|Overall Study|Participant withdrew consent|1|||
155221077|NCT03446040|560248729|FG008|Overall Study|Participant withdrew consent|0|||
155221078|NCT03446040|560248730|FG009|Overall Study|Participant withdrew consent|0|||
155221079|NCT03446040|560248731|FG010|Overall Study|Participant withdrew consent|0|||
155221080|NCT03446040|560248732|FG011|Overall Study|Participant withdrew consent|0|||
155221081|NCT03446040|560248733|FG012|Overall Study|Participant withdrew consent|0|||
155221082|NCT03446040|560248734|FG013|Overall Study|Participant withdrew consent|0|||
155221083|NCT03446040|560248721|FG000|Overall Study|Not reported|0|||
155221084|NCT03446040|560248722|FG001|Overall Study|Not reported|0|||
155221085|NCT03446040|560248723|FG002|Overall Study|Not reported|1|||
155221086|NCT03446040|560248724|FG003|Overall Study|Not reported|0|||
155221087|NCT03446040|560248725|FG004|Overall Study|Not reported|0|||
155221088|NCT03446040|560248726|FG005|Overall Study|Not reported|0|||
155221089|NCT03446040|560248727|FG006|Overall Study|Not reported|0|||
155221090|NCT03446040|560248728|FG007|Overall Study|Not reported|0|||
155221091|NCT03446040|560248729|FG008|Overall Study|Not reported|0|||
155221092|NCT03446040|560248730|FG009|Overall Study|Not reported|0|||
155221093|NCT03446040|560248731|FG010|Overall Study|Not reported|0|||
155221094|NCT03446040|560248732|FG011|Overall Study|Not reported|0|||
155221095|NCT03446040|560248733|FG012|Overall Study|Not reported|0|||
155221096|NCT03446040|560248734|FG013|Overall Study|Not reported|0|||
155221097|NCT00456521|560248735|FG000|Overall Study|Adverse Event|150|||
155221098|NCT00456521|560248736|FG001|Overall Study|Adverse Event|25|||
155221099|NCT00456521|560248735|FG000|Overall Study|Withdrawal by Subject|43|||
155221100|NCT00456521|560248736|FG001|Overall Study|Withdrawal by Subject|24|||
155221101|NCT00456521|560248735|FG000|Overall Study|Lost to Follow-up|22|||
155221102|NCT00456521|560248736|FG001|Overall Study|Lost to Follow-up|17|||
155221103|NCT00456521|560248735|FG000|Overall Study|Lack of Efficacy|3|||
155221104|NCT00456521|560248736|FG001|Overall Study|Lack of Efficacy|6|||
155221105|NCT00456521|560248735|FG000|Overall Study|Protocol Violation|4|||
155221106|NCT00456521|560248736|FG001|Overall Study|Protocol Violation|0|||
155221107|NCT00456521|560248735|FG000|Overall Study|Pregnancy|1|||
155221108|NCT00456521|560248736|FG001|Overall Study|Pregnancy|1|||
155221109|NCT00456521|560248735|FG000|Overall Study|Drug non-compliance, moved, other|26|||
155221110|NCT00456521|560248736|FG001|Overall Study|Drug non-compliance, moved, other|11|||
155221111|NCT01316276|560248737|FG000|Overall Study|Death|1|||
155221112|NCT01316276|560248737|FG000|Overall Study|Adverse Event|19|||
155221113|NCT01316276|560248737|FG000|Overall Study|Withdrawal of consent|24|||
155221114|NCT01316276|560248737|FG000|Overall Study|Lost to Follow-up|1|||
155221115|NCT01316276|560248737|FG000|Overall Study|Other|22|||
155221116|NCT00605475|560248738|FG000|Overall Study|Abnormal Laboratory Values|0|||
155221117|NCT00605475|560248739|FG001|Overall Study|Abnormal Laboratory Values|0|||
155221118|NCT00605475|560248740|FG002|Overall Study|Abnormal Laboratory Values|0|||
155221119|NCT00605475|560248741|FG003|Overall Study|Abnormal Laboratory Values|0|||
155221120|NCT00605475|560248742|FG004|Overall Study|Abnormal Laboratory Values|0|||
155221121|NCT00605475|560248743|FG005|Overall Study|Abnormal Laboratory Values|0|||
155221122|NCT00605475|560248744|FG006|Overall Study|Abnormal Laboratory Values|0|||
155221123|NCT00605475|560248745|FG007|Overall Study|Abnormal Laboratory Values|0|||
155221124|NCT00605475|560248746|FG008|Overall Study|Abnormal Laboratory Values|1|||
155221125|NCT00605475|560248747|FG009|Overall Study|Abnormal Laboratory Values|0|||
155221126|NCT00605475|560248738|FG000|Overall Study|Administrative problems|0|||
155221127|NCT00605475|560248739|FG001|Overall Study|Administrative problems|0|||
155221128|NCT00605475|560248740|FG002|Overall Study|Administrative problems|0|||
155221129|NCT00605475|560248741|FG003|Overall Study|Administrative problems|0|||
155221130|NCT00605475|560248742|FG004|Overall Study|Administrative problems|0|||
155221131|NCT00605475|560248743|FG005|Overall Study|Administrative problems|0|||
155221132|NCT00605475|560248744|FG006|Overall Study|Administrative problems|1|||
155221133|NCT00605475|560248745|FG007|Overall Study|Administrative problems|0|||
155221134|NCT00605475|560248746|FG008|Overall Study|Administrative problems|0|||
155221135|NCT00605475|560248747|FG009|Overall Study|Administrative problems|0|||
155221136|NCT00605475|560248738|FG000|Overall Study|Lost to Follow-up|0|||
155221137|NCT00605475|560248739|FG001|Overall Study|Lost to Follow-up|0|||
155221138|NCT00605475|560248740|FG002|Overall Study|Lost to Follow-up|0|||
155221139|NCT00605475|560248741|FG003|Overall Study|Lost to Follow-up|0|||
155221140|NCT00605475|560248742|FG004|Overall Study|Lost to Follow-up|0|||
155221141|NCT00605475|560248743|FG005|Overall Study|Lost to Follow-up|0|||
155221142|NCT00605475|560248744|FG006|Overall Study|Lost to Follow-up|0|||
155221143|NCT00605475|560248745|FG007|Overall Study|Lost to Follow-up|0|||
155221144|NCT00605475|560248746|FG008|Overall Study|Lost to Follow-up|1|||
155221145|NCT00605475|560248747|FG009|Overall Study|Lost to Follow-up|1|||
155221146|NCT00605475|560248738|FG000|Overall Study|Protocol Violation|0|||
155221147|NCT00605475|560248739|FG001|Overall Study|Protocol Violation|0|||
155221148|NCT00605475|560248740|FG002|Overall Study|Protocol Violation|0|||
155221149|NCT00605475|560248741|FG003|Overall Study|Protocol Violation|0|||
155221150|NCT00605475|560248742|FG004|Overall Study|Protocol Violation|1|||
155221151|NCT00605475|560248743|FG005|Overall Study|Protocol Violation|0|||
155221152|NCT00605475|560248744|FG006|Overall Study|Protocol Violation|0|||
155221153|NCT00605475|560248745|FG007|Overall Study|Protocol Violation|0|||
155221154|NCT00605475|560248746|FG008|Overall Study|Protocol Violation|0|||
155221155|NCT00605475|560248747|FG009|Overall Study|Protocol Violation|0|||
155221156|NCT00605475|560248738|FG000|Overall Study|Withdrawal by Subject|0|||
155221157|NCT00605475|560248739|FG001|Overall Study|Withdrawal by Subject|0|||
155221158|NCT00605475|560248740|FG002|Overall Study|Withdrawal by Subject|0|||
155221159|NCT00605475|560248741|FG003|Overall Study|Withdrawal by Subject|0|||
155221160|NCT00605475|560248742|FG004|Overall Study|Withdrawal by Subject|0|||
155221161|NCT00605475|560248743|FG005|Overall Study|Withdrawal by Subject|2|||
155221162|NCT00605475|560248744|FG006|Overall Study|Withdrawal by Subject|0|||
155221163|NCT00605475|560248745|FG007|Overall Study|Withdrawal by Subject|0|||
155221164|NCT00605475|560248746|FG008|Overall Study|Withdrawal by Subject|0|||
155221165|NCT00605475|560248747|FG009|Overall Study|Withdrawal by Subject|1|||
155221166|NCT02596854|560248748|FG000|Overall Study|Withdrawn|8|||
155221167|NCT00464568|560248755|FG000|Overall Study|Adverse Event|2|||
155221168|NCT00507442|560248756|FG000|Overall Study|Adverse Event|8|||
155221169|NCT00507442|560248757|FG001|Overall Study|Adverse Event|11|||
155221170|NCT00507442|560248758|FG002|Overall Study|Adverse Event|4|||
155221171|NCT00507442|560248759|FG003|Overall Study|Adverse Event|1|||
155221172|NCT00507442|560248756|FG000|Overall Study|Protocol Violation|0|||
155221173|NCT00507442|560248757|FG001|Overall Study|Protocol Violation|1|||
155221174|NCT00507442|560248758|FG002|Overall Study|Protocol Violation|0|||
155221175|NCT00507442|560248759|FG003|Overall Study|Protocol Violation|0|||
155221176|NCT00507442|560248756|FG000|Overall Study|Lost to Follow-up|0|||
155221177|NCT00507442|560248757|FG001|Overall Study|Lost to Follow-up|0|||
155221178|NCT00507442|560248758|FG002|Overall Study|Lost to Follow-up|1|||
155221179|NCT00507442|560248759|FG003|Overall Study|Lost to Follow-up|0|||
155221180|NCT00507442|560248756|FG000|Overall Study|Physician Decision|0|||
155221181|NCT00507442|560248757|FG001|Overall Study|Physician Decision|2|||
155221182|NCT00507442|560248758|FG002|Overall Study|Physician Decision|4|||
155221183|NCT00507442|560248759|FG003|Overall Study|Physician Decision|1|||
155221184|NCT00507442|560248756|FG000|Overall Study|Progressive Disease|2|||
155221185|NCT00507442|560248757|FG001|Overall Study|Progressive Disease|4|||
155221186|NCT00507442|560248758|FG002|Overall Study|Progressive Disease|2|||
155221187|NCT00507442|560248759|FG003|Overall Study|Progressive Disease|0|||
155221188|NCT00507442|560248756|FG000|Overall Study|Withdrawal by Subject|4|||
155221189|NCT00507442|560248757|FG001|Overall Study|Withdrawal by Subject|4|||
155221190|NCT00507442|560248758|FG002|Overall Study|Withdrawal by Subject|2|||
155221191|NCT00507442|560248759|FG003|Overall Study|Withdrawal by Subject|1|||
155221192|NCT00507442|560248756|FG000|Overall Study|Other|2|||
155221193|NCT00507442|560248757|FG001|Overall Study|Other|5|||
155221194|NCT00507442|560248758|FG002|Overall Study|Other|2|||
155221195|NCT00507442|560248759|FG003|Overall Study|Other|2|||
155221196|NCT03506373|560248762|FG000|Overall Study|Adverse Event|6|||
155221197|NCT03506373|560248762|FG000|Overall Study|Withdrawal by Subject|2|||
155221198|NCT03506373|560248762|FG000|Overall Study|Disease progression|5|||
155221199|NCT03506373|560248762|FG000|Overall Study|Other|3|||
155221200|NCT00107198|560248763|FG000|Overall Study|Lack of Efficacy|28|||
155221201|NCT00107198|560248763|FG000|Overall Study|Lost to Follow-up|12|||
155221202|NCT00107198|560248763|FG000|Overall Study|Protocol Violation|1|||
155221203|NCT00107198|560248763|FG000|Overall Study|Withdrawal by Subject|6|||
155221204|NCT00107198|560248763|FG000|Overall Study|Ineligible|5|||
155221205|NCT04649164|560248766|FG000|Overall Study|Withdrawal by Subject|1|||
155221206|NCT04649164|560248767|FG001|Overall Study|Withdrawal by Subject|1|||
155221207|NCT04649164|560248768|FG002|Overall Study|Withdrawal by Subject|2|||
155221208|NCT04649164|560248766|FG000|Overall Study|Participant's care recipient expired|0|||
155221209|NCT04649164|560248767|FG001|Overall Study|Participant's care recipient expired|0|||
155221210|NCT04649164|560248768|FG002|Overall Study|Participant's care recipient expired|2|||
155221211|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|5|||
155221212|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221213|NCT00304356|560248769|FG000|Nitazoxanide|number is 0|1|||
155221214|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221215|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221216|NCT00304356|560248769|FG000|Nitazoxanide|Physician Decision|1|||
155221217|NCT04120974|560248770|FG000|Overall Study|Death|1|||
155221218|NCT04120974|560248770|FG000|Overall Study|Physician Decision|1|||
155221219|NCT04120974|560248770|FG000|Overall Study|Lost to Follow-up|6|||
155221220|NCT00741039|560248774|FG000|Overall Study|Patient non-compliance|2|||
155221221|NCT00741039|560248775|FG001|Overall Study|Patient non-compliance|0|||
155221222|NCT00768300|560248776|FG000|Overall Study|Randomized but not treated|1|||
155221223|NCT00768300|560248777|FG001|Overall Study|Randomized but not treated|1|||
155221224|NCT00768300|560248776|FG000|Overall Study|Adverse Event|10|||
155221225|NCT00768300|560248777|FG001|Overall Study|Adverse Event|2|||
155221226|NCT00768300|560248776|FG000|Overall Study|Protocol Violation|6|||
155221227|NCT00768300|560248777|FG001|Overall Study|Protocol Violation|1|||
155221228|NCT00768300|560248776|FG000|Overall Study|Withdrawal by Subject|13|||
155221229|NCT00768300|560248777|FG001|Overall Study|Withdrawal by Subject|7|||
155221230|NCT00768300|560248776|FG000|Overall Study|Physician Decision|2|||
155221231|NCT00768300|560248777|FG001|Overall Study|Physician Decision|3|||
155221232|NCT00768300|560248776|FG000|Overall Study|Study discontinued by Sponsor|271|||
155221233|NCT00768300|560248777|FG001|Overall Study|Study discontinued by Sponsor|140|||
155221234|NCT00768300|560248776|FG000|Overall Study|Death|21|||
155221235|NCT00768300|560248777|FG001|Overall Study|Death|5|||
155221236|NCT00768300|560248776|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
155221237|NCT00768300|560248777|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
155221238|NCT00768300|560248776|FG000|Overall Study|Screen failure following randomization|1|||
155221239|NCT00768300|560248777|FG001|Overall Study|Screen failure following randomization|0|||
155221240|NCT00768300|560248776|FG000|Overall Study|Received lung transplant|1|||
155221241|NCT00768300|560248777|FG001|Overall Study|Received lung transplant|1|||
155221242|NCT00768300|560248776|FG000|Overall Study|Lost to Follow-up|0|||
155221243|NCT00768300|560248777|FG001|Overall Study|Lost to Follow-up|1|||
155221244|NCT00768300|560248776|FG000|Overall Study|Began prohibited concomitant medication|0|||
155221245|NCT00768300|560248777|FG001|Overall Study|Began prohibited concomitant medication|1|||
155221246|NCT00768300|560248776|FG000|Overall Study|Treated but never dosed with Study drug|1|||
155221247|NCT00768300|560248777|FG001|Overall Study|Treated but never dosed with Study drug|0|||
155221248|NCT00768300|560248776|FG000|Overall Study|Missing data|1|||
155221249|NCT00768300|560248777|FG001|Overall Study|Missing data|0|||
155221250|NCT02068222|560248778|FG000|Overall Study|Lost to Follow-up|1|||
155221251|NCT00735878|560248779|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
155221252|NCT00735878|560248780|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
155221253|NCT00735878|560248781|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
155221254|NCT02867709|560248782|FG000|Treatment Period|Adverse Event|1|||
155221255|NCT02867709|560248783|FG001|Treatment Period|Adverse Event|1|||
155221256|NCT02867709|560248784|FG002|Treatment Period|Adverse Event|2|||
155221257|NCT02867709|560248782|FG000|Treatment Period|Withdrawal of Consent|7|||
155221258|NCT02867709|560248783|FG001|Treatment Period|Withdrawal of Consent|9|||
155221259|NCT02867709|560248784|FG002|Treatment Period|Withdrawal of Consent|8|||
155221260|NCT02867709|560248782|FG000|Treatment Period|Lost to Follow-up|17|||
155221261|NCT02867709|560248783|FG001|Treatment Period|Lost to Follow-up|20|||
155221262|NCT02867709|560248784|FG002|Treatment Period|Lost to Follow-up|20|||
155221263|NCT02867709|560248782|FG000|Treatment Period|Lack of Qualifying Event|42|||
155221264|NCT02867709|560248783|FG001|Treatment Period|Lack of Qualifying Event|55|||
155221265|NCT02867709|560248784|FG002|Treatment Period|Lack of Qualifying Event|42|||
155221266|NCT02867709|560248782|FG000|Treatment Period|Protocol Violation|3|||
155221267|NCT02867709|560248783|FG001|Treatment Period|Protocol Violation|2|||
155221268|NCT02867709|560248784|FG002|Treatment Period|Protocol Violation|3|||
155221269|NCT02867709|560248782|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
155221270|NCT02867709|560248783|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
155221271|NCT02867709|560248784|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
155221272|NCT02867709|560248782|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
155221273|NCT02867709|560248783|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
155221274|NCT02867709|560248784|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
155221275|NCT02867709|560248782|FG000|Safety Follow-up Period|Pregnancy|0|||
155221276|NCT02867709|560248783|FG001|Safety Follow-up Period|Pregnancy|1|||
155221277|NCT02867709|560248784|FG002|Safety Follow-up Period|Pregnancy|0|||
155221278|NCT02867709|560248782|FG000|Safety Follow-up Period|Protocol Violation|0|||
155221279|NCT02867709|560248783|FG001|Safety Follow-up Period|Protocol Violation|1|||
155221280|NCT02867709|560248784|FG002|Safety Follow-up Period|Protocol Violation|1|||
155221281|NCT03188094|560248790|FG000|Overall Study|Screen failure|1|||
155221282|NCT03188094|560248791|FG001|Overall Study|Screen failure|0|||
155221283|NCT03188094|560248792|FG002|Overall Study|Screen failure|0|||
155221284|NCT03188094|560248790|FG000|Overall Study|Pregnancy|3|||
155221285|NCT03188094|560248791|FG001|Overall Study|Pregnancy|0|||
155221286|NCT03188094|560248792|FG002|Overall Study|Pregnancy|0|||
155221287|NCT03188094|560248790|FG000|Overall Study|Ineligible|1|||
155221288|NCT03188094|560248791|FG001|Overall Study|Ineligible|0|||
155221289|NCT03188094|560248792|FG002|Overall Study|Ineligible|0|||
155221290|NCT03188094|560248790|FG000|Overall Study|Lost to Follow-up|0|||
155221291|NCT03188094|560248791|FG001|Overall Study|Lost to Follow-up|0|||
155221292|NCT03188094|560248792|FG002|Overall Study|Lost to Follow-up|17|||
155221293|NCT02946047|560248793|FG000|Overall Study|Adverse Event|1|||
155221294|NCT02946047|560248794|FG001|Overall Study|Adverse Event|0|||
155221295|NCT02946047|560248795|FG002|Overall Study|Adverse Event|0|||
155221296|NCT02946047|560248796|FG003|Overall Study|Adverse Event|0|||
155221297|NCT03615105|560248797|FG000|Overall Study|Protocol Violation|1|||
155221298|NCT03615105|560248798|FG001|Overall Study|Protocol Violation|0|||
155221299|NCT03615105|560248799|FG002|Overall Study|Protocol Violation|0|||
155221300|NCT03615105|560248797|FG000|Overall Study|Death|0|||
155221301|NCT03615105|560248798|FG001|Overall Study|Death|2|||
155221302|NCT03615105|560248799|FG002|Overall Study|Death|0|||
155221303|NCT05041322|560248800|FG000|Baseline|Withdrawal by Subject|1|||
155221304|NCT05041322|560248801|FG001|Baseline|Withdrawal by Subject|0|||
155221305|NCT05041322|560248800|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
155221306|NCT05041322|560248801|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
155221307|NCT05041322|560248800|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
155221308|NCT05041322|560248801|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
155221309|NCT04690751|560248803|FG000|Overall Study|Protocol Violation|0|||
155221310|NCT04690751|560248804|FG001|Overall Study|Protocol Violation|1|||
155221311|NCT04690751|560248805|FG002|Overall Study|Protocol Violation|0|||
155221312|NCT04690751|560248806|FG003|Overall Study|Protocol Violation|1|||
155221313|NCT04690751|560248807|FG004|Overall Study|Protocol Violation|2|||
155221314|NCT04690751|560248808|FG005|Overall Study|Protocol Violation|0|||
155221315|NCT04690751|560248803|FG000|Overall Study|Adverse Event|0|||
155221316|NCT04690751|560248804|FG001|Overall Study|Adverse Event|0|||
155221317|NCT04690751|560248805|FG002|Overall Study|Adverse Event|1|||
155221318|NCT04690751|560248806|FG003|Overall Study|Adverse Event|0|||
155221319|NCT04690751|560248807|FG004|Overall Study|Adverse Event|0|||
155221320|NCT04690751|560248808|FG005|Overall Study|Adverse Event|0|||
155221321|NCT04690751|560248803|FG000|Overall Study|Positive urine drug screen test|0|||
155221322|NCT04690751|560248804|FG001|Overall Study|Positive urine drug screen test|0|||
155221323|NCT04690751|560248805|FG002|Overall Study|Positive urine drug screen test|0|||
155221324|NCT04690751|560248806|FG003|Overall Study|Positive urine drug screen test|0|||
155221325|NCT04690751|560248807|FG004|Overall Study|Positive urine drug screen test|1|||
155221326|NCT04690751|560248808|FG005|Overall Study|Positive urine drug screen test|0|||
155221327|NCT01344161|560248809|FG000|Overall Study|Lost to Follow-up|4|||
155221328|NCT01344161|560248810|FG001|Overall Study|Lost to Follow-up|1|||
155221329|NCT01344161|560248809|FG000|Overall Study|Pregnancy|0|||
155221330|NCT01344161|560248810|FG001|Overall Study|Pregnancy|1|||
155221331|NCT01344161|560248809|FG000|Overall Study|Protocol Violation|1|||
155221332|NCT01344161|560248810|FG001|Overall Study|Protocol Violation|1|||
155221333|NCT04364620|560248811|FG000|Overall Study|Disease Progression|20|||
155221334|NCT04364620|560248811|FG000|Overall Study|Adverse Event|5|||
155221335|NCT04364620|560248811|FG000|Overall Study|Physician Decision|4|||
155221336|NCT04364620|560248811|FG000|Overall Study|Death|3|||
155221337|NCT04364620|560248811|FG000|Overall Study|Other|2|||
155221338|NCT04364620|560248811|FG000|Overall Study|Withdrawal by Subject|1|||
155221339|NCT01124604|560250340|FG000|Overall Study|Adverse Event|10|||
155221340|NCT01124604|560250341|FG001|Overall Study|Adverse Event|1|||
155221341|NCT01124604|560250340|FG000|Overall Study|Lack of Efficacy|1|||
155221342|NCT01124604|560250341|FG001|Overall Study|Lack of Efficacy|0|||
155221343|NCT01124604|560250340|FG000|Overall Study|Withdrawal by Subject|4|||
155221344|NCT01124604|560250341|FG001|Overall Study|Withdrawal by Subject|0|||
155221345|NCT01124604|560250340|FG000|Overall Study|Disease Progression|0|||
155221346|NCT01124604|560250341|FG001|Overall Study|Disease Progression|1|||
155221347|NCT00076011|560250342|FG000|Overall Study|Death|1|||
155221348|NCT00076011|560250342|FG000|Overall Study|Adverse Event|10|||
155221349|NCT00076011|560250342|FG000|Overall Study|Lack of Efficacy|25|||
155221350|NCT00076011|560250342|FG000|Overall Study|Withdrawal by Subject|1|||
155221351|NCT00076011|560250342|FG000|Overall Study|Study terminated by sponsor|3|||
155221352|NCT00076011|560250342|FG000|Overall Study|Other|11|||
155221353|NCT00076011|560250342|FG000|Overall Study|Ongoing|1|||
155221354|NCT06134817|560250343|FG000|Overall Study|Physician Departure - termination of study|1|||
155221355|NCT03406858|560250346|FG000|Overall Study|Failure to receive treatment drug.|1|||
155221356|NCT03406858|560250346|FG000|Overall Study|ineligible|1|||
155221357|NCT00405587|560250347|FG000|Overall Study|Death|0|||
155221358|NCT00405587|560250348|FG001|Overall Study|Death|0|||
155221359|NCT00405587|560250349|FG002|Overall Study|Death|0|||
155221360|NCT00405587|560250350|FG003|Overall Study|Death|1|||
155221361|NCT00405587|560250347|FG000|Overall Study|Disease Progression|22|||
155221362|NCT00405587|560250348|FG001|Overall Study|Disease Progression|23|||
155221363|NCT00405587|560250349|FG002|Overall Study|Disease Progression|21|||
155221364|NCT00405587|560250350|FG003|Overall Study|Disease Progression|17|||
155221365|NCT00405587|560250347|FG000|Overall Study|Physician Decision|3|||
155221366|NCT00405587|560250348|FG001|Overall Study|Physician Decision|2|||
155221367|NCT00405587|560250349|FG002|Overall Study|Physician Decision|0|||
155221368|NCT00405587|560250350|FG003|Overall Study|Physician Decision|0|||
155221369|NCT00405587|560250347|FG000|Overall Study|Adverse Event|1|||
155221370|NCT00405587|560250348|FG001|Overall Study|Adverse Event|0|||
155221371|NCT00405587|560250349|FG002|Overall Study|Adverse Event|0|||
155221372|NCT00405587|560250350|FG003|Overall Study|Adverse Event|0|||
155221373|NCT00405587|560250347|FG000|Overall Study|Lost to Follow-up|0|||
155221374|NCT00405587|560250348|FG001|Overall Study|Lost to Follow-up|1|||
155221375|NCT00405587|560250349|FG002|Overall Study|Lost to Follow-up|1|||
155221376|NCT00405587|560250350|FG003|Overall Study|Lost to Follow-up|0|||
155221377|NCT00405587|560250347|FG000|Overall Study|Radiation induced necrosis|0|||
155221378|NCT00405587|560250348|FG001|Overall Study|Radiation induced necrosis|1|||
155221379|NCT00405587|560250349|FG002|Overall Study|Radiation induced necrosis|0|||
155221380|NCT00405587|560250350|FG003|Overall Study|Radiation induced necrosis|0|||
155221381|NCT00405587|560250347|FG000|Overall Study|Withdrawal by Subject|0|||
155221382|NCT00405587|560250348|FG001|Overall Study|Withdrawal by Subject|0|||
155221383|NCT00405587|560250349|FG002|Overall Study|Withdrawal by Subject|0|||
155221384|NCT00405587|560250350|FG003|Overall Study|Withdrawal by Subject|2|||
155221385|NCT00405587|560250347|FG000|Overall Study|Participant not dosed|0|||
155221386|NCT00405587|560250348|FG001|Overall Study|Participant not dosed|1|||
155221387|NCT00405587|560250349|FG002|Overall Study|Participant not dosed|0|||
155221388|NCT00405587|560250350|FG003|Overall Study|Participant not dosed|0|||
155221389|NCT06027866|560250351|FG000|Overall Study|Withdrawal by Subject|2|||
155221390|NCT00930579|560250354|FG000|Overall Study|Withdrawal by Subject|1|||
155221391|NCT00930579|560250354|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
155221392|NCT02672423|560250355|FG000|Period 1|Adverse Event|0|||
155221393|NCT02672423|560250356|FG001|Period 1|Adverse Event|0|||
155221394|NCT02672423|560250357|FG002|Period 1|Adverse Event|0|||
155221395|NCT02672423|560250358|FG003|Period 1|Adverse Event|0|||
155221396|NCT02672423|560250359|FG004|Period 1|Adverse Event|1|||
155221397|NCT02672423|560250360|FG005|Period 1|Adverse Event|0|||
155221398|NCT02672423|560250361|FG006|Period 1|Adverse Event|0|||
155221399|NCT02672423|560250362|FG007|Period 1|Adverse Event|0|||
155221400|NCT02672423|560250363|FG008|Period 1|Adverse Event|0|||
155221401|NCT02672423|560250364|FG009|Period 1|Adverse Event|0|||
155221402|NCT02672423|560250355|FG000|Period 2|Withdrawal by Subject|0|||
155221403|NCT02672423|560250356|FG001|Period 2|Withdrawal by Subject|0|||
155221404|NCT02672423|560250357|FG002|Period 2|Withdrawal by Subject|1|||
155221405|NCT02672423|560250358|FG003|Period 2|Withdrawal by Subject|0|||
155221406|NCT02672423|560250359|FG004|Period 2|Withdrawal by Subject|0|||
155221407|NCT02672423|560250360|FG005|Period 2|Withdrawal by Subject|0|||
155221408|NCT02672423|560250361|FG006|Period 2|Withdrawal by Subject|0|||
155221409|NCT02672423|560250362|FG007|Period 2|Withdrawal by Subject|0|||
155221410|NCT02672423|560250363|FG008|Period 2|Withdrawal by Subject|0|||
155221411|NCT02672423|560250364|FG009|Period 2|Withdrawal by Subject|0|||
155221412|NCT02672423|560250355|FG000|Period 3|Withdrawal by Subject|0|||
155221413|NCT02672423|560250356|FG001|Period 3|Withdrawal by Subject|0|||
155221414|NCT02672423|560250357|FG002|Period 3|Withdrawal by Subject|0|||
155221415|NCT02672423|560250358|FG003|Period 3|Withdrawal by Subject|0|||
155221416|NCT02672423|560250359|FG004|Period 3|Withdrawal by Subject|0|||
155221417|NCT02672423|560250360|FG005|Period 3|Withdrawal by Subject|0|||
155221418|NCT02672423|560250361|FG006|Period 3|Withdrawal by Subject|0|||
155221419|NCT02672423|560250362|FG007|Period 3|Withdrawal by Subject|1|||
155221420|NCT02672423|560250363|FG008|Period 3|Withdrawal by Subject|0|||
155221421|NCT02672423|560250364|FG009|Period 3|Withdrawal by Subject|0|||
155221422|NCT02672423|560250355|FG000|Period 3|Physician Decision|0|||
155221423|NCT02672423|560250356|FG001|Period 3|Physician Decision|0|||
155221424|NCT02672423|560250357|FG002|Period 3|Physician Decision|0|||
155221425|NCT02672423|560250358|FG003|Period 3|Physician Decision|0|||
155221426|NCT02672423|560250359|FG004|Period 3|Physician Decision|0|||
155221427|NCT02672423|560250360|FG005|Period 3|Physician Decision|1|||
155221428|NCT02672423|560250361|FG006|Period 3|Physician Decision|0|||
155221429|NCT02672423|560250362|FG007|Period 3|Physician Decision|0|||
155221430|NCT02672423|560250363|FG008|Period 3|Physician Decision|0|||
155221431|NCT02672423|560250364|FG009|Period 3|Physician Decision|0|||
155221432|NCT01046682|560250369|FG000|Overall Study|Adverse Event|2|||
155221433|NCT01046682|560250370|FG001|Overall Study|Adverse Event|0|||
155221434|NCT05071183|560250371|FG000|Overall Study|Death|1|||
155221435|NCT05071183|560250372|FG001|Overall Study|Death|2|||
155221436|NCT05071183|560250373|FG002|Overall Study|Death|0|||
155221437|NCT05071183|560250371|FG000|Overall Study|Other Reasons|1|||
155221438|NCT05071183|560250372|FG001|Overall Study|Other Reasons|3|||
155221439|NCT05071183|560250373|FG002|Overall Study|Other Reasons|2|||
155221440|NCT02046148|560250374|FG000|Overall Study|Lost to Follow-up|1|||
155221441|NCT02046148|560250375|FG001|Overall Study|Lost to Follow-up|1|||
155221442|NCT02046148|560250374|FG000|Overall Study|Withdrawal by Subject|0|||
155221443|NCT02046148|560250375|FG001|Overall Study|Withdrawal by Subject|2|||
155221444|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
155221445|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
155221446|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
155221447|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
155221448|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
155221449|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
155221450|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
155221451|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
155221452|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
155221453|NCT00885755|560250383|FG000|Part I: Trastuzumab+Taxane|Death|0|||
155221454|NCT00885755|560250384|FG001|Part I: Trastuzumab+Taxane|Death|0|||
155221455|NCT00885755|560250385|FG002|Part I: Trastuzumab+Taxane|Death|1|||
155221456|NCT00885755|560250383|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
155221457|NCT00885755|560250384|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
155221458|NCT00885755|560250385|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
155221459|NCT02939560|560250390|FG000|Overall Study|Withdrawal by Subject|2|||
155221460|NCT02939560|560250390|FG000|Overall Study|Protocol Violation|1|||
155221461|NCT03340025|560250393|FG000|Overall Study|Lost to Follow-up|2|||
155221462|NCT03340025|560250394|FG001|Overall Study|Lost to Follow-up|2|||
155221463|NCT02420691|560250395|FG000|Overall Study|Adverse Event|3|||
155221464|NCT02420691|560250395|FG000|Overall Study|Withdrawal by Subject|3|||
155221465|NCT00325754|560250396|FG000|Overall Study|Adverse Event|4|||
155221466|NCT00325754|560250397|FG001|Overall Study|Adverse Event|1|||
155221467|NCT01752855|560250407|FG000|Overall Study|Adverse Event|1|||
155221468|NCT01752855|560250408|FG001|Overall Study|Adverse Event|0|||
155221469|NCT01752855|560250407|FG000|Overall Study|Withdrew Consent|0|||
155221470|NCT01752855|560250408|FG001|Overall Study|Withdrew Consent|2|||
155221471|NCT01752855|560250407|FG000|Overall Study|Lack of Efficacy|0|||
155221472|NCT01752855|560250408|FG001|Overall Study|Lack of Efficacy|2|||
155221473|NCT02625090|560250409|FG000|Overall Study|Participant wants to be pregnant|2|||
155221474|NCT02625090|560250409|FG000|Overall Study|For the Promoter|1|||
155221475|NCT02625090|560250409|FG000|Overall Study|Sponsor's Decision|9|||
155221476|NCT02625090|560250409|FG000|Overall Study|Somnolence|1|||
155221477|NCT02625090|560250409|FG000|Overall Study|Study terminated by Sponsor|7|||
155221478|NCT02625090|560250409|FG000|Overall Study|Negative Benefit/Risk|1|||
155221479|NCT02625090|560250409|FG000|Overall Study|Protocol Deviation|2|||
155221480|NCT02625090|560250409|FG000|Overall Study|Lack of Efficacy|16|||
155221481|NCT02625090|560250409|FG000|Overall Study|Adverse Event|3|||
155221482|NCT02250443|560250410|FG000|Overall Study|Administrative problems|7|||
155221483|NCT02250443|560250410|FG000|Overall Study|Adverse Event|3|||
155221484|NCT03168464|560250411|FG000|Overall Study|Death|9|||
155221485|NCT03168464|560250411|FG000|Overall Study|Progression of disease|6|||
155221486|NCT01549964|560250414|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
155221487|NCT01549964|560250415|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
155221488|NCT01549964|560250416|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
155221489|NCT01549964|560250417|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
155221490|NCT01549964|560250414|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
155221491|NCT01549964|560250415|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
155221492|NCT01549964|560250416|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
155221493|NCT01549964|560250417|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
155221494|NCT01549964|560250414|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
155221495|NCT01549964|560250415|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
155221496|NCT01549964|560250416|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
155221497|NCT01549964|560250417|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
155221498|NCT01549964|560250414|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
155221499|NCT01549964|560250415|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
155221500|NCT01549964|560250416|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
155221501|NCT01549964|560250417|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
155221502|NCT01549964|560250414|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
155221503|NCT01549964|560250415|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
155221504|NCT01549964|560250416|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
155221505|NCT01549964|560250417|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
155221506|NCT01549964|560250414|FG000|24-Week Treatment Period|Other|1|||
155221507|NCT01549964|560250415|FG001|24-Week Treatment Period|Other|0|||
155221508|NCT01549964|560250416|FG002|24-Week Treatment Period|Other|1|||
155221509|NCT01549964|560250417|FG003|24-Week Treatment Period|Other|0|||
155221510|NCT01549964|560250414|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
155221511|NCT01549964|560250415|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
155221512|NCT01549964|560250416|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
155221513|NCT01549964|560250417|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
155221514|NCT01549964|560250414|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
155221515|NCT01549964|560250415|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
155221516|NCT01549964|560250416|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
155221517|NCT01549964|560250417|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
155221518|NCT01549964|560250414|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
155221519|NCT01549964|560250415|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
155221520|NCT01549964|560250416|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
155221521|NCT01549964|560250417|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
155221522|NCT01549964|560250414|FG000|80-Week Extension Period|Pregnancy|0|||
155221523|NCT01549964|560250415|FG001|80-Week Extension Period|Pregnancy|0|||
155221524|NCT01549964|560250416|FG002|80-Week Extension Period|Pregnancy|1|||
155221525|NCT01549964|560250417|FG003|80-Week Extension Period|Pregnancy|0|||
155221526|NCT01549964|560250414|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
155221527|NCT01549964|560250415|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
155221528|NCT01549964|560250416|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
155221529|NCT01549964|560250417|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
155221530|NCT01549964|560250414|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
155221531|NCT01549964|560250415|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
155221532|NCT01549964|560250416|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
155221533|NCT01549964|560250417|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
155221534|NCT01549964|560250414|FG000|80-Week Extension Period|Lost to Follow-up|1|||
155221535|NCT01549964|560250415|FG001|80-Week Extension Period|Lost to Follow-up|0|||
155221536|NCT01549964|560250416|FG002|80-Week Extension Period|Lost to Follow-up|2|||
155221537|NCT01549964|560250417|FG003|80-Week Extension Period|Lost to Follow-up|1|||
155221538|NCT01549964|560250414|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
155221539|NCT01549964|560250415|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
155221540|NCT01549964|560250416|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
155221541|NCT01549964|560250417|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
155221542|NCT00634088|560250418|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
155221543|NCT00634088|560250419|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
155221544|NCT00634088|560250420|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
155221545|NCT00634088|560250421|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
155221546|NCT00634088|560250418|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
155221547|NCT00634088|560250419|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
155221548|NCT00634088|560250420|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
155221549|NCT00634088|560250421|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
155221550|NCT00634088|560250418|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
155221551|NCT00634088|560250419|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
155221552|NCT00634088|560250420|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
155221553|NCT00634088|560250421|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
155221554|NCT00634088|560250418|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
155221555|NCT00634088|560250419|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
155221556|NCT00634088|560250420|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
155221557|NCT00634088|560250421|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
155221558|NCT00634088|560250418|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
155221559|NCT00634088|560250419|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
155221560|NCT00634088|560250420|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
155221561|NCT00634088|560250421|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
155221562|NCT00634088|560250418|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
155221563|NCT00634088|560250419|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
155221564|NCT00634088|560250420|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
155221565|NCT00634088|560250421|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
155221566|NCT02290821|560250424|FG000|Overall Study|Withdrawal by Subject|1|||
155221567|NCT02290821|560250425|FG001|Overall Study|Withdrawal by Subject|1|||
155221568|NCT02290821|560250424|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
155221569|NCT02290821|560250425|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
155221570|NCT02290821|560250424|FG000|Overall Study|Lost to Follow-up|3|||
155221571|NCT02290821|560250425|FG001|Overall Study|Lost to Follow-up|2|||
155221572|NCT02439320|560250430|FG000|Overall Study|Adverse Event|0|||
155221573|NCT02439320|560250431|FG001|Overall Study|Adverse Event|2|||
155221574|NCT02439320|560250432|FG002|Overall Study|Adverse Event|0|||
155221575|NCT02439320|560250430|FG000|Overall Study|Lost to Follow-up|37|||
155221576|NCT02439320|560250431|FG001|Overall Study|Lost to Follow-up|34|||
155221577|NCT02439320|560250432|FG002|Overall Study|Lost to Follow-up|42|||
155221578|NCT02439320|560250430|FG000|Overall Study|Death|0|||
155221579|NCT02439320|560250431|FG001|Overall Study|Death|1|||
155221580|NCT02439320|560250432|FG002|Overall Study|Death|0|||
155221581|NCT02439320|560250430|FG000|Overall Study|Noncompliance with Protocol|10|||
155221582|NCT02439320|560250431|FG001|Overall Study|Noncompliance with Protocol|11|||
155221583|NCT02439320|560250432|FG002|Overall Study|Noncompliance with Protocol|7|||
155221584|NCT02439320|560250430|FG000|Overall Study|Pregnancy|0|||
155221585|NCT02439320|560250431|FG001|Overall Study|Pregnancy|1|||
155221586|NCT02439320|560250432|FG002|Overall Study|Pregnancy|1|||
155221587|NCT02439320|560250430|FG000|Overall Study|Withdrawal by Subject|12|||
155221588|NCT02439320|560250431|FG001|Overall Study|Withdrawal by Subject|16|||
155221589|NCT02439320|560250432|FG002|Overall Study|Withdrawal by Subject|14|||
155221590|NCT02439320|560250430|FG000|Overall Study|Physician Decision|2|||
155221591|NCT02439320|560250431|FG001|Overall Study|Physician Decision|1|||
155221592|NCT02439320|560250432|FG002|Overall Study|Physician Decision|0|||
155221593|NCT02439320|560250430|FG000|Overall Study|Sponsor Request|0|||
155221594|NCT02439320|560250431|FG001|Overall Study|Sponsor Request|2|||
155221595|NCT02439320|560250432|FG002|Overall Study|Sponsor Request|1|||
155221596|NCT02439320|560250430|FG000|Overall Study|Randomization Failure|35|||
155221597|NCT02439320|560250431|FG001|Overall Study|Randomization Failure|46|||
155221598|NCT02439320|560250432|FG002|Overall Study|Randomization Failure|34|||
155221599|NCT01520363|560250437|FG000|Overall Study|Withdrawal by Subject|2|||
155221600|NCT01520363|560250438|FG001|Overall Study|Withdrawal by Subject|0|||
155221601|NCT04191382|560250443|FG000|Overall Study|Withdrawal by Subject|1|||
155221602|NCT04191382|560250444|FG001|Overall Study|Withdrawal by Subject|0|||
155221603|NCT04191382|560250445|FG002|Overall Study|Withdrawal by Subject|0|||
155221604|NCT00878709|560250450|FG000|Overall Study|Withdrawal by Subject|197|||
155221605|NCT00878709|560250451|FG001|Overall Study|Withdrawal by Subject|120|||
155221606|NCT00878709|560250450|FG000|Overall Study|Lost to Follow-up|35|||
155221607|NCT00878709|560250451|FG001|Overall Study|Lost to Follow-up|33|||
155221608|NCT00878709|560250450|FG000|Overall Study|Other Reasons|93|||
155221609|NCT00878709|560250451|FG001|Overall Study|Other Reasons|84|||
155221610|NCT02225743|560250452|FG000|Overall Study|Withdrawal by Subject|18|||
155221611|NCT00322842|560250455|FG000|Overall Study|Withdrawal by Subject|0|||
155221612|NCT00322842|560250456|FG001|Overall Study|Withdrawal by Subject|1|||
155221613|NCT00322842|560250455|FG000|Overall Study|Lost to Follow-up|0|||
155221614|NCT00322842|560250456|FG001|Overall Study|Lost to Follow-up|1|||
155221615|NCT00322842|560250455|FG000|Overall Study|Refused transplant|1|||
155221616|NCT00322842|560250456|FG001|Overall Study|Refused transplant|0|||
155221617|NCT00322842|560250455|FG000|Overall Study|Death|1|||
155221618|NCT00322842|560250456|FG001|Overall Study|Death|0|||
155221619|NCT00323492|560250457|FG000|Study Phase 1|Adverse Event|2|||
155221620|NCT00323492|560250458|FG001|Study Phase 1|Adverse Event|0|||
155221621|NCT00323492|560250459|FG002|Study Phase 1|Adverse Event|0|||
155221622|NCT00323492|560250457|FG000|Study Phase 2|Adverse Event|1|||
155221623|NCT00323492|560250458|FG001|Study Phase 2|Adverse Event|0|||
155221624|NCT00323492|560250459|FG002|Study Phase 2|Adverse Event|0|||
155221625|NCT00323492|560250457|FG000|Study Phase 2|Physician Decision|1|||
155221626|NCT00323492|560250458|FG001|Study Phase 2|Physician Decision|0|||
155221627|NCT00323492|560250459|FG002|Study Phase 2|Physician Decision|0|||
155221628|NCT00323492|560250457|FG000|Study Phase 2|Lost to Follow-up|1|||
155221629|NCT00323492|560250458|FG001|Study Phase 2|Lost to Follow-up|0|||
155221630|NCT00323492|560250459|FG002|Study Phase 2|Lost to Follow-up|0|||
155221631|NCT00323492|560250457|FG000|Study Phase 2|Withdrawal by Subject|0|||
155221632|NCT00323492|560250458|FG001|Study Phase 2|Withdrawal by Subject|1|||
155221633|NCT00323492|560250459|FG002|Study Phase 2|Withdrawal by Subject|0|||
155221634|NCT00323492|560250457|FG000|Study Phase 2|Noncompliance with study schedule|0|||
155221635|NCT00323492|560250458|FG001|Study Phase 2|Noncompliance with study schedule|0|||
155221636|NCT00323492|560250459|FG002|Study Phase 2|Noncompliance with study schedule|1|||
155221637|NCT00323492|560250457|FG000|Study Phase 2|Protocol Violation|1|||
155221638|NCT00323492|560250458|FG001|Study Phase 2|Protocol Violation|0|||
155221639|NCT00323492|560250459|FG002|Study Phase 2|Protocol Violation|0|||
155221640|NCT02486042|560250460|FG000|Overall Study|Physician Decision|1|||
155221641|NCT02486042|560250461|FG001|Overall Study|Physician Decision|7|||
155221642|NCT02486042|560250460|FG000|Overall Study|Hospital transfer|2|||
155221643|NCT02486042|560250461|FG001|Overall Study|Hospital transfer|2|||
155221644|NCT02486042|560250460|FG000|Overall Study|Withdrawal by Subject|0|||
155221645|NCT02486042|560250461|FG001|Overall Study|Withdrawal by Subject|2|||
155221646|NCT00281684|560250475|FG000|Overall Study|Lost to Follow-up|0|||
155221647|NCT00281684|560250476|FG001|Overall Study|Lost to Follow-up|0|||
155221648|NCT00281684|560250477|FG002|Overall Study|Lost to Follow-up|1|||
155221649|NCT00281684|560250478|FG003|Overall Study|Lost to Follow-up|0|||
155221650|NCT00281684|560250475|FG000|Overall Study|Withdrawal by Subject|1|||
155221651|NCT00281684|560250476|FG001|Overall Study|Withdrawal by Subject|0|||
155221652|NCT00281684|560250477|FG002|Overall Study|Withdrawal by Subject|0|||
155221653|NCT00281684|560250478|FG003|Overall Study|Withdrawal by Subject|0|||
155221654|NCT03979638|560250479|FG000|Period 1|Physician Decision|1|||
155221655|NCT03979638|560250480|FG001|Period 1|Physician Decision|1|||
155221656|NCT03979638|560250479|FG000|Period 1|Withdrawal by Subject|4|||
155221657|NCT03979638|560250480|FG001|Period 1|Withdrawal by Subject|3|||
155221658|NCT03979638|560250479|FG000|Period 1|Study terminated by Sponsor|1|||
155221659|NCT03979638|560250480|FG001|Period 1|Study terminated by Sponsor|3|||
155221660|NCT03979638|560250479|FG000|Period 1|Protocol Violation|1|||
155221661|NCT03979638|560250480|FG001|Period 1|Protocol Violation|0|||
155221662|NCT03979638|560250479|FG000|Period 2|Study terminated by Sponsor|1|||
155221663|NCT03979638|560250480|FG001|Period 2|Study terminated by Sponsor|1|||
155221664|NCT00578942|560250483|FG000|Overall Study|Lost to Follow-up|1|||
155221665|NCT03200899|560250484|FG000|Overall Study|Lost to Follow-up|10|||
155221666|NCT03200899|560250485|FG001|Overall Study|Lost to Follow-up|23|||
155221667|NCT01400516|560250494|FG000|Primary Trial|Withdrawal by Subject|0|||
155221668|NCT01400516|560250495|FG001|Primary Trial|Withdrawal by Subject|2|||
155221669|NCT00549562|560250496|FG000|Overall Study|Adverse Event|1|||
155221670|NCT00549562|560250496|FG000|Overall Study|Lack of Efficacy|1|||
155221671|NCT00699972|560252078|FG000|Overall Study|Adverse Event|7|||
155221672|NCT00699972|560252079|FG001|Overall Study|Adverse Event|9|||
155221673|NCT00699972|560252080|FG002|Overall Study|Adverse Event|24|||
155221674|NCT00699972|560252078|FG000|Overall Study|Lost to Follow-up|0|||
155221675|NCT00699972|560252079|FG001|Overall Study|Lost to Follow-up|2|||
155221676|NCT00699972|560252080|FG002|Overall Study|Lost to Follow-up|0|||
155221677|NCT00699972|560252078|FG000|Overall Study|Withdrawal by Subject|3|||
155221678|NCT00699972|560252079|FG001|Overall Study|Withdrawal by Subject|7|||
155221679|NCT00699972|560252080|FG002|Overall Study|Withdrawal by Subject|4|||
155221680|NCT00699972|560252078|FG000|Overall Study|Lack of Efficacy|2|||
155221681|NCT00699972|560252079|FG001|Overall Study|Lack of Efficacy|0|||
155221682|NCT00699972|560252080|FG002|Overall Study|Lack of Efficacy|2|||
155221683|NCT00699972|560252078|FG000|Overall Study|Administrative/Other|3|||
155221684|NCT00699972|560252079|FG001|Overall Study|Administrative/Other|1|||
155221685|NCT00699972|560252080|FG002|Overall Study|Administrative/Other|4|||
155221686|NCT00699972|560252078|FG000|Overall Study|Randomized, Not Treated|1|||
155221687|NCT00699972|560252079|FG001|Overall Study|Randomized, Not Treated|0|||
155221688|NCT00699972|560252080|FG002|Overall Study|Randomized, Not Treated|1|||
155221689|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
155221690|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
155221691|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
155221692|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
155221693|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
155221694|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
155221695|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
155221696|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
155221697|NCT01541969|560252090|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
155221698|NCT01541969|560252091|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
155221699|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
155221700|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
155221701|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
155221702|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
155221703|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
155221704|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
155221705|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
155221706|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
155221707|NCT01541969|560252090|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
155221708|NCT01541969|560252091|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
155221709|NCT01365507|560252092|FG000|Overall Study|Withdrawal Criteria|8|||
155221710|NCT01365507|560252093|FG001|Overall Study|Withdrawal Criteria|5|||
155221711|NCT01365507|560252092|FG000|Overall Study|Unclassified|1|||
155221712|NCT01365507|560252093|FG001|Overall Study|Unclassified|4|||
155221713|NCT02255500|560252096|FG000|Overall Study|Withdrawal by Subject|1|||
155221714|NCT02255500|560252097|FG001|Overall Study|Withdrawal by Subject|0|||
155221715|NCT01012622|560252098|FG000|Overall Study|Withdrawal by Subject|6|||
155221716|NCT01012622|560252098|FG000|Overall Study|Lost to Follow-up|5|||
155221717|NCT01012622|560252098|FG000|Overall Study|Adverse Event|7|||
155221718|NCT01012622|560252098|FG000|Overall Study|non-compliance with the drug|9|||
155221719|NCT01012622|560252098|FG000|Overall Study|Other|1|||
155221720|NCT01012622|560252098|FG000|Overall Study|screening failure|1|||
155221721|NCT01012622|560252098|FG000|Overall Study|withdrawal of consent by a parent|2|||
155221722|NCT04254978|560252101|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
155221723|NCT04254978|560252101|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
155221724|NCT04254978|560252101|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
155221725|NCT04254978|560252101|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
155221726|NCT04254978|560252101|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
155221727|NCT04254978|560252101|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
155221728|NCT03257631|560252102|FG000|Overall Study|Death|1|||
155221729|NCT03257631|560252103|FG001|Overall Study|Death|0|||
155221730|NCT03257631|560252104|FG002|Overall Study|Death|1|||
155221731|NCT03257631|560252105|FG003|Overall Study|Death|1|||
155221732|NCT03257631|560252102|FG000|Overall Study|Progressive Disease|10|||
155221733|NCT03257631|560252103|FG001|Overall Study|Progressive Disease|9|||
155221734|NCT03257631|560252104|FG002|Overall Study|Progressive Disease|17|||
155221735|NCT03257631|560252105|FG003|Overall Study|Progressive Disease|8|||
155221736|NCT03257631|560252102|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155221737|NCT03257631|560252103|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155221738|NCT03257631|560252104|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
155221739|NCT03257631|560252105|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
155221740|NCT03257631|560252102|FG000|Overall Study|Adverse Event|0|||
155221741|NCT03257631|560252103|FG001|Overall Study|Adverse Event|0|||
155221742|NCT03257631|560252104|FG002|Overall Study|Adverse Event|2|||
155221743|NCT03257631|560252105|FG003|Overall Study|Adverse Event|0|||
155221744|NCT03509675|560252109|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
155221745|NCT03509675|560252110|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
155221746|NCT03509675|560252109|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
155221747|NCT03509675|560252110|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
155221748|NCT03509675|560252109|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
155221749|NCT03509675|560252110|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
155221750|NCT03509675|560252109|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
155221751|NCT03509675|560252110|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
155221752|NCT00902564|560252111|FG000|Overall Study|Withdrawal by Subject|2|||
155221753|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
155221754|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
155221755|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
155221756|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
155221757|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
155221758|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
155221759|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
155221760|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
155221761|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
155221762|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
155221763|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
155221764|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
155221765|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
155221766|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
155221767|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
155221768|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
155221769|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
155221770|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
155221771|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
155221772|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
155221773|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
155221774|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
155221775|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
155221776|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
155221777|NCT00277212|560252112|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
155221778|NCT00277212|560252113|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
155221779|NCT00277212|560252114|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
155221780|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
155221781|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
155221782|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
155221783|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
155221784|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
155221785|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
155221786|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
155221787|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
155221788|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
155221789|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
155221790|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
155221791|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
155221792|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
155221793|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
155221794|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
155221795|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
155221796|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
155221797|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
155221798|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
155221799|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
155221800|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
155221801|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
155221802|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
155221803|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
155221804|NCT00277212|560252112|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
155221805|NCT00277212|560252113|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
155221806|NCT00277212|560252114|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
155221807|NCT03336216|560252117|FG000|Randomization|Not reported|2|||
155221808|NCT03336216|560252118|FG001|Randomization|Not reported|0|||
155221809|NCT03336216|560252119|FG002|Randomization|Not reported|1|||
155221810|NCT03336216|560252120|FG003|Randomization|Not reported|0|||
155221811|NCT03336216|560252117|FG000|Randomization|Other reasons|1|||
155221812|NCT03336216|560252118|FG001|Randomization|Other reasons|1|||
155221813|NCT03336216|560252119|FG002|Randomization|Other reasons|1|||
155221814|NCT03336216|560252120|FG003|Randomization|Other reasons|0|||
155221815|NCT03336216|560252117|FG000|Randomization|Participant no longer meets study criteria|0|||
155221816|NCT03336216|560252118|FG001|Randomization|Participant no longer meets study criteria|2|||
155221817|NCT03336216|560252119|FG002|Randomization|Participant no longer meets study criteria|4|||
155221818|NCT03336216|560252120|FG003|Randomization|Participant no longer meets study criteria|1|||
155221819|NCT03336216|560252117|FG000|Randomization|Lost to Follow-up|1|||
155221820|NCT03336216|560252118|FG001|Randomization|Lost to Follow-up|0|||
155221821|NCT03336216|560252119|FG002|Randomization|Lost to Follow-up|0|||
155221822|NCT03336216|560252120|FG003|Randomization|Lost to Follow-up|0|||
155221823|NCT03336216|560252117|FG000|Randomization|Participant withdrew consent|9|||
155221824|NCT03336216|560252118|FG001|Randomization|Participant withdrew consent|1|||
155221825|NCT03336216|560252119|FG002|Randomization|Participant withdrew consent|0|||
155221826|NCT03336216|560252120|FG003|Randomization|Participant withdrew consent|0|||
155221827|NCT03336216|560252117|FG000|Randomization|Adverse Event|1|||
155221828|NCT03336216|560252118|FG001|Randomization|Adverse Event|1|||
155221829|NCT03336216|560252119|FG002|Randomization|Adverse Event|0|||
155221830|NCT03336216|560252120|FG003|Randomization|Adverse Event|0|||
155221831|NCT03336216|560252117|FG000|Treatment|Adverse Event|2|||
155221832|NCT03336216|560252118|FG001|Treatment|Adverse Event|3|||
155221833|NCT03336216|560252119|FG002|Treatment|Adverse Event|4|||
155221834|NCT03336216|560252120|FG003|Treatment|Adverse Event|4|||
155221835|NCT03336216|560252117|FG000|Treatment|Participant request to discontinue treatment|2|||
155221836|NCT03336216|560252118|FG001|Treatment|Participant request to discontinue treatment|1|||
155221837|NCT03336216|560252119|FG002|Treatment|Participant request to discontinue treatment|2|||
155221838|NCT03336216|560252120|FG003|Treatment|Participant request to discontinue treatment|2|||
155221839|NCT03336216|560252117|FG000|Treatment|Participant withdrew consent|7|||
155221840|NCT03336216|560252118|FG001|Treatment|Participant withdrew consent|2|||
155221841|NCT03336216|560252119|FG002|Treatment|Participant withdrew consent|3|||
155221842|NCT03336216|560252120|FG003|Treatment|Participant withdrew consent|2|||
155221843|NCT03336216|560252117|FG000|Treatment|Death|2|||
155221844|NCT03336216|560252118|FG001|Treatment|Death|3|||
155221845|NCT03336216|560252119|FG002|Treatment|Death|3|||
155221846|NCT03336216|560252120|FG003|Treatment|Death|4|||
155221847|NCT03336216|560252117|FG000|Treatment|Participant no longer meets study criteria|0|||
155221848|NCT03336216|560252118|FG001|Treatment|Participant no longer meets study criteria|1|||
155221849|NCT03336216|560252119|FG002|Treatment|Participant no longer meets study criteria|0|||
155221850|NCT03336216|560252120|FG003|Treatment|Participant no longer meets study criteria|0|||
155221851|NCT03336216|560252117|FG000|Treatment|Other reasons|2|||
155221852|NCT03336216|560252118|FG001|Treatment|Other reasons|0|||
155221853|NCT03336216|560252119|FG002|Treatment|Other reasons|0|||
155221854|NCT03336216|560252120|FG003|Treatment|Other reasons|3|||
155221855|NCT03336216|560252117|FG000|Treatment|Disease progression|23|||
155221856|NCT03336216|560252118|FG001|Treatment|Disease progression|34|||
155221857|NCT03336216|560252119|FG002|Treatment|Disease progression|33|||
155221858|NCT03336216|560252120|FG003|Treatment|Disease progression|26|||
155221859|NCT03336216|560252117|FG000|Treatment|Study drug toxicity|0|||
155221860|NCT03336216|560252118|FG001|Treatment|Study drug toxicity|3|||
155221861|NCT03336216|560252119|FG002|Treatment|Study drug toxicity|2|||
155221862|NCT03336216|560252120|FG003|Treatment|Study drug toxicity|0|||
155221863|NCT03336216|560252117|FG000|Treatment|Adverse Event unrelated to study drug|1|||
155221864|NCT03336216|560252118|FG001|Treatment|Adverse Event unrelated to study drug|1|||
155221865|NCT03336216|560252119|FG002|Treatment|Adverse Event unrelated to study drug|1|||
155221866|NCT03336216|560252120|FG003|Treatment|Adverse Event unrelated to study drug|0|||
155221867|NCT03336216|560252117|FG000|Treatment|Disease Recurrence|1|||
155221868|NCT03336216|560252118|FG001|Treatment|Disease Recurrence|0|||
155221869|NCT03336216|560252119|FG002|Treatment|Disease Recurrence|0|||
155221870|NCT03336216|560252120|FG003|Treatment|Disease Recurrence|0|||
155221871|NCT05620576|560252121|FG000|Overall Study|Adverse Event|1|||
155221872|NCT05620576|560252122|FG001|Overall Study|Adverse Event|1|||
155221873|NCT05620576|560252121|FG000|Overall Study|Lost to Follow-up|3|||
155221874|NCT05620576|560252122|FG001|Overall Study|Lost to Follow-up|1|||
155221875|NCT05620576|560252121|FG000|Overall Study|Physician Decision|0|||
155221876|NCT05620576|560252122|FG001|Overall Study|Physician Decision|1|||
155221877|NCT05620576|560252121|FG000|Overall Study|Protocol Deviation|1|||
155221878|NCT05620576|560252122|FG001|Overall Study|Protocol Deviation|1|||
155221879|NCT05620576|560252121|FG000|Overall Study|Withdrawal by Subject|2|||
155221880|NCT05620576|560252122|FG001|Overall Study|Withdrawal by Subject|3|||
155221881|NCT00922766|560252125|FG000|Overall Study|Death|3|||
155221882|NCT00922766|560252125|FG000|Overall Study|Withdrawal by Subject|2|||
155221883|NCT00922766|560252125|FG000|Overall Study|Other|1|||
155221884|NCT00922766|560252125|FG000|Overall Study|Adverse Event|1|||
155221885|NCT02622828|560252126|FG000|Overall Study|participant withdrew|3|||
155221886|NCT01231581|560252132|FG000|Overall Study|Lost to Follow-up|2|||
155221887|NCT01231581|560252133|FG001|Overall Study|Lost to Follow-up|2|||
155221888|NCT01231581|560252132|FG000|Overall Study|Withdrawal by Subject|6|||
155221889|NCT01231581|560252133|FG001|Overall Study|Withdrawal by Subject|9|||
155221890|NCT01231581|560252132|FG000|Overall Study|Study Closed/Terminated|6|||
155221891|NCT01231581|560252133|FG001|Overall Study|Study Closed/Terminated|5|||
155221892|NCT01231581|560252132|FG000|Overall Study|Death|65|||
155221893|NCT01231581|560252133|FG001|Overall Study|Death|64|||
155221894|NCT01231581|560252132|FG000|Overall Study|Ongoing|1|||
155221895|NCT01231581|560252133|FG001|Overall Study|Ongoing|0|||
155221896|NCT03616912|560252134|FG000|Overall Study|Adverse Event|17|||
155221897|NCT03616912|560252135|FG001|Overall Study|Adverse Event|21|||
155221898|NCT03616912|560252136|FG002|Overall Study|Adverse Event|9|||
155221899|NCT03616912|560252137|FG003|Overall Study|Adverse Event|0|||
155221900|NCT03616912|560252138|FG004|Overall Study|Adverse Event|0|||
155221901|NCT03616912|560252139|FG005|Overall Study|Adverse Event|0|||
155221902|NCT03616912|560252134|FG000|Overall Study|Death|1|||
155221903|NCT03616912|560252135|FG001|Overall Study|Death|1|||
155221904|NCT03616912|560252136|FG002|Overall Study|Death|0|||
155221905|NCT03616912|560252137|FG003|Overall Study|Death|0|||
155221906|NCT03616912|560252138|FG004|Overall Study|Death|0|||
155221907|NCT03616912|560252139|FG005|Overall Study|Death|0|||
155221908|NCT03616912|560252134|FG000|Overall Study|Lack of Efficacy|13|||
155221909|NCT03616912|560252135|FG001|Overall Study|Lack of Efficacy|6|||
155221910|NCT03616912|560252136|FG002|Overall Study|Lack of Efficacy|8|||
155221911|NCT03616912|560252137|FG003|Overall Study|Lack of Efficacy|4|||
155221912|NCT03616912|560252138|FG004|Overall Study|Lack of Efficacy|5|||
155221913|NCT03616912|560252139|FG005|Overall Study|Lack of Efficacy|1|||
155221914|NCT03616912|560252134|FG000|Overall Study|Lost to Follow-up|1|||
155221915|NCT03616912|560252135|FG001|Overall Study|Lost to Follow-up|2|||
155221916|NCT03616912|560252136|FG002|Overall Study|Lost to Follow-up|3|||
155221917|NCT03616912|560252137|FG003|Overall Study|Lost to Follow-up|0|||
155221918|NCT03616912|560252138|FG004|Overall Study|Lost to Follow-up|0|||
155221919|NCT03616912|560252139|FG005|Overall Study|Lost to Follow-up|0|||
155221920|NCT03616912|560252134|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
155221921|NCT03616912|560252135|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
155221922|NCT03616912|560252136|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
155221923|NCT03616912|560252137|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
155221924|NCT03616912|560252138|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
155221925|NCT03616912|560252139|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
155221926|NCT03616912|560252134|FG000|Overall Study|Withdrawal by Subject|12|||
155221927|NCT03616912|560252135|FG001|Overall Study|Withdrawal by Subject|12|||
155221928|NCT03616912|560252136|FG002|Overall Study|Withdrawal by Subject|15|||
155221929|NCT03616912|560252137|FG003|Overall Study|Withdrawal by Subject|2|||
155221930|NCT03616912|560252138|FG004|Overall Study|Withdrawal by Subject|0|||
155221931|NCT03616912|560252139|FG005|Overall Study|Withdrawal by Subject|2|||
155221932|NCT03616912|560252134|FG000|Overall Study|Study Terminated by Sponsor|0|||
155221933|NCT03616912|560252135|FG001|Overall Study|Study Terminated by Sponsor|0|||
155221934|NCT03616912|560252136|FG002|Overall Study|Study Terminated by Sponsor|0|||
155221935|NCT03616912|560252137|FG003|Overall Study|Study Terminated by Sponsor|10|||
155221936|NCT03616912|560252138|FG004|Overall Study|Study Terminated by Sponsor|9|||
155221937|NCT03616912|560252139|FG005|Overall Study|Study Terminated by Sponsor|11|||
155221938|NCT03616912|560252134|FG000|Overall Study|Protocol Deviation|1|||
155221939|NCT03616912|560252135|FG001|Overall Study|Protocol Deviation|1|||
155221940|NCT03616912|560252136|FG002|Overall Study|Protocol Deviation|0|||
155221941|NCT03616912|560252137|FG003|Overall Study|Protocol Deviation|0|||
155221942|NCT03616912|560252138|FG004|Overall Study|Protocol Deviation|0|||
155221943|NCT03616912|560252139|FG005|Overall Study|Protocol Deviation|0|||
155221944|NCT03616912|560252134|FG000|Overall Study|Pregnancy|1|||
155221945|NCT03616912|560252135|FG001|Overall Study|Pregnancy|0|||
155221946|NCT03616912|560252136|FG002|Overall Study|Pregnancy|4|||
155221947|NCT03616912|560252137|FG003|Overall Study|Pregnancy|0|||
155221948|NCT03616912|560252138|FG004|Overall Study|Pregnancy|0|||
155221949|NCT03616912|560252139|FG005|Overall Study|Pregnancy|0|||
155221950|NCT03616912|560252134|FG000|Overall Study|Protocol Violation|1|||
155221951|NCT03616912|560252135|FG001|Overall Study|Protocol Violation|0|||
155221952|NCT03616912|560252136|FG002|Overall Study|Protocol Violation|2|||
155221953|NCT03616912|560252137|FG003|Overall Study|Protocol Violation|0|||
155221954|NCT03616912|560252138|FG004|Overall Study|Protocol Violation|0|||
155221955|NCT03616912|560252139|FG005|Overall Study|Protocol Violation|0|||
155221956|NCT03616912|560252134|FG000|Overall Study|Physician Decision|2|||
155221957|NCT03616912|560252135|FG001|Overall Study|Physician Decision|0|||
155221958|NCT03616912|560252136|FG002|Overall Study|Physician Decision|0|||
155221959|NCT03616912|560252137|FG003|Overall Study|Physician Decision|0|||
155221960|NCT03616912|560252138|FG004|Overall Study|Physician Decision|1|||
155221961|NCT03616912|560252139|FG005|Overall Study|Physician Decision|0|||
155221962|NCT03616912|560252134|FG000|Overall Study|Randomized But Never Treated|0|||
155221963|NCT03616912|560252135|FG001|Overall Study|Randomized But Never Treated|2|||
155221964|NCT03616912|560252136|FG002|Overall Study|Randomized But Never Treated|0|||
155221965|NCT03616912|560252137|FG003|Overall Study|Randomized But Never Treated|0|||
155221966|NCT03616912|560252138|FG004|Overall Study|Randomized But Never Treated|0|||
155221967|NCT03616912|560252139|FG005|Overall Study|Randomized But Never Treated|0|||
155221968|NCT01859507|560252140|FG000|Overall Study|left the country|4|||
155221969|NCT01762943|560252142|FG000|Overall Study|Physician Decision|1|||
155221970|NCT01762943|560252143|FG001|Overall Study|Physician Decision|1|||
155221971|NCT01762943|560252142|FG000|Overall Study|Protocol Violation|1|||
155221972|NCT01762943|560252143|FG001|Overall Study|Protocol Violation|0|||
155221973|NCT01762943|560252142|FG000|Overall Study|Withdrawal by Subject|2|||
155221974|NCT01762943|560252143|FG001|Overall Study|Withdrawal by Subject|1|||
155221975|NCT02404311|560252144|FG000|Part A: Month 0-18|Death|2|||
155221976|NCT02404311|560252145|FG001|Part A: Month 0-18|Death|0|||
155221977|NCT02404311|560252146|FG002|Part A: Month 0-18|Death|0|||
155221978|NCT02404311|560252147|FG003|Part A: Month 0-18|Death|0|||
155221979|NCT02404311|560252148|FG004|Part A: Month 0-18|Death|0|||
155221980|NCT02404311|560252144|FG000|Part A: Month 0-18|Physician Decision|1|||
155221981|NCT02404311|560252145|FG001|Part A: Month 0-18|Physician Decision|0|||
155221982|NCT02404311|560252146|FG002|Part A: Month 0-18|Physician Decision|0|||
155221983|NCT02404311|560252147|FG003|Part A: Month 0-18|Physician Decision|0|||
155221984|NCT02404311|560252148|FG004|Part A: Month 0-18|Physician Decision|0|||
155221985|NCT02404311|560252144|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
155221986|NCT02404311|560252145|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
155221987|NCT02404311|560252146|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
155221988|NCT02404311|560252147|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
155221989|NCT02404311|560252148|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
155221990|NCT02404311|560252144|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
155221991|NCT02404311|560252145|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
155221992|NCT02404311|560252146|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
155221993|NCT02404311|560252147|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
155221994|NCT02404311|560252148|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
155221995|NCT02404311|560252144|FG000|Part A: Month 0-18|HIV Infection|6|||
155221996|NCT02404311|560252145|FG001|Part A: Month 0-18|HIV Infection|2|||
155221997|NCT02404311|560252146|FG002|Part A: Month 0-18|HIV Infection|0|||
155221998|NCT02404311|560252147|FG003|Part A: Month 0-18|HIV Infection|0|||
155221999|NCT02404311|560252148|FG004|Part A: Month 0-18|HIV Infection|0|||
155222000|NCT02404311|560252144|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
155222001|NCT02404311|560252145|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
155222002|NCT02404311|560252146|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
155222003|NCT02404311|560252147|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
155222004|NCT02404311|560252148|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
155222005|NCT03314584|560252156|FG000|Overall Study|Withdrawal by Subject|3|||
155222006|NCT03314584|560252157|FG001|Overall Study|Withdrawal by Subject|3|||
155222007|NCT03314584|560252156|FG000|Overall Study|Lost to Follow-up|4|||
155222008|NCT03314584|560252157|FG001|Overall Study|Lost to Follow-up|0|||
155222009|NCT02864251|560252159|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
155222010|NCT02864251|560252160|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
155222011|NCT02864251|560252161|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
155222012|NCT02864251|560252159|FG000|Pre-Treatment|Withdrawal by Participant|0|||
155222013|NCT02864251|560252160|FG001|Pre-Treatment|Withdrawal by Participant|0|||
155222014|NCT02864251|560252161|FG002|Pre-Treatment|Withdrawal by Participant|4|||
155222015|NCT02864251|560252159|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
155222016|NCT02864251|560252160|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
155222017|NCT02864251|560252161|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
155222018|NCT02864251|560252159|FG000|Pre-Treatment|Other Reasons|0|||
155222019|NCT02864251|560252160|FG001|Pre-Treatment|Other Reasons|1|||
155222020|NCT02864251|560252161|FG002|Pre-Treatment|Other Reasons|1|||
155222021|NCT02864251|560252159|FG000|Treatment|Disease Progression|109|||
155222022|NCT02864251|560252160|FG001|Treatment|Disease Progression|52|||
155222023|NCT02864251|560252161|FG002|Treatment|Disease Progression|101|||
155222024|NCT02864251|560252159|FG000|Treatment|Study Drug Toxicity|9|||
155222025|NCT02864251|560252160|FG001|Treatment|Study Drug Toxicity|4|||
155222026|NCT02864251|560252161|FG002|Treatment|Study Drug Toxicity|10|||
155222027|NCT02864251|560252159|FG000|Treatment|Death|0|||
155222028|NCT02864251|560252160|FG001|Treatment|Death|2|||
155222029|NCT02864251|560252161|FG002|Treatment|Death|3|||
155222030|NCT02864251|560252159|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
155222031|NCT02864251|560252160|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
155222032|NCT02864251|560252161|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
155222033|NCT02864251|560252159|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
155222034|NCT02864251|560252160|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
155222035|NCT02864251|560252161|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
155222036|NCT02864251|560252159|FG000|Treatment|Withdrawal by Participant|8|||
155222037|NCT02864251|560252160|FG001|Treatment|Withdrawal by Participant|5|||
155222038|NCT02864251|560252161|FG002|Treatment|Withdrawal by Participant|13|||
155222039|NCT02864251|560252159|FG000|Treatment|Maximum Clinical Benefit|1|||
155222040|NCT02864251|560252160|FG001|Treatment|Maximum Clinical Benefit|0|||
155222041|NCT02864251|560252161|FG002|Treatment|Maximum Clinical Benefit|1|||
155222042|NCT02864251|560252159|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
155222043|NCT02864251|560252160|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
155222044|NCT02864251|560252161|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
155222045|NCT02864251|560252159|FG000|Treatment|Other Reasons|1|||
155222046|NCT02864251|560252160|FG001|Treatment|Other Reasons|1|||
155222047|NCT02864251|560252161|FG002|Treatment|Other Reasons|4|||
155222048|NCT02864251|560252159|FG000|Treatment|Administrative Reason by Sponsor|1|||
155222049|NCT02864251|560252160|FG001|Treatment|Administrative Reason by Sponsor|0|||
155222050|NCT02864251|560252161|FG002|Treatment|Administrative Reason by Sponsor|0|||
155222051|NCT01480076|560252167|FG000|Overall Study|Run-in Failure|52|||
155222052|NCT01480076|560252167|FG000|Overall Study|Adverse Event|39|||
155222053|NCT01480076|560252167|FG000|Overall Study|Death|2|||
155222054|NCT01480076|560252167|FG000|Overall Study|Disease Progression|5|||
155222055|NCT01480076|560252167|FG000|Overall Study|Non-compliance With Study Protocol|15|||
155222056|NCT01480076|560252167|FG000|Overall Study|Withdrawal by Subject|105|||
155222057|NCT01480076|560252167|FG000|Overall Study|Lost to Follow-up|7|||
155222058|NCT01480076|560252167|FG000|Overall Study|Investigator Decision|13|||
155222059|NCT01480076|560252167|FG000|Overall Study|Other|52|||
155222060|NCT00704535|560252168|FG000|Overall Study|Adverse Event|2|||
155222061|NCT00704535|560252168|FG000|Overall Study|Death|2|||
155222062|NCT00704535|560252168|FG000|Overall Study|Lost to Follow-up|8|||
155222063|NCT00704535|560252168|FG000|Overall Study|Protocol Violation|10|||
155222064|NCT00704535|560252168|FG000|Overall Study|Completed status not on Case Report Form|124|||
155222065|NCT02503332|560252169|FG000|Overall Study|Adverse Event|17|||
155222066|NCT02503332|560252170|FG001|Overall Study|Adverse Event|5|||
155222067|NCT02503332|560252171|FG002|Overall Study|Adverse Event|3|||
155222068|NCT02503332|560252172|FG003|Overall Study|Adverse Event|1|||
155222069|NCT02503332|560252169|FG000|Overall Study|Investigator's Decision|5|||
155222070|NCT02503332|560252170|FG001|Overall Study|Investigator's Decision|1|||
155222071|NCT02503332|560252171|FG002|Overall Study|Investigator's Decision|0|||
155222072|NCT02503332|560252172|FG003|Overall Study|Investigator's Decision|0|||
155222073|NCT02503332|560252169|FG000|Overall Study|Sponsor's Decision|1|||
155222074|NCT02503332|560252170|FG001|Overall Study|Sponsor's Decision|0|||
155222075|NCT02503332|560252171|FG002|Overall Study|Sponsor's Decision|0|||
155222076|NCT02503332|560252172|FG003|Overall Study|Sponsor's Decision|1|||
155222077|NCT02503332|560252169|FG000|Overall Study|Subject Request|6|||
155222078|NCT02503332|560252170|FG001|Overall Study|Subject Request|5|||
155222079|NCT02503332|560252171|FG002|Overall Study|Subject Request|2|||
155222080|NCT02503332|560252172|FG003|Overall Study|Subject Request|1|||
155222081|NCT02503332|560252169|FG000|Overall Study|Death|0|||
155222082|NCT02503332|560252170|FG001|Overall Study|Death|2|||
155222083|NCT02503332|560252171|FG002|Overall Study|Death|2|||
155222084|NCT02503332|560252172|FG003|Overall Study|Death|0|||
155222085|NCT02503332|560252169|FG000|Overall Study|Other|5|||
155222086|NCT02503332|560252170|FG001|Overall Study|Other|6|||
155222087|NCT02503332|560252171|FG002|Overall Study|Other|1|||
155222088|NCT02503332|560252172|FG003|Overall Study|Other|1|||
155222089|NCT05694546|560252174|FG000|Overall Study|Lost to Follow-up|11|||
155222090|NCT02120950|560252175|FG000|Overall Study|Adverse Event|5|||
155222091|NCT02120950|560252176|FG001|Overall Study|Adverse Event|4|||
155222092|NCT02120950|560252177|FG002|Overall Study|Adverse Event|3|||
155222093|NCT02120950|560252175|FG000|Overall Study|Death|3|||
155222094|NCT02120950|560252176|FG001|Overall Study|Death|0|||
155222095|NCT02120950|560252177|FG002|Overall Study|Death|1|||
155222096|NCT02120950|560252175|FG000|Overall Study|Withdrawal by Subject|6|||
155222097|NCT02120950|560252176|FG001|Overall Study|Withdrawal by Subject|3|||
155222098|NCT02120950|560252177|FG002|Overall Study|Withdrawal by Subject|2|||
155222099|NCT02120950|560252175|FG000|Overall Study|Protocol Violation|1|||
155222100|NCT02120950|560252176|FG001|Overall Study|Protocol Violation|1|||
155222101|NCT02120950|560252177|FG002|Overall Study|Protocol Violation|7|||
155222102|NCT02120950|560252175|FG000|Overall Study|Other reasons|5|||
155222103|NCT02120950|560252176|FG001|Overall Study|Other reasons|4|||
155222104|NCT02120950|560252177|FG002|Overall Study|Other reasons|1|||
155222105|NCT02120950|560252175|FG000|Overall Study|Lost to Follow-up|0|||
155222106|NCT02120950|560252176|FG001|Overall Study|Lost to Follow-up|2|||
155222107|NCT02120950|560252177|FG002|Overall Study|Lost to Follow-up|1|||
155222108|NCT02424383|560252178|FG000|Overall Study|Withdrawal by Subject|32|||
155222109|NCT02424383|560252178|FG000|Overall Study|Death|170|||
155222110|NCT02424383|560252178|FG000|Overall Study|Sponsor's decision|3|||
155222111|NCT02424383|560252178|FG000|Overall Study|Investigator's decision|44|||
155222112|NCT02424383|560252178|FG000|Overall Study|Lost to Follow-up|81|||
155222113|NCT02424383|560252178|FG000|Overall Study|Other|7|||
155222114|NCT02424383|560252178|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
155222115|NCT02438722|560252182|FG000|Overall Study|Adverse Event|12|||
155222116|NCT02438722|560252183|FG001|Overall Study|Adverse Event|9|||
155222117|NCT02438722|560252182|FG000|Overall Study|Refusal unrelated to AE|2|||
155222118|NCT02438722|560252183|FG001|Overall Study|Refusal unrelated to AE|5|||
155222119|NCT02438722|560252182|FG000|Overall Study|Disease progression/relapse|46|||
155222120|NCT02438722|560252183|FG001|Overall Study|Disease progression/relapse|51|||
155222121|NCT02438722|560252182|FG000|Overall Study|Death|0|||
155222122|NCT02438722|560252183|FG001|Overall Study|Death|3|||
155222123|NCT02438722|560252182|FG000|Overall Study|Physician Decision|2|||
155222124|NCT02438722|560252183|FG001|Overall Study|Physician Decision|2|||
155222125|NCT02438722|560252182|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
155222126|NCT02438722|560252183|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
155222127|NCT02438722|560252182|FG000|Overall Study|Withdrawal by Subject|0|||
155222128|NCT02438722|560252183|FG001|Overall Study|Withdrawal by Subject|1|||
155222129|NCT02438722|560252182|FG000|Overall Study|On protocol treatment|15|||
155222130|NCT02438722|560252183|FG001|Overall Study|On protocol treatment|14|||
155222131|NCT02438722|560252182|FG000|Overall Study|Did not receive protocol treatment|5|||
155222132|NCT02438722|560252183|FG001|Overall Study|Did not receive protocol treatment|0|||
155222133|NCT03343483|560252184|FG000|Overall Study|Death|0|||
155222134|NCT03343483|560252185|FG001|Overall Study|Death|3|||
155222135|NCT03343483|560252184|FG000|Overall Study|Lost to Follow-up|9|||
155222136|NCT03343483|560252185|FG001|Overall Study|Lost to Follow-up|13|||
155222137|NCT03343483|560252184|FG000|Overall Study|Withdrawal by Subject|8|||
155222138|NCT03343483|560252185|FG001|Overall Study|Withdrawal by Subject|17|||
155222139|NCT01488097|560252188|FG000|Overall Study|Lost to Follow-up|1|||
155222140|NCT01577758|560252189|FG000|Dose Escalation Phase|Adverse Event|0|||
155222141|NCT01577758|560252190|FG001|Dose Escalation Phase|Adverse Event|0|||
155222142|NCT01577758|560252191|FG002|Dose Escalation Phase|Adverse Event|0|||
155222143|NCT01577758|560252192|FG003|Dose Escalation Phase|Adverse Event|0|||
155222144|NCT01577758|560252193|FG004|Dose Escalation Phase|Adverse Event|0|||
155222145|NCT01577758|560252194|FG005|Dose Escalation Phase|Adverse Event|2|||
155222146|NCT01577758|560252195|FG006|Dose Escalation Phase|Adverse Event|1|||
155222147|NCT01577758|560252196|FG007|Dose Escalation Phase|Adverse Event|0|||
155222148|NCT01577758|560252189|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222149|NCT01577758|560252190|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222150|NCT01577758|560252191|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
155222151|NCT01577758|560252192|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222152|NCT01577758|560252193|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
155222153|NCT01577758|560252194|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
155222154|NCT01577758|560252195|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222155|NCT01577758|560252196|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
155222156|NCT01577758|560252189|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
155222157|NCT01577758|560252190|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
155222158|NCT01577758|560252191|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
155222159|NCT01577758|560252192|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
155222160|NCT01577758|560252193|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
155222161|NCT01577758|560252194|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
155222162|NCT01577758|560252195|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
155222163|NCT01577758|560252196|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
155222164|NCT01577758|560252189|FG000|Dose Escalation Phase|Progression Disease|2|||
155222165|NCT01577758|560252190|FG001|Dose Escalation Phase|Progression Disease|2|||
155222166|NCT01577758|560252191|FG002|Dose Escalation Phase|Progression Disease|1|||
155222167|NCT01577758|560252192|FG003|Dose Escalation Phase|Progression Disease|2|||
155222168|NCT01577758|560252193|FG004|Dose Escalation Phase|Progression Disease|5|||
155222169|NCT01577758|560252194|FG005|Dose Escalation Phase|Progression Disease|0|||
155222170|NCT01577758|560252195|FG006|Dose Escalation Phase|Progression Disease|0|||
155222171|NCT01577758|560252196|FG007|Dose Escalation Phase|Progression Disease|0|||
155222172|NCT01577758|560252189|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222173|NCT01577758|560252190|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222174|NCT01577758|560252191|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222175|NCT01577758|560252192|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222176|NCT01577758|560252193|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222177|NCT01577758|560252194|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222178|NCT01577758|560252195|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
155222179|NCT01577758|560252196|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
155222180|NCT01577758|560252189|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222181|NCT01577758|560252190|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222182|NCT01577758|560252191|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222183|NCT01577758|560252192|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222184|NCT01577758|560252193|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222185|NCT01577758|560252194|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222186|NCT01577758|560252195|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
155222187|NCT01577758|560252196|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
155222188|NCT01577758|560252189|FG000|mCRC Expansion Phase|Progression Disease|0|||
155222189|NCT01577758|560252190|FG001|mCRC Expansion Phase|Progression Disease|0|||
155222190|NCT01577758|560252191|FG002|mCRC Expansion Phase|Progression Disease|0|||
155222191|NCT01577758|560252192|FG003|mCRC Expansion Phase|Progression Disease|0|||
155222192|NCT01577758|560252193|FG004|mCRC Expansion Phase|Progression Disease|0|||
155222193|NCT01577758|560252194|FG005|mCRC Expansion Phase|Progression Disease|0|||
155222194|NCT01577758|560252195|FG006|mCRC Expansion Phase|Progression Disease|0|||
155222195|NCT01577758|560252196|FG007|mCRC Expansion Phase|Progression Disease|19|||
155222196|NCT01293240|560252197|FG000|Overall Study|Noncompliance|2|||
155222197|NCT00751348|560252201|FG000|Overall Study|Withdrawal by Subject|5|||
155222198|NCT00751348|560252202|FG001|Overall Study|Withdrawal by Subject|2|||
155222199|NCT00751348|560252201|FG000|Overall Study|Migration from study area|1|||
155222200|NCT00751348|560252202|FG001|Overall Study|Migration from study area|0|||
155222201|NCT02404350|560252208|FG000|Overall Study|Adverse Event|2|||
155222202|NCT02404350|560252209|FG001|Overall Study|Adverse Event|2|||
155222203|NCT02404350|560252210|FG002|Overall Study|Adverse Event|3|||
155222204|NCT02404350|560252211|FG003|Overall Study|Adverse Event|9|||
155222205|NCT02404350|560252208|FG000|Overall Study|Lack of Efficacy|3|||
155222206|NCT02404350|560252209|FG001|Overall Study|Lack of Efficacy|1|||
155222207|NCT02404350|560252210|FG002|Overall Study|Lack of Efficacy|0|||
155222208|NCT02404350|560252211|FG003|Overall Study|Lack of Efficacy|3|||
155222209|NCT02404350|560252208|FG000|Overall Study|Lost to Follow-up|2|||
155222210|NCT02404350|560252209|FG001|Overall Study|Lost to Follow-up|0|||
155222211|NCT02404350|560252210|FG002|Overall Study|Lost to Follow-up|0|||
155222212|NCT02404350|560252211|FG003|Overall Study|Lost to Follow-up|1|||
155222213|NCT02404350|560252208|FG000|Overall Study|Physician Decision|1|||
155222214|NCT02404350|560252209|FG001|Overall Study|Physician Decision|0|||
155222215|NCT02404350|560252210|FG002|Overall Study|Physician Decision|0|||
155222216|NCT02404350|560252211|FG003|Overall Study|Physician Decision|2|||
155222217|NCT02404350|560252208|FG000|Overall Study|Pregnancy|0|||
155222218|NCT02404350|560252209|FG001|Overall Study|Pregnancy|0|||
155222219|NCT02404350|560252210|FG002|Overall Study|Pregnancy|0|||
155222220|NCT02404350|560252211|FG003|Overall Study|Pregnancy|1|||
155222221|NCT02404350|560252208|FG000|Overall Study|Withdrawal by Subject|7|||
155222222|NCT02404350|560252209|FG001|Overall Study|Withdrawal by Subject|3|||
155222223|NCT02404350|560252210|FG002|Overall Study|Withdrawal by Subject|3|||
155222224|NCT02404350|560252211|FG003|Overall Study|Withdrawal by Subject|19|||
155222225|NCT02404350|560252208|FG000|Overall Study|Due to Non-compliance with treatment|0|||
155222226|NCT02404350|560252209|FG001|Overall Study|Due to Non-compliance with treatment|0|||
155222227|NCT02404350|560252210|FG002|Overall Study|Due to Non-compliance with treatment|0|||
155222228|NCT02404350|560252211|FG003|Overall Study|Due to Non-compliance with treatment|1|||
155222229|NCT02404350|560252208|FG000|Overall Study|Due to Technical problems|0|||
155222230|NCT02404350|560252209|FG001|Overall Study|Due to Technical problems|0|||
155222231|NCT02404350|560252210|FG002|Overall Study|Due to Technical problems|0|||
155222232|NCT02404350|560252211|FG003|Overall Study|Due to Technical problems|1|||
155222233|NCT05389657|560252212|FG000|Overall Study|Lost to Follow-up|7|||
155222234|NCT05389657|560252213|FG001|Overall Study|Lost to Follow-up|8|||
155222235|NCT05237206|560252215|FG000|Overall Study|screen failure-did not receive treatment|8|||
155222236|NCT05237206|560252215|FG000|Overall Study|did not receive treatment|3|||
155222237|NCT03261947|560252216|FG000|Overall Study|Death|10|||
155222238|NCT03261947|560252217|FG001|Overall Study|Death|13|||
155222239|NCT03261947|560252218|FG002|Overall Study|Death|17|||
155222240|NCT03261947|560252219|FG003|Overall Study|Death|12|||
155222241|NCT03261947|560252220|FG004|Overall Study|Death|8|||
155222242|NCT03261947|560252216|FG000|Overall Study|Lost to Follow-up|0|||
155222243|NCT03261947|560252217|FG001|Overall Study|Lost to Follow-up|0|||
155222244|NCT03261947|560252218|FG002|Overall Study|Lost to Follow-up|2|||
155222245|NCT03261947|560252219|FG003|Overall Study|Lost to Follow-up|1|||
155222246|NCT03261947|560252220|FG004|Overall Study|Lost to Follow-up|0|||
155222247|NCT03261947|560252216|FG000|Overall Study|Withdrawal by Subject|0|||
155222248|NCT03261947|560252217|FG001|Overall Study|Withdrawal by Subject|0|||
155222249|NCT03261947|560252218|FG002|Overall Study|Withdrawal by Subject|3|||
155222250|NCT03261947|560252219|FG003|Overall Study|Withdrawal by Subject|0|||
155222251|NCT03261947|560252220|FG004|Overall Study|Withdrawal by Subject|1|||
155222252|NCT03261947|560252216|FG000|Overall Study|Site Terminated by Sponsor|0|||
155222253|NCT03261947|560252217|FG001|Overall Study|Site Terminated by Sponsor|0|||
155222254|NCT03261947|560252218|FG002|Overall Study|Site Terminated by Sponsor|4|||
155222255|NCT03261947|560252219|FG003|Overall Study|Site Terminated by Sponsor|7|||
155222256|NCT03261947|560252220|FG004|Overall Study|Site Terminated by Sponsor|5|||
155222257|NCT03261947|560252216|FG000|Overall Study|Reason not Specified|2|||
155222258|NCT03261947|560252217|FG001|Overall Study|Reason not Specified|0|||
155222259|NCT03261947|560252218|FG002|Overall Study|Reason not Specified|4|||
155222260|NCT03261947|560252219|FG003|Overall Study|Reason not Specified|1|||
155222261|NCT03261947|560252220|FG004|Overall Study|Reason not Specified|3|||
155222262|NCT03969992|560252221|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
155222263|NCT03969992|560252222|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
155222264|NCT03969992|560252223|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
155222265|NCT03969992|560252221|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
155222266|NCT03969992|560252222|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
155222267|NCT03969992|560252223|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
155222268|NCT03969992|560252221|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
155222269|NCT03969992|560252222|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
155222270|NCT03969992|560252223|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
155222271|NCT03969992|560252221|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
155222272|NCT03969992|560252222|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
155222273|NCT03969992|560252223|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
155222274|NCT03969992|560252221|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
155222275|NCT03969992|560252222|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
155222276|NCT03969992|560252223|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
155222277|NCT01476696|560252224|FG000|Overall Study|Sponsor decision|2|||
155222278|NCT01476696|560252225|FG001|Overall Study|Sponsor decision|1|||
155222279|NCT01476696|560252226|FG002|Overall Study|Sponsor decision|0|||
155222280|NCT01476696|560252224|FG000|Overall Study|Withdrawal by Subject|1|||
155222281|NCT01476696|560252225|FG001|Overall Study|Withdrawal by Subject|0|||
155222282|NCT01476696|560252226|FG002|Overall Study|Withdrawal by Subject|0|||
155222283|NCT03965962|560252234|FG000|Overall Study|Adverse Event|1|||
155222284|NCT03965962|560252235|FG001|Overall Study|Adverse Event|0|||
155222285|NCT03965962|560252236|FG002|Overall Study|Adverse Event|0|||
155222286|NCT03965962|560252237|FG003|Overall Study|Adverse Event|0|||
155222287|NCT03965962|560252234|FG000|Overall Study|Protocol Violation|21|||
155222288|NCT03965962|560252235|FG001|Overall Study|Protocol Violation|4|||
155222289|NCT03965962|560252236|FG002|Overall Study|Protocol Violation|10|||
155222290|NCT03965962|560252237|FG003|Overall Study|Protocol Violation|5|||
155222291|NCT03965962|560252234|FG000|Overall Study|Lost to Follow-up|0|||
155222292|NCT03965962|560252235|FG001|Overall Study|Lost to Follow-up|1|||
155222293|NCT03965962|560252236|FG002|Overall Study|Lost to Follow-up|0|||
155222294|NCT03965962|560252237|FG003|Overall Study|Lost to Follow-up|0|||
155222295|NCT03965962|560252234|FG000|Overall Study|Withdrawal by Subject|3|||
155222296|NCT03965962|560252235|FG001|Overall Study|Withdrawal by Subject|0|||
155222297|NCT03965962|560252236|FG002|Overall Study|Withdrawal by Subject|0|||
155222298|NCT03965962|560252237|FG003|Overall Study|Withdrawal by Subject|1|||
155222299|NCT02590939|560252238|FG000|Overall Study|Withdrawal by Subject|3|||
155222300|NCT02590939|560252239|FG001|Overall Study|Withdrawal by Subject|1|||
155222301|NCT02590939|560252238|FG000|Overall Study|Failed the nociceptive test|2|||
155222302|NCT02590939|560252239|FG001|Overall Study|Failed the nociceptive test|1|||
155222303|NCT00156533|560253510|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
155222304|NCT00156533|560253511|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
155222305|NCT00156533|560253512|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
155222306|NCT00156533|560253513|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
155222307|NCT00156533|560253510|FG000|Overall Study|Withdrawal by Subject|1|||
155222308|NCT00156533|560253511|FG001|Overall Study|Withdrawal by Subject|0|||
155222309|NCT00156533|560253512|FG002|Overall Study|Withdrawal by Subject|0|||
155222310|NCT00156533|560253513|FG003|Overall Study|Withdrawal by Subject|1|||
155222311|NCT00156533|560253510|FG000|Overall Study|Failed Screening|1|||
155222312|NCT00156533|560253511|FG001|Overall Study|Failed Screening|0|||
155222313|NCT00156533|560253512|FG002|Overall Study|Failed Screening|1|||
155222314|NCT00156533|560253513|FG003|Overall Study|Failed Screening|1|||
155222315|NCT03265249|560253516|FG000|Overall Study|Withdrawal by Subject|0|||
155222316|NCT03265249|560253517|FG001|Overall Study|Withdrawal by Subject|1|||
155222317|NCT01614990|560253518|FG000|Overall Study|Protocol Violation|1|||
155222318|NCT01614990|560253519|FG001|Overall Study|Protocol Violation|1|||
155222319|NCT04171414|560253531|FG000|Overall Study|Death|1|||
155222320|NCT04171414|560253531|FG000|Overall Study|Withdrawal by Subject|1|||
155222321|NCT02586493|560253534|FG000|Overall Study|Adverse Event|4|||
155222322|NCT02586493|560253534|FG000|Overall Study|Protocol Violation|6|||
155222323|NCT02586493|560253534|FG000|Overall Study|Lost to Follow-up|1|||
155222324|NCT02586493|560253534|FG000|Overall Study|Withdrawal by Subject|1|||
155222325|NCT04343521|560253547|FG000|Overall Study|Adverse Event|0|||
155222326|NCT04343521|560253548|FG001|Overall Study|Adverse Event|2|||
155222327|NCT04343521|560253547|FG000|Overall Study|Death|1|||
155222328|NCT04343521|560253548|FG001|Overall Study|Death|2|||
155222329|NCT04343521|560253547|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
155222330|NCT04343521|560253548|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
155222331|NCT04343521|560253547|FG000|Overall Study|Withdrawal by Subject|70|||
155222332|NCT04343521|560253548|FG001|Overall Study|Withdrawal by Subject|95|||
155222333|NCT04343521|560253547|FG000|Overall Study|Withdrawal by study team|6|||
155222334|NCT04343521|560253548|FG001|Overall Study|Withdrawal by study team|12|||
155222335|NCT02532647|560253551|FG000|Overall Study|Did not receive trial medication|1|||
155222336|NCT02532647|560253552|FG001|Overall Study|Did not receive trial medication|0|||
155222337|NCT02532647|560253553|FG002|Overall Study|Did not receive trial medication|1|||
155222338|NCT01505608|560253558|FG000|Phase I|Lack of Efficacy|0|||
155222339|NCT01505608|560253559|FG001|Phase I|Lack of Efficacy|4|||
155222340|NCT01505608|560253558|FG000|Phase I|Adverse Event|0|||
155222341|NCT01505608|560253559|FG001|Phase I|Adverse Event|1|||
155222342|NCT01505608|560253558|FG000|Phase I|Withdrawal by Subject|0|||
155222343|NCT01505608|560253559|FG001|Phase I|Withdrawal by Subject|1|||
155222344|NCT01505608|560253558|FG000|Phase II|Lack of Efficacy|2|||
155222345|NCT01505608|560253559|FG001|Phase II|Lack of Efficacy|1|||
155222346|NCT01505608|560253558|FG000|Phase II|Protocol Violation|0|||
155222347|NCT01505608|560253559|FG001|Phase II|Protocol Violation|1|||
155222348|NCT01251380|560253562|FG000|Overall Study|Other (Not otherwise specified)|12|||
155222349|NCT01251380|560253562|FG000|Overall Study|Withdrawal by Subject|6|||
155222350|NCT01251380|560253562|FG000|Overall Study|Lack of Efficacy|1|||
155222351|NCT01251380|560253562|FG000|Overall Study|Adverse Event|1|||
155222352|NCT01251380|560253562|FG000|Overall Study|Lost to Follow-up|2|||
155222353|NCT00600756|560253563|FG000|Analysis After 6 Months|Adverse Event|43|||
155222354|NCT00600756|560253564|FG001|Analysis After 6 Months|Adverse Event|33|||
155222355|NCT00600756|560253563|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
155222356|NCT00600756|560253564|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
155222357|NCT00600756|560253563|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
155222358|NCT00600756|560253564|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
155222359|NCT00600756|560253563|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
155222360|NCT00600756|560253564|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
155222361|NCT00600756|560253563|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
155222362|NCT00600756|560253564|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
155222363|NCT00600756|560253563|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
155222364|NCT00600756|560253564|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
155222365|NCT00600756|560253563|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
155222366|NCT00600756|560253564|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
155222367|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
155222368|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
155222369|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
155222370|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
155222371|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
155222372|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
155222373|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
155222374|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
155222375|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
155222376|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
155222377|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
155222378|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
155222379|NCT00600756|560253563|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
155222380|NCT00600756|560253564|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
155222381|NCT00768144|560253565|FG000|Overall Study|Adverse Event|13|||
155222382|NCT00768144|560253565|FG000|Overall Study|Progressive Disease|21|||
155222383|NCT00768144|560253565|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
155222384|NCT00768144|560253565|FG000|Overall Study|Pt Withdrew Consent|1|||
155222385|NCT01712854|560253566|FG000|Overall Study|Physician Decision|1|||
155222386|NCT01150123|560253567|FG000|Overall Study|Withdrawal by Subject|1|||
155222387|NCT01150123|560253568|FG001|Overall Study|Withdrawal by Subject|1|||
155222388|NCT01150123|560253569|FG002|Overall Study|Withdrawal by Subject|2|||
155222389|NCT01150123|560253570|FG003|Overall Study|Withdrawal by Subject|1|||
155222390|NCT01150123|560253571|FG004|Overall Study|Withdrawal by Subject|1|||
155222391|NCT01150123|560253572|FG005|Overall Study|Withdrawal by Subject|1|||
155222392|NCT01150123|560253573|FG006|Overall Study|Withdrawal by Subject|0|||
155222393|NCT01150123|560253574|FG007|Overall Study|Withdrawal by Subject|3|||
155222394|NCT01150123|560253575|FG008|Overall Study|Withdrawal by Subject|2|||
155222395|NCT01150123|560253576|FG009|Overall Study|Withdrawal by Subject|0|||
155222396|NCT01150123|560253577|FG010|Overall Study|Withdrawal by Subject|1|||
155222397|NCT01150123|560253578|FG011|Overall Study|Withdrawal by Subject|0|||
155222398|NCT01150123|560253579|FG012|Overall Study|Withdrawal by Subject|1|||
155222399|NCT01150123|560253580|FG013|Overall Study|Withdrawal by Subject|0|||
155222400|NCT01150123|560253581|FG014|Overall Study|Withdrawal by Subject|0|||
155222401|NCT01150123|560253582|FG015|Overall Study|Withdrawal by Subject|1|||
155222402|NCT01150123|560253583|FG016|Overall Study|Withdrawal by Subject|0|||
155222403|NCT01150123|560253584|FG017|Overall Study|Withdrawal by Subject|1|||
155222404|NCT01150123|560253567|FG000|Overall Study|Lost to Follow-up|2|||
155222405|NCT01150123|560253568|FG001|Overall Study|Lost to Follow-up|1|||
155222406|NCT01150123|560253569|FG002|Overall Study|Lost to Follow-up|2|||
155222407|NCT01150123|560253570|FG003|Overall Study|Lost to Follow-up|2|||
155222408|NCT01150123|560253571|FG004|Overall Study|Lost to Follow-up|2|||
155222409|NCT01150123|560253572|FG005|Overall Study|Lost to Follow-up|5|||
155222410|NCT01150123|560253573|FG006|Overall Study|Lost to Follow-up|0|||
155222411|NCT01150123|560253574|FG007|Overall Study|Lost to Follow-up|0|||
155222412|NCT01150123|560253575|FG008|Overall Study|Lost to Follow-up|3|||
155222413|NCT01150123|560253576|FG009|Overall Study|Lost to Follow-up|1|||
155222414|NCT01150123|560253577|FG010|Overall Study|Lost to Follow-up|1|||
155222415|NCT01150123|560253578|FG011|Overall Study|Lost to Follow-up|1|||
155222416|NCT01150123|560253579|FG012|Overall Study|Lost to Follow-up|2|||
155222417|NCT01150123|560253580|FG013|Overall Study|Lost to Follow-up|0|||
155222418|NCT01150123|560253581|FG014|Overall Study|Lost to Follow-up|0|||
155222419|NCT01150123|560253582|FG015|Overall Study|Lost to Follow-up|0|||
155222420|NCT01150123|560253583|FG016|Overall Study|Lost to Follow-up|0|||
155222421|NCT01150123|560253584|FG017|Overall Study|Lost to Follow-up|0|||
155222422|NCT02171260|560253585|FG000|Overall Study|Death|0|||
155222423|NCT02171260|560253586|FG001|Overall Study|Death|0|||
155222424|NCT02171260|560253587|FG002|Overall Study|Death|0|||
155222425|NCT02171260|560253588|FG003|Overall Study|Death|1|||
155222426|NCT02171260|560253585|FG000|Overall Study|Physician Decision|1|||
155222427|NCT02171260|560253586|FG001|Overall Study|Physician Decision|0|||
155222428|NCT02171260|560253587|FG002|Overall Study|Physician Decision|1|||
155222429|NCT02171260|560253588|FG003|Overall Study|Physician Decision|0|||
155222430|NCT02171260|560253585|FG000|Overall Study|Withdrawal by Subject|1|||
155222431|NCT02171260|560253586|FG001|Overall Study|Withdrawal by Subject|0|||
155222432|NCT02171260|560253587|FG002|Overall Study|Withdrawal by Subject|0|||
155222433|NCT02171260|560253588|FG003|Overall Study|Withdrawal by Subject|0|||
155222434|NCT02171260|560253585|FG000|Overall Study|Evidence of progressive disease|4|||
155222435|NCT02171260|560253586|FG001|Overall Study|Evidence of progressive disease|6|||
155222436|NCT02171260|560253587|FG002|Overall Study|Evidence of progressive disease|4|||
155222437|NCT02171260|560253588|FG003|Overall Study|Evidence of progressive disease|4|||
155222438|NCT01466387|560253591|FG000|Overall Study|Adverse Event|0|||
155222439|NCT01466387|560253592|FG001|Overall Study|Adverse Event|0|||
155222440|NCT01466387|560253593|FG002|Overall Study|Adverse Event|1|||
155222441|NCT01466387|560253594|FG003|Overall Study|Adverse Event|1|||
155222442|NCT01466387|560253595|FG004|Overall Study|Adverse Event|0|||
155222443|NCT01466387|560253596|FG005|Overall Study|Adverse Event|0|||
155222444|NCT01466387|560253591|FG000|Overall Study|Lost to Follow-up|0|||
155222445|NCT01466387|560253592|FG001|Overall Study|Lost to Follow-up|0|||
155222446|NCT01466387|560253593|FG002|Overall Study|Lost to Follow-up|0|||
155222447|NCT01466387|560253594|FG003|Overall Study|Lost to Follow-up|0|||
155222448|NCT01466387|560253595|FG004|Overall Study|Lost to Follow-up|0|||
155222449|NCT01466387|560253596|FG005|Overall Study|Lost to Follow-up|1|||
155222450|NCT01466387|560253591|FG000|Overall Study|Protocol Violation|1|||
155222451|NCT01466387|560253592|FG001|Overall Study|Protocol Violation|0|||
155222452|NCT01466387|560253593|FG002|Overall Study|Protocol Violation|0|||
155222453|NCT01466387|560253594|FG003|Overall Study|Protocol Violation|1|||
155222454|NCT01466387|560253595|FG004|Overall Study|Protocol Violation|0|||
155222455|NCT01466387|560253596|FG005|Overall Study|Protocol Violation|0|||
155222456|NCT01319877|560253597|FG000|Overall Study|Lost to Follow-up|100|||
155222457|NCT01319877|560253598|FG001|Overall Study|Lost to Follow-up|37|||
155222458|NCT01319877|560253597|FG000|Overall Study|Physician Decision|2|||
155222459|NCT01319877|560253598|FG001|Overall Study|Physician Decision|0|||
155222460|NCT01319877|560253597|FG000|Overall Study|Disease Progression|2|||
155222461|NCT01319877|560253598|FG001|Overall Study|Disease Progression|2|||
155222462|NCT01319877|560253597|FG000|Overall Study|Withdrawal by Subject|0|||
155222463|NCT01319877|560253598|FG001|Overall Study|Withdrawal by Subject|1|||
155222464|NCT01319877|560253597|FG000|Overall Study|Reason Not Specified|4|||
155222465|NCT01319877|560253598|FG001|Overall Study|Reason Not Specified|5|||
155222466|NCT02347189|560253601|FG000|Overall Study|No implant attempted of study device|9|||
155222467|NCT02347189|560253601|FG000|Overall Study|No primary outcome data available|2|||
155222468|NCT02677987|560253602|FG000|Overall Study|Withdrawal by Subject|3|||
155222469|NCT02677987|560253603|FG001|Overall Study|Withdrawal by Subject|0|||
155222470|NCT02677987|560253602|FG000|Overall Study|Lost to Follow-up|1|||
155222471|NCT02677987|560253603|FG001|Overall Study|Lost to Follow-up|0|||
155222472|NCT03320564|560253605|FG000|Overall Study|Protocol Violation|1|||
155222473|NCT00673179|560253606|FG000|Overall Study|Toxicity/Complications|3|||
155222474|NCT00673179|560253607|FG001|Overall Study|Toxicity/Complications|0|||
155222475|NCT00352846|560253608|FG000|Overall Study|Disease progression|0|||
155222476|NCT00352846|560253609|FG001|Overall Study|Disease progression|2|||
155222477|NCT00352846|560253608|FG000|Overall Study|Withdrawal by Subject|3|||
155222478|NCT00352846|560253609|FG001|Overall Study|Withdrawal by Subject|8|||
155222479|NCT00352846|560253608|FG000|Overall Study|Ineligible|3|||
155222480|NCT00352846|560253609|FG001|Overall Study|Ineligible|2|||
155222481|NCT00352846|560253608|FG000|Overall Study|Non-compliance|2|||
155222482|NCT00352846|560253609|FG001|Overall Study|Non-compliance|0|||
155222483|NCT00352846|560253608|FG000|Overall Study|Death|0|||
155222484|NCT00352846|560253609|FG001|Overall Study|Death|1|||
155222485|NCT01527682|560253610|FG000|Overall Study|Protocol Violation|8|||
155222486|NCT01531387|560253611|FG000|Overall Study|Early termination of study|11|||
155222487|NCT01531387|560253612|FG001|Overall Study|Early termination of study|11|||
155222488|NCT00600938|560253615|FG000|Core Study|Abnormal test procedure result(s)|3|||
155222489|NCT00600938|560253616|FG001|Core Study|Abnormal test procedure result(s)|2|||
155222490|NCT00600938|560253617|FG002|Core Study|Abnormal test procedure result(s)|0|||
155222491|NCT00600938|560253618|FG003|Core Study|Abnormal test procedure result(s)|0|||
155222492|NCT00600938|560253615|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
155222493|NCT00600938|560253616|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
155222494|NCT00600938|560253617|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
155222495|NCT00600938|560253618|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
155222496|NCT00600938|560253615|FG000|Core Study|Patient withdrew consent|7|||
155222497|NCT00600938|560253616|FG001|Core Study|Patient withdrew consent|12|||
155222498|NCT00600938|560253617|FG002|Core Study|Patient withdrew consent|0|||
155222499|NCT00600938|560253618|FG003|Core Study|Patient withdrew consent|0|||
155222500|NCT00600938|560253615|FG000|Core Study|Lost to Follow-up|3|||
155222501|NCT00600938|560253616|FG001|Core Study|Lost to Follow-up|2|||
155222502|NCT00600938|560253617|FG002|Core Study|Lost to Follow-up|0|||
155222503|NCT00600938|560253618|FG003|Core Study|Lost to Follow-up|0|||
155222504|NCT00600938|560253615|FG000|Core Study|Death|1|||
155222505|NCT00600938|560253616|FG001|Core Study|Death|1|||
155222506|NCT00600938|560253617|FG002|Core Study|Death|0|||
155222507|NCT00600938|560253618|FG003|Core Study|Death|0|||
155222508|NCT00600938|560253615|FG000|Core Study|Protocol Violation|1|||
155222509|NCT00600938|560253616|FG001|Core Study|Protocol Violation|2|||
155222510|NCT00600938|560253617|FG002|Core Study|Protocol Violation|0|||
155222511|NCT00600938|560253618|FG003|Core Study|Protocol Violation|0|||
155222512|NCT00600938|560253615|FG000|Extension Study|Adverse Event|1|||
155222513|NCT00600938|560253616|FG001|Extension Study|Adverse Event|0|||
155222514|NCT00600938|560253617|FG002|Extension Study|Adverse Event|2|||
155222515|NCT00600938|560253618|FG003|Extension Study|Adverse Event|0|||
155222516|NCT00600938|560253615|FG000|Extension Study|Abnormal test procedure results|0|||
155222517|NCT00600938|560253616|FG001|Extension Study|Abnormal test procedure results|1|||
155222518|NCT00600938|560253617|FG002|Extension Study|Abnormal test procedure results|1|||
155222519|NCT00600938|560253618|FG003|Extension Study|Abnormal test procedure results|1|||
155222520|NCT00600938|560253615|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
155222521|NCT00600938|560253616|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
155222522|NCT00600938|560253617|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
155222523|NCT00600938|560253618|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
155222524|NCT00600938|560253615|FG000|Extension Study|Withdrawal by Subject|2|||
155222525|NCT00600938|560253616|FG001|Extension Study|Withdrawal by Subject|2|||
155222526|NCT00600938|560253617|FG002|Extension Study|Withdrawal by Subject|3|||
155222527|NCT00600938|560253618|FG003|Extension Study|Withdrawal by Subject|0|||
155222528|NCT00600938|560253615|FG000|Extension Study|Lost to Follow-up|1|||
155222529|NCT00600938|560253616|FG001|Extension Study|Lost to Follow-up|1|||
155222530|NCT00600938|560253617|FG002|Extension Study|Lost to Follow-up|2|||
155222531|NCT00600938|560253618|FG003|Extension Study|Lost to Follow-up|0|||
155222532|NCT00600938|560253615|FG000|Extension Study|Death|1|||
155222533|NCT00600938|560253616|FG001|Extension Study|Death|0|||
155222534|NCT00600938|560253617|FG002|Extension Study|Death|0|||
155222535|NCT00600938|560253618|FG003|Extension Study|Death|0|||
155222536|NCT04220411|560253619|FG000|Overall Study|Adverse Event|0|||
155222537|NCT04220411|560253620|FG001|Overall Study|Adverse Event|0|||
155222538|NCT04220411|560253621|FG002|Overall Study|Adverse Event|0|||
155222539|NCT04220411|560253622|FG003|Overall Study|Adverse Event|1|||
155222540|NCT02680639|560253623|FG000|Screening Period|Screen Failure|7|||
155222541|NCT02680639|560253624|FG001|Screening Period|Screen Failure|0|||
155222542|NCT02680639|560253625|FG002|Screening Period|Screen Failure|0|||
155222543|NCT02678676|560253626|FG000|Overall Study|Death|619|||
155222544|NCT02678676|560253627|FG001|Overall Study|Death|649|||
155222545|NCT02678676|560253626|FG000|Overall Study|Withdrawal by Subject|13|||
155222546|NCT02678676|560253627|FG001|Overall Study|Withdrawal by Subject|5|||
155222547|NCT02678676|560253626|FG000|Overall Study|Lost to Follow-up|171|||
155222548|NCT02678676|560253627|FG001|Overall Study|Lost to Follow-up|151|||
155222549|NCT02678676|560253626|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
155222550|NCT02678676|560253627|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
155222551|NCT02496533|560253639|FG000|Overall Study|Lack of data on outcome|3|||
155222552|NCT02496533|560253640|FG001|Overall Study|Lack of data on outcome|0|||
155222553|NCT02496533|560253639|FG000|Overall Study|Patient did not complete all measures|0|||
155222554|NCT02496533|560253640|FG001|Overall Study|Patient did not complete all measures|4|||
155222555|NCT02496533|560253639|FG000|Overall Study|Late for radiologic testing|0|||
155222556|NCT02496533|560253640|FG001|Overall Study|Late for radiologic testing|2|||
155222557|NCT05756790|560253641|FG000|Overall Study|Withdrawal by Subject|1|||
155222558|NCT05756790|560253642|FG001|Overall Study|Withdrawal by Subject|1|||
155222559|NCT05756790|560253643|FG002|Overall Study|Withdrawal by Subject|1|||
155222560|NCT05756790|560253644|FG003|Overall Study|Withdrawal by Subject|1|||
155222561|NCT05756790|560253645|FG004|Overall Study|Withdrawal by Subject|0|||
155222562|NCT05756790|560253646|FG005|Overall Study|Withdrawal by Subject|0|||
155222563|NCT05756790|560253641|FG000|Overall Study|Protocol Violation|0|||
155222564|NCT05756790|560253642|FG001|Overall Study|Protocol Violation|0|||
155222565|NCT05756790|560253643|FG002|Overall Study|Protocol Violation|1|||
155222566|NCT05756790|560253644|FG003|Overall Study|Protocol Violation|1|||
155222567|NCT05756790|560253645|FG004|Overall Study|Protocol Violation|0|||
155222568|NCT05756790|560253646|FG005|Overall Study|Protocol Violation|0|||
155222569|NCT05756790|560253641|FG000|Overall Study|Ineligible|0|||
155222570|NCT05756790|560253642|FG001|Overall Study|Ineligible|0|||
155222571|NCT05756790|560253643|FG002|Overall Study|Ineligible|0|||
155222572|NCT05756790|560253644|FG003|Overall Study|Ineligible|0|||
155222573|NCT05756790|560253645|FG004|Overall Study|Ineligible|2|||
155222574|NCT05756790|560253646|FG005|Overall Study|Ineligible|2|||
155222575|NCT03256552|560254923|FG000|Overall Study|Protocol Violation|1|||
155222576|NCT03256552|560254923|FG000|Overall Study|Physician Decision|1|||
155222577|NCT03256552|560254923|FG000|Overall Study|Adverse Event|1|||
155222578|NCT03256552|560254923|FG000|Overall Study|Withdrawal by Subject|2|||
155222579|NCT02268409|560254928|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
155222580|NCT02268409|560254928|FG000|Overall Study|Death|1|||
155222581|NCT02268409|560254928|FG000|Overall Study|Lost to Follow-up|1|||
155222582|NCT02268409|560254928|FG000|Overall Study|Protocol Violation|3|||
155222583|NCT02268409|560254928|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
155222584|NCT02268409|560254928|FG000|Overall Study|Withdrawal by Subject|5|||
155222585|NCT00427635|560254929|FG000|Treatment Phase|Withdrawal by Subject|1|||
155222586|NCT00427635|560254930|FG001|Treatment Phase|Withdrawal by Subject|0|||
155222587|NCT00427635|560254929|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
155222588|NCT00427635|560254930|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
155222589|NCT00838201|560254933|FG000|Overall Study|Investigator decision, or other reasons|2|||
155222590|NCT00838201|560254934|FG001|Overall Study|Investigator decision, or other reasons|3|||
155222591|NCT00838201|560254933|FG000|Overall Study|Noncompliance|0|||
155222592|NCT00838201|560254934|FG001|Overall Study|Noncompliance|1|||
155222593|NCT00838201|560254933|FG000|Overall Study|Administrative decision|1|||
155222594|NCT00838201|560254934|FG001|Overall Study|Administrative decision|2|||
155222595|NCT00838201|560254933|FG000|Overall Study|Disease progression|3|||
155222596|NCT00838201|560254934|FG001|Overall Study|Disease progression|3|||
155222597|NCT00838201|560254933|FG000|Overall Study|Consent withdrawn|16|||
155222598|NCT00838201|560254934|FG001|Overall Study|Consent withdrawn|19|||
155222599|NCT00838201|560254933|FG000|Overall Study|Lost to Follow-up|4|||
155222600|NCT00838201|560254934|FG001|Overall Study|Lost to Follow-up|3|||
155222601|NCT00838201|560254933|FG000|Overall Study|Adverse Event|5|||
155222602|NCT00838201|560254934|FG001|Overall Study|Adverse Event|9|||
155222603|NCT00838201|560254933|FG000|Overall Study|Death|11|||
155222604|NCT00838201|560254934|FG001|Overall Study|Death|13|||
155222605|NCT00489853|560254935|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
155222606|NCT00489853|560254936|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
155222607|NCT00489853|560254937|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
155222608|NCT00489853|560254935|FG000|Wash-out Period 1|Adverse Event|0|||
155222609|NCT00489853|560254936|FG001|Wash-out Period 1|Adverse Event|1|||
155222610|NCT00489853|560254937|FG002|Wash-out Period 1|Adverse Event|1|||
155222611|NCT00489853|560254935|FG000|Wash-out Period 1|Protocol Violation|0|||
155222612|NCT00489853|560254936|FG001|Wash-out Period 1|Protocol Violation|1|||
155222613|NCT00489853|560254937|FG002|Wash-out Period 1|Protocol Violation|1|||
155222614|NCT00489853|560254935|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
155222615|NCT00489853|560254936|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
155222616|NCT00489853|560254937|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
155222617|NCT00489853|560254935|FG000|Wash-out Period 2|Adverse Event|1|||
155222618|NCT00489853|560254936|FG001|Wash-out Period 2|Adverse Event|1|||
155222619|NCT00489853|560254937|FG002|Wash-out Period 2|Adverse Event|0|||
155222620|NCT00489853|560254935|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
155222621|NCT00489853|560254936|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
155222622|NCT00489853|560254937|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
155222623|NCT00489853|560254935|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
155222624|NCT00489853|560254936|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
155222625|NCT00489853|560254937|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
155222626|NCT05083442|560254938|FG000|Overall Study|Lost to Follow-up|1|||
155222627|NCT05083442|560254939|FG001|Overall Study|Lost to Follow-up|0|||
155222628|NCT05083442|560254938|FG000|Overall Study|Lack of Efficacy|0|||
155222629|NCT05083442|560254939|FG001|Overall Study|Lack of Efficacy|1|||
155222630|NCT05083442|560254938|FG000|Overall Study|Withdrawal by Subject|1|||
155222631|NCT05083442|560254939|FG001|Overall Study|Withdrawal by Subject|3|||
155222632|NCT05083442|560254938|FG000|Overall Study|scheduling difficulties|1|||
155222633|NCT05083442|560254939|FG001|Overall Study|scheduling difficulties|2|||
155222634|NCT03873987|560254947|FG000|Overall Study|Adverse Event|1|||
155222635|NCT03873987|560254948|FG001|Overall Study|Adverse Event|0|||
155222636|NCT03873987|560254947|FG000|Overall Study|staff was unable to start a new IV line|1|||
155222637|NCT03873987|560254948|FG001|Overall Study|staff was unable to start a new IV line|0|||
155222638|NCT03873987|560254947|FG000|Overall Study|Lost to Follow-up|0|||
155222639|NCT03873987|560254948|FG001|Overall Study|Lost to Follow-up|1|||
155222640|NCT00004888|560254949|FG000|Overall Study|Adverse Event|5|||
155222641|NCT00004888|560254950|FG001|Overall Study|Adverse Event|10|||
155222642|NCT00004888|560254949|FG000|Overall Study|Withdrawal by Subject|0|||
155222643|NCT00004888|560254950|FG001|Overall Study|Withdrawal by Subject|3|||
155222644|NCT00004888|560254949|FG000|Overall Study|Physician Decision|1|||
155222645|NCT00004888|560254950|FG001|Overall Study|Physician Decision|1|||
155222646|NCT00004888|560254949|FG000|Overall Study|Progressive Disease|4|||
155222647|NCT00004888|560254950|FG001|Overall Study|Progressive Disease|9|||
155222648|NCT00004888|560254949|FG000|Overall Study|Death without progressive disease|0|||
155222649|NCT00004888|560254950|FG001|Overall Study|Death without progressive disease|1|||
155222650|NCT00004888|560254949|FG000|Overall Study|Toxic death|1|||
155222651|NCT00004888|560254950|FG001|Overall Study|Toxic death|0|||
155222652|NCT00136084|560254951|FG000|Overall Study|Death|12|||
155222653|NCT00136084|560254952|FG001|Overall Study|Death|5|||
155222654|NCT00136084|560254951|FG000|Overall Study|Unacceptable toxicity|8|||
155222655|NCT00136084|560254952|FG001|Overall Study|Unacceptable toxicity|11|||
155222656|NCT00136084|560254951|FG000|Overall Study|Relapse|20|||
155222657|NCT00136084|560254952|FG001|Overall Study|Relapse|23|||
155222658|NCT00136084|560254951|FG000|Overall Study|Lost to Follow-up|2|||
155222659|NCT00136084|560254952|FG001|Overall Study|Lost to Follow-up|0|||
155222660|NCT00136084|560254951|FG000|Overall Study|No Response|1|||
155222661|NCT00136084|560254952|FG001|Overall Study|No Response|2|||
155222662|NCT00136084|560254951|FG000|Overall Study|Withdrawal by Subject|5|||
155222663|NCT00136084|560254952|FG001|Overall Study|Withdrawal by Subject|1|||
155222664|NCT02579265|560254953|FG000|Overall Study|Weaned off earlier than 28 days|44|||
155222665|NCT02579265|560254954|FG001|Overall Study|Weaned off earlier than 28 days|43|||
155222666|NCT02579265|560254953|FG000|Overall Study|Adverse Event|2|||
155222667|NCT02579265|560254954|FG001|Overall Study|Adverse Event|0|||
155222668|NCT02579265|560254953|FG000|Overall Study|Any other reason not specified|0|||
155222669|NCT02579265|560254954|FG001|Overall Study|Any other reason not specified|2|||
155222670|NCT02579265|560254953|FG000|Overall Study|Withdrawal by Subject|2|||
155222671|NCT02579265|560254954|FG001|Overall Study|Withdrawal by Subject|0|||
155222672|NCT02579265|560254953|FG000|Overall Study|Physician Decision|1|||
155222673|NCT02579265|560254954|FG001|Overall Study|Physician Decision|0|||
155222674|NCT02579265|560254953|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
155222675|NCT02579265|560254954|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
155222676|NCT02174848|560254955|FG000|Overall Study|Adverse Event|2|||
155222677|NCT02174848|560254956|FG001|Overall Study|Adverse Event|1|||
155222678|NCT02174848|560254955|FG000|Overall Study|Withdrawal by Subject|3|||
155222679|NCT02174848|560254956|FG001|Overall Study|Withdrawal by Subject|3|||
155222680|NCT02174848|560254955|FG000|Overall Study|Lost to Follow-up|0|||
155222681|NCT02174848|560254956|FG001|Overall Study|Lost to Follow-up|1|||
155222682|NCT02174848|560254955|FG000|Overall Study|Worsening of disease|1|||
155222683|NCT02174848|560254956|FG001|Overall Study|Worsening of disease|1|||
155222684|NCT02174848|560254955|FG000|Overall Study|Unable to comply with study requirements|1|||
155222685|NCT02174848|560254956|FG001|Overall Study|Unable to comply with study requirements|0|||
155222686|NCT02520011|560254958|FG000|Overall Study|Adverse Event|0|||
155222687|NCT02520011|560254959|FG001|Overall Study|Adverse Event|1|||
155222688|NCT02520011|560254960|FG002|Overall Study|Adverse Event|2|||
155222689|NCT02520011|560254958|FG000|Overall Study|Death|0|||
155222690|NCT02520011|560254959|FG001|Overall Study|Death|8|||
155222691|NCT02520011|560254960|FG002|Overall Study|Death|1|||
155222692|NCT02520011|560254958|FG000|Overall Study|Lack of Efficacy|4|||
155222693|NCT02520011|560254959|FG001|Overall Study|Lack of Efficacy|26|||
155222694|NCT02520011|560254960|FG002|Overall Study|Lack of Efficacy|4|||
155222695|NCT02520011|560254958|FG000|Overall Study|Physician Decision|0|||
155222696|NCT02520011|560254959|FG001|Overall Study|Physician Decision|2|||
155222697|NCT02520011|560254960|FG002|Overall Study|Physician Decision|0|||
155222698|NCT02520011|560254958|FG000|Overall Study|Withdrawal by Subject|1|||
155222699|NCT02520011|560254959|FG001|Overall Study|Withdrawal by Subject|3|||
155222700|NCT02520011|560254960|FG002|Overall Study|Withdrawal by Subject|0|||
155222701|NCT02520011|560254958|FG000|Overall Study|Protocol Deviation|0|||
155222702|NCT02520011|560254959|FG001|Overall Study|Protocol Deviation|1|||
155222703|NCT02520011|560254960|FG002|Overall Study|Protocol Deviation|0|||
155222704|NCT02520011|560254958|FG000|Overall Study|Patient went to hospice|0|||
155222705|NCT02520011|560254959|FG001|Overall Study|Patient went to hospice|1|||
155222706|NCT02520011|560254960|FG002|Overall Study|Patient went to hospice|0|||
155222707|NCT02520011|560254958|FG000|Overall Study|Progressive disease following response|0|||
155222708|NCT02520011|560254959|FG001|Overall Study|Progressive disease following response|4|||
155222709|NCT02520011|560254960|FG002|Overall Study|Progressive disease following response|2|||
155222710|NCT00644969|560254961|FG000|Treatment Phase|Randomized, not treated|1|||
155222711|NCT00644969|560254962|FG001|Treatment Phase|Randomized, not treated|0|||
155222712|NCT00644969|560254961|FG000|Treatment Phase|Adverse Event|3|||
155222713|NCT00644969|560254962|FG001|Treatment Phase|Adverse Event|0|||
155222714|NCT00644969|560254961|FG000|Treatment Phase|Withdrawal by Subject|4|||
155222715|NCT00644969|560254962|FG001|Treatment Phase|Withdrawal by Subject|0|||
155222716|NCT00644969|560254961|FG000|Treatment Phase|Lost to Follow-up|2|||
155222717|NCT00644969|560254962|FG001|Treatment Phase|Lost to Follow-up|2|||
155222718|NCT00644969|560254961|FG000|Treatment Phase|Other|4|||
155222719|NCT00644969|560254962|FG001|Treatment Phase|Other|1|||
155222720|NCT00644969|560254961|FG000|Post Treatment Phase|Death|1|||
155222721|NCT00644969|560254962|FG001|Post Treatment Phase|Death|0|||
155222722|NCT00644969|560254961|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
155222723|NCT00644969|560254962|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
155222724|NCT00644969|560254961|FG000|Post Treatment Phase|Lost to Follow-up|4|||
155222725|NCT00644969|560254962|FG001|Post Treatment Phase|Lost to Follow-up|1|||
155222726|NCT00644969|560254961|FG000|Post Treatment Phase|Other|1|||
155222727|NCT00644969|560254962|FG001|Post Treatment Phase|Other|0|||
155222728|NCT02449239|560254963|FG000|Induction Phase|Lack of Efficacy|64|||
155222729|NCT02449239|560254963|FG000|Induction Phase|Adverse Event|1|||
155222730|NCT02449239|560254963|FG000|Induction Phase|Lost to Follow-up|1|||
155222731|NCT02449239|560254963|FG000|Induction Phase|Protocol Violation|1|||
155222732|NCT02449239|560254963|FG000|Induction Phase|Physician Decision|1|||
155222733|NCT02449239|560254963|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
155222734|NCT02449239|560254963|FG000|Induction Phase|Withdrawal by Subject|1|||
155222735|NCT02449239|560254963|FG000|Maintenance Month 3|Lack of Efficacy|14|||
155222736|NCT02449239|560254963|FG000|Maintenance Month 6|Lack of Efficacy|10|||
155222737|NCT02449239|560254963|FG000|Maintenance Month 6|Adverse Event|2|||
155222738|NCT02449239|560254963|FG000|Maintenance Month 6|Physician Decision|1|||
155222739|NCT02449239|560254963|FG000|Maintenance Month 9|Lack of Efficacy|2|||
155222740|NCT02449239|560254963|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
155222741|NCT02449239|560254963|FG000|Maintenance Month 12|Lack of Efficacy|5|||
155222742|NCT02449239|560254963|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
155222743|NCT02449239|560254963|FG000|Maintenance Month 12|Subject moved from area|1|||
155222744|NCT02449239|560254963|FG000|Maintenance Month 15|Lack of Efficacy|1|||
155222745|NCT02449239|560254963|FG000|Maintenance Month 21|Lack of Efficacy|1|||
155222746|NCT02449239|560254963|FG000|Maintenance Month 21|Sponsor decision|1|||
155222747|NCT03239470|560254964|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
155222748|NCT03239470|560254965|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
155222749|NCT01023581|560254966|FG000|Overall Study|Adverse Event|4|||
155222750|NCT01023581|560254967|FG001|Overall Study|Adverse Event|4|||
155222751|NCT01023581|560254968|FG002|Overall Study|Adverse Event|7|||
155222752|NCT01023581|560254969|FG003|Overall Study|Adverse Event|3|||
155222753|NCT01023581|560254970|FG004|Overall Study|Adverse Event|2|||
155222754|NCT01023581|560254971|FG005|Overall Study|Adverse Event|5|||
155222755|NCT01023581|560254972|FG006|Overall Study|Adverse Event|11|||
155222756|NCT01023581|560254966|FG000|Overall Study|Major protocol deviation|2|||
155222757|NCT01023581|560254967|FG001|Overall Study|Major protocol deviation|0|||
155222758|NCT01023581|560254968|FG002|Overall Study|Major protocol deviation|3|||
155222759|NCT01023581|560254969|FG003|Overall Study|Major protocol deviation|0|||
155222760|NCT01023581|560254970|FG004|Overall Study|Major protocol deviation|0|||
155222761|NCT01023581|560254971|FG005|Overall Study|Major protocol deviation|0|||
155222762|NCT01023581|560254972|FG006|Overall Study|Major protocol deviation|0|||
155222763|NCT01023581|560254966|FG000|Overall Study|Lost to Follow-up|4|||
155222764|NCT01023581|560254967|FG001|Overall Study|Lost to Follow-up|8|||
155222765|NCT01023581|560254968|FG002|Overall Study|Lost to Follow-up|7|||
155222766|NCT01023581|560254969|FG003|Overall Study|Lost to Follow-up|2|||
155222767|NCT01023581|560254970|FG004|Overall Study|Lost to Follow-up|5|||
155222768|NCT01023581|560254971|FG005|Overall Study|Lost to Follow-up|2|||
155222769|NCT01023581|560254972|FG006|Overall Study|Lost to Follow-up|2|||
155222770|NCT01023581|560254966|FG000|Overall Study|Withdrawal by Subject|13|||
155222771|NCT01023581|560254967|FG001|Overall Study|Withdrawal by Subject|8|||
155222772|NCT01023581|560254968|FG002|Overall Study|Withdrawal by Subject|16|||
155222773|NCT01023581|560254969|FG003|Overall Study|Withdrawal by Subject|10|||
155222774|NCT01023581|560254970|FG004|Overall Study|Withdrawal by Subject|6|||
155222775|NCT01023581|560254971|FG005|Overall Study|Withdrawal by Subject|8|||
155222776|NCT01023581|560254972|FG006|Overall Study|Withdrawal by Subject|5|||
155222777|NCT01023581|560254966|FG000|Overall Study|Pregnancy|0|||
155222778|NCT01023581|560254967|FG001|Overall Study|Pregnancy|0|||
155222779|NCT01023581|560254968|FG002|Overall Study|Pregnancy|0|||
155222780|NCT01023581|560254969|FG003|Overall Study|Pregnancy|2|||
155222781|NCT01023581|560254970|FG004|Overall Study|Pregnancy|0|||
155222782|NCT01023581|560254971|FG005|Overall Study|Pregnancy|1|||
155222783|NCT01023581|560254972|FG006|Overall Study|Pregnancy|0|||
155222784|NCT01023581|560254966|FG000|Overall Study|Lack of Efficacy|9|||
155222785|NCT01023581|560254967|FG001|Overall Study|Lack of Efficacy|3|||
155222786|NCT01023581|560254968|FG002|Overall Study|Lack of Efficacy|6|||
155222787|NCT01023581|560254969|FG003|Overall Study|Lack of Efficacy|2|||
155222788|NCT01023581|560254970|FG004|Overall Study|Lack of Efficacy|1|||
155222789|NCT01023581|560254971|FG005|Overall Study|Lack of Efficacy|2|||
155222790|NCT01023581|560254972|FG006|Overall Study|Lack of Efficacy|1|||
155222791|NCT01023581|560254966|FG000|Overall Study|Physician Decision|2|||
155222792|NCT01023581|560254967|FG001|Overall Study|Physician Decision|0|||
155222793|NCT01023581|560254968|FG002|Overall Study|Physician Decision|2|||
155222794|NCT01023581|560254969|FG003|Overall Study|Physician Decision|1|||
155222795|NCT01023581|560254970|FG004|Overall Study|Physician Decision|1|||
155222796|NCT01023581|560254971|FG005|Overall Study|Physician Decision|1|||
155222797|NCT01023581|560254972|FG006|Overall Study|Physician Decision|1|||
155222798|NCT01023581|560254966|FG000|Overall Study|Other|1|||
155222799|NCT01023581|560254967|FG001|Overall Study|Other|0|||
155222800|NCT01023581|560254968|FG002|Overall Study|Other|1|||
155222801|NCT01023581|560254969|FG003|Overall Study|Other|0|||
155222802|NCT01023581|560254970|FG004|Overall Study|Other|1|||
155222803|NCT01023581|560254971|FG005|Overall Study|Other|0|||
155222804|NCT01023581|560254972|FG006|Overall Study|Other|0|||
155222805|NCT01176292|560254976|FG000|Overall Study|Lost to Follow-up|2|||
155222806|NCT01176292|560254977|FG001|Overall Study|Lost to Follow-up|4|||
155222807|NCT01176292|560254976|FG000|Overall Study|Adverse Event|1|||
155222808|NCT01176292|560254977|FG001|Overall Study|Adverse Event|1|||
155222809|NCT01176292|560254976|FG000|Overall Study|Physician Decision|0|||
155222810|NCT01176292|560254977|FG001|Overall Study|Physician Decision|2|||
155222811|NCT01176292|560254976|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
155222812|NCT01176292|560254977|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
155222813|NCT00997503|560254978|FG000|Overall Study|Death|53|||
155222814|NCT00997503|560254978|FG000|Overall Study|Withdrawal by Subject|76|||
155222815|NCT00997503|560254978|FG000|Overall Study|Lost to Follow-up|33|||
155222816|NCT00997503|560254978|FG000|Overall Study|Adverse Event|3|||
155222817|NCT00997503|560254978|FG000|Overall Study|Physician Decision|10|||
155222818|NCT00997503|560254978|FG000|Overall Study|Missed 12-month follow-up|85|||
155222819|NCT00997503|560254978|FG000|Overall Study|Other reason|13|||
155222820|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
155222821|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
155222822|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
155222823|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
155222824|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
155222825|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
155222826|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
155222827|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
155222828|NCT00380393|560254979|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
155222829|NCT00380393|560254980|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
155222830|NCT00380393|560254979|FG000|Month 14|Withdrawal by Subject|9|||
155222831|NCT00380393|560254980|FG001|Month 14|Withdrawal by Subject|7|||
155222832|NCT00380393|560254979|FG000|Month 14|Death|1|||
155222833|NCT00380393|560254980|FG001|Month 14|Death|0|||
155222834|NCT00380393|560254979|FG000|Month 14|Lost to Follow-up|0|||
155222835|NCT00380393|560254980|FG001|Month 14|Lost to Follow-up|1|||
155222836|NCT00380393|560254979|FG000|Month 14|Migrated/moved from study area|39|||
155222837|NCT00380393|560254980|FG001|Month 14|Migrated/moved from study area|42|||
155222838|NCT00380393|560254979|FG000|Month 14|Protocol Violation|2|||
155222839|NCT00380393|560254980|FG001|Month 14|Protocol Violation|0|||
155222840|NCT00380393|560254979|FG000|Month 14|Others|6|||
155222841|NCT00380393|560254980|FG001|Month 14|Others|6|||
155222842|NCT01933048|560254981|FG000|Overall Study|Lost to Follow-up|15|||
155222843|NCT01933048|560254982|FG001|Overall Study|Lost to Follow-up|18|||
155222844|NCT01933048|560254981|FG000|Overall Study|personal reasons|1|||
155222845|NCT01933048|560254982|FG001|Overall Study|personal reasons|1|||
155222846|NCT01933048|560254981|FG000|Overall Study|Protocol Violation|7|||
155222847|NCT01933048|560254982|FG001|Overall Study|Protocol Violation|8|||
155222848|NCT01933048|560254981|FG000|Overall Study|Physician Decision|1|||
155222849|NCT01933048|560254982|FG001|Overall Study|Physician Decision|0|||
155222850|NCT01933048|560254981|FG000|Overall Study|unknown reasons|1|||
155222851|NCT01933048|560254982|FG001|Overall Study|unknown reasons|1|||
155222852|NCT02780804|560254983|FG000|Overall Study|Death|1|||
155222853|NCT02780804|560254984|FG001|Overall Study|Death|0|||
155222854|NCT02780804|560254985|FG002|Overall Study|Death|0|||
155222855|NCT02780804|560254983|FG000|Overall Study|Lack of Efficacy|5|||
155222856|NCT02780804|560254984|FG001|Overall Study|Lack of Efficacy|8|||
155222857|NCT02780804|560254985|FG002|Overall Study|Lack of Efficacy|4|||
155222858|NCT02780804|560254983|FG000|Overall Study|Physician Decision|0|||
155222859|NCT02780804|560254984|FG001|Overall Study|Physician Decision|0|||
155222860|NCT02780804|560254985|FG002|Overall Study|Physician Decision|2|||
155222861|NCT02780804|560254983|FG000|Overall Study|Withdrawal by Subject|0|||
155222862|NCT02780804|560254984|FG001|Overall Study|Withdrawal by Subject|1|||
155222863|NCT02780804|560254985|FG002|Overall Study|Withdrawal by Subject|0|||
155222864|NCT02476968|560254986|FG000|Overall Study|Other|0|||
155222865|NCT02476968|560254987|FG001|Overall Study|Other|2|||
155222866|NCT02476968|560254988|FG002|Overall Study|Other|0|||
155222867|NCT02476968|560254986|FG000|Overall Study|Lost to Follow-up|10|||
155222868|NCT02476968|560254987|FG001|Overall Study|Lost to Follow-up|0|||
155222869|NCT02476968|560254988|FG002|Overall Study|Lost to Follow-up|1|||
155222870|NCT02476968|560254986|FG000|Overall Study|Death|48|||
155222871|NCT02476968|560254987|FG001|Overall Study|Death|8|||
155222872|NCT02476968|560254988|FG002|Overall Study|Death|1|||
155222873|NCT02476968|560254986|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155222874|NCT02476968|560254987|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155222875|NCT02476968|560254988|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
155222876|NCT02476968|560254986|FG000|Overall Study|Patient decision|37|||
155222877|NCT02476968|560254987|FG001|Overall Study|Patient decision|8|||
155222878|NCT02476968|560254988|FG002|Overall Study|Patient decision|0|||
155222879|NCT03897179|560254995|FG000|Overall Study|Withdrawal by Subject|1|||
155222880|NCT01085097|560254999|FG000|Overall Study|Adverse Event|0|||
155222881|NCT01085097|560255000|FG001|Overall Study|Adverse Event|0|||
155222882|NCT01085097|560255001|FG002|Overall Study|Adverse Event|2|||
155222883|NCT01085097|560254999|FG000|Overall Study|Treatment failure|2|||
155222884|NCT01085097|560255000|FG001|Overall Study|Treatment failure|0|||
155222885|NCT01085097|560255001|FG002|Overall Study|Treatment failure|0|||
155222886|NCT01737047|560255004|FG000|Overall Study|Death|10|||
155222887|NCT01737047|560255005|FG001|Overall Study|Death|0|||
155222888|NCT01737047|560255006|FG002|Overall Study|Death|1|||
155222889|NCT01737047|560255004|FG000|Overall Study|Withdrawal by Subject|17|||
155222890|NCT01737047|560255005|FG001|Overall Study|Withdrawal by Subject|11|||
155222891|NCT01737047|560255006|FG002|Overall Study|Withdrawal by Subject|4|||
155222892|NCT06049043|560255007|FG000|Overall Study|Lost to Follow-up|11|||
155222893|NCT06049043|560255008|FG001|Overall Study|Lost to Follow-up|9|||
155222894|NCT03089606|560255009|FG000|Overall Study|Progression after Cycle 1|1|||
155222895|NCT00335972|560255010|FG000|Overall Study|not given treatments|0|||
155222896|NCT00335972|560255011|FG001|Overall Study|not given treatments|3|||
155222897|NCT02140567|560255014|FG000|Overall Study|Problems with recording equipment|6|||
155222898|NCT02802592|560255016|FG000|Overall Study|Study terminated due to loss of funding|4|||
155222899|NCT02882854|560255017|FG000|Overall Study|Lost to Follow-up|1|||
155222900|NCT02882854|560255018|FG001|Overall Study|Lost to Follow-up|2|||
155222901|NCT02882854|560255017|FG000|Overall Study|Physician Decision|0|||
155222902|NCT02882854|560255018|FG001|Overall Study|Physician Decision|1|||
155222903|NCT01358357|560255021|FG000|Open Label Phase|Adverse Event|0|||
155222904|NCT01358357|560255022|FG001|Open Label Phase|Adverse Event|0|||
155222905|NCT01358357|560255023|FG002|Open Label Phase|Adverse Event|59|||
155222906|NCT01358357|560255021|FG000|Open Label Phase|Lack of Efficacy|0|||
155222907|NCT01358357|560255022|FG001|Open Label Phase|Lack of Efficacy|0|||
155222908|NCT01358357|560255023|FG002|Open Label Phase|Lack of Efficacy|107|||
155222909|NCT01358357|560255021|FG000|Open Label Phase|Lost to Follow-up|0|||
155222910|NCT01358357|560255022|FG001|Open Label Phase|Lost to Follow-up|0|||
155222911|NCT01358357|560255023|FG002|Open Label Phase|Lost to Follow-up|76|||
155222912|NCT01358357|560255021|FG000|Open Label Phase|Protocol Violation|0|||
155222913|NCT01358357|560255022|FG001|Open Label Phase|Protocol Violation|0|||
155222914|NCT01358357|560255023|FG002|Open Label Phase|Protocol Violation|45|||
155222915|NCT01358357|560255021|FG000|Open Label Phase|Withdrawal by Subject|0|||
155222916|NCT01358357|560255022|FG001|Open Label Phase|Withdrawal by Subject|0|||
155222917|NCT01358357|560255023|FG002|Open Label Phase|Withdrawal by Subject|112|||
155222918|NCT01358357|560255021|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
155222919|NCT01358357|560255022|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
155222920|NCT01358357|560255023|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
155222921|NCT01358357|560255021|FG000|Open Label Phase|Terminated at study completion|0|||
155222922|NCT01358357|560255022|FG001|Open Label Phase|Terminated at study completion|0|||
155222923|NCT01358357|560255023|FG002|Open Label Phase|Terminated at study completion|5|||
155222924|NCT01358357|560255021|FG000|Open Label Phase|Mood episode|0|||
155222925|NCT01358357|560255022|FG001|Open Label Phase|Mood episode|0|||
155222926|NCT01358357|560255023|FG002|Open Label Phase|Mood episode|42|||
155222927|NCT01358357|560255021|FG000|Double-Blind Phase|Adverse Event|8|||
155222928|NCT01358357|560255022|FG001|Double-Blind Phase|Adverse Event|5|||
155222929|NCT01358357|560255023|FG002|Double-Blind Phase|Adverse Event|0|||
155222930|NCT01358357|560255021|FG000|Double-Blind Phase|Lost to Follow-up|5|||
155222931|NCT01358357|560255022|FG001|Double-Blind Phase|Lost to Follow-up|7|||
155222932|NCT01358357|560255023|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155222933|NCT01358357|560255021|FG000|Double-Blind Phase|Protocol Violation|1|||
155222934|NCT01358357|560255022|FG001|Double-Blind Phase|Protocol Violation|11|||
155222935|NCT01358357|560255023|FG002|Double-Blind Phase|Protocol Violation|0|||
155222936|NCT01358357|560255021|FG000|Double-Blind Phase|Protocol Violation|16|||
155222937|NCT01358357|560255022|FG001|Double-Blind Phase|Protocol Violation|12|||
155222938|NCT01358357|560255023|FG002|Double-Blind Phase|Protocol Violation|0|||
155222939|NCT01358357|560255021|FG000|Double-Blind Phase|Terminated at study completion|2|||
155222940|NCT01358357|560255022|FG001|Double-Blind Phase|Terminated at study completion|0|||
155222941|NCT01358357|560255023|FG002|Double-Blind Phase|Terminated at study completion|0|||
155222942|NCT01358357|560255021|FG000|Double-Blind Phase|Recurrence of mood event|48|||
155222943|NCT01358357|560255022|FG001|Double-Blind Phase|Recurrence of mood event|64|||
155222944|NCT01358357|560255023|FG002|Double-Blind Phase|Recurrence of mood event|0|||
155222945|NCT01358357|560255021|FG000|Double-Blind Phase|Administrative|0|||
155222946|NCT01358357|560255022|FG001|Double-Blind Phase|Administrative|1|||
155222947|NCT01358357|560255023|FG002|Double-Blind Phase|Administrative|0|||
155222948|NCT01826487|560255024|FG000|Overall Study|Adverse Event|1|||
155222949|NCT01826487|560255025|FG001|Overall Study|Adverse Event|1|||
155222950|NCT01826487|560255024|FG000|Overall Study|Lost to Follow-up|1|||
155222951|NCT01826487|560255025|FG001|Overall Study|Lost to Follow-up|0|||
155222952|NCT01826487|560255024|FG000|Overall Study|Withdrawal by Subject|1|||
155222953|NCT01826487|560255025|FG001|Overall Study|Withdrawal by Subject|3|||
155222954|NCT01826487|560255024|FG000|Overall Study|Protocol Violation|1|||
155222955|NCT01826487|560255025|FG001|Overall Study|Protocol Violation|1|||
155222956|NCT00729183|560255026|FG000|Overall Study|Adverse Event|11|||
155222957|NCT00729183|560255027|FG001|Overall Study|Adverse Event|5|||
155222958|NCT00729183|560255026|FG000|Overall Study|Lack of Efficacy|0|||
155222959|NCT00729183|560255027|FG001|Overall Study|Lack of Efficacy|1|||
155222960|NCT00729183|560255026|FG000|Overall Study|Lost to Follow-up|3|||
155222961|NCT00729183|560255027|FG001|Overall Study|Lost to Follow-up|1|||
155222962|NCT00729183|560255026|FG000|Overall Study|Physician Decision|1|||
155222963|NCT00729183|560255027|FG001|Overall Study|Physician Decision|1|||
155222964|NCT00729183|560255026|FG000|Overall Study|Protocol Violation|1|||
155222965|NCT00729183|560255027|FG001|Overall Study|Protocol Violation|0|||
155222966|NCT00729183|560255026|FG000|Overall Study|Withdrawal by Subject|9|||
155222967|NCT00729183|560255027|FG001|Overall Study|Withdrawal by Subject|7|||
155222968|NCT01359254|560255030|FG000|Overall Study|Death|1|||
155222969|NCT01359254|560255031|FG001|Overall Study|Death|0|||
155222970|NCT04668950|560255036|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
155222971|NCT04668950|560255037|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
155222972|NCT04668950|560255036|FG000|Overall Study|Could not confirm started study medication|15|||
155222973|NCT04668950|560255037|FG001|Overall Study|Could not confirm started study medication|15|||
155222974|NCT04668950|560255036|FG000|Overall Study|Could not confirm baseline status|6|||
155222975|NCT04668950|560255037|FG001|Overall Study|Could not confirm baseline status|2|||
155222976|NCT04668950|560255036|FG000|Overall Study|Drop out and did not start medication|15|||
155222977|NCT04668950|560255037|FG001|Overall Study|Drop out and did not start medication|17|||
155222978|NCT04668950|560255036|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
155222979|NCT04668950|560255037|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
155222980|NCT04668950|560255036|FG000|Overall Study|Other|2|||
155222981|NCT04668950|560255037|FG001|Overall Study|Other|4|||
155222982|NCT01124643|560255040|FG000|Overall Study|Death|1|||
155222983|NCT02028988|560255041|FG000|Overall Study|Withdrawal by Subject|2|||
155222984|NCT01342510|560255044|FG000|Overall Study|Protocol Violation|12|||
155222985|NCT01342510|560255045|FG001|Overall Study|Protocol Violation|6|||
155222986|NCT01342510|560255046|FG002|Overall Study|Protocol Violation|13|||
155222987|NCT01342510|560255047|FG003|Overall Study|Protocol Violation|11|||
155222988|NCT00323115|560255048|FG000|Vaccine Administration|Adverse Event|1|||
155222989|NCT00323115|560255048|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
155222990|NCT04365556|560255049|FG000|Overall Study|No longer eligible due to treatment plan|1|||
155222991|NCT04365556|560255050|FG001|Overall Study|No longer eligible due to treatment plan|0|||
155222992|NCT04365556|560255049|FG000|Overall Study|Lost to Follow-up|3|||
155222993|NCT04365556|560255050|FG001|Overall Study|Lost to Follow-up|2|||
155222994|NCT04439318|560255051|FG000|Overall Study|Ineligible|1|||
155222995|NCT04439318|560255051|FG000|Overall Study|Never Started Treatment|3|||
155222996|NCT04439318|560255051|FG000|Overall Study|Adverse Event|10|||
155222997|NCT04439318|560255051|FG000|Overall Study|Death|2|||
155222998|NCT04439318|560255051|FG000|Overall Study|Disease Progression|25|||
155222999|NCT04439318|560255051|FG000|Overall Study|Other Complicating Disease|2|||
155223000|NCT04439318|560255051|FG000|Overall Study|Withdrawal by Subject|4|||
155223001|NCT04439318|560255051|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
155223002|NCT04439318|560255051|FG000|Overall Study|Non-Compliance|1|||
155223003|NCT04439318|560255051|FG000|Overall Study|Still on Treatment|1|||
155223004|NCT02558790|560256929|FG000|Overall Study|Lost to Follow-up|2|||
155223005|NCT02558790|560256929|FG000|Overall Study|Physician Decision|1|||
155223006|NCT02558790|560256929|FG000|Overall Study|Withdrawal by Subject|1|||
155223007|NCT02558790|560256929|FG000|Overall Study|Screen Fail|3|||
155223008|NCT04476030|560256933|FG000|Overall Study|Withdrawal by Subject|20|||
155223009|NCT04476030|560256934|FG001|Overall Study|Withdrawal by Subject|16|||
155223010|NCT04476030|560256933|FG000|Overall Study|Adverse Event|10|||
155223011|NCT04476030|560256934|FG001|Overall Study|Adverse Event|11|||
155223012|NCT04476030|560256933|FG000|Overall Study|Lost to Follow-up|7|||
155223013|NCT04476030|560256934|FG001|Overall Study|Lost to Follow-up|4|||
155223014|NCT04476030|560256933|FG000|Overall Study|Physician Decision|1|||
155223015|NCT04476030|560256934|FG001|Overall Study|Physician Decision|1|||
155223016|NCT04476030|560256933|FG000|Overall Study|Protocol Deviation|2|||
155223017|NCT04476030|560256934|FG001|Overall Study|Protocol Deviation|0|||
155223018|NCT04476030|560256933|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
155223019|NCT04476030|560256934|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
155223020|NCT04476030|560256933|FG000|Overall Study|Randomized but not Dosed|2|||
155223021|NCT04476030|560256934|FG001|Overall Study|Randomized but not Dosed|8|||
155223022|NCT02042924|560256935|FG000|Overall Study|Early Death|1|||
155223023|NCT04920123|560256940|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155223024|NCT04920123|560256941|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
155223025|NCT04920123|560256942|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
155223026|NCT00278954|560256946|FG000|Overall Study|Adverse Event|3|||
155223027|NCT00278954|560256946|FG000|Overall Study|Lost to Follow-up|1|||
155223028|NCT00278954|560256946|FG000|Overall Study|Withdrawal by Subject|1|||
155223029|NCT02211131|560256950|FG000|Overall Study|Death|26|||
155223030|NCT02211131|560256951|FG001|Overall Study|Death|16|||
155223031|NCT02211131|560256950|FG000|Overall Study|Lost to Follow-up|4|||
155223032|NCT02211131|560256951|FG001|Overall Study|Lost to Follow-up|3|||
155223033|NCT02211131|560256950|FG000|Overall Study|Decision by Sponsor|1|||
155223034|NCT02211131|560256951|FG001|Overall Study|Decision by Sponsor|1|||
155223035|NCT02211131|560256950|FG000|Overall Study|Withdrawal by Subject|3|||
155223036|NCT02211131|560256951|FG001|Overall Study|Withdrawal by Subject|8|||
155223037|NCT05664490|560256952|FG000|Overall Study|Withdrawal by Subject|0|||
155223038|NCT05664490|560256953|FG001|Overall Study|Withdrawal by Subject|1|||
155223039|NCT05664490|560256952|FG000|Overall Study|Lost to Follow-up|14|||
155223040|NCT05664490|560256953|FG001|Overall Study|Lost to Follow-up|22|||
155223041|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
155223042|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
155223043|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
155223044|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
155223045|NCT01589445|560256958|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
155223046|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
155223047|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
155223048|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
155223049|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
155223050|NCT01589445|560256958|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
155223051|NCT01990495|560256959|FG000|Overall Study|Physician Decision|5|||
155223052|NCT01990495|560256960|FG001|Overall Study|Physician Decision|4|||
155223053|NCT03412084|560256961|FG000|Overall Study|Withdrawal by Subject|2|||
155223054|NCT03412084|560256962|FG001|Overall Study|Withdrawal by Subject|0|||
155223055|NCT03412084|560256961|FG000|Overall Study|Participant moved|1|||
155223056|NCT03412084|560256962|FG001|Overall Study|Participant moved|0|||
155223057|NCT03412084|560256961|FG000|Overall Study|Lost to Follow-up|1|||
155223058|NCT03412084|560256962|FG001|Overall Study|Lost to Follow-up|1|||
155223059|NCT01928862|560256968|FG000|Overall Study|Lost to Follow-up|1|||
155223060|NCT01928862|560256969|FG001|Overall Study|Lost to Follow-up|0|||
155223061|NCT01928862|560256970|FG002|Overall Study|Lost to Follow-up|0|||
155223062|NCT01928862|560256971|FG003|Overall Study|Lost to Follow-up|0|||
155223063|NCT01928862|560256972|FG004|Overall Study|Lost to Follow-up|1|||
155223064|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
155223065|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
155223066|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
155223067|NCT01478321|560256973|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
155223068|NCT01478321|560256973|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
155223069|NCT01478321|560256973|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
155223070|NCT01478321|560256973|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
155223071|NCT01478321|560256973|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
155223072|NCT00314574|560256978|FG000|Overall Study|Death|3|||
155223073|NCT00314574|560256979|FG001|Overall Study|Death|0|||
155223074|NCT00314574|560256978|FG000|Overall Study|Adverse Event|11|||
155223075|NCT00314574|560256979|FG001|Overall Study|Adverse Event|16|||
155223076|NCT00314574|560256978|FG000|Overall Study|Lost to Follow-up|19|||
155223077|NCT00314574|560256979|FG001|Overall Study|Lost to Follow-up|25|||
155223078|NCT00314574|560256978|FG000|Overall Study|Withdrawal by Subject|33|||
155223079|NCT00314574|560256979|FG001|Overall Study|Withdrawal by Subject|22|||
155223080|NCT00314574|560256978|FG000|Overall Study|Physician Decision|22|||
155223081|NCT00314574|560256979|FG001|Overall Study|Physician Decision|15|||
155223082|NCT00314574|560256978|FG000|Overall Study|Pregnancy|6|||
155223083|NCT00314574|560256979|FG001|Overall Study|Pregnancy|4|||
155223084|NCT00314574|560256978|FG000|Overall Study|Data unknown at database lock|0|||
155223085|NCT00314574|560256979|FG001|Overall Study|Data unknown at database lock|1|||
155223086|NCT02053753|560256984|FG000|Overall Study|Withdrawal by Subject|2|||
155223087|NCT02053753|560256985|FG001|Overall Study|Withdrawal by Subject|4|||
155223088|NCT02053753|560256984|FG000|Overall Study|Decision by Sponsor|1|||
155223089|NCT02053753|560256985|FG001|Overall Study|Decision by Sponsor|1|||
155223090|NCT02053753|560256984|FG000|Overall Study|Lost to Follow-up|4|||
155223091|NCT02053753|560256985|FG001|Overall Study|Lost to Follow-up|3|||
155223092|NCT00449956|560256986|FG000|Overall Study|Adverse Event|7|||
155223093|NCT00449956|560256987|FG001|Overall Study|Adverse Event|1|||
155223094|NCT00449956|560256988|FG002|Overall Study|Adverse Event|6|||
155223095|NCT00449956|560256986|FG000|Overall Study|Lack of Efficacy|0|||
155223096|NCT00449956|560256987|FG001|Overall Study|Lack of Efficacy|0|||
155223097|NCT00449956|560256988|FG002|Overall Study|Lack of Efficacy|1|||
155223098|NCT00449956|560256986|FG000|Overall Study|Protocol Violation|1|||
155223099|NCT00449956|560256987|FG001|Overall Study|Protocol Violation|1|||
155223100|NCT00449956|560256988|FG002|Overall Study|Protocol Violation|1|||
155223101|NCT00449956|560256986|FG000|Overall Study|Withdrawal by Subject|0|||
155223102|NCT00449956|560256987|FG001|Overall Study|Withdrawal by Subject|1|||
155223103|NCT00449956|560256988|FG002|Overall Study|Withdrawal by Subject|0|||
155223104|NCT00449956|560256986|FG000|Overall Study|Physician Decision|2|||
155223105|NCT00449956|560256987|FG001|Overall Study|Physician Decision|1|||
155223106|NCT00449956|560256988|FG002|Overall Study|Physician Decision|1|||
155223107|NCT02972632|560256997|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155223108|NCT02972632|560256997|FG000|Overall Study|Lost to Follow-up|4|||
155223109|NCT02972632|560256997|FG000|Overall Study|Voluntary Withdrawal|10|||
155223110|NCT01828034|560256998|FG000|Overall Study|Withdrawal by Subject|0|||
155223111|NCT01828034|560256999|FG001|Overall Study|Withdrawal by Subject|0|||
155223112|NCT01828034|560257000|FG002|Overall Study|Withdrawal by Subject|0|||
155223113|NCT01828034|560257001|FG003|Overall Study|Withdrawal by Subject|1|||
155223114|NCT02023151|560257002|FG000|Overall Study|Lost to Follow-up|4|||
155223115|NCT04064294|560257003|FG000|Overall Study|Adverse Event|1|||
155223116|NCT04064294|560257004|FG001|Overall Study|Adverse Event|0|||
155223117|NCT04064294|560257005|FG002|Overall Study|Adverse Event|0|||
155223118|NCT03450707|560257006|FG000|Overall Study|Outside enrollment window|4|||
155223119|NCT03450707|560257007|FG001|Overall Study|Outside enrollment window|1|||
155223120|NCT03450707|560257006|FG000|Overall Study|Death|1|||
155223121|NCT03450707|560257007|FG001|Overall Study|Death|0|||
155223122|NCT03450707|560257006|FG000|Overall Study|Indication for thiamine|1|||
155223123|NCT03450707|560257007|FG001|Overall Study|Indication for thiamine|1|||
155223124|NCT03450707|560257006|FG000|Overall Study|Evidence of traumatic brain injury|1|||
155223125|NCT03450707|560257007|FG001|Overall Study|Evidence of traumatic brain injury|0|||
155223126|NCT03450707|560257006|FG000|Overall Study|Following commands|0|||
155223127|NCT03450707|560257007|FG001|Overall Study|Following commands|3|||
155223128|NCT03450707|560257006|FG000|Overall Study|Lactate < 3.5|0|||
155223129|NCT03450707|560257007|FG001|Overall Study|Lactate < 3.5|2|||
155223130|NCT03450707|560257006|FG000|Overall Study|Rearrest with ECMO|0|||
155223131|NCT03450707|560257007|FG001|Overall Study|Rearrest with ECMO|1|||
155223132|NCT03450707|560257006|FG000|Overall Study|Indication for thiamine + head CT results|0|||
155223133|NCT03450707|560257007|FG001|Overall Study|Indication for thiamine + head CT results|1|||
155223134|NCT03450707|560257006|FG000|Overall Study|Family/patient goals of care|0|||
155223135|NCT03450707|560257007|FG001|Overall Study|Family/patient goals of care|1|||
155223136|NCT01988571|560257008|FG000|Overall Study|Death|3|||
155223137|NCT01988571|560257009|FG001|Overall Study|Death|1|||
155223138|NCT01988571|560257008|FG000|Overall Study|Physician Decision|2|||
155223139|NCT01988571|560257009|FG001|Overall Study|Physician Decision|1|||
155223140|NCT01988571|560257008|FG000|Overall Study|Lost to Follow-up|3|||
155223141|NCT01988571|560257009|FG001|Overall Study|Lost to Follow-up|0|||
155223142|NCT01988571|560257008|FG000|Overall Study|Withdrawal by Subject|31|||
155223143|NCT01988571|560257009|FG001|Overall Study|Withdrawal by Subject|33|||
155223144|NCT00481195|560257013|FG000|Overall Study|Adverse Event|16|||
155223145|NCT00481195|560257014|FG001|Overall Study|Adverse Event|11|||
155223146|NCT00481195|560257013|FG000|Overall Study|Lack of Efficacy|1|||
155223147|NCT00481195|560257014|FG001|Overall Study|Lack of Efficacy|3|||
155223148|NCT00481195|560257013|FG000|Overall Study|Lost to Follow-up|4|||
155223149|NCT00481195|560257014|FG001|Overall Study|Lost to Follow-up|6|||
155223150|NCT00481195|560257013|FG000|Overall Study|Physician Decision|3|||
155223151|NCT00481195|560257014|FG001|Overall Study|Physician Decision|1|||
155223152|NCT00481195|560257013|FG000|Overall Study|Protocol Violation|10|||
155223153|NCT00481195|560257014|FG001|Overall Study|Protocol Violation|7|||
155223154|NCT00481195|560257013|FG000|Overall Study|Withdrawal by Subject|3|||
155223155|NCT00481195|560257014|FG001|Overall Study|Withdrawal by Subject|9|||
155223156|NCT00481195|560257013|FG000|Overall Study|Miscellaneous|2|||
155223157|NCT00481195|560257014|FG001|Overall Study|Miscellaneous|2|||
155223158|NCT02932904|560257022|FG000|Overall Study|Reason not Specified|1|||
155223159|NCT02932904|560257023|FG001|Overall Study|Reason not Specified|0|||
155223160|NCT02932904|560257024|FG002|Overall Study|Reason not Specified|2|||
155223161|NCT02932904|560257025|FG003|Overall Study|Reason not Specified|2|||
155223162|NCT02932904|560257022|FG000|Overall Study|Noncompliance with Study Drug|2|||
155223163|NCT02932904|560257023|FG001|Overall Study|Noncompliance with Study Drug|3|||
155223164|NCT02932904|560257024|FG002|Overall Study|Noncompliance with Study Drug|3|||
155223165|NCT02932904|560257025|FG003|Overall Study|Noncompliance with Study Drug|4|||
155223166|NCT02932904|560257022|FG000|Overall Study|Pregnancy|0|||
155223167|NCT02932904|560257023|FG001|Overall Study|Pregnancy|1|||
155223168|NCT02932904|560257024|FG002|Overall Study|Pregnancy|1|||
155223169|NCT02932904|560257025|FG003|Overall Study|Pregnancy|0|||
155223170|NCT02932904|560257022|FG000|Overall Study|Study Termination|0|||
155223171|NCT02932904|560257023|FG001|Overall Study|Study Termination|1|||
155223172|NCT02932904|560257024|FG002|Overall Study|Study Termination|0|||
155223173|NCT02932904|560257025|FG003|Overall Study|Study Termination|0|||
155223174|NCT02932904|560257022|FG000|Overall Study|Voluntary Withdrawal|2|||
155223175|NCT02932904|560257023|FG001|Overall Study|Voluntary Withdrawal|1|||
155223176|NCT02932904|560257024|FG002|Overall Study|Voluntary Withdrawal|4|||
155223177|NCT02932904|560257025|FG003|Overall Study|Voluntary Withdrawal|2|||
155223178|NCT02932904|560257022|FG000|Overall Study|Lost to Follow-up|5|||
155223179|NCT02932904|560257023|FG001|Overall Study|Lost to Follow-up|3|||
155223180|NCT02932904|560257024|FG002|Overall Study|Lost to Follow-up|6|||
155223181|NCT02932904|560257025|FG003|Overall Study|Lost to Follow-up|0|||
155223182|NCT02932904|560257022|FG000|Overall Study|Significant Protocol Deviation|2|||
155223183|NCT02932904|560257023|FG001|Overall Study|Significant Protocol Deviation|3|||
155223184|NCT02932904|560257024|FG002|Overall Study|Significant Protocol Deviation|6|||
155223185|NCT02932904|560257025|FG003|Overall Study|Significant Protocol Deviation|1|||
155223186|NCT02932904|560257022|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155223187|NCT02932904|560257023|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
155223188|NCT02932904|560257024|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
155223189|NCT02932904|560257025|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
155223190|NCT02932904|560257022|FG000|Overall Study|Randomized But Not Treated|1|||
155223191|NCT02932904|560257023|FG001|Overall Study|Randomized But Not Treated|1|||
155223192|NCT02932904|560257024|FG002|Overall Study|Randomized But Not Treated|0|||
155223193|NCT02932904|560257025|FG003|Overall Study|Randomized But Not Treated|2|||
155223194|NCT03144180|560257029|FG000|Overall Study|STAT Delivery|1|||
155223195|NCT03144180|560257030|FG001|Overall Study|STAT Delivery|1|||
155223196|NCT03144180|560257029|FG000|Overall Study|Provider forgot to fill out forms|1|||
155223197|NCT03144180|560257030|FG001|Overall Study|Provider forgot to fill out forms|3|||
155223198|NCT03144180|560257029|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
155223199|NCT03144180|560257030|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
155223200|NCT03144180|560257029|FG000|Overall Study|Scrub tech removed tube cap|0|||
155223201|NCT03144180|560257030|FG001|Overall Study|Scrub tech removed tube cap|1|||
155223202|NCT00337103|560257031|FG000|Overall Study|Progressive Disease|414|||
155223203|NCT00337103|560257032|FG001|Overall Study|Progressive Disease|410|||
155223204|NCT00337103|560257031|FG000|Overall Study|Adverse Event|45|||
155223205|NCT00337103|560257032|FG001|Overall Study|Adverse Event|59|||
155223206|NCT00337103|560257031|FG000|Overall Study|Subject Choice|34|||
155223207|NCT00337103|560257032|FG001|Overall Study|Subject Choice|27|||
155223208|NCT00337103|560257031|FG000|Overall Study|Clinical Progression|27|||
155223209|NCT00337103|560257032|FG001|Overall Study|Clinical Progression|24|||
155223210|NCT00337103|560257031|FG000|Overall Study|Physician Decision|15|||
155223211|NCT00337103|560257032|FG001|Overall Study|Physician Decision|14|||
155223212|NCT00337103|560257031|FG000|Overall Study|Withdrawal by Subject|8|||
155223213|NCT00337103|560257032|FG001|Overall Study|Withdrawal by Subject|5|||
155223214|NCT00337103|560257031|FG000|Overall Study|Other|5|||
155223215|NCT00337103|560257032|FG001|Overall Study|Other|6|||
155223216|NCT00337103|560257031|FG000|Overall Study|Entry Criteria Not Met|4|||
155223217|NCT00337103|560257032|FG001|Overall Study|Entry Criteria Not Met|1|||
155223218|NCT00337103|560257031|FG000|Overall Study|Lost to Follow-up|1|||
155223219|NCT00337103|560257032|FG001|Overall Study|Lost to Follow-up|2|||
155223220|NCT00337103|560257031|FG000|Overall Study|Death|1|||
155223221|NCT00337103|560257032|FG001|Overall Study|Death|0|||
155223222|NCT02016482|560257035|FG000|Period A|Adverse Event|3|||
155223223|NCT02016482|560257036|FG001|Period A|Adverse Event|5|||
155223224|NCT02016482|560257035|FG000|Period A|Withdrawal by Subject|3|||
155223225|NCT02016482|560257036|FG001|Period A|Withdrawal by Subject|4|||
155223226|NCT02016482|560257035|FG000|Period A|Lost to Follow-up|3|||
155223227|NCT02016482|560257036|FG001|Period A|Lost to Follow-up|3|||
155223228|NCT02016482|560257035|FG000|Period A|Lack of Efficacy|2|||
155223229|NCT02016482|560257036|FG001|Period A|Lack of Efficacy|1|||
155223230|NCT02016482|560257035|FG000|Period A|Other|3|||
155223231|NCT02016482|560257036|FG001|Period A|Other|0|||
155223232|NCT02016482|560257035|FG000|Period A|Protocol Violation|0|||
155223233|NCT02016482|560257036|FG001|Period A|Protocol Violation|1|||
155223234|NCT02016482|560257035|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
155223235|NCT02016482|560257036|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
155223236|NCT02016482|560257035|FG000|Period B|Withdrawal by Subject|1|||
155223237|NCT02016482|560257036|FG001|Period B|Withdrawal by Subject|1|||
155223238|NCT02016482|560257035|FG000|Period B|Lost to Follow-up|2|||
155223239|NCT02016482|560257036|FG001|Period B|Lost to Follow-up|0|||
155223240|NCT02016482|560257035|FG000|Period B|Lack of Efficacy|6|||
155223241|NCT02016482|560257036|FG001|Period B|Lack of Efficacy|4|||
155223242|NCT02016482|560257035|FG000|Period B|Other|4|||
155223243|NCT02016482|560257036|FG001|Period B|Other|0|||
155223244|NCT02016482|560257035|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
155223245|NCT02016482|560257036|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
155223246|NCT03387813|560257037|FG000|Overall Study|Death|40|||
155223247|NCT03387813|560257038|FG001|Overall Study|Death|37|||
155223248|NCT03387813|560257039|FG002|Overall Study|Death|190|||
155223249|NCT03387813|560257037|FG000|Overall Study|Withdrawal by Subject|9|||
155223250|NCT03387813|560257038|FG001|Overall Study|Withdrawal by Subject|19|||
155223251|NCT03387813|560257039|FG002|Overall Study|Withdrawal by Subject|32|||
155223252|NCT03387813|560257037|FG000|Overall Study|Lost to Follow-up|3|||
155223253|NCT03387813|560257038|FG001|Overall Study|Lost to Follow-up|9|||
155223254|NCT03387813|560257039|FG002|Overall Study|Lost to Follow-up|15|||
155223255|NCT03387813|560257037|FG000|Overall Study|Non-Compliance|6|||
155223256|NCT03387813|560257038|FG001|Overall Study|Non-Compliance|6|||
155223257|NCT03387813|560257039|FG002|Overall Study|Non-Compliance|31|||
155223258|NCT03387813|560257037|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
155223259|NCT03387813|560257038|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
155223260|NCT03387813|560257039|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
155223261|NCT01289847|560257040|FG000|Overall Study|Patient could not comply with visits|1|||
155223262|NCT02063737|560257054|FG000|Overall Study|Lost to Follow-up|11|||
155223263|NCT02063737|560257055|FG001|Overall Study|Lost to Follow-up|4|||
155223264|NCT00439556|560257058|FG000|Overall Study|Patient was taken off study for non-comp|0|||
155223265|NCT00439556|560257059|FG001|Overall Study|Patient was taken off study for non-comp|1|||
155223266|NCT00439556|560257060|FG002|Overall Study|Patient was taken off study for non-comp|0|||
155223267|NCT03818516|560257061|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
155223268|NCT04372602|560257064|FG000|Overall Study|Withdrawal by Subject|1|||
155223269|NCT04372602|560257065|FG001|Overall Study|Withdrawal by Subject|1|||
155223270|NCT04372602|560257064|FG000|Overall Study|Adverse Event|0|||
155223271|NCT04372602|560257065|FG001|Overall Study|Adverse Event|1|||
155223272|NCT04372602|560257064|FG000|Overall Study|Transitioned to comfort care|0|||
155223273|NCT04372602|560257065|FG001|Overall Study|Transitioned to comfort care|1|||
155223274|NCT01324388|560257066|FG000|Part 1 of Study|Adverse Event|2|||
155223275|NCT01324388|560257067|FG001|Part 1 of Study|Adverse Event|0|||
155223276|NCT01324388|560257068|FG002|Part 1 of Study|Adverse Event|0|||
155223277|NCT01324388|560257069|FG003|Part 1 of Study|Adverse Event|0|||
155223278|NCT01324388|560257066|FG000|Part 1 of Study|Protocol Violation|1|||
155223279|NCT01324388|560257067|FG001|Part 1 of Study|Protocol Violation|2|||
155223280|NCT01324388|560257068|FG002|Part 1 of Study|Protocol Violation|0|||
155223281|NCT01324388|560257069|FG003|Part 1 of Study|Protocol Violation|0|||
155223282|NCT01324388|560257066|FG000|Part 1 of Study|Physician Decision|1|||
155223283|NCT01324388|560257067|FG001|Part 1 of Study|Physician Decision|0|||
155223284|NCT01324388|560257068|FG002|Part 1 of Study|Physician Decision|0|||
155223285|NCT01324388|560257069|FG003|Part 1 of Study|Physician Decision|0|||
155223286|NCT01324388|560257066|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
155223287|NCT01324388|560257067|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
155223288|NCT01324388|560257068|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
155223289|NCT01324388|560257069|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
155223290|NCT01324388|560257066|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
155223291|NCT01324388|560257067|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
155223292|NCT01324388|560257068|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
155223293|NCT01324388|560257069|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
155223294|NCT01405963|560257070|FG000|Overall Study|Moved Away|2|||
155223295|NCT01405963|560257071|FG001|Overall Study|Moved Away|0|||
155223296|NCT01405963|560257070|FG000|Overall Study|Adverse Event|0|||
155223297|NCT01405963|560257071|FG001|Overall Study|Adverse Event|1|||
155223298|NCT01405963|560257070|FG000|Overall Study|Lost to Follow-up|0|||
155223299|NCT01405963|560257071|FG001|Overall Study|Lost to Follow-up|1|||
155223300|NCT03742141|560257074|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
155223301|NCT01498640|560257075|FG000|Overall Study|Lost to Follow-up|1|||
155223302|NCT01498640|560257075|FG000|Overall Study|Death|1|||
155223303|NCT01498640|560257075|FG000|Overall Study|Other|3|||
155223304|NCT00850395|560257080|FG000|Overall Study|Death|1|||
155223305|NCT00850395|560257080|FG000|Overall Study|Adverse Event|1|||
155223306|NCT00850395|560257080|FG000|Overall Study|Insufficient clinical response|3|||
155223307|NCT00850395|560257080|FG000|Overall Study|Other|5|||
155223308|NCT00129129|560257081|FG000|Primary Phase|Adverse Event|2|||
155223309|NCT00129129|560257082|FG001|Primary Phase|Adverse Event|1|||
155223310|NCT00129129|560257083|FG002|Primary Phase|Adverse Event|0|||
155223311|NCT00129129|560257084|FG003|Primary Phase|Adverse Event|0|||
155223312|NCT00129129|560257085|FG004|Primary Phase|Adverse Event|0|||
155223313|NCT00129129|560257081|FG000|Primary Phase|Withdrawal by Subject|12|||
155223314|NCT00129129|560257082|FG001|Primary Phase|Withdrawal by Subject|10|||
155223315|NCT00129129|560257083|FG002|Primary Phase|Withdrawal by Subject|0|||
155223316|NCT00129129|560257084|FG003|Primary Phase|Withdrawal by Subject|0|||
155223317|NCT00129129|560257085|FG004|Primary Phase|Withdrawal by Subject|0|||
155223318|NCT00129129|560257081|FG000|Primary Phase|Migration from study area|1|||
155223319|NCT00129129|560257082|FG001|Primary Phase|Migration from study area|3|||
155223320|NCT00129129|560257083|FG002|Primary Phase|Migration from study area|0|||
155223321|NCT00129129|560257084|FG003|Primary Phase|Migration from study area|0|||
155223322|NCT00129129|560257085|FG004|Primary Phase|Migration from study area|0|||
155223323|NCT00129129|560257081|FG000|Primary Phase|Lost to Follow-up|8|||
155223324|NCT00129129|560257082|FG001|Primary Phase|Lost to Follow-up|6|||
155223325|NCT00129129|560257083|FG002|Primary Phase|Lost to Follow-up|0|||
155223326|NCT00129129|560257084|FG003|Primary Phase|Lost to Follow-up|0|||
155223327|NCT00129129|560257085|FG004|Primary Phase|Lost to Follow-up|0|||
155223328|NCT00129129|560257081|FG000|Primary Phase|Other|2|||
155223329|NCT00129129|560257082|FG001|Primary Phase|Other|5|||
155223330|NCT00129129|560257083|FG002|Primary Phase|Other|0|||
155223331|NCT00129129|560257084|FG003|Primary Phase|Other|0|||
155223332|NCT00129129|560257085|FG004|Primary Phase|Other|0|||
155223333|NCT00129129|560257081|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
155223334|NCT00129129|560257082|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
155223335|NCT00129129|560257083|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
155223336|NCT00129129|560257084|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
155223337|NCT00129129|560257085|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
155223338|NCT00129129|560257081|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
155223339|NCT00129129|560257082|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
155223340|NCT00129129|560257083|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
155223341|NCT00129129|560257084|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
155223342|NCT00129129|560257085|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
155223343|NCT00129129|560257081|FG000|Fourth Dose Phase|Migration from study area|0|||
155223344|NCT00129129|560257082|FG001|Fourth Dose Phase|Migration from study area|0|||
155223345|NCT00129129|560257083|FG002|Fourth Dose Phase|Migration from study area|0|||
155223346|NCT00129129|560257084|FG003|Fourth Dose Phase|Migration from study area|0|||
155223347|NCT00129129|560257085|FG004|Fourth Dose Phase|Migration from study area|2|||
155223348|NCT00129129|560257081|FG000|Fourth Dose Phase|Other|0|||
155223349|NCT00129129|560257082|FG001|Fourth Dose Phase|Other|0|||
155223350|NCT00129129|560257083|FG002|Fourth Dose Phase|Other|0|||
155223351|NCT00129129|560257084|FG003|Fourth Dose Phase|Other|1|||
155223352|NCT00129129|560257085|FG004|Fourth Dose Phase|Other|1|||
155223353|NCT00129129|560257081|FG000|Fourth Dose Phase|Protocol Violation|0|||
155223354|NCT00129129|560257082|FG001|Fourth Dose Phase|Protocol Violation|0|||
155223355|NCT00129129|560257083|FG002|Fourth Dose Phase|Protocol Violation|0|||
155223356|NCT00129129|560257084|FG003|Fourth Dose Phase|Protocol Violation|1|||
155223357|NCT00129129|560257085|FG004|Fourth Dose Phase|Protocol Violation|0|||
155223358|NCT03774433|560257088|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
155223359|NCT00108160|560257089|FG000|Overall Study|Lost to Follow-up|25|||
155223360|NCT00108160|560257090|FG001|Overall Study|Lost to Follow-up|12|||
155223361|NCT00108160|560257089|FG000|Overall Study|Death|1|||
155223362|NCT00108160|560257090|FG001|Overall Study|Death|2|||
155223363|NCT00108160|560257089|FG000|Overall Study|Withdrawal by Subject|4|||
155223364|NCT00108160|560257090|FG001|Overall Study|Withdrawal by Subject|2|||
155223365|NCT00108160|560257089|FG000|Overall Study|Protocol Violation|9|||
155223366|NCT00108160|560257090|FG001|Overall Study|Protocol Violation|5|||
155223367|NCT01062555|560257091|FG000|Phase 1|Death|10|||
155223368|NCT01062555|560257092|FG001|Phase 1|Death|17|||
155223369|NCT01062555|560257093|FG002|Phase 1|Death|0|||
155223370|NCT01062555|560257094|FG003|Phase 1|Death|0|||
155223371|NCT01062555|560257091|FG000|Phase 1|Graft Failure|12|||
155223372|NCT01062555|560257092|FG001|Phase 1|Graft Failure|8|||
155223373|NCT01062555|560257093|FG002|Phase 1|Graft Failure|0|||
155223374|NCT01062555|560257094|FG003|Phase 1|Graft Failure|0|||
155223375|NCT01062555|560257091|FG000|Phase 1|Withdrawal by Subject|1|||
155223376|NCT01062555|560257092|FG001|Phase 1|Withdrawal by Subject|1|||
155223377|NCT01062555|560257093|FG002|Phase 1|Withdrawal by Subject|0|||
155223378|NCT01062555|560257094|FG003|Phase 1|Withdrawal by Subject|0|||
155223379|NCT01062555|560257091|FG000|Phase 2|Death|0|||
155223380|NCT01062555|560257092|FG001|Phase 2|Death|0|||
155223381|NCT01062555|560257093|FG002|Phase 2|Death|8|||
155223382|NCT01062555|560257094|FG003|Phase 2|Death|3|||
155223383|NCT01062555|560257091|FG000|Phase 2|Graft failure|0|||
155223384|NCT01062555|560257092|FG001|Phase 2|Graft failure|0|||
155223385|NCT01062555|560257093|FG002|Phase 2|Graft failure|7|||
155223386|NCT01062555|560257094|FG003|Phase 2|Graft failure|4|||
155223387|NCT01062555|560257091|FG000|Phase 2|Withdrawal by Subject|0|||
155223388|NCT01062555|560257092|FG001|Phase 2|Withdrawal by Subject|0|||
155223389|NCT01062555|560257093|FG002|Phase 2|Withdrawal by Subject|0|||
155223390|NCT01062555|560257094|FG003|Phase 2|Withdrawal by Subject|7|||
155223391|NCT01062555|560257091|FG000|Phase 2|Protocol Violation|0|||
155223392|NCT01062555|560257092|FG001|Phase 2|Protocol Violation|0|||
155223393|NCT01062555|560257093|FG002|Phase 2|Protocol Violation|0|||
155223394|NCT01062555|560257094|FG003|Phase 2|Protocol Violation|3|||
155223395|NCT01062555|560257091|FG000|Phase 2|Physician Decision|0|||
155223396|NCT01062555|560257092|FG001|Phase 2|Physician Decision|0|||
155223397|NCT01062555|560257093|FG002|Phase 2|Physician Decision|0|||
155223398|NCT01062555|560257094|FG003|Phase 2|Physician Decision|17|||
155223399|NCT04837131|560257095|FG000|Overall Study|Death|1|||
155223400|NCT04837131|560257095|FG000|Overall Study|Withdrawal by Subject|1|||
155223401|NCT04837131|560257095|FG000|Overall Study|Adverse Event|1|||
155223402|NCT04837131|560257095|FG000|Overall Study|Protocol Violation|1|||
155223403|NCT00403273|560258298|FG000|Overall Study|Lost to Follow-up|3|||
155223404|NCT00403273|560258299|FG001|Overall Study|Lost to Follow-up|2|||
155223405|NCT00403273|560258298|FG000|Overall Study|Physician Decision|0|||
155223406|NCT00403273|560258299|FG001|Overall Study|Physician Decision|1|||
155223407|NCT00403273|560258298|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
155223408|NCT00403273|560258299|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
155223409|NCT00589108|560258300|FG000|Overall Study|Lost to Follow-up|1|||
155223410|NCT00589108|560258301|FG001|Overall Study|Lost to Follow-up|1|||
155223411|NCT00589108|560258302|FG002|Overall Study|Lost to Follow-up|1|||
155223412|NCT00589108|560258300|FG000|Overall Study|Death|3|||
155223413|NCT00589108|560258301|FG001|Overall Study|Death|3|||
155223414|NCT00589108|560258302|FG002|Overall Study|Death|4|||
155223415|NCT03026257|560258304|FG000|Overall Study|Adverse Event|3|||
155223416|NCT03026257|560258305|FG001|Overall Study|Adverse Event|0|||
155223417|NCT03026257|560258306|FG002|Overall Study|Adverse Event|0|||
155223418|NCT03026257|560258307|FG003|Overall Study|Adverse Event|0|||
155223419|NCT03026257|560258308|FG004|Overall Study|Adverse Event|0|||
155223420|NCT03026257|560258309|FG005|Overall Study|Adverse Event|0|||
155223421|NCT03026257|560258304|FG000|Overall Study|Lost to Follow-up|1|||
155223422|NCT03026257|560258305|FG001|Overall Study|Lost to Follow-up|0|||
155223423|NCT03026257|560258306|FG002|Overall Study|Lost to Follow-up|0|||
155223424|NCT03026257|560258307|FG003|Overall Study|Lost to Follow-up|0|||
155223425|NCT03026257|560258308|FG004|Overall Study|Lost to Follow-up|0|||
155223426|NCT03026257|560258309|FG005|Overall Study|Lost to Follow-up|0|||
155223427|NCT03026257|560258304|FG000|Overall Study|Protocol Violation|1|||
155223428|NCT03026257|560258305|FG001|Overall Study|Protocol Violation|0|||
155223429|NCT03026257|560258306|FG002|Overall Study|Protocol Violation|0|||
155223430|NCT03026257|560258307|FG003|Overall Study|Protocol Violation|1|||
155223431|NCT03026257|560258308|FG004|Overall Study|Protocol Violation|1|||
155223432|NCT03026257|560258309|FG005|Overall Study|Protocol Violation|0|||
155223433|NCT03026257|560258304|FG000|Overall Study|Withdrawal by Subject|1|||
155223434|NCT03026257|560258305|FG001|Overall Study|Withdrawal by Subject|1|||
155223435|NCT03026257|560258306|FG002|Overall Study|Withdrawal by Subject|0|||
155223436|NCT03026257|560258307|FG003|Overall Study|Withdrawal by Subject|0|||
155223437|NCT03026257|560258308|FG004|Overall Study|Withdrawal by Subject|0|||
155223438|NCT03026257|560258309|FG005|Overall Study|Withdrawal by Subject|0|||
155223439|NCT02181556|560258310|FG000|Overall Study|Withdrawal by Subject|1|||
155223440|NCT04380857|560258311|FG000|Overall Study|Lost to Follow-up|3|||
155223441|NCT04380857|560258312|FG001|Overall Study|Lost to Follow-up|3|||
155223442|NCT04865354|560258313|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
155223443|NCT04865354|560258314|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
155223444|NCT04865354|560258313|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
155223445|NCT04865354|560258314|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
155223446|NCT04865354|560258313|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
155223447|NCT04865354|560258314|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
155223448|NCT01465022|560258315|FG000|Overall Study|Lost to Follow-up|15|||
155223449|NCT01465022|560258316|FG001|Overall Study|Lost to Follow-up|14|||
155223450|NCT01465022|560258317|FG002|Overall Study|Lost to Follow-up|0|||
155223451|NCT01465022|560258315|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
155223452|NCT01465022|560258316|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
155223453|NCT01465022|560258317|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
155223454|NCT01465022|560258315|FG000|Overall Study|Not Randomized|0|||
155223455|NCT01465022|560258316|FG001|Overall Study|Not Randomized|0|||
155223456|NCT01465022|560258317|FG002|Overall Study|Not Randomized|70|||
155223457|NCT02256891|560258318|FG000|Overall Study|Death|0|||
155223458|NCT02256891|560258319|FG001|Overall Study|Death|2|||
155223459|NCT02256891|560258318|FG000|Overall Study|Lost to Follow-up|0|||
155223460|NCT02256891|560258319|FG001|Overall Study|Lost to Follow-up|3|||
155223461|NCT02256891|560258318|FG000|Overall Study|Physician Decision|7|||
155223462|NCT02256891|560258319|FG001|Overall Study|Physician Decision|3|||
155223463|NCT02256891|560258318|FG000|Overall Study|Screen Fail|5|||
155223464|NCT02256891|560258319|FG001|Overall Study|Screen Fail|4|||
155223465|NCT02256891|560258318|FG000|Overall Study|Equipment Malfunction|0|||
155223466|NCT02256891|560258319|FG001|Overall Study|Equipment Malfunction|1|||
155223467|NCT02487394|560258326|FG000|Phase 1|Withdrawal by Subject|0|||
155223468|NCT02487394|560258327|FG001|Phase 1|Withdrawal by Subject|1|||
155223469|NCT00218296|560258337|FG000|Overall Study|Lost to Follow-up|9|||
155223470|NCT00218296|560258338|FG001|Overall Study|Lost to Follow-up|7|||
155223471|NCT00218296|560258337|FG000|Overall Study|Withdrawal by Subject|36|||
155223472|NCT00218296|560258338|FG001|Overall Study|Withdrawal by Subject|47|||
155223473|NCT00218296|560258337|FG000|Overall Study|Randomized but did not enter treatment|66|||
155223474|NCT00218296|560258338|FG001|Overall Study|Randomized but did not enter treatment|67|||
155223475|NCT02711800|560258357|FG000|Overall Study|Lost to Follow-up|1|||
155223476|NCT02711800|560258357|FG000|Overall Study|Withdrawal by Subject|1|||
155223477|NCT05442554|560258362|FG000|Overall Study|Adverse Event|1|||
155223478|NCT01446965|560258364|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
155223479|NCT01446965|560258365|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
155223480|NCT01446965|560258364|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
155223481|NCT01446965|560258365|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
155223482|NCT00004412|560258366|FG000|Randomized Period|Moved to Crossover Period|3|||
155223483|NCT00004412|560258367|FG001|Randomized Period|Moved to Crossover Period|0|||
155223484|NCT00004412|560258368|FG002|Randomized Period|Moved to Crossover Period|0|||
155223485|NCT00006478|560258369|FG000|Overall Study|Vaccine could not be produced|1|||
155223486|NCT00006478|560258369|FG000|Overall Study|Physician Decision|6|||
155223487|NCT02039674|560258380|FG000|Overall Study|Adverse Event|0|||
155223488|NCT02039674|560258381|FG001|Overall Study|Adverse Event|0|||
155223489|NCT02039674|560258382|FG002|Overall Study|Adverse Event|0|||
155223490|NCT02039674|560258383|FG003|Overall Study|Adverse Event|1|||
155223491|NCT02039674|560258384|FG004|Overall Study|Adverse Event|0|||
155223492|NCT02039674|560258385|FG005|Overall Study|Adverse Event|0|||
155223493|NCT02039674|560258386|FG006|Overall Study|Adverse Event|0|||
155223494|NCT02039674|560258387|FG007|Overall Study|Adverse Event|0|||
155223495|NCT02039674|560258388|FG008|Overall Study|Adverse Event|2|||
155223496|NCT02039674|560258389|FG009|Overall Study|Adverse Event|1|||
155223497|NCT02039674|560258390|FG010|Overall Study|Adverse Event|0|||
155223498|NCT02039674|560258391|FG011|Overall Study|Adverse Event|2|||
155223499|NCT02039674|560258392|FG012|Overall Study|Adverse Event|3|||
155223500|NCT02039674|560258393|FG013|Overall Study|Adverse Event|1|||
155223501|NCT02039674|560258380|FG000|Overall Study|Death|2|||
155223502|NCT02039674|560258381|FG001|Overall Study|Death|0|||
155223503|NCT02039674|560258382|FG002|Overall Study|Death|2|||
155223504|NCT02039674|560258383|FG003|Overall Study|Death|3|||
155223505|NCT02039674|560258384|FG004|Overall Study|Death|0|||
155223506|NCT02039674|560258385|FG005|Overall Study|Death|0|||
155223507|NCT02039674|560258386|FG006|Overall Study|Death|1|||
155223508|NCT02039674|560258387|FG007|Overall Study|Death|0|||
155223509|NCT02039674|560258388|FG008|Overall Study|Death|2|||
155223510|NCT02039674|560258389|FG009|Overall Study|Death|0|||
155223511|NCT02039674|560258390|FG010|Overall Study|Death|1|||
155223512|NCT02039674|560258391|FG011|Overall Study|Death|3|||
155223513|NCT02039674|560258392|FG012|Overall Study|Death|2|||
155223514|NCT02039674|560258393|FG013|Overall Study|Death|8|||
155223515|NCT02039674|560258380|FG000|Overall Study|Excluded Medication|1|||
155223516|NCT02039674|560258381|FG001|Overall Study|Excluded Medication|1|||
155223517|NCT02039674|560258382|FG002|Overall Study|Excluded Medication|0|||
155223518|NCT02039674|560258383|FG003|Overall Study|Excluded Medication|1|||
155223519|NCT02039674|560258384|FG004|Overall Study|Excluded Medication|0|||
155223520|NCT02039674|560258385|FG005|Overall Study|Excluded Medication|1|||
155223521|NCT02039674|560258386|FG006|Overall Study|Excluded Medication|0|||
155223522|NCT02039674|560258387|FG007|Overall Study|Excluded Medication|0|||
155223523|NCT02039674|560258388|FG008|Overall Study|Excluded Medication|2|||
155223524|NCT02039674|560258389|FG009|Overall Study|Excluded Medication|3|||
155223525|NCT02039674|560258390|FG010|Overall Study|Excluded Medication|5|||
155223526|NCT02039674|560258391|FG011|Overall Study|Excluded Medication|6|||
155223527|NCT02039674|560258392|FG012|Overall Study|Excluded Medication|8|||
155223528|NCT02039674|560258393|FG013|Overall Study|Excluded Medication|3|||
155223529|NCT02039674|560258380|FG000|Overall Study|Lost to Follow-up|0|||
155223530|NCT02039674|560258381|FG001|Overall Study|Lost to Follow-up|0|||
155223531|NCT02039674|560258382|FG002|Overall Study|Lost to Follow-up|0|||
155223532|NCT02039674|560258383|FG003|Overall Study|Lost to Follow-up|0|||
155223533|NCT02039674|560258384|FG004|Overall Study|Lost to Follow-up|1|||
155223534|NCT02039674|560258385|FG005|Overall Study|Lost to Follow-up|1|||
155223535|NCT02039674|560258386|FG006|Overall Study|Lost to Follow-up|0|||
155223536|NCT02039674|560258387|FG007|Overall Study|Lost to Follow-up|0|||
155223537|NCT02039674|560258388|FG008|Overall Study|Lost to Follow-up|0|||
155223538|NCT02039674|560258389|FG009|Overall Study|Lost to Follow-up|0|||
155223539|NCT02039674|560258390|FG010|Overall Study|Lost to Follow-up|0|||
155223540|NCT02039674|560258391|FG011|Overall Study|Lost to Follow-up|2|||
155223541|NCT02039674|560258392|FG012|Overall Study|Lost to Follow-up|2|||
155223542|NCT02039674|560258393|FG013|Overall Study|Lost to Follow-up|1|||
155223543|NCT02039674|560258380|FG000|Overall Study|Physician Decision|0|||
155223544|NCT02039674|560258381|FG001|Overall Study|Physician Decision|0|||
155223545|NCT02039674|560258382|FG002|Overall Study|Physician Decision|0|||
155223546|NCT02039674|560258383|FG003|Overall Study|Physician Decision|0|||
155223547|NCT02039674|560258384|FG004|Overall Study|Physician Decision|0|||
155223548|NCT02039674|560258385|FG005|Overall Study|Physician Decision|0|||
155223549|NCT02039674|560258386|FG006|Overall Study|Physician Decision|0|||
155223550|NCT02039674|560258387|FG007|Overall Study|Physician Decision|0|||
155223551|NCT02039674|560258388|FG008|Overall Study|Physician Decision|0|||
155223552|NCT02039674|560258389|FG009|Overall Study|Physician Decision|0|||
155223553|NCT02039674|560258390|FG010|Overall Study|Physician Decision|0|||
155223554|NCT02039674|560258391|FG011|Overall Study|Physician Decision|1|||
155223555|NCT02039674|560258392|FG012|Overall Study|Physician Decision|1|||
155223556|NCT02039674|560258393|FG013|Overall Study|Physician Decision|0|||
155223557|NCT02039674|560258380|FG000|Overall Study|Progressive Disease|8|||
155223558|NCT02039674|560258381|FG001|Overall Study|Progressive Disease|8|||
155223559|NCT02039674|560258382|FG002|Overall Study|Progressive Disease|6|||
155223560|NCT02039674|560258383|FG003|Overall Study|Progressive Disease|7|||
155223561|NCT02039674|560258384|FG004|Overall Study|Progressive Disease|9|||
155223562|NCT02039674|560258385|FG005|Overall Study|Progressive Disease|10|||
155223563|NCT02039674|560258386|FG006|Overall Study|Progressive Disease|1|||
155223564|NCT02039674|560258387|FG007|Overall Study|Progressive Disease|3|||
155223565|NCT02039674|560258388|FG008|Overall Study|Progressive Disease|6|||
155223566|NCT02039674|560258389|FG009|Overall Study|Progressive Disease|4|||
155223567|NCT02039674|560258390|FG010|Overall Study|Progressive Disease|0|||
155223568|NCT02039674|560258391|FG011|Overall Study|Progressive Disease|34|||
155223569|NCT02039674|560258392|FG012|Overall Study|Progressive Disease|34|||
155223570|NCT02039674|560258393|FG013|Overall Study|Progressive Disease|18|||
155223571|NCT02039674|560258380|FG000|Overall Study|Withdrawal by Subject|1|||
155223572|NCT02039674|560258381|FG001|Overall Study|Withdrawal by Subject|2|||
155223573|NCT02039674|560258382|FG002|Overall Study|Withdrawal by Subject|3|||
155223574|NCT02039674|560258383|FG003|Overall Study|Withdrawal by Subject|0|||
155223575|NCT02039674|560258384|FG004|Overall Study|Withdrawal by Subject|1|||
155223576|NCT02039674|560258385|FG005|Overall Study|Withdrawal by Subject|0|||
155223577|NCT02039674|560258386|FG006|Overall Study|Withdrawal by Subject|0|||
155223578|NCT02039674|560258387|FG007|Overall Study|Withdrawal by Subject|0|||
155223579|NCT02039674|560258388|FG008|Overall Study|Withdrawal by Subject|0|||
155223580|NCT02039674|560258389|FG009|Overall Study|Withdrawal by Subject|1|||
155223581|NCT02039674|560258390|FG010|Overall Study|Withdrawal by Subject|1|||
155223582|NCT02039674|560258391|FG011|Overall Study|Withdrawal by Subject|4|||
155223583|NCT02039674|560258392|FG012|Overall Study|Withdrawal by Subject|6|||
155223584|NCT02039674|560258393|FG013|Overall Study|Withdrawal by Subject|2|||
155223585|NCT02039674|560258380|FG000|Overall Study|Clinical Progression|0|||
155223586|NCT02039674|560258381|FG001|Overall Study|Clinical Progression|0|||
155223587|NCT02039674|560258382|FG002|Overall Study|Clinical Progression|0|||
155223588|NCT02039674|560258383|FG003|Overall Study|Clinical Progression|0|||
155223589|NCT02039674|560258384|FG004|Overall Study|Clinical Progression|0|||
155223590|NCT02039674|560258385|FG005|Overall Study|Clinical Progression|0|||
155223591|NCT02039674|560258386|FG006|Overall Study|Clinical Progression|1|||
155223592|NCT02039674|560258387|FG007|Overall Study|Clinical Progression|0|||
155223593|NCT02039674|560258388|FG008|Overall Study|Clinical Progression|0|||
155223594|NCT02039674|560258389|FG009|Overall Study|Clinical Progression|0|||
155223595|NCT02039674|560258390|FG010|Overall Study|Clinical Progression|0|||
155223596|NCT02039674|560258391|FG011|Overall Study|Clinical Progression|0|||
155223597|NCT02039674|560258392|FG012|Overall Study|Clinical Progression|1|||
155223598|NCT02039674|560258393|FG013|Overall Study|Clinical Progression|0|||
155223599|NCT02039674|560258380|FG000|Overall Study|Sponsor Decision|1|||
155223600|NCT02039674|560258381|FG001|Overall Study|Sponsor Decision|1|||
155223601|NCT02039674|560258382|FG002|Overall Study|Sponsor Decision|1|||
155223602|NCT02039674|560258383|FG003|Overall Study|Sponsor Decision|1|||
155223603|NCT02039674|560258384|FG004|Overall Study|Sponsor Decision|1|||
155223604|NCT02039674|560258385|FG005|Overall Study|Sponsor Decision|0|||
155223605|NCT02039674|560258386|FG006|Overall Study|Sponsor Decision|0|||
155223606|NCT02039674|560258387|FG007|Overall Study|Sponsor Decision|0|||
155223607|NCT02039674|560258388|FG008|Overall Study|Sponsor Decision|0|||
155223608|NCT02039674|560258389|FG009|Overall Study|Sponsor Decision|3|||
155223609|NCT02039674|560258390|FG010|Overall Study|Sponsor Decision|0|||
155223610|NCT02039674|560258391|FG011|Overall Study|Sponsor Decision|8|||
155223611|NCT02039674|560258392|FG012|Overall Study|Sponsor Decision|5|||
155223612|NCT02039674|560258393|FG013|Overall Study|Sponsor Decision|0|||
155223613|NCT02039674|560258380|FG000|Overall Study|Other|0|||
155223614|NCT02039674|560258381|FG001|Overall Study|Other|0|||
155223615|NCT02039674|560258382|FG002|Overall Study|Other|0|||
155223616|NCT02039674|560258383|FG003|Overall Study|Other|0|||
155223617|NCT02039674|560258384|FG004|Overall Study|Other|0|||
155223618|NCT02039674|560258385|FG005|Overall Study|Other|0|||
155223619|NCT02039674|560258386|FG006|Overall Study|Other|0|||
155223620|NCT02039674|560258387|FG007|Overall Study|Other|0|||
155223621|NCT02039674|560258388|FG008|Overall Study|Other|0|||
155223622|NCT02039674|560258389|FG009|Overall Study|Other|0|||
155223623|NCT02039674|560258390|FG010|Overall Study|Other|0|||
155223624|NCT02039674|560258391|FG011|Overall Study|Other|0|||
155223625|NCT02039674|560258392|FG012|Overall Study|Other|1|||
155223626|NCT02039674|560258393|FG013|Overall Study|Other|0|||
155223627|NCT01408030|560258394|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
155223628|NCT01408030|560258395|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
155223629|NCT01408030|560258396|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
155223630|NCT01408030|560258397|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
155223631|NCT01408030|560258394|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
155223632|NCT01408030|560258395|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
155223633|NCT01408030|560258396|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
155223634|NCT01408030|560258397|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
155223635|NCT01408030|560258394|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
155223636|NCT01408030|560258395|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
155223637|NCT01408030|560258396|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
155223638|NCT01408030|560258397|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
155223639|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
155223640|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
155223641|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
155223642|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
155223643|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
155223644|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
155223645|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
155223646|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
155223647|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
155223648|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
155223649|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
155223650|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
155223651|NCT01408030|560258394|FG000|Observation Phase (Off Drug)|Other|1|||
155223652|NCT01408030|560258395|FG001|Observation Phase (Off Drug)|Other|1|||
155223653|NCT01408030|560258396|FG002|Observation Phase (Off Drug)|Other|1|||
155223654|NCT01408030|560258397|FG003|Observation Phase (Off Drug)|Other|1|||
155223655|NCT05045144|560258399|FG000|Overall Study|Lost to Follow-up|3|||
155223656|NCT05045144|560258400|FG001|Overall Study|Lost to Follow-up|2|||
155223657|NCT05045144|560258401|FG002|Overall Study|Lost to Follow-up|3|||
155223658|NCT05045144|560258402|FG003|Overall Study|Lost to Follow-up|5|||
155223659|NCT05045144|560258403|FG004|Overall Study|Lost to Follow-up|13|||
155223660|NCT05045144|560258399|FG000|Overall Study|Withdrawal by Subject|0|||
155223661|NCT05045144|560258400|FG001|Overall Study|Withdrawal by Subject|1|||
155223662|NCT05045144|560258401|FG002|Overall Study|Withdrawal by Subject|0|||
155223663|NCT05045144|560258402|FG003|Overall Study|Withdrawal by Subject|0|||
155223664|NCT05045144|560258403|FG004|Overall Study|Withdrawal by Subject|0|||
155223665|NCT05045144|560258399|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223666|NCT05045144|560258400|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223667|NCT05045144|560258401|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155223668|NCT05045144|560258402|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223669|NCT05045144|560258403|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
155223670|NCT02965703|560258404|FG000|Overall Study|Withdrawal by Subject|6|||
155223671|NCT02965703|560258405|FG001|Overall Study|Withdrawal by Subject|3|||
155223672|NCT02965703|560258406|FG002|Overall Study|Withdrawal by Subject|1|||
155223673|NCT02965703|560258404|FG000|Overall Study|Protocol Violation|1|||
155223674|NCT02965703|560258405|FG001|Overall Study|Protocol Violation|0|||
155223675|NCT02965703|560258406|FG002|Overall Study|Protocol Violation|0|||
155223676|NCT02965703|560258404|FG000|Overall Study|Adverse Event|1|||
155223677|NCT02965703|560258405|FG001|Overall Study|Adverse Event|1|||
155223678|NCT02965703|560258406|FG002|Overall Study|Adverse Event|0|||
155223679|NCT02965703|560258404|FG000|Overall Study|Lost to Follow-up|2|||
155223680|NCT02965703|560258405|FG001|Overall Study|Lost to Follow-up|1|||
155223681|NCT02965703|560258406|FG002|Overall Study|Lost to Follow-up|1|||
155223682|NCT02081079|560258407|FG000|Overall Study|Lack of Efficacy|3|||
155223683|NCT02081079|560258408|FG001|Overall Study|Lack of Efficacy|2|||
155223684|NCT02081079|560258407|FG000|Overall Study|Lost to Follow-up|1|||
155223685|NCT02081079|560258408|FG001|Overall Study|Lost to Follow-up|0|||
155223686|NCT02968979|560258414|FG000|Overall Study|Protocol Violation|7|||
155223687|NCT02968979|560258414|FG000|Overall Study|Withdrawal by Subject|1|||
155223688|NCT01471379|560258415|FG000|Overall Study|Adverse Event|1|||
155223689|NCT01471379|560258416|FG001|Overall Study|Adverse Event|0|||
155223690|NCT01471379|560258417|FG002|Overall Study|Adverse Event|0|||
155223691|NCT01471379|560258415|FG000|Overall Study|Study terminated|0|||
155223692|NCT01471379|560258416|FG001|Overall Study|Study terminated|1|||
155223693|NCT01471379|560258417|FG002|Overall Study|Study terminated|0|||
155223694|NCT00788827|560258418|FG000|Overall Study|Lack of Efficacy|2|||
155223695|NCT01200797|560258425|FG000|Overall Study|symptomatic deterioration|2|||
155223696|NCT01200797|560258425|FG000|Overall Study|Adverse Event|4|||
155223697|NCT01200797|560258425|FG000|Overall Study|Disease Progression|13|||
155223698|NCT03608774|560258426|FG000|Overall Study|Lost to Follow-up|5|||
155223699|NCT03608774|560258427|FG001|Overall Study|Lost to Follow-up|5|||
155223700|NCT03608774|560258426|FG000|Overall Study|Withdrawal by Subject|1|||
155223701|NCT03608774|560258427|FG001|Overall Study|Withdrawal by Subject|0|||
155223702|NCT03608774|560258426|FG000|Overall Study|Protocol Violation|1|||
155223703|NCT03608774|560258427|FG001|Overall Study|Protocol Violation|0|||
155223704|NCT03608774|560258426|FG000|Overall Study|Not eligible at enrollment|0|||
155223705|NCT03608774|560258427|FG001|Overall Study|Not eligible at enrollment|1|||
155223706|NCT03608774|560258426|FG000|Overall Study|Health related event|0|||
155223707|NCT03608774|560258427|FG001|Overall Study|Health related event|1|||
155223708|NCT00851799|560258430|FG000|Overall Study|Death|1|||
155223709|NCT00851799|560258431|FG001|Overall Study|Death|0|||
155223710|NCT00851799|560258432|FG002|Overall Study|Death|1|||
155223711|NCT00851799|560258430|FG000|Overall Study|Lost to Follow-up|5|||
155223712|NCT00851799|560258431|FG001|Overall Study|Lost to Follow-up|3|||
155223713|NCT00851799|560258432|FG002|Overall Study|Lost to Follow-up|10|||
155223714|NCT00851799|560258430|FG000|Overall Study|Not able to get to clinic|8|||
155223715|NCT00851799|560258431|FG001|Overall Study|Not able to get to clinic|5|||
155223716|NCT00851799|560258432|FG002|Overall Study|Not able to get to clinic|9|||
155223717|NCT00851799|560258430|FG000|Overall Study|Not willing to adhere to requirements|1|||
155223718|NCT00851799|560258431|FG001|Overall Study|Not willing to adhere to requirements|2|||
155223719|NCT00851799|560258432|FG002|Overall Study|Not willing to adhere to requirements|2|||
155223720|NCT00851799|560258430|FG000|Overall Study|Withdrew consent prior study completion|1|||
155223721|NCT00851799|560258431|FG001|Overall Study|Withdrew consent prior study completion|2|||
155223722|NCT00851799|560258432|FG002|Overall Study|Withdrew consent prior study completion|1|||
155223723|NCT00851799|560258430|FG000|Overall Study|Severe Debilitation|0|||
155223724|NCT00851799|560258431|FG001|Overall Study|Severe Debilitation|1|||
155223725|NCT00851799|560258432|FG002|Overall Study|Severe Debilitation|0|||
155223726|NCT00851799|560258430|FG000|Overall Study|Completed protocol due to pregnancy|0|||
155223727|NCT00851799|560258431|FG001|Overall Study|Completed protocol due to pregnancy|0|||
155223728|NCT00851799|560258432|FG002|Overall Study|Completed protocol due to pregnancy|1|||
155223729|NCT00502697|560260268|FG000|Overall Study|Withdrawal by Subject|3|||
155223730|NCT00502697|560260269|FG001|Overall Study|Withdrawal by Subject|1|||
155223731|NCT00502697|560260268|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
155223732|NCT00502697|560260269|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
155223733|NCT00502697|560260268|FG000|Overall Study|found not to meet eligibility criteria|3|||
155223734|NCT00502697|560260269|FG001|Overall Study|found not to meet eligibility criteria|4|||
155223735|NCT00502697|560260268|FG000|Overall Study|did not meet assignment criteria|4|||
155223736|NCT00502697|560260269|FG001|Overall Study|did not meet assignment criteria|2|||
155223737|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
155223738|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
155223739|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
155223740|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
155223741|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
155223742|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
155223743|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
155223744|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
155223745|NCT04033003|560260277|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
155223746|NCT04033003|560260278|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
155223747|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
155223748|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
155223749|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
155223750|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
155223751|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
155223752|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
155223753|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
155223754|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
155223755|NCT04033003|560260277|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
155223756|NCT04033003|560260278|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
155223757|NCT04033003|560260277|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
155223758|NCT04033003|560260278|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
155223759|NCT04033003|560260277|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
155223760|NCT04033003|560260278|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
155223761|NCT04033003|560260277|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
155223762|NCT04033003|560260278|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
155223763|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
155223764|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
155223765|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
155223766|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
155223767|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
155223768|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
155223769|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
155223770|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
155223771|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
155223772|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
155223773|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
155223774|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
155223775|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
155223776|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
155223777|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
155223778|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Death|5|||
155223779|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Death|0|||
155223780|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Death|2|||
155223781|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Death|0|||
155223782|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Death|4|||
155223783|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
155223784|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
155223785|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
155223786|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
155223787|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
155223788|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
155223789|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
155223790|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
155223791|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
155223792|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
155223793|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
155223794|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
155223795|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
155223796|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
155223797|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
155223798|NCT01604343|560260279|FG000|Prior to W52 Administration(Through W52)|Other|15|||
155223799|NCT01604343|560260280|FG001|Prior to W52 Administration(Through W52)|Other|0|||
155223800|NCT01604343|560260281|FG002|Prior to W52 Administration(Through W52)|Other|10|||
155223801|NCT01604343|560260282|FG003|Prior to W52 Administration(Through W52)|Other|0|||
155223802|NCT01604343|560260283|FG004|Prior to W52 Administration(Through W52)|Other|6|||
155223803|NCT01604343|560260279|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
155223804|NCT01604343|560260280|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
155223805|NCT01604343|560260281|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
155223806|NCT01604343|560260282|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
155223807|NCT01604343|560260283|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
155223808|NCT01604343|560260279|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
155223809|NCT01604343|560260280|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
155223810|NCT01604343|560260281|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
155223811|NCT01604343|560260282|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
155223812|NCT01604343|560260283|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
155223813|NCT01604343|560260279|FG000|Week 52 to Week 104|Adverse Event|0|||
155223814|NCT01604343|560260280|FG001|Week 52 to Week 104|Adverse Event|12|||
155223815|NCT01604343|560260281|FG002|Week 52 to Week 104|Adverse Event|26|||
155223816|NCT01604343|560260282|FG003|Week 52 to Week 104|Adverse Event|21|||
155223817|NCT01604343|560260283|FG004|Week 52 to Week 104|Adverse Event|27|||
155223818|NCT01604343|560260279|FG000|Week 52 to Week 104|Death|0|||
155223819|NCT01604343|560260280|FG001|Week 52 to Week 104|Death|4|||
155223820|NCT01604343|560260281|FG002|Week 52 to Week 104|Death|2|||
155223821|NCT01604343|560260282|FG003|Week 52 to Week 104|Death|5|||
155223822|NCT01604343|560260283|FG004|Week 52 to Week 104|Death|0|||
155223823|NCT01604343|560260279|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
155223824|NCT01604343|560260280|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
155223825|NCT01604343|560260281|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
155223826|NCT01604343|560260282|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
155223827|NCT01604343|560260283|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
155223828|NCT01604343|560260279|FG000|Week 52 to Week 104|Physician Decision|0|||
155223829|NCT01604343|560260280|FG001|Week 52 to Week 104|Physician Decision|1|||
155223830|NCT01604343|560260281|FG002|Week 52 to Week 104|Physician Decision|0|||
155223831|NCT01604343|560260282|FG003|Week 52 to Week 104|Physician Decision|0|||
155223832|NCT01604343|560260283|FG004|Week 52 to Week 104|Physician Decision|2|||
155223833|NCT01604343|560260279|FG000|Week 52 to Week 104|Pregnancy|0|||
155223834|NCT01604343|560260280|FG001|Week 52 to Week 104|Pregnancy|0|||
155223835|NCT01604343|560260281|FG002|Week 52 to Week 104|Pregnancy|1|||
155223836|NCT01604343|560260282|FG003|Week 52 to Week 104|Pregnancy|2|||
155223837|NCT01604343|560260283|FG004|Week 52 to Week 104|Pregnancy|1|||
155223838|NCT01604343|560260279|FG000|Week 52 to Week 104|Other|0|||
155223839|NCT01604343|560260280|FG001|Week 52 to Week 104|Other|11|||
155223840|NCT01604343|560260281|FG002|Week 52 to Week 104|Other|11|||
155223841|NCT01604343|560260282|FG003|Week 52 to Week 104|Other|6|||
155223842|NCT01604343|560260283|FG004|Week 52 to Week 104|Other|3|||
155223843|NCT01604343|560260279|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
155223844|NCT01604343|560260280|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
155223845|NCT01604343|560260281|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
155223846|NCT01604343|560260282|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
155223847|NCT01604343|560260283|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
155223848|NCT01604343|560260279|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
155223849|NCT01604343|560260280|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
155223850|NCT01604343|560260281|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
155223851|NCT01604343|560260282|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
155223852|NCT01604343|560260283|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
155223853|NCT01604343|560260279|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
155223854|NCT01604343|560260280|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
155223855|NCT01604343|560260281|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
155223856|NCT01604343|560260282|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
155223857|NCT01604343|560260283|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
155223858|NCT03161483|560260292|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
155223859|NCT03161483|560260293|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
155223860|NCT03161483|560260294|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
155223861|NCT03161483|560260295|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
155223862|NCT03161483|560260292|FG000|Treatment Period|Death|1|||
155223863|NCT03161483|560260293|FG001|Treatment Period|Death|0|||
155223864|NCT03161483|560260294|FG002|Treatment Period|Death|0|||
155223865|NCT03161483|560260295|FG003|Treatment Period|Death|0|||
155223866|NCT03161483|560260292|FG000|Treatment Period|Adverse Event|5|||
155223867|NCT03161483|560260293|FG001|Treatment Period|Adverse Event|2|||
155223868|NCT03161483|560260294|FG002|Treatment Period|Adverse Event|1|||
155223869|NCT03161483|560260295|FG003|Treatment Period|Adverse Event|11|||
155223870|NCT03161483|560260292|FG000|Treatment Period|Pregnancy|1|||
155223871|NCT03161483|560260293|FG001|Treatment Period|Pregnancy|0|||
155223872|NCT03161483|560260294|FG002|Treatment Period|Pregnancy|0|||
155223873|NCT03161483|560260295|FG003|Treatment Period|Pregnancy|0|||
155223874|NCT03161483|560260292|FG000|Treatment Period|Lack of Efficacy|0|||
155223875|NCT03161483|560260293|FG001|Treatment Period|Lack of Efficacy|0|||
155223876|NCT03161483|560260294|FG002|Treatment Period|Lack of Efficacy|0|||
155223877|NCT03161483|560260295|FG003|Treatment Period|Lack of Efficacy|1|||
155223878|NCT03161483|560260292|FG000|Treatment Period|Withdrawal by Subject|2|||
155223879|NCT03161483|560260293|FG001|Treatment Period|Withdrawal by Subject|5|||
155223880|NCT03161483|560260294|FG002|Treatment Period|Withdrawal by Subject|2|||
155223881|NCT03161483|560260295|FG003|Treatment Period|Withdrawal by Subject|6|||
155223882|NCT03161483|560260292|FG000|Treatment Period|Lost to Follow-up|0|||
155223883|NCT03161483|560260293|FG001|Treatment Period|Lost to Follow-up|0|||
155223884|NCT03161483|560260294|FG002|Treatment Period|Lost to Follow-up|0|||
155223885|NCT03161483|560260295|FG003|Treatment Period|Lost to Follow-up|1|||
155223886|NCT03161483|560260292|FG000|Treatment Period|Protocol Violation|0|||
155223887|NCT03161483|560260293|FG001|Treatment Period|Protocol Violation|0|||
155223888|NCT03161483|560260294|FG002|Treatment Period|Protocol Violation|0|||
155223889|NCT03161483|560260295|FG003|Treatment Period|Protocol Violation|1|||
155223890|NCT03161483|560260292|FG000|Treatment Period|Other reasons|1|||
155223891|NCT03161483|560260293|FG001|Treatment Period|Other reasons|1|||
155223892|NCT03161483|560260294|FG002|Treatment Period|Other reasons|0|||
155223893|NCT03161483|560260295|FG003|Treatment Period|Other reasons|0|||
155223894|NCT00743652|560260302|FG000|Overall Study|Parent/Legal Guardian Request|3|||
155223895|NCT00743652|560260303|FG001|Overall Study|Parent/Legal Guardian Request|2|||
155223896|NCT00743652|560260304|FG002|Overall Study|Parent/Legal Guardian Request|2|||
155223897|NCT00743652|560260305|FG003|Overall Study|Parent/Legal Guardian Request|2|||
155223898|NCT00743652|560260306|FG004|Overall Study|Parent/Legal Guardian Request|0|||
155223899|NCT00743652|560260302|FG000|Overall Study|Adverse Event|3|||
155223900|NCT00743652|560260303|FG001|Overall Study|Adverse Event|0|||
155223901|NCT00743652|560260304|FG002|Overall Study|Adverse Event|0|||
155223902|NCT00743652|560260305|FG003|Overall Study|Adverse Event|0|||
155223903|NCT00743652|560260306|FG004|Overall Study|Adverse Event|0|||
155223904|NCT00743652|560260302|FG000|Overall Study|Death|2|||
155223905|NCT00743652|560260303|FG001|Overall Study|Death|0|||
155223906|NCT00743652|560260304|FG002|Overall Study|Death|0|||
155223907|NCT00743652|560260305|FG003|Overall Study|Death|0|||
155223908|NCT00743652|560260306|FG004|Overall Study|Death|0|||
155223909|NCT00743652|560260302|FG000|Overall Study|Investigator Request|0|||
155223910|NCT00743652|560260303|FG001|Overall Study|Investigator Request|0|||
155223911|NCT00743652|560260304|FG002|Overall Study|Investigator Request|0|||
155223912|NCT00743652|560260305|FG003|Overall Study|Investigator Request|2|||
155223913|NCT00743652|560260306|FG004|Overall Study|Investigator Request|0|||
155223914|NCT00743652|560260302|FG000|Overall Study|Other|1|||
155223915|NCT00743652|560260303|FG001|Overall Study|Other|1|||
155223916|NCT00743652|560260304|FG002|Overall Study|Other|0|||
155223917|NCT00743652|560260305|FG003|Overall Study|Other|0|||
155223918|NCT00743652|560260306|FG004|Overall Study|Other|0|||
155223919|NCT00743652|560260302|FG000|Overall Study|Lost to Follow-up|1|||
155223920|NCT00743652|560260303|FG001|Overall Study|Lost to Follow-up|0|||
155223921|NCT00743652|560260304|FG002|Overall Study|Lost to Follow-up|0|||
155223922|NCT00743652|560260305|FG003|Overall Study|Lost to Follow-up|0|||
155223923|NCT00743652|560260306|FG004|Overall Study|Lost to Follow-up|0|||
155223924|NCT00805766|560260307|FG000|Screening Period|Adverse Event|1|||
155223925|NCT00805766|560260307|FG000|Screening Period|Lack of Efficacy|2|||
155223926|NCT00805766|560260307|FG000|Screening Period|Pregnancy|1|||
155223927|NCT00805766|560260307|FG000|Screening Period|Responder|2|||
155223928|NCT00805766|560260307|FG000|Increased Dose Period|Adverse Event|4|||
155223929|NCT00805766|560260307|FG000|Increased Dose Period|Lack of Efficacy|7|||
155223930|NCT00805766|560260307|FG000|Increased Dose Period|Pregnancy|1|||
155223931|NCT00805766|560260307|FG000|Increased Dose Period|Withdrawal by Subject|1|||
155223932|NCT00228917|560260312|FG000|Overall Study|Migrated/moved from study area|0|||
155223933|NCT00228917|560260313|FG001|Overall Study|Migrated/moved from study area|0|||
155223934|NCT00228917|560260314|FG002|Overall Study|Migrated/moved from study area|0|||
155223935|NCT00228917|560260315|FG003|Overall Study|Migrated/moved from study area|0|||
155223936|NCT00228917|560260316|FG004|Overall Study|Migrated/moved from study area|0|||
155223937|NCT00228917|560260317|FG005|Overall Study|Migrated/moved from study area|2|||
155223938|NCT00228917|560260318|FG006|Overall Study|Migrated/moved from study area|0|||
155223939|NCT00228917|560260319|FG007|Overall Study|Migrated/moved from study area|0|||
155223940|NCT00409617|560260320|FG000|Overall Study|Adverse Event|57|||
155223941|NCT00409617|560260320|FG000|Overall Study|Lack of Efficacy|54|||
155223942|NCT00409617|560260320|FG000|Overall Study|Lost to Follow-up|2|||
155223943|NCT00409617|560260320|FG000|Overall Study|Protocol Violation|24|||
155223944|NCT00409617|560260320|FG000|Overall Study|Withdrawal by Subject|8|||
155223945|NCT00409617|560260320|FG000|Overall Study|Administrative reasons|1|||
155223946|NCT00409617|560260320|FG000|Overall Study|Not described|14|||
155223947|NCT00149747|560260323|FG000|Overall Study|Death|1|||
155223948|NCT00149747|560260324|FG001|Overall Study|Death|0|||
155223949|NCT00149747|560260323|FG000|Overall Study|Withdrawal by Subject|3|||
155223950|NCT00149747|560260324|FG001|Overall Study|Withdrawal by Subject|3|||
155223951|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
155223952|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
155223953|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
155223954|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
155223955|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
155223956|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
155223957|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
155223958|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155223959|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155223960|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
155223961|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
155223962|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
155223963|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
155223964|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
155223965|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
155223966|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
155223967|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223968|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223969|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223970|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
155223971|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
155223972|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
155223973|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
155223974|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
155223975|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
155223976|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223977|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
155223978|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223979|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223980|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
155223981|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223982|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223983|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223984|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
155223985|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
155223986|NCT03373383|560260325|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
155223987|NCT03373383|560260326|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
155223988|NCT03373383|560260327|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
155223989|NCT03373383|560260328|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
155223990|NCT03373383|560260329|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
155223991|NCT03373383|560260325|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
155223992|NCT03373383|560260326|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223993|NCT03373383|560260327|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223994|NCT03373383|560260328|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223995|NCT03373383|560260329|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
155223996|NCT02159521|560260330|FG000|Overall Study|Enrolled but not treated|3|||
155223997|NCT02159521|560260330|FG000|Overall Study|Withdrawal by Subject|7|||
155223998|NCT02159521|560260330|FG000|Overall Study|Lost to Follow-up|6|||
155223999|NCT02159521|560260330|FG000|Overall Study|Death|1|||
155224000|NCT02159521|560260330|FG000|Overall Study|Other than specified|1|||
155224001|NCT04753164|560260333|FG000|Overall Study|Adverse Event|0|||
155224002|NCT04753164|560260334|FG001|Overall Study|Adverse Event|2|||
155224003|NCT04753164|560260333|FG000|Overall Study|Withdrawal by Subject|9|||
155224004|NCT04753164|560260334|FG001|Overall Study|Withdrawal by Subject|7|||
155224005|NCT04753164|560260333|FG000|Overall Study|Lost to Follow-up|6|||
155224006|NCT04753164|560260334|FG001|Overall Study|Lost to Follow-up|6|||
155224007|NCT04753164|560260333|FG000|Overall Study|Other|12|||
155224008|NCT04753164|560260334|FG001|Overall Study|Other|5|||
155224009|NCT00694369|560260335|FG000|Overall Study|Adverse Event|0|||
155224010|NCT00694369|560260336|FG001|Overall Study|Adverse Event|1|||
155224011|NCT00694369|560260337|FG002|Overall Study|Adverse Event|0|||
155224012|NCT00694369|560260338|FG003|Overall Study|Adverse Event|1|||
155224013|NCT00694369|560260339|FG004|Overall Study|Adverse Event|3|||
155224014|NCT00694369|560260335|FG000|Overall Study|Lost to Follow-up|0|||
155224015|NCT00694369|560260336|FG001|Overall Study|Lost to Follow-up|0|||
155224016|NCT00694369|560260337|FG002|Overall Study|Lost to Follow-up|1|||
155224017|NCT00694369|560260338|FG003|Overall Study|Lost to Follow-up|1|||
155224018|NCT00694369|560260339|FG004|Overall Study|Lost to Follow-up|0|||
155224019|NCT00694369|560260335|FG000|Overall Study|Physician Decision|0|||
155224020|NCT00694369|560260336|FG001|Overall Study|Physician Decision|0|||
155224021|NCT00694369|560260337|FG002|Overall Study|Physician Decision|0|||
155224022|NCT00694369|560260338|FG003|Overall Study|Physician Decision|0|||
155224023|NCT00694369|560260339|FG004|Overall Study|Physician Decision|1|||
155224024|NCT00694369|560260335|FG000|Overall Study|Protocol Violation|0|||
155224025|NCT00694369|560260336|FG001|Overall Study|Protocol Violation|1|||
155224026|NCT00694369|560260337|FG002|Overall Study|Protocol Violation|0|||
155224027|NCT00694369|560260338|FG003|Overall Study|Protocol Violation|0|||
155224028|NCT00694369|560260339|FG004|Overall Study|Protocol Violation|0|||
155224029|NCT00694369|560260335|FG000|Overall Study|Withdrawal by Subject|1|||
155224030|NCT00694369|560260336|FG001|Overall Study|Withdrawal by Subject|1|||
155224031|NCT00694369|560260337|FG002|Overall Study|Withdrawal by Subject|1|||
155224032|NCT00694369|560260338|FG003|Overall Study|Withdrawal by Subject|1|||
155224033|NCT00694369|560260339|FG004|Overall Study|Withdrawal by Subject|2|||
155224034|NCT00907374|560260340|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
155224035|NCT00907374|560260341|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
155224036|NCT02871739|560260342|FG000|Overall Study|Lost to Follow-up|3|||
155224037|NCT02871739|560260343|FG001|Overall Study|Lost to Follow-up|2|||
155224038|NCT02871739|560260344|FG002|Overall Study|Lost to Follow-up|0|||
155224039|NCT02871739|560260345|FG003|Overall Study|Lost to Follow-up|2|||
155224040|NCT01354496|560260351|FG000|Period 1|Adverse Event|0|||
155224041|NCT01354496|560260352|FG001|Period 1|Adverse Event|0|||
155224042|NCT01354496|560260353|FG002|Period 1|Adverse Event|1|||
155224043|NCT01354496|560260354|FG003|Period 1|Adverse Event|0|||
155224044|NCT01354496|560260355|FG004|Period 1|Adverse Event|0|||
155224045|NCT01354496|560260356|FG005|Period 1|Adverse Event|0|||
155224046|NCT01354496|560260351|FG000|Period 1|Physician Decision|0|||
155224047|NCT01354496|560260352|FG001|Period 1|Physician Decision|0|||
155224048|NCT01354496|560260353|FG002|Period 1|Physician Decision|1|||
155224049|NCT01354496|560260354|FG003|Period 1|Physician Decision|0|||
155224050|NCT01354496|560260355|FG004|Period 1|Physician Decision|0|||
155224051|NCT01354496|560260356|FG005|Period 1|Physician Decision|0|||
155224052|NCT01354496|560260351|FG000|Period 2|Adverse Event|0|||
155224053|NCT01354496|560260352|FG001|Period 2|Adverse Event|0|||
155224054|NCT01354496|560260353|FG002|Period 2|Adverse Event|0|||
155224055|NCT01354496|560260354|FG003|Period 2|Adverse Event|1|||
155224056|NCT01354496|560260355|FG004|Period 2|Adverse Event|0|||
155224057|NCT01354496|560260356|FG005|Period 2|Adverse Event|0|||
155224058|NCT01354496|560260351|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224059|NCT01354496|560260352|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
155224060|NCT01354496|560260353|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224061|NCT01354496|560260354|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
155224062|NCT01354496|560260355|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224063|NCT01354496|560260356|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
155224064|NCT01524692|560260359|FG000|Overall Study|Withdrawal by Subject|3|||
155224065|NCT03190889|560260360|FG000|Overall Study|Lost to Follow-up|7|||
155224066|NCT03190889|560260361|FG001|Overall Study|Lost to Follow-up|7|||
155224067|NCT03190889|560260362|FG002|Overall Study|Lost to Follow-up|3|||
155224068|NCT03190889|560260360|FG000|Overall Study|Withdrawal by Subject|1|||
155224069|NCT03190889|560260361|FG001|Overall Study|Withdrawal by Subject|1|||
155224070|NCT03190889|560260362|FG002|Overall Study|Withdrawal by Subject|2|||
155224071|NCT03190889|560260360|FG000|Overall Study|Did not complete protocol|4|||
155224072|NCT03190889|560260361|FG001|Overall Study|Did not complete protocol|9|||
155224073|NCT03190889|560260362|FG002|Overall Study|Did not complete protocol|0|||
155224074|NCT03190889|560260360|FG000|Overall Study|COVID-19|1|||
155224075|NCT03190889|560260361|FG001|Overall Study|COVID-19|0|||
155224076|NCT03190889|560260362|FG002|Overall Study|COVID-19|2|||
155224077|NCT01709695|560260363|FG000|Overall Study|Withdrawal by Subject|1|||
155224078|NCT01709695|560260364|FG001|Overall Study|Withdrawal by Subject|1|||
155224079|NCT04007523|560260365|FG000|Overall Study|Withdrawal by Subject|0|||
155224080|NCT04007523|560260366|FG001|Overall Study|Withdrawal by Subject|1|||
155224081|NCT04007523|560260367|FG002|Overall Study|Withdrawal by Subject|1|||
155224082|NCT04007523|560260368|FG003|Overall Study|Withdrawal by Subject|0|||
155224083|NCT04007523|560260365|FG000|Overall Study|ICU Transfer|0|||
155224084|NCT04007523|560260366|FG001|Overall Study|ICU Transfer|1|||
155224085|NCT04007523|560260367|FG002|Overall Study|ICU Transfer|0|||
155224086|NCT04007523|560260368|FG003|Overall Study|ICU Transfer|0|||
155224087|NCT04007523|560260365|FG000|Overall Study|COVID hospital closure|0|||
155224088|NCT04007523|560260366|FG001|Overall Study|COVID hospital closure|0|||
155224089|NCT04007523|560260367|FG002|Overall Study|COVID hospital closure|1|||
155224090|NCT04007523|560260368|FG003|Overall Study|COVID hospital closure|2|||
155224091|NCT04007523|560260365|FG000|Overall Study|Surgery cancelled|0|||
155224092|NCT04007523|560260366|FG001|Overall Study|Surgery cancelled|0|||
155224093|NCT04007523|560260367|FG002|Overall Study|Surgery cancelled|1|||
155224094|NCT04007523|560260368|FG003|Overall Study|Surgery cancelled|1|||
155224095|NCT02136576|560260372|FG000|Overall Study|Lost to Follow-up|2|||
155224096|NCT02136576|560260373|FG001|Overall Study|Lost to Follow-up|0|||
155224097|NCT02136576|560260374|FG002|Overall Study|Lost to Follow-up|0|||
155224098|NCT00537381|560260375|FG000|Overall Study|Adverse Event|13|||
155224099|NCT00537381|560260376|FG001|Overall Study|Adverse Event|9|||
155224100|NCT00537381|560260375|FG000|Overall Study|Death|3|||
155224101|NCT00537381|560260376|FG001|Overall Study|Death|3|||
155224102|NCT00537381|560260375|FG000|Overall Study|Withdrawal by Subject|5|||
155224103|NCT00537381|560260376|FG001|Overall Study|Withdrawal by Subject|14|||
155224104|NCT00537381|560260375|FG000|Overall Study|Physician Decision|7|||
155224105|NCT00537381|560260376|FG001|Overall Study|Physician Decision|6|||
155224106|NCT00537381|560260375|FG000|Overall Study|Disease Progression|9|||
155224107|NCT00537381|560260376|FG001|Overall Study|Disease Progression|18|||
155224108|NCT00537381|560260375|FG000|Overall Study|Sponsor decision|14|||
155224109|NCT00537381|560260376|FG001|Overall Study|Sponsor decision|9|||
155224110|NCT00537381|560260375|FG000|Overall Study|Other|5|||
155224111|NCT00537381|560260376|FG001|Overall Study|Other|3|||
155224112|NCT00680901|560260377|FG000|Overall Study|Ongoing: On Study Treatment|1|||
155224113|NCT00680901|560260378|FG001|Overall Study|Ongoing: On Study Treatment|0|||
155224114|NCT00680901|560260377|FG000|Overall Study|Ongoing: In Follow Up|1|||
155224115|NCT00680901|560260378|FG001|Overall Study|Ongoing: In Follow Up|0|||
155224116|NCT00680901|560260377|FG000|Overall Study|Adverse Event|1|||
155224117|NCT00680901|560260378|FG001|Overall Study|Adverse Event|1|||
155224118|NCT00680901|560260377|FG000|Overall Study|Lost to Follow-up|3|||
155224119|NCT00680901|560260378|FG001|Overall Study|Lost to Follow-up|5|||
155224120|NCT00680901|560260377|FG000|Overall Study|Subject decided to withdraw from the study|4|||
155224121|NCT00680901|560260378|FG001|Overall Study|Subject decided to withdraw from the study|15|||
155224122|NCT00680901|560260377|FG000|Overall Study|Sponsor decision|1|||
155224123|NCT00680901|560260378|FG001|Overall Study|Sponsor decision|0|||
155224124|NCT00680901|560260377|FG000|Overall Study|Physician Decision|0|||
155224125|NCT00680901|560260378|FG001|Overall Study|Physician Decision|2|||
155224126|NCT00680901|560260377|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
155224127|NCT00680901|560260378|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
155224128|NCT00680901|560260377|FG000|Overall Study|Other protocol defined stopping criteria|17|||
155224129|NCT00680901|560260378|FG001|Overall Study|Other protocol defined stopping criteria|17|||
155224130|NCT03717480|560260385|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
155224131|NCT01708174|560260386|FG000|Treatment Period|Withdrawal by Subject|1|||
155224132|NCT01708174|560260387|FG001|Treatment Period|Withdrawal by Subject|0|||
155224133|NCT01708174|560260388|FG002|Treatment Period|Withdrawal by Subject|0|||
155224134|NCT01708174|560260386|FG000|Treatment Period|Progressive disease|0|||
155224135|NCT01708174|560260387|FG001|Treatment Period|Progressive disease|1|||
155224136|NCT01708174|560260388|FG002|Treatment Period|Progressive disease|0|||
155224137|NCT01708174|560260386|FG000|Treatment Period|Death|0|||
155224138|NCT01708174|560260387|FG001|Treatment Period|Death|0|||
155224139|NCT01708174|560260388|FG002|Treatment Period|Death|1|||
155224140|NCT01708174|560260386|FG000|Treatment Period|Adverse Event|0|||
155224141|NCT01708174|560260387|FG001|Treatment Period|Adverse Event|1|||
155224142|NCT01708174|560260388|FG002|Treatment Period|Adverse Event|0|||
155224143|NCT01894152|560260389|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
155224144|NCT02741700|560260390|FG000|Overall Study|Lost to Follow-up|17|||
155224145|NCT02741700|560260391|FG001|Overall Study|Lost to Follow-up|8|||
155224146|NCT02741700|560260390|FG000|Overall Study|Withdrawal by Subject|2|||
155224147|NCT02741700|560260391|FG001|Overall Study|Withdrawal by Subject|5|||
155224148|NCT02741700|560260390|FG000|Overall Study|Physician Decision|3|||
155224149|NCT02741700|560260391|FG001|Overall Study|Physician Decision|0|||
155224150|NCT02741700|560260390|FG000|Overall Study|Moved out of State|0|||
155224151|NCT02741700|560260391|FG001|Overall Study|Moved out of State|1|||
155224152|NCT02741700|560260390|FG000|Overall Study|Death|4|||
155224153|NCT02741700|560260391|FG001|Overall Study|Death|5|||
155224154|NCT00923559|560260392|FG000|Overall Study|Lost to Follow-up|2|||
155224155|NCT00923559|560260393|FG001|Overall Study|Lost to Follow-up|3|||
155224156|NCT01774786|560260394|FG000|Overall Study|Death|300|||
155224157|NCT01774786|560260395|FG001|Overall Study|Death|319|||
155224158|NCT01774786|560260394|FG000|Overall Study|Lost to Follow-up|6|||
155224159|NCT01774786|560260395|FG001|Overall Study|Lost to Follow-up|7|||
155224160|NCT01774786|560260394|FG000|Overall Study|Withdrawal by Subject|18|||
155224161|NCT01774786|560260395|FG001|Overall Study|Withdrawal by Subject|14|||
155224162|NCT01774786|560260394|FG000|Overall Study|Physician Decision|2|||
155224163|NCT01774786|560260395|FG001|Overall Study|Physician Decision|0|||
155224164|NCT01774786|560260394|FG000|Overall Study|Non-compliance|0|||
155224165|NCT01774786|560260395|FG001|Overall Study|Non-compliance|1|||
155224166|NCT01774786|560260394|FG000|Overall Study|Reason Not Specified|2|||
155224167|NCT01774786|560260395|FG001|Overall Study|Reason Not Specified|5|||
155224168|NCT02268812|560260396|FG000|Overall Study|Adverse Event|8|||
155224169|NCT02268812|560260397|FG001|Overall Study|Adverse Event|26|||
155224170|NCT02268812|560260398|FG002|Overall Study|Adverse Event|7|||
155224171|NCT02268812|560260399|FG003|Overall Study|Adverse Event|10|||
155224172|NCT02268812|560260396|FG000|Overall Study|Protocol deviation|0|||
155224173|NCT02268812|560260397|FG001|Overall Study|Protocol deviation|0|||
155224174|NCT02268812|560260398|FG002|Overall Study|Protocol deviation|1|||
155224175|NCT02268812|560260399|FG003|Overall Study|Protocol deviation|0|||
155224176|NCT02268812|560260396|FG000|Overall Study|Withdrawal by Subject|0|||
155224177|NCT02268812|560260397|FG001|Overall Study|Withdrawal by Subject|1|||
155224178|NCT02268812|560260398|FG002|Overall Study|Withdrawal by Subject|0|||
155224179|NCT02268812|560260399|FG003|Overall Study|Withdrawal by Subject|0|||
155224180|NCT02268812|560260396|FG000|Overall Study|Physician Decision|3|||
155224181|NCT02268812|560260397|FG001|Overall Study|Physician Decision|1|||
155224182|NCT02268812|560260398|FG002|Overall Study|Physician Decision|0|||
155224183|NCT02268812|560260399|FG003|Overall Study|Physician Decision|1|||
155224184|NCT02268812|560260396|FG000|Overall Study|Other|5|||
155224185|NCT02268812|560260397|FG001|Overall Study|Other|4|||
155224186|NCT02268812|560260398|FG002|Overall Study|Other|1|||
155224187|NCT02268812|560260399|FG003|Overall Study|Other|3|||
155224188|NCT00075582|560260400|FG000|Overall Study|Adverse Event|3|||
155224189|NCT00075582|560260401|FG001|Overall Study|Adverse Event|1|||
155224190|NCT00075582|560260400|FG000|Overall Study|Lack of Efficacy|4|||
155224191|NCT00075582|560260401|FG001|Overall Study|Lack of Efficacy|8|||
155224192|NCT00075582|560260400|FG000|Overall Study|Physician Decision|5|||
155224193|NCT00075582|560260401|FG001|Overall Study|Physician Decision|8|||
155224194|NCT00075582|560260400|FG000|Overall Study|Withdrawal by Subject|2|||
155224195|NCT00075582|560260401|FG001|Overall Study|Withdrawal by Subject|2|||
155224196|NCT00075582|560260400|FG000|Overall Study|Ineligible for study|36|||
155224197|NCT00075582|560260401|FG001|Overall Study|Ineligible for study|16|||
155224198|NCT02385084|560260402|FG000|Period 2|Protocol Violation|0|||
155224199|NCT02385084|560260403|FG001|Period 2|Protocol Violation|0|||
155224200|NCT02385084|560260404|FG002|Period 2|Protocol Violation|1|||
155224201|NCT02385084|560260405|FG003|Period 2|Protocol Violation|0|||
155224202|NCT02385084|560260406|FG004|Period 2|Protocol Violation|0|||
155224203|NCT02385084|560260407|FG005|Period 2|Protocol Violation|0|||
155224204|NCT04544293|560260408|FG000|Double-blind|Adverse Event|2|||
155224205|NCT04544293|560260409|FG001|Double-blind|Adverse Event|1|||
155224206|NCT04544293|560260408|FG000|Double-blind|Pregnancy|0|||
155224207|NCT04544293|560260409|FG001|Double-blind|Pregnancy|1|||
155224208|NCT04544293|560260408|FG000|Double-blind|Lost to Follow-up|0|||
155224209|NCT04544293|560260409|FG001|Double-blind|Lost to Follow-up|1|||
155224210|NCT04544293|560260408|FG000|Open-Label Extension|Study ongoing|79|||
155224211|NCT04544293|560260409|FG001|Open-Label Extension|Study ongoing|81|||
155224212|NCT01951157|560260416|FG000|Overall Study|Progressive Disease|12|||
155224213|NCT01951157|560260417|FG001|Overall Study|Progressive Disease|13|||
155224214|NCT01951157|560260418|FG002|Overall Study|Progressive Disease|10|||
155224215|NCT01951157|560260416|FG000|Overall Study|Treatment-unrelated AE|1|||
155224216|NCT01951157|560260417|FG001|Overall Study|Treatment-unrelated AE|0|||
155224217|NCT01951157|560260418|FG002|Overall Study|Treatment-unrelated AE|3|||
155224218|NCT01951157|560260416|FG000|Overall Study|Study Termination|0|||
155224219|NCT01951157|560260417|FG001|Overall Study|Study Termination|0|||
155224220|NCT01951157|560260418|FG002|Overall Study|Study Termination|1|||
155224221|NCT01951157|560260416|FG000|Overall Study|Physician Decision|5|||
155224222|NCT01951157|560260417|FG001|Overall Study|Physician Decision|3|||
155224223|NCT01951157|560260418|FG002|Overall Study|Physician Decision|2|||
155224224|NCT01951157|560260416|FG000|Overall Study|Non-treatmentrelated death|2|||
155224225|NCT01951157|560260417|FG001|Overall Study|Non-treatmentrelated death|2|||
155224226|NCT01951157|560260418|FG002|Overall Study|Non-treatmentrelated death|2|||
155224227|NCT01951157|560260416|FG000|Overall Study|No treated|0|||
155224228|NCT01951157|560260417|FG001|Overall Study|No treated|1|||
155224229|NCT01951157|560260418|FG002|Overall Study|No treated|0|||
155224230|NCT01951157|560260416|FG000|Overall Study|Treatment-related AE|2|||
155224231|NCT01951157|560260417|FG001|Overall Study|Treatment-related AE|0|||
155224232|NCT01951157|560260418|FG002|Overall Study|Treatment-related AE|4|||
155224233|NCT01951157|560260416|FG000|Overall Study|Consent withdrawn by subject|0|||
155224234|NCT01951157|560260417|FG001|Overall Study|Consent withdrawn by subject|1|||
155224235|NCT01951157|560260418|FG002|Overall Study|Consent withdrawn by subject|3|||
155224236|NCT01951157|560260416|FG000|Overall Study|Treatment-related death|0|||
155224237|NCT01951157|560260417|FG001|Overall Study|Treatment-related death|2|||
155224238|NCT01951157|560260418|FG002|Overall Study|Treatment-related death|0|||
155224239|NCT00744627|560260419|FG000|Overall Study|Adverse Event|6|||
155224240|NCT00744627|560260420|FG001|Overall Study|Adverse Event|9|||
155224241|NCT00744627|560260419|FG000|Overall Study|Lack of Efficacy|7|||
155224242|NCT00744627|560260420|FG001|Overall Study|Lack of Efficacy|3|||
155224243|NCT00744627|560260419|FG000|Overall Study|Noncompliance|0|||
155224244|NCT00744627|560260420|FG001|Overall Study|Noncompliance|1|||
155224245|NCT00744627|560260419|FG000|Overall Study|Protocol Deviations|0|||
155224246|NCT00744627|560260420|FG001|Overall Study|Protocol Deviations|2|||
155224247|NCT00744627|560260419|FG000|Overall Study|Voluntary Withdrawal|9|||
155224248|NCT00744627|560260420|FG001|Overall Study|Voluntary Withdrawal|6|||
155224249|NCT00744627|560260419|FG000|Overall Study|Lost to Follow-up|2|||
155224250|NCT00744627|560260420|FG001|Overall Study|Lost to Follow-up|1|||
155224251|NCT00744627|560260419|FG000|Overall Study|Other|1|||
155224252|NCT00744627|560260420|FG001|Overall Study|Other|0|||
155224253|NCT02268786|560260421|FG000|Overall Study|No Euploid Embryos available|42|||
155224254|NCT02268786|560260422|FG001|Overall Study|No Euploid Embryos available|0|||
155224255|NCT02268786|560260421|FG000|Overall Study|Withdrawal by Subject|7|||
155224256|NCT02268786|560260422|FG001|Overall Study|Withdrawal by Subject|14|||
155224257|NCT02268786|560260421|FG000|Overall Study|Thaw Failure|6|||
155224258|NCT02268786|560260422|FG001|Overall Study|Thaw Failure|4|||
155224259|NCT02268786|560260421|FG000|Overall Study|Protocol Violation|1|||
155224260|NCT02268786|560260422|FG001|Overall Study|Protocol Violation|0|||
155224261|NCT04809220|560260425|FG000|Overall Study|Adverse Event|4|||
155224262|NCT04809220|560260426|FG001|Overall Study|Adverse Event|0|||
155224263|NCT04809220|560260425|FG000|Overall Study|Death|1|||
155224264|NCT04809220|560260426|FG001|Overall Study|Death|0|||
155224265|NCT04809220|560260425|FG000|Overall Study|Lost to Follow-up|3|||
155224266|NCT04809220|560260426|FG001|Overall Study|Lost to Follow-up|0|||
155224267|NCT04809220|560260425|FG000|Overall Study|Physician Decision|0|||
155224268|NCT04809220|560260426|FG001|Overall Study|Physician Decision|1|||
155224269|NCT04809220|560260425|FG000|Overall Study|Withdrawal by Subject|9|||
155224270|NCT04809220|560260426|FG001|Overall Study|Withdrawal by Subject|5|||
155224271|NCT04809220|560260425|FG000|Overall Study|Due to long-term overseas business trips|1|||
155224272|NCT04809220|560260426|FG001|Overall Study|Due to long-term overseas business trips|0|||
155224273|NCT00642668|560260435|FG000|Overall Study|Lost to Follow-up|1|||
155224274|NCT00642668|560260435|FG000|Overall Study|Adverse Event|2|||
155224275|NCT00642668|560260435|FG000|Overall Study|Death|2|||
155224276|NCT00642668|560260435|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155224277|NCT00642668|560260435|FG000|Overall Study|Failure to Return|1|||
155224278|NCT00642668|560260435|FG000|Overall Study|Dialysis Initiation|5|||
155224279|NCT00642668|560260435|FG000|Overall Study|Blood Transfusion|2|||
155224280|NCT01586819|560260436|FG000|Overall Study|Withdrawal by Subject|1|||
155224281|NCT01586819|560260437|FG001|Overall Study|Withdrawal by Subject|0|||
155224282|NCT00896337|560260438|FG000|Overall Study|Death|7|||
155224283|NCT00896337|560260438|FG000|Overall Study|Withdrawal by Subject|7|||
155224284|NCT00896337|560260438|FG000|Overall Study|Lost to Follow-up|11|||
155224285|NCT01132495|560260449|FG000|Overall Study|Various reasons|40|||
155224286|NCT01132495|560260450|FG001|Overall Study|Various reasons|38|||
155224287|NCT01132495|560260451|FG002|Overall Study|Various reasons|20|||
155224288|NCT01132495|560260452|FG003|Overall Study|Various reasons|12|||
155224289|NCT01796197|560260455|FG000|Overall Study|Lost to Follow-up|1|||
155224290|NCT01796197|560260455|FG000|Overall Study|Lack of Efficacy|1|||
155224291|NCT00244712|560260456|FG000|Overall Study|Adverse Event|20|||
155224292|NCT00244712|560260457|FG001|Overall Study|Adverse Event|21|||
155224293|NCT00244712|560260456|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
155224294|NCT00244712|560260457|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
155224295|NCT00244712|560260456|FG000|Overall Study|Lack of Compliance|10|||
155224296|NCT00244712|560260457|FG001|Overall Study|Lack of Compliance|11|||
155224297|NCT00244712|560260456|FG000|Overall Study|Lost to Follow-up|45|||
155224298|NCT00244712|560260457|FG001|Overall Study|Lost to Follow-up|52|||
155224299|NCT00244712|560260456|FG000|Overall Study|Withdrawal by Subject|13|||
155224300|NCT00244712|560260457|FG001|Overall Study|Withdrawal by Subject|23|||
155224301|NCT00244712|560260456|FG000|Overall Study|Protocol Violation, disease progression|13|||
155224302|NCT00244712|560260457|FG001|Overall Study|Protocol Violation, disease progression|11|||
155224303|NCT01077804|560260460|FG000|Overall Study|Unreachable|102|||
155224304|NCT01077804|560260460|FG000|Overall Study|Refused to continue|79|||
155224305|NCT01077804|560260460|FG000|Overall Study|Other|18|||
155224306|NCT02776917|560260461|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
155224307|NCT00574405|560262447|FG000|Overall Study|Withdrawal by Subject|3|||
155224308|NCT00574405|560262448|FG001|Overall Study|Withdrawal by Subject|2|||
155224309|NCT01336738|560262449|FG000|Overall Study|Adverse Event|0|||
155224310|NCT01336738|560262450|FG001|Overall Study|Adverse Event|3|||
155224311|NCT01336738|560262451|FG002|Overall Study|Adverse Event|2|||
155224312|NCT01336738|560262452|FG003|Overall Study|Adverse Event|1|||
155224313|NCT01336738|560262453|FG004|Overall Study|Adverse Event|3|||
155224314|NCT01336738|560262449|FG000|Overall Study|Lost to Follow-up|2|||
155224315|NCT01336738|560262450|FG001|Overall Study|Lost to Follow-up|1|||
155224316|NCT01336738|560262451|FG002|Overall Study|Lost to Follow-up|2|||
155224317|NCT01336738|560262452|FG003|Overall Study|Lost to Follow-up|2|||
155224318|NCT01336738|560262453|FG004|Overall Study|Lost to Follow-up|2|||
155224319|NCT01336738|560262449|FG000|Overall Study|Did not meet entrance criteria|0|||
155224320|NCT01336738|560262450|FG001|Overall Study|Did not meet entrance criteria|1|||
155224321|NCT01336738|560262451|FG002|Overall Study|Did not meet entrance criteria|0|||
155224322|NCT01336738|560262452|FG003|Overall Study|Did not meet entrance criteria|0|||
155224323|NCT01336738|560262453|FG004|Overall Study|Did not meet entrance criteria|0|||
155224324|NCT01336738|560262449|FG000|Overall Study|Protocol Violation|0|||
155224325|NCT01336738|560262450|FG001|Overall Study|Protocol Violation|1|||
155224326|NCT01336738|560262451|FG002|Overall Study|Protocol Violation|0|||
155224327|NCT01336738|560262452|FG003|Overall Study|Protocol Violation|0|||
155224328|NCT01336738|560262453|FG004|Overall Study|Protocol Violation|0|||
155224329|NCT01336738|560262449|FG000|Overall Study|Withdrawal by Subject|2|||
155224330|NCT01336738|560262450|FG001|Overall Study|Withdrawal by Subject|0|||
155224331|NCT01336738|560262451|FG002|Overall Study|Withdrawal by Subject|2|||
155224332|NCT01336738|560262452|FG003|Overall Study|Withdrawal by Subject|1|||
155224333|NCT01336738|560262453|FG004|Overall Study|Withdrawal by Subject|1|||
155224334|NCT01336738|560262449|FG000|Overall Study|Other|3|||
155224335|NCT01336738|560262450|FG001|Overall Study|Other|3|||
155224336|NCT01336738|560262451|FG002|Overall Study|Other|2|||
155224337|NCT01336738|560262452|FG003|Overall Study|Other|3|||
155224338|NCT01336738|560262453|FG004|Overall Study|Other|4|||
155224339|NCT01083433|560262454|FG000|Overall Study|Lost to Follow-up|2|||
155224340|NCT01083433|560262455|FG001|Overall Study|Lost to Follow-up|1|||
155224341|NCT01083433|560262456|FG002|Overall Study|Lost to Follow-up|1|||
155224342|NCT01083433|560262454|FG000|Overall Study|Withdrawal by Subject|0|||
155224343|NCT01083433|560262455|FG001|Overall Study|Withdrawal by Subject|5|||
155224344|NCT01083433|560262456|FG002|Overall Study|Withdrawal by Subject|3|||
155224345|NCT01083433|560262454|FG000|Overall Study|Pregnancy|0|||
155224346|NCT01083433|560262455|FG001|Overall Study|Pregnancy|0|||
155224347|NCT01083433|560262456|FG002|Overall Study|Pregnancy|1|||
155224348|NCT01332149|560262458|FG000|Overall Study|Adverse Event|11|||
155224349|NCT01332149|560262459|FG001|Overall Study|Adverse Event|9|||
155224350|NCT01332149|560262458|FG000|Overall Study|Other unspecified|5|||
155224351|NCT01332149|560262459|FG001|Overall Study|Other unspecified|7|||
155224352|NCT01332149|560262458|FG000|Overall Study|Protocol Violation|1|||
155224353|NCT01332149|560262459|FG001|Overall Study|Protocol Violation|3|||
155224354|NCT01332149|560262458|FG000|Overall Study|Withdrawal by Subject|4|||
155224355|NCT01332149|560262459|FG001|Overall Study|Withdrawal by Subject|5|||
155224356|NCT01332149|560262458|FG000|Overall Study|Lost to Follow-up|1|||
155224357|NCT01332149|560262459|FG001|Overall Study|Lost to Follow-up|1|||
155224358|NCT01332149|560262458|FG000|Overall Study|Insufficient clinical response|4|||
155224359|NCT01332149|560262459|FG001|Overall Study|Insufficient clinical response|7|||
155224360|NCT01332149|560262458|FG000|Overall Study|Did not meet entrance criteria|3|||
155224361|NCT01332149|560262459|FG001|Overall Study|Did not meet entrance criteria|4|||
155224362|NCT01332149|560262458|FG000|Overall Study|Randomized but not treated|1|||
155224363|NCT01332149|560262459|FG001|Overall Study|Randomized but not treated|2|||
155224364|NCT04982029|560262460|FG000|Overall Study|Lost to Follow-up|2|||
155224365|NCT04982029|560262461|FG001|Overall Study|Lost to Follow-up|3|||
155224366|NCT04615949|560262462|FG000|Overall Study|Withdrawal by Subject|2|||
155224367|NCT04615949|560262463|FG001|Overall Study|Withdrawal by Subject|4|||
155224368|NCT04615949|560262462|FG000|Overall Study|Lost to Follow-up|2|||
155224369|NCT04615949|560262463|FG001|Overall Study|Lost to Follow-up|2|||
155224370|NCT04615949|560262462|FG000|Overall Study|Death|0|||
155224371|NCT04615949|560262463|FG001|Overall Study|Death|2|||
155224372|NCT03036566|560262464|FG000|Overall Study|Lost to Follow-up|3|||
155224373|NCT05458856|560262465|FG000|Overall Study|Withdrawal by Subject|5|||
155224374|NCT05458856|560262465|FG000|Overall Study|Death|4|||
155224375|NCT05458856|560262465|FG000|Overall Study|Protocol Deviation|3|||
155224376|NCT05458856|560262465|FG000|Overall Study|Physician Decision|1|||
155224377|NCT00110812|560262468|FG000|Main Study|Death|0|||
155224378|NCT00110812|560262469|FG001|Main Study|Death|0|||
155224379|NCT00110812|560262470|FG002|Main Study|Death|2|||
155224380|NCT00110812|560262468|FG000|Main Study|Withdrawal by Subject|0|||
155224381|NCT00110812|560262469|FG001|Main Study|Withdrawal by Subject|0|||
155224382|NCT00110812|560262470|FG002|Main Study|Withdrawal by Subject|1|||
155224383|NCT00110812|560262468|FG000|Main Study|Lost to Follow-up|8|||
155224384|NCT00110812|560262469|FG001|Main Study|Lost to Follow-up|11|||
155224385|NCT00110812|560262470|FG002|Main Study|Lost to Follow-up|10|||
155224386|NCT00110812|560262468|FG000|Extended Follow-up|Death|1|||
155224387|NCT00110812|560262469|FG001|Extended Follow-up|Death|0|||
155224388|NCT00110812|560262470|FG002|Extended Follow-up|Death|3|||
155224389|NCT00110812|560262468|FG000|Extended Follow-up|Withdrawal by Subject|0|||
155224390|NCT00110812|560262469|FG001|Extended Follow-up|Withdrawal by Subject|1|||
155224391|NCT00110812|560262470|FG002|Extended Follow-up|Withdrawal by Subject|0|||
155224392|NCT00110812|560262468|FG000|Extended Follow-up|Lost to Follow-up|1|||
155224393|NCT00110812|560262469|FG001|Extended Follow-up|Lost to Follow-up|3|||
155224394|NCT00110812|560262470|FG002|Extended Follow-up|Lost to Follow-up|1|||
155224395|NCT01344369|560262471|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
155224396|NCT01344369|560262472|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
155224397|NCT01344369|560262471|FG000|Washout of 28 Days|Physician Decision|0|||
155224398|NCT01344369|560262472|FG001|Washout of 28 Days|Physician Decision|1|||
155224399|NCT01344369|560262471|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
155224400|NCT01344369|560262472|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
155224401|NCT01886833|560262473|FG000|Overall Study|IgA not available from both periods|204|||
155224402|NCT01454726|560262474|FG000|Overall Study|Withdrawal by Subject|0|||
155224403|NCT01454726|560262475|FG001|Overall Study|Withdrawal by Subject|1|||
155224404|NCT02919670|560262478|FG000|Overall Study|Only 17 participants met compliance|43|||
155224405|NCT02919670|560262479|FG001|Overall Study|Only 17 participants met compliance|39|||
155224406|NCT01714310|560262480|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
155224407|NCT01714310|560262481|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
155224408|NCT01714310|560262482|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
155224409|NCT01714310|560262480|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
155224410|NCT01714310|560262481|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
155224411|NCT01714310|560262482|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
155224412|NCT01714310|560262480|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
155224413|NCT01714310|560262481|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
155224414|NCT01714310|560262482|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
155224415|NCT01714310|560262480|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
155224416|NCT01714310|560262481|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
155224417|NCT01714310|560262482|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
155224418|NCT01641367|560262483|FG000|Cohorts|Death|18|||
155224419|NCT01641367|560262484|FG001|Cohorts|Death|1|||
155224420|NCT01641367|560262485|FG002|Cohorts|Death|2|||
155224421|NCT01641367|560262486|FG003|Cohorts|Death|0|||
155224422|NCT01641367|560262487|FG004|Cohorts|Death|1|||
155224423|NCT01641367|560262488|FG005|Cohorts|Death|1|||
155224424|NCT01641367|560262489|FG006|Cohorts|Death|0|||
155224425|NCT01641367|560262490|FG007|Cohorts|Death|0|||
155224426|NCT01641367|560262483|FG000|Cohorts|Lost to Follow-up|16|||
155224427|NCT01641367|560262484|FG001|Cohorts|Lost to Follow-up|0|||
155224428|NCT01641367|560262485|FG002|Cohorts|Lost to Follow-up|2|||
155224429|NCT01641367|560262486|FG003|Cohorts|Lost to Follow-up|0|||
155224430|NCT01641367|560262487|FG004|Cohorts|Lost to Follow-up|2|||
155224431|NCT01641367|560262488|FG005|Cohorts|Lost to Follow-up|0|||
155224432|NCT01641367|560262489|FG006|Cohorts|Lost to Follow-up|0|||
155224433|NCT01641367|560262490|FG007|Cohorts|Lost to Follow-up|0|||
155224434|NCT01641367|560262483|FG000|Randomized Adherence Intervention|Death|0|||
155224435|NCT01641367|560262484|FG001|Randomized Adherence Intervention|Death|0|||
155224436|NCT01641367|560262485|FG002|Randomized Adherence Intervention|Death|0|||
155224437|NCT01641367|560262486|FG003|Randomized Adherence Intervention|Death|0|||
155224438|NCT01641367|560262487|FG004|Randomized Adherence Intervention|Death|0|||
155224439|NCT01641367|560262488|FG005|Randomized Adherence Intervention|Death|0|||
155224440|NCT01641367|560262489|FG006|Randomized Adherence Intervention|Death|11|||
155224441|NCT01641367|560262490|FG007|Randomized Adherence Intervention|Death|12|||
155224442|NCT01641367|560262483|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224443|NCT01641367|560262484|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224444|NCT01641367|560262485|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224445|NCT01641367|560262486|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224446|NCT01641367|560262487|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224447|NCT01641367|560262488|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
155224448|NCT01641367|560262489|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
155224449|NCT01641367|560262490|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
155224450|NCT00826267|560262491|FG000|Overall Study|Other Adverse Event|1|||
155224451|NCT00826267|560262492|FG001|Overall Study|Other Adverse Event|0|||
155224452|NCT00826267|560262493|FG002|Overall Study|Other Adverse Event|0|||
155224453|NCT01675882|560262496|FG000|Overall Study|Adverse Event|0|||
155224454|NCT01675882|560262497|FG001|Overall Study|Adverse Event|2|||
155224455|NCT01675882|560262498|FG002|Overall Study|Adverse Event|1|||
155224456|NCT01675882|560262499|FG003|Overall Study|Adverse Event|0|||
155224457|NCT01675882|560262496|FG000|Overall Study|Participant unwilling to continue|2|||
155224458|NCT01675882|560262497|FG001|Overall Study|Participant unwilling to continue|4|||
155224459|NCT01675882|560262498|FG002|Overall Study|Participant unwilling to continue|2|||
155224460|NCT01675882|560262499|FG003|Overall Study|Participant unwilling to continue|1|||
155224461|NCT01675882|560262496|FG000|Overall Study|Lost to Follow-up|0|||
155224462|NCT01675882|560262497|FG001|Overall Study|Lost to Follow-up|1|||
155224463|NCT01675882|560262498|FG002|Overall Study|Lost to Follow-up|0|||
155224464|NCT01675882|560262499|FG003|Overall Study|Lost to Follow-up|0|||
155224465|NCT01675882|560262496|FG000|Overall Study|Non-compliance|0|||
155224466|NCT01675882|560262497|FG001|Overall Study|Non-compliance|0|||
155224467|NCT01675882|560262498|FG002|Overall Study|Non-compliance|0|||
155224468|NCT01675882|560262499|FG003|Overall Study|Non-compliance|1|||
155224469|NCT00850200|560262500|FG000|Overall Study|Physician Decision|2|||
155224470|NCT00850200|560262500|FG000|Overall Study|Did not recieve treatment|2|||
155224471|NCT00850200|560262500|FG000|Overall Study|Withdrawal by Subject|1|||
155224472|NCT02129803|560262506|FG000|Overall Study|Protocol Violation|4|||
155224473|NCT02129803|560262507|FG001|Overall Study|Protocol Violation|0|||
155224474|NCT02129803|560262506|FG000|Overall Study|Physician Decision|0|||
155224475|NCT02129803|560262507|FG001|Overall Study|Physician Decision|1|||
155224476|NCT02129803|560262506|FG000|Overall Study|Difficulty sleeping|1|||
155224477|NCT02129803|560262507|FG001|Overall Study|Difficulty sleeping|0|||
155224478|NCT02129803|560262506|FG000|Overall Study|Morning headache|0|||
155224479|NCT02129803|560262507|FG001|Overall Study|Morning headache|1|||
155224480|NCT02129803|560262506|FG000|Overall Study|Withdrawal by Subject|1|||
155224481|NCT02129803|560262507|FG001|Overall Study|Withdrawal by Subject|1|||
155224482|NCT02689258|560262511|FG000|Overall Study|Subject Non-Compliance|0|||
155224483|NCT02689258|560262512|FG001|Overall Study|Subject Non-Compliance|1|||
155224484|NCT02689258|560262513|FG002|Overall Study|Subject Non-Compliance|0|||
155224485|NCT02689258|560262514|FG003|Overall Study|Subject Non-Compliance|0|||
155224486|NCT02689258|560262515|FG004|Overall Study|Subject Non-Compliance|0|||
155224487|NCT02689258|560262516|FG005|Overall Study|Subject Non-Compliance|0|||
155224488|NCT02689258|560262517|FG006|Overall Study|Subject Non-Compliance|0|||
155224489|NCT02689258|560262518|FG007|Overall Study|Subject Non-Compliance|0|||
155224490|NCT02689258|560262519|FG008|Overall Study|Subject Non-Compliance|0|||
155224491|NCT02689258|560262520|FG009|Overall Study|Subject Non-Compliance|0|||
155224492|NCT02689258|560262521|FG010|Overall Study|Subject Non-Compliance|0|||
155224493|NCT02689258|560262522|FG011|Overall Study|Subject Non-Compliance|0|||
155224494|NCT02689258|560262511|FG000|Overall Study|Subject Refusal to Continue|0|||
155224495|NCT02689258|560262512|FG001|Overall Study|Subject Refusal to Continue|1|||
155224496|NCT02689258|560262513|FG002|Overall Study|Subject Refusal to Continue|0|||
155224497|NCT02689258|560262514|FG003|Overall Study|Subject Refusal to Continue|0|||
155224498|NCT02689258|560262515|FG004|Overall Study|Subject Refusal to Continue|0|||
155224499|NCT02689258|560262516|FG005|Overall Study|Subject Refusal to Continue|0|||
155224500|NCT02689258|560262517|FG006|Overall Study|Subject Refusal to Continue|0|||
155224501|NCT02689258|560262518|FG007|Overall Study|Subject Refusal to Continue|0|||
155224502|NCT02689258|560262519|FG008|Overall Study|Subject Refusal to Continue|1|||
155224503|NCT02689258|560262520|FG009|Overall Study|Subject Refusal to Continue|0|||
155224504|NCT02689258|560262521|FG010|Overall Study|Subject Refusal to Continue|0|||
155224505|NCT02689258|560262522|FG011|Overall Study|Subject Refusal to Continue|1|||
155224506|NCT02689258|560262511|FG000|Overall Study|Other|0|||
155224507|NCT02689258|560262512|FG001|Overall Study|Other|2|||
155224508|NCT02689258|560262513|FG002|Overall Study|Other|0|||
155224509|NCT02689258|560262514|FG003|Overall Study|Other|0|||
155224510|NCT02689258|560262515|FG004|Overall Study|Other|1|||
155224511|NCT02689258|560262516|FG005|Overall Study|Other|0|||
155224512|NCT02689258|560262517|FG006|Overall Study|Other|0|||
155224513|NCT02689258|560262518|FG007|Overall Study|Other|0|||
155224514|NCT02689258|560262519|FG008|Overall Study|Other|1|||
155224515|NCT02689258|560262520|FG009|Overall Study|Other|0|||
155224516|NCT02689258|560262521|FG010|Overall Study|Other|0|||
155224517|NCT02689258|560262522|FG011|Overall Study|Other|0|||
155224518|NCT00594464|560262524|FG000|Overall Study|Withdrawal by Subject|1|||
155224519|NCT00594464|560262524|FG000|Overall Study|Delay in operation|2|||
155224520|NCT00785486|560262525|FG000|Midazolam Alone|Withdrawal by Subject|1|||
155224521|NCT02907359|560262530|FG000|Overall Study|Death|234|||
155224522|NCT02907359|560262531|FG001|Overall Study|Death|117|||
155224523|NCT02907359|560262530|FG000|Overall Study|Withdrawal by Subject|6|||
155224524|NCT02907359|560262531|FG001|Overall Study|Withdrawal by Subject|11|||
155224525|NCT02907359|560262530|FG000|Overall Study|Lost to Follow-up|1|||
155224526|NCT02907359|560262531|FG001|Overall Study|Lost to Follow-up|0|||
155224527|NCT03131440|560262532|FG000|Overall Study|Withdrawal by Subject|1|||
155224528|NCT03131440|560262533|FG001|Overall Study|Withdrawal by Subject|3|||
155224529|NCT03131440|560262534|FG002|Overall Study|Withdrawal by Subject|0|||
155224530|NCT03131440|560262535|FG003|Overall Study|Withdrawal by Subject|0|||
155224531|NCT03131440|560262536|FG004|Overall Study|Withdrawal by Subject|1|||
155224532|NCT03131440|560262537|FG005|Overall Study|Withdrawal by Subject|0|||
155224533|NCT03131440|560262538|FG006|Overall Study|Withdrawal by Subject|0|||
155224534|NCT03131440|560262539|FG007|Overall Study|Withdrawal by Subject|1|||
155224535|NCT03131440|560262540|FG008|Overall Study|Withdrawal by Subject|1|||
155224536|NCT03131440|560262541|FG009|Overall Study|Withdrawal by Subject|1|||
155224537|NCT03131440|560262542|FG010|Overall Study|Withdrawal by Subject|0|||
155224538|NCT03131440|560262543|FG011|Overall Study|Withdrawal by Subject|1|||
155224539|NCT03131440|560262544|FG012|Overall Study|Withdrawal by Subject|1|||
155224540|NCT03131440|560262545|FG013|Overall Study|Withdrawal by Subject|0|||
155224541|NCT03131440|560262546|FG014|Overall Study|Withdrawal by Subject|1|||
155224542|NCT03131440|560262547|FG015|Overall Study|Withdrawal by Subject|0|||
155224543|NCT03131440|560262548|FG016|Overall Study|Withdrawal by Subject|0|||
155224544|NCT03131440|560262549|FG017|Overall Study|Withdrawal by Subject|0|||
155224545|NCT03131440|560262550|FG018|Overall Study|Withdrawal by Subject|1|||
155224546|NCT03131440|560262551|FG019|Overall Study|Withdrawal by Subject|0|||
155224547|NCT03131440|560262552|FG020|Overall Study|Withdrawal by Subject|1|||
155224548|NCT03131440|560262553|FG021|Overall Study|Withdrawal by Subject|1|||
155224549|NCT03131440|560262554|FG022|Overall Study|Withdrawal by Subject|1|||
155224550|NCT03131440|560262555|FG023|Overall Study|Withdrawal by Subject|0|||
155224551|NCT03131440|560262556|FG024|Overall Study|Withdrawal by Subject|0|||
155224552|NCT03131440|560262557|FG025|Overall Study|Withdrawal by Subject|0|||
155224553|NCT03131440|560262558|FG026|Overall Study|Withdrawal by Subject|0|||
155224554|NCT03131440|560262559|FG027|Overall Study|Withdrawal by Subject|0|||
155224555|NCT03131440|560262560|FG028|Overall Study|Withdrawal by Subject|0|||
155224556|NCT03131440|560262561|FG029|Overall Study|Withdrawal by Subject|0|||
155224557|NCT03131440|560262562|FG030|Overall Study|Withdrawal by Subject|1|||
155224558|NCT03131440|560262563|FG031|Overall Study|Withdrawal by Subject|0|||
155224559|NCT03131440|560262532|FG000|Overall Study|Lost to Follow-up|0|||
155224560|NCT03131440|560262533|FG001|Overall Study|Lost to Follow-up|0|||
155224561|NCT03131440|560262534|FG002|Overall Study|Lost to Follow-up|0|||
155224562|NCT03131440|560262535|FG003|Overall Study|Lost to Follow-up|0|||
155224563|NCT03131440|560262536|FG004|Overall Study|Lost to Follow-up|0|||
155224564|NCT03131440|560262537|FG005|Overall Study|Lost to Follow-up|1|||
155224565|NCT03131440|560262538|FG006|Overall Study|Lost to Follow-up|0|||
155224566|NCT03131440|560262539|FG007|Overall Study|Lost to Follow-up|0|||
155224567|NCT03131440|560262540|FG008|Overall Study|Lost to Follow-up|0|||
155224568|NCT03131440|560262541|FG009|Overall Study|Lost to Follow-up|0|||
155224569|NCT03131440|560262542|FG010|Overall Study|Lost to Follow-up|0|||
155224570|NCT03131440|560262543|FG011|Overall Study|Lost to Follow-up|0|||
155224571|NCT03131440|560262544|FG012|Overall Study|Lost to Follow-up|0|||
155224572|NCT03131440|560262545|FG013|Overall Study|Lost to Follow-up|0|||
155224573|NCT03131440|560262546|FG014|Overall Study|Lost to Follow-up|0|||
155224574|NCT03131440|560262547|FG015|Overall Study|Lost to Follow-up|0|||
155224575|NCT03131440|560262548|FG016|Overall Study|Lost to Follow-up|0|||
155224576|NCT03131440|560262549|FG017|Overall Study|Lost to Follow-up|0|||
155224577|NCT03131440|560262550|FG018|Overall Study|Lost to Follow-up|0|||
155224578|NCT03131440|560262551|FG019|Overall Study|Lost to Follow-up|2|||
155224579|NCT03131440|560262552|FG020|Overall Study|Lost to Follow-up|1|||
155224580|NCT03131440|560262553|FG021|Overall Study|Lost to Follow-up|0|||
155224581|NCT03131440|560262554|FG022|Overall Study|Lost to Follow-up|1|||
155224582|NCT03131440|560262555|FG023|Overall Study|Lost to Follow-up|0|||
155224583|NCT03131440|560262556|FG024|Overall Study|Lost to Follow-up|1|||
155224584|NCT03131440|560262557|FG025|Overall Study|Lost to Follow-up|0|||
155224585|NCT03131440|560262558|FG026|Overall Study|Lost to Follow-up|0|||
155224586|NCT03131440|560262559|FG027|Overall Study|Lost to Follow-up|2|||
155224587|NCT03131440|560262560|FG028|Overall Study|Lost to Follow-up|0|||
155224588|NCT03131440|560262561|FG029|Overall Study|Lost to Follow-up|2|||
155224589|NCT03131440|560262562|FG030|Overall Study|Lost to Follow-up|0|||
155224590|NCT03131440|560262563|FG031|Overall Study|Lost to Follow-up|0|||
155224591|NCT03131440|560262532|FG000|Overall Study|Death|0|||
155224592|NCT03131440|560262533|FG001|Overall Study|Death|0|||
155224593|NCT03131440|560262534|FG002|Overall Study|Death|0|||
155224594|NCT03131440|560262535|FG003|Overall Study|Death|0|||
155224595|NCT03131440|560262536|FG004|Overall Study|Death|0|||
155224596|NCT03131440|560262537|FG005|Overall Study|Death|0|||
155224597|NCT03131440|560262538|FG006|Overall Study|Death|0|||
155224598|NCT03131440|560262539|FG007|Overall Study|Death|0|||
155224599|NCT03131440|560262540|FG008|Overall Study|Death|0|||
155224600|NCT03131440|560262541|FG009|Overall Study|Death|0|||
155224601|NCT03131440|560262542|FG010|Overall Study|Death|0|||
155224602|NCT03131440|560262543|FG011|Overall Study|Death|0|||
155224603|NCT03131440|560262544|FG012|Overall Study|Death|0|||
155224604|NCT03131440|560262545|FG013|Overall Study|Death|0|||
155224605|NCT03131440|560262546|FG014|Overall Study|Death|0|||
155224606|NCT03131440|560262547|FG015|Overall Study|Death|0|||
155224607|NCT03131440|560262548|FG016|Overall Study|Death|0|||
155224608|NCT03131440|560262549|FG017|Overall Study|Death|0|||
155224609|NCT03131440|560262550|FG018|Overall Study|Death|0|||
155224610|NCT03131440|560262551|FG019|Overall Study|Death|0|||
155224611|NCT03131440|560262552|FG020|Overall Study|Death|0|||
155224612|NCT03131440|560262553|FG021|Overall Study|Death|0|||
155224613|NCT03131440|560262554|FG022|Overall Study|Death|0|||
155224614|NCT03131440|560262555|FG023|Overall Study|Death|0|||
155224615|NCT03131440|560262556|FG024|Overall Study|Death|0|||
155224616|NCT03131440|560262557|FG025|Overall Study|Death|1|||
155224617|NCT03131440|560262558|FG026|Overall Study|Death|0|||
155224618|NCT03131440|560262559|FG027|Overall Study|Death|0|||
155224619|NCT03131440|560262560|FG028|Overall Study|Death|0|||
155224620|NCT03131440|560262561|FG029|Overall Study|Death|0|||
155224621|NCT03131440|560262562|FG030|Overall Study|Death|0|||
155224622|NCT03131440|560262563|FG031|Overall Study|Death|0|||
155224623|NCT00746941|560262566|FG000|Overall Study|Death|2|||
155224624|NCT00746941|560262567|FG001|Overall Study|Death|0|||
155224625|NCT00746941|560262568|FG002|Overall Study|Death|0|||
155224626|NCT00746941|560262569|FG003|Overall Study|Death|6|||
155224627|NCT00746941|560262566|FG000|Overall Study|Physician Decision|0|||
155224628|NCT00746941|560262567|FG001|Overall Study|Physician Decision|0|||
155224629|NCT00746941|560262568|FG002|Overall Study|Physician Decision|2|||
155224630|NCT00746941|560262569|FG003|Overall Study|Physician Decision|0|||
155224631|NCT00746941|560262566|FG000|Overall Study|Withdrawal by Subject|3|||
155224632|NCT00746941|560262567|FG001|Overall Study|Withdrawal by Subject|0|||
155224633|NCT00746941|560262568|FG002|Overall Study|Withdrawal by Subject|0|||
155224634|NCT00746941|560262569|FG003|Overall Study|Withdrawal by Subject|2|||
155224635|NCT00746941|560262566|FG000|Overall Study|Other, reason not provided|2|||
155224636|NCT00746941|560262567|FG001|Overall Study|Other, reason not provided|4|||
155224637|NCT00746941|560262568|FG002|Overall Study|Other, reason not provided|0|||
155224638|NCT00746941|560262569|FG003|Overall Study|Other, reason not provided|4|||
155224639|NCT00746941|560262566|FG000|Overall Study|Adverse Event|0|||
155224640|NCT00746941|560262567|FG001|Overall Study|Adverse Event|0|||
155224641|NCT00746941|560262568|FG002|Overall Study|Adverse Event|0|||
155224642|NCT00746941|560262569|FG003|Overall Study|Adverse Event|1|||
155224643|NCT02197806|560262579|FG000|Overall Study|Adverse Event|0|||
155224644|NCT02197806|560262580|FG001|Overall Study|Adverse Event|1|||
155224645|NCT02197806|560262581|FG002|Overall Study|Adverse Event|0|||
155224646|NCT02197806|560262582|FG003|Overall Study|Adverse Event|1|||
155224647|NCT03065244|560262584|FG000|Overall Study|Lost to Follow-up|1|||
155224648|NCT03065244|560262585|FG001|Overall Study|Lost to Follow-up|1|||
155224649|NCT03065244|560262584|FG000|Overall Study|Diagnosed with a different disease|1|||
155224650|NCT03065244|560262585|FG001|Overall Study|Diagnosed with a different disease|1|||
155224651|NCT03065244|560262584|FG000|Overall Study|Protocol Violation|0|||
155224652|NCT03065244|560262585|FG001|Overall Study|Protocol Violation|1|||
155224653|NCT03065244|560262584|FG000|Overall Study|Withdrawal by Subject|1|||
155224654|NCT03065244|560262585|FG001|Overall Study|Withdrawal by Subject|1|||
155224655|NCT00500292|560262586|FG000|Overall Study|Adverse Event|3|||
155224656|NCT00500292|560262587|FG001|Overall Study|Adverse Event|6|||
155224657|NCT00500292|560262588|FG002|Overall Study|Adverse Event|4|||
155224658|NCT00500292|560262586|FG000|Overall Study|Condition under investigation worsened|21|||
155224659|NCT00500292|560262587|FG001|Overall Study|Condition under investigation worsened|23|||
155224660|NCT00500292|560262588|FG002|Overall Study|Condition under investigation worsened|19|||
155224661|NCT00500292|560262586|FG000|Overall Study|Withdrawal by Subject|0|||
155224662|NCT00500292|560262587|FG001|Overall Study|Withdrawal by Subject|1|||
155224663|NCT00500292|560262588|FG002|Overall Study|Withdrawal by Subject|0|||
155224664|NCT00500292|560262586|FG000|Overall Study|Other|1|||
155224665|NCT00500292|560262587|FG001|Overall Study|Other|1|||
155224666|NCT00500292|560262588|FG002|Overall Study|Other|4|||
155224667|NCT03560531|560262592|FG000|Overall Study|Death|4|||
155224668|NCT03560531|560262593|FG001|Overall Study|Death|1|||
155224669|NCT03560531|560262594|FG002|Overall Study|Death|1|||
155224670|NCT03560531|560262595|FG003|Overall Study|Death|2|||
155224671|NCT03560531|560262596|FG004|Overall Study|Death|6|||
155224672|NCT03560531|560262597|FG005|Overall Study|Death|1|||
155224673|NCT03560531|560262598|FG006|Overall Study|Death|4|||
155224674|NCT03560531|560262599|FG007|Overall Study|Death|8|||
155224675|NCT03560531|560262600|FG008|Overall Study|Death|1|||
155224676|NCT03560531|560262601|FG009|Overall Study|Death|3|||
155224677|NCT03560531|560262602|FG010|Overall Study|Death|2|||
155224678|NCT03560531|560262603|FG011|Overall Study|Death|0|||
155224679|NCT03560531|560262604|FG012|Overall Study|Death|4|||
155224680|NCT03560531|560262605|FG013|Overall Study|Death|1|||
155224681|NCT03560531|560262592|FG000|Overall Study|Lost to Follow-up|1|||
155224682|NCT03560531|560262593|FG001|Overall Study|Lost to Follow-up|1|||
155224683|NCT03560531|560262594|FG002|Overall Study|Lost to Follow-up|0|||
155224684|NCT03560531|560262595|FG003|Overall Study|Lost to Follow-up|0|||
155224685|NCT03560531|560262596|FG004|Overall Study|Lost to Follow-up|0|||
155224686|NCT03560531|560262597|FG005|Overall Study|Lost to Follow-up|0|||
155224687|NCT03560531|560262598|FG006|Overall Study|Lost to Follow-up|1|||
155224688|NCT03560531|560262599|FG007|Overall Study|Lost to Follow-up|0|||
155224689|NCT03560531|560262600|FG008|Overall Study|Lost to Follow-up|0|||
155224690|NCT03560531|560262601|FG009|Overall Study|Lost to Follow-up|0|||
155224691|NCT03560531|560262602|FG010|Overall Study|Lost to Follow-up|0|||
155224692|NCT03560531|560262603|FG011|Overall Study|Lost to Follow-up|0|||
155224693|NCT03560531|560262604|FG012|Overall Study|Lost to Follow-up|0|||
155224694|NCT03560531|560262605|FG013|Overall Study|Lost to Follow-up|0|||
155224695|NCT03560531|560262592|FG000|Overall Study|Withdrawal by Subject|1|||
155224696|NCT03560531|560262593|FG001|Overall Study|Withdrawal by Subject|0|||
155224697|NCT03560531|560262594|FG002|Overall Study|Withdrawal by Subject|0|||
155224698|NCT03560531|560262595|FG003|Overall Study|Withdrawal by Subject|0|||
155224699|NCT03560531|560262596|FG004|Overall Study|Withdrawal by Subject|0|||
155224700|NCT03560531|560262597|FG005|Overall Study|Withdrawal by Subject|0|||
155224701|NCT03560531|560262598|FG006|Overall Study|Withdrawal by Subject|0|||
155224702|NCT03560531|560262599|FG007|Overall Study|Withdrawal by Subject|3|||
155224703|NCT03560531|560262600|FG008|Overall Study|Withdrawal by Subject|2|||
155224704|NCT03560531|560262601|FG009|Overall Study|Withdrawal by Subject|0|||
155224705|NCT03560531|560262602|FG010|Overall Study|Withdrawal by Subject|0|||
155224706|NCT03560531|560262603|FG011|Overall Study|Withdrawal by Subject|0|||
155224707|NCT03560531|560262604|FG012|Overall Study|Withdrawal by Subject|2|||
155224708|NCT03560531|560262605|FG013|Overall Study|Withdrawal by Subject|0|||
155224709|NCT03560531|560262592|FG000|Overall Study|Study end per-protocol|1|||
155224710|NCT03560531|560262593|FG001|Overall Study|Study end per-protocol|1|||
155224711|NCT03560531|560262594|FG002|Overall Study|Study end per-protocol|2|||
155224712|NCT03560531|560262595|FG003|Overall Study|Study end per-protocol|0|||
155224713|NCT03560531|560262596|FG004|Overall Study|Study end per-protocol|1|||
155224714|NCT03560531|560262597|FG005|Overall Study|Study end per-protocol|0|||
155224715|NCT03560531|560262598|FG006|Overall Study|Study end per-protocol|0|||
155224716|NCT03560531|560262599|FG007|Overall Study|Study end per-protocol|0|||
155224717|NCT03560531|560262600|FG008|Overall Study|Study end per-protocol|0|||
155224718|NCT03560531|560262601|FG009|Overall Study|Study end per-protocol|0|||
155224719|NCT03560531|560262602|FG010|Overall Study|Study end per-protocol|0|||
155224720|NCT03560531|560262603|FG011|Overall Study|Study end per-protocol|0|||
155224721|NCT03560531|560262604|FG012|Overall Study|Study end per-protocol|0|||
155224722|NCT03560531|560262605|FG013|Overall Study|Study end per-protocol|0|||
155224723|NCT03560531|560262592|FG000|Overall Study|Early study termination by sponsor|9|||
155224724|NCT03560531|560262593|FG001|Overall Study|Early study termination by sponsor|0|||
155224725|NCT03560531|560262594|FG002|Overall Study|Early study termination by sponsor|0|||
155224726|NCT03560531|560262595|FG003|Overall Study|Early study termination by sponsor|4|||
155224727|NCT03560531|560262596|FG004|Overall Study|Early study termination by sponsor|8|||
155224728|NCT03560531|560262597|FG005|Overall Study|Early study termination by sponsor|2|||
155224729|NCT03560531|560262598|FG006|Overall Study|Early study termination by sponsor|5|||
155224730|NCT03560531|560262599|FG007|Overall Study|Early study termination by sponsor|64|||
155224731|NCT03560531|560262600|FG008|Overall Study|Early study termination by sponsor|7|||
155224732|NCT03560531|560262601|FG009|Overall Study|Early study termination by sponsor|2|||
155224733|NCT03560531|560262602|FG010|Overall Study|Early study termination by sponsor|16|||
155224734|NCT03560531|560262603|FG011|Overall Study|Early study termination by sponsor|2|||
155224735|NCT03560531|560262604|FG012|Overall Study|Early study termination by sponsor|6|||
155224736|NCT03560531|560262605|FG013|Overall Study|Early study termination by sponsor|2|||
155224737|NCT03745144|560262606|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
155224738|NCT03745144|560262607|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
155224739|NCT03745144|560262608|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
155224740|NCT03745144|560262606|FG000|Period 1|Other|0|||
155224741|NCT03745144|560262607|FG001|Period 1|Other|0|||
155224742|NCT03745144|560262608|FG002|Period 1|Other|1|||
155224743|NCT01177540|560262609|FG000|Overall Study|Adverse Event|1|||
155224744|NCT01177540|560262610|FG001|Overall Study|Adverse Event|0|||
155224745|NCT02818777|560262616|FG000|Overall Study|Adverse Event|3|||
155224746|NCT00747435|560262628|FG000|Overall Study|Lost to Follow-up|2|||
155224747|NCT00747435|560262628|FG000|Overall Study|Withdrawal by Subject|3|||
155224748|NCT00747435|560262628|FG000|Overall Study|Still undergoing follow up|1|||
155224749|NCT01324349|560262629|FG000|Overall Study|Death|1|||
155224750|NCT01324349|560262630|FG001|Overall Study|Death|1|||
155224751|NCT01324349|560262629|FG000|Overall Study|Withdrawal by Subject|0|||
155224752|NCT01324349|560262630|FG001|Overall Study|Withdrawal by Subject|1|||
155224753|NCT00748215|560262631|FG000|Overall Study|Withdrawal by Subject|7|||
155224754|NCT00748215|560262632|FG001|Overall Study|Withdrawal by Subject|7|||
155224755|NCT00748215|560262631|FG000|Overall Study|Treatment change|2|||
155224756|NCT00748215|560262632|FG001|Overall Study|Treatment change|1|||
155224757|NCT00748215|560262631|FG000|Overall Study|Change in patient condition|0|||
155224758|NCT00748215|560262632|FG001|Overall Study|Change in patient condition|3|||
155224759|NCT00748215|560262631|FG000|Overall Study|Non-compliant|0|||
155224760|NCT00748215|560262632|FG001|Overall Study|Non-compliant|2|||
155224761|NCT00748215|560262631|FG000|Overall Study|Adverse Event|0|||
155224762|NCT00748215|560262632|FG001|Overall Study|Adverse Event|5|||
155224763|NCT02013167|560262633|FG000|Overall Study|Withdrawal by Subject|15|||
155224764|NCT02013167|560262634|FG001|Overall Study|Withdrawal by Subject|14|||
155224765|NCT02013167|560262633|FG000|Overall Study|Sponsor Decision|1|||
155224766|NCT02013167|560262634|FG001|Overall Study|Sponsor Decision|3|||
155224767|NCT02013167|560262633|FG000|Overall Study|Lost to Follow-up|0|||
155224768|NCT02013167|560262634|FG001|Overall Study|Lost to Follow-up|1|||
155224769|NCT02013167|560262633|FG000|Overall Study|Death|85|||
155224770|NCT02013167|560262634|FG001|Overall Study|Death|160|||
155224771|NCT01113879|560262639|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
155224772|NCT01113879|560262640|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
155224773|NCT04151290|560262641|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
155224774|NCT01449526|560262642|FG000|Overall Study|Lost to Follow-up|1|||
155224775|NCT01449526|560262643|FG001|Overall Study|Lost to Follow-up|2|||
155224776|NCT01449526|560262642|FG000|Overall Study|Withdrawal by Subject|1|||
155224777|NCT01449526|560262643|FG001|Overall Study|Withdrawal by Subject|1|||
155224778|NCT01449526|560262642|FG000|Overall Study|Symptoms/complaints|0|||
155224779|NCT01449526|560262643|FG001|Overall Study|Symptoms/complaints|1|||
155224780|NCT01449526|560262642|FG000|Overall Study|Lack of Motivation|0|||
155224781|NCT01449526|560262643|FG001|Overall Study|Lack of Motivation|1|||
155224782|NCT01449526|560262642|FG000|Overall Study|Cannot maintain visits|0|||
155224783|NCT01449526|560262643|FG001|Overall Study|Cannot maintain visits|1|||
155224784|NCT00082433|560262644|FG000|Overall Study|Adverse Event|12|||
155224785|NCT00082433|560262645|FG001|Overall Study|Adverse Event|17|||
155224786|NCT00082433|560262644|FG000|Overall Study|Death|8|||
155224787|NCT00082433|560262645|FG001|Overall Study|Death|18|||
155224788|NCT00082433|560262644|FG000|Overall Study|Disease Progression/Relapse|270|||
155224789|NCT00082433|560262645|FG001|Overall Study|Disease Progression/Relapse|388|||
155224790|NCT00082433|560262644|FG000|Overall Study|Physician Decision|50|||
155224791|NCT00082433|560262645|FG001|Overall Study|Physician Decision|61|||
155224792|NCT00082433|560262644|FG000|Overall Study|Lost to Follow-up|1|||
155224793|NCT00082433|560262645|FG001|Overall Study|Lost to Follow-up|2|||
155224794|NCT00082433|560262644|FG000|Overall Study|Study Drug Toxicity|179|||
155224795|NCT00082433|560262645|FG001|Overall Study|Study Drug Toxicity|66|||
155224796|NCT00082433|560262644|FG000|Overall Study|Withdrawal by Subject|55|||
155224797|NCT00082433|560262645|FG001|Overall Study|Withdrawal by Subject|30|||
155224798|NCT00082433|560262644|FG000|Overall Study|Still On Treatment|2|||
155224799|NCT00082433|560262645|FG001|Overall Study|Still On Treatment|1|||
155224800|NCT00082433|560262644|FG000|Overall Study|Not Treated|12|||
155224801|NCT00082433|560262645|FG001|Overall Study|Not Treated|11|||
155224802|NCT00082433|560262644|FG000|Overall Study|Ineligible|2|||
155224803|NCT00082433|560262645|FG001|Overall Study|Ineligible|1|||
155224804|NCT00082433|560262644|FG000|Overall Study|Noncompliance|2|||
155224805|NCT00082433|560262645|FG001|Overall Study|Noncompliance|1|||
155224806|NCT00082433|560262644|FG000|Overall Study|New primary cancer|1|||
155224807|NCT00082433|560262645|FG001|Overall Study|New primary cancer|0|||
155224808|NCT00082433|560262644|FG000|Overall Study|Impending surgery|0|||
155224809|NCT00082433|560262645|FG001|Overall Study|Impending surgery|1|||
155224810|NCT02276612|560262648|FG000|Overall Study|Death|1|||
155224811|NCT02276612|560262649|FG001|Overall Study|Death|0|||
155224812|NCT02276612|560262648|FG000|Overall Study|Pregnancy|1|||
155224813|NCT02276612|560262649|FG001|Overall Study|Pregnancy|0|||
155224814|NCT02276612|560262648|FG000|Overall Study|Withdrew Consent|1|||
155224815|NCT02276612|560262649|FG001|Overall Study|Withdrew Consent|0|||
155224816|NCT02276612|560262648|FG000|Overall Study|Lost to Follow-up|1|||
155224817|NCT02276612|560262649|FG001|Overall Study|Lost to Follow-up|0|||
155224818|NCT04097821|560262650|FG000|Overall Study|Subject Decision|0|||
155224819|NCT04097821|560262651|FG001|Overall Study|Subject Decision|0|||
155224820|NCT04097821|560262652|FG002|Overall Study|Subject Decision|0|||
155224821|NCT04097821|560262653|FG003|Overall Study|Subject Decision|1|||
155224822|NCT04097821|560262654|FG004|Overall Study|Subject Decision|2|||
155224823|NCT04097821|560262655|FG005|Overall Study|Subject Decision|2|||
155224824|NCT04097821|560262656|FG006|Overall Study|Subject Decision|0|||
155224825|NCT04097821|560262657|FG007|Overall Study|Subject Decision|1|||
155224826|NCT04097821|560262650|FG000|Overall Study|Death|0|||
155224827|NCT04097821|560262651|FG001|Overall Study|Death|0|||
155224828|NCT04097821|560262652|FG002|Overall Study|Death|3|||
155224829|NCT04097821|560262653|FG003|Overall Study|Death|1|||
155224830|NCT04097821|560262654|FG004|Overall Study|Death|0|||
155224831|NCT04097821|560262655|FG005|Overall Study|Death|0|||
155224832|NCT04097821|560262656|FG006|Overall Study|Death|0|||
155224833|NCT04097821|560262657|FG007|Overall Study|Death|0|||
155224834|NCT04097821|560262650|FG000|Overall Study|Physician Decision|1|||
155224835|NCT04097821|560262651|FG001|Overall Study|Physician Decision|2|||
155224836|NCT04097821|560262652|FG002|Overall Study|Physician Decision|0|||
155224837|NCT04097821|560262653|FG003|Overall Study|Physician Decision|0|||
155224838|NCT04097821|560262654|FG004|Overall Study|Physician Decision|0|||
155224839|NCT04097821|560262655|FG005|Overall Study|Physician Decision|0|||
155224840|NCT04097821|560262656|FG006|Overall Study|Physician Decision|0|||
155224841|NCT04097821|560262657|FG007|Overall Study|Physician Decision|0|||
155224842|NCT04097821|560262650|FG000|Overall Study|Adverse Event|0|||
155224843|NCT04097821|560262651|FG001|Overall Study|Adverse Event|0|||
155224844|NCT04097821|560262652|FG002|Overall Study|Adverse Event|1|||
155224845|NCT04097821|560262653|FG003|Overall Study|Adverse Event|1|||
155224846|NCT04097821|560262654|FG004|Overall Study|Adverse Event|0|||
155224847|NCT04097821|560262655|FG005|Overall Study|Adverse Event|0|||
155224848|NCT04097821|560262656|FG006|Overall Study|Adverse Event|0|||
155224849|NCT04097821|560262657|FG007|Overall Study|Adverse Event|0|||
155224850|NCT04097821|560262650|FG000|Overall Study|New Therapy For Study Indication|0|||
155224851|NCT04097821|560262651|FG001|Overall Study|New Therapy For Study Indication|0|||
155224852|NCT04097821|560262652|FG002|Overall Study|New Therapy For Study Indication|0|||
155224853|NCT04097821|560262653|FG003|Overall Study|New Therapy For Study Indication|0|||
155224854|NCT04097821|560262654|FG004|Overall Study|New Therapy For Study Indication|0|||
155224855|NCT04097821|560262655|FG005|Overall Study|New Therapy For Study Indication|0|||
155224856|NCT04097821|560262656|FG006|Overall Study|New Therapy For Study Indication|1|||
155224857|NCT04097821|560262657|FG007|Overall Study|New Therapy For Study Indication|0|||
155224858|NCT03003520|560264563|FG000|Overall Study|Adverse Event|9|||
155224859|NCT03003520|560264564|FG001|Overall Study|Adverse Event|0|||
155224860|NCT03003520|560264563|FG000|Overall Study|Death|1|||
155224861|NCT03003520|560264564|FG001|Overall Study|Death|0|||
155224862|NCT03003520|560264563|FG000|Overall Study|Other reasons|4|||
155224863|NCT03003520|560264564|FG001|Overall Study|Other reasons|0|||
155224864|NCT03003520|560264563|FG000|Overall Study|Withdrawal by Subject|6|||
155224865|NCT03003520|560264564|FG001|Overall Study|Withdrawal by Subject|0|||
155224866|NCT03003520|560264563|FG000|Overall Study|Progressive disease|9|||
155224867|NCT03003520|560264564|FG001|Overall Study|Progressive disease|1|||
155224868|NCT03264404|560264565|FG000|Overall Study|Death|2|||
155224869|NCT03264404|560264565|FG000|Overall Study|Physician Decision|1|||
155224870|NCT03264404|560264565|FG000|Overall Study|Disease Progression|28|||
155224871|NCT03264404|560264565|FG000|Overall Study|Adverse Event|1|||
155224872|NCT03264404|560264565|FG000|Overall Study|Off study prior to treatment|2|||
155224873|NCT01852292|560264571|FG000|Overall Study|Untreated - did not receive study drug|3|||
155224874|NCT01852292|560264572|FG001|Overall Study|Untreated - did not receive study drug|1|||
155224875|NCT01852292|560264571|FG000|Overall Study|Death|9|||
155224876|NCT01852292|560264572|FG001|Overall Study|Death|8|||
155224877|NCT01852292|560264571|FG000|Overall Study|Patient/guardian decision|8|||
155224878|NCT01852292|560264572|FG001|Overall Study|Patient/guardian decision|4|||
155224879|NCT01852292|560264571|FG000|Overall Study|Adverse Event|8|||
155224880|NCT01852292|560264572|FG001|Overall Study|Adverse Event|11|||
155224881|NCT01852292|560264571|FG000|Overall Study|Physician Decision|6|||
155224882|NCT01852292|560264572|FG001|Overall Study|Physician Decision|2|||
155224883|NCT01852292|560264571|FG000|Overall Study|Protocol Violation|2|||
155224884|NCT01852292|560264572|FG001|Overall Study|Protocol Violation|0|||
155224885|NCT01852292|560264571|FG000|Overall Study|Non-compliance with study treatment|1|||
155224886|NCT01852292|560264572|FG001|Overall Study|Non-compliance with study treatment|0|||
155224887|NCT01852292|560264571|FG000|Overall Study|Study terminated by Sponsor|0|||
155224888|NCT01852292|560264572|FG001|Overall Study|Study terminated by Sponsor|1|||
155224889|NCT01852292|560264571|FG000|Overall Study|Progressive disease|42|||
155224890|NCT01852292|560264572|FG001|Overall Study|Progressive disease|52|||
155224891|NCT01914666|560264573|FG000|Treatment Period|Lack of Efficacy|0|||
155224892|NCT01914666|560264574|FG001|Treatment Period|Lack of Efficacy|0|||
155224893|NCT01914666|560264575|FG002|Treatment Period|Lack of Efficacy|2|||
155224894|NCT01914666|560264573|FG000|Treatment Period|Adverse Event|10|||
155224895|NCT01914666|560264574|FG001|Treatment Period|Adverse Event|4|||
155224896|NCT01914666|560264575|FG002|Treatment Period|Adverse Event|2|||
155224897|NCT01914666|560264573|FG000|Treatment Period|Withdrawal by Subject|3|||
155224898|NCT01914666|560264574|FG001|Treatment Period|Withdrawal by Subject|2|||
155224899|NCT01914666|560264575|FG002|Treatment Period|Withdrawal by Subject|2|||
155224900|NCT01914666|560264573|FG000|Treatment Period|Physician Decision|0|||
155224901|NCT01914666|560264574|FG001|Treatment Period|Physician Decision|0|||
155224902|NCT01914666|560264575|FG002|Treatment Period|Physician Decision|2|||
155224903|NCT01572038|560264578|FG000|Overall Study|Death|648|||
155224904|NCT01572038|560264578|FG000|Overall Study|Withdrawal by Subject|204|||
155224905|NCT01572038|560264578|FG000|Overall Study|Lost to Follow-up|81|||
155224906|NCT01572038|560264578|FG000|Overall Study|Physician Decision|20|||
155224907|NCT01572038|560264578|FG000|Overall Study|Patient Decision|14|||
155224908|NCT01572038|560264578|FG000|Overall Study|Progressive Disease|8|||
155224909|NCT01572038|560264578|FG000|Overall Study|Site Closed Before Completing Form|6|||
155224910|NCT01572038|560264578|FG000|Overall Study|Enrolled into Another Trial|3|||
155224911|NCT01572038|560264578|FG000|Overall Study|Participated in Another Trial|3|||
155224912|NCT01572038|560264578|FG000|Overall Study|Termination by Sponsor|2|||
155224913|NCT01572038|560264578|FG000|Overall Study|Patient Deterioration|1|||
155224914|NCT01572038|560264578|FG000|Overall Study|Sponsor Decision|1|||
155224915|NCT03711162|560264579|FG000|Overall Study|Adverse Event|5|||
155224916|NCT03711162|560264580|FG001|Overall Study|Adverse Event|2|||
155224917|NCT03711162|560264581|FG002|Overall Study|Adverse Event|4|||
155224918|NCT03711162|560264579|FG000|Overall Study|Death|11|||
155224919|NCT03711162|560264580|FG001|Overall Study|Death|7|||
155224920|NCT03711162|560264581|FG002|Overall Study|Death|8|||
155224921|NCT03711162|560264579|FG000|Overall Study|Lost to Follow-up|1|||
155224922|NCT03711162|560264580|FG001|Overall Study|Lost to Follow-up|0|||
155224923|NCT03711162|560264581|FG002|Overall Study|Lost to Follow-up|1|||
155224924|NCT03711162|560264579|FG000|Overall Study|Study Terminated by Sponsor|139|||
155224925|NCT03711162|560264580|FG001|Overall Study|Study Terminated by Sponsor|152|||
155224926|NCT03711162|560264581|FG002|Overall Study|Study Terminated by Sponsor|146|||
155224927|NCT03711162|560264579|FG000|Overall Study|Withdrawal by Subject|17|||
155224928|NCT03711162|560264580|FG001|Overall Study|Withdrawal by Subject|10|||
155224929|NCT03711162|560264581|FG002|Overall Study|Withdrawal by Subject|10|||
155224930|NCT03711162|560264579|FG000|Overall Study|Miscellaneous|1|||
155224931|NCT03711162|560264580|FG001|Overall Study|Miscellaneous|2|||
155224932|NCT03711162|560264581|FG002|Overall Study|Miscellaneous|2|||
155224933|NCT03711162|560264579|FG000|Overall Study|Not Treated|1|||
155224934|NCT03711162|560264580|FG001|Overall Study|Not Treated|0|||
155224935|NCT03711162|560264581|FG002|Overall Study|Not Treated|1|||
155224936|NCT03711162|560264579|FG000|Overall Study|Physician Decision|0|||
155224937|NCT03711162|560264580|FG001|Overall Study|Physician Decision|2|||
155224938|NCT03711162|560264581|FG002|Overall Study|Physician Decision|0|||
155224939|NCT03711162|560264579|FG000|Overall Study|Lack of Efficacy|0|||
155224940|NCT03711162|560264580|FG001|Overall Study|Lack of Efficacy|0|||
155224941|NCT03711162|560264581|FG002|Overall Study|Lack of Efficacy|2|||
155224942|NCT03711162|560264579|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
155224943|NCT03711162|560264580|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
155224944|NCT03711162|560264581|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
155224945|NCT01275066|560264584|FG000|Overall Study|Withdrawal by Subject|0|||
155224946|NCT01275066|560264585|FG001|Overall Study|Withdrawal by Subject|0|||
155224947|NCT01275066|560264586|FG002|Overall Study|Withdrawal by Subject|1|||
155224948|NCT01275066|560264584|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
155224949|NCT01275066|560264585|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
155224950|NCT01275066|560264586|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
155224951|NCT00394212|560264589|FG000|Overall Study|Lost to Follow-up|3|||
155224952|NCT00394212|560264590|FG001|Overall Study|Lost to Follow-up|0|||
155224953|NCT00394212|560264589|FG000|Overall Study|Withdrawal by Subject|4|||
155224954|NCT00394212|560264590|FG001|Overall Study|Withdrawal by Subject|1|||
155224955|NCT00588445|560264591|FG000|Overall Study|Protocol Violation|1|||
155224956|NCT00588445|560264591|FG000|Overall Study|Withdrawal by Subject|3|||
155224957|NCT00588445|560264591|FG000|Overall Study|Disease Progression|1|||
155224958|NCT00588445|560264591|FG000|Overall Study|Not Treated|10|||
155224959|NCT03240133|560264592|FG000|Overall Study|Withdrawal by Subject|0|||
155224960|NCT03240133|560264593|FG001|Overall Study|Withdrawal by Subject|1|||
155224961|NCT03240133|560264594|FG002|Overall Study|Withdrawal by Subject|0|||
155224962|NCT03240133|560264592|FG000|Overall Study|Adverse Event|1|||
155224963|NCT03240133|560264593|FG001|Overall Study|Adverse Event|1|||
155224964|NCT03240133|560264594|FG002|Overall Study|Adverse Event|0|||
155224965|NCT03240133|560264592|FG000|Overall Study|Rash|1|||
155224966|NCT03240133|560264593|FG001|Overall Study|Rash|0|||
155224967|NCT03240133|560264594|FG002|Overall Study|Rash|0|||
155224968|NCT03240133|560264592|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
155224969|NCT03240133|560264593|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
155224970|NCT03240133|560264594|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
155224971|NCT03240133|560264592|FG000|Overall Study|Intercurrent illness.|0|||
155224972|NCT03240133|560264593|FG001|Overall Study|Intercurrent illness.|1|||
155224973|NCT03240133|560264594|FG002|Overall Study|Intercurrent illness.|0|||
155224974|NCT03240133|560264592|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
155224975|NCT03240133|560264593|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
155224976|NCT03240133|560264594|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
155224977|NCT00116831|560264597|FG000|Overall Study|Adverse Event|14|||
155224978|NCT00116831|560264598|FG001|Overall Study|Adverse Event|16|||
155224979|NCT00116831|560264597|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
155224980|NCT00116831|560264598|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
155224981|NCT00116831|560264597|FG000|Overall Study|Lost to Follow-up|8|||
155224982|NCT00116831|560264598|FG001|Overall Study|Lost to Follow-up|6|||
155224983|NCT00116831|560264597|FG000|Overall Study|Protocol Violation|3|||
155224984|NCT00116831|560264598|FG001|Overall Study|Protocol Violation|6|||
155224985|NCT00116831|560264597|FG000|Overall Study|Hypoglycaemic events|1|||
155224986|NCT00116831|560264598|FG001|Overall Study|Hypoglycaemic events|0|||
155224987|NCT00116831|560264597|FG000|Overall Study|Low haemoglobin on screening|1|||
155224988|NCT00116831|560264598|FG001|Overall Study|Low haemoglobin on screening|0|||
155224989|NCT00116831|560264597|FG000|Overall Study|Withdrawn investigational product|1|||
155224990|NCT00116831|560264598|FG001|Overall Study|Withdrawn investigational product|0|||
155224991|NCT00116831|560264597|FG000|Overall Study|Withdrawal by Subject|32|||
155224992|NCT00116831|560264598|FG001|Overall Study|Withdrawal by Subject|32|||
155224993|NCT00116831|560264597|FG000|Overall Study|Insufficient therapeutic effect|0|||
155224994|NCT00116831|560264598|FG001|Overall Study|Insufficient therapeutic effect|1|||
155224995|NCT00116831|560264597|FG000|Overall Study|Missing data for participant|1|||
155224996|NCT00116831|560264598|FG001|Overall Study|Missing data for participant|0|||
155224997|NCT02945410|560264599|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155224998|NCT02945410|560264600|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
155224999|NCT02945410|560264601|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225000|NCT02945410|560264602|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225001|NCT02945410|560264603|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225002|NCT02945410|560264604|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
155225003|NCT02945410|560264599|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
155225004|NCT02945410|560264600|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
155225005|NCT02945410|560264601|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
155225006|NCT02945410|560264602|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
155225007|NCT02945410|560264603|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
155225008|NCT02945410|560264604|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
155225009|NCT02945410|560264599|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225010|NCT02945410|560264600|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225011|NCT02945410|560264601|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
155225012|NCT02945410|560264602|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225013|NCT02945410|560264603|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
155225014|NCT02945410|560264604|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
155225015|NCT04904185|560264605|FG000|Overall Study|Expansion failure|1|||
155225016|NCT04904185|560264606|FG001|Overall Study|Expansion failure|0|||
155225017|NCT04904185|560264605|FG000|Overall Study|Late response on prior treatment|1|||
155225018|NCT04904185|560264606|FG001|Overall Study|Late response on prior treatment|0|||
155225019|NCT04200248|560264613|FG000|Overall Study|Personal reasons|0|||
155225020|NCT04200248|560264614|FG001|Overall Study|Personal reasons|0|||
155225021|NCT04200248|560264615|FG002|Overall Study|Personal reasons|1|||
155225022|NCT04200248|560264613|FG000|Overall Study|Discontinued prior to treatment|3|||
155225023|NCT04200248|560264614|FG001|Overall Study|Discontinued prior to treatment|3|||
155225024|NCT04200248|560264615|FG002|Overall Study|Discontinued prior to treatment|2|||
155225025|NCT02342704|560264618|FG000|Overall Study|Physician Decision|0|||
155225026|NCT02342704|560264619|FG001|Overall Study|Physician Decision|3|||
155225027|NCT02342704|560264618|FG000|Overall Study|Sponsor Termination|49|||
155225028|NCT02342704|560264619|FG001|Overall Study|Sponsor Termination|43|||
155225029|NCT02342704|560264618|FG000|Overall Study|Other|0|||
155225030|NCT02342704|560264619|FG001|Overall Study|Other|1|||
155225031|NCT02342704|560264618|FG000|Overall Study|Withdrawal by Subject|1|||
155225032|NCT02342704|560264619|FG001|Overall Study|Withdrawal by Subject|0|||
155225033|NCT02342704|560264618|FG000|Overall Study|Lost to Follow-up|2|||
155225034|NCT02342704|560264619|FG001|Overall Study|Lost to Follow-up|1|||
155225035|NCT02342704|560264618|FG000|Overall Study|Adverse Event|1|||
155225036|NCT02342704|560264619|FG001|Overall Study|Adverse Event|3|||
155225037|NCT00302003|560264620|FG000|Overall Study|Lack of Efficacy|62|||
155225038|NCT00302003|560264620|FG000|Overall Study|Lost to Follow-up|1|||
155225039|NCT00302003|560264620|FG000|Overall Study|Physician Decision|2|||
155225040|NCT00302003|560264620|FG000|Overall Study|Withdrawal by Subject|5|||
155225041|NCT00302003|560264620|FG000|Overall Study|Ineligible|9|||
155225042|NCT00302003|560264620|FG000|Overall Study|Protocol Violation|1|||
155225043|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
155225044|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
155225045|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
155225046|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
155225047|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
155225048|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
155225049|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
155225050|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
155225051|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
155225052|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
155225053|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
155225054|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
155225055|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
155225056|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
155225057|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
155225058|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
155225059|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
155225060|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
155225061|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
155225062|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
155225063|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
155225064|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
155225065|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
155225066|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
155225067|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
155225068|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
155225069|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
155225070|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
155225071|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
155225072|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
155225073|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
155225074|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
155225075|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
155225076|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
155225077|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
155225078|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
155225079|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
155225080|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
155225081|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
155225082|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
155225083|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
155225084|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
155225085|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
155225086|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
155225087|NCT01218516|560264621|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
155225088|NCT01218516|560264622|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
155225089|NCT01218516|560264623|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
155225090|NCT01218516|560264624|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
155225091|NCT01539226|560264625|FG000|Overall Study|Withdrawal by Subject|24|||
155225092|NCT01539226|560264626|FG001|Overall Study|Withdrawal by Subject|54|||
155225093|NCT01539226|560264625|FG000|Overall Study|Lost to Follow-up|20|||
155225094|NCT01539226|560264626|FG001|Overall Study|Lost to Follow-up|54|||
155225095|NCT01539226|560264625|FG000|Overall Study|Death|1|||
155225096|NCT01539226|560264626|FG001|Overall Study|Death|2|||
155225097|NCT01539226|560264625|FG000|Overall Study|Adverse Event|2|||
155225098|NCT01539226|560264626|FG001|Overall Study|Adverse Event|0|||
155225099|NCT01539226|560264625|FG000|Overall Study|Pregnancy|13|||
155225100|NCT01539226|560264626|FG001|Overall Study|Pregnancy|29|||
155225101|NCT01539226|560264625|FG000|Overall Study|inappropriate enrollment|0|||
155225102|NCT01539226|560264626|FG001|Overall Study|inappropriate enrollment|1|||
155225103|NCT01539226|560264625|FG000|Overall Study|Multiple Reasons|3|||
155225104|NCT01539226|560264626|FG001|Overall Study|Multiple Reasons|1|||
155225105|NCT01539226|560264625|FG000|Overall Study|not HIV seroconversion-related|93|||
155225106|NCT01539226|560264626|FG001|Overall Study|not HIV seroconversion-related|176|||
155225107|NCT01539226|560264625|FG000|Overall Study|HIV seroconversion-related|55|||
155225108|NCT01539226|560264626|FG001|Overall Study|HIV seroconversion-related|80|||
155225109|NCT01539226|560264625|FG000|Overall Study|Non-compliance|6|||
155225110|NCT01539226|560264626|FG001|Overall Study|Non-compliance|8|||
155225111|NCT01632891|560264627|FG000|Overall Study|Lost to Follow-up|0|||
155225112|NCT01632891|560264628|FG001|Overall Study|Lost to Follow-up|1|||
155225113|NCT01632891|560264627|FG000|Overall Study|Withdrawal by Subject|1|||
155225114|NCT01632891|560264628|FG001|Overall Study|Withdrawal by Subject|0|||
155225115|NCT02118428|560264636|FG000|Overall Study|Physician Decision|0|||
155225116|NCT02118428|560264637|FG001|Overall Study|Physician Decision|1|||
155225117|NCT02118428|560264638|FG002|Overall Study|Physician Decision|0|||
155225118|NCT02118428|560264636|FG000|Overall Study|Withdrawal by Subject|2|||
155225119|NCT02118428|560264637|FG001|Overall Study|Withdrawal by Subject|2|||
155225120|NCT02118428|560264638|FG002|Overall Study|Withdrawal by Subject|0|||
155225121|NCT02118428|560264636|FG000|Overall Study|Death|7|||
155225122|NCT02118428|560264637|FG001|Overall Study|Death|5|||
155225123|NCT02118428|560264638|FG002|Overall Study|Death|0|||
155225124|NCT02118428|560264636|FG000|Overall Study|Lost to Follow-up|3|||
155225125|NCT02118428|560264637|FG001|Overall Study|Lost to Follow-up|1|||
155225126|NCT02118428|560264638|FG002|Overall Study|Lost to Follow-up|0|||
155225127|NCT02118428|560264636|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
155225128|NCT02118428|560264637|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
155225129|NCT02118428|560264638|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
155225130|NCT00735371|560264647|FG000|Overall Study|Adverse Event|3|||
155225131|NCT00735371|560264648|FG001|Overall Study|Adverse Event|3|||
155225132|NCT00735371|560264649|FG002|Overall Study|Adverse Event|4|||
155225133|NCT00735371|560264650|FG003|Overall Study|Adverse Event|1|||
155225134|NCT00735371|560264647|FG000|Overall Study|Protocol Violation|2|||
155225135|NCT00735371|560264648|FG001|Overall Study|Protocol Violation|2|||
155225136|NCT00735371|560264649|FG002|Overall Study|Protocol Violation|0|||
155225137|NCT00735371|560264650|FG003|Overall Study|Protocol Violation|3|||
155225138|NCT00735371|560264647|FG000|Overall Study|Withdrawal by Subject|0|||
155225139|NCT00735371|560264648|FG001|Overall Study|Withdrawal by Subject|2|||
155225140|NCT00735371|560264649|FG002|Overall Study|Withdrawal by Subject|2|||
155225141|NCT00735371|560264650|FG003|Overall Study|Withdrawal by Subject|0|||
155225142|NCT00735371|560264647|FG000|Overall Study|Lost to Follow-up|1|||
155225143|NCT00735371|560264648|FG001|Overall Study|Lost to Follow-up|1|||
155225144|NCT00735371|560264649|FG002|Overall Study|Lost to Follow-up|3|||
155225145|NCT00735371|560264650|FG003|Overall Study|Lost to Follow-up|1|||
155225146|NCT00735371|560264647|FG000|Overall Study|Lack of Efficacy|4|||
155225147|NCT00735371|560264648|FG001|Overall Study|Lack of Efficacy|2|||
155225148|NCT00735371|560264649|FG002|Overall Study|Lack of Efficacy|0|||
155225149|NCT00735371|560264650|FG003|Overall Study|Lack of Efficacy|4|||
155225150|NCT00735371|560264647|FG000|Overall Study|Sponsor Decision|3|||
155225151|NCT00735371|560264648|FG001|Overall Study|Sponsor Decision|1|||
155225152|NCT00735371|560264649|FG002|Overall Study|Sponsor Decision|0|||
155225153|NCT00735371|560264650|FG003|Overall Study|Sponsor Decision|1|||
155225154|NCT00735371|560264647|FG000|Overall Study|Protocol Violation|0|||
155225155|NCT00735371|560264648|FG001|Overall Study|Protocol Violation|1|||
155225156|NCT00735371|560264649|FG002|Overall Study|Protocol Violation|2|||
155225157|NCT00735371|560264650|FG003|Overall Study|Protocol Violation|0|||
155225158|NCT00735371|560264647|FG000|Overall Study|Prior Vyvanse Exposure|1|||
155225159|NCT00735371|560264648|FG001|Overall Study|Prior Vyvanse Exposure|1|||
155225160|NCT00735371|560264649|FG002|Overall Study|Prior Vyvanse Exposure|0|||
155225161|NCT00735371|560264650|FG003|Overall Study|Prior Vyvanse Exposure|0|||
155225162|NCT00735371|560264647|FG000|Overall Study|Exclusion criteria|1|||
155225163|NCT00735371|560264648|FG001|Overall Study|Exclusion criteria|0|||
155225164|NCT00735371|560264649|FG002|Overall Study|Exclusion criteria|0|||
155225165|NCT00735371|560264650|FG003|Overall Study|Exclusion criteria|0|||
155225166|NCT00436748|560264653|FG000|Overall Study|Ineligibility Determined|1|||
155225167|NCT00436748|560264654|FG001|Overall Study|Ineligibility Determined|1|||
155225168|NCT00436748|560264653|FG000|Overall Study|Adverse Event|0|||
155225169|NCT00436748|560264654|FG001|Overall Study|Adverse Event|2|||
155225170|NCT00436748|560264653|FG000|Overall Study|Consent Withdrawn|1|||
155225171|NCT00436748|560264654|FG001|Overall Study|Consent Withdrawn|4|||
155225172|NCT00436748|560264653|FG000|Overall Study|Administrative Decision|1|||
155225173|NCT00436748|560264654|FG001|Overall Study|Administrative Decision|0|||
155225174|NCT00436748|560264653|FG000|Overall Study|Lost to Follow-up|0|||
155225175|NCT00436748|560264654|FG001|Overall Study|Lost to Follow-up|1|||
155225176|NCT00436748|560264653|FG000|Overall Study|Protocol-specified Criteria|5|||
155225177|NCT00436748|560264654|FG001|Overall Study|Protocol-specified Criteria|4|||
155225178|NCT00436748|560264653|FG000|Overall Study|Other|3|||
155225179|NCT00436748|560264654|FG001|Overall Study|Other|0|||
155225180|NCT01610791|560264655|FG000|Overall Study|Lost to Follow-up|7|||
155225181|NCT01610791|560264655|FG000|Overall Study|Adverse Event|6|||
155225182|NCT01610791|560264655|FG000|Overall Study|Physician Decision|1|||
155225183|NCT01610791|560264655|FG000|Overall Study|Adverse event and Investigator decision|1|||
155225184|NCT01610791|560264655|FG000|Overall Study|Death|1|||
155225185|NCT01610791|560264655|FG000|Overall Study|Not determined|5|||
155225186|NCT04627064|560264658|FG000|Overall Study|Progressive disease|8|||
155225187|NCT04627064|560264659|FG001|Overall Study|Progressive disease|0|||
155225188|NCT04627064|560264658|FG000|Overall Study|Withdrawal by Subject|2|||
155225189|NCT04627064|560264659|FG001|Overall Study|Withdrawal by Subject|0|||
155225190|NCT04627064|560264658|FG000|Overall Study|Physician Decision|1|||
155225191|NCT04627064|560264659|FG001|Overall Study|Physician Decision|0|||
155225192|NCT00097721|560264660|FG000|Overall Study|Adverse Event|8|||
155225193|NCT00097721|560264661|FG001|Overall Study|Adverse Event|1|||
155225194|NCT00097721|560264660|FG000|Overall Study|Withdrawal by Subject|6|||
155225195|NCT00097721|560264661|FG001|Overall Study|Withdrawal by Subject|1|||
155225196|NCT00097721|560264660|FG000|Overall Study|Progressive Disease|55|||
155225197|NCT00097721|560264661|FG001|Overall Study|Progressive Disease|27|||
155225198|NCT00097721|560264660|FG000|Overall Study|Physician Decision|1|||
155225199|NCT00097721|560264661|FG001|Overall Study|Physician Decision|3|||
155225200|NCT00097721|560264660|FG000|Overall Study|Reason not given|1|||
155225201|NCT00097721|560264661|FG001|Overall Study|Reason not given|1|||
155225202|NCT02126969|560264664|FG000|Overall Study|Withdrawal by Subject|1|||
155225203|NCT02126969|560264665|FG001|Overall Study|Withdrawal by Subject|2|||
155225204|NCT01533246|560264668|FG000|Overall Study|Adverse Event|1|||
155225205|NCT01533246|560264668|FG000|Overall Study|Withdrawal by Subject|1|||
155225206|NCT00354172|560264669|FG000|Overall Study|Did not receive transplant|1|||
155225207|NCT03792672|560264672|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
155225208|NCT03792672|560264673|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225209|NCT03792672|560264674|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225210|NCT03792672|560264675|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
155225211|NCT03792672|560264676|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225212|NCT03792672|560264677|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
155225213|NCT03792672|560264672|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
155225214|NCT03792672|560264673|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
155225215|NCT03792672|560264674|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
155225216|NCT03792672|560264675|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
155225217|NCT03792672|560264676|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
155225218|NCT03792672|560264677|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
155225219|NCT03792672|560264672|FG000|Treatment Period 4 (2 Days)|Other|1|||
155225220|NCT03792672|560264673|FG001|Treatment Period 4 (2 Days)|Other|0|||
155225221|NCT03792672|560264674|FG002|Treatment Period 4 (2 Days)|Other|0|||
155225222|NCT03792672|560264675|FG003|Treatment Period 4 (2 Days)|Other|0|||
155225223|NCT03792672|560264676|FG004|Treatment Period 4 (2 Days)|Other|0|||
155225224|NCT03792672|560264677|FG005|Treatment Period 4 (2 Days)|Other|0|||
155225225|NCT00453999|560264678|FG000|Overall Study|Adverse Event|1|||
155225226|NCT00453999|560264679|FG001|Overall Study|Adverse Event|2|||
155225227|NCT00453999|560264680|FG002|Overall Study|Adverse Event|1|||
155225228|NCT00453999|560264678|FG000|Overall Study|Lost to Follow-up|0|||
155225229|NCT00453999|560264679|FG001|Overall Study|Lost to Follow-up|1|||
155225230|NCT00453999|560264680|FG002|Overall Study|Lost to Follow-up|1|||
155225231|NCT00453999|560264678|FG000|Overall Study|Withdrawal by Subject|2|||
155225232|NCT00453999|560264679|FG001|Overall Study|Withdrawal by Subject|1|||
155225233|NCT00453999|560264680|FG002|Overall Study|Withdrawal by Subject|1|||
155225234|NCT00453999|560264678|FG000|Overall Study|Subject Request|2|||
155225235|NCT00453999|560264679|FG001|Overall Study|Subject Request|1|||
155225236|NCT00453999|560264680|FG002|Overall Study|Subject Request|0|||
155225237|NCT04238728|560264682|FG000|Overall Study|Withdrawal by Subject|1|||
155225238|NCT04238728|560264682|FG000|Overall Study|Lost to Follow-up|2|||
155225239|NCT00829296|560264685|FG000|Overall Study|Adverse Event|5|||
155225240|NCT00829296|560264686|FG001|Overall Study|Adverse Event|4|||
155225241|NCT04960228|560264688|FG000|Overall Study|Withdrawal by Subject|216|||
155225242|NCT04960228|560264689|FG001|Overall Study|Withdrawal by Subject|35|||
155225243|NCT04960228|560264688|FG000|Overall Study|Failed attention check|69|||
155225244|NCT04960228|560264689|FG001|Overall Study|Failed attention check|148|||
155225245|NCT04960228|560264688|FG000|Overall Study|Flagged for response quality by Dynata|3|||
155225246|NCT04960228|560264689|FG001|Overall Study|Flagged for response quality by Dynata|3|||
155225247|NCT01987427|560264690|FG000|Overall Study|Adverse Event|4|||
155225248|NCT01987427|560264691|FG001|Overall Study|Adverse Event|2|||
155225249|NCT01987427|560264692|FG002|Overall Study|Adverse Event|8|||
155225250|NCT01987427|560264690|FG000|Overall Study|Lost to Follow-up|6|||
155225251|NCT01987427|560264691|FG001|Overall Study|Lost to Follow-up|6|||
155225252|NCT01987427|560264692|FG002|Overall Study|Lost to Follow-up|9|||
155225253|NCT01987427|560264690|FG000|Overall Study|Withdrawal by Subject|2|||
155225254|NCT01987427|560264691|FG001|Overall Study|Withdrawal by Subject|1|||
155225255|NCT01987427|560264692|FG002|Overall Study|Withdrawal by Subject|3|||
155225256|NCT01987427|560264690|FG000|Overall Study|Lack of Efficacy|1|||
155225257|NCT01987427|560264691|FG001|Overall Study|Lack of Efficacy|0|||
155225258|NCT01987427|560264692|FG002|Overall Study|Lack of Efficacy|0|||
155225259|NCT01987427|560264690|FG000|Overall Study|Other|1|||
155225260|NCT01987427|560264691|FG001|Overall Study|Other|1|||
155225261|NCT01987427|560264692|FG002|Overall Study|Other|0|||
155225262|NCT01073865|560264694|FG000|Overall Study|Reasons other than below|19|||
155225263|NCT01073865|560264695|FG001|Overall Study|Reasons other than below|31|||
155225264|NCT01073865|560264694|FG000|Overall Study|Lost to Follow-up|1|||
155225265|NCT01073865|560264695|FG001|Overall Study|Lost to Follow-up|1|||
155225266|NCT01073865|560264694|FG000|Overall Study|Death|3|||
155225267|NCT01073865|560264695|FG001|Overall Study|Death|2|||
155225268|NCT01073865|560264694|FG000|Overall Study|Withdrawal by Subject|5|||
155225269|NCT01073865|560264695|FG001|Overall Study|Withdrawal by Subject|5|||
155225270|NCT02547129|560264699|FG000|Overall Study|Difficulty with ongoing infection|1|||
155225271|NCT02547129|560264700|FG001|Overall Study|Difficulty with ongoing infection|0|||
155225272|NCT03925324|560264701|FG000|Overall Study|Death|1|||
155225273|NCT03925324|560264702|FG001|Overall Study|Death|1|||
155225274|NCT00794196|560264704|FG000|Overall Study|Lost to Follow-up|5|||
155225275|NCT00794196|560264705|FG001|Overall Study|Lost to Follow-up|23|||
155225276|NCT04414553|560264706|FG000|Overall Study|Lost to Follow-up|20|||
155225277|NCT02319031|560264710|FG000|Treatment Period|Death|1|||
155225278|NCT02319031|560264711|FG001|Treatment Period|Death|0|||
155225279|NCT04371380|560264716|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
155225280|NCT04371380|560264717|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
155225281|NCT04371380|560264718|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
155225282|NCT02244580|560264719|FG000|Overall Study|No cancer tissues available|241|||
155225283|NCT02910167|560264722|FG000|Overall Study|Adverse Event|1|||
155225284|NCT02910167|560264722|FG000|Overall Study|Lost to Follow-up|18|||
155225285|NCT01418937|560264723|FG000|Overall Study|Lost to Follow-up|5|||
155225286|NCT01418937|560264723|FG000|Overall Study|Protocol Violation|1|||
155225287|NCT01418937|560264723|FG000|Overall Study|Pregnancy|1|||
155225288|NCT01418937|560264723|FG000|Overall Study|Withdrawal by Subject|1|||
155225289|NCT00856908|560264741|FG000|Overall Study|Lost to Follow-up|1|||
155225290|NCT00856908|560264742|FG001|Overall Study|Lost to Follow-up|0|||
155225291|NCT01063595|560264743|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
155225292|NCT01063595|560264744|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
155225293|NCT01063595|560264743|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
155225294|NCT01063595|560264744|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
155225295|NCT01063595|560264743|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
155225296|NCT01063595|560264744|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
155225297|NCT01063595|560264743|FG000|First Intervention|Adverse Event|1|||
155225298|NCT01063595|560264744|FG001|First Intervention|Adverse Event|4|||
155225299|NCT01063595|560264743|FG000|First Intervention|Withdrawal by Subject|1|||
155225300|NCT01063595|560264744|FG001|First Intervention|Withdrawal by Subject|0|||
155225301|NCT01063595|560264743|FG000|First Intervention|Reason not Specified|0|||
155225302|NCT01063595|560264744|FG001|First Intervention|Reason not Specified|1|||
155225303|NCT04059146|560264747|FG000|Overall Study|Withdrawal by Subject|0|||
155225304|NCT04059146|560264748|FG001|Overall Study|Withdrawal by Subject|1|||
155225305|NCT01623596|560264749|FG000|Overall Study|Abnormal laboratory values|2|||
155225306|NCT01623596|560264750|FG001|Overall Study|Abnormal laboratory values|0|||
155225307|NCT01623596|560264749|FG000|Overall Study|Administrative problems|9|||
155225308|NCT01623596|560264750|FG001|Overall Study|Administrative problems|13|||
155225309|NCT01623596|560264749|FG000|Overall Study|Adverse Event|20|||
155225310|NCT01623596|560264750|FG001|Overall Study|Adverse Event|29|||
155225311|NCT01623596|560264749|FG000|Overall Study|Death|0|||
155225312|NCT01623596|560264750|FG001|Overall Study|Death|2|||
155225313|NCT01623596|560264749|FG000|Overall Study|Lost to Follow-up|12|||
155225314|NCT01623596|560264750|FG001|Overall Study|Lost to Follow-up|16|||
155225315|NCT01623596|560264749|FG000|Overall Study|Withdrawal by Subject|13|||
155225316|NCT01623596|560264750|FG001|Overall Study|Withdrawal by Subject|31|||
155225317|NCT01623596|560264749|FG000|Overall Study|Patient no longer requires study drug|1|||
155225318|NCT01623596|560264750|FG001|Overall Study|Patient no longer requires study drug|0|||
155225319|NCT01623596|560264749|FG000|Overall Study|Protocol Violation|0|||
155225320|NCT01623596|560264750|FG001|Overall Study|Protocol Violation|6|||
155225321|NCT01623596|560264749|FG000|Overall Study|Lack of Efficacy|5|||
155225322|NCT01623596|560264750|FG001|Overall Study|Lack of Efficacy|3|||
155225323|NCT01070316|560264751|FG000|Extension Phase|Lack of Efficacy|3|||
155225324|NCT01070316|560264751|FG000|Extension Phase|Withdrawal by Subject|1|||
155225325|NCT00026793|560264752|FG000|Overall Study|Death on study due to underlying disease|4|||
155225326|NCT00026793|560264752|FG000|Overall Study|Physician Decision|2|||
155225327|NCT00026793|560264752|FG000|Overall Study|Off study|2|||
155225328|NCT04243538|560264753|FG000|Overall Study|Withdrawal by Subject|0|||
155225329|NCT04243538|560264754|FG001|Overall Study|Withdrawal by Subject|2|||
155225330|NCT04243538|560264753|FG000|Overall Study|Lost to Follow-up|0|||
155225331|NCT04243538|560264754|FG001|Overall Study|Lost to Follow-up|3|||
155225332|NCT00655564|560264755|FG000|Overall Study|Adverse Event|1|||
155225333|NCT00655564|560264755|FG000|Overall Study|Lost to Follow-up|1|||
155225334|NCT00655564|560264755|FG000|Overall Study|Desired Alternate Therapy|1|||
155225335|NCT04536727|560264756|FG000|Overall Study|Lost to Follow-up|1|||
155225336|NCT04536727|560264757|FG001|Overall Study|Lost to Follow-up|1|||
155225337|NCT04536727|560264756|FG000|Overall Study|Death|0|||
155225338|NCT04536727|560264757|FG001|Overall Study|Death|1|||
155225339|NCT00500370|560264761|FG000|Overall Study|Adverse Event|9|||
155225340|NCT00500370|560264762|FG001|Overall Study|Adverse Event|3|||
155225341|NCT00500370|560264761|FG000|Overall Study|Lost to Follow-up|10|||
155225342|NCT00500370|560264762|FG001|Overall Study|Lost to Follow-up|10|||
155225343|NCT00500370|560264761|FG000|Overall Study|Protocol Violation|2|||
155225344|NCT00500370|560264762|FG001|Overall Study|Protocol Violation|4|||
155225345|NCT00500370|560264761|FG000|Overall Study|Sponsor Decision|2|||
155225346|NCT00500370|560264762|FG001|Overall Study|Sponsor Decision|0|||
155225347|NCT00500370|560264761|FG000|Overall Study|Subject Decision|10|||
155225348|NCT00500370|560264762|FG001|Overall Study|Subject Decision|17|||
155225349|NCT05627518|560264763|FG000|Treatment Period 1|Adverse Event|0|||
155225350|NCT05627518|560264764|FG001|Treatment Period 1|Adverse Event|0|||
155225351|NCT05627518|560264765|FG002|Treatment Period 1|Adverse Event|1|||
155225352|NCT05627518|560264766|FG003|Treatment Period 1|Adverse Event|0|||
155225353|NCT05627518|560264767|FG004|Treatment Period 1|Adverse Event|0|||
155225354|NCT05627518|560264768|FG005|Treatment Period 1|Adverse Event|0|||
155225355|NCT05627518|560264769|FG006|Treatment Period 1|Adverse Event|0|||
155225356|NCT05627518|560264770|FG007|Treatment Period 1|Adverse Event|1|||
155225357|NCT05627518|560264763|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155225358|NCT05627518|560264764|FG001|Treatment Period 1|Withdrawal by Subject|0|||
155225359|NCT05627518|560264765|FG002|Treatment Period 1|Withdrawal by Subject|1|||
155225360|NCT05627518|560264766|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155225361|NCT05627518|560264767|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155225362|NCT05627518|560264768|FG005|Treatment Period 1|Withdrawal by Subject|1|||
155225363|NCT05627518|560264769|FG006|Treatment Period 1|Withdrawal by Subject|0|||
155225364|NCT05627518|560264770|FG007|Treatment Period 1|Withdrawal by Subject|0|||
155225365|NCT05627518|560264763|FG000|Treatment Period 1|Protocol Violation|0|||
155225366|NCT05627518|560264764|FG001|Treatment Period 1|Protocol Violation|0|||
155225367|NCT05627518|560264765|FG002|Treatment Period 1|Protocol Violation|0|||
155225368|NCT05627518|560264766|FG003|Treatment Period 1|Protocol Violation|0|||
155225369|NCT05627518|560264767|FG004|Treatment Period 1|Protocol Violation|0|||
155225370|NCT05627518|560264768|FG005|Treatment Period 1|Protocol Violation|0|||
155225371|NCT05627518|560264769|FG006|Treatment Period 1|Protocol Violation|6|||
155225372|NCT05627518|560264770|FG007|Treatment Period 1|Protocol Violation|6|||
155225373|NCT05627518|560264763|FG000|Treatment Period 2|Adverse Event|1|||
155225374|NCT05627518|560264764|FG001|Treatment Period 2|Adverse Event|0|||
155225375|NCT05627518|560264765|FG002|Treatment Period 2|Adverse Event|0|||
155225376|NCT05627518|560264766|FG003|Treatment Period 2|Adverse Event|0|||
155225377|NCT05627518|560264767|FG004|Treatment Period 2|Adverse Event|0|||
155225378|NCT05627518|560264768|FG005|Treatment Period 2|Adverse Event|0|||
155225379|NCT05627518|560264769|FG006|Treatment Period 2|Adverse Event|0|||
155225380|NCT05627518|560264770|FG007|Treatment Period 2|Adverse Event|0|||
155225381|NCT05627518|560264763|FG000|Treatment Period 2|Withdrawal by Subject|1|||
155225382|NCT05627518|560264764|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155225383|NCT05627518|560264765|FG002|Treatment Period 2|Withdrawal by Subject|0|||
155225384|NCT05627518|560264766|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155225385|NCT05627518|560264767|FG004|Treatment Period 2|Withdrawal by Subject|0|||
155225386|NCT05627518|560264768|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155225387|NCT05627518|560264769|FG006|Treatment Period 2|Withdrawal by Subject|0|||
155225388|NCT05627518|560264770|FG007|Treatment Period 2|Withdrawal by Subject|0|||
155225389|NCT00749463|560266494|FG000|Overall Study|Adverse Event|0|||
155225390|NCT00749463|560266495|FG001|Overall Study|Adverse Event|4|||
155225391|NCT00749463|560266496|FG002|Overall Study|Adverse Event|1|||
155225392|NCT00749463|560266494|FG000|Overall Study|Withdrawal by Subject|1|||
155225393|NCT00749463|560266495|FG001|Overall Study|Withdrawal by Subject|0|||
155225394|NCT00749463|560266496|FG002|Overall Study|Withdrawal by Subject|0|||
155225395|NCT00782210|560266498|FG000|Overall Study|Adverse Event|21|||
155225396|NCT00782210|560266499|FG001|Overall Study|Adverse Event|17|||
155225397|NCT00782210|560266500|FG002|Overall Study|Adverse Event|16|||
155225398|NCT00782210|560266498|FG000|Overall Study|Lost to Follow-up|2|||
155225399|NCT00782210|560266499|FG001|Overall Study|Lost to Follow-up|1|||
155225400|NCT00782210|560266500|FG002|Overall Study|Lost to Follow-up|2|||
155225401|NCT00782210|560266498|FG000|Overall Study|Withdrawal by Subject|11|||
155225402|NCT00782210|560266499|FG001|Overall Study|Withdrawal by Subject|8|||
155225403|NCT00782210|560266500|FG002|Overall Study|Withdrawal by Subject|11|||
155225404|NCT00782210|560266498|FG000|Overall Study|Non compliance with protocol|0|||
155225405|NCT00782210|560266499|FG001|Overall Study|Non compliance with protocol|3|||
155225406|NCT00782210|560266500|FG002|Overall Study|Non compliance with protocol|2|||
155225407|NCT00782210|560266498|FG000|Overall Study|Lack of Efficacy|13|||
155225408|NCT00782210|560266499|FG001|Overall Study|Lack of Efficacy|4|||
155225409|NCT00782210|560266500|FG002|Overall Study|Lack of Efficacy|1|||
155225410|NCT00782210|560266498|FG000|Overall Study|Other reason not described above|3|||
155225411|NCT00782210|560266499|FG001|Overall Study|Other reason not described above|2|||
155225412|NCT00782210|560266500|FG002|Overall Study|Other reason not described above|3|||
155225413|NCT05358821|560266503|FG000|Overall Study|Withdrawal by Subject|0|||
155225414|NCT05358821|560266504|FG001|Overall Study|Withdrawal by Subject|1|||
155225415|NCT05358821|560266505|FG002|Overall Study|Withdrawal by Subject|0|||
155225416|NCT05358821|560266503|FG000|Overall Study|Withdrawal of Consent|0|||
155225417|NCT05358821|560266504|FG001|Overall Study|Withdrawal of Consent|0|||
155225418|NCT05358821|560266505|FG002|Overall Study|Withdrawal of Consent|1|||
155225419|NCT02704364|560266506|FG000|Overall Study|Adverse Event|1|||
155225420|NCT02704364|560266507|FG001|Overall Study|Adverse Event|1|||
155225421|NCT02704364|560266508|FG002|Overall Study|Adverse Event|0|||
155225422|NCT02704364|560266506|FG000|Overall Study|Noncompliance with study drug|1|||
155225423|NCT02704364|560266507|FG001|Overall Study|Noncompliance with study drug|1|||
155225424|NCT02704364|560266508|FG002|Overall Study|Noncompliance with study drug|0|||
155225425|NCT02704364|560266506|FG000|Overall Study|Other|0|||
155225426|NCT02704364|560266507|FG001|Overall Study|Other|1|||
155225427|NCT02704364|560266508|FG002|Overall Study|Other|1|||
155225428|NCT02086110|560266511|FG000|Overall Study|Withdrawal by Subject|1|||
155225429|NCT02086110|560266512|FG001|Overall Study|Withdrawal by Subject|1|||
155225430|NCT01869192|560266513|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
155225431|NCT01869192|560266514|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
155225432|NCT01869192|560266513|FG000|Postoperative Chemotherapy|Physician Decision|0|||
155225433|NCT01869192|560266514|FG001|Postoperative Chemotherapy|Physician Decision|2|||
155225434|NCT01203072|560266518|FG000|Overall Study|Adverse Event|5|||
155225435|NCT01203072|560266519|FG001|Overall Study|Adverse Event|3|||
155225436|NCT01203072|560266520|FG002|Overall Study|Adverse Event|2|||
155225437|NCT01203072|560266521|FG003|Overall Study|Adverse Event|4|||
155225438|NCT01203072|560266522|FG004|Overall Study|Adverse Event|2|||
155225439|NCT01203072|560266518|FG000|Overall Study|Lack of Efficacy|1|||
155225440|NCT01203072|560266519|FG001|Overall Study|Lack of Efficacy|0|||
155225441|NCT01203072|560266520|FG002|Overall Study|Lack of Efficacy|0|||
155225442|NCT01203072|560266521|FG003|Overall Study|Lack of Efficacy|0|||
155225443|NCT01203072|560266522|FG004|Overall Study|Lack of Efficacy|0|||
155225444|NCT01203072|560266518|FG000|Overall Study|Lost to Follow-up|0|||
155225445|NCT01203072|560266519|FG001|Overall Study|Lost to Follow-up|1|||
155225446|NCT01203072|560266520|FG002|Overall Study|Lost to Follow-up|0|||
155225447|NCT01203072|560266521|FG003|Overall Study|Lost to Follow-up|0|||
155225448|NCT01203072|560266522|FG004|Overall Study|Lost to Follow-up|0|||
155225449|NCT01203072|560266518|FG000|Overall Study|Protocol Violation|2|||
155225450|NCT01203072|560266519|FG001|Overall Study|Protocol Violation|0|||
155225451|NCT01203072|560266520|FG002|Overall Study|Protocol Violation|0|||
155225452|NCT01203072|560266521|FG003|Overall Study|Protocol Violation|0|||
155225453|NCT01203072|560266522|FG004|Overall Study|Protocol Violation|1|||
155225454|NCT01203072|560266518|FG000|Overall Study|Withdrawal by Subject|2|||
155225455|NCT01203072|560266519|FG001|Overall Study|Withdrawal by Subject|2|||
155225456|NCT01203072|560266520|FG002|Overall Study|Withdrawal by Subject|1|||
155225457|NCT01203072|560266521|FG003|Overall Study|Withdrawal by Subject|2|||
155225458|NCT01203072|560266522|FG004|Overall Study|Withdrawal by Subject|3|||
155225459|NCT02272413|560266524|FG000|Randomized Through Treatment Start|Not treated|3|||
155225460|NCT02272413|560266525|FG001|Randomized Through Treatment Start|Not treated|5|||
155225461|NCT02272413|560266524|FG000|Pre-switch Period|Adverse Event|38|||
155225462|NCT02272413|560266525|FG001|Pre-switch Period|Adverse Event|37|||
155225463|NCT02272413|560266524|FG000|Pre-switch Period|Death|26|||
155225464|NCT02272413|560266525|FG001|Pre-switch Period|Death|26|||
155225465|NCT02272413|560266524|FG000|Pre-switch Period|Withdrawal by Subject|27|||
155225466|NCT02272413|560266525|FG001|Pre-switch Period|Withdrawal by Subject|15|||
155225467|NCT02272413|560266524|FG000|Pre-switch Period|Physician Decision|6|||
155225468|NCT02272413|560266525|FG001|Pre-switch Period|Physician Decision|18|||
155225469|NCT02272413|560266524|FG000|Pre-switch Period|Progressive disease|185|||
155225470|NCT02272413|560266525|FG001|Pre-switch Period|Progressive disease|173|||
155225471|NCT02272413|560266524|FG000|Pre-switch Period|Lost to Follow-up|0|||
155225472|NCT02272413|560266525|FG001|Pre-switch Period|Lost to Follow-up|2|||
155225473|NCT02272413|560266524|FG000|Pre-switch Period|Protocol Violation|1|||
155225474|NCT02272413|560266525|FG001|Pre-switch Period|Protocol Violation|0|||
155225475|NCT02272413|560266524|FG000|Pre-switch Period|Other than listed|10|||
155225476|NCT02272413|560266525|FG001|Pre-switch Period|Other than listed|11|||
155225477|NCT02272413|560266524|FG000|Post-switch Period|Adverse Event|4|||
155225478|NCT02272413|560266525|FG001|Post-switch Period|Adverse Event|4|||
155225479|NCT02272413|560266524|FG000|Post-switch Period|Death|3|||
155225480|NCT02272413|560266525|FG001|Post-switch Period|Death|2|||
155225481|NCT02272413|560266524|FG000|Post-switch Period|Withdrawal by Subject|1|||
155225482|NCT02272413|560266525|FG001|Post-switch Period|Withdrawal by Subject|2|||
155225483|NCT02272413|560266524|FG000|Post-switch Period|Physician Decision|1|||
155225484|NCT02272413|560266525|FG001|Post-switch Period|Physician Decision|1|||
155225485|NCT02272413|560266524|FG000|Post-switch Period|Progressive disease|21|||
155225486|NCT02272413|560266525|FG001|Post-switch Period|Progressive disease|21|||
155225487|NCT02272413|560266524|FG000|Post-switch Period|Study terminated by sponsor|8|||
155225488|NCT02272413|560266525|FG001|Post-switch Period|Study terminated by sponsor|11|||
155225489|NCT02272413|560266524|FG000|Post-switch Period|Other than listed|4|||
155225490|NCT02272413|560266525|FG001|Post-switch Period|Other than listed|5|||
155225491|NCT02286193|560266531|FG000|Overall Study|Referred: CRS unable to make contact|62|||
155225492|NCT02286193|560266531|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
155225493|NCT02286193|560266531|FG000|Overall Study|Referred: Declined service|38|||
155225494|NCT00423891|560266532|FG000|Enrolled|Withdrawal by Subject|0|||
155225495|NCT00423891|560266533|FG001|Enrolled|Withdrawal by Subject|0|||
155225496|NCT00423891|560266534|FG002|Enrolled|Withdrawal by Subject|1|||
155225497|NCT00423891|560266532|FG000|Enrolled|Lost to Follow-up|0|||
155225498|NCT00423891|560266533|FG001|Enrolled|Lost to Follow-up|0|||
155225499|NCT00423891|560266534|FG002|Enrolled|Lost to Follow-up|1|||
155225500|NCT00423891|560266532|FG000|Enrolled|No longer met criteria|11|||
155225501|NCT00423891|560266533|FG001|Enrolled|No longer met criteria|2|||
155225502|NCT00423891|560266534|FG002|Enrolled|No longer met criteria|1|||
155225503|NCT00423891|560266532|FG000|Treatment|Withdrawal by Subject|1|||
155225504|NCT00423891|560266533|FG001|Treatment|Withdrawal by Subject|0|||
155225505|NCT00423891|560266534|FG002|Treatment|Withdrawal by Subject|0|||
155225506|NCT00423891|560266532|FG000|Treatment|Lost to Follow-up|1|||
155225507|NCT00423891|560266533|FG001|Treatment|Lost to Follow-up|0|||
155225508|NCT00423891|560266534|FG002|Treatment|Lost to Follow-up|0|||
155225509|NCT00423891|560266532|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
155225510|NCT00423891|560266533|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
155225511|NCT00423891|560266534|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
155225512|NCT00423891|560266532|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
155225513|NCT00423891|560266533|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
155225514|NCT00423891|560266534|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
155225515|NCT02871375|560266535|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
155225516|NCT02871375|560266536|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
155225517|NCT04327999|560266544|FG000|Overall Study|Protocol Violation|1|||
155225518|NCT02872116|560266549|FG000|Pre-Treatment|Disease Progression|0|||
155225519|NCT02872116|560266550|FG001|Pre-Treatment|Disease Progression|1|||
155225520|NCT02872116|560266551|FG002|Pre-Treatment|Disease Progression|0|||
155225521|NCT02872116|560266549|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
155225522|NCT02872116|560266550|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
155225523|NCT02872116|560266551|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
155225524|NCT02872116|560266549|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
155225525|NCT02872116|560266550|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
155225526|NCT02872116|560266551|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
155225527|NCT02872116|560266549|FG000|Pre-Treatment|Participant withdrew consent|2|||
155225528|NCT02872116|560266550|FG001|Pre-Treatment|Participant withdrew consent|20|||
155225529|NCT02872116|560266551|FG002|Pre-Treatment|Participant withdrew consent|3|||
155225530|NCT02872116|560266549|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
155225531|NCT02872116|560266550|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
155225532|NCT02872116|560266551|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
155225533|NCT02872116|560266549|FG000|Pre-Treatment|Other reasons|1|||
155225534|NCT02872116|560266550|FG001|Pre-Treatment|Other reasons|2|||
155225535|NCT02872116|560266551|FG002|Pre-Treatment|Other reasons|2|||
155225536|NCT02872116|560266549|FG000|Treatment|Death|121|||
155225537|NCT02872116|560266550|FG001|Treatment|Death|94|||
155225538|NCT02872116|560266551|FG002|Treatment|Death|68|||
155225539|NCT02872116|560266549|FG000|Treatment|Lost to Follow-up|5|||
155225540|NCT02872116|560266550|FG001|Treatment|Lost to Follow-up|7|||
155225541|NCT02872116|560266551|FG002|Treatment|Lost to Follow-up|3|||
155225542|NCT02872116|560266549|FG000|Treatment|Participant withdrew consent|20|||
155225543|NCT02872116|560266550|FG001|Treatment|Participant withdrew consent|40|||
155225544|NCT02872116|560266551|FG002|Treatment|Participant withdrew consent|8|||
155225545|NCT02872116|560266549|FG000|Treatment|Other reasons|13|||
155225546|NCT02872116|560266550|FG001|Treatment|Other reasons|12|||
155225547|NCT02872116|560266551|FG002|Treatment|Other reasons|5|||
155225548|NCT02346136|560266552|FG000|Overall Study|Withdrawal by Subject|7|||
155225549|NCT02346136|560266553|FG001|Overall Study|Withdrawal by Subject|5|||
155225550|NCT02346136|560266552|FG000|Overall Study|Death|1|||
155225551|NCT02346136|560266553|FG001|Overall Study|Death|0|||
155225552|NCT02346136|560266552|FG000|Overall Study|Study termination|14|||
155225553|NCT02346136|560266553|FG001|Overall Study|Study termination|18|||
155225554|NCT00606892|560266560|FG000|First Intervention|Protocol Violation|1|||
155225555|NCT00606892|560266561|FG001|First Intervention|Protocol Violation|4|||
155225556|NCT04225923|560266570|FG000|Overall Study|Protocol Violation|1|||
155225557|NCT04225923|560266571|FG001|Overall Study|Protocol Violation|0|||
155225558|NCT04225923|560266572|FG002|Overall Study|Protocol Violation|1|||
155225559|NCT04225923|560266570|FG000|Overall Study|Withdrawal by Subject|4|||
155225560|NCT04225923|560266571|FG001|Overall Study|Withdrawal by Subject|1|||
155225561|NCT04225923|560266572|FG002|Overall Study|Withdrawal by Subject|3|||
155225562|NCT04225923|560266570|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
155225563|NCT04225923|560266571|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
155225564|NCT04225923|560266572|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
155225565|NCT00855309|560266573|FG000|Overall Study|patient never recieved drug|1|||
155225566|NCT00855309|560266574|FG001|Overall Study|patient never recieved drug|0|||
155225567|NCT01907828|560266580|FG000|Overall Study|Exclusion criteria not met|0|||
155225568|NCT01907828|560266581|FG001|Overall Study|Exclusion criteria not met|1|||
155225569|NCT01907828|560266580|FG000|Overall Study|Withdrawal by Subject|3|||
155225570|NCT01907828|560266581|FG001|Overall Study|Withdrawal by Subject|4|||
155225571|NCT01907828|560266580|FG000|Overall Study|Lost to Follow-up|3|||
155225572|NCT01907828|560266581|FG001|Overall Study|Lost to Follow-up|0|||
155225573|NCT01907828|560266580|FG000|Overall Study|Participant refused 24-month follow-up|1|||
155225574|NCT01907828|560266581|FG001|Overall Study|Participant refused 24-month follow-up|0|||
155225575|NCT01907828|560266580|FG000|Overall Study|Participant met exclusion criteria|0|||
155225576|NCT01907828|560266581|FG001|Overall Study|Participant met exclusion criteria|1|||
155225577|NCT01364428|560266586|FG000|Overall Study|Adverse Event|1|||
155225578|NCT01364428|560266587|FG001|Overall Study|Adverse Event|2|||
155225579|NCT01364428|560266586|FG000|Overall Study|Protocol Violation|2|||
155225580|NCT01364428|560266587|FG001|Overall Study|Protocol Violation|0|||
155225581|NCT01364428|560266586|FG000|Overall Study|Withdrawal Criteria|14|||
155225582|NCT01364428|560266587|FG001|Overall Study|Withdrawal Criteria|10|||
155225583|NCT01364428|560266586|FG000|Overall Study|Other|3|||
155225584|NCT01364428|560266587|FG001|Overall Study|Other|3|||
155225585|NCT01585766|560266588|FG000|Overall Study|Withdrawal by Subject|0|||
155225586|NCT01585766|560266589|FG001|Overall Study|Withdrawal by Subject|1|||
155225587|NCT01585766|560266590|FG002|Overall Study|Withdrawal by Subject|1|||
155225588|NCT01585766|560266591|FG003|Overall Study|Withdrawal by Subject|0|||
155225589|NCT01585766|560266592|FG004|Overall Study|Withdrawal by Subject|0|||
155225590|NCT01585766|560266593|FG005|Overall Study|Withdrawal by Subject|0|||
155225591|NCT01585766|560266588|FG000|Overall Study|Death|0|||
155225592|NCT01585766|560266589|FG001|Overall Study|Death|1|||
155225593|NCT01585766|560266590|FG002|Overall Study|Death|0|||
155225594|NCT01585766|560266591|FG003|Overall Study|Death|0|||
155225595|NCT01585766|560266592|FG004|Overall Study|Death|0|||
155225596|NCT01585766|560266593|FG005|Overall Study|Death|0|||
155225597|NCT01585766|560266588|FG000|Overall Study|Physician Decision|0|||
155225598|NCT01585766|560266589|FG001|Overall Study|Physician Decision|0|||
155225599|NCT01585766|560266590|FG002|Overall Study|Physician Decision|1|||
155225600|NCT01585766|560266591|FG003|Overall Study|Physician Decision|0|||
155225601|NCT01585766|560266592|FG004|Overall Study|Physician Decision|0|||
155225602|NCT01585766|560266593|FG005|Overall Study|Physician Decision|0|||
155225603|NCT00582933|560266594|FG000|Overall Study|Physician Decision|3|||
155225604|NCT01371656|560266600|FG000|Overall Study|Death|7|||
155225605|NCT01371656|560266601|FG001|Overall Study|Death|4|||
155225606|NCT01371656|560266600|FG000|Overall Study|Physician Decision|46|||
155225607|NCT01371656|560266601|FG001|Overall Study|Physician Decision|7|||
155225608|NCT01371656|560266600|FG000|Overall Study|Withdrawal by Subject|7|||
155225609|NCT01371656|560266601|FG001|Overall Study|Withdrawal by Subject|0|||
155225610|NCT01371656|560266600|FG000|Overall Study|Ineligible|4|||
155225611|NCT01371656|560266601|FG001|Overall Study|Ineligible|3|||
155225612|NCT00696137|560266606|FG000|Overall Study|Withdrawal by Subject|2|||
155225613|NCT04334460|560266620|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
155225614|NCT04334460|560266621|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
155225615|NCT04334460|560266620|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
155225616|NCT04334460|560266621|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
155225617|NCT01465464|560266622|FG000|Overall Study|Adverse Event|96|||
155225618|NCT01465464|560266623|FG001|Overall Study|Adverse Event|49|||
155225619|NCT01465464|560266622|FG000|Overall Study|Lack of Efficacy|139|||
155225620|NCT01465464|560266623|FG001|Overall Study|Lack of Efficacy|190|||
155225621|NCT01465464|560266622|FG000|Overall Study|Physician Decision|13|||
155225622|NCT01465464|560266623|FG001|Overall Study|Physician Decision|5|||
155225623|NCT01465464|560266622|FG000|Overall Study|Protocol Violation|1|||
155225624|NCT01465464|560266623|FG001|Overall Study|Protocol Violation|1|||
155225625|NCT01465464|560266622|FG000|Overall Study|Withdrawal by Subject|46|||
155225626|NCT01465464|560266623|FG001|Overall Study|Withdrawal by Subject|30|||
155225627|NCT01465464|560266622|FG000|Overall Study|Other|9|||
155225628|NCT01465464|560266623|FG001|Overall Study|Other|3|||
155225629|NCT01465464|560266622|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
155225630|NCT01465464|560266623|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
155225631|NCT00775437|560266629|FG000|Overall Study|Loss of efficacy|2|||
155225632|NCT00775437|560266629|FG000|Overall Study|Withdrawal by Subject|3|||
155225633|NCT00775437|560266629|FG000|Overall Study|Lost to Follow-up|1|||
155225634|NCT01183975|560266630|FG000|Overall Study|Lost to Follow-up|73|||
155225635|NCT03316885|560266631|FG000|Overall Study|Adverse Event|1|||
155225636|NCT03316885|560266631|FG000|Overall Study|Death|10|||
155225637|NCT03316885|560266631|FG000|Overall Study|Lost to Follow-up|4|||
155225638|NCT03316885|560266631|FG000|Overall Study|Withdrawal by Subject|9|||
155225639|NCT03316885|560266631|FG000|Overall Study|COVID related|8|||
155225640|NCT04964128|560266640|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
155225641|NCT04964128|560266640|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
155225642|NCT02120794|560266641|FG000|Overall Study|Withdrawal by Subject|43|||
155225643|NCT02120794|560266641|FG000|Overall Study|Adverse Event|10|||
155225644|NCT02120794|560266641|FG000|Overall Study|Physician Decision|4|||
155225645|NCT02120794|560266641|FG000|Overall Study|Due to insurance coverage|1|||
155225646|NCT00994240|560266644|FG000|Overall Study|Lost to Follow-up|3|||
155225647|NCT00994240|560266645|FG001|Overall Study|Lost to Follow-up|2|||
155225648|NCT00994240|560266644|FG000|Overall Study|Withdrawal by Subject|1|||
155225649|NCT00994240|560266645|FG001|Overall Study|Withdrawal by Subject|0|||
155225650|NCT00994240|560266644|FG000|Overall Study|study termination|2|||
155225651|NCT00994240|560266645|FG001|Overall Study|study termination|3|||
155225652|NCT01148511|560266646|FG000|Exposed to Study Drug|Protocol Violation|2|||
155225653|NCT01148511|560266647|FG001|Exposed to Study Drug|Protocol Violation|0|||
155225654|NCT01148511|560266648|FG002|Exposed to Study Drug|Protocol Violation|0|||
155225655|NCT01148511|560266646|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
155225656|NCT01148511|560266647|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
155225657|NCT01148511|560266648|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
155225658|NCT01148511|560266646|FG000|Randomized|Adverse Event|0|||
155225659|NCT01148511|560266647|FG001|Randomized|Adverse Event|1|||
155225660|NCT01148511|560266648|FG002|Randomized|Adverse Event|0|||
155225661|NCT01148511|560266646|FG000|Randomized|Protocol Violation|0|||
155225662|NCT01148511|560266647|FG001|Randomized|Protocol Violation|2|||
155225663|NCT01148511|560266648|FG002|Randomized|Protocol Violation|1|||
155225664|NCT01148511|560266646|FG000|Randomized|Lost to Follow-up|0|||
155225665|NCT01148511|560266647|FG001|Randomized|Lost to Follow-up|1|||
155225666|NCT01148511|560266648|FG002|Randomized|Lost to Follow-up|1|||
155225667|NCT01148511|560266646|FG000|Randomized|Consent withdrawal|0|||
155225668|NCT01148511|560266647|FG001|Randomized|Consent withdrawal|5|||
155225669|NCT01148511|560266648|FG002|Randomized|Consent withdrawal|3|||
155225670|NCT01148511|560266646|FG000|Randomized|Other|0|||
155225671|NCT01148511|560266647|FG001|Randomized|Other|1|||
155225672|NCT01148511|560266648|FG002|Randomized|Other|1|||
155225673|NCT04258605|560266650|FG000|Overall Study|Death|1|||
155225674|NCT04258605|560266651|FG001|Overall Study|Death|0|||
155225675|NCT04258605|560266650|FG000|Overall Study|Early study termination|21|||
155225676|NCT04258605|560266651|FG001|Overall Study|Early study termination|2|||
155225677|NCT00842348|560266655|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
155225678|NCT00842348|560266656|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
155225679|NCT00842348|560266655|FG000|Study 729|Disease progression/death|19|||
155225680|NCT00842348|560266656|FG001|Study 729|Disease progression/death|30|||
155225681|NCT00842348|560266655|FG000|Study 729|Adverse Event|1|||
155225682|NCT00842348|560266656|FG001|Study 729|Adverse Event|1|||
155225683|NCT00842348|560266655|FG000|Study 729|Protocol Violation|1|||
155225684|NCT00842348|560266656|FG001|Study 729|Protocol Violation|1|||
155225685|NCT00842348|560266655|FG000|Study 729|Withdrawal by Subject|2|||
155225686|NCT00842348|560266656|FG001|Study 729|Withdrawal by Subject|4|||
155225687|NCT00842348|560266655|FG000|Study 729|Due to Sponsor stopping the study|1|||
155225688|NCT00842348|560266656|FG001|Study 729|Due to Sponsor stopping the study|1|||
155225689|NCT00842348|560266655|FG000|Study 729|Due to non-availability of IP|0|||
155225690|NCT00842348|560266656|FG001|Study 729|Due to non-availability of IP|1|||
155225691|NCT00842348|560266655|FG000|Study 729|Sponsor's decision|1|||
155225692|NCT00842348|560266656|FG001|Study 729|Sponsor's decision|0|||
155225693|NCT00842348|560266655|FG000|Study 729|Surgical resection|1|||
155225694|NCT00842348|560266656|FG001|Study 729|Surgical resection|0|||
155225695|NCT03274986|560266657|FG000|Overall Study|Withdrawal by Subject|0|||
155225696|NCT03274986|560266658|FG001|Overall Study|Withdrawal by Subject|1|||
155225697|NCT03274986|560266657|FG000|Overall Study|Lost to Follow-up|0|||
155225698|NCT03274986|560266658|FG001|Overall Study|Lost to Follow-up|1|||
155225699|NCT02196324|560266661|FG000|Overall Study|Withdrawal by Subject|8|||
155225700|NCT02196324|560266662|FG001|Overall Study|Withdrawal by Subject|4|||
155225701|NCT02196324|560266661|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
155225702|NCT02196324|560266662|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
155225703|NCT02196324|560266661|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
155225704|NCT02196324|560266662|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
155225705|NCT02196324|560266661|FG000|Overall Study|Other|1|||
155225706|NCT02196324|560266662|FG001|Overall Study|Other|0|||
155225707|NCT02620046|560266663|FG000|Overall Study|Adverse Event|22|||
155225708|NCT02620046|560266664|FG001|Overall Study|Adverse Event|42|||
155225709|NCT02620046|560266663|FG000|Overall Study|Lost to Follow-up|4|||
155225710|NCT02620046|560266664|FG001|Overall Study|Lost to Follow-up|10|||
155225711|NCT02620046|560266663|FG000|Overall Study|Withdrawal by Subject|36|||
155225712|NCT02620046|560266664|FG001|Overall Study|Withdrawal by Subject|66|||
155225713|NCT02620046|560266663|FG000|Overall Study|Site Termination|3|||
155225714|NCT02620046|560266664|FG001|Overall Study|Site Termination|3|||
155225715|NCT02620046|560266663|FG000|Overall Study|Pregnancy|3|||
155225716|NCT02620046|560266664|FG001|Overall Study|Pregnancy|7|||
155225717|NCT02620046|560266663|FG000|Overall Study|Lack of Efficacy|81|||
155225718|NCT02620046|560266664|FG001|Overall Study|Lack of Efficacy|146|||
155225719|NCT02620046|560266663|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
155225720|NCT02620046|560266664|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
155225721|NCT02620046|560266663|FG000|Overall Study|Reason Not Specified|13|||
155225722|NCT02620046|560266664|FG001|Overall Study|Reason Not Specified|21|||
155225723|NCT02620046|560266663|FG000|Overall Study|Significant Protocol Deviation|0|||
155225724|NCT02620046|560266664|FG001|Overall Study|Significant Protocol Deviation|1|||
155225725|NCT02970968|560268578|FG000|Overall Study|Withdrawal by Subject|3|||
155225726|NCT02970968|560268579|FG001|Overall Study|Withdrawal by Subject|3|||
155225727|NCT02970968|560268578|FG000|Overall Study|Adverse Event|1|||
155225728|NCT02970968|560268579|FG001|Overall Study|Adverse Event|2|||
155225729|NCT02970968|560268578|FG000|Overall Study|Lost to Follow-up|1|||
155225730|NCT02970968|560268579|FG001|Overall Study|Lost to Follow-up|1|||
155225731|NCT02970968|560268578|FG000|Overall Study|Non-Compliance|0|||
155225732|NCT02970968|560268579|FG001|Overall Study|Non-Compliance|1|||
155225733|NCT02565381|560268580|FG000|Overall Study|Lost to Follow-up|1|||
155225734|NCT02565381|560268581|FG001|Overall Study|Lost to Follow-up|0|||
155225735|NCT02565381|560268582|FG002|Overall Study|Lost to Follow-up|1|||
155225736|NCT05308901|560268585|FG000|Overall Study|Death|6|||
155225737|NCT02388737|560268586|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
155225738|NCT02388737|560268587|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
155225739|NCT02388737|560268588|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
155225740|NCT02388737|560268586|FG000|Overall Study|Major Protocol Deviation|18|||
155225741|NCT02388737|560268587|FG001|Overall Study|Major Protocol Deviation|25|||
155225742|NCT02388737|560268588|FG002|Overall Study|Major Protocol Deviation|22|||
155225743|NCT02388737|560268586|FG000|Overall Study|Lost to Follow-up|5|||
155225744|NCT02388737|560268587|FG001|Overall Study|Lost to Follow-up|1|||
155225745|NCT02388737|560268588|FG002|Overall Study|Lost to Follow-up|4|||
155225746|NCT02388737|560268586|FG000|Overall Study|Voluntary Withdrawal|10|||
155225747|NCT02388737|560268587|FG001|Overall Study|Voluntary Withdrawal|18|||
155225748|NCT02388737|560268588|FG002|Overall Study|Voluntary Withdrawal|17|||
155225749|NCT02388737|560268586|FG000|Overall Study|Lack of Efficacy|3|||
155225750|NCT02388737|560268587|FG001|Overall Study|Lack of Efficacy|0|||
155225751|NCT02388737|560268588|FG002|Overall Study|Lack of Efficacy|3|||
155225752|NCT02388737|560268586|FG000|Overall Study|Reason Not Specified|5|||
155225753|NCT02388737|560268587|FG001|Overall Study|Reason Not Specified|5|||
155225754|NCT02388737|560268588|FG002|Overall Study|Reason Not Specified|4|||
155225755|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
155225756|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
155225757|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
155225758|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
155225759|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
155225760|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
155225761|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
155225762|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
155225763|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
155225764|NCT03252522|560268589|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
155225765|NCT03252522|560268590|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
155225766|NCT03252522|560268591|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
155225767|NCT03252522|560268589|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
155225768|NCT03252522|560268590|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
155225769|NCT03252522|560268591|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
155225770|NCT03252522|560268589|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
155225771|NCT03252522|560268590|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
155225772|NCT03252522|560268591|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
155225773|NCT03252522|560268589|FG000|Phase 2: Open Label|Adverse Event|0|||
155225774|NCT03252522|560268590|FG001|Phase 2: Open Label|Adverse Event|0|||
155225775|NCT03252522|560268591|FG002|Phase 2: Open Label|Adverse Event|2|||
155225776|NCT03252522|560268589|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
155225777|NCT03252522|560268590|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
155225778|NCT03252522|560268591|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
155225779|NCT03299842|560268593|FG000|Overall Study|Caregiver withdrew consent|2|||
155225780|NCT03299842|560268593|FG000|Overall Study|Child would not keep the watch on|3|||
155225781|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Adverse Event|2|||
155225782|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Adverse Event|3|||
155225783|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Adverse Event|4|||
155225784|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Adverse Event|4|||
155225785|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
155225786|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
155225787|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
155225788|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
155225789|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
155225790|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
155225791|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
155225792|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
155225793|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
155225794|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
155225795|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
155225796|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
155225797|NCT00071812|560268594|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
155225798|NCT00071812|560268595|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
155225799|NCT00071812|560268596|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
155225800|NCT00071812|560268597|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
155225801|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
155225802|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
155225803|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
155225804|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
155225805|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155225806|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155225807|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155225808|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
155225809|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155225810|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155225811|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155225812|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
155225813|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155225814|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155225815|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155225816|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
155225817|NCT00071812|560268594|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155225818|NCT00071812|560268595|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155225819|NCT00071812|560268596|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
155225820|NCT00071812|560268597|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
155225821|NCT01816139|560268600|FG000|Overall Study|Adverse Event|6|||
155225822|NCT01816139|560268601|FG001|Overall Study|Adverse Event|8|||
155225823|NCT01816139|560268600|FG000|Overall Study|Lack of Efficacy|1|||
155225824|NCT01816139|560268601|FG001|Overall Study|Lack of Efficacy|2|||
155225825|NCT01816139|560268600|FG000|Overall Study|Lost to Follow-up|5|||
155225826|NCT01816139|560268601|FG001|Overall Study|Lost to Follow-up|3|||
155225827|NCT01816139|560268600|FG000|Overall Study|Withdrew Consent|6|||
155225828|NCT01816139|560268601|FG001|Overall Study|Withdrew Consent|4|||
155225829|NCT01816139|560268600|FG000|Overall Study|Protocol Violation|6|||
155225830|NCT01816139|560268601|FG001|Overall Study|Protocol Violation|3|||
155225831|NCT01816139|560268600|FG000|Overall Study|Reason not Specified|4|||
155225832|NCT01816139|560268601|FG001|Overall Study|Reason not Specified|2|||
155225833|NCT01940120|560268602|FG000|Overall Study|Death|40|||
155225834|NCT01940120|560268602|FG000|Overall Study|Withdrawal by Subject|8|||
155225835|NCT01888497|560268603|FG000|Washout Period 1|Withdrawal by Subject|0|||
155225836|NCT01888497|560268604|FG001|Washout Period 1|Withdrawal by Subject|0|||
155225837|NCT01888497|560268605|FG002|Washout Period 1|Withdrawal by Subject|1|||
155225838|NCT01888497|560268606|FG003|Washout Period 1|Withdrawal by Subject|1|||
155225839|NCT01888497|560268603|FG000|Washout Period 2|Adverse Event|0|||
155225840|NCT01888497|560268604|FG001|Washout Period 2|Adverse Event|0|||
155225841|NCT01888497|560268605|FG002|Washout Period 2|Adverse Event|0|||
155225842|NCT01888497|560268606|FG003|Washout Period 2|Adverse Event|1|||
155225843|NCT01888497|560268603|FG000|Washout Period 2|Withdrawal by Subject|0|||
155225844|NCT01888497|560268604|FG001|Washout Period 2|Withdrawal by Subject|0|||
155225845|NCT01888497|560268605|FG002|Washout Period 2|Withdrawal by Subject|0|||
155225846|NCT01888497|560268606|FG003|Washout Period 2|Withdrawal by Subject|1|||
155225847|NCT04152447|560268607|FG000|Overall Study|Lost to Follow-up|1|||
155225848|NCT04152447|560268608|FG001|Overall Study|Lost to Follow-up|0|||
155225849|NCT04152447|560268607|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
155225850|NCT04152447|560268608|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
155225851|NCT04152447|560268607|FG000|Overall Study|Withdrawal by Subject|0|||
155225852|NCT04152447|560268608|FG001|Overall Study|Withdrawal by Subject|1|||
155225853|NCT04152447|560268607|FG000|Overall Study|Found ineligible after enrolling|1|||
155225854|NCT04152447|560268608|FG001|Overall Study|Found ineligible after enrolling|1|||
155225855|NCT04152447|560268607|FG000|Overall Study|Did not receive VR headset in time.|0|||
155225856|NCT04152447|560268608|FG001|Overall Study|Did not receive VR headset in time.|2|||
155225857|NCT04013191|560268609|FG000|Overall Study|Adverse Event|1|||
155225858|NCT04013191|560268610|FG001|Overall Study|Adverse Event|0|||
155225859|NCT04127786|560268621|FG000|Primary Series|Adverse Event|1|||
155225860|NCT04127786|560268622|FG001|Primary Series|Adverse Event|0|||
155225861|NCT04127786|560268623|FG002|Primary Series|Adverse Event|0|||
155225862|NCT04127786|560268624|FG003|Primary Series|Adverse Event|1|||
155225863|NCT04127786|560268625|FG004|Primary Series|Adverse Event|0|||
155225864|NCT04127786|560268626|FG005|Primary Series|Adverse Event|1|||
155225865|NCT04127786|560268621|FG000|Primary Series|Protocol Violation|5|||
155225866|NCT04127786|560268622|FG001|Primary Series|Protocol Violation|3|||
155225867|NCT04127786|560268623|FG002|Primary Series|Protocol Violation|4|||
155225868|NCT04127786|560268624|FG003|Primary Series|Protocol Violation|3|||
155225869|NCT04127786|560268625|FG004|Primary Series|Protocol Violation|2|||
155225870|NCT04127786|560268626|FG005|Primary Series|Protocol Violation|0|||
155225871|NCT04127786|560268621|FG000|Primary Series|Withdrawal by Subject|0|||
155225872|NCT04127786|560268622|FG001|Primary Series|Withdrawal by Subject|0|||
155225873|NCT04127786|560268623|FG002|Primary Series|Withdrawal by Subject|0|||
155225874|NCT04127786|560268624|FG003|Primary Series|Withdrawal by Subject|1|||
155225875|NCT04127786|560268625|FG004|Primary Series|Withdrawal by Subject|0|||
155225876|NCT04127786|560268626|FG005|Primary Series|Withdrawal by Subject|0|||
155225877|NCT04127786|560268621|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
155225878|NCT04127786|560268622|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
155225879|NCT04127786|560268623|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
155225880|NCT04127786|560268624|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
155225881|NCT04127786|560268625|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
155225882|NCT04127786|560268626|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
155225883|NCT04127786|560268621|FG000|Booster Phase|Withdrawal by Subject|2|||
155225884|NCT04127786|560268622|FG001|Booster Phase|Withdrawal by Subject|0|||
155225885|NCT04127786|560268623|FG002|Booster Phase|Withdrawal by Subject|0|||
155225886|NCT04127786|560268624|FG003|Booster Phase|Withdrawal by Subject|0|||
155225887|NCT04127786|560268625|FG004|Booster Phase|Withdrawal by Subject|0|||
155225888|NCT04127786|560268626|FG005|Booster Phase|Withdrawal by Subject|0|||
155225889|NCT03034954|560268627|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
155225890|NCT03034954|560268628|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
155225891|NCT03568942|560268633|FG000|Overall Study|Family emergency|1|||
155225892|NCT03568942|560268633|FG000|Overall Study|Lost to Follow-up|1|||
155225893|NCT00358527|560268634|FG000|Overall Study|Adverse Event|4|||
155225894|NCT00358527|560268635|FG001|Overall Study|Adverse Event|0|||
155225895|NCT00358527|560268634|FG000|Overall Study|Withdrawal by Subject|1|||
155225896|NCT00358527|560268635|FG001|Overall Study|Withdrawal by Subject|1|||
155225897|NCT00358527|560268634|FG000|Overall Study|Non-compliance with protocol|6|||
155225898|NCT00358527|560268635|FG001|Overall Study|Non-compliance with protocol|1|||
155225899|NCT00358527|560268634|FG000|Overall Study|Administrative|2|||
155225900|NCT00358527|560268635|FG001|Overall Study|Administrative|1|||
155225901|NCT04144166|560268636|FG000|Overall Study|Discharged before study start|1|||
155225902|NCT04144166|560268636|FG000|Overall Study|Pregnancy|1|||
155225903|NCT04144166|560268636|FG000|Overall Study|Nail polish could not be removed from finger|1|||
155225904|NCT00913744|560268638|FG000|Overall Study|Adverse Event|2|||
155225905|NCT00913744|560268639|FG001|Overall Study|Adverse Event|0|||
155225906|NCT00913744|560268638|FG000|Overall Study|Withdrawal by Subject|2|||
155225907|NCT00913744|560268639|FG001|Overall Study|Withdrawal by Subject|1|||
155225908|NCT00913744|560268638|FG000|Overall Study|Death|1|||
155225909|NCT00913744|560268639|FG001|Overall Study|Death|0|||
155225910|NCT00805935|560268640|FG000|Overall Study|Stimulation Failure|1|||
155225911|NCT00805935|560268641|FG001|Overall Study|Stimulation Failure|5|||
155225912|NCT00805935|560268642|FG002|Overall Study|Stimulation Failure|2|||
155225913|NCT00805935|560268643|FG003|Overall Study|Stimulation Failure|2|||
155225914|NCT00805935|560268640|FG000|Overall Study|Cycle cancelled|0|||
155225915|NCT00805935|560268641|FG001|Overall Study|Cycle cancelled|0|||
155225916|NCT00805935|560268642|FG002|Overall Study|Cycle cancelled|2|||
155225917|NCT00805935|560268643|FG003|Overall Study|Cycle cancelled|0|||
155225918|NCT00805935|560268640|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
155225919|NCT00805935|560268641|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
155225920|NCT00805935|560268642|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
155225921|NCT00805935|560268643|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
155225922|NCT00805935|560268640|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
155225923|NCT00805935|560268641|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
155225924|NCT00805935|560268642|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
155225925|NCT00805935|560268643|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
155225926|NCT00805935|560268640|FG000|Overall Study|Lost to Follow-up|1|||
155225927|NCT00805935|560268641|FG001|Overall Study|Lost to Follow-up|0|||
155225928|NCT00805935|560268642|FG002|Overall Study|Lost to Follow-up|0|||
155225929|NCT00805935|560268643|FG003|Overall Study|Lost to Follow-up|0|||
155225930|NCT00805935|560268640|FG000|Overall Study|No positive serum pregnancy|8|||
155225931|NCT00805935|560268641|FG001|Overall Study|No positive serum pregnancy|7|||
155225932|NCT00805935|560268642|FG002|Overall Study|No positive serum pregnancy|6|||
155225933|NCT00805935|560268643|FG003|Overall Study|No positive serum pregnancy|5|||
155225934|NCT00805935|560268640|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155225935|NCT00805935|560268641|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155225936|NCT00805935|560268642|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
155225937|NCT00805935|560268643|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
155225938|NCT00805935|560268640|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
155225939|NCT00805935|560268641|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
155225940|NCT00805935|560268642|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
155225941|NCT00805935|560268643|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
155225942|NCT00805935|560268640|FG000|Overall Study|Biochemical pregnancy|0|||
155225943|NCT00805935|560268641|FG001|Overall Study|Biochemical pregnancy|1|||
155225944|NCT00805935|560268642|FG002|Overall Study|Biochemical pregnancy|0|||
155225945|NCT00805935|560268643|FG003|Overall Study|Biochemical pregnancy|0|||
155225946|NCT00805935|560268640|FG000|Overall Study|Chemical pregnancy|0|||
155225947|NCT00805935|560268641|FG001|Overall Study|Chemical pregnancy|5|||
155225948|NCT00805935|560268642|FG002|Overall Study|Chemical pregnancy|3|||
155225949|NCT00805935|560268643|FG003|Overall Study|Chemical pregnancy|2|||
155225950|NCT00805935|560268640|FG000|Overall Study|Ectopic pregnancy|0|||
155225951|NCT00805935|560268641|FG001|Overall Study|Ectopic pregnancy|0|||
155225952|NCT00805935|560268642|FG002|Overall Study|Ectopic pregnancy|1|||
155225953|NCT00805935|560268643|FG003|Overall Study|Ectopic pregnancy|0|||
155225954|NCT00805935|560268640|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
155225955|NCT00805935|560268641|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
155225956|NCT00805935|560268642|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
155225957|NCT00805935|560268643|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
155225958|NCT02433834|560268644|FG000|Overall Study|Protocol-specified criteria|7|||
155225959|NCT02433834|560268644|FG000|Overall Study|Protocol Violation|3|||
155225960|NCT02433834|560268644|FG000|Overall Study|Lost to Follow-up|6|||
155225961|NCT02433834|560268644|FG000|Overall Study|Withdrawal by Subject|14|||
155225962|NCT02433834|560268644|FG000|Overall Study|Adverse Event|6|||
155225963|NCT02433834|560268644|FG000|Overall Study|Physician Decision|1|||
155225964|NCT00283439|560268646|FG000|Overall Study|Adverse Event|0|||
155225965|NCT00283439|560268647|FG001|Overall Study|Adverse Event|0|||
155225966|NCT00283439|560268648|FG002|Overall Study|Adverse Event|0|||
155225967|NCT00283439|560268649|FG003|Overall Study|Adverse Event|1|||
155225968|NCT00283439|560268646|FG000|Overall Study|Death|0|||
155225969|NCT00283439|560268647|FG001|Overall Study|Death|0|||
155225970|NCT00283439|560268648|FG002|Overall Study|Death|1|||
155225971|NCT00283439|560268649|FG003|Overall Study|Death|0|||
155225972|NCT00283439|560268646|FG000|Overall Study|Disease progression|0|||
155225973|NCT00283439|560268647|FG001|Overall Study|Disease progression|1|||
155225974|NCT00283439|560268648|FG002|Overall Study|Disease progression|0|||
155225975|NCT00283439|560268649|FG003|Overall Study|Disease progression|0|||
155225976|NCT00283439|560268646|FG000|Overall Study|Requirement for alternative therapy|1|||
155225977|NCT00283439|560268647|FG001|Overall Study|Requirement for alternative therapy|2|||
155225978|NCT00283439|560268648|FG002|Overall Study|Requirement for alternative therapy|5|||
155225979|NCT00283439|560268649|FG003|Overall Study|Requirement for alternative therapy|2|||
155225980|NCT00283439|560268646|FG000|Overall Study|Stem cell transplant|6|||
155225981|NCT00283439|560268647|FG001|Overall Study|Stem cell transplant|6|||
155225982|NCT00283439|560268648|FG002|Overall Study|Stem cell transplant|4|||
155225983|NCT00283439|560268649|FG003|Overall Study|Stem cell transplant|3|||
155225984|NCT00283439|560268646|FG000|Overall Study|Treatment discontinued|0|||
155225985|NCT00283439|560268647|FG001|Overall Study|Treatment discontinued|2|||
155225986|NCT00283439|560268648|FG002|Overall Study|Treatment discontinued|1|||
155225987|NCT00283439|560268649|FG003|Overall Study|Treatment discontinued|3|||
155225988|NCT00283439|560268646|FG000|Overall Study|Other|1|||
155225989|NCT00283439|560268647|FG001|Overall Study|Other|0|||
155225990|NCT00283439|560268648|FG002|Overall Study|Other|0|||
155225991|NCT00283439|560268649|FG003|Overall Study|Other|0|||
155225992|NCT00333229|560268650|FG000|Overall Study|Lack of Efficacy|0|||
155225993|NCT00333229|560268651|FG001|Overall Study|Lack of Efficacy|1|||
155225994|NCT00348556|560268654|FG000|Overall Study|Adverse Event|1|||
155225995|NCT01466270|560268655|FG000|Overall Study|Withdrawal by Subject|4|||
155225996|NCT01466270|560268656|FG001|Overall Study|Withdrawal by Subject|1|||
155225997|NCT01466270|560268655|FG000|Overall Study|Physician Decision|1|||
155225998|NCT01466270|560268656|FG001|Overall Study|Physician Decision|0|||
155225999|NCT01466270|560268655|FG000|Overall Study|Lost to Follow-up|1|||
155226000|NCT01466270|560268656|FG001|Overall Study|Lost to Follow-up|3|||
155226001|NCT01466270|560268655|FG000|Overall Study|Progression|1|||
155226002|NCT01466270|560268656|FG001|Overall Study|Progression|0|||
155226003|NCT01466270|560268655|FG000|Overall Study|Toxicity|4|||
155226004|NCT01466270|560268656|FG001|Overall Study|Toxicity|1|||
155226005|NCT01466270|560268655|FG000|Overall Study|Multiple|1|||
155226006|NCT01466270|560268656|FG001|Overall Study|Multiple|1|||
155226007|NCT01944059|560268657|FG000|Overall Study|Lost to Follow-up|1|||
155226008|NCT01944059|560268657|FG000|Overall Study|Physician Decision|3|||
155226009|NCT01944059|560268657|FG000|Overall Study|Withdrawal by Subject|1|||
155226010|NCT01944059|560268657|FG000|Overall Study|Adverse Event|2|||
155226011|NCT02821962|560268658|FG000|Overall Study|Lost to Follow-up|2|||
155226012|NCT02821962|560268659|FG001|Overall Study|Lost to Follow-up|0|||
155226013|NCT00430092|560268661|FG000|Overall Study|Adverse Event|0|||
155226014|NCT00430092|560268662|FG001|Overall Study|Adverse Event|0|||
155226015|NCT00430092|560268663|FG002|Overall Study|Adverse Event|1|||
155226016|NCT00430092|560268661|FG000|Overall Study|Lack of Efficacy|5|||
155226017|NCT00430092|560268662|FG001|Overall Study|Lack of Efficacy|2|||
155226018|NCT00430092|560268663|FG002|Overall Study|Lack of Efficacy|54|||
155226019|NCT00430092|560268661|FG000|Overall Study|Lost to Follow-up|1|||
155226020|NCT00430092|560268662|FG001|Overall Study|Lost to Follow-up|0|||
155226021|NCT00430092|560268663|FG002|Overall Study|Lost to Follow-up|0|||
155226022|NCT00430092|560268661|FG000|Overall Study|Protocol Violation|0|||
155226023|NCT00430092|560268662|FG001|Overall Study|Protocol Violation|1|||
155226024|NCT00430092|560268663|FG002|Overall Study|Protocol Violation|1|||
155226025|NCT00430092|560268661|FG000|Overall Study|Withdrawal by Subject|0|||
155226026|NCT00430092|560268662|FG001|Overall Study|Withdrawal by Subject|1|||
155226027|NCT00430092|560268663|FG002|Overall Study|Withdrawal by Subject|1|||
155226028|NCT00654381|560268664|FG000|1st Stage|Adverse Event|3|||
155226029|NCT00654381|560268665|FG001|1st Stage|Adverse Event|3|||
155226030|NCT00654381|560268666|FG002|1st Stage|Adverse Event|3|||
155226031|NCT00654381|560268667|FG003|1st Stage|Adverse Event|3|||
155226032|NCT00654381|560268668|FG004|1st Stage|Adverse Event|2|||
155226033|NCT00654381|560268669|FG005|1st Stage|Adverse Event|1|||
155226034|NCT00654381|560268664|FG000|1st Stage|Withdrawal by Subject|0|||
155226035|NCT00654381|560268665|FG001|1st Stage|Withdrawal by Subject|0|||
155226036|NCT00654381|560268666|FG002|1st Stage|Withdrawal by Subject|0|||
155226037|NCT00654381|560268667|FG003|1st Stage|Withdrawal by Subject|1|||
155226038|NCT00654381|560268668|FG004|1st Stage|Withdrawal by Subject|0|||
155226039|NCT00654381|560268669|FG005|1st Stage|Withdrawal by Subject|1|||
155226040|NCT00654381|560268664|FG000|1st Stage|Investigator's decision|0|||
155226041|NCT00654381|560268665|FG001|1st Stage|Investigator's decision|0|||
155226042|NCT00654381|560268666|FG002|1st Stage|Investigator's decision|0|||
155226043|NCT00654381|560268667|FG003|1st Stage|Investigator's decision|1|||
155226044|NCT00654381|560268668|FG004|1st Stage|Investigator's decision|0|||
155226045|NCT00654381|560268669|FG005|1st Stage|Investigator's decision|0|||
155226046|NCT00654381|560268664|FG000|2nd Stage|Adverse Event|2|||
155226047|NCT00654381|560268665|FG001|2nd Stage|Adverse Event|0|||
155226048|NCT00654381|560268666|FG002|2nd Stage|Adverse Event|2|||
155226049|NCT00654381|560268667|FG003|2nd Stage|Adverse Event|3|||
155226050|NCT00654381|560268668|FG004|2nd Stage|Adverse Event|7|||
155226051|NCT00654381|560268669|FG005|2nd Stage|Adverse Event|2|||
155226052|NCT00654381|560268664|FG000|2nd Stage|Withdrawal by Subject|0|||
155226053|NCT00654381|560268665|FG001|2nd Stage|Withdrawal by Subject|0|||
155226054|NCT00654381|560268666|FG002|2nd Stage|Withdrawal by Subject|0|||
155226055|NCT00654381|560268667|FG003|2nd Stage|Withdrawal by Subject|0|||
155226056|NCT00654381|560268668|FG004|2nd Stage|Withdrawal by Subject|1|||
155226057|NCT00654381|560268669|FG005|2nd Stage|Withdrawal by Subject|1|||
155226058|NCT00654381|560268664|FG000|2nd Stage|Investigator's decision|0|||
155226059|NCT00654381|560268665|FG001|2nd Stage|Investigator's decision|0|||
155226060|NCT00654381|560268666|FG002|2nd Stage|Investigator's decision|1|||
155226061|NCT00654381|560268667|FG003|2nd Stage|Investigator's decision|1|||
155226062|NCT00654381|560268668|FG004|2nd Stage|Investigator's decision|0|||
155226063|NCT00654381|560268669|FG005|2nd Stage|Investigator's decision|0|||
155226064|NCT00654381|560268664|FG000|Extension Stage|Adverse Event|1|||
155226065|NCT00654381|560268665|FG001|Extension Stage|Adverse Event|2|||
155226066|NCT00654381|560268666|FG002|Extension Stage|Adverse Event|9|||
155226067|NCT00654381|560268667|FG003|Extension Stage|Adverse Event|7|||
155226068|NCT00654381|560268668|FG004|Extension Stage|Adverse Event|1|||
155226069|NCT00654381|560268669|FG005|Extension Stage|Adverse Event|1|||
155226070|NCT00654381|560268664|FG000|Extension Stage|Protocol Violation|0|||
155226071|NCT00654381|560268665|FG001|Extension Stage|Protocol Violation|0|||
155226072|NCT00654381|560268666|FG002|Extension Stage|Protocol Violation|0|||
155226073|NCT00654381|560268667|FG003|Extension Stage|Protocol Violation|1|||
155226074|NCT00654381|560268668|FG004|Extension Stage|Protocol Violation|0|||
155226075|NCT00654381|560268669|FG005|Extension Stage|Protocol Violation|0|||
155226076|NCT00654381|560268664|FG000|Extension Stage|Lack of Efficacy|0|||
155226077|NCT00654381|560268665|FG001|Extension Stage|Lack of Efficacy|0|||
155226078|NCT00654381|560268666|FG002|Extension Stage|Lack of Efficacy|1|||
155226079|NCT00654381|560268667|FG003|Extension Stage|Lack of Efficacy|0|||
155226080|NCT00654381|560268668|FG004|Extension Stage|Lack of Efficacy|0|||
155226081|NCT00654381|560268669|FG005|Extension Stage|Lack of Efficacy|0|||
155226082|NCT00654381|560268664|FG000|Extension Stage|Withdrawal by Subject|0|||
155226083|NCT00654381|560268665|FG001|Extension Stage|Withdrawal by Subject|0|||
155226084|NCT00654381|560268666|FG002|Extension Stage|Withdrawal by Subject|1|||
155226085|NCT00654381|560268667|FG003|Extension Stage|Withdrawal by Subject|1|||
155226086|NCT00654381|560268668|FG004|Extension Stage|Withdrawal by Subject|1|||
155226087|NCT00654381|560268669|FG005|Extension Stage|Withdrawal by Subject|1|||
155226088|NCT00654381|560268664|FG000|Extension Stage|Closure of the trial site|0|||
155226089|NCT00654381|560268665|FG001|Extension Stage|Closure of the trial site|0|||
155226090|NCT00654381|560268666|FG002|Extension Stage|Closure of the trial site|0|||
155226091|NCT00654381|560268667|FG003|Extension Stage|Closure of the trial site|0|||
155226092|NCT00654381|560268668|FG004|Extension Stage|Closure of the trial site|1|||
155226093|NCT00654381|560268669|FG005|Extension Stage|Closure of the trial site|1|||
155226094|NCT00048542|560268679|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155226095|NCT00048542|560268680|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
155226096|NCT00048542|560268681|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
155226097|NCT00048542|560268682|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155226098|NCT00048542|560268683|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155226099|NCT00048542|560268684|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
155226100|NCT00048542|560268685|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
155226101|NCT00048542|560268686|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
155226102|NCT00048542|560268679|FG000|Double-Blind Phase|Protocol Violation|0|||
155226103|NCT00048542|560268680|FG001|Double-Blind Phase|Protocol Violation|0|||
155226104|NCT00048542|560268681|FG002|Double-Blind Phase|Protocol Violation|1|||
155226105|NCT00048542|560268682|FG003|Double-Blind Phase|Protocol Violation|0|||
155226106|NCT00048542|560268683|FG004|Double-Blind Phase|Protocol Violation|0|||
155226107|NCT00048542|560268684|FG005|Double-Blind Phase|Protocol Violation|0|||
155226108|NCT00048542|560268685|FG006|Double-Blind Phase|Protocol Violation|0|||
155226109|NCT00048542|560268686|FG007|Double-Blind Phase|Protocol Violation|0|||
155226110|NCT00048542|560268679|FG000|Double-Blind Phase|Sponsor request or decision|2|||
155226111|NCT00048542|560268680|FG001|Double-Blind Phase|Sponsor request or decision|0|||
155226112|NCT00048542|560268681|FG002|Double-Blind Phase|Sponsor request or decision|0|||
155226113|NCT00048542|560268682|FG003|Double-Blind Phase|Sponsor request or decision|0|||
155226114|NCT00048542|560268683|FG004|Double-Blind Phase|Sponsor request or decision|0|||
155226115|NCT00048542|560268684|FG005|Double-Blind Phase|Sponsor request or decision|0|||
155226116|NCT00048542|560268685|FG006|Double-Blind Phase|Sponsor request or decision|0|||
155226117|NCT00048542|560268686|FG007|Double-Blind Phase|Sponsor request or decision|0|||
155226118|NCT00048542|560268679|FG000|Double-Blind Phase|Randomized in error|1|||
155226119|NCT00048542|560268680|FG001|Double-Blind Phase|Randomized in error|0|||
155226120|NCT00048542|560268681|FG002|Double-Blind Phase|Randomized in error|0|||
155226121|NCT00048542|560268682|FG003|Double-Blind Phase|Randomized in error|0|||
155226122|NCT00048542|560268683|FG004|Double-Blind Phase|Randomized in error|0|||
155226123|NCT00048542|560268684|FG005|Double-Blind Phase|Randomized in error|0|||
155226124|NCT00048542|560268685|FG006|Double-Blind Phase|Randomized in error|0|||
155226125|NCT00048542|560268686|FG007|Double-Blind Phase|Randomized in error|0|||
155226126|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226127|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226128|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226129|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226130|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
155226131|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
155226132|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226133|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
155226134|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226135|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226136|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226137|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226138|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226139|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
155226140|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226141|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
155226142|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226143|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226144|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226145|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226146|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
155226147|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
155226148|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226149|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
155226150|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
155226151|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
155226152|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
155226153|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
155226154|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
155226155|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
155226156|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
155226157|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
155226158|NCT00048542|560268679|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226159|NCT00048542|560268680|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226160|NCT00048542|560268681|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226161|NCT00048542|560268682|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226162|NCT00048542|560268683|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
155226163|NCT00048542|560268684|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
155226164|NCT00048542|560268685|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226165|NCT00048542|560268686|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
155226166|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226167|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226168|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226169|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226170|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226171|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
155226172|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
155226173|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
155226174|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226175|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226176|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226177|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226178|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226179|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
155226180|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
155226181|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
155226182|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226183|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226184|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226185|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226186|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226187|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
155226188|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
155226189|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
155226190|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226191|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226192|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226193|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226194|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226195|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
155226196|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
155226197|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
155226198|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226199|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226200|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226201|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226202|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226203|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
155226204|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
155226205|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
155226206|NCT00048542|560268679|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226207|NCT00048542|560268680|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226208|NCT00048542|560268681|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226209|NCT00048542|560268682|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226210|NCT00048542|560268683|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226211|NCT00048542|560268684|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
155226212|NCT00048542|560268685|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
155226213|NCT00048542|560268686|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
155226214|NCT00006489|560268692|FG000|Overall Study|Adverse Event|3|||
155226215|NCT00006489|560268693|FG001|Overall Study|Adverse Event|2|||
155226216|NCT00006489|560268694|FG002|Overall Study|Adverse Event|4|||
155226217|NCT00006489|560268695|FG003|Overall Study|Adverse Event|3|||
155226218|NCT00006489|560268692|FG000|Overall Study|Withdrawal by Subject|10|||
155226219|NCT00006489|560268693|FG001|Overall Study|Withdrawal by Subject|9|||
155226220|NCT00006489|560268694|FG002|Overall Study|Withdrawal by Subject|9|||
155226221|NCT00006489|560268695|FG003|Overall Study|Withdrawal by Subject|6|||
155226222|NCT00006489|560268692|FG000|Overall Study|Scheduling Conflict|0|||
155226223|NCT00006489|560268693|FG001|Overall Study|Scheduling Conflict|3|||
155226224|NCT00006489|560268694|FG002|Overall Study|Scheduling Conflict|2|||
155226225|NCT00006489|560268695|FG003|Overall Study|Scheduling Conflict|1|||
155226226|NCT00006489|560268692|FG000|Overall Study|Death|0|||
155226227|NCT00006489|560268693|FG001|Overall Study|Death|0|||
155226228|NCT00006489|560268694|FG002|Overall Study|Death|0|||
155226229|NCT00006489|560268695|FG003|Overall Study|Death|1|||
155226230|NCT00578175|560268696|FG000|Overall Study|Adverse Event|0|||
155226231|NCT00578175|560268697|FG001|Overall Study|Adverse Event|1|||
155226232|NCT00578175|560268698|FG002|Overall Study|Adverse Event|1|||
155226233|NCT00578175|560268696|FG000|Overall Study|Other reasons|70|||
155226234|NCT00578175|560268697|FG001|Overall Study|Other reasons|42|||
155226235|NCT00578175|560268698|FG002|Overall Study|Other reasons|23|||
155226236|NCT02308735|560268699|FG000|Overall Study|Physician Decision|2|||
155226237|NCT02308735|560268700|FG001|Overall Study|Physician Decision|0|||
155226238|NCT02308735|560268701|FG002|Overall Study|Physician Decision|0|||
155226239|NCT02308735|560268702|FG003|Overall Study|Physician Decision|2|||
155226240|NCT01417481|560268709|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
155226241|NCT01417481|560268710|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155226242|NCT03029624|560268711|FG000|Overall Study|Adverse Event|1|||
155226243|NCT03029624|560268711|FG000|Overall Study|Withdrawal by Subject|1|||
155226244|NCT03029624|560268711|FG000|Overall Study|Lack of Efficacy|1|||
155226245|NCT03029624|560268711|FG000|Overall Study|MRI need|2|||
155226246|NCT02376166|560268712|FG000|Overall Study|Adverse Event|1|||
155226247|NCT02376166|560268712|FG000|Overall Study|Discontinued metformin early|2|||
155226248|NCT04180020|560268713|FG000|Overall Study|missed visit|18|||
155226249|NCT04180020|560268714|FG001|Overall Study|missed visit|16|||
155226250|NCT04180020|560268713|FG000|Overall Study|Death|2|||
155226251|NCT04180020|560268714|FG001|Overall Study|Death|3|||
155226252|NCT04180020|560268713|FG000|Overall Study|Withdrawal by Subject|1|||
155226253|NCT04180020|560268714|FG001|Overall Study|Withdrawal by Subject|5|||
155226254|NCT04180020|560268713|FG000|Overall Study|incarcerated|1|||
155226255|NCT04180020|560268714|FG001|Overall Study|incarcerated|1|||
155226256|NCT04180020|560268713|FG000|Overall Study|Physician Decision|0|||
155226257|NCT04180020|560268714|FG001|Overall Study|Physician Decision|2|||
155226258|NCT01640366|560268716|FG000|Overall Study|Withdrawal by Subject|1|||
155226259|NCT01640366|560268716|FG000|Overall Study|Protocol Violation|16|||
155226260|NCT01640366|560268716|FG000|Overall Study|Lost to Follow-up|5|||
155226261|NCT02739269|560268723|FG000|Overall Study|Protocol Violation|5|||
155226262|NCT02739269|560268724|FG001|Overall Study|Protocol Violation|0|||
155226263|NCT02739269|560268723|FG000|Overall Study|Cycle cancellation|2|||
155226264|NCT02739269|560268724|FG001|Overall Study|Cycle cancellation|2|||
155226265|NCT02739269|560268723|FG000|Overall Study|Withdrawal by Subject|0|||
155226266|NCT02739269|560268724|FG001|Overall Study|Withdrawal by Subject|2|||
155226267|NCT03554291|560268727|FG000|Overall Study|Death|2|||
155226268|NCT03554291|560268728|FG001|Overall Study|Death|1|||
155226269|NCT03554291|560268727|FG000|Overall Study|Lost to Follow-up|1|||
155226270|NCT03554291|560268728|FG001|Overall Study|Lost to Follow-up|0|||
155226271|NCT03554291|560268727|FG000|Overall Study|Withdrawal by Subject|1|||
155226272|NCT03554291|560268728|FG001|Overall Study|Withdrawal by Subject|0|||
155226273|NCT03554291|560268727|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
155226274|NCT03554291|560268728|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
155226275|NCT01228747|560268729|FG000|Overall Study|Adverse Event|8|||
155226276|NCT01228747|560268730|FG001|Overall Study|Adverse Event|4|||
155226277|NCT01228747|560268729|FG000|Overall Study|Lack of Efficacy|40|||
155226278|NCT01228747|560268730|FG001|Overall Study|Lack of Efficacy|27|||
155226279|NCT01228747|560268729|FG000|Overall Study|Protocol Violation|6|||
155226280|NCT01228747|560268730|FG001|Overall Study|Protocol Violation|5|||
155226281|NCT01228747|560268729|FG000|Overall Study|Lost to Follow-up|4|||
155226282|NCT01228747|560268730|FG001|Overall Study|Lost to Follow-up|3|||
155226283|NCT01228747|560268729|FG000|Overall Study|Withdrawal by Subject|5|||
155226284|NCT01228747|560268730|FG001|Overall Study|Withdrawal by Subject|1|||
155226285|NCT01228747|560268729|FG000|Overall Study|Other Reason|2|||
155226286|NCT01228747|560268730|FG001|Overall Study|Other Reason|5|||
155226287|NCT04251221|560268736|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
155226288|NCT04251221|560268737|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
155226289|NCT01165138|560268738|FG000|Overall Study|Adverse Event|0|||
155226290|NCT01165138|560268739|FG001|Overall Study|Adverse Event|1|||
155226291|NCT01165138|560268740|FG002|Overall Study|Adverse Event|0|||
155226292|NCT01165138|560268741|FG003|Overall Study|Adverse Event|2|||
155226293|NCT01165138|560268738|FG000|Overall Study|Lack of Efficacy|0|||
155226294|NCT01165138|560268739|FG001|Overall Study|Lack of Efficacy|32|||
155226295|NCT01165138|560268740|FG002|Overall Study|Lack of Efficacy|6|||
155226296|NCT01165138|560268741|FG003|Overall Study|Lack of Efficacy|7|||
155226297|NCT01165138|560268738|FG000|Overall Study|Protocol Violation|0|||
155226298|NCT01165138|560268739|FG001|Overall Study|Protocol Violation|7|||
155226299|NCT01165138|560268740|FG002|Overall Study|Protocol Violation|0|||
155226300|NCT01165138|560268741|FG003|Overall Study|Protocol Violation|2|||
155226301|NCT01165138|560268738|FG000|Overall Study|Lost to Follow-up|0|||
155226302|NCT01165138|560268739|FG001|Overall Study|Lost to Follow-up|0|||
155226303|NCT01165138|560268740|FG002|Overall Study|Lost to Follow-up|1|||
155226304|NCT01165138|560268741|FG003|Overall Study|Lost to Follow-up|2|||
155226305|NCT01165138|560268738|FG000|Overall Study|Physician Decision|0|||
155226306|NCT01165138|560268739|FG001|Overall Study|Physician Decision|6|||
155226307|NCT01165138|560268740|FG002|Overall Study|Physician Decision|7|||
155226308|NCT01165138|560268741|FG003|Overall Study|Physician Decision|6|||
155226309|NCT01165138|560268738|FG000|Overall Study|Withdrawal by Subject|0|||
155226310|NCT01165138|560268739|FG001|Overall Study|Withdrawal by Subject|6|||
155226311|NCT01165138|560268740|FG002|Overall Study|Withdrawal by Subject|6|||
155226312|NCT01165138|560268741|FG003|Overall Study|Withdrawal by Subject|3|||
155226313|NCT02641379|560268742|FG000|Overall Study|Exclusion criterion during screening|1|||
155226314|NCT02641379|560268743|FG001|Overall Study|Exclusion criterion during screening|0|||
155226315|NCT02641379|560268744|FG002|Overall Study|Exclusion criterion during screening|0|||
155226316|NCT02641379|560268745|FG003|Overall Study|Exclusion criterion during screening|1|||
155226317|NCT02641379|560268746|FG004|Overall Study|Exclusion criterion during screening|2|||
155226318|NCT02641379|560268747|FG005|Overall Study|Exclusion criterion during screening|0|||
155226319|NCT02641379|560268748|FG006|Overall Study|Exclusion criterion during screening|0|||
155226320|NCT02641379|560268749|FG007|Overall Study|Exclusion criterion during screening|0|||
155226321|NCT02641379|560268750|FG008|Overall Study|Exclusion criterion during screening|0|||
155226322|NCT02641379|560268751|FG009|Overall Study|Exclusion criterion during screening|0|||
155226323|NCT02641379|560268752|FG010|Overall Study|Exclusion criterion during screening|0|||
155226324|NCT02641379|560268742|FG000|Overall Study|Withdrawal of informed consent|0|||
155226325|NCT02641379|560268743|FG001|Overall Study|Withdrawal of informed consent|1|||
155226326|NCT02641379|560268744|FG002|Overall Study|Withdrawal of informed consent|0|||
155226327|NCT02641379|560268745|FG003|Overall Study|Withdrawal of informed consent|0|||
155226328|NCT02641379|560268746|FG004|Overall Study|Withdrawal of informed consent|0|||
155226329|NCT02641379|560268747|FG005|Overall Study|Withdrawal of informed consent|0|||
155226330|NCT02641379|560268748|FG006|Overall Study|Withdrawal of informed consent|0|||
155226331|NCT02641379|560268749|FG007|Overall Study|Withdrawal of informed consent|1|||
155226332|NCT02641379|560268750|FG008|Overall Study|Withdrawal of informed consent|0|||
155226333|NCT02641379|560268751|FG009|Overall Study|Withdrawal of informed consent|0|||
155226334|NCT02641379|560268752|FG010|Overall Study|Withdrawal of informed consent|0|||
155226335|NCT02641379|560268742|FG000|Overall Study|Adverse Event|7|||
155226336|NCT02641379|560268743|FG001|Overall Study|Adverse Event|8|||
155226337|NCT02641379|560268744|FG002|Overall Study|Adverse Event|2|||
155226338|NCT02641379|560268745|FG003|Overall Study|Adverse Event|2|||
155226339|NCT02641379|560268746|FG004|Overall Study|Adverse Event|5|||
155226340|NCT02641379|560268747|FG005|Overall Study|Adverse Event|1|||
155226341|NCT02641379|560268748|FG006|Overall Study|Adverse Event|5|||
155226342|NCT02641379|560268749|FG007|Overall Study|Adverse Event|0|||
155226343|NCT02641379|560268750|FG008|Overall Study|Adverse Event|1|||
155226344|NCT02641379|560268751|FG009|Overall Study|Adverse Event|1|||
155226345|NCT02641379|560268752|FG010|Overall Study|Adverse Event|5|||
155226346|NCT02641379|560268742|FG000|Overall Study|Lack of Efficacy|0|||
155226347|NCT02641379|560268743|FG001|Overall Study|Lack of Efficacy|0|||
155226348|NCT02641379|560268744|FG002|Overall Study|Lack of Efficacy|2|||
155226349|NCT02641379|560268745|FG003|Overall Study|Lack of Efficacy|0|||
155226350|NCT02641379|560268746|FG004|Overall Study|Lack of Efficacy|0|||
155226351|NCT02641379|560268747|FG005|Overall Study|Lack of Efficacy|2|||
155226352|NCT02641379|560268748|FG006|Overall Study|Lack of Efficacy|0|||
155226353|NCT02641379|560268749|FG007|Overall Study|Lack of Efficacy|5|||
155226354|NCT02641379|560268750|FG008|Overall Study|Lack of Efficacy|0|||
155226355|NCT02641379|560268751|FG009|Overall Study|Lack of Efficacy|0|||
155226356|NCT02641379|560268752|FG010|Overall Study|Lack of Efficacy|0|||
155226357|NCT02641379|560268742|FG000|Overall Study|Participant unable to attend study visit|4|||
155226358|NCT02641379|560268743|FG001|Overall Study|Participant unable to attend study visit|10|||
155226359|NCT02641379|560268744|FG002|Overall Study|Participant unable to attend study visit|1|||
155226360|NCT02641379|560268745|FG003|Overall Study|Participant unable to attend study visit|2|||
155226361|NCT02641379|560268746|FG004|Overall Study|Participant unable to attend study visit|5|||
155226362|NCT02641379|560268747|FG005|Overall Study|Participant unable to attend study visit|1|||
155226363|NCT02641379|560268748|FG006|Overall Study|Participant unable to attend study visit|1|||
155226364|NCT02641379|560268749|FG007|Overall Study|Participant unable to attend study visit|1|||
155226365|NCT02641379|560268750|FG008|Overall Study|Participant unable to attend study visit|0|||
155226366|NCT02641379|560268751|FG009|Overall Study|Participant unable to attend study visit|2|||
155226367|NCT02641379|560268752|FG010|Overall Study|Participant unable to attend study visit|0|||
155226368|NCT02641379|560268742|FG000|Overall Study|Participant's compliance|0|||
155226369|NCT02641379|560268743|FG001|Overall Study|Participant's compliance|1|||
155226370|NCT02641379|560268744|FG002|Overall Study|Participant's compliance|0|||
155226371|NCT02641379|560268745|FG003|Overall Study|Participant's compliance|1|||
155226372|NCT02641379|560268746|FG004|Overall Study|Participant's compliance|0|||
155226373|NCT02641379|560268747|FG005|Overall Study|Participant's compliance|2|||
155226374|NCT02641379|560268748|FG006|Overall Study|Participant's compliance|0|||
155226375|NCT02641379|560268749|FG007|Overall Study|Participant's compliance|0|||
155226376|NCT02641379|560268750|FG008|Overall Study|Participant's compliance|1|||
155226377|NCT02641379|560268751|FG009|Overall Study|Participant's compliance|1|||
155226378|NCT02641379|560268752|FG010|Overall Study|Participant's compliance|1|||
155226379|NCT02641379|560268742|FG000|Overall Study|Participant cannot be reached|4|||
155226380|NCT02641379|560268743|FG001|Overall Study|Participant cannot be reached|4|||
155226381|NCT02641379|560268744|FG002|Overall Study|Participant cannot be reached|0|||
155226382|NCT02641379|560268745|FG003|Overall Study|Participant cannot be reached|8|||
155226383|NCT02641379|560268746|FG004|Overall Study|Participant cannot be reached|2|||
155226384|NCT02641379|560268747|FG005|Overall Study|Participant cannot be reached|1|||
155226385|NCT02641379|560268748|FG006|Overall Study|Participant cannot be reached|0|||
155226386|NCT02641379|560268749|FG007|Overall Study|Participant cannot be reached|1|||
155226387|NCT02641379|560268750|FG008|Overall Study|Participant cannot be reached|0|||
155226388|NCT02641379|560268751|FG009|Overall Study|Participant cannot be reached|2|||
155226389|NCT02641379|560268752|FG010|Overall Study|Participant cannot be reached|1|||
155226390|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 24|15|||
155226391|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 24|21|||
155226392|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 24|62|||
155226393|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 24|0|||
155226394|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 24|0|||
155226395|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 24|6|||
155226396|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 24|3|||
155226397|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 24|8|||
155226398|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 24|0|||
155226399|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 24|1|||
155226400|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 24|0|||
155226401|NCT02641379|560268742|FG000|Overall Study|PCR positive at follow up 2|1|||
155226402|NCT02641379|560268743|FG001|Overall Study|PCR positive at follow up 2|0|||
155226403|NCT02641379|560268744|FG002|Overall Study|PCR positive at follow up 2|0|||
155226404|NCT02641379|560268745|FG003|Overall Study|PCR positive at follow up 2|0|||
155226405|NCT02641379|560268746|FG004|Overall Study|PCR positive at follow up 2|0|||
155226406|NCT02641379|560268747|FG005|Overall Study|PCR positive at follow up 2|0|||
155226407|NCT02641379|560268748|FG006|Overall Study|PCR positive at follow up 2|0|||
155226408|NCT02641379|560268749|FG007|Overall Study|PCR positive at follow up 2|0|||
155226409|NCT02641379|560268750|FG008|Overall Study|PCR positive at follow up 2|0|||
155226410|NCT02641379|560268751|FG009|Overall Study|PCR positive at follow up 2|0|||
155226411|NCT02641379|560268752|FG010|Overall Study|PCR positive at follow up 2|0|||
155226412|NCT02641379|560268742|FG000|Overall Study|Participant showed relapse|1|||
155226413|NCT02641379|560268743|FG001|Overall Study|Participant showed relapse|0|||
155226414|NCT02641379|560268744|FG002|Overall Study|Participant showed relapse|0|||
155226415|NCT02641379|560268745|FG003|Overall Study|Participant showed relapse|0|||
155226416|NCT02641379|560268746|FG004|Overall Study|Participant showed relapse|0|||
155226417|NCT02641379|560268747|FG005|Overall Study|Participant showed relapse|0|||
155226418|NCT02641379|560268748|FG006|Overall Study|Participant showed relapse|1|||
155226419|NCT02641379|560268749|FG007|Overall Study|Participant showed relapse|0|||
155226420|NCT02641379|560268750|FG008|Overall Study|Participant showed relapse|0|||
155226421|NCT02641379|560268751|FG009|Overall Study|Participant showed relapse|0|||
155226422|NCT02641379|560268752|FG010|Overall Study|Participant showed relapse|0|||
155226423|NCT02641379|560268742|FG000|Overall Study|Participant stopped study/treatment|1|||
155226424|NCT02641379|560268743|FG001|Overall Study|Participant stopped study/treatment|3|||
155226425|NCT02641379|560268744|FG002|Overall Study|Participant stopped study/treatment|1|||
155226426|NCT02641379|560268745|FG003|Overall Study|Participant stopped study/treatment|0|||
155226427|NCT02641379|560268746|FG004|Overall Study|Participant stopped study/treatment|0|||
155226428|NCT02641379|560268747|FG005|Overall Study|Participant stopped study/treatment|1|||
155226429|NCT02641379|560268748|FG006|Overall Study|Participant stopped study/treatment|2|||
155226430|NCT02641379|560268749|FG007|Overall Study|Participant stopped study/treatment|0|||
155226431|NCT02641379|560268750|FG008|Overall Study|Participant stopped study/treatment|1|||
155226432|NCT02641379|560268751|FG009|Overall Study|Participant stopped study/treatment|0|||
155226433|NCT02641379|560268752|FG010|Overall Study|Participant stopped study/treatment|0|||
155226434|NCT02641379|560268742|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
155226435|NCT02641379|560268743|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
155226436|NCT02641379|560268744|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
155226437|NCT02641379|560268745|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
155226438|NCT02641379|560268746|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
155226439|NCT02641379|560268747|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
155226440|NCT02641379|560268748|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
155226441|NCT02641379|560268749|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
155226442|NCT02641379|560268750|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
155226443|NCT02641379|560268751|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
155226444|NCT02641379|560268752|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
155226445|NCT02641379|560268742|FG000|Overall Study|Financial problems|0|||
155226446|NCT02641379|560268743|FG001|Overall Study|Financial problems|1|||
155226447|NCT02641379|560268744|FG002|Overall Study|Financial problems|0|||
155226448|NCT02641379|560268745|FG003|Overall Study|Financial problems|0|||
155226449|NCT02641379|560268746|FG004|Overall Study|Financial problems|0|||
155226450|NCT02641379|560268747|FG005|Overall Study|Financial problems|0|||
155226451|NCT02641379|560268748|FG006|Overall Study|Financial problems|0|||
155226452|NCT02641379|560268749|FG007|Overall Study|Financial problems|0|||
155226453|NCT02641379|560268750|FG008|Overall Study|Financial problems|0|||
155226454|NCT02641379|560268751|FG009|Overall Study|Financial problems|0|||
155226455|NCT02641379|560268752|FG010|Overall Study|Financial problems|0|||
155226456|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 68|0|||
155226457|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 68|1|||
155226458|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 68|0|||
155226459|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 68|0|||
155226460|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 68|0|||
155226461|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 68|0|||
155226462|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 68|0|||
155226463|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 68|0|||
155226464|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 68|0|||
155226465|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 68|0|||
155226466|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 68|0|||
155226467|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 48|0|||
155226468|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 48|1|||
155226469|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 48|0|||
155226470|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 48|0|||
155226471|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 48|0|||
155226472|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 48|0|||
155226473|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 48|0|||
155226474|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 48|0|||
155226475|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 48|0|||
155226476|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 48|0|||
155226477|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 48|0|||
155226478|NCT02641379|560268742|FG000|Overall Study|PCR not performed at Week 12|0|||
155226479|NCT02641379|560268743|FG001|Overall Study|PCR not performed at Week 12|0|||
155226480|NCT02641379|560268744|FG002|Overall Study|PCR not performed at Week 12|1|||
155226481|NCT02641379|560268745|FG003|Overall Study|PCR not performed at Week 12|0|||
155226482|NCT02641379|560268746|FG004|Overall Study|PCR not performed at Week 12|0|||
155226483|NCT02641379|560268747|FG005|Overall Study|PCR not performed at Week 12|0|||
155226484|NCT02641379|560268748|FG006|Overall Study|PCR not performed at Week 12|0|||
155226485|NCT02641379|560268749|FG007|Overall Study|PCR not performed at Week 12|0|||
155226486|NCT02641379|560268750|FG008|Overall Study|PCR not performed at Week 12|0|||
155226487|NCT02641379|560268751|FG009|Overall Study|PCR not performed at Week 12|0|||
155226488|NCT02641379|560268752|FG010|Overall Study|PCR not performed at Week 12|0|||
155226489|NCT02641379|560268742|FG000|Overall Study|No PCR at baseline|0|||
155226490|NCT02641379|560268743|FG001|Overall Study|No PCR at baseline|0|||
155226491|NCT02641379|560268744|FG002|Overall Study|No PCR at baseline|1|||
155226492|NCT02641379|560268745|FG003|Overall Study|No PCR at baseline|0|||
155226493|NCT02641379|560268746|FG004|Overall Study|No PCR at baseline|0|||
155226494|NCT02641379|560268747|FG005|Overall Study|No PCR at baseline|0|||
155226495|NCT02641379|560268748|FG006|Overall Study|No PCR at baseline|0|||
155226496|NCT02641379|560268749|FG007|Overall Study|No PCR at baseline|0|||
155226497|NCT02641379|560268750|FG008|Overall Study|No PCR at baseline|0|||
155226498|NCT02641379|560268751|FG009|Overall Study|No PCR at baseline|0|||
155226499|NCT02641379|560268752|FG010|Overall Study|No PCR at baseline|0|||
155226500|NCT02641379|560268742|FG000|Overall Study|PCR positive at Week 28|0|||
155226501|NCT02641379|560268743|FG001|Overall Study|PCR positive at Week 28|0|||
155226502|NCT02641379|560268744|FG002|Overall Study|PCR positive at Week 28|1|||
155226503|NCT02641379|560268745|FG003|Overall Study|PCR positive at Week 28|0|||
155226504|NCT02641379|560268746|FG004|Overall Study|PCR positive at Week 28|0|||
155226505|NCT02641379|560268747|FG005|Overall Study|PCR positive at Week 28|0|||
155226506|NCT02641379|560268748|FG006|Overall Study|PCR positive at Week 28|0|||
155226507|NCT02641379|560268749|FG007|Overall Study|PCR positive at Week 28|0|||
155226508|NCT02641379|560268750|FG008|Overall Study|PCR positive at Week 28|0|||
155226509|NCT02641379|560268751|FG009|Overall Study|PCR positive at Week 28|0|||
155226510|NCT02641379|560268752|FG010|Overall Study|PCR positive at Week 28|0|||
155226511|NCT02641379|560268742|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
155226512|NCT02641379|560268743|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
155226513|NCT02641379|560268744|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
155226514|NCT02641379|560268745|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
155226515|NCT02641379|560268746|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
155226516|NCT02641379|560268747|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
155226517|NCT02641379|560268748|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
155226518|NCT02641379|560268749|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
155226519|NCT02641379|560268750|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
155226520|NCT02641379|560268751|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
155226521|NCT02641379|560268752|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
155226522|NCT02641379|560268742|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
155226523|NCT02641379|560268743|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
155226524|NCT02641379|560268744|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
155226525|NCT02641379|560268745|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
155226526|NCT02641379|560268746|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
155226527|NCT02641379|560268747|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
155226528|NCT02641379|560268748|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
155226529|NCT02641379|560268749|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
155226530|NCT02641379|560268750|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
155226531|NCT02641379|560268751|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
155226532|NCT02641379|560268752|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
155226533|NCT02641379|560268742|FG000|Overall Study|Baseline viral load unavailable|0|||
155226534|NCT02641379|560268743|FG001|Overall Study|Baseline viral load unavailable|0|||
155226535|NCT02641379|560268744|FG002|Overall Study|Baseline viral load unavailable|0|||
155226536|NCT02641379|560268745|FG003|Overall Study|Baseline viral load unavailable|1|||
155226537|NCT02641379|560268746|FG004|Overall Study|Baseline viral load unavailable|0|||
155226538|NCT02641379|560268747|FG005|Overall Study|Baseline viral load unavailable|0|||
155226539|NCT02641379|560268748|FG006|Overall Study|Baseline viral load unavailable|0|||
155226540|NCT02641379|560268749|FG007|Overall Study|Baseline viral load unavailable|0|||
155226541|NCT02641379|560268750|FG008|Overall Study|Baseline viral load unavailable|0|||
155226542|NCT02641379|560268751|FG009|Overall Study|Baseline viral load unavailable|0|||
155226543|NCT02641379|560268752|FG010|Overall Study|Baseline viral load unavailable|0|||
155226544|NCT02641379|560268742|FG000|Overall Study|Blood could not be drawn|0|||
155226545|NCT02641379|560268743|FG001|Overall Study|Blood could not be drawn|0|||
155226546|NCT02641379|560268744|FG002|Overall Study|Blood could not be drawn|0|||
155226547|NCT02641379|560268745|FG003|Overall Study|Blood could not be drawn|0|||
155226548|NCT02641379|560268746|FG004|Overall Study|Blood could not be drawn|1|||
155226549|NCT02641379|560268747|FG005|Overall Study|Blood could not be drawn|0|||
155226550|NCT02641379|560268748|FG006|Overall Study|Blood could not be drawn|0|||
155226551|NCT02641379|560268749|FG007|Overall Study|Blood could not be drawn|0|||
155226552|NCT02641379|560268750|FG008|Overall Study|Blood could not be drawn|0|||
155226553|NCT02641379|560268751|FG009|Overall Study|Blood could not be drawn|0|||
155226554|NCT02641379|560268752|FG010|Overall Study|Blood could not be drawn|0|||
155226555|NCT02641379|560268742|FG000|Overall Study|Protocol Violation|0|||
155226556|NCT02641379|560268743|FG001|Overall Study|Protocol Violation|0|||
155226557|NCT02641379|560268744|FG002|Overall Study|Protocol Violation|0|||
155226558|NCT02641379|560268745|FG003|Overall Study|Protocol Violation|0|||
155226559|NCT02641379|560268746|FG004|Overall Study|Protocol Violation|2|||
155226560|NCT02641379|560268747|FG005|Overall Study|Protocol Violation|0|||
155226561|NCT02641379|560268748|FG006|Overall Study|Protocol Violation|0|||
155226562|NCT02641379|560268749|FG007|Overall Study|Protocol Violation|0|||
155226563|NCT02641379|560268750|FG008|Overall Study|Protocol Violation|1|||
155226564|NCT02641379|560268751|FG009|Overall Study|Protocol Violation|0|||
155226565|NCT02641379|560268752|FG010|Overall Study|Protocol Violation|0|||
155226566|NCT02641379|560268742|FG000|Overall Study|Participation in sili rescue study|0|||
155226567|NCT02641379|560268743|FG001|Overall Study|Participation in sili rescue study|0|||
155226568|NCT02641379|560268744|FG002|Overall Study|Participation in sili rescue study|0|||
155226569|NCT02641379|560268745|FG003|Overall Study|Participation in sili rescue study|0|||
155226570|NCT02641379|560268746|FG004|Overall Study|Participation in sili rescue study|0|||
155226571|NCT02641379|560268747|FG005|Overall Study|Participation in sili rescue study|1|||
155226572|NCT02641379|560268748|FG006|Overall Study|Participation in sili rescue study|0|||
155226573|NCT02641379|560268749|FG007|Overall Study|Participation in sili rescue study|0|||
155226574|NCT02641379|560268750|FG008|Overall Study|Participation in sili rescue study|0|||
155226575|NCT02641379|560268751|FG009|Overall Study|Participation in sili rescue study|0|||
155226576|NCT02641379|560268752|FG010|Overall Study|Participation in sili rescue study|0|||
155226577|NCT02641379|560268742|FG000|Overall Study|Lost to Follow-up|0|||
155226578|NCT02641379|560268743|FG001|Overall Study|Lost to Follow-up|0|||
155226579|NCT02641379|560268744|FG002|Overall Study|Lost to Follow-up|0|||
155226580|NCT02641379|560268745|FG003|Overall Study|Lost to Follow-up|0|||
155226581|NCT02641379|560268746|FG004|Overall Study|Lost to Follow-up|0|||
155226582|NCT02641379|560268747|FG005|Overall Study|Lost to Follow-up|0|||
155226583|NCT02641379|560268748|FG006|Overall Study|Lost to Follow-up|0|||
155226584|NCT02641379|560268749|FG007|Overall Study|Lost to Follow-up|0|||
155226585|NCT02641379|560268750|FG008|Overall Study|Lost to Follow-up|1|||
155226586|NCT02641379|560268751|FG009|Overall Study|Lost to Follow-up|0|||
155226587|NCT02641379|560268752|FG010|Overall Study|Lost to Follow-up|0|||
155226588|NCT02641379|560268742|FG000|Overall Study|Source data not found|0|||
155226589|NCT02641379|560268743|FG001|Overall Study|Source data not found|0|||
155226590|NCT02641379|560268744|FG002|Overall Study|Source data not found|0|||
155226591|NCT02641379|560268745|FG003|Overall Study|Source data not found|0|||
155226592|NCT02641379|560268746|FG004|Overall Study|Source data not found|0|||
155226593|NCT02641379|560268747|FG005|Overall Study|Source data not found|1|||
155226594|NCT02641379|560268748|FG006|Overall Study|Source data not found|0|||
155226595|NCT02641379|560268749|FG007|Overall Study|Source data not found|0|||
155226596|NCT02641379|560268750|FG008|Overall Study|Source data not found|0|||
155226597|NCT02641379|560268751|FG009|Overall Study|Source data not found|0|||
155226598|NCT02641379|560268752|FG010|Overall Study|Source data not found|0|||
155226599|NCT02641379|560268742|FG000|Overall Study|Participant showed weight reduction|0|||
155226600|NCT02641379|560268743|FG001|Overall Study|Participant showed weight reduction|0|||
155226601|NCT02641379|560268744|FG002|Overall Study|Participant showed weight reduction|0|||
155226602|NCT02641379|560268745|FG003|Overall Study|Participant showed weight reduction|0|||
155226603|NCT02641379|560268746|FG004|Overall Study|Participant showed weight reduction|0|||
155226604|NCT02641379|560268747|FG005|Overall Study|Participant showed weight reduction|0|||
155226605|NCT02641379|560268748|FG006|Overall Study|Participant showed weight reduction|0|||
155226606|NCT02641379|560268749|FG007|Overall Study|Participant showed weight reduction|1|||
155226607|NCT02641379|560268750|FG008|Overall Study|Participant showed weight reduction|0|||
155226608|NCT02641379|560268751|FG009|Overall Study|Participant showed weight reduction|0|||
155226609|NCT02641379|560268752|FG010|Overall Study|Participant showed weight reduction|0|||
155226610|NCT02641379|560268742|FG000|Overall Study|Non-response Week 12|0|||
155226611|NCT02641379|560268743|FG001|Overall Study|Non-response Week 12|0|||
155226612|NCT02641379|560268744|FG002|Overall Study|Non-response Week 12|0|||
155226613|NCT02641379|560268745|FG003|Overall Study|Non-response Week 12|0|||
155226614|NCT02641379|560268746|FG004|Overall Study|Non-response Week 12|0|||
155226615|NCT02641379|560268747|FG005|Overall Study|Non-response Week 12|0|||
155226616|NCT02641379|560268748|FG006|Overall Study|Non-response Week 12|0|||
155226617|NCT02641379|560268749|FG007|Overall Study|Non-response Week 12|1|||
155226618|NCT02641379|560268750|FG008|Overall Study|Non-response Week 12|0|||
155226619|NCT02641379|560268751|FG009|Overall Study|Non-response Week 12|0|||
155226620|NCT02641379|560268752|FG010|Overall Study|Non-response Week 12|0|||
155226621|NCT02641379|560268742|FG000|Overall Study|No 2 Log drop at Week 12|0|||
155226622|NCT02641379|560268743|FG001|Overall Study|No 2 Log drop at Week 12|0|||
155226623|NCT02641379|560268744|FG002|Overall Study|No 2 Log drop at Week 12|0|||
155226624|NCT02641379|560268745|FG003|Overall Study|No 2 Log drop at Week 12|0|||
155226625|NCT02641379|560268746|FG004|Overall Study|No 2 Log drop at Week 12|0|||
155226626|NCT02641379|560268747|FG005|Overall Study|No 2 Log drop at Week 12|0|||
155226627|NCT02641379|560268748|FG006|Overall Study|No 2 Log drop at Week 12|0|||
155226628|NCT02641379|560268749|FG007|Overall Study|No 2 Log drop at Week 12|0|||
155226629|NCT02641379|560268750|FG008|Overall Study|No 2 Log drop at Week 12|0|||
155226630|NCT02641379|560268751|FG009|Overall Study|No 2 Log drop at Week 12|0|||
155226631|NCT02641379|560268752|FG010|Overall Study|No 2 Log drop at Week 12|1|||
155226632|NCT02641379|560268742|FG000|Overall Study|Negative PCR result|0|||
155226633|NCT02641379|560268743|FG001|Overall Study|Negative PCR result|0|||
155226634|NCT02641379|560268744|FG002|Overall Study|Negative PCR result|0|||
155226635|NCT02641379|560268745|FG003|Overall Study|Negative PCR result|0|||
155226636|NCT02641379|560268746|FG004|Overall Study|Negative PCR result|0|||
155226637|NCT02641379|560268747|FG005|Overall Study|Negative PCR result|0|||
155226638|NCT02641379|560268748|FG006|Overall Study|Negative PCR result|0|||
155226639|NCT02641379|560268749|FG007|Overall Study|Negative PCR result|0|||
155226640|NCT02641379|560268750|FG008|Overall Study|Negative PCR result|0|||
155226641|NCT02641379|560268751|FG009|Overall Study|Negative PCR result|1|||
155226642|NCT02641379|560268752|FG010|Overall Study|Negative PCR result|0|||
155226643|NCT02641379|560268742|FG000|Overall Study|Participant's PCR high|0|||
155226644|NCT02641379|560268743|FG001|Overall Study|Participant's PCR high|0|||
155226645|NCT02641379|560268744|FG002|Overall Study|Participant's PCR high|0|||
155226646|NCT02641379|560268745|FG003|Overall Study|Participant's PCR high|0|||
155226647|NCT02641379|560268746|FG004|Overall Study|Participant's PCR high|0|||
155226648|NCT02641379|560268747|FG005|Overall Study|Participant's PCR high|0|||
155226649|NCT02641379|560268748|FG006|Overall Study|Participant's PCR high|0|||
155226650|NCT02641379|560268749|FG007|Overall Study|Participant's PCR high|1|||
155226651|NCT02641379|560268750|FG008|Overall Study|Participant's PCR high|0|||
155226652|NCT02641379|560268751|FG009|Overall Study|Participant's PCR high|0|||
155226653|NCT02641379|560268752|FG010|Overall Study|Participant's PCR high|0|||
155226654|NCT02641379|560268742|FG000|Overall Study|Participant treated after Week 24|0|||
155226655|NCT02641379|560268743|FG001|Overall Study|Participant treated after Week 24|0|||
155226656|NCT02641379|560268744|FG002|Overall Study|Participant treated after Week 24|0|||
155226657|NCT02641379|560268745|FG003|Overall Study|Participant treated after Week 24|0|||
155226658|NCT02641379|560268746|FG004|Overall Study|Participant treated after Week 24|0|||
155226659|NCT02641379|560268747|FG005|Overall Study|Participant treated after Week 24|0|||
155226660|NCT02641379|560268748|FG006|Overall Study|Participant treated after Week 24|0|||
155226661|NCT02641379|560268749|FG007|Overall Study|Participant treated after Week 24|0|||
155226662|NCT02641379|560268750|FG008|Overall Study|Participant treated after Week 24|1|||
155226663|NCT02641379|560268751|FG009|Overall Study|Participant treated after Week 24|0|||
155226664|NCT02641379|560268752|FG010|Overall Study|Participant treated after Week 24|0|||
155226665|NCT02641379|560268742|FG000|Overall Study|Missing PCR result at Week 8|0|||
155226666|NCT02641379|560268743|FG001|Overall Study|Missing PCR result at Week 8|0|||
155226667|NCT02641379|560268744|FG002|Overall Study|Missing PCR result at Week 8|0|||
155226668|NCT02641379|560268745|FG003|Overall Study|Missing PCR result at Week 8|0|||
155226669|NCT02641379|560268746|FG004|Overall Study|Missing PCR result at Week 8|0|||
155226670|NCT02641379|560268747|FG005|Overall Study|Missing PCR result at Week 8|0|||
155226671|NCT02641379|560268748|FG006|Overall Study|Missing PCR result at Week 8|0|||
155226672|NCT02641379|560268749|FG007|Overall Study|Missing PCR result at Week 8|0|||
155226673|NCT02641379|560268750|FG008|Overall Study|Missing PCR result at Week 8|0|||
155226674|NCT02641379|560268751|FG009|Overall Study|Missing PCR result at Week 8|1|||
155226675|NCT02641379|560268752|FG010|Overall Study|Missing PCR result at Week 8|0|||
155226676|NCT02641379|560268742|FG000|Overall Study|PCR positive|0|||
155226677|NCT02641379|560268743|FG001|Overall Study|PCR positive|0|||
155226678|NCT02641379|560268744|FG002|Overall Study|PCR positive|0|||
155226679|NCT02641379|560268745|FG003|Overall Study|PCR positive|0|||
155226680|NCT02641379|560268746|FG004|Overall Study|PCR positive|0|||
155226681|NCT02641379|560268747|FG005|Overall Study|PCR positive|0|||
155226682|NCT02641379|560268748|FG006|Overall Study|PCR positive|1|||
155226683|NCT02641379|560268749|FG007|Overall Study|PCR positive|0|||
155226684|NCT02641379|560268750|FG008|Overall Study|PCR positive|0|||
155226685|NCT02641379|560268751|FG009|Overall Study|PCR positive|0|||
155226686|NCT02641379|560268752|FG010|Overall Study|PCR positive|0|||
155226687|NCT01398956|560268753|FG000|Overall Study|Withdrawal by Subject|4|||
155226688|NCT01398956|560268753|FG000|Overall Study|AE, non-serious non-fatal|4|||
155226689|NCT01398956|560268753|FG000|Overall Study|Withdrawal Criteria No.3|1|||
155226690|NCT01398956|560268753|FG000|Overall Study|Subject moved a long distance|1|||
155226691|NCT00962104|560268756|FG000|Overall Study|Adverse Event|10|||
155226692|NCT00962104|560268757|FG001|Overall Study|Adverse Event|3|||
155226693|NCT00962104|560268756|FG000|Overall Study|Entry Criteria Not Met|1|||
155226694|NCT00962104|560268757|FG001|Overall Study|Entry Criteria Not Met|2|||
155226695|NCT00962104|560268756|FG000|Overall Study|Lack of Efficacy|0|||
155226696|NCT00962104|560268757|FG001|Overall Study|Lack of Efficacy|1|||
155226697|NCT00962104|560268756|FG000|Overall Study|Lost to Follow-up|10|||
155226698|NCT00962104|560268757|FG001|Overall Study|Lost to Follow-up|4|||
155226699|NCT00962104|560268756|FG000|Overall Study|Physician Decision|1|||
155226700|NCT00962104|560268757|FG001|Overall Study|Physician Decision|0|||
155226701|NCT00962104|560268756|FG000|Overall Study|Protocol Violation|6|||
155226702|NCT00962104|560268757|FG001|Overall Study|Protocol Violation|8|||
155226703|NCT00962104|560268756|FG000|Overall Study|Sponsor Decision|0|||
155226704|NCT00962104|560268757|FG001|Overall Study|Sponsor Decision|1|||
155226705|NCT00962104|560268756|FG000|Overall Study|Withdrawal by Subject|10|||
155226706|NCT00962104|560268757|FG001|Overall Study|Withdrawal by Subject|6|||
155226707|NCT00962104|560268756|FG000|Overall Study|Other|2|||
155226708|NCT00962104|560268757|FG001|Overall Study|Other|0|||
155226709|NCT02554656|560270594|FG000|Overall Study|Protocol Violation|3|||
155226710|NCT03240575|560270595|FG000|Overall Study|Adverse Event|0|||
155226711|NCT03240575|560270596|FG001|Overall Study|Adverse Event|2|||
155226712|NCT03240575|560270597|FG002|Overall Study|Adverse Event|0|||
155226713|NCT03240575|560270598|FG003|Overall Study|Adverse Event|1|||
155226714|NCT03240575|560270595|FG000|Overall Study|Withdrawal by Subject|2|||
155226715|NCT03240575|560270596|FG001|Overall Study|Withdrawal by Subject|11|||
155226716|NCT03240575|560270597|FG002|Overall Study|Withdrawal by Subject|0|||
155226717|NCT03240575|560270598|FG003|Overall Study|Withdrawal by Subject|1|||
155226718|NCT03240575|560270595|FG000|Overall Study|Other|0|||
155226719|NCT03240575|560270596|FG001|Overall Study|Other|1|||
155226720|NCT03240575|560270597|FG002|Overall Study|Other|0|||
155226721|NCT03240575|560270598|FG003|Overall Study|Other|0|||
155226722|NCT01140477|560270601|FG000|Overall Study|Lost to Follow-up|4|||
155226723|NCT01140477|560270602|FG001|Overall Study|Lost to Follow-up|0|||
155226724|NCT01140477|560270601|FG000|Overall Study|Withdrawal by Subject|1|||
155226725|NCT01140477|560270602|FG001|Overall Study|Withdrawal by Subject|4|||
155226726|NCT01140477|560270601|FG000|Overall Study|Surgical complication preventing implant|2|||
155226727|NCT01140477|560270602|FG001|Overall Study|Surgical complication preventing implant|0|||
155226728|NCT01140477|560270601|FG000|Overall Study|Death|1|||
155226729|NCT01140477|560270602|FG001|Overall Study|Death|1|||
155226730|NCT01140477|560270601|FG000|Overall Study|Subject explanted|0|||
155226731|NCT01140477|560270602|FG001|Overall Study|Subject explanted|1|||
155226732|NCT04482179|560270603|FG000|Overall Study|Death|1|||
155226733|NCT04482179|560270604|FG001|Overall Study|Death|0|||
155226734|NCT04482179|560270603|FG000|Overall Study|Withdrawal by Subject|1|||
155226735|NCT04482179|560270604|FG001|Overall Study|Withdrawal by Subject|0|||
155226736|NCT01481116|560270607|FG000|Overall Study|Adverse Event|26|||
155226737|NCT01481116|560270608|FG001|Overall Study|Adverse Event|26|||
155226738|NCT01481116|560270609|FG002|Overall Study|Adverse Event|42|||
155226739|NCT01481116|560270607|FG000|Overall Study|Major Protocol Deviation|3|||
155226740|NCT01481116|560270608|FG001|Overall Study|Major Protocol Deviation|7|||
155226741|NCT01481116|560270609|FG002|Overall Study|Major Protocol Deviation|1|||
155226742|NCT01481116|560270607|FG000|Overall Study|Lost to Follow-up|8|||
155226743|NCT01481116|560270608|FG001|Overall Study|Lost to Follow-up|12|||
155226744|NCT01481116|560270609|FG002|Overall Study|Lost to Follow-up|11|||
155226745|NCT01481116|560270607|FG000|Overall Study|Withdrawal by Subject|37|||
155226746|NCT01481116|560270608|FG001|Overall Study|Withdrawal by Subject|33|||
155226747|NCT01481116|560270609|FG002|Overall Study|Withdrawal by Subject|37|||
155226748|NCT01481116|560270607|FG000|Overall Study|Study Termination|730|||
155226749|NCT01481116|560270608|FG001|Overall Study|Study Termination|729|||
155226750|NCT01481116|560270609|FG002|Overall Study|Study Termination|713|||
155226751|NCT01481116|560270607|FG000|Overall Study|Pregnancy|0|||
155226752|NCT01481116|560270608|FG001|Overall Study|Pregnancy|0|||
155226753|NCT01481116|560270609|FG002|Overall Study|Pregnancy|1|||
155226754|NCT01481116|560270607|FG000|Overall Study|Lack of Efficacy|3|||
155226755|NCT01481116|560270608|FG001|Overall Study|Lack of Efficacy|3|||
155226756|NCT01481116|560270609|FG002|Overall Study|Lack of Efficacy|1|||
155226757|NCT01481116|560270607|FG000|Overall Study|Contraindications|1|||
155226758|NCT01481116|560270608|FG001|Overall Study|Contraindications|1|||
155226759|NCT01481116|560270609|FG002|Overall Study|Contraindications|0|||
155226760|NCT01481116|560270607|FG000|Overall Study|Other|1|||
155226761|NCT01481116|560270608|FG001|Overall Study|Other|1|||
155226762|NCT01481116|560270609|FG002|Overall Study|Other|0|||
155226763|NCT01481116|560270607|FG000|Overall Study|Participant Started Taking Glipizide|1|||
155226764|NCT01481116|560270608|FG001|Overall Study|Participant Started Taking Glipizide|0|||
155226765|NCT01481116|560270609|FG002|Overall Study|Participant Started Taking Glipizide|0|||
155226766|NCT01481116|560270607|FG000|Overall Study|Participant Moved Out of Area|2|||
155226767|NCT01481116|560270608|FG001|Overall Study|Participant Moved Out of Area|0|||
155226768|NCT01481116|560270609|FG002|Overall Study|Participant Moved Out of Area|1|||
155226769|NCT01481116|560270607|FG000|Overall Study|Participant Moved Out of Country|1|||
155226770|NCT01481116|560270608|FG001|Overall Study|Participant Moved Out of Country|0|||
155226771|NCT01481116|560270609|FG002|Overall Study|Participant Moved Out of Country|1|||
155226772|NCT01481116|560270607|FG000|Overall Study|Investigator Decision|3|||
155226773|NCT01481116|560270608|FG001|Overall Study|Investigator Decision|2|||
155226774|NCT01481116|560270609|FG002|Overall Study|Investigator Decision|1|||
155226775|NCT01481116|560270607|FG000|Overall Study|Sponsor Decision|0|||
155226776|NCT01481116|560270608|FG001|Overall Study|Sponsor Decision|1|||
155226777|NCT01481116|560270609|FG002|Overall Study|Sponsor Decision|3|||
155226778|NCT01481116|560270607|FG000|Overall Study|Non-Compliant With Study Drug|0|||
155226779|NCT01481116|560270608|FG001|Overall Study|Non-Compliant With Study Drug|1|||
155226780|NCT01481116|560270609|FG002|Overall Study|Non-Compliant With Study Drug|1|||
155226781|NCT01481116|560270607|FG000|Overall Study|Investigator's Discretion|2|||
155226782|NCT01481116|560270608|FG001|Overall Study|Investigator's Discretion|0|||
155226783|NCT01481116|560270609|FG002|Overall Study|Investigator's Discretion|0|||
155226784|NCT01481116|560270607|FG000|Overall Study|Death|2|||
155226785|NCT01481116|560270608|FG001|Overall Study|Death|1|||
155226786|NCT01481116|560270609|FG002|Overall Study|Death|0|||
155226787|NCT01481116|560270607|FG000|Overall Study|Hypoglycemic Event|4|||
155226788|NCT01481116|560270608|FG001|Overall Study|Hypoglycemic Event|0|||
155226789|NCT01481116|560270609|FG002|Overall Study|Hypoglycemic Event|0|||
155226790|NCT01232296|560270610|FG000|Overall Study|Adverse Event|24|||
155226791|NCT01232296|560270611|FG001|Overall Study|Adverse Event|12|||
155226792|NCT01232296|560270610|FG000|Overall Study|Physician Decision|1|||
155226793|NCT01232296|560270611|FG001|Overall Study|Physician Decision|1|||
155226794|NCT01232296|560270610|FG000|Overall Study|Progressive disease|43|||
155226795|NCT01232296|560270611|FG001|Overall Study|Progressive disease|61|||
155226796|NCT01232296|560270610|FG000|Overall Study|Study terminated by sponsor|0|||
155226797|NCT01232296|560270611|FG001|Overall Study|Study terminated by sponsor|1|||
155226798|NCT01232296|560270610|FG000|Overall Study|Technical problems|3|||
155226799|NCT01232296|560270611|FG001|Overall Study|Technical problems|0|||
155226800|NCT01232296|560270610|FG000|Overall Study|Subject/guardian decision|10|||
155226801|NCT01232296|560270611|FG001|Overall Study|Subject/guardian decision|2|||
155226802|NCT01232296|560270610|FG000|Overall Study|Death|1|||
155226803|NCT01232296|560270611|FG001|Overall Study|Death|6|||
155226804|NCT00559962|560270613|FG000|Overall Study|Adverse Event|1|||
155226805|NCT00559962|560270614|FG001|Overall Study|Adverse Event|7|||
155226806|NCT00559962|560270615|FG002|Overall Study|Adverse Event|8|||
155226807|NCT00559962|560270616|FG003|Overall Study|Adverse Event|5|||
155226808|NCT00559962|560270617|FG004|Overall Study|Adverse Event|11|||
155226809|NCT00559962|560270618|FG005|Overall Study|Adverse Event|4|||
155226810|NCT00559962|560270619|FG006|Overall Study|Adverse Event|4|||
155226811|NCT00559962|560270620|FG007|Overall Study|Adverse Event|2|||
155226812|NCT00559962|560270613|FG000|Overall Study|Lost to Follow-up|0|||
155226813|NCT00559962|560270614|FG001|Overall Study|Lost to Follow-up|1|||
155226814|NCT00559962|560270615|FG002|Overall Study|Lost to Follow-up|0|||
155226815|NCT00559962|560270616|FG003|Overall Study|Lost to Follow-up|0|||
155226816|NCT00559962|560270617|FG004|Overall Study|Lost to Follow-up|0|||
155226817|NCT00559962|560270618|FG005|Overall Study|Lost to Follow-up|0|||
155226818|NCT00559962|560270619|FG006|Overall Study|Lost to Follow-up|0|||
155226819|NCT00559962|560270620|FG007|Overall Study|Lost to Follow-up|0|||
155226820|NCT00559962|560270613|FG000|Overall Study|Withdrawal by Subject|1|||
155226821|NCT00559962|560270614|FG001|Overall Study|Withdrawal by Subject|1|||
155226822|NCT00559962|560270615|FG002|Overall Study|Withdrawal by Subject|2|||
155226823|NCT00559962|560270616|FG003|Overall Study|Withdrawal by Subject|0|||
155226824|NCT00559962|560270617|FG004|Overall Study|Withdrawal by Subject|3|||
155226825|NCT00559962|560270618|FG005|Overall Study|Withdrawal by Subject|1|||
155226826|NCT00559962|560270619|FG006|Overall Study|Withdrawal by Subject|0|||
155226827|NCT00559962|560270620|FG007|Overall Study|Withdrawal by Subject|2|||
155226828|NCT00559962|560270613|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
155226829|NCT00559962|560270614|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
155226830|NCT00559962|560270615|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
155226831|NCT00559962|560270616|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
155226832|NCT00559962|560270617|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
155226833|NCT00559962|560270618|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
155226834|NCT00559962|560270619|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
155226835|NCT00559962|560270620|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
155226836|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
155226837|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
155226838|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
155226839|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
155226840|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
155226841|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
155226842|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
155226843|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
155226844|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
155226845|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
155226846|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
155226847|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
155226848|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
155226849|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
155226850|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
155226851|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
155226852|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
155226853|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
155226854|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Death|0|||
155226855|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Death|0|||
155226856|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Death|1|||
155226857|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Death|0|||
155226858|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Death|0|||
155226859|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Death|0|||
155226860|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Death|0|||
155226861|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Death|0|||
155226862|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Death|0|||
155226863|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
155226864|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
155226865|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
155226866|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226867|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226868|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226869|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226870|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226871|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
155226872|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
155226873|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
155226874|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
155226875|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226876|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226877|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226878|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226879|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226880|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
155226881|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
155226882|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
155226883|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
155226884|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
155226885|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
155226886|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
155226887|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
155226888|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
155226889|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
155226890|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
155226891|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
155226892|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
155226893|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
155226894|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
155226895|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
155226896|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
155226897|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
155226898|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
155226899|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
155226900|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
155226901|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
155226902|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226903|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226904|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226905|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226906|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226907|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
155226908|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226909|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
155226910|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226911|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226912|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226913|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226914|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226915|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226916|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
155226917|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
155226918|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
155226919|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
155226920|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
155226921|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
155226922|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
155226923|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
155226924|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
155226925|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
155226926|NCT00404352|560270621|FG000|Double Blind (up to 24 Month)|Other|0|||
155226927|NCT00404352|560270622|FG001|Double Blind (up to 24 Month)|Other|1|||
155226928|NCT00404352|560270623|FG002|Double Blind (up to 24 Month)|Other|0|||
155226929|NCT00404352|560270624|FG003|Double Blind (up to 24 Month)|Other|0|||
155226930|NCT00404352|560270625|FG004|Double Blind (up to 24 Month)|Other|0|||
155226931|NCT00404352|560270626|FG005|Double Blind (up to 24 Month)|Other|0|||
155226932|NCT00404352|560270627|FG006|Double Blind (up to 24 Month)|Other|0|||
155226933|NCT00404352|560270628|FG007|Double Blind (up to 24 Month)|Other|0|||
155226934|NCT00404352|560270629|FG008|Double Blind (up to 24 Month)|Other|0|||
155226935|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
155226936|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
155226937|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
155226938|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
155226939|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
155226940|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
155226941|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
155226942|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
155226943|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
155226944|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
155226945|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
155226946|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
155226947|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
155226948|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
155226949|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
155226950|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
155226951|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
155226952|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
155226953|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226954|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226955|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226956|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226957|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
155226958|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226959|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226960|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226961|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
155226962|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226963|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226964|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226965|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226966|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226967|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
155226968|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226969|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226970|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
155226971|NCT00404352|560270621|FG000|Open Label (up to 24 Month)|Disease progression|0|||
155226972|NCT00404352|560270622|FG001|Open Label (up to 24 Month)|Disease progression|0|||
155226973|NCT00404352|560270623|FG002|Open Label (up to 24 Month)|Disease progression|0|||
155226974|NCT00404352|560270624|FG003|Open Label (up to 24 Month)|Disease progression|1|||
155226975|NCT00404352|560270625|FG004|Open Label (up to 24 Month)|Disease progression|0|||
155226976|NCT00404352|560270626|FG005|Open Label (up to 24 Month)|Disease progression|0|||
155226977|NCT00404352|560270627|FG006|Open Label (up to 24 Month)|Disease progression|0|||
155226978|NCT00404352|560270628|FG007|Open Label (up to 24 Month)|Disease progression|0|||
155226979|NCT00404352|560270629|FG008|Open Label (up to 24 Month)|Disease progression|0|||
155226980|NCT00404352|560270621|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226981|NCT00404352|560270622|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226982|NCT00404352|560270623|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226983|NCT00404352|560270624|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226984|NCT00404352|560270625|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226985|NCT00404352|560270626|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226986|NCT00404352|560270627|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
155226987|NCT00404352|560270628|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
155226988|NCT00404352|560270629|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
155226989|NCT00404352|560270621|FG000|Open Label Extension (up to 36 Months)|Other|0|||
155226990|NCT00404352|560270622|FG001|Open Label Extension (up to 36 Months)|Other|0|||
155226991|NCT00404352|560270623|FG002|Open Label Extension (up to 36 Months)|Other|0|||
155226992|NCT00404352|560270624|FG003|Open Label Extension (up to 36 Months)|Other|0|||
155226993|NCT00404352|560270625|FG004|Open Label Extension (up to 36 Months)|Other|0|||
155226994|NCT00404352|560270626|FG005|Open Label Extension (up to 36 Months)|Other|0|||
155226995|NCT00404352|560270627|FG006|Open Label Extension (up to 36 Months)|Other|0|||
155226996|NCT00404352|560270628|FG007|Open Label Extension (up to 36 Months)|Other|0|||
155226997|NCT00404352|560270629|FG008|Open Label Extension (up to 36 Months)|Other|2|||
155226998|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
155226999|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227000|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227001|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227002|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227003|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227004|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155227005|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
155227006|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227007|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227008|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227009|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227010|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227011|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155227012|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
155227013|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227014|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227015|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227016|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227017|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227018|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155227019|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
155227020|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227021|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227022|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227023|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227024|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227025|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155227026|NCT01479621|560270632|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
155227027|NCT01479621|560270633|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227028|NCT01479621|560270634|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227029|NCT01479621|560270635|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227030|NCT01479621|560270636|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227031|NCT01479621|560270637|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227032|NCT01479621|560270638|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155227033|NCT01479621|560270632|FG000|Treatment Period|Adverse Event|0|||
155227034|NCT01479621|560270633|FG001|Treatment Period|Adverse Event|0|||
155227035|NCT01479621|560270634|FG002|Treatment Period|Adverse Event|0|||
155227036|NCT01479621|560270635|FG003|Treatment Period|Adverse Event|0|||
155227037|NCT01479621|560270636|FG004|Treatment Period|Adverse Event|1|||
155227038|NCT01479621|560270637|FG005|Treatment Period|Adverse Event|2|||
155227039|NCT01479621|560270638|FG006|Treatment Period|Adverse Event|2|||
155227040|NCT01479621|560270632|FG000|Treatment Period|Withdrawal by Subject|0|||
155227041|NCT01479621|560270633|FG001|Treatment Period|Withdrawal by Subject|4|||
155227042|NCT01479621|560270634|FG002|Treatment Period|Withdrawal by Subject|2|||
155227043|NCT01479621|560270635|FG003|Treatment Period|Withdrawal by Subject|2|||
155227044|NCT01479621|560270636|FG004|Treatment Period|Withdrawal by Subject|5|||
155227045|NCT01479621|560270637|FG005|Treatment Period|Withdrawal by Subject|5|||
155227046|NCT01479621|560270638|FG006|Treatment Period|Withdrawal by Subject|1|||
155227047|NCT01479621|560270632|FG000|Treatment Period|Physician Decision|0|||
155227048|NCT01479621|560270633|FG001|Treatment Period|Physician Decision|0|||
155227049|NCT01479621|560270634|FG002|Treatment Period|Physician Decision|0|||
155227050|NCT01479621|560270635|FG003|Treatment Period|Physician Decision|0|||
155227051|NCT01479621|560270636|FG004|Treatment Period|Physician Decision|1|||
155227052|NCT01479621|560270637|FG005|Treatment Period|Physician Decision|1|||
155227053|NCT01479621|560270638|FG006|Treatment Period|Physician Decision|0|||
155227054|NCT01479621|560270632|FG000|Treatment Period|Non-compliance to study drug|0|||
155227055|NCT01479621|560270633|FG001|Treatment Period|Non-compliance to study drug|1|||
155227056|NCT01479621|560270634|FG002|Treatment Period|Non-compliance to study drug|0|||
155227057|NCT01479621|560270635|FG003|Treatment Period|Non-compliance to study drug|0|||
155227058|NCT01479621|560270636|FG004|Treatment Period|Non-compliance to study drug|0|||
155227059|NCT01479621|560270637|FG005|Treatment Period|Non-compliance to study drug|0|||
155227060|NCT01479621|560270638|FG006|Treatment Period|Non-compliance to study drug|1|||
155227061|NCT01479621|560270632|FG000|Treatment Period|Protocol Violation|0|||
155227062|NCT01479621|560270633|FG001|Treatment Period|Protocol Violation|9|||
155227063|NCT01479621|560270634|FG002|Treatment Period|Protocol Violation|6|||
155227064|NCT01479621|560270635|FG003|Treatment Period|Protocol Violation|5|||
155227065|NCT01479621|560270636|FG004|Treatment Period|Protocol Violation|2|||
155227066|NCT01479621|560270637|FG005|Treatment Period|Protocol Violation|10|||
155227067|NCT01479621|560270638|FG006|Treatment Period|Protocol Violation|6|||
155227068|NCT01479621|560270632|FG000|Treatment Period|Pregnancy|0|||
155227069|NCT01479621|560270633|FG001|Treatment Period|Pregnancy|0|||
155227070|NCT01479621|560270634|FG002|Treatment Period|Pregnancy|2|||
155227071|NCT01479621|560270635|FG003|Treatment Period|Pregnancy|0|||
155227072|NCT01479621|560270636|FG004|Treatment Period|Pregnancy|0|||
155227073|NCT01479621|560270637|FG005|Treatment Period|Pregnancy|0|||
155227074|NCT01479621|560270638|FG006|Treatment Period|Pregnancy|0|||
155227075|NCT01479621|560270632|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
155227076|NCT01479621|560270633|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
155227077|NCT01479621|560270634|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
155227078|NCT01479621|560270635|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
155227079|NCT01479621|560270636|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
155227080|NCT01479621|560270637|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
155227081|NCT01479621|560270638|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
155227082|NCT01479621|560270632|FG000|Treatment Period|Lost to Follow-up|0|||
155227083|NCT01479621|560270633|FG001|Treatment Period|Lost to Follow-up|0|||
155227084|NCT01479621|560270634|FG002|Treatment Period|Lost to Follow-up|1|||
155227085|NCT01479621|560270635|FG003|Treatment Period|Lost to Follow-up|0|||
155227086|NCT01479621|560270636|FG004|Treatment Period|Lost to Follow-up|2|||
155227087|NCT01479621|560270637|FG005|Treatment Period|Lost to Follow-up|2|||
155227088|NCT01479621|560270638|FG006|Treatment Period|Lost to Follow-up|1|||
155227089|NCT01479621|560270632|FG000|Treatment Period|Met stopping criteria|0|||
155227090|NCT01479621|560270633|FG001|Treatment Period|Met stopping criteria|8|||
155227091|NCT01479621|560270634|FG002|Treatment Period|Met stopping criteria|7|||
155227092|NCT01479621|560270635|FG003|Treatment Period|Met stopping criteria|4|||
155227093|NCT01479621|560270636|FG004|Treatment Period|Met stopping criteria|9|||
155227094|NCT01479621|560270637|FG005|Treatment Period|Met stopping criteria|20|||
155227095|NCT01479621|560270638|FG006|Treatment Period|Met stopping criteria|6|||
155227096|NCT03216850|560270640|FG000|Overall Study|Pre-analytical error|6|||
155227097|NCT00405548|560270641|FG000|Overall Study|Cognitive Memory problems on study day|1|||
155227098|NCT00405548|560270642|FG001|Overall Study|Cognitive Memory problems on study day|0|||
155227099|NCT00405548|560270641|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
155227100|NCT00405548|560270642|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
155227101|NCT00405548|560270641|FG000|Overall Study|Unable to self-administer shots|1|||
155227102|NCT00405548|560270642|FG001|Overall Study|Unable to self-administer shots|0|||
155227103|NCT00405548|560270641|FG000|Overall Study|Venous access failed during study day|1|||
155227104|NCT00405548|560270642|FG001|Overall Study|Venous access failed during study day|0|||
155227105|NCT00405548|560270641|FG000|Overall Study|Withdrawal by Subject|1|||
155227106|NCT00405548|560270642|FG001|Overall Study|Withdrawal by Subject|0|||
155227107|NCT01116232|560270643|FG000|Overall Study|Progressive diease|4|||
155227108|NCT00811577|560270644|FG000|Overall Study|Lost to Follow-up|7|||
155227109|NCT00811577|560270645|FG001|Overall Study|Lost to Follow-up|1|||
155227110|NCT00811577|560270644|FG000|Overall Study|Withdrawal by Subject|3|||
155227111|NCT00811577|560270645|FG001|Overall Study|Withdrawal by Subject|0|||
155227112|NCT01068509|560270646|FG000|Overall Study|Death|0|||
155227113|NCT01068509|560270647|FG001|Overall Study|Death|0|||
155227114|NCT01068509|560270648|FG002|Overall Study|Death|1|||
155227115|NCT01068509|560270646|FG000|Overall Study|Disease Progression|5|||
155227116|NCT01068509|560270647|FG001|Overall Study|Disease Progression|20|||
155227117|NCT01068509|560270648|FG002|Overall Study|Disease Progression|18|||
155227118|NCT01068509|560270646|FG000|Overall Study|Lost to Follow-up|1|||
155227119|NCT01068509|560270647|FG001|Overall Study|Lost to Follow-up|0|||
155227120|NCT01068509|560270648|FG002|Overall Study|Lost to Follow-up|0|||
155227121|NCT01068509|560270646|FG000|Overall Study|Withdrew Consent|0|||
155227122|NCT01068509|560270647|FG001|Overall Study|Withdrew Consent|1|||
155227123|NCT01068509|560270648|FG002|Overall Study|Withdrew Consent|2|||
155227124|NCT01068509|560270646|FG000|Overall Study|Reason Not Specified|0|||
155227125|NCT01068509|560270647|FG001|Overall Study|Reason Not Specified|1|||
155227126|NCT01068509|560270648|FG002|Overall Study|Reason Not Specified|0|||
155227127|NCT00329407|560270653|FG000|Overall Study|Withdrawal by Subject|1|||
155227128|NCT02357940|560270654|FG000|Overall Study|Adverse Event|0|||
155227129|NCT02357940|560270655|FG001|Overall Study|Adverse Event|1|||
155227130|NCT02357940|560270654|FG000|Overall Study|Investigator's judgement|0|||
155227131|NCT02357940|560270655|FG001|Overall Study|Investigator's judgement|1|||
155227132|NCT02442778|560270656|FG000|Overall Study|Adverse Event|2|||
155227133|NCT02442778|560270657|FG001|Overall Study|Adverse Event|6|||
155227134|NCT02442778|560270658|FG002|Overall Study|Adverse Event|6|||
155227135|NCT02442778|560270656|FG000|Overall Study|Death|0|||
155227136|NCT02442778|560270657|FG001|Overall Study|Death|2|||
155227137|NCT02442778|560270658|FG002|Overall Study|Death|0|||
155227138|NCT02442778|560270656|FG000|Overall Study|Lack of Efficacy|1|||
155227139|NCT02442778|560270657|FG001|Overall Study|Lack of Efficacy|0|||
155227140|NCT02442778|560270658|FG002|Overall Study|Lack of Efficacy|0|||
155227141|NCT02442778|560270656|FG000|Overall Study|Lost to Follow-up|1|||
155227142|NCT02442778|560270657|FG001|Overall Study|Lost to Follow-up|1|||
155227143|NCT02442778|560270658|FG002|Overall Study|Lost to Follow-up|1|||
155227144|NCT02442778|560270656|FG000|Overall Study|Non-compliance with study drug|2|||
155227145|NCT02442778|560270657|FG001|Overall Study|Non-compliance with study drug|0|||
155227146|NCT02442778|560270658|FG002|Overall Study|Non-compliance with study drug|1|||
155227147|NCT02442778|560270656|FG000|Overall Study|Physician Decision|1|||
155227148|NCT02442778|560270657|FG001|Overall Study|Physician Decision|1|||
155227149|NCT02442778|560270658|FG002|Overall Study|Physician Decision|1|||
155227150|NCT02442778|560270656|FG000|Overall Study|Protocol Deviation|3|||
155227151|NCT02442778|560270657|FG001|Overall Study|Protocol Deviation|0|||
155227152|NCT02442778|560270658|FG002|Overall Study|Protocol Deviation|1|||
155227153|NCT02442778|560270656|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
155227154|NCT02442778|560270657|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
155227155|NCT02442778|560270658|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
155227156|NCT02442778|560270656|FG000|Overall Study|Withdrawal by Subject|4|||
155227157|NCT02442778|560270657|FG001|Overall Study|Withdrawal by Subject|4|||
155227158|NCT02442778|560270658|FG002|Overall Study|Withdrawal by Subject|3|||
155227159|NCT02442778|560270656|FG000|Overall Study|Reason not specified|1|||
155227160|NCT02442778|560270657|FG001|Overall Study|Reason not specified|4|||
155227161|NCT02442778|560270658|FG002|Overall Study|Reason not specified|0|||
155227162|NCT01644175|560270663|FG000|Overall Study|Randomized But Not Treated|0|||
155227163|NCT01644175|560270664|FG001|Overall Study|Randomized But Not Treated|2|||
155227164|NCT01644175|560270663|FG000|Overall Study|Adverse Event|8|||
155227165|NCT01644175|560270664|FG001|Overall Study|Adverse Event|13|||
155227166|NCT01644175|560270663|FG000|Overall Study|Death|1|||
155227167|NCT01644175|560270664|FG001|Overall Study|Death|2|||
155227168|NCT01644175|560270663|FG000|Overall Study|Poor compliance to protocol|9|||
155227169|NCT01644175|560270664|FG001|Overall Study|Poor compliance to protocol|10|||
155227170|NCT01644175|560270663|FG000|Overall Study|Physician Decision|1|||
155227171|NCT01644175|560270664|FG001|Overall Study|Physician Decision|2|||
155227172|NCT01644175|560270663|FG000|Overall Study|Participant Moved|1|||
155227173|NCT01644175|560270664|FG001|Overall Study|Participant Moved|2|||
155227174|NCT01644175|560270663|FG000|Overall Study|Consent withdrawn by participant|3|||
155227175|NCT01644175|560270664|FG001|Overall Study|Consent withdrawn by participant|4|||
155227176|NCT01644175|560270663|FG000|Overall Study|Related to Autoinjector Administration|2|||
155227177|NCT01644175|560270664|FG001|Overall Study|Related to Autoinjector Administration|1|||
155227178|NCT01644175|560270663|FG000|Overall Study|Last visit outside protocol visit window|4|||
155227179|NCT01644175|560270664|FG001|Overall Study|Last visit outside protocol visit window|11|||
155227180|NCT01644175|560270663|FG000|Overall Study|Selection criteria finally not met|0|||
155227181|NCT01644175|560270664|FG001|Overall Study|Selection criteria finally not met|1|||
155227182|NCT01644175|560270663|FG000|Overall Study|Site closure|2|||
155227183|NCT01644175|560270664|FG001|Overall Study|Site closure|2|||
155227184|NCT01644175|560270663|FG000|Overall Study|Lost to Follow-up|1|||
155227185|NCT01644175|560270664|FG001|Overall Study|Lost to Follow-up|0|||
155227186|NCT01644175|560270663|FG000|Overall Study|Other than specified above|0|||
155227187|NCT01644175|560270664|FG001|Overall Study|Other than specified above|3|||
155227188|NCT00451035|560270671|FG000|Overall Study|Disease progression|11|||
155227189|NCT00451035|560270671|FG000|Overall Study|Death|3|||
155227190|NCT00451035|560270671|FG000|Overall Study|New anti-neoplastic therapy|3|||
155227191|NCT01712256|560270677|FG000|Overall Study|Lost to Follow-up|1|||
155227192|NCT00603746|560270682|FG000|Overall Study|Adverse Event|2|||
155227193|NCT00603746|560270683|FG001|Overall Study|Adverse Event|3|||
155227194|NCT00603746|560270684|FG002|Overall Study|Adverse Event|0|||
155227195|NCT00603746|560270685|FG003|Overall Study|Adverse Event|1|||
155227196|NCT00603746|560270686|FG004|Overall Study|Adverse Event|0|||
155227197|NCT00603746|560270687|FG005|Overall Study|Adverse Event|4|||
155227198|NCT00603746|560270682|FG000|Overall Study|Lack of Efficacy|34|||
155227199|NCT00603746|560270683|FG001|Overall Study|Lack of Efficacy|11|||
155227200|NCT00603746|560270684|FG002|Overall Study|Lack of Efficacy|6|||
155227201|NCT00603746|560270685|FG003|Overall Study|Lack of Efficacy|11|||
155227202|NCT00603746|560270686|FG004|Overall Study|Lack of Efficacy|12|||
155227203|NCT00603746|560270687|FG005|Overall Study|Lack of Efficacy|8|||
155227204|NCT00603746|560270682|FG000|Overall Study|Protocol Violation|0|||
155227205|NCT00603746|560270683|FG001|Overall Study|Protocol Violation|3|||
155227206|NCT00603746|560270684|FG002|Overall Study|Protocol Violation|1|||
155227207|NCT00603746|560270685|FG003|Overall Study|Protocol Violation|0|||
155227208|NCT00603746|560270686|FG004|Overall Study|Protocol Violation|1|||
155227209|NCT00603746|560270687|FG005|Overall Study|Protocol Violation|0|||
155227210|NCT00603746|560270682|FG000|Overall Study|Lost to Follow-up|0|||
155227211|NCT00603746|560270683|FG001|Overall Study|Lost to Follow-up|1|||
155227212|NCT00603746|560270684|FG002|Overall Study|Lost to Follow-up|1|||
155227213|NCT00603746|560270685|FG003|Overall Study|Lost to Follow-up|0|||
155227214|NCT00603746|560270686|FG004|Overall Study|Lost to Follow-up|0|||
155227215|NCT00603746|560270687|FG005|Overall Study|Lost to Follow-up|0|||
155227216|NCT00603746|560270682|FG000|Overall Study|Physician Decision|1|||
155227217|NCT00603746|560270683|FG001|Overall Study|Physician Decision|0|||
155227218|NCT00603746|560270684|FG002|Overall Study|Physician Decision|0|||
155227219|NCT00603746|560270685|FG003|Overall Study|Physician Decision|0|||
155227220|NCT00603746|560270686|FG004|Overall Study|Physician Decision|1|||
155227221|NCT00603746|560270687|FG005|Overall Study|Physician Decision|0|||
155227222|NCT00603746|560270682|FG000|Overall Study|Withdrawal by Subject|1|||
155227223|NCT00603746|560270683|FG001|Overall Study|Withdrawal by Subject|0|||
155227224|NCT00603746|560270684|FG002|Overall Study|Withdrawal by Subject|0|||
155227225|NCT00603746|560270685|FG003|Overall Study|Withdrawal by Subject|1|||
155227226|NCT00603746|560270686|FG004|Overall Study|Withdrawal by Subject|3|||
155227227|NCT00603746|560270687|FG005|Overall Study|Withdrawal by Subject|1|||
155227228|NCT01524627|560270692|FG000|Overall Study|Physician Decision|0|||
155227229|NCT01524627|560270693|FG001|Overall Study|Physician Decision|1|||
155227230|NCT01524627|560270692|FG000|Overall Study|Lost to Follow-up|1|||
155227231|NCT01524627|560270693|FG001|Overall Study|Lost to Follow-up|1|||
155227232|NCT03323658|560270694|FG000|Overall Study|Adverse Event|0|||
155227233|NCT03323658|560270695|FG001|Overall Study|Adverse Event|1|||
155227234|NCT03323658|560270696|FG002|Overall Study|Adverse Event|0|||
155227235|NCT03913091|560270697|FG000|Overall Study|Lost to Follow-up|18|||
155227236|NCT03913091|560270698|FG001|Overall Study|Lost to Follow-up|11|||
155227237|NCT03913091|560270697|FG000|Overall Study|Required additional meds/surgery|1|||
155227238|NCT03913091|560270698|FG001|Overall Study|Required additional meds/surgery|2|||
155227239|NCT03913091|560270697|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
155227240|NCT03913091|560270698|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
155227241|NCT00969553|560270699|FG000|Overall Study|Progressive disease (PD)|2|||
155227242|NCT00969553|560270700|FG001|Overall Study|Progressive disease (PD)|2|||
155227243|NCT00969553|560270701|FG002|Overall Study|Progressive disease (PD)|6|||
155227244|NCT00969553|560270702|FG003|Overall Study|Progressive disease (PD)|9|||
155227245|NCT00969553|560270703|FG004|Overall Study|Progressive disease (PD)|2|||
155227246|NCT00969553|560270704|FG005|Overall Study|Progressive disease (PD)|4|||
155227247|NCT00969553|560270705|FG006|Overall Study|Progressive disease (PD)|2|||
155227248|NCT00969553|560270706|FG007|Overall Study|Progressive disease (PD)|12|||
155227249|NCT00969553|560270707|FG008|Overall Study|Progressive disease (PD)|3|||
155227250|NCT00969553|560270699|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227251|NCT00969553|560270700|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227252|NCT00969553|560270701|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227253|NCT00969553|560270702|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227254|NCT00969553|560270703|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
155227255|NCT00969553|560270704|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227256|NCT00969553|560270705|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227257|NCT00969553|560270706|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227258|NCT00969553|560270707|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
155227259|NCT00969553|560270699|FG000|Overall Study|Other Adverse Event|0|||
155227260|NCT00969553|560270700|FG001|Overall Study|Other Adverse Event|0|||
155227261|NCT00969553|560270701|FG002|Overall Study|Other Adverse Event|0|||
155227262|NCT00969553|560270702|FG003|Overall Study|Other Adverse Event|1|||
155227263|NCT00969553|560270703|FG004|Overall Study|Other Adverse Event|0|||
155227264|NCT00969553|560270704|FG005|Overall Study|Other Adverse Event|0|||
155227265|NCT00969553|560270705|FG006|Overall Study|Other Adverse Event|1|||
155227266|NCT00969553|560270706|FG007|Overall Study|Other Adverse Event|0|||
155227267|NCT00969553|560270707|FG008|Overall Study|Other Adverse Event|0|||
155227268|NCT00969553|560270699|FG000|Overall Study|Refused cont. medication|1|||
155227269|NCT00969553|560270700|FG001|Overall Study|Refused cont. medication|1|||
155227270|NCT00969553|560270701|FG002|Overall Study|Refused cont. medication|0|||
155227271|NCT00969553|560270702|FG003|Overall Study|Refused cont. medication|2|||
155227272|NCT00969553|560270703|FG004|Overall Study|Refused cont. medication|0|||
155227273|NCT00969553|560270704|FG005|Overall Study|Refused cont. medication|0|||
155227274|NCT00969553|560270705|FG006|Overall Study|Refused cont. medication|0|||
155227275|NCT00969553|560270706|FG007|Overall Study|Refused cont. medication|1|||
155227276|NCT00969553|560270707|FG008|Overall Study|Refused cont. medication|0|||
155227277|NCT00969553|560270699|FG000|Overall Study|Not specified above|0|||
155227278|NCT00969553|560270700|FG001|Overall Study|Not specified above|0|||
155227279|NCT00969553|560270701|FG002|Overall Study|Not specified above|0|||
155227280|NCT00969553|560270702|FG003|Overall Study|Not specified above|4|||
155227281|NCT00969553|560270703|FG004|Overall Study|Not specified above|0|||
155227282|NCT00969553|560270704|FG005|Overall Study|Not specified above|0|||
155227283|NCT00969553|560270705|FG006|Overall Study|Not specified above|1|||
155227284|NCT00969553|560270706|FG007|Overall Study|Not specified above|1|||
155227285|NCT00969553|560270707|FG008|Overall Study|Not specified above|0|||
155227286|NCT00615056|560270708|FG000|Overall Study|Death|31|||
155227287|NCT00615056|560270709|FG001|Overall Study|Death|31|||
155227288|NCT00615056|560270710|FG002|Overall Study|Death|21|||
155227289|NCT00615056|560270711|FG003|Overall Study|Death|23|||
155227290|NCT00615056|560270708|FG000|Overall Study|Lost to Follow-up|1|||
155227291|NCT00615056|560270709|FG001|Overall Study|Lost to Follow-up|2|||
155227292|NCT00615056|560270710|FG002|Overall Study|Lost to Follow-up|4|||
155227293|NCT00615056|560270711|FG003|Overall Study|Lost to Follow-up|5|||
155227294|NCT00615056|560270708|FG000|Overall Study|Other|13|||
155227295|NCT00615056|560270709|FG001|Overall Study|Other|15|||
155227296|NCT00615056|560270710|FG002|Overall Study|Other|10|||
155227297|NCT00615056|560270711|FG003|Overall Study|Other|7|||
155227298|NCT00615056|560270708|FG000|Overall Study|Objective progression or relapse|0|||
155227299|NCT00615056|560270709|FG001|Overall Study|Objective progression or relapse|2|||
155227300|NCT00615056|560270710|FG002|Overall Study|Objective progression or relapse|0|||
155227301|NCT00615056|560270711|FG003|Overall Study|Objective progression or relapse|0|||
155227302|NCT00615056|560270708|FG000|Overall Study|Withdrawal by Subject|0|||
155227303|NCT00615056|560270709|FG001|Overall Study|Withdrawal by Subject|1|||
155227304|NCT00615056|560270710|FG002|Overall Study|Withdrawal by Subject|1|||
155227305|NCT00615056|560270711|FG003|Overall Study|Withdrawal by Subject|0|||
155227306|NCT00615056|560270708|FG000|Overall Study|Discontinued by Sponsor|1|||
155227307|NCT00615056|560270709|FG001|Overall Study|Discontinued by Sponsor|0|||
155227308|NCT00615056|560270710|FG002|Overall Study|Discontinued by Sponsor|0|||
155227309|NCT00615056|560270711|FG003|Overall Study|Discontinued by Sponsor|0|||
155227310|NCT00615056|560270708|FG000|Overall Study|Randomized but not treated|3|||
155227311|NCT00615056|560270709|FG001|Overall Study|Randomized but not treated|0|||
155227312|NCT00615056|560270710|FG002|Overall Study|Randomized but not treated|0|||
155227313|NCT00615056|560270711|FG003|Overall Study|Randomized but not treated|0|||
155227314|NCT01380184|560270715|FG000|Part 1 (19 Days)|Adverse Event|1|||
155227315|NCT01380184|560270715|FG000|Part 2|Adverse Event|5|||
155227316|NCT01380184|560270715|FG000|Part 2|Disease Progression|8|||
155227317|NCT01380184|560270715|FG000|Part 2|Lost to Follow-up|1|||
155227318|NCT04248816|560270716|FG000|Overall Study|Ineligible post-randomization|7|||
155227319|NCT04248816|560270717|FG001|Overall Study|Ineligible post-randomization|21|||
155227320|NCT04248816|560270718|FG002|Overall Study|Ineligible post-randomization|25|||
155227321|NCT03350503|560270719|FG000|Overall Study|Adverse Event|5|||
155227322|NCT03350503|560270719|FG000|Overall Study|Withdrawal by Subject|5|||
155227323|NCT03350503|560270719|FG000|Overall Study|Continuation impossible due to move|4|||
155227324|NCT03350503|560270719|FG000|Overall Study|Physician Decision|3|||
155227325|NCT00262067|560270722|FG000|Overall Study|Death|190|||
155227326|NCT00262067|560270723|FG001|Overall Study|Death|89|||
155227327|NCT00262067|560270724|FG002|Overall Study|Death|186|||
155227328|NCT00262067|560270725|FG003|Overall Study|Death|99|||
155227329|NCT00262067|560270722|FG000|Overall Study|Lost to Follow-up|5|||
155227330|NCT00262067|560270723|FG001|Overall Study|Lost to Follow-up|4|||
155227331|NCT00262067|560270724|FG002|Overall Study|Lost to Follow-up|7|||
155227332|NCT00262067|560270725|FG003|Overall Study|Lost to Follow-up|5|||
155227333|NCT00262067|560270722|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
155227334|NCT00262067|560270723|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
155227335|NCT00262067|560270724|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
155227336|NCT00262067|560270725|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
155227337|NCT00262067|560270722|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
155227338|NCT00262067|560270723|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
155227339|NCT00262067|560270724|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
155227340|NCT00262067|560270725|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
155227341|NCT03829046|560270726|FG000|Overall Study|Withdrawal by Subject|1|||
155227342|NCT03829046|560270727|FG001|Overall Study|Withdrawal by Subject|0|||
155227343|NCT01399593|560270732|FG000|Overall Study|Physician Decision|1|||
155227344|NCT01399593|560270733|FG001|Overall Study|Physician Decision|0|||
155227345|NCT01399593|560270732|FG000|Overall Study|Adverse Event|1|||
155227346|NCT01399593|560270733|FG001|Overall Study|Adverse Event|0|||
155227347|NCT01399593|560270732|FG000|Overall Study|Death|1|||
155227348|NCT01399593|560270733|FG001|Overall Study|Death|1|||
155227349|NCT01399593|560270732|FG000|Overall Study|Transplantectomy|0|||
155227350|NCT01399593|560270733|FG001|Overall Study|Transplantectomy|1|||
155227351|NCT00344773|560270735|FG000|Overall Study|Adverse Event|2|||
155227352|NCT00344773|560270735|FG000|Overall Study|Objective Disease Progression|16|||
155227353|NCT00344773|560270735|FG000|Overall Study|Withdrawal by Subject|1|||
155227354|NCT00344773|560270735|FG000|Overall Study|Not Eligible for the study|2|||
155227355|NCT02849548|560270745|FG000|Overall Study|Lost to Follow-up|1|||
155227356|NCT02849548|560270746|FG001|Overall Study|Lost to Follow-up|2|||
155227357|NCT02849548|560270745|FG000|Overall Study|Protocol Violation|1|||
155227358|NCT02849548|560270746|FG001|Overall Study|Protocol Violation|0|||
155227359|NCT00714259|560270747|FG000|Overall Study|Death|2|||
155227360|NCT04804813|560270749|FG000|Overall Study|Protocol Violation|2|||
155227361|NCT04804813|560270750|FG001|Overall Study|Protocol Violation|0|||
155227362|NCT04804813|560270749|FG000|Overall Study|Withdrawal by Subject|1|||
155227363|NCT04804813|560270750|FG001|Overall Study|Withdrawal by Subject|0|||
155227364|NCT00560950|560270752|FG000|Overall Study|Lost to Follow-up|1|||
155227365|NCT00560950|560270753|FG001|Overall Study|Lost to Follow-up|0|||
155227366|NCT01581593|560272166|FG000|Overall Study|Withdrawal by Subject|1|||
155227367|NCT02586012|560272167|FG000|Overall Study|Withdrawal by Subject|1|||
155227368|NCT02586012|560272168|FG001|Overall Study|Withdrawal by Subject|1|||
155227369|NCT02586012|560272169|FG002|Overall Study|Withdrawal by Subject|0|||
155227370|NCT02586012|560272170|FG003|Overall Study|Withdrawal by Subject|1|||
155227371|NCT02586012|560272171|FG004|Overall Study|Withdrawal by Subject|0|||
155227372|NCT02586012|560272172|FG005|Overall Study|Withdrawal by Subject|2|||
155227373|NCT02586012|560272167|FG000|Overall Study|Protocol Violation|0|||
155227374|NCT02586012|560272168|FG001|Overall Study|Protocol Violation|0|||
155227375|NCT02586012|560272169|FG002|Overall Study|Protocol Violation|0|||
155227376|NCT02586012|560272170|FG003|Overall Study|Protocol Violation|0|||
155227377|NCT02586012|560272171|FG004|Overall Study|Protocol Violation|0|||
155227378|NCT02586012|560272172|FG005|Overall Study|Protocol Violation|1|||
155227379|NCT02586012|560272167|FG000|Overall Study|study terminated|0|||
155227380|NCT02586012|560272168|FG001|Overall Study|study terminated|2|||
155227381|NCT02586012|560272169|FG002|Overall Study|study terminated|1|||
155227382|NCT02586012|560272170|FG003|Overall Study|study terminated|1|||
155227383|NCT02586012|560272171|FG004|Overall Study|study terminated|1|||
155227384|NCT02586012|560272172|FG005|Overall Study|study terminated|0|||
155227385|NCT03277846|560272173|FG000|Overall Study|Inpatient stay too brief|12|||
155227386|NCT03277846|560272174|FG001|Overall Study|Inpatient stay too brief|11|||
155227387|NCT05168475|560272175|FG000|Period 1|Protocol Violation|1|||
155227388|NCT05168475|560272175|FG000|Period 1|IMP shortage|2|||
155227389|NCT05168475|560272175|FG000|Period 1|Not randomised|2|||
155227390|NCT05168475|560272175|FG000|Period 2|IMP shortage|1|||
155227391|NCT01589822|560272176|FG000|Overall Study|Withdrawal by Subject|1|||
155227392|NCT01589822|560272177|FG001|Overall Study|Withdrawal by Subject|2|||
155227393|NCT01589822|560272178|FG002|Overall Study|Withdrawal by Subject|0|||
155227394|NCT01589822|560272176|FG000|Overall Study|Death|1|||
155227395|NCT01589822|560272177|FG001|Overall Study|Death|0|||
155227396|NCT01589822|560272178|FG002|Overall Study|Death|0|||
155227397|NCT01589822|560272176|FG000|Overall Study|Missed 90 day visit|2|||
155227398|NCT01589822|560272177|FG001|Overall Study|Missed 90 day visit|1|||
155227399|NCT01589822|560272178|FG002|Overall Study|Missed 90 day visit|1|||
155227400|NCT01302964|560272179|FG000|Overall Study|Adverse Event|1|||
155227401|NCT01302964|560272180|FG001|Overall Study|Adverse Event|0|||
155227402|NCT01904604|560272183|FG000|Overall Study|Withdrew before receiving dosing|0|||
155227403|NCT01904604|560272184|FG001|Overall Study|Withdrew before receiving dosing|1|||
155227404|NCT01904604|560272185|FG002|Overall Study|Withdrew before receiving dosing|0|||
155227405|NCT01904604|560272183|FG000|Overall Study|Non-compliance|1|||
155227406|NCT01904604|560272184|FG001|Overall Study|Non-compliance|0|||
155227407|NCT01904604|560272185|FG002|Overall Study|Non-compliance|0|||
155227408|NCT01904604|560272183|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
155227409|NCT01904604|560272184|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
155227410|NCT01904604|560272185|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
155227411|NCT01904604|560272183|FG000|Overall Study|Patch site reactions|1|||
155227412|NCT01904604|560272184|FG001|Overall Study|Patch site reactions|1|||
155227413|NCT01904604|560272185|FG002|Overall Study|Patch site reactions|0|||
155227414|NCT01904604|560272183|FG000|Overall Study|Increased syncope|0|||
155227415|NCT01904604|560272184|FG001|Overall Study|Increased syncope|1|||
155227416|NCT01904604|560272185|FG002|Overall Study|Increased syncope|0|||
155227417|NCT01904604|560272183|FG000|Overall Study|Unrelated illness|0|||
155227418|NCT01904604|560272184|FG001|Overall Study|Unrelated illness|1|||
155227419|NCT01904604|560272185|FG002|Overall Study|Unrelated illness|0|||
155227420|NCT01904604|560272183|FG000|Overall Study|Passed Week 52 OFC|1|||
155227421|NCT01904604|560272184|FG001|Overall Study|Passed Week 52 OFC|0|||
155227422|NCT01904604|560272185|FG002|Overall Study|Passed Week 52 OFC|0|||
155227423|NCT01904604|560272183|FG000|Overall Study|Withdrawal by Subject|1|||
155227424|NCT01904604|560272184|FG001|Overall Study|Withdrawal by Subject|2|||
155227425|NCT01904604|560272185|FG002|Overall Study|Withdrawal by Subject|0|||
155227426|NCT01904604|560272183|FG000|Overall Study|Participant Relocated|1|||
155227427|NCT01904604|560272184|FG001|Overall Study|Participant Relocated|1|||
155227428|NCT01904604|560272185|FG002|Overall Study|Participant Relocated|1|||
155227429|NCT01904604|560272183|FG000|Overall Study|Lost to Follow-up|0|||
155227430|NCT01904604|560272184|FG001|Overall Study|Lost to Follow-up|0|||
155227431|NCT01904604|560272185|FG002|Overall Study|Lost to Follow-up|1|||
155227432|NCT01945489|560272188|FG000|Cycle 1|Adverse Event|2|||
155227433|NCT01945489|560272189|FG001|Cycle 1|Adverse Event|0|||
155227434|NCT01945489|560272188|FG000|Cycle 1|Lost to Follow-up|4|||
155227435|NCT01945489|560272189|FG001|Cycle 1|Lost to Follow-up|0|||
155227436|NCT01945489|560272188|FG000|Cycle 1|Personal Reasons|4|||
155227437|NCT01945489|560272189|FG001|Cycle 1|Personal Reasons|2|||
155227438|NCT01945489|560272188|FG000|Cycle 1|Protocol Violation|0|||
155227439|NCT01945489|560272189|FG001|Cycle 1|Protocol Violation|1|||
155227440|NCT01945489|560272188|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
155227441|NCT01945489|560272189|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
155227442|NCT01945489|560272188|FG000|Cycle 2|Adverse Event|1|||
155227443|NCT01945489|560272189|FG001|Cycle 2|Adverse Event|0|||
155227444|NCT01945489|560272188|FG000|Cycle 2|Lost to Follow-up|0|||
155227445|NCT01945489|560272189|FG001|Cycle 2|Lost to Follow-up|1|||
155227446|NCT00697346|560272191|FG000|Overall Study|Adverse Event|4|||
155227447|NCT00697346|560272192|FG001|Overall Study|Adverse Event|5|||
155227448|NCT00697346|560272193|FG002|Overall Study|Adverse Event|0|||
155227449|NCT00697346|560272191|FG000|Overall Study|Progressive Disease|19|||
155227450|NCT00697346|560272192|FG001|Overall Study|Progressive Disease|18|||
155227451|NCT00697346|560272193|FG002|Overall Study|Progressive Disease|0|||
155227452|NCT00697346|560272191|FG000|Overall Study|Symptomatic Deterioration|0|||
155227453|NCT00697346|560272192|FG001|Overall Study|Symptomatic Deterioration|1|||
155227454|NCT00697346|560272193|FG002|Overall Study|Symptomatic Deterioration|0|||
155227455|NCT00697346|560272191|FG000|Overall Study|Withdrawal by Subject|2|||
155227456|NCT00697346|560272192|FG001|Overall Study|Withdrawal by Subject|2|||
155227457|NCT00697346|560272193|FG002|Overall Study|Withdrawal by Subject|0|||
155227458|NCT00697346|560272191|FG000|Overall Study|Reason not Specified|3|||
155227459|NCT00697346|560272192|FG001|Overall Study|Reason not Specified|0|||
155227460|NCT00697346|560272193|FG002|Overall Study|Reason not Specified|1|||
155227461|NCT03569371|560272194|FG000|Overall Study|Lack of Efficacy|1|||
155227462|NCT03569371|560272194|FG000|Overall Study|Lost to Follow-up|1|||
155227463|NCT03569371|560272194|FG000|Overall Study|Adverse Event|1|||
155227464|NCT03643562|560272195|FG000|Overall Study|Adverse Event|1|||
155227465|NCT03643562|560272196|FG001|Overall Study|Adverse Event|0|||
155227466|NCT03643562|560272195|FG000|Overall Study|Lack of Efficacy|0|||
155227467|NCT03643562|560272196|FG001|Overall Study|Lack of Efficacy|1|||
155227468|NCT03643562|560272195|FG000|Overall Study|Physician Decision|0|||
155227469|NCT03643562|560272196|FG001|Overall Study|Physician Decision|1|||
155227470|NCT03643562|560272195|FG000|Overall Study|Study Terminated by Sponsor|2|||
155227471|NCT03643562|560272196|FG001|Overall Study|Study Terminated by Sponsor|10|||
155227472|NCT03643562|560272195|FG000|Overall Study|Withdrawal by Subject|2|||
155227473|NCT03643562|560272196|FG001|Overall Study|Withdrawal by Subject|2|||
155227474|NCT03643562|560272195|FG000|Overall Study|Other than specified|3|||
155227475|NCT03643562|560272196|FG001|Overall Study|Other than specified|2|||
155227476|NCT04145895|560272197|FG000|Overall Study|Physician Decision|2|||
155227477|NCT04145895|560272198|FG001|Overall Study|Physician Decision|0|||
155227478|NCT04145895|560272197|FG000|Overall Study|Withdrawal by Subject|0|||
155227479|NCT04145895|560272198|FG001|Overall Study|Withdrawal by Subject|2|||
155227480|NCT01236755|560272199|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
155227481|NCT01236755|560272199|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
155227482|NCT01236755|560272199|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
155227483|NCT01236755|560272199|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
155227484|NCT03848845|560272200|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
155227485|NCT03848845|560272201|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
155227486|NCT03848845|560272202|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
155227487|NCT03848845|560272203|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
155227488|NCT03848845|560272200|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
155227489|NCT03848845|560272201|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
155227490|NCT03848845|560272202|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
155227491|NCT03848845|560272203|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
155227492|NCT03848845|560272200|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
155227493|NCT03848845|560272201|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
155227494|NCT03848845|560272202|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
155227495|NCT03848845|560272203|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
155227496|NCT03848845|560272200|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
155227497|NCT03848845|560272201|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
155227498|NCT03848845|560272202|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
155227499|NCT03848845|560272203|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
155227500|NCT00596011|560272206|FG000|Overall Study|Withdrawal by Subject|2|||
155227501|NCT00596011|560272207|FG001|Overall Study|Withdrawal by Subject|3|||
155227502|NCT00596011|560272206|FG000|Overall Study|Adverse Event|11|||
155227503|NCT00596011|560272207|FG001|Overall Study|Adverse Event|7|||
155227504|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
155227505|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
155227506|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
155227507|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
155227508|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
155227509|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
155227510|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
155227511|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
155227512|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
155227513|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
155227514|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
155227515|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
155227516|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
155227517|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
155227518|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
155227519|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
155227520|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
155227521|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
155227522|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
155227523|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
155227524|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
155227525|NCT00934544|560272208|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
155227526|NCT00934544|560272209|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
155227527|NCT00934544|560272210|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
155227528|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
155227529|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
155227530|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
155227531|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
155227532|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
155227533|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
155227534|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
155227535|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
155227536|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
155227537|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
155227538|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
155227539|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
155227540|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
155227541|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
155227542|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
155227543|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
155227544|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
155227545|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
155227546|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
155227547|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
155227548|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
155227549|NCT00934544|560272208|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
155227550|NCT00934544|560272209|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
155227551|NCT00934544|560272210|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
155227552|NCT02643251|560272211|FG000|Overall Study|Adverse Event|3|||
155227553|NCT02643251|560272212|FG001|Overall Study|Adverse Event|1|||
155227554|NCT02643251|560272211|FG000|Overall Study|Withdrawal by Subject|2|||
155227555|NCT02643251|560272212|FG001|Overall Study|Withdrawal by Subject|0|||
155227556|NCT02643251|560272211|FG000|Overall Study|Lost to Follow-up|4|||
155227557|NCT02643251|560272212|FG001|Overall Study|Lost to Follow-up|1|||
155227558|NCT02643251|560272211|FG000|Overall Study|Protocol Violation|1|||
155227559|NCT02643251|560272212|FG001|Overall Study|Protocol Violation|0|||
155227560|NCT02643251|560272211|FG000|Overall Study|PI Decision to terminate patient|1|||
155227561|NCT02643251|560272212|FG001|Overall Study|PI Decision to terminate patient|0|||
155227562|NCT00240071|560272213|FG000|Overall Study|Withdrawal by Subject|3|||
155227563|NCT04206293|560272225|FG000|Overall Study|Consent withdrawal|1|||
155227564|NCT01956110|560272230|FG000|Overall Study|Protocol Violation|25|||
155227565|NCT01956110|560272231|FG001|Overall Study|Protocol Violation|11|||
155227566|NCT01956110|560272230|FG000|Overall Study|Adverse Event|9|||
155227567|NCT01956110|560272231|FG001|Overall Study|Adverse Event|10|||
155227568|NCT01956110|560272230|FG000|Overall Study|Personal reasons|1|||
155227569|NCT01956110|560272231|FG001|Overall Study|Personal reasons|1|||
155227570|NCT03325166|560272236|FG000|Overall Study|Adverse Event|1|||
155227571|NCT00706966|560272238|FG000|Overall Study|Adverse Event|1|||
155227572|NCT01631474|560272243|FG000|Overall Study|Lost to Follow-up|8|||
155227573|NCT01631474|560272244|FG001|Overall Study|Lost to Follow-up|5|||
155227574|NCT01631474|560272245|FG002|Overall Study|Lost to Follow-up|7|||
155227575|NCT01631474|560272246|FG003|Overall Study|Lost to Follow-up|5|||
155227576|NCT01631474|560272247|FG004|Overall Study|Lost to Follow-up|5|||
155227577|NCT01631474|560272243|FG000|Overall Study|Withdrawal by Subject|4|||
155227578|NCT01631474|560272244|FG001|Overall Study|Withdrawal by Subject|4|||
155227579|NCT01631474|560272245|FG002|Overall Study|Withdrawal by Subject|2|||
155227580|NCT01631474|560272246|FG003|Overall Study|Withdrawal by Subject|6|||
155227581|NCT01631474|560272247|FG004|Overall Study|Withdrawal by Subject|5|||
155227582|NCT01631474|560272243|FG000|Overall Study|Lack of Efficacy|2|||
155227583|NCT01631474|560272244|FG001|Overall Study|Lack of Efficacy|2|||
155227584|NCT01631474|560272245|FG002|Overall Study|Lack of Efficacy|0|||
155227585|NCT01631474|560272246|FG003|Overall Study|Lack of Efficacy|0|||
155227586|NCT01631474|560272247|FG004|Overall Study|Lack of Efficacy|2|||
155227587|NCT01631474|560272243|FG000|Overall Study|Noncompliance with Study Drug|0|||
155227588|NCT01631474|560272244|FG001|Overall Study|Noncompliance with Study Drug|0|||
155227589|NCT01631474|560272245|FG002|Overall Study|Noncompliance with Study Drug|0|||
155227590|NCT01631474|560272246|FG003|Overall Study|Noncompliance with Study Drug|0|||
155227591|NCT01631474|560272247|FG004|Overall Study|Noncompliance with Study Drug|1|||
155227592|NCT01631474|560272243|FG000|Overall Study|Adverse Event|0|||
155227593|NCT01631474|560272244|FG001|Overall Study|Adverse Event|1|||
155227594|NCT01631474|560272245|FG002|Overall Study|Adverse Event|0|||
155227595|NCT01631474|560272246|FG003|Overall Study|Adverse Event|0|||
155227596|NCT01631474|560272247|FG004|Overall Study|Adverse Event|0|||
155227597|NCT01467076|560272248|FG000|Overall Study|Lost to Follow-up|1|||
155227598|NCT01467076|560272249|FG001|Overall Study|Lost to Follow-up|0|||
155227599|NCT01467076|560272250|FG002|Overall Study|Lost to Follow-up|0|||
155227600|NCT03354429|560272251|FG000|Overall Study|Withdrawal by Subject|8|||
155227601|NCT03354429|560272252|FG001|Overall Study|Withdrawal by Subject|7|||
155227602|NCT03354429|560272251|FG000|Overall Study|Lost to Follow-up|1|||
155227603|NCT03354429|560272252|FG001|Overall Study|Lost to Follow-up|0|||
155227604|NCT03100825|560272253|FG000|Overall Study|Participant/Guardian Decision|7|||
155227605|NCT03100825|560272253|FG000|Overall Study|Physician Decision|1|||
155227606|NCT00994448|560272255|FG000|Overall Study|Adverse Event|1|||
155227607|NCT00994448|560272256|FG001|Overall Study|Adverse Event|0|||
155227608|NCT00994448|560272255|FG000|Overall Study|Lost to Follow-up|5|||
155227609|NCT00994448|560272256|FG001|Overall Study|Lost to Follow-up|1|||
155227610|NCT00994448|560272255|FG000|Overall Study|Withdrawal by Subject|1|||
155227611|NCT00994448|560272256|FG001|Overall Study|Withdrawal by Subject|1|||
155227612|NCT00994448|560272255|FG000|Overall Study|Physician Decision|1|||
155227613|NCT00994448|560272256|FG001|Overall Study|Physician Decision|0|||
155227614|NCT05923229|560272259|FG000|Overall Study|Withdrawal by Subject|3|||
155227615|NCT05923229|560272260|FG001|Overall Study|Withdrawal by Subject|0|||
155227616|NCT05923229|560272259|FG000|Overall Study|Health related|2|||
155227617|NCT05923229|560272260|FG001|Overall Study|Health related|1|||
155227618|NCT04164901|560272261|FG000|Overall Study|Withdrawal by Subject|4|||
155227619|NCT04164901|560272262|FG001|Overall Study|Withdrawal by Subject|4|||
155227620|NCT04098458|560272263|FG000|Overall Study|Death|1|||
155227621|NCT04098458|560272263|FG000|Overall Study|did not meet study inclusion criteria|3|||
155227622|NCT01800916|560272264|FG000|Test Period 1 (1 Week)|Convex product user|0|||
155227623|NCT01800916|560272265|FG001|Test Period 1 (1 Week)|Convex product user|0|||
155227624|NCT01800916|560272266|FG002|Test Period 1 (1 Week)|Convex product user|0|||
155227625|NCT01800916|560272267|FG003|Test Period 1 (1 Week)|Convex product user|1|||
155227626|NCT01800916|560272268|FG004|Test Period 1 (1 Week)|Convex product user|0|||
155227627|NCT01800916|560272269|FG005|Test Period 1 (1 Week)|Convex product user|0|||
155227628|NCT01800916|560272270|FG006|Test Period 1 (1 Week)|Convex product user|0|||
155227629|NCT01800916|560272271|FG007|Test Period 1 (1 Week)|Convex product user|0|||
155227630|NCT01800916|560272272|FG008|Test Period 1 (1 Week)|Convex product user|0|||
155227631|NCT01800916|560272264|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
155227632|NCT01800916|560272265|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
155227633|NCT01800916|560272266|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
155227634|NCT01800916|560272267|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
155227635|NCT01800916|560272268|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
155227636|NCT01800916|560272269|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
155227637|NCT01800916|560272270|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
155227638|NCT01800916|560272271|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
155227639|NCT01800916|560272272|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
155227640|NCT01461096|560272273|FG000|Overall Study|Death|3|||
155227641|NCT01461096|560272274|FG001|Overall Study|Death|6|||
155227642|NCT01461096|560272273|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155227643|NCT01461096|560272274|FG001|Overall Study|Severe debilitation, unable to continue|1|||
155227644|NCT01461096|560272273|FG000|Overall Study|Subj not able to get to clinic|15|||
155227645|NCT01461096|560272274|FG001|Overall Study|Subj not able to get to clinic|13|||
155227646|NCT01461096|560272273|FG000|Overall Study|Site is closing|27|||
155227647|NCT01461096|560272274|FG001|Overall Study|Site is closing|30|||
155227648|NCT01461096|560272273|FG000|Overall Study|Withdrawal by Subject|5|||
155227649|NCT01461096|560272274|FG001|Overall Study|Withdrawal by Subject|3|||
155227650|NCT01461096|560272273|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
155227651|NCT01461096|560272274|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
155227652|NCT01461096|560272273|FG000|Overall Study|Lost to Follow-up|8|||
155227653|NCT01461096|560272274|FG001|Overall Study|Lost to Follow-up|4|||
155227654|NCT04889625|560272275|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
155227655|NCT04889625|560272276|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
155227656|NCT04889625|560272275|FG000|Period 1|Subject out of window|0|||
155227657|NCT04889625|560272276|FG001|Period 1|Subject out of window|1|||
155227658|NCT04889625|560272275|FG000|Period 1|Wrong add power dispensed|0|||
155227659|NCT04889625|560272276|FG001|Period 1|Wrong add power dispensed|1|||
155227660|NCT04889625|560272275|FG000|Period 1|Discontinued due to fitting guide error|1|||
155227661|NCT04889625|560272276|FG001|Period 1|Discontinued due to fitting guide error|1|||
155227662|NCT04889625|560272275|FG000|Period 2|Test article no longer available|1|||
155227663|NCT04889625|560272276|FG001|Period 2|Test article no longer available|0|||
155227664|NCT04889625|560272275|FG000|Period 2|Incorrect lens dispensed|1|||
155227665|NCT04889625|560272276|FG001|Period 2|Incorrect lens dispensed|0|||
155227666|NCT04889625|560272275|FG000|Period 2|Wrong add power dispensed|0|||
155227667|NCT04889625|560272276|FG001|Period 2|Wrong add power dispensed|1|||
155227668|NCT03047135|560272289|FG000|Overall Study|Still being treated|3|||
155227669|NCT01256593|560272290|FG000|Overall Study|Protocol Violation|26|||
155227670|NCT01256593|560272290|FG000|Overall Study|No Drug Administration Information|2|||
155227671|NCT01256593|560272290|FG000|Overall Study|No Visit After Treatment|186|||
155227672|NCT05619692|560272291|FG000|Overall Study|Adverse Event|2|||
155227673|NCT05619692|560272292|FG001|Overall Study|Adverse Event|2|||
155227674|NCT05619692|560272291|FG000|Overall Study|Withdrawal by Participant|3|||
155227675|NCT05619692|560272292|FG001|Overall Study|Withdrawal by Participant|4|||
155227676|NCT05619692|560272291|FG000|Overall Study|Lost to Follow-up|2|||
155227677|NCT05619692|560272292|FG001|Overall Study|Lost to Follow-up|1|||
155227678|NCT05619692|560272291|FG000|Overall Study|Randomized but not treated|1|||
155227679|NCT05619692|560272292|FG001|Overall Study|Randomized but not treated|3|||
155227680|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Death|3|||
155227681|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Death|2|||
155227682|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Death|0|||
155227683|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Death|0|||
155227684|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Death|0|||
155227685|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Death|0|||
155227686|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Death|0|||
155227687|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Death|0|||
155227688|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
155227689|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227690|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227691|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227692|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227693|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227694|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227695|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
155227696|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227697|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
155227698|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227699|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227700|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227701|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227702|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227703|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
155227704|NCT02036502|560272299|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
155227705|NCT02036502|560272300|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
155227706|NCT02036502|560272301|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
155227707|NCT02036502|560272302|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
155227708|NCT02036502|560272303|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
155227709|NCT02036502|560272304|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
155227710|NCT02036502|560272305|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
155227711|NCT02036502|560272306|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
155227712|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227713|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227714|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
155227715|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
155227716|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
155227717|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227718|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227719|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
155227720|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227721|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227722|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
155227723|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227724|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227725|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227726|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227727|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
155227728|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Death|0|||
155227729|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Death|0|||
155227730|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Death|1|||
155227731|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Death|0|||
155227732|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Death|0|||
155227733|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Death|0|||
155227734|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Death|0|||
155227735|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Death|0|||
155227736|NCT02036502|560272299|FG000|Part 2:Dose Confirmation|Not treated|0|||
155227737|NCT02036502|560272300|FG001|Part 2:Dose Confirmation|Not treated|0|||
155227738|NCT02036502|560272301|FG002|Part 2:Dose Confirmation|Not treated|0|||
155227739|NCT02036502|560272302|FG003|Part 2:Dose Confirmation|Not treated|1|||
155227740|NCT02036502|560272303|FG004|Part 2:Dose Confirmation|Not treated|0|||
155227741|NCT02036502|560272304|FG005|Part 2:Dose Confirmation|Not treated|0|||
155227742|NCT02036502|560272305|FG006|Part 2:Dose Confirmation|Not treated|0|||
155227743|NCT02036502|560272306|FG007|Part 2:Dose Confirmation|Not treated|0|||
155227744|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Adverse Event|0|||
155227745|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Adverse Event|0|||
155227746|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Adverse Event|0|||
155227747|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Adverse Event|0|||
155227748|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Adverse Event|0|||
155227749|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Adverse Event|4|||
155227750|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Adverse Event|0|||
155227751|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Adverse Event|2|||
155227752|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Death|0|||
155227753|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Death|0|||
155227754|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Death|0|||
155227755|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Death|0|||
155227756|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Death|0|||
155227757|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Death|24|||
155227758|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Death|0|||
155227759|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Death|3|||
155227760|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227761|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227762|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227763|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227764|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227765|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227766|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
155227767|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
155227768|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Physician Decision|0|||
155227769|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Physician Decision|0|||
155227770|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Physician Decision|0|||
155227771|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Physician Decision|0|||
155227772|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Physician Decision|0|||
155227773|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Physician Decision|1|||
155227774|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Physician Decision|0|||
155227775|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Physician Decision|0|||
155227776|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
155227777|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
155227778|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
155227779|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
155227780|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
155227781|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
155227782|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
155227783|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
155227784|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227785|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227786|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227787|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227788|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227789|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
155227790|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
155227791|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
155227792|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227793|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227794|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227795|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227796|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
155227797|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
155227798|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
155227799|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
155227800|NCT02036502|560272299|FG000|Part 3:Dose Expansion|Not Treated|0|||
155227801|NCT02036502|560272300|FG001|Part 3:Dose Expansion|Not Treated|0|||
155227802|NCT02036502|560272301|FG002|Part 3:Dose Expansion|Not Treated|0|||
155227803|NCT02036502|560272302|FG003|Part 3:Dose Expansion|Not Treated|0|||
155227804|NCT02036502|560272303|FG004|Part 3:Dose Expansion|Not Treated|0|||
155227805|NCT02036502|560272304|FG005|Part 3:Dose Expansion|Not Treated|2|||
155227806|NCT02036502|560272305|FG006|Part 3:Dose Expansion|Not Treated|0|||
155227807|NCT02036502|560272306|FG007|Part 3:Dose Expansion|Not Treated|0|||
155227808|NCT00978068|560272312|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
155227809|NCT00978068|560272313|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
155227810|NCT00978068|560272312|FG000|Overall Study|Death|1|||
155227811|NCT00978068|560272313|FG001|Overall Study|Death|2|||
155227812|NCT00978068|560272312|FG000|Overall Study|Lost to Follow-up|1|||
155227813|NCT00978068|560272313|FG001|Overall Study|Lost to Follow-up|2|||
155227814|NCT00978068|560272312|FG000|Overall Study|Physician Decision|0|||
155227815|NCT00978068|560272313|FG001|Overall Study|Physician Decision|1|||
155227816|NCT00978068|560272312|FG000|Overall Study|Unable to Comply with Study|0|||
155227817|NCT00978068|560272313|FG001|Overall Study|Unable to Comply with Study|2|||
155227818|NCT02357147|560272319|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
155227819|NCT02357147|560272320|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
155227820|NCT02357147|560272319|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
155227821|NCT02357147|560272320|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
155227822|NCT02357147|560272319|FG000|Combination Treatment Phase|Investigator Discretion|1|||
155227823|NCT02357147|560272320|FG001|Combination Treatment Phase|Investigator Discretion|1|||
155227824|NCT02357147|560272319|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
155227825|NCT02357147|560272320|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
155227826|NCT02357147|560272319|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
155227827|NCT02357147|560272320|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
155227828|NCT02357147|560272319|FG000|Combination Treatment Phase|Adverse Event|12|||
155227829|NCT02357147|560272320|FG001|Combination Treatment Phase|Adverse Event|4|||
155227830|NCT02357147|560272319|FG000|Combination Treatment Phase|Death|1|||
155227831|NCT02357147|560272320|FG001|Combination Treatment Phase|Death|1|||
155227832|NCT02357147|560272319|FG000|Combination Treatment Phase|Sponsor Decision|0|||
155227833|NCT02357147|560272320|FG001|Combination Treatment Phase|Sponsor Decision|12|||
155227834|NCT02357147|560272319|FG000|Combination Treatment Phase|Other|1|||
155227835|NCT02357147|560272320|FG001|Combination Treatment Phase|Other|0|||
155227836|NCT02357147|560272319|FG000|Combination Treatment Phase|Not treated|0|||
155227837|NCT02357147|560272320|FG001|Combination Treatment Phase|Not treated|2|||
155227838|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
155227839|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
155227840|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
155227841|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
155227842|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
155227843|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
155227844|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Adverse Event|0|||
155227845|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Adverse Event|3|||
155227846|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
155227847|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
155227848|NCT02357147|560272319|FG000|Maintenance Treatment Phase|Not Treated|1|||
155227849|NCT02357147|560272320|FG001|Maintenance Treatment Phase|Not Treated|0|||
155227850|NCT03962543|560272321|FG000|Treatment Phase|Death|0|||
155227851|NCT03962543|560272322|FG001|Treatment Phase|Death|1|||
155227852|NCT03962543|560272321|FG000|Treatment Phase|Withdrawal by Subject|3|||
155227853|NCT03962543|560272322|FG001|Treatment Phase|Withdrawal by Subject|0|||
155227854|NCT03962543|560272321|FG000|Treatment Phase|Adverse Event|3|||
155227855|NCT03962543|560272322|FG001|Treatment Phase|Adverse Event|12|||
155227856|NCT03962543|560272321|FG000|Treatment Phase|Lost to Follow-up|1|||
155227857|NCT03962543|560272322|FG001|Treatment Phase|Lost to Follow-up|2|||
155227858|NCT03962543|560272321|FG000|Treatment Phase|Radiographic PD|9|||
155227859|NCT03962543|560272322|FG001|Treatment Phase|Radiographic PD|3|||
155227860|NCT03962543|560272321|FG000|Treatment Phase|Participant Decision|3|||
155227861|NCT03962543|560272322|FG001|Treatment Phase|Participant Decision|8|||
155227862|NCT03962543|560272321|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
155227863|NCT03962543|560272322|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
155227864|NCT03962543|560272321|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
155227865|NCT03962543|560272322|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
155227866|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
155227867|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
155227868|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
155227869|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
155227870|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
155227871|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
155227872|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
155227873|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
155227874|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
155227875|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
155227876|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
155227877|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
155227878|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
155227879|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
155227880|NCT03962543|560272321|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
155227881|NCT03962543|560272322|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
155227882|NCT01101841|560274064|FG000|Overall Study|Adverse Event|15|||
155227883|NCT01101841|560274065|FG001|Overall Study|Adverse Event|15|||
155227884|NCT01101841|560274064|FG000|Overall Study|Lost to Follow-up|9|||
155227885|NCT01101841|560274065|FG001|Overall Study|Lost to Follow-up|3|||
155227886|NCT01101841|560274064|FG000|Overall Study|Withdrawal by Subject|21|||
155227887|NCT01101841|560274065|FG001|Overall Study|Withdrawal by Subject|40|||
155227888|NCT01101841|560274064|FG000|Overall Study|Protocol Violation|1|||
155227889|NCT01101841|560274065|FG001|Overall Study|Protocol Violation|1|||
155227890|NCT01101841|560274064|FG000|Overall Study|Physician Decision|0|||
155227891|NCT01101841|560274065|FG001|Overall Study|Physician Decision|2|||
155227892|NCT01101841|560274064|FG000|Overall Study|Lack of Efficacy|0|||
155227893|NCT01101841|560274065|FG001|Overall Study|Lack of Efficacy|2|||
155227894|NCT01101841|560274064|FG000|Overall Study|Other|0|||
155227895|NCT01101841|560274065|FG001|Overall Study|Other|1|||
155227896|NCT01101841|560274064|FG000|Overall Study|Suicidality Tracking Scale|3|||
155227897|NCT01101841|560274065|FG001|Overall Study|Suicidality Tracking Scale|1|||
155227898|NCT01101841|560274064|FG000|Overall Study|Eligibility Criteria|1|||
155227899|NCT01101841|560274065|FG001|Overall Study|Eligibility Criteria|2|||
155227900|NCT00653224|560274068|FG000|Overall Study|Adverse Event|2|||
155227901|NCT00653224|560274069|FG001|Overall Study|Adverse Event|1|||
155227902|NCT00653224|560274068|FG000|Overall Study|Lack of Efficacy|1|||
155227903|NCT00653224|560274069|FG001|Overall Study|Lack of Efficacy|2|||
155227904|NCT00653224|560274068|FG000|Overall Study|Loss of efficacy|1|||
155227905|NCT00653224|560274069|FG001|Overall Study|Loss of efficacy|0|||
155227906|NCT00653224|560274068|FG000|Overall Study|Lost to Follow-up|1|||
155227907|NCT00653224|560274069|FG001|Overall Study|Lost to Follow-up|0|||
155227908|NCT00653224|560274068|FG000|Overall Study|Other|2|||
155227909|NCT00653224|560274069|FG001|Overall Study|Other|4|||
155227910|NCT03756558|560274070|FG000|Overall Study|Death|1|||
155227911|NCT03756558|560274070|FG000|Overall Study|Lost to Follow-up|2|||
155227912|NCT03756558|560274070|FG000|Overall Study|Withdrawal by Subject|2|||
155227913|NCT00773175|560274074|FG000|Overall Study|Adverse Event|2|||
155227914|NCT00773175|560274075|FG001|Overall Study|Adverse Event|0|||
155227915|NCT00773175|560274074|FG000|Overall Study|Consent Withdrawn|0|||
155227916|NCT00773175|560274075|FG001|Overall Study|Consent Withdrawn|2|||
155227917|NCT00503841|560274076|FG000|Overall Study|All screen failures|44|||
155227918|NCT01982253|560274082|FG000|Overall Study|Withdrawal by Subject|1|||
155227919|NCT01982253|560274083|FG001|Overall Study|Withdrawal by Subject|0|||
155227920|NCT01982253|560274084|FG002|Overall Study|Withdrawal by Subject|0|||
155227921|NCT01982253|560274082|FG000|Overall Study|Study terminated by sponsor|1|||
155227922|NCT01982253|560274083|FG001|Overall Study|Study terminated by sponsor|4|||
155227923|NCT01982253|560274084|FG002|Overall Study|Study terminated by sponsor|4|||
155227924|NCT02789176|560274088|FG000|Overall Study|Death|0|||
155227925|NCT02789176|560274089|FG001|Overall Study|Death|0|||
155227926|NCT02789176|560274090|FG002|Overall Study|Death|3|||
155227927|NCT02789176|560274091|FG003|Overall Study|Death|0|||
155227928|NCT02789176|560274088|FG000|Overall Study|Withdrawal by Subject|0|||
155227929|NCT02789176|560274089|FG001|Overall Study|Withdrawal by Subject|0|||
155227930|NCT02789176|560274090|FG002|Overall Study|Withdrawal by Subject|1|||
155227931|NCT02789176|560274091|FG003|Overall Study|Withdrawal by Subject|0|||
155227932|NCT02789176|560274088|FG000|Overall Study|Lost to Follow-up|8|||
155227933|NCT02789176|560274089|FG001|Overall Study|Lost to Follow-up|2|||
155227934|NCT02789176|560274090|FG002|Overall Study|Lost to Follow-up|6|||
155227935|NCT02789176|560274091|FG003|Overall Study|Lost to Follow-up|1|||
155227936|NCT02223767|560274092|FG000|Overall Study|Withdrawal by Subject|4|||
155227937|NCT02223767|560274093|FG001|Overall Study|Withdrawal by Subject|4|||
155227938|NCT02347527|560274094|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
155227939|NCT02347527|560274095|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
155227940|NCT02347527|560274096|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
155227941|NCT02347527|560274097|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
155227942|NCT02347527|560274094|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
155227943|NCT02347527|560274095|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
155227944|NCT02347527|560274096|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
155227945|NCT02347527|560274097|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
155227946|NCT02347527|560274094|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
155227947|NCT02347527|560274095|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
155227948|NCT02347527|560274096|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
155227949|NCT02347527|560274097|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
155227950|NCT02347527|560274094|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
155227951|NCT02347527|560274095|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
155227952|NCT02347527|560274096|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
155227953|NCT02347527|560274097|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
155227954|NCT02347527|560274094|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
155227955|NCT02347527|560274095|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
155227956|NCT02347527|560274096|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
155227957|NCT02347527|560274097|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
155227958|NCT00192075|560274098|FG000|Overall Study|Disease Progression|23|||
155227959|NCT00192075|560274099|FG001|Overall Study|Disease Progression|6|||
155227960|NCT00192075|560274098|FG000|Overall Study|Adverse Event|1|||
155227961|NCT00192075|560274099|FG001|Overall Study|Adverse Event|3|||
155227962|NCT00192075|560274098|FG000|Overall Study|Death|0|||
155227963|NCT00192075|560274099|FG001|Overall Study|Death|1|||
155227964|NCT00192075|560274098|FG000|Overall Study|Lack of Efficacy|0|||
155227965|NCT00192075|560274099|FG001|Overall Study|Lack of Efficacy|0|||
155227966|NCT00192075|560274098|FG000|Overall Study|Physician Decision|3|||
155227967|NCT00192075|560274099|FG001|Overall Study|Physician Decision|0|||
155227968|NCT00192075|560274098|FG000|Overall Study|Withdrawal by Subject|5|||
155227969|NCT00192075|560274099|FG001|Overall Study|Withdrawal by Subject|5|||
155227970|NCT00192075|560274098|FG000|Overall Study|Patient Non-Compliance|0|||
155227971|NCT00192075|560274099|FG001|Overall Study|Patient Non-Compliance|1|||
155227972|NCT00192075|560274098|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
155227973|NCT00192075|560274099|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
155227974|NCT00192075|560274098|FG000|Overall Study|Other|5|||
155227975|NCT00192075|560274099|FG001|Overall Study|Other|2|||
155227976|NCT00910715|560274102|FG000|Overall Study|Lost to Follow-up|22|||
155227977|NCT00910715|560274103|FG001|Overall Study|Lost to Follow-up|26|||
155227978|NCT00910715|560274104|FG002|Overall Study|Lost to Follow-up|0|||
155227979|NCT02412631|560274105|FG000|Overall Study|Adverse Event|1|||
155227980|NCT02412631|560274106|FG001|Overall Study|Adverse Event|2|||
155227981|NCT02412631|560274105|FG000|Overall Study|Lost to Follow-up|5|||
155227982|NCT02412631|560274106|FG001|Overall Study|Lost to Follow-up|9|||
155227983|NCT02412631|560274105|FG000|Overall Study|Withdrawal by Subject|9|||
155227984|NCT02412631|560274106|FG001|Overall Study|Withdrawal by Subject|3|||
155227985|NCT02412631|560274105|FG000|Overall Study|Early stop by FDA|5|||
155227986|NCT02412631|560274106|FG001|Overall Study|Early stop by FDA|2|||
155227987|NCT02412631|560274105|FG000|Overall Study|Unspecified reason|6|||
155227988|NCT02412631|560274106|FG001|Overall Study|Unspecified reason|8|||
155227989|NCT02884089|560274107|FG000|Period 1|Dosing error|2|||
155227990|NCT02884089|560274108|FG001|Period 1|Dosing error|2|||
155227991|NCT02884089|560274109|FG002|Period 1|Dosing error|0|||
155227992|NCT02884089|560274110|FG003|Period 1|Dosing error|0|||
155227993|NCT02884089|560274107|FG000|Washout Period 1|Lost to Follow-up|0|||
155227994|NCT02884089|560274108|FG001|Washout Period 1|Lost to Follow-up|1|||
155227995|NCT02884089|560274109|FG002|Washout Period 1|Lost to Follow-up|0|||
155227996|NCT02884089|560274110|FG003|Washout Period 1|Lost to Follow-up|1|||
155227997|NCT02884089|560274107|FG000|Washout Period 1|Withdrawal by Subject|0|||
155227998|NCT02884089|560274108|FG001|Washout Period 1|Withdrawal by Subject|1|||
155227999|NCT02884089|560274109|FG002|Washout Period 1|Withdrawal by Subject|0|||
155228000|NCT02884089|560274110|FG003|Washout Period 1|Withdrawal by Subject|0|||
155228001|NCT02884089|560274107|FG000|Period 2|Adverse Event|1|||
155228002|NCT02884089|560274108|FG001|Period 2|Adverse Event|0|||
155228003|NCT02884089|560274109|FG002|Period 2|Adverse Event|0|||
155228004|NCT02884089|560274110|FG003|Period 2|Adverse Event|0|||
155228005|NCT02884089|560274107|FG000|Period 3|Withdrawal by Subject|0|||
155228006|NCT02884089|560274108|FG001|Period 3|Withdrawal by Subject|0|||
155228007|NCT02884089|560274109|FG002|Period 3|Withdrawal by Subject|1|||
155228008|NCT02884089|560274110|FG003|Period 3|Withdrawal by Subject|0|||
155228009|NCT02884089|560274107|FG000|Washout Period 3|Withdrawal by Subject|0|||
155228010|NCT02884089|560274108|FG001|Washout Period 3|Withdrawal by Subject|0|||
155228011|NCT02884089|560274109|FG002|Washout Period 3|Withdrawal by Subject|1|||
155228012|NCT02884089|560274110|FG003|Washout Period 3|Withdrawal by Subject|0|||
155228013|NCT02884089|560274107|FG000|Washout Period 3|Lost to Follow-up|0|||
155228014|NCT02884089|560274108|FG001|Washout Period 3|Lost to Follow-up|0|||
155228015|NCT02884089|560274109|FG002|Washout Period 3|Lost to Follow-up|0|||
155228016|NCT02884089|560274110|FG003|Washout Period 3|Lost to Follow-up|1|||
155228017|NCT02884089|560274107|FG000|Period 4|Withdrawal by Subject|0|||
155228018|NCT02884089|560274108|FG001|Period 4|Withdrawal by Subject|1|||
155228019|NCT02884089|560274109|FG002|Period 4|Withdrawal by Subject|0|||
155228020|NCT02884089|560274110|FG003|Period 4|Withdrawal by Subject|0|||
155228021|NCT02884089|560274107|FG000|Period 4|Lost to Follow-up|1|||
155228022|NCT02884089|560274108|FG001|Period 4|Lost to Follow-up|0|||
155228023|NCT02884089|560274109|FG002|Period 4|Lost to Follow-up|0|||
155228024|NCT02884089|560274110|FG003|Period 4|Lost to Follow-up|0|||
155228025|NCT02884089|560274107|FG000|Follow-up Visit|Withdrawal by Subject|1|||
155228026|NCT02884089|560274108|FG001|Follow-up Visit|Withdrawal by Subject|0|||
155228027|NCT02884089|560274109|FG002|Follow-up Visit|Withdrawal by Subject|0|||
155228028|NCT02884089|560274110|FG003|Follow-up Visit|Withdrawal by Subject|1|||
155228029|NCT05288556|560274116|FG000|Overall Study|Protocol Violation|1|||
155228030|NCT05288556|560274116|FG000|Overall Study|Withdrawal by Subject|1|||
155228031|NCT02465528|560274117|FG000|Overall Study|Progressive disease|0|||
155228032|NCT02465528|560274118|FG001|Overall Study|Progressive disease|2|||
155228033|NCT02465528|560274119|FG002|Overall Study|Progressive disease|9|||
155228034|NCT02465528|560274120|FG003|Overall Study|Progressive disease|4|||
155228035|NCT02465528|560274117|FG000|Overall Study|Study terminated by sponsor|1|||
155228036|NCT02465528|560274118|FG001|Overall Study|Study terminated by sponsor|2|||
155228037|NCT02465528|560274119|FG002|Overall Study|Study terminated by sponsor|0|||
155228038|NCT02465528|560274120|FG003|Overall Study|Study terminated by sponsor|0|||
155228039|NCT02465528|560274117|FG000|Overall Study|Withdrawal by Subject|0|||
155228040|NCT02465528|560274118|FG001|Overall Study|Withdrawal by Subject|0|||
155228041|NCT02465528|560274119|FG002|Overall Study|Withdrawal by Subject|2|||
155228042|NCT02465528|560274120|FG003|Overall Study|Withdrawal by Subject|0|||
155228043|NCT02465528|560274117|FG000|Overall Study|Adverse Event|0|||
155228044|NCT02465528|560274118|FG001|Overall Study|Adverse Event|0|||
155228045|NCT02465528|560274119|FG002|Overall Study|Adverse Event|0|||
155228046|NCT02465528|560274120|FG003|Overall Study|Adverse Event|1|||
155228047|NCT02465528|560274117|FG000|Overall Study|Physician Decision|0|||
155228048|NCT02465528|560274118|FG001|Overall Study|Physician Decision|0|||
155228049|NCT02465528|560274119|FG002|Overall Study|Physician Decision|1|||
155228050|NCT02465528|560274120|FG003|Overall Study|Physician Decision|0|||
155228051|NCT05040152|560274125|FG000|Overall Study|Withdrawal by Subject|5|||
155228052|NCT05040152|560274126|FG001|Overall Study|Withdrawal by Subject|0|||
155228053|NCT05040152|560274125|FG000|Overall Study|Lost to Follow-up|0|||
155228054|NCT05040152|560274126|FG001|Overall Study|Lost to Follow-up|2|||
155228055|NCT03400332|560274127|FG000|Pre-Treatment|Other reasons|0|||
155228056|NCT03400332|560274128|FG001|Pre-Treatment|Other reasons|0|||
155228057|NCT03400332|560274129|FG002|Pre-Treatment|Other reasons|0|||
155228058|NCT03400332|560274130|FG003|Pre-Treatment|Other reasons|0|||
155228059|NCT03400332|560274131|FG004|Pre-Treatment|Other reasons|0|||
155228060|NCT03400332|560274132|FG005|Pre-Treatment|Other reasons|0|||
155228061|NCT03400332|560274133|FG006|Pre-Treatment|Other reasons|0|||
155228062|NCT03400332|560274134|FG007|Pre-Treatment|Other reasons|0|||
155228063|NCT03400332|560274135|FG008|Pre-Treatment|Other reasons|1|||
155228064|NCT03400332|560274127|FG000|Pre-Treatment|No longer met study criteria|0|||
155228065|NCT03400332|560274128|FG001|Pre-Treatment|No longer met study criteria|0|||
155228066|NCT03400332|560274129|FG002|Pre-Treatment|No longer met study criteria|0|||
155228067|NCT03400332|560274130|FG003|Pre-Treatment|No longer met study criteria|0|||
155228068|NCT03400332|560274131|FG004|Pre-Treatment|No longer met study criteria|0|||
155228069|NCT03400332|560274132|FG005|Pre-Treatment|No longer met study criteria|0|||
155228070|NCT03400332|560274133|FG006|Pre-Treatment|No longer met study criteria|0|||
155228071|NCT03400332|560274134|FG007|Pre-Treatment|No longer met study criteria|0|||
155228072|NCT03400332|560274135|FG008|Pre-Treatment|No longer met study criteria|1|||
155228073|NCT03400332|560274127|FG000|Pre-Treatment|Withdrawal by Subject|0|||
155228074|NCT03400332|560274128|FG001|Pre-Treatment|Withdrawal by Subject|0|||
155228075|NCT03400332|560274129|FG002|Pre-Treatment|Withdrawal by Subject|0|||
155228076|NCT03400332|560274130|FG003|Pre-Treatment|Withdrawal by Subject|0|||
155228077|NCT03400332|560274131|FG004|Pre-Treatment|Withdrawal by Subject|0|||
155228078|NCT03400332|560274132|FG005|Pre-Treatment|Withdrawal by Subject|0|||
155228079|NCT03400332|560274133|FG006|Pre-Treatment|Withdrawal by Subject|0|||
155228080|NCT03400332|560274134|FG007|Pre-Treatment|Withdrawal by Subject|0|||
155228081|NCT03400332|560274135|FG008|Pre-Treatment|Withdrawal by Subject|1|||
155228082|NCT03400332|560274127|FG000|Treatment|Participant withdrew consent|2|||
155228083|NCT03400332|560274128|FG001|Treatment|Participant withdrew consent|2|||
155228084|NCT03400332|560274129|FG002|Treatment|Participant withdrew consent|0|||
155228085|NCT03400332|560274130|FG003|Treatment|Participant withdrew consent|0|||
155228086|NCT03400332|560274131|FG004|Treatment|Participant withdrew consent|3|||
155228087|NCT03400332|560274132|FG005|Treatment|Participant withdrew consent|3|||
155228088|NCT03400332|560274133|FG006|Treatment|Participant withdrew consent|1|||
155228089|NCT03400332|560274134|FG007|Treatment|Participant withdrew consent|1|||
155228090|NCT03400332|560274135|FG008|Treatment|Participant withdrew consent|1|||
155228091|NCT03400332|560274127|FG000|Treatment|Other reasons|0|||
155228092|NCT03400332|560274128|FG001|Treatment|Other reasons|1|||
155228093|NCT03400332|560274129|FG002|Treatment|Other reasons|1|||
155228094|NCT03400332|560274130|FG003|Treatment|Other reasons|0|||
155228095|NCT03400332|560274131|FG004|Treatment|Other reasons|3|||
155228096|NCT03400332|560274132|FG005|Treatment|Other reasons|1|||
155228097|NCT03400332|560274133|FG006|Treatment|Other reasons|2|||
155228098|NCT03400332|560274134|FG007|Treatment|Other reasons|0|||
155228099|NCT03400332|560274135|FG008|Treatment|Other reasons|1|||
155228100|NCT03400332|560274127|FG000|Treatment|Lost to Follow-up|0|||
155228101|NCT03400332|560274128|FG001|Treatment|Lost to Follow-up|1|||
155228102|NCT03400332|560274129|FG002|Treatment|Lost to Follow-up|0|||
155228103|NCT03400332|560274130|FG003|Treatment|Lost to Follow-up|0|||
155228104|NCT03400332|560274131|FG004|Treatment|Lost to Follow-up|0|||
155228105|NCT03400332|560274132|FG005|Treatment|Lost to Follow-up|0|||
155228106|NCT03400332|560274133|FG006|Treatment|Lost to Follow-up|0|||
155228107|NCT03400332|560274134|FG007|Treatment|Lost to Follow-up|0|||
155228108|NCT03400332|560274135|FG008|Treatment|Lost to Follow-up|0|||
155228109|NCT03400332|560274127|FG000|Treatment|Death|3|||
155228110|NCT03400332|560274128|FG001|Treatment|Death|1|||
155228111|NCT03400332|560274129|FG002|Treatment|Death|2|||
155228112|NCT03400332|560274130|FG003|Treatment|Death|3|||
155228113|NCT03400332|560274131|FG004|Treatment|Death|6|||
155228114|NCT03400332|560274132|FG005|Treatment|Death|2|||
155228115|NCT03400332|560274133|FG006|Treatment|Death|1|||
155228116|NCT03400332|560274134|FG007|Treatment|Death|3|||
155228117|NCT03400332|560274135|FG008|Treatment|Death|6|||
155228118|NCT03795610|560274139|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
155228119|NCT03795610|560274139|FG000|Overall Study|Withdrawal by Subject|1|||
155228120|NCT03795610|560274139|FG000|Overall Study|Screen Failure (Unknown)|1|||
155228121|NCT02775344|560274140|FG000|Overall Study|No ovarian cyst identified|3|||
155228122|NCT02775344|560274141|FG001|Overall Study|No ovarian cyst identified|2|||
155228123|NCT00235872|560274142|FG000|Overall Study|Adverse Event|34|||
155228124|NCT00235872|560274142|FG000|Overall Study|Death|1|||
155228125|NCT00235872|560274142|FG000|Overall Study|Lost to Follow-up|1|||
155228126|NCT00235872|560274142|FG000|Overall Study|Withdrawal by Subject|50|||
155228127|NCT00235872|560274142|FG000|Overall Study|Administrative reason|61|||
155228128|NCT02027844|560274143|FG000|Overall Study|Withdrawal by Subject|3|||
155228129|NCT02027844|560274144|FG001|Overall Study|Withdrawal by Subject|2|||
155228130|NCT02027844|560274145|FG002|Overall Study|Withdrawal by Subject|1|||
155228131|NCT02027844|560274143|FG000|Overall Study|Lost to Follow-up|0|||
155228132|NCT02027844|560274144|FG001|Overall Study|Lost to Follow-up|2|||
155228133|NCT02027844|560274145|FG002|Overall Study|Lost to Follow-up|1|||
155228134|NCT02027844|560274143|FG000|Overall Study|Protocol Violation|0|||
155228135|NCT02027844|560274144|FG001|Overall Study|Protocol Violation|2|||
155228136|NCT02027844|560274145|FG002|Overall Study|Protocol Violation|0|||
155228137|NCT02027844|560274143|FG000|Overall Study|Incomlete data|2|||
155228138|NCT02027844|560274144|FG001|Overall Study|Incomlete data|0|||
155228139|NCT02027844|560274145|FG002|Overall Study|Incomlete data|0|||
155228140|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
155228141|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
155228142|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Graft loss|1|||
155228143|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Graft loss|2|||
155228144|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Death|5|||
155228145|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Death|3|||
155228146|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
155228147|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
155228148|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
155228149|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
155228150|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
155228151|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
155228152|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
155228153|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
155228154|NCT00378014|560274146|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
155228155|NCT00378014|560274147|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
155228156|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
155228157|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
155228158|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Death|1|||
155228159|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Death|2|||
155228160|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
155228161|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
155228162|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
155228163|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
155228164|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
155228165|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
155228166|NCT00378014|560274146|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
155228167|NCT00378014|560274147|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
155228168|NCT00414661|560274151|FG000|Overall Study|Death|2|||
155228169|NCT00414661|560274152|FG001|Overall Study|Death|5|||
155228170|NCT00414661|560274153|FG002|Overall Study|Death|0|||
155228171|NCT00414661|560274154|FG003|Overall Study|Death|0|||
155228172|NCT00414661|560274151|FG000|Overall Study|Lost to Follow-up|1|||
155228173|NCT00414661|560274152|FG001|Overall Study|Lost to Follow-up|4|||
155228174|NCT00414661|560274153|FG002|Overall Study|Lost to Follow-up|0|||
155228175|NCT00414661|560274154|FG003|Overall Study|Lost to Follow-up|1|||
155228176|NCT00414661|560274151|FG000|Overall Study|Withdrawal by Subject|5|||
155228177|NCT00414661|560274152|FG001|Overall Study|Withdrawal by Subject|2|||
155228178|NCT00414661|560274153|FG002|Overall Study|Withdrawal by Subject|2|||
155228179|NCT00414661|560274154|FG003|Overall Study|Withdrawal by Subject|2|||
155228180|NCT00414661|560274151|FG000|Overall Study|Other|6|||
155228181|NCT00414661|560274152|FG001|Overall Study|Other|3|||
155228182|NCT00414661|560274153|FG002|Overall Study|Other|0|||
155228183|NCT00414661|560274154|FG003|Overall Study|Other|0|||
155228184|NCT02852265|560274155|FG000|3-month Follow-up|Lost to Follow-up|1|||
155228185|NCT02852265|560274156|FG001|3-month Follow-up|Lost to Follow-up|1|||
155228186|NCT04370691|560274165|FG000|Overall Study|Pending visit|48|||
155228187|NCT04370691|560274165|FG000|Overall Study|Have Not Reached Lower Window|15|||
155228188|NCT04370691|560274165|FG000|Overall Study|Termination|14|||
155228189|NCT04370691|560274165|FG000|Overall Study|Missed or Overdue|10|||
155228190|NCT03013543|560274166|FG000|Overall Study|Withdrawal by Subject|0|||
155228191|NCT03013543|560274167|FG001|Overall Study|Withdrawal by Subject|2|||
155228192|NCT03013543|560274168|FG002|Overall Study|Withdrawal by Subject|0|||
155228193|NCT03013543|560274169|FG003|Overall Study|Withdrawal by Subject|5|||
155228194|NCT03013543|560274170|FG004|Overall Study|Withdrawal by Subject|6|||
155228195|NCT03013543|560274171|FG005|Overall Study|Withdrawal by Subject|2|||
155228196|NCT03013543|560274172|FG006|Overall Study|Withdrawal by Subject|3|||
155228197|NCT03013543|560274173|FG007|Overall Study|Withdrawal by Subject|1|||
155228198|NCT03013543|560274174|FG008|Overall Study|Withdrawal by Subject|0|||
155228199|NCT03013543|560274175|FG009|Overall Study|Withdrawal by Subject|4|||
155228200|NCT03013543|560274166|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155228201|NCT03013543|560274167|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
155228202|NCT03013543|560274168|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
155228203|NCT03013543|560274169|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
155228204|NCT03013543|560274170|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
155228205|NCT03013543|560274171|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
155228206|NCT03013543|560274172|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
155228207|NCT03013543|560274173|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
155228208|NCT03013543|560274174|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
155228209|NCT03013543|560274175|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
155228210|NCT03013543|560274166|FG000|Overall Study|Other|0|||
155228211|NCT03013543|560274167|FG001|Overall Study|Other|0|||
155228212|NCT03013543|560274168|FG002|Overall Study|Other|2|||
155228213|NCT03013543|560274169|FG003|Overall Study|Other|0|||
155228214|NCT03013543|560274170|FG004|Overall Study|Other|2|||
155228215|NCT03013543|560274171|FG005|Overall Study|Other|0|||
155228216|NCT03013543|560274172|FG006|Overall Study|Other|0|||
155228217|NCT03013543|560274173|FG007|Overall Study|Other|0|||
155228218|NCT03013543|560274174|FG008|Overall Study|Other|1|||
155228219|NCT03013543|560274175|FG009|Overall Study|Other|0|||
155228220|NCT03013543|560274166|FG000|Overall Study|Adverse Event|0|||
155228221|NCT03013543|560274167|FG001|Overall Study|Adverse Event|0|||
155228222|NCT03013543|560274168|FG002|Overall Study|Adverse Event|0|||
155228223|NCT03013543|560274169|FG003|Overall Study|Adverse Event|3|||
155228224|NCT03013543|560274170|FG004|Overall Study|Adverse Event|2|||
155228225|NCT03013543|560274171|FG005|Overall Study|Adverse Event|1|||
155228226|NCT03013543|560274172|FG006|Overall Study|Adverse Event|3|||
155228227|NCT03013543|560274173|FG007|Overall Study|Adverse Event|8|||
155228228|NCT03013543|560274174|FG008|Overall Study|Adverse Event|0|||
155228229|NCT03013543|560274175|FG009|Overall Study|Adverse Event|2|||
155228230|NCT03013543|560274166|FG000|Overall Study|Death|0|||
155228231|NCT03013543|560274167|FG001|Overall Study|Death|0|||
155228232|NCT03013543|560274168|FG002|Overall Study|Death|0|||
155228233|NCT03013543|560274169|FG003|Overall Study|Death|1|||
155228234|NCT03013543|560274170|FG004|Overall Study|Death|0|||
155228235|NCT03013543|560274171|FG005|Overall Study|Death|0|||
155228236|NCT03013543|560274172|FG006|Overall Study|Death|0|||
155228237|NCT03013543|560274173|FG007|Overall Study|Death|0|||
155228238|NCT03013543|560274174|FG008|Overall Study|Death|0|||
155228239|NCT03013543|560274175|FG009|Overall Study|Death|0|||
155228240|NCT03013543|560274166|FG000|Overall Study|Lack of Efficacy|0|||
155228241|NCT03013543|560274167|FG001|Overall Study|Lack of Efficacy|0|||
155228242|NCT03013543|560274168|FG002|Overall Study|Lack of Efficacy|0|||
155228243|NCT03013543|560274169|FG003|Overall Study|Lack of Efficacy|1|||
155228244|NCT03013543|560274170|FG004|Overall Study|Lack of Efficacy|0|||
155228245|NCT03013543|560274171|FG005|Overall Study|Lack of Efficacy|0|||
155228246|NCT03013543|560274172|FG006|Overall Study|Lack of Efficacy|0|||
155228247|NCT03013543|560274173|FG007|Overall Study|Lack of Efficacy|0|||
155228248|NCT03013543|560274174|FG008|Overall Study|Lack of Efficacy|0|||
155228249|NCT03013543|560274175|FG009|Overall Study|Lack of Efficacy|0|||
155228250|NCT03013543|560274166|FG000|Overall Study|Lost to Follow-up|0|||
155228251|NCT03013543|560274167|FG001|Overall Study|Lost to Follow-up|0|||
155228252|NCT03013543|560274168|FG002|Overall Study|Lost to Follow-up|0|||
155228253|NCT03013543|560274169|FG003|Overall Study|Lost to Follow-up|1|||
155228254|NCT03013543|560274170|FG004|Overall Study|Lost to Follow-up|0|||
155228255|NCT03013543|560274171|FG005|Overall Study|Lost to Follow-up|0|||
155228256|NCT03013543|560274172|FG006|Overall Study|Lost to Follow-up|1|||
155228257|NCT03013543|560274173|FG007|Overall Study|Lost to Follow-up|0|||
155228258|NCT03013543|560274174|FG008|Overall Study|Lost to Follow-up|0|||
155228259|NCT03013543|560274175|FG009|Overall Study|Lost to Follow-up|2|||
155228260|NCT03013543|560274166|FG000|Overall Study|Non-Compliance With Study Drug|0|||
155228261|NCT03013543|560274167|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155228262|NCT03013543|560274168|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155228263|NCT03013543|560274169|FG003|Overall Study|Non-Compliance With Study Drug|0|||
155228264|NCT03013543|560274170|FG004|Overall Study|Non-Compliance With Study Drug|0|||
155228265|NCT03013543|560274171|FG005|Overall Study|Non-Compliance With Study Drug|0|||
155228266|NCT03013543|560274172|FG006|Overall Study|Non-Compliance With Study Drug|0|||
155228267|NCT03013543|560274173|FG007|Overall Study|Non-Compliance With Study Drug|0|||
155228268|NCT03013543|560274174|FG008|Overall Study|Non-Compliance With Study Drug|1|||
155228269|NCT03013543|560274175|FG009|Overall Study|Non-Compliance With Study Drug|0|||
155228270|NCT03013543|560274166|FG000|Overall Study|Physician Decision|0|||
155228271|NCT03013543|560274167|FG001|Overall Study|Physician Decision|0|||
155228272|NCT03013543|560274168|FG002|Overall Study|Physician Decision|0|||
155228273|NCT03013543|560274169|FG003|Overall Study|Physician Decision|0|||
155228274|NCT03013543|560274170|FG004|Overall Study|Physician Decision|1|||
155228275|NCT03013543|560274171|FG005|Overall Study|Physician Decision|0|||
155228276|NCT03013543|560274172|FG006|Overall Study|Physician Decision|0|||
155228277|NCT03013543|560274173|FG007|Overall Study|Physician Decision|0|||
155228278|NCT03013543|560274174|FG008|Overall Study|Physician Decision|0|||
155228279|NCT03013543|560274175|FG009|Overall Study|Physician Decision|0|||
155228280|NCT03013543|560274166|FG000|Overall Study|Protocol Violation|0|||
155228281|NCT03013543|560274167|FG001|Overall Study|Protocol Violation|0|||
155228282|NCT03013543|560274168|FG002|Overall Study|Protocol Violation|0|||
155228283|NCT03013543|560274169|FG003|Overall Study|Protocol Violation|0|||
155228284|NCT03013543|560274170|FG004|Overall Study|Protocol Violation|0|||
155228285|NCT03013543|560274171|FG005|Overall Study|Protocol Violation|0|||
155228286|NCT03013543|560274172|FG006|Overall Study|Protocol Violation|0|||
155228287|NCT03013543|560274173|FG007|Overall Study|Protocol Violation|0|||
155228288|NCT03013543|560274174|FG008|Overall Study|Protocol Violation|0|||
155228289|NCT03013543|560274175|FG009|Overall Study|Protocol Violation|1|||
155228290|NCT00323414|560274176|FG000|Overall Study|Withdrawal by Subject|0|||
155228291|NCT00323414|560274177|FG001|Overall Study|Withdrawal by Subject|1|||
155228292|NCT02552316|560274178|FG000|Overall Study|Withdrawal by Subject|1|||
155228293|NCT02552316|560274178|FG000|Overall Study|Withdrawal due to non-compliance|1|||
155228294|NCT04116710|560274181|FG000|Overall Study|Death|4|||
155228295|NCT04116710|560274182|FG001|Overall Study|Death|6|||
155228296|NCT04116710|560274183|FG002|Overall Study|Death|3|||
155228297|NCT04116710|560274184|FG003|Overall Study|Death|1|||
155228298|NCT04116710|560274181|FG000|Overall Study|Withdrawal by Subject|0|||
155228299|NCT04116710|560274182|FG001|Overall Study|Withdrawal by Subject|0|||
155228300|NCT04116710|560274183|FG002|Overall Study|Withdrawal by Subject|0|||
155228301|NCT04116710|560274184|FG003|Overall Study|Withdrawal by Subject|1|||
155228302|NCT04049760|560274188|FG000|Overall Study|Withdrawal by Subject|1|||
155228303|NCT00974571|560274189|FG000|Overall Study|Adverse Event|31|||
155228304|NCT00974571|560274190|FG001|Overall Study|Adverse Event|4|||
155228305|NCT00974571|560274191|FG002|Overall Study|Adverse Event|27|||
155228306|NCT00974571|560274189|FG000|Overall Study|Lack of Efficacy|3|||
155228307|NCT00974571|560274190|FG001|Overall Study|Lack of Efficacy|2|||
155228308|NCT00974571|560274191|FG002|Overall Study|Lack of Efficacy|9|||
155228309|NCT00974571|560274189|FG000|Overall Study|Lost to Follow-up|2|||
155228310|NCT00974571|560274190|FG001|Overall Study|Lost to Follow-up|1|||
155228311|NCT00974571|560274191|FG002|Overall Study|Lost to Follow-up|2|||
155228312|NCT00974571|560274189|FG000|Overall Study|Protocol Violation|13|||
155228313|NCT00974571|560274190|FG001|Overall Study|Protocol Violation|4|||
155228314|NCT00974571|560274191|FG002|Overall Study|Protocol Violation|18|||
155228315|NCT00974571|560274189|FG000|Overall Study|Withdrawal by Subject|14|||
155228316|NCT00974571|560274190|FG001|Overall Study|Withdrawal by Subject|5|||
155228317|NCT00974571|560274191|FG002|Overall Study|Withdrawal by Subject|16|||
155228318|NCT00974571|560274189|FG000|Overall Study|Patient Moved|1|||
155228319|NCT00974571|560274190|FG001|Overall Study|Patient Moved|0|||
155228320|NCT00974571|560274191|FG002|Overall Study|Patient Moved|1|||
155228321|NCT00974571|560274189|FG000|Overall Study|Other|4|||
155228322|NCT00974571|560274190|FG001|Overall Study|Other|0|||
155228323|NCT00974571|560274191|FG002|Overall Study|Other|10|||
155228324|NCT03778931|560274197|FG000|Overall Study|Withdrawal by Subject|12|||
155228325|NCT03778931|560274198|FG001|Overall Study|Withdrawal by Subject|25|||
155228326|NCT03778931|560274197|FG000|Overall Study|Physician Decision|1|||
155228327|NCT03778931|560274198|FG001|Overall Study|Physician Decision|3|||
155228328|NCT03778931|560274197|FG000|Overall Study|Participant Noncompliance|1|||
155228329|NCT03778931|560274198|FG001|Overall Study|Participant Noncompliance|1|||
155228330|NCT03778931|560274197|FG000|Overall Study|Lost to Follow-up|4|||
155228331|NCT03778931|560274198|FG001|Overall Study|Lost to Follow-up|1|||
155228332|NCT03778931|560274197|FG000|Overall Study|Death|69|||
155228333|NCT03778931|560274198|FG001|Overall Study|Death|79|||
155228334|NCT02130765|560274199|FG000|Overall Study|Did not receive treatment|4|||
155228335|NCT02130765|560274200|FG001|Overall Study|Did not receive treatment|0|||
155228336|NCT02130765|560274201|FG002|Overall Study|Did not receive treatment|0|||
155228337|NCT02130765|560274202|FG003|Overall Study|Did not receive treatment|0|||
155228338|NCT00717769|560274210|FG000|Overall Study|Adverse Event|9|||
155228339|NCT00717769|560274211|FG001|Overall Study|Adverse Event|6|||
155228340|NCT00717769|560274212|FG002|Overall Study|Adverse Event|1|||
155228341|NCT00717769|560274210|FG000|Overall Study|Lack of compliance|0|||
155228342|NCT00717769|560274211|FG001|Overall Study|Lack of compliance|2|||
155228343|NCT00717769|560274212|FG002|Overall Study|Lack of compliance|0|||
155228344|NCT00717769|560274210|FG000|Overall Study|Lost to Follow-up|3|||
155228345|NCT00717769|560274211|FG001|Overall Study|Lost to Follow-up|4|||
155228346|NCT00717769|560274212|FG002|Overall Study|Lost to Follow-up|0|||
155228347|NCT00717769|560274210|FG000|Overall Study|Lack of Efficacy|1|||
155228348|NCT00717769|560274211|FG001|Overall Study|Lack of Efficacy|2|||
155228349|NCT00717769|560274212|FG002|Overall Study|Lack of Efficacy|0|||
155228350|NCT00717769|560274210|FG000|Overall Study|Protocol Violation|0|||
155228351|NCT00717769|560274211|FG001|Overall Study|Protocol Violation|2|||
155228352|NCT00717769|560274212|FG002|Overall Study|Protocol Violation|0|||
155228353|NCT00717769|560274210|FG000|Overall Study|Sponsor decision|1|||
155228354|NCT00717769|560274211|FG001|Overall Study|Sponsor decision|0|||
155228355|NCT00717769|560274212|FG002|Overall Study|Sponsor decision|10|||
155228356|NCT00717769|560274210|FG000|Overall Study|Withdrew consent|2|||
155228357|NCT00717769|560274211|FG001|Overall Study|Withdrew consent|2|||
155228358|NCT00717769|560274212|FG002|Overall Study|Withdrew consent|0|||
155228359|NCT00692770|560274213|FG000|Overall Study|Protocol Violation|2|||
155228360|NCT00692770|560274214|FG001|Overall Study|Protocol Violation|7|||
155228361|NCT00692770|560274213|FG000|Overall Study|Withdrawal by Subject|97|||
155228362|NCT00692770|560274214|FG001|Overall Study|Withdrawal by Subject|36|||
155228363|NCT00692770|560274213|FG000|Overall Study|Adverse Event|136|||
155228364|NCT00692770|560274214|FG001|Overall Study|Adverse Event|41|||
155228365|NCT00692770|560274213|FG000|Overall Study|Death|10|||
155228366|NCT00692770|560274214|FG001|Overall Study|Death|5|||
155228367|NCT00692770|560274213|FG000|Overall Study|Lost to Follow-up|7|||
155228368|NCT00692770|560274214|FG001|Overall Study|Lost to Follow-up|3|||
155228369|NCT00692770|560274213|FG000|Overall Study|Non-compliant with study medication|11|||
155228370|NCT00692770|560274214|FG001|Overall Study|Non-compliant with study medication|5|||
155228371|NCT00692770|560274213|FG000|Overall Study|Progression by clinical judgment|2|||
155228372|NCT00692770|560274214|FG001|Overall Study|Progression by clinical judgment|3|||
155228373|NCT00692770|560274213|FG000|Overall Study|Physician decision not protocol driven|10|||
155228374|NCT00692770|560274214|FG001|Overall Study|Physician decision not protocol driven|14|||
155228375|NCT00692770|560274213|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
155228376|NCT00692770|560274214|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
155228377|NCT00692770|560274213|FG000|Overall Study|Protocol driven decision point|3|||
155228378|NCT00692770|560274214|FG001|Overall Study|Protocol driven decision point|7|||
155228379|NCT00692770|560274213|FG000|Overall Study|Completed all planned assessments|79|||
155228380|NCT00692770|560274214|FG001|Overall Study|Completed all planned assessments|101|||
155228381|NCT00692770|560274213|FG000|Overall Study|Radiological and clinical progression|8|||
155228382|NCT00692770|560274214|FG001|Overall Study|Radiological and clinical progression|8|||
155228383|NCT00692770|560274213|FG000|Overall Study|Clinical endpoint reached|16|||
155228384|NCT00692770|560274214|FG001|Overall Study|Clinical endpoint reached|43|||
155228385|NCT00692770|560274213|FG000|Overall Study|Study terminated by sponsor|2|||
155228386|NCT00692770|560274214|FG001|Overall Study|Study terminated by sponsor|2|||
155228387|NCT00692770|560274213|FG000|Overall Study|Randomized but not treated|3|||
155228388|NCT00692770|560274214|FG001|Overall Study|Randomized but not treated|4|||
155228389|NCT04327986|560274215|FG000|Overall Study|Physician Decision|2|||
155228390|NCT04327986|560274216|FG001|Overall Study|Physician Decision|0|||
155228391|NCT04327986|560274217|FG002|Overall Study|Physician Decision|0|||
155228392|NCT04327986|560274215|FG000|Overall Study|Death|1|||
155228393|NCT04327986|560274216|FG001|Overall Study|Death|0|||
155228394|NCT04327986|560274217|FG002|Overall Study|Death|0|||
155228395|NCT02917031|560274219|FG000|Overall Study|Reason not specified|7|||
155228396|NCT02917031|560274220|FG001|Overall Study|Reason not specified|5|||
155228397|NCT02917031|560274221|FG002|Overall Study|Reason not specified|6|||
155228398|NCT02917031|560274219|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
155228399|NCT02917031|560274220|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
155228400|NCT02917031|560274221|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
155228401|NCT02917031|560274219|FG000|Overall Study|Withdrawal by Subject|3|||
155228402|NCT02917031|560274220|FG001|Overall Study|Withdrawal by Subject|3|||
155228403|NCT02917031|560274221|FG002|Overall Study|Withdrawal by Subject|0|||
155228404|NCT02917031|560274219|FG000|Overall Study|Physician Decision|1|||
155228405|NCT02917031|560274220|FG001|Overall Study|Physician Decision|0|||
155228406|NCT02917031|560274221|FG002|Overall Study|Physician Decision|0|||
155228407|NCT02917031|560274219|FG000|Overall Study|Adverse Event|4|||
155228408|NCT02917031|560274220|FG001|Overall Study|Adverse Event|1|||
155228409|NCT02917031|560274221|FG002|Overall Study|Adverse Event|5|||
155228410|NCT02917031|560274219|FG000|Overall Study|Death|2|||
155228411|NCT02917031|560274220|FG001|Overall Study|Death|3|||
155228412|NCT02917031|560274221|FG002|Overall Study|Death|4|||
155228413|NCT02896400|560275571|FG000|1 Month Follow-up|Lost to Follow-up|7|||
155228414|NCT02896400|560275572|FG001|1 Month Follow-up|Lost to Follow-up|7|||
155228415|NCT02896400|560275573|FG002|1 Month Follow-up|Lost to Follow-up|5|||
155228416|NCT02896400|560275574|FG003|1 Month Follow-up|Lost to Follow-up|8|||
155228417|NCT02896400|560275575|FG004|1 Month Follow-up|Lost to Follow-up|9|||
155228418|NCT02896400|560275576|FG005|1 Month Follow-up|Lost to Follow-up|6|||
155228419|NCT02896400|560275577|FG006|1 Month Follow-up|Lost to Follow-up|5|||
155228420|NCT02896400|560275578|FG007|1 Month Follow-up|Lost to Follow-up|6|||
155228421|NCT02896400|560275579|FG008|1 Month Follow-up|Lost to Follow-up|4|||
155228422|NCT02896400|560275580|FG009|1 Month Follow-up|Lost to Follow-up|7|||
155228423|NCT02896400|560275581|FG010|1 Month Follow-up|Lost to Follow-up|5|||
155228424|NCT02896400|560275582|FG011|1 Month Follow-up|Lost to Follow-up|5|||
155228425|NCT02896400|560275583|FG012|1 Month Follow-up|Lost to Follow-up|3|||
155228426|NCT02896400|560275584|FG013|1 Month Follow-up|Lost to Follow-up|4|||
155228427|NCT02896400|560275585|FG014|1 Month Follow-up|Lost to Follow-up|1|||
155228428|NCT02896400|560275586|FG015|1 Month Follow-up|Lost to Follow-up|2|||
155228429|NCT02896400|560275571|FG000|1 Month Follow-up|Death|0|||
155228430|NCT02896400|560275572|FG001|1 Month Follow-up|Death|0|||
155228431|NCT02896400|560275573|FG002|1 Month Follow-up|Death|0|||
155228432|NCT02896400|560275574|FG003|1 Month Follow-up|Death|0|||
155228433|NCT02896400|560275575|FG004|1 Month Follow-up|Death|0|||
155228434|NCT02896400|560275576|FG005|1 Month Follow-up|Death|0|||
155228435|NCT02896400|560275577|FG006|1 Month Follow-up|Death|0|||
155228436|NCT02896400|560275578|FG007|1 Month Follow-up|Death|0|||
155228437|NCT02896400|560275579|FG008|1 Month Follow-up|Death|0|||
155228438|NCT02896400|560275580|FG009|1 Month Follow-up|Death|0|||
155228439|NCT02896400|560275581|FG010|1 Month Follow-up|Death|0|||
155228440|NCT02896400|560275582|FG011|1 Month Follow-up|Death|0|||
155228441|NCT02896400|560275583|FG012|1 Month Follow-up|Death|0|||
155228442|NCT02896400|560275584|FG013|1 Month Follow-up|Death|0|||
155228443|NCT02896400|560275585|FG014|1 Month Follow-up|Death|0|||
155228444|NCT02896400|560275586|FG015|1 Month Follow-up|Death|1|||
155228445|NCT02896400|560275571|FG000|3 Month Follow-up|Lost to Follow-up|6|||
155228446|NCT02896400|560275572|FG001|3 Month Follow-up|Lost to Follow-up|3|||
155228447|NCT02896400|560275573|FG002|3 Month Follow-up|Lost to Follow-up|6|||
155228448|NCT02896400|560275574|FG003|3 Month Follow-up|Lost to Follow-up|11|||
155228449|NCT02896400|560275575|FG004|3 Month Follow-up|Lost to Follow-up|12|||
155228450|NCT02896400|560275576|FG005|3 Month Follow-up|Lost to Follow-up|6|||
155228451|NCT02896400|560275577|FG006|3 Month Follow-up|Lost to Follow-up|4|||
155228452|NCT02896400|560275578|FG007|3 Month Follow-up|Lost to Follow-up|3|||
155228453|NCT02896400|560275579|FG008|3 Month Follow-up|Lost to Follow-up|6|||
155228454|NCT02896400|560275580|FG009|3 Month Follow-up|Lost to Follow-up|5|||
155228455|NCT02896400|560275581|FG010|3 Month Follow-up|Lost to Follow-up|6|||
155228456|NCT02896400|560275582|FG011|3 Month Follow-up|Lost to Follow-up|6|||
155228457|NCT02896400|560275583|FG012|3 Month Follow-up|Lost to Follow-up|3|||
155228458|NCT02896400|560275584|FG013|3 Month Follow-up|Lost to Follow-up|5|||
155228459|NCT02896400|560275585|FG014|3 Month Follow-up|Lost to Follow-up|3|||
155228460|NCT02896400|560275586|FG015|3 Month Follow-up|Lost to Follow-up|2|||
155228461|NCT02896400|560275571|FG000|3 Month Follow-up|Death|0|||
155228462|NCT02896400|560275572|FG001|3 Month Follow-up|Death|0|||
155228463|NCT02896400|560275573|FG002|3 Month Follow-up|Death|0|||
155228464|NCT02896400|560275574|FG003|3 Month Follow-up|Death|0|||
155228465|NCT02896400|560275575|FG004|3 Month Follow-up|Death|0|||
155228466|NCT02896400|560275576|FG005|3 Month Follow-up|Death|0|||
155228467|NCT02896400|560275577|FG006|3 Month Follow-up|Death|0|||
155228468|NCT02896400|560275578|FG007|3 Month Follow-up|Death|0|||
155228469|NCT02896400|560275579|FG008|3 Month Follow-up|Death|0|||
155228470|NCT02896400|560275580|FG009|3 Month Follow-up|Death|0|||
155228471|NCT02896400|560275581|FG010|3 Month Follow-up|Death|0|||
155228472|NCT02896400|560275582|FG011|3 Month Follow-up|Death|0|||
155228473|NCT02896400|560275583|FG012|3 Month Follow-up|Death|0|||
155228474|NCT02896400|560275584|FG013|3 Month Follow-up|Death|1|||
155228475|NCT02896400|560275585|FG014|3 Month Follow-up|Death|1|||
155228476|NCT02896400|560275586|FG015|3 Month Follow-up|Death|0|||
155228477|NCT02896400|560275571|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228478|NCT02896400|560275572|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228479|NCT02896400|560275573|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228480|NCT02896400|560275574|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228481|NCT02896400|560275575|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228482|NCT02896400|560275576|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228483|NCT02896400|560275577|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
155228484|NCT02896400|560275578|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
155228485|NCT02896400|560275579|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228486|NCT02896400|560275580|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228487|NCT02896400|560275581|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228488|NCT02896400|560275582|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228489|NCT02896400|560275583|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228490|NCT02896400|560275584|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
155228491|NCT02896400|560275585|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
155228492|NCT02896400|560275586|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
155228493|NCT02896400|560275571|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
155228494|NCT02896400|560275572|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228495|NCT02896400|560275573|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
155228496|NCT02896400|560275574|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
155228497|NCT02896400|560275575|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
155228498|NCT02896400|560275576|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228499|NCT02896400|560275577|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228500|NCT02896400|560275578|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
155228501|NCT02896400|560275579|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
155228502|NCT02896400|560275580|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
155228503|NCT02896400|560275581|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
155228504|NCT02896400|560275582|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
155228505|NCT02896400|560275583|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
155228506|NCT02896400|560275584|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
155228507|NCT02896400|560275585|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
155228508|NCT02896400|560275586|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
155228509|NCT02984020|560275587|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
155228510|NCT02984020|560275587|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
155228511|NCT02984020|560275587|FG000|Overall Study|Other significant protocol violation|2|||
155228512|NCT01700179|560275588|FG000|Overall Study|Physician Decision|2|||
155228513|NCT01896895|560275589|FG000|Double-blind MP|Physician Decision|0|||
155228514|NCT01896895|560275590|FG001|Double-blind MP|Physician Decision|0|||
155228515|NCT01896895|560275591|FG002|Double-blind MP|Physician Decision|1|||
155228516|NCT01896895|560275592|FG003|Double-blind MP|Physician Decision|0|||
155228517|NCT01896895|560275589|FG000|Double-blind MP|Withdrawal by Subject|0|||
155228518|NCT01896895|560275590|FG001|Double-blind MP|Withdrawal by Subject|2|||
155228519|NCT01896895|560275591|FG002|Double-blind MP|Withdrawal by Subject|1|||
155228520|NCT01896895|560275592|FG003|Double-blind MP|Withdrawal by Subject|0|||
155228521|NCT01896895|560275589|FG000|Double-blind MP|Lost to Follow-up|1|||
155228522|NCT01896895|560275590|FG001|Double-blind MP|Lost to Follow-up|0|||
155228523|NCT01896895|560275591|FG002|Double-blind MP|Lost to Follow-up|1|||
155228524|NCT01896895|560275592|FG003|Double-blind MP|Lost to Follow-up|0|||
155228525|NCT01207778|560275593|FG000|Overall Study|Lost to Follow-up|0|||
155228526|NCT01207778|560275594|FG001|Overall Study|Lost to Follow-up|3|||
155228527|NCT01207778|560275595|FG002|Overall Study|Lost to Follow-up|3|||
155228528|NCT00646204|560275598|FG000|Overall Study|Adverse Event|3|||
155228529|NCT00646204|560275599|FG001|Overall Study|Adverse Event|0|||
155228530|NCT00646204|560275598|FG000|Overall Study|Withdrawal by Subject|1|||
155228531|NCT00646204|560275599|FG001|Overall Study|Withdrawal by Subject|0|||
155228532|NCT00779675|560275601|FG000|Treatment Period|Adverse Event|87|||
155228533|NCT00779675|560275601|FG000|Treatment Period|Treatment Failure|80|||
155228534|NCT00779675|560275601|FG000|Treatment Period|Transferred to Another Study|38|||
155228535|NCT00779675|560275601|FG000|Treatment Period|Lost to Follow-up|23|||
155228536|NCT00779675|560275601|FG000|Treatment Period|Withdrawal by Subject|46|||
155228537|NCT00779675|560275601|FG000|Treatment Period|Protocol Violation|54|||
155228538|NCT00779675|560275601|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
155228539|NCT00779675|560275601|FG000|Treatment Period|Administrative|3|||
155228540|NCT00779675|560275601|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
155228541|NCT00779675|560275601|FG000|Extended Treatment Period|Protocol Violation|13|||
155228542|NCT00779675|560275601|FG000|Extended Treatment Period|Adverse Event|6|||
155228543|NCT00779675|560275601|FG000|Extended Treatment Period|Treatment Failure|11|||
155228544|NCT00779675|560275601|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
155228545|NCT00779675|560275601|FG000|Extended Treatment Period|Lost to Follow-up|6|||
155228546|NCT01633944|560275614|FG000|Open-label Titration Phase|Adverse Event|109|||
155228547|NCT01633944|560275615|FG001|Open-label Titration Phase|Adverse Event|0|||
155228548|NCT01633944|560275616|FG002|Open-label Titration Phase|Adverse Event|0|||
155228549|NCT01633944|560275614|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
155228550|NCT01633944|560275615|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
155228551|NCT01633944|560275616|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
155228552|NCT01633944|560275614|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
155228553|NCT01633944|560275615|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
155228554|NCT01633944|560275616|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
155228555|NCT01633944|560275614|FG000|Open-label Titration Phase|Protocol Violation|24|||
155228556|NCT01633944|560275615|FG001|Open-label Titration Phase|Protocol Violation|0|||
155228557|NCT01633944|560275616|FG002|Open-label Titration Phase|Protocol Violation|0|||
155228558|NCT01633944|560275614|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
155228559|NCT01633944|560275615|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
155228560|NCT01633944|560275616|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
155228561|NCT01633944|560275614|FG000|Open-label Titration Phase|Other|68|||
155228562|NCT01633944|560275615|FG001|Open-label Titration Phase|Other|0|||
155228563|NCT01633944|560275616|FG002|Open-label Titration Phase|Other|0|||
155228564|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Adverse Event|0|||
155228565|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Adverse Event|13|||
155228566|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Adverse Event|7|||
155228567|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
155228568|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
155228569|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
155228570|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
155228571|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
155228572|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
155228573|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
155228574|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
155228575|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
155228576|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
155228577|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
155228578|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
155228579|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
155228580|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
155228581|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
155228582|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
155228583|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
155228584|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
155228585|NCT01633944|560275614|FG000|Double-blind Treatment Phase|Other|0|||
155228586|NCT01633944|560275615|FG001|Double-blind Treatment Phase|Other|7|||
155228587|NCT01633944|560275616|FG002|Double-blind Treatment Phase|Other|0|||
155228588|NCT00463060|560275620|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
155228589|NCT00463060|560275620|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
155228590|NCT01400841|560275621|FG000|Initial Study Phase (6 Months)|Death|1|||
155228591|NCT01400841|560275621|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
155228592|NCT00701129|560275622|FG000|Overall Study|Death|2|||
155228593|NCT00770120|560275625|FG000|Overall Study|Progression|31|||
155228594|NCT00770120|560275625|FG000|Overall Study|Adverse Event|11|||
155228595|NCT00770120|560275625|FG000|Overall Study|Not Protocol Specified|11|||
155228596|NCT00770120|560275625|FG000|Overall Study|Death|3|||
155228597|NCT00770120|560275625|FG000|Overall Study|Withdrawal by Subject|2|||
155228598|NCT00770120|560275625|FG000|Overall Study|Ineligible|1|||
155228599|NCT00770120|560275625|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
155228600|NCT00770120|560275625|FG000|Overall Study|Reason under Review|1|||
155228601|NCT04304001|560275626|FG000|Overall Study|Lost to Follow-up|13|||
155228602|NCT04304001|560275627|FG001|Overall Study|Lost to Follow-up|9|||
155228603|NCT03752619|560275628|FG000|Overall Study|Lost to Follow-up|2|||
155228604|NCT03752619|560275629|FG001|Overall Study|Lost to Follow-up|1|||
155228605|NCT03752619|560275628|FG000|Overall Study|Withdrawal by Subject|1|||
155228606|NCT03752619|560275629|FG001|Overall Study|Withdrawal by Subject|1|||
155228607|NCT03752619|560275628|FG000|Overall Study|Adverse Event|0|||
155228608|NCT03752619|560275629|FG001|Overall Study|Adverse Event|1|||
155228609|NCT03907683|560275630|FG000|Overall Study|Pregnancy|1|||
155228610|NCT03907683|560275630|FG000|Overall Study|Withdrawal by Subject|1|||
155228611|NCT00727714|560275631|FG000|Overall Study|Lost to Follow-up|2|||
155228612|NCT00486265|560275634|FG000|Overall Study|Adverse Event|1|||
155228613|NCT00486265|560275634|FG000|Overall Study|Lack of Efficacy|8|||
155228614|NCT01452412|560275635|FG000|Overall Study|Withdrawal by Subject|15|||
155228615|NCT01452412|560275636|FG001|Overall Study|Withdrawal by Subject|11|||
155228616|NCT01452412|560275635|FG000|Overall Study|Adverse Event|4|||
155228617|NCT01452412|560275636|FG001|Overall Study|Adverse Event|3|||
155228618|NCT01452412|560275635|FG000|Overall Study|Lost to Follow-up|5|||
155228619|NCT01452412|560275636|FG001|Overall Study|Lost to Follow-up|3|||
155228620|NCT01452412|560275635|FG000|Overall Study|Death|1|||
155228621|NCT01452412|560275636|FG001|Overall Study|Death|0|||
155228622|NCT01452412|560275635|FG000|Overall Study|Initiated dialysis|1|||
155228623|NCT01452412|560275636|FG001|Overall Study|Initiated dialysis|0|||
155228624|NCT01452412|560275635|FG000|Overall Study|Other|2|||
155228625|NCT01452412|560275636|FG001|Overall Study|Other|0|||
155228626|NCT05132127|560275637|FG000|Overall Study|Adverse Event|1|||
155228627|NCT02659020|560275639|FG000|Overall Study|Adverse Event|0|||
155228628|NCT02659020|560275640|FG001|Overall Study|Adverse Event|0|||
155228629|NCT02659020|560275641|FG002|Overall Study|Adverse Event|0|||
155228630|NCT02659020|560275642|FG003|Overall Study|Adverse Event|2|||
155228631|NCT02659020|560275643|FG004|Overall Study|Adverse Event|0|||
155228632|NCT02659020|560275644|FG005|Overall Study|Adverse Event|0|||
155228633|NCT02659020|560275645|FG006|Overall Study|Adverse Event|2|||
155228634|NCT02659020|560275639|FG000|Overall Study|Lost to Follow-up|1|||
155228635|NCT02659020|560275640|FG001|Overall Study|Lost to Follow-up|2|||
155228636|NCT02659020|560275641|FG002|Overall Study|Lost to Follow-up|1|||
155228637|NCT02659020|560275642|FG003|Overall Study|Lost to Follow-up|6|||
155228638|NCT02659020|560275643|FG004|Overall Study|Lost to Follow-up|1|||
155228639|NCT02659020|560275644|FG005|Overall Study|Lost to Follow-up|5|||
155228640|NCT02659020|560275645|FG006|Overall Study|Lost to Follow-up|0|||
155228641|NCT02659020|560275639|FG000|Overall Study|Physician Decision|0|||
155228642|NCT02659020|560275640|FG001|Overall Study|Physician Decision|0|||
155228643|NCT02659020|560275641|FG002|Overall Study|Physician Decision|0|||
155228644|NCT02659020|560275642|FG003|Overall Study|Physician Decision|1|||
155228645|NCT02659020|560275643|FG004|Overall Study|Physician Decision|1|||
155228646|NCT02659020|560275644|FG005|Overall Study|Physician Decision|0|||
155228647|NCT02659020|560275645|FG006|Overall Study|Physician Decision|1|||
155228648|NCT02659020|560275639|FG000|Overall Study|Withdrawal by Subject|2|||
155228649|NCT02659020|560275640|FG001|Overall Study|Withdrawal by Subject|1|||
155228650|NCT02659020|560275641|FG002|Overall Study|Withdrawal by Subject|0|||
155228651|NCT02659020|560275642|FG003|Overall Study|Withdrawal by Subject|3|||
155228652|NCT02659020|560275643|FG004|Overall Study|Withdrawal by Subject|3|||
155228653|NCT02659020|560275644|FG005|Overall Study|Withdrawal by Subject|6|||
155228654|NCT02659020|560275645|FG006|Overall Study|Withdrawal by Subject|3|||
155228655|NCT02659020|560275639|FG000|Overall Study|Progressive Disease|0|||
155228656|NCT02659020|560275640|FG001|Overall Study|Progressive Disease|0|||
155228657|NCT02659020|560275641|FG002|Overall Study|Progressive Disease|0|||
155228658|NCT02659020|560275642|FG003|Overall Study|Progressive Disease|4|||
155228659|NCT02659020|560275643|FG004|Overall Study|Progressive Disease|1|||
155228660|NCT02659020|560275644|FG005|Overall Study|Progressive Disease|0|||
155228661|NCT02659020|560275645|FG006|Overall Study|Progressive Disease|2|||
155228662|NCT04382911|560275646|FG000|Overall Study|unable to be imaged prior to surgery|2|||
155228663|NCT01120210|560275650|FG000|MAIN INFUSION|Adverse Event|1|||
155228664|NCT01120210|560275651|FG001|MAIN INFUSION|Adverse Event|0|||
155228665|NCT01120210|560275650|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
155228666|NCT01120210|560275651|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
155228667|NCT02703636|560275663|FG000|Overall Study|Adverse Event|14|||
155228668|NCT02703636|560275663|FG000|Overall Study|Study stopped by sponsor|1|||
155228669|NCT02703636|560275663|FG000|Overall Study|Withdrawal by Subject|1|||
155228670|NCT01554618|560275679|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
155228671|NCT01554618|560275680|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
155228672|NCT01554618|560275679|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
155228673|NCT01554618|560275680|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
155228674|NCT01554618|560275679|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
155228675|NCT01554618|560275680|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
155228676|NCT01554618|560275679|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
155228677|NCT01554618|560275680|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
155228678|NCT01554618|560275679|FG000|Open-Label Extension Period|Physician Decision|0|||
155228679|NCT01554618|560275680|FG001|Open-Label Extension Period|Physician Decision|1|||
155228680|NCT01554618|560275679|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
155228681|NCT01554618|560275680|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
155228682|NCT00477672|560275681|FG000|Overall Study|Adverse Event|3|||
155228683|NCT00477672|560275682|FG001|Overall Study|Adverse Event|5|||
155228684|NCT00477672|560275683|FG002|Overall Study|Adverse Event|6|||
155228685|NCT00477672|560275681|FG000|Overall Study|Death|0|||
155228686|NCT00477672|560275682|FG001|Overall Study|Death|1|||
155228687|NCT00477672|560275683|FG002|Overall Study|Death|0|||
155228688|NCT00477672|560275681|FG000|Overall Study|Disease progression|0|||
155228689|NCT00477672|560275682|FG001|Overall Study|Disease progression|1|||
155228690|NCT00477672|560275683|FG002|Overall Study|Disease progression|0|||
155228691|NCT00477672|560275681|FG000|Overall Study|Physician Decision|1|||
155228692|NCT00477672|560275682|FG001|Overall Study|Physician Decision|0|||
155228693|NCT00477672|560275683|FG002|Overall Study|Physician Decision|0|||
155228694|NCT00477672|560275681|FG000|Overall Study|Protocol noncompliance|0|||
155228695|NCT00477672|560275682|FG001|Overall Study|Protocol noncompliance|2|||
155228696|NCT00477672|560275683|FG002|Overall Study|Protocol noncompliance|0|||
155228697|NCT00477672|560275681|FG000|Overall Study|Consent withdrawn|2|||
155228698|NCT00477672|560275682|FG001|Overall Study|Consent withdrawn|5|||
155228699|NCT00477672|560275683|FG002|Overall Study|Consent withdrawn|10|||
155228700|NCT00477672|560275681|FG000|Overall Study|Discretion of Sponsor|1|||
155228701|NCT00477672|560275682|FG001|Overall Study|Discretion of Sponsor|2|||
155228702|NCT00477672|560275683|FG002|Overall Study|Discretion of Sponsor|0|||
155228703|NCT02275481|560275684|FG000|Overall Study|Death|2|||
155228704|NCT02275481|560275685|FG001|Overall Study|Death|1|||
155228705|NCT02275481|560275684|FG000|Overall Study|Lost to Follow-up|2|||
155228706|NCT02275481|560275685|FG001|Overall Study|Lost to Follow-up|0|||
155228707|NCT02275481|560275684|FG000|Overall Study|Withdrawal by Subject|3|||
155228708|NCT02275481|560275685|FG001|Overall Study|Withdrawal by Subject|0|||
155228709|NCT02275481|560275684|FG000|Overall Study|all other reasons combined|2|||
155228710|NCT02275481|560275685|FG001|Overall Study|all other reasons combined|1|||
155228711|NCT02275481|560275684|FG000|Overall Study|Physician Decision|0|||
155228712|NCT02275481|560275685|FG001|Overall Study|Physician Decision|1|||
155228713|NCT01215227|560275686|FG000|Overall Study|Adverse Event|11|||
155228714|NCT01215227|560275687|FG001|Overall Study|Adverse Event|11|||
155228715|NCT01215227|560275688|FG002|Overall Study|Adverse Event|4|||
155228716|NCT01215227|560275689|FG003|Overall Study|Adverse Event|8|||
155228717|NCT01215227|560275690|FG004|Overall Study|Adverse Event|7|||
155228718|NCT01215227|560275691|FG005|Overall Study|Adverse Event|6|||
155228719|NCT01215227|560275686|FG000|Overall Study|Treatment Failure|8|||
155228720|NCT01215227|560275687|FG001|Overall Study|Treatment Failure|4|||
155228721|NCT01215227|560275688|FG002|Overall Study|Treatment Failure|1|||
155228722|NCT01215227|560275689|FG003|Overall Study|Treatment Failure|5|||
155228723|NCT01215227|560275690|FG004|Overall Study|Treatment Failure|1|||
155228724|NCT01215227|560275691|FG005|Overall Study|Treatment Failure|1|||
155228725|NCT01215227|560275686|FG000|Overall Study|Lost to Follow-up|1|||
155228726|NCT01215227|560275687|FG001|Overall Study|Lost to Follow-up|4|||
155228727|NCT01215227|560275688|FG002|Overall Study|Lost to Follow-up|1|||
155228728|NCT01215227|560275689|FG003|Overall Study|Lost to Follow-up|1|||
155228729|NCT01215227|560275690|FG004|Overall Study|Lost to Follow-up|1|||
155228730|NCT01215227|560275691|FG005|Overall Study|Lost to Follow-up|2|||
155228731|NCT01215227|560275686|FG000|Overall Study|Subject Withdrew Consent|16|||
155228732|NCT01215227|560275687|FG001|Overall Study|Subject Withdrew Consent|20|||
155228733|NCT01215227|560275688|FG002|Overall Study|Subject Withdrew Consent|7|||
155228734|NCT01215227|560275689|FG003|Overall Study|Subject Withdrew Consent|10|||
155228735|NCT01215227|560275690|FG004|Overall Study|Subject Withdrew Consent|11|||
155228736|NCT01215227|560275691|FG005|Overall Study|Subject Withdrew Consent|8|||
155228737|NCT01215227|560275686|FG000|Overall Study|Non-Compliance With Protocol|2|||
155228738|NCT01215227|560275687|FG001|Overall Study|Non-Compliance With Protocol|6|||
155228739|NCT01215227|560275688|FG002|Overall Study|Non-Compliance With Protocol|1|||
155228740|NCT01215227|560275689|FG003|Overall Study|Non-Compliance With Protocol|0|||
155228741|NCT01215227|560275690|FG004|Overall Study|Non-Compliance With Protocol|0|||
155228742|NCT01215227|560275691|FG005|Overall Study|Non-Compliance With Protocol|0|||
155228743|NCT01215227|560275686|FG000|Overall Study|Administrative|83|||
155228744|NCT01215227|560275687|FG001|Overall Study|Administrative|73|||
155228745|NCT01215227|560275688|FG002|Overall Study|Administrative|42|||
155228746|NCT01215227|560275689|FG003|Overall Study|Administrative|24|||
155228747|NCT01215227|560275690|FG004|Overall Study|Administrative|28|||
155228748|NCT01215227|560275691|FG005|Overall Study|Administrative|40|||
155228749|NCT01215227|560275686|FG000|Overall Study|Missing Status|0|||
155228750|NCT01215227|560275687|FG001|Overall Study|Missing Status|1|||
155228751|NCT01215227|560275688|FG002|Overall Study|Missing Status|0|||
155228752|NCT01215227|560275689|FG003|Overall Study|Missing Status|0|||
155228753|NCT01215227|560275690|FG004|Overall Study|Missing Status|0|||
155228754|NCT01215227|560275691|FG005|Overall Study|Missing Status|0|||
155228755|NCT01215227|560275686|FG000|Overall Study|Randomized but not treated|0|||
155228756|NCT01215227|560275687|FG001|Overall Study|Randomized but not treated|0|||
155228757|NCT01215227|560275688|FG002|Overall Study|Randomized but not treated|1|||
155228758|NCT01215227|560275689|FG003|Overall Study|Randomized but not treated|1|||
155228759|NCT01215227|560275690|FG004|Overall Study|Randomized but not treated|0|||
155228760|NCT01215227|560275691|FG005|Overall Study|Randomized but not treated|1|||
155228761|NCT01393405|560275692|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
155228762|NCT01393405|560275693|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
155228763|NCT01393405|560275694|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
155228764|NCT01393405|560275692|FG000|Induction Period (week1-16)|Adverse Event|16|||
155228765|NCT01393405|560275693|FG001|Induction Period (week1-16)|Adverse Event|0|||
155228766|NCT01393405|560275694|FG002|Induction Period (week1-16)|Adverse Event|0|||
155228767|NCT01393405|560275692|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
155228768|NCT01393405|560275693|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
155228769|NCT01393405|560275694|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
155228770|NCT01393405|560275692|FG000|Maintenance Period Week|Lack of Efficacy|0|||
155228771|NCT01393405|560275693|FG001|Maintenance Period Week|Lack of Efficacy|22|||
155228772|NCT01393405|560275694|FG002|Maintenance Period Week|Lack of Efficacy|22|||
155228773|NCT01393405|560275692|FG000|Maintenance Period Week|Adverse Event|0|||
155228774|NCT01393405|560275693|FG001|Maintenance Period Week|Adverse Event|5|||
155228775|NCT01393405|560275694|FG002|Maintenance Period Week|Adverse Event|2|||
155228776|NCT01393405|560275692|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
155228777|NCT01393405|560275693|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
155228778|NCT01393405|560275694|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
155228779|NCT01393405|560275692|FG000|Maintenance Period Week|Lost to Follow-up|0|||
155228780|NCT01393405|560275693|FG001|Maintenance Period Week|Lost to Follow-up|1|||
155228781|NCT01393405|560275694|FG002|Maintenance Period Week|Lost to Follow-up|0|||
155228782|NCT02281552|560275701|FG000|Overall Study|Medication error|1|||
155228783|NCT02281552|560275702|FG001|Overall Study|Medication error|0|||
155228784|NCT02281552|560275701|FG000|Overall Study|Insufficient clinical response|0|||
155228785|NCT02281552|560275702|FG001|Overall Study|Insufficient clinical response|1|||
155228786|NCT02281552|560275701|FG000|Overall Study|Adverse Event|3|||
155228787|NCT02281552|560275702|FG001|Overall Study|Adverse Event|9|||
155228788|NCT01224639|560275703|FG000|Overall Study|Withdrawal by Subject|0|||
155228789|NCT01224639|560275704|FG001|Overall Study|Withdrawal by Subject|0|||
155228790|NCT01224639|560275705|FG002|Overall Study|Withdrawal by Subject|0|||
155228791|NCT01224639|560275706|FG003|Overall Study|Withdrawal by Subject|0|||
155228792|NCT01224639|560275707|FG004|Overall Study|Withdrawal by Subject|2|||
155228793|NCT01224639|560275708|FG005|Overall Study|Withdrawal by Subject|0|||
155228794|NCT01224639|560275709|FG006|Overall Study|Withdrawal by Subject|1|||
155228795|NCT01224639|560275710|FG007|Overall Study|Withdrawal by Subject|1|||
155228796|NCT01224639|560275703|FG000|Overall Study|Adverse Event|0|||
155228797|NCT01224639|560275704|FG001|Overall Study|Adverse Event|0|||
155228798|NCT01224639|560275705|FG002|Overall Study|Adverse Event|0|||
155228799|NCT01224639|560275706|FG003|Overall Study|Adverse Event|0|||
155228800|NCT01224639|560275707|FG004|Overall Study|Adverse Event|0|||
155228801|NCT01224639|560275708|FG005|Overall Study|Adverse Event|0|||
155228802|NCT01224639|560275709|FG006|Overall Study|Adverse Event|0|||
155228803|NCT01224639|560275710|FG007|Overall Study|Adverse Event|1|||
155228804|NCT04656132|560275711|FG000|Overall Study|Lost to Follow-up|4|||
155228805|NCT04656132|560275711|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
155228806|NCT04365699|560275712|FG000|Overall Study|Death|2|||
155228807|NCT04365699|560275713|FG001|Overall Study|Death|5|||
155228808|NCT04365699|560275714|FG002|Overall Study|Death|15|||
155228809|NCT03925727|560275716|FG000|Overall Study|Adverse Event|4|||
155228810|NCT03925727|560275717|FG001|Overall Study|Adverse Event|0|||
155228811|NCT03925727|560275718|FG002|Overall Study|Adverse Event|3|||
155228812|NCT03925727|560275716|FG000|Overall Study|Protocol Violation|1|||
155228813|NCT03925727|560275717|FG001|Overall Study|Protocol Violation|2|||
155228814|NCT03925727|560275718|FG002|Overall Study|Protocol Violation|2|||
155228815|NCT03925727|560275716|FG000|Overall Study|Withdrawal by Subject|3|||
155228816|NCT03925727|560275717|FG001|Overall Study|Withdrawal by Subject|2|||
155228817|NCT03925727|560275718|FG002|Overall Study|Withdrawal by Subject|4|||
155228818|NCT03925727|560275716|FG000|Overall Study|Administrative Reasons|3|||
155228819|NCT03925727|560275717|FG001|Overall Study|Administrative Reasons|1|||
155228820|NCT03925727|560275718|FG002|Overall Study|Administrative Reasons|2|||
155228821|NCT03925727|560275716|FG000|Overall Study|Randomized in error or Disqualified|8|||
155228822|NCT03925727|560275717|FG001|Overall Study|Randomized in error or Disqualified|1|||
155228823|NCT03925727|560275718|FG002|Overall Study|Randomized in error or Disqualified|7|||
155228824|NCT02321462|560275721|FG000|Overall Study|Withdrawal by Subject|5|||
155228825|NCT02321462|560275722|FG001|Overall Study|Withdrawal by Subject|2|||
155228826|NCT02321462|560275721|FG000|Overall Study|Subject withdrawn before any treatment|1|||
155228827|NCT02321462|560275722|FG001|Overall Study|Subject withdrawn before any treatment|1|||
155228828|NCT03044197|560275733|FG000|Overall Study|Withdrawal by Subject|3|||
155228829|NCT03044197|560275734|FG001|Overall Study|Withdrawal by Subject|1|||
155228830|NCT00834912|560275735|FG000|Treatment Period 1|Adverse Event|0|||
155228831|NCT00834912|560275736|FG001|Treatment Period 1|Adverse Event|1|||
155228832|NCT00834912|560275737|FG002|Treatment Period 1|Adverse Event|0|||
155228833|NCT00834912|560275738|FG003|Treatment Period 1|Adverse Event|1|||
155228834|NCT00834912|560275739|FG004|Treatment Period 1|Adverse Event|0|||
155228835|NCT00834912|560275740|FG005|Treatment Period 1|Adverse Event|0|||
155228836|NCT00834912|560275735|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155228837|NCT00834912|560275736|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155228838|NCT00834912|560275737|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155228839|NCT00834912|560275738|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155228840|NCT00834912|560275739|FG004|Treatment Period 2|Withdrawal by Subject|1|||
155228841|NCT00834912|560275740|FG005|Treatment Period 2|Withdrawal by Subject|0|||
155228842|NCT01574352|560275743|FG000|Overall Study|Withdrawal by Subject|6|||
155228843|NCT01574352|560275744|FG001|Overall Study|Withdrawal by Subject|13|||
155228844|NCT01574352|560275743|FG000|Overall Study|Injury in non-camp related sport|1|||
155228845|NCT01574352|560275744|FG001|Overall Study|Injury in non-camp related sport|0|||
155228846|NCT06425458|560275745|FG000|Overall Study|Removed by study team|2|||
155228847|NCT06425458|560275745|FG000|Overall Study|Lost to Follow-up|5|||
155228848|NCT01340976|560277877|FG000|Overall Study|Physician Decision|2|||
155228849|NCT01340976|560277878|FG001|Overall Study|Physician Decision|0|||
155228850|NCT01340976|560277879|FG002|Overall Study|Physician Decision|1|||
155228851|NCT01340976|560277880|FG003|Overall Study|Physician Decision|1|||
155228852|NCT01340976|560277881|FG004|Overall Study|Physician Decision|1|||
155228853|NCT01340976|560277882|FG005|Overall Study|Physician Decision|0|||
155228854|NCT01340976|560277877|FG000|Overall Study|Death|0|||
155228855|NCT01340976|560277878|FG001|Overall Study|Death|1|||
155228856|NCT01340976|560277879|FG002|Overall Study|Death|0|||
155228857|NCT01340976|560277880|FG003|Overall Study|Death|0|||
155228858|NCT01340976|560277881|FG004|Overall Study|Death|0|||
155228859|NCT01340976|560277882|FG005|Overall Study|Death|0|||
155228860|NCT01340976|560277877|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
155228861|NCT01340976|560277878|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228862|NCT01340976|560277879|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228863|NCT01340976|560277880|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228864|NCT01340976|560277881|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228865|NCT01340976|560277882|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
155228866|NCT01340976|560277877|FG000|Overall Study|Withdrawal by Subject|0|||
155228867|NCT01340976|560277878|FG001|Overall Study|Withdrawal by Subject|0|||
155228868|NCT01340976|560277879|FG002|Overall Study|Withdrawal by Subject|0|||
155228869|NCT01340976|560277880|FG003|Overall Study|Withdrawal by Subject|1|||
155228870|NCT01340976|560277881|FG004|Overall Study|Withdrawal by Subject|1|||
155228871|NCT01340976|560277882|FG005|Overall Study|Withdrawal by Subject|0|||
155228872|NCT01340976|560277877|FG000|Overall Study|Other anemia treatment|1|||
155228873|NCT01340976|560277878|FG001|Overall Study|Other anemia treatment|0|||
155228874|NCT01340976|560277879|FG002|Overall Study|Other anemia treatment|2|||
155228875|NCT01340976|560277880|FG003|Overall Study|Other anemia treatment|1|||
155228876|NCT01340976|560277881|FG004|Overall Study|Other anemia treatment|0|||
155228877|NCT01340976|560277882|FG005|Overall Study|Other anemia treatment|1|||
155228878|NCT01340976|560277877|FG000|Overall Study|Adverse Event|0|||
155228879|NCT01340976|560277878|FG001|Overall Study|Adverse Event|1|||
155228880|NCT01340976|560277879|FG002|Overall Study|Adverse Event|0|||
155228881|NCT01340976|560277880|FG003|Overall Study|Adverse Event|0|||
155228882|NCT01340976|560277881|FG004|Overall Study|Adverse Event|0|||
155228883|NCT01340976|560277882|FG005|Overall Study|Adverse Event|0|||
155228884|NCT02953821|560277883|FG000|Overall Study|Adverse Event|0|||
155228885|NCT02953821|560277884|FG001|Overall Study|Adverse Event|4|||
155228886|NCT02953821|560277883|FG000|Overall Study|Death|1|||
155228887|NCT02953821|560277884|FG001|Overall Study|Death|0|||
155228888|NCT02953821|560277883|FG000|Overall Study|Progressive Disease|5|||
155228889|NCT02953821|560277884|FG001|Overall Study|Progressive Disease|1|||
155228890|NCT02953821|560277883|FG000|Overall Study|Lost to Follow-up|2|||
155228891|NCT02953821|560277884|FG001|Overall Study|Lost to Follow-up|0|||
155228892|NCT02953821|560277883|FG000|Overall Study|Physician Decision|1|||
155228893|NCT02953821|560277884|FG001|Overall Study|Physician Decision|1|||
155228894|NCT02953821|560277883|FG000|Overall Study|Withdrawal by Subject|3|||
155228895|NCT02953821|560277884|FG001|Overall Study|Withdrawal by Subject|3|||
155228896|NCT02953821|560277883|FG000|Overall Study|Change of address|0|||
155228897|NCT02953821|560277884|FG001|Overall Study|Change of address|1|||
155228898|NCT02953821|560277883|FG000|Overall Study|Lack of Efficacy|1|||
155228899|NCT02953821|560277884|FG001|Overall Study|Lack of Efficacy|0|||
155228900|NCT02953821|560277883|FG000|Overall Study|Out of state for indeterminate time|0|||
155228901|NCT02953821|560277884|FG001|Overall Study|Out of state for indeterminate time|1|||
155228902|NCT02953821|560277883|FG000|Overall Study|No improvement|0|||
155228903|NCT02953821|560277884|FG001|Overall Study|No improvement|1|||
155228904|NCT02953821|560277883|FG000|Overall Study|Refused follow-up visit|2|||
155228905|NCT02953821|560277884|FG001|Overall Study|Refused follow-up visit|1|||
155228906|NCT01067352|560277885|FG000|Overall Study|Withdrawal by Subject|1|||
155228907|NCT01067352|560277886|FG001|Overall Study|Withdrawal by Subject|2|||
155228908|NCT01067352|560277887|FG002|Overall Study|Withdrawal by Subject|1|||
155228909|NCT01067352|560277885|FG000|Overall Study|Physician Decision|0|||
155228910|NCT01067352|560277886|FG001|Overall Study|Physician Decision|1|||
155228911|NCT01067352|560277887|FG002|Overall Study|Physician Decision|0|||
155228912|NCT02566759|560277888|FG000|All Parts|Withdrawal by Subject|0|||
155228913|NCT02566759|560277889|FG001|All Parts|Withdrawal by Subject|1|||
155228914|NCT02566759|560277890|FG002|All Parts|Withdrawal by Subject|0|||
155228915|NCT02566759|560277891|FG003|All Parts|Withdrawal by Subject|0|||
155228916|NCT02566759|560277892|FG004|All Parts|Withdrawal by Subject|0|||
155228917|NCT02566759|560277893|FG005|All Parts|Withdrawal by Subject|0|||
155228918|NCT02566759|560277894|FG006|All Parts|Withdrawal by Subject|0|||
155228919|NCT02566759|560277895|FG007|All Parts|Withdrawal by Subject|0|||
155228920|NCT02566759|560277896|FG008|All Parts|Withdrawal by Subject|0|||
155228921|NCT02566759|560277897|FG009|All Parts|Withdrawal by Subject|0|||
155228922|NCT02566759|560277898|FG010|All Parts|Withdrawal by Subject|0|||
155228923|NCT02566759|560277899|FG011|All Parts|Withdrawal by Subject|0|||
155228924|NCT02566759|560277900|FG012|All Parts|Withdrawal by Subject|0|||
155228925|NCT02566759|560277901|FG013|All Parts|Withdrawal by Subject|0|||
155228926|NCT02566759|560277902|FG014|All Parts|Withdrawal by Subject|0|||
155228927|NCT02566759|560277903|FG015|All Parts|Withdrawal by Subject|0|||
155228928|NCT02566759|560277904|FG016|All Parts|Withdrawal by Subject|0|||
155228929|NCT02566759|560277888|FG000|All Parts|Adverse Event|0|||
155228930|NCT02566759|560277889|FG001|All Parts|Adverse Event|0|||
155228931|NCT02566759|560277890|FG002|All Parts|Adverse Event|0|||
155228932|NCT02566759|560277891|FG003|All Parts|Adverse Event|0|||
155228933|NCT02566759|560277892|FG004|All Parts|Adverse Event|0|||
155228934|NCT02566759|560277893|FG005|All Parts|Adverse Event|0|||
155228935|NCT02566759|560277894|FG006|All Parts|Adverse Event|0|||
155228936|NCT02566759|560277895|FG007|All Parts|Adverse Event|0|||
155228937|NCT02566759|560277896|FG008|All Parts|Adverse Event|0|||
155228938|NCT02566759|560277897|FG009|All Parts|Adverse Event|0|||
155228939|NCT02566759|560277898|FG010|All Parts|Adverse Event|0|||
155228940|NCT02566759|560277899|FG011|All Parts|Adverse Event|0|||
155228941|NCT02566759|560277900|FG012|All Parts|Adverse Event|1|||
155228942|NCT02566759|560277901|FG013|All Parts|Adverse Event|3|||
155228943|NCT02566759|560277902|FG014|All Parts|Adverse Event|0|||
155228944|NCT02566759|560277903|FG015|All Parts|Adverse Event|0|||
155228945|NCT02566759|560277904|FG016|All Parts|Adverse Event|0|||
155228946|NCT02566759|560277888|FG000|All Parts|Other|0|||
155228947|NCT02566759|560277889|FG001|All Parts|Other|0|||
155228948|NCT02566759|560277890|FG002|All Parts|Other|0|||
155228949|NCT02566759|560277891|FG003|All Parts|Other|0|||
155228950|NCT02566759|560277892|FG004|All Parts|Other|0|||
155228951|NCT02566759|560277893|FG005|All Parts|Other|0|||
155228952|NCT02566759|560277894|FG006|All Parts|Other|0|||
155228953|NCT02566759|560277895|FG007|All Parts|Other|0|||
155228954|NCT02566759|560277896|FG008|All Parts|Other|0|||
155228955|NCT02566759|560277897|FG009|All Parts|Other|0|||
155228956|NCT02566759|560277898|FG010|All Parts|Other|0|||
155228957|NCT02566759|560277899|FG011|All Parts|Other|0|||
155228958|NCT02566759|560277900|FG012|All Parts|Other|0|||
155228959|NCT02566759|560277901|FG013|All Parts|Other|2|||
155228960|NCT02566759|560277902|FG014|All Parts|Other|0|||
155228961|NCT02566759|560277903|FG015|All Parts|Other|0|||
155228962|NCT02566759|560277904|FG016|All Parts|Other|0|||
155228963|NCT02566759|560277888|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228964|NCT02566759|560277889|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228965|NCT02566759|560277890|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228966|NCT02566759|560277891|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228967|NCT02566759|560277892|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228968|NCT02566759|560277893|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228969|NCT02566759|560277894|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228970|NCT02566759|560277895|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228971|NCT02566759|560277896|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228972|NCT02566759|560277897|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228973|NCT02566759|560277898|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228974|NCT02566759|560277899|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228975|NCT02566759|560277900|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228976|NCT02566759|560277901|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228977|NCT02566759|560277902|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228978|NCT02566759|560277903|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
155228979|NCT02566759|560277904|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
155228980|NCT01096784|560277905|FG000|Overall Study|Withdrawal by Subject|2|||
155228981|NCT01096784|560277906|FG001|Overall Study|Withdrawal by Subject|1|||
155228982|NCT01096784|560277905|FG000|Overall Study|Adverse Event|11|||
155228983|NCT01096784|560277906|FG001|Overall Study|Adverse Event|9|||
155228984|NCT01096784|560277905|FG000|Overall Study|Protocol Deviation|2|||
155228985|NCT01096784|560277906|FG001|Overall Study|Protocol Deviation|2|||
155228986|NCT01096784|560277905|FG000|Overall Study|Administrative Decision|0|||
155228987|NCT01096784|560277906|FG001|Overall Study|Administrative Decision|1|||
155228988|NCT01096784|560277905|FG000|Overall Study|Other Unspecified|0|||
155228989|NCT01096784|560277906|FG001|Overall Study|Other Unspecified|1|||
155228990|NCT00976898|560277907|FG000|Overall Study|Protocol Violation|1|||
155228991|NCT00976898|560277907|FG000|Overall Study|Adverse Event|1|||
155228992|NCT00976898|560277907|FG000|Overall Study|Physician Decision|1|||
155228993|NCT00976898|560277907|FG000|Overall Study|Liver Transplant|1|||
155228994|NCT00976898|560277907|FG000|Overall Study|Progressive Disease|1|||
155228995|NCT05107128|560277908|FG000|Overall Study|Adverse Event|2|||
155228996|NCT05107128|560277909|FG001|Overall Study|Adverse Event|0|||
155228997|NCT05107128|560277908|FG000|Overall Study|Withdrawal by Subject|3|||
155228998|NCT05107128|560277909|FG001|Overall Study|Withdrawal by Subject|3|||
155228999|NCT05107128|560277908|FG000|Overall Study|Withdrawal of Consent|0|||
155229000|NCT05107128|560277909|FG001|Overall Study|Withdrawal of Consent|1|||
155229001|NCT05107128|560277908|FG000|Overall Study|Reason Not Specified|2|||
155229002|NCT05107128|560277909|FG001|Overall Study|Reason Not Specified|0|||
155229003|NCT03761628|560277910|FG000|Overall Study|Withdrawal by Subject|3|||
155229004|NCT03761628|560277910|FG000|Overall Study|Physician Decision|1|||
155229005|NCT03761628|560277910|FG000|Overall Study|Pregnancy|1|||
155229006|NCT03761628|560277910|FG000|Overall Study|Lost to Follow-up|1|||
155229007|NCT05459129|560277913|FG000|Overall Study|Death|1|||
155229008|NCT05459129|560277914|FG001|Overall Study|Death|0|||
155229009|NCT05459129|560277913|FG000|Overall Study|Study Terminated By Sponsor|5|||
155229010|NCT05459129|560277914|FG001|Overall Study|Study Terminated By Sponsor|6|||
155229011|NCT03064126|560277915|FG000|Overall Study|Death|40|||
155229012|NCT03064126|560277916|FG001|Overall Study|Death|16|||
155229013|NCT03064126|560277917|FG002|Overall Study|Death|4|||
155229014|NCT03064126|560277918|FG003|Overall Study|Death|2|||
155229015|NCT03064126|560277915|FG000|Overall Study|Withdrawal by Subject|17|||
155229016|NCT03064126|560277916|FG001|Overall Study|Withdrawal by Subject|9|||
155229017|NCT03064126|560277917|FG002|Overall Study|Withdrawal by Subject|0|||
155229018|NCT03064126|560277918|FG003|Overall Study|Withdrawal by Subject|2|||
155229019|NCT03064126|560277915|FG000|Overall Study|Lost to Follow-up|7|||
155229020|NCT03064126|560277916|FG001|Overall Study|Lost to Follow-up|3|||
155229021|NCT03064126|560277917|FG002|Overall Study|Lost to Follow-up|0|||
155229022|NCT03064126|560277918|FG003|Overall Study|Lost to Follow-up|0|||
155229023|NCT03064126|560277915|FG000|Overall Study|Adverse Event|2|||
155229024|NCT03064126|560277916|FG001|Overall Study|Adverse Event|0|||
155229025|NCT03064126|560277917|FG002|Overall Study|Adverse Event|0|||
155229026|NCT03064126|560277918|FG003|Overall Study|Adverse Event|0|||
155229027|NCT03064126|560277915|FG000|Overall Study|Physician Decision|3|||
155229028|NCT03064126|560277916|FG001|Overall Study|Physician Decision|0|||
155229029|NCT03064126|560277917|FG002|Overall Study|Physician Decision|0|||
155229030|NCT03064126|560277918|FG003|Overall Study|Physician Decision|0|||
155229031|NCT03064126|560277915|FG000|Overall Study|Other reason for early termination|3|||
155229032|NCT03064126|560277916|FG001|Overall Study|Other reason for early termination|2|||
155229033|NCT03064126|560277917|FG002|Overall Study|Other reason for early termination|0|||
155229034|NCT03064126|560277918|FG003|Overall Study|Other reason for early termination|0|||
155229035|NCT03064126|560277915|FG000|Overall Study|Missed Visit|3|||
155229036|NCT03064126|560277916|FG001|Overall Study|Missed Visit|1|||
155229037|NCT03064126|560277917|FG002|Overall Study|Missed Visit|0|||
155229038|NCT03064126|560277918|FG003|Overall Study|Missed Visit|0|||
155229039|NCT04649151|560277924|FG000|Overall Study|Pregnancy|0|||
155229040|NCT04649151|560277925|FG001|Overall Study|Pregnancy|0|||
155229041|NCT04649151|560277926|FG002|Overall Study|Pregnancy|0|||
155229042|NCT04649151|560277927|FG003|Overall Study|Pregnancy|0|||
155229043|NCT04649151|560277928|FG004|Overall Study|Pregnancy|3|||
155229044|NCT04649151|560277924|FG000|Overall Study|Physician Decision|10|||
155229045|NCT04649151|560277925|FG001|Overall Study|Physician Decision|0|||
155229046|NCT04649151|560277926|FG002|Overall Study|Physician Decision|0|||
155229047|NCT04649151|560277927|FG003|Overall Study|Physician Decision|1|||
155229048|NCT04649151|560277928|FG004|Overall Study|Physician Decision|1|||
155229049|NCT04649151|560277924|FG000|Overall Study|Protocol Deviation|25|||
155229050|NCT04649151|560277925|FG001|Overall Study|Protocol Deviation|3|||
155229051|NCT04649151|560277926|FG002|Overall Study|Protocol Deviation|0|||
155229052|NCT04649151|560277927|FG003|Overall Study|Protocol Deviation|0|||
155229053|NCT04649151|560277928|FG004|Overall Study|Protocol Deviation|0|||
155229054|NCT04649151|560277924|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
155229055|NCT04649151|560277925|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
155229056|NCT04649151|560277926|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
155229057|NCT04649151|560277927|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
155229058|NCT04649151|560277928|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
155229059|NCT04649151|560277924|FG000|Overall Study|Withdrawal by Subject|370|||
155229060|NCT04649151|560277925|FG001|Overall Study|Withdrawal by Subject|113|||
155229061|NCT04649151|560277926|FG002|Overall Study|Withdrawal by Subject|2|||
155229062|NCT04649151|560277927|FG003|Overall Study|Withdrawal by Subject|7|||
155229063|NCT04649151|560277928|FG004|Overall Study|Withdrawal by Subject|15|||
155229064|NCT04649151|560277924|FG000|Overall Study|Adverse Event|1|||
155229065|NCT04649151|560277925|FG001|Overall Study|Adverse Event|0|||
155229066|NCT04649151|560277926|FG002|Overall Study|Adverse Event|0|||
155229067|NCT04649151|560277927|FG003|Overall Study|Adverse Event|0|||
155229068|NCT04649151|560277928|FG004|Overall Study|Adverse Event|0|||
155229069|NCT04649151|560277924|FG000|Overall Study|Lost to Follow-up|256|||
155229070|NCT04649151|560277925|FG001|Overall Study|Lost to Follow-up|29|||
155229071|NCT04649151|560277926|FG002|Overall Study|Lost to Follow-up|10|||
155229072|NCT04649151|560277927|FG003|Overall Study|Lost to Follow-up|3|||
155229073|NCT04649151|560277928|FG004|Overall Study|Lost to Follow-up|6|||
155229074|NCT04649151|560277924|FG000|Overall Study|Other than specified|59|||
155229075|NCT04649151|560277925|FG001|Overall Study|Other than specified|294|||
155229076|NCT04649151|560277926|FG002|Overall Study|Other than specified|0|||
155229077|NCT04649151|560277927|FG003|Overall Study|Other than specified|0|||
155229078|NCT04649151|560277928|FG004|Overall Study|Other than specified|4|||
155229079|NCT04649151|560277924|FG000|Overall Study|Death|0|||
155229080|NCT04649151|560277925|FG001|Overall Study|Death|0|||
155229081|NCT04649151|560277926|FG002|Overall Study|Death|0|||
155229082|NCT04649151|560277927|FG003|Overall Study|Death|0|||
155229083|NCT04649151|560277928|FG004|Overall Study|Death|1|||
155229084|NCT04476017|560277929|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
155229085|NCT04476017|560277930|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
155229086|NCT03909165|560277938|FG000|Overall Study|Physician Decision|0|||
155229087|NCT03909165|560277939|FG001|Overall Study|Physician Decision|1|||
155229088|NCT03909165|560277940|FG002|Overall Study|Physician Decision|0|||
155229089|NCT03909165|560277941|FG003|Overall Study|Physician Decision|0|||
155229090|NCT03909165|560277942|FG004|Overall Study|Physician Decision|0|||
155229091|NCT03909165|560277938|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229092|NCT03909165|560277939|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229093|NCT03909165|560277940|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229094|NCT03909165|560277941|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
155229095|NCT03909165|560277942|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
155229096|NCT03909165|560277938|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
155229097|NCT03909165|560277939|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
155229098|NCT03909165|560277940|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
155229099|NCT03909165|560277941|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
155229100|NCT03909165|560277942|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
155229101|NCT03909165|560277938|FG000|Overall Study|Previous Drug Exposure|0|||
155229102|NCT03909165|560277939|FG001|Overall Study|Previous Drug Exposure|0|||
155229103|NCT03909165|560277940|FG002|Overall Study|Previous Drug Exposure|1|||
155229104|NCT03909165|560277941|FG003|Overall Study|Previous Drug Exposure|0|||
155229105|NCT03909165|560277942|FG004|Overall Study|Previous Drug Exposure|0|||
155229106|NCT03909165|560277938|FG000|Overall Study|Early Discharge|1|||
155229107|NCT03909165|560277939|FG001|Overall Study|Early Discharge|0|||
155229108|NCT03909165|560277940|FG002|Overall Study|Early Discharge|0|||
155229109|NCT03909165|560277941|FG003|Overall Study|Early Discharge|0|||
155229110|NCT03909165|560277942|FG004|Overall Study|Early Discharge|0|||
155229111|NCT06034496|560277943|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
155229112|NCT06034496|560277944|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
155229113|NCT06034496|560277943|FG000|Overall Study|Withdrawal by Subject|5|||
155229114|NCT06034496|560277944|FG001|Overall Study|Withdrawal by Subject|4|||
155229115|NCT02018458|560277945|FG000|Overall Study|Death|4|||
155229116|NCT01428193|560277948|FG000|Overall Study|Physician Decision|1|||
155229117|NCT01428193|560277948|FG000|Overall Study|Elevated screening liver enzymes|1|||
155229118|NCT03277261|560277953|FG000|Overall Study|Adverse Event|17|||
155229119|NCT03277261|560277954|FG001|Overall Study|Adverse Event|1|||
155229120|NCT03277261|560277953|FG000|Overall Study|Participant Withdrawal of Consent|6|||
155229121|NCT03277261|560277954|FG001|Overall Study|Participant Withdrawal of Consent|15|||
155229122|NCT03277261|560277953|FG000|Overall Study|Investigator / Sponsor Decision|4|||
155229123|NCT03277261|560277954|FG001|Overall Study|Investigator / Sponsor Decision|2|||
155229124|NCT03277261|560277953|FG000|Overall Study|Pregnancy|2|||
155229125|NCT03277261|560277954|FG001|Overall Study|Pregnancy|0|||
155229126|NCT03277261|560277953|FG000|Overall Study|Lost to Follow-up|2|||
155229127|NCT03277261|560277954|FG001|Overall Study|Lost to Follow-up|2|||
155229128|NCT03277261|560277953|FG000|Overall Study|Lack of Efficacy|2|||
155229129|NCT03277261|560277954|FG001|Overall Study|Lack of Efficacy|2|||
155229130|NCT03277261|560277953|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
155229131|NCT03277261|560277954|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
155229132|NCT03762083|560277955|FG000|Overall Study|Withdrawal by Subject|2|||
155229133|NCT03762083|560277955|FG000|Overall Study|Physician Decision|1|||
155229134|NCT03491150|560277956|FG000|Overall Study|Adverse Event|1|||
155229135|NCT03491150|560277957|FG001|Overall Study|Adverse Event|0|||
155229136|NCT03491150|560277956|FG000|Overall Study|Study Terminated by Sponsor|74|||
155229137|NCT03491150|560277957|FG001|Overall Study|Study Terminated by Sponsor|70|||
155229138|NCT03491150|560277956|FG000|Overall Study|Other|0|||
155229139|NCT03491150|560277957|FG001|Overall Study|Other|1|||
155229140|NCT03491150|560277956|FG000|Overall Study|Withdrawal by Subject|1|||
155229141|NCT03491150|560277957|FG001|Overall Study|Withdrawal by Subject|2|||
155229142|NCT00937547|560277966|FG000|Overall Study|misdiagnosis|1|||
155229143|NCT00937547|560277967|FG001|Overall Study|misdiagnosis|6|||
155229144|NCT00937547|560277968|FG002|Overall Study|misdiagnosis|7|||
155229145|NCT00325234|560277969|FG000|Overall Study|Adverse Event|10|||
155229146|NCT00325234|560277970|FG001|Overall Study|Adverse Event|7|||
155229147|NCT00325234|560277969|FG000|Overall Study|Death due to Study Disease|1|||
155229148|NCT00325234|560277970|FG001|Overall Study|Death due to Study Disease|0|||
155229149|NCT00325234|560277969|FG000|Overall Study|Entry Criteria Not Met|1|||
155229150|NCT00325234|560277970|FG001|Overall Study|Entry Criteria Not Met|2|||
155229151|NCT00325234|560277969|FG000|Overall Study|Subject Decision|6|||
155229152|NCT00325234|560277970|FG001|Overall Study|Subject Decision|8|||
155229153|NCT00325234|560277969|FG000|Overall Study|Physician Decision|17|||
155229154|NCT00325234|560277970|FG001|Overall Study|Physician Decision|12|||
155229155|NCT00325234|560277969|FG000|Overall Study|Progressive Disease|34|||
155229156|NCT00325234|560277970|FG001|Overall Study|Progressive Disease|37|||
155229157|NCT01234467|560277971|FG000|Overall Study|Adverse Event|3|||
155229158|NCT01234467|560277971|FG000|Overall Study|Death|2|||
155229159|NCT01234467|560277971|FG000|Overall Study|Withdrawal by Subject|2|||
155229160|NCT01234467|560277971|FG000|Overall Study|Disease Progression|2|||
155229161|NCT01234467|560277971|FG000|Overall Study|Clinical deterioration|1|||
155229162|NCT01234467|560277971|FG000|Overall Study|Physician Decision|1|||
155229163|NCT01234467|560277971|FG000|Overall Study|Other complicating disease (stroke)|1|||
155229164|NCT02644967|560277975|FG000|Overall Study|Death|26|||
155229165|NCT02644967|560277975|FG000|Overall Study|Physician Decision|1|||
155229166|NCT02644967|560277975|FG000|Overall Study|Withdrawal by Subject|2|||
155229167|NCT02644967|560277975|FG000|Overall Study|Protocol Violation|1|||
155229168|NCT02644967|560277975|FG000|Overall Study|Progressive Disease|1|||
155229169|NCT02644967|560277975|FG000|Overall Study|Study Terminated by Sponsor|4|||
155229170|NCT02287896|560277976|FG000|Second Injection Visit|Withdrawal by Subject|0|||
155229171|NCT02287896|560277977|FG001|Second Injection Visit|Withdrawal by Subject|1|||
155229172|NCT05179421|560277978|FG000|First Infusion Day|Adverse Event|1|||
155229173|NCT05179421|560277979|FG001|First Infusion Day|Adverse Event|0|||
155229174|NCT03746522|560277981|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
155229175|NCT03746522|560277982|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
155229176|NCT03746522|560277983|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
155229177|NCT03746522|560277981|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
155229178|NCT03746522|560277982|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
155229179|NCT03746522|560277983|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
155229180|NCT03746522|560277981|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
155229181|NCT03746522|560277982|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
155229182|NCT03746522|560277983|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
155229183|NCT03746522|560277981|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
155229184|NCT03746522|560277982|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
155229185|NCT03746522|560277983|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
155229186|NCT03746522|560277981|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
155229187|NCT03746522|560277982|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
155229188|NCT03746522|560277983|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
155229189|NCT01639040|560277984|FG000|Overall Study|Adverse Event|1|||
155229190|NCT01639040|560277985|FG001|Overall Study|Adverse Event|0|||
155229191|NCT01077960|560277989|FG000|Overall Study|Adverse Event|6|||
155229192|NCT01077960|560277989|FG000|Overall Study|Protocol Violation|3|||
155229193|NCT01077960|560277989|FG000|Overall Study|Lost to Follow-up|5|||
155229194|NCT01077960|560277989|FG000|Overall Study|Subject decision|1|||
155229195|NCT01077960|560277989|FG000|Overall Study|Reason unspecified|1|||
155229196|NCT02457598|560277990|FG000|Overall Study|Progressive Disease|2|||
155229197|NCT02457598|560277991|FG001|Overall Study|Progressive Disease|2|||
155229198|NCT02457598|560277992|FG002|Overall Study|Progressive Disease|1|||
155229199|NCT02457598|560277993|FG003|Overall Study|Progressive Disease|11|||
155229200|NCT02457598|560277994|FG004|Overall Study|Progressive Disease|7|||
155229201|NCT02457598|560277995|FG005|Overall Study|Progressive Disease|3|||
155229202|NCT02457598|560277996|FG006|Overall Study|Progressive Disease|2|||
155229203|NCT02457598|560277997|FG007|Overall Study|Progressive Disease|1|||
155229204|NCT02457598|560277998|FG008|Overall Study|Progressive Disease|1|||
155229205|NCT02457598|560277999|FG009|Overall Study|Progressive Disease|2|||
155229206|NCT02457598|560278000|FG010|Overall Study|Progressive Disease|45|||
155229207|NCT02457598|560278001|FG011|Overall Study|Progressive Disease|6|||
155229208|NCT02457598|560278002|FG012|Overall Study|Progressive Disease|2|||
155229209|NCT02457598|560278003|FG013|Overall Study|Progressive Disease|2|||
155229210|NCT02457598|560278004|FG014|Overall Study|Progressive Disease|10|||
155229211|NCT02457598|560278005|FG015|Overall Study|Progressive Disease|1|||
155229212|NCT02457598|560278006|FG016|Overall Study|Progressive Disease|1|||
155229213|NCT02457598|560277990|FG000|Overall Study|Investigator's Discretion|0|||
155229214|NCT02457598|560277991|FG001|Overall Study|Investigator's Discretion|2|||
155229215|NCT02457598|560277992|FG002|Overall Study|Investigator's Discretion|2|||
155229216|NCT02457598|560277993|FG003|Overall Study|Investigator's Discretion|2|||
155229217|NCT02457598|560277994|FG004|Overall Study|Investigator's Discretion|0|||
155229218|NCT02457598|560277995|FG005|Overall Study|Investigator's Discretion|0|||
155229219|NCT02457598|560277996|FG006|Overall Study|Investigator's Discretion|0|||
155229220|NCT02457598|560277997|FG007|Overall Study|Investigator's Discretion|1|||
155229221|NCT02457598|560277998|FG008|Overall Study|Investigator's Discretion|2|||
155229222|NCT02457598|560277999|FG009|Overall Study|Investigator's Discretion|0|||
155229223|NCT02457598|560278000|FG010|Overall Study|Investigator's Discretion|10|||
155229224|NCT02457598|560278001|FG011|Overall Study|Investigator's Discretion|2|||
155229225|NCT02457598|560278002|FG012|Overall Study|Investigator's Discretion|2|||
155229226|NCT02457598|560278003|FG013|Overall Study|Investigator's Discretion|1|||
155229227|NCT02457598|560278004|FG014|Overall Study|Investigator's Discretion|5|||
155229228|NCT02457598|560278005|FG015|Overall Study|Investigator's Discretion|0|||
155229229|NCT02457598|560278006|FG016|Overall Study|Investigator's Discretion|0|||
155229230|NCT02457598|560277990|FG000|Overall Study|Study Terminated by Sponsor|0|||
155229231|NCT02457598|560277991|FG001|Overall Study|Study Terminated by Sponsor|1|||
155229232|NCT02457598|560277992|FG002|Overall Study|Study Terminated by Sponsor|0|||
155229233|NCT02457598|560277993|FG003|Overall Study|Study Terminated by Sponsor|4|||
155229234|NCT02457598|560277994|FG004|Overall Study|Study Terminated by Sponsor|1|||
155229235|NCT02457598|560277995|FG005|Overall Study|Study Terminated by Sponsor|0|||
155229236|NCT02457598|560277996|FG006|Overall Study|Study Terminated by Sponsor|1|||
155229237|NCT02457598|560277997|FG007|Overall Study|Study Terminated by Sponsor|0|||
155229238|NCT02457598|560277998|FG008|Overall Study|Study Terminated by Sponsor|0|||
155229239|NCT02457598|560277999|FG009|Overall Study|Study Terminated by Sponsor|0|||
155229240|NCT02457598|560278000|FG010|Overall Study|Study Terminated by Sponsor|4|||
155229241|NCT02457598|560278001|FG011|Overall Study|Study Terminated by Sponsor|0|||
155229242|NCT02457598|560278002|FG012|Overall Study|Study Terminated by Sponsor|1|||
155229243|NCT02457598|560278003|FG013|Overall Study|Study Terminated by Sponsor|0|||
155229244|NCT02457598|560278004|FG014|Overall Study|Study Terminated by Sponsor|8|||
155229245|NCT02457598|560278005|FG015|Overall Study|Study Terminated by Sponsor|1|||
155229246|NCT02457598|560278006|FG016|Overall Study|Study Terminated by Sponsor|0|||
155229247|NCT02457598|560277990|FG000|Overall Study|Adverse Event|0|||
155229248|NCT02457598|560277991|FG001|Overall Study|Adverse Event|1|||
155229249|NCT02457598|560277992|FG002|Overall Study|Adverse Event|1|||
155229250|NCT02457598|560277993|FG003|Overall Study|Adverse Event|4|||
155229251|NCT02457598|560277994|FG004|Overall Study|Adverse Event|1|||
155229252|NCT02457598|560277995|FG005|Overall Study|Adverse Event|0|||
155229253|NCT02457598|560277996|FG006|Overall Study|Adverse Event|0|||
155229254|NCT02457598|560277997|FG007|Overall Study|Adverse Event|1|||
155229255|NCT02457598|560277998|FG008|Overall Study|Adverse Event|0|||
155229256|NCT02457598|560277999|FG009|Overall Study|Adverse Event|1|||
155229257|NCT02457598|560278000|FG010|Overall Study|Adverse Event|6|||
155229258|NCT02457598|560278001|FG011|Overall Study|Adverse Event|0|||
155229259|NCT02457598|560278002|FG012|Overall Study|Adverse Event|0|||
155229260|NCT02457598|560278003|FG013|Overall Study|Adverse Event|1|||
155229261|NCT02457598|560278004|FG014|Overall Study|Adverse Event|2|||
155229262|NCT02457598|560278005|FG015|Overall Study|Adverse Event|0|||
155229263|NCT02457598|560278006|FG016|Overall Study|Adverse Event|0|||
155229264|NCT02457598|560277990|FG000|Overall Study|Death|0|||
155229265|NCT02457598|560277991|FG001|Overall Study|Death|0|||
155229266|NCT02457598|560277992|FG002|Overall Study|Death|0|||
155229267|NCT02457598|560277993|FG003|Overall Study|Death|3|||
155229268|NCT02457598|560277994|FG004|Overall Study|Death|0|||
155229269|NCT02457598|560277995|FG005|Overall Study|Death|1|||
155229270|NCT02457598|560277996|FG006|Overall Study|Death|0|||
155229271|NCT02457598|560277997|FG007|Overall Study|Death|0|||
155229272|NCT02457598|560277998|FG008|Overall Study|Death|0|||
155229273|NCT02457598|560277999|FG009|Overall Study|Death|0|||
155229274|NCT02457598|560278000|FG010|Overall Study|Death|3|||
155229275|NCT02457598|560278001|FG011|Overall Study|Death|0|||
155229276|NCT02457598|560278002|FG012|Overall Study|Death|0|||
155229277|NCT02457598|560278003|FG013|Overall Study|Death|1|||
155229278|NCT02457598|560278004|FG014|Overall Study|Death|2|||
155229279|NCT02457598|560278005|FG015|Overall Study|Death|0|||
155229280|NCT02457598|560278006|FG016|Overall Study|Death|1|||
155229281|NCT02457598|560277990|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229282|NCT02457598|560277991|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
155229283|NCT02457598|560277992|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229284|NCT02457598|560277993|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229285|NCT02457598|560277994|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229286|NCT02457598|560277995|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229287|NCT02457598|560277996|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229288|NCT02457598|560277997|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229289|NCT02457598|560277998|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229290|NCT02457598|560277999|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229291|NCT02457598|560278000|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
155229292|NCT02457598|560278001|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229293|NCT02457598|560278002|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229294|NCT02457598|560278003|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
155229295|NCT02457598|560278004|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229296|NCT02457598|560278005|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229297|NCT02457598|560278006|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
155229298|NCT02457598|560277990|FG000|Overall Study|Withdrew Consent|0|||
155229299|NCT02457598|560277991|FG001|Overall Study|Withdrew Consent|0|||
155229300|NCT02457598|560277992|FG002|Overall Study|Withdrew Consent|0|||
155229301|NCT02457598|560277993|FG003|Overall Study|Withdrew Consent|0|||
155229302|NCT02457598|560277994|FG004|Overall Study|Withdrew Consent|0|||
155229303|NCT02457598|560277995|FG005|Overall Study|Withdrew Consent|0|||
155229304|NCT02457598|560277996|FG006|Overall Study|Withdrew Consent|0|||
155229305|NCT02457598|560277997|FG007|Overall Study|Withdrew Consent|2|||
155229306|NCT02457598|560277998|FG008|Overall Study|Withdrew Consent|0|||
155229307|NCT02457598|560277999|FG009|Overall Study|Withdrew Consent|0|||
155229308|NCT02457598|560278000|FG010|Overall Study|Withdrew Consent|3|||
155229309|NCT02457598|560278001|FG011|Overall Study|Withdrew Consent|0|||
155229310|NCT02457598|560278002|FG012|Overall Study|Withdrew Consent|0|||
155229311|NCT02457598|560278003|FG013|Overall Study|Withdrew Consent|1|||
155229312|NCT02457598|560278004|FG014|Overall Study|Withdrew Consent|0|||
155229313|NCT02457598|560278005|FG015|Overall Study|Withdrew Consent|0|||
155229314|NCT02457598|560278006|FG016|Overall Study|Withdrew Consent|0|||
155229315|NCT02457598|560277990|FG000|Overall Study|Unacceptable Toxicity|0|||
155229316|NCT02457598|560277991|FG001|Overall Study|Unacceptable Toxicity|0|||
155229317|NCT02457598|560277992|FG002|Overall Study|Unacceptable Toxicity|0|||
155229318|NCT02457598|560277993|FG003|Overall Study|Unacceptable Toxicity|0|||
155229319|NCT02457598|560277994|FG004|Overall Study|Unacceptable Toxicity|0|||
155229320|NCT02457598|560277995|FG005|Overall Study|Unacceptable Toxicity|0|||
155229321|NCT02457598|560277996|FG006|Overall Study|Unacceptable Toxicity|0|||
155229322|NCT02457598|560277997|FG007|Overall Study|Unacceptable Toxicity|0|||
155229323|NCT02457598|560277998|FG008|Overall Study|Unacceptable Toxicity|0|||
155229324|NCT02457598|560277999|FG009|Overall Study|Unacceptable Toxicity|0|||
155229325|NCT02457598|560278000|FG010|Overall Study|Unacceptable Toxicity|1|||
155229326|NCT02457598|560278001|FG011|Overall Study|Unacceptable Toxicity|0|||
155229327|NCT02457598|560278002|FG012|Overall Study|Unacceptable Toxicity|1|||
155229328|NCT02457598|560278003|FG013|Overall Study|Unacceptable Toxicity|1|||
155229329|NCT02457598|560278004|FG014|Overall Study|Unacceptable Toxicity|1|||
155229330|NCT02457598|560278005|FG015|Overall Study|Unacceptable Toxicity|0|||
155229331|NCT02457598|560278006|FG016|Overall Study|Unacceptable Toxicity|0|||
155229332|NCT02457598|560277990|FG000|Overall Study|Intercurrent Illness|0|||
155229333|NCT02457598|560277991|FG001|Overall Study|Intercurrent Illness|0|||
155229334|NCT02457598|560277992|FG002|Overall Study|Intercurrent Illness|0|||
155229335|NCT02457598|560277993|FG003|Overall Study|Intercurrent Illness|0|||
155229336|NCT02457598|560277994|FG004|Overall Study|Intercurrent Illness|0|||
155229337|NCT02457598|560277995|FG005|Overall Study|Intercurrent Illness|0|||
155229338|NCT02457598|560277996|FG006|Overall Study|Intercurrent Illness|0|||
155229339|NCT02457598|560277997|FG007|Overall Study|Intercurrent Illness|0|||
155229340|NCT02457598|560277998|FG008|Overall Study|Intercurrent Illness|0|||
155229341|NCT02457598|560277999|FG009|Overall Study|Intercurrent Illness|0|||
155229342|NCT02457598|560278000|FG010|Overall Study|Intercurrent Illness|1|||
155229343|NCT02457598|560278001|FG011|Overall Study|Intercurrent Illness|0|||
155229344|NCT02457598|560278002|FG012|Overall Study|Intercurrent Illness|0|||
155229345|NCT02457598|560278003|FG013|Overall Study|Intercurrent Illness|0|||
155229346|NCT02457598|560278004|FG014|Overall Study|Intercurrent Illness|0|||
155229347|NCT02457598|560278005|FG015|Overall Study|Intercurrent Illness|0|||
155229348|NCT02457598|560278006|FG016|Overall Study|Intercurrent Illness|0|||
155229349|NCT02457598|560277990|FG000|Overall Study|Protocol Violation|0|||
155229350|NCT02457598|560277991|FG001|Overall Study|Protocol Violation|0|||
155229351|NCT02457598|560277992|FG002|Overall Study|Protocol Violation|0|||
155229352|NCT02457598|560277993|FG003|Overall Study|Protocol Violation|0|||
155229353|NCT02457598|560277994|FG004|Overall Study|Protocol Violation|0|||
155229354|NCT02457598|560277995|FG005|Overall Study|Protocol Violation|0|||
155229355|NCT02457598|560277996|FG006|Overall Study|Protocol Violation|0|||
155229356|NCT02457598|560277997|FG007|Overall Study|Protocol Violation|0|||
155229357|NCT02457598|560277998|FG008|Overall Study|Protocol Violation|0|||
155229358|NCT02457598|560277999|FG009|Overall Study|Protocol Violation|0|||
155229359|NCT02457598|560278000|FG010|Overall Study|Protocol Violation|1|||
155229360|NCT02457598|560278001|FG011|Overall Study|Protocol Violation|0|||
155229361|NCT02457598|560278002|FG012|Overall Study|Protocol Violation|0|||
155229362|NCT02457598|560278003|FG013|Overall Study|Protocol Violation|0|||
155229363|NCT02457598|560278004|FG014|Overall Study|Protocol Violation|0|||
155229364|NCT02457598|560278005|FG015|Overall Study|Protocol Violation|0|||
155229365|NCT02457598|560278006|FG016|Overall Study|Protocol Violation|0|||
155229366|NCT03837899|560278007|FG000|Overall Study|Death|6|||
155229367|NCT03837899|560278008|FG001|Overall Study|Death|8|||
155229368|NCT03837899|560278009|FG002|Overall Study|Death|3|||
155229369|NCT03837899|560278010|FG003|Overall Study|Death|7|||
155229370|NCT03837899|560278011|FG004|Overall Study|Death|8|||
155229371|NCT03837899|560278012|FG005|Overall Study|Death|7|||
155229372|NCT03837899|560278007|FG000|Overall Study|Moved to post-trial access program|0|||
155229373|NCT03837899|560278008|FG001|Overall Study|Moved to post-trial access program|1|||
155229374|NCT03837899|560278009|FG002|Overall Study|Moved to post-trial access program|0|||
155229375|NCT03837899|560278010|FG003|Overall Study|Moved to post-trial access program|0|||
155229376|NCT03837899|560278011|FG004|Overall Study|Moved to post-trial access program|0|||
155229377|NCT03837899|560278012|FG005|Overall Study|Moved to post-trial access program|0|||
155229378|NCT03837899|560278007|FG000|Overall Study|Other|0|||
155229379|NCT03837899|560278008|FG001|Overall Study|Other|0|||
155229380|NCT03837899|560278009|FG002|Overall Study|Other|0|||
155229381|NCT03837899|560278010|FG003|Overall Study|Other|0|||
155229382|NCT03837899|560278011|FG004|Overall Study|Other|0|||
155229383|NCT03837899|560278012|FG005|Overall Study|Other|2|||
155229384|NCT03837899|560278007|FG000|Overall Study|Lost to Follow-up|0|||
155229385|NCT03837899|560278008|FG001|Overall Study|Lost to Follow-up|1|||
155229386|NCT03837899|560278009|FG002|Overall Study|Lost to Follow-up|0|||
155229387|NCT03837899|560278010|FG003|Overall Study|Lost to Follow-up|0|||
155229388|NCT03837899|560278011|FG004|Overall Study|Lost to Follow-up|0|||
155229389|NCT03837899|560278012|FG005|Overall Study|Lost to Follow-up|0|||
155229390|NCT03837899|560278007|FG000|Overall Study|Withdrawal by Subject|0|||
155229391|NCT03837899|560278008|FG001|Overall Study|Withdrawal by Subject|0|||
155229392|NCT03837899|560278009|FG002|Overall Study|Withdrawal by Subject|0|||
155229393|NCT03837899|560278010|FG003|Overall Study|Withdrawal by Subject|1|||
155229394|NCT03837899|560278011|FG004|Overall Study|Withdrawal by Subject|0|||
155229395|NCT03837899|560278012|FG005|Overall Study|Withdrawal by Subject|0|||
155229396|NCT03837899|560278007|FG000|Overall Study|Study specific discontinuation criteria|0|||
155229397|NCT03837899|560278008|FG001|Overall Study|Study specific discontinuation criteria|1|||
155229398|NCT03837899|560278009|FG002|Overall Study|Study specific discontinuation criteria|0|||
155229399|NCT03837899|560278010|FG003|Overall Study|Study specific discontinuation criteria|0|||
155229400|NCT03837899|560278011|FG004|Overall Study|Study specific discontinuation criteria|3|||
155229401|NCT03837899|560278012|FG005|Overall Study|Study specific discontinuation criteria|1|||
155229402|NCT00393939|560278016|FG000|Overall Study|Protocol Violation|1|||
155229403|NCT00393939|560278017|FG001|Overall Study|Protocol Violation|1|||
155229404|NCT00393939|560278016|FG000|Overall Study|Lost to Follow-up|2|||
155229405|NCT00393939|560278017|FG001|Overall Study|Lost to Follow-up|4|||
155229406|NCT00393939|560278016|FG000|Overall Study|Death|10|||
155229407|NCT00393939|560278017|FG001|Overall Study|Death|4|||
155229408|NCT00393939|560278016|FG000|Overall Study|Sponsor|5|||
155229409|NCT00393939|560278017|FG001|Overall Study|Sponsor|13|||
155229410|NCT00393939|560278016|FG000|Overall Study|Objective progression or relapse|239|||
155229411|NCT00393939|560278017|FG001|Overall Study|Objective progression or relapse|223|||
155229412|NCT00393939|560278016|FG000|Overall Study|Withdrawal by Subject|2|||
155229413|NCT00393939|560278017|FG001|Overall Study|Withdrawal by Subject|7|||
155229414|NCT00393939|560278016|FG000|Overall Study|Other|37|||
155229415|NCT00393939|560278017|FG001|Overall Study|Other|45|||
155229416|NCT01494610|560278018|FG000|Period 1|Withdrawal by Subject|1|||
155229417|NCT01494610|560278019|FG001|Period 1|Withdrawal by Subject|1|||
155229418|NCT01494610|560278018|FG000|Period 3|Adverse Event|1|||
155229419|NCT01494610|560278019|FG001|Period 3|Adverse Event|0|||
155229420|NCT01494610|560278018|FG000|Period 3|Withdrawal by Subject|1|||
155229421|NCT01494610|560278019|FG001|Period 3|Withdrawal by Subject|0|||
155229422|NCT01494610|560278018|FG000|Period 4|Protocol Violation|1|||
155229423|NCT01494610|560278019|FG001|Period 4|Protocol Violation|0|||
155229424|NCT02385799|560278020|FG000|Overall Study|Lost to Follow-up|1|||
155229425|NCT02385799|560278021|FG001|Overall Study|Lost to Follow-up|2|||
155229426|NCT02385799|560278020|FG000|Overall Study|Adverse Event|4|||
155229427|NCT02385799|560278021|FG001|Overall Study|Adverse Event|2|||
155229428|NCT02385799|560278020|FG000|Overall Study|Withdrawal by Subject|0|||
155229429|NCT02385799|560278021|FG001|Overall Study|Withdrawal by Subject|4|||
155229430|NCT01110915|560278026|FG000|Overall Study|Death|2|||
155229431|NCT01110915|560278027|FG001|Overall Study|Death|1|||
155229432|NCT01110915|560278026|FG000|Overall Study|Lost to Follow-up|1|||
155229433|NCT01110915|560278027|FG001|Overall Study|Lost to Follow-up|0|||
155229434|NCT01110915|560278026|FG000|Overall Study|Withdrawal by Subject|7|||
155229435|NCT01110915|560278027|FG001|Overall Study|Withdrawal by Subject|1|||
155229436|NCT02948842|560278028|FG000|Overall Study|Withdrawal by Subject|4|||
155229437|NCT01537783|560278029|FG000|Overall Study|Lost to Follow-up|11|||
155229438|NCT01537783|560278030|FG001|Overall Study|Lost to Follow-up|2|||
155229439|NCT02350309|560278031|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229440|NCT02350309|560278032|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229441|NCT02350309|560278033|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
155229442|NCT02350309|560278034|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229443|NCT02350309|560278035|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229444|NCT02350309|560278036|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
155229445|NCT02350309|560278031|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229446|NCT02350309|560278032|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229447|NCT02350309|560278033|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229448|NCT02350309|560278034|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229449|NCT02350309|560278035|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
155229450|NCT02350309|560278036|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
155229451|NCT01205165|560278037|FG000|Overall Study|Lost to Follow-up|2|||
155229452|NCT01736696|560278040|FG000|Overall Study|Withdrawal by Subject|0|||
155229453|NCT01736696|560278041|FG001|Overall Study|Withdrawal by Subject|0|||
155229454|NCT01736696|560278042|FG002|Overall Study|Withdrawal by Subject|1|||
155229455|NCT01736696|560278043|FG003|Overall Study|Withdrawal by Subject|0|||
155229456|NCT01736696|560278044|FG004|Overall Study|Withdrawal by Subject|0|||
155229457|NCT01736696|560278045|FG005|Overall Study|Withdrawal by Subject|0|||
155229458|NCT01736696|560278046|FG006|Overall Study|Withdrawal by Subject|0|||
155229459|NCT04011410|560278047|FG000|Overall Study|Withdrawal by Subject|1|||
155229460|NCT01455012|560278048|FG000|Overall Study|Adverse Event|0|||
155229461|NCT01455012|560278049|FG001|Overall Study|Adverse Event|2|||
155229462|NCT01455012|560278048|FG000|Overall Study|Lack of Efficacy|6|||
155229463|NCT01455012|560278049|FG001|Overall Study|Lack of Efficacy|1|||
155229464|NCT01455012|560278048|FG000|Overall Study|Withdrawal by Subject|3|||
155229465|NCT01455012|560278049|FG001|Overall Study|Withdrawal by Subject|1|||
155229466|NCT01455012|560278048|FG000|Overall Study|Unknown reason|2|||
155229467|NCT01455012|560278049|FG001|Overall Study|Unknown reason|0|||
155229468|NCT01434290|560278054|FG000|Overall Study|Protocol Violation|6|||
155229469|NCT01434290|560278055|FG001|Overall Study|Protocol Violation|3|||
155229470|NCT01434290|560278054|FG000|Overall Study|No protocol treatment|2|||
155229471|NCT01434290|560278055|FG001|Overall Study|No protocol treatment|4|||
155229472|NCT03945981|560278056|FG000|Overall Study|Lost to Follow-up|12|||
155229473|NCT03945981|560278056|FG000|Overall Study|Physician Decision|4|||
155229474|NCT03945981|560278056|FG000|Overall Study|Withdrawal by Subject|6|||
155229475|NCT03945981|560278056|FG000|Overall Study|Protocol Violation|1|||
155229476|NCT00256698|560278059|FG000|Overall Study|Withdrawal by Subject|7|||
155229477|NCT00256698|560278060|FG001|Overall Study|Withdrawal by Subject|7|||
155229478|NCT00256698|560278059|FG000|Overall Study|Adverse Event|13|||
155229479|NCT00256698|560278060|FG001|Overall Study|Adverse Event|6|||
155229480|NCT00256698|560278059|FG000|Overall Study|Protocol Violation|6|||
155229481|NCT00256698|560278060|FG001|Overall Study|Protocol Violation|5|||
155229482|NCT00256698|560278059|FG000|Overall Study|Lost to Follow-up|1|||
155229483|NCT00256698|560278060|FG001|Overall Study|Lost to Follow-up|3|||
155229484|NCT00256698|560278059|FG000|Overall Study|disease progression|97|||
155229485|NCT00256698|560278060|FG001|Overall Study|disease progression|105|||
155229486|NCT00256698|560278059|FG000|Overall Study|still ongoing at data cut-off|41|||
155229487|NCT00256698|560278060|FG001|Overall Study|still ongoing at data cut-off|46|||
155229488|NCT00256698|560278059|FG000|Overall Study|withdrawn due to osteoporosis|1|||
155229489|NCT00256698|560278060|FG001|Overall Study|withdrawn due to osteoporosis|0|||
155229490|NCT00256698|560278059|FG000|Overall Study|Prematurely Discontinued|1|||
155229491|NCT00256698|560278060|FG001|Overall Study|Prematurely Discontinued|0|||
155229492|NCT02777125|560278062|FG000|Overall Study|Consent form violation|14|||
155229493|NCT02777125|560278063|FG001|Overall Study|Consent form violation|12|||
155229494|NCT02777125|560278062|FG000|Overall Study|Assent form violation|21|||
155229495|NCT02777125|560278063|FG001|Overall Study|Assent form violation|23|||
155229496|NCT02777125|560278062|FG000|Overall Study|Protocol Violation|8|||
155229497|NCT02777125|560278063|FG001|Overall Study|Protocol Violation|12|||
155229498|NCT00634647|560280110|FG000|Overall Study|death on study|3|||
155229499|NCT00634647|560280110|FG000|Overall Study|refused further treatment|3|||
155229500|NCT00634647|560280110|FG000|Overall Study|declined to participate before treatment|1|||
155229501|NCT00667342|560280111|FG000|Overall Study|Protocol Violation|1|||
155229502|NCT00667342|560280112|FG001|Overall Study|Protocol Violation|0|||
155229503|NCT00667342|560280113|FG002|Overall Study|Protocol Violation|0|||
155229504|NCT00667342|560280111|FG000|Overall Study|Withdrawal by Subject|1|||
155229505|NCT00667342|560280112|FG001|Overall Study|Withdrawal by Subject|0|||
155229506|NCT00667342|560280113|FG002|Overall Study|Withdrawal by Subject|0|||
155229507|NCT00667342|560280111|FG000|Overall Study|Physician Decision|3|||
155229508|NCT00667342|560280112|FG001|Overall Study|Physician Decision|0|||
155229509|NCT00667342|560280113|FG002|Overall Study|Physician Decision|0|||
155229510|NCT00667342|560280111|FG000|Overall Study|Relapse or tumor progression|9|||
155229511|NCT00667342|560280112|FG001|Overall Study|Relapse or tumor progression|0|||
155229512|NCT00667342|560280113|FG002|Overall Study|Relapse or tumor progression|7|||
155229513|NCT00667342|560280111|FG000|Overall Study|Adverse Event|0|||
155229514|NCT00667342|560280112|FG001|Overall Study|Adverse Event|0|||
155229515|NCT00667342|560280113|FG002|Overall Study|Adverse Event|1|||
155229516|NCT00667342|560280111|FG000|Overall Study|Ineligible|0|||
155229517|NCT00667342|560280112|FG001|Overall Study|Ineligible|0|||
155229518|NCT00667342|560280113|FG002|Overall Study|Ineligible|1|||
155229519|NCT01433263|560280114|FG000|Overall Study|Adverse Event|3|||
155229520|NCT01433263|560280115|FG001|Overall Study|Adverse Event|1|||
155229521|NCT01433263|560280114|FG000|Overall Study|Death|5|||
155229522|NCT01433263|560280115|FG001|Overall Study|Death|3|||
155229523|NCT01433263|560280114|FG000|Overall Study|Lost to Follow-up|0|||
155229524|NCT01433263|560280115|FG001|Overall Study|Lost to Follow-up|1|||
155229525|NCT01433263|560280114|FG000|Overall Study|Protocol Deviation|1|||
155229526|NCT01433263|560280115|FG001|Overall Study|Protocol Deviation|0|||
155229527|NCT01433263|560280114|FG000|Overall Study|Withdrawal by Subject|10|||
155229528|NCT01433263|560280115|FG001|Overall Study|Withdrawal by Subject|7|||
155229529|NCT04709237|560280117|FG000|Overall Study|Lost to Follow-up|1|||
155229530|NCT04709237|560280118|FG001|Overall Study|Lost to Follow-up|0|||
155229531|NCT04709237|560280119|FG002|Overall Study|Lost to Follow-up|0|||
155229532|NCT02610192|560280120|FG000|Overall Study|Received other treatment|8|||
155229533|NCT02610192|560280120|FG000|Overall Study|Physician Decision|1|||
155229534|NCT05723770|560280126|FG000|Overall Study|Lost to Follow-up|4|||
155229535|NCT05723770|560280126|FG000|Overall Study|Withdrawal by Subject|2|||
155229536|NCT00145509|560280127|FG000|Overall Study|Adverse Event|10|||
155229537|NCT00145509|560280128|FG001|Overall Study|Adverse Event|3|||
155229538|NCT00145509|560280127|FG000|Overall Study|Lack of Efficacy|3|||
155229539|NCT00145509|560280128|FG001|Overall Study|Lack of Efficacy|1|||
155229540|NCT00145509|560280127|FG000|Overall Study|Lost to Follow-up|5|||
155229541|NCT00145509|560280128|FG001|Overall Study|Lost to Follow-up|9|||
155229542|NCT00145509|560280127|FG000|Overall Study|Withdrew Consent|2|||
155229543|NCT00145509|560280128|FG001|Overall Study|Withdrew Consent|7|||
155229544|NCT00145509|560280127|FG000|Overall Study|Reason not provided|2|||
155229545|NCT00145509|560280128|FG001|Overall Study|Reason not provided|1|||
155229546|NCT01359592|560280129|FG000|Initial Registration|Adverse Event|1|||
155229547|NCT01359592|560280130|FG001|Initial Registration|Adverse Event|0|||
155229548|NCT01359592|560280131|FG002|Initial Registration|Adverse Event|0|||
155229549|NCT01359592|560280132|FG003|Initial Registration|Adverse Event|0|||
155229550|NCT01359592|560280129|FG000|Initial Registration|Death|1|||
155229551|NCT01359592|560280130|FG001|Initial Registration|Death|0|||
155229552|NCT01359592|560280131|FG002|Initial Registration|Death|0|||
155229553|NCT01359592|560280132|FG003|Initial Registration|Death|0|||
155229554|NCT01359592|560280129|FG000|Initial Registration|Other reason not protocol specified|1|||
155229555|NCT01359592|560280130|FG001|Initial Registration|Other reason not protocol specified|0|||
155229556|NCT01359592|560280131|FG002|Initial Registration|Other reason not protocol specified|0|||
155229557|NCT01359592|560280132|FG003|Initial Registration|Other reason not protocol specified|0|||
155229558|NCT01359592|560280129|FG000|Initial Registration|Ineligible|26|||
155229559|NCT01359592|560280130|FG001|Initial Registration|Ineligible|0|||
155229560|NCT01359592|560280131|FG002|Initial Registration|Ineligible|0|||
155229561|NCT01359592|560280132|FG003|Initial Registration|Ineligible|0|||
155229562|NCT01359592|560280129|FG000|PET-Directed Therapy|Adverse Event|0|||
155229563|NCT01359592|560280130|FG001|PET-Directed Therapy|Adverse Event|0|||
155229564|NCT01359592|560280131|FG002|PET-Directed Therapy|Adverse Event|1|||
155229565|NCT01359592|560280132|FG003|PET-Directed Therapy|Adverse Event|0|||
155229566|NCT01359592|560280129|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
155229567|NCT01359592|560280130|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
155229568|NCT01359592|560280131|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
155229569|NCT01359592|560280132|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
155229570|NCT01359592|560280129|FG000|PET-Directed Therapy|Ineligible|0|||
155229571|NCT01359592|560280130|FG001|PET-Directed Therapy|Ineligible|0|||
155229572|NCT01359592|560280131|FG002|PET-Directed Therapy|Ineligible|24|||
155229573|NCT01359592|560280132|FG003|PET-Directed Therapy|Ineligible|0|||
155229574|NCT00326612|560280137|FG000|Overall Study|They did not have a seizure requiring tx|129|||
155229575|NCT00326612|560280138|FG001|Overall Study|They did not have a seizure requiring tx|137|||
155229576|NCT00419562|560280139|FG000|Overall Study|Lost to Follow-up|12|||
155229577|NCT00419562|560280140|FG001|Overall Study|Lost to Follow-up|13|||
155229578|NCT00419562|560280139|FG000|Overall Study|Withdrawal by Subject|20|||
155229579|NCT00419562|560280140|FG001|Overall Study|Withdrawal by Subject|18|||
155229580|NCT00419562|560280139|FG000|Overall Study|Participant Institutionalized|1|||
155229581|NCT00419562|560280140|FG001|Overall Study|Participant Institutionalized|0|||
155229582|NCT02365636|560280145|FG000|Overall Study|Adverse Event|3|||
155229583|NCT02365636|560280146|FG001|Overall Study|Adverse Event|3|||
155229584|NCT02365636|560280147|FG002|Overall Study|Adverse Event|2|||
155229585|NCT02365636|560280145|FG000|Overall Study|Protocol Violation|1|||
155229586|NCT02365636|560280146|FG001|Overall Study|Protocol Violation|4|||
155229587|NCT02365636|560280147|FG002|Overall Study|Protocol Violation|0|||
155229588|NCT02365636|560280145|FG000|Overall Study|Lost to Follow-up|0|||
155229589|NCT02365636|560280146|FG001|Overall Study|Lost to Follow-up|0|||
155229590|NCT02365636|560280147|FG002|Overall Study|Lost to Follow-up|1|||
155229591|NCT02365636|560280145|FG000|Overall Study|Other|2|||
155229592|NCT02365636|560280146|FG001|Overall Study|Other|0|||
155229593|NCT02365636|560280147|FG002|Overall Study|Other|0|||
155229594|NCT00355238|560280148|FG000|Overall Study|Adverse event unrelated to study drug|2|||
155229595|NCT00355238|560280149|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155229596|NCT00355238|560280150|FG002|Overall Study|Adverse event unrelated to study drug|0|||
155229597|NCT00355238|560280151|FG003|Overall Study|Adverse event unrelated to study drug|1|||
155229598|NCT00355238|560280148|FG000|Overall Study|Death|1|||
155229599|NCT00355238|560280149|FG001|Overall Study|Death|0|||
155229600|NCT00355238|560280150|FG002|Overall Study|Death|0|||
155229601|NCT00355238|560280151|FG003|Overall Study|Death|0|||
155229602|NCT00355238|560280148|FG000|Overall Study|Disease progression|37|||
155229603|NCT00355238|560280149|FG001|Overall Study|Disease progression|36|||
155229604|NCT00355238|560280150|FG002|Overall Study|Disease progression|16|||
155229605|NCT00355238|560280151|FG003|Overall Study|Disease progression|11|||
155229606|NCT00355238|560280148|FG000|Overall Study|Study drug toxicity|11|||
155229607|NCT00355238|560280149|FG001|Overall Study|Study drug toxicity|7|||
155229608|NCT00355238|560280150|FG002|Overall Study|Study drug toxicity|5|||
155229609|NCT00355238|560280151|FG003|Overall Study|Study drug toxicity|2|||
155229610|NCT00355238|560280148|FG000|Overall Study|Participant withdrew consent|3|||
155229611|NCT00355238|560280149|FG001|Overall Study|Participant withdrew consent|1|||
155229612|NCT00355238|560280150|FG002|Overall Study|Participant withdrew consent|0|||
155229613|NCT00355238|560280151|FG003|Overall Study|Participant withdrew consent|0|||
155229614|NCT00355238|560280148|FG000|Overall Study|Participant request to discontinue study treatment|1|||
155229615|NCT00355238|560280149|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155229616|NCT00355238|560280150|FG002|Overall Study|Participant request to discontinue study treatment|1|||
155229617|NCT00355238|560280151|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155229618|NCT01454934|560280152|FG000|Overall Study|Clinical progression|28|||
155229619|NCT01454934|560280153|FG001|Overall Study|Clinical progression|25|||
155229620|NCT01454934|560280152|FG000|Overall Study|Other|6|||
155229621|NCT01454934|560280153|FG001|Overall Study|Other|17|||
155229622|NCT01454934|560280152|FG000|Overall Study|Adverse Event|28|||
155229623|NCT01454934|560280153|FG001|Overall Study|Adverse Event|24|||
155229624|NCT01454934|560280152|FG000|Overall Study|Withdrawn consent|2|||
155229625|NCT01454934|560280153|FG001|Overall Study|Withdrawn consent|5|||
155229626|NCT01454934|560280152|FG000|Overall Study|Withdrawal by Subject|11|||
155229627|NCT01454934|560280153|FG001|Overall Study|Withdrawal by Subject|15|||
155229628|NCT01454934|560280152|FG000|Overall Study|Disease progression|194|||
155229629|NCT01454934|560280153|FG001|Overall Study|Disease progression|181|||
155229630|NCT01454934|560280152|FG000|Overall Study|Lost to Follow-up|0|||
155229631|NCT01454934|560280153|FG001|Overall Study|Lost to Follow-up|1|||
155229632|NCT01454934|560280152|FG000|Overall Study|Not treated|1|||
155229633|NCT01454934|560280153|FG001|Overall Study|Not treated|2|||
155229634|NCT00749775|560280154|FG000|Overall Study|Protocol Violation|24|||
155229635|NCT00749775|560280154|FG000|Overall Study|Lost to Follow-up|36|||
155229636|NCT00749775|560280154|FG000|Overall Study|No visit after first day of treatment|44|||
155229637|NCT00749775|560280154|FG000|Overall Study|No drug administration|3|||
155229638|NCT05044234|560280155|FG000|Overall Study|Lost to Follow-up|2|||
155229639|NCT05044234|560280156|FG001|Overall Study|Lost to Follow-up|1|||
155229640|NCT05044234|560280157|FG002|Overall Study|Lost to Follow-up|1|||
155229641|NCT05044234|560280158|FG003|Overall Study|Lost to Follow-up|2|||
155229642|NCT05044234|560280155|FG000|Overall Study|Withdrawal by Subject|6|||
155229643|NCT05044234|560280156|FG001|Overall Study|Withdrawal by Subject|4|||
155229644|NCT05044234|560280157|FG002|Overall Study|Withdrawal by Subject|5|||
155229645|NCT05044234|560280158|FG003|Overall Study|Withdrawal by Subject|8|||
155229646|NCT05044234|560280155|FG000|Overall Study|Study terminated by Sponsor|21|||
155229647|NCT05044234|560280156|FG001|Overall Study|Study terminated by Sponsor|21|||
155229648|NCT05044234|560280157|FG002|Overall Study|Study terminated by Sponsor|20|||
155229649|NCT05044234|560280158|FG003|Overall Study|Study terminated by Sponsor|14|||
155229650|NCT05044234|560280155|FG000|Overall Study|Other, not specified|0|||
155229651|NCT05044234|560280156|FG001|Overall Study|Other, not specified|0|||
155229652|NCT05044234|560280157|FG002|Overall Study|Other, not specified|1|||
155229653|NCT05044234|560280158|FG003|Overall Study|Other, not specified|2|||
155229654|NCT05044234|560280155|FG000|Overall Study|Delayed data entry|0|||
155229655|NCT05044234|560280156|FG001|Overall Study|Delayed data entry|0|||
155229656|NCT05044234|560280157|FG002|Overall Study|Delayed data entry|0|||
155229657|NCT05044234|560280158|FG003|Overall Study|Delayed data entry|1|||
155229658|NCT00480636|560280159|FG000|Overall Study|Death|12|||
155229659|NCT00480636|560280159|FG000|Overall Study|Lost to Follow-up|4|||
155229660|NCT00480636|560280159|FG000|Overall Study|Other|2|||
155229661|NCT00480636|560280159|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
155229662|NCT03912233|560280160|FG000|Overall Study|Adverse Event|1|||
155229663|NCT03912233|560280161|FG001|Overall Study|Adverse Event|0|||
155229664|NCT03912233|560280162|FG002|Overall Study|Adverse Event|0|||
155229665|NCT03912233|560280163|FG003|Overall Study|Adverse Event|0|||
155229666|NCT03912233|560280164|FG004|Overall Study|Adverse Event|0|||
155229667|NCT03912233|560280165|FG005|Overall Study|Adverse Event|0|||
155229668|NCT03912233|560280160|FG000|Overall Study|Physician Decision|1|||
155229669|NCT03912233|560280161|FG001|Overall Study|Physician Decision|0|||
155229670|NCT03912233|560280162|FG002|Overall Study|Physician Decision|0|||
155229671|NCT03912233|560280163|FG003|Overall Study|Physician Decision|0|||
155229672|NCT03912233|560280164|FG004|Overall Study|Physician Decision|0|||
155229673|NCT03912233|560280165|FG005|Overall Study|Physician Decision|0|||
155229674|NCT03912233|560280160|FG000|Overall Study|Other|0|||
155229675|NCT03912233|560280161|FG001|Overall Study|Other|0|||
155229676|NCT03912233|560280162|FG002|Overall Study|Other|0|||
155229677|NCT03912233|560280163|FG003|Overall Study|Other|0|||
155229678|NCT03912233|560280164|FG004|Overall Study|Other|7|||
155229679|NCT03912233|560280165|FG005|Overall Study|Other|12|||
155229680|NCT02583256|560280168|FG000|Overall Study|Withdrawal by Subject|0|||
155229681|NCT02583256|560280169|FG001|Overall Study|Withdrawal by Subject|1|||
155229682|NCT02583256|560280170|FG002|Overall Study|Withdrawal by Subject|1|||
155229683|NCT02583256|560280171|FG003|Overall Study|Withdrawal by Subject|0|||
155229684|NCT02583256|560280168|FG000|Overall Study|Lost to Follow-up|1|||
155229685|NCT02583256|560280169|FG001|Overall Study|Lost to Follow-up|1|||
155229686|NCT02583256|560280170|FG002|Overall Study|Lost to Follow-up|0|||
155229687|NCT02583256|560280171|FG003|Overall Study|Lost to Follow-up|1|||
155229688|NCT02583256|560280168|FG000|Overall Study|Administrative/Other|2|||
155229689|NCT02583256|560280169|FG001|Overall Study|Administrative/Other|0|||
155229690|NCT02583256|560280170|FG002|Overall Study|Administrative/Other|1|||
155229691|NCT02583256|560280171|FG003|Overall Study|Administrative/Other|2|||
155229692|NCT02177266|560280177|FG000|Overall Study|Adverse Event|0|||
155229693|NCT02177266|560280178|FG001|Overall Study|Adverse Event|1|||
155229694|NCT02177266|560280177|FG000|Overall Study|Withdrawal by Subject|1|||
155229695|NCT02177266|560280178|FG001|Overall Study|Withdrawal by Subject|0|||
155229696|NCT01023659|560280179|FG000|Overall Study|Lost to Follow-up|73|||
155229697|NCT01023659|560280180|FG001|Overall Study|Lost to Follow-up|228|||
155229698|NCT01023659|560280181|FG002|Overall Study|Lost to Follow-up|99|||
155229699|NCT04537806|560280184|FG000|Overall Study|Randomized but not treated|1|||
155229700|NCT04537806|560280185|FG001|Overall Study|Randomized but not treated|0|||
155229701|NCT04537806|560280184|FG000|Overall Study|Adverse Event|1|||
155229702|NCT04537806|560280185|FG001|Overall Study|Adverse Event|1|||
155229703|NCT03019627|560280186|FG000|Overall Study|Adverse Event|8|||
155229704|NCT03019627|560280187|FG001|Overall Study|Adverse Event|0|||
155229705|NCT03019627|560280186|FG000|Overall Study|Unrelated to adverse event|1|||
155229706|NCT03019627|560280187|FG001|Overall Study|Unrelated to adverse event|3|||
155229707|NCT03019627|560280186|FG000|Overall Study|Lost to Follow-up|2|||
155229708|NCT03019627|560280187|FG001|Overall Study|Lost to Follow-up|1|||
155229709|NCT03019627|560280186|FG000|Overall Study|not compliance|2|||
155229710|NCT03019627|560280187|FG001|Overall Study|not compliance|2|||
155229711|NCT03019627|560280186|FG000|Overall Study|Other|2|||
155229712|NCT03019627|560280187|FG001|Overall Study|Other|2|||
155229713|NCT03364049|560280188|FG000|Overall Study|Death|6|||
155229714|NCT03364049|560280189|FG001|Overall Study|Death|4|||
155229715|NCT03364049|560280190|FG002|Overall Study|Death|5|||
155229716|NCT03364049|560280191|FG003|Overall Study|Death|14|||
155229717|NCT03364049|560280188|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
155229718|NCT03364049|560280189|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
155229719|NCT03364049|560280190|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
155229720|NCT03364049|560280191|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
155229721|NCT03364049|560280188|FG000|Overall Study|Withdrawal by Subject|0|||
155229722|NCT03364049|560280189|FG001|Overall Study|Withdrawal by Subject|1|||
155229723|NCT03364049|560280190|FG002|Overall Study|Withdrawal by Subject|1|||
155229724|NCT03364049|560280191|FG003|Overall Study|Withdrawal by Subject|1|||
155229725|NCT00546715|560280192|FG000|Overall Study|Withdrawal by Subject|0|||
155229726|NCT00546715|560280193|FG001|Overall Study|Withdrawal by Subject|1|||
155229727|NCT00546715|560280194|FG002|Overall Study|Withdrawal by Subject|0|||
155229728|NCT00546715|560280195|FG003|Overall Study|Withdrawal by Subject|0|||
155229729|NCT00418691|560280196|FG000|Overall Study|Lost to Follow-up|1|||
155229730|NCT00418691|560280197|FG001|Overall Study|Lost to Follow-up|2|||
155229731|NCT00418691|560280198|FG002|Overall Study|Lost to Follow-up|3|||
155229732|NCT00418691|560280196|FG000|Overall Study|Started new medication voiding entry|0|||
155229733|NCT00418691|560280197|FG001|Overall Study|Started new medication voiding entry|0|||
155229734|NCT00418691|560280198|FG002|Overall Study|Started new medication voiding entry|1|||
155229735|NCT00418691|560280196|FG000|Overall Study|Progressive Disease|1|||
155229736|NCT00418691|560280197|FG001|Overall Study|Progressive Disease|0|||
155229737|NCT00418691|560280198|FG002|Overall Study|Progressive Disease|1|||
155229738|NCT02477020|560280201|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
155229739|NCT02477020|560280202|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
155229740|NCT02477020|560280201|FG000|Overall Study|Voluntary Withdrawal|7|||
155229741|NCT02477020|560280202|FG001|Overall Study|Voluntary Withdrawal|16|||
155229742|NCT02477020|560280201|FG000|Overall Study|Reason not Specified|3|||
155229743|NCT02477020|560280202|FG001|Overall Study|Reason not Specified|1|||
155229744|NCT02477020|560280201|FG000|Overall Study|Lack of Efficacy|14|||
155229745|NCT02477020|560280202|FG001|Overall Study|Lack of Efficacy|5|||
155229746|NCT01802775|560280203|FG000|Overall Study|Death|0|||
155229747|NCT01802775|560280204|FG001|Overall Study|Death|3|||
155229748|NCT01802775|560280203|FG000|Overall Study|Reason not provided|0|||
155229749|NCT01802775|560280204|FG001|Overall Study|Reason not provided|1|||
155229750|NCT01802775|560280203|FG000|Overall Study|Physician Decision|1|||
155229751|NCT01802775|560280204|FG001|Overall Study|Physician Decision|0|||
155229752|NCT01802775|560280203|FG000|Overall Study|Adverse Event|1|||
155229753|NCT01802775|560280204|FG001|Overall Study|Adverse Event|1|||
155229754|NCT01802775|560280203|FG000|Overall Study|Withdrawal by Subject|3|||
155229755|NCT01802775|560280204|FG001|Overall Study|Withdrawal by Subject|5|||
155229756|NCT01802775|560280203|FG000|Overall Study|Lost to Follow-up|1|||
155229757|NCT01802775|560280204|FG001|Overall Study|Lost to Follow-up|2|||
155229758|NCT00519649|560280207|FG000|Overall Study|Withdrawal by Subject|1|||
155229759|NCT01465802|560280208|FG000|Overall Study|Study terminated by sponsor|1|||
155229760|NCT01465802|560280209|FG001|Overall Study|Study terminated by sponsor|0|||
155229761|NCT01465802|560280210|FG002|Overall Study|Study terminated by sponsor|0|||
155229762|NCT01465802|560280211|FG003|Overall Study|Study terminated by sponsor|1|||
155229763|NCT01465802|560280212|FG004|Overall Study|Study terminated by sponsor|7|||
155229764|NCT01465802|560280208|FG000|Overall Study|Withdrawal by Subject|7|||
155229765|NCT01465802|560280209|FG001|Overall Study|Withdrawal by Subject|7|||
155229766|NCT01465802|560280210|FG002|Overall Study|Withdrawal by Subject|0|||
155229767|NCT01465802|560280211|FG003|Overall Study|Withdrawal by Subject|8|||
155229768|NCT01465802|560280212|FG004|Overall Study|Withdrawal by Subject|1|||
155229769|NCT01465802|560280208|FG000|Overall Study|Lost to Follow-up|1|||
155229770|NCT01465802|560280209|FG001|Overall Study|Lost to Follow-up|1|||
155229771|NCT01465802|560280210|FG002|Overall Study|Lost to Follow-up|0|||
155229772|NCT01465802|560280211|FG003|Overall Study|Lost to Follow-up|0|||
155229773|NCT01465802|560280212|FG004|Overall Study|Lost to Follow-up|0|||
155229774|NCT01465802|560280208|FG000|Overall Study|Reason not specified|9|||
155229775|NCT01465802|560280209|FG001|Overall Study|Reason not specified|4|||
155229776|NCT01465802|560280210|FG002|Overall Study|Reason not specified|0|||
155229777|NCT01465802|560280211|FG003|Overall Study|Reason not specified|10|||
155229778|NCT01465802|560280212|FG004|Overall Study|Reason not specified|2|||
155229779|NCT01465802|560280208|FG000|Overall Study|Death|15|||
155229780|NCT01465802|560280209|FG001|Overall Study|Death|12|||
155229781|NCT01465802|560280210|FG002|Overall Study|Death|0|||
155229782|NCT01465802|560280211|FG003|Overall Study|Death|10|||
155229783|NCT01465802|560280212|FG004|Overall Study|Death|2|||
155229784|NCT03852316|560280213|FG000|Overall Study|Protocol Violation|1|||
155229785|NCT03852316|560280213|FG000|Overall Study|Withdrawal by Subject|2|||
155229786|NCT03852316|560280213|FG000|Overall Study|Enrolled but Device not Utilized|1|||
155229787|NCT03219333|560280214|FG000|Overall Study|Withdrawal by Subject|9|||
155229788|NCT03219333|560280215|FG001|Overall Study|Withdrawal by Subject|4|||
155229789|NCT03219333|560280214|FG000|Overall Study|Lost to Follow-up|1|||
155229790|NCT03219333|560280215|FG001|Overall Study|Lost to Follow-up|1|||
155229791|NCT03219333|560280214|FG000|Overall Study|Death|104|||
155229792|NCT03219333|560280215|FG001|Overall Study|Death|72|||
155229793|NCT03219333|560280214|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
155229794|NCT03219333|560280215|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
155229795|NCT03219333|560280214|FG000|Overall Study|Other|2|||
155229796|NCT03219333|560280215|FG001|Overall Study|Other|2|||
155229797|NCT02975934|560280216|FG000|Treatment Phase|Never initiated study drug|0|||
155229798|NCT02975934|560280217|FG001|Treatment Phase|Never initiated study drug|5|||
155229799|NCT02975934|560280218|FG002|Treatment Phase|Never initiated study drug|0|||
155229800|NCT02075840|560280220|FG000|Overall Study|Withdrawal by Subject|13|||
155229801|NCT02075840|560280221|FG001|Overall Study|Withdrawal by Subject|22|||
155229802|NCT02075840|560280220|FG000|Overall Study|Reason not specified|1|||
155229803|NCT02075840|560280221|FG001|Overall Study|Reason not specified|0|||
155229804|NCT02075840|560280220|FG000|Overall Study|Adverse Event|0|||
155229805|NCT02075840|560280221|FG001|Overall Study|Adverse Event|2|||
155229806|NCT02075840|560280220|FG000|Overall Study|Death|35|||
155229807|NCT02075840|560280221|FG001|Overall Study|Death|40|||
155229808|NCT02075840|560280220|FG000|Overall Study|Lost to Follow-up|3|||
155229809|NCT02075840|560280221|FG001|Overall Study|Lost to Follow-up|2|||
155229810|NCT02075840|560280220|FG000|Overall Study|Physician Decision|1|||
155229811|NCT02075840|560280221|FG001|Overall Study|Physician Decision|3|||
155229812|NCT02075840|560280220|FG000|Overall Study|Ongoing at CCOD|99|||
155229813|NCT02075840|560280221|FG001|Overall Study|Ongoing at CCOD|82|||
155229814|NCT00433654|560280226|FG000|Overall Study|Death|4|||
155229815|NCT00433654|560280227|FG001|Overall Study|Death|0|||
155229816|NCT00433654|560280226|FG000|Overall Study|Missed visit|6|||
155229817|NCT00433654|560280227|FG001|Overall Study|Missed visit|3|||
155229818|NCT00433654|560280226|FG000|Overall Study|Subject not yet due for visit|4|||
155229819|NCT00433654|560280227|FG001|Overall Study|Subject not yet due for visit|0|||
155229820|NCT00433654|560280226|FG000|Overall Study|Withdrawal by Subject|1|||
155229821|NCT00433654|560280227|FG001|Overall Study|Withdrawal by Subject|2|||
155229822|NCT04033159|560280232|FG000|Washout Period|Physician Decision|0|||
155229823|NCT04033159|560280233|FG001|Washout Period|Physician Decision|1|||
155229824|NCT04033159|560280234|FG002|Washout Period|Physician Decision|0|||
155229825|NCT04033159|560280232|FG000|Washout Period|Study terminated by Sponsor|0|||
155229826|NCT04033159|560280233|FG001|Washout Period|Study terminated by Sponsor|7|||
155229827|NCT04033159|560280234|FG002|Washout Period|Study terminated by Sponsor|0|||
155229828|NCT04033159|560280232|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
155229829|NCT04033159|560280233|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
155229830|NCT04033159|560280234|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
155229831|NCT00116558|560280237|FG000|Overall Study|Death|11|||
155229832|NCT00116558|560280238|FG001|Overall Study|Death|5|||
155229833|NCT00116558|560280239|FG002|Overall Study|Death|3|||
155229834|NCT00116558|560280237|FG000|Overall Study|Withdrawal by Subject|17|||
155229835|NCT00116558|560280238|FG001|Overall Study|Withdrawal by Subject|3|||
155229836|NCT00116558|560280239|FG002|Overall Study|Withdrawal by Subject|12|||
155229837|NCT00116558|560280237|FG000|Overall Study|disease progression|3|||
155229838|NCT00116558|560280238|FG001|Overall Study|disease progression|7|||
155229839|NCT00116558|560280239|FG002|Overall Study|disease progression|18|||
155229840|NCT00357370|560280240|FG000|Cohort 2|Lack of Efficacy|0|||
155229841|NCT00357370|560280241|FG001|Cohort 2|Lack of Efficacy|2|||
155229842|NCT00357370|560280242|FG002|Cohort 2|Lack of Efficacy|1|||
155229843|NCT00357370|560280240|FG000|Cohort 2|Adverse Event|1|||
155229844|NCT00357370|560280241|FG001|Cohort 2|Adverse Event|1|||
155229845|NCT00357370|560280242|FG002|Cohort 2|Adverse Event|1|||
155229846|NCT00357370|560280240|FG000|Cohort 2|Lost to Follow-up|0|||
155229847|NCT00357370|560280241|FG001|Cohort 2|Lost to Follow-up|1|||
155229848|NCT00357370|560280242|FG002|Cohort 2|Lost to Follow-up|0|||
155229849|NCT00357370|560280240|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
155229850|NCT00357370|560280241|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
155229851|NCT00357370|560280242|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
155229852|NCT00357370|560280240|FG000|Cohort 2|Withdrawal by Subject|0|||
155229853|NCT00357370|560280241|FG001|Cohort 2|Withdrawal by Subject|2|||
155229854|NCT00357370|560280242|FG002|Cohort 2|Withdrawal by Subject|0|||
155229855|NCT01143090|560280243|FG000|Overall Study|Lack of Efficacy|2|||
155229856|NCT01143090|560280243|FG000|Overall Study|Adverse Event|17|||
155229857|NCT01143090|560280243|FG000|Overall Study|Lost to Follow-up|9|||
155229858|NCT01143090|560280243|FG000|Overall Study|Protocol Violation|2|||
155229859|NCT01143090|560280243|FG000|Overall Study|Withdrawal by Subject|18|||
155229860|NCT01143090|560280243|FG000|Overall Study|Non-compliance with study drug|1|||
155229861|NCT01143090|560280243|FG000|Overall Study|Failure to meet eligibility criteria|1|||
155229862|NCT01143090|560280243|FG000|Overall Study|Administrative|1|||
155229863|NCT00499603|560280244|FG000|Overall Study|Adverse Event|0|||
155229864|NCT00499603|560280245|FG001|Overall Study|Adverse Event|1|||
155229865|NCT05220397|560280248|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229866|NCT05220397|560280249|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229867|NCT05220397|560280250|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
155229868|NCT05220397|560280251|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229869|NCT05220397|560280252|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
155229870|NCT02052739|560280253|FG000|Overall Study|Withdrew due to Adverse Event|3|||
155229871|NCT02052739|560280254|FG001|Overall Study|Withdrew due to Adverse Event|0|||
155229872|NCT02052739|560280253|FG000|Overall Study|Participant Died|2|||
155229873|NCT02052739|560280254|FG001|Overall Study|Participant Died|1|||
155229874|NCT02043015|560280255|FG000|Overall Study|Lost to Follow-up|4|||
155229875|NCT02043015|560280255|FG000|Overall Study|Withdrawal by Subject|4|||
155229876|NCT02043015|560280255|FG000|Overall Study|Removed once target enrollment reached|15|||
155229877|NCT02043015|560280255|FG000|Overall Study|Participant moved away from study city|4|||
155229878|NCT02043015|560280255|FG000|Overall Study|Incarceration|1|||
155229879|NCT01403974|560280256|FG000|Overall Study|Progressive disease according to RECIST|3|||
155229880|NCT01403974|560280257|FG001|Overall Study|Progressive disease according to RECIST|3|||
155229881|NCT01403974|560280258|FG002|Overall Study|Progressive disease according to RECIST|2|||
155229882|NCT01403974|560280259|FG003|Overall Study|Progressive disease according to RECIST|3|||
155229883|NCT01403974|560280260|FG004|Overall Study|Progressive disease according to RECIST|3|||
155229884|NCT01403974|560280261|FG005|Overall Study|Progressive disease according to RECIST|2|||
155229885|NCT01403974|560280262|FG006|Overall Study|Progressive disease according to RECIST|3|||
155229886|NCT01403974|560280263|FG007|Overall Study|Progressive disease according to RECIST|2|||
155229887|NCT01403974|560280264|FG008|Overall Study|Progressive disease according to RECIST|6|||
155229888|NCT01403974|560280265|FG009|Overall Study|Progressive disease according to RECIST|2|||
155229889|NCT01403974|560280266|FG010|Overall Study|Progressive disease according to RECIST|3|||
155229890|NCT01403974|560280267|FG011|Overall Study|Progressive disease according to RECIST|2|||
155229891|NCT01403974|560280268|FG012|Overall Study|Progressive disease according to RECIST|2|||
155229892|NCT01403974|560280269|FG013|Overall Study|Progressive disease according to RECIST|3|||
155229893|NCT01403974|560280270|FG014|Overall Study|Progressive disease according to RECIST|1|||
155229894|NCT01403974|560280271|FG015|Overall Study|Progressive disease according to RECIST|8|||
155229895|NCT01403974|560280256|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
155229896|NCT01403974|560280257|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
155229897|NCT01403974|560280258|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
155229898|NCT01403974|560280259|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
155229899|NCT01403974|560280260|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
155229900|NCT01403974|560280261|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
155229901|NCT01403974|560280262|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
155229902|NCT01403974|560280263|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
155229903|NCT01403974|560280264|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
155229904|NCT01403974|560280265|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
155229905|NCT01403974|560280266|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
155229906|NCT01403974|560280267|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
155229907|NCT01403974|560280268|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
155229908|NCT01403974|560280269|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
155229909|NCT01403974|560280270|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
155229910|NCT01403974|560280271|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
155229911|NCT01403974|560280256|FG000|Overall Study|Refused to continue study medication|0|||
155229912|NCT01403974|560280257|FG001|Overall Study|Refused to continue study medication|0|||
155229913|NCT01403974|560280258|FG002|Overall Study|Refused to continue study medication|0|||
155229914|NCT01403974|560280259|FG003|Overall Study|Refused to continue study medication|0|||
155229915|NCT01403974|560280260|FG004|Overall Study|Refused to continue study medication|0|||
155229916|NCT01403974|560280261|FG005|Overall Study|Refused to continue study medication|1|||
155229917|NCT01403974|560280262|FG006|Overall Study|Refused to continue study medication|0|||
155229918|NCT01403974|560280263|FG007|Overall Study|Refused to continue study medication|0|||
155229919|NCT01403974|560280264|FG008|Overall Study|Refused to continue study medication|1|||
155229920|NCT01403974|560280265|FG009|Overall Study|Refused to continue study medication|0|||
155229921|NCT01403974|560280266|FG010|Overall Study|Refused to continue study medication|1|||
155229922|NCT01403974|560280267|FG011|Overall Study|Refused to continue study medication|0|||
155229923|NCT01403974|560280268|FG012|Overall Study|Refused to continue study medication|0|||
155229924|NCT01403974|560280269|FG013|Overall Study|Refused to continue study medication|0|||
155229925|NCT01403974|560280270|FG014|Overall Study|Refused to continue study medication|0|||
155229926|NCT01403974|560280271|FG015|Overall Study|Refused to continue study medication|4|||
155229927|NCT01403974|560280256|FG000|Overall Study|Adverse Event|0|||
155229928|NCT01403974|560280257|FG001|Overall Study|Adverse Event|0|||
155229929|NCT01403974|560280258|FG002|Overall Study|Adverse Event|1|||
155229930|NCT01403974|560280259|FG003|Overall Study|Adverse Event|0|||
155229931|NCT01403974|560280260|FG004|Overall Study|Adverse Event|0|||
155229932|NCT01403974|560280261|FG005|Overall Study|Adverse Event|0|||
155229933|NCT01403974|560280262|FG006|Overall Study|Adverse Event|0|||
155229934|NCT01403974|560280263|FG007|Overall Study|Adverse Event|1|||
155229935|NCT01403974|560280264|FG008|Overall Study|Adverse Event|0|||
155229936|NCT01403974|560280265|FG009|Overall Study|Adverse Event|0|||
155229937|NCT01403974|560280266|FG010|Overall Study|Adverse Event|0|||
155229938|NCT01403974|560280267|FG011|Overall Study|Adverse Event|0|||
155229939|NCT01403974|560280268|FG012|Overall Study|Adverse Event|1|||
155229940|NCT01403974|560280269|FG013|Overall Study|Adverse Event|0|||
155229941|NCT01403974|560280270|FG014|Overall Study|Adverse Event|0|||
155229942|NCT01403974|560280271|FG015|Overall Study|Adverse Event|0|||
155229943|NCT01403974|560280256|FG000|Overall Study|Other than specified|0|||
155229944|NCT01403974|560280257|FG001|Overall Study|Other than specified|0|||
155229945|NCT01403974|560280258|FG002|Overall Study|Other than specified|0|||
155229946|NCT01403974|560280259|FG003|Overall Study|Other than specified|0|||
155229947|NCT01403974|560280260|FG004|Overall Study|Other than specified|0|||
155229948|NCT01403974|560280261|FG005|Overall Study|Other than specified|0|||
155229949|NCT01403974|560280262|FG006|Overall Study|Other than specified|0|||
155229950|NCT01403974|560280263|FG007|Overall Study|Other than specified|0|||
155229951|NCT01403974|560280264|FG008|Overall Study|Other than specified|0|||
155229952|NCT01403974|560280265|FG009|Overall Study|Other than specified|1|||
155229953|NCT01403974|560280266|FG010|Overall Study|Other than specified|0|||
155229954|NCT01403974|560280267|FG011|Overall Study|Other than specified|1|||
155229955|NCT01403974|560280268|FG012|Overall Study|Other than specified|0|||
155229956|NCT01403974|560280269|FG013|Overall Study|Other than specified|0|||
155229957|NCT01403974|560280270|FG014|Overall Study|Other than specified|0|||
155229958|NCT01403974|560280271|FG015|Overall Study|Other than specified|0|||
155229959|NCT01526889|560280272|FG000|Treatment Period|Adverse Event|2|||
155229960|NCT01526889|560280273|FG001|Treatment Period|Adverse Event|0|||
155229961|NCT01526889|560280272|FG000|Treatment Extension Period|Administrative problems|1|||
155229962|NCT01526889|560280273|FG001|Treatment Extension Period|Administrative problems|0|||
155229963|NCT03995953|560280276|FG000|Overall Study|Death|3|||
155229964|NCT03995953|560280277|FG001|Overall Study|Death|0|||
155229965|NCT03995953|560280278|FG002|Overall Study|Death|3|||
155229966|NCT03995953|560280279|FG003|Overall Study|Death|0|||
155229967|NCT03995953|560280280|FG004|Overall Study|Death|3|||
155229968|NCT03995953|560280281|FG005|Overall Study|Death|0|||
155229969|NCT03995953|560280282|FG006|Overall Study|Death|0|||
155229970|NCT03995953|560280283|FG007|Overall Study|Death|0|||
155229971|NCT03995953|560280284|FG008|Overall Study|Death|1|||
155229972|NCT03995953|560280285|FG009|Overall Study|Death|0|||
155229973|NCT03995953|560280286|FG010|Overall Study|Death|0|||
155229974|NCT03995953|560280287|FG011|Overall Study|Death|0|||
155229975|NCT03995953|560280276|FG000|Overall Study|Lost to Follow-up|6|||
155229976|NCT03995953|560280277|FG001|Overall Study|Lost to Follow-up|54|||
155229977|NCT03995953|560280278|FG002|Overall Study|Lost to Follow-up|3|||
155229978|NCT03995953|560280279|FG003|Overall Study|Lost to Follow-up|32|||
155229979|NCT03995953|560280280|FG004|Overall Study|Lost to Follow-up|5|||
155229980|NCT03995953|560280281|FG005|Overall Study|Lost to Follow-up|44|||
155229981|NCT03995953|560280282|FG006|Overall Study|Lost to Follow-up|0|||
155229982|NCT03995953|560280283|FG007|Overall Study|Lost to Follow-up|31|||
155229983|NCT03995953|560280284|FG008|Overall Study|Lost to Follow-up|8|||
155229984|NCT03995953|560280285|FG009|Overall Study|Lost to Follow-up|36|||
155229985|NCT03995953|560280286|FG010|Overall Study|Lost to Follow-up|5|||
155229986|NCT03995953|560280287|FG011|Overall Study|Lost to Follow-up|41|||
155229987|NCT03995953|560280276|FG000|Overall Study|Withdrawal by Subject|4|||
155229988|NCT03995953|560280277|FG001|Overall Study|Withdrawal by Subject|0|||
155229989|NCT03995953|560280278|FG002|Overall Study|Withdrawal by Subject|1|||
155229990|NCT03995953|560280279|FG003|Overall Study|Withdrawal by Subject|0|||
155229991|NCT03995953|560280280|FG004|Overall Study|Withdrawal by Subject|1|||
155229992|NCT03995953|560280281|FG005|Overall Study|Withdrawal by Subject|0|||
155229993|NCT03995953|560280282|FG006|Overall Study|Withdrawal by Subject|1|||
155229994|NCT03995953|560280283|FG007|Overall Study|Withdrawal by Subject|0|||
155229995|NCT03995953|560280284|FG008|Overall Study|Withdrawal by Subject|3|||
155229996|NCT03995953|560280285|FG009|Overall Study|Withdrawal by Subject|0|||
155229997|NCT03995953|560280286|FG010|Overall Study|Withdrawal by Subject|3|||
155229998|NCT03995953|560280287|FG011|Overall Study|Withdrawal by Subject|0|||
155229999|NCT03995953|560280276|FG000|Overall Study|Health Issues|0|||
155230000|NCT03995953|560280277|FG001|Overall Study|Health Issues|0|||
155230001|NCT03995953|560280278|FG002|Overall Study|Health Issues|0|||
155230002|NCT03995953|560280279|FG003|Overall Study|Health Issues|0|||
155230003|NCT03995953|560280280|FG004|Overall Study|Health Issues|1|||
155230004|NCT03995953|560280281|FG005|Overall Study|Health Issues|0|||
155230005|NCT03995953|560280282|FG006|Overall Study|Health Issues|0|||
155230006|NCT03995953|560280283|FG007|Overall Study|Health Issues|0|||
155230007|NCT03995953|560280284|FG008|Overall Study|Health Issues|4|||
155230008|NCT03995953|560280285|FG009|Overall Study|Health Issues|0|||
155230009|NCT03995953|560280286|FG010|Overall Study|Health Issues|0|||
155230010|NCT03995953|560280287|FG011|Overall Study|Health Issues|0|||
155230011|NCT03995953|560280276|FG000|Overall Study|Relocated|11|||
155230012|NCT03995953|560280277|FG001|Overall Study|Relocated|0|||
155230013|NCT03995953|560280278|FG002|Overall Study|Relocated|16|||
155230014|NCT03995953|560280279|FG003|Overall Study|Relocated|0|||
155230015|NCT03995953|560280280|FG004|Overall Study|Relocated|14|||
155230016|NCT03995953|560280281|FG005|Overall Study|Relocated|0|||
155230017|NCT03995953|560280282|FG006|Overall Study|Relocated|16|||
155230018|NCT03995953|560280283|FG007|Overall Study|Relocated|0|||
155230019|NCT03995953|560280284|FG008|Overall Study|Relocated|14|||
155230020|NCT03995953|560280285|FG009|Overall Study|Relocated|0|||
155230021|NCT03995953|560280286|FG010|Overall Study|Relocated|15|||
155230022|NCT03995953|560280287|FG011|Overall Study|Relocated|0|||
155230023|NCT00006184|560280288|FG000|Overall Study|Death|1|||
155230024|NCT00006184|560280289|FG001|Overall Study|Death|0|||
155230025|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
155230026|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
155230027|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
155230028|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
155230029|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
155230030|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
155230031|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
155230032|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
155230033|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
155230034|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
155230035|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
155230036|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
155230037|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
155230038|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
155230039|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
155230040|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
155230041|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
155230042|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
155230043|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
155230044|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
155230045|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
155230046|NCT02161718|560280290|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
155230047|NCT02161718|560280291|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
155230048|NCT02161718|560280292|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
155230049|NCT02161718|560280290|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
155230050|NCT02161718|560280291|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
155230051|NCT02161718|560280292|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
155230052|NCT02161718|560280290|FG000|Post- Randomization Period|Lost to Follow-up|0|||
155230053|NCT02161718|560280291|FG001|Post- Randomization Period|Lost to Follow-up|9|||
155230054|NCT02161718|560280292|FG002|Post- Randomization Period|Lost to Follow-up|15|||
155230055|NCT02161718|560280290|FG000|Post- Randomization Period|Adverse Event|0|||
155230056|NCT02161718|560280291|FG001|Post- Randomization Period|Adverse Event|9|||
155230057|NCT02161718|560280292|FG002|Post- Randomization Period|Adverse Event|10|||
155230058|NCT02161718|560280290|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
155230059|NCT02161718|560280291|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
155230060|NCT02161718|560280292|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
155230061|NCT02161718|560280290|FG000|Post- Randomization Period|Physician Decision|0|||
155230062|NCT02161718|560280291|FG001|Post- Randomization Period|Physician Decision|2|||
155230063|NCT02161718|560280292|FG002|Post- Randomization Period|Physician Decision|4|||
155230064|NCT02161718|560280290|FG000|Post- Randomization Period|Protocol Violation|0|||
155230065|NCT02161718|560280291|FG001|Post- Randomization Period|Protocol Violation|2|||
155230066|NCT02161718|560280292|FG002|Post- Randomization Period|Protocol Violation|3|||
155230067|NCT02161718|560280290|FG000|Post- Randomization Period|Lack of Efficacy|0|||
155230068|NCT02161718|560280291|FG001|Post- Randomization Period|Lack of Efficacy|0|||
155230069|NCT02161718|560280292|FG002|Post- Randomization Period|Lack of Efficacy|1|||
155230070|NCT02161718|560280290|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
155230071|NCT02161718|560280291|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
155230072|NCT02161718|560280292|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
155230073|NCT02161718|560280290|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
155230074|NCT02161718|560280291|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
155230075|NCT02161718|560280292|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
155230076|NCT02161718|560280290|FG000|Post- Randomization Period|Relocation|0|||
155230077|NCT02161718|560280291|FG001|Post- Randomization Period|Relocation|3|||
155230078|NCT02161718|560280292|FG002|Post- Randomization Period|Relocation|0|||
155230079|NCT00207142|560280295|FG000|Induction Phase|Adverse Event|9|||
155230080|NCT00207142|560280296|FG001|Induction Phase|Adverse Event|0|||
155230081|NCT00207142|560280297|FG002|Induction Phase|Adverse Event|0|||
155230082|NCT00207142|560280298|FG003|Induction Phase|Adverse Event|0|||
155230083|NCT00207142|560280295|FG000|Induction Phase|Death|1|||
155230084|NCT00207142|560280296|FG001|Induction Phase|Death|0|||
155230085|NCT00207142|560280297|FG002|Induction Phase|Death|0|||
155230086|NCT00207142|560280298|FG003|Induction Phase|Death|0|||
155230087|NCT00207142|560280295|FG000|Induction Phase|Lack of Efficacy|1|||
155230088|NCT00207142|560280296|FG001|Induction Phase|Lack of Efficacy|0|||
155230089|NCT00207142|560280297|FG002|Induction Phase|Lack of Efficacy|0|||
155230090|NCT00207142|560280298|FG003|Induction Phase|Lack of Efficacy|0|||
155230091|NCT00207142|560280295|FG000|Induction Phase|Lost to Follow-up|5|||
155230092|NCT00207142|560280296|FG001|Induction Phase|Lost to Follow-up|0|||
155230093|NCT00207142|560280297|FG002|Induction Phase|Lost to Follow-up|0|||
155230094|NCT00207142|560280298|FG003|Induction Phase|Lost to Follow-up|0|||
155230095|NCT00207142|560280295|FG000|Induction Phase|Physician Decision|2|||
155230096|NCT00207142|560280296|FG001|Induction Phase|Physician Decision|0|||
155230097|NCT00207142|560280297|FG002|Induction Phase|Physician Decision|0|||
155230098|NCT00207142|560280298|FG003|Induction Phase|Physician Decision|0|||
155230099|NCT00207142|560280295|FG000|Induction Phase|Poor/noncompliance|2|||
155230100|NCT00207142|560280296|FG001|Induction Phase|Poor/noncompliance|0|||
155230101|NCT00207142|560280297|FG002|Induction Phase|Poor/noncompliance|0|||
155230102|NCT00207142|560280298|FG003|Induction Phase|Poor/noncompliance|0|||
155230103|NCT00207142|560280295|FG000|Induction Phase|Pregnancy|1|||
155230104|NCT00207142|560280296|FG001|Induction Phase|Pregnancy|0|||
155230105|NCT00207142|560280297|FG002|Induction Phase|Pregnancy|0|||
155230106|NCT00207142|560280298|FG003|Induction Phase|Pregnancy|0|||
155230107|NCT00207142|560280295|FG000|Induction Phase|Subject no longer meets study criteria|3|||
155230108|NCT00207142|560280296|FG001|Induction Phase|Subject no longer meets study criteria|0|||
155230109|NCT00207142|560280297|FG002|Induction Phase|Subject no longer meets study criteria|0|||
155230110|NCT00207142|560280298|FG003|Induction Phase|Subject no longer meets study criteria|0|||
155230111|NCT00207142|560280295|FG000|Induction Phase|Withdrawal by Subject|4|||
155230112|NCT00207142|560280296|FG001|Induction Phase|Withdrawal by Subject|0|||
155230113|NCT00207142|560280297|FG002|Induction Phase|Withdrawal by Subject|0|||
155230114|NCT00207142|560280298|FG003|Induction Phase|Withdrawal by Subject|0|||
155230115|NCT00207142|560280295|FG000|Induction Phase|Incarceration|1|||
155230116|NCT00207142|560280296|FG001|Induction Phase|Incarceration|0|||
155230117|NCT00207142|560280297|FG002|Induction Phase|Incarceration|0|||
155230118|NCT00207142|560280298|FG003|Induction Phase|Incarceration|0|||
155230119|NCT00207142|560280295|FG000|Induction Phase|Missing lab data|1|||
155230120|NCT00207142|560280296|FG001|Induction Phase|Missing lab data|0|||
155230121|NCT00207142|560280297|FG002|Induction Phase|Missing lab data|0|||
155230122|NCT00207142|560280298|FG003|Induction Phase|Missing lab data|0|||
155230123|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
155230124|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
155230125|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
155230126|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
155230127|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
155230128|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
155230129|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
155230130|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
155230131|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
155230132|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
155230133|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
155230134|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
155230135|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
155230136|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
155230137|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
155230138|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
155230139|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
155230140|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
155230141|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
155230142|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
155230143|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
155230144|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
155230145|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
155230146|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
155230147|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
155230148|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
155230149|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
155230150|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
155230151|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Death|0|||
155230152|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Death|0|||
155230153|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Death|0|||
155230154|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Death|1|||
155230155|NCT00207142|560280295|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
155230156|NCT00207142|560280296|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
155230157|NCT00207142|560280297|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
155230158|NCT00207142|560280298|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
155230159|NCT01857063|560280299|FG000|Period 1 (7 Days)|Adverse Event|0|||
155230160|NCT01857063|560280300|FG001|Period 1 (7 Days)|Adverse Event|1|||
155230161|NCT01857063|560280299|FG000|Period 1 (7 Days)|Physician Decision|1|||
155230162|NCT01857063|560280300|FG001|Period 1 (7 Days)|Physician Decision|0|||
155230163|NCT01857063|560280299|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
155230164|NCT01857063|560280300|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
155230165|NCT01857063|560280299|FG000|Period 2 (7 Days)|Adverse Event|2|||
155230166|NCT01857063|560280300|FG001|Period 2 (7 Days)|Adverse Event|1|||
155230167|NCT01857063|560280299|FG000|Period 2 (7 Days)|Physician Decision|1|||
155230168|NCT01857063|560280300|FG001|Period 2 (7 Days)|Physician Decision|1|||
155230169|NCT01857063|560280299|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
155230170|NCT01857063|560280300|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
155230171|NCT04958109|560280301|FG000|Overall Study|Withdrawal by Subject|0|||
155230172|NCT04958109|560280302|FG001|Overall Study|Withdrawal by Subject|1|||
155230173|NCT04958109|560280301|FG000|Overall Study|Lost to Follow-up|0|||
155230174|NCT04958109|560280302|FG001|Overall Study|Lost to Follow-up|1|||
155230175|NCT01256710|560280303|FG000|Overall Study|Death|449|||
155230176|NCT01256710|560280303|FG000|Overall Study|System Explant|67|||
155230177|NCT01256710|560280303|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
155230178|NCT01256710|560280303|FG000|Overall Study|Lost to Follow-up|67|||
155230179|NCT01256710|560280303|FG000|Overall Study|Withdrawal by Subject|29|||
155230180|NCT01256710|560280303|FG000|Overall Study|Physician Decision|9|||
155230181|NCT01256710|560280303|FG000|Overall Study|Subject Noncompliance|2|||
155230182|NCT01256710|560280303|FG000|Overall Study|Study Terminated by Sponsor|273|||
155230183|NCT00058825|560280304|FG000|Overall Study|Relapse|9|||
155230184|NCT00058825|560280304|FG000|Overall Study|Progressive Disease|5|||
155230185|NCT00058825|560280304|FG000|Overall Study|Graft Failure|5|||
155230186|NCT00058825|560280304|FG000|Overall Study|Death|3|||
155230187|NCT02681302|560280306|FG000|Overall Study|Withdrawal by Subject|1|||
155230188|NCT02681302|560280307|FG001|Overall Study|Withdrawal by Subject|1|||
155230189|NCT02681302|560280308|FG002|Overall Study|Withdrawal by Subject|0|||
155230190|NCT02681302|560280309|FG003|Overall Study|Withdrawal by Subject|0|||
155230191|NCT02681302|560280310|FG004|Overall Study|Withdrawal by Subject|1|||
155230192|NCT02681302|560280311|FG005|Overall Study|Withdrawal by Subject|0|||
155230193|NCT02681302|560280306|FG000|Overall Study|Screen Failure|2|||
155230194|NCT02681302|560280307|FG001|Overall Study|Screen Failure|4|||
155230195|NCT02681302|560280308|FG002|Overall Study|Screen Failure|2|||
155230196|NCT02681302|560280309|FG003|Overall Study|Screen Failure|0|||
155230197|NCT02681302|560280310|FG004|Overall Study|Screen Failure|1|||
155230198|NCT02681302|560280311|FG005|Overall Study|Screen Failure|1|||
155230199|NCT02681302|560280306|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230200|NCT02681302|560280307|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230201|NCT02681302|560280308|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230202|NCT02681302|560280309|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230203|NCT02681302|560280310|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
155230204|NCT02681302|560280311|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
155230205|NCT00838565|560280312|FG000|Overall Study|Withdrawal by Subject|0|||
155230206|NCT00838565|560280313|FG001|Overall Study|Withdrawal by Subject|0|||
155230207|NCT00838565|560280314|FG002|Overall Study|Withdrawal by Subject|1|||
155230208|NCT00838565|560280315|FG003|Overall Study|Withdrawal by Subject|0|||
155230209|NCT00838565|560280316|FG004|Overall Study|Withdrawal by Subject|0|||
155230210|NCT00838565|560280317|FG005|Overall Study|Withdrawal by Subject|2|||
155230211|NCT00838565|560280312|FG000|Overall Study|Other|0|||
155230212|NCT00838565|560280313|FG001|Overall Study|Other|2|||
155230213|NCT00838565|560280314|FG002|Overall Study|Other|0|||
155230214|NCT00838565|560280315|FG003|Overall Study|Other|0|||
155230215|NCT00838565|560280316|FG004|Overall Study|Other|0|||
155230216|NCT00838565|560280317|FG005|Overall Study|Other|0|||
155230217|NCT00838565|560280312|FG000|Overall Study|Randomized but not Treated|0|||
155230218|NCT00838565|560280313|FG001|Overall Study|Randomized but not Treated|1|||
155230219|NCT00838565|560280314|FG002|Overall Study|Randomized but not Treated|0|||
155230220|NCT00838565|560280315|FG003|Overall Study|Randomized but not Treated|0|||
155230221|NCT00838565|560280316|FG004|Overall Study|Randomized but not Treated|0|||
155230222|NCT00838565|560280317|FG005|Overall Study|Randomized but not Treated|0|||
155230223|NCT00458484|560280318|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
155230224|NCT00458484|560280319|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
155230225|NCT00458484|560280320|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
155230226|NCT00458484|560280321|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
155230227|NCT00458484|560280322|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
155230228|NCT00458484|560280323|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
155230229|NCT00458484|560280324|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
155230230|NCT01838642|560280325|FG000|Overall Study|Died on study|1|||
155230231|NCT01557400|560280326|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
155230232|NCT01557400|560280326|FG000|Overall Study|Adverse Event|3|||
155230233|NCT01557400|560280326|FG000|Overall Study|Lost to Follow-up|5|||
155230234|NCT01557400|560280326|FG000|Overall Study|Withdrawal by Subject|9|||
155230235|NCT00245765|560280328|FG000|Overall Study|Adverse Event|1|||
155230236|NCT00245765|560280329|FG001|Overall Study|Adverse Event|1|||
155230237|NCT00245765|560280330|FG002|Overall Study|Adverse Event|0|||
155230238|NCT00245765|560280328|FG000|Overall Study|Lack of Efficacy|14|||
155230239|NCT00245765|560280329|FG001|Overall Study|Lack of Efficacy|7|||
155230240|NCT00245765|560280330|FG002|Overall Study|Lack of Efficacy|0|||
155230241|NCT00245765|560280328|FG000|Overall Study|Lost to Follow-up|1|||
155230242|NCT00245765|560280329|FG001|Overall Study|Lost to Follow-up|2|||
155230243|NCT00245765|560280330|FG002|Overall Study|Lost to Follow-up|0|||
155230244|NCT00245765|560280328|FG000|Overall Study|Withdrawal by Subject|1|||
155230245|NCT00245765|560280329|FG001|Overall Study|Withdrawal by Subject|0|||
155230246|NCT00245765|560280330|FG002|Overall Study|Withdrawal by Subject|3|||
155230247|NCT00245765|560280328|FG000|Overall Study|Other reason|2|||
155230248|NCT00245765|560280329|FG001|Overall Study|Other reason|0|||
155230249|NCT00245765|560280330|FG002|Overall Study|Other reason|1|||
155230250|NCT00245765|560280328|FG000|Overall Study|Other|13|||
155230251|NCT00245765|560280329|FG001|Overall Study|Other|4|||
155230252|NCT00245765|560280330|FG002|Overall Study|Other|4|||
155230253|NCT04477304|560280333|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
155230254|NCT04477304|560280334|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
155230255|NCT03548584|560281752|FG000|Overall Study|Lost to Follow-up|0|||
155230256|NCT03548584|560281753|FG001|Overall Study|Lost to Follow-up|0|||
155230257|NCT03548584|560281754|FG002|Overall Study|Lost to Follow-up|1|||
155230258|NCT03548584|560281752|FG000|Overall Study|Adverse Event|1|||
155230259|NCT03548584|560281753|FG001|Overall Study|Adverse Event|11|||
155230260|NCT03548584|560281754|FG002|Overall Study|Adverse Event|5|||
155230261|NCT03548584|560281752|FG000|Overall Study|Site Terminated by Sponsor|1|||
155230262|NCT03548584|560281753|FG001|Overall Study|Site Terminated by Sponsor|3|||
155230263|NCT03548584|560281754|FG002|Overall Study|Site Terminated by Sponsor|2|||
155230264|NCT03548584|560281752|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
155230265|NCT03548584|560281753|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
155230266|NCT03548584|560281754|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
155230267|NCT03548584|560281752|FG000|Overall Study|Lack of Efficacy|0|||
155230268|NCT03548584|560281753|FG001|Overall Study|Lack of Efficacy|1|||
155230269|NCT03548584|560281754|FG002|Overall Study|Lack of Efficacy|0|||
155230270|NCT03548584|560281752|FG000|Overall Study|Non-compliance with Study Drug|0|||
155230271|NCT03548584|560281753|FG001|Overall Study|Non-compliance with Study Drug|1|||
155230272|NCT03548584|560281754|FG002|Overall Study|Non-compliance with Study Drug|0|||
155230273|NCT03548584|560281752|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
155230274|NCT03548584|560281753|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
155230275|NCT03548584|560281754|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
155230276|NCT00293384|560281755|FG000|Overall Study|Non-compliance|2|||
155230277|NCT00293384|560281755|FG000|Overall Study|Missed dosage/study drug|1|||
155230278|NCT00293384|560281755|FG000|Overall Study|Ineligible|2|||
155230279|NCT00640510|560281756|FG000|Overall Study|Lack of Efficacy|0|||
155230280|NCT00640510|560281757|FG001|Overall Study|Lack of Efficacy|1|||
155230281|NCT00640510|560281756|FG000|Overall Study|Protocol Violation|1|||
155230282|NCT00640510|560281757|FG001|Overall Study|Protocol Violation|0|||
155230283|NCT00640510|560281756|FG000|Overall Study|Physician Decision|0|||
155230284|NCT00640510|560281757|FG001|Overall Study|Physician Decision|1|||
155230285|NCT01440322|560281758|FG000|Overall Study|Discomfort|2|||
155230286|NCT01440322|560281759|FG001|Overall Study|Discomfort|0|||
155230287|NCT01440322|560281758|FG000|Overall Study|Biomicroscopy|1|||
155230288|NCT01440322|560281759|FG001|Overall Study|Biomicroscopy|0|||
155230289|NCT01440322|560281758|FG000|Overall Study|Symptoms and Problems|1|||
155230290|NCT01440322|560281759|FG001|Overall Study|Symptoms and Problems|0|||
155230291|NCT01440322|560281758|FG000|Overall Study|Unacceptable Subjective Vision|1|||
155230292|NCT01440322|560281759|FG001|Overall Study|Unacceptable Subjective Vision|0|||
155230293|NCT01440322|560281758|FG000|Overall Study|Other Product Related|1|||
155230294|NCT01440322|560281759|FG001|Overall Study|Other Product Related|0|||
155230295|NCT01440322|560281758|FG000|Overall Study|Unrelated Medical Problem|0|||
155230296|NCT01440322|560281759|FG001|Overall Study|Unrelated Medical Problem|1|||
155230297|NCT01440322|560281758|FG000|Overall Study|Other Non-Product Related|1|||
155230298|NCT01440322|560281759|FG001|Overall Study|Other Non-Product Related|0|||
155230299|NCT02624284|560281768|FG000|Overall Study|Withdrawal by Subject|3|||
155230300|NCT02624284|560281769|FG001|Overall Study|Withdrawal by Subject|6|||
155230301|NCT02624284|560281770|FG002|Overall Study|Withdrawal by Subject|3|||
155230302|NCT02624284|560281768|FG000|Overall Study|Protocol Violation|9|||
155230303|NCT02624284|560281769|FG001|Overall Study|Protocol Violation|10|||
155230304|NCT02624284|560281770|FG002|Overall Study|Protocol Violation|7|||
155230305|NCT02624284|560281768|FG000|Overall Study|Revealed exclusionary condition|2|||
155230306|NCT02624284|560281769|FG001|Overall Study|Revealed exclusionary condition|2|||
155230307|NCT02624284|560281770|FG002|Overall Study|Revealed exclusionary condition|0|||
155230308|NCT02624284|560281768|FG000|Overall Study|Adverse Event|0|||
155230309|NCT02624284|560281769|FG001|Overall Study|Adverse Event|0|||
155230310|NCT02624284|560281770|FG002|Overall Study|Adverse Event|1|||
155230311|NCT01782313|560281771|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
155230312|NCT01782313|560281771|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
155230313|NCT01782313|560281771|FG000|Treated Cycle 3|Progressive Disease|21|||
155230314|NCT01782313|560281771|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
155230315|NCT01782313|560281771|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
155230316|NCT01782313|560281771|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
155230317|NCT01782313|560281771|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
155230318|NCT01782313|560281771|FG000|Survival Follow up|Lost to Follow-up|1|||
155230319|NCT00958776|560281772|FG000|Overall Study|Adverse Event|0|||
155230320|NCT00958776|560281773|FG001|Overall Study|Adverse Event|1|||
155230321|NCT00958776|560281772|FG000|Overall Study|Physician Decision|1|||
155230322|NCT00958776|560281773|FG001|Overall Study|Physician Decision|0|||
155230323|NCT00958776|560281772|FG000|Overall Study|Lost to Follow-up|2|||
155230324|NCT00958776|560281773|FG001|Overall Study|Lost to Follow-up|6|||
155230325|NCT00958776|560281772|FG000|Overall Study|Withdrawal by Subject|7|||
155230326|NCT00958776|560281773|FG001|Overall Study|Withdrawal by Subject|16|||
155230327|NCT00958776|560281772|FG000|Overall Study|Protocol Violation|1|||
155230328|NCT00958776|560281773|FG001|Overall Study|Protocol Violation|1|||
155230329|NCT00958776|560281772|FG000|Overall Study|Death|2|||
155230330|NCT00958776|560281773|FG001|Overall Study|Death|1|||
155230331|NCT00958776|560281772|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
155230332|NCT00958776|560281773|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
155230333|NCT00958776|560281772|FG000|Overall Study|Missing|1|||
155230334|NCT00958776|560281773|FG001|Overall Study|Missing|1|||
155230335|NCT00326911|560281774|FG000|Overall Study|Hospitalization prior to treatment|0|||
155230336|NCT00326911|560281775|FG001|Overall Study|Hospitalization prior to treatment|1|||
155230337|NCT00326911|560281774|FG000|Overall Study|Physician decision prior to treatment|1|||
155230338|NCT00326911|560281775|FG001|Overall Study|Physician decision prior to treatment|0|||
155230339|NCT00326911|560281774|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
155230340|NCT00326911|560281775|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
155230341|NCT02506816|560281782|FG000|Overall Study|Adverse Event|3|||
155230342|NCT02103478|560281787|FG000|Overall Study|Adverse Event|0|||
155230343|NCT02103478|560281788|FG001|Overall Study|Adverse Event|0|||
155230344|NCT02103478|560281789|FG002|Overall Study|Adverse Event|1|||
155230345|NCT02103478|560281790|FG003|Overall Study|Adverse Event|1|||
155230346|NCT02103478|560281791|FG004|Overall Study|Adverse Event|2|||
155230347|NCT02103478|560281792|FG005|Overall Study|Adverse Event|1|||
155230348|NCT02103478|560281793|FG006|Overall Study|Adverse Event|0|||
155230349|NCT02103478|560281794|FG007|Overall Study|Adverse Event|0|||
155230350|NCT02103478|560281795|FG008|Overall Study|Adverse Event|0|||
155230351|NCT02103478|560281787|FG000|Overall Study|Death|2|||
155230352|NCT02103478|560281788|FG001|Overall Study|Death|2|||
155230353|NCT02103478|560281789|FG002|Overall Study|Death|1|||
155230354|NCT02103478|560281790|FG003|Overall Study|Death|1|||
155230355|NCT02103478|560281791|FG004|Overall Study|Death|5|||
155230356|NCT02103478|560281792|FG005|Overall Study|Death|15|||
155230357|NCT02103478|560281793|FG006|Overall Study|Death|14|||
155230358|NCT02103478|560281794|FG007|Overall Study|Death|10|||
155230359|NCT02103478|560281795|FG008|Overall Study|Death|11|||
155230360|NCT02103478|560281787|FG000|Overall Study|Progressive Disease|2|||
155230361|NCT02103478|560281788|FG001|Overall Study|Progressive Disease|1|||
155230362|NCT02103478|560281789|FG002|Overall Study|Progressive Disease|2|||
155230363|NCT02103478|560281790|FG003|Overall Study|Progressive Disease|0|||
155230364|NCT02103478|560281791|FG004|Overall Study|Progressive Disease|9|||
155230365|NCT02103478|560281792|FG005|Overall Study|Progressive Disease|1|||
155230366|NCT02103478|560281793|FG006|Overall Study|Progressive Disease|2|||
155230367|NCT02103478|560281794|FG007|Overall Study|Progressive Disease|0|||
155230368|NCT02103478|560281795|FG008|Overall Study|Progressive Disease|1|||
155230369|NCT02103478|560281787|FG000|Overall Study|Withdrawal by Subject|2|||
155230370|NCT02103478|560281788|FG001|Overall Study|Withdrawal by Subject|0|||
155230371|NCT02103478|560281789|FG002|Overall Study|Withdrawal by Subject|0|||
155230372|NCT02103478|560281790|FG003|Overall Study|Withdrawal by Subject|4|||
155230373|NCT02103478|560281791|FG004|Overall Study|Withdrawal by Subject|0|||
155230374|NCT02103478|560281792|FG005|Overall Study|Withdrawal by Subject|0|||
155230375|NCT02103478|560281793|FG006|Overall Study|Withdrawal by Subject|1|||
155230376|NCT02103478|560281794|FG007|Overall Study|Withdrawal by Subject|1|||
155230377|NCT02103478|560281795|FG008|Overall Study|Withdrawal by Subject|0|||
155230378|NCT02103478|560281787|FG000|Overall Study|Lost to Follow-up|0|||
155230379|NCT02103478|560281788|FG001|Overall Study|Lost to Follow-up|0|||
155230380|NCT02103478|560281789|FG002|Overall Study|Lost to Follow-up|0|||
155230381|NCT02103478|560281790|FG003|Overall Study|Lost to Follow-up|0|||
155230382|NCT02103478|560281791|FG004|Overall Study|Lost to Follow-up|0|||
155230383|NCT02103478|560281792|FG005|Overall Study|Lost to Follow-up|0|||
155230384|NCT02103478|560281793|FG006|Overall Study|Lost to Follow-up|0|||
155230385|NCT02103478|560281794|FG007|Overall Study|Lost to Follow-up|1|||
155230386|NCT02103478|560281795|FG008|Overall Study|Lost to Follow-up|0|||
155230387|NCT02103478|560281787|FG000|Overall Study|Other|1|||
155230388|NCT02103478|560281788|FG001|Overall Study|Other|3|||
155230389|NCT02103478|560281789|FG002|Overall Study|Other|2|||
155230390|NCT02103478|560281790|FG003|Overall Study|Other|0|||
155230391|NCT02103478|560281791|FG004|Overall Study|Other|3|||
155230392|NCT02103478|560281792|FG005|Overall Study|Other|8|||
155230393|NCT02103478|560281793|FG006|Overall Study|Other|8|||
155230394|NCT02103478|560281794|FG007|Overall Study|Other|4|||
155230395|NCT02103478|560281795|FG008|Overall Study|Other|2|||
155230396|NCT00723606|560281796|FG000|Overall Study|Adverse Event|2|||
155230397|NCT00723606|560281797|FG001|Overall Study|Adverse Event|5|||
155230398|NCT00723606|560281796|FG000|Overall Study|Other|2|||
155230399|NCT00723606|560281797|FG001|Overall Study|Other|0|||
155230400|NCT00723606|560281796|FG000|Overall Study|Withdrawal by Subject|0|||
155230401|NCT00723606|560281797|FG001|Overall Study|Withdrawal by Subject|2|||
155230402|NCT01470469|560281798|FG000|Overall Study|Withdrawal by Subject|4|||
155230403|NCT01470469|560281799|FG001|Overall Study|Withdrawal by Subject|6|||
155230404|NCT01470469|560281798|FG000|Overall Study|Lack of Efficacy|1|||
155230405|NCT01470469|560281799|FG001|Overall Study|Lack of Efficacy|7|||
155230406|NCT01470469|560281798|FG000|Overall Study|Adverse Event|0|||
155230407|NCT01470469|560281799|FG001|Overall Study|Adverse Event|7|||
155230408|NCT01470469|560281798|FG000|Overall Study|Lost to Follow-up|2|||
155230409|NCT01470469|560281799|FG001|Overall Study|Lost to Follow-up|2|||
155230410|NCT01470469|560281798|FG000|Overall Study|Protocol Violation|1|||
155230411|NCT01470469|560281799|FG001|Overall Study|Protocol Violation|1|||
155230412|NCT01470469|560281798|FG000|Overall Study|Other|2|||
155230413|NCT01470469|560281799|FG001|Overall Study|Other|1|||
155230414|NCT03362502|560281800|FG000|Overall Study|Death|0|||
155230415|NCT03362502|560281801|FG001|Overall Study|Death|0|||
155230416|NCT03362502|560281802|FG002|Overall Study|Death|1|||
155230417|NCT02388997|560281829|FG000|Overall Study|Adverse Event|1|||
155230418|NCT02388997|560281830|FG001|Overall Study|Adverse Event|2|||
155230419|NCT02388997|560281829|FG000|Overall Study|Withdrawal by Subject|2|||
155230420|NCT02388997|560281830|FG001|Overall Study|Withdrawal by Subject|1|||
155230421|NCT02388997|560281829|FG000|Overall Study|Lung function exclusion criteria|0|||
155230422|NCT02388997|560281830|FG001|Overall Study|Lung function exclusion criteria|2|||
155230423|NCT02388997|560281829|FG000|Overall Study|Tested positive for virus during run-in|0|||
155230424|NCT02388997|560281830|FG001|Overall Study|Tested positive for virus during run-in|1|||
155230425|NCT00715793|560281833|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
155230426|NCT00715793|560281834|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
155230427|NCT00715793|560281833|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
155230428|NCT00715793|560281834|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
155230429|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230430|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
155230431|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
155230432|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
155230433|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230434|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230435|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230436|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230437|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230438|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230439|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230440|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230441|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230442|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230443|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230444|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230445|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230446|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230447|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230448|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230449|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230450|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230451|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230452|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
155230453|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230454|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
155230455|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230456|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230457|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230458|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230459|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230460|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230461|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230462|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230463|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230464|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230465|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230466|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230467|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230468|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230469|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230470|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230471|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230472|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230473|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230474|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230475|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230476|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
155230477|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230478|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
155230479|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230480|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230481|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230482|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230483|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230484|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230485|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230486|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230487|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230488|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230489|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230490|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230491|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230492|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230493|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230494|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230495|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230496|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230497|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230498|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230499|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230500|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
155230501|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
155230502|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
155230503|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
155230504|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
155230505|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230506|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230507|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230508|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230509|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230510|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230511|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230512|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230513|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230514|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230515|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230516|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230517|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230518|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230519|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230520|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230521|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230522|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230523|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230524|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
155230525|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
155230526|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
155230527|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
155230528|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
155230529|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230530|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230531|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230532|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230533|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230534|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230535|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230536|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230537|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230538|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230539|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230540|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230541|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230542|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230543|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230544|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230545|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230546|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230547|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230548|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
155230549|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230550|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
155230551|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230552|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
155230553|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230554|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230555|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230556|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230557|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230558|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230559|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230560|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230561|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230562|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230563|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230564|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230565|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230566|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230567|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230568|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230569|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230570|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230571|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230572|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
155230573|NCT02346240|560281835|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230574|NCT02346240|560281836|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230575|NCT02346240|560281837|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
155230576|NCT02346240|560281838|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230577|NCT02346240|560281839|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230578|NCT02346240|560281840|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230579|NCT02346240|560281841|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230580|NCT02346240|560281842|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230581|NCT02346240|560281843|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230582|NCT02346240|560281844|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230583|NCT02346240|560281845|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230584|NCT02346240|560281846|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230585|NCT02346240|560281847|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230586|NCT02346240|560281848|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230587|NCT02346240|560281849|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230588|NCT02346240|560281850|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230589|NCT02346240|560281851|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230590|NCT02346240|560281852|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230591|NCT02346240|560281853|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230592|NCT02346240|560281854|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230593|NCT02346240|560281855|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230594|NCT02346240|560281856|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230595|NCT02346240|560281857|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230596|NCT02346240|560281858|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
155230597|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230598|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230599|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230600|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230601|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230602|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230603|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230604|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155230605|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155230606|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230607|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230608|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230609|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230610|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155230611|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
155230612|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
155230613|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
155230614|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230615|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230616|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230617|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230618|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230619|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230620|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
155230621|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230622|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230623|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230624|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230625|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230626|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230627|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230628|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230629|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230630|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230631|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230632|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230633|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230634|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
155230635|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230636|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
155230637|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230638|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230639|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230640|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230641|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230642|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230643|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230644|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
155230645|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230646|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230647|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230648|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230649|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230650|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230651|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230652|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230653|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230654|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230655|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230656|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230657|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230658|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230659|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
155230660|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230661|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230662|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230663|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230664|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230665|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230666|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230667|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230668|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
155230669|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230670|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230671|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230672|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230673|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230674|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230675|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230676|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230677|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230678|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230679|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230680|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
155230681|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230682|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
155230683|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
155230684|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
155230685|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
155230686|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230687|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230688|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230689|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230690|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230691|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230692|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
155230693|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230694|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230695|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230696|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230697|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230698|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230699|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230700|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230701|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230702|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230703|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230704|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230705|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230706|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
155230707|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
155230708|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
155230709|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
155230710|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230711|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230712|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230713|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230714|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230715|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230716|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
155230717|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230718|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230719|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230720|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230721|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230722|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230723|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
155230724|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230725|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230726|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230727|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230728|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230729|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230730|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230731|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230732|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230733|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230734|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230735|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230736|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230737|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230738|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230739|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230740|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
155230741|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230742|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230743|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230744|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230745|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230746|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230747|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230748|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230749|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230750|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230751|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230752|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230753|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230754|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230755|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
155230756|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230757|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230758|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230759|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230760|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230761|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230762|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230763|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230764|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
155230765|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230766|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230767|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230768|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230769|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230770|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230771|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230772|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230773|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230774|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
155230775|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230776|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230777|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230778|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230779|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230780|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230781|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230782|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230783|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230784|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230785|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230786|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230787|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230788|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
155230789|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230790|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230791|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230792|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230793|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230794|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230795|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230796|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230797|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230798|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230799|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
155230800|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230801|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230802|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230803|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230804|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230805|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230806|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230807|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230808|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230809|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230810|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230811|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230812|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
155230813|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230814|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230815|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230816|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230817|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230818|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230819|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230820|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230821|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230822|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230823|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230824|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230825|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230826|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230827|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
155230828|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230829|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230830|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230831|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230832|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230833|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230834|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230835|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230836|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
155230837|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230838|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230839|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230840|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230841|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230842|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230843|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230844|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230845|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230846|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230847|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230848|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230849|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230850|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230851|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
155230852|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230853|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230854|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230855|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230856|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230857|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230858|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230859|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230860|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
155230861|NCT02346240|560281835|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230862|NCT02346240|560281836|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230863|NCT02346240|560281837|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230864|NCT02346240|560281838|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230865|NCT02346240|560281839|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230866|NCT02346240|560281840|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230867|NCT02346240|560281841|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230868|NCT02346240|560281842|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230869|NCT02346240|560281843|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230870|NCT02346240|560281844|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230871|NCT02346240|560281845|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230872|NCT02346240|560281846|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230873|NCT02346240|560281847|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230874|NCT02346240|560281848|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230875|NCT02346240|560281849|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
155230876|NCT02346240|560281850|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230877|NCT02346240|560281851|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230878|NCT02346240|560281852|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230879|NCT02346240|560281853|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230880|NCT02346240|560281854|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230881|NCT02346240|560281855|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230882|NCT02346240|560281856|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230883|NCT02346240|560281857|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230884|NCT02346240|560281858|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
155230885|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230886|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230887|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230888|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230889|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230890|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230891|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230892|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230893|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230894|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230895|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230896|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230897|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230898|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230899|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230900|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230901|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
155230902|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
155230903|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
155230904|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
155230905|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
155230906|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
155230907|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
155230908|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
155230909|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230910|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230911|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230912|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230913|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230914|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230915|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230916|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230917|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230918|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230919|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230920|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230921|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230922|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230923|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230924|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230925|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230926|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230927|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
155230928|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
155230929|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230930|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
155230931|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230932|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
155230933|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230934|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230935|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230936|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230937|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230938|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230939|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230940|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230941|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230942|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230943|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230944|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230945|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230946|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230947|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230948|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230949|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230950|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230951|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155230952|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230953|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230954|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
155230955|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230956|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
155230957|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230958|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230959|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230960|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230961|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230962|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230963|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230964|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230965|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230966|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230967|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230968|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230969|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230970|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230971|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230972|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230973|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230974|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230975|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230976|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230977|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230978|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
155230979|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230980|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
155230981|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230982|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230983|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230984|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230985|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230986|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230987|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230988|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230989|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230990|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230991|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230992|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230993|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230994|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230995|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230996|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230997|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155230998|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
155230999|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
155231000|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
155231001|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
155231002|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155231003|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155231004|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
155231005|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231006|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231007|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231008|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231009|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231010|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231011|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231012|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231013|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231014|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231015|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231016|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231017|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231018|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231019|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231020|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231021|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231022|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231023|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
155231024|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155231025|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
155231026|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
155231027|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155231028|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
155231029|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231030|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231031|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231032|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231033|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231034|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231035|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231036|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231037|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231038|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231039|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231040|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231041|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231042|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231043|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231044|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231045|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231046|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231047|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
155231048|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231049|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
155231050|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
155231051|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
155231052|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
155231053|NCT02346240|560281835|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231054|NCT02346240|560281836|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231055|NCT02346240|560281837|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231056|NCT02346240|560281838|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231057|NCT02346240|560281839|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231058|NCT02346240|560281840|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231059|NCT02346240|560281841|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231060|NCT02346240|560281842|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231061|NCT02346240|560281843|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231062|NCT02346240|560281844|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231063|NCT02346240|560281845|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231064|NCT02346240|560281846|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231065|NCT02346240|560281847|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231066|NCT02346240|560281848|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231067|NCT02346240|560281849|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231068|NCT02346240|560281850|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231069|NCT02346240|560281851|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231070|NCT02346240|560281852|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231071|NCT02346240|560281853|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
155231072|NCT02346240|560281854|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231073|NCT02346240|560281855|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231074|NCT02346240|560281856|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231075|NCT02346240|560281857|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231076|NCT02346240|560281858|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
155231077|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231078|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231079|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
155231080|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231081|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231082|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
155231083|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
155231084|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
155231085|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
155231086|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
155231087|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
155231088|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
155231089|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
155231090|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
155231091|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
155231092|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231093|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231094|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231095|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231096|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231097|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
155231098|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155231099|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231100|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
155231101|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231102|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231103|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
155231104|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
155231105|NCT01573624|560281859|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
155231106|NCT01573624|560281860|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
155231107|NCT01573624|560281861|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231108|NCT01573624|560281862|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231109|NCT01573624|560281863|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
155231110|NCT01573624|560281864|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231111|NCT01573624|560281865|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
155231112|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231113|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231114|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231115|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231116|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231117|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
155231118|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
155231119|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231120|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
155231121|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231122|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
155231123|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231124|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
155231125|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
155231126|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
155231127|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231128|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
155231129|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
155231130|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231131|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231132|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
155231133|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231134|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231135|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231136|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231137|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231138|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
155231139|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
155231140|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231141|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231142|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231143|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
155231144|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231145|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
155231146|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
155231147|NCT01573624|560281859|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231148|NCT01573624|560281860|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231149|NCT01573624|560281861|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231150|NCT01573624|560281862|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231151|NCT01573624|560281863|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231152|NCT01573624|560281864|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231153|NCT01573624|560281865|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231154|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
155231155|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
155231156|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
155231157|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
155231158|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
155231159|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
155231160|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
155231161|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231162|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
155231163|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231164|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231165|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231166|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
155231167|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
155231168|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
155231169|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231170|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231171|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231172|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231173|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231174|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
155231175|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231176|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155231177|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155231178|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231179|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231180|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
155231181|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
155231182|NCT01573624|560281859|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
155231183|NCT01573624|560281860|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231184|NCT01573624|560281861|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231185|NCT01573624|560281862|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231186|NCT01573624|560281863|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231187|NCT01573624|560281864|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231188|NCT01573624|560281865|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
155231189|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
155231190|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231191|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231192|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231193|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231194|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
155231195|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
155231196|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
155231197|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231198|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231199|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231200|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231201|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
155231202|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
155231203|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231204|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
155231205|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231206|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231207|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231208|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231209|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
155231210|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231211|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
155231212|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231213|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231214|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231215|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231216|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
155231217|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231218|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231219|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231220|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231221|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
155231222|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155231223|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
155231224|NCT01573624|560281859|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231225|NCT01573624|560281860|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231226|NCT01573624|560281861|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231227|NCT01573624|560281862|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231228|NCT01573624|560281863|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231229|NCT01573624|560281864|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
155231230|NCT01573624|560281865|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
155231231|NCT01573624|560281859|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
155231232|NCT01573624|560281860|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155231233|NCT01573624|560281861|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155231234|NCT01573624|560281862|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
155231235|NCT01573624|560281863|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
155231236|NCT01573624|560281864|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
155231237|NCT01573624|560281865|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
155231238|NCT01573624|560281859|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231239|NCT01573624|560281860|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
155231240|NCT01573624|560281861|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231241|NCT01573624|560281862|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231242|NCT01573624|560281863|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231243|NCT01573624|560281864|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
155231244|NCT01573624|560281865|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
155231245|NCT01573624|560281859|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
155231246|NCT01573624|560281860|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231247|NCT01573624|560281861|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231248|NCT01573624|560281862|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231249|NCT01573624|560281863|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231250|NCT01573624|560281864|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231251|NCT01573624|560281865|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
155231252|NCT01573624|560281859|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231253|NCT01573624|560281860|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231254|NCT01573624|560281861|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231255|NCT01573624|560281862|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231256|NCT01573624|560281863|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
155231257|NCT01573624|560281864|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
155231258|NCT01573624|560281865|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
155231259|NCT01573624|560281859|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
155231260|NCT01573624|560281860|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231261|NCT01573624|560281861|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231262|NCT01573624|560281862|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231263|NCT01573624|560281863|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231264|NCT01573624|560281864|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231265|NCT01573624|560281865|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
155231266|NCT02942017|560281866|FG000|Overall Study|Adverse Event|0|||
155231267|NCT02942017|560281867|FG001|Overall Study|Adverse Event|1|||
155231268|NCT02942017|560281866|FG000|Overall Study|Withdrawal by Subject|0|||
155231269|NCT02942017|560281867|FG001|Overall Study|Withdrawal by Subject|1|||
155231270|NCT02942017|560281866|FG000|Overall Study|Lost to Follow-up|1|||
155231271|NCT02942017|560281867|FG001|Overall Study|Lost to Follow-up|1|||
155231272|NCT02942017|560281866|FG000|Overall Study|Randomized but not dosed|1|||
155231273|NCT02942017|560281867|FG001|Overall Study|Randomized but not dosed|3|||
155231274|NCT04399161|560281868|FG000|Overall Study|Withdrawal by Subject|1|||
155231275|NCT04399161|560281869|FG001|Overall Study|Withdrawal by Subject|0|||
155231276|NCT04399161|560281870|FG002|Overall Study|Withdrawal by Subject|2|||
155231277|NCT04399161|560281868|FG000|Overall Study|Protocol Violation|1|||
155231278|NCT04399161|560281869|FG001|Overall Study|Protocol Violation|2|||
155231279|NCT04399161|560281870|FG002|Overall Study|Protocol Violation|0|||
155231280|NCT03417141|560281871|FG000|Overall Study|Withdrawal by Subject|1|||
155231281|NCT03417141|560281871|FG000|Overall Study|Protocol Violation|3|||
155231282|NCT02722928|560281872|FG000|Overall Study|Standard CT was not as required per prot|5|||
155231283|NCT02722928|560281873|FG001|Overall Study|Standard CT was not as required per prot|13|||
155231284|NCT02722928|560281872|FG000|Overall Study|Required Intraoperative MRI|5|||
155231285|NCT02722928|560281873|FG001|Overall Study|Required Intraoperative MRI|7|||
155231286|NCT03571516|560281874|FG000|Overall Study|Severe diarrhea|1|||
155231287|NCT03571516|560281875|FG001|Overall Study|Severe diarrhea|0|||
155231288|NCT03571516|560281874|FG000|Overall Study|Withdrawal by Subject|0|||
155231289|NCT03571516|560281875|FG001|Overall Study|Withdrawal by Subject|1|||
155231290|NCT04552587|560281876|FG000|Overall Study|Lost to Follow-up|4|||
155231291|NCT01822132|560281877|FG000|Overall Study|Lost to Follow-up|4|||
155231292|NCT01822132|560281878|FG001|Overall Study|Lost to Follow-up|2|||
155231293|NCT00291668|560281880|FG000|Overall Study|Lack of Efficacy|1|||
155231294|NCT00291668|560281881|FG001|Overall Study|Lack of Efficacy|0|||
155231295|NCT00291668|560281882|FG002|Overall Study|Lack of Efficacy|0|||
155231296|NCT00291668|560281880|FG000|Overall Study|SAE, non-fatal|1|||
155231297|NCT00291668|560281881|FG001|Overall Study|SAE, non-fatal|1|||
155231298|NCT00291668|560281882|FG002|Overall Study|SAE, non-fatal|1|||
155231299|NCT00291668|560281880|FG000|Overall Study|AE, non-serious non-fatal|1|||
155231300|NCT00291668|560281881|FG001|Overall Study|AE, non-serious non-fatal|0|||
155231301|NCT00291668|560281882|FG002|Overall Study|AE, non-serious non-fatal|0|||
155231302|NCT00291668|560281880|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
155231303|NCT00291668|560281881|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155231304|NCT00291668|560281882|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
155231305|NCT00313612|560281883|FG000|Overall Study|Patient never received treatment|0|||
155231306|NCT00313612|560281884|FG001|Overall Study|Patient never received treatment|1|||
155231307|NCT02540954|560281885|FG000|Overall Study|Physician Decision|3|||
155231308|NCT02540954|560281886|FG001|Overall Study|Physician Decision|1|||
155231309|NCT02540954|560281885|FG000|Overall Study|Withdrawal by Subject|6|||
155231310|NCT02540954|560281886|FG001|Overall Study|Withdrawal by Subject|5|||
155231311|NCT02540954|560281885|FG000|Overall Study|Lost to Follow-up|1|||
155231312|NCT02540954|560281886|FG001|Overall Study|Lost to Follow-up|1|||
155231313|NCT02540954|560281885|FG000|Overall Study|Adverse Event|4|||
155231314|NCT02540954|560281886|FG001|Overall Study|Adverse Event|2|||
155231315|NCT02540954|560281885|FG000|Overall Study|Death|0|||
155231316|NCT02540954|560281886|FG001|Overall Study|Death|3|||
155231317|NCT02540954|560281885|FG000|Overall Study|Treatment failure|1|||
155231318|NCT02540954|560281886|FG001|Overall Study|Treatment failure|0|||
155231319|NCT02540954|560281885|FG000|Overall Study|Other reason|4|||
155231320|NCT02540954|560281886|FG001|Overall Study|Other reason|2|||
155231321|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
155231322|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
155231323|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
155231324|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
155231325|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
155231326|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
155231327|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
155231328|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
155231329|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
155231330|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
155231331|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
155231332|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
155231333|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
155231334|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
155231335|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
155231336|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
155231337|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
155231338|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
155231339|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
155231340|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
155231341|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Other|3|||
155231342|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Other|0|||
155231343|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Other|2|||
155231344|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Other|2|||
155231345|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Other|7|||
155231346|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231347|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231348|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231349|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
155231350|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231351|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231352|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231353|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231354|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231355|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
155231356|NCT00213148|560281887|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
155231357|NCT00213148|560281888|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
155231358|NCT00213148|560281889|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
155231359|NCT00213148|560281890|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
155231360|NCT00213148|560281891|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
155231361|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
155231362|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
155231363|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
155231364|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
155231365|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
155231366|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
155231367|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
155231368|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
155231369|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
155231370|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
155231371|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Other|2|||
155231372|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Other|1|||
155231373|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Other|2|||
155231374|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Other|8|||
155231375|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Other|7|||
155231376|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231377|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
155231378|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231379|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231380|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
155231381|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
155231382|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231383|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231384|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231385|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
155231386|NCT00213148|560281887|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
155231387|NCT00213148|560281888|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
155231388|NCT00213148|560281889|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
155231389|NCT00213148|560281890|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
155231390|NCT00213148|560281891|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
155231391|NCT00213148|560281887|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
155231392|NCT00213148|560281888|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
155231393|NCT00213148|560281889|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
155231394|NCT00213148|560281890|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
155231395|NCT00213148|560281891|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
155231396|NCT00213148|560281887|FG000|Cycle 3 (1 Month)|Other|0|||
155231397|NCT00213148|560281888|FG001|Cycle 3 (1 Month)|Other|0|||
155231398|NCT00213148|560281889|FG002|Cycle 3 (1 Month)|Other|1|||
155231399|NCT00213148|560281890|FG003|Cycle 3 (1 Month)|Other|1|||
155231400|NCT00213148|560281891|FG004|Cycle 3 (1 Month)|Other|0|||
155231401|NCT01723228|560281892|FG000|Overall Study|Adverse Event|2|||
155231402|NCT01723228|560281893|FG001|Overall Study|Adverse Event|6|||
155231403|NCT01723228|560281892|FG000|Overall Study|Withdrawal by Subject|2|||
155231404|NCT01723228|560281893|FG001|Overall Study|Withdrawal by Subject|1|||
155231405|NCT01723228|560281892|FG000|Overall Study|Protocol Violation|0|||
155231406|NCT01723228|560281893|FG001|Overall Study|Protocol Violation|2|||
155231407|NCT01723228|560281892|FG000|Overall Study|Lost to Follow-up|2|||
155231408|NCT01723228|560281893|FG001|Overall Study|Lost to Follow-up|1|||
155231409|NCT01723228|560281892|FG000|Overall Study|Other|2|||
155231410|NCT01723228|560281893|FG001|Overall Study|Other|1|||
155231411|NCT02434770|560281894|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
155231412|NCT02434770|560281895|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
155231413|NCT02434770|560281896|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
155231414|NCT02434770|560281894|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
155231415|NCT02434770|560281895|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
155231416|NCT02434770|560281896|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
155231417|NCT02434770|560281894|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
155231418|NCT02434770|560281895|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
155231419|NCT02434770|560281896|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
155231420|NCT02434770|560281894|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
155231421|NCT02434770|560281895|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
155231422|NCT02434770|560281896|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
155231423|NCT02434770|560281894|FG000|Week 1 to Week 18|Death|1|||
155231424|NCT02434770|560281895|FG001|Week 1 to Week 18|Death|0|||
155231425|NCT02434770|560281896|FG002|Week 1 to Week 18|Death|0|||
155231426|NCT02434770|560281894|FG000|Week 18 to Week|Lost to Follow-up|2|||
155231427|NCT02434770|560281895|FG001|Week 18 to Week|Lost to Follow-up|2|||
155231428|NCT02434770|560281896|FG002|Week 18 to Week|Lost to Follow-up|1|||
155231429|NCT02434770|560281894|FG000|Week 18 to Week|Withdrawal by Subject|0|||
155231430|NCT02434770|560281895|FG001|Week 18 to Week|Withdrawal by Subject|0|||
155231431|NCT02434770|560281896|FG002|Week 18 to Week|Withdrawal by Subject|2|||
155231432|NCT02434770|560281894|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
155231433|NCT02434770|560281895|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
155231434|NCT02434770|560281896|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
155231435|NCT03080961|560281897|FG000|Overall Study|Withdrawal by Subject|3|||
155231436|NCT00660348|560281898|FG000|Overall Study|Withdrawal by Subject|1|||
155231437|NCT00660348|560281899|FG001|Overall Study|Withdrawal by Subject|0|||
155231438|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
155231439|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
155231440|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
155231441|NCT01282424|560281905|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
155231442|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
155231443|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
155231444|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
155231445|NCT01282424|560281905|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
155231446|NCT02741115|560281906|FG000|Overall Study|Adverse Event|1|||
155231447|NCT02741115|560281907|FG001|Overall Study|Adverse Event|0|||
155231448|NCT02741115|560281906|FG000|Overall Study|Lost to Follow-up|7|||
155231449|NCT02741115|560281907|FG001|Overall Study|Lost to Follow-up|4|||
155231450|NCT02741115|560281906|FG000|Overall Study|Withdrawal by Subject|4|||
155231451|NCT02741115|560281907|FG001|Overall Study|Withdrawal by Subject|2|||
155231452|NCT04602624|560281908|FG000|Overall Study|Protocol Deviation|1|||
155231453|NCT04602624|560281908|FG000|Overall Study|Withdrawal by Participant|1|||
155231454|NCT00445328|560281909|FG000|Overall Study|Death|0|||
155231455|NCT00445328|560281910|FG001|Overall Study|Death|1|||
155231456|NCT00445328|560281909|FG000|Overall Study|Adverse Event|0|||
155231457|NCT00445328|560281910|FG001|Overall Study|Adverse Event|3|||
155231458|NCT00445328|560281909|FG000|Overall Study|Other|0|||
155231459|NCT00445328|560281910|FG001|Overall Study|Other|2|||
155231460|NCT00445328|560281909|FG000|Overall Study|Withdrawal by Subject|2|||
155231461|NCT00445328|560281910|FG001|Overall Study|Withdrawal by Subject|0|||
155231462|NCT00445328|560281909|FG000|Overall Study|Protocol Violation|1|||
155231463|NCT00445328|560281910|FG001|Overall Study|Protocol Violation|0|||
155231464|NCT00316199|560281911|FG000|Overall Study|Adverse Event|2|||
155231465|NCT00316199|560281911|FG000|Overall Study|Death|8|||
155231466|NCT00316199|560281911|FG000|Overall Study|Lost to Follow-up|2|||
155231467|NCT03316872|560281912|FG000|Overall Study|Death|1|||
155231468|NCT02742103|560283140|FG000|Overall Study|Protocol Violation|1|||
155231469|NCT02742103|560283141|FG001|Overall Study|Protocol Violation|0|||
155231470|NCT02742103|560283140|FG000|Overall Study|Death|2|||
155231471|NCT02742103|560283141|FG001|Overall Study|Death|2|||
155231472|NCT02742103|560283140|FG000|Overall Study|Adverse Event|1|||
155231473|NCT02742103|560283141|FG001|Overall Study|Adverse Event|0|||
155231474|NCT02742103|560283140|FG000|Overall Study|Moved to another town|0|||
155231475|NCT02742103|560283141|FG001|Overall Study|Moved to another town|1|||
155231476|NCT02742103|560283140|FG000|Overall Study|Withdrawal by Subject|5|||
155231477|NCT02742103|560283141|FG001|Overall Study|Withdrawal by Subject|2|||
155231478|NCT04346615|560283142|FG000|Overall Study|Lost to Follow-up|0|||
155231479|NCT04346615|560283143|FG001|Overall Study|Lost to Follow-up|2|||
155231480|NCT04346615|560283142|FG000|Overall Study|Withdrawal by Subject|1|||
155231481|NCT04346615|560283143|FG001|Overall Study|Withdrawal by Subject|0|||
155231482|NCT04346615|560283142|FG000|Overall Study|Death|5|||
155231483|NCT04346615|560283143|FG001|Overall Study|Death|1|||
155231484|NCT04346615|560283142|FG000|Overall Study|Other|0|||
155231485|NCT04346615|560283143|FG001|Overall Study|Other|2|||
155231486|NCT04346615|560283142|FG000|Overall Study|Randomized not treated|1|||
155231487|NCT04346615|560283143|FG001|Overall Study|Randomized not treated|0|||
155231488|NCT00533949|560283146|FG000|Overall Study|Protocol Violation|12|||
155231489|NCT00533949|560283147|FG001|Overall Study|Protocol Violation|12|||
155231490|NCT00533949|560283148|FG002|Overall Study|Protocol Violation|9|||
155231491|NCT00533949|560283149|FG003|Overall Study|Protocol Violation|9|||
155231492|NCT00533949|560283146|FG000|Overall Study|Withdrawal by Subject|3|||
155231493|NCT00533949|560283147|FG001|Overall Study|Withdrawal by Subject|2|||
155231494|NCT00533949|560283148|FG002|Overall Study|Withdrawal by Subject|1|||
155231495|NCT00533949|560283149|FG003|Overall Study|Withdrawal by Subject|1|||
155231496|NCT00727194|560283150|FG000|Screening Period|Low QMG scores|0|||
155231497|NCT00727194|560283151|FG001|Screening Period|Low QMG scores|0|||
155231498|NCT00727194|560283152|FG002|Screening Period|Low QMG scores|6|||
155231499|NCT00727194|560283150|FG000|Screening Period|Lacked AChR antibodies|0|||
155231500|NCT00727194|560283151|FG001|Screening Period|Lacked AChR antibodies|0|||
155231501|NCT00727194|560283152|FG002|Screening Period|Lacked AChR antibodies|5|||
155231502|NCT00727194|560283150|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
155231503|NCT00727194|560283151|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
155231504|NCT00727194|560283152|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
155231505|NCT00727194|560283150|FG000|Screening Period|Severe infections|0|||
155231506|NCT00727194|560283151|FG001|Screening Period|Severe infections|0|||
155231507|NCT00727194|560283152|FG002|Screening Period|Severe infections|2|||
155231508|NCT00727194|560283150|FG000|Screening Period|History of thymoma|0|||
155231509|NCT00727194|560283151|FG001|Screening Period|History of thymoma|0|||
155231510|NCT00727194|560283152|FG002|Screening Period|History of thymoma|1|||
155231511|NCT00727194|560283150|FG000|Treatment Period 2|Lack of Efficacy|0|||
155231512|NCT00727194|560283151|FG001|Treatment Period 2|Lack of Efficacy|1|||
155231513|NCT00727194|560283152|FG002|Treatment Period 2|Lack of Efficacy|0|||
155231514|NCT01677195|560283159|FG000|Overall Study|Lost to Follow-up|14|||
155231515|NCT01677195|560283160|FG001|Overall Study|Lost to Follow-up|22|||
155231516|NCT01677195|560283161|FG002|Overall Study|Lost to Follow-up|22|||
155231517|NCT01677195|560283159|FG000|Overall Study|Withdrawal by Subject|1|||
155231518|NCT01677195|560283160|FG001|Overall Study|Withdrawal by Subject|0|||
155231519|NCT01677195|560283161|FG002|Overall Study|Withdrawal by Subject|1|||
155231520|NCT01677195|560283159|FG000|Overall Study|Adverse Event|6|||
155231521|NCT01677195|560283160|FG001|Overall Study|Adverse Event|4|||
155231522|NCT01677195|560283161|FG002|Overall Study|Adverse Event|1|||
155231523|NCT01677195|560283159|FG000|Overall Study|Physician Decision|1|||
155231524|NCT01677195|560283160|FG001|Overall Study|Physician Decision|2|||
155231525|NCT01677195|560283161|FG002|Overall Study|Physician Decision|2|||
155231526|NCT01677195|560283159|FG000|Overall Study|Pregnancy|0|||
155231527|NCT01677195|560283160|FG001|Overall Study|Pregnancy|1|||
155231528|NCT01677195|560283161|FG002|Overall Study|Pregnancy|0|||
155231529|NCT01677195|560283159|FG000|Overall Study|Protocol Violation|7|||
155231530|NCT01677195|560283160|FG001|Overall Study|Protocol Violation|3|||
155231531|NCT01677195|560283161|FG002|Overall Study|Protocol Violation|4|||
155231532|NCT04368429|560283162|FG000|Overall Study|Adverse Event|1|||
155231533|NCT04368429|560283163|FG001|Overall Study|Adverse Event|0|||
155231534|NCT03633396|560283164|FG000|Overall Study|Withdrawal by Subject|4|||
155231535|NCT03633396|560283165|FG001|Overall Study|Withdrawal by Subject|4|||
155231536|NCT03633396|560283164|FG000|Overall Study|Adverse Event|1|||
155231537|NCT03633396|560283165|FG001|Overall Study|Adverse Event|1|||
155231538|NCT03633396|560283164|FG000|Overall Study|Lack of Efficacy|1|||
155231539|NCT03633396|560283165|FG001|Overall Study|Lack of Efficacy|0|||
155231540|NCT03633396|560283164|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
155231541|NCT03633396|560283165|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
155231542|NCT01012817|560283166|FG000|Overall Study|Withdrawal by Subject|0|||
155231543|NCT01012817|560283167|FG001|Overall Study|Withdrawal by Subject|0|||
155231544|NCT01012817|560283168|FG002|Overall Study|Withdrawal by Subject|0|||
155231545|NCT01012817|560283169|FG003|Overall Study|Withdrawal by Subject|1|||
155231546|NCT01012817|560283170|FG004|Overall Study|Withdrawal by Subject|0|||
155231547|NCT01012817|560283171|FG005|Overall Study|Withdrawal by Subject|0|||
155231548|NCT01012817|560283172|FG006|Overall Study|Withdrawal by Subject|0|||
155231549|NCT01012817|560283173|FG007|Overall Study|Withdrawal by Subject|1|||
155231550|NCT01012817|560283174|FG008|Overall Study|Withdrawal by Subject|0|||
155231551|NCT01012817|560283175|FG009|Overall Study|Withdrawal by Subject|0|||
155231552|NCT01012817|560283176|FG010|Overall Study|Withdrawal by Subject|1|||
155231553|NCT01012817|560283177|FG011|Overall Study|Withdrawal by Subject|1|||
155231554|NCT01012817|560283178|FG012|Overall Study|Withdrawal by Subject|0|||
155231555|NCT01012817|560283179|FG013|Overall Study|Withdrawal by Subject|1|||
155231556|NCT01012817|560283166|FG000|Overall Study|Adverse Event|0|||
155231557|NCT01012817|560283167|FG001|Overall Study|Adverse Event|0|||
155231558|NCT01012817|560283168|FG002|Overall Study|Adverse Event|0|||
155231559|NCT01012817|560283169|FG003|Overall Study|Adverse Event|0|||
155231560|NCT01012817|560283170|FG004|Overall Study|Adverse Event|0|||
155231561|NCT01012817|560283171|FG005|Overall Study|Adverse Event|1|||
155231562|NCT01012817|560283172|FG006|Overall Study|Adverse Event|0|||
155231563|NCT01012817|560283173|FG007|Overall Study|Adverse Event|0|||
155231564|NCT01012817|560283174|FG008|Overall Study|Adverse Event|0|||
155231565|NCT01012817|560283175|FG009|Overall Study|Adverse Event|0|||
155231566|NCT01012817|560283176|FG010|Overall Study|Adverse Event|1|||
155231567|NCT01012817|560283177|FG011|Overall Study|Adverse Event|0|||
155231568|NCT01012817|560283178|FG012|Overall Study|Adverse Event|0|||
155231569|NCT01012817|560283179|FG013|Overall Study|Adverse Event|1|||
155231570|NCT00023673|560283180|FG000|Overall Study|Ineligible / no protocol treatment|0|||
155231571|NCT00023673|560283181|FG001|Overall Study|Ineligible / no protocol treatment|0|||
155231572|NCT00023673|560283182|FG002|Overall Study|Ineligible / no protocol treatment|0|||
155231573|NCT00023673|560283183|FG003|Overall Study|Ineligible / no protocol treatment|1|||
155231574|NCT00023673|560283180|FG000|Overall Study|Patient withdrew consent|0|||
155231575|NCT00023673|560283181|FG001|Overall Study|Patient withdrew consent|0|||
155231576|NCT00023673|560283182|FG002|Overall Study|Patient withdrew consent|0|||
155231577|NCT00023673|560283183|FG003|Overall Study|Patient withdrew consent|1|||
155231578|NCT02472756|560283184|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
155231579|NCT02472756|560283184|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
155231580|NCT02472756|560283184|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
155231581|NCT02472756|560283184|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
155231582|NCT02472756|560283184|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
155231583|NCT00110266|560283185|FG000|Overall Study|Adverse Event|27|||
155231584|NCT00110266|560283185|FG000|Overall Study|Abnormal laboratory value|15|||
155231585|NCT00110266|560283185|FG000|Overall Study|Withdrawal by Subject|16|||
155231586|NCT00110266|560283185|FG000|Overall Study|Death|17|||
155231587|NCT00110266|560283185|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155231588|NCT00110266|560283185|FG000|Overall Study|Participant condition no longer requires study drug|1|||
155231589|NCT01344057|560283188|FG000|Overall Study|Premature Withdrawal|1|||
155231590|NCT00548808|560283194|FG000|Overall Study|Lost to Follow-up|9|||
155231591|NCT00548808|560283195|FG001|Overall Study|Lost to Follow-up|3|||
155231592|NCT00548808|560283194|FG000|Overall Study|Protocol Violation|8|||
155231593|NCT00548808|560283195|FG001|Overall Study|Protocol Violation|8|||
155231594|NCT00548808|560283194|FG000|Overall Study|Withdrawal by Subject|8|||
155231595|NCT00548808|560283195|FG001|Overall Study|Withdrawal by Subject|4|||
155231596|NCT00548808|560283194|FG000|Overall Study|Physician Decision|6|||
155231597|NCT00548808|560283195|FG001|Overall Study|Physician Decision|3|||
155231598|NCT00548808|560283194|FG000|Overall Study|Adverse Event|4|||
155231599|NCT00548808|560283195|FG001|Overall Study|Adverse Event|5|||
155231600|NCT00548808|560283194|FG000|Overall Study|Death|2|||
155231601|NCT00548808|560283195|FG001|Overall Study|Death|0|||
155231602|NCT00548808|560283194|FG000|Overall Study|Entry Criteria Not Met|2|||
155231603|NCT00548808|560283195|FG001|Overall Study|Entry Criteria Not Met|2|||
155231604|NCT00548808|560283194|FG000|Overall Study|Lack of Efficacy|2|||
155231605|NCT00548808|560283195|FG001|Overall Study|Lack of Efficacy|0|||
155231606|NCT00548808|560283194|FG000|Overall Study|Sponsor Decision|1|||
155231607|NCT00548808|560283195|FG001|Overall Study|Sponsor Decision|1|||
155231608|NCT04300296|560283196|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
155231609|NCT04300296|560283197|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231610|NCT04300296|560283198|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231611|NCT04300296|560283199|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231612|NCT04300296|560283200|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231613|NCT04300296|560283201|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
155231614|NCT04300296|560283196|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231615|NCT04300296|560283197|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231616|NCT04300296|560283198|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231617|NCT04300296|560283199|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231618|NCT04300296|560283200|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
155231619|NCT04300296|560283201|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
155231620|NCT04300296|560283196|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
155231621|NCT04300296|560283197|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
155231622|NCT04300296|560283198|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
155231623|NCT04300296|560283199|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
155231624|NCT04300296|560283200|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
155231625|NCT04300296|560283201|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
155231626|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
155231627|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
155231628|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
155231629|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
155231630|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
155231631|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
155231632|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
155231633|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
155231634|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
155231635|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
155231636|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
155231637|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
155231638|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231639|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
155231640|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231641|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231642|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231643|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
155231644|NCT04300296|560283196|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
155231645|NCT04300296|560283197|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
155231646|NCT04300296|560283198|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
155231647|NCT04300296|560283199|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
155231648|NCT04300296|560283200|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
155231649|NCT04300296|560283201|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
155231650|NCT00279708|560283204|FG000|Overall Study|Withdrawal by Subject|2|||
155231651|NCT00279708|560283205|FG001|Overall Study|Withdrawal by Subject|3|||
155231652|NCT00279708|560283204|FG000|Overall Study|Adverse Event|1|||
155231653|NCT00279708|560283205|FG001|Overall Study|Adverse Event|1|||
155231654|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Adverse Event|9|||
155231655|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Adverse Event|2|||
155231656|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
155231657|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
155231658|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
155231659|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
155231660|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Physician Decision|1|||
155231661|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Physician Decision|1|||
155231662|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Pregnancy|2|||
155231663|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Pregnancy|0|||
155231664|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
155231665|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
155231666|NCT02896127|560283206|FG000|COMPLETED WEEK 52|Technical problems|1|||
155231667|NCT02896127|560283207|FG001|COMPLETED WEEK 52|Technical problems|0|||
155231668|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
155231669|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
155231670|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
155231671|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
155231672|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
155231673|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
155231674|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
155231675|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
155231676|NCT02896127|560283206|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
155231677|NCT02896127|560283207|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
155231678|NCT02940691|560283208|FG000|Overall Study|Lost to Follow-up|5|||
155231679|NCT02940691|560283208|FG000|Overall Study|Incarceration|1|||
155231680|NCT03592641|560283211|FG000|Overall Study|Withdrawal by Subject|1|||
155231681|NCT01049919|560283213|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
155231682|NCT01049919|560283214|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
155231683|NCT01049919|560283213|FG000|Overall Study|Withdrawal by Subject|5|||
155231684|NCT01049919|560283214|FG001|Overall Study|Withdrawal by Subject|0|||
155231685|NCT01049919|560283213|FG000|Overall Study|Lost to Follow-up|6|||
155231686|NCT01049919|560283214|FG001|Overall Study|Lost to Follow-up|1|||
155231687|NCT01049919|560283213|FG000|Overall Study|Physician Decision|2|||
155231688|NCT01049919|560283214|FG001|Overall Study|Physician Decision|0|||
155231689|NCT01049919|560283213|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
155231690|NCT01049919|560283214|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
155231691|NCT01049919|560283213|FG000|Overall Study|Early study termination by sponsor.|2|||
155231692|NCT01049919|560283214|FG001|Overall Study|Early study termination by sponsor.|0|||
155231693|NCT01126541|560283215|FG000|Overall Study|Adverse Event|0|||
155231694|NCT01126541|560283216|FG001|Overall Study|Adverse Event|2|||
155231695|NCT01126541|560283217|FG002|Overall Study|Adverse Event|4|||
155231696|NCT01126541|560283215|FG000|Overall Study|Death|0|||
155231697|NCT01126541|560283216|FG001|Overall Study|Death|1|||
155231698|NCT01126541|560283217|FG002|Overall Study|Death|0|||
155231699|NCT01126541|560283215|FG000|Overall Study|Lack of Efficacy|6|||
155231700|NCT01126541|560283216|FG001|Overall Study|Lack of Efficacy|1|||
155231701|NCT01126541|560283217|FG002|Overall Study|Lack of Efficacy|11|||
155231702|NCT01126541|560283215|FG000|Overall Study|Lost to Follow-up|1|||
155231703|NCT01126541|560283216|FG001|Overall Study|Lost to Follow-up|2|||
155231704|NCT01126541|560283217|FG002|Overall Study|Lost to Follow-up|2|||
155231705|NCT01126541|560283215|FG000|Overall Study|Withdrawal by Subject|2|||
155231706|NCT01126541|560283216|FG001|Overall Study|Withdrawal by Subject|5|||
155231707|NCT01126541|560283217|FG002|Overall Study|Withdrawal by Subject|6|||
155231708|NCT01126541|560283215|FG000|Overall Study|Protocol Violation|0|||
155231709|NCT01126541|560283216|FG001|Overall Study|Protocol Violation|0|||
155231710|NCT01126541|560283217|FG002|Overall Study|Protocol Violation|1|||
155231711|NCT01126541|560283215|FG000|Overall Study|Administrative reason or other|1|||
155231712|NCT01126541|560283216|FG001|Overall Study|Administrative reason or other|1|||
155231713|NCT01126541|560283217|FG002|Overall Study|Administrative reason or other|2|||
155231714|NCT02984995|560283218|FG000|Overall Study|Required stem cell transplant|13|||
155231715|NCT02984995|560283219|FG001|Overall Study|Required stem cell transplant|2|||
155231716|NCT02984995|560283218|FG000|Overall Study|Progressive disease|11|||
155231717|NCT02984995|560283219|FG001|Overall Study|Progressive disease|1|||
155231718|NCT02984995|560283218|FG000|Overall Study|Adverse Event|1|||
155231719|NCT02984995|560283219|FG001|Overall Study|Adverse Event|0|||
155231720|NCT04354831|560283220|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
155231721|NCT04354831|560283221|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
155231722|NCT02504372|560283225|FG000|Overall Study|Death|136|||
155231723|NCT02504372|560283226|FG001|Overall Study|Death|154|||
155231724|NCT02504372|560283225|FG000|Overall Study|Lost to Follow-up|0|||
155231725|NCT02504372|560283226|FG001|Overall Study|Lost to Follow-up|2|||
155231726|NCT02504372|560283225|FG000|Overall Study|Withdrawal of consent|25|||
155231727|NCT02504372|560283226|FG001|Overall Study|Withdrawal of consent|16|||
155231728|NCT02504372|560283225|FG000|Overall Study|Participants ongoing|429|||
155231729|NCT02504372|560283226|FG001|Overall Study|Participants ongoing|415|||
155231730|NCT03323099|560283227|FG000|Overall Study|Withdrawal by Subject|6|||
155231731|NCT03323099|560283228|FG001|Overall Study|Withdrawal by Subject|12|||
155231732|NCT03323099|560283227|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
155231733|NCT03323099|560283228|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
155231734|NCT00767676|560283229|FG000|Overall Study|Investigator error|54|||
155231735|NCT01502644|560283232|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
155231736|NCT01502644|560283233|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
155231737|NCT01502644|560283234|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
155231738|NCT01502644|560283235|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
155231739|NCT01502644|560283232|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
155231740|NCT01502644|560283233|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
155231741|NCT01502644|560283234|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
155231742|NCT01502644|560283235|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
155231743|NCT01502644|560283232|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
155231744|NCT01502644|560283233|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
155231745|NCT01502644|560283234|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
155231746|NCT01502644|560283235|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
155231747|NCT01502644|560283232|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
155231748|NCT01502644|560283233|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
155231749|NCT01502644|560283234|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
155231750|NCT01502644|560283235|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
155231751|NCT01502644|560283232|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
155231752|NCT01502644|560283233|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
155231753|NCT01502644|560283234|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
155231754|NCT01502644|560283235|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
155231755|NCT00547703|560283238|FG000|Overall Study|Lost to Follow-up|1|||
155231756|NCT00547703|560283239|FG001|Overall Study|Lost to Follow-up|0|||
155231757|NCT03120013|560283244|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
155231758|NCT03120013|560283245|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
155231759|NCT05059600|560283246|FG000|Overall Study|Enrolled but not Treated|10|||
155231760|NCT04907032|560283252|FG000|Overall Study|Withdrawal by Subject|7|||
155231761|NCT04907032|560283253|FG001|Overall Study|Withdrawal by Subject|1|||
155231762|NCT02253810|560283254|FG000|Overall Study|Withdrawal by Subject|2|||
155231763|NCT02253810|560283255|FG001|Overall Study|Withdrawal by Subject|1|||
155231764|NCT02253810|560283254|FG000|Overall Study|Unknown concomitant procedure|3|||
155231765|NCT02253810|560283255|FG001|Overall Study|Unknown concomitant procedure|2|||
155231766|NCT03465878|560283258|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
155231767|NCT03465878|560283259|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
155231768|NCT03465878|560283260|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
155231769|NCT03465878|560283261|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
155231770|NCT03465878|560283258|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
155231771|NCT03465878|560283259|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
155231772|NCT03465878|560283260|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
155231773|NCT03465878|560283261|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
155231774|NCT03465878|560283258|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
155231775|NCT03465878|560283259|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
155231776|NCT03465878|560283260|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
155231777|NCT03465878|560283261|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
155231778|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
155231779|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
155231780|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
155231781|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155231782|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155231783|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155231784|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231785|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231786|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
155231787|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231788|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231789|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
155231790|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
155231791|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
155231792|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
155231793|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155231794|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155231795|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155231796|NCT04019041|560283262|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231797|NCT04019041|560283263|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231798|NCT04019041|560283264|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
155231799|NCT04019041|560283265|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231800|NCT04019041|560283266|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231801|NCT04019041|560283267|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
155231802|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155231803|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155231804|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155231805|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
155231806|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
155231807|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
155231808|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231809|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231810|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231811|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
155231812|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231813|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
155231814|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231815|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231816|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231817|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231818|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
155231819|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
155231820|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155231821|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155231822|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155231823|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
155231824|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
155231825|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
155231826|NCT04019041|560283262|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231827|NCT04019041|560283263|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231828|NCT04019041|560283264|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231829|NCT04019041|560283265|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155231830|NCT04019041|560283266|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
155231831|NCT04019041|560283267|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
155231832|NCT01393743|560283268|FG000|Core Study|Adverse Event|5|||
155231833|NCT01393743|560283269|FG001|Core Study|Adverse Event|9|||
155231834|NCT01393743|560283270|FG002|Core Study|Adverse Event|0|||
155231835|NCT01393743|560283268|FG000|Core Study|Lost to Follow-up|1|||
155231836|NCT01393743|560283269|FG001|Core Study|Lost to Follow-up|1|||
155231837|NCT01393743|560283270|FG002|Core Study|Lost to Follow-up|0|||
155231838|NCT01393743|560283268|FG000|Core Study|Participant's Choice|2|||
155231839|NCT01393743|560283269|FG001|Core Study|Participant's Choice|3|||
155231840|NCT01393743|560283270|FG002|Core Study|Participant's Choice|0|||
155231841|NCT01393743|560283268|FG000|Core Study|Inadequate therapeutic effect|2|||
155231842|NCT01393743|560283269|FG001|Core Study|Inadequate therapeutic effect|0|||
155231843|NCT01393743|560283270|FG002|Core Study|Inadequate therapeutic effect|0|||
155231844|NCT01393743|560283268|FG000|Extension Phase|Adverse Event|0|||
155231845|NCT01393743|560283269|FG001|Extension Phase|Adverse Event|0|||
155231846|NCT01393743|560283270|FG002|Extension Phase|Adverse Event|12|||
155231847|NCT01393743|560283268|FG000|Extension Phase|Lost to Follow-up|0|||
155231848|NCT01393743|560283269|FG001|Extension Phase|Lost to Follow-up|0|||
155231849|NCT01393743|560283270|FG002|Extension Phase|Lost to Follow-up|2|||
155231850|NCT01393743|560283268|FG000|Extension Phase|Participant choice|0|||
155231851|NCT01393743|560283269|FG001|Extension Phase|Participant choice|0|||
155231852|NCT01393743|560283270|FG002|Extension Phase|Participant choice|16|||
155231853|NCT01393743|560283268|FG000|Extension Phase|Inadequate therapeutic effect|0|||
155231854|NCT01393743|560283269|FG001|Extension Phase|Inadequate therapeutic effect|0|||
155231855|NCT01393743|560283270|FG002|Extension Phase|Inadequate therapeutic effect|7|||
155231856|NCT01393743|560283268|FG000|Extension Phase|Withdrawal by Subject|0|||
155231857|NCT01393743|560283269|FG001|Extension Phase|Withdrawal by Subject|0|||
155231858|NCT01393743|560283270|FG002|Extension Phase|Withdrawal by Subject|8|||
155231859|NCT01393743|560283268|FG000|Extension Phase|Pregnancy|0|||
155231860|NCT01393743|560283269|FG001|Extension Phase|Pregnancy|0|||
155231861|NCT01393743|560283270|FG002|Extension Phase|Pregnancy|1|||
155231862|NCT01393743|560283268|FG000|Extension Phase|Other|0|||
155231863|NCT01393743|560283269|FG001|Extension Phase|Other|0|||
155231864|NCT01393743|560283270|FG002|Extension Phase|Other|14|||
155231865|NCT01524770|560283277|FG000|First Intervention|Withdrawal by Subject|1|||
155231866|NCT01524770|560283278|FG001|First Intervention|Withdrawal by Subject|0|||
155231867|NCT01524770|560283277|FG000|First Intervention|Adverse Event|1|||
155231868|NCT01524770|560283278|FG001|First Intervention|Adverse Event|1|||
155231869|NCT01524770|560283277|FG000|First Intervention|Protocol Violation|1|||
155231870|NCT01524770|560283278|FG001|First Intervention|Protocol Violation|0|||
155231871|NCT01864291|560283280|FG000|Overall Study|need for revision surgery|2|||
155231872|NCT01806896|560283281|FG000|Overall Study|Adverse Event|2|||
155231873|NCT01806896|560283282|FG001|Overall Study|Adverse Event|0|||
155231874|NCT01806896|560283281|FG000|Overall Study|Other|1|||
155231875|NCT01806896|560283282|FG001|Overall Study|Other|0|||
155231876|NCT01282216|560283283|FG000|Overall Study|Graft failure|0|||
155231877|NCT01282216|560283284|FG001|Overall Study|Graft failure|0|||
155231878|NCT01282216|560283285|FG002|Overall Study|Graft failure|3|||
155231879|NCT01282216|560283286|FG003|Overall Study|Graft failure|2|||
155231880|NCT01282216|560283283|FG000|Overall Study|Physician Decision|0|||
155231881|NCT01282216|560283284|FG001|Overall Study|Physician Decision|0|||
155231882|NCT01282216|560283285|FG002|Overall Study|Physician Decision|11|||
155231883|NCT01282216|560283286|FG003|Overall Study|Physician Decision|0|||
155231884|NCT01282216|560283283|FG000|Overall Study|Relapse|0|||
155231885|NCT01282216|560283284|FG001|Overall Study|Relapse|0|||
155231886|NCT01282216|560283285|FG002|Overall Study|Relapse|17|||
155231887|NCT01282216|560283286|FG003|Overall Study|Relapse|6|||
155231888|NCT01282216|560283283|FG000|Overall Study|Death|0|||
155231889|NCT01282216|560283284|FG001|Overall Study|Death|0|||
155231890|NCT01282216|560283285|FG002|Overall Study|Death|2|||
155231891|NCT01282216|560283286|FG003|Overall Study|Death|0|||
155231892|NCT02448875|560283287|FG000|Overall Study|Adverse Event|2|||
155231893|NCT02448875|560283288|FG001|Overall Study|Adverse Event|1|||
155231894|NCT02448875|560283289|FG002|Overall Study|Adverse Event|0|||
155231895|NCT02448875|560283287|FG000|Overall Study|Lost to Follow-up|1|||
155231896|NCT02448875|560283288|FG001|Overall Study|Lost to Follow-up|0|||
155231897|NCT02448875|560283289|FG002|Overall Study|Lost to Follow-up|0|||
155231898|NCT02448875|560283287|FG000|Overall Study|Investigator Decision|3|||
155231899|NCT02448875|560283288|FG001|Overall Study|Investigator Decision|0|||
155231900|NCT02448875|560283289|FG002|Overall Study|Investigator Decision|1|||
155231901|NCT02448875|560283287|FG000|Overall Study|Withdrawal by Subject|1|||
155231902|NCT02448875|560283288|FG001|Overall Study|Withdrawal by Subject|0|||
155231903|NCT02448875|560283289|FG002|Overall Study|Withdrawal by Subject|0|||
155231904|NCT00590954|560283291|FG000|Overall Study|Inevaluable|2|||
155231905|NCT02283788|560283292|FG000|Overall Study|Adverse Event|1|||
155231906|NCT02283788|560283293|FG001|Overall Study|Adverse Event|3|||
155231907|NCT02283788|560283294|FG002|Overall Study|Adverse Event|5|||
155231908|NCT02283788|560283295|FG003|Overall Study|Adverse Event|1|||
155231909|NCT02283788|560283292|FG000|Overall Study|Withdrawal by Subject|0|||
155231910|NCT02283788|560283293|FG001|Overall Study|Withdrawal by Subject|1|||
155231911|NCT02283788|560283294|FG002|Overall Study|Withdrawal by Subject|0|||
155231912|NCT02283788|560283295|FG003|Overall Study|Withdrawal by Subject|1|||
155231913|NCT04269161|560284431|FG000|Overall Study|Change of modality and no longer eligible|3|||
155231914|NCT04269161|560284432|FG001|Overall Study|Change of modality and no longer eligible|3|||
155231915|NCT04269161|560284431|FG000|Overall Study|Required procedure outside of NICU|1|||
155231916|NCT04269161|560284432|FG001|Overall Study|Required procedure outside of NICU|0|||
155231917|NCT04269161|560284431|FG000|Overall Study|Equipment issue|1|||
155231918|NCT04269161|560284432|FG001|Overall Study|Equipment issue|1|||
155231919|NCT02096835|560284433|FG000|Overall Study|Withdrawal by Subject|1|||
155231920|NCT02096835|560284434|FG001|Overall Study|Withdrawal by Subject|0|||
155231921|NCT02096835|560284435|FG002|Overall Study|Withdrawal by Subject|0|||
155231922|NCT02096835|560284433|FG000|Overall Study|converted to open procedures|1|||
155231923|NCT02096835|560284434|FG001|Overall Study|converted to open procedures|0|||
155231924|NCT02096835|560284435|FG002|Overall Study|converted to open procedures|0|||
155231925|NCT02096835|560284433|FG000|Overall Study|Lost to Follow-up|1|||
155231926|NCT02096835|560284434|FG001|Overall Study|Lost to Follow-up|0|||
155231927|NCT02096835|560284435|FG002|Overall Study|Lost to Follow-up|1|||
155231928|NCT03107988|560284444|FG000|Overall Study|Adverse Event|0|||
155231929|NCT03107988|560284445|FG001|Overall Study|Adverse Event|0|||
155231930|NCT03107988|560284446|FG002|Overall Study|Adverse Event|0|||
155231931|NCT03107988|560284447|FG003|Overall Study|Adverse Event|1|||
155231932|NCT03107988|560284448|FG004|Overall Study|Adverse Event|0|||
155231933|NCT03107988|560284449|FG005|Overall Study|Adverse Event|1|||
155231934|NCT03107988|560284450|FG006|Overall Study|Adverse Event|0|||
155231935|NCT03107988|560284451|FG007|Overall Study|Adverse Event|1|||
155231936|NCT03107988|560284452|FG008|Overall Study|Adverse Event|0|||
155231937|NCT03107988|560284453|FG009|Overall Study|Adverse Event|0|||
155231938|NCT03107988|560284454|FG010|Overall Study|Adverse Event|0|||
155231939|NCT03107988|560284455|FG011|Overall Study|Adverse Event|0|||
155231940|NCT03107988|560284456|FG012|Overall Study|Adverse Event|0|||
155231941|NCT03107988|560284444|FG000|Overall Study|Disease Progression or Relapse|1|||
155231942|NCT03107988|560284445|FG001|Overall Study|Disease Progression or Relapse|2|||
155231943|NCT03107988|560284446|FG002|Overall Study|Disease Progression or Relapse|2|||
155231944|NCT03107988|560284447|FG003|Overall Study|Disease Progression or Relapse|5|||
155231945|NCT03107988|560284448|FG004|Overall Study|Disease Progression or Relapse|1|||
155231946|NCT03107988|560284449|FG005|Overall Study|Disease Progression or Relapse|1|||
155231947|NCT03107988|560284450|FG006|Overall Study|Disease Progression or Relapse|0|||
155231948|NCT03107988|560284451|FG007|Overall Study|Disease Progression or Relapse|0|||
155231949|NCT03107988|560284452|FG008|Overall Study|Disease Progression or Relapse|0|||
155231950|NCT03107988|560284453|FG009|Overall Study|Disease Progression or Relapse|1|||
155231951|NCT03107988|560284454|FG010|Overall Study|Disease Progression or Relapse|4|||
155231952|NCT03107988|560284455|FG011|Overall Study|Disease Progression or Relapse|0|||
155231953|NCT03107988|560284456|FG012|Overall Study|Disease Progression or Relapse|0|||
155231954|NCT03107988|560284444|FG000|Overall Study|Ineligible|0|||
155231955|NCT03107988|560284445|FG001|Overall Study|Ineligible|0|||
155231956|NCT03107988|560284446|FG002|Overall Study|Ineligible|0|||
155231957|NCT03107988|560284447|FG003|Overall Study|Ineligible|0|||
155231958|NCT03107988|560284448|FG004|Overall Study|Ineligible|0|||
155231959|NCT03107988|560284449|FG005|Overall Study|Ineligible|0|||
155231960|NCT03107988|560284450|FG006|Overall Study|Ineligible|0|||
155231961|NCT03107988|560284451|FG007|Overall Study|Ineligible|0|||
155231962|NCT03107988|560284452|FG008|Overall Study|Ineligible|1|||
155231963|NCT03107988|560284453|FG009|Overall Study|Ineligible|0|||
155231964|NCT03107988|560284454|FG010|Overall Study|Ineligible|0|||
155231965|NCT03107988|560284455|FG011|Overall Study|Ineligible|0|||
155231966|NCT03107988|560284456|FG012|Overall Study|Ineligible|0|||
155231967|NCT01018264|560284457|FG000|Overall Study|Withdrawal by Subject|1|||
155231968|NCT01018264|560284458|FG001|Overall Study|Withdrawal by Subject|0|||
155231969|NCT01018264|560284457|FG000|Overall Study|Lost to Follow-up|0|||
155231970|NCT01018264|560284458|FG001|Overall Study|Lost to Follow-up|1|||
155231971|NCT00812929|560284459|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
155231972|NCT00812929|560284460|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
155231973|NCT00812929|560284461|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
155231974|NCT00812929|560284462|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
155231975|NCT00812929|560284463|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
155231976|NCT00812929|560284464|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
155231977|NCT00812929|560284465|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
155231978|NCT00812929|560284466|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
155231979|NCT00812929|560284467|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
155231980|NCT00812929|560284468|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
155231981|NCT00812929|560284459|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
155231982|NCT00812929|560284460|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
155231983|NCT00812929|560284461|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
155231984|NCT00812929|560284462|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
155231985|NCT00812929|560284463|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
155231986|NCT00812929|560284464|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
155231987|NCT00812929|560284465|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
155231988|NCT00812929|560284466|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
155231989|NCT00812929|560284467|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
155231990|NCT00812929|560284468|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
155231991|NCT00812929|560284459|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
155231992|NCT00812929|560284460|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
155231993|NCT00812929|560284461|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
155231994|NCT00812929|560284462|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
155231995|NCT00812929|560284463|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
155231996|NCT00812929|560284464|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
155231997|NCT00812929|560284465|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
155231998|NCT00812929|560284466|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
155231999|NCT00812929|560284467|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
155232000|NCT00812929|560284468|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
155232001|NCT04027686|560284469|FG000|Overall Study|Lost to Follow-up|2|||
155232002|NCT04027686|560284470|FG001|Overall Study|Lost to Follow-up|0|||
155232003|NCT04027686|560284469|FG000|Overall Study|Withdrawal by Subject|0|||
155232004|NCT04027686|560284470|FG001|Overall Study|Withdrawal by Subject|1|||
155232005|NCT00079274|560284471|FG000|Overall Study|Withdrawal by Subject|111|||
155232006|NCT00079274|560284472|FG001|Overall Study|Withdrawal by Subject|10|||
155232007|NCT00079274|560284473|FG002|Overall Study|Withdrawal by Subject|12|||
155232008|NCT00079274|560284474|FG003|Overall Study|Withdrawal by Subject|163|||
155232009|NCT00079274|560284475|FG004|Overall Study|Withdrawal by Subject|7|||
155232010|NCT00079274|560284476|FG005|Overall Study|Withdrawal by Subject|8|||
155232011|NCT00079274|560284477|FG006|Overall Study|Withdrawal by Subject|0|||
155232012|NCT00079274|560284471|FG000|Overall Study|Adverse Event|130|||
155232013|NCT00079274|560284472|FG001|Overall Study|Adverse Event|8|||
155232014|NCT00079274|560284473|FG002|Overall Study|Adverse Event|8|||
155232015|NCT00079274|560284474|FG003|Overall Study|Adverse Event|184|||
155232016|NCT00079274|560284475|FG004|Overall Study|Adverse Event|7|||
155232017|NCT00079274|560284476|FG005|Overall Study|Adverse Event|8|||
155232018|NCT00079274|560284477|FG006|Overall Study|Adverse Event|0|||
155232019|NCT00079274|560284471|FG000|Overall Study|Recurrence|21|||
155232020|NCT00079274|560284472|FG001|Overall Study|Recurrence|0|||
155232021|NCT00079274|560284473|FG002|Overall Study|Recurrence|1|||
155232022|NCT00079274|560284474|FG003|Overall Study|Recurrence|15|||
155232023|NCT00079274|560284475|FG004|Overall Study|Recurrence|0|||
155232024|NCT00079274|560284476|FG005|Overall Study|Recurrence|2|||
155232025|NCT00079274|560284477|FG006|Overall Study|Recurrence|0|||
155232026|NCT00079274|560284471|FG000|Overall Study|Alternate Treatment|6|||
155232027|NCT00079274|560284472|FG001|Overall Study|Alternate Treatment|1|||
155232028|NCT00079274|560284473|FG002|Overall Study|Alternate Treatment|0|||
155232029|NCT00079274|560284474|FG003|Overall Study|Alternate Treatment|3|||
155232030|NCT00079274|560284475|FG004|Overall Study|Alternate Treatment|0|||
155232031|NCT00079274|560284476|FG005|Overall Study|Alternate Treatment|0|||
155232032|NCT00079274|560284477|FG006|Overall Study|Alternate Treatment|0|||
155232033|NCT00079274|560284471|FG000|Overall Study|Other Medical Problems|6|||
155232034|NCT00079274|560284472|FG001|Overall Study|Other Medical Problems|1|||
155232035|NCT00079274|560284473|FG002|Overall Study|Other Medical Problems|0|||
155232036|NCT00079274|560284474|FG003|Overall Study|Other Medical Problems|7|||
155232037|NCT00079274|560284475|FG004|Overall Study|Other Medical Problems|0|||
155232038|NCT00079274|560284476|FG005|Overall Study|Other Medical Problems|0|||
155232039|NCT00079274|560284477|FG006|Overall Study|Other Medical Problems|0|||
155232040|NCT00079274|560284471|FG000|Overall Study|Death|4|||
155232041|NCT00079274|560284472|FG001|Overall Study|Death|0|||
155232042|NCT00079274|560284473|FG002|Overall Study|Death|1|||
155232043|NCT00079274|560284474|FG003|Overall Study|Death|15|||
155232044|NCT00079274|560284475|FG004|Overall Study|Death|0|||
155232045|NCT00079274|560284476|FG005|Overall Study|Death|0|||
155232046|NCT00079274|560284477|FG006|Overall Study|Death|0|||
155232047|NCT00079274|560284471|FG000|Overall Study|Cytogenetic resistance|0|||
155232048|NCT00079274|560284472|FG001|Overall Study|Cytogenetic resistance|0|||
155232049|NCT00079274|560284473|FG002|Overall Study|Cytogenetic resistance|0|||
155232050|NCT00079274|560284474|FG003|Overall Study|Cytogenetic resistance|2|||
155232051|NCT00079274|560284475|FG004|Overall Study|Cytogenetic resistance|0|||
155232052|NCT00079274|560284476|FG005|Overall Study|Cytogenetic resistance|0|||
155232053|NCT00079274|560284477|FG006|Overall Study|Cytogenetic resistance|0|||
155232054|NCT00079274|560284471|FG000|Overall Study|Other|43|||
155232055|NCT00079274|560284472|FG001|Overall Study|Other|7|||
155232056|NCT00079274|560284473|FG002|Overall Study|Other|5|||
155232057|NCT00079274|560284474|FG003|Overall Study|Other|55|||
155232058|NCT00079274|560284475|FG004|Overall Study|Other|1|||
155232059|NCT00079274|560284476|FG005|Overall Study|Other|2|||
155232060|NCT00079274|560284477|FG006|Overall Study|Other|0|||
155232061|NCT01696032|560284478|FG000|Overall Study|Withdrawal by Subject|0|||
155232062|NCT01696032|560284479|FG001|Overall Study|Withdrawal by Subject|0|||
155232063|NCT01696032|560284480|FG002|Overall Study|Withdrawal by Subject|1|||
155232064|NCT01696032|560284481|FG003|Overall Study|Withdrawal by Subject|2|||
155232065|NCT01696032|560284478|FG000|Overall Study|Death|14|||
155232066|NCT01696032|560284479|FG001|Overall Study|Death|4|||
155232067|NCT01696032|560284480|FG002|Overall Study|Death|43|||
155232068|NCT01696032|560284481|FG003|Overall Study|Death|18|||
155232069|NCT01696032|560284478|FG000|Overall Study|Lost to Follow-up|0|||
155232070|NCT01696032|560284479|FG001|Overall Study|Lost to Follow-up|1|||
155232071|NCT01696032|560284480|FG002|Overall Study|Lost to Follow-up|0|||
155232072|NCT01696032|560284481|FG003|Overall Study|Lost to Follow-up|0|||
155232073|NCT01696032|560284478|FG000|Overall Study|Database lock|0|||
155232074|NCT01696032|560284479|FG001|Overall Study|Database lock|1|||
155232075|NCT01696032|560284480|FG002|Overall Study|Database lock|7|||
155232076|NCT01696032|560284481|FG003|Overall Study|Database lock|2|||
155232077|NCT00376168|560284484|FG000|Overall Study|Adverse Event|1|||
155232078|NCT00376168|560284485|FG001|Overall Study|Adverse Event|1|||
155232079|NCT00376168|560284484|FG000|Overall Study|Pregnancy|1|||
155232080|NCT00376168|560284485|FG001|Overall Study|Pregnancy|0|||
155232081|NCT01020019|560284486|FG000|Overall Study|Lost to Follow-up|21|||
155232082|NCT01020019|560284487|FG001|Overall Study|Lost to Follow-up|18|||
155232083|NCT01020019|560284486|FG000|Overall Study|Adverse Event|1|||
155232084|NCT01020019|560284487|FG001|Overall Study|Adverse Event|5|||
155232085|NCT01020019|560284486|FG000|Overall Study|not interested in treatment|4|||
155232086|NCT01020019|560284487|FG001|Overall Study|not interested in treatment|4|||
155232087|NCT01020019|560284486|FG000|Overall Study|moving|0|||
155232088|NCT01020019|560284487|FG001|Overall Study|moving|2|||
155232089|NCT02375672|560284488|FG000|Overall Study|remain on follow up|20|||
155232090|NCT04115358|560284489|FG000|Overall Study|exfoliation|0|||
155232091|NCT04115358|560284490|FG001|Overall Study|exfoliation|0|||
155232092|NCT04115358|560284491|FG002|Overall Study|exfoliation|1|||
155232093|NCT02152995|560284494|FG000|Overall Study|Withdrawal by Subject|1|||
155232094|NCT02152995|560284495|FG001|Overall Study|Withdrawal by Subject|0|||
155232095|NCT02098109|560284496|FG000|Overall Study|Protocol Violation|3|||
155232096|NCT02098109|560284497|FG001|Overall Study|Protocol Violation|0|||
155232097|NCT01565291|560284498|FG000|Overall Study|Withdrawal by Subject|1|||
155232098|NCT01565291|560284499|FG001|Overall Study|Withdrawal by Subject|0|||
155232099|NCT03508219|560284506|FG000|Overall Study|Death|2|||
155232100|NCT03508219|560284506|FG000|Overall Study|Withdrawal by Subject|1|||
155232101|NCT03508219|560284506|FG000|Overall Study|Lost to Follow-up|4|||
155232102|NCT03508219|560284506|FG000|Overall Study|Missed visit|2|||
155232103|NCT04466891|560284507|FG000|Overall Study|Death|60|||
155232104|NCT04466891|560284508|FG001|Overall Study|Death|6|||
155232105|NCT04466891|560284507|FG000|Overall Study|Withdrawal by Subject|8|||
155232106|NCT04466891|560284508|FG001|Overall Study|Withdrawal by Subject|1|||
155232107|NCT04466891|560284507|FG000|Overall Study|Study terminated by sponsor|5|||
155232108|NCT04466891|560284508|FG001|Overall Study|Study terminated by sponsor|0|||
155232109|NCT04466891|560284507|FG000|Overall Study|Lost to Follow-up|2|||
155232110|NCT04466891|560284508|FG001|Overall Study|Lost to Follow-up|0|||
155232111|NCT04466891|560284507|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
155232112|NCT04466891|560284508|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
155232113|NCT02782949|560284512|FG000|Overall Study|Protocol Violation|1|||
155232114|NCT02782949|560284513|FG001|Overall Study|Protocol Violation|0|||
155232115|NCT02782949|560284512|FG000|Overall Study|Withdrawal by Subject|0|||
155232116|NCT02782949|560284513|FG001|Overall Study|Withdrawal by Subject|1|||
155232117|NCT02239536|560284518|FG000|Overall Study|Non-neoplastic polyp|23|||
155232118|NCT02239536|560284519|FG001|Overall Study|Non-neoplastic polyp|17|||
155232119|NCT04074317|560284520|FG000|Third Period|Withdrawal by Subject|0|||
155232120|NCT04074317|560284521|FG001|Third Period|Withdrawal by Subject|0|||
155232121|NCT04074317|560284522|FG002|Third Period|Withdrawal by Subject|0|||
155232122|NCT04074317|560284523|FG003|Third Period|Withdrawal by Subject|1|||
155232123|NCT04074317|560284524|FG004|Third Period|Withdrawal by Subject|0|||
155232124|NCT04074317|560284525|FG005|Third Period|Withdrawal by Subject|0|||
155232125|NCT03091192|560284526|FG000|Overall Study|Study terminated by sponsor|21|||
155232126|NCT03091192|560284527|FG001|Overall Study|Study terminated by sponsor|14|||
155232127|NCT03091192|560284526|FG000|Overall Study|Death|9|||
155232128|NCT03091192|560284527|FG001|Overall Study|Death|13|||
155232129|NCT03091192|560284526|FG000|Overall Study|Withdrawal by Subject|2|||
155232130|NCT03091192|560284527|FG001|Overall Study|Withdrawal by Subject|0|||
155232131|NCT03091192|560284526|FG000|Overall Study|Lost to Follow-up|1|||
155232132|NCT03091192|560284527|FG001|Overall Study|Lost to Follow-up|0|||
155232133|NCT01038778|560284528|FG000|Overall Study|Withdrawal by Subject|0|||
155232134|NCT01038778|560284529|FG001|Overall Study|Withdrawal by Subject|2|||
155232135|NCT01038778|560284530|FG002|Overall Study|Withdrawal by Subject|3|||
155232136|NCT06023394|560284531|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
155232137|NCT06023394|560284532|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
155232138|NCT06023394|560284531|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
155232139|NCT06023394|560284532|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
155232140|NCT06023394|560284531|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
155232141|NCT06023394|560284532|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
155232142|NCT06023394|560284531|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
155232143|NCT06023394|560284532|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
155232144|NCT05645432|560284533|FG000|Overall Study|Withdrawal by Subject|1|||
155232145|NCT03195478|560284534|FG000|Overall Study|Disease Progression|5|||
155232146|NCT03195478|560284535|FG001|Overall Study|Disease Progression|4|||
155232147|NCT03195478|560284536|FG002|Overall Study|Disease Progression|6|||
155232148|NCT03195478|560284537|FG003|Overall Study|Disease Progression|1|||
155232149|NCT03195478|560284534|FG000|Overall Study|Study Drug Toxicity|2|||
155232150|NCT03195478|560284535|FG001|Overall Study|Study Drug Toxicity|0|||
155232151|NCT03195478|560284536|FG002|Overall Study|Study Drug Toxicity|0|||
155232152|NCT03195478|560284537|FG003|Overall Study|Study Drug Toxicity|1|||
155232153|NCT03195478|560284534|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
155232154|NCT03195478|560284535|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
155232155|NCT03195478|560284536|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
155232156|NCT03195478|560284537|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
155232157|NCT03195478|560284534|FG000|Overall Study|Participant Withdrew Consent|1|||
155232158|NCT03195478|560284535|FG001|Overall Study|Participant Withdrew Consent|0|||
155232159|NCT03195478|560284536|FG002|Overall Study|Participant Withdrew Consent|0|||
155232160|NCT03195478|560284537|FG003|Overall Study|Participant Withdrew Consent|0|||
155232161|NCT03195478|560284534|FG000|Overall Study|Maximum Clinical benefit|0|||
155232162|NCT03195478|560284535|FG001|Overall Study|Maximum Clinical benefit|0|||
155232163|NCT03195478|560284536|FG002|Overall Study|Maximum Clinical benefit|1|||
155232164|NCT03195478|560284537|FG003|Overall Study|Maximum Clinical benefit|0|||
155232165|NCT03195478|560284534|FG000|Overall Study|Other Reasons|0|||
155232166|NCT03195478|560284535|FG001|Overall Study|Other Reasons|0|||
155232167|NCT03195478|560284536|FG002|Overall Study|Other Reasons|1|||
155232168|NCT03195478|560284537|FG003|Overall Study|Other Reasons|0|||
155232169|NCT02143414|560286292|FG000|Induction|Adverse Event|1|||
155232170|NCT02143414|560286293|FG001|Induction|Adverse Event|2|||
155232171|NCT02143414|560286292|FG000|Induction|Death|1|||
155232172|NCT02143414|560286293|FG001|Induction|Death|2|||
155232173|NCT02143414|560286292|FG000|Induction|Patient refusal|1|||
155232174|NCT02143414|560286293|FG001|Induction|Patient refusal|1|||
155232175|NCT02143414|560286292|FG000|Induction|Refractory|1|||
155232176|NCT02143414|560286293|FG001|Induction|Refractory|0|||
155232177|NCT02143414|560286292|FG000|Induction|Began alternative treatment|1|||
155232178|NCT02143414|560286293|FG001|Induction|Began alternative treatment|0|||
155232179|NCT02143414|560286292|FG000|Induction|Ineligible for postremission|5|||
155232180|NCT02143414|560286293|FG001|Induction|Ineligible for postremission|1|||
155232181|NCT02143414|560286292|FG000|Post-remission|Adverse Event|0|||
155232182|NCT02143414|560286293|FG001|Post-remission|Adverse Event|2|||
155232183|NCT02143414|560286292|FG000|Post-remission|Disease progression/relapse|5|||
155232184|NCT02143414|560286293|FG001|Post-remission|Disease progression/relapse|0|||
155232185|NCT02143414|560286292|FG000|Maintenance|Adverse Event|4|||
155232186|NCT02143414|560286293|FG001|Maintenance|Adverse Event|6|||
155232187|NCT02143414|560286292|FG000|Maintenance|Disease progression/relapse|3|||
155232188|NCT02143414|560286293|FG001|Maintenance|Disease progression/relapse|2|||
155232189|NCT02143414|560286292|FG000|Maintenance|Patient refusal|2|||
155232190|NCT02143414|560286293|FG001|Maintenance|Patient refusal|1|||
155232191|NCT02143414|560286292|FG000|Maintenance|Physician Decision|1|||
155232192|NCT02143414|560286293|FG001|Maintenance|Physician Decision|0|||
155232193|NCT02143414|560286292|FG000|Maintenance|Death|0|||
155232194|NCT02143414|560286293|FG001|Maintenance|Death|1|||
155232195|NCT02143414|560286292|FG000|Maintenance|On protocol treatment|0|||
155232196|NCT02143414|560286293|FG001|Maintenance|On protocol treatment|6|||
155232197|NCT00978731|560286297|FG000|Overall Study|Death|4|||
155232198|NCT00978731|560286298|FG001|Overall Study|Death|1|||
155232199|NCT00978731|560286299|FG002|Overall Study|Death|1|||
155232200|NCT00978731|560286300|FG003|Overall Study|Death|0|||
155232201|NCT00978731|560286297|FG000|Overall Study|Lost to Follow-up|0|||
155232202|NCT00978731|560286298|FG001|Overall Study|Lost to Follow-up|0|||
155232203|NCT00978731|560286299|FG002|Overall Study|Lost to Follow-up|0|||
155232204|NCT00978731|560286300|FG003|Overall Study|Lost to Follow-up|1|||
155232205|NCT00978731|560286297|FG000|Overall Study|Adverse Event|5|||
155232206|NCT00978731|560286298|FG001|Overall Study|Adverse Event|2|||
155232207|NCT00978731|560286299|FG002|Overall Study|Adverse Event|0|||
155232208|NCT00978731|560286300|FG003|Overall Study|Adverse Event|0|||
155232209|NCT00978731|560286297|FG000|Overall Study|Participant's request|1|||
155232210|NCT00978731|560286298|FG001|Overall Study|Participant's request|0|||
155232211|NCT00978731|560286299|FG002|Overall Study|Participant's request|0|||
155232212|NCT00978731|560286300|FG003|Overall Study|Participant's request|0|||
155232213|NCT00978731|560286297|FG000|Overall Study|Administrative reason|3|||
155232214|NCT00978731|560286298|FG001|Overall Study|Administrative reason|3|||
155232215|NCT00978731|560286299|FG002|Overall Study|Administrative reason|1|||
155232216|NCT00978731|560286300|FG003|Overall Study|Administrative reason|0|||
155232217|NCT00978731|560286297|FG000|Overall Study|Deterioration without progression|0|||
155232218|NCT00978731|560286298|FG001|Overall Study|Deterioration without progression|1|||
155232219|NCT00978731|560286299|FG002|Overall Study|Deterioration without progression|0|||
155232220|NCT00978731|560286300|FG003|Overall Study|Deterioration without progression|0|||
155232221|NCT00978731|560286297|FG000|Overall Study|Disease progression/relapse|5|||
155232222|NCT00978731|560286298|FG001|Overall Study|Disease progression/relapse|4|||
155232223|NCT00978731|560286299|FG002|Overall Study|Disease progression/relapse|2|||
155232224|NCT00978731|560286300|FG003|Overall Study|Disease progression/relapse|2|||
155232225|NCT00978731|560286297|FG000|Overall Study|Study closure|3|||
155232226|NCT00978731|560286298|FG001|Overall Study|Study closure|4|||
155232227|NCT00978731|560286299|FG002|Overall Study|Study closure|1|||
155232228|NCT00978731|560286300|FG003|Overall Study|Study closure|1|||
155232229|NCT00978731|560286297|FG000|Overall Study|No response|1|||
155232230|NCT00978731|560286298|FG001|Overall Study|No response|0|||
155232231|NCT00978731|560286299|FG002|Overall Study|No response|0|||
155232232|NCT00978731|560286300|FG003|Overall Study|No response|0|||
155232233|NCT02649972|560286306|FG000|Overall Study|Not treated|1|||
155232234|NCT00501540|560286311|FG000|Overall Study|Death|5|||
155232235|NCT02331446|560286312|FG000|Overall Study|Lost to Follow-up|2|||
155232236|NCT02331446|560286313|FG001|Overall Study|Lost to Follow-up|1|||
155232237|NCT02331446|560286314|FG002|Overall Study|Lost to Follow-up|0|||
155232238|NCT02331446|560286315|FG003|Overall Study|Lost to Follow-up|1|||
155232239|NCT02331446|560286312|FG000|Overall Study|Personal Problem|2|||
155232240|NCT02331446|560286313|FG001|Overall Study|Personal Problem|0|||
155232241|NCT02331446|560286314|FG002|Overall Study|Personal Problem|0|||
155232242|NCT02331446|560286315|FG003|Overall Study|Personal Problem|0|||
155232243|NCT02331446|560286312|FG000|Overall Study|Disease|0|||
155232244|NCT02331446|560286313|FG001|Overall Study|Disease|2|||
155232245|NCT02331446|560286314|FG002|Overall Study|Disease|2|||
155232246|NCT02331446|560286315|FG003|Overall Study|Disease|1|||
155232247|NCT02331446|560286312|FG000|Overall Study|Physician Decision|0|||
155232248|NCT02331446|560286313|FG001|Overall Study|Physician Decision|1|||
155232249|NCT02331446|560286314|FG002|Overall Study|Physician Decision|0|||
155232250|NCT02331446|560286315|FG003|Overall Study|Physician Decision|1|||
155232251|NCT02331446|560286312|FG000|Overall Study|Lost before baseline analysis|0|||
155232252|NCT02331446|560286313|FG001|Overall Study|Lost before baseline analysis|1|||
155232253|NCT02331446|560286314|FG002|Overall Study|Lost before baseline analysis|1|||
155232254|NCT02331446|560286315|FG003|Overall Study|Lost before baseline analysis|0|||
155232255|NCT04879745|560286316|FG000|Overall Study|Lost to Follow-up|4|||
155232256|NCT04879745|560286317|FG001|Overall Study|Lost to Follow-up|1|||
155232257|NCT00120042|560286318|FG000|Overall Study|all completed protocl|0|||
155232258|NCT00120042|560286319|FG001|Overall Study|all completed protocl|0|||
155232259|NCT00120042|560286320|FG002|Overall Study|all completed protocl|0|||
155232260|NCT04532112|560286323|FG000|Overall Study|Adverse Event|3|||
155232261|NCT04532112|560286324|FG001|Overall Study|Adverse Event|0|||
155232262|NCT00529386|560286325|FG000|Overall Study|Lost to Follow-up|1|||
155232263|NCT02939404|560286326|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
155232264|NCT02939404|560286327|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
155232265|NCT02939404|560286326|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
155232266|NCT02939404|560286327|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
155232267|NCT04182100|560286328|FG000|Overall Study|Adverse Event|1|||
155232268|NCT04182100|560286328|FG000|Overall Study|Withdrawal by Subject|1|||
155232269|NCT04439240|560286336|FG000|Overall Study|Ineligible|2|||
155232270|NCT04439240|560286336|FG000|Overall Study|Never started treatment|2|||
155232271|NCT04439240|560286336|FG000|Overall Study|Adverse Event|12|||
155232272|NCT04439240|560286336|FG000|Overall Study|Death|2|||
155232273|NCT04439240|560286336|FG000|Overall Study|Disease progression|25|||
155232274|NCT04439240|560286336|FG000|Overall Study|Other diseases|2|||
155232275|NCT04439240|560286336|FG000|Overall Study|Withdrawal by Subject|3|||
155232276|NCT04439240|560286336|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
155232277|NCT04439240|560286336|FG000|Overall Study|Symptomatic decline|1|||
155232278|NCT04439240|560286336|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
155232279|NCT04439240|560286336|FG000|Overall Study|Clinical progression|1|||
155232280|NCT00813124|560286338|FG000|Overall Study|Death|2|||
155232281|NCT00813124|560286338|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
155232282|NCT00813124|560286338|FG000|Overall Study|Withdrawal by Subject|1|||
155232283|NCT00617240|560286345|FG000|Overall Study|Lack of Efficacy|1|||
155232284|NCT00617240|560286346|FG001|Overall Study|Lack of Efficacy|0|||
155232285|NCT01611259|560286347|FG000|Overall Study|Physician Decision|1|||
155232286|NCT01611259|560286347|FG000|Overall Study|Lack of Efficacy|2|||
155232287|NCT01611259|560286347|FG000|Overall Study|Adverse Event|4|||
155232288|NCT01611259|560286347|FG000|Overall Study|Withdrawal by Subject|7|||
155232289|NCT04936685|560286348|FG000|Overall Study|Protocol Violation|1|||
155232290|NCT04936685|560286349|FG001|Overall Study|Protocol Violation|0|||
155232291|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
155232292|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
155232293|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
155232294|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
155232295|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
155232296|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
155232297|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
155232298|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
155232299|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
155232300|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
155232301|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
155232302|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
155232303|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
155232304|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
155232305|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
155232306|NCT00280566|560286350|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
155232307|NCT00280566|560286351|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
155232308|NCT00280566|560286352|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
155232309|NCT00280566|560286350|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
155232310|NCT00280566|560286351|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
155232311|NCT00280566|560286352|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
155232312|NCT00280566|560286350|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
155232313|NCT00280566|560286351|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
155232314|NCT00280566|560286352|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
155232315|NCT00280566|560286350|FG000|Period 2 Double Blind|Adverse Event|0|||
155232316|NCT00280566|560286351|FG001|Period 2 Double Blind|Adverse Event|11|||
155232317|NCT00280566|560286352|FG002|Period 2 Double Blind|Adverse Event|15|||
155232318|NCT00280566|560286350|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
155232319|NCT00280566|560286351|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
155232320|NCT00280566|560286352|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
155232321|NCT00280566|560286350|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
155232322|NCT00280566|560286351|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
155232323|NCT00280566|560286352|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
155232324|NCT00280566|560286350|FG000|Period 2 Double Blind|miscellaneous|0|||
155232325|NCT00280566|560286351|FG001|Period 2 Double Blind|miscellaneous|10|||
155232326|NCT00280566|560286352|FG002|Period 2 Double Blind|miscellaneous|5|||
155232327|NCT01302392|560286353|FG000|Overall Study|Lost to Follow-up|1|||
155232328|NCT01302392|560286354|FG001|Overall Study|Lost to Follow-up|0|||
155232329|NCT01302392|560286353|FG000|Overall Study|Withdrawal by Subject|6|||
155232330|NCT01302392|560286354|FG001|Overall Study|Withdrawal by Subject|1|||
155232331|NCT03604692|560286358|FG000|Overall Study|Investigator's Decision|0|||
155232332|NCT03604692|560286359|FG001|Overall Study|Investigator's Decision|0|||
155232333|NCT03604692|560286360|FG002|Overall Study|Investigator's Decision|0|||
155232334|NCT03604692|560286361|FG003|Overall Study|Investigator's Decision|1|||
155232335|NCT03604692|560286362|FG004|Overall Study|Investigator's Decision|0|||
155232336|NCT03604692|560286363|FG005|Overall Study|Investigator's Decision|7|||
155232337|NCT03604692|560286358|FG000|Overall Study|Withdrawal by Subject|0|||
155232338|NCT03604692|560286359|FG001|Overall Study|Withdrawal by Subject|0|||
155232339|NCT03604692|560286360|FG002|Overall Study|Withdrawal by Subject|0|||
155232340|NCT03604692|560286361|FG003|Overall Study|Withdrawal by Subject|0|||
155232341|NCT03604692|560286362|FG004|Overall Study|Withdrawal by Subject|0|||
155232342|NCT03604692|560286363|FG005|Overall Study|Withdrawal by Subject|2|||
155232343|NCT03604692|560286358|FG000|Overall Study|Progressive Disease|1|||
155232344|NCT03604692|560286359|FG001|Overall Study|Progressive Disease|0|||
155232345|NCT03604692|560286360|FG002|Overall Study|Progressive Disease|1|||
155232346|NCT03604692|560286361|FG003|Overall Study|Progressive Disease|0|||
155232347|NCT03604692|560286362|FG004|Overall Study|Progressive Disease|3|||
155232348|NCT03604692|560286363|FG005|Overall Study|Progressive Disease|4|||
155232349|NCT03604692|560286358|FG000|Overall Study|Difficulty Coming into Site|0|||
155232350|NCT03604692|560286359|FG001|Overall Study|Difficulty Coming into Site|0|||
155232351|NCT03604692|560286360|FG002|Overall Study|Difficulty Coming into Site|0|||
155232352|NCT03604692|560286361|FG003|Overall Study|Difficulty Coming into Site|0|||
155232353|NCT03604692|560286362|FG004|Overall Study|Difficulty Coming into Site|0|||
155232354|NCT03604692|560286363|FG005|Overall Study|Difficulty Coming into Site|1|||
155232355|NCT03604692|560286358|FG000|Overall Study|Death|0|||
155232356|NCT03604692|560286359|FG001|Overall Study|Death|0|||
155232357|NCT03604692|560286360|FG002|Overall Study|Death|1|||
155232358|NCT03604692|560286361|FG003|Overall Study|Death|0|||
155232359|NCT03604692|560286362|FG004|Overall Study|Death|0|||
155232360|NCT03604692|560286363|FG005|Overall Study|Death|0|||
155232361|NCT03604692|560286358|FG000|Overall Study|Drug Intolerance|0|||
155232362|NCT03604692|560286359|FG001|Overall Study|Drug Intolerance|0|||
155232363|NCT03604692|560286360|FG002|Overall Study|Drug Intolerance|0|||
155232364|NCT03604692|560286361|FG003|Overall Study|Drug Intolerance|1|||
155232365|NCT03604692|560286362|FG004|Overall Study|Drug Intolerance|0|||
155232366|NCT03604692|560286363|FG005|Overall Study|Drug Intolerance|0|||
155232367|NCT03604692|560286358|FG000|Overall Study|Noncompliance with follow-up visit|0|||
155232368|NCT03604692|560286359|FG001|Overall Study|Noncompliance with follow-up visit|0|||
155232369|NCT03604692|560286360|FG002|Overall Study|Noncompliance with follow-up visit|0|||
155232370|NCT03604692|560286361|FG003|Overall Study|Noncompliance with follow-up visit|1|||
155232371|NCT03604692|560286362|FG004|Overall Study|Noncompliance with follow-up visit|0|||
155232372|NCT03604692|560286363|FG005|Overall Study|Noncompliance with follow-up visit|0|||
155232373|NCT03604692|560286358|FG000|Overall Study|Not Treated|0|||
155232374|NCT03604692|560286359|FG001|Overall Study|Not Treated|0|||
155232375|NCT03604692|560286360|FG002|Overall Study|Not Treated|0|||
155232376|NCT03604692|560286361|FG003|Overall Study|Not Treated|0|||
155232377|NCT03604692|560286362|FG004|Overall Study|Not Treated|1|||
155232378|NCT03604692|560286363|FG005|Overall Study|Not Treated|0|||
155232379|NCT00637195|560286364|FG000|Overall Study|Lost to Follow-up|1|||
155232380|NCT00637195|560286365|FG001|Overall Study|Lost to Follow-up|0|||
155232381|NCT00637195|560286364|FG000|Overall Study|Other|2|||
155232382|NCT00637195|560286365|FG001|Overall Study|Other|0|||
155232383|NCT00637195|560286364|FG000|Overall Study|Withdrawal by Subject|0|||
155232384|NCT00637195|560286365|FG001|Overall Study|Withdrawal by Subject|1|||
155232385|NCT05091528|560286370|FG000|Overall Study|Study Termination by Sponsor|0|||
155232386|NCT05091528|560286371|FG001|Overall Study|Study Termination by Sponsor|1|||
155232387|NCT05091528|560286372|FG002|Overall Study|Study Termination by Sponsor|0|||
155232388|NCT05091528|560286373|FG003|Overall Study|Study Termination by Sponsor|1|||
155232389|NCT02214121|560286374|FG000|Part A|Patient decision|2|||
155232390|NCT02214121|560286375|FG001|Part A|Patient decision|0|||
155232391|NCT02214121|560286376|FG002|Part A|Patient decision|0|||
155232392|NCT02214121|560286374|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
155232393|NCT02214121|560286375|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
155232394|NCT02214121|560286376|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
155232395|NCT02214121|560286374|FG000|Part A|Other|1|||
155232396|NCT02214121|560286375|FG001|Part A|Other|0|||
155232397|NCT02214121|560286376|FG002|Part A|Other|0|||
155232398|NCT02214121|560286374|FG000|Part B|Patient decision|0|||
155232399|NCT02214121|560286375|FG001|Part B|Patient decision|1|||
155232400|NCT02214121|560286376|FG002|Part B|Patient decision|0|||
155232401|NCT02214121|560286374|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
155232402|NCT02214121|560286375|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
155232403|NCT02214121|560286376|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
155232404|NCT02214121|560286374|FG000|Part B|Lost to Follow-up|0|||
155232405|NCT02214121|560286375|FG001|Part B|Lost to Follow-up|0|||
155232406|NCT02214121|560286376|FG002|Part B|Lost to Follow-up|1|||
155232407|NCT02203591|560286377|FG000|Overall Study|Did not meet treatment day baseline|147|||
155232408|NCT02203591|560286378|FG001|Overall Study|Did not meet treatment day baseline|141|||
155232409|NCT02203591|560286379|FG002|Overall Study|Did not meet treatment day baseline|150|||
155232410|NCT02203591|560286380|FG003|Overall Study|Did not meet treatment day baseline|45|||
155232411|NCT02203591|560286381|FG004|Overall Study|Did not meet treatment day baseline|33|||
155232412|NCT02203591|560286382|FG005|Overall Study|Did not meet treatment day baseline|35|||
155232413|NCT02203591|560286383|FG006|Overall Study|Did not meet treatment day baseline|29|||
155232414|NCT02203591|560286384|FG007|Overall Study|Did not meet treatment day baseline|12|||
155232415|NCT02203591|560286377|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
155232416|NCT02203591|560286378|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
155232417|NCT02203591|560286379|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
155232418|NCT02203591|560286380|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
155232419|NCT02203591|560286381|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
155232420|NCT02203591|560286382|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
155232421|NCT02203591|560286383|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
155232422|NCT02203591|560286384|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
155232423|NCT03306264|560286387|FG000|Overall Study|Death|33|||
155232424|NCT03306264|560286388|FG001|Overall Study|Death|25|||
155232425|NCT03306264|560286389|FG002|Overall Study|Death|34|||
155232426|NCT03306264|560286390|FG003|Overall Study|Death|34|||
155232427|NCT03306264|560286387|FG000|Overall Study|Complete Consent Withdrawal|4|||
155232428|NCT03306264|560286388|FG001|Overall Study|Complete Consent Withdrawal|4|||
155232429|NCT03306264|560286389|FG002|Overall Study|Complete Consent Withdrawal|1|||
155232430|NCT03306264|560286390|FG003|Overall Study|Complete Consent Withdrawal|8|||
155232431|NCT03306264|560286387|FG000|Overall Study|Lost to Follow-up|1|||
155232432|NCT03306264|560286388|FG001|Overall Study|Lost to Follow-up|0|||
155232433|NCT03306264|560286389|FG002|Overall Study|Lost to Follow-up|1|||
155232434|NCT03306264|560286390|FG003|Overall Study|Lost to Follow-up|0|||
155232435|NCT03306264|560286387|FG000|Overall Study|Rollover to ASTX727-06|10|||
155232436|NCT03306264|560286388|FG001|Overall Study|Rollover to ASTX727-06|18|||
155232437|NCT03306264|560286389|FG002|Overall Study|Rollover to ASTX727-06|4|||
155232438|NCT03306264|560286390|FG003|Overall Study|Rollover to ASTX727-06|2|||
155232439|NCT03306264|560286387|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
155232440|NCT03306264|560286388|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
155232441|NCT03306264|560286389|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
155232442|NCT03306264|560286390|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
155232443|NCT02114879|560286391|FG000|Overall Study|Withdrawal by Subject|9|||
155232444|NCT02114879|560286392|FG001|Overall Study|Withdrawal by Subject|5|||
155232445|NCT02114879|560286391|FG000|Overall Study|Death|6|||
155232446|NCT02114879|560286392|FG001|Overall Study|Death|11|||
155232447|NCT02114879|560286391|FG000|Overall Study|Lost to Follow-up|4|||
155232448|NCT02114879|560286392|FG001|Overall Study|Lost to Follow-up|6|||
155232449|NCT02114879|560286391|FG000|Overall Study|Physician Decision|0|||
155232450|NCT02114879|560286392|FG001|Overall Study|Physician Decision|2|||
155232451|NCT02519712|560286398|FG000|Overall Study|Disease Relapse|1|||
155232452|NCT02519712|560286398|FG000|Overall Study|Disease Progression|1|||
155232453|NCT02519712|560286398|FG000|Overall Study|Accruals are donors|2|||
155232454|NCT00613509|560286399|FG000|Cycle 1|Adverse Event|2|||
155232455|NCT00613509|560286400|FG001|Cycle 1|Adverse Event|1|||
155232456|NCT00613509|560286399|FG000|Cycle 1|Disease Progression|2|||
155232457|NCT00613509|560286400|FG001|Cycle 1|Disease Progression|6|||
155232458|NCT00613509|560286399|FG000|Cycle 1|Unacceptable Toxicity|1|||
155232459|NCT00613509|560286400|FG001|Cycle 1|Unacceptable Toxicity|0|||
155232460|NCT00613509|560286399|FG000|Cycle 1|Other administrative reason|0|||
155232461|NCT00613509|560286400|FG001|Cycle 1|Other administrative reason|1|||
155232462|NCT04847674|560286401|FG000|Overall Study|Withdrawal by Subject|0|||
155232463|NCT04847674|560286402|FG001|Overall Study|Withdrawal by Subject|1|||
155232464|NCT04847674|560286403|FG002|Overall Study|Withdrawal by Subject|0|||
155232465|NCT04847674|560286401|FG000|Overall Study|Lost to Follow-up|0|||
155232466|NCT04847674|560286402|FG001|Overall Study|Lost to Follow-up|0|||
155232467|NCT04847674|560286403|FG002|Overall Study|Lost to Follow-up|2|||
155232468|NCT04847674|560286401|FG000|Overall Study|Other than specified|21|||
155232469|NCT04847674|560286402|FG001|Overall Study|Other than specified|20|||
155232470|NCT04847674|560286403|FG002|Overall Study|Other than specified|20|||
155232471|NCT00677807|560286404|FG000|Overall Study|Adverse Event|4|||
155232472|NCT00677807|560286405|FG001|Overall Study|Adverse Event|1|||
155232473|NCT00677807|560286406|FG002|Overall Study|Adverse Event|6|||
155232474|NCT00677807|560286404|FG000|Overall Study|Lack of Efficacy|0|||
155232475|NCT00677807|560286405|FG001|Overall Study|Lack of Efficacy|0|||
155232476|NCT00677807|560286406|FG002|Overall Study|Lack of Efficacy|2|||
155232477|NCT00677807|560286404|FG000|Overall Study|Participant no longer needs study drug|0|||
155232478|NCT00677807|560286405|FG001|Overall Study|Participant no longer needs study drug|0|||
155232479|NCT00677807|560286406|FG002|Overall Study|Participant no longer needs study drug|1|||
155232480|NCT00677807|560286404|FG000|Overall Study|Withdrawal by Subject|10|||
155232481|NCT00677807|560286405|FG001|Overall Study|Withdrawal by Subject|3|||
155232482|NCT00677807|560286406|FG002|Overall Study|Withdrawal by Subject|6|||
155232483|NCT00677807|560286404|FG000|Overall Study|Lost to Follow-up|2|||
155232484|NCT00677807|560286405|FG001|Overall Study|Lost to Follow-up|2|||
155232485|NCT00677807|560286406|FG002|Overall Study|Lost to Follow-up|2|||
155232486|NCT00677807|560286404|FG000|Overall Study|Administrative problems|1|||
155232487|NCT00677807|560286405|FG001|Overall Study|Administrative problems|1|||
155232488|NCT00677807|560286406|FG002|Overall Study|Administrative problems|2|||
155232489|NCT00677807|560286404|FG000|Overall Study|Death|0|||
155232490|NCT00677807|560286405|FG001|Overall Study|Death|1|||
155232491|NCT00677807|560286406|FG002|Overall Study|Death|1|||
155232492|NCT00677807|560286404|FG000|Overall Study|Protocol Deviation|1|||
155232493|NCT00677807|560286405|FG001|Overall Study|Protocol Deviation|3|||
155232494|NCT00677807|560286406|FG002|Overall Study|Protocol Deviation|0|||
155232495|NCT01420081|560286407|FG000|Overall Study|Death|1|||
155232496|NCT01420081|560286408|FG001|Overall Study|Death|0|||
155232497|NCT01420081|560286409|FG002|Overall Study|Death|8|||
155232498|NCT01420081|560286410|FG003|Overall Study|Death|0|||
155232499|NCT01420081|560286411|FG004|Overall Study|Death|7|||
155232500|NCT01420081|560286412|FG005|Overall Study|Death|12|||
155232501|NCT01420081|560286413|FG006|Overall Study|Death|0|||
155232502|NCT01420081|560286414|FG007|Overall Study|Death|1|||
155232503|NCT01420081|560286415|FG008|Overall Study|Death|1|||
155232504|NCT01420081|560286407|FG000|Overall Study|Lost to Follow-up|0|||
155232505|NCT01420081|560286408|FG001|Overall Study|Lost to Follow-up|0|||
155232506|NCT01420081|560286409|FG002|Overall Study|Lost to Follow-up|0|||
155232507|NCT01420081|560286410|FG003|Overall Study|Lost to Follow-up|0|||
155232508|NCT01420081|560286411|FG004|Overall Study|Lost to Follow-up|1|||
155232509|NCT01420081|560286412|FG005|Overall Study|Lost to Follow-up|1|||
155232510|NCT01420081|560286413|FG006|Overall Study|Lost to Follow-up|0|||
155232511|NCT01420081|560286414|FG007|Overall Study|Lost to Follow-up|0|||
155232512|NCT01420081|560286415|FG008|Overall Study|Lost to Follow-up|0|||
155232513|NCT01420081|560286407|FG000|Overall Study|Study Terminated by Sponsor|2|||
155232514|NCT01420081|560286408|FG001|Overall Study|Study Terminated by Sponsor|1|||
155232515|NCT01420081|560286409|FG002|Overall Study|Study Terminated by Sponsor|1|||
155232516|NCT01420081|560286410|FG003|Overall Study|Study Terminated by Sponsor|3|||
155232517|NCT01420081|560286411|FG004|Overall Study|Study Terminated by Sponsor|11|||
155232518|NCT01420081|560286412|FG005|Overall Study|Study Terminated by Sponsor|7|||
155232519|NCT01420081|560286413|FG006|Overall Study|Study Terminated by Sponsor|3|||
155232520|NCT01420081|560286414|FG007|Overall Study|Study Terminated by Sponsor|2|||
155232521|NCT01420081|560286415|FG008|Overall Study|Study Terminated by Sponsor|2|||
155232522|NCT01420081|560286407|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
155232523|NCT01420081|560286408|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
155232524|NCT01420081|560286409|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
155232525|NCT01420081|560286410|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
155232526|NCT01420081|560286411|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
155232527|NCT01420081|560286412|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
155232528|NCT01420081|560286413|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
155232529|NCT01420081|560286414|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
155232530|NCT01420081|560286415|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
155232531|NCT01420081|560286407|FG000|Overall Study|Other Reasons|0|||
155232532|NCT01420081|560286408|FG001|Overall Study|Other Reasons|0|||
155232533|NCT01420081|560286409|FG002|Overall Study|Other Reasons|1|||
155232534|NCT01420081|560286410|FG003|Overall Study|Other Reasons|0|||
155232535|NCT01420081|560286411|FG004|Overall Study|Other Reasons|0|||
155232536|NCT01420081|560286412|FG005|Overall Study|Other Reasons|0|||
155232537|NCT01420081|560286413|FG006|Overall Study|Other Reasons|0|||
155232538|NCT01420081|560286414|FG007|Overall Study|Other Reasons|0|||
155232539|NCT01420081|560286415|FG008|Overall Study|Other Reasons|0|||
155232540|NCT02469610|560286416|FG000|Overall Study|Death|1|||
155232541|NCT02469610|560286417|FG001|Overall Study|Death|0|||
155232542|NCT02469610|560286416|FG000|Overall Study|Lost to Follow-up|1|||
155232543|NCT02469610|560286417|FG001|Overall Study|Lost to Follow-up|0|||
155232544|NCT02469610|560286416|FG000|Overall Study|exclusion criteria|2|||
155232545|NCT02469610|560286417|FG001|Overall Study|exclusion criteria|1|||
155232546|NCT00414388|560286420|FG000|Overall Study|Adverse Event|1|||
155232547|NCT03467425|560286421|FG000|Overall Study|Adverse Event|9|||
155232548|NCT03467425|560286422|FG001|Overall Study|Adverse Event|9|||
155232549|NCT03467425|560286421|FG000|Overall Study|Lack of Efficacy|3|||
155232550|NCT03467425|560286422|FG001|Overall Study|Lack of Efficacy|1|||
155232551|NCT03467425|560286421|FG000|Overall Study|Protocol Violation|0|||
155232552|NCT03467425|560286422|FG001|Overall Study|Protocol Violation|1|||
155232553|NCT03467425|560286421|FG000|Overall Study|Lost to Follow-up|18|||
155232554|NCT03467425|560286422|FG001|Overall Study|Lost to Follow-up|25|||
155232555|NCT03467425|560286421|FG000|Overall Study|Physician Decision|2|||
155232556|NCT03467425|560286422|FG001|Overall Study|Physician Decision|1|||
155232557|NCT03467425|560286421|FG000|Overall Study|Withdrawal by Subject|15|||
155232558|NCT03467425|560286422|FG001|Overall Study|Withdrawal by Subject|17|||
155232559|NCT00025883|560286424|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
155232560|NCT00025883|560286424|FG000|Overall Study|no baseline data|1|||
155232561|NCT00025883|560286424|FG000|Overall Study|Death|1|||
155232562|NCT00025883|560286424|FG000|Overall Study|Adverse Event|1|||
155232563|NCT00025883|560286424|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
155232564|NCT00678561|560286425|FG000|Overall Study|Adverse Event|0|||
155232565|NCT00678561|560286426|FG001|Overall Study|Adverse Event|1|||
155232566|NCT00678561|560286427|FG002|Overall Study|Adverse Event|1|||
155232567|NCT00678561|560286428|FG003|Overall Study|Adverse Event|0|||
155232568|NCT00678561|560286429|FG004|Overall Study|Adverse Event|1|||
155232569|NCT00678561|560286430|FG005|Overall Study|Adverse Event|0|||
155232570|NCT00678561|560286431|FG006|Overall Study|Adverse Event|0|||
155232571|NCT00678561|560286432|FG007|Overall Study|Adverse Event|0|||
155232572|NCT00678561|560286425|FG000|Overall Study|Protocol Violation|0|||
155232573|NCT00678561|560286426|FG001|Overall Study|Protocol Violation|0|||
155232574|NCT00678561|560286427|FG002|Overall Study|Protocol Violation|0|||
155232575|NCT00678561|560286428|FG003|Overall Study|Protocol Violation|0|||
155232576|NCT00678561|560286429|FG004|Overall Study|Protocol Violation|1|||
155232577|NCT00678561|560286430|FG005|Overall Study|Protocol Violation|1|||
155232578|NCT00678561|560286431|FG006|Overall Study|Protocol Violation|0|||
155232579|NCT00678561|560286432|FG007|Overall Study|Protocol Violation|0|||
155232580|NCT00678561|560286425|FG000|Overall Study|Withdrawal by Subject|0|||
155232581|NCT00678561|560286426|FG001|Overall Study|Withdrawal by Subject|0|||
155232582|NCT00678561|560286427|FG002|Overall Study|Withdrawal by Subject|0|||
155232583|NCT00678561|560286428|FG003|Overall Study|Withdrawal by Subject|0|||
155232584|NCT00678561|560286429|FG004|Overall Study|Withdrawal by Subject|0|||
155232585|NCT00678561|560286430|FG005|Overall Study|Withdrawal by Subject|0|||
155232586|NCT00678561|560286431|FG006|Overall Study|Withdrawal by Subject|0|||
155232587|NCT00678561|560286432|FG007|Overall Study|Withdrawal by Subject|1|||
155232588|NCT00218543|560286433|FG000|Overall Study|Lost to Follow-up|8|||
155232589|NCT00218543|560286433|FG000|Overall Study|relocated|1|||
155232590|NCT00218543|560286433|FG000|Overall Study|Withdrawal by Subject|1|||
155232591|NCT00218543|560286433|FG000|Overall Study|Physician Decision|3|||
155232592|NCT00218543|560286433|FG000|Overall Study|Adverse Event|2|||
155232593|NCT02920983|560286434|FG000|Dispense 1|Unacceptable Lens Fit|0|||
155232594|NCT02920983|560286435|FG001|Dispense 1|Unacceptable Lens Fit|0|||
155232595|NCT02920983|560286436|FG002|Dispense 1|Unacceptable Lens Fit|0|||
155232596|NCT02920983|560286437|FG003|Dispense 1|Unacceptable Lens Fit|0|||
155232597|NCT02920983|560286438|FG004|Dispense 1|Unacceptable Lens Fit|1|||
155232598|NCT02920983|560286439|FG005|Dispense 1|Unacceptable Lens Fit|0|||
155232599|NCT02920983|560286434|FG000|Dispense 2|Unscceptable lens fit|1|||
155232600|NCT02920983|560286435|FG001|Dispense 2|Unscceptable lens fit|0|||
155232601|NCT02920983|560286436|FG002|Dispense 2|Unscceptable lens fit|0|||
155232602|NCT02920983|560286437|FG003|Dispense 2|Unscceptable lens fit|0|||
155232603|NCT02920983|560286438|FG004|Dispense 2|Unscceptable lens fit|1|||
155232604|NCT02920983|560286439|FG005|Dispense 2|Unscceptable lens fit|0|||
155232605|NCT02920983|560286434|FG000|Dispense 3|Unacceptable Lens Fit|1|||
155232606|NCT02920983|560286435|FG001|Dispense 3|Unacceptable Lens Fit|1|||
155232607|NCT02920983|560286436|FG002|Dispense 3|Unacceptable Lens Fit|0|||
155232608|NCT02920983|560286437|FG003|Dispense 3|Unacceptable Lens Fit|0|||
155232609|NCT02920983|560286438|FG004|Dispense 3|Unacceptable Lens Fit|1|||
155232610|NCT02920983|560286439|FG005|Dispense 3|Unacceptable Lens Fit|0|||
155232611|NCT01451424|560286440|FG000|Overall Study|Withdrawal by Subject|1|||
155232612|NCT01451424|560286441|FG001|Overall Study|Withdrawal by Subject|1|||
155232613|NCT01451424|560286442|FG002|Overall Study|Withdrawal by Subject|0|||
155232614|NCT01451424|560286443|FG003|Overall Study|Withdrawal by Subject|2|||
155232615|NCT01451424|560286440|FG000|Overall Study|Lost to Follow-up|0|||
155232616|NCT01451424|560286441|FG001|Overall Study|Lost to Follow-up|1|||
155232617|NCT01451424|560286442|FG002|Overall Study|Lost to Follow-up|0|||
155232618|NCT01451424|560286443|FG003|Overall Study|Lost to Follow-up|1|||
155232619|NCT01451424|560286440|FG000|Overall Study|Physician Decision|0|||
155232620|NCT01451424|560286441|FG001|Overall Study|Physician Decision|0|||
155232621|NCT01451424|560286442|FG002|Overall Study|Physician Decision|1|||
155232622|NCT01451424|560286443|FG003|Overall Study|Physician Decision|1|||
155232623|NCT01451424|560286440|FG000|Overall Study|Adverse Event|0|||
155232624|NCT01451424|560286441|FG001|Overall Study|Adverse Event|0|||
155232625|NCT01451424|560286442|FG002|Overall Study|Adverse Event|0|||
155232626|NCT01451424|560286443|FG003|Overall Study|Adverse Event|1|||
155232627|NCT01387607|560286449|FG000|Overall Study|Adverse Event|23|||
155232628|NCT01387607|560286450|FG001|Overall Study|Adverse Event|11|||
155232629|NCT01387607|560286449|FG000|Overall Study|Lack of Efficacy|8|||
155232630|NCT01387607|560286450|FG001|Overall Study|Lack of Efficacy|6|||
155232631|NCT01387607|560286449|FG000|Overall Study|Lost to Follow-up|2|||
155232632|NCT01387607|560286450|FG001|Overall Study|Lost to Follow-up|1|||
155232633|NCT01387607|560286449|FG000|Overall Study|No longer meets eligibility criteria|0|||
155232634|NCT01387607|560286450|FG001|Overall Study|No longer meets eligibility criteria|1|||
155232635|NCT01387607|560286449|FG000|Overall Study|Protocol Violation|1|||
155232636|NCT01387607|560286450|FG001|Overall Study|Protocol Violation|5|||
155232637|NCT01387607|560286449|FG000|Overall Study|Withdrawal by Subject|13|||
155232638|NCT01387607|560286450|FG001|Overall Study|Withdrawal by Subject|14|||
155232639|NCT01387607|560286449|FG000|Overall Study|Other|1|||
155232640|NCT01387607|560286450|FG001|Overall Study|Other|1|||
155232641|NCT01387607|560286449|FG000|Overall Study|Randomized, not treated|3|||
155232642|NCT01387607|560286450|FG001|Overall Study|Randomized, not treated|6|||
155232643|NCT02908529|560286452|FG000|Overall Study|Lost to Follow-up|0|||
155232644|NCT02908529|560286453|FG001|Overall Study|Lost to Follow-up|2|||
155232645|NCT00689481|560286454|FG000|Overall Study|Adverse Event|7|||
155232646|NCT00689481|560286455|FG001|Overall Study|Adverse Event|1|||
155232647|NCT00689481|560286454|FG000|Overall Study|Lost to Follow-up|4|||
155232648|NCT00689481|560286455|FG001|Overall Study|Lost to Follow-up|3|||
155232649|NCT00689481|560286454|FG000|Overall Study|Lack of Efficacy|4|||
155232650|NCT00689481|560286455|FG001|Overall Study|Lack of Efficacy|3|||
155232651|NCT00689481|560286454|FG000|Overall Study|Non-compliance with study treatment|1|||
155232652|NCT00689481|560286455|FG001|Overall Study|Non-compliance with study treatment|1|||
155232653|NCT00689481|560286454|FG000|Overall Study|Withdrawal by Subject|8|||
155232654|NCT00689481|560286455|FG001|Overall Study|Withdrawal by Subject|4|||
155232655|NCT00689481|560286454|FG000|Overall Study|Excluded medication started during study|0|||
155232656|NCT00689481|560286455|FG001|Overall Study|Excluded medication started during study|1|||
155232657|NCT00689481|560286454|FG000|Overall Study|Subject early term, left on vacation|0|||
155232658|NCT00689481|560286455|FG001|Overall Study|Subject early term, left on vacation|1|||
155232659|NCT00528528|560286456|FG000|Overall Study|Lost to Follow-up|0|||
155232660|NCT00528528|560286457|FG001|Overall Study|Lost to Follow-up|0|||
155232661|NCT00528528|560286458|FG002|Overall Study|Lost to Follow-up|1|||
155232662|NCT00528528|560286459|FG003|Overall Study|Lost to Follow-up|1|||
155232663|NCT00528528|560286456|FG000|Overall Study|Ineligible to continue the trial|0|||
155232664|NCT00528528|560286457|FG001|Overall Study|Ineligible to continue the trial|0|||
155232665|NCT00528528|560286458|FG002|Overall Study|Ineligible to continue the trial|0|||
155232666|NCT00528528|560286459|FG003|Overall Study|Ineligible to continue the trial|1|||
155232667|NCT00528528|560286456|FG000|Overall Study|Other|0|||
155232668|NCT00528528|560286457|FG001|Overall Study|Other|1|||
155232669|NCT00528528|560286458|FG002|Overall Study|Other|0|||
155232670|NCT00528528|560286459|FG003|Overall Study|Other|0|||
155232671|NCT00528528|560286456|FG000|Overall Study|Withdrawal by Subject|3|||
155232672|NCT00528528|560286457|FG001|Overall Study|Withdrawal by Subject|2|||
155232673|NCT00528528|560286458|FG002|Overall Study|Withdrawal by Subject|1|||
155232674|NCT00528528|560286459|FG003|Overall Study|Withdrawal by Subject|1|||
155232675|NCT00528528|560286456|FG000|Overall Study|Ongoing participant|0|||
155232676|NCT00528528|560286457|FG001|Overall Study|Ongoing participant|0|||
155232677|NCT00528528|560286458|FG002|Overall Study|Ongoing participant|1|||
155232678|NCT00528528|560286459|FG003|Overall Study|Ongoing participant|0|||
155232679|NCT03238911|560286463|FG000|Overall Study|Withdrawal by Subject|1|||
155232680|NCT03238911|560286464|FG001|Overall Study|Withdrawal by Subject|2|||
155232681|NCT03238911|560286463|FG000|Overall Study|Lost to Follow-up|2|||
155232682|NCT03238911|560286464|FG001|Overall Study|Lost to Follow-up|1|||
155232683|NCT02097134|560287977|FG000|Overall Study|Physician Decision|4|||
155232684|NCT02097134|560287977|FG000|Overall Study|Non-Protocol Therapy|1|||
155232685|NCT02097134|560287977|FG000|Overall Study|Progressive Disease|3|||
155232686|NCT02097134|560287977|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
155232687|NCT03285646|560287984|FG000|Overall Study|Adverse Event|1|||
155232688|NCT03285646|560287985|FG001|Overall Study|Adverse Event|0|||
155232689|NCT03285646|560287984|FG000|Overall Study|Withdrawal by Subject|10|||
155232690|NCT03285646|560287985|FG001|Overall Study|Withdrawal by Subject|2|||
155232691|NCT03285646|560287984|FG000|Overall Study|Lost to Follow-up|2|||
155232692|NCT03285646|560287985|FG001|Overall Study|Lost to Follow-up|1|||
155232693|NCT03285646|560287984|FG000|Overall Study|Investigator/Sponsor Decision|0|||
155232694|NCT03285646|560287985|FG001|Overall Study|Investigator/Sponsor Decision|1|||
155232695|NCT00424372|560287988|FG000|Overall Study|Death|1|||
155232696|NCT00424372|560287988|FG000|Overall Study|Adverse Event|18|||
155232697|NCT00424372|560287988|FG000|Overall Study|Lack of Efficacy|6|||
155232698|NCT00424372|560287988|FG000|Overall Study|Withdrawal by Subject|4|||
155232699|NCT00424372|560287988|FG000|Overall Study|Protocol Violation|1|||
155232700|NCT00424372|560287988|FG000|Overall Study|Health deterioration|1|||
155232701|NCT02652624|560287989|FG000|Randomized Phase|Pregnancy|3|||
155232702|NCT02652624|560287990|FG001|Randomized Phase|Pregnancy|1|||
155232703|NCT02652624|560287989|FG000|Randomized Phase|Investigator's Discretion|0|||
155232704|NCT02652624|560287990|FG001|Randomized Phase|Investigator's Discretion|2|||
155232705|NCT02652624|560287989|FG000|Randomized Phase|Death|0|||
155232706|NCT02652624|560287990|FG001|Randomized Phase|Death|1|||
155232707|NCT02652624|560287989|FG000|Randomized Phase|Lost to Follow-up|0|||
155232708|NCT02652624|560287990|FG001|Randomized Phase|Lost to Follow-up|1|||
155232709|NCT02652624|560287989|FG000|Extension Phase|Lost to Follow-up|3|||
155232710|NCT02652624|560287990|FG001|Extension Phase|Lost to Follow-up|1|||
155232711|NCT02652624|560287989|FG000|Extension Phase|Pregnancy|1|||
155232712|NCT02652624|560287990|FG001|Extension Phase|Pregnancy|1|||
155232713|NCT02652624|560287989|FG000|Extension Phase|Adverse Event|0|||
155232714|NCT02652624|560287990|FG001|Extension Phase|Adverse Event|1|||
155232715|NCT02652624|560287989|FG000|Extension Phase|Withdrew Consent|0|||
155232716|NCT02652624|560287990|FG001|Extension Phase|Withdrew Consent|1|||
155232717|NCT00796861|560287993|FG000|Overall Study|Withdrawal by Subject|2|||
155232718|NCT00796861|560287993|FG000|Overall Study|Death|2|||
155232719|NCT02664038|560287996|FG000|13 Week|Lost to Follow-up|7|||
155232720|NCT02664038|560287997|FG001|13 Week|Lost to Follow-up|14|||
155232721|NCT02664038|560287996|FG000|13 Week|Withdrawal by Subject|1|||
155232722|NCT02664038|560287997|FG001|13 Week|Withdrawal by Subject|0|||
155232723|NCT02664038|560287996|FG000|26 Week|Lost to Follow-up|5|||
155232724|NCT02664038|560287997|FG001|26 Week|Lost to Follow-up|4|||
155232725|NCT04456699|560288008|FG000|Overall Study|Death|48|||
155232726|NCT04456699|560288009|FG001|Overall Study|Death|50|||
155232727|NCT04456699|560288010|FG002|Overall Study|Death|52|||
155232728|NCT04456699|560288008|FG000|Overall Study|Physician Decision|0|||
155232729|NCT04456699|560288009|FG001|Overall Study|Physician Decision|0|||
155232730|NCT04456699|560288010|FG002|Overall Study|Physician Decision|2|||
155232731|NCT04456699|560288008|FG000|Overall Study|Sponsor Decision|55|||
155232732|NCT04456699|560288009|FG001|Overall Study|Sponsor Decision|61|||
155232733|NCT04456699|560288010|FG002|Overall Study|Sponsor Decision|50|||
155232734|NCT04456699|560288008|FG000|Overall Study|Withdrawal by Subject|8|||
155232735|NCT04456699|560288009|FG001|Overall Study|Withdrawal by Subject|4|||
155232736|NCT04456699|560288010|FG002|Overall Study|Withdrawal by Subject|5|||
155232737|NCT01147653|560288016|FG000|Year 2|Withdrawal by Subject|2|||
155232738|NCT01147653|560288017|FG001|Year 2|Withdrawal by Subject|3|||
155232739|NCT00670228|560288018|FG000|Overall Study|Adverse Event|1|||
155232740|NCT00670228|560288019|FG001|Overall Study|Adverse Event|0|||
155232741|NCT00670228|560288018|FG000|Overall Study|Death or MACE|0|||
155232742|NCT00670228|560288019|FG001|Overall Study|Death or MACE|1|||
155232743|NCT00670228|560288018|FG000|Overall Study|Not treated|2|||
155232744|NCT00670228|560288019|FG001|Overall Study|Not treated|2|||
155232745|NCT00670228|560288018|FG000|Overall Study|Not meeting the selection criteria|2|||
155232746|NCT00670228|560288019|FG001|Overall Study|Not meeting the selection criteria|0|||
155232747|NCT05267054|560288020|FG000|Overall Study|Death|13|||
155232748|NCT05267054|560288021|FG001|Overall Study|Death|14|||
155232749|NCT05267054|560288020|FG000|Overall Study|Study Ended by Sponsor|9|||
155232750|NCT05267054|560288021|FG001|Overall Study|Study Ended by Sponsor|13|||
155232751|NCT05267054|560288020|FG000|Overall Study|Lost to Follow-up|1|||
155232752|NCT05267054|560288021|FG001|Overall Study|Lost to Follow-up|1|||
155232753|NCT05267054|560288020|FG000|Overall Study|Withdrawal by Subject|1|||
155232754|NCT05267054|560288021|FG001|Overall Study|Withdrawal by Subject|1|||
155232755|NCT01813019|560288025|FG000|Overall Study|Adverse Event|0|||
155232756|NCT01813019|560288026|FG001|Overall Study|Adverse Event|3|||
155232757|NCT01813019|560288025|FG000|Overall Study|Withdrawal by Subject|3|||
155232758|NCT01813019|560288026|FG001|Overall Study|Withdrawal by Subject|2|||
155232759|NCT01813019|560288025|FG000|Overall Study|administrative problems|2|||
155232760|NCT01813019|560288026|FG001|Overall Study|administrative problems|0|||
155232761|NCT01813019|560288025|FG000|Overall Study|Protocol Deviation|2|||
155232762|NCT01813019|560288026|FG001|Overall Study|Protocol Deviation|1|||
155232763|NCT01193556|560288027|FG000|Overall Study|Study termination|26|||
155232764|NCT01193556|560288028|FG001|Overall Study|Study termination|25|||
155232765|NCT03921411|560288034|FG000|Overall Study|Withdrawal by Subject|1|||
155232766|NCT03921411|560288034|FG000|Overall Study|Protocol Deviation|2|||
155232767|NCT03921411|560288034|FG000|Overall Study|Enrolled, but never treated|2|||
155232768|NCT01541826|560288035|FG000|Overall Study|Lost to Follow-up|2|||
155232769|NCT01541826|560288036|FG001|Overall Study|Lost to Follow-up|3|||
155232770|NCT01541826|560288037|FG002|Overall Study|Lost to Follow-up|0|||
155232771|NCT01541826|560288035|FG000|Overall Study|Withdrawal by Subject|2|||
155232772|NCT01541826|560288036|FG001|Overall Study|Withdrawal by Subject|0|||
155232773|NCT01541826|560288037|FG002|Overall Study|Withdrawal by Subject|0|||
155232774|NCT01365273|560288038|FG000|Overall Study|Lost to Follow-up|1|||
155232775|NCT01365273|560288039|FG001|Overall Study|Lost to Follow-up|0|||
155232776|NCT01365273|560288038|FG000|Overall Study|Protocol Violation|0|||
155232777|NCT01365273|560288039|FG001|Overall Study|Protocol Violation|1|||
155232778|NCT01365273|560288038|FG000|Overall Study|Physician Decision|1|||
155232779|NCT01365273|560288039|FG001|Overall Study|Physician Decision|0|||
155232780|NCT02705820|560288052|FG000|Overall Study|Death|2|||
155232781|NCT02705820|560288052|FG000|Overall Study|Disease Progression|34|||
155232782|NCT02705820|560288052|FG000|Overall Study|Clinical Deterioration|3|||
155232783|NCT02702401|560288054|FG000|Overall Study|Death|242|||
155232784|NCT02702401|560288055|FG001|Overall Study|Death|125|||
155232785|NCT02702401|560288054|FG000|Overall Study|Withdrawal by Subject|15|||
155232786|NCT02702401|560288055|FG001|Overall Study|Withdrawal by Subject|5|||
155232787|NCT02702401|560288054|FG000|Overall Study|Sponsor Decision|19|||
155232788|NCT02702401|560288055|FG001|Overall Study|Sponsor Decision|3|||
155232789|NCT02702401|560288054|FG000|Overall Study|Physician Decision|1|||
155232790|NCT02702401|560288055|FG001|Overall Study|Physician Decision|2|||
155232791|NCT02702401|560288054|FG000|Overall Study|Lost to Follow-up|1|||
155232792|NCT02702401|560288055|FG001|Overall Study|Lost to Follow-up|0|||
155232793|NCT01462357|560288061|FG000|Overall Study|Death|0|||
155232794|NCT01462357|560288062|FG001|Overall Study|Death|0|||
155232795|NCT01462357|560288063|FG002|Overall Study|Death|1|||
155232796|NCT01462357|560288061|FG000|Overall Study|Withdrawal by Subject|3|||
155232797|NCT01462357|560288062|FG001|Overall Study|Withdrawal by Subject|11|||
155232798|NCT01462357|560288063|FG002|Overall Study|Withdrawal by Subject|3|||
155232799|NCT01462357|560288061|FG000|Overall Study|Migrated/moved from study area|2|||
155232800|NCT01462357|560288062|FG001|Overall Study|Migrated/moved from study area|3|||
155232801|NCT01462357|560288063|FG002|Overall Study|Migrated/moved from study area|1|||
155232802|NCT01462357|560288061|FG000|Overall Study|Lost to Follow-up|3|||
155232803|NCT01462357|560288062|FG001|Overall Study|Lost to Follow-up|5|||
155232804|NCT01462357|560288063|FG002|Overall Study|Lost to Follow-up|7|||
155232805|NCT04292730|560288073|FG000|Overall Study|Lost to Follow-up|8|||
155232806|NCT04292730|560288074|FG001|Overall Study|Lost to Follow-up|12|||
155232807|NCT04292730|560288075|FG002|Overall Study|Lost to Follow-up|12|||
155232808|NCT04292730|560288076|FG003|Overall Study|Lost to Follow-up|48|||
155232809|NCT04292730|560288073|FG000|Overall Study|Death|2|||
155232810|NCT04292730|560288074|FG001|Overall Study|Death|2|||
155232811|NCT04292730|560288075|FG002|Overall Study|Death|4|||
155232812|NCT04292730|560288076|FG003|Overall Study|Death|12|||
155232813|NCT04292730|560288073|FG000|Overall Study|Withdrew Consent|2|||
155232814|NCT04292730|560288074|FG001|Overall Study|Withdrew Consent|2|||
155232815|NCT04292730|560288075|FG002|Overall Study|Withdrew Consent|5|||
155232816|NCT04292730|560288076|FG003|Overall Study|Withdrew Consent|6|||
155232817|NCT04292730|560288073|FG000|Overall Study|Non-Compliance with Study Drug|0|||
155232818|NCT04292730|560288074|FG001|Overall Study|Non-Compliance with Study Drug|1|||
155232819|NCT04292730|560288075|FG002|Overall Study|Non-Compliance with Study Drug|0|||
155232820|NCT04292730|560288076|FG003|Overall Study|Non-Compliance with Study Drug|0|||
155232821|NCT04292730|560288073|FG000|Overall Study|Protocol Violation|0|||
155232822|NCT04292730|560288074|FG001|Overall Study|Protocol Violation|0|||
155232823|NCT04292730|560288075|FG002|Overall Study|Protocol Violation|1|||
155232824|NCT04292730|560288076|FG003|Overall Study|Protocol Violation|0|||
155232825|NCT04292730|560288073|FG000|Overall Study|Randomized but not Treated|8|||
155232826|NCT04292730|560288074|FG001|Overall Study|Randomized but not Treated|4|||
155232827|NCT04292730|560288075|FG002|Overall Study|Randomized but not Treated|0|||
155232828|NCT04292730|560288076|FG003|Overall Study|Randomized but not Treated|14|||
155232829|NCT01527292|560288077|FG000|Overall Study|Physician Decision|0|||
155232830|NCT01527292|560288078|FG001|Overall Study|Physician Decision|3|||
155232831|NCT00314366|560288081|FG000|Overall Study|not treated due to patient medical condi|1|||
155232832|NCT00314366|560288082|FG001|Overall Study|not treated due to patient medical condi|0|||
155232833|NCT03400033|560288083|FG000|Overall Study|Withdrawal by Subject|1|||
155232834|NCT03400033|560288084|FG001|Overall Study|Withdrawal by Subject|2|||
155232835|NCT00006916|560288085|FG000|Overall Study|Device not inserted|4|||
155232836|NCT00006916|560288085|FG000|Overall Study|Complication of device insertion|1|||
155232837|NCT00558103|560288086|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
155232838|NCT00558103|560288087|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
155232839|NCT00558103|560288088|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
155232840|NCT00558103|560288089|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
155232841|NCT00558103|560288090|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
155232842|NCT00558103|560288091|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
155232843|NCT00558103|560288086|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
155232844|NCT00558103|560288087|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
155232845|NCT00558103|560288088|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
155232846|NCT00558103|560288089|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
155232847|NCT00558103|560288090|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
155232848|NCT00558103|560288091|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
155232849|NCT00558103|560288086|FG000|Randomized Treatment Phase|Disease Progression|1|||
155232850|NCT00558103|560288087|FG001|Randomized Treatment Phase|Disease Progression|0|||
155232851|NCT00558103|560288088|FG002|Randomized Treatment Phase|Disease Progression|1|||
155232852|NCT00558103|560288089|FG003|Randomized Treatment Phase|Disease Progression|0|||
155232853|NCT00558103|560288090|FG004|Randomized Treatment Phase|Disease Progression|0|||
155232854|NCT00558103|560288091|FG005|Randomized Treatment Phase|Disease Progression|0|||
155232855|NCT00558103|560288086|FG000|Randomized Treatment Phase|Adverse Event|0|||
155232856|NCT00558103|560288087|FG001|Randomized Treatment Phase|Adverse Event|0|||
155232857|NCT00558103|560288088|FG002|Randomized Treatment Phase|Adverse Event|0|||
155232858|NCT00558103|560288089|FG003|Randomized Treatment Phase|Adverse Event|1|||
155232859|NCT00558103|560288090|FG004|Randomized Treatment Phase|Adverse Event|1|||
155232860|NCT00558103|560288091|FG005|Randomized Treatment Phase|Adverse Event|0|||
155232861|NCT00558103|560288086|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
155232862|NCT00558103|560288087|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
155232863|NCT00558103|560288088|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
155232864|NCT00558103|560288089|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
155232865|NCT00558103|560288090|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
155232866|NCT00558103|560288091|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
155232867|NCT00558103|560288086|FG000|Monotherapy Extension Phase|Disease Progression|0|||
155232868|NCT00558103|560288087|FG001|Monotherapy Extension Phase|Disease Progression|0|||
155232869|NCT00558103|560288088|FG002|Monotherapy Extension Phase|Disease Progression|0|||
155232870|NCT00558103|560288089|FG003|Monotherapy Extension Phase|Disease Progression|0|||
155232871|NCT00558103|560288090|FG004|Monotherapy Extension Phase|Disease Progression|0|||
155232872|NCT00558103|560288091|FG005|Monotherapy Extension Phase|Disease Progression|8|||
155232873|NCT02457325|560288092|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
155232874|NCT02457325|560288093|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
155232875|NCT01574703|560288094|FG000|Overall Study|Adverse Event|0|||
155232876|NCT01574703|560288095|FG001|Overall Study|Adverse Event|2|||
155232877|NCT01574703|560288096|FG002|Overall Study|Adverse Event|1|||
155232878|NCT01574703|560288097|FG003|Overall Study|Adverse Event|1|||
155232879|NCT01574703|560288094|FG000|Overall Study|Protocol Violation|0|||
155232880|NCT01574703|560288095|FG001|Overall Study|Protocol Violation|0|||
155232881|NCT01574703|560288096|FG002|Overall Study|Protocol Violation|0|||
155232882|NCT01574703|560288097|FG003|Overall Study|Protocol Violation|1|||
155232883|NCT01574703|560288094|FG000|Overall Study|Unspecified Reason|27|||
155232884|NCT01574703|560288095|FG001|Overall Study|Unspecified Reason|15|||
155232885|NCT01574703|560288096|FG002|Overall Study|Unspecified Reason|20|||
155232886|NCT01574703|560288097|FG003|Overall Study|Unspecified Reason|16|||
155232887|NCT01574703|560288094|FG000|Overall Study|Withdrawal by Subject|53|||
155232888|NCT01574703|560288095|FG001|Overall Study|Withdrawal by Subject|52|||
155232889|NCT01574703|560288096|FG002|Overall Study|Withdrawal by Subject|36|||
155232890|NCT01574703|560288097|FG003|Overall Study|Withdrawal by Subject|61|||
155232891|NCT01574703|560288094|FG000|Overall Study|Met Withdrawal Criteria|0|||
155232892|NCT01574703|560288095|FG001|Overall Study|Met Withdrawal Criteria|1|||
155232893|NCT01574703|560288096|FG002|Overall Study|Met Withdrawal Criteria|1|||
155232894|NCT01574703|560288097|FG003|Overall Study|Met Withdrawal Criteria|0|||
155232895|NCT01574703|560288094|FG000|Overall Study|Lost to Follow-up|43|||
155232896|NCT01574703|560288095|FG001|Overall Study|Lost to Follow-up|41|||
155232897|NCT01574703|560288096|FG002|Overall Study|Lost to Follow-up|46|||
155232898|NCT01574703|560288097|FG003|Overall Study|Lost to Follow-up|35|||
155232899|NCT01574703|560288094|FG000|Overall Study|Death|2|||
155232900|NCT01574703|560288095|FG001|Overall Study|Death|1|||
155232901|NCT01574703|560288096|FG002|Overall Study|Death|1|||
155232902|NCT01574703|560288097|FG003|Overall Study|Death|0|||
155232903|NCT02751983|560288103|FG000|Treatment|Stopped ACT, but Remained in study|2|||
155232904|NCT02751983|560288104|FG001|Treatment|Stopped ACT, but Remained in study|0|||
155232905|NCT02751983|560288103|FG000|Treatment|Discharged prior to beginning ACT|2|||
155232906|NCT02751983|560288104|FG001|Treatment|Discharged prior to beginning ACT|0|||
155232907|NCT02751983|560288103|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
155232908|NCT02751983|560288104|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
155232909|NCT02751983|560288103|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
155232910|NCT02751983|560288104|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
155232911|NCT02751983|560288103|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
155232912|NCT02751983|560288104|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
155232913|NCT00989833|560288105|FG000|Overall Study|Lost to Follow-up|0|||
155232914|NCT00989833|560288106|FG001|Overall Study|Lost to Follow-up|1|||
155232915|NCT00989833|560288107|FG002|Overall Study|Lost to Follow-up|0|||
155232916|NCT00989833|560288105|FG000|Overall Study|Protocol Violation|1|||
155232917|NCT00989833|560288106|FG001|Overall Study|Protocol Violation|2|||
155232918|NCT00989833|560288107|FG002|Overall Study|Protocol Violation|1|||
155232919|NCT00989833|560288105|FG000|Overall Study|Withdrawal by Subject|0|||
155232920|NCT00989833|560288106|FG001|Overall Study|Withdrawal by Subject|0|||
155232921|NCT00989833|560288107|FG002|Overall Study|Withdrawal by Subject|1|||
155232922|NCT00989833|560288105|FG000|Overall Study|Incorrectly randomized|1|||
155232923|NCT00989833|560288106|FG001|Overall Study|Incorrectly randomized|0|||
155232924|NCT00989833|560288107|FG002|Overall Study|Incorrectly randomized|0|||
155232925|NCT00308711|560288108|FG000|Overall Study|Withdrawal by Subject|1|||
155232926|NCT00308711|560288109|FG001|Overall Study|Withdrawal by Subject|0|||
155232927|NCT00308711|560288110|FG002|Overall Study|Withdrawal by Subject|1|||
155232928|NCT00308711|560288108|FG000|Overall Study|Protocol Violation|0|||
155232929|NCT00308711|560288109|FG001|Overall Study|Protocol Violation|1|||
155232930|NCT00308711|560288110|FG002|Overall Study|Protocol Violation|1|||
155232931|NCT00308711|560288108|FG000|Overall Study|Lost to Follow-up|0|||
155232932|NCT00308711|560288109|FG001|Overall Study|Lost to Follow-up|1|||
155232933|NCT00308711|560288110|FG002|Overall Study|Lost to Follow-up|0|||
155232934|NCT00308711|560288108|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
155232935|NCT00308711|560288109|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
155232936|NCT00308711|560288110|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
155232937|NCT00308711|560288108|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
155232938|NCT00308711|560288109|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
155232939|NCT00308711|560288110|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
155232940|NCT02318693|560288111|FG000|Overall Study|Protocol Violation|0|||
155232941|NCT02318693|560288112|FG001|Overall Study|Protocol Violation|1|||
155232942|NCT04497987|560288113|FG000|Overall Study|Adverse Event|1|||
155232943|NCT04497987|560288114|FG001|Overall Study|Adverse Event|0|||
155232944|NCT04497987|560288113|FG000|Overall Study|Death|21|||
155232945|NCT04497987|560288114|FG001|Overall Study|Death|13|||
155232946|NCT04497987|560288113|FG000|Overall Study|Lost to Follow-up|19|||
155232947|NCT04497987|560288114|FG001|Overall Study|Lost to Follow-up|17|||
155232948|NCT04497987|560288113|FG000|Overall Study|Other - as reported by the investigator|22|||
155232949|NCT04497987|560288114|FG001|Overall Study|Other - as reported by the investigator|16|||
155232950|NCT04497987|560288113|FG000|Overall Study|Physician Decision|1|||
155232951|NCT04497987|560288114|FG001|Overall Study|Physician Decision|0|||
155232952|NCT04497987|560288113|FG000|Overall Study|Withdrawal by Subject|35|||
155232953|NCT04497987|560288114|FG001|Overall Study|Withdrawal by Subject|21|||
155232954|NCT03337724|560288123|FG000|Overall Study|Reason not Specified|12|||
155232955|NCT03337724|560288124|FG001|Overall Study|Reason not Specified|21|||
155232956|NCT03337724|560288125|FG002|Overall Study|Reason not Specified|9|||
155232957|NCT03337724|560288126|FG003|Overall Study|Reason not Specified|9|||
155232958|NCT03337724|560288127|FG004|Overall Study|Reason not Specified|29|||
155232959|NCT03337724|560288123|FG000|Overall Study|Withdrawal by Subject|13|||
155232960|NCT03337724|560288124|FG001|Overall Study|Withdrawal by Subject|15|||
155232961|NCT03337724|560288125|FG002|Overall Study|Withdrawal by Subject|4|||
155232962|NCT03337724|560288126|FG003|Overall Study|Withdrawal by Subject|15|||
155232963|NCT03337724|560288127|FG004|Overall Study|Withdrawal by Subject|6|||
155232964|NCT03337724|560288123|FG000|Overall Study|Protocol Deviation|0|||
155232965|NCT03337724|560288124|FG001|Overall Study|Protocol Deviation|1|||
155232966|NCT03337724|560288125|FG002|Overall Study|Protocol Deviation|1|||
155232967|NCT03337724|560288126|FG003|Overall Study|Protocol Deviation|1|||
155232968|NCT03337724|560288127|FG004|Overall Study|Protocol Deviation|0|||
155232969|NCT03337724|560288123|FG000|Overall Study|Adverse Event|1|||
155232970|NCT03337724|560288124|FG001|Overall Study|Adverse Event|1|||
155232971|NCT03337724|560288125|FG002|Overall Study|Adverse Event|0|||
155232972|NCT03337724|560288126|FG003|Overall Study|Adverse Event|1|||
155232973|NCT03337724|560288127|FG004|Overall Study|Adverse Event|0|||
155232974|NCT03337724|560288123|FG000|Overall Study|Death|40|||
155232975|NCT03337724|560288124|FG001|Overall Study|Death|89|||
155232976|NCT03337724|560288125|FG002|Overall Study|Death|43|||
155232977|NCT03337724|560288126|FG003|Overall Study|Death|76|||
155232978|NCT03337724|560288127|FG004|Overall Study|Death|50|||
155232979|NCT03337724|560288123|FG000|Overall Study|Lost to Follow-up|5|||
155232980|NCT03337724|560288124|FG001|Overall Study|Lost to Follow-up|5|||
155232981|NCT03337724|560288125|FG002|Overall Study|Lost to Follow-up|4|||
155232982|NCT03337724|560288126|FG003|Overall Study|Lost to Follow-up|7|||
155232983|NCT03337724|560288127|FG004|Overall Study|Lost to Follow-up|4|||
155232984|NCT03337724|560288123|FG000|Overall Study|Physician Decision|16|||
155232985|NCT03337724|560288124|FG001|Overall Study|Physician Decision|34|||
155232986|NCT03337724|560288125|FG002|Overall Study|Physician Decision|14|||
155232987|NCT03337724|560288126|FG003|Overall Study|Physician Decision|34|||
155232988|NCT03337724|560288127|FG004|Overall Study|Physician Decision|13|||
155232989|NCT03337724|560288123|FG000|Overall Study|Progressive Disease|0|||
155232990|NCT03337724|560288124|FG001|Overall Study|Progressive Disease|2|||
155232991|NCT03337724|560288125|FG002|Overall Study|Progressive Disease|1|||
155232992|NCT03337724|560288126|FG003|Overall Study|Progressive Disease|2|||
155232993|NCT03337724|560288127|FG004|Overall Study|Progressive Disease|0|||
155232994|NCT03337724|560288123|FG000|Overall Study|Symptomatic Deterioration|0|||
155232995|NCT03337724|560288124|FG001|Overall Study|Symptomatic Deterioration|0|||
155232996|NCT03337724|560288125|FG002|Overall Study|Symptomatic Deterioration|0|||
155232997|NCT03337724|560288126|FG003|Overall Study|Symptomatic Deterioration|1|||
155232998|NCT03337724|560288127|FG004|Overall Study|Symptomatic Deterioration|0|||
155232999|NCT00773097|560288128|FG000|Overall Study|Withdrawal by Subject|1|||
155233000|NCT00773097|560288128|FG000|Overall Study|Physician Decision|6|||
155233001|NCT00991302|560290289|FG000|Overall Study|Death|0|||
155233002|NCT00991302|560290290|FG001|Overall Study|Death|1|||
155233003|NCT00991302|560290289|FG000|Overall Study|Lost to Follow-up|14|||
155233004|NCT00991302|560290290|FG001|Overall Study|Lost to Follow-up|12|||
155233005|NCT01707004|560290291|FG000|Overall Study|Physician Decision|3|||
155233006|NCT03085927|560290293|FG000|Overall Study|Withdrawal by Subject|1|||
155233007|NCT03085927|560290294|FG001|Overall Study|Withdrawal by Subject|4|||
155233008|NCT03085927|560290293|FG000|Overall Study|Lost to Follow-up|3|||
155233009|NCT03085927|560290294|FG001|Overall Study|Lost to Follow-up|1|||
155233010|NCT03085927|560290293|FG000|Overall Study|Death|1|||
155233011|NCT03085927|560290294|FG001|Overall Study|Death|0|||
155233012|NCT03085927|560290293|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
155233013|NCT03085927|560290294|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
155233014|NCT03085927|560290293|FG000|Overall Study|Dyad Became Ineligible|0|||
155233015|NCT03085927|560290294|FG001|Overall Study|Dyad Became Ineligible|1|||
155233016|NCT02573324|560290297|FG000|Overall Study|Withdrawal by Subject|26|||
155233017|NCT02573324|560290298|FG001|Overall Study|Withdrawal by Subject|23|||
155233018|NCT02573324|560290299|FG002|Overall Study|Withdrawal by Subject|3|||
155233019|NCT02573324|560290297|FG000|Overall Study|Lost to Follow-up|4|||
155233020|NCT02573324|560290298|FG001|Overall Study|Lost to Follow-up|5|||
155233021|NCT02573324|560290299|FG002|Overall Study|Lost to Follow-up|0|||
155233022|NCT02573324|560290297|FG000|Overall Study|Study Terminated by Sponsor|107|||
155233023|NCT02573324|560290298|FG001|Overall Study|Study Terminated by Sponsor|89|||
155233024|NCT02573324|560290299|FG002|Overall Study|Study Terminated by Sponsor|2|||
155233025|NCT02573324|560290297|FG000|Overall Study|Death|182|||
155233026|NCT02573324|560290298|FG001|Overall Study|Death|200|||
155233027|NCT02573324|560290299|FG002|Overall Study|Death|1|||
155233028|NCT02573324|560290297|FG000|Overall Study|Other, Not Specified|20|||
155233029|NCT02573324|560290298|FG001|Overall Study|Other, Not Specified|27|||
155233030|NCT02573324|560290299|FG002|Overall Study|Other, Not Specified|0|||
155233031|NCT02573324|560290297|FG000|Overall Study|Unknown Reason|2|||
155233032|NCT02573324|560290298|FG001|Overall Study|Unknown Reason|0|||
155233033|NCT02573324|560290299|FG002|Overall Study|Unknown Reason|0|||
155233034|NCT02349711|560290300|FG000|Overall Study|Withdrawal by Subject|2|||
155233035|NCT02349711|560290301|FG001|Overall Study|Withdrawal by Subject|1|||
155233036|NCT02349711|560290300|FG000|Overall Study|Lost to Follow-up|1|||
155233037|NCT02349711|560290301|FG001|Overall Study|Lost to Follow-up|1|||
155233038|NCT00941733|560290302|FG000|Overall Study|Death|24|||
155233039|NCT00941733|560290303|FG001|Overall Study|Death|10|||
155233040|NCT00941733|560290302|FG000|Overall Study|Withdrawal by Subject|14|||
155233041|NCT00941733|560290303|FG001|Overall Study|Withdrawal by Subject|6|||
155233042|NCT00941733|560290302|FG000|Overall Study|Adverse Event|20|||
155233043|NCT00941733|560290303|FG001|Overall Study|Adverse Event|4|||
155233044|NCT00941733|560290302|FG000|Overall Study|Lost to Follow-up|1|||
155233045|NCT00941733|560290303|FG001|Overall Study|Lost to Follow-up|2|||
155233046|NCT00941733|560290302|FG000|Overall Study|Protocol Violation|15|||
155233047|NCT00941733|560290303|FG001|Overall Study|Protocol Violation|6|||
155233048|NCT00194012|560290304|FG000|Randomized Phase|Lack of Efficacy|8|||
155233049|NCT00194012|560290305|FG001|Randomized Phase|Lack of Efficacy|18|||
155233050|NCT00194012|560290304|FG000|Randomized Phase|Study nonadherence|2|||
155233051|NCT00194012|560290305|FG001|Randomized Phase|Study nonadherence|1|||
155233052|NCT00194012|560290304|FG000|Randomized Phase|Withdrawal by Subject|3|||
155233053|NCT00194012|560290305|FG001|Randomized Phase|Withdrawal by Subject|3|||
155233054|NCT00194012|560290304|FG000|Randomized Phase|Adverse Event|2|||
155233055|NCT00194012|560290305|FG001|Randomized Phase|Adverse Event|1|||
155233056|NCT00194012|560290304|FG000|Randomized Phase|Participant reported having a rash|1|||
155233057|NCT00194012|560290305|FG001|Randomized Phase|Participant reported having a rash|0|||
155233058|NCT00194012|560290304|FG000|Randomized Phase|Emesis and enuresis|0|||
155233059|NCT00194012|560290305|FG001|Randomized Phase|Emesis and enuresis|1|||
155233060|NCT00194012|560290304|FG000|Randomized Phase|Oral/nasal twitching|0|||
155233061|NCT00194012|560290305|FG001|Randomized Phase|Oral/nasal twitching|1|||
155233062|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Weight Gain|1|||
155233063|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Weight Gain|0|||
155233064|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
155233065|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
155233066|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
155233067|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
155233068|NCT00194012|560290304|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
155233069|NCT00194012|560290305|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
155233070|NCT01105533|560290310|FG000|Overall Study|Death|0|||
155233071|NCT01105533|560290311|FG001|Overall Study|Death|0|||
155233072|NCT01105533|560290312|FG002|Overall Study|Death|0|||
155233073|NCT01105533|560290313|FG003|Overall Study|Death|0|||
155233074|NCT01105533|560290314|FG004|Overall Study|Death|1|||
155233075|NCT01105533|560290315|FG005|Overall Study|Death|0|||
155233076|NCT01105533|560290316|FG006|Overall Study|Death|0|||
155233077|NCT01105533|560290317|FG007|Overall Study|Death|0|||
155233078|NCT01105533|560290318|FG008|Overall Study|Death|0|||
155233079|NCT01105533|560290310|FG000|Overall Study|Lack of Efficacy|1|||
155233080|NCT01105533|560290311|FG001|Overall Study|Lack of Efficacy|1|||
155233081|NCT01105533|560290312|FG002|Overall Study|Lack of Efficacy|3|||
155233082|NCT01105533|560290313|FG003|Overall Study|Lack of Efficacy|3|||
155233083|NCT01105533|560290314|FG004|Overall Study|Lack of Efficacy|4|||
155233084|NCT01105533|560290315|FG005|Overall Study|Lack of Efficacy|5|||
155233085|NCT01105533|560290316|FG006|Overall Study|Lack of Efficacy|3|||
155233086|NCT01105533|560290317|FG007|Overall Study|Lack of Efficacy|2|||
155233087|NCT01105533|560290318|FG008|Overall Study|Lack of Efficacy|9|||
155233088|NCT01105533|560290310|FG000|Overall Study|Adverse Event|0|||
155233089|NCT01105533|560290311|FG001|Overall Study|Adverse Event|0|||
155233090|NCT01105533|560290312|FG002|Overall Study|Adverse Event|0|||
155233091|NCT01105533|560290313|FG003|Overall Study|Adverse Event|0|||
155233092|NCT01105533|560290314|FG004|Overall Study|Adverse Event|1|||
155233093|NCT01105533|560290315|FG005|Overall Study|Adverse Event|2|||
155233094|NCT01105533|560290316|FG006|Overall Study|Adverse Event|2|||
155233095|NCT01105533|560290317|FG007|Overall Study|Adverse Event|0|||
155233096|NCT01105533|560290318|FG008|Overall Study|Adverse Event|1|||
155233097|NCT01105533|560290310|FG000|Overall Study|Other|0|||
155233098|NCT01105533|560290311|FG001|Overall Study|Other|0|||
155233099|NCT01105533|560290312|FG002|Overall Study|Other|0|||
155233100|NCT01105533|560290313|FG003|Overall Study|Other|0|||
155233101|NCT01105533|560290314|FG004|Overall Study|Other|1|||
155233102|NCT01105533|560290315|FG005|Overall Study|Other|0|||
155233103|NCT01105533|560290316|FG006|Overall Study|Other|3|||
155233104|NCT01105533|560290317|FG007|Overall Study|Other|1|||
155233105|NCT01105533|560290318|FG008|Overall Study|Other|2|||
155233106|NCT01105533|560290310|FG000|Overall Study|Physician Decision|0|||
155233107|NCT01105533|560290311|FG001|Overall Study|Physician Decision|0|||
155233108|NCT01105533|560290312|FG002|Overall Study|Physician Decision|0|||
155233109|NCT01105533|560290313|FG003|Overall Study|Physician Decision|0|||
155233110|NCT01105533|560290314|FG004|Overall Study|Physician Decision|0|||
155233111|NCT01105533|560290315|FG005|Overall Study|Physician Decision|0|||
155233112|NCT01105533|560290316|FG006|Overall Study|Physician Decision|0|||
155233113|NCT01105533|560290317|FG007|Overall Study|Physician Decision|1|||
155233114|NCT01105533|560290318|FG008|Overall Study|Physician Decision|0|||
155233115|NCT01610700|560290319|FG000|Overall Study|Adverse Event|3|||
155233116|NCT01610700|560290320|FG001|Overall Study|Adverse Event|1|||
155233117|NCT01610700|560290319|FG000|Overall Study|Withdrawal by Subject|0|||
155233118|NCT01610700|560290320|FG001|Overall Study|Withdrawal by Subject|1|||
155233119|NCT01610700|560290319|FG000|Overall Study|subject took one dose of street cannabis|0|||
155233120|NCT01610700|560290320|FG001|Overall Study|subject took one dose of street cannabis|1|||
155233121|NCT01639001|560290326|FG000|Overall Study|Refused further follow-up|9|||
155233122|NCT01639001|560290327|FG001|Overall Study|Refused further follow-up|12|||
155233123|NCT01639001|560290326|FG000|Overall Study|Lost to Follow-up|3|||
155233124|NCT01639001|560290327|FG001|Overall Study|Lost to Follow-up|0|||
155233125|NCT01639001|560290326|FG000|Overall Study|Death|62|||
155233126|NCT01639001|560290327|FG001|Overall Study|Death|61|||
155233127|NCT01639001|560290326|FG000|Overall Study|Randomized but not treated|0|||
155233128|NCT01639001|560290327|FG001|Overall Study|Randomized but not treated|2|||
155233129|NCT01639001|560290326|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
155233130|NCT01639001|560290327|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
155233131|NCT02453594|560290328|FG000|Overall Study|Protocol Violation|0|||
155233132|NCT02453594|560290329|FG001|Overall Study|Protocol Violation|0|||
155233133|NCT02453594|560290330|FG002|Overall Study|Protocol Violation|1|||
155233134|NCT02453594|560290328|FG000|Overall Study|Cohort Was Closed|17|||
155233135|NCT02453594|560290329|FG001|Overall Study|Cohort Was Closed|21|||
155233136|NCT02453594|560290330|FG002|Overall Study|Cohort Was Closed|14|||
155233137|NCT02453594|560290328|FG000|Overall Study|Death|20|||
155233138|NCT02453594|560290329|FG001|Overall Study|Death|24|||
155233139|NCT02453594|560290330|FG002|Overall Study|Death|16|||
155233140|NCT02453594|560290328|FG000|Overall Study|Lost to Follow-up|6|||
155233141|NCT02453594|560290329|FG001|Overall Study|Lost to Follow-up|14|||
155233142|NCT02453594|560290330|FG002|Overall Study|Lost to Follow-up|2|||
155233143|NCT02453594|560290328|FG000|Overall Study|Physician Decision|2|||
155233144|NCT02453594|560290329|FG001|Overall Study|Physician Decision|4|||
155233145|NCT02453594|560290330|FG002|Overall Study|Physician Decision|0|||
155233146|NCT02453594|560290328|FG000|Overall Study|Site Terminated by Sponsor|1|||
155233147|NCT02453594|560290329|FG001|Overall Study|Site Terminated by Sponsor|0|||
155233148|NCT02453594|560290330|FG002|Overall Study|Site Terminated by Sponsor|1|||
155233149|NCT02453594|560290328|FG000|Overall Study|Transitioned to Extension Study|16|||
155233150|NCT02453594|560290329|FG001|Overall Study|Transitioned to Extension Study|9|||
155233151|NCT02453594|560290330|FG002|Overall Study|Transitioned to Extension Study|16|||
155233152|NCT02453594|560290328|FG000|Overall Study|Withdrawal by Subject|7|||
155233153|NCT02453594|560290329|FG001|Overall Study|Withdrawal by Subject|9|||
155233154|NCT02453594|560290330|FG002|Overall Study|Withdrawal by Subject|11|||
155233155|NCT00679341|560290332|FG000|Overall Study|Disease progression|42|||
155233156|NCT00679341|560290333|FG001|Overall Study|Disease progression|36|||
155233157|NCT00679341|560290332|FG000|Overall Study|Adverse Event|5|||
155233158|NCT00679341|560290333|FG001|Overall Study|Adverse Event|6|||
155233159|NCT00679341|560290332|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
155233160|NCT00679341|560290333|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
155233161|NCT00679341|560290332|FG000|Overall Study|Death|1|||
155233162|NCT00679341|560290333|FG001|Overall Study|Death|1|||
155233163|NCT00679341|560290332|FG000|Overall Study|Other|1|||
155233164|NCT00679341|560290333|FG001|Overall Study|Other|0|||
155233165|NCT00679341|560290332|FG000|Overall Study|Physician Decision|1|||
155233166|NCT00679341|560290333|FG001|Overall Study|Physician Decision|0|||
155233167|NCT00679341|560290332|FG000|Overall Study|Not treated|0|||
155233168|NCT00679341|560290333|FG001|Overall Study|Not treated|2|||
155233169|NCT00679341|560290332|FG000|Overall Study|Physician/patient decision to withdraw|0|||
155233170|NCT00679341|560290333|FG001|Overall Study|Physician/patient decision to withdraw|6|||
155233171|NCT02660359|560290334|FG000|Overall Study|Protocol Deviation|0|||
155233172|NCT02660359|560290335|FG001|Overall Study|Protocol Deviation|0|||
155233173|NCT02660359|560290336|FG002|Overall Study|Protocol Deviation|1|||
155233174|NCT02660359|560290334|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
155233175|NCT02660359|560290335|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
155233176|NCT02660359|560290336|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
155233177|NCT02660359|560290334|FG000|Overall Study|Lack of Efficacy|1|||
155233178|NCT02660359|560290335|FG001|Overall Study|Lack of Efficacy|1|||
155233179|NCT02660359|560290336|FG002|Overall Study|Lack of Efficacy|1|||
155233180|NCT02660359|560290334|FG000|Overall Study|Adverse Event|0|||
155233181|NCT02660359|560290335|FG001|Overall Study|Adverse Event|1|||
155233182|NCT02660359|560290336|FG002|Overall Study|Adverse Event|0|||
155233183|NCT02660359|560290334|FG000|Overall Study|Other|2|||
155233184|NCT02660359|560290335|FG001|Overall Study|Other|1|||
155233185|NCT02660359|560290336|FG002|Overall Study|Other|3|||
155233186|NCT02660359|560290334|FG000|Overall Study|Withdrawal by Subject|7|||
155233187|NCT02660359|560290335|FG001|Overall Study|Withdrawal by Subject|5|||
155233188|NCT02660359|560290336|FG002|Overall Study|Withdrawal by Subject|8|||
155233189|NCT02660359|560290334|FG000|Overall Study|Lost to Follow-up|3|||
155233190|NCT02660359|560290335|FG001|Overall Study|Lost to Follow-up|3|||
155233191|NCT02660359|560290336|FG002|Overall Study|Lost to Follow-up|0|||
155233192|NCT00306592|560290337|FG000|Overall Study|Adverse Event|8|||
155233193|NCT00306592|560290338|FG001|Overall Study|Adverse Event|15|||
155233194|NCT00306592|560290337|FG000|Overall Study|Lost to Follow-up|1|||
155233195|NCT00306592|560290338|FG001|Overall Study|Lost to Follow-up|0|||
155233196|NCT00306592|560290337|FG000|Overall Study|Noncompliance|0|||
155233197|NCT00306592|560290338|FG001|Overall Study|Noncompliance|2|||
155233198|NCT00306592|560290337|FG000|Overall Study|Persistent Antibodies|6|||
155233199|NCT00306592|560290338|FG001|Overall Study|Persistent Antibodies|3|||
155233200|NCT00306592|560290337|FG000|Overall Study|Voluntary|10|||
155233201|NCT00306592|560290338|FG001|Overall Study|Voluntary|6|||
155233202|NCT00306592|560290337|FG000|Overall Study|Other|5|||
155233203|NCT00306592|560290338|FG001|Overall Study|Other|10|||
155233204|NCT00306592|560290337|FG000|Overall Study|Other|1|||
155233205|NCT00306592|560290338|FG001|Overall Study|Other|2|||
155233206|NCT00306592|560290337|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
155233207|NCT00306592|560290338|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
155233208|NCT04101526|560290339|FG000|Overall Study|Did not complete all sleep diary entries|0|||
155233209|NCT04101526|560290340|FG001|Overall Study|Did not complete all sleep diary entries|1|||
155233210|NCT00953329|560290343|FG000|Overall Study|Lack of Efficacy|1|||
155233211|NCT01434823|560290344|FG000|Overall Study|Incomplete data in medical record|4|||
155233212|NCT01434823|560290345|FG001|Overall Study|Incomplete data in medical record|7|||
155233213|NCT03670810|560290347|FG000|Main Study|Adverse Event|37|||
155233214|NCT03670810|560290348|FG001|Main Study|Adverse Event|38|||
155233215|NCT03670810|560290349|FG002|Main Study|Adverse Event|3|||
155233216|NCT03670810|560290350|FG003|Main Study|Adverse Event|4|||
155233217|NCT03670810|560290351|FG004|Main Study|Adverse Event|4|||
155233218|NCT03670810|560290352|FG005|Main Study|Adverse Event|5|||
155233219|NCT03670810|560290353|FG006|Main Study|Adverse Event|0|||
155233220|NCT03670810|560290354|FG007|Main Study|Adverse Event|0|||
155233221|NCT03670810|560290355|FG008|Main Study|Adverse Event|0|||
155233222|NCT03670810|560290347|FG000|Main Study|Lack of Efficacy|8|||
155233223|NCT03670810|560290348|FG001|Main Study|Lack of Efficacy|9|||
155233224|NCT03670810|560290349|FG002|Main Study|Lack of Efficacy|3|||
155233225|NCT03670810|560290350|FG003|Main Study|Lack of Efficacy|4|||
155233226|NCT03670810|560290351|FG004|Main Study|Lack of Efficacy|0|||
155233227|NCT03670810|560290352|FG005|Main Study|Lack of Efficacy|0|||
155233228|NCT03670810|560290353|FG006|Main Study|Lack of Efficacy|0|||
155233229|NCT03670810|560290354|FG007|Main Study|Lack of Efficacy|0|||
155233230|NCT03670810|560290355|FG008|Main Study|Lack of Efficacy|0|||
155233231|NCT03670810|560290347|FG000|Main Study|Lost to Follow-up|9|||
155233232|NCT03670810|560290348|FG001|Main Study|Lost to Follow-up|7|||
155233233|NCT03670810|560290349|FG002|Main Study|Lost to Follow-up|4|||
155233234|NCT03670810|560290350|FG003|Main Study|Lost to Follow-up|6|||
155233235|NCT03670810|560290351|FG004|Main Study|Lost to Follow-up|1|||
155233236|NCT03670810|560290352|FG005|Main Study|Lost to Follow-up|0|||
155233237|NCT03670810|560290353|FG006|Main Study|Lost to Follow-up|0|||
155233238|NCT03670810|560290354|FG007|Main Study|Lost to Follow-up|0|||
155233239|NCT03670810|560290355|FG008|Main Study|Lost to Follow-up|0|||
155233240|NCT03670810|560290347|FG000|Main Study|Non-compliance with Study Drug|0|||
155233241|NCT03670810|560290348|FG001|Main Study|Non-compliance with Study Drug|2|||
155233242|NCT03670810|560290349|FG002|Main Study|Non-compliance with Study Drug|3|||
155233243|NCT03670810|560290350|FG003|Main Study|Non-compliance with Study Drug|0|||
155233244|NCT03670810|560290351|FG004|Main Study|Non-compliance with Study Drug|0|||
155233245|NCT03670810|560290352|FG005|Main Study|Non-compliance with Study Drug|0|||
155233246|NCT03670810|560290353|FG006|Main Study|Non-compliance with Study Drug|0|||
155233247|NCT03670810|560290354|FG007|Main Study|Non-compliance with Study Drug|1|||
155233248|NCT03670810|560290355|FG008|Main Study|Non-compliance with Study Drug|0|||
155233249|NCT03670810|560290347|FG000|Main Study|Physician Decision|3|||
155233250|NCT03670810|560290348|FG001|Main Study|Physician Decision|0|||
155233251|NCT03670810|560290349|FG002|Main Study|Physician Decision|1|||
155233252|NCT03670810|560290350|FG003|Main Study|Physician Decision|0|||
155233253|NCT03670810|560290351|FG004|Main Study|Physician Decision|0|||
155233254|NCT03670810|560290352|FG005|Main Study|Physician Decision|0|||
155233255|NCT03670810|560290353|FG006|Main Study|Physician Decision|1|||
155233256|NCT03670810|560290354|FG007|Main Study|Physician Decision|1|||
155233257|NCT03670810|560290355|FG008|Main Study|Physician Decision|0|||
155233258|NCT03670810|560290347|FG000|Main Study|Pregnancy|1|||
155233259|NCT03670810|560290348|FG001|Main Study|Pregnancy|2|||
155233260|NCT03670810|560290349|FG002|Main Study|Pregnancy|0|||
155233261|NCT03670810|560290350|FG003|Main Study|Pregnancy|0|||
155233262|NCT03670810|560290351|FG004|Main Study|Pregnancy|0|||
155233263|NCT03670810|560290352|FG005|Main Study|Pregnancy|0|||
155233264|NCT03670810|560290353|FG006|Main Study|Pregnancy|0|||
155233265|NCT03670810|560290354|FG007|Main Study|Pregnancy|0|||
155233266|NCT03670810|560290355|FG008|Main Study|Pregnancy|0|||
155233267|NCT03670810|560290347|FG000|Main Study|Protocol Deviation|2|||
155233268|NCT03670810|560290348|FG001|Main Study|Protocol Deviation|12|||
155233269|NCT03670810|560290349|FG002|Main Study|Protocol Deviation|8|||
155233270|NCT03670810|560290350|FG003|Main Study|Protocol Deviation|4|||
155233271|NCT03670810|560290351|FG004|Main Study|Protocol Deviation|0|||
155233272|NCT03670810|560290352|FG005|Main Study|Protocol Deviation|0|||
155233273|NCT03670810|560290353|FG006|Main Study|Protocol Deviation|0|||
155233274|NCT03670810|560290354|FG007|Main Study|Protocol Deviation|0|||
155233275|NCT03670810|560290355|FG008|Main Study|Protocol Deviation|0|||
155233276|NCT03670810|560290347|FG000|Main Study|Withdrawal by Subject|21|||
155233277|NCT03670810|560290348|FG001|Main Study|Withdrawal by Subject|21|||
155233278|NCT03670810|560290349|FG002|Main Study|Withdrawal by Subject|8|||
155233279|NCT03670810|560290350|FG003|Main Study|Withdrawal by Subject|9|||
155233280|NCT03670810|560290351|FG004|Main Study|Withdrawal by Subject|5|||
155233281|NCT03670810|560290352|FG005|Main Study|Withdrawal by Subject|2|||
155233282|NCT03670810|560290353|FG006|Main Study|Withdrawal by Subject|1|||
155233283|NCT03670810|560290354|FG007|Main Study|Withdrawal by Subject|1|||
155233284|NCT03670810|560290355|FG008|Main Study|Withdrawal by Subject|0|||
155233285|NCT03670810|560290347|FG000|Main Study|Participant did not want to take the three other treatments|1|||
155233286|NCT03670810|560290348|FG001|Main Study|Participant did not want to take the three other treatments|0|||
155233287|NCT03670810|560290349|FG002|Main Study|Participant did not want to take the three other treatments|0|||
155233288|NCT03670810|560290350|FG003|Main Study|Participant did not want to take the three other treatments|0|||
155233289|NCT03670810|560290351|FG004|Main Study|Participant did not want to take the three other treatments|0|||
155233290|NCT03670810|560290352|FG005|Main Study|Participant did not want to take the three other treatments|0|||
155233291|NCT03670810|560290353|FG006|Main Study|Participant did not want to take the three other treatments|0|||
155233292|NCT03670810|560290354|FG007|Main Study|Participant did not want to take the three other treatments|0|||
155233293|NCT03670810|560290355|FG008|Main Study|Participant did not want to take the three other treatments|0|||
155233294|NCT03670810|560290347|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233295|NCT03670810|560290348|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
155233296|NCT03670810|560290349|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233297|NCT03670810|560290350|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233298|NCT03670810|560290351|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233299|NCT03670810|560290352|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233300|NCT03670810|560290353|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233301|NCT03670810|560290354|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233302|NCT03670810|560290355|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
155233303|NCT03670810|560290347|FG000|Main Study|Travel and Coronavirus issues|0|||
155233304|NCT03670810|560290348|FG001|Main Study|Travel and Coronavirus issues|0|||
155233305|NCT03670810|560290349|FG002|Main Study|Travel and Coronavirus issues|0|||
155233306|NCT03670810|560290350|FG003|Main Study|Travel and Coronavirus issues|1|||
155233307|NCT03670810|560290351|FG004|Main Study|Travel and Coronavirus issues|0|||
155233308|NCT03670810|560290352|FG005|Main Study|Travel and Coronavirus issues|0|||
155233309|NCT03670810|560290353|FG006|Main Study|Travel and Coronavirus issues|0|||
155233310|NCT03670810|560290354|FG007|Main Study|Travel and Coronavirus issues|0|||
155233311|NCT03670810|560290355|FG008|Main Study|Travel and Coronavirus issues|0|||
155233312|NCT03670810|560290347|FG000|Open Label Extension|Protocol Deviation|0|||
155233313|NCT03670810|560290348|FG001|Open Label Extension|Protocol Deviation|0|||
155233314|NCT03670810|560290349|FG002|Open Label Extension|Protocol Deviation|0|||
155233315|NCT03670810|560290350|FG003|Open Label Extension|Protocol Deviation|0|||
155233316|NCT03670810|560290351|FG004|Open Label Extension|Protocol Deviation|0|||
155233317|NCT03670810|560290352|FG005|Open Label Extension|Protocol Deviation|0|||
155233318|NCT03670810|560290353|FG006|Open Label Extension|Protocol Deviation|0|||
155233319|NCT03670810|560290354|FG007|Open Label Extension|Protocol Deviation|0|||
155233320|NCT03670810|560290355|FG008|Open Label Extension|Protocol Deviation|5|||
155233321|NCT03670810|560290347|FG000|Open Label Extension|Death|0|||
155233322|NCT03670810|560290348|FG001|Open Label Extension|Death|0|||
155233323|NCT03670810|560290349|FG002|Open Label Extension|Death|0|||
155233324|NCT03670810|560290350|FG003|Open Label Extension|Death|0|||
155233325|NCT03670810|560290351|FG004|Open Label Extension|Death|0|||
155233326|NCT03670810|560290352|FG005|Open Label Extension|Death|0|||
155233327|NCT03670810|560290353|FG006|Open Label Extension|Death|0|||
155233328|NCT03670810|560290354|FG007|Open Label Extension|Death|0|||
155233329|NCT03670810|560290355|FG008|Open Label Extension|Death|1|||
155233330|NCT03670810|560290347|FG000|Open Label Extension|COVID-19|0|||
155233331|NCT03670810|560290348|FG001|Open Label Extension|COVID-19|0|||
155233332|NCT03670810|560290349|FG002|Open Label Extension|COVID-19|0|||
155233333|NCT03670810|560290350|FG003|Open Label Extension|COVID-19|0|||
155233334|NCT03670810|560290351|FG004|Open Label Extension|COVID-19|0|||
155233335|NCT03670810|560290352|FG005|Open Label Extension|COVID-19|0|||
155233336|NCT03670810|560290353|FG006|Open Label Extension|COVID-19|0|||
155233337|NCT03670810|560290354|FG007|Open Label Extension|COVID-19|0|||
155233338|NCT03670810|560290355|FG008|Open Label Extension|COVID-19|1|||
155233339|NCT03670810|560290347|FG000|Open Label Extension|Lack of Efficacy|0|||
155233340|NCT03670810|560290348|FG001|Open Label Extension|Lack of Efficacy|0|||
155233341|NCT03670810|560290349|FG002|Open Label Extension|Lack of Efficacy|0|||
155233342|NCT03670810|560290350|FG003|Open Label Extension|Lack of Efficacy|0|||
155233343|NCT03670810|560290351|FG004|Open Label Extension|Lack of Efficacy|0|||
155233344|NCT03670810|560290352|FG005|Open Label Extension|Lack of Efficacy|0|||
155233345|NCT03670810|560290353|FG006|Open Label Extension|Lack of Efficacy|0|||
155233346|NCT03670810|560290354|FG007|Open Label Extension|Lack of Efficacy|0|||
155233347|NCT03670810|560290355|FG008|Open Label Extension|Lack of Efficacy|39|||
155233348|NCT03670810|560290347|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
155233349|NCT03670810|560290348|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
155233350|NCT03670810|560290349|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
155233351|NCT03670810|560290350|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
155233352|NCT03670810|560290351|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
155233353|NCT03670810|560290352|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
155233354|NCT03670810|560290353|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
155233355|NCT03670810|560290354|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
155233356|NCT03670810|560290355|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
155233357|NCT03670810|560290347|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233358|NCT03670810|560290348|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233359|NCT03670810|560290349|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233360|NCT03670810|560290350|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233361|NCT03670810|560290351|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233362|NCT03670810|560290352|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233363|NCT03670810|560290353|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233364|NCT03670810|560290354|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
155233365|NCT03670810|560290355|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
155233366|NCT03670810|560290347|FG000|Open Label Extension|Withdrawal by Subject|0|||
155233367|NCT03670810|560290348|FG001|Open Label Extension|Withdrawal by Subject|0|||
155233368|NCT03670810|560290349|FG002|Open Label Extension|Withdrawal by Subject|0|||
155233369|NCT03670810|560290350|FG003|Open Label Extension|Withdrawal by Subject|0|||
155233370|NCT03670810|560290351|FG004|Open Label Extension|Withdrawal by Subject|0|||
155233371|NCT03670810|560290352|FG005|Open Label Extension|Withdrawal by Subject|0|||
155233372|NCT03670810|560290353|FG006|Open Label Extension|Withdrawal by Subject|0|||
155233373|NCT03670810|560290354|FG007|Open Label Extension|Withdrawal by Subject|0|||
155233374|NCT03670810|560290355|FG008|Open Label Extension|Withdrawal by Subject|46|||
155233375|NCT03670810|560290347|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233376|NCT03670810|560290348|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233377|NCT03670810|560290349|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233378|NCT03670810|560290350|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233379|NCT03670810|560290351|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233380|NCT03670810|560290352|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233381|NCT03670810|560290353|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233382|NCT03670810|560290354|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
155233383|NCT03670810|560290355|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
155233384|NCT03670810|560290347|FG000|Open Label Extension|Physician Decision|0|||
155233385|NCT03670810|560290348|FG001|Open Label Extension|Physician Decision|0|||
155233386|NCT03670810|560290349|FG002|Open Label Extension|Physician Decision|0|||
155233387|NCT03670810|560290350|FG003|Open Label Extension|Physician Decision|0|||
155233388|NCT03670810|560290351|FG004|Open Label Extension|Physician Decision|0|||
155233389|NCT03670810|560290352|FG005|Open Label Extension|Physician Decision|0|||
155233390|NCT03670810|560290353|FG006|Open Label Extension|Physician Decision|0|||
155233391|NCT03670810|560290354|FG007|Open Label Extension|Physician Decision|0|||
155233392|NCT03670810|560290355|FG008|Open Label Extension|Physician Decision|2|||
155233393|NCT03670810|560290347|FG000|Open Label Extension|Non-compliance with study drug|0|||
155233394|NCT03670810|560290348|FG001|Open Label Extension|Non-compliance with study drug|0|||
155233395|NCT03670810|560290349|FG002|Open Label Extension|Non-compliance with study drug|0|||
155233396|NCT03670810|560290350|FG003|Open Label Extension|Non-compliance with study drug|0|||
155233397|NCT03670810|560290351|FG004|Open Label Extension|Non-compliance with study drug|0|||
155233398|NCT03670810|560290352|FG005|Open Label Extension|Non-compliance with study drug|0|||
155233399|NCT03670810|560290353|FG006|Open Label Extension|Non-compliance with study drug|0|||
155233400|NCT03670810|560290354|FG007|Open Label Extension|Non-compliance with study drug|0|||
155233401|NCT03670810|560290355|FG008|Open Label Extension|Non-compliance with study drug|5|||
155233402|NCT03670810|560290347|FG000|Open Label Extension|Pregnancy|0|||
155233403|NCT03670810|560290348|FG001|Open Label Extension|Pregnancy|0|||
155233404|NCT03670810|560290349|FG002|Open Label Extension|Pregnancy|0|||
155233405|NCT03670810|560290350|FG003|Open Label Extension|Pregnancy|0|||
155233406|NCT03670810|560290351|FG004|Open Label Extension|Pregnancy|0|||
155233407|NCT03670810|560290352|FG005|Open Label Extension|Pregnancy|0|||
155233408|NCT03670810|560290353|FG006|Open Label Extension|Pregnancy|0|||
155233409|NCT03670810|560290354|FG007|Open Label Extension|Pregnancy|0|||
155233410|NCT03670810|560290355|FG008|Open Label Extension|Pregnancy|3|||
155233411|NCT03670810|560290347|FG000|Open Label Extension|Adverse Event|0|||
155233412|NCT03670810|560290348|FG001|Open Label Extension|Adverse Event|0|||
155233413|NCT03670810|560290349|FG002|Open Label Extension|Adverse Event|0|||
155233414|NCT03670810|560290350|FG003|Open Label Extension|Adverse Event|0|||
155233415|NCT03670810|560290351|FG004|Open Label Extension|Adverse Event|0|||
155233416|NCT03670810|560290352|FG005|Open Label Extension|Adverse Event|0|||
155233417|NCT03670810|560290353|FG006|Open Label Extension|Adverse Event|0|||
155233418|NCT03670810|560290354|FG007|Open Label Extension|Adverse Event|0|||
155233419|NCT03670810|560290355|FG008|Open Label Extension|Adverse Event|24|||
155233420|NCT03670810|560290347|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
155233421|NCT03670810|560290348|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
155233422|NCT03670810|560290349|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
155233423|NCT03670810|560290350|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
155233424|NCT03670810|560290351|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
155233425|NCT03670810|560290352|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
155233426|NCT03670810|560290353|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
155233427|NCT03670810|560290354|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
155233428|NCT03670810|560290355|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
155233429|NCT03670810|560290347|FG000|Open Label Extension|Lost to Follow-up|0|||
155233430|NCT03670810|560290348|FG001|Open Label Extension|Lost to Follow-up|0|||
155233431|NCT03670810|560290349|FG002|Open Label Extension|Lost to Follow-up|0|||
155233432|NCT03670810|560290350|FG003|Open Label Extension|Lost to Follow-up|0|||
155233433|NCT03670810|560290351|FG004|Open Label Extension|Lost to Follow-up|0|||
155233434|NCT03670810|560290352|FG005|Open Label Extension|Lost to Follow-up|0|||
155233435|NCT03670810|560290353|FG006|Open Label Extension|Lost to Follow-up|0|||
155233436|NCT03670810|560290354|FG007|Open Label Extension|Lost to Follow-up|0|||
155233437|NCT03670810|560290355|FG008|Open Label Extension|Lost to Follow-up|23|||
155233438|NCT00678691|560290356|FG000|Overall Study|Adverse Event|6|||
155233439|NCT00678691|560290357|FG001|Overall Study|Adverse Event|4|||
155233440|NCT02606136|560290372|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
155233441|NCT02606136|560290372|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
155233442|NCT02606136|560290372|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
155233443|NCT02606136|560290372|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
155233444|NCT06640829|560290373|FG000|Overall Study|Withdrawal by Subject|1|||
155233445|NCT06640829|560290373|FG000|Overall Study|Lost to Follow-up|1|||
155233446|NCT01350128|560290374|FG000|Overall Study|Withdrawal by Subject|3|||
155233447|NCT01350128|560290374|FG000|Overall Study|Protocol discontinuation criteria|8|||
155233448|NCT01350128|560290374|FG000|Overall Study|Physician Decision|1|||
155233449|NCT01350128|560290374|FG000|Overall Study|Lost to Follow-up|2|||
155233450|NCT01252290|560290375|FG000|Overall Study|Withdrawal by Subject|1|||
155233451|NCT02075437|560290379|FG000|Overall Study|Withdrawal by Subject|5|||
155233452|NCT02075437|560290379|FG000|Overall Study|Lost to Follow-up|1|||
155233453|NCT01632800|560290380|FG000|Overall Study|Subject did not fit in apparatus|1|||
155233454|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Adverse Event|41|||
155233455|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Adverse Event|24|||
155233456|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
155233457|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
155233458|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
155233459|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
155233460|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Physician Decision|0|||
155233461|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Physician Decision|6|||
155233462|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
155233463|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
155233464|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
155233465|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
155233466|NCT00673452|560290381|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
155233467|NCT00673452|560290382|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
155233468|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
155233469|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
155233470|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
155233471|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
155233472|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
155233473|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
155233474|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
155233475|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
155233476|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
155233477|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
155233478|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
155233479|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
155233480|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
155233481|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
155233482|NCT00673452|560290381|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
155233483|NCT00673452|560290382|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
155233484|NCT02410811|560290386|FG000|Overall Study|Withdrawal by Subject|0|||
155233485|NCT02410811|560290387|FG001|Overall Study|Withdrawal by Subject|0|||
155233486|NCT02410811|560290388|FG002|Overall Study|Withdrawal by Subject|1|||
155233487|NCT02410811|560290389|FG003|Overall Study|Withdrawal by Subject|0|||
155233488|NCT00353366|560290390|FG000|Overall Study|Adverse Event|8|||
155233489|NCT00353366|560290390|FG000|Overall Study|Protocol Violation|12|||
155233490|NCT00353366|560290390|FG000|Overall Study|Withdrawal by Subject|12|||
155233491|NCT00353366|560290390|FG000|Overall Study|Lost to Follow-up|92|||
155233492|NCT00353366|560290390|FG000|Overall Study|Other|19|||
155233493|NCT00259857|560290391|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
155233494|NCT00259857|560290392|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
155233495|NCT00259857|560290391|FG000|24 Months Treatment|Lost to Follow-up|0|||
155233496|NCT00259857|560290392|FG001|24 Months Treatment|Lost to Follow-up|3|||
155233497|NCT01552226|560290395|FG000|Overall Study|Withdrawal by Subject|4|||
155233498|NCT01552226|560290396|FG001|Overall Study|Withdrawal by Subject|4|||
155233499|NCT01469065|560290400|FG000|Overall Study|Lack of Efficacy|0|||
155233500|NCT01469065|560290401|FG001|Overall Study|Lack of Efficacy|0|||
155233501|NCT01469065|560290402|FG002|Overall Study|Lack of Efficacy|0|||
155233502|NCT01469065|560290403|FG003|Overall Study|Lack of Efficacy|0|||
155233503|NCT01469065|560290404|FG004|Overall Study|Lack of Efficacy|1|||
155233504|NCT01469065|560290400|FG000|Overall Study|Other|0|||
155233505|NCT01469065|560290401|FG001|Overall Study|Other|1|||
155233506|NCT01469065|560290402|FG002|Overall Study|Other|0|||
155233507|NCT01469065|560290403|FG003|Overall Study|Other|0|||
155233508|NCT01469065|560290404|FG004|Overall Study|Other|0|||
155233509|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
155233510|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
155233511|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
155233512|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
155233513|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
155233514|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
155233515|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
155233516|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
155233517|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
155233518|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
155233519|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
155233520|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
155233521|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
155233522|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
155233523|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
155233524|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
155233525|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
155233526|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
155233527|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
155233528|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
155233529|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
155233530|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
155233531|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
155233532|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
155233533|NCT04542070|560290405|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
155233534|NCT04542070|560290406|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
155233535|NCT04542070|560290407|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
155233536|NCT04542070|560290408|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
155233537|NCT04542070|560290405|FG000|Maintenance + Extension Period|Adverse Event|10|||
155233538|NCT04542070|560290406|FG001|Maintenance + Extension Period|Adverse Event|2|||
155233539|NCT04542070|560290407|FG002|Maintenance + Extension Period|Adverse Event|0|||
155233540|NCT04542070|560290408|FG003|Maintenance + Extension Period|Adverse Event|0|||
155233541|NCT04542070|560290405|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
155233542|NCT04542070|560290406|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
155233543|NCT04542070|560290407|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
155233544|NCT04542070|560290408|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
155233545|NCT04542070|560290405|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
155233546|NCT04542070|560290406|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
155233547|NCT04542070|560290407|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
155233548|NCT04542070|560290408|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
155233549|NCT04542070|560290405|FG000|Maintenance + Extension Period|Physician Decision|1|||
155233550|NCT04542070|560290406|FG001|Maintenance + Extension Period|Physician Decision|1|||
155233551|NCT04542070|560290407|FG002|Maintenance + Extension Period|Physician Decision|0|||
155233552|NCT04542070|560290408|FG003|Maintenance + Extension Period|Physician Decision|0|||
155233553|NCT04542070|560290405|FG000|Maintenance + Extension Period|Protocol Violation|2|||
155233554|NCT04542070|560290406|FG001|Maintenance + Extension Period|Protocol Violation|5|||
155233555|NCT04542070|560290407|FG002|Maintenance + Extension Period|Protocol Violation|0|||
155233556|NCT04542070|560290408|FG003|Maintenance + Extension Period|Protocol Violation|0|||
155233557|NCT04542070|560290405|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
155233558|NCT04542070|560290406|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
155233559|NCT04542070|560290407|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
155233560|NCT04542070|560290408|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
155233561|NCT04542070|560290405|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
155233562|NCT04542070|560290406|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
155233563|NCT04542070|560290407|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
155233564|NCT04542070|560290408|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
155233565|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
155233566|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
155233567|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
155233568|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
155233569|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
155233570|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
155233571|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
155233572|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
155233573|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
155233574|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
155233575|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
155233576|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
155233577|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
155233578|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
155233579|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
155233580|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
155233581|NCT04542070|560290405|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
155233582|NCT04542070|560290406|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
155233583|NCT04542070|560290407|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
155233584|NCT04542070|560290408|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
155233585|NCT02985736|560290409|FG000|Overall Study|Lost to Follow-up|3|||
155233586|NCT03049813|560290410|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
155233587|NCT03049813|560290411|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
155233588|NCT03049813|560290412|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
155233589|NCT03049813|560290413|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
155233590|NCT03049813|560290410|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
155233591|NCT03049813|560290411|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
155233592|NCT03049813|560290412|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
155233593|NCT03049813|560290413|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
155233594|NCT03049813|560290410|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
155233595|NCT03049813|560290411|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
155233596|NCT03049813|560290412|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
155233597|NCT03049813|560290413|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
155233598|NCT03049813|560290410|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
155233599|NCT03049813|560290411|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
155233600|NCT03049813|560290412|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
155233601|NCT03049813|560290413|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
155233602|NCT03025828|560290419|FG000|Overall Study|Lost to Follow-up|1|||
155233603|NCT00094653|560290420|FG000|Overall Study|Death|306|||
155233604|NCT00094653|560290421|FG001|Overall Study|Death|100|||
155233605|NCT00094653|560290422|FG002|Overall Study|Death|119|||
155233606|NCT00094653|560290420|FG000|Overall Study|Subject Withdrew Consent|10|||
155233607|NCT00094653|560290421|FG001|Overall Study|Subject Withdrew Consent|2|||
155233608|NCT00094653|560290422|FG002|Overall Study|Subject Withdrew Consent|3|||
155233609|NCT00094653|560290420|FG000|Overall Study|Other|2|||
155233610|NCT00094653|560290421|FG001|Overall Study|Other|2|||
155233611|NCT00094653|560290422|FG002|Overall Study|Other|2|||
155233612|NCT00094653|560290420|FG000|Overall Study|Lost to Follow-up|3|||
155233613|NCT00094653|560290421|FG001|Overall Study|Lost to Follow-up|2|||
155233614|NCT00094653|560290422|FG002|Overall Study|Lost to Follow-up|1|||
155233615|NCT00094653|560290420|FG000|Overall Study|Protocol Violation|0|||
155233616|NCT00094653|560290421|FG001|Overall Study|Protocol Violation|0|||
155233617|NCT00094653|560290422|FG002|Overall Study|Protocol Violation|1|||
155233618|NCT00854581|560290425|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
155233619|NCT00854581|560290425|FG000|Induction (Up to Day 21)|Death|1|||
155233620|NCT00854581|560290425|FG000|Induction (Up to Day 21)|Physician Decision|1|||
155233621|NCT00854581|560290425|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
155233622|NCT03181542|560290427|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
155233623|NCT03181542|560290428|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
155233624|NCT00806546|560290440|FG000|Overall Study|Enrolled, not treated|35|||
155233625|NCT00806546|560290440|FG000|Overall Study|Lost to Follow-up|32|||
155233626|NCT00806546|560290440|FG000|Overall Study|Adverse Event|74|||
155233627|NCT00806546|560290440|FG000|Overall Study|Withdrawal by Subject|75|||
155233628|NCT00806546|560290440|FG000|Overall Study|Protocol Violation|49|||
155233629|NCT00806546|560290440|FG000|Overall Study|Various|42|||
155233630|NCT01247090|560290441|FG000|Overall Study|Physician Decision|1|||
155233631|NCT01247090|560290442|FG001|Overall Study|Physician Decision|0|||
155233632|NCT01247090|560290443|FG002|Overall Study|Physician Decision|0|||
155233633|NCT01247090|560290441|FG000|Overall Study|Withdrawal by Subject|0|||
155233634|NCT01247090|560290442|FG001|Overall Study|Withdrawal by Subject|1|||
155233635|NCT01247090|560290443|FG002|Overall Study|Withdrawal by Subject|0|||
155233636|NCT03385239|560290453|FG000|Overall Study|Voluntary Withdrawal|2|||
155233637|NCT03385239|560290454|FG001|Overall Study|Voluntary Withdrawal|3|||
155233638|NCT03385239|560290455|FG002|Overall Study|Voluntary Withdrawal|2|||
155233639|NCT03385239|560290456|FG003|Overall Study|Voluntary Withdrawal|3|||
155233640|NCT03385239|560290457|FG004|Overall Study|Voluntary Withdrawal|0|||
155233641|NCT03385239|560290453|FG000|Overall Study|Adverse Event|0|||
155233642|NCT03385239|560290454|FG001|Overall Study|Adverse Event|0|||
155233643|NCT03385239|560290455|FG002|Overall Study|Adverse Event|1|||
155233644|NCT03385239|560290456|FG003|Overall Study|Adverse Event|0|||
155233645|NCT03385239|560290457|FG004|Overall Study|Adverse Event|0|||
155233646|NCT03385239|560290453|FG000|Overall Study|Other|0|||
155233647|NCT03385239|560290454|FG001|Overall Study|Other|0|||
155233648|NCT03385239|560290455|FG002|Overall Study|Other|0|||
155233649|NCT03385239|560290456|FG003|Overall Study|Other|1|||
155233650|NCT03385239|560290457|FG004|Overall Study|Other|0|||
155233651|NCT02167256|560290460|FG000|Overall Study|Adverse Event|13|||
155233652|NCT02167256|560290461|FG001|Overall Study|Adverse Event|6|||
155233653|NCT02167256|560290460|FG000|Overall Study|Withdrawal by Subject|4|||
155233654|NCT02167256|560290461|FG001|Overall Study|Withdrawal by Subject|4|||
155233655|NCT02167256|560290460|FG000|Overall Study|non-compliance|3|||
155233656|NCT02167256|560290461|FG001|Overall Study|non-compliance|0|||
155233657|NCT02167256|560290460|FG000|Overall Study|Study partner unable to participate|1|||
155233658|NCT02167256|560290461|FG001|Overall Study|Study partner unable to participate|0|||
155233659|NCT03139916|560290462|FG000|Overall Study|Withdrawal by Subject|2|||
155233660|NCT03139916|560290462|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
155233661|NCT01957475|560290463|FG000|Test Period 1|Withdrawal by Subject|1|||
155233662|NCT01957475|560290464|FG001|Test Period 1|Withdrawal by Subject|0|||
155233663|NCT01957475|560290463|FG000|Test Period 1|Other|1|||
155233664|NCT01957475|560290464|FG001|Test Period 1|Other|0|||
155233665|NCT01957475|560290463|FG000|Test Period 1|Lack of Efficacy|0|||
155233666|NCT01957475|560290464|FG001|Test Period 1|Lack of Efficacy|1|||
155233667|NCT01957475|560290463|FG000|Test Period 2|Adverse Event|1|||
155233668|NCT01957475|560290464|FG001|Test Period 2|Adverse Event|0|||
155233669|NCT03591575|560290465|FG000|Overall Study|Adverse Event|2|||
155233670|NCT03591575|560290466|FG001|Overall Study|Adverse Event|0|||
155233671|NCT03591575|560290465|FG000|Overall Study|Withdrawal by Subject|4|||
155233672|NCT03591575|560290466|FG001|Overall Study|Withdrawal by Subject|1|||
155233673|NCT00813358|560290469|FG000|Overall Study|Death|32|||
155233674|NCT00813358|560290469|FG000|Overall Study|Lost to Follow-up|12|||
155233675|NCT00813358|560290469|FG000|Overall Study|other endpoints|5|||
155233676|NCT00813358|560290469|FG000|Overall Study|Withdrawal by Subject|20|||
155233677|NCT00700011|560290470|FG000|Overall Study|Death|0|||
155233678|NCT00700011|560290471|FG001|Overall Study|Death|1|||
155233679|NCT00004031|560290472|FG000|Overall Study|Adverse Event|5|||
155233680|NCT00004031|560290473|FG001|Overall Study|Adverse Event|0|||
155233681|NCT00004031|560290472|FG000|Overall Study|Refusal unrelated to adverse events|2|||
155233682|NCT00004031|560290473|FG001|Overall Study|Refusal unrelated to adverse events|11|||
155233683|NCT00004031|560290472|FG000|Overall Study|Progression/relapse|9|||
155233684|NCT00004031|560290473|FG001|Overall Study|Progression/relapse|4|||
155233685|NCT00004031|560290472|FG000|Overall Study|Death|3|||
155233686|NCT00004031|560290473|FG001|Overall Study|Death|1|||
155233687|NCT00004031|560290472|FG000|Overall Study|Other- not protocol specified|3|||
155233688|NCT00004031|560290473|FG001|Overall Study|Other- not protocol specified|3|||
155233689|NCT00004031|560290472|FG000|Overall Study|Reason under review|3|||
155233690|NCT00004031|560290473|FG001|Overall Study|Reason under review|2|||
155233691|NCT02553421|560290474|FG000|Overall Study|Lost to Follow-up|21|||
155233692|NCT02553421|560290475|FG001|Overall Study|Lost to Follow-up|1|||
155233693|NCT02553421|560290474|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
155233694|NCT02553421|560290475|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
155233695|NCT02553421|560290474|FG000|Overall Study|Improper Device Placement|3|||
155233696|NCT02553421|560290475|FG001|Overall Study|Improper Device Placement|0|||
155233697|NCT04084769|560290479|FG000|Overall Study|Protocol Violation|1|||
155233698|NCT04084769|560290480|FG001|Overall Study|Protocol Violation|3|||
155233699|NCT04084769|560290481|FG002|Overall Study|Protocol Violation|0|||
155233700|NCT04084769|560290482|FG003|Overall Study|Protocol Violation|1|||
155233701|NCT04084769|560290479|FG000|Overall Study|Withdrawal by Subject|0|||
155233702|NCT04084769|560290480|FG001|Overall Study|Withdrawal by Subject|1|||
155233703|NCT04084769|560290481|FG002|Overall Study|Withdrawal by Subject|0|||
155233704|NCT04084769|560290482|FG003|Overall Study|Withdrawal by Subject|0|||
155233705|NCT04084769|560290479|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155233706|NCT04084769|560290480|FG001|Overall Study|Withdrawal by parent/guardian|0|||
155233707|NCT04084769|560290481|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155233708|NCT04084769|560290482|FG003|Overall Study|Withdrawal by parent/guardian|1|||
155233709|NCT04084769|560290479|FG000|Overall Study|Lost to Follow-up|2|||
155233710|NCT04084769|560290480|FG001|Overall Study|Lost to Follow-up|0|||
155233711|NCT04084769|560290481|FG002|Overall Study|Lost to Follow-up|0|||
155233712|NCT04084769|560290482|FG003|Overall Study|Lost to Follow-up|0|||
155233713|NCT04579679|560290483|FG000|Overall Study|New Antitumor Therapy|6|||
155233714|NCT04579679|560290484|FG001|Overall Study|New Antitumor Therapy|4|||
155233715|NCT04579679|560290485|FG002|Overall Study|New Antitumor Therapy|7|||
155233716|NCT04579679|560290486|FG003|Overall Study|New Antitumor Therapy|0|||
155233717|NCT04579679|560290483|FG000|Overall Study|Withdrawal of Consent|1|||
155233718|NCT04579679|560290484|FG001|Overall Study|Withdrawal of Consent|1|||
155233719|NCT04579679|560290485|FG002|Overall Study|Withdrawal of Consent|2|||
155233720|NCT04579679|560290486|FG003|Overall Study|Withdrawal of Consent|4|||
155233721|NCT04579679|560290483|FG000|Overall Study|Death|2|||
155233722|NCT04579679|560290484|FG001|Overall Study|Death|2|||
155233723|NCT04579679|560290485|FG002|Overall Study|Death|2|||
155233724|NCT04579679|560290486|FG003|Overall Study|Death|0|||
155233725|NCT04579679|560290483|FG000|Overall Study|Adverse Event|0|||
155233726|NCT04579679|560290484|FG001|Overall Study|Adverse Event|4|||
155233727|NCT04579679|560290485|FG002|Overall Study|Adverse Event|0|||
155233728|NCT04579679|560290486|FG003|Overall Study|Adverse Event|0|||
155233729|NCT04579679|560290483|FG000|Overall Study|Disease Progression|9|||
155233730|NCT04579679|560290484|FG001|Overall Study|Disease Progression|13|||
155233731|NCT04579679|560290485|FG002|Overall Study|Disease Progression|7|||
155233732|NCT04579679|560290486|FG003|Overall Study|Disease Progression|0|||
155233733|NCT04579679|560290483|FG000|Overall Study|Physician Decision|0|||
155233734|NCT04579679|560290484|FG001|Overall Study|Physician Decision|0|||
155233735|NCT04579679|560290485|FG002|Overall Study|Physician Decision|1|||
155233736|NCT04579679|560290486|FG003|Overall Study|Physician Decision|0|||
155233737|NCT04579679|560290483|FG000|Overall Study|Study Terminated by Sponsor|2|||
155233738|NCT04579679|560290484|FG001|Overall Study|Study Terminated by Sponsor|7|||
155233739|NCT04579679|560290485|FG002|Overall Study|Study Terminated by Sponsor|1|||
155233740|NCT04579679|560290486|FG003|Overall Study|Study Terminated by Sponsor|0|||
155233741|NCT01709318|560292409|FG000|Overall Study|Adverse Event|3|||
155233742|NCT01709318|560292410|FG001|Overall Study|Adverse Event|4|||
155233743|NCT01709318|560292411|FG002|Overall Study|Adverse Event|2|||
155233744|NCT01709318|560292412|FG003|Overall Study|Adverse Event|2|||
155233745|NCT01709318|560292413|FG004|Overall Study|Adverse Event|0|||
155233746|NCT01709318|560292414|FG005|Overall Study|Adverse Event|1|||
155233747|NCT01709318|560292415|FG006|Overall Study|Adverse Event|2|||
155233748|NCT01709318|560292409|FG000|Overall Study|Lost to Follow-up|2|||
155233749|NCT01709318|560292410|FG001|Overall Study|Lost to Follow-up|0|||
155233750|NCT01709318|560292411|FG002|Overall Study|Lost to Follow-up|0|||
155233751|NCT01709318|560292412|FG003|Overall Study|Lost to Follow-up|0|||
155233752|NCT01709318|560292413|FG004|Overall Study|Lost to Follow-up|1|||
155233753|NCT01709318|560292414|FG005|Overall Study|Lost to Follow-up|1|||
155233754|NCT01709318|560292415|FG006|Overall Study|Lost to Follow-up|1|||
155233755|NCT01709318|560292409|FG000|Overall Study|Non-compliance with Study Drug|0|||
155233756|NCT01709318|560292410|FG001|Overall Study|Non-compliance with Study Drug|2|||
155233757|NCT01709318|560292411|FG002|Overall Study|Non-compliance with Study Drug|1|||
155233758|NCT01709318|560292412|FG003|Overall Study|Non-compliance with Study Drug|1|||
155233759|NCT01709318|560292413|FG004|Overall Study|Non-compliance with Study Drug|0|||
155233760|NCT01709318|560292414|FG005|Overall Study|Non-compliance with Study Drug|0|||
155233761|NCT01709318|560292415|FG006|Overall Study|Non-compliance with Study Drug|2|||
155233762|NCT01709318|560292409|FG000|Overall Study|Physician Decision|0|||
155233763|NCT01709318|560292410|FG001|Overall Study|Physician Decision|0|||
155233764|NCT01709318|560292411|FG002|Overall Study|Physician Decision|0|||
155233765|NCT01709318|560292412|FG003|Overall Study|Physician Decision|0|||
155233766|NCT01709318|560292413|FG004|Overall Study|Physician Decision|0|||
155233767|NCT01709318|560292414|FG005|Overall Study|Physician Decision|0|||
155233768|NCT01709318|560292415|FG006|Overall Study|Physician Decision|1|||
155233769|NCT01709318|560292409|FG000|Overall Study|Pregnancy|0|||
155233770|NCT01709318|560292410|FG001|Overall Study|Pregnancy|0|||
155233771|NCT01709318|560292411|FG002|Overall Study|Pregnancy|0|||
155233772|NCT01709318|560292412|FG003|Overall Study|Pregnancy|0|||
155233773|NCT01709318|560292413|FG004|Overall Study|Pregnancy|1|||
155233774|NCT01709318|560292414|FG005|Overall Study|Pregnancy|0|||
155233775|NCT01709318|560292415|FG006|Overall Study|Pregnancy|0|||
155233776|NCT01709318|560292409|FG000|Overall Study|Protocol Violation|0|||
155233777|NCT01709318|560292410|FG001|Overall Study|Protocol Violation|0|||
155233778|NCT01709318|560292411|FG002|Overall Study|Protocol Violation|0|||
155233779|NCT01709318|560292412|FG003|Overall Study|Protocol Violation|0|||
155233780|NCT01709318|560292413|FG004|Overall Study|Protocol Violation|2|||
155233781|NCT01709318|560292414|FG005|Overall Study|Protocol Violation|0|||
155233782|NCT01709318|560292415|FG006|Overall Study|Protocol Violation|1|||
155233783|NCT01709318|560292409|FG000|Overall Study|Technical Problems|1|||
155233784|NCT01709318|560292410|FG001|Overall Study|Technical Problems|0|||
155233785|NCT01709318|560292411|FG002|Overall Study|Technical Problems|0|||
155233786|NCT01709318|560292412|FG003|Overall Study|Technical Problems|0|||
155233787|NCT01709318|560292413|FG004|Overall Study|Technical Problems|0|||
155233788|NCT01709318|560292414|FG005|Overall Study|Technical Problems|0|||
155233789|NCT01709318|560292415|FG006|Overall Study|Technical Problems|0|||
155233790|NCT01709318|560292409|FG000|Overall Study|Withdrawal by Subject|3|||
155233791|NCT01709318|560292410|FG001|Overall Study|Withdrawal by Subject|0|||
155233792|NCT01709318|560292411|FG002|Overall Study|Withdrawal by Subject|3|||
155233793|NCT01709318|560292412|FG003|Overall Study|Withdrawal by Subject|3|||
155233794|NCT01709318|560292413|FG004|Overall Study|Withdrawal by Subject|0|||
155233795|NCT01709318|560292414|FG005|Overall Study|Withdrawal by Subject|2|||
155233796|NCT01709318|560292415|FG006|Overall Study|Withdrawal by Subject|4|||
155233797|NCT01709318|560292409|FG000|Overall Study|Other Protocol Specified Criteria|0|||
155233798|NCT01709318|560292410|FG001|Overall Study|Other Protocol Specified Criteria|1|||
155233799|NCT01709318|560292411|FG002|Overall Study|Other Protocol Specified Criteria|0|||
155233800|NCT01709318|560292412|FG003|Overall Study|Other Protocol Specified Criteria|0|||
155233801|NCT01709318|560292413|FG004|Overall Study|Other Protocol Specified Criteria|0|||
155233802|NCT01709318|560292414|FG005|Overall Study|Other Protocol Specified Criteria|0|||
155233803|NCT01709318|560292415|FG006|Overall Study|Other Protocol Specified Criteria|0|||
155233804|NCT02383758|560292416|FG000|Overall Study|Withdrawal by Subject|0|||
155233805|NCT02383758|560292417|FG001|Overall Study|Withdrawal by Subject|2|||
155233806|NCT03892889|560292418|FG000|Overall Study|Adverse Event|17|||
155233807|NCT03892889|560292418|FG000|Overall Study|Lack of Efficacy|1|||
155233808|NCT03892889|560292418|FG000|Overall Study|Lost to Follow-up|46|||
155233809|NCT03892889|560292418|FG000|Overall Study|Non-compliance with study drug|22|||
155233810|NCT03892889|560292418|FG000|Overall Study|Pregnancy|1|||
155233811|NCT03892889|560292418|FG000|Overall Study|Protocol Deviation|3|||
155233812|NCT03892889|560292418|FG000|Overall Study|Withdrawal by Subject|50|||
155233813|NCT03892889|560292418|FG000|Overall Study|Withdrawal by Caregiver|1|||
155233814|NCT03892889|560292418|FG000|Overall Study|Study Terminated by Sponsor|50|||
155233815|NCT03892889|560292418|FG000|Overall Study|Physician Decision|8|||
155233816|NCT03892889|560292418|FG000|Overall Study|Reason not Specified|5|||
155233817|NCT02066298|560292419|FG000|Overall Study|Lost to Follow-up|3|||
155233818|NCT02066298|560292420|FG001|Overall Study|Lost to Follow-up|2|||
155233819|NCT02066298|560292421|FG002|Overall Study|Lost to Follow-up|3|||
155233820|NCT02066298|560292422|FG003|Overall Study|Lost to Follow-up|2|||
155233821|NCT02066298|560292423|FG004|Overall Study|Lost to Follow-up|3|||
155233822|NCT02066298|560292424|FG005|Overall Study|Lost to Follow-up|4|||
155233823|NCT02066298|560292419|FG000|Overall Study|Withdrawal by Subject|6|||
155233824|NCT02066298|560292420|FG001|Overall Study|Withdrawal by Subject|6|||
155233825|NCT02066298|560292421|FG002|Overall Study|Withdrawal by Subject|6|||
155233826|NCT02066298|560292422|FG003|Overall Study|Withdrawal by Subject|4|||
155233827|NCT02066298|560292423|FG004|Overall Study|Withdrawal by Subject|5|||
155233828|NCT02066298|560292424|FG005|Overall Study|Withdrawal by Subject|8|||
155233829|NCT02066298|560292419|FG000|Overall Study|Physician Decision|0|||
155233830|NCT02066298|560292420|FG001|Overall Study|Physician Decision|0|||
155233831|NCT02066298|560292421|FG002|Overall Study|Physician Decision|1|||
155233832|NCT02066298|560292422|FG003|Overall Study|Physician Decision|0|||
155233833|NCT02066298|560292423|FG004|Overall Study|Physician Decision|1|||
155233834|NCT02066298|560292424|FG005|Overall Study|Physician Decision|0|||
155233835|NCT04260191|560292425|FG000|Overall Study|Decision by Sponsor|0|||
155233836|NCT04260191|560292426|FG001|Overall Study|Decision by Sponsor|1|||
155233837|NCT04260191|560292427|FG002|Overall Study|Decision by Sponsor|0|||
155233838|NCT04260191|560292425|FG000|Overall Study|Withdrawal by Subject|1|||
155233839|NCT04260191|560292426|FG001|Overall Study|Withdrawal by Subject|0|||
155233840|NCT04260191|560292427|FG002|Overall Study|Withdrawal by Subject|3|||
155233841|NCT04260191|560292425|FG000|Overall Study|Death|4|||
155233842|NCT04260191|560292426|FG001|Overall Study|Death|3|||
155233843|NCT04260191|560292427|FG002|Overall Study|Death|2|||
155233844|NCT01519518|560292429|FG000|Overall Study|Consent not available|7|||
155233845|NCT01519518|560292430|FG001|Overall Study|Consent not available|10|||
155233846|NCT00298896|560292435|FG000|Overall Study|Death|3|||
155233847|NCT00298896|560292435|FG000|Overall Study|Physician Decision|2|||
155233848|NCT00298896|560292435|FG000|Overall Study|Intercurrent Illness|1|||
155233849|NCT00298896|560292435|FG000|Overall Study|Disease Progression|41|||
155233850|NCT00298896|560292435|FG000|Overall Study|Withdrawal by Subject|2|||
155233851|NCT00298896|560292435|FG000|Overall Study|Assigned to treatment in error|1|||
155233852|NCT02488629|560292440|FG000|Overall Study|Lack of Efficacy|3|||
155233853|NCT02488629|560292441|FG001|Overall Study|Lack of Efficacy|1|||
155233854|NCT02488629|560292442|FG002|Overall Study|Lack of Efficacy|0|||
155233855|NCT02488629|560292443|FG003|Overall Study|Lack of Efficacy|0|||
155233856|NCT02488629|560292440|FG000|Overall Study|Withdrawal by Subject|0|||
155233857|NCT02488629|560292441|FG001|Overall Study|Withdrawal by Subject|1|||
155233858|NCT02488629|560292442|FG002|Overall Study|Withdrawal by Subject|0|||
155233859|NCT02488629|560292443|FG003|Overall Study|Withdrawal by Subject|0|||
155233860|NCT00654628|560292444|FG000|6-week Active Treatment Period|Adverse Event|9|||
155233861|NCT00654628|560292444|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
155233862|NCT00654628|560292444|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
155233863|NCT00654628|560292444|FG000|6-week Active Treatment Period|Out of window period|1|||
155233864|NCT00654628|560292444|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
155233865|NCT00654628|560292444|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
155233866|NCT00912405|560292445|FG000|Overall Study|Lost to Follow-up|5|||
155233867|NCT01797536|560292446|FG000|Overall Study|Adverse Event|0|||
155233868|NCT01797536|560292447|FG001|Overall Study|Adverse Event|1|||
155233869|NCT01797536|560292448|FG002|Overall Study|Adverse Event|0|||
155233870|NCT01797536|560292449|FG003|Overall Study|Adverse Event|0|||
155233871|NCT00844545|560292453|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
155233872|NCT00844545|560292453|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
155233873|NCT00844545|560292453|FG000|Extension Treatment Period|Adverse Event|2|||
155233874|NCT00844545|560292453|FG000|Post Treatment Period|Withdrawal by Subject|1|||
155233875|NCT01532687|560292457|FG000|Overall Study|Death|2|||
155233876|NCT01532687|560292458|FG001|Overall Study|Death|0|||
155233877|NCT01532687|560292457|FG000|Overall Study|Adverse Event|6|||
155233878|NCT01532687|560292458|FG001|Overall Study|Adverse Event|1|||
155233879|NCT01532687|560292457|FG000|Overall Study|Withdrawal by Subject|1|||
155233880|NCT01532687|560292458|FG001|Overall Study|Withdrawal by Subject|0|||
155233881|NCT01532687|560292457|FG000|Overall Study|Physician Decision|2|||
155233882|NCT01532687|560292458|FG001|Overall Study|Physician Decision|1|||
155233883|NCT01532687|560292457|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
155233884|NCT01532687|560292458|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
155233885|NCT00403455|560292459|FG000|Overall Study|Withdrawal by Subject|1|||
155233886|NCT03160703|560292460|FG000|Overall Study|Withdrawal by Subject|0|||
155233887|NCT03160703|560292461|FG001|Overall Study|Withdrawal by Subject|0|||
155233888|NCT03160703|560292462|FG002|Overall Study|Withdrawal by Subject|0|||
155233889|NCT03160703|560292463|FG003|Overall Study|Withdrawal by Subject|1|||
155233890|NCT01358981|560292470|FG000|Period 1|Withdrawal by Subject|0|||
155233891|NCT01358981|560292471|FG001|Period 1|Withdrawal by Subject|0|||
155233892|NCT01358981|560292472|FG002|Period 1|Withdrawal by Subject|0|||
155233893|NCT01358981|560292473|FG003|Period 1|Withdrawal by Subject|1|||
155233894|NCT01358981|560292474|FG004|Period 1|Withdrawal by Subject|0|||
155233895|NCT01358981|560292475|FG005|Period 1|Withdrawal by Subject|0|||
155233896|NCT01358981|560292476|FG006|Period 1|Withdrawal by Subject|0|||
155233897|NCT02738775|560292477|FG000|Overall Study|Withdrawal by Subject|0|||
155233898|NCT02738775|560292478|FG001|Overall Study|Withdrawal by Subject|1|||
155233899|NCT02738775|560292479|FG002|Overall Study|Withdrawal by Subject|0|||
155233900|NCT02738775|560292480|FG003|Overall Study|Withdrawal by Subject|0|||
155233901|NCT02738775|560292481|FG004|Overall Study|Withdrawal by Subject|0|||
155233902|NCT02738775|560292482|FG005|Overall Study|Withdrawal by Subject|0|||
155233903|NCT02738775|560292477|FG000|Overall Study|Adverse Event|0|||
155233904|NCT02738775|560292478|FG001|Overall Study|Adverse Event|0|||
155233905|NCT02738775|560292479|FG002|Overall Study|Adverse Event|0|||
155233906|NCT02738775|560292480|FG003|Overall Study|Adverse Event|1|||
155233907|NCT02738775|560292481|FG004|Overall Study|Adverse Event|0|||
155233908|NCT02738775|560292482|FG005|Overall Study|Adverse Event|0|||
155233909|NCT02738775|560292477|FG000|Overall Study|Pregnancy|0|||
155233910|NCT02738775|560292478|FG001|Overall Study|Pregnancy|1|||
155233911|NCT02738775|560292479|FG002|Overall Study|Pregnancy|0|||
155233912|NCT02738775|560292480|FG003|Overall Study|Pregnancy|0|||
155233913|NCT02738775|560292481|FG004|Overall Study|Pregnancy|0|||
155233914|NCT02738775|560292482|FG005|Overall Study|Pregnancy|0|||
155233915|NCT02738775|560292477|FG000|Overall Study|Missing|0|||
155233916|NCT02738775|560292478|FG001|Overall Study|Missing|0|||
155233917|NCT02738775|560292479|FG002|Overall Study|Missing|0|||
155233918|NCT02738775|560292480|FG003|Overall Study|Missing|0|||
155233919|NCT02738775|560292481|FG004|Overall Study|Missing|0|||
155233920|NCT02738775|560292482|FG005|Overall Study|Missing|1|||
155233921|NCT01060384|560292483|FG000|Overall Study|Withdrawal by Subject|0|||
155233922|NCT01060384|560292484|FG001|Overall Study|Withdrawal by Subject|1|||
155233923|NCT01060384|560292485|FG002|Overall Study|Withdrawal by Subject|0|||
155233924|NCT01060384|560292486|FG003|Overall Study|Withdrawal by Subject|0|||
155233925|NCT01060384|560292487|FG004|Overall Study|Withdrawal by Subject|0|||
155233926|NCT01060384|560292483|FG000|Overall Study|Death|0|||
155233927|NCT01060384|560292484|FG001|Overall Study|Death|0|||
155233928|NCT01060384|560292485|FG002|Overall Study|Death|0|||
155233929|NCT01060384|560292486|FG003|Overall Study|Death|0|||
155233930|NCT01060384|560292487|FG004|Overall Study|Death|1|||
155233931|NCT01060384|560292483|FG000|Overall Study|Intercurrent illness|0|||
155233932|NCT01060384|560292484|FG001|Overall Study|Intercurrent illness|0|||
155233933|NCT01060384|560292485|FG002|Overall Study|Intercurrent illness|0|||
155233934|NCT01060384|560292486|FG003|Overall Study|Intercurrent illness|0|||
155233935|NCT01060384|560292487|FG004|Overall Study|Intercurrent illness|1|||
155233936|NCT01401530|560292488|FG000|Overall Study|Disease Progression|1|||
155233937|NCT01401530|560292489|FG001|Overall Study|Disease Progression|2|||
155233938|NCT01401530|560292490|FG002|Overall Study|Disease Progression|1|||
155233939|NCT01401530|560292488|FG000|Overall Study|Adverse Event|1|||
155233940|NCT01401530|560292489|FG001|Overall Study|Adverse Event|1|||
155233941|NCT01401530|560292490|FG002|Overall Study|Adverse Event|1|||
155233942|NCT01401530|560292488|FG000|Overall Study|Participant Choice|1|||
155233943|NCT01401530|560292489|FG001|Overall Study|Participant Choice|2|||
155233944|NCT01401530|560292490|FG002|Overall Study|Participant Choice|1|||
155233945|NCT01401530|560292488|FG000|Overall Study|Physician Decision|0|||
155233946|NCT01401530|560292489|FG001|Overall Study|Physician Decision|1|||
155233947|NCT01401530|560292490|FG002|Overall Study|Physician Decision|0|||
155233948|NCT02247349|560292491|FG000|Overall Study|Disease Progression|7|||
155233949|NCT02247349|560292492|FG001|Overall Study|Disease Progression|4|||
155233950|NCT02247349|560292493|FG002|Overall Study|Disease Progression|26|||
155233951|NCT02247349|560292494|FG003|Overall Study|Disease Progression|31|||
155233952|NCT02247349|560292495|FG004|Overall Study|Disease Progression|16|||
155233953|NCT02247349|560292496|FG005|Overall Study|Disease Progression|6|||
155233954|NCT02247349|560292491|FG000|Overall Study|Study drug toxicity|0|||
155233955|NCT02247349|560292492|FG001|Overall Study|Study drug toxicity|1|||
155233956|NCT02247349|560292493|FG002|Overall Study|Study drug toxicity|1|||
155233957|NCT02247349|560292494|FG003|Overall Study|Study drug toxicity|1|||
155233958|NCT02247349|560292495|FG004|Overall Study|Study drug toxicity|2|||
155233959|NCT02247349|560292496|FG005|Overall Study|Study drug toxicity|2|||
155233960|NCT02247349|560292491|FG000|Overall Study|Death|0|||
155233961|NCT02247349|560292492|FG001|Overall Study|Death|0|||
155233962|NCT02247349|560292493|FG002|Overall Study|Death|0|||
155233963|NCT02247349|560292494|FG003|Overall Study|Death|1|||
155233964|NCT02247349|560292495|FG004|Overall Study|Death|0|||
155233965|NCT02247349|560292496|FG005|Overall Study|Death|0|||
155233966|NCT02247349|560292491|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
155233967|NCT02247349|560292492|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
155233968|NCT02247349|560292493|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
155233969|NCT02247349|560292494|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
155233970|NCT02247349|560292495|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
155233971|NCT02247349|560292496|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
155233972|NCT02247349|560292491|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155233973|NCT02247349|560292492|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155233974|NCT02247349|560292493|FG002|Overall Study|Participant request to discontinue study treatment|1|||
155233975|NCT02247349|560292494|FG003|Overall Study|Participant request to discontinue study treatment|2|||
155233976|NCT02247349|560292495|FG004|Overall Study|Participant request to discontinue study treatment|1|||
155233977|NCT02247349|560292496|FG005|Overall Study|Participant request to discontinue study treatment|0|||
155233978|NCT02247349|560292491|FG000|Overall Study|Withdrawal by Subject|0|||
155233979|NCT02247349|560292492|FG001|Overall Study|Withdrawal by Subject|1|||
155233980|NCT02247349|560292493|FG002|Overall Study|Withdrawal by Subject|0|||
155233981|NCT02247349|560292494|FG003|Overall Study|Withdrawal by Subject|0|||
155233982|NCT02247349|560292495|FG004|Overall Study|Withdrawal by Subject|0|||
155233983|NCT02247349|560292496|FG005|Overall Study|Withdrawal by Subject|0|||
155233984|NCT02247349|560292491|FG000|Overall Study|Administrative reason by sponsor|0|||
155233985|NCT02247349|560292492|FG001|Overall Study|Administrative reason by sponsor|0|||
155233986|NCT02247349|560292493|FG002|Overall Study|Administrative reason by sponsor|0|||
155233987|NCT02247349|560292494|FG003|Overall Study|Administrative reason by sponsor|0|||
155233988|NCT02247349|560292495|FG004|Overall Study|Administrative reason by sponsor|1|||
155233989|NCT02247349|560292496|FG005|Overall Study|Administrative reason by sponsor|0|||
155233990|NCT02247349|560292491|FG000|Overall Study|Other reasons|0|||
155233991|NCT02247349|560292492|FG001|Overall Study|Other reasons|0|||
155233992|NCT02247349|560292493|FG002|Overall Study|Other reasons|1|||
155233993|NCT02247349|560292494|FG003|Overall Study|Other reasons|0|||
155233994|NCT02247349|560292495|FG004|Overall Study|Other reasons|0|||
155233995|NCT02247349|560292496|FG005|Overall Study|Other reasons|0|||
155233996|NCT03969212|560292497|FG000|Overall Study|Adverse Event|1|||
155233997|NCT03969212|560292498|FG001|Overall Study|Adverse Event|0|||
155233998|NCT03969212|560292499|FG002|Overall Study|Adverse Event|0|||
155233999|NCT03969212|560292500|FG003|Overall Study|Adverse Event|0|||
155234000|NCT03969212|560292497|FG000|Overall Study|Lost to Follow-up|2|||
155234001|NCT03969212|560292498|FG001|Overall Study|Lost to Follow-up|2|||
155234002|NCT03969212|560292499|FG002|Overall Study|Lost to Follow-up|2|||
155234003|NCT03969212|560292500|FG003|Overall Study|Lost to Follow-up|2|||
155234004|NCT03969212|560292497|FG000|Overall Study|Protocol Violation|0|||
155234005|NCT03969212|560292498|FG001|Overall Study|Protocol Violation|0|||
155234006|NCT03969212|560292499|FG002|Overall Study|Protocol Violation|0|||
155234007|NCT03969212|560292500|FG003|Overall Study|Protocol Violation|1|||
155234008|NCT03969212|560292497|FG000|Overall Study|Withdrawal by Subject|7|||
155234009|NCT03969212|560292498|FG001|Overall Study|Withdrawal by Subject|13|||
155234010|NCT03969212|560292499|FG002|Overall Study|Withdrawal by Subject|5|||
155234011|NCT03969212|560292500|FG003|Overall Study|Withdrawal by Subject|11|||
155234012|NCT03969212|560292497|FG000|Overall Study|Physician Decision|0|||
155234013|NCT03969212|560292498|FG001|Overall Study|Physician Decision|0|||
155234014|NCT03969212|560292499|FG002|Overall Study|Physician Decision|1|||
155234015|NCT03969212|560292500|FG003|Overall Study|Physician Decision|0|||
155234016|NCT03969212|560292497|FG000|Overall Study|Reason not Specified|22|||
155234017|NCT03969212|560292498|FG001|Overall Study|Reason not Specified|23|||
155234018|NCT03969212|560292499|FG002|Overall Study|Reason not Specified|28|||
155234019|NCT03969212|560292500|FG003|Overall Study|Reason not Specified|26|||
155234020|NCT03511560|560292501|FG000|Overall Study|Death|0|||
155234021|NCT03511560|560292502|FG001|Overall Study|Death|1|||
155234022|NCT03511560|560292501|FG000|Overall Study|Adverse Event|0|||
155234023|NCT03511560|560292502|FG001|Overall Study|Adverse Event|2|||
155234024|NCT03511560|560292501|FG000|Overall Study|Transplant cancelled|0|||
155234025|NCT03511560|560292502|FG001|Overall Study|Transplant cancelled|1|||
155234026|NCT03511560|560292501|FG000|Overall Study|Patient switched to another drug|1|||
155234027|NCT03511560|560292502|FG001|Overall Study|Patient switched to another drug|0|||
155234028|NCT00382733|560292507|FG000|Overall Study|Withdrawal by Subject|0|||
155234029|NCT00382733|560292508|FG001|Overall Study|Withdrawal by Subject|1|||
155234030|NCT00382733|560292509|FG002|Overall Study|Withdrawal by Subject|0|||
155234031|NCT00382733|560292510|FG003|Overall Study|Withdrawal by Subject|0|||
155234032|NCT00382733|560292511|FG004|Overall Study|Withdrawal by Subject|0|||
155234033|NCT03075644|560292512|FG000|Overall Study|Withdrawal by Subject|1|||
155234034|NCT03075644|560292513|FG001|Overall Study|Withdrawal by Subject|1|||
155234035|NCT00439140|560292514|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
155234036|NCT00439140|560292515|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
155234037|NCT00439140|560292516|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
155234038|NCT00439140|560292514|FG000|Treatment Cycle 1|Personal reasons|0|||
155234039|NCT00439140|560292515|FG001|Treatment Cycle 1|Personal reasons|2|||
155234040|NCT00439140|560292516|FG002|Treatment Cycle 1|Personal reasons|0|||
155234041|NCT00439140|560292514|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
155234042|NCT00439140|560292515|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
155234043|NCT00439140|560292516|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
155234044|NCT00439140|560292514|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
155234045|NCT00439140|560292515|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
155234046|NCT00439140|560292516|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
155234047|NCT00439140|560292514|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
155234048|NCT00439140|560292515|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
155234049|NCT00439140|560292516|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
155234050|NCT01458171|560292519|FG000|Overall Study|Adverse Event|1|||
155234051|NCT00578565|560292524|FG000|Overall Study|Adverse Event|3|||
155234052|NCT02143843|560292526|FG000|Overall Study|Adverse Event|8|||
155234053|NCT02143843|560292526|FG000|Overall Study|Lack of Efficacy|2|||
155234054|NCT02143843|560292526|FG000|Overall Study|Withdrawal by Subject|2|||
155234055|NCT00480779|560292527|FG000|Overall Study|Other|2|||
155234056|NCT00480779|560292528|FG001|Overall Study|Other|0|||
155234057|NCT00480779|560292527|FG000|Overall Study|Job and Health-related|0|||
155234058|NCT00480779|560292528|FG001|Overall Study|Job and Health-related|3|||
155234059|NCT01339390|560292531|FG000|Overall Study|Death|32|||
155234060|NCT01339390|560292532|FG001|Overall Study|Death|29|||
155234061|NCT01339390|560292531|FG000|Overall Study|Lost to Follow-up|125|||
155234062|NCT01339390|560292532|FG001|Overall Study|Lost to Follow-up|127|||
155234063|NCT00378703|560292535|FG000|Overall Study|Disease progression|59|||
155234064|NCT00378703|560292536|FG001|Overall Study|Disease progression|43|||
155234065|NCT00378703|560292537|FG002|Overall Study|Disease progression|48|||
155234066|NCT00378703|560292538|FG003|Overall Study|Disease progression|49|||
155234067|NCT00378703|560292535|FG000|Overall Study|Adverse Event|11|||
155234068|NCT00378703|560292536|FG001|Overall Study|Adverse Event|17|||
155234069|NCT00378703|560292537|FG002|Overall Study|Adverse Event|20|||
155234070|NCT00378703|560292538|FG003|Overall Study|Adverse Event|18|||
155234071|NCT00378703|560292535|FG000|Overall Study|Death|2|||
155234072|NCT00378703|560292536|FG001|Overall Study|Death|2|||
155234073|NCT00378703|560292537|FG002|Overall Study|Death|4|||
155234074|NCT00378703|560292538|FG003|Overall Study|Death|3|||
155234075|NCT00378703|560292535|FG000|Overall Study|Withdrawal by Subject|4|||
155234076|NCT00378703|560292536|FG001|Overall Study|Withdrawal by Subject|8|||
155234077|NCT00378703|560292537|FG002|Overall Study|Withdrawal by Subject|5|||
155234078|NCT00378703|560292538|FG003|Overall Study|Withdrawal by Subject|7|||
155234079|NCT00378703|560292535|FG000|Overall Study|Physician Decision|1|||
155234080|NCT00378703|560292536|FG001|Overall Study|Physician Decision|4|||
155234081|NCT00378703|560292537|FG002|Overall Study|Physician Decision|1|||
155234082|NCT00378703|560292538|FG003|Overall Study|Physician Decision|0|||
155234083|NCT00378703|560292535|FG000|Overall Study|Alternative therapy|4|||
155234084|NCT00378703|560292536|FG001|Overall Study|Alternative therapy|2|||
155234085|NCT00378703|560292537|FG002|Overall Study|Alternative therapy|0|||
155234086|NCT00378703|560292538|FG003|Overall Study|Alternative therapy|0|||
155234087|NCT00378703|560292535|FG000|Overall Study|Other complicated disease|0|||
155234088|NCT00378703|560292536|FG001|Overall Study|Other complicated disease|2|||
155234089|NCT00378703|560292537|FG002|Overall Study|Other complicated disease|2|||
155234090|NCT00378703|560292538|FG003|Overall Study|Other complicated disease|0|||
155234091|NCT00378703|560292535|FG000|Overall Study|Symptomatic deterioration|0|||
155234092|NCT00378703|560292536|FG001|Overall Study|Symptomatic deterioration|1|||
155234093|NCT00378703|560292537|FG002|Overall Study|Symptomatic deterioration|0|||
155234094|NCT00378703|560292538|FG003|Overall Study|Symptomatic deterioration|2|||
155234095|NCT00378703|560292535|FG000|Overall Study|Surgery|1|||
155234096|NCT00378703|560292536|FG001|Overall Study|Surgery|0|||
155234097|NCT00378703|560292537|FG002|Overall Study|Surgery|0|||
155234098|NCT00378703|560292538|FG003|Overall Study|Surgery|1|||
155234099|NCT00378703|560292535|FG000|Overall Study|Joint decision of physician and patient|1|||
155234100|NCT00378703|560292536|FG001|Overall Study|Joint decision of physician and patient|0|||
155234101|NCT00378703|560292537|FG002|Overall Study|Joint decision of physician and patient|0|||
155234102|NCT00378703|560292538|FG003|Overall Study|Joint decision of physician and patient|0|||
155234103|NCT00378703|560292535|FG000|Overall Study|Adverse events and progressive disease|0|||
155234104|NCT00378703|560292536|FG001|Overall Study|Adverse events and progressive disease|0|||
155234105|NCT00378703|560292537|FG002|Overall Study|Adverse events and progressive disease|0|||
155234106|NCT00378703|560292538|FG003|Overall Study|Adverse events and progressive disease|1|||
155234107|NCT00378703|560292535|FG000|Overall Study|Relocation|0|||
155234108|NCT00378703|560292536|FG001|Overall Study|Relocation|0|||
155234109|NCT00378703|560292537|FG002|Overall Study|Relocation|1|||
155234110|NCT00378703|560292538|FG003|Overall Study|Relocation|0|||
155234111|NCT00378703|560292535|FG000|Overall Study|Ineligible|4|||
155234112|NCT00378703|560292536|FG001|Overall Study|Ineligible|7|||
155234113|NCT00378703|560292537|FG002|Overall Study|Ineligible|7|||
155234114|NCT00378703|560292538|FG003|Overall Study|Ineligible|7|||
155234115|NCT00378703|560292535|FG000|Overall Study|Never started treatment|1|||
155234116|NCT00378703|560292536|FG001|Overall Study|Never started treatment|4|||
155234117|NCT00378703|560292537|FG002|Overall Study|Never started treatment|0|||
155234118|NCT00378703|560292538|FG003|Overall Study|Never started treatment|0|||
155234119|NCT00378703|560292535|FG000|Overall Study|Other|1|||
155234120|NCT00378703|560292536|FG001|Overall Study|Other|1|||
155234121|NCT00378703|560292537|FG002|Overall Study|Other|2|||
155234122|NCT00378703|560292538|FG003|Overall Study|Other|3|||
155234123|NCT01482767|560292544|FG000|Overall Study|Death|1|||
155234124|NCT01482767|560292545|FG001|Overall Study|Death|1|||
155234125|NCT01482767|560292544|FG000|Overall Study|Withdrawal by Subject|7|||
155234126|NCT01482767|560292545|FG001|Overall Study|Withdrawal by Subject|5|||
155234127|NCT01482767|560292544|FG000|Overall Study|Lost to Follow-up|12|||
155234128|NCT01482767|560292545|FG001|Overall Study|Lost to Follow-up|6|||
155234129|NCT01482767|560292544|FG000|Overall Study|Adverse Event|0|||
155234130|NCT01482767|560292545|FG001|Overall Study|Adverse Event|3|||
155234131|NCT01482767|560292544|FG000|Overall Study|Site closure|22|||
155234132|NCT01482767|560292545|FG001|Overall Study|Site closure|14|||
155234133|NCT01482767|560292544|FG000|Overall Study|Non-adherence to study requirements|4|||
155234134|NCT01482767|560292545|FG001|Overall Study|Non-adherence to study requirements|7|||
155234135|NCT01482767|560292544|FG000|Overall Study|Alternate HCV treatment|7|||
155234136|NCT01482767|560292545|FG001|Overall Study|Alternate HCV treatment|8|||
155234137|NCT01482767|560292544|FG000|Overall Study|Ineligible|0|||
155234138|NCT01482767|560292545|FG001|Overall Study|Ineligible|5|||
155234139|NCT01482767|560292544|FG000|Overall Study|Nurse error|1|||
155234140|NCT01482767|560292545|FG001|Overall Study|Nurse error|0|||
155234141|NCT01541930|560292550|FG000|Overall Study|Withdrawal by Subject|1|||
155234142|NCT01466192|560292551|FG000|Overall Study|Physician Decision|1|||
155234143|NCT01466192|560292551|FG000|Overall Study|Withdrawal by Subject|3|||
155234144|NCT03665038|560292553|FG000|Overall Study|Lost to Follow-up|0|||
155234145|NCT03665038|560292554|FG001|Overall Study|Lost to Follow-up|0|||
155234146|NCT03665038|560292555|FG002|Overall Study|Lost to Follow-up|1|||
155234147|NCT03013491|560292556|FG000|Main Study|Death|2|||
155234148|NCT03013491|560292557|FG001|Main Study|Death|2|||
155234149|NCT03013491|560292558|FG002|Main Study|Death|5|||
155234150|NCT03013491|560292559|FG003|Main Study|Death|3|||
155234151|NCT03013491|560292560|FG004|Main Study|Death|9|||
155234152|NCT03013491|560292561|FG005|Main Study|Death|12|||
155234153|NCT03013491|560292562|FG006|Main Study|Death|3|||
155234154|NCT03013491|560292563|FG007|Main Study|Death|5|||
155234155|NCT03013491|560292564|FG008|Main Study|Death|1|||
155234156|NCT03013491|560292565|FG009|Main Study|Death|2|||
155234157|NCT03013491|560292566|FG010|Main Study|Death|4|||
155234158|NCT03013491|560292567|FG011|Main Study|Death|1|||
155234159|NCT03013491|560292568|FG012|Main Study|Death|1|||
155234160|NCT03013491|560292569|FG013|Main Study|Death|4|||
155234161|NCT03013491|560292570|FG014|Main Study|Death|0|||
155234162|NCT03013491|560292571|FG015|Main Study|Death|3|||
155234163|NCT03013491|560292572|FG016|Main Study|Death|5|||
155234164|NCT03013491|560292573|FG017|Main Study|Death|1|||
155234165|NCT03013491|560292574|FG018|Main Study|Death|47|||
155234166|NCT03013491|560292556|FG000|Main Study|Lost to Follow-up|0|||
155234167|NCT03013491|560292557|FG001|Main Study|Lost to Follow-up|0|||
155234168|NCT03013491|560292558|FG002|Main Study|Lost to Follow-up|1|||
155234169|NCT03013491|560292559|FG003|Main Study|Lost to Follow-up|0|||
155234170|NCT03013491|560292560|FG004|Main Study|Lost to Follow-up|1|||
155234171|NCT03013491|560292561|FG005|Main Study|Lost to Follow-up|0|||
155234172|NCT03013491|560292562|FG006|Main Study|Lost to Follow-up|0|||
155234173|NCT03013491|560292563|FG007|Main Study|Lost to Follow-up|0|||
155234174|NCT03013491|560292564|FG008|Main Study|Lost to Follow-up|0|||
155234175|NCT03013491|560292565|FG009|Main Study|Lost to Follow-up|0|||
155234176|NCT03013491|560292566|FG010|Main Study|Lost to Follow-up|0|||
155234177|NCT03013491|560292567|FG011|Main Study|Lost to Follow-up|0|||
155234178|NCT03013491|560292568|FG012|Main Study|Lost to Follow-up|0|||
155234179|NCT03013491|560292569|FG013|Main Study|Lost to Follow-up|0|||
155234180|NCT03013491|560292570|FG014|Main Study|Lost to Follow-up|0|||
155234181|NCT03013491|560292571|FG015|Main Study|Lost to Follow-up|0|||
155234182|NCT03013491|560292572|FG016|Main Study|Lost to Follow-up|0|||
155234183|NCT03013491|560292573|FG017|Main Study|Lost to Follow-up|0|||
155234184|NCT03013491|560292574|FG018|Main Study|Lost to Follow-up|3|||
155234185|NCT03013491|560292556|FG000|Main Study|Termination of the study by Sponsor|0|||
155234186|NCT03013491|560292557|FG001|Main Study|Termination of the study by Sponsor|0|||
155234187|NCT03013491|560292558|FG002|Main Study|Termination of the study by Sponsor|2|||
155234188|NCT03013491|560292559|FG003|Main Study|Termination of the study by Sponsor|0|||
155234189|NCT03013491|560292560|FG004|Main Study|Termination of the study by Sponsor|1|||
155234190|NCT03013491|560292561|FG005|Main Study|Termination of the study by Sponsor|2|||
155234191|NCT03013491|560292562|FG006|Main Study|Termination of the study by Sponsor|0|||
155234192|NCT03013491|560292563|FG007|Main Study|Termination of the study by Sponsor|0|||
155234193|NCT03013491|560292564|FG008|Main Study|Termination of the study by Sponsor|1|||
155234194|NCT03013491|560292565|FG009|Main Study|Termination of the study by Sponsor|1|||
155234195|NCT03013491|560292566|FG010|Main Study|Termination of the study by Sponsor|1|||
155234196|NCT03013491|560292567|FG011|Main Study|Termination of the study by Sponsor|2|||
155234197|NCT03013491|560292568|FG012|Main Study|Termination of the study by Sponsor|0|||
155234198|NCT03013491|560292569|FG013|Main Study|Termination of the study by Sponsor|0|||
155234199|NCT03013491|560292570|FG014|Main Study|Termination of the study by Sponsor|0|||
155234200|NCT03013491|560292571|FG015|Main Study|Termination of the study by Sponsor|0|||
155234201|NCT03013491|560292572|FG016|Main Study|Termination of the study by Sponsor|0|||
155234202|NCT03013491|560292573|FG017|Main Study|Termination of the study by Sponsor|1|||
155234203|NCT03013491|560292574|FG018|Main Study|Termination of the study by Sponsor|13|||
155234204|NCT03013491|560292556|FG000|Main Study|Withdrawal by Subject|0|||
155234205|NCT03013491|560292557|FG001|Main Study|Withdrawal by Subject|0|||
155234206|NCT03013491|560292558|FG002|Main Study|Withdrawal by Subject|0|||
155234207|NCT03013491|560292559|FG003|Main Study|Withdrawal by Subject|4|||
155234208|NCT03013491|560292560|FG004|Main Study|Withdrawal by Subject|2|||
155234209|NCT03013491|560292561|FG005|Main Study|Withdrawal by Subject|1|||
155234210|NCT03013491|560292562|FG006|Main Study|Withdrawal by Subject|0|||
155234211|NCT03013491|560292563|FG007|Main Study|Withdrawal by Subject|0|||
155234212|NCT03013491|560292564|FG008|Main Study|Withdrawal by Subject|0|||
155234213|NCT03013491|560292565|FG009|Main Study|Withdrawal by Subject|0|||
155234214|NCT03013491|560292566|FG010|Main Study|Withdrawal by Subject|1|||
155234215|NCT03013491|560292567|FG011|Main Study|Withdrawal by Subject|2|||
155234216|NCT03013491|560292568|FG012|Main Study|Withdrawal by Subject|0|||
155234217|NCT03013491|560292569|FG013|Main Study|Withdrawal by Subject|2|||
155234218|NCT03013491|560292570|FG014|Main Study|Withdrawal by Subject|0|||
155234219|NCT03013491|560292571|FG015|Main Study|Withdrawal by Subject|0|||
155234220|NCT03013491|560292572|FG016|Main Study|Withdrawal by Subject|0|||
155234221|NCT03013491|560292573|FG017|Main Study|Withdrawal by Subject|0|||
155234222|NCT03013491|560292574|FG018|Main Study|Withdrawal by Subject|18|||
155234223|NCT03013491|560292556|FG000|Main Study|Disease progression|0|||
155234224|NCT03013491|560292557|FG001|Main Study|Disease progression|0|||
155234225|NCT03013491|560292558|FG002|Main Study|Disease progression|0|||
155234226|NCT03013491|560292559|FG003|Main Study|Disease progression|1|||
155234227|NCT03013491|560292560|FG004|Main Study|Disease progression|0|||
155234228|NCT03013491|560292561|FG005|Main Study|Disease progression|0|||
155234229|NCT03013491|560292562|FG006|Main Study|Disease progression|0|||
155234230|NCT03013491|560292563|FG007|Main Study|Disease progression|0|||
155234231|NCT03013491|560292564|FG008|Main Study|Disease progression|1|||
155234232|NCT03013491|560292565|FG009|Main Study|Disease progression|0|||
155234233|NCT03013491|560292566|FG010|Main Study|Disease progression|1|||
155234234|NCT03013491|560292567|FG011|Main Study|Disease progression|0|||
155234235|NCT03013491|560292568|FG012|Main Study|Disease progression|0|||
155234236|NCT03013491|560292569|FG013|Main Study|Disease progression|0|||
155234237|NCT03013491|560292570|FG014|Main Study|Disease progression|0|||
155234238|NCT03013491|560292571|FG015|Main Study|Disease progression|0|||
155234239|NCT03013491|560292572|FG016|Main Study|Disease progression|0|||
155234240|NCT03013491|560292573|FG017|Main Study|Disease progression|0|||
155234241|NCT03013491|560292574|FG018|Main Study|Disease progression|4|||
155234242|NCT03013491|560292556|FG000|Main Study|Symptomatic deterioration|0|||
155234243|NCT03013491|560292557|FG001|Main Study|Symptomatic deterioration|0|||
155234244|NCT03013491|560292558|FG002|Main Study|Symptomatic deterioration|0|||
155234245|NCT03013491|560292559|FG003|Main Study|Symptomatic deterioration|0|||
155234246|NCT03013491|560292560|FG004|Main Study|Symptomatic deterioration|0|||
155234247|NCT03013491|560292561|FG005|Main Study|Symptomatic deterioration|1|||
155234248|NCT03013491|560292562|FG006|Main Study|Symptomatic deterioration|0|||
155234249|NCT03013491|560292563|FG007|Main Study|Symptomatic deterioration|0|||
155234250|NCT03013491|560292564|FG008|Main Study|Symptomatic deterioration|0|||
155234251|NCT03013491|560292565|FG009|Main Study|Symptomatic deterioration|0|||
155234252|NCT03013491|560292566|FG010|Main Study|Symptomatic deterioration|0|||
155234253|NCT03013491|560292567|FG011|Main Study|Symptomatic deterioration|0|||
155234254|NCT03013491|560292568|FG012|Main Study|Symptomatic deterioration|0|||
155234255|NCT03013491|560292569|FG013|Main Study|Symptomatic deterioration|0|||
155234256|NCT03013491|560292570|FG014|Main Study|Symptomatic deterioration|0|||
155234257|NCT03013491|560292571|FG015|Main Study|Symptomatic deterioration|0|||
155234258|NCT03013491|560292572|FG016|Main Study|Symptomatic deterioration|0|||
155234259|NCT03013491|560292573|FG017|Main Study|Symptomatic deterioration|0|||
155234260|NCT03013491|560292574|FG018|Main Study|Symptomatic deterioration|0|||
155234261|NCT03013491|560292556|FG000|Main Study|Protocol version 8.0 approval|0|||
155234262|NCT03013491|560292557|FG001|Main Study|Protocol version 8.0 approval|0|||
155234263|NCT03013491|560292558|FG002|Main Study|Protocol version 8.0 approval|0|||
155234264|NCT03013491|560292559|FG003|Main Study|Protocol version 8.0 approval|0|||
155234265|NCT03013491|560292560|FG004|Main Study|Protocol version 8.0 approval|0|||
155234266|NCT03013491|560292561|FG005|Main Study|Protocol version 8.0 approval|0|||
155234267|NCT03013491|560292562|FG006|Main Study|Protocol version 8.0 approval|0|||
155234268|NCT03013491|560292563|FG007|Main Study|Protocol version 8.0 approval|0|||
155234269|NCT03013491|560292564|FG008|Main Study|Protocol version 8.0 approval|0|||
155234270|NCT03013491|560292565|FG009|Main Study|Protocol version 8.0 approval|0|||
155234271|NCT03013491|560292566|FG010|Main Study|Protocol version 8.0 approval|1|||
155234272|NCT03013491|560292567|FG011|Main Study|Protocol version 8.0 approval|0|||
155234273|NCT03013491|560292568|FG012|Main Study|Protocol version 8.0 approval|0|||
155234274|NCT03013491|560292569|FG013|Main Study|Protocol version 8.0 approval|0|||
155234275|NCT03013491|560292570|FG014|Main Study|Protocol version 8.0 approval|0|||
155234276|NCT03013491|560292571|FG015|Main Study|Protocol version 8.0 approval|0|||
155234277|NCT03013491|560292572|FG016|Main Study|Protocol version 8.0 approval|0|||
155234278|NCT03013491|560292573|FG017|Main Study|Protocol version 8.0 approval|0|||
155234279|NCT03013491|560292574|FG018|Main Study|Protocol version 8.0 approval|0|||
155234280|NCT03013491|560292556|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
155234281|NCT03013491|560292557|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
155234282|NCT03013491|560292558|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
155234283|NCT03013491|560292559|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
155234284|NCT03013491|560292560|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
155234285|NCT03013491|560292561|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
155234286|NCT03013491|560292562|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
155234287|NCT03013491|560292563|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
155234288|NCT03013491|560292564|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
155234289|NCT03013491|560292565|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
155234290|NCT03013491|560292566|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
155234291|NCT03013491|560292567|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
155234292|NCT03013491|560292568|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
155234293|NCT03013491|560292569|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
155234294|NCT03013491|560292570|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
155234295|NCT03013491|560292571|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
155234296|NCT03013491|560292572|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
155234297|NCT03013491|560292573|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
155234298|NCT03013491|560292574|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
155234299|NCT03013491|560292556|FG000|Main Study|Start of new anticancer therapy|0|||
155234300|NCT03013491|560292557|FG001|Main Study|Start of new anticancer therapy|0|||
155234301|NCT03013491|560292558|FG002|Main Study|Start of new anticancer therapy|0|||
155234302|NCT03013491|560292559|FG003|Main Study|Start of new anticancer therapy|0|||
155234303|NCT03013491|560292560|FG004|Main Study|Start of new anticancer therapy|0|||
155234304|NCT03013491|560292561|FG005|Main Study|Start of new anticancer therapy|0|||
155234305|NCT03013491|560292562|FG006|Main Study|Start of new anticancer therapy|0|||
155234306|NCT03013491|560292563|FG007|Main Study|Start of new anticancer therapy|0|||
155234307|NCT03013491|560292564|FG008|Main Study|Start of new anticancer therapy|0|||
155234308|NCT03013491|560292565|FG009|Main Study|Start of new anticancer therapy|0|||
155234309|NCT03013491|560292566|FG010|Main Study|Start of new anticancer therapy|0|||
155234310|NCT03013491|560292567|FG011|Main Study|Start of new anticancer therapy|0|||
155234311|NCT03013491|560292568|FG012|Main Study|Start of new anticancer therapy|0|||
155234312|NCT03013491|560292569|FG013|Main Study|Start of new anticancer therapy|0|||
155234313|NCT03013491|560292570|FG014|Main Study|Start of new anticancer therapy|0|||
155234314|NCT03013491|560292571|FG015|Main Study|Start of new anticancer therapy|0|||
155234315|NCT03013491|560292572|FG016|Main Study|Start of new anticancer therapy|0|||
155234316|NCT03013491|560292573|FG017|Main Study|Start of new anticancer therapy|0|||
155234317|NCT03013491|560292574|FG018|Main Study|Start of new anticancer therapy|2|||
155234318|NCT03013491|560292556|FG000|Long-term Extension|Disease progression|0|||
155234319|NCT03013491|560292557|FG001|Long-term Extension|Disease progression|0|||
155234320|NCT03013491|560292558|FG002|Long-term Extension|Disease progression|0|||
155234321|NCT03013491|560292559|FG003|Long-term Extension|Disease progression|1|||
155234322|NCT03013491|560292560|FG004|Long-term Extension|Disease progression|0|||
155234323|NCT03013491|560292561|FG005|Long-term Extension|Disease progression|0|||
155234324|NCT03013491|560292562|FG006|Long-term Extension|Disease progression|0|||
155234325|NCT03013491|560292563|FG007|Long-term Extension|Disease progression|0|||
155234326|NCT03013491|560292564|FG008|Long-term Extension|Disease progression|0|||
155234327|NCT03013491|560292565|FG009|Long-term Extension|Disease progression|0|||
155234328|NCT03013491|560292566|FG010|Long-term Extension|Disease progression|0|||
155234329|NCT03013491|560292567|FG011|Long-term Extension|Disease progression|0|||
155234330|NCT03013491|560292568|FG012|Long-term Extension|Disease progression|0|||
155234331|NCT03013491|560292569|FG013|Long-term Extension|Disease progression|0|||
155234332|NCT03013491|560292570|FG014|Long-term Extension|Disease progression|0|||
155234333|NCT03013491|560292571|FG015|Long-term Extension|Disease progression|0|||
155234334|NCT03013491|560292572|FG016|Long-term Extension|Disease progression|0|||
155234335|NCT03013491|560292573|FG017|Long-term Extension|Disease progression|0|||
155234336|NCT03013491|560292574|FG018|Long-term Extension|Disease progression|1|||
155234337|NCT03013491|560292556|FG000|Long-term Extension|Withdrawal by Subject|0|||
155234338|NCT03013491|560292557|FG001|Long-term Extension|Withdrawal by Subject|0|||
155234339|NCT03013491|560292558|FG002|Long-term Extension|Withdrawal by Subject|0|||
155234340|NCT03013491|560292559|FG003|Long-term Extension|Withdrawal by Subject|0|||
155234341|NCT03013491|560292560|FG004|Long-term Extension|Withdrawal by Subject|0|||
155234342|NCT03013491|560292561|FG005|Long-term Extension|Withdrawal by Subject|0|||
155234343|NCT03013491|560292562|FG006|Long-term Extension|Withdrawal by Subject|0|||
155234344|NCT03013491|560292563|FG007|Long-term Extension|Withdrawal by Subject|1|||
155234345|NCT03013491|560292564|FG008|Long-term Extension|Withdrawal by Subject|0|||
155234346|NCT03013491|560292565|FG009|Long-term Extension|Withdrawal by Subject|0|||
155234347|NCT03013491|560292566|FG010|Long-term Extension|Withdrawal by Subject|0|||
155234348|NCT03013491|560292567|FG011|Long-term Extension|Withdrawal by Subject|0|||
155234349|NCT03013491|560292568|FG012|Long-term Extension|Withdrawal by Subject|0|||
155234350|NCT03013491|560292569|FG013|Long-term Extension|Withdrawal by Subject|0|||
155234351|NCT03013491|560292570|FG014|Long-term Extension|Withdrawal by Subject|0|||
155234352|NCT03013491|560292571|FG015|Long-term Extension|Withdrawal by Subject|0|||
155234353|NCT03013491|560292572|FG016|Long-term Extension|Withdrawal by Subject|0|||
155234354|NCT03013491|560292573|FG017|Long-term Extension|Withdrawal by Subject|0|||
155234355|NCT03013491|560292574|FG018|Long-term Extension|Withdrawal by Subject|0|||
155234356|NCT03013491|560292556|FG000|Long-term Extension|Adverse Event|0|||
155234357|NCT03013491|560292557|FG001|Long-term Extension|Adverse Event|0|||
155234358|NCT03013491|560292558|FG002|Long-term Extension|Adverse Event|0|||
155234359|NCT03013491|560292559|FG003|Long-term Extension|Adverse Event|0|||
155234360|NCT03013491|560292560|FG004|Long-term Extension|Adverse Event|0|||
155234361|NCT03013491|560292561|FG005|Long-term Extension|Adverse Event|0|||
155234362|NCT03013491|560292562|FG006|Long-term Extension|Adverse Event|0|||
155234363|NCT03013491|560292563|FG007|Long-term Extension|Adverse Event|0|||
155234364|NCT03013491|560292564|FG008|Long-term Extension|Adverse Event|0|||
155234365|NCT03013491|560292565|FG009|Long-term Extension|Adverse Event|0|||
155234366|NCT03013491|560292566|FG010|Long-term Extension|Adverse Event|0|||
155234367|NCT03013491|560292567|FG011|Long-term Extension|Adverse Event|0|||
155234368|NCT03013491|560292568|FG012|Long-term Extension|Adverse Event|0|||
155234369|NCT03013491|560292569|FG013|Long-term Extension|Adverse Event|0|||
155234370|NCT03013491|560292570|FG014|Long-term Extension|Adverse Event|0|||
155234371|NCT03013491|560292571|FG015|Long-term Extension|Adverse Event|0|||
155234372|NCT03013491|560292572|FG016|Long-term Extension|Adverse Event|0|||
155234373|NCT03013491|560292573|FG017|Long-term Extension|Adverse Event|0|||
155234374|NCT03013491|560292574|FG018|Long-term Extension|Adverse Event|1|||
155234375|NCT03013491|560292556|FG000|Long-term Extension|Death|0|||
155234376|NCT03013491|560292557|FG001|Long-term Extension|Death|0|||
155234377|NCT03013491|560292558|FG002|Long-term Extension|Death|0|||
155234378|NCT03013491|560292559|FG003|Long-term Extension|Death|0|||
155234379|NCT03013491|560292560|FG004|Long-term Extension|Death|0|||
155234380|NCT03013491|560292561|FG005|Long-term Extension|Death|0|||
155234381|NCT03013491|560292562|FG006|Long-term Extension|Death|0|||
155234382|NCT03013491|560292563|FG007|Long-term Extension|Death|0|||
155234383|NCT03013491|560292564|FG008|Long-term Extension|Death|0|||
155234384|NCT03013491|560292565|FG009|Long-term Extension|Death|0|||
155234385|NCT03013491|560292566|FG010|Long-term Extension|Death|0|||
155234386|NCT03013491|560292567|FG011|Long-term Extension|Death|0|||
155234387|NCT03013491|560292568|FG012|Long-term Extension|Death|0|||
155234388|NCT03013491|560292569|FG013|Long-term Extension|Death|0|||
155234389|NCT03013491|560292570|FG014|Long-term Extension|Death|0|||
155234390|NCT03013491|560292571|FG015|Long-term Extension|Death|0|||
155234391|NCT03013491|560292572|FG016|Long-term Extension|Death|0|||
155234392|NCT03013491|560292573|FG017|Long-term Extension|Death|0|||
155234393|NCT03013491|560292574|FG018|Long-term Extension|Death|1|||
155234394|NCT04740034|560292577|FG000|Overall Study|Death|0|||
155234395|NCT04740034|560292578|FG001|Overall Study|Death|1|||
155234396|NCT04740034|560292579|FG002|Overall Study|Death|2|||
155234397|NCT04740034|560292580|FG003|Overall Study|Death|3|||
155234398|NCT04740034|560292581|FG004|Overall Study|Death|4|||
155234399|NCT04740034|560292582|FG005|Overall Study|Death|4|||
155234400|NCT04740034|560292583|FG006|Overall Study|Death|2|||
155234401|NCT04740034|560292584|FG007|Overall Study|Death|2|||
155234402|NCT04740034|560292585|FG008|Overall Study|Death|2|||
155234403|NCT04740034|560292586|FG009|Overall Study|Death|4|||
155234404|NCT04740034|560292587|FG010|Overall Study|Death|0|||
155234405|NCT04740034|560292577|FG000|Overall Study|Lost to Follow-up|0|||
155234406|NCT04740034|560292578|FG001|Overall Study|Lost to Follow-up|0|||
155234407|NCT04740034|560292579|FG002|Overall Study|Lost to Follow-up|0|||
155234408|NCT04740034|560292580|FG003|Overall Study|Lost to Follow-up|1|||
155234409|NCT04740034|560292581|FG004|Overall Study|Lost to Follow-up|2|||
155234410|NCT04740034|560292582|FG005|Overall Study|Lost to Follow-up|2|||
155234411|NCT04740034|560292583|FG006|Overall Study|Lost to Follow-up|0|||
155234412|NCT04740034|560292584|FG007|Overall Study|Lost to Follow-up|0|||
155234413|NCT04740034|560292585|FG008|Overall Study|Lost to Follow-up|0|||
155234414|NCT04740034|560292586|FG009|Overall Study|Lost to Follow-up|1|||
155234415|NCT04740034|560292587|FG010|Overall Study|Lost to Follow-up|0|||
155234416|NCT04740034|560292577|FG000|Overall Study|Withdrawal by Subject|1|||
155234417|NCT04740034|560292578|FG001|Overall Study|Withdrawal by Subject|0|||
155234418|NCT04740034|560292579|FG002|Overall Study|Withdrawal by Subject|0|||
155234419|NCT04740034|560292580|FG003|Overall Study|Withdrawal by Subject|0|||
155234420|NCT04740034|560292581|FG004|Overall Study|Withdrawal by Subject|0|||
155234421|NCT04740034|560292582|FG005|Overall Study|Withdrawal by Subject|0|||
155234422|NCT04740034|560292583|FG006|Overall Study|Withdrawal by Subject|0|||
155234423|NCT04740034|560292584|FG007|Overall Study|Withdrawal by Subject|1|||
155234424|NCT04740034|560292585|FG008|Overall Study|Withdrawal by Subject|0|||
155234425|NCT04740034|560292586|FG009|Overall Study|Withdrawal by Subject|1|||
155234426|NCT04740034|560292587|FG010|Overall Study|Withdrawal by Subject|0|||
155234427|NCT04740034|560292577|FG000|Overall Study|Decision by sponsor|0|||
155234428|NCT04740034|560292578|FG001|Overall Study|Decision by sponsor|0|||
155234429|NCT04740034|560292579|FG002|Overall Study|Decision by sponsor|1|||
155234430|NCT04740034|560292580|FG003|Overall Study|Decision by sponsor|0|||
155234431|NCT04740034|560292581|FG004|Overall Study|Decision by sponsor|0|||
155234432|NCT04740034|560292582|FG005|Overall Study|Decision by sponsor|0|||
155234433|NCT04740034|560292583|FG006|Overall Study|Decision by sponsor|1|||
155234434|NCT04740034|560292584|FG007|Overall Study|Decision by sponsor|2|||
155234435|NCT04740034|560292585|FG008|Overall Study|Decision by sponsor|1|||
155234436|NCT04740034|560292586|FG009|Overall Study|Decision by sponsor|1|||
155234437|NCT04740034|560292587|FG010|Overall Study|Decision by sponsor|2|||
155234438|NCT03890367|560292594|FG000|Overall Study|Withdrawal by parent/guardian|1|||
155234439|NCT03890367|560292595|FG001|Overall Study|Withdrawal by parent/guardian|3|||
155234440|NCT03890367|560292596|FG002|Overall Study|Withdrawal by parent/guardian|0|||
155234441|NCT03890367|560292594|FG000|Overall Study|Protocol deviation|2|||
155234442|NCT03890367|560292595|FG001|Overall Study|Protocol deviation|2|||
155234443|NCT03890367|560292596|FG002|Overall Study|Protocol deviation|1|||
155234444|NCT03890367|560292594|FG000|Overall Study|Lost to Follow-up|1|||
155234445|NCT03890367|560292595|FG001|Overall Study|Lost to Follow-up|1|||
155234446|NCT03890367|560292596|FG002|Overall Study|Lost to Follow-up|0|||
155234447|NCT02556710|560295088|FG000|Overall Study|Surgical treatment|3|||
155234448|NCT02556710|560295089|FG001|Overall Study|Surgical treatment|0|||
155234449|NCT02556710|560295088|FG000|Overall Study|Required proscribed pain medication|2|||
155234450|NCT02556710|560295089|FG001|Overall Study|Required proscribed pain medication|1|||
155234451|NCT02556710|560295088|FG000|Overall Study|Lack of Efficacy|1|||
155234452|NCT02556710|560295089|FG001|Overall Study|Lack of Efficacy|0|||
155234453|NCT02556710|560295088|FG000|Overall Study|Worsening osteoarthritis|1|||
155234454|NCT02556710|560295089|FG001|Overall Study|Worsening osteoarthritis|0|||
155234455|NCT02556710|560295088|FG000|Overall Study|Moved out of state|1|||
155234456|NCT02556710|560295089|FG001|Overall Study|Moved out of state|0|||
155234457|NCT02556710|560295088|FG000|Overall Study|Missing reason|3|||
155234458|NCT02556710|560295089|FG001|Overall Study|Missing reason|1|||
155234459|NCT02556710|560295088|FG000|Overall Study|Pain as lack of efficacy|0|||
155234460|NCT02556710|560295089|FG001|Overall Study|Pain as lack of efficacy|4|||
155234461|NCT04524403|560295090|FG000|Overall Study|Withdrawal by Subject|10|||
155234462|NCT04524403|560295091|FG001|Overall Study|Withdrawal by Subject|3|||
155234463|NCT04524403|560295092|FG002|Overall Study|Withdrawal by Subject|8|||
155234464|NCT04524403|560295090|FG000|Overall Study|Lost to Follow-up|3|||
155234465|NCT04524403|560295091|FG001|Overall Study|Lost to Follow-up|4|||
155234466|NCT04524403|560295092|FG002|Overall Study|Lost to Follow-up|3|||
155234467|NCT04524403|560295090|FG000|Overall Study|Adverse Event|3|||
155234468|NCT04524403|560295091|FG001|Overall Study|Adverse Event|1|||
155234469|NCT04524403|560295092|FG002|Overall Study|Adverse Event|4|||
155234470|NCT04524403|560295090|FG000|Overall Study|Non-compliant with study drug|1|||
155234471|NCT04524403|560295091|FG001|Overall Study|Non-compliant with study drug|2|||
155234472|NCT04524403|560295092|FG002|Overall Study|Non-compliant with study drug|3|||
155234473|NCT04524403|560295090|FG000|Overall Study|Moved|0|||
155234474|NCT04524403|560295091|FG001|Overall Study|Moved|1|||
155234475|NCT04524403|560295092|FG002|Overall Study|Moved|0|||
155234476|NCT03370341|560295093|FG000|Overall Study|Lost to Follow-up|0|||
155234477|NCT03370341|560295094|FG001|Overall Study|Lost to Follow-up|1|||
155234478|NCT00646958|560295103|FG000|Overall Study|Lack of Efficacy|1|||
155234479|NCT00646958|560295104|FG001|Overall Study|Lack of Efficacy|0|||
155234480|NCT00646958|560295105|FG002|Overall Study|Lack of Efficacy|0|||
155234481|NCT00646958|560295103|FG000|Overall Study|Adverse Event|4|||
155234482|NCT00646958|560295104|FG001|Overall Study|Adverse Event|0|||
155234483|NCT00646958|560295105|FG002|Overall Study|Adverse Event|0|||
155234484|NCT00646958|560295103|FG000|Overall Study|Lost to Follow-up|1|||
155234485|NCT00646958|560295104|FG001|Overall Study|Lost to Follow-up|5|||
155234486|NCT00646958|560295105|FG002|Overall Study|Lost to Follow-up|7|||
155234487|NCT00646958|560295103|FG000|Overall Study|Protocol Violation|1|||
155234488|NCT00646958|560295104|FG001|Overall Study|Protocol Violation|1|||
155234489|NCT00646958|560295105|FG002|Overall Study|Protocol Violation|0|||
155234490|NCT00646958|560295103|FG000|Overall Study|Abnormal screening lab tests|1|||
155234491|NCT00646958|560295104|FG001|Overall Study|Abnormal screening lab tests|1|||
155234492|NCT00646958|560295105|FG002|Overall Study|Abnormal screening lab tests|0|||
155234493|NCT00646958|560295103|FG000|Overall Study|Withdrawal by Subject|1|||
155234494|NCT00646958|560295104|FG001|Overall Study|Withdrawal by Subject|2|||
155234495|NCT00646958|560295105|FG002|Overall Study|Withdrawal by Subject|0|||
155234496|NCT00646958|560295103|FG000|Overall Study|Did not receive study drug|2|||
155234497|NCT00646958|560295104|FG001|Overall Study|Did not receive study drug|0|||
155234498|NCT00646958|560295105|FG002|Overall Study|Did not receive study drug|2|||
155234499|NCT01607905|560295106|FG000|Overall Study|Withdrawal by participant|7|||
155234500|NCT01607905|560295107|FG001|Overall Study|Withdrawal by participant|2|||
155234501|NCT01607905|560295108|FG002|Overall Study|Withdrawal by participant|4|||
155234502|NCT01607905|560295109|FG003|Overall Study|Withdrawal by participant|6|||
155234503|NCT01607905|560295110|FG004|Overall Study|Withdrawal by participant|0|||
155234504|NCT01607905|560295111|FG005|Overall Study|Withdrawal by participant|4|||
155234505|NCT01607905|560295112|FG006|Overall Study|Withdrawal by participant|12|||
155234506|NCT01607905|560295106|FG000|Overall Study|Incidence or severity of AEs|5|||
155234507|NCT01607905|560295107|FG001|Overall Study|Incidence or severity of AEs|1|||
155234508|NCT01607905|560295108|FG002|Overall Study|Incidence or severity of AEs|1|||
155234509|NCT01607905|560295109|FG003|Overall Study|Incidence or severity of AEs|3|||
155234510|NCT01607905|560295110|FG004|Overall Study|Incidence or severity of AEs|0|||
155234511|NCT01607905|560295111|FG005|Overall Study|Incidence or severity of AEs|2|||
155234512|NCT01607905|560295112|FG006|Overall Study|Incidence or severity of AEs|8|||
155234513|NCT01607905|560295106|FG000|Overall Study|Disease progression|44|||
155234514|NCT01607905|560295107|FG001|Overall Study|Disease progression|16|||
155234515|NCT01607905|560295108|FG002|Overall Study|Disease progression|15|||
155234516|NCT01607905|560295109|FG003|Overall Study|Disease progression|11|||
155234517|NCT01607905|560295110|FG004|Overall Study|Disease progression|6|||
155234518|NCT01607905|560295111|FG005|Overall Study|Disease progression|7|||
155234519|NCT01607905|560295112|FG006|Overall Study|Disease progression|21|||
155234520|NCT01607905|560295106|FG000|Overall Study|Non-compliance with study procedures|0|||
155234521|NCT01607905|560295107|FG001|Overall Study|Non-compliance with study procedures|0|||
155234522|NCT01607905|560295108|FG002|Overall Study|Non-compliance with study procedures|0|||
155234523|NCT01607905|560295109|FG003|Overall Study|Non-compliance with study procedures|0|||
155234524|NCT01607905|560295110|FG004|Overall Study|Non-compliance with study procedures|0|||
155234525|NCT01607905|560295111|FG005|Overall Study|Non-compliance with study procedures|0|||
155234526|NCT01607905|560295112|FG006|Overall Study|Non-compliance with study procedures|1|||
155234527|NCT01607905|560295106|FG000|Overall Study|Death|1|||
155234528|NCT01607905|560295107|FG001|Overall Study|Death|1|||
155234529|NCT01607905|560295108|FG002|Overall Study|Death|1|||
155234530|NCT01607905|560295109|FG003|Overall Study|Death|1|||
155234531|NCT01607905|560295110|FG004|Overall Study|Death|0|||
155234532|NCT01607905|560295111|FG005|Overall Study|Death|0|||
155234533|NCT01607905|560295112|FG006|Overall Study|Death|3|||
155234534|NCT01607905|560295106|FG000|Overall Study|Other treatments become available|1|||
155234535|NCT01607905|560295107|FG001|Overall Study|Other treatments become available|0|||
155234536|NCT01607905|560295108|FG002|Overall Study|Other treatments become available|0|||
155234537|NCT01607905|560295109|FG003|Overall Study|Other treatments become available|0|||
155234538|NCT01607905|560295110|FG004|Overall Study|Other treatments become available|0|||
155234539|NCT01607905|560295111|FG005|Overall Study|Other treatments become available|0|||
155234540|NCT01607905|560295112|FG006|Overall Study|Other treatments become available|1|||
155234541|NCT01607905|560295106|FG000|Overall Study|Investigator discretion|0|||
155234542|NCT01607905|560295107|FG001|Overall Study|Investigator discretion|0|||
155234543|NCT01607905|560295108|FG002|Overall Study|Investigator discretion|0|||
155234544|NCT01607905|560295109|FG003|Overall Study|Investigator discretion|0|||
155234545|NCT01607905|560295110|FG004|Overall Study|Investigator discretion|0|||
155234546|NCT01607905|560295111|FG005|Overall Study|Investigator discretion|1|||
155234547|NCT01607905|560295112|FG006|Overall Study|Investigator discretion|0|||
155234548|NCT01607905|560295106|FG000|Overall Study|Other|1|||
155234549|NCT01607905|560295107|FG001|Overall Study|Other|0|||
155234550|NCT01607905|560295108|FG002|Overall Study|Other|0|||
155234551|NCT01607905|560295109|FG003|Overall Study|Other|0|||
155234552|NCT01607905|560295110|FG004|Overall Study|Other|0|||
155234553|NCT01607905|560295111|FG005|Overall Study|Other|0|||
155234554|NCT01607905|560295112|FG006|Overall Study|Other|1|||
155234555|NCT01607905|560295106|FG000|Overall Study|Randomized but not treated|1|||
155234556|NCT01607905|560295107|FG001|Overall Study|Randomized but not treated|0|||
155234557|NCT01607905|560295108|FG002|Overall Study|Randomized but not treated|0|||
155234558|NCT01607905|560295109|FG003|Overall Study|Randomized but not treated|0|||
155234559|NCT01607905|560295110|FG004|Overall Study|Randomized but not treated|1|||
155234560|NCT01607905|560295111|FG005|Overall Study|Randomized but not treated|1|||
155234561|NCT01607905|560295112|FG006|Overall Study|Randomized but not treated|0|||
155234562|NCT01310413|560295113|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
155234563|NCT01310413|560295114|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
155234564|NCT01310413|560295115|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
155234565|NCT01310413|560295116|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
155234566|NCT01310413|560295117|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
155234567|NCT01310413|560295118|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
155234568|NCT01310413|560295119|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
155234569|NCT01310413|560295113|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
155234570|NCT01310413|560295114|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
155234571|NCT01310413|560295115|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
155234572|NCT01310413|560295116|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
155234573|NCT01310413|560295117|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
155234574|NCT01310413|560295118|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
155234575|NCT01310413|560295119|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
155234576|NCT01310413|560295113|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
155234577|NCT01310413|560295114|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
155234578|NCT01310413|560295115|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
155234579|NCT01310413|560295116|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
155234580|NCT01310413|560295117|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
155234581|NCT01310413|560295118|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
155234582|NCT01310413|560295119|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
155234583|NCT01310413|560295113|FG000|Day 0 to Day 385|Other|1|||
155234584|NCT01310413|560295114|FG001|Day 0 to Day 385|Other|0|||
155234585|NCT01310413|560295115|FG002|Day 0 to Day 385|Other|3|||
155234586|NCT01310413|560295116|FG003|Day 0 to Day 385|Other|0|||
155234587|NCT01310413|560295117|FG004|Day 0 to Day 385|Other|0|||
155234588|NCT01310413|560295118|FG005|Day 0 to Day 385|Other|0|||
155234589|NCT01310413|560295119|FG006|Day 0 to Day 385|Other|0|||
155234590|NCT01310413|560295113|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234591|NCT01310413|560295114|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234592|NCT01310413|560295115|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234593|NCT01310413|560295116|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234594|NCT01310413|560295117|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234595|NCT01310413|560295118|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
155234596|NCT01310413|560295119|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
155234597|NCT01310413|560295113|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
155234598|NCT01310413|560295114|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
155234599|NCT01310413|560295115|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
155234600|NCT01310413|560295116|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
155234601|NCT01310413|560295117|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
155234602|NCT01310413|560295118|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
155234603|NCT01310413|560295119|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
155234604|NCT02564471|560295120|FG000|Overall Study|Adverse Event|1|||
155234605|NCT02564471|560295121|FG001|Overall Study|Adverse Event|0|||
155234606|NCT02564471|560295122|FG002|Overall Study|Adverse Event|0|||
155234607|NCT02564471|560295123|FG003|Overall Study|Adverse Event|0|||
155234608|NCT02564471|560295120|FG000|Overall Study|Withdrawal by Subject|2|||
155234609|NCT02564471|560295121|FG001|Overall Study|Withdrawal by Subject|1|||
155234610|NCT02564471|560295122|FG002|Overall Study|Withdrawal by Subject|3|||
155234611|NCT02564471|560295123|FG003|Overall Study|Withdrawal by Subject|0|||
155234612|NCT02564471|560295120|FG000|Overall Study|Lost to Follow-up|0|||
155234613|NCT02564471|560295121|FG001|Overall Study|Lost to Follow-up|2|||
155234614|NCT02564471|560295122|FG002|Overall Study|Lost to Follow-up|0|||
155234615|NCT02564471|560295123|FG003|Overall Study|Lost to Follow-up|0|||
155234616|NCT00630877|560295126|FG000|Overall Study|Adverse Event|11|||
155234617|NCT00630877|560295127|FG001|Overall Study|Adverse Event|8|||
155234618|NCT00630877|560295128|FG002|Overall Study|Adverse Event|7|||
155234619|NCT00630877|560295126|FG000|Overall Study|Withdrawal by Subject|3|||
155234620|NCT00630877|560295127|FG001|Overall Study|Withdrawal by Subject|4|||
155234621|NCT00630877|560295128|FG002|Overall Study|Withdrawal by Subject|0|||
155234622|NCT00630877|560295126|FG000|Overall Study|Lost to Follow-up|2|||
155234623|NCT00630877|560295127|FG001|Overall Study|Lost to Follow-up|0|||
155234624|NCT00630877|560295128|FG002|Overall Study|Lost to Follow-up|0|||
155234625|NCT00630877|560295126|FG000|Overall Study|Noncompliance|2|||
155234626|NCT00630877|560295127|FG001|Overall Study|Noncompliance|3|||
155234627|NCT00630877|560295128|FG002|Overall Study|Noncompliance|1|||
155234628|NCT00630877|560295126|FG000|Overall Study|Protocol violation|1|||
155234629|NCT00630877|560295127|FG001|Overall Study|Protocol violation|0|||
155234630|NCT00630877|560295128|FG002|Overall Study|Protocol violation|1|||
155234631|NCT00630877|560295126|FG000|Overall Study|Personal reasons|0|||
155234632|NCT00630877|560295127|FG001|Overall Study|Personal reasons|0|||
155234633|NCT00630877|560295128|FG002|Overall Study|Personal reasons|1|||
155234634|NCT01643473|560295129|FG000|Overall Study|Lost to Follow-up|1|||
155234635|NCT01643473|560295130|FG001|Overall Study|Lost to Follow-up|0|||
155234636|NCT02033889|560295131|FG000|Overall Study|Adverse Event|3|||
155234637|NCT02033889|560295132|FG001|Overall Study|Adverse Event|1|||
155234638|NCT02033889|560295133|FG002|Overall Study|Adverse Event|3|||
155234639|NCT02033889|560295131|FG000|Overall Study|Death|3|||
155234640|NCT02033889|560295132|FG001|Overall Study|Death|1|||
155234641|NCT02033889|560295133|FG002|Overall Study|Death|2|||
155234642|NCT02033889|560295131|FG000|Overall Study|Excluded Medication|1|||
155234643|NCT02033889|560295132|FG001|Overall Study|Excluded Medication|1|||
155234644|NCT02033889|560295133|FG002|Overall Study|Excluded Medication|0|||
155234645|NCT02033889|560295131|FG000|Overall Study|Lost to Follow-up|8|||
155234646|NCT02033889|560295132|FG001|Overall Study|Lost to Follow-up|5|||
155234647|NCT02033889|560295133|FG002|Overall Study|Lost to Follow-up|6|||
155234648|NCT02033889|560295131|FG000|Overall Study|Non-Compliance With Study Drug|1|||
155234649|NCT02033889|560295132|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155234650|NCT02033889|560295133|FG002|Overall Study|Non-Compliance With Study Drug|0|||
155234651|NCT02033889|560295131|FG000|Overall Study|Physician Decision|0|||
155234652|NCT02033889|560295132|FG001|Overall Study|Physician Decision|1|||
155234653|NCT02033889|560295133|FG002|Overall Study|Physician Decision|1|||
155234654|NCT02033889|560295131|FG000|Overall Study|Participant moved|0|||
155234655|NCT02033889|560295132|FG001|Overall Study|Participant moved|1|||
155234656|NCT02033889|560295133|FG002|Overall Study|Participant moved|0|||
155234657|NCT02033889|560295131|FG000|Overall Study|Withdrawal by Subject|18|||
155234658|NCT02033889|560295132|FG001|Overall Study|Withdrawal by Subject|10|||
155234659|NCT02033889|560295133|FG002|Overall Study|Withdrawal by Subject|13|||
155234660|NCT02343458|560295134|FG000|Overall Study|Adverse Event|15|||
155234661|NCT02343458|560295135|FG001|Overall Study|Adverse Event|14|||
155234662|NCT02343458|560295136|FG002|Overall Study|Adverse Event|15|||
155234663|NCT02343458|560295137|FG003|Overall Study|Adverse Event|3|||
155234664|NCT02343458|560295134|FG000|Overall Study|Lack of Efficacy|3|||
155234665|NCT02343458|560295135|FG001|Overall Study|Lack of Efficacy|8|||
155234666|NCT02343458|560295136|FG002|Overall Study|Lack of Efficacy|4|||
155234667|NCT02343458|560295137|FG003|Overall Study|Lack of Efficacy|8|||
155234668|NCT02343458|560295134|FG000|Overall Study|Withdrawal by Subject|18|||
155234669|NCT02343458|560295135|FG001|Overall Study|Withdrawal by Subject|17|||
155234670|NCT02343458|560295136|FG002|Overall Study|Withdrawal by Subject|23|||
155234671|NCT02343458|560295137|FG003|Overall Study|Withdrawal by Subject|14|||
155234672|NCT02343458|560295134|FG000|Overall Study|Physician Decision|1|||
155234673|NCT02343458|560295135|FG001|Overall Study|Physician Decision|4|||
155234674|NCT02343458|560295136|FG002|Overall Study|Physician Decision|2|||
155234675|NCT02343458|560295137|FG003|Overall Study|Physician Decision|2|||
155234676|NCT02343458|560295134|FG000|Overall Study|Lost to Follow-up|5|||
155234677|NCT02343458|560295135|FG001|Overall Study|Lost to Follow-up|5|||
155234678|NCT02343458|560295136|FG002|Overall Study|Lost to Follow-up|3|||
155234679|NCT02343458|560295137|FG003|Overall Study|Lost to Follow-up|1|||
155234680|NCT02343458|560295134|FG000|Overall Study|Protocol Violation|2|||
155234681|NCT02343458|560295135|FG001|Overall Study|Protocol Violation|5|||
155234682|NCT02343458|560295136|FG002|Overall Study|Protocol Violation|2|||
155234683|NCT02343458|560295137|FG003|Overall Study|Protocol Violation|2|||
155234684|NCT02343458|560295134|FG000|Overall Study|Protocol Specified Criteria|17|||
155234685|NCT02343458|560295135|FG001|Overall Study|Protocol Specified Criteria|13|||
155234686|NCT02343458|560295136|FG002|Overall Study|Protocol Specified Criteria|14|||
155234687|NCT02343458|560295137|FG003|Overall Study|Protocol Specified Criteria|8|||
155234688|NCT01312909|560295138|FG000|Overall Study|Randomized but not treated|1|||
155234689|NCT01312909|560295139|FG001|Overall Study|Randomized but not treated|3|||
155234690|NCT01312909|560295140|FG002|Overall Study|Randomized but not treated|1|||
155234691|NCT01312909|560295138|FG000|Overall Study|Adverse Event|1|||
155234692|NCT01312909|560295139|FG001|Overall Study|Adverse Event|0|||
155234693|NCT01312909|560295140|FG002|Overall Study|Adverse Event|3|||
155234694|NCT01312909|560295138|FG000|Overall Study|Protocol Violation|2|||
155234695|NCT01312909|560295139|FG001|Overall Study|Protocol Violation|0|||
155234696|NCT01312909|560295140|FG002|Overall Study|Protocol Violation|2|||
155234697|NCT01312909|560295138|FG000|Overall Study|Other|9|||
155234698|NCT01312909|560295139|FG001|Overall Study|Other|6|||
155234699|NCT01312909|560295140|FG002|Overall Study|Other|11|||
155234700|NCT01312909|560295138|FG000|Overall Study|Withdrawal by Subject|8|||
155234701|NCT01312909|560295139|FG001|Overall Study|Withdrawal by Subject|10|||
155234702|NCT01312909|560295140|FG002|Overall Study|Withdrawal by Subject|7|||
155234703|NCT01312909|560295138|FG000|Overall Study|Lost to Follow-up|21|||
155234704|NCT01312909|560295139|FG001|Overall Study|Lost to Follow-up|17|||
155234705|NCT01312909|560295140|FG002|Overall Study|Lost to Follow-up|20|||
155234706|NCT01312909|560295138|FG000|Overall Study|Insufficient clinical response|0|||
155234707|NCT01312909|560295139|FG001|Overall Study|Insufficient clinical response|0|||
155234708|NCT01312909|560295140|FG002|Overall Study|Insufficient clinical response|1|||
155234709|NCT01312909|560295138|FG000|Overall Study|Entrance criteria not met|0|||
155234710|NCT01312909|560295139|FG001|Overall Study|Entrance criteria not met|0|||
155234711|NCT01312909|560295140|FG002|Overall Study|Entrance criteria not met|2|||
155234712|NCT01913041|560295146|FG000|Overall Study|Protocol Violation|35|||
155234713|NCT01913041|560295146|FG000|Overall Study|Withdrawal by Subject|3|||
155234714|NCT01913041|560295146|FG000|Overall Study|Physician Decision|1|||
155234715|NCT01513317|560295147|FG000|Overall Study|Withdrawal by Subject|15|||
155234716|NCT01513317|560295148|FG001|Overall Study|Withdrawal by Subject|4|||
155234717|NCT01513317|560295147|FG000|Overall Study|Death|1|||
155234718|NCT01513317|560295148|FG001|Overall Study|Death|1|||
155234719|NCT01513317|560295147|FG000|Overall Study|Study terminated by sponsor|18|||
155234720|NCT01513317|560295148|FG001|Overall Study|Study terminated by sponsor|18|||
155234721|NCT01513317|560295147|FG000|Overall Study|Other|0|||
155234722|NCT01513317|560295148|FG001|Overall Study|Other|1|||
155234723|NCT00182689|560295149|FG000|Overall Study|Adverse Event|8|||
155234724|NCT00182689|560295150|FG001|Overall Study|Adverse Event|11|||
155234725|NCT00182689|560295149|FG000|Overall Study|Withdrawal by Subject|2|||
155234726|NCT00182689|560295150|FG001|Overall Study|Withdrawal by Subject|2|||
155234727|NCT00182689|560295149|FG000|Overall Study|Progression|27|||
155234728|NCT00182689|560295150|FG001|Overall Study|Progression|29|||
155234729|NCT00182689|560295149|FG000|Overall Study|Death|1|||
155234730|NCT00182689|560295150|FG001|Overall Study|Death|0|||
155234731|NCT00182689|560295149|FG000|Overall Study|not protocol specified|0|||
155234732|NCT00182689|560295150|FG001|Overall Study|not protocol specified|3|||
155234733|NCT00182689|560295149|FG000|Overall Study|Ineligible|1|||
155234734|NCT00182689|560295150|FG001|Overall Study|Ineligible|4|||
155234735|NCT00182689|560295149|FG000|Overall Study|Never received treatment|1|||
155234736|NCT00182689|560295150|FG001|Overall Study|Never received treatment|0|||
155234737|NCT02564198|560295151|FG000|Overall Study|Withdrawal by Subject|2|||
155234738|NCT02564198|560295152|FG001|Overall Study|Withdrawal by Subject|4|||
155234739|NCT02564198|560295153|FG002|Overall Study|Withdrawal by Subject|0|||
155234740|NCT02564198|560295151|FG000|Overall Study|Adverse Event|0|||
155234741|NCT02564198|560295152|FG001|Overall Study|Adverse Event|1|||
155234742|NCT02564198|560295153|FG002|Overall Study|Adverse Event|0|||
155234743|NCT01640301|560295154|FG000|Overall Study|Death|0|||
155234744|NCT01640301|560295155|FG001|Overall Study|Death|8|||
155234745|NCT02200042|560295158|FG000|Overall Study|Withdrawal by Subject|0|||
155234746|NCT02200042|560295159|FG001|Overall Study|Withdrawal by Subject|1|||
155234747|NCT01969838|560295160|FG000|Double-blind Phase|Adverse Event|10|||
155234748|NCT01969838|560295161|FG001|Double-blind Phase|Adverse Event|4|||
155234749|NCT01969838|560295162|FG002|Double-blind Phase|Adverse Event|0|||
155234750|NCT01969838|560295163|FG003|Double-blind Phase|Adverse Event|0|||
155234751|NCT01969838|560295160|FG000|Double-blind Phase|Death|5|||
155234752|NCT01969838|560295161|FG001|Double-blind Phase|Death|2|||
155234753|NCT01969838|560295162|FG002|Double-blind Phase|Death|0|||
155234754|NCT01969838|560295163|FG003|Double-blind Phase|Death|0|||
155234755|NCT01969838|560295160|FG000|Double-blind Phase|Physician Decision|5|||
155234756|NCT01969838|560295161|FG001|Double-blind Phase|Physician Decision|1|||
155234757|NCT01969838|560295162|FG002|Double-blind Phase|Physician Decision|0|||
155234758|NCT01969838|560295163|FG003|Double-blind Phase|Physician Decision|0|||
155234759|NCT01969838|560295160|FG000|Double-blind Phase|Subject Decision|4|||
155234760|NCT01969838|560295161|FG001|Double-blind Phase|Subject Decision|2|||
155234761|NCT01969838|560295162|FG002|Double-blind Phase|Subject Decision|0|||
155234762|NCT01969838|560295163|FG003|Double-blind Phase|Subject Decision|0|||
155234763|NCT01969838|560295160|FG000|Double-blind Phase|Disease Progression|2|||
155234764|NCT01969838|560295161|FG001|Double-blind Phase|Disease Progression|0|||
155234765|NCT01969838|560295162|FG002|Double-blind Phase|Disease Progression|0|||
155234766|NCT01969838|560295163|FG003|Double-blind Phase|Disease Progression|0|||
155234767|NCT01969838|560295160|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
155234768|NCT01969838|560295161|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
155234769|NCT01969838|560295162|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
155234770|NCT01969838|560295163|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
155234771|NCT01969838|560295160|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
155234772|NCT01969838|560295161|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
155234773|NCT01969838|560295162|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
155234774|NCT01969838|560295163|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
155234775|NCT01969838|560295160|FG000|Open-label Phase|Adverse Event|0|||
155234776|NCT01969838|560295161|FG001|Open-label Phase|Adverse Event|0|||
155234777|NCT01969838|560295162|FG002|Open-label Phase|Adverse Event|37|||
155234778|NCT01969838|560295163|FG003|Open-label Phase|Adverse Event|49|||
155234779|NCT01969838|560295160|FG000|Open-label Phase|Disease Progression|0|||
155234780|NCT01969838|560295161|FG001|Open-label Phase|Disease Progression|0|||
155234781|NCT01969838|560295162|FG002|Open-label Phase|Disease Progression|26|||
155234782|NCT01969838|560295163|FG003|Open-label Phase|Disease Progression|27|||
155234783|NCT01969838|560295160|FG000|Open-label Phase|Lack of Efficacy|0|||
155234784|NCT01969838|560295161|FG001|Open-label Phase|Lack of Efficacy|0|||
155234785|NCT01969838|560295162|FG002|Open-label Phase|Lack of Efficacy|17|||
155234786|NCT01969838|560295163|FG003|Open-label Phase|Lack of Efficacy|19|||
155234787|NCT01969838|560295160|FG000|Open-label Phase|Subject Decision|0|||
155234788|NCT01969838|560295161|FG001|Open-label Phase|Subject Decision|0|||
155234789|NCT01969838|560295162|FG002|Open-label Phase|Subject Decision|14|||
155234790|NCT01969838|560295163|FG003|Open-label Phase|Subject Decision|15|||
155234791|NCT01969838|560295160|FG000|Open-label Phase|Death|0|||
155234792|NCT01969838|560295161|FG001|Open-label Phase|Death|0|||
155234793|NCT01969838|560295162|FG002|Open-label Phase|Death|13|||
155234794|NCT01969838|560295163|FG003|Open-label Phase|Death|11|||
155234795|NCT01969838|560295160|FG000|Open-label Phase|Physician Decision|0|||
155234796|NCT01969838|560295161|FG001|Open-label Phase|Physician Decision|0|||
155234797|NCT01969838|560295162|FG002|Open-label Phase|Physician Decision|9|||
155234798|NCT01969838|560295163|FG003|Open-label Phase|Physician Decision|14|||
155234799|NCT01969838|560295160|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
155234800|NCT01969838|560295161|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
155234801|NCT01969838|560295162|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
155234802|NCT01969838|560295163|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
155234803|NCT00408993|560295164|FG000|Overall Study|Adverse Event|15|||
155234804|NCT00408993|560295165|FG001|Overall Study|Adverse Event|4|||
155234805|NCT00408993|560295164|FG000|Overall Study|Protocol Violation|1|||
155234806|NCT00408993|560295165|FG001|Overall Study|Protocol Violation|6|||
155234807|NCT00408993|560295164|FG000|Overall Study|Lack of Efficacy|1|||
155234808|NCT00408993|560295165|FG001|Overall Study|Lack of Efficacy|4|||
155234809|NCT00408993|560295164|FG000|Overall Study|Withdrawal by Subject|2|||
155234810|NCT00408993|560295165|FG001|Overall Study|Withdrawal by Subject|3|||
155234811|NCT02880371|560295166|FG000|Phase 1b|Lost to Follow-up|1|||
155234812|NCT02880371|560295167|FG001|Phase 1b|Lost to Follow-up|0|||
155234813|NCT02880371|560295168|FG002|Phase 1b|Lost to Follow-up|0|||
155234814|NCT02880371|560295169|FG003|Phase 1b|Lost to Follow-up|0|||
155234815|NCT02880371|560295170|FG004|Phase 1b|Lost to Follow-up|0|||
155234816|NCT02880371|560295171|FG005|Phase 1b|Lost to Follow-up|0|||
155234817|NCT02880371|560295172|FG006|Phase 1b|Lost to Follow-up|0|||
155234818|NCT02880371|560295173|FG007|Phase 1b|Lost to Follow-up|0|||
155234819|NCT02880371|560295166|FG000|Phase 1b|Participants terminated by Sponsor|1|||
155234820|NCT02880371|560295167|FG001|Phase 1b|Participants terminated by Sponsor|0|||
155234821|NCT02880371|560295168|FG002|Phase 1b|Participants terminated by Sponsor|0|||
155234822|NCT02880371|560295169|FG003|Phase 1b|Participants terminated by Sponsor|0|||
155234823|NCT02880371|560295170|FG004|Phase 1b|Participants terminated by Sponsor|0|||
155234824|NCT02880371|560295171|FG005|Phase 1b|Participants terminated by Sponsor|0|||
155234825|NCT02880371|560295172|FG006|Phase 1b|Participants terminated by Sponsor|0|||
155234826|NCT02880371|560295173|FG007|Phase 1b|Participants terminated by Sponsor|0|||
155234827|NCT02880371|560295166|FG000|Phase 1b|Withdrawal by Subject|0|||
155234828|NCT02880371|560295167|FG001|Phase 1b|Withdrawal by Subject|0|||
155234829|NCT02880371|560295168|FG002|Phase 1b|Withdrawal by Subject|1|||
155234830|NCT02880371|560295169|FG003|Phase 1b|Withdrawal by Subject|0|||
155234831|NCT02880371|560295170|FG004|Phase 1b|Withdrawal by Subject|0|||
155234832|NCT02880371|560295171|FG005|Phase 1b|Withdrawal by Subject|0|||
155234833|NCT02880371|560295172|FG006|Phase 1b|Withdrawal by Subject|0|||
155234834|NCT02880371|560295173|FG007|Phase 1b|Withdrawal by Subject|0|||
155234835|NCT02880371|560295166|FG000|Phase 1b|Death|4|||
155234836|NCT02880371|560295167|FG001|Phase 1b|Death|6|||
155234837|NCT02880371|560295168|FG002|Phase 1b|Death|5|||
155234838|NCT02880371|560295169|FG003|Phase 1b|Death|1|||
155234839|NCT02880371|560295170|FG004|Phase 1b|Death|0|||
155234840|NCT02880371|560295171|FG005|Phase 1b|Death|0|||
155234841|NCT02880371|560295172|FG006|Phase 1b|Death|0|||
155234842|NCT02880371|560295173|FG007|Phase 1b|Death|0|||
155234843|NCT02880371|560295166|FG000|Phase 1b|Enrolled but not Treated|0|||
155234844|NCT02880371|560295167|FG001|Phase 1b|Enrolled but not Treated|1|||
155234845|NCT02880371|560295168|FG002|Phase 1b|Enrolled but not Treated|0|||
155234846|NCT02880371|560295169|FG003|Phase 1b|Enrolled but not Treated|0|||
155234847|NCT02880371|560295170|FG004|Phase 1b|Enrolled but not Treated|0|||
155234848|NCT02880371|560295171|FG005|Phase 1b|Enrolled but not Treated|0|||
155234849|NCT02880371|560295172|FG006|Phase 1b|Enrolled but not Treated|0|||
155234850|NCT02880371|560295173|FG007|Phase 1b|Enrolled but not Treated|0|||
155234851|NCT02880371|560295166|FG000|Phase 2|Enrolled but not Treated|0|||
155234852|NCT02880371|560295167|FG001|Phase 2|Enrolled but not Treated|0|||
155234853|NCT02880371|560295168|FG002|Phase 2|Enrolled but not Treated|0|||
155234854|NCT02880371|560295169|FG003|Phase 2|Enrolled but not Treated|0|||
155234855|NCT02880371|560295170|FG004|Phase 2|Enrolled but not Treated|0|||
155234856|NCT02880371|560295171|FG005|Phase 2|Enrolled but not Treated|1|||
155234857|NCT02880371|560295172|FG006|Phase 2|Enrolled but not Treated|1|||
155234858|NCT02880371|560295173|FG007|Phase 2|Enrolled but not Treated|0|||
155234859|NCT02880371|560295166|FG000|Phase 2|Other|0|||
155234860|NCT02880371|560295167|FG001|Phase 2|Other|0|||
155234861|NCT02880371|560295168|FG002|Phase 2|Other|0|||
155234862|NCT02880371|560295169|FG003|Phase 2|Other|0|||
155234863|NCT02880371|560295170|FG004|Phase 2|Other|0|||
155234864|NCT02880371|560295171|FG005|Phase 2|Other|1|||
155234865|NCT02880371|560295172|FG006|Phase 2|Other|2|||
155234866|NCT02880371|560295173|FG007|Phase 2|Other|1|||
155234867|NCT02880371|560295166|FG000|Phase 2|Participants terminated by Sponsor|0|||
155234868|NCT02880371|560295167|FG001|Phase 2|Participants terminated by Sponsor|0|||
155234869|NCT02880371|560295168|FG002|Phase 2|Participants terminated by Sponsor|0|||
155234870|NCT02880371|560295169|FG003|Phase 2|Participants terminated by Sponsor|0|||
155234871|NCT02880371|560295170|FG004|Phase 2|Participants terminated by Sponsor|1|||
155234872|NCT02880371|560295171|FG005|Phase 2|Participants terminated by Sponsor|6|||
155234873|NCT02880371|560295172|FG006|Phase 2|Participants terminated by Sponsor|1|||
155234874|NCT02880371|560295173|FG007|Phase 2|Participants terminated by Sponsor|5|||
155234875|NCT02880371|560295166|FG000|Phase 2|Death|0|||
155234876|NCT02880371|560295167|FG001|Phase 2|Death|0|||
155234877|NCT02880371|560295168|FG002|Phase 2|Death|0|||
155234878|NCT02880371|560295169|FG003|Phase 2|Death|0|||
155234879|NCT02880371|560295170|FG004|Phase 2|Death|1|||
155234880|NCT02880371|560295171|FG005|Phase 2|Death|10|||
155234881|NCT02880371|560295172|FG006|Phase 2|Death|20|||
155234882|NCT02880371|560295173|FG007|Phase 2|Death|5|||
155234883|NCT02880371|560295166|FG000|Phase 2|Lost to Follow-up|0|||
155234884|NCT02880371|560295167|FG001|Phase 2|Lost to Follow-up|0|||
155234885|NCT02880371|560295168|FG002|Phase 2|Lost to Follow-up|0|||
155234886|NCT02880371|560295169|FG003|Phase 2|Lost to Follow-up|0|||
155234887|NCT02880371|560295170|FG004|Phase 2|Lost to Follow-up|0|||
155234888|NCT02880371|560295171|FG005|Phase 2|Lost to Follow-up|0|||
155234889|NCT02880371|560295172|FG006|Phase 2|Lost to Follow-up|3|||
155234890|NCT02880371|560295173|FG007|Phase 2|Lost to Follow-up|0|||
155234891|NCT02880371|560295166|FG000|Phase 2|Withdrawal by Subject|0|||
155234892|NCT02880371|560295167|FG001|Phase 2|Withdrawal by Subject|0|||
155234893|NCT02880371|560295168|FG002|Phase 2|Withdrawal by Subject|0|||
155234894|NCT02880371|560295169|FG003|Phase 2|Withdrawal by Subject|0|||
155234895|NCT02880371|560295170|FG004|Phase 2|Withdrawal by Subject|0|||
155234896|NCT02880371|560295171|FG005|Phase 2|Withdrawal by Subject|1|||
155234897|NCT02880371|560295172|FG006|Phase 2|Withdrawal by Subject|1|||
155234898|NCT02880371|560295173|FG007|Phase 2|Withdrawal by Subject|0|||
155234899|NCT02880371|560295166|FG000|Phase 2|End of Study page not completed by error|0|||
155234900|NCT02880371|560295167|FG001|Phase 2|End of Study page not completed by error|0|||
155234901|NCT02880371|560295168|FG002|Phase 2|End of Study page not completed by error|0|||
155234902|NCT02880371|560295169|FG003|Phase 2|End of Study page not completed by error|0|||
155234903|NCT02880371|560295170|FG004|Phase 2|End of Study page not completed by error|0|||
155234904|NCT02880371|560295171|FG005|Phase 2|End of Study page not completed by error|1|||
155234905|NCT02880371|560295172|FG006|Phase 2|End of Study page not completed by error|0|||
155234906|NCT02880371|560295173|FG007|Phase 2|End of Study page not completed by error|0|||
155234907|NCT01777997|560295176|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
155234908|NCT01777997|560295176|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
155234909|NCT01777997|560295176|FG000|Weeks 48 to 72/96 on ART|Death|1|||
155234910|NCT01777997|560295176|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
155234911|NCT01694706|560295177|FG000|Overall Study|Adverse Event|0|||
155234912|NCT01694706|560295178|FG001|Overall Study|Adverse Event|1|||
155234913|NCT01694706|560295179|FG002|Overall Study|Adverse Event|0|||
155234914|NCT01694706|560295177|FG000|Overall Study|other reason not defined above|1|||
155234915|NCT01694706|560295178|FG001|Overall Study|other reason not defined above|0|||
155234916|NCT01694706|560295179|FG002|Overall Study|other reason not defined above|0|||
155234917|NCT01923181|560295180|FG000|Overall Study|Protocol Violation|2|||
155234918|NCT01923181|560295181|FG001|Overall Study|Protocol Violation|2|||
155234919|NCT01923181|560295182|FG002|Overall Study|Protocol Violation|0|||
155234920|NCT01923181|560295183|FG003|Overall Study|Protocol Violation|2|||
155234921|NCT01923181|560295184|FG004|Overall Study|Protocol Violation|2|||
155234922|NCT01923181|560295185|FG005|Overall Study|Protocol Violation|1|||
155234923|NCT01923181|560295186|FG006|Overall Study|Protocol Violation|1|||
155234924|NCT01923181|560295187|FG007|Overall Study|Protocol Violation|2|||
155234925|NCT01923181|560295188|FG008|Overall Study|Protocol Violation|1|||
155234926|NCT01923181|560295180|FG000|Overall Study|Withdrawal by Subject|0|||
155234927|NCT01923181|560295181|FG001|Overall Study|Withdrawal by Subject|1|||
155234928|NCT01923181|560295182|FG002|Overall Study|Withdrawal by Subject|0|||
155234929|NCT01923181|560295183|FG003|Overall Study|Withdrawal by Subject|1|||
155234930|NCT01923181|560295184|FG004|Overall Study|Withdrawal by Subject|4|||
155234931|NCT01923181|560295185|FG005|Overall Study|Withdrawal by Subject|2|||
155234932|NCT01923181|560295186|FG006|Overall Study|Withdrawal by Subject|4|||
155234933|NCT01923181|560295187|FG007|Overall Study|Withdrawal by Subject|3|||
155234934|NCT01923181|560295188|FG008|Overall Study|Withdrawal by Subject|1|||
155234935|NCT01923181|560295180|FG000|Overall Study|Other|1|||
155234936|NCT01923181|560295181|FG001|Overall Study|Other|0|||
155234937|NCT01923181|560295182|FG002|Overall Study|Other|0|||
155234938|NCT01923181|560295183|FG003|Overall Study|Other|1|||
155234939|NCT01923181|560295184|FG004|Overall Study|Other|0|||
155234940|NCT01923181|560295185|FG005|Overall Study|Other|0|||
155234941|NCT01923181|560295186|FG006|Overall Study|Other|0|||
155234942|NCT01923181|560295187|FG007|Overall Study|Other|0|||
155234943|NCT01923181|560295188|FG008|Overall Study|Other|0|||
155234944|NCT01923181|560295180|FG000|Overall Study|Lost to Follow-up|0|||
155234945|NCT01923181|560295181|FG001|Overall Study|Lost to Follow-up|3|||
155234946|NCT01923181|560295182|FG002|Overall Study|Lost to Follow-up|2|||
155234947|NCT01923181|560295183|FG003|Overall Study|Lost to Follow-up|1|||
155234948|NCT01923181|560295184|FG004|Overall Study|Lost to Follow-up|2|||
155234949|NCT01923181|560295185|FG005|Overall Study|Lost to Follow-up|1|||
155234950|NCT01923181|560295186|FG006|Overall Study|Lost to Follow-up|3|||
155234951|NCT01923181|560295187|FG007|Overall Study|Lost to Follow-up|3|||
155234952|NCT01923181|560295188|FG008|Overall Study|Lost to Follow-up|1|||
155234953|NCT02944578|560295189|FG000|Overall Study|Physician Decision|1|||
155234954|NCT02944578|560295190|FG001|Overall Study|Physician Decision|0|||
155234955|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
155234956|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
155234957|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
155234958|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
155234959|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
155234960|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
155234961|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155234962|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
155234963|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
155234964|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155234965|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
155234966|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
155234967|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
155234968|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
155234969|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
155234970|NCT01257204|560295191|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
155234971|NCT01257204|560295192|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
155234972|NCT01257204|560295193|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
155234973|NCT01257204|560295191|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
155234974|NCT01257204|560295192|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
155234975|NCT01257204|560295193|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
155234976|NCT01257204|560295191|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
155234977|NCT01257204|560295192|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
155234978|NCT01257204|560295193|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
155234979|NCT01257204|560295191|FG000|Follow-up Period (up to Week 48)|Other|0|||
155234980|NCT01257204|560295192|FG001|Follow-up Period (up to Week 48)|Other|0|||
155234981|NCT01257204|560295193|FG002|Follow-up Period (up to Week 48)|Other|5|||
155234982|NCT03394391|560295195|FG000|Overall Study|Lost to Follow-up|1|||
155234983|NCT03394391|560295196|FG001|Overall Study|Lost to Follow-up|2|||
155234984|NCT02932891|560295197|FG000|Overall Study|Lost to Follow-up|2|||
155234985|NCT02932891|560295197|FG000|Overall Study|HPA Suppress|2|||
155234986|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234987|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
155234988|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234989|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234990|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234991|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
155234992|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
155234993|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
155234994|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
155234995|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155234996|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155234997|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
155234998|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
155234999|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235000|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235001|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235002|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235003|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
155235004|NCT04622254|560295198|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235005|NCT04622254|560295199|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
155235006|NCT04622254|560295200|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
155235007|NCT04622254|560295201|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235008|NCT04622254|560295202|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235009|NCT04622254|560295203|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
155235010|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235011|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235012|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235013|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
155235014|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235015|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
155235016|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235017|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235018|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235019|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
155235020|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
155235021|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
155235022|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235023|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235024|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235025|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
155235026|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235027|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
155235028|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235029|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235030|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235031|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
155235032|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235033|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
155235034|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155235035|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155235036|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
155235037|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
155235038|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
155235039|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
155235040|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155235041|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155235042|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
155235043|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
155235044|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
155235045|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
155235046|NCT04622254|560295198|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
155235047|NCT04622254|560295199|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
155235048|NCT04622254|560295200|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
155235049|NCT04622254|560295201|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
155235050|NCT04622254|560295202|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
155235051|NCT04622254|560295203|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
155235052|NCT00451282|560295208|FG000|Overall Study|Lost to Follow-up|6|||
155235053|NCT00451282|560295209|FG001|Overall Study|Lost to Follow-up|5|||
155235054|NCT00098839|560295210|FG000|Overall Study|Adverse Event|5|||
155235055|NCT00098839|560295211|FG001|Overall Study|Adverse Event|2|||
155235056|NCT00098839|560295210|FG000|Overall Study|Death|1|||
155235057|NCT00098839|560295211|FG001|Overall Study|Death|2|||
155235058|NCT00098839|560295210|FG000|Overall Study|Physician Decision|4|||
155235059|NCT00098839|560295211|FG001|Overall Study|Physician Decision|14|||
155235060|NCT00098839|560295210|FG000|Overall Study|Withdrawal by Subject|1|||
155235061|NCT00098839|560295211|FG001|Overall Study|Withdrawal by Subject|0|||
155235062|NCT00098839|560295210|FG000|Overall Study|Refusal of further protocol therapy|3|||
155235063|NCT00098839|560295211|FG001|Overall Study|Refusal of further protocol therapy|1|||
155235064|NCT00098839|560295210|FG000|Overall Study|Relapse|6|||
155235065|NCT00098839|560295211|FG001|Overall Study|Relapse|3|||
155235066|NCT00098839|560295210|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
155235067|NCT00098839|560295211|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
155235068|NCT00098839|560295210|FG000|Overall Study|Ineligible|2|||
155235069|NCT00098839|560295211|FG001|Overall Study|Ineligible|0|||
155235070|NCT00577122|560295212|FG000|Overall Study|Adverse Event|0|||
155235071|NCT00577122|560295213|FG001|Overall Study|Adverse Event|2|||
155235072|NCT00577122|560295212|FG000|Overall Study|Progression, relapse during active trt|6|||
155235073|NCT00577122|560295213|FG001|Overall Study|Progression, relapse during active trt|8|||
155235074|NCT00577122|560295212|FG000|Overall Study|Prog, refract disease during active trt|8|||
155235075|NCT00577122|560295213|FG001|Overall Study|Prog, refract disease during active trt|5|||
155235076|NCT00577122|560295212|FG000|Overall Study|Alternative Therapy|0|||
155235077|NCT00577122|560295213|FG001|Overall Study|Alternative Therapy|1|||
155235078|NCT00456092|560295216|FG000|Extension Phase|Grade 2 or Greater AE|2|||
155235079|NCT00456092|560295217|FG001|Extension Phase|Grade 2 or Greater AE|2|||
155235080|NCT00456092|560295218|FG002|Extension Phase|Grade 2 or Greater AE|0|||
155235081|NCT00456092|560295219|FG003|Extension Phase|Grade 2 or Greater AE|0|||
155235082|NCT00456092|560295220|FG004|Extension Phase|Grade 2 or Greater AE|2|||
155235083|NCT00456092|560295216|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
155235084|NCT00456092|560295217|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
155235085|NCT00456092|560295218|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
155235086|NCT00456092|560295219|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
155235087|NCT00456092|560295220|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
155235088|NCT00456092|560295216|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
155235089|NCT00456092|560295217|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
155235090|NCT00456092|560295218|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
155235091|NCT00456092|560295219|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
155235092|NCT00456092|560295220|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
155235093|NCT00456092|560295216|FG000|Extension Phase|Withdrew Consent|2|||
155235094|NCT00456092|560295217|FG001|Extension Phase|Withdrew Consent|0|||
155235095|NCT00456092|560295218|FG002|Extension Phase|Withdrew Consent|0|||
155235096|NCT00456092|560295219|FG003|Extension Phase|Withdrew Consent|0|||
155235097|NCT00456092|560295220|FG004|Extension Phase|Withdrew Consent|0|||
155235098|NCT00456092|560295216|FG000|Extension Phase|Lost to Follow-up|1|||
155235099|NCT00456092|560295217|FG001|Extension Phase|Lost to Follow-up|1|||
155235100|NCT00456092|560295218|FG002|Extension Phase|Lost to Follow-up|0|||
155235101|NCT00456092|560295219|FG003|Extension Phase|Lost to Follow-up|0|||
155235102|NCT00456092|560295220|FG004|Extension Phase|Lost to Follow-up|1|||
155235103|NCT00456092|560295216|FG000|Extension Phase|Other|2|||
155235104|NCT00456092|560295217|FG001|Extension Phase|Other|0|||
155235105|NCT00456092|560295218|FG002|Extension Phase|Other|0|||
155235106|NCT00456092|560295219|FG003|Extension Phase|Other|1|||
155235107|NCT00456092|560295220|FG004|Extension Phase|Other|1|||
155235108|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
155235109|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
155235110|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
155235111|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
155235112|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
155235113|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
155235114|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
155235115|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
155235116|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
155235117|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
155235118|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
155235119|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235120|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235121|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235122|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
155235123|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
155235124|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
155235125|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
155235126|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
155235127|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
155235128|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
155235129|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
155235130|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
155235131|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
155235132|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
155235133|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
155235134|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
155235135|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
155235136|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
155235137|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
155235138|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
155235139|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
155235140|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
155235141|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
155235142|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
155235143|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155235144|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155235145|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
155235146|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155235147|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
155235148|NCT00456092|560295216|FG000|Treatment Phase (12 Weeks)|Other|1|||
155235149|NCT00456092|560295217|FG001|Treatment Phase (12 Weeks)|Other|0|||
155235150|NCT00456092|560295218|FG002|Treatment Phase (12 Weeks)|Other|1|||
155235151|NCT00456092|560295219|FG003|Treatment Phase (12 Weeks)|Other|0|||
155235152|NCT00456092|560295220|FG004|Treatment Phase (12 Weeks)|Other|0|||
155235153|NCT03228680|560295221|FG000|Overall Study|Adverse Event|13|||
155235154|NCT03228680|560295222|FG001|Overall Study|Adverse Event|18|||
155235155|NCT03228680|560295221|FG000|Overall Study|Randomization failure|0|||
155235156|NCT03228680|560295222|FG001|Overall Study|Randomization failure|1|||
155235157|NCT03228680|560295221|FG000|Overall Study|Withdrawal by Subject|1|||
155235158|NCT03228680|560295222|FG001|Overall Study|Withdrawal by Subject|0|||
155235159|NCT03228680|560295221|FG000|Overall Study|Other|9|||
155235160|NCT03228680|560295222|FG001|Overall Study|Other|16|||
155235161|NCT02039427|560295230|FG000|Overall Study|Duration of surgery > 3h|1|||
155235162|NCT02039427|560295231|FG001|Overall Study|Duration of surgery > 3h|1|||
155235163|NCT02039427|560295232|FG002|Overall Study|Duration of surgery > 3h|0|||
155235164|NCT02039427|560295233|FG003|Overall Study|Duration of surgery > 3h|0|||
155235165|NCT02039427|560295230|FG000|Overall Study|Withdrawal on concent|0|||
155235166|NCT02039427|560295231|FG001|Overall Study|Withdrawal on concent|0|||
155235167|NCT02039427|560295232|FG002|Overall Study|Withdrawal on concent|0|||
155235168|NCT02039427|560295233|FG003|Overall Study|Withdrawal on concent|1|||
155235169|NCT02039427|560295230|FG000|Overall Study|Cancellation of surgery|0|||
155235170|NCT02039427|560295231|FG001|Overall Study|Cancellation of surgery|0|||
155235171|NCT02039427|560295232|FG002|Overall Study|Cancellation of surgery|1|||
155235172|NCT02039427|560295233|FG003|Overall Study|Cancellation of surgery|0|||
155235173|NCT02039427|560295230|FG000|Overall Study|Loss of follow - up|1|||
155235174|NCT02039427|560295231|FG001|Overall Study|Loss of follow - up|0|||
155235175|NCT02039427|560295232|FG002|Overall Study|Loss of follow - up|2|||
155235176|NCT02039427|560295233|FG003|Overall Study|Loss of follow - up|4|||
155235177|NCT02039427|560295230|FG000|Overall Study|Steroid Use|1|||
155235178|NCT02039427|560295231|FG001|Overall Study|Steroid Use|0|||
155235179|NCT02039427|560295232|FG002|Overall Study|Steroid Use|0|||
155235180|NCT02039427|560295233|FG003|Overall Study|Steroid Use|0|||
155235181|NCT00087568|560295237|FG000|Overall Study|Adverse Event|4|||
155235182|NCT00087568|560295238|FG001|Overall Study|Adverse Event|0|||
155235183|NCT00087568|560295237|FG000|Overall Study|Withdrawal by Subject|1|||
155235184|NCT00087568|560295238|FG001|Overall Study|Withdrawal by Subject|1|||
155235185|NCT00087568|560295237|FG000|Overall Study|Lost to Follow-up|1|||
155235186|NCT00087568|560295238|FG001|Overall Study|Lost to Follow-up|0|||
155235187|NCT00087568|560295237|FG000|Overall Study|Lack of Efficacy|24|||
155235188|NCT00087568|560295238|FG001|Overall Study|Lack of Efficacy|1|||
155235189|NCT00226941|560295239|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
155235190|NCT00226941|560295240|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
155235191|NCT00226941|560295241|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
155235192|NCT00226941|560295242|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
155235193|NCT00226941|560295239|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
155235194|NCT00226941|560295240|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
155235195|NCT00226941|560295241|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
155235196|NCT00226941|560295242|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
155235197|NCT01513291|560295243|FG000|Treatment Period|Adverse Event|8|||
155235198|NCT01513291|560295244|FG001|Treatment Period|Adverse Event|4|||
155235199|NCT01513291|560295245|FG002|Treatment Period|Adverse Event|0|||
155235200|NCT01513291|560295246|FG003|Treatment Period|Adverse Event|0|||
155235201|NCT01513291|560295247|FG004|Treatment Period|Adverse Event|0|||
155235202|NCT01513291|560295243|FG000|Treatment Period|Lack of Efficacy|3|||
155235203|NCT01513291|560295244|FG001|Treatment Period|Lack of Efficacy|0|||
155235204|NCT01513291|560295245|FG002|Treatment Period|Lack of Efficacy|0|||
155235205|NCT01513291|560295246|FG003|Treatment Period|Lack of Efficacy|0|||
155235206|NCT01513291|560295247|FG004|Treatment Period|Lack of Efficacy|0|||
155235207|NCT01513291|560295243|FG000|Treatment Period|Lost to Follow-up|2|||
155235208|NCT01513291|560295244|FG001|Treatment Period|Lost to Follow-up|3|||
155235209|NCT01513291|560295245|FG002|Treatment Period|Lost to Follow-up|0|||
155235210|NCT01513291|560295246|FG003|Treatment Period|Lost to Follow-up|0|||
155235211|NCT01513291|560295247|FG004|Treatment Period|Lost to Follow-up|0|||
155235212|NCT01513291|560295243|FG000|Treatment Period|Physician Decision|1|||
155235213|NCT01513291|560295244|FG001|Treatment Period|Physician Decision|0|||
155235214|NCT01513291|560295245|FG002|Treatment Period|Physician Decision|0|||
155235215|NCT01513291|560295246|FG003|Treatment Period|Physician Decision|0|||
155235216|NCT01513291|560295247|FG004|Treatment Period|Physician Decision|0|||
155235217|NCT01513291|560295243|FG000|Treatment Period|Protocol Violation|1|||
155235218|NCT01513291|560295244|FG001|Treatment Period|Protocol Violation|2|||
155235219|NCT01513291|560295245|FG002|Treatment Period|Protocol Violation|0|||
155235220|NCT01513291|560295246|FG003|Treatment Period|Protocol Violation|0|||
155235221|NCT01513291|560295247|FG004|Treatment Period|Protocol Violation|0|||
155235222|NCT01513291|560295243|FG000|Treatment Period|Withdrawal by Subject|8|||
155235223|NCT01513291|560295244|FG001|Treatment Period|Withdrawal by Subject|5|||
155235224|NCT01513291|560295245|FG002|Treatment Period|Withdrawal by Subject|0|||
155235225|NCT01513291|560295246|FG003|Treatment Period|Withdrawal by Subject|0|||
155235226|NCT01513291|560295247|FG004|Treatment Period|Withdrawal by Subject|0|||
155235227|NCT01513291|560295243|FG000|Treatment Period|Randomized not treated|0|||
155235228|NCT01513291|560295244|FG001|Treatment Period|Randomized not treated|2|||
155235229|NCT01513291|560295245|FG002|Treatment Period|Randomized not treated|0|||
155235230|NCT01513291|560295246|FG003|Treatment Period|Randomized not treated|0|||
155235231|NCT01513291|560295247|FG004|Treatment Period|Randomized not treated|0|||
155235232|NCT01513291|560295243|FG000|Run-out Period|Lost to Follow-up|0|||
155235233|NCT01513291|560295244|FG001|Run-out Period|Lost to Follow-up|0|||
155235234|NCT01513291|560295245|FG002|Run-out Period|Lost to Follow-up|0|||
155235235|NCT01513291|560295246|FG003|Run-out Period|Lost to Follow-up|1|||
155235236|NCT01513291|560295247|FG004|Run-out Period|Lost to Follow-up|0|||
155235237|NCT01513291|560295243|FG000|Run-out Period|Withdrawal by Subject|0|||
155235238|NCT01513291|560295244|FG001|Run-out Period|Withdrawal by Subject|0|||
155235239|NCT01513291|560295245|FG002|Run-out Period|Withdrawal by Subject|0|||
155235240|NCT01513291|560295246|FG003|Run-out Period|Withdrawal by Subject|1|||
155235241|NCT01513291|560295247|FG004|Run-out Period|Withdrawal by Subject|0|||
155235242|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
155235243|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
155235244|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
155235245|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
155235246|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
155235247|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
155235248|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
155235249|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
155235250|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
155235251|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
155235252|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
155235253|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
155235254|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
155235255|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
155235256|NCT03732638|560295248|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
155235257|NCT03732638|560295249|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
155235258|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
155235259|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
155235260|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
155235261|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
155235262|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
155235263|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
155235264|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
155235265|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
155235266|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
155235267|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
155235268|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
155235269|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
155235270|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
155235271|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
155235272|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
155235273|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
155235274|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
155235275|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
155235276|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
155235277|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
155235278|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
155235279|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
155235280|NCT03732638|560295248|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
155235281|NCT03732638|560295249|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
155235282|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
155235283|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
155235284|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
155235285|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
155235286|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
155235287|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
155235288|NCT03732638|560295248|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
155235289|NCT03732638|560295249|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
155235290|NCT03728582|560295254|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
155235291|NCT03728582|560295255|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
155235292|NCT03728582|560295254|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
155235293|NCT03728582|560295255|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
155235294|NCT02992899|560295256|FG000|Overall Study|Withdrawal by Subject|1|||
155235295|NCT02992899|560295257|FG001|Overall Study|Withdrawal by Subject|0|||
155235296|NCT02992899|560295256|FG000|Overall Study|Lost to Follow-up|1|||
155235297|NCT02992899|560295257|FG001|Overall Study|Lost to Follow-up|3|||
155235298|NCT01332305|560295260|FG000|Overall Study|Adverse Event|1|||
155235299|NCT01332305|560295261|FG001|Overall Study|Adverse Event|4|||
155235300|NCT01332305|560295262|FG002|Overall Study|Adverse Event|6|||
155235301|NCT01332305|560295263|FG003|Overall Study|Adverse Event|3|||
155235302|NCT01332305|560295264|FG004|Overall Study|Adverse Event|5|||
155235303|NCT01332305|560295260|FG000|Overall Study|Withdrawal by Subject|6|||
155235304|NCT01332305|560295261|FG001|Overall Study|Withdrawal by Subject|5|||
155235305|NCT01332305|560295262|FG002|Overall Study|Withdrawal by Subject|4|||
155235306|NCT01332305|560295263|FG003|Overall Study|Withdrawal by Subject|1|||
155235307|NCT01332305|560295264|FG004|Overall Study|Withdrawal by Subject|0|||
155235308|NCT01332305|560295260|FG000|Overall Study|Lost to Follow-up|0|||
155235309|NCT01332305|560295261|FG001|Overall Study|Lost to Follow-up|2|||
155235310|NCT01332305|560295262|FG002|Overall Study|Lost to Follow-up|3|||
155235311|NCT01332305|560295263|FG003|Overall Study|Lost to Follow-up|2|||
155235312|NCT01332305|560295264|FG004|Overall Study|Lost to Follow-up|3|||
155235313|NCT01332305|560295260|FG000|Overall Study|Protocol Violation|1|||
155235314|NCT01332305|560295261|FG001|Overall Study|Protocol Violation|2|||
155235315|NCT01332305|560295262|FG002|Overall Study|Protocol Violation|1|||
155235316|NCT01332305|560295263|FG003|Overall Study|Protocol Violation|0|||
155235317|NCT01332305|560295264|FG004|Overall Study|Protocol Violation|3|||
155235318|NCT01332305|560295260|FG000|Overall Study|Withdrawal by Sponsor|1|||
155235319|NCT01332305|560295261|FG001|Overall Study|Withdrawal by Sponsor|0|||
155235320|NCT01332305|560295262|FG002|Overall Study|Withdrawal by Sponsor|0|||
155235321|NCT01332305|560295263|FG003|Overall Study|Withdrawal by Sponsor|1|||
155235322|NCT01332305|560295264|FG004|Overall Study|Withdrawal by Sponsor|1|||
155235323|NCT01332305|560295260|FG000|Overall Study|Treatment Failure|1|||
155235324|NCT01332305|560295261|FG001|Overall Study|Treatment Failure|1|||
155235325|NCT01332305|560295262|FG002|Overall Study|Treatment Failure|0|||
155235326|NCT01332305|560295263|FG003|Overall Study|Treatment Failure|0|||
155235327|NCT01332305|560295264|FG004|Overall Study|Treatment Failure|0|||
155235328|NCT01332305|560295260|FG000|Overall Study|Physician Decision|0|||
155235329|NCT01332305|560295261|FG001|Overall Study|Physician Decision|0|||
155235330|NCT01332305|560295262|FG002|Overall Study|Physician Decision|0|||
155235331|NCT01332305|560295263|FG003|Overall Study|Physician Decision|1|||
155235332|NCT01332305|560295264|FG004|Overall Study|Physician Decision|0|||
155235333|NCT01600040|560295267|FG000|Overall Study|Withdrawal by Subject|1|||
155235334|NCT01263873|560295268|FG000|Overall Study|One provider unable to complete numbers|1|||
155235335|NCT01263873|560295269|FG001|Overall Study|One provider unable to complete numbers|1|||
155235336|NCT00642304|560295274|FG000|Overall Study|Adverse Event|1|||
155235337|NCT00642304|560295274|FG000|Overall Study|Death|1|||
155235338|NCT00642304|560295274|FG000|Overall Study|Blood transfusion|2|||
155235339|NCT00642304|560295274|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
155235340|NCT00642304|560295274|FG000|Overall Study|Transplantation|1|||
155235341|NCT03217136|560295280|FG000|Overall Study|Lost to Follow-up|2|||
155235342|NCT03217136|560295281|FG001|Overall Study|Lost to Follow-up|1|||
155235343|NCT03217136|560295280|FG000|Overall Study|Site Randomized Participant in Error|0|||
155235344|NCT03217136|560295281|FG001|Overall Study|Site Randomized Participant in Error|1|||
155235345|NCT03217136|560295280|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
155235346|NCT03217136|560295281|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
155235347|NCT03217136|560295280|FG000|Overall Study|Dispensing Error|1|||
155235348|NCT03217136|560295281|FG001|Overall Study|Dispensing Error|0|||
155235349|NCT03217136|560295280|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
155235350|NCT03217136|560295281|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
155235351|NCT03192150|560295282|FG000|Overall Study|Adverse Event|14|||
155235352|NCT03192150|560295283|FG001|Overall Study|Adverse Event|12|||
155235353|NCT03192150|560295282|FG000|Overall Study|Lack of Efficacy|23|||
155235354|NCT03192150|560295283|FG001|Overall Study|Lack of Efficacy|30|||
155235355|NCT03192150|560295282|FG000|Overall Study|Lost to Follow-up|1|||
155235356|NCT03192150|560295283|FG001|Overall Study|Lost to Follow-up|1|||
155235357|NCT03192150|560295282|FG000|Overall Study|Withdrawal by Subject|4|||
155235358|NCT03192150|560295283|FG001|Overall Study|Withdrawal by Subject|2|||
155235359|NCT03192150|560295282|FG000|Overall Study|Protocol Violation|5|||
155235360|NCT03192150|560295283|FG001|Overall Study|Protocol Violation|2|||
155235361|NCT03192150|560295282|FG000|Overall Study|Surgery Canceled|6|||
155235362|NCT03192150|560295283|FG001|Overall Study|Surgery Canceled|2|||
155235363|NCT03192150|560295282|FG000|Overall Study|Other-Various Administrative Reasons|2|||
155235364|NCT03192150|560295283|FG001|Overall Study|Other-Various Administrative Reasons|5|||
155235365|NCT01824303|560295284|FG000|Randomized Study|Withdrawal by Subject|1|||
155235366|NCT01824303|560295285|FG001|Randomized Study|Withdrawal by Subject|1|||
155235367|NCT01824303|560295284|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
155235368|NCT01824303|560295285|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
155235369|NCT01859715|560295289|FG000|Overall Study|No 2nd VAS|16|||
155235370|NCT01859715|560295290|FG001|Overall Study|No 2nd VAS|8|||
155235371|NCT01859715|560295291|FG002|Overall Study|No 2nd VAS|23|||
155235372|NCT00086580|560295292|FG000|Treatment Period|Disease progression|9|||
155235373|NCT00086580|560295293|FG001|Treatment Period|Disease progression|8|||
155235374|NCT00086580|560295292|FG000|Treatment Period|Unable to comply with protocol|3|||
155235375|NCT00086580|560295293|FG001|Treatment Period|Unable to comply with protocol|1|||
155235376|NCT00086580|560295292|FG000|Treatment Period|Withdrawal by Subject|7|||
155235377|NCT00086580|560295293|FG001|Treatment Period|Withdrawal by Subject|8|||
155235378|NCT00086580|560295292|FG000|Treatment Period|Physician Decision|13|||
155235379|NCT00086580|560295293|FG001|Treatment Period|Physician Decision|7|||
155235380|NCT00086580|560295292|FG000|Treatment Period|AE - not treatment related|7|||
155235381|NCT00086580|560295293|FG001|Treatment Period|AE - not treatment related|7|||
155235382|NCT00086580|560295292|FG000|Treatment Period|Toxicity - treatment related|15|||
155235383|NCT00086580|560295293|FG001|Treatment Period|Toxicity - treatment related|15|||
155235384|NCT00086580|560295292|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
155235385|NCT00086580|560295293|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
155235386|NCT00086580|560295292|FG000|Treatment Period|Death|5|||
155235387|NCT00086580|560295293|FG001|Treatment Period|Death|7|||
155235388|NCT00086580|560295292|FG000|Treatment Period|Other|5|||
155235389|NCT00086580|560295293|FG001|Treatment Period|Other|3|||
155235390|NCT00086580|560295292|FG000|Follow-up Period|Disease progression|72|||
155235391|NCT00086580|560295293|FG001|Follow-up Period|Disease progression|99|||
155235392|NCT00086580|560295292|FG000|Follow-up Period|Unable to comply with protocol|5|||
155235393|NCT00086580|560295293|FG001|Follow-up Period|Unable to comply with protocol|0|||
155235394|NCT00086580|560295292|FG000|Follow-up Period|Withdrawal by Subject|6|||
155235395|NCT00086580|560295293|FG001|Follow-up Period|Withdrawal by Subject|6|||
155235396|NCT00086580|560295292|FG000|Follow-up Period|Physician Decision|0|||
155235397|NCT00086580|560295293|FG001|Follow-up Period|Physician Decision|1|||
155235398|NCT00086580|560295292|FG000|Follow-up Period|AE - not related|1|||
155235399|NCT00086580|560295293|FG001|Follow-up Period|AE - not related|0|||
155235400|NCT00086580|560295292|FG000|Follow-up Period|Death|13|||
155235401|NCT00086580|560295293|FG001|Follow-up Period|Death|7|||
155235402|NCT00086580|560295292|FG000|Follow-up Period|Other|7|||
155235403|NCT00086580|560295293|FG001|Follow-up Period|Other|6|||
155235404|NCT00086580|560295292|FG000|Observation Period|Unable to comply with protocol|1|||
155235405|NCT00086580|560295293|FG001|Observation Period|Unable to comply with protocol|1|||
155235406|NCT00086580|560295292|FG000|Observation Period|Withdrawal by Subject|4|||
155235407|NCT00086580|560295293|FG001|Observation Period|Withdrawal by Subject|2|||
155235408|NCT00086580|560295292|FG000|Observation Period|Death|33|||
155235409|NCT00086580|560295293|FG001|Observation Period|Death|55|||
155235410|NCT00086580|560295292|FG000|Observation Period|Other|8|||
155235411|NCT00086580|560295293|FG001|Observation Period|Other|7|||
155235412|NCT01000051|560295297|FG000|Overall Study|Withdrawal by Subject|1|||
155235413|NCT01000051|560295298|FG001|Overall Study|Withdrawal by Subject|1|||
155235414|NCT01000051|560295297|FG000|Overall Study|Disease Progression|1|||
155235415|NCT01000051|560295298|FG001|Overall Study|Disease Progression|0|||
155235416|NCT01000051|560295297|FG000|Overall Study|Serious noncompliance|1|||
155235417|NCT01000051|560295298|FG001|Overall Study|Serious noncompliance|0|||
155235418|NCT03773757|560295301|FG000|Overall Study|Withdrawal by Subject|2|||
155235419|NCT03773757|560295302|FG001|Overall Study|Withdrawal by Subject|4|||
155235420|NCT00550836|560295303|FG000|Overall Study|Withdrawal by Subject|3|||
155235421|NCT00550836|560295304|FG001|Overall Study|Withdrawal by Subject|9|||
155235422|NCT00179413|560295305|FG000|Overall Study|Adverse Event|38|||
155235423|NCT00179413|560295306|FG001|Overall Study|Adverse Event|20|||
155235424|NCT00179413|560295305|FG000|Overall Study|Withdrawal by Subject|87|||
155235425|NCT00179413|560295306|FG001|Overall Study|Withdrawal by Subject|95|||
155235426|NCT01192152|560295307|FG000|Period 1|left prematurely (while on treatment B)|0|||
155235427|NCT01192152|560295308|FG001|Period 1|left prematurely (while on treatment B)|1|||
155235428|NCT01192152|560295307|FG000|Period 3|family emergency|1|||
155235429|NCT01192152|560295308|FG001|Period 3|family emergency|0|||
155235430|NCT00827372|560296801|FG000|Overall Study|Adverse Event|5|||
155235431|NCT00827372|560296801|FG000|Overall Study|Lack of Efficacy|3|||
155235432|NCT00659646|560296802|FG000|Overall Study|Protocol Violation|12|||
155235433|NCT00659646|560296803|FG001|Overall Study|Protocol Violation|8|||
155235434|NCT00659646|560296802|FG000|Overall Study|Adverse Event|1|||
155235435|NCT00659646|560296803|FG001|Overall Study|Adverse Event|0|||
155235436|NCT00659646|560296802|FG000|Overall Study|Lost to Follow-up|1|||
155235437|NCT00659646|560296803|FG001|Overall Study|Lost to Follow-up|0|||
155235438|NCT00659646|560296802|FG000|Overall Study|protocol noncompliance after randomized|1|||
155235439|NCT00659646|560296803|FG001|Overall Study|protocol noncompliance after randomized|0|||
155235440|NCT02348489|560296807|FG000|Overall Study|Death|336|||
155235441|NCT02348489|560296808|FG001|Overall Study|Death|335|||
155235442|NCT02348489|560296807|FG000|Overall Study|Withdrawal by Subject|14|||
155235443|NCT02348489|560296808|FG001|Overall Study|Withdrawal by Subject|27|||
155235444|NCT02348489|560296807|FG000|Overall Study|Lost to Follow-up|3|||
155235445|NCT02348489|560296808|FG001|Overall Study|Lost to Follow-up|5|||
155235446|NCT02866682|560296809|FG000|Overall Study|Death|0|||
155235447|NCT02866682|560296810|FG001|Overall Study|Death|1|||
155235448|NCT02866682|560296809|FG000|Overall Study|Lost to Follow-up|0|||
155235449|NCT02866682|560296810|FG001|Overall Study|Lost to Follow-up|4|||
155235450|NCT02866682|560296809|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
155235451|NCT02866682|560296810|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
155235452|NCT02866682|560296809|FG000|Overall Study|Other|0|||
155235453|NCT02866682|560296810|FG001|Overall Study|Other|1|||
155235454|NCT00201006|560296811|FG000|Overall Study|Withdrawal by Subject|7|||
155235455|NCT00201006|560296812|FG001|Overall Study|Withdrawal by Subject|2|||
155235456|NCT00201006|560296813|FG002|Overall Study|Withdrawal by Subject|3|||
155235457|NCT00201006|560296811|FG000|Overall Study|Adverse Event|1|||
155235458|NCT00201006|560296812|FG001|Overall Study|Adverse Event|0|||
155235459|NCT00201006|560296813|FG002|Overall Study|Adverse Event|1|||
155235460|NCT01750268|560296815|FG000|Overall Study|Lost to Follow-up|0|||
155235461|NCT01750268|560296816|FG001|Overall Study|Lost to Follow-up|2|||
155235462|NCT01750268|560296815|FG000|Overall Study|Physician Decision|0|||
155235463|NCT01750268|560296816|FG001|Overall Study|Physician Decision|3|||
155235464|NCT01750268|560296815|FG000|Overall Study|Withdrawal by Subject|2|||
155235465|NCT01750268|560296816|FG001|Overall Study|Withdrawal by Subject|0|||
155235466|NCT02086591|560296821|FG000|Overall Study|Adverse Event|1|||
155235467|NCT02086591|560296821|FG000|Overall Study|Withdrawal by Subject|1|||
155235468|NCT02086591|560296821|FG000|Overall Study|protocol terminated|3|||
155235469|NCT01529645|560296822|FG000|Overall Study|Lost to Follow-up|0|||
155235470|NCT01529645|560296823|FG001|Overall Study|Lost to Follow-up|1|||
155235471|NCT01529645|560296824|FG002|Overall Study|Lost to Follow-up|1|||
155235472|NCT01529645|560296825|FG003|Overall Study|Lost to Follow-up|1|||
155235473|NCT01529645|560296826|FG004|Overall Study|Lost to Follow-up|1|||
155235474|NCT01529645|560296827|FG005|Overall Study|Lost to Follow-up|0|||
155235475|NCT01529645|560296828|FG006|Overall Study|Lost to Follow-up|2|||
155235476|NCT01529645|560296829|FG007|Overall Study|Lost to Follow-up|0|||
155235477|NCT01529645|560296830|FG008|Overall Study|Lost to Follow-up|1|||
155235478|NCT01529645|560296831|FG009|Overall Study|Lost to Follow-up|0|||
155235479|NCT01529645|560296822|FG000|Overall Study|SAE - Premature contractions|0|||
155235480|NCT01529645|560296823|FG001|Overall Study|SAE - Premature contractions|0|||
155235481|NCT01529645|560296824|FG002|Overall Study|SAE - Premature contractions|1|||
155235482|NCT01529645|560296825|FG003|Overall Study|SAE - Premature contractions|0|||
155235483|NCT01529645|560296826|FG004|Overall Study|SAE - Premature contractions|0|||
155235484|NCT01529645|560296827|FG005|Overall Study|SAE - Premature contractions|0|||
155235485|NCT01529645|560296828|FG006|Overall Study|SAE - Premature contractions|0|||
155235486|NCT01529645|560296829|FG007|Overall Study|SAE - Premature contractions|0|||
155235487|NCT01529645|560296830|FG008|Overall Study|SAE - Premature contractions|0|||
155235488|NCT01529645|560296831|FG009|Overall Study|SAE - Premature contractions|0|||
155235489|NCT01529645|560296822|FG000|Overall Study|Withdrawal by Subject|2|||
155235490|NCT01529645|560296823|FG001|Overall Study|Withdrawal by Subject|0|||
155235491|NCT01529645|560296824|FG002|Overall Study|Withdrawal by Subject|0|||
155235492|NCT01529645|560296825|FG003|Overall Study|Withdrawal by Subject|1|||
155235493|NCT01529645|560296826|FG004|Overall Study|Withdrawal by Subject|1|||
155235494|NCT01529645|560296827|FG005|Overall Study|Withdrawal by Subject|1|||
155235495|NCT01529645|560296828|FG006|Overall Study|Withdrawal by Subject|0|||
155235496|NCT01529645|560296829|FG007|Overall Study|Withdrawal by Subject|0|||
155235497|NCT01529645|560296830|FG008|Overall Study|Withdrawal by Subject|0|||
155235498|NCT01529645|560296831|FG009|Overall Study|Withdrawal by Subject|0|||
155235499|NCT00274716|560296836|FG000|Phase A|Other non-reported reason|4|||
155235500|NCT00274716|560296837|FG001|Phase A|Other non-reported reason|2|||
155235501|NCT00274716|560296838|FG002|Phase A|Other non-reported reason|1|||
155235502|NCT00274716|560296839|FG003|Phase A|Other non-reported reason|2|||
155235503|NCT00274716|560296840|FG004|Phase A|Other non-reported reason|0|||
155235504|NCT00274716|560296841|FG005|Phase A|Other non-reported reason|1|||
155235505|NCT00274716|560296836|FG000|Phase A|Participant moved|0|||
155235506|NCT00274716|560296837|FG001|Phase A|Participant moved|0|||
155235507|NCT00274716|560296838|FG002|Phase A|Participant moved|1|||
155235508|NCT00274716|560296839|FG003|Phase A|Participant moved|0|||
155235509|NCT00274716|560296840|FG004|Phase A|Participant moved|0|||
155235510|NCT00274716|560296841|FG005|Phase A|Participant moved|1|||
155235511|NCT00274716|560296836|FG000|Phase A|Site Terminated|0|||
155235512|NCT00274716|560296837|FG001|Phase A|Site Terminated|0|||
155235513|NCT00274716|560296838|FG002|Phase A|Site Terminated|0|||
155235514|NCT00274716|560296839|FG003|Phase A|Site Terminated|1|||
155235515|NCT00274716|560296840|FG004|Phase A|Site Terminated|0|||
155235516|NCT00274716|560296841|FG005|Phase A|Site Terminated|0|||
155235517|NCT00274716|560296836|FG000|Phase A|Protocol Violation|1|||
155235518|NCT00274716|560296837|FG001|Phase A|Protocol Violation|0|||
155235519|NCT00274716|560296838|FG002|Phase A|Protocol Violation|0|||
155235520|NCT00274716|560296839|FG003|Phase A|Protocol Violation|1|||
155235521|NCT00274716|560296840|FG004|Phase A|Protocol Violation|0|||
155235522|NCT00274716|560296841|FG005|Phase A|Protocol Violation|0|||
155235523|NCT00274716|560296836|FG000|Phase A|Met criteria for discontinuation|1|||
155235524|NCT00274716|560296837|FG001|Phase A|Met criteria for discontinuation|1|||
155235525|NCT00274716|560296838|FG002|Phase A|Met criteria for discontinuation|0|||
155235526|NCT00274716|560296839|FG003|Phase A|Met criteria for discontinuation|0|||
155235527|NCT00274716|560296840|FG004|Phase A|Met criteria for discontinuation|0|||
155235528|NCT00274716|560296841|FG005|Phase A|Met criteria for discontinuation|0|||
155235529|NCT00274716|560296836|FG000|Phase A|Withdrawal by Subject|2|||
155235530|NCT00274716|560296837|FG001|Phase A|Withdrawal by Subject|2|||
155235531|NCT00274716|560296838|FG002|Phase A|Withdrawal by Subject|1|||
155235532|NCT00274716|560296839|FG003|Phase A|Withdrawal by Subject|3|||
155235533|NCT00274716|560296840|FG004|Phase A|Withdrawal by Subject|0|||
155235534|NCT00274716|560296841|FG005|Phase A|Withdrawal by Subject|1|||
155235535|NCT00274716|560296836|FG000|Phase A|Adverse Event|2|||
155235536|NCT00274716|560296837|FG001|Phase A|Adverse Event|3|||
155235537|NCT00274716|560296838|FG002|Phase A|Adverse Event|3|||
155235538|NCT00274716|560296839|FG003|Phase A|Adverse Event|0|||
155235539|NCT00274716|560296840|FG004|Phase A|Adverse Event|2|||
155235540|NCT00274716|560296841|FG005|Phase A|Adverse Event|0|||
155235541|NCT00274716|560296836|FG000|Phase A|Completed but did not enter Phase B|1|||
155235542|NCT00274716|560296837|FG001|Phase A|Completed but did not enter Phase B|2|||
155235543|NCT00274716|560296838|FG002|Phase A|Completed but did not enter Phase B|2|||
155235544|NCT00274716|560296839|FG003|Phase A|Completed but did not enter Phase B|2|||
155235545|NCT00274716|560296840|FG004|Phase A|Completed but did not enter Phase B|1|||
155235546|NCT00274716|560296841|FG005|Phase A|Completed but did not enter Phase B|1|||
155235547|NCT00274716|560296836|FG000|Phase B|Adverse Event|0|||
155235548|NCT00274716|560296837|FG001|Phase B|Adverse Event|0|||
155235549|NCT00274716|560296838|FG002|Phase B|Adverse Event|2|||
155235550|NCT00274716|560296839|FG003|Phase B|Adverse Event|0|||
155235551|NCT00274716|560296840|FG004|Phase B|Adverse Event|0|||
155235552|NCT00274716|560296841|FG005|Phase B|Adverse Event|1|||
155235553|NCT00274716|560296836|FG000|Phase B|Protocol Violation|0|||
155235554|NCT00274716|560296837|FG001|Phase B|Protocol Violation|2|||
155235555|NCT00274716|560296838|FG002|Phase B|Protocol Violation|0|||
155235556|NCT00274716|560296839|FG003|Phase B|Protocol Violation|0|||
155235557|NCT00274716|560296840|FG004|Phase B|Protocol Violation|0|||
155235558|NCT00274716|560296841|FG005|Phase B|Protocol Violation|0|||
155235559|NCT00274716|560296836|FG000|Phase B|Withdrawal by Subject|0|||
155235560|NCT00274716|560296837|FG001|Phase B|Withdrawal by Subject|1|||
155235561|NCT00274716|560296838|FG002|Phase B|Withdrawal by Subject|0|||
155235562|NCT00274716|560296839|FG003|Phase B|Withdrawal by Subject|0|||
155235563|NCT00274716|560296840|FG004|Phase B|Withdrawal by Subject|0|||
155235564|NCT00274716|560296841|FG005|Phase B|Withdrawal by Subject|0|||
155235565|NCT00274716|560296836|FG000|Phase B|Participant moved|1|||
155235566|NCT00274716|560296837|FG001|Phase B|Participant moved|0|||
155235567|NCT00274716|560296838|FG002|Phase B|Participant moved|0|||
155235568|NCT00274716|560296839|FG003|Phase B|Participant moved|0|||
155235569|NCT00274716|560296840|FG004|Phase B|Participant moved|0|||
155235570|NCT00274716|560296841|FG005|Phase B|Participant moved|0|||
155235571|NCT00274716|560296836|FG000|Phase B|Other non-reported reason|0|||
155235572|NCT00274716|560296837|FG001|Phase B|Other non-reported reason|0|||
155235573|NCT00274716|560296838|FG002|Phase B|Other non-reported reason|1|||
155235574|NCT00274716|560296839|FG003|Phase B|Other non-reported reason|1|||
155235575|NCT00274716|560296840|FG004|Phase B|Other non-reported reason|0|||
155235576|NCT00274716|560296841|FG005|Phase B|Other non-reported reason|0|||
155235577|NCT00274716|560296836|FG000|Phase B|Lost to Follow-up|0|||
155235578|NCT00274716|560296837|FG001|Phase B|Lost to Follow-up|1|||
155235579|NCT00274716|560296838|FG002|Phase B|Lost to Follow-up|0|||
155235580|NCT00274716|560296839|FG003|Phase B|Lost to Follow-up|0|||
155235581|NCT00274716|560296840|FG004|Phase B|Lost to Follow-up|0|||
155235582|NCT00274716|560296841|FG005|Phase B|Lost to Follow-up|0|||
155235583|NCT04193202|560296842|FG000|Overall Study|Adverse Event|2|||
155235584|NCT04193202|560296843|FG001|Overall Study|Adverse Event|1|||
155235585|NCT04193202|560296842|FG000|Overall Study|Death|0|||
155235586|NCT04193202|560296843|FG001|Overall Study|Death|1|||
155235587|NCT04193202|560296842|FG000|Overall Study|Physician Decision|1|||
155235588|NCT04193202|560296843|FG001|Overall Study|Physician Decision|1|||
155235589|NCT04193202|560296842|FG000|Overall Study|Protocol Violation|2|||
155235590|NCT04193202|560296843|FG001|Overall Study|Protocol Violation|2|||
155235591|NCT04193202|560296842|FG000|Overall Study|Withdrawal by Subject|11|||
155235592|NCT04193202|560296843|FG001|Overall Study|Withdrawal by Subject|5|||
155235593|NCT00723801|560296844|FG000|Overall Study|Lost to Follow-up|1|||
155235594|NCT00723801|560296845|FG001|Overall Study|Lost to Follow-up|2|||
155235595|NCT00723801|560296844|FG000|Overall Study|Protocol Violation|2|||
155235596|NCT00723801|560296845|FG001|Overall Study|Protocol Violation|1|||
155235597|NCT02167035|560296846|FG000|Overall Study|Adverse Event|2|||
155235598|NCT02167035|560296847|FG001|Overall Study|Adverse Event|2|||
155235599|NCT02167035|560296846|FG000|Overall Study|Lost to Follow-up|3|||
155235600|NCT02167035|560296847|FG001|Overall Study|Lost to Follow-up|3|||
155235601|NCT02167035|560296846|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
155235602|NCT02167035|560296847|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
155235603|NCT02148003|560296848|FG000|Overall Study|Failed inclusion criteria|1|||
155235604|NCT02148003|560296849|FG001|Overall Study|Failed inclusion criteria|0|||
155235605|NCT02148003|560296848|FG000|Overall Study|Met exclusion criteria|0|||
155235606|NCT02148003|560296849|FG001|Overall Study|Met exclusion criteria|1|||
155235607|NCT02148003|560296848|FG000|Overall Study|Withdrawal by Subject|0|||
155235608|NCT02148003|560296849|FG001|Overall Study|Withdrawal by Subject|1|||
155235609|NCT02489981|560296850|FG000|Overall Study|Adverse Event|21|||
155235610|NCT02489981|560296850|FG000|Overall Study|Insufficient effectiveness|16|||
155235611|NCT02489981|560296850|FG000|Overall Study|Improved|31|||
155235612|NCT02489981|560296850|FG000|Overall Study|Lost to Follow-up|31|||
155235613|NCT02489981|560296850|FG000|Overall Study|Other than listed|28|||
155235614|NCT01565993|560296858|FG000|Overall Study|Physician Decision|0|||
155235615|NCT01565993|560296859|FG001|Overall Study|Physician Decision|3|||
155235616|NCT02732847|560296860|FG000|Overall Study|some filled early|42|||
155235617|NCT02732847|560296861|FG001|Overall Study|some filled early|42|||
155235618|NCT02370888|560296862|FG000|Overall Study|disease progression|2|||
155235619|NCT02370888|560296862|FG000|Overall Study|did not meet chimerism criteria|6|||
155235620|NCT01034397|560296863|FG000|Overall Study|Lack of compliance|0|||
155235621|NCT01034397|560296864|FG001|Overall Study|Lack of compliance|1|||
155235622|NCT01034397|560296863|FG000|Overall Study|Lack of Efficacy|3|||
155235623|NCT01034397|560296864|FG001|Overall Study|Lack of Efficacy|0|||
155235624|NCT01034397|560296863|FG000|Overall Study|Adverse Event|4|||
155235625|NCT01034397|560296864|FG001|Overall Study|Adverse Event|0|||
155235626|NCT01034397|560296863|FG000|Overall Study|Other|0|||
155235627|NCT01034397|560296864|FG001|Overall Study|Other|1|||
155235628|NCT04574362|560296865|FG000|Overall Study|Other|0|||
155235629|NCT04574362|560296866|FG001|Overall Study|Other|5|||
155235630|NCT04574362|560296865|FG000|Overall Study|COVID-19|0|||
155235631|NCT04574362|560296866|FG001|Overall Study|COVID-19|1|||
155235632|NCT04574362|560296865|FG000|Overall Study|Adverse Event|1|||
155235633|NCT04574362|560296866|FG001|Overall Study|Adverse Event|1|||
155235634|NCT04574362|560296865|FG000|Overall Study|Withdrawal by Subject|2|||
155235635|NCT04574362|560296866|FG001|Overall Study|Withdrawal by Subject|4|||
155235636|NCT04574362|560296865|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
155235637|NCT04574362|560296866|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
155235638|NCT04574362|560296865|FG000|Overall Study|Participant refused to come to the hospital|1|||
155235639|NCT04574362|560296866|FG001|Overall Study|Participant refused to come to the hospital|0|||
155235640|NCT04574362|560296865|FG000|Overall Study|Participant refused the visit|1|||
155235641|NCT04574362|560296866|FG001|Overall Study|Participant refused the visit|0|||
155235642|NCT04574362|560296865|FG000|Overall Study|Participant quit early because of business trip|1|||
155235643|NCT04574362|560296866|FG001|Overall Study|Participant quit early because of business trip|0|||
155235644|NCT01785524|560296867|FG000|Overall Study|Withdrawal by Subject|2|||
155235645|NCT01785524|560296868|FG001|Overall Study|Withdrawal by Subject|2|||
155235646|NCT02104557|560296869|FG000|Overall Study|Adverse Event|24|||
155235647|NCT02104557|560296869|FG000|Overall Study|Lost to Follow-up|34|||
155235648|NCT02104557|560296869|FG000|Overall Study|Violated the usage and dosage|14|||
155235649|NCT02104557|560296869|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
155235650|NCT02104557|560296869|FG000|Overall Study|Administered Sayana prior to the contract|1|||
155235651|NCT02104557|560296869|FG000|Overall Study|Other|17|||
155235652|NCT02104557|560296869|FG000|Overall Study|Change to other contraception methods|5|||
155235653|NCT02104557|560296869|FG000|Overall Study|Discontinuation due to no pain|1|||
155235654|NCT02104557|560296869|FG000|Overall Study|Withdrawal consent|2|||
155235655|NCT02104557|560296869|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
155235656|NCT02104557|560296869|FG000|Overall Study|Discontinuation of contraception|9|||
155235657|NCT02579616|560296870|FG000|Overall Study|Participants did not receive treatment|3|||
155235658|NCT02178475|560296871|FG000|Overall Study|Withdrawal by Subject|7|||
155235659|NCT02178475|560296871|FG000|Overall Study|Lost to Follow-up|10|||
155235660|NCT02178475|560296871|FG000|Overall Study|Death|13|||
155235661|NCT02178475|560296871|FG000|Overall Study|Protocol-specified Criteria|99|||
155235662|NCT01430585|560296872|FG000|Overall Study|Death|1|||
155235663|NCT01430585|560296872|FG000|Overall Study|Objective Progression or Relapse|3|||
155235664|NCT01430585|560296872|FG000|Overall Study|Study Terminated by Sponsor|3|||
155235665|NCT01430585|560296872|FG000|Overall Study|Other|7|||
155235666|NCT00482391|560296873|FG000|Overall Study|Withdrawal by Subject|1|||
155235667|NCT00482391|560296873|FG000|Overall Study|Adverse Event|1|||
155235668|NCT00482391|560296873|FG000|Overall Study|Death|1|||
155235669|NCT01448850|560296874|FG000|Overall Study|Death|3|||
155235670|NCT01448850|560296875|FG001|Overall Study|Death|6|||
155235671|NCT01448850|560296874|FG000|Overall Study|Withdrawal by Subject|13|||
155235672|NCT01448850|560296875|FG001|Overall Study|Withdrawal by Subject|21|||
155235673|NCT01448850|560296874|FG000|Overall Study|Lost to Follow-up|3|||
155235674|NCT01448850|560296875|FG001|Overall Study|Lost to Follow-up|1|||
155235675|NCT01448850|560296874|FG000|Overall Study|Other|15|||
155235676|NCT01448850|560296875|FG001|Overall Study|Other|12|||
155235677|NCT00779766|560296876|FG000|Month 24|Serious Adverse Event|2|||
155235678|NCT00779766|560296877|FG001|Month 24|Serious Adverse Event|3|||
155235679|NCT00779766|560296876|FG000|Month 24|Adverse Event|3|||
155235680|NCT00779766|560296877|FG001|Month 24|Adverse Event|3|||
155235681|NCT00779766|560296876|FG000|Month 24|Protocol Violation|3|||
155235682|NCT00779766|560296877|FG001|Month 24|Protocol Violation|1|||
155235683|NCT00779766|560296876|FG000|Month 24|Withdrawal by Subject|159|||
155235684|NCT00779766|560296877|FG001|Month 24|Withdrawal by Subject|127|||
155235685|NCT00779766|560296876|FG000|Month 24|Migrated/moved from study area|138|||
155235686|NCT00779766|560296877|FG001|Month 24|Migrated/moved from study area|162|||
155235687|NCT00779766|560296876|FG000|Month 24|Lost to Follow-up|9|||
155235688|NCT00779766|560296877|FG001|Month 24|Lost to Follow-up|9|||
155235689|NCT00779766|560296876|FG000|Month 24|Other|18|||
155235690|NCT00779766|560296877|FG001|Month 24|Other|27|||
155235691|NCT00779766|560296876|FG000|Month 48|Withdrawal by Subject|68|||
155235692|NCT00779766|560296877|FG001|Month 48|Withdrawal by Subject|63|||
155235693|NCT00779766|560296876|FG000|Month 48|Migrated/moved from study area|76|||
155235694|NCT00779766|560296877|FG001|Month 48|Migrated/moved from study area|75|||
155235695|NCT00779766|560296876|FG000|Month 48|Lost to Follow-up|29|||
155235696|NCT00779766|560296877|FG001|Month 48|Lost to Follow-up|30|||
155235697|NCT00779766|560296876|FG000|Month 48|Other|1|||
155235698|NCT00779766|560296877|FG001|Month 48|Other|0|||
155235699|NCT00779766|560296876|FG000|Month 72|Withdrawal by Subject|55|||
155235700|NCT00779766|560296877|FG001|Month 72|Withdrawal by Subject|71|||
155235701|NCT00779766|560296876|FG000|Month 72|Migrated/moved from study area|124|||
155235702|NCT00779766|560296877|FG001|Month 72|Migrated/moved from study area|109|||
155235703|NCT00779766|560296876|FG000|Month 72|Lost to Follow-up|6|||
155235704|NCT00779766|560296877|FG001|Month 72|Lost to Follow-up|8|||
155235705|NCT00779766|560296876|FG000|Month 72|Other|0|||
155235706|NCT00779766|560296877|FG001|Month 72|Other|1|||
155235707|NCT01412424|560296882|FG000|Core Treatment Period|Treatment Failure|24|||
155235708|NCT01412424|560296882|FG000|Core Treatment Period|Adverse Event|21|||
155235709|NCT01412424|560296882|FG000|Core Treatment Period|Patient Request|5|||
155235710|NCT01412424|560296882|FG000|Core Treatment Period|Lost to Follow-up|2|||
155235711|NCT01412424|560296882|FG000|Core Treatment Period|Sponsor Request|1|||
155235712|NCT01412424|560296882|FG000|Extension Treatment Period|Adverse Event|2|||
155235713|NCT01412424|560296882|FG000|Extension Treatment Period|Treatment Failure|2|||
155235714|NCT01412424|560296882|FG000|Extension Treatment Period|Patient Request|2|||
155235715|NCT01274637|560296883|FG000|Overall Study|Withdrawal by Subject|0|||
155235716|NCT01274637|560296884|FG001|Overall Study|Withdrawal by Subject|1|||
155235717|NCT01274637|560296883|FG000|Overall Study|Lost to Follow-up|0|||
155235718|NCT01274637|560296884|FG001|Overall Study|Lost to Follow-up|1|||
155235719|NCT03296696|560296891|FG000|Overall Study|Started Other Antitumor Therapy|1|||
155235720|NCT03296696|560296892|FG001|Overall Study|Started Other Antitumor Therapy|2|||
155235721|NCT03296696|560296893|FG002|Overall Study|Started Other Antitumor Therapy|1|||
155235722|NCT03296696|560296894|FG003|Overall Study|Started Other Antitumor Therapy|2|||
155235723|NCT03296696|560296895|FG004|Overall Study|Started Other Antitumor Therapy|1|||
155235724|NCT03296696|560296896|FG005|Overall Study|Started Other Antitumor Therapy|1|||
155235725|NCT03296696|560296897|FG006|Overall Study|Started Other Antitumor Therapy|2|||
155235726|NCT03296696|560296898|FG007|Overall Study|Started Other Antitumor Therapy|3|||
155235727|NCT03296696|560296899|FG008|Overall Study|Started Other Antitumor Therapy|1|||
155235728|NCT03296696|560296900|FG009|Overall Study|Started Other Antitumor Therapy|0|||
155235729|NCT03296696|560296891|FG000|Overall Study|Death|0|||
155235730|NCT03296696|560296892|FG001|Overall Study|Death|1|||
155235731|NCT03296696|560296893|FG002|Overall Study|Death|1|||
155235732|NCT03296696|560296894|FG003|Overall Study|Death|2|||
155235733|NCT03296696|560296895|FG004|Overall Study|Death|2|||
155235734|NCT03296696|560296896|FG005|Overall Study|Death|3|||
155235735|NCT03296696|560296897|FG006|Overall Study|Death|1|||
155235736|NCT03296696|560296898|FG007|Overall Study|Death|2|||
155235737|NCT03296696|560296899|FG008|Overall Study|Death|0|||
155235738|NCT03296696|560296900|FG009|Overall Study|Death|0|||
155235739|NCT03296696|560296891|FG000|Overall Study|Withdrawal by Subject|0|||
155235740|NCT03296696|560296892|FG001|Overall Study|Withdrawal by Subject|0|||
155235741|NCT03296696|560296893|FG002|Overall Study|Withdrawal by Subject|1|||
155235742|NCT03296696|560296894|FG003|Overall Study|Withdrawal by Subject|0|||
155235743|NCT03296696|560296895|FG004|Overall Study|Withdrawal by Subject|1|||
155235744|NCT03296696|560296896|FG005|Overall Study|Withdrawal by Subject|0|||
155235745|NCT03296696|560296897|FG006|Overall Study|Withdrawal by Subject|0|||
155235746|NCT03296696|560296898|FG007|Overall Study|Withdrawal by Subject|0|||
155235747|NCT03296696|560296899|FG008|Overall Study|Withdrawal by Subject|0|||
155235748|NCT03296696|560296900|FG009|Overall Study|Withdrawal by Subject|1|||
155235749|NCT04694131|560296901|FG000|Overall Study|Withdrawal by Subject|7|||
155235750|NCT04694131|560296901|FG000|Overall Study|Screen Failure|1|||
155235751|NCT04694131|560296901|FG000|Overall Study|High stimulation threshold|3|||
155235752|NCT00261716|560296902|FG000|Overall Study|Withdrawal by Subject|6|||
155235753|NCT00261716|560296903|FG001|Overall Study|Withdrawal by Subject|8|||
155235754|NCT00261716|560296902|FG000|Overall Study|Lost to Follow-up|0|||
155235755|NCT00261716|560296903|FG001|Overall Study|Lost to Follow-up|2|||
155235756|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
155235757|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
155235758|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
155235759|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
155235760|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
155235761|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
155235762|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
155235763|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
155235764|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
155235765|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
155235766|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
155235767|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
155235768|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
155235769|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
155235770|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
155235771|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
155235772|NCT02047110|560296906|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
155235773|NCT02047110|560296907|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
155235774|NCT02047110|560296908|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
155235775|NCT02047110|560296909|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
155235776|NCT02047110|560296906|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
155235777|NCT02047110|560296907|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
155235778|NCT02047110|560296908|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
155235779|NCT02047110|560296909|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
155235780|NCT02047110|560296906|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
155235781|NCT02047110|560296907|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
155235782|NCT02047110|560296908|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
155235783|NCT02047110|560296909|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
155235784|NCT02047110|560296906|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
155235785|NCT02047110|560296907|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
155235786|NCT02047110|560296908|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
155235787|NCT02047110|560296909|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
155235788|NCT02047110|560296906|FG000|Escape Treatment Period|Adverse Event|1|||
155235789|NCT02047110|560296907|FG001|Escape Treatment Period|Adverse Event|2|||
155235790|NCT02047110|560296908|FG002|Escape Treatment Period|Adverse Event|2|||
155235791|NCT02047110|560296909|FG003|Escape Treatment Period|Adverse Event|0|||
155235792|NCT02047110|560296906|FG000|Escape Treatment Period|Other than specified|1|||
155235793|NCT02047110|560296907|FG001|Escape Treatment Period|Other than specified|2|||
155235794|NCT02047110|560296908|FG002|Escape Treatment Period|Other than specified|0|||
155235795|NCT02047110|560296909|FG003|Escape Treatment Period|Other than specified|1|||
155235796|NCT02047110|560296906|FG000|OLE Treatment Period|Other than specified|0|||
155235797|NCT02047110|560296907|FG001|OLE Treatment Period|Other than specified|0|||
155235798|NCT02047110|560296908|FG002|OLE Treatment Period|Other than specified|1|||
155235799|NCT02047110|560296909|FG003|OLE Treatment Period|Other than specified|0|||
155235800|NCT00705575|560296910|FG000|Overall Study|Abnormal laboratory value(s)|0|||
155235801|NCT00705575|560296911|FG001|Overall Study|Abnormal laboratory value(s)|3|||
155235802|NCT00705575|560296910|FG000|Overall Study|Abnormal test procedure result(s)|2|||
155235803|NCT00705575|560296911|FG001|Overall Study|Abnormal test procedure result(s)|12|||
155235804|NCT00705575|560296910|FG000|Overall Study|Adverse Event|11|||
155235805|NCT00705575|560296911|FG001|Overall Study|Adverse Event|15|||
155235806|NCT00705575|560296910|FG000|Overall Study|Lost to Follow-up|3|||
155235807|NCT00705575|560296911|FG001|Overall Study|Lost to Follow-up|4|||
155235808|NCT00705575|560296910|FG000|Overall Study|Protocol Violation|2|||
155235809|NCT00705575|560296911|FG001|Overall Study|Protocol Violation|2|||
155235810|NCT00705575|560296910|FG000|Overall Study|Withdrawal by Subject|5|||
155235811|NCT00705575|560296911|FG001|Overall Study|Withdrawal by Subject|10|||
155235812|NCT02170727|560296913|FG000|Overall Study|Lost to Follow-up|1|||
155235813|NCT02170727|560296914|FG001|Overall Study|Lost to Follow-up|0|||
155235814|NCT02170727|560296913|FG000|Overall Study|Withdrawal by Subject|2|||
155235815|NCT02170727|560296914|FG001|Overall Study|Withdrawal by Subject|0|||
155235816|NCT01959581|560296917|FG000|Overall Study|Lost to Follow-up|5|||
155235817|NCT00057746|560296918|FG000|Overall Study|Withdrawal by Subject|0|||
155235818|NCT00057746|560296919|FG001|Overall Study|Withdrawal by Subject|0|||
155235819|NCT00057746|560296920|FG002|Overall Study|Withdrawal by Subject|1|||
155235820|NCT01660412|560296925|FG000|Overall Study|Protocol Violation|0|||
155235821|NCT01660412|560296926|FG001|Overall Study|Protocol Violation|3|||
155235822|NCT03551210|560296927|FG000|Overall Study|Adverse Event|5|||
155235823|NCT03551210|560296928|FG001|Overall Study|Adverse Event|6|||
155235824|NCT03551210|560296927|FG000|Overall Study|Withdrawal by Subject|1|||
155235825|NCT03551210|560296928|FG001|Overall Study|Withdrawal by Subject|7|||
155235826|NCT03551210|560296927|FG000|Overall Study|Needed in other antibiotic treatment|2|||
155235827|NCT03551210|560296928|FG001|Overall Study|Needed in other antibiotic treatment|5|||
155235828|NCT03551210|560296927|FG000|Overall Study|Lost to Follow-up|1|||
155235829|NCT03551210|560296928|FG001|Overall Study|Lost to Follow-up|1|||
155235830|NCT03551210|560296927|FG000|Overall Study|Absence of visit 4 and 5|1|||
155235831|NCT03551210|560296928|FG001|Overall Study|Absence of visit 4 and 5|0|||
155235832|NCT03551210|560296927|FG000|Overall Study|No drug for dispensing|0|||
155235833|NCT03551210|560296928|FG001|Overall Study|No drug for dispensing|1|||
155235834|NCT03265119|560296929|FG000|Overall Study|Adverse Event|2|||
155235835|NCT03265119|560296930|FG001|Overall Study|Adverse Event|1|||
155235836|NCT03265119|560296929|FG000|Overall Study|Lack of Efficacy|3|||
155235837|NCT03265119|560296930|FG001|Overall Study|Lack of Efficacy|0|||
155235838|NCT03265119|560296929|FG000|Overall Study|Protocol Violation|1|||
155235839|NCT03265119|560296930|FG001|Overall Study|Protocol Violation|2|||
155235840|NCT03265119|560296929|FG000|Overall Study|Withdrawal by Subject|2|||
155235841|NCT03265119|560296930|FG001|Overall Study|Withdrawal by Subject|4|||
155235842|NCT03265119|560296929|FG000|Overall Study|Lost to Follow-up|1|||
155235843|NCT03265119|560296930|FG001|Overall Study|Lost to Follow-up|0|||
155235844|NCT03265119|560296929|FG000|Overall Study|Lack of Compliance|1|||
155235845|NCT03265119|560296930|FG001|Overall Study|Lack of Compliance|0|||
155235846|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
155235847|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235848|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235849|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235850|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235851|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
155235852|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
155235853|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235854|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235855|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235856|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235857|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
155235858|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
155235859|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235860|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235861|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235862|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235863|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
155235864|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
155235865|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235866|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235867|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235868|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235869|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
155235870|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
155235871|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235872|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235873|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235874|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235875|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
155235876|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
155235877|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235878|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235879|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235880|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235881|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
155235882|NCT02139644|560298193|FG000|Run-In Period (Pre-assignment)|Other|6|||
155235883|NCT02139644|560298194|FG001|Run-In Period (Pre-assignment)|Other|0|||
155235884|NCT02139644|560298195|FG002|Run-In Period (Pre-assignment)|Other|0|||
155235885|NCT02139644|560298196|FG003|Run-In Period (Pre-assignment)|Other|0|||
155235886|NCT02139644|560298197|FG004|Run-In Period (Pre-assignment)|Other|0|||
155235887|NCT02139644|560298198|FG005|Run-In Period (Pre-assignment)|Other|0|||
155235888|NCT02139644|560298193|FG000|Treatment Period|Adverse Event|0|||
155235889|NCT02139644|560298194|FG001|Treatment Period|Adverse Event|0|||
155235890|NCT02139644|560298195|FG002|Treatment Period|Adverse Event|3|||
155235891|NCT02139644|560298196|FG003|Treatment Period|Adverse Event|2|||
155235892|NCT02139644|560298197|FG004|Treatment Period|Adverse Event|1|||
155235893|NCT02139644|560298198|FG005|Treatment Period|Adverse Event|6|||
155235894|NCT02139644|560298193|FG000|Treatment Period|Withdrawal by Subject|0|||
155235895|NCT02139644|560298194|FG001|Treatment Period|Withdrawal by Subject|0|||
155235896|NCT02139644|560298195|FG002|Treatment Period|Withdrawal by Subject|2|||
155235897|NCT02139644|560298196|FG003|Treatment Period|Withdrawal by Subject|2|||
155235898|NCT02139644|560298197|FG004|Treatment Period|Withdrawal by Subject|3|||
155235899|NCT02139644|560298198|FG005|Treatment Period|Withdrawal by Subject|2|||
155235900|NCT02139644|560298193|FG000|Treatment Period|Non-compliance|0|||
155235901|NCT02139644|560298194|FG001|Treatment Period|Non-compliance|0|||
155235902|NCT02139644|560298195|FG002|Treatment Period|Non-compliance|0|||
155235903|NCT02139644|560298196|FG003|Treatment Period|Non-compliance|1|||
155235904|NCT02139644|560298197|FG004|Treatment Period|Non-compliance|0|||
155235905|NCT02139644|560298198|FG005|Treatment Period|Non-compliance|0|||
155235906|NCT02139644|560298193|FG000|Treatment Period|Protocol Violation|0|||
155235907|NCT02139644|560298194|FG001|Treatment Period|Protocol Violation|0|||
155235908|NCT02139644|560298195|FG002|Treatment Period|Protocol Violation|0|||
155235909|NCT02139644|560298196|FG003|Treatment Period|Protocol Violation|1|||
155235910|NCT02139644|560298197|FG004|Treatment Period|Protocol Violation|1|||
155235911|NCT02139644|560298198|FG005|Treatment Period|Protocol Violation|1|||
155235912|NCT02139644|560298193|FG000|Treatment Period|Disease progression|0|||
155235913|NCT02139644|560298194|FG001|Treatment Period|Disease progression|0|||
155235914|NCT02139644|560298195|FG002|Treatment Period|Disease progression|0|||
155235915|NCT02139644|560298196|FG003|Treatment Period|Disease progression|1|||
155235916|NCT02139644|560298197|FG004|Treatment Period|Disease progression|1|||
155235917|NCT02139644|560298198|FG005|Treatment Period|Disease progression|2|||
155235918|NCT02139644|560298193|FG000|Treatment Period|Lost to Follow-up|0|||
155235919|NCT02139644|560298194|FG001|Treatment Period|Lost to Follow-up|0|||
155235920|NCT02139644|560298195|FG002|Treatment Period|Lost to Follow-up|1|||
155235921|NCT02139644|560298196|FG003|Treatment Period|Lost to Follow-up|1|||
155235922|NCT02139644|560298197|FG004|Treatment Period|Lost to Follow-up|1|||
155235923|NCT02139644|560298198|FG005|Treatment Period|Lost to Follow-up|1|||
155235924|NCT02139644|560298193|FG000|Treatment Period|Lack of Efficacy|0|||
155235925|NCT02139644|560298194|FG001|Treatment Period|Lack of Efficacy|0|||
155235926|NCT02139644|560298195|FG002|Treatment Period|Lack of Efficacy|1|||
155235927|NCT02139644|560298196|FG003|Treatment Period|Lack of Efficacy|0|||
155235928|NCT02139644|560298197|FG004|Treatment Period|Lack of Efficacy|1|||
155235929|NCT02139644|560298198|FG005|Treatment Period|Lack of Efficacy|4|||
155235930|NCT02139644|560298193|FG000|Treatment Period|Other|0|||
155235931|NCT02139644|560298194|FG001|Treatment Period|Other|3|||
155235932|NCT02139644|560298195|FG002|Treatment Period|Other|1|||
155235933|NCT02139644|560298196|FG003|Treatment Period|Other|1|||
155235934|NCT02139644|560298197|FG004|Treatment Period|Other|0|||
155235935|NCT02139644|560298198|FG005|Treatment Period|Other|1|||
155235936|NCT00600821|560298203|FG000|Overall Study|Death|45|||
155235937|NCT00600821|560298204|FG001|Overall Study|Death|46|||
155235938|NCT00600821|560298203|FG000|Overall Study|Lost to Follow-up|2|||
155235939|NCT00600821|560298204|FG001|Overall Study|Lost to Follow-up|2|||
155235940|NCT00600821|560298203|FG000|Overall Study|Withdrawal by Subject|1|||
155235941|NCT00600821|560298204|FG001|Overall Study|Withdrawal by Subject|1|||
155235942|NCT00600821|560298203|FG000|Overall Study|Terminated by sponsor|8|||
155235943|NCT00600821|560298204|FG001|Overall Study|Terminated by sponsor|6|||
155235944|NCT00600821|560298203|FG000|Overall Study|Objective progression or relapse|0|||
155235945|NCT00600821|560298204|FG001|Overall Study|Objective progression or relapse|1|||
155235946|NCT00600821|560298203|FG000|Overall Study|Randomized but not treated|0|||
155235947|NCT00600821|560298204|FG001|Overall Study|Randomized but not treated|1|||
155235948|NCT00600821|560298203|FG000|Overall Study|Other|2|||
155235949|NCT00600821|560298204|FG001|Overall Study|Other|3|||
155235950|NCT02602288|560298207|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
155235951|NCT02602288|560298208|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
155235952|NCT02602288|560298207|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
155235953|NCT02602288|560298208|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
155235954|NCT02602288|560298207|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
155235955|NCT02602288|560298208|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
155235956|NCT02602288|560298207|FG000|12 Month Follow-up|Lost to Follow-up|0|||
155235957|NCT02602288|560298208|FG001|12 Month Follow-up|Lost to Follow-up|4|||
155235958|NCT02602288|560298207|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
155235959|NCT02602288|560298208|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
155235960|NCT01076400|560298212|FG000|Overall Study|Adverse Event|2|||
155235961|NCT01076400|560298213|FG001|Overall Study|Adverse Event|0|||
155235962|NCT01076400|560298214|FG002|Overall Study|Adverse Event|0|||
155235963|NCT01076400|560298212|FG000|Overall Study|Progressive Disease|5|||
155235964|NCT01076400|560298213|FG001|Overall Study|Progressive Disease|0|||
155235965|NCT01076400|560298214|FG002|Overall Study|Progressive Disease|0|||
155235966|NCT02766608|560298217|FG000|Overall Study|Adverse Event|27|||
155235967|NCT02766608|560298218|FG001|Overall Study|Adverse Event|22|||
155235968|NCT02766608|560298219|FG002|Overall Study|Adverse Event|17|||
155235969|NCT02766608|560298220|FG003|Overall Study|Adverse Event|13|||
155235970|NCT02766608|560298221|FG004|Overall Study|Adverse Event|12|||
155235971|NCT02766608|560298217|FG000|Overall Study|Withdrawal by Subject|21|||
155235972|NCT02766608|560298218|FG001|Overall Study|Withdrawal by Subject|20|||
155235973|NCT02766608|560298219|FG002|Overall Study|Withdrawal by Subject|24|||
155235974|NCT02766608|560298220|FG003|Overall Study|Withdrawal by Subject|13|||
155235975|NCT02766608|560298221|FG004|Overall Study|Withdrawal by Subject|10|||
155235976|NCT02766608|560298217|FG000|Overall Study|Lack of Efficacy|16|||
155235977|NCT02766608|560298218|FG001|Overall Study|Lack of Efficacy|15|||
155235978|NCT02766608|560298219|FG002|Overall Study|Lack of Efficacy|32|||
155235979|NCT02766608|560298220|FG003|Overall Study|Lack of Efficacy|8|||
155235980|NCT02766608|560298221|FG004|Overall Study|Lack of Efficacy|2|||
155235981|NCT02766608|560298217|FG000|Overall Study|Lost to Follow-up|6|||
155235982|NCT02766608|560298218|FG001|Overall Study|Lost to Follow-up|3|||
155235983|NCT02766608|560298219|FG002|Overall Study|Lost to Follow-up|5|||
155235984|NCT02766608|560298220|FG003|Overall Study|Lost to Follow-up|2|||
155235985|NCT02766608|560298221|FG004|Overall Study|Lost to Follow-up|2|||
155235986|NCT02766608|560298217|FG000|Overall Study|Physician Decision|3|||
155235987|NCT02766608|560298218|FG001|Overall Study|Physician Decision|2|||
155235988|NCT02766608|560298219|FG002|Overall Study|Physician Decision|3|||
155235989|NCT02766608|560298220|FG003|Overall Study|Physician Decision|1|||
155235990|NCT02766608|560298221|FG004|Overall Study|Physician Decision|2|||
155235991|NCT02766608|560298217|FG000|Overall Study|Protocol disc criteria|3|||
155235992|NCT02766608|560298218|FG001|Overall Study|Protocol disc criteria|3|||
155235993|NCT02766608|560298219|FG002|Overall Study|Protocol disc criteria|4|||
155235994|NCT02766608|560298220|FG003|Overall Study|Protocol disc criteria|0|||
155235995|NCT02766608|560298221|FG004|Overall Study|Protocol disc criteria|0|||
155235996|NCT02766608|560298217|FG000|Overall Study|Protocol Violation|0|||
155235997|NCT02766608|560298218|FG001|Overall Study|Protocol Violation|4|||
155235998|NCT02766608|560298219|FG002|Overall Study|Protocol Violation|4|||
155235999|NCT02766608|560298220|FG003|Overall Study|Protocol Violation|0|||
155236000|NCT02766608|560298221|FG004|Overall Study|Protocol Violation|1|||
155236001|NCT02766608|560298217|FG000|Overall Study|Administrative Reasons|3|||
155236002|NCT02766608|560298218|FG001|Overall Study|Administrative Reasons|1|||
155236003|NCT02766608|560298219|FG002|Overall Study|Administrative Reasons|1|||
155236004|NCT02766608|560298220|FG003|Overall Study|Administrative Reasons|0|||
155236005|NCT02766608|560298221|FG004|Overall Study|Administrative Reasons|0|||
155236006|NCT02080091|560298223|FG000|Overall Study|Study Terminated|22|||
155236007|NCT02080091|560298223|FG000|Overall Study|Death|1|||
155236008|NCT02080091|560298223|FG000|Overall Study|Withdrawal by Subject|1|||
155236009|NCT02080091|560298223|FG000|Overall Study|Other|1|||
155236010|NCT03019536|560298224|FG000|Overall Study|Withdrawal by Subject|1|||
155236011|NCT03019536|560298225|FG001|Overall Study|Withdrawal by Subject|1|||
155236012|NCT03019536|560298226|FG002|Overall Study|Withdrawal by Subject|0|||
155236013|NCT03019536|560298224|FG000|Overall Study|Adverse Event|0|||
155236014|NCT03019536|560298225|FG001|Overall Study|Adverse Event|0|||
155236015|NCT03019536|560298226|FG002|Overall Study|Adverse Event|2|||
155236016|NCT01265953|560298229|FG000|Overall Study|Non compliance|5|||
155236017|NCT01265953|560298230|FG001|Overall Study|Non compliance|3|||
155236018|NCT03143829|560298231|FG000|Overall Study|Withdrawal by Subject|2|||
155236019|NCT03143829|560298232|FG001|Overall Study|Withdrawal by Subject|5|||
155236020|NCT03143829|560298231|FG000|Overall Study|Lost to Follow-up|0|||
155236021|NCT03143829|560298232|FG001|Overall Study|Lost to Follow-up|2|||
155236022|NCT03143829|560298231|FG000|Overall Study|Death|1|||
155236023|NCT03143829|560298232|FG001|Overall Study|Death|1|||
155236024|NCT03143829|560298231|FG000|Overall Study|changed treatment, no longer eligible|2|||
155236025|NCT03143829|560298232|FG001|Overall Study|changed treatment, no longer eligible|2|||
155236026|NCT03738865|560298237|FG000|Overall Study|Withdrawal by Subject|3|||
155236027|NCT03738865|560298238|FG001|Overall Study|Withdrawal by Subject|3|||
155236028|NCT03738865|560298237|FG000|Overall Study|Adverse Event|2|||
155236029|NCT03738865|560298238|FG001|Overall Study|Adverse Event|0|||
155236030|NCT03738865|560298237|FG000|Overall Study|Physician Decision|0|||
155236031|NCT03738865|560298238|FG001|Overall Study|Physician Decision|1|||
155236032|NCT04086472|560298239|FG000|Overall Study|Lost to Follow-up|1|||
155236033|NCT04086472|560298240|FG001|Overall Study|Lost to Follow-up|0|||
155236034|NCT04086472|560298241|FG002|Overall Study|Lost to Follow-up|0|||
155236035|NCT04086472|560298242|FG003|Overall Study|Lost to Follow-up|0|||
155236036|NCT04086472|560298243|FG004|Overall Study|Lost to Follow-up|1|||
155236037|NCT04086472|560298239|FG000|Overall Study|Physician Decision|0|||
155236038|NCT04086472|560298240|FG001|Overall Study|Physician Decision|1|||
155236039|NCT04086472|560298241|FG002|Overall Study|Physician Decision|1|||
155236040|NCT04086472|560298242|FG003|Overall Study|Physician Decision|0|||
155236041|NCT04086472|560298243|FG004|Overall Study|Physician Decision|0|||
155236042|NCT04086472|560298239|FG000|Overall Study|Withdrawal by Subject|1|||
155236043|NCT04086472|560298240|FG001|Overall Study|Withdrawal by Subject|1|||
155236044|NCT04086472|560298241|FG002|Overall Study|Withdrawal by Subject|1|||
155236045|NCT04086472|560298242|FG003|Overall Study|Withdrawal by Subject|0|||
155236046|NCT04086472|560298243|FG004|Overall Study|Withdrawal by Subject|0|||
155236047|NCT04086472|560298239|FG000|Overall Study|Various reasons|2|||
155236048|NCT04086472|560298240|FG001|Overall Study|Various reasons|0|||
155236049|NCT04086472|560298241|FG002|Overall Study|Various reasons|0|||
155236050|NCT04086472|560298242|FG003|Overall Study|Various reasons|3|||
155236051|NCT04086472|560298243|FG004|Overall Study|Various reasons|1|||
155236052|NCT03348904|560298244|FG000|Overall Study|Administrative reason by the sponsor|0|||
155236053|NCT03348904|560298245|FG001|Overall Study|Administrative reason by the sponsor|1|||
155236054|NCT03348904|560298246|FG002|Overall Study|Administrative reason by the sponsor|0|||
155236055|NCT00048724|560298247|FG000|Overall Study|Adverse Event|53|||
155236056|NCT00048724|560298248|FG001|Overall Study|Adverse Event|12|||
155236057|NCT00048724|560298247|FG000|Overall Study|Withdrawal by Subject|34|||
155236058|NCT00048724|560298248|FG001|Overall Study|Withdrawal by Subject|54|||
155236059|NCT00048724|560298247|FG000|Overall Study|Lost to Follow-up|5|||
155236060|NCT00048724|560298248|FG001|Overall Study|Lost to Follow-up|5|||
155236061|NCT00048724|560298247|FG000|Overall Study|Protocol-defined Clinical Event|17|||
155236062|NCT00048724|560298248|FG001|Overall Study|Protocol-defined Clinical Event|32|||
155236063|NCT00048724|560298247|FG000|Overall Study|Noncompliance With Protocol|4|||
155236064|NCT00048724|560298248|FG001|Overall Study|Noncompliance With Protocol|12|||
155236065|NCT00048724|560298247|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
155236066|NCT00048724|560298248|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
155236067|NCT00048724|560298247|FG000|Overall Study|Administrative|1|||
155236068|NCT00048724|560298248|FG001|Overall Study|Administrative|1|||
155236069|NCT01743092|560298249|FG000|Overall Study|Lost to Follow-up|14|||
155236070|NCT01743092|560298250|FG001|Overall Study|Lost to Follow-up|15|||
155236071|NCT03586869|560298251|FG000|Overall Study|Progressive Disease|3|||
155236072|NCT04116229|560298252|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
155236073|NCT04116229|560298253|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
155236074|NCT04116229|560298252|FG000|Overall Study|Scheduling not possible.|0|||
155236075|NCT04116229|560298253|FG001|Overall Study|Scheduling not possible.|1|||
155236076|NCT02809976|560298256|FG000|Overall Study|Lost to Follow-up|1|||
155236077|NCT02809976|560298256|FG000|Overall Study|Withdrawal by Subject|1|||
155236078|NCT00211081|560298258|FG000|Overall Study|Withdrawal by Subject|2|||
155236079|NCT00113516|560298259|FG000|Part 1|Adverse Event|6|||
155236080|NCT00113516|560298260|FG001|Part 1|Adverse Event|0|||
155236081|NCT00113516|560298259|FG000|Part 1|Death|3|||
155236082|NCT00113516|560298260|FG001|Part 1|Death|0|||
155236083|NCT00113516|560298259|FG000|Part 1|Other|3|||
155236084|NCT00113516|560298260|FG001|Part 1|Other|0|||
155236085|NCT00113516|560298259|FG000|Part 1|Withdrawal by Subject|2|||
155236086|NCT00113516|560298260|FG001|Part 1|Withdrawal by Subject|0|||
155236087|NCT00113516|560298259|FG000|Part 1|Lack of Efficacy|2|||
155236088|NCT00113516|560298260|FG001|Part 1|Lack of Efficacy|0|||
155236089|NCT00113516|560298259|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
155236090|NCT00113516|560298260|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
155236091|NCT00113516|560298259|FG000|Part 1|Laboratory Abnormality|1|||
155236092|NCT00113516|560298260|FG001|Part 1|Laboratory Abnormality|0|||
155236093|NCT00113516|560298259|FG000|Part 1|Ongoing|1|||
155236094|NCT00113516|560298260|FG001|Part 1|Ongoing|0|||
155236095|NCT00113516|560298259|FG000|Part 1|Missing|65|||
155236096|NCT00113516|560298260|FG001|Part 1|Missing|0|||
155236097|NCT00113516|560298259|FG000|Part 2|Adverse Event|0|||
155236098|NCT00113516|560298260|FG001|Part 2|Adverse Event|16|||
155236099|NCT00113516|560298259|FG000|Part 2|Death|0|||
155236100|NCT00113516|560298260|FG001|Part 2|Death|5|||
155236101|NCT00113516|560298259|FG000|Part 2|Lack of Efficacy|0|||
155236102|NCT00113516|560298260|FG001|Part 2|Lack of Efficacy|37|||
155236103|NCT00113516|560298259|FG000|Part 2|Withdrawal by Subject|0|||
155236104|NCT00113516|560298260|FG001|Part 2|Withdrawal by Subject|3|||
155236105|NCT00113516|560298259|FG000|Part 2|Other|0|||
155236106|NCT00113516|560298260|FG001|Part 2|Other|3|||
155236107|NCT00113516|560298259|FG000|Part 2|Laboratory Abnormality|0|||
155236108|NCT00113516|560298260|FG001|Part 2|Laboratory Abnormality|1|||
155236109|NCT00113516|560298259|FG000|Part 2|Ongoing|0|||
155236110|NCT00113516|560298260|FG001|Part 2|Ongoing|1|||
155236111|NCT00047463|560298261|FG000|Overall Study|Withdrawal by Subject|0|||
155236112|NCT00047463|560298262|FG001|Overall Study|Withdrawal by Subject|3|||
155236113|NCT00111228|560298270|FG000|Overall Study|Withdrawal by Subject|5|||
155236114|NCT00111228|560298271|FG001|Overall Study|Withdrawal by Subject|1|||
155236115|NCT00111228|560298272|FG002|Overall Study|Withdrawal by Subject|0|||
155236116|NCT03698773|560298279|FG000|Overall Study|Lost to Follow-up|2|||
155236117|NCT03698773|560298280|FG001|Overall Study|Lost to Follow-up|1|||
155236118|NCT03235024|560298281|FG000|Overall Study|Adverse Event|2|||
155236119|NCT03235024|560298282|FG001|Overall Study|Adverse Event|2|||
155236120|NCT03235024|560298281|FG000|Overall Study|Death|1|||
155236121|NCT03235024|560298282|FG001|Overall Study|Death|0|||
155236122|NCT03235024|560298281|FG000|Overall Study|Lost to Follow-up|2|||
155236123|NCT03235024|560298282|FG001|Overall Study|Lost to Follow-up|5|||
155236124|NCT03235024|560298281|FG000|Overall Study|Protocol Violation|1|||
155236125|NCT03235024|560298282|FG001|Overall Study|Protocol Violation|0|||
155236126|NCT03235024|560298281|FG000|Overall Study|Withdrawal by Subject|0|||
155236127|NCT03235024|560298282|FG001|Overall Study|Withdrawal by Subject|3|||
155236128|NCT02357576|560298283|FG000|Treatment Period|Withdrawal by Subject|0|||
155236129|NCT02357576|560298284|FG001|Treatment Period|Withdrawal by Subject|1|||
155236130|NCT02357576|560298283|FG000|Treatment Period|Physician Decision|0|||
155236131|NCT02357576|560298284|FG001|Treatment Period|Physician Decision|1|||
155236132|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
155236133|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
155236134|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
155236135|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
155236136|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
155236137|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
155236138|NCT02357576|560298283|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
155236139|NCT02357576|560298284|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
155236140|NCT03495908|560298285|FG000|Overall Study|Withdrawal by Subject|3|||
155236141|NCT03495908|560298286|FG001|Overall Study|Withdrawal by Subject|1|||
155236142|NCT03495908|560298285|FG000|Overall Study|Lost to Follow-up|1|||
155236143|NCT03495908|560298286|FG001|Overall Study|Lost to Follow-up|4|||
155236144|NCT03495908|560298285|FG000|Overall Study|Adverse Event|0|||
155236145|NCT03495908|560298286|FG001|Overall Study|Adverse Event|2|||
155236146|NCT03495908|560298285|FG000|Overall Study|Death|1|||
155236147|NCT03495908|560298286|FG001|Overall Study|Death|0|||
155236148|NCT03495908|560298285|FG000|Overall Study|Physician Decision|5|||
155236149|NCT03495908|560298286|FG001|Overall Study|Physician Decision|4|||
155236150|NCT03495908|560298285|FG000|Overall Study|No documented reason|0|||
155236151|NCT03495908|560298286|FG001|Overall Study|No documented reason|2|||
155236152|NCT02802345|560298291|FG000|Overall Study|Not Treated|0|||
155236153|NCT02802345|560298292|FG001|Overall Study|Not Treated|1|||
155236154|NCT02802345|560298291|FG000|Overall Study|Adverse Event|28|||
155236155|NCT02802345|560298292|FG001|Overall Study|Adverse Event|20|||
155236156|NCT02802345|560298291|FG000|Overall Study|Withdrawal by Subject|3|||
155236157|NCT02802345|560298292|FG001|Overall Study|Withdrawal by Subject|3|||
155236158|NCT02802345|560298291|FG000|Overall Study|Protocol Violation|0|||
155236159|NCT02802345|560298292|FG001|Overall Study|Protocol Violation|1|||
155236160|NCT02802345|560298291|FG000|Overall Study|Other than listed|1|||
155236161|NCT02802345|560298292|FG001|Overall Study|Other than listed|5|||
155236162|NCT02075320|560298295|FG000|Overall Study|Withdrawal by Subject|2|||
155236163|NCT01109316|560298297|FG000|Study Period 1|Adverse Event|0|||
155236164|NCT01109316|560298298|FG001|Study Period 1|Adverse Event|0|||
155236165|NCT01109316|560298299|FG002|Study Period 1|Adverse Event|1|||
155236166|NCT01109316|560298300|FG003|Study Period 1|Adverse Event|0|||
155236167|NCT01109316|560298301|FG004|Study Period 1|Adverse Event|0|||
155236168|NCT01109316|560298302|FG005|Study Period 1|Adverse Event|0|||
155236169|NCT01109316|560298297|FG000|Study Period 1|Lost to Follow-up|0|||
155236170|NCT01109316|560298298|FG001|Study Period 1|Lost to Follow-up|0|||
155236171|NCT01109316|560298299|FG002|Study Period 1|Lost to Follow-up|1|||
155236172|NCT01109316|560298300|FG003|Study Period 1|Lost to Follow-up|1|||
155236173|NCT01109316|560298301|FG004|Study Period 1|Lost to Follow-up|0|||
155236174|NCT01109316|560298302|FG005|Study Period 1|Lost to Follow-up|0|||
155236175|NCT01109316|560298297|FG000|Study Period 1|Withdrawal by Subject|0|||
155236176|NCT01109316|560298298|FG001|Study Period 1|Withdrawal by Subject|0|||
155236177|NCT01109316|560298299|FG002|Study Period 1|Withdrawal by Subject|1|||
155236178|NCT01109316|560298300|FG003|Study Period 1|Withdrawal by Subject|0|||
155236179|NCT01109316|560298301|FG004|Study Period 1|Withdrawal by Subject|2|||
155236180|NCT01109316|560298302|FG005|Study Period 1|Withdrawal by Subject|0|||
155236181|NCT01109316|560298297|FG000|Study Period 1|Sponsor Decision|0|||
155236182|NCT01109316|560298298|FG001|Study Period 1|Sponsor Decision|0|||
155236183|NCT01109316|560298299|FG002|Study Period 1|Sponsor Decision|0|||
155236184|NCT01109316|560298300|FG003|Study Period 1|Sponsor Decision|0|||
155236185|NCT01109316|560298301|FG004|Study Period 1|Sponsor Decision|0|||
155236186|NCT01109316|560298302|FG005|Study Period 1|Sponsor Decision|2|||
155236187|NCT01109316|560298297|FG000|Study Period 2|Entry Criteria Not Met|0|||
155236188|NCT01109316|560298298|FG001|Study Period 2|Entry Criteria Not Met|1|||
155236189|NCT01109316|560298299|FG002|Study Period 2|Entry Criteria Not Met|0|||
155236190|NCT01109316|560298300|FG003|Study Period 2|Entry Criteria Not Met|0|||
155236191|NCT01109316|560298301|FG004|Study Period 2|Entry Criteria Not Met|0|||
155236192|NCT01109316|560298302|FG005|Study Period 2|Entry Criteria Not Met|0|||
155236193|NCT01109316|560298297|FG000|Study Period 2|Physician Decision|0|||
155236194|NCT01109316|560298298|FG001|Study Period 2|Physician Decision|0|||
155236195|NCT01109316|560298299|FG002|Study Period 2|Physician Decision|0|||
155236196|NCT01109316|560298300|FG003|Study Period 2|Physician Decision|1|||
155236197|NCT01109316|560298301|FG004|Study Period 2|Physician Decision|0|||
155236198|NCT01109316|560298302|FG005|Study Period 2|Physician Decision|0|||
155236199|NCT01109316|560298297|FG000|Study Period 2|Protocol Violation|1|||
155236200|NCT01109316|560298298|FG001|Study Period 2|Protocol Violation|0|||
155236201|NCT01109316|560298299|FG002|Study Period 2|Protocol Violation|0|||
155236202|NCT01109316|560298300|FG003|Study Period 2|Protocol Violation|0|||
155236203|NCT01109316|560298301|FG004|Study Period 2|Protocol Violation|0|||
155236204|NCT01109316|560298302|FG005|Study Period 2|Protocol Violation|0|||
155236205|NCT01109316|560298297|FG000|Study Period 2|Withdrawal by Subject|0|||
155236206|NCT01109316|560298298|FG001|Study Period 2|Withdrawal by Subject|0|||
155236207|NCT01109316|560298299|FG002|Study Period 2|Withdrawal by Subject|1|||
155236208|NCT01109316|560298300|FG003|Study Period 2|Withdrawal by Subject|0|||
155236209|NCT01109316|560298301|FG004|Study Period 2|Withdrawal by Subject|0|||
155236210|NCT01109316|560298302|FG005|Study Period 2|Withdrawal by Subject|1|||
155236211|NCT01109316|560298297|FG000|Study Period 3|Lost to Follow-up|0|||
155236212|NCT01109316|560298298|FG001|Study Period 3|Lost to Follow-up|0|||
155236213|NCT01109316|560298299|FG002|Study Period 3|Lost to Follow-up|0|||
155236214|NCT01109316|560298300|FG003|Study Period 3|Lost to Follow-up|0|||
155236215|NCT01109316|560298301|FG004|Study Period 3|Lost to Follow-up|1|||
155236216|NCT01109316|560298302|FG005|Study Period 3|Lost to Follow-up|0|||
155236217|NCT01109316|560298297|FG000|Study Period 3|Withdrawal by Subject|1|||
155236218|NCT01109316|560298298|FG001|Study Period 3|Withdrawal by Subject|0|||
155236219|NCT01109316|560298299|FG002|Study Period 3|Withdrawal by Subject|0|||
155236220|NCT01109316|560298300|FG003|Study Period 3|Withdrawal by Subject|0|||
155236221|NCT01109316|560298301|FG004|Study Period 3|Withdrawal by Subject|1|||
155236222|NCT01109316|560298302|FG005|Study Period 3|Withdrawal by Subject|0|||
155236223|NCT01826825|560298312|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
155236224|NCT01826825|560298313|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
155236225|NCT00515827|560298314|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
155236226|NCT00515827|560298315|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
155236227|NCT00515827|560298314|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
155236228|NCT00515827|560298315|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
155236229|NCT03254134|560298317|FG000|Overall Study|Not eligible patients|599|||
155236230|NCT03254134|560298318|FG001|Overall Study|Not eligible patients|3630|||
155236231|NCT01712984|560298323|FG000|Overall Study|Adverse Event|0|||
155236232|NCT01712984|560298324|FG001|Overall Study|Adverse Event|0|||
155236233|NCT01712984|560298325|FG002|Overall Study|Adverse Event|1|||
155236234|NCT01712984|560298323|FG000|Overall Study|Protocol Violation|2|||
155236235|NCT01712984|560298324|FG001|Overall Study|Protocol Violation|0|||
155236236|NCT01712984|560298325|FG002|Overall Study|Protocol Violation|1|||
155236237|NCT01712984|560298323|FG000|Overall Study|Lost to Follow-up|8|||
155236238|NCT01712984|560298324|FG001|Overall Study|Lost to Follow-up|10|||
155236239|NCT01712984|560298325|FG002|Overall Study|Lost to Follow-up|1|||
155236240|NCT01712984|560298323|FG000|Overall Study|Withdrawal by Subject|6|||
155236241|NCT01712984|560298324|FG001|Overall Study|Withdrawal by Subject|6|||
155236242|NCT01712984|560298325|FG002|Overall Study|Withdrawal by Subject|7|||
155236243|NCT01552772|560298326|FG000|Overall Study|Lost to Follow-up|2|||
155236244|NCT01552772|560298326|FG000|Overall Study|Adverse Event|1|||
155236245|NCT01552772|560298326|FG000|Overall Study|Protocol Deviation|1|||
155236246|NCT01848990|560298327|FG000|Overall Study|Adverse Event|6|||
155236247|NCT01848990|560298328|FG001|Overall Study|Adverse Event|2|||
155236248|NCT01848990|560298329|FG002|Overall Study|Adverse Event|0|||
155236249|NCT01848990|560298327|FG000|Overall Study|Lost to Follow-up|6|||
155236250|NCT01848990|560298328|FG001|Overall Study|Lost to Follow-up|2|||
155236251|NCT01848990|560298329|FG002|Overall Study|Lost to Follow-up|2|||
155236252|NCT01848990|560298327|FG000|Overall Study|Protocol Violation|1|||
155236253|NCT01848990|560298328|FG001|Overall Study|Protocol Violation|1|||
155236254|NCT01848990|560298329|FG002|Overall Study|Protocol Violation|0|||
155236255|NCT01848990|560298327|FG000|Overall Study|Withdrawal by Subject|29|||
155236256|NCT01848990|560298328|FG001|Overall Study|Withdrawal by Subject|10|||
155236257|NCT01848990|560298329|FG002|Overall Study|Withdrawal by Subject|11|||
155236258|NCT01848990|560298327|FG000|Overall Study|Physician Decision|1|||
155236259|NCT01848990|560298328|FG001|Overall Study|Physician Decision|1|||
155236260|NCT01848990|560298329|FG002|Overall Study|Physician Decision|0|||
155236261|NCT01848990|560298327|FG000|Overall Study|Non Compliance|1|||
155236262|NCT01848990|560298328|FG001|Overall Study|Non Compliance|0|||
155236263|NCT01848990|560298329|FG002|Overall Study|Non Compliance|0|||
155236264|NCT01848990|560298327|FG000|Overall Study|Death|1|||
155236265|NCT01848990|560298328|FG001|Overall Study|Death|0|||
155236266|NCT01848990|560298329|FG002|Overall Study|Death|1|||
155236267|NCT01848990|560298327|FG000|Overall Study|Other|1|||
155236268|NCT01848990|560298328|FG001|Overall Study|Other|4|||
155236269|NCT01848990|560298329|FG002|Overall Study|Other|2|||
155236270|NCT00512096|560298338|FG000|Overall Study|Adverse Event|2|||
155236271|NCT00512096|560298338|FG000|Overall Study|Withdrawal by Subject|2|||
155236272|NCT00512096|560298338|FG000|Overall Study|Lack of Efficacy|3|||
155236273|NCT02391948|560300096|FG000|6-month Assessment|Death|0|||
155236274|NCT02391948|560300097|FG001|6-month Assessment|Death|0|||
155236275|NCT02391948|560300098|FG002|6-month Assessment|Death|0|||
155236276|NCT02391948|560300099|FG003|6-month Assessment|Death|0|||
155236277|NCT02391948|560300100|FG004|6-month Assessment|Death|1|||
155236278|NCT02391948|560300096|FG000|6-month Assessment|Withdrawal by Subject|0|||
155236279|NCT02391948|560300097|FG001|6-month Assessment|Withdrawal by Subject|0|||
155236280|NCT02391948|560300098|FG002|6-month Assessment|Withdrawal by Subject|1|||
155236281|NCT02391948|560300099|FG003|6-month Assessment|Withdrawal by Subject|2|||
155236282|NCT02391948|560300100|FG004|6-month Assessment|Withdrawal by Subject|0|||
155236283|NCT02391948|560300096|FG000|6-month Assessment|Lost to Follow-up|4|||
155236284|NCT02391948|560300097|FG001|6-month Assessment|Lost to Follow-up|5|||
155236285|NCT02391948|560300098|FG002|6-month Assessment|Lost to Follow-up|2|||
155236286|NCT02391948|560300099|FG003|6-month Assessment|Lost to Follow-up|3|||
155236287|NCT02391948|560300100|FG004|6-month Assessment|Lost to Follow-up|1|||
155236288|NCT02391948|560300096|FG000|6-month Assessment|Medical issue/illness|1|||
155236289|NCT02391948|560300097|FG001|6-month Assessment|Medical issue/illness|1|||
155236290|NCT02391948|560300098|FG002|6-month Assessment|Medical issue/illness|0|||
155236291|NCT02391948|560300099|FG003|6-month Assessment|Medical issue/illness|0|||
155236292|NCT02391948|560300100|FG004|6-month Assessment|Medical issue/illness|0|||
155236293|NCT02391948|560300096|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
155236294|NCT02391948|560300097|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
155236295|NCT02391948|560300098|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
155236296|NCT02391948|560300099|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
155236297|NCT02391948|560300100|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
155236298|NCT02391948|560300096|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
155236299|NCT02391948|560300097|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
155236300|NCT02391948|560300098|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
155236301|NCT02391948|560300099|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
155236302|NCT02391948|560300100|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
155236303|NCT02391948|560300096|FG000|12-month Assessment|Death|0|||
155236304|NCT02391948|560300097|FG001|12-month Assessment|Death|0|||
155236305|NCT02391948|560300098|FG002|12-month Assessment|Death|0|||
155236306|NCT02391948|560300099|FG003|12-month Assessment|Death|1|||
155236307|NCT02391948|560300100|FG004|12-month Assessment|Death|0|||
155236308|NCT02391948|560300096|FG000|12-month Assessment|Withdrawal by Subject|1|||
155236309|NCT02391948|560300097|FG001|12-month Assessment|Withdrawal by Subject|0|||
155236310|NCT02391948|560300098|FG002|12-month Assessment|Withdrawal by Subject|0|||
155236311|NCT02391948|560300099|FG003|12-month Assessment|Withdrawal by Subject|1|||
155236312|NCT02391948|560300100|FG004|12-month Assessment|Withdrawal by Subject|0|||
155236313|NCT02391948|560300096|FG000|12-month Assessment|Lost to Follow-up|5|||
155236314|NCT02391948|560300097|FG001|12-month Assessment|Lost to Follow-up|4|||
155236315|NCT02391948|560300098|FG002|12-month Assessment|Lost to Follow-up|4|||
155236316|NCT02391948|560300099|FG003|12-month Assessment|Lost to Follow-up|4|||
155236317|NCT02391948|560300100|FG004|12-month Assessment|Lost to Follow-up|5|||
155236318|NCT02391948|560300096|FG000|12-month Assessment|Medical issue/illness|0|||
155236319|NCT02391948|560300097|FG001|12-month Assessment|Medical issue/illness|1|||
155236320|NCT02391948|560300098|FG002|12-month Assessment|Medical issue/illness|0|||
155236321|NCT02391948|560300099|FG003|12-month Assessment|Medical issue/illness|1|||
155236322|NCT02391948|560300100|FG004|12-month Assessment|Medical issue/illness|0|||
155236323|NCT02391948|560300096|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
155236324|NCT02391948|560300097|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
155236325|NCT02391948|560300098|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
155236326|NCT02391948|560300099|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
155236327|NCT02391948|560300100|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
155236328|NCT02391948|560300096|FG000|18-month Assessment|Death|0|||
155236329|NCT02391948|560300097|FG001|18-month Assessment|Death|0|||
155236330|NCT02391948|560300098|FG002|18-month Assessment|Death|0|||
155236331|NCT02391948|560300099|FG003|18-month Assessment|Death|1|||
155236332|NCT02391948|560300100|FG004|18-month Assessment|Death|1|||
155236333|NCT02391948|560300096|FG000|18-month Assessment|Withdrawal by Subject|1|||
155236334|NCT02391948|560300097|FG001|18-month Assessment|Withdrawal by Subject|0|||
155236335|NCT02391948|560300098|FG002|18-month Assessment|Withdrawal by Subject|0|||
155236336|NCT02391948|560300099|FG003|18-month Assessment|Withdrawal by Subject|1|||
155236337|NCT02391948|560300100|FG004|18-month Assessment|Withdrawal by Subject|0|||
155236338|NCT02391948|560300096|FG000|18-month Assessment|Lost to Follow-up|2|||
155236339|NCT02391948|560300097|FG001|18-month Assessment|Lost to Follow-up|6|||
155236340|NCT02391948|560300098|FG002|18-month Assessment|Lost to Follow-up|2|||
155236341|NCT02391948|560300099|FG003|18-month Assessment|Lost to Follow-up|2|||
155236342|NCT02391948|560300100|FG004|18-month Assessment|Lost to Follow-up|3|||
155236343|NCT02391948|560300096|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
155236344|NCT02391948|560300097|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
155236345|NCT02391948|560300098|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
155236346|NCT02391948|560300099|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
155236347|NCT02391948|560300100|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
155236348|NCT02391948|560300096|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
155236349|NCT02391948|560300097|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
155236350|NCT02391948|560300098|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
155236351|NCT02391948|560300099|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
155236352|NCT02391948|560300100|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
155236353|NCT02391948|560300096|FG000|24-month Assessment|Death|0|||
155236354|NCT02391948|560300097|FG001|24-month Assessment|Death|0|||
155236355|NCT02391948|560300098|FG002|24-month Assessment|Death|0|||
155236356|NCT02391948|560300099|FG003|24-month Assessment|Death|0|||
155236357|NCT02391948|560300100|FG004|24-month Assessment|Death|1|||
155236358|NCT02391948|560300096|FG000|24-month Assessment|Withdrawal by Subject|1|||
155236359|NCT02391948|560300097|FG001|24-month Assessment|Withdrawal by Subject|1|||
155236360|NCT02391948|560300098|FG002|24-month Assessment|Withdrawal by Subject|0|||
155236361|NCT02391948|560300099|FG003|24-month Assessment|Withdrawal by Subject|0|||
155236362|NCT02391948|560300100|FG004|24-month Assessment|Withdrawal by Subject|1|||
155236363|NCT02391948|560300096|FG000|24-month Assessment|Lost to Follow-up|5|||
155236364|NCT02391948|560300097|FG001|24-month Assessment|Lost to Follow-up|4|||
155236365|NCT02391948|560300098|FG002|24-month Assessment|Lost to Follow-up|0|||
155236366|NCT02391948|560300099|FG003|24-month Assessment|Lost to Follow-up|0|||
155236367|NCT02391948|560300100|FG004|24-month Assessment|Lost to Follow-up|0|||
155236368|NCT02391948|560300096|FG000|24-month Assessment|Medical issue/illness|0|||
155236369|NCT02391948|560300097|FG001|24-month Assessment|Medical issue/illness|0|||
155236370|NCT02391948|560300098|FG002|24-month Assessment|Medical issue/illness|1|||
155236371|NCT02391948|560300099|FG003|24-month Assessment|Medical issue/illness|0|||
155236372|NCT02391948|560300100|FG004|24-month Assessment|Medical issue/illness|0|||
155236373|NCT02391948|560300096|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
155236374|NCT02391948|560300097|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
155236375|NCT02391948|560300098|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
155236376|NCT02391948|560300099|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
155236377|NCT02391948|560300100|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
155236378|NCT01602315|560300101|FG000|Overall Study|Protocol Violation|0|||
155236379|NCT01602315|560300102|FG001|Overall Study|Protocol Violation|0|||
155236380|NCT01602315|560300103|FG002|Overall Study|Protocol Violation|0|||
155236381|NCT01602315|560300104|FG003|Overall Study|Protocol Violation|0|||
155236382|NCT01602315|560300105|FG004|Overall Study|Protocol Violation|0|||
155236383|NCT01602315|560300106|FG005|Overall Study|Protocol Violation|1|||
155236384|NCT01602315|560300107|FG006|Overall Study|Protocol Violation|0|||
155236385|NCT01602315|560300101|FG000|Overall Study|Physician Decision|2|||
155236386|NCT01602315|560300102|FG001|Overall Study|Physician Decision|0|||
155236387|NCT01602315|560300103|FG002|Overall Study|Physician Decision|0|||
155236388|NCT01602315|560300104|FG003|Overall Study|Physician Decision|0|||
155236389|NCT01602315|560300105|FG004|Overall Study|Physician Decision|2|||
155236390|NCT01602315|560300106|FG005|Overall Study|Physician Decision|1|||
155236391|NCT01602315|560300107|FG006|Overall Study|Physician Decision|1|||
155236392|NCT01602315|560300101|FG000|Overall Study|Disease progression|6|||
155236393|NCT01602315|560300102|FG001|Overall Study|Disease progression|3|||
155236394|NCT01602315|560300103|FG002|Overall Study|Disease progression|10|||
155236395|NCT01602315|560300104|FG003|Overall Study|Disease progression|1|||
155236396|NCT01602315|560300105|FG004|Overall Study|Disease progression|41|||
155236397|NCT01602315|560300106|FG005|Overall Study|Disease progression|12|||
155236398|NCT01602315|560300107|FG006|Overall Study|Disease progression|15|||
155236399|NCT01602315|560300101|FG000|Overall Study|Death|1|||
155236400|NCT01602315|560300102|FG001|Overall Study|Death|1|||
155236401|NCT01602315|560300103|FG002|Overall Study|Death|1|||
155236402|NCT01602315|560300104|FG003|Overall Study|Death|1|||
155236403|NCT01602315|560300105|FG004|Overall Study|Death|7|||
155236404|NCT01602315|560300106|FG005|Overall Study|Death|2|||
155236405|NCT01602315|560300107|FG006|Overall Study|Death|2|||
155236406|NCT01602315|560300101|FG000|Overall Study|Withdrawal by Subject|2|||
155236407|NCT01602315|560300102|FG001|Overall Study|Withdrawal by Subject|0|||
155236408|NCT01602315|560300103|FG002|Overall Study|Withdrawal by Subject|2|||
155236409|NCT01602315|560300104|FG003|Overall Study|Withdrawal by Subject|0|||
155236410|NCT01602315|560300105|FG004|Overall Study|Withdrawal by Subject|6|||
155236411|NCT01602315|560300106|FG005|Overall Study|Withdrawal by Subject|0|||
155236412|NCT01602315|560300107|FG006|Overall Study|Withdrawal by Subject|1|||
155236413|NCT01602315|560300101|FG000|Overall Study|Adverse Event|5|||
155236414|NCT01602315|560300102|FG001|Overall Study|Adverse Event|1|||
155236415|NCT01602315|560300103|FG002|Overall Study|Adverse Event|5|||
155236416|NCT01602315|560300104|FG003|Overall Study|Adverse Event|4|||
155236417|NCT01602315|560300105|FG004|Overall Study|Adverse Event|15|||
155236418|NCT01602315|560300106|FG005|Overall Study|Adverse Event|3|||
155236419|NCT01602315|560300107|FG006|Overall Study|Adverse Event|9|||
155236420|NCT01602315|560300101|FG000|Overall Study|Subject/guardian decision|0|||
155236421|NCT01602315|560300102|FG001|Overall Study|Subject/guardian decision|0|||
155236422|NCT01602315|560300103|FG002|Overall Study|Subject/guardian decision|0|||
155236423|NCT01602315|560300104|FG003|Overall Study|Subject/guardian decision|0|||
155236424|NCT01602315|560300105|FG004|Overall Study|Subject/guardian decision|0|||
155236425|NCT01602315|560300106|FG005|Overall Study|Subject/guardian decision|0|||
155236426|NCT01602315|560300107|FG006|Overall Study|Subject/guardian decision|1|||
155236427|NCT01602315|560300101|FG000|Overall Study|Cross-over patients to combo treatment|0|||
155236428|NCT01602315|560300102|FG001|Overall Study|Cross-over patients to combo treatment|0|||
155236429|NCT01602315|560300103|FG002|Overall Study|Cross-over patients to combo treatment|0|||
155236430|NCT01602315|560300104|FG003|Overall Study|Cross-over patients to combo treatment|0|||
155236431|NCT01602315|560300105|FG004|Overall Study|Cross-over patients to combo treatment|0|||
155236432|NCT01602315|560300106|FG005|Overall Study|Cross-over patients to combo treatment|16|||
155236433|NCT01602315|560300107|FG006|Overall Study|Cross-over patients to combo treatment|0|||
155236434|NCT02212730|560300110|FG000|Overall Study|Tumor not of the required cell histology|1|||
155236435|NCT02212730|560300111|FG001|Overall Study|Tumor not of the required cell histology|0|||
155236436|NCT02212730|560300110|FG000|Overall Study|Withdrawal by Subject|1|||
155236437|NCT02212730|560300111|FG001|Overall Study|Withdrawal by Subject|0|||
155236438|NCT02212730|560300110|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
155236439|NCT02212730|560300111|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
155236440|NCT02691455|560300114|FG000|Overall Study|Withdrawal by Subject|1|||
155236441|NCT02691455|560300115|FG001|Overall Study|Withdrawal by Subject|2|||
155236442|NCT02691455|560300114|FG000|Overall Study|Lost to Follow-up|15|||
155236443|NCT02691455|560300115|FG001|Overall Study|Lost to Follow-up|15|||
155236444|NCT02057757|560300116|FG000|Overall Study|Withdrawal by Subject|3|||
155236445|NCT02057757|560300117|FG001|Overall Study|Withdrawal by Subject|5|||
155236446|NCT02057757|560300116|FG000|Overall Study|Death|2|||
155236447|NCT02057757|560300117|FG001|Overall Study|Death|0|||
155236448|NCT02057757|560300116|FG000|Overall Study|Lost to Follow-up|8|||
155236449|NCT02057757|560300117|FG001|Overall Study|Lost to Follow-up|3|||
155236450|NCT02057757|560300116|FG000|Overall Study|Non-compliance|1|||
155236451|NCT02057757|560300117|FG001|Overall Study|Non-compliance|0|||
155236452|NCT00440271|560300118|FG000|Overall Study|Protocol Violation|1|||
155236453|NCT00440271|560300119|FG001|Overall Study|Protocol Violation|1|||
155236454|NCT00440271|560300118|FG000|Overall Study|Adverse Event|0|||
155236455|NCT00440271|560300119|FG001|Overall Study|Adverse Event|1|||
155236456|NCT00440271|560300118|FG000|Overall Study|Lost to Follow-up|1|||
155236457|NCT00440271|560300119|FG001|Overall Study|Lost to Follow-up|0|||
155236458|NCT00440271|560300118|FG000|Overall Study|Withdrawal by Subject|0|||
155236459|NCT00440271|560300119|FG001|Overall Study|Withdrawal by Subject|2|||
155236460|NCT00440271|560300118|FG000|Overall Study|Lack of Efficacy|0|||
155236461|NCT00440271|560300119|FG001|Overall Study|Lack of Efficacy|1|||
155236462|NCT00440271|560300118|FG000|Overall Study|Due to closure of trial|8|||
155236463|NCT00440271|560300119|FG001|Overall Study|Due to closure of trial|10|||
155236464|NCT00440271|560300118|FG000|Overall Study|Other|2|||
155236465|NCT00440271|560300119|FG001|Overall Study|Other|0|||
155236466|NCT02252081|560300132|FG000|Overall Study|Withdrawal by Subject|2|||
155236467|NCT02252081|560300133|FG001|Overall Study|Withdrawal by Subject|1|||
155236468|NCT02252081|560300132|FG000|Overall Study|Adverse Event|4|||
155236469|NCT02252081|560300133|FG001|Overall Study|Adverse Event|1|||
155236470|NCT02252081|560300132|FG000|Overall Study|non compliance & others|0|||
155236471|NCT02252081|560300133|FG001|Overall Study|non compliance & others|2|||
155236472|NCT00436280|560300139|FG000|Period 1: Induction|Adverse Event|8|||
155236473|NCT00436280|560300139|FG000|Period 1: Induction|Progressive Disease|12|||
155236474|NCT00436280|560300139|FG000|Period 1: Induction|Stable Disease|6|||
155236475|NCT00436280|560300139|FG000|Period 1: Induction|Withdrawal by Subject|1|||
155236476|NCT00436280|560300139|FG000|Period 1: Induction|Death|1|||
155236477|NCT00436280|560300139|FG000|Period 2: Consolidation|Adverse Event|1|||
155236478|NCT00436280|560300139|FG000|Period 2: Consolidation|Progressive Disease|10|||
155236479|NCT00436280|560300139|FG000|Period 2: Consolidation|Stable Disease|1|||
155236480|NCT00436280|560300139|FG000|Period 2: Consolidation|Physician Decision|2|||
155236481|NCT00436280|560300139|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
155236482|NCT00436280|560300139|FG000|Period 2: Consolidation|Death|1|||
155236483|NCT00436280|560300139|FG000|Period 3: Maintenance|Adverse Event|6|||
155236484|NCT00436280|560300139|FG000|Period 3: Maintenance|Progressive Disease|12|||
155236485|NCT03603964|560300140|FG000|Overall Study|Death|9|||
155236486|NCT03603964|560300140|FG000|Overall Study|Withdrawal by participant|7|||
155236487|NCT03603964|560300140|FG000|Overall Study|Study terminated by Sponsor|19|||
155236488|NCT00563797|560300141|FG000|Overall Study|Lost to Follow-up|7|||
155236489|NCT00563797|560300142|FG001|Overall Study|Lost to Follow-up|2|||
155236490|NCT03755765|560300143|FG000|Overall Study|Withdrawal by Subject|2|||
155236491|NCT03755765|560300144|FG001|Overall Study|Withdrawal by Subject|4|||
155236492|NCT03755765|560300145|FG002|Overall Study|Withdrawal by Subject|4|||
155236493|NCT01158222|560300148|FG000|Overall Study|Not eligible for intermediate phase|17|||
155236494|NCT01490060|560300149|FG000|Cycle 1|Change of Treatment|0|||
155236495|NCT01490060|560300150|FG001|Cycle 1|Change of Treatment|1|||
155236496|NCT01490060|560300151|FG002|Cycle 1|Change of Treatment|1|||
155236497|NCT01490060|560300152|FG003|Cycle 1|Change of Treatment|1|||
155236498|NCT01490060|560300149|FG000|Cycle 1|Insurance Denied|0|||
155236499|NCT01490060|560300150|FG001|Cycle 1|Insurance Denied|0|||
155236500|NCT01490060|560300151|FG002|Cycle 1|Insurance Denied|2|||
155236501|NCT01490060|560300152|FG003|Cycle 1|Insurance Denied|0|||
155236502|NCT01490060|560300149|FG000|Cycle 1|Withdrawal by Subject|0|||
155236503|NCT01490060|560300150|FG001|Cycle 1|Withdrawal by Subject|0|||
155236504|NCT01490060|560300151|FG002|Cycle 1|Withdrawal by Subject|0|||
155236505|NCT01490060|560300152|FG003|Cycle 1|Withdrawal by Subject|1|||
155236506|NCT01490060|560300149|FG000|Cycle 1|Treatment at Another Facility|0|||
155236507|NCT01490060|560300150|FG001|Cycle 1|Treatment at Another Facility|0|||
155236508|NCT01490060|560300151|FG002|Cycle 1|Treatment at Another Facility|0|||
155236509|NCT01490060|560300152|FG003|Cycle 1|Treatment at Another Facility|1|||
155236510|NCT01490060|560300149|FG000|Cycle 2|Change of Treatment|1|||
155236511|NCT01490060|560300150|FG001|Cycle 2|Change of Treatment|1|||
155236512|NCT01490060|560300151|FG002|Cycle 2|Change of Treatment|0|||
155236513|NCT01490060|560300152|FG003|Cycle 2|Change of Treatment|0|||
155236514|NCT01490060|560300149|FG000|Cycle 2|Non-Compliance|0|||
155236515|NCT01490060|560300150|FG001|Cycle 2|Non-Compliance|0|||
155236516|NCT01490060|560300151|FG002|Cycle 2|Non-Compliance|1|||
155236517|NCT01490060|560300152|FG003|Cycle 2|Non-Compliance|0|||
155236518|NCT01490060|560300149|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
155236519|NCT01490060|560300150|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
155236520|NCT01490060|560300151|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
155236521|NCT01490060|560300152|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
155236522|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
155236523|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
155236524|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
155236525|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
155236526|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
155236527|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
155236528|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
155236529|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
155236530|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
155236531|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
155236532|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
155236533|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
155236534|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
155236535|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
155236536|NCT02464969|560300153|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
155236537|NCT02464969|560300154|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
155236538|NCT02464969|560300153|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
155236539|NCT02464969|560300154|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
155236540|NCT02464969|560300153|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
155236541|NCT02464969|560300154|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
155236542|NCT02464969|560300153|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
155236543|NCT02464969|560300154|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
155236544|NCT02399085|560300161|FG000|Overall Study|Adverse Event|16|||
155236545|NCT02399085|560300161|FG000|Overall Study|Death|2|||
155236546|NCT02399085|560300161|FG000|Overall Study|Withdrawal by Subject|8|||
155236547|NCT02399085|560300161|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
155236548|NCT02399085|560300161|FG000|Overall Study|Physician Decision|5|||
155236549|NCT00699699|560300162|FG000|Overall Study|Adverse Event|36|||
155236550|NCT00699699|560300162|FG000|Overall Study|Individual different reasons|21|||
155236551|NCT00414050|560300163|FG000|Overall Study|Adverse Event|1|||
155236552|NCT00414050|560300164|FG001|Overall Study|Adverse Event|1|||
155236553|NCT00414050|560300165|FG002|Overall Study|Adverse Event|1|||
155236554|NCT00414050|560300166|FG003|Overall Study|Adverse Event|1|||
155236555|NCT00414050|560300163|FG000|Overall Study|Lost to Follow-up|2|||
155236556|NCT00414050|560300164|FG001|Overall Study|Lost to Follow-up|2|||
155236557|NCT00414050|560300165|FG002|Overall Study|Lost to Follow-up|1|||
155236558|NCT00414050|560300166|FG003|Overall Study|Lost to Follow-up|1|||
155236559|NCT00414050|560300163|FG000|Overall Study|Withdrawal by Subject|5|||
155236560|NCT00414050|560300164|FG001|Overall Study|Withdrawal by Subject|3|||
155236561|NCT00414050|560300165|FG002|Overall Study|Withdrawal by Subject|2|||
155236562|NCT00414050|560300166|FG003|Overall Study|Withdrawal by Subject|4|||
155236563|NCT00414050|560300163|FG000|Overall Study|Subject discontinued for other reason|1|||
155236564|NCT00414050|560300164|FG001|Overall Study|Subject discontinued for other reason|2|||
155236565|NCT00414050|560300165|FG002|Overall Study|Subject discontinued for other reason|2|||
155236566|NCT00414050|560300166|FG003|Overall Study|Subject discontinued for other reason|1|||
155236567|NCT00414050|560300163|FG000|Overall Study|Subject Moved|0|||
155236568|NCT00414050|560300164|FG001|Overall Study|Subject Moved|0|||
155236569|NCT00414050|560300165|FG002|Overall Study|Subject Moved|0|||
155236570|NCT00414050|560300166|FG003|Overall Study|Subject Moved|1|||
155236571|NCT00720876|560300177|FG000|Overall Study|found to be ineligible after starting tx|2|||
155236572|NCT03304379|560300179|FG000|Overall Study|Protocol Violation|8|||
155236573|NCT03304379|560300180|FG001|Overall Study|Protocol Violation|10|||
155236574|NCT03304379|560300181|FG002|Overall Study|Protocol Violation|5|||
155236575|NCT03304379|560300182|FG003|Overall Study|Protocol Violation|0|||
155236576|NCT03304379|560300183|FG004|Overall Study|Protocol Violation|2|||
155236577|NCT03304379|560300179|FG000|Overall Study|Adverse Event|4|||
155236578|NCT03304379|560300180|FG001|Overall Study|Adverse Event|20|||
155236579|NCT03304379|560300181|FG002|Overall Study|Adverse Event|17|||
155236580|NCT03304379|560300182|FG003|Overall Study|Adverse Event|1|||
155236581|NCT03304379|560300183|FG004|Overall Study|Adverse Event|0|||
155236582|NCT03304379|560300179|FG000|Overall Study|Lack of Efficacy|17|||
155236583|NCT03304379|560300180|FG001|Overall Study|Lack of Efficacy|16|||
155236584|NCT03304379|560300181|FG002|Overall Study|Lack of Efficacy|20|||
155236585|NCT03304379|560300182|FG003|Overall Study|Lack of Efficacy|0|||
155236586|NCT03304379|560300183|FG004|Overall Study|Lack of Efficacy|0|||
155236587|NCT03304379|560300179|FG000|Overall Study|Physician Decision|6|||
155236588|NCT03304379|560300180|FG001|Overall Study|Physician Decision|10|||
155236589|NCT03304379|560300181|FG002|Overall Study|Physician Decision|6|||
155236590|NCT03304379|560300182|FG003|Overall Study|Physician Decision|9|||
155236591|NCT03304379|560300183|FG004|Overall Study|Physician Decision|10|||
155236592|NCT03304379|560300179|FG000|Overall Study|Withdrawal by Subject|26|||
155236593|NCT03304379|560300180|FG001|Overall Study|Withdrawal by Subject|58|||
155236594|NCT03304379|560300181|FG002|Overall Study|Withdrawal by Subject|66|||
155236595|NCT03304379|560300182|FG003|Overall Study|Withdrawal by Subject|3|||
155236596|NCT03304379|560300183|FG004|Overall Study|Withdrawal by Subject|5|||
155236597|NCT03304379|560300179|FG000|Overall Study|Lost to Follow-up|8|||
155236598|NCT03304379|560300180|FG001|Overall Study|Lost to Follow-up|24|||
155236599|NCT03304379|560300181|FG002|Overall Study|Lost to Follow-up|35|||
155236600|NCT03304379|560300182|FG003|Overall Study|Lost to Follow-up|4|||
155236601|NCT03304379|560300183|FG004|Overall Study|Lost to Follow-up|0|||
155236602|NCT03304379|560300179|FG000|Overall Study|Death|1|||
155236603|NCT03304379|560300180|FG001|Overall Study|Death|2|||
155236604|NCT03304379|560300181|FG002|Overall Study|Death|0|||
155236605|NCT03304379|560300182|FG003|Overall Study|Death|0|||
155236606|NCT03304379|560300183|FG004|Overall Study|Death|0|||
155236607|NCT03304379|560300179|FG000|Overall Study|Other|0|||
155236608|NCT03304379|560300180|FG001|Overall Study|Other|1|||
155236609|NCT03304379|560300181|FG002|Overall Study|Other|0|||
155236610|NCT03304379|560300182|FG003|Overall Study|Other|0|||
155236611|NCT03304379|560300183|FG004|Overall Study|Other|0|||
155236612|NCT01559311|560300191|FG000|Overall Study|Protocol Violation|0|||
155236613|NCT01559311|560300192|FG001|Overall Study|Protocol Violation|0|||
155236614|NCT01559311|560300193|FG002|Overall Study|Protocol Violation|2|||
155236615|NCT01559311|560300191|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
155236616|NCT01559311|560300192|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
155236617|NCT01559311|560300193|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
155236618|NCT01559311|560300191|FG000|Overall Study|Withdrawal by Subject|2|||
155236619|NCT01559311|560300192|FG001|Overall Study|Withdrawal by Subject|1|||
155236620|NCT01559311|560300193|FG002|Overall Study|Withdrawal by Subject|0|||
155236621|NCT01559311|560300191|FG000|Overall Study|Death|0|||
155236622|NCT01559311|560300192|FG001|Overall Study|Death|2|||
155236623|NCT01559311|560300193|FG002|Overall Study|Death|3|||
155236624|NCT01559311|560300191|FG000|Overall Study|Lost to Follow-up|0|||
155236625|NCT01559311|560300192|FG001|Overall Study|Lost to Follow-up|3|||
155236626|NCT01559311|560300193|FG002|Overall Study|Lost to Follow-up|2|||
155236627|NCT01559311|560300191|FG000|Overall Study|Adverse Event|0|||
155236628|NCT01559311|560300192|FG001|Overall Study|Adverse Event|0|||
155236629|NCT01559311|560300193|FG002|Overall Study|Adverse Event|1|||
155236630|NCT01649856|560300194|FG000|Overall Study|Withdrawal by Subject|14|||
155236631|NCT01649856|560300195|FG001|Overall Study|Withdrawal by Subject|14|||
155236632|NCT01649856|560300194|FG000|Overall Study|Protocol Violation|4|||
155236633|NCT01649856|560300195|FG001|Overall Study|Protocol Violation|4|||
155236634|NCT01649856|560300194|FG000|Overall Study|Treatment Failure|1|||
155236635|NCT01649856|560300195|FG001|Overall Study|Treatment Failure|1|||
155236636|NCT01649856|560300194|FG000|Overall Study|Death|69|||
155236637|NCT01649856|560300195|FG001|Overall Study|Death|34|||
155236638|NCT01649856|560300194|FG000|Overall Study|Stable or Progressed Disease|5|||
155236639|NCT01649856|560300195|FG001|Overall Study|Stable or Progressed Disease|3|||
155236640|NCT01649856|560300194|FG000|Overall Study|Lost to Follow-up|20|||
155236641|NCT01649856|560300195|FG001|Overall Study|Lost to Follow-up|16|||
155236642|NCT01649856|560300194|FG000|Overall Study|Lack of Compliance|6|||
155236643|NCT01649856|560300195|FG001|Overall Study|Lack of Compliance|1|||
155236644|NCT01649856|560300194|FG000|Overall Study|Other|20|||
155236645|NCT01649856|560300195|FG001|Overall Study|Other|5|||
155236646|NCT00179647|560300196|FG000|Overall Study|Adverse Event|294|||
155236647|NCT00179647|560300196|FG000|Overall Study|Lack of Efficacy|478|||
155236648|NCT00179647|560300196|FG000|Overall Study|Withdrawal by Subject|83|||
155236649|NCT00179647|560300196|FG000|Overall Study|Lost to Follow-up|4|||
155236650|NCT00179647|560300196|FG000|Overall Study|Death|94|||
155236651|NCT00179647|560300196|FG000|Overall Study|Other|960|||
155236652|NCT05013905|560300197|FG000|Overall Study|Adverse Event|1|||
155236653|NCT05013905|560300197|FG000|Overall Study|Lack of Efficacy|1|||
155236654|NCT01849588|560300199|FG000|Overall Study|Lack of Efficacy|3|||
155236655|NCT02550652|560300207|FG000|Overall Study|Death|1|||
155236656|NCT02550652|560300208|FG001|Overall Study|Death|4|||
155236657|NCT02550652|560300207|FG000|Overall Study|Lack of Efficacy|1|||
155236658|NCT02550652|560300208|FG001|Overall Study|Lack of Efficacy|0|||
155236659|NCT02550652|560300207|FG000|Overall Study|Withdrawal by Subject|4|||
155236660|NCT02550652|560300208|FG001|Overall Study|Withdrawal by Subject|7|||
155236661|NCT02550652|560300207|FG000|Overall Study|Post Trial Access|1|||
155236662|NCT02550652|560300208|FG001|Overall Study|Post Trial Access|0|||
155236663|NCT02550652|560300207|FG000|Overall Study|Lost to Follow-up|1|||
155236664|NCT02550652|560300208|FG001|Overall Study|Lost to Follow-up|3|||
155236665|NCT02550652|560300207|FG000|Overall Study|Physician Decision|0|||
155236666|NCT02550652|560300208|FG001|Overall Study|Physician Decision|2|||
155236667|NCT02550652|560300207|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
155236668|NCT02550652|560300208|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
155236669|NCT03027466|560300209|FG000|Overall Study|Opting out of the app|1869|||
155236670|NCT03027466|560300210|FG001|Overall Study|Opting out of the app|1819|||
155236671|NCT03027466|560300211|FG002|Overall Study|Opting out of the app|1743|||
155236672|NCT03027466|560300212|FG003|Overall Study|Opting out of the app|1821|||
155236673|NCT01706250|560300213|FG000|Overall Study|Lost to Follow-up|2|||
155236674|NCT03286140|560300214|FG000|Overall Study|Withdrawal by Subject|10|||
155236675|NCT03286140|560300215|FG001|Overall Study|Withdrawal by Subject|5|||
155236676|NCT03286140|560300214|FG000|Overall Study|Lost to Follow-up|5|||
155236677|NCT03286140|560300215|FG001|Overall Study|Lost to Follow-up|10|||
155236678|NCT03286140|560300214|FG000|Overall Study|Failure to comply|0|||
155236679|NCT03286140|560300215|FG001|Overall Study|Failure to comply|1|||
155236680|NCT02158039|560300216|FG000|Overall Study|Withdrawal by Subject|1|||
155236681|NCT02158039|560300216|FG000|Overall Study|Screen Failure|9|||
155236682|NCT02563028|560300218|FG000|Overall Study|Lack of equipment|1|||
155236683|NCT02563028|560300218|FG000|Overall Study|Unable to elicit VEP post induction|1|||
155236684|NCT01009099|560300219|FG000|Overall Study|Lost to Follow-up|1|||
155236685|NCT01009099|560300220|FG001|Overall Study|Lost to Follow-up|0|||
155236686|NCT01009099|560300219|FG000|Overall Study|Physician Decision|3|||
155236687|NCT01009099|560300220|FG001|Overall Study|Physician Decision|2|||
155236688|NCT01009099|560300219|FG000|Overall Study|Withdrawal by Subject|1|||
155236689|NCT01009099|560300220|FG001|Overall Study|Withdrawal by Subject|1|||
155236690|NCT01009099|560300219|FG000|Overall Study|Death|0|||
155236691|NCT01009099|560300220|FG001|Overall Study|Death|1|||
155236692|NCT01856543|560300221|FG000|Overall Study|Treatment discontinued|6|||
155236693|NCT01856543|560300222|FG001|Overall Study|Treatment discontinued|3|||
155236694|NCT01856543|560300221|FG000|Overall Study|Withdrawn before start|7|||
155236695|NCT01856543|560300222|FG001|Overall Study|Withdrawn before start|3|||
155236696|NCT02188485|560300223|FG000|Overall Study|Withdrawal by Subject|2|||
155236697|NCT02188485|560300224|FG001|Overall Study|Withdrawal by Subject|1|||
155236698|NCT02188485|560300223|FG000|Overall Study|PI withdrew, lack of capacity|0|||
155236699|NCT02188485|560300224|FG001|Overall Study|PI withdrew, lack of capacity|2|||
155236700|NCT00799617|560300225|FG000|Main Testosterone Trial|Randomized in error|1|||
155236701|NCT00799617|560300226|FG001|Main Testosterone Trial|Randomized in error|1|||
155236702|NCT00799617|560300225|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
155236703|NCT00799617|560300226|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
155236704|NCT00799617|560300225|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
155236705|NCT00799617|560300226|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
155236706|NCT00799617|560300225|FG000|Sexual Funtion Trial|No Baseline Data|4|||
155236707|NCT00799617|560300226|FG001|Sexual Funtion Trial|No Baseline Data|7|||
155236708|NCT00799617|560300225|FG000|Physical Function Trial|Lost to Follow-up|6|||
155236709|NCT00799617|560300226|FG001|Physical Function Trial|Lost to Follow-up|11|||
155236710|NCT00799617|560300225|FG000|Vitality Trial|Lost to Follow-up|7|||
155236711|NCT00799617|560300226|FG001|Vitality Trial|Lost to Follow-up|22|||
155236712|NCT00799617|560300225|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
155236713|NCT00799617|560300226|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
155236714|NCT00799617|560300225|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
155236715|NCT00799617|560300226|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
155236716|NCT00799617|560300225|FG000|Bone Trial|Month 12 scan not available|6|||
155236717|NCT00799617|560300226|FG001|Bone Trial|Month 12 scan not available|16|||
155236718|NCT00799617|560300225|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
155236719|NCT00799617|560300226|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
155236720|NCT00799617|560300225|FG000|Anemia Trial|Withdrawal by Subject|3|||
155236721|NCT00799617|560300226|FG001|Anemia Trial|Withdrawal by Subject|3|||
155236722|NCT04545515|560300227|FG000|Overall Study|Adverse Event|1|||
155236723|NCT04545515|560300227|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
155236724|NCT04545515|560300227|FG000|Overall Study|Commercial drug is available for participant|7|||
155236725|NCT03149237|560300230|FG000|Overall Study|Withdrawal by Subject|4|||
155236726|NCT03149237|560300231|FG001|Overall Study|Withdrawal by Subject|5|||
155236727|NCT04587193|560300232|FG000|Overall Study|Screen failure after consent|3|||
155236728|NCT04587193|560300233|FG001|Overall Study|Screen failure after consent|0|||
155236729|NCT04587193|560300232|FG000|Overall Study|Device broke during study|3|||
155236730|NCT04587193|560300233|FG001|Overall Study|Device broke during study|2|||
155236731|NCT02501096|560300234|FG000|Overall Study|Lost to Follow-up|0|||
155236732|NCT02501096|560300235|FG001|Overall Study|Lost to Follow-up|0|||
155236733|NCT02501096|560300236|FG002|Overall Study|Lost to Follow-up|0|||
155236734|NCT02501096|560300237|FG003|Overall Study|Lost to Follow-up|0|||
155236735|NCT02501096|560300238|FG004|Overall Study|Lost to Follow-up|1|||
155236736|NCT02501096|560300239|FG005|Overall Study|Lost to Follow-up|1|||
155236737|NCT02501096|560300240|FG006|Overall Study|Lost to Follow-up|3|||
155236738|NCT02501096|560300241|FG007|Overall Study|Lost to Follow-up|0|||
155236739|NCT02501096|560300242|FG008|Overall Study|Lost to Follow-up|0|||
155236740|NCT02501096|560300234|FG000|Overall Study|Withdrawal by Subject|1|||
155236741|NCT02501096|560300235|FG001|Overall Study|Withdrawal by Subject|0|||
155236742|NCT02501096|560300236|FG002|Overall Study|Withdrawal by Subject|7|||
155236743|NCT02501096|560300237|FG003|Overall Study|Withdrawal by Subject|13|||
155236744|NCT02501096|560300238|FG004|Overall Study|Withdrawal by Subject|2|||
155236745|NCT02501096|560300239|FG005|Overall Study|Withdrawal by Subject|2|||
155236746|NCT02501096|560300240|FG006|Overall Study|Withdrawal by Subject|2|||
155236747|NCT02501096|560300241|FG007|Overall Study|Withdrawal by Subject|3|||
155236748|NCT02501096|560300242|FG008|Overall Study|Withdrawal by Subject|0|||
155236749|NCT02501096|560300234|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
155236750|NCT02501096|560300235|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
155236751|NCT02501096|560300236|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
155236752|NCT02501096|560300237|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
155236753|NCT02501096|560300238|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
155236754|NCT02501096|560300239|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
155236755|NCT02501096|560300240|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
155236756|NCT02501096|560300241|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
155236757|NCT02501096|560300242|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
155236758|NCT02501096|560300234|FG000|Overall Study|Death|1|||
155236759|NCT02501096|560300235|FG001|Overall Study|Death|1|||
155236760|NCT02501096|560300236|FG002|Overall Study|Death|88|||
155236761|NCT02501096|560300237|FG003|Overall Study|Death|74|||
155236762|NCT02501096|560300238|FG004|Overall Study|Death|15|||
155236763|NCT02501096|560300239|FG005|Overall Study|Death|16|||
155236764|NCT02501096|560300240|FG006|Overall Study|Death|15|||
155236765|NCT02501096|560300241|FG007|Overall Study|Death|16|||
155236766|NCT02501096|560300242|FG008|Overall Study|Death|1|||
155236767|NCT03878134|560300243|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
155236768|NCT03851016|560300244|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
155236769|NCT03851016|560300245|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
155236770|NCT00853658|560300246|FG000|Overall Study|Death|713|||
155236771|NCT00853658|560300247|FG001|Overall Study|Death|768|||
155236772|NCT00853658|560300248|FG002|Overall Study|Death|753|||
155236773|NCT00853658|560300246|FG000|Overall Study|Lost to Follow-up|11|||
155236774|NCT00853658|560300247|FG001|Overall Study|Lost to Follow-up|6|||
155236775|NCT00853658|560300248|FG002|Overall Study|Lost to Follow-up|11|||
155236776|NCT00853658|560300246|FG000|Overall Study|H.A. Request|26|||
155236777|NCT00853658|560300247|FG001|Overall Study|H.A. Request|23|||
155236778|NCT00853658|560300248|FG002|Overall Study|H.A. Request|19|||
155236779|NCT00853658|560300246|FG000|Overall Study|IRB request|0|||
155236780|NCT00853658|560300247|FG001|Overall Study|IRB request|0|||
155236781|NCT00853658|560300248|FG002|Overall Study|IRB request|2|||
155236782|NCT00853658|560300246|FG000|Overall Study|Vital Status known (alive) at study end|2|||
155236783|NCT00853658|560300247|FG001|Overall Study|Vital Status known (alive) at study end|3|||
155236784|NCT00853658|560300248|FG002|Overall Study|Vital Status known (alive) at study end|3|||
155236785|NCT00853658|560300246|FG000|Overall Study|Vital Status unknown at study end|1|||
155236786|NCT00853658|560300247|FG001|Overall Study|Vital Status unknown at study end|1|||
155236787|NCT00853658|560300248|FG002|Overall Study|Vital Status unknown at study end|0|||
155236788|NCT00853658|560300246|FG000|Overall Study|Vital Status at study end N/A|8|||
155236789|NCT00853658|560300247|FG001|Overall Study|Vital Status at study end N/A|10|||
155236790|NCT00853658|560300248|FG002|Overall Study|Vital Status at study end N/A|10|||
155236791|NCT00853658|560300246|FG000|Overall Study|Patient's request|21|||
155236792|NCT00853658|560300247|FG001|Overall Study|Patient's request|17|||
155236793|NCT00853658|560300248|FG002|Overall Study|Patient's request|11|||
155236794|NCT00853658|560300246|FG000|Overall Study|Missing study completion information|5|||
155236795|NCT00853658|560300247|FG001|Overall Study|Missing study completion information|4|||
155236796|NCT00853658|560300248|FG002|Overall Study|Missing study completion information|6|||
155236797|NCT01227512|560300249|FG000|Overall Study|Physician Decision|6|||
155236798|NCT01227512|560300250|FG001|Overall Study|Physician Decision|6|||
155236799|NCT01227512|560300249|FG000|Overall Study|Adverse Event|4|||
155236800|NCT01227512|560300250|FG001|Overall Study|Adverse Event|3|||
155236801|NCT01227512|560300249|FG000|Overall Study|Withdrawal by Subject|3|||
155236802|NCT01227512|560300250|FG001|Overall Study|Withdrawal by Subject|0|||
155236803|NCT01227512|560300249|FG000|Overall Study|Participant met withdrawal criteria|0|||
155236804|NCT01227512|560300250|FG001|Overall Study|Participant met withdrawal criteria|1|||
155236805|NCT02774681|560300257|FG000|Treatment on Study|Progressive Disease|7|||
155236806|NCT02774681|560300257|FG000|Follow-Up for 3 Years|Death|11|||
155236807|NCT02774681|560300257|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
155236808|NCT01069289|560300258|FG000|Overall Study|Withdrawal by Subject|15|||
155236809|NCT01069289|560300259|FG001|Overall Study|Withdrawal by Subject|26|||
155236810|NCT01069289|560300258|FG000|Overall Study|Adverse Event|21|||
155236811|NCT01069289|560300259|FG001|Overall Study|Adverse Event|28|||
155236812|NCT01069289|560300258|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155236813|NCT01069289|560300259|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155236814|NCT01069289|560300258|FG000|Overall Study|Severe non-compliance to protocol|3|||
155236815|NCT01069289|560300259|FG001|Overall Study|Severe non-compliance to protocol|2|||
155236816|NCT01069289|560300258|FG000|Overall Study|Due to deteriorating health condition|1|||
155236817|NCT01069289|560300259|FG001|Overall Study|Due to deteriorating health condition|0|||
155236818|NCT00298038|560300260|FG000|Overall Study|Lost to Follow-up|0|||
155236819|NCT00298038|560300261|FG001|Overall Study|Lost to Follow-up|1|||
155236820|NCT00298038|560300260|FG000|Overall Study|Liver Transplant|0|||
155236821|NCT00298038|560300261|FG001|Overall Study|Liver Transplant|1|||
155236822|NCT00298038|560300260|FG000|Overall Study|Protocol Violation|1|||
155236823|NCT00298038|560300261|FG001|Overall Study|Protocol Violation|3|||
155236824|NCT00298038|560300260|FG000|Overall Study|Death|6|||
155236825|NCT00298038|560300261|FG001|Overall Study|Death|3|||
155236826|NCT00298038|560300260|FG000|Overall Study|Withdrawal by Subject|6|||
155236827|NCT00298038|560300261|FG001|Overall Study|Withdrawal by Subject|9|||
155236828|NCT00298038|560300260|FG000|Overall Study|Adverse Event|8|||
155236829|NCT00298038|560300261|FG001|Overall Study|Adverse Event|7|||
155236830|NCT00298038|560300260|FG000|Overall Study|Breakthrough overt HE episode|28|||
155236831|NCT00298038|560300261|FG001|Overall Study|Breakthrough overt HE episode|69|||
155236832|NCT00298038|560300260|FG000|Overall Study|Noncompliance|1|||
155236833|NCT00298038|560300261|FG001|Overall Study|Noncompliance|0|||
155236834|NCT00298038|560300260|FG000|Overall Study|Cocaine Abuse|1|||
155236835|NCT00298038|560300261|FG001|Overall Study|Cocaine Abuse|0|||
155236836|NCT00298038|560300260|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
155236837|NCT00298038|560300261|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
155236838|NCT02696096|560300262|FG000|Overall Study|ruled out at screening|1|||
155236839|NCT02696096|560300262|FG000|Overall Study|did not attend second fMRI|1|||
155236840|NCT01940705|560300263|FG000|Overall Study|Lost to Follow-up|1|||
155236841|NCT01940705|560300264|FG001|Overall Study|Lost to Follow-up|3|||
155236842|NCT01940705|560300265|FG002|Overall Study|Lost to Follow-up|2|||
155236843|NCT01940705|560300266|FG003|Overall Study|Lost to Follow-up|2|||
155236844|NCT01940705|560300263|FG000|Overall Study|Withdrawal by Subject|2|||
155236845|NCT01940705|560300264|FG001|Overall Study|Withdrawal by Subject|2|||
155236846|NCT01940705|560300265|FG002|Overall Study|Withdrawal by Subject|3|||
155236847|NCT01940705|560300266|FG003|Overall Study|Withdrawal by Subject|2|||
155236848|NCT01940705|560300263|FG000|Overall Study|Intervention not given|0|||
155236849|NCT01940705|560300264|FG001|Overall Study|Intervention not given|3|||
155236850|NCT01940705|560300265|FG002|Overall Study|Intervention not given|3|||
155236851|NCT01940705|560300266|FG003|Overall Study|Intervention not given|0|||
155236852|NCT01940705|560300263|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
155236853|NCT01940705|560300264|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
155236854|NCT01940705|560300265|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
155236855|NCT01940705|560300266|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
155236856|NCT02447991|560300267|FG000|Overall Study|Withdrawn by subject - no data|0|||
155236857|NCT02447991|560300268|FG001|Overall Study|Withdrawn by subject - no data|2|||
155236858|NCT02447991|560300267|FG000|Overall Study|Withdrawn by Subject - with data|4|||
155236859|NCT02447991|560300268|FG001|Overall Study|Withdrawn by Subject - with data|4|||
155236860|NCT02447991|560300267|FG000|Overall Study|Lost to Follow-up - no data|3|||
155236861|NCT02447991|560300268|FG001|Overall Study|Lost to Follow-up - no data|6|||
155236862|NCT02447991|560300267|FG000|Overall Study|Lost to follow-up - with data|0|||
155236863|NCT02447991|560300268|FG001|Overall Study|Lost to follow-up - with data|3|||
155236864|NCT02447991|560300267|FG000|Overall Study|End of study - no treatment results|3|||
155236865|NCT02447991|560300268|FG001|Overall Study|End of study - no treatment results|6|||
155236866|NCT02447991|560300267|FG000|Overall Study|End of study - partial treatment results|0|||
155236867|NCT02447991|560300268|FG001|Overall Study|End of study - partial treatment results|9|||
155236868|NCT01976845|560300269|FG000|Overall Study|Physician Decision|8|||
155236869|NCT01976845|560300270|FG001|Overall Study|Physician Decision|8|||
155236870|NCT01976845|560300271|FG002|Overall Study|Physician Decision|3|||
155236871|NCT03042312|560302128|FG000|Overall Study|Administrative Reason|1|||
155236872|NCT03042312|560302129|FG001|Overall Study|Administrative Reason|1|||
155236873|NCT03042312|560302128|FG000|Overall Study|Adverse Event|0|||
155236874|NCT03042312|560302129|FG001|Overall Study|Adverse Event|1|||
155236875|NCT03042312|560302128|FG000|Overall Study|Lost to Follow-up|1|||
155236876|NCT03042312|560302129|FG001|Overall Study|Lost to Follow-up|3|||
155236877|NCT03042312|560302128|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
155236878|NCT03042312|560302129|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
155236879|NCT03042312|560302128|FG000|Overall Study|Withdrawal by Subject|4|||
155236880|NCT03042312|560302129|FG001|Overall Study|Withdrawal by Subject|5|||
155236881|NCT02293005|560302132|FG000|Overall Study|Adverse Event|2|||
155236882|NCT02293005|560302132|FG000|Overall Study|Death|4|||
155236883|NCT02293005|560302132|FG000|Overall Study|Lost to Follow-up|1|||
155236884|NCT02293005|560302132|FG000|Overall Study|Withdrawal by Subject|2|||
155236885|NCT02293005|560302132|FG000|Overall Study|Progression|17|||
155236886|NCT00938431|560302138|FG000|Overall Study|Adverse Event|5|||
155236887|NCT00938431|560302139|FG001|Overall Study|Adverse Event|8|||
155236888|NCT00938431|560302140|FG002|Overall Study|Adverse Event|6|||
155236889|NCT00938431|560302138|FG000|Overall Study|Lack of Efficacy|0|||
155236890|NCT00938431|560302139|FG001|Overall Study|Lack of Efficacy|1|||
155236891|NCT00938431|560302140|FG002|Overall Study|Lack of Efficacy|0|||
155236892|NCT00938431|560302138|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
155236893|NCT00938431|560302139|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
155236894|NCT00938431|560302140|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
155236895|NCT00938431|560302138|FG000|Overall Study|Dosing compliance issue|0|||
155236896|NCT00938431|560302139|FG001|Overall Study|Dosing compliance issue|0|||
155236897|NCT00938431|560302140|FG002|Overall Study|Dosing compliance issue|1|||
155236898|NCT00938431|560302138|FG000|Overall Study|Reached maximum dose early|0|||
155236899|NCT00938431|560302139|FG001|Overall Study|Reached maximum dose early|0|||
155236900|NCT00938431|560302140|FG002|Overall Study|Reached maximum dose early|1|||
155236901|NCT01774903|560302141|FG000|Overall Study|Adverse Event|7|||
155236902|NCT01774903|560302141|FG000|Overall Study|Withdrawal by Subject|2|||
155236903|NCT01774903|560302141|FG000|Overall Study|Lack of Efficacy|1|||
155236904|NCT01774903|560302141|FG000|Overall Study|Ineligible to continue the trial|1|||
155236905|NCT00961259|560302146|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
155236906|NCT00961259|560302147|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
155236907|NCT00961259|560302148|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
155236908|NCT01252251|560302149|FG000|Overall Study|Withdrawal by Subject|1|||
155236909|NCT01324024|560302150|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
155236910|NCT01324024|560302151|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155236911|NCT00530023|560302152|FG000|Overall Study|Withdrawal by Subject|0|||
155236912|NCT00530023|560302153|FG001|Overall Study|Withdrawal by Subject|1|||
155236913|NCT01858194|560302159|FG000|Overall Study|Total Artificial Heart Implant|0|||
155236914|NCT01858194|560302160|FG001|Overall Study|Total Artificial Heart Implant|1|||
155236915|NCT01858194|560302159|FG000|Overall Study|Lost to Follow-up|0|||
155236916|NCT01858194|560302160|FG001|Overall Study|Lost to Follow-up|1|||
155236917|NCT00205712|560302172|FG000|Overall Study|Lost to Follow-up|0|||
155236918|NCT00205712|560302173|FG001|Overall Study|Lost to Follow-up|1|||
155236919|NCT00096044|560302174|FG000|Overall Study|Withdrawal by Subject|9|||
155236920|NCT00096044|560302174|FG000|Overall Study|Adverse Event|21|||
155236921|NCT00096044|560302174|FG000|Overall Study|Disease Progression|4|||
155236922|NCT02442830|560302175|FG000|Overall Study|Technical Failure|0|||
155236923|NCT02442830|560302176|FG001|Overall Study|Technical Failure|1|||
155236924|NCT00437034|560302177|FG000|Overall Study|Adverse Event|1|||
155236925|NCT00437034|560302177|FG000|Overall Study|Disease progression during treatment|5|||
155236926|NCT02460224|560302179|FG000|Overall Study|Adverse Event|0|||
155236927|NCT02460224|560302180|FG001|Overall Study|Adverse Event|0|||
155236928|NCT02460224|560302181|FG002|Overall Study|Adverse Event|0|||
155236929|NCT02460224|560302182|FG003|Overall Study|Adverse Event|0|||
155236930|NCT02460224|560302183|FG004|Overall Study|Adverse Event|0|||
155236931|NCT02460224|560302184|FG005|Overall Study|Adverse Event|0|||
155236932|NCT02460224|560302185|FG006|Overall Study|Adverse Event|1|||
155236933|NCT02460224|560302186|FG007|Overall Study|Adverse Event|0|||
155236934|NCT02460224|560302187|FG008|Overall Study|Adverse Event|0|||
155236935|NCT02460224|560302188|FG009|Overall Study|Adverse Event|0|||
155236936|NCT02460224|560302189|FG010|Overall Study|Adverse Event|0|||
155236937|NCT02460224|560302190|FG011|Overall Study|Adverse Event|0|||
155236938|NCT02460224|560302191|FG012|Overall Study|Adverse Event|1|||
155236939|NCT02460224|560302192|FG013|Overall Study|Adverse Event|0|||
155236940|NCT02460224|560302193|FG014|Overall Study|Adverse Event|0|||
155236941|NCT02460224|560302194|FG015|Overall Study|Adverse Event|0|||
155236942|NCT02460224|560302195|FG016|Overall Study|Adverse Event|1|||
155236943|NCT02460224|560302196|FG017|Overall Study|Adverse Event|0|||
155236944|NCT02460224|560302197|FG018|Overall Study|Adverse Event|1|||
155236945|NCT02460224|560302198|FG019|Overall Study|Adverse Event|0|||
155236946|NCT02460224|560302199|FG020|Overall Study|Adverse Event|1|||
155236947|NCT02460224|560302200|FG021|Overall Study|Adverse Event|1|||
155236948|NCT02460224|560302201|FG022|Overall Study|Adverse Event|1|||
155236949|NCT02460224|560302202|FG023|Overall Study|Adverse Event|0|||
155236950|NCT02460224|560302203|FG024|Overall Study|Adverse Event|0|||
155236951|NCT02460224|560302204|FG025|Overall Study|Adverse Event|0|||
155236952|NCT02460224|560302205|FG026|Overall Study|Adverse Event|11|||
155236953|NCT02460224|560302206|FG027|Overall Study|Adverse Event|1|||
155236954|NCT02460224|560302207|FG028|Overall Study|Adverse Event|6|||
155236955|NCT02460224|560302179|FG000|Overall Study|Death|0|||
155236956|NCT02460224|560302180|FG001|Overall Study|Death|0|||
155236957|NCT02460224|560302181|FG002|Overall Study|Death|0|||
155236958|NCT02460224|560302182|FG003|Overall Study|Death|0|||
155236959|NCT02460224|560302183|FG004|Overall Study|Death|0|||
155236960|NCT02460224|560302184|FG005|Overall Study|Death|2|||
155236961|NCT02460224|560302185|FG006|Overall Study|Death|1|||
155236962|NCT02460224|560302186|FG007|Overall Study|Death|0|||
155236963|NCT02460224|560302187|FG008|Overall Study|Death|0|||
155236964|NCT02460224|560302188|FG009|Overall Study|Death|1|||
155236965|NCT02460224|560302189|FG010|Overall Study|Death|0|||
155236966|NCT02460224|560302190|FG011|Overall Study|Death|0|||
155236967|NCT02460224|560302191|FG012|Overall Study|Death|0|||
155236968|NCT02460224|560302192|FG013|Overall Study|Death|1|||
155236969|NCT02460224|560302193|FG014|Overall Study|Death|0|||
155236970|NCT02460224|560302194|FG015|Overall Study|Death|0|||
155236971|NCT02460224|560302195|FG016|Overall Study|Death|2|||
155236972|NCT02460224|560302196|FG017|Overall Study|Death|1|||
155236973|NCT02460224|560302197|FG018|Overall Study|Death|0|||
155236974|NCT02460224|560302198|FG019|Overall Study|Death|2|||
155236975|NCT02460224|560302199|FG020|Overall Study|Death|0|||
155236976|NCT02460224|560302200|FG021|Overall Study|Death|0|||
155236977|NCT02460224|560302201|FG022|Overall Study|Death|0|||
155236978|NCT02460224|560302202|FG023|Overall Study|Death|0|||
155236979|NCT02460224|560302203|FG024|Overall Study|Death|1|||
155236980|NCT02460224|560302204|FG025|Overall Study|Death|1|||
155236981|NCT02460224|560302205|FG026|Overall Study|Death|5|||
155236982|NCT02460224|560302206|FG027|Overall Study|Death|0|||
155236983|NCT02460224|560302207|FG028|Overall Study|Death|1|||
155236984|NCT02460224|560302179|FG000|Overall Study|Lost to Follow-up|0|||
155236985|NCT02460224|560302180|FG001|Overall Study|Lost to Follow-up|0|||
155236986|NCT02460224|560302181|FG002|Overall Study|Lost to Follow-up|0|||
155236987|NCT02460224|560302182|FG003|Overall Study|Lost to Follow-up|0|||
155236988|NCT02460224|560302183|FG004|Overall Study|Lost to Follow-up|0|||
155236989|NCT02460224|560302184|FG005|Overall Study|Lost to Follow-up|0|||
155236990|NCT02460224|560302185|FG006|Overall Study|Lost to Follow-up|0|||
155236991|NCT02460224|560302186|FG007|Overall Study|Lost to Follow-up|0|||
155236992|NCT02460224|560302187|FG008|Overall Study|Lost to Follow-up|0|||
155236993|NCT02460224|560302188|FG009|Overall Study|Lost to Follow-up|0|||
155236994|NCT02460224|560302189|FG010|Overall Study|Lost to Follow-up|0|||
155236995|NCT02460224|560302190|FG011|Overall Study|Lost to Follow-up|0|||
155236996|NCT02460224|560302191|FG012|Overall Study|Lost to Follow-up|0|||
155236997|NCT02460224|560302192|FG013|Overall Study|Lost to Follow-up|0|||
155236998|NCT02460224|560302193|FG014|Overall Study|Lost to Follow-up|0|||
155236999|NCT02460224|560302194|FG015|Overall Study|Lost to Follow-up|0|||
155237000|NCT02460224|560302195|FG016|Overall Study|Lost to Follow-up|0|||
155237001|NCT02460224|560302196|FG017|Overall Study|Lost to Follow-up|0|||
155237002|NCT02460224|560302197|FG018|Overall Study|Lost to Follow-up|0|||
155237003|NCT02460224|560302198|FG019|Overall Study|Lost to Follow-up|0|||
155237004|NCT02460224|560302199|FG020|Overall Study|Lost to Follow-up|0|||
155237005|NCT02460224|560302200|FG021|Overall Study|Lost to Follow-up|0|||
155237006|NCT02460224|560302201|FG022|Overall Study|Lost to Follow-up|1|||
155237007|NCT02460224|560302202|FG023|Overall Study|Lost to Follow-up|0|||
155237008|NCT02460224|560302203|FG024|Overall Study|Lost to Follow-up|0|||
155237009|NCT02460224|560302204|FG025|Overall Study|Lost to Follow-up|0|||
155237010|NCT02460224|560302205|FG026|Overall Study|Lost to Follow-up|0|||
155237011|NCT02460224|560302206|FG027|Overall Study|Lost to Follow-up|0|||
155237012|NCT02460224|560302207|FG028|Overall Study|Lost to Follow-up|0|||
155237013|NCT02460224|560302179|FG000|Overall Study|Physician Decision|0|||
155237014|NCT02460224|560302180|FG001|Overall Study|Physician Decision|1|||
155237015|NCT02460224|560302181|FG002|Overall Study|Physician Decision|0|||
155237016|NCT02460224|560302182|FG003|Overall Study|Physician Decision|0|||
155237017|NCT02460224|560302183|FG004|Overall Study|Physician Decision|1|||
155237018|NCT02460224|560302184|FG005|Overall Study|Physician Decision|0|||
155237019|NCT02460224|560302185|FG006|Overall Study|Physician Decision|0|||
155237020|NCT02460224|560302186|FG007|Overall Study|Physician Decision|1|||
155237021|NCT02460224|560302187|FG008|Overall Study|Physician Decision|0|||
155237022|NCT02460224|560302188|FG009|Overall Study|Physician Decision|0|||
155237023|NCT02460224|560302189|FG010|Overall Study|Physician Decision|0|||
155237024|NCT02460224|560302190|FG011|Overall Study|Physician Decision|1|||
155237025|NCT02460224|560302191|FG012|Overall Study|Physician Decision|0|||
155237026|NCT02460224|560302192|FG013|Overall Study|Physician Decision|1|||
155237027|NCT02460224|560302193|FG014|Overall Study|Physician Decision|0|||
155237028|NCT02460224|560302194|FG015|Overall Study|Physician Decision|0|||
155237029|NCT02460224|560302195|FG016|Overall Study|Physician Decision|2|||
155237030|NCT02460224|560302196|FG017|Overall Study|Physician Decision|1|||
155237031|NCT02460224|560302197|FG018|Overall Study|Physician Decision|1|||
155237032|NCT02460224|560302198|FG019|Overall Study|Physician Decision|2|||
155237033|NCT02460224|560302199|FG020|Overall Study|Physician Decision|1|||
155237034|NCT02460224|560302200|FG021|Overall Study|Physician Decision|1|||
155237035|NCT02460224|560302201|FG022|Overall Study|Physician Decision|0|||
155237036|NCT02460224|560302202|FG023|Overall Study|Physician Decision|0|||
155237037|NCT02460224|560302203|FG024|Overall Study|Physician Decision|1|||
155237038|NCT02460224|560302204|FG025|Overall Study|Physician Decision|0|||
155237039|NCT02460224|560302205|FG026|Overall Study|Physician Decision|14|||
155237040|NCT02460224|560302206|FG027|Overall Study|Physician Decision|1|||
155237041|NCT02460224|560302207|FG028|Overall Study|Physician Decision|6|||
155237042|NCT02460224|560302179|FG000|Overall Study|Progressive disease|15|||
155237043|NCT02460224|560302180|FG001|Overall Study|Progressive disease|11|||
155237044|NCT02460224|560302181|FG002|Overall Study|Progressive disease|5|||
155237045|NCT02460224|560302182|FG003|Overall Study|Progressive disease|6|||
155237046|NCT02460224|560302183|FG004|Overall Study|Progressive disease|3|||
155237047|NCT02460224|560302184|FG005|Overall Study|Progressive disease|26|||
155237048|NCT02460224|560302185|FG006|Overall Study|Progressive disease|28|||
155237049|NCT02460224|560302186|FG007|Overall Study|Progressive disease|4|||
155237050|NCT02460224|560302187|FG008|Overall Study|Progressive disease|5|||
155237051|NCT02460224|560302188|FG009|Overall Study|Progressive disease|9|||
155237052|NCT02460224|560302189|FG010|Overall Study|Progressive disease|5|||
155237053|NCT02460224|560302190|FG011|Overall Study|Progressive disease|4|||
155237054|NCT02460224|560302191|FG012|Overall Study|Progressive disease|5|||
155237055|NCT02460224|560302192|FG013|Overall Study|Progressive disease|4|||
155237056|NCT02460224|560302193|FG014|Overall Study|Progressive disease|5|||
155237057|NCT02460224|560302194|FG015|Overall Study|Progressive disease|5|||
155237058|NCT02460224|560302195|FG016|Overall Study|Progressive disease|15|||
155237059|NCT02460224|560302196|FG017|Overall Study|Progressive disease|3|||
155237060|NCT02460224|560302197|FG018|Overall Study|Progressive disease|8|||
155237061|NCT02460224|560302198|FG019|Overall Study|Progressive disease|3|||
155237062|NCT02460224|560302199|FG020|Overall Study|Progressive disease|4|||
155237063|NCT02460224|560302200|FG021|Overall Study|Progressive disease|9|||
155237064|NCT02460224|560302201|FG022|Overall Study|Progressive disease|4|||
155237065|NCT02460224|560302202|FG023|Overall Study|Progressive disease|11|||
155237066|NCT02460224|560302203|FG024|Overall Study|Progressive disease|4|||
155237067|NCT02460224|560302204|FG025|Overall Study|Progressive disease|5|||
155237068|NCT02460224|560302205|FG026|Overall Study|Progressive disease|85|||
155237069|NCT02460224|560302206|FG027|Overall Study|Progressive disease|17|||
155237070|NCT02460224|560302207|FG028|Overall Study|Progressive disease|77|||
155237071|NCT02460224|560302179|FG000|Overall Study|Subject/guardian decision|2|||
155237072|NCT02460224|560302180|FG001|Overall Study|Subject/guardian decision|0|||
155237073|NCT02460224|560302181|FG002|Overall Study|Subject/guardian decision|1|||
155237074|NCT02460224|560302182|FG003|Overall Study|Subject/guardian decision|0|||
155237075|NCT02460224|560302183|FG004|Overall Study|Subject/guardian decision|2|||
155237076|NCT02460224|560302184|FG005|Overall Study|Subject/guardian decision|2|||
155237077|NCT02460224|560302185|FG006|Overall Study|Subject/guardian decision|0|||
155237078|NCT02460224|560302186|FG007|Overall Study|Subject/guardian decision|0|||
155237079|NCT02460224|560302187|FG008|Overall Study|Subject/guardian decision|1|||
155237080|NCT02460224|560302188|FG009|Overall Study|Subject/guardian decision|1|||
155237081|NCT02460224|560302189|FG010|Overall Study|Subject/guardian decision|0|||
155237082|NCT02460224|560302190|FG011|Overall Study|Subject/guardian decision|1|||
155237083|NCT02460224|560302191|FG012|Overall Study|Subject/guardian decision|0|||
155237084|NCT02460224|560302192|FG013|Overall Study|Subject/guardian decision|0|||
155237085|NCT02460224|560302193|FG014|Overall Study|Subject/guardian decision|0|||
155237086|NCT02460224|560302194|FG015|Overall Study|Subject/guardian decision|1|||
155237087|NCT02460224|560302195|FG016|Overall Study|Subject/guardian decision|0|||
155237088|NCT02460224|560302196|FG017|Overall Study|Subject/guardian decision|1|||
155237089|NCT02460224|560302197|FG018|Overall Study|Subject/guardian decision|2|||
155237090|NCT02460224|560302198|FG019|Overall Study|Subject/guardian decision|0|||
155237091|NCT02460224|560302199|FG020|Overall Study|Subject/guardian decision|0|||
155237092|NCT02460224|560302200|FG021|Overall Study|Subject/guardian decision|1|||
155237093|NCT02460224|560302201|FG022|Overall Study|Subject/guardian decision|0|||
155237094|NCT02460224|560302202|FG023|Overall Study|Subject/guardian decision|0|||
155237095|NCT02460224|560302203|FG024|Overall Study|Subject/guardian decision|0|||
155237096|NCT02460224|560302204|FG025|Overall Study|Subject/guardian decision|0|||
155237097|NCT02460224|560302205|FG026|Overall Study|Subject/guardian decision|6|||
155237098|NCT02460224|560302206|FG027|Overall Study|Subject/guardian decision|2|||
155237099|NCT02460224|560302207|FG028|Overall Study|Subject/guardian decision|3|||
155237100|NCT00586469|560302208|FG000|Overall Study|Adverse Event|0|||
155237101|NCT00586469|560302209|FG001|Overall Study|Adverse Event|1|||
155237102|NCT04055116|560302210|FG000|First Intervention|Physician Decision|2|||
155237103|NCT04055116|560302211|FG001|First Intervention|Physician Decision|7|||
155237104|NCT01978184|560302212|FG000|Overall Study|Progressive disease|5|||
155237105|NCT01978184|560302213|FG001|Overall Study|Progressive disease|5|||
155237106|NCT01978184|560302212|FG000|Overall Study|Other than PDA|2|||
155237107|NCT01978184|560302213|FG001|Overall Study|Other than PDA|2|||
155237108|NCT01978184|560302212|FG000|Overall Study|Physician Decision|0|||
155237109|NCT01978184|560302213|FG001|Overall Study|Physician Decision|3|||
155237110|NCT01978184|560302212|FG000|Overall Study|Noncompliance|1|||
155237111|NCT01978184|560302213|FG001|Overall Study|Noncompliance|2|||
155237112|NCT01978184|560302212|FG000|Overall Study|Death|1|||
155237113|NCT01978184|560302213|FG001|Overall Study|Death|0|||
155237114|NCT01978184|560302212|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
155237115|NCT01978184|560302213|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
155237116|NCT02047604|560302220|FG000|Overall Study|Withdrawal by Subject|0|||
155237117|NCT02047604|560302221|FG001|Overall Study|Withdrawal by Subject|0|||
155237118|NCT02047604|560302222|FG002|Overall Study|Withdrawal by Subject|0|||
155237119|NCT02047604|560302223|FG003|Overall Study|Withdrawal by Subject|0|||
155237120|NCT02047604|560302224|FG004|Overall Study|Withdrawal by Subject|1|||
155237121|NCT02047604|560302225|FG005|Overall Study|Withdrawal by Subject|1|||
155237122|NCT01208233|560302227|FG000|Overall Study|Adverse Event|0|||
155237123|NCT01208233|560302228|FG001|Overall Study|Adverse Event|1|||
155237124|NCT01208233|560302229|FG002|Overall Study|Adverse Event|2|||
155237125|NCT01208233|560302230|FG003|Overall Study|Adverse Event|0|||
155237126|NCT01208233|560302231|FG004|Overall Study|Adverse Event|3|||
155237127|NCT01208233|560302232|FG005|Overall Study|Adverse Event|5|||
155237128|NCT01208233|560302227|FG000|Overall Study|Death|0|||
155237129|NCT01208233|560302228|FG001|Overall Study|Death|0|||
155237130|NCT01208233|560302229|FG002|Overall Study|Death|0|||
155237131|NCT01208233|560302230|FG003|Overall Study|Death|0|||
155237132|NCT01208233|560302231|FG004|Overall Study|Death|3|||
155237133|NCT01208233|560302232|FG005|Overall Study|Death|5|||
155237134|NCT01208233|560302227|FG000|Overall Study|Did not meet entrance criteria|2|||
155237135|NCT01208233|560302228|FG001|Overall Study|Did not meet entrance criteria|1|||
155237136|NCT01208233|560302229|FG002|Overall Study|Did not meet entrance criteria|1|||
155237137|NCT01208233|560302230|FG003|Overall Study|Did not meet entrance criteria|0|||
155237138|NCT01208233|560302231|FG004|Overall Study|Did not meet entrance criteria|1|||
155237139|NCT01208233|560302232|FG005|Overall Study|Did not meet entrance criteria|0|||
155237140|NCT01208233|560302227|FG000|Overall Study|Medication error without adverse event|0|||
155237141|NCT01208233|560302228|FG001|Overall Study|Medication error without adverse event|0|||
155237142|NCT01208233|560302229|FG002|Overall Study|Medication error without adverse event|0|||
155237143|NCT01208233|560302230|FG003|Overall Study|Medication error without adverse event|0|||
155237144|NCT01208233|560302231|FG004|Overall Study|Medication error without adverse event|0|||
155237145|NCT01208233|560302232|FG005|Overall Study|Medication error without adverse event|1|||
155237146|NCT01208233|560302227|FG000|Overall Study|Study terminated by sponsor|0|||
155237147|NCT01208233|560302228|FG001|Overall Study|Study terminated by sponsor|0|||
155237148|NCT01208233|560302229|FG002|Overall Study|Study terminated by sponsor|0|||
155237149|NCT01208233|560302230|FG003|Overall Study|Study terminated by sponsor|0|||
155237150|NCT01208233|560302231|FG004|Overall Study|Study terminated by sponsor|10|||
155237151|NCT01208233|560302232|FG005|Overall Study|Study terminated by sponsor|7|||
155237152|NCT01208233|560302227|FG000|Overall Study|Protocol Violation|0|||
155237153|NCT01208233|560302228|FG001|Overall Study|Protocol Violation|0|||
155237154|NCT01208233|560302229|FG002|Overall Study|Protocol Violation|0|||
155237155|NCT01208233|560302230|FG003|Overall Study|Protocol Violation|0|||
155237156|NCT01208233|560302231|FG004|Overall Study|Protocol Violation|3|||
155237157|NCT01208233|560302232|FG005|Overall Study|Protocol Violation|0|||
155237158|NCT01208233|560302227|FG000|Overall Study|Other|2|||
155237159|NCT01208233|560302228|FG001|Overall Study|Other|1|||
155237160|NCT01208233|560302229|FG002|Overall Study|Other|0|||
155237161|NCT01208233|560302230|FG003|Overall Study|Other|0|||
155237162|NCT01208233|560302231|FG004|Overall Study|Other|0|||
155237163|NCT01208233|560302232|FG005|Overall Study|Other|1|||
155237164|NCT01208233|560302227|FG000|Overall Study|Withdrawal by Subject|1|||
155237165|NCT01208233|560302228|FG001|Overall Study|Withdrawal by Subject|0|||
155237166|NCT01208233|560302229|FG002|Overall Study|Withdrawal by Subject|1|||
155237167|NCT01208233|560302230|FG003|Overall Study|Withdrawal by Subject|1|||
155237168|NCT01208233|560302231|FG004|Overall Study|Withdrawal by Subject|4|||
155237169|NCT01208233|560302232|FG005|Overall Study|Withdrawal by Subject|2|||
155237170|NCT01181895|560302233|FG000|Overall Study|Adverse Event|3|||
155237171|NCT01181895|560302234|FG001|Overall Study|Adverse Event|1|||
155237172|NCT01181895|560302235|FG002|Overall Study|Adverse Event|1|||
155237173|NCT01181895|560302233|FG000|Overall Study|Lack of Efficacy|8|||
155237174|NCT01181895|560302234|FG001|Overall Study|Lack of Efficacy|9|||
155237175|NCT01181895|560302235|FG002|Overall Study|Lack of Efficacy|9|||
155237176|NCT01181895|560302233|FG000|Overall Study|Protocol Violation|2|||
155237177|NCT01181895|560302234|FG001|Overall Study|Protocol Violation|1|||
155237178|NCT01181895|560302235|FG002|Overall Study|Protocol Violation|0|||
155237179|NCT01181895|560302233|FG000|Overall Study|Lost to Follow-up|0|||
155237180|NCT01181895|560302234|FG001|Overall Study|Lost to Follow-up|1|||
155237181|NCT01181895|560302235|FG002|Overall Study|Lost to Follow-up|2|||
155237182|NCT01181895|560302233|FG000|Overall Study|Investigator Discretion|1|||
155237183|NCT01181895|560302234|FG001|Overall Study|Investigator Discretion|2|||
155237184|NCT01181895|560302235|FG002|Overall Study|Investigator Discretion|1|||
155237185|NCT01181895|560302233|FG000|Overall Study|Withdrawal by Subject|3|||
155237186|NCT01181895|560302234|FG001|Overall Study|Withdrawal by Subject|0|||
155237187|NCT01181895|560302235|FG002|Overall Study|Withdrawal by Subject|5|||
155237188|NCT00023452|560302236|FG000|Overall Study|Ineligible for Study|163|||
155237189|NCT00023452|560302237|FG001|Overall Study|Ineligible for Study|159|||
155237190|NCT00023452|560302236|FG000|Overall Study|Out of Window|129|||
155237191|NCT00023452|560302237|FG001|Overall Study|Out of Window|69|||
155237192|NCT00023452|560302236|FG000|Overall Study|Death|2|||
155237193|NCT00023452|560302237|FG001|Overall Study|Death|0|||
155237194|NCT00023452|560302236|FG000|Overall Study|Withdrawal by Subject|66|||
155237195|NCT00023452|560302237|FG001|Overall Study|Withdrawal by Subject|54|||
155237196|NCT00023452|560302236|FG000|Overall Study|Adverse Event|139|||
155237197|NCT00023452|560302237|FG001|Overall Study|Adverse Event|196|||
155237198|NCT00023452|560302236|FG000|Overall Study|Lost to Follow-up|293|||
155237199|NCT00023452|560302237|FG001|Overall Study|Lost to Follow-up|60|||
155237200|NCT00023452|560302236|FG000|Overall Study|Physician Decision|49|||
155237201|NCT00023452|560302237|FG001|Overall Study|Physician Decision|21|||
155237202|NCT00023452|560302236|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
155237203|NCT00023452|560302237|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
155237204|NCT00023452|560302236|FG000|Overall Study|Pregnant|53|||
155237205|NCT00023452|560302237|FG001|Overall Study|Pregnant|20|||
155237206|NCT00023452|560302236|FG000|Overall Study|Other|204|||
155237207|NCT00023452|560302237|FG001|Overall Study|Other|69|||
155237208|NCT00459134|560302244|FG000|Overall Study|Physician Decision|1|||
155237209|NCT00459134|560302245|FG001|Overall Study|Physician Decision|1|||
155237210|NCT00459134|560302244|FG000|Overall Study|Withdrawal by Subject|8|||
155237211|NCT00459134|560302245|FG001|Overall Study|Withdrawal by Subject|7|||
155237212|NCT00459134|560302244|FG000|Overall Study|Lost to Follow-up|6|||
155237213|NCT00459134|560302245|FG001|Overall Study|Lost to Follow-up|7|||
155237214|NCT00459134|560302244|FG000|Overall Study|Surgery|1|||
155237215|NCT00459134|560302245|FG001|Overall Study|Surgery|2|||
155237216|NCT00459134|560302244|FG000|Overall Study|Toxicity|4|||
155237217|NCT00459134|560302245|FG001|Overall Study|Toxicity|5|||
155237218|NCT00459134|560302244|FG000|Overall Study|Progression|1|||
155237219|NCT00459134|560302245|FG001|Overall Study|Progression|0|||
155237220|NCT00459134|560302244|FG000|Overall Study|Multiple Reasons|2|||
155237221|NCT00459134|560302245|FG001|Overall Study|Multiple Reasons|3|||
155237222|NCT00829621|560302246|FG000|Overall Study|Death|1|||
155237223|NCT00829621|560302247|FG001|Overall Study|Death|0|||
155237224|NCT00829621|560302246|FG000|Overall Study|Lost to Follow-up|3|||
155237225|NCT00829621|560302247|FG001|Overall Study|Lost to Follow-up|4|||
155237226|NCT02770391|560302250|FG000|Overall Study|Lost to Follow-up|2|||
155237227|NCT02770391|560302250|FG000|Overall Study|Withdrawal by Subject|1|||
155237228|NCT02770391|560302250|FG000|Overall Study|Surgery delayed unevaluable|2|||
155237229|NCT02770391|560302250|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
155237230|NCT03333486|560302253|FG000|Overall Study|Withdrawal by Subject|1|||
155237231|NCT03333486|560302253|FG000|Overall Study|Lost to Follow-up|1|||
155237232|NCT01755416|560302259|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
155237233|NCT01755416|560302260|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
155237234|NCT00441337|560302268|FG000|Overall Study|Disease Progression|6|||
155237235|NCT00441337|560302269|FG001|Overall Study|Disease Progression|6|||
155237236|NCT00441337|560302270|FG002|Overall Study|Disease Progression|4|||
155237237|NCT00441337|560302271|FG003|Overall Study|Disease Progression|18|||
155237238|NCT00441337|560302268|FG000|Overall Study|Lost to Follow-up|0|||
155237239|NCT00441337|560302269|FG001|Overall Study|Lost to Follow-up|0|||
155237240|NCT00441337|560302270|FG002|Overall Study|Lost to Follow-up|0|||
155237241|NCT00441337|560302271|FG003|Overall Study|Lost to Follow-up|1|||
155237242|NCT00441337|560302268|FG000|Overall Study|Sponsor Decision|0|||
155237243|NCT00441337|560302269|FG001|Overall Study|Sponsor Decision|0|||
155237244|NCT00441337|560302270|FG002|Overall Study|Sponsor Decision|1|||
155237245|NCT00441337|560302271|FG003|Overall Study|Sponsor Decision|2|||
155237246|NCT00441337|560302268|FG000|Overall Study|Did not meet inclusion criteria|0|||
155237247|NCT00441337|560302269|FG001|Overall Study|Did not meet inclusion criteria|0|||
155237248|NCT00441337|560302270|FG002|Overall Study|Did not meet inclusion criteria|1|||
155237249|NCT00441337|560302271|FG003|Overall Study|Did not meet inclusion criteria|0|||
155237250|NCT04258839|560303873|FG000|Overall Study|Adverse Event|2|||
155237251|NCT04258839|560303874|FG001|Overall Study|Adverse Event|4|||
155237252|NCT04258839|560303873|FG000|Overall Study|Lack of Efficacy|0|||
155237253|NCT04258839|560303874|FG001|Overall Study|Lack of Efficacy|2|||
155237254|NCT04258839|560303873|FG000|Overall Study|Lost to Follow-up|2|||
155237255|NCT04258839|560303874|FG001|Overall Study|Lost to Follow-up|0|||
155237256|NCT04258839|560303873|FG000|Overall Study|Withdrawal by Subject|1|||
155237257|NCT04258839|560303874|FG001|Overall Study|Withdrawal by Subject|2|||
155237258|NCT04258839|560303873|FG000|Overall Study|Withdrawal by Caregiver|5|||
155237259|NCT04258839|560303874|FG001|Overall Study|Withdrawal by Caregiver|6|||
155237260|NCT04258839|560303873|FG000|Overall Study|Reason not Specified|0|||
155237261|NCT04258839|560303874|FG001|Overall Study|Reason not Specified|1|||
155237262|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Adverse Event|4|||
155237263|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Adverse Event|1|||
155237264|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Adverse Event|1|||
155237265|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
155237266|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
155237267|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
155237268|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Pregnancy|3|||
155237269|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Pregnancy|0|||
155237270|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Pregnancy|0|||
155237271|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
155237272|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
155237273|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
155237274|NCT03328897|560303875|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
155237275|NCT03328897|560303876|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
155237276|NCT03328897|560303877|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
155237277|NCT03328897|560303875|FG000|Follow-up Epoch|Adverse Event|4|||
155237278|NCT03328897|560303876|FG001|Follow-up Epoch|Adverse Event|0|||
155237279|NCT03328897|560303877|FG002|Follow-up Epoch|Adverse Event|1|||
155237280|NCT03328897|560303875|FG000|Follow-up Epoch|Lack of Efficacy|1|||
155237281|NCT03328897|560303876|FG001|Follow-up Epoch|Lack of Efficacy|1|||
155237282|NCT03328897|560303877|FG002|Follow-up Epoch|Lack of Efficacy|1|||
155237283|NCT03328897|560303875|FG000|Follow-up Epoch|Lost to Follow-up|0|||
155237284|NCT03328897|560303876|FG001|Follow-up Epoch|Lost to Follow-up|1|||
155237285|NCT03328897|560303877|FG002|Follow-up Epoch|Lost to Follow-up|0|||
155237286|NCT03328897|560303875|FG000|Follow-up Epoch|Pregnancy|1|||
155237287|NCT03328897|560303876|FG001|Follow-up Epoch|Pregnancy|0|||
155237288|NCT03328897|560303877|FG002|Follow-up Epoch|Pregnancy|0|||
155237289|NCT03328897|560303875|FG000|Follow-up Epoch|Patient/guardian decision|2|||
155237290|NCT03328897|560303876|FG001|Follow-up Epoch|Patient/guardian decision|1|||
155237291|NCT03328897|560303877|FG002|Follow-up Epoch|Patient/guardian decision|0|||
155237292|NCT02648698|560303881|FG000|Overall Study|Protocol Violation|1|||
155237293|NCT02648698|560303882|FG001|Overall Study|Protocol Violation|5|||
155237294|NCT00317772|560303885|FG000|Overall Study|Adverse Event|0|||
155237295|NCT00317772|560303886|FG001|Overall Study|Adverse Event|0|||
155237296|NCT00317772|560303887|FG002|Overall Study|Adverse Event|0|||
155237297|NCT00317772|560303888|FG003|Overall Study|Adverse Event|2|||
155237298|NCT00317772|560303885|FG000|Overall Study|Disease Progression|2|||
155237299|NCT00317772|560303886|FG001|Overall Study|Disease Progression|2|||
155237300|NCT00317772|560303887|FG002|Overall Study|Disease Progression|1|||
155237301|NCT00317772|560303888|FG003|Overall Study|Disease Progression|7|||
155237302|NCT00966940|560303889|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
155237303|NCT00966940|560303890|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
155237304|NCT00966940|560303889|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
155237305|NCT00966940|560303890|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
155237306|NCT01040871|560303893|FG000|Overall Study|Adverse Event|6|||
155237307|NCT01040871|560303894|FG001|Overall Study|Adverse Event|2|||
155237308|NCT01040871|560303893|FG000|Overall Study|Withdrawal by Subject|2|||
155237309|NCT01040871|560303894|FG001|Overall Study|Withdrawal by Subject|0|||
155237310|NCT01040871|560303893|FG000|Overall Study|Death|1|||
155237311|NCT01040871|560303894|FG001|Overall Study|Death|3|||
155237312|NCT01040871|560303893|FG000|Overall Study|Lack of Efficacy|1|||
155237313|NCT01040871|560303894|FG001|Overall Study|Lack of Efficacy|1|||
155237314|NCT01040871|560303893|FG000|Overall Study|drug supply issue|1|||
155237315|NCT01040871|560303894|FG001|Overall Study|drug supply issue|0|||
155237316|NCT01040871|560303893|FG000|Overall Study|Randomized and Not Treated|2|||
155237317|NCT01040871|560303894|FG001|Overall Study|Randomized and Not Treated|1|||
155237318|NCT02886572|560303895|FG000|Overall Study|Death|8|||
155237319|NCT02621606|560303896|FG000|Overall Study|Withdrawal by Subject|0|||
155237320|NCT02621606|560303897|FG001|Overall Study|Withdrawal by Subject|1|||
155237321|NCT02621606|560303898|FG002|Overall Study|Withdrawal by Subject|0|||
155237322|NCT01175824|560303899|FG000|Overall Study|Adverse Event|2|||
155237323|NCT01175824|560303900|FG001|Overall Study|Adverse Event|1|||
155237324|NCT01175824|560303899|FG000|Overall Study|Lack of Efficacy|2|||
155237325|NCT01175824|560303900|FG001|Overall Study|Lack of Efficacy|0|||
155237326|NCT01175824|560303899|FG000|Overall Study|Lost to Follow-up|0|||
155237327|NCT01175824|560303900|FG001|Overall Study|Lost to Follow-up|1|||
155237328|NCT01175824|560303899|FG000|Overall Study|Physician Decision|0|||
155237329|NCT01175824|560303900|FG001|Overall Study|Physician Decision|4|||
155237330|NCT01175824|560303899|FG000|Overall Study|Protocol Violation|2|||
155237331|NCT01175824|560303900|FG001|Overall Study|Protocol Violation|5|||
155237332|NCT01175824|560303899|FG000|Overall Study|Withdrawal by Subject|3|||
155237333|NCT01175824|560303900|FG001|Overall Study|Withdrawal by Subject|7|||
155237334|NCT01175824|560303899|FG000|Overall Study|Sponsor Decision|1|||
155237335|NCT01175824|560303900|FG001|Overall Study|Sponsor Decision|0|||
155237336|NCT01175824|560303899|FG000|Overall Study|Entry Criteria Not Met|6|||
155237337|NCT01175824|560303900|FG001|Overall Study|Entry Criteria Not Met|4|||
155237338|NCT03455855|560303901|FG000|Overall Study|Lost to Follow-up|4|||
155237339|NCT03455855|560303902|FG001|Overall Study|Lost to Follow-up|2|||
155237340|NCT00924950|560303903|FG000|Overall Study|Lost to Follow-up|2|||
155237341|NCT00009737|560303904|FG000|Overall Study|Adverse Event|112|||
155237342|NCT00009737|560303905|FG001|Overall Study|Adverse Event|75|||
155237343|NCT00009737|560303904|FG000|Overall Study|Death|4|||
155237344|NCT00009737|560303905|FG001|Overall Study|Death|6|||
155237345|NCT00009737|560303904|FG000|Overall Study|Lack of Efficacy|17|||
155237346|NCT00009737|560303905|FG001|Overall Study|Lack of Efficacy|15|||
155237347|NCT00009737|560303904|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
155237348|NCT00009737|560303905|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
155237349|NCT00009737|560303904|FG000|Overall Study|Other Protocol Violation|1|||
155237350|NCT00009737|560303905|FG001|Overall Study|Other Protocol Violation|0|||
155237351|NCT00009737|560303904|FG000|Overall Study|Refused Treatment|15|||
155237352|NCT00009737|560303905|FG001|Overall Study|Refused Treatment|16|||
155237353|NCT00009737|560303904|FG000|Overall Study|Lost to Follow-up|1|||
155237354|NCT00009737|560303905|FG001|Overall Study|Lost to Follow-up|1|||
155237355|NCT00009737|560303904|FG000|Overall Study|Administrative/Other Reasons|7|||
155237356|NCT00009737|560303905|FG001|Overall Study|Administrative/Other Reasons|1|||
155237357|NCT01163682|560303907|FG000|Overall Study|Lost to Follow-up|6|||
155237358|NCT01163682|560303908|FG001|Overall Study|Lost to Follow-up|9|||
155237359|NCT01931839|560303909|FG000|Overall Study|Death|0|||
155237360|NCT01931839|560303910|FG001|Overall Study|Death|1|||
155237361|NCT01931839|560303911|FG002|Overall Study|Death|2|||
155237362|NCT01931839|560303912|FG003|Overall Study|Death|0|||
155237363|NCT01931839|560303913|FG004|Overall Study|Death|0|||
155237364|NCT01931839|560303914|FG005|Overall Study|Death|0|||
155237365|NCT01931839|560303915|FG006|Overall Study|Death|0|||
155237366|NCT01931839|560303909|FG000|Overall Study|Physician Decision|1|||
155237367|NCT01931839|560303910|FG001|Overall Study|Physician Decision|0|||
155237368|NCT01931839|560303911|FG002|Overall Study|Physician Decision|1|||
155237369|NCT01931839|560303912|FG003|Overall Study|Physician Decision|0|||
155237370|NCT01931839|560303913|FG004|Overall Study|Physician Decision|0|||
155237371|NCT01931839|560303914|FG005|Overall Study|Physician Decision|0|||
155237372|NCT01931839|560303915|FG006|Overall Study|Physician Decision|1|||
155237373|NCT01931839|560303909|FG000|Overall Study|Withdrawal of consent|0|||
155237374|NCT01931839|560303910|FG001|Overall Study|Withdrawal of consent|0|||
155237375|NCT01931839|560303911|FG002|Overall Study|Withdrawal of consent|0|||
155237376|NCT01931839|560303912|FG003|Overall Study|Withdrawal of consent|0|||
155237377|NCT01931839|560303913|FG004|Overall Study|Withdrawal of consent|1|||
155237378|NCT01931839|560303914|FG005|Overall Study|Withdrawal of consent|0|||
155237379|NCT01931839|560303915|FG006|Overall Study|Withdrawal of consent|0|||
155237380|NCT01931839|560303909|FG000|Overall Study|Adverse Event|9|||
155237381|NCT01931839|560303910|FG001|Overall Study|Adverse Event|4|||
155237382|NCT01931839|560303911|FG002|Overall Study|Adverse Event|1|||
155237383|NCT01931839|560303912|FG003|Overall Study|Adverse Event|3|||
155237384|NCT01931839|560303913|FG004|Overall Study|Adverse Event|0|||
155237385|NCT01931839|560303914|FG005|Overall Study|Adverse Event|0|||
155237386|NCT01931839|560303915|FG006|Overall Study|Adverse Event|1|||
155237387|NCT01931839|560303909|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
155237388|NCT01931839|560303910|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
155237389|NCT01931839|560303911|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
155237390|NCT01931839|560303912|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
155237391|NCT01931839|560303913|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
155237392|NCT01931839|560303914|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
155237393|NCT01931839|560303915|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
155237394|NCT01931839|560303909|FG000|Overall Study|Other non-compliance|15|||
155237395|NCT01931839|560303910|FG001|Overall Study|Other non-compliance|9|||
155237396|NCT01931839|560303911|FG002|Overall Study|Other non-compliance|12|||
155237397|NCT01931839|560303912|FG003|Overall Study|Other non-compliance|3|||
155237398|NCT01931839|560303913|FG004|Overall Study|Other non-compliance|0|||
155237399|NCT01931839|560303914|FG005|Overall Study|Other non-compliance|3|||
155237400|NCT01931839|560303915|FG006|Overall Study|Other non-compliance|0|||
155237401|NCT01931839|560303909|FG000|Overall Study|Lost to Follow-up|1|||
155237402|NCT01931839|560303910|FG001|Overall Study|Lost to Follow-up|2|||
155237403|NCT01931839|560303911|FG002|Overall Study|Lost to Follow-up|4|||
155237404|NCT01931839|560303912|FG003|Overall Study|Lost to Follow-up|5|||
155237405|NCT01931839|560303913|FG004|Overall Study|Lost to Follow-up|0|||
155237406|NCT01931839|560303914|FG005|Overall Study|Lost to Follow-up|0|||
155237407|NCT01931839|560303915|FG006|Overall Study|Lost to Follow-up|0|||
155237408|NCT01931839|560303909|FG000|Overall Study|Other|4|||
155237409|NCT01931839|560303910|FG001|Overall Study|Other|2|||
155237410|NCT01931839|560303911|FG002|Overall Study|Other|6|||
155237411|NCT01931839|560303912|FG003|Overall Study|Other|0|||
155237412|NCT01931839|560303913|FG004|Overall Study|Other|0|||
155237413|NCT01931839|560303914|FG005|Overall Study|Other|0|||
155237414|NCT01931839|560303915|FG006|Overall Study|Other|0|||
155237415|NCT03224468|560303916|FG000|Overall Study|Did not obtain MM card|53|||
155237416|NCT03224468|560303917|FG001|Overall Study|Did not obtain MM card|0|||
155237417|NCT03224468|560303916|FG000|Overall Study|Lost to Follow-up|4|||
155237418|NCT03224468|560303917|FG001|Overall Study|Lost to Follow-up|11|||
155237419|NCT03224468|560303916|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
155237420|NCT03224468|560303917|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
155237421|NCT02571452|560303918|FG000|Overall Study Treatment|Protocol Violation|0|||
155237422|NCT02571452|560303919|FG001|Overall Study Treatment|Protocol Violation|1|||
155237423|NCT02571452|560303918|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
155237424|NCT02571452|560303919|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
155237425|NCT02571452|560303918|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
155237426|NCT02571452|560303919|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
155237427|NCT02863354|560303922|FG000|Year 1|Lost to Follow-up|1|||
155237428|NCT02863354|560303923|FG001|Year 1|Lost to Follow-up|1|||
155237429|NCT02863354|560303922|FG000|Year 1|Withdrawal by Subject|3|||
155237430|NCT02863354|560303923|FG001|Year 1|Withdrawal by Subject|0|||
155237431|NCT02863354|560303922|FG000|Year 1|Death|0|||
155237432|NCT02863354|560303923|FG001|Year 1|Death|1|||
155237433|NCT02863354|560303922|FG000|Year 2|Lost to Follow-up|2|||
155237434|NCT02863354|560303923|FG001|Year 2|Lost to Follow-up|2|||
155237435|NCT00724451|560303929|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
155237436|NCT00724451|560303929|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
155237437|NCT00724451|560303929|FG000|Overall Study|Not Eligible for Treatment|431|||
155237438|NCT00724451|560303929|FG000|Overall Study|Participant Refused Treatment|89|||
155237439|NCT00724451|560303929|FG000|Overall Study|Never Started Treatment|89|||
155237440|NCT00724451|560303929|FG000|Overall Study|Unknown; No Data Sources Available|9|||
155237441|NCT00724451|560303929|FG000|Overall Study|Physician Decision|116|||
155237442|NCT00724451|560303929|FG000|Overall Study|Withdrawal by Subject|45|||
155237443|NCT00724451|560303929|FG000|Overall Study|Investigator + Participant Decision|13|||
155237444|NCT01599650|560303934|FG000|Overall Study|Administrative issue|1|||
155237445|NCT01599650|560303935|FG001|Overall Study|Administrative issue|0|||
155237446|NCT01599650|560303936|FG002|Overall Study|Administrative issue|1|||
155237447|NCT01599650|560303934|FG000|Overall Study|Physician Decision|2|||
155237448|NCT01599650|560303935|FG001|Overall Study|Physician Decision|0|||
155237449|NCT01599650|560303936|FG002|Overall Study|Physician Decision|7|||
155237450|NCT01599650|560303934|FG000|Overall Study|Protocol Violation|0|||
155237451|NCT01599650|560303935|FG001|Overall Study|Protocol Violation|3|||
155237452|NCT01599650|560303936|FG002|Overall Study|Protocol Violation|0|||
155237453|NCT01599650|560303934|FG000|Overall Study|Death|2|||
155237454|NCT01599650|560303935|FG001|Overall Study|Death|1|||
155237455|NCT01599650|560303936|FG002|Overall Study|Death|2|||
155237456|NCT01599650|560303934|FG000|Overall Study|Lost to Follow-up|3|||
155237457|NCT01599650|560303935|FG001|Overall Study|Lost to Follow-up|3|||
155237458|NCT01599650|560303936|FG002|Overall Study|Lost to Follow-up|3|||
155237459|NCT01599650|560303934|FG000|Overall Study|Withdrawal by Subject|11|||
155237460|NCT01599650|560303935|FG001|Overall Study|Withdrawal by Subject|11|||
155237461|NCT01599650|560303936|FG002|Overall Study|Withdrawal by Subject|10|||
155237462|NCT01599650|560303934|FG000|Overall Study|Adverse Event|3|||
155237463|NCT01599650|560303935|FG001|Overall Study|Adverse Event|8|||
155237464|NCT01599650|560303936|FG002|Overall Study|Adverse Event|4|||
155237465|NCT02520531|560303950|FG000|Overall Study|Revision of study device components|2|||
155237466|NCT02520531|560303951|FG001|Overall Study|Revision of study device components|2|||
155237467|NCT02520531|560303950|FG000|Overall Study|Death|1|||
155237468|NCT02520531|560303951|FG001|Overall Study|Death|2|||
155237469|NCT02520531|560303950|FG000|Overall Study|Lost to Follow-up|1|||
155237470|NCT02520531|560303951|FG001|Overall Study|Lost to Follow-up|1|||
155237471|NCT02520531|560303950|FG000|Overall Study|Meet exclusion criterion|0|||
155237472|NCT02520531|560303951|FG001|Overall Study|Meet exclusion criterion|1|||
155237473|NCT02520531|560303950|FG000|Overall Study|Withdrawal by Subject|1|||
155237474|NCT02520531|560303951|FG001|Overall Study|Withdrawal by Subject|0|||
155237475|NCT02520531|560303950|FG000|Overall Study|Not study device|1|||
155237476|NCT02520531|560303951|FG001|Overall Study|Not study device|0|||
155237477|NCT00622635|560303952|FG000|Treatment Period 1|Adverse Event|0|||
155237478|NCT00622635|560303953|FG001|Treatment Period 1|Adverse Event|0|||
155237479|NCT00622635|560303954|FG002|Treatment Period 1|Adverse Event|1|||
155237480|NCT00622635|560303955|FG003|Treatment Period 1|Adverse Event|0|||
155237481|NCT00622635|560303956|FG004|Treatment Period 1|Adverse Event|0|||
155237482|NCT00622635|560303957|FG005|Treatment Period 1|Adverse Event|0|||
155237483|NCT00622635|560303952|FG000|Treatment Period 1|Withdrawal by Subject|0|||
155237484|NCT00622635|560303953|FG001|Treatment Period 1|Withdrawal by Subject|1|||
155237485|NCT00622635|560303954|FG002|Treatment Period 1|Withdrawal by Subject|0|||
155237486|NCT00622635|560303955|FG003|Treatment Period 1|Withdrawal by Subject|0|||
155237487|NCT00622635|560303956|FG004|Treatment Period 1|Withdrawal by Subject|0|||
155237488|NCT00622635|560303957|FG005|Treatment Period 1|Withdrawal by Subject|0|||
155237489|NCT00622635|560303952|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237490|NCT00622635|560303953|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237491|NCT00622635|560303954|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237492|NCT00622635|560303955|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237493|NCT00622635|560303956|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
155237494|NCT00622635|560303957|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
155237495|NCT00622635|560303952|FG000|Treatment Period 2|Adverse Event|1|||
155237496|NCT00622635|560303953|FG001|Treatment Period 2|Adverse Event|0|||
155237497|NCT00622635|560303954|FG002|Treatment Period 2|Adverse Event|0|||
155237498|NCT00622635|560303955|FG003|Treatment Period 2|Adverse Event|0|||
155237499|NCT00622635|560303956|FG004|Treatment Period 2|Adverse Event|0|||
155237500|NCT00622635|560303957|FG005|Treatment Period 2|Adverse Event|0|||
155237501|NCT00622635|560303952|FG000|Treatment Period 3|Adverse Event|0|||
155237502|NCT00622635|560303953|FG001|Treatment Period 3|Adverse Event|0|||
155237503|NCT00622635|560303954|FG002|Treatment Period 3|Adverse Event|0|||
155237504|NCT00622635|560303955|FG003|Treatment Period 3|Adverse Event|2|||
155237505|NCT00622635|560303956|FG004|Treatment Period 3|Adverse Event|0|||
155237506|NCT00622635|560303957|FG005|Treatment Period 3|Adverse Event|0|||
155237507|NCT00622635|560303952|FG000|Treatment Period 3|Withdrawal by Subject|0|||
155237508|NCT00622635|560303953|FG001|Treatment Period 3|Withdrawal by Subject|0|||
155237509|NCT00622635|560303954|FG002|Treatment Period 3|Withdrawal by Subject|0|||
155237510|NCT00622635|560303955|FG003|Treatment Period 3|Withdrawal by Subject|1|||
155237511|NCT00622635|560303956|FG004|Treatment Period 3|Withdrawal by Subject|0|||
155237512|NCT00622635|560303957|FG005|Treatment Period 3|Withdrawal by Subject|0|||
155237513|NCT00835406|560303958|FG000|Period: First Intervention|Adverse Event|0|||
155237514|NCT00835406|560303959|FG001|Period: First Intervention|Adverse Event|1|||
155237515|NCT00835406|560303958|FG000|Period: First Intervention|Withdrawal by Subject|2|||
155237516|NCT00835406|560303959|FG001|Period: First Intervention|Withdrawal by Subject|0|||
155237517|NCT00835406|560303958|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
155237518|NCT00835406|560303959|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
155237519|NCT00281840|560303960|FG000|Overall Study|Adverse Event|12|||
155237520|NCT00281840|560303960|FG000|Overall Study|Physician Decision|6|||
155237521|NCT00281840|560303960|FG000|Overall Study|Withdrawal by Subject|3|||
155237522|NCT00281840|560303960|FG000|Overall Study|Disease Progression|2|||
155237523|NCT00281840|560303960|FG000|Overall Study|exceed maximum delay in treatment|1|||
155237524|NCT00281840|560303960|FG000|Overall Study|Complicating Disease|1|||
155237525|NCT02138214|560303963|FG000|Overall Study|Withdrawal by Subject|0|||
155237526|NCT02138214|560303964|FG001|Overall Study|Withdrawal by Subject|1|||
155237527|NCT02138214|560303965|FG002|Overall Study|Withdrawal by Subject|0|||
155237528|NCT02138214|560303963|FG000|Overall Study|Lost to Follow-up|0|||
155237529|NCT02138214|560303964|FG001|Overall Study|Lost to Follow-up|2|||
155237530|NCT02138214|560303965|FG002|Overall Study|Lost to Follow-up|4|||
155237531|NCT02138214|560303963|FG000|Overall Study|Screen Failure|0|||
155237532|NCT02138214|560303964|FG001|Overall Study|Screen Failure|1|||
155237533|NCT02138214|560303965|FG002|Overall Study|Screen Failure|0|||
155237534|NCT02185768|560303966|FG000|Overall Study|Patients were not treated|2|||
155237535|NCT02486406|560303968|FG000|Overall Study|Withdrew consent|1|||
155237536|NCT02486406|560303969|FG001|Overall Study|Withdrew consent|0|||
155237537|NCT02486406|560303970|FG002|Overall Study|Withdrew consent|0|||
155237538|NCT02486406|560303971|FG003|Overall Study|Withdrew consent|1|||
155237539|NCT02486406|560303968|FG000|Overall Study|Lost to Follow-up|1|||
155237540|NCT02486406|560303969|FG001|Overall Study|Lost to Follow-up|3|||
155237541|NCT02486406|560303970|FG002|Overall Study|Lost to Follow-up|1|||
155237542|NCT02486406|560303971|FG003|Overall Study|Lost to Follow-up|3|||
155237543|NCT02486406|560303968|FG000|Overall Study|Other, not specified|0|||
155237544|NCT02486406|560303969|FG001|Overall Study|Other, not specified|0|||
155237545|NCT02486406|560303970|FG002|Overall Study|Other, not specified|1|||
155237546|NCT02486406|560303971|FG003|Overall Study|Other, not specified|0|||
155237547|NCT01079234|560303974|FG000|Main: Week 0 to 26|Adverse Event|5|||
155237548|NCT01079234|560303975|FG001|Main: Week 0 to 26|Adverse Event|4|||
155237549|NCT01079234|560303976|FG002|Main: Week 0 to 26|Adverse Event|1|||
155237550|NCT01079234|560303977|FG003|Main: Week 0 to 26|Adverse Event|0|||
155237551|NCT01079234|560303974|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
155237552|NCT01079234|560303975|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
155237553|NCT01079234|560303976|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
155237554|NCT01079234|560303977|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
155237555|NCT01079234|560303974|FG000|Main: Week 0 to 26|Protocol Violation|6|||
155237556|NCT01079234|560303975|FG001|Main: Week 0 to 26|Protocol Violation|2|||
155237557|NCT01079234|560303976|FG002|Main: Week 0 to 26|Protocol Violation|4|||
155237558|NCT01079234|560303977|FG003|Main: Week 0 to 26|Protocol Violation|0|||
155237559|NCT01079234|560303974|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
155237560|NCT01079234|560303975|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
155237561|NCT01079234|560303976|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
155237562|NCT01079234|560303977|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
155237563|NCT01079234|560303974|FG000|Main: Week 0 to 26|Unclassified|7|||
155237564|NCT01079234|560303975|FG001|Main: Week 0 to 26|Unclassified|13|||
155237565|NCT01079234|560303976|FG002|Main: Week 0 to 26|Unclassified|4|||
155237566|NCT01079234|560303977|FG003|Main: Week 0 to 26|Unclassified|0|||
155237567|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Adverse Event|0|||
155237568|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Adverse Event|0|||
155237569|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Adverse Event|1|||
155237570|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Adverse Event|0|||
155237571|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
155237572|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
155237573|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
155237574|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
155237575|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
155237576|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
155237577|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
155237578|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
155237579|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
155237580|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
155237581|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
155237582|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
155237583|NCT01079234|560303974|FG000|Extension: Week 27 to 52|Unclassified|0|||
155237584|NCT01079234|560303975|FG001|Extension: Week 27 to 52|Unclassified|0|||
155237585|NCT01079234|560303976|FG002|Extension: Week 27 to 52|Unclassified|4|||
155237586|NCT01079234|560303977|FG003|Extension: Week 27 to 52|Unclassified|7|||
155237587|NCT05402995|560303987|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
155237588|NCT05402995|560303988|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
155237589|NCT05402995|560303989|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
155237590|NCT05402995|560303990|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
155237591|NCT01071512|560303993|FG000|Overall Study|Adverse Event|1|||
155237592|NCT01071512|560303993|FG000|Overall Study|Development of antibodies to drug|2|||
155237593|NCT01071512|560303993|FG000|Overall Study|positive anti-JC virus antibody test|2|||
155237594|NCT02316717|560303996|FG000|Overall Study|Adverse Event|2|||
155237595|NCT02316717|560303997|FG001|Overall Study|Adverse Event|2|||
155237596|NCT02316717|560303998|FG002|Overall Study|Adverse Event|0|||
155237597|NCT02316717|560303996|FG000|Overall Study|Lost to Follow-up|1|||
155237598|NCT02316717|560303997|FG001|Overall Study|Lost to Follow-up|2|||
155237599|NCT02316717|560303998|FG002|Overall Study|Lost to Follow-up|1|||
155237600|NCT02316717|560303996|FG000|Overall Study|Non compliance|3|||
155237601|NCT02316717|560303997|FG001|Overall Study|Non compliance|1|||
155237602|NCT02316717|560303998|FG002|Overall Study|Non compliance|0|||
155237603|NCT02316717|560303996|FG000|Overall Study|Protocol Violation|2|||
155237604|NCT02316717|560303997|FG001|Overall Study|Protocol Violation|0|||
155237605|NCT02316717|560303998|FG002|Overall Study|Protocol Violation|0|||
155237606|NCT02316717|560303996|FG000|Overall Study|Withdrawal by Subject|2|||
155237607|NCT02316717|560303997|FG001|Overall Study|Withdrawal by Subject|1|||
155237608|NCT02316717|560303998|FG002|Overall Study|Withdrawal by Subject|1|||
155237609|NCT02316717|560303996|FG000|Overall Study|Death|0|||
155237610|NCT02316717|560303997|FG001|Overall Study|Death|0|||
155237611|NCT02316717|560303998|FG002|Overall Study|Death|1|||
155237612|NCT02316717|560303996|FG000|Overall Study|Physician Decision|0|||
155237613|NCT02316717|560303997|FG001|Overall Study|Physician Decision|1|||
155237614|NCT02316717|560303998|FG002|Overall Study|Physician Decision|0|||
155237615|NCT02316717|560303996|FG000|Overall Study|TBC|1|||
155237616|NCT02316717|560303997|FG001|Overall Study|TBC|0|||
155237617|NCT02316717|560303998|FG002|Overall Study|TBC|0|||
155237618|NCT00183872|560303999|FG000|Overall Study|Death|3|||
155237619|NCT00183872|560303999|FG000|Overall Study|Adverse Event|9|||
155237620|NCT00183872|560303999|FG000|Overall Study|Withdrawal by Subject|2|||
155237621|NCT00183872|560303999|FG000|Overall Study|Drug delayed more than 28 days|2|||
155237622|NCT02052466|560304000|FG000|Overall Study|Withdrawal by Subject|1|||
155237623|NCT02052466|560304000|FG000|Overall Study|Acromial fracture|1|||
155237624|NCT00508742|560304001|FG000|Period 1: Infant Series|Adverse Event|5|||
155237625|NCT00508742|560304002|FG001|Period 1: Infant Series|Adverse Event|4|||
155237626|NCT00508742|560304001|FG000|Period 1: Infant Series|Protocol Violation|1|||
155237627|NCT00508742|560304002|FG001|Period 1: Infant Series|Protocol Violation|0|||
155237628|NCT00508742|560304001|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
155237629|NCT00508742|560304002|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
155237630|NCT00508742|560304001|FG000|Period 1: Infant Series|Physician Decision|1|||
155237631|NCT00508742|560304002|FG001|Period 1: Infant Series|Physician Decision|0|||
155237632|NCT00508742|560304001|FG000|Period 1: Infant Series|Other|4|||
155237633|NCT00508742|560304002|FG001|Period 1: Infant Series|Other|1|||
155237634|NCT00508742|560304001|FG000|Period 2: After Infant Series|Adverse Event|2|||
155237635|NCT00508742|560304002|FG001|Period 2: After Infant Series|Adverse Event|6|||
155237636|NCT00508742|560304001|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
155237637|NCT00508742|560304002|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
155237638|NCT00508742|560304001|FG000|Period 2: After Infant Series|Protocol Violation|1|||
155237639|NCT00508742|560304002|FG001|Period 2: After Infant Series|Protocol Violation|0|||
155237640|NCT00508742|560304001|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
155237641|NCT00508742|560304002|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
155237642|NCT00508742|560304001|FG000|Period 2: After Infant Series|Failed to Return|1|||
155237643|NCT00508742|560304002|FG001|Period 2: After Infant Series|Failed to Return|0|||
155237644|NCT00508742|560304001|FG000|Period 2: After Infant Series|Other|2|||
155237645|NCT00508742|560304002|FG001|Period 2: After Infant Series|Other|1|||
155237646|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Adverse Event|1|||
155237647|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Adverse Event|0|||
155237648|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
155237649|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
155237650|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
155237651|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
155237652|NCT00508742|560304001|FG000|Period 3: Toddler Dose|Other|5|||
155237653|NCT00508742|560304002|FG001|Period 3: Toddler Dose|Other|4|||
155237654|NCT00595582|560304004|FG000|Overall Study|Pilot study that PI terminated|2|||
155237655|NCT00595582|560304004|FG000|Overall Study|Lost to Follow-up|1|||
155237656|NCT00595582|560304004|FG000|Overall Study|Adverse Event|2|||
155237657|NCT00595582|560304004|FG000|Overall Study|Physician Decision|5|||
155237658|NCT02797262|560304005|FG000|Overall Study|Withdrawal by Subject|5|||
155237659|NCT02797262|560304006|FG001|Overall Study|Withdrawal by Subject|1|||
155237660|NCT02797262|560304005|FG000|Overall Study|Lost to Follow-up|10|||
155237661|NCT02797262|560304006|FG001|Overall Study|Lost to Follow-up|7|||
155237662|NCT02797262|560304005|FG000|Overall Study|Death|1|||
155237663|NCT02797262|560304006|FG001|Overall Study|Death|2|||
155237664|NCT02797262|560304005|FG000|Overall Study|Adverse Event|1|||
155237665|NCT02797262|560304006|FG001|Overall Study|Adverse Event|0|||
155237666|NCT02797262|560304005|FG000|Overall Study|COVID-19|2|||
155237667|NCT02797262|560304006|FG001|Overall Study|COVID-19|1|||
155237668|NCT02797262|560304005|FG000|Overall Study|Out-of-country|1|||
155237669|NCT02797262|560304006|FG001|Overall Study|Out-of-country|0|||
155237670|NCT01600586|560304007|FG000|Overall Study|Physician Decision|3|||
155237671|NCT01600586|560304008|FG001|Overall Study|Physician Decision|3|||
155237672|NCT03146650|560304011|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
155237673|NCT03146650|560304011|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
155237674|NCT03146650|560304011|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
155237675|NCT03146650|560304011|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
155237676|NCT03146650|560304011|FG000|2 Year Follow-up|Death|11|||
155237677|NCT03146650|560304011|FG000|2 Year Follow-up|Still in follow-up|7|||
155237678|NCT03146650|560304011|FG000|2 Year Follow-up|Lost to Follow-up|1|||
155237679|NCT02460198|560304012|FG000|Overall Study|Adverse Event|1|||
155237680|NCT02460198|560304013|FG001|Overall Study|Adverse Event|3|||
155237681|NCT02460198|560304012|FG000|Overall Study|Death|36|||
155237682|NCT02460198|560304013|FG001|Overall Study|Death|28|||
155237683|NCT02460198|560304012|FG000|Overall Study|Lost to Follow-up|1|||
155237684|NCT02460198|560304013|FG001|Overall Study|Lost to Follow-up|1|||
155237685|NCT02460198|560304012|FG000|Overall Study|Transferred to Extension Study|15|||
155237686|NCT02460198|560304013|FG001|Overall Study|Transferred to Extension Study|15|||
155237687|NCT02460198|560304012|FG000|Overall Study|Withdrawal by Subject|2|||
155237688|NCT02460198|560304013|FG001|Overall Study|Withdrawal by Subject|4|||
155237689|NCT02460198|560304012|FG000|Overall Study|Site Terminated By Sponsor|0|||
155237690|NCT02460198|560304013|FG001|Overall Study|Site Terminated By Sponsor|1|||
155237691|NCT02460198|560304012|FG000|Overall Study|Did Not Continue on Extension Study|6|||
155237692|NCT02460198|560304013|FG001|Overall Study|Did Not Continue on Extension Study|11|||
155237693|NCT00931307|560304014|FG000|Overall Study|Lack of Efficacy|12|||
155237694|NCT00931307|560304014|FG000|Overall Study|Biomicroscopy|1|||
155237695|NCT00965848|560304015|FG000|Overall Study|Protocol Violation|3|||
155237696|NCT00965848|560304016|FG001|Overall Study|Protocol Violation|0|||
155237697|NCT00965848|560304017|FG002|Overall Study|Protocol Violation|1|||
155237698|NCT00965848|560304015|FG000|Overall Study|Death|11|||
155237699|NCT00965848|560304016|FG001|Overall Study|Death|1|||
155237700|NCT00965848|560304017|FG002|Overall Study|Death|5|||
155237701|NCT00965848|560304015|FG000|Overall Study|Lost to Follow-up|0|||
155237702|NCT00965848|560304016|FG001|Overall Study|Lost to Follow-up|0|||
155237703|NCT00965848|560304017|FG002|Overall Study|Lost to Follow-up|1|||
155237704|NCT00965848|560304015|FG000|Overall Study|Withdrawal by Subject|1|||
155237705|NCT00965848|560304016|FG001|Overall Study|Withdrawal by Subject|0|||
155237706|NCT00965848|560304017|FG002|Overall Study|Withdrawal by Subject|0|||
155237707|NCT00965848|560304015|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
155237708|NCT00965848|560304016|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
155237709|NCT00965848|560304017|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
155237710|NCT00965848|560304015|FG000|Overall Study|Not Clinically Evaluable|7|||
155237711|NCT00965848|560304016|FG001|Overall Study|Not Clinically Evaluable|1|||
155237712|NCT00965848|560304017|FG002|Overall Study|Not Clinically Evaluable|1|||
155237713|NCT00965848|560304015|FG000|Overall Study|Other|5|||
155237714|NCT00965848|560304016|FG001|Overall Study|Other|0|||
155237715|NCT00965848|560304017|FG002|Overall Study|Other|1|||
155237716|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
155237717|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
155237718|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
155237719|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
155237720|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
155237721|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
155237722|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
155237723|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
155237724|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
155237725|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
155237726|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
155237727|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
155237728|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
155237729|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
155237730|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
155237731|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
155237732|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
155237733|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
155237734|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
155237735|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
155237736|NCT00813761|560304018|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
155237737|NCT00813761|560304019|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
155237738|NCT00813761|560304020|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
155237739|NCT00813761|560304021|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
155237740|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
155237741|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
155237742|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
155237743|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
155237744|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
155237745|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
155237746|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
155237747|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
155237748|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
155237749|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
155237750|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
155237751|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
155237752|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
155237753|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
155237754|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
155237755|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
155237756|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
155237757|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
155237758|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
155237759|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
155237760|NCT00813761|560304018|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
155237761|NCT00813761|560304019|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
155237762|NCT00813761|560304020|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
155237763|NCT00813761|560304021|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
155237764|NCT00691210|560304022|FG000|Overall Study|Progression of Disease|0|||
155237765|NCT00691210|560304023|FG001|Overall Study|Progression of Disease|0|||
155237766|NCT00691210|560304024|FG002|Overall Study|Progression of Disease|0|||
155237767|NCT00691210|560304025|FG003|Overall Study|Progression of Disease|2|||
155237768|NCT00691210|560304026|FG004|Overall Study|Progression of Disease|0|||
155237769|NCT00691210|560304027|FG005|Overall Study|Progression of Disease|0|||
155237770|NCT00691210|560304028|FG006|Overall Study|Progression of Disease|0|||
155237771|NCT00691210|560304029|FG007|Overall Study|Progression of Disease|0|||
155237772|NCT00691210|560304022|FG000|Overall Study|Lack of Efficacy|0|||
155237773|NCT00691210|560304023|FG001|Overall Study|Lack of Efficacy|0|||
155237774|NCT00691210|560304024|FG002|Overall Study|Lack of Efficacy|0|||
155237775|NCT00691210|560304025|FG003|Overall Study|Lack of Efficacy|1|||
155237776|NCT00691210|560304026|FG004|Overall Study|Lack of Efficacy|0|||
155237777|NCT00691210|560304027|FG005|Overall Study|Lack of Efficacy|1|||
155237778|NCT00691210|560304028|FG006|Overall Study|Lack of Efficacy|0|||
155237779|NCT00691210|560304029|FG007|Overall Study|Lack of Efficacy|0|||
155237780|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
155237781|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
155237782|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
155237783|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
155237784|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
155237785|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
155237786|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
155237787|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
155237788|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
155237789|NCT00983814|560304032|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
155237790|NCT00983814|560304033|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
155237791|NCT00983814|560304034|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
155237792|NCT00983814|560304032|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
155237793|NCT00983814|560304033|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
155237794|NCT00983814|560304034|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
155237795|NCT00555438|560304037|FG000|10 Days Post-operative|Death|4|||
155237796|NCT00555438|560304037|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
155237797|NCT02707640|560304038|FG000|Overall Study|Adverse Event|4|||
155237798|NCT02707640|560304039|FG001|Overall Study|Adverse Event|2|||
155237799|NCT02707640|560304038|FG000|Overall Study|Death|1|||
155237800|NCT02707640|560304039|FG001|Overall Study|Death|2|||
155237801|NCT02707640|560304038|FG000|Overall Study|Physician Decision|2|||
155237802|NCT02707640|560304039|FG001|Overall Study|Physician Decision|0|||
155237803|NCT02707640|560304038|FG000|Overall Study|Withdrawal by Subject|0|||
155237804|NCT02707640|560304039|FG001|Overall Study|Withdrawal by Subject|1|||
155237805|NCT02707640|560304038|FG000|Overall Study|Participant's Personal Decision|1|||
155237806|NCT02707640|560304039|FG001|Overall Study|Participant's Personal Decision|2|||
155237807|NCT02707640|560304038|FG000|Overall Study|Sponsor Discretion|1|||
155237808|NCT02707640|560304039|FG001|Overall Study|Sponsor Discretion|0|||
155237809|NCT02517905|560304040|FG000|Overall Study|Lost to Follow-up|4|||
155237810|NCT02517905|560304041|FG001|Overall Study|Lost to Follow-up|0|||
155237811|NCT02517905|560304040|FG000|Overall Study|Withdrawal by Subject|4|||
155237812|NCT02517905|560304041|FG001|Overall Study|Withdrawal by Subject|0|||
155237813|NCT02517905|560304040|FG000|Overall Study|Screen failure|2|||
155237814|NCT02517905|560304041|FG001|Overall Study|Screen failure|2|||
155237815|NCT02758236|560304046|FG000|Overall Study|Investigator discretion|43|||
155237816|NCT05789875|560304047|FG000|Overall Study|Lost to Follow-up|6|||
155237817|NCT01994395|560304048|FG000|Overall Study|Withdrawal by Subject|1|||
155237818|NCT01994395|560304049|FG001|Overall Study|Withdrawal by Subject|2|||
155237819|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
155237820|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
155237821|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
155237822|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
155237823|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
155237824|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
155237825|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
155237826|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
155237827|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
155237828|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
155237829|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
155237830|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
155237831|NCT03246529|560304055|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
155237832|NCT03246529|560304056|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
155237833|NCT03246529|560304057|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
155237834|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
155237835|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
155237836|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
155237837|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
155237838|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
155237839|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
155237840|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
155237841|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
155237842|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
155237843|NCT03246529|560304055|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
155237844|NCT03246529|560304056|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
155237845|NCT03246529|560304057|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
155237846|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
155237847|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
155237848|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
155237849|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Death|1|||
155237850|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Death|0|||
155237851|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Death|0|||
155237852|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
155237853|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
155237854|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
155237855|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
155237856|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
155237857|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
155237858|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
155237859|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
155237860|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
155237861|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
155237862|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
155237863|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
155237864|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
155237865|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
155237866|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
155237867|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
155237868|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
155237869|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
155237870|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
155237871|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
155237872|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
155237873|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
155237874|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
155237875|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
155237876|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
155237877|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
155237878|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
155237879|NCT03655236|560304058|FG000|Subject Disposition in Part 1 Period|Other|0|||
155237880|NCT03655236|560304059|FG001|Subject Disposition in Part 1 Period|Other|2|||
155237881|NCT03655236|560304060|FG002|Subject Disposition in Part 1 Period|Other|2|||
155237882|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
155237883|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
155237884|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
155237885|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
155237886|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
155237887|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
155237888|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
155237889|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
155237890|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
155237891|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
155237892|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
155237893|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
155237894|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
155237895|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
155237896|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
155237897|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
155237898|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
155237899|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
155237900|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
155237901|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
155237902|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
155237903|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
155237904|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
155237905|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
155237906|NCT03655236|560304058|FG000|Subject Disposition in Part 2 Period|Other|1|||
155237907|NCT03655236|560304059|FG001|Subject Disposition in Part 2 Period|Other|0|||
155237908|NCT03655236|560304060|FG002|Subject Disposition in Part 2 Period|Other|0|||
155237909|NCT01818336|560305289|FG000|Overall Study|Declined retest visit|0|||
155237910|NCT01818336|560305290|FG001|Overall Study|Declined retest visit|11|||
155237911|NCT01818336|560305289|FG000|Overall Study|Lost to Follow-up|0|||
155237912|NCT01818336|560305290|FG001|Overall Study|Lost to Follow-up|1|||
155237913|NCT00608829|560305293|FG000|Overall Study|Death|6|||
155237914|NCT00608829|560305293|FG000|Overall Study|Withdrawal by Subject|4|||
155237915|NCT00608829|560305293|FG000|Overall Study|Subject refuses to follow up or return.|5|||
155237916|NCT00672477|560305296|FG000|Overall Study|Adverse Event|10|||
155237917|NCT00672477|560305297|FG001|Overall Study|Adverse Event|7|||
155237918|NCT00672477|560305296|FG000|Overall Study|Death|7|||
155237919|NCT00672477|560305297|FG001|Overall Study|Death|11|||
155237920|NCT00672477|560305296|FG000|Overall Study|Physician Decision|2|||
155237921|NCT00672477|560305297|FG001|Overall Study|Physician Decision|0|||
155237922|NCT00672477|560305296|FG000|Overall Study|Protocol Violation|1|||
155237923|NCT00672477|560305297|FG001|Overall Study|Protocol Violation|1|||
155237924|NCT00672477|560305296|FG000|Overall Study|Withdrawal by Subject|5|||
155237925|NCT00672477|560305297|FG001|Overall Study|Withdrawal by Subject|3|||
155237926|NCT00672477|560305296|FG000|Overall Study|Lack of Efficacy|1|||
155237927|NCT00672477|560305297|FG001|Overall Study|Lack of Efficacy|1|||
155237928|NCT00672477|560305296|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
155237929|NCT00672477|560305297|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
155237930|NCT00982319|560305299|FG000|Overall Study|Surgery date change|1|||
155237931|NCT00982319|560305300|FG001|Overall Study|Surgery date change|0|||
155237932|NCT00982319|560305299|FG000|Overall Study|Preop values out of acceptable range|1|||
155237933|NCT00982319|560305300|FG001|Overall Study|Preop values out of acceptable range|1|||
155237934|NCT00982319|560305299|FG000|Overall Study|Pregnancy|0|||
155237935|NCT00982319|560305300|FG001|Overall Study|Pregnancy|1|||
155237936|NCT00975975|560305301|FG000|Overall Study|Death|6|||
155237937|NCT02496884|560305307|FG000|Overall Study|Counted twice as enrolled|2|||
155237938|NCT02496884|560305308|FG001|Overall Study|Counted twice as enrolled|0|||
155237939|NCT02496884|560305309|FG002|Overall Study|Counted twice as enrolled|0|||
155237940|NCT02496884|560305310|FG003|Overall Study|Counted twice as enrolled|0|||
155237941|NCT02496884|560305307|FG000|Overall Study|Withdrawal by Subject|0|||
155237942|NCT02496884|560305308|FG001|Overall Study|Withdrawal by Subject|3|||
155237943|NCT02496884|560305309|FG002|Overall Study|Withdrawal by Subject|0|||
155237944|NCT02496884|560305310|FG003|Overall Study|Withdrawal by Subject|0|||
155237945|NCT00097591|560305311|FG000|Overall Study|Withdrawal of consent|342|||
155237946|NCT00097591|560305312|FG001|Overall Study|Withdrawal of consent|323|||
155237947|NCT00097591|560305311|FG000|Overall Study|Less than 6 months on study drug|9|||
155237948|NCT00097591|560305312|FG001|Overall Study|Less than 6 months on study drug|7|||
155237949|NCT00097591|560305311|FG000|Overall Study|Unable to attend termination visit|53|||
155237950|NCT00097591|560305312|FG001|Overall Study|Unable to attend termination visit|51|||
155237951|NCT00097591|560305311|FG000|Overall Study|Lost to follow up|6|||
155237952|NCT00097591|560305312|FG001|Overall Study|Lost to follow up|10|||
155237953|NCT00097591|560305311|FG000|Overall Study|Other|0|||
155237954|NCT00097591|560305312|FG001|Overall Study|Other|3|||
155237955|NCT00807092|560305315|FG000|Overall Study|Adverse Event|0|||
155237956|NCT00807092|560305316|FG001|Overall Study|Adverse Event|1|||
155237957|NCT00807092|560305315|FG000|Overall Study|Protocol Violation|0|||
155237958|NCT00807092|560305316|FG001|Overall Study|Protocol Violation|2|||
155237959|NCT00807092|560305315|FG000|Overall Study|Withdrawal by Subject|1|||
155237960|NCT00807092|560305316|FG001|Overall Study|Withdrawal by Subject|0|||
155237961|NCT00807092|560305315|FG000|Overall Study|CGMS data collection failed|0|||
155237962|NCT00807092|560305316|FG001|Overall Study|CGMS data collection failed|1|||
155237963|NCT02013765|560305324|FG000|Overall Study|Trial was terminated by sponsor|1|||
155237964|NCT03095417|560305327|FG000|Overall Study|missed|1|||
155237965|NCT03095417|560305328|FG001|Overall Study|missed|2|||
155237966|NCT03095417|560305329|FG002|Overall Study|missed|0|||
155237967|NCT03095417|560305330|FG003|Overall Study|missed|1|||
155237968|NCT03095417|560305327|FG000|Overall Study|Lost to Follow-up|2|||
155237969|NCT03095417|560305328|FG001|Overall Study|Lost to Follow-up|2|||
155237970|NCT03095417|560305329|FG002|Overall Study|Lost to Follow-up|1|||
155237971|NCT03095417|560305330|FG003|Overall Study|Lost to Follow-up|0|||
155237972|NCT03095417|560305327|FG000|Overall Study|refusal|0|||
155237973|NCT03095417|560305328|FG001|Overall Study|refusal|1|||
155237974|NCT03095417|560305329|FG002|Overall Study|refusal|0|||
155237975|NCT03095417|560305330|FG003|Overall Study|refusal|1|||
155237976|NCT03095417|560305327|FG000|Overall Study|Withdrawal by Subject|8|||
155237977|NCT03095417|560305328|FG001|Overall Study|Withdrawal by Subject|2|||
155237978|NCT03095417|560305329|FG002|Overall Study|Withdrawal by Subject|5|||
155237979|NCT03095417|560305330|FG003|Overall Study|Withdrawal by Subject|4|||
155237980|NCT03095417|560305327|FG000|Overall Study|Physician Decision|1|||
155237981|NCT03095417|560305328|FG001|Overall Study|Physician Decision|2|||
155237982|NCT03095417|560305329|FG002|Overall Study|Physician Decision|2|||
155237983|NCT03095417|560305330|FG003|Overall Study|Physician Decision|2|||
155237984|NCT03095417|560305327|FG000|Overall Study|Death|1|||
155237985|NCT03095417|560305328|FG001|Overall Study|Death|2|||
155237986|NCT03095417|560305329|FG002|Overall Study|Death|1|||
155237987|NCT03095417|560305330|FG003|Overall Study|Death|3|||
155237988|NCT01260922|560305333|FG000|First Intervention|Withdrawal by Subject|0|||
155237989|NCT01260922|560305334|FG001|First Intervention|Withdrawal by Subject|1|||
155237990|NCT01260922|560305333|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
155237991|NCT01260922|560305334|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
155237992|NCT01260922|560305333|FG000|Second Intervention|Emesis|0|||
155237993|NCT01260922|560305334|FG001|Second Intervention|Emesis|2|||
155237994|NCT01731171|560305335|FG000|Overall Study|Withdrawal by Subject|4|||
155237995|NCT01731171|560305336|FG001|Overall Study|Withdrawal by Subject|1|||
155237996|NCT01731171|560305335|FG000|Overall Study|Lost to Follow-up|3|||
155237997|NCT01731171|560305336|FG001|Overall Study|Lost to Follow-up|2|||
155237998|NCT01731171|560305335|FG000|Overall Study|Moved out of Area|0|||
155237999|NCT01731171|560305336|FG001|Overall Study|Moved out of Area|2|||
155238000|NCT01731171|560305335|FG000|Overall Study|Terminated for Lack of Adherence|0|||
155238001|NCT01731171|560305336|FG001|Overall Study|Terminated for Lack of Adherence|1|||
155238002|NCT01731171|560305335|FG000|Overall Study|Terminated for Safety Reasons|0|||
155238003|NCT01731171|560305336|FG001|Overall Study|Terminated for Safety Reasons|1|||
155238004|NCT01410110|560305337|FG000|Overall Study|Withdrawal by Subject|4|||
155238005|NCT01410110|560305338|FG001|Overall Study|Withdrawal by Subject|2|||
155238006|NCT01416805|560305339|FG000|Overall Study|Lost to Follow-up|4|||
155238007|NCT01416805|560305340|FG001|Overall Study|Lost to Follow-up|4|||
155238008|NCT03653429|560305341|FG000|Overall Study|Physician Decision|4|||
155238009|NCT03653429|560305342|FG001|Overall Study|Physician Decision|10|||
155238010|NCT02604589|560305347|FG000|Overall Study|catheter dislodgement|0|||
155238011|NCT02604589|560305348|FG001|Overall Study|catheter dislodgement|0|||
155238012|NCT02604589|560305349|FG002|Overall Study|catheter dislodgement|1|||
155238013|NCT01700946|560305350|FG000|Overall Study|Lost to Follow-up|1|||
155238014|NCT01700946|560305351|FG001|Overall Study|Lost to Follow-up|0|||
155238015|NCT01700946|560305350|FG000|Overall Study|Physician Decision|7|||
155238016|NCT01700946|560305351|FG001|Overall Study|Physician Decision|12|||
155238017|NCT01700946|560305350|FG000|Overall Study|Withdrawal by Subject|0|||
155238018|NCT01700946|560305351|FG001|Overall Study|Withdrawal by Subject|2|||
155238019|NCT01700946|560305350|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
155238020|NCT01700946|560305351|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
155238021|NCT01700946|560305350|FG000|Overall Study|Relapse|2|||
155238022|NCT01700946|560305351|FG001|Overall Study|Relapse|1|||
155238023|NCT01700946|560305350|FG000|Overall Study|Unacceptable toxicity|1|||
155238024|NCT01700946|560305351|FG001|Overall Study|Unacceptable toxicity|0|||
155238025|NCT04632940|560305359|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
155238026|NCT04632940|560305360|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
155238027|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
155238028|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
155238029|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
155238030|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
155238031|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
155238032|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
155238033|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
155238034|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
155238035|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
155238036|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
155238037|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Other than specified|0|||
155238038|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Other than specified|1|||
155238039|NCT04632940|560305359|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
155238040|NCT04632940|560305360|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
155238041|NCT00684424|560305361|FG000|Overall Study|Adverse Event|1|||
155238042|NCT00684424|560305361|FG000|Overall Study|Lost to Follow-up|2|||
155238043|NCT00684424|560305361|FG000|Overall Study|Other|2|||
155238044|NCT01723904|560305365|FG000|Overall Study|Noncompliant|3|||
155238045|NCT01723904|560305365|FG000|Overall Study|Adverse Event|5|||
155238046|NCT01723904|560305365|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
155238047|NCT02610140|560305378|FG000|Randomization and Treatment Period|Radiological progression|23|||
155238048|NCT02610140|560305379|FG001|Randomization and Treatment Period|Radiological progression|15|||
155238049|NCT02610140|560305378|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
155238050|NCT02610140|560305379|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
155238051|NCT02610140|560305378|FG000|Randomization and Treatment Period|Protocol Violation|1|||
155238052|NCT02610140|560305379|FG001|Randomization and Treatment Period|Protocol Violation|0|||
155238053|NCT02610140|560305378|FG000|Randomization and Treatment Period|Physician Decision|0|||
155238054|NCT02610140|560305379|FG001|Randomization and Treatment Period|Physician Decision|1|||
155238055|NCT02610140|560305378|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
155238056|NCT02610140|560305379|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
155238057|NCT02610140|560305378|FG000|Randomization and Treatment Period|Death|7|||
155238058|NCT02610140|560305379|FG001|Randomization and Treatment Period|Death|1|||
155238059|NCT02610140|560305378|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
155238060|NCT02610140|560305379|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
155238061|NCT02610140|560305378|FG000|Randomization and Treatment Period|Adverse Event|44|||
155238062|NCT02610140|560305379|FG001|Randomization and Treatment Period|Adverse Event|13|||
155238063|NCT02610140|560305378|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
155238064|NCT02610140|560305379|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
155238065|NCT02610140|560305378|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
155238066|NCT02610140|560305379|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
155238067|NCT02610140|560305378|FG000|Randomization and Treatment Period|Not treated|3|||
155238068|NCT02610140|560305379|FG001|Randomization and Treatment Period|Not treated|10|||
155238069|NCT02610140|560305378|FG000|Safety Follow-up|Other|0|||
155238070|NCT02610140|560305379|FG001|Safety Follow-up|Other|2|||
155238071|NCT02610140|560305378|FG000|Safety Follow-up|Lost to Follow-up|1|||
155238072|NCT02610140|560305379|FG001|Safety Follow-up|Lost to Follow-up|0|||
155238073|NCT02610140|560305378|FG000|Safety Follow-up|No follow-up|5|||
155238074|NCT02610140|560305379|FG001|Safety Follow-up|No follow-up|3|||
155238075|NCT02610140|560305378|FG000|Safety Follow-up|Death|12|||
155238076|NCT02610140|560305379|FG001|Safety Follow-up|Death|2|||
155238077|NCT02610140|560305378|FG000|Safety Follow-up|Deterioration of general conditions|15|||
155238078|NCT02610140|560305379|FG001|Safety Follow-up|Deterioration of general conditions|5|||
155238079|NCT02610140|560305378|FG000|Safety Follow-up|Withdrawal by Subject|12|||
155238080|NCT02610140|560305379|FG001|Safety Follow-up|Withdrawal by Subject|12|||
155238081|NCT02610140|560305378|FG000|Active Follow-up|Progressive disease - radiological|30|||
155238082|NCT02610140|560305379|FG001|Active Follow-up|Progressive disease - radiological|22|||
155238083|NCT02610140|560305378|FG000|Active Follow-up|Death|8|||
155238084|NCT02610140|560305379|FG001|Active Follow-up|Death|1|||
155238085|NCT02610140|560305378|FG000|Active Follow-up|Withdrawal by Subject|4|||
155238086|NCT02610140|560305379|FG001|Active Follow-up|Withdrawal by Subject|0|||
155238087|NCT02610140|560305378|FG000|Active Follow-up|Progressive disease - clinical|1|||
155238088|NCT02610140|560305379|FG001|Active Follow-up|Progressive disease - clinical|2|||
155238089|NCT02610140|560305378|FG000|Active Follow-up|Deterioration of general conditions|1|||
155238090|NCT02610140|560305379|FG001|Active Follow-up|Deterioration of general conditions|0|||
155238091|NCT02610140|560305378|FG000|Active Follow-up|Ongoing but not completed|4|||
155238092|NCT02610140|560305379|FG001|Active Follow-up|Ongoing but not completed|1|||
155238093|NCT02610140|560305378|FG000|Long-term Follow-up|Death|86|||
155238094|NCT02610140|560305379|FG001|Long-term Follow-up|Death|44|||
155238095|NCT02610140|560305378|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
155238096|NCT02610140|560305379|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
155238097|NCT02610140|560305378|FG000|Long-term Follow-up|Lost to Follow-up|1|||
155238098|NCT02610140|560305379|FG001|Long-term Follow-up|Lost to Follow-up|2|||
155238099|NCT02610140|560305378|FG000|Long-term Follow-up|Ongoing but not completed|30|||
155238100|NCT02610140|560305379|FG001|Long-term Follow-up|Ongoing but not completed|17|||
155238101|NCT00887341|560305380|FG000|Overall Study|Refused treatment|1|||
155238102|NCT00887341|560305381|FG001|Overall Study|Refused treatment|0|||
155238103|NCT00887341|560305380|FG000|Overall Study|Withdrawal by Subject|1|||
155238104|NCT00887341|560305381|FG001|Overall Study|Withdrawal by Subject|1|||
155238105|NCT00887341|560305380|FG000|Overall Study|Adverse Event|0|||
155238106|NCT00887341|560305381|FG001|Overall Study|Adverse Event|1|||
155238107|NCT00887341|560305380|FG000|Overall Study|Lost to Follow-up|0|||
155238108|NCT00887341|560305381|FG001|Overall Study|Lost to Follow-up|1|||
155238109|NCT02617589|560305382|FG000|Randomization|Request to Discontinue Study Treatment|1|||
155238110|NCT02617589|560305383|FG001|Randomization|Request to Discontinue Study Treatment|3|||
155238111|NCT02617589|560305382|FG000|Randomization|Participant Withdrew Consent|1|||
155238112|NCT02617589|560305383|FG001|Randomization|Participant Withdrew Consent|2|||
155238113|NCT02617589|560305382|FG000|Treatment|Other Reasons|3|||
155238114|NCT02617589|560305383|FG001|Treatment|Other Reasons|3|||
155238115|NCT02617589|560305382|FG000|Treatment|Poor/Non Compliance|1|||
155238116|NCT02617589|560305383|FG001|Treatment|Poor/Non Compliance|1|||
155238117|NCT02617589|560305382|FG000|Treatment|Maximum Clinical Benefit|0|||
155238118|NCT02617589|560305383|FG001|Treatment|Maximum Clinical Benefit|2|||
155238119|NCT02617589|560305382|FG000|Treatment|Participant Withdrew Consent|2|||
155238120|NCT02617589|560305383|FG001|Treatment|Participant Withdrew Consent|6|||
155238121|NCT02617589|560305382|FG000|Treatment|Participant Request to Discontinue|12|||
155238122|NCT02617589|560305383|FG001|Treatment|Participant Request to Discontinue|21|||
155238123|NCT02617589|560305382|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
155238124|NCT02617589|560305383|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
155238125|NCT02617589|560305382|FG000|Treatment|Death|1|||
155238126|NCT02617589|560305383|FG001|Treatment|Death|1|||
155238127|NCT02617589|560305382|FG000|Treatment|Study Drug Toxicity|27|||
155238128|NCT02617589|560305383|FG001|Treatment|Study Drug Toxicity|20|||
155238129|NCT02617589|560305382|FG000|Treatment|Disease Progression|216|||
155238130|NCT02617589|560305383|FG001|Treatment|Disease Progression|136|||
155238131|NCT01752933|560305386|FG000|Treatment|Disease Progression|3|||
155238132|NCT01752933|560305387|FG001|Treatment|Disease Progression|29|||
155238133|NCT01752933|560305386|FG000|Treatment|Withdrawal by Subject|0|||
155238134|NCT01752933|560305387|FG001|Treatment|Withdrawal by Subject|5|||
155238135|NCT01752933|560305386|FG000|Treatment|Adverse Event|1|||
155238136|NCT01752933|560305387|FG001|Treatment|Adverse Event|4|||
155238137|NCT01752933|560305386|FG000|Treatment|Physician Decision|0|||
155238138|NCT01752933|560305387|FG001|Treatment|Physician Decision|3|||
155238139|NCT01752933|560305386|FG000|Treatment|Death|0|||
155238140|NCT01752933|560305387|FG001|Treatment|Death|2|||
155238141|NCT01752933|560305386|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
155238142|NCT01752933|560305387|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
155238143|NCT01752933|560305386|FG000|Treatment|Patient noncompliant|0|||
155238144|NCT01752933|560305387|FG001|Treatment|Patient noncompliant|1|||
155238145|NCT01752933|560305386|FG000|Treatment|Patient unable to travel to appointments|0|||
155238146|NCT01752933|560305387|FG001|Treatment|Patient unable to travel to appointments|1|||
155238147|NCT01752933|560305386|FG000|Overall Study and Follow-up|Death|4|||
155238148|NCT01752933|560305387|FG001|Overall Study and Follow-up|Death|34|||
155238149|NCT01752933|560305386|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
155238150|NCT01752933|560305387|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
155238151|NCT01752933|560305386|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
155238152|NCT01752933|560305387|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
155238153|NCT01752933|560305386|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
155238154|NCT01752933|560305387|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
155238155|NCT01591681|560305388|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
155238156|NCT01591681|560305388|FG000|Overall Study|Failed to use system during run-in|1|||
155238157|NCT03062891|560305389|FG000|Overall Study|Withdrawal by Subject|2|||
155238158|NCT03062891|560305390|FG001|Overall Study|Withdrawal by Subject|0|||
155238159|NCT03062891|560305389|FG000|Overall Study|Lost to Follow-up|50|||
155238160|NCT03062891|560305390|FG001|Overall Study|Lost to Follow-up|38|||
155238161|NCT03509948|560305394|FG000|Overall Study|Protocol Violation|0|||
155238162|NCT03509948|560305395|FG001|Overall Study|Protocol Violation|1|||
155238163|NCT03221257|560305396|FG000|Overall Study|Lost to Follow-up|0|||
155238164|NCT03221257|560305397|FG001|Overall Study|Lost to Follow-up|1|||
155238165|NCT03221257|560305396|FG000|Overall Study|Withdrawal by Subject|1|||
155238166|NCT03221257|560305397|FG001|Overall Study|Withdrawal by Subject|1|||
155238167|NCT01334866|560305406|FG000|Overall Study|Withdrawal by Subject|10|||
155238168|NCT01334866|560305406|FG000|Overall Study|Lost to Follow-up|3|||
155238169|NCT01334866|560305406|FG000|Overall Study|Physician Decision|3|||
155238170|NCT01334866|560305406|FG000|Overall Study|medically necessary prior to procedure|2|||
155238171|NCT01334866|560305406|FG000|Overall Study|medically necessary post-procedure|1|||
155238172|NCT00958880|560305414|FG000|Overall Study|Lost to Follow-up|2|||
155238173|NCT00958880|560305415|FG001|Overall Study|Lost to Follow-up|2|||
155238174|NCT01971346|560305416|FG000|Overall Study|Protocol Violation|3|||
155238175|NCT01971346|560305416|FG000|Overall Study|Lost to Follow-up|2|||
155238176|NCT01971346|560305416|FG000|Overall Study|Withdrawal by Subject|2|||
155238177|NCT01971346|560305416|FG000|Overall Study|Physician Decision|1|||
155238178|NCT04187196|560305419|FG000|Overall Study|Screen Failure|2|||
155238179|NCT04187196|560305420|FG001|Overall Study|Screen Failure|0|||
155238180|NCT01687166|560305421|FG000|Overall Study|Attempt subject|2|||
155238181|NCT01687166|560305422|FG001|Overall Study|Attempt subject|3|||
155238182|NCT01687166|560305423|FG002|Overall Study|Attempt subject|2|||
155238183|NCT01687166|560305424|FG003|Overall Study|Attempt subject|0|||
155238184|NCT01687166|560305421|FG000|Overall Study|Did not meet eligibility criteria|4|||
155238185|NCT01687166|560305422|FG001|Overall Study|Did not meet eligibility criteria|6|||
155238186|NCT01687166|560305423|FG002|Overall Study|Did not meet eligibility criteria|1|||
155238187|NCT01687166|560305424|FG003|Overall Study|Did not meet eligibility criteria|1|||
155238188|NCT01687166|560305421|FG000|Overall Study|Adverse Event|2|||
155238189|NCT01687166|560305422|FG001|Overall Study|Adverse Event|1|||
155238190|NCT01687166|560305423|FG002|Overall Study|Adverse Event|0|||
155238191|NCT01687166|560305424|FG003|Overall Study|Adverse Event|0|||
155238192|NCT01687166|560305421|FG000|Overall Study|Physician Decision|3|||
155238193|NCT01687166|560305422|FG001|Overall Study|Physician Decision|2|||
155238194|NCT01687166|560305423|FG002|Overall Study|Physician Decision|1|||
155238195|NCT01687166|560305424|FG003|Overall Study|Physician Decision|0|||
155238196|NCT01687166|560305421|FG000|Overall Study|Withdrawal by Subject|11|||
155238197|NCT01687166|560305422|FG001|Overall Study|Withdrawal by Subject|4|||
155238198|NCT01687166|560305423|FG002|Overall Study|Withdrawal by Subject|3|||
155238199|NCT01687166|560305424|FG003|Overall Study|Withdrawal by Subject|0|||
155238200|NCT01687166|560305421|FG000|Overall Study|Lost to Follow-up|2|||
155238201|NCT01687166|560305422|FG001|Overall Study|Lost to Follow-up|5|||
155238202|NCT01687166|560305423|FG002|Overall Study|Lost to Follow-up|1|||
155238203|NCT01687166|560305424|FG003|Overall Study|Lost to Follow-up|0|||
155238204|NCT01687166|560305421|FG000|Overall Study|Equipment/Device Availability|0|||
155238205|NCT01687166|560305422|FG001|Overall Study|Equipment/Device Availability|1|||
155238206|NCT01687166|560305423|FG002|Overall Study|Equipment/Device Availability|0|||
155238207|NCT01687166|560305424|FG003|Overall Study|Equipment/Device Availability|0|||
155238208|NCT01687166|560305421|FG000|Overall Study|Death|1|||
155238209|NCT01687166|560305422|FG001|Overall Study|Death|1|||
155238210|NCT01687166|560305423|FG002|Overall Study|Death|0|||
155238211|NCT01687166|560305424|FG003|Overall Study|Death|0|||
155238212|NCT01687166|560305421|FG000|Overall Study|Protocol Violation|1|||
155238213|NCT01687166|560305422|FG001|Overall Study|Protocol Violation|1|||
155238214|NCT01687166|560305423|FG002|Overall Study|Protocol Violation|1|||
155238215|NCT01687166|560305424|FG003|Overall Study|Protocol Violation|0|||
155238216|NCT01687166|560305421|FG000|Overall Study|Subject moved out of state|0|||
155238217|NCT01687166|560305422|FG001|Overall Study|Subject moved out of state|1|||
155238218|NCT01687166|560305423|FG002|Overall Study|Subject moved out of state|0|||
155238219|NCT01687166|560305424|FG003|Overall Study|Subject moved out of state|0|||
155238220|NCT01687166|560305421|FG000|Overall Study|Patient unable to be compliant|1|||
155238221|NCT01687166|560305422|FG001|Overall Study|Patient unable to be compliant|0|||
155238222|NCT01687166|560305423|FG002|Overall Study|Patient unable to be compliant|0|||
155238223|NCT01687166|560305424|FG003|Overall Study|Patient unable to be compliant|0|||
155238224|NCT01687166|560305421|FG000|Overall Study|Physician choice to use different device|1|||
155238225|NCT01687166|560305422|FG001|Overall Study|Physician choice to use different device|2|||
155238226|NCT01687166|560305423|FG002|Overall Study|Physician choice to use different device|4|||
155238227|NCT01687166|560305424|FG003|Overall Study|Physician choice to use different device|0|||
155238228|NCT01687166|560305421|FG000|Overall Study|Insurance|0|||
155238229|NCT01687166|560305422|FG001|Overall Study|Insurance|0|||
155238230|NCT01687166|560305423|FG002|Overall Study|Insurance|1|||
155238231|NCT01687166|560305424|FG003|Overall Study|Insurance|1|||
155238232|NCT02755831|560305425|FG000|Overall Study|Lost to Follow-up|3|||
155238233|NCT02755831|560305426|FG001|Overall Study|Lost to Follow-up|3|||
155238234|NCT02296112|560305427|FG000|Overall Study|Disease progression|7|||
155238235|NCT02296112|560305427|FG000|Overall Study|Toxicity|1|||
155238236|NCT02296112|560305427|FG000|Overall Study|Began an alternate therapy|1|||
155238237|NCT00298831|560305428|FG000|Overall Study|Adverse Event|1|||
155238238|NCT00298831|560305428|FG000|Overall Study|Lost to Follow-up|3|||
155238239|NCT00298831|560305428|FG000|Overall Study|Withdrawal by Subject|1|||
155238240|NCT00298831|560305428|FG000|Overall Study|Participants did not receive treatment|27|||
155238241|NCT01516879|560305429|FG000|Overall Study|Withdrawal by Subject|9|||
155238242|NCT01516879|560305430|FG001|Overall Study|Withdrawal by Subject|11|||
155238243|NCT01516879|560305429|FG000|Overall Study|Death|0|||
155238244|NCT01516879|560305430|FG001|Overall Study|Death|2|||
155238245|NCT01516879|560305429|FG000|Overall Study|Lost to Follow-up|2|||
155238246|NCT01516879|560305430|FG001|Overall Study|Lost to Follow-up|11|||
155238247|NCT01516879|560305429|FG000|Overall Study|Other|5|||
155238248|NCT01516879|560305430|FG001|Overall Study|Other|10|||
155238249|NCT01720069|560305431|FG000|Overall Study|Could not use e-diary correctly|0|||
155238250|NCT01720069|560305432|FG001|Overall Study|Could not use e-diary correctly|1|||
155238251|NCT01720069|560305433|FG002|Overall Study|Could not use e-diary correctly|1|||
155238252|NCT01720069|560305431|FG000|Overall Study|Randomised without baseline values|0|||
155238253|NCT01720069|560305432|FG001|Overall Study|Randomised without baseline values|0|||
155238254|NCT01720069|560305433|FG002|Overall Study|Randomised without baseline values|1|||
155238255|NCT01720069|560305431|FG000|Overall Study|Adverse Event|0|||
155238256|NCT01720069|560305432|FG001|Overall Study|Adverse Event|0|||
155238257|NCT01720069|560305433|FG002|Overall Study|Adverse Event|1|||
155238258|NCT01720069|560305431|FG000|Overall Study|Lack of Efficacy|0|||
155238259|NCT01720069|560305432|FG001|Overall Study|Lack of Efficacy|4|||
155238260|NCT01720069|560305433|FG002|Overall Study|Lack of Efficacy|0|||
155238261|NCT01720069|560305431|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
155238262|NCT01720069|560305432|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
155238263|NCT01720069|560305433|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
155238264|NCT01720069|560305431|FG000|Overall Study|Withdrawal by Subject|0|||
155238265|NCT01720069|560305432|FG001|Overall Study|Withdrawal by Subject|2|||
155238266|NCT01720069|560305433|FG002|Overall Study|Withdrawal by Subject|1|||
155238267|NCT01720069|560305431|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
155238268|NCT01720069|560305432|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
155238269|NCT01720069|560305433|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
155238270|NCT01720069|560305431|FG000|Overall Study|Non-compliance on using e-diary|0|||
155238271|NCT01720069|560305432|FG001|Overall Study|Non-compliance on using e-diary|0|||
155238272|NCT01720069|560305433|FG002|Overall Study|Non-compliance on using e-diary|1|||
155238273|NCT01720069|560305431|FG000|Overall Study|Lost to Follow-up|0|||
155238274|NCT01720069|560305432|FG001|Overall Study|Lost to Follow-up|0|||
155238275|NCT01720069|560305433|FG002|Overall Study|Lost to Follow-up|1|||
155238276|NCT04568122|560305434|FG000|Overall Study|Lost to Follow-up|48|||
155238277|NCT04568122|560305435|FG001|Overall Study|Lost to Follow-up|44|||
155238278|NCT04568122|560305436|FG002|Overall Study|Lost to Follow-up|4|||
155238279|NCT04568122|560305437|FG003|Overall Study|Lost to Follow-up|0|||
155238280|NCT04568122|560305438|FG004|Overall Study|Lost to Follow-up|0|||
155238281|NCT03136068|560307154|FG000|Overall Study|Lost to Follow-up|1|||
155238282|NCT03136068|560307155|FG001|Overall Study|Lost to Follow-up|1|||
155238283|NCT03136068|560307154|FG000|Overall Study|Protocol Violation|1|||
155238284|NCT03136068|560307155|FG001|Overall Study|Protocol Violation|0|||
155238285|NCT00432380|560307159|FG000|Overall Study|Migrated/moved from study area|3|||
155238286|NCT00432380|560307160|FG001|Overall Study|Migrated/moved from study area|4|||
155238287|NCT00432380|560307161|FG002|Overall Study|Migrated/moved from study area|1|||
155238288|NCT00432380|560307159|FG000|Overall Study|Adverse Event|1|||
155238289|NCT00432380|560307160|FG001|Overall Study|Adverse Event|0|||
155238290|NCT00432380|560307161|FG002|Overall Study|Adverse Event|0|||
155238291|NCT01071395|560307169|FG000|Overall Study|Withdrawal by Subject|2|||
155238292|NCT01071395|560307170|FG001|Overall Study|Withdrawal by Subject|1|||
155238293|NCT01071395|560307169|FG000|Overall Study|Adverse Event|3|||
155238294|NCT01071395|560307170|FG001|Overall Study|Adverse Event|1|||
155238295|NCT02805257|560307171|FG000|Overall Study|Lost to Follow-up|7|||
155238296|NCT02805257|560307172|FG001|Overall Study|Lost to Follow-up|6|||
155238297|NCT02805257|560307171|FG000|Overall Study|Death|0|||
155238298|NCT02805257|560307172|FG001|Overall Study|Death|1|||
155238299|NCT00612066|560307173|FG000|Overall Study|Adverse Event|1|||
155238300|NCT01043874|560307177|FG000|Overall Study|Adverse Event|3|||
155238301|NCT01043874|560307177|FG000|Overall Study|Withdrawal by Subject|1|||
155238302|NCT01043874|560307177|FG000|Overall Study|Lack of Efficacy|1|||
155238303|NCT01043874|560307177|FG000|Overall Study|Administrative Problems|1|||
155238304|NCT03422003|560307178|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
155238305|NCT03422003|560307179|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
155238306|NCT03422003|560307178|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
155238307|NCT03422003|560307179|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
155238308|NCT01337089|560307180|FG000|Overall Study|Adverse Event|237|||
155238309|NCT01337089|560307180|FG000|Overall Study|Withdrawal by Subject|129|||
155238310|NCT01337089|560307180|FG000|Overall Study|Withdrawal by Investigator|33|||
155238311|NCT01337089|560307180|FG000|Overall Study|Met Withdrawal Criteria|3|||
155238312|NCT01337089|560307180|FG000|Overall Study|Lost to Follow-up|2|||
155238313|NCT01404312|560307181|FG000|Overall Study|Death|21|||
155238314|NCT01404312|560307182|FG001|Overall Study|Death|27|||
155238315|NCT01404312|560307181|FG000|Overall Study|Withdrawal by Subject|15|||
155238316|NCT01404312|560307182|FG001|Overall Study|Withdrawal by Subject|18|||
155238317|NCT01404312|560307181|FG000|Overall Study|Participant Unable to get to clinic|93|||
155238318|NCT01404312|560307182|FG001|Overall Study|Participant Unable to get to clinic|103|||
155238319|NCT01404312|560307181|FG000|Overall Study|Lost to Follow-up|115|||
155238320|NCT01404312|560307182|FG001|Overall Study|Lost to Follow-up|111|||
155238321|NCT01404312|560307181|FG000|Overall Study|Site closed|22|||
155238322|NCT01404312|560307182|FG001|Overall Study|Site closed|21|||
155238323|NCT01404312|560307181|FG000|Overall Study|Participant not willing to adhere to req|31|||
155238324|NCT01404312|560307182|FG001|Overall Study|Participant not willing to adhere to req|29|||
155238325|NCT01404312|560307181|FG000|Overall Study|Severe debilitation, unable to continue|1|||
155238326|NCT01404312|560307182|FG001|Overall Study|Severe debilitation, unable to continue|2|||
155238327|NCT04419493|560307183|FG000|Wash-out After Period 1|Adverse Event|1|||
155238328|NCT04419493|560307184|FG001|Wash-out After Period 1|Adverse Event|2|||
155238329|NCT04419493|560307185|FG002|Wash-out After Period 1|Adverse Event|1|||
155238330|NCT04419493|560307186|FG003|Wash-out After Period 1|Adverse Event|0|||
155238331|NCT00524134|560307187|FG000|Overall Study|Withdrawal by Subject|1|||
155238332|NCT00524134|560307187|FG000|Overall Study|Physician Decision|1|||
155238333|NCT03266588|560307188|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
155238334|NCT03266588|560307189|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
155238335|NCT03266588|560307190|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
155238336|NCT03266588|560307188|FG000|Observational Period|Withdrawal by Subject|44|||
155238337|NCT03266588|560307189|FG001|Observational Period|Withdrawal by Subject|22|||
155238338|NCT03266588|560307190|FG002|Observational Period|Withdrawal by Subject|13|||
155238339|NCT03266588|560307188|FG000|Observational Period|Non-compliance|18|||
155238340|NCT03266588|560307189|FG001|Observational Period|Non-compliance|12|||
155238341|NCT03266588|560307190|FG002|Observational Period|Non-compliance|10|||
155238342|NCT03266588|560307188|FG000|Observational Period|Lost to Follow-up|8|||
155238343|NCT03266588|560307189|FG001|Observational Period|Lost to Follow-up|12|||
155238344|NCT03266588|560307190|FG002|Observational Period|Lost to Follow-up|4|||
155238345|NCT03266588|560307188|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
155238346|NCT03266588|560307189|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
155238347|NCT03266588|560307190|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
155238348|NCT03266588|560307188|FG000|Observational Period|Protocol Deviation|1|||
155238349|NCT03266588|560307189|FG001|Observational Period|Protocol Deviation|0|||
155238350|NCT03266588|560307190|FG002|Observational Period|Protocol Deviation|0|||
155238351|NCT03266588|560307188|FG000|Observational Period|Other Reasons|3|||
155238352|NCT03266588|560307189|FG001|Observational Period|Other Reasons|0|||
155238353|NCT03266588|560307190|FG002|Observational Period|Other Reasons|1|||
155238354|NCT03266588|560307188|FG000|Long-term Treatment Period|Adverse Event|33|||
155238355|NCT03266588|560307189|FG001|Long-term Treatment Period|Adverse Event|17|||
155238356|NCT03266588|560307190|FG002|Long-term Treatment Period|Adverse Event|8|||
155238357|NCT03266588|560307188|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
155238358|NCT03266588|560307189|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
155238359|NCT03266588|560307190|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
155238360|NCT03266588|560307188|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
155238361|NCT03266588|560307189|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
155238362|NCT03266588|560307190|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
155238363|NCT03266588|560307188|FG000|Long-term Treatment Period|Non-Compliance|126|||
155238364|NCT03266588|560307189|FG001|Long-term Treatment Period|Non-Compliance|57|||
155238365|NCT03266588|560307190|FG002|Long-term Treatment Period|Non-Compliance|7|||
155238366|NCT03266588|560307188|FG000|Long-term Treatment Period|Pregnancy|11|||
155238367|NCT03266588|560307189|FG001|Long-term Treatment Period|Pregnancy|5|||
155238368|NCT03266588|560307190|FG002|Long-term Treatment Period|Pregnancy|0|||
155238369|NCT03266588|560307188|FG000|Long-term Treatment Period|Protocol Deviation|17|||
155238370|NCT03266588|560307189|FG001|Long-term Treatment Period|Protocol Deviation|10|||
155238371|NCT03266588|560307190|FG002|Long-term Treatment Period|Protocol Deviation|4|||
155238372|NCT03266588|560307188|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
155238373|NCT03266588|560307189|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
155238374|NCT03266588|560307190|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
155238375|NCT03266588|560307188|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
155238376|NCT03266588|560307189|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
155238377|NCT03266588|560307190|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
155238378|NCT03266588|560307188|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
155238379|NCT03266588|560307189|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
155238380|NCT03266588|560307190|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
155238381|NCT03266588|560307188|FG000|Long-term Treatment Period|Other Reasons|5|||
155238382|NCT03266588|560307189|FG001|Long-term Treatment Period|Other Reasons|0|||
155238383|NCT03266588|560307190|FG002|Long-term Treatment Period|Other Reasons|0|||
155238384|NCT03266588|560307188|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
155238385|NCT03266588|560307189|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
155238386|NCT03266588|560307190|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
155238387|NCT02627677|560307192|FG000|Overall Study|Adverse event (not progressive disease)|1|||
155238388|NCT02627677|560307193|FG001|Overall Study|Adverse event (not progressive disease)|4|||
155238389|NCT02627677|560307194|FG002|Overall Study|Adverse event (not progressive disease)|1|||
155238390|NCT02627677|560307192|FG000|Overall Study|Progressive disease|1|||
155238391|NCT02627677|560307193|FG001|Overall Study|Progressive disease|3|||
155238392|NCT02627677|560307194|FG002|Overall Study|Progressive disease|0|||
155238393|NCT02627677|560307192|FG000|Overall Study|Lack of Efficacy|1|||
155238394|NCT02627677|560307193|FG001|Overall Study|Lack of Efficacy|2|||
155238395|NCT02627677|560307194|FG002|Overall Study|Lack of Efficacy|0|||
155238396|NCT02627677|560307192|FG000|Overall Study|Lost to Follow-up|0|||
155238397|NCT02627677|560307193|FG001|Overall Study|Lost to Follow-up|0|||
155238398|NCT02627677|560307194|FG002|Overall Study|Lost to Follow-up|1|||
155238399|NCT02627677|560307192|FG000|Overall Study|Pregnancy|0|||
155238400|NCT02627677|560307193|FG001|Overall Study|Pregnancy|1|||
155238401|NCT02627677|560307194|FG002|Overall Study|Pregnancy|0|||
155238402|NCT02627677|560307192|FG000|Overall Study|Study Terminated by Sponsor|5|||
155238403|NCT02627677|560307193|FG001|Overall Study|Study Terminated by Sponsor|10|||
155238404|NCT02627677|560307194|FG002|Overall Study|Study Terminated by Sponsor|6|||
155238405|NCT02627677|560307192|FG000|Overall Study|Physician Decision|0|||
155238406|NCT02627677|560307193|FG001|Overall Study|Physician Decision|0|||
155238407|NCT02627677|560307194|FG002|Overall Study|Physician Decision|2|||
155238408|NCT02627677|560307192|FG000|Overall Study|Withdrawal by Subject|2|||
155238409|NCT02627677|560307193|FG001|Overall Study|Withdrawal by Subject|1|||
155238410|NCT02627677|560307194|FG002|Overall Study|Withdrawal by Subject|1|||
155238411|NCT02627677|560307192|FG000|Overall Study|Reason not Specified|0|||
155238412|NCT02627677|560307193|FG001|Overall Study|Reason not Specified|0|||
155238413|NCT02627677|560307194|FG002|Overall Study|Reason not Specified|1|||
155238414|NCT02627677|560307192|FG000|Overall Study|Randomized but not Treated|1|||
155238415|NCT02627677|560307193|FG001|Overall Study|Randomized but not Treated|0|||
155238416|NCT02627677|560307194|FG002|Overall Study|Randomized but not Treated|0|||
155238417|NCT03087591|560307197|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
155238418|NCT03087591|560307197|FG000|Overall Study|Withdrawal by Subject|1|||
155238419|NCT01073618|560307200|FG000|Overall Study|Death|208|||
155238420|NCT01073618|560307200|FG000|Overall Study|Adverse Event|19|||
155238421|NCT01073618|560307200|FG000|Overall Study|Other|80|||
155238422|NCT02696850|560307201|FG000|Overall Study|Withdrawal by Subject|3|||
155238423|NCT02696850|560307202|FG001|Overall Study|Withdrawal by Subject|3|||
155238424|NCT02696850|560307201|FG000|Overall Study|Lost to Follow-up|8|||
155238425|NCT02696850|560307202|FG001|Overall Study|Lost to Follow-up|5|||
155238426|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
155238427|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
155238428|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
155238429|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
155238430|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Death|235|||
155238431|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Death|167|||
155238432|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Death|1|||
155238433|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Death|0|||
155238434|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
155238435|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
155238436|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
155238437|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
155238438|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
155238439|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
155238440|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
155238441|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
155238442|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Other|1|||
155238443|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Other|2|||
155238444|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Other|0|||
155238445|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Other|0|||
155238446|NCT00673049|560307205|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
155238447|NCT00673049|560307206|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
155238448|NCT00673049|560307207|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
155238449|NCT00673049|560307208|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
155238450|NCT00673049|560307205|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
155238451|NCT00673049|560307206|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
155238452|NCT00673049|560307207|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
155238453|NCT00673049|560307208|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
155238454|NCT00673049|560307205|FG000|After Progression on Erlotinib|Death|0|||
155238455|NCT00673049|560307206|FG001|After Progression on Erlotinib|Death|0|||
155238456|NCT00673049|560307207|FG002|After Progression on Erlotinib|Death|0|||
155238457|NCT00673049|560307208|FG003|After Progression on Erlotinib|Death|71|||
155238458|NCT00673049|560307205|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
155238459|NCT00673049|560307206|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
155238460|NCT00673049|560307207|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
155238461|NCT00673049|560307208|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
155238462|NCT00673049|560307205|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
155238463|NCT00673049|560307206|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
155238464|NCT00673049|560307207|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
155238465|NCT00673049|560307208|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
155238466|NCT00673049|560307205|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
155238467|NCT00673049|560307206|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
155238468|NCT00673049|560307207|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
155238469|NCT00673049|560307208|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
155238470|NCT01933334|560307215|FG000|Overall Study|Adverse Event|5|||
155238471|NCT01933334|560307216|FG001|Overall Study|Adverse Event|1|||
155238472|NCT01933334|560307215|FG000|Overall Study|Withdrawal by Subject|0|||
155238473|NCT01933334|560307216|FG001|Overall Study|Withdrawal by Subject|1|||
155238474|NCT02039505|560307217|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
155238475|NCT02039505|560307218|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
155238476|NCT02039505|560307219|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
155238477|NCT02039505|560307220|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238478|NCT02039505|560307221|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238479|NCT02039505|560307222|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238480|NCT02039505|560307223|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
155238481|NCT02039505|560307217|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
155238482|NCT02039505|560307218|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
155238483|NCT02039505|560307219|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
155238484|NCT02039505|560307220|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238485|NCT02039505|560307221|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238486|NCT02039505|560307222|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238487|NCT02039505|560307223|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
155238488|NCT02039505|560307217|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
155238489|NCT02039505|560307218|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238490|NCT02039505|560307219|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238491|NCT02039505|560307220|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238492|NCT02039505|560307221|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238493|NCT02039505|560307222|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238494|NCT02039505|560307223|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
155238495|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238496|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238497|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238498|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
155238499|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
155238500|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
155238501|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
155238502|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238503|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238504|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238505|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
155238506|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
155238507|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
155238508|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
155238509|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238510|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238511|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238512|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
155238513|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
155238514|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
155238515|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
155238516|NCT02039505|560307217|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238517|NCT02039505|560307218|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238518|NCT02039505|560307219|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238519|NCT02039505|560307220|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
155238520|NCT02039505|560307221|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238521|NCT02039505|560307222|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238522|NCT02039505|560307223|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
155238523|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238524|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238525|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238526|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238527|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238528|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
155238529|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
155238530|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238531|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238532|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238533|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238534|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238535|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
155238536|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
155238537|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238538|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238539|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238540|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238541|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238542|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
155238543|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
155238544|NCT02039505|560307217|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238545|NCT02039505|560307218|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238546|NCT02039505|560307219|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238547|NCT02039505|560307220|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238548|NCT02039505|560307221|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238549|NCT02039505|560307222|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
155238550|NCT02039505|560307223|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
155238551|NCT04265755|560307224|FG000|Overall Study|Withdrawal by Subject|39|||
155238552|NCT04265755|560307224|FG000|Overall Study|Decision by sponsor|2|||
155238553|NCT04265755|560307224|FG000|Overall Study|Lost to Follow-up|11|||
155238554|NCT04265755|560307224|FG000|Overall Study|Death|1|||
155238555|NCT01863446|560307227|FG000|Overall Study|Withdrawal by Subject|1|||
155238556|NCT01863446|560307228|FG001|Overall Study|Withdrawal by Subject|0|||
155238557|NCT01863446|560307229|FG002|Overall Study|Withdrawal by Subject|1|||
155238558|NCT01863446|560307230|FG003|Overall Study|Withdrawal by Subject|2|||
155238559|NCT01863446|560307227|FG000|Overall Study|Physician Decision|0|||
155238560|NCT01863446|560307228|FG001|Overall Study|Physician Decision|0|||
155238561|NCT01863446|560307229|FG002|Overall Study|Physician Decision|1|||
155238562|NCT01863446|560307230|FG003|Overall Study|Physician Decision|0|||
155238563|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
155238564|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
155238565|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
155238566|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
155238567|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
155238568|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
155238569|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Death|1|||
155238570|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Death|0|||
155238571|NCT02554773|560307231|FG000|Original Dose Regimen (SAS 1)|Other|4|||
155238572|NCT02554773|560307232|FG001|Original Dose Regimen (SAS 1)|Other|0|||
155238573|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
155238574|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
155238575|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
155238576|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
155238577|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
155238578|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
155238579|NCT02554773|560307231|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
155238580|NCT02554773|560307232|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
155238581|NCT01794949|560307237|FG000|Overall Study|Lost to Follow-up|1|||
155238582|NCT01794949|560307238|FG001|Overall Study|Lost to Follow-up|0|||
155238583|NCT04713748|560307247|FG000|Overall Study|Not enough kits allocated|35|||
155238584|NCT00406029|560307252|FG000|Overall Study|Adverse Event|12|||
155238585|NCT00406029|560307253|FG001|Overall Study|Adverse Event|2|||
155238586|NCT00406029|560307254|FG002|Overall Study|Adverse Event|5|||
155238587|NCT00406029|560307255|FG003|Overall Study|Adverse Event|10|||
155238588|NCT00406029|560307256|FG004|Overall Study|Adverse Event|7|||
155238589|NCT00406029|560307252|FG000|Overall Study|Withdrawal by Subject|3|||
155238590|NCT00406029|560307253|FG001|Overall Study|Withdrawal by Subject|4|||
155238591|NCT00406029|560307254|FG002|Overall Study|Withdrawal by Subject|2|||
155238592|NCT00406029|560307255|FG003|Overall Study|Withdrawal by Subject|2|||
155238593|NCT00406029|560307256|FG004|Overall Study|Withdrawal by Subject|0|||
155238594|NCT00406029|560307252|FG000|Overall Study|Protocol Violation|1|||
155238595|NCT00406029|560307253|FG001|Overall Study|Protocol Violation|2|||
155238596|NCT00406029|560307254|FG002|Overall Study|Protocol Violation|0|||
155238597|NCT00406029|560307255|FG003|Overall Study|Protocol Violation|2|||
155238598|NCT00406029|560307256|FG004|Overall Study|Protocol Violation|0|||
155238599|NCT00406029|560307252|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238600|NCT00406029|560307253|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238601|NCT00406029|560307254|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
155238602|NCT00406029|560307255|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238603|NCT00406029|560307256|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
155238604|NCT00406029|560307252|FG000|Overall Study|Randomized in Error|0|||
155238605|NCT00406029|560307253|FG001|Overall Study|Randomized in Error|0|||
155238606|NCT00406029|560307254|FG002|Overall Study|Randomized in Error|2|||
155238607|NCT00406029|560307255|FG003|Overall Study|Randomized in Error|3|||
155238608|NCT00406029|560307256|FG004|Overall Study|Randomized in Error|1|||
155238609|NCT00889421|560307257|FG000|Overall Study|Lack of Efficacy|3|||
155238610|NCT01958918|560307258|FG000|Overall Study|Death|1|||
155238611|NCT01958918|560307259|FG001|Overall Study|Death|3|||
155238612|NCT01958918|560307258|FG000|Overall Study|Lost to Follow-up|4|||
155238613|NCT01958918|560307259|FG001|Overall Study|Lost to Follow-up|7|||
155238614|NCT01958918|560307258|FG000|Overall Study|Withdrawal by Subject|13|||
155238615|NCT01958918|560307259|FG001|Overall Study|Withdrawal by Subject|8|||
155238616|NCT01958918|560307258|FG000|Overall Study|Lack of Efficacy|13|||
155238617|NCT01958918|560307259|FG001|Overall Study|Lack of Efficacy|10|||
155238618|NCT01958918|560307258|FG000|Overall Study|Adverse Event|12|||
155238619|NCT01958918|560307259|FG001|Overall Study|Adverse Event|12|||
155238620|NCT01958918|560307258|FG000|Overall Study|administrative problems|0|||
155238621|NCT01958918|560307259|FG001|Overall Study|administrative problems|2|||
155238622|NCT02114892|560307263|FG000|Overall Study|Lost to Follow-up|1|||
155238623|NCT02114892|560307264|FG001|Overall Study|Lost to Follow-up|2|||
155238624|NCT04479618|560307268|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
155238625|NCT04479618|560307269|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
155238626|NCT04479618|560307270|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
155238627|NCT04479618|560307268|FG000|Overall Study|Lack of Efficacy|1|||
155238628|NCT04479618|560307269|FG001|Overall Study|Lack of Efficacy|0|||
155238629|NCT04479618|560307270|FG002|Overall Study|Lack of Efficacy|0|||
155238630|NCT04479618|560307268|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
155238631|NCT04479618|560307269|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
155238632|NCT04479618|560307270|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
155238633|NCT04479618|560307268|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
155238634|NCT04479618|560307269|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
155238635|NCT04479618|560307270|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
155238636|NCT04479618|560307268|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
155238637|NCT04479618|560307269|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
155238638|NCT04479618|560307270|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
155238639|NCT04479618|560307268|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
155238640|NCT04479618|560307269|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
155238641|NCT04479618|560307270|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
155238642|NCT00659269|560307275|FG000|Overall Study|Physician Decision|1|||
155238643|NCT00659269|560307276|FG001|Overall Study|Physician Decision|1|||
155238644|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238645|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238646|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238647|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238648|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
155238649|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
155238650|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
155238651|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238652|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238653|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238654|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
155238655|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
155238656|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238657|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
155238658|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
155238659|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238660|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238661|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
155238662|NCT00718042|560307278|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238663|NCT00718042|560307279|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
155238664|NCT00718042|560307280|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238665|NCT00718042|560307281|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238666|NCT00718042|560307282|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238667|NCT00718042|560307283|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
155238668|NCT00718042|560307278|FG000|Donor Follow-up|Lost to Follow-up|13|||
155238669|NCT00718042|560307279|FG001|Donor Follow-up|Lost to Follow-up|0|||
155238670|NCT00718042|560307280|FG002|Donor Follow-up|Lost to Follow-up|0|||
155238671|NCT00718042|560307281|FG003|Donor Follow-up|Lost to Follow-up|0|||
155238672|NCT00718042|560307282|FG004|Donor Follow-up|Lost to Follow-up|19|||
155238673|NCT00718042|560307283|FG005|Donor Follow-up|Lost to Follow-up|0|||
155238674|NCT04327934|560307284|FG000|Overall Study|Did not qualify|7|||
155238675|NCT04327934|560307285|FG001|Overall Study|Did not qualify|4|||
155238676|NCT04327934|560307284|FG000|Overall Study|Physician Decision|0|||
155238677|NCT04327934|560307285|FG001|Overall Study|Physician Decision|1|||
155238678|NCT02443298|560307286|FG000|Overall Study|Adverse Event|3|||
155238679|NCT02443298|560307287|FG001|Overall Study|Adverse Event|3|||
155238680|NCT02443298|560307286|FG000|Overall Study|Withdrawal by Subject|1|||
155238681|NCT02443298|560307287|FG001|Overall Study|Withdrawal by Subject|2|||
155238682|NCT01877421|560307288|FG000|Phase 2|Lost to Follow-up|0|||
155238683|NCT01877421|560307289|FG001|Phase 2|Lost to Follow-up|0|||
155238684|NCT01877421|560307290|FG002|Phase 2|Lost to Follow-up|0|||
155238685|NCT01877421|560307291|FG003|Phase 2|Lost to Follow-up|0|||
155238686|NCT01877421|560307292|FG004|Phase 2|Lost to Follow-up|0|||
155238687|NCT01877421|560307293|FG005|Phase 2|Lost to Follow-up|0|||
155238688|NCT01877421|560307294|FG006|Phase 2|Lost to Follow-up|1|||
155238689|NCT01877421|560307295|FG007|Phase 2|Lost to Follow-up|0|||
155238690|NCT01877421|560307296|FG008|Phase 2|Lost to Follow-up|0|||
155238691|NCT01877421|560307297|FG009|Phase 2|Lost to Follow-up|0|||
155238692|NCT01877421|560307298|FG010|Phase 2|Lost to Follow-up|0|||
155238693|NCT01877421|560307299|FG011|Phase 2|Lost to Follow-up|0|||
155238694|NCT01877421|560307300|FG012|Phase 2|Lost to Follow-up|0|||
155238695|NCT01877421|560307301|FG013|Phase 2|Lost to Follow-up|0|||
155238696|NCT01877421|560307302|FG014|Phase 2|Lost to Follow-up|0|||
155238697|NCT01877421|560307303|FG015|Phase 2|Lost to Follow-up|0|||
155238698|NCT01877421|560307304|FG016|Phase 2|Lost to Follow-up|0|||
155238699|NCT01877421|560307305|FG017|Phase 2|Lost to Follow-up|0|||
155238700|NCT01877421|560307288|FG000|Phase 2|Withdrawal by Subject|0|||
155238701|NCT01877421|560307289|FG001|Phase 2|Withdrawal by Subject|0|||
155238702|NCT01877421|560307290|FG002|Phase 2|Withdrawal by Subject|0|||
155238703|NCT01877421|560307291|FG003|Phase 2|Withdrawal by Subject|0|||
155238704|NCT01877421|560307292|FG004|Phase 2|Withdrawal by Subject|0|||
155238705|NCT01877421|560307293|FG005|Phase 2|Withdrawal by Subject|0|||
155238706|NCT01877421|560307294|FG006|Phase 2|Withdrawal by Subject|0|||
155238707|NCT01877421|560307295|FG007|Phase 2|Withdrawal by Subject|0|||
155238708|NCT01877421|560307296|FG008|Phase 2|Withdrawal by Subject|1|||
155238709|NCT01877421|560307297|FG009|Phase 2|Withdrawal by Subject|0|||
155238710|NCT01877421|560307298|FG010|Phase 2|Withdrawal by Subject|1|||
155238711|NCT01877421|560307299|FG011|Phase 2|Withdrawal by Subject|0|||
155238712|NCT01877421|560307300|FG012|Phase 2|Withdrawal by Subject|1|||
155238713|NCT01877421|560307301|FG013|Phase 2|Withdrawal by Subject|0|||
155238714|NCT01877421|560307302|FG014|Phase 2|Withdrawal by Subject|0|||
155238715|NCT01877421|560307303|FG015|Phase 2|Withdrawal by Subject|1|||
155238716|NCT01877421|560307304|FG016|Phase 2|Withdrawal by Subject|0|||
155238717|NCT01877421|560307305|FG017|Phase 2|Withdrawal by Subject|0|||
155238718|NCT01877421|560307288|FG000|Phase 2|Protocol Violation|0|||
155238719|NCT01877421|560307289|FG001|Phase 2|Protocol Violation|0|||
155238720|NCT01877421|560307290|FG002|Phase 2|Protocol Violation|0|||
155238721|NCT01877421|560307291|FG003|Phase 2|Protocol Violation|0|||
155238722|NCT01877421|560307292|FG004|Phase 2|Protocol Violation|0|||
155238723|NCT01877421|560307293|FG005|Phase 2|Protocol Violation|0|||
155238724|NCT01877421|560307294|FG006|Phase 2|Protocol Violation|0|||
155238725|NCT01877421|560307295|FG007|Phase 2|Protocol Violation|0|||
155238726|NCT01877421|560307296|FG008|Phase 2|Protocol Violation|0|||
155238727|NCT01877421|560307297|FG009|Phase 2|Protocol Violation|0|||
155238728|NCT01877421|560307298|FG010|Phase 2|Protocol Violation|1|||
155238729|NCT01877421|560307299|FG011|Phase 2|Protocol Violation|0|||
155238730|NCT01877421|560307300|FG012|Phase 2|Protocol Violation|0|||
155238731|NCT01877421|560307301|FG013|Phase 2|Protocol Violation|0|||
155238732|NCT01877421|560307302|FG014|Phase 2|Protocol Violation|0|||
155238733|NCT01877421|560307303|FG015|Phase 2|Protocol Violation|0|||
155238734|NCT01877421|560307304|FG016|Phase 2|Protocol Violation|0|||
155238735|NCT01877421|560307305|FG017|Phase 2|Protocol Violation|0|||
155238736|NCT00908960|560307318|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
155238737|NCT00908960|560307319|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
155238738|NCT00908960|560307320|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
155238739|NCT01158924|560307321|FG000|Overall Study|Withdrawal by Subject|1|||
155238740|NCT01158924|560307322|FG001|Overall Study|Withdrawal by Subject|2|||
155238741|NCT01158924|560307321|FG000|Overall Study|Lost to Follow-up|0|||
155238742|NCT01158924|560307322|FG001|Overall Study|Lost to Follow-up|1|||
155238743|NCT03795922|560307323|FG000|Overall Study|Adverse Event|2|||
155238744|NCT03795922|560307324|FG001|Overall Study|Adverse Event|1|||
155238745|NCT03795922|560307323|FG000|Overall Study|Withdrawal by Subject|5|||
155238746|NCT03795922|560307324|FG001|Overall Study|Withdrawal by Subject|13|||
155238747|NCT03795922|560307323|FG000|Overall Study|Lost to Follow-up|2|||
155238748|NCT03795922|560307324|FG001|Overall Study|Lost to Follow-up|3|||
155238749|NCT03795922|560307323|FG000|Overall Study|Pregnancy|0|||
155238750|NCT03795922|560307324|FG001|Overall Study|Pregnancy|1|||
155238751|NCT03795922|560307323|FG000|Overall Study|Physician Decision|1|||
155238752|NCT03795922|560307324|FG001|Overall Study|Physician Decision|2|||
155238753|NCT03795922|560307323|FG000|Overall Study|Protocol Violation|0|||
155238754|NCT03795922|560307324|FG001|Overall Study|Protocol Violation|1|||
155238755|NCT03795922|560307323|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
155238756|NCT03795922|560307324|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
155238757|NCT04788147|560307325|FG000|Overall Study|Screen Failure|3|||
155238758|NCT04788147|560307326|FG001|Overall Study|Screen Failure|10|||
155238759|NCT04788147|560307325|FG000|Overall Study|Incomplete RMRS image session|2|||
155238760|NCT04788147|560307326|FG001|Overall Study|Incomplete RMRS image session|0|||
155238761|NCT00781326|560307329|FG000|Phase I|Adverse Event|1|||
155238762|NCT00781326|560307329|FG000|Phase I|Withdrawal by Subject|1|||
155238763|NCT00781326|560307329|FG000|Phase I|Physician Decision|2|||
155238764|NCT05101252|560307330|FG000|Overall Study|Unsatisfactory Test Article|1|||
155238765|NCT05101252|560307331|FG001|Overall Study|Unsatisfactory Test Article|0|||
155238766|NCT05101252|560307330|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155238767|NCT05101252|560307331|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
155238768|NCT05101252|560307330|FG000|Overall Study|Withdrew Consent during study|0|||
155238769|NCT05101252|560307331|FG001|Overall Study|Withdrew Consent during study|1|||
155238770|NCT05101252|560307330|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
155238771|NCT05101252|560307331|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
155238772|NCT03732248|560307332|FG000|Overall Study|Withdrawal by Subject|1|||
155238773|NCT03732248|560307333|FG001|Overall Study|Withdrawal by Subject|0|||
155238774|NCT02266381|560307334|FG000|Overall Study|Physician Decision|3|||
155238775|NCT02266381|560307335|FG001|Overall Study|Physician Decision|5|||
155238776|NCT02266381|560307336|FG002|Overall Study|Physician Decision|4|||
155238777|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
155238778|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
155238779|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
155238780|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
155238781|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
155238782|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
155238783|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
155238784|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
155238785|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
155238786|NCT00403546|560307339|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
155238787|NCT00403546|560307340|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
155238788|NCT00403546|560307341|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
155238789|NCT00403546|560307339|FG000|Screening Phase|Screening Failure|22|||
155238790|NCT00403546|560307340|FG001|Screening Phase|Screening Failure|0|||
155238791|NCT00403546|560307341|FG002|Screening Phase|Screening Failure|0|||
155238792|NCT00403546|560307339|FG000|Screening Phase|Adverse Event|1|||
155238793|NCT00403546|560307340|FG001|Screening Phase|Adverse Event|0|||
155238794|NCT00403546|560307341|FG002|Screening Phase|Adverse Event|0|||
155238795|NCT00403546|560307339|FG000|Screening Phase|Terminated Prior to Randomization|5|||
155238796|NCT00403546|560307340|FG001|Screening Phase|Terminated Prior to Randomization|0|||
155238797|NCT00403546|560307341|FG002|Screening Phase|Terminated Prior to Randomization|0|||
155238798|NCT00403546|560307339|FG000|Randomized Trial|Early Terminations|0|||
155238799|NCT00403546|560307340|FG001|Randomized Trial|Early Terminations|17|||
155238800|NCT00403546|560307341|FG002|Randomized Trial|Early Terminations|16|||
155238801|NCT00793910|560307342|FG000|Overall Study|discarded study pills|0|||
155238802|NCT00793910|560307343|FG001|Overall Study|discarded study pills|1|||
155238803|NCT00793910|560307342|FG000|Overall Study|did not pick up medications|1|||
155238804|NCT00793910|560307343|FG001|Overall Study|did not pick up medications|1|||
155238805|NCT00793910|560307342|FG000|Overall Study|ineligible based on entry criteria|2|||
155238806|NCT00793910|560307343|FG001|Overall Study|ineligible based on entry criteria|3|||
155238807|NCT00793910|560307342|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
155238808|NCT00793910|560307343|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
155238809|NCT00793910|560307342|FG000|Overall Study|Withdrawal by Subject|0|||
155238810|NCT00793910|560307343|FG001|Overall Study|Withdrawal by Subject|1|||
155238811|NCT03634579|560307346|FG000|Overall Study|study termination|9|||
155238812|NCT02480621|560307347|FG000|Randomization|Withdrawal by Subject|1|||
155238813|NCT02480621|560307348|FG001|Randomization|Withdrawal by Subject|0|||
155238814|NCT02480621|560307347|FG000|Randomization|Surgeon did not give intervention|0|||
155238815|NCT02480621|560307348|FG001|Randomization|Surgeon did not give intervention|1|||
155238816|NCT02480621|560307347|FG000|Follow Up|Lost to Follow-up|4|||
155238817|NCT02480621|560307348|FG001|Follow Up|Lost to Follow-up|2|||
155238818|NCT00235989|560307349|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238819|NCT00235989|560307350|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238820|NCT00235989|560307351|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238821|NCT00235989|560307352|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238822|NCT00235989|560307353|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
155238823|NCT00235989|560307354|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
155238824|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
155238825|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
155238826|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
155238827|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
155238828|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
155238829|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
155238830|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
155238831|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238832|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
155238833|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238834|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238835|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
155238836|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
155238837|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
155238838|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
155238839|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
155238840|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
155238841|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
155238842|NCT00235989|560307349|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
155238843|NCT00235989|560307350|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
155238844|NCT00235989|560307351|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
155238845|NCT00235989|560307352|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
155238846|NCT00235989|560307353|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
155238847|NCT00235989|560307354|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
155238848|NCT06748040|560307365|FG000|Overall Study|Death|3|||
155238849|NCT06748040|560307366|FG001|Overall Study|Death|4|||
155238850|NCT06748040|560307365|FG000|Overall Study|Lost to Follow-up|134|||
155238851|NCT06748040|560307366|FG001|Overall Study|Lost to Follow-up|132|||
155238852|NCT06748040|560307365|FG000|Overall Study|Withdrawal by Subject|3|||
155238853|NCT06748040|560307366|FG001|Overall Study|Withdrawal by Subject|5|||
155238854|NCT01782131|560309293|FG000|Overall Study|Death|93|||
155238855|NCT01782131|560309294|FG001|Overall Study|Death|96|||
155238856|NCT01782131|560309293|FG000|Overall Study|Lost to Follow-up|1|||
155238857|NCT01782131|560309294|FG001|Overall Study|Lost to Follow-up|3|||
155238858|NCT01782131|560309293|FG000|Overall Study|Withdrawal by Subject|10|||
155238859|NCT01782131|560309294|FG001|Overall Study|Withdrawal by Subject|10|||
155238860|NCT01782131|560309293|FG000|Overall Study|Randomized but not treated|5|||
155238861|NCT01782131|560309294|FG001|Overall Study|Randomized but not treated|5|||
155238862|NCT01782131|560309293|FG000|Overall Study|Reason not provided|0|||
155238863|NCT01782131|560309294|FG001|Overall Study|Reason not provided|1|||
155238864|NCT01627249|560309295|FG000|Overall Study|Death|3|||
155238865|NCT01627249|560309296|FG001|Overall Study|Death|5|||
155238866|NCT01627249|560309297|FG002|Overall Study|Death|3|||
155238867|NCT01627249|560309295|FG000|Overall Study|Withdrawal by Subject|12|||
155238868|NCT01627249|560309296|FG001|Overall Study|Withdrawal by Subject|6|||
155238869|NCT01627249|560309297|FG002|Overall Study|Withdrawal by Subject|9|||
155238870|NCT01627249|560309295|FG000|Overall Study|Missed Visit|1|||
155238871|NCT01627249|560309296|FG001|Overall Study|Missed Visit|1|||
155238872|NCT01627249|560309297|FG002|Overall Study|Missed Visit|0|||
155238873|NCT00796718|560309298|FG000|Overall Study|Adverse Event|2|||
155238874|NCT00796718|560309298|FG000|Overall Study|Exclusion Criteria|1|||
155238875|NCT00796718|560309298|FG000|Overall Study|Lost to Follow-up|5|||
155238876|NCT00796718|560309298|FG000|Overall Study|Withdrawal by Informed Consent|1|||
155238877|NCT02318329|560309302|FG000|Overall Study|Progressive Disease|2|||
155238878|NCT02318329|560309303|FG001|Overall Study|Progressive Disease|3|||
155238879|NCT02318329|560309304|FG002|Overall Study|Progressive Disease|2|||
155238880|NCT02318329|560309305|FG003|Overall Study|Progressive Disease|3|||
155238881|NCT02318329|560309306|FG004|Overall Study|Progressive Disease|3|||
155238882|NCT02318329|560309307|FG005|Overall Study|Progressive Disease|3|||
155238883|NCT02318329|560309308|FG006|Overall Study|Progressive Disease|1|||
155238884|NCT02318329|560309309|FG007|Overall Study|Progressive Disease|1|||
155238885|NCT02318329|560309310|FG008|Overall Study|Progressive Disease|5|||
155238886|NCT02318329|560309311|FG009|Overall Study|Progressive Disease|39|||
155238887|NCT02318329|560309302|FG000|Overall Study|Death|0|||
155238888|NCT02318329|560309303|FG001|Overall Study|Death|0|||
155238889|NCT02318329|560309304|FG002|Overall Study|Death|0|||
155238890|NCT02318329|560309305|FG003|Overall Study|Death|0|||
155238891|NCT02318329|560309306|FG004|Overall Study|Death|0|||
155238892|NCT02318329|560309307|FG005|Overall Study|Death|0|||
155238893|NCT02318329|560309308|FG006|Overall Study|Death|0|||
155238894|NCT02318329|560309309|FG007|Overall Study|Death|0|||
155238895|NCT02318329|560309310|FG008|Overall Study|Death|0|||
155238896|NCT02318329|560309311|FG009|Overall Study|Death|5|||
155238897|NCT02318329|560309302|FG000|Overall Study|Lost to Follow-up|0|||
155238898|NCT02318329|560309303|FG001|Overall Study|Lost to Follow-up|0|||
155238899|NCT02318329|560309304|FG002|Overall Study|Lost to Follow-up|0|||
155238900|NCT02318329|560309305|FG003|Overall Study|Lost to Follow-up|0|||
155238901|NCT02318329|560309306|FG004|Overall Study|Lost to Follow-up|0|||
155238902|NCT02318329|560309307|FG005|Overall Study|Lost to Follow-up|0|||
155238903|NCT02318329|560309308|FG006|Overall Study|Lost to Follow-up|0|||
155238904|NCT02318329|560309309|FG007|Overall Study|Lost to Follow-up|0|||
155238905|NCT02318329|560309310|FG008|Overall Study|Lost to Follow-up|0|||
155238906|NCT02318329|560309311|FG009|Overall Study|Lost to Follow-up|1|||
155238907|NCT02318329|560309302|FG000|Overall Study|Withdrawal by Subject|0|||
155238908|NCT02318329|560309303|FG001|Overall Study|Withdrawal by Subject|0|||
155238909|NCT02318329|560309304|FG002|Overall Study|Withdrawal by Subject|0|||
155238910|NCT02318329|560309305|FG003|Overall Study|Withdrawal by Subject|0|||
155238911|NCT02318329|560309306|FG004|Overall Study|Withdrawal by Subject|0|||
155238912|NCT02318329|560309307|FG005|Overall Study|Withdrawal by Subject|0|||
155238913|NCT02318329|560309308|FG006|Overall Study|Withdrawal by Subject|0|||
155238914|NCT02318329|560309309|FG007|Overall Study|Withdrawal by Subject|0|||
155238915|NCT02318329|560309310|FG008|Overall Study|Withdrawal by Subject|0|||
155238916|NCT02318329|560309311|FG009|Overall Study|Withdrawal by Subject|6|||
155238917|NCT02318329|560309302|FG000|Overall Study|Other|1|||
155238918|NCT02318329|560309303|FG001|Overall Study|Other|1|||
155238919|NCT02318329|560309304|FG002|Overall Study|Other|1|||
155238920|NCT02318329|560309305|FG003|Overall Study|Other|0|||
155238921|NCT02318329|560309306|FG004|Overall Study|Other|0|||
155238922|NCT02318329|560309307|FG005|Overall Study|Other|0|||
155238923|NCT02318329|560309308|FG006|Overall Study|Other|0|||
155238924|NCT02318329|560309309|FG007|Overall Study|Other|0|||
155238925|NCT02318329|560309310|FG008|Overall Study|Other|1|||
155238926|NCT02318329|560309311|FG009|Overall Study|Other|1|||
155238927|NCT02044510|560309312|FG000|Overall Study|Adverse Event|1|||
155238928|NCT02044510|560309313|FG001|Overall Study|Adverse Event|2|||
155238929|NCT02979535|560309316|FG000|Overall Study|Non compliance with the protocol|78|||
155238930|NCT02979535|560309317|FG001|Overall Study|Non compliance with the protocol|82|||
155238931|NCT02979535|560309316|FG000|Overall Study|Consent withdrawn by participant|11|||
155238932|NCT02979535|560309317|FG001|Overall Study|Consent withdrawn by participant|18|||
155238933|NCT02979535|560309316|FG000|Overall Study|Lost to Follow-up|6|||
155238934|NCT02979535|560309317|FG001|Overall Study|Lost to Follow-up|1|||
155238935|NCT00767000|560309320|FG000|54-week Study|Adverse Event|4|||
155238936|NCT00767000|560309321|FG001|54-week Study|Adverse Event|6|||
155238937|NCT00767000|560309322|FG002|54-week Study|Adverse Event|6|||
155238938|NCT00767000|560309323|FG003|54-week Study|Adverse Event|8|||
155238939|NCT00767000|560309324|FG004|54-week Study|Adverse Event|4|||
155238940|NCT00767000|560309320|FG000|54-week Study|Creaninine/creatinine clearance|2|||
155238941|NCT00767000|560309321|FG001|54-week Study|Creaninine/creatinine clearance|1|||
155238942|NCT00767000|560309322|FG002|54-week Study|Creaninine/creatinine clearance|2|||
155238943|NCT00767000|560309323|FG003|54-week Study|Creaninine/creatinine clearance|2|||
155238944|NCT00767000|560309324|FG004|54-week Study|Creaninine/creatinine clearance|4|||
155238945|NCT00767000|560309320|FG000|54-week Study|Hyperglycemia|0|||
155238946|NCT00767000|560309321|FG001|54-week Study|Hyperglycemia|0|||
155238947|NCT00767000|560309322|FG002|54-week Study|Hyperglycemia|1|||
155238948|NCT00767000|560309323|FG003|54-week Study|Hyperglycemia|0|||
155238949|NCT00767000|560309324|FG004|54-week Study|Hyperglycemia|1|||
155238950|NCT00767000|560309320|FG000|54-week Study|Hypoglycemia|0|||
155238951|NCT00767000|560309321|FG001|54-week Study|Hypoglycemia|1|||
155238952|NCT00767000|560309322|FG002|54-week Study|Hypoglycemia|0|||
155238953|NCT00767000|560309323|FG003|54-week Study|Hypoglycemia|0|||
155238954|NCT00767000|560309324|FG004|54-week Study|Hypoglycemia|0|||
155238955|NCT00767000|560309320|FG000|54-week Study|Interruption of study medication|0|||
155238956|NCT00767000|560309321|FG001|54-week Study|Interruption of study medication|0|||
155238957|NCT00767000|560309322|FG002|54-week Study|Interruption of study medication|1|||
155238958|NCT00767000|560309323|FG003|54-week Study|Interruption of study medication|0|||
155238959|NCT00767000|560309324|FG004|54-week Study|Interruption of study medication|0|||
155238960|NCT00767000|560309320|FG000|54-week Study|Lack of Efficacy|2|||
155238961|NCT00767000|560309321|FG001|54-week Study|Lack of Efficacy|0|||
155238962|NCT00767000|560309322|FG002|54-week Study|Lack of Efficacy|1|||
155238963|NCT00767000|560309323|FG003|54-week Study|Lack of Efficacy|0|||
155238964|NCT00767000|560309324|FG004|54-week Study|Lack of Efficacy|5|||
155238965|NCT00767000|560309320|FG000|54-week Study|Lost to Follow-up|4|||
155238966|NCT00767000|560309321|FG001|54-week Study|Lost to Follow-up|0|||
155238967|NCT00767000|560309322|FG002|54-week Study|Lost to Follow-up|1|||
155238968|NCT00767000|560309323|FG003|54-week Study|Lost to Follow-up|4|||
155238969|NCT00767000|560309324|FG004|54-week Study|Lost to Follow-up|2|||
155238970|NCT00767000|560309320|FG000|54-week Study|Physician Decision|4|||
155238971|NCT00767000|560309321|FG001|54-week Study|Physician Decision|0|||
155238972|NCT00767000|560309322|FG002|54-week Study|Physician Decision|1|||
155238973|NCT00767000|560309323|FG003|54-week Study|Physician Decision|1|||
155238974|NCT00767000|560309324|FG004|54-week Study|Physician Decision|1|||
155238975|NCT00767000|560309320|FG000|54-week Study|Progressive disease|0|||
155238976|NCT00767000|560309321|FG001|54-week Study|Progressive disease|0|||
155238977|NCT00767000|560309322|FG002|54-week Study|Progressive disease|1|||
155238978|NCT00767000|560309323|FG003|54-week Study|Progressive disease|0|||
155238979|NCT00767000|560309324|FG004|54-week Study|Progressive disease|0|||
155238980|NCT00767000|560309320|FG000|54-week Study|Protocol Violation|0|||
155238981|NCT00767000|560309321|FG001|54-week Study|Protocol Violation|0|||
155238982|NCT00767000|560309322|FG002|54-week Study|Protocol Violation|1|||
155238983|NCT00767000|560309323|FG003|54-week Study|Protocol Violation|2|||
155238984|NCT00767000|560309324|FG004|54-week Study|Protocol Violation|0|||
155238985|NCT00767000|560309320|FG000|54-week Study|Withdrawal by Subject|2|||
155238986|NCT00767000|560309321|FG001|54-week Study|Withdrawal by Subject|3|||
155238987|NCT00767000|560309322|FG002|54-week Study|Withdrawal by Subject|5|||
155238988|NCT00767000|560309323|FG003|54-week Study|Withdrawal by Subject|11|||
155238989|NCT00767000|560309324|FG004|54-week Study|Withdrawal by Subject|13|||
155238990|NCT00767000|560309320|FG000|54-week Study|Study terminated by sponsor|90|||
155238991|NCT00767000|560309321|FG001|54-week Study|Study terminated by sponsor|102|||
155238992|NCT00767000|560309322|FG002|54-week Study|Study terminated by sponsor|89|||
155238993|NCT00767000|560309323|FG003|54-week Study|Study terminated by sponsor|196|||
155238994|NCT00767000|560309324|FG004|54-week Study|Study terminated by sponsor|194|||
155238995|NCT00767000|560309320|FG000|54-week Study|Reason not reported|0|||
155238996|NCT00767000|560309321|FG001|54-week Study|Reason not reported|0|||
155238997|NCT00767000|560309322|FG002|54-week Study|Reason not reported|0|||
155238998|NCT00767000|560309323|FG003|54-week Study|Reason not reported|1|||
155238999|NCT00767000|560309324|FG004|54-week Study|Reason not reported|0|||
155239000|NCT00767000|560309320|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
155239001|NCT00767000|560309321|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
155239002|NCT00767000|560309322|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
155239003|NCT00767000|560309323|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
155239004|NCT00767000|560309324|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
155239005|NCT01722331|560309326|FG000|Part 1|Adverse Event|5|||
155239006|NCT01722331|560309327|FG001|Part 1|Adverse Event|0|||
155239007|NCT01722331|560309328|FG002|Part 1|Adverse Event|0|||
155239008|NCT01722331|560309329|FG003|Part 1|Adverse Event|0|||
155239009|NCT01722331|560309330|FG004|Part 1|Adverse Event|0|||
155239010|NCT01722331|560309331|FG005|Part 1|Adverse Event|0|||
155239011|NCT01722331|560309332|FG006|Part 1|Adverse Event|0|||
155239012|NCT01722331|560309326|FG000|Part 1|Lack of Efficacy|0|||
155239013|NCT01722331|560309327|FG001|Part 1|Lack of Efficacy|0|||
155239014|NCT01722331|560309328|FG002|Part 1|Lack of Efficacy|1|||
155239015|NCT01722331|560309329|FG003|Part 1|Lack of Efficacy|0|||
155239016|NCT01722331|560309330|FG004|Part 1|Lack of Efficacy|2|||
155239017|NCT01722331|560309331|FG005|Part 1|Lack of Efficacy|0|||
155239018|NCT01722331|560309332|FG006|Part 1|Lack of Efficacy|0|||
155239019|NCT01722331|560309326|FG000|Part 1|Lost to Follow-up|1|||
155239020|NCT01722331|560309327|FG001|Part 1|Lost to Follow-up|0|||
155239021|NCT01722331|560309328|FG002|Part 1|Lost to Follow-up|2|||
155239022|NCT01722331|560309329|FG003|Part 1|Lost to Follow-up|0|||
155239023|NCT01722331|560309330|FG004|Part 1|Lost to Follow-up|1|||
155239024|NCT01722331|560309331|FG005|Part 1|Lost to Follow-up|0|||
155239025|NCT01722331|560309332|FG006|Part 1|Lost to Follow-up|0|||
155239026|NCT01722331|560309326|FG000|Part 1|Physician Decision|0|||
155239027|NCT01722331|560309327|FG001|Part 1|Physician Decision|0|||
155239028|NCT01722331|560309328|FG002|Part 1|Physician Decision|3|||
155239029|NCT01722331|560309329|FG003|Part 1|Physician Decision|0|||
155239030|NCT01722331|560309330|FG004|Part 1|Physician Decision|1|||
155239031|NCT01722331|560309331|FG005|Part 1|Physician Decision|0|||
155239032|NCT01722331|560309332|FG006|Part 1|Physician Decision|0|||
155239033|NCT01722331|560309326|FG000|Part 1|Pregnancy|1|||
155239034|NCT01722331|560309327|FG001|Part 1|Pregnancy|0|||
155239035|NCT01722331|560309328|FG002|Part 1|Pregnancy|0|||
155239036|NCT01722331|560309329|FG003|Part 1|Pregnancy|0|||
155239037|NCT01722331|560309330|FG004|Part 1|Pregnancy|0|||
155239038|NCT01722331|560309331|FG005|Part 1|Pregnancy|0|||
155239039|NCT01722331|560309332|FG006|Part 1|Pregnancy|0|||
155239040|NCT01722331|560309326|FG000|Part 1|Progressive Disease|0|||
155239041|NCT01722331|560309327|FG001|Part 1|Progressive Disease|0|||
155239042|NCT01722331|560309328|FG002|Part 1|Progressive Disease|0|||
155239043|NCT01722331|560309329|FG003|Part 1|Progressive Disease|0|||
155239044|NCT01722331|560309330|FG004|Part 1|Progressive Disease|1|||
155239045|NCT01722331|560309331|FG005|Part 1|Progressive Disease|0|||
155239046|NCT01722331|560309332|FG006|Part 1|Progressive Disease|0|||
155239047|NCT01722331|560309326|FG000|Part 1|Protocol Violation|1|||
155239048|NCT01722331|560309327|FG001|Part 1|Protocol Violation|0|||
155239049|NCT01722331|560309328|FG002|Part 1|Protocol Violation|0|||
155239050|NCT01722331|560309329|FG003|Part 1|Protocol Violation|0|||
155239051|NCT01722331|560309330|FG004|Part 1|Protocol Violation|1|||
155239052|NCT01722331|560309331|FG005|Part 1|Protocol Violation|0|||
155239053|NCT01722331|560309332|FG006|Part 1|Protocol Violation|0|||
155239054|NCT01722331|560309326|FG000|Part 1|Withdrawal by Subject|2|||
155239055|NCT01722331|560309327|FG001|Part 1|Withdrawal by Subject|0|||
155239056|NCT01722331|560309328|FG002|Part 1|Withdrawal by Subject|3|||
155239057|NCT01722331|560309329|FG003|Part 1|Withdrawal by Subject|0|||
155239058|NCT01722331|560309330|FG004|Part 1|Withdrawal by Subject|3|||
155239059|NCT01722331|560309331|FG005|Part 1|Withdrawal by Subject|0|||
155239060|NCT01722331|560309332|FG006|Part 1|Withdrawal by Subject|0|||
155239061|NCT01722331|560309326|FG000|Part 2|Adverse Event|3|||
155239062|NCT01722331|560309327|FG001|Part 2|Adverse Event|0|||
155239063|NCT01722331|560309328|FG002|Part 2|Adverse Event|0|||
155239064|NCT01722331|560309329|FG003|Part 2|Adverse Event|0|||
155239065|NCT01722331|560309330|FG004|Part 2|Adverse Event|0|||
155239066|NCT01722331|560309331|FG005|Part 2|Adverse Event|1|||
155239067|NCT01722331|560309332|FG006|Part 2|Adverse Event|0|||
155239068|NCT01722331|560309326|FG000|Part 2|Lack of Efficacy|3|||
155239069|NCT01722331|560309327|FG001|Part 2|Lack of Efficacy|0|||
155239070|NCT01722331|560309328|FG002|Part 2|Lack of Efficacy|11|||
155239071|NCT01722331|560309329|FG003|Part 2|Lack of Efficacy|0|||
155239072|NCT01722331|560309330|FG004|Part 2|Lack of Efficacy|0|||
155239073|NCT01722331|560309331|FG005|Part 2|Lack of Efficacy|3|||
155239074|NCT01722331|560309332|FG006|Part 2|Lack of Efficacy|3|||
155239075|NCT01722331|560309326|FG000|Part 2|Lost to Follow-up|0|||
155239076|NCT01722331|560309327|FG001|Part 2|Lost to Follow-up|0|||
155239077|NCT01722331|560309328|FG002|Part 2|Lost to Follow-up|3|||
155239078|NCT01722331|560309329|FG003|Part 2|Lost to Follow-up|0|||
155239079|NCT01722331|560309330|FG004|Part 2|Lost to Follow-up|0|||
155239080|NCT01722331|560309331|FG005|Part 2|Lost to Follow-up|1|||
155239081|NCT01722331|560309332|FG006|Part 2|Lost to Follow-up|1|||
155239082|NCT01722331|560309326|FG000|Part 2|Non-Compliance with Study Drug|1|||
155239083|NCT01722331|560309327|FG001|Part 2|Non-Compliance with Study Drug|0|||
155239084|NCT01722331|560309328|FG002|Part 2|Non-Compliance with Study Drug|1|||
155239085|NCT01722331|560309329|FG003|Part 2|Non-Compliance with Study Drug|0|||
155239086|NCT01722331|560309330|FG004|Part 2|Non-Compliance with Study Drug|0|||
155239087|NCT01722331|560309331|FG005|Part 2|Non-Compliance with Study Drug|0|||
155239088|NCT01722331|560309332|FG006|Part 2|Non-Compliance with Study Drug|0|||
155239089|NCT01722331|560309326|FG000|Part 2|Physician Decision|0|||
155239090|NCT01722331|560309327|FG001|Part 2|Physician Decision|0|||
155239091|NCT01722331|560309328|FG002|Part 2|Physician Decision|2|||
155239092|NCT01722331|560309329|FG003|Part 2|Physician Decision|0|||
155239093|NCT01722331|560309330|FG004|Part 2|Physician Decision|0|||
155239094|NCT01722331|560309331|FG005|Part 2|Physician Decision|0|||
155239095|NCT01722331|560309332|FG006|Part 2|Physician Decision|0|||
155239096|NCT01722331|560309326|FG000|Part 2|Pregnancy|0|||
155239097|NCT01722331|560309327|FG001|Part 2|Pregnancy|0|||
155239098|NCT01722331|560309328|FG002|Part 2|Pregnancy|0|||
155239099|NCT01722331|560309329|FG003|Part 2|Pregnancy|0|||
155239100|NCT01722331|560309330|FG004|Part 2|Pregnancy|0|||
155239101|NCT01722331|560309331|FG005|Part 2|Pregnancy|1|||
155239102|NCT01722331|560309332|FG006|Part 2|Pregnancy|0|||
155239103|NCT01722331|560309326|FG000|Part 2|Progressive Disease|0|||
155239104|NCT01722331|560309327|FG001|Part 2|Progressive Disease|0|||
155239105|NCT01722331|560309328|FG002|Part 2|Progressive Disease|1|||
155239106|NCT01722331|560309329|FG003|Part 2|Progressive Disease|0|||
155239107|NCT01722331|560309330|FG004|Part 2|Progressive Disease|0|||
155239108|NCT01722331|560309331|FG005|Part 2|Progressive Disease|0|||
155239109|NCT01722331|560309332|FG006|Part 2|Progressive Disease|0|||
155239110|NCT01722331|560309326|FG000|Part 2|Protocol Violation|1|||
155239111|NCT01722331|560309327|FG001|Part 2|Protocol Violation|0|||
155239112|NCT01722331|560309328|FG002|Part 2|Protocol Violation|0|||
155239113|NCT01722331|560309329|FG003|Part 2|Protocol Violation|0|||
155239114|NCT01722331|560309330|FG004|Part 2|Protocol Violation|0|||
155239115|NCT01722331|560309331|FG005|Part 2|Protocol Violation|0|||
155239116|NCT01722331|560309332|FG006|Part 2|Protocol Violation|0|||
155239117|NCT01722331|560309326|FG000|Part 2|Withdrawal by Subject|5|||
155239118|NCT01722331|560309327|FG001|Part 2|Withdrawal by Subject|0|||
155239119|NCT01722331|560309328|FG002|Part 2|Withdrawal by Subject|3|||
155239120|NCT01722331|560309329|FG003|Part 2|Withdrawal by Subject|0|||
155239121|NCT01722331|560309330|FG004|Part 2|Withdrawal by Subject|0|||
155239122|NCT01722331|560309331|FG005|Part 2|Withdrawal by Subject|2|||
155239123|NCT01722331|560309332|FG006|Part 2|Withdrawal by Subject|2|||
155239124|NCT01722331|560309326|FG000|Part 2|Other Protocol Specified Criteria|6|||
155239125|NCT01722331|560309327|FG001|Part 2|Other Protocol Specified Criteria|0|||
155239126|NCT01722331|560309328|FG002|Part 2|Other Protocol Specified Criteria|10|||
155239127|NCT01722331|560309329|FG003|Part 2|Other Protocol Specified Criteria|0|||
155239128|NCT01722331|560309330|FG004|Part 2|Other Protocol Specified Criteria|0|||
155239129|NCT01722331|560309331|FG005|Part 2|Other Protocol Specified Criteria|2|||
155239130|NCT01722331|560309332|FG006|Part 2|Other Protocol Specified Criteria|1|||
155239131|NCT01722331|560309326|FG000|Part 3|Adverse Event|2|||
155239132|NCT01722331|560309327|FG001|Part 3|Adverse Event|2|||
155239133|NCT01722331|560309328|FG002|Part 3|Adverse Event|0|||
155239134|NCT01722331|560309329|FG003|Part 3|Adverse Event|1|||
155239135|NCT01722331|560309330|FG004|Part 3|Adverse Event|0|||
155239136|NCT01722331|560309331|FG005|Part 3|Adverse Event|0|||
155239137|NCT01722331|560309332|FG006|Part 3|Adverse Event|0|||
155239138|NCT01722331|560309326|FG000|Part 3|Death|1|||
155239139|NCT01722331|560309327|FG001|Part 3|Death|0|||
155239140|NCT01722331|560309328|FG002|Part 3|Death|0|||
155239141|NCT01722331|560309329|FG003|Part 3|Death|0|||
155239142|NCT01722331|560309330|FG004|Part 3|Death|0|||
155239143|NCT01722331|560309331|FG005|Part 3|Death|0|||
155239144|NCT01722331|560309332|FG006|Part 3|Death|0|||
155239145|NCT01722331|560309326|FG000|Part 3|Lack of Efficacy|1|||
155239146|NCT01722331|560309327|FG001|Part 3|Lack of Efficacy|0|||
155239147|NCT01722331|560309328|FG002|Part 3|Lack of Efficacy|0|||
155239148|NCT01722331|560309329|FG003|Part 3|Lack of Efficacy|0|||
155239149|NCT01722331|560309330|FG004|Part 3|Lack of Efficacy|0|||
155239150|NCT01722331|560309331|FG005|Part 3|Lack of Efficacy|0|||
155239151|NCT01722331|560309332|FG006|Part 3|Lack of Efficacy|0|||
155239152|NCT01722331|560309326|FG000|Part 3|Lost to Follow-up|3|||
155239153|NCT01722331|560309327|FG001|Part 3|Lost to Follow-up|4|||
155239154|NCT01722331|560309328|FG002|Part 3|Lost to Follow-up|0|||
155239155|NCT01722331|560309329|FG003|Part 3|Lost to Follow-up|0|||
155239156|NCT01722331|560309330|FG004|Part 3|Lost to Follow-up|0|||
155239157|NCT01722331|560309331|FG005|Part 3|Lost to Follow-up|1|||
155239158|NCT01722331|560309332|FG006|Part 3|Lost to Follow-up|0|||
155239159|NCT01722331|560309326|FG000|Part 3|Non-Compliance with Study Drug|0|||
155239160|NCT01722331|560309327|FG001|Part 3|Non-Compliance with Study Drug|1|||
155239161|NCT01722331|560309328|FG002|Part 3|Non-Compliance with Study Drug|0|||
155239162|NCT01722331|560309329|FG003|Part 3|Non-Compliance with Study Drug|0|||
155239163|NCT01722331|560309330|FG004|Part 3|Non-Compliance with Study Drug|0|||
155239164|NCT01722331|560309331|FG005|Part 3|Non-Compliance with Study Drug|0|||
155239165|NCT01722331|560309332|FG006|Part 3|Non-Compliance with Study Drug|0|||
155239166|NCT01722331|560309326|FG000|Part 3|Physician Decision|1|||
155239167|NCT01722331|560309327|FG001|Part 3|Physician Decision|1|||
155239168|NCT01722331|560309328|FG002|Part 3|Physician Decision|0|||
155239169|NCT01722331|560309329|FG003|Part 3|Physician Decision|0|||
155239170|NCT01722331|560309330|FG004|Part 3|Physician Decision|0|||
155239171|NCT01722331|560309331|FG005|Part 3|Physician Decision|0|||
155239172|NCT01722331|560309332|FG006|Part 3|Physician Decision|1|||
155239173|NCT01722331|560309326|FG000|Part 3|Protocol Violation|2|||
155239174|NCT01722331|560309327|FG001|Part 3|Protocol Violation|1|||
155239175|NCT01722331|560309328|FG002|Part 3|Protocol Violation|0|||
155239176|NCT01722331|560309329|FG003|Part 3|Protocol Violation|0|||
155239177|NCT01722331|560309330|FG004|Part 3|Protocol Violation|0|||
155239178|NCT01722331|560309331|FG005|Part 3|Protocol Violation|0|||
155239179|NCT01722331|560309332|FG006|Part 3|Protocol Violation|0|||
155239180|NCT01722331|560309326|FG000|Part 3|Withdrawal by Subject|4|||
155239181|NCT01722331|560309327|FG001|Part 3|Withdrawal by Subject|7|||
155239182|NCT01722331|560309328|FG002|Part 3|Withdrawal by Subject|0|||
155239183|NCT01722331|560309329|FG003|Part 3|Withdrawal by Subject|0|||
155239184|NCT01722331|560309330|FG004|Part 3|Withdrawal by Subject|0|||
155239185|NCT01722331|560309331|FG005|Part 3|Withdrawal by Subject|2|||
155239186|NCT01722331|560309332|FG006|Part 3|Withdrawal by Subject|1|||
155239187|NCT01722331|560309326|FG000|Part 3|Other Protocol Specified Criteria|1|||
155239188|NCT01722331|560309327|FG001|Part 3|Other Protocol Specified Criteria|1|||
155239189|NCT01722331|560309328|FG002|Part 3|Other Protocol Specified Criteria|0|||
155239190|NCT01722331|560309329|FG003|Part 3|Other Protocol Specified Criteria|0|||
155239191|NCT01722331|560309330|FG004|Part 3|Other Protocol Specified Criteria|0|||
155239192|NCT01722331|560309331|FG005|Part 3|Other Protocol Specified Criteria|0|||
155239193|NCT01722331|560309332|FG006|Part 3|Other Protocol Specified Criteria|0|||
155239194|NCT00353704|560309345|FG000|Overall Study|Protocol Violation|3|||
155239195|NCT00353704|560309346|FG001|Overall Study|Protocol Violation|1|||
155239196|NCT02525133|560309347|FG000|Overall Study|Adverse Event|0|||
155239197|NCT02525133|560309348|FG001|Overall Study|Adverse Event|1|||
155239198|NCT02525133|560309347|FG000|Overall Study|Death|0|||
155239199|NCT02525133|560309348|FG001|Overall Study|Death|1|||
155239200|NCT02525133|560309347|FG000|Overall Study|did not meet randomization criteria|1|||
155239201|NCT02525133|560309348|FG001|Overall Study|did not meet randomization criteria|0|||
155239202|NCT02525133|560309347|FG000|Overall Study|Lost to Follow-up|5|||
155239203|NCT02525133|560309348|FG001|Overall Study|Lost to Follow-up|1|||
155239204|NCT02525133|560309347|FG000|Overall Study|randomized not enrolled|3|||
155239205|NCT02525133|560309348|FG001|Overall Study|randomized not enrolled|0|||
155239206|NCT02525133|560309347|FG000|Overall Study|Withdrawal by Subject|1|||
155239207|NCT02525133|560309348|FG001|Overall Study|Withdrawal by Subject|0|||
155239208|NCT01343082|560309349|FG000|The run-in Period|Not meeting criteria|3|||
155239209|NCT01343082|560309350|FG001|The run-in Period|Not meeting criteria|4|||
155239210|NCT01343082|560309351|FG002|The run-in Period|Not meeting criteria|5|||
155239211|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
155239212|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
155239213|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
155239214|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
155239215|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
155239216|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
155239217|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
155239218|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
155239219|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
155239220|NCT01343082|560309349|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
155239221|NCT01343082|560309350|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
155239222|NCT01343082|560309351|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
155239223|NCT01154166|560309352|FG000|Overall Study|Adverse Event|14|||
155239224|NCT01154166|560309353|FG001|Overall Study|Adverse Event|9|||
155239225|NCT01154166|560309352|FG000|Overall Study|Lost to Follow-up|1|||
155239226|NCT01154166|560309353|FG001|Overall Study|Lost to Follow-up|1|||
155239227|NCT01154166|560309352|FG000|Overall Study|Protocol Violation|4|||
155239228|NCT01154166|560309353|FG001|Overall Study|Protocol Violation|1|||
155239229|NCT01154166|560309352|FG000|Overall Study|Withdrawal by Subject|10|||
155239230|NCT01154166|560309353|FG001|Overall Study|Withdrawal by Subject|1|||
155239231|NCT01154166|560309352|FG000|Overall Study|Lack of Efficacy|3|||
155239232|NCT01154166|560309353|FG001|Overall Study|Lack of Efficacy|0|||
155239233|NCT01154166|560309352|FG000|Overall Study|Disease Progression|1|||
155239234|NCT01154166|560309353|FG001|Overall Study|Disease Progression|0|||
155239235|NCT01154166|560309352|FG000|Overall Study|Poor Compliance|1|||
155239236|NCT01154166|560309353|FG001|Overall Study|Poor Compliance|0|||
155239237|NCT01375049|560309354|FG000|Overall Study|Adverse Event|2|||
155239238|NCT01375049|560309354|FG000|Overall Study|Lost to Follow-up|1|||
155239239|NCT01375049|560309354|FG000|Overall Study|Withdrawal by Subject|2|||
155239240|NCT01375049|560309354|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
155239241|NCT03614793|560309355|FG000|Overall Study|Lost to Follow-up|1|||
155239242|NCT03614793|560309356|FG001|Overall Study|Lost to Follow-up|2|||
155239243|NCT03614793|560309355|FG000|Overall Study|Lack of Efficacy|0|||
155239244|NCT03614793|560309356|FG001|Overall Study|Lack of Efficacy|5|||
155239245|NCT03614793|560309355|FG000|Overall Study|Withdrawal by Subject|0|||
155239246|NCT03614793|560309356|FG001|Overall Study|Withdrawal by Subject|1|||
155239247|NCT03614793|560309355|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
155239248|NCT03614793|560309356|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
155239249|NCT02082522|560309357|FG000|Overall Study|Sponsor termination|5|||
155239250|NCT02082522|560309358|FG001|Overall Study|Sponsor termination|3|||
155239251|NCT02082522|560309357|FG000|Overall Study|Withdrawal by Subject|2|||
155239252|NCT02082522|560309358|FG001|Overall Study|Withdrawal by Subject|4|||
155239253|NCT02082522|560309357|FG000|Overall Study|Death|1|||
155239254|NCT02082522|560309358|FG001|Overall Study|Death|0|||
155239255|NCT02082522|560309357|FG000|Overall Study|Lost to Follow-up|1|||
155239256|NCT02082522|560309358|FG001|Overall Study|Lost to Follow-up|0|||
155239257|NCT02082522|560309357|FG000|Overall Study|Physician Decision|3|||
155239258|NCT02082522|560309358|FG001|Overall Study|Physician Decision|1|||
155239259|NCT02082522|560309357|FG000|Overall Study|Disease progression|2|||
155239260|NCT02082522|560309358|FG001|Overall Study|Disease progression|2|||
155239261|NCT02082522|560309357|FG000|Overall Study|Chemotherapy change|1|||
155239262|NCT02082522|560309358|FG001|Overall Study|Chemotherapy change|3|||
155239263|NCT01575561|560309359|FG000|Overall Study|Adverse Event|9|||
155239264|NCT01575561|560309359|FG000|Overall Study|Lack of Efficacy|8|||
155239265|NCT01575561|560309359|FG000|Overall Study|Lost to Follow-up|6|||
155239266|NCT01575561|560309359|FG000|Overall Study|Protocol Violation|4|||
155239267|NCT01575561|560309359|FG000|Overall Study|Withdrawal by Subject|11|||
155239268|NCT01575561|560309359|FG000|Overall Study|administration|1|||
155239269|NCT00633984|560309360|FG000|Overall Study|Lost to Follow-up|0|||
155239270|NCT00633984|560309361|FG001|Overall Study|Lost to Follow-up|6|||
155239271|NCT00633984|560309360|FG000|Overall Study|Withdrawal by Subject|8|||
155239272|NCT00633984|560309361|FG001|Overall Study|Withdrawal by Subject|7|||
155239273|NCT00633984|560309360|FG000|Overall Study|Hospitalized|1|||
155239274|NCT00633984|560309361|FG001|Overall Study|Hospitalized|0|||
155239275|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
155239276|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
155239277|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
155239278|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Death|1|||
155239279|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
155239280|NCT02840877|560309362|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
155239281|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
155239282|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Treatment failure|1|||
155239283|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
155239284|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
155239285|NCT02840877|560309362|FG000|12 Weeks to 6 Months|Death|1|||
155239286|NCT02840877|560309362|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
155239287|NCT02840877|560309362|FG000|6 Months to 18 Months|Treatment failure|7|||
155239288|NCT02840877|560309362|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
155239289|NCT02840877|560309362|FG000|6 Months to 18 Months|Moved/transferred out|6|||
155239290|NCT02840877|560309362|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
155239291|NCT02840877|560309362|FG000|6 Months to 18 Months|Death|4|||
155239292|NCT02840877|560309362|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
155239293|NCT02840877|560309362|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
155239294|NCT02840877|560309362|FG000|6 Months to 18 Months|Still in study.|14|||
155239295|NCT01168999|560309363|FG000|Overall Study|Lost to Follow-up|2|||
155239296|NCT01168999|560309364|FG001|Overall Study|Lost to Follow-up|1|||
155239297|NCT01168999|560309365|FG002|Overall Study|Lost to Follow-up|0|||
155239298|NCT01168999|560309366|FG003|Overall Study|Lost to Follow-up|0|||
155239299|NCT01276327|560309367|FG000|Overall Study|Adverse Event|1|||
155239300|NCT01276327|560309368|FG001|Overall Study|Adverse Event|3|||
155239301|NCT01276327|560309367|FG000|Overall Study|Withdrawal by Subject|1|||
155239302|NCT01276327|560309368|FG001|Overall Study|Withdrawal by Subject|0|||
155239303|NCT03766646|560309370|FG000|Overall Study|Withdrawal by Subject|1|||
155239304|NCT03766646|560309371|FG001|Overall Study|Withdrawal by Subject|0|||
155239305|NCT03766646|560309370|FG000|Overall Study|Protocol Violation|0|||
155239306|NCT03766646|560309371|FG001|Overall Study|Protocol Violation|3|||
155239307|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
155239308|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
155239309|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
155239310|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239311|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239312|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239313|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239314|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239315|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
155239316|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
155239317|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
155239318|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
155239319|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239320|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239321|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239322|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239323|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239324|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
155239325|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239326|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
155239327|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
155239328|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239329|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239330|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239331|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239332|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239333|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
155239334|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
155239335|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
155239336|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
155239337|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239338|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239339|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239340|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239341|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239342|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
155239343|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239344|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
155239345|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239346|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239347|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239348|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239349|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239350|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239351|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
155239352|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
155239353|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239354|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239355|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239356|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239357|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239358|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239359|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239360|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
155239361|NCT01172938|560309382|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239362|NCT01172938|560309383|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
155239363|NCT01172938|560309384|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
155239364|NCT01172938|560309385|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239365|NCT01172938|560309386|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239366|NCT01172938|560309387|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239367|NCT01172938|560309388|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239368|NCT01172938|560309389|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239369|NCT01172938|560309390|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
155239370|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239371|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
155239372|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
155239373|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
155239374|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
155239375|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
155239376|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239377|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239378|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
155239379|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239380|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
155239381|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
155239382|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
155239383|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
155239384|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
155239385|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239386|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239387|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
155239388|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239389|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239390|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
155239391|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239392|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239393|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239394|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239395|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239396|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
155239397|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
155239398|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
155239399|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
155239400|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
155239401|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
155239402|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
155239403|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
155239404|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
155239405|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
155239406|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239407|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
155239408|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
155239409|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
155239410|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239411|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239412|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239413|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239414|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
155239415|NCT01172938|560309382|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239416|NCT01172938|560309383|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239417|NCT01172938|560309384|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239418|NCT01172938|560309385|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239419|NCT01172938|560309386|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239420|NCT01172938|560309387|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
155239421|NCT01172938|560309388|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
155239422|NCT01172938|560309389|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239423|NCT01172938|560309390|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
155239424|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239425|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
155239426|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
155239427|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239428|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239429|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239430|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
155239431|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
155239432|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
155239433|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239434|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
155239435|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
155239436|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239437|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239438|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239439|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239440|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
155239441|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
155239442|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239443|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239444|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
155239445|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239446|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239447|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239448|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239449|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239450|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
155239451|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239452|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
155239453|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
155239454|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239455|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239456|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239457|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
155239458|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
155239459|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
155239460|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239461|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239462|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
155239463|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239464|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239465|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239466|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239467|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239468|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
155239469|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239470|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
155239471|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
155239472|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239473|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239474|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239475|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239476|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
155239477|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
155239478|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239479|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
155239480|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239481|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239482|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239483|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239484|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239485|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
155239486|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
155239487|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239488|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
155239489|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239490|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239491|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239492|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239493|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239494|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239495|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
155239496|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239497|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239498|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239499|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239500|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239501|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239502|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239503|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
155239504|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
155239505|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239506|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
155239507|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
155239508|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239509|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239510|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239511|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
155239512|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
155239513|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
155239514|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239515|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
155239516|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
155239517|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239518|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239519|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239520|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
155239521|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
155239522|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
155239523|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239524|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239525|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239526|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239527|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239528|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239529|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239530|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
155239531|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
155239532|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239533|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
155239534|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239535|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239536|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239537|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239538|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239539|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239540|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
155239541|NCT01172938|560309382|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239542|NCT01172938|560309383|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239543|NCT01172938|560309384|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
155239544|NCT01172938|560309385|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239545|NCT01172938|560309386|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239546|NCT01172938|560309387|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239547|NCT01172938|560309388|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239548|NCT01172938|560309389|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239549|NCT01172938|560309390|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
155239550|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239551|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
155239552|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
155239553|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239554|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239555|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239556|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239557|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
155239558|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
155239559|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239560|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
155239561|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
155239562|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239563|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239564|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239565|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
155239566|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
155239567|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
155239568|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239569|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
155239570|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
155239571|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239572|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239573|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239574|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
155239575|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
155239576|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
155239577|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239578|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239579|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
155239580|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239581|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239582|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239583|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239584|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
155239585|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
155239586|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239587|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239588|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239589|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239590|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239591|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239592|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239593|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
155239594|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
155239595|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239596|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239597|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
155239598|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239599|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239600|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239601|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
155239602|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
155239603|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
155239604|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239605|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239606|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
155239607|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239608|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239609|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239610|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239611|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239612|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
155239613|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239614|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
155239615|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239616|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239617|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239618|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239619|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239620|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
155239621|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
155239622|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239623|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
155239624|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
155239625|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239626|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239627|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239628|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239629|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
155239630|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
155239631|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239632|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239633|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
155239634|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239635|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239636|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239637|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239638|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239639|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
155239640|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239641|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239642|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
155239643|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239644|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239645|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239646|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239647|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239648|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
155239649|NCT01172938|560309382|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239650|NCT01172938|560309383|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239651|NCT01172938|560309384|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239652|NCT01172938|560309385|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239653|NCT01172938|560309386|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239654|NCT01172938|560309387|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239655|NCT01172938|560309388|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239656|NCT01172938|560309389|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
155239657|NCT01172938|560309390|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
155239658|NCT01033747|560309391|FG000|Overall Study|Adverse Event|9|||
155239659|NCT01033747|560309392|FG001|Overall Study|Adverse Event|4|||
155239660|NCT01033747|560309391|FG000|Overall Study|Abnormal Laboratory Value|1|||
155239661|NCT01033747|560309392|FG001|Overall Study|Abnormal Laboratory Value|0|||
155239662|NCT01033747|560309391|FG000|Overall Study|Abnormal test procedure|0|||
155239663|NCT01033747|560309392|FG001|Overall Study|Abnormal test procedure|1|||
155239664|NCT01033747|560309391|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
155239665|NCT01033747|560309392|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
155239666|NCT01033747|560309391|FG000|Overall Study|Protocol Violation|1|||
155239667|NCT01033747|560309392|FG001|Overall Study|Protocol Violation|0|||
155239668|NCT01033747|560309391|FG000|Overall Study|Withdrawal by Subject|9|||
155239669|NCT01033747|560309392|FG001|Overall Study|Withdrawal by Subject|6|||
155239670|NCT01033747|560309391|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
155239671|NCT01033747|560309392|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
155239672|NCT01033747|560309391|FG000|Overall Study|Stopped at end of Extension 1|2|||
155239673|NCT01033747|560309392|FG001|Overall Study|Stopped at end of Extension 1|0|||
155239674|NCT00003498|560309393|FG000|Overall Study|Not evaluable.|4|||
155239675|NCT02956629|560309394|FG000|Overall Study|Adverse Event|0|||
155239676|NCT02956629|560309395|FG001|Overall Study|Adverse Event|0|||
155239677|NCT02956629|560309396|FG002|Overall Study|Adverse Event|1|||
155239678|NCT02956629|560309397|FG003|Overall Study|Adverse Event|0|||
155239679|NCT02956629|560309398|FG004|Overall Study|Adverse Event|0|||
155239680|NCT02956629|560309399|FG005|Overall Study|Adverse Event|0|||
155239681|NCT02956629|560309394|FG000|Overall Study|Lost to Follow-up|2|||
155239682|NCT02956629|560309395|FG001|Overall Study|Lost to Follow-up|5|||
155239683|NCT02956629|560309396|FG002|Overall Study|Lost to Follow-up|3|||
155239684|NCT02956629|560309397|FG003|Overall Study|Lost to Follow-up|1|||
155239685|NCT02956629|560309398|FG004|Overall Study|Lost to Follow-up|0|||
155239686|NCT02956629|560309399|FG005|Overall Study|Lost to Follow-up|1|||
155239687|NCT02956629|560309394|FG000|Overall Study|Withdrawal by Subject|3|||
155239688|NCT02956629|560309395|FG001|Overall Study|Withdrawal by Subject|1|||
155239689|NCT02956629|560309396|FG002|Overall Study|Withdrawal by Subject|0|||
155239690|NCT02956629|560309397|FG003|Overall Study|Withdrawal by Subject|0|||
155239691|NCT02956629|560309398|FG004|Overall Study|Withdrawal by Subject|0|||
155239692|NCT02956629|560309399|FG005|Overall Study|Withdrawal by Subject|0|||
155239693|NCT04067141|560309406|FG000|First Intervention|Withdrawal by Subject|0|||
155239694|NCT04067141|560309407|FG001|First Intervention|Withdrawal by Subject|1|||
155239695|NCT04067141|560309406|FG000|Second Intervention|Adverse Event|0|||
155239696|NCT04067141|560309407|FG001|Second Intervention|Adverse Event|2|||
155239697|NCT01557946|560309408|FG000|Overall Study|Adverse Event|3|||
155239698|NCT01557946|560309409|FG001|Overall Study|Adverse Event|0|||
155239699|NCT01978119|560309411|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
155239700|NCT01978119|560309412|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
155239701|NCT01978119|560309411|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
155239702|NCT01978119|560309412|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
155239703|NCT01978119|560309411|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
155239704|NCT01978119|560309412|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
155239705|NCT00812812|560309414|FG000|Overall Study|Adverse Event|2|||
155239706|NCT00812812|560309415|FG001|Overall Study|Adverse Event|1|||
155239707|NCT00812812|560309414|FG000|Overall Study|Lack of Efficacy|1|||
155239708|NCT00812812|560309415|FG001|Overall Study|Lack of Efficacy|0|||
155239709|NCT00812812|560309414|FG000|Overall Study|Lost to Follow-up|0|||
155239710|NCT00812812|560309415|FG001|Overall Study|Lost to Follow-up|1|||
155239711|NCT00812812|560309414|FG000|Overall Study|Withdrawal by Subject|0|||
155239712|NCT00812812|560309415|FG001|Overall Study|Withdrawal by Subject|2|||
155239713|NCT01047683|560309416|FG000|Overall Study|Adverse Event|3|||
155239714|NCT01047683|560309417|FG001|Overall Study|Adverse Event|1|||
155239715|NCT01047683|560309418|FG002|Overall Study|Adverse Event|0|||
155239716|NCT01047683|560309416|FG000|Overall Study|Withdrew Consent|1|||
155239717|NCT01047683|560309417|FG001|Overall Study|Withdrew Consent|4|||
155239718|NCT01047683|560309418|FG002|Overall Study|Withdrew Consent|2|||
155239719|NCT01047683|560309416|FG000|Overall Study|Lost to Follow-up|0|||
155239720|NCT01047683|560309417|FG001|Overall Study|Lost to Follow-up|1|||
155239721|NCT01047683|560309418|FG002|Overall Study|Lost to Follow-up|0|||
155239722|NCT01047683|560309416|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
155239723|NCT01047683|560309417|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
155239724|NCT01047683|560309418|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
155239725|NCT02822794|560309419|FG000|Overall Study|Withdrew Consent|1|||
155239726|NCT02822794|560309420|FG001|Overall Study|Withdrew Consent|0|||
155239727|NCT05061446|560309423|FG000|Overall Study|Adverse Event|2|||
155239728|NCT05061446|560309424|FG001|Overall Study|Adverse Event|0|||
155239729|NCT05061446|560309425|FG002|Overall Study|Adverse Event|0|||
155239730|NCT05061446|560309423|FG000|Overall Study|Participant no longer available due to personal reason|0|||
155239731|NCT05061446|560309424|FG001|Overall Study|Participant no longer available due to personal reason|1|||
155239732|NCT05061446|560309425|FG002|Overall Study|Participant no longer available due to personal reason|0|||
155239733|NCT05857527|560309430|FG000|Overall Study|Withdrawal by Subject|0|||
155239734|NCT05857527|560309431|FG001|Overall Study|Withdrawal by Subject|1|||
155239735|NCT02543346|560309432|FG000|Second Priming Visit|Withdrawal by Subject|0|||
155239736|NCT02543346|560309433|FG001|Second Priming Visit|Withdrawal by Subject|2|||
155239737|NCT02543346|560309434|FG002|Second Priming Visit|Withdrawal by Subject|2|||
155239738|NCT02543346|560309435|FG003|Second Priming Visit|Withdrawal by Subject|2|||
155239739|NCT02543346|560309432|FG000|Second Priming Visit|Adverse Event|1|||
155239740|NCT02543346|560309433|FG001|Second Priming Visit|Adverse Event|0|||
155239741|NCT02543346|560309434|FG002|Second Priming Visit|Adverse Event|0|||
155239742|NCT02543346|560309435|FG003|Second Priming Visit|Adverse Event|0|||
155239743|NCT01440946|560309440|FG000|Overall Study|Lost to Follow-up|1|||
155239744|NCT01440946|560309441|FG001|Overall Study|Lost to Follow-up|1|||
155239745|NCT01440946|560309440|FG000|Overall Study|Physician Decision|1|||
155239746|NCT01440946|560309441|FG001|Overall Study|Physician Decision|0|||
155239747|NCT01975389|560309442|FG000|Overall Study|Adverse Event|10|||
155239748|NCT01975389|560309443|FG001|Overall Study|Adverse Event|6|||
155239749|NCT01975389|560309442|FG000|Overall Study|Death|61|||
155239750|NCT01975389|560309443|FG001|Overall Study|Death|54|||
155239751|NCT01975389|560309442|FG000|Overall Study|Lost to Follow-up|81|||
155239752|NCT01975389|560309443|FG001|Overall Study|Lost to Follow-up|86|||
155239753|NCT01975389|560309442|FG000|Overall Study|Withdrawal by Subject|90|||
155239754|NCT01975389|560309443|FG001|Overall Study|Withdrawal by Subject|76|||
155239755|NCT01975389|560309442|FG000|Overall Study|Other|6|||
155239756|NCT01975389|560309443|FG001|Overall Study|Other|9|||
155239757|NCT01975389|560309442|FG000|Overall Study|Randomized, not treated|4|||
155239758|NCT01975389|560309443|FG001|Overall Study|Randomized, not treated|5|||
155239759|NCT02127307|560309444|FG000|Overall Study|Protocol Violation|36|||
155239760|NCT02127307|560309444|FG000|Overall Study|Lost to Follow-up|2|||
155239761|NCT02127307|560309444|FG000|Overall Study|Death|101|||
155239762|NCT02127307|560309444|FG000|Overall Study|Other than specified above|169|||
155239763|NCT01312961|560309445|FG000|Overall Study|Adverse Event|3|||
155239764|NCT01312961|560309446|FG001|Overall Study|Adverse Event|3|||
155239765|NCT01312961|560309445|FG000|Overall Study|Lack of Efficacy|11|||
155239766|NCT01312961|560309446|FG001|Overall Study|Lack of Efficacy|1|||
155239767|NCT01312961|560309445|FG000|Overall Study|Poor compliance to protocol|1|||
155239768|NCT01312961|560309446|FG001|Overall Study|Poor compliance to protocol|0|||
155239769|NCT01312961|560309445|FG000|Overall Study|Other than specified above|2|||
155239770|NCT01312961|560309446|FG001|Overall Study|Other than specified above|3|||
155239771|NCT04666441|560309452|FG000|Overall Study|Lost to Follow-up|1|||
155239772|NCT04666441|560309453|FG001|Overall Study|Lost to Follow-up|4|||
155239773|NCT04666441|560309454|FG002|Overall Study|Lost to Follow-up|1|||
155239774|NCT04666441|560309455|FG003|Overall Study|Lost to Follow-up|3|||
155239775|NCT04666441|560309456|FG004|Overall Study|Lost to Follow-up|0|||
155239776|NCT04666441|560309457|FG005|Overall Study|Lost to Follow-up|2|||
155239777|NCT04666441|560309458|FG006|Overall Study|Lost to Follow-up|2|||
155239778|NCT04666441|560309459|FG007|Overall Study|Lost to Follow-up|2|||
155239779|NCT04666441|560309452|FG000|Overall Study|Subject Decision|1|||
155239780|NCT04666441|560309453|FG001|Overall Study|Subject Decision|1|||
155239781|NCT04666441|560309454|FG002|Overall Study|Subject Decision|3|||
155239782|NCT04666441|560309455|FG003|Overall Study|Subject Decision|1|||
155239783|NCT04666441|560309456|FG004|Overall Study|Subject Decision|0|||
155239784|NCT04666441|560309457|FG005|Overall Study|Subject Decision|1|||
155239785|NCT04666441|560309458|FG006|Overall Study|Subject Decision|3|||
155239786|NCT04666441|560309459|FG007|Overall Study|Subject Decision|2|||
155239787|NCT00766415|560309460|FG000|Overall Study|Withdrawal by Subject|0|||
155239788|NCT00766415|560309461|FG001|Overall Study|Withdrawal by Subject|1|||
155239789|NCT01114516|560309462|FG000|Overall Study|Lost to Follow-up|2|||
155239790|NCT01114516|560309463|FG001|Overall Study|Lost to Follow-up|1|||
155239791|NCT00132769|560309464|FG000|Overall Study|Withdrawal by Subject|1|||
155239792|NCT00132769|560309465|FG001|Overall Study|Withdrawal by Subject|3|||
155239793|NCT00132769|560309464|FG000|Overall Study|Lack of Efficacy|7|||
155239794|NCT00132769|560309465|FG001|Overall Study|Lack of Efficacy|6|||
155239795|NCT00132769|560309464|FG000|Overall Study|Adverse Event|2|||
155239796|NCT00132769|560309465|FG001|Overall Study|Adverse Event|1|||
155239797|NCT00132769|560309464|FG000|Overall Study|Protocol Violation|1|||
155239798|NCT00132769|560309465|FG001|Overall Study|Protocol Violation|1|||
155239799|NCT01431508|560309466|FG000|Overall Study|Lack of Efficacy|1|||
155239800|NCT01431508|560309466|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
155239801|NCT00129259|560309468|FG000|Overall Study|Lost to Follow-up|1|||
155239802|NCT00129259|560309469|FG001|Overall Study|Lost to Follow-up|1|||
155239803|NCT00129259|560309468|FG000|Overall Study|Withdrawal by Subject|2|||
155239804|NCT00129259|560309469|FG001|Overall Study|Withdrawal by Subject|1|||
155239805|NCT00129259|560309468|FG000|Overall Study|Only available minimal phone assessments|0|||
155239806|NCT00129259|560309469|FG001|Overall Study|Only available minimal phone assessments|1|||
155239807|NCT03794089|560311521|FG000|Overall Study|Lost to Follow-up|4|||
155239808|NCT03794089|560311522|FG001|Overall Study|Lost to Follow-up|1|||
155239809|NCT03794089|560311521|FG000|Overall Study|Withdrawal by Subject|2|||
155239810|NCT03794089|560311522|FG001|Overall Study|Withdrawal by Subject|0|||
155239811|NCT03985423|560311523|FG000|Overall Study|Adverse Event|1|||
155239812|NCT03985423|560311523|FG000|Overall Study|Death|2|||
155239813|NCT03985423|560311523|FG000|Overall Study|Physician Decision|1|||
155239814|NCT03985423|560311523|FG000|Overall Study|Withdrawal by Subject|2|||
155239815|NCT03985423|560311523|FG000|Overall Study|Lack of insurance and citizenship|1|||
155239816|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Adverse Event|5|||
155239817|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Adverse Event|8|||
155239818|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Adverse Event|4|||
155239819|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Adverse Event|8|||
155239820|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
155239821|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
155239822|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
155239823|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
155239824|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
155239825|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
155239826|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
155239827|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
155239828|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Physician Decision|1|||
155239829|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Physician Decision|0|||
155239830|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Physician Decision|0|||
155239831|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Physician Decision|0|||
155239832|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
155239833|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
155239834|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
155239835|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
155239836|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Pregnancy|0|||
155239837|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Pregnancy|1|||
155239838|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Pregnancy|0|||
155239839|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Pregnancy|0|||
155239840|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
155239841|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
155239842|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
155239843|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
155239844|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Death|0|||
155239845|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Death|1|||
155239846|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Death|0|||
155239847|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Death|0|||
155239848|NCT00071487|560311528|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
155239849|NCT00071487|560311529|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
155239850|NCT00071487|560311530|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
155239851|NCT00071487|560311531|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
155239852|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
155239853|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
155239854|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
155239855|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
155239856|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155239857|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155239858|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
155239859|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
155239860|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155239861|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155239862|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
155239863|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
155239864|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
155239865|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
155239866|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
155239867|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
155239868|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155239869|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155239870|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
155239871|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
155239872|NCT00071487|560311528|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155239873|NCT00071487|560311529|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155239874|NCT00071487|560311530|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
155239875|NCT00071487|560311531|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
155239876|NCT00581945|560311532|FG000|Overall Study|Adverse Event|4|||
155239877|NCT00581945|560311533|FG001|Overall Study|Adverse Event|4|||
155239878|NCT00581945|560311532|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155239879|NCT00581945|560311533|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
155239880|NCT00581945|560311532|FG000|Overall Study|Withdrawal by Subject|2|||
155239881|NCT00581945|560311533|FG001|Overall Study|Withdrawal by Subject|6|||
155239882|NCT00581945|560311532|FG000|Overall Study|Death|1|||
155239883|NCT00581945|560311533|FG001|Overall Study|Death|0|||
155239884|NCT04820673|560311537|FG000|Overall Study|Adverse Event|6|||
155239885|NCT04820673|560311537|FG000|Overall Study|Due to Lack of Effectiveness|1|||
155239886|NCT04820673|560311537|FG000|Overall Study|Pregnancy|1|||
155239887|NCT04820673|560311537|FG000|Overall Study|Voluntary Withdrawal|20|||
155239888|NCT04820673|560311537|FG000|Overall Study|Lost to Follow-up|10|||
155239889|NCT02032901|560311540|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
155239890|NCT02032901|560311541|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
155239891|NCT02032901|560311540|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
155239892|NCT02032901|560311541|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
155239893|NCT00982020|560311542|FG000|Overall Study|Adverse Event|19|||
155239894|NCT00982020|560311543|FG001|Overall Study|Adverse Event|15|||
155239895|NCT00982020|560311542|FG000|Overall Study|Withdrawal by Subject|11|||
155239896|NCT00982020|560311543|FG001|Overall Study|Withdrawal by Subject|14|||
155239897|NCT00982020|560311542|FG000|Overall Study|Lost to Follow-up|5|||
155239898|NCT00982020|560311543|FG001|Overall Study|Lost to Follow-up|11|||
155239899|NCT00982020|560311542|FG000|Overall Study|Lack of Efficacy|10|||
155239900|NCT00982020|560311543|FG001|Overall Study|Lack of Efficacy|4|||
155239901|NCT00982020|560311542|FG000|Overall Study|Parent/Caregiver Decision|5|||
155239902|NCT00982020|560311543|FG001|Overall Study|Parent/Caregiver Decision|5|||
155239903|NCT00982020|560311542|FG000|Overall Study|Treatment Non-compliance|3|||
155239904|NCT00982020|560311543|FG001|Overall Study|Treatment Non-compliance|6|||
155239905|NCT00982020|560311542|FG000|Overall Study|Physician Decision|2|||
155239906|NCT00982020|560311543|FG001|Overall Study|Physician Decision|5|||
155239907|NCT00982020|560311542|FG000|Overall Study|Entry Criteria Not Met|2|||
155239908|NCT00982020|560311543|FG001|Overall Study|Entry Criteria Not Met|1|||
155239909|NCT00982020|560311542|FG000|Overall Study|Protocol Violation|0|||
155239910|NCT00982020|560311543|FG001|Overall Study|Protocol Violation|2|||
155239911|NCT00982020|560311542|FG000|Overall Study|Clinical Relapse|0|||
155239912|NCT00982020|560311543|FG001|Overall Study|Clinical Relapse|1|||
155239913|NCT04317586|560311544|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
155239914|NCT04317586|560311544|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
155239915|NCT03003676|560311545|FG000|Overall Study|Lack of Efficacy|5|||
155239916|NCT03003676|560311546|FG001|Overall Study|Lack of Efficacy|7|||
155239917|NCT03003676|560311545|FG000|Overall Study|Withdrawal by Subject|0|||
155239918|NCT03003676|560311546|FG001|Overall Study|Withdrawal by Subject|1|||
155239919|NCT03003676|560311545|FG000|Overall Study|Hepatitis B infection|1|||
155239920|NCT03003676|560311546|FG001|Overall Study|Hepatitis B infection|0|||
155239921|NCT02530619|560311547|FG000|Registered for Study|Withdrawal by Subject|2|||
155239922|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
155239923|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
155239924|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
155239925|NCT02530619|560311547|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
155239926|NCT02530619|560311547|FG000|Follow-up Period (6 Months)|Death|4|||
155239927|NCT02530619|560311547|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
155239928|NCT02530619|560311547|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
155239929|NCT01854554|560311555|FG000|Overall Study|Denial of Insurance Coverage|12|||
155239930|NCT01854554|560311556|FG001|Overall Study|Denial of Insurance Coverage|0|||
155239931|NCT01854554|560311555|FG000|Overall Study|Decided to get treatment locally|1|||
155239932|NCT01854554|560311556|FG001|Overall Study|Decided to get treatment locally|5|||
155239933|NCT01854554|560311555|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
155239934|NCT01854554|560311556|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
155239935|NCT01854554|560311555|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155239936|NCT01854554|560311556|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
155239937|NCT01854554|560311555|FG000|Overall Study|Progression|0|||
155239938|NCT01854554|560311556|FG001|Overall Study|Progression|1|||
155239939|NCT01854554|560311555|FG000|Overall Study|Lost to Follow-up|0|||
155239940|NCT01854554|560311556|FG001|Overall Study|Lost to Follow-up|1|||
155239941|NCT02819726|560311557|FG000|Part A (All Participants)|Lost to Follow-up|0|||
155239942|NCT02819726|560311558|FG001|Part A (All Participants)|Lost to Follow-up|1|||
155239943|NCT02819726|560311559|FG002|Part A (All Participants)|Lost to Follow-up|0|||
155239944|NCT02819726|560311560|FG003|Part A (All Participants)|Lost to Follow-up|0|||
155239945|NCT02819726|560311557|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
155239946|NCT02819726|560311558|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
155239947|NCT02819726|560311559|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
155239948|NCT02819726|560311560|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
155239949|NCT02819726|560311557|FG000|Part A (All Participants)|Protocol non-compliance|3|||
155239950|NCT02819726|560311558|FG001|Part A (All Participants)|Protocol non-compliance|4|||
155239951|NCT02819726|560311559|FG002|Part A (All Participants)|Protocol non-compliance|5|||
155239952|NCT02819726|560311560|FG003|Part A (All Participants)|Protocol non-compliance|0|||
155239953|NCT02819726|560311557|FG000|Part B (All Participants)|Lost to Follow-up|1|||
155239954|NCT02819726|560311558|FG001|Part B (All Participants)|Lost to Follow-up|1|||
155239955|NCT02819726|560311559|FG002|Part B (All Participants)|Lost to Follow-up|2|||
155239956|NCT02819726|560311560|FG003|Part B (All Participants)|Lost to Follow-up|2|||
155239957|NCT02819726|560311557|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
155239958|NCT02819726|560311558|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
155239959|NCT02819726|560311559|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
155239960|NCT02819726|560311560|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
155239961|NCT02819726|560311557|FG000|Part B (All Participants)|Protocol non-compliance|0|||
155239962|NCT02819726|560311558|FG001|Part B (All Participants)|Protocol non-compliance|0|||
155239963|NCT02819726|560311559|FG002|Part B (All Participants)|Protocol non-compliance|1|||
155239964|NCT02819726|560311560|FG003|Part B (All Participants)|Protocol non-compliance|0|||
155239965|NCT00359762|560311561|FG000|Period II|Adverse Event|17|||
155239966|NCT00359762|560311562|FG001|Period II|Adverse Event|0|||
155239967|NCT00359762|560311563|FG002|Period II|Adverse Event|0|||
155239968|NCT00359762|560311564|FG003|Period II|Adverse Event|0|||
155239969|NCT00359762|560311565|FG004|Period II|Adverse Event|49|||
155239970|NCT00359762|560311561|FG000|Period II|Protocol Violation|18|||
155239971|NCT00359762|560311562|FG001|Period II|Protocol Violation|0|||
155239972|NCT00359762|560311563|FG002|Period II|Protocol Violation|0|||
155239973|NCT00359762|560311564|FG003|Period II|Protocol Violation|0|||
155239974|NCT00359762|560311565|FG004|Period II|Protocol Violation|11|||
155239975|NCT00359762|560311561|FG000|Period II|Physician Decision|17|||
155239976|NCT00359762|560311562|FG001|Period II|Physician Decision|0|||
155239977|NCT00359762|560311563|FG002|Period II|Physician Decision|0|||
155239978|NCT00359762|560311564|FG003|Period II|Physician Decision|0|||
155239979|NCT00359762|560311565|FG004|Period II|Physician Decision|23|||
155239980|NCT00359762|560311561|FG000|Period II|Death|2|||
155239981|NCT00359762|560311562|FG001|Period II|Death|0|||
155239982|NCT00359762|560311563|FG002|Period II|Death|0|||
155239983|NCT00359762|560311564|FG003|Period II|Death|0|||
155239984|NCT00359762|560311565|FG004|Period II|Death|4|||
155239985|NCT00359762|560311561|FG000|Period II|Lack of Efficacy|11|||
155239986|NCT00359762|560311562|FG001|Period II|Lack of Efficacy|0|||
155239987|NCT00359762|560311563|FG002|Period II|Lack of Efficacy|0|||
155239988|NCT00359762|560311564|FG003|Period II|Lack of Efficacy|0|||
155239989|NCT00359762|560311565|FG004|Period II|Lack of Efficacy|8|||
155239990|NCT00359762|560311561|FG000|Period II|Lost to follow up|5|||
155239991|NCT00359762|560311562|FG001|Period II|Lost to follow up|0|||
155239992|NCT00359762|560311563|FG002|Period II|Lost to follow up|0|||
155239993|NCT00359762|560311564|FG003|Period II|Lost to follow up|0|||
155239994|NCT00359762|560311565|FG004|Period II|Lost to follow up|5|||
155239995|NCT00359762|560311561|FG000|Period II|Entry Criteria Not Met|8|||
155239996|NCT00359762|560311562|FG001|Period II|Entry Criteria Not Met|0|||
155239997|NCT00359762|560311563|FG002|Period II|Entry Criteria Not Met|0|||
155239998|NCT00359762|560311564|FG003|Period II|Entry Criteria Not Met|0|||
155239999|NCT00359762|560311565|FG004|Period II|Entry Criteria Not Met|4|||
155240000|NCT00359762|560311561|FG000|Period II|Subject Decision|50|||
155240001|NCT00359762|560311562|FG001|Period II|Subject Decision|0|||
155240002|NCT00359762|560311563|FG002|Period II|Subject Decision|0|||
155240003|NCT00359762|560311564|FG003|Period II|Subject Decision|0|||
155240004|NCT00359762|560311565|FG004|Period II|Subject Decision|70|||
155240005|NCT00359762|560311561|FG000|Period III|Protocol Violation|0|||
155240006|NCT00359762|560311562|FG001|Period III|Protocol Violation|5|||
155240007|NCT00359762|560311563|FG002|Period III|Protocol Violation|3|||
155240008|NCT00359762|560311564|FG003|Period III|Protocol Violation|8|||
155240009|NCT00359762|560311565|FG004|Period III|Protocol Violation|0|||
155240010|NCT00359762|560311561|FG000|Period III|Adverse Event|0|||
155240011|NCT00359762|560311562|FG001|Period III|Adverse Event|3|||
155240012|NCT00359762|560311563|FG002|Period III|Adverse Event|4|||
155240013|NCT00359762|560311564|FG003|Period III|Adverse Event|10|||
155240014|NCT00359762|560311565|FG004|Period III|Adverse Event|0|||
155240015|NCT00359762|560311561|FG000|Period III|Physician Decision|0|||
155240016|NCT00359762|560311562|FG001|Period III|Physician Decision|5|||
155240017|NCT00359762|560311563|FG002|Period III|Physician Decision|9|||
155240018|NCT00359762|560311564|FG003|Period III|Physician Decision|15|||
155240019|NCT00359762|560311565|FG004|Period III|Physician Decision|0|||
155240020|NCT00359762|560311561|FG000|Period III|Lack of Efficacy|0|||
155240021|NCT00359762|560311562|FG001|Period III|Lack of Efficacy|7|||
155240022|NCT00359762|560311563|FG002|Period III|Lack of Efficacy|5|||
155240023|NCT00359762|560311564|FG003|Period III|Lack of Efficacy|9|||
155240024|NCT00359762|560311565|FG004|Period III|Lack of Efficacy|0|||
155240025|NCT00359762|560311561|FG000|Period III|Lost to follow up|0|||
155240026|NCT00359762|560311562|FG001|Period III|Lost to follow up|1|||
155240027|NCT00359762|560311563|FG002|Period III|Lost to follow up|1|||
155240028|NCT00359762|560311564|FG003|Period III|Lost to follow up|2|||
155240029|NCT00359762|560311565|FG004|Period III|Lost to follow up|0|||
155240030|NCT00359762|560311561|FG000|Period III|Entry Criteria Not Met|0|||
155240031|NCT00359762|560311562|FG001|Period III|Entry Criteria Not Met|1|||
155240032|NCT00359762|560311563|FG002|Period III|Entry Criteria Not Met|0|||
155240033|NCT00359762|560311564|FG003|Period III|Entry Criteria Not Met|1|||
155240034|NCT00359762|560311565|FG004|Period III|Entry Criteria Not Met|0|||
155240035|NCT00359762|560311561|FG000|Period III|Subject Decision|0|||
155240036|NCT00359762|560311562|FG001|Period III|Subject Decision|7|||
155240037|NCT00359762|560311563|FG002|Period III|Subject Decision|8|||
155240038|NCT00359762|560311564|FG003|Period III|Subject Decision|20|||
155240039|NCT00359762|560311565|FG004|Period III|Subject Decision|0|||
155240040|NCT02613481|560311568|FG000|Overall Study|Lost to Follow-up|7|||
155240041|NCT02613481|560311568|FG000|Overall Study|Withdrawal by Subject|2|||
155240042|NCT00803023|560311573|FG000|Overall Study|Adverse Event|5|||
155240043|NCT00803023|560311574|FG001|Overall Study|Adverse Event|4|||
155240044|NCT00803023|560311575|FG002|Overall Study|Adverse Event|8|||
155240045|NCT00803023|560311576|FG003|Overall Study|Adverse Event|6|||
155240046|NCT00803023|560311573|FG000|Overall Study|Withdrawal by Subject|0|||
155240047|NCT00803023|560311574|FG001|Overall Study|Withdrawal by Subject|2|||
155240048|NCT00803023|560311575|FG002|Overall Study|Withdrawal by Subject|0|||
155240049|NCT00803023|560311576|FG003|Overall Study|Withdrawal by Subject|0|||
155240050|NCT00803023|560311573|FG000|Overall Study|Lost to Follow-up|0|||
155240051|NCT00803023|560311574|FG001|Overall Study|Lost to Follow-up|1|||
155240052|NCT00803023|560311575|FG002|Overall Study|Lost to Follow-up|2|||
155240053|NCT00803023|560311576|FG003|Overall Study|Lost to Follow-up|1|||
155240054|NCT00803023|560311573|FG000|Overall Study|Lack of Efficacy|0|||
155240055|NCT00803023|560311574|FG001|Overall Study|Lack of Efficacy|1|||
155240056|NCT00803023|560311575|FG002|Overall Study|Lack of Efficacy|1|||
155240057|NCT00803023|560311576|FG003|Overall Study|Lack of Efficacy|1|||
155240058|NCT02647658|560311577|FG000|Overall Study|Consent refusal|15|||
155240059|NCT02647658|560311578|FG001|Overall Study|Consent refusal|24|||
155240060|NCT01542528|560311579|FG000|Overall Study|Lost to Follow-up|2|||
155240061|NCT01542528|560311580|FG001|Overall Study|Lost to Follow-up|1|||
155240062|NCT01542528|560311579|FG000|Overall Study|Physician Decision|1|||
155240063|NCT01542528|560311580|FG001|Overall Study|Physician Decision|0|||
155240064|NCT01542528|560311579|FG000|Overall Study|Withdrawal by Subject|9|||
155240065|NCT01542528|560311580|FG001|Overall Study|Withdrawal by Subject|6|||
155240066|NCT05282004|560311581|FG000|Overall Study|Adverse Event|2|||
155240067|NCT04382326|560311585|FG000|Overall Study|Adverse Event, not serious|1|||
155240068|NCT04382326|560311586|FG001|Overall Study|Adverse Event, not serious|2|||
155240069|NCT04382326|560311585|FG000|Overall Study|Other|1|||
155240070|NCT04382326|560311586|FG001|Overall Study|Other|0|||
155240071|NCT04382326|560311585|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
155240072|NCT04382326|560311586|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
155240073|NCT04382326|560311585|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
155240074|NCT04382326|560311586|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
155240075|NCT04382326|560311585|FG000|Overall Study|Protocol Violation|29|||
155240076|NCT04382326|560311586|FG001|Overall Study|Protocol Violation|23|||
155240077|NCT04382326|560311585|FG000|Overall Study|Physician Decision|0|||
155240078|NCT04382326|560311586|FG001|Overall Study|Physician Decision|1|||
155240079|NCT04382326|560311585|FG000|Overall Study|Lost to Follow-up|48|||
155240080|NCT04382326|560311586|FG001|Overall Study|Lost to Follow-up|63|||
155240081|NCT04382326|560311585|FG000|Overall Study|Adverse Event, non-fatal|1|||
155240082|NCT04382326|560311586|FG001|Overall Study|Adverse Event, non-fatal|1|||
155240083|NCT02461589|560311592|FG000|Overall Study|Withdrawal by Subject|5|||
155240084|NCT02461589|560311593|FG001|Overall Study|Withdrawal by Subject|1|||
155240085|NCT02461589|560311594|FG002|Overall Study|Withdrawal by Subject|3|||
155240086|NCT02461589|560311595|FG003|Overall Study|Withdrawal by Subject|2|||
155240087|NCT02461589|560311596|FG004|Overall Study|Withdrawal by Subject|1|||
155240088|NCT02461589|560311597|FG005|Overall Study|Withdrawal by Subject|2|||
155240089|NCT02461589|560311598|FG006|Overall Study|Withdrawal by Subject|1|||
155240090|NCT02461589|560311599|FG007|Overall Study|Withdrawal by Subject|3|||
155240091|NCT02461589|560311600|FG008|Overall Study|Withdrawal by Subject|3|||
155240092|NCT02461589|560311601|FG009|Overall Study|Withdrawal by Subject|1|||
155240093|NCT02461589|560311592|FG000|Overall Study|Lost to Follow-up|0|||
155240094|NCT02461589|560311593|FG001|Overall Study|Lost to Follow-up|0|||
155240095|NCT02461589|560311594|FG002|Overall Study|Lost to Follow-up|2|||
155240096|NCT02461589|560311595|FG003|Overall Study|Lost to Follow-up|3|||
155240097|NCT02461589|560311596|FG004|Overall Study|Lost to Follow-up|1|||
155240098|NCT02461589|560311597|FG005|Overall Study|Lost to Follow-up|1|||
155240099|NCT02461589|560311598|FG006|Overall Study|Lost to Follow-up|3|||
155240100|NCT02461589|560311599|FG007|Overall Study|Lost to Follow-up|1|||
155240101|NCT02461589|560311600|FG008|Overall Study|Lost to Follow-up|3|||
155240102|NCT02461589|560311601|FG009|Overall Study|Lost to Follow-up|1|||
155240103|NCT02461589|560311592|FG000|Overall Study|Death|0|||
155240104|NCT02461589|560311593|FG001|Overall Study|Death|0|||
155240105|NCT02461589|560311594|FG002|Overall Study|Death|0|||
155240106|NCT02461589|560311595|FG003|Overall Study|Death|0|||
155240107|NCT02461589|560311596|FG004|Overall Study|Death|0|||
155240108|NCT02461589|560311597|FG005|Overall Study|Death|0|||
155240109|NCT02461589|560311598|FG006|Overall Study|Death|0|||
155240110|NCT02461589|560311599|FG007|Overall Study|Death|1|||
155240111|NCT02461589|560311600|FG008|Overall Study|Death|0|||
155240112|NCT02461589|560311601|FG009|Overall Study|Death|0|||
155240113|NCT02461589|560311592|FG000|Overall Study|Unclassified|0|||
155240114|NCT02461589|560311593|FG001|Overall Study|Unclassified|0|||
155240115|NCT02461589|560311594|FG002|Overall Study|Unclassified|0|||
155240116|NCT02461589|560311595|FG003|Overall Study|Unclassified|0|||
155240117|NCT02461589|560311596|FG004|Overall Study|Unclassified|0|||
155240118|NCT02461589|560311597|FG005|Overall Study|Unclassified|0|||
155240119|NCT02461589|560311598|FG006|Overall Study|Unclassified|1|||
155240120|NCT02461589|560311599|FG007|Overall Study|Unclassified|0|||
155240121|NCT02461589|560311600|FG008|Overall Study|Unclassified|0|||
155240122|NCT02461589|560311601|FG009|Overall Study|Unclassified|2|||
155240123|NCT02461589|560311592|FG000|Overall Study|Missing follow-up information|1|||
155240124|NCT02461589|560311593|FG001|Overall Study|Missing follow-up information|1|||
155240125|NCT02461589|560311594|FG002|Overall Study|Missing follow-up information|0|||
155240126|NCT02461589|560311595|FG003|Overall Study|Missing follow-up information|0|||
155240127|NCT02461589|560311596|FG004|Overall Study|Missing follow-up information|0|||
155240128|NCT02461589|560311597|FG005|Overall Study|Missing follow-up information|0|||
155240129|NCT02461589|560311598|FG006|Overall Study|Missing follow-up information|1|||
155240130|NCT02461589|560311599|FG007|Overall Study|Missing follow-up information|0|||
155240131|NCT02461589|560311600|FG008|Overall Study|Missing follow-up information|0|||
155240132|NCT02461589|560311601|FG009|Overall Study|Missing follow-up information|0|||
155240133|NCT02461589|560311592|FG000|Overall Study|Withdrawal from trial before exposure|0|||
155240134|NCT02461589|560311593|FG001|Overall Study|Withdrawal from trial before exposure|0|||
155240135|NCT02461589|560311594|FG002|Overall Study|Withdrawal from trial before exposure|0|||
155240136|NCT02461589|560311595|FG003|Overall Study|Withdrawal from trial before exposure|0|||
155240137|NCT02461589|560311596|FG004|Overall Study|Withdrawal from trial before exposure|0|||
155240138|NCT02461589|560311597|FG005|Overall Study|Withdrawal from trial before exposure|0|||
155240139|NCT02461589|560311598|FG006|Overall Study|Withdrawal from trial before exposure|0|||
155240140|NCT02461589|560311599|FG007|Overall Study|Withdrawal from trial before exposure|0|||
155240141|NCT02461589|560311600|FG008|Overall Study|Withdrawal from trial before exposure|0|||
155240142|NCT02461589|560311601|FG009|Overall Study|Withdrawal from trial before exposure|1|||
155240143|NCT01038921|560311602|FG000|Overall Study|Withdrawal by Subject|1|||
155240144|NCT01038921|560311603|FG001|Overall Study|Withdrawal by Subject|0|||
155240145|NCT01038921|560311602|FG000|Overall Study|Physician Decision|1|||
155240146|NCT01038921|560311603|FG001|Overall Study|Physician Decision|0|||
155240147|NCT03295201|560311606|FG000|Overall Study|Lost to Follow-up|1|||
155240148|NCT03295201|560311607|FG001|Overall Study|Lost to Follow-up|1|||
155240149|NCT03295201|560311606|FG000|Overall Study|Hospital admission|0|||
155240150|NCT03295201|560311607|FG001|Overall Study|Hospital admission|1|||
155240151|NCT02519504|560311608|FG000|Overall Study|Protocol Violation|6|||
155240152|NCT02519504|560311609|FG001|Overall Study|Protocol Violation|5|||
155240153|NCT02519504|560311608|FG000|Overall Study|Ineligible for direct testing|12|||
155240154|NCT02519504|560311609|FG001|Overall Study|Ineligible for direct testing|12|||
155240155|NCT02519504|560311608|FG000|Overall Study|Did not participate in direct testing|95|||
155240156|NCT02519504|560311609|FG001|Overall Study|Did not participate in direct testing|86|||
155240157|NCT00572572|560311610|FG000|Overall Study|Withdrawal by Subject|3|||
155240158|NCT00572572|560311611|FG001|Overall Study|Withdrawal by Subject|6|||
155240159|NCT01831089|560311612|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
155240160|NCT01831089|560311613|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
155240161|NCT01831089|560311614|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
155240162|NCT01831089|560311615|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
155240163|NCT01831089|560311616|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
155240164|NCT01831089|560311617|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
155240165|NCT01831089|560311612|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
155240166|NCT01831089|560311613|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
155240167|NCT01831089|560311614|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
155240168|NCT01831089|560311615|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
155240169|NCT01831089|560311616|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
155240170|NCT01831089|560311617|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
155240171|NCT01831089|560311612|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240172|NCT01831089|560311613|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
155240173|NCT01831089|560311614|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240174|NCT01831089|560311615|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240175|NCT01831089|560311616|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240176|NCT01831089|560311617|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
155240177|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
155240178|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
155240179|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
155240180|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
155240181|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
155240182|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
155240183|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240184|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240185|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
155240186|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240187|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240188|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
155240189|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
155240190|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
155240191|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
155240192|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
155240193|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
155240194|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
155240195|NCT01831089|560311612|FG000|Cohort III: Dose Level 3|Global end of study|0|||
155240196|NCT01831089|560311613|FG001|Cohort III: Dose Level 3|Global end of study|0|||
155240197|NCT01831089|560311614|FG002|Cohort III: Dose Level 3|Global end of study|1|||
155240198|NCT01831089|560311615|FG003|Cohort III: Dose Level 3|Global end of study|0|||
155240199|NCT01831089|560311616|FG004|Cohort III: Dose Level 3|Global end of study|0|||
155240200|NCT01831089|560311617|FG005|Cohort III: Dose Level 3|Global end of study|0|||
155240201|NCT01831089|560311612|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
155240202|NCT01831089|560311613|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
155240203|NCT01831089|560311614|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
155240204|NCT01831089|560311615|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
155240205|NCT01831089|560311616|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
155240206|NCT01831089|560311617|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
155240207|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
155240208|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
155240209|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
155240210|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
155240211|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
155240212|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
155240213|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240214|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240215|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240216|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240217|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
155240218|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
155240219|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Death|0|||
155240220|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Death|0|||
155240221|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Death|0|||
155240222|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Death|0|||
155240223|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Death|1|||
155240224|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Death|0|||
155240225|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Global end of study|0|||
155240226|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Global end of study|0|||
155240227|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Global end of study|0|||
155240228|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Global end of study|0|||
155240229|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Global end of study|2|||
155240230|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Global end of study|0|||
155240231|NCT01831089|560311612|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240232|NCT01831089|560311613|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240233|NCT01831089|560311614|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240234|NCT01831089|560311615|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240235|NCT01831089|560311616|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
155240236|NCT01831089|560311617|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
155240237|NCT01831089|560311612|FG000|Cohort B: Arm B|Progressive disease|0|||
155240238|NCT01831089|560311613|FG001|Cohort B: Arm B|Progressive disease|0|||
155240239|NCT01831089|560311614|FG002|Cohort B: Arm B|Progressive disease|0|||
155240240|NCT01831089|560311615|FG003|Cohort B: Arm B|Progressive disease|0|||
155240241|NCT01831089|560311616|FG004|Cohort B: Arm B|Progressive disease|0|||
155240242|NCT01831089|560311617|FG005|Cohort B: Arm B|Progressive disease|8|||
155240243|NCT01831089|560311612|FG000|Cohort B: Arm B|Physician Decision|0|||
155240244|NCT01831089|560311613|FG001|Cohort B: Arm B|Physician Decision|0|||
155240245|NCT01831089|560311614|FG002|Cohort B: Arm B|Physician Decision|0|||
155240246|NCT01831089|560311615|FG003|Cohort B: Arm B|Physician Decision|0|||
155240247|NCT01831089|560311616|FG004|Cohort B: Arm B|Physician Decision|0|||
155240248|NCT01831089|560311617|FG005|Cohort B: Arm B|Physician Decision|2|||
155240249|NCT01831089|560311612|FG000|Cohort B: Arm B|Never treated|0|||
155240250|NCT01831089|560311613|FG001|Cohort B: Arm B|Never treated|0|||
155240251|NCT01831089|560311614|FG002|Cohort B: Arm B|Never treated|0|||
155240252|NCT01831089|560311615|FG003|Cohort B: Arm B|Never treated|0|||
155240253|NCT01831089|560311616|FG004|Cohort B: Arm B|Never treated|0|||
155240254|NCT01831089|560311617|FG005|Cohort B: Arm B|Never treated|2|||
155240255|NCT01831089|560311612|FG000|Cohort B: Arm B|Adverse Event|0|||
155240256|NCT01831089|560311613|FG001|Cohort B: Arm B|Adverse Event|0|||
155240257|NCT01831089|560311614|FG002|Cohort B: Arm B|Adverse Event|0|||
155240258|NCT01831089|560311615|FG003|Cohort B: Arm B|Adverse Event|0|||
155240259|NCT01831089|560311616|FG004|Cohort B: Arm B|Adverse Event|0|||
155240260|NCT01831089|560311617|FG005|Cohort B: Arm B|Adverse Event|1|||
155240261|NCT01831089|560311612|FG000|Cohort B: Arm B|Global end of study|0|||
155240262|NCT01831089|560311613|FG001|Cohort B: Arm B|Global end of study|0|||
155240263|NCT01831089|560311614|FG002|Cohort B: Arm B|Global end of study|0|||
155240264|NCT01831089|560311615|FG003|Cohort B: Arm B|Global end of study|0|||
155240265|NCT01831089|560311616|FG004|Cohort B: Arm B|Global end of study|0|||
155240266|NCT01831089|560311617|FG005|Cohort B: Arm B|Global end of study|1|||
155240267|NCT02548962|560311618|FG000|Overall Study|Withdrawal by Subject|1|||
155240268|NCT02548962|560311619|FG001|Overall Study|Withdrawal by Subject|0|||
155240269|NCT01485861|560311622|FG000|Phase Ib|Death|1|||
155240270|NCT01485861|560311623|FG001|Phase Ib|Death|0|||
155240271|NCT01485861|560311624|FG002|Phase Ib|Death|0|||
155240272|NCT01485861|560311625|FG003|Phase Ib|Death|0|||
155240273|NCT01485861|560311626|FG004|Phase Ib|Death|0|||
155240274|NCT01485861|560311627|FG005|Phase Ib|Death|0|||
155240275|NCT01485861|560311622|FG000|Phase Ib|Physician Decision|1|||
155240276|NCT01485861|560311623|FG001|Phase Ib|Physician Decision|1|||
155240277|NCT01485861|560311624|FG002|Phase Ib|Physician Decision|0|||
155240278|NCT01485861|560311625|FG003|Phase Ib|Physician Decision|0|||
155240279|NCT01485861|560311626|FG004|Phase Ib|Physician Decision|0|||
155240280|NCT01485861|560311627|FG005|Phase Ib|Physician Decision|0|||
155240281|NCT01485861|560311622|FG000|Phase Ib|Adverse Event|0|||
155240282|NCT01485861|560311623|FG001|Phase Ib|Adverse Event|4|||
155240283|NCT01485861|560311624|FG002|Phase Ib|Adverse Event|0|||
155240284|NCT01485861|560311625|FG003|Phase Ib|Adverse Event|0|||
155240285|NCT01485861|560311626|FG004|Phase Ib|Adverse Event|0|||
155240286|NCT01485861|560311627|FG005|Phase Ib|Adverse Event|0|||
155240287|NCT01485861|560311622|FG000|Phase Ib|Progression of disease|5|||
155240288|NCT01485861|560311623|FG001|Phase Ib|Progression of disease|0|||
155240289|NCT01485861|560311624|FG002|Phase Ib|Progression of disease|0|||
155240290|NCT01485861|560311625|FG003|Phase Ib|Progression of disease|0|||
155240291|NCT01485861|560311626|FG004|Phase Ib|Progression of disease|0|||
155240292|NCT01485861|560311627|FG005|Phase Ib|Progression of disease|0|||
155240293|NCT01485861|560311622|FG000|Phase Ib|Other|3|||
155240294|NCT01485861|560311623|FG001|Phase Ib|Other|0|||
155240295|NCT01485861|560311624|FG002|Phase Ib|Other|0|||
155240296|NCT01485861|560311625|FG003|Phase Ib|Other|0|||
155240297|NCT01485861|560311626|FG004|Phase Ib|Other|0|||
155240298|NCT01485861|560311627|FG005|Phase Ib|Other|0|||
155240299|NCT01485861|560311622|FG000|Phase Ib|Withdrawal by Subject|4|||
155240300|NCT01485861|560311623|FG001|Phase Ib|Withdrawal by Subject|1|||
155240301|NCT01485861|560311624|FG002|Phase Ib|Withdrawal by Subject|0|||
155240302|NCT01485861|560311625|FG003|Phase Ib|Withdrawal by Subject|0|||
155240303|NCT01485861|560311626|FG004|Phase Ib|Withdrawal by Subject|0|||
155240304|NCT01485861|560311627|FG005|Phase Ib|Withdrawal by Subject|0|||
155240305|NCT01485861|560311622|FG000|Phase II|Death|0|||
155240306|NCT01485861|560311623|FG001|Phase II|Death|0|||
155240307|NCT01485861|560311624|FG002|Phase II|Death|67|||
155240308|NCT01485861|560311625|FG003|Phase II|Death|71|||
155240309|NCT01485861|560311626|FG004|Phase II|Death|68|||
155240310|NCT01485861|560311627|FG005|Phase II|Death|0|||
155240311|NCT01485861|560311622|FG000|Phase II|Progression of Disease|0|||
155240312|NCT01485861|560311623|FG001|Phase II|Progression of Disease|0|||
155240313|NCT01485861|560311624|FG002|Phase II|Progression of Disease|1|||
155240314|NCT01485861|560311625|FG003|Phase II|Progression of Disease|0|||
155240315|NCT01485861|560311626|FG004|Phase II|Progression of Disease|0|||
155240316|NCT01485861|560311627|FG005|Phase II|Progression of Disease|0|||
155240317|NCT01485861|560311622|FG000|Phase II|Other|0|||
155240318|NCT01485861|560311623|FG001|Phase II|Other|0|||
155240319|NCT01485861|560311624|FG002|Phase II|Other|0|||
155240320|NCT01485861|560311625|FG003|Phase II|Other|1|||
155240321|NCT01485861|560311626|FG004|Phase II|Other|0|||
155240322|NCT01485861|560311627|FG005|Phase II|Other|0|||
155240323|NCT01485861|560311622|FG000|Phase II|Withdrawal by Subject|0|||
155240324|NCT01485861|560311623|FG001|Phase II|Withdrawal by Subject|0|||
155240325|NCT01485861|560311624|FG002|Phase II|Withdrawal by Subject|6|||
155240326|NCT01485861|560311625|FG003|Phase II|Withdrawal by Subject|3|||
155240327|NCT01485861|560311626|FG004|Phase II|Withdrawal by Subject|4|||
155240328|NCT01485861|560311627|FG005|Phase II|Withdrawal by Subject|0|||
155240329|NCT01485861|560311622|FG000|Phase II|Lost to Follow-up|0|||
155240330|NCT01485861|560311623|FG001|Phase II|Lost to Follow-up|0|||
155240331|NCT01485861|560311624|FG002|Phase II|Lost to Follow-up|2|||
155240332|NCT01485861|560311625|FG003|Phase II|Lost to Follow-up|3|||
155240333|NCT01485861|560311626|FG004|Phase II|Lost to Follow-up|5|||
155240334|NCT01485861|560311627|FG005|Phase II|Lost to Follow-up|0|||
155240335|NCT01485861|560311622|FG000|Phase II|Study Ended|0|||
155240336|NCT01485861|560311623|FG001|Phase II|Study Ended|0|||
155240337|NCT01485861|560311624|FG002|Phase II|Study Ended|7|||
155240338|NCT01485861|560311625|FG003|Phase II|Study Ended|8|||
155240339|NCT01485861|560311626|FG004|Phase II|Study Ended|6|||
155240340|NCT01485861|560311627|FG005|Phase II|Study Ended|0|||
155240341|NCT01485861|560311622|FG000|Safety Phase|Death|0|||
155240342|NCT01485861|560311623|FG001|Safety Phase|Death|0|||
155240343|NCT01485861|560311624|FG002|Safety Phase|Death|0|||
155240344|NCT01485861|560311625|FG003|Safety Phase|Death|0|||
155240345|NCT01485861|560311626|FG004|Safety Phase|Death|0|||
155240346|NCT01485861|560311627|FG005|Safety Phase|Death|2|||
155240347|NCT01485861|560311622|FG000|Safety Phase|Adverse Event|0|||
155240348|NCT01485861|560311623|FG001|Safety Phase|Adverse Event|0|||
155240349|NCT01485861|560311624|FG002|Safety Phase|Adverse Event|0|||
155240350|NCT01485861|560311625|FG003|Safety Phase|Adverse Event|0|||
155240351|NCT01485861|560311626|FG004|Safety Phase|Adverse Event|0|||
155240352|NCT01485861|560311627|FG005|Safety Phase|Adverse Event|1|||
155240353|NCT01485861|560311622|FG000|Safety Phase|Other|0|||
155240354|NCT01485861|560311623|FG001|Safety Phase|Other|0|||
155240355|NCT01485861|560311624|FG002|Safety Phase|Other|0|||
155240356|NCT01485861|560311625|FG003|Safety Phase|Other|0|||
155240357|NCT01485861|560311626|FG004|Safety Phase|Other|0|||
155240358|NCT01485861|560311627|FG005|Safety Phase|Other|5|||
155240359|NCT01485861|560311622|FG000|Safety Phase|Progression of Disease|0|||
155240360|NCT01485861|560311623|FG001|Safety Phase|Progression of Disease|0|||
155240361|NCT01485861|560311624|FG002|Safety Phase|Progression of Disease|0|||
155240362|NCT01485861|560311625|FG003|Safety Phase|Progression of Disease|0|||
155240363|NCT01485861|560311626|FG004|Safety Phase|Progression of Disease|0|||
155240364|NCT01485861|560311627|FG005|Safety Phase|Progression of Disease|9|||
155240365|NCT01485861|560311622|FG000|Safety Phase|Withdrawal by Subject|0|||
155240366|NCT01485861|560311623|FG001|Safety Phase|Withdrawal by Subject|0|||
155240367|NCT01485861|560311624|FG002|Safety Phase|Withdrawal by Subject|0|||
155240368|NCT01485861|560311625|FG003|Safety Phase|Withdrawal by Subject|0|||
155240369|NCT01485861|560311626|FG004|Safety Phase|Withdrawal by Subject|0|||
155240370|NCT01485861|560311627|FG005|Safety Phase|Withdrawal by Subject|6|||
155240371|NCT01485861|560311622|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240372|NCT01485861|560311623|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240373|NCT01485861|560311624|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240374|NCT01485861|560311625|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240375|NCT01485861|560311626|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
155240376|NCT01485861|560311627|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
155240377|NCT04111497|560311628|FG000|Overall Study|relapse of primary disease|1|||
155240378|NCT04111497|560311628|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
155240379|NCT03056690|560311629|FG000|Overall Study|Adverse Event|3|||
155240380|NCT03056690|560311630|FG001|Overall Study|Adverse Event|2|||
155240381|NCT03056690|560311629|FG000|Overall Study|Lack of Efficacy|1|||
155240382|NCT03056690|560311630|FG001|Overall Study|Lack of Efficacy|2|||
155240383|NCT03056690|560311629|FG000|Overall Study|Lost to Follow-up|3|||
155240384|NCT03056690|560311630|FG001|Overall Study|Lost to Follow-up|2|||
155240385|NCT03056690|560311629|FG000|Overall Study|Protocol Violation|2|||
155240386|NCT03056690|560311630|FG001|Overall Study|Protocol Violation|2|||
155240387|NCT03056690|560311629|FG000|Overall Study|Withdrawal by Subject|3|||
155240388|NCT03056690|560311630|FG001|Overall Study|Withdrawal by Subject|6|||
155240389|NCT03056690|560311629|FG000|Overall Study|Non-compliance with Study Drug|1|||
155240390|NCT03056690|560311630|FG001|Overall Study|Non-compliance with Study Drug|0|||
155240391|NCT03056690|560311629|FG000|Overall Study|Miscellaneous|1|||
155240392|NCT03056690|560311630|FG001|Overall Study|Miscellaneous|2|||
155240393|NCT02056301|560311632|FG000|Overall Study|Protocol Violation|1|||
155240394|NCT02056301|560311633|FG001|Overall Study|Protocol Violation|2|||
155240395|NCT02056301|560311632|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
155240396|NCT02056301|560311633|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
155240397|NCT02056301|560311632|FG000|Overall Study|Withdrawal by Subject|0|||
155240398|NCT02056301|560311633|FG001|Overall Study|Withdrawal by Subject|1|||
155240399|NCT02056301|560311632|FG000|Overall Study|Issues with epidural|0|||
155240400|NCT02056301|560311633|FG001|Overall Study|Issues with epidural|3|||
155240401|NCT02328326|560311634|FG000|Overall Study|Withdrawal by Subject|10|||
155240402|NCT02328326|560311635|FG001|Overall Study|Withdrawal by Subject|3|||
155240403|NCT02328326|560311634|FG000|Overall Study|Death|2|||
155240404|NCT02328326|560311635|FG001|Overall Study|Death|1|||
155240405|NCT02328326|560311634|FG000|Overall Study|Lost to Follow-up|10|||
155240406|NCT02328326|560311635|FG001|Overall Study|Lost to Follow-up|4|||
155240407|NCT01748994|560311636|FG000|Overall Study|Lost to Follow-up|8|||
155240408|NCT01748994|560311637|FG001|Overall Study|Lost to Follow-up|6|||
155240409|NCT02141516|560311638|FG000|Overall Study|Adverse Event|0|||
155240410|NCT02141516|560311639|FG001|Overall Study|Adverse Event|1|||
155240411|NCT02141516|560311640|FG002|Overall Study|Adverse Event|0|||
155240412|NCT02141516|560311638|FG000|Overall Study|Lost to Follow-up|0|||
155240413|NCT02141516|560311639|FG001|Overall Study|Lost to Follow-up|1|||
155240414|NCT02141516|560311640|FG002|Overall Study|Lost to Follow-up|0|||
155240415|NCT02141516|560311638|FG000|Overall Study|Other|0|||
155240416|NCT02141516|560311639|FG001|Overall Study|Other|3|||
155240417|NCT02141516|560311640|FG002|Overall Study|Other|0|||
155240418|NCT00861341|560311641|FG000|Overall Study|Withdrawal by Subject|2|||
155240419|NCT00983580|560311648|FG000|Overall Study|Cancel Prior to treatment|1|||
155240420|NCT00983580|560311649|FG001|Overall Study|Cancel Prior to treatment|3|||
155240421|NCT00983580|560311648|FG000|Overall Study|Protocol Violation|1|||
155240422|NCT00983580|560311649|FG001|Overall Study|Protocol Violation|1|||
155240423|NCT00983580|560311648|FG000|Overall Study|Ineligible|3|||
155240424|NCT00983580|560311649|FG001|Overall Study|Ineligible|0|||
155240425|NCT01337297|560311651|FG000|Overall Study|They entered to single anodal tDCS|4|||
155240426|NCT01337297|560311652|FG001|Overall Study|They entered to single anodal tDCS|3|||
155240427|NCT01337297|560311651|FG000|Overall Study|Lost to Follow-up|1|||
155240428|NCT01337297|560311652|FG001|Overall Study|Lost to Follow-up|3|||
155240429|NCT02778204|560311653|FG000|Overall Study|Adverse Event|1|||
155240430|NCT02778204|560311654|FG001|Overall Study|Adverse Event|0|||
155240431|NCT02778204|560311655|FG002|Overall Study|Adverse Event|0|||
155240432|NCT02778204|560311656|FG003|Overall Study|Adverse Event|0|||
155240433|NCT02778204|560311653|FG000|Overall Study|Withdrawal by Subject|0|||
155240434|NCT02778204|560311654|FG001|Overall Study|Withdrawal by Subject|0|||
155240435|NCT02778204|560311655|FG002|Overall Study|Withdrawal by Subject|1|||
155240436|NCT02778204|560311656|FG003|Overall Study|Withdrawal by Subject|2|||
155240437|NCT02778204|560311653|FG000|Overall Study|Lost to Follow-up|1|||
155240438|NCT02778204|560311654|FG001|Overall Study|Lost to Follow-up|0|||
155240439|NCT02778204|560311655|FG002|Overall Study|Lost to Follow-up|2|||
155240440|NCT02778204|560311656|FG003|Overall Study|Lost to Follow-up|1|||
155240441|NCT02778204|560311653|FG000|Overall Study|Protocol Violation|0|||
155240442|NCT02778204|560311654|FG001|Overall Study|Protocol Violation|0|||
155240443|NCT02778204|560311655|FG002|Overall Study|Protocol Violation|1|||
155240444|NCT02778204|560311656|FG003|Overall Study|Protocol Violation|0|||
155240445|NCT02778204|560311653|FG000|Overall Study|Eligibility Violation|0|||
155240446|NCT02778204|560311654|FG001|Overall Study|Eligibility Violation|0|||
155240447|NCT02778204|560311655|FG002|Overall Study|Eligibility Violation|0|||
155240448|NCT02778204|560311656|FG003|Overall Study|Eligibility Violation|1|||
155240449|NCT04122443|560311657|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
155240450|NCT04122443|560311658|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
155240451|NCT04122443|560311659|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
155240452|NCT04122443|560311657|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
155240453|NCT04122443|560311658|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
155240454|NCT04122443|560311659|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
155240455|NCT01072201|560311660|FG000|Overall Study|Lost to Follow-up|0|||
155240456|NCT01072201|560311661|FG001|Overall Study|Lost to Follow-up|1|||
155240457|NCT00360334|560311662|FG000|Overall Study|Adverse Event|7|||
155240458|NCT00360334|560311663|FG001|Overall Study|Adverse Event|4|||
155240459|NCT00360334|560311662|FG000|Overall Study|Protocol Violation|1|||
155240460|NCT00360334|560311663|FG001|Overall Study|Protocol Violation|1|||
155240461|NCT00360334|560311662|FG000|Overall Study|Physician Decision|2|||
155240462|NCT00360334|560311663|FG001|Overall Study|Physician Decision|3|||
155240463|NCT00360334|560311662|FG000|Overall Study|Lack of Efficacy|0|||
155240464|NCT00360334|560311663|FG001|Overall Study|Lack of Efficacy|1|||
155240465|NCT00360334|560311662|FG000|Overall Study|Entry criterion not met|1|||
155240466|NCT00360334|560311663|FG001|Overall Study|Entry criterion not met|2|||
155240467|NCT00360334|560311662|FG000|Overall Study|Subject decision|8|||
155240468|NCT00360334|560311663|FG001|Overall Study|Subject decision|2|||
155240469|NCT01916304|560311664|FG000|Overall Study|Screening failure|17|||
155240470|NCT01898793|560311665|FG000|Overall Study|Death|2|||
155240471|NCT01898793|560311666|FG001|Overall Study|Death|1|||
155240472|NCT01898793|560311667|FG002|Overall Study|Death|4|||
155240473|NCT01898793|560311668|FG003|Overall Study|Death|0|||
155240474|NCT01898793|560311669|FG004|Overall Study|Death|0|||
155240475|NCT01898793|560311670|FG005|Overall Study|Death|0|||
155240476|NCT01898793|560311671|FG006|Overall Study|Death|0|||
155240477|NCT01306617|560311677|FG000|Overall Study|Adverse Event|1|||
155240478|NCT01306617|560311678|FG001|Overall Study|Adverse Event|0|||
155240479|NCT01306617|560311679|FG002|Overall Study|Adverse Event|0|||
155240480|NCT01306617|560311677|FG000|Overall Study|Virologic Failure|0|||
155240481|NCT01306617|560311678|FG001|Overall Study|Virologic Failure|0|||
155240482|NCT01306617|560311679|FG002|Overall Study|Virologic Failure|5|||
155240483|NCT01306617|560311677|FG000|Overall Study|Non-compliance|0|||
155240484|NCT01306617|560311678|FG001|Overall Study|Non-compliance|1|||
155240485|NCT01306617|560311679|FG002|Overall Study|Non-compliance|0|||
155240486|NCT04028388|560311687|FG000|Overall Study|Evaluations missing|3|||
155240487|NCT04028388|560311688|FG001|Overall Study|Evaluations missing|6|||
155240488|NCT04028388|560311687|FG000|Overall Study|Not started|2|||
155240489|NCT04028388|560311688|FG001|Overall Study|Not started|0|||
155240490|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240491|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240492|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240493|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240494|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240495|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240496|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240497|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240498|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240499|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240500|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240501|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
155240502|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240503|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240504|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240505|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
155240506|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240507|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
155240508|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
155240509|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
155240510|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
155240511|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
155240512|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
155240513|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
155240514|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
155240515|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
155240516|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
155240517|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
155240518|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240519|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240520|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240521|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
155240522|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240523|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240524|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240525|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240526|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240527|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
155240528|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
155240529|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240530|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240531|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
155240532|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
155240533|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
155240534|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240535|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240536|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240537|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
155240538|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240539|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240540|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240541|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240542|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240543|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
155240544|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240545|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240546|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240547|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240548|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240549|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
155240550|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240551|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240552|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240553|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
155240554|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240555|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240556|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240557|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240558|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240559|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
155240560|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240561|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240562|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240563|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240564|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240565|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240566|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240567|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240568|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240569|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
155240570|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240571|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240572|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240573|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240574|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240575|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240576|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240577|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240578|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
155240579|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240580|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240581|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240582|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240583|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240584|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240585|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
155240586|NCT01609556|560311695|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
155240587|NCT01609556|560311696|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240588|NCT01609556|560311697|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240589|NCT01609556|560311698|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240590|NCT01609556|560311699|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240591|NCT01609556|560311700|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
155240592|NCT01609556|560311701|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240593|NCT01609556|560311702|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240594|NCT01609556|560311703|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240595|NCT01609556|560311704|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240596|NCT01609556|560311705|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
155240597|NCT01609556|560311706|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240598|NCT01609556|560311707|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240599|NCT01609556|560311708|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240600|NCT01609556|560311709|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240601|NCT01609556|560311710|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
155240602|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240603|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240604|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240605|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240606|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240607|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240608|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240609|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240610|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240611|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240612|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240613|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
155240614|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
155240615|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
155240616|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
155240617|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
155240618|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240619|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240620|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240621|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240622|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240623|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240624|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240625|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240626|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240627|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240628|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240629|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
155240630|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
155240631|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
155240632|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
155240633|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
155240634|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240635|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240636|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240637|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240638|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240639|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240640|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240641|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240642|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240643|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240644|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240645|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
155240646|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
155240647|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
155240648|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
155240649|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
155240650|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240651|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240652|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240653|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240654|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240655|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240656|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240657|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240658|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240659|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240660|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240661|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240662|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
155240663|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240664|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240665|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
155240666|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240667|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240668|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240669|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240670|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240671|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240672|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240673|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240674|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240675|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240676|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240677|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
155240678|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
155240679|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
155240680|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
155240681|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
155240682|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240683|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240684|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240685|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240686|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240687|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240688|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240689|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240690|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240691|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240692|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240693|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240694|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240695|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240696|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
155240697|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
155240698|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240699|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240700|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240701|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240702|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240703|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240704|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240705|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240706|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240707|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240708|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240709|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240710|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
155240711|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
155240712|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
155240713|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
155240714|NCT01609556|560311695|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240715|NCT01609556|560311696|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240716|NCT01609556|560311697|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240717|NCT01609556|560311698|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240718|NCT01609556|560311699|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240719|NCT01609556|560311700|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240720|NCT01609556|560311701|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240721|NCT01609556|560311702|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240722|NCT01609556|560311703|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240723|NCT01609556|560311704|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240724|NCT01609556|560311705|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240725|NCT01609556|560311706|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240726|NCT01609556|560311707|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
155240727|NCT01609556|560311708|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240728|NCT01609556|560311709|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240729|NCT01609556|560311710|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
155240730|NCT01632579|560311713|FG000|Washout Period|Adverse Event|1|||
155240731|NCT01632579|560311714|FG001|Washout Period|Adverse Event|0|||
155240732|NCT01632579|560311715|FG002|Washout Period|Adverse Event|0|||
155240733|NCT01632579|560311716|FG003|Washout Period|Adverse Event|0|||
155240734|NCT01632579|560311717|FG004|Washout Period|Adverse Event|0|||
155240735|NCT01632579|560311718|FG005|Washout Period|Adverse Event|0|||
155240736|NCT01632579|560311719|FG006|Washout Period|Adverse Event|0|||
155240737|NCT01632579|560311720|FG007|Washout Period|Adverse Event|0|||
155240738|NCT01632579|560311721|FG008|Washout Period|Adverse Event|0|||
155240739|NCT01632579|560311713|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
155240740|NCT01632579|560311714|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
155240741|NCT01632579|560311715|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
155240742|NCT01632579|560311716|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
155240743|NCT01632579|560311717|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
155240744|NCT01632579|560311718|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
155240745|NCT01632579|560311719|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
155240746|NCT01632579|560311720|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
155240747|NCT01632579|560311721|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
155240748|NCT02788175|560311722|FG000|Overall Study|Protocol Violation|3|||
155240749|NCT02788175|560311722|FG000|Overall Study|Withdrawal by Subject|4|||
155240750|NCT02788175|560311722|FG000|Overall Study|Ineligible prior to study agent|6|||
155240751|NCT00162136|560311723|FG000|Overall Study|Adverse Event|1|||
155240752|NCT00162136|560311723|FG000|Overall Study|Death|1|||
155240753|NCT00162136|560311723|FG000|Overall Study|Disease Progression/Relapse|23|||
155240754|NCT00162136|560311723|FG000|Overall Study|Investigator Request|5|||
155240755|NCT00162136|560311723|FG000|Overall Study|Study Drug Toxicity|4|||
155240756|NCT00162136|560311723|FG000|Overall Study|Withdrawal by Subject|1|||
155240757|NCT00898677|560311726|FG000|Overall Study|Adverse Event|0|||
155240758|NCT00898677|560311727|FG001|Overall Study|Adverse Event|0|||
155240759|NCT00898677|560311728|FG002|Overall Study|Adverse Event|1|||
155240760|NCT00898677|560311729|FG003|Overall Study|Adverse Event|0|||
155240761|NCT00898677|560311726|FG000|Overall Study|Lost to Follow-up|0|||
155240762|NCT00898677|560311727|FG001|Overall Study|Lost to Follow-up|0|||
155240763|NCT00898677|560311728|FG002|Overall Study|Lost to Follow-up|2|||
155240764|NCT00898677|560311729|FG003|Overall Study|Lost to Follow-up|0|||
155240765|NCT00898677|560311726|FG000|Overall Study|Protocol Violation|1|||
155240766|NCT00898677|560311727|FG001|Overall Study|Protocol Violation|1|||
155240767|NCT00898677|560311728|FG002|Overall Study|Protocol Violation|2|||
155240768|NCT00898677|560311729|FG003|Overall Study|Protocol Violation|0|||
155240769|NCT00898677|560311726|FG000|Overall Study|Withdrawal by Subject|0|||
155240770|NCT00898677|560311727|FG001|Overall Study|Withdrawal by Subject|0|||
155240771|NCT00898677|560311728|FG002|Overall Study|Withdrawal by Subject|0|||
155240772|NCT00898677|560311729|FG003|Overall Study|Withdrawal by Subject|1|||
155240773|NCT00898677|560311726|FG000|Overall Study|Not Treated: Adverse Event|0|||
155240774|NCT00898677|560311727|FG001|Overall Study|Not Treated: Adverse Event|2|||
155240775|NCT00898677|560311728|FG002|Overall Study|Not Treated: Adverse Event|1|||
155240776|NCT00898677|560311729|FG003|Overall Study|Not Treated: Adverse Event|0|||
155240777|NCT00898677|560311726|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
155240778|NCT00898677|560311727|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
155240779|NCT00898677|560311728|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
155240780|NCT00898677|560311729|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
155240781|NCT00898677|560311726|FG000|Overall Study|Not Treated: Pregnancy|0|||
155240782|NCT00898677|560311727|FG001|Overall Study|Not Treated: Pregnancy|0|||
155240783|NCT00898677|560311728|FG002|Overall Study|Not Treated: Pregnancy|1|||
155240784|NCT00898677|560311729|FG003|Overall Study|Not Treated: Pregnancy|0|||
155240785|NCT00898677|560311726|FG000|Overall Study|Not Treated: Protocol Violation|2|||
155240786|NCT00898677|560311727|FG001|Overall Study|Not Treated: Protocol Violation|0|||
155240787|NCT00898677|560311728|FG002|Overall Study|Not Treated: Protocol Violation|2|||
155240788|NCT00898677|560311729|FG003|Overall Study|Not Treated: Protocol Violation|0|||
155240789|NCT00898677|560311726|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
155240790|NCT00898677|560311727|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
155240791|NCT00898677|560311728|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
155240792|NCT00898677|560311729|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
155240793|NCT00898677|560311726|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
155240794|NCT00898677|560311727|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
155240795|NCT00898677|560311728|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
155240796|NCT00898677|560311729|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
155240797|NCT00898677|560311726|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
155240798|NCT00898677|560311727|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
155240799|NCT00898677|560311728|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
155240800|NCT00898677|560311729|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
155240801|NCT00898677|560311726|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
155240802|NCT00898677|560311727|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
155240803|NCT00898677|560311728|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
155240804|NCT00898677|560311729|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
155240805|NCT00898677|560311726|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
155240806|NCT00898677|560311727|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
155240807|NCT00898677|560311728|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
155240808|NCT00898677|560311729|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
155240809|NCT00898677|560311726|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
155240810|NCT00898677|560311727|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
155240811|NCT00898677|560311728|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
155240812|NCT00898677|560311729|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
155240813|NCT00898677|560311726|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
155240814|NCT00898677|560311727|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
155240815|NCT00898677|560311728|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
155240816|NCT00898677|560311729|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
155240817|NCT00836875|560311731|FG000|Overall Study|Death|3|||
155240818|NCT00836875|560311732|FG001|Overall Study|Death|2|||
155240819|NCT00836875|560311731|FG000|Overall Study|Withdrawal by Subject|0|||
155240820|NCT00836875|560311732|FG001|Overall Study|Withdrawal by Subject|1|||
155240821|NCT01539291|560313540|FG000|Study GS-US-312-0116|Adverse Event|9|||
155240822|NCT01539291|560313541|FG001|Study GS-US-312-0116|Adverse Event|0|||
155240823|NCT01539291|560313542|FG002|Study GS-US-312-0116|Adverse Event|0|||
155240824|NCT01539291|560313543|FG003|Study GS-US-312-0116|Adverse Event|0|||
155240825|NCT01539291|560313540|FG000|Study GS-US-312-0116|Physician Decision|1|||
155240826|NCT01539291|560313541|FG001|Study GS-US-312-0116|Physician Decision|0|||
155240827|NCT01539291|560313542|FG002|Study GS-US-312-0116|Physician Decision|0|||
155240828|NCT01539291|560313543|FG003|Study GS-US-312-0116|Physician Decision|0|||
155240829|NCT01539291|560313540|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
155240830|NCT01539291|560313541|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
155240831|NCT01539291|560313542|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
155240832|NCT01539291|560313543|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
155240833|NCT01539291|560313540|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
155240834|NCT01539291|560313541|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
155240835|NCT01539291|560313542|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
155240836|NCT01539291|560313543|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
155240837|NCT01539291|560313540|FG000|Study GS-US-312-0116|Other|1|||
155240838|NCT01539291|560313541|FG001|Study GS-US-312-0116|Other|0|||
155240839|NCT01539291|560313542|FG002|Study GS-US-312-0116|Other|0|||
155240840|NCT01539291|560313543|FG003|Study GS-US-312-0116|Other|0|||
155240841|NCT01539291|560313540|FG000|Study GS-US-312-0117|Adverse Event|22|||
155240842|NCT01539291|560313541|FG001|Study GS-US-312-0117|Adverse Event|1|||
155240843|NCT01539291|560313542|FG002|Study GS-US-312-0117|Adverse Event|9|||
155240844|NCT01539291|560313543|FG003|Study GS-US-312-0117|Adverse Event|12|||
155240845|NCT01539291|560313540|FG000|Study GS-US-312-0117|Physician Decision|9|||
155240846|NCT01539291|560313541|FG001|Study GS-US-312-0117|Physician Decision|0|||
155240847|NCT01539291|560313542|FG002|Study GS-US-312-0117|Physician Decision|6|||
155240848|NCT01539291|560313543|FG003|Study GS-US-312-0117|Physician Decision|4|||
155240849|NCT01539291|560313540|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
155240850|NCT01539291|560313541|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
155240851|NCT01539291|560313542|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
155240852|NCT01539291|560313543|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
155240853|NCT01539291|560313540|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
155240854|NCT01539291|560313541|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
155240855|NCT01539291|560313542|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
155240856|NCT01539291|560313543|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
155240857|NCT01539291|560313540|FG000|Study GS-US-312-0117|Other|2|||
155240858|NCT01539291|560313541|FG001|Study GS-US-312-0117|Other|1|||
155240859|NCT01539291|560313542|FG002|Study GS-US-312-0117|Other|1|||
155240860|NCT01539291|560313543|FG003|Study GS-US-312-0117|Other|1|||
155240861|NCT01045447|560313556|FG000|Overall Study|Adverse Event|0|||
155240862|NCT01045447|560313557|FG001|Overall Study|Adverse Event|1|||
155240863|NCT01045447|560313556|FG000|Overall Study|Lack of Efficacy|3|||
155240864|NCT01045447|560313557|FG001|Overall Study|Lack of Efficacy|1|||
155240865|NCT01045447|560313556|FG000|Overall Study|Protocol Violation|6|||
155240866|NCT01045447|560313557|FG001|Overall Study|Protocol Violation|3|||
155240867|NCT01045447|560313556|FG000|Overall Study|Withdrawal Criteria|10|||
155240868|NCT01045447|560313557|FG001|Overall Study|Withdrawal Criteria|10|||
155240869|NCT01045447|560313556|FG000|Overall Study|Unclassified|17|||
155240870|NCT01045447|560313557|FG001|Overall Study|Unclassified|13|||
155240871|NCT00129987|560313558|FG000|1st Educational Session|Withdrawal by Subject|141|||
155240872|NCT00129987|560313559|FG001|1st Educational Session|Withdrawal by Subject|109|||
155240873|NCT00129987|560313558|FG000|1 Year|Withdrawal by Subject|32|||
155240874|NCT00129987|560313559|FG001|1 Year|Withdrawal by Subject|21|||
155240875|NCT00116805|560313560|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
155240876|NCT00116805|560313561|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
155240877|NCT00116805|560313560|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
155240878|NCT00116805|560313561|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
155240879|NCT00116805|560313560|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
155240880|NCT00116805|560313561|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
155240881|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
155240882|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
155240883|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
155240884|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
155240885|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
155240886|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
155240887|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
155240888|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
155240889|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
155240890|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
155240891|NCT00116805|560313560|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
155240892|NCT00116805|560313561|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
155240893|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
155240894|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
155240895|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
155240896|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
155240897|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
155240898|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
155240899|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
155240900|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
155240901|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
155240902|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
155240903|NCT00116805|560313560|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
155240904|NCT00116805|560313561|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
155240905|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
155240906|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
155240907|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
155240908|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
155240909|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
155240910|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
155240911|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
155240912|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
155240913|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
155240914|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
155240915|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
155240916|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
155240917|NCT00116805|560313560|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
155240918|NCT00116805|560313561|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
155240919|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
155240920|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
155240921|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
155240922|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
155240923|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
155240924|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
155240925|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
155240926|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
155240927|NCT00116805|560313560|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
155240928|NCT00116805|560313561|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
155240929|NCT00116805|560313560|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
155240930|NCT00116805|560313561|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
155240931|NCT00116805|560313560|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
155240932|NCT00116805|560313561|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
155240933|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
155240934|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
155240935|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
155240936|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
155240937|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
155240938|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
155240939|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
155240940|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
155240941|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
155240942|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
155240943|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
155240944|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
155240945|NCT00116805|560313560|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
155240946|NCT00116805|560313561|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
155240947|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
155240948|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
155240949|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
155240950|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
155240951|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
155240952|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
155240953|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
155240954|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
155240955|NCT00116805|560313560|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
155240956|NCT00116805|560313561|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
155240957|NCT00116805|560313560|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
155240958|NCT00116805|560313561|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
155240959|NCT00116805|560313560|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
155240960|NCT00116805|560313561|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
155240961|NCT00116805|560313560|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
155240962|NCT00116805|560313561|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
155240963|NCT00116805|560313560|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
155240964|NCT00116805|560313561|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
155240965|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
155240966|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
155240967|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
155240968|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
155240969|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Adverse Event|5|||
155240970|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Adverse Event|3|||
155240971|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Adverse Event|4|||
155240972|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Adverse Event|10|||
155240973|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
155240974|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
155240975|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
155240976|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
155240977|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
155240978|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
155240979|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
155240980|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
155240981|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Pregnancy|5|||
155240982|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Pregnancy|0|||
155240983|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Pregnancy|3|||
155240984|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Pregnancy|2|||
155240985|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Non-compliance|1|||
155240986|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Non-compliance|4|||
155240987|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Non-compliance|0|||
155240988|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Non-compliance|3|||
155240989|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Other|0|||
155240990|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Other|3|||
155240991|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Other|3|||
155240992|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Other|1|||
155240993|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
155240994|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
155240995|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
155240996|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
155240997|NCT01760954|560313562|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
155240998|NCT01760954|560313563|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
155240999|NCT01760954|560313564|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
155241000|NCT01760954|560313565|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
155241001|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
155241002|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
155241003|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
155241004|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
155241005|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
155241006|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
155241007|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
155241008|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
155241009|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
155241010|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
155241011|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
155241012|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
155241013|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
155241014|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
155241015|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
155241016|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
155241017|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
155241018|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
155241019|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
155241020|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
155241021|NCT01760954|560313562|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
155241022|NCT01760954|560313563|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
155241023|NCT01760954|560313564|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
155241024|NCT01760954|560313565|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
155241025|NCT01159938|560313566|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241026|NCT01159938|560313567|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241027|NCT01159938|560313568|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
155241028|NCT01159938|560313569|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241029|NCT01159938|560313570|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
155241030|NCT04837482|560313571|FG000|Period 2|Withdrawal by Subject|0|||
155241031|NCT04837482|560313572|FG001|Period 2|Withdrawal by Subject|1|||
155241032|NCT00587587|560313573|FG000|Overall Study|Lost to Follow-up|6|||
155241033|NCT00587587|560313574|FG001|Overall Study|Lost to Follow-up|1|||
155241034|NCT04808609|560313582|FG000|Overall Study|Lost to Follow-up|0|||
155241035|NCT04808609|560313583|FG001|Overall Study|Lost to Follow-up|2|||
155241036|NCT04808609|560313582|FG000|Overall Study|Administrative Withdrawal|0|||
155241037|NCT04808609|560313583|FG001|Overall Study|Administrative Withdrawal|1|||
155241038|NCT00562159|560313584|FG000|Overall Study|Adverse Event|11|||
155241039|NCT00562159|560313585|FG001|Overall Study|Adverse Event|8|||
155241040|NCT00562159|560313584|FG000|Overall Study|Lost to Follow-up|5|||
155241041|NCT00562159|560313585|FG001|Overall Study|Lost to Follow-up|4|||
155241042|NCT00562159|560313584|FG000|Overall Study|Withdrawal by Subject|9|||
155241043|NCT00562159|560313585|FG001|Overall Study|Withdrawal by Subject|8|||
155241044|NCT00562159|560313584|FG000|Overall Study|Protocol Violation|12|||
155241045|NCT00562159|560313585|FG001|Overall Study|Protocol Violation|12|||
155241046|NCT00562159|560313584|FG000|Overall Study|Did not meet protocol eligibility|1|||
155241047|NCT00562159|560313585|FG001|Overall Study|Did not meet protocol eligibility|1|||
155241048|NCT01181921|560313586|FG000|Overall Study|Lost to Follow-up|1|||
155241049|NCT01762761|560313587|FG000|Overall Study|Adverse Event|15|||
155241050|NCT01762761|560313588|FG001|Overall Study|Adverse Event|17|||
155241051|NCT01762761|560313587|FG000|Overall Study|Lack of Efficacy|9|||
155241052|NCT01762761|560313588|FG001|Overall Study|Lack of Efficacy|25|||
155241053|NCT01762761|560313587|FG000|Overall Study|Protocol Violation|1|||
155241054|NCT01762761|560313588|FG001|Overall Study|Protocol Violation|1|||
155241055|NCT01762761|560313587|FG000|Overall Study|Study closed/terminated|0|||
155241056|NCT01762761|560313588|FG001|Overall Study|Study closed/terminated|2|||
155241057|NCT01762761|560313587|FG000|Overall Study|Lost to Follow-up|3|||
155241058|NCT01762761|560313588|FG001|Overall Study|Lost to Follow-up|6|||
155241059|NCT01762761|560313587|FG000|Overall Study|Physician Decision|4|||
155241060|NCT01762761|560313588|FG001|Overall Study|Physician Decision|6|||
155241061|NCT01762761|560313587|FG000|Overall Study|Withdrawal by Subject|7|||
155241062|NCT01762761|560313588|FG001|Overall Study|Withdrawal by Subject|8|||
155241063|NCT01709227|560313589|FG000|Overall Study|Physician Decision|1|||
155241064|NCT01709227|560313590|FG001|Overall Study|Physician Decision|0|||
155241065|NCT01709227|560313589|FG000|Overall Study|Pleural Peritoneal communication|0|||
155241066|NCT01709227|560313590|FG001|Overall Study|Pleural Peritoneal communication|9|||
155241067|NCT02317575|560313591|FG000|Period 1|Difficulty with venous cannulation|0|||
155241068|NCT02317575|560313592|FG001|Period 1|Difficulty with venous cannulation|1|||
155241069|NCT02317575|560313593|FG002|Period 1|Difficulty with venous cannulation|0|||
155241070|NCT02317575|560313594|FG003|Period 1|Difficulty with venous cannulation|0|||
155241071|NCT02317575|560313595|FG004|Period 1|Difficulty with venous cannulation|0|||
155241072|NCT02317575|560313591|FG000|Period 1|Withdrawal by Subject|1|||
155241073|NCT02317575|560313592|FG001|Period 1|Withdrawal by Subject|0|||
155241074|NCT02317575|560313593|FG002|Period 1|Withdrawal by Subject|0|||
155241075|NCT02317575|560313594|FG003|Period 1|Withdrawal by Subject|0|||
155241076|NCT02317575|560313595|FG004|Period 1|Withdrawal by Subject|0|||
155241077|NCT01046110|560313596|FG000|Overall Study|Adverse Event|9|||
155241078|NCT01046110|560313597|FG001|Overall Study|Adverse Event|2|||
155241079|NCT01046110|560313596|FG000|Overall Study|Lack of Efficacy|0|||
155241080|NCT01046110|560313597|FG001|Overall Study|Lack of Efficacy|1|||
155241081|NCT01046110|560313596|FG000|Overall Study|Protocol Violation|7|||
155241082|NCT01046110|560313597|FG001|Overall Study|Protocol Violation|12|||
155241083|NCT01046110|560313596|FG000|Overall Study|Withdrawal Criteria|3|||
155241084|NCT01046110|560313597|FG001|Overall Study|Withdrawal Criteria|5|||
155241085|NCT01046110|560313596|FG000|Overall Study|Unclassified|36|||
155241086|NCT01046110|560313597|FG001|Overall Study|Unclassified|35|||
155241087|NCT01202773|560313598|FG000|Overall Study|Adverse Event|4|||
155241088|NCT01202773|560313599|FG001|Overall Study|Adverse Event|5|||
155241089|NCT01202773|560313600|FG002|Overall Study|Adverse Event|5|||
155241090|NCT01202773|560313598|FG000|Overall Study|Lack of Efficacy|5|||
155241091|NCT01202773|560313599|FG001|Overall Study|Lack of Efficacy|4|||
155241092|NCT01202773|560313600|FG002|Overall Study|Lack of Efficacy|9|||
155241093|NCT01202773|560313598|FG000|Overall Study|Entry Criteria Not Met|2|||
155241094|NCT01202773|560313599|FG001|Overall Study|Entry Criteria Not Met|0|||
155241095|NCT01202773|560313600|FG002|Overall Study|Entry Criteria Not Met|1|||
155241096|NCT01202773|560313598|FG000|Overall Study|Lost to Follow-up|1|||
155241097|NCT01202773|560313599|FG001|Overall Study|Lost to Follow-up|2|||
155241098|NCT01202773|560313600|FG002|Overall Study|Lost to Follow-up|2|||
155241099|NCT01202773|560313598|FG000|Overall Study|Withdrawal by Subject|13|||
155241100|NCT01202773|560313599|FG001|Overall Study|Withdrawal by Subject|6|||
155241101|NCT01202773|560313600|FG002|Overall Study|Withdrawal by Subject|5|||
155241102|NCT01202773|560313598|FG000|Overall Study|Physician Decision|2|||
155241103|NCT01202773|560313599|FG001|Overall Study|Physician Decision|0|||
155241104|NCT01202773|560313600|FG002|Overall Study|Physician Decision|0|||
155241105|NCT01202773|560313598|FG000|Overall Study|Protocol Violation|11|||
155241106|NCT01202773|560313599|FG001|Overall Study|Protocol Violation|6|||
155241107|NCT01202773|560313600|FG002|Overall Study|Protocol Violation|10|||
155241108|NCT01202773|560313598|FG000|Overall Study|Sponsor Decision|19|||
155241109|NCT01202773|560313599|FG001|Overall Study|Sponsor Decision|20|||
155241110|NCT01202773|560313600|FG002|Overall Study|Sponsor Decision|23|||
155241111|NCT02828111|560313605|FG000|Overall Study|Withdrawal by Subject|0|||
155241112|NCT02828111|560313606|FG001|Overall Study|Withdrawal by Subject|0|||
155241113|NCT02828111|560313607|FG002|Overall Study|Withdrawal by Subject|2|||
155241114|NCT02828111|560313608|FG003|Overall Study|Withdrawal by Subject|0|||
155241115|NCT02828111|560313609|FG004|Overall Study|Withdrawal by Subject|0|||
155241116|NCT02828111|560313605|FG000|Overall Study|Lost to Follow-up|0|||
155241117|NCT02828111|560313606|FG001|Overall Study|Lost to Follow-up|0|||
155241118|NCT02828111|560313607|FG002|Overall Study|Lost to Follow-up|0|||
155241119|NCT02828111|560313608|FG003|Overall Study|Lost to Follow-up|1|||
155241120|NCT02828111|560313609|FG004|Overall Study|Lost to Follow-up|1|||
155241121|NCT03465540|560313610|FG000|Overall Study|Withdrawal by Subject|0|||
155241122|NCT03465540|560313611|FG001|Overall Study|Withdrawal by Subject|0|||
155241123|NCT03465540|560313612|FG002|Overall Study|Withdrawal by Subject|1|||
155241124|NCT03465540|560313613|FG003|Overall Study|Withdrawal by Subject|1|||
155241125|NCT03465540|560313614|FG004|Overall Study|Withdrawal by Subject|1|||
155241126|NCT03465540|560313615|FG005|Overall Study|Withdrawal by Subject|0|||
155241127|NCT03465540|560313610|FG000|Overall Study|Lost to Follow-up|0|||
155241128|NCT03465540|560313611|FG001|Overall Study|Lost to Follow-up|1|||
155241129|NCT03465540|560313612|FG002|Overall Study|Lost to Follow-up|0|||
155241130|NCT03465540|560313613|FG003|Overall Study|Lost to Follow-up|0|||
155241131|NCT03465540|560313614|FG004|Overall Study|Lost to Follow-up|1|||
155241132|NCT03465540|560313615|FG005|Overall Study|Lost to Follow-up|0|||
155241133|NCT03465540|560313610|FG000|Overall Study|Death|1|||
155241134|NCT03465540|560313611|FG001|Overall Study|Death|1|||
155241135|NCT03465540|560313612|FG002|Overall Study|Death|0|||
155241136|NCT03465540|560313613|FG003|Overall Study|Death|2|||
155241137|NCT03465540|560313614|FG004|Overall Study|Death|0|||
155241138|NCT03465540|560313615|FG005|Overall Study|Death|2|||
155241139|NCT03465540|560313610|FG000|Overall Study|Protocol specified criteria|0|||
155241140|NCT03465540|560313611|FG001|Overall Study|Protocol specified criteria|2|||
155241141|NCT03465540|560313612|FG002|Overall Study|Protocol specified criteria|2|||
155241142|NCT03465540|560313613|FG003|Overall Study|Protocol specified criteria|0|||
155241143|NCT03465540|560313614|FG004|Overall Study|Protocol specified criteria|2|||
155241144|NCT03465540|560313615|FG005|Overall Study|Protocol specified criteria|0|||
155241145|NCT04096560|560313616|FG000|Overall Study|Reason not Specified|1|||
155241146|NCT04096560|560313617|FG001|Overall Study|Reason not Specified|0|||
155241147|NCT04096560|560313618|FG002|Overall Study|Reason not Specified|0|||
155241148|NCT04096560|560313619|FG003|Overall Study|Reason not Specified|0|||
155241149|NCT04096560|560313620|FG004|Overall Study|Reason not Specified|1|||
155241150|NCT04096560|560313621|FG005|Overall Study|Reason not Specified|1|||
155241151|NCT04096560|560313622|FG006|Overall Study|Reason not Specified|1|||
155241152|NCT04096560|560313623|FG007|Overall Study|Reason not Specified|0|||
155241153|NCT04096560|560313616|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241154|NCT04096560|560313617|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241155|NCT04096560|560313618|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241156|NCT04096560|560313619|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241157|NCT04096560|560313620|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241158|NCT04096560|560313621|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
155241159|NCT04096560|560313622|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
155241160|NCT04096560|560313623|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
155241161|NCT04096560|560313616|FG000|Overall Study|Study Terminated by Sponsor|0|||
155241162|NCT04096560|560313617|FG001|Overall Study|Study Terminated by Sponsor|0|||
155241163|NCT04096560|560313618|FG002|Overall Study|Study Terminated by Sponsor|0|||
155241164|NCT04096560|560313619|FG003|Overall Study|Study Terminated by Sponsor|5|||
155241165|NCT04096560|560313620|FG004|Overall Study|Study Terminated by Sponsor|6|||
155241166|NCT04096560|560313621|FG005|Overall Study|Study Terminated by Sponsor|4|||
155241167|NCT04096560|560313622|FG006|Overall Study|Study Terminated by Sponsor|6|||
155241168|NCT04096560|560313623|FG007|Overall Study|Study Terminated by Sponsor|1|||
155241169|NCT04096560|560313616|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241170|NCT04096560|560313617|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241171|NCT04096560|560313618|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241172|NCT04096560|560313619|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241173|NCT04096560|560313620|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241174|NCT04096560|560313621|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241175|NCT04096560|560313622|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
155241176|NCT04096560|560313623|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
155241177|NCT00833924|560313626|FG000|Overall Study|Death|21|||
155241178|NCT00833924|560313626|FG000|Overall Study|Conversion|2|||
155241179|NCT00833924|560313626|FG000|Overall Study|Lost to Follow-up|2|||
155241180|NCT00833924|560313626|FG000|Overall Study|Withdrawal by Subject|13|||
155241181|NCT00833924|560313626|FG000|Overall Study|In study follow-up|71|||
155241182|NCT00096941|560313631|FG000|Overall Study|disease progression|3|||
155241183|NCT02401672|560313632|FG000|Overall Study|Withdrawal by Subject|1|||
155241184|NCT02401672|560313633|FG001|Overall Study|Withdrawal by Subject|3|||
155241185|NCT04796610|560313634|FG000|Overall Study|Withdrawal by Subject|1|||
155241186|NCT04796610|560313635|FG001|Overall Study|Withdrawal by Subject|0|||
155241187|NCT04796610|560313636|FG002|Overall Study|Withdrawal by Subject|0|||
155241188|NCT04796610|560313637|FG003|Overall Study|Withdrawal by Subject|0|||
155241189|NCT04796610|560313634|FG000|Overall Study|Lost to Follow-up|2|||
155241190|NCT04796610|560313635|FG001|Overall Study|Lost to Follow-up|0|||
155241191|NCT04796610|560313636|FG002|Overall Study|Lost to Follow-up|1|||
155241192|NCT04796610|560313637|FG003|Overall Study|Lost to Follow-up|1|||
155241193|NCT00733824|560313638|FG000|Phase I|Withdrawal by Subject|1|||
155241194|NCT00733824|560313639|FG001|Phase I|Withdrawal by Subject|0|||
155241195|NCT00733824|560313640|FG002|Phase I|Withdrawal by Subject|0|||
155241196|NCT00733824|560313641|FG003|Phase I|Withdrawal by Subject|0|||
155241197|NCT00733824|560313642|FG004|Phase I|Withdrawal by Subject|0|||
155241198|NCT01459796|560313643|FG000|Overall Study|Non compliance with protocol|2|||
155241199|NCT01459796|560313644|FG001|Overall Study|Non compliance with protocol|4|||
155241200|NCT01459796|560313643|FG000|Overall Study|Adverse Event|5|||
155241201|NCT01459796|560313644|FG001|Overall Study|Adverse Event|5|||
155241202|NCT01459796|560313643|FG000|Overall Study|Withdrawal by Subject|6|||
155241203|NCT01459796|560313644|FG001|Overall Study|Withdrawal by Subject|3|||
155241204|NCT01459796|560313643|FG000|Overall Study|Lost to Follow-up|5|||
155241205|NCT01459796|560313644|FG001|Overall Study|Lost to Follow-up|4|||
155241206|NCT01459796|560313643|FG000|Overall Study|Reason unspecified|1|||
155241207|NCT01459796|560313644|FG001|Overall Study|Reason unspecified|2|||
155241208|NCT01459796|560313643|FG000|Overall Study|Decision by the sponsor|75|||
155241209|NCT01459796|560313644|FG001|Overall Study|Decision by the sponsor|108|||
155241210|NCT00701051|560313645|FG000|Screening|Failed Screening|40|||
155241211|NCT00701051|560313646|FG001|Screening|Failed Screening|0|||
155241212|NCT00701051|560313647|FG002|Screening|Failed Screening|0|||
155241213|NCT00701051|560313645|FG000|Screening|Time conflicts|19|||
155241214|NCT00701051|560313646|FG001|Screening|Time conflicts|0|||
155241215|NCT00701051|560313647|FG002|Screening|Time conflicts|0|||
155241216|NCT00701051|560313645|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
155241217|NCT00701051|560313646|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
155241218|NCT00701051|560313647|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
155241219|NCT01243944|560313656|FG000|Overall Study|Adverse Event|15|||
155241220|NCT01243944|560313657|FG001|Overall Study|Adverse Event|13|||
155241221|NCT01243944|560313656|FG000|Overall Study|Lost to Follow-up|2|||
155241222|NCT01243944|560313657|FG001|Overall Study|Lost to Follow-up|1|||
155241223|NCT01243944|560313656|FG000|Overall Study|Physician Decision|2|||
155241224|NCT01243944|560313657|FG001|Overall Study|Physician Decision|7|||
155241225|NCT01243944|560313656|FG000|Overall Study|Disease progression|12|||
155241226|NCT01243944|560313657|FG001|Overall Study|Disease progression|11|||
155241227|NCT01243944|560313656|FG000|Overall Study|Protocol deviation|1|||
155241228|NCT01243944|560313657|FG001|Overall Study|Protocol deviation|1|||
155241229|NCT01243944|560313656|FG000|Overall Study|Participant decision|10|||
155241230|NCT01243944|560313657|FG001|Overall Study|Participant decision|15|||
155241231|NCT01243944|560313656|FG000|Overall Study|Death|2|||
155241232|NCT01243944|560313657|FG001|Overall Study|Death|3|||
155241233|NCT01243944|560313656|FG000|Overall Study|Non-compliance with study treatment|1|||
155241234|NCT01243944|560313657|FG001|Overall Study|Non-compliance with study treatment|0|||
155241235|NCT03321019|560313666|FG000|Overall Study|Withdrawal by Subject|0|||
155241236|NCT03321019|560313667|FG001|Overall Study|Withdrawal by Subject|6|||
155241237|NCT03321019|560313666|FG000|Overall Study|Lost to Follow-up|0|||
155241238|NCT03321019|560313667|FG001|Overall Study|Lost to Follow-up|22|||
155241239|NCT03880578|560313668|FG000|Overall Study|Withdrawal by Subject|0|||
155241240|NCT03880578|560313669|FG001|Overall Study|Withdrawal by Subject|3|||
155241241|NCT03880578|560313670|FG002|Overall Study|Withdrawal by Subject|1|||
155241242|NCT03880578|560313668|FG000|Overall Study|Death|0|||
155241243|NCT03880578|560313669|FG001|Overall Study|Death|1|||
155241244|NCT03880578|560313670|FG002|Overall Study|Death|0|||
155241245|NCT04934670|560313671|FG000|Overall Study|Death|4|||
155241246|NCT04934670|560313672|FG001|Overall Study|Death|0|||
155241247|NCT04934670|560313671|FG000|Overall Study|Lost to Follow-up|1|||
155241248|NCT04934670|560313672|FG001|Overall Study|Lost to Follow-up|4|||
155241249|NCT01993719|560313673|FG000|First Drug Administration|Not treated|1|||
155241250|NCT01993719|560313674|FG001|First Drug Administration|Not treated|0|||
155241251|NCT01993719|560313675|FG002|First Drug Administration|Not treated|0|||
155241252|NCT01993719|560313676|FG003|First Drug Administration|Not treated|0|||
155241253|NCT01993719|560313677|FG004|First Drug Administration|Not treated|0|||
155241254|NCT02799082|560313681|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
155241255|NCT02799082|560313682|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
155241256|NCT02799082|560313681|FG000|Overall Study|Protocol Violation|0|||
155241257|NCT02799082|560313682|FG001|Overall Study|Protocol Violation|1|||
155241258|NCT01592708|560313683|FG000|Overall Study|Protocol Violation|3|||
155241259|NCT01592708|560313684|FG001|Overall Study|Protocol Violation|0|||
155241260|NCT03433456|560313686|FG000|Overall Study|Death|1|||
155241261|NCT03433456|560313687|FG001|Overall Study|Death|1|||
155241262|NCT03433456|560313686|FG000|Overall Study|Lost to Follow-up|14|||
155241263|NCT03433456|560313687|FG001|Overall Study|Lost to Follow-up|11|||
155241264|NCT03433456|560313686|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
155241265|NCT03433456|560313687|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
155241266|NCT03105362|560313688|FG000|Overall Study|Withdrawal by Subject|1|||
155241267|NCT03105362|560313688|FG000|Overall Study|Lost to Follow-up|1|||
155241268|NCT01198600|560313689|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
155241269|NCT01198600|560313690|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
155241270|NCT01198600|560313691|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
155241271|NCT01198600|560313692|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
155241272|NCT01198600|560313689|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
155241273|NCT01198600|560313690|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
155241274|NCT01198600|560313691|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
155241275|NCT01198600|560313692|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
155241276|NCT01198600|560313689|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
155241277|NCT01198600|560313690|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
155241278|NCT01198600|560313691|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
155241279|NCT01198600|560313692|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
155241280|NCT01198600|560313689|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
155241281|NCT01198600|560313690|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
155241282|NCT01198600|560313691|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
155241283|NCT01198600|560313692|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
155241284|NCT01198600|560313689|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
155241285|NCT01198600|560313690|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
155241286|NCT01198600|560313691|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
155241287|NCT01198600|560313692|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
155241288|NCT01198600|560313689|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
155241289|NCT01198600|560313690|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
155241290|NCT01198600|560313691|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
155241291|NCT01198600|560313692|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
155241292|NCT01198600|560313689|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
155241293|NCT01198600|560313690|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
155241294|NCT01198600|560313691|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
155241295|NCT01198600|560313692|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
155241296|NCT03299192|560313694|FG000|Overall Study|Fell before classes started|1|||
155241297|NCT03299192|560313695|FG001|Overall Study|Fell before classes started|0|||
155241298|NCT03299192|560313696|FG002|Overall Study|Fell before classes started|0|||
155241299|NCT03299192|560313694|FG000|Overall Study|Other|0|||
155241300|NCT03299192|560313695|FG001|Overall Study|Other|2|||
155241301|NCT03299192|560313696|FG002|Overall Study|Other|1|||
155241302|NCT01603875|560313697|FG000|Overall Study|Preexisting rabies antibody|3|||
155241303|NCT01603875|560313698|FG001|Overall Study|Preexisting rabies antibody|4|||
155241304|NCT01603875|560313699|FG002|Overall Study|Preexisting rabies antibody|3|||
155241305|NCT01603875|560313697|FG000|Overall Study|Lost to Follow-up|4|||
155241306|NCT01603875|560313698|FG001|Overall Study|Lost to Follow-up|3|||
155241307|NCT01603875|560313699|FG002|Overall Study|Lost to Follow-up|6|||
155241308|NCT01603875|560313697|FG000|Overall Study|Protocol Violation|0|||
155241309|NCT01603875|560313698|FG001|Overall Study|Protocol Violation|1|||
155241310|NCT01603875|560313699|FG002|Overall Study|Protocol Violation|0|||
155241311|NCT01652716|560313703|FG000|Overall Study|Loss of glucose control|1|||
155241312|NCT01652716|560313704|FG001|Overall Study|Loss of glucose control|0|||
155241313|NCT01652716|560313703|FG000|Overall Study|Administrative|0|||
155241314|NCT01652716|560313704|FG001|Overall Study|Administrative|2|||
155241315|NCT01652716|560313703|FG000|Overall Study|Investigator decision|1|||
155241316|NCT01652716|560313704|FG001|Overall Study|Investigator decision|4|||
155241317|NCT01652716|560313703|FG000|Overall Study|Lost to Follow-up|12|||
155241318|NCT01652716|560313704|FG001|Overall Study|Lost to Follow-up|11|||
155241319|NCT01652716|560313703|FG000|Overall Study|Protocol Violation|2|||
155241320|NCT01652716|560313704|FG001|Overall Study|Protocol Violation|1|||
155241321|NCT01652716|560313703|FG000|Overall Study|Adverse Event|7|||
155241322|NCT01652716|560313704|FG001|Overall Study|Adverse Event|10|||
155241323|NCT01652716|560313703|FG000|Overall Study|Withdrawal by Subject|33|||
155241324|NCT01652716|560313704|FG001|Overall Study|Withdrawal by Subject|18|||
155241325|NCT05204134|560313705|FG000|Overall Study|Withdrawal by Subject|3|||
155241326|NCT05204134|560313705|FG000|Overall Study|Physician Decision|1|||
155241327|NCT01312467|560313706|FG000|Overall Study|Adverse Event|4|||
155241328|NCT01312467|560313706|FG000|Overall Study|Lost to Follow-up|1|||
155241329|NCT01312467|560313706|FG000|Overall Study|Withdrawal by Subject|2|||
155241330|NCT01312467|560313706|FG000|Overall Study|Deported to country of origin|1|||
155241331|NCT01312467|560313706|FG000|Overall Study|Another medical condition|1|||
155241332|NCT01312467|560313706|FG000|Overall Study|Ineligible|4|||
155241333|NCT00061048|560313707|FG000|Overall Study|Adverse Event|2|||
155241334|NCT00061048|560313707|FG000|Overall Study|disease progression|20|||
155241335|NCT02752048|560313708|FG000|Overall Study|Withdrawal by Subject|0|||
155241336|NCT02752048|560313709|FG001|Overall Study|Withdrawal by Subject|0|||
155241337|NCT02752048|560313710|FG002|Overall Study|Withdrawal by Subject|3|||
155241338|NCT03779841|560313714|FG000|Randomized Population|Did Not Receive Treatment|3|||
155241339|NCT03779841|560313715|FG001|Randomized Population|Did Not Receive Treatment|1|||
155241340|NCT03779841|560313716|FG002|Randomized Population|Did Not Receive Treatment|0|||
155241341|NCT03779841|560313714|FG000|Treated (Safety) Population|Adverse Event|1|||
155241342|NCT03779841|560313715|FG001|Treated (Safety) Population|Adverse Event|1|||
155241343|NCT03779841|560313716|FG002|Treated (Safety) Population|Adverse Event|0|||
155241344|NCT03779841|560313714|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
155241345|NCT03779841|560313715|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
155241346|NCT03779841|560313716|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
155241347|NCT03779841|560313714|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
155241348|NCT03779841|560313715|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
155241349|NCT03779841|560313716|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
155241350|NCT03779841|560313714|FG000|Treated (Safety) Population|Death|1|||
155241351|NCT03779841|560313715|FG001|Treated (Safety) Population|Death|0|||
155241352|NCT03779841|560313716|FG002|Treated (Safety) Population|Death|2|||
155241353|NCT00818441|560313717|FG000|Overall Study|Death|69|||
155241354|NCT00818441|560313718|FG001|Overall Study|Death|26|||
155241355|NCT00818441|560313717|FG000|Overall Study|Other|5|||
155241356|NCT00818441|560313718|FG001|Overall Study|Other|0|||
155241357|NCT00818441|560313717|FG000|Overall Study|Lost to Follow-up|2|||
155241358|NCT00818441|560313718|FG001|Overall Study|Lost to Follow-up|1|||
155241359|NCT00818441|560313717|FG000|Overall Study|Withdrawal by Subject|2|||
155241360|NCT00818441|560313718|FG001|Overall Study|Withdrawal by Subject|0|||
155241361|NCT00818441|560313717|FG000|Overall Study|Adverse Event|0|||
155241362|NCT00818441|560313718|FG001|Overall Study|Adverse Event|1|||
155241363|NCT00818441|560313717|FG000|Overall Study|Study terminated by sponsor|11|||
155241364|NCT00818441|560313718|FG001|Overall Study|Study terminated by sponsor|2|||
155241365|NCT04450264|560315592|FG000|Overall Study|Incomplete survey|13|||
155241366|NCT04450264|560315593|FG001|Overall Study|Incomplete survey|19|||
155241367|NCT00970502|560315594|FG000|Overall Study|Withdrawal by Subject|1|||
155241368|NCT02707055|560315595|FG000|Phase 1|Withdrawal by Subject|1|||
155241369|NCT02707055|560315596|FG001|Phase 1|Withdrawal by Subject|2|||
155241370|NCT02707055|560315595|FG000|Phase 1|Physician Decision|0|||
155241371|NCT02707055|560315596|FG001|Phase 1|Physician Decision|1|||
155241372|NCT02707055|560315595|FG000|Phase 2|Adverse Event|1|||
155241373|NCT02707055|560315596|FG001|Phase 2|Adverse Event|2|||
155241374|NCT01880424|560315597|FG000|Overall Study|Adverse Event|7|||
155241375|NCT01880424|560315598|FG001|Overall Study|Adverse Event|6|||
155241376|NCT01880424|560315597|FG000|Overall Study|Lack of Efficacy|1|||
155241377|NCT01880424|560315598|FG001|Overall Study|Lack of Efficacy|4|||
155241378|NCT01880424|560315597|FG000|Overall Study|Lost to Follow-up|3|||
155241379|NCT01880424|560315598|FG001|Overall Study|Lost to Follow-up|2|||
155241380|NCT01880424|560315597|FG000|Overall Study|Protocol Violation|11|||
155241381|NCT01880424|560315598|FG001|Overall Study|Protocol Violation|13|||
155241382|NCT01880424|560315597|FG000|Overall Study|Withdrawal by Subject|10|||
155241383|NCT01880424|560315598|FG001|Overall Study|Withdrawal by Subject|30|||
155241384|NCT01880424|560315597|FG000|Overall Study|Other|1|||
155241385|NCT01880424|560315598|FG001|Overall Study|Other|0|||
155241386|NCT02280044|560315601|FG000|Overall Study|Planned alternate|0|||
155241387|NCT02280044|560315602|FG001|Overall Study|Planned alternate|2|||
155241388|NCT00466193|560315605|FG000|Overall Study|Adverse Event|0|||
155241389|NCT00466193|560315606|FG001|Overall Study|Adverse Event|1|||
155241390|NCT00466193|560315605|FG000|Overall Study|Lost to Follow-up|2|||
155241391|NCT00466193|560315606|FG001|Overall Study|Lost to Follow-up|4|||
155241392|NCT00466193|560315605|FG000|Overall Study|Physician Decision|1|||
155241393|NCT00466193|560315606|FG001|Overall Study|Physician Decision|0|||
155241394|NCT00466193|560315605|FG000|Overall Study|Protocol Violation|1|||
155241395|NCT00466193|560315606|FG001|Overall Study|Protocol Violation|1|||
155241396|NCT00466193|560315605|FG000|Overall Study|Withdrawal by Subject|7|||
155241397|NCT00466193|560315606|FG001|Overall Study|Withdrawal by Subject|2|||
155241398|NCT00466193|560315605|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
155241399|NCT00466193|560315606|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
155241400|NCT00086346|560315607|FG000|Randomization|Did not receive test article|4|||
155241401|NCT00086346|560315608|FG001|Randomization|Did not receive test article|4|||
155241402|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Adverse Event|94|||
155241403|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Adverse Event|11|||
155241404|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
155241405|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
155241406|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
155241407|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
155241408|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
155241409|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
155241410|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
155241411|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
155241412|NCT00086346|560315607|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
155241413|NCT00086346|560315608|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
155241414|NCT02807948|560315609|FG000|Overall Study|Physician Decision|1|||
155241415|NCT02807948|560315610|FG001|Overall Study|Physician Decision|0|||
155241416|NCT02473614|560315611|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
155241417|NCT02473614|560315612|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
155241418|NCT01075074|560315615|FG000|Overall Study|Surgeon changed to open incisional case|1|||
155241419|NCT01075074|560315616|FG001|Overall Study|Surgeon changed to open incisional case|2|||
155241420|NCT01075074|560315617|FG002|Overall Study|Surgeon changed to open incisional case|2|||
155241421|NCT01054729|560315618|FG000|Overall Study|Randomized but Not Treated|0|||
155241422|NCT01054729|560315619|FG001|Overall Study|Randomized but Not Treated|1|||
155241423|NCT01054729|560315620|FG002|Overall Study|Randomized but Not Treated|0|||
155241424|NCT01054729|560315621|FG003|Overall Study|Randomized but Not Treated|0|||
155241425|NCT01054729|560315618|FG000|Overall Study|Adverse Event|1|||
155241426|NCT01054729|560315619|FG001|Overall Study|Adverse Event|1|||
155241427|NCT01054729|560315620|FG002|Overall Study|Adverse Event|2|||
155241428|NCT01054729|560315621|FG003|Overall Study|Adverse Event|1|||
155241429|NCT01054729|560315618|FG000|Overall Study|Withdrawal by Subject|1|||
155241430|NCT01054729|560315619|FG001|Overall Study|Withdrawal by Subject|0|||
155241431|NCT01054729|560315620|FG002|Overall Study|Withdrawal by Subject|1|||
155241432|NCT01054729|560315621|FG003|Overall Study|Withdrawal by Subject|0|||
155241433|NCT01054729|560315618|FG000|Overall Study|Lost to Follow-up|0|||
155241434|NCT01054729|560315619|FG001|Overall Study|Lost to Follow-up|1|||
155241435|NCT01054729|560315620|FG002|Overall Study|Lost to Follow-up|0|||
155241436|NCT01054729|560315621|FG003|Overall Study|Lost to Follow-up|0|||
155241437|NCT01054729|560315618|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
155241438|NCT01054729|560315619|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
155241439|NCT01054729|560315620|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
155241440|NCT01054729|560315621|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
155241441|NCT01054729|560315618|FG000|Overall Study|Non-responder|1|||
155241442|NCT01054729|560315619|FG001|Overall Study|Non-responder|0|||
155241443|NCT01054729|560315620|FG002|Overall Study|Non-responder|1|||
155241444|NCT01054729|560315621|FG003|Overall Study|Non-responder|1|||
155241445|NCT01054729|560315618|FG000|Overall Study|PEG/RBV Non-responder|1|||
155241446|NCT01054729|560315619|FG001|Overall Study|PEG/RBV Non-responder|0|||
155241447|NCT01054729|560315620|FG002|Overall Study|PEG/RBV Non-responder|1|||
155241448|NCT01054729|560315621|FG003|Overall Study|PEG/RBV Non-responder|0|||
155241449|NCT01054729|560315618|FG000|Overall Study|Personal/Obligations|0|||
155241450|NCT01054729|560315619|FG001|Overall Study|Personal/Obligations|1|||
155241451|NCT01054729|560315620|FG002|Overall Study|Personal/Obligations|0|||
155241452|NCT01054729|560315621|FG003|Overall Study|Personal/Obligations|0|||
155241453|NCT01054729|560315618|FG000|Overall Study|Subject moved|0|||
155241454|NCT01054729|560315619|FG001|Overall Study|Subject moved|0|||
155241455|NCT01054729|560315620|FG002|Overall Study|Subject moved|1|||
155241456|NCT01054729|560315621|FG003|Overall Study|Subject moved|0|||
155241457|NCT01054729|560315618|FG000|Overall Study|Lack of Efficacy|0|||
155241458|NCT01054729|560315619|FG001|Overall Study|Lack of Efficacy|0|||
155241459|NCT01054729|560315620|FG002|Overall Study|Lack of Efficacy|0|||
155241460|NCT01054729|560315621|FG003|Overall Study|Lack of Efficacy|1|||
155241461|NCT02162810|560315624|FG000|Overall Study|Protocol Violation|1|||
155241462|NCT02162810|560315625|FG001|Overall Study|Protocol Violation|0|||
155241463|NCT02162810|560315624|FG000|Overall Study|patients did not report compliance|4|||
155241464|NCT02162810|560315625|FG001|Overall Study|patients did not report compliance|1|||
155241465|NCT01465334|560315626|FG000|Overall Study|Disease Progression|1|||
155241466|NCT01465334|560315627|FG001|Overall Study|Disease Progression|0|||
155241467|NCT01465334|560315626|FG000|Overall Study|Adverse Event|1|||
155241468|NCT01465334|560315627|FG001|Overall Study|Adverse Event|0|||
155241469|NCT01465334|560315626|FG000|Overall Study|Richter's transformation|0|||
155241470|NCT01465334|560315627|FG001|Overall Study|Richter's transformation|3|||
155241471|NCT01465334|560315626|FG000|Overall Study|Refractory Disease|0|||
155241472|NCT01465334|560315627|FG001|Overall Study|Refractory Disease|3|||
155241473|NCT04831736|560315633|FG000|Overall Study|Withdrawal by Subject|0|||
155241474|NCT04831736|560315634|FG001|Overall Study|Withdrawal by Subject|1|||
155241475|NCT00795600|560315635|FG000|Overall Study|Adverse Event|1|||
155241476|NCT00795600|560315636|FG001|Overall Study|Adverse Event|1|||
155241477|NCT00795600|560315635|FG000|Overall Study|Protocol Violation|1|||
155241478|NCT00795600|560315636|FG001|Overall Study|Protocol Violation|2|||
155241479|NCT00795600|560315635|FG000|Overall Study|Withdrawal by Subject|1|||
155241480|NCT00795600|560315636|FG001|Overall Study|Withdrawal by Subject|0|||
155241481|NCT00795600|560315635|FG000|Overall Study|Unclassified|1|||
155241482|NCT00795600|560315636|FG001|Overall Study|Unclassified|1|||
155241483|NCT01659021|560315637|FG000|Main Study|Adverse Event|2|||
155241484|NCT01659021|560315638|FG001|Main Study|Adverse Event|3|||
155241485|NCT01659021|560315637|FG000|Main Study|Lost to Follow-up|1|||
155241486|NCT01659021|560315638|FG001|Main Study|Lost to Follow-up|0|||
155241487|NCT01659021|560315637|FG000|Main Study|Unknown Reasons|2|||
155241488|NCT01659021|560315638|FG001|Main Study|Unknown Reasons|1|||
155241489|NCT01659021|560315637|FG000|Main Study|Physician Decision|34|||
155241490|NCT01659021|560315638|FG001|Main Study|Physician Decision|16|||
155241491|NCT01659021|560315637|FG000|Main Study|Withdrawal by Subject|19|||
155241492|NCT01659021|560315638|FG001|Main Study|Withdrawal by Subject|16|||
155241493|NCT01659021|560315637|FG000|Main Study|Study Terminated by Sponsor|16|||
155241494|NCT01659021|560315638|FG001|Main Study|Study Terminated by Sponsor|1|||
155241495|NCT01659021|560315637|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
155241496|NCT01659021|560315638|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
155241497|NCT01659021|560315637|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
155241498|NCT01659021|560315638|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
155241499|NCT03551938|560315644|FG000|3-Month Follow Up|Lost to Follow-up|39|||
155241500|NCT03551938|560315645|FG001|3-Month Follow Up|Lost to Follow-up|38|||
155241501|NCT03551938|560315644|FG000|6-Month Follow Up|Lost to Follow-up|46|||
155241502|NCT03551938|560315645|FG001|6-Month Follow Up|Lost to Follow-up|42|||
155241503|NCT03551938|560315644|FG000|9-Month Follow Up|Lost to Follow-up|44|||
155241504|NCT03551938|560315645|FG001|9-Month Follow Up|Lost to Follow-up|43|||
155241505|NCT01925183|560315646|FG000|Overall Study|Adverse Event|1|||
155241506|NCT01925183|560315647|FG001|Overall Study|Adverse Event|0|||
155241507|NCT01114646|560315648|FG000|Overall Study|Withdrawal by Subject|3|||
155241508|NCT01114646|560315649|FG001|Overall Study|Withdrawal by Subject|2|||
155241509|NCT01233817|560315654|FG000|Overall Study|Lost to Follow-up|1|||
155241510|NCT01233817|560315654|FG000|Overall Study|Withdrawal by Subject|2|||
155241511|NCT02159482|560315657|FG000|Overall Study|Withdrawal by Subject|2|||
155241512|NCT02159482|560315657|FG000|Overall Study|Physician Decision|3|||
155241513|NCT01248884|560315660|FG000|Overall Study|Withdrawal by Subject|1|||
155241514|NCT01248884|560315661|FG001|Overall Study|Withdrawal by Subject|3|||
155241515|NCT01248884|560315662|FG002|Overall Study|Withdrawal by Subject|1|||
155241516|NCT01248884|560315660|FG000|Overall Study|Adverse Event|1|||
155241517|NCT01248884|560315661|FG001|Overall Study|Adverse Event|0|||
155241518|NCT01248884|560315662|FG002|Overall Study|Adverse Event|0|||
155241519|NCT00575588|560315663|FG000|Overall Study|Adverse Event|11|||
155241520|NCT00575588|560315664|FG001|Overall Study|Adverse Event|13|||
155241521|NCT00575588|560315663|FG000|Overall Study|Withdrawal by Subject|27|||
155241522|NCT00575588|560315664|FG001|Overall Study|Withdrawal by Subject|31|||
155241523|NCT00575588|560315663|FG000|Overall Study|Lost to Follow-up|1|||
155241524|NCT00575588|560315664|FG001|Overall Study|Lost to Follow-up|3|||
155241525|NCT00575588|560315663|FG000|Overall Study|Death|4|||
155241526|NCT00575588|560315664|FG001|Overall Study|Death|2|||
155241527|NCT00575588|560315663|FG000|Overall Study|Incorrect enrollment|8|||
155241528|NCT00575588|560315664|FG001|Overall Study|Incorrect enrollment|4|||
155241529|NCT00575588|560315663|FG000|Overall Study|Study specific discontinuation criteria|203|||
155241530|NCT00575588|560315664|FG001|Overall Study|Study specific discontinuation criteria|218|||
155241531|NCT00575588|560315663|FG000|Overall Study|Severe non-compliance to protocol|5|||
155241532|NCT00575588|560315664|FG001|Overall Study|Severe non-compliance to protocol|7|||
155241533|NCT00575588|560315663|FG000|Overall Study|Safety reasons|2|||
155241534|NCT00575588|560315664|FG001|Overall Study|Safety reasons|1|||
155241535|NCT00575588|560315663|FG000|Overall Study|Elevated triglyceride|1|||
155241536|NCT00575588|560315664|FG001|Overall Study|Elevated triglyceride|0|||
155241537|NCT00575588|560315663|FG000|Overall Study|Patient moved|1|||
155241538|NCT00575588|560315664|FG001|Overall Study|Patient moved|3|||
155241539|NCT00575588|560315663|FG000|Overall Study|Impossible to determine HbA1c|0|||
155241540|NCT00575588|560315664|FG001|Overall Study|Impossible to determine HbA1c|1|||
155241541|NCT01430130|560315665|FG000|Overall Study|Lost to Follow-up|1|||
155241542|NCT01430130|560315665|FG000|Overall Study|Infection on Control Side of Incision|1|||
155241543|NCT03525834|560315666|FG000|Overall Study|Progressive disease|1|||
155241544|NCT00840970|560315670|FG000|Overall Study|Adverse Event|0|||
155241545|NCT00840970|560315671|FG001|Overall Study|Adverse Event|0|||
155241546|NCT00840970|560315672|FG002|Overall Study|Adverse Event|1|||
155241547|NCT00534352|560315673|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
155241548|NCT00534352|560315673|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
155241549|NCT00534352|560315673|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
155241550|NCT00534352|560315673|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
155241551|NCT00534352|560315673|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
155241552|NCT00534352|560315673|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
155241553|NCT02059148|560315680|FG000|Treatment 1|Protocol Violation|0|||
155241554|NCT02059148|560315681|FG001|Treatment 1|Protocol Violation|0|||
155241555|NCT02059148|560315682|FG002|Treatment 1|Protocol Violation|0|||
155241556|NCT02059148|560315683|FG003|Treatment 1|Protocol Violation|0|||
155241557|NCT02059148|560315684|FG004|Treatment 1|Protocol Violation|0|||
155241558|NCT02059148|560315685|FG005|Treatment 1|Protocol Violation|1|||
155241559|NCT03321981|560315686|FG000|Overall Study|Progressive Disease (PD)|15|||
155241560|NCT03321981|560315687|FG001|Overall Study|Progressive Disease (PD)|30|||
155241561|NCT03321981|560315688|FG002|Overall Study|Progressive Disease (PD)|47|||
155241562|NCT03321981|560315686|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
155241563|NCT03321981|560315687|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
155241564|NCT03321981|560315688|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
155241565|NCT03321981|560315686|FG000|Overall Study|Adverse Event|0|||
155241566|NCT03321981|560315687|FG001|Overall Study|Adverse Event|0|||
155241567|NCT03321981|560315688|FG002|Overall Study|Adverse Event|2|||
155241568|NCT03321981|560315686|FG000|Overall Study|symptomatic deterioration|0|||
155241569|NCT03321981|560315687|FG001|Overall Study|symptomatic deterioration|1|||
155241570|NCT03321981|560315688|FG002|Overall Study|symptomatic deterioration|1|||
155241571|NCT03321981|560315686|FG000|Overall Study|Lack of compliance|0|||
155241572|NCT03321981|560315687|FG001|Overall Study|Lack of compliance|1|||
155241573|NCT03321981|560315688|FG002|Overall Study|Lack of compliance|0|||
155241574|NCT03321981|560315686|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
155241575|NCT03321981|560315687|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
155241576|NCT03321981|560315688|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
155241577|NCT03321981|560315686|FG000|Overall Study|Death|0|||
155241578|NCT03321981|560315687|FG001|Overall Study|Death|1|||
155241579|NCT03321981|560315688|FG002|Overall Study|Death|0|||
155241580|NCT03321981|560315686|FG000|Overall Study|Subject withdrawal of investigational product|0|||
155241581|NCT03321981|560315687|FG001|Overall Study|Subject withdrawal of investigational product|1|||
155241582|NCT03321981|560315688|FG002|Overall Study|Subject withdrawal of investigational product|0|||
155241583|NCT03321981|560315686|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
155241584|NCT03321981|560315687|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
155241585|NCT03321981|560315688|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
155241586|NCT03321981|560315686|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
155241587|NCT03321981|560315687|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
155241588|NCT03321981|560315688|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
155241589|NCT03067441|560315697|FG000|Overall Study|Withdrawal by Subject|16|||
155241590|NCT03067441|560315698|FG001|Overall Study|Withdrawal by Subject|34|||
155241591|NCT03067441|560315697|FG000|Overall Study|Lost to Follow-up|7|||
155241592|NCT03067441|560315698|FG001|Overall Study|Lost to Follow-up|5|||
155241593|NCT03067441|560315697|FG000|Overall Study|Adverse Event|7|||
155241594|NCT03067441|560315698|FG001|Overall Study|Adverse Event|14|||
155241595|NCT03067441|560315697|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
155241596|NCT03067441|560315698|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
155241597|NCT03067441|560315697|FG000|Overall Study|Physician Decision|1|||
155241598|NCT03067441|560315698|FG001|Overall Study|Physician Decision|3|||
155241599|NCT03067441|560315697|FG000|Overall Study|Other|1|||
155241600|NCT03067441|560315698|FG001|Overall Study|Other|1|||
155241601|NCT01785602|560315715|FG000|Overall Study|Withdrawal by Subject|2|||
155241602|NCT01785602|560315716|FG001|Overall Study|Withdrawal by Subject|0|||
155241603|NCT01785602|560315715|FG000|Overall Study|Lost to Follow-up|1|||
155241604|NCT01785602|560315716|FG001|Overall Study|Lost to Follow-up|1|||
155241605|NCT01785602|560315715|FG000|Overall Study|Adverse Event|3|||
155241606|NCT01785602|560315716|FG001|Overall Study|Adverse Event|5|||
155241607|NCT01785602|560315715|FG000|Overall Study|Administrative problems|7|||
155241608|NCT01785602|560315716|FG001|Overall Study|Administrative problems|3|||
155241609|NCT02041429|560315719|FG000|Overall Study|Progressive Disease|2|||
155241610|NCT02041429|560315720|FG001|Overall Study|Progressive Disease|2|||
155241611|NCT02041429|560315721|FG002|Overall Study|Progressive Disease|3|||
155241612|NCT02041429|560315722|FG003|Overall Study|Progressive Disease|2|||
155241613|NCT02041429|560315719|FG000|Overall Study|Toxicity|0|||
155241614|NCT02041429|560315720|FG001|Overall Study|Toxicity|1|||
155241615|NCT02041429|560315721|FG002|Overall Study|Toxicity|4|||
155241616|NCT02041429|560315722|FG003|Overall Study|Toxicity|2|||
155241617|NCT02041429|560315719|FG000|Overall Study|Withdrawal by Subject|0|||
155241618|NCT02041429|560315720|FG001|Overall Study|Withdrawal by Subject|1|||
155241619|NCT02041429|560315721|FG002|Overall Study|Withdrawal by Subject|0|||
155241620|NCT02041429|560315722|FG003|Overall Study|Withdrawal by Subject|0|||
155241621|NCT02041429|560315719|FG000|Overall Study|On Maintenance Therapy|1|||
155241622|NCT02041429|560315720|FG001|Overall Study|On Maintenance Therapy|0|||
155241623|NCT02041429|560315721|FG002|Overall Study|On Maintenance Therapy|0|||
155241624|NCT02041429|560315722|FG003|Overall Study|On Maintenance Therapy|2|||
155241625|NCT03251924|560315723|FG000|Overall Study|Disease Progression|6|||
155241626|NCT03251924|560315724|FG001|Overall Study|Disease Progression|6|||
155241627|NCT03251924|560315725|FG002|Overall Study|Disease Progression|7|||
155241628|NCT03251924|560315726|FG003|Overall Study|Disease Progression|8|||
155241629|NCT03251924|560315727|FG004|Overall Study|Disease Progression|8|||
155241630|NCT03251924|560315728|FG005|Overall Study|Disease Progression|7|||
155241631|NCT03251924|560315729|FG006|Overall Study|Disease Progression|6|||
155241632|NCT03251924|560315730|FG007|Overall Study|Disease Progression|10|||
155241633|NCT03251924|560315731|FG008|Overall Study|Disease Progression|6|||
155241634|NCT03251924|560315723|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
155241635|NCT03251924|560315724|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
155241636|NCT03251924|560315725|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
155241637|NCT03251924|560315726|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
155241638|NCT03251924|560315727|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
155241639|NCT03251924|560315728|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
155241640|NCT03251924|560315729|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
155241641|NCT03251924|560315730|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
155241642|NCT03251924|560315731|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
155241643|NCT03251924|560315723|FG000|Overall Study|Death|0|||
155241644|NCT03251924|560315724|FG001|Overall Study|Death|1|||
155241645|NCT03251924|560315725|FG002|Overall Study|Death|0|||
155241646|NCT03251924|560315726|FG003|Overall Study|Death|1|||
155241647|NCT03251924|560315727|FG004|Overall Study|Death|1|||
155241648|NCT03251924|560315728|FG005|Overall Study|Death|1|||
155241649|NCT03251924|560315729|FG006|Overall Study|Death|0|||
155241650|NCT03251924|560315730|FG007|Overall Study|Death|0|||
155241651|NCT03251924|560315731|FG008|Overall Study|Death|0|||
155241652|NCT03251924|560315723|FG000|Overall Study|Study Drug Toxicity|0|||
155241653|NCT03251924|560315724|FG001|Overall Study|Study Drug Toxicity|0|||
155241654|NCT03251924|560315725|FG002|Overall Study|Study Drug Toxicity|0|||
155241655|NCT03251924|560315726|FG003|Overall Study|Study Drug Toxicity|1|||
155241656|NCT03251924|560315727|FG004|Overall Study|Study Drug Toxicity|0|||
155241657|NCT03251924|560315728|FG005|Overall Study|Study Drug Toxicity|0|||
155241658|NCT03251924|560315729|FG006|Overall Study|Study Drug Toxicity|0|||
155241659|NCT03251924|560315730|FG007|Overall Study|Study Drug Toxicity|0|||
155241660|NCT03251924|560315731|FG008|Overall Study|Study Drug Toxicity|1|||
155241661|NCT03251924|560315723|FG000|Overall Study|Other Reasons|0|||
155241662|NCT03251924|560315724|FG001|Overall Study|Other Reasons|0|||
155241663|NCT03251924|560315725|FG002|Overall Study|Other Reasons|0|||
155241664|NCT03251924|560315726|FG003|Overall Study|Other Reasons|0|||
155241665|NCT03251924|560315727|FG004|Overall Study|Other Reasons|0|||
155241666|NCT03251924|560315728|FG005|Overall Study|Other Reasons|0|||
155241667|NCT03251924|560315729|FG006|Overall Study|Other Reasons|0|||
155241668|NCT03251924|560315730|FG007|Overall Study|Other Reasons|0|||
155241669|NCT03251924|560315731|FG008|Overall Study|Other Reasons|1|||
155241670|NCT03251924|560315723|FG000|Overall Study|Participant request to discontinue study treatment|0|||
155241671|NCT03251924|560315724|FG001|Overall Study|Participant request to discontinue study treatment|0|||
155241672|NCT03251924|560315725|FG002|Overall Study|Participant request to discontinue study treatment|0|||
155241673|NCT03251924|560315726|FG003|Overall Study|Participant request to discontinue study treatment|0|||
155241674|NCT03251924|560315727|FG004|Overall Study|Participant request to discontinue study treatment|0|||
155241675|NCT03251924|560315728|FG005|Overall Study|Participant request to discontinue study treatment|0|||
155241676|NCT03251924|560315729|FG006|Overall Study|Participant request to discontinue study treatment|0|||
155241677|NCT03251924|560315730|FG007|Overall Study|Participant request to discontinue study treatment|1|||
155241678|NCT03251924|560315731|FG008|Overall Study|Participant request to discontinue study treatment|0|||
155241679|NCT00153101|560315732|FG000|Overall Study|Lost to Follow-up|14|||
155241680|NCT00153101|560315733|FG001|Overall Study|Lost to Follow-up|14|||
155241681|NCT00153101|560315734|FG002|Overall Study|Lost to Follow-up|12|||
155241682|NCT00153101|560315735|FG003|Overall Study|Lost to Follow-up|5|||
155241683|NCT00153101|560315736|FG004|Overall Study|Lost to Follow-up|5|||
155241684|NCT00153101|560315732|FG000|Overall Study|Withdrawal by Subject|3|||
155241685|NCT00153101|560315733|FG001|Overall Study|Withdrawal by Subject|4|||
155241686|NCT00153101|560315734|FG002|Overall Study|Withdrawal by Subject|3|||
155241687|NCT00153101|560315735|FG003|Overall Study|Withdrawal by Subject|3|||
155241688|NCT00153101|560315736|FG004|Overall Study|Withdrawal by Subject|5|||
155241689|NCT03169153|560315737|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155241690|NCT03169153|560315738|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
155241691|NCT03169153|560315737|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
155241692|NCT03169153|560315738|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
155241693|NCT03169153|560315737|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
155241694|NCT03169153|560315738|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
155241695|NCT03169153|560315737|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
155241696|NCT03169153|560315738|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
155241697|NCT00439777|560315739|FG000|Treatment Period|Death|29|||
155241698|NCT00439777|560315740|FG001|Treatment Period|Death|21|||
155241699|NCT00439777|560315739|FG000|Treatment Period|Study terminated by sponsor|125|||
155241700|NCT00439777|560315740|FG001|Treatment Period|Study terminated by sponsor|132|||
155241701|NCT00439777|560315739|FG000|Treatment Period|Site closed by investigator|0|||
155241702|NCT00439777|560315740|FG001|Treatment Period|Site closed by investigator|1|||
155241703|NCT00439777|560315739|FG000|Treatment Period|Did not take study treatment|7|||
155241704|NCT00439777|560315740|FG001|Treatment Period|Did not take study treatment|8|||
155241705|NCT00439777|560315739|FG000|Treatment Period|Adverse Event|111|||
155241706|NCT00439777|560315740|FG001|Treatment Period|Adverse Event|92|||
155241707|NCT00439777|560315739|FG000|Treatment Period|Protocol Violation|23|||
155241708|NCT00439777|560315740|FG001|Treatment Period|Protocol Violation|30|||
155241709|NCT00439777|560315739|FG000|Treatment Period|Withdrawal by Subject|66|||
155241710|NCT00439777|560315740|FG001|Treatment Period|Withdrawal by Subject|118|||
155241711|NCT00439777|560315739|FG000|Treatment Period|Lack of Efficacy|1|||
155241712|NCT00439777|560315740|FG001|Treatment Period|Lack of Efficacy|4|||
155241713|NCT00439777|560315739|FG000|Treatment Period|Lost to Follow-up|8|||
155241714|NCT00439777|560315740|FG001|Treatment Period|Lost to Follow-up|10|||
155241715|NCT00439777|560315739|FG000|Treatment Period|Protocol driven decision point|1|||
155241716|NCT00439777|560315740|FG001|Treatment Period|Protocol driven decision point|3|||
155241717|NCT00439777|560315739|FG000|Treatment Period|Physician Decision|7|||
155241718|NCT00439777|560315740|FG001|Treatment Period|Physician Decision|18|||
155241719|NCT00439777|560315739|FG000|Treatment Period|Clinical endpoint reached|26|||
155241720|NCT00439777|560315740|FG001|Treatment Period|Clinical endpoint reached|13|||
155241721|NCT00439777|560315739|FG000|Treatment Period|Technical problems|3|||
155241722|NCT00439777|560315740|FG001|Treatment Period|Technical problems|1|||
155241723|NCT00439777|560315739|FG000|Treatment Period|Participant convenience|12|||
155241724|NCT00439777|560315740|FG001|Treatment Period|Participant convenience|8|||
155241725|NCT00439777|560315739|FG000|Observational Period|Protocol Violation|0|||
155241726|NCT00439777|560315740|FG001|Observational Period|Protocol Violation|2|||
155241727|NCT00439777|560315739|FG000|Observational Period|Withdrawal by Subject|9|||
155241728|NCT00439777|560315740|FG001|Observational Period|Withdrawal by Subject|5|||
155241729|NCT00439777|560315739|FG000|Observational Period|Lost to Follow-up|1|||
155241730|NCT00439777|560315740|FG001|Observational Period|Lost to Follow-up|11|||
155241731|NCT00439777|560315739|FG000|Observational Period|Death|27|||
155241732|NCT00439777|560315740|FG001|Observational Period|Death|20|||
155241733|NCT00439777|560315739|FG000|Observational Period|Study terminated by sponsor|3|||
155241734|NCT00439777|560315740|FG001|Observational Period|Study terminated by sponsor|1|||
155241735|NCT00439777|560315739|FG000|Observational Period|Protocol driven decision point|0|||
155241736|NCT00439777|560315740|FG001|Observational Period|Protocol driven decision point|1|||
155241737|NCT00439777|560315739|FG000|Observational Period|Lack of Efficacy|1|||
155241738|NCT00439777|560315740|FG001|Observational Period|Lack of Efficacy|0|||
155241739|NCT00439777|560315739|FG000|Observational Period|Technical problems|0|||
155241740|NCT00439777|560315740|FG001|Observational Period|Technical problems|1|||
155241741|NCT00784043|560315741|FG000|Overall Study|Withdrawal by Subject|8|||
155241742|NCT00784043|560315742|FG001|Overall Study|Withdrawal by Subject|5|||
155241743|NCT00784043|560315741|FG000|Overall Study|Protocol Terminated|23|||
155241744|NCT00784043|560315742|FG001|Overall Study|Protocol Terminated|1|||
155241745|NCT03791398|560315749|FG000|Overall Study|Progression of Disease Under Study|2|||
155241746|NCT03791398|560315750|FG001|Overall Study|Progression of Disease Under Study|0|||
155241747|NCT03791398|560315751|FG002|Overall Study|Progression of Disease Under Study|0|||
155241748|NCT02207829|560315752|FG000|Overall Study|Adverse Event|10|||
155241749|NCT02207829|560315753|FG001|Overall Study|Adverse Event|9|||
155241750|NCT02207829|560315752|FG000|Overall Study|Lack of Efficacy|7|||
155241751|NCT02207829|560315753|FG001|Overall Study|Lack of Efficacy|5|||
155241752|NCT02207829|560315752|FG000|Overall Study|Lost to Follow-up|2|||
155241753|NCT02207829|560315753|FG001|Overall Study|Lost to Follow-up|2|||
155241754|NCT02207829|560315752|FG000|Overall Study|Protocol deviation|5|||
155241755|NCT02207829|560315753|FG001|Overall Study|Protocol deviation|4|||
155241756|NCT02207829|560315752|FG000|Overall Study|Withdrew consent|18|||
155241757|NCT02207829|560315753|FG001|Overall Study|Withdrew consent|14|||
155241758|NCT01418209|560315754|FG000|Overall Study|Withdrawal by Subject|1|||
155241759|NCT01418209|560315755|FG001|Overall Study|Withdrawal by Subject|0|||
155241760|NCT01418209|560315756|FG002|Overall Study|Withdrawal by Subject|1|||
155241761|NCT01418209|560315754|FG000|Overall Study|Did not provide hot flash diary data|1|||
155241762|NCT01418209|560315755|FG001|Overall Study|Did not provide hot flash diary data|3|||
155241763|NCT01418209|560315756|FG002|Overall Study|Did not provide hot flash diary data|3|||
155241764|NCT00101101|560315757|FG000|Overall Study|never received vaccine|20|||
155241765|NCT01800903|560315758|FG000|Second Test Period|unable to catheterise|1|||
155241766|NCT01800903|560315759|FG001|Second Test Period|unable to catheterise|0|||
155241767|NCT01800903|560315760|FG002|Second Test Period|unable to catheterise|0|||
155241768|NCT01800903|560315761|FG003|Second Test Period|unable to catheterise|0|||
155241769|NCT01800903|560315762|FG004|Second Test Period|unable to catheterise|0|||
155241770|NCT01800903|560315763|FG005|Second Test Period|unable to catheterise|0|||
155241771|NCT04382612|560315764|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
155241772|NCT01328002|560315766|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
155241773|NCT01328002|560315767|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
155241774|NCT01328002|560315766|FG000|Open-Label Period|Adverse Event|8|||
155241775|NCT01328002|560315767|FG001|Open-Label Period|Adverse Event|0|||
155241776|NCT01328002|560315766|FG000|Open-Label Period|Lack of Efficacy|3|||
155241777|NCT01328002|560315767|FG001|Open-Label Period|Lack of Efficacy|0|||
155241778|NCT01328002|560315766|FG000|Open-Label Period|Protocol Violation|2|||
155241779|NCT01328002|560315767|FG001|Open-Label Period|Protocol Violation|0|||
155241780|NCT01328002|560315766|FG000|Open-Label Period|Withdrawal by Subject|9|||
155241781|NCT01328002|560315767|FG001|Open-Label Period|Withdrawal by Subject|0|||
155241782|NCT01328002|560315766|FG000|Open-Label Period|Lost to Follow-up|6|||
155241783|NCT01328002|560315767|FG001|Open-Label Period|Lost to Follow-up|0|||
155241784|NCT01328002|560315766|FG000|Open-Label Period|Other Reason|2|||
155241785|NCT01328002|560315767|FG001|Open-Label Period|Other Reason|0|||
155241786|NCT01328002|560315766|FG000|Double-Blind Period|Adverse Event|1|||
155241787|NCT01328002|560315767|FG001|Double-Blind Period|Adverse Event|0|||
155241788|NCT01328002|560315766|FG000|Double-Blind Period|Lack of Efficacy|1|||
155241789|NCT01328002|560315767|FG001|Double-Blind Period|Lack of Efficacy|0|||
155241790|NCT01578551|560315768|FG000|Overall Study|Adverse Event|1|||
155241791|NCT01578551|560315769|FG001|Overall Study|Adverse Event|0|||
155241792|NCT00074282|560317769|FG000|Step 1|Adverse Event|32|||
155241793|NCT00074282|560317770|FG001|Step 1|Adverse Event|0|||
155241794|NCT00074282|560317771|FG002|Step 1|Adverse Event|0|||
155241795|NCT00074282|560317769|FG000|Step 1|Death|6|||
155241796|NCT00074282|560317770|FG001|Step 1|Death|0|||
155241797|NCT00074282|560317771|FG002|Step 1|Death|0|||
155241798|NCT00074282|560317769|FG000|Step 1|Withdrawal by Subject|7|||
155241799|NCT00074282|560317770|FG001|Step 1|Withdrawal by Subject|0|||
155241800|NCT00074282|560317771|FG002|Step 1|Withdrawal by Subject|0|||
155241801|NCT00074282|560317769|FG000|Step 1|Disease progression|2|||
155241802|NCT00074282|560317770|FG001|Step 1|Disease progression|0|||
155241803|NCT00074282|560317771|FG002|Step 1|Disease progression|0|||
155241804|NCT00074282|560317769|FG000|Step 1|Alternative therapy|2|||
155241805|NCT00074282|560317770|FG001|Step 1|Alternative therapy|0|||
155241806|NCT00074282|560317771|FG002|Step 1|Alternative therapy|0|||
155241807|NCT00074282|560317769|FG000|Step 1|Other complicating disease|2|||
155241808|NCT00074282|560317770|FG001|Step 1|Other complicating disease|0|||
155241809|NCT00074282|560317771|FG002|Step 1|Other complicating disease|0|||
155241810|NCT00074282|560317769|FG000|Step 1|Physician Decision|1|||
155241811|NCT00074282|560317770|FG001|Step 1|Physician Decision|0|||
155241812|NCT00074282|560317771|FG002|Step 1|Physician Decision|0|||
155241813|NCT00074282|560317769|FG000|Step 1|Ineligible|4|||
155241814|NCT00074282|560317770|FG001|Step 1|Ineligible|0|||
155241815|NCT00074282|560317771|FG002|Step 1|Ineligible|0|||
155241816|NCT00074282|560317769|FG000|Step 1|Never started treatment|2|||
155241817|NCT00074282|560317770|FG001|Step 1|Never started treatment|0|||
155241818|NCT00074282|560317771|FG002|Step 1|Never started treatment|0|||
155241819|NCT00074282|560317769|FG000|Step 2|Adverse Event|0|||
155241820|NCT00074282|560317770|FG001|Step 2|Adverse Event|2|||
155241821|NCT00074282|560317771|FG002|Step 2|Adverse Event|12|||
155241822|NCT00074282|560317769|FG000|Step 2|Disease progression|0|||
155241823|NCT00074282|560317770|FG001|Step 2|Disease progression|0|||
155241824|NCT00074282|560317771|FG002|Step 2|Disease progression|5|||
155241825|NCT00074282|560317769|FG000|Step 2|Death|0|||
155241826|NCT00074282|560317770|FG001|Step 2|Death|0|||
155241827|NCT00074282|560317771|FG002|Step 2|Death|3|||
155241828|NCT00074282|560317769|FG000|Step 2|Withdrawal by Subject|0|||
155241829|NCT00074282|560317770|FG001|Step 2|Withdrawal by Subject|0|||
155241830|NCT00074282|560317771|FG002|Step 2|Withdrawal by Subject|2|||
155241831|NCT00074282|560317769|FG000|Step 2|Physician Decision|0|||
155241832|NCT00074282|560317770|FG001|Step 2|Physician Decision|0|||
155241833|NCT00074282|560317771|FG002|Step 2|Physician Decision|1|||
155241834|NCT00074282|560317769|FG000|Step 2|Ineligible|0|||
155241835|NCT00074282|560317770|FG001|Step 2|Ineligible|0|||
155241836|NCT00074282|560317771|FG002|Step 2|Ineligible|1|||
155241837|NCT00464542|560317772|FG000|Pre-treatment|Withdrawal by Subject|2|||
155241838|NCT01773226|560317774|FG000|Overall Study|Withdrawal by Subject|1|||
155241839|NCT02055352|560317775|FG000|Overall Study|Adverse Event|0|||
155241840|NCT02055352|560317776|FG001|Overall Study|Adverse Event|1|||
155241841|NCT02055352|560317775|FG000|Overall Study|Non-eligible|0|||
155241842|NCT02055352|560317776|FG001|Overall Study|Non-eligible|1|||
155241843|NCT02055352|560317775|FG000|Overall Study|Poor compliance|1|||
155241844|NCT02055352|560317776|FG001|Overall Study|Poor compliance|1|||
155241845|NCT02055352|560317775|FG000|Overall Study|Death|1|||
155241846|NCT02055352|560317776|FG001|Overall Study|Death|2|||
155241847|NCT02055352|560317775|FG000|Overall Study|Patient decision|1|||
155241848|NCT02055352|560317776|FG001|Overall Study|Patient decision|1|||
155241849|NCT02055352|560317775|FG000|Overall Study|Use of prohibited treatment|0|||
155241850|NCT02055352|560317776|FG001|Overall Study|Use of prohibited treatment|3|||
155241851|NCT02055352|560317775|FG000|Overall Study|AE, study drug would be detrimental|1|||
155241852|NCT02055352|560317776|FG001|Overall Study|AE, study drug would be detrimental|3|||
155241853|NCT02055352|560317775|FG000|Overall Study|Withdrawal of informed consent|1|||
155241854|NCT02055352|560317776|FG001|Overall Study|Withdrawal of informed consent|0|||
155241855|NCT02055352|560317775|FG000|Overall Study|Reason unknown|1|||
155241856|NCT02055352|560317776|FG001|Overall Study|Reason unknown|5|||
155241857|NCT02105116|560317780|FG000|Overall Study|not eligible for step 2 of trial|5|||
155241858|NCT02105116|560317780|FG000|Overall Study|Death|1|||
155241859|NCT01075321|560317788|FG000|Overall Study|Withdrawal by Subject|0|||
155241860|NCT01075321|560317789|FG001|Overall Study|Withdrawal by Subject|0|||
155241861|NCT01075321|560317790|FG002|Overall Study|Withdrawal by Subject|1|||
155241862|NCT01075321|560317791|FG003|Overall Study|Withdrawal by Subject|1|||
155241863|NCT01075321|560317788|FG000|Overall Study|Protocol Violation|0|||
155241864|NCT01075321|560317789|FG001|Overall Study|Protocol Violation|0|||
155241865|NCT01075321|560317790|FG002|Overall Study|Protocol Violation|1|||
155241866|NCT01075321|560317791|FG003|Overall Study|Protocol Violation|0|||
155241867|NCT01075321|560317788|FG000|Overall Study|Treatment Incomplete due to progression|1|||
155241868|NCT01075321|560317789|FG001|Overall Study|Treatment Incomplete due to progression|0|||
155241869|NCT01075321|560317790|FG002|Overall Study|Treatment Incomplete due to progression|0|||
155241870|NCT01075321|560317791|FG003|Overall Study|Treatment Incomplete due to progression|0|||
155241871|NCT01075321|560317788|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
155241872|NCT01075321|560317789|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
155241873|NCT01075321|560317790|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
155241874|NCT01075321|560317791|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
155241875|NCT02646423|560317792|FG000|Overall Study|Adverse Event|5|||
155241876|NCT02646423|560317793|FG001|Overall Study|Adverse Event|7|||
155241877|NCT02646423|560317792|FG000|Overall Study|Ineligible|2|||
155241878|NCT02646423|560317793|FG001|Overall Study|Ineligible|1|||
155241879|NCT00003457|560317794|FG000|Overall Study|Not evaluable|9|||
155241880|NCT02246998|560317798|FG000|Overall Study|Adverse Event|0|||
155241881|NCT02246998|560317799|FG001|Overall Study|Adverse Event|1|||
155241882|NCT02246998|560317800|FG002|Overall Study|Adverse Event|1|||
155241883|NCT02246998|560317801|FG003|Overall Study|Adverse Event|0|||
155241884|NCT02246998|560317798|FG000|Overall Study|Lost to Follow-up|1|||
155241885|NCT02246998|560317799|FG001|Overall Study|Lost to Follow-up|0|||
155241886|NCT02246998|560317800|FG002|Overall Study|Lost to Follow-up|0|||
155241887|NCT02246998|560317801|FG003|Overall Study|Lost to Follow-up|1|||
155241888|NCT02246998|560317798|FG000|Overall Study|Randomized but Never Dosed|1|||
155241889|NCT02246998|560317799|FG001|Overall Study|Randomized but Never Dosed|2|||
155241890|NCT02246998|560317800|FG002|Overall Study|Randomized but Never Dosed|2|||
155241891|NCT02246998|560317801|FG003|Overall Study|Randomized but Never Dosed|1|||
155241892|NCT04495374|560317802|FG000|Overall Study|Protocol Violation|2|||
155241893|NCT04495374|560317803|FG001|Overall Study|Protocol Violation|1|||
155241894|NCT03727750|560317804|FG000|Overall Study|Death|45|||
155241895|NCT03727750|560317804|FG000|Overall Study|Withdrawal by Subject|2|||
155241896|NCT03727750|560317804|FG000|Overall Study|Lost to Follow-up|1|||
155241897|NCT03727750|560317804|FG000|Overall Study|Other|1|||
155241898|NCT00844194|560317807|FG000|Overall Study|Adverse Event|17|||
155241899|NCT00844194|560317808|FG001|Overall Study|Adverse Event|5|||
155241900|NCT00844194|560317807|FG000|Overall Study|Protocol Violation|1|||
155241901|NCT00844194|560317808|FG001|Overall Study|Protocol Violation|1|||
155241902|NCT00844194|560317807|FG000|Overall Study|Lost to Follow-up|1|||
155241903|NCT00844194|560317808|FG001|Overall Study|Lost to Follow-up|1|||
155241904|NCT00844194|560317807|FG000|Overall Study|Withdrawal by Subject|2|||
155241905|NCT00844194|560317808|FG001|Overall Study|Withdrawal by Subject|1|||
155241906|NCT00844194|560317807|FG000|Overall Study|Lack of Efficacy|3|||
155241907|NCT00844194|560317808|FG001|Overall Study|Lack of Efficacy|0|||
155241908|NCT00844194|560317807|FG000|Overall Study|Other reason (not specified)|1|||
155241909|NCT00844194|560317808|FG001|Overall Study|Other reason (not specified)|0|||
155241910|NCT01992536|560317814|FG000|Overall Study|Administrative Reason|0|||
155241911|NCT01992536|560317815|FG001|Overall Study|Administrative Reason|0|||
155241912|NCT01992536|560317816|FG002|Overall Study|Administrative Reason|0|||
155241913|NCT01992536|560317817|FG003|Overall Study|Administrative Reason|0|||
155241914|NCT01992536|560317818|FG004|Overall Study|Administrative Reason|0|||
155241915|NCT01992536|560317819|FG005|Overall Study|Administrative Reason|0|||
155241916|NCT01992536|560317820|FG006|Overall Study|Administrative Reason|7|||
155241917|NCT01992536|560317821|FG007|Overall Study|Administrative Reason|0|||
155241918|NCT01992536|560317822|FG008|Overall Study|Administrative Reason|0|||
155241919|NCT01992536|560317823|FG009|Overall Study|Administrative Reason|0|||
155241920|NCT01992536|560317814|FG000|Overall Study|Lost to Follow-up|4|||
155241921|NCT01992536|560317815|FG001|Overall Study|Lost to Follow-up|2|||
155241922|NCT01992536|560317816|FG002|Overall Study|Lost to Follow-up|1|||
155241923|NCT01992536|560317817|FG003|Overall Study|Lost to Follow-up|0|||
155241924|NCT01992536|560317818|FG004|Overall Study|Lost to Follow-up|0|||
155241925|NCT01992536|560317819|FG005|Overall Study|Lost to Follow-up|1|||
155241926|NCT01992536|560317820|FG006|Overall Study|Lost to Follow-up|0|||
155241927|NCT01992536|560317821|FG007|Overall Study|Lost to Follow-up|0|||
155241928|NCT01992536|560317822|FG008|Overall Study|Lost to Follow-up|1|||
155241929|NCT01992536|560317823|FG009|Overall Study|Lost to Follow-up|1|||
155241930|NCT01992536|560317814|FG000|Overall Study|Withdrawal by Subject|0|||
155241931|NCT01992536|560317815|FG001|Overall Study|Withdrawal by Subject|1|||
155241932|NCT01992536|560317816|FG002|Overall Study|Withdrawal by Subject|0|||
155241933|NCT01992536|560317817|FG003|Overall Study|Withdrawal by Subject|2|||
155241934|NCT01992536|560317818|FG004|Overall Study|Withdrawal by Subject|0|||
155241935|NCT01992536|560317819|FG005|Overall Study|Withdrawal by Subject|0|||
155241936|NCT01992536|560317820|FG006|Overall Study|Withdrawal by Subject|0|||
155241937|NCT01992536|560317821|FG007|Overall Study|Withdrawal by Subject|0|||
155241938|NCT01992536|560317822|FG008|Overall Study|Withdrawal by Subject|0|||
155241939|NCT01992536|560317823|FG009|Overall Study|Withdrawal by Subject|0|||
155241940|NCT03669081|560317829|FG000|Overall Study|Data could not be validated|1|||
155241941|NCT03669081|560317830|FG001|Overall Study|Data could not be validated|1|||
155241942|NCT02352493|560317831|FG000|Overall Study|Pregnancy|0|||
155241943|NCT02352493|560317832|FG001|Overall Study|Pregnancy|0|||
155241944|NCT02352493|560317833|FG002|Overall Study|Pregnancy|0|||
155241945|NCT02352493|560317834|FG003|Overall Study|Pregnancy|0|||
155241946|NCT02352493|560317835|FG004|Overall Study|Pregnancy|0|||
155241947|NCT02352493|560317836|FG005|Overall Study|Pregnancy|0|||
155241948|NCT02352493|560317837|FG006|Overall Study|Pregnancy|1|||
155241949|NCT02352493|560317838|FG007|Overall Study|Pregnancy|0|||
155241950|NCT02352493|560317839|FG008|Overall Study|Pregnancy|1|||
155241951|NCT02352493|560317840|FG009|Overall Study|Pregnancy|0|||
155241952|NCT02352493|560317841|FG010|Overall Study|Pregnancy|0|||
155241953|NCT02352493|560317842|FG011|Overall Study|Pregnancy|0|||
155241954|NCT02352493|560317843|FG012|Overall Study|Pregnancy|0|||
155241955|NCT02352493|560317844|FG013|Overall Study|Pregnancy|0|||
155241956|NCT02352493|560317845|FG014|Overall Study|Pregnancy|0|||
155241957|NCT02352493|560317846|FG015|Overall Study|Pregnancy|0|||
155241958|NCT02352493|560317847|FG016|Overall Study|Pregnancy|0|||
155241959|NCT02352493|560317848|FG017|Overall Study|Pregnancy|0|||
155241960|NCT02352493|560317831|FG000|Overall Study|Withdrawal by Subject|0|||
155241961|NCT02352493|560317832|FG001|Overall Study|Withdrawal by Subject|0|||
155241962|NCT02352493|560317833|FG002|Overall Study|Withdrawal by Subject|0|||
155241963|NCT02352493|560317834|FG003|Overall Study|Withdrawal by Subject|0|||
155241964|NCT02352493|560317835|FG004|Overall Study|Withdrawal by Subject|0|||
155241965|NCT02352493|560317836|FG005|Overall Study|Withdrawal by Subject|0|||
155241966|NCT02352493|560317837|FG006|Overall Study|Withdrawal by Subject|0|||
155241967|NCT02352493|560317838|FG007|Overall Study|Withdrawal by Subject|0|||
155241968|NCT02352493|560317839|FG008|Overall Study|Withdrawal by Subject|1|||
155241969|NCT02352493|560317840|FG009|Overall Study|Withdrawal by Subject|0|||
155241970|NCT02352493|560317841|FG010|Overall Study|Withdrawal by Subject|0|||
155241971|NCT02352493|560317842|FG011|Overall Study|Withdrawal by Subject|0|||
155241972|NCT02352493|560317843|FG012|Overall Study|Withdrawal by Subject|0|||
155241973|NCT02352493|560317844|FG013|Overall Study|Withdrawal by Subject|0|||
155241974|NCT02352493|560317845|FG014|Overall Study|Withdrawal by Subject|1|||
155241975|NCT02352493|560317846|FG015|Overall Study|Withdrawal by Subject|0|||
155241976|NCT02352493|560317847|FG016|Overall Study|Withdrawal by Subject|0|||
155241977|NCT02352493|560317848|FG017|Overall Study|Withdrawal by Subject|0|||
155241978|NCT02352493|560317831|FG000|Overall Study|Lost to Follow-up|0|||
155241979|NCT02352493|560317832|FG001|Overall Study|Lost to Follow-up|0|||
155241980|NCT02352493|560317833|FG002|Overall Study|Lost to Follow-up|0|||
155241981|NCT02352493|560317834|FG003|Overall Study|Lost to Follow-up|0|||
155241982|NCT02352493|560317835|FG004|Overall Study|Lost to Follow-up|0|||
155241983|NCT02352493|560317836|FG005|Overall Study|Lost to Follow-up|0|||
155241984|NCT02352493|560317837|FG006|Overall Study|Lost to Follow-up|0|||
155241985|NCT02352493|560317838|FG007|Overall Study|Lost to Follow-up|0|||
155241986|NCT02352493|560317839|FG008|Overall Study|Lost to Follow-up|0|||
155241987|NCT02352493|560317840|FG009|Overall Study|Lost to Follow-up|1|||
155241988|NCT02352493|560317841|FG010|Overall Study|Lost to Follow-up|0|||
155241989|NCT02352493|560317842|FG011|Overall Study|Lost to Follow-up|0|||
155241990|NCT02352493|560317843|FG012|Overall Study|Lost to Follow-up|1|||
155241991|NCT02352493|560317844|FG013|Overall Study|Lost to Follow-up|2|||
155241992|NCT02352493|560317845|FG014|Overall Study|Lost to Follow-up|0|||
155241993|NCT02352493|560317846|FG015|Overall Study|Lost to Follow-up|0|||
155241994|NCT02352493|560317847|FG016|Overall Study|Lost to Follow-up|0|||
155241995|NCT02352493|560317848|FG017|Overall Study|Lost to Follow-up|0|||
155241996|NCT00389324|560317849|FG000|Run-In Phase|Adverse Event|1|||
155241997|NCT00389324|560317849|FG000|Run-In Phase|Lost to Follow-up|1|||
155241998|NCT00389324|560317849|FG000|Run-In Phase|Withdrawal by Subject|1|||
155241999|NCT00389324|560317849|FG000|Subcutaneous Phase|Adverse Event|2|||
155242000|NCT00389324|560317849|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
155242001|NCT00389324|560317849|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
155242002|NCT00389324|560317849|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
155242003|NCT03936244|560317854|FG000|Overall Study|Lost to Follow-up|5|||
155242004|NCT03936244|560317855|FG001|Overall Study|Lost to Follow-up|1|||
155242005|NCT03936244|560317854|FG000|Overall Study|Physician Decision|7|||
155242006|NCT03936244|560317855|FG001|Overall Study|Physician Decision|3|||
155242007|NCT00504829|560317856|FG000|Overall Study|Protocol Violation|6|||
155242008|NCT00504829|560317857|FG001|Overall Study|Protocol Violation|4|||
155242009|NCT00504829|560317858|FG002|Overall Study|Protocol Violation|10|||
155242010|NCT01854827|560317859|FG000|Overall Study|Death|1|||
155242011|NCT02667912|560317860|FG000|Overall Study|Death|3|||
155242012|NCT02667912|560317861|FG001|Overall Study|Death|1|||
155242013|NCT02667912|560317860|FG000|Overall Study|Withdrawal by Subject|1|||
155242014|NCT02667912|560317861|FG001|Overall Study|Withdrawal by Subject|2|||
155242015|NCT02667912|560317860|FG000|Overall Study|Withdrawal by Subject|1|||
155242016|NCT02667912|560317861|FG001|Overall Study|Withdrawal by Subject|0|||
155242017|NCT04443218|560317862|FG000|Overall Study|Exited study for other reasons|9|||
155242018|NCT04443218|560317862|FG000|Overall Study|Withdrawal by Subject|1|||
155242019|NCT04443218|560317862|FG000|Overall Study|Lost to Follow-up|4|||
155242020|NCT04443218|560317862|FG000|Overall Study|Death|19|||
155242021|NCT01131312|560317863|FG000|Overall Study|Lost to Follow-up|425|||
155242022|NCT01131312|560317864|FG001|Overall Study|Lost to Follow-up|229|||
155242023|NCT01131312|560317865|FG002|Overall Study|Lost to Follow-up|351|||
155242024|NCT01751568|560317878|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
155242025|NCT01751568|560317879|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
155242026|NCT01751568|560317880|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
155242027|NCT02660944|560317881|FG000|Overall Study|Adverse Event|3|||
155242028|NCT02660944|560317882|FG001|Overall Study|Adverse Event|4|||
155242029|NCT02660944|560317881|FG000|Overall Study|Physician Decision|3|||
155242030|NCT02660944|560317882|FG001|Overall Study|Physician Decision|1|||
155242031|NCT02660944|560317881|FG000|Overall Study|Withdrawal by Subject|5|||
155242032|NCT02660944|560317882|FG001|Overall Study|Withdrawal by Subject|3|||
155242033|NCT02660944|560317881|FG000|Overall Study|Lost to Follow-up|4|||
155242034|NCT02660944|560317882|FG001|Overall Study|Lost to Follow-up|1|||
155242035|NCT02660944|560317881|FG000|Overall Study|Subject schedule|0|||
155242036|NCT02660944|560317882|FG001|Overall Study|Subject schedule|1|||
155242037|NCT02660944|560317881|FG000|Overall Study|Exclusion criteria met|2|||
155242038|NCT02660944|560317882|FG001|Overall Study|Exclusion criteria met|0|||
155242039|NCT02843568|560317883|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
155242040|NCT02843568|560317884|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
155242041|NCT02843568|560317883|FG000|Overall Study|Death|3|||
155242042|NCT02843568|560317884|FG001|Overall Study|Death|3|||
155242043|NCT02843568|560317883|FG000|Overall Study|Withdrawal by Subject|1|||
155242044|NCT02843568|560317884|FG001|Overall Study|Withdrawal by Subject|1|||
155242045|NCT02843568|560317883|FG000|Overall Study|Lost to Follow-up|2|||
155242046|NCT02843568|560317884|FG001|Overall Study|Lost to Follow-up|0|||
155242047|NCT03586999|560317885|FG000|Overall Study|Lack of Efficacy|2|||
155242048|NCT03447769|560317886|FG000|Overall Study|Progressive disease|138|||
155242049|NCT03447769|560317887|FG001|Overall Study|Progressive disease|148|||
155242050|NCT03447769|560317886|FG000|Overall Study|Study terminated by Sponsor|60|||
155242051|NCT03447769|560317887|FG001|Overall Study|Study terminated by Sponsor|44|||
155242052|NCT03447769|560317886|FG000|Overall Study|Adverse Event|34|||
155242053|NCT03447769|560317887|FG001|Overall Study|Adverse Event|31|||
155242054|NCT03447769|560317886|FG000|Overall Study|Patient decision|27|||
155242055|NCT03447769|560317887|FG001|Overall Study|Patient decision|27|||
155242056|NCT03447769|560317886|FG000|Overall Study|Protocol deviation|4|||
155242057|NCT03447769|560317887|FG001|Overall Study|Protocol deviation|6|||
155242058|NCT03447769|560317886|FG000|Overall Study|Death|2|||
155242059|NCT03447769|560317887|FG001|Overall Study|Death|7|||
155242060|NCT03447769|560317886|FG000|Overall Study|Technical problems|1|||
155242061|NCT03447769|560317887|FG001|Overall Study|Technical problems|0|||
155242062|NCT03447769|560317886|FG000|Overall Study|Lost to Follow-up|0|||
155242063|NCT03447769|560317887|FG001|Overall Study|Lost to Follow-up|1|||
155242064|NCT03447769|560317886|FG000|Overall Study|Physician Decision|13|||
155242065|NCT03447769|560317887|FG001|Overall Study|Physician Decision|5|||
155242066|NCT03264989|560317890|FG000|Overall Study|Lost to Follow-up|1|||
155242067|NCT03264989|560317891|FG001|Overall Study|Lost to Follow-up|0|||
155242068|NCT03264989|560317890|FG000|Overall Study|New Therapy for study Indication|1|||
155242069|NCT03264989|560317891|FG001|Overall Study|New Therapy for study Indication|0|||
155242070|NCT03264989|560317890|FG000|Overall Study|Protocol Violation|0|||
155242071|NCT03264989|560317891|FG001|Overall Study|Protocol Violation|1|||
155242072|NCT03264989|560317890|FG000|Overall Study|Patient decision|13|||
155242073|NCT03264989|560317891|FG001|Overall Study|Patient decision|0|||
155242074|NCT03264989|560317890|FG000|Overall Study|Physician Decision|6|||
155242075|NCT03264989|560317891|FG001|Overall Study|Physician Decision|4|||
155242076|NCT03264989|560317890|FG000|Overall Study|Adverse Event|2|||
155242077|NCT03264989|560317891|FG001|Overall Study|Adverse Event|1|||
155242078|NCT03264989|560317890|FG000|Overall Study|Death|1|||
155242079|NCT03264989|560317891|FG001|Overall Study|Death|1|||
155242080|NCT03264989|560317890|FG000|Overall Study|Pregnancy|2|||
155242081|NCT03264989|560317891|FG001|Overall Study|Pregnancy|0|||
155242082|NCT03264989|560317890|FG000|Overall Study|End of Study|19|||
155242083|NCT03264989|560317891|FG001|Overall Study|End of Study|5|||
155242084|NCT00797667|560317897|FG000|Overall Study|Lack of Efficacy|0|||
155242085|NCT00797667|560317898|FG001|Overall Study|Lack of Efficacy|1|||
155242086|NCT00797667|560317899|FG002|Overall Study|Lack of Efficacy|0|||
155242087|NCT00797667|560317897|FG000|Overall Study|Lost to Follow-up|8|||
155242088|NCT00797667|560317898|FG001|Overall Study|Lost to Follow-up|12|||
155242089|NCT00797667|560317899|FG002|Overall Study|Lost to Follow-up|2|||
155242090|NCT00797667|560317897|FG000|Overall Study|Physician Decision|3|||
155242091|NCT00797667|560317898|FG001|Overall Study|Physician Decision|1|||
155242092|NCT00797667|560317899|FG002|Overall Study|Physician Decision|0|||
155242093|NCT00797667|560317897|FG000|Overall Study|Pregnancy|2|||
155242094|NCT00797667|560317898|FG001|Overall Study|Pregnancy|0|||
155242095|NCT00797667|560317899|FG002|Overall Study|Pregnancy|0|||
155242096|NCT00797667|560317897|FG000|Overall Study|Protocol Violation|2|||
155242097|NCT00797667|560317898|FG001|Overall Study|Protocol Violation|7|||
155242098|NCT00797667|560317899|FG002|Overall Study|Protocol Violation|0|||
155242099|NCT00797667|560317897|FG000|Overall Study|Study Terminated by Sponsor|217|||
155242100|NCT00797667|560317898|FG001|Overall Study|Study Terminated by Sponsor|216|||
155242101|NCT00797667|560317899|FG002|Overall Study|Study Terminated by Sponsor|115|||
155242102|NCT00797667|560317897|FG000|Overall Study|Withdrawal by Subject|9|||
155242103|NCT00797667|560317898|FG001|Overall Study|Withdrawal by Subject|14|||
155242104|NCT00797667|560317899|FG002|Overall Study|Withdrawal by Subject|2|||
155242105|NCT00797667|560317897|FG000|Overall Study|Adverse Event|19|||
155242106|NCT00797667|560317898|FG001|Overall Study|Adverse Event|8|||
155242107|NCT00797667|560317899|FG002|Overall Study|Adverse Event|8|||
155242108|NCT01986829|560317900|FG000|Overall Study|Death|1|||
155242109|NCT02673697|560317906|FG000|Overall Study|Adverse Event|2|||
155242110|NCT02673697|560317907|FG001|Overall Study|Adverse Event|0|||
155242111|NCT02673697|560317906|FG000|Overall Study|Death|32|||
155242112|NCT02673697|560317907|FG001|Overall Study|Death|24|||
155242113|NCT02673697|560317906|FG000|Overall Study|Lost to Follow-up|5|||
155242114|NCT02673697|560317907|FG001|Overall Study|Lost to Follow-up|2|||
155242115|NCT02673697|560317906|FG000|Overall Study|Physician Decision|2|||
155242116|NCT02673697|560317907|FG001|Overall Study|Physician Decision|1|||
155242117|NCT02673697|560317906|FG000|Overall Study|Withdrawal by Subject|10|||
155242118|NCT02673697|560317907|FG001|Overall Study|Withdrawal by Subject|7|||
155242119|NCT02673697|560317906|FG000|Overall Study|Change subj medical status|1|||
155242120|NCT02673697|560317907|FG001|Overall Study|Change subj medical status|2|||
155242121|NCT02673697|560317906|FG000|Overall Study|Explant|10|||
155242122|NCT02673697|560317907|FG001|Overall Study|Explant|5|||
155242123|NCT02673697|560317906|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
155242124|NCT02673697|560317907|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
155242125|NCT00437489|560317908|FG000|Overall Study|Study terminated by sponsor|23|||
155242126|NCT00437489|560317909|FG001|Overall Study|Study terminated by sponsor|21|||
155242127|NCT00437489|560317908|FG000|Overall Study|Lost to Follow-up|0|||
155242128|NCT00437489|560317909|FG001|Overall Study|Lost to Follow-up|1|||
155242129|NCT01525082|560317911|FG000|Overall Study|Death|1|||
155242130|NCT02209324|560317915|FG000|Overall Study|Adverse Event|2|||
155242131|NCT02209324|560317915|FG000|Overall Study|Lack of Efficacy|1|||
155242132|NCT02209324|560317915|FG000|Overall Study|Lost to Follow-up|1|||
155242133|NCT02209324|560317915|FG000|Overall Study|Physician Decision|3|||
155242134|NCT02209324|560317915|FG000|Overall Study|Protocol Violation|14|||
155242135|NCT02209324|560317915|FG000|Overall Study|Withdrawal by Subject|8|||
155242136|NCT02209324|560317915|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
155242137|NCT02209324|560317915|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
155242138|NCT02209324|560317915|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
155242139|NCT01985126|560317916|FG000|Overall Study|Death|15|||
155242140|NCT01985126|560317917|FG001|Overall Study|Death|69|||
155242141|NCT01985126|560317916|FG000|Overall Study|Lost to Follow-up|0|||
155242142|NCT01985126|560317917|FG001|Overall Study|Lost to Follow-up|8|||
155242143|NCT01985126|560317916|FG000|Overall Study|Study Terminated By Sponsor|1|||
155242144|NCT01985126|560317917|FG001|Overall Study|Study Terminated By Sponsor|22|||
155242145|NCT01985126|560317916|FG000|Overall Study|Withdrawal by Subject|2|||
155242146|NCT01985126|560317917|FG001|Overall Study|Withdrawal by Subject|7|||
155242147|NCT04177108|560317920|FG000|Overall Study|Withdrawal by Subject|4|||
155242148|NCT04177108|560317921|FG001|Overall Study|Withdrawal by Subject|8|||
155242149|NCT04177108|560317922|FG002|Overall Study|Withdrawal by Subject|9|||
155242150|NCT04177108|560317923|FG003|Overall Study|Withdrawal by Subject|11|||
155242151|NCT04177108|560317924|FG004|Overall Study|Withdrawal by Subject|13|||
155242152|NCT04177108|560317920|FG000|Overall Study|Physician Decision|23|||
155242153|NCT04177108|560317921|FG001|Overall Study|Physician Decision|15|||
155242154|NCT04177108|560317922|FG002|Overall Study|Physician Decision|18|||
155242155|NCT04177108|560317923|FG003|Overall Study|Physician Decision|29|||
155242156|NCT04177108|560317924|FG004|Overall Study|Physician Decision|23|||
155242157|NCT04177108|560317920|FG000|Overall Study|Reason Not Specified|0|||
155242158|NCT04177108|560317921|FG001|Overall Study|Reason Not Specified|1|||
155242159|NCT04177108|560317922|FG002|Overall Study|Reason Not Specified|0|||
155242160|NCT04177108|560317923|FG003|Overall Study|Reason Not Specified|0|||
155242161|NCT04177108|560317924|FG004|Overall Study|Reason Not Specified|2|||
155242162|NCT04177108|560317920|FG000|Overall Study|Lost to Follow-up|0|||
155242163|NCT04177108|560317921|FG001|Overall Study|Lost to Follow-up|0|||
155242164|NCT04177108|560317922|FG002|Overall Study|Lost to Follow-up|1|||
155242165|NCT04177108|560317923|FG003|Overall Study|Lost to Follow-up|1|||
155242166|NCT04177108|560317924|FG004|Overall Study|Lost to Follow-up|1|||
155242167|NCT04177108|560317920|FG000|Overall Study|Death|16|||
155242168|NCT04177108|560317921|FG001|Overall Study|Death|19|||
155242169|NCT04177108|560317922|FG002|Overall Study|Death|13|||
155242170|NCT04177108|560317923|FG003|Overall Study|Death|17|||
155242171|NCT04177108|560317924|FG004|Overall Study|Death|18|||
155242172|NCT04496258|560317925|FG000|Overall Study|Withdrawal by Subject|2|||
155242173|NCT04496258|560317926|FG001|Overall Study|Withdrawal by Subject|1|||
155242174|NCT00499889|560317927|FG000|Overall Study|Infection prior to treatment|1|||
155242175|NCT00766376|560317931|FG000|Overall Study|Withdrawal by Subject|27|||
155242176|NCT03149328|560317934|FG000|Overall Study|Withdrawal by Subject|30|||
155242177|NCT03149328|560317935|FG001|Overall Study|Withdrawal by Subject|26|||
155242178|NCT03149328|560317934|FG000|Overall Study|Changed Dialysis Modality|18|||
155242179|NCT03149328|560317935|FG001|Overall Study|Changed Dialysis Modality|1|||
155242180|NCT03149328|560317934|FG000|Overall Study|Transplant|9|||
155242181|NCT03149328|560317935|FG001|Overall Study|Transplant|1|||
155242182|NCT03149328|560317934|FG000|Overall Study|Lost to Follow-up|25|||
155242183|NCT03149328|560317935|FG001|Overall Study|Lost to Follow-up|16|||
155242184|NCT03149328|560317934|FG000|Overall Study|Left Study Site|1|||
155242185|NCT03149328|560317935|FG001|Overall Study|Left Study Site|2|||
155242186|NCT03149328|560317934|FG000|Overall Study|Language Barrier|1|||
155242187|NCT03149328|560317935|FG001|Overall Study|Language Barrier|0|||
155242188|NCT00852397|560317939|FG000|Overall Study|Adverse Event|4|||
155242189|NCT00852397|560317940|FG001|Overall Study|Adverse Event|6|||
155242190|NCT00852397|560317941|FG002|Overall Study|Adverse Event|4|||
155242191|NCT00852397|560317939|FG000|Overall Study|Death|0|||
155242192|NCT00852397|560317940|FG001|Overall Study|Death|0|||
155242193|NCT00852397|560317941|FG002|Overall Study|Death|1|||
155242194|NCT00852397|560317939|FG000|Overall Study|Withdrawal by Subject|4|||
155242195|NCT00852397|560317940|FG001|Overall Study|Withdrawal by Subject|1|||
155242196|NCT00852397|560317941|FG002|Overall Study|Withdrawal by Subject|2|||
155242197|NCT00852397|560317939|FG000|Overall Study|Study terminated by sponsor|2|||
155242198|NCT00852397|560317940|FG001|Overall Study|Study terminated by sponsor|1|||
155242199|NCT00852397|560317941|FG002|Overall Study|Study terminated by sponsor|6|||
155242200|NCT00852397|560317939|FG000|Overall Study|Difficulty in study site visit|1|||
155242201|NCT00852397|560317940|FG001|Overall Study|Difficulty in study site visit|0|||
155242202|NCT00852397|560317941|FG002|Overall Study|Difficulty in study site visit|0|||
155242203|NCT00852397|560317939|FG000|Overall Study|Protocol Violation|0|||
155242204|NCT00852397|560317940|FG001|Overall Study|Protocol Violation|0|||
155242205|NCT00852397|560317941|FG002|Overall Study|Protocol Violation|1|||
155242206|NCT01968434|560317947|FG000|Overall Study|Lost to Follow-up|3|||
155242207|NCT01968434|560317948|FG001|Overall Study|Lost to Follow-up|6|||
155242208|NCT02199691|560317949|FG000|Overall Study|Protocol Violation|3|||
155242209|NCT02199691|560317950|FG001|Overall Study|Protocol Violation|3|||
155242210|NCT02199691|560317951|FG002|Overall Study|Protocol Violation|6|||
155242211|NCT02199691|560317952|FG003|Overall Study|Protocol Violation|7|||
155242212|NCT02199691|560317949|FG000|Overall Study|Withdrawal by Subject|5|||
155242213|NCT02199691|560317950|FG001|Overall Study|Withdrawal by Subject|3|||
155242214|NCT02199691|560317951|FG002|Overall Study|Withdrawal by Subject|12|||
155242215|NCT02199691|560317952|FG003|Overall Study|Withdrawal by Subject|13|||
155242216|NCT02199691|560317949|FG000|Overall Study|Lost to Follow-up|2|||
155242217|NCT02199691|560317950|FG001|Overall Study|Lost to Follow-up|1|||
155242218|NCT02199691|560317951|FG002|Overall Study|Lost to Follow-up|9|||
155242219|NCT02199691|560317952|FG003|Overall Study|Lost to Follow-up|10|||
155242220|NCT00774995|560317953|FG000|Overall Study|Protocol Violation|0|||
155242221|NCT00774995|560317954|FG001|Overall Study|Protocol Violation|0|||
155242222|NCT00774995|560317955|FG002|Overall Study|Protocol Violation|1|||
155242223|NCT00774995|560317956|FG003|Overall Study|Protocol Violation|0|||
155242224|NCT03964454|560317957|FG000|Overall Study|Lost to Follow-up|13|||
155242225|NCT03964454|560317958|FG001|Overall Study|Lost to Follow-up|7|||
155242226|NCT03964454|560317957|FG000|Overall Study|Withdrawal by Subject|4|||
155242227|NCT03964454|560317958|FG001|Overall Study|Withdrawal by Subject|11|||
155242228|NCT00136955|560319875|FG000|Overall Study|Adverse Event|8|||
155242229|NCT00136955|560319875|FG000|Overall Study|Lost to Follow-up|1|||
155242230|NCT00136955|560319875|FG000|Overall Study|Withdrawal by Subject|2|||
155242231|NCT00136955|560319875|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
155242232|NCT02239510|560319876|FG000|Overall Study|Lost to Follow-up|2|||
155242233|NCT02239510|560319877|FG001|Overall Study|Lost to Follow-up|1|||
155242234|NCT05349617|560319885|FG000|Overall Study|Death|1|||
155242235|NCT05349617|560319886|FG001|Overall Study|Death|1|||
155242236|NCT05349617|560319885|FG000|Overall Study|Lost to Follow-up|3|||
155242237|NCT05349617|560319886|FG001|Overall Study|Lost to Follow-up|8|||
155242238|NCT05349617|560319885|FG000|Overall Study|Withdrawal by Subject|2|||
155242239|NCT05349617|560319886|FG001|Overall Study|Withdrawal by Subject|10|||
155242240|NCT00566228|560319887|FG000|Overall Study|Withdrawal by Subject|1|||
155242241|NCT00566228|560319888|FG001|Overall Study|Withdrawal by Subject|0|||
155242242|NCT00566228|560319887|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
155242243|NCT00566228|560319888|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
155242244|NCT00566228|560319887|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
155242245|NCT00566228|560319888|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
155242246|NCT00566228|560319887|FG000|Overall Study|progressed before infusion could occur|0|||
155242247|NCT00566228|560319888|FG001|Overall Study|progressed before infusion could occur|1|||
155242248|NCT05706506|560319889|FG000|Overall Study|Adverse Event|1|||
155242249|NCT05706506|560319889|FG000|Overall Study|Withdrawal by Subject|4|||
155242250|NCT05706506|560319889|FG000|Overall Study|Lost to Follow-up|2|||
155242251|NCT05706506|560319889|FG000|Overall Study|Inadvertent Enrolment|12|||
155242252|NCT05706506|560319889|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
155242253|NCT05706506|560319889|FG000|Overall Study|Participant Moved Out of State|1|||
155242254|NCT00987467|560319890|FG000|Overall Study|Lost to Follow-up|2|||
155242255|NCT00262834|560319891|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
155242256|NCT00262834|560319892|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
155242257|NCT01303627|560319894|FG000|Overall Study|the failure while performing URS|0|||
155242258|NCT01303627|560319895|FG001|Overall Study|the failure while performing URS|1|||
155242259|NCT02416791|560319897|FG000|6 Months|Lost to Follow-up|0|||
155242260|NCT02416791|560319898|FG001|6 Months|Lost to Follow-up|0|||
155242261|NCT02416791|560319899|FG002|6 Months|Lost to Follow-up|1|||
155242262|NCT01054820|560319900|FG000|Overall Study|Withdrawal by Subject|2|||
155242263|NCT00321919|560319901|FG000|Overall Study|Adverse Event|17|||
155242264|NCT00321919|560319902|FG001|Overall Study|Adverse Event|10|||
155242265|NCT00321919|560319901|FG000|Overall Study|Death|21|||
155242266|NCT00321919|560319902|FG001|Overall Study|Death|17|||
155242267|NCT00321919|560319901|FG000|Overall Study|Insufficient Therapeutic Response|1|||
155242268|NCT00321919|560319902|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155242269|NCT00321919|560319901|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
155242270|NCT00321919|560319902|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
155242271|NCT00321919|560319901|FG000|Overall Study|Refused Treatment|23|||
155242272|NCT00321919|560319902|FG001|Overall Study|Refused Treatment|14|||
155242273|NCT00321919|560319901|FG000|Overall Study|Other Protocol Violation|2|||
155242274|NCT00321919|560319902|FG001|Overall Study|Other Protocol Violation|3|||
155242275|NCT00321919|560319901|FG000|Overall Study|Failure to Return|3|||
155242276|NCT00321919|560319902|FG001|Overall Study|Failure to Return|1|||
155242277|NCT00321919|560319901|FG000|Overall Study|Other withdrawal reason|7|||
155242278|NCT00321919|560319902|FG001|Overall Study|Other withdrawal reason|6|||
155242279|NCT02624804|560319903|FG000|Overall Study|Screen Failure|5|||
155242280|NCT02590354|560319904|FG000|Phase 1|Active hepatitis B or C infection|1|||
155242281|NCT02590354|560319904|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
155242282|NCT02590354|560319904|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
155242283|NCT02590354|560319904|FG000|Phase 1|Subject does not want to participate|20|||
155242284|NCT02590354|560319904|FG000|Phase 1|Lost to Follow-up|1|||
155242285|NCT02590354|560319904|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
155242286|NCT00996996|560319905|FG000|Overall Study|Progressive Disease|10|||
155242287|NCT00996996|560319905|FG000|Overall Study|Non-compliance|8|||
155242288|NCT00996996|560319905|FG000|Overall Study|Lost to Follow-up|9|||
155242289|NCT00996996|560319905|FG000|Overall Study|Death|5|||
155242290|NCT00996996|560319905|FG000|Overall Study|Did Not Receive Study Medications|1|||
155242291|NCT00760929|560319906|FG000|Overall Study|Adverse Event|2|||
155242292|NCT00760929|560319907|FG001|Overall Study|Adverse Event|0|||
155242293|NCT00760929|560319908|FG002|Overall Study|Adverse Event|6|||
155242294|NCT00760929|560319909|FG003|Overall Study|Adverse Event|10|||
155242295|NCT00760929|560319906|FG000|Overall Study|Lack of Efficacy|0|||
155242296|NCT00760929|560319907|FG001|Overall Study|Lack of Efficacy|2|||
155242297|NCT00760929|560319908|FG002|Overall Study|Lack of Efficacy|1|||
155242298|NCT00760929|560319909|FG003|Overall Study|Lack of Efficacy|0|||
155242299|NCT00760929|560319906|FG000|Overall Study|Withdrawal by Subject|1|||
155242300|NCT00760929|560319907|FG001|Overall Study|Withdrawal by Subject|0|||
155242301|NCT00760929|560319908|FG002|Overall Study|Withdrawal by Subject|9|||
155242302|NCT00760929|560319909|FG003|Overall Study|Withdrawal by Subject|1|||
155242303|NCT00760929|560319906|FG000|Overall Study|Lost to Follow-up|0|||
155242304|NCT00760929|560319907|FG001|Overall Study|Lost to Follow-up|0|||
155242305|NCT00760929|560319908|FG002|Overall Study|Lost to Follow-up|1|||
155242306|NCT00760929|560319909|FG003|Overall Study|Lost to Follow-up|0|||
155242307|NCT00760929|560319906|FG000|Overall Study|Progression of Disease|21|||
155242308|NCT00760929|560319907|FG001|Overall Study|Progression of Disease|26|||
155242309|NCT00760929|560319908|FG002|Overall Study|Progression of Disease|38|||
155242310|NCT00760929|560319909|FG003|Overall Study|Progression of Disease|42|||
155242311|NCT00760929|560319906|FG000|Overall Study|Other|2|||
155242312|NCT00760929|560319907|FG001|Overall Study|Other|0|||
155242313|NCT00760929|560319908|FG002|Overall Study|Other|2|||
155242314|NCT00760929|560319909|FG003|Overall Study|Other|1|||
155242315|NCT00760929|560319906|FG000|Overall Study|Death|0|||
155242316|NCT00760929|560319907|FG001|Overall Study|Death|0|||
155242317|NCT00760929|560319908|FG002|Overall Study|Death|1|||
155242318|NCT00760929|560319909|FG003|Overall Study|Death|0|||
155242319|NCT00760929|560319906|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
155242320|NCT00760929|560319907|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
155242321|NCT00760929|560319908|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
155242322|NCT00760929|560319909|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
155242323|NCT02019719|560319910|FG000|Overall Study|Adverse Event|1|||
155242324|NCT02019719|560319911|FG001|Overall Study|Adverse Event|0|||
155242325|NCT02019719|560319912|FG002|Overall Study|Adverse Event|0|||
155242326|NCT02019719|560319913|FG003|Overall Study|Adverse Event|1|||
155242327|NCT02019719|560319914|FG004|Overall Study|Adverse Event|1|||
155242328|NCT02019719|560319910|FG000|Overall Study|Protocol Violation|1|||
155242329|NCT02019719|560319911|FG001|Overall Study|Protocol Violation|1|||
155242330|NCT02019719|560319912|FG002|Overall Study|Protocol Violation|0|||
155242331|NCT02019719|560319913|FG003|Overall Study|Protocol Violation|0|||
155242332|NCT02019719|560319914|FG004|Overall Study|Protocol Violation|0|||
155242333|NCT02019719|560319910|FG000|Overall Study|Protocol defined stopping criteria|2|||
155242334|NCT02019719|560319911|FG001|Overall Study|Protocol defined stopping criteria|0|||
155242335|NCT02019719|560319912|FG002|Overall Study|Protocol defined stopping criteria|0|||
155242336|NCT02019719|560319913|FG003|Overall Study|Protocol defined stopping criteria|1|||
155242337|NCT02019719|560319914|FG004|Overall Study|Protocol defined stopping criteria|1|||
155242338|NCT02019719|560319910|FG000|Overall Study|Physician Decision|2|||
155242339|NCT02019719|560319911|FG001|Overall Study|Physician Decision|0|||
155242340|NCT02019719|560319912|FG002|Overall Study|Physician Decision|0|||
155242341|NCT02019719|560319913|FG003|Overall Study|Physician Decision|0|||
155242342|NCT02019719|560319914|FG004|Overall Study|Physician Decision|0|||
155242343|NCT02348216|560319916|FG000|Overall Study|Death|5|||
155242344|NCT02348216|560319917|FG001|Overall Study|Death|53|||
155242345|NCT02348216|560319918|FG002|Overall Study|Death|11|||
155242346|NCT02348216|560319919|FG003|Overall Study|Death|20|||
155242347|NCT02348216|560319920|FG004|Overall Study|Death|16|||
155242348|NCT02348216|560319921|FG005|Overall Study|Death|32|||
155242349|NCT02348216|560319922|FG006|Overall Study|Death|17|||
155242350|NCT02348216|560319916|FG000|Overall Study|Full consent withdrawal|0|||
155242351|NCT02348216|560319917|FG001|Overall Study|Full consent withdrawal|0|||
155242352|NCT02348216|560319918|FG002|Overall Study|Full consent withdrawal|0|||
155242353|NCT02348216|560319919|FG003|Overall Study|Full consent withdrawal|1|||
155242354|NCT02348216|560319920|FG004|Overall Study|Full consent withdrawal|3|||
155242355|NCT02348216|560319921|FG005|Overall Study|Full consent withdrawal|0|||
155242356|NCT02348216|560319922|FG006|Overall Study|Full consent withdrawal|3|||
155242357|NCT02348216|560319916|FG000|Overall Study|Lost to Follow-up|0|||
155242358|NCT02348216|560319917|FG001|Overall Study|Lost to Follow-up|5|||
155242359|NCT02348216|560319918|FG002|Overall Study|Lost to Follow-up|2|||
155242360|NCT02348216|560319919|FG003|Overall Study|Lost to Follow-up|0|||
155242361|NCT02348216|560319920|FG004|Overall Study|Lost to Follow-up|1|||
155242362|NCT02348216|560319921|FG005|Overall Study|Lost to Follow-up|1|||
155242363|NCT02348216|560319922|FG006|Overall Study|Lost to Follow-up|1|||
155242364|NCT02348216|560319916|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
155242365|NCT02348216|560319917|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
155242366|NCT02348216|560319918|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
155242367|NCT02348216|560319919|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
155242368|NCT02348216|560319920|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
155242369|NCT02348216|560319921|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
155242370|NCT02348216|560319922|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
155242371|NCT02348216|560319916|FG000|Overall Study|Reason not specified|2|||
155242372|NCT02348216|560319917|FG001|Overall Study|Reason not specified|19|||
155242373|NCT02348216|560319918|FG002|Overall Study|Reason not specified|11|||
155242374|NCT02348216|560319919|FG003|Overall Study|Reason not specified|17|||
155242375|NCT02348216|560319920|FG004|Overall Study|Reason not specified|21|||
155242376|NCT02348216|560319921|FG005|Overall Study|Reason not specified|17|||
155242377|NCT02348216|560319922|FG006|Overall Study|Reason not specified|19|||
155242378|NCT01055639|560319923|FG000|Overall Study|Adverse Event|0|||
155242379|NCT01055639|560319924|FG001|Overall Study|Adverse Event|1|||
155242380|NCT01055639|560319923|FG000|Overall Study|Lack of Efficacy|0|||
155242381|NCT01055639|560319924|FG001|Overall Study|Lack of Efficacy|1|||
155242382|NCT01055639|560319923|FG000|Overall Study|Lost to Follow-up|8|||
155242383|NCT01055639|560319924|FG001|Overall Study|Lost to Follow-up|11|||
155242384|NCT01055639|560319923|FG000|Overall Study|Protocol Violation|5|||
155242385|NCT01055639|560319924|FG001|Overall Study|Protocol Violation|5|||
155242386|NCT01055639|560319923|FG000|Overall Study|Withdrawal by Subject|8|||
155242387|NCT01055639|560319924|FG001|Overall Study|Withdrawal by Subject|11|||
155242388|NCT00765245|560319925|FG000|Overall Study|disease progression|3|||
155242389|NCT00765245|560319926|FG001|Overall Study|disease progression|2|||
155242390|NCT00765245|560319925|FG000|Overall Study|Withdrawal by Subject|3|||
155242391|NCT00765245|560319926|FG001|Overall Study|Withdrawal by Subject|0|||
155242392|NCT00765245|560319925|FG000|Overall Study|Adverse Event|5|||
155242393|NCT00765245|560319926|FG001|Overall Study|Adverse Event|0|||
155242394|NCT00765245|560319925|FG000|Overall Study|Physician Decision|1|||
155242395|NCT00765245|560319926|FG001|Overall Study|Physician Decision|0|||
155242396|NCT00765245|560319925|FG000|Overall Study|Death|1|||
155242397|NCT00765245|560319926|FG001|Overall Study|Death|0|||
155242398|NCT02546544|560319930|FG000|Overall Study|Disease Progression|14|||
155242399|NCT02546544|560319930|FG000|Overall Study|Adverse Event|1|||
155242400|NCT02546544|560319930|FG000|Overall Study|Withdrawal by Subject|1|||
155242401|NCT01921348|560319931|FG000|Overall Study|Withdrawal by Subject|1|||
155242402|NCT01921348|560319932|FG001|Overall Study|Withdrawal by Subject|0|||
155242403|NCT01921348|560319931|FG000|Overall Study|Lost to Follow-up|0|||
155242404|NCT01921348|560319932|FG001|Overall Study|Lost to Follow-up|2|||
155242405|NCT02223390|560319933|FG000|Overall Study|Lost to Follow-up|9|||
155242406|NCT02223390|560319934|FG001|Overall Study|Lost to Follow-up|4|||
155242407|NCT02896855|560319936|FG000|Overall Study|Death|50|||
155242408|NCT02896855|560319937|FG001|Overall Study|Death|40|||
155242409|NCT02896855|560319936|FG000|Overall Study|Lost to Follow-up|15|||
155242410|NCT02896855|560319937|FG001|Overall Study|Lost to Follow-up|9|||
155242411|NCT02896855|560319936|FG000|Overall Study|Withdrawal by Subject|7|||
155242412|NCT02896855|560319937|FG001|Overall Study|Withdrawal by Subject|4|||
155242413|NCT02169674|560319938|FG000|Overall Study|Withdrawal by Subject|2|||
155242414|NCT02169674|560319939|FG001|Overall Study|Withdrawal by Subject|1|||
155242415|NCT02169674|560319938|FG000|Overall Study|Seroprotected|30|||
155242416|NCT02169674|560319939|FG001|Overall Study|Seroprotected|76|||
155242417|NCT02169674|560319938|FG000|Overall Study|Lost to Follow-up|0|||
155242418|NCT02169674|560319939|FG001|Overall Study|Lost to Follow-up|1|||
155242419|NCT02511431|560319940|FG000|Treatment|Lost to Follow-up|0|||
155242420|NCT02511431|560319941|FG001|Treatment|Lost to Follow-up|0|||
155242421|NCT02511431|560319942|FG002|Treatment|Lost to Follow-up|1|||
155242422|NCT02511431|560319943|FG003|Treatment|Lost to Follow-up|0|||
155242423|NCT02511431|560319944|FG004|Treatment|Lost to Follow-up|0|||
155242424|NCT02511431|560319945|FG005|Treatment|Lost to Follow-up|1|||
155242425|NCT00614939|560319948|FG000|Overall Study|Withdrawal by Subject|10|||
155242426|NCT00614939|560319949|FG001|Overall Study|Withdrawal by Subject|17|||
155242427|NCT00614939|560319948|FG000|Overall Study|Study specific discontinuation criteris|13|||
155242428|NCT00614939|560319949|FG001|Overall Study|Study specific discontinuation criteris|16|||
155242429|NCT00614939|560319948|FG000|Overall Study|Adverse Event|2|||
155242430|NCT00614939|560319949|FG001|Overall Study|Adverse Event|5|||
155242431|NCT00614939|560319948|FG000|Overall Study|Incorrect enrollment|1|||
155242432|NCT00614939|560319949|FG001|Overall Study|Incorrect enrollment|2|||
155242433|NCT00614939|560319948|FG000|Overall Study|Death|4|||
155242434|NCT00614939|560319949|FG001|Overall Study|Death|3|||
155242435|NCT00614939|560319948|FG000|Overall Study|Poor/non-compliance|4|||
155242436|NCT00614939|560319949|FG001|Overall Study|Poor/non-compliance|0|||
155242437|NCT00614939|560319948|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
155242438|NCT00614939|560319949|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
155242439|NCT00736996|560319950|FG000|Overall Study|Lost to Follow-up|1|||
155242440|NCT00736996|560319951|FG001|Overall Study|Lost to Follow-up|9|||
155242441|NCT00736996|560319952|FG002|Overall Study|Lost to Follow-up|2|||
155242442|NCT01343407|560319954|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
155242443|NCT01343407|560319955|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
155242444|NCT01343407|560319956|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
155242445|NCT01343407|560319957|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
155242446|NCT01343407|560319958|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
155242447|NCT01343407|560319959|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
155242448|NCT01343407|560319954|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242449|NCT01343407|560319955|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242450|NCT01343407|560319956|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
155242451|NCT01343407|560319957|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242452|NCT01343407|560319958|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242453|NCT01343407|560319959|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
155242454|NCT04079933|560319962|FG000|Overall Study|Withdrawal by Subject|3|||
155242455|NCT04079933|560319963|FG001|Overall Study|Withdrawal by Subject|4|||
155242456|NCT04079933|560319962|FG000|Overall Study|Lost to Follow-up|0|||
155242457|NCT04079933|560319963|FG001|Overall Study|Lost to Follow-up|1|||
155242458|NCT02504866|560319964|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
155242459|NCT02504866|560319965|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
155242460|NCT02504866|560319966|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
155242461|NCT01229436|560319967|FG000|Overall Study|Withdrawal by Subject|2|||
155242462|NCT01229436|560319967|FG000|Overall Study|Lost to Follow-up|3|||
155242463|NCT01775137|560319968|FG000|Overall Study|Death|1|||
155242464|NCT01775137|560319968|FG000|Overall Study|Protocol deviation|2|||
155242465|NCT01775137|560319968|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155242466|NCT01775137|560319968|FG000|Overall Study|Adverse Event|1|||
155242467|NCT01775137|560319968|FG000|Overall Study|Withdrawal by participants|5|||
155242468|NCT01343056|560319969|FG000|Overall Study|Lost to Follow-up|7|||
155242469|NCT01343056|560319970|FG001|Overall Study|Lost to Follow-up|5|||
155242470|NCT01343056|560319971|FG002|Overall Study|Lost to Follow-up|3|||
155242471|NCT01343056|560319972|FG003|Overall Study|Lost to Follow-up|9|||
155242472|NCT03893448|560319975|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
155242473|NCT03893448|560319976|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
155242474|NCT03893448|560319975|FG000|Overall Study|Physician Decision|8|||
155242475|NCT03893448|560319976|FG001|Overall Study|Physician Decision|14|||
155242476|NCT03893448|560319975|FG000|Overall Study|Lost to Follow-up|34|||
155242477|NCT03893448|560319976|FG001|Overall Study|Lost to Follow-up|27|||
155242478|NCT03893448|560319975|FG000|Overall Study|Death|1|||
155242479|NCT03893448|560319976|FG001|Overall Study|Death|0|||
155242480|NCT00022516|560319981|FG000|Overall Study|Adverse Event|0|||
155242481|NCT00022516|560319982|FG001|Overall Study|Adverse Event|59|||
155242482|NCT00022516|560319981|FG000|Overall Study|Lack of Efficacy|0|||
155242483|NCT00022516|560319982|FG001|Overall Study|Lack of Efficacy|27|||
155242484|NCT00022516|560319981|FG000|Overall Study|Physician Decision|0|||
155242485|NCT00022516|560319982|FG001|Overall Study|Physician Decision|1|||
155242486|NCT00022516|560319981|FG000|Overall Study|Protocol Violation|1|||
155242487|NCT00022516|560319982|FG001|Overall Study|Protocol Violation|3|||
155242488|NCT00022516|560319981|FG000|Overall Study|Withdrawal by Subject|2|||
155242489|NCT00022516|560319982|FG001|Overall Study|Withdrawal by Subject|113|||
155242490|NCT00022516|560319981|FG000|Overall Study|Incomplete documentation|0|||
155242491|NCT00022516|560319982|FG001|Overall Study|Incomplete documentation|27|||
155242492|NCT01568047|560319983|FG000|Overall Study|Ineligibility|1|||
155242493|NCT01568047|560319984|FG001|Overall Study|Ineligibility|0|||
155242494|NCT01568047|560319985|FG002|Overall Study|Ineligibility|0|||
155242495|NCT01568047|560319986|FG003|Overall Study|Ineligibility|0|||
155242496|NCT01568047|560319983|FG000|Overall Study|Withdrawal by Subject|0|||
155242497|NCT01568047|560319984|FG001|Overall Study|Withdrawal by Subject|1|||
155242498|NCT01568047|560319985|FG002|Overall Study|Withdrawal by Subject|0|||
155242499|NCT01568047|560319986|FG003|Overall Study|Withdrawal by Subject|0|||
155242500|NCT01568047|560319983|FG000|Overall Study|Adverse Event|0|||
155242501|NCT01568047|560319984|FG001|Overall Study|Adverse Event|0|||
155242502|NCT01568047|560319985|FG002|Overall Study|Adverse Event|1|||
155242503|NCT01568047|560319986|FG003|Overall Study|Adverse Event|1|||
155242504|NCT03783923|560319987|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
155242505|NCT03783923|560319988|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
155242506|NCT03783923|560319987|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
155242507|NCT03783923|560319988|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
155242508|NCT03783923|560319987|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
155242509|NCT03783923|560319988|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
155242510|NCT03783923|560319987|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
155242511|NCT03783923|560319988|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
155242512|NCT03783923|560319987|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
155242513|NCT03783923|560319988|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
155242514|NCT01427712|560319992|FG000|Overall Study|Transfer to a different hospital|2|||
155242515|NCT01427712|560319992|FG000|Overall Study|Lost to Follow-up|1|||
155242516|NCT01427712|560319992|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
155242517|NCT01427712|560319992|FG000|Overall Study|Failure to visit|1|||
155242518|NCT00661492|560319993|FG000|Overall Study|Adverse Event|16|||
155242519|NCT00661492|560319994|FG001|Overall Study|Adverse Event|13|||
155242520|NCT00661492|560319993|FG000|Overall Study|Disease Progression|44|||
155242521|NCT00661492|560319994|FG001|Overall Study|Disease Progression|14|||
155242522|NCT00661492|560319993|FG000|Overall Study|Patient Request|6|||
155242523|NCT00661492|560319994|FG001|Overall Study|Patient Request|1|||
155242524|NCT00661492|560319993|FG000|Overall Study|Investigator Request|1|||
155242525|NCT00661492|560319994|FG001|Overall Study|Investigator Request|0|||
155242526|NCT00661492|560319993|FG000|Overall Study|Lost to Follow-up|0|||
155242527|NCT00661492|560319994|FG001|Overall Study|Lost to Follow-up|1|||
155242528|NCT00661492|560319993|FG000|Overall Study|Other|1|||
155242529|NCT00661492|560319994|FG001|Overall Study|Other|0|||
155242530|NCT01143259|560319995|FG000|Overall Study|Withdrawal by Subject|3|||
155242531|NCT01143259|560319996|FG001|Overall Study|Withdrawal by Subject|2|||
155242532|NCT01143259|560319995|FG000|Overall Study|Protocol Violation|13|||
155242533|NCT01143259|560319996|FG001|Overall Study|Protocol Violation|9|||
155242534|NCT01143259|560319995|FG000|Overall Study|Screen Failure|7|||
155242535|NCT01143259|560319996|FG001|Overall Study|Screen Failure|9|||
155242536|NCT00099983|560319997|FG000|Overall Study|Lost to Follow-up|2|||
155242537|NCT00099983|560319998|FG001|Overall Study|Lost to Follow-up|3|||
155242538|NCT00099983|560319997|FG000|Overall Study|Missing Source Documents|14|||
155242539|NCT00099983|560319998|FG001|Overall Study|Missing Source Documents|15|||
155242540|NCT00099983|560319997|FG000|Overall Study|Withdrawal by Subject|3|||
155242541|NCT00099983|560319998|FG001|Overall Study|Withdrawal by Subject|2|||
155242542|NCT00099983|560319997|FG000|Overall Study|Adverse Event|1|||
155242543|NCT00099983|560319998|FG001|Overall Study|Adverse Event|1|||
155242544|NCT00099983|560319997|FG000|Overall Study|Lack of Efficacy|0|||
155242545|NCT00099983|560319998|FG001|Overall Study|Lack of Efficacy|1|||
155242546|NCT00099983|560319997|FG000|Overall Study|Unable to return for appointments|1|||
155242547|NCT00099983|560319998|FG001|Overall Study|Unable to return for appointments|1|||
155242548|NCT00099983|560319997|FG000|Overall Study|Moved|1|||
155242549|NCT00099983|560319998|FG001|Overall Study|Moved|0|||
155242550|NCT00099983|560319997|FG000|Overall Study|Other psychiatric problem|1|||
155242551|NCT00099983|560319998|FG001|Overall Study|Other psychiatric problem|0|||
155242552|NCT00099983|560319997|FG000|Overall Study|Incarcerated|0|||
155242553|NCT00099983|560319998|FG001|Overall Study|Incarcerated|1|||
155242554|NCT00099983|560319997|FG000|Overall Study|Intolerant of burden of visits|0|||
155242555|NCT00099983|560319998|FG001|Overall Study|Intolerant of burden of visits|1|||
155242556|NCT00099983|560319997|FG000|Overall Study|Other issue|1|||
155242557|NCT00099983|560319998|FG001|Overall Study|Other issue|0|||
155242558|NCT02641080|560319999|FG000|Overall Study|Physician Decision|2|||
155242559|NCT02641080|560320000|FG001|Overall Study|Physician Decision|0|||
155242560|NCT02641080|560319999|FG000|Overall Study|Withdrawal by Subject|0|||
155242561|NCT02641080|560320000|FG001|Overall Study|Withdrawal by Subject|1|||
155242562|NCT02641080|560319999|FG000|Overall Study|Rehab Center denied use of pumps|0|||
155242563|NCT02641080|560320000|FG001|Overall Study|Rehab Center denied use of pumps|3|||
155242564|NCT02641080|560319999|FG000|Overall Study|Lost to Follow-up|0|||
155242565|NCT02641080|560320000|FG001|Overall Study|Lost to Follow-up|3|||
155242566|NCT00803634|560320001|FG000|Overall Study|Withdrew Consent|1|||
155242567|NCT00803634|560320002|FG001|Overall Study|Withdrew Consent|0|||
155242568|NCT00803634|560320001|FG000|Overall Study|Lost to Follow-up|2|||
155242569|NCT00803634|560320002|FG001|Overall Study|Lost to Follow-up|3|||
155242570|NCT00803634|560320001|FG000|Overall Study|Death|3|||
155242571|NCT00803634|560320002|FG001|Overall Study|Death|2|||
155242572|NCT03835533|560320003|FG000|Overall Study|Death|5|||
155242573|NCT03835533|560320004|FG001|Overall Study|Death|10|||
155242574|NCT03835533|560320005|FG002|Overall Study|Death|9|||
155242575|NCT03835533|560320003|FG000|Overall Study|Withdrawal by Subject|2|||
155242576|NCT03835533|560320004|FG001|Overall Study|Withdrawal by Subject|2|||
155242577|NCT03835533|560320005|FG002|Overall Study|Withdrawal by Subject|2|||
155242578|NCT03835533|560320003|FG000|Overall Study|Lost to Follow-up|1|||
155242579|NCT03835533|560320004|FG001|Overall Study|Lost to Follow-up|0|||
155242580|NCT03835533|560320005|FG002|Overall Study|Lost to Follow-up|0|||
155242581|NCT01866709|560320012|FG000|Overall Study|Adverse Event|1|||
155242582|NCT01866709|560320013|FG001|Overall Study|Adverse Event|0|||
155242583|NCT03285477|560320015|FG000|Treatment and Response Assessment Period|Death|1|||
155242584|NCT03285477|560320016|FG001|Treatment and Response Assessment Period|Death|0|||
155242585|NCT03285477|560320015|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
155242586|NCT03285477|560320016|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
155242587|NCT03285477|560320015|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
155242588|NCT03285477|560320016|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
155242589|NCT03285477|560320015|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
155242590|NCT03285477|560320016|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
155242591|NCT03285477|560320015|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
155242592|NCT03285477|560320016|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
155242593|NCT00560833|560320017|FG000|Overall Study|Adverse Event|16|||
155242594|NCT00560833|560320018|FG001|Overall Study|Adverse Event|10|||
155242595|NCT00560833|560320019|FG002|Overall Study|Adverse Event|25|||
155242596|NCT00560833|560320020|FG003|Overall Study|Adverse Event|23|||
155242597|NCT00560833|560320021|FG004|Overall Study|Adverse Event|35|||
155242598|NCT00560833|560320017|FG000|Overall Study|Lost to Follow-up|0|||
155242599|NCT00560833|560320018|FG001|Overall Study|Lost to Follow-up|0|||
155242600|NCT00560833|560320019|FG002|Overall Study|Lost to Follow-up|1|||
155242601|NCT00560833|560320020|FG003|Overall Study|Lost to Follow-up|0|||
155242602|NCT00560833|560320021|FG004|Overall Study|Lost to Follow-up|0|||
155242603|NCT00560833|560320017|FG000|Overall Study|Lack of Efficacy|22|||
155242604|NCT00560833|560320018|FG001|Overall Study|Lack of Efficacy|9|||
155242605|NCT00560833|560320019|FG002|Overall Study|Lack of Efficacy|6|||
155242606|NCT00560833|560320020|FG003|Overall Study|Lack of Efficacy|4|||
155242607|NCT00560833|560320021|FG004|Overall Study|Lack of Efficacy|4|||
155242608|NCT00560833|560320017|FG000|Overall Study|Participant uncooperative|5|||
155242609|NCT00560833|560320018|FG001|Overall Study|Participant uncooperative|5|||
155242610|NCT00560833|560320019|FG002|Overall Study|Participant uncooperative|4|||
155242611|NCT00560833|560320020|FG003|Overall Study|Participant uncooperative|4|||
155242612|NCT00560833|560320021|FG004|Overall Study|Participant uncooperative|2|||
155242613|NCT00560833|560320017|FG000|Overall Study|Other|1|||
155242614|NCT00560833|560320018|FG001|Overall Study|Other|1|||
155242615|NCT00560833|560320019|FG002|Overall Study|Other|3|||
155242616|NCT00560833|560320020|FG003|Overall Study|Other|0|||
155242617|NCT00560833|560320021|FG004|Overall Study|Other|0|||
155242618|NCT00560833|560320017|FG000|Overall Study|Never received drug|0|||
155242619|NCT00560833|560320018|FG001|Overall Study|Never received drug|1|||
155242620|NCT00560833|560320019|FG002|Overall Study|Never received drug|0|||
155242621|NCT00560833|560320020|FG003|Overall Study|Never received drug|0|||
155242622|NCT00560833|560320021|FG004|Overall Study|Never received drug|1|||
155242623|NCT03283670|560320022|FG000|Placebo Gas|Withdrawal by Subject|2|||
155242624|NCT03283670|560320022|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
155242625|NCT03283670|560320022|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
155242626|NCT01059617|560320025|FG000|Overall Study|Other|7|||
155242627|NCT01059617|560320026|FG001|Overall Study|Other|1|||
155242628|NCT01059617|560320027|FG002|Overall Study|Other|8|||
155242629|NCT01059617|560320028|FG003|Overall Study|Other|6|||
155242630|NCT01307501|560320029|FG000|Overall Study|Treatment Failure|1|||
155242631|NCT01307501|560320029|FG000|Overall Study|Death|20|||
155242632|NCT01307501|560320029|FG000|Overall Study|Lost to Follow-up|1|||
155242633|NCT01307501|560320029|FG000|Overall Study|Starting Hospice|1|||
155242634|NCT01209624|560320037|FG000|Overall Study|Death|2|||
155242635|NCT01209624|560320037|FG000|Overall Study|Adverse Event|13|||
155242636|NCT01209624|560320037|FG000|Overall Study|Lack of Efficacy|17|||
155242637|NCT01209624|560320037|FG000|Overall Study|Lost to Follow-up|290|||
155242638|NCT01209624|560320037|FG000|Overall Study|Other|4|||
155242639|NCT03403634|560320038|FG000|Overall Study|Disease progression|3|||
155242640|NCT03403634|560320038|FG000|Overall Study|Did not meet eligibility criteria|4|||
155242641|NCT03859323|560322167|FG000|Overall Study|Lost to Follow-up|0|||
155242642|NCT03859323|560322168|FG001|Overall Study|Lost to Follow-up|0|||
155242643|NCT03859323|560322169|FG002|Overall Study|Lost to Follow-up|0|||
155242644|NCT03859323|560322170|FG003|Overall Study|Lost to Follow-up|0|||
155242645|NCT03859323|560322171|FG004|Overall Study|Lost to Follow-up|0|||
155242646|NCT03859323|560322172|FG005|Overall Study|Lost to Follow-up|0|||
155242647|NCT03859323|560322173|FG006|Overall Study|Lost to Follow-up|1|||
155242648|NCT03859323|560322174|FG007|Overall Study|Lost to Follow-up|0|||
155242649|NCT03859323|560322175|FG008|Overall Study|Lost to Follow-up|0|||
155242650|NCT03859323|560322176|FG009|Overall Study|Lost to Follow-up|0|||
155242651|NCT03859323|560322177|FG010|Overall Study|Lost to Follow-up|0|||
155242652|NCT03859323|560322178|FG011|Overall Study|Lost to Follow-up|0|||
155242653|NCT03859323|560322179|FG012|Overall Study|Lost to Follow-up|0|||
155242654|NCT03859323|560322167|FG000|Overall Study|Withdrawal by Subject|0|||
155242655|NCT03859323|560322168|FG001|Overall Study|Withdrawal by Subject|0|||
155242656|NCT03859323|560322169|FG002|Overall Study|Withdrawal by Subject|1|||
155242657|NCT03859323|560322170|FG003|Overall Study|Withdrawal by Subject|0|||
155242658|NCT03859323|560322171|FG004|Overall Study|Withdrawal by Subject|0|||
155242659|NCT03859323|560322172|FG005|Overall Study|Withdrawal by Subject|1|||
155242660|NCT03859323|560322173|FG006|Overall Study|Withdrawal by Subject|0|||
155242661|NCT03859323|560322174|FG007|Overall Study|Withdrawal by Subject|0|||
155242662|NCT03859323|560322175|FG008|Overall Study|Withdrawal by Subject|0|||
155242663|NCT03859323|560322176|FG009|Overall Study|Withdrawal by Subject|1|||
155242664|NCT03859323|560322177|FG010|Overall Study|Withdrawal by Subject|1|||
155242665|NCT03859323|560322178|FG011|Overall Study|Withdrawal by Subject|2|||
155242666|NCT03859323|560322179|FG012|Overall Study|Withdrawal by Subject|1|||
155242667|NCT03859323|560322167|FG000|Overall Study|Pregnancy|0|||
155242668|NCT03859323|560322168|FG001|Overall Study|Pregnancy|0|||
155242669|NCT03859323|560322169|FG002|Overall Study|Pregnancy|0|||
155242670|NCT03859323|560322170|FG003|Overall Study|Pregnancy|0|||
155242671|NCT03859323|560322171|FG004|Overall Study|Pregnancy|0|||
155242672|NCT03859323|560322172|FG005|Overall Study|Pregnancy|0|||
155242673|NCT03859323|560322173|FG006|Overall Study|Pregnancy|0|||
155242674|NCT03859323|560322174|FG007|Overall Study|Pregnancy|0|||
155242675|NCT03859323|560322175|FG008|Overall Study|Pregnancy|0|||
155242676|NCT03859323|560322176|FG009|Overall Study|Pregnancy|1|||
155242677|NCT03859323|560322177|FG010|Overall Study|Pregnancy|0|||
155242678|NCT03859323|560322178|FG011|Overall Study|Pregnancy|0|||
155242679|NCT03859323|560322179|FG012|Overall Study|Pregnancy|0|||
155242680|NCT00993447|560322182|FG000|Overall Study|Withdrawal by Subject|23|||
155242681|NCT00993447|560322183|FG001|Overall Study|Withdrawal by Subject|8|||
155242682|NCT00993447|560322182|FG000|Overall Study|Protocol Violation|12|||
155242683|NCT00993447|560322183|FG001|Overall Study|Protocol Violation|8|||
155242684|NCT00993447|560322182|FG000|Overall Study|Lost to Follow-up|1|||
155242685|NCT00993447|560322183|FG001|Overall Study|Lost to Follow-up|3|||
155242686|NCT00993447|560322182|FG000|Overall Study|Adverse Event|1|||
155242687|NCT00993447|560322183|FG001|Overall Study|Adverse Event|0|||
155242688|NCT04401579|560322185|FG000|Overall Study|Death|23|||
155242689|NCT04401579|560322186|FG001|Overall Study|Death|36|||
155242690|NCT04401579|560322185|FG000|Overall Study|Lost to Follow-up|40|||
155242691|NCT04401579|560322186|FG001|Overall Study|Lost to Follow-up|41|||
155242692|NCT04401579|560322185|FG000|Overall Study|Withdrawal by Subject|8|||
155242693|NCT04401579|560322186|FG001|Overall Study|Withdrawal by Subject|16|||
155242694|NCT04401579|560322185|FG000|Overall Study|Physician Decision|1|||
155242695|NCT04401579|560322186|FG001|Overall Study|Physician Decision|2|||
155242696|NCT04401579|560322185|FG000|Overall Study|Became ineligible after enrollment|1|||
155242697|NCT04401579|560322186|FG001|Overall Study|Became ineligible after enrollment|1|||
155242698|NCT04401579|560322185|FG000|Overall Study|Enrolled but treatment not administered|7|||
155242699|NCT04401579|560322186|FG001|Overall Study|Enrolled but treatment not administered|9|||
155242700|NCT04401579|560322185|FG000|Overall Study|Adverse Event|2|||
155242701|NCT04401579|560322186|FG001|Overall Study|Adverse Event|1|||
155242702|NCT04401579|560322185|FG000|Overall Study|Scheduling error|1|||
155242703|NCT04401579|560322186|FG001|Overall Study|Scheduling error|2|||
155242704|NCT04401579|560322185|FG000|Overall Study|Transferred to another hospital|1|||
155242705|NCT04401579|560322186|FG001|Overall Study|Transferred to another hospital|2|||
155242706|NCT00489970|560322187|FG000|Persistence Year 9|Lost to Follow-up|2|||
155242707|NCT00489970|560322188|FG001|Persistence Year 9|Lost to Follow-up|2|||
155242708|NCT00489970|560322189|FG002|Persistence Year 9|Lost to Follow-up|3|||
155242709|NCT00489970|560322187|FG000|Persistence Year 9|Other|1|||
155242710|NCT00489970|560322188|FG001|Persistence Year 9|Other|0|||
155242711|NCT00489970|560322189|FG002|Persistence Year 9|Other|2|||
155242712|NCT01438411|560322190|FG000|Overall Study|Adverse Event|8|||
155242713|NCT01438411|560322190|FG000|Overall Study|Lost to Follow-up|1|||
155242714|NCT01438411|560322190|FG000|Overall Study|Lack of Efficacy|1|||
155242715|NCT01438411|560322190|FG000|Overall Study|Withdrawal by Subject|3|||
155242716|NCT01863680|560322191|FG000|Overall Study|Adverse Event|17|||
155242717|NCT01863680|560322191|FG000|Overall Study|Risk of OHSS|17|||
155242718|NCT01863680|560322191|FG000|Overall Study|Spontaneous pregnancy|2|||
155242719|NCT01863680|560322191|FG000|Overall Study|Withdrawal by Subject|1|||
155242720|NCT01863680|560322191|FG000|Overall Study|Did not undergo IVF/ET|14|||
155242721|NCT01863680|560322191|FG000|Overall Study|Other|6|||
155242722|NCT00618514|560322192|FG000|Overall Study|Lost to Follow-up|11|||
155242723|NCT00618514|560322193|FG001|Overall Study|Lost to Follow-up|12|||
155242724|NCT00618514|560322194|FG002|Overall Study|Lost to Follow-up|4|||
155242725|NCT03320070|560322201|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
155242726|NCT03320070|560322202|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
155242727|NCT03320070|560322201|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
155242728|NCT03320070|560322202|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
155242729|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
155242730|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
155242731|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
155242732|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
155242733|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
155242734|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
155242735|NCT03320070|560322201|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
155242736|NCT03320070|560322202|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
155242737|NCT02041195|560322203|FG000|Overall Study|Adverse Event|1|||
155242738|NCT02041195|560322204|FG001|Overall Study|Adverse Event|2|||
155242739|NCT02041195|560322205|FG002|Overall Study|Adverse Event|0|||
155242740|NCT02041195|560322206|FG003|Overall Study|Adverse Event|0|||
155242741|NCT02041195|560322207|FG004|Overall Study|Adverse Event|0|||
155242742|NCT02041195|560322208|FG005|Overall Study|Adverse Event|0|||
155242743|NCT02041195|560322209|FG006|Overall Study|Adverse Event|3|||
155242744|NCT02041195|560322210|FG007|Overall Study|Adverse Event|0|||
155242745|NCT02041195|560322203|FG000|Overall Study|Withdrawal by Subject|1|||
155242746|NCT02041195|560322204|FG001|Overall Study|Withdrawal by Subject|0|||
155242747|NCT02041195|560322205|FG002|Overall Study|Withdrawal by Subject|0|||
155242748|NCT02041195|560322206|FG003|Overall Study|Withdrawal by Subject|0|||
155242749|NCT02041195|560322207|FG004|Overall Study|Withdrawal by Subject|0|||
155242750|NCT02041195|560322208|FG005|Overall Study|Withdrawal by Subject|0|||
155242751|NCT02041195|560322209|FG006|Overall Study|Withdrawal by Subject|4|||
155242752|NCT02041195|560322210|FG007|Overall Study|Withdrawal by Subject|3|||
155242753|NCT02041195|560322203|FG000|Overall Study|Unable to comply with study visits|0|||
155242754|NCT02041195|560322204|FG001|Overall Study|Unable to comply with study visits|1|||
155242755|NCT02041195|560322205|FG002|Overall Study|Unable to comply with study visits|0|||
155242756|NCT02041195|560322206|FG003|Overall Study|Unable to comply with study visits|0|||
155242757|NCT02041195|560322207|FG004|Overall Study|Unable to comply with study visits|1|||
155242758|NCT02041195|560322208|FG005|Overall Study|Unable to comply with study visits|0|||
155242759|NCT02041195|560322209|FG006|Overall Study|Unable to comply with study visits|0|||
155242760|NCT02041195|560322210|FG007|Overall Study|Unable to comply with study visits|0|||
155242761|NCT03564496|560322211|FG000|Overall Study|Withdrawal by Subject|1|||
155242762|NCT03564496|560322212|FG001|Overall Study|Withdrawal by Subject|1|||
155242763|NCT03564496|560322213|FG002|Overall Study|Withdrawal by Subject|0|||
155242764|NCT03564496|560322211|FG000|Overall Study|Screen failure|0|||
155242765|NCT03564496|560322212|FG001|Overall Study|Screen failure|3|||
155242766|NCT03564496|560322213|FG002|Overall Study|Screen failure|0|||
155242767|NCT00674986|560322214|FG000|Overall Study|Adverse Event|2|||
155242768|NCT00674986|560322215|FG001|Overall Study|Adverse Event|1|||
155242769|NCT00674986|560322214|FG000|Overall Study|Subject withdrew consent|12|||
155242770|NCT00674986|560322215|FG001|Overall Study|Subject withdrew consent|19|||
155242771|NCT00674986|560322214|FG000|Overall Study|Lost to Follow-up|25|||
155242772|NCT00674986|560322215|FG001|Overall Study|Lost to Follow-up|53|||
155242773|NCT00674986|560322214|FG000|Overall Study|Other reasons|4|||
155242774|NCT00674986|560322215|FG001|Overall Study|Other reasons|8|||
155242775|NCT02244944|560322218|FG000|Overall Study|Withdrawal by Subject|1|||
155242776|NCT02244944|560322218|FG000|Overall Study|Study Terminated|1|||
155242777|NCT01747772|560322219|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
155242778|NCT02492100|560322220|FG000|Overall Study|Death|1|||
155242779|NCT04121962|560322221|FG000|Overall Study|Lost to Follow-up|42|||
155242780|NCT04121962|560322222|FG001|Overall Study|Lost to Follow-up|39|||
155242781|NCT01308749|560322223|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
155242782|NCT01308749|560322224|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
155242783|NCT01308749|560322223|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
155242784|NCT01308749|560322224|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
155242785|NCT01308749|560322223|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
155242786|NCT01308749|560322224|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
155242787|NCT01197950|560322227|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
155242788|NCT01197950|560322228|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
155242789|NCT01197950|560322229|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
155242790|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Adverse Event|3|||
155242791|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Adverse Event|2|||
155242792|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Adverse Event|0|||
155242793|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Adverse Event|0|||
155242794|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Adverse Event|0|||
155242795|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Adverse Event|0|||
155242796|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Adverse Event|0|||
155242797|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
155242798|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
155242799|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242800|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242801|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242802|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242803|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
155242804|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Physician Decision|1|||
155242805|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Physician Decision|0|||
155242806|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Physician Decision|0|||
155242807|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Physician Decision|0|||
155242808|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Physician Decision|0|||
155242809|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Physician Decision|0|||
155242810|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Physician Decision|0|||
155242811|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
155242812|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
155242813|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242814|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242815|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242816|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242817|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
155242818|NCT02265705|560322242|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242819|NCT02265705|560322243|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
155242820|NCT02265705|560322244|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242821|NCT02265705|560322245|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242822|NCT02265705|560322246|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242823|NCT02265705|560322247|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242824|NCT02265705|560322248|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
155242825|NCT02265705|560322242|FG000|Rescue Period|Withdrawal by Subject|0|||
155242826|NCT02265705|560322243|FG001|Rescue Period|Withdrawal by Subject|0|||
155242827|NCT02265705|560322244|FG002|Rescue Period|Withdrawal by Subject|1|||
155242828|NCT02265705|560322245|FG003|Rescue Period|Withdrawal by Subject|0|||
155242829|NCT02265705|560322246|FG004|Rescue Period|Withdrawal by Subject|0|||
155242830|NCT02265705|560322247|FG005|Rescue Period|Withdrawal by Subject|0|||
155242831|NCT02265705|560322248|FG006|Rescue Period|Withdrawal by Subject|0|||
155242832|NCT02265705|560322242|FG000|Rescue Period|Death|0|||
155242833|NCT02265705|560322243|FG001|Rescue Period|Death|0|||
155242834|NCT02265705|560322244|FG002|Rescue Period|Death|1|||
155242835|NCT02265705|560322245|FG003|Rescue Period|Death|0|||
155242836|NCT02265705|560322246|FG004|Rescue Period|Death|0|||
155242837|NCT02265705|560322247|FG005|Rescue Period|Death|0|||
155242838|NCT02265705|560322248|FG006|Rescue Period|Death|0|||
155242839|NCT02265705|560322242|FG000|Rescue Period|Lack of Efficacy|0|||
155242840|NCT02265705|560322243|FG001|Rescue Period|Lack of Efficacy|0|||
155242841|NCT02265705|560322244|FG002|Rescue Period|Lack of Efficacy|1|||
155242842|NCT02265705|560322245|FG003|Rescue Period|Lack of Efficacy|0|||
155242843|NCT02265705|560322246|FG004|Rescue Period|Lack of Efficacy|0|||
155242844|NCT02265705|560322247|FG005|Rescue Period|Lack of Efficacy|0|||
155242845|NCT02265705|560322248|FG006|Rescue Period|Lack of Efficacy|0|||
155242846|NCT02265705|560322242|FG000|Open Label Period|Adverse Event|0|||
155242847|NCT02265705|560322243|FG001|Open Label Period|Adverse Event|0|||
155242848|NCT02265705|560322244|FG002|Open Label Period|Adverse Event|0|||
155242849|NCT02265705|560322245|FG003|Open Label Period|Adverse Event|2|||
155242850|NCT02265705|560322246|FG004|Open Label Period|Adverse Event|2|||
155242851|NCT02265705|560322247|FG005|Open Label Period|Adverse Event|0|||
155242852|NCT02265705|560322248|FG006|Open Label Period|Adverse Event|0|||
155242853|NCT02265705|560322242|FG000|Open Label Period|Physician Decision|0|||
155242854|NCT02265705|560322243|FG001|Open Label Period|Physician Decision|0|||
155242855|NCT02265705|560322244|FG002|Open Label Period|Physician Decision|0|||
155242856|NCT02265705|560322245|FG003|Open Label Period|Physician Decision|0|||
155242857|NCT02265705|560322246|FG004|Open Label Period|Physician Decision|1|||
155242858|NCT02265705|560322247|FG005|Open Label Period|Physician Decision|0|||
155242859|NCT02265705|560322248|FG006|Open Label Period|Physician Decision|0|||
155242860|NCT02265705|560322242|FG000|Open Label Period|Withdrawal by Subject|0|||
155242861|NCT02265705|560322243|FG001|Open Label Period|Withdrawal by Subject|0|||
155242862|NCT02265705|560322244|FG002|Open Label Period|Withdrawal by Subject|0|||
155242863|NCT02265705|560322245|FG003|Open Label Period|Withdrawal by Subject|0|||
155242864|NCT02265705|560322246|FG004|Open Label Period|Withdrawal by Subject|2|||
155242865|NCT02265705|560322247|FG005|Open Label Period|Withdrawal by Subject|0|||
155242866|NCT02265705|560322248|FG006|Open Label Period|Withdrawal by Subject|0|||
155242867|NCT02265705|560322242|FG000|Follow-up Period|Sponsor Decision|0|||
155242868|NCT02265705|560322243|FG001|Follow-up Period|Sponsor Decision|0|||
155242869|NCT02265705|560322244|FG002|Follow-up Period|Sponsor Decision|0|||
155242870|NCT02265705|560322245|FG003|Follow-up Period|Sponsor Decision|0|||
155242871|NCT02265705|560322246|FG004|Follow-up Period|Sponsor Decision|0|||
155242872|NCT02265705|560322247|FG005|Follow-up Period|Sponsor Decision|1|||
155242873|NCT02265705|560322248|FG006|Follow-up Period|Sponsor Decision|6|||
155242874|NCT02265705|560322242|FG000|Follow-up Period|Adverse Event|0|||
155242875|NCT02265705|560322243|FG001|Follow-up Period|Adverse Event|0|||
155242876|NCT02265705|560322244|FG002|Follow-up Period|Adverse Event|0|||
155242877|NCT02265705|560322245|FG003|Follow-up Period|Adverse Event|0|||
155242878|NCT02265705|560322246|FG004|Follow-up Period|Adverse Event|0|||
155242879|NCT02265705|560322247|FG005|Follow-up Period|Adverse Event|0|||
155242880|NCT02265705|560322248|FG006|Follow-up Period|Adverse Event|3|||
155242881|NCT02265705|560322242|FG000|Follow-up Period|Physician Decision|0|||
155242882|NCT02265705|560322243|FG001|Follow-up Period|Physician Decision|0|||
155242883|NCT02265705|560322244|FG002|Follow-up Period|Physician Decision|0|||
155242884|NCT02265705|560322245|FG003|Follow-up Period|Physician Decision|0|||
155242885|NCT02265705|560322246|FG004|Follow-up Period|Physician Decision|0|||
155242886|NCT02265705|560322247|FG005|Follow-up Period|Physician Decision|0|||
155242887|NCT02265705|560322248|FG006|Follow-up Period|Physician Decision|1|||
155242888|NCT02265705|560322242|FG000|Follow-up Period|Withdrawal by Subject|0|||
155242889|NCT02265705|560322243|FG001|Follow-up Period|Withdrawal by Subject|0|||
155242890|NCT02265705|560322244|FG002|Follow-up Period|Withdrawal by Subject|0|||
155242891|NCT02265705|560322245|FG003|Follow-up Period|Withdrawal by Subject|0|||
155242892|NCT02265705|560322246|FG004|Follow-up Period|Withdrawal by Subject|0|||
155242893|NCT02265705|560322247|FG005|Follow-up Period|Withdrawal by Subject|0|||
155242894|NCT02265705|560322248|FG006|Follow-up Period|Withdrawal by Subject|1|||
155242895|NCT00462384|560322250|FG000|Overall Study|Adverse Event|2|||
155242896|NCT00462384|560322250|FG000|Overall Study|Death|2|||
155242897|NCT00462384|560322250|FG000|Overall Study|Withdrawal by Subject|1|||
155242898|NCT00462384|560322250|FG000|Overall Study|Other|4|||
155242899|NCT04000165|560322251|FG000|Overall Study|Physician Decision|1|||
155242900|NCT04000165|560322251|FG000|Overall Study|Withdrawal by Subject|1|||
155242901|NCT01753193|560322252|FG000|Overall Study|Withdrawal by Subject|23|||
155242902|NCT01753193|560322252|FG000|Overall Study|Lost to Follow-up|6|||
155242903|NCT01753193|560322252|FG000|Overall Study|Death|1|||
155242904|NCT01753193|560322252|FG000|Overall Study|Other|16|||
155242905|NCT02682264|560322253|FG000|Overall Study|Withdrawal by Subject|56|||
155242906|NCT02682264|560322254|FG001|Overall Study|Withdrawal by Subject|45|||
155242907|NCT02682264|560322253|FG000|Overall Study|Lost to Follow-up|49|||
155242908|NCT02682264|560322254|FG001|Overall Study|Lost to Follow-up|41|||
155242909|NCT02682264|560322253|FG000|Overall Study|Lack of Efficacy|14|||
155242910|NCT02682264|560322254|FG001|Overall Study|Lack of Efficacy|16|||
155242911|NCT02682264|560322253|FG000|Overall Study|Withdrawal by Parent|6|||
155242912|NCT02682264|560322254|FG001|Overall Study|Withdrawal by Parent|7|||
155242913|NCT02682264|560322253|FG000|Overall Study|Adverse Event|9|||
155242914|NCT02682264|560322254|FG001|Overall Study|Adverse Event|0|||
155242915|NCT02682264|560322253|FG000|Overall Study|Noncompliance with study drug|1|||
155242916|NCT02682264|560322254|FG001|Overall Study|Noncompliance with study drug|4|||
155242917|NCT02682264|560322253|FG000|Overall Study|Pregnancy|1|||
155242918|NCT02682264|560322254|FG001|Overall Study|Pregnancy|2|||
155242919|NCT02682264|560322253|FG000|Overall Study|Recovery|1|||
155242920|NCT02682264|560322254|FG001|Overall Study|Recovery|2|||
155242921|NCT02682264|560322253|FG000|Overall Study|Progressive Disease|1|||
155242922|NCT02682264|560322254|FG001|Overall Study|Progressive Disease|0|||
155242923|NCT02682264|560322253|FG000|Overall Study|Technical Problems|0|||
155242924|NCT02682264|560322254|FG001|Overall Study|Technical Problems|1|||
155242925|NCT02682264|560322253|FG000|Overall Study|Moved abroad and unable to continue|0|||
155242926|NCT02682264|560322254|FG001|Overall Study|Moved abroad and unable to continue|3|||
155242927|NCT02682264|560322253|FG000|Overall Study|Stopped test article application|0|||
155242928|NCT02682264|560322254|FG001|Overall Study|Stopped test article application|1|||
155242929|NCT03879798|560322256|FG000|Overall Study|Adverse Event|0|||
155242930|NCT03879798|560322257|FG001|Overall Study|Adverse Event|0|||
155242931|NCT03879798|560322258|FG002|Overall Study|Adverse Event|0|||
155242932|NCT03879798|560322259|FG003|Overall Study|Adverse Event|0|||
155242933|NCT03879798|560322260|FG004|Overall Study|Adverse Event|0|||
155242934|NCT03879798|560322261|FG005|Overall Study|Adverse Event|1|||
155242935|NCT03879798|560322256|FG000|Overall Study|Lack of Efficacy|0|||
155242936|NCT03879798|560322257|FG001|Overall Study|Lack of Efficacy|0|||
155242937|NCT03879798|560322258|FG002|Overall Study|Lack of Efficacy|0|||
155242938|NCT03879798|560322259|FG003|Overall Study|Lack of Efficacy|0|||
155242939|NCT03879798|560322260|FG004|Overall Study|Lack of Efficacy|0|||
155242940|NCT03879798|560322261|FG005|Overall Study|Lack of Efficacy|1|||
155242941|NCT03879798|560322256|FG000|Overall Study|Withdrawal by Subject|0|||
155242942|NCT03879798|560322257|FG001|Overall Study|Withdrawal by Subject|0|||
155242943|NCT03879798|560322258|FG002|Overall Study|Withdrawal by Subject|0|||
155242944|NCT03879798|560322259|FG003|Overall Study|Withdrawal by Subject|0|||
155242945|NCT03879798|560322260|FG004|Overall Study|Withdrawal by Subject|0|||
155242946|NCT03879798|560322261|FG005|Overall Study|Withdrawal by Subject|1|||
155242947|NCT01255358|560322262|FG000|Overall Study|Adverse Event|2|||
155242948|NCT01255358|560322262|FG000|Overall Study|Protocol Violation|2|||
155242949|NCT06027216|560322263|FG000|Overall Study|Did not qualify|8|||
155242950|NCT03231371|560322264|FG000|Overall Study|Withdrawal by Subject|1|||
155242951|NCT03231371|560322264|FG000|Overall Study|chose or were ineligible to have MRI|12|||
155242952|NCT00345579|560322268|FG000|Overall Study|Adverse Event|9|||
155242953|NCT00345579|560322269|FG001|Overall Study|Adverse Event|6|||
155242954|NCT00345579|560322268|FG000|Overall Study|Protocol Violation|14|||
155242955|NCT00345579|560322269|FG001|Overall Study|Protocol Violation|5|||
155242956|NCT00345579|560322268|FG000|Overall Study|Withdrawal by Subject|50|||
155242957|NCT00345579|560322269|FG001|Overall Study|Withdrawal by Subject|17|||
155242958|NCT00345579|560322268|FG000|Overall Study|Lost to Follow-up|82|||
155242959|NCT00345579|560322269|FG001|Overall Study|Lost to Follow-up|36|||
155242960|NCT00345579|560322268|FG000|Overall Study|Other|9|||
155242961|NCT00345579|560322269|FG001|Overall Study|Other|1|||
155242962|NCT03029208|560322270|FG000|Overall Study|Withdrawal by Subject|2|||
155242963|NCT03029208|560322271|FG001|Overall Study|Withdrawal by Subject|3|||
155242964|NCT03029208|560322270|FG000|Overall Study|Lost to Follow-up|0|||
155242965|NCT03029208|560322271|FG001|Overall Study|Lost to Follow-up|1|||
155242966|NCT03207750|560322274|FG000|Overall Study|Adverse Event|3|||
155242967|NCT03207750|560322275|FG001|Overall Study|Adverse Event|2|||
155242968|NCT03207750|560322274|FG000|Overall Study|Lost to Follow-up|21|||
155242969|NCT03207750|560322275|FG001|Overall Study|Lost to Follow-up|29|||
155242970|NCT03207750|560322274|FG000|Overall Study|Protocol Violation|0|||
155242971|NCT03207750|560322275|FG001|Overall Study|Protocol Violation|1|||
155242972|NCT03207750|560322274|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
155242973|NCT03207750|560322275|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
155242974|NCT03207750|560322274|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
155242975|NCT03207750|560322275|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
155242976|NCT03207750|560322274|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
155242977|NCT03207750|560322275|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
155242978|NCT03207750|560322274|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
155242979|NCT03207750|560322275|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
155242980|NCT03207750|560322274|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
155242981|NCT03207750|560322275|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
155242982|NCT02493361|560322276|FG000|Overall Study|Withdrawal by Subject|3|||
155242983|NCT00856583|560322279|FG000|Overall Study|Lack of Efficacy|389|||
155242984|NCT00856583|560322280|FG001|Overall Study|Lack of Efficacy|377|||
155242985|NCT00856583|560322279|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
155242986|NCT00856583|560322280|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
155242987|NCT00856583|560322279|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
155242988|NCT00856583|560322280|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
155242989|NCT00856583|560322279|FG000|Overall Study|Non-compliance|305|||
155242990|NCT00856583|560322280|FG001|Overall Study|Non-compliance|262|||
155242991|NCT00856583|560322279|FG000|Overall Study|Withdrawal by Subject|1092|||
155242992|NCT00856583|560322280|FG001|Overall Study|Withdrawal by Subject|919|||
155242993|NCT00856583|560322279|FG000|Overall Study|Physician Decision|59|||
155242994|NCT00856583|560322280|FG001|Overall Study|Physician Decision|82|||
155242995|NCT00856583|560322279|FG000|Overall Study|Pregnancy|14|||
155242996|NCT00856583|560322280|FG001|Overall Study|Pregnancy|5|||
155242997|NCT00856583|560322279|FG000|Overall Study|Other|92|||
155242998|NCT00856583|560322280|FG001|Overall Study|Other|104|||
155242999|NCT00856583|560322279|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
155243000|NCT00856583|560322280|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
155243001|NCT01944046|560322281|FG000|Randomized to DB|Adverse Event|5|||
155243002|NCT01944046|560322282|FG001|Randomized to DB|Adverse Event|2|||
155243003|NCT01944046|560322281|FG000|Randomized to DB|Clinical Worsening|3|||
155243004|NCT01944046|560322282|FG001|Randomized to DB|Clinical Worsening|2|||
155243005|NCT01944046|560322281|FG000|Randomized to DB|Lost to Follow-up|3|||
155243006|NCT01944046|560322282|FG001|Randomized to DB|Lost to Follow-up|3|||
155243007|NCT01944046|560322281|FG000|Randomized to DB|Withdrawal by Subject|2|||
155243008|NCT01944046|560322282|FG001|Randomized to DB|Withdrawal by Subject|4|||
155243009|NCT01944046|560322281|FG000|Randomized to DB|Physician Decision|1|||
155243010|NCT01944046|560322282|FG001|Randomized to DB|Physician Decision|2|||
155243011|NCT01944046|560322281|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
155243012|NCT01944046|560322282|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
155243013|NCT01944046|560322281|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
155243014|NCT01944046|560322282|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
155243015|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
155243016|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
155243017|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Adverse Event|6|||
155243018|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Adverse Event|1|||
155243019|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
155243020|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
155243021|NCT01944046|560322281|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
155243022|NCT01944046|560322282|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
155243023|NCT02007577|560322285|FG000|Overall Study|Adverse Event|1|||
155243024|NCT02007577|560322286|FG001|Overall Study|Adverse Event|0|||
155243025|NCT02007577|560322285|FG000|Overall Study|Withdrawal by Subject|0|||
155243026|NCT02007577|560322286|FG001|Overall Study|Withdrawal by Subject|1|||
155243027|NCT02504294|560322289|FG000|Overall Study|Adverse Event|15|||
155243028|NCT02504294|560322290|FG001|Overall Study|Adverse Event|12|||
155243029|NCT02504294|560322289|FG000|Overall Study|Withdrawal by Subject|7|||
155243030|NCT02504294|560322290|FG001|Overall Study|Withdrawal by Subject|1|||
155243031|NCT02504294|560322289|FG000|Overall Study|Protocol Violation|27|||
155243032|NCT02504294|560322290|FG001|Overall Study|Protocol Violation|26|||
155243033|NCT02504294|560322289|FG000|Overall Study|Physician Decision|1|||
155243034|NCT02504294|560322290|FG001|Overall Study|Physician Decision|2|||
155243035|NCT02504294|560322289|FG000|Overall Study|Lost to Follow-up|6|||
155243036|NCT02504294|560322290|FG001|Overall Study|Lost to Follow-up|7|||
155243037|NCT02252211|560322296|FG000|Overall Study|Adverse Event|0|||
155243038|NCT02252211|560322297|FG001|Overall Study|Adverse Event|1|||
155243039|NCT02252211|560322298|FG002|Overall Study|Adverse Event|0|||
155243040|NCT02252211|560322296|FG000|Overall Study|Progressive disease|3|||
155243041|NCT02252211|560322297|FG001|Overall Study|Progressive disease|2|||
155243042|NCT02252211|560322298|FG002|Overall Study|Progressive disease|0|||
155243043|NCT02252211|560322296|FG000|Overall Study|Withdrawal by Subject|1|||
155243044|NCT02252211|560322297|FG001|Overall Study|Withdrawal by Subject|0|||
155243045|NCT02252211|560322298|FG002|Overall Study|Withdrawal by Subject|0|||
155243046|NCT02252211|560322296|FG000|Overall Study|Serious Adverse Event During Screening|1|||
155243047|NCT02252211|560322297|FG001|Overall Study|Serious Adverse Event During Screening|0|||
155243048|NCT02252211|560322298|FG002|Overall Study|Serious Adverse Event During Screening|1|||
155243049|NCT03694548|560322299|FG000|Part A Survey|Protocol Violation|3|||
155243050|NCT03694548|560322300|FG001|Part A Survey|Protocol Violation|3|||
155243051|NCT03694548|560322301|FG002|Part A Survey|Protocol Violation|0|||
155243052|NCT03694548|560322299|FG000|Part B Yoga Program|Protocol Violation|0|||
155243053|NCT03694548|560322300|FG001|Part B Yoga Program|Protocol Violation|0|||
155243054|NCT03694548|560322301|FG002|Part B Yoga Program|Protocol Violation|3|||
155243055|NCT03694548|560322299|FG000|Part B Yoga Program|Did not attend intervention|0|||
155243056|NCT03694548|560322300|FG001|Part B Yoga Program|Did not attend intervention|0|||
155243057|NCT03694548|560322301|FG002|Part B Yoga Program|Did not attend intervention|8|||
155243058|NCT04307186|560322302|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
155243059|NCT04307186|560322302|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
155243060|NCT04307186|560322302|FG000|Washout 3-14 Days|Progressive disease|1|||
155243061|NCT04307186|560322302|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
155243062|NCT04307186|560322302|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
155243063|NCT06281548|560322305|FG000|Overall Study|Lost to Follow-up|3|||
155243064|NCT01618838|560322306|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
155243065|NCT01587651|560322307|FG000|Overall Study|Adverse Event|0|||
155243066|NCT01587651|560322308|FG001|Overall Study|Adverse Event|1|||
155243067|NCT01587651|560322309|FG002|Overall Study|Adverse Event|0|||
155243068|NCT01587651|560322307|FG000|Overall Study|Protocol Violation|0|||
155243069|NCT01587651|560322308|FG001|Overall Study|Protocol Violation|1|||
155243070|NCT01587651|560322309|FG002|Overall Study|Protocol Violation|1|||
155243071|NCT01587651|560322307|FG000|Overall Study|Withdrawal by Subject|0|||
155243072|NCT01587651|560322308|FG001|Overall Study|Withdrawal by Subject|1|||
155243073|NCT01587651|560322309|FG002|Overall Study|Withdrawal by Subject|0|||
155243074|NCT03191903|560322310|FG000|Overall Study|Withdrawal by Subject|6|||
155243075|NCT03191903|560322311|FG001|Overall Study|Withdrawal by Subject|5|||
155243076|NCT03191903|560322312|FG002|Overall Study|Withdrawal by Subject|4|||
155243077|NCT03191903|560322310|FG000|Overall Study|Adverse Event|1|||
155243078|NCT03191903|560322311|FG001|Overall Study|Adverse Event|0|||
155243079|NCT03191903|560322312|FG002|Overall Study|Adverse Event|0|||
155243080|NCT00503685|560322316|FG000|Overall Study|Adverse Event|0|||
155243081|NCT00503685|560322317|FG001|Overall Study|Adverse Event|0|||
155243082|NCT00503685|560322318|FG002|Overall Study|Adverse Event|2|||
155243083|NCT00503685|560322316|FG000|Overall Study|Withdrawal by Subject|0|||
155243084|NCT00503685|560322317|FG001|Overall Study|Withdrawal by Subject|1|||
155243085|NCT00503685|560322318|FG002|Overall Study|Withdrawal by Subject|0|||
155243086|NCT00503685|560322316|FG000|Overall Study|Protocol Violation|0|||
155243087|NCT00503685|560322317|FG001|Overall Study|Protocol Violation|1|||
155243088|NCT00503685|560322318|FG002|Overall Study|Protocol Violation|0|||
155243089|NCT00503685|560322316|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155243090|NCT00503685|560322317|FG001|Overall Study|Eligibility Criteria Not Met|1|||
155243091|NCT00503685|560322318|FG002|Overall Study|Eligibility Criteria Not Met|0|||
155243092|NCT01110239|560322323|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
155243093|NCT01110239|560322324|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
155243094|NCT01110239|560322325|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
155243095|NCT01110239|560322326|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
155243096|NCT01110239|560322323|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
155243097|NCT01110239|560322324|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
155243098|NCT01110239|560322325|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
155243099|NCT01110239|560322326|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
155243100|NCT00080223|560322329|FG000|Overall Study|Adverse Event|23|||
155243101|NCT00080223|560322329|FG000|Overall Study|Death|21|||
155243102|NCT00080223|560322329|FG000|Overall Study|Withdrawal by Subject|13|||
155243103|NCT00080223|560322329|FG000|Overall Study|Lung Transplantation|9|||
155243104|NCT00080223|560322329|FG000|Overall Study|Non-compliance With Study Treatment|7|||
155243105|NCT00080223|560322329|FG000|Overall Study|Participant unwilling to continue|2|||
155243106|NCT00080223|560322329|FG000|Overall Study|Physician Decision|1|||
155243107|NCT03099382|560322338|FG000|Overall Study|Protocol Violation|2|||
155243108|NCT03099382|560322339|FG001|Overall Study|Protocol Violation|3|||
155243109|NCT00499369|560322340|FG000|Overall Study|Adverse Event|2|||
155243110|NCT00499369|560322341|FG001|Overall Study|Adverse Event|2|||
155243111|NCT00499369|560322342|FG002|Overall Study|Adverse Event|3|||
155243112|NCT00499369|560322343|FG003|Overall Study|Adverse Event|1|||
155243113|NCT00499369|560322344|FG004|Overall Study|Adverse Event|2|||
155243114|NCT00499369|560322340|FG000|Overall Study|Withdrawal by Subject|0|||
155243115|NCT00499369|560322341|FG001|Overall Study|Withdrawal by Subject|1|||
155243116|NCT00499369|560322342|FG002|Overall Study|Withdrawal by Subject|1|||
155243117|NCT00499369|560322343|FG003|Overall Study|Withdrawal by Subject|0|||
155243118|NCT00499369|560322344|FG004|Overall Study|Withdrawal by Subject|0|||
155243119|NCT00499369|560322340|FG000|Overall Study|Progression|10|||
155243120|NCT00499369|560322341|FG001|Overall Study|Progression|12|||
155243121|NCT00499369|560322342|FG002|Overall Study|Progression|9|||
155243122|NCT00499369|560322343|FG003|Overall Study|Progression|6|||
155243123|NCT00499369|560322344|FG004|Overall Study|Progression|10|||
155243124|NCT00499369|560322340|FG000|Overall Study|Death|0|||
155243125|NCT00499369|560322341|FG001|Overall Study|Death|1|||
155243126|NCT00499369|560322342|FG002|Overall Study|Death|0|||
155243127|NCT00499369|560322343|FG003|Overall Study|Death|0|||
155243128|NCT00499369|560322344|FG004|Overall Study|Death|0|||
155243129|NCT00499369|560322340|FG000|Overall Study|Not protocol specified|2|||
155243130|NCT00499369|560322341|FG001|Overall Study|Not protocol specified|0|||
155243131|NCT00499369|560322342|FG002|Overall Study|Not protocol specified|3|||
155243132|NCT00499369|560322343|FG003|Overall Study|Not protocol specified|1|||
155243133|NCT00499369|560322344|FG004|Overall Study|Not protocol specified|0|||
155243134|NCT00499369|560322340|FG000|Overall Study|Ineligible|2|||
155243135|NCT00499369|560322341|FG001|Overall Study|Ineligible|2|||
155243136|NCT00499369|560322342|FG002|Overall Study|Ineligible|1|||
155243137|NCT00499369|560322343|FG003|Overall Study|Ineligible|1|||
155243138|NCT00499369|560322344|FG004|Overall Study|Ineligible|0|||
155243139|NCT01898195|560322346|FG000|Smoking Abstinence|Did not have good measurements|35|||
155243140|NCT01898195|560322347|FG001|Smoking Abstinence|Did not have good measurements|38|||
155243141|NCT01898195|560322348|FG002|Smoking Abstinence|Did not have good measurements|36|||
155243142|NCT01802411|560322349|FG000|Overall Study|Death|2|||
155243143|NCT01802411|560322350|FG001|Overall Study|Death|1|||
155243144|NCT01802411|560322349|FG000|Overall Study|Adverse Event|2|||
155243145|NCT01802411|560322350|FG001|Overall Study|Adverse Event|7|||
155243146|NCT01802411|560322349|FG000|Overall Study|Lack of Efficacy|8|||
155243147|NCT01802411|560322350|FG001|Overall Study|Lack of Efficacy|10|||
155243148|NCT01802411|560322349|FG000|Overall Study|Withdrawal by Subject|0|||
155243149|NCT01802411|560322350|FG001|Overall Study|Withdrawal by Subject|2|||
155243150|NCT01802411|560322349|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
155243151|NCT01802411|560322350|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
155243152|NCT01802411|560322349|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
155243153|NCT01802411|560322350|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
155243154|NCT01802411|560322349|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
155243155|NCT01802411|560322350|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
155243156|NCT01337245|560322351|FG000|Overall Study|Lost to Follow-up|1|||
155243157|NCT03930745|560322352|FG000|Overall Study|Lost to Follow-up|10|||
155243158|NCT03930745|560322353|FG001|Overall Study|Lost to Follow-up|5|||
155243159|NCT03930745|560322352|FG000|Overall Study|Withdrawal by Subject|1|||
155243160|NCT03930745|560322353|FG001|Overall Study|Withdrawal by Subject|2|||
155243161|NCT03930745|560322352|FG000|Overall Study|Protocol Violation|2|||
155243162|NCT03930745|560322353|FG001|Overall Study|Protocol Violation|2|||
155243163|NCT03930745|560322352|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
155243164|NCT03930745|560322353|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
155243165|NCT03930745|560322352|FG000|Overall Study|Adverse Event|0|||
155243166|NCT03930745|560322353|FG001|Overall Study|Adverse Event|1|||
155243167|NCT03930745|560322352|FG000|Overall Study|Pregnancy|0|||
155243168|NCT03930745|560322353|FG001|Overall Study|Pregnancy|1|||
155243169|NCT04095858|560322356|FG000|Overall Study|Death|1|||
155243170|NCT04095858|560322357|FG001|Overall Study|Death|0|||
155243171|NCT04095858|560322356|FG000|Overall Study|Study terminated by Sponsor|2|||
155243172|NCT04095858|560322357|FG001|Overall Study|Study terminated by Sponsor|4|||
155243173|NCT00612313|560322374|FG000|Overall Study|Withdrawal by Subject|6|||
155243174|NCT00612313|560322375|FG001|Overall Study|Withdrawal by Subject|9|||
155243175|NCT00612313|560322374|FG000|Overall Study|Lost to Follow-up|11|||
155243176|NCT00612313|560322375|FG001|Overall Study|Lost to Follow-up|4|||
155243177|NCT00428610|560322376|FG000|Overall Study|Death Due to Adverse Event|3|||
155243178|NCT00428610|560322377|FG001|Overall Study|Death Due to Adverse Event|0|||
155243179|NCT00428610|560322378|FG002|Overall Study|Death Due to Adverse Event|5|||
155243180|NCT00428610|560322376|FG000|Overall Study|Death Due to Progressive Disease|0|||
155243181|NCT00428610|560322377|FG001|Overall Study|Death Due to Progressive Disease|0|||
155243182|NCT00428610|560322378|FG002|Overall Study|Death Due to Progressive Disease|2|||
155243183|NCT00428610|560322376|FG000|Overall Study|Adverse Event|2|||
155243184|NCT00428610|560322377|FG001|Overall Study|Adverse Event|3|||
155243185|NCT00428610|560322378|FG002|Overall Study|Adverse Event|2|||
155243186|NCT00428610|560322376|FG000|Overall Study|Investigator Decision|2|||
155243187|NCT00428610|560322377|FG001|Overall Study|Investigator Decision|1|||
155243188|NCT00428610|560322378|FG002|Overall Study|Investigator Decision|1|||
155243189|NCT00428610|560322376|FG000|Overall Study|Progressive Disease|42|||
155243190|NCT00428610|560322377|FG001|Overall Study|Progressive Disease|14|||
155243191|NCT00428610|560322378|FG002|Overall Study|Progressive Disease|22|||
155243192|NCT00428610|560322376|FG000|Overall Study|Withdrawal by Subject|4|||
155243193|NCT00428610|560322377|FG001|Overall Study|Withdrawal by Subject|0|||
155243194|NCT00428610|560322378|FG002|Overall Study|Withdrawal by Subject|0|||
155243195|NCT04745169|560324292|FG000|Overall Study|Kidney transplantation|1|||
155243196|NCT04745169|560324292|FG000|Overall Study|Participant health problems|3|||
155243197|NCT04745169|560324292|FG000|Overall Study|Physician Decision|2|||
155243198|NCT02053350|560324299|FG000|Overall Study|Withdrawal by Subject|1|||
155243199|NCT02053350|560324299|FG000|Overall Study|Adverse Event|4|||
155243200|NCT03521635|560324300|FG000|Overall Study|Adverse Event|1|||
155243201|NCT03521635|560324301|FG001|Overall Study|Adverse Event|1|||
155243202|NCT03521635|560324300|FG000|Overall Study|Refused to complete study visit|1|||
155243203|NCT03521635|560324301|FG001|Overall Study|Refused to complete study visit|0|||
155243204|NCT03521635|560324300|FG000|Overall Study|Refused to continue trial medication|2|||
155243205|NCT03521635|560324301|FG001|Overall Study|Refused to continue trial medication|2|||
155243206|NCT03521635|560324300|FG000|Overall Study|Lost to Follow-up|0|||
155243207|NCT03521635|560324301|FG001|Overall Study|Lost to Follow-up|1|||
155243208|NCT03521635|560324300|FG000|Overall Study|Meet exclusion criteria|0|||
155243209|NCT03521635|560324301|FG001|Overall Study|Meet exclusion criteria|1|||
155243210|NCT03521635|560324300|FG000|Overall Study|Patient not taken study medicine|0|||
155243211|NCT03521635|560324301|FG001|Overall Study|Patient not taken study medicine|1|||
155243212|NCT00896168|560324302|FG000|Overall Study|Adverse Event|4|||
155243213|NCT00896168|560324303|FG001|Overall Study|Adverse Event|7|||
155243214|NCT00896168|560324302|FG000|Overall Study|Treatment failure|8|||
155243215|NCT00896168|560324303|FG001|Overall Study|Treatment failure|10|||
155243216|NCT00896168|560324302|FG000|Overall Study|Lost to Follow-up|1|||
155243217|NCT00896168|560324303|FG001|Overall Study|Lost to Follow-up|1|||
155243218|NCT00896168|560324302|FG000|Overall Study|Other|1|||
155243219|NCT00896168|560324303|FG001|Overall Study|Other|1|||
155243220|NCT03832010|560324304|FG000|Overall Study|Withdrawal by Subject|2|||
155243221|NCT03832010|560324305|FG001|Overall Study|Withdrawal by Subject|1|||
155243222|NCT03832010|560324306|FG002|Overall Study|Withdrawal by Subject|0|||
155243223|NCT03832010|560324304|FG000|Overall Study|Lost to Follow-up|2|||
155243224|NCT03832010|560324305|FG001|Overall Study|Lost to Follow-up|1|||
155243225|NCT03832010|560324306|FG002|Overall Study|Lost to Follow-up|1|||
155243226|NCT01227889|560324307|FG000|Randomized Phase (RP)|Adverse Event|13|||
155243227|NCT01227889|560324308|FG001|Randomized Phase (RP)|Adverse Event|0|||
155243228|NCT01227889|560324307|FG000|Randomized Phase (RP)|Physician Decision|13|||
155243229|NCT01227889|560324308|FG001|Randomized Phase (RP)|Physician Decision|5|||
155243230|NCT01227889|560324307|FG000|Randomized Phase (RP)|Progressive Disease|135|||
155243231|NCT01227889|560324308|FG001|Randomized Phase (RP)|Progressive Disease|52|||
155243232|NCT01227889|560324307|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
155243233|NCT01227889|560324308|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
155243234|NCT01227889|560324307|FG000|Randomized Phase (RP)|Missing|1|||
155243235|NCT01227889|560324308|FG001|Randomized Phase (RP)|Missing|3|||
155243236|NCT01227889|560324307|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
155243237|NCT01227889|560324308|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
155243238|NCT01227889|560324307|FG000|Crossover Phase|Adverse Event|0|||
155243239|NCT01227889|560324308|FG001|Crossover Phase|Adverse Event|1|||
155243240|NCT01227889|560324307|FG000|Crossover Phase|Physician Decision|0|||
155243241|NCT01227889|560324308|FG001|Crossover Phase|Physician Decision|3|||
155243242|NCT01227889|560324307|FG000|Crossover Phase|Progressive Disease|0|||
155243243|NCT01227889|560324308|FG001|Crossover Phase|Progressive Disease|31|||
155243244|NCT01227889|560324307|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
155243245|NCT01227889|560324308|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
155243246|NCT01227889|560324307|FG000|Crossover Phase|Withdrawal by Subject|0|||
155243247|NCT01227889|560324308|FG001|Crossover Phase|Withdrawal by Subject|1|||
155243248|NCT01148810|560324309|FG000|Overall Study|Adverse Event|0|||
155243249|NCT01148810|560324310|FG001|Overall Study|Adverse Event|2|||
155243250|NCT01148810|560324309|FG000|Overall Study|Lack of Efficacy|0|||
155243251|NCT01148810|560324310|FG001|Overall Study|Lack of Efficacy|1|||
155243252|NCT01148810|560324309|FG000|Overall Study|Withdrawal by Subject|0|||
155243253|NCT01148810|560324310|FG001|Overall Study|Withdrawal by Subject|2|||
155243254|NCT01148810|560324309|FG000|Overall Study|Protocol Violation|1|||
155243255|NCT01148810|560324310|FG001|Overall Study|Protocol Violation|0|||
155243256|NCT02417246|560324318|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
155243257|NCT02417246|560324319|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
155243258|NCT02417246|560324318|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
155243259|NCT02417246|560324319|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
155243260|NCT02417246|560324318|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
155243261|NCT02417246|560324319|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
155243262|NCT02417246|560324318|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
155243263|NCT02417246|560324319|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
155243264|NCT04408469|560324323|FG000|Overall Study|Lost to Follow-up|6|||
155243265|NCT04408469|560324324|FG001|Overall Study|Lost to Follow-up|9|||
155243266|NCT04408469|560324323|FG000|Overall Study|Withdrawal by Subject|6|||
155243267|NCT04408469|560324324|FG001|Overall Study|Withdrawal by Subject|1|||
155243268|NCT04408469|560324323|FG000|Overall Study|Dismissal due to ineligibility|0|||
155243269|NCT04408469|560324324|FG001|Overall Study|Dismissal due to ineligibility|1|||
155243270|NCT04321460|560324325|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
155243271|NCT04321460|560324326|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
155243272|NCT02553330|560324329|FG000|Overall Study|Study Terminated by Sponsor|2|||
155243273|NCT02553330|560324330|FG001|Overall Study|Study Terminated by Sponsor|13|||
155243274|NCT02553330|560324331|FG002|Overall Study|Study Terminated by Sponsor|12|||
155243275|NCT02553330|560324329|FG000|Overall Study|Withdrawal by Subject|3|||
155243276|NCT02553330|560324330|FG001|Overall Study|Withdrawal by Subject|19|||
155243277|NCT02553330|560324331|FG002|Overall Study|Withdrawal by Subject|21|||
155243278|NCT02553330|560324329|FG000|Overall Study|Other|0|||
155243279|NCT02553330|560324330|FG001|Overall Study|Other|1|||
155243280|NCT02553330|560324331|FG002|Overall Study|Other|0|||
155243281|NCT02553330|560324329|FG000|Overall Study|Non compliance to study treatment|0|||
155243282|NCT02553330|560324330|FG001|Overall Study|Non compliance to study treatment|1|||
155243283|NCT02553330|560324331|FG002|Overall Study|Non compliance to study treatment|0|||
155243284|NCT02553330|560324329|FG000|Overall Study|Adverse Event|0|||
155243285|NCT02553330|560324330|FG001|Overall Study|Adverse Event|1|||
155243286|NCT02553330|560324331|FG002|Overall Study|Adverse Event|0|||
155243287|NCT02553330|560324329|FG000|Overall Study|Lost to Follow-up|0|||
155243288|NCT02553330|560324330|FG001|Overall Study|Lost to Follow-up|4|||
155243289|NCT02553330|560324331|FG002|Overall Study|Lost to Follow-up|4|||
155243290|NCT01205685|560324332|FG000|Overall Study|Disease Progression|10|||
155243291|NCT01205685|560324332|FG000|Overall Study|Withdrawal by Subject|1|||
155243292|NCT01666002|560324333|FG000|Overall Study|Lost to Follow-up|5|||
155243293|NCT01666002|560324334|FG001|Overall Study|Lost to Follow-up|0|||
155243294|NCT03058679|560324342|FG000|Baseline to Week 6|Lost to Follow-up|3|||
155243295|NCT03058679|560324343|FG001|Baseline to Week 6|Lost to Follow-up|2|||
155243296|NCT03058679|560324342|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
155243297|NCT03058679|560324343|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
155243298|NCT03058679|560324342|FG000|Baseline to Week 6|Adverse Event|6|||
155243299|NCT03058679|560324343|FG001|Baseline to Week 6|Adverse Event|6|||
155243300|NCT03058679|560324342|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
155243301|NCT03058679|560324343|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
155243302|NCT03058679|560324342|FG000|Baseline to Week 6|Difficulty following the diet|0|||
155243303|NCT03058679|560324343|FG001|Baseline to Week 6|Difficulty following the diet|2|||
155243304|NCT03058679|560324342|FG000|Baseline to Week 6|Physician Decision|1|||
155243305|NCT03058679|560324343|FG001|Baseline to Week 6|Physician Decision|0|||
155243306|NCT03058679|560324342|FG000|Week 6 to Week 12|Change in medication|5|||
155243307|NCT03058679|560324343|FG001|Week 6 to Week 12|Change in medication|7|||
155243308|NCT03058679|560324342|FG000|Week 6 to Week 12|Adverse Event|4|||
155243309|NCT03058679|560324343|FG001|Week 6 to Week 12|Adverse Event|3|||
155243310|NCT03058679|560324342|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
155243311|NCT03058679|560324343|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
155243312|NCT03058679|560324342|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
155243313|NCT03058679|560324343|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
155243314|NCT04137380|560324348|FG000|Overall Study|Physician Decision|0|||
155243315|NCT04137380|560324349|FG001|Overall Study|Physician Decision|0|||
155243316|NCT04137380|560324350|FG002|Overall Study|Physician Decision|0|||
155243317|NCT04137380|560324351|FG003|Overall Study|Physician Decision|1|||
155243318|NCT04137380|560324352|FG004|Overall Study|Physician Decision|0|||
155243319|NCT04137380|560324353|FG005|Overall Study|Physician Decision|0|||
155243320|NCT04137380|560324354|FG006|Overall Study|Physician Decision|0|||
155243321|NCT00346034|560324357|FG000|Overall Study|Adverse Event|34|||
155243322|NCT00346034|560324357|FG000|Overall Study|Lack of Efficacy|8|||
155243323|NCT00346034|560324357|FG000|Overall Study|Withdrawal by Subject|13|||
155243324|NCT00346034|560324357|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
155243325|NCT00346034|560324357|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
155243326|NCT00941603|560324361|FG000|Overall Study|Adverse Event|10|||
155243327|NCT00941603|560324362|FG001|Overall Study|Adverse Event|15|||
155243328|NCT00941603|560324363|FG002|Overall Study|Adverse Event|5|||
155243329|NCT00941603|560324364|FG003|Overall Study|Adverse Event|1|||
155243330|NCT00941603|560324365|FG004|Overall Study|Adverse Event|4|||
155243331|NCT00941603|560324366|FG005|Overall Study|Adverse Event|0|||
155243332|NCT00941603|560324361|FG000|Overall Study|Lost to Follow-up|0|||
155243333|NCT00941603|560324362|FG001|Overall Study|Lost to Follow-up|0|||
155243334|NCT00941603|560324363|FG002|Overall Study|Lost to Follow-up|0|||
155243335|NCT00941603|560324364|FG003|Overall Study|Lost to Follow-up|1|||
155243336|NCT00941603|560324365|FG004|Overall Study|Lost to Follow-up|0|||
155243337|NCT00941603|560324366|FG005|Overall Study|Lost to Follow-up|2|||
155243338|NCT00941603|560324361|FG000|Overall Study|Withdrawal by Subject|0|||
155243339|NCT00941603|560324362|FG001|Overall Study|Withdrawal by Subject|0|||
155243340|NCT00941603|560324363|FG002|Overall Study|Withdrawal by Subject|0|||
155243341|NCT00941603|560324364|FG003|Overall Study|Withdrawal by Subject|2|||
155243342|NCT00941603|560324365|FG004|Overall Study|Withdrawal by Subject|0|||
155243343|NCT00941603|560324366|FG005|Overall Study|Withdrawal by Subject|1|||
155243344|NCT00941603|560324361|FG000|Overall Study|Protocol Violation|0|||
155243345|NCT00941603|560324362|FG001|Overall Study|Protocol Violation|1|||
155243346|NCT00941603|560324363|FG002|Overall Study|Protocol Violation|0|||
155243347|NCT00941603|560324364|FG003|Overall Study|Protocol Violation|0|||
155243348|NCT00941603|560324365|FG004|Overall Study|Protocol Violation|0|||
155243349|NCT00941603|560324366|FG005|Overall Study|Protocol Violation|0|||
155243350|NCT00941603|560324361|FG000|Overall Study|Did not meet protocol eligibility|1|||
155243351|NCT00941603|560324362|FG001|Overall Study|Did not meet protocol eligibility|0|||
155243352|NCT00941603|560324363|FG002|Overall Study|Did not meet protocol eligibility|0|||
155243353|NCT00941603|560324364|FG003|Overall Study|Did not meet protocol eligibility|0|||
155243354|NCT00941603|560324365|FG004|Overall Study|Did not meet protocol eligibility|0|||
155243355|NCT00941603|560324366|FG005|Overall Study|Did not meet protocol eligibility|0|||
155243356|NCT02079805|560324367|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
155243357|NCT02079805|560324368|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
155243358|NCT02079805|560324367|FG000|Overall Study|Voluntary Withdrawal|0|||
155243359|NCT02079805|560324368|FG001|Overall Study|Voluntary Withdrawal|1|||
155243360|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
155243361|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
155243362|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
155243363|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
155243364|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
155243365|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
155243366|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
155243367|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
155243368|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
155243369|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
155243370|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
155243371|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
155243372|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
155243373|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155243374|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
155243375|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
155243376|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
155243377|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
155243378|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
155243379|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
155243380|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
155243381|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
155243382|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
155243383|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
155243384|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
155243385|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
155243386|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
155243387|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
155243388|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
155243389|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
155243390|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
155243391|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
155243392|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
155243393|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
155243394|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
155243395|NCT00383435|560324369|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
155243396|NCT00383435|560324370|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
155243397|NCT00383435|560324371|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
155243398|NCT00383435|560324372|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
155243399|NCT00383435|560324373|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
155243400|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
155243401|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
155243402|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
155243403|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
155243404|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
155243405|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243406|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243407|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243408|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
155243409|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
155243410|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
155243411|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
155243412|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
155243413|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
155243414|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
155243415|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
155243416|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
155243417|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
155243418|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
155243419|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
155243420|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155243421|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
155243422|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
155243423|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
155243424|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
155243425|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
155243426|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155243427|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155243428|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
155243429|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
155243430|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155243431|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155243432|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155243433|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
155243434|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
155243435|NCT00383435|560324369|FG000|26-Week Treatment Safety Extension|Administrative|1|||
155243436|NCT00383435|560324370|FG001|26-Week Treatment Safety Extension|Administrative|1|||
155243437|NCT00383435|560324371|FG002|26-Week Treatment Safety Extension|Administrative|0|||
155243438|NCT00383435|560324372|FG003|26-Week Treatment Safety Extension|Administrative|1|||
155243439|NCT00383435|560324373|FG004|26-Week Treatment Safety Extension|Administrative|0|||
155243440|NCT00583557|560324374|FG000|Overall Study|Withdrawal by Subject|18|||
155243441|NCT00583557|560324374|FG000|Overall Study|Adverse Event|9|||
155243442|NCT00583557|560324374|FG000|Overall Study|Lack of Efficacy|31|||
155243443|NCT00583557|560324374|FG000|Overall Study|Lack of Compliance|5|||
155243444|NCT00583557|560324374|FG000|Overall Study|Other|5|||
155243445|NCT00583557|560324374|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
155243446|NCT02347761|560324375|FG000|All Collected|Death|1|||
155243447|NCT02347761|560324376|FG001|All Collected|Death|0|||
155243448|NCT02347761|560324377|FG002|All Collected|Death|0|||
155243449|NCT02347761|560324375|FG000|All Collected|Lost to Follow-up|3|||
155243450|NCT02347761|560324376|FG001|All Collected|Lost to Follow-up|2|||
155243451|NCT02347761|560324377|FG002|All Collected|Lost to Follow-up|3|||
155243452|NCT02347761|560324375|FG000|All Collected|Withdrawal by Subject|11|||
155243453|NCT02347761|560324376|FG001|All Collected|Withdrawal by Subject|11|||
155243454|NCT02347761|560324377|FG002|All Collected|Withdrawal by Subject|22|||
155243455|NCT02347761|560324375|FG000|All Collected|invetigator disretion|2|||
155243456|NCT02347761|560324376|FG001|All Collected|invetigator disretion|0|||
155243457|NCT02347761|560324377|FG002|All Collected|invetigator disretion|0|||
155243458|NCT02347761|560324375|FG000|All Collected|instillation site pain|0|||
155243459|NCT02347761|560324376|FG001|All Collected|instillation site pain|0|||
155243460|NCT02347761|560324377|FG002|All Collected|instillation site pain|1|||
155243461|NCT02347761|560324375|FG000|All Collected|exacerbation of COPD|0|||
155243462|NCT02347761|560324376|FG001|All Collected|exacerbation of COPD|0|||
155243463|NCT02347761|560324377|FG002|All Collected|exacerbation of COPD|1|||
155243464|NCT02347761|560324375|FG000|All Collected|moved/travel|0|||
155243465|NCT02347761|560324376|FG001|All Collected|moved/travel|1|||
155243466|NCT02347761|560324377|FG002|All Collected|moved/travel|0|||
155243467|NCT02347761|560324375|FG000|On Study Treatment|Lack of Efficacy|2|||
155243468|NCT02347761|560324376|FG001|On Study Treatment|Lack of Efficacy|3|||
155243469|NCT02347761|560324377|FG002|On Study Treatment|Lack of Efficacy|4|||
155243470|NCT02347761|560324375|FG000|On Study Treatment|non-compliance with study medication|0|||
155243471|NCT02347761|560324376|FG001|On Study Treatment|non-compliance with study medication|0|||
155243472|NCT02347761|560324377|FG002|On Study Treatment|non-compliance with study medication|2|||
155243473|NCT02347761|560324375|FG000|On Study Treatment|Withdrawal by Subject|7|||
155243474|NCT02347761|560324376|FG001|On Study Treatment|Withdrawal by Subject|3|||
155243475|NCT02347761|560324377|FG002|On Study Treatment|Withdrawal by Subject|5|||
155243476|NCT02347761|560324375|FG000|On Study Treatment|move/travel|2|||
155243477|NCT02347761|560324376|FG001|On Study Treatment|move/travel|6|||
155243478|NCT02347761|560324377|FG002|On Study Treatment|move/travel|5|||
155243479|NCT02347761|560324375|FG000|On Study Treatment|dissastisfaction with device|2|||
155243480|NCT02347761|560324376|FG001|On Study Treatment|dissastisfaction with device|1|||
155243481|NCT02347761|560324377|FG002|On Study Treatment|dissastisfaction with device|4|||
155243482|NCT02347761|560324375|FG000|On Study Treatment|Lost to Follow-up|2|||
155243483|NCT02347761|560324376|FG001|On Study Treatment|Lost to Follow-up|1|||
155243484|NCT02347761|560324377|FG002|On Study Treatment|Lost to Follow-up|1|||
155243485|NCT02347761|560324375|FG000|On Study Treatment|investigator discretion|2|||
155243486|NCT02347761|560324376|FG001|On Study Treatment|investigator discretion|0|||
155243487|NCT02347761|560324377|FG002|On Study Treatment|investigator discretion|0|||
155243488|NCT02347761|560324375|FG000|On Study Treatment|durg not working|0|||
155243489|NCT02347761|560324376|FG001|On Study Treatment|durg not working|1|||
155243490|NCT02347761|560324377|FG002|On Study Treatment|durg not working|1|||
155243491|NCT02347761|560324375|FG000|On Study Treatment|Adverse Event|10|||
155243492|NCT02347761|560324376|FG001|On Study Treatment|Adverse Event|8|||
155243493|NCT02347761|560324377|FG002|On Study Treatment|Adverse Event|20|||
155243494|NCT03950739|560324378|FG000|Treatment Phase|Adverse Event|2|||
155243495|NCT03950739|560324378|FG000|Optional Extension Phase|Death|1|||
155243496|NCT03950739|560324378|FG000|Optional Extension Phase|Progressive Disease|5|||
155243497|NCT03950739|560324378|FG000|Optional Extension Phase|Adverse Event|7|||
155243498|NCT03950739|560324378|FG000|Optional Extension Phase|Lost to Follow-up|2|||
155243499|NCT03950739|560324378|FG000|Optional Extension Phase|Site Closure|2|||
155243500|NCT03950739|560324378|FG000|Optional Extension Phase|Pregnancy|1|||
155243501|NCT03625570|560324379|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
155243502|NCT03625570|560324380|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
155243503|NCT03625570|560324379|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
155243504|NCT03625570|560324380|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
155243505|NCT03625570|560324379|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
155243506|NCT03625570|560324380|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
155243507|NCT03646513|560324381|FG000|Overall Study|Premature study termination|4|||
155243508|NCT01732835|560324382|FG000|6-month Primary Endpoint|Did not receive device|19|||
155243509|NCT01732835|560324382|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
155243510|NCT01732835|560324382|FG000|6-month Primary Endpoint|Adverse Event|3|||
155243511|NCT01732835|560324382|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
155243512|NCT01732835|560324382|FG000|2-year Extended Follow-up|Adverse Event|3|||
155243513|NCT01732835|560324382|FG000|2-year Extended Follow-up|Death|1|||
155243514|NCT02334748|560324383|FG000|Overall Study|Adverse Event|1|||
155243515|NCT02334748|560324383|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
155243516|NCT02334748|560324383|FG000|Overall Study|Patient no longer required study drug|2|||
155243517|NCT02334748|560324383|FG000|Overall Study|Lack of Efficacy|4|||
155243518|NCT01046643|560324384|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
155243519|NCT01046643|560324385|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
155243520|NCT01046643|560324386|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
155243521|NCT01046643|560324387|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
155243522|NCT00817089|560324392|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
155243523|NCT00817089|560324393|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
155243524|NCT00817089|560324394|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
155243525|NCT00817089|560324395|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
155243526|NCT00817089|560324392|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
155243527|NCT00817089|560324393|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
155243528|NCT00817089|560324394|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
155243529|NCT00817089|560324395|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
155243530|NCT02937545|560324406|FG000|Overall Study|Withdrawal by Subject|1|||
155243531|NCT02937545|560324407|FG001|Overall Study|Withdrawal by Subject|2|||
155243532|NCT02937545|560324408|FG002|Overall Study|Withdrawal by Subject|6|||
155243533|NCT02937545|560324409|FG003|Overall Study|Withdrawal by Subject|7|||
155243534|NCT02937545|560324406|FG000|Overall Study|Lost to Follow-up|1|||
155243535|NCT02937545|560324407|FG001|Overall Study|Lost to Follow-up|0|||
155243536|NCT02937545|560324408|FG002|Overall Study|Lost to Follow-up|0|||
155243537|NCT02937545|560324409|FG003|Overall Study|Lost to Follow-up|0|||
155243538|NCT01767116|560324410|FG000|Overall Study|Lost to Follow-up|2|||
155243539|NCT01767116|560324411|FG001|Overall Study|Lost to Follow-up|2|||
155243540|NCT00968669|560324413|FG000|Overall Study|Lost to Follow-up|5|||
155243541|NCT00968669|560324414|FG001|Overall Study|Lost to Follow-up|2|||
155243542|NCT00968669|560324415|FG002|Overall Study|Lost to Follow-up|1|||
155243543|NCT00968669|560324416|FG003|Overall Study|Lost to Follow-up|4|||
155243544|NCT00968669|560324413|FG000|Overall Study|Withdrawal by Subject|9|||
155243545|NCT00968669|560324414|FG001|Overall Study|Withdrawal by Subject|7|||
155243546|NCT00968669|560324415|FG002|Overall Study|Withdrawal by Subject|5|||
155243547|NCT00968669|560324416|FG003|Overall Study|Withdrawal by Subject|3|||
155243548|NCT00968669|560324413|FG000|Overall Study|Pregnancy|0|||
155243549|NCT00968669|560324414|FG001|Overall Study|Pregnancy|0|||
155243550|NCT00968669|560324415|FG002|Overall Study|Pregnancy|2|||
155243551|NCT00968669|560324416|FG003|Overall Study|Pregnancy|0|||
155243552|NCT00968669|560324413|FG000|Overall Study|AE|1|||
155243553|NCT00968669|560324414|FG001|Overall Study|AE|0|||
155243554|NCT00968669|560324415|FG002|Overall Study|AE|0|||
155243555|NCT00968669|560324416|FG003|Overall Study|AE|0|||
155243556|NCT00968669|560324413|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
155243557|NCT00968669|560324414|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
155243558|NCT00968669|560324415|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
155243559|NCT00968669|560324416|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
155243560|NCT00968669|560324413|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
155243561|NCT00968669|560324414|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
155243562|NCT00968669|560324415|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
155243563|NCT00968669|560324416|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
155243564|NCT00968669|560324413|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
155243565|NCT00968669|560324414|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
155243566|NCT00968669|560324415|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
155243567|NCT00968669|560324416|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
155243568|NCT00968669|560324413|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
155243569|NCT00968669|560324414|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
155243570|NCT00968669|560324415|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
155243571|NCT00968669|560324416|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
155243572|NCT00968669|560324413|FG000|Overall Study|EARLY WITHDRAWAL|0|||
155243573|NCT00968669|560324414|FG001|Overall Study|EARLY WITHDRAWAL|1|||
155243574|NCT00968669|560324415|FG002|Overall Study|EARLY WITHDRAWAL|0|||
155243575|NCT00968669|560324416|FG003|Overall Study|EARLY WITHDRAWAL|0|||
155243576|NCT00968669|560324413|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
155243577|NCT00968669|560324414|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
155243578|NCT00968669|560324415|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
155243579|NCT00968669|560324416|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
155243580|NCT00968669|560324413|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
155243581|NCT00968669|560324414|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
155243582|NCT00968669|560324415|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
155243583|NCT00968669|560324416|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
155243584|NCT00968669|560324413|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
155243585|NCT00968669|560324414|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
155243586|NCT00968669|560324415|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
155243587|NCT00968669|560324416|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
155243588|NCT00968669|560324413|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
155243589|NCT00968669|560324414|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
155243590|NCT00968669|560324415|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
155243591|NCT00968669|560324416|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
155243592|NCT00968669|560324413|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
155243593|NCT00968669|560324414|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
155243594|NCT00968669|560324415|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
155243595|NCT00968669|560324416|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
155243596|NCT00968669|560324413|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
155243597|NCT00968669|560324414|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
155243598|NCT00968669|560324415|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
155243599|NCT00968669|560324416|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
155243600|NCT00968669|560324413|FG000|Overall Study|SPONSOR DECISION|0|||
155243601|NCT00968669|560324414|FG001|Overall Study|SPONSOR DECISION|1|||
155243602|NCT00968669|560324415|FG002|Overall Study|SPONSOR DECISION|0|||
155243603|NCT00968669|560324416|FG003|Overall Study|SPONSOR DECISION|0|||
155243604|NCT00968669|560324413|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
155243605|NCT00968669|560324414|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
155243606|NCT00968669|560324415|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
155243607|NCT00968669|560324416|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
155243608|NCT00968669|560324413|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
155243609|NCT00968669|560324414|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
155243610|NCT00968669|560324415|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
155243611|NCT00968669|560324416|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
155243612|NCT00968669|560324413|FG000|Overall Study|SUBJECT INCARCERATED|0|||
155243613|NCT00968669|560324414|FG001|Overall Study|SUBJECT INCARCERATED|1|||
155243614|NCT00968669|560324415|FG002|Overall Study|SUBJECT INCARCERATED|0|||
155243615|NCT00968669|560324416|FG003|Overall Study|SUBJECT INCARCERATED|0|||
155243616|NCT00968669|560324413|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
155243617|NCT00968669|560324414|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
155243618|NCT00968669|560324415|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
155243619|NCT00968669|560324416|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
155243620|NCT00968669|560324413|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
155243621|NCT00968669|560324414|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
155243622|NCT00968669|560324415|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
155243623|NCT00968669|560324416|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
155243624|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
155243625|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
155243626|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
155243627|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
155243628|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
155243629|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
155243630|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
155243631|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
155243632|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Other|0|||
155243633|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Other|1|||
155243634|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Other|0|||
155243635|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Other|0|||
155243636|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
155243637|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
155243638|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
155243639|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
155243640|NCT05799495|560324422|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
155243641|NCT05799495|560324423|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
155243642|NCT05799495|560324424|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
155243643|NCT05799495|560324425|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
155243644|NCT05799495|560324422|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155243645|NCT05799495|560324423|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155243646|NCT05799495|560324424|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
155243647|NCT05799495|560324425|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
155243648|NCT04102501|560324429|FG000|Overall Study|Withdrawal by Subject|7|||
155243649|NCT04102501|560324430|FG001|Overall Study|Withdrawal by Subject|9|||
155243650|NCT04102501|560324429|FG000|Overall Study|Adverse Event|1|||
155243651|NCT04102501|560324430|FG001|Overall Study|Adverse Event|3|||
155243652|NCT02338362|560324432|FG000|Overall Study|Withdrawal by Subject|1|||
155243653|NCT02338362|560324433|FG001|Overall Study|Withdrawal by Subject|1|||
155243654|NCT04798586|560324434|FG000|Overall Study|Death|2|||
155243655|NCT01669343|560324435|FG000|Part A: All Patients|Withdrawal by Subject|7|||
155243656|NCT01669343|560324435|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
155243657|NCT01669343|560324435|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
155243658|NCT01669343|560324435|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
155243659|NCT01669343|560324435|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
155243660|NCT00968617|560324436|FG000|Overall Study|Study terminated by sponsor|6|||
155243661|NCT02371369|560324441|FG000|Part 1|Physician Decision|0|||
155243662|NCT02371369|560324442|FG001|Part 1|Physician Decision|3|||
155243663|NCT02371369|560324441|FG000|Part 1|Adverse Event|8|||
155243664|NCT02371369|560324442|FG001|Part 1|Adverse Event|0|||
155243665|NCT02371369|560324441|FG000|Part 1|Withdrawal by Subject|1|||
155243666|NCT02371369|560324442|FG001|Part 1|Withdrawal by Subject|6|||
155243667|NCT02371369|560324441|FG000|Part 1|Disease progression|0|||
155243668|NCT02371369|560324442|FG001|Part 1|Disease progression|1|||
155243669|NCT02371369|560324441|FG000|Part 1|Protocol Violation|0|||
155243670|NCT02371369|560324442|FG001|Part 1|Protocol Violation|1|||
155243671|NCT02371369|560324441|FG000|Part 2|Adverse Event|6|||
155243672|NCT02371369|560324442|FG001|Part 2|Adverse Event|5|||
155243673|NCT02371369|560324441|FG000|Part 2|Withdrawal by Subject|16|||
155243674|NCT02371369|560324442|FG001|Part 2|Withdrawal by Subject|6|||
155243675|NCT02371369|560324441|FG000|Part 2|Investigator decision|1|||
155243676|NCT02371369|560324442|FG001|Part 2|Investigator decision|2|||
155243677|NCT02371369|560324441|FG000|Part 2|Death|0|||
155243678|NCT02371369|560324442|FG001|Part 2|Death|1|||
155243679|NCT02371369|560324441|FG000|Part 2|Disease progression|1|||
155243680|NCT02371369|560324442|FG001|Part 2|Disease progression|0|||
155243681|NCT02371369|560324441|FG000|Part 2|Subject Noncompliance|1|||
155243682|NCT02371369|560324442|FG001|Part 2|Subject Noncompliance|0|||
155243683|NCT02371369|560324441|FG000|Part 2|Lost to Follow-up|1|||
155243684|NCT02371369|560324442|FG001|Part 2|Lost to Follow-up|1|||
155243685|NCT02371369|560324441|FG000|Part 2|Subject transitioned to commercial supply|6|||
155243686|NCT02371369|560324442|FG001|Part 2|Subject transitioned to commercial supply|4|||
155243687|NCT02371369|560324441|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
155243688|NCT02371369|560324442|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
155243689|NCT02371369|560324441|FG000|Part 2|Surgical resection of tumor|1|||
155243690|NCT02371369|560324442|FG001|Part 2|Surgical resection of tumor|1|||
155243691|NCT02371369|560324441|FG000|Part 2|Other|0|||
155243692|NCT02371369|560324442|FG001|Part 2|Other|1|||
155243693|NCT01024387|560324443|FG000|Overall Study|Radiographic Progression|29|||
155243694|NCT01024387|560324443|FG000|Overall Study|Symptomatic Progression|10|||
155243695|NCT01024387|560324443|FG000|Overall Study|Physician Decision|5|||
155243696|NCT01024387|560324443|FG000|Overall Study|Withdrawal by Subject|5|||
155243697|NCT01024387|560324443|FG000|Overall Study|Death|2|||
155243698|NCT01024387|560324443|FG000|Overall Study|Prolonged Treatment Delay|1|||
155243699|NCT01024387|560324443|FG000|Overall Study|Adverse Event|3|||
155243700|NCT01024387|560324443|FG000|Overall Study|Other|5|||
155243701|NCT03855189|560324444|FG000|Overall Study|Adverse Event|5|||
155243702|NCT03855189|560324445|FG001|Overall Study|Adverse Event|2|||
155243703|NCT03855189|560324446|FG002|Overall Study|Adverse Event|4|||
155243704|NCT03855189|560324444|FG000|Overall Study|Treatment Failure|1|||
155243705|NCT03855189|560324445|FG001|Overall Study|Treatment Failure|1|||
155243706|NCT03855189|560324446|FG002|Overall Study|Treatment Failure|2|||
155243707|NCT03855189|560324444|FG000|Overall Study|Noncompliance with Protocol|0|||
155243708|NCT03855189|560324445|FG001|Overall Study|Noncompliance with Protocol|1|||
155243709|NCT03855189|560324446|FG002|Overall Study|Noncompliance with Protocol|0|||
155243710|NCT03855189|560324444|FG000|Overall Study|Did Not Return|4|||
155243711|NCT03855189|560324445|FG001|Overall Study|Did Not Return|3|||
155243712|NCT03855189|560324446|FG002|Overall Study|Did Not Return|0|||
155243713|NCT00586105|560324448|FG000|Overall Study|Adverse Event|4|||
155243714|NCT00586105|560324448|FG000|Overall Study|Death|2|||
155243715|NCT00586105|560324448|FG000|Overall Study|Protocol Violation|1|||
155243716|NCT00586105|560324448|FG000|Overall Study|Withdrawal by Subject|3|||
155243717|NCT00586105|560324448|FG000|Overall Study|Disease progression|19|||
155243718|NCT00586105|560324448|FG000|Overall Study|Switched to commercial drug|9|||
155243719|NCT00586105|560324448|FG000|Overall Study|Reason not reported|1|||
155243720|NCT00927927|560324455|FG000|Overall Study|Withdrawal by Subject|0|||
155243721|NCT00927927|560324456|FG001|Overall Study|Withdrawal by Subject|0|||
155243722|NCT00927927|560324457|FG002|Overall Study|Withdrawal by Subject|0|||
155243723|NCT00927927|560324458|FG003|Overall Study|Withdrawal by Subject|0|||
155243724|NCT00927927|560324459|FG004|Overall Study|Withdrawal by Subject|0|||
155243725|NCT00927927|560324460|FG005|Overall Study|Withdrawal by Subject|0|||
155243726|NCT00927927|560324461|FG006|Overall Study|Withdrawal by Subject|0|||
155243727|NCT00927927|560324462|FG007|Overall Study|Withdrawal by Subject|2|||
155243728|NCT00927927|560324463|FG008|Overall Study|Withdrawal by Subject|0|||
155243729|NCT00927927|560324464|FG009|Overall Study|Withdrawal by Subject|0|||
155243730|NCT00927927|560324465|FG010|Overall Study|Withdrawal by Subject|0|||
155243731|NCT00927927|560324466|FG011|Overall Study|Withdrawal by Subject|2|||
155243732|NCT00927927|560324467|FG012|Overall Study|Withdrawal by Subject|0|||
155243733|NCT00927927|560324468|FG013|Overall Study|Withdrawal by Subject|0|||
155243734|NCT00927927|560324469|FG014|Overall Study|Withdrawal by Subject|0|||
155243735|NCT01344460|560324470|FG000|Overall Study|Withdrawal by Subject|1|||
155243736|NCT01344460|560324470|FG000|Overall Study|Lost to Follow-up|2|||
155243737|NCT00558285|560324471|FG000|Overall Study|Adverse Event|1|||
155243738|NCT00558285|560324472|FG001|Overall Study|Adverse Event|1|||
155243739|NCT00558285|560324473|FG002|Overall Study|Adverse Event|4|||
155243740|NCT00558285|560324474|FG003|Overall Study|Adverse Event|1|||
155243741|NCT00558285|560324475|FG004|Overall Study|Adverse Event|2|||
155243742|NCT00558285|560324471|FG000|Overall Study|Abnormal test procedure result(s)|1|||
155243743|NCT00558285|560324472|FG001|Overall Study|Abnormal test procedure result(s)|0|||
155243744|NCT00558285|560324473|FG002|Overall Study|Abnormal test procedure result(s)|0|||
155243745|NCT00558285|560324474|FG003|Overall Study|Abnormal test procedure result(s)|0|||
155243746|NCT00558285|560324475|FG004|Overall Study|Abnormal test procedure result(s)|0|||
155243747|NCT00558285|560324471|FG000|Overall Study|Subject withdrew consent|2|||
155243748|NCT00558285|560324472|FG001|Overall Study|Subject withdrew consent|0|||
155243749|NCT00558285|560324473|FG002|Overall Study|Subject withdrew consent|1|||
155243750|NCT00558285|560324474|FG003|Overall Study|Subject withdrew consent|1|||
155243751|NCT00558285|560324475|FG004|Overall Study|Subject withdrew consent|1|||
155243752|NCT00558285|560324471|FG000|Overall Study|Lost to Follow-up|1|||
155243753|NCT00558285|560324472|FG001|Overall Study|Lost to Follow-up|1|||
155243754|NCT00558285|560324473|FG002|Overall Study|Lost to Follow-up|0|||
155243755|NCT00558285|560324474|FG003|Overall Study|Lost to Follow-up|0|||
155243756|NCT00558285|560324475|FG004|Overall Study|Lost to Follow-up|0|||
155243757|NCT00558285|560324471|FG000|Overall Study|Administrative problems|0|||
155243758|NCT00558285|560324472|FG001|Overall Study|Administrative problems|0|||
155243759|NCT00558285|560324473|FG002|Overall Study|Administrative problems|0|||
155243760|NCT00558285|560324474|FG003|Overall Study|Administrative problems|1|||
155243761|NCT00558285|560324475|FG004|Overall Study|Administrative problems|1|||
155243762|NCT00558285|560324471|FG000|Overall Study|Protocol deviation|1|||
155243763|NCT00558285|560324472|FG001|Overall Study|Protocol deviation|1|||
155243764|NCT00558285|560324473|FG002|Overall Study|Protocol deviation|0|||
155243765|NCT00558285|560324474|FG003|Overall Study|Protocol deviation|1|||
155243766|NCT00558285|560324475|FG004|Overall Study|Protocol deviation|0|||
155243767|NCT01682460|560326251|FG000|Overall Study|Withdrawal by Subject|2|||
155243768|NCT01682460|560326251|FG000|Overall Study|Did not meet inclusion criteria|2|||
155243769|NCT00724282|560326252|FG000|Overall Study|Withdrawal by Subject|3|||
155243770|NCT00724282|560326252|FG000|Overall Study|Physician Decision|1|||
155243771|NCT03811912|560326253|FG000|Overall Study|Withdrew Consent|4|||
155243772|NCT03811912|560326254|FG001|Overall Study|Withdrew Consent|2|||
155243773|NCT03586648|560326257|FG000|Period 1|Withdrawal by Subject|0|||
155243774|NCT03586648|560326258|FG001|Period 1|Withdrawal by Subject|1|||
155243775|NCT03586648|560326257|FG000|Period 1|Lost to Follow-up|1|||
155243776|NCT03586648|560326258|FG001|Period 1|Lost to Follow-up|1|||
155243777|NCT03586648|560326257|FG000|Period 1|Adverse Event|1|||
155243778|NCT03586648|560326258|FG001|Period 1|Adverse Event|0|||
155243779|NCT03586648|560326257|FG000|Period 1|Study related symptoms or complaints|2|||
155243780|NCT03586648|560326258|FG001|Period 1|Study related symptoms or complaints|1|||
155243781|NCT03586648|560326257|FG000|Period 1|Physician Decision|0|||
155243782|NCT03586648|560326258|FG001|Period 1|Physician Decision|1|||
155243783|NCT03586648|560326257|FG000|Period 2|Adverse Event|1|||
155243784|NCT03586648|560326258|FG001|Period 2|Adverse Event|0|||
155243785|NCT00377234|560326259|FG000|Overall Study|Adverse Event|14|||
155243786|NCT00377234|560326260|FG001|Overall Study|Adverse Event|17|||
155243787|NCT00377234|560326259|FG000|Overall Study|Withdrawal by Subject|11|||
155243788|NCT00377234|560326260|FG001|Overall Study|Withdrawal by Subject|9|||
155243789|NCT00377234|560326259|FG000|Overall Study|Lost to Follow-up|4|||
155243790|NCT00377234|560326260|FG001|Overall Study|Lost to Follow-up|2|||
155243791|NCT00377234|560326259|FG000|Overall Study|Administrative|2|||
155243792|NCT00377234|560326260|FG001|Overall Study|Administrative|1|||
155243793|NCT00377234|560326259|FG000|Overall Study|Not assigned|3|||
155243794|NCT00377234|560326260|FG001|Overall Study|Not assigned|2|||
155243795|NCT00626522|560326265|FG000|Overall Study|Protocol Violation|0|||
155243796|NCT00626522|560326266|FG001|Overall Study|Protocol Violation|0|||
155243797|NCT00626522|560326267|FG002|Overall Study|Protocol Violation|0|||
155243798|NCT00626522|560326268|FG003|Overall Study|Protocol Violation|0|||
155243799|NCT00626522|560326269|FG004|Overall Study|Protocol Violation|1|||
155243800|NCT00626522|560326270|FG005|Overall Study|Protocol Violation|0|||
155243801|NCT00626522|560326265|FG000|Overall Study|Adverse Event|2|||
155243802|NCT00626522|560326266|FG001|Overall Study|Adverse Event|1|||
155243803|NCT00626522|560326267|FG002|Overall Study|Adverse Event|2|||
155243804|NCT00626522|560326268|FG003|Overall Study|Adverse Event|0|||
155243805|NCT00626522|560326269|FG004|Overall Study|Adverse Event|1|||
155243806|NCT00626522|560326270|FG005|Overall Study|Adverse Event|1|||
155243807|NCT00626522|560326265|FG000|Overall Study|Withdrawal by Subject|2|||
155243808|NCT00626522|560326266|FG001|Overall Study|Withdrawal by Subject|5|||
155243809|NCT00626522|560326267|FG002|Overall Study|Withdrawal by Subject|5|||
155243810|NCT00626522|560326268|FG003|Overall Study|Withdrawal by Subject|0|||
155243811|NCT00626522|560326269|FG004|Overall Study|Withdrawal by Subject|4|||
155243812|NCT00626522|560326270|FG005|Overall Study|Withdrawal by Subject|1|||
155243813|NCT00626522|560326265|FG000|Overall Study|COPD exacerbation|0|||
155243814|NCT00626522|560326266|FG001|Overall Study|COPD exacerbation|0|||
155243815|NCT00626522|560326267|FG002|Overall Study|COPD exacerbation|0|||
155243816|NCT00626522|560326268|FG003|Overall Study|COPD exacerbation|1|||
155243817|NCT00626522|560326269|FG004|Overall Study|COPD exacerbation|1|||
155243818|NCT00626522|560326270|FG005|Overall Study|COPD exacerbation|0|||
155243819|NCT00626522|560326265|FG000|Overall Study|Lost to Follow-up|0|||
155243820|NCT00626522|560326266|FG001|Overall Study|Lost to Follow-up|1|||
155243821|NCT00626522|560326267|FG002|Overall Study|Lost to Follow-up|0|||
155243822|NCT00626522|560326268|FG003|Overall Study|Lost to Follow-up|0|||
155243823|NCT00626522|560326269|FG004|Overall Study|Lost to Follow-up|0|||
155243824|NCT00626522|560326270|FG005|Overall Study|Lost to Follow-up|0|||
155243825|NCT00626522|560326265|FG000|Overall Study|Inconsistent reason reported|1|||
155243826|NCT00626522|560326266|FG001|Overall Study|Inconsistent reason reported|0|||
155243827|NCT00626522|560326267|FG002|Overall Study|Inconsistent reason reported|0|||
155243828|NCT00626522|560326268|FG003|Overall Study|Inconsistent reason reported|0|||
155243829|NCT00626522|560326269|FG004|Overall Study|Inconsistent reason reported|0|||
155243830|NCT00626522|560326270|FG005|Overall Study|Inconsistent reason reported|0|||
155243831|NCT00626522|560326265|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
155243832|NCT00626522|560326266|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
155243833|NCT00626522|560326267|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
155243834|NCT00626522|560326268|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
155243835|NCT00626522|560326269|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
155243836|NCT00626522|560326270|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
155243837|NCT01928719|560326271|FG000|Overall Study|Lost to Follow-up|26|||
155243838|NCT01928719|560326272|FG001|Overall Study|Lost to Follow-up|11|||
155243839|NCT01928719|560326271|FG000|Overall Study|Withdrawal by Subject|22|||
155243840|NCT01928719|560326272|FG001|Overall Study|Withdrawal by Subject|7|||
155243841|NCT01928719|560326271|FG000|Overall Study|Protocol Violation|3|||
155243842|NCT01928719|560326272|FG001|Overall Study|Protocol Violation|1|||
155243843|NCT01928719|560326271|FG000|Overall Study|Adverse Event|1|||
155243844|NCT01928719|560326272|FG001|Overall Study|Adverse Event|0|||
155243845|NCT02367911|560326275|FG000|Overall Study|Withdrawal by Subject|3|||
155243846|NCT02367911|560326276|FG001|Overall Study|Withdrawal by Subject|2|||
155243847|NCT02367911|560326275|FG000|Overall Study|Lost to Follow-up|2|||
155243848|NCT02367911|560326276|FG001|Overall Study|Lost to Follow-up|2|||
155243849|NCT00263666|560326277|FG000|Overall Study|Adverse Event|6|||
155243850|NCT00263666|560326278|FG001|Overall Study|Adverse Event|8|||
155243851|NCT00263666|560326277|FG000|Overall Study|Lost to Follow-up|1|||
155243852|NCT00263666|560326278|FG001|Overall Study|Lost to Follow-up|2|||
155243853|NCT00263666|560326277|FG000|Overall Study|Withdrawal by Subject|0|||
155243854|NCT00263666|560326278|FG001|Overall Study|Withdrawal by Subject|1|||
155243855|NCT00902304|560326279|FG000|Overall Study|Adverse Event|4|||
155243856|NCT00902304|560326280|FG001|Overall Study|Adverse Event|10|||
155243857|NCT00902304|560326281|FG002|Overall Study|Adverse Event|25|||
155243858|NCT00902304|560326279|FG000|Overall Study|Investigator discretion|3|||
155243859|NCT00902304|560326280|FG001|Overall Study|Investigator discretion|5|||
155243860|NCT00902304|560326281|FG002|Overall Study|Investigator discretion|13|||
155243861|NCT00902304|560326279|FG000|Overall Study|Lost to Follow-up|7|||
155243862|NCT00902304|560326280|FG001|Overall Study|Lost to Follow-up|7|||
155243863|NCT00902304|560326281|FG002|Overall Study|Lost to Follow-up|7|||
155243864|NCT00902304|560326279|FG000|Overall Study|Protocol Violation|9|||
155243865|NCT00902304|560326280|FG001|Overall Study|Protocol Violation|18|||
155243866|NCT00902304|560326281|FG002|Overall Study|Protocol Violation|20|||
155243867|NCT00902304|560326279|FG000|Overall Study|Withdrawal by Subject|32|||
155243868|NCT00902304|560326280|FG001|Overall Study|Withdrawal by Subject|22|||
155243869|NCT00902304|560326281|FG002|Overall Study|Withdrawal by Subject|43|||
155243870|NCT00902304|560326279|FG000|Overall Study|includes pregnancy|3|||
155243871|NCT00902304|560326280|FG001|Overall Study|includes pregnancy|9|||
155243872|NCT00902304|560326281|FG002|Overall Study|includes pregnancy|2|||
155243873|NCT00838110|560326282|FG000|Overall Study|Death|0|||
155243874|NCT00838110|560326283|FG001|Overall Study|Death|0|||
155243875|NCT00838110|560326284|FG002|Overall Study|Death|1|||
155243876|NCT00838110|560326285|FG003|Overall Study|Death|2|||
155243877|NCT00838110|560326282|FG000|Overall Study|Adverse Event|11|||
155243878|NCT00838110|560326283|FG001|Overall Study|Adverse Event|10|||
155243879|NCT00838110|560326284|FG002|Overall Study|Adverse Event|8|||
155243880|NCT00838110|560326285|FG003|Overall Study|Adverse Event|7|||
155243881|NCT00838110|560326282|FG000|Overall Study|Withdrawal by Subject|5|||
155243882|NCT00838110|560326283|FG001|Overall Study|Withdrawal by Subject|6|||
155243883|NCT00838110|560326284|FG002|Overall Study|Withdrawal by Subject|3|||
155243884|NCT00838110|560326285|FG003|Overall Study|Withdrawal by Subject|4|||
155243885|NCT00838110|560326282|FG000|Overall Study|Other|3|||
155243886|NCT00838110|560326283|FG001|Overall Study|Other|3|||
155243887|NCT00838110|560326284|FG002|Overall Study|Other|3|||
155243888|NCT00838110|560326285|FG003|Overall Study|Other|2|||
155243889|NCT00838110|560326282|FG000|Overall Study|Protocol Violation|0|||
155243890|NCT00838110|560326283|FG001|Overall Study|Protocol Violation|2|||
155243891|NCT00838110|560326284|FG002|Overall Study|Protocol Violation|1|||
155243892|NCT00838110|560326285|FG003|Overall Study|Protocol Violation|1|||
155243893|NCT00838110|560326282|FG000|Overall Study|Lost to Follow-up|3|||
155243894|NCT00838110|560326283|FG001|Overall Study|Lost to Follow-up|0|||
155243895|NCT00838110|560326284|FG002|Overall Study|Lost to Follow-up|0|||
155243896|NCT00838110|560326285|FG003|Overall Study|Lost to Follow-up|0|||
155243897|NCT00838110|560326282|FG000|Overall Study|Did not meet eligibility criteria|0|||
155243898|NCT00838110|560326283|FG001|Overall Study|Did not meet eligibility criteria|0|||
155243899|NCT00838110|560326284|FG002|Overall Study|Did not meet eligibility criteria|1|||
155243900|NCT00838110|560326285|FG003|Overall Study|Did not meet eligibility criteria|2|||
155243901|NCT00838110|560326282|FG000|Overall Study|Randomized but not treated|0|||
155243902|NCT00838110|560326283|FG001|Overall Study|Randomized but not treated|1|||
155243903|NCT00838110|560326284|FG002|Overall Study|Randomized but not treated|0|||
155243904|NCT00838110|560326285|FG003|Overall Study|Randomized but not treated|0|||
155243905|NCT01003899|560326286|FG000|Overall Study|Other Adverse Event|8|||
155243906|NCT01003899|560326286|FG000|Overall Study|Not entered|4|||
155243907|NCT01003899|560326286|FG000|Overall Study|Not treated|1|||
155243908|NCT01003899|560326286|FG000|Overall Study|Progressive disease|34|||
155243909|NCT00352365|560326287|FG000|Induction Therapy|Adverse Event|7|||
155243910|NCT00352365|560326287|FG000|Induction Therapy|Progression/Relapse|8|||
155243911|NCT00352365|560326287|FG000|Induction Therapy|Death|7|||
155243912|NCT00352365|560326287|FG000|Induction Therapy|Not protocol specified|1|||
155243913|NCT00352365|560326287|FG000|Induction Therapy|Not eligible|3|||
155243914|NCT00352365|560326287|FG000|Induction Therapy|Death before starting protocol therapy|1|||
155243915|NCT00352365|560326287|FG000|Maintenance Therapy|Progression/Relapse|3|||
155243916|NCT00352365|560326287|FG000|Maintenance Therapy|Death|2|||
155243917|NCT00352365|560326287|FG000|Maintenance Therapy|Not protocol specified|3|||
155243918|NCT00352365|560326287|FG000|Maintenance Therapy|Not eligible|4|||
155243919|NCT02811861|560326288|FG000|Overall Study|Radiological Disease Progression|123|||
155243920|NCT02811861|560326289|FG001|Overall Study|Radiological Disease Progression|97|||
155243921|NCT02811861|560326290|FG002|Overall Study|Radiological Disease Progression|174|||
155243922|NCT02811861|560326288|FG000|Overall Study|Clinical Disease Progression|20|||
155243923|NCT02811861|560326289|FG001|Overall Study|Clinical Disease Progression|19|||
155243924|NCT02811861|560326290|FG002|Overall Study|Clinical Disease Progression|22|||
155243925|NCT02811861|560326288|FG000|Overall Study|Adverse Event|63|||
155243926|NCT02811861|560326289|FG001|Overall Study|Adverse Event|60|||
155243927|NCT02811861|560326290|FG002|Overall Study|Adverse Event|41|||
155243928|NCT02811861|560326288|FG000|Overall Study|Lost to Follow-up|0|||
155243929|NCT02811861|560326289|FG001|Overall Study|Lost to Follow-up|0|||
155243930|NCT02811861|560326290|FG002|Overall Study|Lost to Follow-up|1|||
155243931|NCT02811861|560326288|FG000|Overall Study|Subject Choice|29|||
155243932|NCT02811861|560326289|FG001|Overall Study|Subject Choice|17|||
155243933|NCT02811861|560326290|FG002|Overall Study|Subject Choice|23|||
155243934|NCT02811861|560326288|FG000|Overall Study|Withdrawal by Subject|4|||
155243935|NCT02811861|560326289|FG001|Overall Study|Withdrawal by Subject|4|||
155243936|NCT02811861|560326290|FG002|Overall Study|Withdrawal by Subject|9|||
155243937|NCT02811861|560326288|FG000|Overall Study|Other|4|||
155243938|NCT02811861|560326289|FG001|Overall Study|Other|13|||
155243939|NCT02811861|560326290|FG002|Overall Study|Other|3|||
155243940|NCT02811861|560326288|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
155243941|NCT02811861|560326289|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
155243942|NCT02811861|560326290|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
155243943|NCT02811861|560326288|FG000|Overall Study|Randomized but not treated|2|||
155243944|NCT02811861|560326289|FG001|Overall Study|Randomized but not treated|3|||
155243945|NCT02811861|560326290|FG002|Overall Study|Randomized but not treated|17|||
155243946|NCT04743908|560326291|FG000|Overall Study|Death|1|||
155243947|NCT04743908|560326292|FG001|Overall Study|Death|0|||
155243948|NCT04743908|560326291|FG000|Overall Study|Lost to Follow-up|181|||
155243949|NCT04743908|560326292|FG001|Overall Study|Lost to Follow-up|180|||
155243950|NCT04743908|560326291|FG000|Overall Study|Withdrawal by Subject|1|||
155243951|NCT04743908|560326292|FG001|Overall Study|Withdrawal by Subject|2|||
155243952|NCT03822533|560326293|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
155243953|NCT03822533|560326294|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
155243954|NCT03822533|560326293|FG000|3 Month Follow-up|Lost to Follow-up|2|||
155243955|NCT03822533|560326294|FG001|3 Month Follow-up|Lost to Follow-up|2|||
155243956|NCT03822533|560326293|FG000|6 Month Follow-up|Lost to Follow-up|3|||
155243957|NCT03822533|560326294|FG001|6 Month Follow-up|Lost to Follow-up|0|||
155243958|NCT03822533|560326293|FG000|12 Month Follow-up|Lost to Follow-up|2|||
155243959|NCT03822533|560326294|FG001|12 Month Follow-up|Lost to Follow-up|3|||
155243960|NCT03822533|560326293|FG000|12 Month Follow-up|Pregnancy|0|||
155243961|NCT03822533|560326294|FG001|12 Month Follow-up|Pregnancy|1|||
155243962|NCT03822533|560326293|FG000|12 Month Follow-up|Surgery|2|||
155243963|NCT03822533|560326294|FG001|12 Month Follow-up|Surgery|0|||
155243964|NCT03822533|560326293|FG000|12 Month Follow-up|Wrong address|1|||
155243965|NCT03822533|560326294|FG001|12 Month Follow-up|Wrong address|0|||
155243966|NCT03822533|560326293|FG000|12 Month Follow-up|No symptoms|1|||
155243967|NCT03822533|560326294|FG001|12 Month Follow-up|No symptoms|0|||
155243968|NCT03822533|560326293|FG000|12 Month Follow-up|Changed primary care center|0|||
155243969|NCT03822533|560326294|FG001|12 Month Follow-up|Changed primary care center|1|||
155243970|NCT04969783|560326297|FG000|Overall Study|Lost to Follow-up|2|||
155243971|NCT04969783|560326298|FG001|Overall Study|Lost to Follow-up|0|||
155243972|NCT04969783|560326297|FG000|Overall Study|Withdrawal by Subject|4|||
155243973|NCT04969783|560326298|FG001|Overall Study|Withdrawal by Subject|0|||
155243974|NCT04969783|560326297|FG000|Overall Study|Physician Decision|6|||
155243975|NCT04969783|560326298|FG001|Overall Study|Physician Decision|0|||
155243976|NCT02489500|560326299|FG000|Overall Study|Death|1|||
155243977|NCT02489500|560326300|FG001|Overall Study|Death|1|||
155243978|NCT00512135|560326301|FG000|Overall Study|Not Treated|5|||
155243979|NCT00512135|560326301|FG000|Overall Study|Lack of Efficacy|2|||
155243980|NCT00512135|560326301|FG000|Overall Study|Adverse Event|6|||
155243981|NCT00512135|560326301|FG000|Overall Study|Withdrawal by Subject|22|||
155243982|NCT00512135|560326301|FG000|Overall Study|Lost to Follow-up|27|||
155243983|NCT00512135|560326301|FG000|Overall Study|Other|22|||
155243984|NCT03422250|560326302|FG000|Intervention|Adverse Event|0|||
155243985|NCT03422250|560326303|FG001|Intervention|Adverse Event|1|||
155243986|NCT03422250|560326304|FG002|Intervention|Adverse Event|0|||
155243987|NCT03422250|560326305|FG003|Intervention|Adverse Event|1|||
155243988|NCT03422250|560326302|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
155243989|NCT03422250|560326303|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
155243990|NCT03422250|560326304|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
155243991|NCT03422250|560326305|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
155243992|NCT03422250|560326302|FG000|Follow-up|Withdrawal by Subject|0|||
155243993|NCT03422250|560326303|FG001|Follow-up|Withdrawal by Subject|0|||
155243994|NCT03422250|560326304|FG002|Follow-up|Withdrawal by Subject|0|||
155243995|NCT03422250|560326305|FG003|Follow-up|Withdrawal by Subject|1|||
155243996|NCT03422250|560326302|FG000|Follow-up|Adverse Event|0|||
155243997|NCT03422250|560326303|FG001|Follow-up|Adverse Event|0|||
155243998|NCT03422250|560326304|FG002|Follow-up|Adverse Event|0|||
155243999|NCT03422250|560326305|FG003|Follow-up|Adverse Event|1|||
155244000|NCT00377819|560326308|FG000|Overall Study|Adverse Event|2|||
155244001|NCT00377819|560326309|FG001|Overall Study|Adverse Event|3|||
155244002|NCT00377819|560326308|FG000|Overall Study|Withdrawal by Subject|10|||
155244003|NCT00377819|560326309|FG001|Overall Study|Withdrawal by Subject|4|||
155244004|NCT00377819|560326308|FG000|Overall Study|Death|0|||
155244005|NCT00377819|560326309|FG001|Overall Study|Death|1|||
155244006|NCT00377819|560326308|FG000|Overall Study|Lost to Follow-up|0|||
155244007|NCT00377819|560326309|FG001|Overall Study|Lost to Follow-up|1|||
155244008|NCT00377819|560326308|FG000|Overall Study|Protocol Violation|1|||
155244009|NCT00377819|560326309|FG001|Overall Study|Protocol Violation|1|||
155244010|NCT01917526|560326310|FG000|Overall Study|Protocol Violation|1|||
155244011|NCT01917526|560326311|FG001|Overall Study|Protocol Violation|1|||
155244012|NCT02099838|560326312|FG000|Overall Study|Death|1|||
155244013|NCT02099838|560326313|FG001|Overall Study|Death|0|||
155244014|NCT02099838|560326312|FG000|Overall Study|Lost to Follow-up|3|||
155244015|NCT02099838|560326313|FG001|Overall Study|Lost to Follow-up|1|||
155244016|NCT02099838|560326312|FG000|Overall Study|Withdrawal by Subject|0|||
155244017|NCT02099838|560326313|FG001|Overall Study|Withdrawal by Subject|1|||
155244018|NCT01175382|560326316|FG000|Overall Study|Lost to Follow-up|4|||
155244019|NCT01175382|560326317|FG001|Overall Study|Lost to Follow-up|3|||
155244020|NCT01175382|560326318|FG002|Overall Study|Lost to Follow-up|1|||
155244021|NCT01175382|560326316|FG000|Overall Study|Physician Decision|0|||
155244022|NCT01175382|560326317|FG001|Overall Study|Physician Decision|1|||
155244023|NCT01175382|560326318|FG002|Overall Study|Physician Decision|0|||
155244024|NCT01175382|560326316|FG000|Overall Study|Withdrawal by Subject|0|||
155244025|NCT01175382|560326317|FG001|Overall Study|Withdrawal by Subject|0|||
155244026|NCT01175382|560326318|FG002|Overall Study|Withdrawal by Subject|1|||
155244027|NCT01175382|560326316|FG000|Overall Study|No longer having problem|1|||
155244028|NCT01175382|560326317|FG001|Overall Study|No longer having problem|0|||
155244029|NCT01175382|560326318|FG002|Overall Study|No longer having problem|1|||
155244030|NCT01175382|560326316|FG000|Overall Study|Unable/unwilling to attend visits|3|||
155244031|NCT01175382|560326317|FG001|Overall Study|Unable/unwilling to attend visits|1|||
155244032|NCT01175382|560326318|FG002|Overall Study|Unable/unwilling to attend visits|2|||
155244033|NCT01175382|560326316|FG000|Overall Study|Unwilling to follow protocol|0|||
155244034|NCT01175382|560326317|FG001|Overall Study|Unwilling to follow protocol|1|||
155244035|NCT01175382|560326318|FG002|Overall Study|Unwilling to follow protocol|0|||
155244036|NCT01175382|560326316|FG000|Overall Study|Unable to tolerate study meds|0|||
155244037|NCT01175382|560326317|FG001|Overall Study|Unable to tolerate study meds|1|||
155244038|NCT01175382|560326318|FG002|Overall Study|Unable to tolerate study meds|1|||
155244039|NCT00774787|560326319|FG000|Overall Study|Lost to Follow-up|1|||
155244040|NCT04535037|560326320|FG000|Overall Study|Protocol Violation|1|||
155244041|NCT04535037|560326321|FG001|Overall Study|Protocol Violation|0|||
155244042|NCT04535037|560326320|FG000|Overall Study|Withdrawal by Subject|8|||
155244043|NCT04535037|560326321|FG001|Overall Study|Withdrawal by Subject|9|||
155244044|NCT04535037|560326320|FG000|Overall Study|Migrated / moved from the study area|1|||
155244045|NCT04535037|560326321|FG001|Overall Study|Migrated / moved from the study area|4|||
155244046|NCT04535037|560326320|FG000|Overall Study|Other|2|||
155244047|NCT04535037|560326321|FG001|Overall Study|Other|5|||
155244048|NCT02031276|560326322|FG000|Period 1 Double-blind IV|Adverse Event|6|||
155244049|NCT02031276|560326323|FG001|Period 1 Double-blind IV|Adverse Event|5|||
155244050|NCT02031276|560326324|FG002|Period 1 Double-blind IV|Adverse Event|1|||
155244051|NCT02031276|560326322|FG000|Period 1 Double-blind IV|Other|0|||
155244052|NCT02031276|560326323|FG001|Period 1 Double-blind IV|Other|1|||
155244053|NCT02031276|560326324|FG002|Period 1 Double-blind IV|Other|0|||
155244054|NCT02031276|560326322|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
155244055|NCT02031276|560326323|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
155244056|NCT02031276|560326324|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
155244057|NCT02031276|560326322|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
155244058|NCT02031276|560326323|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
155244059|NCT02031276|560326324|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
155244060|NCT02031276|560326322|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
155244061|NCT02031276|560326323|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
155244062|NCT02031276|560326324|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
155244063|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
155244064|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
155244065|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
155244066|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
155244067|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
155244068|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
155244069|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
155244070|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
155244071|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
155244072|NCT02031276|560326322|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
155244073|NCT02031276|560326323|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
155244074|NCT02031276|560326324|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
155244075|NCT02731131|560326325|FG000|Overall Study|Psychiatric Disorder|0|||
155244076|NCT02731131|560326326|FG001|Overall Study|Psychiatric Disorder|1|||
155244077|NCT02731131|560326325|FG000|Overall Study|Refused Therapy|0|||
155244078|NCT02731131|560326326|FG001|Overall Study|Refused Therapy|1|||
155244079|NCT02043782|560326331|FG000|Period 1|Adverse Event|0|||
155244080|NCT02043782|560326332|FG001|Period 1|Adverse Event|0|||
155244081|NCT02043782|560326333|FG002|Period 1|Adverse Event|1|||
155244082|NCT02043782|560326334|FG003|Period 1|Adverse Event|0|||
155244083|NCT02043782|560326335|FG004|Period 1|Adverse Event|0|||
155244084|NCT02043782|560326336|FG005|Period 1|Adverse Event|0|||
155244085|NCT00874029|560326337|FG000|Overall Study|Withdrawal by Subject|10|||
155244086|NCT00874029|560326337|FG000|Overall Study|Pregnancy|4|||
155244087|NCT00874029|560326337|FG000|Overall Study|Physician Decision|1|||
155244088|NCT00874029|560326337|FG000|Overall Study|Adverse Event|1|||
155244089|NCT00874029|560326337|FG000|Overall Study|Lost to Follow-up|5|||
155244090|NCT01953926|560326338|FG000|Overall Study|Withdrawal by Subject|23|||
155244091|NCT01953926|560326339|FG001|Overall Study|Withdrawal by Subject|3|||
155244092|NCT01953926|560326340|FG002|Overall Study|Withdrawal by Subject|3|||
155244093|NCT01953926|560326341|FG003|Overall Study|Withdrawal by Subject|5|||
155244094|NCT01953926|560326342|FG004|Overall Study|Withdrawal by Subject|6|||
155244095|NCT01953926|560326343|FG005|Overall Study|Withdrawal by Subject|0|||
155244096|NCT01953926|560326344|FG006|Overall Study|Withdrawal by Subject|1|||
155244097|NCT01953926|560326338|FG000|Overall Study|Physician Decision|1|||
155244098|NCT01953926|560326339|FG001|Overall Study|Physician Decision|0|||
155244099|NCT01953926|560326340|FG002|Overall Study|Physician Decision|0|||
155244100|NCT01953926|560326341|FG003|Overall Study|Physician Decision|0|||
155244101|NCT01953926|560326342|FG004|Overall Study|Physician Decision|2|||
155244102|NCT01953926|560326343|FG005|Overall Study|Physician Decision|0|||
155244103|NCT01953926|560326344|FG006|Overall Study|Physician Decision|0|||
155244104|NCT01953926|560326338|FG000|Overall Study|Lost to Follow-up|18|||
155244105|NCT01953926|560326339|FG001|Overall Study|Lost to Follow-up|3|||
155244106|NCT01953926|560326340|FG002|Overall Study|Lost to Follow-up|0|||
155244107|NCT01953926|560326341|FG003|Overall Study|Lost to Follow-up|5|||
155244108|NCT01953926|560326342|FG004|Overall Study|Lost to Follow-up|3|||
155244109|NCT01953926|560326343|FG005|Overall Study|Lost to Follow-up|0|||
155244110|NCT01953926|560326344|FG006|Overall Study|Lost to Follow-up|0|||
155244111|NCT01953926|560326338|FG000|Overall Study|Protocol Violation|1|||
155244112|NCT01953926|560326339|FG001|Overall Study|Protocol Violation|0|||
155244113|NCT01953926|560326340|FG002|Overall Study|Protocol Violation|0|||
155244114|NCT01953926|560326341|FG003|Overall Study|Protocol Violation|0|||
155244115|NCT01953926|560326342|FG004|Overall Study|Protocol Violation|0|||
155244116|NCT01953926|560326343|FG005|Overall Study|Protocol Violation|0|||
155244117|NCT01953926|560326344|FG006|Overall Study|Protocol Violation|0|||
155244118|NCT01953926|560326338|FG000|Overall Study|Other, Disease progression|2|||
155244119|NCT01953926|560326339|FG001|Overall Study|Other, Disease progression|1|||
155244120|NCT01953926|560326340|FG002|Overall Study|Other, Disease progression|0|||
155244121|NCT01953926|560326341|FG003|Overall Study|Other, Disease progression|0|||
155244122|NCT01953926|560326342|FG004|Overall Study|Other, Disease progression|1|||
155244123|NCT01953926|560326343|FG005|Overall Study|Other, Disease progression|0|||
155244124|NCT01953926|560326344|FG006|Overall Study|Other, Disease progression|0|||
155244125|NCT01953926|560326338|FG000|Overall Study|Discontinuation of study by sponsor|41|||
155244126|NCT01953926|560326339|FG001|Overall Study|Discontinuation of study by sponsor|7|||
155244127|NCT01953926|560326340|FG002|Overall Study|Discontinuation of study by sponsor|5|||
155244128|NCT01953926|560326341|FG003|Overall Study|Discontinuation of study by sponsor|12|||
155244129|NCT01953926|560326342|FG004|Overall Study|Discontinuation of study by sponsor|46|||
155244130|NCT01953926|560326343|FG005|Overall Study|Discontinuation of study by sponsor|5|||
155244131|NCT01953926|560326344|FG006|Overall Study|Discontinuation of study by sponsor|6|||
155244132|NCT01953926|560326338|FG000|Overall Study|Not Treated|1|||
155244133|NCT01953926|560326339|FG001|Overall Study|Not Treated|0|||
155244134|NCT01953926|560326340|FG002|Overall Study|Not Treated|1|||
155244135|NCT01953926|560326341|FG003|Overall Study|Not Treated|0|||
155244136|NCT01953926|560326342|FG004|Overall Study|Not Treated|0|||
155244137|NCT01953926|560326343|FG005|Overall Study|Not Treated|0|||
155244138|NCT01953926|560326344|FG006|Overall Study|Not Treated|0|||
155244139|NCT01949480|560326346|FG000|Overall Study|Physician Decision|5|||
155244140|NCT01949480|560326347|FG001|Overall Study|Physician Decision|8|||
155244141|NCT00144339|560326348|FG000|Overall Study|Adverse Event|746|||
155244142|NCT00144339|560326349|FG001|Overall Study|Adverse Event|627|||
155244143|NCT00144339|560326348|FG000|Overall Study|Protocol Violation|75|||
155244144|NCT00144339|560326349|FG001|Overall Study|Protocol Violation|48|||
155244145|NCT00144339|560326348|FG000|Overall Study|Withdrawal by Subject|403|||
155244146|NCT00144339|560326349|FG001|Overall Study|Withdrawal by Subject|300|||
155244147|NCT00144339|560326348|FG000|Overall Study|Lost to Follow-up|76|||
155244148|NCT00144339|560326349|FG001|Overall Study|Lost to Follow-up|64|||
155244149|NCT00144339|560326348|FG000|Overall Study|Other|58|||
155244150|NCT00144339|560326349|FG001|Overall Study|Other|60|||
155244151|NCT00305058|560326350|FG000|Overall Study|Participant too young|1|||
155244152|NCT00305058|560326351|FG001|Overall Study|Participant too young|0|||
155244153|NCT00305058|560326350|FG000|Overall Study|Missing data collection instrument|3|||
155244154|NCT00305058|560326351|FG001|Overall Study|Missing data collection instrument|2|||
155244155|NCT00305058|560326350|FG000|Overall Study|Missing outcome data|3|||
155244156|NCT00305058|560326351|FG001|Overall Study|Missing outcome data|2|||
155244157|NCT00288587|560326354|FG000|Overall Study|Death|4|||
155244158|NCT00288587|560326355|FG001|Overall Study|Death|4|||
155244159|NCT00288587|560326354|FG000|Overall Study|Transplant|0|||
155244160|NCT00288587|560326355|FG001|Overall Study|Transplant|3|||
155244161|NCT00288587|560326354|FG000|Overall Study|Adverse Event|0|||
155244162|NCT00288587|560326355|FG001|Overall Study|Adverse Event|1|||
155244163|NCT00288587|560326354|FG000|Overall Study|Physician Decision|0|||
155244164|NCT00288587|560326355|FG001|Overall Study|Physician Decision|2|||
155244165|NCT00288587|560326354|FG000|Overall Study|Severe Aortic Stenosis|1|||
155244166|NCT00288587|560326355|FG001|Overall Study|Severe Aortic Stenosis|0|||
155244167|NCT01136291|560326358|FG000|Overall Study|Lost to Follow-up|1|||
155244168|NCT01136291|560326359|FG001|Overall Study|Lost to Follow-up|1|||
155244169|NCT03238001|560326364|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
155244170|NCT03238001|560326364|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
155244171|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
155244172|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
155244173|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
155244174|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
155244175|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
155244176|NCT03238001|560326364|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
155244177|NCT04964089|560326365|FG000|Overall Study|Adverse Event|8|||
155244178|NCT04964089|560326366|FG001|Overall Study|Adverse Event|6|||
155244179|NCT04964089|560326365|FG000|Overall Study|Non-compliance with study schedule|1|||
155244180|NCT04964089|560326366|FG001|Overall Study|Non-compliance with study schedule|0|||
155244181|NCT04964089|560326365|FG000|Overall Study|Withdrawal by Subject|6|||
155244182|NCT04964089|560326366|FG001|Overall Study|Withdrawal by Subject|5|||
155244183|NCT04964089|560326365|FG000|Overall Study|Lost to Follow-up|1|||
155244184|NCT04964089|560326366|FG001|Overall Study|Lost to Follow-up|1|||
155244185|NCT04964089|560326365|FG000|Overall Study|Progressive disease|4|||
155244186|NCT04964089|560326366|FG001|Overall Study|Progressive disease|0|||
155244187|NCT04964089|560326365|FG000|Overall Study|Physician Decision|1|||
155244188|NCT04964089|560326366|FG001|Overall Study|Physician Decision|0|||
155244189|NCT04964089|560326365|FG000|Overall Study|Participant did not want to continue study treatment|1|||
155244190|NCT04964089|560326366|FG001|Overall Study|Participant did not want to continue study treatment|0|||
155244191|NCT04964089|560326365|FG000|Overall Study|Participant moved to different state|1|||
155244192|NCT04964089|560326366|FG001|Overall Study|Participant moved to different state|0|||
155244193|NCT04964089|560326365|FG000|Overall Study|Participant decided to discontinue|0|||
155244194|NCT04964089|560326366|FG001|Overall Study|Participant decided to discontinue|1|||
155244195|NCT04369469|560326367|FG000|Overall Study|Lost to Follow-up|2|||
155244196|NCT04369469|560326368|FG001|Overall Study|Lost to Follow-up|4|||
155244197|NCT04369469|560326367|FG000|Overall Study|Physician Decision|2|||
155244198|NCT04369469|560326368|FG001|Overall Study|Physician Decision|1|||
155244199|NCT04369469|560326367|FG000|Overall Study|Withdrawal by Subject|2|||
155244200|NCT04369469|560326368|FG001|Overall Study|Withdrawal by Subject|3|||
155244201|NCT04369469|560326367|FG000|Overall Study|Adverse Event|1|||
155244202|NCT04369469|560326368|FG001|Overall Study|Adverse Event|0|||
155244203|NCT04369469|560326367|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
155244204|NCT04369469|560326368|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
155244205|NCT04369469|560326367|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
155244206|NCT04369469|560326368|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
155244207|NCT04369469|560326367|FG000|Overall Study|Unable to Provide Consent|0|||
155244208|NCT04369469|560326368|FG001|Overall Study|Unable to Provide Consent|1|||
155244209|NCT03135522|560326369|FG000|Overall Study|Adverse Event|1|||
155244210|NCT03135522|560326370|FG001|Overall Study|Adverse Event|0|||
155244211|NCT03483623|560326371|FG000|Overall Study|43 complete sets achieved|1|||
155244212|NCT01165281|560326372|FG000|Overall Study|Adverse Event|12|||
155244213|NCT01165281|560326373|FG001|Overall Study|Adverse Event|14|||
155244214|NCT01165281|560326372|FG000|Overall Study|Death|3|||
155244215|NCT01165281|560326373|FG001|Overall Study|Death|4|||
155244216|NCT01165281|560326372|FG000|Overall Study|Lack of Efficacy|4|||
155244217|NCT01165281|560326373|FG001|Overall Study|Lack of Efficacy|1|||
155244218|NCT01165281|560326372|FG000|Overall Study|Lost to Follow-up|0|||
155244219|NCT01165281|560326373|FG001|Overall Study|Lost to Follow-up|1|||
155244220|NCT01165281|560326372|FG000|Overall Study|Physician Decision|8|||
155244221|NCT01165281|560326373|FG001|Overall Study|Physician Decision|1|||
155244222|NCT01165281|560326372|FG000|Overall Study|Protocol Violation|6|||
155244223|NCT01165281|560326373|FG001|Overall Study|Protocol Violation|5|||
155244224|NCT01165281|560326372|FG000|Overall Study|Withdrawal by Subject|8|||
155244225|NCT01165281|560326373|FG001|Overall Study|Withdrawal by Subject|7|||
155244226|NCT01165281|560326372|FG000|Overall Study|Noncompliance with Study Drug|1|||
155244227|NCT01165281|560326373|FG001|Overall Study|Noncompliance with Study Drug|4|||
155244228|NCT01165281|560326372|FG000|Overall Study|Progressive Disease|10|||
155244229|NCT01165281|560326373|FG001|Overall Study|Progressive Disease|14|||
155244230|NCT01165281|560326372|FG000|Overall Study|Other|6|||
155244231|NCT01165281|560326373|FG001|Overall Study|Other|0|||
155244232|NCT02863991|560326374|FG000|Overall Study|Death|0|||
155244233|NCT02863991|560326375|FG001|Overall Study|Death|3|||
155244234|NCT02863991|560326374|FG000|Overall Study|Lack of Efficacy|0|||
155244235|NCT02863991|560326375|FG001|Overall Study|Lack of Efficacy|1|||
155244236|NCT02863991|560326374|FG000|Overall Study|Study Terminated|2|||
155244237|NCT02863991|560326375|FG001|Overall Study|Study Terminated|8|||
155244238|NCT00364858|560326380|FG000|Overall Study|Adverse Event|1|||
155244239|NCT00364858|560326381|FG001|Overall Study|Adverse Event|5|||
155244240|NCT00364858|560326380|FG000|Overall Study|Withdrawal by Subject|1|||
155244241|NCT00364858|560326381|FG001|Overall Study|Withdrawal by Subject|1|||
155244242|NCT00364858|560326380|FG000|Overall Study|Pregnancy|1|||
155244243|NCT00364858|560326381|FG001|Overall Study|Pregnancy|1|||
155244244|NCT00364858|560326380|FG000|Overall Study|Clinical failure|2|||
155244245|NCT00364858|560326381|FG001|Overall Study|Clinical failure|13|||
155244246|NCT00364858|560326380|FG000|Overall Study|Discontinuation at baseline|1|||
155244247|NCT00364858|560326381|FG001|Overall Study|Discontinuation at baseline|0|||
155244248|NCT00364858|560326380|FG000|Overall Study|Non-compliant|1|||
155244249|NCT00364858|560326381|FG001|Overall Study|Non-compliant|0|||
155244250|NCT00364858|560326380|FG000|Overall Study|Return to Q2 regimen|0|||
155244251|NCT00364858|560326381|FG001|Overall Study|Return to Q2 regimen|1|||
155244252|NCT00364858|560326380|FG000|Overall Study|Clinical baseline issue|0|||
155244253|NCT00364858|560326381|FG001|Overall Study|Clinical baseline issue|1|||
155244254|NCT00363766|560326382|FG000|Overall Study|Progressive Disease|15|||
155244255|NCT00363766|560326383|FG001|Overall Study|Progressive Disease|9|||
155244256|NCT00363766|560326382|FG000|Overall Study|Adverse Event|10|||
155244257|NCT00363766|560326383|FG001|Overall Study|Adverse Event|2|||
155244258|NCT00363766|560326382|FG000|Overall Study|Disease Related Death|1|||
155244259|NCT00363766|560326383|FG001|Overall Study|Disease Related Death|3|||
155244260|NCT00363766|560326382|FG000|Overall Study|Not Disease Related Death|3|||
155244261|NCT00363766|560326383|FG001|Overall Study|Not Disease Related Death|4|||
155244262|NCT00363766|560326382|FG000|Overall Study|Withdrawal by Subject|2|||
155244263|NCT00363766|560326383|FG001|Overall Study|Withdrawal by Subject|0|||
155244264|NCT00363766|560326382|FG000|Overall Study|Physician Decision|1|||
155244265|NCT00363766|560326383|FG001|Overall Study|Physician Decision|2|||
155244266|NCT02345512|560326387|FG000|Overall Study|Adverse Event|1|||
155244267|NCT02345512|560326387|FG000|Overall Study|Withdrawal by Subject|1|||
155244268|NCT02121847|560326388|FG000|Overall Study|Administrative Reasons|1|||
155244269|NCT02121847|560326388|FG000|Overall Study|Adverse Event|2|||
155244270|NCT01660906|560326389|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
155244271|NCT03478891|560326395|FG000|Overall Study|Enrolled, but product never administered|0|||
155244272|NCT03478891|560326396|FG001|Overall Study|Enrolled, but product never administered|0|||
155244273|NCT03478891|560326397|FG002|Overall Study|Enrolled, but product never administered|1|||
155244274|NCT03478891|560326395|FG000|Overall Study|Moved from area|0|||
155244275|NCT03478891|560326396|FG001|Overall Study|Moved from area|0|||
155244276|NCT03478891|560326397|FG002|Overall Study|Moved from area|1|||
155244277|NCT03478891|560326395|FG000|Overall Study|Lost to Follow-up|1|||
155244278|NCT03478891|560326396|FG001|Overall Study|Lost to Follow-up|0|||
155244279|NCT03478891|560326397|FG002|Overall Study|Lost to Follow-up|1|||
155244280|NCT03864614|560326402|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
155244281|NCT03864614|560326403|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
155244282|NCT03864614|560326404|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
155244283|NCT03864614|560326405|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
155244284|NCT03864614|560326402|FG000|Overall Study|Withdrawal by Subject|72|||
155244285|NCT03864614|560326403|FG001|Overall Study|Withdrawal by Subject|100|||
155244286|NCT03864614|560326404|FG002|Overall Study|Withdrawal by Subject|1|||
155244287|NCT03864614|560326405|FG003|Overall Study|Withdrawal by Subject|21|||
155244288|NCT03864614|560326402|FG000|Overall Study|Lost to Follow-up|45|||
155244289|NCT03864614|560326403|FG001|Overall Study|Lost to Follow-up|54|||
155244290|NCT03864614|560326404|FG002|Overall Study|Lost to Follow-up|0|||
155244291|NCT03864614|560326405|FG003|Overall Study|Lost to Follow-up|9|||
155244292|NCT03864614|560326402|FG000|Overall Study|Adverse Event|42|||
155244293|NCT03864614|560326403|FG001|Overall Study|Adverse Event|30|||
155244294|NCT03864614|560326404|FG002|Overall Study|Adverse Event|1|||
155244295|NCT03864614|560326405|FG003|Overall Study|Adverse Event|9|||
155244296|NCT03864614|560326402|FG000|Overall Study|Protocol Deviation|6|||
155244297|NCT03864614|560326403|FG001|Overall Study|Protocol Deviation|26|||
155244298|NCT03864614|560326404|FG002|Overall Study|Protocol Deviation|0|||
155244299|NCT03864614|560326405|FG003|Overall Study|Protocol Deviation|1|||
155244300|NCT03864614|560326402|FG000|Overall Study|Physician Decision|7|||
155244301|NCT03864614|560326403|FG001|Overall Study|Physician Decision|10|||
155244302|NCT03864614|560326404|FG002|Overall Study|Physician Decision|1|||
155244303|NCT03864614|560326405|FG003|Overall Study|Physician Decision|5|||
155244304|NCT03864614|560326402|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
155244305|NCT03864614|560326403|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
155244306|NCT03864614|560326404|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
155244307|NCT03864614|560326405|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
155244308|NCT03864614|560326402|FG000|Overall Study|Sponsor Decision|1|||
155244309|NCT03864614|560326403|FG001|Overall Study|Sponsor Decision|2|||
155244310|NCT03864614|560326404|FG002|Overall Study|Sponsor Decision|0|||
155244311|NCT03864614|560326405|FG003|Overall Study|Sponsor Decision|0|||
155244312|NCT03864614|560326402|FG000|Overall Study|Pregnancy|0|||
155244313|NCT03864614|560326403|FG001|Overall Study|Pregnancy|1|||
155244314|NCT03864614|560326404|FG002|Overall Study|Pregnancy|0|||
155244315|NCT03864614|560326405|FG003|Overall Study|Pregnancy|0|||
155244316|NCT03864614|560326402|FG000|Overall Study|Other|7|||
155244317|NCT03864614|560326403|FG001|Overall Study|Other|9|||
155244318|NCT03864614|560326404|FG002|Overall Study|Other|1|||
155244319|NCT03864614|560326405|FG003|Overall Study|Other|4|||
155244320|NCT03864614|560326402|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
155244321|NCT03864614|560326403|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
155244322|NCT03864614|560326404|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
155244323|NCT03864614|560326405|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
155244324|NCT01850004|560326406|FG000|Overall Study|Poor/Non-compliance|1|||
155244325|NCT01850004|560326406|FG000|Overall Study|Participant Withdrew Consent|9|||
155244326|NCT01850004|560326406|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
155244327|NCT01850004|560326406|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
155244328|NCT01850004|560326406|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
155244329|NCT01850004|560326406|FG000|Overall Study|Other Reasons|2|||
155244330|NCT01850004|560326406|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
155244331|NCT01850004|560326406|FG000|Overall Study|Maximum Clinical Benefit|4|||
155244332|NCT04827576|560328616|FG000|Overall Study|Death|5|||
155244333|NCT04827576|560328617|FG001|Overall Study|Death|17|||
155244334|NCT04827576|560328618|FG002|Overall Study|Death|17|||
155244335|NCT04827576|560328619|FG003|Overall Study|Death|32|||
155244336|NCT04827576|560328616|FG000|Overall Study|Study Terminated by Sponsor|2|||
155244337|NCT04827576|560328617|FG001|Overall Study|Study Terminated by Sponsor|9|||
155244338|NCT04827576|560328618|FG002|Overall Study|Study Terminated by Sponsor|7|||
155244339|NCT04827576|560328619|FG003|Overall Study|Study Terminated by Sponsor|5|||
155244340|NCT04827576|560328616|FG000|Overall Study|Investigator's Discretion|1|||
155244341|NCT04827576|560328617|FG001|Overall Study|Investigator's Discretion|0|||
155244342|NCT04827576|560328618|FG002|Overall Study|Investigator's Discretion|2|||
155244343|NCT04827576|560328619|FG003|Overall Study|Investigator's Discretion|5|||
155244344|NCT04827576|560328616|FG000|Overall Study|Withdrew Consent|0|||
155244345|NCT04827576|560328617|FG001|Overall Study|Withdrew Consent|3|||
155244346|NCT04827576|560328618|FG002|Overall Study|Withdrew Consent|0|||
155244347|NCT04827576|560328619|FG003|Overall Study|Withdrew Consent|0|||
155244348|NCT04827576|560328616|FG000|Overall Study|Lost to Follow-up|1|||
155244349|NCT04827576|560328617|FG001|Overall Study|Lost to Follow-up|0|||
155244350|NCT04827576|560328618|FG002|Overall Study|Lost to Follow-up|0|||
155244351|NCT04827576|560328619|FG003|Overall Study|Lost to Follow-up|0|||
155244352|NCT04295564|560328620|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
155244353|NCT04295564|560328621|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
155244354|NCT04537923|560328622|FG000|Overall Study|Adverse Event|2|||
155244355|NCT04537923|560328623|FG001|Overall Study|Adverse Event|1|||
155244356|NCT04537923|560328624|FG002|Overall Study|Adverse Event|2|||
155244357|NCT04537923|560328625|FG003|Overall Study|Adverse Event|4|||
155244358|NCT04537923|560328622|FG000|Overall Study|Death|3|||
155244359|NCT04537923|560328623|FG001|Overall Study|Death|3|||
155244360|NCT04537923|560328624|FG002|Overall Study|Death|1|||
155244361|NCT04537923|560328625|FG003|Overall Study|Death|11|||
155244362|NCT04537923|560328622|FG000|Overall Study|Lost to Follow-up|1|||
155244363|NCT04537923|560328623|FG001|Overall Study|Lost to Follow-up|2|||
155244364|NCT04537923|560328624|FG002|Overall Study|Lost to Follow-up|1|||
155244365|NCT04537923|560328625|FG003|Overall Study|Lost to Follow-up|6|||
155244366|NCT04537923|560328622|FG000|Overall Study|Physician Decision|1|||
155244367|NCT04537923|560328623|FG001|Overall Study|Physician Decision|0|||
155244368|NCT04537923|560328624|FG002|Overall Study|Physician Decision|2|||
155244369|NCT04537923|560328625|FG003|Overall Study|Physician Decision|5|||
155244370|NCT04537923|560328622|FG000|Overall Study|Pregnancy|1|||
155244371|NCT04537923|560328623|FG001|Overall Study|Pregnancy|0|||
155244372|NCT04537923|560328624|FG002|Overall Study|Pregnancy|0|||
155244373|NCT04537923|560328625|FG003|Overall Study|Pregnancy|0|||
155244374|NCT04537923|560328622|FG000|Overall Study|Withdrawal by Subject|4|||
155244375|NCT04537923|560328623|FG001|Overall Study|Withdrawal by Subject|4|||
155244376|NCT04537923|560328624|FG002|Overall Study|Withdrawal by Subject|4|||
155244377|NCT04537923|560328625|FG003|Overall Study|Withdrawal by Subject|58|||
155244378|NCT04537923|560328622|FG000|Overall Study|Missed study visits|2|||
155244379|NCT04537923|560328623|FG001|Overall Study|Missed study visits|0|||
155244380|NCT04537923|560328624|FG002|Overall Study|Missed study visits|0|||
155244381|NCT04537923|560328625|FG003|Overall Study|Missed study visits|3|||
155244382|NCT04537923|560328622|FG000|Overall Study|Sponsor's decision|0|||
155244383|NCT04537923|560328623|FG001|Overall Study|Sponsor's decision|0|||
155244384|NCT04537923|560328624|FG002|Overall Study|Sponsor's decision|1|||
155244385|NCT04537923|560328625|FG003|Overall Study|Sponsor's decision|1|||
155244386|NCT04537923|560328622|FG000|Overall Study|Safety reasons|1|||
155244387|NCT04537923|560328623|FG001|Overall Study|Safety reasons|0|||
155244388|NCT04537923|560328624|FG002|Overall Study|Safety reasons|0|||
155244389|NCT04537923|560328625|FG003|Overall Study|Safety reasons|0|||
155244390|NCT01261611|560328626|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
155244391|NCT01261611|560328627|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
155244392|NCT01261611|560328628|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
155244393|NCT01261611|560328626|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
155244394|NCT01261611|560328627|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
155244395|NCT01261611|560328628|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
155244396|NCT01261611|560328626|FG000|Treatment Cycle 1|Adverse Event|0|||
155244397|NCT01261611|560328627|FG001|Treatment Cycle 1|Adverse Event|1|||
155244398|NCT01261611|560328628|FG002|Treatment Cycle 1|Adverse Event|0|||
155244399|NCT01261611|560328626|FG000|Treatment Cycle 1|Protocol Violation|0|||
155244400|NCT01261611|560328627|FG001|Treatment Cycle 1|Protocol Violation|0|||
155244401|NCT01261611|560328628|FG002|Treatment Cycle 1|Protocol Violation|2|||
155244402|NCT01261611|560328626|FG000|Treatment Cycle 2|Completed study|4|||
155244403|NCT01261611|560328627|FG001|Treatment Cycle 2|Completed study|0|||
155244404|NCT01261611|560328628|FG002|Treatment Cycle 2|Completed study|0|||
155244405|NCT01261611|560328626|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
155244406|NCT01261611|560328627|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
155244407|NCT01261611|560328628|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
155244408|NCT01261611|560328626|FG000|Treatment Cycle 2|Adverse Event|1|||
155244409|NCT01261611|560328627|FG001|Treatment Cycle 2|Adverse Event|0|||
155244410|NCT01261611|560328628|FG002|Treatment Cycle 2|Adverse Event|0|||
155244411|NCT01261611|560328626|FG000|Treatment Cycle 2|Protocol Violation|2|||
155244412|NCT01261611|560328627|FG001|Treatment Cycle 2|Protocol Violation|0|||
155244413|NCT01261611|560328628|FG002|Treatment Cycle 2|Protocol Violation|0|||
155244414|NCT01261611|560328626|FG000|Treatment Cycle 2|Not otherwise specified|2|||
155244415|NCT01261611|560328627|FG001|Treatment Cycle 2|Not otherwise specified|0|||
155244416|NCT01261611|560328628|FG002|Treatment Cycle 2|Not otherwise specified|0|||
155244417|NCT01261611|560328626|FG000|Treatment Cycle 3|Completed study|24|||
155244418|NCT01261611|560328627|FG001|Treatment Cycle 3|Completed study|0|||
155244419|NCT01261611|560328628|FG002|Treatment Cycle 3|Completed study|0|||
155244420|NCT01261611|560328626|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
155244421|NCT01261611|560328627|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
155244422|NCT01261611|560328628|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
155244423|NCT01261611|560328626|FG000|Treatment Cycle 3|Adverse Event|1|||
155244424|NCT01261611|560328627|FG001|Treatment Cycle 3|Adverse Event|0|||
155244425|NCT01261611|560328628|FG002|Treatment Cycle 3|Adverse Event|0|||
155244426|NCT01261611|560328626|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
155244427|NCT01261611|560328627|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
155244428|NCT01261611|560328628|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
155244429|NCT01261611|560328626|FG000|Treatment Cycle 4|Completed study|87|||
155244430|NCT01261611|560328627|FG001|Treatment Cycle 4|Completed study|0|||
155244431|NCT01261611|560328628|FG002|Treatment Cycle 4|Completed study|0|||
155244432|NCT01261611|560328626|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
155244433|NCT01261611|560328627|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
155244434|NCT01261611|560328628|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
155244435|NCT01261611|560328626|FG000|Treatment Cycle 4|Adverse Event|1|||
155244436|NCT01261611|560328627|FG001|Treatment Cycle 4|Adverse Event|0|||
155244437|NCT01261611|560328628|FG002|Treatment Cycle 4|Adverse Event|0|||
155244438|NCT01261611|560328626|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
155244439|NCT01261611|560328627|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
155244440|NCT01261611|560328628|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
155244441|NCT01261611|560328626|FG000|Treatment Cycle 4|Not otherwise specified|3|||
155244442|NCT01261611|560328627|FG001|Treatment Cycle 4|Not otherwise specified|0|||
155244443|NCT01261611|560328628|FG002|Treatment Cycle 4|Not otherwise specified|0|||
155244444|NCT01261611|560328626|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
155244445|NCT01261611|560328627|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
155244446|NCT01261611|560328628|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
155244447|NCT01261611|560328626|FG000|Treatment Cycle 5|Adverse Event|1|||
155244448|NCT01261611|560328627|FG001|Treatment Cycle 5|Adverse Event|0|||
155244449|NCT01261611|560328628|FG002|Treatment Cycle 5|Adverse Event|0|||
155244450|NCT01261611|560328626|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
155244451|NCT01261611|560328627|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
155244452|NCT01261611|560328628|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
155244453|NCT02527798|560328629|FG000|Overall Study|Physician Decision|1|||
155244454|NCT02527798|560328630|FG001|Overall Study|Physician Decision|0|||
155244455|NCT02527798|560328631|FG002|Overall Study|Physician Decision|1|||
155244456|NCT02527798|560328632|FG003|Overall Study|Physician Decision|1|||
155244457|NCT02527798|560328633|FG004|Overall Study|Physician Decision|0|||
155244458|NCT02527798|560328634|FG005|Overall Study|Physician Decision|0|||
155244459|NCT02527798|560328629|FG000|Overall Study|Death|0|||
155244460|NCT02527798|560328630|FG001|Overall Study|Death|0|||
155244461|NCT02527798|560328631|FG002|Overall Study|Death|1|||
155244462|NCT02527798|560328632|FG003|Overall Study|Death|0|||
155244463|NCT02527798|560328633|FG004|Overall Study|Death|0|||
155244464|NCT02527798|560328634|FG005|Overall Study|Death|0|||
155244465|NCT02527798|560328629|FG000|Overall Study|Withdrawal by Subject|0|||
155244466|NCT02527798|560328630|FG001|Overall Study|Withdrawal by Subject|1|||
155244467|NCT02527798|560328631|FG002|Overall Study|Withdrawal by Subject|2|||
155244468|NCT02527798|560328632|FG003|Overall Study|Withdrawal by Subject|0|||
155244469|NCT02527798|560328633|FG004|Overall Study|Withdrawal by Subject|0|||
155244470|NCT02527798|560328634|FG005|Overall Study|Withdrawal by Subject|0|||
155244471|NCT02527798|560328629|FG000|Overall Study|Reason undisclosed|1|||
155244472|NCT02527798|560328630|FG001|Overall Study|Reason undisclosed|0|||
155244473|NCT02527798|560328631|FG002|Overall Study|Reason undisclosed|1|||
155244474|NCT02527798|560328632|FG003|Overall Study|Reason undisclosed|0|||
155244475|NCT02527798|560328633|FG004|Overall Study|Reason undisclosed|0|||
155244476|NCT02527798|560328634|FG005|Overall Study|Reason undisclosed|0|||
155244477|NCT02527798|560328629|FG000|Overall Study|Did not receive intervention|1|||
155244478|NCT02527798|560328630|FG001|Overall Study|Did not receive intervention|1|||
155244479|NCT02527798|560328631|FG002|Overall Study|Did not receive intervention|0|||
155244480|NCT02527798|560328632|FG003|Overall Study|Did not receive intervention|0|||
155244481|NCT02527798|560328633|FG004|Overall Study|Did not receive intervention|0|||
155244482|NCT02527798|560328634|FG005|Overall Study|Did not receive intervention|0|||
155244483|NCT01808690|560328636|FG000|Overall Study|Withdrawal by Subject|1|||
155244484|NCT01808690|560328637|FG001|Overall Study|Withdrawal by Subject|2|||
155244485|NCT02395120|560328638|FG000|Overall Study|Missed follow-up dental exam|57|||
155244486|NCT02395120|560328639|FG001|Overall Study|Missed follow-up dental exam|62|||
155244487|NCT02395120|560328640|FG002|Overall Study|Missed follow-up dental exam|6|||
155244488|NCT02395120|560328641|FG003|Overall Study|Missed follow-up dental exam|6|||
155244489|NCT02395120|560328642|FG004|Overall Study|Missed follow-up dental exam|51|||
155244490|NCT01275625|560328643|FG000|Overall Study|Death|1|||
155244491|NCT01275625|560328643|FG000|Overall Study|Lack of Efficacy|2|||
155244492|NCT01275625|560328643|FG000|Overall Study|Lost to Follow-up|1|||
155244493|NCT01275625|560328643|FG000|Overall Study|Withdrawal by Subject|3|||
155244494|NCT01275625|560328643|FG000|Overall Study|Protocol Violation|1|||
155244495|NCT01275625|560328643|FG000|Overall Study|Adverse Event|4|||
155244496|NCT01275625|560328643|FG000|Overall Study|Other|1|||
155244497|NCT05732454|560328645|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
155244498|NCT05732454|560328646|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
155244499|NCT05732454|560328645|FG000|Part 1: DB Period|Adverse Event|1|||
155244500|NCT05732454|560328646|FG001|Part 1: DB Period|Adverse Event|0|||
155244501|NCT05732454|560328645|FG000|Part 1: DB Period|Lost to Follow-up|1|||
155244502|NCT05732454|560328646|FG001|Part 1: DB Period|Lost to Follow-up|0|||
155244503|NCT05732454|560328645|FG000|Part 1: DB Period|Protocol Violation|0|||
155244504|NCT05732454|560328646|FG001|Part 1: DB Period|Protocol Violation|1|||
155244505|NCT05732454|560328645|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
155244506|NCT05732454|560328646|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
155244507|NCT05732454|560328645|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
155244508|NCT05732454|560328646|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
155244509|NCT05732454|560328645|FG000|Part 1: OLE Period|Adverse Event|0|||
155244510|NCT05732454|560328646|FG001|Part 1: OLE Period|Adverse Event|1|||
155244511|NCT05732454|560328645|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
155244512|NCT05732454|560328646|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
155244513|NCT01153633|560328647|FG000|Overall Study|Protocol Violation|1|||
155244514|NCT01153633|560328648|FG001|Overall Study|Protocol Violation|1|||
155244515|NCT01153633|560328647|FG000|Overall Study|Therapeutic failure|3|||
155244516|NCT01153633|560328648|FG001|Overall Study|Therapeutic failure|3|||
155244517|NCT03725982|560328651|FG000|First Intervention|Withdrawal by Subject|0|||
155244518|NCT03725982|560328652|FG001|First Intervention|Withdrawal by Subject|1|||
155244519|NCT03725982|560328651|FG000|First Intervention|Physician Decision|1|||
155244520|NCT03725982|560328652|FG001|First Intervention|Physician Decision|1|||
155244521|NCT01262651|560328655|FG000|Overall Study|Adverse Event|40|||
155244522|NCT01262651|560328656|FG001|Overall Study|Adverse Event|35|||
155244523|NCT01262651|560328655|FG000|Overall Study|Withdrawal by Subject|15|||
155244524|NCT01262651|560328656|FG001|Overall Study|Withdrawal by Subject|11|||
155244525|NCT01262651|560328655|FG000|Overall Study|Withdrawal by Investigator|2|||
155244526|NCT01262651|560328656|FG001|Overall Study|Withdrawal by Investigator|2|||
155244527|NCT01262651|560328655|FG000|Overall Study|Met Withdrawal Criteria|1|||
155244528|NCT01262651|560328656|FG001|Overall Study|Met Withdrawal Criteria|0|||
155244529|NCT02239679|560328663|FG000|Overall Study|Lost to Follow-up|1|||
155244530|NCT02239679|560328664|FG001|Overall Study|Lost to Follow-up|0|||
155244531|NCT02239679|560328665|FG002|Overall Study|Lost to Follow-up|0|||
155244532|NCT02239679|560328663|FG000|Overall Study|Withdrawal by Subject|2|||
155244533|NCT02239679|560328664|FG001|Overall Study|Withdrawal by Subject|3|||
155244534|NCT02239679|560328665|FG002|Overall Study|Withdrawal by Subject|1|||
155244535|NCT01517802|560328666|FG000|Overall Study|Death|1|||
155244536|NCT02605954|560328670|FG000|Overall Study|Adverse Event|5|||
155244537|NCT02605954|560328671|FG001|Overall Study|Adverse Event|1|||
155244538|NCT02605954|560328670|FG000|Overall Study|Investigator's Discretion|1|||
155244539|NCT02605954|560328671|FG001|Overall Study|Investigator's Discretion|0|||
155244540|NCT02605954|560328670|FG000|Overall Study|Non-Compliance with Study Drug|1|||
155244541|NCT02605954|560328671|FG001|Overall Study|Non-Compliance with Study Drug|0|||
155244542|NCT02605954|560328670|FG000|Overall Study|Withdrew Consent|2|||
155244543|NCT02605954|560328671|FG001|Overall Study|Withdrew Consent|2|||
155244544|NCT02605954|560328670|FG000|Overall Study|Lost to Follow-up|3|||
155244545|NCT02605954|560328671|FG001|Overall Study|Lost to Follow-up|0|||
155244546|NCT02605954|560328670|FG000|Overall Study|Randomized but not treated|0|||
155244547|NCT02605954|560328671|FG001|Overall Study|Randomized but not treated|1|||
155244548|NCT00093145|560328672|FG000|Overall Study|Unacceptable Toxicity Only|2|||
155244549|NCT00093145|560328672|FG000|Overall Study|Physician Decision|5|||
155244550|NCT00093145|560328672|FG000|Overall Study|Withdrawal by Subject|9|||
155244551|NCT00093145|560328672|FG000|Overall Study|Other|1|||
155244552|NCT01310036|560328673|FG000|Overall Study|Administrative/other|10|||
155244553|NCT01310036|560328673|FG000|Overall Study|Withdrew Consent|11|||
155244554|NCT01310036|560328673|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
155244555|NCT01310036|560328673|FG000|Overall Study|Progression of Disease|164|||
155244556|NCT01310036|560328673|FG000|Overall Study|Death|1|||
155244557|NCT01310036|560328673|FG000|Overall Study|Adverse event or intercurrent illness|12|||
155244558|NCT01175668|560328674|FG000|Overall Study|Withdrawal by Subject|2|||
155244559|NCT01175668|560328675|FG001|Overall Study|Withdrawal by Subject|0|||
155244560|NCT00709722|560328676|FG000|Overall Study|Adverse Event|1|||
155244561|NCT03359096|560328677|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
155244562|NCT03359096|560328678|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
155244563|NCT03359096|560328677|FG000|First Intervention (4 Weeks)|Death|1|||
155244564|NCT03359096|560328678|FG001|First Intervention (4 Weeks)|Death|0|||
155244565|NCT03359096|560328677|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
155244566|NCT03359096|560328678|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
155244567|NCT04433767|560328679|FG000|Overall Study|Adverse Event|1|||
155244568|NCT03538626|560328685|FG000|Overall Study|Withdrawal by Subject|0|||
155244569|NCT03538626|560328686|FG001|Overall Study|Withdrawal by Subject|1|||
155244570|NCT03538626|560328687|FG002|Overall Study|Withdrawal by Subject|0|||
155244571|NCT03538626|560328688|FG003|Overall Study|Withdrawal by Subject|0|||
155244572|NCT03538626|560328689|FG004|Overall Study|Withdrawal by Subject|0|||
155244573|NCT03538626|560328690|FG005|Overall Study|Withdrawal by Subject|0|||
155244574|NCT03538626|560328691|FG006|Overall Study|Withdrawal by Subject|0|||
155244575|NCT03538626|560328692|FG007|Overall Study|Withdrawal by Subject|0|||
155244576|NCT03538626|560328685|FG000|Overall Study|Lost to Follow-up|0|||
155244577|NCT03538626|560328686|FG001|Overall Study|Lost to Follow-up|0|||
155244578|NCT03538626|560328687|FG002|Overall Study|Lost to Follow-up|0|||
155244579|NCT03538626|560328688|FG003|Overall Study|Lost to Follow-up|0|||
155244580|NCT03538626|560328689|FG004|Overall Study|Lost to Follow-up|0|||
155244581|NCT03538626|560328690|FG005|Overall Study|Lost to Follow-up|0|||
155244582|NCT03538626|560328691|FG006|Overall Study|Lost to Follow-up|1|||
155244583|NCT03538626|560328692|FG007|Overall Study|Lost to Follow-up|0|||
155244584|NCT01434602|560328697|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244585|NCT01434602|560328698|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
155244586|NCT01434602|560328699|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244587|NCT01434602|560328700|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244588|NCT01434602|560328701|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
155244589|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244590|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244591|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244592|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
155244593|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
155244594|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244595|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244596|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244597|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
155244598|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
155244599|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244600|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244601|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244602|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
155244603|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
155244604|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244605|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244606|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244607|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
155244608|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
155244609|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244610|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244611|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244612|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
155244613|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
155244614|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244615|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244616|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244617|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
155244618|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
155244619|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
155244620|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
155244621|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
155244622|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
155244623|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
155244624|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244625|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244626|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244627|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
155244628|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
155244629|NCT01434602|560328697|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244630|NCT01434602|560328698|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244631|NCT01434602|560328699|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244632|NCT01434602|560328700|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
155244633|NCT01434602|560328701|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
155244634|NCT02232893|560328703|FG000|Overall Study|Withdrawal by Subject|4|||
155244635|NCT02232893|560328704|FG001|Overall Study|Withdrawal by Subject|1|||
155244636|NCT02232893|560328703|FG000|Overall Study|Adverse Event|0|||
155244637|NCT02232893|560328704|FG001|Overall Study|Adverse Event|1|||
155244638|NCT02232893|560328703|FG000|Overall Study|Sponsor request early termination|0|||
155244639|NCT02232893|560328704|FG001|Overall Study|Sponsor request early termination|1|||
155244640|NCT02232893|560328703|FG000|Overall Study|Developed exclusion criteria|0|||
155244641|NCT02232893|560328704|FG001|Overall Study|Developed exclusion criteria|1|||
155244642|NCT02232893|560328703|FG000|Overall Study|Other|0|||
155244643|NCT02232893|560328704|FG001|Overall Study|Other|3|||
155244644|NCT01764945|560328709|FG000|Overall Study|Adverse Event|0|||
155244645|NCT01764945|560328710|FG001|Overall Study|Adverse Event|1|||
155244646|NCT01764945|560328711|FG002|Overall Study|Adverse Event|0|||
155244647|NCT01764945|560328712|FG003|Overall Study|Adverse Event|0|||
155244648|NCT01764945|560328713|FG004|Overall Study|Adverse Event|0|||
155244649|NCT01764945|560328714|FG005|Overall Study|Adverse Event|0|||
155244650|NCT01764945|560328715|FG006|Overall Study|Adverse Event|1|||
155244651|NCT01764945|560328716|FG007|Overall Study|Adverse Event|0|||
155244652|NCT05077267|560328719|FG000|Treatment Period|Lost to Follow-up|0|||
155244653|NCT05077267|560328720|FG001|Treatment Period|Lost to Follow-up|1|||
155244654|NCT05077267|560328721|FG002|Treatment Period|Lost to Follow-up|0|||
155244655|NCT05077267|560328719|FG000|Treatment Period|Withdrawal by Subject|0|||
155244656|NCT05077267|560328720|FG001|Treatment Period|Withdrawal by Subject|1|||
155244657|NCT05077267|560328721|FG002|Treatment Period|Withdrawal by Subject|0|||
155244658|NCT05077267|560328719|FG000|Follow-up Period|Lost to Follow-up|0|||
155244659|NCT05077267|560328720|FG001|Follow-up Period|Lost to Follow-up|5|||
155244660|NCT05077267|560328721|FG002|Follow-up Period|Lost to Follow-up|7|||
155244661|NCT05077267|560328719|FG000|Follow-up Period|Withdrawal by Subject|0|||
155244662|NCT05077267|560328720|FG001|Follow-up Period|Withdrawal by Subject|2|||
155244663|NCT05077267|560328721|FG002|Follow-up Period|Withdrawal by Subject|5|||
155244664|NCT05077267|560328719|FG000|Follow-up Period|Study terminated by sponsor|0|||
155244665|NCT05077267|560328720|FG001|Follow-up Period|Study terminated by sponsor|27|||
155244666|NCT05077267|560328721|FG002|Follow-up Period|Study terminated by sponsor|23|||
155244667|NCT05077267|560328719|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
155244668|NCT05077267|560328720|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
155244669|NCT05077267|560328721|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
155244670|NCT05077267|560328719|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
155244671|NCT05077267|560328720|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
155244672|NCT05077267|560328721|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
155244673|NCT02911948|560328722|FG000|Overall Study|Protocol Violation|0|||
155244674|NCT02911948|560328723|FG001|Overall Study|Protocol Violation|1|||
155244675|NCT02911948|560328722|FG000|Overall Study|Withdrawal by Subject|0|||
155244676|NCT02911948|560328723|FG001|Overall Study|Withdrawal by Subject|2|||
155244677|NCT02911948|560328722|FG000|Overall Study|Lack of Efficacy|0|||
155244678|NCT02911948|560328723|FG001|Overall Study|Lack of Efficacy|1|||
155244679|NCT02911948|560328722|FG000|Overall Study|Unclassified|0|||
155244680|NCT02911948|560328723|FG001|Overall Study|Unclassified|3|||
155244681|NCT03864900|560328732|FG000|Overall Study|Withdrawal by Subject|1|||
155244682|NCT03864900|560328733|FG001|Overall Study|Withdrawal by Subject|1|||
155244683|NCT03864900|560328732|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
155244684|NCT03864900|560328733|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
155244685|NCT03165045|560328734|FG000|Visit 1|No registration after visit 1|9|||
155244686|NCT03165045|560328734|FG000|Visit 1|No treatment documented|10|||
155244687|NCT03165045|560328734|FG000|Visit 1|No visit 1|10|||
155244688|NCT03165045|560328734|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
155244689|NCT03165045|560328734|FG000|Visit 2|No available total CCQ score at all|29|||
155244690|NCT03165045|560328734|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
155244691|NCT02308033|560328735|FG000|Overall Study|Normal Gram stain at Baseline|13|||
155244692|NCT02308033|560328736|FG001|Overall Study|Normal Gram stain at Baseline|10|||
155244693|NCT02308033|560328735|FG000|Overall Study|Positive for STD at Baseline|7|||
155244694|NCT02308033|560328736|FG001|Overall Study|Positive for STD at Baseline|4|||
155244695|NCT02308033|560328735|FG000|Overall Study|Lost to Follow-up|6|||
155244696|NCT02308033|560328736|FG001|Overall Study|Lost to Follow-up|5|||
155244697|NCT00759109|560328737|FG000|Overall Study|Adverse Event|17|||
155244698|NCT00759109|560328738|FG001|Overall Study|Adverse Event|12|||
155244699|NCT00759109|560328737|FG000|Overall Study|Inability to comply|1|||
155244700|NCT00759109|560328738|FG001|Overall Study|Inability to comply|1|||
155244701|NCT00759109|560328737|FG000|Overall Study|Withdrawal by Subject|9|||
155244702|NCT00759109|560328738|FG001|Overall Study|Withdrawal by Subject|5|||
155244703|NCT00759109|560328737|FG000|Overall Study|Death|4|||
155244704|NCT00759109|560328738|FG001|Overall Study|Death|3|||
155244705|NCT00759109|560328737|FG000|Overall Study|Lost to Follow-up|4|||
155244706|NCT00759109|560328738|FG001|Overall Study|Lost to Follow-up|6|||
155244707|NCT00759109|560328737|FG000|Overall Study|Started new therapy|2|||
155244708|NCT00759109|560328738|FG001|Overall Study|Started new therapy|6|||
155244709|NCT00759109|560328737|FG000|Overall Study|HCV RNA negative|1|||
155244710|NCT00759109|560328738|FG001|Overall Study|HCV RNA negative|0|||
155244711|NCT00759109|560328737|FG000|Overall Study|Participant moved to a different city|0|||
155244712|NCT00759109|560328738|FG001|Overall Study|Participant moved to a different city|1|||
155244713|NCT00759109|560328737|FG000|Overall Study|Participant had a liver transplant|0|||
155244714|NCT00759109|560328738|FG001|Overall Study|Participant had a liver transplant|1|||
155244715|NCT00759109|560328737|FG000|Overall Study|Lost during study|1|||
155244716|NCT00759109|560328738|FG001|Overall Study|Lost during study|0|||
155244717|NCT01827904|560328739|FG000|Main Study|Withdrawal by Subject|1|||
155244718|NCT01827904|560328740|FG001|Main Study|Withdrawal by Subject|0|||
155244719|NCT01827904|560328741|FG002|Main Study|Withdrawal by Subject|0|||
155244720|NCT01827904|560328739|FG000|Main Study|Adverse Event|1|||
155244721|NCT01827904|560328740|FG001|Main Study|Adverse Event|0|||
155244722|NCT01827904|560328741|FG002|Main Study|Adverse Event|0|||
155244723|NCT01827904|560328739|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
155244724|NCT01827904|560328740|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
155244725|NCT01827904|560328741|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
155244726|NCT01827904|560328739|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
155244727|NCT01827904|560328740|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
155244728|NCT01827904|560328741|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
155244729|NCT01827904|560328739|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
155244730|NCT01827904|560328740|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
155244731|NCT01827904|560328741|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
155244732|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
155244733|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
155244734|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
155244735|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
155244736|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
155244737|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
155244738|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
155244739|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
155244740|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
155244741|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
155244742|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
155244743|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
155244744|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Physician Decision|1|||
155244745|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Physician Decision|0|||
155244746|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Physician Decision|0|||
155244747|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
155244748|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
155244749|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
155244750|NCT01827904|560328739|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
155244751|NCT01827904|560328740|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
155244752|NCT01827904|560328741|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
155244753|NCT00142909|560328749|FG000|Randomization|Various Reasons|7|||
155244754|NCT00142909|560328750|FG001|Randomization|Various Reasons|10|||
155244755|NCT00142909|560328749|FG000|Medications Begin|Protocol Violation|2|||
155244756|NCT00142909|560328750|FG001|Medications Begin|Protocol Violation|0|||
155244757|NCT00142909|560328749|FG000|Medications Begin|Withdrawal by Subject|5|||
155244758|NCT00142909|560328750|FG001|Medications Begin|Withdrawal by Subject|3|||
155244759|NCT00142909|560328749|FG000|Medications Begin|Withdrawal by Subject|2|||
155244760|NCT00142909|560328750|FG001|Medications Begin|Withdrawal by Subject|0|||
155244761|NCT01660763|560328754|FG000|Overall Study|Lack of Efficacy|45|||
155244762|NCT01660763|560328755|FG001|Overall Study|Lack of Efficacy|50|||
155244763|NCT01660763|560328754|FG000|Overall Study|Adverse Event|22|||
155244764|NCT01660763|560328755|FG001|Overall Study|Adverse Event|7|||
155244765|NCT01660763|560328754|FG000|Overall Study|Protocol Violation|1|||
155244766|NCT01660763|560328755|FG001|Overall Study|Protocol Violation|0|||
155244767|NCT01660763|560328754|FG000|Overall Study|Withdrawal by Subject|4|||
155244768|NCT01660763|560328755|FG001|Overall Study|Withdrawal by Subject|0|||
155244769|NCT01660763|560328754|FG000|Overall Study|Patient ready for early discharge|28|||
155244770|NCT01660763|560328755|FG001|Overall Study|Patient ready for early discharge|4|||
155244771|NCT00345397|560328756|FG000|Overall Study|Death|1|||
155244772|NCT01870843|560328757|FG000|Overall Study|Adverse Event|10|||
155244773|NCT01870843|560328757|FG000|Overall Study|Lost to Follow-up|24|||
155244774|NCT01870843|560328757|FG000|Overall Study|Death|1|||
155244775|NCT01870843|560328757|FG000|Overall Study|Withdrawal by Subject|18|||
155244776|NCT01910519|560328758|FG000|Overall Study|Withdrawal by Subject|2|||
155244777|NCT01910519|560328759|FG001|Overall Study|Withdrawal by Subject|0|||
155244778|NCT01910519|560328758|FG000|Overall Study|Adverse Event|2|||
155244779|NCT01910519|560328759|FG001|Overall Study|Adverse Event|0|||
155244780|NCT04266028|560328760|FG000|Overall Study|Adverse Event|0|||
155244781|NCT04266028|560328761|FG001|Overall Study|Adverse Event|0|||
155244782|NCT04266028|560328762|FG002|Overall Study|Adverse Event|1|||
155244783|NCT04266028|560328763|FG003|Overall Study|Adverse Event|0|||
155244784|NCT04266028|560328764|FG004|Overall Study|Adverse Event|1|||
155244785|NCT04266028|560328765|FG005|Overall Study|Adverse Event|0|||
155244786|NCT04266028|560328766|FG006|Overall Study|Adverse Event|2|||
155244787|NCT04266028|560328767|FG007|Overall Study|Adverse Event|0|||
155244788|NCT04266028|560328760|FG000|Overall Study|temporary halt of the study|0|||
155244789|NCT04266028|560328761|FG001|Overall Study|temporary halt of the study|0|||
155244790|NCT04266028|560328762|FG002|Overall Study|temporary halt of the study|0|||
155244791|NCT04266028|560328763|FG003|Overall Study|temporary halt of the study|0|||
155244792|NCT04266028|560328764|FG004|Overall Study|temporary halt of the study|0|||
155244793|NCT04266028|560328765|FG005|Overall Study|temporary halt of the study|0|||
155244794|NCT04266028|560328766|FG006|Overall Study|temporary halt of the study|2|||
155244795|NCT04266028|560328767|FG007|Overall Study|temporary halt of the study|1|||
155244796|NCT04266028|560328760|FG000|Overall Study|Onset of birch pollen season|0|||
155244797|NCT04266028|560328761|FG001|Overall Study|Onset of birch pollen season|0|||
155244798|NCT04266028|560328762|FG002|Overall Study|Onset of birch pollen season|0|||
155244799|NCT04266028|560328763|FG003|Overall Study|Onset of birch pollen season|0|||
155244800|NCT04266028|560328764|FG004|Overall Study|Onset of birch pollen season|1|||
155244801|NCT04266028|560328765|FG005|Overall Study|Onset of birch pollen season|0|||
155244802|NCT04266028|560328766|FG006|Overall Study|Onset of birch pollen season|0|||
155244803|NCT04266028|560328767|FG007|Overall Study|Onset of birch pollen season|0|||
155244804|NCT03325712|560328768|FG000|Overall Study|Protocol Violation|0|||
155244805|NCT03325712|560328769|FG001|Overall Study|Protocol Violation|0|||
155244806|NCT03325712|560328770|FG002|Overall Study|Protocol Violation|0|||
155244807|NCT03325712|560328771|FG003|Overall Study|Protocol Violation|0|||
155244808|NCT03325712|560328772|FG004|Overall Study|Protocol Violation|1|||
155244809|NCT03325712|560328773|FG005|Overall Study|Protocol Violation|0|||
155244810|NCT03325712|560328774|FG006|Overall Study|Protocol Violation|0|||
155244811|NCT03325712|560328775|FG007|Overall Study|Protocol Violation|0|||
155244812|NCT03325712|560328768|FG000|Overall Study|Adverse Event|0|||
155244813|NCT03325712|560328769|FG001|Overall Study|Adverse Event|0|||
155244814|NCT03325712|560328770|FG002|Overall Study|Adverse Event|0|||
155244815|NCT03325712|560328771|FG003|Overall Study|Adverse Event|0|||
155244816|NCT03325712|560328772|FG004|Overall Study|Adverse Event|1|||
155244817|NCT03325712|560328773|FG005|Overall Study|Adverse Event|0|||
155244818|NCT03325712|560328774|FG006|Overall Study|Adverse Event|0|||
155244819|NCT03325712|560328775|FG007|Overall Study|Adverse Event|0|||
155244820|NCT02265237|560328777|FG000|As Treated (Overall Study)|Adverse Event|1|||
155244821|NCT02265237|560328778|FG001|As Treated (Overall Study)|Adverse Event|1|||
155244822|NCT02265237|560328779|FG002|As Treated (Overall Study)|Adverse Event|0|||
155244823|NCT02265237|560328780|FG003|As Treated (Overall Study)|Adverse Event|0|||
155244824|NCT02265237|560328777|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
155244825|NCT02265237|560328778|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
155244826|NCT02265237|560328779|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
155244827|NCT02265237|560328780|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
155244828|NCT02265237|560328777|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
155244829|NCT02265237|560328778|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
155244830|NCT02265237|560328779|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
155244831|NCT02265237|560328780|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
155244832|NCT02265237|560328777|FG000|As Treated (Overall Study)|Other|2|||
155244833|NCT02265237|560328778|FG001|As Treated (Overall Study)|Other|0|||
155244834|NCT02265237|560328779|FG002|As Treated (Overall Study)|Other|3|||
155244835|NCT02265237|560328780|FG003|As Treated (Overall Study)|Other|1|||
155244836|NCT01178853|560328782|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
155244837|NCT01178853|560328783|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
155244838|NCT01178853|560328782|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
155244839|NCT01178853|560328783|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
155244840|NCT01178853|560328782|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
155244841|NCT01178853|560328783|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
155244842|NCT01178853|560328782|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
155244843|NCT01178853|560328783|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
155244844|NCT01178853|560328782|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
155244845|NCT01178853|560328783|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
155244846|NCT03550313|560328784|FG000|Overall Study|Adverse Event|0|||
155244847|NCT03550313|560328785|FG001|Overall Study|Adverse Event|1|||
155244848|NCT03550313|560328786|FG002|Overall Study|Adverse Event|0|||
155244849|NCT03550313|560328784|FG000|Overall Study|Lost to Follow-up|5|||
155244850|NCT03550313|560328785|FG001|Overall Study|Lost to Follow-up|7|||
155244851|NCT03550313|560328786|FG002|Overall Study|Lost to Follow-up|12|||
155244852|NCT03550313|560328784|FG000|Overall Study|Study terminated by sponsor|44|||
155244853|NCT03550313|560328785|FG001|Overall Study|Study terminated by sponsor|37|||
155244854|NCT03550313|560328786|FG002|Overall Study|Study terminated by sponsor|48|||
155244855|NCT03550313|560328784|FG000|Overall Study|No longer met eligibility criteria|3|||
155244856|NCT03550313|560328785|FG001|Overall Study|No longer met eligibility criteria|5|||
155244857|NCT03550313|560328786|FG002|Overall Study|No longer met eligibility criteria|6|||
155244858|NCT03550313|560328784|FG000|Overall Study|Withdrawal by parent/guardian|20|||
155244859|NCT03550313|560328785|FG001|Overall Study|Withdrawal by parent/guardian|18|||
155244860|NCT03550313|560328786|FG002|Overall Study|Withdrawal by parent/guardian|26|||
155244861|NCT03550313|560328784|FG000|Overall Study|Other|4|||
155244862|NCT03550313|560328785|FG001|Overall Study|Other|2|||
155244863|NCT03550313|560328786|FG002|Overall Study|Other|2|||
155244864|NCT03550313|560328784|FG000|Overall Study|Randomized but not vaccinated|3|||
155244865|NCT03550313|560328785|FG001|Overall Study|Randomized but not vaccinated|23|||
155244866|NCT03550313|560328786|FG002|Overall Study|Randomized but not vaccinated|2|||
155244867|NCT03550313|560328784|FG000|Overall Study|Sites terminated due to quality issues|18|||
155244868|NCT03550313|560328785|FG001|Overall Study|Sites terminated due to quality issues|17|||
155244869|NCT03550313|560328786|FG002|Overall Study|Sites terminated due to quality issues|18|||
155244870|NCT00839072|560328787|FG000|First Intervention Period|Withdrawal by Subject|1|||
155244871|NCT00839072|560328788|FG001|First Intervention Period|Withdrawal by Subject|0|||
155244872|NCT00839072|560328787|FG000|First Intervention Period|Adverse Event|1|||
155244873|NCT00839072|560328788|FG001|First Intervention Period|Adverse Event|1|||
155244874|NCT00839072|560328787|FG000|Second Intervention Period|Withdrawal by Subject|1|||
155244875|NCT00839072|560328788|FG001|Second Intervention Period|Withdrawal by Subject|0|||
155244876|NCT00380068|560328789|FG000|Overall Study|Adverse Event|40|||
155244877|NCT00380068|560328789|FG000|Overall Study|Withdrawal by Subject|10|||
155244878|NCT00380068|560328789|FG000|Overall Study|Not compliant|6|||
155244879|NCT00380068|560328789|FG000|Overall Study|Lost to Follow-up|1|||
155244880|NCT00380068|560328789|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
155244881|NCT00380068|560328789|FG000|Overall Study|Lung transplant|3|||
155244882|NCT00380068|560328789|FG000|Overall Study|Physician Decision|2|||
155244883|NCT00380068|560328789|FG000|Overall Study|Partipant moved away|1|||
155244884|NCT00380068|560328789|FG000|Overall Study|Lack of Efficacy|5|||
155244885|NCT01297062|560328790|FG000|Overall Study|Adverse Event|2|||
155244886|NCT01297062|560328791|FG001|Overall Study|Adverse Event|0|||
155244887|NCT01297062|560328792|FG002|Overall Study|Adverse Event|1|||
155244888|NCT01297062|560328793|FG003|Overall Study|Adverse Event|0|||
155244889|NCT01297062|560328794|FG004|Overall Study|Adverse Event|0|||
155244890|NCT01297062|560328795|FG005|Overall Study|Adverse Event|0|||
155244891|NCT01297062|560328796|FG006|Overall Study|Adverse Event|0|||
155244892|NCT01297062|560328790|FG000|Overall Study|Physician Decision|1|||
155244893|NCT01297062|560328791|FG001|Overall Study|Physician Decision|0|||
155244894|NCT01297062|560328792|FG002|Overall Study|Physician Decision|1|||
155244895|NCT01297062|560328793|FG003|Overall Study|Physician Decision|0|||
155244896|NCT01297062|560328794|FG004|Overall Study|Physician Decision|0|||
155244897|NCT01297062|560328795|FG005|Overall Study|Physician Decision|0|||
155244898|NCT01297062|560328796|FG006|Overall Study|Physician Decision|6|||
155244899|NCT01297062|560328790|FG000|Overall Study|Protocol Violation|0|||
155244900|NCT01297062|560328791|FG001|Overall Study|Protocol Violation|0|||
155244901|NCT01297062|560328792|FG002|Overall Study|Protocol Violation|0|||
155244902|NCT01297062|560328793|FG003|Overall Study|Protocol Violation|0|||
155244903|NCT01297062|560328794|FG004|Overall Study|Protocol Violation|1|||
155244904|NCT01297062|560328795|FG005|Overall Study|Protocol Violation|0|||
155244905|NCT01297062|560328796|FG006|Overall Study|Protocol Violation|0|||
155244906|NCT01297062|560328790|FG000|Overall Study|Subject Decision|1|||
155244907|NCT01297062|560328791|FG001|Overall Study|Subject Decision|1|||
155244908|NCT01297062|560328792|FG002|Overall Study|Subject Decision|0|||
155244909|NCT01297062|560328793|FG003|Overall Study|Subject Decision|1|||
155244910|NCT01297062|560328794|FG004|Overall Study|Subject Decision|1|||
155244911|NCT01297062|560328795|FG005|Overall Study|Subject Decision|1|||
155244912|NCT01297062|560328796|FG006|Overall Study|Subject Decision|2|||
155244913|NCT01682837|560328799|FG000|Baseline|Withdrawal by Subject|5|||
155244914|NCT03021187|560328802|FG000|Overall Study|Death|0|||
155244915|NCT03021187|560328803|FG001|Overall Study|Death|0|||
155244916|NCT03021187|560328804|FG002|Overall Study|Death|3|||
155244917|NCT03021187|560328805|FG003|Overall Study|Death|0|||
155244918|NCT03021187|560328802|FG000|Overall Study|Withdrawal by Subject|0|||
155244919|NCT03021187|560328803|FG001|Overall Study|Withdrawal by Subject|6|||
155244920|NCT03021187|560328804|FG002|Overall Study|Withdrawal by Subject|2|||
155244921|NCT03021187|560328805|FG003|Overall Study|Withdrawal by Subject|5|||
155244922|NCT03021187|560328802|FG000|Overall Study|Lost to Follow-up|10|||
155244923|NCT03021187|560328803|FG001|Overall Study|Lost to Follow-up|3|||
155244924|NCT03021187|560328804|FG002|Overall Study|Lost to Follow-up|1|||
155244925|NCT03021187|560328805|FG003|Overall Study|Lost to Follow-up|4|||
155244926|NCT01664078|560328806|FG000|Overall Study|Death|9|||
155244927|NCT01664078|560328806|FG000|Overall Study|Withdrawal by Subject|4|||
155244928|NCT01664078|560328806|FG000|Overall Study|Lost to Follow-up|2|||
155244929|NCT01664078|560328806|FG000|Overall Study|missed 5 year visit|1|||
155244930|NCT01664078|560328806|FG000|Overall Study|Other|53|||
155244931|NCT04782323|560328807|FG000|Overall Study|Death|1|||
155244932|NCT04782323|560328808|FG001|Overall Study|Death|0|||
155244933|NCT04782323|560328809|FG002|Overall Study|Death|0|||
155244934|NCT04782323|560328810|FG003|Overall Study|Death|0|||
155244935|NCT04782323|560328811|FG004|Overall Study|Death|1|||
155244936|NCT04782323|560328812|FG005|Overall Study|Death|1|||
155244937|NCT04782323|560328813|FG006|Overall Study|Death|1|||
155244938|NCT04782323|560328814|FG007|Overall Study|Death|0|||
155244939|NCT04782323|560328807|FG000|Overall Study|Withdrawal by Subject|0|||
155244940|NCT04782323|560328808|FG001|Overall Study|Withdrawal by Subject|0|||
155244941|NCT04782323|560328809|FG002|Overall Study|Withdrawal by Subject|1|||
155244942|NCT04782323|560328810|FG003|Overall Study|Withdrawal by Subject|0|||
155244943|NCT04782323|560328811|FG004|Overall Study|Withdrawal by Subject|0|||
155244944|NCT04782323|560328812|FG005|Overall Study|Withdrawal by Subject|1|||
155244945|NCT04782323|560328813|FG006|Overall Study|Withdrawal by Subject|0|||
155244946|NCT04782323|560328814|FG007|Overall Study|Withdrawal by Subject|1|||
155244947|NCT04782323|560328807|FG000|Overall Study|Lost to Follow-up|0|||
155244948|NCT04782323|560328808|FG001|Overall Study|Lost to Follow-up|1|||
155244949|NCT04782323|560328809|FG002|Overall Study|Lost to Follow-up|1|||
155244950|NCT04782323|560328810|FG003|Overall Study|Lost to Follow-up|0|||
155244951|NCT04782323|560328811|FG004|Overall Study|Lost to Follow-up|0|||
155244952|NCT04782323|560328812|FG005|Overall Study|Lost to Follow-up|1|||
155244953|NCT04782323|560328813|FG006|Overall Study|Lost to Follow-up|1|||
155244954|NCT04782323|560328814|FG007|Overall Study|Lost to Follow-up|2|||
155244955|NCT04782323|560328807|FG000|Overall Study|randomization in error|1|||
155244956|NCT04782323|560328808|FG001|Overall Study|randomization in error|0|||
155244957|NCT04782323|560328809|FG002|Overall Study|randomization in error|0|||
155244958|NCT04782323|560328810|FG003|Overall Study|randomization in error|0|||
155244959|NCT04782323|560328811|FG004|Overall Study|randomization in error|0|||
155244960|NCT04782323|560328812|FG005|Overall Study|randomization in error|0|||
155244961|NCT04782323|560328813|FG006|Overall Study|randomization in error|0|||
155244962|NCT04782323|560328814|FG007|Overall Study|randomization in error|0|||
155244963|NCT03351049|560328815|FG000|Overall Study|Withdrawal|26|||
155244964|NCT03351049|560328816|FG001|Overall Study|Withdrawal|22|||
155244965|NCT03832192|560328821|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
155244966|NCT03832192|560328822|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
155244967|NCT02730819|560328829|FG000|Overall Study|Lost to Follow-up|9|||
155244968|NCT00156065|560330815|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
155244969|NCT00156065|560330816|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
155244970|NCT00156065|560330817|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
155244971|NCT00156065|560330815|FG000|Overall Study|Adverse Event|8|||
155244972|NCT00156065|560330816|FG001|Overall Study|Adverse Event|11|||
155244973|NCT00156065|560330817|FG002|Overall Study|Adverse Event|4|||
155244974|NCT00156065|560330815|FG000|Overall Study|Lack of Efficacy|2|||
155244975|NCT00156065|560330816|FG001|Overall Study|Lack of Efficacy|9|||
155244976|NCT00156065|560330817|FG002|Overall Study|Lack of Efficacy|3|||
155244977|NCT00156065|560330815|FG000|Overall Study|Withdrawal by Subject|13|||
155244978|NCT00156065|560330816|FG001|Overall Study|Withdrawal by Subject|26|||
155244979|NCT00156065|560330817|FG002|Overall Study|Withdrawal by Subject|16|||
155244980|NCT00156065|560330815|FG000|Overall Study|Lost to Follow-up|5|||
155244981|NCT00156065|560330816|FG001|Overall Study|Lost to Follow-up|7|||
155244982|NCT00156065|560330817|FG002|Overall Study|Lost to Follow-up|1|||
155244983|NCT00156065|560330815|FG000|Overall Study|Other|2|||
155244984|NCT00156065|560330816|FG001|Overall Study|Other|9|||
155244985|NCT00156065|560330817|FG002|Overall Study|Other|3|||
155244986|NCT02891187|560330818|FG000|Overall Study|Lost to Follow-up|1|||
155244987|NCT02891187|560330819|FG001|Overall Study|Lost to Follow-up|2|||
155244988|NCT03581305|560330820|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
155244989|NCT03581305|560330821|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
155244990|NCT03581305|560330820|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
155244991|NCT03581305|560330821|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
155244992|NCT03581305|560330820|FG000|Serotonergic Study|Withdrawal by Subject|5|||
155244993|NCT03581305|560330821|FG001|Serotonergic Study|Withdrawal by Subject|1|||
155244994|NCT01798927|560330822|FG000|Overall Study|Withdrawal by Subject|1|||
155244995|NCT01159691|560330823|FG000|Overall Study|Lost to Follow-up|2|||
155244996|NCT01159691|560330823|FG000|Overall Study|Unknown reasons|1|||
155244997|NCT01159691|560330823|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
155244998|NCT01159691|560330823|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
155244999|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
155245000|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
155245001|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
155245002|NCT01159691|560330823|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
155245003|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
155245004|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
155245005|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
155245006|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
155245007|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
155245008|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
155245009|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
155245010|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
155245011|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
155245012|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
155245013|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
155245014|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
155245015|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
155245016|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
155245017|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
155245018|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
155245019|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
155245020|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
155245021|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
155245022|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
155245023|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
155245024|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
155245025|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
155245026|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
155245027|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245028|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245029|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245030|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245031|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245032|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245033|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245034|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245035|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245036|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245037|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245038|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245039|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245040|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245041|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245042|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
155245043|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245044|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245045|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
155245046|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
155245047|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
155245048|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245049|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245050|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245051|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245052|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245053|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245054|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245055|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245056|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245057|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245058|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245059|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245060|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245061|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245062|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
155245063|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
155245064|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
155245065|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
155245066|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
155245067|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
155245068|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
155245069|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
155245070|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
155245071|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
155245072|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
155245073|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
155245074|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
155245075|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
155245076|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
155245077|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
155245078|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
155245079|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
155245080|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
155245081|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
155245082|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
155245083|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
155245084|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245085|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245086|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245087|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245088|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245089|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245090|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245091|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245092|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245093|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245094|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245095|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245096|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245097|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245098|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245099|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245100|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245101|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245102|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
155245103|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
155245104|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
155245105|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245106|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
155245107|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
155245108|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245109|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245110|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245111|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245112|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245113|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245114|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245115|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245116|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245117|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245118|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245119|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245120|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245121|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245122|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
155245123|NCT01490632|560330829|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245124|NCT01490632|560330830|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245125|NCT01490632|560330831|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245126|NCT01490632|560330832|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245127|NCT01490632|560330833|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
155245128|NCT01490632|560330834|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245129|NCT01490632|560330835|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245130|NCT01490632|560330836|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245131|NCT01490632|560330837|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245132|NCT01490632|560330838|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245133|NCT01490632|560330839|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245134|NCT01490632|560330840|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245135|NCT01490632|560330841|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245136|NCT01490632|560330842|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245137|NCT01490632|560330843|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245138|NCT01490632|560330844|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245139|NCT01490632|560330845|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245140|NCT01490632|560330846|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245141|NCT01490632|560330847|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245142|NCT01490632|560330848|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
155245143|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245144|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245145|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245146|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245147|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245148|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
155245149|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
155245150|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245151|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245152|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
155245153|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
155245154|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
155245155|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245156|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245157|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245158|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245159|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245160|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245161|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245162|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
155245163|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245164|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245165|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245166|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245167|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245168|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245169|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
155245170|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245171|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
155245172|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
155245173|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
155245174|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245175|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245176|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245177|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245178|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245179|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245180|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245181|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245182|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
155245183|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245184|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245185|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245186|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245187|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245188|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245189|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
155245190|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245191|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245192|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
155245193|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245194|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245195|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245196|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245197|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245198|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245199|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245200|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245201|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245202|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
155245203|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245204|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245205|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245206|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245207|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245208|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245209|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
155245210|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245211|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245212|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245213|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245214|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245215|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245216|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245217|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245218|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245219|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245220|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245221|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245222|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
155245223|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245224|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245225|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245226|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245227|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245228|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
155245229|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245230|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245231|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245232|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245233|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245234|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245235|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245236|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245237|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245238|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245239|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245240|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245241|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245242|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
155245243|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245244|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245245|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245246|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245247|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245248|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245249|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
155245250|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245251|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
155245252|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245253|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
155245254|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
155245255|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245256|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245257|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245258|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245259|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245260|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245261|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245262|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
155245263|NCT01490632|560330829|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245264|NCT01490632|560330830|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245265|NCT01490632|560330831|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245266|NCT01490632|560330832|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245267|NCT01490632|560330833|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245268|NCT01490632|560330834|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
155245269|NCT01490632|560330835|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
155245270|NCT01490632|560330836|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
155245271|NCT01490632|560330837|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
155245272|NCT01490632|560330838|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
155245273|NCT01490632|560330839|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
155245274|NCT01490632|560330840|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
155245275|NCT01490632|560330841|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245276|NCT01490632|560330842|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245277|NCT01490632|560330843|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245278|NCT01490632|560330844|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245279|NCT01490632|560330845|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245280|NCT01490632|560330846|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245281|NCT01490632|560330847|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245282|NCT01490632|560330848|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
155245283|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245284|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245285|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245286|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245287|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245288|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245289|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245290|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245291|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245292|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245293|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245294|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245295|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245296|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245297|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
155245298|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
155245299|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245300|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245301|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245302|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
155245303|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245304|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245305|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245306|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245307|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245308|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245309|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245310|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245311|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245312|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245313|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245314|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245315|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245316|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
155245317|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245318|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245319|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245320|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245321|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245322|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
155245323|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245324|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245325|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245326|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245327|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245328|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245329|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245330|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245331|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245332|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245333|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245334|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245335|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245336|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245337|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
155245338|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
155245339|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245340|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245341|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245342|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
155245343|NCT01490632|560330829|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245344|NCT01490632|560330830|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245345|NCT01490632|560330831|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245346|NCT01490632|560330832|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245347|NCT01490632|560330833|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245348|NCT01490632|560330834|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245349|NCT01490632|560330835|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245350|NCT01490632|560330836|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245351|NCT01490632|560330837|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245352|NCT01490632|560330838|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245353|NCT01490632|560330839|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245354|NCT01490632|560330840|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245355|NCT01490632|560330841|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
155245356|NCT01490632|560330842|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
155245357|NCT01490632|560330843|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
155245358|NCT01490632|560330844|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
155245359|NCT01490632|560330845|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245360|NCT01490632|560330846|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245361|NCT01490632|560330847|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245362|NCT01490632|560330848|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
155245363|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
155245364|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
155245365|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
155245366|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
155245367|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
155245368|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
155245369|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
155245370|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
155245371|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
155245372|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
155245373|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
155245374|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
155245375|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
155245376|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
155245377|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
155245378|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
155245379|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
155245380|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
155245381|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
155245382|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
155245383|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Death|0|||
155245384|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Death|0|||
155245385|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Death|0|||
155245386|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Death|0|||
155245387|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Death|0|||
155245388|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Death|0|||
155245389|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Death|0|||
155245390|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Death|0|||
155245391|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Death|0|||
155245392|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Death|0|||
155245393|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Death|0|||
155245394|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Death|0|||
155245395|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Death|0|||
155245396|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Death|0|||
155245397|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Death|0|||
155245398|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Death|0|||
155245399|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Death|0|||
155245400|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Death|0|||
155245401|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Death|1|||
155245402|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Death|0|||
155245403|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245404|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245405|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245406|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245407|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245408|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245409|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245410|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245411|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245412|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245413|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245414|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245415|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245416|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245417|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245418|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245419|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
155245420|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
155245421|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
155245422|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
155245423|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245424|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245425|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245426|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245427|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245428|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245429|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245430|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245431|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245432|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245433|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245434|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245435|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245436|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245437|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245438|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245439|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245440|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245441|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
155245442|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
155245443|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
155245444|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
155245445|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
155245446|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
155245447|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
155245448|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
155245449|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
155245450|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
155245451|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
155245452|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
155245453|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
155245454|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
155245455|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
155245456|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
155245457|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
155245458|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
155245459|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
155245460|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
155245461|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
155245462|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
155245463|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
155245464|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
155245465|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
155245466|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
155245467|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
155245468|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
155245469|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
155245470|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
155245471|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
155245472|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
155245473|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
155245474|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
155245475|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
155245476|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
155245477|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
155245478|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
155245479|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
155245480|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
155245481|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
155245482|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
155245483|NCT01490632|560330829|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245484|NCT01490632|560330830|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245485|NCT01490632|560330831|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245486|NCT01490632|560330832|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245487|NCT01490632|560330833|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245488|NCT01490632|560330834|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245489|NCT01490632|560330835|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245490|NCT01490632|560330836|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245491|NCT01490632|560330837|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245492|NCT01490632|560330838|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245493|NCT01490632|560330839|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245494|NCT01490632|560330840|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245495|NCT01490632|560330841|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245496|NCT01490632|560330842|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245497|NCT01490632|560330843|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245498|NCT01490632|560330844|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245499|NCT01490632|560330845|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
155245500|NCT01490632|560330846|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
155245501|NCT01490632|560330847|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
155245502|NCT01490632|560330848|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
155245503|NCT02332720|560330849|FG000|Part A and Part B|Lost to Follow-up|1|||
155245504|NCT02332720|560330850|FG001|Part A and Part B|Lost to Follow-up|0|||
155245505|NCT02332720|560330851|FG002|Part A and Part B|Lost to Follow-up|0|||
155245506|NCT02332720|560330852|FG003|Part A and Part B|Lost to Follow-up|0|||
155245507|NCT02332720|560330853|FG004|Part A and Part B|Lost to Follow-up|0|||
155245508|NCT02332720|560330854|FG005|Part A and Part B|Lost to Follow-up|2|||
155245509|NCT02332720|560330855|FG006|Part A and Part B|Lost to Follow-up|1|||
155245510|NCT02332720|560330856|FG007|Part A and Part B|Lost to Follow-up|1|||
155245511|NCT02332720|560330857|FG008|Part A and Part B|Lost to Follow-up|0|||
155245512|NCT02332720|560330858|FG009|Part A and Part B|Lost to Follow-up|0|||
155245513|NCT02332720|560330859|FG010|Part A and Part B|Lost to Follow-up|0|||
155245514|NCT02332720|560330860|FG011|Part A and Part B|Lost to Follow-up|0|||
155245515|NCT02332720|560330861|FG012|Part A and Part B|Lost to Follow-up|0|||
155245516|NCT02332720|560330862|FG013|Part A and Part B|Lost to Follow-up|0|||
155245517|NCT02332720|560330863|FG014|Part A and Part B|Lost to Follow-up|0|||
155245518|NCT02332720|560330864|FG015|Part A and Part B|Lost to Follow-up|1|||
155245519|NCT02332720|560330865|FG016|Part A and Part B|Lost to Follow-up|0|||
155245520|NCT02332720|560330866|FG017|Part A and Part B|Lost to Follow-up|0|||
155245521|NCT02332720|560330867|FG018|Part A and Part B|Lost to Follow-up|0|||
155245522|NCT02332720|560330868|FG019|Part A and Part B|Lost to Follow-up|0|||
155245523|NCT02332720|560330869|FG020|Part A and Part B|Lost to Follow-up|0|||
155245524|NCT02332720|560330870|FG021|Part A and Part B|Lost to Follow-up|0|||
155245525|NCT02332720|560330871|FG022|Part A and Part B|Lost to Follow-up|0|||
155245526|NCT02332720|560330849|FG000|Part A and Part B|Adverse Event|0|||
155245527|NCT02332720|560330850|FG001|Part A and Part B|Adverse Event|0|||
155245528|NCT02332720|560330851|FG002|Part A and Part B|Adverse Event|0|||
155245529|NCT02332720|560330852|FG003|Part A and Part B|Adverse Event|0|||
155245530|NCT02332720|560330853|FG004|Part A and Part B|Adverse Event|0|||
155245531|NCT02332720|560330854|FG005|Part A and Part B|Adverse Event|0|||
155245532|NCT02332720|560330855|FG006|Part A and Part B|Adverse Event|0|||
155245533|NCT02332720|560330856|FG007|Part A and Part B|Adverse Event|0|||
155245534|NCT02332720|560330857|FG008|Part A and Part B|Adverse Event|0|||
155245535|NCT02332720|560330858|FG009|Part A and Part B|Adverse Event|0|||
155245536|NCT02332720|560330859|FG010|Part A and Part B|Adverse Event|0|||
155245537|NCT02332720|560330860|FG011|Part A and Part B|Adverse Event|0|||
155245538|NCT02332720|560330861|FG012|Part A and Part B|Adverse Event|0|||
155245539|NCT02332720|560330862|FG013|Part A and Part B|Adverse Event|0|||
155245540|NCT02332720|560330863|FG014|Part A and Part B|Adverse Event|0|||
155245541|NCT02332720|560330864|FG015|Part A and Part B|Adverse Event|0|||
155245542|NCT02332720|560330865|FG016|Part A and Part B|Adverse Event|0|||
155245543|NCT02332720|560330866|FG017|Part A and Part B|Adverse Event|1|||
155245544|NCT02332720|560330867|FG018|Part A and Part B|Adverse Event|0|||
155245545|NCT02332720|560330868|FG019|Part A and Part B|Adverse Event|0|||
155245546|NCT02332720|560330869|FG020|Part A and Part B|Adverse Event|0|||
155245547|NCT02332720|560330870|FG021|Part A and Part B|Adverse Event|0|||
155245548|NCT02332720|560330871|FG022|Part A and Part B|Adverse Event|0|||
155245549|NCT02332720|560330849|FG000|Part A and Part B|Physician Decision|0|||
155245550|NCT02332720|560330850|FG001|Part A and Part B|Physician Decision|0|||
155245551|NCT02332720|560330851|FG002|Part A and Part B|Physician Decision|0|||
155245552|NCT02332720|560330852|FG003|Part A and Part B|Physician Decision|0|||
155245553|NCT02332720|560330853|FG004|Part A and Part B|Physician Decision|0|||
155245554|NCT02332720|560330854|FG005|Part A and Part B|Physician Decision|0|||
155245555|NCT02332720|560330855|FG006|Part A and Part B|Physician Decision|0|||
155245556|NCT02332720|560330856|FG007|Part A and Part B|Physician Decision|0|||
155245557|NCT02332720|560330857|FG008|Part A and Part B|Physician Decision|0|||
155245558|NCT02332720|560330858|FG009|Part A and Part B|Physician Decision|0|||
155245559|NCT02332720|560330859|FG010|Part A and Part B|Physician Decision|0|||
155245560|NCT02332720|560330860|FG011|Part A and Part B|Physician Decision|0|||
155245561|NCT02332720|560330861|FG012|Part A and Part B|Physician Decision|0|||
155245562|NCT02332720|560330862|FG013|Part A and Part B|Physician Decision|0|||
155245563|NCT02332720|560330863|FG014|Part A and Part B|Physician Decision|0|||
155245564|NCT02332720|560330864|FG015|Part A and Part B|Physician Decision|0|||
155245565|NCT02332720|560330865|FG016|Part A and Part B|Physician Decision|0|||
155245566|NCT02332720|560330866|FG017|Part A and Part B|Physician Decision|0|||
155245567|NCT02332720|560330867|FG018|Part A and Part B|Physician Decision|1|||
155245568|NCT02332720|560330868|FG019|Part A and Part B|Physician Decision|0|||
155245569|NCT02332720|560330869|FG020|Part A and Part B|Physician Decision|0|||
155245570|NCT02332720|560330870|FG021|Part A and Part B|Physician Decision|0|||
155245571|NCT02332720|560330871|FG022|Part A and Part B|Physician Decision|0|||
155245572|NCT02332720|560330849|FG000|Part A and Part B|Withdrawal by Subject|0|||
155245573|NCT02332720|560330850|FG001|Part A and Part B|Withdrawal by Subject|0|||
155245574|NCT02332720|560330851|FG002|Part A and Part B|Withdrawal by Subject|0|||
155245575|NCT02332720|560330852|FG003|Part A and Part B|Withdrawal by Subject|0|||
155245576|NCT02332720|560330853|FG004|Part A and Part B|Withdrawal by Subject|0|||
155245577|NCT02332720|560330854|FG005|Part A and Part B|Withdrawal by Subject|1|||
155245578|NCT02332720|560330855|FG006|Part A and Part B|Withdrawal by Subject|0|||
155245579|NCT02332720|560330856|FG007|Part A and Part B|Withdrawal by Subject|0|||
155245580|NCT02332720|560330857|FG008|Part A and Part B|Withdrawal by Subject|0|||
155245581|NCT02332720|560330858|FG009|Part A and Part B|Withdrawal by Subject|0|||
155245582|NCT02332720|560330859|FG010|Part A and Part B|Withdrawal by Subject|0|||
155245583|NCT02332720|560330860|FG011|Part A and Part B|Withdrawal by Subject|0|||
155245584|NCT02332720|560330861|FG012|Part A and Part B|Withdrawal by Subject|0|||
155245585|NCT02332720|560330862|FG013|Part A and Part B|Withdrawal by Subject|0|||
155245586|NCT02332720|560330863|FG014|Part A and Part B|Withdrawal by Subject|0|||
155245587|NCT02332720|560330864|FG015|Part A and Part B|Withdrawal by Subject|0|||
155245588|NCT02332720|560330865|FG016|Part A and Part B|Withdrawal by Subject|0|||
155245589|NCT02332720|560330866|FG017|Part A and Part B|Withdrawal by Subject|0|||
155245590|NCT02332720|560330867|FG018|Part A and Part B|Withdrawal by Subject|0|||
155245591|NCT02332720|560330868|FG019|Part A and Part B|Withdrawal by Subject|1|||
155245592|NCT02332720|560330869|FG020|Part A and Part B|Withdrawal by Subject|0|||
155245593|NCT02332720|560330870|FG021|Part A and Part B|Withdrawal by Subject|0|||
155245594|NCT02332720|560330871|FG022|Part A and Part B|Withdrawal by Subject|0|||
155245595|NCT00384085|560330872|FG000|Overall Study|Adverse Event|5|||
155245596|NCT00384085|560330873|FG001|Overall Study|Adverse Event|5|||
155245597|NCT00384085|560330874|FG002|Overall Study|Adverse Event|4|||
155245598|NCT00384085|560330872|FG000|Overall Study|Lack of Efficacy|0|||
155245599|NCT00384085|560330873|FG001|Overall Study|Lack of Efficacy|3|||
155245600|NCT00384085|560330874|FG002|Overall Study|Lack of Efficacy|2|||
155245601|NCT00384085|560330872|FG000|Overall Study|No longer Requires Study Treatment|1|||
155245602|NCT00384085|560330873|FG001|Overall Study|No longer Requires Study Treatment|0|||
155245603|NCT00384085|560330874|FG002|Overall Study|No longer Requires Study Treatment|1|||
155245604|NCT00384085|560330872|FG000|Overall Study|Protocol Violation|2|||
155245605|NCT00384085|560330873|FG001|Overall Study|Protocol Violation|2|||
155245606|NCT00384085|560330874|FG002|Overall Study|Protocol Violation|2|||
155245607|NCT00384085|560330872|FG000|Overall Study|Lost to Follow-up|9|||
155245608|NCT00384085|560330873|FG001|Overall Study|Lost to Follow-up|9|||
155245609|NCT00384085|560330874|FG002|Overall Study|Lost to Follow-up|10|||
155245610|NCT00384085|560330872|FG000|Overall Study|Progressive Disease|0|||
155245611|NCT00384085|560330873|FG001|Overall Study|Progressive Disease|1|||
155245612|NCT00384085|560330874|FG002|Overall Study|Progressive Disease|0|||
155245613|NCT00384085|560330872|FG000|Overall Study|Withdrawal by Subject|14|||
155245614|NCT00384085|560330873|FG001|Overall Study|Withdrawal by Subject|19|||
155245615|NCT00384085|560330874|FG002|Overall Study|Withdrawal by Subject|29|||
155245616|NCT00384085|560330872|FG000|Overall Study|Patient non-compliant|4|||
155245617|NCT00384085|560330873|FG001|Overall Study|Patient non-compliant|4|||
155245618|NCT00384085|560330874|FG002|Overall Study|Patient non-compliant|5|||
155245619|NCT00384085|560330872|FG000|Overall Study|Physician Decision|1|||
155245620|NCT00384085|560330873|FG001|Overall Study|Physician Decision|0|||
155245621|NCT00384085|560330874|FG002|Overall Study|Physician Decision|0|||
155245622|NCT00384085|560330872|FG000|Overall Study|Loss of site personnel|1|||
155245623|NCT00384085|560330873|FG001|Overall Study|Loss of site personnel|0|||
155245624|NCT00384085|560330874|FG002|Overall Study|Loss of site personnel|1|||
155245625|NCT00384085|560330872|FG000|Overall Study|Sponsor decision|1|||
155245626|NCT00384085|560330873|FG001|Overall Study|Sponsor decision|2|||
155245627|NCT00384085|560330874|FG002|Overall Study|Sponsor decision|1|||
155245628|NCT00384085|560330872|FG000|Overall Study|Patient moved|1|||
155245629|NCT00384085|560330873|FG001|Overall Study|Patient moved|0|||
155245630|NCT00384085|560330874|FG002|Overall Study|Patient moved|1|||
155245631|NCT00384085|560330872|FG000|Overall Study|Patient required surgery|0|||
155245632|NCT00384085|560330873|FG001|Overall Study|Patient required surgery|1|||
155245633|NCT00384085|560330874|FG002|Overall Study|Patient required surgery|0|||
155245634|NCT00467870|560330876|FG000|Overall Study|Adverse Event|13|||
155245635|NCT00467870|560330877|FG001|Overall Study|Adverse Event|9|||
155245636|NCT00467870|560330878|FG002|Overall Study|Adverse Event|1|||
155245637|NCT00467870|560330879|FG003|Overall Study|Adverse Event|15|||
155245638|NCT00467870|560330880|FG004|Overall Study|Adverse Event|15|||
155245639|NCT00467870|560330881|FG005|Overall Study|Adverse Event|1|||
155245640|NCT00467870|560330876|FG000|Overall Study|Protocol Violation|2|||
155245641|NCT00467870|560330877|FG001|Overall Study|Protocol Violation|1|||
155245642|NCT00467870|560330878|FG002|Overall Study|Protocol Violation|1|||
155245643|NCT00467870|560330879|FG003|Overall Study|Protocol Violation|2|||
155245644|NCT00467870|560330880|FG004|Overall Study|Protocol Violation|0|||
155245645|NCT00467870|560330881|FG005|Overall Study|Protocol Violation|0|||
155245646|NCT00467870|560330876|FG000|Overall Study|Withdrawal by Subject|14|||
155245647|NCT00467870|560330877|FG001|Overall Study|Withdrawal by Subject|21|||
155245648|NCT00467870|560330878|FG002|Overall Study|Withdrawal by Subject|0|||
155245649|NCT00467870|560330879|FG003|Overall Study|Withdrawal by Subject|9|||
155245650|NCT00467870|560330880|FG004|Overall Study|Withdrawal by Subject|10|||
155245651|NCT00467870|560330881|FG005|Overall Study|Withdrawal by Subject|1|||
155245652|NCT00467870|560330876|FG000|Overall Study|Lost to Follow-up|5|||
155245653|NCT00467870|560330877|FG001|Overall Study|Lost to Follow-up|3|||
155245654|NCT00467870|560330878|FG002|Overall Study|Lost to Follow-up|1|||
155245655|NCT00467870|560330879|FG003|Overall Study|Lost to Follow-up|1|||
155245656|NCT00467870|560330880|FG004|Overall Study|Lost to Follow-up|3|||
155245657|NCT00467870|560330881|FG005|Overall Study|Lost to Follow-up|0|||
155245658|NCT00467870|560330876|FG000|Overall Study|Subject Non-compliance|3|||
155245659|NCT00467870|560330877|FG001|Overall Study|Subject Non-compliance|4|||
155245660|NCT00467870|560330878|FG002|Overall Study|Subject Non-compliance|0|||
155245661|NCT00467870|560330879|FG003|Overall Study|Subject Non-compliance|1|||
155245662|NCT00467870|560330880|FG004|Overall Study|Subject Non-compliance|5|||
155245663|NCT00467870|560330881|FG005|Overall Study|Subject Non-compliance|0|||
155245664|NCT00467870|560330876|FG000|Overall Study|Other/Unknown|8|||
155245665|NCT00467870|560330877|FG001|Overall Study|Other/Unknown|5|||
155245666|NCT00467870|560330878|FG002|Overall Study|Other/Unknown|1|||
155245667|NCT00467870|560330879|FG003|Overall Study|Other/Unknown|5|||
155245668|NCT00467870|560330880|FG004|Overall Study|Other/Unknown|4|||
155245669|NCT00467870|560330881|FG005|Overall Study|Other/Unknown|0|||
155245670|NCT03489304|560330882|FG000|Overall Study|Lost to Follow-up|4|||
155245671|NCT02261363|560330883|FG000|Overall Study|Lost to Follow-up|21|||
155245672|NCT02301143|560330884|FG000|Induction Period|Enrolled But Not Treated|1|||
155245673|NCT02301143|560330885|FG001|Induction Period|Enrolled But Not Treated|0|||
155245674|NCT02301143|560330884|FG000|Induction Period|Death|1|||
155245675|NCT02301143|560330885|FG001|Induction Period|Death|0|||
155245676|NCT02301143|560330884|FG000|Induction Period|Adverse Event|22|||
155245677|NCT02301143|560330885|FG001|Induction Period|Adverse Event|0|||
155245678|NCT02301143|560330884|FG000|Induction Period|Progressive Disease|8|||
155245679|NCT02301143|560330885|FG001|Induction Period|Progressive Disease|0|||
155245680|NCT02301143|560330884|FG000|Induction Period|Withdrawal by Subject|3|||
155245681|NCT02301143|560330885|FG001|Induction Period|Withdrawal by Subject|0|||
155245682|NCT02301143|560330884|FG000|Induction Period|Noncompliance with Study Drug|1|||
155245683|NCT02301143|560330885|FG001|Induction Period|Noncompliance with Study Drug|0|||
155245684|NCT02301143|560330884|FG000|Induction Period|Physician Decision|4|||
155245685|NCT02301143|560330885|FG001|Induction Period|Physician Decision|0|||
155245686|NCT02301143|560330884|FG000|Induction Period|Symptomatic Deterioration|2|||
155245687|NCT02301143|560330885|FG001|Induction Period|Symptomatic Deterioration|0|||
155245688|NCT02301143|560330884|FG000|Induction Period|Protocol Violation|2|||
155245689|NCT02301143|560330885|FG001|Induction Period|Protocol Violation|0|||
155245690|NCT02301143|560330884|FG000|Induction Period|Other|1|||
155245691|NCT02301143|560330885|FG001|Induction Period|Other|0|||
155245692|NCT02301143|560330884|FG000|Investigator's Choice|Adverse Event|0|||
155245693|NCT02301143|560330885|FG001|Investigator's Choice|Adverse Event|3|||
155245694|NCT02301143|560330884|FG000|Investigator's Choice|Progressive Disease|0|||
155245695|NCT02301143|560330885|FG001|Investigator's Choice|Progressive Disease|3|||
155245696|NCT02301143|560330884|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
155245697|NCT02301143|560330885|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
155245698|NCT02301143|560330884|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
155245699|NCT02301143|560330885|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
155245700|NCT02301143|560330884|FG000|Investigator's Choice|Other|0|||
155245701|NCT02301143|560330885|FG001|Investigator's Choice|Other|1|||
155245702|NCT02301143|560330884|FG000|Investigator's Choice|Unresectable Surgery|0|||
155245703|NCT02301143|560330885|FG001|Investigator's Choice|Unresectable Surgery|1|||
155245704|NCT03214367|560330888|FG000|Lead-in Period|Withdrawal by Subject|50|||
155245705|NCT03214367|560330889|FG001|Lead-in Period|Withdrawal by Subject|0|||
155245706|NCT03214367|560330890|FG002|Lead-in Period|Withdrawal by Subject|0|||
155245707|NCT03214367|560330891|FG003|Lead-in Period|Withdrawal by Subject|0|||
155245708|NCT03214367|560330892|FG004|Lead-in Period|Withdrawal by Subject|2|||
155245709|NCT03214367|560330893|FG005|Lead-in Period|Withdrawal by Subject|0|||
155245710|NCT03214367|560330894|FG006|Lead-in Period|Withdrawal by Subject|0|||
155245711|NCT03214367|560330895|FG007|Lead-in Period|Withdrawal by Subject|0|||
155245712|NCT03214367|560330888|FG000|Lead-in Period|Adverse Event|3|||
155245713|NCT03214367|560330889|FG001|Lead-in Period|Adverse Event|0|||
155245714|NCT03214367|560330890|FG002|Lead-in Period|Adverse Event|0|||
155245715|NCT03214367|560330891|FG003|Lead-in Period|Adverse Event|0|||
155245716|NCT03214367|560330892|FG004|Lead-in Period|Adverse Event|0|||
155245717|NCT03214367|560330893|FG005|Lead-in Period|Adverse Event|0|||
155245718|NCT03214367|560330894|FG006|Lead-in Period|Adverse Event|0|||
155245719|NCT03214367|560330895|FG007|Lead-in Period|Adverse Event|0|||
155245720|NCT03214367|560330888|FG000|Lead-in Period|Lost to Follow-up|12|||
155245721|NCT03214367|560330889|FG001|Lead-in Period|Lost to Follow-up|0|||
155245722|NCT03214367|560330890|FG002|Lead-in Period|Lost to Follow-up|0|||
155245723|NCT03214367|560330891|FG003|Lead-in Period|Lost to Follow-up|0|||
155245724|NCT03214367|560330892|FG004|Lead-in Period|Lost to Follow-up|0|||
155245725|NCT03214367|560330893|FG005|Lead-in Period|Lost to Follow-up|0|||
155245726|NCT03214367|560330894|FG006|Lead-in Period|Lost to Follow-up|0|||
155245727|NCT03214367|560330895|FG007|Lead-in Period|Lost to Follow-up|0|||
155245728|NCT03214367|560330888|FG000|Lead-in Period|Sponsor Decision|11|||
155245729|NCT03214367|560330889|FG001|Lead-in Period|Sponsor Decision|0|||
155245730|NCT03214367|560330890|FG002|Lead-in Period|Sponsor Decision|0|||
155245731|NCT03214367|560330891|FG003|Lead-in Period|Sponsor Decision|0|||
155245732|NCT03214367|560330892|FG004|Lead-in Period|Sponsor Decision|0|||
155245733|NCT03214367|560330893|FG005|Lead-in Period|Sponsor Decision|0|||
155245734|NCT03214367|560330894|FG006|Lead-in Period|Sponsor Decision|0|||
155245735|NCT03214367|560330895|FG007|Lead-in Period|Sponsor Decision|0|||
155245736|NCT03214367|560330888|FG000|Lead-in Period|Physician Decision|12|||
155245737|NCT03214367|560330889|FG001|Lead-in Period|Physician Decision|0|||
155245738|NCT03214367|560330890|FG002|Lead-in Period|Physician Decision|0|||
155245739|NCT03214367|560330891|FG003|Lead-in Period|Physician Decision|0|||
155245740|NCT03214367|560330892|FG004|Lead-in Period|Physician Decision|0|||
155245741|NCT03214367|560330893|FG005|Lead-in Period|Physician Decision|0|||
155245742|NCT03214367|560330894|FG006|Lead-in Period|Physician Decision|0|||
155245743|NCT03214367|560330895|FG007|Lead-in Period|Physician Decision|0|||
155245744|NCT03214367|560330888|FG000|Lead-in Period|Protocol Violation|5|||
155245745|NCT03214367|560330889|FG001|Lead-in Period|Protocol Violation|0|||
155245746|NCT03214367|560330890|FG002|Lead-in Period|Protocol Violation|0|||
155245747|NCT03214367|560330891|FG003|Lead-in Period|Protocol Violation|0|||
155245748|NCT03214367|560330892|FG004|Lead-in Period|Protocol Violation|0|||
155245749|NCT03214367|560330893|FG005|Lead-in Period|Protocol Violation|0|||
155245750|NCT03214367|560330894|FG006|Lead-in Period|Protocol Violation|0|||
155245751|NCT03214367|560330895|FG007|Lead-in Period|Protocol Violation|0|||
155245752|NCT03214367|560330888|FG000|Lead-in Period|Treatment Interruption|1|||
155245753|NCT03214367|560330889|FG001|Lead-in Period|Treatment Interruption|0|||
155245754|NCT03214367|560330890|FG002|Lead-in Period|Treatment Interruption|0|||
155245755|NCT03214367|560330891|FG003|Lead-in Period|Treatment Interruption|0|||
155245756|NCT03214367|560330892|FG004|Lead-in Period|Treatment Interruption|0|||
155245757|NCT03214367|560330893|FG005|Lead-in Period|Treatment Interruption|0|||
155245758|NCT03214367|560330894|FG006|Lead-in Period|Treatment Interruption|0|||
155245759|NCT03214367|560330895|FG007|Lead-in Period|Treatment Interruption|0|||
155245760|NCT03214367|560330888|FG000|Treatment Period|Adverse Event|0|||
155245761|NCT03214367|560330889|FG001|Treatment Period|Adverse Event|1|||
155245762|NCT03214367|560330890|FG002|Treatment Period|Adverse Event|4|||
155245763|NCT03214367|560330891|FG003|Treatment Period|Adverse Event|2|||
155245764|NCT03214367|560330892|FG004|Treatment Period|Adverse Event|0|||
155245765|NCT03214367|560330893|FG005|Treatment Period|Adverse Event|0|||
155245766|NCT03214367|560330894|FG006|Treatment Period|Adverse Event|0|||
155245767|NCT03214367|560330895|FG007|Treatment Period|Adverse Event|0|||
155245768|NCT03214367|560330888|FG000|Treatment Period|Death|0|||
155245769|NCT03214367|560330889|FG001|Treatment Period|Death|1|||
155245770|NCT03214367|560330890|FG002|Treatment Period|Death|1|||
155245771|NCT03214367|560330891|FG003|Treatment Period|Death|1|||
155245772|NCT03214367|560330892|FG004|Treatment Period|Death|0|||
155245773|NCT03214367|560330893|FG005|Treatment Period|Death|0|||
155245774|NCT03214367|560330894|FG006|Treatment Period|Death|0|||
155245775|NCT03214367|560330895|FG007|Treatment Period|Death|0|||
155245776|NCT03214367|560330888|FG000|Treatment Period|Lost to Follow-up|0|||
155245777|NCT03214367|560330889|FG001|Treatment Period|Lost to Follow-up|5|||
155245778|NCT03214367|560330890|FG002|Treatment Period|Lost to Follow-up|3|||
155245779|NCT03214367|560330891|FG003|Treatment Period|Lost to Follow-up|2|||
155245780|NCT03214367|560330892|FG004|Treatment Period|Lost to Follow-up|0|||
155245781|NCT03214367|560330893|FG005|Treatment Period|Lost to Follow-up|2|||
155245782|NCT03214367|560330894|FG006|Treatment Period|Lost to Follow-up|1|||
155245783|NCT03214367|560330895|FG007|Treatment Period|Lost to Follow-up|0|||
155245784|NCT03214367|560330888|FG000|Treatment Period|Sponsor Decision|0|||
155245785|NCT03214367|560330889|FG001|Treatment Period|Sponsor Decision|3|||
155245786|NCT03214367|560330890|FG002|Treatment Period|Sponsor Decision|0|||
155245787|NCT03214367|560330891|FG003|Treatment Period|Sponsor Decision|0|||
155245788|NCT03214367|560330892|FG004|Treatment Period|Sponsor Decision|0|||
155245789|NCT03214367|560330893|FG005|Treatment Period|Sponsor Decision|0|||
155245790|NCT03214367|560330894|FG006|Treatment Period|Sponsor Decision|0|||
155245791|NCT03214367|560330895|FG007|Treatment Period|Sponsor Decision|0|||
155245792|NCT03214367|560330888|FG000|Treatment Period|Physician Decision|0|||
155245793|NCT03214367|560330889|FG001|Treatment Period|Physician Decision|1|||
155245794|NCT03214367|560330890|FG002|Treatment Period|Physician Decision|2|||
155245795|NCT03214367|560330891|FG003|Treatment Period|Physician Decision|0|||
155245796|NCT03214367|560330892|FG004|Treatment Period|Physician Decision|0|||
155245797|NCT03214367|560330893|FG005|Treatment Period|Physician Decision|0|||
155245798|NCT03214367|560330894|FG006|Treatment Period|Physician Decision|0|||
155245799|NCT03214367|560330895|FG007|Treatment Period|Physician Decision|0|||
155245800|NCT03214367|560330888|FG000|Treatment Period|Protocol Violation|0|||
155245801|NCT03214367|560330889|FG001|Treatment Period|Protocol Violation|3|||
155245802|NCT03214367|560330890|FG002|Treatment Period|Protocol Violation|0|||
155245803|NCT03214367|560330891|FG003|Treatment Period|Protocol Violation|0|||
155245804|NCT03214367|560330892|FG004|Treatment Period|Protocol Violation|0|||
155245805|NCT03214367|560330893|FG005|Treatment Period|Protocol Violation|0|||
155245806|NCT03214367|560330894|FG006|Treatment Period|Protocol Violation|0|||
155245807|NCT03214367|560330895|FG007|Treatment Period|Protocol Violation|0|||
155245808|NCT03214367|560330888|FG000|Treatment Period|Withdrawal by Subject|0|||
155245809|NCT03214367|560330889|FG001|Treatment Period|Withdrawal by Subject|20|||
155245810|NCT03214367|560330890|FG002|Treatment Period|Withdrawal by Subject|23|||
155245811|NCT03214367|560330891|FG003|Treatment Period|Withdrawal by Subject|14|||
155245812|NCT03214367|560330892|FG004|Treatment Period|Withdrawal by Subject|0|||
155245813|NCT03214367|560330893|FG005|Treatment Period|Withdrawal by Subject|1|||
155245814|NCT03214367|560330894|FG006|Treatment Period|Withdrawal by Subject|1|||
155245815|NCT03214367|560330895|FG007|Treatment Period|Withdrawal by Subject|1|||
155245816|NCT03268811|560330898|FG000|Overall Study|Adverse Event|0|||
155245817|NCT03268811|560330899|FG001|Overall Study|Adverse Event|1|||
155245818|NCT04726709|560330903|FG000|Overall Study|Withdrawal by Subject|2|||
155245819|NCT04726709|560330904|FG001|Overall Study|Withdrawal by Subject|2|||
155245820|NCT01286779|560330905|FG000|Overall Study|Withdrawal by Subject|9|||
155245821|NCT01286779|560330905|FG000|Overall Study|Protocol Violation|5|||
155245822|NCT01286779|560330905|FG000|Overall Study|Physician Decision|2|||
155245823|NCT01286779|560330905|FG000|Overall Study|Participant had scheduled surgery|1|||
155245824|NCT01286779|560330905|FG000|Overall Study|Participant moved to another country|1|||
155245825|NCT01286779|560330905|FG000|Overall Study|Discontinued by sponsor|1|||
155245826|NCT04827212|560330906|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
155245827|NCT04827212|560330907|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
155245828|NCT04827212|560330906|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
155245829|NCT04827212|560330907|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
155245830|NCT00574080|560330908|FG000|Overall Study|Death|10|||
155245831|NCT00574080|560330909|FG001|Overall Study|Death|10|||
155245832|NCT00599326|560330910|FG000|Overall Study|Lost to Follow-up|1|||
155245833|NCT00599326|560330910|FG000|Overall Study|Noncompliant|1|||
155245834|NCT00784810|560330911|FG000|Overall Study|Adverse Event|32|||
155245835|NCT00784810|560330912|FG001|Overall Study|Adverse Event|20|||
155245836|NCT00784810|560330911|FG000|Overall Study|Lack of Efficacy|14|||
155245837|NCT00784810|560330912|FG001|Overall Study|Lack of Efficacy|11|||
155245838|NCT00784810|560330911|FG000|Overall Study|Withdrawal by Subject|11|||
155245839|NCT00784810|560330912|FG001|Overall Study|Withdrawal by Subject|9|||
155245840|NCT00784810|560330911|FG000|Overall Study|Administrative|5|||
155245841|NCT00784810|560330912|FG001|Overall Study|Administrative|8|||
155245842|NCT00784810|560330911|FG000|Overall Study|Lost to Follow-up|1|||
155245843|NCT00784810|560330912|FG001|Overall Study|Lost to Follow-up|1|||
155245844|NCT04969250|560330913|FG000|Overall Study|Protocol Violation|0|||
155245845|NCT04969250|560330914|FG001|Overall Study|Protocol Violation|2|||
155245846|NCT04969250|560330915|FG002|Overall Study|Protocol Violation|3|||
155245847|NCT04969250|560330916|FG003|Overall Study|Protocol Violation|8|||
155245848|NCT04969250|560330913|FG000|Overall Study|Withdrawal by Subject|0|||
155245849|NCT04969250|560330914|FG001|Overall Study|Withdrawal by Subject|1|||
155245850|NCT04969250|560330915|FG002|Overall Study|Withdrawal by Subject|0|||
155245851|NCT04969250|560330916|FG003|Overall Study|Withdrawal by Subject|0|||
155245852|NCT00563784|560330917|FG000|Overall Study|Withdrawal by Subject|2|||
155245853|NCT00563784|560330917|FG000|Overall Study|Screen Failures|20|||
155245854|NCT02119416|560330918|FG000|Overall Study|Protocol Violation|1|||
155245855|NCT02119416|560330919|FG001|Overall Study|Protocol Violation|1|||
155245856|NCT02119416|560330920|FG002|Overall Study|Protocol Violation|1|||
155245857|NCT02119416|560330918|FG000|Overall Study|wrong pubertal stage|1|||
155245858|NCT02119416|560330919|FG001|Overall Study|wrong pubertal stage|0|||
155245859|NCT02119416|560330920|FG002|Overall Study|wrong pubertal stage|1|||
155245860|NCT04004611|560330921|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245861|NCT04004611|560330922|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245862|NCT04004611|560330923|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245863|NCT04004611|560330924|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245864|NCT04004611|560330925|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245865|NCT04004611|560330926|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245866|NCT04004611|560330927|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245867|NCT04004611|560330928|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
155245868|NCT04004611|560330929|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
155245869|NCT04004611|560330921|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245870|NCT04004611|560330922|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245871|NCT04004611|560330923|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245872|NCT04004611|560330924|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245873|NCT04004611|560330925|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245874|NCT04004611|560330926|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
155245875|NCT04004611|560330927|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
155245876|NCT04004611|560330928|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
155245877|NCT04004611|560330929|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
155245878|NCT04004611|560330921|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245879|NCT04004611|560330922|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245880|NCT04004611|560330923|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245881|NCT04004611|560330924|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245882|NCT04004611|560330925|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
155245883|NCT04004611|560330926|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245884|NCT04004611|560330927|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245885|NCT04004611|560330928|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245886|NCT04004611|560330929|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
155245887|NCT04004611|560330921|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
155245888|NCT04004611|560330922|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
155245889|NCT04004611|560330923|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
155245890|NCT04004611|560330924|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
155245891|NCT04004611|560330925|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
155245892|NCT04004611|560330926|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
155245893|NCT04004611|560330927|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
155245894|NCT04004611|560330928|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
155245895|NCT04004611|560330929|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
155245896|NCT04004611|560330921|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
155245897|NCT04004611|560330922|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245898|NCT04004611|560330923|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
155245899|NCT04004611|560330924|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245900|NCT04004611|560330925|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245901|NCT04004611|560330926|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245902|NCT04004611|560330927|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245903|NCT04004611|560330928|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245904|NCT04004611|560330929|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
155245905|NCT04004611|560330921|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245906|NCT04004611|560330922|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
155245907|NCT04004611|560330923|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245908|NCT04004611|560330924|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245909|NCT04004611|560330925|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245910|NCT04004611|560330926|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245911|NCT04004611|560330927|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245912|NCT04004611|560330928|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245913|NCT04004611|560330929|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
155245914|NCT03434119|560330930|FG000|Overall Study|Randomized but not treated|1|||
155245915|NCT03434119|560330931|FG001|Overall Study|Randomized but not treated|0|||
155245916|NCT03434119|560330930|FG000|Overall Study|Adverse Event|1|||
155245917|NCT03434119|560330931|FG001|Overall Study|Adverse Event|0|||
155245918|NCT03434119|560330930|FG000|Overall Study|Poor Compliance to Protocol|0|||
155245919|NCT03434119|560330931|FG001|Overall Study|Poor Compliance to Protocol|1|||
155245920|NCT03434119|560330930|FG000|Overall Study|Study Terminated by Sponsor|91|||
155245921|NCT03434119|560330931|FG001|Overall Study|Study Terminated by Sponsor|102|||
155245922|NCT03434119|560330930|FG000|Overall Study|Withdrawal by Subject|7|||
155245923|NCT03434119|560330931|FG001|Overall Study|Withdrawal by Subject|5|||
155245924|NCT03434119|560330930|FG000|Overall Study|Other than specified|7|||
155245925|NCT03434119|560330931|FG001|Overall Study|Other than specified|5|||
155245926|NCT04360824|560330932|FG000|Overall Study|Withdrawal by Subject|2|||
155245927|NCT04360824|560330933|FG001|Overall Study|Withdrawal by Subject|1|||
155245928|NCT04360824|560330932|FG000|Overall Study|Did not receive assigned treatment|1|||
155245929|NCT04360824|560330933|FG001|Overall Study|Did not receive assigned treatment|3|||
155245930|NCT00304070|560330934|FG000|Overall Study|Death|0|||
155245931|NCT00304070|560330935|FG001|Overall Study|Death|0|||
155245932|NCT00304070|560330936|FG002|Overall Study|Death|3|||
155245933|NCT00304070|560330934|FG000|Overall Study|Lost to Follow-up|0|||
155245934|NCT00304070|560330935|FG001|Overall Study|Lost to Follow-up|0|||
155245935|NCT00304070|560330936|FG002|Overall Study|Lost to Follow-up|1|||
155245936|NCT00304070|560330934|FG000|Overall Study|Physician Decision|0|||
155245937|NCT00304070|560330935|FG001|Overall Study|Physician Decision|0|||
155245938|NCT00304070|560330936|FG002|Overall Study|Physician Decision|3|||
155245939|NCT00304070|560330934|FG000|Overall Study|Withdrawal by Subject|0|||
155245940|NCT00304070|560330935|FG001|Overall Study|Withdrawal by Subject|0|||
155245941|NCT00304070|560330936|FG002|Overall Study|Withdrawal by Subject|1|||
155245942|NCT00304070|560330934|FG000|Overall Study|Progressive Disease|3|||
155245943|NCT00304070|560330935|FG001|Overall Study|Progressive Disease|7|||
155245944|NCT00304070|560330936|FG002|Overall Study|Progressive Disease|4|||
155245945|NCT00320216|560330937|FG000|Overall Study|Adverse Event|0|||
155245946|NCT00320216|560330938|FG001|Overall Study|Adverse Event|6|||
155245947|NCT00320216|560330939|FG002|Overall Study|Adverse Event|0|||
155245948|NCT00320216|560330940|FG003|Overall Study|Adverse Event|2|||
155245949|NCT00320216|560330941|FG004|Overall Study|Adverse Event|2|||
155245950|NCT00320216|560330937|FG000|Overall Study|Lack of Efficacy|6|||
155245951|NCT00320216|560330938|FG001|Overall Study|Lack of Efficacy|2|||
155245952|NCT00320216|560330939|FG002|Overall Study|Lack of Efficacy|1|||
155245953|NCT00320216|560330940|FG003|Overall Study|Lack of Efficacy|0|||
155245954|NCT00320216|560330941|FG004|Overall Study|Lack of Efficacy|1|||
155245955|NCT00320216|560330937|FG000|Overall Study|Lost to Follow-up|3|||
155245956|NCT00320216|560330938|FG001|Overall Study|Lost to Follow-up|0|||
155245957|NCT00320216|560330939|FG002|Overall Study|Lost to Follow-up|0|||
155245958|NCT00320216|560330940|FG003|Overall Study|Lost to Follow-up|0|||
155245959|NCT00320216|560330941|FG004|Overall Study|Lost to Follow-up|0|||
155245960|NCT00320216|560330937|FG000|Overall Study|Other|7|||
155245961|NCT00320216|560330938|FG001|Overall Study|Other|2|||
155245962|NCT00320216|560330939|FG002|Overall Study|Other|5|||
155245963|NCT00320216|560330940|FG003|Overall Study|Other|1|||
155245964|NCT00320216|560330941|FG004|Overall Study|Other|3|||
155245965|NCT00779246|560330950|FG000|Overall Study|Missing sufficient data for analysis|33|||
155245966|NCT00779246|560330951|FG001|Overall Study|Missing sufficient data for analysis|53|||
155245967|NCT03579459|560330954|FG000|Overall Study|Adverse Event|7|||
155245968|NCT03579459|560330955|FG001|Overall Study|Adverse Event|6|||
155245969|NCT03579459|560330956|FG002|Overall Study|Adverse Event|2|||
155245970|NCT03579459|560330957|FG003|Overall Study|Adverse Event|6|||
155245971|NCT03579459|560330954|FG000|Overall Study|Death|1|||
155245972|NCT03579459|560330955|FG001|Overall Study|Death|0|||
155245973|NCT03579459|560330956|FG002|Overall Study|Death|1|||
155245974|NCT03579459|560330957|FG003|Overall Study|Death|2|||
155245975|NCT03579459|560330954|FG000|Overall Study|Lost to Follow-up|6|||
155245976|NCT03579459|560330955|FG001|Overall Study|Lost to Follow-up|2|||
155245977|NCT03579459|560330956|FG002|Overall Study|Lost to Follow-up|4|||
155245978|NCT03579459|560330957|FG003|Overall Study|Lost to Follow-up|1|||
155245979|NCT03579459|560330954|FG000|Overall Study|Physician Decision|0|||
155245980|NCT03579459|560330955|FG001|Overall Study|Physician Decision|1|||
155245981|NCT03579459|560330956|FG002|Overall Study|Physician Decision|0|||
155245982|NCT03579459|560330957|FG003|Overall Study|Physician Decision|1|||
155245983|NCT03579459|560330954|FG000|Overall Study|Protocol Violation|1|||
155245984|NCT03579459|560330955|FG001|Overall Study|Protocol Violation|2|||
155245985|NCT03579459|560330956|FG002|Overall Study|Protocol Violation|3|||
155245986|NCT03579459|560330957|FG003|Overall Study|Protocol Violation|5|||
155245987|NCT03579459|560330954|FG000|Overall Study|Withdrawal by Subject|12|||
155245988|NCT03579459|560330955|FG001|Overall Study|Withdrawal by Subject|8|||
155245989|NCT03579459|560330956|FG002|Overall Study|Withdrawal by Subject|11|||
155245990|NCT03579459|560330957|FG003|Overall Study|Withdrawal by Subject|8|||
155245991|NCT03579459|560330954|FG000|Overall Study|Medication error without associated adverse event|2|||
155245992|NCT03579459|560330955|FG001|Overall Study|Medication error without associated adverse event|1|||
155245993|NCT03579459|560330956|FG002|Overall Study|Medication error without associated adverse event|1|||
155245994|NCT03579459|560330957|FG003|Overall Study|Medication error without associated adverse event|0|||
155245995|NCT03579459|560330954|FG000|Overall Study|Other|0|||
155245996|NCT03579459|560330955|FG001|Overall Study|Other|1|||
155245997|NCT03579459|560330956|FG002|Overall Study|Other|1|||
155245998|NCT03579459|560330957|FG003|Overall Study|Other|0|||
155245999|NCT03579459|560330954|FG000|Overall Study|Randomized not vaccinated|0|||
155246000|NCT03579459|560330955|FG001|Overall Study|Randomized not vaccinated|2|||
155246001|NCT03579459|560330956|FG002|Overall Study|Randomized not vaccinated|0|||
155246002|NCT03579459|560330957|FG003|Overall Study|Randomized not vaccinated|1|||
155246003|NCT00148343|560330958|FG000|Overall Study|Withdrawal by Subject|12|||
155246004|NCT00148343|560330959|FG001|Overall Study|Withdrawal by Subject|7|||
155246005|NCT00148343|560330958|FG000|Overall Study|Physician Decision|3|||
155246006|NCT00148343|560330959|FG001|Overall Study|Physician Decision|4|||
155246007|NCT02844946|560330963|FG000|Overall Study|Lost to Follow-up|7|||
155246008|NCT02844946|560330964|FG001|Overall Study|Lost to Follow-up|0|||
155246009|NCT02528214|560330970|FG000|Overall Study|Protocol Violation|0|||
155246010|NCT02528214|560330971|FG001|Overall Study|Protocol Violation|1|||
155246011|NCT02528214|560330970|FG000|Overall Study|Adverse Event|0|||
155246012|NCT02528214|560330971|FG001|Overall Study|Adverse Event|1|||
155246013|NCT02528214|560330970|FG000|Overall Study|Other than specified above|0|||
155246014|NCT02528214|560330971|FG001|Overall Study|Other than specified above|1|||
155246015|NCT00407537|560330972|FG000|Overall Study|Death|5|||
155246016|NCT00407537|560330973|FG001|Overall Study|Death|2|||
155246017|NCT00407537|560330972|FG000|Overall Study|Adverse Event|36|||
155246018|NCT00407537|560330973|FG001|Overall Study|Adverse Event|0|||
155246019|NCT00407537|560330972|FG000|Overall Study|Lost to Follow-up|12|||
155246020|NCT00407537|560330973|FG001|Overall Study|Lost to Follow-up|19|||
155246021|NCT00407537|560330972|FG000|Overall Study|Other|6|||
155246022|NCT00407537|560330973|FG001|Overall Study|Other|7|||
155246023|NCT00407537|560330972|FG000|Overall Study|Withdrawal by Subject|34|||
155246024|NCT00407537|560330973|FG001|Overall Study|Withdrawal by Subject|16|||
155246025|NCT02384759|560330974|FG000|Overall Study|Patients not treated|3|||
155246026|NCT02384759|560330975|FG001|Overall Study|Patients not treated|2|||
155246027|NCT01605617|560330976|FG000|First Intervention|Adverse Event|0|||
155246028|NCT01605617|560330977|FG001|First Intervention|Adverse Event|1|||
155246029|NCT01605617|560330976|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
155246030|NCT01605617|560330977|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
155246031|NCT00121238|560330979|FG000|Overall Study|disease progression before intervention|1|||
155246032|NCT00121238|560330979|FG000|Overall Study|Protocol Violation|2|||
155246033|NCT01380327|560330980|FG000|Overall Study|Lost to Follow-up|0|||
155246034|NCT01380327|560330981|FG001|Overall Study|Lost to Follow-up|1|||
155246035|NCT01380327|560330982|FG002|Overall Study|Lost to Follow-up|1|||
155246036|NCT01380327|560330980|FG000|Overall Study|Protocol Violation|3|||
155246037|NCT01380327|560330981|FG001|Overall Study|Protocol Violation|2|||
155246038|NCT01380327|560330982|FG002|Overall Study|Protocol Violation|3|||
155246039|NCT01380327|560330980|FG000|Overall Study|Withdrawal by Subject|0|||
155246040|NCT01380327|560330981|FG001|Overall Study|Withdrawal by Subject|0|||
155246041|NCT01380327|560330982|FG002|Overall Study|Withdrawal by Subject|1|||
155246042|NCT01380327|560330980|FG000|Overall Study|Housing situation precluded ability to k|0|||
155246043|NCT01380327|560330981|FG001|Overall Study|Housing situation precluded ability to k|0|||
155246044|NCT01380327|560330982|FG002|Overall Study|Housing situation precluded ability to k|1|||
155246045|NCT01380327|560330980|FG000|Overall Study|Questionable onset of epilepsy|0|||
155246046|NCT01380327|560330981|FG001|Overall Study|Questionable onset of epilepsy|0|||
155246047|NCT01380327|560330982|FG002|Overall Study|Questionable onset of epilepsy|1|||
155246048|NCT00325468|560330983|FG000|Overall Study|Adverse Event|1|||
155246049|NCT00325468|560330984|FG001|Overall Study|Adverse Event|1|||
155246050|NCT00325468|560330985|FG002|Overall Study|Adverse Event|0|||
155246051|NCT00325468|560330986|FG003|Overall Study|Adverse Event|5|||
155246052|NCT00325468|560330987|FG004|Overall Study|Adverse Event|1|||
155246053|NCT00325468|560330983|FG000|Overall Study|Death|2|||
155246054|NCT00325468|560330984|FG001|Overall Study|Death|0|||
155246055|NCT00325468|560330985|FG002|Overall Study|Death|2|||
155246056|NCT00325468|560330986|FG003|Overall Study|Death|4|||
155246057|NCT00325468|560330987|FG004|Overall Study|Death|0|||
155246058|NCT00325468|560330983|FG000|Overall Study|Lost to Follow-up|0|||
155246059|NCT00325468|560330984|FG001|Overall Study|Lost to Follow-up|0|||
155246060|NCT00325468|560330985|FG002|Overall Study|Lost to Follow-up|1|||
155246061|NCT00325468|560330986|FG003|Overall Study|Lost to Follow-up|2|||
155246062|NCT00325468|560330987|FG004|Overall Study|Lost to Follow-up|2|||
155246063|NCT00325468|560330983|FG000|Overall Study|Physician Decision|1|||
155246064|NCT00325468|560330984|FG001|Overall Study|Physician Decision|1|||
155246065|NCT00325468|560330985|FG002|Overall Study|Physician Decision|0|||
155246066|NCT00325468|560330986|FG003|Overall Study|Physician Decision|1|||
155246067|NCT00325468|560330987|FG004|Overall Study|Physician Decision|0|||
155246068|NCT00325468|560330983|FG000|Overall Study|Withdrawal by Subject|3|||
155246069|NCT00325468|560330984|FG001|Overall Study|Withdrawal by Subject|1|||
155246070|NCT00325468|560330985|FG002|Overall Study|Withdrawal by Subject|0|||
155246071|NCT00325468|560330986|FG003|Overall Study|Withdrawal by Subject|14|||
155246072|NCT00325468|560330987|FG004|Overall Study|Withdrawal by Subject|4|||
155246073|NCT00325468|560330983|FG000|Overall Study|site closure etc|4|||
155246074|NCT00325468|560330984|FG001|Overall Study|site closure etc|2|||
155246075|NCT00325468|560330985|FG002|Overall Study|site closure etc|1|||
155246076|NCT00325468|560330986|FG003|Overall Study|site closure etc|8|||
155246077|NCT00325468|560330987|FG004|Overall Study|site closure etc|1|||
155246078|NCT03593655|560330988|FG000|First Product Use Period|Withdrawal by Subject|1|||
155246079|NCT03593655|560330989|FG001|First Product Use Period|Withdrawal by Subject|1|||
155246080|NCT03593655|560330988|FG000|First Product Use Period|Lost to Follow-up|1|||
155246081|NCT03593655|560330989|FG001|First Product Use Period|Lost to Follow-up|3|||
155246082|NCT03593655|560330988|FG000|Second Product Use Period|Withdrawal by Subject|1|||
155246083|NCT03593655|560330989|FG001|Second Product Use Period|Withdrawal by Subject|1|||
155246084|NCT03593655|560330988|FG000|Second Product Use Period|Lost to Follow-up|1|||
155246085|NCT03593655|560330989|FG001|Second Product Use Period|Lost to Follow-up|0|||
155246086|NCT03593655|560330988|FG000|Third Product Use Period|Lost to Follow-up|1|||
155246087|NCT03593655|560330989|FG001|Third Product Use Period|Lost to Follow-up|2|||
155246088|NCT03593655|560330988|FG000|Third Product Use Period|Physician Decision|0|||
155246089|NCT03593655|560330989|FG001|Third Product Use Period|Physician Decision|1|||
155246090|NCT03593655|560330988|FG000|Third Product Use Period|Withdrawal by Subject|0|||
155246091|NCT03593655|560330989|FG001|Third Product Use Period|Withdrawal by Subject|1|||
155246092|NCT05046795|560330990|FG000|Overall Study|Adverse Event|13|||
155246093|NCT05046795|560330991|FG001|Overall Study|Adverse Event|15|||
155246094|NCT05046795|560330990|FG000|Overall Study|Withdrawal by Subject|4|||
155246095|NCT05046795|560330991|FG001|Overall Study|Withdrawal by Subject|7|||
155246096|NCT05046795|560330990|FG000|Overall Study|Physician Decision|1|||
155246097|NCT05046795|560330991|FG001|Overall Study|Physician Decision|2|||
155246098|NCT05046795|560330990|FG000|Overall Study|Protocol Violation|1|||
155246099|NCT05046795|560330991|FG001|Overall Study|Protocol Violation|2|||
155246100|NCT05046795|560330990|FG000|Overall Study|Death|1|||
155246101|NCT05046795|560330991|FG001|Overall Study|Death|0|||
155246102|NCT05046795|560330990|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
155246103|NCT05046795|560330991|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
155246104|NCT01127178|560330992|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
155246105|NCT01127178|560330993|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
155246106|NCT01127178|560330992|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
155246107|NCT01127178|560330993|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
155246108|NCT01127178|560330992|FG000|Dose Escalation: Treatment Phase|Other|2|||
155246109|NCT01127178|560330993|FG001|Dose Escalation: Treatment Phase|Other|0|||
155246110|NCT01127178|560330992|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
155246111|NCT01127178|560330993|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
155246112|NCT01127178|560330992|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
155246113|NCT01127178|560330993|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
155246114|NCT01127178|560330992|FG000|Dose Escalation: Extension Phase|Other|1|||
155246115|NCT01127178|560330993|FG001|Dose Escalation: Extension Phase|Other|0|||
155246116|NCT02365467|560330997|FG000|Overall Study|Death|3|||
155246117|NCT04667117|560330998|FG000|Investigational Period|Lost to Follow-up|0|||
155246118|NCT04667117|560330999|FG001|Investigational Period|Lost to Follow-up|0|||
155246119|NCT04667117|560331000|FG002|Investigational Period|Lost to Follow-up|1|||
155246120|NCT04667117|560330998|FG000|Investigational Period|Protocol Deviation|0|||
155246121|NCT04667117|560330999|FG001|Investigational Period|Protocol Deviation|1|||
155246122|NCT04667117|560331000|FG002|Investigational Period|Protocol Deviation|0|||
155246123|NCT04667117|560330998|FG000|Extension Period|Lost to Follow-up|1|||
155246124|NCT04667117|560330999|FG001|Extension Period|Lost to Follow-up|0|||
155246125|NCT04667117|560331000|FG002|Extension Period|Lost to Follow-up|0|||
155246126|NCT03965052|560331004|FG000|Overall Study|Protocol Violation|1|||
155246127|NCT03965052|560331005|FG001|Overall Study|Protocol Violation|0|||
155246128|NCT04323436|560331014|FG000|Overall Study|Adverse Event|7|||
155246129|NCT04323436|560331015|FG001|Overall Study|Adverse Event|0|||
155246130|NCT04323436|560331016|FG002|Overall Study|Adverse Event|0|||
155246131|NCT04323436|560331014|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
155246132|NCT04323436|560331015|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
155246133|NCT04323436|560331016|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
155246134|NCT04323436|560331014|FG000|Overall Study|Death|1|||
155246135|NCT04323436|560331015|FG001|Overall Study|Death|0|||
155246136|NCT04323436|560331016|FG002|Overall Study|Death|0|||
155246137|NCT04323436|560331014|FG000|Overall Study|Physician Decision|2|||
155246138|NCT04323436|560331015|FG001|Overall Study|Physician Decision|0|||
155246139|NCT04323436|560331016|FG002|Overall Study|Physician Decision|0|||
155246140|NCT04323436|560331014|FG000|Overall Study|Progressive disease|10|||
155246141|NCT04323436|560331015|FG001|Overall Study|Progressive disease|0|||
155246142|NCT04323436|560331016|FG002|Overall Study|Progressive disease|0|||
155246143|NCT04323436|560331014|FG000|Overall Study|Subject decision|3|||
155246144|NCT04323436|560331015|FG001|Overall Study|Subject decision|0|||
155246145|NCT04323436|560331016|FG002|Overall Study|Subject decision|0|||
155246146|NCT02720484|560331017|FG000|Treatment on Study|Adverse Event|1|||
155246147|NCT02720484|560331017|FG000|Treatment on Study|Withdrawal by Subject|1|||
155246148|NCT02720484|560331017|FG000|Treatment on Study|Progressive Disease|4|||
155246149|NCT02720484|560331017|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
155246150|NCT02720484|560331017|FG000|Follow Up for 2 Years|Death|3|||
155246151|NCT02720484|560331017|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
155246152|NCT01617629|560331022|FG000|Overall Study|Death|2|||
155246153|NCT01617629|560331022|FG000|Overall Study|Investigator's Clinical Judgement|1|||
155246154|NCT01617629|560331022|FG000|Overall Study|Reason Not Specified|1|||
155246155|NCT01617629|560331022|FG000|Overall Study|Participant Withdrew Consent|2|||
155246156|NCT01663636|560331023|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
155246157|NCT01663636|560331024|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
155246158|NCT02715765|560331025|FG000|Overall Study|Study Termination|3|||
155246159|NCT02715765|560331026|FG001|Overall Study|Study Termination|0|||
155246160|NCT02715765|560331027|FG002|Overall Study|Study Termination|0|||
155246161|NCT02838017|560331029|FG000|Overall Study|Lost to Follow-up|14|||
155246162|NCT02838017|560331030|FG001|Overall Study|Lost to Follow-up|11|||
155246163|NCT01692197|560331031|FG000|Overall Study|Failed Screening|3|||
155246164|NCT02120924|560331032|FG000|Overall Study|Lack of Efficacy|1|||
155246165|NCT02120924|560331033|FG001|Overall Study|Lack of Efficacy|2|||
155246166|NCT02120924|560331034|FG002|Overall Study|Lack of Efficacy|3|||
155246167|NCT02120924|560331032|FG000|Overall Study|Adverse Event|0|||
155246168|NCT02120924|560331033|FG001|Overall Study|Adverse Event|1|||
155246169|NCT02120924|560331034|FG002|Overall Study|Adverse Event|3|||
155246170|NCT02120924|560331032|FG000|Overall Study|Withdrawal by Subject|16|||
155246171|NCT02120924|560331033|FG001|Overall Study|Withdrawal by Subject|20|||
155246172|NCT02120924|560331034|FG002|Overall Study|Withdrawal by Subject|8|||
155246173|NCT02120924|560331032|FG000|Overall Study|Lost to Follow-up|14|||
155246174|NCT02120924|560331033|FG001|Overall Study|Lost to Follow-up|14|||
155246175|NCT02120924|560331034|FG002|Overall Study|Lost to Follow-up|11|||
155246176|NCT02120924|560331032|FG000|Overall Study|Pregnancy|2|||
155246177|NCT02120924|560331033|FG001|Overall Study|Pregnancy|0|||
155246178|NCT02120924|560331034|FG002|Overall Study|Pregnancy|0|||
155246179|NCT02120924|560331032|FG000|Overall Study|Protocol Violation|3|||
155246180|NCT02120924|560331033|FG001|Overall Study|Protocol Violation|7|||
155246181|NCT02120924|560331034|FG002|Overall Study|Protocol Violation|2|||
155246182|NCT02120924|560331032|FG000|Overall Study|Physician Decision|0|||
155246183|NCT02120924|560331033|FG001|Overall Study|Physician Decision|1|||
155246184|NCT02120924|560331034|FG002|Overall Study|Physician Decision|1|||
155246185|NCT02120924|560331032|FG000|Overall Study|Death|1|||
155246186|NCT02120924|560331033|FG001|Overall Study|Death|0|||
155246187|NCT02120924|560331034|FG002|Overall Study|Death|0|||
155246188|NCT02120924|560331032|FG000|Overall Study|Compliance with IP|5|||
155246189|NCT02120924|560331033|FG001|Overall Study|Compliance with IP|1|||
155246190|NCT02120924|560331034|FG002|Overall Study|Compliance with IP|1|||
155246191|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
155246192|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
155246193|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
155246194|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
155246195|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
155246196|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
155246197|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
155246198|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
155246199|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
155246200|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
155246201|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
155246202|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
155246203|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
155246204|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
155246205|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
155246206|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
155246207|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
155246208|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
155246209|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
155246210|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
155246211|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
155246212|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
155246213|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
155246214|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
155246215|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
155246216|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
155246217|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
155246218|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
155246219|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
155246220|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
155246221|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
155246222|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
155246223|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
155246224|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
155246225|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
155246226|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
155246227|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
155246228|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
155246229|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
155246230|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
155246231|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
155246232|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
155246233|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
155246234|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
155246235|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
155246236|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
155246237|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
155246238|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
155246239|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
155246240|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
155246241|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
155246242|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
155246243|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
155246244|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
155246245|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
155246246|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
155246247|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
155246248|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
155246249|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
155246250|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
155246251|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
155246252|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
155246253|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
155246254|NCT01884350|560331035|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
155246255|NCT01884350|560331036|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
155246256|NCT01884350|560331037|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
155246257|NCT03588572|560331044|FG000|Visitation 1|Lack of Efficacy|1|||
155246258|NCT03588572|560331045|FG001|Visitation 1|Lack of Efficacy|1|||
155246259|NCT03588572|560331044|FG000|Visitation 2|Lost to Follow-up|1|||
155246260|NCT03588572|560331045|FG001|Visitation 2|Lost to Follow-up|1|||
155246261|NCT03588572|560331044|FG000|Visitation 2|Lack of Efficacy|0|||
155246262|NCT03588572|560331045|FG001|Visitation 2|Lack of Efficacy|1|||
155246263|NCT03588572|560331044|FG000|Visitation 2|Withdrawal by Subject|1|||
155246264|NCT03588572|560331045|FG001|Visitation 2|Withdrawal by Subject|0|||
155246265|NCT03588572|560331044|FG000|Visitation 3|Lost to Follow-up|1|||
155246266|NCT03588572|560331045|FG001|Visitation 3|Lost to Follow-up|1|||
155246267|NCT03588572|560331044|FG000|Visitation 3|Physician Decision|1|||
155246268|NCT03588572|560331045|FG001|Visitation 3|Physician Decision|1|||
155246269|NCT03588572|560331044|FG000|Visitation 3|Withdrawal by Subject|1|||
155246270|NCT03588572|560331045|FG001|Visitation 3|Withdrawal by Subject|0|||
155246271|NCT01308580|560331051|FG000|Overall Study|Lost to Follow-up|12|||
155246272|NCT01308580|560331052|FG001|Overall Study|Lost to Follow-up|7|||
155246273|NCT03823651|560331053|FG000|Overall Study|Death|5|||
155246274|NCT03823651|560331054|FG001|Overall Study|Death|0|||
155246275|NCT03823651|560331053|FG000|Overall Study|Physician Decision|1|||
155246276|NCT03823651|560331054|FG001|Overall Study|Physician Decision|0|||
155246277|NCT03823651|560331053|FG000|Overall Study|Caregiver to patient who died|0|||
155246278|NCT03823651|560331054|FG001|Overall Study|Caregiver to patient who died|5|||
155246279|NCT03823651|560331053|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
155246280|NCT03823651|560331054|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
155246281|NCT05350449|560331055|FG000|Overall Study|Withdrawal by Subject|4|||
155246282|NCT05350449|560331056|FG001|Overall Study|Withdrawal by Subject|8|||
155246283|NCT01625897|560332690|FG000|Overall Study|Adverse Event|27|||
155246284|NCT01625897|560332691|FG001|Overall Study|Adverse Event|10|||
155246285|NCT01625897|560332690|FG000|Overall Study|Physician Decision|0|||
155246286|NCT01625897|560332691|FG001|Overall Study|Physician Decision|1|||
155246287|NCT01625897|560332690|FG000|Overall Study|Withdrawal by Subject|25|||
155246288|NCT01625897|560332691|FG001|Overall Study|Withdrawal by Subject|3|||
155246289|NCT01432366|560332692|FG000|Overall Study|Non-Responder|7|||
155246290|NCT01432366|560332692|FG000|Overall Study|Adverse Event|8|||
155246291|NCT01432366|560332692|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
155246292|NCT01432366|560332692|FG000|Overall Study|Pregnancy|1|||
155246293|NCT01432366|560332692|FG000|Overall Study|Lost to Follow-up|13|||
155246294|NCT01432366|560332692|FG000|Overall Study|Lack of Efficacy|1|||
155246295|NCT01432366|560332692|FG000|Overall Study|Site Closed|20|||
155246296|NCT01432366|560332692|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
155246297|NCT01432366|560332692|FG000|Overall Study|Other|14|||
155246298|NCT04546581|560332694|FG000|Overall Study|Adverse Event|9|||
155246299|NCT04546581|560332695|FG001|Overall Study|Adverse Event|3|||
155246300|NCT04546581|560332694|FG000|Overall Study|Physician Decision|0|||
155246301|NCT04546581|560332695|FG001|Overall Study|Physician Decision|1|||
155246302|NCT04546581|560332694|FG000|Overall Study|Protocol Violation|1|||
155246303|NCT04546581|560332695|FG001|Overall Study|Protocol Violation|2|||
155246304|NCT04546581|560332694|FG000|Overall Study|Withdrawal by Subject|3|||
155246305|NCT04546581|560332695|FG001|Overall Study|Withdrawal by Subject|7|||
155246306|NCT02526693|560332696|FG000|Overall Study|Physician Decision|3|||
155246307|NCT02526693|560332697|FG001|Overall Study|Physician Decision|1|||
155246308|NCT01585103|560332699|FG000|Overall Study|Unable to swallow Cytosponge|6|||
155246309|NCT01349569|560332700|FG000|Overall Study|Lack of Efficacy|4|||
155246310|NCT01944631|560332701|FG000|Overall Study|Adverse Event|1|||
155246311|NCT01944631|560332702|FG001|Overall Study|Adverse Event|0|||
155246312|NCT01944631|560332701|FG000|Overall Study|Lost to Follow-up|3|||
155246313|NCT01944631|560332702|FG001|Overall Study|Lost to Follow-up|1|||
155246314|NCT01944631|560332701|FG000|Overall Study|Withdrawal by Subject|0|||
155246315|NCT01944631|560332702|FG001|Overall Study|Withdrawal by Subject|1|||
155246316|NCT00328510|560332705|FG000|Overall Study|Gag disorder, could not use frame|4|||
155246317|NCT00328510|560332706|FG001|Overall Study|Gag disorder, could not use frame|0|||
155246318|NCT00328510|560332705|FG000|Overall Study|Dentition problems, could not use frame|1|||
155246319|NCT00328510|560332706|FG001|Overall Study|Dentition problems, could not use frame|0|||
155246320|NCT00328510|560332705|FG000|Overall Study|Withdrawal by Subject|4|||
155246321|NCT00328510|560332706|FG001|Overall Study|Withdrawal by Subject|2|||
155246322|NCT00328510|560332705|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
155246323|NCT00328510|560332706|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
155246324|NCT00328510|560332705|FG000|Overall Study|Treatment changed to a single fraction|1|||
155246325|NCT00328510|560332706|FG001|Overall Study|Treatment changed to a single fraction|1|||
155246326|NCT01412944|560332707|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246327|NCT01412944|560332708|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246328|NCT01412944|560332709|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
155246329|NCT01412944|560332710|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246330|NCT01412944|560332711|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246331|NCT01412944|560332712|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
155246332|NCT01412944|560332707|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246333|NCT01412944|560332708|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246334|NCT01412944|560332709|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246335|NCT01412944|560332710|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246336|NCT01412944|560332711|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
155246337|NCT01412944|560332712|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
155246338|NCT01412944|560332707|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246339|NCT01412944|560332708|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246340|NCT01412944|560332709|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246341|NCT01412944|560332710|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246342|NCT01412944|560332711|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
155246343|NCT01412944|560332712|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
155246344|NCT01412944|560332707|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
155246345|NCT01412944|560332708|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246346|NCT01412944|560332709|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246347|NCT01412944|560332710|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246348|NCT01412944|560332711|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246349|NCT01412944|560332712|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
155246350|NCT01412944|560332707|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
155246351|NCT01412944|560332708|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
155246352|NCT01412944|560332709|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
155246353|NCT01412944|560332710|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
155246354|NCT01412944|560332711|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
155246355|NCT01412944|560332712|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
155246356|NCT01412944|560332707|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246357|NCT01412944|560332708|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
155246358|NCT01412944|560332709|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246359|NCT01412944|560332710|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246360|NCT01412944|560332711|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246361|NCT01412944|560332712|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
155246362|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246363|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246364|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246365|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246366|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246367|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246368|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Adverse Event|0|||
155246369|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Adverse Event|0|||
155246370|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Adverse Event|0|||
155246371|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Adverse Event|0|||
155246372|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Adverse Event|1|||
155246373|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Adverse Event|0|||
155246374|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
155246375|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
155246376|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
155246377|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
155246378|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
155246379|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
155246380|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246381|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246382|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246383|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246384|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246385|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
155246386|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246387|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246388|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246389|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246390|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
155246391|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246392|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
155246393|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
155246394|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246395|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246396|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246397|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
155246398|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
155246399|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
155246400|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
155246401|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
155246402|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
155246403|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
155246404|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246405|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
155246406|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246407|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246408|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246409|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
155246410|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246411|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
155246412|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246413|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246414|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246415|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
155246416|NCT01412944|560332707|FG000|Entire: IV + Maintenance|Adverse Event|0|||
155246417|NCT01412944|560332708|FG001|Entire: IV + Maintenance|Adverse Event|1|||
155246418|NCT01412944|560332709|FG002|Entire: IV + Maintenance|Adverse Event|0|||
155246419|NCT01412944|560332710|FG003|Entire: IV + Maintenance|Adverse Event|0|||
155246420|NCT01412944|560332711|FG004|Entire: IV + Maintenance|Adverse Event|0|||
155246421|NCT01412944|560332712|FG005|Entire: IV + Maintenance|Adverse Event|0|||
155246422|NCT01990950|560332713|FG000|Overall Study|Death|3|||
155246423|NCT01990950|560332713|FG000|Overall Study|Lost to Follow-up|2|||
155246424|NCT01990950|560332713|FG000|Overall Study|Withdrawal by Subject|6|||
155246425|NCT02863926|560332714|FG000|Overall Study|Physician Decision|1|||
155246426|NCT02863926|560332715|FG001|Overall Study|Physician Decision|0|||
155246427|NCT02863926|560332714|FG000|Overall Study|Lost to Follow-up|1|||
155246428|NCT02863926|560332715|FG001|Overall Study|Lost to Follow-up|1|||
155246429|NCT02473952|560332720|FG000|Overall Study|Adverse Event|2|||
155246430|NCT02473952|560332721|FG001|Overall Study|Adverse Event|2|||
155246431|NCT02473952|560332720|FG000|Overall Study|Withdrawal by Subject|0|||
155246432|NCT02473952|560332721|FG001|Overall Study|Withdrawal by Subject|6|||
155246433|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
155246434|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
155246435|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Death|1|||
155246436|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Death|0|||
155246437|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
155246438|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
155246439|NCT00455195|560332724|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
155246440|NCT00455195|560332725|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
155246441|NCT00823719|560332726|FG000|Overall Study|Adverse Event|1|||
155246442|NCT00823719|560332727|FG001|Overall Study|Adverse Event|2|||
155246443|NCT00823719|560332726|FG000|Overall Study|Physician Decision|1|||
155246444|NCT00823719|560332727|FG001|Overall Study|Physician Decision|4|||
155246445|NCT00823719|560332726|FG000|Overall Study|Withdrawal by Subject|0|||
155246446|NCT00823719|560332727|FG001|Overall Study|Withdrawal by Subject|1|||
155246447|NCT00823719|560332726|FG000|Overall Study|Disease Progression|4|||
155246448|NCT00823719|560332727|FG001|Overall Study|Disease Progression|4|||
155246449|NCT02117570|560332728|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
155246450|NCT02117570|560332729|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
155246451|NCT02117570|560332730|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
155246452|NCT02117570|560332728|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
155246453|NCT02117570|560332729|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
155246454|NCT02117570|560332730|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
155246455|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
155246456|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
155246457|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
155246458|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
155246459|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
155246460|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
155246461|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
155246462|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
155246463|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
155246464|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
155246465|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
155246466|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
155246467|NCT02117570|560332728|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
155246468|NCT02117570|560332729|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
155246469|NCT02117570|560332730|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
155246470|NCT02148250|560332731|FG000|Screening|Withdrawal by Subject|5|||
155246471|NCT02148250|560332732|FG001|Screening|Withdrawal by Subject|0|||
155246472|NCT02806986|560332738|FG000|Treatment Stage 1|Adverse Event|1|||
155246473|NCT02806986|560332738|FG000|Treatment Stage 2|Adverse Event|3|||
155246474|NCT02806986|560332738|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
155246475|NCT03043664|560332739|FG000|Overall Study|Lost to Follow-up|1|||
155246476|NCT01540851|560332740|FG000|Overall Study|Lost to Follow-up|14|||
155246477|NCT01540851|560332741|FG001|Overall Study|Lost to Follow-up|15|||
155246478|NCT01540851|560332740|FG000|Overall Study|Withdrawal by Subject|7|||
155246479|NCT01540851|560332741|FG001|Overall Study|Withdrawal by Subject|3|||
155246480|NCT03732209|560332742|FG000|Overall Study|Lost to Follow-up|4|||
155246481|NCT03732209|560332743|FG001|Overall Study|Lost to Follow-up|4|||
155246482|NCT03732209|560332742|FG000|Overall Study|Withdrawal by Subject|8|||
155246483|NCT03732209|560332743|FG001|Overall Study|Withdrawal by Subject|9|||
155246484|NCT04139317|560332744|FG000|Overall Study|Adverse Event|10|||
155246485|NCT04139317|560332745|FG001|Overall Study|Adverse Event|2|||
155246486|NCT04139317|560332744|FG000|Overall Study|Death|6|||
155246487|NCT04139317|560332745|FG001|Overall Study|Death|4|||
155246488|NCT04139317|560332744|FG000|Overall Study|Lost to Follow-up|1|||
155246489|NCT04139317|560332745|FG001|Overall Study|Lost to Follow-up|0|||
155246490|NCT04139317|560332744|FG000|Overall Study|Physician Decision|3|||
155246491|NCT04139317|560332745|FG001|Overall Study|Physician Decision|1|||
155246492|NCT04139317|560332744|FG000|Overall Study|Progressive Disease|19|||
155246493|NCT04139317|560332745|FG001|Overall Study|Progressive Disease|9|||
155246494|NCT04139317|560332744|FG000|Overall Study|Subject Decision|2|||
155246495|NCT04139317|560332745|FG001|Overall Study|Subject Decision|2|||
155246496|NCT03621696|560332748|FG000|Overall Study|Not eligible|0|||
155246497|NCT03621696|560332749|FG001|Overall Study|Not eligible|0|||
155246498|NCT03621696|560332750|FG002|Overall Study|Not eligible|0|||
155246499|NCT03621696|560332751|FG003|Overall Study|Not eligible|5|||
155246500|NCT03621696|560332748|FG000|Overall Study|Withdrawal by Subject|1|||
155246501|NCT03621696|560332749|FG001|Overall Study|Withdrawal by Subject|1|||
155246502|NCT03621696|560332750|FG002|Overall Study|Withdrawal by Subject|1|||
155246503|NCT03621696|560332751|FG003|Overall Study|Withdrawal by Subject|0|||
155246504|NCT03621696|560332748|FG000|Overall Study|Physician Decision|0|||
155246505|NCT03621696|560332749|FG001|Overall Study|Physician Decision|0|||
155246506|NCT03621696|560332750|FG002|Overall Study|Physician Decision|1|||
155246507|NCT03621696|560332751|FG003|Overall Study|Physician Decision|0|||
155246508|NCT00413413|560332752|FG000|Single-Blind|Adverse Event|0|||
155246509|NCT00413413|560332753|FG001|Single-Blind|Adverse Event|9|||
155246510|NCT00413413|560332754|FG002|Single-Blind|Adverse Event|0|||
155246511|NCT00413413|560332752|FG000|Single-Blind|Lack of Efficacy|0|||
155246512|NCT00413413|560332753|FG001|Single-Blind|Lack of Efficacy|5|||
155246513|NCT00413413|560332754|FG002|Single-Blind|Lack of Efficacy|0|||
155246514|NCT00413413|560332752|FG000|Single-Blind|Subject no longer requires study drug|0|||
155246515|NCT00413413|560332753|FG001|Single-Blind|Subject no longer requires study drug|151|||
155246516|NCT00413413|560332754|FG002|Single-Blind|Subject no longer requires study drug|0|||
155246517|NCT00413413|560332752|FG000|Single-Blind|Protocol Violation|0|||
155246518|NCT00413413|560332753|FG001|Single-Blind|Protocol Violation|16|||
155246519|NCT00413413|560332754|FG002|Single-Blind|Protocol Violation|0|||
155246520|NCT00413413|560332752|FG000|Single-Blind|Withdrawal by Subject|0|||
155246521|NCT00413413|560332753|FG001|Single-Blind|Withdrawal by Subject|27|||
155246522|NCT00413413|560332754|FG002|Single-Blind|Withdrawal by Subject|0|||
155246523|NCT00413413|560332752|FG000|Single-Blind|Lost to Follow-up|0|||
155246524|NCT00413413|560332753|FG001|Single-Blind|Lost to Follow-up|8|||
155246525|NCT00413413|560332754|FG002|Single-Blind|Lost to Follow-up|0|||
155246526|NCT00413413|560332752|FG000|Double-Blind|Adverse Event|6|||
155246527|NCT00413413|560332753|FG001|Double-Blind|Adverse Event|0|||
155246528|NCT00413413|560332754|FG002|Double-Blind|Adverse Event|5|||
155246529|NCT00413413|560332752|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
155246530|NCT00413413|560332753|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
155246531|NCT00413413|560332754|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
155246532|NCT00413413|560332752|FG000|Double-Blind|Protocol deviation|1|||
155246533|NCT00413413|560332753|FG001|Double-Blind|Protocol deviation|2|||
155246534|NCT00413413|560332754|FG002|Double-Blind|Protocol deviation|1|||
155246535|NCT00413413|560332752|FG000|Double-Blind|Subject withdrew consent|4|||
155246536|NCT00413413|560332753|FG001|Double-Blind|Subject withdrew consent|6|||
155246537|NCT00413413|560332754|FG002|Double-Blind|Subject withdrew consent|9|||
155246538|NCT00413413|560332752|FG000|Double-Blind|Lost to Follow-up|3|||
155246539|NCT00413413|560332753|FG001|Double-Blind|Lost to Follow-up|4|||
155246540|NCT00413413|560332754|FG002|Double-Blind|Lost to Follow-up|2|||
155246541|NCT05348681|560332755|FG000|Overall Study|Study terminated by Sponsor|8|||
155246542|NCT05348681|560332756|FG001|Overall Study|Study terminated by Sponsor|3|||
155246543|NCT05348681|560332755|FG000|Overall Study|Withdrawal by Subject|1|||
155246544|NCT05348681|560332756|FG001|Overall Study|Withdrawal by Subject|1|||
155246545|NCT05348681|560332755|FG000|Overall Study|Lost to Follow-up|1|||
155246546|NCT05348681|560332756|FG001|Overall Study|Lost to Follow-up|1|||
155246547|NCT05348681|560332755|FG000|Overall Study|Adverse Event|1|||
155246548|NCT05348681|560332756|FG001|Overall Study|Adverse Event|0|||
155246549|NCT05348681|560332755|FG000|Overall Study|Other|2|||
155246550|NCT05348681|560332756|FG001|Overall Study|Other|1|||
155246551|NCT00782340|560332757|FG000|Open Label Titration|Adverse Event|12|||
155246552|NCT00782340|560332758|FG001|Open Label Titration|Adverse Event|0|||
155246553|NCT00782340|560332759|FG002|Open Label Titration|Adverse Event|0|||
155246554|NCT00782340|560332757|FG000|Open Label Titration|Treatment failure|50|||
155246555|NCT00782340|560332758|FG001|Open Label Titration|Treatment failure|0|||
155246556|NCT00782340|560332759|FG002|Open Label Titration|Treatment failure|0|||
155246557|NCT00782340|560332757|FG000|Open Label Titration|Protocol Violation|5|||
155246558|NCT00782340|560332758|FG001|Open Label Titration|Protocol Violation|0|||
155246559|NCT00782340|560332759|FG002|Open Label Titration|Protocol Violation|0|||
155246560|NCT00782340|560332757|FG000|Open Label Titration|Withdrawal by Subject|5|||
155246561|NCT00782340|560332758|FG001|Open Label Titration|Withdrawal by Subject|0|||
155246562|NCT00782340|560332759|FG002|Open Label Titration|Withdrawal by Subject|0|||
155246563|NCT00782340|560332757|FG000|Open Label Titration|Enrollment capped|16|||
155246564|NCT00782340|560332758|FG001|Open Label Titration|Enrollment capped|0|||
155246565|NCT00782340|560332759|FG002|Open Label Titration|Enrollment capped|0|||
155246566|NCT00782340|560332757|FG000|Open Label Titration|Did not meet responder criteria|2|||
155246567|NCT00782340|560332758|FG001|Open Label Titration|Did not meet responder criteria|0|||
155246568|NCT00782340|560332759|FG002|Open Label Titration|Did not meet responder criteria|0|||
155246569|NCT00782340|560332757|FG000|Open Label Titration|Lost to Follow-up|5|||
155246570|NCT00782340|560332758|FG001|Open Label Titration|Lost to Follow-up|0|||
155246571|NCT00782340|560332759|FG002|Open Label Titration|Lost to Follow-up|0|||
155246572|NCT00782340|560332757|FG000|Open Label Titration|Randomized in error|6|||
155246573|NCT00782340|560332758|FG001|Open Label Titration|Randomized in error|0|||
155246574|NCT00782340|560332759|FG002|Open Label Titration|Randomized in error|0|||
155246575|NCT00553267|560332761|FG000|Overall Study|Adverse Event|8|||
155246576|NCT00553267|560332762|FG001|Overall Study|Adverse Event|10|||
155246577|NCT00553267|560332763|FG002|Overall Study|Adverse Event|5|||
155246578|NCT00553267|560332761|FG000|Overall Study|Non compliant with protocol|3|||
155246579|NCT00553267|560332762|FG001|Overall Study|Non compliant with protocol|3|||
155246580|NCT00553267|560332763|FG002|Overall Study|Non compliant with protocol|2|||
155246581|NCT00553267|560332761|FG000|Overall Study|Lost to Follow-up|0|||
155246582|NCT00553267|560332762|FG001|Overall Study|Lost to Follow-up|0|||
155246583|NCT00553267|560332763|FG002|Overall Study|Lost to Follow-up|1|||
155246584|NCT00553267|560332761|FG000|Overall Study|Consent withdrawn|2|||
155246585|NCT00553267|560332762|FG001|Overall Study|Consent withdrawn|3|||
155246586|NCT00553267|560332763|FG002|Overall Study|Consent withdrawn|1|||
155246587|NCT00553267|560332761|FG000|Overall Study|Specified category|1|||
155246588|NCT00553267|560332762|FG001|Overall Study|Specified category|2|||
155246589|NCT00553267|560332763|FG002|Overall Study|Specified category|1|||
155246590|NCT04389840|560332764|FG000|Overall Study|Adverse Event|0|||
155246591|NCT04389840|560332765|FG001|Overall Study|Adverse Event|0|||
155246592|NCT04389840|560332766|FG002|Overall Study|Adverse Event|0|||
155246593|NCT04389840|560332767|FG003|Overall Study|Adverse Event|1|||
155246594|NCT04389840|560332768|FG004|Overall Study|Adverse Event|0|||
155246595|NCT04389840|560332769|FG005|Overall Study|Adverse Event|0|||
155246596|NCT04389840|560332764|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
155246597|NCT04389840|560332765|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
155246598|NCT04389840|560332766|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
155246599|NCT04389840|560332767|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
155246600|NCT04389840|560332768|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
155246601|NCT04389840|560332769|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
155246602|NCT04389840|560332764|FG000|Overall Study|Death|0|||
155246603|NCT04389840|560332765|FG001|Overall Study|Death|1|||
155246604|NCT04389840|560332766|FG002|Overall Study|Death|0|||
155246605|NCT04389840|560332767|FG003|Overall Study|Death|0|||
155246606|NCT04389840|560332768|FG004|Overall Study|Death|0|||
155246607|NCT04389840|560332769|FG005|Overall Study|Death|0|||
155246608|NCT00096135|560332775|FG000|Overall Study|Physician Decision|20|||
155246609|NCT00096135|560332776|FG001|Overall Study|Physician Decision|4|||
155246610|NCT00096135|560332775|FG000|Overall Study|Refusal of further protocol therapy|4|||
155246611|NCT00096135|560332776|FG001|Overall Study|Refusal of further protocol therapy|1|||
155246612|NCT00096135|560332775|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
155246613|NCT00096135|560332776|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
155246614|NCT00096135|560332775|FG000|Overall Study|Other, specify|15|||
155246615|NCT00096135|560332776|FG001|Overall Study|Other, specify|3|||
155246616|NCT00096135|560332775|FG000|Overall Study|Ineligible|2|||
155246617|NCT00096135|560332776|FG001|Overall Study|Ineligible|0|||
155246618|NCT01306162|560332777|FG000|Period 1|Adverse Event|0|||
155246619|NCT01306162|560332778|FG001|Period 1|Adverse Event|0|||
155246620|NCT01306162|560332779|FG002|Period 1|Adverse Event|0|||
155246621|NCT01306162|560332780|FG003|Period 1|Adverse Event|1|||
155246622|NCT01306162|560332777|FG000|Washout 1|Non-compliance to protocol|0|||
155246623|NCT01306162|560332778|FG001|Washout 1|Non-compliance to protocol|1|||
155246624|NCT01306162|560332779|FG002|Washout 1|Non-compliance to protocol|0|||
155246625|NCT01306162|560332780|FG003|Washout 1|Non-compliance to protocol|0|||
155246626|NCT00833989|560332784|FG000|Overall Study|Physician Decision|0|||
155246627|NCT00833989|560332785|FG001|Overall Study|Physician Decision|0|||
155246628|NCT00833989|560332786|FG002|Overall Study|Physician Decision|0|||
155246629|NCT00833989|560332787|FG003|Overall Study|Physician Decision|1|||
155246630|NCT00833989|560332784|FG000|Overall Study|Withdrawal by Subject|3|||
155246631|NCT00833989|560332785|FG001|Overall Study|Withdrawal by Subject|0|||
155246632|NCT00833989|560332786|FG002|Overall Study|Withdrawal by Subject|1|||
155246633|NCT00833989|560332787|FG003|Overall Study|Withdrawal by Subject|1|||
155246634|NCT01458574|560332788|FG000|Overall Study|Adverse Event|5|||
155246635|NCT01458574|560332789|FG001|Overall Study|Adverse Event|9|||
155246636|NCT01458574|560332790|FG002|Overall Study|Adverse Event|7|||
155246637|NCT01458574|560332788|FG000|Overall Study|Lack of Efficacy|70|||
155246638|NCT01458574|560332789|FG001|Overall Study|Lack of Efficacy|53|||
155246639|NCT01458574|560332790|FG002|Overall Study|Lack of Efficacy|132|||
155246640|NCT01458574|560332788|FG000|Overall Study|Lost to Follow-up|3|||
155246641|NCT01458574|560332789|FG001|Overall Study|Lost to Follow-up|2|||
155246642|NCT01458574|560332790|FG002|Overall Study|Lost to Follow-up|1|||
155246643|NCT01458574|560332788|FG000|Overall Study|Pregnancy|1|||
155246644|NCT01458574|560332789|FG001|Overall Study|Pregnancy|1|||
155246645|NCT01458574|560332790|FG002|Overall Study|Pregnancy|0|||
155246646|NCT01458574|560332788|FG000|Overall Study|Protocol Violation|0|||
155246647|NCT01458574|560332789|FG001|Overall Study|Protocol Violation|1|||
155246648|NCT01458574|560332790|FG002|Overall Study|Protocol Violation|0|||
155246649|NCT01458574|560332788|FG000|Overall Study|Withdrawal by Subject|6|||
155246650|NCT01458574|560332789|FG001|Overall Study|Withdrawal by Subject|3|||
155246651|NCT01458574|560332790|FG002|Overall Study|Withdrawal by Subject|5|||
155246652|NCT01458574|560332788|FG000|Overall Study|Other|2|||
155246653|NCT01458574|560332789|FG001|Overall Study|Other|1|||
155246654|NCT01458574|560332790|FG002|Overall Study|Other|0|||
155246655|NCT01458574|560332788|FG000|Overall Study|Randomized but not treated|0|||
155246656|NCT01458574|560332789|FG001|Overall Study|Randomized but not treated|1|||
155246657|NCT01458574|560332790|FG002|Overall Study|Randomized but not treated|0|||
155246658|NCT02125786|560332791|FG000|Overall Study|Still in Follow-up|3|||
155246659|NCT02125786|560332791|FG000|Overall Study|Screen Failure|2|||
155246660|NCT02125786|560332791|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
155246661|NCT02125786|560332791|FG000|Overall Study|Progressive Disease|44|||
155246662|NCT02125786|560332791|FG000|Overall Study|Death|8|||
155246663|NCT01365494|560332792|FG000|Overall Study|Adverse Event|1|||
155246664|NCT01365494|560332793|FG001|Overall Study|Adverse Event|0|||
155246665|NCT01365494|560332792|FG000|Overall Study|Withdrawal by Subject|0|||
155246666|NCT01365494|560332793|FG001|Overall Study|Withdrawal by Subject|1|||
155246667|NCT01365494|560332792|FG000|Overall Study|Lost to Follow-up|1|||
155246668|NCT01365494|560332793|FG001|Overall Study|Lost to Follow-up|2|||
155246669|NCT02663128|560332794|FG000|Period 2|Physician Decision|0|||
155246670|NCT02663128|560332795|FG001|Period 2|Physician Decision|0|||
155246671|NCT02663128|560332796|FG002|Period 2|Physician Decision|0|||
155246672|NCT02663128|560332797|FG003|Period 2|Physician Decision|0|||
155246673|NCT02663128|560332798|FG004|Period 2|Physician Decision|1|||
155246674|NCT02663128|560332799|FG005|Period 2|Physician Decision|0|||
155246675|NCT05070897|560332803|FG000|Overall Study|Protocol Violation|123|||
155246676|NCT05070897|560332804|FG001|Overall Study|Protocol Violation|68|||
155246677|NCT03832946|560332805|FG000|Overall Study|Adverse Event|3|||
155246678|NCT03832946|560332806|FG001|Overall Study|Adverse Event|1|||
155246679|NCT03832946|560332805|FG000|Overall Study|Lost to Follow-up|1|||
155246680|NCT03832946|560332806|FG001|Overall Study|Lost to Follow-up|0|||
155246681|NCT03832946|560332805|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
155246682|NCT03832946|560332806|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
155246683|NCT03832946|560332805|FG000|Overall Study|Lack of Efficacy|1|||
155246684|NCT03832946|560332806|FG001|Overall Study|Lack of Efficacy|0|||
155246685|NCT03832946|560332805|FG000|Overall Study|Withdrawal by Subject|12|||
155246686|NCT03832946|560332806|FG001|Overall Study|Withdrawal by Subject|9|||
155246687|NCT03394924|560332807|FG000|Overall Study|Adverse Event|0|||
155246688|NCT03394924|560332808|FG001|Overall Study|Adverse Event|5|||
155246689|NCT03394924|560332809|FG002|Overall Study|Adverse Event|0|||
155246690|NCT03394924|560332807|FG000|Overall Study|Withdrawal by Subject|2|||
155246691|NCT03394924|560332808|FG001|Overall Study|Withdrawal by Subject|0|||
155246692|NCT03394924|560332809|FG002|Overall Study|Withdrawal by Subject|0|||
155246693|NCT03394924|560332807|FG000|Overall Study|Lost to Follow-up|0|||
155246694|NCT03394924|560332808|FG001|Overall Study|Lost to Follow-up|1|||
155246695|NCT03394924|560332809|FG002|Overall Study|Lost to Follow-up|0|||
155246696|NCT03394924|560332807|FG000|Overall Study|Did not meet all inclusion criteria|1|||
155246697|NCT03394924|560332808|FG001|Overall Study|Did not meet all inclusion criteria|0|||
155246698|NCT03394924|560332809|FG002|Overall Study|Did not meet all inclusion criteria|0|||
155246699|NCT03277313|560332816|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
155246700|NCT03277313|560332817|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
155246701|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
155246702|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
155246703|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
155246704|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
155246705|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
155246706|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
155246707|NCT03277313|560332816|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
155246708|NCT03277313|560332817|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
155246709|NCT02005471|560332818|FG000|Main Study|Adverse Event|0|||
155246710|NCT02005471|560332819|FG001|Main Study|Adverse Event|1|||
155246711|NCT02005471|560332820|FG002|Main Study|Adverse Event|0|||
155246712|NCT02005471|560332821|FG003|Main Study|Adverse Event|0|||
155246713|NCT02005471|560332818|FG000|Main Study|Death|83|||
155246714|NCT02005471|560332819|FG001|Main Study|Death|52|||
155246715|NCT02005471|560332820|FG002|Main Study|Death|0|||
155246716|NCT02005471|560332821|FG003|Main Study|Death|0|||
155246717|NCT02005471|560332818|FG000|Main Study|Lost to Follow-up|4|||
155246718|NCT02005471|560332819|FG001|Main Study|Lost to Follow-up|5|||
155246719|NCT02005471|560332820|FG002|Main Study|Lost to Follow-up|0|||
155246720|NCT02005471|560332821|FG003|Main Study|Lost to Follow-up|0|||
155246721|NCT02005471|560332818|FG000|Main Study|Physician Decision|3|||
155246722|NCT02005471|560332819|FG001|Main Study|Physician Decision|1|||
155246723|NCT02005471|560332820|FG002|Main Study|Physician Decision|0|||
155246724|NCT02005471|560332821|FG003|Main Study|Physician Decision|0|||
155246725|NCT02005471|560332818|FG000|Main Study|Withdrawal by Subject|26|||
155246726|NCT02005471|560332819|FG001|Main Study|Withdrawal by Subject|11|||
155246727|NCT02005471|560332820|FG002|Main Study|Withdrawal by Subject|0|||
155246728|NCT02005471|560332821|FG003|Main Study|Withdrawal by Subject|0|||
155246729|NCT02005471|560332818|FG000|Main Study|Reason not Specified|0|||
155246730|NCT02005471|560332819|FG001|Main Study|Reason not Specified|6|||
155246731|NCT02005471|560332820|FG002|Main Study|Reason not Specified|0|||
155246732|NCT02005471|560332821|FG003|Main Study|Reason not Specified|0|||
155246733|NCT02005471|560332818|FG000|Main Study|Randomized but not Dosed|8|||
155246734|NCT02005471|560332819|FG001|Main Study|Randomized but not Dosed|0|||
155246735|NCT02005471|560332820|FG002|Main Study|Randomized but not Dosed|0|||
155246736|NCT02005471|560332821|FG003|Main Study|Randomized but not Dosed|0|||
155246737|NCT02005471|560332818|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
155246738|NCT02005471|560332819|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
155246739|NCT02005471|560332820|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
155246740|NCT02005471|560332821|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
155246741|NCT02005471|560332818|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
155246742|NCT02005471|560332819|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
155246743|NCT02005471|560332820|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
155246744|NCT02005471|560332821|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
155246745|NCT02005471|560332818|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
155246746|NCT02005471|560332819|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
155246747|NCT02005471|560332820|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
155246748|NCT02005471|560332821|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
155246749|NCT00627705|560332823|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
155246750|NCT00627705|560332824|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
155246751|NCT00627705|560332823|FG000|Overall Study|Adverse Event|1|||
155246752|NCT00627705|560332824|FG001|Overall Study|Adverse Event|0|||
155246753|NCT00627705|560332823|FG000|Overall Study|Withdrawal by Subject|0|||
155246754|NCT00627705|560332824|FG001|Overall Study|Withdrawal by Subject|2|||
155246755|NCT00627705|560332823|FG000|Overall Study|Lost to Follow-up|0|||
155246756|NCT00627705|560332824|FG001|Overall Study|Lost to Follow-up|1|||
155246757|NCT02663817|560332825|FG000|Overall Study|Screen failure|2|||
155246758|NCT01410448|560332828|FG000|Overall Study|No conversion to everolimus|0|||
155246759|NCT01410448|560332829|FG001|Overall Study|No conversion to everolimus|24|||
155246760|NCT01410448|560332828|FG000|Overall Study|Graft loss|4|||
155246761|NCT01410448|560332829|FG001|Overall Study|Graft loss|1|||
155246762|NCT01410448|560332828|FG000|Overall Study|Administrative issues|2|||
155246763|NCT01410448|560332829|FG001|Overall Study|Administrative issues|1|||
155246764|NCT01410448|560332828|FG000|Overall Study|Lost to Follow-up|1|||
155246765|NCT01410448|560332829|FG001|Overall Study|Lost to Follow-up|0|||
155246766|NCT01410448|560332828|FG000|Overall Study|Withdrawal by Subject|3|||
155246767|NCT01410448|560332829|FG001|Overall Study|Withdrawal by Subject|2|||
155246768|NCT01410448|560332828|FG000|Overall Study|Protocol Violation|0|||
155246769|NCT01410448|560332829|FG001|Overall Study|Protocol Violation|4|||
155246770|NCT01410448|560332828|FG000|Overall Study|Death|2|||
155246771|NCT01410448|560332829|FG001|Overall Study|Death|3|||
155246772|NCT02535065|560332830|FG000|Overall Study|Death|13|||
155246773|NCT02535065|560332830|FG000|Overall Study|Lost to Follow-up|1|||
155246774|NCT02535065|560332830|FG000|Overall Study|Withdrawal by Subject|6|||
155246775|NCT03712917|560332831|FG000|Overall Study|Pregnancy|0|||
155246776|NCT03712917|560332832|FG001|Overall Study|Pregnancy|0|||
155246777|NCT03712917|560332833|FG002|Overall Study|Pregnancy|1|||
155246778|NCT03712917|560332831|FG000|Overall Study|Adverse Event|0|||
155246779|NCT03712917|560332832|FG001|Overall Study|Adverse Event|4|||
155246780|NCT03712917|560332833|FG002|Overall Study|Adverse Event|3|||
155246781|NCT03712917|560332831|FG000|Overall Study|Lost to Follow-up|9|||
155246782|NCT03712917|560332832|FG001|Overall Study|Lost to Follow-up|4|||
155246783|NCT03712917|560332833|FG002|Overall Study|Lost to Follow-up|5|||
155246784|NCT00932893|560332838|FG000|Overall Study|Death|115|||
155246785|NCT00932893|560332839|FG001|Overall Study|Death|24|||
155246786|NCT00932893|560332838|FG000|Overall Study|Lost to Follow-up|8|||
155246787|NCT00932893|560332839|FG001|Overall Study|Lost to Follow-up|0|||
155246788|NCT00932893|560332838|FG000|Overall Study|Withdrawal by Subject|5|||
155246789|NCT00932893|560332839|FG001|Overall Study|Withdrawal by Subject|2|||
155246790|NCT00932893|560332838|FG000|Overall Study|Other|5|||
155246791|NCT00932893|560332839|FG001|Overall Study|Other|144|||
155246792|NCT00791765|560335176|FG000|Weeks 1 to 12|Adverse Event|0|||
155246793|NCT00791765|560335177|FG001|Weeks 1 to 12|Adverse Event|1|||
155246794|NCT00791765|560335176|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
155246795|NCT00791765|560335177|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
155246796|NCT00791765|560335176|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
155246797|NCT00791765|560335177|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
155246798|NCT00791765|560335176|FG000|Weeks 1 to 12|Physician Decision|1|||
155246799|NCT00791765|560335177|FG001|Weeks 1 to 12|Physician Decision|0|||
155246800|NCT00791765|560335176|FG000|Weeks 1 to 12|Disease progression|3|||
155246801|NCT00791765|560335177|FG001|Weeks 1 to 12|Disease progression|0|||
155246802|NCT00791765|560335176|FG000|Weeks 1 to 12|Ineligibility determined|0|||
155246803|NCT00791765|560335177|FG001|Weeks 1 to 12|Ineligibility determined|3|||
155246804|NCT00791765|560335176|FG000|Weeks 13 to 24|Protocol deviation|2|||
155246805|NCT00791765|560335177|FG001|Weeks 13 to 24|Protocol deviation|0|||
155246806|NCT00791765|560335176|FG000|Weeks 13 to 24|Adverse Event|0|||
155246807|NCT00791765|560335177|FG001|Weeks 13 to 24|Adverse Event|3|||
155246808|NCT00791765|560335176|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
155246809|NCT00791765|560335177|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
155246810|NCT00791765|560335176|FG000|Weeks 13 to 24|Disease progression|0|||
155246811|NCT00791765|560335177|FG001|Weeks 13 to 24|Disease progression|1|||
155246812|NCT00791765|560335176|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
155246813|NCT00791765|560335177|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
155246814|NCT00791765|560335176|FG000|Weeks 13 to 24|Other|0|||
155246815|NCT00791765|560335177|FG001|Weeks 13 to 24|Other|1|||
155246816|NCT00924287|560335179|FG000|Overall Study|Death|1|||
155246817|NCT04579757|560335190|FG000|Overall Study|Adverse Event|0|||
155246818|NCT04579757|560335191|FG001|Overall Study|Adverse Event|0|||
155246819|NCT04579757|560335192|FG002|Overall Study|Adverse Event|0|||
155246820|NCT04579757|560335193|FG003|Overall Study|Adverse Event|2|||
155246821|NCT04579757|560335194|FG004|Overall Study|Adverse Event|1|||
155246822|NCT04579757|560335195|FG005|Overall Study|Adverse Event|1|||
155246823|NCT04579757|560335196|FG006|Overall Study|Adverse Event|0|||
155246824|NCT04579757|560335197|FG007|Overall Study|Adverse Event|0|||
155246825|NCT04579757|560335198|FG008|Overall Study|Adverse Event|0|||
155246826|NCT04579757|560335190|FG000|Overall Study|Death|4|||
155246827|NCT04579757|560335191|FG001|Overall Study|Death|1|||
155246828|NCT04579757|560335192|FG002|Overall Study|Death|14|||
155246829|NCT04579757|560335193|FG003|Overall Study|Death|3|||
155246830|NCT04579757|560335194|FG004|Overall Study|Death|2|||
155246831|NCT04579757|560335195|FG005|Overall Study|Death|7|||
155246832|NCT04579757|560335196|FG006|Overall Study|Death|0|||
155246833|NCT04579757|560335197|FG007|Overall Study|Death|1|||
155246834|NCT04579757|560335198|FG008|Overall Study|Death|3|||
155246835|NCT04579757|560335190|FG000|Overall Study|Physician Decision|0|||
155246836|NCT04579757|560335191|FG001|Overall Study|Physician Decision|0|||
155246837|NCT04579757|560335192|FG002|Overall Study|Physician Decision|0|||
155246838|NCT04579757|560335193|FG003|Overall Study|Physician Decision|2|||
155246839|NCT04579757|560335194|FG004|Overall Study|Physician Decision|1|||
155246840|NCT04579757|560335195|FG005|Overall Study|Physician Decision|1|||
155246841|NCT04579757|560335196|FG006|Overall Study|Physician Decision|1|||
155246842|NCT04579757|560335197|FG007|Overall Study|Physician Decision|0|||
155246843|NCT04579757|560335198|FG008|Overall Study|Physician Decision|0|||
155246844|NCT04579757|560335190|FG000|Overall Study|Study Terminated By Sponsor|0|||
155246845|NCT04579757|560335191|FG001|Overall Study|Study Terminated By Sponsor|0|||
155246846|NCT04579757|560335192|FG002|Overall Study|Study Terminated By Sponsor|0|||
155246847|NCT04579757|560335193|FG003|Overall Study|Study Terminated By Sponsor|0|||
155246848|NCT04579757|560335194|FG004|Overall Study|Study Terminated By Sponsor|2|||
155246849|NCT04579757|560335195|FG005|Overall Study|Study Terminated By Sponsor|0|||
155246850|NCT04579757|560335196|FG006|Overall Study|Study Terminated By Sponsor|0|||
155246851|NCT04579757|560335197|FG007|Overall Study|Study Terminated By Sponsor|2|||
155246852|NCT04579757|560335198|FG008|Overall Study|Study Terminated By Sponsor|0|||
155246853|NCT04579757|560335190|FG000|Overall Study|Withdrawal by Subject|1|||
155246854|NCT04579757|560335191|FG001|Overall Study|Withdrawal by Subject|1|||
155246855|NCT04579757|560335192|FG002|Overall Study|Withdrawal by Subject|0|||
155246856|NCT04579757|560335193|FG003|Overall Study|Withdrawal by Subject|0|||
155246857|NCT04579757|560335194|FG004|Overall Study|Withdrawal by Subject|2|||
155246858|NCT04579757|560335195|FG005|Overall Study|Withdrawal by Subject|1|||
155246859|NCT04579757|560335196|FG006|Overall Study|Withdrawal by Subject|0|||
155246860|NCT04579757|560335197|FG007|Overall Study|Withdrawal by Subject|3|||
155246861|NCT04579757|560335198|FG008|Overall Study|Withdrawal by Subject|0|||
155246862|NCT04579757|560335190|FG000|Overall Study|Radiological or Clinical PD|1|||
155246863|NCT04579757|560335191|FG001|Overall Study|Radiological or Clinical PD|4|||
155246864|NCT04579757|560335192|FG002|Overall Study|Radiological or Clinical PD|1|||
155246865|NCT04579757|560335193|FG003|Overall Study|Radiological or Clinical PD|3|||
155246866|NCT04579757|560335194|FG004|Overall Study|Radiological or Clinical PD|9|||
155246867|NCT04579757|560335195|FG005|Overall Study|Radiological or Clinical PD|4|||
155246868|NCT04579757|560335196|FG006|Overall Study|Radiological or Clinical PD|2|||
155246869|NCT04579757|560335197|FG007|Overall Study|Radiological or Clinical PD|2|||
155246870|NCT04579757|560335198|FG008|Overall Study|Radiological or Clinical PD|0|||
155246871|NCT04579757|560335190|FG000|Overall Study|Start of New Therapy|0|||
155246872|NCT04579757|560335191|FG001|Overall Study|Start of New Therapy|0|||
155246873|NCT04579757|560335192|FG002|Overall Study|Start of New Therapy|0|||
155246874|NCT04579757|560335193|FG003|Overall Study|Start of New Therapy|0|||
155246875|NCT04579757|560335194|FG004|Overall Study|Start of New Therapy|2|||
155246876|NCT04579757|560335195|FG005|Overall Study|Start of New Therapy|1|||
155246877|NCT04579757|560335196|FG006|Overall Study|Start of New Therapy|0|||
155246878|NCT04579757|560335197|FG007|Overall Study|Start of New Therapy|0|||
155246879|NCT04579757|560335198|FG008|Overall Study|Start of New Therapy|0|||
155246880|NCT01843192|560335199|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
155246881|NCT01843192|560335200|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
155246882|NCT01843192|560335201|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
155246883|NCT00856856|560335203|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
155246884|NCT00856856|560335203|FG000|4-year Clinical Follow-up|Missed visit|1|||
155246885|NCT00434057|560335206|FG000|Overall Study|Withdrawal by Subject|1|||
155246886|NCT03073603|560335208|FG000|Overall Study|Noncompliance|3|||
155246887|NCT03073603|560335209|FG001|Overall Study|Noncompliance|1|||
155246888|NCT03073603|560335208|FG000|Overall Study|Adverse Event|5|||
155246889|NCT03073603|560335209|FG001|Overall Study|Adverse Event|3|||
155246890|NCT03073603|560335208|FG000|Overall Study|Physician Decision|1|||
155246891|NCT03073603|560335209|FG001|Overall Study|Physician Decision|2|||
155246892|NCT03073603|560335208|FG000|Overall Study|Required treatment not allowed by protocol|1|||
155246893|NCT03073603|560335209|FG001|Overall Study|Required treatment not allowed by protocol|0|||
155246894|NCT03073603|560335208|FG000|Overall Study|Financial or insurance-related|8|||
155246895|NCT03073603|560335209|FG001|Overall Study|Financial or insurance-related|0|||
155246896|NCT03073603|560335208|FG000|Overall Study|Withdrawal by Subject|0|||
155246897|NCT03073603|560335209|FG001|Overall Study|Withdrawal by Subject|1|||
155246898|NCT03073603|560335208|FG000|Overall Study|Discontinued DMT|4|||
155246899|NCT03073603|560335209|FG001|Overall Study|Discontinued DMT|0|||
155246900|NCT03073603|560335208|FG000|Overall Study|Restarted DMT|0|||
155246901|NCT03073603|560335209|FG001|Overall Study|Restarted DMT|1|||
155246902|NCT03701555|560335210|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
155246903|NCT03701555|560335211|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
155246904|NCT03701555|560335212|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
155246905|NCT03701555|560335213|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
155246906|NCT03701555|560335214|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
155246907|NCT03701555|560335215|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
155246908|NCT03701555|560335216|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
155246909|NCT03701555|560335217|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
155246910|NCT03701555|560335218|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
155246911|NCT03701555|560335219|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
155246912|NCT03701555|560335220|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
155246913|NCT03701555|560335221|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
155246914|NCT03701555|560335222|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
155246915|NCT03701555|560335223|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
155246916|NCT03701555|560335224|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
155246917|NCT03701555|560335225|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
155246918|NCT03701555|560335226|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
155246919|NCT03701555|560335227|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
155246920|NCT03701555|560335228|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
155246921|NCT03701555|560335229|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
155246922|NCT03701555|560335230|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
155246923|NCT03701555|560335231|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
155246924|NCT03701555|560335232|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
155246925|NCT03701555|560335233|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
155246926|NCT03701555|560335234|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
155246927|NCT03701555|560335235|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
155246928|NCT03701555|560335236|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
155246929|NCT03701555|560335237|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
155246930|NCT03701555|560335238|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
155246931|NCT03701555|560335239|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
155246932|NCT03701555|560335240|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
155246933|NCT03701555|560335241|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
155246934|NCT03701555|560335242|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
155246935|NCT03701555|560335243|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
155246936|NCT03701555|560335244|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
155246937|NCT03701555|560335245|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
155246938|NCT03701555|560335210|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
155246939|NCT03701555|560335211|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
155246940|NCT03701555|560335212|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
155246941|NCT03701555|560335213|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
155246942|NCT03701555|560335214|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
155246943|NCT03701555|560335215|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
155246944|NCT03701555|560335216|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
155246945|NCT03701555|560335217|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
155246946|NCT03701555|560335218|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
155246947|NCT03701555|560335219|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
155246948|NCT03701555|560335220|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
155246949|NCT03701555|560335221|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
155246950|NCT03701555|560335222|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
155246951|NCT03701555|560335223|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
155246952|NCT03701555|560335224|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
155246953|NCT03701555|560335225|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
155246954|NCT03701555|560335226|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
155246955|NCT03701555|560335227|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
155246956|NCT03701555|560335228|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
155246957|NCT03701555|560335229|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
155246958|NCT03701555|560335230|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
155246959|NCT03701555|560335231|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
155246960|NCT03701555|560335232|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
155246961|NCT03701555|560335233|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
155246962|NCT03701555|560335234|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
155246963|NCT03701555|560335235|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
155246964|NCT03701555|560335236|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
155246965|NCT03701555|560335237|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
155246966|NCT03701555|560335238|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
155246967|NCT03701555|560335239|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
155246968|NCT03701555|560335240|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
155246969|NCT03701555|560335241|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
155246970|NCT03701555|560335242|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
155246971|NCT03701555|560335243|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
155246972|NCT03701555|560335244|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
155246973|NCT03701555|560335245|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
155246974|NCT03701555|560335210|FG000|Part 2 (Day 1)|Other|0|||
155246975|NCT03701555|560335211|FG001|Part 2 (Day 1)|Other|0|||
155246976|NCT03701555|560335212|FG002|Part 2 (Day 1)|Other|0|||
155246977|NCT03701555|560335213|FG003|Part 2 (Day 1)|Other|0|||
155246978|NCT03701555|560335214|FG004|Part 2 (Day 1)|Other|0|||
155246979|NCT03701555|560335215|FG005|Part 2 (Day 1)|Other|0|||
155246980|NCT03701555|560335216|FG006|Part 2 (Day 1)|Other|0|||
155246981|NCT03701555|560335217|FG007|Part 2 (Day 1)|Other|0|||
155246982|NCT03701555|560335218|FG008|Part 2 (Day 1)|Other|0|||
155246983|NCT03701555|560335219|FG009|Part 2 (Day 1)|Other|0|||
155246984|NCT03701555|560335220|FG010|Part 2 (Day 1)|Other|3|||
155246985|NCT03701555|560335221|FG011|Part 2 (Day 1)|Other|1|||
155246986|NCT03701555|560335222|FG012|Part 2 (Day 1)|Other|0|||
155246987|NCT03701555|560335223|FG013|Part 2 (Day 1)|Other|1|||
155246988|NCT03701555|560335224|FG014|Part 2 (Day 1)|Other|0|||
155246989|NCT03701555|560335225|FG015|Part 2 (Day 1)|Other|2|||
155246990|NCT03701555|560335226|FG016|Part 2 (Day 1)|Other|2|||
155246991|NCT03701555|560335227|FG017|Part 2 (Day 1)|Other|0|||
155246992|NCT03701555|560335228|FG018|Part 2 (Day 1)|Other|0|||
155246993|NCT03701555|560335229|FG019|Part 2 (Day 1)|Other|0|||
155246994|NCT03701555|560335230|FG020|Part 2 (Day 1)|Other|0|||
155246995|NCT03701555|560335231|FG021|Part 2 (Day 1)|Other|0|||
155246996|NCT03701555|560335232|FG022|Part 2 (Day 1)|Other|0|||
155246997|NCT03701555|560335233|FG023|Part 2 (Day 1)|Other|0|||
155246998|NCT03701555|560335234|FG024|Part 2 (Day 1)|Other|0|||
155246999|NCT03701555|560335235|FG025|Part 2 (Day 1)|Other|0|||
155247000|NCT03701555|560335236|FG026|Part 2 (Day 1)|Other|0|||
155247001|NCT03701555|560335237|FG027|Part 2 (Day 1)|Other|0|||
155247002|NCT03701555|560335238|FG028|Part 2 (Day 1)|Other|0|||
155247003|NCT03701555|560335239|FG029|Part 2 (Day 1)|Other|0|||
155247004|NCT03701555|560335240|FG030|Part 2 (Day 1)|Other|0|||
155247005|NCT03701555|560335241|FG031|Part 2 (Day 1)|Other|0|||
155247006|NCT03701555|560335242|FG032|Part 2 (Day 1)|Other|0|||
155247007|NCT03701555|560335243|FG033|Part 2 (Day 1)|Other|0|||
155247008|NCT03701555|560335244|FG034|Part 2 (Day 1)|Other|0|||
155247009|NCT03701555|560335245|FG035|Part 2 (Day 1)|Other|0|||
155247010|NCT03701555|560335210|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
155247011|NCT03701555|560335211|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
155247012|NCT03701555|560335212|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
155247013|NCT03701555|560335213|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
155247014|NCT03701555|560335214|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
155247015|NCT03701555|560335215|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
155247016|NCT03701555|560335216|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
155247017|NCT03701555|560335217|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
155247018|NCT03701555|560335218|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
155247019|NCT03701555|560335219|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
155247020|NCT03701555|560335220|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
155247021|NCT03701555|560335221|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
155247022|NCT03701555|560335222|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
155247023|NCT03701555|560335223|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
155247024|NCT03701555|560335224|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
155247025|NCT03701555|560335225|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
155247026|NCT03701555|560335226|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
155247027|NCT03701555|560335227|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
155247028|NCT03701555|560335228|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
155247029|NCT03701555|560335229|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
155247030|NCT03701555|560335230|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
155247031|NCT03701555|560335231|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
155247032|NCT03701555|560335232|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
155247033|NCT03701555|560335233|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
155247034|NCT03701555|560335234|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
155247035|NCT03701555|560335235|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
155247036|NCT03701555|560335236|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
155247037|NCT03701555|560335237|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
155247038|NCT03701555|560335238|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
155247039|NCT03701555|560335239|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
155247040|NCT03701555|560335240|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
155247041|NCT03701555|560335241|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
155247042|NCT03701555|560335242|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
155247043|NCT03701555|560335243|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
155247044|NCT03701555|560335244|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
155247045|NCT03701555|560335245|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
155247046|NCT03701555|560335210|FG000|Part 3 (Day 1)|Subject Decision|0|||
155247047|NCT03701555|560335211|FG001|Part 3 (Day 1)|Subject Decision|0|||
155247048|NCT03701555|560335212|FG002|Part 3 (Day 1)|Subject Decision|0|||
155247049|NCT03701555|560335213|FG003|Part 3 (Day 1)|Subject Decision|0|||
155247050|NCT03701555|560335214|FG004|Part 3 (Day 1)|Subject Decision|0|||
155247051|NCT03701555|560335215|FG005|Part 3 (Day 1)|Subject Decision|0|||
155247052|NCT03701555|560335216|FG006|Part 3 (Day 1)|Subject Decision|0|||
155247053|NCT03701555|560335217|FG007|Part 3 (Day 1)|Subject Decision|0|||
155247054|NCT03701555|560335218|FG008|Part 3 (Day 1)|Subject Decision|0|||
155247055|NCT03701555|560335219|FG009|Part 3 (Day 1)|Subject Decision|0|||
155247056|NCT03701555|560335220|FG010|Part 3 (Day 1)|Subject Decision|0|||
155247057|NCT03701555|560335221|FG011|Part 3 (Day 1)|Subject Decision|0|||
155247058|NCT03701555|560335222|FG012|Part 3 (Day 1)|Subject Decision|0|||
155247059|NCT03701555|560335223|FG013|Part 3 (Day 1)|Subject Decision|0|||
155247060|NCT03701555|560335224|FG014|Part 3 (Day 1)|Subject Decision|0|||
155247061|NCT03701555|560335225|FG015|Part 3 (Day 1)|Subject Decision|0|||
155247062|NCT03701555|560335226|FG016|Part 3 (Day 1)|Subject Decision|0|||
155247063|NCT03701555|560335227|FG017|Part 3 (Day 1)|Subject Decision|0|||
155247064|NCT03701555|560335228|FG018|Part 3 (Day 1)|Subject Decision|0|||
155247065|NCT03701555|560335229|FG019|Part 3 (Day 1)|Subject Decision|0|||
155247066|NCT03701555|560335230|FG020|Part 3 (Day 1)|Subject Decision|0|||
155247067|NCT03701555|560335231|FG021|Part 3 (Day 1)|Subject Decision|0|||
155247068|NCT03701555|560335232|FG022|Part 3 (Day 1)|Subject Decision|0|||
155247069|NCT03701555|560335233|FG023|Part 3 (Day 1)|Subject Decision|0|||
155247070|NCT03701555|560335234|FG024|Part 3 (Day 1)|Subject Decision|0|||
155247071|NCT03701555|560335235|FG025|Part 3 (Day 1)|Subject Decision|0|||
155247072|NCT03701555|560335236|FG026|Part 3 (Day 1)|Subject Decision|1|||
155247073|NCT03701555|560335237|FG027|Part 3 (Day 1)|Subject Decision|0|||
155247074|NCT03701555|560335238|FG028|Part 3 (Day 1)|Subject Decision|0|||
155247075|NCT03701555|560335239|FG029|Part 3 (Day 1)|Subject Decision|0|||
155247076|NCT03701555|560335240|FG030|Part 3 (Day 1)|Subject Decision|0|||
155247077|NCT03701555|560335241|FG031|Part 3 (Day 1)|Subject Decision|2|||
155247078|NCT03701555|560335242|FG032|Part 3 (Day 1)|Subject Decision|1|||
155247079|NCT03701555|560335243|FG033|Part 3 (Day 1)|Subject Decision|1|||
155247080|NCT03701555|560335244|FG034|Part 3 (Day 1)|Subject Decision|0|||
155247081|NCT03701555|560335245|FG035|Part 3 (Day 1)|Subject Decision|0|||
155247082|NCT03701555|560335210|FG000|Part 3 (Day 1)|Other|0|||
155247083|NCT03701555|560335211|FG001|Part 3 (Day 1)|Other|0|||
155247084|NCT03701555|560335212|FG002|Part 3 (Day 1)|Other|0|||
155247085|NCT03701555|560335213|FG003|Part 3 (Day 1)|Other|0|||
155247086|NCT03701555|560335214|FG004|Part 3 (Day 1)|Other|0|||
155247087|NCT03701555|560335215|FG005|Part 3 (Day 1)|Other|0|||
155247088|NCT03701555|560335216|FG006|Part 3 (Day 1)|Other|0|||
155247089|NCT03701555|560335217|FG007|Part 3 (Day 1)|Other|0|||
155247090|NCT03701555|560335218|FG008|Part 3 (Day 1)|Other|0|||
155247091|NCT03701555|560335219|FG009|Part 3 (Day 1)|Other|0|||
155247092|NCT03701555|560335220|FG010|Part 3 (Day 1)|Other|0|||
155247093|NCT03701555|560335221|FG011|Part 3 (Day 1)|Other|0|||
155247094|NCT03701555|560335222|FG012|Part 3 (Day 1)|Other|0|||
155247095|NCT03701555|560335223|FG013|Part 3 (Day 1)|Other|0|||
155247096|NCT03701555|560335224|FG014|Part 3 (Day 1)|Other|0|||
155247097|NCT03701555|560335225|FG015|Part 3 (Day 1)|Other|0|||
155247098|NCT03701555|560335226|FG016|Part 3 (Day 1)|Other|0|||
155247099|NCT03701555|560335227|FG017|Part 3 (Day 1)|Other|0|||
155247100|NCT03701555|560335228|FG018|Part 3 (Day 1)|Other|0|||
155247101|NCT03701555|560335229|FG019|Part 3 (Day 1)|Other|0|||
155247102|NCT03701555|560335230|FG020|Part 3 (Day 1)|Other|0|||
155247103|NCT03701555|560335231|FG021|Part 3 (Day 1)|Other|0|||
155247104|NCT03701555|560335232|FG022|Part 3 (Day 1)|Other|0|||
155247105|NCT03701555|560335233|FG023|Part 3 (Day 1)|Other|0|||
155247106|NCT03701555|560335234|FG024|Part 3 (Day 1)|Other|1|||
155247107|NCT03701555|560335235|FG025|Part 3 (Day 1)|Other|1|||
155247108|NCT03701555|560335236|FG026|Part 3 (Day 1)|Other|0|||
155247109|NCT03701555|560335237|FG027|Part 3 (Day 1)|Other|0|||
155247110|NCT03701555|560335238|FG028|Part 3 (Day 1)|Other|0|||
155247111|NCT03701555|560335239|FG029|Part 3 (Day 1)|Other|1|||
155247112|NCT03701555|560335240|FG030|Part 3 (Day 1)|Other|1|||
155247113|NCT03701555|560335241|FG031|Part 3 (Day 1)|Other|0|||
155247114|NCT03701555|560335242|FG032|Part 3 (Day 1)|Other|1|||
155247115|NCT03701555|560335243|FG033|Part 3 (Day 1)|Other|1|||
155247116|NCT03701555|560335244|FG034|Part 3 (Day 1)|Other|0|||
155247117|NCT03701555|560335245|FG035|Part 3 (Day 1)|Other|0|||
155247118|NCT04757649|560335246|FG000|Overall Study|Withdrawal by Subject|1|||
155247119|NCT04757649|560335246|FG000|Overall Study|Adverse Event|1|||
155247120|NCT02508311|560335251|FG000|Overall Study|Withdrawal by Subject|1|||
155247121|NCT02508311|560335252|FG001|Overall Study|Withdrawal by Subject|0|||
155247122|NCT04955639|560335253|FG000|Overall Study|Withdrawal by Subject|2|||
155247123|NCT04955639|560335254|FG001|Overall Study|Withdrawal by Subject|2|||
155247124|NCT04955639|560335253|FG000|Overall Study|Week 26 survey not completed|2|||
155247125|NCT04955639|560335254|FG001|Overall Study|Week 26 survey not completed|2|||
155247126|NCT04447404|560335255|FG000|Overall Study|Death|2|||
155247127|NCT04447404|560335256|FG001|Overall Study|Death|0|||
155247128|NCT00413153|560335257|FG000|Overall Study|Withdrawal by Subject|1|||
155247129|NCT00413153|560335258|FG001|Overall Study|Withdrawal by Subject|1|||
155247130|NCT00413153|560335257|FG000|Overall Study|Adverse Event|1|||
155247131|NCT00413153|560335258|FG001|Overall Study|Adverse Event|0|||
155247132|NCT00454051|560335261|FG000|Overall Study|Adverse Event|1|||
155247133|NCT00454051|560335262|FG001|Overall Study|Adverse Event|2|||
155247134|NCT00454051|560335261|FG000|Overall Study|Withdrawal by Subject|1|||
155247135|NCT00454051|560335262|FG001|Overall Study|Withdrawal by Subject|0|||
155247136|NCT00454051|560335261|FG000|Overall Study|Protocol Violation|1|||
155247137|NCT00454051|560335262|FG001|Overall Study|Protocol Violation|1|||
155247138|NCT02097472|560335263|FG000|Received Vaccination 2|Adverse Event|0|||
155247139|NCT02097472|560335264|FG001|Received Vaccination 2|Adverse Event|0|||
155247140|NCT02097472|560335265|FG002|Received Vaccination 2|Adverse Event|0|||
155247141|NCT02097472|560335266|FG003|Received Vaccination 2|Adverse Event|0|||
155247142|NCT02097472|560335267|FG004|Received Vaccination 2|Adverse Event|0|||
155247143|NCT02097472|560335268|FG005|Received Vaccination 2|Adverse Event|0|||
155247144|NCT02097472|560335269|FG006|Received Vaccination 2|Adverse Event|1|||
155247145|NCT02097472|560335270|FG007|Received Vaccination 2|Adverse Event|0|||
155247146|NCT02862106|560335273|FG000|Overall Study|Adverse Event|4|||
155247147|NCT02862106|560335274|FG001|Overall Study|Adverse Event|0|||
155247148|NCT02862106|560335273|FG000|Overall Study|Protocol Violation|16|||
155247149|NCT02862106|560335274|FG001|Overall Study|Protocol Violation|1|||
155247150|NCT02862106|560335273|FG000|Overall Study|Lost to Follow-up|15|||
155247151|NCT02862106|560335274|FG001|Overall Study|Lost to Follow-up|5|||
155247152|NCT02862106|560335273|FG000|Overall Study|Withdrawal by Subject|2|||
155247153|NCT02862106|560335274|FG001|Overall Study|Withdrawal by Subject|0|||
155247154|NCT02862106|560335273|FG000|Overall Study|Subjects moved to other city|1|||
155247155|NCT02862106|560335274|FG001|Overall Study|Subjects moved to other city|0|||
155247156|NCT03966157|560335275|FG000|Overall Study|Physician Decision|1|||
155247157|NCT03966157|560335276|FG001|Overall Study|Physician Decision|0|||
155247158|NCT01221597|560335279|FG000|Overall Study|Adverse Event|4|||
155247159|NCT01221597|560335280|FG001|Overall Study|Adverse Event|1|||
155247160|NCT01221597|560335279|FG000|Overall Study|Withdrawal by Subject|20|||
155247161|NCT01221597|560335280|FG001|Overall Study|Withdrawal by Subject|6|||
155247162|NCT01221597|560335279|FG000|Overall Study|Lost to Follow-up|6|||
155247163|NCT01221597|560335280|FG001|Overall Study|Lost to Follow-up|5|||
155247164|NCT01221597|560335279|FG000|Overall Study|Protocol Violation|1|||
155247165|NCT01221597|560335280|FG001|Overall Study|Protocol Violation|0|||
155247166|NCT01221597|560335279|FG000|Overall Study|Other|3|||
155247167|NCT01221597|560335280|FG001|Overall Study|Other|4|||
155247168|NCT01221597|560335279|FG000|Overall Study|Death|2|||
155247169|NCT01221597|560335280|FG001|Overall Study|Death|0|||
155247170|NCT03305016|560335281|FG000|Overall Study|Withdrawal by Subject|2|||
155247171|NCT04420689|560335283|FG000|Overall Study|COVID-19 related hospitalization|0|||
155247172|NCT04420689|560335284|FG001|Overall Study|COVID-19 related hospitalization|0|||
155247173|NCT04420689|560335285|FG002|Overall Study|COVID-19 related hospitalization|0|||
155247174|NCT04420689|560335286|FG003|Overall Study|COVID-19 related hospitalization|0|||
155247175|NCT04420689|560335287|FG004|Overall Study|COVID-19 related hospitalization|1|||
155247176|NCT04420689|560335288|FG005|Overall Study|COVID-19 related hospitalization|0|||
155247177|NCT04420689|560335289|FG006|Overall Study|COVID-19 related hospitalization|0|||
155247178|NCT04420689|560335283|FG000|Overall Study|Physician Decision|0|||
155247179|NCT04420689|560335284|FG001|Overall Study|Physician Decision|0|||
155247180|NCT04420689|560335285|FG002|Overall Study|Physician Decision|0|||
155247181|NCT04420689|560335286|FG003|Overall Study|Physician Decision|0|||
155247182|NCT04420689|560335287|FG004|Overall Study|Physician Decision|0|||
155247183|NCT04420689|560335288|FG005|Overall Study|Physician Decision|1|||
155247184|NCT04420689|560335289|FG006|Overall Study|Physician Decision|0|||
155247185|NCT02278328|560335295|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
155247186|NCT02278328|560335296|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
155247187|NCT02278328|560335297|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
155247188|NCT02278328|560335295|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
155247189|NCT02278328|560335296|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
155247190|NCT02278328|560335297|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
155247191|NCT02278328|560335295|FG000|Neuropsych Screening|incomplete consent|0|||
155247192|NCT02278328|560335296|FG001|Neuropsych Screening|incomplete consent|0|||
155247193|NCT02278328|560335297|FG002|Neuropsych Screening|incomplete consent|2|||
155247194|NCT00377676|560335298|FG000|Overall Study|Adverse Event|498|||
155247195|NCT00377676|560335299|FG001|Overall Study|Adverse Event|107|||
155247196|NCT00377676|560335298|FG000|Overall Study|Protocol Violation|33|||
155247197|NCT00377676|560335299|FG001|Overall Study|Protocol Violation|27|||
155247198|NCT00377676|560335298|FG000|Overall Study|Death|5|||
155247199|NCT00377676|560335299|FG001|Overall Study|Death|2|||
155247200|NCT00377676|560335298|FG000|Overall Study|Withdrawal by Subject|187|||
155247201|NCT00377676|560335299|FG001|Overall Study|Withdrawal by Subject|72|||
155247202|NCT00377676|560335298|FG000|Overall Study|Lost to Follow-up|120|||
155247203|NCT00377676|560335299|FG001|Overall Study|Lost to Follow-up|56|||
155247204|NCT00377676|560335298|FG000|Overall Study|Other|118|||
155247205|NCT00377676|560335299|FG001|Overall Study|Other|58|||
155247206|NCT03834779|560335300|FG000|Overall Study|Death|1|||
155247207|NCT03834779|560335301|FG001|Overall Study|Death|2|||
155247208|NCT03834779|560335300|FG000|Overall Study|Lost to Follow-up|6|||
155247209|NCT03834779|560335301|FG001|Overall Study|Lost to Follow-up|4|||
155247210|NCT01519206|560335307|FG000|Overall Study|Lost to Follow-up|3|||
155247211|NCT01519206|560335307|FG000|Overall Study|Missed Visit|2|||
155247212|NCT02014116|560335308|FG000|Overall Study|Progressive Disease|3|||
155247213|NCT02014116|560335309|FG001|Overall Study|Progressive Disease|4|||
155247214|NCT02014116|560335310|FG002|Overall Study|Progressive Disease|2|||
155247215|NCT02014116|560335311|FG003|Overall Study|Progressive Disease|6|||
155247216|NCT02014116|560335312|FG004|Overall Study|Progressive Disease|1|||
155247217|NCT02014116|560335313|FG005|Overall Study|Progressive Disease|13|||
155247218|NCT02014116|560335314|FG006|Overall Study|Progressive Disease|1|||
155247219|NCT02014116|560335315|FG007|Overall Study|Progressive Disease|3|||
155247220|NCT02014116|560335316|FG008|Overall Study|Progressive Disease|7|||
155247221|NCT02014116|560335308|FG000|Overall Study|Adverse Event|0|||
155247222|NCT02014116|560335309|FG001|Overall Study|Adverse Event|0|||
155247223|NCT02014116|560335310|FG002|Overall Study|Adverse Event|0|||
155247224|NCT02014116|560335311|FG003|Overall Study|Adverse Event|0|||
155247225|NCT02014116|560335312|FG004|Overall Study|Adverse Event|1|||
155247226|NCT02014116|560335313|FG005|Overall Study|Adverse Event|0|||
155247227|NCT02014116|560335314|FG006|Overall Study|Adverse Event|0|||
155247228|NCT02014116|560335315|FG007|Overall Study|Adverse Event|1|||
155247229|NCT02014116|560335316|FG008|Overall Study|Adverse Event|0|||
155247230|NCT02014116|560335308|FG000|Overall Study|Lost to Follow-up|0|||
155247231|NCT02014116|560335309|FG001|Overall Study|Lost to Follow-up|0|||
155247232|NCT02014116|560335310|FG002|Overall Study|Lost to Follow-up|0|||
155247233|NCT02014116|560335311|FG003|Overall Study|Lost to Follow-up|0|||
155247234|NCT02014116|560335312|FG004|Overall Study|Lost to Follow-up|0|||
155247235|NCT02014116|560335313|FG005|Overall Study|Lost to Follow-up|1|||
155247236|NCT02014116|560335314|FG006|Overall Study|Lost to Follow-up|0|||
155247237|NCT02014116|560335315|FG007|Overall Study|Lost to Follow-up|0|||
155247238|NCT02014116|560335316|FG008|Overall Study|Lost to Follow-up|1|||
155247239|NCT02014116|560335308|FG000|Overall Study|Death|0|||
155247240|NCT02014116|560335309|FG001|Overall Study|Death|0|||
155247241|NCT02014116|560335310|FG002|Overall Study|Death|0|||
155247242|NCT02014116|560335311|FG003|Overall Study|Death|0|||
155247243|NCT02014116|560335312|FG004|Overall Study|Death|0|||
155247244|NCT02014116|560335313|FG005|Overall Study|Death|0|||
155247245|NCT02014116|560335314|FG006|Overall Study|Death|0|||
155247246|NCT02014116|560335315|FG007|Overall Study|Death|1|||
155247247|NCT02014116|560335316|FG008|Overall Study|Death|1|||
155247248|NCT02014116|560335308|FG000|Overall Study|Withdrawal by Subject|0|||
155247249|NCT02014116|560335309|FG001|Overall Study|Withdrawal by Subject|0|||
155247250|NCT02014116|560335310|FG002|Overall Study|Withdrawal by Subject|1|||
155247251|NCT02014116|560335311|FG003|Overall Study|Withdrawal by Subject|1|||
155247252|NCT02014116|560335312|FG004|Overall Study|Withdrawal by Subject|0|||
155247253|NCT02014116|560335313|FG005|Overall Study|Withdrawal by Subject|1|||
155247254|NCT02014116|560335314|FG006|Overall Study|Withdrawal by Subject|0|||
155247255|NCT02014116|560335315|FG007|Overall Study|Withdrawal by Subject|0|||
155247256|NCT02014116|560335316|FG008|Overall Study|Withdrawal by Subject|0|||
155247257|NCT02014116|560335308|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
155247258|NCT02014116|560335309|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
155247259|NCT02014116|560335310|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
155247260|NCT02014116|560335311|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
155247261|NCT02014116|560335312|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
155247262|NCT02014116|560335313|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
155247263|NCT02014116|560335314|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
155247264|NCT02014116|560335315|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
155247265|NCT02014116|560335316|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
155247266|NCT02014116|560335308|FG000|Overall Study|Physician Decision|0|||
155247267|NCT02014116|560335309|FG001|Overall Study|Physician Decision|0|||
155247268|NCT02014116|560335310|FG002|Overall Study|Physician Decision|0|||
155247269|NCT02014116|560335311|FG003|Overall Study|Physician Decision|0|||
155247270|NCT02014116|560335312|FG004|Overall Study|Physician Decision|0|||
155247271|NCT02014116|560335313|FG005|Overall Study|Physician Decision|0|||
155247272|NCT02014116|560335314|FG006|Overall Study|Physician Decision|0|||
155247273|NCT02014116|560335315|FG007|Overall Study|Physician Decision|0|||
155247274|NCT02014116|560335316|FG008|Overall Study|Physician Decision|1|||
155247275|NCT01040130|560335320|FG000|Overall Study|Adverse Event|1|||
155247276|NCT01040130|560335321|FG001|Overall Study|Adverse Event|1|||
155247277|NCT01040130|560335322|FG002|Overall Study|Adverse Event|0|||
155247278|NCT01040130|560335323|FG003|Overall Study|Adverse Event|5|||
155247279|NCT01040130|560335324|FG004|Overall Study|Adverse Event|0|||
155247280|NCT01040130|560335325|FG005|Overall Study|Adverse Event|3|||
155247281|NCT01040130|560335320|FG000|Overall Study|Protocol Violation|0|||
155247282|NCT01040130|560335321|FG001|Overall Study|Protocol Violation|0|||
155247283|NCT01040130|560335322|FG002|Overall Study|Protocol Violation|2|||
155247284|NCT01040130|560335323|FG003|Overall Study|Protocol Violation|0|||
155247285|NCT01040130|560335324|FG004|Overall Study|Protocol Violation|0|||
155247286|NCT01040130|560335325|FG005|Overall Study|Protocol Violation|0|||
155247287|NCT01040130|560335320|FG000|Overall Study|Withdrawal by Subject|0|||
155247288|NCT01040130|560335321|FG001|Overall Study|Withdrawal by Subject|2|||
155247289|NCT01040130|560335322|FG002|Overall Study|Withdrawal by Subject|0|||
155247290|NCT01040130|560335323|FG003|Overall Study|Withdrawal by Subject|0|||
155247291|NCT01040130|560335324|FG004|Overall Study|Withdrawal by Subject|0|||
155247292|NCT01040130|560335325|FG005|Overall Study|Withdrawal by Subject|1|||
155247293|NCT01040130|560335320|FG000|Overall Study|Other reasons not listed above|2|||
155247294|NCT01040130|560335321|FG001|Overall Study|Other reasons not listed above|0|||
155247295|NCT01040130|560335322|FG002|Overall Study|Other reasons not listed above|0|||
155247296|NCT01040130|560335323|FG003|Overall Study|Other reasons not listed above|0|||
155247297|NCT01040130|560335324|FG004|Overall Study|Other reasons not listed above|0|||
155247298|NCT01040130|560335325|FG005|Overall Study|Other reasons not listed above|0|||
155247299|NCT01618864|560335331|FG000|Overall Study|Withdrawal by Subject|2|||
155247300|NCT01618864|560335331|FG000|Overall Study|Lost to Follow-up|2|||
155247301|NCT01109992|560335332|FG000|Overall Study|Withdrawal by Subject|0|||
155247302|NCT01109992|560335333|FG001|Overall Study|Withdrawal by Subject|1|||
155247303|NCT01109992|560335332|FG000|Overall Study|Movement during rest scan.|0|||
155247304|NCT01109992|560335333|FG001|Overall Study|Movement during rest scan.|1|||
155247305|NCT00690755|560335336|FG000|Overall Study|Physician Decision|2|||
155247306|NCT00690755|560335337|FG001|Overall Study|Physician Decision|0|||
155247307|NCT00690755|560335338|FG002|Overall Study|Physician Decision|46|||
155247308|NCT00690755|560335339|FG003|Overall Study|Physician Decision|5|||
155247309|NCT00690755|560335340|FG004|Overall Study|Physician Decision|0|||
155247310|NCT00690755|560335341|FG005|Overall Study|Physician Decision|4|||
155247311|NCT00690755|560335342|FG006|Overall Study|Physician Decision|0|||
155247312|NCT04287920|560335343|FG000|Overall Study|Lost to Follow-up|1|||
155247313|NCT04287920|560335344|FG001|Overall Study|Lost to Follow-up|1|||
155247314|NCT04287920|560335343|FG000|Overall Study|Withdrawal by Subject|0|||
155247315|NCT04287920|560335344|FG001|Overall Study|Withdrawal by Subject|3|||
155247316|NCT02952924|560335347|FG000|Overall Study|Protocol Violation|0|||
155247317|NCT02952924|560335348|FG001|Overall Study|Protocol Violation|0|||
155247318|NCT02952924|560335349|FG002|Overall Study|Protocol Violation|0|||
155247319|NCT02952924|560335350|FG003|Overall Study|Protocol Violation|0|||
155247320|NCT02952924|560335351|FG004|Overall Study|Protocol Violation|0|||
155247321|NCT02952924|560335352|FG005|Overall Study|Protocol Violation|0|||
155247322|NCT02952924|560335353|FG006|Overall Study|Protocol Violation|0|||
155247323|NCT02952924|560335354|FG007|Overall Study|Protocol Violation|0|||
155247324|NCT02952924|560335355|FG008|Overall Study|Protocol Violation|0|||
155247325|NCT02952924|560335356|FG009|Overall Study|Protocol Violation|0|||
155247326|NCT02952924|560335357|FG010|Overall Study|Protocol Violation|0|||
155247327|NCT02952924|560335358|FG011|Overall Study|Protocol Violation|0|||
155247328|NCT02952924|560335359|FG012|Overall Study|Protocol Violation|0|||
155247329|NCT02952924|560335360|FG013|Overall Study|Protocol Violation|0|||
155247330|NCT02952924|560335361|FG014|Overall Study|Protocol Violation|0|||
155247331|NCT02952924|560335362|FG015|Overall Study|Protocol Violation|0|||
155247332|NCT02952924|560335363|FG016|Overall Study|Protocol Violation|0|||
155247333|NCT02952924|560335364|FG017|Overall Study|Protocol Violation|0|||
155247334|NCT02952924|560335365|FG018|Overall Study|Protocol Violation|0|||
155247335|NCT02952924|560335366|FG019|Overall Study|Protocol Violation|1|||
155247336|NCT02952924|560335367|FG020|Overall Study|Protocol Violation|0|||
155247337|NCT02952924|560335368|FG021|Overall Study|Protocol Violation|0|||
155247338|NCT02952924|560335347|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
155247339|NCT02952924|560335348|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
155247340|NCT02952924|560335349|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
155247341|NCT02952924|560335350|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
155247342|NCT02952924|560335351|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
155247343|NCT02952924|560335352|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
155247344|NCT02952924|560335353|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
155247345|NCT02952924|560335354|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
155247346|NCT02952924|560335355|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
155247347|NCT02952924|560335356|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
155247348|NCT02952924|560335357|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
155247349|NCT02952924|560335358|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
155247350|NCT02952924|560335359|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
155247351|NCT02952924|560335360|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
155247352|NCT02952924|560335361|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
155247353|NCT02952924|560335362|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
155247354|NCT02952924|560335363|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
155247355|NCT02952924|560335364|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
155247356|NCT02952924|560335365|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
155247357|NCT02952924|560335366|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
155247358|NCT02952924|560335367|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
155247359|NCT02952924|560335368|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
155247360|NCT02952924|560335347|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247361|NCT02952924|560335348|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247362|NCT02952924|560335349|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247363|NCT02952924|560335350|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247364|NCT02952924|560335351|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247365|NCT02952924|560335352|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247366|NCT02952924|560335353|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247367|NCT02952924|560335354|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247368|NCT02952924|560335355|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247369|NCT02952924|560335356|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247370|NCT02952924|560335357|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247371|NCT02952924|560335358|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247372|NCT02952924|560335359|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247373|NCT02952924|560335360|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247374|NCT02952924|560335361|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247375|NCT02952924|560335362|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247376|NCT02952924|560335363|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247377|NCT02952924|560335364|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247378|NCT02952924|560335365|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247379|NCT02952924|560335366|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247380|NCT02952924|560335367|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
155247381|NCT02952924|560335368|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
155247382|NCT02952924|560335347|FG000|Overall Study|Noncompliance with study drug|0|||
155247383|NCT02952924|560335348|FG001|Overall Study|Noncompliance with study drug|0|||
155247384|NCT02952924|560335349|FG002|Overall Study|Noncompliance with study drug|0|||
155247385|NCT02952924|560335350|FG003|Overall Study|Noncompliance with study drug|0|||
155247386|NCT02952924|560335351|FG004|Overall Study|Noncompliance with study drug|0|||
155247387|NCT02952924|560335352|FG005|Overall Study|Noncompliance with study drug|0|||
155247388|NCT02952924|560335353|FG006|Overall Study|Noncompliance with study drug|0|||
155247389|NCT02952924|560335354|FG007|Overall Study|Noncompliance with study drug|0|||
155247390|NCT02952924|560335355|FG008|Overall Study|Noncompliance with study drug|0|||
155247391|NCT02952924|560335356|FG009|Overall Study|Noncompliance with study drug|0|||
155247392|NCT02952924|560335357|FG010|Overall Study|Noncompliance with study drug|0|||
155247393|NCT02952924|560335358|FG011|Overall Study|Noncompliance with study drug|0|||
155247394|NCT02952924|560335359|FG012|Overall Study|Noncompliance with study drug|0|||
155247395|NCT02952924|560335360|FG013|Overall Study|Noncompliance with study drug|0|||
155247396|NCT02952924|560335361|FG014|Overall Study|Noncompliance with study drug|0|||
155247397|NCT02952924|560335362|FG015|Overall Study|Noncompliance with study drug|0|||
155247398|NCT02952924|560335363|FG016|Overall Study|Noncompliance with study drug|0|||
155247399|NCT02952924|560335364|FG017|Overall Study|Noncompliance with study drug|0|||
155247400|NCT02952924|560335365|FG018|Overall Study|Noncompliance with study drug|0|||
155247401|NCT02952924|560335366|FG019|Overall Study|Noncompliance with study drug|0|||
155247402|NCT02952924|560335367|FG020|Overall Study|Noncompliance with study drug|0|||
155247403|NCT02952924|560335368|FG021|Overall Study|Noncompliance with study drug|1|||
155247404|NCT01435577|560335371|FG000|Overall Study|Adverse Event|10|||
155247405|NCT01435577|560335372|FG001|Overall Study|Adverse Event|0|||
155247406|NCT01435577|560335371|FG000|Overall Study|Lack of Efficacy|7|||
155247407|NCT01435577|560335372|FG001|Overall Study|Lack of Efficacy|51|||
155247408|NCT01435577|560335371|FG000|Overall Study|Alternative treatment started|0|||
155247409|NCT01435577|560335372|FG001|Overall Study|Alternative treatment started|1|||
155247410|NCT03585244|560335373|FG000|Overall Study|Withdrawal by Subject|15|||
155247411|NCT01934218|560335375|FG000|Double-blind Phase|Adverse Event|8|||
155247412|NCT01934218|560335376|FG001|Double-blind Phase|Adverse Event|8|||
155247413|NCT01934218|560335375|FG000|Double-blind Phase|Lack of Efficacy|6|||
155247414|NCT01934218|560335376|FG001|Double-blind Phase|Lack of Efficacy|7|||
155247415|NCT01934218|560335375|FG000|Double-blind Phase|Lost to Follow-up|7|||
155247416|NCT01934218|560335376|FG001|Double-blind Phase|Lost to Follow-up|14|||
155247417|NCT01934218|560335375|FG000|Double-blind Phase|Physician Decision|1|||
155247418|NCT01934218|560335376|FG001|Double-blind Phase|Physician Decision|2|||
155247419|NCT01934218|560335375|FG000|Double-blind Phase|Protocol Violation|4|||
155247420|NCT01934218|560335376|FG001|Double-blind Phase|Protocol Violation|0|||
155247421|NCT01934218|560335375|FG000|Double-blind Phase|Withdrawal by Subject|16|||
155247422|NCT01934218|560335376|FG001|Double-blind Phase|Withdrawal by Subject|13|||
155247423|NCT01934218|560335375|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
155247424|NCT01934218|560335376|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
155247425|NCT01934218|560335375|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
155247426|NCT01934218|560335376|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
155247427|NCT01934218|560335375|FG000|Open-Label Phase|Adverse Event|2|||
155247428|NCT01934218|560335376|FG001|Open-Label Phase|Adverse Event|4|||
155247429|NCT01934218|560335375|FG000|Open-Label Phase|Lack of Efficacy|1|||
155247430|NCT01934218|560335376|FG001|Open-Label Phase|Lack of Efficacy|4|||
155247431|NCT01934218|560335375|FG000|Open-Label Phase|Lost to Follow-up|4|||
155247432|NCT01934218|560335376|FG001|Open-Label Phase|Lost to Follow-up|2|||
155247433|NCT01934218|560335375|FG000|Open-Label Phase|Physician Decision|1|||
155247434|NCT01934218|560335376|FG001|Open-Label Phase|Physician Decision|0|||
155247435|NCT01934218|560335375|FG000|Open-Label Phase|Protocol Violation|1|||
155247436|NCT01934218|560335376|FG001|Open-Label Phase|Protocol Violation|0|||
155247437|NCT01934218|560335375|FG000|Open-Label Phase|Withdrawal by Subject|13|||
155247438|NCT01934218|560335376|FG001|Open-Label Phase|Withdrawal by Subject|11|||
155247439|NCT01934218|560335375|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
155247440|NCT01934218|560335376|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
155247441|NCT01934218|560335375|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
155247442|NCT01934218|560335376|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
155247443|NCT03273946|560335381|FG000|Overall Study|Withdrawal by Subject|5|||
155247444|NCT03273946|560335381|FG000|Overall Study|Unwillingness of the guardian|1|||
155247445|NCT03273946|560335381|FG000|Overall Study|Participant refused to use the drug|2|||
155247446|NCT03273946|560335381|FG000|Overall Study|Participant relative refused to use drug|1|||
155247447|NCT01220557|560335382|FG000|Overall Study|Lost to Follow-up|5|||
155247448|NCT01220557|560335383|FG001|Overall Study|Lost to Follow-up|3|||
155247449|NCT01220557|560335382|FG000|Overall Study|attended less than 6 lessons|1|||
155247450|NCT01220557|560335383|FG001|Overall Study|attended less than 6 lessons|2|||
155247451|NCT02199028|560335388|FG000|Week 1|Adverse Event|1|||
155247452|NCT02199028|560335389|FG001|Week 1|Adverse Event|0|||
155247453|NCT02199028|560335388|FG000|Week 3|Adverse Event|1|||
155247454|NCT02199028|560335389|FG001|Week 3|Adverse Event|0|||
155247455|NCT01881126|560335392|FG000|Overall Study|Non-compliance|1|||
155247456|NCT01881126|560335393|FG001|Overall Study|Non-compliance|1|||
155247457|NCT01881126|560335392|FG000|Overall Study|Adverse Event|0|||
155247458|NCT01881126|560335393|FG001|Overall Study|Adverse Event|1|||
155247459|NCT01983293|560338261|FG000|Overall Study|Withdrawal by Subject|29|||
155247460|NCT01983293|560338262|FG001|Overall Study|Withdrawal by Subject|15|||
155247461|NCT01983293|560338261|FG000|Overall Study|Missing 12-month visit|3|||
155247462|NCT01983293|560338262|FG001|Overall Study|Missing 12-month visit|3|||
155247463|NCT01983293|560338261|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
155247464|NCT01983293|560338262|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
155247465|NCT03147248|560338263|FG000|Overall Study|Adverse Event|0|||
155247466|NCT03147248|560338264|FG001|Overall Study|Adverse Event|2|||
155247467|NCT03147248|560338265|FG002|Overall Study|Adverse Event|2|||
155247468|NCT03147248|560338266|FG003|Overall Study|Adverse Event|2|||
155247469|NCT03147248|560338267|FG004|Overall Study|Adverse Event|6|||
155247470|NCT03147248|560338268|FG005|Overall Study|Adverse Event|11|||
155247471|NCT03147248|560338263|FG000|Overall Study|Disease progression|1|||
155247472|NCT03147248|560338264|FG001|Overall Study|Disease progression|0|||
155247473|NCT03147248|560338265|FG002|Overall Study|Disease progression|0|||
155247474|NCT03147248|560338266|FG003|Overall Study|Disease progression|0|||
155247475|NCT03147248|560338267|FG004|Overall Study|Disease progression|0|||
155247476|NCT03147248|560338268|FG005|Overall Study|Disease progression|2|||
155247477|NCT03147248|560338263|FG000|Overall Study|Withdrawal by Subject|0|||
155247478|NCT03147248|560338264|FG001|Overall Study|Withdrawal by Subject|0|||
155247479|NCT03147248|560338265|FG002|Overall Study|Withdrawal by Subject|0|||
155247480|NCT03147248|560338266|FG003|Overall Study|Withdrawal by Subject|0|||
155247481|NCT03147248|560338267|FG004|Overall Study|Withdrawal by Subject|12|||
155247482|NCT03147248|560338268|FG005|Overall Study|Withdrawal by Subject|9|||
155247483|NCT03147248|560338263|FG000|Overall Study|Protocol Violation|0|||
155247484|NCT03147248|560338264|FG001|Overall Study|Protocol Violation|0|||
155247485|NCT03147248|560338265|FG002|Overall Study|Protocol Violation|0|||
155247486|NCT03147248|560338266|FG003|Overall Study|Protocol Violation|0|||
155247487|NCT03147248|560338267|FG004|Overall Study|Protocol Violation|2|||
155247488|NCT03147248|560338268|FG005|Overall Study|Protocol Violation|0|||
155247489|NCT03147248|560338263|FG000|Overall Study|Lost to Follow-up|0|||
155247490|NCT03147248|560338264|FG001|Overall Study|Lost to Follow-up|0|||
155247491|NCT03147248|560338265|FG002|Overall Study|Lost to Follow-up|0|||
155247492|NCT03147248|560338266|FG003|Overall Study|Lost to Follow-up|0|||
155247493|NCT03147248|560338267|FG004|Overall Study|Lost to Follow-up|2|||
155247494|NCT03147248|560338268|FG005|Overall Study|Lost to Follow-up|0|||
155247495|NCT03147248|560338263|FG000|Overall Study|Pregnancy|0|||
155247496|NCT03147248|560338264|FG001|Overall Study|Pregnancy|0|||
155247497|NCT03147248|560338265|FG002|Overall Study|Pregnancy|0|||
155247498|NCT03147248|560338266|FG003|Overall Study|Pregnancy|0|||
155247499|NCT03147248|560338267|FG004|Overall Study|Pregnancy|1|||
155247500|NCT03147248|560338268|FG005|Overall Study|Pregnancy|0|||
155247501|NCT03147248|560338263|FG000|Overall Study|Death|0|||
155247502|NCT03147248|560338264|FG001|Overall Study|Death|0|||
155247503|NCT03147248|560338265|FG002|Overall Study|Death|0|||
155247504|NCT03147248|560338266|FG003|Overall Study|Death|0|||
155247505|NCT03147248|560338267|FG004|Overall Study|Death|0|||
155247506|NCT03147248|560338268|FG005|Overall Study|Death|4|||
155247507|NCT03147248|560338263|FG000|Overall Study|Physician Decision|0|||
155247508|NCT03147248|560338264|FG001|Overall Study|Physician Decision|0|||
155247509|NCT03147248|560338265|FG002|Overall Study|Physician Decision|0|||
155247510|NCT03147248|560338266|FG003|Overall Study|Physician Decision|0|||
155247511|NCT03147248|560338267|FG004|Overall Study|Physician Decision|2|||
155247512|NCT03147248|560338268|FG005|Overall Study|Physician Decision|4|||
155247513|NCT03147248|560338263|FG000|Overall Study|Prolonged Dosing Interval|0|||
155247514|NCT03147248|560338264|FG001|Overall Study|Prolonged Dosing Interval|0|||
155247515|NCT03147248|560338265|FG002|Overall Study|Prolonged Dosing Interval|0|||
155247516|NCT03147248|560338266|FG003|Overall Study|Prolonged Dosing Interval|0|||
155247517|NCT03147248|560338267|FG004|Overall Study|Prolonged Dosing Interval|1|||
155247518|NCT03147248|560338268|FG005|Overall Study|Prolonged Dosing Interval|1|||
155247519|NCT03750552|560338269|FG000|Overall Study|Adverse Event|5|||
155247520|NCT03750552|560338270|FG001|Overall Study|Adverse Event|1|||
155247521|NCT03750552|560338269|FG000|Overall Study|Withdrawal by Subject|1|||
155247522|NCT03750552|560338270|FG001|Overall Study|Withdrawal by Subject|1|||
155247523|NCT03750552|560338269|FG000|Overall Study|Other|2|||
155247524|NCT03750552|560338270|FG001|Overall Study|Other|0|||
155247525|NCT02062632|560338271|FG000|Overall Study|No treatment data|1|||
155247526|NCT00773968|560338273|FG000|Overall Study|Adverse Event|2|||
155247527|NCT00773968|560338273|FG000|Overall Study|Death|1|||
155247528|NCT00773968|560338273|FG000|Overall Study|Failure to Return|2|||
155247529|NCT00773968|560338273|FG000|Overall Study|Lack of Efficacy|3|||
155247530|NCT00773968|560338273|FG000|Overall Study|Protocol Violation|1|||
155247531|NCT00773968|560338273|FG000|Overall Study|Withdrawal by Subject|11|||
155247532|NCT00773968|560338273|FG000|Overall Study|Screen Failure|17|||
155247533|NCT00773968|560338273|FG000|Overall Study|Other|8|||
155247534|NCT02008890|560338277|FG000|Period 1|Withdrawal by Subject|7|||
155247535|NCT02008890|560338278|FG001|Period 1|Withdrawal by Subject|7|||
155247536|NCT02008890|560338279|FG002|Period 1|Withdrawal by Subject|5|||
155247537|NCT02008890|560338280|FG003|Period 1|Withdrawal by Subject|0|||
155247538|NCT02008890|560338281|FG004|Period 1|Withdrawal by Subject|0|||
155247539|NCT02008890|560338277|FG000|Period 1|Pregnancy|1|||
155247540|NCT02008890|560338278|FG001|Period 1|Pregnancy|0|||
155247541|NCT02008890|560338279|FG002|Period 1|Pregnancy|0|||
155247542|NCT02008890|560338280|FG003|Period 1|Pregnancy|0|||
155247543|NCT02008890|560338281|FG004|Period 1|Pregnancy|0|||
155247544|NCT02008890|560338277|FG000|Period 1|Physician Decision|1|||
155247545|NCT02008890|560338278|FG001|Period 1|Physician Decision|0|||
155247546|NCT02008890|560338279|FG002|Period 1|Physician Decision|1|||
155247547|NCT02008890|560338280|FG003|Period 1|Physician Decision|0|||
155247548|NCT02008890|560338281|FG004|Period 1|Physician Decision|0|||
155247549|NCT02008890|560338277|FG000|Period 1|Adverse Event|6|||
155247550|NCT02008890|560338278|FG001|Period 1|Adverse Event|8|||
155247551|NCT02008890|560338279|FG002|Period 1|Adverse Event|6|||
155247552|NCT02008890|560338280|FG003|Period 1|Adverse Event|0|||
155247553|NCT02008890|560338281|FG004|Period 1|Adverse Event|0|||
155247554|NCT02008890|560338277|FG000|Period 2|Adverse Event|12|||
155247555|NCT02008890|560338278|FG001|Period 2|Adverse Event|7|||
155247556|NCT02008890|560338279|FG002|Period 2|Adverse Event|0|||
155247557|NCT02008890|560338280|FG003|Period 2|Adverse Event|5|||
155247558|NCT02008890|560338281|FG004|Period 2|Adverse Event|5|||
155247559|NCT02008890|560338277|FG000|Period 2|Withdrawal by Subject|11|||
155247560|NCT02008890|560338278|FG001|Period 2|Withdrawal by Subject|8|||
155247561|NCT02008890|560338279|FG002|Period 2|Withdrawal by Subject|0|||
155247562|NCT02008890|560338280|FG003|Period 2|Withdrawal by Subject|7|||
155247563|NCT02008890|560338281|FG004|Period 2|Withdrawal by Subject|2|||
155247564|NCT02008890|560338277|FG000|Period 2|Physician Decision|4|||
155247565|NCT02008890|560338278|FG001|Period 2|Physician Decision|0|||
155247566|NCT02008890|560338279|FG002|Period 2|Physician Decision|0|||
155247567|NCT02008890|560338280|FG003|Period 2|Physician Decision|2|||
155247568|NCT02008890|560338281|FG004|Period 2|Physician Decision|1|||
155247569|NCT02008890|560338277|FG000|Period 2|Lost to Follow-up|0|||
155247570|NCT02008890|560338278|FG001|Period 2|Lost to Follow-up|0|||
155247571|NCT02008890|560338279|FG002|Period 2|Lost to Follow-up|1|||
155247572|NCT02008890|560338280|FG003|Period 2|Lost to Follow-up|0|||
155247573|NCT02008890|560338281|FG004|Period 2|Lost to Follow-up|0|||
155247574|NCT02008890|560338277|FG000|Extension Period|Withdrawal by Subject|3|||
155247575|NCT02008890|560338278|FG001|Extension Period|Withdrawal by Subject|2|||
155247576|NCT02008890|560338279|FG002|Extension Period|Withdrawal by Subject|0|||
155247577|NCT02008890|560338280|FG003|Extension Period|Withdrawal by Subject|4|||
155247578|NCT02008890|560338281|FG004|Extension Period|Withdrawal by Subject|2|||
155247579|NCT02008890|560338277|FG000|Extension Period|Lost to Follow-up|1|||
155247580|NCT02008890|560338278|FG001|Extension Period|Lost to Follow-up|0|||
155247581|NCT02008890|560338279|FG002|Extension Period|Lost to Follow-up|0|||
155247582|NCT02008890|560338280|FG003|Extension Period|Lost to Follow-up|0|||
155247583|NCT02008890|560338281|FG004|Extension Period|Lost to Follow-up|0|||
155247584|NCT02008890|560338277|FG000|Extension Period|Adverse Event|1|||
155247585|NCT02008890|560338278|FG001|Extension Period|Adverse Event|3|||
155247586|NCT02008890|560338279|FG002|Extension Period|Adverse Event|0|||
155247587|NCT02008890|560338280|FG003|Extension Period|Adverse Event|0|||
155247588|NCT02008890|560338281|FG004|Extension Period|Adverse Event|2|||
155247589|NCT02207816|560338282|FG000|Overall Study|Serious Adverse Event|0|||
155247590|NCT02207816|560338283|FG001|Overall Study|Serious Adverse Event|5|||
155247591|NCT02207816|560338284|FG002|Overall Study|Serious Adverse Event|2|||
155247592|NCT02207816|560338282|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155247593|NCT02207816|560338283|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
155247594|NCT02207816|560338284|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
155247595|NCT02207816|560338282|FG000|Overall Study|Withdrawal by Subject|4|||
155247596|NCT02207816|560338283|FG001|Overall Study|Withdrawal by Subject|9|||
155247597|NCT02207816|560338284|FG002|Overall Study|Withdrawal by Subject|7|||
155247598|NCT02207816|560338282|FG000|Overall Study|Migrated/Moved From Study Area|41|||
155247599|NCT02207816|560338283|FG001|Overall Study|Migrated/Moved From Study Area|60|||
155247600|NCT02207816|560338284|FG002|Overall Study|Migrated/Moved From Study Area|51|||
155247601|NCT02207816|560338282|FG000|Overall Study|Lost to Follow-up|3|||
155247602|NCT02207816|560338283|FG001|Overall Study|Lost to Follow-up|9|||
155247603|NCT02207816|560338284|FG002|Overall Study|Lost to Follow-up|1|||
155247604|NCT02207816|560338282|FG000|Overall Study|Other|1|||
155247605|NCT02207816|560338283|FG001|Overall Study|Other|2|||
155247606|NCT02207816|560338284|FG002|Overall Study|Other|4|||
155247607|NCT05912400|560338285|FG000|Overall Study|Lost to Follow-up|1|||
155247608|NCT05912400|560338286|FG001|Overall Study|Lost to Follow-up|0|||
155247609|NCT05912400|560338285|FG000|Overall Study|Physician Decision|6|||
155247610|NCT05912400|560338286|FG001|Overall Study|Physician Decision|0|||
155247611|NCT05912400|560338285|FG000|Overall Study|Withdrawal by Subject|1|||
155247612|NCT05912400|560338286|FG001|Overall Study|Withdrawal by Subject|0|||
155247613|NCT02522494|560338287|FG000|Overall Study|Lost to Follow-up|6|||
155247614|NCT02522494|560338288|FG001|Overall Study|Lost to Follow-up|2|||
155247615|NCT02522494|560338287|FG000|Overall Study|Withdrawal by Subject|1|||
155247616|NCT02522494|560338288|FG001|Overall Study|Withdrawal by Subject|0|||
155247617|NCT02522494|560338287|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
155247618|NCT02522494|560338288|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
155247619|NCT02522494|560338287|FG000|Overall Study|Participant did not watch the video|1|||
155247620|NCT02522494|560338288|FG001|Overall Study|Participant did not watch the video|0|||
155247621|NCT02522494|560338287|FG000|Overall Study|Death|0|||
155247622|NCT02522494|560338288|FG001|Overall Study|Death|1|||
155247623|NCT03240588|560338289|FG000|Overall Study|Death|3|||
155247624|NCT03240588|560338290|FG001|Overall Study|Death|0|||
155247625|NCT03240588|560338291|FG002|Overall Study|Death|0|||
155247626|NCT03240588|560338289|FG000|Overall Study|Adverse Event|5|||
155247627|NCT03240588|560338290|FG001|Overall Study|Adverse Event|4|||
155247628|NCT03240588|560338291|FG002|Overall Study|Adverse Event|0|||
155247629|NCT03240588|560338289|FG000|Overall Study|Lost to Follow-up|9|||
155247630|NCT03240588|560338290|FG001|Overall Study|Lost to Follow-up|4|||
155247631|NCT03240588|560338291|FG002|Overall Study|Lost to Follow-up|0|||
155247632|NCT03240588|560338289|FG000|Overall Study|Physician Decision|3|||
155247633|NCT03240588|560338290|FG001|Overall Study|Physician Decision|2|||
155247634|NCT03240588|560338291|FG002|Overall Study|Physician Decision|0|||
155247635|NCT03240588|560338289|FG000|Overall Study|Did not meet eligibility criteria|0|||
155247636|NCT03240588|560338290|FG001|Overall Study|Did not meet eligibility criteria|6|||
155247637|NCT03240588|560338291|FG002|Overall Study|Did not meet eligibility criteria|0|||
155247638|NCT03240588|560338289|FG000|Overall Study|No longer meets protocol criteria|12|||
155247639|NCT03240588|560338290|FG001|Overall Study|No longer meets protocol criteria|7|||
155247640|NCT03240588|560338291|FG002|Overall Study|No longer meets protocol criteria|0|||
155247641|NCT03240588|560338289|FG000|Overall Study|Withdrawal by Subject|60|||
155247642|NCT03240588|560338290|FG001|Overall Study|Withdrawal by Subject|52|||
155247643|NCT03240588|560338291|FG002|Overall Study|Withdrawal by Subject|7|||
155247644|NCT03240588|560338289|FG000|Overall Study|Other, additional details not available.|0|||
155247645|NCT03240588|560338290|FG001|Overall Study|Other, additional details not available.|12|||
155247646|NCT03240588|560338291|FG002|Overall Study|Other, additional details not available.|1|||
155247647|NCT03240588|560338289|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
155247648|NCT03240588|560338290|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
155247649|NCT03240588|560338291|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
155247650|NCT03240588|560338289|FG000|Overall Study|Closure of study|55|||
155247651|NCT03240588|560338290|FG001|Overall Study|Closure of study|3|||
155247652|NCT03240588|560338291|FG002|Overall Study|Closure of study|0|||
155247653|NCT03240588|560338289|FG000|Overall Study|Subject non-compliance|23|||
155247654|NCT03240588|560338290|FG001|Overall Study|Subject non-compliance|2|||
155247655|NCT03240588|560338291|FG002|Overall Study|Subject non-compliance|1|||
155247656|NCT03240588|560338289|FG000|Overall Study|Device Deficiency|1|||
155247657|NCT03240588|560338290|FG001|Overall Study|Device Deficiency|0|||
155247658|NCT03240588|560338291|FG002|Overall Study|Device Deficiency|0|||
155247659|NCT03240588|560338289|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
155247660|NCT03240588|560338290|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
155247661|NCT03240588|560338291|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
155247662|NCT01259713|560338293|FG000|Overall Study|Adverse Event|54|||
155247663|NCT01259713|560338294|FG001|Overall Study|Adverse Event|23|||
155247664|NCT01259713|560338293|FG000|Overall Study|Death Not Related to IFI|8|||
155247665|NCT01259713|560338294|FG001|Overall Study|Death Not Related to IFI|1|||
155247666|NCT01259713|560338293|FG000|Overall Study|Investigators Discretion|14|||
155247667|NCT01259713|560338294|FG001|Overall Study|Investigators Discretion|6|||
155247668|NCT01259713|560338293|FG000|Overall Study|Lack of Efficacy|2|||
155247669|NCT01259713|560338294|FG001|Overall Study|Lack of Efficacy|0|||
155247670|NCT01259713|560338293|FG000|Overall Study|Protocol Violation|5|||
155247671|NCT01259713|560338294|FG001|Overall Study|Protocol Violation|4|||
155247672|NCT01259713|560338293|FG000|Overall Study|Subject Withdrew Consent|12|||
155247673|NCT01259713|560338294|FG001|Overall Study|Subject Withdrew Consent|7|||
155247674|NCT02091726|560338295|FG000|Overall Study|Lost to Follow-up|6|||
155247675|NCT06111742|560338296|FG000|Overall Study|Did not receive intervention|1|||
155247676|NCT06111742|560338297|FG001|Overall Study|Did not receive intervention|0|||
155247677|NCT06111742|560338298|FG002|Overall Study|Did not receive intervention|0|||
155247678|NCT06111742|560338296|FG000|Overall Study|Withdrawal by Subject|2|||
155247679|NCT06111742|560338297|FG001|Overall Study|Withdrawal by Subject|0|||
155247680|NCT06111742|560338298|FG002|Overall Study|Withdrawal by Subject|0|||
155247681|NCT03461003|560338299|FG000|Overall Study|Lost to Follow-up|2|||
155247682|NCT03461003|560338300|FG001|Overall Study|Lost to Follow-up|2|||
155247683|NCT03461003|560338299|FG000|Overall Study|Withdrawal by Subject|3|||
155247684|NCT03461003|560338300|FG001|Overall Study|Withdrawal by Subject|1|||
155247685|NCT01914926|560338301|FG000|Overall Study|Adverse Event|1|||
155247686|NCT01914926|560338302|FG001|Overall Study|Adverse Event|0|||
155247687|NCT01914926|560338301|FG000|Overall Study|uncooperative, agitated and removed|0|||
155247688|NCT01914926|560338302|FG001|Overall Study|uncooperative, agitated and removed|1|||
155247689|NCT02047045|560338306|FG000|Baseline|Withdrawal by Subject|3|||
155247690|NCT02047045|560338307|FG001|Baseline|Withdrawal by Subject|2|||
155247691|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
155247692|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
155247693|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
155247694|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
155247695|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
155247696|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
155247697|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
155247698|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
155247699|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
155247700|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
155247701|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
155247702|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
155247703|NCT02047045|560338306|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
155247704|NCT02047045|560338307|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
155247705|NCT02047045|560338306|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
155247706|NCT02047045|560338307|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
155247707|NCT03508843|560338308|FG000|Overall Study|Withdrawal by Subject|1|||
155247708|NCT03508843|560338308|FG000|Overall Study|technical difficulties|2|||
155247709|NCT03555396|560338309|FG000|Overall Study|Death|3|||
155247710|NCT03555396|560338310|FG001|Overall Study|Death|1|||
155247711|NCT03555396|560338309|FG000|Overall Study|Lost to Follow-up|0|||
155247712|NCT03555396|560338310|FG001|Overall Study|Lost to Follow-up|2|||
155247713|NCT02536508|560338311|FG000|Overall Study|Withdrawal by Subject|18|||
155247714|NCT02536508|560338312|FG001|Overall Study|Withdrawal by Subject|13|||
155247715|NCT02536508|560338313|FG002|Overall Study|Withdrawal by Subject|7|||
155247716|NCT02536508|560338311|FG000|Overall Study|Adverse Event|14|||
155247717|NCT02536508|560338312|FG001|Overall Study|Adverse Event|13|||
155247718|NCT02536508|560338313|FG002|Overall Study|Adverse Event|6|||
155247719|NCT02536508|560338311|FG000|Overall Study|Lost to Follow-up|12|||
155247720|NCT02536508|560338312|FG001|Overall Study|Lost to Follow-up|4|||
155247721|NCT02536508|560338313|FG002|Overall Study|Lost to Follow-up|0|||
155247722|NCT02536508|560338311|FG000|Overall Study|Lack of Efficacy|3|||
155247723|NCT02536508|560338312|FG001|Overall Study|Lack of Efficacy|5|||
155247724|NCT02536508|560338313|FG002|Overall Study|Lack of Efficacy|4|||
155247725|NCT02536508|560338311|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
155247726|NCT02536508|560338312|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
155247727|NCT02536508|560338313|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
155247728|NCT02536508|560338311|FG000|Overall Study|Physician Decision|0|||
155247729|NCT02536508|560338312|FG001|Overall Study|Physician Decision|4|||
155247730|NCT02536508|560338313|FG002|Overall Study|Physician Decision|2|||
155247731|NCT02536508|560338311|FG000|Overall Study|Major Protocol Deviation|2|||
155247732|NCT02536508|560338312|FG001|Overall Study|Major Protocol Deviation|2|||
155247733|NCT02536508|560338313|FG002|Overall Study|Major Protocol Deviation|2|||
155247734|NCT02536508|560338311|FG000|Overall Study|Administrative Reasons|0|||
155247735|NCT02536508|560338312|FG001|Overall Study|Administrative Reasons|1|||
155247736|NCT02536508|560338313|FG002|Overall Study|Administrative Reasons|0|||
155247737|NCT00922428|560338319|FG000|Overall Study|retrospective/extremely implausible data|2|||
155247738|NCT00922428|560338319|FG000|Overall Study|no medication use or questionable use|13|||
155247739|NCT04862143|560338336|FG000|Overall Study|Adverse Event|1|||
155247740|NCT04862143|560338336|FG000|Overall Study|Study terminated by sponsor|1|||
155247741|NCT02103439|560338337|FG000|Overall Study|Adverse Event|0|||
155247742|NCT02103439|560338338|FG001|Overall Study|Adverse Event|2|||
155247743|NCT02103439|560338337|FG000|Overall Study|Withdrawal by Subject|3|||
155247744|NCT02103439|560338338|FG001|Overall Study|Withdrawal by Subject|1|||
155247745|NCT02370602|560338339|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155247746|NCT02370602|560338340|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155247747|NCT02370602|560338341|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
155247748|NCT02370602|560338342|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
155247749|NCT02370602|560338343|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
155247750|NCT02370602|560338344|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
155247751|NCT02864082|560338348|FG000|Overall Study|Adverse Event|1|||
155247752|NCT02864082|560338349|FG001|Overall Study|Adverse Event|1|||
155247753|NCT02864082|560338348|FG000|Overall Study|Lost to Follow-up|0|||
155247754|NCT02864082|560338349|FG001|Overall Study|Lost to Follow-up|1|||
155247755|NCT02864082|560338348|FG000|Overall Study|Withdrawal by Subject|2|||
155247756|NCT02864082|560338349|FG001|Overall Study|Withdrawal by Subject|2|||
155247757|NCT02310750|560338352|FG000|HP Period 1|Lost to Follow-up|0|||
155247758|NCT02310750|560338353|FG001|HP Period 1|Lost to Follow-up|0|||
155247759|NCT02310750|560338354|FG002|HP Period 1|Lost to Follow-up|0|||
155247760|NCT02310750|560338355|FG003|HP Period 1|Lost to Follow-up|0|||
155247761|NCT02310750|560338356|FG004|HP Period 1|Lost to Follow-up|0|||
155247762|NCT02310750|560338357|FG005|HP Period 1|Lost to Follow-up|0|||
155247763|NCT02310750|560338358|FG006|HP Period 1|Lost to Follow-up|1|||
155247764|NCT02310750|560338359|FG007|HP Period 1|Lost to Follow-up|0|||
155247765|NCT02310750|560338360|FG008|HP Period 1|Lost to Follow-up|0|||
155247766|NCT02310750|560338361|FG009|HP Period 1|Lost to Follow-up|0|||
155247767|NCT02310750|560338362|FG010|HP Period 1|Lost to Follow-up|0|||
155247768|NCT02310750|560338363|FG011|HP Period 1|Lost to Follow-up|0|||
155247769|NCT02310750|560338364|FG012|HP Period 1|Lost to Follow-up|0|||
155247770|NCT02310750|560338365|FG013|HP Period 1|Lost to Follow-up|0|||
155247771|NCT02310750|560338366|FG014|HP Period 1|Lost to Follow-up|0|||
155247772|NCT02310750|560338367|FG015|HP Period 1|Lost to Follow-up|0|||
155247773|NCT02310750|560338352|FG000|HP Period 1|Withdrawal by Subject|1|||
155247774|NCT02310750|560338353|FG001|HP Period 1|Withdrawal by Subject|0|||
155247775|NCT02310750|560338354|FG002|HP Period 1|Withdrawal by Subject|0|||
155247776|NCT02310750|560338355|FG003|HP Period 1|Withdrawal by Subject|1|||
155247777|NCT02310750|560338356|FG004|HP Period 1|Withdrawal by Subject|0|||
155247778|NCT02310750|560338357|FG005|HP Period 1|Withdrawal by Subject|0|||
155247779|NCT02310750|560338358|FG006|HP Period 1|Withdrawal by Subject|0|||
155247780|NCT02310750|560338359|FG007|HP Period 1|Withdrawal by Subject|0|||
155247781|NCT02310750|560338360|FG008|HP Period 1|Withdrawal by Subject|0|||
155247782|NCT02310750|560338361|FG009|HP Period 1|Withdrawal by Subject|0|||
155247783|NCT02310750|560338362|FG010|HP Period 1|Withdrawal by Subject|0|||
155247784|NCT02310750|560338363|FG011|HP Period 1|Withdrawal by Subject|0|||
155247785|NCT02310750|560338364|FG012|HP Period 1|Withdrawal by Subject|0|||
155247786|NCT02310750|560338365|FG013|HP Period 1|Withdrawal by Subject|0|||
155247787|NCT02310750|560338366|FG014|HP Period 1|Withdrawal by Subject|0|||
155247788|NCT02310750|560338367|FG015|HP Period 1|Withdrawal by Subject|0|||
155247789|NCT02310750|560338352|FG000|HP Washout 1|Lost to Follow-up|0|||
155247790|NCT02310750|560338353|FG001|HP Washout 1|Lost to Follow-up|0|||
155247791|NCT02310750|560338354|FG002|HP Washout 1|Lost to Follow-up|1|||
155247792|NCT02310750|560338355|FG003|HP Washout 1|Lost to Follow-up|1|||
155247793|NCT02310750|560338356|FG004|HP Washout 1|Lost to Follow-up|2|||
155247794|NCT02310750|560338357|FG005|HP Washout 1|Lost to Follow-up|2|||
155247795|NCT02310750|560338358|FG006|HP Washout 1|Lost to Follow-up|3|||
155247796|NCT02310750|560338359|FG007|HP Washout 1|Lost to Follow-up|0|||
155247797|NCT02310750|560338360|FG008|HP Washout 1|Lost to Follow-up|0|||
155247798|NCT02310750|560338361|FG009|HP Washout 1|Lost to Follow-up|0|||
155247799|NCT02310750|560338362|FG010|HP Washout 1|Lost to Follow-up|0|||
155247800|NCT02310750|560338363|FG011|HP Washout 1|Lost to Follow-up|0|||
155247801|NCT02310750|560338364|FG012|HP Washout 1|Lost to Follow-up|0|||
155247802|NCT02310750|560338365|FG013|HP Washout 1|Lost to Follow-up|0|||
155247803|NCT02310750|560338366|FG014|HP Washout 1|Lost to Follow-up|0|||
155247804|NCT02310750|560338367|FG015|HP Washout 1|Lost to Follow-up|0|||
155247805|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247806|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247807|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247808|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
155247809|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247810|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
155247811|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247812|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247813|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
155247814|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
155247815|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247816|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247817|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247818|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247819|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247820|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
155247821|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247822|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247823|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247824|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247825|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247826|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247827|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247828|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247829|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247830|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
155247831|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247832|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247833|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247834|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247835|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247836|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
155247837|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247838|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247839|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247840|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247841|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247842|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247843|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247844|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
155247845|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
155247846|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
155247847|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247848|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247849|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247850|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247851|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247852|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
155247853|NCT02310750|560338352|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247854|NCT02310750|560338353|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247855|NCT02310750|560338354|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247856|NCT02310750|560338355|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247857|NCT02310750|560338356|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247858|NCT02310750|560338357|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247859|NCT02310750|560338358|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247860|NCT02310750|560338359|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
155247861|NCT02310750|560338360|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
155247862|NCT02310750|560338361|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247863|NCT02310750|560338362|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247864|NCT02310750|560338363|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247865|NCT02310750|560338364|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247866|NCT02310750|560338365|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247867|NCT02310750|560338366|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247868|NCT02310750|560338367|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
155247869|NCT02310750|560338352|FG000|HP Washout 2|Lost to Follow-up|0|||
155247870|NCT02310750|560338353|FG001|HP Washout 2|Lost to Follow-up|0|||
155247871|NCT02310750|560338354|FG002|HP Washout 2|Lost to Follow-up|0|||
155247872|NCT02310750|560338355|FG003|HP Washout 2|Lost to Follow-up|0|||
155247873|NCT02310750|560338356|FG004|HP Washout 2|Lost to Follow-up|1|||
155247874|NCT02310750|560338357|FG005|HP Washout 2|Lost to Follow-up|0|||
155247875|NCT02310750|560338358|FG006|HP Washout 2|Lost to Follow-up|7|||
155247876|NCT02310750|560338359|FG007|HP Washout 2|Lost to Follow-up|0|||
155247877|NCT02310750|560338360|FG008|HP Washout 2|Lost to Follow-up|0|||
155247878|NCT02310750|560338361|FG009|HP Washout 2|Lost to Follow-up|0|||
155247879|NCT02310750|560338362|FG010|HP Washout 2|Lost to Follow-up|0|||
155247880|NCT02310750|560338363|FG011|HP Washout 2|Lost to Follow-up|0|||
155247881|NCT02310750|560338364|FG012|HP Washout 2|Lost to Follow-up|0|||
155247882|NCT02310750|560338365|FG013|HP Washout 2|Lost to Follow-up|0|||
155247883|NCT02310750|560338366|FG014|HP Washout 2|Lost to Follow-up|0|||
155247884|NCT02310750|560338367|FG015|HP Washout 2|Lost to Follow-up|0|||
155247885|NCT01226745|560338368|FG000|Overall Study|Did not complete schedule of assessments|8|||
155247886|NCT01226745|560338369|FG001|Overall Study|Did not complete schedule of assessments|3|||
155247887|NCT01226745|560338370|FG002|Overall Study|Did not complete schedule of assessments|6|||
155247888|NCT01226745|560338371|FG003|Overall Study|Did not complete schedule of assessments|0|||
155247889|NCT01226745|560338372|FG004|Overall Study|Did not complete schedule of assessments|0|||
155247890|NCT01226745|560338373|FG005|Overall Study|Did not complete schedule of assessments|1|||
155247891|NCT01226745|560338368|FG000|Overall Study|Lost to Follow-up|2|||
155247892|NCT01226745|560338369|FG001|Overall Study|Lost to Follow-up|6|||
155247893|NCT01226745|560338370|FG002|Overall Study|Lost to Follow-up|6|||
155247894|NCT01226745|560338371|FG003|Overall Study|Lost to Follow-up|1|||
155247895|NCT01226745|560338372|FG004|Overall Study|Lost to Follow-up|1|||
155247896|NCT01226745|560338373|FG005|Overall Study|Lost to Follow-up|2|||
155247897|NCT01226745|560338368|FG000|Overall Study|Death|1|||
155247898|NCT01226745|560338369|FG001|Overall Study|Death|0|||
155247899|NCT01226745|560338370|FG002|Overall Study|Death|0|||
155247900|NCT01226745|560338371|FG003|Overall Study|Death|0|||
155247901|NCT01226745|560338372|FG004|Overall Study|Death|0|||
155247902|NCT01226745|560338373|FG005|Overall Study|Death|1|||
155247903|NCT01226745|560338368|FG000|Overall Study|Other|6|||
155247904|NCT01226745|560338369|FG001|Overall Study|Other|7|||
155247905|NCT01226745|560338370|FG002|Overall Study|Other|8|||
155247906|NCT01226745|560338371|FG003|Overall Study|Other|4|||
155247907|NCT01226745|560338372|FG004|Overall Study|Other|3|||
155247908|NCT01226745|560338373|FG005|Overall Study|Other|1|||
155247909|NCT01090453|560338376|FG000|Overall Study|Withdrawal by Subject|1|||
155247910|NCT01090453|560338377|FG001|Overall Study|Withdrawal by Subject|2|||
155247911|NCT01090453|560338376|FG000|Overall Study|Lost to Follow-up|7|||
155247912|NCT01090453|560338377|FG001|Overall Study|Lost to Follow-up|7|||
155247913|NCT01090453|560338376|FG000|Overall Study|Non serious AEs|1|||
155247914|NCT01090453|560338377|FG001|Overall Study|Non serious AEs|0|||
155247915|NCT01090453|560338376|FG000|Overall Study|Protocol Violation|2|||
155247916|NCT01090453|560338377|FG001|Overall Study|Protocol Violation|0|||
155247917|NCT01090453|560338376|FG000|Overall Study|Other|2|||
155247918|NCT01090453|560338377|FG001|Overall Study|Other|4|||
155247919|NCT01090453|560338376|FG000|Overall Study|Eligibility Criteria|0|||
155247920|NCT01090453|560338377|FG001|Overall Study|Eligibility Criteria|1|||
155247921|NCT00522275|560338378|FG000|Overall Study|Adverse Event|35|||
155247922|NCT00522275|560338378|FG000|Overall Study|Lack of Efficacy|80|||
155247923|NCT00522275|560338378|FG000|Overall Study|Subject withdrew consent|16|||
155247924|NCT00522275|560338378|FG000|Overall Study|Protocol deviation|1|||
155247925|NCT00522275|560338378|FG000|Overall Study|Unsatisfactory compliance|11|||
155247926|NCT00522275|560338378|FG000|Overall Study|Lost to Follow-up|8|||
155247927|NCT00522275|560338378|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
155247928|NCT00522275|560338378|FG000|Overall Study|Other: Subject is pregnant|2|||
155247929|NCT00522275|560338378|FG000|Overall Study|Other: Subject relocated|2|||
155247930|NCT00522275|560338378|FG000|Overall Study|Other: Subject arrested|1|||
155247931|NCT00522275|560338378|FG000|Overall Study|Other: Site / clinic closed|4|||
155247932|NCT00522275|560338378|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
155247933|NCT00522275|560338378|FG000|Overall Study|Other: Sponsor request|2|||
155247934|NCT00522275|560338378|FG000|Overall Study|Other: Subject ran out of medication|1|||
155247935|NCT00522275|560338378|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
155247936|NCT05045625|560338379|FG000|Overall Study|Lost to Follow-up|3|||
155247937|NCT03867734|560338380|FG000|Overall Study|Lost to Follow-up|2|||
155247938|NCT00718718|560338381|FG000|Prior to Week 12|Adverse Event|0|||
155247939|NCT00718718|560338382|FG001|Prior to Week 12|Adverse Event|0|||
155247940|NCT00718718|560338383|FG002|Prior to Week 12|Adverse Event|0|||
155247941|NCT00718718|560338384|FG003|Prior to Week 12|Adverse Event|0|||
155247942|NCT00718718|560338385|FG004|Prior to Week 12|Adverse Event|0|||
155247943|NCT00718718|560338386|FG005|Prior to Week 12|Adverse Event|0|||
155247944|NCT00718718|560338387|FG006|Prior to Week 12|Adverse Event|0|||
155247945|NCT00718718|560338388|FG007|Prior to Week 12|Adverse Event|1|||
155247946|NCT00718718|560338389|FG008|Prior to Week 12|Adverse Event|1|||
155247947|NCT00718718|560338390|FG009|Prior to Week 12|Adverse Event|0|||
155247948|NCT00718718|560338381|FG000|Prior to Week 12|Withdrawal by Subject|0|||
155247949|NCT00718718|560338382|FG001|Prior to Week 12|Withdrawal by Subject|0|||
155247950|NCT00718718|560338383|FG002|Prior to Week 12|Withdrawal by Subject|0|||
155247951|NCT00718718|560338384|FG003|Prior to Week 12|Withdrawal by Subject|0|||
155247952|NCT00718718|560338385|FG004|Prior to Week 12|Withdrawal by Subject|3|||
155247953|NCT00718718|560338386|FG005|Prior to Week 12|Withdrawal by Subject|0|||
155247954|NCT00718718|560338387|FG006|Prior to Week 12|Withdrawal by Subject|1|||
155247955|NCT00718718|560338388|FG007|Prior to Week 12|Withdrawal by Subject|1|||
155247956|NCT00718718|560338389|FG008|Prior to Week 12|Withdrawal by Subject|1|||
155247957|NCT00718718|560338390|FG009|Prior to Week 12|Withdrawal by Subject|0|||
155247958|NCT00718718|560338381|FG000|Prior to Week 12|Other|1|||
155247959|NCT00718718|560338382|FG001|Prior to Week 12|Other|0|||
155247960|NCT00718718|560338383|FG002|Prior to Week 12|Other|1|||
155247961|NCT00718718|560338384|FG003|Prior to Week 12|Other|0|||
155247962|NCT00718718|560338385|FG004|Prior to Week 12|Other|0|||
155247963|NCT00718718|560338386|FG005|Prior to Week 12|Other|0|||
155247964|NCT00718718|560338387|FG006|Prior to Week 12|Other|0|||
155247965|NCT00718718|560338388|FG007|Prior to Week 12|Other|0|||
155247966|NCT00718718|560338389|FG008|Prior to Week 12|Other|0|||
155247967|NCT00718718|560338390|FG009|Prior to Week 12|Other|0|||
155247968|NCT00718718|560338381|FG000|Week 12 to End of Study|Adverse Event|0|||
155247969|NCT00718718|560338382|FG001|Week 12 to End of Study|Adverse Event|0|||
155247970|NCT00718718|560338383|FG002|Week 12 to End of Study|Adverse Event|0|||
155247971|NCT00718718|560338384|FG003|Week 12 to End of Study|Adverse Event|0|||
155247972|NCT00718718|560338385|FG004|Week 12 to End of Study|Adverse Event|0|||
155247973|NCT00718718|560338386|FG005|Week 12 to End of Study|Adverse Event|0|||
155247974|NCT00718718|560338387|FG006|Week 12 to End of Study|Adverse Event|0|||
155247975|NCT00718718|560338388|FG007|Week 12 to End of Study|Adverse Event|1|||
155247976|NCT00718718|560338389|FG008|Week 12 to End of Study|Adverse Event|0|||
155247977|NCT00718718|560338390|FG009|Week 12 to End of Study|Adverse Event|0|||
155247978|NCT00718718|560338381|FG000|Week 12 to End of Study|Death|0|||
155247979|NCT00718718|560338382|FG001|Week 12 to End of Study|Death|0|||
155247980|NCT00718718|560338383|FG002|Week 12 to End of Study|Death|0|||
155247981|NCT00718718|560338384|FG003|Week 12 to End of Study|Death|0|||
155247982|NCT00718718|560338385|FG004|Week 12 to End of Study|Death|0|||
155247983|NCT00718718|560338386|FG005|Week 12 to End of Study|Death|1|||
155247984|NCT00718718|560338387|FG006|Week 12 to End of Study|Death|0|||
155247985|NCT00718718|560338388|FG007|Week 12 to End of Study|Death|0|||
155247986|NCT00718718|560338389|FG008|Week 12 to End of Study|Death|0|||
155247987|NCT00718718|560338390|FG009|Week 12 to End of Study|Death|0|||
155247988|NCT00718718|560338381|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
155247989|NCT00718718|560338382|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
155247990|NCT00718718|560338383|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
155247991|NCT00718718|560338384|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
155247992|NCT00718718|560338385|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
155247993|NCT00718718|560338386|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
155247994|NCT00718718|560338387|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
155247995|NCT00718718|560338388|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
155247996|NCT00718718|560338389|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
155247997|NCT00718718|560338390|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
155247998|NCT00718718|560338381|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
155247999|NCT00718718|560338382|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
155248000|NCT00718718|560338383|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
155248001|NCT00718718|560338384|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
155248002|NCT00718718|560338385|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
155248003|NCT00718718|560338386|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
155248004|NCT00718718|560338387|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
155248005|NCT00718718|560338388|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
155248006|NCT00718718|560338389|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
155248007|NCT00718718|560338390|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
155248008|NCT00718718|560338381|FG000|Week 12 to End of Study|Other|0|||
155248009|NCT00718718|560338382|FG001|Week 12 to End of Study|Other|1|||
155248010|NCT00718718|560338383|FG002|Week 12 to End of Study|Other|0|||
155248011|NCT00718718|560338384|FG003|Week 12 to End of Study|Other|1|||
155248012|NCT00718718|560338385|FG004|Week 12 to End of Study|Other|0|||
155248013|NCT00718718|560338386|FG005|Week 12 to End of Study|Other|0|||
155248014|NCT00718718|560338387|FG006|Week 12 to End of Study|Other|1|||
155248015|NCT00718718|560338388|FG007|Week 12 to End of Study|Other|0|||
155248016|NCT00718718|560338389|FG008|Week 12 to End of Study|Other|0|||
155248017|NCT00718718|560338390|FG009|Week 12 to End of Study|Other|0|||
155248018|NCT02276482|560338393|FG000|Overall Study|Adverse Event|1|||
155248019|NCT02276482|560338394|FG001|Overall Study|Adverse Event|0|||
155248020|NCT02276482|560338393|FG000|Overall Study|Withdrawal by Subject|1|||
155248021|NCT02276482|560338394|FG001|Overall Study|Withdrawal by Subject|0|||
155248022|NCT02276482|560338393|FG000|Overall Study|Gram-negative infection|1|||
155248023|NCT02276482|560338394|FG001|Overall Study|Gram-negative infection|0|||
155248024|NCT02276482|560338393|FG000|Overall Study|Reason not specified|0|||
155248025|NCT02276482|560338394|FG001|Overall Study|Reason not specified|1|||
155248026|NCT00253864|560338395|FG000|Overall Study|Lost to Follow-up|5|||
155248027|NCT00253864|560338396|FG001|Overall Study|Lost to Follow-up|8|||
155248028|NCT00360529|560338400|FG000|Overall Study|Adverse Event|10|||
155248029|NCT00360529|560338401|FG001|Overall Study|Adverse Event|23|||
155248030|NCT00360529|560338402|FG002|Overall Study|Adverse Event|33|||
155248031|NCT00360529|560338400|FG000|Overall Study|Protocol Violation|3|||
155248032|NCT00360529|560338401|FG001|Overall Study|Protocol Violation|3|||
155248033|NCT00360529|560338402|FG002|Overall Study|Protocol Violation|11|||
155248034|NCT00360529|560338400|FG000|Overall Study|Lost to Follow-up|14|||
155248035|NCT00360529|560338401|FG001|Overall Study|Lost to Follow-up|10|||
155248036|NCT00360529|560338402|FG002|Overall Study|Lost to Follow-up|13|||
155248037|NCT00360529|560338400|FG000|Overall Study|Withdrawal by Subject|22|||
155248038|NCT00360529|560338401|FG001|Overall Study|Withdrawal by Subject|14|||
155248039|NCT00360529|560338402|FG002|Overall Study|Withdrawal by Subject|18|||
155248040|NCT00360529|560338400|FG000|Overall Study|Lack of Efficacy|8|||
155248041|NCT00360529|560338401|FG001|Overall Study|Lack of Efficacy|6|||
155248042|NCT00360529|560338402|FG002|Overall Study|Lack of Efficacy|5|||
155248043|NCT00360529|560338400|FG000|Overall Study|Reason discontinued not explained above|4|||
155248044|NCT00360529|560338401|FG001|Overall Study|Reason discontinued not explained above|9|||
155248045|NCT00360529|560338402|FG002|Overall Study|Reason discontinued not explained above|11|||
155248046|NCT00110617|560338406|FG000|Overall Study|Adverse Event|2|||
155248047|NCT00110617|560338407|FG001|Overall Study|Adverse Event|4|||
155248048|NCT00110617|560338406|FG000|Overall Study|Abnormal Laboratory Value|4|||
155248049|NCT00110617|560338407|FG001|Overall Study|Abnormal Laboratory Value|2|||
155248050|NCT00110617|560338406|FG000|Overall Study|Lack of Efficacy|1|||
155248051|NCT00110617|560338407|FG001|Overall Study|Lack of Efficacy|0|||
155248052|NCT00110617|560338406|FG000|Overall Study|Patient no longer requires study drug|1|||
155248053|NCT00110617|560338407|FG001|Overall Study|Patient no longer requires study drug|0|||
155248054|NCT00110617|560338406|FG000|Overall Study|Protocol Violation|5|||
155248055|NCT00110617|560338407|FG001|Overall Study|Protocol Violation|0|||
155248056|NCT00110617|560338406|FG000|Overall Study|Withdrawal by Subject|10|||
155248057|NCT00110617|560338407|FG001|Overall Study|Withdrawal by Subject|4|||
155248058|NCT00110617|560338406|FG000|Overall Study|Lost to Follow-up|9|||
155248059|NCT00110617|560338407|FG001|Overall Study|Lost to Follow-up|1|||
155248060|NCT00110617|560338406|FG000|Overall Study|Administrative problems|6|||
155248061|NCT00110617|560338407|FG001|Overall Study|Administrative problems|5|||
155248062|NCT00110617|560338406|FG000|Overall Study|Death|1|||
155248063|NCT00110617|560338407|FG001|Overall Study|Death|1|||
155248064|NCT00110617|560338406|FG000|Overall Study|Did not receive study drug|0|||
155248065|NCT00110617|560338407|FG001|Overall Study|Did not receive study drug|12|||
155248066|NCT04764396|560338408|FG000|Overall Study|Physician Decision|1|||
155248067|NCT04764396|560338409|FG001|Overall Study|Physician Decision|0|||
155248068|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
155248069|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
155248070|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
155248071|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
155248072|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
155248073|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
155248074|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
155248075|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
155248076|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
155248077|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
155248078|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
155248079|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
155248080|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
155248081|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
155248082|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
155248083|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
155248084|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
155248085|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
155248086|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
155248087|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
155248088|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
155248089|NCT01781572|560338411|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
155248090|NCT01781572|560338412|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
155248091|NCT01781572|560338413|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
155248092|NCT01781572|560338411|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
155248093|NCT01781572|560338412|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
155248094|NCT01781572|560338413|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
155248095|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
155248096|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
155248097|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
155248098|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
155248099|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
155248100|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
155248101|NCT01781572|560338411|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
155248102|NCT01781572|560338412|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
155248103|NCT01781572|560338413|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
155248104|NCT01781572|560338411|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
155248105|NCT01781572|560338412|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
155248106|NCT01781572|560338413|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
155248107|NCT01781572|560338411|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
155248108|NCT01781572|560338412|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
155248109|NCT01781572|560338413|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
155248110|NCT01781572|560338411|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
155248111|NCT01781572|560338412|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
155248112|NCT01781572|560338413|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
155248113|NCT01781572|560338411|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
155248114|NCT01781572|560338412|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
155248115|NCT01781572|560338413|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
155248116|NCT01781572|560338411|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
155248117|NCT01781572|560338412|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
155248118|NCT01781572|560338413|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
155248119|NCT01781572|560338411|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
155248120|NCT01781572|560338412|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
155248121|NCT01781572|560338413|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
155248122|NCT01218438|560338414|FG000|Epoch 1|Physician Decision|2|||
155248123|NCT01218438|560338414|FG000|Epoch 1|Adverse Event|1|||
155248124|NCT01218438|560338414|FG000|Epoch 3|Withdrawal by Subject|3|||
155248125|NCT01218438|560338414|FG000|Epoch 3|Adverse Event|1|||
155248126|NCT01218438|560338414|FG000|Epoch 4|Physician Decision|1|||
155248127|NCT01218438|560338414|FG000|Epoch 4|Withdrawal by Subject|2|||
155248128|NCT03230916|560338415|FG000|Overall Study|Withdrawal by Subject|0|||
155248129|NCT03230916|560338416|FG001|Overall Study|Withdrawal by Subject|0|||
155248130|NCT03230916|560338417|FG002|Overall Study|Withdrawal by Subject|0|||
155248131|NCT03230916|560338418|FG003|Overall Study|Withdrawal by Subject|0|||
155248132|NCT03230916|560338419|FG004|Overall Study|Withdrawal by Subject|0|||
155248133|NCT03230916|560338420|FG005|Overall Study|Withdrawal by Subject|1|||
155248134|NCT03230916|560338421|FG006|Overall Study|Withdrawal by Subject|0|||
155248135|NCT03230916|560338422|FG007|Overall Study|Withdrawal by Subject|0|||
155248136|NCT03230916|560338423|FG008|Overall Study|Withdrawal by Subject|0|||
155248137|NCT03230916|560338424|FG009|Overall Study|Withdrawal by Subject|0|||
155248138|NCT03230916|560338425|FG010|Overall Study|Withdrawal by Subject|0|||
155248139|NCT00045110|560338427|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
155248140|NCT00045110|560338428|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
155248141|NCT00045110|560338429|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
155248142|NCT00045110|560338427|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
155248143|NCT00045110|560338428|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
155248144|NCT00045110|560338429|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
155248145|NCT00045110|560338427|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
155248146|NCT00045110|560338428|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
155248147|NCT00045110|560338429|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
155248148|NCT01438541|560338433|FG000|Overall Study|Physician Decision|1|||
155248149|NCT01438541|560338433|FG000|Overall Study|Withdrawal by Subject|1|||
155248150|NCT01438541|560338433|FG000|Overall Study|discharge from the hospital|5|||
155248151|NCT02091167|560338434|FG000|Overall Study|Lost to Follow-up|0|||
155248152|NCT02091167|560338435|FG001|Overall Study|Lost to Follow-up|2|||
155248153|NCT01218646|560338436|FG000|Overall Study|Adverse Event|0|||
155248154|NCT01218646|560338437|FG001|Overall Study|Adverse Event|0|||
155248155|NCT01218646|560338438|FG002|Overall Study|Adverse Event|1|||
155248156|NCT01218646|560338439|FG003|Overall Study|Adverse Event|0|||
155248157|NCT01218646|560338436|FG000|Overall Study|Lost to Follow-up|1|||
155248158|NCT01218646|560338437|FG001|Overall Study|Lost to Follow-up|0|||
155248159|NCT01218646|560338438|FG002|Overall Study|Lost to Follow-up|0|||
155248160|NCT01218646|560338439|FG003|Overall Study|Lost to Follow-up|0|||
155248161|NCT01218646|560338436|FG000|Overall Study|Protocol Violation|0|||
155248162|NCT01218646|560338437|FG001|Overall Study|Protocol Violation|0|||
155248163|NCT01218646|560338438|FG002|Overall Study|Protocol Violation|1|||
155248164|NCT01218646|560338439|FG003|Overall Study|Protocol Violation|1|||
155248165|NCT00722761|560338440|FG000|Overall Study|Lost to Follow-up|1|||
155248166|NCT00722761|560338441|FG001|Overall Study|Lost to Follow-up|4|||
155248167|NCT00722761|560338440|FG000|Overall Study|Withdrawal by Subject|5|||
155248168|NCT00722761|560338441|FG001|Overall Study|Withdrawal by Subject|2|||
155248169|NCT02693665|560338444|FG000|Overall Study|Death|3|||
155248170|NCT02693665|560338445|FG001|Overall Study|Death|2|||
155248171|NCT02693665|560338444|FG000|Overall Study|Lost to Follow-up|7|||
155248172|NCT02693665|560338445|FG001|Overall Study|Lost to Follow-up|3|||
155248173|NCT02693665|560338444|FG000|Overall Study|Protocol Violation|1|||
155248174|NCT02693665|560338445|FG001|Overall Study|Protocol Violation|0|||
155248175|NCT02693665|560338444|FG000|Overall Study|Withdrawal by Subject|2|||
155248176|NCT02693665|560338445|FG001|Overall Study|Withdrawal by Subject|0|||
155248177|NCT02693665|560338444|FG000|Overall Study|patient wanted to leave it behind|1|||
155248178|NCT02693665|560338445|FG001|Overall Study|patient wanted to leave it behind|0|||
155248179|NCT02693665|560338444|FG000|Overall Study|anxiety|1|||
155248180|NCT02693665|560338445|FG001|Overall Study|anxiety|0|||
155248181|NCT02693665|560338444|FG000|Overall Study|family issues|1|||
155248182|NCT02693665|560338445|FG001|Overall Study|family issues|0|||
155248183|NCT02693665|560338444|FG000|Overall Study|no reason given|1|||
155248184|NCT02693665|560338445|FG001|Overall Study|no reason given|0|||
155248185|NCT03096782|560338446|FG000|Overall Study|Death|1|||
155248186|NCT03096782|560338446|FG000|Overall Study|Participant Relapsed|1|||
155248187|NCT03662750|560338447|FG000|Overall Study|Withdrawal by Subject|1|||
155248188|NCT03156023|560338448|FG000|Overall Study|Withdrawal by Subject|1|||
155248189|NCT03156023|560338449|FG001|Overall Study|Withdrawal by Subject|0|||
155248190|NCT03156023|560338450|FG002|Overall Study|Withdrawal by Subject|2|||
155248191|NCT03156023|560338451|FG003|Overall Study|Withdrawal by Subject|1|||
155248192|NCT03156023|560338452|FG004|Overall Study|Withdrawal by Subject|1|||
155248193|NCT03156023|560338448|FG000|Overall Study|Lost to Follow-up|0|||
155248194|NCT03156023|560338449|FG001|Overall Study|Lost to Follow-up|0|||
155248195|NCT03156023|560338450|FG002|Overall Study|Lost to Follow-up|0|||
155248196|NCT03156023|560338451|FG003|Overall Study|Lost to Follow-up|0|||
155248197|NCT03156023|560338452|FG004|Overall Study|Lost to Follow-up|1|||
155248198|NCT05819749|560338457|FG000|Overall Study|Lost to Follow-up|1|||
155248199|NCT00844857|560340826|FG000|Overall Study|Adverse Event|24|||
155248200|NCT00844857|560340827|FG001|Overall Study|Adverse Event|5|||
155248201|NCT00844857|560340826|FG000|Overall Study|Sponsor Decision|1|||
155248202|NCT00844857|560340827|FG001|Overall Study|Sponsor Decision|1|||
155248203|NCT00844857|560340826|FG000|Overall Study|Physician Decision|2|||
155248204|NCT00844857|560340827|FG001|Overall Study|Physician Decision|0|||
155248205|NCT00844857|560340826|FG000|Overall Study|Parent/Caregiver Decision|6|||
155248206|NCT00844857|560340827|FG001|Overall Study|Parent/Caregiver Decision|2|||
155248207|NCT00844857|560340826|FG000|Overall Study|Withdrawal by Subject|8|||
155248208|NCT00844857|560340827|FG001|Overall Study|Withdrawal by Subject|7|||
155248209|NCT00844857|560340826|FG000|Overall Study|Protocol Violation|6|||
155248210|NCT00844857|560340827|FG001|Overall Study|Protocol Violation|0|||
155248211|NCT00844857|560340826|FG000|Overall Study|Lack of Efficacy|5|||
155248212|NCT00844857|560340827|FG001|Overall Study|Lack of Efficacy|5|||
155248213|NCT00844857|560340826|FG000|Overall Study|Clinical Relapse|0|||
155248214|NCT00844857|560340827|FG001|Overall Study|Clinical Relapse|1|||
155248215|NCT00844857|560340826|FG000|Overall Study|Entry Criteria Not Met|0|||
155248216|NCT00844857|560340827|FG001|Overall Study|Entry Criteria Not Met|1|||
155248217|NCT00844857|560340826|FG000|Overall Study|Lost to Follow-up|2|||
155248218|NCT00844857|560340827|FG001|Overall Study|Lost to Follow-up|3|||
155248219|NCT00844857|560340826|FG000|Overall Study|Did Not Take Study Drug|3|||
155248220|NCT00844857|560340827|FG001|Overall Study|Did Not Take Study Drug|1|||
155248221|NCT00844857|560340826|FG000|Overall Study|Good Clinical Practice Violations|21|||
155248222|NCT00844857|560340827|FG001|Overall Study|Good Clinical Practice Violations|11|||
155248223|NCT00570674|560340828|FG000|Overall Study|Withdrawal by Subject|0|||
155248224|NCT00570674|560340829|FG001|Overall Study|Withdrawal by Subject|0|||
155248225|NCT00570674|560340830|FG002|Overall Study|Withdrawal by Subject|1|||
155248226|NCT00570674|560340831|FG003|Overall Study|Withdrawal by Subject|0|||
155248227|NCT00570674|560340832|FG004|Overall Study|Withdrawal by Subject|0|||
155248228|NCT00570674|560340833|FG005|Overall Study|Withdrawal by Subject|0|||
155248229|NCT00570674|560340834|FG006|Overall Study|Withdrawal by Subject|0|||
155248230|NCT03069482|560340835|FG000|Overall Study|Lost to Follow-up|0|||
155248231|NCT03069482|560340836|FG001|Overall Study|Lost to Follow-up|1|||
155248232|NCT03069482|560340835|FG000|Overall Study|Physician Decision|1|||
155248233|NCT03069482|560340836|FG001|Overall Study|Physician Decision|0|||
155248234|NCT01912612|560340845|FG000|Overall Study|Adverse Event|4|||
155248235|NCT01912612|560340846|FG001|Overall Study|Adverse Event|0|||
155248236|NCT01912612|560340847|FG002|Overall Study|Adverse Event|0|||
155248237|NCT01912612|560340845|FG000|Overall Study|Withdrew consent|1|||
155248238|NCT01912612|560340846|FG001|Overall Study|Withdrew consent|0|||
155248239|NCT01912612|560340847|FG002|Overall Study|Withdrew consent|0|||
155248240|NCT01912612|560340845|FG000|Overall Study|Study design change|0|||
155248241|NCT01912612|560340846|FG001|Overall Study|Study design change|0|||
155248242|NCT01912612|560340847|FG002|Overall Study|Study design change|3|||
155248243|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
155248244|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
155248245|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
155248246|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248247|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248248|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248249|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248250|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248251|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248252|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248253|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248254|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248255|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248256|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
155248257|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
155248258|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
155248259|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
155248260|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248261|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248262|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248263|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248264|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248265|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248266|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248267|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248268|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248269|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248270|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
155248271|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
155248272|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
155248273|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
155248274|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248275|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248276|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248277|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248278|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248279|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248280|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248281|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248282|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248283|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248284|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
155248285|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
155248286|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
155248287|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
155248288|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248289|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248290|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248291|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248292|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248293|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248294|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248295|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248296|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248297|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248298|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
155248299|NCT02349295|560340852|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248300|NCT02349295|560340853|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
155248301|NCT02349295|560340854|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
155248302|NCT02349295|560340855|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248303|NCT02349295|560340856|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248304|NCT02349295|560340857|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248305|NCT02349295|560340858|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248306|NCT02349295|560340859|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248307|NCT02349295|560340860|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248308|NCT02349295|560340861|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248309|NCT02349295|560340862|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248310|NCT02349295|560340863|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248311|NCT02349295|560340864|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248312|NCT02349295|560340865|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
155248313|NCT02349295|560340852|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
155248314|NCT02349295|560340853|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
155248315|NCT02349295|560340854|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
155248316|NCT02349295|560340855|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
155248317|NCT02349295|560340856|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
155248318|NCT02349295|560340857|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
155248319|NCT02349295|560340858|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
155248320|NCT02349295|560340859|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
155248321|NCT02349295|560340860|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
155248322|NCT02349295|560340861|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
155248323|NCT02349295|560340862|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
155248324|NCT02349295|560340863|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
155248325|NCT02349295|560340864|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
155248326|NCT02349295|560340865|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
155248327|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248328|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248329|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248330|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248331|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248332|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248333|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248334|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
155248335|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
155248336|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
155248337|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
155248338|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248339|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248340|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
155248341|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248342|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248343|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248344|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248345|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248346|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248347|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248348|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
155248349|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
155248350|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
155248351|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
155248352|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248353|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248354|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
155248355|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248356|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248357|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248358|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248359|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248360|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248361|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248362|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
155248363|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248364|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
155248365|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248366|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248367|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248368|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
155248369|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
155248370|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
155248371|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
155248372|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
155248373|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
155248374|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
155248375|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
155248376|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
155248377|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
155248378|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
155248379|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
155248380|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
155248381|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
155248382|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
155248383|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248384|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248385|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248386|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248387|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248388|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248389|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248390|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
155248391|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
155248392|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
155248393|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
155248394|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248395|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248396|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
155248397|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248398|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248399|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248400|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248401|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248402|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248403|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248404|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
155248405|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
155248406|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248407|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248408|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248409|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248410|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
155248411|NCT02349295|560340852|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248412|NCT02349295|560340853|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248413|NCT02349295|560340854|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248414|NCT02349295|560340855|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248415|NCT02349295|560340856|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248416|NCT02349295|560340857|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248417|NCT02349295|560340858|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248418|NCT02349295|560340859|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
155248419|NCT02349295|560340860|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
155248420|NCT02349295|560340861|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248421|NCT02349295|560340862|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248422|NCT02349295|560340863|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248423|NCT02349295|560340864|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248424|NCT02349295|560340865|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
155248425|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248426|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248427|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248428|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248429|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248430|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248431|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248432|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248433|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248434|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248435|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
155248436|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
155248437|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
155248438|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
155248439|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248440|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248441|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248442|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248443|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248444|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248445|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248446|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248447|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248448|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248449|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248450|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
155248451|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
155248452|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
155248453|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248454|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248455|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248456|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248457|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248458|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248459|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248460|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248461|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248462|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248463|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248464|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
155248465|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
155248466|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
155248467|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248468|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248469|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248470|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248471|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248472|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248473|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248474|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248475|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248476|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248477|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248478|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
155248479|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248480|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
155248481|NCT02349295|560340852|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248482|NCT02349295|560340853|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248483|NCT02349295|560340854|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248484|NCT02349295|560340855|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248485|NCT02349295|560340856|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248486|NCT02349295|560340857|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248487|NCT02349295|560340858|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248488|NCT02349295|560340859|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248489|NCT02349295|560340860|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248490|NCT02349295|560340861|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248491|NCT02349295|560340862|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248492|NCT02349295|560340863|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
155248493|NCT02349295|560340864|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248494|NCT02349295|560340865|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
155248495|NCT00620750|560340874|FG000|Overall Study|Lost to Follow-up|25|||
155248496|NCT04717596|560340876|FG000|Overall Study|Withdrawal by Subject|4|||
155248497|NCT00765843|560340877|FG000|Overall Study|Lost to Follow-up|1|||
155248498|NCT00765843|560340878|FG001|Overall Study|Lost to Follow-up|3|||
155248499|NCT00765843|560340879|FG002|Overall Study|Lost to Follow-up|2|||
155248500|NCT00765843|560340877|FG000|Overall Study|did not return to receive intervention|0|||
155248501|NCT00765843|560340878|FG001|Overall Study|did not return to receive intervention|1|||
155248502|NCT00765843|560340879|FG002|Overall Study|did not return to receive intervention|0|||
155248503|NCT00765843|560340877|FG000|Overall Study|Adverse Event|0|||
155248504|NCT00765843|560340878|FG001|Overall Study|Adverse Event|0|||
155248505|NCT00765843|560340879|FG002|Overall Study|Adverse Event|1|||
155248506|NCT04066114|560340880|FG000|Overall Study|Adverse Event|1|||
155248507|NCT04066114|560340881|FG001|Overall Study|Adverse Event|0|||
155248508|NCT04066114|560340882|FG002|Overall Study|Adverse Event|0|||
155248509|NCT04066114|560340880|FG000|Overall Study|Withdrawal by Subject|1|||
155248510|NCT04066114|560340881|FG001|Overall Study|Withdrawal by Subject|0|||
155248511|NCT04066114|560340882|FG002|Overall Study|Withdrawal by Subject|0|||
155248512|NCT04066114|560340880|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
155248513|NCT04066114|560340881|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
155248514|NCT04066114|560340882|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
155248515|NCT02564523|560340883|FG000|Overall Study|Withdrawal by Subject|3|||
155248516|NCT02564523|560340884|FG001|Overall Study|Withdrawal by Subject|0|||
155248517|NCT02564523|560340885|FG002|Overall Study|Withdrawal by Subject|1|||
155248518|NCT02564523|560340886|FG003|Overall Study|Withdrawal by Subject|0|||
155248519|NCT02564523|560340887|FG004|Overall Study|Withdrawal by Subject|1|||
155248520|NCT02564523|560340888|FG005|Overall Study|Withdrawal by Subject|0|||
155248521|NCT02564523|560340889|FG006|Overall Study|Withdrawal by Subject|1|||
155248522|NCT02564523|560340890|FG007|Overall Study|Withdrawal by Subject|0|||
155248523|NCT02564523|560340891|FG008|Overall Study|Withdrawal by Subject|0|||
155248524|NCT02564523|560340892|FG009|Overall Study|Withdrawal by Subject|0|||
155248525|NCT02564523|560340893|FG010|Overall Study|Withdrawal by Subject|1|||
155248526|NCT02564523|560340894|FG011|Overall Study|Withdrawal by Subject|0|||
155248527|NCT02564523|560340895|FG012|Overall Study|Withdrawal by Subject|1|||
155248528|NCT02564523|560340896|FG013|Overall Study|Withdrawal by Subject|0|||
155248529|NCT02564523|560340897|FG014|Overall Study|Withdrawal by Subject|0|||
155248530|NCT02564523|560340898|FG015|Overall Study|Withdrawal by Subject|0|||
155248531|NCT02564523|560340899|FG016|Overall Study|Withdrawal by Subject|0|||
155248532|NCT02564523|560340900|FG017|Overall Study|Withdrawal by Subject|0|||
155248533|NCT02564523|560340883|FG000|Overall Study|Adverse Event|0|||
155248534|NCT02564523|560340884|FG001|Overall Study|Adverse Event|0|||
155248535|NCT02564523|560340885|FG002|Overall Study|Adverse Event|0|||
155248536|NCT02564523|560340886|FG003|Overall Study|Adverse Event|0|||
155248537|NCT02564523|560340887|FG004|Overall Study|Adverse Event|0|||
155248538|NCT02564523|560340888|FG005|Overall Study|Adverse Event|0|||
155248539|NCT02564523|560340889|FG006|Overall Study|Adverse Event|0|||
155248540|NCT02564523|560340890|FG007|Overall Study|Adverse Event|0|||
155248541|NCT02564523|560340891|FG008|Overall Study|Adverse Event|0|||
155248542|NCT02564523|560340892|FG009|Overall Study|Adverse Event|0|||
155248543|NCT02564523|560340893|FG010|Overall Study|Adverse Event|0|||
155248544|NCT02564523|560340894|FG011|Overall Study|Adverse Event|0|||
155248545|NCT02564523|560340895|FG012|Overall Study|Adverse Event|0|||
155248546|NCT02564523|560340896|FG013|Overall Study|Adverse Event|0|||
155248547|NCT02564523|560340897|FG014|Overall Study|Adverse Event|0|||
155248548|NCT02564523|560340898|FG015|Overall Study|Adverse Event|0|||
155248549|NCT02564523|560340899|FG016|Overall Study|Adverse Event|0|||
155248550|NCT02564523|560340900|FG017|Overall Study|Adverse Event|1|||
155248551|NCT02564523|560340883|FG000|Overall Study|Death|0|||
155248552|NCT02564523|560340884|FG001|Overall Study|Death|0|||
155248553|NCT02564523|560340885|FG002|Overall Study|Death|0|||
155248554|NCT02564523|560340886|FG003|Overall Study|Death|0|||
155248555|NCT02564523|560340887|FG004|Overall Study|Death|0|||
155248556|NCT02564523|560340888|FG005|Overall Study|Death|0|||
155248557|NCT02564523|560340889|FG006|Overall Study|Death|1|||
155248558|NCT02564523|560340890|FG007|Overall Study|Death|0|||
155248559|NCT02564523|560340891|FG008|Overall Study|Death|0|||
155248560|NCT02564523|560340892|FG009|Overall Study|Death|0|||
155248561|NCT02564523|560340893|FG010|Overall Study|Death|1|||
155248562|NCT02564523|560340894|FG011|Overall Study|Death|0|||
155248563|NCT02564523|560340895|FG012|Overall Study|Death|0|||
155248564|NCT02564523|560340896|FG013|Overall Study|Death|0|||
155248565|NCT02564523|560340897|FG014|Overall Study|Death|0|||
155248566|NCT02564523|560340898|FG015|Overall Study|Death|0|||
155248567|NCT02564523|560340899|FG016|Overall Study|Death|0|||
155248568|NCT02564523|560340900|FG017|Overall Study|Death|0|||
155248569|NCT02564523|560340883|FG000|Overall Study|Lost to Follow-up|2|||
155248570|NCT02564523|560340884|FG001|Overall Study|Lost to Follow-up|1|||
155248571|NCT02564523|560340885|FG002|Overall Study|Lost to Follow-up|4|||
155248572|NCT02564523|560340886|FG003|Overall Study|Lost to Follow-up|0|||
155248573|NCT02564523|560340887|FG004|Overall Study|Lost to Follow-up|1|||
155248574|NCT02564523|560340888|FG005|Overall Study|Lost to Follow-up|0|||
155248575|NCT02564523|560340889|FG006|Overall Study|Lost to Follow-up|1|||
155248576|NCT02564523|560340890|FG007|Overall Study|Lost to Follow-up|0|||
155248577|NCT02564523|560340891|FG008|Overall Study|Lost to Follow-up|0|||
155248578|NCT02564523|560340892|FG009|Overall Study|Lost to Follow-up|0|||
155248579|NCT02564523|560340893|FG010|Overall Study|Lost to Follow-up|0|||
155248580|NCT02564523|560340894|FG011|Overall Study|Lost to Follow-up|1|||
155248581|NCT02564523|560340895|FG012|Overall Study|Lost to Follow-up|1|||
155248582|NCT02564523|560340896|FG013|Overall Study|Lost to Follow-up|0|||
155248583|NCT02564523|560340897|FG014|Overall Study|Lost to Follow-up|0|||
155248584|NCT02564523|560340898|FG015|Overall Study|Lost to Follow-up|0|||
155248585|NCT02564523|560340899|FG016|Overall Study|Lost to Follow-up|0|||
155248586|NCT02564523|560340900|FG017|Overall Study|Lost to Follow-up|0|||
155248587|NCT02564523|560340883|FG000|Overall Study|Physician Decision|0|||
155248588|NCT02564523|560340884|FG001|Overall Study|Physician Decision|0|||
155248589|NCT02564523|560340885|FG002|Overall Study|Physician Decision|0|||
155248590|NCT02564523|560340886|FG003|Overall Study|Physician Decision|0|||
155248591|NCT02564523|560340887|FG004|Overall Study|Physician Decision|1|||
155248592|NCT02564523|560340888|FG005|Overall Study|Physician Decision|0|||
155248593|NCT02564523|560340889|FG006|Overall Study|Physician Decision|0|||
155248594|NCT02564523|560340890|FG007|Overall Study|Physician Decision|0|||
155248595|NCT02564523|560340891|FG008|Overall Study|Physician Decision|0|||
155248596|NCT02564523|560340892|FG009|Overall Study|Physician Decision|0|||
155248597|NCT02564523|560340893|FG010|Overall Study|Physician Decision|1|||
155248598|NCT02564523|560340894|FG011|Overall Study|Physician Decision|0|||
155248599|NCT02564523|560340895|FG012|Overall Study|Physician Decision|0|||
155248600|NCT02564523|560340896|FG013|Overall Study|Physician Decision|0|||
155248601|NCT02564523|560340897|FG014|Overall Study|Physician Decision|0|||
155248602|NCT02564523|560340898|FG015|Overall Study|Physician Decision|0|||
155248603|NCT02564523|560340899|FG016|Overall Study|Physician Decision|0|||
155248604|NCT02564523|560340900|FG017|Overall Study|Physician Decision|0|||
155248605|NCT02564523|560340883|FG000|Overall Study|Protocol Violation|2|||
155248606|NCT02564523|560340884|FG001|Overall Study|Protocol Violation|2|||
155248607|NCT02564523|560340885|FG002|Overall Study|Protocol Violation|5|||
155248608|NCT02564523|560340886|FG003|Overall Study|Protocol Violation|0|||
155248609|NCT02564523|560340887|FG004|Overall Study|Protocol Violation|1|||
155248610|NCT02564523|560340888|FG005|Overall Study|Protocol Violation|0|||
155248611|NCT02564523|560340889|FG006|Overall Study|Protocol Violation|0|||
155248612|NCT02564523|560340890|FG007|Overall Study|Protocol Violation|0|||
155248613|NCT02564523|560340891|FG008|Overall Study|Protocol Violation|0|||
155248614|NCT02564523|560340892|FG009|Overall Study|Protocol Violation|0|||
155248615|NCT02564523|560340893|FG010|Overall Study|Protocol Violation|0|||
155248616|NCT02564523|560340894|FG011|Overall Study|Protocol Violation|0|||
155248617|NCT02564523|560340895|FG012|Overall Study|Protocol Violation|0|||
155248618|NCT02564523|560340896|FG013|Overall Study|Protocol Violation|0|||
155248619|NCT02564523|560340897|FG014|Overall Study|Protocol Violation|0|||
155248620|NCT02564523|560340898|FG015|Overall Study|Protocol Violation|0|||
155248621|NCT02564523|560340899|FG016|Overall Study|Protocol Violation|0|||
155248622|NCT02564523|560340900|FG017|Overall Study|Protocol Violation|0|||
155248623|NCT02564523|560340883|FG000|Overall Study|Other|3|||
155248624|NCT02564523|560340884|FG001|Overall Study|Other|0|||
155248625|NCT02564523|560340885|FG002|Overall Study|Other|0|||
155248626|NCT02564523|560340886|FG003|Overall Study|Other|1|||
155248627|NCT02564523|560340887|FG004|Overall Study|Other|0|||
155248628|NCT02564523|560340888|FG005|Overall Study|Other|0|||
155248629|NCT02564523|560340889|FG006|Overall Study|Other|0|||
155248630|NCT02564523|560340890|FG007|Overall Study|Other|0|||
155248631|NCT02564523|560340891|FG008|Overall Study|Other|0|||
155248632|NCT02564523|560340892|FG009|Overall Study|Other|0|||
155248633|NCT02564523|560340893|FG010|Overall Study|Other|0|||
155248634|NCT02564523|560340894|FG011|Overall Study|Other|0|||
155248635|NCT02564523|560340895|FG012|Overall Study|Other|0|||
155248636|NCT02564523|560340896|FG013|Overall Study|Other|0|||
155248637|NCT02564523|560340897|FG014|Overall Study|Other|0|||
155248638|NCT02564523|560340898|FG015|Overall Study|Other|0|||
155248639|NCT02564523|560340899|FG016|Overall Study|Other|0|||
155248640|NCT02564523|560340900|FG017|Overall Study|Other|0|||
155248641|NCT00448539|560340901|FG000|Overall Study|Medication non-compliance|4|||
155248642|NCT00448539|560340902|FG001|Overall Study|Medication non-compliance|1|||
155248643|NCT00448539|560340901|FG000|Overall Study|Protocol Violation|1|||
155248644|NCT00448539|560340902|FG001|Overall Study|Protocol Violation|0|||
155248645|NCT00448539|560340901|FG000|Overall Study|Request of the investigator or sponsor|67|||
155248646|NCT00448539|560340902|FG001|Overall Study|Request of the investigator or sponsor|54|||
155248647|NCT00448539|560340901|FG000|Overall Study|Withdrawal by Subject|20|||
155248648|NCT00448539|560340902|FG001|Overall Study|Withdrawal by Subject|24|||
155248649|NCT00448539|560340901|FG000|Overall Study|Diary non-compliance|1|||
155248650|NCT00448539|560340902|FG001|Overall Study|Diary non-compliance|0|||
155248651|NCT00448539|560340901|FG000|Overall Study|Adverse Event|9|||
155248652|NCT00448539|560340902|FG001|Overall Study|Adverse Event|26|||
155248653|NCT00448539|560340901|FG000|Overall Study|Lack of Efficacy|27|||
155248654|NCT00448539|560340902|FG001|Overall Study|Lack of Efficacy|40|||
155248655|NCT00448539|560340901|FG000|Overall Study|Miscellaneous|2|||
155248656|NCT00448539|560340902|FG001|Overall Study|Miscellaneous|1|||
155248657|NCT00448539|560340901|FG000|Overall Study|Change of meds|2|||
155248658|NCT00448539|560340902|FG001|Overall Study|Change of meds|3|||
155248659|NCT00448539|560340901|FG000|Overall Study|Lost to Follow-up|1|||
155248660|NCT00448539|560340902|FG001|Overall Study|Lost to Follow-up|3|||
155248661|NCT03349710|560340903|FG000|Treatment Period|Death|0|||
155248662|NCT03349710|560340904|FG001|Treatment Period|Death|0|||
155248663|NCT03349710|560340905|FG002|Treatment Period|Death|1|||
155248664|NCT03349710|560340906|FG003|Treatment Period|Death|0|||
155248665|NCT03349710|560340903|FG000|Treatment Period|Disease Progression|0|||
155248666|NCT03349710|560340904|FG001|Treatment Period|Disease Progression|2|||
155248667|NCT03349710|560340905|FG002|Treatment Period|Disease Progression|0|||
155248668|NCT03349710|560340906|FG003|Treatment Period|Disease Progression|1|||
155248669|NCT03349710|560340903|FG000|Treatment Period|Study Drug Toxicity|1|||
155248670|NCT03349710|560340904|FG001|Treatment Period|Study Drug Toxicity|0|||
155248671|NCT03349710|560340905|FG002|Treatment Period|Study Drug Toxicity|1|||
155248672|NCT03349710|560340906|FG003|Treatment Period|Study Drug Toxicity|1|||
155248673|NCT03349710|560340903|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
155248674|NCT03349710|560340904|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
155248675|NCT03349710|560340905|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
155248676|NCT03349710|560340906|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
155248677|NCT03349710|560340903|FG000|Treatment Period|admin reason by sponsor|0|||
155248678|NCT03349710|560340904|FG001|Treatment Period|admin reason by sponsor|7|||
155248679|NCT03349710|560340905|FG002|Treatment Period|admin reason by sponsor|0|||
155248680|NCT03349710|560340906|FG003|Treatment Period|admin reason by sponsor|19|||
155248681|NCT03349710|560340903|FG000|Treatment Period|Other Reason|2|||
155248682|NCT03349710|560340904|FG001|Treatment Period|Other Reason|0|||
155248683|NCT03349710|560340905|FG002|Treatment Period|Other Reason|2|||
155248684|NCT03349710|560340906|FG003|Treatment Period|Other Reason|1|||
155248685|NCT03349710|560340903|FG000|Treatment Period|completed|6|||
155248686|NCT03349710|560340904|FG001|Treatment Period|completed|0|||
155248687|NCT03349710|560340905|FG002|Treatment Period|completed|18|||
155248688|NCT03349710|560340906|FG003|Treatment Period|completed|1|||
155248689|NCT03349710|560340903|FG000|Treatment Period|participant request to discontinue|0|||
155248690|NCT03349710|560340904|FG001|Treatment Period|participant request to discontinue|0|||
155248691|NCT03349710|560340905|FG002|Treatment Period|participant request to discontinue|4|||
155248692|NCT03349710|560340906|FG003|Treatment Period|participant request to discontinue|0|||
155248693|NCT03349710|560340903|FG000|Treatment Period|participant withdrew consent|1|||
155248694|NCT03349710|560340904|FG001|Treatment Period|participant withdrew consent|0|||
155248695|NCT03349710|560340905|FG002|Treatment Period|participant withdrew consent|0|||
155248696|NCT03349710|560340906|FG003|Treatment Period|participant withdrew consent|0|||
155248697|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
155248698|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
155248699|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
155248700|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
155248701|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
155248702|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
155248703|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
155248704|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
155248705|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
155248706|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
155248707|NCT00695903|560340907|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
155248708|NCT00695903|560340908|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
155248709|NCT00695903|560340907|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
155248710|NCT00695903|560340908|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
155248711|NCT00695903|560340907|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
155248712|NCT00695903|560340908|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
155248713|NCT00695903|560340907|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
155248714|NCT00695903|560340908|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
155248715|NCT02696317|560340909|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
155248716|NCT02696317|560340910|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
155248717|NCT02696317|560340909|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
155248718|NCT02696317|560340910|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
155248719|NCT01343368|560340911|FG000|Overall Study|Death|1|||
155248720|NCT01343368|560340912|FG001|Overall Study|Death|0|||
155248721|NCT01343368|560340911|FG000|Overall Study|Lost to Follow-up|1|||
155248722|NCT01343368|560340912|FG001|Overall Study|Lost to Follow-up|0|||
155248723|NCT00237744|560340918|FG000|Overall Study|Withdrawal by Subject|3|||
155248724|NCT00237744|560340919|FG001|Overall Study|Withdrawal by Subject|1|||
155248725|NCT00237744|560340920|FG002|Overall Study|Withdrawal by Subject|0|||
155248726|NCT01369342|560340923|FG000|Overall Study|Withdrawal by Subject|7|||
155248727|NCT01369342|560340924|FG001|Overall Study|Withdrawal by Subject|7|||
155248728|NCT01369342|560340925|FG002|Overall Study|Withdrawal by Subject|2|||
155248729|NCT01369342|560340923|FG000|Overall Study|Lost to Follow-up|5|||
155248730|NCT01369342|560340924|FG001|Overall Study|Lost to Follow-up|2|||
155248731|NCT01369342|560340925|FG002|Overall Study|Lost to Follow-up|1|||
155248732|NCT01369342|560340923|FG000|Overall Study|Not Treated|1|||
155248733|NCT01369342|560340924|FG001|Overall Study|Not Treated|0|||
155248734|NCT01369342|560340925|FG002|Overall Study|Not Treated|0|||
155248735|NCT01816594|560340926|FG000|Overall Study|Local Progress|0|||
155248736|NCT01816594|560340927|FG001|Overall Study|Local Progress|2|||
155248737|NCT01816594|560340926|FG000|Overall Study|Adverse Event|9|||
155248738|NCT01816594|560340927|FG001|Overall Study|Adverse Event|0|||
155248739|NCT01816594|560340926|FG000|Overall Study|Withdrawal by Subject|1|||
155248740|NCT01816594|560340927|FG001|Overall Study|Withdrawal by Subject|0|||
155248741|NCT01816594|560340926|FG000|Overall Study|Physician Decision|1|||
155248742|NCT01816594|560340927|FG001|Overall Study|Physician Decision|0|||
155248743|NCT04723576|560340928|FG000|Overall Study|Withdrawal by Subject|2133|||
155248744|NCT04723576|560340929|FG001|Overall Study|Withdrawal by Subject|3234|||
155248745|NCT03204279|560340933|FG000|Overall Study|Withdrawal by Subject|0|||
155248746|NCT03204279|560340934|FG001|Overall Study|Withdrawal by Subject|1|||
155248747|NCT01064739|560340935|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
155248748|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
155248749|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
155248750|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
155248751|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
155248752|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
155248753|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
155248754|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
155248755|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
155248756|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
155248757|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
155248758|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
155248759|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
155248760|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
155248761|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
155248762|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
155248763|NCT01571362|560340936|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
155248764|NCT01571362|560340937|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
155248765|NCT01571362|560340938|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
155248766|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
155248767|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
155248768|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
155248769|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
155248770|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
155248771|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
155248772|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Adverse Event|0|||
155248773|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Adverse Event|9|||
155248774|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Adverse Event|14|||
155248775|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
155248776|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
155248777|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
155248778|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
155248779|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
155248780|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
155248781|NCT01571362|560340936|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
155248782|NCT01571362|560340937|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
155248783|NCT01571362|560340938|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
155248784|NCT04258020|560340939|FG000|Overall Study|Withdrawal by Subject|1|||
155248785|NCT04258020|560340940|FG001|Overall Study|Withdrawal by Subject|0|||
155248786|NCT03117738|560340941|FG000|Overall Study|Withdrawal by Subject|3|||
155248787|NCT03117738|560340942|FG001|Overall Study|Withdrawal by Subject|1|||
155248788|NCT03117738|560340941|FG000|Overall Study|Lost to Follow-up|1|||
155248789|NCT03117738|560340942|FG001|Overall Study|Lost to Follow-up|4|||
155248790|NCT01669629|560340943|FG000|Period 1|protocol deviation|1|||
155248791|NCT01669629|560340944|FG001|Period 1|protocol deviation|2|||
155248792|NCT00130533|560340950|FG000|Overall Study|Withdrawal by Subject|33|||
155248793|NCT00130533|560340951|FG001|Overall Study|Withdrawal by Subject|6|||
155248794|NCT00130533|560340950|FG000|Overall Study|Adverse Event|34|||
155248795|NCT00130533|560340951|FG001|Overall Study|Adverse Event|1|||
155248796|NCT00130533|560340950|FG000|Overall Study|Disease relapse|9|||
155248797|NCT00130533|560340951|FG001|Overall Study|Disease relapse|13|||
155248798|NCT00130533|560340950|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
155248799|NCT00130533|560340951|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
155248800|NCT00130533|560340950|FG000|Overall Study|Death|4|||
155248801|NCT00130533|560340951|FG001|Overall Study|Death|2|||
155248802|NCT00130533|560340950|FG000|Overall Study|Protocol Violation|5|||
155248803|NCT00130533|560340951|FG001|Overall Study|Protocol Violation|1|||
155248804|NCT00130533|560340950|FG000|Overall Study|Lost to Follow-up|1|||
155248805|NCT00130533|560340951|FG001|Overall Study|Lost to Follow-up|1|||
155248806|NCT00130533|560340950|FG000|Overall Study|Sponsor´s decision|2|||
155248807|NCT00130533|560340951|FG001|Overall Study|Sponsor´s decision|0|||
155248808|NCT00130533|560340950|FG000|Overall Study|Second Primary Malignancy|0|||
155248809|NCT00130533|560340951|FG001|Overall Study|Second Primary Malignancy|1|||
155248810|NCT00130533|560340950|FG000|Overall Study|Other|12|||
155248811|NCT00130533|560340951|FG001|Overall Study|Other|5|||
155248812|NCT03927950|560340952|FG000|Overall Study|Adverse Event|9|||
155248813|NCT01491854|560340953|FG000|Overall Study|mainly due to premature termination|93|||
155248814|NCT01491854|560340953|FG000|Overall Study|Death|1|||
155248815|NCT01491854|560340953|FG000|Overall Study|Withdrawal by Subject|3|||
155248816|NCT01491854|560340953|FG000|Overall Study|Lost to Follow-up|33|||
155248817|NCT01026974|560340954|FG000|Overall Study|Withdrawal by Subject|0|||
155248818|NCT01026974|560340955|FG001|Overall Study|Withdrawal by Subject|1|||
155248819|NCT01026974|560340956|FG002|Overall Study|Withdrawal by Subject|7|||
155248820|NCT01026974|560340957|FG003|Overall Study|Withdrawal by Subject|2|||
155248821|NCT01026974|560340954|FG000|Overall Study|Lost to Follow-up|1|||
155248822|NCT01026974|560340955|FG001|Overall Study|Lost to Follow-up|1|||
155248823|NCT01026974|560340956|FG002|Overall Study|Lost to Follow-up|4|||
155248824|NCT01026974|560340957|FG003|Overall Study|Lost to Follow-up|0|||
155248825|NCT01026974|560340954|FG000|Overall Study|Adverse Event|0|||
155248826|NCT01026974|560340955|FG001|Overall Study|Adverse Event|0|||
155248827|NCT01026974|560340956|FG002|Overall Study|Adverse Event|0|||
155248828|NCT01026974|560340957|FG003|Overall Study|Adverse Event|1|||
155248829|NCT01026974|560340954|FG000|Overall Study|Inappropriate enrollment|0|||
155248830|NCT01026974|560340955|FG001|Overall Study|Inappropriate enrollment|0|||
155248831|NCT01026974|560340956|FG002|Overall Study|Inappropriate enrollment|1|||
155248832|NCT01026974|560340957|FG003|Overall Study|Inappropriate enrollment|0|||
155248833|NCT03638141|560340965|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
155248834|NCT03579563|560340966|FG000|Overall Study|Lost to Follow-up|0|||
155248835|NCT03579563|560340967|FG001|Overall Study|Lost to Follow-up|0|||
155248836|NCT03579563|560340968|FG002|Overall Study|Lost to Follow-up|0|||
155248837|NCT03579563|560340969|FG003|Overall Study|Lost to Follow-up|0|||
155248838|NCT03579563|560340970|FG004|Overall Study|Lost to Follow-up|1|||
155248839|NCT03579563|560340971|FG005|Overall Study|Lost to Follow-up|0|||
155248840|NCT03579563|560340966|FG000|Overall Study|Lack of Efficacy|1|||
155248841|NCT03579563|560340967|FG001|Overall Study|Lack of Efficacy|1|||
155248842|NCT03579563|560340968|FG002|Overall Study|Lack of Efficacy|4|||
155248843|NCT03579563|560340969|FG003|Overall Study|Lack of Efficacy|1|||
155248844|NCT03579563|560340970|FG004|Overall Study|Lack of Efficacy|2|||
155248845|NCT03579563|560340971|FG005|Overall Study|Lack of Efficacy|3|||
155248846|NCT03579563|560340966|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
155248847|NCT03579563|560340967|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155248848|NCT03579563|560340968|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
155248849|NCT03579563|560340969|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
155248850|NCT03579563|560340970|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
155248851|NCT03579563|560340971|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
155248852|NCT03579563|560340966|FG000|Overall Study|Time/distance concern|0|||
155248853|NCT03579563|560340967|FG001|Overall Study|Time/distance concern|0|||
155248854|NCT03579563|560340968|FG002|Overall Study|Time/distance concern|1|||
155248855|NCT03579563|560340969|FG003|Overall Study|Time/distance concern|0|||
155248856|NCT03579563|560340970|FG004|Overall Study|Time/distance concern|0|||
155248857|NCT03579563|560340971|FG005|Overall Study|Time/distance concern|1|||
155248858|NCT03579563|560340966|FG000|Overall Study|COVID shutdown|2|||
155248859|NCT03579563|560340967|FG001|Overall Study|COVID shutdown|3|||
155248860|NCT03579563|560340968|FG002|Overall Study|COVID shutdown|4|||
155248861|NCT03579563|560340969|FG003|Overall Study|COVID shutdown|3|||
155248862|NCT03579563|560340970|FG004|Overall Study|COVID shutdown|1|||
155248863|NCT03579563|560340971|FG005|Overall Study|COVID shutdown|2|||
155248864|NCT03579563|560340966|FG000|Overall Study|Protocol administration error|1|||
155248865|NCT03579563|560340967|FG001|Overall Study|Protocol administration error|0|||
155248866|NCT03579563|560340968|FG002|Overall Study|Protocol administration error|1|||
155248867|NCT03579563|560340969|FG003|Overall Study|Protocol administration error|0|||
155248868|NCT03579563|560340970|FG004|Overall Study|Protocol administration error|1|||
155248869|NCT03579563|560340971|FG005|Overall Study|Protocol administration error|5|||
155248870|NCT03526250|560340972|FG000|Overall Study|Adverse Event|4|||
155248871|NCT03526250|560340972|FG000|Overall Study|Progressive Disease|16|||
155248872|NCT03526250|560340972|FG000|Overall Study|No Treatment|3|||
155248873|NCT04420221|560340973|FG000|Overall Study|Withdrawal by Subject|0|||
155248874|NCT04420221|560340974|FG001|Overall Study|Withdrawal by Subject|0|||
155248875|NCT04420221|560340975|FG002|Overall Study|Withdrawal by Subject|0|||
155248876|NCT04420221|560340976|FG003|Overall Study|Withdrawal by Subject|0|||
155248877|NCT04420221|560340977|FG004|Overall Study|Withdrawal by Subject|0|||
155248878|NCT04420221|560340978|FG005|Overall Study|Withdrawal by Subject|20|||
155248879|NCT04420221|560340979|FG006|Overall Study|Withdrawal by Subject|5|||
155248880|NCT04420221|560340973|FG000|Overall Study|Other|0|||
155248881|NCT04420221|560340974|FG001|Overall Study|Other|0|||
155248882|NCT04420221|560340975|FG002|Overall Study|Other|0|||
155248883|NCT04420221|560340976|FG003|Overall Study|Other|0|||
155248884|NCT04420221|560340977|FG004|Overall Study|Other|0|||
155248885|NCT04420221|560340978|FG005|Overall Study|Other|1|||
155248886|NCT04420221|560340979|FG006|Overall Study|Other|1|||
155248887|NCT04420221|560340973|FG000|Overall Study|Lost to Follow-up|0|||
155248888|NCT04420221|560340974|FG001|Overall Study|Lost to Follow-up|0|||
155248889|NCT04420221|560340975|FG002|Overall Study|Lost to Follow-up|0|||
155248890|NCT04420221|560340976|FG003|Overall Study|Lost to Follow-up|0|||
155248891|NCT04420221|560340977|FG004|Overall Study|Lost to Follow-up|0|||
155248892|NCT04420221|560340978|FG005|Overall Study|Lost to Follow-up|3|||
155248893|NCT04420221|560340979|FG006|Overall Study|Lost to Follow-up|2|||
155248894|NCT04420221|560340973|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
155248895|NCT04420221|560340974|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
155248896|NCT04420221|560340975|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
155248897|NCT04420221|560340976|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
155248898|NCT04420221|560340977|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
155248899|NCT04420221|560340978|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
155248900|NCT04420221|560340979|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
155248901|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
155248902|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
155248903|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
155248904|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
155248905|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
155248906|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
155248907|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
155248908|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
155248909|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
155248910|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
155248911|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
155248912|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
155248913|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
155248914|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
155248915|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
155248916|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
155248917|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
155248918|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
155248919|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
155248920|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
155248921|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
155248922|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
155248923|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
155248924|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
155248925|NCT01715805|560340980|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
155248926|NCT01715805|560340981|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
155248927|NCT01715805|560340982|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
155248928|NCT01715805|560340983|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
155248929|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
155248930|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
155248931|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
155248932|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
155248933|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
155248934|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
155248935|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
155248936|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
155248937|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
155248938|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
155248939|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
155248940|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
155248941|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
155248942|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
155248943|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
155248944|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
155248945|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
155248946|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
155248947|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
155248948|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
155248949|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
155248950|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
155248951|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
155248952|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
155248953|NCT01715805|560340980|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
155248954|NCT01715805|560340981|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
155248955|NCT01715805|560340982|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
155248956|NCT01715805|560340983|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
155248957|NCT02105948|560340988|FG000|Overall Study|Adverse Event|10|||
155248958|NCT02105948|560340989|FG001|Overall Study|Adverse Event|7|||
155248959|NCT02105948|560340990|FG002|Overall Study|Adverse Event|11|||
155248960|NCT02105948|560340991|FG003|Overall Study|Adverse Event|11|||
155248961|NCT02105948|560340988|FG000|Overall Study|Lack of Efficacy|0|||
155248962|NCT02105948|560340989|FG001|Overall Study|Lack of Efficacy|1|||
155248963|NCT02105948|560340990|FG002|Overall Study|Lack of Efficacy|3|||
155248964|NCT02105948|560340991|FG003|Overall Study|Lack of Efficacy|2|||
155248965|NCT02105948|560340988|FG000|Overall Study|Lost to Follow-up|0|||
155248966|NCT02105948|560340989|FG001|Overall Study|Lost to Follow-up|0|||
155248967|NCT02105948|560340990|FG002|Overall Study|Lost to Follow-up|2|||
155248968|NCT02105948|560340991|FG003|Overall Study|Lost to Follow-up|1|||
155248969|NCT02105948|560340988|FG000|Overall Study|Physician Decision|2|||
155248970|NCT02105948|560340989|FG001|Overall Study|Physician Decision|2|||
155248971|NCT02105948|560340990|FG002|Overall Study|Physician Decision|2|||
155248972|NCT02105948|560340991|FG003|Overall Study|Physician Decision|2|||
155248973|NCT02105948|560340988|FG000|Overall Study|Withdrawal by Subject|15|||
155248974|NCT02105948|560340989|FG001|Overall Study|Withdrawal by Subject|10|||
155248975|NCT02105948|560340990|FG002|Overall Study|Withdrawal by Subject|10|||
155248976|NCT02105948|560340991|FG003|Overall Study|Withdrawal by Subject|11|||
155248977|NCT04072159|560340995|FG000|Overall Study|Lost to Follow-up|6|||
155248978|NCT04072159|560340996|FG001|Overall Study|Lost to Follow-up|6|||
155248979|NCT04072159|560340995|FG000|Overall Study|Withdrawal by Subject|2|||
155248980|NCT04072159|560340996|FG001|Overall Study|Withdrawal by Subject|0|||
155248981|NCT01196975|560340998|FG000|Overall Study|Adverse Event|2|||
155248982|NCT01196975|560340999|FG001|Overall Study|Adverse Event|2|||
155248983|NCT01196975|560341000|FG002|Overall Study|Adverse Event|0|||
155248984|NCT01196975|560341001|FG003|Overall Study|Adverse Event|0|||
155248985|NCT01196975|560341002|FG004|Overall Study|Adverse Event|2|||
155248986|NCT01196975|560340998|FG000|Overall Study|Withdrawal by Subject|2|||
155248987|NCT01196975|560340999|FG001|Overall Study|Withdrawal by Subject|1|||
155248988|NCT01196975|560341000|FG002|Overall Study|Withdrawal by Subject|0|||
155248989|NCT01196975|560341001|FG003|Overall Study|Withdrawal by Subject|1|||
155248990|NCT01196975|560341002|FG004|Overall Study|Withdrawal by Subject|0|||
155248991|NCT01196975|560340998|FG000|Overall Study|Lost to Follow-up|11|||
155248992|NCT01196975|560340999|FG001|Overall Study|Lost to Follow-up|6|||
155248993|NCT01196975|560341000|FG002|Overall Study|Lost to Follow-up|5|||
155248994|NCT01196975|560341001|FG003|Overall Study|Lost to Follow-up|5|||
155248995|NCT01196975|560341002|FG004|Overall Study|Lost to Follow-up|11|||
155248996|NCT04558346|560341009|FG000|Overall Study|Withdrawal by Subject|2|||
155248997|NCT04558346|560341010|FG001|Overall Study|Withdrawal by Subject|0|||
155248998|NCT04558346|560341009|FG000|Overall Study|Lost to Follow-up|0|||
155248999|NCT04558346|560341010|FG001|Overall Study|Lost to Follow-up|1|||
155249000|NCT04558346|560341009|FG000|Overall Study|Adverse Event|0|||
155249001|NCT04558346|560341010|FG001|Overall Study|Adverse Event|1|||
155249002|NCT00724971|560341011|FG000|Overall Study|Adverse Event|5|||
155249003|NCT00724971|560341011|FG000|Overall Study|Withdrawal by Subject|1|||
155249004|NCT01462344|560341012|FG000|Overall Study|Withdrawal by Subject|245|||
155249005|NCT01462344|560341013|FG001|Overall Study|Withdrawal by Subject|226|||
155249006|NCT01462344|560341012|FG000|Overall Study|Adverse Event|24|||
155249007|NCT01462344|560341013|FG001|Overall Study|Adverse Event|23|||
155249008|NCT01462344|560341012|FG000|Overall Study|Asthma Exacerbation|34|||
155249009|NCT01462344|560341013|FG001|Overall Study|Asthma Exacerbation|35|||
155249010|NCT01462344|560341012|FG000|Overall Study|Lack of Efficacy|5|||
155249011|NCT01462344|560341013|FG001|Overall Study|Lack of Efficacy|6|||
155249012|NCT01462344|560341012|FG000|Overall Study|Protocol Violation|68|||
155249013|NCT01462344|560341013|FG001|Overall Study|Protocol Violation|53|||
155249014|NCT01462344|560341012|FG000|Overall Study|Lost to Follow-up|7|||
155249015|NCT01462344|560341013|FG001|Overall Study|Lost to Follow-up|7|||
155249016|NCT03086447|560341016|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
155249017|NCT03086447|560341017|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
155249018|NCT03086447|560341016|FG000|Overall Study|Lost Lens|2|||
155249019|NCT03086447|560341017|FG001|Overall Study|Lost Lens|5|||
155249020|NCT03086447|560341016|FG000|Overall Study|Product quality complaint|0|||
155249021|NCT03086447|560341017|FG001|Overall Study|Product quality complaint|1|||
155249022|NCT03086447|560341016|FG000|Overall Study|Lens Damage|1|||
155249023|NCT03086447|560341017|FG001|Overall Study|Lens Damage|6|||
155249024|NCT03086447|560341016|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
155249025|NCT03086447|560341017|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
155249026|NCT03086447|560341016|FG000|Overall Study|Test Article No Longer Available|1|||
155249027|NCT03086447|560341017|FG001|Overall Study|Test Article No Longer Available|0|||
155249028|NCT03086447|560341016|FG000|Overall Study|Protocol Violation|2|||
155249029|NCT03086447|560341017|FG001|Overall Study|Protocol Violation|4|||
155249030|NCT03086447|560341016|FG000|Overall Study|Lost to Follow-up|0|||
155249031|NCT03086447|560341017|FG001|Overall Study|Lost to Follow-up|1|||
155249032|NCT03086447|560341016|FG000|Overall Study|Adverse Event|3|||
155249033|NCT03086447|560341017|FG001|Overall Study|Adverse Event|0|||
155249034|NCT03086447|560341016|FG000|Overall Study|Lens Discomfort|2|||
155249035|NCT03086447|560341017|FG001|Overall Study|Lens Discomfort|1|||
155249036|NCT01128413|560341020|FG000|Overall Study|Withdrawal by Subject|1|||
155249037|NCT01128413|560341021|FG001|Overall Study|Withdrawal by Subject|0|||
155249038|NCT01128413|560341020|FG000|Overall Study|NICOM Monitor Problems|2|||
155249039|NCT01128413|560341021|FG001|Overall Study|NICOM Monitor Problems|1|||
155249040|NCT01128413|560341020|FG000|Overall Study|Pt made DNR|1|||
155249041|NCT01128413|560341021|FG001|Overall Study|Pt made DNR|0|||
155249042|NCT02075593|560341025|FG000|Overall Study|Withdrawal by Subject|1|||
155249043|NCT00726752|560341026|FG000|Overall Study|Lack of Efficacy|6|||
155249044|NCT01588184|560342721|FG000|Overall Study|Death|1|||
155249045|NCT01588184|560342722|FG001|Overall Study|Death|0|||
155249046|NCT01588184|560342723|FG002|Overall Study|Death|0|||
155249047|NCT01588184|560342724|FG003|Overall Study|Death|1|||
155249048|NCT01588184|560342725|FG004|Overall Study|Death|1|||
155249049|NCT01588184|560342726|FG005|Overall Study|Death|1|||
155249050|NCT01588184|560342721|FG000|Overall Study|Withdrawal by Subject|2|||
155249051|NCT01588184|560342722|FG001|Overall Study|Withdrawal by Subject|4|||
155249052|NCT01588184|560342723|FG002|Overall Study|Withdrawal by Subject|0|||
155249053|NCT01588184|560342724|FG003|Overall Study|Withdrawal by Subject|1|||
155249054|NCT01588184|560342725|FG004|Overall Study|Withdrawal by Subject|0|||
155249055|NCT01588184|560342726|FG005|Overall Study|Withdrawal by Subject|0|||
155249056|NCT01588184|560342721|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
155249057|NCT01588184|560342722|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
155249058|NCT01588184|560342723|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
155249059|NCT01588184|560342724|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
155249060|NCT01588184|560342725|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
155249061|NCT01588184|560342726|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
155249062|NCT01588184|560342721|FG000|Overall Study|multiple reasons|0|||
155249063|NCT01588184|560342722|FG001|Overall Study|multiple reasons|3|||
155249064|NCT01588184|560342723|FG002|Overall Study|multiple reasons|0|||
155249065|NCT01588184|560342724|FG003|Overall Study|multiple reasons|1|||
155249066|NCT01588184|560342725|FG004|Overall Study|multiple reasons|0|||
155249067|NCT01588184|560342726|FG005|Overall Study|multiple reasons|0|||
155249068|NCT00907153|560342732|FG000|Overall Study|Lost to Follow-up|1|||
155249069|NCT00907153|560342733|FG001|Overall Study|Lost to Follow-up|1|||
155249070|NCT00907153|560342732|FG000|Overall Study|Withdrawal by Subject|1|||
155249071|NCT00907153|560342733|FG001|Overall Study|Withdrawal by Subject|3|||
155249072|NCT01773070|560342739|FG000|Overall Study|Withdrawal by Subject|24|||
155249073|NCT01773070|560342739|FG000|Overall Study|Lost to Follow-up|39|||
155249074|NCT01773070|560342739|FG000|Overall Study|Other|15|||
155249075|NCT01773070|560342739|FG000|Overall Study|Death (unrelated to study procedures)|3|||
155249076|NCT01559844|560342740|FG000|Overall Study|Consent Withdrawn|7|||
155249077|NCT01559844|560342740|FG000|Overall Study|Death|5|||
155249078|NCT01559844|560342740|FG000|Overall Study|Efficacy Failure|10|||
155249079|NCT01559844|560342740|FG000|Overall Study|No Longer A Transplant Candidate|3|||
155249080|NCT02181803|560342741|FG000|Overall Study|Withdrawal by Subject|0|||
155249081|NCT02181803|560342742|FG001|Overall Study|Withdrawal by Subject|2|||
155249082|NCT02181803|560342743|FG002|Overall Study|Withdrawal by Subject|0|||
155249083|NCT02181803|560342744|FG003|Overall Study|Withdrawal by Subject|0|||
155249084|NCT02181803|560342745|FG004|Overall Study|Withdrawal by Subject|0|||
155249085|NCT02181803|560342746|FG005|Overall Study|Withdrawal by Subject|0|||
155249086|NCT02181803|560342747|FG006|Overall Study|Withdrawal by Subject|0|||
155249087|NCT02181803|560342748|FG007|Overall Study|Withdrawal by Subject|0|||
155249088|NCT02181803|560342749|FG008|Overall Study|Withdrawal by Subject|0|||
155249089|NCT02181803|560342741|FG000|Overall Study|Physician Decision|0|||
155249090|NCT02181803|560342742|FG001|Overall Study|Physician Decision|0|||
155249091|NCT02181803|560342743|FG002|Overall Study|Physician Decision|0|||
155249092|NCT02181803|560342744|FG003|Overall Study|Physician Decision|1|||
155249093|NCT02181803|560342745|FG004|Overall Study|Physician Decision|0|||
155249094|NCT02181803|560342746|FG005|Overall Study|Physician Decision|0|||
155249095|NCT02181803|560342747|FG006|Overall Study|Physician Decision|0|||
155249096|NCT02181803|560342748|FG007|Overall Study|Physician Decision|1|||
155249097|NCT02181803|560342749|FG008|Overall Study|Physician Decision|0|||
155249098|NCT02181803|560342741|FG000|Overall Study|Adverse Event|0|||
155249099|NCT02181803|560342742|FG001|Overall Study|Adverse Event|2|||
155249100|NCT02181803|560342743|FG002|Overall Study|Adverse Event|0|||
155249101|NCT02181803|560342744|FG003|Overall Study|Adverse Event|1|||
155249102|NCT02181803|560342745|FG004|Overall Study|Adverse Event|0|||
155249103|NCT02181803|560342746|FG005|Overall Study|Adverse Event|0|||
155249104|NCT02181803|560342747|FG006|Overall Study|Adverse Event|1|||
155249105|NCT02181803|560342748|FG007|Overall Study|Adverse Event|0|||
155249106|NCT02181803|560342749|FG008|Overall Study|Adverse Event|0|||
155249107|NCT00951041|560342750|FG000|Overall Study|Withdrawal by Subject|1|||
155249108|NCT00951041|560342751|FG001|Overall Study|Withdrawal by Subject|1|||
155249109|NCT00951041|560342750|FG000|Overall Study|Lost to Follow-up|1|||
155249110|NCT00951041|560342751|FG001|Overall Study|Lost to Follow-up|0|||
155249111|NCT00951041|560342750|FG000|Overall Study|Other|3|||
155249112|NCT00951041|560342751|FG001|Overall Study|Other|0|||
155249113|NCT04477187|560342758|FG000|Overall Study|Lost to Follow-up|2|||
155249114|NCT02460991|560342759|FG000|Overall Study|Withdrawal by Subject|0|||
155249115|NCT02460991|560342760|FG001|Overall Study|Withdrawal by Subject|2|||
155249116|NCT01296568|560342761|FG000|Continued Access Phase|Lost to Follow-up|1|||
155249117|NCT01296568|560342761|FG000|Continued Access Phase|Withdrawal by Subject|1|||
155249118|NCT01296568|560342761|FG000|Continued Access Phase|Disease Progression|1|||
155249119|NCT00321854|560342762|FG000|Overall Study|Adverse Event|41|||
155249120|NCT00321854|560342763|FG001|Overall Study|Adverse Event|43|||
155249121|NCT00321854|560342762|FG000|Overall Study|Lack of Efficacy|9|||
155249122|NCT00321854|560342763|FG001|Overall Study|Lack of Efficacy|14|||
155249123|NCT00321854|560342762|FG000|Overall Study|Protocol Violation|6|||
155249124|NCT00321854|560342763|FG001|Overall Study|Protocol Violation|5|||
155249125|NCT00321854|560342762|FG000|Overall Study|Lost to Follow-up|0|||
155249126|NCT00321854|560342763|FG001|Overall Study|Lost to Follow-up|2|||
155249127|NCT00321854|560342762|FG000|Overall Study|Withdrawal by Subject|6|||
155249128|NCT00321854|560342763|FG001|Overall Study|Withdrawal by Subject|17|||
155249129|NCT00321854|560342762|FG000|Overall Study|Other|1|||
155249130|NCT00321854|560342763|FG001|Overall Study|Other|1|||
155249131|NCT03905655|560342764|FG000|Overall Study|Adverse Event|1|||
155249132|NCT03905655|560342765|FG001|Overall Study|Adverse Event|0|||
155249133|NCT03905655|560342766|FG002|Overall Study|Adverse Event|1|||
155249134|NCT03905655|560342767|FG003|Overall Study|Adverse Event|1|||
155249135|NCT02277106|560342768|FG000|Stage 2|Adverse Event|0|||
155249136|NCT02277106|560342769|FG001|Stage 2|Adverse Event|0|||
155249137|NCT02277106|560342770|FG002|Stage 2|Adverse Event|1|||
155249138|NCT01292928|560342771|FG000|Overall Study|Death|8|||
155249139|NCT01292928|560342771|FG000|Overall Study|Withdrawal by Subject|8|||
155249140|NCT01292928|560342771|FG000|Overall Study|Lost to Follow-up|6|||
155249141|NCT01292928|560342771|FG000|Overall Study|Physician Decision|2|||
155249142|NCT01059565|560342772|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
155249143|NCT01059565|560342773|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
155249144|NCT01059565|560342772|FG000|24-Week Randomized Phase|Adverse Event|5|||
155249145|NCT01059565|560342773|FG001|24-Week Randomized Phase|Adverse Event|0|||
155249146|NCT01059565|560342772|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
155249147|NCT01059565|560342773|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
155249148|NCT01059565|560342772|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
155249149|NCT01059565|560342773|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
155249150|NCT01059565|560342772|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
155249151|NCT01059565|560342773|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
155249152|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Adverse Event|2|||
155249153|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Adverse Event|0|||
155249154|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
155249155|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
155249156|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
155249157|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
155249158|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
155249159|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
155249160|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
155249161|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
155249162|NCT01059565|560342772|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
155249163|NCT01059565|560342773|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
155249164|NCT03263429|560342774|FG000|Overall Study|Withdrawal by Subject|0|||
155249165|NCT03263429|560342775|FG001|Overall Study|Withdrawal by Subject|1|||
155249166|NCT03263429|560342776|FG002|Overall Study|Withdrawal by Subject|0|||
155249167|NCT03263429|560342774|FG000|Overall Study|Follow-Up Period Completed|0|||
155249168|NCT03263429|560342775|FG001|Overall Study|Follow-Up Period Completed|2|||
155249169|NCT03263429|560342776|FG002|Overall Study|Follow-Up Period Completed|0|||
155249170|NCT03263429|560342774|FG000|Overall Study|Death|3|||
155249171|NCT03263429|560342775|FG001|Overall Study|Death|5|||
155249172|NCT03263429|560342776|FG002|Overall Study|Death|16|||
155249173|NCT03263429|560342774|FG000|Overall Study|Participant unable to return|0|||
155249174|NCT03263429|560342775|FG001|Overall Study|Participant unable to return|0|||
155249175|NCT03263429|560342776|FG002|Overall Study|Participant unable to return|1|||
155249176|NCT03263429|560342774|FG000|Overall Study|Study Closed|0|||
155249177|NCT03263429|560342775|FG001|Overall Study|Study Closed|0|||
155249178|NCT03263429|560342776|FG002|Overall Study|Study Closed|1|||
155249179|NCT04530448|560342777|FG000|Overall Study|Physician Decision|3|||
155249180|NCT04530448|560342778|FG001|Overall Study|Physician Decision|0|||
155249181|NCT02219932|560342785|FG000|Overall Study|Other|5|||
155249182|NCT02219932|560342786|FG001|Overall Study|Other|11|||
155249183|NCT02219932|560342785|FG000|Overall Study|Death|1|||
155249184|NCT02219932|560342786|FG001|Overall Study|Death|1|||
155249185|NCT02219932|560342785|FG000|Overall Study|Investigator Decision|0|||
155249186|NCT02219932|560342786|FG001|Overall Study|Investigator Decision|1|||
155249187|NCT02219932|560342785|FG000|Overall Study|Consent Withdrawn|11|||
155249188|NCT02219932|560342786|FG001|Overall Study|Consent Withdrawn|7|||
155249189|NCT02219932|560342785|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
155249190|NCT02219932|560342786|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
155249191|NCT02219932|560342785|FG000|Overall Study|Protocol Violation|10|||
155249192|NCT02219932|560342786|FG001|Overall Study|Protocol Violation|6|||
155249193|NCT02219932|560342785|FG000|Overall Study|Pregnancy|1|||
155249194|NCT02219932|560342786|FG001|Overall Study|Pregnancy|0|||
155249195|NCT02219932|560342785|FG000|Overall Study|Lost to Follow-up|4|||
155249196|NCT02219932|560342786|FG001|Overall Study|Lost to Follow-up|2|||
155249197|NCT02219932|560342785|FG000|Overall Study|Adverse Event|23|||
155249198|NCT02219932|560342786|FG001|Overall Study|Adverse Event|21|||
155249199|NCT00511004|560342787|FG000|Overall Study|Lost to Follow-up|0|||
155249200|NCT00511004|560342788|FG001|Overall Study|Lost to Follow-up|0|||
155249201|NCT00511004|560342789|FG002|Overall Study|Lost to Follow-up|4|||
155249202|NCT00990652|560342790|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
155249203|NCT00990652|560342790|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
155249204|NCT05177770|560342791|FG000|Overall Study|Death|4|||
155249205|NCT05177770|560342791|FG000|Overall Study|Withdrawal by Subject|1|||
155249206|NCT05177770|560342791|FG000|Overall Study|Adverse Event prior to dosing|1|||
155249207|NCT01672801|560342796|FG000|Overall Study|Screen Failure|0|||
155249208|NCT01672801|560342797|FG001|Overall Study|Screen Failure|1|||
155249209|NCT02384954|560342805|FG000|Phase 1|Progressive Disease|2|||
155249210|NCT02384954|560342806|FG001|Phase 1|Progressive Disease|0|||
155249211|NCT02384954|560342807|FG002|Phase 1|Progressive Disease|1|||
155249212|NCT02384954|560342808|FG003|Phase 1|Progressive Disease|1|||
155249213|NCT02384954|560342809|FG004|Phase 1|Progressive Disease|0|||
155249214|NCT02384954|560342810|FG005|Phase 1|Progressive Disease|0|||
155249215|NCT02384954|560342811|FG006|Phase 1|Progressive Disease|0|||
155249216|NCT02384954|560342812|FG007|Phase 1|Progressive Disease|0|||
155249217|NCT02384954|560342813|FG008|Phase 1|Progressive Disease|0|||
155249218|NCT02384954|560342805|FG000|Phase 1|Adverse Event|0|||
155249219|NCT02384954|560342806|FG001|Phase 1|Adverse Event|0|||
155249220|NCT02384954|560342807|FG002|Phase 1|Adverse Event|1|||
155249221|NCT02384954|560342808|FG003|Phase 1|Adverse Event|0|||
155249222|NCT02384954|560342809|FG004|Phase 1|Adverse Event|0|||
155249223|NCT02384954|560342810|FG005|Phase 1|Adverse Event|0|||
155249224|NCT02384954|560342811|FG006|Phase 1|Adverse Event|0|||
155249225|NCT02384954|560342812|FG007|Phase 1|Adverse Event|0|||
155249226|NCT02384954|560342813|FG008|Phase 1|Adverse Event|0|||
155249227|NCT02384954|560342805|FG000|Phase 2|Progressive Disease|0|||
155249228|NCT02384954|560342806|FG001|Phase 2|Progressive Disease|0|||
155249229|NCT02384954|560342807|FG002|Phase 2|Progressive Disease|0|||
155249230|NCT02384954|560342808|FG003|Phase 2|Progressive Disease|0|||
155249231|NCT02384954|560342809|FG004|Phase 2|Progressive Disease|0|||
155249232|NCT02384954|560342810|FG005|Phase 2|Progressive Disease|0|||
155249233|NCT02384954|560342811|FG006|Phase 2|Progressive Disease|0|||
155249234|NCT02384954|560342812|FG007|Phase 2|Progressive Disease|1|||
155249235|NCT02384954|560342813|FG008|Phase 2|Progressive Disease|2|||
155249236|NCT02384954|560342805|FG000|Phase 2|Adverse Event|0|||
155249237|NCT02384954|560342806|FG001|Phase 2|Adverse Event|0|||
155249238|NCT02384954|560342807|FG002|Phase 2|Adverse Event|0|||
155249239|NCT02384954|560342808|FG003|Phase 2|Adverse Event|0|||
155249240|NCT02384954|560342809|FG004|Phase 2|Adverse Event|0|||
155249241|NCT02384954|560342810|FG005|Phase 2|Adverse Event|0|||
155249242|NCT02384954|560342811|FG006|Phase 2|Adverse Event|0|||
155249243|NCT02384954|560342812|FG007|Phase 2|Adverse Event|1|||
155249244|NCT02384954|560342813|FG008|Phase 2|Adverse Event|1|||
155249245|NCT02384954|560342805|FG000|Phase 2|Failure to meet continuation criteria|0|||
155249246|NCT02384954|560342806|FG001|Phase 2|Failure to meet continuation criteria|0|||
155249247|NCT02384954|560342807|FG002|Phase 2|Failure to meet continuation criteria|0|||
155249248|NCT02384954|560342808|FG003|Phase 2|Failure to meet continuation criteria|0|||
155249249|NCT02384954|560342809|FG004|Phase 2|Failure to meet continuation criteria|0|||
155249250|NCT02384954|560342810|FG005|Phase 2|Failure to meet continuation criteria|0|||
155249251|NCT02384954|560342811|FG006|Phase 2|Failure to meet continuation criteria|0|||
155249252|NCT02384954|560342812|FG007|Phase 2|Failure to meet continuation criteria|1|||
155249253|NCT02384954|560342813|FG008|Phase 2|Failure to meet continuation criteria|0|||
155249254|NCT02372396|560342817|FG000|Overall Study|Lost to Follow-up|7|||
155249255|NCT02372396|560342818|FG001|Overall Study|Lost to Follow-up|9|||
155249256|NCT00214136|560342823|FG000|Overall Study|Death|5|||
155249257|NCT01272934|560342824|FG000|Overall Study|Adverse Event|0|||
155249258|NCT01272934|560342825|FG001|Overall Study|Adverse Event|1|||
155249259|NCT01272934|560342824|FG000|Overall Study|Abnormal Laboratory Value|0|||
155249260|NCT01272934|560342825|FG001|Overall Study|Abnormal Laboratory Value|1|||
155249261|NCT04313634|560342826|FG000|Overall Study|Adverse Event|2|||
155249262|NCT04313634|560342827|FG001|Overall Study|Adverse Event|2|||
155249263|NCT04313634|560342828|FG002|Overall Study|Adverse Event|0|||
155249264|NCT04313634|560342826|FG000|Overall Study|Withdrawal by Subject|1|||
155249265|NCT04313634|560342827|FG001|Overall Study|Withdrawal by Subject|0|||
155249266|NCT04313634|560342828|FG002|Overall Study|Withdrawal by Subject|1|||
155249267|NCT04313634|560342826|FG000|Overall Study|Protocol Violation|0|||
155249268|NCT04313634|560342827|FG001|Overall Study|Protocol Violation|0|||
155249269|NCT04313634|560342828|FG002|Overall Study|Protocol Violation|1|||
155249270|NCT03595904|560342834|FG000|Overall Study|Protocol Violation|3|||
155249271|NCT03595904|560342835|FG001|Overall Study|Protocol Violation|1|||
155249272|NCT03595904|560342834|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
155249273|NCT03595904|560342835|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
155249274|NCT03595904|560342834|FG000|Overall Study|Insurance complications|1|||
155249275|NCT03595904|560342835|FG001|Overall Study|Insurance complications|0|||
155249276|NCT03595904|560342834|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
155249277|NCT03595904|560342835|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
155249278|NCT01581281|560342836|FG000|Overall Study|Early Study Closure|15|||
155249279|NCT01581281|560342837|FG001|Overall Study|Early Study Closure|6|||
155249280|NCT01581281|560342838|FG002|Overall Study|Early Study Closure|12|||
155249281|NCT02187991|560342841|FG000|Overall Study|Adverse Event|13|||
155249282|NCT02187991|560342842|FG001|Overall Study|Adverse Event|14|||
155249283|NCT02187991|560342843|FG002|Overall Study|Adverse Event|3|||
155249284|NCT02187991|560342844|FG003|Overall Study|Adverse Event|2|||
155249285|NCT02187991|560342841|FG000|Overall Study|Withdrawal by Subject|9|||
155249286|NCT02187991|560342842|FG001|Overall Study|Withdrawal by Subject|6|||
155249287|NCT02187991|560342843|FG002|Overall Study|Withdrawal by Subject|3|||
155249288|NCT02187991|560342844|FG003|Overall Study|Withdrawal by Subject|2|||
155249289|NCT02187991|560342841|FG000|Overall Study|Physician Decision|4|||
155249290|NCT02187991|560342842|FG001|Overall Study|Physician Decision|4|||
155249291|NCT02187991|560342843|FG002|Overall Study|Physician Decision|0|||
155249292|NCT02187991|560342844|FG003|Overall Study|Physician Decision|2|||
155249293|NCT02187991|560342841|FG000|Overall Study|Other, unrelated complication|7|||
155249294|NCT02187991|560342842|FG001|Overall Study|Other, unrelated complication|1|||
155249295|NCT02187991|560342843|FG002|Overall Study|Other, unrelated complication|1|||
155249296|NCT02187991|560342844|FG003|Overall Study|Other, unrelated complication|2|||
155249297|NCT02187991|560342841|FG000|Overall Study|Death|1|||
155249298|NCT02187991|560342842|FG001|Overall Study|Death|3|||
155249299|NCT02187991|560342843|FG002|Overall Study|Death|0|||
155249300|NCT02187991|560342844|FG003|Overall Study|Death|0|||
155249301|NCT01358526|560342853|FG000|Open-label Titration Period|Adverse Event|95|||
155249302|NCT01358526|560342854|FG001|Open-label Titration Period|Adverse Event|0|||
155249303|NCT01358526|560342855|FG002|Open-label Titration Period|Adverse Event|0|||
155249304|NCT01358526|560342853|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
155249305|NCT01358526|560342854|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
155249306|NCT01358526|560342855|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
155249307|NCT01358526|560342853|FG000|Open-label Titration Period|Lost to Follow-up|25|||
155249308|NCT01358526|560342854|FG001|Open-label Titration Period|Lost to Follow-up|0|||
155249309|NCT01358526|560342855|FG002|Open-label Titration Period|Lost to Follow-up|0|||
155249310|NCT01358526|560342853|FG000|Open-label Titration Period|Lack of Efficacy|107|||
155249311|NCT01358526|560342854|FG001|Open-label Titration Period|Lack of Efficacy|0|||
155249312|NCT01358526|560342855|FG002|Open-label Titration Period|Lack of Efficacy|0|||
155249313|NCT01358526|560342853|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
155249314|NCT01358526|560342854|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
155249315|NCT01358526|560342855|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
155249316|NCT01358526|560342853|FG000|Open-label Titration Period|Administrative|8|||
155249317|NCT01358526|560342854|FG001|Open-label Titration Period|Administrative|0|||
155249318|NCT01358526|560342855|FG002|Open-label Titration Period|Administrative|0|||
155249319|NCT01358526|560342853|FG000|Open-label Titration Period|Did not qualify|178|||
155249320|NCT01358526|560342854|FG001|Open-label Titration Period|Did not qualify|0|||
155249321|NCT01358526|560342855|FG002|Open-label Titration Period|Did not qualify|0|||
155249322|NCT01358526|560342853|FG000|Double-blind Phase|Adverse Event|0|||
155249323|NCT01358526|560342854|FG001|Double-blind Phase|Adverse Event|24|||
155249324|NCT01358526|560342855|FG002|Double-blind Phase|Adverse Event|23|||
155249325|NCT01358526|560342853|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155249326|NCT01358526|560342854|FG001|Double-blind Phase|Withdrawal by Subject|10|||
155249327|NCT01358526|560342855|FG002|Double-blind Phase|Withdrawal by Subject|8|||
155249328|NCT01358526|560342853|FG000|Double-blind Phase|Lost to Follow-up|0|||
155249329|NCT01358526|560342854|FG001|Double-blind Phase|Lost to Follow-up|4|||
155249330|NCT01358526|560342855|FG002|Double-blind Phase|Lost to Follow-up|1|||
155249331|NCT01358526|560342853|FG000|Double-blind Phase|Lack of Efficacy|0|||
155249332|NCT01358526|560342854|FG001|Double-blind Phase|Lack of Efficacy|31|||
155249333|NCT01358526|560342855|FG002|Double-blind Phase|Lack of Efficacy|73|||
155249334|NCT01358526|560342853|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
155249335|NCT01358526|560342854|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
155249336|NCT01358526|560342855|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
155249337|NCT01358526|560342853|FG000|Double-blind Phase|Administrative|0|||
155249338|NCT01358526|560342854|FG001|Double-blind Phase|Administrative|6|||
155249339|NCT01358526|560342855|FG002|Double-blind Phase|Administrative|10|||
155249340|NCT01003249|560342858|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155249341|NCT01003249|560342859|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
155249342|NCT01003249|560342858|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
155249343|NCT01003249|560342859|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
155249344|NCT01003249|560342858|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
155249345|NCT01003249|560342859|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
155249346|NCT01003249|560342858|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
155249347|NCT01003249|560342859|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
155249348|NCT02194621|560342860|FG000|Overall Study|6 withdrew prior to randomization|2|||
155249349|NCT02194621|560342861|FG001|Overall Study|6 withdrew prior to randomization|2|||
155249350|NCT02194621|560342862|FG002|Overall Study|6 withdrew prior to randomization|2|||
155249351|NCT02194621|560342860|FG000|Overall Study|Withdrawal by Subject|4|||
155249352|NCT02194621|560342861|FG001|Overall Study|Withdrawal by Subject|4|||
155249353|NCT02194621|560342862|FG002|Overall Study|Withdrawal by Subject|7|||
155249354|NCT00714168|560342870|FG000|Overall Study|Pregnancy|5|||
155249355|NCT00714168|560342871|FG001|Overall Study|Pregnancy|4|||
155249356|NCT00714168|560342870|FG000|Overall Study|Lost to Follow-up|32|||
155249357|NCT00714168|560342871|FG001|Overall Study|Lost to Follow-up|50|||
155249358|NCT00714168|560342870|FG000|Overall Study|Relocation|4|||
155249359|NCT00714168|560342871|FG001|Overall Study|Relocation|3|||
155249360|NCT00714168|560342870|FG000|Overall Study|Non-study medical condition|3|||
155249361|NCT00714168|560342871|FG001|Overall Study|Non-study medical condition|2|||
155249362|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
155249363|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
155249364|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
155249365|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155249366|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155249367|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
155249368|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249369|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249370|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
155249371|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249372|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249373|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
155249374|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
155249375|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
155249376|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249377|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249378|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249379|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
155249380|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
155249381|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
155249382|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
155249383|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155249384|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155249385|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
155249386|NCT04988308|560342873|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
155249387|NCT04988308|560342874|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
155249388|NCT04988308|560342875|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
155249389|NCT04988308|560342876|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
155249390|NCT04988308|560342877|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
155249391|NCT04988308|560342878|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
155249392|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155249393|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155249394|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
155249395|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
155249396|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
155249397|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
155249398|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155249399|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155249400|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
155249401|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
155249402|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
155249403|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
155249404|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155249405|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155249406|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
155249407|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
155249408|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
155249409|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
155249410|NCT04988308|560342873|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
155249411|NCT04988308|560342874|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
155249412|NCT04988308|560342875|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
155249413|NCT04988308|560342876|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
155249414|NCT04988308|560342877|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
155249415|NCT04988308|560342878|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
155249416|NCT00809757|560342882|FG000|Overall Study|Adverse Event|2|||
155249417|NCT00809757|560342883|FG001|Overall Study|Adverse Event|3|||
155249418|NCT00809757|560342884|FG002|Overall Study|Adverse Event|3|||
155249419|NCT00809757|560342882|FG000|Overall Study|Lost to Follow-up|0|||
155249420|NCT00809757|560342883|FG001|Overall Study|Lost to Follow-up|0|||
155249421|NCT00809757|560342884|FG002|Overall Study|Lost to Follow-up|1|||
155249422|NCT00809757|560342882|FG000|Overall Study|Protocol Violation|1|||
155249423|NCT00809757|560342883|FG001|Overall Study|Protocol Violation|1|||
155249424|NCT00809757|560342884|FG002|Overall Study|Protocol Violation|1|||
155249425|NCT00809757|560342882|FG000|Overall Study|Withdrawal by Subject|2|||
155249426|NCT00809757|560342883|FG001|Overall Study|Withdrawal by Subject|1|||
155249427|NCT00809757|560342884|FG002|Overall Study|Withdrawal by Subject|3|||
155249428|NCT00809757|560342882|FG000|Overall Study|Subject Uncooperative|1|||
155249429|NCT00809757|560342883|FG001|Overall Study|Subject Uncooperative|0|||
155249430|NCT00809757|560342884|FG002|Overall Study|Subject Uncooperative|2|||
155249431|NCT00809757|560342882|FG000|Overall Study|Noncompliance with Medication|0|||
155249432|NCT00809757|560342883|FG001|Overall Study|Noncompliance with Medication|0|||
155249433|NCT00809757|560342884|FG002|Overall Study|Noncompliance with Medication|1|||
155249434|NCT00659334|560342885|FG000|Overall Study|Screen Failure|8|||
155249435|NCT00659334|560342886|FG001|Overall Study|Screen Failure|5|||
155249436|NCT00659334|560342887|FG002|Overall Study|Screen Failure|0|||
155249437|NCT00659334|560342888|FG003|Overall Study|Screen Failure|0|||
155249438|NCT00659334|560342889|FG004|Overall Study|Screen Failure|0|||
155249439|NCT00659334|560342890|FG005|Overall Study|Screen Failure|0|||
155249440|NCT00659334|560342891|FG006|Overall Study|Screen Failure|1|||
155249441|NCT03034577|560342892|FG000|Overall Study|Withdrawal by Subject|6|||
155249442|NCT03034577|560342893|FG001|Overall Study|Withdrawal by Subject|9|||
155249443|NCT03034577|560342892|FG000|Overall Study|Lost to Follow-up|25|||
155249444|NCT03034577|560342893|FG001|Overall Study|Lost to Follow-up|26|||
155249445|NCT01174342|560342894|FG000|Overall Study|Conversion to cesarean section|4|||
155249446|NCT02625623|560342895|FG000|Overall Study|Participants randomized but not treated|9|||
155249447|NCT02625623|560342896|FG001|Overall Study|Participants randomized but not treated|1|||
155249448|NCT02338154|560344940|FG000|Overall Study|Death|46|||
155249449|NCT02338154|560344940|FG000|Overall Study|Valve Implant Failure|17|||
155249450|NCT02338154|560344940|FG000|Overall Study|Valve Explant|11|||
155249451|NCT02338154|560344940|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
155249452|NCT02338154|560344940|FG000|Overall Study|Lost to Follow-up|8|||
155249453|NCT02338154|560344940|FG000|Overall Study|Other Reason|3|||
155249454|NCT02338154|560344940|FG000|Overall Study|Patients Without Exit Form|47|||
155249455|NCT02338154|560344940|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
155249456|NCT03393000|560344943|FG000|Overall Study|Death|11|||
155249457|NCT03393000|560344943|FG000|Overall Study|Withdrawal by Subject|2|||
155249458|NCT03393000|560344943|FG000|Overall Study|Physician Decision|1|||
155249459|NCT02388724|560344944|FG000|Overall Study|Reason not Specified|0|||
155249460|NCT02388724|560344945|FG001|Overall Study|Reason not Specified|1|||
155249461|NCT02388724|560344944|FG000|Overall Study|Major Protocol Deviation|3|||
155249462|NCT02388724|560344945|FG001|Overall Study|Major Protocol Deviation|3|||
155249463|NCT02388724|560344944|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
155249464|NCT02388724|560344945|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
155249465|NCT02388724|560344944|FG000|Overall Study|Voluntary Withdrawal|6|||
155249466|NCT02388724|560344945|FG001|Overall Study|Voluntary Withdrawal|5|||
155249467|NCT02388724|560344944|FG000|Overall Study|Randomized but not Treated|0|||
155249468|NCT02388724|560344945|FG001|Overall Study|Randomized but not Treated|2|||
155249469|NCT01217073|560344946|FG000|Base Period|Adverse Event|1|||
155249470|NCT01217073|560344947|FG001|Base Period|Adverse Event|0|||
155249471|NCT01217073|560344948|FG002|Base Period|Adverse Event|1|||
155249472|NCT01217073|560344949|FG003|Base Period|Adverse Event|0|||
155249473|NCT01217073|560344950|FG004|Base Period|Adverse Event|4|||
155249474|NCT01217073|560344951|FG005|Base Period|Adverse Event|1|||
155249475|NCT01217073|560344952|FG006|Base Period|Adverse Event|0|||
155249476|NCT01217073|560344953|FG007|Base Period|Adverse Event|0|||
155249477|NCT01217073|560344946|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
155249478|NCT01217073|560344947|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249479|NCT01217073|560344948|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249480|NCT01217073|560344949|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249481|NCT01217073|560344950|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249482|NCT01217073|560344951|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249483|NCT01217073|560344952|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249484|NCT01217073|560344953|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
155249485|NCT01217073|560344946|FG000|Base Period|Excluded medication|0|||
155249486|NCT01217073|560344947|FG001|Base Period|Excluded medication|0|||
155249487|NCT01217073|560344948|FG002|Base Period|Excluded medication|0|||
155249488|NCT01217073|560344949|FG003|Base Period|Excluded medication|0|||
155249489|NCT01217073|560344950|FG004|Base Period|Excluded medication|1|||
155249490|NCT01217073|560344951|FG005|Base Period|Excluded medication|0|||
155249491|NCT01217073|560344952|FG006|Base Period|Excluded medication|0|||
155249492|NCT01217073|560344953|FG007|Base Period|Excluded medication|0|||
155249493|NCT01217073|560344946|FG000|Base Period|Lack of Efficacy|0|||
155249494|NCT01217073|560344947|FG001|Base Period|Lack of Efficacy|0|||
155249495|NCT01217073|560344948|FG002|Base Period|Lack of Efficacy|0|||
155249496|NCT01217073|560344949|FG003|Base Period|Lack of Efficacy|0|||
155249497|NCT01217073|560344950|FG004|Base Period|Lack of Efficacy|0|||
155249498|NCT01217073|560344951|FG005|Base Period|Lack of Efficacy|1|||
155249499|NCT01217073|560344952|FG006|Base Period|Lack of Efficacy|0|||
155249500|NCT01217073|560344953|FG007|Base Period|Lack of Efficacy|0|||
155249501|NCT01217073|560344946|FG000|Base Period|Lost to Follow-up|0|||
155249502|NCT01217073|560344947|FG001|Base Period|Lost to Follow-up|0|||
155249503|NCT01217073|560344948|FG002|Base Period|Lost to Follow-up|1|||
155249504|NCT01217073|560344949|FG003|Base Period|Lost to Follow-up|1|||
155249505|NCT01217073|560344950|FG004|Base Period|Lost to Follow-up|3|||
155249506|NCT01217073|560344951|FG005|Base Period|Lost to Follow-up|0|||
155249507|NCT01217073|560344952|FG006|Base Period|Lost to Follow-up|0|||
155249508|NCT01217073|560344953|FG007|Base Period|Lost to Follow-up|0|||
155249509|NCT01217073|560344946|FG000|Base Period|Physician Decision|0|||
155249510|NCT01217073|560344947|FG001|Base Period|Physician Decision|0|||
155249511|NCT01217073|560344948|FG002|Base Period|Physician Decision|0|||
155249512|NCT01217073|560344949|FG003|Base Period|Physician Decision|0|||
155249513|NCT01217073|560344950|FG004|Base Period|Physician Decision|1|||
155249514|NCT01217073|560344951|FG005|Base Period|Physician Decision|0|||
155249515|NCT01217073|560344952|FG006|Base Period|Physician Decision|0|||
155249516|NCT01217073|560344953|FG007|Base Period|Physician Decision|0|||
155249517|NCT01217073|560344946|FG000|Base Period|Protocol Violation|1|||
155249518|NCT01217073|560344947|FG001|Base Period|Protocol Violation|0|||
155249519|NCT01217073|560344948|FG002|Base Period|Protocol Violation|0|||
155249520|NCT01217073|560344949|FG003|Base Period|Protocol Violation|0|||
155249521|NCT01217073|560344950|FG004|Base Period|Protocol Violation|1|||
155249522|NCT01217073|560344951|FG005|Base Period|Protocol Violation|2|||
155249523|NCT01217073|560344952|FG006|Base Period|Protocol Violation|0|||
155249524|NCT01217073|560344953|FG007|Base Period|Protocol Violation|0|||
155249525|NCT01217073|560344946|FG000|Base Period|Withdrawal by Subject|4|||
155249526|NCT01217073|560344947|FG001|Base Period|Withdrawal by Subject|5|||
155249527|NCT01217073|560344948|FG002|Base Period|Withdrawal by Subject|5|||
155249528|NCT01217073|560344949|FG003|Base Period|Withdrawal by Subject|1|||
155249529|NCT01217073|560344950|FG004|Base Period|Withdrawal by Subject|5|||
155249530|NCT01217073|560344951|FG005|Base Period|Withdrawal by Subject|5|||
155249531|NCT01217073|560344952|FG006|Base Period|Withdrawal by Subject|0|||
155249532|NCT01217073|560344953|FG007|Base Period|Withdrawal by Subject|0|||
155249533|NCT01217073|560344946|FG000|Extension Period|Adverse Event|0|||
155249534|NCT01217073|560344947|FG001|Extension Period|Adverse Event|0|||
155249535|NCT01217073|560344948|FG002|Extension Period|Adverse Event|0|||
155249536|NCT01217073|560344949|FG003|Extension Period|Adverse Event|0|||
155249537|NCT01217073|560344950|FG004|Extension Period|Adverse Event|0|||
155249538|NCT01217073|560344951|FG005|Extension Period|Adverse Event|0|||
155249539|NCT01217073|560344952|FG006|Extension Period|Adverse Event|19|||
155249540|NCT01217073|560344953|FG007|Extension Period|Adverse Event|5|||
155249541|NCT01217073|560344946|FG000|Extension Period|ALT/AST|0|||
155249542|NCT01217073|560344947|FG001|Extension Period|ALT/AST|0|||
155249543|NCT01217073|560344948|FG002|Extension Period|ALT/AST|0|||
155249544|NCT01217073|560344949|FG003|Extension Period|ALT/AST|0|||
155249545|NCT01217073|560344950|FG004|Extension Period|ALT/AST|0|||
155249546|NCT01217073|560344951|FG005|Extension Period|ALT/AST|0|||
155249547|NCT01217073|560344952|FG006|Extension Period|ALT/AST|2|||
155249548|NCT01217073|560344953|FG007|Extension Period|ALT/AST|0|||
155249549|NCT01217073|560344946|FG000|Extension Period|Contraindication to study medication|0|||
155249550|NCT01217073|560344947|FG001|Extension Period|Contraindication to study medication|0|||
155249551|NCT01217073|560344948|FG002|Extension Period|Contraindication to study medication|0|||
155249552|NCT01217073|560344949|FG003|Extension Period|Contraindication to study medication|0|||
155249553|NCT01217073|560344950|FG004|Extension Period|Contraindication to study medication|0|||
155249554|NCT01217073|560344951|FG005|Extension Period|Contraindication to study medication|0|||
155249555|NCT01217073|560344952|FG006|Extension Period|Contraindication to study medication|1|||
155249556|NCT01217073|560344953|FG007|Extension Period|Contraindication to study medication|0|||
155249557|NCT01217073|560344946|FG000|Extension Period|Creatinine/eGFR|0|||
155249558|NCT01217073|560344947|FG001|Extension Period|Creatinine/eGFR|0|||
155249559|NCT01217073|560344948|FG002|Extension Period|Creatinine/eGFR|0|||
155249560|NCT01217073|560344949|FG003|Extension Period|Creatinine/eGFR|0|||
155249561|NCT01217073|560344950|FG004|Extension Period|Creatinine/eGFR|0|||
155249562|NCT01217073|560344951|FG005|Extension Period|Creatinine/eGFR|0|||
155249563|NCT01217073|560344952|FG006|Extension Period|Creatinine/eGFR|11|||
155249564|NCT01217073|560344953|FG007|Extension Period|Creatinine/eGFR|1|||
155249565|NCT01217073|560344946|FG000|Extension Period|Death|0|||
155249566|NCT01217073|560344947|FG001|Extension Period|Death|0|||
155249567|NCT01217073|560344948|FG002|Extension Period|Death|0|||
155249568|NCT01217073|560344949|FG003|Extension Period|Death|0|||
155249569|NCT01217073|560344950|FG004|Extension Period|Death|0|||
155249570|NCT01217073|560344951|FG005|Extension Period|Death|0|||
155249571|NCT01217073|560344952|FG006|Extension Period|Death|1|||
155249572|NCT01217073|560344953|FG007|Extension Period|Death|0|||
155249573|NCT01217073|560344946|FG000|Extension Period|Excluded medication|0|||
155249574|NCT01217073|560344947|FG001|Extension Period|Excluded medication|0|||
155249575|NCT01217073|560344948|FG002|Extension Period|Excluded medication|0|||
155249576|NCT01217073|560344949|FG003|Extension Period|Excluded medication|0|||
155249577|NCT01217073|560344950|FG004|Extension Period|Excluded medication|0|||
155249578|NCT01217073|560344951|FG005|Extension Period|Excluded medication|0|||
155249579|NCT01217073|560344952|FG006|Extension Period|Excluded medication|2|||
155249580|NCT01217073|560344953|FG007|Extension Period|Excluded medication|0|||
155249581|NCT01217073|560344946|FG000|Extension Period|Lack of Efficacy|0|||
155249582|NCT01217073|560344947|FG001|Extension Period|Lack of Efficacy|0|||
155249583|NCT01217073|560344948|FG002|Extension Period|Lack of Efficacy|0|||
155249584|NCT01217073|560344949|FG003|Extension Period|Lack of Efficacy|0|||
155249585|NCT01217073|560344950|FG004|Extension Period|Lack of Efficacy|0|||
155249586|NCT01217073|560344951|FG005|Extension Period|Lack of Efficacy|0|||
155249587|NCT01217073|560344952|FG006|Extension Period|Lack of Efficacy|3|||
155249588|NCT01217073|560344953|FG007|Extension Period|Lack of Efficacy|0|||
155249589|NCT01217073|560344946|FG000|Extension Period|Lost to Follow-up|0|||
155249590|NCT01217073|560344947|FG001|Extension Period|Lost to Follow-up|0|||
155249591|NCT01217073|560344948|FG002|Extension Period|Lost to Follow-up|0|||
155249592|NCT01217073|560344949|FG003|Extension Period|Lost to Follow-up|0|||
155249593|NCT01217073|560344950|FG004|Extension Period|Lost to Follow-up|0|||
155249594|NCT01217073|560344951|FG005|Extension Period|Lost to Follow-up|0|||
155249595|NCT01217073|560344952|FG006|Extension Period|Lost to Follow-up|9|||
155249596|NCT01217073|560344953|FG007|Extension Period|Lost to Follow-up|1|||
155249597|NCT01217073|560344946|FG000|Extension Period|Non-compliance with study drug|0|||
155249598|NCT01217073|560344947|FG001|Extension Period|Non-compliance with study drug|0|||
155249599|NCT01217073|560344948|FG002|Extension Period|Non-compliance with study drug|0|||
155249600|NCT01217073|560344949|FG003|Extension Period|Non-compliance with study drug|0|||
155249601|NCT01217073|560344950|FG004|Extension Period|Non-compliance with study drug|0|||
155249602|NCT01217073|560344951|FG005|Extension Period|Non-compliance with study drug|0|||
155249603|NCT01217073|560344952|FG006|Extension Period|Non-compliance with study drug|0|||
155249604|NCT01217073|560344953|FG007|Extension Period|Non-compliance with study drug|1|||
155249605|NCT01217073|560344946|FG000|Extension Period|Physician Decision|0|||
155249606|NCT01217073|560344947|FG001|Extension Period|Physician Decision|0|||
155249607|NCT01217073|560344948|FG002|Extension Period|Physician Decision|0|||
155249608|NCT01217073|560344949|FG003|Extension Period|Physician Decision|0|||
155249609|NCT01217073|560344950|FG004|Extension Period|Physician Decision|0|||
155249610|NCT01217073|560344951|FG005|Extension Period|Physician Decision|0|||
155249611|NCT01217073|560344952|FG006|Extension Period|Physician Decision|4|||
155249612|NCT01217073|560344953|FG007|Extension Period|Physician Decision|1|||
155249613|NCT01217073|560344946|FG000|Extension Period|Protocol Violation|0|||
155249614|NCT01217073|560344947|FG001|Extension Period|Protocol Violation|0|||
155249615|NCT01217073|560344948|FG002|Extension Period|Protocol Violation|0|||
155249616|NCT01217073|560344949|FG003|Extension Period|Protocol Violation|0|||
155249617|NCT01217073|560344950|FG004|Extension Period|Protocol Violation|0|||
155249618|NCT01217073|560344951|FG005|Extension Period|Protocol Violation|0|||
155249619|NCT01217073|560344952|FG006|Extension Period|Protocol Violation|2|||
155249620|NCT01217073|560344953|FG007|Extension Period|Protocol Violation|1|||
155249621|NCT01217073|560344946|FG000|Extension Period|Site discontinued study participation|0|||
155249622|NCT01217073|560344947|FG001|Extension Period|Site discontinued study participation|0|||
155249623|NCT01217073|560344948|FG002|Extension Period|Site discontinued study participation|0|||
155249624|NCT01217073|560344949|FG003|Extension Period|Site discontinued study participation|0|||
155249625|NCT01217073|560344950|FG004|Extension Period|Site discontinued study participation|0|||
155249626|NCT01217073|560344951|FG005|Extension Period|Site discontinued study participation|0|||
155249627|NCT01217073|560344952|FG006|Extension Period|Site discontinued study participation|7|||
155249628|NCT01217073|560344953|FG007|Extension Period|Site discontinued study participation|2|||
155249629|NCT01217073|560344946|FG000|Extension Period|Withdrawal by Subject|0|||
155249630|NCT01217073|560344947|FG001|Extension Period|Withdrawal by Subject|0|||
155249631|NCT01217073|560344948|FG002|Extension Period|Withdrawal by Subject|0|||
155249632|NCT01217073|560344949|FG003|Extension Period|Withdrawal by Subject|0|||
155249633|NCT01217073|560344950|FG004|Extension Period|Withdrawal by Subject|0|||
155249634|NCT01217073|560344951|FG005|Extension Period|Withdrawal by Subject|0|||
155249635|NCT01217073|560344952|FG006|Extension Period|Withdrawal by Subject|30|||
155249636|NCT01217073|560344953|FG007|Extension Period|Withdrawal by Subject|8|||
155249637|NCT02015676|560344969|FG000|Overall Study|Adverse Event|2|||
155249638|NCT02015676|560344970|FG001|Overall Study|Adverse Event|18|||
155249639|NCT02015676|560344971|FG002|Overall Study|Adverse Event|0|||
155249640|NCT02015676|560344969|FG000|Overall Study|Lack of Efficacy|2|||
155249641|NCT02015676|560344970|FG001|Overall Study|Lack of Efficacy|4|||
155249642|NCT02015676|560344971|FG002|Overall Study|Lack of Efficacy|0|||
155249643|NCT02015676|560344969|FG000|Overall Study|Protocol Violation|1|||
155249644|NCT02015676|560344970|FG001|Overall Study|Protocol Violation|0|||
155249645|NCT02015676|560344971|FG002|Overall Study|Protocol Violation|0|||
155249646|NCT02015676|560344969|FG000|Overall Study|Withdrawal by Subject|1|||
155249647|NCT02015676|560344970|FG001|Overall Study|Withdrawal by Subject|7|||
155249648|NCT02015676|560344971|FG002|Overall Study|Withdrawal by Subject|1|||
155249649|NCT02015676|560344969|FG000|Overall Study|Administrative reasons|0|||
155249650|NCT02015676|560344970|FG001|Overall Study|Administrative reasons|3|||
155249651|NCT02015676|560344971|FG002|Overall Study|Administrative reasons|1|||
155249652|NCT02015676|560344969|FG000|Overall Study|Death|0|||
155249653|NCT02015676|560344970|FG001|Overall Study|Death|1|||
155249654|NCT02015676|560344971|FG002|Overall Study|Death|0|||
155249655|NCT02015676|560344969|FG000|Overall Study|Disease progression|3|||
155249656|NCT02015676|560344970|FG001|Overall Study|Disease progression|1|||
155249657|NCT02015676|560344971|FG002|Overall Study|Disease progression|1|||
155249658|NCT00476476|560344973|FG000|Overall Study|Adverse Event|2|||
155249659|NCT00476476|560344974|FG001|Overall Study|Adverse Event|7|||
155249660|NCT00476476|560344973|FG000|Overall Study|Progressive Disease|0|||
155249661|NCT00476476|560344974|FG001|Overall Study|Progressive Disease|17|||
155249662|NCT00971048|560344975|FG000|Overall Study|Protocol Violation|1|||
155249663|NCT00971048|560344976|FG001|Overall Study|Protocol Violation|2|||
155249664|NCT00971048|560344977|FG002|Overall Study|Protocol Violation|0|||
155249665|NCT00971048|560344978|FG003|Overall Study|Protocol Violation|1|||
155249666|NCT00971048|560344975|FG000|Overall Study|Adverse Event|0|||
155249667|NCT00971048|560344976|FG001|Overall Study|Adverse Event|0|||
155249668|NCT00971048|560344977|FG002|Overall Study|Adverse Event|1|||
155249669|NCT00971048|560344978|FG003|Overall Study|Adverse Event|0|||
155249670|NCT00971048|560344975|FG000|Overall Study|Physician Decision|0|||
155249671|NCT00971048|560344976|FG001|Overall Study|Physician Decision|0|||
155249672|NCT00971048|560344977|FG002|Overall Study|Physician Decision|0|||
155249673|NCT00971048|560344978|FG003|Overall Study|Physician Decision|1|||
155249674|NCT03321396|560344982|FG000|Overall Study|Physician Decision|1|||
155249675|NCT03280121|560344983|FG000|Overall Study|Physician Decision|1|||
155249676|NCT03280121|560344983|FG000|Overall Study|Lost to Follow-up|1|||
155249677|NCT03280121|560344983|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
155249678|NCT02633137|560344988|FG000|Overall Study|Adverse Event|1|||
155249679|NCT02633137|560344988|FG000|Overall Study|Lack of Efficacy|2|||
155249680|NCT02633137|560344988|FG000|Overall Study|Withdrawal by Subject|1|||
155249681|NCT03996473|560344991|FG000|Treatment Assignment|Withdrawal by Subject|1|||
155249682|NCT03996473|560344991|FG000|Treatment Assignment|Progressive disease|6|||
155249683|NCT03996473|560344991|FG000|Treatment Assignment|Study drug never administered|1|||
155249684|NCT03996473|560344991|FG000|Active Follow-up|Death|1|||
155249685|NCT03996473|560344991|FG000|Long-term Follow-up|Death|5|||
155249686|NCT03759873|560344992|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
155249687|NCT03759873|560344993|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
155249688|NCT03759873|560344994|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
155249689|NCT03759873|560344995|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
155249690|NCT03759873|560344992|FG000|Overall Study|Moved outside eligible area|0|||
155249691|NCT03759873|560344993|FG001|Overall Study|Moved outside eligible area|2|||
155249692|NCT03759873|560344994|FG002|Overall Study|Moved outside eligible area|0|||
155249693|NCT03759873|560344995|FG003|Overall Study|Moved outside eligible area|0|||
155249694|NCT03759873|560344992|FG000|Overall Study|Withdrawal by Subject|0|||
155249695|NCT03759873|560344993|FG001|Overall Study|Withdrawal by Subject|0|||
155249696|NCT03759873|560344994|FG002|Overall Study|Withdrawal by Subject|1|||
155249697|NCT03759873|560344995|FG003|Overall Study|Withdrawal by Subject|0|||
155249698|NCT04349553|560344999|FG000|Overall Study|Withdrawal by Subject|1|||
155249699|NCT04349553|560345000|FG001|Overall Study|Withdrawal by Subject|0|||
155249700|NCT04349553|560345001|FG002|Overall Study|Withdrawal by Subject|1|||
155249701|NCT04349553|560345002|FG003|Overall Study|Withdrawal by Subject|0|||
155249702|NCT01869491|560345005|FG000|Overall Study|Adverse Event|3|||
155249703|NCT01869491|560345006|FG001|Overall Study|Adverse Event|5|||
155249704|NCT01869491|560345005|FG000|Overall Study|Lack of Efficacy|0|||
155249705|NCT01869491|560345006|FG001|Overall Study|Lack of Efficacy|3|||
155249706|NCT01869491|560345005|FG000|Overall Study|Withdrawal by Subject|6|||
155249707|NCT01869491|560345006|FG001|Overall Study|Withdrawal by Subject|7|||
155249708|NCT01869491|560345005|FG000|Overall Study|Lost to Follow-up|11|||
155249709|NCT01869491|560345006|FG001|Overall Study|Lost to Follow-up|9|||
155249710|NCT01869491|560345005|FG000|Overall Study|No further need of investigational product|1|||
155249711|NCT01869491|560345006|FG001|Overall Study|No further need of investigational product|0|||
155249712|NCT01910129|560345014|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
155249713|NCT01910129|560345015|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
155249714|NCT01910129|560345016|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
155249715|NCT01910129|560345014|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
155249716|NCT01910129|560345015|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
155249717|NCT01910129|560345016|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
155249718|NCT03449030|560345018|FG000|Overall Study|Withdrawal by Subject|0|||
155249719|NCT03449030|560345019|FG001|Overall Study|Withdrawal by Subject|0|||
155249720|NCT03449030|560345020|FG002|Overall Study|Withdrawal by Subject|0|||
155249721|NCT03449030|560345021|FG003|Overall Study|Withdrawal by Subject|1|||
155249722|NCT03449030|560345022|FG004|Overall Study|Withdrawal by Subject|1|||
155249723|NCT03449030|560345023|FG005|Overall Study|Withdrawal by Subject|1|||
155249724|NCT03449030|560345024|FG006|Overall Study|Withdrawal by Subject|1|||
155249725|NCT03449030|560345025|FG007|Overall Study|Withdrawal by Subject|2|||
155249726|NCT03449030|560345026|FG008|Overall Study|Withdrawal by Subject|0|||
155249727|NCT03449030|560345027|FG009|Overall Study|Withdrawal by Subject|0|||
155249728|NCT03449030|560345018|FG000|Overall Study|Symptomatic Deterioration|0|||
155249729|NCT03449030|560345019|FG001|Overall Study|Symptomatic Deterioration|1|||
155249730|NCT03449030|560345020|FG002|Overall Study|Symptomatic Deterioration|0|||
155249731|NCT03449030|560345021|FG003|Overall Study|Symptomatic Deterioration|0|||
155249732|NCT03449030|560345022|FG004|Overall Study|Symptomatic Deterioration|0|||
155249733|NCT03449030|560345023|FG005|Overall Study|Symptomatic Deterioration|1|||
155249734|NCT03449030|560345024|FG006|Overall Study|Symptomatic Deterioration|1|||
155249735|NCT03449030|560345025|FG007|Overall Study|Symptomatic Deterioration|0|||
155249736|NCT03449030|560345026|FG008|Overall Study|Symptomatic Deterioration|2|||
155249737|NCT03449030|560345027|FG009|Overall Study|Symptomatic Deterioration|0|||
155249738|NCT03449030|560345018|FG000|Overall Study|Progressive Disease|1|||
155249739|NCT03449030|560345019|FG001|Overall Study|Progressive Disease|0|||
155249740|NCT03449030|560345020|FG002|Overall Study|Progressive Disease|1|||
155249741|NCT03449030|560345021|FG003|Overall Study|Progressive Disease|4|||
155249742|NCT03449030|560345022|FG004|Overall Study|Progressive Disease|5|||
155249743|NCT03449030|560345023|FG005|Overall Study|Progressive Disease|3|||
155249744|NCT03449030|560345024|FG006|Overall Study|Progressive Disease|0|||
155249745|NCT03449030|560345025|FG007|Overall Study|Progressive Disease|1|||
155249746|NCT03449030|560345026|FG008|Overall Study|Progressive Disease|1|||
155249747|NCT03449030|560345027|FG009|Overall Study|Progressive Disease|1|||
155249748|NCT03449030|560345018|FG000|Overall Study|Adverse Event|0|||
155249749|NCT03449030|560345019|FG001|Overall Study|Adverse Event|0|||
155249750|NCT03449030|560345020|FG002|Overall Study|Adverse Event|0|||
155249751|NCT03449030|560345021|FG003|Overall Study|Adverse Event|0|||
155249752|NCT03449030|560345022|FG004|Overall Study|Adverse Event|0|||
155249753|NCT03449030|560345023|FG005|Overall Study|Adverse Event|2|||
155249754|NCT03449030|560345024|FG006|Overall Study|Adverse Event|0|||
155249755|NCT03449030|560345025|FG007|Overall Study|Adverse Event|0|||
155249756|NCT03449030|560345026|FG008|Overall Study|Adverse Event|0|||
155249757|NCT03449030|560345027|FG009|Overall Study|Adverse Event|0|||
155249758|NCT03449030|560345018|FG000|Overall Study|Death|0|||
155249759|NCT03449030|560345019|FG001|Overall Study|Death|0|||
155249760|NCT03449030|560345020|FG002|Overall Study|Death|0|||
155249761|NCT03449030|560345021|FG003|Overall Study|Death|0|||
155249762|NCT03449030|560345022|FG004|Overall Study|Death|1|||
155249763|NCT03449030|560345023|FG005|Overall Study|Death|0|||
155249764|NCT03449030|560345024|FG006|Overall Study|Death|0|||
155249765|NCT03449030|560345025|FG007|Overall Study|Death|0|||
155249766|NCT03449030|560345026|FG008|Overall Study|Death|0|||
155249767|NCT03449030|560345027|FG009|Overall Study|Death|0|||
155249768|NCT00965523|560345028|FG000|Study 221|Progressive Disease|4|||
155249769|NCT00965523|560345028|FG000|Study 221|Physician Decision|3|||
155249770|NCT00965523|560345028|FG000|Study 224|Progressive Disease|5|||
155249771|NCT00965523|560345028|FG000|Study 224|Physician Decision|1|||
155249772|NCT02415400|560345029|FG000|Overall Study|Adverse Event|0|||
155249773|NCT02415400|560345030|FG001|Overall Study|Adverse Event|1|||
155249774|NCT02415400|560345031|FG002|Overall Study|Adverse Event|1|||
155249775|NCT02415400|560345032|FG003|Overall Study|Adverse Event|2|||
155249776|NCT02415400|560345029|FG000|Overall Study|Participant request to stop therapy|4|||
155249777|NCT02415400|560345030|FG001|Overall Study|Participant request to stop therapy|3|||
155249778|NCT02415400|560345031|FG002|Overall Study|Participant request to stop therapy|8|||
155249779|NCT02415400|560345032|FG003|Overall Study|Participant request to stop therapy|6|||
155249780|NCT02415400|560345029|FG000|Overall Study|Participant withdrew consent|14|||
155249781|NCT02415400|560345030|FG001|Overall Study|Participant withdrew consent|12|||
155249782|NCT02415400|560345031|FG002|Overall Study|Participant withdrew consent|30|||
155249783|NCT02415400|560345032|FG003|Overall Study|Participant withdrew consent|21|||
155249784|NCT02415400|560345029|FG000|Overall Study|Death|39|||
155249785|NCT02415400|560345030|FG001|Overall Study|Death|41|||
155249786|NCT02415400|560345031|FG002|Overall Study|Death|35|||
155249787|NCT02415400|560345032|FG003|Overall Study|Death|42|||
155249788|NCT02415400|560345029|FG000|Overall Study|Lost to Follow-up|3|||
155249789|NCT02415400|560345030|FG001|Overall Study|Lost to Follow-up|3|||
155249790|NCT02415400|560345031|FG002|Overall Study|Lost to Follow-up|2|||
155249791|NCT02415400|560345032|FG003|Overall Study|Lost to Follow-up|5|||
155249792|NCT02415400|560345029|FG000|Overall Study|Poor/Non-Compliance|0|||
155249793|NCT02415400|560345030|FG001|Overall Study|Poor/Non-Compliance|1|||
155249794|NCT02415400|560345031|FG002|Overall Study|Poor/Non-Compliance|3|||
155249795|NCT02415400|560345032|FG003|Overall Study|Poor/Non-Compliance|4|||
155249796|NCT02415400|560345029|FG000|Overall Study|Participant no longer meets criteria|2|||
155249797|NCT02415400|560345030|FG001|Overall Study|Participant no longer meets criteria|0|||
155249798|NCT02415400|560345031|FG002|Overall Study|Participant no longer meets criteria|0|||
155249799|NCT02415400|560345032|FG003|Overall Study|Participant no longer meets criteria|1|||
155249800|NCT02415400|560345029|FG000|Overall Study|Participant doesn't answer phone|1|||
155249801|NCT02415400|560345030|FG001|Overall Study|Participant doesn't answer phone|0|||
155249802|NCT02415400|560345031|FG002|Overall Study|Participant doesn't answer phone|0|||
155249803|NCT02415400|560345032|FG003|Overall Study|Participant doesn't answer phone|0|||
155249804|NCT02415400|560345029|FG000|Overall Study|Participant wanted home visits|1|||
155249805|NCT02415400|560345030|FG001|Overall Study|Participant wanted home visits|0|||
155249806|NCT02415400|560345031|FG002|Overall Study|Participant wanted home visits|0|||
155249807|NCT02415400|560345032|FG003|Overall Study|Participant wanted home visits|0|||
155249808|NCT02415400|560345029|FG000|Overall Study|Randomized in error|2|||
155249809|NCT02415400|560345030|FG001|Overall Study|Randomized in error|0|||
155249810|NCT02415400|560345031|FG002|Overall Study|Randomized in error|0|||
155249811|NCT02415400|560345032|FG003|Overall Study|Randomized in error|0|||
155249812|NCT02415400|560345029|FG000|Overall Study|No study drug on site|0|||
155249813|NCT02415400|560345030|FG001|Overall Study|No study drug on site|1|||
155249814|NCT02415400|560345031|FG002|Overall Study|No study drug on site|0|||
155249815|NCT02415400|560345032|FG003|Overall Study|No study drug on site|0|||
155249816|NCT02415400|560345029|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
155249817|NCT02415400|560345030|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
155249818|NCT02415400|560345031|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
155249819|NCT02415400|560345032|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
155249820|NCT02415400|560345029|FG000|Overall Study|Coagulation values cannot be set|0|||
155249821|NCT02415400|560345030|FG001|Overall Study|Coagulation values cannot be set|0|||
155249822|NCT02415400|560345031|FG002|Overall Study|Coagulation values cannot be set|1|||
155249823|NCT02415400|560345032|FG003|Overall Study|Coagulation values cannot be set|0|||
155249824|NCT02415400|560345029|FG000|Overall Study|State regulations prevent participation|0|||
155249825|NCT02415400|560345030|FG001|Overall Study|State regulations prevent participation|0|||
155249826|NCT02415400|560345031|FG002|Overall Study|State regulations prevent participation|1|||
155249827|NCT02415400|560345032|FG003|Overall Study|State regulations prevent participation|0|||
155249828|NCT02415400|560345029|FG000|Overall Study|Poor treatment monitoring|0|||
155249829|NCT02415400|560345030|FG001|Overall Study|Poor treatment monitoring|0|||
155249830|NCT02415400|560345031|FG002|Overall Study|Poor treatment monitoring|1|||
155249831|NCT02415400|560345032|FG003|Overall Study|Poor treatment monitoring|0|||
155249832|NCT02415400|560345029|FG000|Overall Study|Participant in jail|0|||
155249833|NCT02415400|560345030|FG001|Overall Study|Participant in jail|0|||
155249834|NCT02415400|560345031|FG002|Overall Study|Participant in jail|1|||
155249835|NCT02415400|560345032|FG003|Overall Study|Participant in jail|0|||
155249836|NCT02415400|560345029|FG000|Overall Study|Investigator decision|0|||
155249837|NCT02415400|560345030|FG001|Overall Study|Investigator decision|0|||
155249838|NCT02415400|560345031|FG002|Overall Study|Investigator decision|1|||
155249839|NCT02415400|560345032|FG003|Overall Study|Investigator decision|1|||
155249840|NCT02415400|560345029|FG000|Overall Study|Site closure; participant won't transfer|0|||
155249841|NCT02415400|560345030|FG001|Overall Study|Site closure; participant won't transfer|0|||
155249842|NCT02415400|560345031|FG002|Overall Study|Site closure; participant won't transfer|0|||
155249843|NCT02415400|560345032|FG003|Overall Study|Site closure; participant won't transfer|1|||
155249844|NCT01392560|560345040|FG000|Overall Study|Adverse Event|2|||
155249845|NCT01392560|560345040|FG000|Overall Study|not entered|8|||
155249846|NCT01392560|560345040|FG000|Overall Study|discontinued during placebo run-in|2|||
155249847|NCT02081846|560345041|FG000|Overall Study|Withdrawal by Subject|1|||
155249848|NCT02081846|560345042|FG001|Overall Study|Withdrawal by Subject|0|||
155249849|NCT02081846|560345041|FG000|Overall Study|invalid consent|1|||
155249850|NCT02081846|560345042|FG001|Overall Study|invalid consent|0|||
155249851|NCT01939028|560345043|FG000|Overall Study|Withdrawal by Subject|5|||
155249852|NCT01939028|560345043|FG000|Overall Study|Physician Decision|7|||
155249853|NCT00295750|560345047|FG000|Overall Study|Adverse Event|19|||
155249854|NCT00295750|560345048|FG001|Overall Study|Adverse Event|15|||
155249855|NCT00295750|560345049|FG002|Overall Study|Adverse Event|12|||
155249856|NCT00295750|560345047|FG000|Overall Study|Lack of Efficacy|1|||
155249857|NCT00295750|560345048|FG001|Overall Study|Lack of Efficacy|1|||
155249858|NCT00295750|560345049|FG002|Overall Study|Lack of Efficacy|0|||
155249859|NCT00295750|560345047|FG000|Overall Study|Lost to Follow-up|1|||
155249860|NCT00295750|560345048|FG001|Overall Study|Lost to Follow-up|4|||
155249861|NCT00295750|560345049|FG002|Overall Study|Lost to Follow-up|1|||
155249862|NCT00295750|560345047|FG000|Overall Study|Taking prohibited therapy|2|||
155249863|NCT00295750|560345048|FG001|Overall Study|Taking prohibited therapy|3|||
155249864|NCT00295750|560345049|FG002|Overall Study|Taking prohibited therapy|2|||
155249865|NCT00295750|560345047|FG000|Overall Study|Administrative errors|2|||
155249866|NCT00295750|560345048|FG001|Overall Study|Administrative errors|4|||
155249867|NCT00295750|560345049|FG002|Overall Study|Administrative errors|5|||
155249868|NCT00295750|560345047|FG000|Overall Study|Trial drug errors|1|||
155249869|NCT00295750|560345048|FG001|Overall Study|Trial drug errors|1|||
155249870|NCT00295750|560345049|FG002|Overall Study|Trial drug errors|0|||
155249871|NCT00295750|560345047|FG000|Overall Study|Disease progression|2|||
155249872|NCT00295750|560345048|FG001|Overall Study|Disease progression|1|||
155249873|NCT00295750|560345049|FG002|Overall Study|Disease progression|0|||
155249874|NCT00295750|560345047|FG000|Overall Study|Personal reasons|0|||
155249875|NCT00295750|560345048|FG001|Overall Study|Personal reasons|1|||
155249876|NCT00295750|560345049|FG002|Overall Study|Personal reasons|0|||
155249877|NCT00295750|560345047|FG000|Overall Study|Randomized but never received trial drug|4|||
155249878|NCT00295750|560345048|FG001|Overall Study|Randomized but never received trial drug|3|||
155249879|NCT00295750|560345049|FG002|Overall Study|Randomized but never received trial drug|3|||
155249880|NCT00295750|560345047|FG000|Overall Study|Withdrawal by Subject|9|||
155249881|NCT00295750|560345048|FG001|Overall Study|Withdrawal by Subject|4|||
155249882|NCT00295750|560345049|FG002|Overall Study|Withdrawal by Subject|7|||
155249883|NCT00295750|560345047|FG000|Overall Study|Protocol Violation|2|||
155249884|NCT00295750|560345048|FG001|Overall Study|Protocol Violation|4|||
155249885|NCT00295750|560345049|FG002|Overall Study|Protocol Violation|2|||
155249886|NCT00322348|560345050|FG000|Overall Study|Adverse Event|0|||
155249887|NCT00322348|560345051|FG001|Overall Study|Adverse Event|1|||
155249888|NCT00322348|560345050|FG000|Overall Study|Withdrawal by Subject|1|||
155249889|NCT00322348|560345051|FG001|Overall Study|Withdrawal by Subject|4|||
155249890|NCT00322348|560345050|FG000|Overall Study|Lost to Follow-up|1|||
155249891|NCT00322348|560345051|FG001|Overall Study|Lost to Follow-up|0|||
155249892|NCT00322348|560345050|FG000|Overall Study|Death|0|||
155249893|NCT00322348|560345051|FG001|Overall Study|Death|2|||
155249894|NCT00322348|560345050|FG000|Overall Study|Disease Progression|30|||
155249895|NCT00322348|560345051|FG001|Overall Study|Disease Progression|25|||
155249896|NCT00322348|560345050|FG000|Overall Study|Reasons not specified|5|||
155249897|NCT00322348|560345051|FG001|Overall Study|Reasons not specified|1|||
155249898|NCT01650259|560345052|FG000|Overall Study|Improvement|105|||
155249899|NCT01650259|560345053|FG001|Overall Study|Improvement|0|||
155249900|NCT01650259|560345052|FG000|Overall Study|Adverse Event|127|||
155249901|NCT01650259|560345053|FG001|Overall Study|Adverse Event|0|||
155249902|NCT01650259|560345052|FG000|Overall Study|Lack of Efficacy|143|||
155249903|NCT01650259|560345053|FG001|Overall Study|Lack of Efficacy|0|||
155249904|NCT01650259|560345052|FG000|Overall Study|Lost to Follow-up|435|||
155249905|NCT01650259|560345053|FG001|Overall Study|Lost to Follow-up|0|||
155249906|NCT01650259|560345052|FG000|Overall Study|Patients had no visit after entry|70|||
155249907|NCT01650259|560345053|FG001|Overall Study|Patients had no visit after entry|0|||
155249908|NCT01650259|560345052|FG000|Overall Study|CRF not collected|98|||
155249909|NCT01650259|560345053|FG001|Overall Study|CRF not collected|82|||
155249910|NCT01650259|560345052|FG000|Overall Study|Not treated|1|||
155249911|NCT01650259|560345053|FG001|Overall Study|Not treated|7|||
155249912|NCT01650259|560345052|FG000|Overall Study|Other than listed|64|||
155249913|NCT01650259|560345053|FG001|Overall Study|Other than listed|146|||
155249914|NCT00989287|560345065|FG000|Overall Study|Adverse Event|1|||
155249915|NCT00989287|560345066|FG001|Overall Study|Adverse Event|0|||
155249916|NCT00989287|560345065|FG000|Overall Study|Lost to Follow-up|0|||
155249917|NCT00989287|560345066|FG001|Overall Study|Lost to Follow-up|1|||
155249918|NCT00695669|560345067|FG000|Overall Study|Adverse Event|0|||
155249919|NCT00695669|560345068|FG001|Overall Study|Adverse Event|0|||
155249920|NCT00695669|560345069|FG002|Overall Study|Adverse Event|2|||
155249921|NCT00695669|560345070|FG003|Overall Study|Adverse Event|0|||
155249922|NCT00695669|560345067|FG000|Overall Study|Lost to Follow-up|4|||
155249923|NCT00695669|560345068|FG001|Overall Study|Lost to Follow-up|4|||
155249924|NCT00695669|560345069|FG002|Overall Study|Lost to Follow-up|1|||
155249925|NCT00695669|560345070|FG003|Overall Study|Lost to Follow-up|4|||
155249926|NCT01808313|560345089|FG000|Overall Study|Adverse Event|5|||
155249927|NCT01808313|560345089|FG000|Overall Study|Protocol Violation|2|||
155249928|NCT01808313|560345089|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
155249929|NCT01808313|560345089|FG000|Overall Study|Lost to Follow-up|1|||
155249930|NCT01808313|560345089|FG000|Overall Study|Physician Decision|1|||
155249931|NCT04656847|560345092|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
155249932|NCT03301051|560345093|FG000|Overall Study|Adverse Event|0|||
155249933|NCT03301051|560345094|FG001|Overall Study|Adverse Event|4|||
155249934|NCT03301051|560345093|FG000|Overall Study|Withdrawal by Subject|59|||
155249935|NCT03301051|560345094|FG001|Overall Study|Withdrawal by Subject|65|||
155249936|NCT03301051|560345093|FG000|Overall Study|Lost to Follow-up|263|||
155249937|NCT03301051|560345094|FG001|Overall Study|Lost to Follow-up|282|||
155249938|NCT03301051|560345093|FG000|Overall Study|Protocol Violation|1|||
155249939|NCT03301051|560345094|FG001|Overall Study|Protocol Violation|3|||
155249940|NCT03301051|560345093|FG000|Overall Study|Physician Decision|1|||
155249941|NCT03301051|560345094|FG001|Overall Study|Physician Decision|3|||
155249942|NCT03301051|560345093|FG000|Overall Study|Death|1|||
155249943|NCT03301051|560345094|FG001|Overall Study|Death|1|||
155249944|NCT03301051|560345093|FG000|Overall Study|Miscellaneous|8|||
155249945|NCT03301051|560345094|FG001|Overall Study|Miscellaneous|4|||
155249946|NCT03301051|560345093|FG000|Overall Study|Randomized, not vaccinated|13|||
155249947|NCT03301051|560345094|FG001|Overall Study|Randomized, not vaccinated|10|||
155249948|NCT00047879|560345095|FG000|Overall Study|Progressive disease|4|||
155249949|NCT00047879|560345096|FG001|Overall Study|Progressive disease|3|||
155249950|NCT03738150|560345111|FG000|Base Study|Withdrawal by Subject|1|||
155249951|NCT03738150|560345111|FG000|Extension Study|Withdrawal by Subject|1|||
155249952|NCT01962974|560345114|FG000|Overall Study|Study termination|7|||
155249953|NCT04598152|560345116|FG000|Overall Study|Lost to Follow-up|0|||
155249954|NCT04598152|560345117|FG001|Overall Study|Lost to Follow-up|1|||
155249955|NCT01965834|560345122|FG000|Overall Study|Lack of Efficacy|4|||
155249956|NCT03674177|560345125|FG000|Overall Study|Lost to Follow-up|2|||
155249957|NCT03674177|560345126|FG001|Overall Study|Lost to Follow-up|1|||
155249958|NCT03674177|560345127|FG002|Overall Study|Lost to Follow-up|0|||
155249959|NCT03674177|560345128|FG003|Overall Study|Lost to Follow-up|2|||
155249960|NCT03387852|560345129|FG000|Overall Study|Adverse event (AE)|3|||
155249961|NCT03387852|560345130|FG001|Overall Study|Adverse event (AE)|0|||
155249962|NCT03387852|560345131|FG002|Overall Study|Adverse event (AE)|2|||
155249963|NCT03387852|560345132|FG003|Overall Study|Adverse event (AE)|0|||
155249964|NCT03387852|560345129|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
155249965|NCT03387852|560345130|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
155249966|NCT03387852|560345131|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
155249967|NCT03387852|560345132|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
155249968|NCT03387852|560345129|FG000|Overall Study|Withdrawal by participant|1|||
155249969|NCT03387852|560345130|FG001|Overall Study|Withdrawal by participant|1|||
155249970|NCT03387852|560345131|FG002|Overall Study|Withdrawal by participant|3|||
155249971|NCT03387852|560345132|FG003|Overall Study|Withdrawal by participant|2|||
155249972|NCT03387852|560345129|FG000|Overall Study|Other- Unspecified|1|||
155249973|NCT03387852|560345130|FG001|Overall Study|Other- Unspecified|1|||
155249974|NCT03387852|560345131|FG002|Overall Study|Other- Unspecified|2|||
155249975|NCT03387852|560345132|FG003|Overall Study|Other- Unspecified|1|||
155249976|NCT03387852|560345129|FG000|Overall Study|Poor compliance to protocol|0|||
155249977|NCT03387852|560345130|FG001|Overall Study|Poor compliance to protocol|0|||
155249978|NCT03387852|560345131|FG002|Overall Study|Poor compliance to protocol|0|||
155249979|NCT03387852|560345132|FG003|Overall Study|Poor compliance to protocol|1|||
155249980|NCT03387852|560345129|FG000|Overall Study|Randomized and not treated|0|||
155249981|NCT03387852|560345130|FG001|Overall Study|Randomized and not treated|0|||
155249982|NCT03387852|560345131|FG002|Overall Study|Randomized and not treated|0|||
155249983|NCT03387852|560345132|FG003|Overall Study|Randomized and not treated|1|||
155249984|NCT02493127|560345133|FG000|Overall Study|Lost to Follow-up|1|||
155249985|NCT02493127|560345134|FG001|Overall Study|Lost to Follow-up|1|||
155249986|NCT02010060|560345137|FG000|Overall Study|Lost to Follow-up|1|||
155249987|NCT02010060|560345138|FG001|Overall Study|Lost to Follow-up|2|||
155249988|NCT02010060|560345139|FG002|Overall Study|Lost to Follow-up|2|||
155249989|NCT02010060|560345137|FG000|Overall Study|Injury|0|||
155249990|NCT02010060|560345138|FG001|Overall Study|Injury|1|||
155249991|NCT02010060|560345139|FG002|Overall Study|Injury|0|||
155249992|NCT04414696|560345140|FG000|3-month Follow up|Withdrawal by Subject|1|||
155249993|NCT04414696|560345141|FG001|3-month Follow up|Withdrawal by Subject|0|||
155249994|NCT04414696|560345140|FG000|3-month Follow up|Lost to Follow-up|22|||
155249995|NCT04414696|560345141|FG001|3-month Follow up|Lost to Follow-up|23|||
155249996|NCT04414696|560345140|FG000|6-month Follow up|Withdrawal by Subject|1|||
155249997|NCT04414696|560345141|FG001|6-month Follow up|Withdrawal by Subject|2|||
155249998|NCT04414696|560345140|FG000|6-month Follow up|Lost to Follow-up|5|||
155249999|NCT04414696|560345141|FG001|6-month Follow up|Lost to Follow-up|2|||
155250000|NCT02979639|560347332|FG000|Overall Study|Withdrawal based on medical judgement|1|||
155250001|NCT02979639|560347332|FG000|Overall Study|Lost to Follow-up|8|||
155250002|NCT02979639|560347332|FG000|Overall Study|Withdrawal by Subject|3|||
155250003|NCT02979639|560347332|FG000|Overall Study|Adverse Event|2|||
155250004|NCT01877408|560347336|FG000|Overall Study|Lost to Follow-up|0|||
155250005|NCT01877408|560347337|FG001|Overall Study|Lost to Follow-up|2|||
155250006|NCT02621931|560347338|FG000|Overall Study|Death|0|||
155250007|NCT02621931|560347339|FG001|Overall Study|Death|1|||
155250008|NCT02621931|560347340|FG002|Overall Study|Death|0|||
155250009|NCT02621931|560347338|FG000|Overall Study|Adverse Event|8|||
155250010|NCT02621931|560347339|FG001|Overall Study|Adverse Event|5|||
155250011|NCT02621931|560347340|FG002|Overall Study|Adverse Event|7|||
155250012|NCT02621931|560347338|FG000|Overall Study|Withdrawal by Subject|12|||
155250013|NCT02621931|560347339|FG001|Overall Study|Withdrawal by Subject|10|||
155250014|NCT02621931|560347340|FG002|Overall Study|Withdrawal by Subject|11|||
155250015|NCT02621931|560347338|FG000|Overall Study|Protocol Violation|2|||
155250016|NCT02621931|560347339|FG001|Overall Study|Protocol Violation|2|||
155250017|NCT02621931|560347340|FG002|Overall Study|Protocol Violation|2|||
155250018|NCT02621931|560347338|FG000|Overall Study|Pregnancy|2|||
155250019|NCT02621931|560347339|FG001|Overall Study|Pregnancy|0|||
155250020|NCT02621931|560347340|FG002|Overall Study|Pregnancy|0|||
155250021|NCT02621931|560347338|FG000|Overall Study|Noncompliance to study procedures|0|||
155250022|NCT02621931|560347339|FG001|Overall Study|Noncompliance to study procedures|1|||
155250023|NCT02621931|560347340|FG002|Overall Study|Noncompliance to study procedures|2|||
155250024|NCT02621931|560347338|FG000|Overall Study|Lost to Follow-up|8|||
155250025|NCT02621931|560347339|FG001|Overall Study|Lost to Follow-up|7|||
155250026|NCT02621931|560347340|FG002|Overall Study|Lost to Follow-up|10|||
155250027|NCT02621931|560347338|FG000|Overall Study|Lack of Efficacy|0|||
155250028|NCT02621931|560347339|FG001|Overall Study|Lack of Efficacy|0|||
155250029|NCT02621931|560347340|FG002|Overall Study|Lack of Efficacy|1|||
155250030|NCT02621931|560347338|FG000|Overall Study|Other|1|||
155250031|NCT02621931|560347339|FG001|Overall Study|Other|1|||
155250032|NCT02621931|560347340|FG002|Overall Study|Other|3|||
155250033|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250034|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250035|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250036|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
155250037|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250038|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
155250039|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
155250040|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
155250041|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
155250042|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
155250043|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
155250044|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
155250045|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250046|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250047|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250048|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
155250049|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250050|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
155250051|NCT01292603|560347341|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250052|NCT01292603|560347342|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250053|NCT01292603|560347343|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250054|NCT01292603|560347344|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
155250055|NCT01292603|560347345|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250056|NCT01292603|560347346|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
155250057|NCT01292603|560347341|FG000|Part 1: Regular Follow-Up Period|Death|3|||
155250058|NCT01292603|560347342|FG001|Part 1: Regular Follow-Up Period|Death|1|||
155250059|NCT01292603|560347343|FG002|Part 1: Regular Follow-Up Period|Death|3|||
155250060|NCT01292603|560347344|FG003|Part 1: Regular Follow-Up Period|Death|1|||
155250061|NCT01292603|560347345|FG004|Part 1: Regular Follow-Up Period|Death|0|||
155250062|NCT01292603|560347346|FG005|Part 1: Regular Follow-Up Period|Death|0|||
155250063|NCT01292603|560347341|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
155250064|NCT01292603|560347342|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
155250065|NCT01292603|560347343|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
155250066|NCT01292603|560347344|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
155250067|NCT01292603|560347345|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
155250068|NCT01292603|560347346|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
155250069|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Death|0|||
155250070|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Death|0|||
155250071|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Death|0|||
155250072|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Death|0|||
155250073|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Death|1|||
155250074|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Death|0|||
155250075|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250076|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250077|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250078|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250079|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
155250080|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
155250081|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250082|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250083|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250084|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
155250085|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
155250086|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
155250087|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250088|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250089|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250090|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
155250091|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
155250092|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
155250093|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250094|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250095|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250096|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
155250097|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
155250098|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
155250099|NCT01292603|560347341|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250100|NCT01292603|560347342|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250101|NCT01292603|560347343|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250102|NCT01292603|560347344|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250103|NCT01292603|560347345|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
155250104|NCT01292603|560347346|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
155250105|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Death|0|||
155250106|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Death|0|||
155250107|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Death|0|||
155250108|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Death|0|||
155250109|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Death|6|||
155250110|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Death|3|||
155250111|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
155250112|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
155250113|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
155250114|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
155250115|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
155250116|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
155250117|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
155250118|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
155250119|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
155250120|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
155250121|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
155250122|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
155250123|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250124|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250125|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250126|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250127|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
155250128|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
155250129|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250130|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250131|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250132|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250133|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
155250134|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
155250135|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
155250136|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
155250137|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
155250138|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
155250139|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
155250140|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
155250141|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250142|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250143|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250144|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
155250145|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
155250146|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
155250147|NCT01292603|560347341|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
155250148|NCT01292603|560347342|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
155250149|NCT01292603|560347343|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
155250150|NCT01292603|560347344|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
155250151|NCT01292603|560347345|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
155250152|NCT01292603|560347346|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
155250153|NCT01292603|560347341|FG000|Overall Survival Status|Death|3|||
155250154|NCT01292603|560347342|FG001|Overall Survival Status|Death|1|||
155250155|NCT01292603|560347343|FG002|Overall Survival Status|Death|3|||
155250156|NCT01292603|560347344|FG003|Overall Survival Status|Death|1|||
155250157|NCT01292603|560347345|FG004|Overall Survival Status|Death|16|||
155250158|NCT01292603|560347346|FG005|Overall Survival Status|Death|10|||
155250159|NCT03870763|560347349|FG000|Overall Study|Study terminated by sponsor|0|||
155250160|NCT03870763|560347350|FG001|Overall Study|Study terminated by sponsor|2|||
155250161|NCT03870763|560347351|FG002|Overall Study|Study terminated by sponsor|0|||
155250162|NCT03870763|560347349|FG000|Overall Study|Withdrawal by Subject|0|||
155250163|NCT03870763|560347350|FG001|Overall Study|Withdrawal by Subject|1|||
155250164|NCT03870763|560347351|FG002|Overall Study|Withdrawal by Subject|0|||
155250165|NCT03870763|560347349|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
155250166|NCT03870763|560347350|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
155250167|NCT03870763|560347351|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
155250168|NCT02985866|560347352|FG000|Overall Study|Poor CGM data|1|||
155250169|NCT02985866|560347353|FG001|Overall Study|Poor CGM data|1|||
155250170|NCT01949311|560347354|FG000|Overall Study|Lost to Follow-up|73|||
155250171|NCT01949311|560347354|FG000|Overall Study|Terminated by Sponsor|708|||
155250172|NCT01949311|560347354|FG000|Overall Study|Withdrawal by Subject|375|||
155250173|NCT01949311|560347354|FG000|Overall Study|Lack of Efficacy|50|||
155250174|NCT01949311|560347354|FG000|Overall Study|Protocol Deviation|34|||
155250175|NCT01949311|560347354|FG000|Overall Study|Pregnancy|20|||
155250176|NCT01949311|560347354|FG000|Overall Study|Physician Decision|9|||
155250177|NCT01949311|560347354|FG000|Overall Study|Other|4|||
155250178|NCT01949311|560347354|FG000|Overall Study|Adverse Event|107|||
155250179|NCT04279314|560347357|FG000|Overall Study|Adverse Event|55|||
155250180|NCT04279314|560347357|FG000|Overall Study|Withdrawal by Subject|5|||
155250181|NCT04279314|560347357|FG000|Overall Study|Lack of Efficacy|5|||
155250182|NCT04279314|560347357|FG000|Overall Study|Protocol Violation|3|||
155250183|NCT04279314|560347357|FG000|Overall Study|Other (not COVID-19 related)|2|||
155250184|NCT02120027|560347358|FG000|Overall Study|Adverse Event|4|||
155250185|NCT02120027|560347359|FG001|Overall Study|Adverse Event|5|||
155250186|NCT02120027|560347358|FG000|Overall Study|Lack of Efficacy|3|||
155250187|NCT02120027|560347359|FG001|Overall Study|Lack of Efficacy|5|||
155250188|NCT02120027|560347358|FG000|Overall Study|Lost to Follow-up|5|||
155250189|NCT02120027|560347359|FG001|Overall Study|Lost to Follow-up|13|||
155250190|NCT02120027|560347358|FG000|Overall Study|Other|4|||
155250191|NCT02120027|560347359|FG001|Overall Study|Other|0|||
155250192|NCT02120027|560347358|FG000|Overall Study|Physician Decision|4|||
155250193|NCT02120027|560347359|FG001|Overall Study|Physician Decision|3|||
155250194|NCT02120027|560347358|FG000|Overall Study|Protocol Violation|18|||
155250195|NCT02120027|560347359|FG001|Overall Study|Protocol Violation|21|||
155250196|NCT02120027|560347358|FG000|Overall Study|Study terminated by Sponsor|45|||
155250197|NCT02120027|560347359|FG001|Overall Study|Study terminated by Sponsor|47|||
155250198|NCT02120027|560347358|FG000|Overall Study|Withdrawal by Subject|33|||
155250199|NCT02120027|560347359|FG001|Overall Study|Withdrawal by Subject|25|||
155250200|NCT01471054|560347366|FG000|Overall Study|Study terminated prematurely|4|||
155250201|NCT01471054|560347367|FG001|Overall Study|Study terminated prematurely|0|||
155250202|NCT03166618|560347368|FG000|Overall Study|Study was Terminated|0|||
155250203|NCT03166618|560347369|FG001|Overall Study|Study was Terminated|1|||
155250204|NCT03137303|560347371|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
155250205|NCT03137303|560347372|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
155250206|NCT03137303|560347371|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
155250207|NCT03137303|560347372|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
155250208|NCT03137303|560347371|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
155250209|NCT03137303|560347372|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
155250210|NCT03137303|560347371|FG000|T3: 9-month Follow-up|Death|1|||
155250211|NCT03137303|560347372|FG001|T3: 9-month Follow-up|Death|0|||
155250212|NCT03137303|560347371|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
155250213|NCT03137303|560347372|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
155250214|NCT03137303|560347371|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
155250215|NCT03137303|560347372|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
155250216|NCT03137303|560347371|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
155250217|NCT03137303|560347372|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
155250218|NCT03561090|560347373|FG000|Overall Study|Adverse Event|11|||
155250219|NCT03561090|560347374|FG001|Overall Study|Adverse Event|7|||
155250220|NCT03561090|560347373|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155250221|NCT03561090|560347374|FG001|Overall Study|Non-Compliance With Study Drug|0|||
155250222|NCT03561090|560347373|FG000|Overall Study|Protocol Violation|2|||
155250223|NCT03561090|560347374|FG001|Overall Study|Protocol Violation|2|||
155250224|NCT03561090|560347373|FG000|Overall Study|Withdrawal by Subject|7|||
155250225|NCT03561090|560347374|FG001|Overall Study|Withdrawal by Subject|7|||
155250226|NCT03561090|560347373|FG000|Overall Study|Lost to Follow-up|7|||
155250227|NCT03561090|560347374|FG001|Overall Study|Lost to Follow-up|2|||
155250228|NCT03561090|560347373|FG000|Overall Study|Study Terminated by Sponsor|10|||
155250229|NCT03561090|560347374|FG001|Overall Study|Study Terminated by Sponsor|15|||
155250230|NCT03561090|560347373|FG000|Overall Study|Randomized by Mistake|1|||
155250231|NCT03561090|560347374|FG001|Overall Study|Randomized by Mistake|1|||
155250232|NCT03561090|560347373|FG000|Overall Study|Other Not Specified|0|||
155250233|NCT03561090|560347374|FG001|Overall Study|Other Not Specified|2|||
155250234|NCT02566031|560347377|FG000|Overall Study|Patient/guardian decision|14|||
155250235|NCT02566031|560347378|FG001|Overall Study|Patient/guardian decision|7|||
155250236|NCT02566031|560347377|FG000|Overall Study|Protocol deviation|2|||
155250237|NCT02566031|560347378|FG001|Overall Study|Protocol deviation|3|||
155250238|NCT02566031|560347377|FG000|Overall Study|Adverse Event|3|||
155250239|NCT02566031|560347378|FG001|Overall Study|Adverse Event|1|||
155250240|NCT02566031|560347377|FG000|Overall Study|Lost to Follow-up|1|||
155250241|NCT02566031|560347378|FG001|Overall Study|Lost to Follow-up|1|||
155250242|NCT03031938|560347379|FG000|Overall Study|Death|1|||
155250243|NCT03031938|560347380|FG001|Overall Study|Death|0|||
155250244|NCT02479412|560347385|FG000|Overall Study|Adverse Event|0|||
155250245|NCT02479412|560347386|FG001|Overall Study|Adverse Event|0|||
155250246|NCT02479412|560347387|FG002|Overall Study|Adverse Event|1|||
155250247|NCT02479412|560347388|FG003|Overall Study|Adverse Event|0|||
155250248|NCT02479412|560347389|FG004|Overall Study|Adverse Event|0|||
155250249|NCT02479412|560347390|FG005|Overall Study|Adverse Event|0|||
155250250|NCT02479412|560347391|FG006|Overall Study|Adverse Event|0|||
155250251|NCT02479412|560347392|FG007|Overall Study|Adverse Event|0|||
155250252|NCT02479412|560347393|FG008|Overall Study|Adverse Event|0|||
155250253|NCT02479412|560347385|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155250254|NCT02479412|560347386|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155250255|NCT02479412|560347387|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155250256|NCT02479412|560347388|FG003|Overall Study|Study-specific withdrawal criteria|1|||
155250257|NCT02479412|560347389|FG004|Overall Study|Study-specific withdrawal criteria|0|||
155250258|NCT02479412|560347390|FG005|Overall Study|Study-specific withdrawal criteria|0|||
155250259|NCT02479412|560347391|FG006|Overall Study|Study-specific withdrawal criteria|0|||
155250260|NCT02479412|560347392|FG007|Overall Study|Study-specific withdrawal criteria|1|||
155250261|NCT02479412|560347393|FG008|Overall Study|Study-specific withdrawal criteria|1|||
155250262|NCT02479412|560347385|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
155250263|NCT02479412|560347386|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
155250264|NCT02479412|560347387|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
155250265|NCT02479412|560347388|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
155250266|NCT02479412|560347389|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
155250267|NCT02479412|560347390|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
155250268|NCT02479412|560347391|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
155250269|NCT02479412|560347392|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
155250270|NCT02479412|560347393|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
155250271|NCT04402866|560347398|FG000|Overall Study|Discontinued Prior to Treatment|0|||
155250272|NCT04402866|560347399|FG001|Overall Study|Discontinued Prior to Treatment|0|||
155250273|NCT04402866|560347400|FG002|Overall Study|Discontinued Prior to Treatment|0|||
155250274|NCT04402866|560347401|FG003|Overall Study|Discontinued Prior to Treatment|0|||
155250275|NCT04402866|560347402|FG004|Overall Study|Discontinued Prior to Treatment|2|||
155250276|NCT04402866|560347403|FG005|Overall Study|Discontinued Prior to Treatment|3|||
155250277|NCT04402866|560347398|FG000|Overall Study|Adverse Event|2|||
155250278|NCT04402866|560347399|FG001|Overall Study|Adverse Event|1|||
155250279|NCT04402866|560347400|FG002|Overall Study|Adverse Event|0|||
155250280|NCT04402866|560347401|FG003|Overall Study|Adverse Event|0|||
155250281|NCT04402866|560347402|FG004|Overall Study|Adverse Event|13|||
155250282|NCT04402866|560347403|FG005|Overall Study|Adverse Event|8|||
155250283|NCT04402866|560347398|FG000|Overall Study|Miscellaneous|0|||
155250284|NCT04402866|560347399|FG001|Overall Study|Miscellaneous|0|||
155250285|NCT04402866|560347400|FG002|Overall Study|Miscellaneous|1|||
155250286|NCT04402866|560347401|FG003|Overall Study|Miscellaneous|0|||
155250287|NCT04402866|560347402|FG004|Overall Study|Miscellaneous|0|||
155250288|NCT04402866|560347403|FG005|Overall Study|Miscellaneous|0|||
155250289|NCT04402866|560347398|FG000|Overall Study|Lost to Follow-up|0|||
155250290|NCT04402866|560347399|FG001|Overall Study|Lost to Follow-up|0|||
155250291|NCT04402866|560347400|FG002|Overall Study|Lost to Follow-up|0|||
155250292|NCT04402866|560347401|FG003|Overall Study|Lost to Follow-up|0|||
155250293|NCT04402866|560347402|FG004|Overall Study|Lost to Follow-up|0|||
155250294|NCT04402866|560347403|FG005|Overall Study|Lost to Follow-up|1|||
155250295|NCT04402866|560347398|FG000|Overall Study|Withdrawal by Subject|0|||
155250296|NCT04402866|560347399|FG001|Overall Study|Withdrawal by Subject|0|||
155250297|NCT04402866|560347400|FG002|Overall Study|Withdrawal by Subject|0|||
155250298|NCT04402866|560347401|FG003|Overall Study|Withdrawal by Subject|0|||
155250299|NCT04402866|560347402|FG004|Overall Study|Withdrawal by Subject|0|||
155250300|NCT04402866|560347403|FG005|Overall Study|Withdrawal by Subject|2|||
155250301|NCT03667053|560347404|FG000|Overall Study|Withdrawal by Subject|1|||
155250302|NCT03667053|560347405|FG001|Overall Study|Withdrawal by Subject|0|||
155250303|NCT03667053|560347406|FG002|Overall Study|Withdrawal by Subject|0|||
155250304|NCT00515502|560347408|FG000|Treatment Period 1|Adverse Event|0|||
155250305|NCT00515502|560347409|FG001|Treatment Period 1|Adverse Event|0|||
155250306|NCT00515502|560347410|FG002|Treatment Period 1|Adverse Event|0|||
155250307|NCT00515502|560347411|FG003|Treatment Period 1|Adverse Event|0|||
155250308|NCT00515502|560347412|FG004|Treatment Period 1|Adverse Event|0|||
155250309|NCT00515502|560347413|FG005|Treatment Period 1|Adverse Event|0|||
155250310|NCT00515502|560347414|FG006|Treatment Period 1|Adverse Event|1|||
155250311|NCT00515502|560347415|FG007|Treatment Period 1|Adverse Event|0|||
155250312|NCT00515502|560347416|FG008|Treatment Period 1|Adverse Event|1|||
155250313|NCT00515502|560347417|FG009|Treatment Period 1|Adverse Event|0|||
155250314|NCT00515502|560347418|FG010|Treatment Period 1|Adverse Event|0|||
155250315|NCT00515502|560347419|FG011|Treatment Period 1|Adverse Event|1|||
155250316|NCT00515502|560347408|FG000|Treatment Period 2|Adverse Event|0|||
155250317|NCT00515502|560347409|FG001|Treatment Period 2|Adverse Event|1|||
155250318|NCT00515502|560347410|FG002|Treatment Period 2|Adverse Event|0|||
155250319|NCT00515502|560347411|FG003|Treatment Period 2|Adverse Event|0|||
155250320|NCT00515502|560347412|FG004|Treatment Period 2|Adverse Event|0|||
155250321|NCT00515502|560347413|FG005|Treatment Period 2|Adverse Event|0|||
155250322|NCT00515502|560347414|FG006|Treatment Period 2|Adverse Event|0|||
155250323|NCT00515502|560347415|FG007|Treatment Period 2|Adverse Event|0|||
155250324|NCT00515502|560347416|FG008|Treatment Period 2|Adverse Event|0|||
155250325|NCT00515502|560347417|FG009|Treatment Period 2|Adverse Event|0|||
155250326|NCT00515502|560347418|FG010|Treatment Period 2|Adverse Event|0|||
155250327|NCT00515502|560347419|FG011|Treatment Period 2|Adverse Event|0|||
155250328|NCT02732938|560347420|FG000|Overall Study|Death|0|||
155250329|NCT02732938|560347421|FG001|Overall Study|Death|11|||
155250330|NCT02732938|560347422|FG002|Overall Study|Death|0|||
155250331|NCT02732938|560347420|FG000|Overall Study|Randomized but did not receive treatment|0|||
155250332|NCT02732938|560347421|FG001|Overall Study|Randomized but did not receive treatment|1|||
155250333|NCT02732938|560347422|FG002|Overall Study|Randomized but did not receive treatment|0|||
155250334|NCT02732938|560347420|FG000|Overall Study|Refused further follow-up|1|||
155250335|NCT02732938|560347421|FG001|Overall Study|Refused further follow-up|0|||
155250336|NCT02732938|560347422|FG002|Overall Study|Refused further follow-up|0|||
155250337|NCT02732938|560347420|FG000|Overall Study|Study terminated by sponsor|3|||
155250338|NCT02732938|560347421|FG001|Overall Study|Study terminated by sponsor|6|||
155250339|NCT02732938|560347422|FG002|Overall Study|Study terminated by sponsor|0|||
155250340|NCT03647501|560347423|FG000|Overall Study|Lost to Follow-up|1|||
155250341|NCT03647501|560347424|FG001|Overall Study|Lost to Follow-up|1|||
155250342|NCT03647501|560347423|FG000|Overall Study|Withdrawal by Subject|0|||
155250343|NCT03647501|560347424|FG001|Overall Study|Withdrawal by Subject|1|||
155250344|NCT01613248|560347425|FG000|Overall Study|Adverse Event|0|||
155250345|NCT01613248|560347426|FG001|Overall Study|Adverse Event|0|||
155250346|NCT01613248|560347427|FG002|Overall Study|Adverse Event|0|||
155250347|NCT01613248|560347428|FG003|Overall Study|Adverse Event|1|||
155250348|NCT01613248|560347429|FG004|Overall Study|Adverse Event|0|||
155250349|NCT01613248|560347430|FG005|Overall Study|Adverse Event|0|||
155250350|NCT01613248|560347425|FG000|Overall Study|Withdrawal by Subject|3|||
155250351|NCT01613248|560347426|FG001|Overall Study|Withdrawal by Subject|2|||
155250352|NCT01613248|560347427|FG002|Overall Study|Withdrawal by Subject|2|||
155250353|NCT01613248|560347428|FG003|Overall Study|Withdrawal by Subject|5|||
155250354|NCT01613248|560347429|FG004|Overall Study|Withdrawal by Subject|0|||
155250355|NCT01613248|560347430|FG005|Overall Study|Withdrawal by Subject|1|||
155250356|NCT01613248|560347425|FG000|Overall Study|Lost to Follow-up|5|||
155250357|NCT01613248|560347426|FG001|Overall Study|Lost to Follow-up|7|||
155250358|NCT01613248|560347427|FG002|Overall Study|Lost to Follow-up|4|||
155250359|NCT01613248|560347428|FG003|Overall Study|Lost to Follow-up|8|||
155250360|NCT01613248|560347429|FG004|Overall Study|Lost to Follow-up|4|||
155250361|NCT01613248|560347430|FG005|Overall Study|Lost to Follow-up|2|||
155250362|NCT01613248|560347425|FG000|Overall Study|Study Terminated by Sponsor|4|||
155250363|NCT01613248|560347426|FG001|Overall Study|Study Terminated by Sponsor|6|||
155250364|NCT01613248|560347427|FG002|Overall Study|Study Terminated by Sponsor|8|||
155250365|NCT01613248|560347428|FG003|Overall Study|Study Terminated by Sponsor|8|||
155250366|NCT01613248|560347429|FG004|Overall Study|Study Terminated by Sponsor|9|||
155250367|NCT01613248|560347430|FG005|Overall Study|Study Terminated by Sponsor|11|||
155250368|NCT01613248|560347425|FG000|Overall Study|Physician Decision|8|||
155250369|NCT01613248|560347426|FG001|Overall Study|Physician Decision|8|||
155250370|NCT01613248|560347427|FG002|Overall Study|Physician Decision|9|||
155250371|NCT01613248|560347428|FG003|Overall Study|Physician Decision|4|||
155250372|NCT01613248|560347429|FG004|Overall Study|Physician Decision|7|||
155250373|NCT01613248|560347430|FG005|Overall Study|Physician Decision|6|||
155250374|NCT01613248|560347425|FG000|Overall Study|Lack of Qualifying Event|9|||
155250375|NCT01613248|560347426|FG001|Overall Study|Lack of Qualifying Event|11|||
155250376|NCT01613248|560347427|FG002|Overall Study|Lack of Qualifying Event|10|||
155250377|NCT01613248|560347428|FG003|Overall Study|Lack of Qualifying Event|11|||
155250378|NCT01613248|560347429|FG004|Overall Study|Lack of Qualifying Event|15|||
155250379|NCT01613248|560347430|FG005|Overall Study|Lack of Qualifying Event|18|||
155250380|NCT01613248|560347425|FG000|Overall Study|Pregnancy|0|||
155250381|NCT01613248|560347426|FG001|Overall Study|Pregnancy|0|||
155250382|NCT01613248|560347427|FG002|Overall Study|Pregnancy|0|||
155250383|NCT01613248|560347428|FG003|Overall Study|Pregnancy|1|||
155250384|NCT01613248|560347429|FG004|Overall Study|Pregnancy|0|||
155250385|NCT01613248|560347430|FG005|Overall Study|Pregnancy|0|||
155250386|NCT04307004|560347434|FG000|Randomization 1|Withdrawal by Subject|25|||
155250387|NCT04307004|560347435|FG001|Randomization 1|Withdrawal by Subject|26|||
155250388|NCT04307004|560347436|FG002|Randomization 1|Withdrawal by Subject|0|||
155250389|NCT04307004|560347437|FG003|Randomization 1|Withdrawal by Subject|0|||
155250390|NCT04307004|560347434|FG000|Randomization 2|Withdrawal by Subject|0|||
155250391|NCT04307004|560347435|FG001|Randomization 2|Withdrawal by Subject|0|||
155250392|NCT04307004|560347436|FG002|Randomization 2|Withdrawal by Subject|28|||
155250393|NCT04307004|560347437|FG003|Randomization 2|Withdrawal by Subject|23|||
155250394|NCT05545072|560347438|FG000|Overall Study|Lost to Follow-up|1|||
155250395|NCT05545072|560347439|FG001|Overall Study|Lost to Follow-up|0|||
155250396|NCT05545072|560347438|FG000|Overall Study|Study ended prematurely due to funding|2|||
155250397|NCT05545072|560347439|FG001|Overall Study|Study ended prematurely due to funding|2|||
155250398|NCT02395042|560347440|FG000|Treatment 1 Period|Adverse Event|1|||
155250399|NCT02395042|560347441|FG001|Treatment 1 Period|Adverse Event|3|||
155250400|NCT02395042|560347442|FG002|Treatment 1 Period|Adverse Event|1|||
155250401|NCT02395042|560347440|FG000|Treatment 1 Period|Lack of Efficacy|1|||
155250402|NCT02395042|560347441|FG001|Treatment 1 Period|Lack of Efficacy|1|||
155250403|NCT02395042|560347442|FG002|Treatment 1 Period|Lack of Efficacy|0|||
155250404|NCT02395042|560347440|FG000|Treatment 1 Period|Lost to Follow-up|1|||
155250405|NCT02395042|560347441|FG001|Treatment 1 Period|Lost to Follow-up|0|||
155250406|NCT02395042|560347442|FG002|Treatment 1 Period|Lost to Follow-up|0|||
155250407|NCT02395042|560347440|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
155250408|NCT02395042|560347441|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
155250409|NCT02395042|560347442|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
155250410|NCT02395042|560347440|FG000|Treatment 2 Period|Lack of Efficacy|1|||
155250411|NCT02395042|560347441|FG001|Treatment 2 Period|Lack of Efficacy|1|||
155250412|NCT02395042|560347442|FG002|Treatment 2 Period|Lack of Efficacy|0|||
155250413|NCT02647359|560347443|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
155250414|NCT02647359|560347444|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
155250415|NCT02647359|560347443|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
155250416|NCT02647359|560347444|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
155250417|NCT02647359|560347443|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
155250418|NCT02647359|560347444|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
155250419|NCT02647359|560347443|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
155250420|NCT02647359|560347444|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
155250421|NCT02647359|560347443|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
155250422|NCT02647359|560347444|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
155250423|NCT02647359|560347443|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
155250424|NCT02647359|560347444|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
155250425|NCT04642638|560347445|FG000|Overall Study|Withdrawal by Subject|23|||
155250426|NCT04642638|560347446|FG001|Overall Study|Withdrawal by Subject|29|||
155250427|NCT04642638|560347447|FG002|Overall Study|Withdrawal by Subject|9|||
155250428|NCT04642638|560347448|FG003|Overall Study|Withdrawal by Subject|7|||
155250429|NCT04642638|560347449|FG004|Overall Study|Withdrawal by Subject|61|||
155250430|NCT04642638|560347450|FG005|Overall Study|Withdrawal by Subject|27|||
155250431|NCT04642638|560347445|FG000|Overall Study|Lost to Follow-up|17|||
155250432|NCT04642638|560347446|FG001|Overall Study|Lost to Follow-up|18|||
155250433|NCT04642638|560347447|FG002|Overall Study|Lost to Follow-up|5|||
155250434|NCT04642638|560347448|FG003|Overall Study|Lost to Follow-up|5|||
155250435|NCT04642638|560347449|FG004|Overall Study|Lost to Follow-up|6|||
155250436|NCT04642638|560347450|FG005|Overall Study|Lost to Follow-up|3|||
155250437|NCT04642638|560347445|FG000|Overall Study|Adverse Event|0|||
155250438|NCT04642638|560347446|FG001|Overall Study|Adverse Event|0|||
155250439|NCT04642638|560347447|FG002|Overall Study|Adverse Event|1|||
155250440|NCT04642638|560347448|FG003|Overall Study|Adverse Event|0|||
155250441|NCT04642638|560347449|FG004|Overall Study|Adverse Event|10|||
155250442|NCT04642638|560347450|FG005|Overall Study|Adverse Event|3|||
155250443|NCT04642638|560347445|FG000|Overall Study|Reason Not Specified|1|||
155250444|NCT04642638|560347446|FG001|Overall Study|Reason Not Specified|4|||
155250445|NCT04642638|560347447|FG002|Overall Study|Reason Not Specified|0|||
155250446|NCT04642638|560347448|FG003|Overall Study|Reason Not Specified|0|||
155250447|NCT04642638|560347449|FG004|Overall Study|Reason Not Specified|38|||
155250448|NCT04642638|560347450|FG005|Overall Study|Reason Not Specified|16|||
155250449|NCT04642638|560347445|FG000|Overall Study|Physician Decision|0|||
155250450|NCT04642638|560347446|FG001|Overall Study|Physician Decision|0|||
155250451|NCT04642638|560347447|FG002|Overall Study|Physician Decision|0|||
155250452|NCT04642638|560347448|FG003|Overall Study|Physician Decision|0|||
155250453|NCT04642638|560347449|FG004|Overall Study|Physician Decision|2|||
155250454|NCT04642638|560347450|FG005|Overall Study|Physician Decision|1|||
155250455|NCT04642638|560347445|FG000|Overall Study|Protocol Deviation|0|||
155250456|NCT04642638|560347446|FG001|Overall Study|Protocol Deviation|0|||
155250457|NCT04642638|560347447|FG002|Overall Study|Protocol Deviation|0|||
155250458|NCT04642638|560347448|FG003|Overall Study|Protocol Deviation|0|||
155250459|NCT04642638|560347449|FG004|Overall Study|Protocol Deviation|1|||
155250460|NCT04642638|560347450|FG005|Overall Study|Protocol Deviation|3|||
155250461|NCT04642638|560347445|FG000|Overall Study|Study Terminated|0|||
155250462|NCT04642638|560347446|FG001|Overall Study|Study Terminated|0|||
155250463|NCT04642638|560347447|FG002|Overall Study|Study Terminated|0|||
155250464|NCT04642638|560347448|FG003|Overall Study|Study Terminated|0|||
155250465|NCT04642638|560347449|FG004|Overall Study|Study Terminated|484|||
155250466|NCT04642638|560347450|FG005|Overall Study|Study Terminated|250|||
155250467|NCT04642638|560347445|FG000|Overall Study|Pregnancy|0|||
155250468|NCT04642638|560347446|FG001|Overall Study|Pregnancy|0|||
155250469|NCT04642638|560347447|FG002|Overall Study|Pregnancy|0|||
155250470|NCT04642638|560347448|FG003|Overall Study|Pregnancy|0|||
155250471|NCT04642638|560347449|FG004|Overall Study|Pregnancy|1|||
155250472|NCT04642638|560347450|FG005|Overall Study|Pregnancy|0|||
155250473|NCT06476366|560347451|FG000|Overall Study|Lost to Follow-up|1|||
155250474|NCT06476366|560347452|FG001|Overall Study|Lost to Follow-up|3|||
155250475|NCT06476366|560347451|FG000|Overall Study|Adverse Event|1|||
155250476|NCT06476366|560347452|FG001|Overall Study|Adverse Event|0|||
155250477|NCT04313881|560347453|FG000|Overall Study|Death|138|||
155250478|NCT04313881|560347454|FG001|Overall Study|Death|126|||
155250479|NCT04313881|560347453|FG000|Overall Study|Study terminated by sponsor|108|||
155250480|NCT04313881|560347454|FG001|Overall Study|Study terminated by sponsor|129|||
155250481|NCT04313881|560347453|FG000|Overall Study|Consent withdrawn|19|||
155250482|NCT04313881|560347454|FG001|Overall Study|Consent withdrawn|15|||
155250483|NCT04313881|560347453|FG000|Overall Study|Reason not Specified|3|||
155250484|NCT04313881|560347454|FG001|Overall Study|Reason not Specified|1|||
155250485|NCT00727272|560347455|FG000|Washout Period A|Adverse Event|0|||
155250486|NCT00727272|560347456|FG001|Washout Period A|Adverse Event|0|||
155250487|NCT00727272|560347457|FG002|Washout Period A|Adverse Event|1|||
155250488|NCT00727272|560347455|FG000|Washout Period B|Withdrawal by Subject|0|||
155250489|NCT00727272|560347456|FG001|Washout Period B|Withdrawal by Subject|0|||
155250490|NCT00727272|560347457|FG002|Washout Period B|Withdrawal by Subject|1|||
155250491|NCT00651664|560347458|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
155250492|NCT00651664|560347459|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
155250493|NCT00651664|560347460|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
155250494|NCT00651664|560347461|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
155250495|NCT00651664|560347462|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
155250496|NCT00651664|560347463|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
155250497|NCT00651664|560347464|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
155250498|NCT00651664|560347465|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
155250499|NCT00651664|560347466|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
155250500|NCT00651664|560347467|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
155250501|NCT00651664|560347458|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250502|NCT00651664|560347459|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250503|NCT00651664|560347460|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250504|NCT00651664|560347461|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250505|NCT00651664|560347462|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250506|NCT00651664|560347463|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250507|NCT00651664|560347464|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250508|NCT00651664|560347465|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250509|NCT00651664|560347466|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
155250510|NCT00651664|560347467|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
155250511|NCT00651664|560347458|FG000|Overall Study|Progressive Disease|3|||
155250512|NCT00651664|560347459|FG001|Overall Study|Progressive Disease|3|||
155250513|NCT00651664|560347460|FG002|Overall Study|Progressive Disease|3|||
155250514|NCT00651664|560347461|FG003|Overall Study|Progressive Disease|12|||
155250515|NCT00651664|560347462|FG004|Overall Study|Progressive Disease|4|||
155250516|NCT00651664|560347463|FG005|Overall Study|Progressive Disease|1|||
155250517|NCT00651664|560347464|FG006|Overall Study|Progressive Disease|3|||
155250518|NCT00651664|560347465|FG007|Overall Study|Progressive Disease|6|||
155250519|NCT00651664|560347466|FG008|Overall Study|Progressive Disease|5|||
155250520|NCT00651664|560347467|FG009|Overall Study|Progressive Disease|5|||
155250521|NCT00651664|560347458|FG000|Overall Study|Patient Declined Further Treatment|0|||
155250522|NCT00651664|560347459|FG001|Overall Study|Patient Declined Further Treatment|0|||
155250523|NCT00651664|560347460|FG002|Overall Study|Patient Declined Further Treatment|0|||
155250524|NCT00651664|560347461|FG003|Overall Study|Patient Declined Further Treatment|1|||
155250525|NCT00651664|560347462|FG004|Overall Study|Patient Declined Further Treatment|1|||
155250526|NCT00651664|560347463|FG005|Overall Study|Patient Declined Further Treatment|1|||
155250527|NCT00651664|560347464|FG006|Overall Study|Patient Declined Further Treatment|0|||
155250528|NCT00651664|560347465|FG007|Overall Study|Patient Declined Further Treatment|0|||
155250529|NCT00651664|560347466|FG008|Overall Study|Patient Declined Further Treatment|0|||
155250530|NCT00651664|560347467|FG009|Overall Study|Patient Declined Further Treatment|1|||
155250531|NCT00651664|560347458|FG000|Overall Study|Symptomatic Deterioration|0|||
155250532|NCT00651664|560347459|FG001|Overall Study|Symptomatic Deterioration|0|||
155250533|NCT00651664|560347460|FG002|Overall Study|Symptomatic Deterioration|0|||
155250534|NCT00651664|560347461|FG003|Overall Study|Symptomatic Deterioration|1|||
155250535|NCT00651664|560347462|FG004|Overall Study|Symptomatic Deterioration|0|||
155250536|NCT00651664|560347463|FG005|Overall Study|Symptomatic Deterioration|0|||
155250537|NCT00651664|560347464|FG006|Overall Study|Symptomatic Deterioration|1|||
155250538|NCT00651664|560347465|FG007|Overall Study|Symptomatic Deterioration|0|||
155250539|NCT00651664|560347466|FG008|Overall Study|Symptomatic Deterioration|1|||
155250540|NCT00651664|560347467|FG009|Overall Study|Symptomatic Deterioration|0|||
155250541|NCT00651664|560347458|FG000|Overall Study|Reason not Specified|0|||
155250542|NCT00651664|560347459|FG001|Overall Study|Reason not Specified|0|||
155250543|NCT00651664|560347460|FG002|Overall Study|Reason not Specified|0|||
155250544|NCT00651664|560347461|FG003|Overall Study|Reason not Specified|0|||
155250545|NCT00651664|560347462|FG004|Overall Study|Reason not Specified|0|||
155250546|NCT00651664|560347463|FG005|Overall Study|Reason not Specified|0|||
155250547|NCT00651664|560347464|FG006|Overall Study|Reason not Specified|1|||
155250548|NCT00651664|560347465|FG007|Overall Study|Reason not Specified|0|||
155250549|NCT00651664|560347466|FG008|Overall Study|Reason not Specified|0|||
155250550|NCT00651664|560347467|FG009|Overall Study|Reason not Specified|0|||
155250551|NCT04053764|560347468|FG000|Overall Study|Withdrawal by Subject|6|||
155250552|NCT04053764|560347469|FG001|Overall Study|Withdrawal by Subject|2|||
155250553|NCT04053764|560347468|FG000|Overall Study|Physician Decision|2|||
155250554|NCT04053764|560347469|FG001|Overall Study|Physician Decision|1|||
155250555|NCT04053764|560347468|FG000|Overall Study|Adverse Event|1|||
155250556|NCT04053764|560347469|FG001|Overall Study|Adverse Event|0|||
155250557|NCT04053764|560347468|FG000|Overall Study|Pregnancy|1|||
155250558|NCT04053764|560347469|FG001|Overall Study|Pregnancy|0|||
155250559|NCT04732286|560347470|FG000|Overall Study|Progressive Disease|2|||
155250560|NCT04732286|560347470|FG000|Overall Study|Physician Decision|1|||
155250561|NCT04732286|560347470|FG000|Overall Study|Study Terminated by Sponsor|31|||
155250562|NCT04732286|560347470|FG000|Overall Study|Withdrawal by Subject|10|||
155250563|NCT04732286|560347470|FG000|Overall Study|Non-compliance With Study Drug|1|||
155250564|NCT04732286|560347470|FG000|Overall Study|Lost to Follow-up|4|||
155250565|NCT04732286|560347470|FG000|Overall Study|Death|51|||
155250566|NCT00319098|560347474|FG000|Overall Study|Serious adverse event|3|||
155250567|NCT00319098|560347475|FG001|Overall Study|Serious adverse event|0|||
155250568|NCT00319098|560347474|FG000|Overall Study|Adverse Event|20|||
155250569|NCT00319098|560347475|FG001|Overall Study|Adverse Event|1|||
155250570|NCT00319098|560347474|FG000|Overall Study|Withdrawal by Subject|37|||
155250571|NCT00319098|560347475|FG001|Overall Study|Withdrawal by Subject|8|||
155250572|NCT00319098|560347474|FG000|Overall Study|Migrated/moved from study area|2|||
155250573|NCT00319098|560347475|FG001|Overall Study|Migrated/moved from study area|1|||
155250574|NCT00319098|560347474|FG000|Overall Study|Lost to Follow-up|37|||
155250575|NCT00319098|560347475|FG001|Overall Study|Lost to Follow-up|13|||
155250576|NCT00319098|560347474|FG000|Overall Study|Others|33|||
155250577|NCT00319098|560347475|FG001|Overall Study|Others|8|||
155250578|NCT00319098|560347474|FG000|Overall Study|Protocol Violation|3|||
155250579|NCT00319098|560347475|FG001|Overall Study|Protocol Violation|1|||
155250580|NCT00936858|560347480|FG000|Overall Study|Death|3|||
155250581|NCT00936858|560347480|FG000|Overall Study|Progression|29|||
155250582|NCT00936858|560347480|FG000|Overall Study|Withdrawal by Subject|5|||
155250583|NCT00936858|560347480|FG000|Overall Study|Adverse Event|1|||
155250584|NCT00936858|560347480|FG000|Overall Study|Physician Decision|7|||
155250585|NCT00936858|560347480|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
155250586|NCT00936858|560347480|FG000|Overall Study|Lost to Follow-up|1|||
155250587|NCT00584727|560347481|FG000|First Intervention|Discontinuation|0|||
155250588|NCT00584727|560347482|FG001|First Intervention|Discontinuation|0|||
155250589|NCT00584727|560347483|FG002|First Intervention|Discontinuation|1|||
155250590|NCT00584727|560347484|FG003|First Intervention|Discontinuation|0|||
155250591|NCT00584727|560347485|FG004|First Intervention|Discontinuation|0|||
155250592|NCT00584727|560347486|FG005|First Intervention|Discontinuation|0|||
155250593|NCT00584727|560347481|FG000|Third Intervention|Protocol Violation|0|||
155250594|NCT00584727|560347482|FG001|Third Intervention|Protocol Violation|0|||
155250595|NCT00584727|560347483|FG002|Third Intervention|Protocol Violation|1|||
155250596|NCT00584727|560347484|FG003|Third Intervention|Protocol Violation|0|||
155250597|NCT00584727|560347485|FG004|Third Intervention|Protocol Violation|4|||
155250598|NCT00584727|560347486|FG005|Third Intervention|Protocol Violation|2|||
155250599|NCT00092131|560347487|FG000|Treatment Period I|Adverse Event|1|||
155250600|NCT00092131|560347488|FG001|Treatment Period I|Adverse Event|0|||
155250601|NCT00092131|560347487|FG000|Treatment Period II|Adverse Event|0|||
155250602|NCT00092131|560347488|FG001|Treatment Period II|Adverse Event|1|||
155250603|NCT02341417|560347489|FG000|Overall Study|Withdrawal by Subject|0|||
155250604|NCT02341417|560347490|FG001|Overall Study|Withdrawal by Subject|2|||
155250605|NCT02341417|560347491|FG002|Overall Study|Withdrawal by Subject|0|||
155250606|NCT02341417|560347489|FG000|Overall Study|Decision by sponsor|2|||
155250607|NCT02341417|560347490|FG001|Overall Study|Decision by sponsor|0|||
155250608|NCT02341417|560347491|FG002|Overall Study|Decision by sponsor|0|||
155250609|NCT02341417|560347489|FG000|Overall Study|Death|0|||
155250610|NCT02341417|560347490|FG001|Overall Study|Death|0|||
155250611|NCT02341417|560347491|FG002|Overall Study|Death|1|||
155250612|NCT01857531|560347492|FG000|Overall Study|Withdrawal by Subject|4|||
155250613|NCT02576067|560347493|FG000|Overall Study|Death|0|||
155250614|NCT02576067|560347494|FG001|Overall Study|Death|1|||
155250615|NCT02576067|560347493|FG000|Overall Study|Lack of Efficacy|1|||
155250616|NCT02576067|560347494|FG001|Overall Study|Lack of Efficacy|0|||
155250617|NCT02576067|560347493|FG000|Overall Study|Lost to Follow-up|11|||
155250618|NCT02576067|560347494|FG001|Overall Study|Lost to Follow-up|0|||
155250619|NCT02576067|560347493|FG000|Overall Study|Withdrawal by Subject|11|||
155250620|NCT02576067|560347494|FG001|Overall Study|Withdrawal by Subject|2|||
155250621|NCT02576067|560347493|FG000|Overall Study|study closure of main CIRT trial)|0|||
155250622|NCT02576067|560347494|FG001|Overall Study|study closure of main CIRT trial)|8|||
155250623|NCT02576067|560347493|FG000|Overall Study|not randomized, failed run-in|7|||
155250624|NCT02576067|560347494|FG001|Overall Study|not randomized, failed run-in|0|||
155250625|NCT02576067|560347493|FG000|Overall Study|screen failure/ re-enrolled|0|||
155250626|NCT02576067|560347494|FG001|Overall Study|screen failure/ re-enrolled|25|||
155250627|NCT02576067|560347493|FG000|Overall Study|Physician Decision|4|||
155250628|NCT02576067|560347494|FG001|Overall Study|Physician Decision|0|||
155250629|NCT04773587|560347495|FG000|Overall Study|Lost to Follow-up|11|||
155250630|NCT04773587|560347496|FG001|Overall Study|Lost to Follow-up|3|||
155250631|NCT04773587|560347495|FG000|Overall Study|Adverse Event|6|||
155250632|NCT04773587|560347496|FG001|Overall Study|Adverse Event|3|||
155250633|NCT04773587|560347495|FG000|Overall Study|Lack of Efficacy|5|||
155250634|NCT04773587|560347496|FG001|Overall Study|Lack of Efficacy|2|||
155250635|NCT04773587|560347495|FG000|Overall Study|Withdrawal by Subject|4|||
155250636|NCT04773587|560347496|FG001|Overall Study|Withdrawal by Subject|5|||
155250637|NCT04773587|560347495|FG000|Overall Study|Noncompliance|1|||
155250638|NCT04773587|560347496|FG001|Overall Study|Noncompliance|0|||
155250639|NCT04773587|560347495|FG000|Overall Study|Protocol Violation|1|||
155250640|NCT04773587|560347496|FG001|Overall Study|Protocol Violation|0|||
155250641|NCT04773587|560347495|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
155250642|NCT04773587|560347496|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
155250643|NCT00435370|560347497|FG000|Overall Study|Adverse Event|8|||
155250644|NCT00435370|560347498|FG001|Overall Study|Adverse Event|8|||
155250645|NCT00435370|560347497|FG000|Overall Study|Withdrawal by Subject|10|||
155250646|NCT00435370|560347498|FG001|Overall Study|Withdrawal by Subject|10|||
155250647|NCT00435370|560347497|FG000|Overall Study|Antipsychotic medication changed|4|||
155250648|NCT00435370|560347498|FG001|Overall Study|Antipsychotic medication changed|2|||
155250649|NCT02132611|560347499|FG000|Overall Study|Death|2|||
155250650|NCT03943095|560347500|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
155250651|NCT03943095|560347501|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
155250652|NCT03943095|560347500|FG000|Overall Study|Withdrawal by Subject|1|||
155250653|NCT03943095|560347501|FG001|Overall Study|Withdrawal by Subject|0|||
155250654|NCT02298192|560347502|FG000|Overall Study|Unclassified|3|||
155250655|NCT02298192|560347503|FG001|Overall Study|Unclassified|2|||
155250656|NCT02298192|560347502|FG000|Overall Study|Withdrawal criteria|2|||
155250657|NCT02298192|560347503|FG001|Overall Study|Withdrawal criteria|0|||
155250658|NCT02298192|560347502|FG000|Overall Study|Withdrawal by Subject|6|||
155250659|NCT02298192|560347503|FG001|Overall Study|Withdrawal by Subject|1|||
155250660|NCT02298192|560347502|FG000|Overall Study|Lost to Follow-up|2|||
155250661|NCT02298192|560347503|FG001|Overall Study|Lost to Follow-up|1|||
155250662|NCT02298192|560347502|FG000|Overall Study|Adverse Event|6|||
155250663|NCT02298192|560347503|FG001|Overall Study|Adverse Event|2|||
155250664|NCT02352948|560347504|FG000|Overall Study|Death|47|||
155250665|NCT02352948|560347505|FG001|Overall Study|Death|48|||
155250666|NCT02352948|560347506|FG002|Overall Study|Death|114|||
155250667|NCT02352948|560347507|FG003|Overall Study|Death|74|||
155250668|NCT02352948|560347508|FG004|Overall Study|Death|77|||
155250669|NCT02352948|560347509|FG005|Overall Study|Death|44|||
155250670|NCT02352948|560347504|FG000|Overall Study|Lost to Follow-up|1|||
155250671|NCT02352948|560347505|FG001|Overall Study|Lost to Follow-up|0|||
155250672|NCT02352948|560347506|FG002|Overall Study|Lost to Follow-up|2|||
155250673|NCT02352948|560347507|FG003|Overall Study|Lost to Follow-up|1|||
155250674|NCT02352948|560347508|FG004|Overall Study|Lost to Follow-up|2|||
155250675|NCT02352948|560347509|FG005|Overall Study|Lost to Follow-up|1|||
155250676|NCT02352948|560347504|FG000|Overall Study|Withdrawal by Subject|1|||
155250677|NCT02352948|560347505|FG001|Overall Study|Withdrawal by Subject|10|||
155250678|NCT02352948|560347506|FG002|Overall Study|Withdrawal by Subject|11|||
155250679|NCT02352948|560347507|FG003|Overall Study|Withdrawal by Subject|23|||
155250680|NCT02352948|560347508|FG004|Overall Study|Withdrawal by Subject|9|||
155250681|NCT02352948|560347509|FG005|Overall Study|Withdrawal by Subject|4|||
155250682|NCT02352948|560347504|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
155250683|NCT02352948|560347505|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
155250684|NCT02352948|560347506|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
155250685|NCT02352948|560347507|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
155250686|NCT02352948|560347508|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
155250687|NCT02352948|560347509|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
155250688|NCT02352948|560347504|FG000|Overall Study|Other|0|||
155250689|NCT02352948|560347505|FG001|Overall Study|Other|0|||
155250690|NCT02352948|560347506|FG002|Overall Study|Other|2|||
155250691|NCT02352948|560347507|FG003|Overall Study|Other|0|||
155250692|NCT02352948|560347508|FG004|Overall Study|Other|0|||
155250693|NCT02352948|560347509|FG005|Overall Study|Other|0|||
155250694|NCT02096900|560347515|FG000|Overall Study|Did not receive medication|3|||
155250695|NCT02096900|560347516|FG001|Overall Study|Did not receive medication|1|||
155250696|NCT02096900|560347515|FG000|Overall Study|Surgery cancelled- medication received|1|||
155250697|NCT02096900|560347516|FG001|Overall Study|Surgery cancelled- medication received|1|||
155250698|NCT02763384|560347517|FG000|Overall Study|Physician Decision|1|||
155250699|NCT02763384|560347517|FG000|Overall Study|Rapid decline - went on hospice|1|||
155250700|NCT04657211|560347518|FG000|Overall Study|Withdrawal by Subject|21|||
155250701|NCT04657211|560347518|FG000|Overall Study|Lost to Follow-up|113|||
155250702|NCT04657211|560347518|FG000|Overall Study|Death|47|||
155250703|NCT04657211|560347518|FG000|Overall Study|Transfer to another institution|21|||
155250704|NCT04657211|560347518|FG000|Overall Study|Other|29|||
155250705|NCT06273774|560347521|FG000|Overall Study|Participant was out of state.|0|||
155250706|NCT06273774|560347522|FG001|Overall Study|Participant was out of state.|0|||
155250707|NCT06273774|560347523|FG002|Overall Study|Participant was out of state.|0|||
155250708|NCT06273774|560347524|FG003|Overall Study|Participant was out of state.|0|||
155250709|NCT06273774|560347525|FG004|Overall Study|Participant was out of state.|0|||
155250710|NCT06273774|560347526|FG005|Overall Study|Participant was out of state.|1|||
155250711|NCT06273774|560347521|FG000|Overall Study|Lost to Follow-up|0|||
155250712|NCT06273774|560347522|FG001|Overall Study|Lost to Follow-up|0|||
155250713|NCT06273774|560347523|FG002|Overall Study|Lost to Follow-up|0|||
155250714|NCT06273774|560347524|FG003|Overall Study|Lost to Follow-up|0|||
155250715|NCT06273774|560347525|FG004|Overall Study|Lost to Follow-up|1|||
155250716|NCT06273774|560347526|FG005|Overall Study|Lost to Follow-up|0|||
155250717|NCT00660010|560347527|FG000|Overall Study|Withdrawal by Subject|2|||
155250718|NCT00660010|560347527|FG000|Overall Study|Lost to Follow-up|3|||
155250719|NCT00660010|560347527|FG000|Overall Study|Adverse Event|1|||
155250720|NCT00660010|560347527|FG000|Overall Study|Noncompliance with visit schedule|3|||
155250721|NCT06167031|560347530|FG000|Overall Study|Lost to Follow-up|5|||
155250722|NCT06167031|560347531|FG001|Overall Study|Lost to Follow-up|1|||
155250723|NCT00360308|560349887|FG000|Overall Study|Adverse Event|15|||
155250724|NCT00360308|560349888|FG001|Overall Study|Adverse Event|14|||
155250725|NCT00360308|560349889|FG002|Overall Study|Adverse Event|25|||
155250726|NCT00360308|560349887|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
155250727|NCT00360308|560349888|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
155250728|NCT00360308|560349889|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
155250729|NCT00360308|560349887|FG000|Overall Study|Protocol Violation|2|||
155250730|NCT00360308|560349888|FG001|Overall Study|Protocol Violation|1|||
155250731|NCT00360308|560349889|FG002|Overall Study|Protocol Violation|2|||
155250732|NCT00360308|560349887|FG000|Overall Study|Withdrawal by Subject|11|||
155250733|NCT00360308|560349888|FG001|Overall Study|Withdrawal by Subject|7|||
155250734|NCT00360308|560349889|FG002|Overall Study|Withdrawal by Subject|14|||
155250735|NCT00360308|560349887|FG000|Overall Study|Lack of Efficacy|3|||
155250736|NCT00360308|560349888|FG001|Overall Study|Lack of Efficacy|0|||
155250737|NCT00360308|560349889|FG002|Overall Study|Lack of Efficacy|2|||
155250738|NCT00360308|560349887|FG000|Overall Study|Other|2|||
155250739|NCT00360308|560349888|FG001|Overall Study|Other|1|||
155250740|NCT00360308|560349889|FG002|Overall Study|Other|1|||
155250741|NCT00360308|560349887|FG000|Overall Study|Study termination by sponsor|43|||
155250742|NCT00360308|560349888|FG001|Overall Study|Study termination by sponsor|55|||
155250743|NCT00360308|560349889|FG002|Overall Study|Study termination by sponsor|44|||
155250744|NCT04786444|560349890|FG000|Overall Study|Withdrawal by Subject|4|||
155250745|NCT04786444|560349891|FG001|Overall Study|Withdrawal by Subject|7|||
155250746|NCT04786444|560349892|FG002|Overall Study|Withdrawal by Subject|2|||
155250747|NCT04786444|560349890|FG000|Overall Study|Lost to Follow-up|11|||
155250748|NCT04786444|560349891|FG001|Overall Study|Lost to Follow-up|9|||
155250749|NCT04786444|560349892|FG002|Overall Study|Lost to Follow-up|10|||
155250750|NCT04786444|560349890|FG000|Overall Study|Subject would like to become pregnant|0|||
155250751|NCT04786444|560349891|FG001|Overall Study|Subject would like to become pregnant|1|||
155250752|NCT04786444|560349892|FG002|Overall Study|Subject would like to become pregnant|0|||
155250753|NCT00725452|560349900|FG000|Overall Study|Adverse Event|3|||
155250754|NCT00725452|560349900|FG000|Overall Study|Lack of Efficacy|2|||
155250755|NCT00725452|560349900|FG000|Overall Study|Reason not specified|1|||
155250756|NCT00725452|560349900|FG000|Overall Study|Physician Decision|1|||
155250757|NCT00725452|560349900|FG000|Overall Study|Withdrawal by Subject|3|||
155250758|NCT00725452|560349900|FG000|Overall Study|Lost to Follow-up|1|||
155250759|NCT00713648|560349901|FG000|Overall Study|Adverse Event|1|||
155250760|NCT00713648|560349901|FG000|Overall Study|Unclassified|2|||
155250761|NCT00713648|560349901|FG000|Overall Study|According to Protocol|2|||
155250762|NCT00713648|560349901|FG000|Overall Study|Development of antibodies|3|||
155250763|NCT01733732|560349902|FG000|Overall Study|Adverse Event|1|||
155250764|NCT01733732|560349903|FG001|Overall Study|Adverse Event|0|||
155250765|NCT01733732|560349902|FG000|Overall Study|Did not attend all study visits|1|||
155250766|NCT01733732|560349903|FG001|Overall Study|Did not attend all study visits|0|||
155250767|NCT00464815|560349904|FG000|Overall Study|Withdrawal by Subject|6|||
155250768|NCT00464815|560349905|FG001|Overall Study|Withdrawal by Subject|3|||
155250769|NCT01324271|560349913|FG000|Overall Study|Lost to Follow-up|3|||
155250770|NCT01324271|560349914|FG001|Overall Study|Lost to Follow-up|0|||
155250771|NCT01324271|560349913|FG000|Overall Study|Physician Decision|1|||
155250772|NCT01324271|560349914|FG001|Overall Study|Physician Decision|0|||
155250773|NCT02807558|560349915|FG000|Overall Study|Consent withdrawn by participant|4|||
155250774|NCT02807558|560349916|FG001|Overall Study|Consent withdrawn by participant|0|||
155250775|NCT02807558|560349917|FG002|Overall Study|Consent withdrawn by participant|4|||
155250776|NCT02807558|560349918|FG003|Overall Study|Consent withdrawn by participant|2|||
155250777|NCT02807558|560349919|FG004|Overall Study|Consent withdrawn by participant|1|||
155250778|NCT02807558|560349920|FG005|Overall Study|Consent withdrawn by participant|0|||
155250779|NCT02807558|560349915|FG000|Overall Study|Non-compliance with Study Drug|0|||
155250780|NCT02807558|560349916|FG001|Overall Study|Non-compliance with Study Drug|0|||
155250781|NCT02807558|560349917|FG002|Overall Study|Non-compliance with Study Drug|1|||
155250782|NCT02807558|560349918|FG003|Overall Study|Non-compliance with Study Drug|0|||
155250783|NCT02807558|560349919|FG004|Overall Study|Non-compliance with Study Drug|0|||
155250784|NCT02807558|560349920|FG005|Overall Study|Non-compliance with Study Drug|0|||
155250785|NCT02807558|560349915|FG000|Overall Study|Adverse Event|0|||
155250786|NCT02807558|560349916|FG001|Overall Study|Adverse Event|0|||
155250787|NCT02807558|560349917|FG002|Overall Study|Adverse Event|9|||
155250788|NCT02807558|560349918|FG003|Overall Study|Adverse Event|0|||
155250789|NCT02807558|560349919|FG004|Overall Study|Adverse Event|0|||
155250790|NCT02807558|560349920|FG005|Overall Study|Adverse Event|0|||
155250791|NCT02807558|560349915|FG000|Overall Study|Death|23|||
155250792|NCT02807558|560349916|FG001|Overall Study|Death|2|||
155250793|NCT02807558|560349917|FG002|Overall Study|Death|3|||
155250794|NCT02807558|560349918|FG003|Overall Study|Death|43|||
155250795|NCT02807558|560349919|FG004|Overall Study|Death|24|||
155250796|NCT02807558|560349920|FG005|Overall Study|Death|15|||
155250797|NCT02807558|560349915|FG000|Overall Study|Progressive Disease|0|||
155250798|NCT02807558|560349916|FG001|Overall Study|Progressive Disease|0|||
155250799|NCT02807558|560349917|FG002|Overall Study|Progressive Disease|1|||
155250800|NCT02807558|560349918|FG003|Overall Study|Progressive Disease|0|||
155250801|NCT02807558|560349919|FG004|Overall Study|Progressive Disease|0|||
155250802|NCT02807558|560349920|FG005|Overall Study|Progressive Disease|0|||
155250803|NCT02807558|560349915|FG000|Overall Study|Other than specified|1|||
155250804|NCT02807558|560349916|FG001|Overall Study|Other than specified|0|||
155250805|NCT02807558|560349917|FG002|Overall Study|Other than specified|2|||
155250806|NCT02807558|560349918|FG003|Overall Study|Other than specified|0|||
155250807|NCT02807558|560349919|FG004|Overall Study|Other than specified|1|||
155250808|NCT02807558|560349920|FG005|Overall Study|Other than specified|1|||
155250809|NCT02807558|560349915|FG000|Overall Study|Lack of Efficacy|0|||
155250810|NCT02807558|560349916|FG001|Overall Study|Lack of Efficacy|0|||
155250811|NCT02807558|560349917|FG002|Overall Study|Lack of Efficacy|9|||
155250812|NCT02807558|560349918|FG003|Overall Study|Lack of Efficacy|0|||
155250813|NCT02807558|560349919|FG004|Overall Study|Lack of Efficacy|0|||
155250814|NCT02807558|560349920|FG005|Overall Study|Lack of Efficacy|0|||
155250815|NCT06116591|560349921|FG000|Overall Study|No longer met eligibility criteria|0|||
155250816|NCT06116591|560349922|FG001|Overall Study|No longer met eligibility criteria|1|||
155250817|NCT06116591|560349921|FG000|Overall Study|Other: Change in life situation|0|||
155250818|NCT06116591|560349922|FG001|Overall Study|Other: Change in life situation|1|||
155250819|NCT05585307|560349923|FG000|Overall Study|Lost to Follow-up|0|||
155250820|NCT05585307|560349924|FG001|Overall Study|Lost to Follow-up|0|||
155250821|NCT05585307|560349925|FG002|Overall Study|Lost to Follow-up|0|||
155250822|NCT05585307|560349926|FG003|Overall Study|Lost to Follow-up|0|||
155250823|NCT05585307|560349927|FG004|Overall Study|Lost to Follow-up|0|||
155250824|NCT05585307|560349928|FG005|Overall Study|Lost to Follow-up|0|||
155250825|NCT05585307|560349929|FG006|Overall Study|Lost to Follow-up|1|||
155250826|NCT05585307|560349930|FG007|Overall Study|Lost to Follow-up|0|||
155250827|NCT01972841|560349931|FG000|Overall Study|Randomized but Never Received Treatment|2|||
155250828|NCT01972841|560349932|FG001|Overall Study|Randomized but Never Received Treatment|5|||
155250829|NCT01972841|560349933|FG002|Overall Study|Randomized but Never Received Treatment|4|||
155250830|NCT01972841|560349934|FG003|Overall Study|Randomized but Never Received Treatment|2|||
155250831|NCT01972841|560349935|FG004|Overall Study|Randomized but Never Received Treatment|6|||
155250832|NCT01972841|560349936|FG005|Overall Study|Randomized but Never Received Treatment|13|||
155250833|NCT01972841|560349931|FG000|Overall Study|Adverse Event|13|||
155250834|NCT01972841|560349932|FG001|Overall Study|Adverse Event|8|||
155250835|NCT01972841|560349933|FG002|Overall Study|Adverse Event|12|||
155250836|NCT01972841|560349934|FG003|Overall Study|Adverse Event|9|||
155250837|NCT01972841|560349935|FG004|Overall Study|Adverse Event|21|||
155250838|NCT01972841|560349936|FG005|Overall Study|Adverse Event|26|||
155250839|NCT01972841|560349931|FG000|Overall Study|Lack of Efficacy|1|||
155250840|NCT01972841|560349932|FG001|Overall Study|Lack of Efficacy|0|||
155250841|NCT01972841|560349933|FG002|Overall Study|Lack of Efficacy|0|||
155250842|NCT01972841|560349934|FG003|Overall Study|Lack of Efficacy|2|||
155250843|NCT01972841|560349935|FG004|Overall Study|Lack of Efficacy|4|||
155250844|NCT01972841|560349936|FG005|Overall Study|Lack of Efficacy|1|||
155250845|NCT01972841|560349931|FG000|Overall Study|Lost to Follow-up|4|||
155250846|NCT01972841|560349932|FG001|Overall Study|Lost to Follow-up|2|||
155250847|NCT01972841|560349933|FG002|Overall Study|Lost to Follow-up|4|||
155250848|NCT01972841|560349934|FG003|Overall Study|Lost to Follow-up|2|||
155250849|NCT01972841|560349935|FG004|Overall Study|Lost to Follow-up|9|||
155250850|NCT01972841|560349936|FG005|Overall Study|Lost to Follow-up|3|||
155250851|NCT01972841|560349931|FG000|Overall Study|Protocol Violation|2|||
155250852|NCT01972841|560349932|FG001|Overall Study|Protocol Violation|2|||
155250853|NCT01972841|560349933|FG002|Overall Study|Protocol Violation|3|||
155250854|NCT01972841|560349934|FG003|Overall Study|Protocol Violation|5|||
155250855|NCT01972841|560349935|FG004|Overall Study|Protocol Violation|9|||
155250856|NCT01972841|560349936|FG005|Overall Study|Protocol Violation|4|||
155250857|NCT01972841|560349931|FG000|Overall Study|Withdrawal by participants|21|||
155250858|NCT01972841|560349932|FG001|Overall Study|Withdrawal by participants|27|||
155250859|NCT01972841|560349933|FG002|Overall Study|Withdrawal by participants|23|||
155250860|NCT01972841|560349934|FG003|Overall Study|Withdrawal by participants|16|||
155250861|NCT01972841|560349935|FG004|Overall Study|Withdrawal by participants|33|||
155250862|NCT01972841|560349936|FG005|Overall Study|Withdrawal by participants|34|||
155250863|NCT01972841|560349931|FG000|Overall Study|Miscellaneous|0|||
155250864|NCT01972841|560349932|FG001|Overall Study|Miscellaneous|0|||
155250865|NCT01972841|560349933|FG002|Overall Study|Miscellaneous|4|||
155250866|NCT01972841|560349934|FG003|Overall Study|Miscellaneous|1|||
155250867|NCT01972841|560349935|FG004|Overall Study|Miscellaneous|0|||
155250868|NCT01972841|560349936|FG005|Overall Study|Miscellaneous|4|||
155250869|NCT01972841|560349931|FG000|Overall Study|Did not have end of treatment page|0|||
155250870|NCT01972841|560349932|FG001|Overall Study|Did not have end of treatment page|0|||
155250871|NCT01972841|560349933|FG002|Overall Study|Did not have end of treatment page|0|||
155250872|NCT01972841|560349934|FG003|Overall Study|Did not have end of treatment page|0|||
155250873|NCT01972841|560349935|FG004|Overall Study|Did not have end of treatment page|1|||
155250874|NCT01972841|560349936|FG005|Overall Study|Did not have end of treatment page|0|||
155250875|NCT02734212|560349939|FG000|Overall Study|Lost to Follow-up|5|||
155250876|NCT02734212|560349940|FG001|Overall Study|Lost to Follow-up|10|||
155250877|NCT00688636|560349941|FG000|Overall Study|Adverse Event|2|||
155250878|NCT00688636|560349942|FG001|Overall Study|Adverse Event|1|||
155250879|NCT01572727|560349943|FG000|Overall Study|Adverse Event|43|||
155250880|NCT01572727|560349944|FG001|Overall Study|Adverse Event|15|||
155250881|NCT01572727|560349943|FG000|Overall Study|Lost to Follow-up|1|||
155250882|NCT01572727|560349944|FG001|Overall Study|Lost to Follow-up|1|||
155250883|NCT01572727|560349943|FG000|Overall Study|Physician Decision|23|||
155250884|NCT01572727|560349944|FG001|Overall Study|Physician Decision|9|||
155250885|NCT01572727|560349943|FG000|Overall Study|Progressive disease|59|||
155250886|NCT01572727|560349944|FG001|Overall Study|Progressive disease|82|||
155250887|NCT01572727|560349943|FG000|Overall Study|Protocol Violation|0|||
155250888|NCT01572727|560349944|FG001|Overall Study|Protocol Violation|1|||
155250889|NCT01572727|560349943|FG000|Overall Study|Study terminated by sponsor|61|||
155250890|NCT01572727|560349944|FG001|Overall Study|Study terminated by sponsor|83|||
155250891|NCT01572727|560349943|FG000|Overall Study|Parent/guardian decision|14|||
155250892|NCT01572727|560349944|FG001|Overall Study|Parent/guardian decision|9|||
155250893|NCT01572727|560349943|FG000|Overall Study|Death|2|||
155250894|NCT01572727|560349944|FG001|Overall Study|Death|2|||
155250895|NCT01572727|560349943|FG000|Overall Study|Untreated|4|||
155250896|NCT01572727|560349944|FG001|Overall Study|Untreated|7|||
155250897|NCT02195986|560349945|FG000|Overall Study|Adverse Event|3|||
155250898|NCT02195986|560349946|FG001|Overall Study|Adverse Event|0|||
155250899|NCT02195986|560349947|FG002|Overall Study|Adverse Event|0|||
155250900|NCT02195986|560349945|FG000|Overall Study|Withdrawal by Subject|0|||
155250901|NCT02195986|560349946|FG001|Overall Study|Withdrawal by Subject|3|||
155250902|NCT02195986|560349947|FG002|Overall Study|Withdrawal by Subject|0|||
155250903|NCT02195986|560349945|FG000|Overall Study|Family Emergency|0|||
155250904|NCT02195986|560349946|FG001|Overall Study|Family Emergency|0|||
155250905|NCT02195986|560349947|FG002|Overall Study|Family Emergency|1|||
155250906|NCT02195986|560349945|FG000|Overall Study|Protocol Violation|0|||
155250907|NCT02195986|560349946|FG001|Overall Study|Protocol Violation|1|||
155250908|NCT02195986|560349947|FG002|Overall Study|Protocol Violation|1|||
155250909|NCT02195986|560349945|FG000|Overall Study|Non-compliance|0|||
155250910|NCT02195986|560349946|FG001|Overall Study|Non-compliance|1|||
155250911|NCT02195986|560349947|FG002|Overall Study|Non-compliance|0|||
155250912|NCT02834780|560349950|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
155250913|NCT02834780|560349951|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
155250914|NCT02834780|560349952|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
155250915|NCT02834780|560349953|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
155250916|NCT02834780|560349954|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
155250917|NCT02834780|560349955|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
155250918|NCT02834780|560349956|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
155250919|NCT02834780|560349957|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
155250920|NCT02834780|560349958|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
155250921|NCT02834780|560349959|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
155250922|NCT02834780|560349960|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
155250923|NCT02834780|560349961|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
155250924|NCT02834780|560349962|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
155250925|NCT02834780|560349950|FG000|Overall Study|Withdrawal by Subject|0|||
155250926|NCT02834780|560349951|FG001|Overall Study|Withdrawal by Subject|0|||
155250927|NCT02834780|560349952|FG002|Overall Study|Withdrawal by Subject|1|||
155250928|NCT02834780|560349953|FG003|Overall Study|Withdrawal by Subject|0|||
155250929|NCT02834780|560349954|FG004|Overall Study|Withdrawal by Subject|0|||
155250930|NCT02834780|560349955|FG005|Overall Study|Withdrawal by Subject|0|||
155250931|NCT02834780|560349956|FG006|Overall Study|Withdrawal by Subject|0|||
155250932|NCT02834780|560349957|FG007|Overall Study|Withdrawal by Subject|0|||
155250933|NCT02834780|560349958|FG008|Overall Study|Withdrawal by Subject|0|||
155250934|NCT02834780|560349959|FG009|Overall Study|Withdrawal by Subject|0|||
155250935|NCT02834780|560349960|FG010|Overall Study|Withdrawal by Subject|1|||
155250936|NCT02834780|560349961|FG011|Overall Study|Withdrawal by Subject|0|||
155250937|NCT02834780|560349962|FG012|Overall Study|Withdrawal by Subject|0|||
155250938|NCT02834780|560349950|FG000|Overall Study|Adverse Event|0|||
155250939|NCT02834780|560349951|FG001|Overall Study|Adverse Event|0|||
155250940|NCT02834780|560349952|FG002|Overall Study|Adverse Event|0|||
155250941|NCT02834780|560349953|FG003|Overall Study|Adverse Event|0|||
155250942|NCT02834780|560349954|FG004|Overall Study|Adverse Event|1|||
155250943|NCT02834780|560349955|FG005|Overall Study|Adverse Event|0|||
155250944|NCT02834780|560349956|FG006|Overall Study|Adverse Event|1|||
155250945|NCT02834780|560349957|FG007|Overall Study|Adverse Event|1|||
155250946|NCT02834780|560349958|FG008|Overall Study|Adverse Event|0|||
155250947|NCT02834780|560349959|FG009|Overall Study|Adverse Event|2|||
155250948|NCT02834780|560349960|FG010|Overall Study|Adverse Event|0|||
155250949|NCT02834780|560349961|FG011|Overall Study|Adverse Event|3|||
155250950|NCT02834780|560349962|FG012|Overall Study|Adverse Event|2|||
155250951|NCT02834780|560349950|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250952|NCT02834780|560349951|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
155250953|NCT02834780|560349952|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
155250954|NCT02834780|560349953|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250955|NCT02834780|560349954|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250956|NCT02834780|560349955|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250957|NCT02834780|560349956|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250958|NCT02834780|560349957|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
155250959|NCT02834780|560349958|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
155250960|NCT02834780|560349959|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
155250961|NCT02834780|560349960|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
155250962|NCT02834780|560349961|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
155250963|NCT02834780|560349962|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
155250964|NCT02834780|560349950|FG000|Overall Study|Other|1|||
155250965|NCT02834780|560349951|FG001|Overall Study|Other|0|||
155250966|NCT02834780|560349952|FG002|Overall Study|Other|1|||
155250967|NCT02834780|560349953|FG003|Overall Study|Other|2|||
155250968|NCT02834780|560349954|FG004|Overall Study|Other|0|||
155250969|NCT02834780|560349955|FG005|Overall Study|Other|0|||
155250970|NCT02834780|560349956|FG006|Overall Study|Other|0|||
155250971|NCT02834780|560349957|FG007|Overall Study|Other|0|||
155250972|NCT02834780|560349958|FG008|Overall Study|Other|0|||
155250973|NCT02834780|560349959|FG009|Overall Study|Other|0|||
155250974|NCT02834780|560349960|FG010|Overall Study|Other|0|||
155250975|NCT02834780|560349961|FG011|Overall Study|Other|0|||
155250976|NCT02834780|560349962|FG012|Overall Study|Other|1|||
155250977|NCT03150056|560349963|FG000|Overall Study|Withdrawal by Subject|0|||
155250978|NCT03150056|560349964|FG001|Overall Study|Withdrawal by Subject|0|||
155250979|NCT03150056|560349965|FG002|Overall Study|Withdrawal by Subject|0|||
155250980|NCT03150056|560349966|FG003|Overall Study|Withdrawal by Subject|0|||
155250981|NCT03150056|560349967|FG004|Overall Study|Withdrawal by Subject|0|||
155250982|NCT03150056|560349968|FG005|Overall Study|Withdrawal by Subject|2|||
155250983|NCT03150056|560349963|FG000|Overall Study|Study terminated by Sponsor|1|||
155250984|NCT03150056|560349964|FG001|Overall Study|Study terminated by Sponsor|3|||
155250985|NCT03150056|560349965|FG002|Overall Study|Study terminated by Sponsor|1|||
155250986|NCT03150056|560349966|FG003|Overall Study|Study terminated by Sponsor|1|||
155250987|NCT03150056|560349967|FG004|Overall Study|Study terminated by Sponsor|5|||
155250988|NCT03150056|560349968|FG005|Overall Study|Study terminated by Sponsor|6|||
155250989|NCT03150056|560349963|FG000|Overall Study|Death|9|||
155250990|NCT03150056|560349964|FG001|Overall Study|Death|2|||
155250991|NCT03150056|560349965|FG002|Overall Study|Death|2|||
155250992|NCT03150056|560349966|FG003|Overall Study|Death|7|||
155250993|NCT03150056|560349967|FG004|Overall Study|Death|8|||
155250994|NCT03150056|560349968|FG005|Overall Study|Death|10|||
155250995|NCT02270450|560349973|FG000|Overall Study|Refusal unrelated to adverse event|3|||
155250996|NCT02270450|560349974|FG001|Overall Study|Refusal unrelated to adverse event|1|||
155250997|NCT02270450|560349975|FG002|Overall Study|Refusal unrelated to adverse event|5|||
155250998|NCT02270450|560349976|FG003|Overall Study|Refusal unrelated to adverse event|14|||
155250999|NCT02270450|560349973|FG000|Overall Study|Progression/relapse|1|||
155251000|NCT02270450|560349974|FG001|Overall Study|Progression/relapse|2|||
155251001|NCT02270450|560349975|FG002|Overall Study|Progression/relapse|4|||
155251002|NCT02270450|560349976|FG003|Overall Study|Progression/relapse|9|||
155251003|NCT02270450|560349973|FG000|Overall Study|Death|19|||
155251004|NCT02270450|560349974|FG001|Overall Study|Death|19|||
155251005|NCT02270450|560349975|FG002|Overall Study|Death|31|||
155251006|NCT02270450|560349976|FG003|Overall Study|Death|59|||
155251007|NCT02363738|560349977|FG000|Overall Study|Adverse Event|5|||
155251008|NCT02363738|560349978|FG001|Overall Study|Adverse Event|2|||
155251009|NCT02363738|560349977|FG000|Overall Study|Lack of Efficacy|1|||
155251010|NCT02363738|560349978|FG001|Overall Study|Lack of Efficacy|2|||
155251011|NCT02363738|560349977|FG000|Overall Study|Lost to Follow-up|2|||
155251012|NCT02363738|560349978|FG001|Overall Study|Lost to Follow-up|1|||
155251013|NCT03282227|560349979|FG000|Overall Study|Exposure Goals Achieved|60|||
155251014|NCT03282227|560349979|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
155251015|NCT03282227|560349979|FG000|Overall Study|Adverse Event|15|||
155251016|NCT03282227|560349979|FG000|Overall Study|Lost to Follow-up|21|||
155251017|NCT03282227|560349979|FG000|Overall Study|Withdrawal by Subject|20|||
155251018|NCT03282227|560349979|FG000|Overall Study|Lack of Efficacy|12|||
155251019|NCT03282227|560349979|FG000|Overall Study|Sponsor decision|3|||
155251020|NCT03282227|560349979|FG000|Overall Study|Physician Decision|2|||
155251021|NCT03282227|560349979|FG000|Overall Study|Pregnancy|2|||
155251022|NCT03282227|560349979|FG000|Overall Study|Other|1|||
155251023|NCT00700401|560349985|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
155251024|NCT00700401|560349985|FG000|Overall Study|Adverse Event|5|||
155251025|NCT00700401|560349985|FG000|Overall Study|Refused Treatment|2|||
155251026|NCT00700401|560349985|FG000|Overall Study|Lost to Follow-up|1|||
155251027|NCT00700401|560349985|FG000|Overall Study|Treatment never started|1|||
155251028|NCT00700401|560349985|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
155251029|NCT00700401|560349985|FG000|Overall Study|Withdrawal by Subject|2|||
155251030|NCT02491671|560349986|FG000|Overall Study|Adverse Event|6|||
155251031|NCT02491671|560349987|FG001|Overall Study|Adverse Event|8|||
155251032|NCT02491671|560349986|FG000|Overall Study|Death|0|||
155251033|NCT02491671|560349987|FG001|Overall Study|Death|2|||
155251034|NCT02491671|560349986|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
155251035|NCT02491671|560349987|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
155251036|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
155251037|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
155251038|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
155251039|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
155251040|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
155251041|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
155251042|NCT02251990|560349991|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
155251043|NCT02251990|560349992|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
155251044|NCT02251990|560349991|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
155251045|NCT02251990|560349992|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
155251046|NCT02251990|560349991|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
155251047|NCT02251990|560349992|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
155251048|NCT03265600|560349993|FG000|Overall Study|Lost to Follow-up|17|||
155251049|NCT03265600|560349994|FG001|Overall Study|Lost to Follow-up|5|||
155251050|NCT03265600|560349993|FG000|Overall Study|Withdrawal by Subject|4|||
155251051|NCT03265600|560349994|FG001|Overall Study|Withdrawal by Subject|2|||
155251052|NCT03265600|560349993|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
155251053|NCT03265600|560349994|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
155251054|NCT00535730|560349995|FG000|Overall Study|Adverse Event|1|||
155251055|NCT00535730|560349996|FG001|Overall Study|Adverse Event|1|||
155251056|NCT00535730|560349995|FG000|Overall Study|Lost to Follow-up|0|||
155251057|NCT00535730|560349996|FG001|Overall Study|Lost to Follow-up|1|||
155251058|NCT00535730|560349995|FG000|Overall Study|Physician Decision|0|||
155251059|NCT00535730|560349996|FG001|Overall Study|Physician Decision|1|||
155251060|NCT00535730|560349995|FG000|Overall Study|Protocol Violation|1|||
155251061|NCT00535730|560349996|FG001|Overall Study|Protocol Violation|0|||
155251062|NCT00535730|560349995|FG000|Overall Study|Withdrawal by Subject|0|||
155251063|NCT00535730|560349996|FG001|Overall Study|Withdrawal by Subject|4|||
155251064|NCT00729833|560350006|FG000|Overall Study|Death|5|||
155251065|NCT00729833|560350007|FG001|Overall Study|Death|1|||
155251066|NCT00729833|560350008|FG002|Overall Study|Death|3|||
155251067|NCT00729833|560350009|FG003|Overall Study|Death|5|||
155251068|NCT00729833|560350006|FG000|Overall Study|Study Terminated by Sponsor|0|||
155251069|NCT00729833|560350007|FG001|Overall Study|Study Terminated by Sponsor|0|||
155251070|NCT00729833|560350008|FG002|Overall Study|Study Terminated by Sponsor|1|||
155251071|NCT00729833|560350009|FG003|Overall Study|Study Terminated by Sponsor|0|||
155251072|NCT00729833|560350006|FG000|Overall Study|Lost to Follow-up|1|||
155251073|NCT00729833|560350007|FG001|Overall Study|Lost to Follow-up|0|||
155251074|NCT00729833|560350008|FG002|Overall Study|Lost to Follow-up|0|||
155251075|NCT00729833|560350009|FG003|Overall Study|Lost to Follow-up|0|||
155251076|NCT00729833|560350006|FG000|Overall Study|Withdrawal by Subject|3|||
155251077|NCT00729833|560350007|FG001|Overall Study|Withdrawal by Subject|1|||
155251078|NCT00729833|560350008|FG002|Overall Study|Withdrawal by Subject|3|||
155251079|NCT00729833|560350009|FG003|Overall Study|Withdrawal by Subject|0|||
155251080|NCT00729833|560350006|FG000|Overall Study|Unspecified Reasons|11|||
155251081|NCT00729833|560350007|FG001|Overall Study|Unspecified Reasons|5|||
155251082|NCT00729833|560350008|FG002|Overall Study|Unspecified Reasons|5|||
155251083|NCT00729833|560350009|FG003|Overall Study|Unspecified Reasons|1|||
155251084|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
155251085|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
155251086|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
155251087|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
155251088|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
155251089|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
155251090|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
155251091|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
155251092|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
155251093|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
155251094|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
155251095|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
155251096|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
155251097|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
155251098|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
155251099|NCT00355082|560350010|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
155251100|NCT00355082|560350011|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
155251101|NCT00355082|560350012|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
155251102|NCT00355082|560350010|FG000|Continuation Phase|Adverse Event|2|||
155251103|NCT00355082|560350011|FG001|Continuation Phase|Adverse Event|0|||
155251104|NCT00355082|560350012|FG002|Continuation Phase|Adverse Event|1|||
155251105|NCT00355082|560350010|FG000|Continuation Phase|Lost to Follow-up|2|||
155251106|NCT00355082|560350011|FG001|Continuation Phase|Lost to Follow-up|0|||
155251107|NCT00355082|560350012|FG002|Continuation Phase|Lost to Follow-up|1|||
155251108|NCT00355082|560350010|FG000|Continuation Phase|Protocol Violation|1|||
155251109|NCT00355082|560350011|FG001|Continuation Phase|Protocol Violation|0|||
155251110|NCT00355082|560350012|FG002|Continuation Phase|Protocol Violation|1|||
155251111|NCT00355082|560350010|FG000|Continuation Phase|Withdrawal by Subject|4|||
155251112|NCT00355082|560350011|FG001|Continuation Phase|Withdrawal by Subject|0|||
155251113|NCT00355082|560350012|FG002|Continuation Phase|Withdrawal by Subject|0|||
155251114|NCT00355082|560350010|FG000|Continuation Phase|Lack of Efficacy|5|||
155251115|NCT00355082|560350011|FG001|Continuation Phase|Lack of Efficacy|0|||
155251116|NCT00355082|560350012|FG002|Continuation Phase|Lack of Efficacy|0|||
155251117|NCT00355082|560350010|FG000|Continuation Phase|Site Closed by Sponsor|8|||
155251118|NCT00355082|560350011|FG001|Continuation Phase|Site Closed by Sponsor|0|||
155251119|NCT00355082|560350012|FG002|Continuation Phase|Site Closed by Sponsor|0|||
155251120|NCT00355082|560350010|FG000|Continuation Phase|Scheduling Error|1|||
155251121|NCT00355082|560350011|FG001|Continuation Phase|Scheduling Error|0|||
155251122|NCT00355082|560350012|FG002|Continuation Phase|Scheduling Error|0|||
155251123|NCT00355082|560350010|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
155251124|NCT00355082|560350011|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
155251125|NCT00355082|560350012|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
155251126|NCT03570619|560350013|FG000|Overall Study|Adverse Event|2|||
155251127|NCT03570619|560350014|FG001|Overall Study|Adverse Event|0|||
155251128|NCT03570619|560350015|FG002|Overall Study|Adverse Event|1|||
155251129|NCT03570619|560350013|FG000|Overall Study|new diagnosis of new malignancy|1|||
155251130|NCT03570619|560350014|FG001|Overall Study|new diagnosis of new malignancy|0|||
155251131|NCT03570619|560350015|FG002|Overall Study|new diagnosis of new malignancy|0|||
155251132|NCT03570619|560350013|FG000|Overall Study|Physician Decision|1|||
155251133|NCT03570619|560350014|FG001|Overall Study|Physician Decision|1|||
155251134|NCT03570619|560350015|FG002|Overall Study|Physician Decision|0|||
155251135|NCT03570619|560350013|FG000|Overall Study|Withdrawal by Subject|0|||
155251136|NCT03570619|560350014|FG001|Overall Study|Withdrawal by Subject|2|||
155251137|NCT03570619|560350015|FG002|Overall Study|Withdrawal by Subject|0|||
155251138|NCT01954017|560350018|FG000|Overall Study|Adverse Event|0|||
155251139|NCT01954017|560350019|FG001|Overall Study|Adverse Event|0|||
155251140|NCT01954017|560350020|FG002|Overall Study|Adverse Event|1|||
155251141|NCT01954017|560350018|FG000|Overall Study|Death|2|||
155251142|NCT01954017|560350019|FG001|Overall Study|Death|1|||
155251143|NCT01954017|560350020|FG002|Overall Study|Death|1|||
155251144|NCT01954017|560350018|FG000|Overall Study|Withdrawal by Subject|0|||
155251145|NCT01954017|560350019|FG001|Overall Study|Withdrawal by Subject|1|||
155251146|NCT01954017|560350020|FG002|Overall Study|Withdrawal by Subject|0|||
155251147|NCT01954017|560350018|FG000|Overall Study|Protocol Violation|0|||
155251148|NCT01954017|560350019|FG001|Overall Study|Protocol Violation|3|||
155251149|NCT01954017|560350020|FG002|Overall Study|Protocol Violation|2|||
155251150|NCT01954017|560350018|FG000|Overall Study|Necrotizing enterocolitis|1|||
155251151|NCT01954017|560350019|FG001|Overall Study|Necrotizing enterocolitis|0|||
155251152|NCT01954017|560350020|FG002|Overall Study|Necrotizing enterocolitis|1|||
155251153|NCT01954017|560350018|FG000|Overall Study|Enteral intake stopped >7 days|0|||
155251154|NCT01954017|560350019|FG001|Overall Study|Enteral intake stopped >7 days|1|||
155251155|NCT01954017|560350020|FG002|Overall Study|Enteral intake stopped >7 days|1|||
155251156|NCT01954017|560350018|FG000|Overall Study|All other reasons|2|||
155251157|NCT01954017|560350019|FG001|Overall Study|All other reasons|2|||
155251158|NCT01954017|560350020|FG002|Overall Study|All other reasons|7|||
155251159|NCT03346759|560350021|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
155251160|NCT03346759|560350022|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
155251161|NCT03346759|560350021|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
155251162|NCT03346759|560350022|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
155251163|NCT03346759|560350021|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
155251164|NCT03346759|560350022|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
155251165|NCT04177758|560350031|FG000|Overall Study|Lost to Follow-up|19|||
155251166|NCT04177758|560350032|FG001|Overall Study|Lost to Follow-up|11|||
155251167|NCT00744653|560350036|FG000|Overall Study|antineoplastic treatment|11|||
155251168|NCT00744653|560350036|FG000|Overall Study|Death|1|||
155251169|NCT00744653|560350036|FG000|Overall Study|Lost to Follow-up|1|||
155251170|NCT00744653|560350036|FG000|Overall Study|Physician Decision|3|||
155251171|NCT03826667|560350037|FG000|Overall Study|Protocol deviation|21|||
155251172|NCT00808808|560350038|FG000|Overall Study|Vaccinated; survey not completed|131|||
155251173|NCT00808808|560350039|FG001|Overall Study|Vaccinated; survey not completed|169|||
155251174|NCT00808808|560350040|FG002|Overall Study|Vaccinated; survey not completed|302|||
155251175|NCT00808808|560350038|FG000|Overall Study|Employee was not vaccinated.|2686|||
155251176|NCT00808808|560350039|FG001|Overall Study|Employee was not vaccinated.|2268|||
155251177|NCT00808808|560350040|FG002|Overall Study|Employee was not vaccinated.|2255|||
155251178|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
155251179|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
155251180|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
155251181|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
155251182|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
155251183|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
155251184|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
155251185|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
155251186|NCT00679939|560350044|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
155251187|NCT00679939|560350045|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
155251188|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
155251189|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
155251190|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
155251191|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
155251192|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
155251193|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
155251194|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
155251195|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
155251196|NCT00679939|560350044|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
155251197|NCT00679939|560350045|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
155251198|NCT01453595|560350048|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155251199|NCT01453595|560350049|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155251200|NCT01453595|560350050|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155251201|NCT02653482|560350053|FG000|Overall Study|Death|1|||
155251202|NCT02653482|560350054|FG001|Overall Study|Death|1|||
155251203|NCT01864564|560350057|FG000|Overall Study|Lost to Follow-up|17|||
155251204|NCT01864564|560350058|FG001|Overall Study|Lost to Follow-up|23|||
155251205|NCT01864564|560350057|FG000|Overall Study|Withdrawal by Subject|20|||
155251206|NCT01864564|560350058|FG001|Overall Study|Withdrawal by Subject|11|||
155251207|NCT01864564|560350057|FG000|Overall Study|Protocol Violation|0|||
155251208|NCT01864564|560350058|FG001|Overall Study|Protocol Violation|27|||
155251209|NCT01864564|560350057|FG000|Overall Study|not reported|0|||
155251210|NCT01864564|560350058|FG001|Overall Study|not reported|34|||
155251211|NCT03077724|560350059|FG000|Overall Study|Lost to Follow-up|5|||
155251212|NCT03077724|560350060|FG001|Overall Study|Lost to Follow-up|1|||
155251213|NCT03077724|560350059|FG000|Overall Study|Withdrawal by Subject|3|||
155251214|NCT03077724|560350060|FG001|Overall Study|Withdrawal by Subject|1|||
155251215|NCT02269670|560350061|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
155251216|NCT00234065|560350062|FG000|Overall Study|Adverse Event|268|||
155251217|NCT00234065|560350063|FG001|Overall Study|Adverse Event|166|||
155251218|NCT00234065|560350062|FG000|Overall Study|Withdrawal by Subject|73|||
155251219|NCT00234065|560350063|FG001|Overall Study|Withdrawal by Subject|56|||
155251220|NCT00234065|560350062|FG000|Overall Study|Physician Decision|23|||
155251221|NCT00234065|560350063|FG001|Overall Study|Physician Decision|22|||
155251222|NCT00234065|560350062|FG000|Overall Study|Not Classified|111|||
155251223|NCT00234065|560350063|FG001|Overall Study|Not Classified|112|||
155251224|NCT00003508|560351709|FG000|Overall Study|Not evaluable|5|||
155251225|NCT02160314|560351710|FG000|Overall Study|Adverse Event|0|||
155251226|NCT02160314|560351711|FG001|Overall Study|Adverse Event|6|||
155251227|NCT02160314|560351710|FG000|Overall Study|Protocol Violation|0|||
155251228|NCT02160314|560351711|FG001|Overall Study|Protocol Violation|4|||
155251229|NCT02160314|560351710|FG000|Overall Study|Withdrawal by Subject|1|||
155251230|NCT02160314|560351711|FG001|Overall Study|Withdrawal by Subject|2|||
155251231|NCT02160314|560351710|FG000|Overall Study|Lost to Follow-up|0|||
155251232|NCT02160314|560351711|FG001|Overall Study|Lost to Follow-up|1|||
155251233|NCT00593567|560351712|FG000|Overall Study|Adverse Event|2|||
155251234|NCT00593567|560351713|FG001|Overall Study|Adverse Event|0|||
155251235|NCT00593567|560351712|FG000|Overall Study|Physician Decision|2|||
155251236|NCT00593567|560351713|FG001|Overall Study|Physician Decision|0|||
155251237|NCT00593567|560351712|FG000|Overall Study|Protocol Violation|13|||
155251238|NCT00593567|560351713|FG001|Overall Study|Protocol Violation|7|||
155251239|NCT00593567|560351712|FG000|Overall Study|Lack of Efficacy|2|||
155251240|NCT00593567|560351713|FG001|Overall Study|Lack of Efficacy|1|||
155251241|NCT00593567|560351712|FG000|Overall Study|Withdrawal by Subject|1|||
155251242|NCT00593567|560351713|FG001|Overall Study|Withdrawal by Subject|2|||
155251243|NCT03576768|560351719|FG000|Overall Study|Lost to Follow-up|3|||
155251244|NCT03576768|560351720|FG001|Overall Study|Lost to Follow-up|3|||
155251245|NCT03576768|560351721|FG002|Overall Study|Lost to Follow-up|0|||
155251246|NCT03576768|560351722|FG003|Overall Study|Lost to Follow-up|0|||
155251247|NCT00590902|560351723|FG000|Overall Study|Death|1|||
155251248|NCT00785291|560351724|FG000|Overall Study|Never began treatment|8|||
155251249|NCT00785291|560351725|FG001|Overall Study|Never began treatment|4|||
155251250|NCT00785291|560351726|FG002|Overall Study|Never began treatment|4|||
155251251|NCT00785291|560351724|FG000|Overall Study|Adverse Event|39|||
155251252|NCT00785291|560351725|FG001|Overall Study|Adverse Event|70|||
155251253|NCT00785291|560351726|FG002|Overall Study|Adverse Event|56|||
155251254|NCT00785291|560351724|FG000|Overall Study|Death|7|||
155251255|NCT00785291|560351725|FG001|Overall Study|Death|4|||
155251256|NCT00785291|560351726|FG002|Overall Study|Death|3|||
155251257|NCT00785291|560351724|FG000|Overall Study|Withdrawal by Subject|35|||
155251258|NCT00785291|560351725|FG001|Overall Study|Withdrawal by Subject|36|||
155251259|NCT00785291|560351726|FG002|Overall Study|Withdrawal by Subject|17|||
155251260|NCT00785291|560351724|FG000|Overall Study|Alternative Therapy|12|||
155251261|NCT00785291|560351725|FG001|Overall Study|Alternative Therapy|6|||
155251262|NCT00785291|560351726|FG002|Overall Study|Alternative Therapy|7|||
155251263|NCT00785291|560351724|FG000|Overall Study|Complicating illness|6|||
155251264|NCT00785291|560351725|FG001|Overall Study|Complicating illness|4|||
155251265|NCT00785291|560351726|FG002|Overall Study|Complicating illness|4|||
155251266|NCT00785291|560351724|FG000|Overall Study|Other Medical Reasons|29|||
155251267|NCT00785291|560351725|FG001|Overall Study|Other Medical Reasons|25|||
155251268|NCT00785291|560351726|FG002|Overall Study|Other Medical Reasons|15|||
155251269|NCT02119260|560351727|FG000|Overall Study|Adverse Event|1|||
155251270|NCT02119260|560351728|FG001|Overall Study|Adverse Event|0|||
155251271|NCT02119260|560351729|FG002|Overall Study|Adverse Event|0|||
155251272|NCT02119260|560351730|FG003|Overall Study|Adverse Event|0|||
155251273|NCT02119260|560351731|FG004|Overall Study|Adverse Event|0|||
155251274|NCT02119260|560351732|FG005|Overall Study|Adverse Event|0|||
155251275|NCT02119260|560351733|FG006|Overall Study|Adverse Event|0|||
155251276|NCT02119260|560351727|FG000|Overall Study|Withdrew consent|0|||
155251277|NCT02119260|560351728|FG001|Overall Study|Withdrew consent|1|||
155251278|NCT02119260|560351729|FG002|Overall Study|Withdrew consent|1|||
155251279|NCT02119260|560351730|FG003|Overall Study|Withdrew consent|0|||
155251280|NCT02119260|560351731|FG004|Overall Study|Withdrew consent|0|||
155251281|NCT02119260|560351732|FG005|Overall Study|Withdrew consent|0|||
155251282|NCT02119260|560351733|FG006|Overall Study|Withdrew consent|0|||
155251283|NCT02057874|560351735|FG000|Overall Study|participant did not return for scan|1|||
155251284|NCT01738984|560351738|FG000|Overall Study|Pregnancy|4|||
155251285|NCT01738984|560351739|FG001|Overall Study|Pregnancy|0|||
155251286|NCT01738984|560351738|FG000|Overall Study|Withdrawal by Subject|1|||
155251287|NCT01738984|560351739|FG001|Overall Study|Withdrawal by Subject|0|||
155251288|NCT01738984|560351738|FG000|Overall Study|Lost to Follow-up|59|||
155251289|NCT01738984|560351739|FG001|Overall Study|Lost to Follow-up|39|||
155251290|NCT00920426|560351744|FG000|ITZ111451|Adverse Event|1|||
155251291|NCT00920426|560351745|FG001|ITZ111451|Adverse Event|0|||
155251292|NCT00920426|560351746|FG002|ITZ111451|Adverse Event|0|||
155251293|NCT00920426|560351747|FG003|ITZ111451|Adverse Event|0|||
155251294|NCT00955357|560351752|FG000|Titration Phase|Adverse Event|9|||
155251295|NCT00955357|560351753|FG001|Titration Phase|Adverse Event|46|||
155251296|NCT00955357|560351752|FG000|Titration Phase|Lack of Efficacy|0|||
155251297|NCT00955357|560351753|FG001|Titration Phase|Lack of Efficacy|2|||
155251298|NCT00955357|560351752|FG000|Titration Phase|Protocol Violation|3|||
155251299|NCT00955357|560351753|FG001|Titration Phase|Protocol Violation|7|||
155251300|NCT00955357|560351752|FG000|Titration Phase|Lost to Follow-up|1|||
155251301|NCT00955357|560351753|FG001|Titration Phase|Lost to Follow-up|3|||
155251302|NCT00955357|560351752|FG000|Titration Phase|Withdrawal by Subject|3|||
155251303|NCT00955357|560351753|FG001|Titration Phase|Withdrawal by Subject|5|||
155251304|NCT00955357|560351752|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
155251305|NCT00955357|560351753|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
155251306|NCT00955357|560351752|FG000|Titration Phase|Study medication not tolerated|0|||
155251307|NCT00955357|560351753|FG001|Titration Phase|Study medication not tolerated|1|||
155251308|NCT00955357|560351752|FG000|Titration Phase|Non compliance to study procedures|0|||
155251309|NCT00955357|560351753|FG001|Titration Phase|Non compliance to study procedures|1|||
155251310|NCT00955357|560351752|FG000|Maintenance Phase|Adverse Event|3|||
155251311|NCT00955357|560351753|FG001|Maintenance Phase|Adverse Event|23|||
155251312|NCT00955357|560351752|FG000|Maintenance Phase|Lack of Efficacy|0|||
155251313|NCT00955357|560351753|FG001|Maintenance Phase|Lack of Efficacy|4|||
155251314|NCT00955357|560351752|FG000|Maintenance Phase|Protocol Violation|2|||
155251315|NCT00955357|560351753|FG001|Maintenance Phase|Protocol Violation|6|||
155251316|NCT00955357|560351752|FG000|Maintenance Phase|Lost to Follow-up|2|||
155251317|NCT00955357|560351753|FG001|Maintenance Phase|Lost to Follow-up|7|||
155251318|NCT00955357|560351752|FG000|Maintenance Phase|Withdrawal by Subject|4|||
155251319|NCT00955357|560351753|FG001|Maintenance Phase|Withdrawal by Subject|4|||
155251320|NCT00955357|560351752|FG000|Maintenance Phase|Patient moving out of area|0|||
155251321|NCT00955357|560351753|FG001|Maintenance Phase|Patient moving out of area|1|||
155251322|NCT00955357|560351752|FG000|Maintenance Phase|Non compliance to study procedures|1|||
155251323|NCT00955357|560351753|FG001|Maintenance Phase|Non compliance to study procedures|0|||
155251324|NCT02481310|560351754|FG000|Follow up|Still in follow up|0|||
155251325|NCT02481310|560351755|FG001|Follow up|Still in follow up|3|||
155251326|NCT02481310|560351756|FG002|Follow up|Still in follow up|0|||
155251327|NCT00643916|560351758|FG000|Overall Study|Protocol Violation|0|||
155251328|NCT00643916|560351759|FG001|Overall Study|Protocol Violation|1|||
155251329|NCT00643916|560351760|FG002|Overall Study|Protocol Violation|1|||
155251330|NCT00643916|560351761|FG003|Overall Study|Protocol Violation|1|||
155251331|NCT00643916|560351762|FG004|Overall Study|Protocol Violation|0|||
155251332|NCT00643916|560351763|FG005|Overall Study|Protocol Violation|0|||
155251333|NCT00643916|560351758|FG000|Overall Study|Lost to Follow-up|0|||
155251334|NCT00643916|560351759|FG001|Overall Study|Lost to Follow-up|1|||
155251335|NCT00643916|560351760|FG002|Overall Study|Lost to Follow-up|0|||
155251336|NCT00643916|560351761|FG003|Overall Study|Lost to Follow-up|0|||
155251337|NCT00643916|560351762|FG004|Overall Study|Lost to Follow-up|0|||
155251338|NCT00643916|560351763|FG005|Overall Study|Lost to Follow-up|0|||
155251339|NCT00643916|560351758|FG000|Overall Study|Withdrawal by Subject|2|||
155251340|NCT00643916|560351759|FG001|Overall Study|Withdrawal by Subject|2|||
155251341|NCT00643916|560351760|FG002|Overall Study|Withdrawal by Subject|2|||
155251342|NCT00643916|560351761|FG003|Overall Study|Withdrawal by Subject|1|||
155251343|NCT00643916|560351762|FG004|Overall Study|Withdrawal by Subject|0|||
155251344|NCT00643916|560351763|FG005|Overall Study|Withdrawal by Subject|1|||
155251345|NCT00643916|560351758|FG000|Overall Study|Not Vaccinated|2|||
155251346|NCT00643916|560351759|FG001|Overall Study|Not Vaccinated|2|||
155251347|NCT00643916|560351760|FG002|Overall Study|Not Vaccinated|3|||
155251348|NCT00643916|560351761|FG003|Overall Study|Not Vaccinated|0|||
155251349|NCT00643916|560351762|FG004|Overall Study|Not Vaccinated|2|||
155251350|NCT00643916|560351763|FG005|Overall Study|Not Vaccinated|0|||
155251351|NCT02925455|560351768|FG000|Overall Study|Withdrawal by Subject|2|||
155251352|NCT02925455|560351769|FG001|Overall Study|Withdrawal by Subject|0|||
155251353|NCT00686166|560351775|FG000|Overall Study|Adverse Event|7|||
155251354|NCT00686166|560351775|FG000|Overall Study|Withdrawal by Subject|1|||
155251355|NCT00686166|560351775|FG000|Overall Study|Progression/Relapse|1|||
155251356|NCT00686166|560351775|FG000|Overall Study|Death|1|||
155251357|NCT00686166|560351775|FG000|Overall Study|Not Protocol Specified|1|||
155251358|NCT00686166|560351775|FG000|Overall Study|Ineligible|5|||
155251359|NCT00686166|560351775|FG000|Overall Study|Did not begin protocol therapy|4|||
155251360|NCT01514448|560351776|FG000|Overall Study|Death|7|||
155251361|NCT01514448|560351777|FG001|Overall Study|Death|8|||
155251362|NCT01514448|560351776|FG000|Overall Study|Withdrawal by Subject|2|||
155251363|NCT01514448|560351777|FG001|Overall Study|Withdrawal by Subject|0|||
155251364|NCT01514448|560351776|FG000|Overall Study|Lost to Follow-up|2|||
155251365|NCT01514448|560351777|FG001|Overall Study|Lost to Follow-up|0|||
155251366|NCT01514448|560351776|FG000|Overall Study|New Cancer Therapy|1|||
155251367|NCT01514448|560351777|FG001|Overall Study|New Cancer Therapy|0|||
155251368|NCT00985725|560351778|FG000|Overall Study|Adverse Event|4|||
155251369|NCT00985725|560351779|FG001|Overall Study|Adverse Event|1|||
155251370|NCT00985725|560351778|FG000|Overall Study|Protocol Violation|1|||
155251371|NCT00985725|560351779|FG001|Overall Study|Protocol Violation|3|||
155251372|NCT00985725|560351778|FG000|Overall Study|Withdrawal by Subject|4|||
155251373|NCT00985725|560351779|FG001|Overall Study|Withdrawal by Subject|4|||
155251374|NCT00985725|560351778|FG000|Overall Study|Lost to Follow-up|1|||
155251375|NCT00985725|560351779|FG001|Overall Study|Lost to Follow-up|1|||
155251376|NCT00985725|560351778|FG000|Overall Study|Lack of Efficacy|0|||
155251377|NCT00985725|560351779|FG001|Overall Study|Lack of Efficacy|1|||
155251378|NCT00985725|560351778|FG000|Overall Study|Non-compliance|1|||
155251379|NCT00985725|560351779|FG001|Overall Study|Non-compliance|2|||
155251380|NCT00985725|560351778|FG000|Overall Study|Out-of-window visits|0|||
155251381|NCT00985725|560351779|FG001|Overall Study|Out-of-window visits|1|||
155251382|NCT03912259|560351783|FG000|Overall Study|Adverse Event (AE)|2|||
155251383|NCT03912259|560351784|FG001|Overall Study|Adverse Event (AE)|4|||
155251384|NCT03912259|560351783|FG000|Overall Study|Lack of Efficacy|4|||
155251385|NCT03912259|560351784|FG001|Overall Study|Lack of Efficacy|1|||
155251386|NCT03912259|560351783|FG000|Overall Study|Withdrawal by Subject|11|||
155251387|NCT03912259|560351784|FG001|Overall Study|Withdrawal by Subject|1|||
155251388|NCT01549613|560351785|FG000|Overall Study|Lost to Follow-up|11|||
155251389|NCT01549613|560351786|FG001|Overall Study|Lost to Follow-up|11|||
155251390|NCT02131272|560351787|FG000|Overall Study|Withdrawal by parent|0|||
155251391|NCT02131272|560351788|FG001|Overall Study|Withdrawal by parent|1|||
155251392|NCT02131272|560351787|FG000|Overall Study|Withdrawal by Subject|0|||
155251393|NCT02131272|560351788|FG001|Overall Study|Withdrawal by Subject|1|||
155251394|NCT02131272|560351787|FG000|Overall Study|Withdrawal Criteria|1|||
155251395|NCT02131272|560351788|FG001|Overall Study|Withdrawal Criteria|0|||
155251396|NCT01925950|560351789|FG000|Part 2|Withdrawal by Subject|1|||
155251397|NCT01925950|560351790|FG001|Part 2|Withdrawal by Subject|0|||
155251398|NCT00381940|560351791|FG000|Overall Study|Lack of Efficacy|3|||
155251399|NCT00381940|560351791|FG000|Overall Study|Protocol Violation|1|||
155251400|NCT00381940|560351791|FG000|Overall Study|Ineligible|1|||
155251401|NCT03162224|560351792|FG000|Overall Study|Death|4|||
155251402|NCT03162224|560351793|FG001|Overall Study|Death|5|||
155251403|NCT03162224|560351794|FG002|Overall Study|Death|8|||
155251404|NCT03162224|560351792|FG000|Overall Study|Withdrawal by Subject|1|||
155251405|NCT03162224|560351793|FG001|Overall Study|Withdrawal by Subject|0|||
155251406|NCT03162224|560351794|FG002|Overall Study|Withdrawal by Subject|1|||
155251407|NCT03162224|560351792|FG000|Overall Study|Lost to Follow-up|0|||
155251408|NCT03162224|560351793|FG001|Overall Study|Lost to Follow-up|1|||
155251409|NCT03162224|560351794|FG002|Overall Study|Lost to Follow-up|0|||
155251410|NCT03162224|560351792|FG000|Overall Study|Other|6|||
155251411|NCT03162224|560351793|FG001|Overall Study|Other|2|||
155251412|NCT03162224|560351794|FG002|Overall Study|Other|1|||
155251413|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
155251414|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
155251415|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
155251416|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
155251417|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
155251418|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
155251419|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
155251420|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
155251421|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
155251422|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
155251423|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
155251424|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
155251425|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
155251426|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
155251427|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
155251428|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
155251429|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
155251430|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
155251431|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
155251432|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
155251433|NCT04162769|560351795|FG000|Double-blind Treatment (12-Week)|Other|0|||
155251434|NCT04162769|560351796|FG001|Double-blind Treatment (12-Week)|Other|1|||
155251435|NCT04162769|560351797|FG002|Double-blind Treatment (12-Week)|Other|1|||
155251436|NCT04162769|560351798|FG003|Double-blind Treatment (12-Week)|Other|0|||
155251437|NCT04162769|560351795|FG000|OLE Period (52-Week)|Adverse Event|0|||
155251438|NCT04162769|560351796|FG001|OLE Period (52-Week)|Adverse Event|0|||
155251439|NCT04162769|560351797|FG002|OLE Period (52-Week)|Adverse Event|0|||
155251440|NCT04162769|560351798|FG003|OLE Period (52-Week)|Adverse Event|5|||
155251441|NCT04162769|560351795|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
155251442|NCT04162769|560351796|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
155251443|NCT04162769|560351797|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
155251444|NCT04162769|560351798|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
155251445|NCT04162769|560351795|FG000|OLE Period (52-Week)|Physician Decision|0|||
155251446|NCT04162769|560351796|FG001|OLE Period (52-Week)|Physician Decision|0|||
155251447|NCT04162769|560351797|FG002|OLE Period (52-Week)|Physician Decision|0|||
155251448|NCT04162769|560351798|FG003|OLE Period (52-Week)|Physician Decision|1|||
155251449|NCT04162769|560351795|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
155251450|NCT04162769|560351796|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
155251451|NCT04162769|560351797|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
155251452|NCT04162769|560351798|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
155251453|NCT04162769|560351795|FG000|OLE Period (52-Week)|Protocol deviation|0|||
155251454|NCT04162769|560351796|FG001|OLE Period (52-Week)|Protocol deviation|0|||
155251455|NCT04162769|560351797|FG002|OLE Period (52-Week)|Protocol deviation|0|||
155251456|NCT04162769|560351798|FG003|OLE Period (52-Week)|Protocol deviation|2|||
155251457|NCT04052204|560351808|FG000|Overall Study|Death|1|||
155251458|NCT04052204|560351809|FG001|Overall Study|Death|0|||
155251459|NCT04052204|560351810|FG002|Overall Study|Death|0|||
155251460|NCT04052204|560351808|FG000|Overall Study|Progressive disease|1|||
155251461|NCT04052204|560351809|FG001|Overall Study|Progressive disease|0|||
155251462|NCT04052204|560351810|FG002|Overall Study|Progressive disease|0|||
155251463|NCT04052204|560351808|FG000|Overall Study|Other|1|||
155251464|NCT04052204|560351809|FG001|Overall Study|Other|0|||
155251465|NCT04052204|560351810|FG002|Overall Study|Other|0|||
155251466|NCT01433354|560351811|FG000|Overall Study|Adverse Event|6|||
155251467|NCT01433354|560351811|FG000|Overall Study|Lost to Follow-up|1|||
155251468|NCT01433354|560351811|FG000|Overall Study|Administrative problems|90|||
155251469|NCT01433354|560351811|FG000|Overall Study|Protocol Violation|2|||
155251470|NCT01433354|560351811|FG000|Overall Study|Lack of Efficacy|17|||
155251471|NCT01433354|560351811|FG000|Overall Study|Subject Withdrew Consent|3|||
155251472|NCT04794803|560351812|FG000|Overall Study|Death|1|||
155251473|NCT04794803|560351813|FG001|Overall Study|Death|3|||
155251474|NCT04794803|560351812|FG000|Overall Study|Lost to Follow-up|2|||
155251475|NCT04794803|560351813|FG001|Overall Study|Lost to Follow-up|2|||
155251476|NCT04794803|560351812|FG000|Overall Study|Withdrawal by Subject|1|||
155251477|NCT04794803|560351813|FG001|Overall Study|Withdrawal by Subject|0|||
155251478|NCT04794803|560351812|FG000|Overall Study|Physician Decision|1|||
155251479|NCT04794803|560351813|FG001|Overall Study|Physician Decision|1|||
155251480|NCT04794803|560351812|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
155251481|NCT04794803|560351813|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
155251482|NCT04794803|560351812|FG000|Overall Study|Refused to continue the treatment|1|||
155251483|NCT04794803|560351813|FG001|Overall Study|Refused to continue the treatment|0|||
155251484|NCT04794803|560351812|FG000|Overall Study|Patient admitted to ICU|0|||
155251485|NCT04794803|560351813|FG001|Overall Study|Patient admitted to ICU|1|||
155251486|NCT00937924|560351820|FG000|Overall Study|Lost to Follow-up|44|||
155251487|NCT00937924|560351821|FG001|Overall Study|Lost to Follow-up|44|||
155251488|NCT00937924|560351822|FG002|Overall Study|Lost to Follow-up|41|||
155251489|NCT03152526|560351828|FG000|Overall Study|Withdrawal by Subject|0|||
155251490|NCT03152526|560351829|FG001|Overall Study|Withdrawal by Subject|1|||
155251491|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
155251492|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
155251493|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
155251494|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
155251495|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
155251496|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
155251497|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
155251498|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
155251499|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
155251500|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
155251501|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
155251502|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
155251503|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
155251504|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
155251505|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
155251506|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
155251507|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
155251508|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
155251509|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
155251510|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
155251511|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
155251512|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
155251513|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
155251514|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
155251515|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
155251516|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
155251517|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
155251518|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
155251519|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
155251520|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
155251521|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
155251522|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
155251523|NCT04818346|560351830|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
155251524|NCT04818346|560351831|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
155251525|NCT04818346|560351832|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
155251526|NCT04818346|560351833|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
155251527|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
155251528|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
155251529|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
155251530|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
155251531|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
155251532|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
155251533|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
155251534|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
155251535|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
155251536|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
155251537|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
155251538|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
155251539|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
155251540|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
155251541|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
155251542|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
155251543|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
155251544|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
155251545|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
155251546|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
155251547|NCT04818346|560351830|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
155251548|NCT04818346|560351831|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
155251549|NCT04818346|560351832|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
155251550|NCT04818346|560351833|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
155251551|NCT05553808|560351834|FG000|Overall Study|Death|25|||
155251552|NCT05553808|560351835|FG001|Overall Study|Death|62|||
155251553|NCT05553808|560351834|FG000|Overall Study|Site Closed|6|||
155251554|NCT05553808|560351835|FG001|Overall Study|Site Closed|6|||
155251555|NCT05553808|560351834|FG000|Overall Study|Lost to Follow-up|1|||
155251556|NCT05553808|560351835|FG001|Overall Study|Lost to Follow-up|0|||
155251557|NCT05553808|560351834|FG000|Overall Study|Withdrawal by Subject|3|||
155251558|NCT05553808|560351835|FG001|Overall Study|Withdrawal by Subject|2|||
155251559|NCT02273141|560351836|FG000|Overall Study|Adverse Event|0|||
155251560|NCT02273141|560351837|FG001|Overall Study|Adverse Event|1|||
155251561|NCT02273141|560351836|FG000|Overall Study|Lost to Follow-up|1|||
155251562|NCT02273141|560351837|FG001|Overall Study|Lost to Follow-up|3|||
155251563|NCT02273141|560351836|FG000|Overall Study|Withdrawal by Subject|10|||
155251564|NCT02273141|560351837|FG001|Overall Study|Withdrawal by Subject|15|||
155251565|NCT02273141|560351836|FG000|Overall Study|Various|6|||
155251566|NCT02273141|560351837|FG001|Overall Study|Various|6|||
155251567|NCT00492284|560351838|FG000|Overall Study|Adverse Event|0|||
155251568|NCT00492284|560351839|FG001|Overall Study|Adverse Event|1|||
155251569|NCT00492284|560351840|FG002|Overall Study|Adverse Event|1|||
155251570|NCT00492284|560351841|FG003|Overall Study|Adverse Event|2|||
155251571|NCT00492284|560351838|FG000|Overall Study|Lost to Follow-up|0|||
155251572|NCT00492284|560351839|FG001|Overall Study|Lost to Follow-up|0|||
155251573|NCT00492284|560351840|FG002|Overall Study|Lost to Follow-up|3|||
155251574|NCT00492284|560351841|FG003|Overall Study|Lost to Follow-up|1|||
155251575|NCT00492284|560351838|FG000|Overall Study|Death|0|||
155251576|NCT00492284|560351839|FG001|Overall Study|Death|3|||
155251577|NCT00492284|560351840|FG002|Overall Study|Death|2|||
155251578|NCT00492284|560351841|FG003|Overall Study|Death|5|||
155251579|NCT00492284|560351838|FG000|Overall Study|Withdrawal by Subject|1|||
155251580|NCT00492284|560351839|FG001|Overall Study|Withdrawal by Subject|0|||
155251581|NCT00492284|560351840|FG002|Overall Study|Withdrawal by Subject|0|||
155251582|NCT00492284|560351841|FG003|Overall Study|Withdrawal by Subject|2|||
155251583|NCT02293538|560351844|FG000|Overall Study|Adverse Event|0|||
155251584|NCT02293538|560351845|FG001|Overall Study|Adverse Event|1|||
155251585|NCT02293538|560351844|FG000|Overall Study|Lost to Follow-up|1|||
155251586|NCT02293538|560351845|FG001|Overall Study|Lost to Follow-up|0|||
155251587|NCT02293538|560351844|FG000|Overall Study|Withdrawal by Subject|0|||
155251588|NCT02293538|560351845|FG001|Overall Study|Withdrawal by Subject|1|||
155251589|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
155251590|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
155251591|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
155251592|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
155251593|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
155251594|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251595|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
155251596|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251597|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251598|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
155251599|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
155251600|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
155251601|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
155251602|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
155251603|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
155251604|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251605|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251606|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
155251607|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251608|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
155251609|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251610|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251611|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
155251612|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251613|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
155251614|NCT03152552|560351848|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251615|NCT03152552|560351849|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251616|NCT03152552|560351850|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251617|NCT03152552|560351851|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
155251618|NCT03152552|560351852|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
155251619|NCT03152552|560351848|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
155251620|NCT03152552|560351849|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
155251621|NCT03152552|560351850|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
155251622|NCT03152552|560351851|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
155251623|NCT03152552|560351852|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
155251624|NCT02372409|560351855|FG000|Overall Study|Lost to Follow-up|1|||
155251625|NCT02372409|560351856|FG001|Overall Study|Lost to Follow-up|0|||
155251626|NCT02372409|560351855|FG000|Overall Study|Disease progression|1|||
155251627|NCT02372409|560351856|FG001|Overall Study|Disease progression|1|||
155251628|NCT04084314|560351857|FG000|Overall Study|Subject/guardian decision|91|||
155251629|NCT04084314|560351857|FG000|Overall Study|Adverse Event|24|||
155251630|NCT04084314|560351857|FG000|Overall Study|Lost to Follow-up|19|||
155251631|NCT04084314|560351857|FG000|Overall Study|New therapy for study indication|9|||
155251632|NCT04084314|560351857|FG000|Overall Study|Pregnancy|9|||
155251633|NCT04084314|560351857|FG000|Overall Study|Withdrawal of informed consent|8|||
155251634|NCT04084314|560351857|FG000|Overall Study|Physician Decision|4|||
155251635|NCT04084314|560351857|FG000|Overall Study|Protocol Deviation|3|||
155251636|NCT00622167|560351858|FG000|Overall Study|Did not meet angiographic criteria|20|||
155251637|NCT03336619|560351859|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
155251638|NCT03336619|560351860|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
155251639|NCT03336619|560351859|FG000|Overall Study|Withdrawal by Subject|17|||
155251640|NCT03336619|560351860|FG001|Overall Study|Withdrawal by Subject|16|||
155251641|NCT03336619|560351859|FG000|Overall Study|Adverse Event|2|||
155251642|NCT03336619|560351860|FG001|Overall Study|Adverse Event|5|||
155251643|NCT03336619|560351859|FG000|Overall Study|Physician Decision|3|||
155251644|NCT03336619|560351860|FG001|Overall Study|Physician Decision|0|||
155251645|NCT01300546|560351861|FG000|Overall Study|Withdrawal by Subject|1|||
155251646|NCT01300546|560351862|FG001|Overall Study|Withdrawal by Subject|0|||
155251647|NCT01300546|560351861|FG000|Overall Study|Lost to Follow-up|0|||
155251648|NCT01300546|560351862|FG001|Overall Study|Lost to Follow-up|2|||
155251649|NCT01300546|560351861|FG000|Overall Study|Lack of Efficacy|0|||
155251650|NCT01300546|560351862|FG001|Overall Study|Lack of Efficacy|3|||
155251651|NCT01300546|560351861|FG000|Overall Study|Adverse Event|0|||
155251652|NCT01300546|560351862|FG001|Overall Study|Adverse Event|1|||
155251653|NCT02820623|560351863|FG000|Overall Study|Withdrawal by Subject|1|||
155251654|NCT02820623|560351864|FG001|Overall Study|Withdrawal by Subject|3|||
155251655|NCT02820623|560351865|FG002|Overall Study|Withdrawal by Subject|3|||
155251656|NCT02820623|560351863|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
155251657|NCT02820623|560351864|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
155251658|NCT02820623|560351865|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
155251659|NCT02820623|560351863|FG000|Overall Study|Therapist unable to enroll clients|1|||
155251660|NCT02820623|560351864|FG001|Overall Study|Therapist unable to enroll clients|1|||
155251661|NCT02820623|560351865|FG002|Overall Study|Therapist unable to enroll clients|3|||
155251662|NCT02820623|560351863|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
155251663|NCT02820623|560351864|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
155251664|NCT02820623|560351865|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
155251665|NCT00126438|560351872|FG000|Overall Study|Withdrawal due to adverse event|1|||
155251666|NCT00126438|560351873|FG001|Overall Study|Withdrawal due to adverse event|0|||
155251667|NCT00126438|560351872|FG000|Overall Study|Lost to Follow-up|22|||
155251668|NCT00126438|560351873|FG001|Overall Study|Lost to Follow-up|0|||
155251669|NCT00126438|560351872|FG000|Overall Study|Protocol Violation|8|||
155251670|NCT00126438|560351873|FG001|Overall Study|Protocol Violation|8|||
155251671|NCT00126438|560351872|FG000|Overall Study|Withdrawal by Subject|3|||
155251672|NCT00126438|560351873|FG001|Overall Study|Withdrawal by Subject|2|||
155251673|NCT02313428|560351874|FG000|Overall Study|Lost to Follow-up|1|||
155251674|NCT02313428|560351875|FG001|Overall Study|Lost to Follow-up|1|||
155251675|NCT05374421|560351876|FG000|Overall Study|Withdrawal by Subject|3|||
155251676|NCT05374421|560351877|FG001|Overall Study|Withdrawal by Subject|4|||
155251677|NCT05132699|560351880|FG000|Overall Study|Withdrawal by Subject|3|||
155251678|NCT05132699|560351881|FG001|Overall Study|Withdrawal by Subject|0|||
155251679|NCT04370054|560351882|FG000|Treatment Phase|Lost to Follow-up|1|||
155251680|NCT04370054|560351882|FG000|Treatment Phase|Withdrawal by Subject|1|||
155251681|NCT04370054|560351882|FG000|Follow-Up Phase|Ongoing|75|||
155251682|NCT02314624|560353431|FG000|Overall Study|No participating patient|16|||
155251683|NCT02314624|560353432|FG001|Overall Study|No participating patient|13|||
155251684|NCT02314624|560353431|FG000|Overall Study|Participant withdrew|7|||
155251685|NCT02314624|560353432|FG001|Overall Study|Participant withdrew|2|||
155251686|NCT02314624|560353431|FG000|Overall Study|Lost to Follow-up|2|||
155251687|NCT02314624|560353432|FG001|Overall Study|Lost to Follow-up|5|||
155251688|NCT02314624|560353431|FG000|Overall Study|Dropped/Excluded by PI|6|||
155251689|NCT02314624|560353432|FG001|Overall Study|Dropped/Excluded by PI|6|||
155251690|NCT03151005|560353435|FG000|Overall Study|Lost to Follow-up|5|||
155251691|NCT03151005|560353436|FG001|Overall Study|Lost to Follow-up|5|||
155251692|NCT02216123|560353439|FG000|Overall Study|Lost to Follow-up|4|||
155251693|NCT02216123|560353440|FG001|Overall Study|Lost to Follow-up|2|||
155251694|NCT02216123|560353439|FG000|Overall Study|Withdrawal by Subject|2|||
155251695|NCT02216123|560353440|FG001|Overall Study|Withdrawal by Subject|0|||
155251696|NCT05159622|560353441|FG000|Overall Study|Lost to Follow-up|4|||
155251697|NCT05159622|560353442|FG001|Overall Study|Lost to Follow-up|5|||
155251698|NCT02163733|560353443|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
155251699|NCT02163733|560353444|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
155251700|NCT02163733|560353445|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
155251701|NCT02163733|560353443|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
155251702|NCT02163733|560353444|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
155251703|NCT02163733|560353445|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
155251704|NCT02723864|560353446|FG000|Overall Study|Refused further treatment|1|||
155251705|NCT02723864|560353447|FG001|Overall Study|Refused further treatment|0|||
155251706|NCT02723864|560353448|FG002|Overall Study|Refused further treatment|0|||
155251707|NCT02723864|560353449|FG003|Overall Study|Refused further treatment|0|||
155251708|NCT02723864|560353450|FG004|Overall Study|Refused further treatment|1|||
155251709|NCT02723864|560353451|FG005|Overall Study|Refused further treatment|2|||
155251710|NCT02723864|560353452|FG006|Overall Study|Refused further treatment|0|||
155251711|NCT02723864|560353446|FG000|Overall Study|Exceed treatment hold time|0|||
155251712|NCT02723864|560353447|FG001|Overall Study|Exceed treatment hold time|1|||
155251713|NCT02723864|560353448|FG002|Overall Study|Exceed treatment hold time|0|||
155251714|NCT02723864|560353449|FG003|Overall Study|Exceed treatment hold time|0|||
155251715|NCT02723864|560353450|FG004|Overall Study|Exceed treatment hold time|0|||
155251716|NCT02723864|560353451|FG005|Overall Study|Exceed treatment hold time|0|||
155251717|NCT02723864|560353452|FG006|Overall Study|Exceed treatment hold time|0|||
155251718|NCT02723864|560353446|FG000|Overall Study|Clinical progression|0|||
155251719|NCT02723864|560353447|FG001|Overall Study|Clinical progression|0|||
155251720|NCT02723864|560353448|FG002|Overall Study|Clinical progression|1|||
155251721|NCT02723864|560353449|FG003|Overall Study|Clinical progression|0|||
155251722|NCT02723864|560353450|FG004|Overall Study|Clinical progression|0|||
155251723|NCT02723864|560353451|FG005|Overall Study|Clinical progression|3|||
155251724|NCT02723864|560353452|FG006|Overall Study|Clinical progression|1|||
155251725|NCT02723864|560353446|FG000|Overall Study|Physician Decision|0|||
155251726|NCT02723864|560353447|FG001|Overall Study|Physician Decision|0|||
155251727|NCT02723864|560353448|FG002|Overall Study|Physician Decision|0|||
155251728|NCT02723864|560353449|FG003|Overall Study|Physician Decision|0|||
155251729|NCT02723864|560353450|FG004|Overall Study|Physician Decision|0|||
155251730|NCT02723864|560353451|FG005|Overall Study|Physician Decision|0|||
155251731|NCT02723864|560353452|FG006|Overall Study|Physician Decision|1|||
155251732|NCT02723864|560353446|FG000|Overall Study|Changes in patient condition|0|||
155251733|NCT02723864|560353447|FG001|Overall Study|Changes in patient condition|0|||
155251734|NCT02723864|560353448|FG002|Overall Study|Changes in patient condition|0|||
155251735|NCT02723864|560353449|FG003|Overall Study|Changes in patient condition|0|||
155251736|NCT02723864|560353450|FG004|Overall Study|Changes in patient condition|0|||
155251737|NCT02723864|560353451|FG005|Overall Study|Changes in patient condition|1|||
155251738|NCT02723864|560353452|FG006|Overall Study|Changes in patient condition|0|||
155251739|NCT02723864|560353446|FG000|Overall Study|Patient choice|0|||
155251740|NCT02723864|560353447|FG001|Overall Study|Patient choice|0|||
155251741|NCT02723864|560353448|FG002|Overall Study|Patient choice|0|||
155251742|NCT02723864|560353449|FG003|Overall Study|Patient choice|0|||
155251743|NCT02723864|560353450|FG004|Overall Study|Patient choice|0|||
155251744|NCT02723864|560353451|FG005|Overall Study|Patient choice|1|||
155251745|NCT02723864|560353452|FG006|Overall Study|Patient choice|0|||
155251746|NCT02723864|560353446|FG000|Overall Study|Adverse Event|0|||
155251747|NCT02723864|560353447|FG001|Overall Study|Adverse Event|0|||
155251748|NCT02723864|560353448|FG002|Overall Study|Adverse Event|0|||
155251749|NCT02723864|560353449|FG003|Overall Study|Adverse Event|0|||
155251750|NCT02723864|560353450|FG004|Overall Study|Adverse Event|0|||
155251751|NCT02723864|560353451|FG005|Overall Study|Adverse Event|1|||
155251752|NCT02723864|560353452|FG006|Overall Study|Adverse Event|0|||
155251753|NCT02723864|560353446|FG000|Overall Study|Started new treatment|0|||
155251754|NCT02723864|560353447|FG001|Overall Study|Started new treatment|0|||
155251755|NCT02723864|560353448|FG002|Overall Study|Started new treatment|0|||
155251756|NCT02723864|560353449|FG003|Overall Study|Started new treatment|0|||
155251757|NCT02723864|560353450|FG004|Overall Study|Started new treatment|0|||
155251758|NCT02723864|560353451|FG005|Overall Study|Started new treatment|1|||
155251759|NCT02723864|560353452|FG006|Overall Study|Started new treatment|0|||
155251760|NCT02723864|560353446|FG000|Overall Study|Switched to alternative treatment|0|||
155251761|NCT02723864|560353447|FG001|Overall Study|Switched to alternative treatment|0|||
155251762|NCT02723864|560353448|FG002|Overall Study|Switched to alternative treatment|0|||
155251763|NCT02723864|560353449|FG003|Overall Study|Switched to alternative treatment|0|||
155251764|NCT02723864|560353450|FG004|Overall Study|Switched to alternative treatment|0|||
155251765|NCT02723864|560353451|FG005|Overall Study|Switched to alternative treatment|1|||
155251766|NCT02723864|560353452|FG006|Overall Study|Switched to alternative treatment|0|||
155251767|NCT02723864|560353446|FG000|Overall Study|Late determination of ineligibility|0|||
155251768|NCT02723864|560353447|FG001|Overall Study|Late determination of ineligibility|0|||
155251769|NCT02723864|560353448|FG002|Overall Study|Late determination of ineligibility|0|||
155251770|NCT02723864|560353449|FG003|Overall Study|Late determination of ineligibility|0|||
155251771|NCT02723864|560353450|FG004|Overall Study|Late determination of ineligibility|0|||
155251772|NCT02723864|560353451|FG005|Overall Study|Late determination of ineligibility|1|||
155251773|NCT02723864|560353452|FG006|Overall Study|Late determination of ineligibility|0|||
155251774|NCT00082173|560353453|FG000|Overall Study|Withdrawal by Subject|3|||
155251775|NCT00082173|560353454|FG001|Overall Study|Withdrawal by Subject|5|||
155251776|NCT00082173|560353453|FG000|Overall Study|Lost to Follow-up|1|||
155251777|NCT00082173|560353454|FG001|Overall Study|Lost to Follow-up|0|||
155251778|NCT00082173|560353453|FG000|Overall Study|Adverse Event|1|||
155251779|NCT00082173|560353454|FG001|Overall Study|Adverse Event|0|||
155251780|NCT00082173|560353453|FG000|Overall Study|Culture negative or resistant at baselin|5|||
155251781|NCT00082173|560353454|FG001|Overall Study|Culture negative or resistant at baselin|6|||
155251782|NCT00746590|560353455|FG000|Overall Study|Death|1|||
155251783|NCT02633800|560353460|FG000|Overall Study|Death|3|||
155251784|NCT02633800|560353461|FG001|Overall Study|Death|3|||
155251785|NCT02633800|560353460|FG000|Overall Study|Reason not provided|1|||
155251786|NCT02633800|560353461|FG001|Overall Study|Reason not provided|0|||
155251787|NCT02633800|560353460|FG000|Overall Study|Radiologic(al) progression|23|||
155251788|NCT02633800|560353461|FG001|Overall Study|Radiologic(al) progression|23|||
155251789|NCT02633800|560353460|FG000|Overall Study|Clinical progression|3|||
155251790|NCT02633800|560353461|FG001|Overall Study|Clinical progression|6|||
155251791|NCT02633800|560353460|FG000|Overall Study|Study terminated by sponsor|6|||
155251792|NCT02633800|560353461|FG001|Overall Study|Study terminated by sponsor|5|||
155251793|NCT02633800|560353460|FG000|Overall Study|Adverse event, non-fatal|7|||
155251794|NCT02633800|560353461|FG001|Overall Study|Adverse event, non-fatal|2|||
155251795|NCT02633800|560353460|FG000|Overall Study|Withdrawal by Subject|0|||
155251796|NCT02633800|560353461|FG001|Overall Study|Withdrawal by Subject|3|||
155251797|NCT02633800|560353460|FG000|Overall Study|Patient Request|1|||
155251798|NCT02633800|560353461|FG001|Overall Study|Patient Request|1|||
155251799|NCT02261493|560353465|FG000|Overall Study|Noncompliance|0|||
155251800|NCT02261493|560353466|FG001|Overall Study|Noncompliance|0|||
155251801|NCT02261493|560353467|FG002|Overall Study|Noncompliance|2|||
155251802|NCT02261493|560353465|FG000|Overall Study|Physician Decision|0|||
155251803|NCT02261493|560353466|FG001|Overall Study|Physician Decision|1|||
155251804|NCT02261493|560353467|FG002|Overall Study|Physician Decision|0|||
155251805|NCT02261493|560353465|FG000|Overall Study|Undisclosed alcohol abuse|0|||
155251806|NCT02261493|560353466|FG001|Overall Study|Undisclosed alcohol abuse|1|||
155251807|NCT02261493|560353467|FG002|Overall Study|Undisclosed alcohol abuse|0|||
155251808|NCT02261493|560353465|FG000|Overall Study|Protocol Violation|1|||
155251809|NCT02261493|560353466|FG001|Overall Study|Protocol Violation|0|||
155251810|NCT02261493|560353467|FG002|Overall Study|Protocol Violation|0|||
155251811|NCT02261493|560353465|FG000|Overall Study|Personal Reasons|14|||
155251812|NCT02261493|560353466|FG001|Overall Study|Personal Reasons|14|||
155251813|NCT02261493|560353467|FG002|Overall Study|Personal Reasons|16|||
155251814|NCT02261493|560353465|FG000|Overall Study|Lost to Follow-up|14|||
155251815|NCT02261493|560353466|FG001|Overall Study|Lost to Follow-up|27|||
155251816|NCT02261493|560353467|FG002|Overall Study|Lost to Follow-up|8|||
155251817|NCT02261493|560353465|FG000|Overall Study|Pregnancy|1|||
155251818|NCT02261493|560353466|FG001|Overall Study|Pregnancy|2|||
155251819|NCT02261493|560353467|FG002|Overall Study|Pregnancy|0|||
155251820|NCT02261493|560353465|FG000|Overall Study|Lack of Efficacy|0|||
155251821|NCT02261493|560353466|FG001|Overall Study|Lack of Efficacy|1|||
155251822|NCT02261493|560353467|FG002|Overall Study|Lack of Efficacy|0|||
155251823|NCT02261493|560353465|FG000|Overall Study|Adverse Event|0|||
155251824|NCT02261493|560353466|FG001|Overall Study|Adverse Event|1|||
155251825|NCT02261493|560353467|FG002|Overall Study|Adverse Event|0|||
155251826|NCT03643952|560353468|FG000|Overall Study|Lack of Efficacy|1|||
155251827|NCT01358968|560353469|FG000|Period 2|Adverse Event|0|||
155251828|NCT01358968|560353470|FG001|Period 2|Adverse Event|1|||
155251829|NCT01358968|560353471|FG002|Period 2|Adverse Event|0|||
155251830|NCT01358968|560353472|FG003|Period 2|Adverse Event|0|||
155251831|NCT01358968|560353469|FG000|Continued Access Phase|Progression of Disease|0|||
155251832|NCT01358968|560353470|FG001|Continued Access Phase|Progression of Disease|0|||
155251833|NCT01358968|560353471|FG002|Continued Access Phase|Progression of Disease|8|||
155251834|NCT01358968|560353472|FG003|Continued Access Phase|Progression of Disease|4|||
155251835|NCT01358968|560353469|FG000|Continued Access Phase|Protocol Violation|0|||
155251836|NCT01358968|560353470|FG001|Continued Access Phase|Protocol Violation|0|||
155251837|NCT01358968|560353471|FG002|Continued Access Phase|Protocol Violation|0|||
155251838|NCT01358968|560353472|FG003|Continued Access Phase|Protocol Violation|2|||
155251839|NCT01358968|560353469|FG000|Continued Access Phase|Withdrawal by Subject|0|||
155251840|NCT01358968|560353470|FG001|Continued Access Phase|Withdrawal by Subject|0|||
155251841|NCT01358968|560353471|FG002|Continued Access Phase|Withdrawal by Subject|3|||
155251842|NCT01358968|560353472|FG003|Continued Access Phase|Withdrawal by Subject|0|||
155251843|NCT01358968|560353469|FG000|Continued Access Phase|Death|0|||
155251844|NCT01358968|560353470|FG001|Continued Access Phase|Death|0|||
155251845|NCT01358968|560353471|FG002|Continued Access Phase|Death|1|||
155251846|NCT01358968|560353472|FG003|Continued Access Phase|Death|1|||
155251847|NCT01597050|560353473|FG000|Overall Study|Withdrawal by Subject|1|||
155251848|NCT01597050|560353474|FG001|Overall Study|Withdrawal by Subject|0|||
155251849|NCT02065336|560353478|FG000|Extension Phase|Study Terminated by Sponsor|0|||
155251850|NCT02065336|560353479|FG001|Extension Phase|Study Terminated by Sponsor|0|||
155251851|NCT02065336|560353480|FG002|Extension Phase|Study Terminated by Sponsor|0|||
155251852|NCT02065336|560353481|FG003|Extension Phase|Study Terminated by Sponsor|0|||
155251853|NCT02065336|560353482|FG004|Extension Phase|Study Terminated by Sponsor|0|||
155251854|NCT02065336|560353483|FG005|Extension Phase|Study Terminated by Sponsor|0|||
155251855|NCT02065336|560353484|FG006|Extension Phase|Study Terminated by Sponsor|0|||
155251856|NCT02065336|560353485|FG007|Extension Phase|Study Terminated by Sponsor|0|||
155251857|NCT02065336|560353486|FG008|Extension Phase|Study Terminated by Sponsor|2|||
155251858|NCT02065336|560353487|FG009|Extension Phase|Study Terminated by Sponsor|8|||
155251859|NCT01618162|560353513|FG000|Overall Study|Protocol Violation|13|||
155251860|NCT01618162|560353514|FG001|Overall Study|Protocol Violation|10|||
155251861|NCT01618162|560353513|FG000|Overall Study|Adverse Event|9|||
155251862|NCT01618162|560353514|FG001|Overall Study|Adverse Event|2|||
155251863|NCT01618162|560353513|FG000|Overall Study|Withdrawal Criteria|2|||
155251864|NCT01618162|560353514|FG001|Overall Study|Withdrawal Criteria|10|||
155251865|NCT01618162|560353513|FG000|Overall Study|Unclassified|14|||
155251866|NCT01618162|560353514|FG001|Overall Study|Unclassified|13|||
155251867|NCT01654549|560353515|FG000|Overall Study|H.pylori eradication not successful|0|||
155251868|NCT01654549|560353516|FG001|Overall Study|H.pylori eradication not successful|1|||
155251869|NCT04391023|560353521|FG000|Overall Study|Withdrawal by Subject|2|||
155251870|NCT04391023|560353522|FG001|Overall Study|Withdrawal by Subject|2|||
155251871|NCT01270347|560353523|FG000|Core Phase|Adverse Event|1|||
155251872|NCT01270347|560353524|FG001|Core Phase|Adverse Event|6|||
155251873|NCT01270347|560353523|FG000|Core Phase|Withdrawal by Subject|1|||
155251874|NCT01270347|560353524|FG001|Core Phase|Withdrawal by Subject|2|||
155251875|NCT01270347|560353523|FG000|Core Phase|Lost to Follow-up|0|||
155251876|NCT01270347|560353524|FG001|Core Phase|Lost to Follow-up|1|||
155251877|NCT01270347|560353523|FG000|Core Phase|Miscellaneous|8|||
155251878|NCT01270347|560353524|FG001|Core Phase|Miscellaneous|14|||
155251879|NCT01270347|560353523|FG000|Extension Phase|Adverse Event|1|||
155251880|NCT01270347|560353524|FG001|Extension Phase|Adverse Event|3|||
155251881|NCT01270347|560353523|FG000|Extension Phase|Withdrawal by Subject|3|||
155251882|NCT01270347|560353524|FG001|Extension Phase|Withdrawal by Subject|4|||
155251883|NCT01270347|560353523|FG000|Extension Phase|Miscellaneous|2|||
155251884|NCT01270347|560353524|FG001|Extension Phase|Miscellaneous|2|||
155251885|NCT02085408|560353525|FG000|Step 1: Induction|Disease Progression|19|||
155251886|NCT02085408|560353526|FG001|Step 1: Induction|Disease Progression|19|||
155251887|NCT02085408|560353525|FG000|Step 1: Induction|Adverse Event|18|||
155251888|NCT02085408|560353526|FG001|Step 1: Induction|Adverse Event|17|||
155251889|NCT02085408|560353525|FG000|Step 1: Induction|Death|33|||
155251890|NCT02085408|560353526|FG001|Step 1: Induction|Death|30|||
155251891|NCT02085408|560353525|FG000|Step 1: Induction|Withdrawal by Subject|16|||
155251892|NCT02085408|560353526|FG001|Step 1: Induction|Withdrawal by Subject|8|||
155251893|NCT02085408|560353525|FG000|Step 1: Induction|Alternative Therapy|15|||
155251894|NCT02085408|560353526|FG001|Step 1: Induction|Alternative Therapy|19|||
155251895|NCT02085408|560353525|FG000|Step 1: Induction|Complicating Disease|2|||
155251896|NCT02085408|560353526|FG001|Step 1: Induction|Complicating Disease|3|||
155251897|NCT02085408|560353525|FG000|Step 1: Induction|Other|27|||
155251898|NCT02085408|560353526|FG001|Step 1: Induction|Other|39|||
155251899|NCT02085408|560353525|FG000|Step 1: Induction|Never started treatment|6|||
155251900|NCT02085408|560353526|FG001|Step 1: Induction|Never started treatment|4|||
155251901|NCT02085408|560353525|FG000|Step 2: Consolidation|Disease Progression|5|||
155251902|NCT02085408|560353526|FG001|Step 2: Consolidation|Disease Progression|20|||
155251903|NCT02085408|560353525|FG000|Step 2: Consolidation|Adverse Event|9|||
155251904|NCT02085408|560353526|FG001|Step 2: Consolidation|Adverse Event|8|||
155251905|NCT02085408|560353525|FG000|Step 2: Consolidation|Death|4|||
155251906|NCT02085408|560353526|FG001|Step 2: Consolidation|Death|3|||
155251907|NCT02085408|560353525|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
155251908|NCT02085408|560353526|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
155251909|NCT02085408|560353525|FG000|Step 2: Consolidation|Alternative Therapy|9|||
155251910|NCT02085408|560353526|FG001|Step 2: Consolidation|Alternative Therapy|3|||
155251911|NCT02085408|560353525|FG000|Step 2: Consolidation|Complicating Disease|0|||
155251912|NCT02085408|560353526|FG001|Step 2: Consolidation|Complicating Disease|2|||
155251913|NCT02085408|560353525|FG000|Step 2: Consolidation|Other|6|||
155251914|NCT02085408|560353526|FG001|Step 2: Consolidation|Other|6|||
155251915|NCT02085408|560353525|FG000|Step 2: Consolidation|Never started treatment|4|||
155251916|NCT02085408|560353526|FG001|Step 2: Consolidation|Never started treatment|3|||
155251917|NCT02085408|560353525|FG000|Step 3: Maintenance|Disease Progression|13|||
155251918|NCT02085408|560353526|FG001|Step 3: Maintenance|Disease Progression|11|||
155251919|NCT02085408|560353525|FG000|Step 3: Maintenance|Adverse Event|2|||
155251920|NCT02085408|560353526|FG001|Step 3: Maintenance|Adverse Event|4|||
155251921|NCT02085408|560353525|FG000|Step 3: Maintenance|Death|1|||
155251922|NCT02085408|560353526|FG001|Step 3: Maintenance|Death|2|||
155251923|NCT02085408|560353525|FG000|Step 3: Maintenance|Alternative Therapy|1|||
155251924|NCT02085408|560353526|FG001|Step 3: Maintenance|Alternative Therapy|1|||
155251925|NCT02085408|560353525|FG000|Step 3: Maintenance|Complicating Disease|0|||
155251926|NCT02085408|560353526|FG001|Step 3: Maintenance|Complicating Disease|1|||
155251927|NCT02085408|560353525|FG000|Step 3: Maintenance|Other|3|||
155251928|NCT02085408|560353526|FG001|Step 3: Maintenance|Other|2|||
155251929|NCT02085408|560353525|FG000|Step 3: Maintenance|Never started treatment|5|||
155251930|NCT02085408|560353526|FG001|Step 3: Maintenance|Never started treatment|1|||
155251931|NCT02189798|560353527|FG000|Extended Use Phase|Withdrawal by Subject|0|||
155251932|NCT02189798|560353528|FG001|Extended Use Phase|Withdrawal by Subject|4|||
155251933|NCT02189798|560353527|FG000|Extended Use Phase|Physician Decision|1|||
155251934|NCT02189798|560353528|FG001|Extended Use Phase|Physician Decision|0|||
155251935|NCT02189798|560353527|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
155251936|NCT02189798|560353528|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
155251937|NCT02189798|560353527|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
155251938|NCT02189798|560353528|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
155251939|NCT02189798|560353527|FG000|Extended Use Phase|Travel Issues|2|||
155251940|NCT02189798|560353528|FG001|Extended Use Phase|Travel Issues|1|||
155251941|NCT02189798|560353527|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
155251942|NCT02189798|560353528|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
155251943|NCT01362140|560353531|FG000|Overall Study|Noncompliance|1|||
155251944|NCT01362140|560353532|FG001|Overall Study|Noncompliance|0|||
155251945|NCT01362140|560353531|FG000|Overall Study|Adverse Event|2|||
155251946|NCT01362140|560353532|FG001|Overall Study|Adverse Event|2|||
155251947|NCT01362140|560353531|FG000|Overall Study|Withdrawal by Subject|3|||
155251948|NCT01362140|560353532|FG001|Overall Study|Withdrawal by Subject|3|||
155251949|NCT01362140|560353531|FG000|Overall Study|Administrative Decision|0|||
155251950|NCT01362140|560353532|FG001|Overall Study|Administrative Decision|1|||
155251951|NCT01362140|560353531|FG000|Overall Study|Death|2|||
155251952|NCT01362140|560353532|FG001|Overall Study|Death|1|||
155251953|NCT01362140|560353531|FG000|Overall Study|Other|1|||
155251954|NCT01362140|560353532|FG001|Overall Study|Other|1|||
155251955|NCT01362140|560353531|FG000|Overall Study|Protocol-specified Criteria|1|||
155251956|NCT01362140|560353532|FG001|Overall Study|Protocol-specified Criteria|2|||
155251957|NCT01362140|560353531|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
155251958|NCT01362140|560353532|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
155251959|NCT00529399|560353535|FG000|Overall Study|Lost to Follow-up|1|||
155251960|NCT00529399|560353536|FG001|Overall Study|Lost to Follow-up|0|||
155251961|NCT00529399|560353537|FG002|Overall Study|Lost to Follow-up|1|||
155251962|NCT00529399|560353535|FG000|Overall Study|Withdrawal by Subject|1|||
155251963|NCT00529399|560353536|FG001|Overall Study|Withdrawal by Subject|0|||
155251964|NCT00529399|560353537|FG002|Overall Study|Withdrawal by Subject|1|||
155251965|NCT00529399|560353535|FG000|Overall Study|Non-compliant|0|||
155251966|NCT00529399|560353536|FG001|Overall Study|Non-compliant|1|||
155251967|NCT00529399|560353537|FG002|Overall Study|Non-compliant|0|||
155251968|NCT03695172|560353538|FG000|Overall Study|Withdrawal by Subject|1|||
155251969|NCT03695172|560353539|FG001|Overall Study|Withdrawal by Subject|1|||
155251970|NCT03695172|560353540|FG002|Overall Study|Withdrawal by Subject|0|||
155251971|NCT01474681|560353559|FG000|Overall Study|Death|0|||
155251972|NCT01474681|560353560|FG001|Overall Study|Death|3|||
155251973|NCT01474681|560353561|FG002|Overall Study|Death|2|||
155251974|NCT01474681|560353562|FG003|Overall Study|Death|6|||
155251975|NCT01483924|560353565|FG000|Overall Study|Withdrawal by Subject|2|||
155251976|NCT01483924|560353566|FG001|Overall Study|Withdrawal by Subject|0|||
155251977|NCT01483924|560353567|FG002|Overall Study|Withdrawal by Subject|0|||
155251978|NCT01483924|560353568|FG003|Overall Study|Withdrawal by Subject|1|||
155251979|NCT01483924|560353569|FG004|Overall Study|Withdrawal by Subject|1|||
155251980|NCT01483924|560353565|FG000|Overall Study|Adverse Event|0|||
155251981|NCT01483924|560353566|FG001|Overall Study|Adverse Event|0|||
155251982|NCT01483924|560353567|FG002|Overall Study|Adverse Event|1|||
155251983|NCT01483924|560353568|FG003|Overall Study|Adverse Event|1|||
155251984|NCT01483924|560353569|FG004|Overall Study|Adverse Event|0|||
155251985|NCT01483924|560353565|FG000|Overall Study|Non-compliance|0|||
155251986|NCT01483924|560353566|FG001|Overall Study|Non-compliance|0|||
155251987|NCT01483924|560353567|FG002|Overall Study|Non-compliance|0|||
155251988|NCT01483924|560353568|FG003|Overall Study|Non-compliance|1|||
155251989|NCT01483924|560353569|FG004|Overall Study|Non-compliance|1|||
155251990|NCT01483924|560353565|FG000|Overall Study|Sponsor concern over ECG result|0|||
155251991|NCT01483924|560353566|FG001|Overall Study|Sponsor concern over ECG result|0|||
155251992|NCT01483924|560353567|FG002|Overall Study|Sponsor concern over ECG result|0|||
155251993|NCT01483924|560353568|FG003|Overall Study|Sponsor concern over ECG result|1|||
155251994|NCT01483924|560353569|FG004|Overall Study|Sponsor concern over ECG result|0|||
155251995|NCT00003298|560353570|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
155251996|NCT00003298|560353570|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
155251997|NCT00003298|560353570|FG000|Surgery|Unresectable at surgery|3|||
155251998|NCT00003298|560353570|FG000|Surgery|Progression before surgery|2|||
155251999|NCT00003298|560353570|FG000|Surgery|Unevaluable and off study|2|||
155252000|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
155252001|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
155252002|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
155252003|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
155252004|NCT00003298|560353570|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
155252005|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
155252006|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
155252007|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
155252008|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
155252009|NCT00003298|560353570|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
155252010|NCT04330638|560353575|FG000|Overall Study|Adverse Event|9|||
155252011|NCT04330638|560353576|FG001|Overall Study|Adverse Event|10|||
155252012|NCT04330638|560353577|FG002|Overall Study|Adverse Event|15|||
155252013|NCT04330638|560353578|FG003|Overall Study|Adverse Event|6|||
155252014|NCT04330638|560353579|FG004|Overall Study|Adverse Event|10|||
155252015|NCT04330638|560353580|FG005|Overall Study|Adverse Event|5|||
155252016|NCT04330638|560353575|FG000|Overall Study|Other|2|||
155252017|NCT04330638|560353576|FG001|Overall Study|Other|2|||
155252018|NCT04330638|560353577|FG002|Overall Study|Other|5|||
155252019|NCT04330638|560353578|FG003|Overall Study|Other|1|||
155252020|NCT04330638|560353579|FG004|Overall Study|Other|3|||
155252021|NCT04330638|560353580|FG005|Overall Study|Other|2|||
155252022|NCT04330638|560353575|FG000|Overall Study|Withdrawal by Subject|4|||
155252023|NCT04330638|560353576|FG001|Overall Study|Withdrawal by Subject|0|||
155252024|NCT04330638|560353577|FG002|Overall Study|Withdrawal by Subject|0|||
155252025|NCT04330638|560353578|FG003|Overall Study|Withdrawal by Subject|0|||
155252026|NCT04330638|560353579|FG004|Overall Study|Withdrawal by Subject|0|||
155252027|NCT04330638|560353580|FG005|Overall Study|Withdrawal by Subject|0|||
155252028|NCT04330638|560353575|FG000|Overall Study|Lost to Follow-up|3|||
155252029|NCT04330638|560353576|FG001|Overall Study|Lost to Follow-up|2|||
155252030|NCT04330638|560353577|FG002|Overall Study|Lost to Follow-up|3|||
155252031|NCT04330638|560353578|FG003|Overall Study|Lost to Follow-up|2|||
155252032|NCT04330638|560353579|FG004|Overall Study|Lost to Follow-up|3|||
155252033|NCT04330638|560353580|FG005|Overall Study|Lost to Follow-up|0|||
155252034|NCT01041638|560353584|FG000|Overall Study|Adverse Event|4|||
155252035|NCT01041638|560353584|FG000|Overall Study|Death|1|||
155252036|NCT01041638|560353584|FG000|Overall Study|Lack of Efficacy|7|||
155252037|NCT01041638|560353584|FG000|Overall Study|Physician Decision|4|||
155252038|NCT01041638|560353584|FG000|Overall Study|Withdrawal by Subject|11|||
155252039|NCT05207813|560353585|FG000|Overall Study|Lost to Follow-up|2|||
155252040|NCT03762473|560353589|FG000|Overall Study|Death|1|||
155252041|NCT03762473|560353590|FG001|Overall Study|Death|0|||
155252042|NCT00710424|560353593|FG000|Overall Study|Adverse Event|30|||
155252043|NCT00710424|560353594|FG001|Overall Study|Adverse Event|12|||
155252044|NCT00710424|560353593|FG000|Overall Study|Lack of Efficacy|4|||
155252045|NCT00710424|560353594|FG001|Overall Study|Lack of Efficacy|5|||
155252046|NCT00710424|560353593|FG000|Overall Study|Withdrawal by Subject|5|||
155252047|NCT00710424|560353594|FG001|Overall Study|Withdrawal by Subject|3|||
155252048|NCT00710424|560353593|FG000|Overall Study|Lost to Follow-up|0|||
155252049|NCT00710424|560353594|FG001|Overall Study|Lost to Follow-up|1|||
155252050|NCT00710424|560353593|FG000|Overall Study|Refused medication, no side effects|1|||
155252051|NCT00710424|560353594|FG001|Overall Study|Refused medication, no side effects|0|||
155252052|NCT00710424|560353593|FG000|Overall Study|Non-compliance with stable analgesia|1|||
155252053|NCT00710424|560353594|FG001|Overall Study|Non-compliance with stable analgesia|0|||
155252054|NCT00710424|560353593|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
155252055|NCT00710424|560353594|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
155252056|NCT00710424|560353593|FG000|Overall Study|Subject thought medication changed|1|||
155252057|NCT00710424|560353594|FG001|Overall Study|Subject thought medication changed|0|||
155252058|NCT00710424|560353593|FG000|Overall Study|Ceased treatment due to travel|1|||
155252059|NCT00710424|560353594|FG001|Overall Study|Ceased treatment due to travel|0|||
155252060|NCT00710424|560353593|FG000|Overall Study|Subject preferred paracetamol|0|||
155252061|NCT00710424|560353594|FG001|Overall Study|Subject preferred paracetamol|1|||
155252062|NCT00710424|560353593|FG000|Overall Study|Felt good so stopped treatment|0|||
155252063|NCT00710424|560353594|FG001|Overall Study|Felt good so stopped treatment|1|||
155252064|NCT01986881|560355565|FG000|Overall Study|Death|228|||
155252065|NCT01986881|560355566|FG001|Overall Study|Death|233|||
155252066|NCT01986881|560355567|FG002|Overall Study|Death|247|||
155252067|NCT01986881|560355565|FG000|Overall Study|Lost to Follow-up|51|||
155252068|NCT01986881|560355566|FG001|Overall Study|Lost to Follow-up|44|||
155252069|NCT01986881|560355567|FG002|Overall Study|Lost to Follow-up|55|||
155252070|NCT01986881|560355565|FG000|Overall Study|Physician Decision|7|||
155252071|NCT01986881|560355566|FG001|Overall Study|Physician Decision|4|||
155252072|NCT01986881|560355567|FG002|Overall Study|Physician Decision|6|||
155252073|NCT01986881|560355565|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
155252074|NCT01986881|560355566|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
155252075|NCT01986881|560355567|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
155252076|NCT01986881|560355565|FG000|Overall Study|Withdrawal by Subject|41|||
155252077|NCT01986881|560355566|FG001|Overall Study|Withdrawal by Subject|60|||
155252078|NCT01986881|560355567|FG002|Overall Study|Withdrawal by Subject|45|||
155252079|NCT01986881|560355565|FG000|Overall Study|Subject Moved|0|||
155252080|NCT01986881|560355566|FG001|Overall Study|Subject Moved|1|||
155252081|NCT01986881|560355567|FG002|Overall Study|Subject Moved|0|||
155252082|NCT01986881|560355565|FG000|Overall Study|Other|1|||
155252083|NCT01986881|560355566|FG001|Overall Study|Other|2|||
155252084|NCT01986881|560355567|FG002|Overall Study|Other|2|||
155252085|NCT01258608|560355568|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
155252086|NCT01258608|560355569|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
155252087|NCT01258608|560355568|FG000|Overall Study|Clinical progression|1|||
155252088|NCT01258608|560355569|FG001|Overall Study|Clinical progression|0|||
155252089|NCT01258608|560355568|FG000|Overall Study|Sponsor decision|0|||
155252090|NCT01258608|560355569|FG001|Overall Study|Sponsor decision|1|||
155252091|NCT01258608|560355568|FG000|Overall Study|Physician Decision|6|||
155252092|NCT01258608|560355569|FG001|Overall Study|Physician Decision|1|||
155252093|NCT01258608|560355568|FG000|Overall Study|Lost to Follow-up|0|||
155252094|NCT01258608|560355569|FG001|Overall Study|Lost to Follow-up|1|||
155252095|NCT01258608|560355568|FG000|Overall Study|Lack of compliance|1|||
155252096|NCT01258608|560355569|FG001|Overall Study|Lack of compliance|0|||
155252097|NCT01258608|560355568|FG000|Overall Study|Lack of Efficacy|0|||
155252098|NCT01258608|560355569|FG001|Overall Study|Lack of Efficacy|1|||
155252099|NCT01258608|560355568|FG000|Overall Study|Adverse Event|6|||
155252100|NCT01258608|560355569|FG001|Overall Study|Adverse Event|10|||
155252101|NCT01258608|560355568|FG000|Overall Study|Withdrawal by Subject|6|||
155252102|NCT01258608|560355569|FG001|Overall Study|Withdrawal by Subject|5|||
155252103|NCT04205630|560355570|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
155252104|NCT04205630|560355570|FG000|Overall Study|Disease clinical progression|7|||
155252105|NCT04205630|560355570|FG000|Overall Study|Withdrawal by Subject|2|||
155252106|NCT04205630|560355570|FG000|Overall Study|Adverse Event|17|||
155252107|NCT04205630|560355570|FG000|Overall Study|Other|1|||
155252108|NCT02943408|560355576|FG000|Overall Study|Lost to Follow-up|7|||
155252109|NCT02943408|560355577|FG001|Overall Study|Lost to Follow-up|1|||
155252110|NCT02943408|560355576|FG000|Overall Study|Withdrawal by Subject|0|||
155252111|NCT02943408|560355577|FG001|Overall Study|Withdrawal by Subject|1|||
155252112|NCT01621126|560355580|FG000|Overall Study|Physician Decision|6|||
155252113|NCT00886340|560355581|FG000|Overall Study|Withdrawal by Subject|0|||
155252114|NCT00886340|560355582|FG001|Overall Study|Withdrawal by Subject|7|||
155252115|NCT03224182|560355583|FG000|Overall Study|Study Drug Not Instilled|6|||
155252116|NCT03224182|560355584|FG001|Overall Study|Study Drug Not Instilled|1|||
155252117|NCT03224182|560355583|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
155252118|NCT03224182|560355584|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
155252119|NCT03224182|560355583|FG000|Overall Study|Withdrew of Consent|4|||
155252120|NCT03224182|560355584|FG001|Overall Study|Withdrew of Consent|2|||
155252121|NCT03224182|560355583|FG000|Overall Study|Investigator Decision|3|||
155252122|NCT03224182|560355584|FG001|Overall Study|Investigator Decision|1|||
155252123|NCT03224182|560355583|FG000|Overall Study|Sponsor Decision|26|||
155252124|NCT03224182|560355584|FG001|Overall Study|Sponsor Decision|12|||
155252125|NCT03224182|560355583|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
155252126|NCT03224182|560355584|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
155252127|NCT03224182|560355583|FG000|Overall Study|Lost to Follow-up|1|||
155252128|NCT03224182|560355584|FG001|Overall Study|Lost to Follow-up|0|||
155252129|NCT03224182|560355583|FG000|Overall Study|Participant Had Recurrence|11|||
155252130|NCT03224182|560355584|FG001|Overall Study|Participant Had Recurrence|5|||
155252131|NCT03224182|560355583|FG000|Overall Study|Death|0|||
155252132|NCT03224182|560355584|FG001|Overall Study|Death|1|||
155252133|NCT03224182|560355583|FG000|Overall Study|Reason not Specified|3|||
155252134|NCT03224182|560355584|FG001|Overall Study|Reason not Specified|3|||
155252135|NCT03224182|560355583|FG000|Overall Study|Other|1|||
155252136|NCT03224182|560355584|FG001|Overall Study|Other|0|||
155252137|NCT02606279|560355585|FG000|Overall Study|Lost to Follow-up|0|||
155252138|NCT02606279|560355586|FG001|Overall Study|Lost to Follow-up|1|||
155252139|NCT02184611|560355589|FG000|Overall Study|Lack of Efficacy|11|||
155252140|NCT02184611|560355590|FG001|Overall Study|Lack of Efficacy|15|||
155252141|NCT02184611|560355589|FG000|Overall Study|Withdrawal by Subject|5|||
155252142|NCT02184611|560355590|FG001|Overall Study|Withdrawal by Subject|6|||
155252143|NCT02184611|560355589|FG000|Overall Study|Adverse Event|4|||
155252144|NCT02184611|560355590|FG001|Overall Study|Adverse Event|5|||
155252145|NCT02184611|560355589|FG000|Overall Study|Protocol Violation|1|||
155252146|NCT02184611|560355590|FG001|Overall Study|Protocol Violation|1|||
155252147|NCT02184611|560355589|FG000|Overall Study|Protocol defined stopping criteria|0|||
155252148|NCT02184611|560355590|FG001|Overall Study|Protocol defined stopping criteria|1|||
155252149|NCT00160680|560355591|FG000|Overall Study|Adverse Event|0|||
155252150|NCT00160680|560355592|FG001|Overall Study|Adverse Event|1|||
155252151|NCT00160680|560355591|FG000|Overall Study|Lack of Efficacy|2|||
155252152|NCT00160680|560355592|FG001|Overall Study|Lack of Efficacy|1|||
155252153|NCT00160680|560355591|FG000|Overall Study|Lost to Follow-up|3|||
155252154|NCT00160680|560355592|FG001|Overall Study|Lost to Follow-up|2|||
155252155|NCT00160680|560355591|FG000|Overall Study|Withdrawal by Subject|4|||
155252156|NCT00160680|560355592|FG001|Overall Study|Withdrawal by Subject|9|||
155252157|NCT04493216|560355593|FG000|Overall Study|Study terminated by sponsor|30|||
155252158|NCT04493216|560355594|FG001|Overall Study|Study terminated by sponsor|33|||
155252159|NCT04493216|560355595|FG002|Overall Study|Study terminated by sponsor|28|||
155252160|NCT04493216|560355596|FG003|Overall Study|Study terminated by sponsor|27|||
155252161|NCT04493216|560355593|FG000|Overall Study|Withdrawal by Subject|2|||
155252162|NCT04493216|560355594|FG001|Overall Study|Withdrawal by Subject|1|||
155252163|NCT04493216|560355595|FG002|Overall Study|Withdrawal by Subject|1|||
155252164|NCT04493216|560355596|FG003|Overall Study|Withdrawal by Subject|2|||
155252165|NCT04493216|560355593|FG000|Overall Study|Protocol Violation|1|||
155252166|NCT04493216|560355594|FG001|Overall Study|Protocol Violation|2|||
155252167|NCT04493216|560355595|FG002|Overall Study|Protocol Violation|0|||
155252168|NCT04493216|560355596|FG003|Overall Study|Protocol Violation|2|||
155252169|NCT04493216|560355593|FG000|Overall Study|Physician Decision|0|||
155252170|NCT04493216|560355594|FG001|Overall Study|Physician Decision|0|||
155252171|NCT04493216|560355595|FG002|Overall Study|Physician Decision|1|||
155252172|NCT04493216|560355596|FG003|Overall Study|Physician Decision|0|||
155252173|NCT04493216|560355593|FG000|Overall Study|Lost to Follow-up|2|||
155252174|NCT04493216|560355594|FG001|Overall Study|Lost to Follow-up|1|||
155252175|NCT04493216|560355595|FG002|Overall Study|Lost to Follow-up|0|||
155252176|NCT04493216|560355596|FG003|Overall Study|Lost to Follow-up|1|||
155252177|NCT04493216|560355593|FG000|Overall Study|Adverse Event|1|||
155252178|NCT04493216|560355594|FG001|Overall Study|Adverse Event|4|||
155252179|NCT04493216|560355595|FG002|Overall Study|Adverse Event|5|||
155252180|NCT04493216|560355596|FG003|Overall Study|Adverse Event|2|||
155252181|NCT04493216|560355593|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
155252182|NCT04493216|560355594|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
155252183|NCT04493216|560355595|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
155252184|NCT04493216|560355596|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
155252185|NCT03318523|560355599|FG000|PC Period: Up to Year 1|Adverse Event|1|||
155252186|NCT03318523|560355600|FG001|PC Period: Up to Year 1|Adverse Event|0|||
155252187|NCT03318523|560355601|FG002|PC Period: Up to Year 1|Adverse Event|2|||
155252188|NCT03318523|560355602|FG003|PC Period: Up to Year 1|Adverse Event|0|||
155252189|NCT03318523|560355603|FG004|PC Period: Up to Year 1|Adverse Event|0|||
155252190|NCT03318523|560355604|FG005|PC Period: Up to Year 1|Adverse Event|0|||
155252191|NCT03318523|560355605|FG006|PC Period: Up to Year 1|Adverse Event|0|||
155252192|NCT03318523|560355606|FG007|PC Period: Up to Year 1|Adverse Event|0|||
155252193|NCT03318523|560355607|FG008|PC Period: Up to Year 1|Adverse Event|0|||
155252194|NCT03318523|560355608|FG009|PC Period: Up to Year 1|Adverse Event|0|||
155252195|NCT03318523|560355599|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
155252196|NCT03318523|560355600|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
155252197|NCT03318523|560355601|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252198|NCT03318523|560355602|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
155252199|NCT03318523|560355603|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252200|NCT03318523|560355604|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252201|NCT03318523|560355605|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252202|NCT03318523|560355606|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252203|NCT03318523|560355607|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252204|NCT03318523|560355608|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
155252205|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252206|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252207|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252208|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252209|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
155252210|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252211|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252212|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
155252213|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
155252214|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
155252215|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252216|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252217|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252218|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252219|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
155252220|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252221|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
155252222|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
155252223|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
155252224|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
155252225|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252226|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252227|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252228|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252229|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252230|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
155252231|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252232|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252233|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252234|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
155252235|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252236|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252237|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252238|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252239|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252240|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252241|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252242|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252243|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
155252244|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
155252245|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252246|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252247|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252248|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
155252249|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
155252250|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
155252251|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
155252252|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
155252253|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
155252254|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
155252255|NCT03318523|560355599|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252256|NCT03318523|560355600|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252257|NCT03318523|560355601|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252258|NCT03318523|560355602|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252259|NCT03318523|560355603|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
155252260|NCT03318523|560355604|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252261|NCT03318523|560355605|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252262|NCT03318523|560355606|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
155252263|NCT03318523|560355607|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
155252264|NCT03318523|560355608|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
155252265|NCT01615328|560355613|FG000|Overall Study|Lost to Follow-up|3|||
155252266|NCT01615328|560355614|FG001|Overall Study|Lost to Follow-up|5|||
155252267|NCT00254982|560355615|FG000|Overall Study|Other|2|||
155252268|NCT00254982|560355616|FG001|Overall Study|Other|1|||
155252269|NCT00254982|560355615|FG000|Overall Study|Lack of Efficacy|5|||
155252270|NCT00254982|560355616|FG001|Overall Study|Lack of Efficacy|3|||
155252271|NCT00254982|560355615|FG000|Overall Study|Lost to Follow-up|5|||
155252272|NCT00254982|560355616|FG001|Overall Study|Lost to Follow-up|3|||
155252273|NCT00254982|560355615|FG000|Overall Study|Adverse Event|18|||
155252274|NCT00254982|560355616|FG001|Overall Study|Adverse Event|16|||
155252275|NCT00254982|560355615|FG000|Overall Study|Withdrawal by Subject|1|||
155252276|NCT00254982|560355616|FG001|Overall Study|Withdrawal by Subject|1|||
155252277|NCT00254982|560355615|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
155252278|NCT00254982|560355616|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
155252279|NCT00254982|560355615|FG000|Overall Study|Protocol deviation|1|||
155252280|NCT00254982|560355616|FG001|Overall Study|Protocol deviation|1|||
155252281|NCT00254982|560355615|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
155252282|NCT00254982|560355616|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
155252283|NCT00254982|560355615|FG000|Overall Study|Malignancy|0|||
155252284|NCT00254982|560355616|FG001|Overall Study|Malignancy|2|||
155252285|NCT00254982|560355615|FG000|Overall Study|Opportunistic infection|1|||
155252286|NCT00254982|560355616|FG001|Overall Study|Opportunistic infection|0|||
155252287|NCT00254982|560355615|FG000|Overall Study|Abnormal liver function tests|2|||
155252288|NCT00254982|560355616|FG001|Overall Study|Abnormal liver function tests|1|||
155252289|NCT00483184|560355617|FG000|Overall Study|Withdrawal by Subject|2|||
155252290|NCT00483184|560355618|FG001|Overall Study|Withdrawal by Subject|2|||
155252291|NCT00483184|560355619|FG002|Overall Study|Withdrawal by Subject|0|||
155252292|NCT00483184|560355617|FG000|Overall Study|Lost to Follow-up|1|||
155252293|NCT00483184|560355618|FG001|Overall Study|Lost to Follow-up|0|||
155252294|NCT00483184|560355619|FG002|Overall Study|Lost to Follow-up|0|||
155252295|NCT00483184|560355617|FG000|Overall Study|Adverse Event|1|||
155252296|NCT00483184|560355618|FG001|Overall Study|Adverse Event|2|||
155252297|NCT00483184|560355619|FG002|Overall Study|Adverse Event|2|||
155252298|NCT00483184|560355617|FG000|Overall Study|Protocol Violation|1|||
155252299|NCT00483184|560355618|FG001|Overall Study|Protocol Violation|0|||
155252300|NCT00483184|560355619|FG002|Overall Study|Protocol Violation|1|||
155252301|NCT02794285|560355622|FG000|Overall Study|Adverse Event|11|||
155252302|NCT02794285|560355623|FG001|Overall Study|Adverse Event|4|||
155252303|NCT02794285|560355624|FG002|Overall Study|Adverse Event|5|||
155252304|NCT02794285|560355625|FG003|Overall Study|Adverse Event|8|||
155252305|NCT02794285|560355622|FG000|Overall Study|Condition Under Investigation Improved|1|||
155252306|NCT02794285|560355623|FG001|Overall Study|Condition Under Investigation Improved|0|||
155252307|NCT02794285|560355624|FG002|Overall Study|Condition Under Investigation Improved|0|||
155252308|NCT02794285|560355625|FG003|Overall Study|Condition Under Investigation Improved|0|||
155252309|NCT02794285|560355622|FG000|Overall Study|Condition Under Investigation Worsened|0|||
155252310|NCT02794285|560355623|FG001|Overall Study|Condition Under Investigation Worsened|2|||
155252311|NCT02794285|560355624|FG002|Overall Study|Condition Under Investigation Worsened|1|||
155252312|NCT02794285|560355625|FG003|Overall Study|Condition Under Investigation Worsened|0|||
155252313|NCT02794285|560355622|FG000|Overall Study|Death|2|||
155252314|NCT02794285|560355623|FG001|Overall Study|Death|1|||
155252315|NCT02794285|560355624|FG002|Overall Study|Death|2|||
155252316|NCT02794285|560355625|FG003|Overall Study|Death|0|||
155252317|NCT02794285|560355622|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
155252318|NCT02794285|560355623|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
155252319|NCT02794285|560355624|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
155252320|NCT02794285|560355625|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
155252321|NCT02794285|560355622|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
155252322|NCT02794285|560355623|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
155252323|NCT02794285|560355624|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
155252324|NCT02794285|560355625|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
155252325|NCT02794285|560355622|FG000|Overall Study|Lack of Efficacy|10|||
155252326|NCT02794285|560355623|FG001|Overall Study|Lack of Efficacy|6|||
155252327|NCT02794285|560355624|FG002|Overall Study|Lack of Efficacy|3|||
155252328|NCT02794285|560355625|FG003|Overall Study|Lack of Efficacy|3|||
155252329|NCT02794285|560355622|FG000|Overall Study|Lost to Follow-up|5|||
155252330|NCT02794285|560355623|FG001|Overall Study|Lost to Follow-up|6|||
155252331|NCT02794285|560355624|FG002|Overall Study|Lost to Follow-up|3|||
155252332|NCT02794285|560355625|FG003|Overall Study|Lost to Follow-up|1|||
155252333|NCT02794285|560355622|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
155252334|NCT02794285|560355623|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
155252335|NCT02794285|560355624|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
155252336|NCT02794285|560355625|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
155252337|NCT02794285|560355622|FG000|Overall Study|Withdrawal by Subject|38|||
155252338|NCT02794285|560355623|FG001|Overall Study|Withdrawal by Subject|29|||
155252339|NCT02794285|560355624|FG002|Overall Study|Withdrawal by Subject|20|||
155252340|NCT02794285|560355625|FG003|Overall Study|Withdrawal by Subject|12|||
155252341|NCT02794285|560355622|FG000|Overall Study|Missing|1|||
155252342|NCT02794285|560355623|FG001|Overall Study|Missing|0|||
155252343|NCT02794285|560355624|FG002|Overall Study|Missing|0|||
155252344|NCT02794285|560355625|FG003|Overall Study|Missing|0|||
155252345|NCT02794285|560355622|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
155252346|NCT02794285|560355623|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
155252347|NCT02794285|560355624|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
155252348|NCT02794285|560355625|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
155252349|NCT02794285|560355622|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
155252350|NCT02794285|560355623|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
155252351|NCT02794285|560355624|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
155252352|NCT02794285|560355625|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
155252353|NCT03252587|560355626|FG000|Overall Study|Adverse Event|3|||
155252354|NCT03252587|560355627|FG001|Overall Study|Adverse Event|8|||
155252355|NCT03252587|560355628|FG002|Overall Study|Adverse Event|6|||
155252356|NCT03252587|560355629|FG003|Overall Study|Adverse Event|12|||
155252357|NCT03252587|560355626|FG000|Overall Study|Lack of Efficacy|7|||
155252358|NCT03252587|560355627|FG001|Overall Study|Lack of Efficacy|2|||
155252359|NCT03252587|560355628|FG002|Overall Study|Lack of Efficacy|2|||
155252360|NCT03252587|560355629|FG003|Overall Study|Lack of Efficacy|4|||
155252361|NCT03252587|560355626|FG000|Overall Study|Lost to Follow-up|2|||
155252362|NCT03252587|560355627|FG001|Overall Study|Lost to Follow-up|0|||
155252363|NCT03252587|560355628|FG002|Overall Study|Lost to Follow-up|0|||
155252364|NCT03252587|560355629|FG003|Overall Study|Lost to Follow-up|2|||
155252365|NCT03252587|560355626|FG000|Overall Study|Pregnancy|2|||
155252366|NCT03252587|560355627|FG001|Overall Study|Pregnancy|1|||
155252367|NCT03252587|560355628|FG002|Overall Study|Pregnancy|0|||
155252368|NCT03252587|560355629|FG003|Overall Study|Pregnancy|1|||
155252369|NCT03252587|560355626|FG000|Overall Study|Withdrawal by Subject|8|||
155252370|NCT03252587|560355627|FG001|Overall Study|Withdrawal by Subject|4|||
155252371|NCT03252587|560355628|FG002|Overall Study|Withdrawal by Subject|4|||
155252372|NCT03252587|560355629|FG003|Overall Study|Withdrawal by Subject|4|||
155252373|NCT03252587|560355626|FG000|Overall Study|Other Reasons|2|||
155252374|NCT03252587|560355627|FG001|Overall Study|Other Reasons|5|||
155252375|NCT03252587|560355628|FG002|Overall Study|Other Reasons|5|||
155252376|NCT03252587|560355629|FG003|Overall Study|Other Reasons|4|||
155252377|NCT03945188|560355630|FG000|Overall Study|Protocol Violation|1|||
155252378|NCT03945188|560355631|FG001|Overall Study|Protocol Violation|0|||
155252379|NCT03945188|560355630|FG000|Overall Study|Disease worsening|79|||
155252380|NCT03945188|560355631|FG001|Overall Study|Disease worsening|73|||
155252381|NCT03945188|560355630|FG000|Overall Study|Physician Decision|2|||
155252382|NCT03945188|560355631|FG001|Overall Study|Physician Decision|2|||
155252383|NCT03945188|560355630|FG000|Overall Study|Lack of Efficacy|7|||
155252384|NCT03945188|560355631|FG001|Overall Study|Lack of Efficacy|4|||
155252385|NCT03945188|560355630|FG000|Overall Study|Pregnancy|2|||
155252386|NCT03945188|560355631|FG001|Overall Study|Pregnancy|0|||
155252387|NCT03945188|560355630|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
155252388|NCT03945188|560355631|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
155252389|NCT03945188|560355630|FG000|Overall Study|Adverse Event|10|||
155252390|NCT03945188|560355631|FG001|Overall Study|Adverse Event|5|||
155252391|NCT03945188|560355630|FG000|Overall Study|Other|2|||
155252392|NCT03945188|560355631|FG001|Overall Study|Other|2|||
155252393|NCT03945188|560355630|FG000|Overall Study|Lost to Follow-up|1|||
155252394|NCT03945188|560355631|FG001|Overall Study|Lost to Follow-up|2|||
155252395|NCT04969198|560355637|FG000|Overall Study|Withdrawal by Subject|20|||
155252396|NCT04969198|560355637|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
155252397|NCT04969198|560355637|FG000|Overall Study|Lost to Follow-up|20|||
155252398|NCT04009291|560355639|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252399|NCT04009291|560355640|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252400|NCT04009291|560355641|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252401|NCT04009291|560355642|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
155252402|NCT04009291|560355643|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
155252403|NCT04009291|560355639|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252404|NCT04009291|560355640|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252405|NCT04009291|560355641|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252406|NCT04009291|560355642|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
155252407|NCT04009291|560355643|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
155252408|NCT03998618|560355644|FG000|Overall Study|Death|7|||
155252409|NCT03998618|560355645|FG001|Overall Study|Death|11|||
155252410|NCT03998618|560355644|FG000|Overall Study|hospice enrollment|3|||
155252411|NCT03998618|560355645|FG001|Overall Study|hospice enrollment|3|||
155252412|NCT03998618|560355644|FG000|Overall Study|Not feeling well/health problems|3|||
155252413|NCT03998618|560355645|FG001|Overall Study|Not feeling well/health problems|5|||
155252414|NCT03998618|560355644|FG000|Overall Study|Lost to Follow-up|6|||
155252415|NCT03998618|560355645|FG001|Overall Study|Lost to Follow-up|6|||
155252416|NCT03998618|560355644|FG000|Overall Study|Withdrawal by Subject|0|||
155252417|NCT03998618|560355645|FG001|Overall Study|Withdrawal by Subject|4|||
155252418|NCT00335322|560355647|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
155252419|NCT00335322|560355648|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
155252420|NCT00335322|560355649|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
155252421|NCT02576678|560355650|FG000|Overall Study|Adverse Event|0|||
155252422|NCT02576678|560355651|FG001|Overall Study|Adverse Event|0|||
155252423|NCT02576678|560355652|FG002|Overall Study|Adverse Event|2|||
155252424|NCT02576678|560355650|FG000|Overall Study|Withdrawal by Subject|3|||
155252425|NCT02576678|560355651|FG001|Overall Study|Withdrawal by Subject|1|||
155252426|NCT02576678|560355652|FG002|Overall Study|Withdrawal by Subject|2|||
155252427|NCT02576678|560355650|FG000|Overall Study|Lost to Follow-up|0|||
155252428|NCT02576678|560355651|FG001|Overall Study|Lost to Follow-up|0|||
155252429|NCT02576678|560355652|FG002|Overall Study|Lost to Follow-up|1|||
155252430|NCT02576678|560355650|FG000|Overall Study|Miscellaneous|2|||
155252431|NCT02576678|560355651|FG001|Overall Study|Miscellaneous|0|||
155252432|NCT02576678|560355652|FG002|Overall Study|Miscellaneous|0|||
155252433|NCT01988779|560355655|FG000|Overall Study|Withdrawal by Subject|2|||
155252434|NCT01988779|560355656|FG001|Overall Study|Withdrawal by Subject|2|||
155252435|NCT01988779|560355655|FG000|Overall Study|Protocol Violation|1|||
155252436|NCT01988779|560355656|FG001|Overall Study|Protocol Violation|0|||
155252437|NCT02275065|560355657|FG000|Overall Study|Randomized but not treated|1|||
155252438|NCT02275065|560355658|FG001|Overall Study|Randomized but not treated|0|||
155252439|NCT02275065|560355659|FG002|Overall Study|Randomized but not treated|1|||
155252440|NCT02275065|560355660|FG003|Overall Study|Randomized but not treated|1|||
155252441|NCT02275065|560355661|FG004|Overall Study|Randomized but not treated|0|||
155252442|NCT00417079|560355663|FG000|Overall Study|Disease progression|267|||
155252443|NCT00417079|560355664|FG001|Overall Study|Disease progression|180|||
155252444|NCT00417079|560355663|FG000|Overall Study|Adverse Event|32|||
155252445|NCT00417079|560355664|FG001|Overall Study|Adverse Event|67|||
155252446|NCT00417079|560355663|FG000|Overall Study|Non-compliance to protocol|0|||
155252447|NCT00417079|560355664|FG001|Overall Study|Non-compliance to protocol|1|||
155252448|NCT00417079|560355663|FG000|Overall Study|Lost to Follow-up|2|||
155252449|NCT00417079|560355664|FG001|Overall Study|Lost to Follow-up|0|||
155252450|NCT00417079|560355663|FG000|Overall Study|Withdrawal by Subject|17|||
155252451|NCT00417079|560355664|FG001|Overall Study|Withdrawal by Subject|8|||
155252452|NCT00417079|560355663|FG000|Overall Study|Not treated|6|||
155252453|NCT00417079|560355664|FG001|Overall Study|Not treated|7|||
155252454|NCT00417079|560355663|FG000|Overall Study|Screened failure|2|||
155252455|NCT00417079|560355664|FG001|Overall Study|Screened failure|1|||
155252456|NCT00417079|560355663|FG000|Overall Study|Investigator's decision|1|||
155252457|NCT00417079|560355664|FG001|Overall Study|Investigator's decision|4|||
155252458|NCT00417079|560355663|FG000|Overall Study|Non-confirmed Disease progression|1|||
155252459|NCT00417079|560355664|FG001|Overall Study|Non-confirmed Disease progression|1|||
155252460|NCT00417079|560355663|FG000|Overall Study|Clinical deterioration|1|||
155252461|NCT00417079|560355664|FG001|Overall Study|Clinical deterioration|0|||
155252462|NCT00417079|560355663|FG000|Overall Study|Screening error|2|||
155252463|NCT00417079|560355664|FG001|Overall Study|Screening error|1|||
155252464|NCT00417079|560355663|FG000|Overall Study|Withdrawal by subject's family|0|||
155252465|NCT00417079|560355664|FG001|Overall Study|Withdrawal by subject's family|1|||
155252466|NCT00417079|560355663|FG000|Overall Study|Patient unable to come to the clinic|0|||
155252467|NCT00417079|560355664|FG001|Overall Study|Patient unable to come to the clinic|1|||
155252468|NCT00417079|560355663|FG000|Overall Study|abnormal liver function tests|0|||
155252469|NCT00417079|560355664|FG001|Overall Study|abnormal liver function tests|1|||
155252470|NCT01687257|560355666|FG000|Overall Study|Efficacy Failure|6|||
155252471|NCT01687257|560355667|FG001|Overall Study|Efficacy Failure|0|||
155252472|NCT01687257|560355668|FG002|Overall Study|Efficacy Failure|5|||
155252473|NCT01687257|560355666|FG000|Overall Study|Subject Withdrew Consent|1|||
155252474|NCT01687257|560355667|FG001|Overall Study|Subject Withdrew Consent|1|||
155252475|NCT01687257|560355668|FG002|Overall Study|Subject Withdrew Consent|1|||
155252476|NCT01687257|560355666|FG000|Overall Study|Adverse Event|1|||
155252477|NCT01687257|560355667|FG001|Overall Study|Adverse Event|0|||
155252478|NCT01687257|560355668|FG002|Overall Study|Adverse Event|0|||
155252479|NCT01687257|560355666|FG000|Overall Study|Investigator's Discretion|0|||
155252480|NCT01687257|560355667|FG001|Overall Study|Investigator's Discretion|3|||
155252481|NCT01687257|560355668|FG002|Overall Study|Investigator's Discretion|0|||
155252482|NCT01922076|560355669|FG000|Overall Study|Adverse Event|0|||
155252483|NCT01922076|560355670|FG001|Overall Study|Adverse Event|0|||
155252484|NCT01922076|560355671|FG002|Overall Study|Adverse Event|0|||
155252485|NCT01922076|560355672|FG003|Overall Study|Adverse Event|0|||
155252486|NCT01922076|560355673|FG004|Overall Study|Adverse Event|1|||
155252487|NCT01922076|560355674|FG005|Overall Study|Adverse Event|0|||
155252488|NCT01922076|560355675|FG006|Overall Study|Adverse Event|0|||
155252489|NCT01922076|560355669|FG000|Overall Study|Physician Decision|0|||
155252490|NCT01922076|560355670|FG001|Overall Study|Physician Decision|0|||
155252491|NCT01922076|560355671|FG002|Overall Study|Physician Decision|1|||
155252492|NCT01922076|560355672|FG003|Overall Study|Physician Decision|0|||
155252493|NCT01922076|560355673|FG004|Overall Study|Physician Decision|0|||
155252494|NCT01922076|560355674|FG005|Overall Study|Physician Decision|0|||
155252495|NCT01922076|560355675|FG006|Overall Study|Physician Decision|0|||
155252496|NCT01922076|560355669|FG000|Overall Study|Withdrawal by Subject|0|||
155252497|NCT01922076|560355670|FG001|Overall Study|Withdrawal by Subject|0|||
155252498|NCT01922076|560355671|FG002|Overall Study|Withdrawal by Subject|0|||
155252499|NCT01922076|560355672|FG003|Overall Study|Withdrawal by Subject|1|||
155252500|NCT01922076|560355673|FG004|Overall Study|Withdrawal by Subject|0|||
155252501|NCT01922076|560355674|FG005|Overall Study|Withdrawal by Subject|1|||
155252502|NCT01922076|560355675|FG006|Overall Study|Withdrawal by Subject|1|||
155252503|NCT04899349|560355683|FG000|Overall Study|Study terminated by Sponsor|2|||
155252504|NCT04899349|560355684|FG001|Overall Study|Study terminated by Sponsor|0|||
155252505|NCT01018394|560355685|FG000|Overall Study|Withdrawal by Subject|5|||
155252506|NCT01018394|560355686|FG001|Overall Study|Withdrawal by Subject|5|||
155252507|NCT01018394|560355685|FG000|Overall Study|Lost to Follow-up|4|||
155252508|NCT01018394|560355686|FG001|Overall Study|Lost to Follow-up|3|||
155252509|NCT03792126|560355687|FG000|Overall Study|Adverse Event|1|||
155252510|NCT03792126|560355688|FG001|Overall Study|Adverse Event|2|||
155252511|NCT03792126|560355687|FG000|Overall Study|Death|0|||
155252512|NCT03792126|560355688|FG001|Overall Study|Death|1|||
155252513|NCT03792126|560355687|FG000|Overall Study|Lost to Follow-up|1|||
155252514|NCT03792126|560355688|FG001|Overall Study|Lost to Follow-up|0|||
155252515|NCT03792126|560355687|FG000|Overall Study|Withdrawal by Subject|0|||
155252516|NCT03792126|560355688|FG001|Overall Study|Withdrawal by Subject|1|||
155252517|NCT03792126|560355687|FG000|Overall Study|COVID-19 Restrictions|1|||
155252518|NCT03792126|560355688|FG001|Overall Study|COVID-19 Restrictions|3|||
155252519|NCT03792126|560355687|FG000|Overall Study|Symptoms resolved|0|||
155252520|NCT03792126|560355688|FG001|Overall Study|Symptoms resolved|3|||
155252521|NCT03240692|560355689|FG000|Overall Study|Physician Decision|1|||
155252522|NCT03240692|560355689|FG000|Overall Study|Withdrawal by Subject|1|||
155252523|NCT00683644|560355690|FG000|Overall Study|Withdrawal by Subject|4|||
155252524|NCT00683644|560355691|FG001|Overall Study|Withdrawal by Subject|2|||
155252525|NCT00683644|560355690|FG000|Overall Study|Lost to Follow-up|1|||
155252526|NCT00683644|560355691|FG001|Overall Study|Lost to Follow-up|4|||
155252527|NCT00683644|560355690|FG000|Overall Study|Adverse Event|1|||
155252528|NCT00683644|560355691|FG001|Overall Study|Adverse Event|2|||
155252529|NCT00683644|560355690|FG000|Overall Study|Low copper, other health problems,|7|||
155252530|NCT00683644|560355691|FG001|Overall Study|Low copper, other health problems,|6|||
155252531|NCT00617344|560355694|FG000|Overall Study|Serious adverse event|1|||
155252532|NCT00617344|560355695|FG001|Overall Study|Serious adverse event|0|||
155252533|NCT00617344|560355696|FG002|Overall Study|Serious adverse event|0|||
155252534|NCT00617344|560355694|FG000|Overall Study|Other Adverse Event|1|||
155252535|NCT00617344|560355695|FG001|Overall Study|Other Adverse Event|1|||
155252536|NCT00617344|560355696|FG002|Overall Study|Other Adverse Event|0|||
155252537|NCT00617344|560355694|FG000|Overall Study|Protocol Violation|10|||
155252538|NCT00617344|560355695|FG001|Overall Study|Protocol Violation|8|||
155252539|NCT00617344|560355696|FG002|Overall Study|Protocol Violation|5|||
155252540|NCT00617344|560355694|FG000|Overall Study|Lost to Follow-up|5|||
155252541|NCT00617344|560355695|FG001|Overall Study|Lost to Follow-up|4|||
155252542|NCT00617344|560355696|FG002|Overall Study|Lost to Follow-up|1|||
155252543|NCT00617344|560355694|FG000|Overall Study|Withdrawal by Subject|8|||
155252544|NCT00617344|560355695|FG001|Overall Study|Withdrawal by Subject|9|||
155252545|NCT00617344|560355696|FG002|Overall Study|Withdrawal by Subject|2|||
155252546|NCT01178086|560355697|FG000|Overall Study|Participant refusal|7|||
155252547|NCT01178086|560355697|FG000|Overall Study|Physician Decision|44|||
155252548|NCT01178086|560355697|FG000|Overall Study|Switch to other CLL therapy|113|||
155252549|NCT01178086|560355697|FG000|Overall Study|Death|59|||
155252550|NCT01178086|560355697|FG000|Overall Study|Other unspecified|89|||
155252551|NCT01178086|560355697|FG000|Overall Study|Excluded from EAS|20|||
155252552|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
155252553|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
155252554|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
155252555|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
155252556|NCT00983073|560355699|FG000|Titration and Optimal Dose Period|Other reason|4|||
155252557|NCT00983073|560355699|FG000|Maintenance Period|Adverse Event|5|||
155252558|NCT00983073|560355699|FG000|Maintenance Period|Withdrawal by Subject|2|||
155252559|NCT00983073|560355699|FG000|Maintenance Period|Lack of Efficacy|2|||
155252560|NCT00983073|560355699|FG000|Maintenance Period|Other Reason|7|||
155252561|NCT01400503|560355700|FG000|Overall Study|Withdrawal by Subject|1|||
155252562|NCT01400503|560355700|FG000|Overall Study|Study Terminated by Sponsor|58|||
155252563|NCT01400503|560355700|FG000|Overall Study|Other|1|||
155252564|NCT01669122|560355703|FG000|Period I|Lost to Follow-up|1|||
155252565|NCT01669122|560355703|FG000|Washout Period II|Protocol Violation|2|||
155252566|NCT02962908|560355706|FG000|Overall Study|Lost to Follow-up|0|||
155252567|NCT02962908|560355707|FG001|Overall Study|Lost to Follow-up|3|||
155252568|NCT02962908|560355708|FG002|Overall Study|Lost to Follow-up|0|||
155252569|NCT02962908|560355709|FG003|Overall Study|Lost to Follow-up|1|||
155252570|NCT02962908|560355706|FG000|Overall Study|Withdrawal by Subject|0|||
155252571|NCT02962908|560355707|FG001|Overall Study|Withdrawal by Subject|3|||
155252572|NCT02962908|560355708|FG002|Overall Study|Withdrawal by Subject|0|||
155252573|NCT02962908|560355709|FG003|Overall Study|Withdrawal by Subject|2|||
155252574|NCT02962908|560355706|FG000|Overall Study|Protocol Violation|0|||
155252575|NCT02962908|560355707|FG001|Overall Study|Protocol Violation|1|||
155252576|NCT02962908|560355708|FG002|Overall Study|Protocol Violation|0|||
155252577|NCT02962908|560355709|FG003|Overall Study|Protocol Violation|0|||
155252578|NCT02962908|560355706|FG000|Overall Study|Physician Decision|0|||
155252579|NCT02962908|560355707|FG001|Overall Study|Physician Decision|1|||
155252580|NCT02962908|560355708|FG002|Overall Study|Physician Decision|0|||
155252581|NCT02962908|560355709|FG003|Overall Study|Physician Decision|0|||
155252582|NCT01261338|560355710|FG000|Overall Study|Withdrawal by Subject|3|||
155252583|NCT01261338|560355711|FG001|Overall Study|Withdrawal by Subject|2|||
155252584|NCT05557942|560355712|FG000|Overall Study|Death|0|||
155252585|NCT05557942|560355713|FG001|Overall Study|Death|0|||
155252586|NCT05557942|560355714|FG002|Overall Study|Death|0|||
155252587|NCT05557942|560355715|FG003|Overall Study|Death|2|||
155252588|NCT05557942|560355716|FG004|Overall Study|Death|1|||
155252589|NCT05557942|560355717|FG005|Overall Study|Death|1|||
155252590|NCT05557942|560355712|FG000|Overall Study|Physician Decision|1|||
155252591|NCT05557942|560355713|FG001|Overall Study|Physician Decision|1|||
155252592|NCT05557942|560355714|FG002|Overall Study|Physician Decision|2|||
155252593|NCT05557942|560355715|FG003|Overall Study|Physician Decision|3|||
155252594|NCT05557942|560355716|FG004|Overall Study|Physician Decision|0|||
155252595|NCT05557942|560355717|FG005|Overall Study|Physician Decision|2|||
155252596|NCT05557942|560355712|FG000|Overall Study|Study terminated by sponsor|17|||
155252597|NCT05557942|560355713|FG001|Overall Study|Study terminated by sponsor|17|||
155252598|NCT05557942|560355714|FG002|Overall Study|Study terminated by sponsor|14|||
155252599|NCT05557942|560355715|FG003|Overall Study|Study terminated by sponsor|40|||
155252600|NCT05557942|560355716|FG004|Overall Study|Study terminated by sponsor|45|||
155252601|NCT05557942|560355717|FG005|Overall Study|Study terminated by sponsor|37|||
155252602|NCT05557942|560355712|FG000|Overall Study|Protocol Violation|0|||
155252603|NCT05557942|560355713|FG001|Overall Study|Protocol Violation|0|||
155252604|NCT05557942|560355714|FG002|Overall Study|Protocol Violation|0|||
155252605|NCT05557942|560355715|FG003|Overall Study|Protocol Violation|0|||
155252606|NCT05557942|560355716|FG004|Overall Study|Protocol Violation|0|||
155252607|NCT05557942|560355717|FG005|Overall Study|Protocol Violation|1|||
155252608|NCT05557942|560355712|FG000|Overall Study|Withdrawal by Subject|0|||
155252609|NCT05557942|560355713|FG001|Overall Study|Withdrawal by Subject|0|||
155252610|NCT05557942|560355714|FG002|Overall Study|Withdrawal by Subject|0|||
155252611|NCT05557942|560355715|FG003|Overall Study|Withdrawal by Subject|0|||
155252612|NCT05557942|560355716|FG004|Overall Study|Withdrawal by Subject|2|||
155252613|NCT05557942|560355717|FG005|Overall Study|Withdrawal by Subject|0|||
155252614|NCT01962493|560355718|FG000|Overall Study|Adverse Event|1|||
155252615|NCT01962493|560355719|FG001|Overall Study|Adverse Event|2|||
155252616|NCT01962493|560355718|FG000|Overall Study|Protocol Violation|0|||
155252617|NCT01962493|560355719|FG001|Overall Study|Protocol Violation|1|||
155252618|NCT01962493|560355718|FG000|Overall Study|Withdrawal by Subject|4|||
155252619|NCT01962493|560355719|FG001|Overall Study|Withdrawal by Subject|2|||
155252620|NCT01329029|560355726|FG000|Overall Study|Withdrawal by Subject|117|||
155252621|NCT01329029|560355727|FG001|Overall Study|Withdrawal by Subject|87|||
155252622|NCT01329029|560355726|FG000|Overall Study|Adverse Event|82|||
155252623|NCT01329029|560355727|FG001|Overall Study|Adverse Event|29|||
155252624|NCT01329029|560355726|FG000|Overall Study|Death|16|||
155252625|NCT01329029|560355727|FG001|Overall Study|Death|19|||
155252626|NCT01329029|560355726|FG000|Overall Study|Other|14|||
155252627|NCT01329029|560355727|FG001|Overall Study|Other|20|||
155252628|NCT01329029|560355726|FG000|Overall Study|COPD Exacerbation|11|||
155252629|NCT01329029|560355727|FG001|Overall Study|COPD Exacerbation|18|||
155252630|NCT01329029|560355726|FG000|Overall Study|Physician Decision|16|||
155252631|NCT01329029|560355727|FG001|Overall Study|Physician Decision|13|||
155252632|NCT01329029|560355726|FG000|Overall Study|Lost to Follow-up|8|||
155252633|NCT01329029|560355727|FG001|Overall Study|Lost to Follow-up|5|||
155252634|NCT01329029|560355726|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
155252635|NCT01329029|560355727|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
155252636|NCT01332227|560357400|FG000|Overall Study|Adverse Event|4|||
155252637|NCT01332227|560357401|FG001|Overall Study|Adverse Event|1|||
155252638|NCT01332227|560357400|FG000|Overall Study|Withdrawal by Subject|5|||
155252639|NCT01332227|560357401|FG001|Overall Study|Withdrawal by Subject|1|||
155252640|NCT01332227|560357400|FG000|Overall Study|Lost to Follow-up|2|||
155252641|NCT01332227|560357401|FG001|Overall Study|Lost to Follow-up|0|||
155252642|NCT01332227|560357400|FG000|Overall Study|Lack of Efficacy|3|||
155252643|NCT01332227|560357401|FG001|Overall Study|Lack of Efficacy|1|||
155252644|NCT01332227|560357400|FG000|Overall Study|Poor compliance/noncompliance|1|||
155252645|NCT01332227|560357401|FG001|Overall Study|Poor compliance/noncompliance|1|||
155252646|NCT01332227|560357400|FG000|Overall Study|Patient moved from area|1|||
155252647|NCT01332227|560357401|FG001|Overall Study|Patient moved from area|0|||
155252648|NCT01332227|560357400|FG000|Overall Study|Patient began prohibited medication|0|||
155252649|NCT01332227|560357401|FG001|Overall Study|Patient began prohibited medication|1|||
155252650|NCT03751631|560357402|FG000|Overall Study|Withdrawal by Subject|0|||
155252651|NCT03751631|560357403|FG001|Overall Study|Withdrawal by Subject|0|||
155252652|NCT03751631|560357404|FG002|Overall Study|Withdrawal by Subject|1|||
155252653|NCT03751631|560357405|FG003|Overall Study|Withdrawal by Subject|1|||
155252654|NCT03751631|560357406|FG004|Overall Study|Withdrawal by Subject|0|||
155252655|NCT03751631|560357407|FG005|Overall Study|Withdrawal by Subject|0|||
155252656|NCT02822222|560357408|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
155252657|NCT02822222|560357409|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
155252658|NCT00428090|560357411|FG000|Overall Study|Adverse Event|10|||
155252659|NCT00428090|560357412|FG001|Overall Study|Adverse Event|8|||
155252660|NCT00428090|560357413|FG002|Overall Study|Adverse Event|10|||
155252661|NCT00428090|560357414|FG003|Overall Study|Adverse Event|11|||
155252662|NCT00428090|560357411|FG000|Overall Study|Lost to Follow-up|3|||
155252663|NCT00428090|560357412|FG001|Overall Study|Lost to Follow-up|6|||
155252664|NCT00428090|560357413|FG002|Overall Study|Lost to Follow-up|1|||
155252665|NCT00428090|560357414|FG003|Overall Study|Lost to Follow-up|4|||
155252666|NCT00428090|560357411|FG000|Overall Study|Protocol Violation|3|||
155252667|NCT00428090|560357412|FG001|Overall Study|Protocol Violation|1|||
155252668|NCT00428090|560357413|FG002|Overall Study|Protocol Violation|3|||
155252669|NCT00428090|560357414|FG003|Overall Study|Protocol Violation|3|||
155252670|NCT00428090|560357411|FG000|Overall Study|Withdrawal by Subject|10|||
155252671|NCT00428090|560357412|FG001|Overall Study|Withdrawal by Subject|12|||
155252672|NCT00428090|560357413|FG002|Overall Study|Withdrawal by Subject|15|||
155252673|NCT00428090|560357414|FG003|Overall Study|Withdrawal by Subject|5|||
155252674|NCT00428090|560357411|FG000|Overall Study|Sponsor terminated study|0|||
155252675|NCT00428090|560357412|FG001|Overall Study|Sponsor terminated study|1|||
155252676|NCT00428090|560357413|FG002|Overall Study|Sponsor terminated study|0|||
155252677|NCT00428090|560357414|FG003|Overall Study|Sponsor terminated study|0|||
155252678|NCT00428090|560357411|FG000|Overall Study|Non-compliance|4|||
155252679|NCT00428090|560357412|FG001|Overall Study|Non-compliance|0|||
155252680|NCT00428090|560357413|FG002|Overall Study|Non-compliance|1|||
155252681|NCT00428090|560357414|FG003|Overall Study|Non-compliance|3|||
155252682|NCT00428090|560357411|FG000|Overall Study|Par. did not returned to visit|1|||
155252683|NCT00428090|560357412|FG001|Overall Study|Par. did not returned to visit|0|||
155252684|NCT00428090|560357413|FG002|Overall Study|Par. did not returned to visit|0|||
155252685|NCT00428090|560357414|FG003|Overall Study|Par. did not returned to visit|1|||
155252686|NCT00428090|560357411|FG000|Overall Study|Follow-Up visit not possible|1|||
155252687|NCT00428090|560357412|FG001|Overall Study|Follow-Up visit not possible|0|||
155252688|NCT00428090|560357413|FG002|Overall Study|Follow-Up visit not possible|0|||
155252689|NCT00428090|560357414|FG003|Overall Study|Follow-Up visit not possible|0|||
155252690|NCT00428090|560357411|FG000|Overall Study|Prohibited medication used for SAE|1|||
155252691|NCT00428090|560357412|FG001|Overall Study|Prohibited medication used for SAE|0|||
155252692|NCT00428090|560357413|FG002|Overall Study|Prohibited medication used for SAE|0|||
155252693|NCT00428090|560357414|FG003|Overall Study|Prohibited medication used for SAE|0|||
155252694|NCT00428090|560357411|FG000|Overall Study|Death of par.|1|||
155252695|NCT00428090|560357412|FG001|Overall Study|Death of par.|0|||
155252696|NCT00428090|560357413|FG002|Overall Study|Death of par.|1|||
155252697|NCT00428090|560357414|FG003|Overall Study|Death of par.|0|||
155252698|NCT00428090|560357411|FG000|Overall Study|Visit 7 exceed the visit window|0|||
155252699|NCT00428090|560357412|FG001|Overall Study|Visit 7 exceed the visit window|1|||
155252700|NCT00428090|560357413|FG002|Overall Study|Visit 7 exceed the visit window|0|||
155252701|NCT00428090|560357414|FG003|Overall Study|Visit 7 exceed the visit window|0|||
155252702|NCT00428090|560357411|FG000|Overall Study|Medical monitor terminated par.|0|||
155252703|NCT00428090|560357412|FG001|Overall Study|Medical monitor terminated par.|1|||
155252704|NCT00428090|560357413|FG002|Overall Study|Medical monitor terminated par.|0|||
155252705|NCT00428090|560357414|FG003|Overall Study|Medical monitor terminated par.|0|||
155252706|NCT00428090|560357411|FG000|Overall Study|Mental status of par. was|0|||
155252707|NCT00428090|560357412|FG001|Overall Study|Mental status of par. was|1|||
155252708|NCT00428090|560357413|FG002|Overall Study|Mental status of par. was|0|||
155252709|NCT00428090|560357414|FG003|Overall Study|Mental status of par. was|0|||
155252710|NCT00428090|560357411|FG000|Overall Study|Worsening of AD|0|||
155252711|NCT00428090|560357412|FG001|Overall Study|Worsening of AD|0|||
155252712|NCT00428090|560357413|FG002|Overall Study|Worsening of AD|1|||
155252713|NCT00428090|560357414|FG003|Overall Study|Worsening of AD|0|||
155252714|NCT00428090|560357411|FG000|Overall Study|Excluded for concerning QTc value|0|||
155252715|NCT00428090|560357412|FG001|Overall Study|Excluded for concerning QTc value|0|||
155252716|NCT00428090|560357413|FG002|Overall Study|Excluded for concerning QTc value|1|||
155252717|NCT00428090|560357414|FG003|Overall Study|Excluded for concerning QTc value|0|||
155252718|NCT00428090|560357411|FG000|Overall Study|Insufficient AD documentation|0|||
155252719|NCT00428090|560357412|FG001|Overall Study|Insufficient AD documentation|0|||
155252720|NCT00428090|560357413|FG002|Overall Study|Insufficient AD documentation|1|||
155252721|NCT00428090|560357414|FG003|Overall Study|Insufficient AD documentation|0|||
155252722|NCT00428090|560357411|FG000|Overall Study|High MMSE scores|0|||
155252723|NCT00428090|560357412|FG001|Overall Study|High MMSE scores|0|||
155252724|NCT00428090|560357413|FG002|Overall Study|High MMSE scores|1|||
155252725|NCT00428090|560357414|FG003|Overall Study|High MMSE scores|0|||
155252726|NCT00428090|560357411|FG000|Overall Study|Deterioration of cognitive status|0|||
155252727|NCT00428090|560357412|FG001|Overall Study|Deterioration of cognitive status|0|||
155252728|NCT00428090|560357413|FG002|Overall Study|Deterioration of cognitive status|1|||
155252729|NCT00428090|560357414|FG003|Overall Study|Deterioration of cognitive status|0|||
155252730|NCT00428090|560357411|FG000|Overall Study|Serious adverse event|0|||
155252731|NCT00428090|560357412|FG001|Overall Study|Serious adverse event|0|||
155252732|NCT00428090|560357413|FG002|Overall Study|Serious adverse event|1|||
155252733|NCT00428090|560357414|FG003|Overall Study|Serious adverse event|0|||
155252734|NCT00428090|560357411|FG000|Overall Study|Excluded for heart insufficiency|0|||
155252735|NCT00428090|560357412|FG001|Overall Study|Excluded for heart insufficiency|0|||
155252736|NCT00428090|560357413|FG002|Overall Study|Excluded for heart insufficiency|1|||
155252737|NCT00428090|560357414|FG003|Overall Study|Excluded for heart insufficiency|0|||
155252738|NCT00428090|560357411|FG000|Overall Study|Raised Creatinine Value|0|||
155252739|NCT00428090|560357412|FG001|Overall Study|Raised Creatinine Value|0|||
155252740|NCT00428090|560357413|FG002|Overall Study|Raised Creatinine Value|0|||
155252741|NCT00428090|560357414|FG003|Overall Study|Raised Creatinine Value|1|||
155252742|NCT00440531|560357417|FG000|Overall Study|Adverse Event|1|||
155252743|NCT00440531|560357418|FG001|Overall Study|Adverse Event|0|||
155252744|NCT00440531|560357419|FG002|Overall Study|Adverse Event|2|||
155252745|NCT00440531|560357417|FG000|Overall Study|Withdrawal by Subject|2|||
155252746|NCT00440531|560357418|FG001|Overall Study|Withdrawal by Subject|0|||
155252747|NCT00440531|560357419|FG002|Overall Study|Withdrawal by Subject|0|||
155252748|NCT00440531|560357417|FG000|Overall Study|Protocol Violation|1|||
155252749|NCT00440531|560357418|FG001|Overall Study|Protocol Violation|2|||
155252750|NCT00440531|560357419|FG002|Overall Study|Protocol Violation|0|||
155252751|NCT00440531|560357417|FG000|Overall Study|Lost to Follow-up|4|||
155252752|NCT00440531|560357418|FG001|Overall Study|Lost to Follow-up|3|||
155252753|NCT00440531|560357419|FG002|Overall Study|Lost to Follow-up|5|||
155252754|NCT00440531|560357417|FG000|Overall Study|see pre-assignment details|2|||
155252755|NCT00440531|560357418|FG001|Overall Study|see pre-assignment details|0|||
155252756|NCT00440531|560357419|FG002|Overall Study|see pre-assignment details|0|||
155252757|NCT00447057|560357420|FG000|Overall Study|Adverse Event|4|||
155252758|NCT00447057|560357421|FG001|Overall Study|Adverse Event|10|||
155252759|NCT00447057|560357422|FG002|Overall Study|Adverse Event|0|||
155252760|NCT00447057|560357423|FG003|Overall Study|Adverse Event|3|||
155252761|NCT00447057|560357420|FG000|Overall Study|Death due to study disease|6|||
155252762|NCT00447057|560357421|FG001|Overall Study|Death due to study disease|4|||
155252763|NCT00447057|560357422|FG002|Overall Study|Death due to study disease|1|||
155252764|NCT00447057|560357423|FG003|Overall Study|Death due to study disease|1|||
155252765|NCT00447057|560357420|FG000|Overall Study|Lost to Follow-up|0|||
155252766|NCT00447057|560357421|FG001|Overall Study|Lost to Follow-up|1|||
155252767|NCT00447057|560357422|FG002|Overall Study|Lost to Follow-up|0|||
155252768|NCT00447057|560357423|FG003|Overall Study|Lost to Follow-up|0|||
155252769|NCT00447057|560357420|FG000|Overall Study|Entry criteria not met|1|||
155252770|NCT00447057|560357421|FG001|Overall Study|Entry criteria not met|1|||
155252771|NCT00447057|560357422|FG002|Overall Study|Entry criteria not met|0|||
155252772|NCT00447057|560357423|FG003|Overall Study|Entry criteria not met|0|||
155252773|NCT00447057|560357420|FG000|Overall Study|Protocol Violation|0|||
155252774|NCT00447057|560357421|FG001|Overall Study|Protocol Violation|1|||
155252775|NCT00447057|560357422|FG002|Overall Study|Protocol Violation|0|||
155252776|NCT00447057|560357423|FG003|Overall Study|Protocol Violation|0|||
155252777|NCT00447057|560357420|FG000|Overall Study|Withdrawal by Subject|4|||
155252778|NCT00447057|560357421|FG001|Overall Study|Withdrawal by Subject|5|||
155252779|NCT00447057|560357422|FG002|Overall Study|Withdrawal by Subject|1|||
155252780|NCT00447057|560357423|FG003|Overall Study|Withdrawal by Subject|1|||
155252781|NCT00447057|560357420|FG000|Overall Study|Physician Decision|9|||
155252782|NCT00447057|560357421|FG001|Overall Study|Physician Decision|6|||
155252783|NCT00447057|560357422|FG002|Overall Study|Physician Decision|3|||
155252784|NCT00447057|560357423|FG003|Overall Study|Physician Decision|1|||
155252785|NCT00447057|560357420|FG000|Overall Study|Sponsor decision|1|||
155252786|NCT00447057|560357421|FG001|Overall Study|Sponsor decision|1|||
155252787|NCT00447057|560357422|FG002|Overall Study|Sponsor decision|0|||
155252788|NCT00447057|560357423|FG003|Overall Study|Sponsor decision|0|||
155252789|NCT00447057|560357420|FG000|Overall Study|Progressive disease|58|||
155252790|NCT00447057|560357421|FG001|Overall Study|Progressive disease|43|||
155252791|NCT00447057|560357422|FG002|Overall Study|Progressive disease|13|||
155252792|NCT00447057|560357423|FG003|Overall Study|Progressive disease|18|||
155252793|NCT00447057|560357420|FG000|Overall Study|Death due to adverse event|0|||
155252794|NCT00447057|560357421|FG001|Overall Study|Death due to adverse event|0|||
155252795|NCT00447057|560357422|FG002|Overall Study|Death due to adverse event|1|||
155252796|NCT00447057|560357423|FG003|Overall Study|Death due to adverse event|2|||
155252797|NCT00447057|560357420|FG000|Overall Study|Death, study drug related|0|||
155252798|NCT00447057|560357421|FG001|Overall Study|Death, study drug related|1|||
155252799|NCT00447057|560357422|FG002|Overall Study|Death, study drug related|0|||
155252800|NCT00447057|560357423|FG003|Overall Study|Death, study drug related|0|||
155252801|NCT00677833|560357426|FG000|Overall Study|Withdrawal by Subject|4|||
155252802|NCT00677833|560357427|FG001|Overall Study|Withdrawal by Subject|0|||
155252803|NCT00677833|560357428|FG002|Overall Study|Withdrawal by Subject|1|||
155252804|NCT00677833|560357429|FG003|Overall Study|Withdrawal by Subject|3|||
155252805|NCT00677833|560357426|FG000|Overall Study|Lost to Follow-up|0|||
155252806|NCT00677833|560357427|FG001|Overall Study|Lost to Follow-up|0|||
155252807|NCT00677833|560357428|FG002|Overall Study|Lost to Follow-up|1|||
155252808|NCT00677833|560357429|FG003|Overall Study|Lost to Follow-up|0|||
155252809|NCT02583425|560357434|FG000|Screening|Did not meet entry criteria|12|||
155252810|NCT02583425|560357434|FG000|Baseline|Did not meet continued criteria|5|||
155252811|NCT02583425|560357434|FG000|Treatment Period|Adverse Event|1|||
155252812|NCT03232983|560357435|FG000|Period 1|Physician Decision|0|||
155252813|NCT03232983|560357436|FG001|Period 1|Physician Decision|0|||
155252814|NCT03232983|560357437|FG002|Period 1|Physician Decision|1|||
155252815|NCT03232983|560357438|FG003|Period 1|Physician Decision|0|||
155252816|NCT03232983|560357435|FG000|Washout Period 2|Physician Decision|0|||
155252817|NCT03232983|560357436|FG001|Washout Period 2|Physician Decision|0|||
155252818|NCT03232983|560357437|FG002|Washout Period 2|Physician Decision|1|||
155252819|NCT03232983|560357438|FG003|Washout Period 2|Physician Decision|0|||
155252820|NCT03232983|560357435|FG000|Washout Period 2|Withdrawal by Subject|0|||
155252821|NCT03232983|560357436|FG001|Washout Period 2|Withdrawal by Subject|0|||
155252822|NCT03232983|560357437|FG002|Washout Period 2|Withdrawal by Subject|0|||
155252823|NCT03232983|560357438|FG003|Washout Period 2|Withdrawal by Subject|1|||
155252824|NCT03232983|560357435|FG000|Period 4|Withdrawal by Subject|1|||
155252825|NCT03232983|560357436|FG001|Period 4|Withdrawal by Subject|0|||
155252826|NCT03232983|560357437|FG002|Period 4|Withdrawal by Subject|0|||
155252827|NCT03232983|560357438|FG003|Period 4|Withdrawal by Subject|0|||
155252828|NCT02548455|560357439|FG000|Overall Study|Withdrawal by Subject|27|||
155252829|NCT02548455|560357439|FG000|Overall Study|Death|26|||
155252830|NCT02548455|560357439|FG000|Overall Study|Lost to Follow-up|14|||
155252831|NCT02548455|560357439|FG000|Overall Study|Visit not completed|173|||
155252832|NCT00530855|560357440|FG000|Overall Study|Lack of Efficacy|20|||
155252833|NCT00530855|560357440|FG000|Overall Study|Withdrawal by Subject|30|||
155252834|NCT00530855|560357440|FG000|Overall Study|Fatal Serious AE|3|||
155252835|NCT00530855|560357440|FG000|Overall Study|Non Fatal Serious AE|7|||
155252836|NCT00530855|560357440|FG000|Overall Study|Non Fatal Non Serious AE|12|||
155252837|NCT00530855|560357440|FG000|Overall Study|Protocol Violation|3|||
155252838|NCT00530855|560357440|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
155252839|NCT00530855|560357440|FG000|Overall Study|Lost to Follow-up|9|||
155252840|NCT00530855|560357440|FG000|Overall Study|Other reason for premature termination|17|||
155252841|NCT00815295|560357441|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
155252842|NCT00815295|560357442|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
155252843|NCT00815295|560357443|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
155252844|NCT01137474|560357444|FG000|Overall Study|Adverse Event|3|||
155252845|NCT01137474|560357445|FG001|Overall Study|Adverse Event|5|||
155252846|NCT01137474|560357446|FG002|Overall Study|Adverse Event|1|||
155252847|NCT01137474|560357447|FG003|Overall Study|Adverse Event|3|||
155252848|NCT01137474|560357444|FG000|Overall Study|Withdrawal by Subject|7|||
155252849|NCT01137474|560357445|FG001|Overall Study|Withdrawal by Subject|2|||
155252850|NCT01137474|560357446|FG002|Overall Study|Withdrawal by Subject|6|||
155252851|NCT01137474|560357447|FG003|Overall Study|Withdrawal by Subject|9|||
155252852|NCT01137474|560357444|FG000|Overall Study|No longer met study criteria|6|||
155252853|NCT01137474|560357445|FG001|Overall Study|No longer met study criteria|1|||
155252854|NCT01137474|560357446|FG002|Overall Study|No longer met study criteria|0|||
155252855|NCT01137474|560357447|FG003|Overall Study|No longer met study criteria|5|||
155252856|NCT01137474|560357444|FG000|Overall Study|Lost to Follow-up|5|||
155252857|NCT01137474|560357445|FG001|Overall Study|Lost to Follow-up|1|||
155252858|NCT01137474|560357446|FG002|Overall Study|Lost to Follow-up|0|||
155252859|NCT01137474|560357447|FG003|Overall Study|Lost to Follow-up|2|||
155252860|NCT01137474|560357444|FG000|Overall Study|Lack of Efficacy|0|||
155252861|NCT01137474|560357445|FG001|Overall Study|Lack of Efficacy|0|||
155252862|NCT01137474|560357446|FG002|Overall Study|Lack of Efficacy|0|||
155252863|NCT01137474|560357447|FG003|Overall Study|Lack of Efficacy|2|||
155252864|NCT01137474|560357444|FG000|Overall Study|Other|3|||
155252865|NCT01137474|560357445|FG001|Overall Study|Other|1|||
155252866|NCT01137474|560357446|FG002|Overall Study|Other|0|||
155252867|NCT01137474|560357447|FG003|Overall Study|Other|0|||
155252868|NCT01137474|560357444|FG000|Overall Study|Pregnancy|0|||
155252869|NCT01137474|560357445|FG001|Overall Study|Pregnancy|1|||
155252870|NCT01137474|560357446|FG002|Overall Study|Pregnancy|0|||
155252871|NCT01137474|560357447|FG003|Overall Study|Pregnancy|0|||
155252872|NCT01137474|560357444|FG000|Overall Study|Administrative reason by sponsor|0|||
155252873|NCT01137474|560357445|FG001|Overall Study|Administrative reason by sponsor|1|||
155252874|NCT01137474|560357446|FG002|Overall Study|Administrative reason by sponsor|0|||
155252875|NCT01137474|560357447|FG003|Overall Study|Administrative reason by sponsor|0|||
155252876|NCT04124926|560357450|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
155252877|NCT04124926|560357451|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
155252878|NCT04124926|560357452|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
155252879|NCT04124926|560357453|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
155252880|NCT04124926|560357454|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
155252881|NCT04124926|560357450|FG000|Healing Phase|Protocol Violation|0|||
155252882|NCT04124926|560357451|FG001|Healing Phase|Protocol Violation|1|||
155252883|NCT04124926|560357452|FG002|Healing Phase|Protocol Violation|0|||
155252884|NCT04124926|560357453|FG003|Healing Phase|Protocol Violation|0|||
155252885|NCT04124926|560357454|FG004|Healing Phase|Protocol Violation|0|||
155252886|NCT04124926|560357450|FG000|Healing Phase|Lost to Follow-up|5|||
155252887|NCT04124926|560357451|FG001|Healing Phase|Lost to Follow-up|4|||
155252888|NCT04124926|560357452|FG002|Healing Phase|Lost to Follow-up|0|||
155252889|NCT04124926|560357453|FG003|Healing Phase|Lost to Follow-up|0|||
155252890|NCT04124926|560357454|FG004|Healing Phase|Lost to Follow-up|0|||
155252891|NCT04124926|560357450|FG000|Healing Phase|Voluntary Withdrawal|10|||
155252892|NCT04124926|560357451|FG001|Healing Phase|Voluntary Withdrawal|7|||
155252893|NCT04124926|560357452|FG002|Healing Phase|Voluntary Withdrawal|0|||
155252894|NCT04124926|560357453|FG003|Healing Phase|Voluntary Withdrawal|0|||
155252895|NCT04124926|560357454|FG004|Healing Phase|Voluntary Withdrawal|0|||
155252896|NCT04124926|560357450|FG000|Healing Phase|Withdrawal of Consent|5|||
155252897|NCT04124926|560357451|FG001|Healing Phase|Withdrawal of Consent|3|||
155252898|NCT04124926|560357452|FG002|Healing Phase|Withdrawal of Consent|0|||
155252899|NCT04124926|560357453|FG003|Healing Phase|Withdrawal of Consent|0|||
155252900|NCT04124926|560357454|FG004|Healing Phase|Withdrawal of Consent|0|||
155252901|NCT04124926|560357450|FG000|Healing Phase|Miscellaneous|8|||
155252902|NCT04124926|560357451|FG001|Healing Phase|Miscellaneous|7|||
155252903|NCT04124926|560357452|FG002|Healing Phase|Miscellaneous|0|||
155252904|NCT04124926|560357453|FG003|Healing Phase|Miscellaneous|0|||
155252905|NCT04124926|560357454|FG004|Healing Phase|Miscellaneous|0|||
155252906|NCT04124926|560357450|FG000|Healing Phase|Randomized but not Treated|0|||
155252907|NCT04124926|560357451|FG001|Healing Phase|Randomized but not Treated|3|||
155252908|NCT04124926|560357452|FG002|Healing Phase|Randomized but not Treated|0|||
155252909|NCT04124926|560357453|FG003|Healing Phase|Randomized but not Treated|0|||
155252910|NCT04124926|560357454|FG004|Healing Phase|Randomized but not Treated|0|||
155252911|NCT04124926|560357450|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
155252912|NCT04124926|560357451|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
155252913|NCT04124926|560357452|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
155252914|NCT04124926|560357453|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
155252915|NCT04124926|560357454|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
155252916|NCT04124926|560357450|FG000|Maintenance Phase|Protocol Violation|0|||
155252917|NCT04124926|560357451|FG001|Maintenance Phase|Protocol Violation|0|||
155252918|NCT04124926|560357452|FG002|Maintenance Phase|Protocol Violation|3|||
155252919|NCT04124926|560357453|FG003|Maintenance Phase|Protocol Violation|0|||
155252920|NCT04124926|560357454|FG004|Maintenance Phase|Protocol Violation|0|||
155252921|NCT04124926|560357450|FG000|Maintenance Phase|Lost to Follow-up|0|||
155252922|NCT04124926|560357451|FG001|Maintenance Phase|Lost to Follow-up|0|||
155252923|NCT04124926|560357452|FG002|Maintenance Phase|Lost to Follow-up|7|||
155252924|NCT04124926|560357453|FG003|Maintenance Phase|Lost to Follow-up|8|||
155252925|NCT04124926|560357454|FG004|Maintenance Phase|Lost to Follow-up|9|||
155252926|NCT04124926|560357450|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
155252927|NCT04124926|560357451|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
155252928|NCT04124926|560357452|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
155252929|NCT04124926|560357453|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
155252930|NCT04124926|560357454|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
155252931|NCT04124926|560357450|FG000|Maintenance Phase|Pregnancy|0|||
155252932|NCT04124926|560357451|FG001|Maintenance Phase|Pregnancy|0|||
155252933|NCT04124926|560357452|FG002|Maintenance Phase|Pregnancy|0|||
155252934|NCT04124926|560357453|FG003|Maintenance Phase|Pregnancy|1|||
155252935|NCT04124926|560357454|FG004|Maintenance Phase|Pregnancy|0|||
155252936|NCT04124926|560357450|FG000|Maintenance Phase|Lack of Efficacy|0|||
155252937|NCT04124926|560357451|FG001|Maintenance Phase|Lack of Efficacy|0|||
155252938|NCT04124926|560357452|FG002|Maintenance Phase|Lack of Efficacy|0|||
155252939|NCT04124926|560357453|FG003|Maintenance Phase|Lack of Efficacy|0|||
155252940|NCT04124926|560357454|FG004|Maintenance Phase|Lack of Efficacy|1|||
155252941|NCT04124926|560357450|FG000|Maintenance Phase|Withdrawal of Consent|0|||
155252942|NCT04124926|560357451|FG001|Maintenance Phase|Withdrawal of Consent|0|||
155252943|NCT04124926|560357452|FG002|Maintenance Phase|Withdrawal of Consent|5|||
155252944|NCT04124926|560357453|FG003|Maintenance Phase|Withdrawal of Consent|5|||
155252945|NCT04124926|560357454|FG004|Maintenance Phase|Withdrawal of Consent|5|||
155252946|NCT04124926|560357450|FG000|Maintenance Phase|Miscellaneous|0|||
155252947|NCT04124926|560357451|FG001|Maintenance Phase|Miscellaneous|0|||
155252948|NCT04124926|560357452|FG002|Maintenance Phase|Miscellaneous|1|||
155252949|NCT04124926|560357453|FG003|Maintenance Phase|Miscellaneous|2|||
155252950|NCT04124926|560357454|FG004|Maintenance Phase|Miscellaneous|4|||
155252951|NCT04124926|560357450|FG000|Maintenance Phase|Randomized but not Treated|0|||
155252952|NCT04124926|560357451|FG001|Maintenance Phase|Randomized but not Treated|0|||
155252953|NCT04124926|560357452|FG002|Maintenance Phase|Randomized but not Treated|2|||
155252954|NCT04124926|560357453|FG003|Maintenance Phase|Randomized but not Treated|2|||
155252955|NCT04124926|560357454|FG004|Maintenance Phase|Randomized but not Treated|0|||
155252956|NCT03644186|560357458|FG000|Overall Study|Withdrawal by Subject|1|||
155252957|NCT03644186|560357459|FG001|Overall Study|Withdrawal by Subject|1|||
155252958|NCT02701985|560357462|FG000|Overall Study|Withdrawal by Subject|1|||
155252959|NCT02701985|560357463|FG001|Overall Study|Withdrawal by Subject|1|||
155252960|NCT02701985|560357462|FG000|Overall Study|Lost to Follow-up|1|||
155252961|NCT02701985|560357463|FG001|Overall Study|Lost to Follow-up|0|||
155252962|NCT02701985|560357462|FG000|Overall Study|Death|1|||
155252963|NCT02701985|560357463|FG001|Overall Study|Death|0|||
155252964|NCT02701985|560357462|FG000|Overall Study|Adverse Event|0|||
155252965|NCT02701985|560357463|FG001|Overall Study|Adverse Event|5|||
155252966|NCT01640808|560357465|FG000|Overall Study|Unable to continue dynamic CT|14|||
155252967|NCT01640808|560357466|FG001|Overall Study|Unable to continue dynamic CT|4|||
155252968|NCT01640808|560357465|FG000|Overall Study|Withdrawal by Subject|12|||
155252969|NCT01640808|560357466|FG001|Overall Study|Withdrawal by Subject|4|||
155252970|NCT01640808|560357465|FG000|Overall Study|Lost to Follow-up|4|||
155252971|NCT01640808|560357466|FG001|Overall Study|Lost to Follow-up|0|||
155252972|NCT01640808|560357465|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
155252973|NCT01640808|560357466|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
155252974|NCT01640808|560357465|FG000|Overall Study|Administration of anticancer drugs|2|||
155252975|NCT01640808|560357466|FG001|Overall Study|Administration of anticancer drugs|1|||
155252976|NCT01640808|560357465|FG000|Overall Study|Physician Decision|19|||
155252977|NCT01640808|560357466|FG001|Overall Study|Physician Decision|5|||
155252978|NCT01640808|560357465|FG000|Overall Study|Randomized but not treated|4|||
155252979|NCT01640808|560357466|FG001|Overall Study|Randomized but not treated|2|||
155252980|NCT02477111|560357467|FG000|Overall Study|Death|28|||
155252981|NCT02477111|560357467|FG000|Overall Study|Withdrawal by Subject|19|||
155252982|NCT02477111|560357467|FG000|Overall Study|Lost to Follow-up|4|||
155252983|NCT02192502|560357469|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
155252984|NCT02192502|560357470|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
155252985|NCT02192502|560357469|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
155252986|NCT02192502|560357470|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
155252987|NCT02192502|560357469|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
155252988|NCT02192502|560357470|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
155252989|NCT01381692|560357471|FG000|Overall Study|Adverse Event|1|||
155252990|NCT01381692|560357472|FG001|Overall Study|Adverse Event|0|||
155252991|NCT01381692|560357473|FG002|Overall Study|Adverse Event|0|||
155252992|NCT01381692|560357474|FG003|Overall Study|Adverse Event|0|||
155252993|NCT01381692|560357475|FG004|Overall Study|Adverse Event|0|||
155252994|NCT01381692|560357476|FG005|Overall Study|Adverse Event|0|||
155252995|NCT01328574|560357477|FG000|Overall Study|Refused further treatment|1|||
155252996|NCT03206203|560357478|FG000|Treatment|Death|38|||
155252997|NCT03206203|560357479|FG001|Treatment|Death|26|||
155252998|NCT03206203|560357480|FG002|Treatment|Death|0|||
155252999|NCT03206203|560357478|FG000|Treatment|Withdrawal by Subject|1|||
155253000|NCT03206203|560357479|FG001|Treatment|Withdrawal by Subject|0|||
155253001|NCT03206203|560357480|FG002|Treatment|Withdrawal by Subject|0|||
155253002|NCT03206203|560357478|FG000|Treatment|Lost to Follow-up|4|||
155253003|NCT03206203|560357479|FG001|Treatment|Lost to Follow-up|0|||
155253004|NCT03206203|560357480|FG002|Treatment|Lost to Follow-up|0|||
155253005|NCT03206203|560357478|FG000|Treatment|N/A in Follow-Up|8|||
155253006|NCT03206203|560357479|FG001|Treatment|N/A in Follow-Up|1|||
155253007|NCT03206203|560357480|FG002|Treatment|N/A in Follow-Up|0|||
155253008|NCT03206203|560357478|FG000|Treatment|Disease progression|0|||
155253009|NCT03206203|560357479|FG001|Treatment|Disease progression|1|||
155253010|NCT03206203|560357480|FG002|Treatment|Disease progression|0|||
155253011|NCT03206203|560357478|FG000|Treatment|Refused follow-up|0|||
155253012|NCT03206203|560357479|FG001|Treatment|Refused follow-up|1|||
155253013|NCT03206203|560357480|FG002|Treatment|Refused follow-up|0|||
155253014|NCT03206203|560357478|FG000|Treatment|Cross over to Arm 1|0|||
155253015|NCT03206203|560357479|FG001|Treatment|Cross over to Arm 1|19|||
155253016|NCT03206203|560357480|FG002|Treatment|Cross over to Arm 1|0|||
155253017|NCT03206203|560357478|FG000|Optional Cross-Over|Death|0|||
155253018|NCT03206203|560357479|FG001|Optional Cross-Over|Death|0|||
155253019|NCT03206203|560357480|FG002|Optional Cross-Over|Death|14|||
155253020|NCT03206203|560357478|FG000|Optional Cross-Over|Refused follow-up|0|||
155253021|NCT03206203|560357479|FG001|Optional Cross-Over|Refused follow-up|0|||
155253022|NCT03206203|560357480|FG002|Optional Cross-Over|Refused follow-up|2|||
155253023|NCT02308748|560357487|FG000|Period 1|Withdrawal by Subject|0|||
155253024|NCT02308748|560357488|FG001|Period 1|Withdrawal by Subject|0|||
155253025|NCT02308748|560357489|FG002|Period 1|Withdrawal by Subject|1|||
155253026|NCT02308748|560357490|FG003|Period 1|Withdrawal by Subject|0|||
155253027|NCT02308748|560357491|FG004|Period 1|Withdrawal by Subject|0|||
155253028|NCT02308748|560357492|FG005|Period 1|Withdrawal by Subject|0|||
155253029|NCT02308748|560357493|FG006|Period 1|Withdrawal by Subject|0|||
155253030|NCT02308748|560357494|FG007|Period 1|Withdrawal by Subject|0|||
155253031|NCT02308748|560357495|FG008|Period 1|Withdrawal by Subject|0|||
155253032|NCT02308748|560357496|FG009|Period 1|Withdrawal by Subject|0|||
155253033|NCT02308748|560357487|FG000|Period 2|Adverse Event|0|||
155253034|NCT02308748|560357488|FG001|Period 2|Adverse Event|0|||
155253035|NCT02308748|560357489|FG002|Period 2|Adverse Event|0|||
155253036|NCT02308748|560357490|FG003|Period 2|Adverse Event|0|||
155253037|NCT02308748|560357491|FG004|Period 2|Adverse Event|0|||
155253038|NCT02308748|560357492|FG005|Period 2|Adverse Event|0|||
155253039|NCT02308748|560357493|FG006|Period 2|Adverse Event|0|||
155253040|NCT02308748|560357494|FG007|Period 2|Adverse Event|1|||
155253041|NCT02308748|560357495|FG008|Period 2|Adverse Event|0|||
155253042|NCT02308748|560357496|FG009|Period 2|Adverse Event|0|||
155253043|NCT02308748|560357487|FG000|Period 3|Protocol Violation|0|||
155253044|NCT02308748|560357488|FG001|Period 3|Protocol Violation|0|||
155253045|NCT02308748|560357489|FG002|Period 3|Protocol Violation|0|||
155253046|NCT02308748|560357490|FG003|Period 3|Protocol Violation|0|||
155253047|NCT02308748|560357491|FG004|Period 3|Protocol Violation|0|||
155253048|NCT02308748|560357492|FG005|Period 3|Protocol Violation|0|||
155253049|NCT02308748|560357493|FG006|Period 3|Protocol Violation|0|||
155253050|NCT02308748|560357494|FG007|Period 3|Protocol Violation|0|||
155253051|NCT02308748|560357495|FG008|Period 3|Protocol Violation|0|||
155253052|NCT02308748|560357496|FG009|Period 3|Protocol Violation|1|||
155253053|NCT02308748|560357487|FG000|Period 5|Adverse Event|1|||
155253054|NCT02308748|560357488|FG001|Period 5|Adverse Event|0|||
155253055|NCT02308748|560357489|FG002|Period 5|Adverse Event|0|||
155253056|NCT02308748|560357490|FG003|Period 5|Adverse Event|0|||
155253057|NCT02308748|560357491|FG004|Period 5|Adverse Event|0|||
155253058|NCT02308748|560357492|FG005|Period 5|Adverse Event|0|||
155253059|NCT02308748|560357493|FG006|Period 5|Adverse Event|0|||
155253060|NCT02308748|560357494|FG007|Period 5|Adverse Event|0|||
155253061|NCT02308748|560357495|FG008|Period 5|Adverse Event|1|||
155253062|NCT02308748|560357496|FG009|Period 5|Adverse Event|0|||
155253063|NCT01152580|560357497|FG000|Overall Study|Withdrawal by Subject|0|||
155253064|NCT01152580|560357498|FG001|Overall Study|Withdrawal by Subject|1|||
155253065|NCT01994954|560357501|FG000|Overall Study|Death|1|||
155253066|NCT01994954|560357502|FG001|Overall Study|Death|0|||
155253067|NCT01994954|560357501|FG000|Overall Study|Withdrawal by Subject|9|||
155253068|NCT01994954|560357502|FG001|Overall Study|Withdrawal by Subject|14|||
155253069|NCT01994954|560357501|FG000|Overall Study|Physician Decision|2|||
155253070|NCT01994954|560357502|FG001|Overall Study|Physician Decision|2|||
155253071|NCT01994954|560357501|FG000|Overall Study|Lost to Follow-up|8|||
155253072|NCT01994954|560357502|FG001|Overall Study|Lost to Follow-up|10|||
155253073|NCT01994954|560357501|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
155253074|NCT01994954|560357502|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
155253075|NCT00449176|560357503|FG000|Overall Study|Withdrawal by Subject|39|||
155253076|NCT00449176|560357504|FG001|Overall Study|Withdrawal by Subject|43|||
155253077|NCT00449176|560357505|FG002|Overall Study|Withdrawal by Subject|59|||
155253078|NCT00449176|560357503|FG000|Overall Study|Lost to Follow-up|13|||
155253079|NCT00449176|560357504|FG001|Overall Study|Lost to Follow-up|8|||
155253080|NCT00449176|560357505|FG002|Overall Study|Lost to Follow-up|12|||
155253081|NCT00449176|560357503|FG000|Overall Study|Adverse Event|51|||
155253082|NCT00449176|560357504|FG001|Overall Study|Adverse Event|107|||
155253083|NCT00449176|560357505|FG002|Overall Study|Adverse Event|15|||
155253084|NCT00449176|560357503|FG000|Overall Study|Lack of Efficacy|13|||
155253085|NCT00449176|560357504|FG001|Overall Study|Lack of Efficacy|7|||
155253086|NCT00449176|560357505|FG002|Overall Study|Lack of Efficacy|50|||
155253087|NCT00449176|560357503|FG000|Overall Study|Study drug non-compliant|14|||
155253088|NCT00449176|560357504|FG001|Overall Study|Study drug non-compliant|11|||
155253089|NCT00449176|560357505|FG002|Overall Study|Study drug non-compliant|11|||
155253090|NCT00449176|560357503|FG000|Overall Study|all other|22|||
155253091|NCT00449176|560357504|FG001|Overall Study|all other|19|||
155253092|NCT00449176|560357505|FG002|Overall Study|all other|20|||
155253093|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
155253094|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
155253095|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|disease progression|58|||
155253096|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|disease progression|47|||
155253097|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Death|3|||
155253098|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Death|6|||
155253099|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
155253100|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
155253101|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
155253102|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
155253103|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
155253104|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
155253105|NCT02472964|560357506|FG000|Part 1 (up to Week 24)|Other|2|||
155253106|NCT02472964|560357507|FG001|Part 1 (up to Week 24)|Other|1|||
155253107|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
155253108|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
155253109|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
155253110|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
155253111|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Death|0|||
155253112|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Death|1|||
155253113|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
155253114|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
155253115|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
155253116|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
155253117|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
155253118|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
155253119|NCT02472964|560357506|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
155253120|NCT02472964|560357507|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
155253121|NCT01454583|560357508|FG000|1st Year|Lost to Follow-up|1057|||
155253122|NCT01454583|560357509|FG001|1st Year|Lost to Follow-up|318|||
155253123|NCT01454583|560357510|FG002|1st Year|Lost to Follow-up|180|||
155253124|NCT01454583|560357508|FG000|2nd Year|Lost to Follow-up|3965|||
155253125|NCT01454583|560357509|FG001|2nd Year|Lost to Follow-up|1049|||
155253126|NCT01454583|560357510|FG002|2nd Year|Lost to Follow-up|737|||
155253127|NCT01454583|560357508|FG000|3rd Year|Lost to Follow-up|1959|||
155253128|NCT01454583|560357509|FG001|3rd Year|Lost to Follow-up|512|||
155253129|NCT01454583|560357510|FG002|3rd Year|Lost to Follow-up|297|||
155253130|NCT01749982|560357511|FG000|Overall Study|Physician Decision|0|||
155253131|NCT01749982|560357512|FG001|Overall Study|Physician Decision|0|||
155253132|NCT01749982|560357513|FG002|Overall Study|Physician Decision|0|||
155253133|NCT01749982|560357514|FG003|Overall Study|Physician Decision|1|||
155253134|NCT01749982|560357511|FG000|Overall Study|Lost to Follow-up|0|||
155253135|NCT01749982|560357512|FG001|Overall Study|Lost to Follow-up|0|||
155253136|NCT01749982|560357513|FG002|Overall Study|Lost to Follow-up|0|||
155253137|NCT01749982|560357514|FG003|Overall Study|Lost to Follow-up|1|||
155253138|NCT01749982|560357511|FG000|Overall Study|Withdrawal by Subject|0|||
155253139|NCT01749982|560357512|FG001|Overall Study|Withdrawal by Subject|0|||
155253140|NCT01749982|560357513|FG002|Overall Study|Withdrawal by Subject|0|||
155253141|NCT01749982|560357514|FG003|Overall Study|Withdrawal by Subject|1|||
155253142|NCT00113568|560357519|FG000|Overall Study|Adverse Event|97|||
155253143|NCT00113568|560357519|FG000|Overall Study|Death|1|||
155253144|NCT00113568|560357519|FG000|Overall Study|Lack of Efficacy|30|||
155253145|NCT00113568|560357519|FG000|Overall Study|Lost to Follow-up|156|||
155253146|NCT00113568|560357519|FG000|Overall Study|Protocol Violation|32|||
155253147|NCT00113568|560357519|FG000|Overall Study|Withdrawal by Subject|117|||
155253148|NCT00113568|560357519|FG000|Overall Study|Other|112|||
155253149|NCT00377403|560357522|FG000|Overall Study|Unable to contact for telephone intervie|4|||
155253150|NCT00377403|560357523|FG001|Overall Study|Unable to contact for telephone intervie|7|||
155253151|NCT01207102|560357531|FG000|Overall Study|Withdrawal by Subject|5|||
155253152|NCT01207102|560357531|FG000|Overall Study|Adverse Event|2|||
155253153|NCT01207102|560357531|FG000|Overall Study|progression|2|||
155253154|NCT01207102|560357531|FG000|Overall Study|Withdrawal by Treating Physician|1|||
155253155|NCT00736645|560357534|FG000|Overall Study|Adverse Event|0|||
155253156|NCT00736645|560357535|FG001|Overall Study|Adverse Event|2|||
155253157|NCT00736645|560357536|FG002|Overall Study|Adverse Event|0|||
155253158|NCT00736645|560357537|FG003|Overall Study|Adverse Event|0|||
155253159|NCT04403698|560357538|FG000|Overall Study|Adverse Event|1|||
155253160|NCT04403698|560357539|FG001|Overall Study|Adverse Event|1|||
155253161|NCT04403698|560357538|FG000|Overall Study|Lost to Follow-up|1|||
155253162|NCT04403698|560357539|FG001|Overall Study|Lost to Follow-up|0|||
155253163|NCT04403698|560357538|FG000|Overall Study|Protocol Violation|0|||
155253164|NCT04403698|560357539|FG001|Overall Study|Protocol Violation|1|||
155253165|NCT00977665|560357540|FG000|Overall Study|Withdrawal by Subject|1|||
155253166|NCT00977665|560357541|FG001|Overall Study|Withdrawal by Subject|3|||
155253167|NCT00977665|560357540|FG000|Overall Study|Physician Decision|2|||
155253168|NCT00977665|560357541|FG001|Overall Study|Physician Decision|1|||
155253169|NCT00977665|560357540|FG000|Overall Study|Sponsor requested withdrawal|0|||
155253170|NCT00977665|560357541|FG001|Overall Study|Sponsor requested withdrawal|1|||
155253171|NCT00977665|560357540|FG000|Overall Study|Lost to Follow-up|1|||
155253172|NCT00977665|560357541|FG001|Overall Study|Lost to Follow-up|0|||
155253173|NCT00977665|560357540|FG000|Overall Study|Death|3|||
155253174|NCT00977665|560357541|FG001|Overall Study|Death|2|||
155253175|NCT00977665|560357540|FG000|Overall Study|Adverse Event|14|||
155253176|NCT00977665|560357541|FG001|Overall Study|Adverse Event|7|||
155253177|NCT00977665|560357540|FG000|Overall Study|Treatment failure|0|||
155253178|NCT00977665|560357541|FG001|Overall Study|Treatment failure|1|||
155253179|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
155253180|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
155253181|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
155253182|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
155253183|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
155253184|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
155253185|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
155253186|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
155253187|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
155253188|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
155253189|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
155253190|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
155253191|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
155253192|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
155253193|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
155253194|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
155253195|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
155253196|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
155253197|NCT00833638|560357542|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
155253198|NCT00833638|560357543|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
155253199|NCT00833638|560357544|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
155253200|NCT00833638|560357542|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
155253201|NCT00833638|560357543|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
155253202|NCT00833638|560357544|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
155253203|NCT00833638|560357542|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
155253204|NCT00833638|560357543|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
155253205|NCT00833638|560357544|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
155253206|NCT00490646|560357545|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
155253207|NCT00490646|560357546|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
155253208|NCT00490646|560357545|FG000|Overall Study|Never Treated (had an adverse event)|1|||
155253209|NCT00490646|560357546|FG001|Overall Study|Never Treated (had an adverse event)|0|||
155253210|NCT00490646|560357545|FG000|Overall Study|Never Treated (withdrew consent)|0|||
155253211|NCT00490646|560357546|FG001|Overall Study|Never Treated (withdrew consent)|1|||
155253212|NCT02137369|560357547|FG000|Overall Study|Withdrawal by Subject|3|||
155253213|NCT02137369|560357548|FG001|Overall Study|Withdrawal by Subject|2|||
155253214|NCT02137369|560357547|FG000|Overall Study|Adverse Event|2|||
155253215|NCT02137369|560357548|FG001|Overall Study|Adverse Event|0|||
155253216|NCT02137369|560357547|FG000|Overall Study|Lost to Follow-up|1|||
155253217|NCT02137369|560357548|FG001|Overall Study|Lost to Follow-up|0|||
155253218|NCT02137369|560357547|FG000|Overall Study|Moved away|2|||
155253219|NCT02137369|560357548|FG001|Overall Study|Moved away|0|||
155253220|NCT03543254|560357549|FG000|Overall Study|Lost to Follow-up|1|||
155253221|NCT02077166|560357550|FG000|Overall Study|Death|6|||
155253222|NCT02077166|560357551|FG001|Overall Study|Death|7|||
155253223|NCT02077166|560357552|FG002|Overall Study|Death|5|||
155253224|NCT02077166|560357553|FG003|Overall Study|Death|6|||
155253225|NCT02077166|560357554|FG004|Overall Study|Death|4|||
155253226|NCT02077166|560357555|FG005|Overall Study|Death|32|||
155253227|NCT02077166|560357556|FG006|Overall Study|Death|22|||
155253228|NCT02077166|560357550|FG000|Overall Study|Study Closure by Sponsor|3|||
155253229|NCT02077166|560357551|FG001|Overall Study|Study Closure by Sponsor|0|||
155253230|NCT02077166|560357552|FG002|Overall Study|Study Closure by Sponsor|2|||
155253231|NCT02077166|560357553|FG003|Overall Study|Study Closure by Sponsor|2|||
155253232|NCT02077166|560357554|FG004|Overall Study|Study Closure by Sponsor|2|||
155253233|NCT02077166|560357555|FG005|Overall Study|Study Closure by Sponsor|12|||
155253234|NCT02077166|560357556|FG006|Overall Study|Study Closure by Sponsor|4|||
155253235|NCT02077166|560357550|FG000|Overall Study|Lost to Follow-up|0|||
155253236|NCT02077166|560357551|FG001|Overall Study|Lost to Follow-up|0|||
155253237|NCT02077166|560357552|FG002|Overall Study|Lost to Follow-up|0|||
155253238|NCT02077166|560357553|FG003|Overall Study|Lost to Follow-up|0|||
155253239|NCT02077166|560357554|FG004|Overall Study|Lost to Follow-up|0|||
155253240|NCT02077166|560357555|FG005|Overall Study|Lost to Follow-up|1|||
155253241|NCT02077166|560357556|FG006|Overall Study|Lost to Follow-up|0|||
155253242|NCT02077166|560357550|FG000|Overall Study|Withdrawal by Subject|3|||
155253243|NCT02077166|560357551|FG001|Overall Study|Withdrawal by Subject|0|||
155253244|NCT02077166|560357552|FG002|Overall Study|Withdrawal by Subject|1|||
155253245|NCT02077166|560357553|FG003|Overall Study|Withdrawal by Subject|1|||
155253246|NCT02077166|560357554|FG004|Overall Study|Withdrawal by Subject|1|||
155253247|NCT02077166|560357555|FG005|Overall Study|Withdrawal by Subject|3|||
155253248|NCT02077166|560357556|FG006|Overall Study|Withdrawal by Subject|0|||
155253249|NCT02077166|560357550|FG000|Overall Study|Other, Not Specified|0|||
155253250|NCT02077166|560357551|FG001|Overall Study|Other, Not Specified|0|||
155253251|NCT02077166|560357552|FG002|Overall Study|Other, Not Specified|1|||
155253252|NCT02077166|560357553|FG003|Overall Study|Other, Not Specified|0|||
155253253|NCT02077166|560357554|FG004|Overall Study|Other, Not Specified|1|||
155253254|NCT02077166|560357555|FG005|Overall Study|Other, Not Specified|7|||
155253255|NCT02077166|560357556|FG006|Overall Study|Other, Not Specified|8|||
155253256|NCT03519854|560357557|FG000|Overall Study|Technical Error|0|||
155253257|NCT03519854|560357558|FG001|Overall Study|Technical Error|0|||
155253258|NCT03519854|560357559|FG002|Overall Study|Technical Error|1|||
155253259|NCT03519854|560357560|FG003|Overall Study|Technical Error|0|||
155253260|NCT03519854|560357561|FG004|Overall Study|Technical Error|0|||
155253261|NCT03519854|560357562|FG005|Overall Study|Technical Error|0|||
155253262|NCT03519854|560357563|FG006|Overall Study|Technical Error|0|||
155253263|NCT03519854|560357564|FG007|Overall Study|Technical Error|0|||
155253264|NCT03519854|560357565|FG008|Overall Study|Technical Error|0|||
155253265|NCT03519854|560357566|FG009|Overall Study|Technical Error|0|||
155253266|NCT03519854|560357567|FG010|Overall Study|Technical Error|0|||
155253267|NCT03519854|560357568|FG011|Overall Study|Technical Error|0|||
155253268|NCT03519854|560357569|FG012|Overall Study|Technical Error|0|||
155253269|NCT03519854|560357570|FG013|Overall Study|Technical Error|0|||
155253270|NCT03519854|560357571|FG014|Overall Study|Technical Error|0|||
155253271|NCT03519854|560357572|FG015|Overall Study|Technical Error|0|||
155253272|NCT03519854|560357573|FG016|Overall Study|Technical Error|0|||
155253273|NCT03519854|560357574|FG017|Overall Study|Technical Error|0|||
155253274|NCT02899728|560357578|FG000|Overall Study|Withdrawal by Subject|1|||
155253275|NCT02899728|560357579|FG001|Overall Study|Withdrawal by Subject|1|||
155253276|NCT03776136|560357580|FG000|Overall Study|Death|85|||
155253277|NCT03776136|560357580|FG000|Overall Study|Withdrawal by Subject|3|||
155253278|NCT03776136|560357580|FG000|Overall Study|Sponsor Decision|15|||
155253279|NCT03754803|560357581|FG000|Overall Study|Withdrawal by Subject|2|||
155253280|NCT04348604|560357584|FG000|Week 8|Withdrawal by Subject|1|||
155253281|NCT04348604|560357585|FG001|Week 8|Withdrawal by Subject|1|||
155253282|NCT04348604|560357584|FG000|Week 8|Lost to Follow-up|1|||
155253283|NCT04348604|560357585|FG001|Week 8|Lost to Follow-up|2|||
155253284|NCT04348604|560357584|FG000|Week 8|Suspended|0|||
155253285|NCT04348604|560357585|FG001|Week 8|Suspended|1|||
155253286|NCT04348604|560357584|FG000|Week 12|Lost to Follow-up|1|||
155253287|NCT04348604|560357585|FG001|Week 12|Lost to Follow-up|2|||
155253288|NCT04348604|560357584|FG000|Week 12|Withdrawal by Subject|1|||
155253289|NCT04348604|560357585|FG001|Week 12|Withdrawal by Subject|0|||
155253290|NCT04348604|560357584|FG000|Week 24|Lost to Follow-up|2|||
155253291|NCT04348604|560357585|FG001|Week 24|Lost to Follow-up|1|||
155253292|NCT02097108|560357586|FG000|Overall Study|Adverse Event|1|||
155253293|NCT02097108|560357586|FG000|Overall Study|patient was abroad for 6 months|1|||
155253294|NCT00127608|560357589|FG000|Overall Study|VZV DNA negative|1|||
155253295|NCT05245864|560357590|FG000|Overall Study|Withdrawal by Subject|1|||
155253296|NCT05245864|560357591|FG001|Overall Study|Withdrawal by Subject|1|||
155253297|NCT01475136|560357594|FG000|Overall Study|Sponsor Decision|0|||
155253298|NCT01475136|560357595|FG001|Overall Study|Sponsor Decision|1|||
155253299|NCT01475136|560357596|FG002|Overall Study|Sponsor Decision|0|||
155253300|NCT01475136|560357597|FG003|Overall Study|Sponsor Decision|0|||
155253301|NCT01475136|560357594|FG000|Overall Study|Entry Criteria Not Met|0|||
155253302|NCT01475136|560357595|FG001|Overall Study|Entry Criteria Not Met|2|||
155253303|NCT01475136|560357596|FG002|Overall Study|Entry Criteria Not Met|3|||
155253304|NCT01475136|560357597|FG003|Overall Study|Entry Criteria Not Met|1|||
155253305|NCT01475136|560357594|FG000|Overall Study|Withdrawal by Subject|0|||
155253306|NCT01475136|560357595|FG001|Overall Study|Withdrawal by Subject|0|||
155253307|NCT01475136|560357596|FG002|Overall Study|Withdrawal by Subject|0|||
155253308|NCT01475136|560357597|FG003|Overall Study|Withdrawal by Subject|2|||
155253309|NCT01475136|560357594|FG000|Overall Study|Adverse Event|1|||
155253310|NCT01475136|560357595|FG001|Overall Study|Adverse Event|0|||
155253311|NCT01475136|560357596|FG002|Overall Study|Adverse Event|0|||
155253312|NCT01475136|560357597|FG003|Overall Study|Adverse Event|1|||
155253313|NCT01475136|560357594|FG000|Overall Study|Death|0|||
155253314|NCT01475136|560357595|FG001|Overall Study|Death|0|||
155253315|NCT01475136|560357596|FG002|Overall Study|Death|0|||
155253316|NCT01475136|560357597|FG003|Overall Study|Death|1|||
155253317|NCT01323530|560359617|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
155253318|NCT01323530|560359618|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253319|NCT01323530|560359619|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253320|NCT01323530|560359620|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253321|NCT01323530|560359621|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253322|NCT01323530|560359622|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
155253323|NCT01323530|560359623|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
155253324|NCT01323530|560359617|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155253325|NCT01323530|560359618|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155253326|NCT01323530|560359619|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
155253327|NCT01323530|560359620|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155253328|NCT01323530|560359621|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
155253329|NCT01323530|560359622|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155253330|NCT01323530|560359623|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
155253331|NCT01323530|560359617|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253332|NCT01323530|560359618|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
155253333|NCT01323530|560359619|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253334|NCT01323530|560359620|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253335|NCT01323530|560359621|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
155253336|NCT01323530|560359622|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
155253337|NCT01323530|560359623|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
155253338|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253339|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253340|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253341|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253342|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253343|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
155253344|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
155253345|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253346|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253347|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253348|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253349|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253350|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
155253351|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
155253352|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253353|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253354|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253355|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253356|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253357|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
155253358|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
155253359|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253360|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253361|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253362|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253363|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253364|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
155253365|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
155253366|NCT01323530|560359617|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253367|NCT01323530|560359618|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253368|NCT01323530|560359619|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253369|NCT01323530|560359620|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253370|NCT01323530|560359621|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253371|NCT01323530|560359622|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
155253372|NCT01323530|560359623|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
155253373|NCT01194570|560359624|FG000|Overall Study|Adverse Event|22|||
155253374|NCT01194570|560359625|FG001|Overall Study|Adverse Event|40|||
155253375|NCT01194570|560359624|FG000|Overall Study|Death|6|||
155253376|NCT01194570|560359625|FG001|Overall Study|Death|20|||
155253377|NCT01194570|560359624|FG000|Overall Study|Lack of Efficacy|32|||
155253378|NCT01194570|560359625|FG001|Overall Study|Lack of Efficacy|33|||
155253379|NCT01194570|560359624|FG000|Overall Study|Lost to Follow-up|4|||
155253380|NCT01194570|560359625|FG001|Overall Study|Lost to Follow-up|15|||
155253381|NCT01194570|560359624|FG000|Overall Study|Non-Compliance|2|||
155253382|NCT01194570|560359625|FG001|Overall Study|Non-Compliance|2|||
155253383|NCT01194570|560359624|FG000|Overall Study|Non-Compliance With Study Drug|2|||
155253384|NCT01194570|560359625|FG001|Overall Study|Non-Compliance With Study Drug|2|||
155253385|NCT01194570|560359624|FG000|Overall Study|Other|18|||
155253386|NCT01194570|560359625|FG001|Overall Study|Other|47|||
155253387|NCT01194570|560359624|FG000|Overall Study|Physician Decision|10|||
155253388|NCT01194570|560359625|FG001|Overall Study|Physician Decision|25|||
155253389|NCT01194570|560359624|FG000|Overall Study|Protocol Violation|1|||
155253390|NCT01194570|560359625|FG001|Overall Study|Protocol Violation|2|||
155253391|NCT01194570|560359624|FG000|Overall Study|Study Terminated By Sponsor|0|||
155253392|NCT01194570|560359625|FG001|Overall Study|Study Terminated By Sponsor|1|||
155253393|NCT01194570|560359624|FG000|Overall Study|Withdrawal by Subject|57|||
155253394|NCT01194570|560359625|FG001|Overall Study|Withdrawal by Subject|82|||
155253395|NCT01194570|560359624|FG000|Overall Study|Pregnancy|1|||
155253396|NCT01194570|560359625|FG001|Overall Study|Pregnancy|1|||
155253397|NCT04918784|560359629|FG000|Overall Study|Amputation - no longer eligible|1|||
155253398|NCT04918784|560359630|FG001|Overall Study|Amputation - no longer eligible|2|||
155253399|NCT04918784|560359629|FG000|Overall Study|Death|1|||
155253400|NCT04918784|560359630|FG001|Overall Study|Death|0|||
155253401|NCT04918784|560359629|FG000|Overall Study|patient non-compliance|3|||
155253402|NCT04918784|560359630|FG001|Overall Study|patient non-compliance|1|||
155253403|NCT04918784|560359629|FG000|Overall Study|Adverse Event|1|||
155253404|NCT04918784|560359630|FG001|Overall Study|Adverse Event|0|||
155253405|NCT01712009|560359631|FG000|Overall Study|Withdrawal by Subject|24|||
155253406|NCT01712009|560359632|FG001|Overall Study|Withdrawal by Subject|15|||
155253407|NCT01712009|560359633|FG002|Overall Study|Withdrawal by Subject|8|||
155253408|NCT01712009|560359631|FG000|Overall Study|Lost to Follow-up|2|||
155253409|NCT01712009|560359632|FG001|Overall Study|Lost to Follow-up|0|||
155253410|NCT01712009|560359633|FG002|Overall Study|Lost to Follow-up|1|||
155253411|NCT01712009|560359631|FG000|Overall Study|Decision by Sponsor|12|||
155253412|NCT01712009|560359632|FG001|Overall Study|Decision by Sponsor|14|||
155253413|NCT01712009|560359633|FG002|Overall Study|Decision by Sponsor|12|||
155253414|NCT01111123|560359634|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
155253415|NCT01111123|560359635|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
155253416|NCT01111123|560359634|FG000|Maintenance Phase|Lost to Follow-up|0|||
155253417|NCT01111123|560359635|FG001|Maintenance Phase|Lost to Follow-up|2|||
155253418|NCT01203930|560359641|FG000|Overall Study|Disease Progression|0|||
155253419|NCT01203930|560359642|FG001|Overall Study|Disease Progression|4|||
155253420|NCT01203930|560359641|FG000|Overall Study|Death|3|||
155253421|NCT01203930|560359642|FG001|Overall Study|Death|1|||
155253422|NCT01203930|560359641|FG000|Overall Study|Withdrew Consent|1|||
155253423|NCT01203930|560359642|FG001|Overall Study|Withdrew Consent|10|||
155253424|NCT01203930|560359641|FG000|Overall Study|Investigator Request|0|||
155253425|NCT01203930|560359642|FG001|Overall Study|Investigator Request|8|||
155253426|NCT01203930|560359641|FG000|Overall Study|Study Terminated by Sponsor|0|||
155253427|NCT01203930|560359642|FG001|Overall Study|Study Terminated by Sponsor|12|||
155253428|NCT01203930|560359641|FG000|Overall Study|Poor tolerance of study drug|0|||
155253429|NCT01203930|560359642|FG001|Overall Study|Poor tolerance of study drug|1|||
155253430|NCT01203930|560359641|FG000|Overall Study|Adverse Event|17|||
155253431|NCT01203930|560359642|FG001|Overall Study|Adverse Event|5|||
155253432|NCT04050865|560359645|FG000|Overall Study|Adverse Event|1|||
155253433|NCT04050865|560359646|FG001|Overall Study|Adverse Event|0|||
155253434|NCT04050865|560359645|FG000|Overall Study|no insert|1|||
155253435|NCT04050865|560359646|FG001|Overall Study|no insert|0|||
155253436|NCT04050865|560359645|FG000|Overall Study|Only 1 insert|2|||
155253437|NCT04050865|560359646|FG001|Overall Study|Only 1 insert|3|||
155253438|NCT04050865|560359645|FG000|Overall Study|Physician Decision|0|||
155253439|NCT04050865|560359646|FG001|Overall Study|Physician Decision|1|||
155253440|NCT04050865|560359645|FG000|Overall Study|Withdrawal by Subject|0|||
155253441|NCT04050865|560359646|FG001|Overall Study|Withdrawal by Subject|1|||
155253442|NCT01266850|560359647|FG000|Overall Study|Lost to Follow-up|19|||
155253443|NCT01266850|560359648|FG001|Overall Study|Lost to Follow-up|19|||
155253444|NCT01266850|560359649|FG002|Overall Study|Lost to Follow-up|13|||
155253445|NCT01266850|560359650|FG003|Overall Study|Lost to Follow-up|13|||
155253446|NCT01266850|560359651|FG004|Overall Study|Lost to Follow-up|12|||
155253447|NCT01266850|560359647|FG000|Overall Study|Withdrawal by Subject|8|||
155253448|NCT01266850|560359648|FG001|Overall Study|Withdrawal by Subject|9|||
155253449|NCT01266850|560359649|FG002|Overall Study|Withdrawal by Subject|6|||
155253450|NCT01266850|560359650|FG003|Overall Study|Withdrawal by Subject|9|||
155253451|NCT01266850|560359651|FG004|Overall Study|Withdrawal by Subject|12|||
155253452|NCT01266850|560359647|FG000|Overall Study|Physician Decision|3|||
155253453|NCT01266850|560359648|FG001|Overall Study|Physician Decision|6|||
155253454|NCT01266850|560359649|FG002|Overall Study|Physician Decision|4|||
155253455|NCT01266850|560359650|FG003|Overall Study|Physician Decision|4|||
155253456|NCT01266850|560359651|FG004|Overall Study|Physician Decision|3|||
155253457|NCT01266850|560359647|FG000|Overall Study|Protocol Violation|0|||
155253458|NCT01266850|560359648|FG001|Overall Study|Protocol Violation|1|||
155253459|NCT01266850|560359649|FG002|Overall Study|Protocol Violation|0|||
155253460|NCT01266850|560359650|FG003|Overall Study|Protocol Violation|1|||
155253461|NCT01266850|560359651|FG004|Overall Study|Protocol Violation|2|||
155253462|NCT01266850|560359647|FG000|Overall Study|Adverse Event|0|||
155253463|NCT01266850|560359648|FG001|Overall Study|Adverse Event|0|||
155253464|NCT01266850|560359649|FG002|Overall Study|Adverse Event|0|||
155253465|NCT01266850|560359650|FG003|Overall Study|Adverse Event|0|||
155253466|NCT01266850|560359651|FG004|Overall Study|Adverse Event|1|||
155253467|NCT01266850|560359647|FG000|Overall Study|Site Closure|0|||
155253468|NCT01266850|560359648|FG001|Overall Study|Site Closure|1|||
155253469|NCT01266850|560359649|FG002|Overall Study|Site Closure|1|||
155253470|NCT01266850|560359650|FG003|Overall Study|Site Closure|1|||
155253471|NCT01266850|560359651|FG004|Overall Study|Site Closure|0|||
155253472|NCT02035332|560359653|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
155253473|NCT00857207|560359654|FG000|Overall Study|Withdrawal by Subject|13|||
155253474|NCT00857207|560359655|FG001|Overall Study|Withdrawal by Subject|0|||
155253475|NCT00857207|560359654|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
155253476|NCT00857207|560359655|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
155253477|NCT00857207|560359654|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
155253478|NCT00857207|560359655|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
155253479|NCT01791725|560359666|FG000|Overall Study|Withdrawal by Subject|0|||
155253480|NCT01791725|560359667|FG001|Overall Study|Withdrawal by Subject|1|||
155253481|NCT01791725|560359668|FG002|Overall Study|Withdrawal by Subject|0|||
155253482|NCT02690974|560359669|FG000|Overall Study|Adverse Event|16|||
155253483|NCT02690974|560359669|FG000|Overall Study|Death|9|||
155253484|NCT02690974|560359669|FG000|Overall Study|Subject/guardian decision|4|||
155253485|NCT02690974|560359669|FG000|Overall Study|Lost to Follow-up|3|||
155253486|NCT02690974|560359669|FG000|Overall Study|Withdrawal of Informed Consent|3|||
155253487|NCT02690974|560359669|FG000|Overall Study|Physician Decision|2|||
155253488|NCT02690974|560359669|FG000|Overall Study|Non-compliance with study treatment|1|||
155253489|NCT02690974|560359669|FG000|Overall Study|Protocol-defined stopping criteria|1|||
155253490|NCT02690974|560359669|FG000|Overall Study|Protocol Deviation|1|||
155253491|NCT01644734|560359675|FG000|Overall Study|Adverse Event|4|||
155253492|NCT01644734|560359675|FG000|Overall Study|Lost to Follow-up|17|||
155253493|NCT01644734|560359675|FG000|Overall Study|Reasons other than stated above|7|||
155253494|NCT01644734|560359675|FG000|Overall Study|Missing documentation|238|||
155253495|NCT02157779|560359680|FG000|Overall Study|Logistical|9|||
155253496|NCT02157779|560359681|FG001|Overall Study|Logistical|3|||
155253497|NCT02157779|560359680|FG000|Overall Study|Stopped attending, reason unknown|11|||
155253498|NCT02157779|560359681|FG001|Overall Study|Stopped attending, reason unknown|7|||
155253499|NCT02157779|560359680|FG000|Overall Study|No response to outreach after Baseline|1|||
155253500|NCT02157779|560359681|FG001|Overall Study|No response to outreach after Baseline|1|||
155253501|NCT02157779|560359680|FG000|Overall Study|Moved|1|||
155253502|NCT02157779|560359681|FG001|Overall Study|Moved|0|||
155253503|NCT02157779|560359680|FG000|Overall Study|Medical|1|||
155253504|NCT02157779|560359681|FG001|Overall Study|Medical|0|||
155253505|NCT02157779|560359680|FG000|Overall Study|Legal issue|1|||
155253506|NCT02157779|560359681|FG001|Overall Study|Legal issue|0|||
155253507|NCT00487162|560359683|FG000|Overall Study|Adverse Event|0|||
155253508|NCT00487162|560359684|FG001|Overall Study|Adverse Event|1|||
155253509|NCT00487162|560359683|FG000|Overall Study|Physician Decision|0|||
155253510|NCT00487162|560359684|FG001|Overall Study|Physician Decision|1|||
155253511|NCT00487162|560359683|FG000|Overall Study|Withdrawal by Subject|2|||
155253512|NCT00487162|560359684|FG001|Overall Study|Withdrawal by Subject|3|||
155253513|NCT01292876|560359685|FG000|Overall Study|Physician Decision|4|||
155253514|NCT01627327|560359686|FG000|Overall Study|Adverse Event|6|||
155253515|NCT01627327|560359687|FG001|Overall Study|Adverse Event|12|||
155253516|NCT01627327|560359686|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
155253517|NCT01627327|560359687|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
155253518|NCT01627327|560359686|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
155253519|NCT01627327|560359687|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
155253520|NCT01627327|560359686|FG000|Overall Study|Protocol Violation|4|||
155253521|NCT01627327|560359687|FG001|Overall Study|Protocol Violation|10|||
155253522|NCT01627327|560359686|FG000|Overall Study|Lost to Follow-up|1|||
155253523|NCT01627327|560359687|FG001|Overall Study|Lost to Follow-up|3|||
155253524|NCT01627327|560359686|FG000|Overall Study|Physician Decision|1|||
155253525|NCT01627327|560359687|FG001|Overall Study|Physician Decision|0|||
155253526|NCT01627327|560359686|FG000|Overall Study|Withdrawal by Subject|3|||
155253527|NCT01627327|560359687|FG001|Overall Study|Withdrawal by Subject|3|||
155253528|NCT02525874|560359693|FG000|Overall Study|Other|1|||
155253529|NCT02525874|560359693|FG000|Overall Study|Investigator Decision|1|||
155253530|NCT02525874|560359693|FG000|Overall Study|Consent withdrawn|22|||
155253531|NCT02525874|560359693|FG000|Overall Study|Non-compliance with study drug|3|||
155253532|NCT02525874|560359693|FG000|Overall Study|Adverse Event|17|||
155253533|NCT02525874|560359693|FG000|Overall Study|Lost to Follow-up|7|||
155253534|NCT02525874|560359693|FG000|Overall Study|Disease progression, defined by protocol|2|||
155253535|NCT02525874|560359693|FG000|Overall Study|Disease relapse|4|||
155253536|NCT02525874|560359693|FG000|Overall Study|Alternative Treatment for MS|2|||
155253537|NCT02525874|560359693|FG000|Overall Study|New lesions in Brain|1|||
155253538|NCT01692782|560359694|FG000|Overall Study|Adverse Event|12|||
155253539|NCT01692782|560359695|FG001|Overall Study|Adverse Event|32|||
155253540|NCT01692782|560359696|FG002|Overall Study|Adverse Event|2|||
155253541|NCT01692782|560359694|FG000|Overall Study|Lack of Efficacy|1|||
155253542|NCT01692782|560359695|FG001|Overall Study|Lack of Efficacy|2|||
155253543|NCT01692782|560359696|FG002|Overall Study|Lack of Efficacy|0|||
155253544|NCT01692782|560359694|FG000|Overall Study|Lost to Follow-up|2|||
155253545|NCT01692782|560359695|FG001|Overall Study|Lost to Follow-up|7|||
155253546|NCT01692782|560359696|FG002|Overall Study|Lost to Follow-up|1|||
155253547|NCT01692782|560359694|FG000|Overall Study|Pregnancy|1|||
155253548|NCT01692782|560359695|FG001|Overall Study|Pregnancy|0|||
155253549|NCT01692782|560359696|FG002|Overall Study|Pregnancy|0|||
155253550|NCT01692782|560359694|FG000|Overall Study|Protocol Violation|1|||
155253551|NCT01692782|560359695|FG001|Overall Study|Protocol Violation|0|||
155253552|NCT01692782|560359696|FG002|Overall Study|Protocol Violation|2|||
155253553|NCT01692782|560359694|FG000|Overall Study|Non-complance with study drug|0|||
155253554|NCT01692782|560359695|FG001|Overall Study|Non-complance with study drug|4|||
155253555|NCT01692782|560359696|FG002|Overall Study|Non-complance with study drug|1|||
155253556|NCT01692782|560359694|FG000|Overall Study|Non-compliant with study visits|0|||
155253557|NCT01692782|560359695|FG001|Overall Study|Non-compliant with study visits|0|||
155253558|NCT01692782|560359696|FG002|Overall Study|Non-compliant with study visits|1|||
155253559|NCT01692782|560359694|FG000|Overall Study|SAE not related to study drug|0|||
155253560|NCT01692782|560359695|FG001|Overall Study|SAE not related to study drug|1|||
155253561|NCT01692782|560359696|FG002|Overall Study|SAE not related to study drug|0|||
155253562|NCT01692782|560359694|FG000|Overall Study|Withdrawal by Subject|3|||
155253563|NCT01692782|560359695|FG001|Overall Study|Withdrawal by Subject|10|||
155253564|NCT01692782|560359696|FG002|Overall Study|Withdrawal by Subject|3|||
155253565|NCT00338884|560359708|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
155253566|NCT00338884|560359708|FG000|Overall Study|Adverse Event|14|||
155253567|NCT00338884|560359708|FG000|Overall Study|Death|8|||
155253568|NCT00338884|560359708|FG000|Overall Study|Other|4|||
155253569|NCT00338884|560359708|FG000|Overall Study|Global Deterioration of Health Status|3|||
155253570|NCT00338884|560359708|FG000|Overall Study|Withdrawal by Subject|3|||
155253571|NCT00338884|560359708|FG000|Overall Study|Lost to Follow-up|1|||
155253572|NCT00338884|560359708|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
155253573|NCT00423176|560359709|FG000|Overall Study|Adverse Event|4|||
155253574|NCT00423176|560359710|FG001|Overall Study|Adverse Event|6|||
155253575|NCT00423176|560359709|FG000|Overall Study|Treatment Failure|1|||
155253576|NCT00423176|560359710|FG001|Overall Study|Treatment Failure|6|||
155253577|NCT00423176|560359709|FG000|Overall Study|Lost to Follow-up|4|||
155253578|NCT00423176|560359710|FG001|Overall Study|Lost to Follow-up|7|||
155253579|NCT00423176|560359709|FG000|Overall Study|Withdrawal by Subject|4|||
155253580|NCT00423176|560359710|FG001|Overall Study|Withdrawal by Subject|3|||
155253581|NCT00423176|560359709|FG000|Overall Study|Protocol Violation|1|||
155253582|NCT00423176|560359710|FG001|Overall Study|Protocol Violation|3|||
155253583|NCT00423176|560359709|FG000|Overall Study|Did not meet protocol eligibility|2|||
155253584|NCT00423176|560359710|FG001|Overall Study|Did not meet protocol eligibility|4|||
155253585|NCT02013622|560359711|FG000|Overall Study|Lost to Follow-up|10|||
155253586|NCT02013622|560359711|FG000|Overall Study|Adverse Event|3|||
155253587|NCT02013622|560359711|FG000|Overall Study|Met Withdrawal Criteria|3|||
155253588|NCT02013622|560359711|FG000|Overall Study|Withdrawal by Subject|6|||
155253589|NCT02013622|560359711|FG000|Overall Study|Protocol Deviation|1|||
155253590|NCT02013622|560359711|FG000|Overall Study|Lack of Efficacy|1|||
155253591|NCT00224874|560359712|FG000|Overall Study|Withdrawal by Subject|0|||
155253592|NCT00224874|560359713|FG001|Overall Study|Withdrawal by Subject|0|||
155253593|NCT00224874|560359714|FG002|Overall Study|Withdrawal by Subject|1|||
155253594|NCT00224874|560359715|FG003|Overall Study|Withdrawal by Subject|0|||
155253595|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
155253596|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
155253597|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
155253598|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
155253599|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
155253600|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
155253601|NCT02355002|560359716|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
155253602|NCT02355002|560359717|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
155253603|NCT02355002|560359716|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
155253604|NCT02355002|560359717|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
155253605|NCT02355002|560359716|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
155253606|NCT02355002|560359717|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
155253607|NCT02355002|560359716|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
155253608|NCT02355002|560359717|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
155253609|NCT05554237|560359718|FG000|Part 2 (7 Days)|Adverse Event|0|||
155253610|NCT05554237|560359719|FG001|Part 2 (7 Days)|Adverse Event|0|||
155253611|NCT05554237|560359720|FG002|Part 2 (7 Days)|Adverse Event|0|||
155253612|NCT05554237|560359721|FG003|Part 2 (7 Days)|Adverse Event|0|||
155253613|NCT05554237|560359722|FG004|Part 2 (7 Days)|Adverse Event|2|||
155253614|NCT05554237|560359723|FG005|Part 2 (7 Days)|Adverse Event|0|||
155253615|NCT05554237|560359724|FG006|Part 2 (7 Days)|Adverse Event|0|||
155253616|NCT05554237|560359725|FG007|Part 2 (7 Days)|Adverse Event|0|||
155253617|NCT05554237|560359726|FG008|Part 2 (7 Days)|Adverse Event|0|||
155253618|NCT05554237|560359727|FG009|Part 2 (7 Days)|Adverse Event|1|||
155253619|NCT05554237|560359728|FG010|Part 2 (7 Days)|Adverse Event|0|||
155253620|NCT05554237|560359729|FG011|Part 2 (7 Days)|Adverse Event|0|||
155253621|NCT05554237|560359730|FG012|Part 2 (7 Days)|Adverse Event|1|||
155253622|NCT05554237|560359731|FG013|Part 2 (7 Days)|Adverse Event|0|||
155253623|NCT05130970|560359734|FG000|Overall Study|Adverse Event|1|||
155253624|NCT05130970|560359735|FG001|Overall Study|Adverse Event|1|||
155253625|NCT05130970|560359734|FG000|Overall Study|Death|0|||
155253626|NCT05130970|560359735|FG001|Overall Study|Death|1|||
155253627|NCT05130970|560359734|FG000|Overall Study|Lost to Follow-up|0|||
155253628|NCT05130970|560359735|FG001|Overall Study|Lost to Follow-up|1|||
155253629|NCT05130970|560359734|FG000|Overall Study|Physician Decision|0|||
155253630|NCT05130970|560359735|FG001|Overall Study|Physician Decision|1|||
155253631|NCT05130970|560359734|FG000|Overall Study|Withdrawal by Subject|1|||
155253632|NCT05130970|560359735|FG001|Overall Study|Withdrawal by Subject|1|||
155253633|NCT03896035|560359740|FG000|Overall Study|Lost to Follow-up|2|||
155253634|NCT03896035|560359741|FG001|Overall Study|Lost to Follow-up|6|||
155253635|NCT03896035|560359740|FG000|Overall Study|Withdrawal by Subject|0|||
155253636|NCT03896035|560359741|FG001|Overall Study|Withdrawal by Subject|1|||
155253637|NCT03896035|560359740|FG000|Overall Study|Health/family health issues during COVID|0|||
155253638|NCT03896035|560359741|FG001|Overall Study|Health/family health issues during COVID|4|||
155253639|NCT01556438|560359742|FG000|Overall Study|Adverse Event|4|||
155253640|NCT01556438|560359743|FG001|Overall Study|Adverse Event|2|||
155253641|NCT01556438|560359742|FG000|Overall Study|Sponsor Decision|0|||
155253642|NCT01556438|560359743|FG001|Overall Study|Sponsor Decision|2|||
155253643|NCT01556438|560359742|FG000|Overall Study|Progressive Disease|0|||
155253644|NCT01556438|560359743|FG001|Overall Study|Progressive Disease|6|||
155253645|NCT01556438|560359742|FG000|Overall Study|Death|0|||
155253646|NCT01556438|560359743|FG001|Overall Study|Death|1|||
155253647|NCT01506193|560359746|FG000|Overall Study|Protocol Violation|1|||
155253648|NCT01506193|560359747|FG001|Overall Study|Protocol Violation|0|||
155253649|NCT01506193|560359748|FG002|Overall Study|Protocol Violation|1|||
155253650|NCT01506193|560359746|FG000|Overall Study|Migrated/moved from study area|0|||
155253651|NCT01506193|560359747|FG001|Overall Study|Migrated/moved from study area|0|||
155253652|NCT01506193|560359748|FG002|Overall Study|Migrated/moved from study area|1|||
155253653|NCT01506193|560359746|FG000|Overall Study|Adverse event, non-fatal|0|||
155253654|NCT01506193|560359747|FG001|Overall Study|Adverse event, non-fatal|0|||
155253655|NCT01506193|560359748|FG002|Overall Study|Adverse event, non-fatal|1|||
155253656|NCT01506193|560359746|FG000|Overall Study|Withdrawal by Subject|5|||
155253657|NCT01506193|560359747|FG001|Overall Study|Withdrawal by Subject|1|||
155253658|NCT01506193|560359748|FG002|Overall Study|Withdrawal by Subject|8|||
155253659|NCT01506193|560359746|FG000|Overall Study|Lost to Follow-up|8|||
155253660|NCT01506193|560359747|FG001|Overall Study|Lost to Follow-up|3|||
155253661|NCT01506193|560359748|FG002|Overall Study|Lost to Follow-up|3|||
155253662|NCT01388816|560359752|FG000|Overall Study|Adverse Event|0|||
155253663|NCT01388816|560359753|FG001|Overall Study|Adverse Event|2|||
155253664|NCT01388816|560359754|FG002|Overall Study|Adverse Event|0|||
155253665|NCT01388816|560359755|FG003|Overall Study|Adverse Event|0|||
155253666|NCT01388816|560359752|FG000|Overall Study|Lost to Follow-up|0|||
155253667|NCT01388816|560359753|FG001|Overall Study|Lost to Follow-up|1|||
155253668|NCT01388816|560359754|FG002|Overall Study|Lost to Follow-up|0|||
155253669|NCT01388816|560359755|FG003|Overall Study|Lost to Follow-up|0|||
155253670|NCT01388816|560359752|FG000|Overall Study|Withdrawal by Subject|2|||
155253671|NCT01388816|560359753|FG001|Overall Study|Withdrawal by Subject|1|||
155253672|NCT01388816|560359754|FG002|Overall Study|Withdrawal by Subject|1|||
155253673|NCT01388816|560359755|FG003|Overall Study|Withdrawal by Subject|0|||
155253674|NCT01388816|560359752|FG000|Overall Study|Protocol Violation|0|||
155253675|NCT01388816|560359753|FG001|Overall Study|Protocol Violation|0|||
155253676|NCT01388816|560359754|FG002|Overall Study|Protocol Violation|2|||
155253677|NCT01388816|560359755|FG003|Overall Study|Protocol Violation|0|||
155253678|NCT04575467|560359756|FG000|Overall Study|Adverse Event|0|||
155253679|NCT04575467|560359757|FG001|Overall Study|Adverse Event|1|||
155253680|NCT04575467|560359758|FG002|Overall Study|Adverse Event|0|||
155253681|NCT04575467|560359759|FG003|Overall Study|Adverse Event|0|||
155253682|NCT00743366|560359760|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
155253683|NCT00743366|560359761|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
155253684|NCT00675766|560359762|FG000|Overall Study|Lost to Follow-up|6|||
155253685|NCT00675766|560359763|FG001|Overall Study|Lost to Follow-up|5|||
155253686|NCT00675766|560359764|FG002|Overall Study|Lost to Follow-up|21|||
155253687|NCT00675766|560359765|FG003|Overall Study|Lost to Follow-up|26|||
155253688|NCT01967732|560359766|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
155253689|NCT01967732|560359767|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
155253690|NCT01967732|560359768|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
155253691|NCT01967732|560359769|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
155253692|NCT01967732|560359766|FG000|First Intervention (Day 1)|Poor venous access|0|||
155253693|NCT01967732|560359767|FG001|First Intervention (Day 1)|Poor venous access|1|||
155253694|NCT01967732|560359768|FG002|First Intervention (Day 1)|Poor venous access|0|||
155253695|NCT01967732|560359769|FG003|First Intervention (Day 1)|Poor venous access|0|||
155253696|NCT01569438|560359778|FG000|Overall Study|Lack of Efficacy|1|||
155253697|NCT01569438|560359779|FG001|Overall Study|Lack of Efficacy|2|||
155253698|NCT01569438|560359778|FG000|Overall Study|Withdrawal by Subject|0|||
155253699|NCT01569438|560359779|FG001|Overall Study|Withdrawal by Subject|3|||
155253700|NCT01569438|560359778|FG000|Overall Study|Adverse Event|2|||
155253701|NCT01569438|560359779|FG001|Overall Study|Adverse Event|15|||
155253702|NCT01569438|560359778|FG000|Overall Study|Protocol Violation|2|||
155253703|NCT01569438|560359779|FG001|Overall Study|Protocol Violation|0|||
155253704|NCT01569438|560359778|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
155253705|NCT01569438|560359779|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
155253706|NCT01569438|560359778|FG000|Overall Study|Sponsor/Physician decision|1|||
155253707|NCT01569438|560359779|FG001|Overall Study|Sponsor/Physician decision|1|||
155253708|NCT01569438|560359778|FG000|Overall Study|Unable to adhere to study schedule|0|||
155253709|NCT01569438|560359779|FG001|Overall Study|Unable to adhere to study schedule|1|||
155253710|NCT01330433|560359780|FG000|Overall Study|Death|1|||
155253711|NCT01330433|560359781|FG001|Overall Study|Death|3|||
155253712|NCT01330433|560359780|FG000|Overall Study|Lost to Follow-up|1|||
155253713|NCT01330433|560359781|FG001|Overall Study|Lost to Follow-up|0|||
155253714|NCT02300220|560359784|FG000|Overall Study|Lost to Follow-up|1|||
155253715|NCT02300220|560359785|FG001|Overall Study|Lost to Follow-up|2|||
155253716|NCT02300220|560359784|FG000|Overall Study|Death|1|||
155253717|NCT02300220|560359785|FG001|Overall Study|Death|1|||
155253718|NCT02300220|560359784|FG000|Overall Study|Adverse Event|1|||
155253719|NCT02300220|560359785|FG001|Overall Study|Adverse Event|1|||
155253720|NCT02300220|560359784|FG000|Overall Study|Protocol Violation|1|||
155253721|NCT02300220|560359785|FG001|Overall Study|Protocol Violation|0|||
155253722|NCT02300220|560359784|FG000|Overall Study|Withdrawal by Subject|0|||
155253723|NCT02300220|560359785|FG001|Overall Study|Withdrawal by Subject|2|||
155253724|NCT02300220|560359784|FG000|Overall Study|Did not tolerate IMP|0|||
155253725|NCT02300220|560359785|FG001|Overall Study|Did not tolerate IMP|1|||
155253726|NCT04322682|560359786|FG000|Overall Study|Withdrawal by Subject|33|||
155253727|NCT04322682|560359787|FG001|Overall Study|Withdrawal by Subject|47|||
155253728|NCT04322682|560359786|FG000|Overall Study|Death|5|||
155253729|NCT04322682|560359787|FG001|Overall Study|Death|9|||
155253730|NCT04322682|560359786|FG000|Overall Study|Lost to Follow-up|4|||
155253731|NCT04322682|560359787|FG001|Overall Study|Lost to Follow-up|8|||
155253732|NCT04322682|560359786|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
155253733|NCT04322682|560359787|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
155253734|NCT02238379|560359788|FG000|Overall Study|Lost to Follow-up|1|||
155253735|NCT02238379|560359789|FG001|Overall Study|Lost to Follow-up|0|||
155253736|NCT04123067|560359790|FG000|Overall Study|Lost to Follow-up|0|||
155253737|NCT04123067|560359791|FG001|Overall Study|Lost to Follow-up|1|||
155253738|NCT00441090|560359792|FG000|Overall Study|Adverse Event|0|||
155253739|NCT00441090|560359793|FG001|Overall Study|Adverse Event|1|||
155253740|NCT00441090|560359794|FG002|Overall Study|Adverse Event|1|||
155253741|NCT00441090|560359795|FG003|Overall Study|Adverse Event|0|||
155253742|NCT00441090|560359796|FG004|Overall Study|Adverse Event|0|||
155253743|NCT00441090|560359792|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253744|NCT00441090|560359793|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253745|NCT00441090|560359794|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253746|NCT00441090|560359795|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
155253747|NCT00441090|560359796|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
155253748|NCT00441090|560359792|FG000|Overall Study|Withdrawal by Subject|1|||
155253749|NCT00441090|560359793|FG001|Overall Study|Withdrawal by Subject|0|||
155253750|NCT00441090|560359794|FG002|Overall Study|Withdrawal by Subject|1|||
155253751|NCT00441090|560359795|FG003|Overall Study|Withdrawal by Subject|0|||
155253752|NCT00441090|560359796|FG004|Overall Study|Withdrawal by Subject|0|||
155253753|NCT00441090|560359792|FG000|Overall Study|Lack of Efficacy|1|||
155253754|NCT00441090|560359793|FG001|Overall Study|Lack of Efficacy|0|||
155253755|NCT00441090|560359794|FG002|Overall Study|Lack of Efficacy|0|||
155253756|NCT00441090|560359795|FG003|Overall Study|Lack of Efficacy|0|||
155253757|NCT00441090|560359796|FG004|Overall Study|Lack of Efficacy|0|||
155253758|NCT01441102|560359797|FG000|Overall Study|Adverse Event|1|||
155253759|NCT01441102|560359797|FG000|Overall Study|Withdrawal by Subject|2|||
155253760|NCT03085485|560359798|FG000|Overall Study|Death|1|||
155253761|NCT03085485|560359799|FG001|Overall Study|Death|0|||
155253762|NCT03085485|560359798|FG000|Overall Study|Lost to Follow-up|1|||
155253763|NCT03085485|560359799|FG001|Overall Study|Lost to Follow-up|0|||
155253764|NCT01022762|560359800|FG000|Overall Study|Adverse Event|3|||
155253765|NCT01022762|560359801|FG001|Overall Study|Adverse Event|1|||
155253766|NCT01022762|560359800|FG000|Overall Study|Lack of Efficacy|0|||
155253767|NCT01022762|560359801|FG001|Overall Study|Lack of Efficacy|1|||
155253768|NCT01022762|560359800|FG000|Overall Study|Protocol Violation|7|||
155253769|NCT01022762|560359801|FG001|Overall Study|Protocol Violation|6|||
155253770|NCT01022762|560359800|FG000|Overall Study|Unclassified|12|||
155253771|NCT01022762|560359801|FG001|Overall Study|Unclassified|20|||
155253772|NCT00605280|560359802|FG000|Year 1|Protocol Violation|0|||
155253773|NCT00605280|560359803|FG001|Year 1|Protocol Violation|0|||
155253774|NCT00605280|560359804|FG002|Year 1|Protocol Violation|0|||
155253775|NCT00605280|560359805|FG003|Year 1|Protocol Violation|1|||
155253776|NCT00605280|560359802|FG000|Year 1|Adverse Event|3|||
155253777|NCT00605280|560359803|FG001|Year 1|Adverse Event|1|||
155253778|NCT00605280|560359804|FG002|Year 1|Adverse Event|1|||
155253779|NCT00605280|560359805|FG003|Year 1|Adverse Event|5|||
155253780|NCT00605280|560359802|FG000|Year 1|Physician Decision|7|||
155253781|NCT00605280|560359803|FG001|Year 1|Physician Decision|4|||
155253782|NCT00605280|560359804|FG002|Year 1|Physician Decision|0|||
155253783|NCT00605280|560359805|FG003|Year 1|Physician Decision|6|||
155253784|NCT00605280|560359802|FG000|Year 1|Withdrawal by Subject|2|||
155253785|NCT00605280|560359803|FG001|Year 1|Withdrawal by Subject|4|||
155253786|NCT00605280|560359804|FG002|Year 1|Withdrawal by Subject|0|||
155253787|NCT00605280|560359805|FG003|Year 1|Withdrawal by Subject|4|||
155253788|NCT00605280|560359802|FG000|Year 1|Other|2|||
155253789|NCT00605280|560359803|FG001|Year 1|Other|1|||
155253790|NCT00605280|560359804|FG002|Year 1|Other|0|||
155253791|NCT00605280|560359805|FG003|Year 1|Other|1|||
155253792|NCT00605280|560359802|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
155253793|NCT00605280|560359803|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
155253794|NCT00605280|560359804|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
155253795|NCT00605280|560359805|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
155253796|NCT00605280|560359802|FG000|Year 2|Adverse Event|4|||
155253797|NCT00605280|560359803|FG001|Year 2|Adverse Event|0|||
155253798|NCT00605280|560359804|FG002|Year 2|Adverse Event|2|||
155253799|NCT00605280|560359805|FG003|Year 2|Adverse Event|4|||
155253800|NCT00605280|560359802|FG000|Year 2|Physician Decision|11|||
155253801|NCT00605280|560359803|FG001|Year 2|Physician Decision|6|||
155253802|NCT00605280|560359804|FG002|Year 2|Physician Decision|4|||
155253803|NCT00605280|560359805|FG003|Year 2|Physician Decision|11|||
155253804|NCT00605280|560359802|FG000|Year 2|Withdrawal by Subject|4|||
155253805|NCT00605280|560359803|FG001|Year 2|Withdrawal by Subject|0|||
155253806|NCT00605280|560359804|FG002|Year 2|Withdrawal by Subject|0|||
155253807|NCT00605280|560359805|FG003|Year 2|Withdrawal by Subject|4|||
155253808|NCT00605280|560359802|FG000|Year 2|Other|1|||
155253809|NCT00605280|560359803|FG001|Year 2|Other|0|||
155253810|NCT00605280|560359804|FG002|Year 2|Other|0|||
155253811|NCT00605280|560359805|FG003|Year 2|Other|1|||
155253812|NCT00605280|560359802|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
155253813|NCT00605280|560359803|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
155253814|NCT00605280|560359804|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
155253815|NCT00605280|560359805|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
155253816|NCT00605280|560359802|FG000|Year 3 Extension|Adverse Event|2|||
155253817|NCT00605280|560359803|FG001|Year 3 Extension|Adverse Event|0|||
155253818|NCT00605280|560359804|FG002|Year 3 Extension|Adverse Event|0|||
155253819|NCT00605280|560359805|FG003|Year 3 Extension|Adverse Event|2|||
155253820|NCT00605280|560359802|FG000|Year 3 Extension|Physician Decision|0|||
155253821|NCT00605280|560359803|FG001|Year 3 Extension|Physician Decision|0|||
155253822|NCT00605280|560359804|FG002|Year 3 Extension|Physician Decision|0|||
155253823|NCT00605280|560359805|FG003|Year 3 Extension|Physician Decision|2|||
155253824|NCT00605280|560359802|FG000|Year 3 Extension|Withdrawal by Subject|2|||
155253825|NCT00605280|560359803|FG001|Year 3 Extension|Withdrawal by Subject|0|||
155253826|NCT00605280|560359804|FG002|Year 3 Extension|Withdrawal by Subject|0|||
155253827|NCT00605280|560359805|FG003|Year 3 Extension|Withdrawal by Subject|5|||
155253828|NCT00605280|560359802|FG000|Year 3 Extension|Other|2|||
155253829|NCT00605280|560359803|FG001|Year 3 Extension|Other|0|||
155253830|NCT00605280|560359804|FG002|Year 3 Extension|Other|0|||
155253831|NCT00605280|560359805|FG003|Year 3 Extension|Other|0|||
155253832|NCT00605280|560359802|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
155253833|NCT00605280|560359803|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
155253834|NCT00605280|560359804|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
155253835|NCT00605280|560359805|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
155253836|NCT01302119|560359806|FG000|Overall Study|Withdrawal by Subject|30|||
155253837|NCT01302119|560359807|FG001|Overall Study|Withdrawal by Subject|20|||
155253838|NCT01302119|560359806|FG000|Overall Study|Lost to Follow-up|10|||
155253839|NCT01302119|560359807|FG001|Overall Study|Lost to Follow-up|4|||
155253840|NCT01302119|560359806|FG000|Overall Study|Adverse Event|2|||
155253841|NCT01302119|560359807|FG001|Overall Study|Adverse Event|1|||
155253842|NCT01302119|560359806|FG000|Overall Study|Non-compliance|4|||
155253843|NCT01302119|560359807|FG001|Overall Study|Non-compliance|2|||
155253844|NCT01302119|560359806|FG000|Overall Study|Non-specific|4|||
155253845|NCT01302119|560359807|FG001|Overall Study|Non-specific|1|||
155253846|NCT01775904|560359811|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
155253847|NCT01775904|560359811|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
155253848|NCT00518115|560359812|FG000|Overall Study|Adverse Event|6|||
155253849|NCT00518115|560359813|FG001|Overall Study|Adverse Event|1|||
155253850|NCT00518115|560359814|FG002|Overall Study|Adverse Event|5|||
155253851|NCT00518115|560359815|FG003|Overall Study|Adverse Event|6|||
155253852|NCT00518115|560359816|FG004|Overall Study|Adverse Event|5|||
155253853|NCT00518115|560359817|FG005|Overall Study|Adverse Event|5|||
155253854|NCT00518115|560359818|FG006|Overall Study|Adverse Event|5|||
155253855|NCT00518115|560359819|FG007|Overall Study|Adverse Event|10|||
155253856|NCT00518115|560359820|FG008|Overall Study|Adverse Event|2|||
155253857|NCT00518115|560359821|FG009|Overall Study|Adverse Event|9|||
155253858|NCT00518115|560359812|FG000|Overall Study|Lost to Follow-up|0|||
155253859|NCT00518115|560359813|FG001|Overall Study|Lost to Follow-up|0|||
155253860|NCT00518115|560359814|FG002|Overall Study|Lost to Follow-up|2|||
155253861|NCT00518115|560359815|FG003|Overall Study|Lost to Follow-up|3|||
155253862|NCT00518115|560359816|FG004|Overall Study|Lost to Follow-up|1|||
155253863|NCT00518115|560359817|FG005|Overall Study|Lost to Follow-up|3|||
155253864|NCT00518115|560359818|FG006|Overall Study|Lost to Follow-up|0|||
155253865|NCT00518115|560359819|FG007|Overall Study|Lost to Follow-up|1|||
155253866|NCT00518115|560359820|FG008|Overall Study|Lost to Follow-up|1|||
155253867|NCT00518115|560359821|FG009|Overall Study|Lost to Follow-up|1|||
155253868|NCT00518115|560359812|FG000|Overall Study|Protocol Violation|1|||
155253869|NCT00518115|560359813|FG001|Overall Study|Protocol Violation|3|||
155253870|NCT00518115|560359814|FG002|Overall Study|Protocol Violation|1|||
155253871|NCT00518115|560359815|FG003|Overall Study|Protocol Violation|0|||
155253872|NCT00518115|560359816|FG004|Overall Study|Protocol Violation|0|||
155253873|NCT00518115|560359817|FG005|Overall Study|Protocol Violation|0|||
155253874|NCT00518115|560359818|FG006|Overall Study|Protocol Violation|0|||
155253875|NCT00518115|560359819|FG007|Overall Study|Protocol Violation|0|||
155253876|NCT00518115|560359820|FG008|Overall Study|Protocol Violation|0|||
155253877|NCT00518115|560359821|FG009|Overall Study|Protocol Violation|0|||
155253878|NCT00518115|560359812|FG000|Overall Study|Withdrawal by Subject|1|||
155253879|NCT00518115|560359813|FG001|Overall Study|Withdrawal by Subject|1|||
155253880|NCT00518115|560359814|FG002|Overall Study|Withdrawal by Subject|5|||
155253881|NCT00518115|560359815|FG003|Overall Study|Withdrawal by Subject|0|||
155253882|NCT00518115|560359816|FG004|Overall Study|Withdrawal by Subject|2|||
155253883|NCT00518115|560359817|FG005|Overall Study|Withdrawal by Subject|1|||
155253884|NCT00518115|560359818|FG006|Overall Study|Withdrawal by Subject|0|||
155253885|NCT00518115|560359819|FG007|Overall Study|Withdrawal by Subject|2|||
155253886|NCT00518115|560359820|FG008|Overall Study|Withdrawal by Subject|1|||
155253887|NCT00518115|560359821|FG009|Overall Study|Withdrawal by Subject|3|||
155253888|NCT00518115|560359812|FG000|Overall Study|Lack of Efficacy|1|||
155253889|NCT00518115|560359813|FG001|Overall Study|Lack of Efficacy|0|||
155253890|NCT00518115|560359814|FG002|Overall Study|Lack of Efficacy|1|||
155253891|NCT00518115|560359815|FG003|Overall Study|Lack of Efficacy|1|||
155253892|NCT00518115|560359816|FG004|Overall Study|Lack of Efficacy|0|||
155253893|NCT00518115|560359817|FG005|Overall Study|Lack of Efficacy|0|||
155253894|NCT00518115|560359818|FG006|Overall Study|Lack of Efficacy|0|||
155253895|NCT00518115|560359819|FG007|Overall Study|Lack of Efficacy|1|||
155253896|NCT00518115|560359820|FG008|Overall Study|Lack of Efficacy|0|||
155253897|NCT00518115|560359821|FG009|Overall Study|Lack of Efficacy|0|||
155253898|NCT00518115|560359812|FG000|Overall Study|Non-Compliance|1|||
155253899|NCT00518115|560359813|FG001|Overall Study|Non-Compliance|0|||
155253900|NCT00518115|560359814|FG002|Overall Study|Non-Compliance|1|||
155253901|NCT00518115|560359815|FG003|Overall Study|Non-Compliance|0|||
155253902|NCT00518115|560359816|FG004|Overall Study|Non-Compliance|1|||
155253903|NCT00518115|560359817|FG005|Overall Study|Non-Compliance|1|||
155253904|NCT00518115|560359818|FG006|Overall Study|Non-Compliance|1|||
155253905|NCT00518115|560359819|FG007|Overall Study|Non-Compliance|1|||
155253906|NCT00518115|560359820|FG008|Overall Study|Non-Compliance|0|||
155253907|NCT00518115|560359821|FG009|Overall Study|Non-Compliance|1|||
155253908|NCT00518115|560359812|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
155253909|NCT00518115|560359813|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
155253910|NCT00518115|560359814|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253911|NCT00518115|560359815|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253912|NCT00518115|560359816|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253913|NCT00518115|560359817|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
155253914|NCT00518115|560359818|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253915|NCT00518115|560359819|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253916|NCT00518115|560359820|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253917|NCT00518115|560359821|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
155253918|NCT00518115|560359812|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
155253919|NCT00518115|560359813|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253920|NCT00518115|560359814|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253921|NCT00518115|560359815|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253922|NCT00518115|560359816|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253923|NCT00518115|560359817|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253924|NCT00518115|560359818|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253925|NCT00518115|560359819|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253926|NCT00518115|560359820|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253927|NCT00518115|560359821|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
155253928|NCT00518115|560359812|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253929|NCT00518115|560359813|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253930|NCT00518115|560359814|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
155253931|NCT00518115|560359815|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253932|NCT00518115|560359816|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253933|NCT00518115|560359817|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253934|NCT00518115|560359818|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253935|NCT00518115|560359819|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253936|NCT00518115|560359820|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
155253937|NCT00518115|560359821|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
155253938|NCT00518115|560359812|FG000|Overall Study|Wrong Monotherapy Administered|0|||
155253939|NCT00518115|560359813|FG001|Overall Study|Wrong Monotherapy Administered|0|||
155253940|NCT00518115|560359814|FG002|Overall Study|Wrong Monotherapy Administered|1|||
155253941|NCT00518115|560359815|FG003|Overall Study|Wrong Monotherapy Administered|0|||
155253942|NCT00518115|560359816|FG004|Overall Study|Wrong Monotherapy Administered|0|||
155253943|NCT00518115|560359817|FG005|Overall Study|Wrong Monotherapy Administered|0|||
155253944|NCT00518115|560359818|FG006|Overall Study|Wrong Monotherapy Administered|1|||
155253945|NCT00518115|560359819|FG007|Overall Study|Wrong Monotherapy Administered|0|||
155253946|NCT00518115|560359820|FG008|Overall Study|Wrong Monotherapy Administered|0|||
155253947|NCT00518115|560359821|FG009|Overall Study|Wrong Monotherapy Administered|0|||
155253948|NCT00518115|560359812|FG000|Overall Study|Violation of Exclusion Criteria|0|||
155253949|NCT00518115|560359813|FG001|Overall Study|Violation of Exclusion Criteria|0|||
155253950|NCT00518115|560359814|FG002|Overall Study|Violation of Exclusion Criteria|0|||
155253951|NCT00518115|560359815|FG003|Overall Study|Violation of Exclusion Criteria|1|||
155253952|NCT00518115|560359816|FG004|Overall Study|Violation of Exclusion Criteria|0|||
155253953|NCT00518115|560359817|FG005|Overall Study|Violation of Exclusion Criteria|0|||
155253954|NCT00518115|560359818|FG006|Overall Study|Violation of Exclusion Criteria|1|||
155253955|NCT00518115|560359819|FG007|Overall Study|Violation of Exclusion Criteria|0|||
155253956|NCT00518115|560359820|FG008|Overall Study|Violation of Exclusion Criteria|0|||
155253957|NCT00518115|560359821|FG009|Overall Study|Violation of Exclusion Criteria|0|||
155253958|NCT00518115|560359812|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
155253959|NCT00518115|560359813|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
155253960|NCT00518115|560359814|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
155253961|NCT00518115|560359815|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
155253962|NCT00518115|560359816|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
155253963|NCT00518115|560359817|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
155253964|NCT00518115|560359818|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
155253965|NCT00518115|560359819|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
155253966|NCT00518115|560359820|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
155253967|NCT00518115|560359821|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
155253968|NCT00518115|560359812|FG000|Overall Study|Withdrew Consent|0|||
155253969|NCT00518115|560359813|FG001|Overall Study|Withdrew Consent|0|||
155253970|NCT00518115|560359814|FG002|Overall Study|Withdrew Consent|0|||
155253971|NCT00518115|560359815|FG003|Overall Study|Withdrew Consent|0|||
155253972|NCT00518115|560359816|FG004|Overall Study|Withdrew Consent|0|||
155253973|NCT00518115|560359817|FG005|Overall Study|Withdrew Consent|1|||
155253974|NCT00518115|560359818|FG006|Overall Study|Withdrew Consent|0|||
155253975|NCT00518115|560359819|FG007|Overall Study|Withdrew Consent|0|||
155253976|NCT00518115|560359820|FG008|Overall Study|Withdrew Consent|0|||
155253977|NCT00518115|560359821|FG009|Overall Study|Withdrew Consent|0|||
155253978|NCT00518115|560359812|FG000|Overall Study|Moved Out of State|0|||
155253979|NCT00518115|560359813|FG001|Overall Study|Moved Out of State|0|||
155253980|NCT00518115|560359814|FG002|Overall Study|Moved Out of State|0|||
155253981|NCT00518115|560359815|FG003|Overall Study|Moved Out of State|0|||
155253982|NCT00518115|560359816|FG004|Overall Study|Moved Out of State|0|||
155253983|NCT00518115|560359817|FG005|Overall Study|Moved Out of State|0|||
155253984|NCT00518115|560359818|FG006|Overall Study|Moved Out of State|0|||
155253985|NCT00518115|560359819|FG007|Overall Study|Moved Out of State|0|||
155253986|NCT00518115|560359820|FG008|Overall Study|Moved Out of State|0|||
155253987|NCT00518115|560359821|FG009|Overall Study|Moved Out of State|1|||
155253988|NCT04891419|560359822|FG000|Overall Study|Withdrawal by Subject|4|||
155253989|NCT04891419|560359823|FG001|Overall Study|Withdrawal by Subject|0|||
155253990|NCT04891419|560359822|FG000|Overall Study|Lost to Follow-up|1|||
155253991|NCT04891419|560359823|FG001|Overall Study|Lost to Follow-up|3|||
155253992|NCT00680407|560359831|FG000|Overall Study|Lost to Follow-up|3|||
155253993|NCT00680407|560359832|FG001|Overall Study|Lost to Follow-up|3|||
155253994|NCT00680407|560359833|FG002|Overall Study|Lost to Follow-up|1|||
155253995|NCT00680407|560359831|FG000|Overall Study|Withdrawal by Subject|5|||
155253996|NCT00680407|560359832|FG001|Overall Study|Withdrawal by Subject|2|||
155253997|NCT00680407|560359833|FG002|Overall Study|Withdrawal by Subject|2|||
155253998|NCT01377480|560362226|FG000|Overall Study|Protocol Violation|0|||
155253999|NCT01377480|560362227|FG001|Overall Study|Protocol Violation|0|||
155254000|NCT01377480|560362228|FG002|Overall Study|Protocol Violation|0|||
155254001|NCT01377480|560362229|FG003|Overall Study|Protocol Violation|4|||
155254002|NCT01377480|560362226|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
155254003|NCT01377480|560362227|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
155254004|NCT01377480|560362228|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
155254005|NCT01377480|560362229|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
155254006|NCT01377480|560362226|FG000|Overall Study|Withdrawal by Subject|0|||
155254007|NCT01377480|560362227|FG001|Overall Study|Withdrawal by Subject|0|||
155254008|NCT01377480|560362228|FG002|Overall Study|Withdrawal by Subject|1|||
155254009|NCT01377480|560362229|FG003|Overall Study|Withdrawal by Subject|0|||
155254010|NCT01377480|560362226|FG000|Overall Study|Serious adverse event|0|||
155254011|NCT01377480|560362227|FG001|Overall Study|Serious adverse event|0|||
155254012|NCT01377480|560362228|FG002|Overall Study|Serious adverse event|1|||
155254013|NCT01377480|560362229|FG003|Overall Study|Serious adverse event|1|||
155254014|NCT01377480|560362226|FG000|Overall Study|Other|0|||
155254015|NCT01377480|560362227|FG001|Overall Study|Other|0|||
155254016|NCT01377480|560362228|FG002|Overall Study|Other|7|||
155254017|NCT01377480|560362229|FG003|Overall Study|Other|6|||
155254018|NCT04128293|560362236|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254019|NCT04128293|560362237|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254020|NCT04128293|560362238|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254021|NCT04128293|560362239|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
155254022|NCT03014674|560362245|FG000|Overall Study|Withdrawal by Subject|1|||
155254023|NCT03014674|560362246|FG001|Overall Study|Withdrawal by Subject|0|||
155254024|NCT03014674|560362247|FG002|Overall Study|Withdrawal by Subject|0|||
155254025|NCT00499031|560362251|FG000|Overall Study|Improper pre-protocol treatment|1|||
155254026|NCT00499031|560362251|FG000|Overall Study|Required test not done|1|||
155254027|NCT00499031|560362251|FG000|Overall Study|Never treated|1|||
155254028|NCT00911534|560362252|FG000|Overall Study|Adverse Event|4|||
155254029|NCT00911534|560362253|FG001|Overall Study|Adverse Event|4|||
155254030|NCT00911534|560362252|FG000|Overall Study|Lost to Follow-up|2|||
155254031|NCT00911534|560362253|FG001|Overall Study|Lost to Follow-up|4|||
155254032|NCT00911534|560362252|FG000|Overall Study|Withdrawal by Subject|2|||
155254033|NCT00911534|560362253|FG001|Overall Study|Withdrawal by Subject|1|||
155254034|NCT00911534|560362252|FG000|Overall Study|Lack of Efficacy|4|||
155254035|NCT00911534|560362253|FG001|Overall Study|Lack of Efficacy|1|||
155254036|NCT00911534|560362252|FG000|Overall Study|Withdrawal of consent|1|||
155254037|NCT00911534|560362253|FG001|Overall Study|Withdrawal of consent|4|||
155254038|NCT00911534|560362252|FG000|Overall Study|Other|2|||
155254039|NCT00911534|560362253|FG001|Overall Study|Other|2|||
155254040|NCT02677116|560362265|FG000|Overall Study|Adverse Event|0|||
155254041|NCT02677116|560362266|FG001|Overall Study|Adverse Event|1|||
155254042|NCT02677116|560362267|FG002|Overall Study|Adverse Event|0|||
155254043|NCT02677116|560362268|FG003|Overall Study|Adverse Event|0|||
155254044|NCT02677116|560362269|FG004|Overall Study|Adverse Event|0|||
155254045|NCT02677116|560362270|FG005|Overall Study|Adverse Event|1|||
155254046|NCT02677116|560362271|FG006|Overall Study|Adverse Event|1|||
155254047|NCT02677116|560362272|FG007|Overall Study|Adverse Event|0|||
155254048|NCT02677116|560362273|FG008|Overall Study|Adverse Event|0|||
155254049|NCT02677116|560362265|FG000|Overall Study|Physician Decision|0|||
155254050|NCT02677116|560362266|FG001|Overall Study|Physician Decision|2|||
155254051|NCT02677116|560362267|FG002|Overall Study|Physician Decision|3|||
155254052|NCT02677116|560362268|FG003|Overall Study|Physician Decision|2|||
155254053|NCT02677116|560362269|FG004|Overall Study|Physician Decision|1|||
155254054|NCT02677116|560362270|FG005|Overall Study|Physician Decision|3|||
155254055|NCT02677116|560362271|FG006|Overall Study|Physician Decision|1|||
155254056|NCT02677116|560362272|FG007|Overall Study|Physician Decision|1|||
155254057|NCT02677116|560362273|FG008|Overall Study|Physician Decision|2|||
155254058|NCT02677116|560362265|FG000|Overall Study|Withdrawal by parent or guardian|2|||
155254059|NCT02677116|560362266|FG001|Overall Study|Withdrawal by parent or guardian|1|||
155254060|NCT02677116|560362267|FG002|Overall Study|Withdrawal by parent or guardian|0|||
155254061|NCT02677116|560362268|FG003|Overall Study|Withdrawal by parent or guardian|1|||
155254062|NCT02677116|560362269|FG004|Overall Study|Withdrawal by parent or guardian|0|||
155254063|NCT02677116|560362270|FG005|Overall Study|Withdrawal by parent or guardian|0|||
155254064|NCT02677116|560362271|FG006|Overall Study|Withdrawal by parent or guardian|2|||
155254065|NCT02677116|560362272|FG007|Overall Study|Withdrawal by parent or guardian|1|||
155254066|NCT02677116|560362273|FG008|Overall Study|Withdrawal by parent or guardian|0|||
155254067|NCT02677116|560362265|FG000|Overall Study|Withdrawal by Subject|1|||
155254068|NCT02677116|560362266|FG001|Overall Study|Withdrawal by Subject|0|||
155254069|NCT02677116|560362267|FG002|Overall Study|Withdrawal by Subject|0|||
155254070|NCT02677116|560362268|FG003|Overall Study|Withdrawal by Subject|0|||
155254071|NCT02677116|560362269|FG004|Overall Study|Withdrawal by Subject|0|||
155254072|NCT02677116|560362270|FG005|Overall Study|Withdrawal by Subject|0|||
155254073|NCT02677116|560362271|FG006|Overall Study|Withdrawal by Subject|0|||
155254074|NCT02677116|560362272|FG007|Overall Study|Withdrawal by Subject|0|||
155254075|NCT02677116|560362273|FG008|Overall Study|Withdrawal by Subject|0|||
155254076|NCT03342638|560362274|FG000|Overall Study|Withdrawal by Subject|1|||
155254077|NCT03342638|560362275|FG001|Overall Study|Withdrawal by Subject|0|||
155254078|NCT03342638|560362274|FG000|Overall Study|Physician Decision|0|||
155254079|NCT03342638|560362275|FG001|Overall Study|Physician Decision|1|||
155254080|NCT01292239|560362280|FG000|Overall Study|Other|1|||
155254081|NCT01292239|560362281|FG001|Overall Study|Other|1|||
155254082|NCT01292239|560362280|FG000|Overall Study|Withdrawal by Subject|3|||
155254083|NCT01292239|560362281|FG001|Overall Study|Withdrawal by Subject|6|||
155254084|NCT03213158|560362282|FG000|Overall Study|Withdrawal by Subject|1|||
155254085|NCT03213158|560362282|FG000|Overall Study|Physician Decision|2|||
155254086|NCT03649230|560362283|FG000|Overall Study|Adverse Event|12|||
155254087|NCT03649230|560362283|FG000|Overall Study|Death|8|||
155254088|NCT03649230|560362283|FG000|Overall Study|Withdrawal by Subject|6|||
155254089|NCT03649230|560362283|FG000|Overall Study|Physician Decision|5|||
155254090|NCT03649230|560362283|FG000|Overall Study|Disease progression|5|||
155254091|NCT03649230|560362283|FG000|Overall Study|Switched to non-HEC|5|||
155254092|NCT03649230|560362283|FG000|Overall Study|Chemotherapy discontinued|4|||
155254093|NCT03649230|560362283|FG000|Overall Study|Received only 3 HEC cycles|4|||
155254094|NCT03649230|560362283|FG000|Overall Study|Screen Failure|3|||
155254095|NCT03649230|560362283|FG000|Overall Study|Patient stopped treatment|2|||
155254096|NCT03649230|560362283|FG000|Overall Study|Protocol Violation|1|||
155254097|NCT03649230|560362283|FG000|Overall Study|Non-compliance|1|||
155254098|NCT03649230|560362283|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
155254099|NCT01693068|560362287|FG000|Randomization Period|On-study|2|||
155254100|NCT01693068|560362288|FG001|Randomization Period|On-study|5|||
155254101|NCT01693068|560362289|FG002|Randomization Period|On-study|0|||
155254102|NCT01693068|560362287|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
155254103|NCT01693068|560362288|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
155254104|NCT01693068|560362289|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
155254105|NCT00295022|560362292|FG000|Overall Study|Adverse Event|1|||
155254106|NCT00295022|560362293|FG001|Overall Study|Adverse Event|1|||
155254107|NCT00295022|560362294|FG002|Overall Study|Adverse Event|2|||
155254108|NCT00295022|560362292|FG000|Overall Study|Lost to Follow-up|0|||
155254109|NCT00295022|560362293|FG001|Overall Study|Lost to Follow-up|0|||
155254110|NCT00295022|560362294|FG002|Overall Study|Lost to Follow-up|1|||
155254111|NCT00295022|560362292|FG000|Overall Study|Withdrawal by Subject|0|||
155254112|NCT00295022|560362293|FG001|Overall Study|Withdrawal by Subject|0|||
155254113|NCT00295022|560362294|FG002|Overall Study|Withdrawal by Subject|2|||
155254114|NCT00734630|560362296|FG000|Overall Study|Lack of Efficacy|4|||
155254115|NCT00734630|560362297|FG001|Overall Study|Lack of Efficacy|4|||
155254116|NCT00734630|560362296|FG000|Overall Study|Withdrawal by Subject|7|||
155254117|NCT00734630|560362297|FG001|Overall Study|Withdrawal by Subject|9|||
155254118|NCT00734630|560362296|FG000|Overall Study|Lost to Follow-up|13|||
155254119|NCT00734630|560362297|FG001|Overall Study|Lost to Follow-up|7|||
155254120|NCT00734630|560362296|FG000|Overall Study|Protocol Violation|0|||
155254121|NCT00734630|560362297|FG001|Overall Study|Protocol Violation|3|||
155254122|NCT00734630|560362296|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
155254123|NCT00734630|560362297|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
155254124|NCT00734630|560362296|FG000|Overall Study|Adverse Event|3|||
155254125|NCT00734630|560362297|FG001|Overall Study|Adverse Event|6|||
155254126|NCT00734630|560362296|FG000|Overall Study|Randomized in Error|0|||
155254127|NCT00734630|560362297|FG001|Overall Study|Randomized in Error|1|||
155254128|NCT00734630|560362296|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
155254129|NCT00734630|560362297|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
155254130|NCT00734630|560362296|FG000|Overall Study|Poor Compliance|1|||
155254131|NCT00734630|560362297|FG001|Overall Study|Poor Compliance|1|||
155254132|NCT01239030|560362298|FG000|Double Blind|Adverse Event|0|||
155254133|NCT01239030|560362299|FG001|Double Blind|Adverse Event|1|||
155254134|NCT01239030|560362300|FG002|Double Blind|Adverse Event|0|||
155254135|NCT01239030|560362301|FG003|Double Blind|Adverse Event|2|||
155254136|NCT01239030|560362302|FG004|Double Blind|Adverse Event|0|||
155254137|NCT01239030|560362298|FG000|Double Blind|Withdrawal by Subject|0|||
155254138|NCT01239030|560362299|FG001|Double Blind|Withdrawal by Subject|1|||
155254139|NCT01239030|560362300|FG002|Double Blind|Withdrawal by Subject|1|||
155254140|NCT01239030|560362301|FG003|Double Blind|Withdrawal by Subject|0|||
155254141|NCT01239030|560362302|FG004|Double Blind|Withdrawal by Subject|1|||
155254142|NCT01239030|560362298|FG000|Double Blind|Lost to Follow-up|1|||
155254143|NCT01239030|560362299|FG001|Double Blind|Lost to Follow-up|1|||
155254144|NCT01239030|560362300|FG002|Double Blind|Lost to Follow-up|0|||
155254145|NCT01239030|560362301|FG003|Double Blind|Lost to Follow-up|0|||
155254146|NCT01239030|560362302|FG004|Double Blind|Lost to Follow-up|0|||
155254147|NCT01239030|560362298|FG000|Double Blind|Physician Decision|0|||
155254148|NCT01239030|560362299|FG001|Double Blind|Physician Decision|1|||
155254149|NCT01239030|560362300|FG002|Double Blind|Physician Decision|0|||
155254150|NCT01239030|560362301|FG003|Double Blind|Physician Decision|0|||
155254151|NCT01239030|560362302|FG004|Double Blind|Physician Decision|0|||
155254152|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
155254153|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
155254154|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
155254155|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
155254156|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
155254157|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
155254158|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
155254159|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
155254160|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
155254161|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
155254162|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
155254163|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
155254164|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
155254165|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
155254166|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
155254167|NCT01239030|560362298|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
155254168|NCT01239030|560362299|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
155254169|NCT01239030|560362300|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
155254170|NCT01239030|560362301|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
155254171|NCT01239030|560362302|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
155254172|NCT00827918|560362304|FG000|Overall Study|Adverse Event|4|||
155254173|NCT00827918|560362305|FG001|Overall Study|Adverse Event|0|||
155254174|NCT00827918|560362306|FG002|Overall Study|Adverse Event|0|||
155254175|NCT00827918|560362304|FG000|Overall Study|Lack of Efficacy|16|||
155254176|NCT00827918|560362305|FG001|Overall Study|Lack of Efficacy|4|||
155254177|NCT00827918|560362306|FG002|Overall Study|Lack of Efficacy|15|||
155254178|NCT00827918|560362304|FG000|Overall Study|Physician Decision|1|||
155254179|NCT00827918|560362305|FG001|Overall Study|Physician Decision|0|||
155254180|NCT00827918|560362306|FG002|Overall Study|Physician Decision|0|||
155254181|NCT00827918|560362304|FG000|Overall Study|Pregnancy|0|||
155254182|NCT00827918|560362305|FG001|Overall Study|Pregnancy|1|||
155254183|NCT00827918|560362306|FG002|Overall Study|Pregnancy|0|||
155254184|NCT00827918|560362304|FG000|Overall Study|Progressive Disease|1|||
155254185|NCT00827918|560362305|FG001|Overall Study|Progressive Disease|1|||
155254186|NCT00827918|560362306|FG002|Overall Study|Progressive Disease|0|||
155254187|NCT00827918|560362304|FG000|Overall Study|Protocol Violation|0|||
155254188|NCT00827918|560362305|FG001|Overall Study|Protocol Violation|1|||
155254189|NCT00827918|560362306|FG002|Overall Study|Protocol Violation|0|||
155254190|NCT00827918|560362304|FG000|Overall Study|Withdrawal by Subject|6|||
155254191|NCT00827918|560362305|FG001|Overall Study|Withdrawal by Subject|2|||
155254192|NCT00827918|560362306|FG002|Overall Study|Withdrawal by Subject|6|||
155254193|NCT00802074|560362307|FG000|Overall Study|Adverse Event|1|||
155254194|NCT00802074|560362308|FG001|Overall Study|Adverse Event|1|||
155254195|NCT00802074|560362309|FG002|Overall Study|Adverse Event|1|||
155254196|NCT00802074|560362310|FG003|Overall Study|Adverse Event|0|||
155254197|NCT00802074|560362311|FG004|Overall Study|Adverse Event|0|||
155254198|NCT00802074|560362312|FG005|Overall Study|Adverse Event|0|||
155254199|NCT00802074|560362307|FG000|Overall Study|Withdrawal by Subject|1|||
155254200|NCT00802074|560362308|FG001|Overall Study|Withdrawal by Subject|0|||
155254201|NCT00802074|560362309|FG002|Overall Study|Withdrawal by Subject|0|||
155254202|NCT00802074|560362310|FG003|Overall Study|Withdrawal by Subject|0|||
155254203|NCT00802074|560362311|FG004|Overall Study|Withdrawal by Subject|0|||
155254204|NCT00802074|560362312|FG005|Overall Study|Withdrawal by Subject|0|||
155254205|NCT02291614|560362315|FG000|Overall Study|Lost to Follow-up|0|||
155254206|NCT02291614|560362316|FG001|Overall Study|Lost to Follow-up|0|||
155254207|NCT02291614|560362317|FG002|Overall Study|Lost to Follow-up|0|||
155254208|NCT02291614|560362318|FG003|Overall Study|Lost to Follow-up|0|||
155254209|NCT02291614|560362319|FG004|Overall Study|Lost to Follow-up|0|||
155254210|NCT02291614|560362320|FG005|Overall Study|Lost to Follow-up|0|||
155254211|NCT02291614|560362321|FG006|Overall Study|Lost to Follow-up|0|||
155254212|NCT02291614|560362322|FG007|Overall Study|Lost to Follow-up|1|||
155254213|NCT02291614|560362323|FG008|Overall Study|Lost to Follow-up|0|||
155254214|NCT02291614|560362324|FG009|Overall Study|Lost to Follow-up|0|||
155254215|NCT02291614|560362325|FG010|Overall Study|Lost to Follow-up|0|||
155254216|NCT02291614|560362315|FG000|Overall Study|Withdrawal by Subject|0|||
155254217|NCT02291614|560362316|FG001|Overall Study|Withdrawal by Subject|1|||
155254218|NCT02291614|560362317|FG002|Overall Study|Withdrawal by Subject|0|||
155254219|NCT02291614|560362318|FG003|Overall Study|Withdrawal by Subject|0|||
155254220|NCT02291614|560362319|FG004|Overall Study|Withdrawal by Subject|0|||
155254221|NCT02291614|560362320|FG005|Overall Study|Withdrawal by Subject|0|||
155254222|NCT02291614|560362321|FG006|Overall Study|Withdrawal by Subject|0|||
155254223|NCT02291614|560362322|FG007|Overall Study|Withdrawal by Subject|0|||
155254224|NCT02291614|560362323|FG008|Overall Study|Withdrawal by Subject|0|||
155254225|NCT02291614|560362324|FG009|Overall Study|Withdrawal by Subject|2|||
155254226|NCT02291614|560362325|FG010|Overall Study|Withdrawal by Subject|2|||
155254227|NCT02291614|560362315|FG000|Overall Study|Decision by sponsor|0|||
155254228|NCT02291614|560362316|FG001|Overall Study|Decision by sponsor|0|||
155254229|NCT02291614|560362317|FG002|Overall Study|Decision by sponsor|0|||
155254230|NCT02291614|560362318|FG003|Overall Study|Decision by sponsor|1|||
155254231|NCT02291614|560362319|FG004|Overall Study|Decision by sponsor|0|||
155254232|NCT02291614|560362320|FG005|Overall Study|Decision by sponsor|0|||
155254233|NCT02291614|560362321|FG006|Overall Study|Decision by sponsor|0|||
155254234|NCT02291614|560362322|FG007|Overall Study|Decision by sponsor|0|||
155254235|NCT02291614|560362323|FG008|Overall Study|Decision by sponsor|0|||
155254236|NCT02291614|560362324|FG009|Overall Study|Decision by sponsor|0|||
155254237|NCT02291614|560362325|FG010|Overall Study|Decision by sponsor|0|||
155254238|NCT02291614|560362315|FG000|Overall Study|Death|0|||
155254239|NCT02291614|560362316|FG001|Overall Study|Death|0|||
155254240|NCT02291614|560362317|FG002|Overall Study|Death|1|||
155254241|NCT02291614|560362318|FG003|Overall Study|Death|0|||
155254242|NCT02291614|560362319|FG004|Overall Study|Death|1|||
155254243|NCT02291614|560362320|FG005|Overall Study|Death|1|||
155254244|NCT02291614|560362321|FG006|Overall Study|Death|1|||
155254245|NCT02291614|560362322|FG007|Overall Study|Death|0|||
155254246|NCT02291614|560362323|FG008|Overall Study|Death|0|||
155254247|NCT02291614|560362324|FG009|Overall Study|Death|0|||
155254248|NCT02291614|560362325|FG010|Overall Study|Death|0|||
155254249|NCT00127101|560362326|FG000|Base Protocol|Adverse Event|0|||
155254250|NCT00127101|560362327|FG001|Base Protocol|Adverse Event|2|||
155254251|NCT00127101|560362328|FG002|Base Protocol|Adverse Event|1|||
155254252|NCT00127101|560362329|FG003|Base Protocol|Adverse Event|0|||
155254253|NCT00127101|560362330|FG004|Base Protocol|Adverse Event|0|||
155254254|NCT00127101|560362331|FG005|Base Protocol|Adverse Event|0|||
155254255|NCT00127101|560362326|FG000|Base Protocol|Lack of Efficacy|1|||
155254256|NCT00127101|560362327|FG001|Base Protocol|Lack of Efficacy|0|||
155254257|NCT00127101|560362328|FG002|Base Protocol|Lack of Efficacy|0|||
155254258|NCT00127101|560362329|FG003|Base Protocol|Lack of Efficacy|0|||
155254259|NCT00127101|560362330|FG004|Base Protocol|Lack of Efficacy|2|||
155254260|NCT00127101|560362331|FG005|Base Protocol|Lack of Efficacy|0|||
155254261|NCT00127101|560362326|FG000|Base Protocol|Withdrawal by Subject|1|||
155254262|NCT00127101|560362327|FG001|Base Protocol|Withdrawal by Subject|2|||
155254263|NCT00127101|560362328|FG002|Base Protocol|Withdrawal by Subject|1|||
155254264|NCT00127101|560362329|FG003|Base Protocol|Withdrawal by Subject|0|||
155254265|NCT00127101|560362330|FG004|Base Protocol|Withdrawal by Subject|0|||
155254266|NCT00127101|560362331|FG005|Base Protocol|Withdrawal by Subject|1|||
155254267|NCT00127101|560362326|FG000|Continuation Phase|Adverse Event|0|||
155254268|NCT00127101|560362327|FG001|Continuation Phase|Adverse Event|0|||
155254269|NCT00127101|560362328|FG002|Continuation Phase|Adverse Event|0|||
155254270|NCT00127101|560362329|FG003|Continuation Phase|Adverse Event|0|||
155254271|NCT00127101|560362330|FG004|Continuation Phase|Adverse Event|1|||
155254272|NCT00127101|560362331|FG005|Continuation Phase|Adverse Event|1|||
155254273|NCT00127101|560362326|FG000|Continuation Phase|Lack of Efficacy|0|||
155254274|NCT00127101|560362327|FG001|Continuation Phase|Lack of Efficacy|0|||
155254275|NCT00127101|560362328|FG002|Continuation Phase|Lack of Efficacy|0|||
155254276|NCT00127101|560362329|FG003|Continuation Phase|Lack of Efficacy|0|||
155254277|NCT00127101|560362330|FG004|Continuation Phase|Lack of Efficacy|0|||
155254278|NCT00127101|560362331|FG005|Continuation Phase|Lack of Efficacy|1|||
155254279|NCT00127101|560362326|FG000|Continuation Phase|Withdrawal by Subject|0|||
155254280|NCT00127101|560362327|FG001|Continuation Phase|Withdrawal by Subject|0|||
155254281|NCT00127101|560362328|FG002|Continuation Phase|Withdrawal by Subject|1|||
155254282|NCT00127101|560362329|FG003|Continuation Phase|Withdrawal by Subject|0|||
155254283|NCT00127101|560362330|FG004|Continuation Phase|Withdrawal by Subject|2|||
155254284|NCT00127101|560362331|FG005|Continuation Phase|Withdrawal by Subject|1|||
155254285|NCT00843167|560362332|FG000|Treatment Period|Adverse Event|1|||
155254286|NCT00843167|560362333|FG001|Treatment Period|Adverse Event|5|||
155254287|NCT00843167|560362332|FG000|Treatment Period|Withdrawal by Subject|2|||
155254288|NCT00843167|560362333|FG001|Treatment Period|Withdrawal by Subject|3|||
155254289|NCT03743038|560362334|FG000|Overall Study|Physician Decision|1|||
155254290|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
155254291|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
155254292|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
155254293|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
155254294|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
155254295|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
155254296|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254297|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254298|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254299|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
155254300|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
155254301|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254302|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254303|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254304|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
155254305|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
155254306|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
155254307|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
155254308|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
155254309|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
155254310|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
155254311|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254312|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254313|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254314|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
155254315|NCT01662310|560362336|FG000|Run-In or Stabilization Phase|Other|1|||
155254316|NCT01662310|560362337|FG001|Run-In or Stabilization Phase|Other|0|||
155254317|NCT01662310|560362338|FG002|Run-In or Stabilization Phase|Other|0|||
155254318|NCT01662310|560362339|FG003|Run-In or Stabilization Phase|Other|0|||
155254319|NCT01662310|560362340|FG004|Run-In or Stabilization Phase|Other|0|||
155254320|NCT01662310|560362336|FG000|Double-Blind Phase|Adverse Event|0|||
155254321|NCT01662310|560362337|FG001|Double-Blind Phase|Adverse Event|0|||
155254322|NCT01662310|560362338|FG002|Double-Blind Phase|Adverse Event|1|||
155254323|NCT01662310|560362339|FG003|Double-Blind Phase|Adverse Event|0|||
155254324|NCT01662310|560362340|FG004|Double-Blind Phase|Adverse Event|0|||
155254325|NCT01662310|560362336|FG000|Double-Blind Phase|Lost to Follow-up|0|||
155254326|NCT01662310|560362337|FG001|Double-Blind Phase|Lost to Follow-up|3|||
155254327|NCT01662310|560362338|FG002|Double-Blind Phase|Lost to Follow-up|0|||
155254328|NCT01662310|560362339|FG003|Double-Blind Phase|Lost to Follow-up|0|||
155254329|NCT01662310|560362340|FG004|Double-Blind Phase|Lost to Follow-up|0|||
155254330|NCT01662310|560362336|FG000|Double-Blind Phase|Pregnancy|0|||
155254331|NCT01662310|560362337|FG001|Double-Blind Phase|Pregnancy|2|||
155254332|NCT01662310|560362338|FG002|Double-Blind Phase|Pregnancy|0|||
155254333|NCT01662310|560362339|FG003|Double-Blind Phase|Pregnancy|0|||
155254334|NCT01662310|560362340|FG004|Double-Blind Phase|Pregnancy|0|||
155254335|NCT01662310|560362336|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
155254336|NCT01662310|560362337|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
155254337|NCT01662310|560362338|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
155254338|NCT01662310|560362339|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
155254339|NCT01662310|560362340|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
155254340|NCT01662310|560362336|FG000|Double-Blind Phase|Other|0|||
155254341|NCT01662310|560362337|FG001|Double-Blind Phase|Other|0|||
155254342|NCT01662310|560362338|FG002|Double-Blind Phase|Other|1|||
155254343|NCT01662310|560362339|FG003|Double-Blind Phase|Other|0|||
155254344|NCT01662310|560362340|FG004|Double-Blind Phase|Other|0|||
155254345|NCT01662310|560362336|FG000|Double-Blind Phase|Randomized but not treated|0|||
155254346|NCT01662310|560362337|FG001|Double-Blind Phase|Randomized but not treated|1|||
155254347|NCT01662310|560362338|FG002|Double-Blind Phase|Randomized but not treated|0|||
155254348|NCT01662310|560362339|FG003|Double-Blind Phase|Randomized but not treated|0|||
155254349|NCT01662310|560362340|FG004|Double-Blind Phase|Randomized but not treated|0|||
155254350|NCT01662310|560362336|FG000|Open-Label Extension Phase|Adverse Event|0|||
155254351|NCT01662310|560362337|FG001|Open-Label Extension Phase|Adverse Event|0|||
155254352|NCT01662310|560362338|FG002|Open-Label Extension Phase|Adverse Event|0|||
155254353|NCT01662310|560362339|FG003|Open-Label Extension Phase|Adverse Event|3|||
155254354|NCT01662310|560362340|FG004|Open-Label Extension Phase|Adverse Event|0|||
155254355|NCT01662310|560362336|FG000|Open-Label Extension Phase|Death|0|||
155254356|NCT01662310|560362337|FG001|Open-Label Extension Phase|Death|0|||
155254357|NCT01662310|560362338|FG002|Open-Label Extension Phase|Death|0|||
155254358|NCT01662310|560362339|FG003|Open-Label Extension Phase|Death|1|||
155254359|NCT01662310|560362340|FG004|Open-Label Extension Phase|Death|0|||
155254360|NCT01662310|560362336|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
155254361|NCT01662310|560362337|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
155254362|NCT01662310|560362338|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
155254363|NCT01662310|560362339|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
155254364|NCT01662310|560362340|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
155254365|NCT01662310|560362336|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
155254366|NCT01662310|560362337|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
155254367|NCT01662310|560362338|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
155254368|NCT01662310|560362339|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
155254369|NCT01662310|560362340|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
155254370|NCT01662310|560362336|FG000|Open-Label Extension Phase|Pregnancy|0|||
155254371|NCT01662310|560362337|FG001|Open-Label Extension Phase|Pregnancy|0|||
155254372|NCT01662310|560362338|FG002|Open-Label Extension Phase|Pregnancy|0|||
155254373|NCT01662310|560362339|FG003|Open-Label Extension Phase|Pregnancy|1|||
155254374|NCT01662310|560362340|FG004|Open-Label Extension Phase|Pregnancy|0|||
155254375|NCT01662310|560362336|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
155254376|NCT01662310|560362337|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
155254377|NCT01662310|560362338|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
155254378|NCT01662310|560362339|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
155254379|NCT01662310|560362340|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
155254380|NCT02432105|560362346|FG000|Overall Study|Lost to Follow-up|1|||
155254381|NCT02432105|560362347|FG001|Overall Study|Lost to Follow-up|1|||
155254382|NCT02432105|560362348|FG002|Overall Study|Lost to Follow-up|0|||
155254383|NCT02432105|560362346|FG000|Overall Study|Withdrawal by Subject|1|||
155254384|NCT02432105|560362347|FG001|Overall Study|Withdrawal by Subject|0|||
155254385|NCT02432105|560362348|FG002|Overall Study|Withdrawal by Subject|1|||
155254386|NCT02432105|560362346|FG000|Overall Study|Culture positive for yeast|0|||
155254387|NCT02432105|560362347|FG001|Overall Study|Culture positive for yeast|1|||
155254388|NCT02432105|560362348|FG002|Overall Study|Culture positive for yeast|0|||
155254389|NCT02432105|560362346|FG000|Overall Study|Randomized in error|0|||
155254390|NCT02432105|560362347|FG001|Overall Study|Randomized in error|0|||
155254391|NCT02432105|560362348|FG002|Overall Study|Randomized in error|2|||
155254392|NCT01302847|560362350|FG000|Overall Study|Death|0|||
155254393|NCT01302847|560362351|FG001|Overall Study|Death|1|||
155254394|NCT01302847|560362352|FG002|Overall Study|Death|0|||
155254395|NCT01302847|560362353|FG003|Overall Study|Death|0|||
155254396|NCT01302847|560362354|FG004|Overall Study|Death|0|||
155254397|NCT01302847|560362355|FG005|Overall Study|Death|1|||
155254398|NCT01302847|560362356|FG006|Overall Study|Death|1|||
155254399|NCT01302847|560362357|FG007|Overall Study|Death|0|||
155254400|NCT01302847|560362350|FG000|Overall Study|Pregnancy|2|||
155254401|NCT01302847|560362351|FG001|Overall Study|Pregnancy|0|||
155254402|NCT01302847|560362352|FG002|Overall Study|Pregnancy|0|||
155254403|NCT01302847|560362353|FG003|Overall Study|Pregnancy|0|||
155254404|NCT01302847|560362354|FG004|Overall Study|Pregnancy|0|||
155254405|NCT01302847|560362355|FG005|Overall Study|Pregnancy|0|||
155254406|NCT01302847|560362356|FG006|Overall Study|Pregnancy|0|||
155254407|NCT01302847|560362357|FG007|Overall Study|Pregnancy|0|||
155254408|NCT01302847|560362350|FG000|Overall Study|Virologic failure|0|||
155254409|NCT01302847|560362351|FG001|Overall Study|Virologic failure|2|||
155254410|NCT01302847|560362352|FG002|Overall Study|Virologic failure|0|||
155254411|NCT01302847|560362353|FG003|Overall Study|Virologic failure|2|||
155254412|NCT01302847|560362354|FG004|Overall Study|Virologic failure|1|||
155254413|NCT01302847|560362355|FG005|Overall Study|Virologic failure|3|||
155254414|NCT01302847|560362356|FG006|Overall Study|Virologic failure|1|||
155254415|NCT01302847|560362357|FG007|Overall Study|Virologic failure|2|||
155254416|NCT01302847|560362350|FG000|Overall Study|Severe debilitation, unable to continue|0|||
155254417|NCT01302847|560362351|FG001|Overall Study|Severe debilitation, unable to continue|0|||
155254418|NCT01302847|560362352|FG002|Overall Study|Severe debilitation, unable to continue|0|||
155254419|NCT01302847|560362353|FG003|Overall Study|Severe debilitation, unable to continue|0|||
155254420|NCT01302847|560362354|FG004|Overall Study|Severe debilitation, unable to continue|0|||
155254421|NCT01302847|560362355|FG005|Overall Study|Severe debilitation, unable to continue|1|||
155254422|NCT01302847|560362356|FG006|Overall Study|Severe debilitation, unable to continue|1|||
155254423|NCT01302847|560362357|FG007|Overall Study|Severe debilitation, unable to continue|0|||
155254424|NCT01302847|560362350|FG000|Overall Study|Not able to get to clinic|1|||
155254425|NCT01302847|560362351|FG001|Overall Study|Not able to get to clinic|1|||
155254426|NCT01302847|560362352|FG002|Overall Study|Not able to get to clinic|0|||
155254427|NCT01302847|560362353|FG003|Overall Study|Not able to get to clinic|0|||
155254428|NCT01302847|560362354|FG004|Overall Study|Not able to get to clinic|0|||
155254429|NCT01302847|560362355|FG005|Overall Study|Not able to get to clinic|0|||
155254430|NCT01302847|560362356|FG006|Overall Study|Not able to get to clinic|0|||
155254431|NCT01302847|560362357|FG007|Overall Study|Not able to get to clinic|0|||
155254432|NCT01302847|560362350|FG000|Overall Study|Site closing|2|||
155254433|NCT01302847|560362351|FG001|Overall Study|Site closing|2|||
155254434|NCT01302847|560362352|FG002|Overall Study|Site closing|0|||
155254435|NCT01302847|560362353|FG003|Overall Study|Site closing|0|||
155254436|NCT01302847|560362354|FG004|Overall Study|Site closing|0|||
155254437|NCT01302847|560362355|FG005|Overall Study|Site closing|0|||
155254438|NCT01302847|560362356|FG006|Overall Study|Site closing|0|||
155254439|NCT01302847|560362357|FG007|Overall Study|Site closing|0|||
155254440|NCT01302847|560362350|FG000|Overall Study|Withdrawal by Subject|1|||
155254441|NCT01302847|560362351|FG001|Overall Study|Withdrawal by Subject|0|||
155254442|NCT01302847|560362352|FG002|Overall Study|Withdrawal by Subject|0|||
155254443|NCT01302847|560362353|FG003|Overall Study|Withdrawal by Subject|0|||
155254444|NCT01302847|560362354|FG004|Overall Study|Withdrawal by Subject|1|||
155254445|NCT01302847|560362355|FG005|Overall Study|Withdrawal by Subject|0|||
155254446|NCT01302847|560362356|FG006|Overall Study|Withdrawal by Subject|0|||
155254447|NCT01302847|560362357|FG007|Overall Study|Withdrawal by Subject|1|||
155254448|NCT01302847|560362350|FG000|Overall Study|Not willing to adhere to requirements|5|||
155254449|NCT01302847|560362351|FG001|Overall Study|Not willing to adhere to requirements|0|||
155254450|NCT01302847|560362352|FG002|Overall Study|Not willing to adhere to requirements|1|||
155254451|NCT01302847|560362353|FG003|Overall Study|Not willing to adhere to requirements|0|||
155254452|NCT01302847|560362354|FG004|Overall Study|Not willing to adhere to requirements|0|||
155254453|NCT01302847|560362355|FG005|Overall Study|Not willing to adhere to requirements|0|||
155254454|NCT01302847|560362356|FG006|Overall Study|Not willing to adhere to requirements|0|||
155254455|NCT01302847|560362357|FG007|Overall Study|Not willing to adhere to requirements|2|||
155254456|NCT01302847|560362350|FG000|Overall Study|Site unable to contact participant|2|||
155254457|NCT01302847|560362351|FG001|Overall Study|Site unable to contact participant|1|||
155254458|NCT01302847|560362352|FG002|Overall Study|Site unable to contact participant|0|||
155254459|NCT01302847|560362353|FG003|Overall Study|Site unable to contact participant|0|||
155254460|NCT01302847|560362354|FG004|Overall Study|Site unable to contact participant|0|||
155254461|NCT01302847|560362355|FG005|Overall Study|Site unable to contact participant|0|||
155254462|NCT01302847|560362356|FG006|Overall Study|Site unable to contact participant|2|||
155254463|NCT01302847|560362357|FG007|Overall Study|Site unable to contact participant|0|||
155254464|NCT01565707|560362358|FG000|Overall Study|Adverse Event|1|||
155254465|NCT01565707|560362359|FG001|Overall Study|Adverse Event|6|||
155254466|NCT01565707|560362360|FG002|Overall Study|Adverse Event|2|||
155254467|NCT01565707|560362361|FG003|Overall Study|Adverse Event|1|||
155254468|NCT01565707|560362358|FG000|Overall Study|Lost to Follow-up|1|||
155254469|NCT01565707|560362359|FG001|Overall Study|Lost to Follow-up|0|||
155254470|NCT01565707|560362360|FG002|Overall Study|Lost to Follow-up|0|||
155254471|NCT01565707|560362361|FG003|Overall Study|Lost to Follow-up|0|||
155254472|NCT01565707|560362358|FG000|Overall Study|Protocol Violation|1|||
155254473|NCT01565707|560362359|FG001|Overall Study|Protocol Violation|0|||
155254474|NCT01565707|560362360|FG002|Overall Study|Protocol Violation|0|||
155254475|NCT01565707|560362361|FG003|Overall Study|Protocol Violation|1|||
155254476|NCT01565707|560362358|FG000|Overall Study|Withdrawal by Subject|3|||
155254477|NCT01565707|560362359|FG001|Overall Study|Withdrawal by Subject|1|||
155254478|NCT01565707|560362360|FG002|Overall Study|Withdrawal by Subject|1|||
155254479|NCT01565707|560362361|FG003|Overall Study|Withdrawal by Subject|1|||
155254480|NCT01565707|560362358|FG000|Overall Study|Randomized but not evaluable|2|||
155254481|NCT01565707|560362359|FG001|Overall Study|Randomized but not evaluable|0|||
155254482|NCT01565707|560362360|FG002|Overall Study|Randomized but not evaluable|0|||
155254483|NCT01565707|560362361|FG003|Overall Study|Randomized but not evaluable|0|||
155254484|NCT01565707|560362358|FG000|Overall Study|Miscellaneous|1|||
155254485|NCT01565707|560362359|FG001|Overall Study|Miscellaneous|1|||
155254486|NCT01565707|560362360|FG002|Overall Study|Miscellaneous|0|||
155254487|NCT01565707|560362361|FG003|Overall Study|Miscellaneous|2|||
155254488|NCT04302350|560362363|FG000|Overall Study|Physician Decision|1|||
155254489|NCT04302350|560362364|FG001|Overall Study|Physician Decision|1|||
155254490|NCT04302350|560362365|FG002|Overall Study|Physician Decision|2|||
155254491|NCT04302350|560362363|FG000|Overall Study|Lack of Efficacy|1|||
155254492|NCT04302350|560362364|FG001|Overall Study|Lack of Efficacy|1|||
155254493|NCT04302350|560362365|FG002|Overall Study|Lack of Efficacy|4|||
155254494|NCT04302350|560362363|FG000|Overall Study|Adverse Event|0|||
155254495|NCT04302350|560362364|FG001|Overall Study|Adverse Event|1|||
155254496|NCT04302350|560362365|FG002|Overall Study|Adverse Event|2|||
155254497|NCT01371851|560362368|FG000|Overall Study|Lost to Follow-up|5|||
155254498|NCT01371851|560362369|FG001|Overall Study|Lost to Follow-up|8|||
155254499|NCT01371851|560362368|FG000|Overall Study|was arrested and put in jail|0|||
155254500|NCT01371851|560362369|FG001|Overall Study|was arrested and put in jail|1|||
155254501|NCT01371851|560362368|FG000|Overall Study|non study related adverse event|1|||
155254502|NCT01371851|560362369|FG001|Overall Study|non study related adverse event|0|||
155254503|NCT01371851|560362368|FG000|Overall Study|Blood Pressure outside study parameters|2|||
155254504|NCT01371851|560362369|FG001|Overall Study|Blood Pressure outside study parameters|0|||
155254505|NCT02012491|560362370|FG000|Overall Study|Lost to Follow-up|1|||
155254506|NCT02012491|560362371|FG001|Overall Study|Lost to Follow-up|0|||
155254507|NCT02012491|560362370|FG000|Overall Study|Protocol Violation|0|||
155254508|NCT02012491|560362371|FG001|Overall Study|Protocol Violation|1|||
155254509|NCT02012491|560362370|FG000|Overall Study|Withdrawal by Subject|1|||
155254510|NCT02012491|560362371|FG001|Overall Study|Withdrawal by Subject|0|||
155254511|NCT00450411|560362372|FG000|Overall Study|Protocol Violation|6|||
155254512|NCT00450411|560362372|FG000|Overall Study|No protocol treatment|2|||
155254513|NCT03969719|560362383|FG000|Overall Study|Other reasons not specified|1|||
155254514|NCT03969719|560362384|FG001|Overall Study|Other reasons not specified|1|||
155254515|NCT03969719|560362385|FG002|Overall Study|Other reasons not specified|3|||
155254516|NCT03969719|560362383|FG000|Overall Study|Withdrawal by Subject|2|||
155254517|NCT03969719|560362384|FG001|Overall Study|Withdrawal by Subject|3|||
155254518|NCT03969719|560362385|FG002|Overall Study|Withdrawal by Subject|2|||
155254519|NCT03969719|560362383|FG000|Overall Study|Protocol Violation|1|||
155254520|NCT03969719|560362384|FG001|Overall Study|Protocol Violation|2|||
155254521|NCT03969719|560362385|FG002|Overall Study|Protocol Violation|0|||
155254522|NCT03969719|560362383|FG000|Overall Study|Adverse Event|0|||
155254523|NCT03969719|560362384|FG001|Overall Study|Adverse Event|2|||
155254524|NCT03969719|560362385|FG002|Overall Study|Adverse Event|0|||
155254525|NCT03969719|560362383|FG000|Overall Study|Lost to Follow-up|0|||
155254526|NCT03969719|560362384|FG001|Overall Study|Lost to Follow-up|1|||
155254527|NCT03969719|560362385|FG002|Overall Study|Lost to Follow-up|0|||
155254528|NCT05608629|560362386|FG000|Overall Study|Lost to Follow-up|2|||
155254529|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
155254530|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
155254531|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
155254532|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
155254533|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
155254534|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
155254535|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
155254536|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
155254537|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
155254538|NCT02130193|560362387|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
155254539|NCT02130193|560362388|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
155254540|NCT02130193|560362389|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
155254541|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
155254542|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
155254543|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
155254544|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254545|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254546|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254547|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254548|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254549|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
155254550|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
155254551|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
155254552|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
155254553|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254554|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254555|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254556|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254557|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254558|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
155254559|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
155254560|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
155254561|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
155254562|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254563|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254564|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254565|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254566|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254567|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
155254568|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
155254569|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254570|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
155254571|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254572|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254573|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254574|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254575|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254576|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
155254577|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254578|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254579|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
155254580|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254581|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254582|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254583|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254584|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254585|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
155254586|NCT01212770|560362390|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
155254587|NCT01212770|560362391|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
155254588|NCT01212770|560362392|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
155254589|NCT01212770|560362393|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254590|NCT01212770|560362394|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254591|NCT01212770|560362395|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254592|NCT01212770|560362396|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254593|NCT01212770|560362397|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254594|NCT01212770|560362398|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
155254595|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254596|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
155254597|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
155254598|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
155254599|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254600|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254601|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
155254602|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254603|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
155254604|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254605|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
155254606|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
155254607|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
155254608|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
155254609|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
155254610|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254611|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254612|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
155254613|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
155254614|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
155254615|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
155254616|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
155254617|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
155254618|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
155254619|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
155254620|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
155254621|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
155254622|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254623|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254624|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
155254625|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254626|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254627|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254628|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254629|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254630|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
155254631|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254632|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254633|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254634|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
155254635|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254636|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254637|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254638|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254639|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
155254640|NCT01212770|560362390|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254641|NCT01212770|560362391|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254642|NCT01212770|560362392|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
155254643|NCT01212770|560362393|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
155254644|NCT01212770|560362394|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254645|NCT01212770|560362395|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254646|NCT01212770|560362396|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254647|NCT01212770|560362397|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254648|NCT01212770|560362398|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
155254649|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254650|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
155254651|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
155254652|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254653|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254654|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254655|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254656|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
155254657|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
155254658|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254659|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
155254660|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
155254661|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254662|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254663|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254664|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
155254665|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
155254666|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
155254667|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254668|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
155254669|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254670|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254671|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254672|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254673|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254674|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254675|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
155254676|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254677|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
155254678|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
155254679|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254680|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254681|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254682|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
155254683|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
155254684|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
155254685|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254686|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
155254687|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
155254688|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254689|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254690|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254691|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
155254692|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
155254693|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
155254694|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254695|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
155254696|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155254697|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254698|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254699|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254700|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254701|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
155254702|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
155254703|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254704|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155254705|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155254706|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254707|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254708|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254709|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
155254710|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
155254711|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
155254712|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254713|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
155254714|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
155254715|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254716|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254717|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254718|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
155254719|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
155254720|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
155254721|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254722|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
155254723|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
155254724|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254725|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254726|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254727|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
155254728|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155254729|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
155254730|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254731|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
155254732|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254733|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254734|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254735|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254736|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254737|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254738|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
155254739|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254740|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254741|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254742|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254743|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254744|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254745|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254746|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
155254747|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
155254748|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254749|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
155254750|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155254751|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254752|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254753|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254754|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
155254755|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155254756|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
155254757|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254758|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
155254759|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
155254760|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254761|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254762|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254763|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254764|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
155254765|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
155254766|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254767|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
155254768|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
155254769|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254770|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254771|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254772|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254773|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
155254774|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
155254775|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254776|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
155254777|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
155254778|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254779|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254780|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254781|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254782|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
155254783|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
155254784|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254785|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
155254786|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
155254787|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254788|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254789|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254790|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254791|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254792|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
155254793|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254794|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254795|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
155254796|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254797|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254798|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254799|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254800|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254801|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
155254802|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254803|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
155254804|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254805|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254806|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254807|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254808|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254809|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
155254810|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
155254811|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
155254812|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
155254813|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
155254814|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
155254815|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
155254816|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
155254817|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
155254818|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
155254819|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
155254820|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254821|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254822|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
155254823|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254824|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254825|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254826|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254827|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254828|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
155254829|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254830|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254831|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
155254832|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254833|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254834|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254835|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254836|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
155254837|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
155254838|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254839|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254840|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
155254841|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254842|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254843|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254844|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254845|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254846|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
155254847|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254848|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
155254849|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155254850|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254851|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254852|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254853|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254854|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
155254855|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
155254856|NCT01212770|560362390|FG000|Long-term Safety Phase (Year 5)|Death|0|||
155254857|NCT01212770|560362391|FG001|Long-term Safety Phase (Year 5)|Death|0|||
155254858|NCT01212770|560362392|FG002|Long-term Safety Phase (Year 5)|Death|0|||
155254859|NCT01212770|560362393|FG003|Long-term Safety Phase (Year 5)|Death|0|||
155254860|NCT01212770|560362394|FG004|Long-term Safety Phase (Year 5)|Death|0|||
155254861|NCT01212770|560362395|FG005|Long-term Safety Phase (Year 5)|Death|0|||
155254862|NCT01212770|560362396|FG006|Long-term Safety Phase (Year 5)|Death|0|||
155254863|NCT01212770|560362397|FG007|Long-term Safety Phase (Year 5)|Death|1|||
155254864|NCT01212770|560362398|FG008|Long-term Safety Phase (Year 5)|Death|0|||
155254865|NCT00829387|560362401|FG000|Overall Study|Withdrawal by Subject|2|||
155254866|NCT00829387|560362402|FG001|Overall Study|Withdrawal by Subject|3|||
155254867|NCT00829387|560362401|FG000|Overall Study|Disqualified by PI|1|||
155254868|NCT00829387|560362402|FG001|Overall Study|Disqualified by PI|0|||
155254869|NCT00707031|560362410|FG000|Overall Study|Adverse Event|45|||
155254870|NCT00707031|560362411|FG001|Overall Study|Adverse Event|45|||
155254871|NCT00707031|560362410|FG000|Overall Study|Lack of Efficacy|19|||
155254872|NCT00707031|560362411|FG001|Overall Study|Lack of Efficacy|6|||
155254873|NCT00707031|560362410|FG000|Overall Study|Lost to Follow-up|2|||
155254874|NCT00707031|560362411|FG001|Overall Study|Lost to Follow-up|1|||
155254875|NCT00707031|560362410|FG000|Overall Study|Protocol Violation|1|||
155254876|NCT00707031|560362411|FG001|Overall Study|Protocol Violation|0|||
155254877|NCT00707031|560362410|FG000|Overall Study|Withdrawal by Subject|7|||
155254878|NCT00707031|560362411|FG001|Overall Study|Withdrawal by Subject|8|||
155254879|NCT00707031|560362410|FG000|Overall Study|Poor Compliance to Protocol|7|||
155254880|NCT00707031|560362411|FG001|Overall Study|Poor Compliance to Protocol|13|||
155254881|NCT00707031|560362410|FG000|Overall Study|Familial or Personal Reasons|12|||
155254882|NCT00707031|560362411|FG001|Overall Study|Familial or Personal Reasons|15|||
155254883|NCT00707031|560362410|FG000|Overall Study|Serious Noncompliance|2|||
155254884|NCT00707031|560362411|FG001|Overall Study|Serious Noncompliance|3|||
155254885|NCT00707031|560362410|FG000|Overall Study|Sponsor Decision|9|||
155254886|NCT00707031|560362411|FG001|Overall Study|Sponsor Decision|8|||
155254887|NCT02747238|560362412|FG000|Overall Study|Lack of Efficacy|0|||
155254888|NCT02747238|560362413|FG001|Overall Study|Lack of Efficacy|1|||
155254889|NCT02747238|560362412|FG000|Overall Study|Data lost|3|||
155254890|NCT02747238|560362413|FG001|Overall Study|Data lost|5|||
155254891|NCT01951625|560362417|FG000|Treatment Period|Protocol Violation|2|||
155254892|NCT01951625|560362418|FG001|Treatment Period|Protocol Violation|0|||
155254893|NCT01951625|560362419|FG002|Treatment Period|Protocol Violation|1|||
155254894|NCT01951625|560362420|FG003|Treatment Period|Protocol Violation|3|||
155254895|NCT01951625|560362421|FG004|Treatment Period|Protocol Violation|2|||
155254896|NCT01951625|560362417|FG000|Treatment Period|Physician Decision|0|||
155254897|NCT01951625|560362418|FG001|Treatment Period|Physician Decision|0|||
155254898|NCT01951625|560362419|FG002|Treatment Period|Physician Decision|0|||
155254899|NCT01951625|560362420|FG003|Treatment Period|Physician Decision|0|||
155254900|NCT01951625|560362421|FG004|Treatment Period|Physician Decision|1|||
155254901|NCT01951625|560362417|FG000|Treatment Period|Protocol driven decision point|0|||
155254902|NCT01951625|560362418|FG001|Treatment Period|Protocol driven decision point|5|||
155254903|NCT01951625|560362419|FG002|Treatment Period|Protocol driven decision point|0|||
155254904|NCT01951625|560362420|FG003|Treatment Period|Protocol driven decision point|2|||
155254905|NCT01951625|560362421|FG004|Treatment Period|Protocol driven decision point|1|||
155254906|NCT01951625|560362417|FG000|Treatment Period|Non compliance with study drug|1|||
155254907|NCT01951625|560362418|FG001|Treatment Period|Non compliance with study drug|2|||
155254908|NCT01951625|560362419|FG002|Treatment Period|Non compliance with study drug|2|||
155254909|NCT01951625|560362420|FG003|Treatment Period|Non compliance with study drug|0|||
155254910|NCT01951625|560362421|FG004|Treatment Period|Non compliance with study drug|0|||
155254911|NCT01951625|560362417|FG000|Treatment Period|Death|3|||
155254912|NCT01951625|560362418|FG001|Treatment Period|Death|2|||
155254913|NCT01951625|560362419|FG002|Treatment Period|Death|2|||
155254914|NCT01951625|560362420|FG003|Treatment Period|Death|1|||
155254915|NCT01951625|560362421|FG004|Treatment Period|Death|2|||
155254916|NCT01951625|560362417|FG000|Treatment Period|Adverse Event|7|||
155254917|NCT01951625|560362418|FG001|Treatment Period|Adverse Event|10|||
155254918|NCT01951625|560362419|FG002|Treatment Period|Adverse Event|9|||
155254919|NCT01951625|560362420|FG003|Treatment Period|Adverse Event|8|||
155254920|NCT01951625|560362421|FG004|Treatment Period|Adverse Event|8|||
155254921|NCT01951625|560362417|FG000|Treatment Period|Withdrawal by Subject|5|||
155254922|NCT01951625|560362418|FG001|Treatment Period|Withdrawal by Subject|2|||
155254923|NCT01951625|560362419|FG002|Treatment Period|Withdrawal by Subject|1|||
155254924|NCT01951625|560362420|FG003|Treatment Period|Withdrawal by Subject|7|||
155254925|NCT01951625|560362421|FG004|Treatment Period|Withdrawal by Subject|3|||
155254926|NCT01951625|560362417|FG000|Treatment Period|Lost to Follow-up|1|||
155254927|NCT01951625|560362418|FG001|Treatment Period|Lost to Follow-up|0|||
155254928|NCT01951625|560362419|FG002|Treatment Period|Lost to Follow-up|0|||
155254929|NCT01951625|560362420|FG003|Treatment Period|Lost to Follow-up|1|||
155254930|NCT01951625|560362421|FG004|Treatment Period|Lost to Follow-up|0|||
155254931|NCT01951625|560362417|FG000|Follow Up Period|Non-compliance with study drug|1|||
155254932|NCT01951625|560362418|FG001|Follow Up Period|Non-compliance with study drug|0|||
155254933|NCT01951625|560362419|FG002|Follow Up Period|Non-compliance with study drug|0|||
155254934|NCT01951625|560362420|FG003|Follow Up Period|Non-compliance with study drug|0|||
155254935|NCT01951625|560362421|FG004|Follow Up Period|Non-compliance with study drug|0|||
155254936|NCT01951625|560362417|FG000|Follow Up Period|Death|1|||
155254937|NCT01951625|560362418|FG001|Follow Up Period|Death|3|||
155254938|NCT01951625|560362419|FG002|Follow Up Period|Death|2|||
155254939|NCT01951625|560362420|FG003|Follow Up Period|Death|2|||
155254940|NCT01951625|560362421|FG004|Follow Up Period|Death|1|||
155254941|NCT01951625|560362417|FG000|Follow Up Period|Logistical difficulties|1|||
155254942|NCT01951625|560362418|FG001|Follow Up Period|Logistical difficulties|2|||
155254943|NCT01951625|560362419|FG002|Follow Up Period|Logistical difficulties|0|||
155254944|NCT01951625|560362420|FG003|Follow Up Period|Logistical difficulties|0|||
155254945|NCT01951625|560362421|FG004|Follow Up Period|Logistical difficulties|0|||
155254946|NCT01951625|560362417|FG000|Follow Up Period|Adverse Event|0|||
155254947|NCT01951625|560362418|FG001|Follow Up Period|Adverse Event|3|||
155254948|NCT01951625|560362419|FG002|Follow Up Period|Adverse Event|2|||
155254949|NCT01951625|560362420|FG003|Follow Up Period|Adverse Event|3|||
155254950|NCT01951625|560362421|FG004|Follow Up Period|Adverse Event|5|||
155254951|NCT01951625|560362417|FG000|Follow Up Period|Withdrawal by Subject|4|||
155254952|NCT01951625|560362418|FG001|Follow Up Period|Withdrawal by Subject|1|||
155254953|NCT01951625|560362419|FG002|Follow Up Period|Withdrawal by Subject|0|||
155254954|NCT01951625|560362420|FG003|Follow Up Period|Withdrawal by Subject|5|||
155254955|NCT01951625|560362421|FG004|Follow Up Period|Withdrawal by Subject|3|||
155254956|NCT01951625|560362417|FG000|Follow Up Period|Lost to Follow-up|1|||
155254957|NCT01951625|560362418|FG001|Follow Up Period|Lost to Follow-up|0|||
155254958|NCT01951625|560362419|FG002|Follow Up Period|Lost to Follow-up|0|||
155254959|NCT01951625|560362420|FG003|Follow Up Period|Lost to Follow-up|1|||
155254960|NCT01951625|560362421|FG004|Follow Up Period|Lost to Follow-up|1|||
155254961|NCT02030015|560364066|FG000|Overall Study|Withdrawal by Subject|3|||
155254962|NCT02030015|560364066|FG000|Overall Study|Death|13|||
155254963|NCT00514943|560364067|FG000|Stage 1|Progressive disease|4|||
155254964|NCT00514943|560364068|FG001|Stage 1|Progressive disease|8|||
155254965|NCT00514943|560364067|FG000|Stage 1|Other Adverse Event|16|||
155254966|NCT00514943|560364068|FG001|Stage 1|Other Adverse Event|6|||
155254967|NCT00514943|560364067|FG000|Stage 1|Not treated|1|||
155254968|NCT00514943|560364068|FG001|Stage 1|Not treated|2|||
155254969|NCT00514943|560364067|FG000|Stage 1|Patient refused to continue study meds|8|||
155254970|NCT00514943|560364068|FG001|Stage 1|Patient refused to continue study meds|3|||
155254971|NCT00514943|560364067|FG000|Stage 1|Other than stated above|1|||
155254972|NCT00514943|560364068|FG001|Stage 1|Other than stated above|7|||
155254973|NCT00514943|560364067|FG000|Stage 2|Progressive disease|27|||
155254974|NCT00514943|560364068|FG001|Stage 2|Progressive disease|24|||
155254975|NCT00514943|560364067|FG000|Stage 2|Other Adverse Event|3|||
155254976|NCT00514943|560364068|FG001|Stage 2|Other Adverse Event|10|||
155254977|NCT00514943|560364067|FG000|Stage 2|Patient refused to continue study meds|2|||
155254978|NCT00514943|560364068|FG001|Stage 2|Patient refused to continue study meds|0|||
155254979|NCT00514943|560364067|FG000|Stage 2|Other than stated above|0|||
155254980|NCT00514943|560364068|FG001|Stage 2|Other than stated above|2|||
155254981|NCT00833560|560364069|FG000|Overall Study|Toxicity|13|||
155254982|NCT00833560|560364069|FG000|Overall Study|Adverse Event|11|||
155254983|NCT00833560|560364069|FG000|Overall Study|Protocol Violation|6|||
155254984|NCT00833560|560364069|FG000|Overall Study|Lack of Efficacy|4|||
155254985|NCT00833560|560364069|FG000|Overall Study|Death|2|||
155254986|NCT00833560|560364069|FG000|Overall Study|Pregression of other disease|1|||
155254987|NCT00833560|560364069|FG000|Overall Study|Other|5|||
155254988|NCT03382782|560364072|FG000|Cohort 1|Withdrawal by Subject|11|||
155254989|NCT03382782|560364073|FG001|Cohort 1|Withdrawal by Subject|5|||
155254990|NCT03382782|560364074|FG002|Cohort 1|Withdrawal by Subject|0|||
155254991|NCT03382782|560364072|FG000|Cohort 2|Withdrawal by Subject|1|||
155254992|NCT03382782|560364073|FG001|Cohort 2|Withdrawal by Subject|1|||
155254993|NCT03382782|560364074|FG002|Cohort 2|Withdrawal by Subject|0|||
155254994|NCT03382782|560364072|FG000|Cohort 3|Withdrawal by Subject|1|||
155254995|NCT03382782|560364073|FG001|Cohort 3|Withdrawal by Subject|2|||
155254996|NCT03382782|560364074|FG002|Cohort 3|Withdrawal by Subject|0|||
155254997|NCT03409666|560364079|FG000|Overall Study|Physician Decision|0|||
155254998|NCT03409666|560364080|FG001|Overall Study|Physician Decision|1|||
155254999|NCT03409666|560364079|FG000|Overall Study|Protocol Violation|0|||
155255000|NCT03409666|560364080|FG001|Overall Study|Protocol Violation|3|||
155255001|NCT01666951|560364083|FG000|Overall Study|Not dosed|1|||
155255002|NCT01666951|560364084|FG001|Overall Study|Not dosed|1|||
155255003|NCT02366910|560364085|FG000|Overall Study|Withdrawal by Subject|2|||
155255004|NCT02366910|560364085|FG000|Overall Study|Screen Failure|3|||
155255005|NCT02623322|560364086|FG000|Overall Study|Lost to Follow-up|2|||
155255006|NCT02623322|560364087|FG001|Overall Study|Lost to Follow-up|1|||
155255007|NCT02623322|560364088|FG002|Overall Study|Lost to Follow-up|0|||
155255008|NCT03563716|560364089|FG000|Overall Study|Death|20|||
155255009|NCT03563716|560364090|FG001|Overall Study|Death|14|||
155255010|NCT03563716|560364089|FG000|Overall Study|Withdrawal by Subject|3|||
155255011|NCT03563716|560364090|FG001|Overall Study|Withdrawal by Subject|3|||
155255012|NCT03563716|560364089|FG000|Overall Study|Still on Study|45|||
155255013|NCT03563716|560364090|FG001|Overall Study|Still on Study|50|||
155255014|NCT01786512|560364094|FG000|Overall Study|Lost to Follow-up|0|||
155255015|NCT01786512|560364095|FG001|Overall Study|Lost to Follow-up|0|||
155255016|NCT01786512|560364096|FG002|Overall Study|Lost to Follow-up|0|||
155255017|NCT01786512|560364097|FG003|Overall Study|Lost to Follow-up|0|||
155255018|NCT01786512|560364098|FG004|Overall Study|Lost to Follow-up|0|||
155255019|NCT01786512|560364099|FG005|Overall Study|Lost to Follow-up|0|||
155255020|NCT01786512|560364100|FG006|Overall Study|Lost to Follow-up|0|||
155255021|NCT01786512|560364101|FG007|Overall Study|Lost to Follow-up|0|||
155255022|NCT01786512|560364102|FG008|Overall Study|Lost to Follow-up|0|||
155255023|NCT01786512|560364103|FG009|Overall Study|Lost to Follow-up|1|||
155255024|NCT01786512|560364104|FG010|Overall Study|Lost to Follow-up|0|||
155255025|NCT01786512|560364094|FG000|Overall Study|Decision by sponsor|0|||
155255026|NCT01786512|560364095|FG001|Overall Study|Decision by sponsor|0|||
155255027|NCT01786512|560364096|FG002|Overall Study|Decision by sponsor|0|||
155255028|NCT01786512|560364097|FG003|Overall Study|Decision by sponsor|0|||
155255029|NCT01786512|560364098|FG004|Overall Study|Decision by sponsor|0|||
155255030|NCT01786512|560364099|FG005|Overall Study|Decision by sponsor|0|||
155255031|NCT01786512|560364100|FG006|Overall Study|Decision by sponsor|0|||
155255032|NCT01786512|560364101|FG007|Overall Study|Decision by sponsor|0|||
155255033|NCT01786512|560364102|FG008|Overall Study|Decision by sponsor|0|||
155255034|NCT01786512|560364103|FG009|Overall Study|Decision by sponsor|0|||
155255035|NCT01786512|560364104|FG010|Overall Study|Decision by sponsor|2|||
155255036|NCT01786512|560364094|FG000|Overall Study|Withdrawal by Subject|0|||
155255037|NCT01786512|560364095|FG001|Overall Study|Withdrawal by Subject|1|||
155255038|NCT01786512|560364096|FG002|Overall Study|Withdrawal by Subject|0|||
155255039|NCT01786512|560364097|FG003|Overall Study|Withdrawal by Subject|0|||
155255040|NCT01786512|560364098|FG004|Overall Study|Withdrawal by Subject|0|||
155255041|NCT01786512|560364099|FG005|Overall Study|Withdrawal by Subject|0|||
155255042|NCT01786512|560364100|FG006|Overall Study|Withdrawal by Subject|1|||
155255043|NCT01786512|560364101|FG007|Overall Study|Withdrawal by Subject|0|||
155255044|NCT01786512|560364102|FG008|Overall Study|Withdrawal by Subject|0|||
155255045|NCT01786512|560364103|FG009|Overall Study|Withdrawal by Subject|3|||
155255046|NCT01786512|560364104|FG010|Overall Study|Withdrawal by Subject|7|||
155255047|NCT01786512|560364094|FG000|Overall Study|Death|0|||
155255048|NCT01786512|560364095|FG001|Overall Study|Death|0|||
155255049|NCT01786512|560364096|FG002|Overall Study|Death|0|||
155255050|NCT01786512|560364097|FG003|Overall Study|Death|0|||
155255051|NCT01786512|560364098|FG004|Overall Study|Death|0|||
155255052|NCT01786512|560364099|FG005|Overall Study|Death|0|||
155255053|NCT01786512|560364100|FG006|Overall Study|Death|0|||
155255054|NCT01786512|560364101|FG007|Overall Study|Death|0|||
155255055|NCT01786512|560364102|FG008|Overall Study|Death|4|||
155255056|NCT01786512|560364103|FG009|Overall Study|Death|1|||
155255057|NCT01786512|560364104|FG010|Overall Study|Death|3|||
155255058|NCT02450331|560364108|FG000|Overall Study|Death|162|||
155255059|NCT02450331|560364109|FG001|Overall Study|Death|171|||
155255060|NCT02450331|560364108|FG000|Overall Study|Lost to Follow-up|14|||
155255061|NCT02450331|560364109|FG001|Overall Study|Lost to Follow-up|12|||
155255062|NCT02450331|560364108|FG000|Overall Study|Withdrawal by Subject|55|||
155255063|NCT02450331|560364109|FG001|Overall Study|Withdrawal by Subject|44|||
155255064|NCT02450331|560364108|FG000|Overall Study|Non-specified other|1|||
155255065|NCT02450331|560364109|FG001|Overall Study|Non-specified other|1|||
155255066|NCT02080871|560364110|FG000|Overall Study|Death|1|||
155255067|NCT02080871|560364110|FG000|Overall Study|Lost to Follow-up|1|||
155255068|NCT00234052|560364111|FG000|Treatment|Withdrawal by Subject|3|||
155255069|NCT00234052|560364111|FG000|Treatment|Adverse Event|5|||
155255070|NCT00234052|560364111|FG000|Treatment|Death|2|||
155255071|NCT00234052|560364111|FG000|Treatment|Progressive Disease|11|||
155255072|NCT00234052|560364111|FG000|Follow-up for 5 Years|Death|41|||
155255073|NCT00234052|560364111|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
155255074|NCT00234052|560364111|FG000|Follow-up for 5 Years|Other|7|||
155255075|NCT01410474|560364112|FG000|Overall Study|Withdrawal by Subject|0|||
155255076|NCT01410474|560364113|FG001|Overall Study|Withdrawal by Subject|1|||
155255077|NCT02428296|560364114|FG000|Overall Study|Adverse Event|7|||
155255078|NCT02428296|560364114|FG000|Overall Study|Withdrawal by Subject|2|||
155255079|NCT00828984|560364116|FG000|Overall Study|Adverse Event|2|||
155255080|NCT00828984|560364117|FG001|Overall Study|Adverse Event|3|||
155255081|NCT00828984|560364118|FG002|Overall Study|Adverse Event|0|||
155255082|NCT00828984|560364116|FG000|Overall Study|Lost to Follow-up|5|||
155255083|NCT00828984|560364117|FG001|Overall Study|Lost to Follow-up|3|||
155255084|NCT00828984|560364118|FG002|Overall Study|Lost to Follow-up|1|||
155255085|NCT00828984|560364116|FG000|Overall Study|Withdrawal by Subject|4|||
155255086|NCT00828984|560364117|FG001|Overall Study|Withdrawal by Subject|4|||
155255087|NCT00828984|560364118|FG002|Overall Study|Withdrawal by Subject|4|||
155255088|NCT00828984|560364116|FG000|Overall Study|Ineligable|1|||
155255089|NCT00828984|560364117|FG001|Overall Study|Ineligable|2|||
155255090|NCT00828984|560364118|FG002|Overall Study|Ineligable|0|||
155255091|NCT00828984|560364116|FG000|Overall Study|Medical Contraindication|0|||
155255092|NCT00828984|560364117|FG001|Overall Study|Medical Contraindication|1|||
155255093|NCT00828984|560364118|FG002|Overall Study|Medical Contraindication|0|||
155255094|NCT00828984|560364116|FG000|Overall Study|Noncompliant|1|||
155255095|NCT00828984|560364117|FG001|Overall Study|Noncompliant|2|||
155255096|NCT00828984|560364118|FG002|Overall Study|Noncompliant|3|||
155255097|NCT00828984|560364116|FG000|Overall Study|ConMed|1|||
155255098|NCT00828984|560364117|FG001|Overall Study|ConMed|1|||
155255099|NCT00828984|560364118|FG002|Overall Study|ConMed|1|||
155255100|NCT04493931|560364123|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
155255101|NCT04493931|560364124|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255102|NCT04493931|560364125|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255103|NCT04493931|560364126|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255104|NCT04493931|560364127|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255105|NCT04493931|560364128|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255106|NCT04493931|560364129|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
155255107|NCT04493931|560364123|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255108|NCT04493931|560364124|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
155255109|NCT04493931|560364125|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255110|NCT04493931|560364126|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255111|NCT04493931|560364127|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255112|NCT04493931|560364128|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255113|NCT04493931|560364129|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
155255114|NCT04493931|560364123|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255115|NCT04493931|560364124|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
155255116|NCT04493931|560364125|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255117|NCT04493931|560364126|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255118|NCT04493931|560364127|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255119|NCT04493931|560364128|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255120|NCT04493931|560364129|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
155255121|NCT04493931|560364123|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255122|NCT04493931|560364124|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255123|NCT04493931|560364125|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
155255124|NCT04493931|560364126|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255125|NCT04493931|560364127|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255126|NCT04493931|560364128|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255127|NCT04493931|560364129|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
155255128|NCT00863655|560364130|FG000|Overall Study|Protocol Violation|4|||
155255129|NCT00863655|560364131|FG001|Overall Study|Protocol Violation|0|||
155255130|NCT00863655|560364130|FG000|Overall Study|Adverse Event|52|||
155255131|NCT00863655|560364131|FG001|Overall Study|Adverse Event|8|||
155255132|NCT00863655|560364130|FG000|Overall Study|Withdrawal by Subject|47|||
155255133|NCT00863655|560364131|FG001|Overall Study|Withdrawal by Subject|7|||
155255134|NCT00863655|560364130|FG000|Overall Study|Administrative problems|1|||
155255135|NCT00863655|560364131|FG001|Overall Study|Administrative problems|0|||
155255136|NCT00863655|560364130|FG000|Overall Study|Death|7|||
155255137|NCT00863655|560364131|FG001|Overall Study|Death|1|||
155255138|NCT00863655|560364130|FG000|Overall Study|New cancer therapy|5|||
155255139|NCT00863655|560364131|FG001|Overall Study|New cancer therapy|1|||
155255140|NCT00863655|560364130|FG000|Overall Study|Disease progression|364|||
155255141|NCT00863655|560364131|FG001|Overall Study|Disease progression|221|||
155255142|NCT00863655|560364130|FG000|Overall Study|Treatment completed as per protocol|5|||
155255143|NCT00863655|560364131|FG001|Overall Study|Treatment completed as per protocol|1|||
155255144|NCT00002558|560364138|FG000|Overall Study|Withdrawal by Subject|0|||
155255145|NCT00002558|560364139|FG001|Overall Study|Withdrawal by Subject|1|||
155255146|NCT00558428|560364140|FG000|Overall Study|Adverse Event|6|||
155255147|NCT00558428|560364141|FG001|Overall Study|Adverse Event|22|||
155255148|NCT00558428|560364142|FG002|Overall Study|Adverse Event|3|||
155255149|NCT00558428|560364143|FG003|Overall Study|Adverse Event|4|||
155255150|NCT00558428|560364140|FG000|Overall Study|Lost to Follow-up|0|||
155255151|NCT00558428|560364141|FG001|Overall Study|Lost to Follow-up|1|||
155255152|NCT00558428|560364142|FG002|Overall Study|Lost to Follow-up|0|||
155255153|NCT00558428|560364143|FG003|Overall Study|Lost to Follow-up|0|||
155255154|NCT00558428|560364140|FG000|Overall Study|Lack of Efficacy|0|||
155255155|NCT00558428|560364141|FG001|Overall Study|Lack of Efficacy|0|||
155255156|NCT00558428|560364142|FG002|Overall Study|Lack of Efficacy|1|||
155255157|NCT00558428|560364143|FG003|Overall Study|Lack of Efficacy|2|||
155255158|NCT00558428|560364140|FG000|Overall Study|Non compliant with protocol|1|||
155255159|NCT00558428|560364141|FG001|Overall Study|Non compliant with protocol|0|||
155255160|NCT00558428|560364142|FG002|Overall Study|Non compliant with protocol|0|||
155255161|NCT00558428|560364143|FG003|Overall Study|Non compliant with protocol|3|||
155255162|NCT00558428|560364140|FG000|Overall Study|Consent withdrawn|2|||
155255163|NCT00558428|560364141|FG001|Overall Study|Consent withdrawn|1|||
155255164|NCT00558428|560364142|FG002|Overall Study|Consent withdrawn|0|||
155255165|NCT00558428|560364143|FG003|Overall Study|Consent withdrawn|1|||
155255166|NCT00558428|560364140|FG000|Overall Study|Other|3|||
155255167|NCT00558428|560364141|FG001|Overall Study|Other|0|||
155255168|NCT00558428|560364142|FG002|Overall Study|Other|0|||
155255169|NCT00558428|560364143|FG003|Overall Study|Other|1|||
155255170|NCT04528069|560364144|FG000|Overall Study|Adverse Event|1|||
155255171|NCT04528069|560364144|FG000|Overall Study|Lost to Follow-up|1|||
155255172|NCT04528069|560364144|FG000|Overall Study|Patient Unable to Come|1|||
155255173|NCT04528069|560364144|FG000|Overall Study|Patient Unable to Attend|1|||
155255174|NCT01814371|560364145|FG000|Overall Study|Lost to Follow-up|30|||
155255175|NCT01814371|560364146|FG001|Overall Study|Lost to Follow-up|27|||
155255176|NCT02123108|560364152|FG000|Overall Study|Death|2|||
155255177|NCT02123108|560364153|FG001|Overall Study|Death|3|||
155255178|NCT00716092|560364157|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
155255179|NCT00716092|560364158|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
155255180|NCT00716092|560364159|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
155255181|NCT02219048|560364160|FG000|Overall Study|Adverse Event|2|||
155255182|NCT02219048|560364161|FG001|Overall Study|Adverse Event|5|||
155255183|NCT02219048|560364160|FG000|Overall Study|No longer meets eligibility criteria|1|||
155255184|NCT02219048|560364161|FG001|Overall Study|No longer meets eligibility criteria|0|||
155255185|NCT02219048|560364160|FG000|Overall Study|Study terminated by sponsor|16|||
155255186|NCT02219048|560364161|FG001|Overall Study|Study terminated by sponsor|15|||
155255187|NCT02219048|560364160|FG000|Overall Study|Withdrawal by Subject|2|||
155255188|NCT02219048|560364161|FG001|Overall Study|Withdrawal by Subject|0|||
155255189|NCT02219048|560364160|FG000|Overall Study|Other|0|||
155255190|NCT02219048|560364161|FG001|Overall Study|Other|1|||
155255191|NCT02436330|560364162|FG000|Cohort 1|Lost to Follow-up|5|||
155255192|NCT02436330|560364163|FG001|Cohort 1|Lost to Follow-up|2|||
155255193|NCT02436330|560364162|FG000|Cohort 1|Withdrawal by Subject|0|||
155255194|NCT02436330|560364163|FG001|Cohort 1|Withdrawal by Subject|1|||
155255195|NCT02436330|560364162|FG000|Cohort 2|Lost to Follow-up|2|||
155255196|NCT02436330|560364163|FG001|Cohort 2|Lost to Follow-up|0|||
155255197|NCT02436330|560364162|FG000|Cohort 2|Withdrawal by Subject|2|||
155255198|NCT02436330|560364163|FG001|Cohort 2|Withdrawal by Subject|3|||
155255199|NCT02436330|560364162|FG000|Cohort 3|Lost to Follow-up|1|||
155255200|NCT02436330|560364163|FG001|Cohort 3|Lost to Follow-up|0|||
155255201|NCT02436330|560364162|FG000|Cohort 3|Withdrawal by Subject|4|||
155255202|NCT02436330|560364163|FG001|Cohort 3|Withdrawal by Subject|0|||
155255203|NCT02436330|560364162|FG000|Cohort 4|Lost to Follow-up|1|||
155255204|NCT02436330|560364163|FG001|Cohort 4|Lost to Follow-up|0|||
155255205|NCT02436330|560364162|FG000|Cohort 4|Withdrawal by Subject|1|||
155255206|NCT02436330|560364163|FG001|Cohort 4|Withdrawal by Subject|0|||
155255207|NCT02436330|560364162|FG000|Cohort 5|Lost to Follow-up|3|||
155255208|NCT02436330|560364163|FG001|Cohort 5|Lost to Follow-up|2|||
155255209|NCT02436330|560364162|FG000|Cohort 5|Withdrawal by Subject|3|||
155255210|NCT02436330|560364163|FG001|Cohort 5|Withdrawal by Subject|2|||
155255211|NCT02436330|560364162|FG000|Cohort 6|Lost to Follow-up|2|||
155255212|NCT02436330|560364163|FG001|Cohort 6|Lost to Follow-up|0|||
155255213|NCT02436330|560364162|FG000|Cohort 6|Withdrawal by Subject|1|||
155255214|NCT02436330|560364163|FG001|Cohort 6|Withdrawal by Subject|1|||
155255215|NCT00868439|560364164|FG000|Overall Study|Adverse Event|4|||
155255216|NCT00868439|560364165|FG001|Overall Study|Adverse Event|3|||
155255217|NCT00868439|560364164|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
155255218|NCT00868439|560364165|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
155255219|NCT00868439|560364164|FG000|Overall Study|Death|0|||
155255220|NCT00868439|560364165|FG001|Overall Study|Death|1|||
155255221|NCT00868439|560364164|FG000|Overall Study|Protocol Violation|1|||
155255222|NCT00868439|560364165|FG001|Overall Study|Protocol Violation|1|||
155255223|NCT00868439|560364164|FG000|Overall Study|Physician Decision|1|||
155255224|NCT00868439|560364165|FG001|Overall Study|Physician Decision|0|||
155255225|NCT00868439|560364164|FG000|Overall Study|Withdrawal by Subject|0|||
155255226|NCT00868439|560364165|FG001|Overall Study|Withdrawal by Subject|1|||
155255227|NCT01132326|560364166|FG000|Overall Study|Lack of Efficacy|25|||
155255228|NCT01132326|560364166|FG000|Overall Study|Adverse Event|37|||
155255229|NCT01132326|560364166|FG000|Overall Study|Protocol Violation|1|||
155255230|NCT01132326|560364166|FG000|Overall Study|Lost to Follow-up|16|||
155255231|NCT01132326|560364166|FG000|Overall Study|Withdrawal by Subject|40|||
155255232|NCT01132326|560364166|FG000|Overall Study|Physician Decision|10|||
155255233|NCT01132326|560364166|FG000|Overall Study|Study Termination|80|||
155255234|NCT01132326|560364166|FG000|Overall Study|Declining Health|1|||
155255235|NCT01132326|560364166|FG000|Overall Study|Pregnancy|1|||
155255236|NCT01132326|560364166|FG000|Overall Study|Caregiver Withdrew Consent|1|||
155255237|NCT01132326|560364166|FG000|Overall Study|Death|5|||
155255238|NCT01132326|560364166|FG000|Overall Study|Subject Unable to Come To Visits|1|||
155255239|NCT04535947|560364167|FG000|Overall Study|Adverse Event|1|||
155255240|NCT04535947|560364168|FG001|Overall Study|Adverse Event|4|||
155255241|NCT04535947|560364167|FG000|Overall Study|Other reasons not specified|2|||
155255242|NCT04535947|560364168|FG001|Overall Study|Other reasons not specified|0|||
155255243|NCT04535947|560364167|FG000|Overall Study|Withdrawal by Subject|1|||
155255244|NCT04535947|560364168|FG001|Overall Study|Withdrawal by Subject|1|||
155255245|NCT04867369|560364171|FG000|Overall Study|Withdrawal by Subject|1|||
155255246|NCT04867369|560364172|FG001|Overall Study|Withdrawal by Subject|0|||
155255247|NCT04212091|560364173|FG000|Overall Study|Lost to Follow-up|0|||
155255248|NCT04212091|560364174|FG001|Overall Study|Lost to Follow-up|0|||
155255249|NCT04212091|560364175|FG002|Overall Study|Lost to Follow-up|0|||
155255250|NCT04212091|560364176|FG003|Overall Study|Lost to Follow-up|0|||
155255251|NCT04212091|560364177|FG004|Overall Study|Lost to Follow-up|1|||
155255252|NCT04212091|560364178|FG005|Overall Study|Lost to Follow-up|1|||
155255253|NCT04212091|560364173|FG000|Overall Study|Participant unable to adhere to visit|0|||
155255254|NCT04212091|560364174|FG001|Overall Study|Participant unable to adhere to visit|0|||
155255255|NCT04212091|560364175|FG002|Overall Study|Participant unable to adhere to visit|0|||
155255256|NCT04212091|560364176|FG003|Overall Study|Participant unable to adhere to visit|0|||
155255257|NCT04212091|560364177|FG004|Overall Study|Participant unable to adhere to visit|1|||
155255258|NCT04212091|560364178|FG005|Overall Study|Participant unable to adhere to visit|0|||
155255259|NCT03492281|560364179|FG000|Overall Study|Withdrawal by Subject|21|||
155255260|NCT03492281|560364180|FG001|Overall Study|Withdrawal by Subject|14|||
155255261|NCT03492281|560364181|FG002|Overall Study|Withdrawal by Subject|13|||
155255262|NCT03492281|560364179|FG000|Overall Study|Lost to Follow-up|14|||
155255263|NCT03492281|560364180|FG001|Overall Study|Lost to Follow-up|15|||
155255264|NCT03492281|560364181|FG002|Overall Study|Lost to Follow-up|10|||
155255265|NCT03492281|560364179|FG000|Overall Study|Adverse Event|6|||
155255266|NCT03492281|560364180|FG001|Overall Study|Adverse Event|8|||
155255267|NCT03492281|560364181|FG002|Overall Study|Adverse Event|13|||
155255268|NCT03492281|560364179|FG000|Overall Study|Lack of Efficacy|3|||
155255269|NCT03492281|560364180|FG001|Overall Study|Lack of Efficacy|0|||
155255270|NCT03492281|560364181|FG002|Overall Study|Lack of Efficacy|1|||
155255271|NCT03492281|560364179|FG000|Overall Study|Physician Decision|1|||
155255272|NCT03492281|560364180|FG001|Overall Study|Physician Decision|0|||
155255273|NCT03492281|560364181|FG002|Overall Study|Physician Decision|3|||
155255274|NCT03492281|560364179|FG000|Overall Study|Protocol Violation|0|||
155255275|NCT03492281|560364180|FG001|Overall Study|Protocol Violation|2|||
155255276|NCT03492281|560364181|FG002|Overall Study|Protocol Violation|1|||
155255277|NCT03492281|560364179|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
155255278|NCT03492281|560364180|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
155255279|NCT03492281|560364181|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
155255280|NCT03492281|560364179|FG000|Overall Study|Death|0|||
155255281|NCT03492281|560364180|FG001|Overall Study|Death|0|||
155255282|NCT03492281|560364181|FG002|Overall Study|Death|1|||
155255283|NCT03492281|560364179|FG000|Overall Study|Captured as Other in Database|8|||
155255284|NCT03492281|560364180|FG001|Overall Study|Captured as Other in Database|6|||
155255285|NCT03492281|560364181|FG002|Overall Study|Captured as Other in Database|3|||
155255286|NCT00587964|560364182|FG000|Overall Study|Withdrawal by Subject|1|||
155255287|NCT00587964|560364182|FG000|Overall Study|Lost to Follow-up|1|||
155255288|NCT00587964|560364182|FG000|Overall Study|Patient found to be ineligible|1|||
155255289|NCT00587964|560364182|FG000|Overall Study|Patient did not receive intervention|5|||
155255290|NCT00587964|560364182|FG000|Overall Study|Progression of Disease|4|||
155255291|NCT00818753|560364188|FG000|Overall Study|Protocol Violation|1|||
155255292|NCT00818753|560364189|FG001|Overall Study|Protocol Violation|0|||
155255293|NCT00818753|560364190|FG002|Overall Study|Protocol Violation|0|||
155255294|NCT00818753|560364188|FG000|Overall Study|Other reason (not specified)|0|||
155255295|NCT00818753|560364189|FG001|Overall Study|Other reason (not specified)|0|||
155255296|NCT00818753|560364190|FG002|Overall Study|Other reason (not specified)|1|||
155255297|NCT00818753|560364188|FG000|Overall Study|Randomised and not treated|2|||
155255298|NCT00818753|560364189|FG001|Overall Study|Randomised and not treated|0|||
155255299|NCT00818753|560364190|FG002|Overall Study|Randomised and not treated|0|||
155255300|NCT01389973|560364191|FG000|Overall Study|Lost to Follow-up|1|||
155255301|NCT01389973|560364191|FG000|Overall Study|Trial Stopped by Sponsor|9|||
155255302|NCT01389973|560364191|FG000|Overall Study|Other|10|||
155255303|NCT02693743|560364192|FG000|Overall Study|Physician Decision|1|||
155255304|NCT02693743|560364193|FG001|Overall Study|Physician Decision|0|||
155255305|NCT02626780|560364194|FG000|Overall Study|Withdrawal by Subject|3|||
155255306|NCT04304833|560364195|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
155255307|NCT04304833|560364196|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
155255308|NCT02858895|560364197|FG000|Overall Study|Disease progression|31|||
155255309|NCT02858895|560364197|FG000|Overall Study|Death|2|||
155255310|NCT02858895|560364197|FG000|Overall Study|Adverse Event|1|||
155255311|NCT02858895|560364197|FG000|Overall Study|Withdrawal by Subject|3|||
155255312|NCT02858895|560364197|FG000|Overall Study|hospice,|1|||
155255313|NCT02858895|560364197|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
155255314|NCT05338333|560364202|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
155255315|NCT05338333|560364203|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
155255316|NCT00251745|560364204|FG000|Overall Study|Adverse Event|7|||
155255317|NCT00251745|560364205|FG001|Overall Study|Adverse Event|9|||
155255318|NCT00251745|560364206|FG002|Overall Study|Adverse Event|11|||
155255319|NCT00251745|560364204|FG000|Overall Study|Lost to Follow-up|4|||
155255320|NCT00251745|560364205|FG001|Overall Study|Lost to Follow-up|2|||
155255321|NCT00251745|560364206|FG002|Overall Study|Lost to Follow-up|5|||
155255322|NCT00251745|560364204|FG000|Overall Study|Withdrawal by Subject|13|||
155255323|NCT00251745|560364205|FG001|Overall Study|Withdrawal by Subject|7|||
155255324|NCT00251745|560364206|FG002|Overall Study|Withdrawal by Subject|3|||
155255325|NCT00251745|560364204|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
155255326|NCT00251745|560364205|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
155255327|NCT00251745|560364206|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
155255328|NCT00251745|560364204|FG000|Overall Study|Lack of Efficacy|3|||
155255329|NCT00251745|560364205|FG001|Overall Study|Lack of Efficacy|0|||
155255330|NCT00251745|560364206|FG002|Overall Study|Lack of Efficacy|0|||
155255331|NCT00251745|560364204|FG000|Overall Study|Noncompliant|0|||
155255332|NCT00251745|560364205|FG001|Overall Study|Noncompliant|2|||
155255333|NCT00251745|560364206|FG002|Overall Study|Noncompliant|2|||
155255334|NCT00251745|560364204|FG000|Overall Study|Pregnancy|0|||
155255335|NCT00251745|560364205|FG001|Overall Study|Pregnancy|1|||
155255336|NCT00251745|560364206|FG002|Overall Study|Pregnancy|0|||
155255337|NCT00251745|560364204|FG000|Overall Study|Per Subject Request|0|||
155255338|NCT00251745|560364205|FG001|Overall Study|Per Subject Request|0|||
155255339|NCT00251745|560364206|FG002|Overall Study|Per Subject Request|1|||
155255340|NCT00251745|560364204|FG000|Overall Study|Per Investigator Request|1|||
155255341|NCT00251745|560364205|FG001|Overall Study|Per Investigator Request|0|||
155255342|NCT00251745|560364206|FG002|Overall Study|Per Investigator Request|0|||
155255343|NCT00512148|560366552|FG000|Primay Study Period|Withdrawal by Subject|1|||
155255344|NCT03284788|560366557|FG000|Overall Study|Withdrawal by Subject|2|||
155255345|NCT04605978|560366558|FG000|Overall Study|Adverse Event|2|||
155255346|NCT04605978|560366559|FG001|Overall Study|Adverse Event|1|||
155255347|NCT04605978|560366558|FG000|Overall Study|Withdrawal nonmedical reason|1|||
155255348|NCT04605978|560366559|FG001|Overall Study|Withdrawal nonmedical reason|1|||
155255349|NCT03813238|560366560|FG000|Overall Study|Adverse Event|0|||
155255350|NCT03813238|560366561|FG001|Overall Study|Adverse Event|6|||
155255351|NCT03813238|560366560|FG000|Overall Study|Withdrawal by parent/guardian|0|||
155255352|NCT03813238|560366561|FG001|Overall Study|Withdrawal by parent/guardian|2|||
155255353|NCT03813238|560366560|FG000|Overall Study|Lost to Follow-up|0|||
155255354|NCT03813238|560366561|FG001|Overall Study|Lost to Follow-up|1|||
155255355|NCT03813238|560366560|FG000|Overall Study|Other than specified|1|||
155255356|NCT03813238|560366561|FG001|Overall Study|Other than specified|2|||
155255357|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
155255358|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
155255359|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
155255360|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
155255361|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
155255362|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
155255363|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
155255364|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
155255365|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
155255366|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
155255367|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
155255368|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
155255369|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Death|6|||
155255370|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Death|3|||
155255371|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Death|0|||
155255372|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Death|1|||
155255373|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Death|1|||
155255374|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Death|0|||
155255375|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
155255376|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
155255377|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
155255378|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
155255379|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
155255380|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
155255381|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255382|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
155255383|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
155255384|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255385|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255386|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
155255387|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
155255388|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
155255389|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
155255390|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
155255391|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
155255392|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
155255393|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
155255394|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
155255395|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
155255396|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
155255397|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
155255398|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
155255399|NCT03104699|560366562|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
155255400|NCT03104699|560366563|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
155255401|NCT03104699|560366564|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
155255402|NCT03104699|560366565|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
155255403|NCT03104699|560366566|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
155255404|NCT03104699|560366567|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
155255405|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255406|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255407|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255408|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255409|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
155255410|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
155255411|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Death|0|||
155255412|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Death|0|||
155255413|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Death|0|||
155255414|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Death|0|||
155255415|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Death|0|||
155255416|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Death|107|||
155255417|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255418|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255419|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255420|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255421|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
155255422|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
155255423|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255424|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255425|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255426|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255427|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
155255428|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
155255429|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255430|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255431|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255432|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255433|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
155255434|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
155255435|NCT03104699|560366562|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
155255436|NCT03104699|560366563|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
155255437|NCT03104699|560366564|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
155255438|NCT03104699|560366565|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
155255439|NCT03104699|560366566|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
155255440|NCT03104699|560366567|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
155255441|NCT01690130|560366568|FG000|Overall Study|Subject have cancelled visit.|1|||
155255442|NCT01690130|560366569|FG001|Overall Study|Subject have cancelled visit.|0|||
155255443|NCT00605293|560366570|FG000|Overall Study|Death|2|||
155255444|NCT00605293|560366571|FG001|Overall Study|Death|1|||
155255445|NCT00605293|560366570|FG000|Overall Study|Insufficient Therapeutic Response|2|||
155255446|NCT00605293|560366571|FG001|Overall Study|Insufficient Therapeutic Response|0|||
155255447|NCT00605293|560366570|FG000|Overall Study|Adverse Event|1|||
155255448|NCT00605293|560366571|FG001|Overall Study|Adverse Event|0|||
155255449|NCT00605293|560366570|FG000|Overall Study|Holidays Dialysis Out|1|||
155255450|NCT00605293|560366571|FG001|Overall Study|Holidays Dialysis Out|0|||
155255451|NCT00605293|560366570|FG000|Overall Study|Blood Transfusion|7|||
155255452|NCT00605293|560366571|FG001|Overall Study|Blood Transfusion|1|||
155255453|NCT00605293|560366570|FG000|Overall Study|Renal Transplantation|3|||
155255454|NCT00605293|560366571|FG001|Overall Study|Renal Transplantation|1|||
155255455|NCT00605293|560366570|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
155255456|NCT00605293|560366571|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
155255457|NCT00605293|560366570|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
155255458|NCT00605293|560366571|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
155255459|NCT00605293|560366570|FG000|Overall Study|Principal Investigator Decision|0|||
155255460|NCT00605293|560366571|FG001|Overall Study|Principal Investigator Decision|1|||
155255461|NCT03581981|560366572|FG000|Overall Study|Withdrawal by Subject|12|||
155255462|NCT03581981|560366573|FG001|Overall Study|Withdrawal by Subject|13|||
155255463|NCT03581981|560366572|FG000|Overall Study|Physician Decision|1|||
155255464|NCT03581981|560366573|FG001|Overall Study|Physician Decision|2|||
155255465|NCT03581981|560366572|FG000|Overall Study|Lost to Follow-up|0|||
155255466|NCT03581981|560366573|FG001|Overall Study|Lost to Follow-up|4|||
155255467|NCT00420199|560366576|FG000|Overall Study|Participant no longer met study criteria|1|||
155255468|NCT00420199|560366577|FG001|Overall Study|Participant no longer met study criteria|0|||
155255469|NCT01260350|560366582|FG000|Overall Study|Lack of Efficacy|0|||
155255470|NCT01260350|560366583|FG001|Overall Study|Lack of Efficacy|0|||
155255471|NCT01260350|560366584|FG002|Overall Study|Lack of Efficacy|0|||
155255472|NCT01260350|560366585|FG003|Overall Study|Lack of Efficacy|0|||
155255473|NCT01260350|560366586|FG004|Overall Study|Lack of Efficacy|0|||
155255474|NCT01260350|560366587|FG005|Overall Study|Lack of Efficacy|0|||
155255475|NCT01260350|560366588|FG006|Overall Study|Lack of Efficacy|0|||
155255476|NCT01260350|560366589|FG007|Overall Study|Lack of Efficacy|0|||
155255477|NCT01260350|560366590|FG008|Overall Study|Lack of Efficacy|0|||
155255478|NCT01260350|560366591|FG009|Overall Study|Lack of Efficacy|0|||
155255479|NCT01260350|560366592|FG010|Overall Study|Lack of Efficacy|0|||
155255480|NCT01260350|560366593|FG011|Overall Study|Lack of Efficacy|0|||
155255481|NCT01260350|560366594|FG012|Overall Study|Lack of Efficacy|0|||
155255482|NCT01260350|560366595|FG013|Overall Study|Lack of Efficacy|0|||
155255483|NCT01260350|560366596|FG014|Overall Study|Lack of Efficacy|0|||
155255484|NCT01260350|560366597|FG015|Overall Study|Lack of Efficacy|0|||
155255485|NCT01260350|560366598|FG016|Overall Study|Lack of Efficacy|0|||
155255486|NCT01260350|560366599|FG017|Overall Study|Lack of Efficacy|1|||
155255487|NCT01260350|560366600|FG018|Overall Study|Lack of Efficacy|0|||
155255488|NCT01260350|560366601|FG019|Overall Study|Lack of Efficacy|0|||
155255489|NCT01260350|560366602|FG020|Overall Study|Lack of Efficacy|3|||
155255490|NCT01260350|560366603|FG021|Overall Study|Lack of Efficacy|0|||
155255491|NCT01260350|560366582|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255492|NCT01260350|560366583|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255493|NCT01260350|560366584|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255494|NCT01260350|560366585|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255495|NCT01260350|560366586|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255496|NCT01260350|560366587|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255497|NCT01260350|560366588|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255498|NCT01260350|560366589|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255499|NCT01260350|560366590|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
155255500|NCT01260350|560366591|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255501|NCT01260350|560366592|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255502|NCT01260350|560366593|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255503|NCT01260350|560366594|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255504|NCT01260350|560366595|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255505|NCT01260350|560366596|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255506|NCT01260350|560366597|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255507|NCT01260350|560366598|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255508|NCT01260350|560366599|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255509|NCT01260350|560366600|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255510|NCT01260350|560366601|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255511|NCT01260350|560366602|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255512|NCT01260350|560366603|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
155255513|NCT02570126|560366606|FG000|Overall Study|Lost to Follow-up|2|||
155255514|NCT02570126|560366607|FG001|Overall Study|Lost to Follow-up|0|||
155255515|NCT02570126|560366606|FG000|Overall Study|Unable To Arrange Visit 3|1|||
155255516|NCT02570126|560366607|FG001|Overall Study|Unable To Arrange Visit 3|0|||
155255517|NCT02570126|560366606|FG000|Overall Study|Violation Of Procedures GSK|0|||
155255518|NCT02570126|560366607|FG001|Overall Study|Violation Of Procedures GSK|1|||
155255519|NCT02570126|560366606|FG000|Overall Study|Protocol Violation|0|||
155255520|NCT02570126|560366607|FG001|Overall Study|Protocol Violation|1|||
155255521|NCT02570126|560366606|FG000|Overall Study|Withdrawal by Subject|3|||
155255522|NCT02570126|560366607|FG001|Overall Study|Withdrawal by Subject|7|||
155255523|NCT00626028|560366608|FG000|Overall Study|Adverse Event|1|||
155255524|NCT00626028|560366609|FG001|Overall Study|Adverse Event|1|||
155255525|NCT00626028|560366608|FG000|Overall Study|Device Failure|0|||
155255526|NCT00626028|560366609|FG001|Overall Study|Device Failure|1|||
155255527|NCT00626028|560366608|FG000|Overall Study|Physician Decision|2|||
155255528|NCT00626028|560366609|FG001|Overall Study|Physician Decision|1|||
155255529|NCT00626028|560366608|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
155255530|NCT00626028|560366609|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
155255531|NCT05224050|560366610|FG000|Overall Study|Withdrawal by Subject|9|||
155255532|NCT05224050|560366610|FG000|Overall Study|Lost to Follow-up|3|||
155255533|NCT00917579|560366612|FG000|Washout >= 2 Weeks|Adverse Event|1|||
155255534|NCT00917579|560366613|FG001|Washout >= 2 Weeks|Adverse Event|0|||
155255535|NCT00917579|560366612|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
155255536|NCT00917579|560366613|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
155255537|NCT00754338|560366614|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255538|NCT00754338|560366615|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
155255539|NCT00754338|560366616|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
155255540|NCT00754338|560366617|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255541|NCT00754338|560366614|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255542|NCT00754338|560366615|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
155255543|NCT00754338|560366616|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
155255544|NCT00754338|560366617|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
155255545|NCT00831779|560366620|FG000|Overall Study|Lost to Follow-up|1|||
155255546|NCT00831779|560366621|FG001|Overall Study|Lost to Follow-up|0|||
155255547|NCT00831779|560366620|FG000|Overall Study|No longer met criteria|0|||
155255548|NCT00831779|560366621|FG001|Overall Study|No longer met criteria|1|||
155255549|NCT04020341|560366622|FG000|Overall Study|Adverse Event|8|||
155255550|NCT04020341|560366623|FG001|Overall Study|Adverse Event|6|||
155255551|NCT04020341|560366622|FG000|Overall Study|Lost to Follow-up|8|||
155255552|NCT04020341|560366623|FG001|Overall Study|Lost to Follow-up|2|||
155255553|NCT04020341|560366622|FG000|Overall Study|Withdrawal by Subject|16|||
155255554|NCT04020341|560366623|FG001|Overall Study|Withdrawal by Subject|16|||
155255555|NCT04020341|560366622|FG000|Overall Study|Participant not able to swallow the tablet|1|||
155255556|NCT04020341|560366623|FG001|Overall Study|Participant not able to swallow the tablet|0|||
155255557|NCT04020341|560366622|FG000|Overall Study|Physician Decision|0|||
155255558|NCT04020341|560366623|FG001|Overall Study|Physician Decision|2|||
155255559|NCT04020341|560366622|FG000|Overall Study|Protocol Deviation|0|||
155255560|NCT04020341|560366623|FG001|Overall Study|Protocol Deviation|2|||
155255561|NCT05763628|560366624|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
155255562|NCT05763628|560366625|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
155255563|NCT05763628|560366624|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
155255564|NCT05763628|560366625|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
155255565|NCT05763628|560366624|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
155255566|NCT05763628|560366625|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
155255567|NCT04683926|560366633|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
155255568|NCT04683926|560366634|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
155255569|NCT04683926|560366635|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
155255570|NCT04683926|560366636|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
155255571|NCT04385368|560366638|FG000|Overall Study|Death|5|||
155255572|NCT04385368|560366639|FG001|Overall Study|Death|5|||
155255573|NCT04385368|560366638|FG000|Overall Study|Physician Decision|3|||
155255574|NCT04385368|560366639|FG001|Overall Study|Physician Decision|0|||
155255575|NCT04385368|560366638|FG000|Overall Study|Withdrawal by Subject|4|||
155255576|NCT04385368|560366639|FG001|Overall Study|Withdrawal by Subject|3|||
155255577|NCT02054806|560366641|FG000|Overall Study|Sponsor Decision|31|||
155255578|NCT02054806|560366641|FG000|Overall Study|Withdrawal by Subject|43|||
155255579|NCT02054806|560366641|FG000|Overall Study|Protocol Violation|2|||
155255580|NCT02054806|560366641|FG000|Overall Study|Lost to Follow-up|10|||
155255581|NCT02054806|560366641|FG000|Overall Study|Death|391|||
155255582|NCT04721925|560366642|FG000|2-Month Assessment|Lost to Follow-up|5|||
155255583|NCT04721925|560366643|FG001|2-Month Assessment|Lost to Follow-up|3|||
155255584|NCT04721925|560366642|FG000|4-Month Assessment|Lost to Follow-up|3|||
155255585|NCT04721925|560366643|FG001|4-Month Assessment|Lost to Follow-up|6|||
155255586|NCT00677235|560366644|FG000|Overall Study|Withdrawal by Subject|1|||
155255587|NCT00677235|560366645|FG001|Overall Study|Withdrawal by Subject|1|||
155255588|NCT00677235|560366644|FG000|Overall Study|Lost to Follow-up|2|||
155255589|NCT00677235|560366645|FG001|Overall Study|Lost to Follow-up|1|||
155255590|NCT00677235|560366644|FG000|Overall Study|Death|37|||
155255591|NCT00677235|560366645|FG001|Overall Study|Death|36|||
155255592|NCT00677235|560366644|FG000|Overall Study|Adverse Experience|1|||
155255593|NCT00677235|560366645|FG001|Overall Study|Adverse Experience|0|||
155255594|NCT05072080|560366658|FG000|Overall Study|Death|0|||
155255595|NCT05072080|560366659|FG001|Overall Study|Death|0|||
155255596|NCT05072080|560366660|FG002|Overall Study|Death|1|||
155255597|NCT05072080|560366661|FG003|Overall Study|Death|0|||
155255598|NCT05072080|560366658|FG000|Overall Study|Lost to Follow-up|65|||
155255599|NCT05072080|560366659|FG001|Overall Study|Lost to Follow-up|70|||
155255600|NCT05072080|560366660|FG002|Overall Study|Lost to Follow-up|58|||
155255601|NCT05072080|560366661|FG003|Overall Study|Lost to Follow-up|23|||
155255602|NCT05072080|560366658|FG000|Overall Study|Physician Decision|2|||
155255603|NCT05072080|560366659|FG001|Overall Study|Physician Decision|1|||
155255604|NCT05072080|560366660|FG002|Overall Study|Physician Decision|1|||
155255605|NCT05072080|560366661|FG003|Overall Study|Physician Decision|0|||
155255606|NCT05072080|560366658|FG000|Overall Study|Withdrawal by Subject|45|||
155255607|NCT05072080|560366659|FG001|Overall Study|Withdrawal by Subject|30|||
155255608|NCT05072080|560366660|FG002|Overall Study|Withdrawal by Subject|27|||
155255609|NCT05072080|560366661|FG003|Overall Study|Withdrawal by Subject|7|||
155255610|NCT05072080|560366658|FG000|Overall Study|Sponsor Decision|0|||
155255611|NCT05072080|560366659|FG001|Overall Study|Sponsor Decision|1|||
155255612|NCT05072080|560366660|FG002|Overall Study|Sponsor Decision|0|||
155255613|NCT05072080|560366661|FG003|Overall Study|Sponsor Decision|0|||
155255614|NCT05072080|560366658|FG000|Overall Study|Subject moved|1|||
155255615|NCT05072080|560366659|FG001|Overall Study|Subject moved|3|||
155255616|NCT05072080|560366660|FG002|Overall Study|Subject moved|5|||
155255617|NCT05072080|560366661|FG003|Overall Study|Subject moved|2|||
155255618|NCT05072080|560366658|FG000|Overall Study|Withdrawal by parent|0|||
155255619|NCT05072080|560366659|FG001|Overall Study|Withdrawal by parent|0|||
155255620|NCT05072080|560366660|FG002|Overall Study|Withdrawal by parent|1|||
155255621|NCT05072080|560366661|FG003|Overall Study|Withdrawal by parent|0|||
155255622|NCT05072080|560366658|FG000|Overall Study|Subject was deployed|0|||
155255623|NCT05072080|560366659|FG001|Overall Study|Subject was deployed|1|||
155255624|NCT05072080|560366660|FG002|Overall Study|Subject was deployed|0|||
155255625|NCT05072080|560366661|FG003|Overall Study|Subject was deployed|0|||
155255626|NCT05072080|560366658|FG000|Overall Study|Subject left site without receiving dose|0|||
155255627|NCT05072080|560366659|FG001|Overall Study|Subject left site without receiving dose|1|||
155255628|NCT05072080|560366660|FG002|Overall Study|Subject left site without receiving dose|0|||
155255629|NCT05072080|560366661|FG003|Overall Study|Subject left site without receiving dose|0|||
155255630|NCT05072080|560366658|FG000|Overall Study|Subject incarcerated|0|||
155255631|NCT05072080|560366659|FG001|Overall Study|Subject incarcerated|1|||
155255632|NCT05072080|560366660|FG002|Overall Study|Subject incarcerated|0|||
155255633|NCT05072080|560366661|FG003|Overall Study|Subject incarcerated|1|||
155255634|NCT05072080|560366658|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
155255635|NCT05072080|560366659|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
155255636|NCT05072080|560366660|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
155255637|NCT05072080|560366661|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
155255638|NCT05072080|560366658|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
155255639|NCT05072080|560366659|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
155255640|NCT05072080|560366660|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
155255641|NCT05072080|560366661|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
155255642|NCT03205371|560366663|FG000|Overall Study|Withdrawal by Subject|4|||
155255643|NCT03205371|560366664|FG001|Overall Study|Withdrawal by Subject|1|||
155255644|NCT03205371|560366665|FG002|Overall Study|Withdrawal by Subject|0|||
155255645|NCT03205371|560366666|FG003|Overall Study|Withdrawal by Subject|0|||
155255646|NCT03205371|560366667|FG004|Overall Study|Withdrawal by Subject|0|||
155255647|NCT03205371|560366668|FG005|Overall Study|Withdrawal by Subject|0|||
155255648|NCT03205371|560366669|FG006|Overall Study|Withdrawal by Subject|4|||
155255649|NCT03205371|560366670|FG007|Overall Study|Withdrawal by Subject|0|||
155255650|NCT03205371|560366671|FG008|Overall Study|Withdrawal by Subject|2|||
155255651|NCT03205371|560366672|FG009|Overall Study|Withdrawal by Subject|0|||
155255652|NCT03205371|560366673|FG010|Overall Study|Withdrawal by Subject|0|||
155255653|NCT03205371|560366674|FG011|Overall Study|Withdrawal by Subject|1|||
155255654|NCT03205371|560366663|FG000|Overall Study|Lost to Follow-up|0|||
155255655|NCT03205371|560366664|FG001|Overall Study|Lost to Follow-up|0|||
155255656|NCT03205371|560366665|FG002|Overall Study|Lost to Follow-up|0|||
155255657|NCT03205371|560366666|FG003|Overall Study|Lost to Follow-up|0|||
155255658|NCT03205371|560366667|FG004|Overall Study|Lost to Follow-up|0|||
155255659|NCT03205371|560366668|FG005|Overall Study|Lost to Follow-up|0|||
155255660|NCT03205371|560366669|FG006|Overall Study|Lost to Follow-up|5|||
155255661|NCT03205371|560366670|FG007|Overall Study|Lost to Follow-up|2|||
155255662|NCT03205371|560366671|FG008|Overall Study|Lost to Follow-up|3|||
155255663|NCT03205371|560366672|FG009|Overall Study|Lost to Follow-up|0|||
155255664|NCT03205371|560366673|FG010|Overall Study|Lost to Follow-up|0|||
155255665|NCT03205371|560366674|FG011|Overall Study|Lost to Follow-up|0|||
155255666|NCT03205371|560366663|FG000|Overall Study|Protocol Violation|0|||
155255667|NCT03205371|560366664|FG001|Overall Study|Protocol Violation|0|||
155255668|NCT03205371|560366665|FG002|Overall Study|Protocol Violation|0|||
155255669|NCT03205371|560366666|FG003|Overall Study|Protocol Violation|0|||
155255670|NCT03205371|560366667|FG004|Overall Study|Protocol Violation|0|||
155255671|NCT03205371|560366668|FG005|Overall Study|Protocol Violation|0|||
155255672|NCT03205371|560366669|FG006|Overall Study|Protocol Violation|1|||
155255673|NCT03205371|560366670|FG007|Overall Study|Protocol Violation|0|||
155255674|NCT03205371|560366671|FG008|Overall Study|Protocol Violation|0|||
155255675|NCT03205371|560366672|FG009|Overall Study|Protocol Violation|0|||
155255676|NCT03205371|560366673|FG010|Overall Study|Protocol Violation|0|||
155255677|NCT03205371|560366674|FG011|Overall Study|Protocol Violation|0|||
155255678|NCT03205371|560366663|FG000|Overall Study|Adverse Event|0|||
155255679|NCT03205371|560366664|FG001|Overall Study|Adverse Event|0|||
155255680|NCT03205371|560366665|FG002|Overall Study|Adverse Event|0|||
155255681|NCT03205371|560366666|FG003|Overall Study|Adverse Event|0|||
155255682|NCT03205371|560366667|FG004|Overall Study|Adverse Event|0|||
155255683|NCT03205371|560366668|FG005|Overall Study|Adverse Event|0|||
155255684|NCT03205371|560366669|FG006|Overall Study|Adverse Event|0|||
155255685|NCT03205371|560366670|FG007|Overall Study|Adverse Event|1|||
155255686|NCT03205371|560366671|FG008|Overall Study|Adverse Event|0|||
155255687|NCT03205371|560366672|FG009|Overall Study|Adverse Event|0|||
155255688|NCT03205371|560366673|FG010|Overall Study|Adverse Event|0|||
155255689|NCT03205371|560366674|FG011|Overall Study|Adverse Event|0|||
155255690|NCT04918147|560366684|FG000|Overall Study|Disease flare as defined in protocol|0|||
155255691|NCT04918147|560366685|FG001|Overall Study|Disease flare as defined in protocol|2|||
155255692|NCT03565887|560366686|FG000|Overall Study|Adverse Event|1|||
155255693|NCT03565887|560366687|FG001|Overall Study|Adverse Event|0|||
155255694|NCT03565887|560366686|FG000|Overall Study|Withdrawal by Subject|0|||
155255695|NCT03565887|560366687|FG001|Overall Study|Withdrawal by Subject|2|||
155255696|NCT02975973|560366688|FG000|Overall Study|Adverse Event|1|||
155255697|NCT02975973|560366689|FG001|Overall Study|Adverse Event|1|||
155255698|NCT02975973|560366690|FG002|Overall Study|Adverse Event|1|||
155255699|NCT02975973|560366691|FG003|Overall Study|Adverse Event|0|||
155255700|NCT03804710|560366692|FG000|Overall Study|Adverse Event|0|||
155255701|NCT03804710|560366693|FG001|Overall Study|Adverse Event|3|||
155255702|NCT03804710|560366692|FG000|Overall Study|Withdrawal by Subject|2|||
155255703|NCT03804710|560366693|FG001|Overall Study|Withdrawal by Subject|1|||
155255704|NCT03804710|560366692|FG000|Overall Study|Other|0|||
155255705|NCT03804710|560366693|FG001|Overall Study|Other|1|||
155255706|NCT03182868|560366696|FG000|Overall Study|Protocol Violation|3|||
155255707|NCT03182868|560366697|FG001|Overall Study|Protocol Violation|0|||
155255708|NCT03182868|560366698|FG002|Overall Study|Protocol Violation|4|||
155255709|NCT03182868|560366699|FG003|Overall Study|Protocol Violation|1|||
155255710|NCT03182868|560366700|FG004|Overall Study|Protocol Violation|8|||
155255711|NCT02191267|560366702|FG000|Overall Study|Withdrawal by Subject|1|||
155255712|NCT02191267|560366703|FG001|Overall Study|Withdrawal by Subject|0|||
155255713|NCT02191267|560366704|FG002|Overall Study|Withdrawal by Subject|0|||
155255714|NCT01830127|560366710|FG000|Overall Study|Adverse Event|1|||
155255715|NCT01830127|560366711|FG001|Overall Study|Adverse Event|6|||
155255716|NCT01830127|560366710|FG000|Overall Study|Lack of Efficacy|3|||
155255717|NCT01830127|560366711|FG001|Overall Study|Lack of Efficacy|0|||
155255718|NCT01830127|560366710|FG000|Overall Study|Withdrawal by Subject|1|||
155255719|NCT01830127|560366711|FG001|Overall Study|Withdrawal by Subject|1|||
155255720|NCT01830127|560366710|FG000|Overall Study|Other reason not defined above|0|||
155255721|NCT01830127|560366711|FG001|Overall Study|Other reason not defined above|2|||
155255722|NCT00941330|560366716|FG000|Overall Study|Other|1|||
155255723|NCT00941330|560366717|FG001|Overall Study|Other|0|||
155255724|NCT00941330|560366716|FG000|Overall Study|Physician Decision|0|||
155255725|NCT00941330|560366717|FG001|Overall Study|Physician Decision|2|||
155255726|NCT00951275|560366718|FG000|Overall Study|Administrative Reason|1|||
155255727|NCT00951275|560366718|FG000|Overall Study|Adverse Event|7|||
155255728|NCT00951275|560366718|FG000|Overall Study|Withdrawal by Subject|4|||
155255729|NCT00951275|560366718|FG000|Overall Study|Protocol Violation|1|||
155255730|NCT03260868|560366719|FG000|Overall Study|Poor Compliance to Protocol|0|||
155255731|NCT03260868|560366720|FG001|Overall Study|Poor Compliance to Protocol|2|||
155255732|NCT03260868|560366719|FG000|Overall Study|Study Terminated By Sponsor|2|||
155255733|NCT03260868|560366720|FG001|Overall Study|Study Terminated By Sponsor|1|||
155255734|NCT03260868|560366719|FG000|Overall Study|Other than specified above|1|||
155255735|NCT03260868|560366720|FG001|Overall Study|Other than specified above|0|||
155255736|NCT00541450|560366721|FG000|Phase A|Adverse Event|3|||
155255737|NCT00541450|560366722|FG001|Phase A|Adverse Event|0|||
155255738|NCT00541450|560366721|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
155255739|NCT00541450|560366722|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
155255740|NCT00541450|560366721|FG000|Phase A|Hyperglycemia|0|||
155255741|NCT00541450|560366722|FG001|Phase A|Hyperglycemia|1|||
155255742|NCT00541450|560366721|FG000|Phase A|Lost to Follow-up|6|||
155255743|NCT00541450|560366722|FG001|Phase A|Lost to Follow-up|4|||
155255744|NCT00541450|560366721|FG000|Phase A|Physician Decision|2|||
155255745|NCT00541450|560366722|FG001|Phase A|Physician Decision|0|||
155255746|NCT00541450|560366721|FG000|Phase A|Protocol Violation|2|||
155255747|NCT00541450|560366722|FG001|Phase A|Protocol Violation|3|||
155255748|NCT00541450|560366721|FG000|Phase A|Withdrawal by Subject|7|||
155255749|NCT00541450|560366722|FG001|Phase A|Withdrawal by Subject|7|||
155255750|NCT00541450|560366721|FG000|Phase B|Adverse Event|6|||
155255751|NCT00541450|560366722|FG001|Phase B|Adverse Event|6|||
155255752|NCT00541450|560366721|FG000|Phase B|Hyperglycemia|10|||
155255753|NCT00541450|560366722|FG001|Phase B|Hyperglycemia|9|||
155255754|NCT00541450|560366721|FG000|Phase B|Lost to Follow-up|6|||
155255755|NCT00541450|560366722|FG001|Phase B|Lost to Follow-up|4|||
155255756|NCT00541450|560366721|FG000|Phase B|Physician Decision|4|||
155255757|NCT00541450|560366722|FG001|Phase B|Physician Decision|2|||
155255758|NCT00541450|560366721|FG000|Phase B|Pregnancy|0|||
155255759|NCT00541450|560366722|FG001|Phase B|Pregnancy|1|||
155255760|NCT00541450|560366721|FG000|Phase B|Protocol Violation|3|||
155255761|NCT00541450|560366722|FG001|Phase B|Protocol Violation|3|||
155255762|NCT00541450|560366721|FG000|Phase B|Withdrawal by Subject|8|||
155255763|NCT00541450|560366722|FG001|Phase B|Withdrawal by Subject|6|||
155255764|NCT01112579|560366723|FG000|Overall Study|Missed Visit|1|||
155255765|NCT01112579|560366724|FG001|Overall Study|Missed Visit|1|||
155255766|NCT01112579|560366723|FG000|Overall Study|Death|0|||
155255767|NCT01112579|560366724|FG001|Overall Study|Death|2|||
155255768|NCT03645759|560366725|FG000|Overall Study|Lost to Follow-up|3|||
155255769|NCT03645759|560366726|FG001|Overall Study|Lost to Follow-up|2|||
155255770|NCT00902694|560366727|FG000|Overall Study|Death|1|||
155255771|NCT00902694|560366728|FG001|Overall Study|Death|3|||
155255772|NCT00902694|560366727|FG000|Overall Study|Lost to Follow-up|1|||
155255773|NCT00902694|560366728|FG001|Overall Study|Lost to Follow-up|0|||
155255774|NCT00902694|560366727|FG000|Overall Study|Censored per protocol|3|||
155255775|NCT00902694|560366728|FG001|Overall Study|Censored per protocol|1|||
155255776|NCT00902694|560366727|FG000|Overall Study|Pregnancy|1|||
155255777|NCT00902694|560366728|FG001|Overall Study|Pregnancy|1|||
155255778|NCT00902694|560366727|FG000|Overall Study|Incarceration|1|||
155255779|NCT00902694|560366728|FG001|Overall Study|Incarceration|0|||
155255780|NCT00725296|560366729|FG000|Overall Study|Adverse Event|11|||
155255781|NCT00725296|560366729|FG000|Overall Study|Lack of Efficacy|7|||
155255782|NCT00725296|560366729|FG000|Overall Study|Withdrawal by Subject|3|||
155255783|NCT00725296|560366729|FG000|Overall Study|Non-Compliance|2|||
155255784|NCT00725296|560366729|FG000|Overall Study|Lost to Follow-up|1|||
155255785|NCT00725296|560366729|FG000|Overall Study|Other|38|||
155255786|NCT03360942|560366730|FG000|Overall Study|Device explanted|2|||
155255787|NCT03360942|560366730|FG000|Overall Study|Study closure|1|||
155255788|NCT03360942|560366730|FG000|Overall Study|Withdrawal by Subject|2|||
155255789|NCT03456700|560366731|FG000|Overall Study|Withdrawal by Subject|1|||
155255790|NCT00613951|560366734|FG000|Overall Study|Adverse Event|1|||
155255791|NCT00613951|560366735|FG001|Overall Study|Adverse Event|0|||
155255792|NCT00613951|560366736|FG002|Overall Study|Adverse Event|1|||
155255793|NCT00613951|560366734|FG000|Overall Study|Lack of Efficacy|0|||
155255794|NCT00613951|560366735|FG001|Overall Study|Lack of Efficacy|1|||
155255795|NCT00613951|560366736|FG002|Overall Study|Lack of Efficacy|1|||
155255796|NCT00613951|560366734|FG000|Overall Study|Protocol Violation|1|||
155255797|NCT00613951|560366735|FG001|Overall Study|Protocol Violation|1|||
155255798|NCT00613951|560366736|FG002|Overall Study|Protocol Violation|1|||
155255799|NCT00613951|560366734|FG000|Overall Study|Unclassified|5|||
155255800|NCT00613951|560366735|FG001|Overall Study|Unclassified|3|||
155255801|NCT00613951|560366736|FG002|Overall Study|Unclassified|2|||
155255802|NCT00655980|560366738|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
155255803|NCT00655980|560366739|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
155255804|NCT00655980|560366740|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
155255805|NCT05540522|560366742|FG000|Overall Study|Adverse Event|1|||
155255806|NCT05540522|560366743|FG001|Overall Study|Adverse Event|0|||
155255807|NCT05540522|560366744|FG002|Overall Study|Adverse Event|2|||
155255808|NCT05540522|560366745|FG003|Overall Study|Adverse Event|5|||
155255809|NCT05540522|560366742|FG000|Overall Study|Lost to Follow-up|487|||
155255810|NCT05540522|560366743|FG001|Overall Study|Lost to Follow-up|427|||
155255811|NCT05540522|560366744|FG002|Overall Study|Lost to Follow-up|146|||
155255812|NCT05540522|560366745|FG003|Overall Study|Lost to Follow-up|166|||
155255813|NCT05540522|560366742|FG000|Overall Study|Physician Decision|11|||
155255814|NCT05540522|560366743|FG001|Overall Study|Physician Decision|19|||
155255815|NCT05540522|560366744|FG002|Overall Study|Physician Decision|8|||
155255816|NCT05540522|560366745|FG003|Overall Study|Physician Decision|13|||
155255817|NCT05540522|560366742|FG000|Overall Study|Pregnancy|1|||
155255818|NCT05540522|560366743|FG001|Overall Study|Pregnancy|0|||
155255819|NCT05540522|560366744|FG002|Overall Study|Pregnancy|0|||
155255820|NCT05540522|560366745|FG003|Overall Study|Pregnancy|0|||
155255821|NCT05540522|560366742|FG000|Overall Study|Protocol Violation|3|||
155255822|NCT05540522|560366743|FG001|Overall Study|Protocol Violation|1|||
155255823|NCT05540522|560366744|FG002|Overall Study|Protocol Violation|9|||
155255824|NCT05540522|560366745|FG003|Overall Study|Protocol Violation|7|||
155255825|NCT05540522|560366742|FG000|Overall Study|Withdrawal by Subject|168|||
155255826|NCT05540522|560366743|FG001|Overall Study|Withdrawal by Subject|134|||
155255827|NCT05540522|560366744|FG002|Overall Study|Withdrawal by Subject|331|||
155255828|NCT05540522|560366745|FG003|Overall Study|Withdrawal by Subject|322|||
155255829|NCT05540522|560366742|FG000|Overall Study|Death|7|||
155255830|NCT05540522|560366743|FG001|Overall Study|Death|9|||
155255831|NCT05540522|560366744|FG002|Overall Study|Death|49|||
155255832|NCT05540522|560366745|FG003|Overall Study|Death|46|||
155255833|NCT05540522|560366742|FG000|Overall Study|Not vaccinated|34|||
155255834|NCT05540522|560366743|FG001|Overall Study|Not vaccinated|53|||
155255835|NCT05540522|560366744|FG002|Overall Study|Not vaccinated|57|||
155255836|NCT05540522|560366745|FG003|Overall Study|Not vaccinated|50|||
155255837|NCT05540522|560366742|FG000|Overall Study|No longer meets eligibility criteria|0|||
155255838|NCT05540522|560366743|FG001|Overall Study|No longer meets eligibility criteria|0|||
155255839|NCT05540522|560366744|FG002|Overall Study|No longer meets eligibility criteria|3|||
155255840|NCT05540522|560366745|FG003|Overall Study|No longer meets eligibility criteria|2|||
155255841|NCT05540522|560366742|FG000|Overall Study|Other (Unspecified)|8|||
155255842|NCT05540522|560366743|FG001|Overall Study|Other (Unspecified)|10|||
155255843|NCT05540522|560366744|FG002|Overall Study|Other (Unspecified)|4|||
155255844|NCT05540522|560366745|FG003|Overall Study|Other (Unspecified)|2|||
155255845|NCT02459574|560366749|FG000|Overall Study|Withdrawal by Subject|6|||
155255846|NCT02459574|560366750|FG001|Overall Study|Withdrawal by Subject|6|||
155255847|NCT02459574|560366751|FG002|Overall Study|Withdrawal by Subject|2|||
155255848|NCT02459574|560366749|FG000|Overall Study|Lost to Follow-up|1|||
155255849|NCT02459574|560366750|FG001|Overall Study|Lost to Follow-up|1|||
155255850|NCT02459574|560366751|FG002|Overall Study|Lost to Follow-up|0|||
155255851|NCT02459574|560366749|FG000|Overall Study|Death|0|||
155255852|NCT02459574|560366750|FG001|Overall Study|Death|1|||
155255853|NCT02459574|560366751|FG002|Overall Study|Death|0|||
155255854|NCT04508699|560366757|FG000|Overall Study|Lack of Efficacy|2|||
155255855|NCT04508699|560366758|FG001|Overall Study|Lack of Efficacy|15|||
155255856|NCT04508699|560366757|FG000|Overall Study|Withdrawal by Subject|0|||
155255857|NCT04508699|560366758|FG001|Overall Study|Withdrawal by Subject|2|||
155255858|NCT04866017|560366759|FG000|Overall Study|Study Terminated by Sponsor|13|||
155255859|NCT04866017|560366760|FG001|Overall Study|Study Terminated by Sponsor|14|||
155255860|NCT04866017|560366761|FG002|Overall Study|Study Terminated by Sponsor|13|||
155255861|NCT04866017|560366759|FG000|Overall Study|Death|8|||
155255862|NCT04866017|560366760|FG001|Overall Study|Death|4|||
155255863|NCT04866017|560366761|FG002|Overall Study|Death|8|||
155255864|NCT04866017|560366759|FG000|Overall Study|Withdrawal by Subject|1|||
155255865|NCT04866017|560366760|FG001|Overall Study|Withdrawal by Subject|0|||
155255866|NCT04866017|560366761|FG002|Overall Study|Withdrawal by Subject|1|||
155255867|NCT04866017|560366759|FG000|Overall Study|Physician Decision|0|||
155255868|NCT04866017|560366760|FG001|Overall Study|Physician Decision|1|||
155255869|NCT04866017|560366761|FG002|Overall Study|Physician Decision|0|||
155255870|NCT00506493|560366762|FG000|Overall Study|Death|6|||
155255871|NCT00506493|560366762|FG000|Overall Study|Withdrawal by Subject|5|||
155255872|NCT01266642|560366763|FG000|Overall Study|Protocol Violation|0|||
155255873|NCT01266642|560366764|FG001|Overall Study|Protocol Violation|1|||
155255874|NCT01735201|560368094|FG000|Overall Study|Adverse Event|1|||
155255875|NCT01735201|560368095|FG001|Overall Study|Adverse Event|1|||
155255876|NCT01735201|560368096|FG002|Overall Study|Adverse Event|0|||
155255877|NCT01735201|560368097|FG003|Overall Study|Adverse Event|1|||
155255878|NCT01735201|560368098|FG004|Overall Study|Adverse Event|1|||
155255879|NCT01735201|560368099|FG005|Overall Study|Adverse Event|3|||
155255880|NCT01735201|560368100|FG006|Overall Study|Adverse Event|2|||
155255881|NCT01735201|560368101|FG007|Overall Study|Adverse Event|1|||
155255882|NCT01735201|560368094|FG000|Overall Study|Personal Reasons|1|||
155255883|NCT01735201|560368095|FG001|Overall Study|Personal Reasons|0|||
155255884|NCT01735201|560368096|FG002|Overall Study|Personal Reasons|0|||
155255885|NCT01735201|560368097|FG003|Overall Study|Personal Reasons|0|||
155255886|NCT01735201|560368098|FG004|Overall Study|Personal Reasons|0|||
155255887|NCT01735201|560368099|FG005|Overall Study|Personal Reasons|0|||
155255888|NCT01735201|560368100|FG006|Overall Study|Personal Reasons|0|||
155255889|NCT01735201|560368101|FG007|Overall Study|Personal Reasons|0|||
155255890|NCT01735201|560368094|FG000|Overall Study|Protocol Violation|1|||
155255891|NCT01735201|560368095|FG001|Overall Study|Protocol Violation|0|||
155255892|NCT01735201|560368096|FG002|Overall Study|Protocol Violation|0|||
155255893|NCT01735201|560368097|FG003|Overall Study|Protocol Violation|0|||
155255894|NCT01735201|560368098|FG004|Overall Study|Protocol Violation|0|||
155255895|NCT01735201|560368099|FG005|Overall Study|Protocol Violation|0|||
155255896|NCT01735201|560368100|FG006|Overall Study|Protocol Violation|0|||
155255897|NCT01735201|560368101|FG007|Overall Study|Protocol Violation|0|||
155255898|NCT01735201|560368094|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155255899|NCT01735201|560368095|FG001|Overall Study|Other Miscellaneous Reasons|0|||
155255900|NCT01735201|560368096|FG002|Overall Study|Other Miscellaneous Reasons|0|||
155255901|NCT01735201|560368097|FG003|Overall Study|Other Miscellaneous Reasons|1|||
155255902|NCT01735201|560368098|FG004|Overall Study|Other Miscellaneous Reasons|0|||
155255903|NCT01735201|560368099|FG005|Overall Study|Other Miscellaneous Reasons|2|||
155255904|NCT01735201|560368100|FG006|Overall Study|Other Miscellaneous Reasons|1|||
155255905|NCT01735201|560368101|FG007|Overall Study|Other Miscellaneous Reasons|1|||
155255906|NCT02178059|560368107|FG000|Washout|Physician Decision|1|||
155255907|NCT02178059|560368108|FG001|Washout|Physician Decision|0|||
155255908|NCT00289887|560368109|FG000|Overall Study|Adverse Event|3|||
155255909|NCT00289887|560368110|FG001|Overall Study|Adverse Event|3|||
155255910|NCT00289887|560368109|FG000|Overall Study|Lack of Efficacy|3|||
155255911|NCT00289887|560368110|FG001|Overall Study|Lack of Efficacy|11|||
155255912|NCT00289887|560368109|FG000|Overall Study|Lost to Follow-up|3|||
155255913|NCT00289887|560368110|FG001|Overall Study|Lost to Follow-up|3|||
155255914|NCT00289887|560368109|FG000|Overall Study|Protocol Violation|3|||
155255915|NCT00289887|560368110|FG001|Overall Study|Protocol Violation|1|||
155255916|NCT00289887|560368109|FG000|Overall Study|Withdrawal by Subject|3|||
155255917|NCT00289887|560368110|FG001|Overall Study|Withdrawal by Subject|8|||
155255918|NCT00289887|560368109|FG000|Overall Study|Other|7|||
155255919|NCT00289887|560368110|FG001|Overall Study|Other|3|||
155255920|NCT00175825|560368111|FG000|Overall Study|Adverse Event|3|||
155255921|NCT00175825|560368112|FG001|Overall Study|Adverse Event|2|||
155255922|NCT00175825|560368113|FG002|Overall Study|Adverse Event|1|||
155255923|NCT00175825|560368114|FG003|Overall Study|Adverse Event|1|||
155255924|NCT00175825|560368111|FG000|Overall Study|Lost to Follow-up|1|||
155255925|NCT00175825|560368112|FG001|Overall Study|Lost to Follow-up|2|||
155255926|NCT00175825|560368113|FG002|Overall Study|Lost to Follow-up|0|||
155255927|NCT00175825|560368114|FG003|Overall Study|Lost to Follow-up|0|||
155255928|NCT00175825|560368111|FG000|Overall Study|Withdrawal by Subject|1|||
155255929|NCT00175825|560368112|FG001|Overall Study|Withdrawal by Subject|0|||
155255930|NCT00175825|560368113|FG002|Overall Study|Withdrawal by Subject|0|||
155255931|NCT00175825|560368114|FG003|Overall Study|Withdrawal by Subject|0|||
155255932|NCT04098406|560368115|FG000|Overall Study|Adverse Event|2|||
155255933|NCT04098406|560368116|FG001|Overall Study|Adverse Event|1|||
155255934|NCT04098406|560368115|FG000|Overall Study|Withdrawal by Subject|1|||
155255935|NCT04098406|560368116|FG001|Overall Study|Withdrawal by Subject|0|||
155255936|NCT02001194|560368117|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
155255937|NCT02001194|560368118|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
155255938|NCT02001194|560368119|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
155255939|NCT02001194|560368120|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
155255940|NCT02001194|560368117|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
155255941|NCT02001194|560368118|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
155255942|NCT02001194|560368119|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
155255943|NCT02001194|560368120|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
155255944|NCT03040713|560368121|FG000|Overall Study|Positive amyloid scan|3|||
155255945|NCT03338894|560368126|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
155255946|NCT00952367|560368133|FG000|Overall Study|Withdrawal by Subject|2|||
155255947|NCT00952367|560368133|FG000|Overall Study|Noncoordination|1|||
155255948|NCT00952367|560368133|FG000|Overall Study|Protocol Violation|3|||
155255949|NCT01040260|560368134|FG000|Overall Study|Withdrawal by Subject|12|||
155255950|NCT01040260|560368135|FG001|Overall Study|Withdrawal by Subject|6|||
155255951|NCT01040260|560368134|FG000|Overall Study|Lost to Follow-up|3|||
155255952|NCT01040260|560368135|FG001|Overall Study|Lost to Follow-up|5|||
155255953|NCT01113502|560368139|FG000|Overall Study|Withdrawal by Subject|1|||
155255954|NCT01113502|560368140|FG001|Overall Study|Withdrawal by Subject|0|||
155255955|NCT01113502|560368141|FG002|Overall Study|Withdrawal by Subject|1|||
155255956|NCT01113502|560368142|FG003|Overall Study|Withdrawal by Subject|1|||
155255957|NCT01113502|560368143|FG004|Overall Study|Withdrawal by Subject|0|||
155255958|NCT01113502|560368139|FG000|Overall Study|Adverse Event|0|||
155255959|NCT01113502|560368140|FG001|Overall Study|Adverse Event|0|||
155255960|NCT01113502|560368141|FG002|Overall Study|Adverse Event|3|||
155255961|NCT01113502|560368142|FG003|Overall Study|Adverse Event|2|||
155255962|NCT01113502|560368143|FG004|Overall Study|Adverse Event|0|||
155255963|NCT00781391|560368146|FG000|Overall Study|never received study drug|24|||
155255964|NCT00781391|560368147|FG001|Overall Study|never received study drug|23|||
155255965|NCT00781391|560368148|FG002|Overall Study|never received study drug|32|||
155255966|NCT00781391|560368146|FG000|Overall Study|Protocol Violation|19|||
155255967|NCT00781391|560368147|FG001|Overall Study|Protocol Violation|17|||
155255968|NCT00781391|560368148|FG002|Overall Study|Protocol Violation|20|||
155255969|NCT00781391|560368146|FG000|Overall Study|Death|789|||
155255970|NCT00781391|560368147|FG001|Overall Study|Death|730|||
155255971|NCT00781391|560368148|FG002|Overall Study|Death|706|||
155255972|NCT00781391|560368146|FG000|Overall Study|Withdrawal by Subject|47|||
155255973|NCT00781391|560368147|FG001|Overall Study|Withdrawal by Subject|37|||
155255974|NCT00781391|560368148|FG002|Overall Study|Withdrawal by Subject|25|||
155255975|NCT00781391|560368146|FG000|Overall Study|Lost to Follow-up|0|||
155255976|NCT00781391|560368147|FG001|Overall Study|Lost to Follow-up|0|||
155255977|NCT00781391|560368148|FG002|Overall Study|Lost to Follow-up|1|||
155255978|NCT00708916|560368150|FG000|Overall Study|Subject Noncompliance|2|||
155255979|NCT00708916|560368150|FG000|Overall Study|Adverse Event|2|||
155255980|NCT01984684|560368152|FG000|Overall Study|Lost to Follow-up|25|||
155255981|NCT01984684|560368153|FG001|Overall Study|Lost to Follow-up|24|||
155255982|NCT01984684|560368152|FG000|Overall Study|Adverse Event|8|||
155255983|NCT01984684|560368153|FG001|Overall Study|Adverse Event|12|||
155255984|NCT01984684|560368152|FG000|Overall Study|Withdrawal by Subject|9|||
155255985|NCT01984684|560368153|FG001|Overall Study|Withdrawal by Subject|9|||
155255986|NCT01984684|560368152|FG000|Overall Study|Lack of Efficacy|3|||
155255987|NCT01984684|560368153|FG001|Overall Study|Lack of Efficacy|6|||
155255988|NCT01984684|560368152|FG000|Overall Study|Physician Decision|4|||
155255989|NCT01984684|560368153|FG001|Overall Study|Physician Decision|2|||
155255990|NCT01984684|560368152|FG000|Overall Study|Protocol Violation|4|||
155255991|NCT01984684|560368153|FG001|Overall Study|Protocol Violation|2|||
155255992|NCT01984684|560368152|FG000|Overall Study|Death|0|||
155255993|NCT01984684|560368153|FG001|Overall Study|Death|1|||
155255994|NCT01984684|560368152|FG000|Overall Study|Noncompliance with study drug|2|||
155255995|NCT01984684|560368153|FG001|Overall Study|Noncompliance with study drug|1|||
155255996|NCT01984684|560368152|FG000|Overall Study|Subject incarcerated|1|||
155255997|NCT01984684|560368153|FG001|Overall Study|Subject incarcerated|0|||
155255998|NCT01984684|560368152|FG000|Overall Study|Study drug not available at site|1|||
155255999|NCT01984684|560368153|FG001|Overall Study|Study drug not available at site|1|||
155256000|NCT01984684|560368152|FG000|Overall Study|Subject had inadequate IV access|0|||
155256001|NCT01984684|560368153|FG001|Overall Study|Subject had inadequate IV access|1|||
155256002|NCT02835339|560368156|FG000|Overall Study|Did not receive allocated intervention|13|||
155256003|NCT02835339|560368157|FG001|Overall Study|Did not receive allocated intervention|16|||
155256004|NCT01077544|560368158|FG000|Overall Study|New Cancer Therapy|3|||
155256005|NCT01077544|560368159|FG001|Overall Study|New Cancer Therapy|3|||
155256006|NCT01077544|560368158|FG000|Overall Study|Adverse Event|0|||
155256007|NCT01077544|560368159|FG001|Overall Study|Adverse Event|1|||
155256008|NCT01077544|560368158|FG000|Overall Study|Disease Progression|0|||
155256009|NCT01077544|560368159|FG001|Overall Study|Disease Progression|1|||
155256010|NCT04575051|560368161|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
155256011|NCT04575051|560368162|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
155256012|NCT04575051|560368163|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
155256013|NCT04575051|560368164|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
155256014|NCT04575051|560368165|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
155256015|NCT04575051|560368161|FG000|Time Period 1|Missing follow up|1|||
155256016|NCT04575051|560368162|FG001|Time Period 1|Missing follow up|3|||
155256017|NCT04575051|560368163|FG002|Time Period 1|Missing follow up|1|||
155256018|NCT04575051|560368164|FG003|Time Period 1|Missing follow up|3|||
155256019|NCT04575051|560368165|FG004|Time Period 1|Missing follow up|2|||
155256020|NCT04575051|560368161|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
155256021|NCT04575051|560368162|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
155256022|NCT04575051|560368163|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
155256023|NCT04575051|560368164|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
155256024|NCT04575051|560368165|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
155256025|NCT04575051|560368161|FG000|Time Period 2|Missing follow up|1|||
155256026|NCT04575051|560368162|FG001|Time Period 2|Missing follow up|8|||
155256027|NCT04575051|560368163|FG002|Time Period 2|Missing follow up|7|||
155256028|NCT04575051|560368164|FG003|Time Period 2|Missing follow up|0|||
155256029|NCT04575051|560368165|FG004|Time Period 2|Missing follow up|1|||
155256030|NCT04575051|560368161|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
155256031|NCT04575051|560368162|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
155256032|NCT04575051|560368163|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
155256033|NCT04575051|560368164|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
155256034|NCT04575051|560368165|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
155256035|NCT04575051|560368161|FG000|Time Period 3|Missing follow up|8|||
155256036|NCT04575051|560368162|FG001|Time Period 3|Missing follow up|6|||
155256037|NCT04575051|560368163|FG002|Time Period 3|Missing follow up|4|||
155256038|NCT04575051|560368164|FG003|Time Period 3|Missing follow up|3|||
155256039|NCT04575051|560368165|FG004|Time Period 3|Missing follow up|0|||
155256040|NCT04575051|560368161|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
155256041|NCT04575051|560368162|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
155256042|NCT04575051|560368163|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
155256043|NCT04575051|560368164|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
155256044|NCT04575051|560368165|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
155256045|NCT04575051|560368161|FG000|Time Period 4|Missing follow up|17|||
155256046|NCT04575051|560368162|FG001|Time Period 4|Missing follow up|3|||
155256047|NCT04575051|560368163|FG002|Time Period 4|Missing follow up|4|||
155256048|NCT04575051|560368164|FG003|Time Period 4|Missing follow up|2|||
155256049|NCT04575051|560368165|FG004|Time Period 4|Missing follow up|1|||
155256050|NCT04575051|560368161|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
155256051|NCT04575051|560368162|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
155256052|NCT04575051|560368163|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
155256053|NCT04575051|560368164|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
155256054|NCT04575051|560368165|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
155256055|NCT04575051|560368161|FG000|Time Period 5|Missing follow up|11|||
155256056|NCT04575051|560368162|FG001|Time Period 5|Missing follow up|8|||
155256057|NCT04575051|560368163|FG002|Time Period 5|Missing follow up|12|||
155256058|NCT04575051|560368164|FG003|Time Period 5|Missing follow up|3|||
155256059|NCT04575051|560368165|FG004|Time Period 5|Missing follow up|11|||
155256060|NCT03624504|560368166|FG000|Overall Study|Unsuccessful Implant|1|||
155256061|NCT02862457|560368167|FG000|Overall Study|Death|1|||
155256062|NCT02862457|560368168|FG001|Overall Study|Death|3|||
155256063|NCT02862457|560368169|FG002|Overall Study|Death|2|||
155256064|NCT02862457|560368170|FG003|Overall Study|Death|3|||
155256065|NCT02862457|560368171|FG004|Overall Study|Death|0|||
155256066|NCT02862457|560368172|FG005|Overall Study|Death|2|||
155256067|NCT02862457|560368173|FG006|Overall Study|Death|1|||
155256068|NCT02862457|560368167|FG000|Overall Study|Lost to Follow-up|1|||
155256069|NCT02862457|560368168|FG001|Overall Study|Lost to Follow-up|0|||
155256070|NCT02862457|560368169|FG002|Overall Study|Lost to Follow-up|0|||
155256071|NCT02862457|560368170|FG003|Overall Study|Lost to Follow-up|1|||
155256072|NCT02862457|560368171|FG004|Overall Study|Lost to Follow-up|0|||
155256073|NCT02862457|560368172|FG005|Overall Study|Lost to Follow-up|0|||
155256074|NCT02862457|560368173|FG006|Overall Study|Lost to Follow-up|0|||
155256075|NCT02862457|560368167|FG000|Overall Study|Withdrawal by Subject|0|||
155256076|NCT02862457|560368168|FG001|Overall Study|Withdrawal by Subject|0|||
155256077|NCT02862457|560368169|FG002|Overall Study|Withdrawal by Subject|1|||
155256078|NCT02862457|560368170|FG003|Overall Study|Withdrawal by Subject|0|||
155256079|NCT02862457|560368171|FG004|Overall Study|Withdrawal by Subject|0|||
155256080|NCT02862457|560368172|FG005|Overall Study|Withdrawal by Subject|1|||
155256081|NCT02862457|560368173|FG006|Overall Study|Withdrawal by Subject|0|||
155256082|NCT00951483|560368174|FG000|Overall Study|Physician Decision|4|||
155256083|NCT00951483|560368175|FG001|Overall Study|Physician Decision|0|||
155256084|NCT00951483|560368174|FG000|Overall Study|Withdrawal by Subject|15|||
155256085|NCT00951483|560368175|FG001|Overall Study|Withdrawal by Subject|0|||
155256086|NCT03364751|560368176|FG000|Overall Study|Withdrawal by Subject|1|||
155256087|NCT03364751|560368177|FG001|Overall Study|Withdrawal by Subject|0|||
155256088|NCT03364751|560368178|FG002|Overall Study|Withdrawal by Subject|0|||
155256089|NCT03364751|560368179|FG003|Overall Study|Withdrawal by Subject|0|||
155256090|NCT03364751|560368176|FG000|Overall Study|Lost to Follow-up|0|||
155256091|NCT03364751|560368177|FG001|Overall Study|Lost to Follow-up|1|||
155256092|NCT03364751|560368178|FG002|Overall Study|Lost to Follow-up|0|||
155256093|NCT03364751|560368179|FG003|Overall Study|Lost to Follow-up|0|||
155256094|NCT04542018|560368180|FG000|Overall Study|Withdrawal by Subject|0|||
155256095|NCT04542018|560368181|FG001|Overall Study|Withdrawal by Subject|0|||
155256096|NCT04542018|560368182|FG002|Overall Study|Withdrawal by Subject|4|||
155256097|NCT04542018|560368180|FG000|Overall Study|Protocol Violation|0|||
155256098|NCT04542018|560368181|FG001|Overall Study|Protocol Violation|0|||
155256099|NCT04542018|560368182|FG002|Overall Study|Protocol Violation|2|||
155256100|NCT00689221|560368183|FG000|Overall Study|Ongoing at cut-off date|39|||
155256101|NCT00689221|560368184|FG001|Overall Study|Ongoing at cut-off date|36|||
155256102|NCT01939548|560368189|FG000|Overall Study|Non compliance|0|||
155256103|NCT01939548|560368190|FG001|Overall Study|Non compliance|2|||
155256104|NCT01939548|560368191|FG002|Overall Study|Non compliance|0|||
155256105|NCT01939548|560368189|FG000|Overall Study|Study Terminated by Sponsor|17|||
155256106|NCT01939548|560368190|FG001|Overall Study|Study Terminated by Sponsor|19|||
155256107|NCT01939548|560368191|FG002|Overall Study|Study Terminated by Sponsor|12|||
155256108|NCT01939548|560368189|FG000|Overall Study|Insufficient Clinical Response|1|||
155256109|NCT01939548|560368190|FG001|Overall Study|Insufficient Clinical Response|0|||
155256110|NCT01939548|560368191|FG002|Overall Study|Insufficient Clinical Response|0|||
155256111|NCT01939548|560368189|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
155256112|NCT01939548|560368190|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
155256113|NCT01939548|560368191|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
155256114|NCT01939548|560368189|FG000|Overall Study|Withdrawal by Subject|4|||
155256115|NCT01939548|560368190|FG001|Overall Study|Withdrawal by Subject|4|||
155256116|NCT01939548|560368191|FG002|Overall Study|Withdrawal by Subject|1|||
155256117|NCT01939548|560368189|FG000|Overall Study|Protocol Violation|7|||
155256118|NCT01939548|560368190|FG001|Overall Study|Protocol Violation|6|||
155256119|NCT01939548|560368191|FG002|Overall Study|Protocol Violation|5|||
155256120|NCT01939548|560368189|FG000|Overall Study|Lost to Follow-up|5|||
155256121|NCT01939548|560368190|FG001|Overall Study|Lost to Follow-up|5|||
155256122|NCT01939548|560368191|FG002|Overall Study|Lost to Follow-up|3|||
155256123|NCT01939548|560368189|FG000|Overall Study|Adverse Event|2|||
155256124|NCT01939548|560368190|FG001|Overall Study|Adverse Event|9|||
155256125|NCT01939548|560368191|FG002|Overall Study|Adverse Event|7|||
155256126|NCT01939548|560368189|FG000|Overall Study|Death|0|||
155256127|NCT01939548|560368190|FG001|Overall Study|Death|0|||
155256128|NCT01939548|560368191|FG002|Overall Study|Death|1|||
155256129|NCT01939548|560368189|FG000|Overall Study|Participant dropped|0|||
155256130|NCT01939548|560368190|FG001|Overall Study|Participant dropped|0|||
155256131|NCT01939548|560368191|FG002|Overall Study|Participant dropped|1|||
155256132|NCT01939548|560368189|FG000|Overall Study|Participant unwilling to continue|0|||
155256133|NCT01939548|560368190|FG001|Overall Study|Participant unwilling to continue|1|||
155256134|NCT01939548|560368191|FG002|Overall Study|Participant unwilling to continue|0|||
155256135|NCT01939548|560368189|FG000|Overall Study|Participant withdrew consent|0|||
155256136|NCT01939548|560368190|FG001|Overall Study|Participant withdrew consent|2|||
155256137|NCT01939548|560368191|FG002|Overall Study|Participant withdrew consent|0|||
155256138|NCT01939548|560368189|FG000|Overall Study|Did not complete follow-up|0|||
155256139|NCT01939548|560368190|FG001|Overall Study|Did not complete follow-up|1|||
155256140|NCT01939548|560368191|FG002|Overall Study|Did not complete follow-up|0|||
155256141|NCT03311373|560368192|FG000|Overall Study|Adverse Event|1|||
155256142|NCT03311373|560368192|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
155256143|NCT03311373|560368192|FG000|Overall Study|Lost to Follow-up|1|||
155256144|NCT03311373|560368192|FG000|Overall Study|Physician Decision|1|||
155256145|NCT03311373|560368192|FG000|Overall Study|Withdrawal by Subject|3|||
155256146|NCT01297959|560368195|FG000|Overall Study|Adverse Event|0|||
155256147|NCT01297959|560368196|FG001|Overall Study|Adverse Event|1|||
155256148|NCT01297959|560368195|FG000|Overall Study|Protocol Violation|2|||
155256149|NCT01297959|560368196|FG001|Overall Study|Protocol Violation|1|||
155256150|NCT01297959|560368195|FG000|Overall Study|Withdrawal by Subject|5|||
155256151|NCT01297959|560368196|FG001|Overall Study|Withdrawal by Subject|4|||
155256152|NCT01297959|560368195|FG000|Overall Study|Physician Decision|0|||
155256153|NCT01297959|560368196|FG001|Overall Study|Physician Decision|1|||
155256154|NCT01297959|560368195|FG000|Overall Study|Unrelated medical illness / complication|0|||
155256155|NCT01297959|560368196|FG001|Overall Study|Unrelated medical illness / complication|2|||
155256156|NCT01297959|560368195|FG000|Overall Study|Other|13|||
155256157|NCT01297959|560368196|FG001|Overall Study|Other|7|||
155256158|NCT00344461|560368197|FG000|Overall Study|Adverse Event|6|||
155256159|NCT00344461|560368197|FG000|Overall Study|Death|1|||
155256160|NCT00344461|560368197|FG000|Overall Study|Lack of Efficacy|2|||
155256161|NCT00344461|560368197|FG000|Overall Study|Lost to Follow-up|2|||
155256162|NCT00344461|560368197|FG000|Overall Study|Physician Decision|2|||
155256163|NCT00344461|560368197|FG000|Overall Study|Protocol Violation|6|||
155256164|NCT00344461|560368197|FG000|Overall Study|Withdrawal by Subject|2|||
155256165|NCT01667432|560368198|FG000|Overall Study|Premature Study Termination|26|||
155256166|NCT01667432|560368198|FG000|Overall Study|Failure to Return|10|||
155256167|NCT01667432|560368198|FG000|Overall Study|Moved to Another Center|3|||
155256168|NCT01667432|560368198|FG000|Overall Study|Lost to Follow-up|3|||
155256169|NCT01667432|560368198|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
155256170|NCT01667432|560368198|FG000|Overall Study|Insufficient Therapeutic Response|4|||
155256171|NCT01667432|560368198|FG000|Overall Study|Adverse Event|1|||
155256172|NCT01667432|560368198|FG000|Overall Study|Protocol Deviation|2|||
155256173|NCT01667432|560368198|FG000|Overall Study|Principal Investigator Decision|1|||
155256174|NCT01667432|560368198|FG000|Overall Study|Reason Not Specified|2|||
155256175|NCT01667432|560368198|FG000|Overall Study|Missing Information|4|||
155256176|NCT00553696|560368201|FG000|Overall Study|Adverse Event|2|||
155256177|NCT00553696|560368202|FG001|Overall Study|Adverse Event|4|||
155256178|NCT00553696|560368203|FG002|Overall Study|Adverse Event|0|||
155256179|NCT00553696|560368204|FG003|Overall Study|Adverse Event|1|||
155256180|NCT00553696|560368201|FG000|Overall Study|Global deterioration of health status|0|||
155256181|NCT00553696|560368202|FG001|Overall Study|Global deterioration of health status|2|||
155256182|NCT00553696|560368203|FG002|Overall Study|Global deterioration of health status|0|||
155256183|NCT00553696|560368204|FG003|Overall Study|Global deterioration of health status|0|||
155256184|NCT00553696|560368201|FG000|Overall Study|Objective progression or relapse|2|||
155256185|NCT00553696|560368202|FG001|Overall Study|Objective progression or relapse|9|||
155256186|NCT00553696|560368203|FG002|Overall Study|Objective progression or relapse|6|||
155256187|NCT00553696|560368204|FG003|Overall Study|Objective progression or relapse|0|||
155256188|NCT00553696|560368201|FG000|Overall Study|Withdrawal by Subject|0|||
155256189|NCT00553696|560368202|FG001|Overall Study|Withdrawal by Subject|1|||
155256190|NCT00553696|560368203|FG002|Overall Study|Withdrawal by Subject|0|||
155256191|NCT00553696|560368204|FG003|Overall Study|Withdrawal by Subject|0|||
155256192|NCT00686881|560368207|FG000|Overall Study|Withdrawal by Subject|11|||
155256193|NCT00686881|560368208|FG001|Overall Study|Withdrawal by Subject|18|||
155256194|NCT00686881|560368207|FG000|Overall Study|Lost to Follow-up|0|||
155256195|NCT00686881|560368208|FG001|Overall Study|Lost to Follow-up|1|||
155256196|NCT00686881|560368207|FG000|Overall Study|Treatment-related adverse event|10|||
155256197|NCT00686881|560368208|FG001|Overall Study|Treatment-related adverse event|9|||
155256198|NCT00686881|560368207|FG000|Overall Study|Met discontinuation criteria|5|||
155256199|NCT00686881|560368208|FG001|Overall Study|Met discontinuation criteria|0|||
155256200|NCT00686881|560368207|FG000|Overall Study|Onset of malignant tumor|11|||
155256201|NCT00686881|560368208|FG001|Overall Study|Onset of malignant tumor|11|||
155256202|NCT00686881|560368207|FG000|Overall Study|Lack of Efficacy|4|||
155256203|NCT00686881|560368208|FG001|Overall Study|Lack of Efficacy|3|||
155256204|NCT00686881|560368207|FG000|Overall Study|Physician Decision|1|||
155256205|NCT00686881|560368208|FG001|Overall Study|Physician Decision|0|||
155256206|NCT00686881|560368207|FG000|Overall Study|Circumstances of site|1|||
155256207|NCT00686881|560368208|FG001|Overall Study|Circumstances of site|1|||
155256208|NCT00686881|560368207|FG000|Overall Study|Did not meet protocol eligibility|1|||
155256209|NCT00686881|560368208|FG001|Overall Study|Did not meet protocol eligibility|0|||
155256210|NCT00686881|560368207|FG000|Overall Study|Irregular visits|1|||
155256211|NCT00686881|560368208|FG001|Overall Study|Irregular visits|0|||
155256212|NCT00686881|560368207|FG000|Overall Study|Study discontinuation|35|||
155256213|NCT00686881|560368208|FG001|Overall Study|Study discontinuation|32|||
155256214|NCT00686881|560368207|FG000|Overall Study|Never received study drug|2|||
155256215|NCT00686881|560368208|FG001|Overall Study|Never received study drug|6|||
155256216|NCT02085252|560368211|FG000|Overall Study|Withdrawal of Consent|1|||
155256217|NCT02085252|560368212|FG001|Overall Study|Withdrawal of Consent|0|||
155256218|NCT02085252|560368211|FG000|Overall Study|Adverse Event|0|||
155256219|NCT02085252|560368212|FG001|Overall Study|Adverse Event|1|||
155256220|NCT02085252|560368211|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
155256221|NCT02085252|560368212|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
155256222|NCT02085252|560368211|FG000|Overall Study|Reason Not Specified|0|||
155256223|NCT02085252|560368212|FG001|Overall Study|Reason Not Specified|1|||
155256224|NCT02085252|560368211|FG000|Overall Study|Reason Unknown|0|||
155256225|NCT02085252|560368212|FG001|Overall Study|Reason Unknown|1|||
155256226|NCT00671931|560368213|FG000|Overall Study|Physician Decision|1|||
155256227|NCT00671931|560368214|FG001|Overall Study|Physician Decision|0|||
155256228|NCT00671931|560368215|FG002|Overall Study|Physician Decision|0|||
155256229|NCT00671931|560368216|FG003|Overall Study|Physician Decision|2|||
155256230|NCT00671931|560368217|FG004|Overall Study|Physician Decision|1|||
155256231|NCT02925676|560368219|FG000|Overall Study|Withdrawal by Subject|1|||
155256232|NCT02291679|560368220|FG000|Overall Study|Adverse Event|2|||
155256233|NCT02291679|560368221|FG001|Overall Study|Adverse Event|12|||
155256234|NCT02291679|560368222|FG002|Overall Study|Adverse Event|19|||
155256235|NCT02291679|560368220|FG000|Overall Study|Protocol Violation|5|||
155256236|NCT02291679|560368221|FG001|Overall Study|Protocol Violation|1|||
155256237|NCT02291679|560368222|FG002|Overall Study|Protocol Violation|7|||
155256238|NCT02291679|560368220|FG000|Overall Study|Withdrew Consent|18|||
155256239|NCT02291679|560368221|FG001|Overall Study|Withdrew Consent|10|||
155256240|NCT02291679|560368222|FG002|Overall Study|Withdrew Consent|15|||
155256241|NCT02291679|560368220|FG000|Overall Study|Lost to Follow-up|12|||
155256242|NCT02291679|560368221|FG001|Overall Study|Lost to Follow-up|10|||
155256243|NCT02291679|560368222|FG002|Overall Study|Lost to Follow-up|9|||
155256244|NCT02291679|560368220|FG000|Overall Study|Insufficient Therapeutic Response|5|||
155256245|NCT02291679|560368221|FG001|Overall Study|Insufficient Therapeutic Response|5|||
155256246|NCT02291679|560368222|FG002|Overall Study|Insufficient Therapeutic Response|7|||
155256247|NCT02291679|560368220|FG000|Overall Study|Other|2|||
155256248|NCT02291679|560368221|FG001|Overall Study|Other|4|||
155256249|NCT02291679|560368222|FG002|Overall Study|Other|2|||
155256250|NCT02048072|560368223|FG000|Overall Study|Adverse Event|3|||
155256251|NCT02048072|560368223|FG000|Overall Study|Lost to Follow-up|1|||
155256252|NCT01648270|560368224|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
155256253|NCT04969263|560368225|FG000|Overall Study|Death|1|||
155256254|NCT04969263|560368225|FG000|Overall Study|Lost to Follow-up|2|||
155256255|NCT04969263|560368225|FG000|Overall Study|Withdrawal by Subject|5|||
155256256|NCT04969263|560368225|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
155256257|NCT04154787|560368226|FG000|Overall Study|Adverse Event|0|||
155256258|NCT04154787|560368227|FG001|Overall Study|Adverse Event|1|||
155256259|NCT04154787|560368228|FG002|Overall Study|Adverse Event|0|||
155256260|NCT04154787|560368226|FG000|Overall Study|Patient Requires Other Treatment|0|||
155256261|NCT04154787|560368227|FG001|Overall Study|Patient Requires Other Treatment|1|||
155256262|NCT04154787|560368228|FG002|Overall Study|Patient Requires Other Treatment|0|||
155256263|NCT04154787|560368226|FG000|Overall Study|Study Terminated By Sponsor|0|||
155256264|NCT04154787|560368227|FG001|Overall Study|Study Terminated By Sponsor|6|||
155256265|NCT04154787|560368228|FG002|Overall Study|Study Terminated By Sponsor|1|||
155256266|NCT04154787|560368226|FG000|Overall Study|Subject Decision|0|||
155256267|NCT04154787|560368227|FG001|Overall Study|Subject Decision|1|||
155256268|NCT04154787|560368228|FG002|Overall Study|Subject Decision|0|||
155256269|NCT04154787|560368226|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
155256270|NCT04154787|560368227|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
155256271|NCT04154787|560368228|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
155256272|NCT03053050|560368229|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
155256273|NCT03053050|560368230|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
155256274|NCT03053050|560368231|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
155256275|NCT03053050|560368232|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
155256276|NCT03053050|560368229|FG000|Randomized Phase|Withdrew Consent|16|||
155256277|NCT03053050|560368230|FG001|Randomized Phase|Withdrew Consent|8|||
155256278|NCT03053050|560368231|FG002|Randomized Phase|Withdrew Consent|9|||
155256279|NCT03053050|560368232|FG003|Randomized Phase|Withdrew Consent|0|||
155256280|NCT03053050|560368229|FG000|Randomized Phase|Investigator's Discretion|6|||
155256281|NCT03053050|560368230|FG001|Randomized Phase|Investigator's Discretion|6|||
155256282|NCT03053050|560368231|FG002|Randomized Phase|Investigator's Discretion|3|||
155256283|NCT03053050|560368232|FG003|Randomized Phase|Investigator's Discretion|0|||
155256284|NCT03053050|560368229|FG000|Randomized Phase|Lost to Follow-up|5|||
155256285|NCT03053050|560368230|FG001|Randomized Phase|Lost to Follow-up|1|||
155256286|NCT03053050|560368231|FG002|Randomized Phase|Lost to Follow-up|1|||
155256287|NCT03053050|560368232|FG003|Randomized Phase|Lost to Follow-up|0|||
155256288|NCT03053050|560368229|FG000|Randomized Phase|Adverse Event|0|||
155256289|NCT03053050|560368230|FG001|Randomized Phase|Adverse Event|1|||
155256290|NCT03053050|560368231|FG002|Randomized Phase|Adverse Event|0|||
155256291|NCT03053050|560368232|FG003|Randomized Phase|Adverse Event|0|||
155256292|NCT03053050|560368229|FG000|Randomized Phase|Randomized but Never Treated|2|||
155256293|NCT03053050|560368230|FG001|Randomized Phase|Randomized but Never Treated|2|||
155256294|NCT03053050|560368231|FG002|Randomized Phase|Randomized but Never Treated|2|||
155256295|NCT03053050|560368232|FG003|Randomized Phase|Randomized but Never Treated|0|||
155256296|NCT03053050|560368229|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
155256297|NCT03053050|560368230|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
155256298|NCT03053050|560368231|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
155256299|NCT03053050|560368232|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
155256300|NCT03053050|560368229|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
155256301|NCT03053050|560368230|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
155256302|NCT03053050|560368231|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
155256303|NCT03053050|560368232|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
155256304|NCT03053050|560368229|FG000|Open-label Phase|Withdrew Consent|0|||
155256305|NCT03053050|560368230|FG001|Open-label Phase|Withdrew Consent|0|||
155256306|NCT03053050|560368231|FG002|Open-label Phase|Withdrew Consent|0|||
155256307|NCT03053050|560368232|FG003|Open-label Phase|Withdrew Consent|6|||
155256308|NCT03053050|560368229|FG000|Open-label Phase|Investigator's Discretion|0|||
155256309|NCT03053050|560368230|FG001|Open-label Phase|Investigator's Discretion|0|||
155256310|NCT03053050|560368231|FG002|Open-label Phase|Investigator's Discretion|0|||
155256311|NCT03053050|560368232|FG003|Open-label Phase|Investigator's Discretion|4|||
155256312|NCT00999466|560369784|FG000|Main Part|Withdrawal by Subject|0|||
155256313|NCT00999466|560369785|FG001|Main Part|Withdrawal by Subject|0|||
155256314|NCT00999466|560369786|FG002|Main Part|Withdrawal by Subject|2|||
155256315|NCT00999466|560369784|FG000|Main Part|Adverse Event|0|||
155256316|NCT00999466|560369785|FG001|Main Part|Adverse Event|4|||
155256317|NCT00999466|560369786|FG002|Main Part|Adverse Event|2|||
155256318|NCT01357616|560369787|FG000|Overall Study|Adverse Event|1|||
155256319|NCT01357616|560369788|FG001|Overall Study|Adverse Event|1|||
155256320|NCT01357616|560369787|FG000|Overall Study|Lost to Follow-up|4|||
155256321|NCT01357616|560369788|FG001|Overall Study|Lost to Follow-up|3|||
155256322|NCT01357616|560369787|FG000|Overall Study|Protocol Violation|0|||
155256323|NCT01357616|560369788|FG001|Overall Study|Protocol Violation|2|||
155256324|NCT01357616|560369787|FG000|Overall Study|Inadequate Control of IOP|1|||
155256325|NCT01357616|560369788|FG001|Overall Study|Inadequate Control of IOP|2|||
155256326|NCT01357616|560369787|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
155256327|NCT01357616|560369788|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
155256328|NCT01357616|560369787|FG000|Overall Study|Withdrawal by Subject|1|||
155256329|NCT01357616|560369788|FG001|Overall Study|Withdrawal by Subject|0|||
155256330|NCT03255824|560369796|FG000|Overall Study|Under-sedation|2|||
155256331|NCT03255824|560369797|FG001|Overall Study|Under-sedation|1|||
155256332|NCT03432364|560369801|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
155256333|NCT00522301|560369802|FG000|Overall Study|Withdrawal by Subject|1|||
155256334|NCT00522301|560369802|FG000|Overall Study|Adverse Event|5|||
155256335|NCT01699022|560369805|FG000|Overall Study|Early discontinuation from the study|3|||
155256336|NCT04539821|560369806|FG000|Overall Study|Withdrawal by Subject|2|||
155256337|NCT04539821|560369806|FG000|Overall Study|continued care with their physician|20|||
155256338|NCT04539821|560369806|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
155256339|NCT02066402|560369809|FG000|Overall Study|Adverse Event|1|||
155256340|NCT02066402|560369810|FG001|Overall Study|Adverse Event|2|||
155256341|NCT02066402|560369809|FG000|Overall Study|Lost to Follow-up|11|||
155256342|NCT02066402|560369810|FG001|Overall Study|Lost to Follow-up|8|||
155256343|NCT02066402|560369809|FG000|Overall Study|Withdrawal by Subject|14|||
155256344|NCT02066402|560369810|FG001|Overall Study|Withdrawal by Subject|11|||
155256345|NCT02066402|560369809|FG000|Overall Study|Progressive disease-clinical progression|0|||
155256346|NCT02066402|560369810|FG001|Overall Study|Progressive disease-clinical progression|1|||
155256347|NCT02066402|560369809|FG000|Overall Study|Protocol driven decision point|0|||
155256348|NCT02066402|560369810|FG001|Overall Study|Protocol driven decision point|1|||
155256349|NCT00152464|560369811|FG000|Overall Study|Adverse Event|3|||
155256350|NCT00152464|560369812|FG001|Overall Study|Adverse Event|6|||
155256351|NCT00152464|560369811|FG000|Overall Study|Lost to Follow-up|8|||
155256352|NCT00152464|560369812|FG001|Overall Study|Lost to Follow-up|4|||
155256353|NCT00152464|560369811|FG000|Overall Study|Protocol Violation|3|||
155256354|NCT00152464|560369812|FG001|Overall Study|Protocol Violation|1|||
155256355|NCT00152464|560369811|FG000|Overall Study|Withdrawal by Subject|21|||
155256356|NCT00152464|560369812|FG001|Overall Study|Withdrawal by Subject|22|||
155256357|NCT00152464|560369811|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
155256358|NCT00152464|560369812|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
155256359|NCT00152464|560369811|FG000|Overall Study|Eczema deterioration|0|||
155256360|NCT00152464|560369812|FG001|Overall Study|Eczema deterioration|1|||
155256361|NCT00152464|560369811|FG000|Overall Study|Parent decision|1|||
155256362|NCT00152464|560369812|FG001|Overall Study|Parent decision|1|||
155256363|NCT00152464|560369811|FG000|Overall Study|Investigator decision|1|||
155256364|NCT00152464|560369812|FG001|Overall Study|Investigator decision|0|||
155256365|NCT00152464|560369811|FG000|Overall Study|Lack of Efficacy|1|||
155256366|NCT00152464|560369812|FG001|Overall Study|Lack of Efficacy|0|||
155256367|NCT00152464|560369811|FG000|Overall Study|Eczema poorly controlled|1|||
155256368|NCT00152464|560369812|FG001|Overall Study|Eczema poorly controlled|0|||
155256369|NCT00152464|560369811|FG000|Overall Study|Patient relocated|1|||
155256370|NCT00152464|560369812|FG001|Overall Study|Patient relocated|0|||
155256371|NCT02462876|560369813|FG000|Overall Study|Death|3|||
155256372|NCT02462876|560369813|FG000|Overall Study|Lost to Follow-up|7|||
155256373|NCT02462876|560369813|FG000|Overall Study|Surgical Bypass|9|||
155256374|NCT02462876|560369813|FG000|Overall Study|Amputation Above the Metatarsals|1|||
155256375|NCT02462876|560369813|FG000|Overall Study|36 months follow-up visit missed|1|||
155256376|NCT02462876|560369813|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
155256377|NCT02462876|560369813|FG000|Overall Study|Patient did not come back to the vascular department|1|||
155256378|NCT02462876|560369813|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
155256379|NCT02462876|560369813|FG000|Overall Study|Patient refused to come back|1|||
155256380|NCT02462876|560369813|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
155256381|NCT02462876|560369813|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
155256382|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
155256383|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
155256384|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
155256385|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
155256386|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
155256387|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
155256388|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
155256389|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
155256390|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Other|18|||
155256391|NCT02565914|560369814|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
155256392|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
155256393|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Other|1|||
155256394|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
155256395|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
155256396|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
155256397|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
155256398|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
155256399|NCT02565914|560369814|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
155256400|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
155256401|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
155256402|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
155256403|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
155256404|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
155256405|NCT02565914|560369814|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
155256406|NCT04465357|560369815|FG000|Overall Study|Adverse Event|2|||
155256407|NCT04465357|560369815|FG000|Overall Study|Lack of Efficacy|1|||
155256408|NCT04465357|560369815|FG000|Overall Study|Lost to Follow-up|2|||
155256409|NCT04465357|560369815|FG000|Overall Study|Withdrawal by Subject|6|||
155256410|NCT04465357|560369815|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
155256411|NCT00266825|560369822|FG000|Completed Follow-Up|Lost to Follow-up|14|||
155256412|NCT00266825|560369823|FG001|Completed Follow-Up|Lost to Follow-up|19|||
155256413|NCT00266825|560369822|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
155256414|NCT00266825|560369823|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
155256415|NCT00430248|560369824|FG000|Overall Study|Adverse Event|49|||
155256416|NCT00430248|560369825|FG001|Overall Study|Adverse Event|61|||
155256417|NCT00430248|560369826|FG002|Overall Study|Adverse Event|64|||
155256418|NCT00430248|560369824|FG000|Overall Study|Protocol Violation|10|||
155256419|NCT00430248|560369825|FG001|Overall Study|Protocol Violation|2|||
155256420|NCT00430248|560369826|FG002|Overall Study|Protocol Violation|4|||
155256421|NCT00430248|560369824|FG000|Overall Study|Personal Reasons|12|||
155256422|NCT00430248|560369825|FG001|Overall Study|Personal Reasons|24|||
155256423|NCT00430248|560369826|FG002|Overall Study|Personal Reasons|9|||
155256424|NCT00430248|560369824|FG000|Overall Study|Lost to Follow-up|28|||
155256425|NCT00430248|560369825|FG001|Overall Study|Lost to Follow-up|33|||
155256426|NCT00430248|560369826|FG002|Overall Study|Lost to Follow-up|28|||
155256427|NCT00430248|560369824|FG000|Overall Study|Therapeutic Failure|1|||
155256428|NCT00430248|560369825|FG001|Overall Study|Therapeutic Failure|1|||
155256429|NCT00430248|560369826|FG002|Overall Study|Therapeutic Failure|1|||
155256430|NCT00430248|560369824|FG000|Overall Study|Withdrawal by Subject|14|||
155256431|NCT00430248|560369825|FG001|Overall Study|Withdrawal by Subject|20|||
155256432|NCT00430248|560369826|FG002|Overall Study|Withdrawal by Subject|16|||
155256433|NCT00430248|560369824|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155256434|NCT00430248|560369825|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
155256435|NCT00430248|560369826|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
155256436|NCT00430248|560369824|FG000|Overall Study|Gout Flare|3|||
155256437|NCT00430248|560369825|FG001|Overall Study|Gout Flare|7|||
155256438|NCT00430248|560369826|FG002|Overall Study|Gout Flare|2|||
155256439|NCT00430248|560369824|FG000|Overall Study|Reason Not Specified|8|||
155256440|NCT00430248|560369825|FG001|Overall Study|Reason Not Specified|8|||
155256441|NCT00430248|560369826|FG002|Overall Study|Reason Not Specified|11|||
155256442|NCT01754467|560369827|FG000|Overall Study|Lost to Follow-up|1|||
155256443|NCT01970462|560369828|FG000|Overall Study|Lost to Follow-up|0|||
155256444|NCT01970462|560369829|FG001|Overall Study|Lost to Follow-up|2|||
155256445|NCT02230956|560369830|FG000|Overall Study|Adverse Event|1|||
155256446|NCT02230956|560369831|FG001|Overall Study|Adverse Event|1|||
155256447|NCT02230956|560369832|FG002|Overall Study|Adverse Event|0|||
155256448|NCT02230956|560369830|FG000|Overall Study|Lack of Efficacy|1|||
155256449|NCT02230956|560369831|FG001|Overall Study|Lack of Efficacy|1|||
155256450|NCT02230956|560369832|FG002|Overall Study|Lack of Efficacy|1|||
155256451|NCT02230956|560369830|FG000|Overall Study|Lost to Follow-up|1|||
155256452|NCT02230956|560369831|FG001|Overall Study|Lost to Follow-up|1|||
155256453|NCT02230956|560369832|FG002|Overall Study|Lost to Follow-up|2|||
155256454|NCT02230956|560369830|FG000|Overall Study|Personal Reasons|2|||
155256455|NCT02230956|560369831|FG001|Overall Study|Personal Reasons|1|||
155256456|NCT02230956|560369832|FG002|Overall Study|Personal Reasons|1|||
155256457|NCT02230956|560369830|FG000|Overall Study|Protocol Violation|0|||
155256458|NCT02230956|560369831|FG001|Overall Study|Protocol Violation|1|||
155256459|NCT02230956|560369832|FG002|Overall Study|Protocol Violation|1|||
155256460|NCT02230956|560369830|FG000|Overall Study|Other Miscellaneous Reason|0|||
155256461|NCT02230956|560369831|FG001|Overall Study|Other Miscellaneous Reason|1|||
155256462|NCT02230956|560369832|FG002|Overall Study|Other Miscellaneous Reason|2|||
155256463|NCT01970982|560369833|FG000|Overall Study|Withdrawal by Subject|0|||
155256464|NCT01970982|560369834|FG001|Overall Study|Withdrawal by Subject|0|||
155256465|NCT01970982|560369835|FG002|Overall Study|Withdrawal by Subject|2|||
155256466|NCT04555096|560369842|FG000|Overall Study|Death|4|||
155256467|NCT04555096|560369843|FG001|Overall Study|Death|4|||
155256468|NCT04555096|560369842|FG000|Overall Study|Withdrawal by Subject|1|||
155256469|NCT04555096|560369843|FG001|Overall Study|Withdrawal by Subject|0|||
155256470|NCT04555096|560369842|FG000|Overall Study|Other|0|||
155256471|NCT04555096|560369843|FG001|Overall Study|Other|1|||
155256472|NCT03923959|560369846|FG000|Overall Study|Death|16|||
155256473|NCT03923959|560369847|FG001|Overall Study|Death|12|||
155256474|NCT03923959|560369846|FG000|Overall Study|Lost to Follow-up|56|||
155256475|NCT03923959|560369847|FG001|Overall Study|Lost to Follow-up|56|||
155256476|NCT03923959|560369846|FG000|Overall Study|Withdrawal by Subject|1|||
155256477|NCT03923959|560369847|FG001|Overall Study|Withdrawal by Subject|1|||
155256478|NCT03923959|560369846|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
155256479|NCT03923959|560369847|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
155256480|NCT05711641|560369848|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
155256481|NCT05711641|560369849|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
155256482|NCT05711641|560369848|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
155256483|NCT05711641|560369849|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
155256484|NCT03574597|560369850|FG000|Overall Study|Withdrawal by Subject|67|||
155256485|NCT03574597|560369851|FG001|Overall Study|Withdrawal by Subject|96|||
155256486|NCT03574597|560369850|FG000|Overall Study|Lost to Follow-up|192|||
155256487|NCT03574597|560369851|FG001|Overall Study|Lost to Follow-up|188|||
155256488|NCT04040751|560369852|FG000|Overall Study|Withdrawal by Subject|2|||
155256489|NCT04040751|560369853|FG001|Overall Study|Withdrawal by Subject|0|||
155256490|NCT04040751|560369854|FG002|Overall Study|Withdrawal by Subject|2|||
155256491|NCT04040751|560369855|FG003|Overall Study|Withdrawal by Subject|0|||
155256492|NCT02355743|560369856|FG000|Overall Study|Withdrawal by Subject|1|||
155256493|NCT02355743|560369856|FG000|Overall Study|Lost to Follow-up|1|||
155256494|NCT03583554|560369858|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
155256495|NCT03583554|560369859|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
155256496|NCT03583554|560369860|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
155256497|NCT01596582|560369867|FG000|Overall Study|Deemed ineligible after study visit|3|||
155256498|NCT01596582|560369868|FG001|Overall Study|Deemed ineligible after study visit|6|||
155256499|NCT01596582|560369867|FG000|Overall Study|Missing all outcome data|1|||
155256500|NCT01596582|560369868|FG001|Overall Study|Missing all outcome data|1|||
155256501|NCT01428076|560369869|FG000|Overall Study|Adverse Event|0|||
155256502|NCT01428076|560369870|FG001|Overall Study|Adverse Event|1|||
155256503|NCT00262821|560369871|FG000|Overall Study|Ineligible - wrong stage|0|||
155256504|NCT00262821|560369872|FG001|Overall Study|Ineligible - wrong stage|3|||
155256505|NCT00262821|560369871|FG000|Overall Study|Ineligible - wrong cell type|2|||
155256506|NCT00262821|560369872|FG001|Overall Study|Ineligible - wrong cell type|2|||
155256507|NCT00262821|560369871|FG000|Overall Study|Ineligible - wrong primary|0|||
155256508|NCT00262821|560369872|FG001|Overall Study|Ineligible - wrong primary|1|||
155256509|NCT00262821|560369871|FG000|Overall Study|Ineligible - inadequate pathology|1|||
155256510|NCT00262821|560369872|FG001|Overall Study|Ineligible - inadequate pathology|3|||
155256511|NCT00262821|560369871|FG000|Overall Study|Ineligible - elevated creatinine|0|||
155256512|NCT00262821|560369872|FG001|Overall Study|Ineligible - elevated creatinine|2|||
155256513|NCT00262821|560369871|FG000|Overall Study|Ineligible - required test not done|1|||
155256514|NCT00262821|560369872|FG001|Overall Study|Ineligible - required test not done|4|||
155256515|NCT00262821|560369871|FG000|Overall Study|Inevaluable - inadequate data|0|||
155256516|NCT00262821|560369872|FG001|Overall Study|Inevaluable - inadequate data|4|||
155256517|NCT00765388|560369873|FG000|Period 1|Lack of Efficacy|1|||
155256518|NCT00765388|560369874|FG001|Period 1|Lack of Efficacy|2|||
155256519|NCT00765388|560369873|FG000|Period 1|Lost to Follow-up|0|||
155256520|NCT00765388|560369874|FG001|Period 1|Lost to Follow-up|1|||
155256521|NCT00765388|560369873|FG000|Period 1|Herpes Zoster|0|||
155256522|NCT00765388|560369874|FG001|Period 1|Herpes Zoster|1|||
155256523|NCT00765388|560369873|FG000|Period 1|Hip operation|0|||
155256524|NCT00765388|560369874|FG001|Period 1|Hip operation|1|||
155256525|NCT03923933|560369878|FG000|Overall Study|Lost to Follow-up|1|||
155256526|NCT03923933|560369879|FG001|Overall Study|Lost to Follow-up|0|||
155256527|NCT03923933|560369878|FG000|Overall Study|Withdrawal by Subject|0|||
155256528|NCT03923933|560369879|FG001|Overall Study|Withdrawal by Subject|1|||
155256529|NCT02454101|560369880|FG000|Overall Study|Adverse Event|2|||
155256530|NCT02454101|560369881|FG001|Overall Study|Adverse Event|3|||
155256531|NCT02454101|560369880|FG000|Overall Study|Lost to Follow-up|3|||
155256532|NCT02454101|560369881|FG001|Overall Study|Lost to Follow-up|4|||
155256533|NCT02342886|560369882|FG000|Overall Study|Treatment non-compliance|1|||
155256534|NCT02342886|560369883|FG001|Overall Study|Treatment non-compliance|0|||
155256535|NCT02342886|560369884|FG002|Overall Study|Treatment non-compliance|0|||
155256536|NCT02342886|560369885|FG003|Overall Study|Treatment non-compliance|1|||
155256537|NCT02342886|560369886|FG004|Overall Study|Treatment non-compliance|0|||
155256538|NCT02342886|560369882|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
155256539|NCT02342886|560369883|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
155256540|NCT02342886|560369884|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
155256541|NCT02342886|560369885|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
155256542|NCT02342886|560369886|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
155256543|NCT02342886|560369882|FG000|Overall Study|Adverse event/specific toxicity|4|||
155256544|NCT02342886|560369883|FG001|Overall Study|Adverse event/specific toxicity|3|||
155256545|NCT02342886|560369884|FG002|Overall Study|Adverse event/specific toxicity|11|||
155256546|NCT02342886|560369885|FG003|Overall Study|Adverse event/specific toxicity|2|||
155256547|NCT02342886|560369886|FG004|Overall Study|Adverse event/specific toxicity|1|||
155256548|NCT02342886|560369882|FG000|Overall Study|Lost to Follow-up|1|||
155256549|NCT02342886|560369883|FG001|Overall Study|Lost to Follow-up|0|||
155256550|NCT02342886|560369884|FG002|Overall Study|Lost to Follow-up|0|||
155256551|NCT02342886|560369885|FG003|Overall Study|Lost to Follow-up|0|||
155256552|NCT02342886|560369886|FG004|Overall Study|Lost to Follow-up|0|||
155256553|NCT02342886|560369882|FG000|Overall Study|Death|1|||
155256554|NCT02342886|560369883|FG001|Overall Study|Death|2|||
155256555|NCT02342886|560369884|FG002|Overall Study|Death|1|||
155256556|NCT02342886|560369885|FG003|Overall Study|Death|0|||
155256557|NCT02342886|560369886|FG004|Overall Study|Death|1|||
155256558|NCT02342886|560369882|FG000|Overall Study|Withdrawal by Subject|0|||
155256559|NCT02342886|560369883|FG001|Overall Study|Withdrawal by Subject|1|||
155256560|NCT02342886|560369884|FG002|Overall Study|Withdrawal by Subject|0|||
155256561|NCT02342886|560369885|FG003|Overall Study|Withdrawal by Subject|1|||
155256562|NCT02342886|560369886|FG004|Overall Study|Withdrawal by Subject|0|||
155256563|NCT02342886|560369882|FG000|Overall Study|Investigator/sponsor decision|0|||
155256564|NCT02342886|560369883|FG001|Overall Study|Investigator/sponsor decision|2|||
155256565|NCT02342886|560369884|FG002|Overall Study|Investigator/sponsor decision|0|||
155256566|NCT02342886|560369885|FG003|Overall Study|Investigator/sponsor decision|3|||
155256567|NCT02342886|560369886|FG004|Overall Study|Investigator/sponsor decision|1|||
155256568|NCT02342886|560369882|FG000|Overall Study|Pregnancy|0|||
155256569|NCT02342886|560369883|FG001|Overall Study|Pregnancy|0|||
155256570|NCT02342886|560369884|FG002|Overall Study|Pregnancy|2|||
155256571|NCT02342886|560369885|FG003|Overall Study|Pregnancy|0|||
155256572|NCT02342886|560369886|FG004|Overall Study|Pregnancy|0|||
155256573|NCT02342886|560369882|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256574|NCT02342886|560369883|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256575|NCT02342886|560369884|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
155256576|NCT02342886|560369885|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256577|NCT02342886|560369886|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
155256578|NCT02342886|560369882|FG000|Overall Study|Protocol Violation|0|||
155256579|NCT02342886|560369883|FG001|Overall Study|Protocol Violation|0|||
155256580|NCT02342886|560369884|FG002|Overall Study|Protocol Violation|0|||
155256581|NCT02342886|560369885|FG003|Overall Study|Protocol Violation|2|||
155256582|NCT02342886|560369886|FG004|Overall Study|Protocol Violation|0|||
155256583|NCT00765674|560369890|FG000|Overall Study|Adverse Event|7|||
155256584|NCT00765674|560369891|FG001|Overall Study|Adverse Event|2|||
155256585|NCT00765674|560369892|FG002|Overall Study|Adverse Event|8|||
155256586|NCT00765674|560369893|FG003|Overall Study|Adverse Event|11|||
155256587|NCT00765674|560369890|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
155256588|NCT00765674|560369891|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
155256589|NCT00765674|560369892|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
155256590|NCT00765674|560369893|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
155256591|NCT00765674|560369890|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
155256592|NCT00765674|560369891|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
155256593|NCT00765674|560369892|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
155256594|NCT00765674|560369893|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
155256595|NCT00765674|560369890|FG000|Overall Study|Lack of Efficacy|2|||
155256596|NCT00765674|560369891|FG001|Overall Study|Lack of Efficacy|3|||
155256597|NCT00765674|560369892|FG002|Overall Study|Lack of Efficacy|1|||
155256598|NCT00765674|560369893|FG003|Overall Study|Lack of Efficacy|2|||
155256599|NCT00765674|560369890|FG000|Overall Study|Protocol Violation|2|||
155256600|NCT00765674|560369891|FG001|Overall Study|Protocol Violation|0|||
155256601|NCT00765674|560369892|FG002|Overall Study|Protocol Violation|1|||
155256602|NCT00765674|560369893|FG003|Overall Study|Protocol Violation|0|||
155256603|NCT00765674|560369890|FG000|Overall Study|Withdrawal by Subject|5|||
155256604|NCT00765674|560369891|FG001|Overall Study|Withdrawal by Subject|7|||
155256605|NCT00765674|560369892|FG002|Overall Study|Withdrawal by Subject|3|||
155256606|NCT00765674|560369893|FG003|Overall Study|Withdrawal by Subject|8|||
155256607|NCT00765674|560369890|FG000|Overall Study|Lost to Follow-up|4|||
155256608|NCT00765674|560369891|FG001|Overall Study|Lost to Follow-up|6|||
155256609|NCT00765674|560369892|FG002|Overall Study|Lost to Follow-up|2|||
155256610|NCT00765674|560369893|FG003|Overall Study|Lost to Follow-up|1|||
155256611|NCT00765674|560369890|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
155256612|NCT00765674|560369891|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
155256613|NCT00765674|560369892|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
155256614|NCT00765674|560369893|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
155256615|NCT01813474|560369899|FG000|Overall Study|Withdrawal by Subject|0|||
155256616|NCT01813474|560369900|FG001|Overall Study|Withdrawal by Subject|0|||
155256617|NCT01813474|560369901|FG002|Overall Study|Withdrawal by Subject|1|||
155256618|NCT01813474|560369899|FG000|Overall Study|Adverse Event|1|||
155256619|NCT01813474|560369900|FG001|Overall Study|Adverse Event|1|||
155256620|NCT01813474|560369901|FG002|Overall Study|Adverse Event|0|||
155256621|NCT01813474|560369899|FG000|Overall Study|Lack of Efficacy|2|||
155256622|NCT01813474|560369900|FG001|Overall Study|Lack of Efficacy|6|||
155256623|NCT01813474|560369901|FG002|Overall Study|Lack of Efficacy|9|||
155256624|NCT01813474|560369899|FG000|Overall Study|Death|0|||
155256625|NCT01813474|560369900|FG001|Overall Study|Death|0|||
155256626|NCT01813474|560369901|FG002|Overall Study|Death|1|||
155256627|NCT03015402|560369902|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
155256628|NCT03015402|560369903|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
155256629|NCT03015402|560369902|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
155256630|NCT03015402|560369903|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
155256631|NCT00316082|560369904|FG000|Overall Study|Lack of Efficacy|2|||
155256632|NCT00316082|560369905|FG001|Overall Study|Lack of Efficacy|3|||
155256633|NCT00316082|560369906|FG002|Overall Study|Lack of Efficacy|3|||
155256634|NCT00316082|560369907|FG003|Overall Study|Lack of Efficacy|4|||
155256635|NCT00316082|560369908|FG004|Overall Study|Lack of Efficacy|6|||
155256636|NCT00316082|560369904|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
155256637|NCT00316082|560369905|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
155256638|NCT00316082|560369906|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
155256639|NCT00316082|560369907|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
155256640|NCT00316082|560369908|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
155256641|NCT00316082|560369904|FG000|Overall Study|Lost to Follow-up|7|||
155256642|NCT00316082|560369905|FG001|Overall Study|Lost to Follow-up|6|||
155256643|NCT00316082|560369906|FG002|Overall Study|Lost to Follow-up|7|||
155256644|NCT00316082|560369907|FG003|Overall Study|Lost to Follow-up|8|||
155256645|NCT00316082|560369908|FG004|Overall Study|Lost to Follow-up|6|||
155256646|NCT00316082|560369904|FG000|Overall Study|Poor/noncompliance|6|||
155256647|NCT00316082|560369905|FG001|Overall Study|Poor/noncompliance|1|||
155256648|NCT00316082|560369906|FG002|Overall Study|Poor/noncompliance|4|||
155256649|NCT00316082|560369907|FG003|Overall Study|Poor/noncompliance|1|||
155256650|NCT00316082|560369908|FG004|Overall Study|Poor/noncompliance|4|||
155256651|NCT00316082|560369904|FG000|Overall Study|Adverse Event|4|||
155256652|NCT00316082|560369905|FG001|Overall Study|Adverse Event|2|||
155256653|NCT00316082|560369906|FG002|Overall Study|Adverse Event|5|||
155256654|NCT00316082|560369907|FG003|Overall Study|Adverse Event|1|||
155256655|NCT00316082|560369908|FG004|Overall Study|Adverse Event|3|||
155256656|NCT00316082|560369904|FG000|Overall Study|Subject no longer meets study criteria|3|||
155256657|NCT00316082|560369905|FG001|Overall Study|Subject no longer meets study criteria|1|||
155256658|NCT00316082|560369906|FG002|Overall Study|Subject no longer meets study criteria|2|||
155256659|NCT00316082|560369907|FG003|Overall Study|Subject no longer meets study criteria|2|||
155256660|NCT00316082|560369908|FG004|Overall Study|Subject no longer meets study criteria|1|||
155256661|NCT00316082|560369904|FG000|Overall Study|Physician Decision|1|||
155256662|NCT00316082|560369905|FG001|Overall Study|Physician Decision|1|||
155256663|NCT00316082|560369906|FG002|Overall Study|Physician Decision|2|||
155256664|NCT00316082|560369907|FG003|Overall Study|Physician Decision|1|||
155256665|NCT00316082|560369908|FG004|Overall Study|Physician Decision|1|||
155256666|NCT00316082|560369904|FG000|Overall Study|Death|0|||
155256667|NCT00316082|560369905|FG001|Overall Study|Death|0|||
155256668|NCT00316082|560369906|FG002|Overall Study|Death|1|||
155256669|NCT00316082|560369907|FG003|Overall Study|Death|0|||
155256670|NCT00316082|560369908|FG004|Overall Study|Death|0|||
155256671|NCT00316082|560369904|FG000|Overall Study|Administrative reason by sponsor|0|||
155256672|NCT00316082|560369905|FG001|Overall Study|Administrative reason by sponsor|0|||
155256673|NCT00316082|560369906|FG002|Overall Study|Administrative reason by sponsor|1|||
155256674|NCT00316082|560369907|FG003|Overall Study|Administrative reason by sponsor|0|||
155256675|NCT00316082|560369908|FG004|Overall Study|Administrative reason by sponsor|0|||
155256676|NCT02216773|560369911|FG000|Overall Study|Disease progression|4|||
155256677|NCT02216773|560369912|FG001|Overall Study|Disease progression|2|||
155256678|NCT02216773|560369911|FG000|Overall Study|Insufficient FLRV|4|||
155256679|NCT02216773|560369912|FG001|Overall Study|Insufficient FLRV|0|||
155256680|NCT02216773|560369911|FG000|Overall Study|Abandoned|4|||
155256681|NCT02216773|560369912|FG001|Overall Study|Abandoned|3|||
155256682|NCT00528775|560369913|FG000|Overall Study|Other not specified|1|||
155256683|NCT01995461|560369914|FG000|Overall Study|Death|1|||
155256684|NCT01995461|560369914|FG000|Overall Study|Lost to Follow-up|2|||
155256685|NCT01995461|560369914|FG000|Overall Study|Withdrawal by Subject|2|||
155256686|NCT00540124|560369915|FG000|Overall Study|Adverse Event|0|||
155256687|NCT00540124|560369916|FG001|Overall Study|Adverse Event|2|||
155256688|NCT00540124|560369917|FG002|Overall Study|Adverse Event|1|||
155256689|NCT00540124|560369915|FG000|Overall Study|Entry Criteria Not Met|2|||
155256690|NCT00540124|560369916|FG001|Overall Study|Entry Criteria Not Met|0|||
155256691|NCT00540124|560369917|FG002|Overall Study|Entry Criteria Not Met|0|||
155256692|NCT00540124|560369915|FG000|Overall Study|Lack of Efficacy|1|||
155256693|NCT00540124|560369916|FG001|Overall Study|Lack of Efficacy|0|||
155256694|NCT00540124|560369917|FG002|Overall Study|Lack of Efficacy|0|||
155256695|NCT00540124|560369915|FG000|Overall Study|Withdrawal by Subject|1|||
155256696|NCT00540124|560369916|FG001|Overall Study|Withdrawal by Subject|1|||
155256697|NCT00540124|560369917|FG002|Overall Study|Withdrawal by Subject|0|||
155256698|NCT01777854|560369925|FG000|Overall Study|Physician Decision|3|||
155256699|NCT01777854|560369926|FG001|Overall Study|Physician Decision|3|||
155256700|NCT02124265|560369929|FG000|Overall Study|Adverse Event|1|||
155256701|NCT00981084|560369933|FG000|Post Intervention (Data Analysis)|poor effort|1|||
155256702|NCT00981084|560369934|FG001|Post Intervention (Data Analysis)|poor effort|1|||
155256703|NCT00981084|560369933|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
155256704|NCT00981084|560369934|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
155256705|NCT02543658|560371714|FG000|Overall Study|Lack of Efficacy|0|||
155256706|NCT02543658|560371715|FG001|Overall Study|Lack of Efficacy|4|||
155256707|NCT00789815|560371716|FG000|Overall Study|Protocol Violation|6|||
155256708|NCT00789815|560371717|FG001|Overall Study|Protocol Violation|1|||
155256709|NCT00789815|560371716|FG000|Overall Study|Intubation due to massive bleeding|1|||
155256710|NCT00789815|560371717|FG001|Overall Study|Intubation due to massive bleeding|0|||
155256711|NCT01553318|560371724|FG000|Overall Study|Protocol Violation|3|||
155256712|NCT01553318|560371725|FG001|Overall Study|Protocol Violation|2|||
155256713|NCT01787097|560371727|FG000|Overall Study|Withdrawal by Subject|1|||
155256714|NCT01787097|560371728|FG001|Overall Study|Withdrawal by Subject|0|||
155256715|NCT01787097|560371729|FG002|Overall Study|Withdrawal by Subject|0|||
155256716|NCT01787097|560371730|FG003|Overall Study|Withdrawal by Subject|0|||
155256717|NCT00437645|560371742|FG000|Overall Study|Adverse Event|15|||
155256718|NCT00437645|560371743|FG001|Overall Study|Adverse Event|84|||
155256719|NCT00437645|560371742|FG000|Overall Study|Withdrawal by Subject|10|||
155256720|NCT00437645|560371743|FG001|Overall Study|Withdrawal by Subject|22|||
155256721|NCT00437645|560371742|FG000|Overall Study|Protocol Violation|3|||
155256722|NCT00437645|560371743|FG001|Overall Study|Protocol Violation|3|||
155256723|NCT00437645|560371742|FG000|Overall Study|Lost to Follow-up|2|||
155256724|NCT00437645|560371743|FG001|Overall Study|Lost to Follow-up|3|||
155256725|NCT00437645|560371742|FG000|Overall Study|Administrative problems|2|||
155256726|NCT00437645|560371743|FG001|Overall Study|Administrative problems|1|||
155256727|NCT00437645|560371742|FG000|Overall Study|Lack of Efficacy|2|||
155256728|NCT00437645|560371743|FG001|Overall Study|Lack of Efficacy|1|||
155256729|NCT00437645|560371742|FG000|Overall Study|Condition no longer requires study drug|1|||
155256730|NCT00437645|560371743|FG001|Overall Study|Condition no longer requires study drug|1|||
155256731|NCT00662857|560371744|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
155256732|NCT00662857|560371745|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
155256733|NCT00662857|560371744|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
155256734|NCT00662857|560371745|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
155256735|NCT00662857|560371744|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
155256736|NCT00662857|560371745|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
155256737|NCT03966053|560371746|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
155256738|NCT02832622|560371747|FG000|Overall Study|MPP not programmed|1259|||
155256739|NCT02832622|560371747|FG000|Overall Study|Withdrawal by Subject|123|||
155256740|NCT02832622|560371747|FG000|Overall Study|Death|119|||
155256741|NCT02832622|560371747|FG000|Overall Study|Unsuccessful CRT implant|93|||
155256742|NCT02832622|560371747|FG000|Overall Study|Lost to Follow-up|45|||
155256743|NCT02832622|560371747|FG000|Overall Study|Patient non-compliance|42|||
155256744|NCT02832622|560371747|FG000|Overall Study|Withdrawal by other reasons|25|||
155256745|NCT02832622|560371747|FG000|Overall Study|System explant|24|||
155256746|NCT02832622|560371747|FG000|Overall Study|Physician Decision|6|||
155256747|NCT02472652|560371748|FG000|Overall Study|Lost to Follow-up|1|||
155256748|NCT04586569|560371753|FG000|Overall Study|Withdrawal by Subject|0|||
155256749|NCT04586569|560371754|FG001|Overall Study|Withdrawal by Subject|2|||
155256750|NCT04586569|560371753|FG000|Overall Study|No longer eligible|2|||
155256751|NCT04586569|560371754|FG001|Overall Study|No longer eligible|3|||
155256752|NCT04586569|560371753|FG000|Overall Study|Physician Decision|1|||
155256753|NCT04586569|560371754|FG001|Overall Study|Physician Decision|0|||
155256754|NCT00998400|560371755|FG000|Overall Study|Lack of interest/motivation|1|||
155256755|NCT00998400|560371756|FG001|Overall Study|Lack of interest/motivation|2|||
155256756|NCT00998400|560371755|FG000|Overall Study|Logistical problems|1|||
155256757|NCT00998400|560371756|FG001|Overall Study|Logistical problems|0|||
155256758|NCT03704584|560371757|FG000|Overall Study|Withdrawal by Subject|1|||
155256759|NCT03704584|560371758|FG001|Overall Study|Withdrawal by Subject|0|||
155256760|NCT03185832|560371759|FG000|Overall Study|Death|9|||
155256761|NCT03185832|560371760|FG001|Overall Study|Death|14|||
155256762|NCT03185832|560371761|FG002|Overall Study|Death|9|||
155256763|NCT03185832|560371762|FG003|Overall Study|Death|7|||
155256764|NCT03185832|560371759|FG000|Overall Study|Withdrawn - vital status available|0|||
155256765|NCT03185832|560371760|FG001|Overall Study|Withdrawn - vital status available|1|||
155256766|NCT03185832|560371761|FG002|Overall Study|Withdrawn - vital status available|1|||
155256767|NCT03185832|560371762|FG003|Overall Study|Withdrawn - vital status available|4|||
155256768|NCT01777321|560371764|FG000|Overall Study|Withdrawal by Subject|0|||
155256769|NCT01777321|560371765|FG001|Overall Study|Withdrawal by Subject|1|||
155256770|NCT02127372|560371766|FG000|Overall Study|Withdrawal by Subject|1|||
155256771|NCT02127372|560371767|FG001|Overall Study|Withdrawal by Subject|0|||
155256772|NCT02173548|560371768|FG000|Overall Study|Lost to Follow-up|0|||
155256773|NCT02173548|560371769|FG001|Overall Study|Lost to Follow-up|2|||
155256774|NCT02173548|560371768|FG000|Overall Study|Withdrawal by Subject|1|||
155256775|NCT02173548|560371769|FG001|Overall Study|Withdrawal by Subject|0|||
155256776|NCT03597568|560371770|FG000|Overall Study|Withdrawal by Subject|1|||
155256777|NCT03597568|560371771|FG001|Overall Study|Withdrawal by Subject|1|||
155256778|NCT03597568|560371770|FG000|Overall Study|Unable to analyze vascular data|1|||
155256779|NCT03597568|560371771|FG001|Overall Study|Unable to analyze vascular data|1|||
155256780|NCT03822117|560371774|FG000|Overall Study|Death|18|||
155256781|NCT03822117|560371775|FG001|Overall Study|Death|17|||
155256782|NCT03822117|560371776|FG002|Overall Study|Death|12|||
155256783|NCT03822117|560371777|FG003|Overall Study|Death|4|||
155256784|NCT03822117|560371774|FG000|Overall Study|Lost to Follow-up|1|||
155256785|NCT03822117|560371775|FG001|Overall Study|Lost to Follow-up|2|||
155256786|NCT03822117|560371776|FG002|Overall Study|Lost to Follow-up|3|||
155256787|NCT03822117|560371777|FG003|Overall Study|Lost to Follow-up|0|||
155256788|NCT03822117|560371774|FG000|Overall Study|Study Terminated by Sponsor|25|||
155256789|NCT03822117|560371775|FG001|Overall Study|Study Terminated by Sponsor|11|||
155256790|NCT03822117|560371776|FG002|Overall Study|Study Terminated by Sponsor|6|||
155256791|NCT03822117|560371777|FG003|Overall Study|Study Terminated by Sponsor|0|||
155256792|NCT03822117|560371774|FG000|Overall Study|Withdrawal by Subject|4|||
155256793|NCT03822117|560371775|FG001|Overall Study|Withdrawal by Subject|0|||
155256794|NCT03822117|560371776|FG002|Overall Study|Withdrawal by Subject|3|||
155256795|NCT03822117|560371777|FG003|Overall Study|Withdrawal by Subject|0|||
155256796|NCT03822117|560371774|FG000|Overall Study|Disease Progression|1|||
155256797|NCT03822117|560371775|FG001|Overall Study|Disease Progression|2|||
155256798|NCT03822117|560371776|FG002|Overall Study|Disease Progression|1|||
155256799|NCT03822117|560371777|FG003|Overall Study|Disease Progression|0|||
155256800|NCT03822117|560371774|FG000|Overall Study|Never Returned to Hospital|0|||
155256801|NCT03822117|560371775|FG001|Overall Study|Never Returned to Hospital|0|||
155256802|NCT03822117|560371776|FG002|Overall Study|Never Returned to Hospital|1|||
155256803|NCT03822117|560371777|FG003|Overall Study|Never Returned to Hospital|0|||
155256804|NCT05131165|560371780|FG000|Overall Study|Death|1|||
155256805|NCT05131165|560371781|FG001|Overall Study|Death|1|||
155256806|NCT05131165|560371782|FG002|Overall Study|Death|0|||
155256807|NCT05131165|560371780|FG000|Overall Study|Lost to Follow-up|2|||
155256808|NCT05131165|560371781|FG001|Overall Study|Lost to Follow-up|2|||
155256809|NCT05131165|560371782|FG002|Overall Study|Lost to Follow-up|5|||
155256810|NCT05131165|560371780|FG000|Overall Study|Transferred out of clinic|1|||
155256811|NCT05131165|560371781|FG001|Overall Study|Transferred out of clinic|0|||
155256812|NCT05131165|560371782|FG002|Overall Study|Transferred out of clinic|3|||
155256813|NCT05131165|560371780|FG000|Overall Study|Dropped out|1|||
155256814|NCT05131165|560371781|FG001|Overall Study|Dropped out|2|||
155256815|NCT05131165|560371782|FG002|Overall Study|Dropped out|0|||
155256816|NCT01127646|560371785|FG000|Overall Study|Entry Criteria Not Met|1|||
155256817|NCT01127646|560371786|FG001|Overall Study|Entry Criteria Not Met|0|||
155256818|NCT01127646|560371785|FG000|Overall Study|Protocol Violation|0|||
155256819|NCT01127646|560371786|FG001|Overall Study|Protocol Violation|1|||
155256820|NCT03466086|560371787|FG000|Period 1|Sponsor decision due to study timeline|1|||
155256821|NCT03466086|560371788|FG001|Period 1|Sponsor decision due to study timeline|0|||
155256822|NCT03466086|560371787|FG000|Period 1|Withdrawal by Subject|1|||
155256823|NCT03466086|560371788|FG001|Period 1|Withdrawal by Subject|0|||
155256824|NCT03002610|560371792|FG000|Overall Study|Withdrawal by Subject|6|||
155256825|NCT03002610|560371793|FG001|Overall Study|Withdrawal by Subject|25|||
155256826|NCT03002610|560371794|FG002|Overall Study|Withdrawal by Subject|13|||
155256827|NCT03802123|560371795|FG000|Overall Study|Withdrawal by Subject|3|||
155256828|NCT03802123|560371795|FG000|Overall Study|Physician Decision|1|||
155256829|NCT03802123|560371795|FG000|Overall Study|Subject moved to hospice care|1|||
155256830|NCT03802123|560371795|FG000|Overall Study|technician error|1|||
155256831|NCT03802123|560371795|FG000|Overall Study|Death|3|||
155256832|NCT01822587|560371796|FG000|Overall Study|Lost to Follow-up|7|||
155256833|NCT01822587|560371797|FG001|Overall Study|Lost to Follow-up|9|||
155256834|NCT01822587|560371798|FG002|Overall Study|Lost to Follow-up|12|||
155256835|NCT01822587|560371796|FG000|Overall Study|Physician Decision|9|||
155256836|NCT01822587|560371797|FG001|Overall Study|Physician Decision|6|||
155256837|NCT01822587|560371798|FG002|Overall Study|Physician Decision|6|||
155256838|NCT01274182|560371799|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
155256839|NCT01274182|560371800|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
155256840|NCT01274182|560371801|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
155256841|NCT01274182|560371799|FG000|Overall Study|Adverse Event|4|||
155256842|NCT01274182|560371800|FG001|Overall Study|Adverse Event|5|||
155256843|NCT01274182|560371801|FG002|Overall Study|Adverse Event|3|||
155256844|NCT01274182|560371799|FG000|Overall Study|Withdrawal by Subject|5|||
155256845|NCT01274182|560371800|FG001|Overall Study|Withdrawal by Subject|5|||
155256846|NCT01274182|560371801|FG002|Overall Study|Withdrawal by Subject|3|||
155256847|NCT01274182|560371799|FG000|Overall Study|Lost to Follow-up|2|||
155256848|NCT01274182|560371800|FG001|Overall Study|Lost to Follow-up|3|||
155256849|NCT01274182|560371801|FG002|Overall Study|Lost to Follow-up|1|||
155256850|NCT01274182|560371799|FG000|Overall Study|Protocol Violation|3|||
155256851|NCT01274182|560371800|FG001|Overall Study|Protocol Violation|2|||
155256852|NCT01274182|560371801|FG002|Overall Study|Protocol Violation|0|||
155256853|NCT01274182|560371799|FG000|Overall Study|Death|1|||
155256854|NCT01274182|560371800|FG001|Overall Study|Death|0|||
155256855|NCT01274182|560371801|FG002|Overall Study|Death|1|||
155256856|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
155256857|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
155256858|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
155256859|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
155256860|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
155256861|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
155256862|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
155256863|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
155256864|NCT00117676|560371804|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
155256865|NCT00117676|560371805|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
155256866|NCT00117676|560371804|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
155256867|NCT00117676|560371805|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
155256868|NCT00117676|560371804|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
155256869|NCT00117676|560371805|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
155256870|NCT00117676|560371804|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
155256871|NCT00117676|560371805|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
155256872|NCT00117676|560371804|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
155256873|NCT00117676|560371805|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
155256874|NCT00117676|560371804|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
155256875|NCT00117676|560371805|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
155256876|NCT00117676|560371804|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
155256877|NCT00117676|560371805|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
155256878|NCT00117676|560371804|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
155256879|NCT00117676|560371805|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
155256880|NCT00117676|560371804|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
155256881|NCT00117676|560371805|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
155256882|NCT00117676|560371804|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
155256883|NCT00117676|560371805|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
155256884|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
155256885|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
155256886|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
155256887|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
155256888|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
155256889|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
155256890|NCT00117676|560371804|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
155256891|NCT00117676|560371805|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
155256892|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
155256893|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
155256894|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
155256895|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
155256896|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
155256897|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
155256898|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
155256899|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
155256900|NCT00117676|560371804|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
155256901|NCT00117676|560371805|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
155256902|NCT00117676|560371804|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
155256903|NCT00117676|560371805|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
155256904|NCT00117676|560371804|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
155256905|NCT00117676|560371805|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
155256906|NCT00117676|560371804|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
155256907|NCT00117676|560371805|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
155256908|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
155256909|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
155256910|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
155256911|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
155256912|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
155256913|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
155256914|NCT00117676|560371804|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
155256915|NCT00117676|560371805|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
155256916|NCT00117676|560371804|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
155256917|NCT00117676|560371805|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
155256918|NCT00117676|560371804|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
155256919|NCT00117676|560371805|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
155256920|NCT00117676|560371804|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
155256921|NCT00117676|560371805|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
155256922|NCT00117676|560371804|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
155256923|NCT00117676|560371805|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
155256924|NCT00117676|560371804|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
155256925|NCT00117676|560371805|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
155256926|NCT00952822|560371806|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
155256927|NCT00952822|560371807|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
155256928|NCT00952822|560371808|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
155256929|NCT00952822|560371809|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
155256930|NCT00952822|560371806|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
155256931|NCT00952822|560371807|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
155256932|NCT00952822|560371808|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
155256933|NCT00952822|560371809|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
155256934|NCT01362439|560371810|FG000|Overall Study|Adverse Event|1|||
155256935|NCT01362439|560371810|FG000|Overall Study|Lack of Efficacy|3|||
155256936|NCT01362439|560371810|FG000|Overall Study|Lost to Follow-up|2|||
155256937|NCT01362439|560371810|FG000|Overall Study|Study medication non-compliant|1|||
155256938|NCT01362439|560371810|FG000|Overall Study|Participant who withdrew consent|8|||
155256939|NCT03575325|560371814|FG000|Overall Study|Death|1|||
155256940|NCT02712905|560371817|FG000|Monotherapy|Death|2|||
155256941|NCT02712905|560371818|FG001|Monotherapy|Death|5|||
155256942|NCT02712905|560371819|FG002|Monotherapy|Death|0|||
155256943|NCT02712905|560371820|FG003|Monotherapy|Death|3|||
155256944|NCT02712905|560371821|FG004|Monotherapy|Death|15|||
155256945|NCT02712905|560371822|FG005|Monotherapy|Death|1|||
155256946|NCT02712905|560371823|FG006|Monotherapy|Death|3|||
155256947|NCT02712905|560371824|FG007|Monotherapy|Death|3|||
155256948|NCT02712905|560371825|FG008|Monotherapy|Death|0|||
155256949|NCT02712905|560371826|FG009|Monotherapy|Death|27|||
155256950|NCT02712905|560371827|FG010|Monotherapy|Death|2|||
155256951|NCT02712905|560371828|FG011|Monotherapy|Death|5|||
155256952|NCT02712905|560371829|FG012|Monotherapy|Death|0|||
155256953|NCT02712905|560371830|FG013|Monotherapy|Death|0|||
155256954|NCT02712905|560371831|FG014|Monotherapy|Death|0|||
155256955|NCT02712905|560371832|FG015|Monotherapy|Death|0|||
155256956|NCT02712905|560371833|FG016|Monotherapy|Death|0|||
155256957|NCT02712905|560371834|FG017|Monotherapy|Death|0|||
155256958|NCT02712905|560371817|FG000|Monotherapy|Lost to Follow-up|0|||
155256959|NCT02712905|560371818|FG001|Monotherapy|Lost to Follow-up|1|||
155256960|NCT02712905|560371819|FG002|Monotherapy|Lost to Follow-up|0|||
155256961|NCT02712905|560371820|FG003|Monotherapy|Lost to Follow-up|1|||
155256962|NCT02712905|560371821|FG004|Monotherapy|Lost to Follow-up|0|||
155256963|NCT02712905|560371822|FG005|Monotherapy|Lost to Follow-up|0|||
155256964|NCT02712905|560371823|FG006|Monotherapy|Lost to Follow-up|0|||
155256965|NCT02712905|560371824|FG007|Monotherapy|Lost to Follow-up|0|||
155256966|NCT02712905|560371825|FG008|Monotherapy|Lost to Follow-up|0|||
155256967|NCT02712905|560371826|FG009|Monotherapy|Lost to Follow-up|2|||
155256968|NCT02712905|560371827|FG010|Monotherapy|Lost to Follow-up|0|||
155256969|NCT02712905|560371828|FG011|Monotherapy|Lost to Follow-up|0|||
155256970|NCT02712905|560371829|FG012|Monotherapy|Lost to Follow-up|0|||
155256971|NCT02712905|560371830|FG013|Monotherapy|Lost to Follow-up|0|||
155256972|NCT02712905|560371831|FG014|Monotherapy|Lost to Follow-up|0|||
155256973|NCT02712905|560371832|FG015|Monotherapy|Lost to Follow-up|0|||
155256974|NCT02712905|560371833|FG016|Monotherapy|Lost to Follow-up|0|||
155256975|NCT02712905|560371834|FG017|Monotherapy|Lost to Follow-up|0|||
155256976|NCT02712905|560371817|FG000|Monotherapy|Physician Decision|1|||
155256977|NCT02712905|560371818|FG001|Monotherapy|Physician Decision|0|||
155256978|NCT02712905|560371819|FG002|Monotherapy|Physician Decision|0|||
155256979|NCT02712905|560371820|FG003|Monotherapy|Physician Decision|1|||
155256980|NCT02712905|560371821|FG004|Monotherapy|Physician Decision|0|||
155256981|NCT02712905|560371822|FG005|Monotherapy|Physician Decision|0|||
155256982|NCT02712905|560371823|FG006|Monotherapy|Physician Decision|0|||
155256983|NCT02712905|560371824|FG007|Monotherapy|Physician Decision|0|||
155256984|NCT02712905|560371825|FG008|Monotherapy|Physician Decision|0|||
155256985|NCT02712905|560371826|FG009|Monotherapy|Physician Decision|1|||
155256986|NCT02712905|560371827|FG010|Monotherapy|Physician Decision|0|||
155256987|NCT02712905|560371828|FG011|Monotherapy|Physician Decision|0|||
155256988|NCT02712905|560371829|FG012|Monotherapy|Physician Decision|0|||
155256989|NCT02712905|560371830|FG013|Monotherapy|Physician Decision|0|||
155256990|NCT02712905|560371831|FG014|Monotherapy|Physician Decision|0|||
155256991|NCT02712905|560371832|FG015|Monotherapy|Physician Decision|0|||
155256992|NCT02712905|560371833|FG016|Monotherapy|Physician Decision|0|||
155256993|NCT02712905|560371834|FG017|Monotherapy|Physician Decision|0|||
155256994|NCT02712905|560371817|FG000|Monotherapy|Study Terminated by Sponsor|0|||
155256995|NCT02712905|560371818|FG001|Monotherapy|Study Terminated by Sponsor|0|||
155256996|NCT02712905|560371819|FG002|Monotherapy|Study Terminated by Sponsor|0|||
155256997|NCT02712905|560371820|FG003|Monotherapy|Study Terminated by Sponsor|0|||
155256998|NCT02712905|560371821|FG004|Monotherapy|Study Terminated by Sponsor|1|||
155256999|NCT02712905|560371822|FG005|Monotherapy|Study Terminated by Sponsor|0|||
155257000|NCT02712905|560371823|FG006|Monotherapy|Study Terminated by Sponsor|0|||
155257001|NCT02712905|560371824|FG007|Monotherapy|Study Terminated by Sponsor|0|||
155257002|NCT02712905|560371825|FG008|Monotherapy|Study Terminated by Sponsor|0|||
155257003|NCT02712905|560371826|FG009|Monotherapy|Study Terminated by Sponsor|2|||
155257004|NCT02712905|560371827|FG010|Monotherapy|Study Terminated by Sponsor|0|||
155257005|NCT02712905|560371828|FG011|Monotherapy|Study Terminated by Sponsor|0|||
155257006|NCT02712905|560371829|FG012|Monotherapy|Study Terminated by Sponsor|0|||
155257007|NCT02712905|560371830|FG013|Monotherapy|Study Terminated by Sponsor|0|||
155257008|NCT02712905|560371831|FG014|Monotherapy|Study Terminated by Sponsor|0|||
155257009|NCT02712905|560371832|FG015|Monotherapy|Study Terminated by Sponsor|0|||
155257010|NCT02712905|560371833|FG016|Monotherapy|Study Terminated by Sponsor|0|||
155257011|NCT02712905|560371834|FG017|Monotherapy|Study Terminated by Sponsor|0|||
155257012|NCT02712905|560371817|FG000|Monotherapy|Withdrawal by Subject|0|||
155257013|NCT02712905|560371818|FG001|Monotherapy|Withdrawal by Subject|0|||
155257014|NCT02712905|560371819|FG002|Monotherapy|Withdrawal by Subject|1|||
155257015|NCT02712905|560371820|FG003|Monotherapy|Withdrawal by Subject|0|||
155257016|NCT02712905|560371821|FG004|Monotherapy|Withdrawal by Subject|2|||
155257017|NCT02712905|560371822|FG005|Monotherapy|Withdrawal by Subject|0|||
155257018|NCT02712905|560371823|FG006|Monotherapy|Withdrawal by Subject|0|||
155257019|NCT02712905|560371824|FG007|Monotherapy|Withdrawal by Subject|0|||
155257020|NCT02712905|560371825|FG008|Monotherapy|Withdrawal by Subject|0|||
155257021|NCT02712905|560371826|FG009|Monotherapy|Withdrawal by Subject|4|||
155257022|NCT02712905|560371827|FG010|Monotherapy|Withdrawal by Subject|1|||
155257023|NCT02712905|560371828|FG011|Monotherapy|Withdrawal by Subject|2|||
155257024|NCT02712905|560371829|FG012|Monotherapy|Withdrawal by Subject|0|||
155257025|NCT02712905|560371830|FG013|Monotherapy|Withdrawal by Subject|0|||
155257026|NCT02712905|560371831|FG014|Monotherapy|Withdrawal by Subject|0|||
155257027|NCT02712905|560371832|FG015|Monotherapy|Withdrawal by Subject|0|||
155257028|NCT02712905|560371833|FG016|Monotherapy|Withdrawal by Subject|0|||
155257029|NCT02712905|560371834|FG017|Monotherapy|Withdrawal by Subject|0|||
155257030|NCT02712905|560371817|FG000|Monotherapy|Started New Cancer Drug|0|||
155257031|NCT02712905|560371818|FG001|Monotherapy|Started New Cancer Drug|0|||
155257032|NCT02712905|560371819|FG002|Monotherapy|Started New Cancer Drug|0|||
155257033|NCT02712905|560371820|FG003|Monotherapy|Started New Cancer Drug|0|||
155257034|NCT02712905|560371821|FG004|Monotherapy|Started New Cancer Drug|0|||
155257035|NCT02712905|560371822|FG005|Monotherapy|Started New Cancer Drug|1|||
155257036|NCT02712905|560371823|FG006|Monotherapy|Started New Cancer Drug|0|||
155257037|NCT02712905|560371824|FG007|Monotherapy|Started New Cancer Drug|0|||
155257038|NCT02712905|560371825|FG008|Monotherapy|Started New Cancer Drug|0|||
155257039|NCT02712905|560371826|FG009|Monotherapy|Started New Cancer Drug|0|||
155257040|NCT02712905|560371827|FG010|Monotherapy|Started New Cancer Drug|0|||
155257041|NCT02712905|560371828|FG011|Monotherapy|Started New Cancer Drug|0|||
155257042|NCT02712905|560371829|FG012|Monotherapy|Started New Cancer Drug|0|||
155257043|NCT02712905|560371830|FG013|Monotherapy|Started New Cancer Drug|0|||
155257044|NCT02712905|560371831|FG014|Monotherapy|Started New Cancer Drug|0|||
155257045|NCT02712905|560371832|FG015|Monotherapy|Started New Cancer Drug|0|||
155257046|NCT02712905|560371833|FG016|Monotherapy|Started New Cancer Drug|0|||
155257047|NCT02712905|560371834|FG017|Monotherapy|Started New Cancer Drug|0|||
155257048|NCT02712905|560371817|FG000|Monotherapy|Adverse Event|0|||
155257049|NCT02712905|560371818|FG001|Monotherapy|Adverse Event|0|||
155257050|NCT02712905|560371819|FG002|Monotherapy|Adverse Event|0|||
155257051|NCT02712905|560371820|FG003|Monotherapy|Adverse Event|0|||
155257052|NCT02712905|560371821|FG004|Monotherapy|Adverse Event|0|||
155257053|NCT02712905|560371822|FG005|Monotherapy|Adverse Event|0|||
155257054|NCT02712905|560371823|FG006|Monotherapy|Adverse Event|0|||
155257055|NCT02712905|560371824|FG007|Monotherapy|Adverse Event|0|||
155257056|NCT02712905|560371825|FG008|Monotherapy|Adverse Event|1|||
155257057|NCT02712905|560371826|FG009|Monotherapy|Adverse Event|0|||
155257058|NCT02712905|560371827|FG010|Monotherapy|Adverse Event|0|||
155257059|NCT02712905|560371828|FG011|Monotherapy|Adverse Event|0|||
155257060|NCT02712905|560371829|FG012|Monotherapy|Adverse Event|0|||
155257061|NCT02712905|560371830|FG013|Monotherapy|Adverse Event|0|||
155257062|NCT02712905|560371831|FG014|Monotherapy|Adverse Event|0|||
155257063|NCT02712905|560371832|FG015|Monotherapy|Adverse Event|0|||
155257064|NCT02712905|560371833|FG016|Monotherapy|Adverse Event|0|||
155257065|NCT02712905|560371834|FG017|Monotherapy|Adverse Event|0|||
155257066|NCT02712905|560371817|FG000|Combination Therapy|Death|0|||
155257067|NCT02712905|560371818|FG001|Combination Therapy|Death|0|||
155257068|NCT02712905|560371819|FG002|Combination Therapy|Death|0|||
155257069|NCT02712905|560371820|FG003|Combination Therapy|Death|0|||
155257070|NCT02712905|560371821|FG004|Combination Therapy|Death|0|||
155257071|NCT02712905|560371822|FG005|Combination Therapy|Death|0|||
155257072|NCT02712905|560371823|FG006|Combination Therapy|Death|0|||
155257073|NCT02712905|560371824|FG007|Combination Therapy|Death|0|||
155257074|NCT02712905|560371825|FG008|Combination Therapy|Death|0|||
155257075|NCT02712905|560371826|FG009|Combination Therapy|Death|0|||
155257076|NCT02712905|560371827|FG010|Combination Therapy|Death|0|||
155257077|NCT02712905|560371828|FG011|Combination Therapy|Death|0|||
155257078|NCT02712905|560371829|FG012|Combination Therapy|Death|5|||
155257079|NCT02712905|560371830|FG013|Combination Therapy|Death|6|||
155257080|NCT02712905|560371831|FG014|Combination Therapy|Death|1|||
155257081|NCT02712905|560371832|FG015|Combination Therapy|Death|3|||
155257082|NCT02712905|560371833|FG016|Combination Therapy|Death|1|||
155257083|NCT02712905|560371834|FG017|Combination Therapy|Death|3|||
155257084|NCT02712905|560371817|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
155257085|NCT02712905|560371818|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
155257086|NCT02712905|560371819|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
155257087|NCT02712905|560371820|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
155257088|NCT02712905|560371821|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
155257089|NCT02712905|560371822|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
155257090|NCT02712905|560371823|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
155257091|NCT02712905|560371824|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
155257092|NCT02712905|560371825|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
155257093|NCT02712905|560371826|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
155257094|NCT02712905|560371827|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
155257095|NCT02712905|560371828|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
155257096|NCT02712905|560371829|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
155257097|NCT02712905|560371830|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
155257098|NCT02712905|560371831|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
155257099|NCT02712905|560371832|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
155257100|NCT02712905|560371833|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
155257101|NCT02712905|560371834|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
155257102|NCT02712905|560371817|FG000|Combination Therapy|Withdrawal by Subject|0|||
155257103|NCT02712905|560371818|FG001|Combination Therapy|Withdrawal by Subject|0|||
155257104|NCT02712905|560371819|FG002|Combination Therapy|Withdrawal by Subject|0|||
155257105|NCT02712905|560371820|FG003|Combination Therapy|Withdrawal by Subject|0|||
155257106|NCT02712905|560371821|FG004|Combination Therapy|Withdrawal by Subject|0|||
155257107|NCT02712905|560371822|FG005|Combination Therapy|Withdrawal by Subject|0|||
155257108|NCT02712905|560371823|FG006|Combination Therapy|Withdrawal by Subject|0|||
155257109|NCT02712905|560371824|FG007|Combination Therapy|Withdrawal by Subject|0|||
155257110|NCT02712905|560371825|FG008|Combination Therapy|Withdrawal by Subject|0|||
155257111|NCT02712905|560371826|FG009|Combination Therapy|Withdrawal by Subject|0|||
155257112|NCT02712905|560371827|FG010|Combination Therapy|Withdrawal by Subject|0|||
155257113|NCT02712905|560371828|FG011|Combination Therapy|Withdrawal by Subject|0|||
155257114|NCT02712905|560371829|FG012|Combination Therapy|Withdrawal by Subject|0|||
155257115|NCT02712905|560371830|FG013|Combination Therapy|Withdrawal by Subject|0|||
155257116|NCT02712905|560371831|FG014|Combination Therapy|Withdrawal by Subject|0|||
155257117|NCT02712905|560371832|FG015|Combination Therapy|Withdrawal by Subject|1|||
155257118|NCT02712905|560371833|FG016|Combination Therapy|Withdrawal by Subject|0|||
155257119|NCT02712905|560371834|FG017|Combination Therapy|Withdrawal by Subject|2|||
155257120|NCT02712905|560371817|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257121|NCT02712905|560371818|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257122|NCT02712905|560371819|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257123|NCT02712905|560371820|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257124|NCT02712905|560371821|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257125|NCT02712905|560371822|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257126|NCT02712905|560371823|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257127|NCT02712905|560371824|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257128|NCT02712905|560371825|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257129|NCT02712905|560371826|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257130|NCT02712905|560371827|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257131|NCT02712905|560371828|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257132|NCT02712905|560371829|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257133|NCT02712905|560371830|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257134|NCT02712905|560371831|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257135|NCT02712905|560371832|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
155257136|NCT02712905|560371833|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257137|NCT02712905|560371834|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
155257138|NCT03178266|560371837|FG000|Overall Study|Death|0|||
155257139|NCT03178266|560371838|FG001|Overall Study|Death|1|||
155257140|NCT03178266|560371837|FG000|Overall Study|Disont. Early|0|||
155257141|NCT03178266|560371838|FG001|Overall Study|Disont. Early|1|||
155257142|NCT03178266|560371837|FG000|Overall Study|Withdrawal by Subject|0|||
155257143|NCT03178266|560371838|FG001|Overall Study|Withdrawal by Subject|2|||
155257144|NCT01812655|560371839|FG000|Overall Study|Protocol Violation|1|||
155257145|NCT01812655|560371840|FG001|Overall Study|Protocol Violation|1|||
155257146|NCT01812655|560371841|FG002|Overall Study|Protocol Violation|0|||
155257147|NCT02363946|560371842|FG000|Overall Study|Lost to Follow-up|0|||
155257148|NCT02363946|560371843|FG001|Overall Study|Lost to Follow-up|0|||
155257149|NCT02363946|560371844|FG002|Overall Study|Lost to Follow-up|0|||
155257150|NCT02363946|560371845|FG003|Overall Study|Lost to Follow-up|0|||
155257151|NCT02363946|560371846|FG004|Overall Study|Lost to Follow-up|0|||
155257152|NCT02363946|560371847|FG005|Overall Study|Lost to Follow-up|0|||
155257153|NCT02363946|560371848|FG006|Overall Study|Lost to Follow-up|0|||
155257154|NCT02363946|560371849|FG007|Overall Study|Lost to Follow-up|1|||
155257155|NCT02363946|560371850|FG008|Overall Study|Lost to Follow-up|0|||
155257156|NCT02363946|560371851|FG009|Overall Study|Lost to Follow-up|0|||
155257157|NCT02363946|560371852|FG010|Overall Study|Lost to Follow-up|0|||
155257158|NCT02363946|560371853|FG011|Overall Study|Lost to Follow-up|0|||
155257159|NCT02363946|560371854|FG012|Overall Study|Lost to Follow-up|0|||
155257160|NCT04435665|560371855|FG000|Overall Study|Lost to Follow-up|0|||
155257161|NCT04435665|560371856|FG001|Overall Study|Lost to Follow-up|0|||
155257162|NCT04435665|560371857|FG002|Overall Study|Lost to Follow-up|0|||
155257163|NCT04435665|560371858|FG003|Overall Study|Lost to Follow-up|1|||
155257164|NCT00419263|560371859|FG000|Overall Study|Lost to Follow-up|2|||
155257165|NCT00419263|560371860|FG001|Overall Study|Lost to Follow-up|1|||
155257166|NCT00419263|560371861|FG002|Overall Study|Lost to Follow-up|1|||
155257167|NCT00419263|560371859|FG000|Overall Study|Randomized in Error, Not Treated|1|||
155257168|NCT00419263|560371860|FG001|Overall Study|Randomized in Error, Not Treated|1|||
155257169|NCT00419263|560371861|FG002|Overall Study|Randomized in Error, Not Treated|0|||
155257170|NCT00419263|560371859|FG000|Overall Study|Adverse Event|0|||
155257171|NCT00419263|560371860|FG001|Overall Study|Adverse Event|0|||
155257172|NCT00419263|560371861|FG002|Overall Study|Adverse Event|1|||
155257173|NCT00419263|560371859|FG000|Overall Study|Withdrawal by Subject|0|||
155257174|NCT00419263|560371860|FG001|Overall Study|Withdrawal by Subject|0|||
155257175|NCT00419263|560371861|FG002|Overall Study|Withdrawal by Subject|1|||
155257176|NCT00862134|560371862|FG000|Overall Study|Death|1|||
155257177|NCT00862134|560371863|FG001|Overall Study|Death|0|||
155257178|NCT00862134|560371862|FG000|Overall Study|Physician Decision|0|||
155257179|NCT00862134|560371863|FG001|Overall Study|Physician Decision|1|||
155257180|NCT00862134|560371862|FG000|Overall Study|Withdrawal by Subject|1|||
155257181|NCT00862134|560371863|FG001|Overall Study|Withdrawal by Subject|2|||
155257182|NCT00862134|560371862|FG000|Overall Study|Sponsor terminated study|5|||
155257183|NCT00862134|560371863|FG001|Overall Study|Sponsor terminated study|7|||
155257184|NCT00862134|560371862|FG000|Overall Study|Adverse Event|2|||
155257185|NCT00862134|560371863|FG001|Overall Study|Adverse Event|2|||
155257186|NCT00862134|560371862|FG000|Overall Study|Withdrew prior to dosing|2|||
155257187|NCT00862134|560371863|FG001|Overall Study|Withdrew prior to dosing|0|||
155257188|NCT01494584|560371865|FG000|Overall Study|Study Closed/Terminated|1|||
155257189|NCT00374322|560371870|FG000|Overall Study|Lost to Follow-up|92|||
155257190|NCT00374322|560371871|FG001|Overall Study|Lost to Follow-up|90|||
155257191|NCT00374322|560371870|FG000|Overall Study|Protocol Violation|8|||
155257192|NCT00374322|560371871|FG001|Overall Study|Protocol Violation|3|||
155257193|NCT00374322|560371870|FG000|Overall Study|Withdrawal by Subject|235|||
155257194|NCT00374322|560371871|FG001|Overall Study|Withdrawal by Subject|167|||
155257195|NCT00374322|560371870|FG000|Overall Study|Sponsor Terminated Study|866|||
155257196|NCT00374322|560371871|FG001|Overall Study|Sponsor Terminated Study|990|||
155257197|NCT00374322|560371870|FG000|Overall Study|Physician Decision|36|||
155257198|NCT00374322|560371871|FG001|Overall Study|Physician Decision|32|||
155257199|NCT00374322|560371870|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
155257200|NCT00374322|560371871|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
155257201|NCT00374322|560371870|FG000|Overall Study|Sponsor Decision|2|||
155257202|NCT00374322|560371871|FG001|Overall Study|Sponsor Decision|3|||
155257203|NCT00374322|560371870|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
155257204|NCT00374322|560371871|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
155257205|NCT00374322|560371870|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
155257206|NCT00374322|560371871|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
155257207|NCT00374322|560371870|FG000|Overall Study|Severe Toxicity|1|||
155257208|NCT00374322|560371871|FG001|Overall Study|Severe Toxicity|0|||
155257209|NCT00374322|560371870|FG000|Overall Study|Site Closed|2|||
155257210|NCT00374322|560371871|FG001|Overall Study|Site Closed|2|||
155257211|NCT00374322|560371870|FG000|Overall Study|Participant Changed Physician|1|||
155257212|NCT00374322|560371871|FG001|Overall Study|Participant Changed Physician|0|||
155257213|NCT00374322|560371870|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
155257214|NCT00374322|560371871|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
155257215|NCT00374322|560371870|FG000|Overall Study|Noncompliance with Study Requirements|0|||
155257216|NCT00374322|560371871|FG001|Overall Study|Noncompliance with Study Requirements|1|||
155257217|NCT00374322|560371870|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
155257218|NCT00374322|560371871|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
155257219|NCT00374322|560371870|FG000|Overall Study|Did Not Receive Study Medication|8|||
155257220|NCT00374322|560371871|FG001|Overall Study|Did Not Receive Study Medication|6|||
155257221|NCT01298999|560371881|FG000|Overall Study|Physician Decision|0|||
155257222|NCT01298999|560371882|FG001|Overall Study|Physician Decision|1|||
155257223|NCT01298999|560371881|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
155257224|NCT01298999|560371882|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
155257225|NCT02532179|560373567|FG000|Overall Study|Lost to Follow-up|1|||
155257226|NCT02532179|560373567|FG000|Overall Study|Pregnancy|1|||
155257227|NCT02532179|560373567|FG000|Overall Study|Subject received depot steroid injection|1|||
155257228|NCT01337674|560373571|FG000|Treatment Period 1|Adverse Event|0|||
155257229|NCT01337674|560373572|FG001|Treatment Period 1|Adverse Event|1|||
155257230|NCT01337674|560373573|FG002|Treatment Period 1|Adverse Event|0|||
155257231|NCT01337674|560373574|FG003|Treatment Period 1|Adverse Event|0|||
155257232|NCT01337674|560373571|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
155257233|NCT01337674|560373572|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
155257234|NCT01337674|560373573|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
155257235|NCT01337674|560373574|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
155257236|NCT01337674|560373571|FG000|Treatment Period 2|Withdrawal by Subject|0|||
155257237|NCT01337674|560373572|FG001|Treatment Period 2|Withdrawal by Subject|0|||
155257238|NCT01337674|560373573|FG002|Treatment Period 2|Withdrawal by Subject|1|||
155257239|NCT01337674|560373574|FG003|Treatment Period 2|Withdrawal by Subject|0|||
155257240|NCT00119405|560373575|FG000|Overall Study|Withdrawal by Subject|1|||
155257241|NCT00939484|560373576|FG000|Overall Study|Progression/Relapse|8|||
155257242|NCT00939484|560373577|FG001|Overall Study|Progression/Relapse|20|||
155257243|NCT00939484|560373578|FG002|Overall Study|Progression/Relapse|3|||
155257244|NCT04233372|560373579|FG000|Overall Study|Lost to Follow-up|104|||
155257245|NCT04233372|560373579|FG000|Overall Study|Adverse Event|8|||
155257246|NCT04233372|560373579|FG000|Overall Study|Withdrawal by Subject|2|||
155257247|NCT04958785|560373580|FG000|Overall Study|Study Terminated by Sponsor|4|||
155257248|NCT04958785|560373581|FG001|Overall Study|Study Terminated by Sponsor|10|||
155257249|NCT04958785|560373582|FG002|Overall Study|Study Terminated by Sponsor|7|||
155257250|NCT04958785|560373583|FG003|Overall Study|Study Terminated by Sponsor|6|||
155257251|NCT04958785|560373584|FG004|Overall Study|Study Terminated by Sponsor|34|||
155257252|NCT04958785|560373580|FG000|Overall Study|Death|2|||
155257253|NCT04958785|560373581|FG001|Overall Study|Death|3|||
155257254|NCT04958785|560373582|FG002|Overall Study|Death|4|||
155257255|NCT04958785|560373583|FG003|Overall Study|Death|5|||
155257256|NCT04958785|560373584|FG004|Overall Study|Death|5|||
155257257|NCT04958785|560373580|FG000|Overall Study|Withdrew consent|2|||
155257258|NCT04958785|560373581|FG001|Overall Study|Withdrew consent|0|||
155257259|NCT04958785|560373582|FG002|Overall Study|Withdrew consent|3|||
155257260|NCT04958785|560373583|FG003|Overall Study|Withdrew consent|1|||
155257261|NCT04958785|560373584|FG004|Overall Study|Withdrew consent|0|||
155257262|NCT04958785|560373580|FG000|Overall Study|Investigator's discretion|0|||
155257263|NCT04958785|560373581|FG001|Overall Study|Investigator's discretion|1|||
155257264|NCT04958785|560373582|FG002|Overall Study|Investigator's discretion|0|||
155257265|NCT04958785|560373583|FG003|Overall Study|Investigator's discretion|1|||
155257266|NCT04958785|560373584|FG004|Overall Study|Investigator's discretion|2|||
155257267|NCT04958785|560373580|FG000|Overall Study|Adverse Event|0|||
155257268|NCT04958785|560373581|FG001|Overall Study|Adverse Event|0|||
155257269|NCT04958785|560373582|FG002|Overall Study|Adverse Event|0|||
155257270|NCT04958785|560373583|FG003|Overall Study|Adverse Event|0|||
155257271|NCT04958785|560373584|FG004|Overall Study|Adverse Event|1|||
155257272|NCT04958785|560373580|FG000|Overall Study|Lost to Follow-up|0|||
155257273|NCT04958785|560373581|FG001|Overall Study|Lost to Follow-up|0|||
155257274|NCT04958785|560373582|FG002|Overall Study|Lost to Follow-up|0|||
155257275|NCT04958785|560373583|FG003|Overall Study|Lost to Follow-up|0|||
155257276|NCT04958785|560373584|FG004|Overall Study|Lost to Follow-up|1|||
155257277|NCT03938454|560373585|FG000|Overall Study|Protocol Violation|1|||
155257278|NCT03938454|560373585|FG000|Overall Study|Withdrawal by Subject|2|||
155257279|NCT03938454|560373585|FG000|Overall Study|Lost to Follow-up|3|||
155257280|NCT01090310|560373586|FG000|Core Study|Adverse Event|2|||
155257281|NCT01090310|560373587|FG001|Core Study|Adverse Event|2|||
155257282|NCT01090310|560373588|FG002|Core Study|Adverse Event|1|||
155257283|NCT01090310|560373589|FG003|Core Study|Adverse Event|1|||
155257284|NCT01090310|560373586|FG000|Core Study|Subject withdrew consent|0|||
155257285|NCT01090310|560373587|FG001|Core Study|Subject withdrew consent|3|||
155257286|NCT01090310|560373588|FG002|Core Study|Subject withdrew consent|1|||
155257287|NCT01090310|560373589|FG003|Core Study|Subject withdrew consent|1|||
155257288|NCT01090310|560373586|FG000|Core Study|Abnormal test procedure result|0|||
155257289|NCT01090310|560373587|FG001|Core Study|Abnormal test procedure result|0|||
155257290|NCT01090310|560373588|FG002|Core Study|Abnormal test procedure result|1|||
155257291|NCT01090310|560373589|FG003|Core Study|Abnormal test procedure result|0|||
155257292|NCT01090310|560373586|FG000|Core Study|Administrative reasons|5|||
155257293|NCT01090310|560373587|FG001|Core Study|Administrative reasons|6|||
155257294|NCT01090310|560373588|FG002|Core Study|Administrative reasons|4|||
155257295|NCT01090310|560373589|FG003|Core Study|Administrative reasons|4|||
155257296|NCT01090310|560373586|FG000|Core Study|Protocol deviation|1|||
155257297|NCT01090310|560373587|FG001|Core Study|Protocol deviation|0|||
155257298|NCT01090310|560373588|FG002|Core Study|Protocol deviation|0|||
155257299|NCT01090310|560373589|FG003|Core Study|Protocol deviation|1|||
155257300|NCT01090310|560373586|FG000|Extension Study|Aministrative problems|13|||
155257301|NCT01090310|560373587|FG001|Extension Study|Aministrative problems|15|||
155257302|NCT01090310|560373588|FG002|Extension Study|Aministrative problems|14|||
155257303|NCT01090310|560373589|FG003|Extension Study|Aministrative problems|18|||
155257304|NCT01090310|560373586|FG000|Extension Study|Adverse Event|0|||
155257305|NCT01090310|560373587|FG001|Extension Study|Adverse Event|0|||
155257306|NCT01090310|560373588|FG002|Extension Study|Adverse Event|0|||
155257307|NCT01090310|560373589|FG003|Extension Study|Adverse Event|1|||
155257308|NCT01090310|560373586|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
155257309|NCT01090310|560373587|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
155257310|NCT01090310|560373588|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
155257311|NCT01090310|560373589|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
155257312|NCT01090310|560373586|FG000|Extension Study|Subject withdrew consent|0|||
155257313|NCT01090310|560373587|FG001|Extension Study|Subject withdrew consent|1|||
155257314|NCT01090310|560373588|FG002|Extension Study|Subject withdrew consent|0|||
155257315|NCT01090310|560373589|FG003|Extension Study|Subject withdrew consent|0|||
155257316|NCT00695786|560373590|FG000|Overall Study|Adverse Event|0|||
155257317|NCT00695786|560373591|FG001|Overall Study|Adverse Event|3|||
155257318|NCT00695786|560373592|FG002|Overall Study|Adverse Event|4|||
155257319|NCT00695786|560373593|FG003|Overall Study|Adverse Event|2|||
155257320|NCT00695786|560373590|FG000|Overall Study|Lost to Follow-up|0|||
155257321|NCT00695786|560373591|FG001|Overall Study|Lost to Follow-up|5|||
155257322|NCT00695786|560373592|FG002|Overall Study|Lost to Follow-up|1|||
155257323|NCT00695786|560373593|FG003|Overall Study|Lost to Follow-up|1|||
155257324|NCT00695786|560373590|FG000|Overall Study|Withdrawal by Subject|0|||
155257325|NCT00695786|560373591|FG001|Overall Study|Withdrawal by Subject|4|||
155257326|NCT00695786|560373592|FG002|Overall Study|Withdrawal by Subject|3|||
155257327|NCT00695786|560373593|FG003|Overall Study|Withdrawal by Subject|1|||
155257328|NCT00695786|560373590|FG000|Overall Study|Deemed Ineligible|1|||
155257329|NCT00695786|560373591|FG001|Overall Study|Deemed Ineligible|0|||
155257330|NCT00695786|560373592|FG002|Overall Study|Deemed Ineligible|0|||
155257331|NCT00695786|560373593|FG003|Overall Study|Deemed Ineligible|0|||
155257332|NCT00695786|560373590|FG000|Overall Study|Lack of Efficacy|0|||
155257333|NCT00695786|560373591|FG001|Overall Study|Lack of Efficacy|0|||
155257334|NCT00695786|560373592|FG002|Overall Study|Lack of Efficacy|0|||
155257335|NCT00695786|560373593|FG003|Overall Study|Lack of Efficacy|4|||
155257336|NCT01224925|560373594|FG000|Overall Study|Lost to Follow-up|3|||
155257337|NCT01224925|560373595|FG001|Overall Study|Lost to Follow-up|2|||
155257338|NCT04244396|560373599|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
155257339|NCT04244396|560373599|FG000|Overall Study|Withdrawal by Subject|2|||
155257340|NCT04244396|560373599|FG000|Overall Study|Study termination|37|||
155257341|NCT00949884|560373600|FG000|Overall Study|Adverse Event|14|||
155257342|NCT00949884|560373601|FG001|Overall Study|Adverse Event|3|||
155257343|NCT00949884|560373602|FG002|Overall Study|Adverse Event|12|||
155257344|NCT00949884|560373600|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
155257345|NCT00949884|560373601|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
155257346|NCT00949884|560373602|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
155257347|NCT00949884|560373600|FG000|Overall Study|Lost to Follow-up|7|||
155257348|NCT00949884|560373601|FG001|Overall Study|Lost to Follow-up|5|||
155257349|NCT00949884|560373602|FG002|Overall Study|Lost to Follow-up|5|||
155257350|NCT00949884|560373600|FG000|Overall Study|Physician Decision|5|||
155257351|NCT00949884|560373601|FG001|Overall Study|Physician Decision|0|||
155257352|NCT00949884|560373602|FG002|Overall Study|Physician Decision|6|||
155257353|NCT00949884|560373600|FG000|Overall Study|Treatment non-compliance|5|||
155257354|NCT00949884|560373601|FG001|Overall Study|Treatment non-compliance|0|||
155257355|NCT00949884|560373602|FG002|Overall Study|Treatment non-compliance|8|||
155257356|NCT00949884|560373600|FG000|Overall Study|Withdrawal by Subject|13|||
155257357|NCT00949884|560373601|FG001|Overall Study|Withdrawal by Subject|4|||
155257358|NCT00949884|560373602|FG002|Overall Study|Withdrawal by Subject|16|||
155257359|NCT00949884|560373600|FG000|Overall Study|Lack of Efficacy|4|||
155257360|NCT00949884|560373601|FG001|Overall Study|Lack of Efficacy|2|||
155257361|NCT00949884|560373602|FG002|Overall Study|Lack of Efficacy|7|||
155257362|NCT00949884|560373600|FG000|Overall Study|Study terminated by sponsor|0|||
155257363|NCT00949884|560373601|FG001|Overall Study|Study terminated by sponsor|0|||
155257364|NCT00949884|560373602|FG002|Overall Study|Study terminated by sponsor|1|||
155257365|NCT00245102|560373603|FG000|Overall Study|Not Treated|1|||
155257366|NCT00245102|560373604|FG001|Overall Study|Not Treated|0|||
155257367|NCT00245102|560373605|FG002|Overall Study|Not Treated|1|||
155257368|NCT00245102|560373606|FG003|Overall Study|Not Treated|0|||
155257369|NCT00245102|560373607|FG004|Overall Study|Not Treated|0|||
155257370|NCT00245102|560373608|FG005|Overall Study|Not Treated|0|||
155257371|NCT00245102|560373603|FG000|Overall Study|Protocol Violation|1|||
155257372|NCT00245102|560373604|FG001|Overall Study|Protocol Violation|0|||
155257373|NCT00245102|560373605|FG002|Overall Study|Protocol Violation|0|||
155257374|NCT00245102|560373606|FG003|Overall Study|Protocol Violation|0|||
155257375|NCT00245102|560373607|FG004|Overall Study|Protocol Violation|0|||
155257376|NCT00245102|560373608|FG005|Overall Study|Protocol Violation|0|||
155257377|NCT00245102|560373603|FG000|Overall Study|Death|0|||
155257378|NCT00245102|560373604|FG001|Overall Study|Death|0|||
155257379|NCT00245102|560373605|FG002|Overall Study|Death|0|||
155257380|NCT00245102|560373606|FG003|Overall Study|Death|1|||
155257381|NCT00245102|560373607|FG004|Overall Study|Death|0|||
155257382|NCT00245102|560373608|FG005|Overall Study|Death|0|||
155257383|NCT00245102|560373603|FG000|Overall Study|Adverse Event|4|||
155257384|NCT00245102|560373604|FG001|Overall Study|Adverse Event|2|||
155257385|NCT00245102|560373605|FG002|Overall Study|Adverse Event|5|||
155257386|NCT00245102|560373606|FG003|Overall Study|Adverse Event|1|||
155257387|NCT00245102|560373607|FG004|Overall Study|Adverse Event|0|||
155257388|NCT00245102|560373608|FG005|Overall Study|Adverse Event|2|||
155257389|NCT00245102|560373603|FG000|Overall Study|Decline in performance|0|||
155257390|NCT00245102|560373604|FG001|Overall Study|Decline in performance|2|||
155257391|NCT00245102|560373605|FG002|Overall Study|Decline in performance|0|||
155257392|NCT00245102|560373606|FG003|Overall Study|Decline in performance|1|||
155257393|NCT00245102|560373607|FG004|Overall Study|Decline in performance|0|||
155257394|NCT00245102|560373608|FG005|Overall Study|Decline in performance|2|||
155257395|NCT00245102|560373603|FG000|Overall Study|Participant needed surgery|0|||
155257396|NCT00245102|560373604|FG001|Overall Study|Participant needed surgery|0|||
155257397|NCT00245102|560373605|FG002|Overall Study|Participant needed surgery|1|||
155257398|NCT00245102|560373606|FG003|Overall Study|Participant needed surgery|0|||
155257399|NCT00245102|560373607|FG004|Overall Study|Participant needed surgery|0|||
155257400|NCT00245102|560373608|FG005|Overall Study|Participant needed surgery|0|||
155257401|NCT00245102|560373603|FG000|Overall Study|Clinical progression|1|||
155257402|NCT00245102|560373604|FG001|Overall Study|Clinical progression|0|||
155257403|NCT00245102|560373605|FG002|Overall Study|Clinical progression|0|||
155257404|NCT00245102|560373606|FG003|Overall Study|Clinical progression|0|||
155257405|NCT00245102|560373607|FG004|Overall Study|Clinical progression|0|||
155257406|NCT00245102|560373608|FG005|Overall Study|Clinical progression|0|||
155257407|NCT02293395|560373613|FG000|Overall Study|Lost to Follow-up|1|||
155257408|NCT02293395|560373614|FG001|Overall Study|Lost to Follow-up|0|||
155257409|NCT02293395|560373613|FG000|Overall Study|Withdrawal by Subject|8|||
155257410|NCT02293395|560373614|FG001|Overall Study|Withdrawal by Subject|7|||
155257411|NCT00224770|560373617|FG000|Overall Study|Lost to Follow-up|4|||
155257412|NCT00224770|560373618|FG001|Overall Study|Lost to Follow-up|2|||
155257413|NCT00224770|560373619|FG002|Overall Study|Lost to Follow-up|0|||
155257414|NCT01106430|560373620|FG000|Overall Study|Adverse Event|8|||
155257415|NCT01106430|560373621|FG001|Overall Study|Adverse Event|10|||
155257416|NCT01106430|560373620|FG000|Overall Study|Lack of Efficacy|2|||
155257417|NCT01106430|560373621|FG001|Overall Study|Lack of Efficacy|13|||
155257418|NCT01106430|560373620|FG000|Overall Study|Lost to Follow-up|5|||
155257419|NCT01106430|560373621|FG001|Overall Study|Lost to Follow-up|1|||
155257420|NCT01106430|560373620|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
155257421|NCT01106430|560373621|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
155257422|NCT01106430|560373620|FG000|Overall Study|Moved Out Of State|0|||
155257423|NCT01106430|560373621|FG001|Overall Study|Moved Out Of State|1|||
155257424|NCT01106430|560373620|FG000|Overall Study|Refused To Take Medication|0|||
155257425|NCT01106430|560373621|FG001|Overall Study|Refused To Take Medication|1|||
155257426|NCT01106430|560373620|FG000|Overall Study|Noncompliance|0|||
155257427|NCT01106430|560373621|FG001|Overall Study|Noncompliance|1|||
155257428|NCT01106430|560373620|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
155257429|NCT01106430|560373621|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
155257430|NCT01106430|560373620|FG000|Overall Study|Previous Use Of Marijuana|1|||
155257431|NCT01106430|560373621|FG001|Overall Study|Previous Use Of Marijuana|0|||
155257432|NCT01106430|560373620|FG000|Overall Study|Protocol Violation|7|||
155257433|NCT01106430|560373621|FG001|Overall Study|Protocol Violation|2|||
155257434|NCT01106430|560373620|FG000|Overall Study|Withdrawal by Subject|8|||
155257435|NCT01106430|560373621|FG001|Overall Study|Withdrawal by Subject|4|||
155257436|NCT00989092|560373626|FG000|Overall Study|Physician Decision|9|||
155257437|NCT00989092|560373627|FG001|Overall Study|Physician Decision|6|||
155257438|NCT00989092|560373626|FG000|Overall Study|Adverse Event|20|||
155257439|NCT00989092|560373627|FG001|Overall Study|Adverse Event|1|||
155257440|NCT00989092|560373626|FG000|Overall Study|Chemotherapy initiated|12|||
155257441|NCT00989092|560373627|FG001|Overall Study|Chemotherapy initiated|4|||
155257442|NCT00989092|560373626|FG000|Overall Study|Withdrawal by Subject|17|||
155257443|NCT00989092|560373627|FG001|Overall Study|Withdrawal by Subject|9|||
155257444|NCT00989092|560373626|FG000|Overall Study|Death|14|||
155257445|NCT00989092|560373627|FG001|Overall Study|Death|2|||
155257446|NCT00989092|560373626|FG000|Overall Study|Ineligibility determined|3|||
155257447|NCT00989092|560373627|FG001|Overall Study|Ineligibility determined|3|||
155257448|NCT00989092|560373626|FG000|Overall Study|Lost to Follow-up|6|||
155257449|NCT00989092|560373627|FG001|Overall Study|Lost to Follow-up|2|||
155257450|NCT00989092|560373626|FG000|Overall Study|Other|3|||
155257451|NCT00989092|560373627|FG001|Overall Study|Other|1|||
155257452|NCT00989092|560373626|FG000|Overall Study|Protocol deviation|2|||
155257453|NCT00989092|560373627|FG001|Overall Study|Protocol deviation|0|||
155257454|NCT00989092|560373626|FG000|Overall Study|Erythropoietin therapy initiated|2|||
155257455|NCT00989092|560373627|FG001|Overall Study|Erythropoietin therapy initiated|0|||
155257456|NCT00989092|560373626|FG000|Overall Study|Did not receive study drug|2|||
155257457|NCT00989092|560373627|FG001|Overall Study|Did not receive study drug|0|||
155257458|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
155257459|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
155257460|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
155257461|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
155257462|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
155257463|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
155257464|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Death|1|||
155257465|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Death|0|||
155257466|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Adverse Event|1|||
155257467|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Adverse Event|0|||
155257468|NCT02586025|560373631|FG000|Neoadjuvant Treatment|Physician Decision|2|||
155257469|NCT02586025|560373632|FG001|Neoadjuvant Treatment|Physician Decision|1|||
155257470|NCT02586025|560373631|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
155257471|NCT02586025|560373632|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
155257472|NCT02586025|560373631|FG000|Adjuvant Treatment|Recurrent Disease|4|||
155257473|NCT02586025|560373632|FG001|Adjuvant Treatment|Recurrent Disease|5|||
155257474|NCT02586025|560373631|FG000|Adjuvant Treatment|Physician Decision|0|||
155257475|NCT02586025|560373632|FG001|Adjuvant Treatment|Physician Decision|1|||
155257476|NCT02586025|560373631|FG000|Adjuvant Treatment|Pregnancy|1|||
155257477|NCT02586025|560373632|FG001|Adjuvant Treatment|Pregnancy|0|||
155257478|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Death|11|||
155257479|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Death|11|||
155257480|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
155257481|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
155257482|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
155257483|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
155257484|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
155257485|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
155257486|NCT02586025|560373631|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
155257487|NCT02586025|560373632|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
155257488|NCT01083641|560373633|FG000|Overall Study|Withdrawal by Subject|2|||
155257489|NCT03439189|560373634|FG000|Overall Study|Protocol Violation|19|||
155257490|NCT03439189|560373634|FG000|Overall Study|Lack of Efficacy|63|||
155257491|NCT03412812|560373635|FG000|Level 1|Death|3|||
155257492|NCT03412812|560373636|FG001|Level 1|Death|0|||
155257493|NCT03412812|560373635|FG000|Level 1|Adverse Event|0|||
155257494|NCT03412812|560373636|FG001|Level 1|Adverse Event|1|||
155257495|NCT03837509|560373637|FG000|Phase 1|Death|5|||
155257496|NCT03837509|560373638|FG001|Phase 1|Death|2|||
155257497|NCT03837509|560373639|FG002|Phase 1|Death|0|||
155257498|NCT03837509|560373640|FG003|Phase 1|Death|0|||
155257499|NCT03837509|560373641|FG004|Phase 1|Death|0|||
155257500|NCT03837509|560373637|FG000|Phase 2|Death|0|||
155257501|NCT03837509|560373638|FG001|Phase 2|Death|0|||
155257502|NCT03837509|560373639|FG002|Phase 2|Death|0|||
155257503|NCT03837509|560373640|FG003|Phase 2|Death|1|||
155257504|NCT03837509|560373641|FG004|Phase 2|Death|1|||
155257505|NCT03548207|560373646|FG000|Overall Study|Death|10|||
155257506|NCT03548207|560373647|FG001|Overall Study|Death|23|||
155257507|NCT03548207|560373648|FG002|Overall Study|Death|3|||
155257508|NCT03548207|560373646|FG000|Overall Study|Lost to Follow-up|0|||
155257509|NCT03548207|560373647|FG001|Overall Study|Lost to Follow-up|2|||
155257510|NCT03548207|560373648|FG002|Overall Study|Lost to Follow-up|0|||
155257511|NCT03548207|560373646|FG000|Overall Study|Withdrawal by Subject|0|||
155257512|NCT03548207|560373647|FG001|Overall Study|Withdrawal by Subject|3|||
155257513|NCT03548207|560373648|FG002|Overall Study|Withdrawal by Subject|0|||
155257514|NCT03548207|560373646|FG000|Overall Study|Sponsor decision|19|||
155257515|NCT03548207|560373647|FG001|Overall Study|Sponsor decision|40|||
155257516|NCT03548207|560373648|FG002|Overall Study|Sponsor decision|6|||
155257517|NCT03548207|560373646|FG000|Overall Study|Randomized but not treated|6|||
155257518|NCT03548207|560373647|FG001|Overall Study|Randomized but not treated|10|||
155257519|NCT03548207|560373648|FG002|Overall Study|Randomized but not treated|4|||
155257520|NCT01756352|560373649|FG000|Overall Study|moved away and lost to followup|1|||
155257521|NCT00415610|560373650|FG000|Overall Study|Death|3|||
155257522|NCT00415610|560373651|FG001|Overall Study|Death|2|||
155257523|NCT00415610|560373652|FG002|Overall Study|Death|5|||
155257524|NCT00526630|560373653|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
155257525|NCT00526630|560373654|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
155257526|NCT00526630|560373653|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
155257527|NCT00526630|560373654|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
155257528|NCT00337272|560373655|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
155257529|NCT00337272|560373656|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
155257530|NCT00337272|560373655|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
155257531|NCT00337272|560373656|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
155257532|NCT00337272|560373655|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
155257533|NCT00337272|560373656|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
155257534|NCT00337272|560373655|FG000|Treatment Period|Non-compliance|1|||
155257535|NCT00337272|560373656|FG001|Treatment Period|Non-compliance|1|||
155257536|NCT00337272|560373655|FG000|Treatment Period|Withdrawal by Subject|0|||
155257537|NCT00337272|560373656|FG001|Treatment Period|Withdrawal by Subject|1|||
155257538|NCT00337272|560373655|FG000|Withdrawal Period|Non-compliance|0|||
155257539|NCT00337272|560373656|FG001|Withdrawal Period|Non-compliance|1|||
155257540|NCT03320018|560373657|FG000|Treatment Period|Withdrawal by Subject|1|||
155257541|NCT03320018|560373658|FG001|Treatment Period|Withdrawal by Subject|0|||
155257542|NCT03320018|560373657|FG000|Day 90 Follow up|Death|0|||
155257543|NCT03320018|560373658|FG001|Day 90 Follow up|Death|1|||
155257544|NCT02641392|560373659|FG000|Overall Study|Lost to Follow-up|0|||
155257545|NCT02641392|560373660|FG001|Overall Study|Lost to Follow-up|0|||
155257546|NCT02641392|560373661|FG002|Overall Study|Lost to Follow-up|2|||
155257547|NCT02641392|560373659|FG000|Overall Study|Withdrawal by Subject|0|||
155257548|NCT02641392|560373660|FG001|Overall Study|Withdrawal by Subject|0|||
155257549|NCT02641392|560373661|FG002|Overall Study|Withdrawal by Subject|17|||
155257550|NCT02641392|560373659|FG000|Overall Study|Adverse Event|0|||
155257551|NCT02641392|560373660|FG001|Overall Study|Adverse Event|1|||
155257552|NCT02641392|560373661|FG002|Overall Study|Adverse Event|25|||
155257553|NCT02641392|560373659|FG000|Overall Study|Study Terminated by Sponsor|4|||
155257554|NCT02641392|560373660|FG001|Overall Study|Study Terminated by Sponsor|12|||
155257555|NCT02641392|560373661|FG002|Overall Study|Study Terminated by Sponsor|144|||
155257556|NCT02641392|560373659|FG000|Overall Study|Lack of Efficacy|0|||
155257557|NCT02641392|560373660|FG001|Overall Study|Lack of Efficacy|0|||
155257558|NCT02641392|560373661|FG002|Overall Study|Lack of Efficacy|101|||
155257559|NCT02641392|560373659|FG000|Overall Study|Miscellaneous|0|||
155257560|NCT02641392|560373660|FG001|Overall Study|Miscellaneous|0|||
155257561|NCT02641392|560373661|FG002|Overall Study|Miscellaneous|3|||
155257562|NCT02641392|560373659|FG000|Overall Study|Death|0|||
155257563|NCT02641392|560373660|FG001|Overall Study|Death|0|||
155257564|NCT02641392|560373661|FG002|Overall Study|Death|1|||
155257565|NCT02691182|560373662|FG000|Overall Study|Withdrawal by Subject|4|||
155257566|NCT02691182|560373663|FG001|Overall Study|Withdrawal by Subject|7|||
155257567|NCT02691182|560373664|FG002|Overall Study|Withdrawal by Subject|6|||
155257568|NCT02691182|560373665|FG003|Overall Study|Withdrawal by Subject|8|||
155257569|NCT02691182|560373662|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
155257570|NCT02691182|560373663|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
155257571|NCT02691182|560373664|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
155257572|NCT02691182|560373665|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
155257573|NCT02691182|560373662|FG000|Overall Study|Lost to Follow-up|8|||
155257574|NCT02691182|560373663|FG001|Overall Study|Lost to Follow-up|33|||
155257575|NCT02691182|560373664|FG002|Overall Study|Lost to Follow-up|19|||
155257576|NCT02691182|560373665|FG003|Overall Study|Lost to Follow-up|22|||
155257577|NCT02691182|560373662|FG000|Overall Study|Adverse Event|3|||
155257578|NCT02691182|560373663|FG001|Overall Study|Adverse Event|10|||
155257579|NCT02691182|560373664|FG002|Overall Study|Adverse Event|10|||
155257580|NCT02691182|560373665|FG003|Overall Study|Adverse Event|11|||
155257581|NCT02691182|560373662|FG000|Overall Study|Physician Decision|3|||
155257582|NCT02691182|560373663|FG001|Overall Study|Physician Decision|7|||
155257583|NCT02691182|560373664|FG002|Overall Study|Physician Decision|14|||
155257584|NCT02691182|560373665|FG003|Overall Study|Physician Decision|8|||
155257585|NCT02691182|560373662|FG000|Overall Study|Lack of Efficacy|0|||
155257586|NCT02691182|560373663|FG001|Overall Study|Lack of Efficacy|0|||
155257587|NCT02691182|560373664|FG002|Overall Study|Lack of Efficacy|0|||
155257588|NCT02691182|560373665|FG003|Overall Study|Lack of Efficacy|4|||
155257589|NCT02691182|560373662|FG000|Overall Study|Protocol Violation|2|||
155257590|NCT02691182|560373663|FG001|Overall Study|Protocol Violation|6|||
155257591|NCT02691182|560373664|FG002|Overall Study|Protocol Violation|6|||
155257592|NCT02691182|560373665|FG003|Overall Study|Protocol Violation|8|||
155257593|NCT02691182|560373662|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
155257594|NCT02691182|560373663|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
155257595|NCT02691182|560373664|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
155257596|NCT02691182|560373665|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
155257597|NCT02691182|560373662|FG000|Overall Study|Missing|0|||
155257598|NCT02691182|560373663|FG001|Overall Study|Missing|5|||
155257599|NCT02691182|560373664|FG002|Overall Study|Missing|1|||
155257600|NCT02691182|560373665|FG003|Overall Study|Missing|5|||
155257601|NCT02799784|560373672|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
155257602|NCT02799784|560373673|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
155257603|NCT02799784|560373672|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
155257604|NCT02799784|560373673|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
155257605|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
155257606|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
155257607|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
155257608|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
155257609|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
155257610|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
155257611|NCT02799784|560373672|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
155257612|NCT02799784|560373673|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
155257613|NCT02954354|560373674|FG000|Overall Study|Adverse Event|2|||
155257614|NCT02954354|560373675|FG001|Overall Study|Adverse Event|2|||
155257615|NCT02954354|560373676|FG002|Overall Study|Adverse Event|4|||
155257616|NCT02954354|560373674|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
155257617|NCT02954354|560373675|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
155257618|NCT02954354|560373676|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
155257619|NCT02954354|560373674|FG000|Overall Study|Lack of Efficacy|0|||
155257620|NCT02954354|560373675|FG001|Overall Study|Lack of Efficacy|2|||
155257621|NCT02954354|560373676|FG002|Overall Study|Lack of Efficacy|0|||
155257622|NCT02954354|560373674|FG000|Overall Study|Withdrawal by Subject|17|||
155257623|NCT02954354|560373675|FG001|Overall Study|Withdrawal by Subject|9|||
155257624|NCT02954354|560373676|FG002|Overall Study|Withdrawal by Subject|11|||
155257625|NCT02954354|560373674|FG000|Overall Study|Lost to Follow-up|12|||
155257626|NCT02954354|560373675|FG001|Overall Study|Lost to Follow-up|5|||
155257627|NCT02954354|560373676|FG002|Overall Study|Lost to Follow-up|0|||
155257628|NCT02954354|560373674|FG000|Overall Study|Miscellaneous|2|||
155257629|NCT02954354|560373675|FG001|Overall Study|Miscellaneous|2|||
155257630|NCT02954354|560373676|FG002|Overall Study|Miscellaneous|1|||
155257631|NCT03440372|560373680|FG000|Treatment|Adverse Event|16|||
155257632|NCT03440372|560373681|FG001|Treatment|Adverse Event|8|||
155257633|NCT03440372|560373680|FG000|Treatment|Lack of Efficacy|4|||
155257634|NCT03440372|560373681|FG001|Treatment|Lack of Efficacy|2|||
155257635|NCT03440372|560373680|FG000|Treatment|Withdrawal by Subject|12|||
155257636|NCT03440372|560373681|FG001|Treatment|Withdrawal by Subject|8|||
155257637|NCT03440372|560373680|FG000|Treatment|Lost to Follow-up|1|||
155257638|NCT03440372|560373681|FG001|Treatment|Lost to Follow-up|0|||
155257639|NCT03440372|560373680|FG000|Treatment|Pregnancy|1|||
155257640|NCT03440372|560373681|FG001|Treatment|Pregnancy|0|||
155257641|NCT03440372|560373680|FG000|Treatment|Study Terminated by Sponsor|2|||
155257642|NCT03440372|560373681|FG001|Treatment|Study Terminated by Sponsor|1|||
155257643|NCT03440372|560373680|FG000|Treatment|Other Reason|2|||
155257644|NCT03440372|560373681|FG001|Treatment|Other Reason|3|||
155257645|NCT03945292|560373682|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
155257646|NCT03945292|560373683|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257647|NCT03945292|560373684|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
155257648|NCT03945292|560373685|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257649|NCT03945292|560373686|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257650|NCT03945292|560373687|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257651|NCT03945292|560373688|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257652|NCT03945292|560373689|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
155257653|NCT03945292|560373682|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257654|NCT03945292|560373683|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257655|NCT03945292|560373684|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
155257656|NCT03945292|560373685|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257657|NCT03945292|560373686|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257658|NCT03945292|560373687|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257659|NCT03945292|560373688|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257660|NCT03945292|560373689|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
155257661|NCT03945292|560373682|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257662|NCT03945292|560373683|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257663|NCT03945292|560373684|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257664|NCT03945292|560373685|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257665|NCT03945292|560373686|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257666|NCT03945292|560373687|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257667|NCT03945292|560373688|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
155257668|NCT03945292|560373689|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
155257669|NCT03721965|560373703|FG000|Overall Study|Death|1|||
155257670|NCT03721965|560373703|FG000|Overall Study|Study Terminated by Sponsor|1|||
155257671|NCT01328080|560373704|FG000|Overall Study|Lost to Follow-up|5|||
155257672|NCT01499082|560373707|FG000|Overall Study|Randomized but not Treated|0|||
155257673|NCT01499082|560373708|FG001|Overall Study|Randomized but not Treated|1|||
155257674|NCT01499082|560373707|FG000|Overall Study|Adverse Event|12|||
155257675|NCT01499082|560373708|FG001|Overall Study|Adverse Event|16|||
155257676|NCT01499082|560373707|FG000|Overall Study|Lack of Efficacy|1|||
155257677|NCT01499082|560373708|FG001|Overall Study|Lack of Efficacy|1|||
155257678|NCT01499082|560373707|FG000|Overall Study|Protocol Violation|6|||
155257679|NCT01499082|560373708|FG001|Overall Study|Protocol Violation|8|||
155257680|NCT01499082|560373707|FG000|Overall Study|Diverse Reasons|18|||
155257681|NCT01499082|560373708|FG001|Overall Study|Diverse Reasons|14|||
155257682|NCT01499082|560373707|FG000|Overall Study|Site Closure for Noncompliance|5|||
155257683|NCT01499082|560373708|FG001|Overall Study|Site Closure for Noncompliance|2|||
155257684|NCT01499082|560373707|FG000|Overall Study|Hypoglycemia|2|||
155257685|NCT01499082|560373708|FG001|Overall Study|Hypoglycemia|3|||
155257686|NCT01499082|560373707|FG000|Overall Study|Lost to Follow-up|1|||
155257687|NCT01499082|560373708|FG001|Overall Study|Lost to Follow-up|3|||
155257688|NCT05380947|560373713|FG000|Washout Period 1|Not attend visit|1|||
155257689|NCT05380947|560373714|FG001|Washout Period 1|Not attend visit|0|||
155257690|NCT05380947|560373715|FG002|Washout Period 1|Not attend visit|0|||
155257691|NCT05380947|560373716|FG003|Washout Period 1|Not attend visit|0|||
155257692|NCT05380947|560373713|FG000|Washout Period 2|Adverse Event|1|||
155257693|NCT05380947|560373714|FG001|Washout Period 2|Adverse Event|0|||
155257694|NCT05380947|560373715|FG002|Washout Period 2|Adverse Event|0|||
155257695|NCT05380947|560373716|FG003|Washout Period 2|Adverse Event|0|||
155257696|NCT05380947|560373713|FG000|Washout Period 3|Adverse Event|0|||
155257697|NCT05380947|560373714|FG001|Washout Period 3|Adverse Event|1|||
155257698|NCT05380947|560373715|FG002|Washout Period 3|Adverse Event|0|||
155257699|NCT05380947|560373716|FG003|Washout Period 3|Adverse Event|0|||
155257700|NCT05380947|560373713|FG000|Washout Period 3|Not attend visit|0|||
155257701|NCT05380947|560373714|FG001|Washout Period 3|Not attend visit|1|||
155257702|NCT05380947|560373715|FG002|Washout Period 3|Not attend visit|0|||
155257703|NCT05380947|560373716|FG003|Washout Period 3|Not attend visit|1|||
155257704|NCT01563536|560373717|FG000|Overall Study|Withdrawal by Subject|0|||
155257705|NCT01563536|560373718|FG001|Overall Study|Withdrawal by Subject|2|||
155257706|NCT01563536|560373717|FG000|Overall Study|Lost to Follow-up|1|||
155257707|NCT01563536|560373718|FG001|Overall Study|Lost to Follow-up|0|||
155257708|NCT00058123|560373721|FG000|Overall Study|Wrong histology|9|||
155257709|NCT00058123|560373721|FG000|Overall Study|Received >3 prior treatments|1|||
155257710|NCT02151266|560373724|FG000|Overall Study|Lost to Follow-up|1|||
155257711|NCT02151266|560373725|FG001|Overall Study|Lost to Follow-up|4|||
155257712|NCT02151266|560373726|FG002|Overall Study|Lost to Follow-up|1|||
155257713|NCT02151266|560373724|FG000|Overall Study|Did NOT receive intervention|3|||
155257714|NCT02151266|560373725|FG001|Overall Study|Did NOT receive intervention|6|||
155257715|NCT02151266|560373726|FG002|Overall Study|Did NOT receive intervention|2|||
155257716|NCT02151266|560373724|FG000|Overall Study|Not able to exercise|4|||
155257717|NCT02151266|560373725|FG001|Overall Study|Not able to exercise|5|||
155257718|NCT02151266|560373726|FG002|Overall Study|Not able to exercise|4|||
155257719|NCT01169675|560373727|FG000|Overall Study|Progressive disease|13|||
155257720|NCT01169675|560373728|FG001|Overall Study|Progressive disease|2|||
155257721|NCT01169675|560373729|FG002|Overall Study|Progressive disease|5|||
155257722|NCT01169675|560373730|FG003|Overall Study|Progressive disease|15|||
155257723|NCT01169675|560373731|FG004|Overall Study|Progressive disease|1|||
155257724|NCT01169675|560373727|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
155257725|NCT01169675|560373728|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155257726|NCT01169675|560373729|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155257727|NCT01169675|560373730|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
155257728|NCT01169675|560373731|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
155257729|NCT01169675|560373727|FG000|Overall Study|Adverse Event|5|||
155257730|NCT01169675|560373728|FG001|Overall Study|Adverse Event|1|||
155257731|NCT01169675|560373729|FG002|Overall Study|Adverse Event|2|||
155257732|NCT01169675|560373730|FG003|Overall Study|Adverse Event|0|||
155257733|NCT01169675|560373731|FG004|Overall Study|Adverse Event|0|||
155257734|NCT01169675|560373727|FG000|Overall Study|Withdrawal by Subject|1|||
155257735|NCT01169675|560373728|FG001|Overall Study|Withdrawal by Subject|0|||
155257736|NCT01169675|560373729|FG002|Overall Study|Withdrawal by Subject|0|||
155257737|NCT01169675|560373730|FG003|Overall Study|Withdrawal by Subject|1|||
155257738|NCT01169675|560373731|FG004|Overall Study|Withdrawal by Subject|2|||
155257739|NCT01169675|560373727|FG000|Overall Study|Other Reason Not Defined Above|0|||
155257740|NCT01169675|560373728|FG001|Overall Study|Other Reason Not Defined Above|0|||
155257741|NCT01169675|560373729|FG002|Overall Study|Other Reason Not Defined Above|0|||
155257742|NCT01169675|560373730|FG003|Overall Study|Other Reason Not Defined Above|1|||
155257743|NCT01169675|560373731|FG004|Overall Study|Other Reason Not Defined Above|1|||
155257744|NCT02816138|560373734|FG000|Overall Study|Adverse Event|1|||
155257745|NCT04839965|560373735|FG000|Overall Study|Death|6|||
155257746|NCT04839965|560373736|FG001|Overall Study|Death|6|||
155257747|NCT04839965|560373735|FG000|Overall Study|Lost to Follow-up|1|||
155257748|NCT04839965|560373736|FG001|Overall Study|Lost to Follow-up|0|||
155257749|NCT02355028|560373737|FG000|Overall Study|Adverse Event|2|||
155257750|NCT02355028|560373738|FG001|Overall Study|Adverse Event|0|||
155257751|NCT02355028|560373737|FG000|Overall Study|Withdrawal by Subject|1|||
155257752|NCT02355028|560373738|FG001|Overall Study|Withdrawal by Subject|1|||
155257753|NCT02355028|560373737|FG000|Overall Study|Deemed ineligible after randomization|8|||
155257754|NCT02355028|560373738|FG001|Overall Study|Deemed ineligible after randomization|4|||
155257755|NCT02276222|560373739|FG000|Overall Study|Adverse Event|62|||
155257756|NCT02276222|560373740|FG001|Overall Study|Adverse Event|11|||
155257757|NCT02276222|560373739|FG000|Overall Study|Death|3|||
155257758|NCT02276222|560373740|FG001|Overall Study|Death|4|||
155257759|NCT02276222|560373739|FG000|Overall Study|Lack of Efficacy|13|||
155257760|NCT02276222|560373740|FG001|Overall Study|Lack of Efficacy|3|||
155257761|NCT02276222|560373739|FG000|Overall Study|Protocol Violation|3|||
155257762|NCT02276222|560373740|FG001|Overall Study|Protocol Violation|2|||
155257763|NCT02276222|560373739|FG000|Overall Study|Withdrawal by Subject|79|||
155257764|NCT02276222|560373740|FG001|Overall Study|Withdrawal by Subject|33|||
155257765|NCT02276222|560373739|FG000|Overall Study|non compliance with study medication|6|||
155257766|NCT02276222|560373740|FG001|Overall Study|non compliance with study medication|2|||
155257767|NCT02276222|560373739|FG000|Overall Study|sponsor decision|0|||
155257768|NCT02276222|560373740|FG001|Overall Study|sponsor decision|3|||
155257769|NCT02276222|560373739|FG000|Overall Study|Lost to Follow-up|15|||
155257770|NCT02276222|560373740|FG001|Overall Study|Lost to Follow-up|5|||
155257771|NCT02276222|560373739|FG000|Overall Study|Physician Decision|2|||
155257772|NCT02276222|560373740|FG001|Overall Study|Physician Decision|1|||
155257773|NCT02276222|560373739|FG000|Overall Study|sheduling conflict|1|||
155257774|NCT02276222|560373740|FG001|Overall Study|sheduling conflict|0|||
155257775|NCT02276222|560373739|FG000|Overall Study|subject withdrew after randomization|1|||
155257776|NCT02276222|560373740|FG001|Overall Study|subject withdrew after randomization|0|||
155257777|NCT04102579|560373741|FG000|Overall Study|Withdrawal by Subject|3|||
155257778|NCT04102579|560373742|FG001|Overall Study|Withdrawal by Subject|4|||
155257779|NCT04102579|560373741|FG000|Overall Study|Lost to Follow-up|0|||
155257780|NCT04102579|560373742|FG001|Overall Study|Lost to Follow-up|1|||
155257781|NCT04102579|560373741|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
155257782|NCT04102579|560373742|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
155257783|NCT04102579|560373741|FG000|Overall Study|Other than Specified|1|||
155257784|NCT04102579|560373742|FG001|Overall Study|Other than Specified|0|||
155257785|NCT04102579|560373741|FG000|Overall Study|Not Dosed with Study Drug|0|||
155257786|NCT04102579|560373742|FG001|Overall Study|Not Dosed with Study Drug|1|||
155257787|NCT05899686|560373743|FG000|Overall Study|Protocol Violation|1|||
155257788|NCT02170025|560373744|FG000|Overall Study|Adverse Event|2|||
155257789|NCT02170025|560373745|FG001|Overall Study|Adverse Event|0|||
155257790|NCT00572195|560373746|FG000|Overall Study|Withdrawal by Subject|50|||
155257791|NCT00572195|560373746|FG000|Overall Study|Death|9|||
155257792|NCT00572195|560373746|FG000|Overall Study|Adverse Event|4|||
155257793|NCT00572195|560373746|FG000|Overall Study|Lost to Follow-up|5|||
155257794|NCT01525602|560373747|FG000|Overall Study|Adverse Event|1|||
155257795|NCT01525602|560373748|FG001|Overall Study|Adverse Event|0|||
155257796|NCT01525602|560373749|FG002|Overall Study|Adverse Event|1|||
155257797|NCT01525602|560373750|FG003|Overall Study|Adverse Event|1|||
155257798|NCT01525602|560373751|FG004|Overall Study|Adverse Event|3|||
155257799|NCT01525602|560373752|FG005|Overall Study|Adverse Event|3|||
155257800|NCT01525602|560373753|FG006|Overall Study|Adverse Event|0|||
155257801|NCT01525602|560373754|FG007|Overall Study|Adverse Event|1|||
155257802|NCT01525602|560373747|FG000|Overall Study|Disease progression|6|||
155257803|NCT01525602|560373748|FG001|Overall Study|Disease progression|3|||
155257804|NCT01525602|560373749|FG002|Overall Study|Disease progression|2|||
155257805|NCT01525602|560373750|FG003|Overall Study|Disease progression|5|||
155257806|NCT01525602|560373751|FG004|Overall Study|Disease progression|22|||
155257807|NCT01525602|560373752|FG005|Overall Study|Disease progression|2|||
155257808|NCT01525602|560373753|FG006|Overall Study|Disease progression|3|||
155257809|NCT01525602|560373754|FG007|Overall Study|Disease progression|3|||
155257810|NCT01525602|560373747|FG000|Overall Study|Clinical progression|2|||
155257811|NCT01525602|560373748|FG001|Overall Study|Clinical progression|0|||
155257812|NCT01525602|560373749|FG002|Overall Study|Clinical progression|0|||
155257813|NCT01525602|560373750|FG003|Overall Study|Clinical progression|0|||
155257814|NCT01525602|560373751|FG004|Overall Study|Clinical progression|0|||
155257815|NCT01525602|560373752|FG005|Overall Study|Clinical progression|0|||
155257816|NCT01525602|560373753|FG006|Overall Study|Clinical progression|1|||
155257817|NCT01525602|560373754|FG007|Overall Study|Clinical progression|1|||
155257818|NCT01525602|560373747|FG000|Overall Study|Non-compliance|0|||
155257819|NCT01525602|560373748|FG001|Overall Study|Non-compliance|0|||
155257820|NCT01525602|560373749|FG002|Overall Study|Non-compliance|0|||
155257821|NCT01525602|560373750|FG003|Overall Study|Non-compliance|0|||
155257822|NCT01525602|560373751|FG004|Overall Study|Non-compliance|1|||
155257823|NCT01525602|560373752|FG005|Overall Study|Non-compliance|0|||
155257824|NCT01525602|560373753|FG006|Overall Study|Non-compliance|0|||
155257825|NCT01525602|560373754|FG007|Overall Study|Non-compliance|0|||
155257826|NCT01525602|560373747|FG000|Overall Study|Withdrawal by Subject|0|||
155257827|NCT01525602|560373748|FG001|Overall Study|Withdrawal by Subject|0|||
155257828|NCT01525602|560373749|FG002|Overall Study|Withdrawal by Subject|0|||
155257829|NCT01525602|560373750|FG003|Overall Study|Withdrawal by Subject|0|||
155257830|NCT01525602|560373751|FG004|Overall Study|Withdrawal by Subject|3|||
155257831|NCT01525602|560373752|FG005|Overall Study|Withdrawal by Subject|1|||
155257832|NCT01525602|560373753|FG006|Overall Study|Withdrawal by Subject|0|||
155257833|NCT01525602|560373754|FG007|Overall Study|Withdrawal by Subject|1|||
155257834|NCT01525602|560373747|FG000|Overall Study|Physician Decision|0|||
155257835|NCT01525602|560373748|FG001|Overall Study|Physician Decision|0|||
155257836|NCT01525602|560373749|FG002|Overall Study|Physician Decision|0|||
155257837|NCT01525602|560373750|FG003|Overall Study|Physician Decision|0|||
155257838|NCT01525602|560373751|FG004|Overall Study|Physician Decision|3|||
155257839|NCT01525602|560373752|FG005|Overall Study|Physician Decision|0|||
155257840|NCT01525602|560373753|FG006|Overall Study|Physician Decision|1|||
155257841|NCT01525602|560373754|FG007|Overall Study|Physician Decision|0|||
155257842|NCT01525602|560373747|FG000|Overall Study|Death|0|||
155257843|NCT01525602|560373748|FG001|Overall Study|Death|0|||
155257844|NCT01525602|560373749|FG002|Overall Study|Death|0|||
155257845|NCT01525602|560373750|FG003|Overall Study|Death|0|||
155257846|NCT01525602|560373751|FG004|Overall Study|Death|1|||
155257847|NCT01525602|560373752|FG005|Overall Study|Death|1|||
155257848|NCT01525602|560373753|FG006|Overall Study|Death|0|||
155257849|NCT01525602|560373754|FG007|Overall Study|Death|0|||
155257850|NCT01525602|560373747|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257851|NCT01525602|560373748|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257852|NCT01525602|560373749|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257853|NCT01525602|560373750|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257854|NCT01525602|560373751|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257855|NCT01525602|560373752|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
155257856|NCT01525602|560373753|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
155257857|NCT01525602|560373754|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
155257858|NCT03703466|560373755|FG000|Overall Study|Death|2|||
155257859|NCT03703466|560373756|FG001|Overall Study|Death|1|||
155257860|NCT03703466|560373757|FG002|Overall Study|Death|0|||
155257861|NCT03703466|560373755|FG000|Overall Study|Withdrawal by Subject|0|||
155257862|NCT03703466|560373756|FG001|Overall Study|Withdrawal by Subject|3|||
155257863|NCT03703466|560373757|FG002|Overall Study|Withdrawal by Subject|0|||
155257864|NCT03703466|560373755|FG000|Overall Study|Completed < 3 Cycles|2|||
155257865|NCT03703466|560373756|FG001|Overall Study|Completed < 3 Cycles|2|||
155257866|NCT03703466|560373757|FG002|Overall Study|Completed < 3 Cycles|2|||
155257867|NCT02563002|560375630|FG000|Overall Study|Death|72|||
155257868|NCT02563002|560375631|FG001|Overall Study|Death|87|||
155257869|NCT02563002|560375630|FG000|Overall Study|Lost to Follow-up|5|||
155257870|NCT02563002|560375631|FG001|Overall Study|Lost to Follow-up|0|||
155257871|NCT02563002|560375630|FG000|Overall Study|Physician Decision|0|||
155257872|NCT02563002|560375631|FG001|Overall Study|Physician Decision|2|||
155257873|NCT02563002|560375630|FG000|Overall Study|Withdrawal by Subject|2|||
155257874|NCT02563002|560375631|FG001|Overall Study|Withdrawal by Subject|10|||
155257875|NCT02563002|560375630|FG000|Overall Study|Sponsor decision|74|||
155257876|NCT02563002|560375631|FG001|Overall Study|Sponsor decision|55|||
155257877|NCT03518125|560375638|FG000|Overall Study|Lost to Follow-up|0|||
155257878|NCT03518125|560375639|FG001|Overall Study|Lost to Follow-up|2|||
155257879|NCT03518125|560375640|FG002|Overall Study|Lost to Follow-up|0|||
155257880|NCT03518125|560375641|FG003|Overall Study|Lost to Follow-up|0|||
155257881|NCT03518125|560375642|FG004|Overall Study|Lost to Follow-up|3|||
155257882|NCT03518125|560375643|FG005|Overall Study|Lost to Follow-up|5|||
155257883|NCT03518125|560375638|FG000|Overall Study|Physician Decision|0|||
155257884|NCT03518125|560375639|FG001|Overall Study|Physician Decision|1|||
155257885|NCT03518125|560375640|FG002|Overall Study|Physician Decision|0|||
155257886|NCT03518125|560375641|FG003|Overall Study|Physician Decision|0|||
155257887|NCT03518125|560375642|FG004|Overall Study|Physician Decision|0|||
155257888|NCT03518125|560375643|FG005|Overall Study|Physician Decision|0|||
155257889|NCT03518125|560375638|FG000|Overall Study|Withdrawal by Subject|1|||
155257890|NCT03518125|560375639|FG001|Overall Study|Withdrawal by Subject|1|||
155257891|NCT03518125|560375640|FG002|Overall Study|Withdrawal by Subject|0|||
155257892|NCT03518125|560375641|FG003|Overall Study|Withdrawal by Subject|1|||
155257893|NCT03518125|560375642|FG004|Overall Study|Withdrawal by Subject|1|||
155257894|NCT03518125|560375643|FG005|Overall Study|Withdrawal by Subject|3|||
155257895|NCT03518125|560375638|FG000|Overall Study|Missed Day 394 Visit|1|||
155257896|NCT03518125|560375639|FG001|Overall Study|Missed Day 394 Visit|0|||
155257897|NCT03518125|560375640|FG002|Overall Study|Missed Day 394 Visit|0|||
155257898|NCT03518125|560375641|FG003|Overall Study|Missed Day 394 Visit|0|||
155257899|NCT03518125|560375642|FG004|Overall Study|Missed Day 394 Visit|0|||
155257900|NCT03518125|560375643|FG005|Overall Study|Missed Day 394 Visit|0|||
155257901|NCT04452877|560375644|FG000|Overall Study|Adverse Event|5|||
155257902|NCT04452877|560375644|FG000|Overall Study|Lost to Follow-up|1|||
155257903|NCT04452877|560375644|FG000|Overall Study|Physician Decision|4|||
155257904|NCT04452877|560375644|FG000|Overall Study|Progressive Disease|18|||
155257905|NCT04452877|560375644|FG000|Overall Study|Withdrawal by Subject|3|||
155257906|NCT05453110|560375647|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
155257907|NCT05453110|560375648|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
155257908|NCT05453110|560375649|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
155257909|NCT01662063|560375653|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
155257910|NCT01662063|560375654|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
155257911|NCT01662063|560375655|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
155257912|NCT01662063|560375653|FG000|Overall Study|Lack of Efficacy|1|||
155257913|NCT01662063|560375654|FG001|Overall Study|Lack of Efficacy|6|||
155257914|NCT01662063|560375655|FG002|Overall Study|Lack of Efficacy|0|||
155257915|NCT01662063|560375653|FG000|Overall Study|Lost to Follow-up|0|||
155257916|NCT01662063|560375654|FG001|Overall Study|Lost to Follow-up|4|||
155257917|NCT01662063|560375655|FG002|Overall Study|Lost to Follow-up|0|||
155257918|NCT01662063|560375653|FG000|Overall Study|Protocol Violation|1|||
155257919|NCT01662063|560375654|FG001|Overall Study|Protocol Violation|0|||
155257920|NCT01662063|560375655|FG002|Overall Study|Protocol Violation|0|||
155257921|NCT01662063|560375653|FG000|Overall Study|Withdrawal by Subject|2|||
155257922|NCT01662063|560375654|FG001|Overall Study|Withdrawal by Subject|4|||
155257923|NCT01662063|560375655|FG002|Overall Study|Withdrawal by Subject|1|||
155257924|NCT01662063|560375653|FG000|Overall Study|Physician Decision|0|||
155257925|NCT01662063|560375654|FG001|Overall Study|Physician Decision|2|||
155257926|NCT01662063|560375655|FG002|Overall Study|Physician Decision|0|||
155257927|NCT01662063|560375653|FG000|Overall Study|Other|0|||
155257928|NCT01662063|560375654|FG001|Overall Study|Other|1|||
155257929|NCT01662063|560375655|FG002|Overall Study|Other|0|||
155257930|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
155257931|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
155257932|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
155257933|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
155257934|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
155257935|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
155257936|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
155257937|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
155257938|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
155257939|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
155257940|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
155257941|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
155257942|NCT00293267|560375656|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
155257943|NCT00293267|560375657|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
155257944|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
155257945|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
155257946|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
155257947|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
155257948|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
155257949|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
155257950|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
155257951|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
155257952|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Death|3|||
155257953|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Death|0|||
155257954|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
155257955|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
155257956|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
155257957|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
155257958|NCT00293267|560375656|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
155257959|NCT00293267|560375657|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
155257960|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
155257961|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
155257962|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
155257963|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
155257964|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
155257965|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
155257966|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
155257967|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
155257968|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
155257969|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
155257970|NCT00293267|560375656|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
155257971|NCT00293267|560375657|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
155257972|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
155257973|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
155257974|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
155257975|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
155257976|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
155257977|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
155257978|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
155257979|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
155257980|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
155257981|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
155257982|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
155257983|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
155257984|NCT00293267|560375656|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
155257985|NCT00293267|560375657|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
155257986|NCT01050816|560375658|FG000|Overall Study|Lost to Follow-up|2|||
155257987|NCT01050816|560375658|FG000|Overall Study|patient's refusal|2|||
155257988|NCT01123382|560375661|FG000|Overall Study|Withdrawal by Subject|1|||
155257989|NCT01123382|560375662|FG001|Overall Study|Withdrawal by Subject|4|||
155257990|NCT01123382|560375661|FG000|Overall Study|Lost to Follow-up|1|||
155257991|NCT01123382|560375662|FG001|Overall Study|Lost to Follow-up|2|||
155257992|NCT02740049|560375663|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
155257993|NCT02274857|560375664|FG000|Overall Study|Adverse Event|1|||
155257994|NCT02274857|560375665|FG001|Overall Study|Adverse Event|0|||
155257995|NCT02274857|560375664|FG000|Overall Study|Death|1|||
155257996|NCT02274857|560375665|FG001|Overall Study|Death|2|||
155257997|NCT02274857|560375664|FG000|Overall Study|Lost to Follow-up|3|||
155257998|NCT02274857|560375665|FG001|Overall Study|Lost to Follow-up|0|||
155257999|NCT02274857|560375664|FG000|Overall Study|Physician Decision|2|||
155258000|NCT02274857|560375665|FG001|Overall Study|Physician Decision|0|||
155258001|NCT02274857|560375664|FG000|Overall Study|Trial screen failure|0|||
155258002|NCT02274857|560375665|FG001|Overall Study|Trial screen failure|2|||
155258003|NCT02274857|560375664|FG000|Overall Study|Withdrawal by Subject|11|||
155258004|NCT02274857|560375665|FG001|Overall Study|Withdrawal by Subject|2|||
155258005|NCT02274857|560375664|FG000|Overall Study|Other|2|||
155258006|NCT02274857|560375665|FG001|Overall Study|Other|0|||
155258007|NCT02403180|560375668|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
155258008|NCT02403180|560375669|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
155258009|NCT02403180|560375668|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
155258010|NCT02403180|560375669|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
155258011|NCT04570436|560375675|FG000|Overall Study|Adverse Event|0|||
155258012|NCT04570436|560375676|FG001|Overall Study|Adverse Event|0|||
155258013|NCT04570436|560375677|FG002|Overall Study|Adverse Event|1|||
155258014|NCT04570436|560375678|FG003|Overall Study|Adverse Event|0|||
155258015|NCT04570436|560375679|FG004|Overall Study|Adverse Event|0|||
155258016|NCT04570436|560375680|FG005|Overall Study|Adverse Event|0|||
155258017|NCT04570436|560375681|FG006|Overall Study|Adverse Event|0|||
155258018|NCT04570436|560375682|FG007|Overall Study|Adverse Event|0|||
155258019|NCT04570436|560375683|FG008|Overall Study|Adverse Event|0|||
155258020|NCT04570436|560375684|FG009|Overall Study|Adverse Event|0|||
155258021|NCT04570436|560375675|FG000|Overall Study|Physician Decision|1|||
155258022|NCT04570436|560375676|FG001|Overall Study|Physician Decision|0|||
155258023|NCT04570436|560375677|FG002|Overall Study|Physician Decision|0|||
155258024|NCT04570436|560375678|FG003|Overall Study|Physician Decision|0|||
155258025|NCT04570436|560375679|FG004|Overall Study|Physician Decision|0|||
155258026|NCT04570436|560375680|FG005|Overall Study|Physician Decision|0|||
155258027|NCT04570436|560375681|FG006|Overall Study|Physician Decision|0|||
155258028|NCT04570436|560375682|FG007|Overall Study|Physician Decision|0|||
155258029|NCT04570436|560375683|FG008|Overall Study|Physician Decision|0|||
155258030|NCT04570436|560375684|FG009|Overall Study|Physician Decision|0|||
155258031|NCT00594854|560375687|FG000|Overall Study|Study terminated|7|||
155258032|NCT00594854|560375688|FG001|Overall Study|Study terminated|10|||
155258033|NCT03172702|560375691|FG000|Overall Study|Adverse Event|9|||
155258034|NCT03172702|560375691|FG000|Overall Study|Death|2|||
155258035|NCT03172702|560375691|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
155258036|NCT03172702|560375691|FG000|Overall Study|Withdrawal by Subject|5|||
155258037|NCT03172702|560375691|FG000|Overall Study|Other|2|||
155258038|NCT03292146|560375692|FG000|Baseline to 12 months|Relocation|1|||
155258039|NCT03292146|560375693|FG001|Baseline to 12 months|Relocation|0|||
155258040|NCT03292146|560375692|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
155258041|NCT03292146|560375693|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
155258042|NCT03292146|560375692|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
155258043|NCT03292146|560375693|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
155258044|NCT03292146|560375692|FG000|12 months to 24 months|Planning pregnancy|2|||
155258045|NCT03292146|560375693|FG001|12 months to 24 months|Planning pregnancy|2|||
155258046|NCT03292146|560375692|FG000|12 months to 24 months|Personal reasons|1|||
155258047|NCT03292146|560375693|FG001|12 months to 24 months|Personal reasons|0|||
155258048|NCT03292146|560375692|FG000|12 months to 24 months|Lost to Follow-up|0|||
155258049|NCT03292146|560375693|FG001|12 months to 24 months|Lost to Follow-up|1|||
155258050|NCT06134180|560375696|FG000|Overall Study|Lost to Follow-up|4|||
155258051|NCT03039023|560375697|FG000|Overall Study|Withdrawal by Subject|1|||
155258052|NCT03039023|560375698|FG001|Overall Study|Withdrawal by Subject|0|||
155258053|NCT03039023|560375699|FG002|Overall Study|Withdrawal by Subject|1|||
155258054|NCT03039023|560375700|FG003|Overall Study|Withdrawal by Subject|1|||
155258055|NCT03039023|560375701|FG004|Overall Study|Withdrawal by Subject|0|||
155258056|NCT03039023|560375697|FG000|Overall Study|Physician Decision|0|||
155258057|NCT03039023|560375698|FG001|Overall Study|Physician Decision|0|||
155258058|NCT03039023|560375699|FG002|Overall Study|Physician Decision|0|||
155258059|NCT03039023|560375700|FG003|Overall Study|Physician Decision|1|||
155258060|NCT03039023|560375701|FG004|Overall Study|Physician Decision|0|||
155258061|NCT02340026|560375702|FG000|Treatment Phase|Withdrawal by Subject|2|||
155258062|NCT02340026|560375703|FG001|Treatment Phase|Withdrawal by Subject|2|||
155258063|NCT02340026|560375702|FG000|Follow-up Phase|Lost to Follow-up|1|||
155258064|NCT02340026|560375703|FG001|Follow-up Phase|Lost to Follow-up|0|||
155258065|NCT02684006|560375704|FG000|Overall Study|Other|18|||
155258066|NCT02684006|560375705|FG001|Overall Study|Other|6|||
155258067|NCT02684006|560375704|FG000|Overall Study|Protocol Violation|2|||
155258068|NCT02684006|560375705|FG001|Overall Study|Protocol Violation|1|||
155258069|NCT02684006|560375704|FG000|Overall Study|Non-compliance with study drug|1|||
155258070|NCT02684006|560375705|FG001|Overall Study|Non-compliance with study drug|1|||
155258071|NCT02684006|560375704|FG000|Overall Study|No longer met eligibility criteria|6|||
155258072|NCT02684006|560375705|FG001|Overall Study|No longer met eligibility criteria|2|||
155258073|NCT02684006|560375704|FG000|Overall Study|Lost to Follow-up|0|||
155258074|NCT02684006|560375705|FG001|Overall Study|Lost to Follow-up|1|||
155258075|NCT02684006|560375704|FG000|Overall Study|Death|25|||
155258076|NCT02684006|560375705|FG001|Overall Study|Death|22|||
155258077|NCT02684006|560375704|FG000|Overall Study|Global deterioration of health status|18|||
155258078|NCT02684006|560375705|FG001|Overall Study|Global deterioration of health status|20|||
155258079|NCT02684006|560375704|FG000|Overall Study|Physician Decision|15|||
155258080|NCT02684006|560375705|FG001|Overall Study|Physician Decision|8|||
155258081|NCT02684006|560375704|FG000|Overall Study|Adverse Event|86|||
155258082|NCT02684006|560375705|FG001|Overall Study|Adverse Event|65|||
155258083|NCT02684006|560375704|FG000|Overall Study|Withdrawal by Subject|29|||
155258084|NCT02684006|560375705|FG001|Overall Study|Withdrawal by Subject|43|||
155258085|NCT02684006|560375704|FG000|Overall Study|Progressive disease|236|||
155258086|NCT02684006|560375705|FG001|Overall Study|Progressive disease|266|||
155258087|NCT02684006|560375704|FG000|Overall Study|Participation terminated by sponsor|6|||
155258088|NCT02684006|560375705|FG001|Overall Study|Participation terminated by sponsor|9|||
155258089|NCT04642898|560375706|FG000|Overall Study|Withdrawal by Subject|2|||
155258090|NCT04642898|560375707|FG001|Overall Study|Withdrawal by Subject|4|||
155258091|NCT04642898|560375708|FG002|Overall Study|Withdrawal by Subject|4|||
155258092|NCT04642898|560375709|FG003|Overall Study|Withdrawal by Subject|6|||
155258093|NCT04642898|560375710|FG004|Overall Study|Withdrawal by Subject|2|||
155258094|NCT04642898|560375711|FG005|Overall Study|Withdrawal by Subject|6|||
155258095|NCT04642898|560375706|FG000|Overall Study|Lost to Follow-up|0|||
155258096|NCT04642898|560375707|FG001|Overall Study|Lost to Follow-up|0|||
155258097|NCT04642898|560375708|FG002|Overall Study|Lost to Follow-up|0|||
155258098|NCT04642898|560375709|FG003|Overall Study|Lost to Follow-up|2|||
155258099|NCT04642898|560375710|FG004|Overall Study|Lost to Follow-up|0|||
155258100|NCT04642898|560375711|FG005|Overall Study|Lost to Follow-up|1|||
155258101|NCT04642898|560375706|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
155258102|NCT04642898|560375707|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
155258103|NCT04642898|560375708|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
155258104|NCT04642898|560375709|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
155258105|NCT04642898|560375710|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
155258106|NCT04642898|560375711|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
155258107|NCT04642898|560375706|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258108|NCT04642898|560375707|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258109|NCT04642898|560375708|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258110|NCT04642898|560375709|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258111|NCT04642898|560375710|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
155258112|NCT04642898|560375711|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
155258113|NCT04495179|560375712|FG000|Overall Study|Lost to Follow-up|0|||
155258114|NCT04495179|560375713|FG001|Overall Study|Lost to Follow-up|1|||
155258115|NCT04495179|560375712|FG000|Overall Study|Withdrawal by Subject|2|||
155258116|NCT04495179|560375713|FG001|Overall Study|Withdrawal by Subject|4|||
155258117|NCT04495179|560375712|FG000|Overall Study|Study terminated by sponsor|0|||
155258118|NCT04495179|560375713|FG001|Overall Study|Study terminated by sponsor|18|||
155258119|NCT04495179|560375712|FG000|Overall Study|Death|0|||
155258120|NCT04495179|560375713|FG001|Overall Study|Death|4|||
155258121|NCT04495179|560375712|FG000|Overall Study|Adverse Event|0|||
155258122|NCT04495179|560375713|FG001|Overall Study|Adverse Event|1|||
155258123|NCT04280562|560375714|FG000|Study|Adverse Event|2|||
155258124|NCT04280562|560375715|FG001|Study|Adverse Event|0|||
155258125|NCT04280562|560375714|FG000|Study|Lost to Follow-up|3|||
155258126|NCT04280562|560375715|FG001|Study|Lost to Follow-up|3|||
155258127|NCT01368965|560375719|FG000|Overall Study|Lost to Follow-up|12|||
155258128|NCT00162370|560375720|FG000|Efficacy Population|Lost to Follow-up|51|||
155258129|NCT00569582|560375721|FG000|Overall Study|Withdrawal by Subject|5|||
155258130|NCT00569582|560375721|FG000|Overall Study|Death|2|||
155258131|NCT00569582|560375721|FG000|Overall Study|Adverse Event|7|||
155258132|NCT00569582|560375721|FG000|Overall Study|Subject was too ill to travel.|1|||
155258133|NCT00569582|560375721|FG000|Overall Study|Subject was non-compliant.|1|||
155258134|NCT04559568|560375722|FG000|Overall Study|Physician Decision|0|||
155258135|NCT04559568|560375723|FG001|Overall Study|Physician Decision|0|||
155258136|NCT04559568|560375724|FG002|Overall Study|Physician Decision|0|||
155258137|NCT04559568|560375725|FG003|Overall Study|Physician Decision|0|||
155258138|NCT04559568|560375726|FG004|Overall Study|Physician Decision|0|||
155258139|NCT04559568|560375727|FG005|Overall Study|Physician Decision|0|||
155258140|NCT04559568|560375728|FG006|Overall Study|Physician Decision|0|||
155258141|NCT04559568|560375729|FG007|Overall Study|Physician Decision|0|||
155258142|NCT04559568|560375730|FG008|Overall Study|Physician Decision|0|||
155258143|NCT04559568|560375731|FG009|Overall Study|Physician Decision|1|||
155258144|NCT04559568|560375732|FG010|Overall Study|Physician Decision|0|||
155258145|NCT04559568|560375722|FG000|Overall Study|Withdrawal by Subject|0|||
155258146|NCT04559568|560375723|FG001|Overall Study|Withdrawal by Subject|0|||
155258147|NCT04559568|560375724|FG002|Overall Study|Withdrawal by Subject|0|||
155258148|NCT04559568|560375725|FG003|Overall Study|Withdrawal by Subject|0|||
155258149|NCT04559568|560375726|FG004|Overall Study|Withdrawal by Subject|0|||
155258150|NCT04559568|560375727|FG005|Overall Study|Withdrawal by Subject|0|||
155258151|NCT04559568|560375728|FG006|Overall Study|Withdrawal by Subject|0|||
155258152|NCT04559568|560375729|FG007|Overall Study|Withdrawal by Subject|0|||
155258153|NCT04559568|560375730|FG008|Overall Study|Withdrawal by Subject|0|||
155258154|NCT04559568|560375731|FG009|Overall Study|Withdrawal by Subject|0|||
155258155|NCT04559568|560375732|FG010|Overall Study|Withdrawal by Subject|1|||
155258156|NCT05103384|560375735|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
155258157|NCT02612311|560375736|FG000|Overall Study|Adverse Event|16|||
155258158|NCT02612311|560375737|FG001|Overall Study|Adverse Event|12|||
155258159|NCT02612311|560375738|FG002|Overall Study|Adverse Event|7|||
155258160|NCT02612311|560375739|FG003|Overall Study|Adverse Event|13|||
155258161|NCT02612311|560375736|FG000|Overall Study|Death|29|||
155258162|NCT02612311|560375737|FG001|Overall Study|Death|10|||
155258163|NCT02612311|560375738|FG002|Overall Study|Death|11|||
155258164|NCT02612311|560375739|FG003|Overall Study|Death|11|||
155258165|NCT02612311|560375736|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
155258166|NCT02612311|560375737|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
155258167|NCT02612311|560375738|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
155258168|NCT02612311|560375739|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
155258169|NCT02612311|560375736|FG000|Overall Study|Investigator's Decision|11|||
155258170|NCT02612311|560375737|FG001|Overall Study|Investigator's Decision|15|||
155258171|NCT02612311|560375738|FG002|Overall Study|Investigator's Decision|6|||
155258172|NCT02612311|560375739|FG003|Overall Study|Investigator's Decision|6|||
155258173|NCT02612311|560375736|FG000|Overall Study|Lack of Efficacy|0|||
155258174|NCT02612311|560375737|FG001|Overall Study|Lack of Efficacy|0|||
155258175|NCT02612311|560375738|FG002|Overall Study|Lack of Efficacy|1|||
155258176|NCT02612311|560375739|FG003|Overall Study|Lack of Efficacy|1|||
155258177|NCT02612311|560375736|FG000|Overall Study|Lost to Follow-up|2|||
155258178|NCT02612311|560375737|FG001|Overall Study|Lost to Follow-up|2|||
155258179|NCT02612311|560375738|FG002|Overall Study|Lost to Follow-up|1|||
155258180|NCT02612311|560375739|FG003|Overall Study|Lost to Follow-up|2|||
155258181|NCT02612311|560375736|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
155258182|NCT02612311|560375737|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
155258183|NCT02612311|560375738|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
155258184|NCT02612311|560375739|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
155258185|NCT02612311|560375736|FG000|Overall Study|Site Terminated by Sponsor|29|||
155258186|NCT02612311|560375737|FG001|Overall Study|Site Terminated by Sponsor|12|||
155258187|NCT02612311|560375738|FG002|Overall Study|Site Terminated by Sponsor|13|||
155258188|NCT02612311|560375739|FG003|Overall Study|Site Terminated by Sponsor|5|||
155258189|NCT02612311|560375736|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
155258190|NCT02612311|560375737|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
155258191|NCT02612311|560375738|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
155258192|NCT02612311|560375739|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
155258193|NCT02612311|560375736|FG000|Overall Study|Reason Not Specified|3|||
155258194|NCT02612311|560375737|FG001|Overall Study|Reason Not Specified|7|||
155258195|NCT02612311|560375738|FG002|Overall Study|Reason Not Specified|4|||
155258196|NCT02612311|560375739|FG003|Overall Study|Reason Not Specified|5|||
155258197|NCT02612311|560375736|FG000|Overall Study|Unknown/Missing|10|||
155258198|NCT02612311|560375737|FG001|Overall Study|Unknown/Missing|13|||
155258199|NCT02612311|560375738|FG002|Overall Study|Unknown/Missing|4|||
155258200|NCT02612311|560375739|FG003|Overall Study|Unknown/Missing|0|||
155258201|NCT02612311|560375736|FG000|Overall Study|Non-Compliance with Study|1|||
155258202|NCT02612311|560375737|FG001|Overall Study|Non-Compliance with Study|0|||
155258203|NCT02612311|560375738|FG002|Overall Study|Non-Compliance with Study|0|||
155258204|NCT02612311|560375739|FG003|Overall Study|Non-Compliance with Study|0|||
155258205|NCT04085328|560375745|FG000|Overall Study|Witihdrew Consent|16|||
155258206|NCT04085328|560375746|FG001|Overall Study|Witihdrew Consent|16|||
155258207|NCT04085328|560375745|FG000|Overall Study|Adverse Event|8|||
155258208|NCT04085328|560375746|FG001|Overall Study|Adverse Event|7|||
155258209|NCT04085328|560375745|FG000|Overall Study|Lost to Follow-up|7|||
155258210|NCT04085328|560375746|FG001|Overall Study|Lost to Follow-up|2|||
155258211|NCT04085328|560375745|FG000|Overall Study|Physician Decision|0|||
155258212|NCT04085328|560375746|FG001|Overall Study|Physician Decision|1|||
155258213|NCT04085328|560375745|FG000|Overall Study|Pregnancy|0|||
155258214|NCT04085328|560375746|FG001|Overall Study|Pregnancy|1|||
155258215|NCT04085328|560375745|FG000|Overall Study|Reasons Related to COVID-19|5|||
155258216|NCT04085328|560375746|FG001|Overall Study|Reasons Related to COVID-19|8|||
155258217|NCT04085328|560375745|FG000|Overall Study|Did not meet inclusion criteria|1|||
155258218|NCT04085328|560375746|FG001|Overall Study|Did not meet inclusion criteria|1|||
155258219|NCT04085328|560375745|FG000|Overall Study|Early termination|1|||
155258220|NCT04085328|560375746|FG001|Overall Study|Early termination|0|||
155258221|NCT00514735|560375747|FG000|Overall Study|Withdrawal by Subject|13|||
155258222|NCT00514735|560375748|FG001|Overall Study|Withdrawal by Subject|5|||
155258223|NCT00514735|560375747|FG000|Overall Study|Death|1|||
155258224|NCT00514735|560375748|FG001|Overall Study|Death|0|||
155258225|NCT00514735|560375747|FG000|Overall Study|Lost to Follow-up|0|||
155258226|NCT00514735|560375748|FG001|Overall Study|Lost to Follow-up|1|||
155258227|NCT00724152|560375750|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
155258228|NCT00724152|560375751|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
155258229|NCT00724152|560375752|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
155258230|NCT00724152|560375750|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
155258231|NCT00724152|560375751|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
155258232|NCT00724152|560375752|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
155258233|NCT03266770|560375755|FG000|Overall Study|Physician Decision|3|||
155258234|NCT03266770|560375755|FG000|Overall Study|Insufficient study supplies|1|||
155258235|NCT03266770|560375755|FG000|Overall Study|Adverse Event|1|||
155258236|NCT04274894|560375756|FG000|Overall Study|Adverse Event|7|||
155258237|NCT04274894|560375756|FG000|Overall Study|Withdrew consent|5|||
155258238|NCT04274894|560375756|FG000|Overall Study|Lost to Follow-up|9|||
155258239|NCT04274894|560375756|FG000|Overall Study|COVID-19 infection|1|||
155258240|NCT04274894|560375756|FG000|Overall Study|Other, not specified|20|||
155258241|NCT01936857|560375757|FG000|Overall Study|Sent to prison or 06 center|11|||
155258242|NCT01936857|560375758|FG001|Overall Study|Sent to prison or 06 center|12|||
155258243|NCT01936857|560375757|FG000|Overall Study|Lost to Follow-up|10|||
155258244|NCT01936857|560375758|FG001|Overall Study|Lost to Follow-up|7|||
155258245|NCT01936857|560375757|FG000|Overall Study|Death|7|||
155258246|NCT01936857|560375758|FG001|Overall Study|Death|3|||
155258247|NCT01936857|560375757|FG000|Overall Study|Moved|2|||
155258248|NCT01936857|560375758|FG001|Overall Study|Moved|1|||
155258249|NCT01936857|560375757|FG000|Overall Study|Withdrawal by Subject|1|||
155258250|NCT01936857|560375758|FG001|Overall Study|Withdrawal by Subject|0|||
155258251|NCT01936857|560375757|FG000|Overall Study|Side effect of medication|1|||
155258252|NCT01936857|560375758|FG001|Overall Study|Side effect of medication|0|||
155258253|NCT01936857|560375757|FG000|Overall Study|Other|2|||
155258254|NCT01936857|560375758|FG001|Overall Study|Other|2|||
155258255|NCT00490282|560375759|FG000|Overall Study|Withdrawal by Subject|3|||
155258256|NCT04510675|560375762|FG000|Overall Study|Withdrawal by Subject|5|||
155258257|NCT00810264|560375767|FG000|Overall Study|Lost to Follow-up|191|||
155258258|NCT00810264|560375767|FG000|Overall Study|Withdrawal by subject or physician|721|||
155258259|NCT00810264|560375767|FG000|Overall Study|Death|641|||
155258260|NCT00538590|560375778|FG000|Overall Study|Death|1|||
155258261|NCT00538590|560375779|FG001|Overall Study|Death|0|||
155258262|NCT01256567|560375780|FG000|Overall Study|Withdrawal by Subject|1|||
155258263|NCT00567190|560375786|FG000|Overall Study|Death|235|||
155258264|NCT00567190|560375787|FG001|Overall Study|Death|280|||
155258265|NCT00567190|560375786|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
155258266|NCT00567190|560375787|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
155258267|NCT00636610|560375793|FG000|Overall Study|Adverse Event|4|||
155258268|NCT00636610|560375794|FG001|Overall Study|Adverse Event|4|||
155258269|NCT00636610|560375793|FG000|Overall Study|Death|6|||
155258270|NCT00636610|560375794|FG001|Overall Study|Death|3|||
155258271|NCT00636610|560375793|FG000|Overall Study|Physician decision to withdraw patient|15|||
155258272|NCT00636610|560375794|FG001|Overall Study|Physician decision to withdraw patient|9|||
155258273|NCT00636610|560375793|FG000|Overall Study|Subject decision to withdraw|15|||
155258274|NCT00636610|560375794|FG001|Overall Study|Subject decision to withdraw|11|||
155258275|NCT00636610|560375793|FG000|Overall Study|Disease progression - radiographic|41|||
155258276|NCT00636610|560375794|FG001|Overall Study|Disease progression - radiographic|51|||
155258277|NCT00636610|560375793|FG000|Overall Study|Disease progression - clinical|8|||
155258278|NCT00636610|560375794|FG001|Overall Study|Disease progression - clinical|3|||
155258279|NCT00636610|560375793|FG000|Overall Study|Reason for discontinuation not available|3|||
155258280|NCT00636610|560375794|FG001|Overall Study|Reason for discontinuation not available|2|||
155258281|NCT02412137|560375799|FG000|Overall Study|Withdrawal by Subject|2|||
155258282|NCT02412137|560375800|FG001|Overall Study|Withdrawal by Subject|0|||
155258283|NCT02412137|560375799|FG000|Overall Study|Lost to Follow-up|21|||
155258284|NCT02412137|560375800|FG001|Overall Study|Lost to Follow-up|14|||
155258285|NCT02412137|560375799|FG000|Overall Study|Physician Decision|28|||
155258286|NCT02412137|560375800|FG001|Overall Study|Physician Decision|9|||
155258287|NCT03355326|560375809|FG000|Overall Study|Protocol Violation|3|||
155258288|NCT03355326|560375810|FG001|Overall Study|Protocol Violation|3|||
155258289|NCT02240108|560377547|FG000|Overall Study|Other than specified|8|||
155258290|NCT02240108|560377548|FG001|Overall Study|Other than specified|6|||
155258291|NCT02240108|560377547|FG000|Overall Study|Adverse Event|1|||
155258292|NCT02240108|560377548|FG001|Overall Study|Adverse Event|9|||
155258293|NCT02240108|560377547|FG000|Overall Study|Pregnancy|1|||
155258294|NCT02240108|560377548|FG001|Overall Study|Pregnancy|0|||
155258295|NCT02240108|560377547|FG000|Overall Study|Withdrawal by Subject|4|||
155258296|NCT02240108|560377548|FG001|Overall Study|Withdrawal by Subject|9|||
155258297|NCT02240108|560377547|FG000|Overall Study|StudyTerminated by Sponsor|0|||
155258298|NCT02240108|560377548|FG001|Overall Study|StudyTerminated by Sponsor|1|||
155258299|NCT05178121|560377555|FG000|Overall Study|Other|4|||
155258300|NCT05178121|560377555|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
155258301|NCT01953003|560377556|FG000|Overall Study|Not treated|0|||
155258302|NCT01953003|560377557|FG001|Overall Study|Not treated|1|||
155258303|NCT01953003|560377556|FG000|Overall Study|Progressive disease|35|||
155258304|NCT01953003|560377557|FG001|Overall Study|Progressive disease|45|||
155258305|NCT01953003|560377556|FG000|Overall Study|Related Adverse events|7|||
155258306|NCT01953003|560377557|FG001|Overall Study|Related Adverse events|2|||
155258307|NCT01953003|560377556|FG000|Overall Study|Non-related adverse events|0|||
155258308|NCT01953003|560377557|FG001|Overall Study|Non-related adverse events|2|||
155258309|NCT01953003|560377556|FG000|Overall Study|Protocol Violation|0|||
155258310|NCT01953003|560377557|FG001|Overall Study|Protocol Violation|1|||
155258311|NCT01953003|560377556|FG000|Overall Study|Withdrawal by Subject|14|||
155258312|NCT01953003|560377557|FG001|Overall Study|Withdrawal by Subject|4|||
155258313|NCT00553501|560377560|FG000|Overall Study|Adverse Event|2|||
155258314|NCT00553501|560377560|FG000|Overall Study|Death|1|||
155258315|NCT00553501|560377560|FG000|Overall Study|Progression|1|||
155258316|NCT01464021|560377564|FG000|Overall Study|Withdrawal by Subject|13|||
155258317|NCT01464021|560377564|FG000|Overall Study|Lost to Follow-up|1|||
155258318|NCT01464021|560377564|FG000|Overall Study|Lack of Efficacy|1|||
155258319|NCT01464021|560377564|FG000|Overall Study|various|11|||
155258320|NCT03391765|560377566|FG000|Overall Study|Adverse Event|2|||
155258321|NCT03391765|560377567|FG001|Overall Study|Adverse Event|0|||
155258322|NCT03391765|560377568|FG002|Overall Study|Adverse Event|0|||
155258323|NCT03391765|560377569|FG003|Overall Study|Adverse Event|2|||
155258324|NCT03391765|560377566|FG000|Overall Study|Withdrew consent|5|||
155258325|NCT03391765|560377567|FG001|Overall Study|Withdrew consent|7|||
155258326|NCT03391765|560377568|FG002|Overall Study|Withdrew consent|2|||
155258327|NCT03391765|560377569|FG003|Overall Study|Withdrew consent|5|||
155258328|NCT03391765|560377566|FG000|Overall Study|Other, not specified|44|||
155258329|NCT03391765|560377567|FG001|Overall Study|Other, not specified|38|||
155258330|NCT03391765|560377568|FG002|Overall Study|Other, not specified|21|||
155258331|NCT03391765|560377569|FG003|Overall Study|Other, not specified|16|||
155258332|NCT00944658|560377570|FG000|Treatment 12 Weeks|Adverse Event|0|||
155258333|NCT00944658|560377571|FG001|Treatment 12 Weeks|Adverse Event|2|||
155258334|NCT03315143|560377598|FG000|Overall Study|Death|240|||
155258335|NCT03315143|560377599|FG001|Overall Study|Death|246|||
155258336|NCT03315143|560377598|FG000|Overall Study|Withdrawal by Subject|57|||
155258337|NCT03315143|560377599|FG001|Overall Study|Withdrawal by Subject|68|||
155258338|NCT03315143|560377598|FG000|Overall Study|Site Terminated by Sponsor|256|||
155258339|NCT03315143|560377599|FG001|Overall Study|Site Terminated by Sponsor|282|||
155258340|NCT03315143|560377598|FG000|Overall Study|Study Terminated by Sponsor|4723|||
155258341|NCT03315143|560377599|FG001|Overall Study|Study Terminated by Sponsor|4664|||
155258342|NCT03315143|560377598|FG000|Overall Study|Reason not Specified|16|||
155258343|NCT03315143|560377599|FG001|Overall Study|Reason not Specified|32|||
155258344|NCT01242748|560377600|FG000|Overall Study|Adverse Event|10|||
155258345|NCT01242748|560377601|FG001|Overall Study|Adverse Event|5|||
155258346|NCT01242748|560377600|FG000|Overall Study|Lost to Follow-up|6|||
155258347|NCT01242748|560377601|FG001|Overall Study|Lost to Follow-up|2|||
155258348|NCT01242748|560377600|FG000|Overall Study|Physician Decision|3|||
155258349|NCT01242748|560377601|FG001|Overall Study|Physician Decision|2|||
155258350|NCT01242748|560377600|FG000|Overall Study|Protocol Violation|1|||
155258351|NCT01242748|560377601|FG001|Overall Study|Protocol Violation|0|||
155258352|NCT01242748|560377600|FG000|Overall Study|Withdrawal by Subject|10|||
155258353|NCT01242748|560377601|FG001|Overall Study|Withdrawal by Subject|2|||
155258354|NCT01242748|560377600|FG000|Overall Study|Miscellaneous reasons|8|||
155258355|NCT01242748|560377601|FG001|Overall Study|Miscellaneous reasons|3|||
155258356|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
155258357|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
155258358|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
155258359|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
155258360|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
155258361|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
155258362|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
155258363|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
155258364|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
155258365|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
155258366|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
155258367|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
155258368|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
155258369|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
155258370|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
155258371|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
155258372|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
155258373|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
155258374|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
155258375|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
155258376|NCT00549757|560377611|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
155258377|NCT00549757|560377612|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
155258378|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Death|143|||
155258379|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Death|136|||
155258380|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
155258381|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
155258382|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
155258383|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
155258384|NCT00549757|560377611|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
155258385|NCT00549757|560377612|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
155258386|NCT00105235|560377613|FG000|Overall Study|Death|4|||
155258387|NCT00105235|560377613|FG000|Overall Study|Physician Decision|1|||
155258388|NCT00105235|560377613|FG000|Overall Study|Withdrawal by Subject|2|||
155258389|NCT02052310|560377614|FG000|Overall Study|Death|64|||
155258390|NCT02052310|560377615|FG001|Overall Study|Death|54|||
155258391|NCT02052310|560377614|FG000|Overall Study|Withdrawal by Subject|37|||
155258392|NCT02052310|560377615|FG001|Overall Study|Withdrawal by Subject|49|||
155258393|NCT02052310|560377614|FG000|Overall Study|Other than specified|32|||
155258394|NCT02052310|560377615|FG001|Overall Study|Other than specified|29|||
155258395|NCT02052310|560377614|FG000|Overall Study|Adverse Event|29|||
155258396|NCT02052310|560377615|FG001|Overall Study|Adverse Event|22|||
155258397|NCT02052310|560377614|FG000|Overall Study|Kidney Transplant|23|||
155258398|NCT02052310|560377615|FG001|Overall Study|Kidney Transplant|29|||
155258399|NCT02052310|560377614|FG000|Overall Study|Physician Decision|14|||
155258400|NCT02052310|560377615|FG001|Overall Study|Physician Decision|7|||
155258401|NCT02052310|560377614|FG000|Overall Study|Lack of Efficacy|6|||
155258402|NCT02052310|560377615|FG001|Overall Study|Lack of Efficacy|1|||
155258403|NCT02052310|560377614|FG000|Overall Study|Site Terminated by Sponsor|5|||
155258404|NCT02052310|560377615|FG001|Overall Study|Site Terminated by Sponsor|13|||
155258405|NCT02052310|560377614|FG000|Overall Study|Lost to Follow-up|4|||
155258406|NCT02052310|560377615|FG001|Overall Study|Lost to Follow-up|2|||
155258407|NCT02052310|560377614|FG000|Overall Study|Protocol Violation|1|||
155258408|NCT02052310|560377615|FG001|Overall Study|Protocol Violation|6|||
155258409|NCT01964326|560377616|FG000|Overall Study|Adverse Event|48|||
155258410|NCT01964326|560377616|FG000|Overall Study|Death|2|||
155258411|NCT01964326|560377616|FG000|Overall Study|Protocol Violation|4|||
155258412|NCT01964326|560377616|FG000|Overall Study|Lost to Follow-up|88|||
155258413|NCT01964326|560377616|FG000|Overall Study|Withdrawal by Subject|87|||
155258414|NCT01964326|560377616|FG000|Overall Study|Pregnancy|1|||
155258415|NCT01964326|560377616|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
155258416|NCT01964326|560377616|FG000|Overall Study|Physician Decision|55|||
155258417|NCT01964326|560377616|FG000|Overall Study|Investigator Discretion|1|||
155258418|NCT01964326|560377616|FG000|Overall Study|Other|9|||
155258419|NCT01964326|560377616|FG000|Overall Study|Did not meet eligibility criteria|1|||
155258420|NCT02093663|560377625|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
155258421|NCT02093663|560377626|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258422|NCT02093663|560377627|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258423|NCT02093663|560377628|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258424|NCT02093663|560377629|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
155258425|NCT02093663|560377625|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
155258426|NCT02093663|560377626|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258427|NCT02093663|560377627|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258428|NCT02093663|560377628|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258429|NCT02093663|560377629|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258430|NCT02093663|560377625|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
155258431|NCT02093663|560377626|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
155258432|NCT02093663|560377627|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
155258433|NCT02093663|560377628|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
155258434|NCT02093663|560377629|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
155258435|NCT02093663|560377625|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258436|NCT02093663|560377626|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258437|NCT02093663|560377627|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
155258438|NCT02093663|560377628|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258439|NCT02093663|560377629|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
155258440|NCT02093663|560377625|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258441|NCT02093663|560377626|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258442|NCT02093663|560377627|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
155258443|NCT02093663|560377628|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258444|NCT02093663|560377629|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
155258445|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
155258446|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
155258447|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
155258448|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
155258449|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
155258450|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
155258451|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
155258452|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
155258453|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
155258454|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
155258455|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
155258456|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
155258457|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
155258458|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
155258459|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
155258460|NCT02093663|560377625|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258461|NCT02093663|560377626|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258462|NCT02093663|560377627|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258463|NCT02093663|560377628|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
155258464|NCT02093663|560377629|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
155258465|NCT05906368|560377632|FG000|Overall Study|Withdrawal by Subject|1|||
155258466|NCT05906368|560377633|FG001|Overall Study|Withdrawal by Subject|1|||
155258467|NCT05906368|560377632|FG000|Overall Study|Ineligibility criteria identified|2|||
155258468|NCT05906368|560377633|FG001|Overall Study|Ineligibility criteria identified|0|||
155258469|NCT00595504|560377636|FG000|Overall Study|Withdrawal by Subject|1|||
155258470|NCT00595504|560377637|FG001|Overall Study|Withdrawal by Subject|3|||
155258471|NCT00595504|560377636|FG000|Overall Study|Physician Decision|1|||
155258472|NCT00595504|560377637|FG001|Overall Study|Physician Decision|0|||
155258473|NCT01477853|560377638|FG000|Phase A|Adverse Event|1|||
155258474|NCT01477853|560377639|FG001|Phase A|Adverse Event|2|||
155258475|NCT01477853|560377640|FG002|Phase A|Adverse Event|2|||
155258476|NCT01477853|560377638|FG000|Phase A|Lost to Follow-up|4|||
155258477|NCT01477853|560377639|FG001|Phase A|Lost to Follow-up|3|||
155258478|NCT01477853|560377640|FG002|Phase A|Lost to Follow-up|2|||
155258479|NCT01477853|560377638|FG000|Phase A|Physician Decision|1|||
155258480|NCT01477853|560377639|FG001|Phase A|Physician Decision|0|||
155258481|NCT01477853|560377640|FG002|Phase A|Physician Decision|1|||
155258482|NCT01477853|560377638|FG000|Phase A|Study terminated by sponsor|37|||
155258483|NCT01477853|560377639|FG001|Phase A|Study terminated by sponsor|40|||
155258484|NCT01477853|560377640|FG002|Phase A|Study terminated by sponsor|39|||
155258485|NCT01477853|560377638|FG000|Phase B|Lost to Follow-up|0|||
155258486|NCT01477853|560377639|FG001|Phase B|Lost to Follow-up|1|||
155258487|NCT01477853|560377640|FG002|Phase B|Lost to Follow-up|0|||
155258488|NCT01477853|560377638|FG000|Phase B|Study terminated by sponsor|12|||
155258489|NCT01477853|560377639|FG001|Phase B|Study terminated by sponsor|10|||
155258490|NCT01477853|560377640|FG002|Phase B|Study terminated by sponsor|11|||
155258491|NCT01804816|560377641|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
155258492|NCT01804816|560377641|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
155258493|NCT01235546|560377642|FG000|Overall Study|Staff error, medication not administered|1|||
155258494|NCT01235546|560377643|FG001|Overall Study|Staff error, medication not administered|0|||
155258495|NCT01235546|560377642|FG000|Overall Study|Protocol Violation|1|||
155258496|NCT01235546|560377643|FG001|Overall Study|Protocol Violation|1|||
155258497|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
155258498|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
155258499|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
155258500|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
155258501|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
155258502|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
155258503|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
155258504|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
155258505|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258506|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258507|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258508|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
155258509|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
155258510|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
155258511|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
155258512|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
155258513|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
155258514|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
155258515|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
155258516|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258517|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
155258518|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258519|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258520|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
155258521|NCT01256411|560377644|FG000|Extension by Maximum Treatment|Adverse Event|4|||
155258522|NCT01256411|560377645|FG001|Extension by Maximum Treatment|Adverse Event|2|||
155258523|NCT01256411|560377646|FG002|Extension by Maximum Treatment|Adverse Event|1|||
155258524|NCT01256411|560377647|FG003|Extension by Maximum Treatment|Adverse Event|0|||
155258525|NCT01256411|560377648|FG004|Extension by Maximum Treatment|Adverse Event|0|||
155258526|NCT01256411|560377649|FG005|Extension by Maximum Treatment|Adverse Event|0|||
155258527|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258528|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258529|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258530|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
155258531|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
155258532|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
155258533|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258534|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258535|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258536|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258537|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
155258538|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
155258539|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258540|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258541|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258542|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258543|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
155258544|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
155258545|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258546|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258547|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258548|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
155258549|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
155258550|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
155258551|NCT01256411|560377644|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258552|NCT01256411|560377645|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258553|NCT01256411|560377646|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258554|NCT01256411|560377647|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
155258555|NCT01256411|560377648|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
155258556|NCT01256411|560377649|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
155258557|NCT01445652|560377651|FG000|Overall Study|Not comfortable in lenses|5|||
155258558|NCT01445652|560377652|FG001|Overall Study|Not comfortable in lenses|0|||
155258559|NCT01445652|560377651|FG000|Overall Study|Failed to attend scheduled visit|2|||
155258560|NCT01445652|560377652|FG001|Overall Study|Failed to attend scheduled visit|3|||
155258561|NCT01445652|560377651|FG000|Overall Study|Failed teach session|2|||
155258562|NCT01445652|560377652|FG001|Overall Study|Failed teach session|0|||
155258563|NCT01445652|560377651|FG000|Overall Study|Adverse Event|1|||
155258564|NCT01445652|560377652|FG001|Overall Study|Adverse Event|0|||
155258565|NCT00929162|560377653|FG000|Overall Study|Adverse Event|8|||
155258566|NCT00929162|560377654|FG001|Overall Study|Adverse Event|5|||
155258567|NCT00929162|560377653|FG000|Overall Study|Withdrawal by Subject|3|||
155258568|NCT00929162|560377654|FG001|Overall Study|Withdrawal by Subject|1|||
155258569|NCT00929162|560377653|FG000|Overall Study|Protocol Violation|32|||
155258570|NCT00929162|560377654|FG001|Overall Study|Protocol Violation|30|||
155258571|NCT00929162|560377653|FG000|Overall Study|Other termination reason|5|||
155258572|NCT00929162|560377654|FG001|Overall Study|Other termination reason|6|||
155258573|NCT00658567|560377656|FG000|Overall Study|Adverse Event|5|||
155258574|NCT00658567|560377657|FG001|Overall Study|Adverse Event|2|||
155258575|NCT00658567|560377658|FG002|Overall Study|Adverse Event|3|||
155258576|NCT00658567|560377656|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
155258577|NCT00658567|560377657|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
155258578|NCT00658567|560377658|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
155258579|NCT00658567|560377656|FG000|Overall Study|Physician Decision|0|||
155258580|NCT00658567|560377657|FG001|Overall Study|Physician Decision|1|||
155258581|NCT00658567|560377658|FG002|Overall Study|Physician Decision|0|||
155258582|NCT00658567|560377656|FG000|Overall Study|At Discretion of Sponsor|1|||
155258583|NCT00658567|560377657|FG001|Overall Study|At Discretion of Sponsor|1|||
155258584|NCT00658567|560377658|FG002|Overall Study|At Discretion of Sponsor|1|||
155258585|NCT01755702|560377659|FG000|Wash Out Period I|Other Reason|3|||
155258586|NCT01755702|560377659|FG000|Washout Period II|Other Reason|5|||
155258587|NCT00691938|560377660|FG000|Overall Study|QTc prolongation|1|||
155258588|NCT00691938|560377661|FG001|Overall Study|QTc prolongation|0|||
155258589|NCT00691938|560377662|FG002|Overall Study|QTc prolongation|0|||
155258590|NCT00691938|560377663|FG003|Overall Study|QTc prolongation|0|||
155258591|NCT00691938|560377664|FG004|Overall Study|QTc prolongation|0|||
155258592|NCT00691938|560377665|FG005|Overall Study|QTc prolongation|0|||
155258593|NCT00691938|560377666|FG006|Overall Study|QTc prolongation|0|||
155258594|NCT04860518|560377668|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
155258595|NCT04860518|560377669|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
155258596|NCT03701399|560377672|FG000|Overall Study|Adverse Event|3|||
155258597|NCT03701399|560377673|FG001|Overall Study|Adverse Event|5|||
155258598|NCT03701399|560377672|FG000|Overall Study|Withdrawal by Subject|6|||
155258599|NCT03701399|560377673|FG001|Overall Study|Withdrawal by Subject|3|||
155258600|NCT03701399|560377672|FG000|Overall Study|Investigators decision|1|||
155258601|NCT03701399|560377673|FG001|Overall Study|Investigators decision|2|||
155258602|NCT03701399|560377672|FG000|Overall Study|Lost to Follow-up|1|||
155258603|NCT03701399|560377673|FG001|Overall Study|Lost to Follow-up|2|||
155258604|NCT03701399|560377672|FG000|Overall Study|Death|1|||
155258605|NCT03701399|560377673|FG001|Overall Study|Death|1|||
155258606|NCT03701399|560377672|FG000|Overall Study|Randomized but not treated|1|||
155258607|NCT03701399|560377673|FG001|Overall Study|Randomized but not treated|0|||
155258608|NCT00448448|560377674|FG000|Overall Study|Withdrawal by Subject|13|||
155258609|NCT00448448|560377675|FG001|Overall Study|Withdrawal by Subject|2|||
155258610|NCT00448448|560377674|FG000|Overall Study|On protocol when study ended|83|||
155258611|NCT00448448|560377675|FG001|Overall Study|On protocol when study ended|36|||
155258612|NCT00448448|560377674|FG000|Overall Study|Lost to Follow-up|2|||
155258613|NCT00448448|560377675|FG001|Overall Study|Lost to Follow-up|1|||
155258614|NCT00448448|560377674|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
155258615|NCT00448448|560377675|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
155258616|NCT00448448|560377674|FG000|Overall Study|Signed consent lost|0|||
155258617|NCT00448448|560377675|FG001|Overall Study|Signed consent lost|1|||
155258618|NCT00946296|560377676|FG000|Overall Study|Physician Decision|3|||
155258619|NCT00946296|560377677|FG001|Overall Study|Physician Decision|0|||
155258620|NCT04751942|560377681|FG000|Overall Study|Lost to Follow-up|9|||
155258621|NCT04751942|560377682|FG001|Overall Study|Lost to Follow-up|6|||
155258622|NCT01422408|560377683|FG000|Overall Study|Adverse Event|1|||
155258623|NCT01422408|560377683|FG000|Overall Study|Withdrawal by Subject|3|||
155258624|NCT03599349|560377693|FG000|Overall Study|Lost to Follow-up|1|||
155258625|NCT02638948|560377696|FG000|Overall Study|Withdrawal by Subject|4|||
155258626|NCT02638948|560377697|FG001|Overall Study|Withdrawal by Subject|5|||
155258627|NCT02638948|560377698|FG002|Overall Study|Withdrawal by Subject|3|||
155258628|NCT02638948|560377699|FG003|Overall Study|Withdrawal by Subject|1|||
155258629|NCT02638948|560377696|FG000|Overall Study|Administrative Reason by Sponsor|0|||
155258630|NCT02638948|560377697|FG001|Overall Study|Administrative Reason by Sponsor|1|||
155258631|NCT02638948|560377698|FG002|Overall Study|Administrative Reason by Sponsor|0|||
155258632|NCT02638948|560377699|FG003|Overall Study|Administrative Reason by Sponsor|4|||
155258633|NCT02638948|560377696|FG000|Overall Study|Adverse Event|0|||
155258634|NCT02638948|560377697|FG001|Overall Study|Adverse Event|0|||
155258635|NCT02638948|560377698|FG002|Overall Study|Adverse Event|1|||
155258636|NCT02638948|560377699|FG003|Overall Study|Adverse Event|1|||
155258637|NCT02638948|560377696|FG000|Overall Study|Lack of Efficacy|1|||
155258638|NCT02638948|560377697|FG001|Overall Study|Lack of Efficacy|1|||
155258639|NCT02638948|560377698|FG002|Overall Study|Lack of Efficacy|0|||
155258640|NCT02638948|560377699|FG003|Overall Study|Lack of Efficacy|0|||
155258641|NCT02638948|560377696|FG000|Overall Study|Lost to Follow-up|0|||
155258642|NCT02638948|560377697|FG001|Overall Study|Lost to Follow-up|0|||
155258643|NCT02638948|560377698|FG002|Overall Study|Lost to Follow-up|1|||
155258644|NCT02638948|560377699|FG003|Overall Study|Lost to Follow-up|1|||
155258645|NCT02638948|560377696|FG000|Overall Study|Poor/Non-Compliance|0|||
155258646|NCT02638948|560377697|FG001|Overall Study|Poor/Non-Compliance|2|||
155258647|NCT02638948|560377698|FG002|Overall Study|Poor/Non-Compliance|1|||
155258648|NCT02638948|560377699|FG003|Overall Study|Poor/Non-Compliance|0|||
155258649|NCT02638948|560377696|FG000|Overall Study|Participant no longer met study criteria|0|||
155258650|NCT02638948|560377697|FG001|Overall Study|Participant no longer met study criteria|1|||
155258651|NCT02638948|560377698|FG002|Overall Study|Participant no longer met study criteria|0|||
155258652|NCT02638948|560377699|FG003|Overall Study|Participant no longer met study criteria|0|||
155258653|NCT02638948|560377696|FG000|Overall Study|Other than specified above|4|||
155258654|NCT02638948|560377697|FG001|Overall Study|Other than specified above|1|||
155258655|NCT02638948|560377698|FG002|Overall Study|Other than specified above|1|||
155258656|NCT02638948|560377699|FG003|Overall Study|Other than specified above|1|||
155258657|NCT05007392|560377700|FG000|Overall Study|Randomized but not treated|1|||
155258658|NCT05007392|560377701|FG001|Overall Study|Randomized but not treated|2|||
155258659|NCT05007392|560377700|FG000|Overall Study|Other|5|||
155258660|NCT05007392|560377701|FG001|Overall Study|Other|4|||
155258661|NCT05007392|560377700|FG000|Overall Study|Lost to Follow-up|1|||
155258662|NCT05007392|560377701|FG001|Overall Study|Lost to Follow-up|2|||
155258663|NCT05007392|560377700|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
155258664|NCT05007392|560377701|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
155258665|NCT05007392|560377700|FG000|Overall Study|Use of prohibited concomitant drug|1|||
155258666|NCT05007392|560377701|FG001|Overall Study|Use of prohibited concomitant drug|1|||
155258667|NCT05007392|560377700|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
155258668|NCT05007392|560377701|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
155258669|NCT05007392|560377700|FG000|Overall Study|Adverse Event|10|||
155258670|NCT05007392|560377701|FG001|Overall Study|Adverse Event|6|||
155258671|NCT05007392|560377700|FG000|Overall Study|Participant choice|5|||
155258672|NCT05007392|560377701|FG001|Overall Study|Participant choice|10|||
155258673|NCT05007392|560377700|FG000|Overall Study|Withdrawal of consent|5|||
155258674|NCT05007392|560377701|FG001|Overall Study|Withdrawal of consent|4|||
155258675|NCT01218126|560377702|FG000|Overall Study|Adverse Event|8|||
155258676|NCT01218126|560377703|FG001|Overall Study|Adverse Event|10|||
155258677|NCT01218126|560377704|FG002|Overall Study|Adverse Event|12|||
155258678|NCT01218126|560377705|FG003|Overall Study|Adverse Event|16|||
155258679|NCT01218126|560377702|FG000|Overall Study|Lack of Efficacy|7|||
155258680|NCT01218126|560377703|FG001|Overall Study|Lack of Efficacy|2|||
155258681|NCT01218126|560377704|FG002|Overall Study|Lack of Efficacy|2|||
155258682|NCT01218126|560377705|FG003|Overall Study|Lack of Efficacy|6|||
155258683|NCT01218126|560377702|FG000|Overall Study|Protocol Violation|5|||
155258684|NCT01218126|560377703|FG001|Overall Study|Protocol Violation|2|||
155258685|NCT01218126|560377704|FG002|Overall Study|Protocol Violation|2|||
155258686|NCT01218126|560377705|FG003|Overall Study|Protocol Violation|3|||
155258687|NCT01218126|560377702|FG000|Overall Study|Protocol-defined stopping criteria|1|||
155258688|NCT01218126|560377703|FG001|Overall Study|Protocol-defined stopping criteria|1|||
155258689|NCT01218126|560377704|FG002|Overall Study|Protocol-defined stopping criteria|0|||
155258690|NCT01218126|560377705|FG003|Overall Study|Protocol-defined stopping criteria|0|||
155258691|NCT01218126|560377702|FG000|Overall Study|Lost to Follow-up|0|||
155258692|NCT01218126|560377703|FG001|Overall Study|Lost to Follow-up|0|||
155258693|NCT01218126|560377704|FG002|Overall Study|Lost to Follow-up|0|||
155258694|NCT01218126|560377705|FG003|Overall Study|Lost to Follow-up|2|||
155258695|NCT01218126|560377702|FG000|Overall Study|Physician Decision|1|||
155258696|NCT01218126|560377703|FG001|Overall Study|Physician Decision|2|||
155258697|NCT01218126|560377704|FG002|Overall Study|Physician Decision|4|||
155258698|NCT01218126|560377705|FG003|Overall Study|Physician Decision|2|||
155258699|NCT01218126|560377702|FG000|Overall Study|Withdrawal by Subject|2|||
155258700|NCT01218126|560377703|FG001|Overall Study|Withdrawal by Subject|5|||
155258701|NCT01218126|560377704|FG002|Overall Study|Withdrawal by Subject|4|||
155258702|NCT01218126|560377705|FG003|Overall Study|Withdrawal by Subject|6|||
155258703|NCT01860703|560377708|FG000|Overall Study|Adverse Event|1|||
155258704|NCT01860703|560377709|FG001|Overall Study|Adverse Event|4|||
155258705|NCT01860703|560377710|FG002|Overall Study|Adverse Event|0|||
155258706|NCT01860703|560377711|FG003|Overall Study|Adverse Event|2|||
155258707|NCT01860703|560377708|FG000|Overall Study|Withdrawal by Subject|0|||
155258708|NCT01860703|560377709|FG001|Overall Study|Withdrawal by Subject|1|||
155258709|NCT01860703|560377710|FG002|Overall Study|Withdrawal by Subject|0|||
155258710|NCT01860703|560377711|FG003|Overall Study|Withdrawal by Subject|0|||
155258711|NCT01860703|560377708|FG000|Overall Study|Personal reason|1|||
155258712|NCT01860703|560377709|FG001|Overall Study|Personal reason|0|||
155258713|NCT01860703|560377710|FG002|Overall Study|Personal reason|1|||
155258714|NCT01860703|560377711|FG003|Overall Study|Personal reason|0|||
155258715|NCT06213701|560377715|FG000|Overall Study|Withdrawal by Subject|2|||
155258716|NCT06213701|560377716|FG001|Overall Study|Withdrawal by Subject|1|||
155258717|NCT06213701|560377717|FG002|Overall Study|Withdrawal by Subject|0|||
155258718|NCT02453685|560377720|FG000|Overall Study|Adverse Event|0|||
155258719|NCT02453685|560377721|FG001|Overall Study|Adverse Event|1|||
155258720|NCT02453685|560377720|FG000|Overall Study|Protocol Violation|7|||
155258721|NCT02453685|560377721|FG001|Overall Study|Protocol Violation|4|||
155258722|NCT02453685|560377720|FG000|Overall Study|Lost to Follow-up|0|||
155258723|NCT02453685|560377721|FG001|Overall Study|Lost to Follow-up|1|||
155258724|NCT02453685|560377720|FG000|Overall Study|Withdrawal by Subject|8|||
155258725|NCT02453685|560377721|FG001|Overall Study|Withdrawal by Subject|4|||
155258726|NCT02453685|560377720|FG000|Overall Study|Unclassified|4|||
155258727|NCT02453685|560377721|FG001|Overall Study|Unclassified|2|||
155258728|NCT00453986|560377722|FG000|Overall Study|Lost to Follow-up|6|||
155258729|NCT00453986|560377723|FG001|Overall Study|Lost to Follow-up|5|||
155258730|NCT00453986|560377724|FG002|Overall Study|Lost to Follow-up|6|||
155258731|NCT00453986|560377725|FG003|Overall Study|Lost to Follow-up|2|||
155258732|NCT00453986|560377726|FG004|Overall Study|Lost to Follow-up|0|||
155258733|NCT03221387|560377727|FG000|Overall Study|Lost to Follow-up|1|||
155258734|NCT03221387|560377727|FG000|Overall Study|Lung transplant|1|||
155258735|NCT00522626|560377728|FG000|Overall Study|Lost to Follow-up|7|||
155258736|NCT00803452|560377729|FG000|Overall Study|Adverse Event|0|||
155258737|NCT00803452|560377730|FG001|Overall Study|Adverse Event|2|||
155258738|NCT00803452|560377729|FG000|Overall Study|Lost to Follow-up|0|||
155258739|NCT00803452|560377730|FG001|Overall Study|Lost to Follow-up|3|||
155258740|NCT02365519|560377732|FG000|Randomized and Treated|Adverse Event|0|||
155258741|NCT02365519|560377733|FG001|Randomized and Treated|Adverse Event|1|||
155258742|NCT02365519|560377734|FG002|Randomized and Treated|Adverse Event|0|||
155258743|NCT02365519|560377732|FG000|Randomized and Treated|Withdrawal by Subject|0|||
155258744|NCT02365519|560377733|FG001|Randomized and Treated|Withdrawal by Subject|1|||
155258745|NCT02365519|560377734|FG002|Randomized and Treated|Withdrawal by Subject|1|||
155258746|NCT01971723|560377735|FG000|Overall Study|Withdrawal by Subject|1|||
155258747|NCT01971723|560377736|FG001|Overall Study|Withdrawal by Subject|1|||
155258748|NCT01971723|560377735|FG000|Overall Study|Protocol Violation|1|||
155258749|NCT01971723|560377736|FG001|Overall Study|Protocol Violation|2|||
155258750|NCT03076970|560379527|FG000|Washout Period 2|Adverse Event|0|||
155258751|NCT03076970|560379528|FG001|Washout Period 2|Adverse Event|0|||
155258752|NCT03076970|560379529|FG002|Washout Period 2|Adverse Event|0|||
155258753|NCT03076970|560379530|FG003|Washout Period 2|Adverse Event|0|||
155258754|NCT03076970|560379531|FG004|Washout Period 2|Adverse Event|1|||
155258755|NCT03076970|560379532|FG005|Washout Period 2|Adverse Event|0|||
155258756|NCT03076970|560379527|FG000|Period 3|Withdrawal by Subject|0|||
155258757|NCT03076970|560379528|FG001|Period 3|Withdrawal by Subject|0|||
155258758|NCT03076970|560379529|FG002|Period 3|Withdrawal by Subject|0|||
155258759|NCT03076970|560379530|FG003|Period 3|Withdrawal by Subject|0|||
155258760|NCT03076970|560379531|FG004|Period 3|Withdrawal by Subject|0|||
155258761|NCT03076970|560379532|FG005|Period 3|Withdrawal by Subject|1|||
155258762|NCT03076970|560379527|FG000|Period 3|Failure to meet I/E criteria|0|||
155258763|NCT03076970|560379528|FG001|Period 3|Failure to meet I/E criteria|0|||
155258764|NCT03076970|560379529|FG002|Period 3|Failure to meet I/E criteria|0|||
155258765|NCT03076970|560379530|FG003|Period 3|Failure to meet I/E criteria|0|||
155258766|NCT03076970|560379531|FG004|Period 3|Failure to meet I/E criteria|1|||
155258767|NCT03076970|560379532|FG005|Period 3|Failure to meet I/E criteria|0|||
155258768|NCT01364922|560379533|FG000|Open-label (OL) Period|Adverse Event|7|||
155258769|NCT01364922|560379534|FG001|Open-label (OL) Period|Adverse Event|0|||
155258770|NCT01364922|560379535|FG002|Open-label (OL) Period|Adverse Event|0|||
155258771|NCT01364922|560379533|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
155258772|NCT01364922|560379534|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
155258773|NCT01364922|560379535|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
155258774|NCT01364922|560379533|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
155258775|NCT01364922|560379534|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
155258776|NCT01364922|560379535|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
155258777|NCT01364922|560379533|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
155258778|NCT01364922|560379534|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
155258779|NCT01364922|560379535|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
155258780|NCT01364922|560379533|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
155258781|NCT01364922|560379534|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
155258782|NCT01364922|560379535|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
155258783|NCT01364922|560379533|FG000|Open-label (OL) Period|Other, Unspecified|1|||
155258784|NCT01364922|560379534|FG001|Open-label (OL) Period|Other, Unspecified|0|||
155258785|NCT01364922|560379535|FG002|Open-label (OL) Period|Other, Unspecified|0|||
155258786|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
155258787|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
155258788|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
155258789|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
155258790|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
155258791|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
155258792|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Adverse Event|0|||
155258793|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Adverse Event|0|||
155258794|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Adverse Event|1|||
155258795|NCT01364922|560379533|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
155258796|NCT01364922|560379534|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
155258797|NCT01364922|560379535|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
155258798|NCT01289418|560379537|FG000|Day 8 Survey|email address invalid|283|||
155258799|NCT01289418|560379537|FG000|Day 8 Survey|participants did not complete the survey|1935|||
155258800|NCT01289418|560379537|FG000|Day 29 Survey|email address invalid|283|||
155258801|NCT01289418|560379537|FG000|Day 29 Survey|participants did not complete the survey|2185|||
155258802|NCT01352585|560379538|FG000|Overall Study|Adverse Event|2|||
155258803|NCT01352585|560379539|FG001|Overall Study|Adverse Event|1|||
155258804|NCT01352585|560379538|FG000|Overall Study|Lost to Follow-up|1|||
155258805|NCT01352585|560379539|FG001|Overall Study|Lost to Follow-up|0|||
155258806|NCT01352585|560379538|FG000|Overall Study|Other|5|||
155258807|NCT01352585|560379539|FG001|Overall Study|Other|2|||
155258808|NCT00838682|560379540|FG000|Overall Study|Lost to Follow-up|21|||
155258809|NCT00838682|560379541|FG001|Overall Study|Lost to Follow-up|14|||
155258810|NCT00838682|560379540|FG000|Overall Study|detection of exclusion criteria|4|||
155258811|NCT00838682|560379541|FG001|Overall Study|detection of exclusion criteria|3|||
155258812|NCT00838682|560379540|FG000|Overall Study|Protocol Violation|0|||
155258813|NCT00838682|560379541|FG001|Overall Study|Protocol Violation|1|||
155258814|NCT00838682|560379540|FG000|Overall Study|Withdrawal by Subject|0|||
155258815|NCT00838682|560379541|FG001|Overall Study|Withdrawal by Subject|1|||
155258816|NCT03928028|560379542|FG000|Overall Study|Physician Decision|9|||
155258817|NCT03928028|560379543|FG001|Overall Study|Physician Decision|6|||
155258818|NCT03928028|560379544|FG002|Overall Study|Physician Decision|3|||
155258819|NCT03928028|560379542|FG000|Overall Study|Withdrawal by Subject|12|||
155258820|NCT03928028|560379543|FG001|Overall Study|Withdrawal by Subject|3|||
155258821|NCT03928028|560379544|FG002|Overall Study|Withdrawal by Subject|3|||
155258822|NCT04525547|560379550|FG000|Overall Study|Not treated with Ofev|2|||
155258823|NCT04525547|560379550|FG000|Overall Study|Off-label use|2|||
155258824|NCT04525547|560379550|FG000|Overall Study|Lost to Follow-up|1|||
155258825|NCT00800202|560379551|FG000|Overall Study|Adverse Event|7|||
155258826|NCT00800202|560379552|FG001|Overall Study|Adverse Event|6|||
155258827|NCT00800202|560379551|FG000|Overall Study|Death|1|||
155258828|NCT00800202|560379552|FG001|Overall Study|Death|0|||
155258829|NCT00800202|560379551|FG000|Overall Study|Other|5|||
155258830|NCT00800202|560379552|FG001|Overall Study|Other|0|||
155258831|NCT00800202|560379551|FG000|Overall Study|Disease Progression|54|||
155258832|NCT00800202|560379552|FG001|Overall Study|Disease Progression|18|||
155258833|NCT00180479|560379553|FG000|Overall Study|Death|4|||
155258834|NCT00180479|560379554|FG001|Overall Study|Death|2|||
155258835|NCT00180479|560379553|FG000|Overall Study|Lost to Follow-up|9|||
155258836|NCT00180479|560379554|FG001|Overall Study|Lost to Follow-up|7|||
155258837|NCT00180479|560379553|FG000|Overall Study|Withdrawal by Subject|3|||
155258838|NCT00180479|560379554|FG001|Overall Study|Withdrawal by Subject|3|||
155258839|NCT00180479|560379553|FG000|Overall Study|Informed consent not signed|0|||
155258840|NCT00180479|560379554|FG001|Overall Study|Informed consent not signed|1|||
155258841|NCT02459262|560379555|FG000|Overall Study|Withdrawal by Subject|0|||
155258842|NCT02459262|560379556|FG001|Overall Study|Withdrawal by Subject|0|||
155258843|NCT02459262|560379557|FG002|Overall Study|Withdrawal by Subject|0|||
155258844|NCT02459262|560379558|FG003|Overall Study|Withdrawal by Subject|0|||
155258845|NCT02459262|560379559|FG004|Overall Study|Withdrawal by Subject|0|||
155258846|NCT02459262|560379560|FG005|Overall Study|Withdrawal by Subject|0|||
155258847|NCT02459262|560379561|FG006|Overall Study|Withdrawal by Subject|0|||
155258848|NCT02459262|560379562|FG007|Overall Study|Withdrawal by Subject|0|||
155258849|NCT02459262|560379563|FG008|Overall Study|Withdrawal by Subject|0|||
155258850|NCT02459262|560379564|FG009|Overall Study|Withdrawal by Subject|1|||
155258851|NCT02459262|560379565|FG010|Overall Study|Withdrawal by Subject|0|||
155258852|NCT05168579|560379566|FG000|Overall Study|Lack of Consent|1|||
155258853|NCT05168579|560379567|FG001|Overall Study|Lack of Consent|0|||
155258854|NCT05168579|560379566|FG000|Overall Study|Conflicts with time|2|||
155258855|NCT05168579|560379567|FG001|Overall Study|Conflicts with time|0|||
155258856|NCT05168579|560379566|FG000|Overall Study|Time slots were full|3|||
155258857|NCT05168579|560379567|FG001|Overall Study|Time slots were full|0|||
155258858|NCT05168579|560379566|FG000|Overall Study|Lost to Follow-up|0|||
155258859|NCT05168579|560379567|FG001|Overall Study|Lost to Follow-up|15|||
155258860|NCT00840801|560379568|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
155258861|NCT00840801|560379569|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
155258862|NCT00840801|560379570|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
155258863|NCT00840801|560379568|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
155258864|NCT00840801|560379569|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
155258865|NCT00840801|560379570|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
155258866|NCT00840801|560379568|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
155258867|NCT00840801|560379569|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
155258868|NCT00840801|560379570|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
155258869|NCT00840801|560379568|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
155258870|NCT00840801|560379569|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
155258871|NCT00840801|560379570|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
155258872|NCT00508404|560379571|FG000|Overall Study|Ongoing at Data Cut-off|12|||
155258873|NCT00508404|560379571|FG000|Overall Study|Adverse Event|2|||
155258874|NCT00508404|560379571|FG000|Overall Study|Death|16|||
155258875|NCT00508404|560379571|FG000|Overall Study|Physician Decision|2|||
155258876|NCT00508404|560379571|FG000|Overall Study|Withdrawal by Subject|3|||
155258877|NCT00508404|560379571|FG000|Overall Study|Protocol-specified Criteria|2|||
155258878|NCT00508404|560379571|FG000|Overall Study|Lost to Follow-up|2|||
155258879|NCT00508404|560379571|FG000|Overall Study|Other - Not Specified|3|||
155258880|NCT01505387|560379572|FG000|Overall Study|Protocol Violation|1|||
155258881|NCT01505387|560379573|FG001|Overall Study|Protocol Violation|0|||
155258882|NCT01505387|560379572|FG000|Overall Study|Withdrawal by Subject|1|||
155258883|NCT01505387|560379573|FG001|Overall Study|Withdrawal by Subject|1|||
155258884|NCT01424930|560379574|FG000|Overall Study|Adverse Event|0|||
155258885|NCT01424930|560379575|FG001|Overall Study|Adverse Event|1|||
155258886|NCT01424930|560379574|FG000|Overall Study|Death|1|||
155258887|NCT01424930|560379575|FG001|Overall Study|Death|0|||
155258888|NCT01424930|560379574|FG000|Overall Study|Progressive Disease|3|||
155258889|NCT01424930|560379575|FG001|Overall Study|Progressive Disease|6|||
155258890|NCT01424930|560379574|FG000|Overall Study|Screen Failure|0|||
155258891|NCT01424930|560379575|FG001|Overall Study|Screen Failure|1|||
155258892|NCT01424930|560379574|FG000|Overall Study|Reason not specified|0|||
155258893|NCT01424930|560379575|FG001|Overall Study|Reason not specified|6|||
155258894|NCT01197508|560379578|FG000|Overall Study|Withdrawal by Subject|8|||
155258895|NCT01197508|560379579|FG001|Overall Study|Withdrawal by Subject|7|||
155258896|NCT01197508|560379580|FG002|Overall Study|Withdrawal by Subject|15|||
155258897|NCT01197508|560379581|FG003|Overall Study|Withdrawal by Subject|4|||
155258898|NCT01197508|560379578|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
155258899|NCT01197508|560379579|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
155258900|NCT01197508|560379580|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
155258901|NCT01197508|560379581|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
155258902|NCT01197508|560379578|FG000|Overall Study|Adverse Event|10|||
155258903|NCT01197508|560379579|FG001|Overall Study|Adverse Event|13|||
155258904|NCT01197508|560379580|FG002|Overall Study|Adverse Event|23|||
155258905|NCT01197508|560379581|FG003|Overall Study|Adverse Event|3|||
155258906|NCT01197508|560379578|FG000|Overall Study|Severe non-compliance to protocol|0|||
155258907|NCT01197508|560379579|FG001|Overall Study|Severe non-compliance to protocol|3|||
155258908|NCT01197508|560379580|FG002|Overall Study|Severe non-compliance to protocol|1|||
155258909|NCT01197508|560379581|FG003|Overall Study|Severe non-compliance to protocol|3|||
155258910|NCT01197508|560379578|FG000|Overall Study|Condition under investigation worsened|1|||
155258911|NCT01197508|560379579|FG001|Overall Study|Condition under investigation worsened|1|||
155258912|NCT01197508|560379580|FG002|Overall Study|Condition under investigation worsened|1|||
155258913|NCT01197508|560379581|FG003|Overall Study|Condition under investigation worsened|1|||
155258914|NCT01197508|560379578|FG000|Overall Study|Lack of Efficacy|1|||
155258915|NCT01197508|560379579|FG001|Overall Study|Lack of Efficacy|2|||
155258916|NCT01197508|560379580|FG002|Overall Study|Lack of Efficacy|2|||
155258917|NCT01197508|560379581|FG003|Overall Study|Lack of Efficacy|1|||
155258918|NCT01197508|560379578|FG000|Overall Study|Study-specific withdrawal criteria|0|||
155258919|NCT01197508|560379579|FG001|Overall Study|Study-specific withdrawal criteria|0|||
155258920|NCT01197508|560379580|FG002|Overall Study|Study-specific withdrawal criteria|1|||
155258921|NCT01197508|560379581|FG003|Overall Study|Study-specific withdrawal criteria|2|||
155258922|NCT01197508|560379578|FG000|Overall Study|Lost to Follow-up|1|||
155258923|NCT01197508|560379579|FG001|Overall Study|Lost to Follow-up|1|||
155258924|NCT01197508|560379580|FG002|Overall Study|Lost to Follow-up|2|||
155258925|NCT01197508|560379581|FG003|Overall Study|Lost to Follow-up|0|||
155258926|NCT01197508|560379578|FG000|Overall Study|Other|2|||
155258927|NCT01197508|560379579|FG001|Overall Study|Other|3|||
155258928|NCT01197508|560379580|FG002|Overall Study|Other|2|||
155258929|NCT01197508|560379581|FG003|Overall Study|Other|2|||
155258930|NCT03286751|560379582|FG000|Washout Period 1|Withdrawal by Subject|0|||
155258931|NCT03286751|560379583|FG001|Washout Period 1|Withdrawal by Subject|0|||
155258932|NCT03286751|560379584|FG002|Washout Period 1|Withdrawal by Subject|0|||
155258933|NCT03286751|560379585|FG003|Washout Period 1|Withdrawal by Subject|0|||
155258934|NCT03286751|560379586|FG004|Washout Period 1|Withdrawal by Subject|1|||
155258935|NCT03286751|560379587|FG005|Washout Period 1|Withdrawal by Subject|0|||
155258936|NCT03286751|560379582|FG000|Washout Period 2|Personal Reasons|0|||
155258937|NCT03286751|560379583|FG001|Washout Period 2|Personal Reasons|1|||
155258938|NCT03286751|560379584|FG002|Washout Period 2|Personal Reasons|0|||
155258939|NCT03286751|560379585|FG003|Washout Period 2|Personal Reasons|0|||
155258940|NCT03286751|560379586|FG004|Washout Period 2|Personal Reasons|0|||
155258941|NCT03286751|560379587|FG005|Washout Period 2|Personal Reasons|0|||
155258942|NCT03286751|560379582|FG000|Washout Period 5|Adverse Event|0|||
155258943|NCT03286751|560379583|FG001|Washout Period 5|Adverse Event|0|||
155258944|NCT03286751|560379584|FG002|Washout Period 5|Adverse Event|0|||
155258945|NCT03286751|560379585|FG003|Washout Period 5|Adverse Event|0|||
155258946|NCT03286751|560379586|FG004|Washout Period 5|Adverse Event|1|||
155258947|NCT03286751|560379587|FG005|Washout Period 5|Adverse Event|0|||
155258948|NCT01621880|560379588|FG000|Overall Study|Adverse Event|5|||
155258949|NCT01621880|560379589|FG001|Overall Study|Adverse Event|1|||
155258950|NCT01621880|560379588|FG000|Overall Study|Withdrawal by Subject|5|||
155258951|NCT01621880|560379589|FG001|Overall Study|Withdrawal by Subject|4|||
155258952|NCT03086330|560379596|FG000|Overall Study|Withdrawal by Subject|3|||
155258953|NCT03086330|560379597|FG001|Overall Study|Withdrawal by Subject|2|||
155258954|NCT03086330|560379596|FG000|Overall Study|Lost to Follow-up|1|||
155258955|NCT03086330|560379597|FG001|Overall Study|Lost to Follow-up|2|||
155258956|NCT00645164|560379598|FG000|Overall Study|Lost to Follow-up|2|||
155258957|NCT00645164|560379598|FG000|Overall Study|Withdrawal by Subject|4|||
155258958|NCT00645164|560379598|FG000|Overall Study|Protocol Violation|1|||
155258959|NCT03338829|560379601|FG000|Overall Study|Lost to Follow-up|4|||
155258960|NCT03338829|560379602|FG001|Overall Study|Lost to Follow-up|2|||
155258961|NCT03338829|560379603|FG002|Overall Study|Lost to Follow-up|4|||
155258962|NCT03338829|560379601|FG000|Overall Study|Pregnancy loss|1|||
155258963|NCT03338829|560379602|FG001|Overall Study|Pregnancy loss|1|||
155258964|NCT03338829|560379603|FG002|Overall Study|Pregnancy loss|0|||
155258965|NCT03338829|560379601|FG000|Overall Study|Protocol Violation|0|||
155258966|NCT03338829|560379602|FG001|Overall Study|Protocol Violation|1|||
155258967|NCT03338829|560379603|FG002|Overall Study|Protocol Violation|0|||
155258968|NCT03434678|560379606|FG000|Overall Study|Withdrawal by Subject|13|||
155258969|NCT03434678|560379607|FG001|Overall Study|Withdrawal by Subject|13|||
155258970|NCT03434678|560379606|FG000|Overall Study|Found to be ineligible post randomization|2|||
155258971|NCT03434678|560379607|FG001|Overall Study|Found to be ineligible post randomization|1|||
155258972|NCT06060457|560379608|FG000|Overall Study|Adverse Event|1|||
155258973|NCT06060457|560379609|FG001|Overall Study|Adverse Event|1|||
155258974|NCT06060457|560379608|FG000|Overall Study|Death|2|||
155258975|NCT06060457|560379609|FG001|Overall Study|Death|2|||
155258976|NCT06060457|560379608|FG000|Overall Study|Lost to Follow-up|17|||
155258977|NCT06060457|560379609|FG001|Overall Study|Lost to Follow-up|19|||
155258978|NCT06060457|560379608|FG000|Overall Study|Physician Decision|0|||
155258979|NCT06060457|560379609|FG001|Overall Study|Physician Decision|1|||
155258980|NCT06060457|560379608|FG000|Overall Study|Protocol Violation|1|||
155258981|NCT06060457|560379609|FG001|Overall Study|Protocol Violation|1|||
155258982|NCT06060457|560379608|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
155258983|NCT06060457|560379609|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
155258984|NCT06060457|560379608|FG000|Overall Study|Withdrawal by Subject|12|||
155258985|NCT06060457|560379609|FG001|Overall Study|Withdrawal by Subject|15|||
155258986|NCT06060457|560379608|FG000|Overall Study|Other Than Specified|2|||
155258987|NCT06060457|560379609|FG001|Overall Study|Other Than Specified|1|||
155258988|NCT02061202|560379610|FG000|Overall Study|Lost to Follow-up|1|||
155258989|NCT02061202|560379611|FG001|Overall Study|Lost to Follow-up|1|||
155258990|NCT05608499|560379616|FG000|Overall Study|Lack of Efficacy|1|||
155258991|NCT05608499|560379617|FG001|Overall Study|Lack of Efficacy|0|||
155258992|NCT05608499|560379616|FG000|Overall Study|Lost to Follow-up|0|||
155258993|NCT05608499|560379617|FG001|Overall Study|Lost to Follow-up|1|||
155258994|NCT02660827|560379620|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
155258995|NCT02660827|560379620|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
155258996|NCT02660827|560379620|FG000|From Study to End of Continued Access|Adverse Event|3|||
155258997|NCT02660827|560379620|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
155258998|NCT02660827|560379620|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
155258999|NCT02660827|560379620|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
155259000|NCT02660827|560379620|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
155259001|NCT02660827|560379620|FG000|Period 2: Continued Access Period|Adverse Event|3|||
155259002|NCT04672941|560379621|FG000|Overall Study|Investigator decision|1|||
155259003|NCT04672941|560379621|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
155259004|NCT04672941|560379621|FG000|Overall Study|COVID-19 related but no adverse event|1|||
155259005|NCT04672941|560379621|FG000|Overall Study|Adverse Event|2|||
155259006|NCT04672941|560379621|FG000|Overall Study|Lost to Follow-up|2|||
155259007|NCT00045305|560379622|FG000|Overall Study|Lack of Efficacy|6|||
155259008|NCT00045305|560379622|FG000|Overall Study|Adverse Event|3|||
155259009|NCT00045305|560379622|FG000|Overall Study|Death|3|||
155259010|NCT00045305|560379622|FG000|Overall Study|site error|2|||
155259011|NCT03848403|560379625|FG000|Period 2 (Day 8)|Adverse Event|1|||
155259012|NCT03848403|560379626|FG001|Period 2 (Day 8)|Adverse Event|2|||
155259013|NCT03848403|560379627|FG002|Period 2 (Day 8)|Adverse Event|2|||
155259014|NCT03848403|560379625|FG000|Period 2 (Day 8)|Physician Decision|0|||
155259015|NCT03848403|560379626|FG001|Period 2 (Day 8)|Physician Decision|1|||
155259016|NCT03848403|560379627|FG002|Period 2 (Day 8)|Physician Decision|0|||
155259017|NCT03848403|560379625|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
155259018|NCT03848403|560379626|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
155259019|NCT03848403|560379627|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
155259020|NCT02279043|560379628|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
155259021|NCT02279043|560379629|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
155259022|NCT02279043|560379630|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
155259023|NCT02279043|560379628|FG000|Overall Study|Lost to Follow-up|46|||
155259024|NCT02279043|560379629|FG001|Overall Study|Lost to Follow-up|88|||
155259025|NCT02279043|560379630|FG002|Overall Study|Lost to Follow-up|0|||
155259026|NCT00168038|560379631|FG000|Overall Study|Adverse Event|1|||
155259027|NCT00168038|560379631|FG000|Overall Study|Therapy failure|1|||
155259028|NCT02657031|560379635|FG000|Overall Study|Adverse Event|1|||
155259029|NCT02657031|560379636|FG001|Overall Study|Adverse Event|2|||
155259030|NCT04198805|560379637|FG000|Overall Study|Death|0|||
155259031|NCT04198805|560379638|FG001|Overall Study|Death|0|||
155259032|NCT04198805|560379639|FG002|Overall Study|Death|0|||
155259033|NCT04198805|560379640|FG003|Overall Study|Death|1|||
155259034|NCT04198805|560379637|FG000|Overall Study|Early Termination|8|||
155259035|NCT04198805|560379638|FG001|Overall Study|Early Termination|4|||
155259036|NCT04198805|560379639|FG002|Overall Study|Early Termination|6|||
155259037|NCT04198805|560379640|FG003|Overall Study|Early Termination|9|||
155259038|NCT03184792|560379643|FG000|Overall Study|Pandemic|2|||
155259039|NCT03184792|560379644|FG001|Overall Study|Pandemic|2|||
155259040|NCT02495025|560379645|FG000|Overall Study|Lost to Follow-up|21|||
155259041|NCT02495025|560379646|FG001|Overall Study|Lost to Follow-up|14|||
155259042|NCT02495025|560379645|FG000|Overall Study|Withdrawal by Subject|5|||
155259043|NCT02495025|560379646|FG001|Overall Study|Withdrawal by Subject|0|||
155259044|NCT00313820|560379648|FG000|Assigned to Treatment|Other|1|||
155259045|NCT00313820|560379649|FG001|Assigned to Treatment|Other|0|||
155259046|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
155259047|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
155259048|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
155259049|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
155259050|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
155259051|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
155259052|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
155259053|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
155259054|NCT00313820|560379648|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
155259055|NCT00313820|560379649|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
155259056|NCT02134587|560379653|FG000|Overall Study|Did not completed all meetings|30|||
155259057|NCT00265889|560379654|FG000|Overall Study|Physician Decision|1|||
155259058|NCT00265889|560379654|FG000|Overall Study|Protocol Violation|1|||
155259059|NCT00265889|560379654|FG000|Overall Study|Insurance denied the request|3|||
155259060|NCT02778100|560379660|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
155259061|NCT02778100|560379661|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
155259062|NCT01515748|560379669|FG000|Overall Study|Withdrawal by Subject|32|||
155259063|NCT01515748|560379670|FG001|Overall Study|Withdrawal by Subject|41|||
155259064|NCT01515748|560379669|FG000|Overall Study|Lost to Follow-up|2|||
155259065|NCT01515748|560379670|FG001|Overall Study|Lost to Follow-up|4|||
155259066|NCT01515748|560379669|FG000|Overall Study|Other than specified above|5|||
155259067|NCT01515748|560379670|FG001|Overall Study|Other than specified above|10|||
155259068|NCT01024608|560379673|FG000|Overall Study|Adverse Event|1|||
155259069|NCT01024608|560379674|FG001|Overall Study|Adverse Event|0|||
155259070|NCT01024608|560379673|FG000|Overall Study|Withdrawal by Subject|1|||
155259071|NCT01024608|560379674|FG001|Overall Study|Withdrawal by Subject|0|||
155259072|NCT01024608|560379673|FG000|Overall Study|Lost to Follow-up|0|||
155259073|NCT01024608|560379674|FG001|Overall Study|Lost to Follow-up|1|||
155259074|NCT01024608|560379673|FG000|Overall Study|Protocol Violation|0|||
155259075|NCT01024608|560379674|FG001|Overall Study|Protocol Violation|3|||
155259076|NCT01024608|560379673|FG000|Overall Study|Never received study treatment|2|||
155259077|NCT01024608|560379674|FG001|Overall Study|Never received study treatment|0|||
155259078|NCT04349280|560379675|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
155259079|NCT04349280|560379676|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
155259080|NCT04349280|560379675|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
155259081|NCT04349280|560379676|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
155259082|NCT04349280|560379675|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
155259083|NCT04349280|560379676|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
155259084|NCT05809596|560379679|FG000|Overall Study|Death|16|||
155259085|NCT05809596|560379679|FG000|Overall Study|Withdrawal by Subject|4|||
155259086|NCT05809596|560379679|FG000|Overall Study|Physician Decision|1|||
155259087|NCT05809596|560379679|FG000|Overall Study|Missed Visit|2|||
155259088|NCT05809596|560379679|FG000|Overall Study|Other|3|||
155259089|NCT03770494|560379681|FG000|Overall Study|Lost to Follow-up|0|||
155259090|NCT03770494|560379682|FG001|Overall Study|Lost to Follow-up|0|||
155259091|NCT03770494|560379683|FG002|Overall Study|Lost to Follow-up|1|||
155259092|NCT03770494|560379684|FG003|Overall Study|Lost to Follow-up|1|||
155259093|NCT03770494|560379685|FG004|Overall Study|Lost to Follow-up|1|||
155259094|NCT03770494|560379686|FG005|Overall Study|Lost to Follow-up|0|||
155259095|NCT03770494|560379687|FG006|Overall Study|Lost to Follow-up|0|||
155259096|NCT03770494|560379688|FG007|Overall Study|Lost to Follow-up|0|||
155259097|NCT03770494|560379689|FG008|Overall Study|Lost to Follow-up|0|||
155259098|NCT03770494|560379690|FG009|Overall Study|Lost to Follow-up|0|||
155259099|NCT03770494|560379691|FG010|Overall Study|Lost to Follow-up|0|||
155259100|NCT03770494|560379692|FG011|Overall Study|Lost to Follow-up|0|||
155259101|NCT03770494|560379693|FG012|Overall Study|Lost to Follow-up|0|||
155259102|NCT03770494|560379694|FG013|Overall Study|Lost to Follow-up|0|||
155259103|NCT03770494|560379681|FG000|Overall Study|Study terminated by sponsor|1|||
155259104|NCT03770494|560379682|FG001|Overall Study|Study terminated by sponsor|2|||
155259105|NCT03770494|560379683|FG002|Overall Study|Study terminated by sponsor|1|||
155259106|NCT03770494|560379684|FG003|Overall Study|Study terminated by sponsor|1|||
155259107|NCT03770494|560379685|FG004|Overall Study|Study terminated by sponsor|1|||
155259108|NCT03770494|560379686|FG005|Overall Study|Study terminated by sponsor|2|||
155259109|NCT03770494|560379687|FG006|Overall Study|Study terminated by sponsor|1|||
155259110|NCT03770494|560379688|FG007|Overall Study|Study terminated by sponsor|2|||
155259111|NCT03770494|560379689|FG008|Overall Study|Study terminated by sponsor|1|||
155259112|NCT03770494|560379690|FG009|Overall Study|Study terminated by sponsor|2|||
155259113|NCT03770494|560379691|FG010|Overall Study|Study terminated by sponsor|1|||
155259114|NCT03770494|560379692|FG011|Overall Study|Study terminated by sponsor|2|||
155259115|NCT03770494|560379693|FG012|Overall Study|Study terminated by sponsor|0|||
155259116|NCT03770494|560379694|FG013|Overall Study|Study terminated by sponsor|0|||
155259117|NCT03770494|560379681|FG000|Overall Study|Withdrawal by Subject|1|||
155259118|NCT03770494|560379682|FG001|Overall Study|Withdrawal by Subject|1|||
155259119|NCT03770494|560379683|FG002|Overall Study|Withdrawal by Subject|0|||
155259120|NCT03770494|560379684|FG003|Overall Study|Withdrawal by Subject|0|||
155259121|NCT03770494|560379685|FG004|Overall Study|Withdrawal by Subject|2|||
155259122|NCT03770494|560379686|FG005|Overall Study|Withdrawal by Subject|2|||
155259123|NCT03770494|560379687|FG006|Overall Study|Withdrawal by Subject|2|||
155259124|NCT03770494|560379688|FG007|Overall Study|Withdrawal by Subject|0|||
155259125|NCT03770494|560379689|FG008|Overall Study|Withdrawal by Subject|2|||
155259126|NCT03770494|560379690|FG009|Overall Study|Withdrawal by Subject|3|||
155259127|NCT03770494|560379691|FG010|Overall Study|Withdrawal by Subject|1|||
155259128|NCT03770494|560379692|FG011|Overall Study|Withdrawal by Subject|0|||
155259129|NCT03770494|560379693|FG012|Overall Study|Withdrawal by Subject|0|||
155259130|NCT03770494|560379694|FG013|Overall Study|Withdrawal by Subject|0|||
155259131|NCT00608582|560379704|FG000|Overall Study|Lost to Follow-up|2|||
155259132|NCT00608582|560379705|FG001|Overall Study|Lost to Follow-up|0|||
155259133|NCT00608582|560379704|FG000|Overall Study|No Best Response in Phase 1 located|1|||
155259134|NCT00608582|560379705|FG001|Overall Study|No Best Response in Phase 1 located|1|||
155259135|NCT00608582|560379704|FG000|Overall Study|Illicit Drug Use|1|||
155259136|NCT00608582|560379705|FG001|Overall Study|Illicit Drug Use|0|||
155259137|NCT00608582|560379704|FG000|Overall Study|Early stage Design Change|0|||
155259138|NCT00608582|560379705|FG001|Overall Study|Early stage Design Change|3|||
155259139|NCT04922554|560379706|FG000|Overall Study|Adverse Event|4|||
155259140|NCT04922554|560379707|FG001|Overall Study|Adverse Event|0|||
155259141|NCT04922554|560379706|FG000|Overall Study|Withdrawal by Subject|1|||
155259142|NCT04922554|560379707|FG001|Overall Study|Withdrawal by Subject|0|||
155259143|NCT01984697|560380927|FG000|Overall Study|Adverse Event|0|||
155259144|NCT01984697|560380928|FG001|Overall Study|Adverse Event|0|||
155259145|NCT01984697|560380929|FG002|Overall Study|Adverse Event|2|||
155259146|NCT01984697|560380930|FG003|Overall Study|Adverse Event|0|||
155259147|NCT01984697|560380931|FG004|Overall Study|Adverse Event|0|||
155259148|NCT01984697|560380927|FG000|Overall Study|Lost to Follow-up|14|||
155259149|NCT01984697|560380928|FG001|Overall Study|Lost to Follow-up|5|||
155259150|NCT01984697|560380929|FG002|Overall Study|Lost to Follow-up|10|||
155259151|NCT01984697|560380930|FG003|Overall Study|Lost to Follow-up|6|||
155259152|NCT01984697|560380931|FG004|Overall Study|Lost to Follow-up|21|||
155259153|NCT01984697|560380927|FG000|Overall Study|Physician Decision|3|||
155259154|NCT01984697|560380928|FG001|Overall Study|Physician Decision|0|||
155259155|NCT01984697|560380929|FG002|Overall Study|Physician Decision|0|||
155259156|NCT01984697|560380930|FG003|Overall Study|Physician Decision|1|||
155259157|NCT01984697|560380931|FG004|Overall Study|Physician Decision|0|||
155259158|NCT01984697|560380927|FG000|Overall Study|Protocol Violation|8|||
155259159|NCT01984697|560380928|FG001|Overall Study|Protocol Violation|5|||
155259160|NCT01984697|560380929|FG002|Overall Study|Protocol Violation|3|||
155259161|NCT01984697|560380930|FG003|Overall Study|Protocol Violation|2|||
155259162|NCT01984697|560380931|FG004|Overall Study|Protocol Violation|0|||
155259163|NCT01984697|560380927|FG000|Overall Study|Withdrawal by Subject|15|||
155259164|NCT01984697|560380928|FG001|Overall Study|Withdrawal by Subject|21|||
155259165|NCT01984697|560380929|FG002|Overall Study|Withdrawal by Subject|13|||
155259166|NCT01984697|560380930|FG003|Overall Study|Withdrawal by Subject|11|||
155259167|NCT01984697|560380931|FG004|Overall Study|Withdrawal by Subject|13|||
155259168|NCT01984697|560380927|FG000|Overall Study|Missed last follow-up visit|1|||
155259169|NCT01984697|560380928|FG001|Overall Study|Missed last follow-up visit|0|||
155259170|NCT01984697|560380929|FG002|Overall Study|Missed last follow-up visit|0|||
155259171|NCT01984697|560380930|FG003|Overall Study|Missed last follow-up visit|0|||
155259172|NCT01984697|560380931|FG004|Overall Study|Missed last follow-up visit|0|||
155259173|NCT01984697|560380927|FG000|Overall Study|Death|0|||
155259174|NCT01984697|560380928|FG001|Overall Study|Death|0|||
155259175|NCT01984697|560380929|FG002|Overall Study|Death|0|||
155259176|NCT01984697|560380930|FG003|Overall Study|Death|1|||
155259177|NCT01984697|560380931|FG004|Overall Study|Death|0|||
155259178|NCT01984697|560380927|FG000|Overall Study|Pregnancy|2|||
155259179|NCT01984697|560380928|FG001|Overall Study|Pregnancy|0|||
155259180|NCT01984697|560380929|FG002|Overall Study|Pregnancy|1|||
155259181|NCT01984697|560380930|FG003|Overall Study|Pregnancy|0|||
155259182|NCT01984697|560380931|FG004|Overall Study|Pregnancy|1|||
155259183|NCT01345630|560380932|FG000|Overall Study|Adverse Event|22|||
155259184|NCT01345630|560380933|FG001|Overall Study|Adverse Event|23|||
155259185|NCT01345630|560380932|FG000|Overall Study|Lost to Follow-up|17|||
155259186|NCT01345630|560380933|FG001|Overall Study|Lost to Follow-up|16|||
155259187|NCT01345630|560380932|FG000|Overall Study|Protocol Violation|4|||
155259188|NCT01345630|560380933|FG001|Overall Study|Protocol Violation|1|||
155259189|NCT01345630|560380932|FG000|Overall Study|Medication error without associated AE|0|||
155259190|NCT01345630|560380933|FG001|Overall Study|Medication error without associated AE|1|||
155259191|NCT01345630|560380932|FG000|Overall Study|Study terminated by sponsor|254|||
155259192|NCT01345630|560380933|FG001|Overall Study|Study terminated by sponsor|285|||
155259193|NCT01345630|560380932|FG000|Overall Study|Other reasons|6|||
155259194|NCT01345630|560380933|FG001|Overall Study|Other reasons|8|||
155259195|NCT01345630|560380932|FG000|Overall Study|Withdrawn due to pregnancy|1|||
155259196|NCT01345630|560380933|FG001|Overall Study|Withdrawn due to pregnancy|2|||
155259197|NCT01345630|560380932|FG000|Overall Study|No longer willing to participate|9|||
155259198|NCT01345630|560380933|FG001|Overall Study|No longer willing to participate|12|||
155259199|NCT01345630|560380932|FG000|Overall Study|Insufficient clinical response|48|||
155259200|NCT01345630|560380933|FG001|Overall Study|Insufficient clinical response|11|||
155259201|NCT00949715|560380936|FG000|Overall Study|Physician Decision|1|||
155259202|NCT00949715|560380937|FG001|Overall Study|Physician Decision|0|||
155259203|NCT00949715|560380936|FG000|Overall Study|Lost to Follow-up|1|||
155259204|NCT00949715|560380937|FG001|Overall Study|Lost to Follow-up|0|||
155259205|NCT00949715|560380936|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
155259206|NCT00949715|560380937|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
155259207|NCT01582789|560380938|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
155259208|NCT01582789|560380939|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
155259209|NCT01255592|560380940|FG000|Overall Study|Adverse Event|5|||
155259210|NCT01255592|560380941|FG001|Overall Study|Adverse Event|0|||
155259211|NCT01255592|560380940|FG000|Overall Study|Withdrawal by Subject|1|||
155259212|NCT01255592|560380941|FG001|Overall Study|Withdrawal by Subject|0|||
155259213|NCT01255592|560380940|FG000|Overall Study|Other|0|||
155259214|NCT01255592|560380941|FG001|Overall Study|Other|1|||
155259215|NCT01783418|560380949|FG000|Overall Study|Withdrawal by Subject|1|||
155259216|NCT01783418|560380950|FG001|Overall Study|Withdrawal by Subject|0|||
155259217|NCT00089141|560380951|FG000|Overall Study|Termination of trial|18|||
155259218|NCT00089141|560380952|FG001|Overall Study|Termination of trial|24|||
155259219|NCT00508261|560380955|FG000|Overall Study|Other|0|||
155259220|NCT00508261|560380956|FG001|Overall Study|Other|1|||
155259221|NCT00508261|560380957|FG002|Overall Study|Other|1|||
155259222|NCT00508261|560380958|FG003|Overall Study|Other|0|||
155259223|NCT00508261|560380955|FG000|Overall Study|Serious Adverse Event|0|||
155259224|NCT00508261|560380956|FG001|Overall Study|Serious Adverse Event|1|||
155259225|NCT00508261|560380957|FG002|Overall Study|Serious Adverse Event|0|||
155259226|NCT00508261|560380958|FG003|Overall Study|Serious Adverse Event|0|||
155259227|NCT00508261|560380955|FG000|Overall Study|Withdrawal by Subject|3|||
155259228|NCT00508261|560380956|FG001|Overall Study|Withdrawal by Subject|4|||
155259229|NCT00508261|560380957|FG002|Overall Study|Withdrawal by Subject|4|||
155259230|NCT00508261|560380958|FG003|Overall Study|Withdrawal by Subject|0|||
155259231|NCT00508261|560380955|FG000|Overall Study|Migrated/ moved from study area|0|||
155259232|NCT00508261|560380956|FG001|Overall Study|Migrated/ moved from study area|1|||
155259233|NCT00508261|560380957|FG002|Overall Study|Migrated/ moved from study area|0|||
155259234|NCT00508261|560380958|FG003|Overall Study|Migrated/ moved from study area|0|||
155259235|NCT00508261|560380955|FG000|Overall Study|Lost to Follow-up|0|||
155259236|NCT00508261|560380956|FG001|Overall Study|Lost to Follow-up|1|||
155259237|NCT00508261|560380957|FG002|Overall Study|Lost to Follow-up|1|||
155259238|NCT00508261|560380958|FG003|Overall Study|Lost to Follow-up|1|||
155259239|NCT04082884|560380959|FG000|Overall Study|Withdrawal by Subject|1|||
155259240|NCT00827541|560380960|FG000|Overall Study|Exitus|1|||
155259241|NCT00827541|560380961|FG001|Overall Study|Exitus|8|||
155259242|NCT00827541|560380960|FG000|Overall Study|Other|1|||
155259243|NCT00827541|560380961|FG001|Overall Study|Other|3|||
155259244|NCT00827541|560380960|FG000|Overall Study|Pathogen not susceptible|1|||
155259245|NCT00827541|560380961|FG001|Overall Study|Pathogen not susceptible|0|||
155259246|NCT00827541|560380960|FG000|Overall Study|Lack of effectiveness|1|||
155259247|NCT00827541|560380961|FG001|Overall Study|Lack of effectiveness|0|||
155259248|NCT01649232|560380962|FG000|Overall Study|Physician Decision|2|||
155259249|NCT01649232|560380963|FG001|Overall Study|Physician Decision|0|||
155259250|NCT02347657|560380964|FG000|Overall Study|Physician Decision|0|||
155259251|NCT02347657|560380965|FG001|Overall Study|Physician Decision|1|||
155259252|NCT02347657|560380964|FG000|Overall Study|Adverse Event|8|||
155259253|NCT02347657|560380965|FG001|Overall Study|Adverse Event|4|||
155259254|NCT02347657|560380964|FG000|Overall Study|Withdrawal by Subject|6|||
155259255|NCT02347657|560380965|FG001|Overall Study|Withdrawal by Subject|7|||
155259256|NCT02347657|560380964|FG000|Overall Study|Randomized but not treated|1|||
155259257|NCT02347657|560380965|FG001|Overall Study|Randomized but not treated|0|||
155259258|NCT02347657|560380964|FG000|Overall Study|Other|3|||
155259259|NCT02347657|560380965|FG001|Overall Study|Other|3|||
155259260|NCT01078155|560380967|FG000|Overall Study|Adverse Event|7|||
155259261|NCT01078155|560380967|FG000|Overall Study|Lack of Efficacy|16|||
155259262|NCT01078155|560380967|FG000|Overall Study|Participant's Decision|6|||
155259263|NCT01078155|560380967|FG000|Overall Study|Lost to Follow-up|15|||
155259264|NCT01119768|560380968|FG000|Treatment Period|Lack of Efficacy|18|||
155259265|NCT01119768|560380969|FG001|Treatment Period|Lack of Efficacy|25|||
155259266|NCT01301391|560380970|FG000|Overall Study|Death|13|||
155259267|NCT01301391|560380970|FG000|Overall Study|Lost to Follow-up|3|||
155259268|NCT01301391|560380970|FG000|Overall Study|Physician Decision|2|||
155259269|NCT01301391|560380970|FG000|Overall Study|Sponsor's decision|8|||
155259270|NCT01059643|560380971|FG000|Overall Study|Adverse Event|3|||
155259271|NCT01059643|560380971|FG000|Overall Study|Withdrawal by Subject|2|||
155259272|NCT01059643|560380971|FG000|Overall Study|Physician Decision|1|||
155259273|NCT01949870|560380972|FG000|Overall Study|Lack of Efficacy|2|||
155259274|NCT01949870|560380972|FG000|Overall Study|Adverse Event|1|||
155259275|NCT01949870|560380972|FG000|Overall Study|Study termination|1|||
155259276|NCT01949870|560380972|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
155259277|NCT04044456|560380978|FG000|Overall Study|Lost to Follow-up|4|||
155259278|NCT04044456|560380979|FG001|Overall Study|Lost to Follow-up|1|||
155259279|NCT04044456|560380978|FG000|Overall Study|Withdrawal by Subject|1|||
155259280|NCT04044456|560380979|FG001|Overall Study|Withdrawal by Subject|0|||
155259281|NCT00330174|560380980|FG000|Overall Study|Withdrawal by Subject|7|||
155259282|NCT00330174|560380981|FG001|Overall Study|Withdrawal by Subject|7|||
155259283|NCT00330174|560380980|FG000|Overall Study|Lost to Follow-up|4|||
155259284|NCT00330174|560380981|FG001|Overall Study|Lost to Follow-up|1|||
155259285|NCT00330174|560380980|FG000|Overall Study|Clinical deterioration|1|||
155259286|NCT00330174|560380981|FG001|Overall Study|Clinical deterioration|2|||
155259287|NCT00330174|560380980|FG000|Overall Study|Excessive missed visits|3|||
155259288|NCT00330174|560380981|FG001|Overall Study|Excessive missed visits|8|||
155259289|NCT00330174|560380980|FG000|Overall Study|Miscellaneous reasons|7|||
155259290|NCT00330174|560380981|FG001|Overall Study|Miscellaneous reasons|1|||
155259291|NCT02316769|560380984|FG000|Overall Study|Physician Decision|1|||
155259292|NCT02316769|560380985|FG001|Overall Study|Physician Decision|0|||
155259293|NCT02316769|560380984|FG000|Overall Study|Withdrawal by Subject|1|||
155259294|NCT02316769|560380985|FG001|Overall Study|Withdrawal by Subject|0|||
155259295|NCT01281644|560380988|FG000|Overall Study|Lost to Follow-up|3|||
155259296|NCT01281644|560380988|FG000|Overall Study|Withdrawal by Subject|2|||
155259297|NCT04393441|560380990|FG000|Overall Study|Adverse Event|0|||
155259298|NCT04393441|560380991|FG001|Overall Study|Adverse Event|3|||
155259299|NCT04393441|560380990|FG000|Overall Study|Withdrawal by Subject|5|||
155259300|NCT04393441|560380991|FG001|Overall Study|Withdrawal by Subject|7|||
155259301|NCT04393441|560380990|FG000|Overall Study|Lost to Follow-up|0|||
155259302|NCT04393441|560380991|FG001|Overall Study|Lost to Follow-up|2|||
155259303|NCT04393441|560380990|FG000|Overall Study|Protocol Deviation|2|||
155259304|NCT04393441|560380991|FG001|Overall Study|Protocol Deviation|1|||
155259305|NCT04393441|560380990|FG000|Overall Study|Reason not Specified|1|||
155259306|NCT04393441|560380991|FG001|Overall Study|Reason not Specified|1|||
155259307|NCT02782169|560380992|FG000|Overall Study|Lost to Follow-up|1|||
155259308|NCT02782169|560380993|FG001|Overall Study|Lost to Follow-up|2|||
155259309|NCT04003610|560380994|FG000|Overall Study|Lost to Follow-up|0|||
155259310|NCT04003610|560380995|FG001|Overall Study|Lost to Follow-up|1|||
155259311|NCT04003610|560380996|FG002|Overall Study|Lost to Follow-up|0|||
155259312|NCT04003610|560380994|FG000|Overall Study|Death|0|||
155259313|NCT04003610|560380995|FG001|Overall Study|Death|0|||
155259314|NCT04003610|560380996|FG002|Overall Study|Death|3|||
155259315|NCT04003610|560380994|FG000|Overall Study|Study Terminated by Sponsor|0|||
155259316|NCT04003610|560380995|FG001|Overall Study|Study Terminated by Sponsor|0|||
155259317|NCT04003610|560380996|FG002|Overall Study|Study Terminated by Sponsor|3|||
155259318|NCT00771810|560380997|FG000|Overall Study|Adverse Event|3|||
155259319|NCT00771810|560380998|FG001|Overall Study|Adverse Event|0|||
155259320|NCT00771810|560380999|FG002|Overall Study|Adverse Event|2|||
155259321|NCT00771810|560380997|FG000|Overall Study|Lost to Follow-up|0|||
155259322|NCT00771810|560380998|FG001|Overall Study|Lost to Follow-up|0|||
155259323|NCT00771810|560380999|FG002|Overall Study|Lost to Follow-up|1|||
155259324|NCT00771810|560380997|FG000|Overall Study|Physician Decision|1|||
155259325|NCT00771810|560380998|FG001|Overall Study|Physician Decision|2|||
155259326|NCT00771810|560380999|FG002|Overall Study|Physician Decision|2|||
155259327|NCT00771810|560380997|FG000|Overall Study|Protocol Violation|0|||
155259328|NCT00771810|560380998|FG001|Overall Study|Protocol Violation|1|||
155259329|NCT00771810|560380999|FG002|Overall Study|Protocol Violation|1|||
155259330|NCT00771810|560380997|FG000|Overall Study|Withdrawal by Subject|1|||
155259331|NCT00771810|560380998|FG001|Overall Study|Withdrawal by Subject|2|||
155259332|NCT00771810|560380999|FG002|Overall Study|Withdrawal by Subject|0|||
155259333|NCT00771810|560380997|FG000|Overall Study|Other|0|||
155259334|NCT00771810|560380998|FG001|Overall Study|Other|0|||
155259335|NCT00771810|560380999|FG002|Overall Study|Other|1|||
155259336|NCT02953938|560381004|FG000|Overall Study|Adverse Event|0|||
155259337|NCT02953938|560381005|FG001|Overall Study|Adverse Event|1|||
155259338|NCT02953938|560381004|FG000|Overall Study|Withdrawal by Subject|1|||
155259339|NCT02953938|560381005|FG001|Overall Study|Withdrawal by Subject|1|||
155259340|NCT03419364|560381010|FG000|Overall Study|Delivery due to maternal condition|2|||
155259341|NCT03419364|560381011|FG001|Overall Study|Delivery due to maternal condition|0|||
155259342|NCT03419364|560381012|FG002|Overall Study|Delivery due to maternal condition|0|||
155259343|NCT03188055|560381016|FG000|Overall Study|Unavailable for training|0|||
155259344|NCT03188055|560381017|FG001|Overall Study|Unavailable for training|0|||
155259345|NCT03188055|560381018|FG002|Overall Study|Unavailable for training|19|||
155259346|NCT03188055|560381019|FG003|Overall Study|Unavailable for training|0|||
155259347|NCT03188055|560381020|FG004|Overall Study|Unavailable for training|0|||
155259348|NCT03188055|560381021|FG005|Overall Study|Unavailable for training|0|||
155259349|NCT03188055|560381016|FG000|Overall Study|Lost to Follow-up|0|||
155259350|NCT03188055|560381017|FG001|Overall Study|Lost to Follow-up|18|||
155259351|NCT03188055|560381018|FG002|Overall Study|Lost to Follow-up|0|||
155259352|NCT03188055|560381019|FG003|Overall Study|Lost to Follow-up|11|||
155259353|NCT03188055|560381020|FG004|Overall Study|Lost to Follow-up|0|||
155259354|NCT03188055|560381021|FG005|Overall Study|Lost to Follow-up|0|||
155259355|NCT03188055|560381016|FG000|Overall Study|Withdrawal by Subject|0|||
155259356|NCT03188055|560381017|FG001|Overall Study|Withdrawal by Subject|1|||
155259357|NCT03188055|560381018|FG002|Overall Study|Withdrawal by Subject|0|||
155259358|NCT03188055|560381019|FG003|Overall Study|Withdrawal by Subject|1|||
155259359|NCT03188055|560381020|FG004|Overall Study|Withdrawal by Subject|0|||
155259360|NCT03188055|560381021|FG005|Overall Study|Withdrawal by Subject|0|||
155259361|NCT03017079|560381022|FG000|Overall Study|Physician Decision|1|||
155259362|NCT03017079|560381023|FG001|Overall Study|Physician Decision|1|||
155259363|NCT03017079|560381022|FG000|Overall Study|Death|3|||
155259364|NCT03017079|560381023|FG001|Overall Study|Death|2|||
155259365|NCT03017079|560381022|FG000|Overall Study|Lack of Efficacy|2|||
155259366|NCT03017079|560381023|FG001|Overall Study|Lack of Efficacy|2|||
155259367|NCT03017079|560381022|FG000|Overall Study|Protocol Violation|0|||
155259368|NCT03017079|560381023|FG001|Overall Study|Protocol Violation|1|||
155259369|NCT03657277|560381024|FG000|Overall Study|Physician Decision|2|||
155259370|NCT03657277|560381024|FG000|Overall Study|Lost to Follow-up|1|||
155259371|NCT03657277|560381024|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
155259372|NCT00657618|560381029|FG000|Overall Study|Adverse Event|32|||
155259373|NCT00657618|560381029|FG000|Overall Study|Withdrawal by Subject|8|||
155259374|NCT00657618|560381029|FG000|Overall Study|negative for leishmaniasis|2|||
155259375|NCT00657618|560381029|FG000|Overall Study|didn't start due to schedule conflicts|1|||
155259376|NCT04120233|560381030|FG000|Overall Study|Adverse Event|0|||
155259377|NCT04120233|560381031|FG001|Overall Study|Adverse Event|0|||
155259378|NCT04120233|560381032|FG002|Overall Study|Adverse Event|0|||
155259379|NCT04120233|560381033|FG003|Overall Study|Adverse Event|0|||
155259380|NCT04120233|560381034|FG004|Overall Study|Adverse Event|1|||
155259381|NCT04120233|560381035|FG005|Overall Study|Adverse Event|0|||
155259382|NCT03764774|560381036|FG000|Overall Study|Withdrawal by Subject|0|||
155259383|NCT03764774|560381037|FG001|Overall Study|Withdrawal by Subject|0|||
155259384|NCT03764774|560381038|FG002|Overall Study|Withdrawal by Subject|0|||
155259385|NCT03764774|560381039|FG003|Overall Study|Withdrawal by Subject|0|||
155259386|NCT03764774|560381040|FG004|Overall Study|Withdrawal by Subject|0|||
155259387|NCT03764774|560381041|FG005|Overall Study|Withdrawal by Subject|0|||
155259388|NCT03764774|560381042|FG006|Overall Study|Withdrawal by Subject|0|||
155259389|NCT03764774|560381043|FG007|Overall Study|Withdrawal by Subject|0|||
155259390|NCT03764774|560381044|FG008|Overall Study|Withdrawal by Subject|0|||
155259391|NCT03764774|560381045|FG009|Overall Study|Withdrawal by Subject|0|||
155259392|NCT03764774|560381046|FG010|Overall Study|Withdrawal by Subject|1|||
155259393|NCT03764774|560381047|FG011|Overall Study|Withdrawal by Subject|0|||
155259394|NCT03764774|560381048|FG012|Overall Study|Withdrawal by Subject|0|||
155259395|NCT03764774|560381049|FG013|Overall Study|Withdrawal by Subject|0|||
155259396|NCT03764774|560381036|FG000|Overall Study|Adverse Event|0|||
155259397|NCT03764774|560381037|FG001|Overall Study|Adverse Event|0|||
155259398|NCT03764774|560381038|FG002|Overall Study|Adverse Event|0|||
155259399|NCT03764774|560381039|FG003|Overall Study|Adverse Event|0|||
155259400|NCT03764774|560381040|FG004|Overall Study|Adverse Event|0|||
155259401|NCT03764774|560381041|FG005|Overall Study|Adverse Event|0|||
155259402|NCT03764774|560381042|FG006|Overall Study|Adverse Event|0|||
155259403|NCT03764774|560381043|FG007|Overall Study|Adverse Event|0|||
155259404|NCT03764774|560381044|FG008|Overall Study|Adverse Event|0|||
155259405|NCT03764774|560381045|FG009|Overall Study|Adverse Event|0|||
155259406|NCT03764774|560381046|FG010|Overall Study|Adverse Event|0|||
155259407|NCT03764774|560381047|FG011|Overall Study|Adverse Event|0|||
155259408|NCT03764774|560381048|FG012|Overall Study|Adverse Event|2|||
155259409|NCT03764774|560381049|FG013|Overall Study|Adverse Event|0|||
155259410|NCT03764774|560381036|FG000|Overall Study|Lost to Follow-up|0|||
155259411|NCT03764774|560381037|FG001|Overall Study|Lost to Follow-up|0|||
155259412|NCT03764774|560381038|FG002|Overall Study|Lost to Follow-up|0|||
155259413|NCT03764774|560381039|FG003|Overall Study|Lost to Follow-up|0|||
155259414|NCT03764774|560381040|FG004|Overall Study|Lost to Follow-up|0|||
155259415|NCT03764774|560381041|FG005|Overall Study|Lost to Follow-up|0|||
155259416|NCT03764774|560381042|FG006|Overall Study|Lost to Follow-up|0|||
155259417|NCT03764774|560381043|FG007|Overall Study|Lost to Follow-up|0|||
155259418|NCT03764774|560381044|FG008|Overall Study|Lost to Follow-up|0|||
155259419|NCT03764774|560381045|FG009|Overall Study|Lost to Follow-up|0|||
155259420|NCT03764774|560381046|FG010|Overall Study|Lost to Follow-up|0|||
155259421|NCT03764774|560381047|FG011|Overall Study|Lost to Follow-up|0|||
155259422|NCT03764774|560381048|FG012|Overall Study|Lost to Follow-up|0|||
155259423|NCT03764774|560381049|FG013|Overall Study|Lost to Follow-up|1|||
155259424|NCT03764774|560381036|FG000|Overall Study|Physician Decision|0|||
155259425|NCT03764774|560381037|FG001|Overall Study|Physician Decision|0|||
155259426|NCT03764774|560381038|FG002|Overall Study|Physician Decision|0|||
155259427|NCT03764774|560381039|FG003|Overall Study|Physician Decision|0|||
155259428|NCT03764774|560381040|FG004|Overall Study|Physician Decision|0|||
155259429|NCT03764774|560381041|FG005|Overall Study|Physician Decision|0|||
155259430|NCT03764774|560381042|FG006|Overall Study|Physician Decision|0|||
155259431|NCT03764774|560381043|FG007|Overall Study|Physician Decision|0|||
155259432|NCT03764774|560381044|FG008|Overall Study|Physician Decision|0|||
155259433|NCT03764774|560381045|FG009|Overall Study|Physician Decision|4|||
155259434|NCT03764774|560381046|FG010|Overall Study|Physician Decision|1|||
155259435|NCT03764774|560381047|FG011|Overall Study|Physician Decision|4|||
155259436|NCT03764774|560381048|FG012|Overall Study|Physician Decision|9|||
155259437|NCT03764774|560381049|FG013|Overall Study|Physician Decision|0|||
155259438|NCT03764774|560381036|FG000|Overall Study|Study Termination|0|||
155259439|NCT03764774|560381037|FG001|Overall Study|Study Termination|0|||
155259440|NCT03764774|560381038|FG002|Overall Study|Study Termination|0|||
155259441|NCT03764774|560381039|FG003|Overall Study|Study Termination|0|||
155259442|NCT03764774|560381040|FG004|Overall Study|Study Termination|0|||
155259443|NCT03764774|560381041|FG005|Overall Study|Study Termination|0|||
155259444|NCT03764774|560381042|FG006|Overall Study|Study Termination|0|||
155259445|NCT03764774|560381043|FG007|Overall Study|Study Termination|0|||
155259446|NCT03764774|560381044|FG008|Overall Study|Study Termination|0|||
155259447|NCT03764774|560381045|FG009|Overall Study|Study Termination|1|||
155259448|NCT03764774|560381046|FG010|Overall Study|Study Termination|0|||
155259449|NCT03764774|560381047|FG011|Overall Study|Study Termination|0|||
155259450|NCT03764774|560381048|FG012|Overall Study|Study Termination|0|||
155259451|NCT03764774|560381049|FG013|Overall Study|Study Termination|2|||
155259452|NCT00861614|560382373|FG000|Overall Study|Disease Progression|182|||
155259453|NCT00861614|560382374|FG001|Overall Study|Disease Progression|263|||
155259454|NCT00861614|560382373|FG000|Overall Study|Study Drug Toxicity|79|||
155259455|NCT00861614|560382374|FG001|Overall Study|Study Drug Toxicity|6|||
155259456|NCT00861614|560382373|FG000|Overall Study|Death|32|||
155259457|NCT00861614|560382374|FG001|Overall Study|Death|19|||
155259458|NCT00861614|560382373|FG000|Overall Study|Adverse Event|27|||
155259459|NCT00861614|560382374|FG001|Overall Study|Adverse Event|23|||
155259460|NCT00861614|560382373|FG000|Overall Study|Withdrawal by Subject|34|||
155259461|NCT00861614|560382374|FG001|Overall Study|Withdrawal by Subject|35|||
155259462|NCT00861614|560382373|FG000|Overall Study|Other|17|||
155259463|NCT00861614|560382374|FG001|Overall Study|Other|22|||
155259464|NCT02259517|560382375|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
155259465|NCT02259517|560382376|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
155259466|NCT02259517|560382377|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
155259467|NCT02259517|560382375|FG000|Overall Study|Withdrawal by Subject|0|||
155259468|NCT02259517|560382376|FG001|Overall Study|Withdrawal by Subject|0|||
155259469|NCT02259517|560382377|FG002|Overall Study|Withdrawal by Subject|3|||
155259470|NCT02276066|560382381|FG000|Overall Study|Lost to Follow-up|21|||
155259471|NCT02276066|560382382|FG001|Overall Study|Lost to Follow-up|11|||
155259472|NCT05050578|560382383|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
155259473|NCT05050578|560382384|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
155259474|NCT05050578|560382383|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
155259475|NCT05050578|560382384|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
155259476|NCT05050578|560382383|FG000|Period 2, 30 Days|Protocol Violation|0|||
155259477|NCT05050578|560382384|FG001|Period 2, 30 Days|Protocol Violation|1|||
155259478|NCT02243280|560382385|FG000|Treated|Adverse Event|1|||
155259479|NCT02243280|560382386|FG001|Treated|Adverse Event|0|||
155259480|NCT02243280|560382387|FG002|Treated|Adverse Event|0|||
155259481|NCT02243280|560382388|FG003|Treated|Adverse Event|0|||
155259482|NCT02243280|560382389|FG004|Treated|Adverse Event|0|||
155259483|NCT02243280|560382390|FG005|Treated|Adverse Event|0|||
155259484|NCT02243280|560382391|FG006|Treated|Adverse Event|0|||
155259485|NCT02243280|560382392|FG007|Treated|Adverse Event|0|||
155259486|NCT02243280|560382393|FG008|Treated|Adverse Event|0|||
155259487|NCT02243280|560382394|FG009|Treated|Adverse Event|0|||
155259488|NCT02243280|560382395|FG010|Treated|Adverse Event|1|||
154924261|NCT01869959|559146446|FG004|Treatment Period|Withdrawal by Subject|0|||
155259489|NCT02243280|560382385|FG000|Treated|Lost to Follow-up|0|||
155259490|NCT02243280|560382386|FG001|Treated|Lost to Follow-up|0|||
155259491|NCT02243280|560382387|FG002|Treated|Lost to Follow-up|0|||
155259492|NCT02243280|560382388|FG003|Treated|Lost to Follow-up|0|||
155259493|NCT02243280|560382389|FG004|Treated|Lost to Follow-up|0|||
155259494|NCT02243280|560382390|FG005|Treated|Lost to Follow-up|0|||
155259495|NCT02243280|560382391|FG006|Treated|Lost to Follow-up|0|||
155259496|NCT02243280|560382392|FG007|Treated|Lost to Follow-up|0|||
155259497|NCT02243280|560382393|FG008|Treated|Lost to Follow-up|1|||
155259498|NCT02243280|560382394|FG009|Treated|Lost to Follow-up|0|||
155259499|NCT02243280|560382395|FG010|Treated|Lost to Follow-up|2|||
155259500|NCT03386032|560382396|FG000|Overall Study|Lack of Efficacy|6|||
155259501|NCT03386032|560382397|FG001|Overall Study|Lack of Efficacy|2|||
155259502|NCT03386032|560382398|FG002|Overall Study|Lack of Efficacy|0|||
155259503|NCT03386032|560382396|FG000|Overall Study|Adverse Event|2|||
155259504|NCT03386032|560382397|FG001|Overall Study|Adverse Event|2|||
155259505|NCT03386032|560382398|FG002|Overall Study|Adverse Event|0|||
155259506|NCT03386032|560382396|FG000|Overall Study|Withdrawal by Subject|1|||
155259507|NCT03386032|560382397|FG001|Overall Study|Withdrawal by Subject|0|||
155259508|NCT03386032|560382398|FG002|Overall Study|Withdrawal by Subject|0|||
155259509|NCT03386032|560382396|FG000|Overall Study|Lost to Follow-up|9|||
155259510|NCT03386032|560382397|FG001|Overall Study|Lost to Follow-up|3|||
155259511|NCT03386032|560382398|FG002|Overall Study|Lost to Follow-up|0|||
155259512|NCT01807156|560382399|FG000|Overall Study|Physician Decision|1|||
155259513|NCT02710292|560382404|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
155259514|NCT02710292|560382405|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
155259515|NCT02710292|560382404|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
155259516|NCT02710292|560382405|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
155259517|NCT03122119|560382406|FG000|Overall Study|Did not meet eligibility critria|1|||
155259518|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
155259519|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
155259520|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
155259521|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
155259522|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
155259523|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
155259524|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
155259525|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
155259526|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
155259527|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
155259528|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
155259529|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
155259530|NCT01493687|560382409|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
155259531|NCT01493687|560382410|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
155259532|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
155259533|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
155259534|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
155259535|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
155259536|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
155259537|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
155259538|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
155259539|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
155259540|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
155259541|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
155259542|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
155259543|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
155259544|NCT01493687|560382409|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
155259545|NCT01493687|560382410|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
155259546|NCT01493687|560382409|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
155259547|NCT01493687|560382410|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
155259548|NCT02364180|560382413|FG000|Overall Study|Screen Fail|1|||
155259549|NCT02323646|560382414|FG000|Treatment Course 1|Adverse Event|1|||
155259550|NCT02323646|560382415|FG001|Treatment Course 1|Adverse Event|0|||
155259551|NCT02323646|560382416|FG002|Treatment Course 1|Adverse Event|1|||
155259552|NCT02323646|560382414|FG000|Treatment Course 1|Heavy Bleeding|1|||
155259553|NCT02323646|560382415|FG001|Treatment Course 1|Heavy Bleeding|1|||
155259554|NCT02323646|560382416|FG002|Treatment Course 1|Heavy Bleeding|0|||
155259555|NCT02323646|560382414|FG000|Treatment Course 1|Lost to Follow-up|1|||
155259556|NCT02323646|560382415|FG001|Treatment Course 1|Lost to Follow-up|0|||
155259557|NCT02323646|560382416|FG002|Treatment Course 1|Lost to Follow-up|2|||
155259558|NCT02323646|560382414|FG000|Treatment Course 1|Withdrawal by Subject|0|||
155259559|NCT02323646|560382415|FG001|Treatment Course 1|Withdrawal by Subject|2|||
155259560|NCT02323646|560382416|FG002|Treatment Course 1|Withdrawal by Subject|0|||
155259561|NCT02323646|560382414|FG000|Treatment Course 2|Adverse Event|1|||
155259562|NCT02323646|560382415|FG001|Treatment Course 2|Adverse Event|0|||
155259563|NCT02323646|560382416|FG002|Treatment Course 2|Adverse Event|1|||
155259564|NCT02323646|560382414|FG000|Treatment Course 2|Lost to Follow-up|0|||
155259565|NCT02323646|560382415|FG001|Treatment Course 2|Lost to Follow-up|0|||
155259566|NCT02323646|560382416|FG002|Treatment Course 2|Lost to Follow-up|1|||
155259567|NCT02323646|560382414|FG000|Treatment Course 2|Non-compliance|0|||
155259568|NCT02323646|560382415|FG001|Treatment Course 2|Non-compliance|1|||
155259569|NCT02323646|560382416|FG002|Treatment Course 2|Non-compliance|1|||
155259570|NCT00521144|560382417|FG000|Overall Study|Not Treated|0|||
155259571|NCT00521144|560382418|FG001|Overall Study|Not Treated|0|||
155259572|NCT00521144|560382419|FG002|Overall Study|Not Treated|0|||
155259573|NCT00521144|560382420|FG003|Overall Study|Not Treated|1|||
155259574|NCT00521144|560382421|FG004|Overall Study|Not Treated|0|||
155259575|NCT00521144|560382417|FG000|Overall Study|Adverse Event|0|||
155259576|NCT00521144|560382418|FG001|Overall Study|Adverse Event|1|||
155259577|NCT00521144|560382419|FG002|Overall Study|Adverse Event|0|||
155259578|NCT00521144|560382420|FG003|Overall Study|Adverse Event|0|||
155259579|NCT00521144|560382421|FG004|Overall Study|Adverse Event|1|||
155259580|NCT00521144|560382417|FG000|Overall Study|Progressive Disease|4|||
155259581|NCT00521144|560382418|FG001|Overall Study|Progressive Disease|2|||
155259582|NCT00521144|560382419|FG002|Overall Study|Progressive Disease|2|||
155259583|NCT00521144|560382420|FG003|Overall Study|Progressive Disease|0|||
155259584|NCT00521144|560382421|FG004|Overall Study|Progressive Disease|6|||
155259585|NCT02901626|560382422|FG000|Overall Study|Lost to Follow-up|1|||
155259586|NCT02901626|560382423|FG001|Overall Study|Lost to Follow-up|1|||
155259587|NCT00659490|560382426|FG000|Overall Study|Lost to Follow-up|2|||
155259588|NCT00659490|560382427|FG001|Overall Study|Lost to Follow-up|0|||
155259589|NCT00659490|560382428|FG002|Overall Study|Lost to Follow-up|1|||
155259590|NCT05674890|560382429|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
155259591|NCT05674890|560382430|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
155259592|NCT05674890|560382429|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
155259593|NCT05674890|560382430|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
155259594|NCT05674890|560382429|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
155259595|NCT05674890|560382430|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
155259596|NCT01750879|560382431|FG000|Overall Study|Adverse Event|8|||
155259597|NCT01750879|560382432|FG001|Overall Study|Adverse Event|0|||
155259598|NCT01750879|560382431|FG000|Overall Study|Lack of Efficacy|1|||
155259599|NCT01750879|560382432|FG001|Overall Study|Lack of Efficacy|0|||
155259600|NCT01750879|560382431|FG000|Overall Study|Withdrawal by Subject|1|||
155259601|NCT01750879|560382432|FG001|Overall Study|Withdrawal by Subject|0|||
155259602|NCT01750879|560382431|FG000|Overall Study|Did not complete per protocol|0|||
155259603|NCT01750879|560382432|FG001|Overall Study|Did not complete per protocol|3|||
155259604|NCT02421666|560382433|FG000|6-month Follow-up|Lost to Follow-up|8|||
155259605|NCT02421666|560382434|FG001|6-month Follow-up|Lost to Follow-up|7|||
155259606|NCT02421666|560382433|FG000|6-month Follow-up|Withdrawal by Subject|5|||
155259607|NCT02421666|560382434|FG001|6-month Follow-up|Withdrawal by Subject|6|||
155259608|NCT02421666|560382433|FG000|12-month Follow-up|Lost to Follow-up|5|||
155259609|NCT02421666|560382434|FG001|12-month Follow-up|Lost to Follow-up|5|||
155259610|NCT02421666|560382433|FG000|12-month Follow-up|Withdrawal by Subject|6|||
155259611|NCT02421666|560382434|FG001|12-month Follow-up|Withdrawal by Subject|11|||
155259612|NCT01226511|560382437|FG000|Acute Treatment Period|Adverse Event|7|||
155259613|NCT01226511|560382438|FG001|Acute Treatment Period|Adverse Event|6|||
155259614|NCT01226511|560382437|FG000|Acute Treatment Period|Lack of Efficacy|2|||
155259615|NCT01226511|560382438|FG001|Acute Treatment Period|Lack of Efficacy|1|||
155259616|NCT01226511|560382437|FG000|Acute Treatment Period|Lost to Follow-up|3|||
155259617|NCT01226511|560382438|FG001|Acute Treatment Period|Lost to Follow-up|6|||
155259618|NCT01226511|560382437|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
155259619|NCT01226511|560382438|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
155259620|NCT01226511|560382437|FG000|Acute Treatment Period|Protocol Violation|5|||
155259621|NCT01226511|560382438|FG001|Acute Treatment Period|Protocol Violation|5|||
155259622|NCT01226511|560382437|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
155259623|NCT01226511|560382438|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
155259624|NCT01226511|560382437|FG000|Extension Treatment Period|Adverse Event|8|||
155259625|NCT01226511|560382438|FG001|Extension Treatment Period|Adverse Event|8|||
155259626|NCT01226511|560382437|FG000|Extension Treatment Period|Lack of Efficacy|3|||
155259627|NCT01226511|560382438|FG001|Extension Treatment Period|Lack of Efficacy|2|||
155259628|NCT01226511|560382437|FG000|Extension Treatment Period|Lost to Follow-up|4|||
155259629|NCT01226511|560382438|FG001|Extension Treatment Period|Lost to Follow-up|3|||
155259630|NCT01226511|560382437|FG000|Extension Treatment Period|Protocol Violation|2|||
155259631|NCT01226511|560382438|FG001|Extension Treatment Period|Protocol Violation|2|||
155259632|NCT01226511|560382437|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
155259633|NCT01226511|560382438|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
155259634|NCT01226511|560382437|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
155259635|NCT01226511|560382438|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
155259636|NCT01226511|560382437|FG000|Extension Treatment Period|Sponsor Decision|1|||
155259637|NCT01226511|560382438|FG001|Extension Treatment Period|Sponsor Decision|1|||
155259638|NCT01226511|560382437|FG000|Taper Period|Adverse Event|1|||
155259639|NCT01226511|560382438|FG001|Taper Period|Adverse Event|0|||
155259640|NCT01226511|560382437|FG000|Taper Period|Lost to Follow-up|2|||
155259641|NCT01226511|560382438|FG001|Taper Period|Lost to Follow-up|2|||
155259642|NCT01226511|560382437|FG000|Taper Period|Protocol Violation|1|||
155259643|NCT01226511|560382438|FG001|Taper Period|Protocol Violation|0|||
155259644|NCT01226511|560382437|FG000|Taper Period|Parent/Caregiver Decision|1|||
155259645|NCT01226511|560382438|FG001|Taper Period|Parent/Caregiver Decision|1|||
155259646|NCT02923739|560382441|FG000|Overall Study|Withdrawal by Subject|2|||
155259647|NCT02923739|560382442|FG001|Overall Study|Withdrawal by Subject|0|||
155259648|NCT02923739|560382443|FG002|Overall Study|Withdrawal by Subject|0|||
155259649|NCT02923739|560382444|FG003|Overall Study|Withdrawal by Subject|0|||
155259650|NCT02923739|560382441|FG000|Overall Study|Failed Screening|3|||
155259651|NCT02923739|560382442|FG001|Overall Study|Failed Screening|0|||
155259652|NCT02923739|560382443|FG002|Overall Study|Failed Screening|0|||
155259653|NCT02923739|560382444|FG003|Overall Study|Failed Screening|0|||
155259654|NCT00677352|560382447|FG000|Treatment Phase|Adverse Event|14|||
155259655|NCT00677352|560382448|FG001|Treatment Phase|Adverse Event|22|||
155259656|NCT00677352|560382447|FG000|Treatment Phase|Lack of Efficacy|2|||
155259657|NCT00677352|560382448|FG001|Treatment Phase|Lack of Efficacy|3|||
155259658|NCT00677352|560382447|FG000|Treatment Phase|Lost to Follow-up|0|||
155259659|NCT00677352|560382448|FG001|Treatment Phase|Lost to Follow-up|1|||
155259660|NCT00677352|560382447|FG000|Treatment Phase|Withdrawal by Subject|7|||
155259661|NCT00677352|560382448|FG001|Treatment Phase|Withdrawal by Subject|7|||
155259662|NCT00677352|560382447|FG000|Treatment Phase|Physician Decision|1|||
155259663|NCT00677352|560382448|FG001|Treatment Phase|Physician Decision|0|||
155259664|NCT00677352|560382447|FG000|Treatment Phase|Pregnancy|0|||
155259665|NCT00677352|560382448|FG001|Treatment Phase|Pregnancy|1|||
155259666|NCT00677352|560382447|FG000|Treatment Phase|Protocol Violation|1|||
155259667|NCT00677352|560382448|FG001|Treatment Phase|Protocol Violation|1|||
155259668|NCT00677352|560382447|FG000|Treatment Phase|Transference or work related matter|0|||
155259669|NCT00677352|560382448|FG001|Treatment Phase|Transference or work related matter|5|||
155259670|NCT00677352|560382447|FG000|Treatment Phase|Not treated|0|||
155259671|NCT00677352|560382448|FG001|Treatment Phase|Not treated|2|||
155259672|NCT00677352|560382447|FG000|Tapering Phase|Adverse Event|1|||
155259673|NCT00677352|560382448|FG001|Tapering Phase|Adverse Event|5|||
155259674|NCT00677352|560382447|FG000|Tapering Phase|Withdrawal by Subject|5|||
155259675|NCT00677352|560382448|FG001|Tapering Phase|Withdrawal by Subject|3|||
155259676|NCT00677352|560382447|FG000|Tapering Phase|Pregnancy|0|||
155259677|NCT00677352|560382448|FG001|Tapering Phase|Pregnancy|1|||
155259678|NCT00677352|560382447|FG000|Tapering Phase|Job transfer|0|||
155259679|NCT00677352|560382448|FG001|Tapering Phase|Job transfer|1|||
155259680|NCT02182973|560382449|FG000|Overall Study|Withdrawal by Subject|3|||
155259681|NCT02182973|560382450|FG001|Overall Study|Withdrawal by Subject|0|||
155259682|NCT00948974|560382451|FG000|Overall Study|Lost to Follow-up|23|||
155259683|NCT00948974|560382452|FG001|Overall Study|Lost to Follow-up|20|||
155259684|NCT01814748|560382453|FG000|Overall Study|Lost to Follow-up|1|||
155259685|NCT01814748|560382454|FG001|Overall Study|Lost to Follow-up|2|||
155259686|NCT01814748|560382453|FG000|Overall Study|Study site terminated by sponsor|1|||
155259687|NCT01814748|560382454|FG001|Overall Study|Study site terminated by sponsor|1|||
155259688|NCT01814748|560382453|FG000|Overall Study|Withdrawal by Subject|6|||
155259689|NCT01814748|560382454|FG001|Overall Study|Withdrawal by Subject|4|||
155259690|NCT01972529|560382455|FG000|Overall Study|Adverse Event|0|||
155259691|NCT01972529|560382456|FG001|Overall Study|Adverse Event|1|||
155259692|NCT01972529|560382457|FG002|Overall Study|Adverse Event|0|||
155259693|NCT01972529|560382458|FG003|Overall Study|Adverse Event|0|||
155259694|NCT01972529|560382455|FG000|Overall Study|Lost to Follow-up|1|||
155259695|NCT01972529|560382456|FG001|Overall Study|Lost to Follow-up|0|||
155259696|NCT01972529|560382457|FG002|Overall Study|Lost to Follow-up|0|||
155259697|NCT01972529|560382458|FG003|Overall Study|Lost to Follow-up|0|||
155259698|NCT01972529|560382455|FG000|Overall Study|Participant Choice|0|||
155259699|NCT01972529|560382456|FG001|Overall Study|Participant Choice|1|||
155259700|NCT01972529|560382457|FG002|Overall Study|Participant Choice|0|||
155259701|NCT01972529|560382458|FG003|Overall Study|Participant Choice|0|||
155259702|NCT01972529|560382455|FG000|Overall Study|Withdrawl of Consent|1|||
155259703|NCT01972529|560382456|FG001|Overall Study|Withdrawl of Consent|2|||
155259704|NCT01972529|560382457|FG002|Overall Study|Withdrawl of Consent|0|||
155259705|NCT01972529|560382458|FG003|Overall Study|Withdrawl of Consent|1|||
155259706|NCT01972529|560382455|FG000|Overall Study|Other|0|||
155259707|NCT01972529|560382456|FG001|Overall Study|Other|0|||
155259708|NCT01972529|560382457|FG002|Overall Study|Other|0|||
155259709|NCT01972529|560382458|FG003|Overall Study|Other|2|||
155259710|NCT01972529|560382455|FG000|Overall Study|Not treated|0|||
155259711|NCT01972529|560382456|FG001|Overall Study|Not treated|1|||
155259712|NCT01972529|560382457|FG002|Overall Study|Not treated|2|||
155259713|NCT01972529|560382458|FG003|Overall Study|Not treated|1|||
155259714|NCT01376323|560382471|FG000|Overall Study|Adverse Event|1|||
155259715|NCT01376323|560382472|FG001|Overall Study|Adverse Event|0|||
155259716|NCT01376323|560382473|FG002|Overall Study|Adverse Event|0|||
155259717|NCT01376323|560382474|FG003|Overall Study|Adverse Event|2|||
155259718|NCT01376323|560382475|FG004|Overall Study|Adverse Event|0|||
155259719|NCT01376323|560382471|FG000|Overall Study|Lost to Follow-up|0|||
155259720|NCT01376323|560382472|FG001|Overall Study|Lost to Follow-up|0|||
155259721|NCT01376323|560382473|FG002|Overall Study|Lost to Follow-up|0|||
155259722|NCT01376323|560382474|FG003|Overall Study|Lost to Follow-up|2|||
155259723|NCT01376323|560382475|FG004|Overall Study|Lost to Follow-up|0|||
155259724|NCT01376323|560382471|FG000|Overall Study|Physician Decision|1|||
155259725|NCT01376323|560382472|FG001|Overall Study|Physician Decision|0|||
155259726|NCT01376323|560382473|FG002|Overall Study|Physician Decision|2|||
155259727|NCT01376323|560382474|FG003|Overall Study|Physician Decision|1|||
155259728|NCT01376323|560382475|FG004|Overall Study|Physician Decision|1|||
155259729|NCT01376323|560382471|FG000|Overall Study|Withdrawal by Subject|0|||
155259730|NCT01376323|560382472|FG001|Overall Study|Withdrawal by Subject|1|||
155259731|NCT01376323|560382473|FG002|Overall Study|Withdrawal by Subject|1|||
155259732|NCT01376323|560382474|FG003|Overall Study|Withdrawal by Subject|0|||
155259733|NCT01376323|560382475|FG004|Overall Study|Withdrawal by Subject|0|||
155259734|NCT04681729|560382476|FG000|Overall Study|Lack of Efficacy|2|||
155259735|NCT04681729|560382477|FG001|Overall Study|Lack of Efficacy|2|||
155259736|NCT04681729|560382476|FG000|Overall Study|Withdrawal by Subject|8|||
155259737|NCT04681729|560382477|FG001|Overall Study|Withdrawal by Subject|9|||
155259738|NCT02436811|560382478|FG000|Overall Study|Lost to Follow-up|2|||
155259739|NCT02436811|560382479|FG001|Overall Study|Lost to Follow-up|9|||
155259740|NCT02436811|560382480|FG002|Overall Study|Lost to Follow-up|7|||
155259741|NCT02227875|560382481|FG000|Overall Study|Protocol Violation|10|||
155259742|NCT02227875|560382482|FG001|Overall Study|Protocol Violation|7|||
155259743|NCT02227875|560382481|FG000|Overall Study|Other|1|||
155259744|NCT02227875|560382482|FG001|Overall Study|Other|3|||
155259745|NCT02227875|560382481|FG000|Overall Study|Physician Decision|1|||
155259746|NCT02227875|560382482|FG001|Overall Study|Physician Decision|0|||
155259747|NCT02227875|560382481|FG000|Overall Study|Adverse Event|3|||
155259748|NCT02227875|560382482|FG001|Overall Study|Adverse Event|0|||
155259749|NCT02227875|560382481|FG000|Overall Study|Withdrawal by Subject|12|||
155259750|NCT02227875|560382482|FG001|Overall Study|Withdrawal by Subject|13|||
155259751|NCT02227875|560382481|FG000|Overall Study|Lost to Follow-up|10|||
155259752|NCT02227875|560382482|FG001|Overall Study|Lost to Follow-up|10|||
155259753|NCT04209725|560382483|FG000|Overall Study|Adverse Event|1|||
155259754|NCT01201811|560382486|FG000|Overall Study|Adverse Event|6|||
155259755|NCT01201811|560382486|FG000|Overall Study|Disease progression|3|||
155259756|NCT01201811|560382486|FG000|Overall Study|Withdrawal by Subject|3|||
155259757|NCT01201811|560382486|FG000|Overall Study|Death|4|||
155259758|NCT01201811|560382486|FG000|Overall Study|Treatment Failure|2|||
155259759|NCT01201811|560382486|FG000|Overall Study|Physician Decision|1|||
155259760|NCT02856113|560382487|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
155259761|NCT02856113|560382488|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
155259762|NCT02856113|560382487|FG000|Overall Study|Significant Protocol Deviation|1|||
155259763|NCT02856113|560382488|FG001|Overall Study|Significant Protocol Deviation|0|||
155259764|NCT02856113|560382487|FG000|Overall Study|Lost to Follow-up|3|||
155259765|NCT02856113|560382488|FG001|Overall Study|Lost to Follow-up|5|||
155259766|NCT02856113|560382487|FG000|Overall Study|Voluntary Withdrawal|3|||
155259767|NCT02856113|560382488|FG001|Overall Study|Voluntary Withdrawal|5|||
155259768|NCT02856113|560382487|FG000|Overall Study|Pregnancy|0|||
155259769|NCT02856113|560382488|FG001|Overall Study|Pregnancy|1|||
155259770|NCT02856113|560382487|FG000|Overall Study|Principal Investigator Discretion|2|||
155259771|NCT02856113|560382488|FG001|Overall Study|Principal Investigator Discretion|1|||
155259772|NCT02856113|560382487|FG000|Overall Study|Randomized but not Treated|1|||
155259773|NCT02856113|560382488|FG001|Overall Study|Randomized but not Treated|0|||
155259774|NCT02856113|560382487|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
155259775|NCT02856113|560382488|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
155259776|NCT03494166|560382489|FG000|Overall Study|Death|0|||
155259777|NCT03494166|560382490|FG001|Overall Study|Death|0|||
155259778|NCT03494166|560382491|FG002|Overall Study|Death|0|||
155259779|NCT03494166|560382492|FG003|Overall Study|Death|1|||
155259780|NCT03494166|560382493|FG004|Overall Study|Death|3|||
155259781|NCT03494166|560382494|FG005|Overall Study|Death|0|||
155259782|NCT03494166|560382489|FG000|Overall Study|Lost to Follow-up|2|||
155259783|NCT03494166|560382490|FG001|Overall Study|Lost to Follow-up|2|||
155259784|NCT03494166|560382491|FG002|Overall Study|Lost to Follow-up|2|||
155259785|NCT03494166|560382492|FG003|Overall Study|Lost to Follow-up|2|||
155259786|NCT03494166|560382493|FG004|Overall Study|Lost to Follow-up|14|||
155259787|NCT03494166|560382494|FG005|Overall Study|Lost to Follow-up|0|||
155259788|NCT03494166|560382489|FG000|Overall Study|Withdrawal by Subject|10|||
155259789|NCT03494166|560382490|FG001|Overall Study|Withdrawal by Subject|7|||
155259790|NCT03494166|560382491|FG002|Overall Study|Withdrawal by Subject|0|||
155259791|NCT03494166|560382492|FG003|Overall Study|Withdrawal by Subject|5|||
155259792|NCT03494166|560382493|FG004|Overall Study|Withdrawal by Subject|3|||
155259793|NCT03494166|560382494|FG005|Overall Study|Withdrawal by Subject|17|||
155259794|NCT03494166|560382489|FG000|Overall Study|Screen failure|1|||
155259795|NCT03494166|560382490|FG001|Overall Study|Screen failure|0|||
155259796|NCT03494166|560382491|FG002|Overall Study|Screen failure|0|||
155259797|NCT03494166|560382492|FG003|Overall Study|Screen failure|0|||
155259798|NCT03494166|560382493|FG004|Overall Study|Screen failure|1|||
155259799|NCT03494166|560382494|FG005|Overall Study|Screen failure|0|||
155259800|NCT02831257|560382495|FG000|Overall Study|Lack of Efficacy|3|||
155259801|NCT02831257|560382495|FG000|Overall Study|Adverse Event|2|||
155259802|NCT02831257|560382495|FG000|Overall Study|Physician Decision|1|||
155259803|NCT02831257|560382495|FG000|Overall Study|Withdrawal by Subject|6|||
155259804|NCT02277990|560382496|FG000|Overall Study|Death|170|||
155259805|NCT02277990|560382497|FG001|Overall Study|Death|188|||
155259806|NCT02277990|560382496|FG000|Overall Study|Withdrawal by Subject|64|||
155259807|NCT02277990|560382497|FG001|Overall Study|Withdrawal by Subject|53|||
155259808|NCT02277990|560382496|FG000|Overall Study|Physician Decision|40|||
155259809|NCT02277990|560382497|FG001|Overall Study|Physician Decision|34|||
155259810|NCT02277990|560382496|FG000|Overall Study|Lost to Follow-up|66|||
155259811|NCT02277990|560382497|FG001|Overall Study|Lost to Follow-up|69|||
155259812|NCT02277990|560382496|FG000|Overall Study|Had other reason|26|||
155259813|NCT02277990|560382497|FG001|Overall Study|Had other reason|32|||
155259814|NCT04179032|560382500|FG000|Part B (Up to Week 52)|Adverse Event|1|||
155259815|NCT04179032|560382500|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
155259816|NCT04179032|560382500|FG000|Access Extension Phase|Ongoing|11|||
155259817|NCT00386022|560382511|FG000|Plus Estrogen|Lost to Follow-up|2|||
155259818|NCT00386022|560382512|FG001|Plus Estrogen|Lost to Follow-up|0|||
155259819|NCT00386022|560382511|FG000|Plus Estrogen|Adverse Event|0|||
155259820|NCT00386022|560382512|FG001|Plus Estrogen|Adverse Event|1|||
155259821|NCT03078816|560382513|FG000|Overall Study|Withdrawal by Subject|1|||
155259822|NCT02114151|560382514|FG000|Overall Study|Death|1|||
155259823|NCT02114151|560382514|FG000|Overall Study|Lost to Follow-up|1|||
155259824|NCT02114151|560382514|FG000|Overall Study|Withdrawal by Subject|5|||
155259825|NCT04992546|560382515|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
155259826|NCT04992546|560382515|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
155259827|NCT04992546|560382515|FG000|Open-Label Treatment Period|Adverse Event|3|||
155259828|NCT04992546|560382515|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
155259829|NCT01659151|560382519|FG000|Overall Study|Inadequate TIL growth|1|||
155259830|NCT05774197|560382520|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
155259831|NCT04981678|560382523|FG000|Overall Study|Lost to Follow-up|0|||
155259832|NCT04981678|560382524|FG001|Overall Study|Lost to Follow-up|1|||
155259833|NCT03421808|560382525|FG000|Overall Study|COVID related problems|2|||
155259834|NCT03421808|560382526|FG001|Overall Study|COVID related problems|0|||
155259835|NCT03421808|560382525|FG000|Overall Study|Withdrawal by Subject|1|||
155259836|NCT03421808|560382526|FG001|Overall Study|Withdrawal by Subject|0|||
155259837|NCT03421808|560382525|FG000|Overall Study|Protocol Violation|0|||
155259838|NCT03421808|560382526|FG001|Overall Study|Protocol Violation|1|||
155259839|NCT01370525|560384106|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
155259840|NCT01370525|560384107|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
155259841|NCT01370525|560384106|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
155259842|NCT01370525|560384107|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
155259843|NCT01370525|560384106|FG000|Overall Study|Adverse Event|0|||
155259844|NCT01370525|560384107|FG001|Overall Study|Adverse Event|1|||
155259845|NCT01370525|560384106|FG000|Overall Study|Protocol Violation|2|||
155259846|NCT01370525|560384107|FG001|Overall Study|Protocol Violation|1|||
155259847|NCT01370525|560384106|FG000|Overall Study|Lost to follow up|2|||
155259848|NCT01370525|560384107|FG001|Overall Study|Lost to follow up|6|||
155259849|NCT04791761|560384108|FG000|Overall Study|Lost to Follow-up|8|||
155259850|NCT04791761|560384109|FG001|Overall Study|Lost to Follow-up|6|||
155259851|NCT04791761|560384110|FG002|Overall Study|Lost to Follow-up|10|||
155259852|NCT04791761|560384108|FG000|Overall Study|Withdrawal by Subject|0|||
155259853|NCT04791761|560384109|FG001|Overall Study|Withdrawal by Subject|1|||
155259854|NCT04791761|560384110|FG002|Overall Study|Withdrawal by Subject|1|||
155259855|NCT04791761|560384108|FG000|Overall Study|Protocol Violation|0|||
155259856|NCT04791761|560384109|FG001|Overall Study|Protocol Violation|1|||
155259857|NCT04791761|560384110|FG002|Overall Study|Protocol Violation|1|||
155259858|NCT00335452|560384111|FG000|Overall Study|Death|156|||
155259859|NCT00335452|560384112|FG001|Overall Study|Death|144|||
155259860|NCT00335452|560384113|FG002|Overall Study|Death|158|||
155259861|NCT00335452|560384114|FG003|Overall Study|Death|129|||
155259862|NCT00335452|560384111|FG000|Overall Study|Lost to Follow-up|2|||
155259863|NCT00335452|560384112|FG001|Overall Study|Lost to Follow-up|3|||
155259864|NCT00335452|560384113|FG002|Overall Study|Lost to Follow-up|1|||
155259865|NCT00335452|560384114|FG003|Overall Study|Lost to Follow-up|2|||
155259866|NCT02736825|560384116|FG000|Overall Study|Lost to Follow-up|10|||
155259867|NCT02736825|560384117|FG001|Overall Study|Lost to Follow-up|11|||
155259868|NCT02736825|560384116|FG000|Overall Study|Early Termination|0|||
155259869|NCT02736825|560384117|FG001|Overall Study|Early Termination|1|||
155259870|NCT00790452|560384118|FG000|Overall Study|Drug supply issue|1|||
155259871|NCT00790452|560384119|FG001|Overall Study|Drug supply issue|0|||
155259872|NCT02940574|560384120|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
155259873|NCT02940574|560384121|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
155259874|NCT02940574|560384120|FG000|1-year Follow-up|Lost to Follow-up|3|||
155259875|NCT02940574|560384121|FG001|1-year Follow-up|Lost to Follow-up|4|||
155259876|NCT00387894|560384122|FG000|Overall Study|Withdrawal by Subject|1|||
155259877|NCT04810221|560384123|FG000|Overall Study|Physician Decision|3|||
155259878|NCT03642938|560384124|FG000|Overall Study|Withdrawal by Subject|0|||
155259879|NCT03642938|560384125|FG001|Overall Study|Withdrawal by Subject|0|||
155259880|NCT03642938|560384126|FG002|Overall Study|Withdrawal by Subject|0|||
155259881|NCT03642938|560384127|FG003|Overall Study|Withdrawal by Subject|1|||
155259882|NCT00643123|560384135|FG000|Overall Study|Lost to Follow-up|4|||
155259883|NCT00643123|560384136|FG001|Overall Study|Lost to Follow-up|0|||
155259884|NCT00643123|560384135|FG000|Overall Study|Withdrawal by Subject|1|||
155259885|NCT00643123|560384136|FG001|Overall Study|Withdrawal by Subject|1|||
155259886|NCT02133872|560384138|FG000|Overall Study|Withdrawal by Subject|5|||
155259887|NCT02133872|560384139|FG001|Overall Study|Withdrawal by Subject|3|||
155259888|NCT02133872|560384140|FG002|Overall Study|Withdrawal by Subject|0|||
155259889|NCT00238433|560384146|FG000|Overall Study|Screen failure|1|||
155259890|NCT00238433|560384146|FG000|Overall Study|Lost to Follow-up|1|||
155259891|NCT00238433|560384146|FG000|Overall Study|Death|1|||
155259892|NCT00409682|560384148|FG000|Open-label Induction Period|Adverse Event|1|||
155259893|NCT00409682|560384149|FG001|Open-label Induction Period|Adverse Event|0|||
155259894|NCT00409682|560384150|FG002|Open-label Induction Period|Adverse Event|0|||
155259895|NCT00409682|560384148|FG000|Open-label Induction Period|Lack of Efficacy|1|||
155259896|NCT00409682|560384149|FG001|Open-label Induction Period|Lack of Efficacy|0|||
155259897|NCT00409682|560384150|FG002|Open-label Induction Period|Lack of Efficacy|0|||
155259898|NCT00409682|560384148|FG000|Open-label Induction Period|Protocol Violation|1|||
155259899|NCT00409682|560384149|FG001|Open-label Induction Period|Protocol Violation|0|||
155259900|NCT00409682|560384150|FG002|Open-label Induction Period|Protocol Violation|0|||
155259901|NCT00409682|560384148|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
155259902|NCT00409682|560384149|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
155259903|NCT00409682|560384150|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
155259904|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
155259905|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
155259906|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
155259907|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
155259908|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
155259909|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
155259910|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
155259911|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
155259912|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
155259913|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
155259914|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
155259915|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
155259916|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
155259917|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
155259918|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
155259919|NCT00409682|560384148|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
155259920|NCT00409682|560384149|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
155259921|NCT00409682|560384150|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
155259922|NCT04710927|560384151|FG000|Overall Study|Lost to Follow-up|7|||
155259923|NCT04710927|560384152|FG001|Overall Study|Lost to Follow-up|6|||
155259924|NCT04710927|560384153|FG002|Overall Study|Lost to Follow-up|5|||
155259925|NCT00118716|560384154|FG000|Overall Study|Adverse Event|2|||
155259926|NCT00118716|560384155|FG001|Overall Study|Adverse Event|7|||
155259927|NCT00118716|560384154|FG000|Overall Study|Protocol Violation|5|||
155259928|NCT00118716|560384155|FG001|Overall Study|Protocol Violation|4|||
155259929|NCT00118716|560384154|FG000|Overall Study|Withdrawal by Subject|0|||
155259930|NCT00118716|560384155|FG001|Overall Study|Withdrawal by Subject|1|||
155259931|NCT00118716|560384154|FG000|Overall Study|Exacerbation|2|||
155259932|NCT00118716|560384155|FG001|Overall Study|Exacerbation|2|||
155259933|NCT00118716|560384154|FG000|Overall Study|Discontinued by sponsor|1|||
155259934|NCT00118716|560384155|FG001|Overall Study|Discontinued by sponsor|1|||
155259935|NCT00118716|560384154|FG000|Overall Study|Non-compliance|1|||
155259936|NCT00118716|560384155|FG001|Overall Study|Non-compliance|3|||
155259937|NCT00118716|560384154|FG000|Overall Study|misrandomized|1|||
155259938|NCT00118716|560384155|FG001|Overall Study|misrandomized|1|||
155259939|NCT00118716|560384154|FG000|Overall Study|Expired drug use|1|||
155259940|NCT00118716|560384155|FG001|Overall Study|Expired drug use|2|||
155259941|NCT00118716|560384154|FG000|Overall Study|Investigator discretion|0|||
155259942|NCT00118716|560384155|FG001|Overall Study|Investigator discretion|1|||
155259943|NCT00855062|560384157|FG000|Step1|Early Study Closure|5|||
155259944|NCT00855062|560384158|FG001|Step1|Early Study Closure|7|||
155259945|NCT00855062|560384157|FG000|Step1|Adverse Event|1|||
155259946|NCT00855062|560384158|FG001|Step1|Adverse Event|1|||
155259947|NCT00855062|560384157|FG000|Step1|Protocol Violation|1|||
155259948|NCT00855062|560384158|FG001|Step1|Protocol Violation|0|||
155259949|NCT00855062|560384157|FG000|Step1|Pregnancy|1|||
155259950|NCT00855062|560384158|FG001|Step1|Pregnancy|0|||
155259951|NCT00855062|560384157|FG000|Step1|Withdrawal by Subject|2|||
155259952|NCT00855062|560384158|FG001|Step1|Withdrawal by Subject|3|||
155259953|NCT00855062|560384157|FG000|Step2|Early Study Closure|6|||
155259954|NCT00855062|560384158|FG001|Step2|Early Study Closure|2|||
155259955|NCT00855062|560384157|FG000|Step2|Adverse Event|0|||
155259956|NCT00855062|560384158|FG001|Step2|Adverse Event|3|||
155259957|NCT00855062|560384157|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
155259958|NCT00855062|560384158|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
155259959|NCT03595332|560384164|FG000|Overall Study|Lost to Follow-up|16|||
155259960|NCT03595332|560384165|FG001|Overall Study|Lost to Follow-up|22|||
155259961|NCT03595332|560384164|FG000|Overall Study|Unable to retrieve ID from school|0|||
155259962|NCT03595332|560384165|FG001|Overall Study|Unable to retrieve ID from school|2|||
155259963|NCT03138733|560384177|FG000|Overall Study|Death|17|||
155259964|NCT03138733|560384178|FG001|Overall Study|Death|18|||
155259965|NCT03138733|560384177|FG000|Overall Study|Withdrawal by Subject|11|||
155259966|NCT03138733|560384178|FG001|Overall Study|Withdrawal by Subject|6|||
155259967|NCT03138733|560384177|FG000|Overall Study|Lost to Follow-up|3|||
155259968|NCT03138733|560384178|FG001|Overall Study|Lost to Follow-up|2|||
155259969|NCT03138733|560384177|FG000|Overall Study|Adverse Event|1|||
155259970|NCT03138733|560384178|FG001|Overall Study|Adverse Event|0|||
155259971|NCT03138733|560384177|FG000|Overall Study|Protocol Violation|1|||
155259972|NCT03138733|560384178|FG001|Overall Study|Protocol Violation|3|||
155259973|NCT03138733|560384177|FG000|Overall Study|Administrative or logistical reason|1|||
155259974|NCT03138733|560384178|FG001|Overall Study|Administrative or logistical reason|0|||
155259975|NCT03138733|560384177|FG000|Overall Study|The patient was transferred to another hospital|1|||
155259976|NCT03138733|560384178|FG001|Overall Study|The patient was transferred to another hospital|0|||
155259977|NCT02618967|560384186|FG000|Overall Study|Lost to Follow-up|0|||
155259978|NCT02618967|560384187|FG001|Overall Study|Lost to Follow-up|0|||
155259979|NCT02618967|560384188|FG002|Overall Study|Lost to Follow-up|1|||
155259980|NCT02618967|560384189|FG003|Overall Study|Lost to Follow-up|0|||
155259981|NCT02618967|560384190|FG004|Overall Study|Lost to Follow-up|2|||
155259982|NCT02618967|560384191|FG005|Overall Study|Lost to Follow-up|0|||
155259983|NCT02618967|560384192|FG006|Overall Study|Lost to Follow-up|0|||
155259984|NCT02618967|560384193|FG007|Overall Study|Lost to Follow-up|0|||
155259985|NCT02618967|560384186|FG000|Overall Study|Withdrawal by Subject|1|||
155259986|NCT02618967|560384187|FG001|Overall Study|Withdrawal by Subject|0|||
155259987|NCT02618967|560384188|FG002|Overall Study|Withdrawal by Subject|0|||
155259988|NCT02618967|560384189|FG003|Overall Study|Withdrawal by Subject|0|||
155259989|NCT02618967|560384190|FG004|Overall Study|Withdrawal by Subject|0|||
155259990|NCT02618967|560384191|FG005|Overall Study|Withdrawal by Subject|0|||
155259991|NCT02618967|560384192|FG006|Overall Study|Withdrawal by Subject|0|||
155259992|NCT02618967|560384193|FG007|Overall Study|Withdrawal by Subject|0|||
155259993|NCT01533493|560384194|FG000|Overall Study|Adverse Event|2|||
155259994|NCT01533493|560384195|FG001|Overall Study|Adverse Event|1|||
155259995|NCT01533493|560384194|FG000|Overall Study|Withdrawal by Subject|1|||
155259996|NCT01533493|560384195|FG001|Overall Study|Withdrawal by Subject|2|||
155259997|NCT01533493|560384194|FG000|Overall Study|Lost to Follow-up|2|||
155259998|NCT01533493|560384195|FG001|Overall Study|Lost to Follow-up|0|||
155259999|NCT05614089|560384201|FG000|Overall Study|Pregnancy|5|||
155260000|NCT05614089|560384202|FG001|Overall Study|Pregnancy|2|||
155260001|NCT05614089|560384201|FG000|Overall Study|Lost to Follow-up|5|||
155260002|NCT05614089|560384202|FG001|Overall Study|Lost to Follow-up|1|||
155260003|NCT05614089|560384201|FG000|Overall Study|Death|0|||
155260004|NCT05614089|560384202|FG001|Overall Study|Death|1|||
155260005|NCT05614089|560384201|FG000|Overall Study|Adverse Event|1|||
155260006|NCT05614089|560384202|FG001|Overall Study|Adverse Event|0|||
155260007|NCT02521285|560384203|FG000|Overall Study|Lost to Follow-up|1|||
155260008|NCT02521285|560384204|FG001|Overall Study|Lost to Follow-up|1|||
155260009|NCT02521285|560384203|FG000|Overall Study|Withdrawal by Subject|1|||
155260010|NCT02521285|560384204|FG001|Overall Study|Withdrawal by Subject|1|||
155260011|NCT02521285|560384203|FG000|Overall Study|Adverse Event|0|||
155260012|NCT02521285|560384204|FG001|Overall Study|Adverse Event|1|||
155260013|NCT05701995|560384206|FG000|Pre-Treatment|Randomization Error|1|||
155260014|NCT05701995|560384207|FG001|Pre-Treatment|Randomization Error|1|||
155260015|NCT05701995|560384206|FG000|Treatment|Withdrawal by Subject|8|||
155260016|NCT05701995|560384207|FG001|Treatment|Withdrawal by Subject|4|||
155260017|NCT05701995|560384206|FG000|Treatment|Lost to Follow-up|2|||
155260018|NCT05701995|560384207|FG001|Treatment|Lost to Follow-up|3|||
155260019|NCT05701995|560384206|FG000|Treatment|Adverse Event|3|||
155260020|NCT05701995|560384207|FG001|Treatment|Adverse Event|1|||
155260021|NCT05701995|560384206|FG000|Treatment|Other Reason|1|||
155260022|NCT05701995|560384207|FG001|Treatment|Other Reason|1|||
155260023|NCT05701995|560384206|FG000|Treatment|Death|1|||
155260024|NCT05701995|560384207|FG001|Treatment|Death|0|||
155260025|NCT05701995|560384206|FG000|Treatment|Physician Decision|0|||
155260026|NCT05701995|560384207|FG001|Treatment|Physician Decision|1|||
155260027|NCT00715429|560384208|FG000|Overall Study|Did not complete the study diary|0|||
155260028|NCT00715429|560384209|FG001|Overall Study|Did not complete the study diary|1|||
155260029|NCT04899245|560384214|FG000|Overall Study|Withdrawal by Subject|3|||
155260030|NCT04899245|560384215|FG001|Overall Study|Withdrawal by Subject|5|||
155260031|NCT04899245|560384216|FG002|Overall Study|Withdrawal by Subject|2|||
155260032|NCT04899245|560384214|FG000|Overall Study|No longer eligible - Left staff position|0|||
155260033|NCT04899245|560384215|FG001|Overall Study|No longer eligible - Left staff position|0|||
155260034|NCT04899245|560384216|FG002|Overall Study|No longer eligible - Left staff position|1|||
155260035|NCT04899245|560384214|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
155260036|NCT04899245|560384215|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
155260037|NCT04899245|560384216|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
155260038|NCT04899245|560384214|FG000|Overall Study|No longer eligible - Moved away from area|2|||
155260039|NCT04899245|560384215|FG001|Overall Study|No longer eligible - Moved away from area|2|||
155260040|NCT04899245|560384216|FG002|Overall Study|No longer eligible - Moved away from area|0|||
155260041|NCT03933826|560384219|FG000|Overall Study|Withdrawal by Subject|8|||
155260042|NCT03933826|560384220|FG001|Overall Study|Withdrawal by Subject|1|||
155260043|NCT03933826|560384219|FG000|Overall Study|Death|19|||
155260044|NCT03933826|560384220|FG001|Overall Study|Death|11|||
155260045|NCT03933826|560384219|FG000|Overall Study|Lost to Follow-up|41|||
155260046|NCT03933826|560384220|FG001|Overall Study|Lost to Follow-up|13|||
155260047|NCT00500903|560384221|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
155260048|NCT00500903|560384222|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
155260049|NCT00500903|560384223|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
155260050|NCT00500903|560384221|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
155260051|NCT00500903|560384222|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
155260052|NCT00500903|560384223|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
155260053|NCT00500903|560384221|FG000|Overall Study|Progressive Disease|41|||
155260054|NCT00500903|560384222|FG001|Overall Study|Progressive Disease|2|||
155260055|NCT00500903|560384223|FG002|Overall Study|Progressive Disease|15|||
155260056|NCT00500903|560384221|FG000|Overall Study|Patient Declined Further Treatment|0|||
155260057|NCT00500903|560384222|FG001|Overall Study|Patient Declined Further Treatment|0|||
155260058|NCT00500903|560384223|FG002|Overall Study|Patient Declined Further Treatment|3|||
155260059|NCT00500903|560384221|FG000|Overall Study|Symptomatic Deterioration|2|||
155260060|NCT00500903|560384222|FG001|Overall Study|Symptomatic Deterioration|0|||
155260061|NCT00500903|560384223|FG002|Overall Study|Symptomatic Deterioration|0|||
155260062|NCT00500903|560384221|FG000|Overall Study|Reason Not Specified|10|||
155260063|NCT00500903|560384222|FG001|Overall Study|Reason Not Specified|0|||
155260064|NCT00500903|560384223|FG002|Overall Study|Reason Not Specified|2|||
155260065|NCT01648348|560384224|FG000|Overall Study|Cancel|1|||
155260066|NCT01648348|560384225|FG001|Overall Study|Cancel|0|||
155260067|NCT01648348|560384226|FG002|Overall Study|Cancel|0|||
155260068|NCT01648348|560384227|FG003|Overall Study|Cancel|0|||
155260069|NCT01648348|560384228|FG004|Overall Study|Cancel|3|||
155260070|NCT01648348|560384229|FG005|Overall Study|Cancel|6|||
155260071|NCT01648348|560384224|FG000|Overall Study|Replaced for MTD analysis|1|||
155260072|NCT01648348|560384225|FG001|Overall Study|Replaced for MTD analysis|0|||
155260073|NCT01648348|560384226|FG002|Overall Study|Replaced for MTD analysis|1|||
155260074|NCT01648348|560384227|FG003|Overall Study|Replaced for MTD analysis|0|||
155260075|NCT01648348|560384228|FG004|Overall Study|Replaced for MTD analysis|0|||
155260076|NCT01648348|560384229|FG005|Overall Study|Replaced for MTD analysis|0|||
155260077|NCT00696410|560384230|FG000|Overall Study|Lost to Follow-up|2|||
155260078|NCT00696410|560384231|FG001|Overall Study|Lost to Follow-up|0|||
155260079|NCT00696410|560384230|FG000|Overall Study|Withdrawal by Subject|8|||
155260080|NCT00696410|560384231|FG001|Overall Study|Withdrawal by Subject|0|||
155260081|NCT00696410|560384230|FG000|Overall Study|Physician Decision|3|||
155260082|NCT00696410|560384231|FG001|Overall Study|Physician Decision|0|||
155260083|NCT01951638|560384236|FG000|Treatment Period|Protocol Violation|0|||
155260084|NCT01951638|560384237|FG001|Treatment Period|Protocol Violation|0|||
155260085|NCT01951638|560384238|FG002|Treatment Period|Protocol Violation|0|||
155260086|NCT01951638|560384239|FG003|Treatment Period|Protocol Violation|2|||
155260087|NCT01951638|560384240|FG004|Treatment Period|Protocol Violation|0|||
155260088|NCT01951638|560384236|FG000|Treatment Period|Protocol-driven decision point|1|||
155260089|NCT01951638|560384237|FG001|Treatment Period|Protocol-driven decision point|3|||
155260090|NCT01951638|560384238|FG002|Treatment Period|Protocol-driven decision point|0|||
155260091|NCT01951638|560384239|FG003|Treatment Period|Protocol-driven decision point|0|||
155260092|NCT01951638|560384240|FG004|Treatment Period|Protocol-driven decision point|0|||
155260093|NCT01951638|560384236|FG000|Treatment Period|Logistical difficulties|0|||
155260094|NCT01951638|560384237|FG001|Treatment Period|Logistical difficulties|1|||
155260095|NCT01951638|560384238|FG002|Treatment Period|Logistical difficulties|1|||
155260096|NCT01951638|560384239|FG003|Treatment Period|Logistical difficulties|0|||
155260097|NCT01951638|560384240|FG004|Treatment Period|Logistical difficulties|0|||
155260098|NCT01951638|560384236|FG000|Treatment Period|Withdrawal by Subject|9|||
155260099|NCT01951638|560384237|FG001|Treatment Period|Withdrawal by Subject|6|||
155260100|NCT01951638|560384238|FG002|Treatment Period|Withdrawal by Subject|4|||
155260101|NCT01951638|560384239|FG003|Treatment Period|Withdrawal by Subject|5|||
155260102|NCT01951638|560384240|FG004|Treatment Period|Withdrawal by Subject|4|||
155260103|NCT01951638|560384236|FG000|Treatment Period|Death|0|||
155260104|NCT01951638|560384237|FG001|Treatment Period|Death|0|||
155260105|NCT01951638|560384238|FG002|Treatment Period|Death|0|||
155260106|NCT01951638|560384239|FG003|Treatment Period|Death|3|||
155260107|NCT01951638|560384240|FG004|Treatment Period|Death|1|||
155260108|NCT01951638|560384236|FG000|Treatment Period|Adverse Event|3|||
155260109|NCT01951638|560384237|FG001|Treatment Period|Adverse Event|4|||
155260110|NCT01951638|560384238|FG002|Treatment Period|Adverse Event|8|||
155260111|NCT01951638|560384239|FG003|Treatment Period|Adverse Event|6|||
155260112|NCT01951638|560384240|FG004|Treatment Period|Adverse Event|5|||
155260113|NCT01951638|560384236|FG000|Follow-up Period|Protocol Violation|0|||
155260114|NCT01951638|560384237|FG001|Follow-up Period|Protocol Violation|0|||
155260115|NCT01951638|560384238|FG002|Follow-up Period|Protocol Violation|0|||
155260116|NCT01951638|560384239|FG003|Follow-up Period|Protocol Violation|1|||
155260117|NCT01951638|560384240|FG004|Follow-up Period|Protocol Violation|0|||
155260118|NCT01951638|560384236|FG000|Follow-up Period|Logistical difficulties|0|||
155260119|NCT01951638|560384237|FG001|Follow-up Period|Logistical difficulties|2|||
155260120|NCT01951638|560384238|FG002|Follow-up Period|Logistical difficulties|0|||
155260121|NCT01951638|560384239|FG003|Follow-up Period|Logistical difficulties|0|||
155260122|NCT01951638|560384240|FG004|Follow-up Period|Logistical difficulties|1|||
155260123|NCT01951638|560384236|FG000|Follow-up Period|Withdrawal by Subject|1|||
155260124|NCT01951638|560384237|FG001|Follow-up Period|Withdrawal by Subject|5|||
155260125|NCT01951638|560384238|FG002|Follow-up Period|Withdrawal by Subject|2|||
155260126|NCT01951638|560384239|FG003|Follow-up Period|Withdrawal by Subject|1|||
155260127|NCT01951638|560384240|FG004|Follow-up Period|Withdrawal by Subject|2|||
155260128|NCT01951638|560384236|FG000|Follow-up Period|Lost to Follow-up|0|||
155260129|NCT01951638|560384237|FG001|Follow-up Period|Lost to Follow-up|1|||
155260130|NCT01951638|560384238|FG002|Follow-up Period|Lost to Follow-up|0|||
155260131|NCT01951638|560384239|FG003|Follow-up Period|Lost to Follow-up|1|||
155260132|NCT01951638|560384240|FG004|Follow-up Period|Lost to Follow-up|0|||
155260133|NCT01951638|560384236|FG000|Follow-up Period|Death|1|||
155260134|NCT01951638|560384237|FG001|Follow-up Period|Death|0|||
155260135|NCT01951638|560384238|FG002|Follow-up Period|Death|1|||
155260136|NCT01951638|560384239|FG003|Follow-up Period|Death|4|||
155260137|NCT01951638|560384240|FG004|Follow-up Period|Death|1|||
155260138|NCT01951638|560384236|FG000|Follow-up Period|Adverse Event|0|||
155260139|NCT01951638|560384237|FG001|Follow-up Period|Adverse Event|1|||
155260140|NCT01951638|560384238|FG002|Follow-up Period|Adverse Event|2|||
155260141|NCT01951638|560384239|FG003|Follow-up Period|Adverse Event|1|||
155260142|NCT01951638|560384240|FG004|Follow-up Period|Adverse Event|1|||
155260143|NCT00552084|560384241|FG000|Overall Study|Adverse Event|2|||
155260144|NCT00552084|560384242|FG001|Overall Study|Adverse Event|3|||
155260145|NCT00552084|560384241|FG000|Overall Study|Withdrawal by Subject|4|||
155260146|NCT00552084|560384242|FG001|Overall Study|Withdrawal by Subject|5|||
155260147|NCT00552084|560384241|FG000|Overall Study|Protocol Violation|1|||
155260148|NCT00552084|560384242|FG001|Overall Study|Protocol Violation|0|||
155260149|NCT00552084|560384241|FG000|Overall Study|change in anti-arrythmic drug|1|||
155260150|NCT00552084|560384242|FG001|Overall Study|change in anti-arrythmic drug|1|||
155260151|NCT01338025|560384243|FG000|Overall Study|Unexpected closure of study|10|||
155260152|NCT01338025|560384244|FG001|Overall Study|Unexpected closure of study|9|||
155260153|NCT01338025|560384243|FG000|Overall Study|Withdrawal by Subject|0|||
155260154|NCT01338025|560384244|FG001|Overall Study|Withdrawal by Subject|2|||
155260155|NCT01338025|560384243|FG000|Overall Study|Found ineligible after starting|1|||
155260156|NCT01338025|560384244|FG001|Overall Study|Found ineligible after starting|0|||
155260157|NCT02286089|560384247|FG000|Overall Study|Ongoing in Study|1|||
155260158|NCT02286089|560384248|FG001|Overall Study|Ongoing in Study|1|||
155260159|NCT02286089|560384249|FG002|Overall Study|Ongoing in Study|4|||
155260160|NCT02286089|560384250|FG003|Overall Study|Ongoing in Study|10|||
155260161|NCT02286089|560384247|FG000|Overall Study|Withdrawal by Subject|0|||
155260162|NCT02286089|560384248|FG001|Overall Study|Withdrawal by Subject|0|||
155260163|NCT02286089|560384249|FG002|Overall Study|Withdrawal by Subject|2|||
155260164|NCT02286089|560384250|FG003|Overall Study|Withdrawal by Subject|2|||
155260165|NCT05073133|560384252|FG000|Overall Study|Death|2|||
155260166|NCT05002218|560384256|FG000|Overall Study|Lost to Follow-up|5|||
155260167|NCT05002218|560384257|FG001|Overall Study|Lost to Follow-up|6|||
155260168|NCT06223373|560384258|FG000|Overall Study|Lost to Follow-up|1|||
155260169|NCT06223373|560384259|FG001|Overall Study|Lost to Follow-up|2|||
155260170|NCT01728792|560385834|FG000|Overall Study|Withdrawal of Consent|1|||
155260171|NCT01728792|560385835|FG001|Overall Study|Withdrawal of Consent|1|||
155260172|NCT01728792|560385836|FG002|Overall Study|Withdrawal of Consent|0|||
155260173|NCT01728792|560385837|FG003|Overall Study|Withdrawal of Consent|1|||
155260174|NCT01728792|560385838|FG004|Overall Study|Withdrawal of Consent|0|||
155260175|NCT01728792|560385834|FG000|Overall Study|Lost to Follow-up|2|||
155260176|NCT01728792|560385835|FG001|Overall Study|Lost to Follow-up|1|||
155260177|NCT01728792|560385836|FG002|Overall Study|Lost to Follow-up|4|||
155260178|NCT01728792|560385837|FG003|Overall Study|Lost to Follow-up|2|||
155260179|NCT01728792|560385838|FG004|Overall Study|Lost to Follow-up|0|||
155260180|NCT03559218|560385839|FG000|Overall Study|Withdrawal by Subject|1|||
155260181|NCT03559218|560385840|FG001|Overall Study|Withdrawal by Subject|0|||
155260182|NCT04277455|560385841|FG000|Overall Study|Lost to Follow-up|1|||
155260183|NCT04737109|560385849|FG000|Study Treatment|Disease Progression|5|||
155260184|NCT04737109|560385850|FG001|Study Treatment|Disease Progression|0|||
155260185|NCT04737109|560385851|FG002|Study Treatment|Disease Progression|0|||
155260186|NCT04737109|560385852|FG003|Study Treatment|Disease Progression|0|||
155260187|NCT04737109|560385849|FG000|Study Treatment|Death on study|1|||
155260188|NCT04737109|560385850|FG001|Study Treatment|Death on study|0|||
155260189|NCT04737109|560385851|FG002|Study Treatment|Death on study|0|||
155260190|NCT04737109|560385852|FG003|Study Treatment|Death on study|0|||
155260191|NCT03092375|560385853|FG000|Overall Study|Lack of Efficacy|0|||
155260192|NCT03092375|560385854|FG001|Overall Study|Lack of Efficacy|1|||
155260193|NCT03092375|560385855|FG002|Overall Study|Lack of Efficacy|1|||
155260194|NCT03092375|560385856|FG003|Overall Study|Lack of Efficacy|0|||
155260195|NCT01679301|560385857|FG000|Screening Period|screen failure|3|||
155260196|NCT01679301|560385858|FG001|Screening Period|screen failure|0|||
155260197|NCT01679301|560385859|FG002|Screening Period|screen failure|0|||
155260198|NCT03328143|560385860|FG000|Overall Study|Declined|3|||
155260199|NCT03328143|560385860|FG000|Overall Study|Required increased sedation|4|||
155260200|NCT03328143|560385860|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
155260201|NCT03328143|560385860|FG000|Overall Study|Surgery cancelled|1|||
155260202|NCT02305381|560385861|FG000|Overall Study|Unclassified|5|||
155260203|NCT02305381|560385862|FG001|Overall Study|Unclassified|5|||
155260204|NCT02305381|560385863|FG002|Overall Study|Unclassified|7|||
155260205|NCT04857034|560385866|FG000|Placebo-Controlled Period|Request to discontinue|2|||
155260206|NCT04857034|560385867|FG001|Placebo-Controlled Period|Request to discontinue|2|||
155260207|NCT04857034|560385868|FG002|Placebo-Controlled Period|Request to discontinue|0|||
155260208|NCT04857034|560385869|FG003|Placebo-Controlled Period|Request to discontinue|0|||
155260209|NCT04857034|560385870|FG004|Placebo-Controlled Period|Request to discontinue|0|||
155260210|NCT04857034|560385866|FG000|Placebo-Controlled Period|withdrew consent|1|||
155260211|NCT04857034|560385867|FG001|Placebo-Controlled Period|withdrew consent|1|||
155260212|NCT04857034|560385868|FG002|Placebo-Controlled Period|withdrew consent|2|||
155260213|NCT04857034|560385869|FG003|Placebo-Controlled Period|withdrew consent|0|||
155260214|NCT04857034|560385870|FG004|Placebo-Controlled Period|withdrew consent|0|||
155260215|NCT04857034|560385866|FG000|Placebo-Controlled Period|Pregnancy|1|||
155260216|NCT04857034|560385867|FG001|Placebo-Controlled Period|Pregnancy|1|||
155260217|NCT04857034|560385868|FG002|Placebo-Controlled Period|Pregnancy|0|||
155260218|NCT04857034|560385869|FG003|Placebo-Controlled Period|Pregnancy|0|||
155260219|NCT04857034|560385870|FG004|Placebo-Controlled Period|Pregnancy|0|||
155260220|NCT04857034|560385866|FG000|Placebo-Controlled Period|Ongoing study period|0|||
155260221|NCT04857034|560385867|FG001|Placebo-Controlled Period|Ongoing study period|1|||
155260222|NCT04857034|560385868|FG002|Placebo-Controlled Period|Ongoing study period|0|||
155260223|NCT04857034|560385869|FG003|Placebo-Controlled Period|Ongoing study period|0|||
155260224|NCT04857034|560385870|FG004|Placebo-Controlled Period|Ongoing study period|0|||
155260225|NCT04857034|560385866|FG000|Active Treatment Period|Lack of Efficacy|1|||
155260226|NCT04857034|560385867|FG001|Active Treatment Period|Lack of Efficacy|0|||
155260227|NCT04857034|560385868|FG002|Active Treatment Period|Lack of Efficacy|0|||
155260228|NCT04857034|560385869|FG003|Active Treatment Period|Lack of Efficacy|0|||
155260229|NCT04857034|560385870|FG004|Active Treatment Period|Lack of Efficacy|0|||
155260230|NCT04857034|560385866|FG000|Active Treatment Period|request to discontinue|0|||
155260231|NCT04857034|560385867|FG001|Active Treatment Period|request to discontinue|1|||
155260232|NCT04857034|560385868|FG002|Active Treatment Period|request to discontinue|0|||
155260233|NCT04857034|560385869|FG003|Active Treatment Period|request to discontinue|1|||
155260234|NCT04857034|560385870|FG004|Active Treatment Period|request to discontinue|0|||
155260235|NCT04857034|560385866|FG000|Active Treatment Period|administrative reason by sponsor|1|||
155260236|NCT04857034|560385867|FG001|Active Treatment Period|administrative reason by sponsor|5|||
155260237|NCT04857034|560385868|FG002|Active Treatment Period|administrative reason by sponsor|0|||
155260238|NCT04857034|560385869|FG003|Active Treatment Period|administrative reason by sponsor|2|||
155260239|NCT04857034|560385870|FG004|Active Treatment Period|administrative reason by sponsor|2|||
155260240|NCT04857034|560385866|FG000|Active Treatment Period|other reasons|1|||
155260241|NCT04857034|560385867|FG001|Active Treatment Period|other reasons|1|||
155260242|NCT04857034|560385868|FG002|Active Treatment Period|other reasons|0|||
155260243|NCT04857034|560385869|FG003|Active Treatment Period|other reasons|0|||
155260244|NCT04857034|560385870|FG004|Active Treatment Period|other reasons|1|||
155260245|NCT04857034|560385866|FG000|Active Treatment Period|Ongoing Study Period|2|||
155260246|NCT04857034|560385867|FG001|Active Treatment Period|Ongoing Study Period|4|||
155260247|NCT04857034|560385868|FG002|Active Treatment Period|Ongoing Study Period|0|||
155260248|NCT04857034|560385869|FG003|Active Treatment Period|Ongoing Study Period|1|||
155260249|NCT04857034|560385870|FG004|Active Treatment Period|Ongoing Study Period|0|||
155260250|NCT00520975|560385871|FG000|Overall Study|Disease progression|31|||
155260251|NCT00520975|560385872|FG001|Overall Study|Disease progression|23|||
155260252|NCT00520975|560385871|FG000|Overall Study|Adverse Event|7|||
155260253|NCT00520975|560385872|FG001|Overall Study|Adverse Event|10|||
155260254|NCT00520975|560385871|FG000|Overall Study|Death|0|||
155260255|NCT00520975|560385872|FG001|Overall Study|Death|2|||
155260256|NCT00520975|560385871|FG000|Overall Study|Withdrawal by Subject|3|||
155260257|NCT00520975|560385872|FG001|Overall Study|Withdrawal by Subject|5|||
155260258|NCT00520975|560385871|FG000|Overall Study|Other therapy|2|||
155260259|NCT00520975|560385872|FG001|Overall Study|Other therapy|4|||
155260260|NCT00520975|560385871|FG000|Overall Study|Other reasons|4|||
155260261|NCT00520975|560385872|FG001|Overall Study|Other reasons|2|||
155260262|NCT00520975|560385871|FG000|Overall Study|Not start protocol therapy|1|||
155260263|NCT00520975|560385872|FG001|Overall Study|Not start protocol therapy|2|||
155260264|NCT00642902|560385873|FG000|Overall Study|Adverse Event|0|||
155260265|NCT00642902|560385874|FG001|Overall Study|Adverse Event|1|||
155260266|NCT00642902|560385875|FG002|Overall Study|Adverse Event|3|||
155260267|NCT00642902|560385876|FG003|Overall Study|Adverse Event|1|||
155260268|NCT00642902|560385873|FG000|Overall Study|Lost to Follow-up|1|||
155260269|NCT00642902|560385874|FG001|Overall Study|Lost to Follow-up|1|||
155260270|NCT00642902|560385875|FG002|Overall Study|Lost to Follow-up|0|||
155260271|NCT00642902|560385876|FG003|Overall Study|Lost to Follow-up|0|||
155260272|NCT00642902|560385873|FG000|Overall Study|Lack of Efficacy|0|||
155260273|NCT00642902|560385874|FG001|Overall Study|Lack of Efficacy|3|||
155260274|NCT00642902|560385875|FG002|Overall Study|Lack of Efficacy|3|||
155260275|NCT00642902|560385876|FG003|Overall Study|Lack of Efficacy|0|||
155260276|NCT00642902|560385873|FG000|Overall Study|Death|1|||
155260277|NCT00642902|560385874|FG001|Overall Study|Death|0|||
155260278|NCT00642902|560385875|FG002|Overall Study|Death|0|||
155260279|NCT00642902|560385876|FG003|Overall Study|Death|0|||
155260280|NCT00642902|560385873|FG000|Overall Study|Premature termination of clinical trial|37|||
155260281|NCT00642902|560385874|FG001|Overall Study|Premature termination of clinical trial|32|||
155260282|NCT00642902|560385875|FG002|Overall Study|Premature termination of clinical trial|35|||
155260283|NCT00642902|560385876|FG003|Overall Study|Premature termination of clinical trial|35|||
155260284|NCT00642902|560385873|FG000|Overall Study|Randomized, but not treated|0|||
155260285|NCT00642902|560385874|FG001|Overall Study|Randomized, but not treated|0|||
155260286|NCT00642902|560385875|FG002|Overall Study|Randomized, but not treated|1|||
155260287|NCT00642902|560385876|FG003|Overall Study|Randomized, but not treated|0|||
155260288|NCT00642902|560385873|FG000|Overall Study|Other|1|||
155260289|NCT00642902|560385874|FG001|Overall Study|Other|5|||
155260290|NCT00642902|560385875|FG002|Overall Study|Other|1|||
155260291|NCT00642902|560385876|FG003|Overall Study|Other|4|||
155260292|NCT03953898|560385877|FG000|Overall Study|Lack of Efficacy|8|||
155260293|NCT03953898|560385877|FG000|Overall Study|Death|3|||
155260294|NCT03953898|560385877|FG000|Overall Study|Withdrawal by Subject|2|||
155260295|NCT03953898|560385877|FG000|Overall Study|Adverse Event|1|||
155260296|NCT00246337|560385878|FG000|Overall Study|Lost to Follow-up|3|||
155260297|NCT00246337|560385879|FG001|Overall Study|Lost to Follow-up|0|||
155260298|NCT00246337|560385880|FG002|Overall Study|Lost to Follow-up|0|||
155260299|NCT00246337|560385881|FG003|Overall Study|Lost to Follow-up|0|||
155260300|NCT00246337|560385882|FG004|Overall Study|Lost to Follow-up|2|||
155260301|NCT00246337|560385883|FG005|Overall Study|Lost to Follow-up|2|||
155260302|NCT00246337|560385884|FG006|Overall Study|Lost to Follow-up|1|||
155260303|NCT00246337|560385885|FG007|Overall Study|Lost to Follow-up|2|||
155260304|NCT00246337|560385886|FG008|Overall Study|Lost to Follow-up|0|||
155260305|NCT00246337|560385878|FG000|Overall Study|Protocol Violation|1|||
155260306|NCT00246337|560385879|FG001|Overall Study|Protocol Violation|0|||
155260307|NCT00246337|560385880|FG002|Overall Study|Protocol Violation|0|||
155260308|NCT00246337|560385881|FG003|Overall Study|Protocol Violation|0|||
155260309|NCT00246337|560385882|FG004|Overall Study|Protocol Violation|1|||
155260310|NCT00246337|560385883|FG005|Overall Study|Protocol Violation|0|||
155260311|NCT00246337|560385884|FG006|Overall Study|Protocol Violation|1|||
155260312|NCT00246337|560385885|FG007|Overall Study|Protocol Violation|1|||
155260313|NCT00246337|560385886|FG008|Overall Study|Protocol Violation|0|||
155260314|NCT00246337|560385878|FG000|Overall Study|Withdrawal by Subject|2|||
155260315|NCT00246337|560385879|FG001|Overall Study|Withdrawal by Subject|0|||
155260316|NCT00246337|560385880|FG002|Overall Study|Withdrawal by Subject|0|||
155260317|NCT00246337|560385881|FG003|Overall Study|Withdrawal by Subject|0|||
155260318|NCT00246337|560385882|FG004|Overall Study|Withdrawal by Subject|0|||
155260319|NCT00246337|560385883|FG005|Overall Study|Withdrawal by Subject|0|||
155260320|NCT00246337|560385884|FG006|Overall Study|Withdrawal by Subject|1|||
155260321|NCT00246337|560385885|FG007|Overall Study|Withdrawal by Subject|1|||
155260322|NCT00246337|560385886|FG008|Overall Study|Withdrawal by Subject|0|||
155260323|NCT00246337|560385878|FG000|Overall Study|Lack of Qualifying Event|8|||
155260324|NCT00246337|560385879|FG001|Overall Study|Lack of Qualifying Event|2|||
155260325|NCT00246337|560385880|FG002|Overall Study|Lack of Qualifying Event|1|||
155260326|NCT00246337|560385881|FG003|Overall Study|Lack of Qualifying Event|1|||
155260327|NCT00246337|560385882|FG004|Overall Study|Lack of Qualifying Event|1|||
155260328|NCT00246337|560385883|FG005|Overall Study|Lack of Qualifying Event|3|||
155260329|NCT00246337|560385884|FG006|Overall Study|Lack of Qualifying Event|3|||
155260330|NCT00246337|560385885|FG007|Overall Study|Lack of Qualifying Event|2|||
155260331|NCT00246337|560385886|FG008|Overall Study|Lack of Qualifying Event|5|||
155260332|NCT00246337|560385878|FG000|Overall Study|Site Terminated|10|||
155260333|NCT00246337|560385879|FG001|Overall Study|Site Terminated|0|||
155260334|NCT00246337|560385880|FG002|Overall Study|Site Terminated|0|||
155260335|NCT00246337|560385881|FG003|Overall Study|Site Terminated|0|||
155260336|NCT00246337|560385882|FG004|Overall Study|Site Terminated|0|||
155260337|NCT00246337|560385883|FG005|Overall Study|Site Terminated|7|||
155260338|NCT00246337|560385884|FG006|Overall Study|Site Terminated|1|||
155260339|NCT00246337|560385885|FG007|Overall Study|Site Terminated|6|||
155260340|NCT00246337|560385886|FG008|Overall Study|Site Terminated|2|||
155260341|NCT00246337|560385878|FG000|Overall Study|Abnormal baseline lab values|7|||
155260342|NCT00246337|560385879|FG001|Overall Study|Abnormal baseline lab values|0|||
155260343|NCT00246337|560385880|FG002|Overall Study|Abnormal baseline lab values|2|||
155260344|NCT00246337|560385881|FG003|Overall Study|Abnormal baseline lab values|0|||
155260345|NCT00246337|560385882|FG004|Overall Study|Abnormal baseline lab values|0|||
155260346|NCT00246337|560385883|FG005|Overall Study|Abnormal baseline lab values|2|||
155260347|NCT00246337|560385884|FG006|Overall Study|Abnormal baseline lab values|2|||
155260348|NCT00246337|560385885|FG007|Overall Study|Abnormal baseline lab values|0|||
155260349|NCT00246337|560385886|FG008|Overall Study|Abnormal baseline lab values|4|||
155260350|NCT00246337|560385878|FG000|Overall Study|Overwhelmed|0|||
155260351|NCT00246337|560385879|FG001|Overall Study|Overwhelmed|0|||
155260352|NCT00246337|560385880|FG002|Overall Study|Overwhelmed|0|||
155260353|NCT00246337|560385881|FG003|Overall Study|Overwhelmed|0|||
155260354|NCT00246337|560385882|FG004|Overall Study|Overwhelmed|0|||
155260355|NCT00246337|560385883|FG005|Overall Study|Overwhelmed|1|||
155260356|NCT00246337|560385884|FG006|Overall Study|Overwhelmed|0|||
155260357|NCT00246337|560385885|FG007|Overall Study|Overwhelmed|0|||
155260358|NCT00246337|560385886|FG008|Overall Study|Overwhelmed|0|||
155260359|NCT00246337|560385878|FG000|Overall Study|Protocol Violator|1|||
155260360|NCT00246337|560385879|FG001|Overall Study|Protocol Violator|0|||
155260361|NCT00246337|560385880|FG002|Overall Study|Protocol Violator|0|||
155260362|NCT00246337|560385881|FG003|Overall Study|Protocol Violator|0|||
155260363|NCT00246337|560385882|FG004|Overall Study|Protocol Violator|0|||
155260364|NCT00246337|560385883|FG005|Overall Study|Protocol Violator|0|||
155260365|NCT00246337|560385884|FG006|Overall Study|Protocol Violator|0|||
155260366|NCT00246337|560385885|FG007|Overall Study|Protocol Violator|0|||
155260367|NCT00246337|560385886|FG008|Overall Study|Protocol Violator|0|||
155260368|NCT00246337|560385878|FG000|Overall Study|Reported as completing trial in error|0|||
155260369|NCT00246337|560385879|FG001|Overall Study|Reported as completing trial in error|0|||
155260370|NCT00246337|560385880|FG002|Overall Study|Reported as completing trial in error|0|||
155260371|NCT00246337|560385881|FG003|Overall Study|Reported as completing trial in error|0|||
155260372|NCT00246337|560385882|FG004|Overall Study|Reported as completing trial in error|0|||
155260373|NCT00246337|560385883|FG005|Overall Study|Reported as completing trial in error|0|||
155260374|NCT00246337|560385884|FG006|Overall Study|Reported as completing trial in error|0|||
155260375|NCT00246337|560385885|FG007|Overall Study|Reported as completing trial in error|1|||
155260376|NCT00246337|560385886|FG008|Overall Study|Reported as completing trial in error|0|||
155260377|NCT02696564|560385889|FG000|Overall Study|Death|1|||
155260378|NCT02696564|560385890|FG001|Overall Study|Death|2|||
155260379|NCT02696564|560385889|FG000|Overall Study|Withdrawal by Subject|3|||
155260380|NCT02696564|560385890|FG001|Overall Study|Withdrawal by Subject|2|||
155260381|NCT02696564|560385889|FG000|Overall Study|Lost to Follow-up|3|||
155260382|NCT02696564|560385890|FG001|Overall Study|Lost to Follow-up|3|||
155260383|NCT02696564|560385889|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
155260384|NCT02696564|560385890|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
155260385|NCT02696564|560385889|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
155260386|NCT02696564|560385890|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
155260387|NCT02696564|560385889|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
155260388|NCT02696564|560385890|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
155260389|NCT02696564|560385889|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
155260390|NCT02696564|560385890|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
155260391|NCT02696564|560385889|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
155260392|NCT02696564|560385890|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
155260393|NCT05267600|560385895|FG000|Overall Study|Adverse Event|1|||
155260394|NCT05267600|560385896|FG001|Overall Study|Adverse Event|4|||
155260395|NCT05267600|560385895|FG000|Overall Study|Death|1|||
155260396|NCT05267600|560385896|FG001|Overall Study|Death|2|||
155260397|NCT05267600|560385895|FG000|Overall Study|Lack of Efficacy|1|||
155260398|NCT05267600|560385896|FG001|Overall Study|Lack of Efficacy|2|||
155260399|NCT05267600|560385895|FG000|Overall Study|Lost to Follow-up|3|||
155260400|NCT05267600|560385896|FG001|Overall Study|Lost to Follow-up|0|||
155260401|NCT05267600|560385895|FG000|Overall Study|Physician Decision|4|||
155260402|NCT05267600|560385896|FG001|Overall Study|Physician Decision|0|||
155260403|NCT05267600|560385895|FG000|Overall Study|Treatment Unblinded|0|||
155260404|NCT05267600|560385896|FG001|Overall Study|Treatment Unblinded|1|||
155260405|NCT05267600|560385895|FG000|Overall Study|Withdrawal by Subject|5|||
155260406|NCT05267600|560385896|FG001|Overall Study|Withdrawal by Subject|4|||
155260407|NCT03633929|560385897|FG000|Overall Study|Lost to Follow-up|1|||
155260408|NCT03633929|560385897|FG000|Overall Study|Did not login to software. Did not participate|3|||
155260409|NCT00106184|560385902|FG000|Overall Study|Withdrawal by Subject|3|||
155260410|NCT00106184|560385903|FG001|Overall Study|Withdrawal by Subject|2|||
155260411|NCT01722162|560385904|FG000|Overall Study|Withdrawal by Subject|1|||
155260412|NCT01722162|560385905|FG001|Overall Study|Withdrawal by Subject|1|||
155260413|NCT01722162|560385904|FG000|Overall Study|Found ineligible|1|||
155260414|NCT01722162|560385905|FG001|Overall Study|Found ineligible|0|||
155260415|NCT01722162|560385904|FG000|Overall Study|Unrelated to study adverse event|2|||
155260416|NCT01722162|560385905|FG001|Overall Study|Unrelated to study adverse event|2|||
155260417|NCT01722162|560385904|FG000|Overall Study|Adverse Event|1|||
155260418|NCT01722162|560385905|FG001|Overall Study|Adverse Event|1|||
155260419|NCT01722162|560385904|FG000|Overall Study|Insurance denial post enrollment|0|||
155260420|NCT01722162|560385905|FG001|Overall Study|Insurance denial post enrollment|1|||
155260421|NCT01722162|560385904|FG000|Overall Study|Noncompliance|0|||
155260422|NCT01722162|560385905|FG001|Overall Study|Noncompliance|1|||
155260423|NCT05292534|560385906|FG000|Overall Study|Protocol Violation|3|||
155260424|NCT05292534|560385907|FG001|Overall Study|Protocol Violation|4|||
155260425|NCT05292534|560385906|FG000|Overall Study|Withdrawal by Subject|0|||
155260426|NCT05292534|560385907|FG001|Overall Study|Withdrawal by Subject|1|||
155260427|NCT01538472|560385908|FG000|Overall Study|Disease Progression|3|||
155260428|NCT01538472|560385908|FG000|Overall Study|Death|1|||
155260429|NCT02309112|560385909|FG000|Overall Study|Withdrawal by Subject|1|||
155260430|NCT02309112|560385910|FG001|Overall Study|Withdrawal by Subject|0|||
155260431|NCT02309112|560385911|FG002|Overall Study|Withdrawal by Subject|1|||
155260432|NCT02309112|560385909|FG000|Overall Study|Lost to Follow-up|0|||
155260433|NCT02309112|560385910|FG001|Overall Study|Lost to Follow-up|1|||
155260434|NCT02309112|560385911|FG002|Overall Study|Lost to Follow-up|0|||
155260435|NCT01889186|560385912|FG000|Overall Study|Adverse event- not related to progression|18|||
155260436|NCT01889186|560385913|FG001|Overall Study|Adverse event- not related to progression|5|||
155260437|NCT01889186|560385912|FG000|Overall Study|Adverse event- related to progression|7|||
155260438|NCT01889186|560385913|FG001|Overall Study|Adverse event- related to progression|2|||
155260439|NCT01889186|560385912|FG000|Overall Study|COVID-19 logistical restrictions|1|||
155260440|NCT01889186|560385913|FG001|Overall Study|COVID-19 logistical restrictions|0|||
155260441|NCT01889186|560385912|FG000|Overall Study|Investigator request|1|||
155260442|NCT01889186|560385913|FG001|Overall Study|Investigator request|1|||
155260443|NCT01889186|560385912|FG000|Overall Study|Progressive disease- Richter's|12|||
155260444|NCT01889186|560385913|FG001|Overall Study|Progressive disease- Richter's|7|||
155260445|NCT01889186|560385912|FG000|Overall Study|Progressive disease per protocol|46|||
155260446|NCT01889186|560385913|FG001|Overall Study|Progressive disease per protocol|17|||
155260447|NCT01889186|560385912|FG000|Overall Study|Stem cell transplant|2|||
155260448|NCT01889186|560385913|FG001|Overall Study|Stem cell transplant|1|||
155260449|NCT01889186|560385912|FG000|Overall Study|Withdrew consent|2|||
155260450|NCT01889186|560385913|FG001|Overall Study|Withdrew consent|3|||
155260451|NCT01889186|560385912|FG000|Overall Study|Other, not specified|18|||
155260452|NCT01889186|560385913|FG001|Overall Study|Other, not specified|15|||
155260453|NCT01896869|560385915|FG000|Overall Study|Withdrawal by Subject|0|||
155260454|NCT01896869|560385916|FG001|Overall Study|Withdrawal by Subject|6|||
155260455|NCT01896869|560385915|FG000|Overall Study|Lost to Follow-up|1|||
155260456|NCT01896869|560385916|FG001|Overall Study|Lost to Follow-up|0|||
155260457|NCT00454571|560385924|FG000|Overall Study|Adverse Event|2|||
155260458|NCT00454571|560385925|FG001|Overall Study|Adverse Event|0|||
155260459|NCT00454571|560385924|FG000|Overall Study|Physician Decision|0|||
155260460|NCT00454571|560385925|FG001|Overall Study|Physician Decision|1|||
155260461|NCT00454571|560385924|FG000|Overall Study|Protocol Violation|1|||
155260462|NCT00454571|560385925|FG001|Overall Study|Protocol Violation|0|||
155260463|NCT00454571|560385924|FG000|Overall Study|Withdrawal by Subject|10|||
155260464|NCT00454571|560385925|FG001|Overall Study|Withdrawal by Subject|5|||
155260465|NCT01960725|560385926|FG000|Overall Study|Lost to Follow-up|4|||
155260466|NCT01960725|560385927|FG001|Overall Study|Lost to Follow-up|3|||
155260467|NCT01960725|560385926|FG000|Overall Study|Withdrawal by Subject|1|||
155260468|NCT01960725|560385927|FG001|Overall Study|Withdrawal by Subject|0|||
155260469|NCT01960725|560385926|FG000|Overall Study|unable to obtain blood sample|1|||
155260470|NCT01960725|560385927|FG001|Overall Study|unable to obtain blood sample|2|||
155260471|NCT01058304|560385930|FG000|Overall Study|Withdrawal by Subject|8|||
155260472|NCT01058304|560385931|FG001|Overall Study|Withdrawal by Subject|5|||
155260473|NCT01058304|560385930|FG000|Overall Study|Lost to Follow-up|13|||
155260474|NCT01058304|560385931|FG001|Overall Study|Lost to Follow-up|16|||
155260475|NCT01058304|560385930|FG000|Overall Study|Developed exclusion criterion|6|||
155260476|NCT01058304|560385931|FG001|Overall Study|Developed exclusion criterion|12|||
155260477|NCT02496767|560385932|FG000|Open-label Lead-in Phase|Adverse Event|176|||
155260478|NCT02496767|560385933|FG001|Open-label Lead-in Phase|Adverse Event|0|||
155260479|NCT02496767|560385934|FG002|Open-label Lead-in Phase|Adverse Event|0|||
155260480|NCT02496767|560385935|FG003|Open-label Lead-in Phase|Adverse Event|0|||
155260481|NCT02496767|560385936|FG004|Open-label Lead-in Phase|Adverse Event|0|||
155260482|NCT02496767|560385937|FG005|Open-label Lead-in Phase|Adverse Event|0|||
155260483|NCT02496767|560385938|FG006|Open-label Lead-in Phase|Adverse Event|0|||
155260484|NCT02496767|560385939|FG007|Open-label Lead-in Phase|Adverse Event|0|||
155260485|NCT02496767|560385932|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
155260486|NCT02496767|560385933|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
155260487|NCT02496767|560385934|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
155260488|NCT02496767|560385935|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
155260489|NCT02496767|560385936|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
155260490|NCT02496767|560385937|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
155260491|NCT02496767|560385938|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
155260492|NCT02496767|560385939|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
155260493|NCT02496767|560385932|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
155260494|NCT02496767|560385933|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260495|NCT02496767|560385934|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260496|NCT02496767|560385935|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260497|NCT02496767|560385936|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260498|NCT02496767|560385937|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260499|NCT02496767|560385938|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260500|NCT02496767|560385939|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
155260501|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260502|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
155260503|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
155260504|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
155260505|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
155260506|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260507|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260508|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
155260509|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260510|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
155260511|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
155260512|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
155260513|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
155260514|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260515|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260516|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
155260517|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
155260518|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
155260519|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
155260520|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
155260521|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
155260522|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
155260523|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
155260524|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
155260525|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
155260526|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
155260527|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
155260528|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
155260529|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
155260530|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
155260531|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
155260532|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
155260533|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260534|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
155260535|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
155260536|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
155260537|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
155260538|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260539|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260540|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
155260541|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260542|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
155260543|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
155260544|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260545|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260546|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260547|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260548|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
155260549|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260550|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
155260551|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260552|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
155260553|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
155260554|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260555|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260556|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
155260557|NCT02496767|560385932|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260558|NCT02496767|560385933|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
155260559|NCT02496767|560385934|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260560|NCT02496767|560385935|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260561|NCT02496767|560385936|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260562|NCT02496767|560385937|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260563|NCT02496767|560385938|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260564|NCT02496767|560385939|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
155260565|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260566|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260567|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260568|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260569|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260570|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
155260571|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
155260572|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
155260573|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260574|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260575|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260576|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260577|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
155260578|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
155260579|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
155260580|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
155260581|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Death|0|||
155260582|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Death|0|||
155260583|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Death|0|||
155260584|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Death|0|||
155260585|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Death|0|||
155260586|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Death|0|||
155260587|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Death|1|||
155260588|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Death|2|||
155260589|NCT02496767|560385932|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260590|NCT02496767|560385933|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260591|NCT02496767|560385934|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260592|NCT02496767|560385935|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260593|NCT02496767|560385936|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
155260594|NCT02496767|560385937|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
155260595|NCT02496767|560385938|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
155260596|NCT02496767|560385939|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
155260597|NCT04035200|560385940|FG000|Overall Study|Lost to Follow-up|0|||
155260598|NCT04035200|560385941|FG001|Overall Study|Lost to Follow-up|1|||
155260599|NCT04035200|560385942|FG002|Overall Study|Lost to Follow-up|0|||
155260600|NCT04035200|560385940|FG000|Overall Study|Withdrawal by Subject|1|||
155260601|NCT04035200|560385941|FG001|Overall Study|Withdrawal by Subject|4|||
155260602|NCT04035200|560385942|FG002|Overall Study|Withdrawal by Subject|4|||
155260603|NCT04035200|560385940|FG000|Overall Study|COVID-19|1|||
155260604|NCT04035200|560385941|FG001|Overall Study|COVID-19|0|||
155260605|NCT04035200|560385942|FG002|Overall Study|COVID-19|0|||
155260606|NCT04035200|560385940|FG000|Overall Study|Early Termination|0|||
155260607|NCT04035200|560385941|FG001|Overall Study|Early Termination|1|||
155260608|NCT04035200|560385942|FG002|Overall Study|Early Termination|0|||
155260609|NCT04035200|560385940|FG000|Overall Study|Non-compliance|0|||
155260610|NCT04035200|560385941|FG001|Overall Study|Non-compliance|1|||
155260611|NCT04035200|560385942|FG002|Overall Study|Non-compliance|0|||
155260612|NCT01089374|560385943|FG000|Overall Study|Lost to Follow-up|3|||
155260613|NCT01089374|560385944|FG001|Overall Study|Lost to Follow-up|0|||
155260614|NCT01089374|560385943|FG000|Overall Study|Withdrawal by Subject|1|||
155260615|NCT01089374|560385944|FG001|Overall Study|Withdrawal by Subject|0|||
155260616|NCT01089374|560385943|FG000|Overall Study|Study closed early - low accrual|6|||
155260617|NCT01089374|560385944|FG001|Overall Study|Study closed early - low accrual|0|||
155260618|NCT03641313|560385953|FG000|Overall Study|Death|1|||
155260619|NCT03641313|560385953|FG000|Overall Study|Withdrawal by Subject|2|||
155260620|NCT03641313|560385953|FG000|Overall Study|Declining health|1|||
155260621|NCT03641313|560385953|FG000|Overall Study|Adverse Event|1|||
155260622|NCT03033225|560385954|FG000|Overall Study|Withdrawal by Subject|5|||
155260623|NCT05163522|560385955|FG000|Overall Study|Withdrawal by Subject|0|||
155260624|NCT05163522|560385956|FG001|Overall Study|Withdrawal by Subject|0|||
155260625|NCT05163522|560385957|FG002|Overall Study|Withdrawal by Subject|1|||
155260626|NCT05163522|560385958|FG003|Overall Study|Withdrawal by Subject|0|||
155260627|NCT05163522|560385959|FG004|Overall Study|Withdrawal by Subject|0|||
155260628|NCT05163522|560385960|FG005|Overall Study|Withdrawal by Subject|0|||
155260629|NCT05163522|560385961|FG006|Overall Study|Withdrawal by Subject|0|||
155260630|NCT05163522|560385962|FG007|Overall Study|Withdrawal by Subject|0|||
155260631|NCT05163522|560385963|FG008|Overall Study|Withdrawal by Subject|0|||
155260632|NCT05163522|560385964|FG009|Overall Study|Withdrawal by Subject|0|||
155260633|NCT05163522|560385965|FG010|Overall Study|Withdrawal by Subject|0|||
155260634|NCT03937219|560385968|FG000|Overall Study|Death|223|||
155260635|NCT03937219|560385969|FG001|Overall Study|Death|211|||
155260636|NCT03937219|560385968|FG000|Overall Study|Withdrawal by Subject|17|||
155260637|NCT03937219|560385969|FG001|Overall Study|Withdrawal by Subject|25|||
155260638|NCT03937219|560385968|FG000|Overall Study|Lost to Follow-up|3|||
155260639|NCT03937219|560385969|FG001|Overall Study|Lost to Follow-up|4|||
155260640|NCT00031486|560385975|FG000|Overall Study|Adverse Event|1|||
155260641|NCT00031486|560385976|FG001|Overall Study|Adverse Event|0|||
155260642|NCT00031486|560385975|FG000|Overall Study|Lost to Follow-up|0|||
155260643|NCT00031486|560385976|FG001|Overall Study|Lost to Follow-up|1|||
155260644|NCT00031486|560385975|FG000|Overall Study|Withdrawal by Subject|3|||
155260645|NCT00031486|560385976|FG001|Overall Study|Withdrawal by Subject|2|||
155260646|NCT00031486|560385975|FG000|Overall Study|Death|0|||
155260647|NCT00031486|560385976|FG001|Overall Study|Death|3|||
155260648|NCT00031486|560385975|FG000|Overall Study|Non-compliant|0|||
155260649|NCT00031486|560385976|FG001|Overall Study|Non-compliant|4|||
155260650|NCT00031486|560385975|FG000|Overall Study|Did not meet eligibility requirement|2|||
155260651|NCT00031486|560385976|FG001|Overall Study|Did not meet eligibility requirement|1|||
155260652|NCT00031486|560385975|FG000|Overall Study|Other|1|||
155260653|NCT00031486|560385976|FG001|Overall Study|Other|1|||
155260654|NCT03685591|560385979|FG000|Overall Study|Global Deterioration of Health Status|0|||
155260655|NCT03685591|560385980|FG001|Overall Study|Global Deterioration of Health Status|0|||
155260656|NCT03685591|560385981|FG002|Overall Study|Global Deterioration of Health Status|0|||
155260657|NCT03685591|560385982|FG003|Overall Study|Global Deterioration of Health Status|1|||
155260658|NCT03685591|560385983|FG004|Overall Study|Global Deterioration of Health Status|2|||
155260659|NCT03685591|560385984|FG005|Overall Study|Global Deterioration of Health Status|4|||
155260660|NCT03685591|560385985|FG006|Overall Study|Global Deterioration of Health Status|1|||
155260661|NCT03685591|560385986|FG007|Overall Study|Global Deterioration of Health Status|1|||
155260662|NCT03685591|560385987|FG008|Overall Study|Global Deterioration of Health Status|0|||
155260663|NCT03685591|560385979|FG000|Overall Study|Progressive Disease|1|||
155260664|NCT03685591|560385980|FG001|Overall Study|Progressive Disease|1|||
155260665|NCT03685591|560385981|FG002|Overall Study|Progressive Disease|0|||
155260666|NCT03685591|560385982|FG003|Overall Study|Progressive Disease|3|||
155260667|NCT03685591|560385983|FG004|Overall Study|Progressive Disease|5|||
155260668|NCT03685591|560385984|FG005|Overall Study|Progressive Disease|4|||
155260669|NCT03685591|560385985|FG006|Overall Study|Progressive Disease|3|||
155260670|NCT03685591|560385986|FG007|Overall Study|Progressive Disease|2|||
155260671|NCT03685591|560385987|FG008|Overall Study|Progressive Disease|1|||
155260672|NCT03685591|560385979|FG000|Overall Study|Other|0|||
155260673|NCT03685591|560385980|FG001|Overall Study|Other|0|||
155260674|NCT03685591|560385981|FG002|Overall Study|Other|1|||
155260675|NCT03685591|560385982|FG003|Overall Study|Other|0|||
155260676|NCT03685591|560385983|FG004|Overall Study|Other|2|||
155260677|NCT03685591|560385984|FG005|Overall Study|Other|3|||
155260678|NCT03685591|560385985|FG006|Overall Study|Other|0|||
155260679|NCT03685591|560385986|FG007|Overall Study|Other|0|||
155260680|NCT03685591|560385987|FG008|Overall Study|Other|0|||
155260681|NCT03685591|560385979|FG000|Overall Study|Withdrawal by Subject|0|||
155260682|NCT03685591|560385980|FG001|Overall Study|Withdrawal by Subject|0|||
155260683|NCT03685591|560385981|FG002|Overall Study|Withdrawal by Subject|0|||
155260684|NCT03685591|560385982|FG003|Overall Study|Withdrawal by Subject|0|||
155260685|NCT03685591|560385983|FG004|Overall Study|Withdrawal by Subject|3|||
155260686|NCT03685591|560385984|FG005|Overall Study|Withdrawal by Subject|2|||
155260687|NCT03685591|560385985|FG006|Overall Study|Withdrawal by Subject|0|||
155260688|NCT03685591|560385986|FG007|Overall Study|Withdrawal by Subject|0|||
155260689|NCT03685591|560385987|FG008|Overall Study|Withdrawal by Subject|1|||
155260690|NCT03685591|560385979|FG000|Overall Study|Adverse Event|0|||
155260691|NCT03685591|560385980|FG001|Overall Study|Adverse Event|0|||
155260692|NCT03685591|560385981|FG002|Overall Study|Adverse Event|0|||
155260693|NCT03685591|560385982|FG003|Overall Study|Adverse Event|1|||
155260694|NCT03685591|560385983|FG004|Overall Study|Adverse Event|1|||
155260695|NCT03685591|560385984|FG005|Overall Study|Adverse Event|4|||
155260696|NCT03685591|560385985|FG006|Overall Study|Adverse Event|0|||
155260697|NCT03685591|560385986|FG007|Overall Study|Adverse Event|1|||
155260698|NCT03685591|560385987|FG008|Overall Study|Adverse Event|1|||
155260699|NCT01685138|560385988|FG000|Overall Study|Lost to Follow-up|1|||
155260700|NCT01685138|560385988|FG000|Overall Study|Protocol Violation|1|||
155260701|NCT01685138|560385988|FG000|Overall Study|No longer requires treatment|1|||
155260702|NCT01685138|560385988|FG000|Overall Study|Subject/guardian decision|2|||
155260703|NCT01685138|560385988|FG000|Overall Study|Physician Decision|6|||
155260704|NCT01685138|560385988|FG000|Overall Study|Death|10|||
155260705|NCT01685138|560385988|FG000|Overall Study|Adverse Event|18|||
155260706|NCT01685138|560385988|FG000|Overall Study|Progressive disease|53|||
155260707|NCT03988166|560385991|FG000|Overall Study|Lost to Follow-up|2|||
155260708|NCT03988166|560385991|FG000|Overall Study|Death|1|||
155260709|NCT02703922|560385993|FG000|Overall Study|Death|5|||
155260710|NCT02703922|560385994|FG001|Overall Study|Death|8|||
155260711|NCT02703922|560385993|FG000|Overall Study|Lost to Follow-up|10|||
155260712|NCT02703922|560385994|FG001|Overall Study|Lost to Follow-up|10|||
155260713|NCT05805657|560386001|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
155260714|NCT05805657|560386002|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
155260715|NCT04058353|560386003|FG000|Overall Study|Adverse Event|2|||
155260716|NCT04058353|560386004|FG001|Overall Study|Adverse Event|1|||
155260717|NCT04058353|560386003|FG000|Overall Study|Physician Decision|1|||
155260718|NCT04058353|560386004|FG001|Overall Study|Physician Decision|0|||
155260719|NCT04058353|560386003|FG000|Overall Study|Other|1|||
155260720|NCT04058353|560386004|FG001|Overall Study|Other|0|||
155260721|NCT00316173|560386007|FG000|Run-in Phase|Adverse Event|1|||
155260722|NCT00316173|560386008|FG001|Run-in Phase|Adverse Event|0|||
155260723|NCT00316173|560386007|FG000|Run-in Phase|Protocol Violation|1|||
155260724|NCT00316173|560386008|FG001|Run-in Phase|Protocol Violation|0|||
155260725|NCT00316173|560386007|FG000|Run-in Phase|Study Follow-up Stopped|5|||
155260726|NCT00316173|560386008|FG001|Run-in Phase|Study Follow-up Stopped|0|||
155260727|NCT00316173|560386007|FG000|Treatment Phase|Adverse Event|0|||
155260728|NCT00316173|560386008|FG001|Treatment Phase|Adverse Event|1|||
155260729|NCT00316173|560386007|FG000|Treatment Phase|Lack of Efficacy|0|||
155260730|NCT00316173|560386008|FG001|Treatment Phase|Lack of Efficacy|3|||
155260731|NCT00316173|560386007|FG000|Treatment Phase|Lost to Follow-up|0|||
155260732|NCT00316173|560386008|FG001|Treatment Phase|Lost to Follow-up|3|||
155260733|NCT00316173|560386007|FG000|Treatment Phase|Withdrawal by Subject|0|||
155260734|NCT00316173|560386008|FG001|Treatment Phase|Withdrawal by Subject|1|||
155260735|NCT00316173|560386007|FG000|Treatment Phase|Study Follow-up Stopped|0|||
155260736|NCT00316173|560386008|FG001|Treatment Phase|Study Follow-up Stopped|34|||
155260737|NCT02390531|560386009|FG000|Overall Study|Death|0|||
155260738|NCT02390531|560386010|FG001|Overall Study|Death|2|||
155260739|NCT02390531|560386011|FG002|Overall Study|Death|0|||
155260740|NCT02390531|560386012|FG003|Overall Study|Death|1|||
155260741|NCT02390531|560386013|FG004|Overall Study|Death|0|||
155260742|NCT02390531|560386014|FG005|Overall Study|Death|0|||
155260743|NCT02390531|560386015|FG006|Overall Study|Death|0|||
155260744|NCT02390531|560386016|FG007|Overall Study|Death|1|||
155260745|NCT02390531|560386009|FG000|Overall Study|Protocol Violation|0|||
155260746|NCT02390531|560386010|FG001|Overall Study|Protocol Violation|0|||
155260747|NCT02390531|560386011|FG002|Overall Study|Protocol Violation|0|||
155260748|NCT02390531|560386012|FG003|Overall Study|Protocol Violation|0|||
155260749|NCT02390531|560386013|FG004|Overall Study|Protocol Violation|1|||
155260750|NCT02390531|560386014|FG005|Overall Study|Protocol Violation|0|||
155260751|NCT02390531|560386015|FG006|Overall Study|Protocol Violation|2|||
155260752|NCT02390531|560386016|FG007|Overall Study|Protocol Violation|0|||
155260753|NCT03779906|560386017|FG000|Overall Study|Lost to Follow-up|7|||
155260754|NCT03779906|560386017|FG000|Overall Study|COVID pandemic|1|||
155260755|NCT00847405|560387695|FG000|First Intervention|Adverse Event|0|||
155260756|NCT00847405|560387696|FG001|First Intervention|Adverse Event|1|||
155260757|NCT00847405|560387695|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
155260758|NCT00847405|560387696|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
155260759|NCT02790073|560387699|FG000|Overall Study|Death|1|||
155260760|NCT02790073|560387699|FG000|Overall Study|Withdrawal from HD|1|||
155260761|NCT02790073|560387699|FG000|Overall Study|Withdrawal by Subject|1|||
155260762|NCT02882282|560387700|FG000|Overall Study|Adverse Event|1|||
155260763|NCT02882282|560387701|FG001|Overall Study|Adverse Event|0|||
155260764|NCT00514683|560387702|FG000|Overall Study|Not treated|2|||
155260765|NCT00514683|560387703|FG001|Overall Study|Not treated|1|||
155260766|NCT00514683|560387704|FG002|Overall Study|Not treated|0|||
155260767|NCT00514683|560387705|FG003|Overall Study|Not treated|0|||
155260768|NCT00514683|560387706|FG004|Overall Study|Not treated|1|||
155260769|NCT00514683|560387702|FG000|Overall Study|Adverse Event|21|||
155260770|NCT00514683|560387703|FG001|Overall Study|Adverse Event|20|||
155260771|NCT00514683|560387704|FG002|Overall Study|Adverse Event|15|||
155260772|NCT00514683|560387705|FG003|Overall Study|Adverse Event|13|||
155260773|NCT00514683|560387706|FG004|Overall Study|Adverse Event|27|||
155260774|NCT00514683|560387702|FG000|Overall Study|Protocol Violation|1|||
155260775|NCT00514683|560387703|FG001|Overall Study|Protocol Violation|1|||
155260776|NCT00514683|560387704|FG002|Overall Study|Protocol Violation|0|||
155260777|NCT00514683|560387705|FG003|Overall Study|Protocol Violation|1|||
155260778|NCT00514683|560387706|FG004|Overall Study|Protocol Violation|0|||
155260779|NCT00514683|560387702|FG000|Overall Study|Withdrawal by Subject|2|||
155260780|NCT00514683|560387703|FG001|Overall Study|Withdrawal by Subject|2|||
155260781|NCT00514683|560387704|FG002|Overall Study|Withdrawal by Subject|1|||
155260782|NCT00514683|560387705|FG003|Overall Study|Withdrawal by Subject|0|||
155260783|NCT00514683|560387706|FG004|Overall Study|Withdrawal by Subject|4|||
155260784|NCT00514683|560387702|FG000|Overall Study|Reason other than listed above|0|||
155260785|NCT00514683|560387703|FG001|Overall Study|Reason other than listed above|1|||
155260786|NCT00514683|560387704|FG002|Overall Study|Reason other than listed above|2|||
155260787|NCT00514683|560387705|FG003|Overall Study|Reason other than listed above|0|||
155260788|NCT00514683|560387706|FG004|Overall Study|Reason other than listed above|1|||
155260789|NCT02487498|560387707|FG000|Period: Period 1|Adverse Event|2|||
155260790|NCT02487498|560387708|FG001|Period: Period 1|Adverse Event|4|||
155260791|NCT02487498|560387707|FG000|Period: Period 1|Subject/guardian decision|2|||
155260792|NCT02487498|560387708|FG001|Period: Period 1|Subject/guardian decision|4|||
155260793|NCT02487498|560387707|FG000|Period: Period 1|Lost to Follow-up|0|||
155260794|NCT02487498|560387708|FG001|Period: Period 1|Lost to Follow-up|2|||
155260795|NCT02487498|560387707|FG000|Period: Period 1|Lack of Efficacy|1|||
155260796|NCT02487498|560387708|FG001|Period: Period 1|Lack of Efficacy|0|||
155260797|NCT02487498|560387707|FG000|Period: Period 1|Physician Decision|0|||
155260798|NCT02487498|560387708|FG001|Period: Period 1|Physician Decision|1|||
155260799|NCT02487498|560387707|FG000|Period: Period 1|Protocol deviation|1|||
155260800|NCT02487498|560387708|FG001|Period: Period 1|Protocol deviation|0|||
155260801|NCT02487498|560387707|FG000|Period: Washout|Subject/guardian decision|0|||
155260802|NCT02487498|560387708|FG001|Period: Washout|Subject/guardian decision|5|||
155260803|NCT02487498|560387707|FG000|Period: Washout|Lack of Efficacy|1|||
155260804|NCT02487498|560387708|FG001|Period: Washout|Lack of Efficacy|1|||
155260805|NCT02487498|560387707|FG000|Period: Washout|Physician Decision|1|||
155260806|NCT02487498|560387708|FG001|Period: Washout|Physician Decision|0|||
155260807|NCT02487498|560387707|FG000|Period: Washout|Non-compliance with study treatment|0|||
155260808|NCT02487498|560387708|FG001|Period: Washout|Non-compliance with study treatment|1|||
155260809|NCT02487498|560387707|FG000|Period: Period 2|Adverse Event|2|||
155260810|NCT02487498|560387708|FG001|Period: Period 2|Adverse Event|2|||
155260811|NCT02487498|560387707|FG000|Period: Period 2|Subject/guardian decision|2|||
155260812|NCT02487498|560387708|FG001|Period: Period 2|Subject/guardian decision|1|||
155260813|NCT02487498|560387707|FG000|Period: Period 2|Lost to Follow-up|1|||
155260814|NCT02487498|560387708|FG001|Period: Period 2|Lost to Follow-up|1|||
155260815|NCT02487498|560387707|FG000|Period: Period 2|Death|0|||
155260816|NCT02487498|560387708|FG001|Period: Period 2|Death|1|||
155260817|NCT02487498|560387707|FG000|Period: Period 2|Physician Decision|1|||
155260818|NCT02487498|560387708|FG001|Period: Period 2|Physician Decision|0|||
155260819|NCT00676130|560387715|FG000|Overall Study|Lost to Follow-up|0|||
155260820|NCT00676130|560387716|FG001|Overall Study|Lost to Follow-up|1|||
155260821|NCT00676130|560387715|FG000|Overall Study|Found ineligible|3|||
155260822|NCT00676130|560387716|FG001|Overall Study|Found ineligible|2|||
155260823|NCT00676130|560387715|FG000|Overall Study|Withdrawal by Subject|0|||
155260824|NCT00676130|560387716|FG001|Overall Study|Withdrawal by Subject|1|||
155260825|NCT01564368|560387717|FG000|Overall Study|Ineligible|18|||
155260826|NCT01564368|560387717|FG000|Overall Study|Not Randomized in Parent study|116|||
155260827|NCT01564368|560387717|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
155260828|NCT01564368|560387717|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
155260829|NCT01802437|560387718|FG000|Overall Study|Lost to Follow-up|1|||
155260830|NCT01802437|560387719|FG001|Overall Study|Lost to Follow-up|0|||
155260831|NCT01802437|560387718|FG000|Overall Study|Withdrawal by Subject|3|||
155260832|NCT01802437|560387719|FG001|Overall Study|Withdrawal by Subject|4|||
155260833|NCT01682213|560387722|FG000|Overall Study|Withdrawal by Subject|2|||
155260834|NCT01181726|560387723|FG000|First Intervention|Adverse Event|1|||
155260835|NCT01181726|560387724|FG001|First Intervention|Adverse Event|0|||
155260836|NCT04998604|560387725|FG000|Overall Study|Adverse Event|3|||
155260837|NCT04998604|560387726|FG001|Overall Study|Adverse Event|2|||
155260838|NCT04998604|560387725|FG000|Overall Study|Withdrawal by Subject|2|||
155260839|NCT04998604|560387726|FG001|Overall Study|Withdrawal by Subject|4|||
155260840|NCT04998604|560387725|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
155260841|NCT04998604|560387726|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
155260842|NCT00429663|560387727|FG000|Overall Study|Lost to Follow-up|24|||
155260843|NCT00429663|560387728|FG001|Overall Study|Lost to Follow-up|31|||
155260844|NCT00429663|560387727|FG000|Overall Study|Physician Decision|6|||
155260845|NCT00429663|560387728|FG001|Overall Study|Physician Decision|3|||
155260846|NCT00429663|560387727|FG000|Overall Study|Withdrawal by Subject|2|||
155260847|NCT00429663|560387728|FG001|Overall Study|Withdrawal by Subject|5|||
155260848|NCT00429663|560387727|FG000|Overall Study|Death|4|||
155260849|NCT00429663|560387728|FG001|Overall Study|Death|0|||
155260850|NCT03261271|560387734|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
155260851|NCT03261271|560387735|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
155260852|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
155260853|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
155260854|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
155260855|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
155260856|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
155260857|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
155260858|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
155260859|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
155260860|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
155260861|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
155260862|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
155260863|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
155260864|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155260865|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155260866|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
155260867|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
155260868|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
155260869|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155260870|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155260871|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
155260872|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Death|2|||
155260873|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Death|2|||
155260874|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Death|0|||
155260875|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Death|0|||
155260876|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Death|0|||
155260877|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
155260878|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
155260879|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
155260880|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
155260881|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
155260882|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260883|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
155260884|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260885|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260886|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
155260887|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
155260888|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
155260889|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
155260890|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
155260891|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
155260892|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
155260893|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260894|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260895|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260896|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
155260897|NCT03420781|560387736|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
155260898|NCT03420781|560387737|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260899|NCT03420781|560387738|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260900|NCT03420781|560387739|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260901|NCT03420781|560387740|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
155260902|NCT03420781|560387736|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260903|NCT03420781|560387737|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260904|NCT03420781|560387738|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260905|NCT03420781|560387739|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
155260906|NCT03420781|560387740|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
155260907|NCT03420781|560387736|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260908|NCT03420781|560387737|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260909|NCT03420781|560387738|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260910|NCT03420781|560387739|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
155260911|NCT03420781|560387740|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
155260912|NCT03420781|560387736|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
155260913|NCT03420781|560387737|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
155260914|NCT03420781|560387738|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
155260915|NCT03420781|560387739|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
155260916|NCT03420781|560387740|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
155260917|NCT04067401|560387741|FG000|Overall Study|Withdrawal by Subject|7|||
155260918|NCT04067401|560387742|FG001|Overall Study|Withdrawal by Subject|0|||
155260919|NCT04067401|560387741|FG000|Overall Study|no data provided|1|||
155260920|NCT04067401|560387742|FG001|Overall Study|no data provided|0|||
155260921|NCT02657317|560387743|FG000|Overall Study|Withdrawal by Subject|2|||
155260922|NCT02657317|560387744|FG001|Overall Study|Withdrawal by Subject|0|||
155260923|NCT02657317|560387743|FG000|Overall Study|Lost to Follow-up|3|||
155260924|NCT02657317|560387744|FG001|Overall Study|Lost to Follow-up|3|||
155260925|NCT02857426|560387745|FG000|Overall Study|Disease progression|34|||
155260926|NCT02857426|560387746|FG001|Overall Study|Disease progression|13|||
155260927|NCT02857426|560387745|FG000|Overall Study|Study drug toxicity|4|||
155260928|NCT02857426|560387746|FG001|Overall Study|Study drug toxicity|1|||
155260929|NCT02857426|560387745|FG000|Overall Study|Death|1|||
155260930|NCT02857426|560387746|FG001|Overall Study|Death|0|||
155260931|NCT02857426|560387745|FG000|Overall Study|Adverse event unrelated to study drug|6|||
155260932|NCT02857426|560387746|FG001|Overall Study|Adverse event unrelated to study drug|2|||
155260933|NCT02857426|560387745|FG000|Overall Study|Participant withdrew consent|1|||
155260934|NCT02857426|560387746|FG001|Overall Study|Participant withdrew consent|1|||
155260935|NCT02857426|560387745|FG000|Overall Study|Maximum clinical benefit|1|||
155260936|NCT02857426|560387746|FG001|Overall Study|Maximum clinical benefit|0|||
155260937|NCT02857426|560387745|FG000|Overall Study|Completed treatment|0|||
155260938|NCT02857426|560387746|FG001|Overall Study|Completed treatment|2|||
155260939|NCT02110901|560387747|FG000|Overall Study|Death|6|||
155260940|NCT02110901|560387748|FG001|Overall Study|Death|3|||
155260941|NCT02110901|560387747|FG000|Overall Study|Lost to Follow-up|12|||
155260942|NCT02110901|560387748|FG001|Overall Study|Lost to Follow-up|8|||
155260943|NCT02110901|560387747|FG000|Overall Study|Withdrawal by Subject|7|||
155260944|NCT02110901|560387748|FG001|Overall Study|Withdrawal by Subject|3|||
155260945|NCT02110901|560387747|FG000|Overall Study|received a kidney transplant|5|||
155260946|NCT02110901|560387748|FG001|Overall Study|received a kidney transplant|0|||
155260947|NCT02634788|560387749|FG000|Overall Study|Adverse Event|0|||
155260948|NCT02634788|560387750|FG001|Overall Study|Adverse Event|8|||
155260949|NCT02634788|560387751|FG002|Overall Study|Adverse Event|3|||
155260950|NCT02634788|560387752|FG003|Overall Study|Adverse Event|1|||
155260951|NCT02634788|560387749|FG000|Overall Study|Lack of Efficacy|4|||
155260952|NCT02634788|560387750|FG001|Overall Study|Lack of Efficacy|0|||
155260953|NCT02634788|560387751|FG002|Overall Study|Lack of Efficacy|1|||
155260954|NCT02634788|560387752|FG003|Overall Study|Lack of Efficacy|4|||
155260955|NCT02634788|560387749|FG000|Overall Study|Lost to Follow-up|0|||
155260956|NCT02634788|560387750|FG001|Overall Study|Lost to Follow-up|1|||
155260957|NCT02634788|560387751|FG002|Overall Study|Lost to Follow-up|0|||
155260958|NCT02634788|560387752|FG003|Overall Study|Lost to Follow-up|0|||
155260959|NCT02634788|560387749|FG000|Overall Study|Withdrawal by Subject|0|||
155260960|NCT02634788|560387750|FG001|Overall Study|Withdrawal by Subject|1|||
155260961|NCT02634788|560387751|FG002|Overall Study|Withdrawal by Subject|1|||
155260962|NCT02634788|560387752|FG003|Overall Study|Withdrawal by Subject|0|||
155260963|NCT00758459|560387753|FG000|Overall Study|Adverse Event|3|||
155260964|NCT00758459|560387754|FG001|Overall Study|Adverse Event|2|||
155260965|NCT00758459|560387753|FG000|Overall Study|Protocol Violation|0|||
155260966|NCT00758459|560387754|FG001|Overall Study|Protocol Violation|1|||
155260967|NCT00758459|560387753|FG000|Overall Study|Withdrawal by Subject|0|||
155260968|NCT00758459|560387754|FG001|Overall Study|Withdrawal by Subject|1|||
155260969|NCT00855595|560387766|FG000|Overall Study|Withdrawal by Subject|1|||
155260970|NCT00855595|560387767|FG001|Overall Study|Withdrawal by Subject|2|||
155260971|NCT00855595|560387766|FG000|Overall Study|Lost to Follow-up|3|||
155260972|NCT00855595|560387767|FG001|Overall Study|Lost to Follow-up|3|||
155260973|NCT00855595|560387766|FG000|Overall Study|Adverse Event|1|||
155260974|NCT00855595|560387767|FG001|Overall Study|Adverse Event|1|||
155260975|NCT00855595|560387766|FG000|Overall Study|patient moved out of state|1|||
155260976|NCT00855595|560387767|FG001|Overall Study|patient moved out of state|0|||
155260977|NCT00855595|560387766|FG000|Overall Study|patient left country|0|||
155260978|NCT00855595|560387767|FG001|Overall Study|patient left country|1|||
155260979|NCT01780935|560387768|FG000|Overall Study|Admin problems due to early termination|321|||
155260980|NCT01780935|560387769|FG001|Overall Study|Admin problems due to early termination|309|||
155260981|NCT01780935|560387768|FG000|Overall Study|Adverse Event|2|||
155260982|NCT01780935|560387769|FG001|Overall Study|Adverse Event|4|||
155260983|NCT01780935|560387768|FG000|Overall Study|Death|1|||
155260984|NCT01780935|560387769|FG001|Overall Study|Death|6|||
155260985|NCT01780935|560387768|FG000|Overall Study|Lost to Follow-up|2|||
155260986|NCT01780935|560387769|FG001|Overall Study|Lost to Follow-up|6|||
155260987|NCT01780935|560387768|FG000|Overall Study|Physician Decision|1|||
155260988|NCT01780935|560387769|FG001|Overall Study|Physician Decision|1|||
155260989|NCT01780935|560387768|FG000|Overall Study|Protocol deviation|0|||
155260990|NCT01780935|560387769|FG001|Overall Study|Protocol deviation|1|||
155260991|NCT01780935|560387768|FG000|Overall Study|Patient withdrew consent|8|||
155260992|NCT01780935|560387769|FG001|Overall Study|Patient withdrew consent|9|||
155260993|NCT00611858|560387770|FG000|Overall Study|Adverse Event|2|||
155260994|NCT00611858|560387770|FG000|Overall Study|Withdrawal by Subject|2|||
155260995|NCT01844284|560387771|FG000|Overall Study|Lost to Follow-up|12|||
155260996|NCT01844284|560387772|FG001|Overall Study|Lost to Follow-up|7|||
155260997|NCT01820559|560387773|FG000|Overall Study|Adverse Event|4|||
155260998|NCT01820559|560387774|FG001|Overall Study|Adverse Event|6|||
155260999|NCT01820559|560387775|FG002|Overall Study|Adverse Event|13|||
155261000|NCT01820559|560387773|FG000|Overall Study|Withdrawal by Subject|1|||
155261001|NCT01820559|560387774|FG001|Overall Study|Withdrawal by Subject|2|||
155261002|NCT01820559|560387775|FG002|Overall Study|Withdrawal by Subject|5|||
155261003|NCT01820559|560387773|FG000|Overall Study|Protocol Violation|2|||
155261004|NCT01820559|560387774|FG001|Overall Study|Protocol Violation|1|||
155261005|NCT01820559|560387775|FG002|Overall Study|Protocol Violation|3|||
155261006|NCT01820559|560387773|FG000|Overall Study|Subject's non-compliance|1|||
155261007|NCT01820559|560387774|FG001|Overall Study|Subject's non-compliance|0|||
155261008|NCT01820559|560387775|FG002|Overall Study|Subject's non-compliance|2|||
155261009|NCT01820559|560387773|FG000|Overall Study|Lost to Follow-up|3|||
155261010|NCT01820559|560387774|FG001|Overall Study|Lost to Follow-up|2|||
155261011|NCT01820559|560387775|FG002|Overall Study|Lost to Follow-up|2|||
155261012|NCT01820559|560387773|FG000|Overall Study|At sponsor request|0|||
155261013|NCT01820559|560387774|FG001|Overall Study|At sponsor request|0|||
155261014|NCT01820559|560387775|FG002|Overall Study|At sponsor request|1|||
155261015|NCT01820559|560387773|FG000|Overall Study|Lack of Efficacy|3|||
155261016|NCT01820559|560387774|FG001|Overall Study|Lack of Efficacy|2|||
155261017|NCT01820559|560387775|FG002|Overall Study|Lack of Efficacy|3|||
155261018|NCT02755597|560387776|FG000|Overall Study|Withdrew consent|27|||
155261019|NCT02755597|560387777|FG001|Overall Study|Withdrew consent|11|||
155261020|NCT02755597|560387776|FG000|Overall Study|Lost to Follow-up|1|||
155261021|NCT02755597|560387777|FG001|Overall Study|Lost to Follow-up|0|||
155261022|NCT02755597|560387776|FG000|Overall Study|Death|78|||
155261023|NCT02755597|560387777|FG001|Overall Study|Death|36|||
155261024|NCT02755597|560387776|FG000|Overall Study|Study terminated by Sponsor|67|||
155261025|NCT02755597|560387777|FG001|Overall Study|Study terminated by Sponsor|47|||
155261026|NCT02755597|560387776|FG000|Overall Study|Other, not specified|20|||
155261027|NCT02755597|560387777|FG001|Overall Study|Other, not specified|3|||
155261028|NCT02755597|560387776|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
155261029|NCT02755597|560387777|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
155261030|NCT00166296|560387778|FG000|Overall Study|Withdrawal by Subject|1|||
155261031|NCT00166296|560387779|FG001|Overall Study|Withdrawal by Subject|3|||
155261032|NCT00166296|560387778|FG000|Overall Study|Adverse Event|2|||
155261033|NCT00166296|560387779|FG001|Overall Study|Adverse Event|4|||
155261034|NCT00166296|560387778|FG000|Overall Study|Lost to Follow-up|4|||
155261035|NCT00166296|560387779|FG001|Overall Study|Lost to Follow-up|2|||
155261036|NCT03351738|560387780|FG000|Overall Study|Withdrawal by Subject|0|||
155261037|NCT03351738|560387781|FG001|Overall Study|Withdrawal by Subject|1|||
155261038|NCT03351738|560387782|FG002|Overall Study|Withdrawal by Subject|0|||
155261039|NCT03351738|560387783|FG003|Overall Study|Withdrawal by Subject|1|||
155261040|NCT03351738|560387784|FG004|Overall Study|Withdrawal by Subject|0|||
155261041|NCT03351738|560387785|FG005|Overall Study|Withdrawal by Subject|0|||
155261042|NCT02597036|560387788|FG000|Overall Study|Progressive Disease|0|||
155261043|NCT02597036|560387789|FG001|Overall Study|Progressive Disease|0|||
155261044|NCT02597036|560387790|FG002|Overall Study|Progressive Disease|0|||
155261045|NCT02597036|560387791|FG003|Overall Study|Progressive Disease|0|||
155261046|NCT02597036|560387792|FG004|Overall Study|Progressive Disease|1|||
155261047|NCT02597036|560387793|FG005|Overall Study|Progressive Disease|1|||
155261048|NCT02597036|560387794|FG006|Overall Study|Progressive Disease|1|||
155261049|NCT02597036|560387795|FG007|Overall Study|Progressive Disease|0|||
155261050|NCT02597036|560387796|FG008|Overall Study|Progressive Disease|0|||
155261051|NCT02597036|560387797|FG009|Overall Study|Progressive Disease|0|||
155261052|NCT02597036|560387798|FG010|Overall Study|Progressive Disease|0|||
155261053|NCT02597036|560387799|FG011|Overall Study|Progressive Disease|0|||
155261054|NCT02597036|560387788|FG000|Overall Study|Adverse Event|0|||
155261055|NCT02597036|560387789|FG001|Overall Study|Adverse Event|0|||
155261056|NCT02597036|560387790|FG002|Overall Study|Adverse Event|0|||
155261057|NCT02597036|560387791|FG003|Overall Study|Adverse Event|0|||
155261058|NCT02597036|560387792|FG004|Overall Study|Adverse Event|0|||
155261059|NCT02597036|560387793|FG005|Overall Study|Adverse Event|0|||
155261060|NCT02597036|560387794|FG006|Overall Study|Adverse Event|0|||
155261061|NCT02597036|560387795|FG007|Overall Study|Adverse Event|1|||
155261062|NCT02597036|560387796|FG008|Overall Study|Adverse Event|0|||
155261063|NCT02597036|560387797|FG009|Overall Study|Adverse Event|0|||
155261064|NCT02597036|560387798|FG010|Overall Study|Adverse Event|0|||
155261065|NCT02597036|560387799|FG011|Overall Study|Adverse Event|1|||
155261066|NCT02597036|560387788|FG000|Overall Study|Death|0|||
155261067|NCT02597036|560387789|FG001|Overall Study|Death|0|||
155261068|NCT02597036|560387790|FG002|Overall Study|Death|0|||
155261069|NCT02597036|560387791|FG003|Overall Study|Death|0|||
155261070|NCT02597036|560387792|FG004|Overall Study|Death|0|||
155261071|NCT02597036|560387793|FG005|Overall Study|Death|0|||
155261072|NCT02597036|560387794|FG006|Overall Study|Death|0|||
155261073|NCT02597036|560387795|FG007|Overall Study|Death|0|||
155261074|NCT02597036|560387796|FG008|Overall Study|Death|0|||
155261075|NCT02597036|560387797|FG009|Overall Study|Death|1|||
155261076|NCT02597036|560387798|FG010|Overall Study|Death|1|||
155261077|NCT02597036|560387799|FG011|Overall Study|Death|0|||
155261078|NCT02597036|560387788|FG000|Overall Study|Lost to Follow-up|0|||
155261079|NCT02597036|560387789|FG001|Overall Study|Lost to Follow-up|0|||
155261080|NCT02597036|560387790|FG002|Overall Study|Lost to Follow-up|0|||
155261081|NCT02597036|560387791|FG003|Overall Study|Lost to Follow-up|0|||
155261082|NCT02597036|560387792|FG004|Overall Study|Lost to Follow-up|0|||
155261083|NCT02597036|560387793|FG005|Overall Study|Lost to Follow-up|0|||
155261084|NCT02597036|560387794|FG006|Overall Study|Lost to Follow-up|0|||
155261085|NCT02597036|560387795|FG007|Overall Study|Lost to Follow-up|0|||
155261086|NCT02597036|560387796|FG008|Overall Study|Lost to Follow-up|0|||
155261087|NCT02597036|560387797|FG009|Overall Study|Lost to Follow-up|0|||
155261088|NCT02597036|560387798|FG010|Overall Study|Lost to Follow-up|1|||
155261089|NCT02597036|560387799|FG011|Overall Study|Lost to Follow-up|0|||
155261090|NCT02597036|560387788|FG000|Overall Study|Withdrawal by Subject|0|||
155261091|NCT02597036|560387789|FG001|Overall Study|Withdrawal by Subject|0|||
155261092|NCT02597036|560387790|FG002|Overall Study|Withdrawal by Subject|0|||
155261093|NCT02597036|560387791|FG003|Overall Study|Withdrawal by Subject|0|||
155261094|NCT02597036|560387792|FG004|Overall Study|Withdrawal by Subject|0|||
155261095|NCT02597036|560387793|FG005|Overall Study|Withdrawal by Subject|0|||
155261096|NCT02597036|560387794|FG006|Overall Study|Withdrawal by Subject|0|||
155261097|NCT02597036|560387795|FG007|Overall Study|Withdrawal by Subject|0|||
155261098|NCT02597036|560387796|FG008|Overall Study|Withdrawal by Subject|0|||
155261099|NCT02597036|560387797|FG009|Overall Study|Withdrawal by Subject|0|||
155261100|NCT02597036|560387798|FG010|Overall Study|Withdrawal by Subject|0|||
155261101|NCT02597036|560387799|FG011|Overall Study|Withdrawal by Subject|1|||
155261102|NCT06351371|560387800|FG000|Overall Study|Mutation Status Not Confirmed|9|||
155261103|NCT06351371|560387800|FG000|Overall Study|Ineligible|1|||
155261104|NCT06351371|560387800|FG000|Overall Study|Adverse Event|4|||
155261105|NCT06351371|560387800|FG000|Overall Study|Death|1|||
155261106|NCT06351371|560387800|FG000|Overall Study|Disease progression|14|||
155261107|NCT06351371|560387800|FG000|Overall Study|Withdrawal by Subject|3|||
155261108|NCT06351371|560387800|FG000|Overall Study|Physician Decision|3|||
155261109|NCT03759834|560387801|FG000|Overall Study|Withdrawal by Subject|1|||
155261110|NCT02515279|560387802|FG000|Overall Study|Adverse Event|7|||
155261111|NCT02515279|560387802|FG000|Overall Study|Lack of Efficacy|31|||
155261112|NCT02515279|560387802|FG000|Overall Study|Lost to Follow-up|9|||
155261113|NCT02515279|560387802|FG000|Overall Study|Withdrawal by Subject|18|||
155261114|NCT02515279|560387802|FG000|Overall Study|End-of-treatment visit not attended|17|||
155261115|NCT02515279|560387802|FG000|Overall Study|Other|22|||
155261116|NCT01800968|560387803|FG000|Overall Study|Death|23|||
155261117|NCT01800968|560387804|FG001|Overall Study|Death|16|||
155261118|NCT01800968|560387803|FG000|Overall Study|Lost to Follow-up|5|||
155261119|NCT01800968|560387804|FG001|Overall Study|Lost to Follow-up|7|||
155261120|NCT01800968|560387803|FG000|Overall Study|Withdrawal by Subject|7|||
155261121|NCT01800968|560387804|FG001|Overall Study|Withdrawal by Subject|9|||
155261122|NCT01800968|560387803|FG000|Overall Study|Physician Decision|1|||
155261123|NCT01800968|560387804|FG001|Overall Study|Physician Decision|0|||
155261124|NCT04987762|560387806|FG000|Overall Study|Study was Terminated by Sponsor|103|||
155261125|NCT03185481|560387807|FG000|Overall Study|Adverse Event|1|||
155261126|NCT03185481|560387807|FG000|Overall Study|Study Terminated by Sponsor|4|||
155261127|NCT00701038|560387813|FG000|Overall Study|study amended pilot group of patients|4|||
155261128|NCT00701038|560387814|FG001|Overall Study|study amended pilot group of patients|4|||
155261129|NCT03371940|560387820|FG000|Overall Study|Withdrawal by Subject|8|||
155261130|NCT03371940|560387821|FG001|Overall Study|Withdrawal by Subject|1|||
155261131|NCT03371940|560387822|FG002|Overall Study|Withdrawal by Subject|3|||
155261132|NCT03371940|560387823|FG003|Overall Study|Withdrawal by Subject|4|||
155261133|NCT05099926|560387824|FG000|Overall Study|Lost to Follow-up|1|||
155261134|NCT00689026|560387827|FG000|Overall Study|Withdrawal by Subject|13|||
155261135|NCT00689026|560387828|FG001|Overall Study|Withdrawal by Subject|6|||
155261136|NCT02618616|560387829|FG000|Overall Study|Lack of Efficacy|4|||
155261137|NCT02618616|560387830|FG001|Overall Study|Lack of Efficacy|0|||
155261138|NCT02618616|560387829|FG000|Overall Study|Pregnancy|0|||
155261139|NCT02618616|560387830|FG001|Overall Study|Pregnancy|1|||
155261140|NCT02618616|560387829|FG000|Overall Study|Adverse Event|8|||
155261141|NCT02618616|560387830|FG001|Overall Study|Adverse Event|0|||
155261142|NCT02618616|560387829|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
155261143|NCT02618616|560387830|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
155261144|NCT02618616|560387829|FG000|Overall Study|Consent withdrawn by subject|8|||
155261145|NCT02618616|560387830|FG001|Overall Study|Consent withdrawn by subject|5|||
155261146|NCT02618616|560387829|FG000|Overall Study|Lost to Follow-up|0|||
155261147|NCT02618616|560387830|FG001|Overall Study|Lost to Follow-up|1|||
155261148|NCT03764072|560387833|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261149|NCT03764072|560387834|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261150|NCT03764072|560387835|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
155261151|NCT03764072|560387836|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261152|NCT03764072|560387837|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261153|NCT03764072|560387838|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
155261154|NCT03764072|560387833|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
155261155|NCT03764072|560387834|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
155261156|NCT03764072|560387835|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
155261157|NCT03764072|560387836|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
155261158|NCT03764072|560387837|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
155261159|NCT03764072|560387838|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
155261160|NCT03764072|560387833|FG000|Overall Study|Lost to Follow-up|0|||
155261161|NCT03764072|560387834|FG001|Overall Study|Lost to Follow-up|0|||
155261162|NCT03764072|560387835|FG002|Overall Study|Lost to Follow-up|0|||
155261163|NCT03764072|560387836|FG003|Overall Study|Lost to Follow-up|0|||
155261164|NCT03764072|560387837|FG004|Overall Study|Lost to Follow-up|1|||
155261165|NCT03764072|560387838|FG005|Overall Study|Lost to Follow-up|0|||
155261166|NCT00766675|560389473|FG000|Overall Study|Adverse Event|16|||
155261167|NCT00766675|560389473|FG000|Overall Study|Lost to Follow-up|2|||
155261168|NCT00766675|560389473|FG000|Overall Study|Withdrawal by Subject|11|||
155261169|NCT00766675|560389473|FG000|Overall Study|Protocol Violation|8|||
155261170|NCT00766675|560389473|FG000|Overall Study|Participant took prohibited medication|1|||
155261171|NCT00766675|560389473|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
155261172|NCT00766675|560389473|FG000|Overall Study|Insufficient therapy|1|||
155261173|NCT03308825|560389474|FG000|Overall Study|Lost to Follow-up|2|||
155261174|NCT03308825|560389475|FG001|Overall Study|Lost to Follow-up|2|||
155261175|NCT03308825|560389476|FG002|Overall Study|Lost to Follow-up|1|||
155261176|NCT03308825|560389477|FG003|Overall Study|Lost to Follow-up|0|||
155261177|NCT03308825|560389474|FG000|Overall Study|Protocol Violation|0|||
155261178|NCT03308825|560389475|FG001|Overall Study|Protocol Violation|2|||
155261179|NCT03308825|560389476|FG002|Overall Study|Protocol Violation|0|||
155261180|NCT03308825|560389477|FG003|Overall Study|Protocol Violation|0|||
155261181|NCT02044848|560389479|FG000|Overall Study|Administrative Problems|2|||
155261182|NCT02044848|560389480|FG001|Overall Study|Administrative Problems|3|||
155261183|NCT00045708|560389481|FG000|Phase 1|early progressive disease|0|||
155261184|NCT00045708|560389482|FG001|Phase 1|early progressive disease|1|||
155261185|NCT00045708|560389483|FG002|Phase 1|early progressive disease|0|||
155261186|NCT00685945|560389485|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
155261187|NCT03183388|560389486|FG000|Overall Study|Lost to Follow-up|3|||
155261188|NCT03183388|560389487|FG001|Overall Study|Lost to Follow-up|5|||
155261189|NCT03183388|560389486|FG000|Overall Study|Physician Decision|1|||
155261190|NCT03183388|560389487|FG001|Overall Study|Physician Decision|4|||
155261191|NCT03183388|560389486|FG000|Overall Study|Withdrawal by Subject|4|||
155261192|NCT03183388|560389487|FG001|Overall Study|Withdrawal by Subject|1|||
155261193|NCT03183388|560389486|FG000|Overall Study|Moved|1|||
155261194|NCT03183388|560389487|FG001|Overall Study|Moved|0|||
155261195|NCT03183388|560389486|FG000|Overall Study|Met Exclusion Criteria|2|||
155261196|NCT03183388|560389487|FG001|Overall Study|Met Exclusion Criteria|2|||
155261197|NCT03183388|560389486|FG000|Overall Study|COVID Pandemic Related|2|||
155261198|NCT03183388|560389487|FG001|Overall Study|COVID Pandemic Related|4|||
155261199|NCT01679236|560389488|FG000|Overall Study|Lost to Follow-up|15|||
155261200|NCT01679236|560389489|FG001|Overall Study|Lost to Follow-up|15|||
155261201|NCT00803101|560389500|FG000|Overall Study|Death / Serious Adverse Event|4|||
155261202|NCT00803101|560389501|FG001|Overall Study|Death / Serious Adverse Event|6|||
155261203|NCT00803101|560389500|FG000|Overall Study|Withdrawal by Subject|6|||
155261204|NCT00803101|560389501|FG001|Overall Study|Withdrawal by Subject|4|||
155261205|NCT00803101|560389500|FG000|Overall Study|Lost to Follow-up|2|||
155261206|NCT00803101|560389501|FG001|Overall Study|Lost to Follow-up|2|||
155261207|NCT00803101|560389500|FG000|Overall Study|Protocol Violation|1|||
155261208|NCT00803101|560389501|FG001|Overall Study|Protocol Violation|7|||
155261209|NCT00803101|560389500|FG000|Overall Study|Surgery finished outside protocol window|1|||
155261210|NCT00803101|560389501|FG001|Overall Study|Surgery finished outside protocol window|1|||
155261211|NCT00803101|560389500|FG000|Overall Study|Patient died outside SAE report period|1|||
155261212|NCT00803101|560389501|FG001|Overall Study|Patient died outside SAE report period|0|||
155261213|NCT00803101|560389500|FG000|Overall Study|Patient did not attend scheduled visit|2|||
155261214|NCT00803101|560389501|FG001|Overall Study|Patient did not attend scheduled visit|1|||
155261215|NCT00803101|560389500|FG000|Overall Study|Patient did not have surgery|1|||
155261216|NCT00803101|560389501|FG001|Overall Study|Patient did not have surgery|1|||
155261217|NCT01782742|560389502|FG000|Double-blind Treatment Phase|Adverse Event|1|||
155261218|NCT01782742|560389503|FG001|Double-blind Treatment Phase|Adverse Event|0|||
155261219|NCT01529008|560389504|FG000|Bone Marrow Harvesting|Physician Decision|1|||
155261220|NCT01529008|560389505|FG001|Bone Marrow Harvesting|Physician Decision|1|||
155261221|NCT01529008|560389504|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
155261222|NCT01529008|560389505|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
155261223|NCT01529008|560389504|FG000|Treatment|Adverse Event|6|||
155261224|NCT01529008|560389505|FG001|Treatment|Adverse Event|0|||
155261225|NCT01529008|560389504|FG000|Treatment|Other|3|||
155261226|NCT01529008|560389505|FG001|Treatment|Other|1|||
155261227|NCT01529008|560389504|FG000|Efficacy Analysis|Protocol Violation|2|||
155261228|NCT01529008|560389505|FG001|Efficacy Analysis|Protocol Violation|0|||
155261229|NCT01529008|560389504|FG000|Efficacy Analysis|Physician Decision|0|||
155261230|NCT01529008|560389505|FG001|Efficacy Analysis|Physician Decision|1|||
155261231|NCT01529008|560389504|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
155261232|NCT01529008|560389505|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
155261233|NCT04170686|560389506|FG000|Screening|Physician Decision|12|||
155261234|NCT04170686|560389507|FG001|Screening|Physician Decision|13|||
155261235|NCT04170686|560389506|FG000|Randomization and Treatment|Lost to Follow-up|26|||
155261236|NCT04170686|560389507|FG001|Randomization and Treatment|Lost to Follow-up|15|||
155261237|NCT04425902|560389510|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
155261238|NCT01191840|560389511|FG000|Overall Study|withdrew consent|2|||
155261239|NCT01191840|560389512|FG001|Overall Study|withdrew consent|1|||
155261240|NCT01191840|560389511|FG000|Overall Study|Subject discontinued treatment|1|||
155261241|NCT01191840|560389512|FG001|Overall Study|Subject discontinued treatment|2|||
155261242|NCT01191840|560389511|FG000|Overall Study|Lost to Follow-up|4|||
155261243|NCT01191840|560389512|FG001|Overall Study|Lost to Follow-up|6|||
155261244|NCT01191840|560389511|FG000|Overall Study|Non Staph Infection|4|||
155261245|NCT01191840|560389512|FG001|Overall Study|Non Staph Infection|3|||
155261246|NCT01191840|560389511|FG000|Overall Study|ineligible at enrollment|1|||
155261247|NCT01191840|560389512|FG001|Overall Study|ineligible at enrollment|0|||
155261248|NCT01191840|560389511|FG000|Overall Study|IRB approval lapse|0|||
155261249|NCT01191840|560389512|FG001|Overall Study|IRB approval lapse|2|||
155261250|NCT01191840|560389511|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
155261251|NCT01191840|560389512|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
155261252|NCT01191840|560389511|FG000|Overall Study|Withdrawal by Subject|2|||
155261253|NCT01191840|560389512|FG001|Overall Study|Withdrawal by Subject|0|||
155261254|NCT04669600|560389513|FG000|Overall Study|Withdrawal by Subject|1|||
155261255|NCT04669600|560389513|FG000|Overall Study|Other|6|||
155261256|NCT00331344|560389523|FG000|Phase I|Adverse Event|0|||
155261257|NCT00331344|560389524|FG001|Phase I|Adverse Event|0|||
155261258|NCT00331344|560389525|FG002|Phase I|Adverse Event|0|||
155261259|NCT00331344|560389526|FG003|Phase I|Adverse Event|1|||
155261260|NCT00331344|560389527|FG004|Phase I|Adverse Event|2|||
155261261|NCT00331344|560389528|FG005|Phase I|Adverse Event|2|||
155261262|NCT00331344|560389529|FG006|Phase I|Adverse Event|0|||
155261263|NCT00331344|560389530|FG007|Phase I|Adverse Event|1|||
155261264|NCT00331344|560389531|FG008|Phase I|Adverse Event|0|||
155261265|NCT00331344|560389523|FG000|Phase II|Death|0|||
155261266|NCT00331344|560389524|FG001|Phase II|Death|0|||
155261267|NCT00331344|560389525|FG002|Phase II|Death|0|||
155261268|NCT00331344|560389526|FG003|Phase II|Death|0|||
155261269|NCT00331344|560389527|FG004|Phase II|Death|0|||
155261270|NCT00331344|560389528|FG005|Phase II|Death|0|||
155261271|NCT00331344|560389529|FG006|Phase II|Death|0|||
155261272|NCT00331344|560389530|FG007|Phase II|Death|0|||
155261273|NCT00331344|560389531|FG008|Phase II|Death|4|||
155261274|NCT04538144|560389532|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
155261275|NCT04538144|560389533|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
155261276|NCT04538144|560389534|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
155261277|NCT04538144|560389535|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
155261278|NCT02228967|560389536|FG000|Overall Study|Lost to Follow-up|146|||
155261279|NCT02228967|560389537|FG001|Overall Study|Lost to Follow-up|142|||
155261280|NCT02228967|560389536|FG000|Overall Study|Withdrawal by Subject|13|||
155261281|NCT02228967|560389537|FG001|Overall Study|Withdrawal by Subject|18|||
155261282|NCT01264380|560389538|FG000|Period C|Disease Progression|0|||
155261283|NCT01264380|560389539|FG001|Period C|Disease Progression|0|||
155261284|NCT01264380|560389540|FG002|Period C|Disease Progression|4|||
155261285|NCT01264380|560389538|FG000|Period C|Death|0|||
155261286|NCT01264380|560389539|FG001|Period C|Death|0|||
155261287|NCT01264380|560389540|FG002|Period C|Death|2|||
155261288|NCT01264380|560389538|FG000|Period C|Follow-up for survival status|0|||
155261289|NCT01264380|560389539|FG001|Period C|Follow-up for survival status|0|||
155261290|NCT01264380|560389540|FG002|Period C|Follow-up for survival status|6|||
155261291|NCT01264380|560389538|FG000|Period C|Withdrawal by Subject|0|||
155261292|NCT01264380|560389539|FG001|Period C|Withdrawal by Subject|0|||
155261293|NCT01264380|560389540|FG002|Period C|Withdrawal by Subject|1|||
155261294|NCT01264380|560389538|FG000|Period C|Adverse Event|0|||
155261295|NCT01264380|560389539|FG001|Period C|Adverse Event|0|||
155261296|NCT01264380|560389540|FG002|Period C|Adverse Event|1|||
155261297|NCT04207840|560389542|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
155261298|NCT04207840|560389543|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
155261299|NCT04207840|560389544|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
155261300|NCT04207840|560389542|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
155261301|NCT04207840|560389543|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
155261302|NCT04207840|560389544|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
155261303|NCT03243422|560389545|FG000|Overall Study|Death|20|||
155261304|NCT03243422|560389546|FG001|Overall Study|Death|21|||
155261305|NCT03243422|560389545|FG000|Overall Study|Lost to Follow-up|9|||
155261306|NCT03243422|560389546|FG001|Overall Study|Lost to Follow-up|21|||
155261307|NCT03243422|560389545|FG000|Overall Study|Withdrawal by Subject|22|||
155261308|NCT03243422|560389546|FG001|Overall Study|Withdrawal by Subject|8|||
155261309|NCT02173054|560389547|FG000|Overall Study|lack of compliance|1|||
155261310|NCT02173054|560389548|FG001|Overall Study|lack of compliance|0|||
155261311|NCT02173054|560389549|FG002|Overall Study|lack of compliance|0|||
155261312|NCT02173054|560389547|FG000|Overall Study|Withdrawal by Subject|0|||
155261313|NCT02173054|560389548|FG001|Overall Study|Withdrawal by Subject|0|||
155261314|NCT02173054|560389549|FG002|Overall Study|Withdrawal by Subject|1|||
155261315|NCT01330316|560389550|FG000|Overall Study|Adverse Event|2|||
155261316|NCT01330316|560389551|FG001|Overall Study|Adverse Event|2|||
155261317|NCT01330316|560389550|FG000|Overall Study|Lack of Efficacy|0|||
155261318|NCT01330316|560389551|FG001|Overall Study|Lack of Efficacy|10|||
155261319|NCT01330316|560389550|FG000|Overall Study|Lost to Follow-up|0|||
155261320|NCT01330316|560389551|FG001|Overall Study|Lost to Follow-up|1|||
155261321|NCT01330316|560389550|FG000|Overall Study|Withdrawal by Subject|0|||
155261322|NCT01330316|560389551|FG001|Overall Study|Withdrawal by Subject|1|||
155261323|NCT01330316|560389550|FG000|Overall Study|other than above|0|||
155261324|NCT01330316|560389551|FG001|Overall Study|other than above|1|||
155261325|NCT01337986|560389554|FG000|Overall Study|Adverse Event|2|||
155261326|NCT01337986|560389555|FG001|Overall Study|Adverse Event|2|||
155261327|NCT01337986|560389554|FG000|Overall Study|Lost to Follow-up|1|||
155261328|NCT01337986|560389555|FG001|Overall Study|Lost to Follow-up|0|||
155261329|NCT01337986|560389554|FG000|Overall Study|Protocol Violation|0|||
155261330|NCT01337986|560389555|FG001|Overall Study|Protocol Violation|3|||
155261331|NCT01520402|560389557|FG000|Overall Study|Withdrawal by Subject|2|||
155261332|NCT01520402|560389557|FG000|Overall Study|Physician Decision|3|||
155261333|NCT02287584|560389558|FG000|the Double-blind Phase|Adverse Event|17|||
155261334|NCT02287584|560389559|FG001|the Double-blind Phase|Adverse Event|17|||
155261335|NCT02287584|560389560|FG002|the Double-blind Phase|Adverse Event|12|||
155261336|NCT02287584|560389561|FG003|the Double-blind Phase|Adverse Event|0|||
155261337|NCT02287584|560389562|FG004|the Double-blind Phase|Adverse Event|0|||
155261338|NCT02287584|560389563|FG005|the Double-blind Phase|Adverse Event|0|||
155261339|NCT02287584|560389558|FG000|the Double-blind Phase|Lack of Efficacy|18|||
155261340|NCT02287584|560389559|FG001|the Double-blind Phase|Lack of Efficacy|8|||
155261341|NCT02287584|560389560|FG002|the Double-blind Phase|Lack of Efficacy|8|||
155261342|NCT02287584|560389561|FG003|the Double-blind Phase|Lack of Efficacy|0|||
155261343|NCT02287584|560389562|FG004|the Double-blind Phase|Lack of Efficacy|0|||
155261344|NCT02287584|560389563|FG005|the Double-blind Phase|Lack of Efficacy|0|||
155261345|NCT02287584|560389558|FG000|the Double-blind Phase|Lost to Follow-up|0|||
155261346|NCT02287584|560389559|FG001|the Double-blind Phase|Lost to Follow-up|1|||
155261347|NCT02287584|560389560|FG002|the Double-blind Phase|Lost to Follow-up|1|||
155261348|NCT02287584|560389561|FG003|the Double-blind Phase|Lost to Follow-up|0|||
155261349|NCT02287584|560389562|FG004|the Double-blind Phase|Lost to Follow-up|0|||
155261350|NCT02287584|560389563|FG005|the Double-blind Phase|Lost to Follow-up|0|||
155261351|NCT02287584|560389558|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
155261352|NCT02287584|560389559|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
155261353|NCT02287584|560389560|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
155261354|NCT02287584|560389561|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
155261355|NCT02287584|560389562|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
155261356|NCT02287584|560389563|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
155261357|NCT02287584|560389558|FG000|the Double-blind Phase|Pregnancy|0|||
155261358|NCT02287584|560389559|FG001|the Double-blind Phase|Pregnancy|1|||
155261359|NCT02287584|560389560|FG002|the Double-blind Phase|Pregnancy|0|||
155261360|NCT02287584|560389561|FG003|the Double-blind Phase|Pregnancy|0|||
155261361|NCT02287584|560389562|FG004|the Double-blind Phase|Pregnancy|0|||
155261362|NCT02287584|560389563|FG005|the Double-blind Phase|Pregnancy|0|||
155261363|NCT02287584|560389558|FG000|the Double-blind Phase|Protocol Violation|0|||
155261364|NCT02287584|560389559|FG001|the Double-blind Phase|Protocol Violation|3|||
155261365|NCT02287584|560389560|FG002|the Double-blind Phase|Protocol Violation|0|||
155261366|NCT02287584|560389561|FG003|the Double-blind Phase|Protocol Violation|0|||
155261367|NCT02287584|560389562|FG004|the Double-blind Phase|Protocol Violation|0|||
155261368|NCT02287584|560389563|FG005|the Double-blind Phase|Protocol Violation|0|||
155261369|NCT02287584|560389558|FG000|the Double-blind Phase|other reasons|0|||
155261370|NCT02287584|560389559|FG001|the Double-blind Phase|other reasons|0|||
155261371|NCT02287584|560389560|FG002|the Double-blind Phase|other reasons|1|||
155261372|NCT02287584|560389561|FG003|the Double-blind Phase|other reasons|0|||
155261373|NCT02287584|560389562|FG004|the Double-blind Phase|other reasons|0|||
155261374|NCT02287584|560389563|FG005|the Double-blind Phase|other reasons|0|||
155261375|NCT02287584|560389558|FG000|the Open-label Phase|Did not receive drug|0|||
155261376|NCT02287584|560389559|FG001|the Open-label Phase|Did not receive drug|0|||
155261377|NCT02287584|560389560|FG002|the Open-label Phase|Did not receive drug|0|||
155261378|NCT02287584|560389561|FG003|the Open-label Phase|Did not receive drug|7|||
155261379|NCT02287584|560389562|FG004|the Open-label Phase|Did not receive drug|6|||
155261380|NCT02287584|560389563|FG005|the Open-label Phase|Did not receive drug|4|||
155261381|NCT02287584|560389558|FG000|the Open-label Phase|Adverse Event|0|||
155261382|NCT02287584|560389559|FG001|the Open-label Phase|Adverse Event|0|||
155261383|NCT02287584|560389560|FG002|the Open-label Phase|Adverse Event|0|||
155261384|NCT02287584|560389561|FG003|the Open-label Phase|Adverse Event|15|||
155261385|NCT02287584|560389562|FG004|the Open-label Phase|Adverse Event|12|||
155261386|NCT02287584|560389563|FG005|the Open-label Phase|Adverse Event|16|||
155261387|NCT02287584|560389558|FG000|the Open-label Phase|Lack of Efficacy|0|||
155261388|NCT02287584|560389559|FG001|the Open-label Phase|Lack of Efficacy|0|||
155261389|NCT02287584|560389560|FG002|the Open-label Phase|Lack of Efficacy|0|||
155261390|NCT02287584|560389561|FG003|the Open-label Phase|Lack of Efficacy|8|||
155261391|NCT02287584|560389562|FG004|the Open-label Phase|Lack of Efficacy|3|||
155261392|NCT02287584|560389563|FG005|the Open-label Phase|Lack of Efficacy|7|||
155261393|NCT02287584|560389558|FG000|the Open-label Phase|Lost to Follow-up|0|||
155261394|NCT02287584|560389559|FG001|the Open-label Phase|Lost to Follow-up|0|||
155261395|NCT02287584|560389560|FG002|the Open-label Phase|Lost to Follow-up|0|||
155261396|NCT02287584|560389561|FG003|the Open-label Phase|Lost to Follow-up|4|||
155261397|NCT02287584|560389562|FG004|the Open-label Phase|Lost to Follow-up|1|||
155261398|NCT02287584|560389563|FG005|the Open-label Phase|Lost to Follow-up|2|||
155261399|NCT02287584|560389558|FG000|the Open-label Phase|Withdrawal by Subject|0|||
155261400|NCT02287584|560389559|FG001|the Open-label Phase|Withdrawal by Subject|0|||
155261401|NCT02287584|560389560|FG002|the Open-label Phase|Withdrawal by Subject|0|||
155261402|NCT02287584|560389561|FG003|the Open-label Phase|Withdrawal by Subject|18|||
155261403|NCT02287584|560389562|FG004|the Open-label Phase|Withdrawal by Subject|29|||
155261404|NCT02287584|560389563|FG005|the Open-label Phase|Withdrawal by Subject|21|||
155261405|NCT02287584|560389558|FG000|the Open-label Phase|non-compliance|0|||
155261406|NCT02287584|560389559|FG001|the Open-label Phase|non-compliance|0|||
155261407|NCT02287584|560389560|FG002|the Open-label Phase|non-compliance|0|||
155261408|NCT02287584|560389561|FG003|the Open-label Phase|non-compliance|2|||
155261409|NCT02287584|560389562|FG004|the Open-label Phase|non-compliance|5|||
155261410|NCT02287584|560389563|FG005|the Open-label Phase|non-compliance|1|||
155261411|NCT02287584|560389558|FG000|the Open-label Phase|other reasons|0|||
155261412|NCT02287584|560389559|FG001|the Open-label Phase|other reasons|0|||
155261413|NCT02287584|560389560|FG002|the Open-label Phase|other reasons|0|||
155261414|NCT02287584|560389561|FG003|the Open-label Phase|other reasons|3|||
155261415|NCT02287584|560389562|FG004|the Open-label Phase|other reasons|6|||
155261416|NCT02287584|560389563|FG005|the Open-label Phase|other reasons|6|||
155261417|NCT03430063|560389567|FG000|Overall Study|Adverse Event|0|||
155261418|NCT03430063|560389568|FG001|Overall Study|Adverse Event|1|||
155261419|NCT03430063|560389569|FG002|Overall Study|Adverse Event|0|||
155261420|NCT03430063|560389567|FG000|Overall Study|Death|3|||
155261421|NCT03430063|560389568|FG001|Overall Study|Death|2|||
155261422|NCT03430063|560389569|FG002|Overall Study|Death|3|||
155261423|NCT03430063|560389567|FG000|Overall Study|Lost to Follow-up|0|||
155261424|NCT03430063|560389568|FG001|Overall Study|Lost to Follow-up|1|||
155261425|NCT03430063|560389569|FG002|Overall Study|Lost to Follow-up|0|||
155261426|NCT03430063|560389567|FG000|Overall Study|Withdrawal by Subject|0|||
155261427|NCT03430063|560389568|FG001|Overall Study|Withdrawal by Subject|0|||
155261428|NCT03430063|560389569|FG002|Overall Study|Withdrawal by Subject|1|||
155261429|NCT03430063|560389567|FG000|Overall Study|Withdrawal of consent|3|||
155261430|NCT03430063|560389568|FG001|Overall Study|Withdrawal of consent|1|||
155261431|NCT03430063|560389569|FG002|Overall Study|Withdrawal of consent|2|||
155261432|NCT03430063|560389567|FG000|Overall Study|Progressive disease|1|||
155261433|NCT03430063|560389568|FG001|Overall Study|Progressive disease|2|||
155261434|NCT03430063|560389569|FG002|Overall Study|Progressive disease|1|||
155261435|NCT03430063|560389567|FG000|Overall Study|Other un-specified|1|||
155261436|NCT03430063|560389568|FG001|Overall Study|Other un-specified|1|||
155261437|NCT03430063|560389569|FG002|Overall Study|Other un-specified|0|||
155261438|NCT03430063|560389567|FG000|Overall Study|Randomized, but never treated|0|||
155261439|NCT03430063|560389568|FG001|Overall Study|Randomized, but never treated|0|||
155261440|NCT03430063|560389569|FG002|Overall Study|Randomized, but never treated|1|||
155261441|NCT03124199|560389570|FG000|Overall Study|Lost to Follow-up|4|||
155261442|NCT03086018|560389571|FG000|Final Testing for End of Trial|Adverse Event|1|||
155261443|NCT03086018|560389571|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
155261444|NCT01892345|560389572|FG000|Overall Study|Adverse Event|0|||
155261445|NCT01892345|560389573|FG001|Overall Study|Adverse Event|2|||
155261446|NCT01892345|560389572|FG000|Overall Study|Death|1|||
155261447|NCT01892345|560389573|FG001|Overall Study|Death|0|||
155261448|NCT01892345|560389572|FG000|Overall Study|Lost to Follow-up|3|||
155261449|NCT01892345|560389573|FG001|Overall Study|Lost to Follow-up|0|||
155261450|NCT01892345|560389572|FG000|Overall Study|Withdrawal by Subject|12|||
155261451|NCT01892345|560389573|FG001|Overall Study|Withdrawal by Subject|1|||
155261452|NCT00621543|560389577|FG000|Overall Study|Lost to Follow-up|23|||
155261453|NCT02192970|560389578|FG000|Overall Study|Lost to Follow-up|6|||
155261454|NCT02192970|560389579|FG001|Overall Study|Lost to Follow-up|0|||
155261455|NCT03745222|560389580|FG000|Overall Study|Withdrawal by Subject|0|||
155261456|NCT03745222|560389581|FG001|Overall Study|Withdrawal by Subject|1|||
155261457|NCT03745222|560389582|FG002|Overall Study|Withdrawal by Subject|0|||
155261458|NCT00792103|560389583|FG000|Overall Study|Enrolled, not treated|15|||
155261459|NCT00792103|560389583|FG000|Overall Study|Lost to Follow-up|17|||
155261460|NCT00792103|560389583|FG000|Overall Study|Adverse Event|25|||
155261461|NCT00792103|560389583|FG000|Overall Study|Withdrawal by Subject|52|||
155261462|NCT00792103|560389583|FG000|Overall Study|Protocol Violation|10|||
155261463|NCT00792103|560389583|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
155261464|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
155261465|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
155261466|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
155261467|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
155261468|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
155261469|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
155261470|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
155261471|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
155261472|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
155261473|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
155261474|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
155261475|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
155261476|NCT04711603|560389584|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
155261477|NCT04711603|560389585|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
155261478|NCT04711603|560389586|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
155261479|NCT04711603|560389587|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
155261480|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
155261481|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
155261482|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
155261483|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
155261484|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
155261485|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
155261486|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
155261487|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
155261488|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
155261489|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
155261490|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
155261491|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
155261492|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
155261493|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
155261494|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
155261495|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
155261496|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
155261497|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
155261498|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
155261499|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
155261500|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
155261501|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
155261502|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
155261503|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
155261504|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
155261505|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
155261506|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
155261507|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
155261508|NCT04711603|560389584|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
155261509|NCT04711603|560389585|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
155261510|NCT04711603|560389586|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
155261511|NCT04711603|560389587|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
155261512|NCT05479604|560389588|FG000|Overall Study|Lost to Follow-up|1|||
155261513|NCT05479604|560389589|FG001|Overall Study|Lost to Follow-up|5|||
155261514|NCT01591382|560389590|FG000|Overall Study|Discharged Prior to Study Completion|2|||
155261515|NCT01591382|560389591|FG001|Overall Study|Discharged Prior to Study Completion|1|||
155261516|NCT01591382|560389590|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
155261517|NCT01591382|560389591|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
155261518|NCT04252742|560389593|FG000|Overall Study|Decision by sponsor|0|||
155261519|NCT04252742|560389594|FG001|Overall Study|Decision by sponsor|2|||
155261520|NCT04252742|560389593|FG000|Overall Study|Withdrawal by Subject|15|||
155261521|NCT04252742|560389594|FG001|Overall Study|Withdrawal by Subject|9|||
155261522|NCT04252742|560389593|FG000|Overall Study|Lost to Follow-up|0|||
155261523|NCT04252742|560389594|FG001|Overall Study|Lost to Follow-up|1|||
155261524|NCT02068495|560389601|FG000|Overall Study|Case Report Forms Uncollected|60|||
155261525|NCT02068495|560389601|FG000|Overall Study|Protocol Deviation|49|||
155261526|NCT01666808|560389604|FG000|Overall Study|Lost to Follow-up|9|||
155261527|NCT01666808|560389605|FG001|Overall Study|Lost to Follow-up|15|||
155261528|NCT01666808|560389604|FG000|Overall Study|Withdrawal by Subject|3|||
155261529|NCT01666808|560389605|FG001|Overall Study|Withdrawal by Subject|1|||
155261530|NCT01666808|560389604|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
155261531|NCT01666808|560389605|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
155261532|NCT02220894|560389609|FG000|Overall Study|Adverse Event|127|||
155261533|NCT02220894|560389610|FG001|Overall Study|Adverse Event|74|||
155261534|NCT02220894|560389609|FG000|Overall Study|Death|418|||
155261535|NCT02220894|560389610|FG001|Overall Study|Death|508|||
155261536|NCT02220894|560389609|FG000|Overall Study|Lost to Follow-up|0|||
155261537|NCT02220894|560389610|FG001|Overall Study|Lost to Follow-up|4|||
155261538|NCT02220894|560389609|FG000|Overall Study|Site Terminated by Sponsor|2|||
155261539|NCT02220894|560389610|FG001|Overall Study|Site Terminated by Sponsor|0|||
155261540|NCT02220894|560389609|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
155261541|NCT02220894|560389610|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
155261542|NCT02220894|560389609|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
155261543|NCT02220894|560389610|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
155261544|NCT02220894|560389609|FG000|Overall Study|Withdrawal by Subject|10|||
155261545|NCT02220894|560389610|FG001|Overall Study|Withdrawal by Subject|9|||
155261546|NCT03217747|560389611|FG000|Overall Study|Adverse Event|0|||
155261547|NCT03217747|560389612|FG001|Overall Study|Adverse Event|1|||
155261548|NCT03217747|560389613|FG002|Overall Study|Adverse Event|0|||
155261549|NCT03217747|560389614|FG003|Overall Study|Adverse Event|0|||
155261550|NCT03217747|560389615|FG004|Overall Study|Adverse Event|0|||
155261551|NCT03217747|560389616|FG005|Overall Study|Adverse Event|0|||
155261552|NCT03217747|560389617|FG006|Overall Study|Adverse Event|0|||
155261553|NCT03217747|560389618|FG007|Overall Study|Adverse Event|0|||
155261554|NCT03217747|560389619|FG008|Overall Study|Adverse Event|0|||
155261555|NCT03217747|560389620|FG009|Overall Study|Adverse Event|0|||
155261556|NCT03217747|560389621|FG010|Overall Study|Adverse Event|0|||
155261557|NCT03217747|560389622|FG011|Overall Study|Adverse Event|0|||
155261558|NCT03217747|560389623|FG012|Overall Study|Adverse Event|1|||
155261559|NCT03217747|560389624|FG013|Overall Study|Adverse Event|1|||
155261560|NCT03217747|560389611|FG000|Overall Study|Death|0|||
155261561|NCT03217747|560389612|FG001|Overall Study|Death|0|||
155261562|NCT03217747|560389613|FG002|Overall Study|Death|0|||
155261563|NCT03217747|560389614|FG003|Overall Study|Death|0|||
155261564|NCT03217747|560389615|FG004|Overall Study|Death|0|||
155261565|NCT03217747|560389616|FG005|Overall Study|Death|0|||
155261566|NCT03217747|560389617|FG006|Overall Study|Death|0|||
155261567|NCT03217747|560389618|FG007|Overall Study|Death|0|||
155261568|NCT03217747|560389619|FG008|Overall Study|Death|1|||
155261569|NCT03217747|560389620|FG009|Overall Study|Death|0|||
155261570|NCT03217747|560389621|FG010|Overall Study|Death|0|||
155261571|NCT03217747|560389622|FG011|Overall Study|Death|0|||
155261572|NCT03217747|560389623|FG012|Overall Study|Death|0|||
155261573|NCT03217747|560389624|FG013|Overall Study|Death|0|||
155261574|NCT03217747|560389611|FG000|Overall Study|Lack of Efficacy|12|||
155261575|NCT03217747|560389612|FG001|Overall Study|Lack of Efficacy|6|||
155261576|NCT03217747|560389613|FG002|Overall Study|Lack of Efficacy|15|||
155261577|NCT03217747|560389614|FG003|Overall Study|Lack of Efficacy|11|||
155261578|NCT03217747|560389615|FG004|Overall Study|Lack of Efficacy|3|||
155261579|NCT03217747|560389616|FG005|Overall Study|Lack of Efficacy|14|||
155261580|NCT03217747|560389617|FG006|Overall Study|Lack of Efficacy|10|||
155261581|NCT03217747|560389618|FG007|Overall Study|Lack of Efficacy|4|||
155261582|NCT03217747|560389619|FG008|Overall Study|Lack of Efficacy|2|||
155261583|NCT03217747|560389620|FG009|Overall Study|Lack of Efficacy|7|||
155261584|NCT03217747|560389621|FG010|Overall Study|Lack of Efficacy|3|||
155261585|NCT03217747|560389622|FG011|Overall Study|Lack of Efficacy|1|||
155261586|NCT03217747|560389623|FG012|Overall Study|Lack of Efficacy|3|||
155261587|NCT03217747|560389624|FG013|Overall Study|Lack of Efficacy|1|||
155261588|NCT03217747|560389611|FG000|Overall Study|Withdrawal by Subject|2|||
155261589|NCT03217747|560389612|FG001|Overall Study|Withdrawal by Subject|1|||
155261590|NCT03217747|560389613|FG002|Overall Study|Withdrawal by Subject|1|||
155261591|NCT03217747|560389614|FG003|Overall Study|Withdrawal by Subject|1|||
155261592|NCT03217747|560389615|FG004|Overall Study|Withdrawal by Subject|1|||
155261593|NCT03217747|560389616|FG005|Overall Study|Withdrawal by Subject|2|||
155261594|NCT03217747|560389617|FG006|Overall Study|Withdrawal by Subject|1|||
155261595|NCT03217747|560389618|FG007|Overall Study|Withdrawal by Subject|0|||
155261596|NCT03217747|560389619|FG008|Overall Study|Withdrawal by Subject|0|||
155261597|NCT03217747|560389620|FG009|Overall Study|Withdrawal by Subject|0|||
155261598|NCT03217747|560389621|FG010|Overall Study|Withdrawal by Subject|0|||
155261599|NCT03217747|560389622|FG011|Overall Study|Withdrawal by Subject|1|||
155261600|NCT03217747|560389623|FG012|Overall Study|Withdrawal by Subject|0|||
155261601|NCT03217747|560389624|FG013|Overall Study|Withdrawal by Subject|1|||
155261602|NCT03217747|560389611|FG000|Overall Study|Toxicity and progression|1|||
155261603|NCT03217747|560389612|FG001|Overall Study|Toxicity and progression|0|||
155261604|NCT03217747|560389613|FG002|Overall Study|Toxicity and progression|0|||
155261605|NCT03217747|560389614|FG003|Overall Study|Toxicity and progression|0|||
155261606|NCT03217747|560389615|FG004|Overall Study|Toxicity and progression|0|||
155261607|NCT03217747|560389616|FG005|Overall Study|Toxicity and progression|0|||
155261608|NCT03217747|560389617|FG006|Overall Study|Toxicity and progression|0|||
155261609|NCT03217747|560389618|FG007|Overall Study|Toxicity and progression|0|||
155261610|NCT03217747|560389619|FG008|Overall Study|Toxicity and progression|0|||
155261611|NCT03217747|560389620|FG009|Overall Study|Toxicity and progression|0|||
155261612|NCT03217747|560389621|FG010|Overall Study|Toxicity and progression|0|||
155261613|NCT03217747|560389622|FG011|Overall Study|Toxicity and progression|0|||
155261614|NCT03217747|560389623|FG012|Overall Study|Toxicity and progression|0|||
155261615|NCT03217747|560389624|FG013|Overall Study|Toxicity and progression|0|||
155261616|NCT03217747|560389611|FG000|Overall Study|Removal of sole target lesion|1|||
155261617|NCT03217747|560389612|FG001|Overall Study|Removal of sole target lesion|0|||
155261618|NCT03217747|560389613|FG002|Overall Study|Removal of sole target lesion|0|||
155261619|NCT03217747|560389614|FG003|Overall Study|Removal of sole target lesion|0|||
155261620|NCT03217747|560389615|FG004|Overall Study|Removal of sole target lesion|0|||
155261621|NCT03217747|560389616|FG005|Overall Study|Removal of sole target lesion|0|||
155261622|NCT03217747|560389617|FG006|Overall Study|Removal of sole target lesion|0|||
155261623|NCT03217747|560389618|FG007|Overall Study|Removal of sole target lesion|0|||
155261624|NCT03217747|560389619|FG008|Overall Study|Removal of sole target lesion|0|||
155261625|NCT03217747|560389620|FG009|Overall Study|Removal of sole target lesion|0|||
155261626|NCT03217747|560389621|FG010|Overall Study|Removal of sole target lesion|0|||
155261627|NCT03217747|560389622|FG011|Overall Study|Removal of sole target lesion|0|||
155261628|NCT03217747|560389623|FG012|Overall Study|Removal of sole target lesion|0|||
155261629|NCT03217747|560389624|FG013|Overall Study|Removal of sole target lesion|0|||
155261630|NCT03217747|560389611|FG000|Overall Study|Stroke|0|||
155261631|NCT03217747|560389612|FG001|Overall Study|Stroke|0|||
155261632|NCT03217747|560389613|FG002|Overall Study|Stroke|0|||
155261633|NCT03217747|560389614|FG003|Overall Study|Stroke|0|||
155261634|NCT03217747|560389615|FG004|Overall Study|Stroke|0|||
155261635|NCT03217747|560389616|FG005|Overall Study|Stroke|1|||
155261636|NCT03217747|560389617|FG006|Overall Study|Stroke|0|||
155261637|NCT03217747|560389618|FG007|Overall Study|Stroke|0|||
155261638|NCT03217747|560389619|FG008|Overall Study|Stroke|0|||
155261639|NCT03217747|560389620|FG009|Overall Study|Stroke|0|||
155261640|NCT03217747|560389621|FG010|Overall Study|Stroke|0|||
155261641|NCT03217747|560389622|FG011|Overall Study|Stroke|1|||
155261642|NCT03217747|560389623|FG012|Overall Study|Stroke|0|||
155261643|NCT03217747|560389624|FG013|Overall Study|Stroke|0|||
155261644|NCT03996291|560389625|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
155261645|NCT03996291|560389626|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
155261646|NCT03996291|560389627|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
155261647|NCT03996291|560389628|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
155261648|NCT03996291|560389629|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
155261649|NCT03996291|560389630|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
155261650|NCT03996291|560389631|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
155261651|NCT03996291|560389632|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
155261652|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261653|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261654|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261655|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261656|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261657|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
155261658|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
155261659|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
155261660|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261661|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261662|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261663|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261664|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
155261665|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261666|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
155261667|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
155261668|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
155261669|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
155261670|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
155261671|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
155261672|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
155261673|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
155261674|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
155261675|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
155261676|NCT03996291|560389625|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261677|NCT03996291|560389626|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261678|NCT03996291|560389627|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261679|NCT03996291|560389628|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261680|NCT03996291|560389629|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
155261681|NCT03996291|560389630|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261682|NCT03996291|560389631|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261683|NCT03996291|560389632|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
155261684|NCT04098250|560389635|FG000|Overall Study|Withdrawal by Subject|1|||
155261685|NCT04098250|560389636|FG001|Overall Study|Withdrawal by Subject|0|||
155261686|NCT04098250|560389635|FG000|Overall Study|Lost to Follow-up|0|||
155261687|NCT04098250|560389636|FG001|Overall Study|Lost to Follow-up|1|||
155261688|NCT00394355|560389637|FG000|Overall Study|Adverse Event|10|||
155261689|NCT00394355|560389638|FG001|Overall Study|Adverse Event|6|||
155261690|NCT00394355|560389639|FG002|Overall Study|Adverse Event|7|||
155261691|NCT00394355|560389640|FG003|Overall Study|Adverse Event|8|||
155261692|NCT00394355|560389637|FG000|Overall Study|Did not meet protocol eligibility|1|||
155261693|NCT00394355|560389638|FG001|Overall Study|Did not meet protocol eligibility|5|||
155261694|NCT00394355|560389639|FG002|Overall Study|Did not meet protocol eligibility|4|||
155261695|NCT00394355|560389640|FG003|Overall Study|Did not meet protocol eligibility|2|||
155261696|NCT00394355|560389637|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
155261697|NCT00394355|560389638|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
155261698|NCT00394355|560389639|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
155261699|NCT00394355|560389640|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
155261700|NCT00394355|560389637|FG000|Overall Study|Subject withdrawal - related to drug|1|||
155261701|NCT00394355|560389638|FG001|Overall Study|Subject withdrawal - related to drug|0|||
155261702|NCT00394355|560389639|FG002|Overall Study|Subject withdrawal - related to drug|0|||
155261703|NCT00394355|560389640|FG003|Overall Study|Subject withdrawal - related to drug|0|||
155261704|NCT00394355|560389637|FG000|Overall Study|Lost to Follow-up|7|||
155261705|NCT00394355|560389638|FG001|Overall Study|Lost to Follow-up|5|||
155261706|NCT00394355|560389639|FG002|Overall Study|Lost to Follow-up|4|||
155261707|NCT00394355|560389640|FG003|Overall Study|Lost to Follow-up|3|||
155261708|NCT00394355|560389637|FG000|Overall Study|Noncompliance with protocol|4|||
155261709|NCT00394355|560389638|FG001|Overall Study|Noncompliance with protocol|3|||
155261710|NCT00394355|560389639|FG002|Overall Study|Noncompliance with protocol|10|||
155261711|NCT00394355|560389640|FG003|Overall Study|Noncompliance with protocol|8|||
155261712|NCT00394355|560389637|FG000|Overall Study|Administrative|0|||
155261713|NCT00394355|560389638|FG001|Overall Study|Administrative|1|||
155261714|NCT00394355|560389639|FG002|Overall Study|Administrative|1|||
155261715|NCT00394355|560389640|FG003|Overall Study|Administrative|1|||
155261716|NCT00394355|560389637|FG000|Overall Study|Lack of Efficacy|0|||
155261717|NCT00394355|560389638|FG001|Overall Study|Lack of Efficacy|0|||
155261718|NCT00394355|560389639|FG002|Overall Study|Lack of Efficacy|2|||
155261719|NCT00394355|560389640|FG003|Overall Study|Lack of Efficacy|3|||
155261720|NCT02612064|560389644|FG000|Overall Study|Withdrawal by Subject|1|||
155261721|NCT02612064|560389645|FG001|Overall Study|Withdrawal by Subject|1|||
155261722|NCT02612064|560389644|FG000|Overall Study|Other|0|||
155261723|NCT02612064|560389645|FG001|Overall Study|Other|2|||
155261724|NCT00284141|560390718|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
155261725|NCT00284141|560390718|FG000|Overall Study|Adverse Event|19|||
155261726|NCT00284141|560390718|FG000|Overall Study|Participant's request|9|||
155261727|NCT00284141|560390718|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
155261728|NCT00284141|560390718|FG000|Overall Study|Clinical deterioration / death|2|||
155261729|NCT00284141|560390718|FG000|Overall Study|General decline|1|||
155261730|NCT00284141|560390718|FG000|Overall Study|Pneumonia|1|||
155261731|NCT00284141|560390718|FG000|Overall Study|Did not take study medication|2|||
155261732|NCT00284141|560390718|FG000|Overall Study|Ongoing treatment|2|||
155261733|NCT01995539|560390720|FG000|Overall Study|Screening Failure|1|||
155261734|NCT01995539|560390720|FG000|Overall Study|Withdrawal by Investigator|15|||
155261735|NCT01995539|560390720|FG000|Overall Study|Withdrawal by Subject|11|||
155261736|NCT01995539|560390720|FG000|Overall Study|Lost to Follow-up|5|||
155261737|NCT01995539|560390720|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
155261738|NCT03474107|560390723|FG000|Overall Study|Adverse Event|42|||
155261739|NCT03474107|560390724|FG001|Overall Study|Adverse Event|46|||
155261740|NCT03474107|560390723|FG000|Overall Study|Death|2|||
155261741|NCT03474107|560390724|FG001|Overall Study|Death|2|||
155261742|NCT03474107|560390723|FG000|Overall Study|Lost to Follow-up|0|||
155261743|NCT03474107|560390724|FG001|Overall Study|Lost to Follow-up|1|||
155261744|NCT03474107|560390723|FG000|Overall Study|Progressive Disease|177|||
155261745|NCT03474107|560390724|FG001|Overall Study|Progressive Disease|180|||
155261746|NCT03474107|560390723|FG000|Overall Study|Protocol Violation|1|||
155261747|NCT03474107|560390724|FG001|Overall Study|Protocol Violation|1|||
155261748|NCT03474107|560390723|FG000|Overall Study|Withdrawal by Subject|15|||
155261749|NCT03474107|560390724|FG001|Overall Study|Withdrawal by Subject|27|||
155261750|NCT03474107|560390723|FG000|Overall Study|Physician Decision|7|||
155261751|NCT03474107|560390724|FG001|Overall Study|Physician Decision|22|||
155261752|NCT03474107|560390723|FG000|Overall Study|Miscellaneous|1|||
155261753|NCT03474107|560390724|FG001|Overall Study|Miscellaneous|6|||
155261754|NCT00659984|560390728|FG000|Overall Study|Adverse Event|1|||
155261755|NCT02487810|560390729|FG000|Overall Study|Withdrawal by Subject|1|||
155261756|NCT02487810|560390730|FG001|Overall Study|Withdrawal by Subject|0|||
155261757|NCT01287611|560390732|FG000|Overall Study|Lost to Follow-up|29|||
155261758|NCT01287611|560390733|FG001|Overall Study|Lost to Follow-up|16|||
155261759|NCT01287611|560390732|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
155261760|NCT01287611|560390733|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
155261761|NCT00763958|560390734|FG000|Overall Study|did not meet final criteria|4|||
155261762|NCT00763958|560390735|FG001|Overall Study|did not meet final criteria|4|||
155261763|NCT00763958|560390734|FG000|Overall Study|Lost to Follow-up|10|||
155261764|NCT00763958|560390735|FG001|Overall Study|Lost to Follow-up|2|||
155261765|NCT00763958|560390734|FG000|Overall Study|Believed they were receiving placebo|0|||
155261766|NCT00763958|560390735|FG001|Overall Study|Believed they were receiving placebo|5|||
155261767|NCT04074590|560390736|FG000|Overall Study|Adverse Event|1|||
155261768|NCT04074590|560390737|FG001|Overall Study|Adverse Event|0|||
155261769|NCT04074590|560390736|FG000|Overall Study|Physician Decision|1|||
155261770|NCT04074590|560390737|FG001|Overall Study|Physician Decision|0|||
155261771|NCT04074590|560390736|FG000|Overall Study|Withdrawal by Subject|2|||
155261772|NCT04074590|560390737|FG001|Overall Study|Withdrawal by Subject|0|||
155261773|NCT01281202|560390740|FG000|Overall Study|Adverse Event|2|||
155261774|NCT01281202|560390741|FG001|Overall Study|Adverse Event|0|||
155261775|NCT01281202|560390740|FG000|Overall Study|Withdrawal by Subject|2|||
155261776|NCT01281202|560390741|FG001|Overall Study|Withdrawal by Subject|2|||
155261777|NCT01281202|560390740|FG000|Overall Study|Protocol Violation|11|||
155261778|NCT01281202|560390741|FG001|Overall Study|Protocol Violation|10|||
155261779|NCT01281202|560390740|FG000|Overall Study|Administrative|2|||
155261780|NCT01281202|560390741|FG001|Overall Study|Administrative|8|||
155261781|NCT01281202|560390740|FG000|Overall Study|Lost to Follow-up|11|||
155261782|NCT01281202|560390741|FG001|Overall Study|Lost to Follow-up|13|||
155261783|NCT01281202|560390740|FG000|Overall Study|Incarceration|0|||
155261784|NCT01281202|560390741|FG001|Overall Study|Incarceration|3|||
155261785|NCT04581200|560390742|FG000|Overall Study|Lost to Follow-up|6|||
155261786|NCT04581200|560390743|FG001|Overall Study|Lost to Follow-up|5|||
155261787|NCT03131960|560390744|FG000|Overall Study|Adverse Event|0|||
155261788|NCT03131960|560390745|FG001|Overall Study|Adverse Event|1|||
155261789|NCT04359784|560390749|FG000|Overall Study|Death|2|||
155261790|NCT02063828|560390753|FG000|Overall Study|Withdrawal by Subject|4|||
155261791|NCT02063828|560390754|FG001|Overall Study|Withdrawal by Subject|6|||
155261792|NCT02063828|560390755|FG002|Overall Study|Withdrawal by Subject|3|||
155261793|NCT02063828|560390753|FG000|Overall Study|Death|0|||
155261794|NCT02063828|560390754|FG001|Overall Study|Death|0|||
155261795|NCT02063828|560390755|FG002|Overall Study|Death|1|||
155261796|NCT02753595|560390756|FG000|Overall Study|Sponsor termination|2|||
155261797|NCT02753595|560390757|FG001|Overall Study|Sponsor termination|2|||
155261798|NCT01064297|560390761|FG000|Overall Study|Lost to Follow-up|791|||
155261799|NCT01064297|560390762|FG001|Overall Study|Lost to Follow-up|48|||
155261800|NCT01064297|560390763|FG002|Overall Study|Lost to Follow-up|133|||
155261801|NCT00504426|560390766|FG000|Overall Study|Adverse Event|0|||
155261802|NCT00504426|560390767|FG001|Overall Study|Adverse Event|0|||
155261803|NCT00504426|560390768|FG002|Overall Study|Adverse Event|2|||
155261804|NCT00504426|560390769|FG003|Overall Study|Adverse Event|0|||
155261805|NCT00504426|560390766|FG000|Overall Study|Protocol Violation|1|||
155261806|NCT00504426|560390767|FG001|Overall Study|Protocol Violation|1|||
155261807|NCT00504426|560390768|FG002|Overall Study|Protocol Violation|2|||
155261808|NCT00504426|560390769|FG003|Overall Study|Protocol Violation|0|||
155261809|NCT00504426|560390766|FG000|Overall Study|Withdrawal by Subject|2|||
155261810|NCT00504426|560390767|FG001|Overall Study|Withdrawal by Subject|0|||
155261811|NCT00504426|560390768|FG002|Overall Study|Withdrawal by Subject|0|||
155261812|NCT00504426|560390769|FG003|Overall Study|Withdrawal by Subject|0|||
155261813|NCT03248375|560390772|FG000|Overall Study|Lost to Follow-up|5|||
155261814|NCT00633464|560390777|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
155261815|NCT00633464|560390778|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
155261816|NCT00633464|560390777|FG000|Overall Study|Never Treated (Randomized in error)|0|||
155261817|NCT00633464|560390778|FG001|Overall Study|Never Treated (Randomized in error)|1|||
155261818|NCT00717860|560390779|FG000|Overall Study|Clinical adverse experience|5|||
155261819|NCT00717860|560390780|FG001|Overall Study|Clinical adverse experience|9|||
155261820|NCT00717860|560390779|FG000|Overall Study|Laboratory adverse experience|2|||
155261821|NCT00717860|560390780|FG001|Overall Study|Laboratory adverse experience|2|||
155261822|NCT00717860|560390779|FG000|Overall Study|Lack of Efficacy|7|||
155261823|NCT00717860|560390780|FG001|Overall Study|Lack of Efficacy|13|||
155261824|NCT00717860|560390779|FG000|Overall Study|Discontinued for other reason|6|||
155261825|NCT00717860|560390780|FG001|Overall Study|Discontinued for other reason|1|||
155261826|NCT00717860|560390779|FG000|Overall Study|Withdrew consent|7|||
155261827|NCT00717860|560390780|FG001|Overall Study|Withdrew consent|3|||
155261828|NCT00698646|560390784|FG000|Overall Study|Adverse Event|8|||
155261829|NCT00698646|560390785|FG001|Overall Study|Adverse Event|7|||
155261830|NCT00698646|560390786|FG002|Overall Study|Adverse Event|8|||
155261831|NCT00698646|560390784|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
155261832|NCT00698646|560390785|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
155261833|NCT00698646|560390786|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
155261834|NCT00698646|560390784|FG000|Overall Study|Protocol Deviation|6|||
155261835|NCT00698646|560390785|FG001|Overall Study|Protocol Deviation|2|||
155261836|NCT00698646|560390786|FG002|Overall Study|Protocol Deviation|3|||
155261837|NCT00698646|560390784|FG000|Overall Study|Withdrawal by Subject|10|||
155261838|NCT00698646|560390785|FG001|Overall Study|Withdrawal by Subject|11|||
155261839|NCT00698646|560390786|FG002|Overall Study|Withdrawal by Subject|8|||
155261840|NCT00698646|560390784|FG000|Overall Study|Lost to Follow-up|0|||
155261841|NCT00698646|560390785|FG001|Overall Study|Lost to Follow-up|0|||
155261842|NCT00698646|560390786|FG002|Overall Study|Lost to Follow-up|2|||
155261843|NCT00698646|560390784|FG000|Overall Study|Administrative problems|1|||
155261844|NCT00698646|560390785|FG001|Overall Study|Administrative problems|0|||
155261845|NCT00698646|560390786|FG002|Overall Study|Administrative problems|1|||
155261846|NCT00511875|560390792|FG000|Overall Study|Lost to Follow-up|4|||
155261847|NCT00511875|560390793|FG001|Overall Study|Lost to Follow-up|0|||
155261848|NCT00511875|560390792|FG000|Overall Study|Missing variables|1|||
155261849|NCT00511875|560390793|FG001|Overall Study|Missing variables|0|||
155261850|NCT02686034|560390795|FG000|Run-In Period 1|Eligibility|12|||
155261851|NCT02686034|560390796|FG001|Run-In Period 1|Eligibility|10|||
155261852|NCT02686034|560390795|FG000|Run-In Period 1|Withdrawal by Subject|4|||
155261853|NCT02686034|560390796|FG001|Run-In Period 1|Withdrawal by Subject|3|||
155261854|NCT02686034|560390795|FG000|Run-In Period 1|Lost to Follow-up|4|||
155261855|NCT02686034|560390796|FG001|Run-In Period 1|Lost to Follow-up|4|||
155261856|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
155261857|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
155261858|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
155261859|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
155261860|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Adverse Event|0|||
155261861|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Adverse Event|2|||
155261862|NCT02686034|560390795|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
155261863|NCT02686034|560390796|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
155261864|NCT02686034|560390795|FG000|Open Label Period 3|Lost to Follow-up|0|||
155261865|NCT02686034|560390796|FG001|Open Label Period 3|Lost to Follow-up|1|||
155261866|NCT00459342|560390797|FG000|Overall Study|Not eligible|1|||
155261867|NCT00542880|560390798|FG000|Period 1|Eligibility criteria not fulfilled|2|||
155261868|NCT00542880|560390799|FG001|Period 1|Eligibility criteria not fulfilled|6|||
155261869|NCT00542880|560390798|FG000|Period 1|Adverse Event|2|||
155261870|NCT00542880|560390799|FG001|Period 1|Adverse Event|2|||
155261871|NCT00542880|560390798|FG000|Period 1|Development of study-specific criteria|1|||
155261872|NCT00542880|560390799|FG001|Period 1|Development of study-specific criteria|2|||
155261873|NCT00542880|560390798|FG000|Period 1|Withdrawal by Subject|1|||
155261874|NCT00542880|560390799|FG001|Period 1|Withdrawal by Subject|1|||
155261875|NCT00542880|560390798|FG000|Period 1|Protocol Violation|0|||
155261876|NCT00542880|560390799|FG001|Period 1|Protocol Violation|1|||
155261877|NCT00542880|560390798|FG000|Period 2|Adverse Event|5|||
155261878|NCT00542880|560390799|FG001|Period 2|Adverse Event|7|||
155261879|NCT00542880|560390798|FG000|Period 2|Eligibility not fulfilled|0|||
155261880|NCT00542880|560390799|FG001|Period 2|Eligibility not fulfilled|1|||
155261881|NCT00542880|560390798|FG000|Period 2|Discontinuation criteria|2|||
155261882|NCT00542880|560390799|FG001|Period 2|Discontinuation criteria|0|||
155261883|NCT00542880|560390798|FG000|Period 2|Severe non-compliance|0|||
155261884|NCT00542880|560390799|FG001|Period 2|Severe non-compliance|1|||
155261885|NCT00542880|560390798|FG000|Period 2|Other|0|||
155261886|NCT00542880|560390799|FG001|Period 2|Other|1|||
155261887|NCT00542880|560390798|FG000|Period 3|Adverse Event|0|||
155261888|NCT00542880|560390799|FG001|Period 3|Adverse Event|2|||
155261889|NCT00696384|560390800|FG000|Open Label Phase|Adverse Event|27|||
155261890|NCT00696384|560390801|FG001|Open Label Phase|Adverse Event|0|||
155261891|NCT00696384|560390802|FG002|Open Label Phase|Adverse Event|0|||
155261892|NCT00696384|560390800|FG000|Open Label Phase|Protocol Violation|18|||
155261893|NCT00696384|560390801|FG001|Open Label Phase|Protocol Violation|0|||
155261894|NCT00696384|560390802|FG002|Open Label Phase|Protocol Violation|0|||
155261895|NCT00696384|560390800|FG000|Open Label Phase|Lost to Follow-up|24|||
155261896|NCT00696384|560390801|FG001|Open Label Phase|Lost to Follow-up|0|||
155261897|NCT00696384|560390802|FG002|Open Label Phase|Lost to Follow-up|0|||
155261898|NCT00696384|560390800|FG000|Open Label Phase|Withdrawal by Subject|37|||
155261899|NCT00696384|560390801|FG001|Open Label Phase|Withdrawal by Subject|0|||
155261900|NCT00696384|560390802|FG002|Open Label Phase|Withdrawal by Subject|0|||
155261901|NCT00696384|560390800|FG000|Open Label Phase|Other|6|||
155261902|NCT00696384|560390801|FG001|Open Label Phase|Other|0|||
155261903|NCT00696384|560390802|FG002|Open Label Phase|Other|0|||
155261904|NCT00696384|560390800|FG000|Open Label Phase|Lack of Efficacy|3|||
155261905|NCT00696384|560390801|FG001|Open Label Phase|Lack of Efficacy|0|||
155261906|NCT00696384|560390802|FG002|Open Label Phase|Lack of Efficacy|0|||
155261907|NCT00696384|560390800|FG000|Open Label Phase|Physician Decision|4|||
155261908|NCT00696384|560390801|FG001|Open Label Phase|Physician Decision|0|||
155261909|NCT00696384|560390802|FG002|Open Label Phase|Physician Decision|0|||
155261910|NCT00696384|560390800|FG000|Double Blind Phase|Adverse Event|0|||
155261911|NCT00696384|560390801|FG001|Double Blind Phase|Adverse Event|2|||
155261912|NCT00696384|560390802|FG002|Double Blind Phase|Adverse Event|2|||
155261913|NCT00696384|560390800|FG000|Double Blind Phase|Lost to Follow-up|0|||
155261914|NCT00696384|560390801|FG001|Double Blind Phase|Lost to Follow-up|2|||
155261915|NCT00696384|560390802|FG002|Double Blind Phase|Lost to Follow-up|1|||
155261916|NCT00696384|560390800|FG000|Double Blind Phase|Withdrawal by Subject|0|||
155261917|NCT00696384|560390801|FG001|Double Blind Phase|Withdrawal by Subject|4|||
155261918|NCT00696384|560390802|FG002|Double Blind Phase|Withdrawal by Subject|3|||
155261919|NCT00696384|560390800|FG000|Double Blind Phase|Lack of Efficacy|0|||
155261920|NCT00696384|560390801|FG001|Double Blind Phase|Lack of Efficacy|1|||
155261921|NCT00696384|560390802|FG002|Double Blind Phase|Lack of Efficacy|0|||
155261922|NCT00696384|560390800|FG000|Double Blind Phase|Physician Decision|0|||
155261923|NCT00696384|560390801|FG001|Double Blind Phase|Physician Decision|2|||
155261924|NCT00696384|560390802|FG002|Double Blind Phase|Physician Decision|0|||
155261925|NCT01678131|560390803|FG000|Overall Study|Adverse Event|0|||
155261926|NCT01678131|560390804|FG001|Overall Study|Adverse Event|1|||
155261927|NCT01678131|560390805|FG002|Overall Study|Adverse Event|0|||
155261928|NCT01678131|560390803|FG000|Overall Study|Withdrawal by Subject|0|||
155261929|NCT01678131|560390804|FG001|Overall Study|Withdrawal by Subject|0|||
155261930|NCT01678131|560390805|FG002|Overall Study|Withdrawal by Subject|2|||
155261931|NCT00558064|560390806|FG000|Overall Study|Adverse Event|3|||
155261932|NCT00558064|560390807|FG001|Overall Study|Adverse Event|2|||
155261933|NCT00558064|560390806|FG000|Overall Study|Lack of Efficacy|0|||
155261934|NCT00558064|560390807|FG001|Overall Study|Lack of Efficacy|1|||
155261935|NCT00558064|560390806|FG000|Overall Study|Protocol Violation|1|||
155261936|NCT00558064|560390807|FG001|Overall Study|Protocol Violation|0|||
155261937|NCT00558064|560390806|FG000|Overall Study|Lost to Follow-up|0|||
155261938|NCT00558064|560390807|FG001|Overall Study|Lost to Follow-up|1|||
155261939|NCT00558064|560390806|FG000|Overall Study|Withdrawal by Subject|0|||
155261940|NCT00558064|560390807|FG001|Overall Study|Withdrawal by Subject|1|||
155261941|NCT00558064|560390806|FG000|Overall Study|No visit within allowance period|1|||
155261942|NCT00558064|560390807|FG001|Overall Study|No visit within allowance period|0|||
155261943|NCT02027402|560390809|FG000|Overall Study|Withdrawal by Subject|4|||
155261944|NCT02027402|560390810|FG001|Overall Study|Withdrawal by Subject|1|||
155261945|NCT00982930|560390815|FG000|Overall Study|Adverse Event|1|||
155261946|NCT00982930|560390815|FG000|Overall Study|Withdrawal by Subject|1|||
155261947|NCT00982930|560390815|FG000|Overall Study|Administrative Problems|2|||
155261948|NCT00941798|560390816|FG000|Overall Study|Withdrawal by Subject|72|||
155261949|NCT00941798|560390817|FG001|Overall Study|Withdrawal by Subject|74|||
155261950|NCT00941798|560390816|FG000|Overall Study|Adverse Event|43|||
155261951|NCT00941798|560390817|FG001|Overall Study|Adverse Event|23|||
155261952|NCT00941798|560390816|FG000|Overall Study|Lost to Follow-up|29|||
155261953|NCT00941798|560390817|FG001|Overall Study|Lost to Follow-up|23|||
155261954|NCT00941798|560390816|FG000|Overall Study|Protocol Violation|17|||
155261955|NCT00941798|560390817|FG001|Overall Study|Protocol Violation|20|||
155261956|NCT00941798|560390816|FG000|Overall Study|Administrative problems|13|||
155261957|NCT00941798|560390817|FG001|Overall Study|Administrative problems|23|||
155261958|NCT00941798|560390816|FG000|Overall Study|Lack of Efficacy|10|||
155261959|NCT00941798|560390817|FG001|Overall Study|Lack of Efficacy|17|||
155261960|NCT00941798|560390816|FG000|Overall Study|Patient's inability to use device|6|||
155261961|NCT00941798|560390817|FG001|Overall Study|Patient's inability to use device|1|||
155261962|NCT00941798|560390816|FG000|Overall Study|Abnormal test procedure results|3|||
155261963|NCT00941798|560390817|FG001|Overall Study|Abnormal test procedure results|1|||
155261964|NCT00941798|560390816|FG000|Overall Study|Abnormal laboratory values|1|||
155261965|NCT00941798|560390817|FG001|Overall Study|Abnormal laboratory values|2|||
155261966|NCT00941798|560390816|FG000|Overall Study|Death|0|||
155261967|NCT00941798|560390817|FG001|Overall Study|Death|1|||
155261968|NCT04179721|560390820|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
155261969|NCT04179721|560390821|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
155261970|NCT04179721|560390820|FG000|Overall Study|Lost to Follow-up|0|||
155261971|NCT04179721|560390821|FG001|Overall Study|Lost to Follow-up|1|||
155261972|NCT04225988|560390822|FG000|Overall Study|Withdrawal by Subject|2|||
155261973|NCT04225988|560390823|FG001|Overall Study|Withdrawal by Subject|0|||
155261974|NCT00404495|560390824|FG000|Overall Study|Death|37|||
155261975|NCT00404495|560390825|FG001|Overall Study|Death|11|||
155261976|NCT00404495|560390824|FG000|Overall Study|Lost to Follow-up|5|||
155261977|NCT00404495|560390825|FG001|Overall Study|Lost to Follow-up|0|||
155261978|NCT00404495|560390824|FG000|Overall Study|Other|1|||
155261979|NCT00404495|560390825|FG001|Overall Study|Other|0|||
155261980|NCT00404495|560390824|FG000|Overall Study|Withdrawal by Subject|1|||
155261981|NCT00404495|560390825|FG001|Overall Study|Withdrawal by Subject|0|||
155261982|NCT03904043|560390826|FG000|Overall Study|Adverse Event|1|||
155261983|NCT03904043|560390827|FG001|Overall Study|Adverse Event|1|||
155261984|NCT03904043|560390826|FG000|Overall Study|Withdrawal by Subject|1|||
155261985|NCT03904043|560390827|FG001|Overall Study|Withdrawal by Subject|0|||
155261986|NCT03904043|560390826|FG000|Overall Study|Non-compliance|1|||
155261987|NCT03904043|560390827|FG001|Overall Study|Non-compliance|0|||
155261988|NCT03904043|560390826|FG000|Overall Study|Did not start treatment|1|||
155261989|NCT03904043|560390827|FG001|Overall Study|Did not start treatment|0|||
155261990|NCT01493960|560392638|FG000|Overall Study|Adverse Event|0|||
155261991|NCT01493960|560392639|FG001|Overall Study|Adverse Event|1|||
155261992|NCT01493960|560392638|FG000|Overall Study|Lack of Efficacy|15|||
155261993|NCT01493960|560392639|FG001|Overall Study|Lack of Efficacy|9|||
155261994|NCT01493960|560392638|FG000|Overall Study|Protocol Violation|3|||
155261995|NCT01493960|560392639|FG001|Overall Study|Protocol Violation|0|||
155261996|NCT01493960|560392638|FG000|Overall Study|Withdrawal by Subject|10|||
155261997|NCT01493960|560392639|FG001|Overall Study|Withdrawal by Subject|4|||
155261998|NCT01493960|560392638|FG000|Overall Study|Non-specified|4|||
155261999|NCT01493960|560392639|FG001|Overall Study|Non-specified|4|||
155262000|NCT03935217|560392640|FG000|Overall Study|Adverse Event|1|||
155262001|NCT03935217|560392641|FG001|Overall Study|Adverse Event|0|||
155262002|NCT03935217|560392640|FG000|Overall Study|Lost to Follow-up|0|||
155262003|NCT03935217|560392641|FG001|Overall Study|Lost to Follow-up|1|||
155262004|NCT03935217|560392640|FG000|Overall Study|Withdrawal by Subject|0|||
155262005|NCT03935217|560392641|FG001|Overall Study|Withdrawal by Subject|2|||
155262006|NCT01160484|560392643|FG000|Overall Study|Lack of Efficacy|9|||
155262007|NCT01160484|560392643|FG000|Overall Study|Adverse Event|6|||
155262008|NCT01160484|560392643|FG000|Overall Study|Withdrawal by Subject|2|||
155262009|NCT01160484|560392643|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
155262010|NCT00332332|560392644|FG000|Overall Study|Adverse Event|13|||
155262011|NCT00332332|560392644|FG000|Overall Study|Death|1|||
155262012|NCT00332332|560392644|FG000|Overall Study|Withdrawal by Subject|8|||
155262013|NCT00332332|560392644|FG000|Overall Study|Physician Decision|1|||
155262014|NCT00332332|560392644|FG000|Overall Study|Lost to Follow-up|3|||
155262015|NCT00332332|560392644|FG000|Overall Study|Protocol deviation|4|||
155262016|NCT00332332|560392644|FG000|Overall Study|Noncompliance|2|||
155262017|NCT00332332|560392644|FG000|Overall Study|Disease progression|2|||
155262018|NCT00332332|560392644|FG000|Overall Study|Other|18|||
155262019|NCT00332332|560392644|FG000|Overall Study|Did not receive study treatment|16|||
155262020|NCT00755222|560392653|FG000|Overall Study|Withdrawal by Subject|4|||
155262021|NCT00755222|560392654|FG001|Overall Study|Withdrawal by Subject|2|||
155262022|NCT00755222|560392653|FG000|Overall Study|Adverse Event|2|||
155262023|NCT00755222|560392654|FG001|Overall Study|Adverse Event|0|||
155262024|NCT00755222|560392653|FG000|Overall Study|Protocol Violation|2|||
155262025|NCT00755222|560392654|FG001|Overall Study|Protocol Violation|0|||
155262026|NCT01147822|560392661|FG000|Overall Study|Lost to Follow-up|14|||
155262027|NCT01147822|560392662|FG001|Overall Study|Lost to Follow-up|6|||
155262028|NCT01147822|560392661|FG000|Overall Study|Withdrawal by Subject|10|||
155262029|NCT01147822|560392662|FG001|Overall Study|Withdrawal by Subject|16|||
155262030|NCT01147822|560392661|FG000|Overall Study|Physician Decision|9|||
155262031|NCT01147822|560392662|FG001|Overall Study|Physician Decision|8|||
155262032|NCT01147822|560392661|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
155262033|NCT01147822|560392662|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
155262034|NCT01147822|560392661|FG000|Overall Study|Protocol Violation|1|||
155262035|NCT01147822|560392662|FG001|Overall Study|Protocol Violation|1|||
155262036|NCT04382924|560392666|FG000|Overall Study|Death|2|||
155262037|NCT04382924|560392667|FG001|Overall Study|Death|5|||
155262038|NCT04382924|560392668|FG002|Overall Study|Death|4|||
155262039|NCT04382924|560392666|FG000|Overall Study|Protocol Violation|0|||
155262040|NCT04382924|560392667|FG001|Overall Study|Protocol Violation|1|||
155262041|NCT04382924|560392668|FG002|Overall Study|Protocol Violation|1|||
155262042|NCT04382924|560392666|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
155262043|NCT04382924|560392667|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
155262044|NCT04382924|560392668|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
155262045|NCT04382924|560392666|FG000|Overall Study|Withdrawal by Subject|6|||
155262046|NCT04382924|560392667|FG001|Overall Study|Withdrawal by Subject|3|||
155262047|NCT04382924|560392668|FG002|Overall Study|Withdrawal by Subject|6|||
155262048|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
155262049|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
155262050|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
155262051|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
155262052|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
155262053|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
155262054|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
155262055|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
155262056|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
155262057|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
155262058|NCT00261495|560392671|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
155262059|NCT00261495|560392672|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
155262060|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
155262061|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
155262062|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
155262063|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
155262064|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
155262065|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
155262066|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
155262067|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
155262068|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
155262069|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
155262070|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
155262071|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
155262072|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
155262073|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
155262074|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
155262075|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
155262076|NCT00261495|560392671|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
155262077|NCT00261495|560392672|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
155262078|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
155262079|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
155262080|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
155262081|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
155262082|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
155262083|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
155262084|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
155262085|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
155262086|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
155262087|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
155262088|NCT00261495|560392671|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
155262089|NCT00261495|560392672|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
155262090|NCT01932697|560392673|FG000|Overall Study|Received a different amount of tx|1|||
155262091|NCT01932697|560392674|FG001|Overall Study|Received a different amount of tx|0|||
155262092|NCT01932697|560392673|FG000|Overall Study|Ineligible|1|||
155262093|NCT01932697|560392674|FG001|Overall Study|Ineligible|0|||
155262094|NCT00215540|560392688|FG000|Overall Study|Withdrew from study medication|1|||
155262095|NCT00215540|560392689|FG001|Overall Study|Withdrew from study medication|0|||
155262096|NCT00215540|560392690|FG002|Overall Study|Withdrew from study medication|0|||
155262097|NCT03010462|560392691|FG000|Overall Study|Withdrawal by Subject|3|||
155262098|NCT03010462|560392692|FG001|Overall Study|Withdrawal by Subject|1|||
155262099|NCT01492686|560392693|FG000|Double-blind Phase|Adverse Event|0|||
155262100|NCT01492686|560392694|FG001|Double-blind Phase|Adverse Event|2|||
155262101|NCT01492686|560392693|FG000|Double-blind Phase|Physician Decision|0|||
155262102|NCT01492686|560392694|FG001|Double-blind Phase|Physician Decision|1|||
155262103|NCT01492686|560392693|FG000|Double-blind Phase|Withdrawal by Subject|0|||
155262104|NCT01492686|560392694|FG001|Double-blind Phase|Withdrawal by Subject|2|||
155262105|NCT01492686|560392693|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
155262106|NCT01492686|560392694|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
155262107|NCT01492686|560392693|FG000|Open-label Phase|Adverse Event|1|||
155262108|NCT01492686|560392694|FG001|Open-label Phase|Adverse Event|2|||
155262109|NCT01492686|560392693|FG000|Open-label Phase|Physician Decision|1|||
155262110|NCT01492686|560392694|FG001|Open-label Phase|Physician Decision|0|||
155262111|NCT01492686|560392693|FG000|Open-label Phase|Withdrawal by Subject|6|||
155262112|NCT01492686|560392694|FG001|Open-label Phase|Withdrawal by Subject|7|||
155262113|NCT01492686|560392693|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
155262114|NCT01492686|560392694|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
155262115|NCT02313909|560392695|FG000|Overall Study|Consent withdrawn by participant|33|||
155262116|NCT02313909|560392696|FG001|Overall Study|Consent withdrawn by participant|33|||
155262117|NCT02313909|560392695|FG000|Overall Study|Lost to Follow-up|24|||
155262118|NCT02313909|560392696|FG001|Overall Study|Lost to Follow-up|17|||
155262119|NCT02798211|560392697|FG000|Period 1|Adverse Event|1|||
155262120|NCT02798211|560392698|FG001|Period 1|Adverse Event|1|||
155262121|NCT02798211|560392699|FG002|Period 1|Adverse Event|0|||
155262122|NCT02798211|560392700|FG003|Period 1|Adverse Event|0|||
155262123|NCT02798211|560392701|FG004|Period 1|Adverse Event|0|||
155262124|NCT02798211|560392702|FG005|Period 1|Adverse Event|0|||
155262125|NCT02798211|560392697|FG000|Period 1|Lost to Follow-up|2|||
155262126|NCT02798211|560392698|FG001|Period 1|Lost to Follow-up|1|||
155262127|NCT02798211|560392699|FG002|Period 1|Lost to Follow-up|0|||
155262128|NCT02798211|560392700|FG003|Period 1|Lost to Follow-up|0|||
155262129|NCT02798211|560392701|FG004|Period 1|Lost to Follow-up|0|||
155262130|NCT02798211|560392702|FG005|Period 1|Lost to Follow-up|0|||
155262131|NCT02798211|560392697|FG000|Period 1|Protocol Violation|0|||
155262132|NCT02798211|560392698|FG001|Period 1|Protocol Violation|0|||
155262133|NCT02798211|560392699|FG002|Period 1|Protocol Violation|2|||
155262134|NCT02798211|560392700|FG003|Period 1|Protocol Violation|0|||
155262135|NCT02798211|560392701|FG004|Period 1|Protocol Violation|0|||
155262136|NCT02798211|560392702|FG005|Period 1|Protocol Violation|0|||
155262137|NCT02798211|560392697|FG000|Period 1|Withdrawal by Subject|1|||
155262138|NCT02798211|560392698|FG001|Period 1|Withdrawal by Subject|1|||
155262139|NCT02798211|560392699|FG002|Period 1|Withdrawal by Subject|0|||
155262140|NCT02798211|560392700|FG003|Period 1|Withdrawal by Subject|0|||
155262141|NCT02798211|560392701|FG004|Period 1|Withdrawal by Subject|0|||
155262142|NCT02798211|560392702|FG005|Period 1|Withdrawal by Subject|0|||
155262143|NCT02798211|560392697|FG000|Period 1|Death|0|||
155262144|NCT02798211|560392698|FG001|Period 1|Death|0|||
155262145|NCT02798211|560392699|FG002|Period 1|Death|1|||
155262146|NCT02798211|560392700|FG003|Period 1|Death|0|||
155262147|NCT02798211|560392701|FG004|Period 1|Death|0|||
155262148|NCT02798211|560392702|FG005|Period 1|Death|0|||
155262149|NCT02798211|560392697|FG000|Period 1|Withdrawal of Informed Consent|2|||
155262150|NCT02798211|560392698|FG001|Period 1|Withdrawal of Informed Consent|7|||
155262151|NCT02798211|560392699|FG002|Period 1|Withdrawal of Informed Consent|3|||
155262152|NCT02798211|560392700|FG003|Period 1|Withdrawal of Informed Consent|0|||
155262153|NCT02798211|560392701|FG004|Period 1|Withdrawal of Informed Consent|0|||
155262154|NCT02798211|560392702|FG005|Period 1|Withdrawal of Informed Consent|0|||
155262155|NCT02798211|560392697|FG000|Period 2|Withdrawal by Subject|2|||
155262156|NCT02798211|560392698|FG001|Period 2|Withdrawal by Subject|0|||
155262157|NCT02798211|560392699|FG002|Period 2|Withdrawal by Subject|0|||
155262158|NCT02798211|560392700|FG003|Period 2|Withdrawal by Subject|0|||
155262159|NCT02798211|560392701|FG004|Period 2|Withdrawal by Subject|2|||
155262160|NCT02798211|560392702|FG005|Period 2|Withdrawal by Subject|2|||
155262161|NCT02798211|560392697|FG000|Period 2|Adverse Event|5|||
155262162|NCT02798211|560392698|FG001|Period 2|Adverse Event|0|||
155262163|NCT02798211|560392699|FG002|Period 2|Adverse Event|0|||
155262164|NCT02798211|560392700|FG003|Period 2|Adverse Event|0|||
155262165|NCT02798211|560392701|FG004|Period 2|Adverse Event|1|||
155262166|NCT02798211|560392702|FG005|Period 2|Adverse Event|0|||
155262167|NCT02798211|560392697|FG000|Period 2|Lack of Efficacy|1|||
155262168|NCT02798211|560392698|FG001|Period 2|Lack of Efficacy|0|||
155262169|NCT02798211|560392699|FG002|Period 2|Lack of Efficacy|0|||
155262170|NCT02798211|560392700|FG003|Period 2|Lack of Efficacy|1|||
155262171|NCT02798211|560392701|FG004|Period 2|Lack of Efficacy|0|||
155262172|NCT02798211|560392702|FG005|Period 2|Lack of Efficacy|1|||
155262173|NCT02798211|560392697|FG000|Period 2|Lost to Follow-up|3|||
155262174|NCT02798211|560392698|FG001|Period 2|Lost to Follow-up|0|||
155262175|NCT02798211|560392699|FG002|Period 2|Lost to Follow-up|0|||
155262176|NCT02798211|560392700|FG003|Period 2|Lost to Follow-up|0|||
155262177|NCT02798211|560392701|FG004|Period 2|Lost to Follow-up|2|||
155262178|NCT02798211|560392702|FG005|Period 2|Lost to Follow-up|0|||
155262179|NCT02798211|560392697|FG000|Period 2|Physician Decision|1|||
155262180|NCT02798211|560392698|FG001|Period 2|Physician Decision|0|||
155262181|NCT02798211|560392699|FG002|Period 2|Physician Decision|0|||
155262182|NCT02798211|560392700|FG003|Period 2|Physician Decision|1|||
155262183|NCT02798211|560392701|FG004|Period 2|Physician Decision|1|||
155262184|NCT02798211|560392702|FG005|Period 2|Physician Decision|0|||
155262185|NCT02798211|560392697|FG000|Period 2|Pregnancy|0|||
155262186|NCT02798211|560392698|FG001|Period 2|Pregnancy|0|||
155262187|NCT02798211|560392699|FG002|Period 2|Pregnancy|0|||
155262188|NCT02798211|560392700|FG003|Period 2|Pregnancy|2|||
155262189|NCT02798211|560392701|FG004|Period 2|Pregnancy|0|||
155262190|NCT02798211|560392702|FG005|Period 2|Pregnancy|0|||
155262191|NCT02798211|560392697|FG000|Period 2|Technical problems|1|||
155262192|NCT02798211|560392698|FG001|Period 2|Technical problems|0|||
155262193|NCT02798211|560392699|FG002|Period 2|Technical problems|0|||
155262194|NCT02798211|560392700|FG003|Period 2|Technical problems|1|||
155262195|NCT02798211|560392701|FG004|Period 2|Technical problems|0|||
155262196|NCT02798211|560392702|FG005|Period 2|Technical problems|0|||
155262197|NCT02798211|560392697|FG000|Period 2|Withdrawal of Informed Consent|1|||
155262198|NCT02798211|560392698|FG001|Period 2|Withdrawal of Informed Consent|0|||
155262199|NCT02798211|560392699|FG002|Period 2|Withdrawal of Informed Consent|0|||
155262200|NCT02798211|560392700|FG003|Period 2|Withdrawal of Informed Consent|2|||
155262201|NCT02798211|560392701|FG004|Period 2|Withdrawal of Informed Consent|2|||
155262202|NCT02798211|560392702|FG005|Period 2|Withdrawal of Informed Consent|3|||
155262203|NCT01782872|560392703|FG000|Overall Study|Protocol Violation|0|||
155262204|NCT01782872|560392704|FG001|Overall Study|Protocol Violation|0|||
155262205|NCT01782872|560392705|FG002|Overall Study|Protocol Violation|0|||
155262206|NCT01782872|560392706|FG003|Overall Study|Protocol Violation|1|||
155262207|NCT01782872|560392703|FG000|Overall Study|Withdrawal by Subject|0|||
155262208|NCT01782872|560392704|FG001|Overall Study|Withdrawal by Subject|1|||
155262209|NCT01782872|560392705|FG002|Overall Study|Withdrawal by Subject|0|||
155262210|NCT01782872|560392706|FG003|Overall Study|Withdrawal by Subject|0|||
155262211|NCT03505476|560392707|FG000|Overall Study|Physician Decision|18|||
155262212|NCT03505476|560392707|FG000|Overall Study|Device Malfunctioned|101|||
155262213|NCT03505476|560392707|FG000|Overall Study|Data Corrupt|6|||
155262214|NCT03505476|560392707|FG000|Overall Study|Device application insufficiant|3|||
155262215|NCT02748694|560392708|FG000|Overall Study|Voluntary Withdrawal|0|||
155262216|NCT02748694|560392709|FG001|Overall Study|Voluntary Withdrawal|0|||
155262217|NCT02748694|560392710|FG002|Overall Study|Voluntary Withdrawal|0|||
155262218|NCT02748694|560392711|FG003|Overall Study|Voluntary Withdrawal|0|||
155262219|NCT02748694|560392712|FG004|Overall Study|Voluntary Withdrawal|0|||
155262220|NCT02748694|560392713|FG005|Overall Study|Voluntary Withdrawal|0|||
155262221|NCT02748694|560392714|FG006|Overall Study|Voluntary Withdrawal|0|||
155262222|NCT02748694|560392715|FG007|Overall Study|Voluntary Withdrawal|0|||
155262223|NCT02748694|560392716|FG008|Overall Study|Voluntary Withdrawal|0|||
155262224|NCT02748694|560392717|FG009|Overall Study|Voluntary Withdrawal|0|||
155262225|NCT02748694|560392718|FG010|Overall Study|Voluntary Withdrawal|0|||
155262226|NCT02748694|560392719|FG011|Overall Study|Voluntary Withdrawal|0|||
155262227|NCT02748694|560392720|FG012|Overall Study|Voluntary Withdrawal|0|||
155262228|NCT02748694|560392721|FG013|Overall Study|Voluntary Withdrawal|0|||
155262229|NCT02748694|560392722|FG014|Overall Study|Voluntary Withdrawal|2|||
155262230|NCT04026165|560392725|FG000|Run-in Placebo Period|Enrollment Error|13|||
155262231|NCT04026165|560392726|FG001|Run-in Placebo Period|Enrollment Error|0|||
155262232|NCT04026165|560392727|FG002|Run-in Placebo Period|Enrollment Error|0|||
155262233|NCT04026165|560392728|FG003|Run-in Placebo Period|Enrollment Error|0|||
155262234|NCT04026165|560392725|FG000|Run-in Placebo Period|Run-in Failure|4|||
155262235|NCT04026165|560392726|FG001|Run-in Placebo Period|Run-in Failure|0|||
155262236|NCT04026165|560392727|FG002|Run-in Placebo Period|Run-in Failure|0|||
155262237|NCT04026165|560392728|FG003|Run-in Placebo Period|Run-in Failure|0|||
155262238|NCT04026165|560392725|FG000|Run-in Placebo Period|Protocol Violation|2|||
155262239|NCT04026165|560392726|FG001|Run-in Placebo Period|Protocol Violation|0|||
155262240|NCT04026165|560392727|FG002|Run-in Placebo Period|Protocol Violation|0|||
155262241|NCT04026165|560392728|FG003|Run-in Placebo Period|Protocol Violation|0|||
155262242|NCT04026165|560392725|FG000|Run-in Placebo Period|Withdrew Consent|2|||
155262243|NCT04026165|560392726|FG001|Run-in Placebo Period|Withdrew Consent|0|||
155262244|NCT04026165|560392727|FG002|Run-in Placebo Period|Withdrew Consent|0|||
155262245|NCT04026165|560392728|FG003|Run-in Placebo Period|Withdrew Consent|0|||
155262246|NCT04026165|560392725|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
155262247|NCT04026165|560392726|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
155262248|NCT04026165|560392727|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
155262249|NCT04026165|560392728|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
155262250|NCT04026165|560392725|FG000|Run-in SEL Period|Run-in Failure|0|||
155262251|NCT04026165|560392726|FG001|Run-in SEL Period|Run-in Failure|26|||
155262252|NCT04026165|560392727|FG002|Run-in SEL Period|Run-in Failure|0|||
155262253|NCT04026165|560392728|FG003|Run-in SEL Period|Run-in Failure|0|||
155262254|NCT04026165|560392725|FG000|Run-in SEL Period|Withdrew Consent|0|||
155262255|NCT04026165|560392726|FG001|Run-in SEL Period|Withdrew Consent|10|||
155262256|NCT04026165|560392727|FG002|Run-in SEL Period|Withdrew Consent|0|||
155262257|NCT04026165|560392728|FG003|Run-in SEL Period|Withdrew Consent|0|||
155262258|NCT04026165|560392725|FG000|Run-in SEL Period|Enrollment Error|0|||
155262259|NCT04026165|560392726|FG001|Run-in SEL Period|Enrollment Error|4|||
155262260|NCT04026165|560392727|FG002|Run-in SEL Period|Enrollment Error|0|||
155262261|NCT04026165|560392728|FG003|Run-in SEL Period|Enrollment Error|0|||
155262262|NCT04026165|560392725|FG000|Run-in SEL Period|Protocol Violation|0|||
155262263|NCT04026165|560392726|FG001|Run-in SEL Period|Protocol Violation|3|||
155262264|NCT04026165|560392727|FG002|Run-in SEL Period|Protocol Violation|0|||
155262265|NCT04026165|560392728|FG003|Run-in SEL Period|Protocol Violation|0|||
155262266|NCT04026165|560392725|FG000|Run-in SEL Period|Investigator's Discretion|0|||
155262267|NCT04026165|560392726|FG001|Run-in SEL Period|Investigator's Discretion|2|||
155262268|NCT04026165|560392727|FG002|Run-in SEL Period|Investigator's Discretion|0|||
155262269|NCT04026165|560392728|FG003|Run-in SEL Period|Investigator's Discretion|0|||
155262270|NCT04026165|560392725|FG000|Run-in SEL Period|Death|0|||
155262271|NCT04026165|560392726|FG001|Run-in SEL Period|Death|1|||
155262272|NCT04026165|560392727|FG002|Run-in SEL Period|Death|0|||
155262273|NCT04026165|560392728|FG003|Run-in SEL Period|Death|0|||
155262274|NCT04026165|560392725|FG000|Randomized Period|Withdrew Consent|0|||
155262275|NCT04026165|560392726|FG001|Randomized Period|Withdrew Consent|0|||
155262276|NCT04026165|560392727|FG002|Randomized Period|Withdrew Consent|5|||
155262277|NCT04026165|560392728|FG003|Randomized Period|Withdrew Consent|8|||
155262278|NCT04026165|560392725|FG000|Randomized Period|Death|0|||
155262279|NCT04026165|560392726|FG001|Randomized Period|Death|0|||
155262280|NCT04026165|560392727|FG002|Randomized Period|Death|5|||
155262281|NCT04026165|560392728|FG003|Randomized Period|Death|7|||
155262282|NCT04026165|560392725|FG000|Randomized Period|Investigator's Discretion|0|||
155262283|NCT04026165|560392726|FG001|Randomized Period|Investigator's Discretion|0|||
155262284|NCT04026165|560392727|FG002|Randomized Period|Investigator's Discretion|2|||
155262285|NCT04026165|560392728|FG003|Randomized Period|Investigator's Discretion|2|||
155262286|NCT04026165|560392725|FG000|Randomized Period|Lost to Follow-up|0|||
155262287|NCT04026165|560392726|FG001|Randomized Period|Lost to Follow-up|0|||
155262288|NCT04026165|560392727|FG002|Randomized Period|Lost to Follow-up|2|||
155262289|NCT04026165|560392728|FG003|Randomized Period|Lost to Follow-up|2|||
155262290|NCT01059630|560392731|FG000|Overall Study|Death|100|||
155262291|NCT01059630|560392732|FG001|Overall Study|Death|84|||
155262292|NCT01059630|560392731|FG000|Overall Study|Lost to Follow-up|4|||
155262293|NCT01059630|560392732|FG001|Overall Study|Lost to Follow-up|1|||
155262294|NCT01059630|560392731|FG000|Overall Study|Physician Decision|2|||
155262295|NCT01059630|560392732|FG001|Overall Study|Physician Decision|4|||
155262296|NCT01059630|560392731|FG000|Overall Study|Withdrawal by Subject|21|||
155262297|NCT01059630|560392732|FG001|Overall Study|Withdrawal by Subject|14|||
155262298|NCT03170375|560392733|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
155262299|NCT03170375|560392734|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
155262300|NCT03170375|560392735|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
155262301|NCT03170375|560392733|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
155262302|NCT03170375|560392734|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
155262303|NCT03170375|560392735|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
155262304|NCT00441701|560392736|FG000|Overall Study|Adverse Event|3|||
155262305|NCT00441701|560392737|FG001|Overall Study|Adverse Event|2|||
155262306|NCT00441701|560392738|FG002|Overall Study|Adverse Event|1|||
155262307|NCT00441701|560392739|FG003|Overall Study|Adverse Event|0|||
155262308|NCT00441701|560392740|FG004|Overall Study|Adverse Event|2|||
155262309|NCT00441701|560392741|FG005|Overall Study|Adverse Event|2|||
155262310|NCT00441701|560392742|FG006|Overall Study|Adverse Event|0|||
155262311|NCT00441701|560392743|FG007|Overall Study|Adverse Event|0|||
155262312|NCT00441701|560392744|FG008|Overall Study|Adverse Event|0|||
155262313|NCT00441701|560392745|FG009|Overall Study|Adverse Event|0|||
155262314|NCT00441701|560392736|FG000|Overall Study|Lack of Efficacy|2|||
155262315|NCT00441701|560392737|FG001|Overall Study|Lack of Efficacy|0|||
155262316|NCT00441701|560392738|FG002|Overall Study|Lack of Efficacy|2|||
155262317|NCT00441701|560392739|FG003|Overall Study|Lack of Efficacy|2|||
155262318|NCT00441701|560392740|FG004|Overall Study|Lack of Efficacy|0|||
155262319|NCT00441701|560392741|FG005|Overall Study|Lack of Efficacy|1|||
155262320|NCT00441701|560392742|FG006|Overall Study|Lack of Efficacy|0|||
155262321|NCT00441701|560392743|FG007|Overall Study|Lack of Efficacy|0|||
155262322|NCT00441701|560392744|FG008|Overall Study|Lack of Efficacy|0|||
155262323|NCT00441701|560392745|FG009|Overall Study|Lack of Efficacy|0|||
155262324|NCT00441701|560392736|FG000|Overall Study|Withdrawal by Subject|0|||
155262325|NCT00441701|560392737|FG001|Overall Study|Withdrawal by Subject|2|||
155262326|NCT00441701|560392738|FG002|Overall Study|Withdrawal by Subject|1|||
155262327|NCT00441701|560392739|FG003|Overall Study|Withdrawal by Subject|1|||
155262328|NCT00441701|560392740|FG004|Overall Study|Withdrawal by Subject|0|||
155262329|NCT00441701|560392741|FG005|Overall Study|Withdrawal by Subject|0|||
155262330|NCT00441701|560392742|FG006|Overall Study|Withdrawal by Subject|0|||
155262331|NCT00441701|560392743|FG007|Overall Study|Withdrawal by Subject|0|||
155262332|NCT00441701|560392744|FG008|Overall Study|Withdrawal by Subject|0|||
155262333|NCT00441701|560392745|FG009|Overall Study|Withdrawal by Subject|0|||
155262334|NCT00077064|560392746|FG000|Overall Study|Adverse Event|0|||
155262335|NCT00077064|560392747|FG001|Overall Study|Adverse Event|4|||
155262336|NCT00077064|560392746|FG000|Overall Study|Patient refusal|0|||
155262337|NCT00077064|560392747|FG001|Overall Study|Patient refusal|2|||
155262338|NCT02007434|560392753|FG000|Overall Study|Lost to Follow-up|0|||
155262339|NCT02007434|560392754|FG001|Overall Study|Lost to Follow-up|1|||
155262340|NCT02007434|560392755|FG002|Overall Study|Lost to Follow-up|0|||
155262341|NCT02007434|560392756|FG003|Overall Study|Lost to Follow-up|0|||
155262342|NCT02007434|560392757|FG004|Overall Study|Lost to Follow-up|0|||
155262343|NCT02007434|560392758|FG005|Overall Study|Lost to Follow-up|0|||
155262344|NCT02007434|560392759|FG006|Overall Study|Lost to Follow-up|0|||
155262345|NCT02007434|560392760|FG007|Overall Study|Lost to Follow-up|0|||
155262346|NCT02007434|560392753|FG000|Overall Study|Non-compliance|1|||
155262347|NCT02007434|560392754|FG001|Overall Study|Non-compliance|0|||
155262348|NCT02007434|560392755|FG002|Overall Study|Non-compliance|1|||
155262349|NCT02007434|560392756|FG003|Overall Study|Non-compliance|0|||
155262350|NCT02007434|560392757|FG004|Overall Study|Non-compliance|0|||
155262351|NCT02007434|560392758|FG005|Overall Study|Non-compliance|0|||
155262352|NCT02007434|560392759|FG006|Overall Study|Non-compliance|0|||
155262353|NCT02007434|560392760|FG007|Overall Study|Non-compliance|0|||
155262354|NCT03299686|560392774|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
155262355|NCT03299686|560392775|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
155262356|NCT03299686|560392774|FG000|Treatment Epoch|Physician Decision|1|||
155262357|NCT03299686|560392775|FG001|Treatment Epoch|Physician Decision|0|||
155262358|NCT03299686|560392774|FG000|Treatment Epoch|Adverse Event|8|||
155262359|NCT03299686|560392775|FG001|Treatment Epoch|Adverse Event|4|||
155262360|NCT03299686|560392774|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
155262361|NCT03299686|560392775|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
155262362|NCT02709005|560392776|FG000|Overall Study|Lost to Follow-up|1|||
155262363|NCT02709005|560392777|FG001|Overall Study|Lost to Follow-up|1|||
155262364|NCT02709005|560392776|FG000|Overall Study|Withdrawal by Subject|3|||
155262365|NCT02709005|560392777|FG001|Overall Study|Withdrawal by Subject|0|||
155262366|NCT02535364|560392783|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
155262367|NCT02535364|560392783|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
155262368|NCT02535364|560392783|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
155262369|NCT02535364|560392783|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
155262370|NCT02535364|560392783|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
155262371|NCT02535364|560392783|FG000|Part B Screening|Death|2|||
155262372|NCT02535364|560392783|FG000|Part B Screening|Physician Decision|1|||
155262373|NCT02535364|560392783|FG000|Part B Screening|Withdrawal by Subject|1|||
155262374|NCT02535364|560392783|FG000|Part B Screening|Adverse Event|1|||
155262375|NCT02535364|560392783|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
155262376|NCT02535364|560392783|FG000|Study Treatment|Death|1|||
155262377|NCT02535364|560392783|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
155262378|NCT02535364|560392783|FG000|12-Month Follow-up Period|Disease progression|22|||
155262379|NCT02535364|560392783|FG000|12-Month Follow-up Period|Death|5|||
155262380|NCT02535364|560392783|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
155262381|NCT02535364|560392783|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
155262382|NCT02535364|560392783|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
155262383|NCT02889133|560392789|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
155262384|NCT02889133|560392790|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
155262385|NCT02889133|560392789|FG000|Completed Primary Outcome|Manufacturing error|3|||
155262386|NCT02889133|560392790|FG001|Completed Primary Outcome|Manufacturing error|8|||
155262387|NCT02889133|560392789|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
155262388|NCT02889133|560392790|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
155262389|NCT02889133|560392789|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
155262390|NCT02889133|560392790|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
155262391|NCT02889133|560392789|FG000|Completed Primary Outcome|Protocol Violation|1|||
155262392|NCT02889133|560392790|FG001|Completed Primary Outcome|Protocol Violation|0|||
155262393|NCT02889133|560392789|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
155262394|NCT02889133|560392790|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
155262395|NCT02889133|560392789|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
155262396|NCT02889133|560392790|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
155262397|NCT02889133|560392789|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
155262398|NCT02889133|560392790|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
155262399|NCT02889133|560392789|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
155262400|NCT02889133|560392790|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
155262401|NCT02889133|560392789|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
155262402|NCT02889133|560392790|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
155262403|NCT01375205|560392791|FG000|Overall Study|Lost to Follow-up|15|||
155262404|NCT01375205|560392792|FG001|Overall Study|Lost to Follow-up|12|||
155262405|NCT01375205|560392791|FG000|Overall Study|Withdrawal by Subject|6|||
155262406|NCT01375205|560392792|FG001|Overall Study|Withdrawal by Subject|1|||
155262407|NCT01148862|560392793|FG000|Second Intervention|Withdrawal by Subject|0|||
155262408|NCT01148862|560392794|FG001|Second Intervention|Withdrawal by Subject|2|||
155262409|NCT04270747|560392795|FG000|Through Week 16|Adverse Event|1|||
155262410|NCT04270747|560392796|FG001|Through Week 16|Adverse Event|2|||
155262411|NCT04270747|560392797|FG002|Through Week 16|Adverse Event|0|||
155262412|NCT04270747|560392795|FG000|Through Week 16|Death|0|||
155262413|NCT04270747|560392796|FG001|Through Week 16|Death|2|||
155262414|NCT04270747|560392797|FG002|Through Week 16|Death|0|||
155262415|NCT04270747|560392795|FG000|Through Week 16|Consent Withdrawn|3|||
155262416|NCT04270747|560392796|FG001|Through Week 16|Consent Withdrawn|3|||
155262417|NCT04270747|560392797|FG002|Through Week 16|Consent Withdrawn|0|||
155262418|NCT04270747|560392795|FG000|Through Week 16|Physician Decision|1|||
155262419|NCT04270747|560392796|FG001|Through Week 16|Physician Decision|1|||
155262420|NCT04270747|560392797|FG002|Through Week 16|Physician Decision|0|||
155262421|NCT04270747|560392795|FG000|Through Week 16|Lost to Follow-up|2|||
155262422|NCT04270747|560392796|FG001|Through Week 16|Lost to Follow-up|0|||
155262423|NCT04270747|560392797|FG002|Through Week 16|Lost to Follow-up|0|||
155262424|NCT04270747|560392795|FG000|Through Week 16|Protocol Violation|1|||
155262425|NCT04270747|560392796|FG001|Through Week 16|Protocol Violation|2|||
155262426|NCT04270747|560392797|FG002|Through Week 16|Protocol Violation|0|||
155262427|NCT04270747|560392795|FG000|Through Week 16|Protocol Specified Criteria|6|||
155262428|NCT04270747|560392796|FG001|Through Week 16|Protocol Specified Criteria|7|||
155262429|NCT04270747|560392797|FG002|Through Week 16|Protocol Specified Criteria|0|||
155262430|NCT04270747|560392795|FG000|Through Week 16|Miscellaneous|1|||
155262431|NCT04270747|560392796|FG001|Through Week 16|Miscellaneous|1|||
155262432|NCT04270747|560392797|FG002|Through Week 16|Miscellaneous|0|||
155262433|NCT04270747|560392795|FG000|Post Week 16|Adverse Event|7|||
155262434|NCT04270747|560392796|FG001|Post Week 16|Adverse Event|5|||
155262435|NCT04270747|560392797|FG002|Post Week 16|Adverse Event|1|||
155262436|NCT04270747|560392795|FG000|Post Week 16|Death|2|||
155262437|NCT04270747|560392796|FG001|Post Week 16|Death|0|||
155262438|NCT04270747|560392797|FG002|Post Week 16|Death|2|||
155262439|NCT04270747|560392795|FG000|Post Week 16|Consent Withdrawn|4|||
155262440|NCT04270747|560392796|FG001|Post Week 16|Consent Withdrawn|3|||
155262441|NCT04270747|560392797|FG002|Post Week 16|Consent Withdrawn|6|||
155262442|NCT04270747|560392795|FG000|Post Week 16|Physician Decision|3|||
155262443|NCT04270747|560392796|FG001|Post Week 16|Physician Decision|1|||
155262444|NCT04270747|560392797|FG002|Post Week 16|Physician Decision|1|||
155262445|NCT04270747|560392795|FG000|Post Week 16|Lost to Follow-up|2|||
155262446|NCT04270747|560392796|FG001|Post Week 16|Lost to Follow-up|1|||
155262447|NCT04270747|560392797|FG002|Post Week 16|Lost to Follow-up|0|||
155262448|NCT04270747|560392795|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
155262449|NCT04270747|560392796|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
155262450|NCT04270747|560392797|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
155262451|NCT04270747|560392795|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
155262452|NCT04270747|560392796|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
155262453|NCT04270747|560392797|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
155262454|NCT04270747|560392795|FG000|Post Week 16|Miscellaneous|1|||
155262455|NCT04270747|560392796|FG001|Post Week 16|Miscellaneous|0|||
155262456|NCT04270747|560392797|FG002|Post Week 16|Miscellaneous|1|||
155262457|NCT05597722|560392802|FG000|Overall Study|Study was terminated|6|||
155262458|NCT05597722|560392803|FG001|Overall Study|Study was terminated|1|||
155262459|NCT04108000|560392804|FG000|Overall Study|Death of patient|1|||
155262460|NCT04108000|560392805|FG001|Overall Study|Death of patient|0|||
155262461|NCT04108000|560392806|FG002|Overall Study|Death of patient|1|||
155262462|NCT04108000|560392807|FG003|Overall Study|Death of patient|0|||
155262463|NCT04108000|560392804|FG000|Overall Study|Withdrawal by Subject|2|||
155262464|NCT04108000|560392805|FG001|Overall Study|Withdrawal by Subject|2|||
155262465|NCT04108000|560392806|FG002|Overall Study|Withdrawal by Subject|0|||
155262466|NCT04108000|560392807|FG003|Overall Study|Withdrawal by Subject|0|||
155262467|NCT04108000|560392804|FG000|Overall Study|Death of surrogate partner|0|||
155262468|NCT04108000|560392805|FG001|Overall Study|Death of surrogate partner|1|||
155262469|NCT04108000|560392806|FG002|Overall Study|Death of surrogate partner|0|||
155262470|NCT04108000|560392807|FG003|Overall Study|Death of surrogate partner|1|||
155262471|NCT05559866|560392812|FG000|Overall Study|Withdrawal by Subject|1|||
155262472|NCT05559866|560392813|FG001|Overall Study|Withdrawal by Subject|0|||
155262473|NCT03750006|560392814|FG000|Overall Study|Withdrawal by Subject|8|||
155262474|NCT03750006|560392814|FG000|Overall Study|COVID PANDEMIC|11|||
155262475|NCT05619003|560392815|FG000|Overall Study|Adverse Event|1|||
155262476|NCT03538951|560392816|FG000|Overall Study|Withdrawal by Subject|1|||
155262477|NCT03538951|560392817|FG001|Overall Study|Withdrawal by Subject|2|||
155262478|NCT07018999|560392822|FG000|Overall Study|Protocol Violation|0|||
155262479|NCT07018999|560392823|FG001|Overall Study|Protocol Violation|1|||
155262480|NCT07018999|560392822|FG000|Overall Study|Incomplete data entry|4|||
155262481|NCT07018999|560392823|FG001|Overall Study|Incomplete data entry|7|||
155262482|NCT03444376|560392824|FG000|Part A|Disease relapse or Progression|1|||
155262483|NCT03444376|560392824|FG000|Part A|Withdrawal by Subject|2|||
155262484|NCT03444376|560392824|FG000|Part A|Adverse Event|1|||
155262485|NCT03444376|560392824|FG000|Part B|Disease relapse or Progression|18|||
155262486|NCT03444376|560392824|FG000|Part B|Withdrawal by Subject|2|||
155262487|NCT03444376|560392824|FG000|Part B|Adverse Event|2|||
155262488|NCT03444376|560392824|FG000|Part B|Physician Decision|1|||
155262489|NCT03444376|560392824|FG000|Part C|Disease relapse or Progression|43|||
155262490|NCT03444376|560392824|FG000|Part C|Withdrawal by Subject|5|||
155262491|NCT03444376|560392824|FG000|Part C|Adverse Event|2|||
155262492|NCT03444376|560392824|FG000|Part C|Physician Decision|2|||
155262493|NCT03444376|560392824|FG000|Part C|Death|1|||
155262494|NCT00856167|560392826|FG000|Period 1|Withdrawal by Subject|1|||
155262495|NCT00856167|560392827|FG001|Period 1|Withdrawal by Subject|4|||
155262496|NCT00856167|560392828|FG002|Period 1|Withdrawal by Subject|0|||
155262497|NCT00856167|560392829|FG003|Period 1|Withdrawal by Subject|0|||
155262498|NCT00856167|560392826|FG000|Period 1|Lost to Follow-up|2|||
155262499|NCT00856167|560392827|FG001|Period 1|Lost to Follow-up|1|||
155262500|NCT00856167|560392828|FG002|Period 1|Lost to Follow-up|0|||
155262501|NCT00856167|560392829|FG003|Period 1|Lost to Follow-up|0|||
155262502|NCT00856167|560392826|FG000|Period 2|Lost to Follow-up|0|||
155262503|NCT00856167|560392827|FG001|Period 2|Lost to Follow-up|0|||
155262504|NCT00856167|560392828|FG002|Period 2|Lost to Follow-up|3|||
155262505|NCT00856167|560392829|FG003|Period 2|Lost to Follow-up|1|||
155262506|NCT00856167|560392826|FG000|Period 2|Withdrawal by Subject|0|||
155262507|NCT00856167|560392827|FG001|Period 2|Withdrawal by Subject|0|||
155262508|NCT00856167|560392828|FG002|Period 2|Withdrawal by Subject|2|||
155262509|NCT00856167|560392829|FG003|Period 2|Withdrawal by Subject|4|||
155262510|NCT03237858|560394476|FG000|Overall Study|Death|19|||
155262511|NCT03237858|560394476|FG000|Overall Study|Withdrawal by Subject|37|||
155262512|NCT02026232|560394479|FG000|Overall Study|incomplete visit/missing data|3|||
155262513|NCT02026232|560394480|FG001|Overall Study|incomplete visit/missing data|2|||
155262514|NCT01108458|560394481|FG000|Overall Study|Withdrawal by Subject|1|||
155262515|NCT01382602|560394482|FG000|Overall Study|Protocol Violation|0|||
155262516|NCT01382602|560394483|FG001|Overall Study|Protocol Violation|3|||
155262517|NCT01382602|560394482|FG000|Overall Study|Withdrawal by Subject|0|||
155262518|NCT01382602|560394483|FG001|Overall Study|Withdrawal by Subject|1|||
155262519|NCT05056870|560394487|FG000|Period 1|Site COVID-19 Related|3|||
155262520|NCT05056870|560394488|FG001|Period 1|Site COVID-19 Related|3|||
155262521|NCT05056870|560394487|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
155262522|NCT05056870|560394488|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
155262523|NCT05056870|560394487|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
155262524|NCT05056870|560394488|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
155262525|NCT05056870|560394487|FG000|Period 2|COVID-19 Related|1|||
155262526|NCT05056870|560394488|FG001|Period 2|COVID-19 Related|0|||
155262527|NCT05056870|560394487|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
155262528|NCT05056870|560394488|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
155262529|NCT01114204|560394494|FG000|Overall Study|Adverse Event|3|||
155262530|NCT01114204|560394495|FG001|Overall Study|Adverse Event|2|||
155262531|NCT01114204|560394494|FG000|Overall Study|Lost to Follow-up|1|||
155262532|NCT01114204|560394495|FG001|Overall Study|Lost to Follow-up|0|||
155262533|NCT01114204|560394494|FG000|Overall Study|Withdrawal by Subject|10|||
155262534|NCT01114204|560394495|FG001|Overall Study|Withdrawal by Subject|6|||
155262535|NCT01114204|560394494|FG000|Overall Study|Death|1|||
155262536|NCT01114204|560394495|FG001|Overall Study|Death|0|||
155262537|NCT01114204|560394494|FG000|Overall Study|Other-Personal reasons|2|||
155262538|NCT01114204|560394495|FG001|Overall Study|Other-Personal reasons|0|||
155262539|NCT01114204|560394494|FG000|Overall Study|Other-Medical monitor request|1|||
155262540|NCT01114204|560394495|FG001|Overall Study|Other-Medical monitor request|0|||
155262541|NCT01114204|560394494|FG000|Overall Study|Other-Participant request|2|||
155262542|NCT01114204|560394495|FG001|Overall Study|Other-Participant request|0|||
155262543|NCT01114204|560394494|FG000|Overall Study|Other-Protocol Violation|1|||
155262544|NCT01114204|560394495|FG001|Overall Study|Other-Protocol Violation|0|||
155262545|NCT02255357|560394497|FG000|Overall Study|Physician Decision|10|||
155262546|NCT02255357|560394498|FG001|Overall Study|Physician Decision|24|||
155262547|NCT00509236|560394501|FG000|Overall Study|Adverse Event|7|||
155262548|NCT00509236|560394502|FG001|Overall Study|Adverse Event|9|||
155262549|NCT00509236|560394501|FG000|Overall Study|Withdrawal by Subject|5|||
155262550|NCT00509236|560394502|FG001|Overall Study|Withdrawal by Subject|10|||
155262551|NCT00509236|560394501|FG000|Overall Study|Protocol Violation|3|||
155262552|NCT00509236|560394502|FG001|Overall Study|Protocol Violation|0|||
155262553|NCT00509236|560394501|FG000|Overall Study|Excluded Medication|1|||
155262554|NCT00509236|560394502|FG001|Overall Study|Excluded Medication|1|||
155262555|NCT00509236|560394501|FG000|Overall Study|Scheduled Kidney Transplant|1|||
155262556|NCT00509236|560394502|FG001|Overall Study|Scheduled Kidney Transplant|0|||
155262557|NCT00927355|560394505|FG000|Overall Study|Adverse Event|1|||
155262558|NCT00927355|560394506|FG001|Overall Study|Adverse Event|1|||
155262559|NCT01572389|560394507|FG000|Overall Study|Death|1|||
155262560|NCT01572389|560394508|FG001|Overall Study|Death|3|||
155262561|NCT01572389|560394507|FG000|Overall Study|Withdrawal by Subject|14|||
155262562|NCT01572389|560394508|FG001|Overall Study|Withdrawal by Subject|2|||
155262563|NCT01572389|560394507|FG000|Overall Study|Lost to Follow-up|25|||
155262564|NCT01572389|560394508|FG001|Overall Study|Lost to Follow-up|14|||
155262565|NCT01572389|560394507|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
155262566|NCT01572389|560394508|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
155262567|NCT00499863|560394509|FG000|Overall Study|Lack of Efficacy|21|||
155262568|NCT00499863|560394510|FG001|Overall Study|Lack of Efficacy|27|||
155262569|NCT00499863|560394509|FG000|Overall Study|Protocol Violation|12|||
155262570|NCT00499863|560394510|FG001|Overall Study|Protocol Violation|7|||
155262571|NCT00499863|560394509|FG000|Overall Study|Withdrawal by Subject|6|||
155262572|NCT00499863|560394510|FG001|Overall Study|Withdrawal by Subject|4|||
155262573|NCT00499863|560394509|FG000|Overall Study|Adverse Event|8|||
155262574|NCT00499863|560394510|FG001|Overall Study|Adverse Event|2|||
155262575|NCT00499863|560394509|FG000|Overall Study|Sponsor decision|2|||
155262576|NCT00499863|560394510|FG001|Overall Study|Sponsor decision|2|||
155262577|NCT00499863|560394509|FG000|Overall Study|Lost to Follow-up|1|||
155262578|NCT00499863|560394510|FG001|Overall Study|Lost to Follow-up|1|||
155262579|NCT00571701|560394511|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
155262580|NCT00571701|560394512|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
155262581|NCT00571701|560394511|FG000|First Intervention 12 Months|Death|1|||
155262582|NCT00571701|560394512|FG001|First Intervention 12 Months|Death|0|||
155262583|NCT00571701|560394511|FG000|Second Intervention 12 Months|Adverse Event|0|||
155262584|NCT00571701|560394512|FG001|Second Intervention 12 Months|Adverse Event|1|||
155262585|NCT00571701|560394511|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
155262586|NCT00571701|560394512|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
155262587|NCT00691132|560394515|FG000|Overall Study|Adverse Event|2|||
155262588|NCT00691132|560394516|FG001|Overall Study|Adverse Event|3|||
155262589|NCT00691132|560394515|FG000|Overall Study|Withdrawal by Subject|10|||
155262590|NCT00691132|560394516|FG001|Overall Study|Withdrawal by Subject|10|||
155262591|NCT04766086|560394517|FG000|Overall Study|Lost to Follow-up|3|||
155262592|NCT04766086|560394518|FG001|Overall Study|Lost to Follow-up|5|||
155262593|NCT04766086|560394519|FG002|Overall Study|Lost to Follow-up|3|||
155262594|NCT04766086|560394517|FG000|Overall Study|Withdrawal by Subject|1|||
155262595|NCT04766086|560394518|FG001|Overall Study|Withdrawal by Subject|1|||
155262596|NCT04766086|560394519|FG002|Overall Study|Withdrawal by Subject|2|||
155262597|NCT04766086|560394517|FG000|Overall Study|Other|0|||
155262598|NCT04766086|560394518|FG001|Overall Study|Other|0|||
155262599|NCT04766086|560394519|FG002|Overall Study|Other|1|||
155262600|NCT01959347|560394522|FG000|Overall Study|Protocol Violation|9|||
155262601|NCT01959347|560394523|FG001|Overall Study|Protocol Violation|7|||
155262602|NCT03541044|560394524|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
155262603|NCT03541044|560394525|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
155262604|NCT03541044|560394524|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
155262605|NCT03541044|560394525|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
155262606|NCT01282801|560394526|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
155262607|NCT01282801|560394527|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
155262608|NCT01060553|560394528|FG000|Overall Study|Lost to Follow-up|3|||
155262609|NCT01060553|560394529|FG001|Overall Study|Lost to Follow-up|5|||
155262610|NCT01060553|560394528|FG000|Overall Study|Withdrawal by Subject|5|||
155262611|NCT01060553|560394529|FG001|Overall Study|Withdrawal by Subject|5|||
155262612|NCT01060553|560394528|FG000|Overall Study|Lack of Efficacy|1|||
155262613|NCT01060553|560394529|FG001|Overall Study|Lack of Efficacy|0|||
155262614|NCT00312702|560394530|FG000|Immunization Phase|Lost to Follow-up|0|||
155262615|NCT00312702|560394531|FG001|Immunization Phase|Lost to Follow-up|1|||
155262616|NCT00312702|560394532|FG002|Immunization Phase|Lost to Follow-up|0|||
155262617|NCT01462162|560394535|FG000|Overall Study|Adverse Event|5|||
155262618|NCT01462162|560394535|FG000|Overall Study|Lack of Efficacy|4|||
155262619|NCT01462162|560394535|FG000|Overall Study|Abnormal laboratory parameters|1|||
155262620|NCT01462162|560394535|FG000|Overall Study|Other|2|||
155262621|NCT03485911|560394536|FG000|Part 1|Perceived lack of efficacy|1|||
155262622|NCT03485911|560394537|FG001|Part 1|Perceived lack of efficacy|1|||
155262623|NCT03485911|560394538|FG002|Part 1|Perceived lack of efficacy|2|||
155262624|NCT03485911|560394539|FG003|Part 1|Perceived lack of efficacy|0|||
155262625|NCT03485911|560394536|FG000|Part 1|Subject withdrew consent|0|||
155262626|NCT03485911|560394537|FG001|Part 1|Subject withdrew consent|1|||
155262627|NCT03485911|560394538|FG002|Part 1|Subject withdrew consent|0|||
155262628|NCT03485911|560394539|FG003|Part 1|Subject withdrew consent|1|||
155262629|NCT03485911|560394536|FG000|Part 1|Lab abnormalities/AEs|3|||
155262630|NCT03485911|560394537|FG001|Part 1|Lab abnormalities/AEs|1|||
155262631|NCT03485911|560394538|FG002|Part 1|Lab abnormalities/AEs|1|||
155262632|NCT03485911|560394539|FG003|Part 1|Lab abnormalities/AEs|0|||
155262633|NCT03485911|560394536|FG000|Part 1|Withdrew Consent prior to dosing|0|||
155262634|NCT03485911|560394537|FG001|Part 1|Withdrew Consent prior to dosing|0|||
155262635|NCT03485911|560394538|FG002|Part 1|Withdrew Consent prior to dosing|0|||
155262636|NCT03485911|560394539|FG003|Part 1|Withdrew Consent prior to dosing|1|||
155262637|NCT03485911|560394536|FG000|Part 1|Other NOS|0|||
155262638|NCT03485911|560394537|FG001|Part 1|Other NOS|0|||
155262639|NCT03485911|560394538|FG002|Part 1|Other NOS|0|||
155262640|NCT03485911|560394539|FG003|Part 1|Other NOS|1|||
155262641|NCT03485911|560394536|FG000|Part 2|Perceived lack of efficacy|5|||
155262642|NCT03485911|560394537|FG001|Part 2|Perceived lack of efficacy|3|||
155262643|NCT03485911|560394538|FG002|Part 2|Perceived lack of efficacy|0|||
155262644|NCT03485911|560394539|FG003|Part 2|Perceived lack of efficacy|2|||
155262645|NCT03485911|560394536|FG000|Part 2|Subject withdrew consent|1|||
155262646|NCT03485911|560394537|FG001|Part 2|Subject withdrew consent|0|||
155262647|NCT03485911|560394538|FG002|Part 2|Subject withdrew consent|2|||
155262648|NCT03485911|560394539|FG003|Part 2|Subject withdrew consent|1|||
155262649|NCT03485911|560394536|FG000|Part 2|Lab abnormalities/AEs|1|||
155262650|NCT03485911|560394537|FG001|Part 2|Lab abnormalities/AEs|2|||
155262651|NCT03485911|560394538|FG002|Part 2|Lab abnormalities/AEs|0|||
155262652|NCT03485911|560394539|FG003|Part 2|Lab abnormalities/AEs|0|||
155262653|NCT03485911|560394536|FG000|Part 2|Other NOS|0|||
155262654|NCT03485911|560394537|FG001|Part 2|Other NOS|1|||
155262655|NCT03485911|560394538|FG002|Part 2|Other NOS|0|||
155262656|NCT03485911|560394539|FG003|Part 2|Other NOS|0|||
155262657|NCT03485911|560394536|FG000|Part 2|Intercurrent illness/new medical condition|1|||
155262658|NCT03485911|560394537|FG001|Part 2|Intercurrent illness/new medical condition|0|||
155262659|NCT03485911|560394538|FG002|Part 2|Intercurrent illness/new medical condition|0|||
155262660|NCT03485911|560394539|FG003|Part 2|Intercurrent illness/new medical condition|0|||
155262661|NCT03485911|560394536|FG000|Part 2|Investigator judgement|1|||
155262662|NCT03485911|560394537|FG001|Part 2|Investigator judgement|0|||
155262663|NCT03485911|560394538|FG002|Part 2|Investigator judgement|0|||
155262664|NCT03485911|560394539|FG003|Part 2|Investigator judgement|0|||
155262665|NCT03485911|560394536|FG000|Part 3|Perceived lack of efficacy|2|||
155262666|NCT03485911|560394537|FG001|Part 3|Perceived lack of efficacy|2|||
155262667|NCT03485911|560394538|FG002|Part 3|Perceived lack of efficacy|2|||
155262668|NCT03485911|560394539|FG003|Part 3|Perceived lack of efficacy|0|||
155262669|NCT03485911|560394536|FG000|Part 3|Subject withdrew consent|1|||
155262670|NCT03485911|560394537|FG001|Part 3|Subject withdrew consent|4|||
155262671|NCT03485911|560394538|FG002|Part 3|Subject withdrew consent|0|||
155262672|NCT03485911|560394539|FG003|Part 3|Subject withdrew consent|1|||
155262673|NCT03485911|560394536|FG000|Part 3|Lab abnormalities/AEs|1|||
155262674|NCT03485911|560394537|FG001|Part 3|Lab abnormalities/AEs|1|||
155262675|NCT03485911|560394538|FG002|Part 3|Lab abnormalities/AEs|0|||
155262676|NCT03485911|560394539|FG003|Part 3|Lab abnormalities/AEs|2|||
155262677|NCT03485911|560394536|FG000|Part 3|Other NOS|1|||
155262678|NCT03485911|560394537|FG001|Part 3|Other NOS|1|||
155262679|NCT03485911|560394538|FG002|Part 3|Other NOS|0|||
155262680|NCT03485911|560394539|FG003|Part 3|Other NOS|0|||
155262681|NCT03485911|560394536|FG000|Part 3|Intercurrent illness/new medical condition|0|||
155262682|NCT03485911|560394537|FG001|Part 3|Intercurrent illness/new medical condition|1|||
155262683|NCT03485911|560394538|FG002|Part 3|Intercurrent illness/new medical condition|1|||
155262684|NCT03485911|560394539|FG003|Part 3|Intercurrent illness/new medical condition|0|||
155262685|NCT03485911|560394536|FG000|Part 3|Sponsor discontinuation|1|||
155262686|NCT03485911|560394537|FG001|Part 3|Sponsor discontinuation|0|||
155262687|NCT03485911|560394538|FG002|Part 3|Sponsor discontinuation|0|||
155262688|NCT03485911|560394539|FG003|Part 3|Sponsor discontinuation|0|||
155262689|NCT03485911|560394536|FG000|Part 3|Berotralstat provided by alternative means|13|||
155262690|NCT03485911|560394537|FG001|Part 3|Berotralstat provided by alternative means|13|||
155262691|NCT03485911|560394538|FG002|Part 3|Berotralstat provided by alternative means|7|||
155262692|NCT03485911|560394539|FG003|Part 3|Berotralstat provided by alternative means|7|||
155262693|NCT01215357|560394540|FG000|Overall Study|Withdrawal by Subject|3|||
155262694|NCT01215357|560394540|FG000|Overall Study|Protocol Violation|9|||
155262695|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
155262696|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
155262697|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
155262698|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
155262699|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
155262700|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
155262701|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
155262702|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
155262703|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
155262704|NCT03333928|560394541|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
155262705|NCT03333928|560394542|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
155262706|NCT03333928|560394543|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
155262707|NCT03333928|560394541|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
155262708|NCT03333928|560394542|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
155262709|NCT03333928|560394543|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
155262710|NCT03333928|560394541|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
155262711|NCT03333928|560394542|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
155262712|NCT03333928|560394543|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
155262713|NCT03333928|560394541|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
155262714|NCT03333928|560394542|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
155262715|NCT03333928|560394543|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
155262716|NCT03333928|560394541|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
155262717|NCT03333928|560394542|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
155262718|NCT03333928|560394543|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
155262719|NCT01674621|560394554|FG000|Overall Study|Adverse Event|3|||
155262720|NCT01674621|560394555|FG001|Overall Study|Adverse Event|2|||
155262721|NCT01674621|560394556|FG002|Overall Study|Adverse Event|5|||
155262722|NCT01674621|560394557|FG003|Overall Study|Adverse Event|5|||
155262723|NCT01674621|560394558|FG004|Overall Study|Adverse Event|1|||
155262724|NCT01674621|560394554|FG000|Overall Study|Inability to Complete Study Procedures|0|||
155262725|NCT01674621|560394555|FG001|Overall Study|Inability to Complete Study Procedures|0|||
155262726|NCT01674621|560394556|FG002|Overall Study|Inability to Complete Study Procedures|0|||
155262727|NCT01674621|560394557|FG003|Overall Study|Inability to Complete Study Procedures|0|||
155262728|NCT01674621|560394558|FG004|Overall Study|Inability to Complete Study Procedures|2|||
155262729|NCT01674621|560394554|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262730|NCT01674621|560394555|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262731|NCT01674621|560394556|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262732|NCT01674621|560394557|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
155262733|NCT01674621|560394558|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
155262734|NCT01674621|560394554|FG000|Overall Study|Withdrawal by Subject|2|||
155262735|NCT01674621|560394555|FG001|Overall Study|Withdrawal by Subject|5|||
155262736|NCT01674621|560394556|FG002|Overall Study|Withdrawal by Subject|2|||
155262737|NCT01674621|560394557|FG003|Overall Study|Withdrawal by Subject|0|||
155262738|NCT01674621|560394558|FG004|Overall Study|Withdrawal by Subject|1|||
155262739|NCT01674621|560394554|FG000|Overall Study|Other than specified|0|||
155262740|NCT01674621|560394555|FG001|Overall Study|Other than specified|1|||
155262741|NCT01674621|560394556|FG002|Overall Study|Other than specified|0|||
155262742|NCT01674621|560394557|FG003|Overall Study|Other than specified|0|||
155262743|NCT01674621|560394558|FG004|Overall Study|Other than specified|2|||
155262744|NCT01859793|560394559|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
155262745|NCT01859793|560394560|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
155262746|NCT01859793|560394559|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
155262747|NCT01859793|560394560|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
155262748|NCT01859793|560394559|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
155262749|NCT01859793|560394560|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
155262750|NCT01859793|560394559|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
155262751|NCT01859793|560394560|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
155262752|NCT04543188|560394561|FG000|Phase 1a|Adverse Event|0|||
155262753|NCT04543188|560394562|FG001|Phase 1a|Adverse Event|0|||
155262754|NCT04543188|560394563|FG002|Phase 1a|Adverse Event|0|||
155262755|NCT04543188|560394564|FG003|Phase 1a|Adverse Event|1|||
155262756|NCT04543188|560394565|FG004|Phase 1a|Adverse Event|0|||
155262757|NCT04543188|560394566|FG005|Phase 1a|Adverse Event|0|||
155262758|NCT04543188|560394567|FG006|Phase 1a|Adverse Event|1|||
155262759|NCT04543188|560394568|FG007|Phase 1a|Adverse Event|0|||
155262760|NCT04543188|560394569|FG008|Phase 1a|Adverse Event|0|||
155262761|NCT04543188|560394570|FG009|Phase 1a|Adverse Event|0|||
155262762|NCT04543188|560394571|FG010|Phase 1a|Adverse Event|0|||
155262763|NCT04543188|560394572|FG011|Phase 1a|Adverse Event|0|||
155262764|NCT04543188|560394573|FG012|Phase 1a|Adverse Event|0|||
155262765|NCT04543188|560394574|FG013|Phase 1a|Adverse Event|0|||
155262766|NCT04543188|560394575|FG014|Phase 1a|Adverse Event|0|||
155262767|NCT04543188|560394561|FG000|Phase 1a|Other (Death)|0|||
155262768|NCT04543188|560394562|FG001|Phase 1a|Other (Death)|1|||
155262769|NCT04543188|560394563|FG002|Phase 1a|Other (Death)|0|||
155262770|NCT04543188|560394564|FG003|Phase 1a|Other (Death)|0|||
155262771|NCT04543188|560394565|FG004|Phase 1a|Other (Death)|1|||
155262772|NCT04543188|560394566|FG005|Phase 1a|Other (Death)|0|||
155262773|NCT04543188|560394567|FG006|Phase 1a|Other (Death)|0|||
155262774|NCT04543188|560394568|FG007|Phase 1a|Other (Death)|0|||
155262775|NCT04543188|560394569|FG008|Phase 1a|Other (Death)|0|||
155262776|NCT04543188|560394570|FG009|Phase 1a|Other (Death)|1|||
155262777|NCT04543188|560394571|FG010|Phase 1a|Other (Death)|0|||
155262778|NCT04543188|560394572|FG011|Phase 1a|Other (Death)|0|||
155262779|NCT04543188|560394573|FG012|Phase 1a|Other (Death)|0|||
155262780|NCT04543188|560394574|FG013|Phase 1a|Other (Death)|0|||
155262781|NCT04543188|560394575|FG014|Phase 1a|Other (Death)|0|||
155262782|NCT04543188|560394561|FG000|Phase 1a|Lost to Follow-up|0|||
155262783|NCT04543188|560394562|FG001|Phase 1a|Lost to Follow-up|0|||
155262784|NCT04543188|560394563|FG002|Phase 1a|Lost to Follow-up|0|||
155262785|NCT04543188|560394564|FG003|Phase 1a|Lost to Follow-up|0|||
155262786|NCT04543188|560394565|FG004|Phase 1a|Lost to Follow-up|0|||
155262787|NCT04543188|560394566|FG005|Phase 1a|Lost to Follow-up|0|||
155262788|NCT04543188|560394567|FG006|Phase 1a|Lost to Follow-up|0|||
155262789|NCT04543188|560394568|FG007|Phase 1a|Lost to Follow-up|0|||
155262790|NCT04543188|560394569|FG008|Phase 1a|Lost to Follow-up|0|||
155262791|NCT04543188|560394570|FG009|Phase 1a|Lost to Follow-up|0|||
155262792|NCT04543188|560394571|FG010|Phase 1a|Lost to Follow-up|1|||
155262793|NCT04543188|560394572|FG011|Phase 1a|Lost to Follow-up|0|||
155262794|NCT04543188|560394573|FG012|Phase 1a|Lost to Follow-up|0|||
155262795|NCT04543188|560394574|FG013|Phase 1a|Lost to Follow-up|0|||
155262796|NCT04543188|560394575|FG014|Phase 1a|Lost to Follow-up|0|||
155262797|NCT04543188|560394561|FG000|Phase 1a|Progressive Disease|2|||
155262798|NCT04543188|560394562|FG001|Phase 1a|Progressive Disease|2|||
155262799|NCT04543188|560394563|FG002|Phase 1a|Progressive Disease|3|||
155262800|NCT04543188|560394564|FG003|Phase 1a|Progressive Disease|1|||
155262801|NCT04543188|560394565|FG004|Phase 1a|Progressive Disease|4|||
155262802|NCT04543188|560394566|FG005|Phase 1a|Progressive Disease|2|||
155262803|NCT04543188|560394567|FG006|Phase 1a|Progressive Disease|3|||
155262804|NCT04543188|560394568|FG007|Phase 1a|Progressive Disease|4|||
155262805|NCT04543188|560394569|FG008|Phase 1a|Progressive Disease|1|||
155262806|NCT04543188|560394570|FG009|Phase 1a|Progressive Disease|0|||
155262807|NCT04543188|560394571|FG010|Phase 1a|Progressive Disease|4|||
155262808|NCT04543188|560394572|FG011|Phase 1a|Progressive Disease|0|||
155262809|NCT04543188|560394573|FG012|Phase 1a|Progressive Disease|0|||
155262810|NCT04543188|560394574|FG013|Phase 1a|Progressive Disease|0|||
155262811|NCT04543188|560394575|FG014|Phase 1a|Progressive Disease|0|||
155262812|NCT04543188|560394561|FG000|Phase 1a|Study terminated by sponsor|0|||
155262813|NCT04543188|560394562|FG001|Phase 1a|Study terminated by sponsor|0|||
155262814|NCT04543188|560394563|FG002|Phase 1a|Study terminated by sponsor|0|||
155262815|NCT04543188|560394564|FG003|Phase 1a|Study terminated by sponsor|0|||
155262816|NCT04543188|560394565|FG004|Phase 1a|Study terminated by sponsor|1|||
155262817|NCT04543188|560394566|FG005|Phase 1a|Study terminated by sponsor|0|||
155262818|NCT04543188|560394567|FG006|Phase 1a|Study terminated by sponsor|0|||
155262819|NCT04543188|560394568|FG007|Phase 1a|Study terminated by sponsor|0|||
155262820|NCT04543188|560394569|FG008|Phase 1a|Study terminated by sponsor|0|||
155262821|NCT04543188|560394570|FG009|Phase 1a|Study terminated by sponsor|0|||
155262822|NCT04543188|560394571|FG010|Phase 1a|Study terminated by sponsor|1|||
155262823|NCT04543188|560394572|FG011|Phase 1a|Study terminated by sponsor|0|||
155262824|NCT04543188|560394573|FG012|Phase 1a|Study terminated by sponsor|0|||
155262825|NCT04543188|560394574|FG013|Phase 1a|Study terminated by sponsor|0|||
155262826|NCT04543188|560394575|FG014|Phase 1a|Study terminated by sponsor|0|||
155262827|NCT04543188|560394561|FG000|Phase 1a|Withdrawal by Subject|0|||
155262828|NCT04543188|560394562|FG001|Phase 1a|Withdrawal by Subject|0|||
155262829|NCT04543188|560394563|FG002|Phase 1a|Withdrawal by Subject|0|||
155262830|NCT04543188|560394564|FG003|Phase 1a|Withdrawal by Subject|0|||
155262831|NCT04543188|560394565|FG004|Phase 1a|Withdrawal by Subject|3|||
155262832|NCT04543188|560394566|FG005|Phase 1a|Withdrawal by Subject|0|||
155262833|NCT04543188|560394567|FG006|Phase 1a|Withdrawal by Subject|0|||
155262834|NCT04543188|560394568|FG007|Phase 1a|Withdrawal by Subject|0|||
155262835|NCT04543188|560394569|FG008|Phase 1a|Withdrawal by Subject|1|||
155262836|NCT04543188|560394570|FG009|Phase 1a|Withdrawal by Subject|1|||
155262837|NCT04543188|560394571|FG010|Phase 1a|Withdrawal by Subject|2|||
155262838|NCT04543188|560394572|FG011|Phase 1a|Withdrawal by Subject|0|||
155262839|NCT04543188|560394573|FG012|Phase 1a|Withdrawal by Subject|0|||
155262840|NCT04543188|560394574|FG013|Phase 1a|Withdrawal by Subject|0|||
155262841|NCT04543188|560394575|FG014|Phase 1a|Withdrawal by Subject|0|||
155262842|NCT04543188|560394561|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
155262843|NCT04543188|560394562|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
155262844|NCT04543188|560394563|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
155262845|NCT04543188|560394564|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
155262846|NCT04543188|560394565|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
155262847|NCT04543188|560394566|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
155262848|NCT04543188|560394567|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
155262849|NCT04543188|560394568|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
155262850|NCT04543188|560394569|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
155262851|NCT04543188|560394570|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
155262852|NCT04543188|560394571|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
155262853|NCT04543188|560394572|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
155262854|NCT04543188|560394573|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
155262855|NCT04543188|560394574|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
155262856|NCT04543188|560394575|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
155262857|NCT04543188|560394561|FG000|Phase 1a|Other|0|||
155262858|NCT04543188|560394562|FG001|Phase 1a|Other|0|||
155262859|NCT04543188|560394563|FG002|Phase 1a|Other|0|||
155262860|NCT04543188|560394564|FG003|Phase 1a|Other|0|||
155262861|NCT04543188|560394565|FG004|Phase 1a|Other|0|||
155262862|NCT04543188|560394566|FG005|Phase 1a|Other|0|||
155262863|NCT04543188|560394567|FG006|Phase 1a|Other|0|||
155262864|NCT04543188|560394568|FG007|Phase 1a|Other|0|||
155262865|NCT04543188|560394569|FG008|Phase 1a|Other|0|||
155262866|NCT04543188|560394570|FG009|Phase 1a|Other|1|||
155262867|NCT04543188|560394571|FG010|Phase 1a|Other|0|||
155262868|NCT04543188|560394572|FG011|Phase 1a|Other|0|||
155262869|NCT04543188|560394573|FG012|Phase 1a|Other|0|||
155262870|NCT04543188|560394574|FG013|Phase 1a|Other|0|||
155262871|NCT04543188|560394575|FG014|Phase 1a|Other|0|||
155262872|NCT04543188|560394561|FG000|Phase 1b|Adverse Event|0|||
155262873|NCT04543188|560394562|FG001|Phase 1b|Adverse Event|0|||
155262874|NCT04543188|560394563|FG002|Phase 1b|Adverse Event|0|||
155262875|NCT04543188|560394564|FG003|Phase 1b|Adverse Event|0|||
155262876|NCT04543188|560394565|FG004|Phase 1b|Adverse Event|0|||
155262877|NCT04543188|560394566|FG005|Phase 1b|Adverse Event|0|||
155262878|NCT04543188|560394567|FG006|Phase 1b|Adverse Event|0|||
155262879|NCT04543188|560394568|FG007|Phase 1b|Adverse Event|0|||
155262880|NCT04543188|560394569|FG008|Phase 1b|Adverse Event|0|||
155262881|NCT04543188|560394570|FG009|Phase 1b|Adverse Event|0|||
155262882|NCT04543188|560394571|FG010|Phase 1b|Adverse Event|0|||
155262883|NCT04543188|560394572|FG011|Phase 1b|Adverse Event|0|||
155262884|NCT04543188|560394573|FG012|Phase 1b|Adverse Event|0|||
155262885|NCT04543188|560394574|FG013|Phase 1b|Adverse Event|0|||
155262886|NCT04543188|560394575|FG014|Phase 1b|Adverse Event|2|||
155262887|NCT04543188|560394561|FG000|Phase 1b|Other (Death)|0|||
155262888|NCT04543188|560394562|FG001|Phase 1b|Other (Death)|0|||
155262889|NCT04543188|560394563|FG002|Phase 1b|Other (Death)|0|||
155262890|NCT04543188|560394564|FG003|Phase 1b|Other (Death)|0|||
155262891|NCT04543188|560394565|FG004|Phase 1b|Other (Death)|0|||
155262892|NCT04543188|560394566|FG005|Phase 1b|Other (Death)|0|||
155262893|NCT04543188|560394567|FG006|Phase 1b|Other (Death)|0|||
155262894|NCT04543188|560394568|FG007|Phase 1b|Other (Death)|0|||
155262895|NCT04543188|560394569|FG008|Phase 1b|Other (Death)|0|||
155262896|NCT04543188|560394570|FG009|Phase 1b|Other (Death)|0|||
155262897|NCT04543188|560394571|FG010|Phase 1b|Other (Death)|0|||
155262898|NCT04543188|560394572|FG011|Phase 1b|Other (Death)|0|||
155262899|NCT04543188|560394573|FG012|Phase 1b|Other (Death)|1|||
155262900|NCT04543188|560394574|FG013|Phase 1b|Other (Death)|0|||
155262901|NCT04543188|560394575|FG014|Phase 1b|Other (Death)|1|||
155262902|NCT04543188|560394561|FG000|Phase 1b|Progressive Disease|0|||
155262903|NCT04543188|560394562|FG001|Phase 1b|Progressive Disease|0|||
155262904|NCT04543188|560394563|FG002|Phase 1b|Progressive Disease|0|||
155262905|NCT04543188|560394564|FG003|Phase 1b|Progressive Disease|0|||
155262906|NCT04543188|560394565|FG004|Phase 1b|Progressive Disease|0|||
155262907|NCT04543188|560394566|FG005|Phase 1b|Progressive Disease|0|||
155262908|NCT04543188|560394567|FG006|Phase 1b|Progressive Disease|0|||
155262909|NCT04543188|560394568|FG007|Phase 1b|Progressive Disease|0|||
155262910|NCT04543188|560394569|FG008|Phase 1b|Progressive Disease|0|||
155262911|NCT04543188|560394570|FG009|Phase 1b|Progressive Disease|0|||
155262912|NCT04543188|560394571|FG010|Phase 1b|Progressive Disease|0|||
155262913|NCT04543188|560394572|FG011|Phase 1b|Progressive Disease|0|||
155262914|NCT04543188|560394573|FG012|Phase 1b|Progressive Disease|2|||
155262915|NCT04543188|560394574|FG013|Phase 1b|Progressive Disease|1|||
155262916|NCT04543188|560394575|FG014|Phase 1b|Progressive Disease|5|||
155262917|NCT04543188|560394561|FG000|Phase 1b|Study Terminated By Sponsor|0|||
155262918|NCT04543188|560394562|FG001|Phase 1b|Study Terminated By Sponsor|0|||
155262919|NCT04543188|560394563|FG002|Phase 1b|Study Terminated By Sponsor|0|||
155262920|NCT04543188|560394564|FG003|Phase 1b|Study Terminated By Sponsor|0|||
155262921|NCT04543188|560394565|FG004|Phase 1b|Study Terminated By Sponsor|0|||
155262922|NCT04543188|560394566|FG005|Phase 1b|Study Terminated By Sponsor|0|||
155262923|NCT04543188|560394567|FG006|Phase 1b|Study Terminated By Sponsor|0|||
155262924|NCT04543188|560394568|FG007|Phase 1b|Study Terminated By Sponsor|0|||
155262925|NCT04543188|560394569|FG008|Phase 1b|Study Terminated By Sponsor|0|||
155262926|NCT04543188|560394570|FG009|Phase 1b|Study Terminated By Sponsor|0|||
155262927|NCT04543188|560394571|FG010|Phase 1b|Study Terminated By Sponsor|0|||
155262928|NCT04543188|560394572|FG011|Phase 1b|Study Terminated By Sponsor|1|||
155262929|NCT04543188|560394573|FG012|Phase 1b|Study Terminated By Sponsor|1|||
155262930|NCT04543188|560394574|FG013|Phase 1b|Study Terminated By Sponsor|0|||
155262931|NCT04543188|560394575|FG014|Phase 1b|Study Terminated By Sponsor|1|||
155262932|NCT04543188|560394561|FG000|Phase 1b|Withdrawal by Subject|0|||
155262933|NCT04543188|560394562|FG001|Phase 1b|Withdrawal by Subject|0|||
155262934|NCT04543188|560394563|FG002|Phase 1b|Withdrawal by Subject|0|||
155262935|NCT04543188|560394564|FG003|Phase 1b|Withdrawal by Subject|0|||
155262936|NCT04543188|560394565|FG004|Phase 1b|Withdrawal by Subject|0|||
155262937|NCT04543188|560394566|FG005|Phase 1b|Withdrawal by Subject|0|||
155262938|NCT04543188|560394567|FG006|Phase 1b|Withdrawal by Subject|0|||
155262939|NCT04543188|560394568|FG007|Phase 1b|Withdrawal by Subject|0|||
155262940|NCT04543188|560394569|FG008|Phase 1b|Withdrawal by Subject|0|||
155262941|NCT04543188|560394570|FG009|Phase 1b|Withdrawal by Subject|0|||
155262942|NCT04543188|560394571|FG010|Phase 1b|Withdrawal by Subject|0|||
155262943|NCT04543188|560394572|FG011|Phase 1b|Withdrawal by Subject|0|||
155262944|NCT04543188|560394573|FG012|Phase 1b|Withdrawal by Subject|0|||
155262945|NCT04543188|560394574|FG013|Phase 1b|Withdrawal by Subject|0|||
155262946|NCT04543188|560394575|FG014|Phase 1b|Withdrawal by Subject|2|||
155262947|NCT03815019|560394576|FG000|Overall Study|Withdrawal by Subject|6|||
155262948|NCT03815019|560394577|FG001|Overall Study|Withdrawal by Subject|8|||
155262949|NCT05960097|560394580|FG000|Overall Study|Lost to Follow-up|3|||
155262950|NCT05960097|560394581|FG001|Overall Study|Lost to Follow-up|1|||
155262951|NCT05960097|560394582|FG002|Overall Study|Lost to Follow-up|1|||
155262952|NCT05960097|560394583|FG003|Overall Study|Lost to Follow-up|2|||
155262953|NCT05960097|560394584|FG004|Overall Study|Lost to Follow-up|1|||
155262954|NCT05960097|560394585|FG005|Overall Study|Lost to Follow-up|1|||
155262955|NCT05960097|560394586|FG006|Overall Study|Lost to Follow-up|2|||
155262956|NCT05960097|560394587|FG007|Overall Study|Lost to Follow-up|3|||
155262957|NCT05960097|560394580|FG000|Overall Study|Physician Decision|0|||
155262958|NCT05960097|560394581|FG001|Overall Study|Physician Decision|0|||
155262959|NCT05960097|560394582|FG002|Overall Study|Physician Decision|0|||
155262960|NCT05960097|560394583|FG003|Overall Study|Physician Decision|0|||
155262961|NCT05960097|560394584|FG004|Overall Study|Physician Decision|0|||
155262962|NCT05960097|560394585|FG005|Overall Study|Physician Decision|0|||
155262963|NCT05960097|560394586|FG006|Overall Study|Physician Decision|1|||
155262964|NCT05960097|560394587|FG007|Overall Study|Physician Decision|0|||
155262965|NCT05960097|560394580|FG000|Overall Study|Withdrawal by Subject|1|||
155262966|NCT05960097|560394581|FG001|Overall Study|Withdrawal by Subject|0|||
155262967|NCT05960097|560394582|FG002|Overall Study|Withdrawal by Subject|0|||
155262968|NCT05960097|560394583|FG003|Overall Study|Withdrawal by Subject|1|||
155262969|NCT05960097|560394584|FG004|Overall Study|Withdrawal by Subject|1|||
155262970|NCT05960097|560394585|FG005|Overall Study|Withdrawal by Subject|0|||
155262971|NCT05960097|560394586|FG006|Overall Study|Withdrawal by Subject|0|||
155262972|NCT05960097|560394587|FG007|Overall Study|Withdrawal by Subject|0|||
155262973|NCT05960097|560394580|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262974|NCT05960097|560394581|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262975|NCT05960097|560394582|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
155262976|NCT05960097|560394583|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262977|NCT05960097|560394584|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262978|NCT05960097|560394585|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262979|NCT05960097|560394586|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262980|NCT05960097|560394587|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
155262981|NCT01784068|560394588|FG000|NTCS Phase|Adverse Event|5|||
155262982|NCT01784068|560394589|FG001|NTCS Phase|Adverse Event|0|||
155262983|NCT01784068|560394588|FG000|NTCS Phase|Physician Decision|2|||
155262984|NCT01784068|560394589|FG001|NTCS Phase|Physician Decision|0|||
155262985|NCT01784068|560394588|FG000|NTCS Phase|Patient/guardian decision|3|||
155262986|NCT01784068|560394589|FG001|NTCS Phase|Patient/guardian decision|0|||
155262987|NCT01784068|560394588|FG000|NTCS Phase|Death|2|||
155262988|NCT01784068|560394589|FG001|NTCS Phase|Death|0|||
155262989|NCT01784068|560394588|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
155262990|NCT01784068|560394589|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
155262991|NCT01784068|560394588|FG000|TFR Phase|Physician Decision|0|||
155262992|NCT01784068|560394589|FG001|TFR Phase|Physician Decision|1|||
155262993|NCT01784068|560394588|FG000|TFR Phase|Patient/guardian decision|0|||
155262994|NCT01784068|560394589|FG001|TFR Phase|Patient/guardian decision|3|||
155262995|NCT01784068|560394588|FG000|TFR Phase|Death|0|||
155262996|NCT01784068|560394589|FG001|TFR Phase|Death|1|||
155262997|NCT01784068|560394588|FG000|TFR Phase|Lack of Efficacy|0|||
155262998|NCT01784068|560394589|FG001|TFR Phase|Lack of Efficacy|88|||
155262999|NCT01489189|560394606|FG000|Overall Study|Withdrawal by Subject|20|||
155263000|NCT01489189|560394607|FG001|Overall Study|Withdrawal by Subject|23|||
155263001|NCT01489189|560394606|FG000|Overall Study|Death|10|||
155263002|NCT01489189|560394607|FG001|Overall Study|Death|8|||
155263003|NCT01489189|560394606|FG000|Overall Study|Missed Visit|1|||
155263004|NCT01489189|560394607|FG001|Overall Study|Missed Visit|4|||
155263005|NCT00112580|560394608|FG000|Overall Study|Adverse Event|1|||
155263006|NCT00112580|560394609|FG001|Overall Study|Adverse Event|2|||
155263007|NCT00112580|560394608|FG000|Overall Study|Disease progression|5|||
155263008|NCT00112580|560394609|FG001|Overall Study|Disease progression|16|||
155263009|NCT00112580|560394608|FG000|Overall Study|Participant withdrew consent|2|||
155263010|NCT00112580|560394609|FG001|Overall Study|Participant withdrew consent|1|||
155263011|NCT06027619|560394610|FG000|Overall Study|Adverse Event|0|||
155263012|NCT06027619|560394611|FG001|Overall Study|Adverse Event|0|||
155263013|NCT06027619|560394612|FG002|Overall Study|Adverse Event|1|||
155263014|NCT03075501|560396316|FG000|Overall Study|Scheduling difficulties|15|||
155263015|NCT03075501|560396317|FG001|Overall Study|Scheduling difficulties|9|||
155263016|NCT03610737|560396324|FG000|Overall Study|Withdrawal by Subject|1|||
155263017|NCT03610737|560396325|FG001|Overall Study|Withdrawal by Subject|5|||
155263018|NCT03610737|560396324|FG000|Overall Study|Death|1|||
155263019|NCT03610737|560396325|FG001|Overall Study|Death|0|||
155263020|NCT03610737|560396324|FG000|Overall Study|Not treated|5|||
155263021|NCT03610737|560396325|FG001|Overall Study|Not treated|2|||
155263022|NCT03610737|560396324|FG000|Overall Study|Missed Visit|1|||
155263023|NCT03610737|560396325|FG001|Overall Study|Missed Visit|2|||
155263024|NCT01392300|560396326|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
155263025|NCT01392300|560396327|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
155263026|NCT01392300|560396328|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
155263027|NCT01392300|560396326|FG000|Main Period (MP)|Withdrawal by Subject|5|||
155263028|NCT01392300|560396327|FG001|Main Period (MP)|Withdrawal by Subject|1|||
155263029|NCT01392300|560396328|FG002|Main Period (MP)|Withdrawal by Subject|0|||
155263030|NCT01392300|560396326|FG000|Main Period (MP)|Lost to Follow-up|3|||
155263031|NCT01392300|560396327|FG001|Main Period (MP)|Lost to Follow-up|3|||
155263032|NCT01392300|560396328|FG002|Main Period (MP)|Lost to Follow-up|0|||
155263033|NCT01392300|560396326|FG000|Main Period (MP)|Non-compliance|1|||
155263034|NCT01392300|560396327|FG001|Main Period (MP)|Non-compliance|0|||
155263035|NCT01392300|560396328|FG002|Main Period (MP)|Non-compliance|0|||
155263036|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
155263037|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
155263038|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
155263039|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
155263040|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
155263041|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
155263042|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
155263043|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
155263044|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
155263045|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Death|0|||
155263046|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Death|0|||
155263047|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Death|4|||
155263048|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
155263049|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
155263050|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
155263051|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
155263052|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
155263053|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
155263054|NCT01392300|560396326|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
155263055|NCT01392300|560396327|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
155263056|NCT01392300|560396328|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
155263057|NCT02207725|560396329|FG000|Overall Study|Did Not Receive Treatment|0|||
155263058|NCT02207725|560396330|FG001|Overall Study|Did Not Receive Treatment|1|||
155263059|NCT02207725|560396331|FG002|Overall Study|Did Not Receive Treatment|1|||
155263060|NCT02207725|560396332|FG003|Overall Study|Did Not Receive Treatment|1|||
155263061|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
155263062|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
155263063|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
155263064|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
155263065|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
155263066|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
155263067|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
155263068|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
155263069|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
155263070|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
155263071|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
155263072|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
155263073|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
155263074|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
155263075|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
155263076|NCT03145766|560396333|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
155263077|NCT03145766|560396334|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
155263078|NCT03145766|560396335|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
155263079|NCT03145766|560396336|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
155263080|NCT03145766|560396337|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
155263081|NCT03145766|560396333|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
155263082|NCT03145766|560396334|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
155263083|NCT03145766|560396335|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
155263084|NCT03145766|560396336|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
155263085|NCT03145766|560396337|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
155263086|NCT03145766|560396333|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
155263087|NCT03145766|560396334|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
155263088|NCT03145766|560396335|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
155263089|NCT03145766|560396336|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
155263090|NCT03145766|560396337|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
155263091|NCT03145766|560396333|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
155263092|NCT03145766|560396334|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
155263093|NCT03145766|560396335|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
155263094|NCT03145766|560396336|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
155263095|NCT03145766|560396337|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
155263096|NCT02799472|560396340|FG000|Overall Study|Withdrawal by Subject|2|||
155263097|NCT02799472|560396341|FG001|Overall Study|Withdrawal by Subject|4|||
155263098|NCT02799472|560396340|FG000|Overall Study|Lack of Efficacy|2|||
155263099|NCT02799472|560396341|FG001|Overall Study|Lack of Efficacy|0|||
155263100|NCT02799472|560396340|FG000|Overall Study|Lost to Follow-up|0|||
155263101|NCT02799472|560396341|FG001|Overall Study|Lost to Follow-up|1|||
155263102|NCT01966003|560396342|FG000|Overall Study|Death|43|||
155263103|NCT01966003|560396343|FG001|Overall Study|Death|36|||
155263104|NCT01966003|560396342|FG000|Overall Study|Protocol Violation|6|||
155263105|NCT01966003|560396343|FG001|Overall Study|Protocol Violation|4|||
155263106|NCT01966003|560396342|FG000|Overall Study|Lost to Follow-up|4|||
155263107|NCT01966003|560396343|FG001|Overall Study|Lost to Follow-up|3|||
155263108|NCT01966003|560396342|FG000|Overall Study|Physician Decision|12|||
155263109|NCT01966003|560396343|FG001|Overall Study|Physician Decision|13|||
155263110|NCT01966003|560396342|FG000|Overall Study|Withdrawal by Subject|29|||
155263111|NCT01966003|560396343|FG001|Overall Study|Withdrawal by Subject|19|||
155263112|NCT01966003|560396342|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
155263113|NCT01966003|560396343|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
155263114|NCT01966003|560396342|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
155263115|NCT01966003|560396343|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
155263116|NCT01966003|560396342|FG000|Overall Study|Other|1|||
155263117|NCT01966003|560396343|FG001|Overall Study|Other|1|||
155263118|NCT02801669|560396344|FG000|Overall Study|Death|66|||
155263119|NCT02801669|560396345|FG001|Overall Study|Death|69|||
155263120|NCT02801669|560396344|FG000|Overall Study|Withdrawal by Subject|81|||
155263121|NCT02801669|560396345|FG001|Overall Study|Withdrawal by Subject|77|||
155263122|NCT02801669|560396344|FG000|Overall Study|Other|4|||
155263123|NCT02801669|560396345|FG001|Overall Study|Other|6|||
155263124|NCT00674570|560396346|FG000|Overall Study|Withdrawal by Subject|0|||
155263125|NCT00674570|560396347|FG001|Overall Study|Withdrawal by Subject|2|||
155263126|NCT00674570|560396348|FG002|Overall Study|Withdrawal by Subject|0|||
155263127|NCT02569437|560396350|FG000|Overall Study|Lost to Follow-up|12|||
155263128|NCT02569437|560396351|FG001|Overall Study|Lost to Follow-up|14|||
155263129|NCT00985985|560396352|FG000|Overall Study|Adverse Event|4|||
155263130|NCT00985985|560396353|FG001|Overall Study|Adverse Event|2|||
155263131|NCT00985985|560396354|FG002|Overall Study|Adverse Event|2|||
155263132|NCT00985985|560396355|FG003|Overall Study|Adverse Event|2|||
155263133|NCT00985985|560396352|FG000|Overall Study|Lost to Follow-up|4|||
155263134|NCT00985985|560396353|FG001|Overall Study|Lost to Follow-up|11|||
155263135|NCT00985985|560396354|FG002|Overall Study|Lost to Follow-up|2|||
155263136|NCT00985985|560396355|FG003|Overall Study|Lost to Follow-up|3|||
155263137|NCT00985985|560396352|FG000|Overall Study|Protocol Violation|1|||
155263138|NCT00985985|560396353|FG001|Overall Study|Protocol Violation|2|||
155263139|NCT00985985|560396354|FG002|Overall Study|Protocol Violation|0|||
155263140|NCT00985985|560396355|FG003|Overall Study|Protocol Violation|1|||
155263141|NCT00985985|560396352|FG000|Overall Study|Lack of Efficacy|5|||
155263142|NCT00985985|560396353|FG001|Overall Study|Lack of Efficacy|6|||
155263143|NCT00985985|560396354|FG002|Overall Study|Lack of Efficacy|1|||
155263144|NCT00985985|560396355|FG003|Overall Study|Lack of Efficacy|3|||
155263145|NCT00985985|560396352|FG000|Overall Study|Withdrawal by Subject|4|||
155263146|NCT00985985|560396353|FG001|Overall Study|Withdrawal by Subject|2|||
155263147|NCT00985985|560396354|FG002|Overall Study|Withdrawal by Subject|2|||
155263148|NCT00985985|560396355|FG003|Overall Study|Withdrawal by Subject|2|||
155263149|NCT00985985|560396352|FG000|Overall Study|Other Reason|6|||
155263150|NCT00985985|560396353|FG001|Overall Study|Other Reason|1|||
155263151|NCT00985985|560396354|FG002|Overall Study|Other Reason|4|||
155263152|NCT00985985|560396355|FG003|Overall Study|Other Reason|2|||
155263153|NCT02343003|560396356|FG000|Overall Study|Withdrawal by Subject|9|||
155263154|NCT02343003|560396357|FG001|Overall Study|Withdrawal by Subject|4|||
155263155|NCT02343003|560396356|FG000|Overall Study|Lost to Follow-up|5|||
155263156|NCT02343003|560396357|FG001|Overall Study|Lost to Follow-up|1|||
155263157|NCT02343003|560396356|FG000|Overall Study|Protocol Violation|1|||
155263158|NCT02343003|560396357|FG001|Overall Study|Protocol Violation|0|||
155263159|NCT02343003|560396356|FG000|Overall Study|Death|0|||
155263160|NCT02343003|560396357|FG001|Overall Study|Death|1|||
155263161|NCT02343003|560396356|FG000|Overall Study|exclusion criteria met|1|||
155263162|NCT02343003|560396357|FG001|Overall Study|exclusion criteria met|1|||
155263163|NCT02343003|560396356|FG000|Overall Study|terminated by sponsor|2|||
155263164|NCT02343003|560396357|FG001|Overall Study|terminated by sponsor|0|||
155263165|NCT01153269|560396360|FG000|Overall Study|Withdrawal by Subject|1|||
155263166|NCT01153269|560396360|FG000|Overall Study|Antiretroviral therapy break|1|||
155263167|NCT02635724|560396371|FG000|Overall Study|Withdrawal by Subject|0|||
155263168|NCT02635724|560396372|FG001|Overall Study|Withdrawal by Subject|1|||
155263169|NCT02635724|560396373|FG002|Overall Study|Withdrawal by Subject|0|||
155263170|NCT02424591|560396378|FG000|Overall Study|Protocol Violation|2|||
155263171|NCT02424591|560396379|FG001|Overall Study|Protocol Violation|3|||
155263172|NCT00770432|560396380|FG000|Overall Study|Other|4|||
155263173|NCT00770432|560396381|FG001|Overall Study|Other|6|||
155263174|NCT00770432|560396380|FG000|Overall Study|Non-compliance|0|||
155263175|NCT00770432|560396381|FG001|Overall Study|Non-compliance|1|||
155263176|NCT01453348|560396382|FG000|Overall Study|Death|0|||
155263177|NCT01453348|560396383|FG001|Overall Study|Death|0|||
155263178|NCT01453348|560396384|FG002|Overall Study|Death|1|||
155263179|NCT01453348|560396382|FG000|Overall Study|Withdrawal by Subject|0|||
155263180|NCT01453348|560396383|FG001|Overall Study|Withdrawal by Subject|1|||
155263181|NCT01453348|560396384|FG002|Overall Study|Withdrawal by Subject|0|||
155263182|NCT01453348|560396382|FG000|Overall Study|Protocol Violation|1|||
155263183|NCT01453348|560396383|FG001|Overall Study|Protocol Violation|0|||
155263184|NCT01453348|560396384|FG002|Overall Study|Protocol Violation|0|||
155263185|NCT01498822|560396387|FG000|Overall Study|Protocol Violation|8|||
155263186|NCT01498822|560396388|FG001|Overall Study|Protocol Violation|4|||
155263187|NCT01498822|560396387|FG000|Overall Study|Other Reason|5|||
155263188|NCT01498822|560396388|FG001|Overall Study|Other Reason|2|||
155263189|NCT01498822|560396387|FG000|Overall Study|Lack of Efficacy|7|||
155263190|NCT01498822|560396388|FG001|Overall Study|Lack of Efficacy|2|||
155263191|NCT01498822|560396387|FG000|Overall Study|AE, non-serious non-fatal|8|||
155263192|NCT01498822|560396388|FG001|Overall Study|AE, non-serious non-fatal|17|||
155263193|NCT01498822|560396387|FG000|Overall Study|SAE, non-fatal|2|||
155263194|NCT01498822|560396388|FG001|Overall Study|SAE, non-fatal|2|||
155263195|NCT01498822|560396387|FG000|Overall Study|Adverse Event, serious fatal|1|||
155263196|NCT01498822|560396388|FG001|Overall Study|Adverse Event, serious fatal|1|||
155263197|NCT01498822|560396387|FG000|Overall Study|Withdrawal by Subject|15|||
155263198|NCT01498822|560396388|FG001|Overall Study|Withdrawal by Subject|25|||
155263199|NCT01498822|560396387|FG000|Overall Study|Lost to Follow-up|8|||
155263200|NCT01498822|560396388|FG001|Overall Study|Lost to Follow-up|3|||
155263201|NCT03592277|560396392|FG000|Overall Study|Withdrawal by Subject|6|||
155263202|NCT03592277|560396393|FG001|Overall Study|Withdrawal by Subject|8|||
155263203|NCT01781390|560396394|FG000|Overall Study|Withdrawal of Consent|0|||
155263204|NCT01781390|560396395|FG001|Overall Study|Withdrawal of Consent|3|||
155263205|NCT01781390|560396396|FG002|Overall Study|Withdrawal of Consent|1|||
155263206|NCT01781390|560396394|FG000|Overall Study|Lost to Follow-up|1|||
155263207|NCT01781390|560396395|FG001|Overall Study|Lost to Follow-up|1|||
155263208|NCT01781390|560396396|FG002|Overall Study|Lost to Follow-up|1|||
155263209|NCT01781390|560396394|FG000|Overall Study|Adverse Event|1|||
155263210|NCT01781390|560396395|FG001|Overall Study|Adverse Event|2|||
155263211|NCT01781390|560396396|FG002|Overall Study|Adverse Event|1|||
155263212|NCT01781390|560396394|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
155263213|NCT01781390|560396395|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
155263214|NCT01781390|560396396|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
155263215|NCT04707196|560396397|FG000|Overall Study|Withdrawal by Subject|9|||
155263216|NCT04707196|560396398|FG001|Overall Study|Withdrawal by Subject|6|||
155263217|NCT04707196|560396397|FG000|Overall Study|Lost to Follow-up|1|||
155263218|NCT04707196|560396398|FG001|Overall Study|Lost to Follow-up|0|||
155263219|NCT04707196|560396397|FG000|Overall Study|Protocol Violation|4|||
155263220|NCT04707196|560396398|FG001|Overall Study|Protocol Violation|1|||
155263221|NCT04707196|560396397|FG000|Overall Study|Adverse Event|2|||
155263222|NCT04707196|560396398|FG001|Overall Study|Adverse Event|2|||
155263223|NCT04707196|560396397|FG000|Overall Study|Death|3|||
155263224|NCT04707196|560396398|FG001|Overall Study|Death|1|||
155263225|NCT04707196|560396397|FG000|Overall Study|Non-compliance with study drug|1|||
155263226|NCT04707196|560396398|FG001|Overall Study|Non-compliance with study drug|0|||
155263227|NCT04707196|560396397|FG000|Overall Study|Progressive disease|9|||
155263228|NCT04707196|560396398|FG001|Overall Study|Progressive disease|10|||
155263229|NCT01862796|560396400|FG000|Overall Study|Prohibited medications|0|||
155263230|NCT01862796|560396401|FG001|Overall Study|Prohibited medications|0|||
155263231|NCT01862796|560396402|FG002|Overall Study|Prohibited medications|1|||
155263232|NCT04404478|560396403|FG000|Overall Study|Withdrawal by Subject|1|||
155263233|NCT04404478|560396404|FG001|Overall Study|Withdrawal by Subject|3|||
155263234|NCT03056534|560396414|FG000|Overall Study|Participant withdrew consent|8|||
155263235|NCT03056534|560396414|FG000|Overall Study|Participant not able to return|6|||
155263236|NCT03056534|560396414|FG000|Overall Study|Lost to Follow-up|37|||
155263237|NCT03056534|560396414|FG000|Overall Study|Investigator judgment|1|||
155263238|NCT03056534|560396414|FG000|Overall Study|Death|4|||
155263239|NCT03056534|560396414|FG000|Overall Study|Adverse Event|1|||
155263240|NCT03056534|560396414|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
155263241|NCT04146896|560396417|FG000|Overall Study|Adverse Event|5|||
155263242|NCT04146896|560396418|FG001|Overall Study|Adverse Event|8|||
155263243|NCT04146896|560396417|FG000|Overall Study|Lack of Efficacy|3|||
155263244|NCT04146896|560396418|FG001|Overall Study|Lack of Efficacy|2|||
155263245|NCT04146896|560396417|FG000|Overall Study|Lost to Follow-up|0|||
155263246|NCT04146896|560396418|FG001|Overall Study|Lost to Follow-up|1|||
155263247|NCT04146896|560396417|FG000|Overall Study|Non-compliance|5|||
155263248|NCT04146896|560396418|FG001|Overall Study|Non-compliance|4|||
155263249|NCT04146896|560396417|FG000|Overall Study|Withdrawal by Subject|3|||
155263250|NCT04146896|560396418|FG001|Overall Study|Withdrawal by Subject|5|||
155263251|NCT04146896|560396417|FG000|Overall Study|Randomized in error|1|||
155263252|NCT04146896|560396418|FG001|Overall Study|Randomized in error|2|||
155263253|NCT01597505|560396419|FG000|Overall Study|Physician Decision|5|||
155263254|NCT01597505|560396420|FG001|Overall Study|Physician Decision|0|||
155263255|NCT01597505|560396419|FG000|Overall Study|Adverse Event|19|||
155263256|NCT01597505|560396420|FG001|Overall Study|Adverse Event|7|||
155263257|NCT01597505|560396419|FG000|Overall Study|Lost to Follow-up|4|||
155263258|NCT01597505|560396420|FG001|Overall Study|Lost to Follow-up|2|||
155263259|NCT01597505|560396419|FG000|Overall Study|Withdrawal by Subject|10|||
155263260|NCT01597505|560396420|FG001|Overall Study|Withdrawal by Subject|18|||
155263261|NCT01597505|560396419|FG000|Overall Study|Other|5|||
155263262|NCT01597505|560396420|FG001|Overall Study|Other|6|||
155263263|NCT01597505|560396419|FG000|Overall Study|Missing|1|||
155263264|NCT01597505|560396420|FG001|Overall Study|Missing|0|||
155263265|NCT02675465|560396421|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263266|NCT02675465|560396422|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263267|NCT02675465|560396423|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
155263268|NCT02675465|560396424|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
155263269|NCT02675465|560396425|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263270|NCT02675465|560396426|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
155263271|NCT02675465|560396421|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263272|NCT02675465|560396422|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263273|NCT02675465|560396423|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
155263274|NCT02675465|560396424|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263275|NCT02675465|560396425|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263276|NCT02675465|560396426|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
155263277|NCT02675465|560396421|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
155263278|NCT02675465|560396422|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
155263279|NCT02675465|560396423|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
155263280|NCT02675465|560396424|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
155263281|NCT02675465|560396425|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
155263282|NCT02675465|560396426|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
155263283|NCT02675465|560396421|FG000|Stage 4: Long Term Extension|Death|0|||
155263284|NCT02675465|560396422|FG001|Stage 4: Long Term Extension|Death|0|||
155263285|NCT02675465|560396423|FG002|Stage 4: Long Term Extension|Death|0|||
155263286|NCT02675465|560396424|FG003|Stage 4: Long Term Extension|Death|1|||
155263287|NCT02675465|560396425|FG004|Stage 4: Long Term Extension|Death|0|||
155263288|NCT02675465|560396426|FG005|Stage 4: Long Term Extension|Death|0|||
155263289|NCT05031078|560396427|FG000|Overall Study|Withdrawal by Subject|0|||
155263290|NCT05031078|560396428|FG001|Overall Study|Withdrawal by Subject|1|||
155263291|NCT05031078|560396429|FG002|Overall Study|Withdrawal by Subject|0|||
155263292|NCT05398796|560396432|FG000|Overall Study|Participant moved from the area|0|||
155263293|NCT05398796|560396433|FG001|Overall Study|Participant moved from the area|1|||
155263294|NCT05398796|560396434|FG002|Overall Study|Participant moved from the area|0|||
155263295|NCT05398796|560396435|FG003|Overall Study|Participant moved from the area|0|||
155263296|NCT05004688|560396436|FG000|Overall Study|Protocol Violation|7|||
155263297|NCT05004688|560396436|FG000|Overall Study|Physician Decision|2|||
155263298|NCT05004688|560396436|FG000|Overall Study|Withdrawal by Subject|2|||
155263299|NCT00728962|560396437|FG000|Implant Placement Surgery|Adverse Event|8|||
155263300|NCT00728962|560396437|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
155263301|NCT00728962|560396437|FG000|Implant Placement Surgery|Protocol Violation|1|||
155263302|NCT00728962|560396437|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
155263303|NCT00728962|560396437|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
155263304|NCT04954586|560396438|FG000|Overall Study|Withdrawal by Subject|5|||
155263305|NCT00532155|560396439|FG000|Overall Study|Adverse Event|66|||
155263306|NCT00532155|560396440|FG001|Overall Study|Adverse Event|123|||
155263307|NCT00532155|560396439|FG000|Overall Study|Lack of Efficacy|332|||
155263308|NCT00532155|560396440|FG001|Overall Study|Lack of Efficacy|255|||
155263309|NCT00532155|560396439|FG000|Overall Study|Protocol Violation|1|||
155263310|NCT00532155|560396440|FG001|Overall Study|Protocol Violation|3|||
155263311|NCT00532155|560396439|FG000|Overall Study|Lost to Follow-up|2|||
155263312|NCT00532155|560396440|FG001|Overall Study|Lost to Follow-up|0|||
155263313|NCT00532155|560396439|FG000|Overall Study|Physician Decision|16|||
155263314|NCT00532155|560396440|FG001|Overall Study|Physician Decision|15|||
155263315|NCT00532155|560396439|FG000|Overall Study|Withdrawal by Subject|23|||
155263316|NCT00532155|560396440|FG001|Overall Study|Withdrawal by Subject|44|||
155263317|NCT00532155|560396439|FG000|Overall Study|Consent withdrawn|5|||
155263318|NCT00532155|560396440|FG001|Overall Study|Consent withdrawn|7|||
155263319|NCT00532155|560396439|FG000|Overall Study|Moved|1|||
155263320|NCT00532155|560396440|FG001|Overall Study|Moved|0|||
155263321|NCT00532155|560396439|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
155263322|NCT00532155|560396440|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
155263323|NCT00532155|560396439|FG000|Overall Study|Occurence of a second cancer|0|||
155263324|NCT00532155|560396440|FG001|Overall Study|Occurence of a second cancer|1|||
155263325|NCT00532155|560396439|FG000|Overall Study|Occurence of a secondary cancer|0|||
155263326|NCT00532155|560396440|FG001|Overall Study|Occurence of a secondary cancer|1|||
155263327|NCT00532155|560396439|FG000|Overall Study|Promotor ended study|1|||
155263328|NCT00532155|560396440|FG001|Overall Study|Promotor ended study|0|||
155263329|NCT00532155|560396439|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
155263330|NCT00532155|560396440|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
155263331|NCT00532155|560396439|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
155263332|NCT00532155|560396440|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
155263333|NCT00532155|560396439|FG000|Overall Study|Study stopped|1|||
155263334|NCT00532155|560396440|FG001|Overall Study|Study stopped|0|||
155263335|NCT00532155|560396439|FG000|Overall Study|Study terminated by sponsor|1|||
155263336|NCT00532155|560396440|FG001|Overall Study|Study terminated by sponsor|0|||
155263337|NCT00532155|560396439|FG000|Overall Study|Study termination stop further treatment|4|||
155263338|NCT00532155|560396440|FG001|Overall Study|Study termination stop further treatment|0|||
155263339|NCT00532155|560396439|FG000|Overall Study|Did not receive study medication|2|||
155263340|NCT00532155|560396440|FG001|Overall Study|Did not receive study medication|6|||
155263341|NCT03483038|560396441|FG000|Overall Study|Subjects still in follow-up|18|||
155263342|NCT02134925|560396442|FG000|Overall Study|Withdrawal by Subject|1|||
155263343|NCT02134925|560396443|FG001|Overall Study|Withdrawal by Subject|0|||
155263344|NCT02134925|560396442|FG000|Overall Study|Cancel|1|||
155263345|NCT02134925|560396443|FG001|Overall Study|Cancel|6|||
155263346|NCT04027348|560396444|FG000|Overall Study|Adverse Event|2|||
155263347|NCT02158884|560396445|FG000|Baseline Assessment|Missed performance assessment|3|||
155263348|NCT02158884|560396445|FG000|Baseline Assessment|Missed SMFA|1|||
155263349|NCT02158884|560396445|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
155263350|NCT02158884|560396445|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
155263351|NCT02158884|560396445|FG000|6 Month Assessment|Missed SMFA|20|||
155263352|NCT02158884|560396445|FG000|12 Month Assessment|Missed SMFA|17|||
155263353|NCT02487472|560396446|FG000|Overall Study|Did not complete telephonic interviews|9|||
155263354|NCT02487472|560396446|FG000|Overall Study|Other|2|||
155263355|NCT01313286|560396447|FG000|Period 1|Withdrawal by Subject|2|||
155263356|NCT01313286|560396448|FG001|Period 1|Withdrawal by Subject|0|||
155263357|NCT04843930|560396449|FG000|Randomization|Withdrawal by Subject|6|||
155263358|NCT04843930|560396450|FG001|Randomization|Withdrawal by Subject|6|||
155263359|NCT04843930|560396451|FG002|Randomization|Withdrawal by Subject|0|||
155263360|NCT04843930|560396452|FG003|Randomization|Withdrawal by Subject|0|||
155263361|NCT04843930|560396449|FG000|Week 6 Assessment|Adverse Event|3|||
155263362|NCT04843930|560396450|FG001|Week 6 Assessment|Adverse Event|0|||
155263363|NCT04843930|560396451|FG002|Week 6 Assessment|Adverse Event|0|||
155263364|NCT04843930|560396452|FG003|Week 6 Assessment|Adverse Event|0|||
155263365|NCT04843930|560396449|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
155263366|NCT04843930|560396450|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
155263367|NCT04843930|560396451|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
155263368|NCT04843930|560396452|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
155263369|NCT04843930|560396449|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
155263370|NCT04843930|560396450|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
155263371|NCT04843930|560396451|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
155263372|NCT04843930|560396452|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
155263373|NCT05158296|560396453|FG000|Overall Study|Sponsor Decision|2|||
155263374|NCT05158296|560396454|FG001|Overall Study|Sponsor Decision|3|||
155263375|NCT05158296|560396455|FG002|Overall Study|Sponsor Decision|2|||
155263376|NCT02552238|560396456|FG000|Overall Study|Withdrawal by Subject|2|||
155263377|NCT02552238|560396456|FG000|Overall Study|Adverse Event|2|||
155263378|NCT04241094|560396460|FG000|Overall Study|Dropped out of treatment|4|||
155263379|NCT04241094|560396460|FG000|Overall Study|Ineligible after clinical assessment|2|||
155263380|NCT04241094|560396460|FG000|Overall Study|Lost to Follow-up|2|||
155263381|NCT01669798|560396461|FG000|Overall Study|Physician Decision|5|||
155263382|NCT05918978|560396462|FG000|Overall Study|Study Terminated by Sponsor|17|||
155263383|NCT05918978|560396463|FG001|Overall Study|Study Terminated by Sponsor|11|||
155263384|NCT05918978|560396462|FG000|Overall Study|Withdrawal by Subject|1|||
155263385|NCT05918978|560396463|FG001|Overall Study|Withdrawal by Subject|1|||
155263386|NCT05918978|560396462|FG000|Overall Study|Adverse Event|1|||
155263387|NCT05918978|560396463|FG001|Overall Study|Adverse Event|0|||
155263388|NCT05918978|560396462|FG000|Overall Study|Other|0|||
155263389|NCT05918978|560396463|FG001|Overall Study|Other|1|||
155263390|NCT00622180|560396464|FG000|Overall Study|Lost to Follow-up|1|||
155263391|NCT00622180|560396465|FG001|Overall Study|Lost to Follow-up|2|||
155263392|NCT00279201|560396466|FG000|Initiation|Death|1|||
155263393|NCT00279201|560396467|FG001|Initiation|Death|5|||
155263394|NCT00279201|560396468|FG002|Initiation|Death|0|||
155263395|NCT00279201|560396469|FG003|Initiation|Death|0|||
155263396|NCT00279201|560396470|FG004|Initiation|Death|0|||
155263397|NCT00279201|560396471|FG005|Initiation|Death|0|||
155263398|NCT00279201|560396466|FG000|Initiation|Adverse Event|6|||
155263399|NCT00279201|560396467|FG001|Initiation|Adverse Event|15|||
155263400|NCT00279201|560396468|FG002|Initiation|Adverse Event|0|||
155263401|NCT00279201|560396469|FG003|Initiation|Adverse Event|0|||
155263402|NCT00279201|560396470|FG004|Initiation|Adverse Event|0|||
155263403|NCT00279201|560396471|FG005|Initiation|Adverse Event|0|||
155263404|NCT00279201|560396466|FG000|Initiation|Lost to Follow-up|42|||
155263405|NCT00279201|560396467|FG001|Initiation|Lost to Follow-up|41|||
155263406|NCT00279201|560396468|FG002|Initiation|Lost to Follow-up|0|||
155263407|NCT00279201|560396469|FG003|Initiation|Lost to Follow-up|0|||
155263408|NCT00279201|560396470|FG004|Initiation|Lost to Follow-up|0|||
155263409|NCT00279201|560396471|FG005|Initiation|Lost to Follow-up|0|||
155263410|NCT00279201|560396466|FG000|Initiation|Entry Criteria Exclusion|7|||
155263411|NCT00279201|560396467|FG001|Initiation|Entry Criteria Exclusion|9|||
155263412|NCT00279201|560396468|FG002|Initiation|Entry Criteria Exclusion|0|||
155263413|NCT00279201|560396469|FG003|Initiation|Entry Criteria Exclusion|0|||
155263414|NCT00279201|560396470|FG004|Initiation|Entry Criteria Exclusion|0|||
155263415|NCT00279201|560396471|FG005|Initiation|Entry Criteria Exclusion|0|||
155263416|NCT00279201|560396466|FG000|Initiation|Protocol Violation|9|||
155263417|NCT00279201|560396467|FG001|Initiation|Protocol Violation|10|||
155263418|NCT00279201|560396468|FG002|Initiation|Protocol Violation|0|||
155263419|NCT00279201|560396469|FG003|Initiation|Protocol Violation|0|||
155263420|NCT00279201|560396470|FG004|Initiation|Protocol Violation|0|||
155263421|NCT00279201|560396471|FG005|Initiation|Protocol Violation|0|||
155263422|NCT00279201|560396466|FG000|Initiation|Withdrawal by Subject|35|||
155263423|NCT00279201|560396467|FG001|Initiation|Withdrawal by Subject|41|||
155263424|NCT00279201|560396468|FG002|Initiation|Withdrawal by Subject|0|||
155263425|NCT00279201|560396469|FG003|Initiation|Withdrawal by Subject|0|||
155263426|NCT00279201|560396470|FG004|Initiation|Withdrawal by Subject|0|||
155263427|NCT00279201|560396471|FG005|Initiation|Withdrawal by Subject|0|||
155263428|NCT00279201|560396466|FG000|Initiation|Physician Decision|15|||
155263429|NCT00279201|560396467|FG001|Initiation|Physician Decision|18|||
155263430|NCT00279201|560396468|FG002|Initiation|Physician Decision|0|||
155263431|NCT00279201|560396469|FG003|Initiation|Physician Decision|0|||
155263432|NCT00279201|560396470|FG004|Initiation|Physician Decision|0|||
155263433|NCT00279201|560396471|FG005|Initiation|Physician Decision|0|||
155263434|NCT00279201|560396466|FG000|Initiation|Sponsor Decision|13|||
155263435|NCT00279201|560396467|FG001|Initiation|Sponsor Decision|5|||
155263436|NCT00279201|560396468|FG002|Initiation|Sponsor Decision|0|||
155263437|NCT00279201|560396469|FG003|Initiation|Sponsor Decision|0|||
155263438|NCT00279201|560396470|FG004|Initiation|Sponsor Decision|0|||
155263439|NCT00279201|560396471|FG005|Initiation|Sponsor Decision|0|||
155263440|NCT00279201|560396466|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263441|NCT00279201|560396467|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
155263442|NCT00279201|560396468|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263443|NCT00279201|560396469|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263444|NCT00279201|560396470|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263445|NCT00279201|560396471|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
155263446|NCT00279201|560396466|FG000|Maintenance|Lack of Efficacy|32|||
155263447|NCT00279201|560396467|FG001|Maintenance|Lack of Efficacy|30|||
155263448|NCT00279201|560396468|FG002|Maintenance|Lack of Efficacy|0|||
155263449|NCT00279201|560396469|FG003|Maintenance|Lack of Efficacy|0|||
155263450|NCT00279201|560396470|FG004|Maintenance|Lack of Efficacy|0|||
155263451|NCT00279201|560396471|FG005|Maintenance|Lack of Efficacy|0|||
155263452|NCT00279201|560396466|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
155263453|NCT00279201|560396467|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
155263454|NCT00279201|560396468|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263455|NCT00279201|560396469|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263456|NCT00279201|560396470|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263457|NCT00279201|560396471|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
155263458|NCT00279201|560396466|FG000|Maintenance|Adverse Event|4|||
155263459|NCT00279201|560396467|FG001|Maintenance|Adverse Event|4|||
155263460|NCT00279201|560396468|FG002|Maintenance|Adverse Event|0|||
155263461|NCT00279201|560396469|FG003|Maintenance|Adverse Event|0|||
155263462|NCT00279201|560396470|FG004|Maintenance|Adverse Event|0|||
155263463|NCT00279201|560396471|FG005|Maintenance|Adverse Event|0|||
155263464|NCT00279201|560396466|FG000|Maintenance|Death|4|||
155263465|NCT00279201|560396467|FG001|Maintenance|Death|4|||
155263466|NCT00279201|560396468|FG002|Maintenance|Death|0|||
155263467|NCT00279201|560396469|FG003|Maintenance|Death|0|||
155263468|NCT00279201|560396470|FG004|Maintenance|Death|0|||
155263469|NCT00279201|560396471|FG005|Maintenance|Death|0|||
155263470|NCT00279201|560396466|FG000|Maintenance|Lost to Follow-up|17|||
155263471|NCT00279201|560396467|FG001|Maintenance|Lost to Follow-up|13|||
155263472|NCT00279201|560396468|FG002|Maintenance|Lost to Follow-up|0|||
155263473|NCT00279201|560396469|FG003|Maintenance|Lost to Follow-up|0|||
155263474|NCT00279201|560396470|FG004|Maintenance|Lost to Follow-up|0|||
155263475|NCT00279201|560396471|FG005|Maintenance|Lost to Follow-up|0|||
155263476|NCT00279201|560396466|FG000|Maintenance|Entry Criteria Exclusion|1|||
155263477|NCT00279201|560396467|FG001|Maintenance|Entry Criteria Exclusion|4|||
155263478|NCT00279201|560396468|FG002|Maintenance|Entry Criteria Exclusion|0|||
155263479|NCT00279201|560396469|FG003|Maintenance|Entry Criteria Exclusion|0|||
155263480|NCT00279201|560396470|FG004|Maintenance|Entry Criteria Exclusion|0|||
155263481|NCT00279201|560396471|FG005|Maintenance|Entry Criteria Exclusion|0|||
155263482|NCT00279201|560396466|FG000|Maintenance|Protocol Violation|16|||
155263483|NCT00279201|560396467|FG001|Maintenance|Protocol Violation|24|||
155263484|NCT00279201|560396468|FG002|Maintenance|Protocol Violation|0|||
155263485|NCT00279201|560396469|FG003|Maintenance|Protocol Violation|0|||
155263486|NCT00279201|560396470|FG004|Maintenance|Protocol Violation|0|||
155263487|NCT00279201|560396471|FG005|Maintenance|Protocol Violation|0|||
155263488|NCT00279201|560396466|FG000|Maintenance|Withdrawal by Subject|18|||
155263489|NCT00279201|560396467|FG001|Maintenance|Withdrawal by Subject|18|||
155263490|NCT00279201|560396468|FG002|Maintenance|Withdrawal by Subject|0|||
155263491|NCT00279201|560396469|FG003|Maintenance|Withdrawal by Subject|0|||
155263492|NCT00279201|560396470|FG004|Maintenance|Withdrawal by Subject|0|||
155263493|NCT00279201|560396471|FG005|Maintenance|Withdrawal by Subject|0|||
155263494|NCT00279201|560396466|FG000|Maintenance|Physician Decision|9|||
155263495|NCT00279201|560396467|FG001|Maintenance|Physician Decision|9|||
155263496|NCT00279201|560396468|FG002|Maintenance|Physician Decision|0|||
155263497|NCT00279201|560396469|FG003|Maintenance|Physician Decision|0|||
155263498|NCT00279201|560396470|FG004|Maintenance|Physician Decision|0|||
155263499|NCT00279201|560396471|FG005|Maintenance|Physician Decision|0|||
155263500|NCT00279201|560396466|FG000|Maintenance|Sponsor Decision|4|||
155263501|NCT00279201|560396467|FG001|Maintenance|Sponsor Decision|0|||
155263502|NCT00279201|560396468|FG002|Maintenance|Sponsor Decision|0|||
155263503|NCT00279201|560396469|FG003|Maintenance|Sponsor Decision|0|||
155263504|NCT00279201|560396470|FG004|Maintenance|Sponsor Decision|0|||
155263505|NCT00279201|560396471|FG005|Maintenance|Sponsor Decision|0|||
155263506|NCT00279201|560396466|FG000|Maintenance|HbA1c>7.5%|123|||
155263507|NCT00279201|560396467|FG001|Maintenance|HbA1c>7.5%|126|||
155263508|NCT00279201|560396468|FG002|Maintenance|HbA1c>7.5%|0|||
155263509|NCT00279201|560396469|FG003|Maintenance|HbA1c>7.5%|0|||
155263510|NCT00279201|560396470|FG004|Maintenance|HbA1c>7.5%|0|||
155263511|NCT00279201|560396471|FG005|Maintenance|HbA1c>7.5%|0|||
155263512|NCT00279201|560396466|FG000|Intensification Addendum|Withdrawal by Subject|0|||
155263513|NCT00279201|560396467|FG001|Intensification Addendum|Withdrawal by Subject|0|||
155263514|NCT00279201|560396468|FG002|Intensification Addendum|Withdrawal by Subject|12|||
155263515|NCT00279201|560396469|FG003|Intensification Addendum|Withdrawal by Subject|14|||
155263516|NCT00279201|560396470|FG004|Intensification Addendum|Withdrawal by Subject|9|||
155263517|NCT00279201|560396471|FG005|Intensification Addendum|Withdrawal by Subject|18|||
155263518|NCT00279201|560396466|FG000|Intensification Addendum|Lost to Follow-up|0|||
155263519|NCT00279201|560396467|FG001|Intensification Addendum|Lost to Follow-up|0|||
155263520|NCT00279201|560396468|FG002|Intensification Addendum|Lost to Follow-up|4|||
155263521|NCT00279201|560396469|FG003|Intensification Addendum|Lost to Follow-up|6|||
155263522|NCT00279201|560396470|FG004|Intensification Addendum|Lost to Follow-up|7|||
155263523|NCT00279201|560396471|FG005|Intensification Addendum|Lost to Follow-up|7|||
155263524|NCT00279201|560396466|FG000|Intensification Addendum|Protocol Violation|0|||
155263525|NCT00279201|560396467|FG001|Intensification Addendum|Protocol Violation|0|||
155263526|NCT00279201|560396468|FG002|Intensification Addendum|Protocol Violation|2|||
155263527|NCT00279201|560396469|FG003|Intensification Addendum|Protocol Violation|2|||
155263528|NCT00279201|560396470|FG004|Intensification Addendum|Protocol Violation|6|||
155263529|NCT00279201|560396471|FG005|Intensification Addendum|Protocol Violation|6|||
155263530|NCT00279201|560396466|FG000|Intensification Addendum|Adverse Event|0|||
155263531|NCT00279201|560396467|FG001|Intensification Addendum|Adverse Event|0|||
155263532|NCT00279201|560396468|FG002|Intensification Addendum|Adverse Event|0|||
155263533|NCT00279201|560396469|FG003|Intensification Addendum|Adverse Event|4|||
155263534|NCT00279201|560396470|FG004|Intensification Addendum|Adverse Event|1|||
155263535|NCT00279201|560396471|FG005|Intensification Addendum|Adverse Event|3|||
155263536|NCT00279201|560396466|FG000|Intensification Addendum|Physician Decision|0|||
155263537|NCT00279201|560396467|FG001|Intensification Addendum|Physician Decision|0|||
155263538|NCT00279201|560396468|FG002|Intensification Addendum|Physician Decision|4|||
155263539|NCT00279201|560396469|FG003|Intensification Addendum|Physician Decision|1|||
155263540|NCT00279201|560396470|FG004|Intensification Addendum|Physician Decision|3|||
155263541|NCT00279201|560396471|FG005|Intensification Addendum|Physician Decision|2|||
155263542|NCT00279201|560396466|FG000|Intensification Addendum|Sponsor Decision|0|||
155263543|NCT00279201|560396467|FG001|Intensification Addendum|Sponsor Decision|0|||
155263544|NCT00279201|560396468|FG002|Intensification Addendum|Sponsor Decision|0|||
155263545|NCT00279201|560396469|FG003|Intensification Addendum|Sponsor Decision|0|||
155263546|NCT00279201|560396470|FG004|Intensification Addendum|Sponsor Decision|1|||
155263547|NCT00279201|560396471|FG005|Intensification Addendum|Sponsor Decision|1|||
155263548|NCT00279201|560396466|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
155263549|NCT00279201|560396467|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
155263550|NCT00279201|560396468|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
155263551|NCT00279201|560396469|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
155263552|NCT00279201|560396470|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
155263553|NCT00279201|560396471|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
155263554|NCT00279201|560396466|FG000|Intensification Addendum|Lack of Efficacy|0|||
155263555|NCT00279201|560396467|FG001|Intensification Addendum|Lack of Efficacy|0|||
155263556|NCT00279201|560396468|FG002|Intensification Addendum|Lack of Efficacy|0|||
155263557|NCT00279201|560396469|FG003|Intensification Addendum|Lack of Efficacy|1|||
155263558|NCT00279201|560396470|FG004|Intensification Addendum|Lack of Efficacy|1|||
155263559|NCT00279201|560396471|FG005|Intensification Addendum|Lack of Efficacy|0|||
155263560|NCT00279201|560396466|FG000|Intensification Addendum|Death|0|||
155263561|NCT00279201|560396467|FG001|Intensification Addendum|Death|0|||
155263562|NCT00279201|560396468|FG002|Intensification Addendum|Death|0|||
155263563|NCT00279201|560396469|FG003|Intensification Addendum|Death|0|||
155263564|NCT00279201|560396470|FG004|Intensification Addendum|Death|1|||
155263565|NCT00279201|560396471|FG005|Intensification Addendum|Death|0|||
155263566|NCT02272725|560396475|FG000|Overall Study|equipment malfunction|2|||
155263567|NCT02272725|560396476|FG001|Overall Study|equipment malfunction|0|||
155263568|NCT01816763|560398163|FG000|Overall Study|The main reason for an incomplete survey|4|||
155263569|NCT01816763|560398164|FG001|Overall Study|The main reason for an incomplete survey|15|||
155263570|NCT01816763|560398165|FG002|Overall Study|The main reason for an incomplete survey|11|||
155263571|NCT01373931|560398172|FG000|Lead-in Period|Adverse Event|2|||
155263572|NCT01373931|560398173|FG001|Lead-in Period|Adverse Event|0|||
155263573|NCT01373931|560398172|FG000|Period 1|Adverse Event|2|||
155263574|NCT01373931|560398173|FG001|Period 1|Adverse Event|0|||
155263575|NCT01373931|560398172|FG000|Period 1|Withdrawal by Subject|0|||
155263576|NCT01373931|560398173|FG001|Period 1|Withdrawal by Subject|2|||
155263577|NCT00742079|560398174|FG000|Overall Study|Lost to Follow-up|0|||
155263578|NCT00742079|560398175|FG001|Overall Study|Lost to Follow-up|1|||
155263579|NCT00991341|560398176|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
155263580|NCT00991341|560398177|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
155263581|NCT00991341|560398176|FG000|Overall Study|Death|3|||
155263582|NCT00991341|560398177|FG001|Overall Study|Death|0|||
155263583|NCT00991341|560398176|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
155263584|NCT00991341|560398177|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
155263585|NCT00991341|560398176|FG000|Overall Study|Physician Decision|1|||
155263586|NCT00991341|560398177|FG001|Overall Study|Physician Decision|2|||
155263587|NCT00991341|560398176|FG000|Overall Study|Withdrawal by Subject|3|||
155263588|NCT00991341|560398177|FG001|Overall Study|Withdrawal by Subject|4|||
155263589|NCT04461795|560398179|FG000|Overall Study|Lost to Follow-up|2|||
155263590|NCT04461795|560398179|FG000|Overall Study|Withdrawal by Subject|2|||
155263591|NCT04461795|560398179|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
155263592|NCT00615264|560398180|FG000|Overall Study|Withdrawal by Subject|17|||
155263593|NCT00615264|560398181|FG001|Overall Study|Withdrawal by Subject|19|||
155263594|NCT00615264|560398180|FG000|Overall Study|Lost to Follow-up|6|||
155263595|NCT00615264|560398181|FG001|Overall Study|Lost to Follow-up|13|||
155263596|NCT00615264|560398180|FG000|Overall Study|Adverse Event|8|||
155263597|NCT00615264|560398181|FG001|Overall Study|Adverse Event|5|||
155263598|NCT00615264|560398180|FG000|Overall Study|Death|1|||
155263599|NCT00615264|560398181|FG001|Overall Study|Death|1|||
155263600|NCT00615264|560398180|FG000|Overall Study|Protocol Violation|11|||
155263601|NCT00615264|560398181|FG001|Overall Study|Protocol Violation|7|||
155263602|NCT00615264|560398180|FG000|Overall Study|Not defined|7|||
155263603|NCT00615264|560398181|FG001|Overall Study|Not defined|4|||
155263604|NCT00615264|560398180|FG000|Overall Study|Dermal Hypersensitivity|0|||
155263605|NCT00615264|560398181|FG001|Overall Study|Dermal Hypersensitivity|3|||
155263606|NCT00058422|560398182|FG000|Overall Study|Not treated|2|||
155263607|NCT00185640|560398183|FG000|Overall Study|Not Eligible|4|||
155263608|NCT00185640|560398183|FG000|Overall Study|Withdrawal by Subject|3|||
155263609|NCT00185640|560398183|FG000|Overall Study|Death|138|||
155263610|NCT02396537|560398192|FG000|Overall Study|Protocol Violation|0|||
155263611|NCT02396537|560398193|FG001|Overall Study|Protocol Violation|1|||
155263612|NCT01982435|560398194|FG000|Overall Study|Adverse Event|1|||
155263613|NCT01982435|560398195|FG001|Overall Study|Adverse Event|0|||
155263614|NCT00871403|560398196|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
155263615|NCT00871403|560398197|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
155263616|NCT00871403|560398198|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
155263617|NCT00871403|560398196|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
155263618|NCT00871403|560398197|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
155263619|NCT00871403|560398198|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
155263620|NCT00871403|560398196|FG000|Combination Treatment Phase|Adverse Event|0|||
155263621|NCT00871403|560398197|FG001|Combination Treatment Phase|Adverse Event|17|||
155263622|NCT00871403|560398198|FG002|Combination Treatment Phase|Adverse Event|2|||
155263623|NCT00871403|560398196|FG000|Combination Treatment Phase|Disease Progression|0|||
155263624|NCT00871403|560398197|FG001|Combination Treatment Phase|Disease Progression|8|||
155263625|NCT00871403|560398198|FG002|Combination Treatment Phase|Disease Progression|5|||
155263626|NCT00871403|560398196|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
155263627|NCT00871403|560398197|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
155263628|NCT00871403|560398198|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
155263629|NCT00871403|560398196|FG000|Combination Treatment Phase|Physician Decision|0|||
155263630|NCT00871403|560398197|FG001|Combination Treatment Phase|Physician Decision|1|||
155263631|NCT00871403|560398198|FG002|Combination Treatment Phase|Physician Decision|3|||
155263632|NCT00871403|560398196|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
155263633|NCT00871403|560398197|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
155263634|NCT00871403|560398198|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
155263635|NCT00871403|560398196|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
155263636|NCT00871403|560398197|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
155263637|NCT00871403|560398198|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
155263638|NCT00708435|560398202|FG000|Overall Study|Death / Serious Adverse Event|10|||
155263639|NCT00708435|560398203|FG001|Overall Study|Death / Serious Adverse Event|5|||
155263640|NCT00708435|560398202|FG000|Overall Study|Lost to Follow-up|9|||
155263641|NCT00708435|560398203|FG001|Overall Study|Lost to Follow-up|4|||
155263642|NCT00708435|560398202|FG000|Overall Study|Withdrawal by Subject|3|||
155263643|NCT00708435|560398203|FG001|Overall Study|Withdrawal by Subject|7|||
155263644|NCT00708435|560398202|FG000|Overall Study|Adverse Event|1|||
155263645|NCT00708435|560398203|FG001|Overall Study|Adverse Event|0|||
155263646|NCT00708435|560398202|FG000|Overall Study|Protocol Violation|0|||
155263647|NCT00708435|560398203|FG001|Overall Study|Protocol Violation|1|||
155263648|NCT00708435|560398202|FG000|Overall Study|Intervention by primary care physician|1|||
155263649|NCT00708435|560398203|FG001|Overall Study|Intervention by primary care physician|0|||
155263650|NCT00708435|560398202|FG000|Overall Study|Refused hospitalization|1|||
155263651|NCT00708435|560398203|FG001|Overall Study|Refused hospitalization|0|||
155263652|NCT01691521|560398204|FG000|Overall Study|Adverse Event|4|||
155263653|NCT01691521|560398205|FG001|Overall Study|Adverse Event|0|||
155263654|NCT01691521|560398206|FG002|Overall Study|Adverse Event|1|||
155263655|NCT01691521|560398204|FG000|Overall Study|Lack of Efficacy|1|||
155263656|NCT01691521|560398205|FG001|Overall Study|Lack of Efficacy|1|||
155263657|NCT01691521|560398206|FG002|Overall Study|Lack of Efficacy|2|||
155263658|NCT01691521|560398204|FG000|Overall Study|Protocol Violation|0|||
155263659|NCT01691521|560398205|FG001|Overall Study|Protocol Violation|3|||
155263660|NCT01691521|560398206|FG002|Overall Study|Protocol Violation|0|||
155263661|NCT01691521|560398204|FG000|Overall Study|Lost to Follow-up|0|||
155263662|NCT01691521|560398205|FG001|Overall Study|Lost to Follow-up|2|||
155263663|NCT01691521|560398206|FG002|Overall Study|Lost to Follow-up|2|||
155263664|NCT01691521|560398204|FG000|Overall Study|Physician Decision|2|||
155263665|NCT01691521|560398205|FG001|Overall Study|Physician Decision|1|||
155263666|NCT01691521|560398206|FG002|Overall Study|Physician Decision|0|||
155263667|NCT01691521|560398204|FG000|Overall Study|Withdrawal by Subject|5|||
155263668|NCT01691521|560398205|FG001|Overall Study|Withdrawal by Subject|9|||
155263669|NCT01691521|560398206|FG002|Overall Study|Withdrawal by Subject|4|||
155263670|NCT03954743|560398207|FG000|Overall Study|Adverse Event|1|||
155263671|NCT03954743|560398208|FG001|Overall Study|Adverse Event|0|||
155263672|NCT03954743|560398207|FG000|Overall Study|Lost to Follow-up|6|||
155263673|NCT03954743|560398208|FG001|Overall Study|Lost to Follow-up|4|||
155263674|NCT03954743|560398207|FG000|Overall Study|Protocol Violation|1|||
155263675|NCT03954743|560398208|FG001|Overall Study|Protocol Violation|0|||
155263676|NCT03954743|560398207|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
155263677|NCT03954743|560398208|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
155263678|NCT03954743|560398207|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
155263679|NCT03954743|560398208|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
155263680|NCT02281760|560398209|FG000|Overall Study|Withdrawal by Subject|1|||
155263681|NCT00860067|560398210|FG000|Overall Study|Lost to Follow-up|46|||
155263682|NCT00860067|560398211|FG001|Overall Study|Lost to Follow-up|9|||
155263683|NCT00860067|560398212|FG002|Overall Study|Lost to Follow-up|9|||
155263684|NCT00860067|560398210|FG000|Overall Study|Withdrawal by Subject|4|||
155263685|NCT00860067|560398211|FG001|Overall Study|Withdrawal by Subject|0|||
155263686|NCT00860067|560398212|FG002|Overall Study|Withdrawal by Subject|0|||
155263687|NCT00860067|560398210|FG000|Overall Study|Pregnancy|1|||
155263688|NCT00860067|560398211|FG001|Overall Study|Pregnancy|0|||
155263689|NCT00860067|560398212|FG002|Overall Study|Pregnancy|0|||
155263690|NCT00100932|560398213|FG000|Overall Study|Adverse Event|11|||
155263691|NCT00100932|560398214|FG001|Overall Study|Adverse Event|2|||
155263692|NCT00100932|560398213|FG000|Overall Study|Withdrawal by Subject|6|||
155263693|NCT00100932|560398214|FG001|Overall Study|Withdrawal by Subject|0|||
155263694|NCT00100932|560398213|FG000|Overall Study|Progressive Disease|44|||
155263695|NCT00100932|560398214|FG001|Overall Study|Progressive Disease|18|||
155263696|NCT00100932|560398213|FG000|Overall Study|Physician Decision|7|||
155263697|NCT00100932|560398214|FG001|Overall Study|Physician Decision|5|||
155263698|NCT00100932|560398213|FG000|Overall Study|Other|5|||
155263699|NCT00100932|560398214|FG001|Overall Study|Other|2|||
155263700|NCT02387996|560398219|FG000|Overall Study|Disease Progression|167|||
155263701|NCT02387996|560398219|FG000|Overall Study|Study Drug Toxicity|31|||
155263702|NCT02387996|560398219|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
155263703|NCT02387996|560398219|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
155263704|NCT02387996|560398219|FG000|Overall Study|Subject Withdrew Consent|5|||
155263705|NCT02387996|560398219|FG000|Overall Study|Lost to Follow-up|1|||
155263706|NCT02387996|560398219|FG000|Overall Study|Poor/Non-Compliance|1|||
155263707|NCT02387996|560398219|FG000|Overall Study|Other Reasons|5|||
155263708|NCT02387996|560398219|FG000|Overall Study|Death|1|||
155263709|NCT02756832|560398224|FG000|Overall Study|Lost for Observation after Baseline|6|||
155263710|NCT02756832|560398224|FG000|Overall Study|Lost for Observation|13|||
155263711|NCT02756832|560398224|FG000|Overall Study|Patient's Unwillingness|12|||
155263712|NCT02756832|560398224|FG000|Overall Study|Insufficient Efficacy|2|||
155263713|NCT02756832|560398224|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
155263714|NCT02756832|560398224|FG000|Overall Study|Reason not Specified|9|||
155263715|NCT02756832|560398224|FG000|Overall Study|Protocol Deviation|10|||
155263716|NCT00622713|560398225|FG000|Overall Study|Adverse Event|35|||
155263717|NCT00622713|560398225|FG000|Overall Study|Administrative problems|4|||
155263718|NCT00622713|560398225|FG000|Overall Study|Withdrawal by Subject|11|||
155263719|NCT00622713|560398225|FG000|Overall Study|Lost to Follow-up|5|||
155263720|NCT00622713|560398225|FG000|Overall Study|Death|2|||
155263721|NCT00622713|560398225|FG000|Overall Study|Subject no longer required study drug|1|||
155263722|NCT00622713|560398225|FG000|Overall Study|Did not meet eligibility criteria|1|||
155263723|NCT03728972|560398236|FG000|Overall Study|Death|1|||
155263724|NCT03728972|560398237|FG001|Overall Study|Death|0|||
155263725|NCT03728972|560398236|FG000|Overall Study|Lack of Efficacy|1|||
155263726|NCT03728972|560398237|FG001|Overall Study|Lack of Efficacy|0|||
155263727|NCT03728972|560398236|FG000|Overall Study|Physician Decision|3|||
155263728|NCT03728972|560398237|FG001|Overall Study|Physician Decision|0|||
155263729|NCT03728972|560398236|FG000|Overall Study|Disease progression|4|||
155263730|NCT03728972|560398237|FG001|Overall Study|Disease progression|3|||
155263731|NCT00895622|560398245|FG000|Overall Study|Protocol Violation|5|||
155263732|NCT00895622|560398246|FG001|Overall Study|Protocol Violation|4|||
155263733|NCT00895622|560398247|FG002|Overall Study|Protocol Violation|4|||
155263734|NCT03635489|560398251|FG000|Overall Study|Death|19|||
155263735|NCT03635489|560398252|FG001|Overall Study|Death|13|||
155263736|NCT03635489|560398251|FG000|Overall Study|Lost to Follow-up|1|||
155263737|NCT03635489|560398252|FG001|Overall Study|Lost to Follow-up|2|||
155263738|NCT03635489|560398251|FG000|Overall Study|Withdrawal by Subject|1|||
155263739|NCT03635489|560398252|FG001|Overall Study|Withdrawal by Subject|2|||
155263740|NCT03635489|560398251|FG000|Overall Study|Study Ended by Sponsor|28|||
155263741|NCT03635489|560398252|FG001|Overall Study|Study Ended by Sponsor|34|||
155263742|NCT02010632|560398253|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
155263743|NCT02010632|560398254|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
155263744|NCT01547299|560398255|FG000|Overall Study|Withdrawal by Subject|2|||
155263745|NCT01547299|560398256|FG001|Overall Study|Withdrawal by Subject|2|||
155263746|NCT01987817|560398257|FG000|Overall Study|Adverse Event|4|||
155263747|NCT01987817|560398258|FG001|Overall Study|Adverse Event|0|||
155263748|NCT01987817|560398257|FG000|Overall Study|Withdrawal by Subject|1|||
155263749|NCT01987817|560398258|FG001|Overall Study|Withdrawal by Subject|1|||
155263750|NCT01987817|560398257|FG000|Overall Study|Physician Decision|1|||
155263751|NCT01987817|560398258|FG001|Overall Study|Physician Decision|0|||
155263752|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
155263753|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263754|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263755|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263756|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263757|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263758|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
155263759|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
155263760|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263761|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263762|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263763|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263764|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263765|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
155263766|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
155263767|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263768|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263769|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263770|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263771|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263772|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
155263773|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
155263774|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263775|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263776|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263777|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263778|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263779|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
155263780|NCT01576718|560398261|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
155263781|NCT01576718|560398262|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263782|NCT01576718|560398263|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263783|NCT01576718|560398264|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263784|NCT01576718|560398265|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263785|NCT01576718|560398266|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263786|NCT01576718|560398267|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
155263787|NCT01576718|560398261|FG000|Treatment Period|Adverse Event|0|||
155263788|NCT01576718|560398262|FG001|Treatment Period|Adverse Event|1|||
155263789|NCT01576718|560398263|FG002|Treatment Period|Adverse Event|1|||
155263790|NCT01576718|560398264|FG003|Treatment Period|Adverse Event|1|||
155263791|NCT01576718|560398265|FG004|Treatment Period|Adverse Event|1|||
155263792|NCT01576718|560398266|FG005|Treatment Period|Adverse Event|1|||
155263793|NCT01576718|560398267|FG006|Treatment Period|Adverse Event|0|||
155263794|NCT01576718|560398261|FG000|Treatment Period|Withdrawal by Subject|0|||
155263795|NCT01576718|560398262|FG001|Treatment Period|Withdrawal by Subject|1|||
155263796|NCT01576718|560398263|FG002|Treatment Period|Withdrawal by Subject|1|||
155263797|NCT01576718|560398264|FG003|Treatment Period|Withdrawal by Subject|0|||
155263798|NCT01576718|560398265|FG004|Treatment Period|Withdrawal by Subject|2|||
155263799|NCT01576718|560398266|FG005|Treatment Period|Withdrawal by Subject|4|||
155263800|NCT01576718|560398267|FG006|Treatment Period|Withdrawal by Subject|2|||
155263801|NCT01576718|560398261|FG000|Treatment Period|Physician Decision|0|||
155263802|NCT01576718|560398262|FG001|Treatment Period|Physician Decision|1|||
155263803|NCT01576718|560398263|FG002|Treatment Period|Physician Decision|1|||
155263804|NCT01576718|560398264|FG003|Treatment Period|Physician Decision|1|||
155263805|NCT01576718|560398265|FG004|Treatment Period|Physician Decision|1|||
155263806|NCT01576718|560398266|FG005|Treatment Period|Physician Decision|0|||
155263807|NCT01576718|560398267|FG006|Treatment Period|Physician Decision|0|||
155263808|NCT01576718|560398261|FG000|Treatment Period|Protocol Violation|0|||
155263809|NCT01576718|560398262|FG001|Treatment Period|Protocol Violation|5|||
155263810|NCT01576718|560398263|FG002|Treatment Period|Protocol Violation|4|||
155263811|NCT01576718|560398264|FG003|Treatment Period|Protocol Violation|10|||
155263812|NCT01576718|560398265|FG004|Treatment Period|Protocol Violation|6|||
155263813|NCT01576718|560398266|FG005|Treatment Period|Protocol Violation|8|||
155263814|NCT01576718|560398267|FG006|Treatment Period|Protocol Violation|12|||
155263815|NCT01576718|560398261|FG000|Treatment Period|Sponsor request|0|||
155263816|NCT01576718|560398262|FG001|Treatment Period|Sponsor request|1|||
155263817|NCT01576718|560398263|FG002|Treatment Period|Sponsor request|0|||
155263818|NCT01576718|560398264|FG003|Treatment Period|Sponsor request|0|||
155263819|NCT01576718|560398265|FG004|Treatment Period|Sponsor request|0|||
155263820|NCT01576718|560398266|FG005|Treatment Period|Sponsor request|1|||
155263821|NCT01576718|560398267|FG006|Treatment Period|Sponsor request|0|||
155263822|NCT01576718|560398261|FG000|Treatment Period|Met stopping criteria|0|||
155263823|NCT01576718|560398262|FG001|Treatment Period|Met stopping criteria|16|||
155263824|NCT01576718|560398263|FG002|Treatment Period|Met stopping criteria|13|||
155263825|NCT01576718|560398264|FG003|Treatment Period|Met stopping criteria|19|||
155263826|NCT01576718|560398265|FG004|Treatment Period|Met stopping criteria|16|||
155263827|NCT01576718|560398266|FG005|Treatment Period|Met stopping criteria|33|||
155263828|NCT01576718|560398267|FG006|Treatment Period|Met stopping criteria|15|||
155263829|NCT01576718|560398261|FG000|Treatment Period|Lost to Follow-up|0|||
155263830|NCT01576718|560398262|FG001|Treatment Period|Lost to Follow-up|0|||
155263831|NCT01576718|560398263|FG002|Treatment Period|Lost to Follow-up|0|||
155263832|NCT01576718|560398264|FG003|Treatment Period|Lost to Follow-up|0|||
155263833|NCT01576718|560398265|FG004|Treatment Period|Lost to Follow-up|1|||
155263834|NCT01576718|560398266|FG005|Treatment Period|Lost to Follow-up|0|||
155263835|NCT01576718|560398267|FG006|Treatment Period|Lost to Follow-up|0|||
155263836|NCT01576718|560398261|FG000|Treatment Period|Noncompliance to study medication|0|||
155263837|NCT01576718|560398262|FG001|Treatment Period|Noncompliance to study medication|0|||
155263838|NCT01576718|560398263|FG002|Treatment Period|Noncompliance to study medication|0|||
155263839|NCT01576718|560398264|FG003|Treatment Period|Noncompliance to study medication|0|||
155263840|NCT01576718|560398265|FG004|Treatment Period|Noncompliance to study medication|0|||
155263841|NCT01576718|560398266|FG005|Treatment Period|Noncompliance to study medication|1|||
155263842|NCT01576718|560398267|FG006|Treatment Period|Noncompliance to study medication|1|||
155263843|NCT01874145|560398268|FG000|Core Period|Non-compliance|1|||
155263844|NCT01874145|560398269|FG001|Core Period|Non-compliance|0|||
155263845|NCT01874145|560398268|FG000|Core Period|Protocol Violation|1|||
155263846|NCT01874145|560398269|FG001|Core Period|Protocol Violation|1|||
155263847|NCT01874145|560398268|FG000|Core Period|Physician Decision|1|||
155263848|NCT01874145|560398269|FG001|Core Period|Physician Decision|1|||
155263849|NCT01874145|560398268|FG000|Core Period|Adverse Event|0|||
155263850|NCT01874145|560398269|FG001|Core Period|Adverse Event|1|||
155263851|NCT01874145|560398268|FG000|Core Period|Withdrawal by Subject|0|||
155263852|NCT01874145|560398269|FG001|Core Period|Withdrawal by Subject|4|||
155263853|NCT01874145|560398268|FG000|Extension Period|Adverse Event|3|||
155263854|NCT01874145|560398269|FG001|Extension Period|Adverse Event|2|||
155263855|NCT01874145|560398268|FG000|Extension Period|Withdrawal by Subject|2|||
155263856|NCT01874145|560398269|FG001|Extension Period|Withdrawal by Subject|1|||
155263857|NCT01874145|560398268|FG000|Extension Period|Lost to Follow-up|1|||
155263858|NCT01874145|560398269|FG001|Extension Period|Lost to Follow-up|1|||
155263859|NCT04631705|560398270|FG000|Overall Study|Withdrawal by Subject|0|||
155263860|NCT04631705|560398271|FG001|Overall Study|Withdrawal by Subject|0|||
155263861|NCT04631705|560398272|FG002|Overall Study|Withdrawal by Subject|0|||
155263862|NCT04631705|560398273|FG003|Overall Study|Withdrawal by Subject|0|||
155263863|NCT04631705|560398274|FG004|Overall Study|Withdrawal by Subject|0|||
155263864|NCT04631705|560398275|FG005|Overall Study|Withdrawal by Subject|0|||
155263865|NCT04631705|560398276|FG006|Overall Study|Withdrawal by Subject|1|||
155263866|NCT04631705|560398277|FG007|Overall Study|Withdrawal by Subject|0|||
155263867|NCT04631705|560398278|FG008|Overall Study|Withdrawal by Subject|0|||
155263868|NCT06387472|560398286|FG000|Overall Study|Withdrawal by Subject|1|||
155263869|NCT06387472|560398286|FG000|Overall Study|Lost to Follow-up|2|||
155263870|NCT06387472|560398286|FG000|Overall Study|Physician Decision|1|||
155263871|NCT04182880|560398287|FG000|Overall Study|Pregnancy|1|||
155263872|NCT04182880|560398288|FG001|Overall Study|Pregnancy|0|||
155263873|NCT02036645|560398289|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263874|NCT02036645|560398290|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263875|NCT02036645|560398291|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263876|NCT02036645|560398292|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263877|NCT02036645|560398293|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263878|NCT02036645|560398294|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263879|NCT02036645|560398295|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
155263880|NCT02036645|560398296|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263881|NCT02036645|560398297|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263882|NCT02036645|560398298|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263883|NCT02036645|560398299|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263884|NCT02036645|560398300|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
155263885|NCT02036645|560398289|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263886|NCT02036645|560398290|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263887|NCT02036645|560398291|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263888|NCT02036645|560398292|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
155263889|NCT02036645|560398293|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263890|NCT02036645|560398294|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263891|NCT02036645|560398295|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263892|NCT02036645|560398296|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263893|NCT02036645|560398297|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263894|NCT02036645|560398298|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263895|NCT02036645|560398299|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263896|NCT02036645|560398300|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
155263897|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
155263898|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
155263899|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
155263900|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
155263901|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
155263902|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
155263903|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
155263904|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
155263905|NCT02332590|560398307|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
155263906|NCT02332590|560398308|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
155263907|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
155263908|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
155263909|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
155263910|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
155263911|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
155263912|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
155263913|NCT02332590|560398307|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
155263914|NCT02332590|560398308|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
155263915|NCT01806584|560398315|FG000|Overall Study|Adverse Event|2|||
155263916|NCT01806584|560398316|FG001|Overall Study|Adverse Event|1|||
155263917|NCT01806584|560398315|FG000|Overall Study|Death|1|||
155263918|NCT01806584|560398316|FG001|Overall Study|Death|0|||
155263919|NCT01806584|560398315|FG000|Overall Study|Lost to Follow-up|0|||
155263920|NCT01806584|560398316|FG001|Overall Study|Lost to Follow-up|2|||
155263921|NCT01806584|560398315|FG000|Overall Study|Study terminated by sponsor|9|||
155263922|NCT01806584|560398316|FG001|Overall Study|Study terminated by sponsor|14|||
155263923|NCT01806584|560398315|FG000|Overall Study|Withdrawal by Subject|1|||
155263924|NCT01806584|560398316|FG001|Overall Study|Withdrawal by Subject|1|||
155263925|NCT01806584|560398315|FG000|Overall Study|Other unspecified|1|||
155263926|NCT01806584|560398316|FG001|Overall Study|Other unspecified|0|||
155263927|NCT03995784|560398321|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
155263928|NCT04739761|560398325|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
155263929|NCT04739761|560398326|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
155263930|NCT04739761|560398325|FG000|Overall Study|By complete response from the participant|1|||
155263931|NCT04739761|560398326|FG001|Overall Study|By complete response from the participant|0|||
155263932|NCT04739761|560398325|FG000|Overall Study|Lost to Follow-up|3|||
155263933|NCT04739761|560398326|FG001|Overall Study|Lost to Follow-up|3|||
155263934|NCT04739761|560398325|FG000|Overall Study|Death|13|||
155263935|NCT04739761|560398326|FG001|Overall Study|Death|13|||
155263936|NCT04739761|560398325|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
155263937|NCT04739761|560398326|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
155263938|NCT04739761|560398325|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
155263939|NCT04739761|560398326|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
155263940|NCT04739761|560398325|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
155263941|NCT04739761|560398326|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
155263942|NCT04739761|560398325|FG000|Overall Study|Adverse Event|0|||
155263943|NCT04739761|560398326|FG001|Overall Study|Adverse Event|3|||
155263944|NCT04739761|560398325|FG000|Overall Study|Participant decision|1|||
155263945|NCT04739761|560398326|FG001|Overall Study|Participant decision|0|||
155263946|NCT04739761|560398325|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
155263947|NCT04739761|560398326|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
155263948|NCT04739761|560398325|FG000|Overall Study|Participant immediately started next line of treatment|1|||
155263949|NCT04739761|560398326|FG001|Overall Study|Participant immediately started next line of treatment|0|||
155263950|NCT04739761|560398325|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
155263951|NCT04739761|560398326|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
155263952|NCT04739761|560398325|FG000|Overall Study|Lack of clinical benefit|1|||
155263953|NCT04739761|560398326|FG001|Overall Study|Lack of clinical benefit|0|||
155263954|NCT04739761|560398325|FG000|Overall Study|Disease progression|5|||
155263955|NCT04739761|560398326|FG001|Overall Study|Disease progression|5|||
155263956|NCT04739761|560398325|FG000|Overall Study|Withdrawal by Subject|14|||
155263957|NCT04739761|560398326|FG001|Overall Study|Withdrawal by Subject|13|||
155263958|NCT04739761|560398325|FG000|Overall Study|Protocol Violation|1|||
155263959|NCT04739761|560398326|FG001|Overall Study|Protocol Violation|0|||
155263960|NCT04739761|560398325|FG000|Overall Study|Physician Decision|2|||
155263961|NCT04739761|560398326|FG001|Overall Study|Physician Decision|0|||
155263962|NCT03881696|560398327|FG000|Overall Study|Adverse Event|2|||
155263963|NCT03881696|560398328|FG001|Overall Study|Adverse Event|0|||
155263964|NCT03881696|560398327|FG000|Overall Study|Withdrawal by Subject|2|||
155263965|NCT03881696|560398328|FG001|Overall Study|Withdrawal by Subject|0|||
155263966|NCT03881696|560398327|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
155263967|NCT03881696|560398328|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
155263968|NCT03881696|560398327|FG000|Overall Study|Failure to meet continuation criteria|1|||
155263969|NCT03881696|560398328|FG001|Overall Study|Failure to meet continuation criteria|0|||
155263970|NCT01061333|560398330|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
155263971|NCT01061333|560398331|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
155263972|NCT01186328|560399999|FG000|Overall Study|Death|1|||
155263973|NCT01186328|560400000|FG001|Overall Study|Death|0|||
155263974|NCT01186328|560400001|FG002|Overall Study|Death|0|||
155263975|NCT02202434|560400002|FG000|Overall Study|Death|70|||
155263976|NCT02202434|560400003|FG001|Overall Study|Death|39|||
155263977|NCT02202434|560400004|FG002|Overall Study|Death|13|||
155263978|NCT02202434|560400005|FG003|Overall Study|Death|27|||
155263979|NCT02202434|560400002|FG000|Overall Study|Lost to Follow-up|1|||
155263980|NCT02202434|560400003|FG001|Overall Study|Lost to Follow-up|1|||
155263981|NCT02202434|560400004|FG002|Overall Study|Lost to Follow-up|1|||
155263982|NCT02202434|560400005|FG003|Overall Study|Lost to Follow-up|0|||
155263983|NCT02202434|560400002|FG000|Overall Study|Physician Decision|2|||
155263984|NCT02202434|560400003|FG001|Overall Study|Physician Decision|3|||
155263985|NCT02202434|560400004|FG002|Overall Study|Physician Decision|0|||
155263986|NCT02202434|560400005|FG003|Overall Study|Physician Decision|0|||
155263987|NCT02202434|560400002|FG000|Overall Study|Withdrawal by Subject|13|||
155263988|NCT02202434|560400003|FG001|Overall Study|Withdrawal by Subject|14|||
155263989|NCT02202434|560400004|FG002|Overall Study|Withdrawal by Subject|1|||
155263990|NCT02202434|560400005|FG003|Overall Study|Withdrawal by Subject|4|||
155263991|NCT02202434|560400002|FG000|Overall Study|Completed Study|1|||
155263992|NCT02202434|560400003|FG001|Overall Study|Completed Study|0|||
155263993|NCT02202434|560400004|FG002|Overall Study|Completed Study|0|||
155263994|NCT02202434|560400005|FG003|Overall Study|Completed Study|0|||
155263995|NCT02202434|560400002|FG000|Overall Study|Visit Missed|21|||
155263996|NCT02202434|560400003|FG001|Overall Study|Visit Missed|12|||
155263997|NCT02202434|560400004|FG002|Overall Study|Visit Missed|0|||
155263998|NCT02202434|560400005|FG003|Overall Study|Visit Missed|5|||
155263999|NCT02202434|560400002|FG000|Overall Study|Other|1|||
155264000|NCT02202434|560400003|FG001|Overall Study|Other|0|||
155264001|NCT02202434|560400004|FG002|Overall Study|Other|0|||
155264002|NCT02202434|560400005|FG003|Overall Study|Other|1|||
155264003|NCT04858802|560400006|FG000|Overall Study|Lost to Follow-up|1|||
155264004|NCT04858802|560400007|FG001|Overall Study|Lost to Follow-up|1|||
155264005|NCT04858802|560400006|FG000|Overall Study|Withdrawal by Subject|1|||
155264006|NCT04858802|560400007|FG001|Overall Study|Withdrawal by Subject|1|||
155264007|NCT02714868|560400009|FG000|Overall Study|Withdrawal by Subject|3|||
155264008|NCT02714868|560400010|FG001|Overall Study|Withdrawal by Subject|0|||
155264009|NCT02714868|560400009|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
155264010|NCT02714868|560400010|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
155264011|NCT02714868|560400009|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
155264012|NCT02714868|560400010|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
155264013|NCT00710606|560400016|FG000|Overall Study|Adverse Event|0|||
155264014|NCT00710606|560400017|FG001|Overall Study|Adverse Event|2|||
155264015|NCT02670538|560400020|FG000|Overall Study|Withdrawal of Consent|8|||
155264016|NCT02670538|560400021|FG001|Overall Study|Withdrawal of Consent|6|||
155264017|NCT02670538|560400022|FG002|Overall Study|Withdrawal of Consent|5|||
155264018|NCT02670538|560400020|FG000|Overall Study|Lost to Follow-up|8|||
155264019|NCT02670538|560400021|FG001|Overall Study|Lost to Follow-up|12|||
155264020|NCT02670538|560400022|FG002|Overall Study|Lost to Follow-up|7|||
155264021|NCT02670538|560400020|FG000|Overall Study|Adverse Event|5|||
155264022|NCT02670538|560400021|FG001|Overall Study|Adverse Event|5|||
155264023|NCT02670538|560400022|FG002|Overall Study|Adverse Event|11|||
155264024|NCT02670538|560400020|FG000|Overall Study|Lack of Efficacy|7|||
155264025|NCT02670538|560400021|FG001|Overall Study|Lack of Efficacy|1|||
155264026|NCT02670538|560400022|FG002|Overall Study|Lack of Efficacy|2|||
155264027|NCT02670538|560400020|FG000|Overall Study|Protocol Violation|3|||
155264028|NCT02670538|560400021|FG001|Overall Study|Protocol Violation|4|||
155264029|NCT02670538|560400022|FG002|Overall Study|Protocol Violation|1|||
155264030|NCT02670538|560400020|FG000|Overall Study|Noncompliance with Study Drug|1|||
155264031|NCT02670538|560400021|FG001|Overall Study|Noncompliance with Study Drug|3|||
155264032|NCT02670538|560400022|FG002|Overall Study|Noncompliance with Study Drug|2|||
155264033|NCT02670538|560400020|FG000|Overall Study|Other Miscellaneous Reasons|0|||
155264034|NCT02670538|560400021|FG001|Overall Study|Other Miscellaneous Reasons|1|||
155264035|NCT02670538|560400022|FG002|Overall Study|Other Miscellaneous Reasons|2|||
155264036|NCT05648357|560400023|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
155264037|NCT00255346|560400024|FG000|Overall Study|Adverse Event|1|||
155264038|NCT00255346|560400025|FG001|Overall Study|Adverse Event|0|||
155264039|NCT00255346|560400026|FG002|Overall Study|Adverse Event|0|||
155264040|NCT00255346|560400027|FG003|Overall Study|Adverse Event|0|||
155264041|NCT00255346|560400028|FG004|Overall Study|Adverse Event|0|||
155264042|NCT00674323|560400029|FG000|Overall Study|Adverse Event|0|||
155264043|NCT00674323|560400030|FG001|Overall Study|Adverse Event|1|||
155264044|NCT00674323|560400031|FG002|Overall Study|Adverse Event|0|||
155264045|NCT00674323|560400029|FG000|Overall Study|Protocol Violation|1|||
155264046|NCT00674323|560400030|FG001|Overall Study|Protocol Violation|0|||
155264047|NCT00674323|560400031|FG002|Overall Study|Protocol Violation|0|||
155264048|NCT02243202|560400033|FG000|Overall Study|Adverse Event|5|||
155264049|NCT02243202|560400034|FG001|Overall Study|Adverse Event|6|||
155264050|NCT02243202|560400035|FG002|Overall Study|Adverse Event|10|||
155264051|NCT02243202|560400036|FG003|Overall Study|Adverse Event|4|||
155264052|NCT02243202|560400033|FG000|Overall Study|Lost to Follow-up|9|||
155264053|NCT02243202|560400034|FG001|Overall Study|Lost to Follow-up|9|||
155264054|NCT02243202|560400035|FG002|Overall Study|Lost to Follow-up|14|||
155264055|NCT02243202|560400036|FG003|Overall Study|Lost to Follow-up|11|||
155264056|NCT02243202|560400033|FG000|Overall Study|Protocol Violation|3|||
155264057|NCT02243202|560400034|FG001|Overall Study|Protocol Violation|1|||
155264058|NCT02243202|560400035|FG002|Overall Study|Protocol Violation|2|||
155264059|NCT02243202|560400036|FG003|Overall Study|Protocol Violation|1|||
155264060|NCT02243202|560400033|FG000|Overall Study|Withdrawal by Subject|7|||
155264061|NCT02243202|560400034|FG001|Overall Study|Withdrawal by Subject|6|||
155264062|NCT02243202|560400035|FG002|Overall Study|Withdrawal by Subject|4|||
155264063|NCT02243202|560400036|FG003|Overall Study|Withdrawal by Subject|4|||
155264064|NCT02243202|560400033|FG000|Overall Study|Other|1|||
155264065|NCT02243202|560400034|FG001|Overall Study|Other|3|||
155264066|NCT02243202|560400035|FG002|Overall Study|Other|1|||
155264067|NCT02243202|560400036|FG003|Overall Study|Other|2|||
155264068|NCT02243202|560400033|FG000|Overall Study|Randomized but not received treatment|0|||
155264069|NCT02243202|560400034|FG001|Overall Study|Randomized but not received treatment|0|||
155264070|NCT02243202|560400035|FG002|Overall Study|Randomized but not received treatment|0|||
155264071|NCT02243202|560400036|FG003|Overall Study|Randomized but not received treatment|1|||
155264072|NCT02013388|560400039|FG000|Overall Study|work emergency|1|||
155264073|NCT02013388|560400040|FG001|Overall Study|work emergency|0|||
155264074|NCT02013388|560400041|FG002|Overall Study|work emergency|0|||
155264075|NCT02013388|560400042|FG003|Overall Study|work emergency|0|||
155264076|NCT02013388|560400043|FG004|Overall Study|work emergency|1|||
155264077|NCT02013388|560400044|FG005|Overall Study|work emergency|0|||
155264078|NCT02013388|560400045|FG006|Overall Study|work emergency|0|||
155264079|NCT02013388|560400046|FG007|Overall Study|work emergency|0|||
155264080|NCT02110732|560400061|FG000|Overall Study|Physician Decision|5|||
155264081|NCT02110732|560400062|FG001|Overall Study|Physician Decision|2|||
155264082|NCT02110732|560400061|FG000|Overall Study|Lost to Follow-up|1|||
155264083|NCT02110732|560400062|FG001|Overall Study|Lost to Follow-up|1|||
155264084|NCT00633932|560400063|FG000|Overall Study|Adverse Event|1|||
155264085|NCT00633932|560400064|FG001|Overall Study|Adverse Event|3|||
155264086|NCT00633932|560400065|FG002|Overall Study|Adverse Event|4|||
155264087|NCT00633932|560400063|FG000|Overall Study|Withdrawal by Subject|3|||
155264088|NCT00633932|560400064|FG001|Overall Study|Withdrawal by Subject|9|||
155264089|NCT00633932|560400065|FG002|Overall Study|Withdrawal by Subject|1|||
155264090|NCT00633932|560400063|FG000|Overall Study|Lost to Follow-up|1|||
155264091|NCT00633932|560400064|FG001|Overall Study|Lost to Follow-up|0|||
155264092|NCT00633932|560400065|FG002|Overall Study|Lost to Follow-up|2|||
155264093|NCT00633932|560400063|FG000|Overall Study|Protocol Violation|5|||
155264094|NCT00633932|560400064|FG001|Overall Study|Protocol Violation|2|||
155264095|NCT00633932|560400065|FG002|Overall Study|Protocol Violation|3|||
155264096|NCT00633932|560400063|FG000|Overall Study|Physician Decision|0|||
155264097|NCT00633932|560400064|FG001|Overall Study|Physician Decision|0|||
155264098|NCT00633932|560400065|FG002|Overall Study|Physician Decision|1|||
155264099|NCT00633932|560400063|FG000|Overall Study|Doctor's judgement|1|||
155264100|NCT00633932|560400064|FG001|Overall Study|Doctor's judgement|0|||
155264101|NCT00633932|560400065|FG002|Overall Study|Doctor's judgement|0|||
155264102|NCT00633932|560400063|FG000|Overall Study|Moved Away|1|||
155264103|NCT00633932|560400064|FG001|Overall Study|Moved Away|0|||
155264104|NCT00633932|560400065|FG002|Overall Study|Moved Away|0|||
155264105|NCT04836858|560400066|FG000|Overall Study|Adverse Event|0|||
155264106|NCT04836858|560400067|FG001|Overall Study|Adverse Event|0|||
155264107|NCT04836858|560400068|FG002|Overall Study|Adverse Event|0|||
155264108|NCT04836858|560400069|FG003|Overall Study|Adverse Event|1|||
155264109|NCT04836858|560400066|FG000|Overall Study|Lost to Follow-up|1|||
155264110|NCT04836858|560400067|FG001|Overall Study|Lost to Follow-up|0|||
155264111|NCT04836858|560400068|FG002|Overall Study|Lost to Follow-up|0|||
155264112|NCT04836858|560400069|FG003|Overall Study|Lost to Follow-up|0|||
155264113|NCT04836858|560400066|FG000|Overall Study|Subject/Guardian decision|3|||
155264114|NCT04836858|560400067|FG001|Overall Study|Subject/Guardian decision|0|||
155264115|NCT04836858|560400068|FG002|Overall Study|Subject/Guardian decision|0|||
155264116|NCT04836858|560400069|FG003|Overall Study|Subject/Guardian decision|1|||
155264117|NCT04836858|560400066|FG000|Overall Study|Randomized but not treated|4|||
155264118|NCT04836858|560400067|FG001|Overall Study|Randomized but not treated|0|||
155264119|NCT04836858|560400068|FG002|Overall Study|Randomized but not treated|0|||
155264120|NCT04836858|560400069|FG003|Overall Study|Randomized but not treated|0|||
155264121|NCT00539643|560400070|FG000|Overall Study|Adverse Event|1|||
155264122|NCT00539643|560400071|FG001|Overall Study|Adverse Event|0|||
155264123|NCT00539643|560400070|FG000|Overall Study|Death|2|||
155264124|NCT00539643|560400071|FG001|Overall Study|Death|1|||
155264125|NCT00539643|560400070|FG000|Overall Study|Physician Decision|3|||
155264126|NCT00539643|560400071|FG001|Overall Study|Physician Decision|1|||
155264127|NCT00539643|560400070|FG000|Overall Study|Withdrawal by Subject|0|||
155264128|NCT00539643|560400071|FG001|Overall Study|Withdrawal by Subject|1|||
155264129|NCT02228395|560400072|FG000|First Intervention Period|No longer willing to participate|1|||
155264130|NCT02228395|560400073|FG001|First Intervention Period|No longer willing to participate|0|||
155264131|NCT02228395|560400074|FG002|First Intervention Period|No longer willing to participate|0|||
155264132|NCT02228395|560400072|FG000|First Intervention Period|Unable to comply with study dates|0|||
155264133|NCT02228395|560400073|FG001|First Intervention Period|Unable to comply with study dates|1|||
155264134|NCT02228395|560400074|FG002|First Intervention Period|Unable to comply with study dates|1|||
155264135|NCT01446796|560400075|FG000|Overall Study|Withdrawal by Subject|1|||
155264136|NCT01446796|560400076|FG001|Overall Study|Withdrawal by Subject|0|||
155264137|NCT00988221|560400077|FG000|Part I|Adverse Event|0|||
155264138|NCT00988221|560400078|FG001|Part I|Adverse Event|1|||
155264139|NCT00988221|560400079|FG002|Part I|Adverse Event|2|||
155264140|NCT00988221|560400080|FG003|Part I|Adverse Event|0|||
155264141|NCT00988221|560400077|FG000|Part I|Insufficient Therapeutic Response|4|||
155264142|NCT00988221|560400078|FG001|Part I|Insufficient Therapeutic Response|6|||
155264143|NCT00988221|560400079|FG002|Part I|Insufficient Therapeutic Response|5|||
155264144|NCT00988221|560400080|FG003|Part I|Insufficient Therapeutic Response|0|||
155264145|NCT00988221|560400077|FG000|Part I|Refused Treatment|0|||
155264146|NCT00988221|560400078|FG001|Part I|Refused Treatment|2|||
155264147|NCT00988221|560400079|FG002|Part I|Refused Treatment|1|||
155264148|NCT00988221|560400080|FG003|Part I|Refused Treatment|0|||
155264149|NCT00988221|560400077|FG000|Part I|Lost to Follow-up|0|||
155264150|NCT00988221|560400078|FG001|Part I|Lost to Follow-up|1|||
155264151|NCT00988221|560400079|FG002|Part I|Lost to Follow-up|0|||
155264152|NCT00988221|560400080|FG003|Part I|Lost to Follow-up|0|||
155264153|NCT00988221|560400077|FG000|Part II|Adverse Event|1|||
155264154|NCT00988221|560400078|FG001|Part II|Adverse Event|0|||
155264155|NCT00988221|560400079|FG002|Part II|Adverse Event|0|||
155264156|NCT00988221|560400080|FG003|Part II|Adverse Event|1|||
155264157|NCT00988221|560400077|FG000|Part II|Withdrawal by Subject|0|||
155264158|NCT00988221|560400078|FG001|Part II|Withdrawal by Subject|0|||
155264159|NCT00988221|560400079|FG002|Part II|Withdrawal by Subject|2|||
155264160|NCT00988221|560400080|FG003|Part II|Withdrawal by Subject|2|||
155264161|NCT00988221|560400077|FG000|Part II|Reason not Specified|0|||
155264162|NCT00988221|560400078|FG001|Part II|Reason not Specified|0|||
155264163|NCT00988221|560400079|FG002|Part II|Reason not Specified|1|||
155264164|NCT00988221|560400080|FG003|Part II|Reason not Specified|0|||
155264165|NCT00988221|560400077|FG000|Part III|Adverse Event|1|||
155264166|NCT00988221|560400078|FG001|Part III|Adverse Event|0|||
155264167|NCT00988221|560400079|FG002|Part III|Adverse Event|1|||
155264168|NCT00988221|560400080|FG003|Part III|Adverse Event|0|||
155264169|NCT00988221|560400077|FG000|Part III|Insufficient Therapeutic Response|0|||
155264170|NCT00988221|560400078|FG001|Part III|Insufficient Therapeutic Response|1|||
155264171|NCT00988221|560400079|FG002|Part III|Insufficient Therapeutic Response|1|||
155264172|NCT00988221|560400080|FG003|Part III|Insufficient Therapeutic Response|0|||
155264173|NCT00988221|560400077|FG000|Part III|Refused Treatment|0|||
155264174|NCT00988221|560400078|FG001|Part III|Refused Treatment|0|||
155264175|NCT00988221|560400079|FG002|Part III|Refused Treatment|1|||
155264176|NCT00988221|560400080|FG003|Part III|Refused Treatment|0|||
155264177|NCT00954733|560400081|FG000|Overall Study|blood gas machine did not work|1|||
155264178|NCT03579290|560400082|FG000|Overall Study|Lost to Follow-up|9|||
155264179|NCT02712398|560400092|FG000|Overall Study|Withdrawal by Subject|6|||
155264180|NCT02712398|560400092|FG000|Overall Study|Lost to Follow-up|6|||
155264181|NCT02712398|560400092|FG000|Overall Study|Sponsor Decision|1|||
155264182|NCT02712398|560400092|FG000|Overall Study|Physician Decision|1|||
155264183|NCT02712398|560400092|FG000|Overall Study|Death|2|||
155264184|NCT02712398|560400092|FG000|Overall Study|Re-operation|21|||
155264185|NCT01725386|560400094|FG000|Overall Study|Death|84|||
155264186|NCT01725386|560400095|FG001|Overall Study|Death|40|||
155264187|NCT01725386|560400094|FG000|Overall Study|Lost to Follow-up|81|||
155264188|NCT01725386|560400095|FG001|Overall Study|Lost to Follow-up|6|||
155264189|NCT01725386|560400094|FG000|Overall Study|Withdrawal by Subject|10|||
155264190|NCT01725386|560400095|FG001|Overall Study|Withdrawal by Subject|0|||
155264191|NCT00879996|560400099|FG000|Overall Study|Lost to Follow-up|7|||
155264192|NCT00879996|560400100|FG001|Overall Study|Lost to Follow-up|6|||
155264193|NCT00879996|560400099|FG000|Overall Study|non-compliance|6|||
155264194|NCT00879996|560400100|FG001|Overall Study|non-compliance|4|||
155264195|NCT00879996|560400099|FG000|Overall Study|Physician Decision|1|||
155264196|NCT00879996|560400100|FG001|Overall Study|Physician Decision|2|||
155264197|NCT00879996|560400099|FG000|Overall Study|psychiatric problem|0|||
155264198|NCT00879996|560400100|FG001|Overall Study|psychiatric problem|1|||
155264199|NCT00879996|560400099|FG000|Overall Study|put on parole|1|||
155264200|NCT00879996|560400100|FG001|Overall Study|put on parole|0|||
155264201|NCT02914314|560400105|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
155264202|NCT02914314|560400106|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
155264203|NCT02914314|560400107|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
155264204|NCT02914314|560400108|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
155264205|NCT02914314|560400105|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
155264206|NCT02914314|560400106|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
155264207|NCT02914314|560400107|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
155264208|NCT02914314|560400108|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
155264209|NCT02914314|560400105|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
155264210|NCT02914314|560400106|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
155264211|NCT02914314|560400107|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
155264212|NCT02914314|560400108|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
155264213|NCT02914314|560400105|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
155264214|NCT02914314|560400106|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
155264215|NCT02914314|560400107|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
155264216|NCT02914314|560400108|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
155264217|NCT02914314|560400105|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
155264218|NCT02914314|560400106|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
155264219|NCT02914314|560400107|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
155264220|NCT02914314|560400108|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
155264221|NCT04772053|560400109|FG000|Overall Study|Physician Decision|2|||
155264222|NCT04772053|560400109|FG000|Overall Study|Withdrawal by Subject|3|||
155264223|NCT04772053|560400109|FG000|Overall Study|Study Terminated by Sponsor|1|||
155264224|NCT03107377|560400110|FG000|Overall Study|Adverse Event|3|||
155264225|NCT03107377|560400111|FG001|Overall Study|Adverse Event|3|||
155264226|NCT03107377|560400110|FG000|Overall Study|Protocol Violation|9|||
155264227|NCT03107377|560400111|FG001|Overall Study|Protocol Violation|12|||
155264228|NCT03107377|560400110|FG000|Overall Study|Physician Decision|3|||
155264229|NCT03107377|560400111|FG001|Overall Study|Physician Decision|6|||
155264230|NCT03107377|560400110|FG000|Overall Study|Pregnancy|7|||
155264231|NCT03107377|560400111|FG001|Overall Study|Pregnancy|7|||
155264232|NCT03107377|560400110|FG000|Overall Study|Withdrawal by Subject|16|||
155264233|NCT03107377|560400111|FG001|Overall Study|Withdrawal by Subject|22|||
155264234|NCT03107377|560400110|FG000|Overall Study|Lost to Follow-up|37|||
155264235|NCT03107377|560400111|FG001|Overall Study|Lost to Follow-up|34|||
155264236|NCT03107377|560400110|FG000|Overall Study|Other reason not specified|16|||
155264237|NCT03107377|560400111|FG001|Overall Study|Other reason not specified|15|||
155264238|NCT03787680|560400112|FG000|Overall Study|Physician Decision|2|||
155264239|NCT03787680|560400113|FG001|Overall Study|Physician Decision|3|||
155264240|NCT03787680|560400112|FG000|Overall Study|Adverse Event|7|||
155264241|NCT03787680|560400113|FG001|Overall Study|Adverse Event|3|||
155264242|NCT03787680|560400112|FG000|Overall Study|Withdrawal by Subject|2|||
155264243|NCT03787680|560400113|FG001|Overall Study|Withdrawal by Subject|1|||
155264244|NCT05454410|560400116|FG000|Overall Study|Withdrawal by Subject|0|||
155264245|NCT05454410|560400117|FG001|Overall Study|Withdrawal by Subject|0|||
155264246|NCT05454410|560400118|FG002|Overall Study|Withdrawal by Subject|1|||
155264247|NCT05454410|560400119|FG003|Overall Study|Withdrawal by Subject|1|||
155264248|NCT01368900|560400124|FG000|Overall Study|Lost to Follow-up|7|||
155264249|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
155264250|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
155264251|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
155264252|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
155264253|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
155264254|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
155264255|NCT02034708|560400129|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
155264256|NCT02034708|560400130|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
155264257|NCT00654901|560400131|FG000|Overall Study|Lost to Follow-up|1|||
155264258|NCT00654901|560400132|FG001|Overall Study|Lost to Follow-up|0|||
155264259|NCT00654901|560400133|FG002|Overall Study|Lost to Follow-up|1|||
155264260|NCT00654901|560400134|FG003|Overall Study|Lost to Follow-up|0|||
155264261|NCT00654901|560400131|FG000|Overall Study|Withdrawal by Subject|3|||
155264262|NCT00654901|560400132|FG001|Overall Study|Withdrawal by Subject|0|||
155264263|NCT00654901|560400133|FG002|Overall Study|Withdrawal by Subject|1|||
155264264|NCT00654901|560400134|FG003|Overall Study|Withdrawal by Subject|0|||
155264265|NCT00652938|560400139|FG000|Overall Study|Adverse Event|1|||
155264266|NCT00652938|560400140|FG001|Overall Study|Adverse Event|0|||
155264267|NCT00652938|560400141|FG002|Overall Study|Adverse Event|2|||
155264268|NCT00652938|560400139|FG000|Overall Study|Withdrawal by Subject|0|||
155264269|NCT00652938|560400140|FG001|Overall Study|Withdrawal by Subject|6|||
155264270|NCT00652938|560400141|FG002|Overall Study|Withdrawal by Subject|1|||
155264271|NCT00652938|560400139|FG000|Overall Study|Lost to Follow-up|0|||
155264272|NCT00652938|560400140|FG001|Overall Study|Lost to Follow-up|0|||
155264273|NCT00652938|560400141|FG002|Overall Study|Lost to Follow-up|2|||
155264274|NCT00652938|560400139|FG000|Overall Study|fear of blood sampling|0|||
155264275|NCT00652938|560400140|FG001|Overall Study|fear of blood sampling|1|||
155264276|NCT00652938|560400141|FG002|Overall Study|fear of blood sampling|0|||
155264277|NCT00782496|560400145|FG000|Overall Study|Lost to Follow-up|14|||
155264278|NCT00782496|560400146|FG001|Overall Study|Lost to Follow-up|15|||
155264279|NCT00117156|560400148|FG000|Overall Study|Adverse Event|9|||
155264280|NCT00117156|560400148|FG000|Overall Study|Physician Decision|1|||
155264281|NCT00117156|560400148|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
155264282|NCT02070484|560400150|FG000|Overall Study|Withdrawal by Subject|1|||
155264283|NCT02070484|560400151|FG001|Overall Study|Withdrawal by Subject|0|||
155264284|NCT01521884|560400152|FG000|Overall Study|Non Responders|10|||
155264285|NCT01521884|560400152|FG000|Overall Study|Adverse Event|5|||
155264286|NCT01521884|560400152|FG000|Overall Study|Pregnancy|1|||
155264287|NCT01521884|560400152|FG000|Overall Study|Withdrawal by Subject|1|||
155264288|NCT01521884|560400152|FG000|Overall Study|Physician Decision|2|||
155264289|NCT01521884|560400152|FG000|Overall Study|Protocol Violation|3|||
155264290|NCT01521884|560400152|FG000|Overall Study|Participant non-eligible|1|||
155264291|NCT01521884|560400152|FG000|Overall Study|Lost to Follow-up|4|||
155264292|NCT02821819|560400153|FG000|Overall Study|Protocol Violation|1|||
155264293|NCT00975221|560402688|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
155264294|NCT00975221|560402689|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
155264295|NCT00975221|560402688|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
155264296|NCT00975221|560402689|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
155264297|NCT00975221|560402688|FG000|Titration Phase (Weeks 1-12)|Other|0|||
155264298|NCT00975221|560402689|FG001|Titration Phase (Weeks 1-12)|Other|1|||
155264299|NCT00975221|560402688|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
155264300|NCT00975221|560402689|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
155264301|NCT00975221|560402688|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
155264302|NCT00975221|560402689|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
155264303|NCT00975221|560402688|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
155264304|NCT00975221|560402689|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
155264305|NCT01862991|560402692|FG000|Overall Study|Lost to Follow-up|2|||
155264306|NCT01862991|560402693|FG001|Overall Study|Lost to Follow-up|1|||
155264307|NCT01862991|560402694|FG002|Overall Study|Lost to Follow-up|1|||
155264308|NCT01862991|560402692|FG000|Overall Study|Protocol Violation|1|||
155264309|NCT01862991|560402693|FG001|Overall Study|Protocol Violation|0|||
155264310|NCT01862991|560402694|FG002|Overall Study|Protocol Violation|0|||
155264311|NCT00857805|560402698|FG000|Overall Study|Withdrawal by Subject|1|||
155264312|NCT00857805|560402699|FG001|Overall Study|Withdrawal by Subject|1|||
155264313|NCT01289041|560402700|FG000|Overall Study|Adverse Event|24|||
155264314|NCT01289041|560402700|FG000|Overall Study|Physician Decision|1|||
155264315|NCT01289041|560402700|FG000|Overall Study|Progressive Disease|41|||
155264316|NCT01289041|560402700|FG000|Overall Study|Withdrawal by Subject|3|||
155264317|NCT01289041|560402700|FG000|Overall Study|Death|1|||
155264318|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Adverse Event|0|||
155264319|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Adverse Event|0|||
155264320|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Adverse Event|0|||
155264321|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Adverse Event|0|||
155264322|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Adverse Event|0|||
155264323|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Adverse Event|1|||
155264324|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Adverse Event|0|||
155264325|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Adverse Event|1|||
155264326|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Adverse Event|0|||
155264327|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Adverse Event|0|||
155264328|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264329|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264330|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264331|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
155264332|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
155264333|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
155264334|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264335|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264336|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264337|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
155264338|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Physician Decision|0|||
155264339|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Physician Decision|0|||
155264340|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Physician Decision|0|||
155264341|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Physician Decision|0|||
155264342|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Physician Decision|0|||
155264343|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Physician Decision|0|||
155264344|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Physician Decision|1|||
155264345|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Physician Decision|0|||
155264346|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Physician Decision|0|||
155264347|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Physician Decision|0|||
155264348|NCT05044325|560402704|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264349|NCT05044325|560402705|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264350|NCT05044325|560402706|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
155264351|NCT05044325|560402707|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264352|NCT05044325|560402708|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264353|NCT05044325|560402709|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264354|NCT05044325|560402710|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264355|NCT05044325|560402711|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264356|NCT05044325|560402712|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264357|NCT05044325|560402713|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
155264358|NCT05044325|560402704|FG000|Part A:Treatment Period 2|Adverse Event|0|||
155264359|NCT05044325|560402705|FG001|Part A:Treatment Period 2|Adverse Event|1|||
155264360|NCT05044325|560402706|FG002|Part A:Treatment Period 2|Adverse Event|0|||
155264361|NCT05044325|560402707|FG003|Part A:Treatment Period 2|Adverse Event|0|||
155264362|NCT05044325|560402708|FG004|Part A:Treatment Period 2|Adverse Event|1|||
155264363|NCT05044325|560402709|FG005|Part A:Treatment Period 2|Adverse Event|1|||
155264364|NCT05044325|560402710|FG006|Part A:Treatment Period 2|Adverse Event|0|||
155264365|NCT05044325|560402711|FG007|Part A:Treatment Period 2|Adverse Event|0|||
155264366|NCT05044325|560402712|FG008|Part A:Treatment Period 2|Adverse Event|0|||
155264367|NCT05044325|560402713|FG009|Part A:Treatment Period 2|Adverse Event|0|||
155264368|NCT05044325|560402704|FG000|Part A:Treatment Period 2|Physician Decision|0|||
155264369|NCT05044325|560402705|FG001|Part A:Treatment Period 2|Physician Decision|0|||
155264370|NCT05044325|560402706|FG002|Part A:Treatment Period 2|Physician Decision|0|||
155264371|NCT05044325|560402707|FG003|Part A:Treatment Period 2|Physician Decision|0|||
155264372|NCT05044325|560402708|FG004|Part A:Treatment Period 2|Physician Decision|0|||
155264373|NCT05044325|560402709|FG005|Part A:Treatment Period 2|Physician Decision|1|||
155264374|NCT05044325|560402710|FG006|Part A:Treatment Period 2|Physician Decision|0|||
155264375|NCT05044325|560402711|FG007|Part A:Treatment Period 2|Physician Decision|0|||
155264376|NCT05044325|560402712|FG008|Part A:Treatment Period 2|Physician Decision|0|||
155264377|NCT05044325|560402713|FG009|Part A:Treatment Period 2|Physician Decision|0|||
155264378|NCT05044325|560402704|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264379|NCT05044325|560402705|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264380|NCT05044325|560402706|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264381|NCT05044325|560402707|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
155264382|NCT05044325|560402708|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
155264383|NCT05044325|560402709|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264384|NCT05044325|560402710|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264385|NCT05044325|560402711|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264386|NCT05044325|560402712|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264387|NCT05044325|560402713|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
155264388|NCT01250119|560402716|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
155264389|NCT01250119|560402717|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
155264390|NCT01250119|560402716|FG000|Diagnostic Phase|Participants Not Tested|44|||
155264391|NCT01250119|560402717|FG001|Diagnostic Phase|Participants Not Tested|0|||
155264392|NCT01250119|560402716|FG000|Treatment Phase|Progressive Disease|0|||
155264393|NCT01250119|560402717|FG001|Treatment Phase|Progressive Disease|32|||
155264394|NCT01250119|560402716|FG000|Treatment Phase|Death|0|||
155264395|NCT01250119|560402717|FG001|Treatment Phase|Death|2|||
155264396|NCT01250119|560402716|FG000|Treatment Phase|Withdrawal by Subject|0|||
155264397|NCT01250119|560402717|FG001|Treatment Phase|Withdrawal by Subject|1|||
155264398|NCT01250119|560402716|FG000|Treatment Phase|Adverse Event|0|||
155264399|NCT01250119|560402717|FG001|Treatment Phase|Adverse Event|2|||
155264400|NCT01250119|560402716|FG000|Treatment Phase|Unknown reason|0|||
155264401|NCT01250119|560402717|FG001|Treatment Phase|Unknown reason|4|||
155264402|NCT04887948|560402728|FG000|Overall Study|Death|1|||
155264403|NCT04887948|560402729|FG001|Overall Study|Death|0|||
155264404|NCT04887948|560402730|FG002|Overall Study|Death|0|||
155264405|NCT04887948|560402728|FG000|Overall Study|Lost to Follow-up|1|||
155264406|NCT04887948|560402729|FG001|Overall Study|Lost to Follow-up|0|||
155264407|NCT04887948|560402730|FG002|Overall Study|Lost to Follow-up|3|||
155264408|NCT04887948|560402728|FG000|Overall Study|Physician Decision|0|||
155264409|NCT04887948|560402729|FG001|Overall Study|Physician Decision|4|||
155264410|NCT04887948|560402730|FG002|Overall Study|Physician Decision|1|||
155264411|NCT04887948|560402728|FG000|Overall Study|Protocol Violation|1|||
155264412|NCT04887948|560402729|FG001|Overall Study|Protocol Violation|1|||
155264413|NCT04887948|560402730|FG002|Overall Study|Protocol Violation|0|||
155264414|NCT04887948|560402728|FG000|Overall Study|Withdrawal by Subject|0|||
155264415|NCT04887948|560402729|FG001|Overall Study|Withdrawal by Subject|6|||
155264416|NCT04887948|560402730|FG002|Overall Study|Withdrawal by Subject|1|||
155264417|NCT04887948|560402728|FG000|Overall Study|No longer met eligibility criteria|1|||
155264418|NCT04887948|560402729|FG001|Overall Study|No longer met eligibility criteria|2|||
155264419|NCT04887948|560402730|FG002|Overall Study|No longer met eligibility criteria|1|||
155264420|NCT04887948|560402728|FG000|Overall Study|Other|2|||
155264421|NCT04887948|560402729|FG001|Overall Study|Other|1|||
155264422|NCT04887948|560402730|FG002|Overall Study|Other|1|||
155264423|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
155264424|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
155264425|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Adverse Event|2|||
155264426|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Adverse Event|5|||
155264427|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
155264428|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
155264429|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
155264430|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
155264431|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Randomized by error|0|||
155264432|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Randomized by error|5|||
155264433|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
155264434|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
155264435|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
155264436|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
155264437|NCT02948959|560402731|FG000|52 Weeks Treatment Period|Change of residence location|0|||
155264438|NCT02948959|560402732|FG001|52 Weeks Treatment Period|Change of residence location|1|||
155264439|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
155264440|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
155264441|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
155264442|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
155264443|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
155264444|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
155264445|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
155264446|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
155264447|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
155264448|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
155264449|NCT02948959|560402731|FG000|12 Weeks Follow-up Period|Study site closure|1|||
155264450|NCT02948959|560402732|FG001|12 Weeks Follow-up Period|Study site closure|0|||
155264451|NCT00787319|560402733|FG000|Overall Study|Lost to Follow-up|2|||
155264452|NCT00787319|560402733|FG000|Overall Study|Withdrawal by Subject|15|||
155264453|NCT00787319|560402733|FG000|Overall Study|Adverse Event|3|||
155264454|NCT00787319|560402733|FG000|Overall Study|Objective progression or relapse|30|||
155264455|NCT00787319|560402733|FG000|Overall Study|Lack of Efficacy|1|||
155264456|NCT00787319|560402733|FG000|Overall Study|Budget exhausted/exceeded|1|||
155264457|NCT00787319|560402733|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
155264458|NCT00787319|560402733|FG000|Overall Study|No health insurance reimbursement|2|||
155264459|NCT00787319|560402733|FG000|Overall Study|Stabilized disease findings|3|||
155264460|NCT00787319|560402733|FG000|Overall Study|Inactive disease|5|||
155264461|NCT02312856|560402734|FG000|Overall Study|Death|1|||
155264462|NCT02312856|560402734|FG000|Overall Study|Lost to Follow-up|3|||
155264463|NCT01932294|560402735|FG000|Overall Study|Death|43|||
155264464|NCT01932294|560402735|FG000|Overall Study|Lost to Follow-up|8|||
155264465|NCT01932294|560402735|FG000|Overall Study|VAD Implantation|20|||
155264466|NCT01932294|560402735|FG000|Overall Study|Heart Transplantation|16|||
155264467|NCT01932294|560402735|FG000|Overall Study|Transferred to other hospitals|12|||
155264468|NCT04415151|560402736|FG000|Overall Study|Death|1|||
155264469|NCT04415151|560402737|FG001|Overall Study|Death|1|||
155264470|NCT04415151|560402736|FG000|Overall Study|Withdrawal by Subject|1|||
155264471|NCT04415151|560402737|FG001|Overall Study|Withdrawal by Subject|0|||
155264472|NCT00409786|560402738|FG000|Overall Study|Withdrawal by Subject|3|||
155264473|NCT00638235|560402739|FG000|Overall Study|Lost to Follow-up|31|||
155264474|NCT00638235|560402740|FG001|Overall Study|Lost to Follow-up|3|||
155264475|NCT00638235|560402741|FG002|Overall Study|Lost to Follow-up|18|||
155264476|NCT00638235|560402742|FG003|Overall Study|Lost to Follow-up|10|||
155264477|NCT00638235|560402743|FG004|Overall Study|Lost to Follow-up|13|||
155264478|NCT00638235|560402744|FG005|Overall Study|Lost to Follow-up|26|||
155264479|NCT00638235|560402745|FG006|Overall Study|Lost to Follow-up|0|||
155264480|NCT00638235|560402746|FG007|Overall Study|Lost to Follow-up|1|||
155264481|NCT00638235|560402747|FG008|Overall Study|Lost to Follow-up|18|||
155264482|NCT00597714|560402752|FG000|Overall Study|Death|56|||
155264483|NCT00597714|560402753|FG001|Overall Study|Death|46|||
155264484|NCT00597714|560402754|FG002|Overall Study|Death|0|||
155264485|NCT00597714|560402752|FG000|Overall Study|Recipient death|0|||
155264486|NCT00597714|560402753|FG001|Overall Study|Recipient death|0|||
155264487|NCT00597714|560402754|FG002|Overall Study|Recipient death|10|||
155264488|NCT01641926|560402763|FG000|Overall Study|Adverse Event|5|||
155264489|NCT01641926|560402764|FG001|Overall Study|Adverse Event|2|||
155264490|NCT01641926|560402765|FG002|Overall Study|Adverse Event|3|||
155264491|NCT01641926|560402766|FG003|Overall Study|Adverse Event|1|||
155264492|NCT01641926|560402763|FG000|Overall Study|Lost to Follow-up|2|||
155264493|NCT01641926|560402764|FG001|Overall Study|Lost to Follow-up|2|||
155264494|NCT01641926|560402765|FG002|Overall Study|Lost to Follow-up|1|||
155264495|NCT01641926|560402766|FG003|Overall Study|Lost to Follow-up|0|||
155264496|NCT01641926|560402763|FG000|Overall Study|Physician Decision|6|||
155264497|NCT01641926|560402764|FG001|Overall Study|Physician Decision|5|||
155264498|NCT01641926|560402765|FG002|Overall Study|Physician Decision|0|||
155264499|NCT01641926|560402766|FG003|Overall Study|Physician Decision|1|||
155264500|NCT01641926|560402763|FG000|Overall Study|Protocol Violation|1|||
155264501|NCT01641926|560402764|FG001|Overall Study|Protocol Violation|0|||
155264502|NCT01641926|560402765|FG002|Overall Study|Protocol Violation|0|||
155264503|NCT01641926|560402766|FG003|Overall Study|Protocol Violation|1|||
155264504|NCT01641926|560402763|FG000|Overall Study|Withdrawal by Subject|13|||
155264505|NCT01641926|560402764|FG001|Overall Study|Withdrawal by Subject|5|||
155264506|NCT01641926|560402765|FG002|Overall Study|Withdrawal by Subject|6|||
155264507|NCT01641926|560402766|FG003|Overall Study|Withdrawal by Subject|1|||
155264508|NCT01641926|560402763|FG000|Overall Study|Not Treated|1|||
155264509|NCT01641926|560402764|FG001|Overall Study|Not Treated|1|||
155264510|NCT01641926|560402765|FG002|Overall Study|Not Treated|1|||
155264511|NCT01641926|560402766|FG003|Overall Study|Not Treated|0|||
155264512|NCT03673462|560402767|FG000|Overall Study|Adverse Event|11|||
155264513|NCT03673462|560402768|FG001|Overall Study|Adverse Event|1|||
155264514|NCT03673462|560402767|FG000|Overall Study|Protocol Violation|25|||
155264515|NCT03673462|560402768|FG001|Overall Study|Protocol Violation|11|||
155264516|NCT03673462|560402767|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
155264517|NCT03673462|560402768|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
155264518|NCT03673462|560402767|FG000|Overall Study|Lost to Follow-up|102|||
155264519|NCT03673462|560402768|FG001|Overall Study|Lost to Follow-up|19|||
155264520|NCT01480596|560402774|FG000|Overall Study|Adverse Event|3|||
155264521|NCT01480596|560402775|FG001|Overall Study|Adverse Event|0|||
155264522|NCT01480596|560402774|FG000|Overall Study|MG exacerbation or change in medication|2|||
155264523|NCT01480596|560402775|FG001|Overall Study|MG exacerbation or change in medication|2|||
155264524|NCT02387216|560402776|FG000|Overall Study|Progressive disease|2|||
155264525|NCT02387216|560402777|FG001|Overall Study|Progressive disease|0|||
155264526|NCT02387216|560402776|FG000|Overall Study|Withdrawal by Subject|3|||
155264527|NCT02387216|560402777|FG001|Overall Study|Withdrawal by Subject|5|||
155264528|NCT02387216|560402776|FG000|Overall Study|Physician Decision|2|||
155264529|NCT02387216|560402777|FG001|Overall Study|Physician Decision|0|||
155264530|NCT02387216|560402776|FG000|Overall Study|Sponsor Decision|28|||
155264531|NCT02387216|560402777|FG001|Overall Study|Sponsor Decision|12|||
155264532|NCT02387216|560402776|FG000|Overall Study|Death|60|||
155264533|NCT02387216|560402777|FG001|Overall Study|Death|23|||
155264534|NCT02387216|560402776|FG000|Overall Study|Other|5|||
155264535|NCT02387216|560402777|FG001|Overall Study|Other|4|||
155264536|NCT02387216|560402776|FG000|Overall Study|Lost to Follow-up|0|||
155264537|NCT02387216|560402777|FG001|Overall Study|Lost to Follow-up|3|||
155264538|NCT02917265|560402780|FG000|Overall Study|Physician Decision|1|||
155264539|NCT02917265|560402781|FG001|Overall Study|Physician Decision|0|||
155264540|NCT02917265|560402780|FG000|Overall Study|Withdrawal by Subject|1|||
155264541|NCT02917265|560402781|FG001|Overall Study|Withdrawal by Subject|0|||
155264542|NCT00979602|560402792|FG000|Overall Study|Serious Adverse Event|5|||
155264543|NCT00979602|560402793|FG001|Overall Study|Serious Adverse Event|3|||
155264544|NCT00979602|560402792|FG000|Overall Study|Protocol Violation|3|||
155264545|NCT00979602|560402793|FG001|Overall Study|Protocol Violation|0|||
155264546|NCT00979602|560402792|FG000|Overall Study|Withdrawal by Subject|31|||
155264547|NCT00979602|560402793|FG001|Overall Study|Withdrawal by Subject|25|||
155264548|NCT00979602|560402792|FG000|Overall Study|Lost to Follow-up|100|||
155264549|NCT00979602|560402793|FG001|Overall Study|Lost to Follow-up|96|||
155264550|NCT00979602|560402792|FG000|Overall Study|Migrated/moved from study area|3|||
155264551|NCT00979602|560402793|FG001|Overall Study|Migrated/moved from study area|6|||
155264552|NCT00979602|560402792|FG000|Overall Study|Others|3|||
155264553|NCT00979602|560402793|FG001|Overall Study|Others|3|||
155264554|NCT01216163|560402797|FG000|Overall Study|Withdrawal by Subject|1|||
155264555|NCT01216163|560402798|FG001|Overall Study|Withdrawal by Subject|1|||
155264556|NCT01216163|560402799|FG002|Overall Study|Withdrawal by Subject|0|||
155264557|NCT02002182|560402801|FG000|Overall Study|Withdraw from study|3|||
155264558|NCT02002182|560402802|FG001|Overall Study|Withdraw from study|1|||
155264559|NCT02002182|560402801|FG000|Overall Study|Health Reasons|1|||
155264560|NCT02002182|560402802|FG001|Overall Study|Health Reasons|0|||
155264561|NCT02002182|560402801|FG000|Overall Study|Death|1|||
155264562|NCT02002182|560402802|FG001|Overall Study|Death|0|||
155264563|NCT03879408|560402813|FG000|Overall Study|Lost to Follow-up|0|||
155264564|NCT03879408|560402814|FG001|Overall Study|Lost to Follow-up|3|||
155264565|NCT03879408|560402815|FG002|Overall Study|Lost to Follow-up|2|||
155264566|NCT03879408|560402816|FG003|Overall Study|Lost to Follow-up|1|||
155264567|NCT03879408|560402817|FG004|Overall Study|Lost to Follow-up|0|||
155264568|NCT03879408|560402813|FG000|Overall Study|Withdrawal by Subject|2|||
155264569|NCT03879408|560402814|FG001|Overall Study|Withdrawal by Subject|1|||
155264570|NCT03879408|560402815|FG002|Overall Study|Withdrawal by Subject|1|||
155264571|NCT03879408|560402816|FG003|Overall Study|Withdrawal by Subject|0|||
155264572|NCT03879408|560402817|FG004|Overall Study|Withdrawal by Subject|1|||
155264573|NCT01320943|560402818|FG000|Overall Study|Lost to Follow-up|1|||
155264574|NCT01320943|560402819|FG001|Overall Study|Lost to Follow-up|0|||
155264575|NCT01320943|560402818|FG000|Overall Study|Physician Decision|0|||
155264576|NCT01320943|560402819|FG001|Overall Study|Physician Decision|1|||
155264577|NCT01320943|560402818|FG000|Overall Study|Randomized but not Treated|0|||
155264578|NCT01320943|560402819|FG001|Overall Study|Randomized but not Treated|1|||
155264579|NCT01490125|560402820|FG000|Period I|Adverse Event|4|||
155264580|NCT01490125|560402821|FG001|Period I|Adverse Event|1|||
155264581|NCT01490125|560402822|FG002|Period I|Adverse Event|1|||
155264582|NCT01490125|560402823|FG003|Period I|Adverse Event|3|||
155264583|NCT01490125|560402824|FG004|Period I|Adverse Event|2|||
155264584|NCT01490125|560402825|FG005|Period I|Adverse Event|4|||
155264585|NCT01490125|560402820|FG000|Period I|Protocol Violation|1|||
155264586|NCT01490125|560402821|FG001|Period I|Protocol Violation|1|||
155264587|NCT01490125|560402822|FG002|Period I|Protocol Violation|1|||
155264588|NCT01490125|560402823|FG003|Period I|Protocol Violation|1|||
155264589|NCT01490125|560402824|FG004|Period I|Protocol Violation|0|||
155264590|NCT01490125|560402825|FG005|Period I|Protocol Violation|0|||
155264591|NCT01490125|560402820|FG000|Period I|Withdrawal by Subject|1|||
155264592|NCT01490125|560402821|FG001|Period I|Withdrawal by Subject|3|||
155264593|NCT01490125|560402822|FG002|Period I|Withdrawal by Subject|2|||
155264594|NCT01490125|560402823|FG003|Period I|Withdrawal by Subject|1|||
155264595|NCT01490125|560402824|FG004|Period I|Withdrawal by Subject|2|||
155264596|NCT01490125|560402825|FG005|Period I|Withdrawal by Subject|1|||
155264597|NCT01490125|560402820|FG000|Period II|Adverse Event|2|||
155264598|NCT01490125|560402821|FG001|Period II|Adverse Event|3|||
155264599|NCT01490125|560402822|FG002|Period II|Adverse Event|2|||
155264600|NCT01490125|560402823|FG003|Period II|Adverse Event|2|||
155264601|NCT01490125|560402824|FG004|Period II|Adverse Event|4|||
155264602|NCT01490125|560402825|FG005|Period II|Adverse Event|2|||
155264603|NCT01490125|560402820|FG000|Period II|Protocol Violation|0|||
155264604|NCT01490125|560402821|FG001|Period II|Protocol Violation|0|||
155264605|NCT01490125|560402822|FG002|Period II|Protocol Violation|1|||
155264606|NCT01490125|560402823|FG003|Period II|Protocol Violation|1|||
155264607|NCT01490125|560402824|FG004|Period II|Protocol Violation|0|||
155264608|NCT01490125|560402825|FG005|Period II|Protocol Violation|0|||
155264609|NCT01490125|560402820|FG000|Period II|Lost to Follow-up|0|||
155264610|NCT01490125|560402821|FG001|Period II|Lost to Follow-up|1|||
155264611|NCT01490125|560402822|FG002|Period II|Lost to Follow-up|0|||
155264612|NCT01490125|560402823|FG003|Period II|Lost to Follow-up|0|||
155264613|NCT01490125|560402824|FG004|Period II|Lost to Follow-up|0|||
155264614|NCT01490125|560402825|FG005|Period II|Lost to Follow-up|0|||
155264615|NCT01490125|560402820|FG000|Period II|Withdrawal by Subject|1|||
155264616|NCT01490125|560402821|FG001|Period II|Withdrawal by Subject|0|||
155264617|NCT01490125|560402822|FG002|Period II|Withdrawal by Subject|0|||
155264618|NCT01490125|560402823|FG003|Period II|Withdrawal by Subject|0|||
155264619|NCT01490125|560402824|FG004|Period II|Withdrawal by Subject|0|||
155264620|NCT01490125|560402825|FG005|Period II|Withdrawal by Subject|0|||
155264621|NCT01490125|560402820|FG000|Period III|Adverse Event|3|||
155264622|NCT01490125|560402821|FG001|Period III|Adverse Event|1|||
155264623|NCT01490125|560402822|FG002|Period III|Adverse Event|0|||
155264624|NCT01490125|560402823|FG003|Period III|Adverse Event|1|||
155264625|NCT01490125|560402824|FG004|Period III|Adverse Event|0|||
155264626|NCT01490125|560402825|FG005|Period III|Adverse Event|0|||
155264627|NCT01490125|560402820|FG000|Period III|Death|0|||
155264628|NCT01490125|560402821|FG001|Period III|Death|0|||
155264629|NCT01490125|560402822|FG002|Period III|Death|0|||
155264630|NCT01490125|560402823|FG003|Period III|Death|1|||
155264631|NCT01490125|560402824|FG004|Period III|Death|0|||
155264632|NCT01490125|560402825|FG005|Period III|Death|0|||
155264633|NCT01490125|560402820|FG000|Period III|Lack of Efficacy|0|||
155264634|NCT01490125|560402821|FG001|Period III|Lack of Efficacy|0|||
155264635|NCT01490125|560402822|FG002|Period III|Lack of Efficacy|0|||
155264636|NCT01490125|560402823|FG003|Period III|Lack of Efficacy|0|||
155264637|NCT01490125|560402824|FG004|Period III|Lack of Efficacy|1|||
155264638|NCT01490125|560402825|FG005|Period III|Lack of Efficacy|0|||
155264639|NCT05458024|560402827|FG000|Overall Study|Withdrawal by Subject|1|||
155264640|NCT05458024|560402828|FG001|Overall Study|Withdrawal by Subject|1|||
155264641|NCT04522180|560402829|FG000|Overall Study|Investigator judgement|3|||
155264642|NCT04522180|560402830|FG001|Overall Study|Investigator judgement|4|||
155264643|NCT04522180|560402829|FG000|Overall Study|Voluntary withdrawal|1|||
155264644|NCT04522180|560402830|FG001|Overall Study|Voluntary withdrawal|0|||
155264645|NCT04522180|560402829|FG000|Overall Study|Pregnancy|0|||
155264646|NCT04522180|560402830|FG001|Overall Study|Pregnancy|1|||
155264647|NCT04522180|560402829|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
155264648|NCT04522180|560402830|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
155264649|NCT04522180|560402829|FG000|Overall Study|Reason not specified|8|||
155264650|NCT04522180|560402830|FG001|Overall Study|Reason not specified|5|||
155264651|NCT05807919|560402831|FG000|Overall Study|Received antibiotics - excluded|0|||
155264652|NCT05807919|560402832|FG001|Overall Study|Received antibiotics - excluded|1|||
155264653|NCT05807919|560402831|FG000|Overall Study|Withdrawal by Subject|0|||
155264654|NCT05807919|560402832|FG001|Overall Study|Withdrawal by Subject|3|||
155264655|NCT05807919|560402831|FG000|Overall Study|Adverse Event|1|||
155264656|NCT05807919|560402832|FG001|Overall Study|Adverse Event|1|||
155264657|NCT01931735|560402839|FG000|Randomized Phase|Lost to Follow-up|2|||
155264658|NCT01931735|560402840|FG001|Randomized Phase|Lost to Follow-up|2|||
155264659|NCT01931735|560402841|FG002|Randomized Phase|Lost to Follow-up|5|||
155264660|NCT01931735|560402842|FG003|Randomized Phase|Lost to Follow-up|0|||
155264661|NCT01931735|560402839|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
155264662|NCT01931735|560402840|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
155264663|NCT01931735|560402841|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
155264664|NCT01931735|560402842|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
155264665|NCT01931735|560402839|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
155264666|NCT01931735|560402840|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
155264667|NCT01931735|560402841|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
155264668|NCT01931735|560402842|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
155264669|NCT02719990|560402843|FG000|Overall Study|Physician Decision|2|||
155264670|NCT02719990|560402843|FG000|Overall Study|Withdrawal by Subject|2|||
155264671|NCT02719990|560402843|FG000|Overall Study|Study Terminated By Sponsor|32|||
155264672|NCT02404389|560402844|FG000|Overall Study|Adverse Event|1|||
155264673|NCT02404389|560402845|FG001|Overall Study|Adverse Event|0|||
155264674|NCT02404389|560402846|FG002|Overall Study|Adverse Event|1|||
155264675|NCT02404389|560402847|FG003|Overall Study|Adverse Event|0|||
155264676|NCT02404389|560402848|FG004|Overall Study|Adverse Event|2|||
155264677|NCT02404389|560402844|FG000|Overall Study|Subject/guardian decision|1|||
155264678|NCT02404389|560402845|FG001|Overall Study|Subject/guardian decision|0|||
155264679|NCT02404389|560402846|FG002|Overall Study|Subject/guardian decision|0|||
155264680|NCT02404389|560402847|FG003|Overall Study|Subject/guardian decision|1|||
155264681|NCT02404389|560402848|FG004|Overall Study|Subject/guardian decision|1|||
155264682|NCT03324880|560402849|FG000|Overall Study|Adverse Event|0|||
155264683|NCT03324880|560402850|FG001|Overall Study|Adverse Event|2|||
155264684|NCT03324880|560402849|FG000|Overall Study|Withdrawal by Subject|2|||
155264685|NCT03324880|560402850|FG001|Overall Study|Withdrawal by Subject|2|||
155264686|NCT03324880|560402849|FG000|Overall Study|Lost to Follow-up|0|||
155264687|NCT03324880|560402850|FG001|Overall Study|Lost to Follow-up|1|||
155264688|NCT03324880|560402849|FG000|Overall Study|Product Recall|0|||
155264689|NCT03324880|560402850|FG001|Overall Study|Product Recall|1|||
155264690|NCT01412801|560402851|FG000|Overall Study|Death|0|||
155264691|NCT01412801|560402852|FG001|Overall Study|Death|1|||
155264692|NCT01412801|560402853|FG002|Overall Study|Death|0|||
155264693|NCT01412801|560402854|FG003|Overall Study|Death|4|||
155264694|NCT01412801|560402855|FG004|Overall Study|Death|2|||
155264695|NCT01412801|560402856|FG005|Overall Study|Death|2|||
155264696|NCT01412801|560402851|FG000|Overall Study|Lost to Follow-up|1|||
155264697|NCT01412801|560402852|FG001|Overall Study|Lost to Follow-up|2|||
155264698|NCT01412801|560402853|FG002|Overall Study|Lost to Follow-up|4|||
155264699|NCT01412801|560402854|FG003|Overall Study|Lost to Follow-up|0|||
155264700|NCT01412801|560402855|FG004|Overall Study|Lost to Follow-up|1|||
155264701|NCT01412801|560402856|FG005|Overall Study|Lost to Follow-up|1|||
155264702|NCT01412801|560402851|FG000|Overall Study|Withdrawal by Subject|3|||
155264703|NCT01412801|560402852|FG001|Overall Study|Withdrawal by Subject|2|||
155264704|NCT01412801|560402853|FG002|Overall Study|Withdrawal by Subject|1|||
155264705|NCT01412801|560402854|FG003|Overall Study|Withdrawal by Subject|0|||
155264706|NCT01412801|560402855|FG004|Overall Study|Withdrawal by Subject|0|||
155264707|NCT01412801|560402856|FG005|Overall Study|Withdrawal by Subject|0|||
155264708|NCT01412801|560402851|FG000|Overall Study|Relocated to another area|0|||
155264709|NCT01412801|560402852|FG001|Overall Study|Relocated to another area|0|||
155264710|NCT01412801|560402853|FG002|Overall Study|Relocated to another area|2|||
155264711|NCT01412801|560402854|FG003|Overall Study|Relocated to another area|0|||
155264712|NCT01412801|560402855|FG004|Overall Study|Relocated to another area|0|||
155264713|NCT01412801|560402856|FG005|Overall Study|Relocated to another area|0|||
155264714|NCT00717314|560402860|FG000|Overall Study|Adverse Event|3|||
155264715|NCT00717314|560402861|FG001|Overall Study|Adverse Event|2|||
155264716|NCT00717314|560402860|FG000|Overall Study|Protocol Violation|1|||
155264717|NCT00717314|560402861|FG001|Overall Study|Protocol Violation|0|||
155264718|NCT00717314|560402860|FG000|Overall Study|Lost to Follow-up|1|||
155264719|NCT00717314|560402861|FG001|Overall Study|Lost to Follow-up|5|||
155264720|NCT00717314|560402860|FG000|Overall Study|Withdrawal by Subject|1|||
155264721|NCT00717314|560402861|FG001|Overall Study|Withdrawal by Subject|3|||
155264722|NCT05076149|560402862|FG000|Overall Study|Adverse Event|3|||
155264723|NCT05076149|560402863|FG001|Overall Study|Adverse Event|9|||
155264724|NCT05076149|560402862|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
155264725|NCT05076149|560402863|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
155264726|NCT05076149|560402862|FG000|Overall Study|Lost to Follow-up|0|||
155264727|NCT05076149|560402863|FG001|Overall Study|Lost to Follow-up|1|||
155264728|NCT05076149|560402862|FG000|Overall Study|Commercial drug is available for participant|0|||
155264729|NCT05076149|560402863|FG001|Overall Study|Commercial drug is available for participant|1|||
155264730|NCT05076149|560402862|FG000|Overall Study|Other non compliance|1|||
155264731|NCT05076149|560402863|FG001|Overall Study|Other non compliance|1|||
155264732|NCT05076149|560402862|FG000|Overall Study|Physician Decision|0|||
155264733|NCT05076149|560402863|FG001|Overall Study|Physician Decision|1|||
155264734|NCT05076149|560402862|FG000|Overall Study|Other|5|||
155264735|NCT05076149|560402863|FG001|Overall Study|Other|4|||
155264736|NCT05096208|560402864|FG000|Overall Study|Lost to Follow-up|3|||
155264737|NCT05096208|560402865|FG001|Overall Study|Lost to Follow-up|5|||
155264738|NCT05096208|560402866|FG002|Overall Study|Lost to Follow-up|5|||
155264739|NCT05096208|560402867|FG003|Overall Study|Lost to Follow-up|2|||
155264740|NCT05096208|560402864|FG000|Overall Study|Withdrawal by Subject|0|||
155264741|NCT05096208|560402865|FG001|Overall Study|Withdrawal by Subject|1|||
155264742|NCT05096208|560402866|FG002|Overall Study|Withdrawal by Subject|2|||
155264743|NCT05096208|560402867|FG003|Overall Study|Withdrawal by Subject|3|||
155264744|NCT05096208|560402864|FG000|Overall Study|No longer met eligibility criteria|1|||
155264745|NCT05096208|560402865|FG001|Overall Study|No longer met eligibility criteria|0|||
155264746|NCT05096208|560402866|FG002|Overall Study|No longer met eligibility criteria|0|||
155264747|NCT05096208|560402867|FG003|Overall Study|No longer met eligibility criteria|0|||
155264748|NCT05096208|560402864|FG000|Overall Study|Other|0|||
155264749|NCT05096208|560402865|FG001|Overall Study|Other|0|||
155264750|NCT05096208|560402866|FG002|Overall Study|Other|1|||
155264751|NCT05096208|560402867|FG003|Overall Study|Other|0|||
155264752|NCT02087501|560402868|FG000|Overall Study|Death|7|||
155264753|NCT02087501|560402868|FG000|Overall Study|Open repair of aneurysm|1|||
155264754|NCT02087501|560402868|FG000|Overall Study|Lost to Follow-up|2|||
155264755|NCT00094328|560402869|FG000|Overall Study|Lost to Follow-up|1|||
155264756|NCT01483937|560402872|FG000|Overall Study|Withdrawal by Subject|4|||
155264757|NCT01483937|560402873|FG001|Overall Study|Withdrawal by Subject|3|||
155264758|NCT01919970|560402874|FG000|Overall Study|Withdrawal by Subject|3|||
155264759|NCT01919970|560402875|FG001|Overall Study|Withdrawal by Subject|0|||
155264760|NCT02213328|560402876|FG000|Overall Study|Withdrawal by Subject|10|||
155264761|NCT02213328|560402876|FG000|Overall Study|Physician Decision|2|||
155264762|NCT02213328|560402876|FG000|Overall Study|Lost to Follow-up|16|||
155264763|NCT00990340|560402877|FG000|First 14-day Treatment|Not Compliant|2|||
155264764|NCT00990340|560402878|FG001|First 14-day Treatment|Not Compliant|1|||
155264765|NCT00990340|560402877|FG000|First 14-day Treatment|Lost to Follow-up|2|||
155264766|NCT00990340|560402878|FG001|First 14-day Treatment|Lost to Follow-up|1|||
155264767|NCT00990340|560402877|FG000|First 14-day Treatment|Protocol Violation|2|||
155264768|NCT00990340|560402878|FG001|First 14-day Treatment|Protocol Violation|2|||
155264769|NCT04615182|560402879|FG000|Overall Study|Re-transplanted|2|||
155264770|NCT04615182|560402879|FG000|Overall Study|Protocol Violation|6|||
155264771|NCT04615182|560402879|FG000|Overall Study|Death|6|||
155264772|NCT04615182|560402879|FG000|Overall Study|Death and protocol violation|1|||
155264773|NCT01126060|560402880|FG000|Overall Study|Protocol Violation|0|||
155264774|NCT01126060|560402881|FG001|Overall Study|Protocol Violation|2|||
155264775|NCT00402337|560402882|FG000|Overall Study|Adverse Event|0|||
155264776|NCT00402337|560402883|FG001|Overall Study|Adverse Event|2|||
155264777|NCT00402337|560402884|FG002|Overall Study|Adverse Event|2|||
155264778|NCT00402337|560402885|FG003|Overall Study|Adverse Event|3|||
155264779|NCT00402337|560402886|FG004|Overall Study|Adverse Event|2|||
155264780|NCT00402337|560402882|FG000|Overall Study|Noncompliance|0|||
155264781|NCT00402337|560402883|FG001|Overall Study|Noncompliance|0|||
155264782|NCT00402337|560402884|FG002|Overall Study|Noncompliance|0|||
155264783|NCT00402337|560402885|FG003|Overall Study|Noncompliance|0|||
155264784|NCT00402337|560402886|FG004|Overall Study|Noncompliance|2|||
155264785|NCT00402337|560402882|FG000|Overall Study|Withdrawal by Subject|5|||
155264786|NCT00402337|560402883|FG001|Overall Study|Withdrawal by Subject|3|||
155264787|NCT00402337|560402884|FG002|Overall Study|Withdrawal by Subject|1|||
155264788|NCT00402337|560402885|FG003|Overall Study|Withdrawal by Subject|6|||
155264789|NCT00402337|560402886|FG004|Overall Study|Withdrawal by Subject|4|||
155264790|NCT00402337|560402882|FG000|Overall Study|Lost to Follow-up|0|||
155264791|NCT00402337|560402883|FG001|Overall Study|Lost to Follow-up|0|||
155264792|NCT00402337|560402884|FG002|Overall Study|Lost to Follow-up|1|||
155264793|NCT00402337|560402885|FG003|Overall Study|Lost to Follow-up|2|||
155264794|NCT00402337|560402886|FG004|Overall Study|Lost to Follow-up|0|||
155264795|NCT00402337|560402882|FG000|Overall Study|Physician Decision|0|||
155264796|NCT00402337|560402883|FG001|Overall Study|Physician Decision|0|||
155264797|NCT00402337|560402884|FG002|Overall Study|Physician Decision|0|||
155264798|NCT00402337|560402885|FG003|Overall Study|Physician Decision|1|||
155264799|NCT00402337|560402886|FG004|Overall Study|Physician Decision|0|||
155264800|NCT00402337|560402882|FG000|Overall Study|Other Reason|0|||
155264801|NCT00402337|560402883|FG001|Overall Study|Other Reason|1|||
155264802|NCT00402337|560402884|FG002|Overall Study|Other Reason|0|||
155264803|NCT00402337|560402885|FG003|Overall Study|Other Reason|0|||
155264804|NCT00402337|560402886|FG004|Overall Study|Other Reason|0|||
155264805|NCT03565068|560402887|FG000|Overall Study|Protocol Violation|0|||
155264806|NCT03565068|560402888|FG001|Overall Study|Protocol Violation|0|||
155264807|NCT03565068|560402889|FG002|Overall Study|Protocol Violation|0|||
155264808|NCT03565068|560402890|FG003|Overall Study|Protocol Violation|0|||
155264809|NCT03565068|560402891|FG004|Overall Study|Protocol Violation|1|||
155264810|NCT03565068|560402892|FG005|Overall Study|Protocol Violation|0|||
155264811|NCT03565068|560402893|FG006|Overall Study|Protocol Violation|0|||
155264812|NCT03565068|560402894|FG007|Overall Study|Protocol Violation|1|||
155264813|NCT03565068|560402895|FG008|Overall Study|Protocol Violation|0|||
155264814|NCT03565068|560402887|FG000|Overall Study|Sponsor decision|0|||
155264815|NCT03565068|560402888|FG001|Overall Study|Sponsor decision|0|||
155264816|NCT03565068|560402889|FG002|Overall Study|Sponsor decision|0|||
155264817|NCT03565068|560402890|FG003|Overall Study|Sponsor decision|0|||
155264818|NCT03565068|560402891|FG004|Overall Study|Sponsor decision|1|||
155264819|NCT03565068|560402892|FG005|Overall Study|Sponsor decision|1|||
155264820|NCT03565068|560402893|FG006|Overall Study|Sponsor decision|0|||
155264821|NCT03565068|560402894|FG007|Overall Study|Sponsor decision|0|||
155264822|NCT03565068|560402895|FG008|Overall Study|Sponsor decision|0|||
155264823|NCT03565068|560402887|FG000|Overall Study|Withdrawal by Subject|0|||
155264824|NCT03565068|560402888|FG001|Overall Study|Withdrawal by Subject|0|||
155264825|NCT03565068|560402889|FG002|Overall Study|Withdrawal by Subject|1|||
155264826|NCT03565068|560402890|FG003|Overall Study|Withdrawal by Subject|0|||
155264827|NCT03565068|560402891|FG004|Overall Study|Withdrawal by Subject|2|||
155264828|NCT03565068|560402892|FG005|Overall Study|Withdrawal by Subject|0|||
155264829|NCT03565068|560402893|FG006|Overall Study|Withdrawal by Subject|1|||
155264830|NCT03565068|560402894|FG007|Overall Study|Withdrawal by Subject|5|||
155264831|NCT03565068|560402895|FG008|Overall Study|Withdrawal by Subject|1|||
155264832|NCT03565068|560402887|FG000|Overall Study|Physician Decision|0|||
155264833|NCT03565068|560402888|FG001|Overall Study|Physician Decision|0|||
155264834|NCT03565068|560402889|FG002|Overall Study|Physician Decision|0|||
155264835|NCT03565068|560402890|FG003|Overall Study|Physician Decision|0|||
155264836|NCT03565068|560402891|FG004|Overall Study|Physician Decision|0|||
155264837|NCT03565068|560402892|FG005|Overall Study|Physician Decision|0|||
155264838|NCT03565068|560402893|FG006|Overall Study|Physician Decision|0|||
155264839|NCT03565068|560402894|FG007|Overall Study|Physician Decision|1|||
155264840|NCT03565068|560402895|FG008|Overall Study|Physician Decision|0|||
155264841|NCT03565068|560402887|FG000|Overall Study|Lost to Follow-up|0|||
155264842|NCT03565068|560402888|FG001|Overall Study|Lost to Follow-up|0|||
155264843|NCT03565068|560402889|FG002|Overall Study|Lost to Follow-up|0|||
155264844|NCT03565068|560402890|FG003|Overall Study|Lost to Follow-up|0|||
155264845|NCT03565068|560402891|FG004|Overall Study|Lost to Follow-up|0|||
155264846|NCT03565068|560402892|FG005|Overall Study|Lost to Follow-up|0|||
155264847|NCT03565068|560402893|FG006|Overall Study|Lost to Follow-up|0|||
155264848|NCT03565068|560402894|FG007|Overall Study|Lost to Follow-up|1|||
155264849|NCT03565068|560402895|FG008|Overall Study|Lost to Follow-up|0|||
155264850|NCT02764775|560404986|FG000|Overall Study|Death|1|||
155264851|NCT02764775|560404986|FG000|Overall Study|Lost to Follow-up|2|||
155264852|NCT02764775|560404986|FG000|Overall Study|Withdrawal by Subject|3|||
155264853|NCT00429494|560404987|FG000|Overall Study|Withdrawal by Subject|9|||
155264854|NCT00429494|560404987|FG000|Overall Study|Death|6|||
155264855|NCT00976703|560404990|FG000|Overall Study|Physician Decision|1|||
155264856|NCT00976703|560404991|FG001|Overall Study|Physician Decision|1|||
155264857|NCT00976703|560404990|FG000|Overall Study|ineligible for study|2|||
155264858|NCT00976703|560404991|FG001|Overall Study|ineligible for study|2|||
155264859|NCT02243631|560404994|FG000|Overall Study|no synovial fluid on second aspirate|0|||
155264860|NCT02243631|560404995|FG001|Overall Study|no synovial fluid on second aspirate|1|||
155264861|NCT01992549|560405000|FG000|Overall Study|Lost to Follow-up|2|||
155264862|NCT01992549|560405000|FG000|Overall Study|Serious Adverse Event|1|||
155264863|NCT01992549|560405000|FG000|Overall Study|Product Switch to Extend Half Life|1|||
155264864|NCT00840996|560405002|FG000|Overall Study|Withdrawal by Subject|1|||
155264865|NCT00840996|560405003|FG001|Overall Study|Withdrawal by Subject|0|||
155264866|NCT04022889|560405004|FG000|Stage 1: Period 1|Adverse Event|1|||
155264867|NCT04022889|560405005|FG001|Stage 1: Period 1|Adverse Event|0|||
155264868|NCT04022889|560405006|FG002|Stage 1: Period 1|Adverse Event|0|||
155264869|NCT04022889|560405004|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
155264870|NCT04022889|560405005|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
155264871|NCT04022889|560405006|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
155264872|NCT04022889|560405004|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
155264873|NCT04022889|560405005|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
155264874|NCT04022889|560405006|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
155264875|NCT04022889|560405004|FG000|Stage 2|Screen Failure|0|||
155264876|NCT04022889|560405005|FG001|Stage 2|Screen Failure|0|||
155264877|NCT04022889|560405006|FG002|Stage 2|Screen Failure|3|||
155264878|NCT04022889|560405004|FG000|Stage 2|Ineligible for apheresis donation|0|||
155264879|NCT04022889|560405005|FG001|Stage 2|Ineligible for apheresis donation|0|||
155264880|NCT04022889|560405006|FG002|Stage 2|Ineligible for apheresis donation|2|||
155264881|NCT04022889|560405004|FG000|Stage 2|Adverse Event|0|||
155264882|NCT04022889|560405005|FG001|Stage 2|Adverse Event|0|||
155264883|NCT04022889|560405006|FG002|Stage 2|Adverse Event|2|||
155264884|NCT04022889|560405004|FG000|Stage 2|Protocol Violation|0|||
155264885|NCT04022889|560405005|FG001|Stage 2|Protocol Violation|0|||
155264886|NCT04022889|560405006|FG002|Stage 2|Protocol Violation|1|||
155264887|NCT04022889|560405004|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
155264888|NCT04022889|560405005|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
155264889|NCT04022889|560405006|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
155264890|NCT01900054|560405010|FG000|Overall Study|Physician Decision|1|||
155264891|NCT01900054|560405010|FG000|Overall Study|Withdrawal by Subject|1|||
155264892|NCT02762981|560405013|FG000|Overall Study|Adverse Event|2|||
155264893|NCT02762981|560405014|FG001|Overall Study|Adverse Event|3|||
155264894|NCT02762981|560405015|FG002|Overall Study|Adverse Event|1|||
155264895|NCT02762981|560405016|FG003|Overall Study|Adverse Event|1|||
155264896|NCT02762981|560405017|FG004|Overall Study|Adverse Event|3|||
155264897|NCT02762981|560405013|FG000|Overall Study|Physician Decision|0|||
155264898|NCT02762981|560405014|FG001|Overall Study|Physician Decision|1|||
155264899|NCT02762981|560405015|FG002|Overall Study|Physician Decision|0|||
155264900|NCT02762981|560405016|FG003|Overall Study|Physician Decision|0|||
155264901|NCT02762981|560405017|FG004|Overall Study|Physician Decision|1|||
155264902|NCT02762981|560405013|FG000|Overall Study|Disease progression|11|||
155264903|NCT02762981|560405014|FG001|Overall Study|Disease progression|23|||
155264904|NCT02762981|560405015|FG002|Overall Study|Disease progression|4|||
155264905|NCT02762981|560405016|FG003|Overall Study|Disease progression|10|||
155264906|NCT02762981|560405017|FG004|Overall Study|Disease progression|1|||
155264907|NCT02762981|560405013|FG000|Overall Study|Enrolled not treated|1|||
155264908|NCT02762981|560405014|FG001|Overall Study|Enrolled not treated|5|||
155264909|NCT02762981|560405015|FG002|Overall Study|Enrolled not treated|0|||
155264910|NCT02762981|560405016|FG003|Overall Study|Enrolled not treated|2|||
155264911|NCT02762981|560405017|FG004|Overall Study|Enrolled not treated|0|||
155264912|NCT02762981|560405013|FG000|Overall Study|Other|2|||
155264913|NCT02762981|560405014|FG001|Overall Study|Other|3|||
155264914|NCT02762981|560405015|FG002|Overall Study|Other|1|||
155264915|NCT02762981|560405016|FG003|Overall Study|Other|0|||
155264916|NCT02762981|560405017|FG004|Overall Study|Other|0|||
155264917|NCT02762981|560405013|FG000|Overall Study|Missing|1|||
155264918|NCT02762981|560405014|FG001|Overall Study|Missing|0|||
155264919|NCT02762981|560405015|FG002|Overall Study|Missing|0|||
155264920|NCT02762981|560405016|FG003|Overall Study|Missing|0|||
155264921|NCT02762981|560405017|FG004|Overall Study|Missing|0|||
155264922|NCT02762981|560405013|FG000|Overall Study|Withdrawal by Subject|0|||
155264923|NCT02762981|560405014|FG001|Overall Study|Withdrawal by Subject|5|||
155264924|NCT02762981|560405015|FG002|Overall Study|Withdrawal by Subject|1|||
155264925|NCT02762981|560405016|FG003|Overall Study|Withdrawal by Subject|3|||
155264926|NCT02762981|560405017|FG004|Overall Study|Withdrawal by Subject|0|||
155264927|NCT00957931|560405018|FG000|Overall Study|Death|4|||
155264928|NCT00605319|560405023|FG000|Overall Study|Adverse Event|6|||
155264929|NCT02991482|560405025|FG000|Overall Study|Disease progression|56|||
155264930|NCT02991482|560405026|FG001|Overall Study|Disease progression|47|||
155264931|NCT02991482|560405025|FG000|Overall Study|Death|4|||
155264932|NCT02991482|560405026|FG001|Overall Study|Death|4|||
155264933|NCT02991482|560405025|FG000|Overall Study|Adverse Event|1|||
155264934|NCT02991482|560405026|FG001|Overall Study|Adverse Event|6|||
155264935|NCT02991482|560405025|FG000|Overall Study|Patient decision|1|||
155264936|NCT02991482|560405026|FG001|Overall Study|Patient decision|1|||
155264937|NCT02991482|560405025|FG000|Overall Study|Physician Decision|0|||
155264938|NCT02991482|560405026|FG001|Overall Study|Physician Decision|6|||
155264939|NCT02991482|560405025|FG000|Overall Study|Clinical deterioration|1|||
155264940|NCT02991482|560405026|FG001|Overall Study|Clinical deterioration|0|||
155264941|NCT02991482|560405025|FG000|Overall Study|Patient feeling too unwell|1|||
155264942|NCT02991482|560405026|FG001|Overall Study|Patient feeling too unwell|0|||
155264943|NCT02991482|560405025|FG000|Overall Study|Worsening of performance status|0|||
155264944|NCT02991482|560405026|FG001|Overall Study|Worsening of performance status|1|||
155264945|NCT02991482|560405025|FG000|Overall Study|Death prior to study drug initiation|1|||
155264946|NCT02991482|560405026|FG001|Overall Study|Death prior to study drug initiation|0|||
155264947|NCT02991482|560405025|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
155264948|NCT02991482|560405026|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
155264949|NCT02887989|560405027|FG000|Overall Study|Withdrawal by Subject|8|||
155264950|NCT02887989|560405028|FG001|Overall Study|Withdrawal by Subject|11|||
155264951|NCT02887989|560405027|FG000|Overall Study|Death|1|||
155264952|NCT02887989|560405028|FG001|Overall Study|Death|0|||
155264953|NCT02045433|560405029|FG000|Overall Study|Withdrawal by Subject|1|||
155264954|NCT01559454|560405030|FG000|Overall Study|Lost to Follow-up|3|||
155264955|NCT01559454|560405031|FG001|Overall Study|Lost to Follow-up|2|||
155264956|NCT01559454|560405030|FG000|Overall Study|Withdrawal by Subject|0|||
155264957|NCT01559454|560405031|FG001|Overall Study|Withdrawal by Subject|1|||
155264958|NCT01559454|560405030|FG000|Overall Study|Physician Decision|0|||
155264959|NCT01559454|560405031|FG001|Overall Study|Physician Decision|1|||
155264960|NCT01559454|560405030|FG000|Overall Study|Protocol Violation|0|||
155264961|NCT01559454|560405031|FG001|Overall Study|Protocol Violation|1|||
155264962|NCT01559454|560405030|FG000|Overall Study|Lack of Efficacy|0|||
155264963|NCT01559454|560405031|FG001|Overall Study|Lack of Efficacy|1|||
155264964|NCT00462670|560405036|FG000|Overall Study|Adverse Event|3|||
155264965|NCT00462670|560405037|FG001|Overall Study|Adverse Event|5|||
155264966|NCT00462670|560405036|FG000|Overall Study|Lack of Efficacy|1|||
155264967|NCT00462670|560405037|FG001|Overall Study|Lack of Efficacy|0|||
155264968|NCT00462670|560405036|FG000|Overall Study|Protocol Violation|1|||
155264969|NCT00462670|560405037|FG001|Overall Study|Protocol Violation|0|||
155264970|NCT00462670|560405036|FG000|Overall Study|Resolution of signs and symptoms|0|||
155264971|NCT00462670|560405037|FG001|Overall Study|Resolution of signs and symptoms|2|||
155264972|NCT00482274|560405038|FG000|Overall Study|Adverse Event|1|||
155264973|NCT03075904|560405045|FG000|Overall Study|Physician Decision|3|||
155264974|NCT03075904|560405045|FG000|Overall Study|Need for Medication not Permitted|1|||
155264975|NCT01588990|560405046|FG000|Phase A|Withdrawal by Subject|5|||
155264976|NCT01588990|560405046|FG000|Phase A|Physician Decision|11|||
155264977|NCT01588990|560405046|FG000|Phase A|Other|14|||
155264978|NCT01588990|560405046|FG000|Phase A|Lost to Follow-up|1|||
155264979|NCT01588990|560405046|FG000|Phase A|Death|5|||
155264980|NCT01588990|560405046|FG000|Phase A|Adverse Event|28|||
155264981|NCT01588990|560405046|FG000|Phase A|Still on therapy at end of study|6|||
155264982|NCT01588990|560405046|FG000|Phase B|Adverse Event|2|||
155264983|NCT01588990|560405046|FG000|Phase B|Still on therapy at end of study|5|||
155264984|NCT01588990|560405046|FG000|Phase B|Withdrawal by Subject|3|||
155264985|NCT01588990|560405046|FG000|Phase B|Physician Decision|4|||
155264986|NCT01588990|560405046|FG000|Phase B|Other|2|||
155264987|NCT01287520|560405047|FG000|Overall Study|Adverse Event|2|||
155264988|NCT01287520|560405048|FG001|Overall Study|Adverse Event|2|||
155264989|NCT01287520|560405049|FG002|Overall Study|Adverse Event|2|||
155264990|NCT01287520|560405050|FG003|Overall Study|Adverse Event|1|||
155264991|NCT01287520|560405051|FG004|Overall Study|Adverse Event|1|||
155264992|NCT01287520|560405052|FG005|Overall Study|Adverse Event|2|||
155264993|NCT01287520|560405053|FG006|Overall Study|Adverse Event|0|||
155264994|NCT01287520|560405054|FG007|Overall Study|Adverse Event|2|||
155264995|NCT01287520|560405055|FG008|Overall Study|Adverse Event|0|||
155264996|NCT01287520|560405047|FG000|Overall Study|Physician Decision|1|||
155264997|NCT01287520|560405048|FG001|Overall Study|Physician Decision|1|||
155264998|NCT01287520|560405049|FG002|Overall Study|Physician Decision|2|||
155264999|NCT01287520|560405050|FG003|Overall Study|Physician Decision|0|||
155265000|NCT01287520|560405051|FG004|Overall Study|Physician Decision|1|||
155265001|NCT01287520|560405052|FG005|Overall Study|Physician Decision|1|||
155265002|NCT01287520|560405053|FG006|Overall Study|Physician Decision|0|||
155265003|NCT01287520|560405054|FG007|Overall Study|Physician Decision|1|||
155265004|NCT01287520|560405055|FG008|Overall Study|Physician Decision|0|||
155265005|NCT01287520|560405047|FG000|Overall Study|Progressive disease|0|||
155265006|NCT01287520|560405048|FG001|Overall Study|Progressive disease|4|||
155265007|NCT01287520|560405049|FG002|Overall Study|Progressive disease|1|||
155265008|NCT01287520|560405050|FG003|Overall Study|Progressive disease|6|||
155265009|NCT01287520|560405051|FG004|Overall Study|Progressive disease|1|||
155265010|NCT01287520|560405052|FG005|Overall Study|Progressive disease|0|||
155265011|NCT01287520|560405053|FG006|Overall Study|Progressive disease|2|||
155265012|NCT01287520|560405054|FG007|Overall Study|Progressive disease|2|||
155265013|NCT01287520|560405055|FG008|Overall Study|Progressive disease|4|||
155265014|NCT01287520|560405047|FG000|Overall Study|Withdrawal by Subject|0|||
155265015|NCT01287520|560405048|FG001|Overall Study|Withdrawal by Subject|0|||
155265016|NCT01287520|560405049|FG002|Overall Study|Withdrawal by Subject|0|||
155265017|NCT01287520|560405050|FG003|Overall Study|Withdrawal by Subject|0|||
155265018|NCT01287520|560405051|FG004|Overall Study|Withdrawal by Subject|0|||
155265019|NCT01287520|560405052|FG005|Overall Study|Withdrawal by Subject|1|||
155265020|NCT01287520|560405053|FG006|Overall Study|Withdrawal by Subject|0|||
155265021|NCT01287520|560405054|FG007|Overall Study|Withdrawal by Subject|0|||
155265022|NCT01287520|560405055|FG008|Overall Study|Withdrawal by Subject|1|||
155265023|NCT03587142|560405056|FG000|Overall Study|Lost to Follow-up|5|||
155265024|NCT03587142|560405057|FG001|Overall Study|Lost to Follow-up|3|||
155265025|NCT03587142|560405056|FG000|Overall Study|Did not complete the f4 visit|3|||
155265026|NCT03587142|560405057|FG001|Overall Study|Did not complete the f4 visit|7|||
155265027|NCT01800201|560405058|FG000|Overall Study|Withdrawal by Subject|2|||
155265028|NCT01800201|560405059|FG001|Overall Study|Withdrawal by Subject|0|||
155265029|NCT01800201|560405058|FG000|Overall Study|patient privacy concerns|1|||
155265030|NCT01800201|560405059|FG001|Overall Study|patient privacy concerns|1|||
155265031|NCT01800201|560405058|FG000|Overall Study|did not want to use device|0|||
155265032|NCT01800201|560405059|FG001|Overall Study|did not want to use device|1|||
155265033|NCT01800201|560405058|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
155265034|NCT01800201|560405059|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
155265035|NCT04503096|560405062|FG000|Overall Study|Withdrawal by Subject|3|||
155265036|NCT01576367|560405063|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
155265037|NCT01576367|560405063|FG000|Overall Study|Moved to commercial use after 6 months|1|||
155265038|NCT04359771|560405067|FG000|Overall Study|Lack of Efficacy|2|||
155265039|NCT04359771|560405068|FG001|Overall Study|Lack of Efficacy|2|||
155265040|NCT00909480|560405073|FG000|Overall Study|Adverse Event|5|||
155265041|NCT00909480|560405074|FG001|Overall Study|Adverse Event|3|||
155265042|NCT00909480|560405073|FG000|Overall Study|Protocol Violation|6|||
155265043|NCT00909480|560405074|FG001|Overall Study|Protocol Violation|8|||
155265044|NCT00909480|560405073|FG000|Overall Study|Withdrawal criteria|9|||
155265045|NCT00909480|560405074|FG001|Overall Study|Withdrawal criteria|11|||
155265046|NCT00909480|560405073|FG000|Overall Study|Unclassified|18|||
155265047|NCT00909480|560405074|FG001|Overall Study|Unclassified|19|||
155265048|NCT03528174|560405077|FG000|Overall Study|Adverse Event|1|||
155265049|NCT03528174|560405077|FG000|Overall Study|sensors dislodged|1|||
155265050|NCT02904902|560405080|FG000|Overall Study|Withdrawal by Subject|1|||
155265051|NCT01719237|560405081|FG000|Overall Study|Physician Decision|0|||
155265052|NCT01719237|560405082|FG001|Overall Study|Physician Decision|1|||
155265053|NCT02118337|560405090|FG000|Overall Study|Other|1|||
155265054|NCT02118337|560405091|FG001|Overall Study|Other|0|||
155265055|NCT02118337|560405092|FG002|Overall Study|Other|0|||
155265056|NCT02118337|560405093|FG003|Overall Study|Other|0|||
155265057|NCT02118337|560405094|FG004|Overall Study|Other|2|||
155265058|NCT02118337|560405095|FG005|Overall Study|Other|3|||
155265059|NCT02118337|560405096|FG006|Overall Study|Other|1|||
155265060|NCT02118337|560405097|FG007|Overall Study|Other|28|||
155265061|NCT02118337|560405098|FG008|Overall Study|Other|15|||
155265062|NCT02118337|560405090|FG000|Overall Study|Lost to Follow-up|0|||
155265063|NCT02118337|560405091|FG001|Overall Study|Lost to Follow-up|0|||
155265064|NCT02118337|560405092|FG002|Overall Study|Lost to Follow-up|0|||
155265065|NCT02118337|560405093|FG003|Overall Study|Lost to Follow-up|0|||
155265066|NCT02118337|560405094|FG004|Overall Study|Lost to Follow-up|0|||
155265067|NCT02118337|560405095|FG005|Overall Study|Lost to Follow-up|0|||
155265068|NCT02118337|560405096|FG006|Overall Study|Lost to Follow-up|0|||
155265069|NCT02118337|560405097|FG007|Overall Study|Lost to Follow-up|1|||
155265070|NCT02118337|560405098|FG008|Overall Study|Lost to Follow-up|0|||
155265071|NCT02118337|560405090|FG000|Overall Study|Withdrawal by Subject|1|||
155265072|NCT02118337|560405091|FG001|Overall Study|Withdrawal by Subject|3|||
155265073|NCT02118337|560405092|FG002|Overall Study|Withdrawal by Subject|2|||
155265074|NCT02118337|560405093|FG003|Overall Study|Withdrawal by Subject|1|||
155265075|NCT02118337|560405094|FG004|Overall Study|Withdrawal by Subject|2|||
155265076|NCT02118337|560405095|FG005|Overall Study|Withdrawal by Subject|2|||
155265077|NCT02118337|560405096|FG006|Overall Study|Withdrawal by Subject|1|||
155265078|NCT02118337|560405097|FG007|Overall Study|Withdrawal by Subject|4|||
155265079|NCT02118337|560405098|FG008|Overall Study|Withdrawal by Subject|2|||
155265080|NCT02118337|560405090|FG000|Overall Study|Death|2|||
155265081|NCT02118337|560405091|FG001|Overall Study|Death|2|||
155265082|NCT02118337|560405092|FG002|Overall Study|Death|1|||
155265083|NCT02118337|560405093|FG003|Overall Study|Death|2|||
155265084|NCT02118337|560405094|FG004|Overall Study|Death|5|||
155265085|NCT02118337|560405095|FG005|Overall Study|Death|1|||
155265086|NCT02118337|560405096|FG006|Overall Study|Death|2|||
155265087|NCT02118337|560405097|FG007|Overall Study|Death|9|||
155265088|NCT02118337|560405098|FG008|Overall Study|Death|4|||
155265089|NCT00453102|560405100|FG000|Overall Study|Withdrawal by Subject|2|||
155265090|NCT05400746|560405105|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
155265091|NCT05400746|560405106|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
155265092|NCT05400746|560405107|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
155265093|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
155265094|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
155265095|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
155265096|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
155265097|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
155265098|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
155265099|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
155265100|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Physician Decision|4|||
155265101|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Physician Decision|1|||
155265102|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Physician Decision|3|||
155265103|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Physician Decision|0|||
155265104|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Physician Decision|0|||
155265105|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Physician Decision|1|||
155265106|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Physician Decision|0|||
155265107|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Other|0|||
155265108|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Other|1|||
155265109|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Other|0|||
155265110|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Other|0|||
155265111|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Other|0|||
155265112|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Other|0|||
155265113|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Other|0|||
155265114|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265115|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265116|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265117|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265118|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265119|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
155265120|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
155265121|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
155265122|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
155265123|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
155265124|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
155265125|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
155265126|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
155265127|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
155265128|NCT05375955|560405108|FG000|Treatment (12 Weeks)|Pregnancy|0|||
155265129|NCT05375955|560405109|FG001|Treatment (12 Weeks)|Pregnancy|0|||
155265130|NCT05375955|560405110|FG002|Treatment (12 Weeks)|Pregnancy|1|||
155265131|NCT05375955|560405111|FG003|Treatment (12 Weeks)|Pregnancy|0|||
155265132|NCT05375955|560405112|FG004|Treatment (12 Weeks)|Pregnancy|0|||
155265133|NCT05375955|560405113|FG005|Treatment (12 Weeks)|Pregnancy|0|||
155265134|NCT05375955|560405114|FG006|Treatment (12 Weeks)|Pregnancy|0|||
155265135|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265136|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265137|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
155265138|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265139|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265140|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265141|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
155265142|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
155265143|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265144|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
155265145|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265146|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265147|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
155265148|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
155265149|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Other|0|||
155265150|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Other|1|||
155265151|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Other|0|||
155265152|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Other|0|||
155265153|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Other|0|||
155265154|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Other|0|||
155265155|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Other|0|||
155265156|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
155265157|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265158|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
155265159|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265160|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265161|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265162|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
155265163|NCT05375955|560405108|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265164|NCT05375955|560405109|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
155265165|NCT05375955|560405110|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265166|NCT05375955|560405111|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
155265167|NCT05375955|560405112|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265168|NCT05375955|560405113|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
155265169|NCT05375955|560405114|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
155265170|NCT03724396|560405115|FG000|Overall Study|Lost to Follow-up|1|||
155265171|NCT03724396|560405116|FG001|Overall Study|Lost to Follow-up|1|||
155265172|NCT03724396|560405115|FG000|Overall Study|Withdrawal by Subject|1|||
155265173|NCT03724396|560405116|FG001|Overall Study|Withdrawal by Subject|0|||
155265174|NCT03489057|560405117|FG000|Overall Study|Lost to Follow-up|16|||
155265175|NCT03489057|560405118|FG001|Overall Study|Lost to Follow-up|16|||
155265176|NCT03489057|560405119|FG002|Overall Study|Lost to Follow-up|14|||
155265177|NCT03489057|560405120|FG003|Overall Study|Lost to Follow-up|14|||
155265178|NCT03489057|560405117|FG000|Overall Study|Withdrawal by Subject|12|||
155265179|NCT03489057|560405118|FG001|Overall Study|Withdrawal by Subject|12|||
155265180|NCT03489057|560405119|FG002|Overall Study|Withdrawal by Subject|8|||
155265181|NCT03489057|560405120|FG003|Overall Study|Withdrawal by Subject|8|||
155265182|NCT03489057|560405117|FG000|Overall Study|Protocol Violation|7|||
155265183|NCT03489057|560405118|FG001|Overall Study|Protocol Violation|7|||
155265184|NCT03489057|560405119|FG002|Overall Study|Protocol Violation|2|||
155265185|NCT03489057|560405120|FG003|Overall Study|Protocol Violation|2|||
155265186|NCT00943306|560405123|FG000|Overall Study|Physician Decision|1|||
155265187|NCT00943306|560405123|FG000|Overall Study|Death|1|||
155265188|NCT00943306|560405123|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
155265189|NCT00733980|560405124|FG000|Overall Study|Adverse Event|5|||
155265190|NCT00733980|560405125|FG001|Overall Study|Adverse Event|2|||
155265191|NCT00733980|560405124|FG000|Overall Study|Lack of Efficacy|0|||
155265192|NCT00733980|560405125|FG001|Overall Study|Lack of Efficacy|1|||
155265193|NCT00733980|560405124|FG000|Overall Study|Protocol Violation|2|||
155265194|NCT00733980|560405125|FG001|Overall Study|Protocol Violation|1|||
155265195|NCT00733980|560405124|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
155265196|NCT00733980|560405125|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
155265197|NCT00733980|560405124|FG000|Overall Study|Lost to Follow-up|6|||
155265198|NCT00733980|560405125|FG001|Overall Study|Lost to Follow-up|11|||
155265199|NCT00733980|560405124|FG000|Overall Study|Physician Decision|2|||
155265200|NCT00733980|560405125|FG001|Overall Study|Physician Decision|3|||
155265201|NCT00733980|560405124|FG000|Overall Study|Withdrawal by Subject|6|||
155265202|NCT00733980|560405125|FG001|Overall Study|Withdrawal by Subject|2|||
155265203|NCT02739347|560405126|FG000|Overall Study|Adverse Event|3|||
155265204|NCT02739347|560405127|FG001|Overall Study|Adverse Event|0|||
155265205|NCT02739347|560405126|FG000|Overall Study|Protocol Violation|0|||
155265206|NCT02739347|560405127|FG001|Overall Study|Protocol Violation|1|||
155265207|NCT02739347|560405126|FG000|Overall Study|Lost to Follow-up|0|||
155265208|NCT02739347|560405127|FG001|Overall Study|Lost to Follow-up|2|||
155265209|NCT01235403|560405129|FG000|Overall Study|Adverse Event|14|||
155265210|NCT01235403|560405129|FG000|Overall Study|Lost to Follow-up|2|||
155265211|NCT01235403|560405129|FG000|Overall Study|Withdrawal by Subject|4|||
155265212|NCT01235403|560405129|FG000|Overall Study|Lack of Efficacy|2|||
155265213|NCT01235403|560405129|FG000|Overall Study|Other reasons for premature termination|4|||
155265214|NCT03682705|560405130|FG000|Overall Study|Adverse Event|1|||
155265215|NCT03682705|560405131|FG001|Overall Study|Adverse Event|1|||
155265216|NCT03682705|560405132|FG002|Overall Study|Adverse Event|1|||
155265217|NCT03682705|560405133|FG003|Overall Study|Adverse Event|0|||
155265218|NCT03682705|560405134|FG004|Overall Study|Adverse Event|1|||
155265219|NCT03682705|560405135|FG005|Overall Study|Adverse Event|1|||
155265220|NCT03682705|560405130|FG000|Overall Study|Withdrawal by Subject|1|||
155265221|NCT03682705|560405131|FG001|Overall Study|Withdrawal by Subject|3|||
155265222|NCT03682705|560405132|FG002|Overall Study|Withdrawal by Subject|2|||
155265223|NCT03682705|560405133|FG003|Overall Study|Withdrawal by Subject|4|||
155265224|NCT03682705|560405134|FG004|Overall Study|Withdrawal by Subject|0|||
155265225|NCT03682705|560405135|FG005|Overall Study|Withdrawal by Subject|1|||
155265226|NCT03682705|560405130|FG000|Overall Study|Other, not specified|0|||
155265227|NCT03682705|560405131|FG001|Overall Study|Other, not specified|0|||
155265228|NCT03682705|560405132|FG002|Overall Study|Other, not specified|0|||
155265229|NCT03682705|560405133|FG003|Overall Study|Other, not specified|1|||
155265230|NCT03682705|560405134|FG004|Overall Study|Other, not specified|2|||
155265231|NCT03682705|560405135|FG005|Overall Study|Other, not specified|0|||
155265232|NCT03682705|560405130|FG000|Overall Study|Lost to Follow-up|0|||
155265233|NCT03682705|560405131|FG001|Overall Study|Lost to Follow-up|0|||
155265234|NCT03682705|560405132|FG002|Overall Study|Lost to Follow-up|0|||
155265235|NCT03682705|560405133|FG003|Overall Study|Lost to Follow-up|0|||
155265236|NCT03682705|560405134|FG004|Overall Study|Lost to Follow-up|3|||
155265237|NCT03682705|560405135|FG005|Overall Study|Lost to Follow-up|0|||
155265238|NCT00265330|560405136|FG000|Overall Study|Adverse Event|41|||
155265239|NCT00265330|560405136|FG000|Overall Study|Lost to Follow-up|8|||
155265240|NCT00265330|560405136|FG000|Overall Study|Withdrawal by Subject|34|||
155265241|NCT00265330|560405136|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
155265242|NCT00265330|560405136|FG000|Overall Study|Lack of Efficacy|4|||
155265243|NCT00265330|560405136|FG000|Overall Study|Family Scheduling Conflicts|1|||
155265244|NCT00265330|560405136|FG000|Overall Study|Began Taking Formulary Geodon|1|||
155265245|NCT00265330|560405136|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
155265246|NCT00265330|560405136|FG000|Overall Study|Site Closed by Sponsor|1|||
155265247|NCT00265330|560405136|FG000|Overall Study|Principal Investigators Request|1|||
155265248|NCT00265330|560405136|FG000|Overall Study|Withdrew Consent|1|||
155265249|NCT00265330|560405136|FG000|Overall Study|Protocol Violation|1|||
155265250|NCT04043962|560405137|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
155265251|NCT04043962|560405137|FG000|Post-Treatment|Withdrawal by Subject|5|||
155265252|NCT04043962|560405137|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
155265253|NCT02658630|560405138|FG000|Overall Study|Withdrawal by Subject|4|||
155265254|NCT02613221|560405139|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
155265255|NCT02613221|560405139|FG000|Overall Study|Adverse Event|2|||
155265256|NCT02613221|560405139|FG000|Overall Study|Voluntary Discontinuation|1|||
155265257|NCT02613221|560405139|FG000|Overall Study|Delayed Treatment|1|||
155265258|NCT02613221|560405139|FG000|Overall Study|Enrolled but Not Treated|1|||
155265259|NCT01786330|560405147|FG000|Overall Study|Withdrawal by Subject|0|||
155265260|NCT01786330|560405148|FG001|Overall Study|Withdrawal by Subject|1|||
155265261|NCT01786330|560405147|FG000|Overall Study|Lost to Follow-up|0|||
155265262|NCT01786330|560405148|FG001|Overall Study|Lost to Follow-up|1|||
155265263|NCT01786330|560405147|FG000|Overall Study|Excluded intraoperatively|0|||
155265264|NCT01786330|560405148|FG001|Overall Study|Excluded intraoperatively|1|||
155265265|NCT01786330|560405147|FG000|Overall Study|Protocol Violation|1|||
155265266|NCT01786330|560405148|FG001|Overall Study|Protocol Violation|0|||
155265267|NCT00311155|560406987|FG000|Overall Study|Adverse Event|21|||
155265268|NCT00311155|560406987|FG000|Overall Study|Withdrawal by Subject|17|||
155265269|NCT00311155|560406987|FG000|Overall Study|Did not meet entry criteria|55|||
155265270|NCT01590771|560406993|FG000|Overall Study|Other Protocol Specified Criteria|5|||
155265271|NCT01590771|560406994|FG001|Overall Study|Other Protocol Specified Criteria|14|||
155265272|NCT01590771|560406993|FG000|Overall Study|Withdrawal by Subject|8|||
155265273|NCT01590771|560406994|FG001|Overall Study|Withdrawal by Subject|15|||
155265274|NCT01590771|560406993|FG000|Overall Study|Protocol Violation|1|||
155265275|NCT01590771|560406994|FG001|Overall Study|Protocol Violation|2|||
155265276|NCT01590771|560406993|FG000|Overall Study|Lost to Follow-up|1|||
155265277|NCT01590771|560406994|FG001|Overall Study|Lost to Follow-up|1|||
155265278|NCT01590771|560406993|FG000|Overall Study|Lack of Efficacy|1|||
155265279|NCT01590771|560406994|FG001|Overall Study|Lack of Efficacy|0|||
155265280|NCT01590771|560406993|FG000|Overall Study|Adverse Event|3|||
155265281|NCT01590771|560406994|FG001|Overall Study|Adverse Event|7|||
155265282|NCT01785628|560406997|FG000|Overall Study|Lost to Follow-up|2|||
155265283|NCT01785628|560406998|FG001|Overall Study|Lost to Follow-up|3|||
155265284|NCT00767104|560407001|FG000|Overall Study|Lost to Follow-up|1|||
155265285|NCT00767104|560407002|FG001|Overall Study|Lost to Follow-up|2|||
155265286|NCT03285295|560407005|FG000|Alinity s HBsAg|Protocol Violation|11|||
155265287|NCT03285295|560407006|FG001|Alinity s HBsAg|Protocol Violation|0|||
155265288|NCT03285295|560407007|FG002|Alinity s HBsAg|Protocol Violation|0|||
155265289|NCT03285295|560407008|FG003|Alinity s HBsAg|Protocol Violation|0|||
155265290|NCT03285295|560407009|FG004|Alinity s HBsAg|Protocol Violation|0|||
155265291|NCT03285295|560407005|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
155265292|NCT03285295|560407006|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265293|NCT03285295|560407007|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265294|NCT03285295|560407008|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265295|NCT03285295|560407009|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
155265296|NCT03285295|560407005|FG000|Alinity s HBsAg|No Results Generated|74|||
155265297|NCT03285295|560407006|FG001|Alinity s HBsAg|No Results Generated|6|||
155265298|NCT03285295|560407007|FG002|Alinity s HBsAg|No Results Generated|0|||
155265299|NCT03285295|560407008|FG003|Alinity s HBsAg|No Results Generated|0|||
155265300|NCT03285295|560407009|FG004|Alinity s HBsAg|No Results Generated|0|||
155265301|NCT03285295|560407005|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
155265302|NCT03285295|560407006|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
155265303|NCT03285295|560407007|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
155265304|NCT03285295|560407008|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
155265305|NCT03285295|560407009|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
155265306|NCT03285295|560407005|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
155265307|NCT03285295|560407006|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265308|NCT03285295|560407007|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265309|NCT03285295|560407008|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265310|NCT03285295|560407009|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
155265311|NCT03285295|560407005|FG000|Alinity s HTLV I/II|No Results Generated|70|||
155265312|NCT03285295|560407006|FG001|Alinity s HTLV I/II|No Results Generated|0|||
155265313|NCT03285295|560407007|FG002|Alinity s HTLV I/II|No Results Generated|0|||
155265314|NCT03285295|560407008|FG003|Alinity s HTLV I/II|No Results Generated|0|||
155265315|NCT03285295|560407009|FG004|Alinity s HTLV I/II|No Results Generated|0|||
155265316|NCT03285295|560407005|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
155265317|NCT03285295|560407006|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265318|NCT03285295|560407007|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265319|NCT03285295|560407008|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265320|NCT03285295|560407009|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
155265321|NCT03285295|560407005|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
155265322|NCT03285295|560407006|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
155265323|NCT03285295|560407007|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
155265324|NCT03285295|560407008|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
155265325|NCT03285295|560407009|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
155265326|NCT03285295|560407005|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
155265327|NCT03285295|560407006|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265328|NCT03285295|560407007|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265329|NCT03285295|560407008|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265330|NCT03285295|560407009|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
155265331|NCT03285295|560407005|FG000|Alinity s Anti-HCV|No Results Generated|71|||
155265332|NCT03285295|560407006|FG001|Alinity s Anti-HCV|No Results Generated|0|||
155265333|NCT03285295|560407007|FG002|Alinity s Anti-HCV|No Results Generated|0|||
155265334|NCT03285295|560407008|FG003|Alinity s Anti-HCV|No Results Generated|0|||
155265335|NCT03285295|560407009|FG004|Alinity s Anti-HCV|No Results Generated|0|||
155265336|NCT03285295|560407005|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
155265337|NCT03285295|560407006|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265338|NCT03285295|560407007|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265339|NCT03285295|560407008|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265340|NCT03285295|560407009|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
155265341|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
155265342|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265343|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265344|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265345|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
155265346|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
155265347|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265348|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265349|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265350|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
155265351|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
155265352|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265353|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265354|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265355|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
155265356|NCT03285295|560407005|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
155265357|NCT03285295|560407006|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265358|NCT03285295|560407007|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265359|NCT03285295|560407008|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265360|NCT03285295|560407009|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
155265361|NCT03285295|560407005|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
155265362|NCT03285295|560407006|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
155265363|NCT03285295|560407007|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
155265364|NCT03285295|560407008|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
155265365|NCT03285295|560407009|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
155265366|NCT03285295|560407005|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
155265367|NCT03285295|560407006|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
155265368|NCT03285295|560407007|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
155265369|NCT03285295|560407008|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
155265370|NCT03285295|560407009|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
155265371|NCT03285295|560407005|FG000|Alinity s Anti-HBc|No Results Generated|70|||
155265372|NCT03285295|560407006|FG001|Alinity s Anti-HBc|No Results Generated|0|||
155265373|NCT03285295|560407007|FG002|Alinity s Anti-HBc|No Results Generated|0|||
155265374|NCT03285295|560407008|FG003|Alinity s Anti-HBc|No Results Generated|0|||
155265375|NCT03285295|560407009|FG004|Alinity s Anti-HBc|No Results Generated|0|||
155265376|NCT03285295|560407005|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
155265377|NCT03285295|560407006|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265378|NCT03285295|560407007|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265379|NCT03285295|560407008|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265380|NCT03285295|560407009|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
155265381|NCT03285295|560407005|FG000|Alinity s Chagas|Protocol Violation|76|||
155265382|NCT03285295|560407006|FG001|Alinity s Chagas|Protocol Violation|0|||
155265383|NCT03285295|560407007|FG002|Alinity s Chagas|Protocol Violation|0|||
155265384|NCT03285295|560407008|FG003|Alinity s Chagas|Protocol Violation|0|||
155265385|NCT03285295|560407009|FG004|Alinity s Chagas|Protocol Violation|0|||
155265386|NCT03285295|560407005|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
155265387|NCT03285295|560407006|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
155265388|NCT03285295|560407007|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
155265389|NCT03285295|560407008|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
155265390|NCT03285295|560407009|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
155265391|NCT03285295|560407005|FG000|Alinity s Chagas|No Results Generated|105|||
155265392|NCT03285295|560407006|FG001|Alinity s Chagas|No Results Generated|0|||
155265393|NCT03285295|560407007|FG002|Alinity s Chagas|No Results Generated|0|||
155265394|NCT03285295|560407008|FG003|Alinity s Chagas|No Results Generated|0|||
155265395|NCT03285295|560407009|FG004|Alinity s Chagas|No Results Generated|0|||
155265396|NCT03285295|560407005|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
155265397|NCT03285295|560407006|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265398|NCT03285295|560407007|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265399|NCT03285295|560407008|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265400|NCT03285295|560407009|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
155265401|NCT03015116|560407010|FG000|Overall Study|Lost to Follow-up|3|||
155265402|NCT03015116|560407011|FG001|Overall Study|Lost to Follow-up|0|||
155265403|NCT03015116|560407012|FG002|Overall Study|Lost to Follow-up|2|||
155265404|NCT03015116|560407010|FG000|Overall Study|Withdrawal by Subject|3|||
155265405|NCT03015116|560407011|FG001|Overall Study|Withdrawal by Subject|1|||
155265406|NCT03015116|560407012|FG002|Overall Study|Withdrawal by Subject|0|||
155265407|NCT03015116|560407010|FG000|Overall Study|Subject has New Medical Status|1|||
155265408|NCT03015116|560407011|FG001|Overall Study|Subject has New Medical Status|0|||
155265409|NCT03015116|560407012|FG002|Overall Study|Subject has New Medical Status|0|||
155265410|NCT03015116|560407010|FG000|Overall Study|Physician Decision|0|||
155265411|NCT03015116|560407011|FG001|Overall Study|Physician Decision|1|||
155265412|NCT03015116|560407012|FG002|Overall Study|Physician Decision|0|||
155265413|NCT02200939|560407016|FG000|Overall Study|Participant withdrew consent|0|||
155265414|NCT02200939|560407017|FG001|Overall Study|Participant withdrew consent|1|||
155265415|NCT02200939|560407016|FG000|Overall Study|Lost to Follow-up|2|||
155265416|NCT02200939|560407017|FG001|Overall Study|Lost to Follow-up|9|||
155265417|NCT02200939|560407016|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
155265418|NCT02200939|560407017|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
155265419|NCT04567693|560407018|FG000|Overall Study|Death|0|||
155265420|NCT04567693|560407019|FG001|Overall Study|Death|0|||
155265421|NCT04567693|560407020|FG002|Overall Study|Death|2|||
155265422|NCT04567693|560407018|FG000|Overall Study|Lost to Follow-up|1|||
155265423|NCT04567693|560407019|FG001|Overall Study|Lost to Follow-up|0|||
155265424|NCT04567693|560407020|FG002|Overall Study|Lost to Follow-up|2|||
155265425|NCT04567693|560407018|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
155265426|NCT04567693|560407019|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
155265427|NCT04567693|560407020|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
155265428|NCT04867785|560407021|FG000|Overall Study|Adverse Event|1|||
155265429|NCT04867785|560407022|FG001|Overall Study|Adverse Event|0|||
155265430|NCT04867785|560407023|FG002|Overall Study|Adverse Event|1|||
155265431|NCT04867785|560407024|FG003|Overall Study|Adverse Event|0|||
154924262|NCT01965600|559146447|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
154924263|NCT01965600|559146448|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
154924264|NCT01965600|559146449|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
154924265|NCT01965600|559146450|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
154924266|NCT01965600|559146447|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
154924267|NCT01965600|559146448|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
154924268|NCT01965600|559146449|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
154924269|NCT01965600|559146450|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
154924270|NCT01965600|559146447|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
154924271|NCT01965600|559146448|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
154924272|NCT01965600|559146449|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
154924273|NCT01965600|559146450|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
154924274|NCT01965600|559146447|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
154924275|NCT01965600|559146448|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
154924276|NCT01965600|559146449|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
154924277|NCT01965600|559146450|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
154924278|NCT01965600|559146447|FG000|Second Intervention|Study terminated by Sponsor|0|||
154924279|NCT01965600|559146448|FG001|Second Intervention|Study terminated by Sponsor|0|||
154924280|NCT01965600|559146449|FG002|Second Intervention|Study terminated by Sponsor|2|||
154924281|NCT01965600|559146450|FG003|Second Intervention|Study terminated by Sponsor|2|||
154924282|NCT00157157|559146454|FG000|Overall Study|Withdrawal by Subject|6|||
154924283|NCT00157157|559146454|FG000|Overall Study|Physician Decision|1|||
154924284|NCT00157157|559146454|FG000|Overall Study|Lost to Follow-up|1|||
154924285|NCT00157157|559146454|FG000|Overall Study|Enrolled in another study|1|||
154924286|NCT00157157|559146454|FG000|Overall Study|Met exclusion criteria|1|||
154924287|NCT00157157|559146454|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
154924288|NCT02260804|559146455|FG000|Induction Study Period|Protocol Violation|2|||
154924289|NCT02260804|559146456|FG001|Induction Study Period|Protocol Violation|0|||
154924290|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
154924291|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
154924292|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
154924293|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
154924294|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
154924295|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
154924296|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
154924297|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
154924298|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
154924299|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
154924300|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
154924301|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
154924302|NCT02260804|559146455|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
154924303|NCT02260804|559146456|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
154924304|NCT02260804|559146455|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
154924305|NCT02260804|559146456|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
154924306|NCT02260804|559146455|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
154924307|NCT02260804|559146456|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
154924308|NCT02260804|559146455|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
154924309|NCT02260804|559146456|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
155265432|NCT04867785|560407025|FG004|Overall Study|Adverse Event|0|||
155265433|NCT04867785|560407026|FG005|Overall Study|Adverse Event|0|||
155265434|NCT04867785|560407027|FG006|Overall Study|Adverse Event|0|||
155265435|NCT04867785|560407028|FG007|Overall Study|Adverse Event|2|||
155265436|NCT04867785|560407021|FG000|Overall Study|Lost to Follow-up|4|||
155265437|NCT04867785|560407022|FG001|Overall Study|Lost to Follow-up|4|||
155265438|NCT04867785|560407023|FG002|Overall Study|Lost to Follow-up|3|||
155265439|NCT04867785|560407024|FG003|Overall Study|Lost to Follow-up|2|||
155265440|NCT04867785|560407025|FG004|Overall Study|Lost to Follow-up|0|||
155265441|NCT04867785|560407026|FG005|Overall Study|Lost to Follow-up|1|||
155265442|NCT04867785|560407027|FG006|Overall Study|Lost to Follow-up|0|||
155265443|NCT04867785|560407028|FG007|Overall Study|Lost to Follow-up|1|||
155265444|NCT04867785|560407021|FG000|Overall Study|Withdrawal by Subject|6|||
155265445|NCT04867785|560407022|FG001|Overall Study|Withdrawal by Subject|2|||
155265446|NCT04867785|560407023|FG002|Overall Study|Withdrawal by Subject|2|||
155265447|NCT04867785|560407024|FG003|Overall Study|Withdrawal by Subject|1|||
155265448|NCT04867785|560407025|FG004|Overall Study|Withdrawal by Subject|2|||
155265449|NCT04867785|560407026|FG005|Overall Study|Withdrawal by Subject|0|||
155265450|NCT04867785|560407027|FG006|Overall Study|Withdrawal by Subject|2|||
155265451|NCT04867785|560407028|FG007|Overall Study|Withdrawal by Subject|5|||
155265452|NCT04867785|560407021|FG000|Overall Study|Physician Decision|0|||
155265453|NCT04867785|560407022|FG001|Overall Study|Physician Decision|0|||
155265454|NCT04867785|560407023|FG002|Overall Study|Physician Decision|0|||
155265455|NCT04867785|560407024|FG003|Overall Study|Physician Decision|0|||
155265456|NCT04867785|560407025|FG004|Overall Study|Physician Decision|0|||
155265457|NCT04867785|560407026|FG005|Overall Study|Physician Decision|0|||
155265458|NCT04867785|560407027|FG006|Overall Study|Physician Decision|0|||
155265459|NCT04867785|560407028|FG007|Overall Study|Physician Decision|1|||
155265460|NCT04867785|560407021|FG000|Overall Study|Inadvertent Enrollment|0|||
155265461|NCT04867785|560407022|FG001|Overall Study|Inadvertent Enrollment|0|||
155265462|NCT04867785|560407023|FG002|Overall Study|Inadvertent Enrollment|0|||
155265463|NCT04867785|560407024|FG003|Overall Study|Inadvertent Enrollment|1|||
155265464|NCT04867785|560407025|FG004|Overall Study|Inadvertent Enrollment|1|||
155265465|NCT04867785|560407026|FG005|Overall Study|Inadvertent Enrollment|0|||
155265466|NCT04867785|560407027|FG006|Overall Study|Inadvertent Enrollment|0|||
155265467|NCT04867785|560407028|FG007|Overall Study|Inadvertent Enrollment|1|||
155265468|NCT04867785|560407021|FG000|Overall Study|Eligibility Criteria Not Met|0|||
155265469|NCT04867785|560407022|FG001|Overall Study|Eligibility Criteria Not Met|0|||
155265470|NCT04867785|560407023|FG002|Overall Study|Eligibility Criteria Not Met|0|||
155265471|NCT04867785|560407024|FG003|Overall Study|Eligibility Criteria Not Met|0|||
155265472|NCT04867785|560407025|FG004|Overall Study|Eligibility Criteria Not Met|0|||
155265473|NCT04867785|560407026|FG005|Overall Study|Eligibility Criteria Not Met|0|||
155265474|NCT04867785|560407027|FG006|Overall Study|Eligibility Criteria Not Met|0|||
155265475|NCT04867785|560407028|FG007|Overall Study|Eligibility Criteria Not Met|1|||
155265476|NCT00553202|560407041|FG000|Overall Study|Death|16|||
155265477|NCT00553202|560407041|FG000|Overall Study|Lost to Follow-up|1|||
155265478|NCT00553202|560407041|FG000|Overall Study|Physician Decision|28|||
155265479|NCT00553202|560407041|FG000|Overall Study|Withdrawal by Subject|1|||
155265480|NCT00553202|560407041|FG000|Overall Study|No donor identified|16|||
155265481|NCT00553202|560407041|FG000|Overall Study|Fails to meet organ function|6|||
155265482|NCT00369681|560407042|FG000|Overall Study|Death|1|||
155265483|NCT02966002|560407046|FG000|Overall Study|Withdrawal by Subject|2|||
155265484|NCT02966002|560407046|FG000|Overall Study|Adverse Event|1|||
155265485|NCT02966002|560407046|FG000|Overall Study|Lost to Follow-up|1|||
155265486|NCT01350141|560407047|FG000|Overall Study|Lost to Follow-up|1|||
155265487|NCT01350141|560407048|FG001|Overall Study|Lost to Follow-up|0|||
155265488|NCT01350141|560407049|FG002|Overall Study|Lost to Follow-up|1|||
155265489|NCT01350141|560407047|FG000|Overall Study|Withdrawal by Subject|1|||
155265490|NCT01350141|560407048|FG001|Overall Study|Withdrawal by Subject|0|||
155265491|NCT01350141|560407049|FG002|Overall Study|Withdrawal by Subject|0|||
155265492|NCT01350141|560407047|FG000|Overall Study|Randomized but not treated|1|||
155265493|NCT01350141|560407048|FG001|Overall Study|Randomized but not treated|0|||
155265494|NCT01350141|560407049|FG002|Overall Study|Randomized but not treated|0|||
155265495|NCT02367716|560407050|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
155265496|NCT01473381|560407051|FG000|Overall Study|Adverse Event|8|||
155265497|NCT01473381|560407052|FG001|Overall Study|Adverse Event|20|||
155265498|NCT01473381|560407053|FG002|Overall Study|Adverse Event|25|||
155265499|NCT01473381|560407054|FG003|Overall Study|Adverse Event|17|||
155265500|NCT01473381|560407051|FG000|Overall Study|Insufficient Therapeutic Response|10|||
155265501|NCT01473381|560407052|FG001|Overall Study|Insufficient Therapeutic Response|1|||
155265502|NCT01473381|560407053|FG002|Overall Study|Insufficient Therapeutic Response|2|||
155265503|NCT01473381|560407054|FG003|Overall Study|Insufficient Therapeutic Response|3|||
155265504|NCT01473381|560407051|FG000|Overall Study|Protocol Violation|17|||
155265505|NCT01473381|560407052|FG001|Overall Study|Protocol Violation|23|||
155265506|NCT01473381|560407053|FG002|Overall Study|Protocol Violation|19|||
155265507|NCT01473381|560407054|FG003|Overall Study|Protocol Violation|17|||
155265508|NCT01473381|560407051|FG000|Overall Study|Withdrawal of Consent|20|||
155265509|NCT01473381|560407052|FG001|Overall Study|Withdrawal of Consent|21|||
155265510|NCT01473381|560407053|FG002|Overall Study|Withdrawal of Consent|20|||
155265511|NCT01473381|560407054|FG003|Overall Study|Withdrawal of Consent|26|||
155265512|NCT01473381|560407051|FG000|Overall Study|Lost to Follow-up|25|||
155265513|NCT01473381|560407052|FG001|Overall Study|Lost to Follow-up|28|||
155265514|NCT01473381|560407053|FG002|Overall Study|Lost to Follow-up|35|||
155265515|NCT01473381|560407054|FG003|Overall Study|Lost to Follow-up|23|||
155265516|NCT01473381|560407051|FG000|Overall Study|Other Reasons|0|||
155265517|NCT01473381|560407052|FG001|Overall Study|Other Reasons|0|||
155265518|NCT01473381|560407053|FG002|Overall Study|Other Reasons|1|||
155265519|NCT01473381|560407054|FG003|Overall Study|Other Reasons|3|||
155265520|NCT02508532|560407060|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265521|NCT02508532|560407061|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265522|NCT02508532|560407062|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265523|NCT02508532|560407063|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265524|NCT02508532|560407064|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265525|NCT02508532|560407065|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265526|NCT02508532|560407066|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
155265527|NCT02508532|560407067|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265528|NCT02508532|560407068|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
155265529|NCT02508532|560407060|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265530|NCT02508532|560407061|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265531|NCT02508532|560407062|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265532|NCT02508532|560407063|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265533|NCT02508532|560407064|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265534|NCT02508532|560407065|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265535|NCT02508532|560407066|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265536|NCT02508532|560407067|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
155265537|NCT02508532|560407068|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
155265538|NCT02508532|560407060|FG000|Part 2 - Treatment|Disease Progression|0|||
155265539|NCT02508532|560407061|FG001|Part 2 - Treatment|Disease Progression|0|||
155265540|NCT02508532|560407062|FG002|Part 2 - Treatment|Disease Progression|0|||
155265541|NCT02508532|560407063|FG003|Part 2 - Treatment|Disease Progression|0|||
155265542|NCT02508532|560407064|FG004|Part 2 - Treatment|Disease Progression|0|||
155265543|NCT02508532|560407065|FG005|Part 2 - Treatment|Disease Progression|0|||
155265544|NCT02508532|560407066|FG006|Part 2 - Treatment|Disease Progression|0|||
155265545|NCT02508532|560407067|FG007|Part 2 - Treatment|Disease Progression|0|||
155265546|NCT02508532|560407068|FG008|Part 2 - Treatment|Disease Progression|118|||
155265547|NCT02508532|560407060|FG000|Part 2 - Treatment|Adverse Event|0|||
155265548|NCT02508532|560407061|FG001|Part 2 - Treatment|Adverse Event|0|||
155265549|NCT02508532|560407062|FG002|Part 2 - Treatment|Adverse Event|0|||
155265550|NCT02508532|560407063|FG003|Part 2 - Treatment|Adverse Event|0|||
155265551|NCT02508532|560407064|FG004|Part 2 - Treatment|Adverse Event|0|||
155265552|NCT02508532|560407065|FG005|Part 2 - Treatment|Adverse Event|0|||
155265553|NCT02508532|560407066|FG006|Part 2 - Treatment|Adverse Event|0|||
155265554|NCT02508532|560407067|FG007|Part 2 - Treatment|Adverse Event|0|||
155265555|NCT02508532|560407068|FG008|Part 2 - Treatment|Adverse Event|49|||
155265556|NCT02508532|560407060|FG000|Part 2 - Treatment|Physician Decision|0|||
155265557|NCT02508532|560407061|FG001|Part 2 - Treatment|Physician Decision|0|||
155265558|NCT02508532|560407062|FG002|Part 2 - Treatment|Physician Decision|0|||
155265559|NCT02508532|560407063|FG003|Part 2 - Treatment|Physician Decision|0|||
155265560|NCT02508532|560407064|FG004|Part 2 - Treatment|Physician Decision|0|||
155265561|NCT02508532|560407065|FG005|Part 2 - Treatment|Physician Decision|0|||
155265562|NCT02508532|560407066|FG006|Part 2 - Treatment|Physician Decision|0|||
155265563|NCT02508532|560407067|FG007|Part 2 - Treatment|Physician Decision|0|||
155265564|NCT02508532|560407068|FG008|Part 2 - Treatment|Physician Decision|12|||
155265565|NCT02508532|560407060|FG000|Part 2 - Treatment|Administrative|0|||
155265566|NCT02508532|560407061|FG001|Part 2 - Treatment|Administrative|0|||
155265567|NCT02508532|560407062|FG002|Part 2 - Treatment|Administrative|0|||
155265568|NCT02508532|560407063|FG003|Part 2 - Treatment|Administrative|0|||
155265569|NCT02508532|560407064|FG004|Part 2 - Treatment|Administrative|0|||
155265570|NCT02508532|560407065|FG005|Part 2 - Treatment|Administrative|0|||
155265571|NCT02508532|560407066|FG006|Part 2 - Treatment|Administrative|0|||
155265572|NCT02508532|560407067|FG007|Part 2 - Treatment|Administrative|0|||
155265573|NCT02508532|560407068|FG008|Part 2 - Treatment|Administrative|3|||
155265574|NCT02508532|560407060|FG000|Part 2 - Treatment|Sponsor Decision|0|||
155265575|NCT02508532|560407061|FG001|Part 2 - Treatment|Sponsor Decision|0|||
155265576|NCT02508532|560407062|FG002|Part 2 - Treatment|Sponsor Decision|0|||
155265577|NCT02508532|560407063|FG003|Part 2 - Treatment|Sponsor Decision|0|||
155265578|NCT02508532|560407064|FG004|Part 2 - Treatment|Sponsor Decision|0|||
155265579|NCT02508532|560407065|FG005|Part 2 - Treatment|Sponsor Decision|0|||
155265580|NCT02508532|560407066|FG006|Part 2 - Treatment|Sponsor Decision|0|||
155265581|NCT02508532|560407067|FG007|Part 2 - Treatment|Sponsor Decision|0|||
155265582|NCT02508532|560407068|FG008|Part 2 - Treatment|Sponsor Decision|28|||
155265583|NCT02508532|560407060|FG000|Part 2 - Treatment|Death|0|||
155265584|NCT02508532|560407061|FG001|Part 2 - Treatment|Death|0|||
155265585|NCT02508532|560407062|FG002|Part 2 - Treatment|Death|0|||
155265586|NCT02508532|560407063|FG003|Part 2 - Treatment|Death|0|||
155265587|NCT02508532|560407064|FG004|Part 2 - Treatment|Death|0|||
155265588|NCT02508532|560407065|FG005|Part 2 - Treatment|Death|0|||
155265589|NCT02508532|560407066|FG006|Part 2 - Treatment|Death|0|||
155265590|NCT02508532|560407067|FG007|Part 2 - Treatment|Death|0|||
155265591|NCT02508532|560407068|FG008|Part 2 - Treatment|Death|1|||
155265592|NCT02508532|560407060|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
155265593|NCT02508532|560407061|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
155265594|NCT02508532|560407062|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
155265595|NCT02508532|560407063|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
155265596|NCT02508532|560407064|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
155265597|NCT02508532|560407065|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
155265598|NCT02508532|560407066|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
155265599|NCT02508532|560407067|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
155265600|NCT02508532|560407068|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
155265601|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
155265602|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265603|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265604|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265605|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265606|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265607|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
155265608|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
155265609|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
155265610|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
155265611|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265612|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
155265613|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265614|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265615|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265616|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265617|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
155265618|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
155265619|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Death|0|||
155265620|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Death|4|||
155265621|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Death|2|||
155265622|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Death|4|||
155265623|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Death|3|||
155265624|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Death|0|||
155265625|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Death|0|||
155265626|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Death|1|||
155265627|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Death|111|||
155265628|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
155265629|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
155265630|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
155265631|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265632|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265633|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265634|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265635|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
155265636|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
155265637|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265638|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265639|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265640|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265641|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265642|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265643|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265644|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
155265645|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
155265646|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265647|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265648|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
155265649|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265650|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
155265651|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265652|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265653|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
155265654|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
155265655|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265656|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265657|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265658|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265659|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265660|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265661|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265662|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
155265663|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
155265664|NCT02508532|560407060|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
155265665|NCT02508532|560407061|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
155265666|NCT02508532|560407062|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
155265667|NCT02508532|560407063|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
155265668|NCT02508532|560407064|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
155265669|NCT02508532|560407065|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
155265670|NCT02508532|560407066|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
155265671|NCT02508532|560407067|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
155265672|NCT02508532|560407068|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
155265673|NCT02768662|560407069|FG000|Overall Study|Adverse Event|1|||
155265674|NCT02768662|560407069|FG000|Overall Study|Lost to Follow-up|4|||
155265675|NCT02768662|560407069|FG000|Overall Study|Withdrawal by Subject|3|||
155265676|NCT02768662|560407069|FG000|Overall Study|Study terminated by Sponsor|78|||
155265677|NCT04041440|560407071|FG000|Overall Study|Withdrawal by Subject|0|||
155265678|NCT04041440|560407072|FG001|Overall Study|Withdrawal by Subject|1|||
155265679|NCT04041440|560407071|FG000|Overall Study|Lost to Follow-up|0|||
155265680|NCT04041440|560407072|FG001|Overall Study|Lost to Follow-up|1|||
155265681|NCT02306265|560407073|FG000|Overall Study|Withdrawal by Subject|1|||
155265682|NCT01346514|560407074|FG000|Overall Study|Lost to Follow-up|19|||
155265683|NCT01346514|560407075|FG001|Overall Study|Lost to Follow-up|30|||
155265684|NCT01346514|560407074|FG000|Overall Study|Withdrawal by Subject|7|||
155265685|NCT01346514|560407075|FG001|Overall Study|Withdrawal by Subject|3|||
155265686|NCT01346514|560407074|FG000|Overall Study|Death|3|||
155265687|NCT01346514|560407075|FG001|Overall Study|Death|4|||
155265688|NCT03002038|560407077|FG000|Overall Study|Adverse Event|3|||
155265689|NCT03002038|560407078|FG001|Overall Study|Adverse Event|1|||
155265690|NCT03002038|560407077|FG000|Overall Study|Withdrawal by Subject|8|||
155265691|NCT03002038|560407078|FG001|Overall Study|Withdrawal by Subject|4|||
155265692|NCT03002038|560407077|FG000|Overall Study|Immigration to another region|0|||
155265693|NCT03002038|560407078|FG001|Overall Study|Immigration to another region|2|||
155265694|NCT04251065|560407079|FG000|Overall Study|Death|2|||
155265695|NCT04251065|560407079|FG000|Overall Study|Lack of Efficacy|3|||
155265696|NCT04251065|560407079|FG000|Overall Study|Death|1|||
155265697|NCT04296890|560407080|FG000|Overall Study|Withdrawal by Subject|1|||
155265698|NCT04296890|560407080|FG000|Overall Study|Death|62|||
155265699|NCT04296890|560407080|FG000|Overall Study|Lost to Follow-up|3|||
155265700|NCT04296890|560407080|FG000|Overall Study|Other than specified|2|||
155265701|NCT02237508|560407082|FG000|Overall Study|Withdrawal by Subject|0|||
155265702|NCT02237508|560407083|FG001|Overall Study|Withdrawal by Subject|2|||
155265703|NCT02237508|560407084|FG002|Overall Study|Withdrawal by Subject|0|||
155265704|NCT02237508|560407085|FG003|Overall Study|Withdrawal by Subject|1|||
155265705|NCT02237508|560407086|FG004|Overall Study|Withdrawal by Subject|0|||
155265706|NCT02237508|560407087|FG005|Overall Study|Withdrawal by Subject|1|||
155265707|NCT02237508|560407088|FG006|Overall Study|Withdrawal by Subject|1|||
155265708|NCT02237508|560407089|FG007|Overall Study|Withdrawal by Subject|0|||
155265709|NCT02237508|560407090|FG008|Overall Study|Withdrawal by Subject|1|||
155265710|NCT02237508|560407091|FG009|Overall Study|Withdrawal by Subject|0|||
155265711|NCT02237508|560407082|FG000|Overall Study|Physician Decision|0|||
155265712|NCT02237508|560407083|FG001|Overall Study|Physician Decision|1|||
155265713|NCT02237508|560407084|FG002|Overall Study|Physician Decision|0|||
155265714|NCT02237508|560407085|FG003|Overall Study|Physician Decision|0|||
155265715|NCT02237508|560407086|FG004|Overall Study|Physician Decision|0|||
155265716|NCT02237508|560407087|FG005|Overall Study|Physician Decision|0|||
155265717|NCT02237508|560407088|FG006|Overall Study|Physician Decision|0|||
155265718|NCT02237508|560407089|FG007|Overall Study|Physician Decision|0|||
155265719|NCT02237508|560407090|FG008|Overall Study|Physician Decision|0|||
155265720|NCT02237508|560407091|FG009|Overall Study|Physician Decision|0|||
155265721|NCT02237508|560407082|FG000|Overall Study|Protocol Violation|0|||
155265722|NCT02237508|560407083|FG001|Overall Study|Protocol Violation|0|||
155265723|NCT02237508|560407084|FG002|Overall Study|Protocol Violation|1|||
155265724|NCT02237508|560407085|FG003|Overall Study|Protocol Violation|0|||
155265725|NCT02237508|560407086|FG004|Overall Study|Protocol Violation|0|||
155265726|NCT02237508|560407087|FG005|Overall Study|Protocol Violation|0|||
155265727|NCT02237508|560407088|FG006|Overall Study|Protocol Violation|0|||
155265728|NCT02237508|560407089|FG007|Overall Study|Protocol Violation|0|||
155265729|NCT02237508|560407090|FG008|Overall Study|Protocol Violation|0|||
155265730|NCT02237508|560407091|FG009|Overall Study|Protocol Violation|0|||
155265731|NCT01650519|560407092|FG000|Overall Study|Withdrawal by Subject|1|||
155265732|NCT01650519|560407093|FG001|Overall Study|Withdrawal by Subject|0|||
155265733|NCT00747123|560407095|FG000|Overall Study|Investigator's request|0|||
155265734|NCT00747123|560407096|FG001|Overall Study|Investigator's request|0|||
155265735|NCT00747123|560407097|FG002|Overall Study|Investigator's request|1|||
155265736|NCT00747123|560407098|FG003|Overall Study|Investigator's request|0|||
155265737|NCT00747123|560407095|FG000|Overall Study|Withdrew consent|0|||
155265738|NCT00747123|560407096|FG001|Overall Study|Withdrew consent|1|||
155265739|NCT00747123|560407097|FG002|Overall Study|Withdrew consent|0|||
155265740|NCT00747123|560407098|FG003|Overall Study|Withdrew consent|0|||
155265741|NCT00747123|560407095|FG000|Overall Study|Adverse Event|0|||
155265742|NCT00747123|560407096|FG001|Overall Study|Adverse Event|1|||
155265743|NCT00747123|560407097|FG002|Overall Study|Adverse Event|0|||
155265744|NCT00747123|560407098|FG003|Overall Study|Adverse Event|1|||
155265745|NCT02277743|560407101|FG000|Overall Study|Protocol Violation|1|||
155265746|NCT02277743|560407102|FG001|Overall Study|Protocol Violation|1|||
155265747|NCT02277743|560407103|FG002|Overall Study|Protocol Violation|1|||
155265748|NCT02277743|560407101|FG000|Overall Study|Adverse Event|10|||
155265749|NCT02277743|560407102|FG001|Overall Study|Adverse Event|6|||
155265750|NCT02277743|560407103|FG002|Overall Study|Adverse Event|6|||
155265751|NCT02277743|560407101|FG000|Overall Study|Lack of Efficacy|11|||
155265752|NCT02277743|560407102|FG001|Overall Study|Lack of Efficacy|4|||
155265753|NCT02277743|560407103|FG002|Overall Study|Lack of Efficacy|3|||
155265754|NCT02277743|560407101|FG000|Overall Study|Other than specified above|18|||
155265755|NCT02277743|560407102|FG001|Overall Study|Other than specified above|5|||
155265756|NCT02277743|560407103|FG002|Overall Study|Other than specified above|16|||
155265757|NCT01224158|560407107|FG000|Overall Study|Withdrawal by Subject|1|||
155265758|NCT01224158|560407108|FG001|Overall Study|Withdrawal by Subject|0|||
155265759|NCT02055157|560407111|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
155265760|NCT02055157|560407112|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
155265761|NCT02055157|560407113|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
155265762|NCT02055157|560407114|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
155265763|NCT02055157|560407111|FG000|Initial 6 Months|Adverse Event|0|||
155265764|NCT02055157|560407112|FG001|Initial 6 Months|Adverse Event|0|||
155265765|NCT02055157|560407113|FG002|Initial 6 Months|Adverse Event|0|||
155265766|NCT02055157|560407114|FG003|Initial 6 Months|Adverse Event|1|||
155265767|NCT02055157|560407111|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
155265768|NCT02055157|560407112|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
155265769|NCT02055157|560407113|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
155265770|NCT02055157|560407114|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
155265771|NCT02055157|560407111|FG000|18-month Extension|Investigator decision|0|||
155265772|NCT02055157|560407112|FG001|18-month Extension|Investigator decision|1|||
155265773|NCT02055157|560407113|FG002|18-month Extension|Investigator decision|0|||
155265774|NCT02055157|560407114|FG003|18-month Extension|Investigator decision|0|||
155265775|NCT02055157|560407111|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
155265776|NCT02055157|560407112|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
155265777|NCT02055157|560407113|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
155265778|NCT02055157|560407114|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
155265779|NCT03976466|560407115|FG000|Overall Study|Lost to Follow-up|1|||
155265780|NCT03976466|560407116|FG001|Overall Study|Lost to Follow-up|3|||
155265781|NCT00733499|560407119|FG000|Pre-operative|Protocol Violation|0|||
155265782|NCT00733499|560407120|FG001|Pre-operative|Protocol Violation|1|||
155265783|NCT00733499|560407119|FG000|3 Months Follow-up|Death|1|||
155265784|NCT00733499|560407120|FG001|3 Months Follow-up|Death|2|||
155265785|NCT00733499|560407119|FG000|6 Months Follow-up|Death|0|||
155265786|NCT00733499|560407120|FG001|6 Months Follow-up|Death|2|||
155265787|NCT00733499|560407119|FG000|6 Months Follow-up|Adverse Event|0|||
155265788|NCT00733499|560407120|FG001|6 Months Follow-up|Adverse Event|1|||
155265789|NCT00733499|560407119|FG000|12 Months Follow-up|Death|2|||
155265790|NCT00733499|560407120|FG001|12 Months Follow-up|Death|1|||
155265791|NCT00733499|560407119|FG000|24 Months Follow-up|Death|0|||
155265792|NCT00733499|560407120|FG001|24 Months Follow-up|Death|1|||
155265793|NCT00733499|560407119|FG000|5 Year Followup|Adverse Event|2|||
155265794|NCT00733499|560407120|FG001|5 Year Followup|Adverse Event|2|||
155265795|NCT00733499|560407119|FG000|5 Year Followup|Non device related AE|0|||
155265796|NCT00733499|560407120|FG001|5 Year Followup|Non device related AE|1|||
155265797|NCT00733499|560407119|FG000|5 Year Followup|Revision of Study Implant|0|||
155265798|NCT00733499|560407120|FG001|5 Year Followup|Revision of Study Implant|1|||
155265799|NCT00733499|560407119|FG000|5 Year Followup|Lost to Follow-up|2|||
155265800|NCT00733499|560407120|FG001|5 Year Followup|Lost to Follow-up|0|||
155265801|NCT00733499|560407119|FG000|5 Year Followup|Death|13|||
155265802|NCT00733499|560407120|FG001|5 Year Followup|Death|19|||
155265803|NCT00733499|560407119|FG000|5 Year Followup|missing, unable to locate|0|||
155265804|NCT00733499|560407120|FG001|5 Year Followup|missing, unable to locate|1|||
155265805|NCT00733499|560407119|FG000|5 Year Followup|Withdrawal by Subject|4|||
155265806|NCT00733499|560407120|FG001|5 Year Followup|Withdrawal by Subject|1|||
155265807|NCT00733499|560407119|FG000|10 Year Followup|Death|9|||
155265808|NCT00733499|560407120|FG001|10 Year Followup|Death|7|||
155265809|NCT00733499|560407119|FG000|10 Year Followup|Adverse Event|3|||
155265810|NCT00733499|560407120|FG001|10 Year Followup|Adverse Event|3|||
155265811|NCT00733499|560407119|FG000|10 Year Followup|Lost to Follow-up|3|||
155265812|NCT00733499|560407120|FG001|10 Year Followup|Lost to Follow-up|2|||
155265813|NCT00733499|560407119|FG000|10 Year Followup|Withdrawal by Subject|5|||
155265814|NCT00733499|560407120|FG001|10 Year Followup|Withdrawal by Subject|5|||
155265815|NCT00733499|560407119|FG000|10 Year Followup|missing, unable to locate|0|||
155265816|NCT00733499|560407120|FG001|10 Year Followup|missing, unable to locate|2|||
155265817|NCT00576732|560407121|FG000|DOUBLE BLIND|Adverse Event|0|||
155265818|NCT00576732|560407122|FG001|DOUBLE BLIND|Adverse Event|0|||
155265819|NCT00576732|560407123|FG002|DOUBLE BLIND|Adverse Event|1|||
155265820|NCT00576732|560407124|FG003|DOUBLE BLIND|Adverse Event|0|||
155265821|NCT00576732|560407125|FG004|DOUBLE BLIND|Adverse Event|0|||
155265822|NCT00576732|560407126|FG005|DOUBLE BLIND|Adverse Event|0|||
155265823|NCT00576732|560407121|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
155265824|NCT00576732|560407122|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
155265825|NCT00576732|560407123|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
155265826|NCT00576732|560407124|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
155265827|NCT00576732|560407125|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
155265828|NCT00576732|560407126|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
155265829|NCT00576732|560407121|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
155265830|NCT00576732|560407122|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
155265831|NCT00576732|560407123|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
155265832|NCT00576732|560407124|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
155265833|NCT00576732|560407125|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
155265834|NCT00576732|560407126|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
155265835|NCT00576732|560407121|FG000|DOUBLE BLIND|OTHER|0|||
155265836|NCT00576732|560407122|FG001|DOUBLE BLIND|OTHER|2|||
155265837|NCT00576732|560407123|FG002|DOUBLE BLIND|OTHER|1|||
155265838|NCT00576732|560407124|FG003|DOUBLE BLIND|OTHER|0|||
155265839|NCT00576732|560407125|FG004|DOUBLE BLIND|OTHER|0|||
155265840|NCT00576732|560407126|FG005|DOUBLE BLIND|OTHER|0|||
155265841|NCT00576732|560407121|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
155265842|NCT00576732|560407122|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
155265843|NCT00576732|560407123|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
155265844|NCT00576732|560407124|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
155265845|NCT00576732|560407125|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
155265846|NCT00576732|560407126|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
155265847|NCT00576732|560407121|FG000|DOUBLE BLIND|Protocol Violation|1|||
155265848|NCT00576732|560407122|FG001|DOUBLE BLIND|Protocol Violation|0|||
155265849|NCT00576732|560407123|FG002|DOUBLE BLIND|Protocol Violation|0|||
155265850|NCT00576732|560407124|FG003|DOUBLE BLIND|Protocol Violation|0|||
155265851|NCT00576732|560407125|FG004|DOUBLE BLIND|Protocol Violation|0|||
155265852|NCT00576732|560407126|FG005|DOUBLE BLIND|Protocol Violation|0|||
155265853|NCT00576732|560407121|FG000|OPEN LABEL|Adverse Event|0|||
155265854|NCT00576732|560407122|FG001|OPEN LABEL|Adverse Event|0|||
155265855|NCT00576732|560407123|FG002|OPEN LABEL|Adverse Event|0|||
155265856|NCT00576732|560407124|FG003|OPEN LABEL|Adverse Event|4|||
155265857|NCT00576732|560407125|FG004|OPEN LABEL|Adverse Event|0|||
155265858|NCT00576732|560407126|FG005|OPEN LABEL|Adverse Event|1|||
155265859|NCT00576732|560407121|FG000|OPEN LABEL|Lost to Follow-up|0|||
155265860|NCT00576732|560407122|FG001|OPEN LABEL|Lost to Follow-up|0|||
155265861|NCT00576732|560407123|FG002|OPEN LABEL|Lost to Follow-up|0|||
155265862|NCT00576732|560407124|FG003|OPEN LABEL|Lost to Follow-up|2|||
155265863|NCT00576732|560407125|FG004|OPEN LABEL|Lost to Follow-up|1|||
155265864|NCT00576732|560407126|FG005|OPEN LABEL|Lost to Follow-up|1|||
155265865|NCT00576732|560407121|FG000|OPEN LABEL|Withdrawal by Subject|0|||
155265866|NCT00576732|560407122|FG001|OPEN LABEL|Withdrawal by Subject|0|||
155265867|NCT00576732|560407123|FG002|OPEN LABEL|Withdrawal by Subject|0|||
155265868|NCT00576732|560407124|FG003|OPEN LABEL|Withdrawal by Subject|1|||
155265869|NCT00576732|560407125|FG004|OPEN LABEL|Withdrawal by Subject|0|||
155265870|NCT00576732|560407126|FG005|OPEN LABEL|Withdrawal by Subject|1|||
155265871|NCT00576732|560407121|FG000|OPEN LABEL|OTHER|0|||
155265872|NCT00576732|560407122|FG001|OPEN LABEL|OTHER|0|||
155265873|NCT00576732|560407123|FG002|OPEN LABEL|OTHER|0|||
155265874|NCT00576732|560407124|FG003|OPEN LABEL|OTHER|0|||
155265875|NCT00576732|560407125|FG004|OPEN LABEL|OTHER|0|||
155265876|NCT00576732|560407126|FG005|OPEN LABEL|OTHER|2|||
155265877|NCT00576732|560407121|FG000|OPEN LABEL|Lack of Efficacy|0|||
155265878|NCT00576732|560407122|FG001|OPEN LABEL|Lack of Efficacy|0|||
155265879|NCT00576732|560407123|FG002|OPEN LABEL|Lack of Efficacy|0|||
155265880|NCT00576732|560407124|FG003|OPEN LABEL|Lack of Efficacy|2|||
155265881|NCT00576732|560407125|FG004|OPEN LABEL|Lack of Efficacy|2|||
155265882|NCT00576732|560407126|FG005|OPEN LABEL|Lack of Efficacy|3|||
155265883|NCT00576732|560407121|FG000|OPEN LABEL|Protocol Violation|0|||
155265884|NCT00576732|560407122|FG001|OPEN LABEL|Protocol Violation|0|||
155265885|NCT00576732|560407123|FG002|OPEN LABEL|Protocol Violation|0|||
155265886|NCT00576732|560407124|FG003|OPEN LABEL|Protocol Violation|2|||
155265887|NCT00576732|560407125|FG004|OPEN LABEL|Protocol Violation|1|||
155265888|NCT00576732|560407126|FG005|OPEN LABEL|Protocol Violation|0|||
155265889|NCT02978443|560407127|FG000|Overall Study|Withdrawal by Subject|1|||
155265890|NCT02978443|560407127|FG000|Overall Study|Adverse Event|3|||
155265891|NCT02978443|560407127|FG000|Overall Study|Disease Progression on study|6|||
155265892|NCT02978443|560407127|FG000|Overall Study|Death|1|||
155265893|NCT02978443|560407127|FG000|Overall Study|Physician Decision|1|||
155265894|NCT02978443|560407127|FG000|Overall Study|Switch to alternative therapy|1|||
155265895|NCT02978443|560407127|FG000|Overall Study|Refused further treatment|1|||
155265896|NCT02296190|560407128|FG000|Overall Study|Lost to Follow-up|0|||
155265897|NCT02296190|560407129|FG001|Overall Study|Lost to Follow-up|0|||
155265898|NCT02296190|560407130|FG002|Overall Study|Lost to Follow-up|0|||
155265899|NCT02296190|560407131|FG003|Overall Study|Lost to Follow-up|0|||
155265900|NCT02296190|560407132|FG004|Overall Study|Lost to Follow-up|1|||
155265901|NCT02296190|560407133|FG005|Overall Study|Lost to Follow-up|0|||
155265902|NCT02296190|560407128|FG000|Overall Study|Failure to induce PSVT|6|||
155265903|NCT02296190|560407129|FG001|Overall Study|Failure to induce PSVT|10|||
155265904|NCT02296190|560407130|FG002|Overall Study|Failure to induce PSVT|5|||
155265905|NCT02296190|560407131|FG003|Overall Study|Failure to induce PSVT|13|||
155265906|NCT02296190|560407132|FG004|Overall Study|Failure to induce PSVT|8|||
155265907|NCT02296190|560407133|FG005|Overall Study|Failure to induce PSVT|0|||
155265908|NCT02296190|560407128|FG000|Overall Study|Physician Decision|1|||
155265909|NCT02296190|560407129|FG001|Overall Study|Physician Decision|1|||
155265910|NCT02296190|560407130|FG002|Overall Study|Physician Decision|0|||
155265911|NCT02296190|560407131|FG003|Overall Study|Physician Decision|1|||
155265912|NCT02296190|560407132|FG004|Overall Study|Physician Decision|2|||
155265913|NCT02296190|560407133|FG005|Overall Study|Physician Decision|0|||
155265914|NCT02296190|560407128|FG000|Overall Study|Withdrawal by Subject|0|||
155265915|NCT02296190|560407129|FG001|Overall Study|Withdrawal by Subject|1|||
155265916|NCT02296190|560407130|FG002|Overall Study|Withdrawal by Subject|0|||
155265917|NCT02296190|560407131|FG003|Overall Study|Withdrawal by Subject|0|||
155265918|NCT02296190|560407132|FG004|Overall Study|Withdrawal by Subject|0|||
155265919|NCT02296190|560407133|FG005|Overall Study|Withdrawal by Subject|0|||
155265920|NCT02296190|560407128|FG000|Overall Study|PSVT < 5 minutes|5|||
155265921|NCT02296190|560407129|FG001|Overall Study|PSVT < 5 minutes|6|||
155265922|NCT02296190|560407130|FG002|Overall Study|PSVT < 5 minutes|6|||
155265923|NCT02296190|560407131|FG003|Overall Study|PSVT < 5 minutes|6|||
155265924|NCT02296190|560407132|FG004|Overall Study|PSVT < 5 minutes|5|||
155265925|NCT02296190|560407133|FG005|Overall Study|PSVT < 5 minutes|0|||
155265926|NCT02296190|560407128|FG000|Overall Study|Patient was given Propofol|0|||
155265927|NCT02296190|560407129|FG001|Overall Study|Patient was given Propofol|1|||
155265928|NCT02296190|560407130|FG002|Overall Study|Patient was given Propofol|0|||
155265929|NCT02296190|560407131|FG003|Overall Study|Patient was given Propofol|1|||
155265930|NCT02296190|560407132|FG004|Overall Study|Patient was given Propofol|0|||
155265931|NCT02296190|560407133|FG005|Overall Study|Patient was given Propofol|0|||
155265932|NCT02296190|560407128|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
155265933|NCT02296190|560407129|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
155265934|NCT02296190|560407130|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
155265935|NCT02296190|560407131|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
155265936|NCT02296190|560407132|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
155265937|NCT02296190|560407133|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
155265938|NCT02296190|560407128|FG000|Overall Study|Blood pressure <100 after sedation|0|||
155265939|NCT02296190|560407129|FG001|Overall Study|Blood pressure <100 after sedation|0|||
155265940|NCT02296190|560407130|FG002|Overall Study|Blood pressure <100 after sedation|0|||
155265941|NCT02296190|560407131|FG003|Overall Study|Blood pressure <100 after sedation|1|||
155265942|NCT02296190|560407132|FG004|Overall Study|Blood pressure <100 after sedation|0|||
155265943|NCT02296190|560407133|FG005|Overall Study|Blood pressure <100 after sedation|0|||
155265944|NCT02296190|560407128|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265945|NCT02296190|560407129|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
155265946|NCT02296190|560407130|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
155265947|NCT02296190|560407131|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265948|NCT02296190|560407132|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265949|NCT02296190|560407133|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
155265950|NCT02296190|560407128|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
155265951|NCT02296190|560407129|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
155265952|NCT02296190|560407130|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
155265953|NCT02296190|560407131|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
155265954|NCT02296190|560407132|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
155265955|NCT02296190|560407133|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
155265956|NCT02296190|560407128|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265957|NCT02296190|560407129|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
155265958|NCT02296190|560407130|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265959|NCT02296190|560407131|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265960|NCT02296190|560407132|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265961|NCT02296190|560407133|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
155265962|NCT02296190|560407128|FG000|Overall Study|Lab result not available in time|1|||
155265963|NCT02296190|560407129|FG001|Overall Study|Lab result not available in time|0|||
155265964|NCT02296190|560407130|FG002|Overall Study|Lab result not available in time|0|||
155265965|NCT02296190|560407131|FG003|Overall Study|Lab result not available in time|0|||
155265966|NCT02296190|560407132|FG004|Overall Study|Lab result not available in time|0|||
155265967|NCT02296190|560407133|FG005|Overall Study|Lab result not available in time|0|||
155265968|NCT00682643|560407135|FG000|Overall Study|Adverse Event|12|||
155265969|NCT00682643|560407136|FG001|Overall Study|Adverse Event|23|||
155265970|NCT00682643|560407135|FG000|Overall Study|Lack of Efficacy|2|||
155265971|NCT00682643|560407136|FG001|Overall Study|Lack of Efficacy|0|||
155265972|NCT00682643|560407135|FG000|Overall Study|Protocol Violation|38|||
155265973|NCT00682643|560407136|FG001|Overall Study|Protocol Violation|76|||
155265974|NCT00682643|560407135|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
155265975|NCT00682643|560407136|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
155265976|NCT00682643|560407135|FG000|Overall Study|Lost to Follow-up|1|||
155265977|NCT00682643|560407136|FG001|Overall Study|Lost to Follow-up|6|||
155265978|NCT00682643|560407135|FG000|Overall Study|Physician Decision|2|||
155265979|NCT00682643|560407136|FG001|Overall Study|Physician Decision|6|||
155265980|NCT00682643|560407135|FG000|Overall Study|Withdrawal by Subject|19|||
155265981|NCT00682643|560407136|FG001|Overall Study|Withdrawal by Subject|53|||
155265982|NCT00682643|560407135|FG000|Overall Study|Did Not Receive Study Drug|1|||
155265983|NCT00682643|560407136|FG001|Overall Study|Did Not Receive Study Drug|1|||
155265984|NCT01875185|560407137|FG000|Overall Study|study was terminated|52|||
155265985|NCT01875185|560407138|FG001|Overall Study|study was terminated|48|||
155265986|NCT00263328|560407139|FG000|Overall Study|Death|0|||
155265987|NCT00263328|560407140|FG001|Overall Study|Death|0|||
155265988|NCT00263328|560407141|FG002|Overall Study|Death|1|||
155265989|NCT00263328|560407139|FG000|Overall Study|Lost to Follow-up|1|||
155265990|NCT00263328|560407140|FG001|Overall Study|Lost to Follow-up|1|||
155265991|NCT00263328|560407141|FG002|Overall Study|Lost to Follow-up|0|||
155265992|NCT00263328|560407139|FG000|Overall Study|Withdrawal by Subject|3|||
155265993|NCT00263328|560407140|FG001|Overall Study|Withdrawal by Subject|0|||
155265994|NCT00263328|560407141|FG002|Overall Study|Withdrawal by Subject|1|||
155265995|NCT00263328|560407139|FG000|Overall Study|Other|3|||
155265996|NCT00263328|560407140|FG001|Overall Study|Other|0|||
155265997|NCT00263328|560407141|FG002|Overall Study|Other|1|||
155265998|NCT00263328|560407139|FG000|Overall Study|Adverse Event|1|||
155265999|NCT00263328|560407140|FG001|Overall Study|Adverse Event|1|||
155266000|NCT00263328|560407141|FG002|Overall Study|Adverse Event|4|||
155266001|NCT01301274|560407146|FG000|Overall Study|Physician Decision|2|||
155266002|NCT01301274|560407147|FG001|Overall Study|Physician Decision|1|||
155266003|NCT02917941|560407148|FG000|Treatment Period|Adverse Event|11|||
155266004|NCT02917941|560407148|FG000|Treatment Period|Progressive Disease|11|||
155266005|NCT02917941|560407148|FG000|Treatment Period|Reason not Specified|2|||
155266006|NCT02917941|560407148|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
155266007|NCT02917941|560407148|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
155266008|NCT01893827|560407149|FG000|Overall Study|Lost to Follow-up|19|||
155266009|NCT01893827|560407150|FG001|Overall Study|Lost to Follow-up|26|||
155266010|NCT00399763|560407151|FG000|Overall Study|Lost to Follow-up|2|||
155266011|NCT00399763|560407152|FG001|Overall Study|Lost to Follow-up|3|||
155266012|NCT03389477|560407155|FG000|Step 1|Withdrawal by Subject|1|||
155266013|NCT03389477|560407156|FG001|Step 1|Withdrawal by Subject|0|||
155266014|NCT03389477|560407155|FG000|Step 2|Withdrawal by Subject|1|||
155266015|NCT03389477|560407156|FG001|Step 2|Withdrawal by Subject|2|||
155266016|NCT03389477|560407155|FG000|Step 2|Disease progression|1|||
155266017|NCT03389477|560407156|FG001|Step 2|Disease progression|0|||
155266018|NCT03389477|560407155|FG000|Step 2|Death|0|||
155266019|NCT03389477|560407156|FG001|Step 2|Death|1|||
155266020|NCT03389477|560407155|FG000|Step 2|Poor performance status and nutrition|0|||
155266021|NCT03389477|560407156|FG001|Step 2|Poor performance status and nutrition|1|||
155266022|NCT03389477|560407155|FG000|Step 3|Withdrawal after 3 cycles|0|||
155266023|NCT03389477|560407156|FG001|Step 3|Withdrawal after 3 cycles|1|||
155266024|NCT03389477|560407155|FG000|Step 3|Still receiving active treatment|4|||
155266025|NCT03389477|560407156|FG001|Step 3|Still receiving active treatment|0|||
155266026|NCT03389477|560407155|FG000|Step 3|Progressive disease after 2 cycles|1|||
155266027|NCT03389477|560407156|FG001|Step 3|Progressive disease after 2 cycles|0|||
155266028|NCT03403426|560407157|FG000|Overall Study|Death|1|||
155266029|NCT03403426|560407157|FG000|Overall Study|Lost to Follow-up|2|||
155266030|NCT03520400|560407160|FG000|Overall Study|Physician Decision|15|||
155266031|NCT03520400|560407161|FG001|Overall Study|Physician Decision|7|||
155266032|NCT00445679|560407164|FG000|Overall Study|Adverse Event|22|||
155266033|NCT00445679|560407165|FG001|Overall Study|Adverse Event|12|||
155266034|NCT00445679|560407166|FG002|Overall Study|Adverse Event|30|||
155266035|NCT00445679|560407167|FG003|Overall Study|Adverse Event|19|||
155266036|NCT00445679|560407164|FG000|Overall Study|Failed to return|1|||
155266037|NCT00445679|560407165|FG001|Overall Study|Failed to return|3|||
155266038|NCT00445679|560407166|FG002|Overall Study|Failed to return|2|||
155266039|NCT00445679|560407167|FG003|Overall Study|Failed to return|2|||
155266040|NCT00445679|560407164|FG000|Overall Study|Physician Decision|0|||
155266041|NCT00445679|560407165|FG001|Overall Study|Physician Decision|0|||
155266042|NCT00445679|560407166|FG002|Overall Study|Physician Decision|1|||
155266043|NCT00445679|560407167|FG003|Overall Study|Physician Decision|0|||
155266044|NCT00445679|560407164|FG000|Overall Study|Lost to Follow-up|10|||
155266045|NCT00445679|560407165|FG001|Overall Study|Lost to Follow-up|6|||
155266046|NCT00445679|560407166|FG002|Overall Study|Lost to Follow-up|6|||
155266047|NCT00445679|560407167|FG003|Overall Study|Lost to Follow-up|5|||
155266048|NCT00445679|560407164|FG000|Overall Study|Compliance|3|||
155266049|NCT00445679|560407165|FG001|Overall Study|Compliance|2|||
155266050|NCT00445679|560407166|FG002|Overall Study|Compliance|1|||
155266051|NCT00445679|560407167|FG003|Overall Study|Compliance|2|||
155266052|NCT00445679|560407164|FG000|Overall Study|Withdrawal of Informed Consent|0|||
155266053|NCT00445679|560407165|FG001|Overall Study|Withdrawal of Informed Consent|0|||
155266054|NCT00445679|560407166|FG002|Overall Study|Withdrawal of Informed Consent|1|||
155266055|NCT00445679|560407167|FG003|Overall Study|Withdrawal of Informed Consent|0|||
155266056|NCT00445679|560407164|FG000|Overall Study|Protocol Violation|2|||
155266057|NCT00445679|560407165|FG001|Overall Study|Protocol Violation|3|||
155266058|NCT00445679|560407166|FG002|Overall Study|Protocol Violation|3|||
155266059|NCT00445679|560407167|FG003|Overall Study|Protocol Violation|1|||
155266060|NCT00445679|560407164|FG000|Overall Study|Withdrawal by Subject|8|||
155266061|NCT00445679|560407165|FG001|Overall Study|Withdrawal by Subject|14|||
155266062|NCT00445679|560407166|FG002|Overall Study|Withdrawal by Subject|20|||
155266063|NCT00445679|560407167|FG003|Overall Study|Withdrawal by Subject|18|||
155266064|NCT00445679|560407164|FG000|Overall Study|Lack of Efficacy|2|||
155266065|NCT00445679|560407165|FG001|Overall Study|Lack of Efficacy|6|||
155266066|NCT00445679|560407166|FG002|Overall Study|Lack of Efficacy|2|||
155266067|NCT00445679|560407167|FG003|Overall Study|Lack of Efficacy|0|||
155266068|NCT01654601|560407168|FG000|1st Administration|Withdrawal by Subject|2|||
155266069|NCT01654601|560407169|FG001|1st Administration|Withdrawal by Subject|0|||
155266070|NCT01654601|560407168|FG000|1st Administration|Protocol Violation|0|||
155266071|NCT01654601|560407169|FG001|1st Administration|Protocol Violation|2|||
155266072|NCT01654601|560407168|FG000|2nd Administration|Adverse Event|1|||
155266073|NCT01654601|560407169|FG001|2nd Administration|Adverse Event|0|||
155266074|NCT01654601|560407168|FG000|2nd Administration|Protocol Violation|0|||
155266075|NCT01654601|560407169|FG001|2nd Administration|Protocol Violation|1|||
155266076|NCT02636270|560407170|FG000|Overall Study|Adverse Event|1|||
155266077|NCT02636270|560407171|FG001|Overall Study|Adverse Event|0|||
155266078|NCT02636270|560407172|FG002|Overall Study|Adverse Event|0|||
155266079|NCT02636270|560407170|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
155266080|NCT02636270|560407171|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
155266081|NCT02636270|560407172|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
155266082|NCT01833143|560407173|FG000|Overall Study|Not Treated|1|||
155266083|NCT00909428|560407174|FG000|Overall Study|Lost to Follow-up|13|||
155266084|NCT00909428|560407175|FG001|Overall Study|Lost to Follow-up|10|||
155266085|NCT00909428|560407176|FG002|Overall Study|Lost to Follow-up|9|||
155266086|NCT03021668|560407177|FG000|Overall Study|Physician Decision|0|||
155266087|NCT03021668|560407178|FG001|Overall Study|Physician Decision|1|||
